<SEC-DOCUMENT>0001628280-23-003312.txt : 20230213
<SEC-HEADER>0001628280-23-003312.hdr.sgml : 20230213
<ACCEPTANCE-DATETIME>20230213164018
ACCESSION NUMBER:		0001628280-23-003312
CONFORMED SUBMISSION TYPE:	S-1
PUBLIC DOCUMENT COUNT:		247
FILED AS OF DATE:		20230213
DATE AS OF CHANGE:		20230213

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LanzaTech Global, Inc.
		CENTRAL INDEX KEY:			0001843724
		STANDARD INDUSTRIAL CLASSIFICATION:	INDUSTRIAL ORGANIC CHEMICALS [2860]
		IRS NUMBER:				861763050
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-269735
		FILM NUMBER:		23619196

	BUSINESS ADDRESS:	
		STREET 1:		8045 LAMON AVENUE
		STREET 2:		SUITE 400
		CITY:			SKOKIE
		STATE:			IL
		ZIP:			60077
		BUSINESS PHONE:		847-324-2400

	MAIL ADDRESS:	
		STREET 1:		8045 LAMON AVENUE
		STREET 2:		SUITE 400
		CITY:			SKOKIE
		STATE:			IL
		ZIP:			60077

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMCI Acquisition Corp. II
		DATE OF NAME CHANGE:	20210201
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1
<SEQUENCE>1
<FILENAME>amci-20230213.htm
<DESCRIPTION>S-1
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:1f450268-e321-4330-aadf-815e69af2b4b,g:fe19691a-e2ec-4bc1-af0c-c42cfd4d1d7c,d:b82e114cd19f45afae73e7a64e42f208--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:srt="http://fasb.org/srt/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:amci="http://amciacquisitioncorp/20230213" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dei="http://xbrl.sec.gov/dei/2022" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>amci-20230213</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80L2ZyYWc6ZjQ2MWNjY2ZkMjI5NDkzNmE2M2FkODBlYWRlOGRiNjQvdGFibGU6MWFhYTQ3ZTY4ZDgzNDgxYzljNmFkZjI5ZDIzNDIyMzEvdGFibGVyYW5nZToxYWFhNDdlNjhkODM0ODFjOWM2YWRmMjlkMjM0MjIzMV85LTEtMS0xLTkwNjA5_5610a865-3378-4df1-aeaa-21c9597ce5af">0001843724</ix:nonNumeric><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80L2ZyYWc6ZjQ2MWNjY2ZkMjI5NDkzNmE2M2FkODBlYWRlOGRiNjQvdGFibGU6MWFhYTQ3ZTY4ZDgzNDgxYzljNmFkZjI5ZDIzNDIyMzEvdGFibGVyYW5nZToxYWFhNDdlNjhkODM0ODFjOWM2YWRmMjlkMjM0MjIzMV8xMC0xLTEtMS05MDYwOQ_1d12db85-2605-4e4b-892a-0ad6eeb93d1b">false</ix:nonNumeric><ix:nonFraction unitRef="usdPerShare" contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMS0xLTEtMS05MDYwOQ_5bf746c1-aaa4-4b08-9297-6485b401608c">0.0001</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMS0xLTEtMS05MDYwOQ_7ac9922d-8362-40a8-8ddd-1d7ff90fbda0">0.0001</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMi0xLTEtMS05MDYwOQ_3f928196-5601-4957-9767-f0c9336b9944">1,000,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMi0xLTEtMS05MDYwOQ_737bbe4c-6c1e-49c5-b812-933168a7413d">1,000,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMy0xLTEtMS05MDYwOQ_46dfcb50-4974-4f20-9bba-b69b23025dfd">0</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMy0xLTEtMS05MDYwOQ_8b4a3e95-2c9d-4af3-b7b7-d4aba0738a9d">0</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfNC0xLTEtMS05MDYwOQ_af74ce2f-c8b9-4565-bf8b-916d65ce6cb3">0</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930" decimals="INF" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfNC0xLTEtMS05MDYwOQ_f59ad42b-74af-4068-a204-5d5a2120df66">0</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i456af52614a84b9987f0558f3c9d3476_I20220930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfNi0xLTEtMS05MDYwOQ_dd1b8f2d-52f4-462c-a97b-950d28c83e08">0.0001</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i1a8ff7f453974014b00746e89fa737d3_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfNi0xLTEtMS05MDYwOQ_f0456f79-7b72-4e5e-9c45-7a75bf618afb">0.0001</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i1a8ff7f453974014b00746e89fa737d3_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfNy0xLTEtMS05MDYwOQ_0b898de0-1946-474c-905d-01e8a44cd257">280,000,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i456af52614a84b9987f0558f3c9d3476_I20220930" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfNy0xLTEtMS05MDYwOQ_760e0fd9-d3c6-493d-b0f3-b8ce777206be">280,000,000</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i1a8ff7f453974014b00746e89fa737d3_I20211231" decimals="2" name="us-gaap:TemporaryEquityRedemptionPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfOC0xLTEtMS05MDYwOQ_7b2afd9c-6474-4bbd-92ad-4100c98919b8">10.00</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i1a8ff7f453974014b00746e89fa737d3_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfOS0xLTEtMS05MDYwOQ_b50c8c18-3ada-4b6e-9da1-cc5117424d85">15,000,000</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i1a8ff7f453974014b00746e89fa737d3_I20211231" decimals="INF" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMTAtMS0xLTEtOTA2MDk_adcf5318-b2fe-45b8-afd2-45f4cc5fd2d8">0.0001</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i39b3f93aa3714933b05800e10c00a387_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMTItMS0xLTEtOTA2MDk_7c48eaa0-d6d4-4f13-addf-ad61bc631733">0.0001</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i39b3f93aa3714933b05800e10c00a387_I20211231" decimals="2" name="us-gaap:TemporaryEquityRedemptionPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMTMtMS0xLTEtOTA2MDk_12536a8b-418e-4f69-bd7d-4dd02564837a">10.00</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i39b3f93aa3714933b05800e10c00a387_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMTQtMS0xLTEtOTA2MDk_8a921baf-6308-48a3-bfa7-d26611e31826">15,000,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="if090e35b3ace4abc92ca72a48339ebd7_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMTQtMS0xLTEtOTA2MDk_b4ce0a2f-97df-4677-b2bf-979e96866ec6">15,000,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="if090e35b3ace4abc92ca72a48339ebd7_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMTUtMS0xLTEtOTA2MDk_042d3ea0-580d-488a-9395-1fa54054008c">15,000,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i39b3f93aa3714933b05800e10c00a387_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMTUtMS0xLTEtOTA2MDk_52f02588-79ce-4776-91f7-ead26a6932e9">15,000,000</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i39b3f93aa3714933b05800e10c00a387_I20211231" decimals="INF" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMTYtMS0xLTEtOTA2MDk_6b3ed23f-400f-4349-b4e9-40341c4b3b00">0.0001</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="if090e35b3ace4abc92ca72a48339ebd7_I20220930" decimals="INF" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMTYtMS0xLTEtOTA2MDk_e47585c6-90b1-41d6-8758-ddf9ec6b5f3d">0.0001</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i2a9d6acf0a3443b8a9bfd210dcef6a0e_I20220930" decimals="INF" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMTgtMS0xLTEtOTA2MDk_0e410db8-1fd1-4c96-ac20-1472fbfdc88b">0</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ib763267d74d64b8fbe45ac357a9f8f08_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMTgtMS0xLTEtOTA2MDk_449e2287-e7e8-43d2-b635-562ea2c118c9">0</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ib763267d74d64b8fbe45ac357a9f8f08_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMTktMS0xLTEtOTA2MDk_5b32247e-e3aa-4ea7-b157-ddb28854f583">0</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i2a9d6acf0a3443b8a9bfd210dcef6a0e_I20220930" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMTktMS0xLTEtOTA2MDk_651e98b9-ad62-4401-82cf-4f349e421e5b">0</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i28b4565471d542708454f455b422d119_I20220930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMjEtMS0xLTEtOTA2MDk_03024671-7acb-48e7-8530-2747002b10d8">0.0001</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="id57512e5cedd4b74bc2f1786d35220d2_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMjEtMS0xLTEtOTA2MDk_e7638b6d-3a02-40b5-b658-04f16b39ee59">0.0001</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i28b4565471d542708454f455b422d119_I20220930" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMjItMS0xLTEtOTA2MDk_5bc71d9c-3440-4b36-8a23-911112a056aa">20,000,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="id57512e5cedd4b74bc2f1786d35220d2_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMjItMS0xLTEtOTA2MDk_6055f394-b61b-4c69-abd5-6c6f35b0e91e">20,000,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i28b4565471d542708454f455b422d119_I20220930" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMjMtMS0xLTEtOTA2MDk_26a52402-89ee-40fc-a60d-68a3b4b18664">3,750,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="id57512e5cedd4b74bc2f1786d35220d2_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMjMtMS0xLTEtOTA2MDk_542305c0-4aaf-4d68-bbf2-0bf4e3eb6831">3,750,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMjMtMS0xLTEtOTA2MDk_a06542a0-3585-4b1c-ad22-e5c002e16bdf">3,750,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMjMtMS0xLTEtOTA2MDk_a8709564-ceb1-45db-a993-e27f00b639c8">3,750,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i89b183b3eb6542b0870815f5da77659b_D20220101-20220930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yMi9mcmFnOmEzZjUxMTZkM2RlZDRiOTBhZDk2NDdkNjRiMmJhNTkwL3RhYmxlOjNmZmZmOTQxZmFmMTRlN2I5MTUzOGRmYmJjMzQyOGZmL3RhYmxlcmFuZ2U6M2ZmZmY5NDFmYWYxNGU3YjkxNTM4ZGZiYmMzNDI4ZmZfMS0xLTEtMS05MDYwOQ_0ad58a23-9f15-4df4-81dc-4b06c8fb9698">562,500</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ibc418deb7a554f8e82e462f5270ec4fe_D20210917-20210917" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yMi9mcmFnOmEzZjUxMTZkM2RlZDRiOTBhZDk2NDdkNjRiMmJhNTkwL3RhYmxlOjNmZmZmOTQxZmFmMTRlN2I5MTUzOGRmYmJjMzQyOGZmL3RhYmxlcmFuZ2U6M2ZmZmY5NDFmYWYxNGU3YjkxNTM4ZGZiYmMzNDI4ZmZfMS0yLTEtMS05MDYwOQ_61a8732f-6f6c-4819-b169-9f436709f86f">562,500</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i6689ad9df05044c9b7cca157156ac7d3_I20220514" decimals="INF" name="amci:NumberOfSharesSurrendered" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yMi9mcmFnOmEzZjUxMTZkM2RlZDRiOTBhZDk2NDdkNjRiMmJhNTkwL3RhYmxlOjNmZmZmOTQxZmFmMTRlN2I5MTUzOGRmYmJjMzQyOGZmL3RhYmxlcmFuZ2U6M2ZmZmY5NDFmYWYxNGU3YjkxNTM4ZGZiYmMzNDI4ZmZfMi0yLTEtMS05MDYwOQ_cc6a84a6-64c2-4489-8397-5674f88dbd8b">718,750</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i6689ad9df05044c9b7cca157156ac7d3_I20220514" decimals="INF" name="amci:AggregateNumberOfSharesOwned" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yMi9mcmFnOmEzZjUxMTZkM2RlZDRiOTBhZDk2NDdkNjRiMmJhNTkwL3RhYmxlOjNmZmZmOTQxZmFmMTRlN2I5MTUzOGRmYmJjMzQyOGZmL3RhYmxlcmFuZ2U6M2ZmZmY5NDFmYWYxNGU3YjkxNTM4ZGZiYmMzNDI4ZmZfMy0yLTEtMS05MDYwOQ_045dc3fb-a3f1-42b7-9361-33f01fd30f46">4,312,500</ix:nonFraction><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="amci:RedemptionPeriodUponClosure" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfOTM5MA_6b8b7a9b-cdb9-4964-a6c2-9088a7366feb">P10D</ix:nonNumeric><ix:nonFraction unitRef="shares" contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806" decimals="INF" name="amci:NumberOfWarrantsIssuedPerUnit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNC9mcmFnOjU4ZDAzNDU0NDIyNjQ5MThiNDc3ZDdjNGM0ZDEwNWI1L3RhYmxlOjA0MDEzZTI2ZjA3NjQxMjdiMDdkN2VmZGEzNGI2YjAzL3RhYmxlcmFuZ2U6MDQwMTNlMjZmMDc2NDEyN2IwN2Q3ZWZkYTM0YjZiMDNfMS0xLTEtMS05MDYwOQ_bc40759b-c589-446b-9b3d-17ac2fc3deb4">0.5</ix:nonFraction><ix:nonNumeric contextRef="i451ff43e2c50495caaa75e2af24f295d_I20220930" name="us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82MS9mcmFnOjUzYTM0YTYwYzQ0ZjQyMDM4ZDNhMTE1YjViYTZjNmMxL3RhYmxlOmJlZGVmM2NiNTA1NDQ5Y2FiMGRjMWQwY2FjY2YwMGIxL3RhYmxlcmFuZ2U6YmVkZWYzY2I1MDU0NDljYWIwZGMxZDBjYWNjZjAwYjFfMS0xLTEtMS05MDYwOQ_119936ac-bf98-4ded-a8d2-841dfb62f668">http://fasb.org/us-gaap/2022#SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares</ix:nonNumeric><ix:nonNumeric contextRef="i98b54305564e42f9abfa073cb3e4947b_I20211231" name="us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82MS9mcmFnOjUzYTM0YTYwYzQ0ZjQyMDM4ZDNhMTE1YjViYTZjNmMxL3RhYmxlOmJlZGVmM2NiNTA1NDQ5Y2FiMGRjMWQwY2FjY2YwMGIxL3RhYmxlcmFuZ2U6YmVkZWYzY2I1MDU0NDljYWIwZGMxZDBjYWNjZjAwYjFfMS0yLTEtMS05MDYwOQ_d85e28b5-0b12-40cc-8eff-9b3082c71ab6">http://fasb.org/us-gaap/2022#SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares</ix:nonNumeric><ix:nonNumeric contextRef="i974a103ab76f4dfebf71b623a294979d_D20220401-20220630" name="us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82MS9mcmFnOjUzYTM0YTYwYzQ0ZjQyMDM4ZDNhMTE1YjViYTZjNmMxL3RhYmxlOjMyYzAyNWQ0OWY0ODQ5NDc5ZWZlMmVkNzUzY2M5YjU1L3RhYmxlcmFuZ2U6MzJjMDI1ZDQ5ZjQ4NDk0NzllZmUyZWQ3NTNjYzliNTVfMS0xLTEtMS05MDYwOQ_82136c93-a7db-40b5-8c08-e3bba8f12ac8">http://fasb.org/us-gaap/2022#FairValueAdjustmentOfWarrants</ix:nonNumeric><ix:nonNumeric contextRef="if1bafc618d6f473f9a793bbc10bcd6dc_D20220101-20220331" name="us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82MS9mcmFnOjUzYTM0YTYwYzQ0ZjQyMDM4ZDNhMTE1YjViYTZjNmMxL3RhYmxlOjMyYzAyNWQ0OWY0ODQ5NDc5ZWZlMmVkNzUzY2M5YjU1L3RhYmxlcmFuZ2U6MzJjMDI1ZDQ5ZjQ4NDk0NzllZmUyZWQ3NTNjYzliNTVfMS0yLTEtMS05MDYwOQ_1d98c9ba-e0a7-4a86-bfca-9fdd5af572fa">http://fasb.org/us-gaap/2022#FairValueAdjustmentOfWarrants</ix:nonNumeric><ix:nonFraction unitRef="usdPerShare" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMS0xLTEtMS05MDYwOQ_e84e1b26-c326-4c65-bccf-d7eb2db1ae4a">0.0001</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMi0xLTEtMS05MDYwOQ_4f2d7613-29f3-495a-81f5-183d9aab08d0">1,000,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMy0xLTEtMS05MDYwOQ_d121b401-bce9-4b62-971f-17557f794464">0</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfNC0xLTEtMS05MDYwOQ_2d74d0c9-88fd-463b-a2b8-cfc6c7f3498b">0</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231" decimals="INF" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfNi0xLTEtMS05MDYwOQ_9e404f70-d6fc-40f6-9741-4676c7ed32f3">0.0001</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfNy0xLTEtMS05MDYwOQ_4d5bf236-0580-4aaa-bb3e-3f1ffb0afcd0">15,000,000</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231" decimals="2" name="us-gaap:TemporaryEquityRedemptionPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfOC0xLTEtMS05MDYwOQ_8951dea4-1f80-4194-9f52-be692cc83764">10.00</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfOS0xLTEtMS05MDYwOQ_b97fe59b-35a5-475b-a54a-5a5fa723d11a">0.0001</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMTAtMS0xLTEtOTA2MDk_947997dd-68cd-482d-b123-40cc4817b070">280,000,000</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i0a43243fe73e4e0982e02d8804f9029b_I20211231" decimals="INF" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMTItMS0xLTEtOTA2MDk_7c7d4086-ff8a-4277-967e-4a8ecccb7c67">0.0001</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i0a43243fe73e4e0982e02d8804f9029b_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMTMtMS0xLTEtOTA2MDk_4b0816d9-ad15-41c1-a635-5ff534a3447b">15,000,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i0a43243fe73e4e0982e02d8804f9029b_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMTQtMS0xLTEtOTA2MDk_0d6f18de-c4ca-418d-9b10-0570fa6d3701">15,000,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i525804f64fa24dab94c10a95e9c90289_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMTQtMS0xLTEtOTA2MDk_409870fa-6199-463f-beb4-a1b47313aa44">15,000,000</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i0a43243fe73e4e0982e02d8804f9029b_I20211231" decimals="2" name="us-gaap:TemporaryEquityRedemptionPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMTUtMS0xLTEtOTA2MDk_088a194c-1b3d-4d8d-b1a6-85936ced9ea7">10.00</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i0a43243fe73e4e0982e02d8804f9029b_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMTYtMS0xLTEtOTA2MDk_93519ddc-8ad2-4c4c-9835-38cfbc88bb13">0.0001</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i64c9dd51c7c74824810ac9d20592fd6b_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMTgtMS0xLTEtOTA2MDk_70fe34cb-8035-4038-ad7f-3d9d2ec75aae">0</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i64c9dd51c7c74824810ac9d20592fd6b_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMTktMS0xLTEtOTA2MDk_caea643c-5235-4385-857a-d2cbc66c090b">0</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i246d06060759490897b705c5ed7fc8f0_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMjEtMS0xLTEtOTA2MDk_d4e4e546-6920-43ed-890a-7639061f1cd1">0.0001</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i246d06060759490897b705c5ed7fc8f0_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMjItMS0xLTEtOTA2MDk_4973ba9a-271c-4ed0-85c7-582070e380f2">20,000,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i246d06060759490897b705c5ed7fc8f0_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMjMtMS0xLTEtOTA2MDk_335efc86-cb04-476a-b2f3-f4afe3bfe186">3,750,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i291fade0df2b465aa82cd6d5ea3294af_I20220930" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMjQtMS0xLTEtOTA2MDk_3539ca90-0c4e-431d-870d-a9ca278a607f">3,750,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i246d06060759490897b705c5ed7fc8f0_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMjQtMS0xLTEtOTA2MDk_4d3af28d-9737-4ec2-9c3d-79eb73ec2237">3,750,000</ix:nonFraction><ix:nonNumeric contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231" name="amci:RedemptionPeriodUponClosure" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfOTMzMA_80eea167-68dd-4f47-a97c-0adf8eb467f8">P10D</ix:nonNumeric><ix:nonFraction unitRef="shares" contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806" decimals="INF" name="amci:NumberOfWarrantsIssuedPerUnit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85NC9mcmFnOmJkYTI3OGY5MDQ0MDRhYjRiMGM3OGQzMDY3MGM0YTJiL3RhYmxlOjJmZGI4NWRjMjdjMTRiODRhNDc4Njc4MTI4OGU3ZmM4L3RhYmxlcmFuZ2U6MmZkYjg1ZGMyN2MxNGI4NGE0Nzg2NzgxMjg4ZTdmYzhfMS0xLTEtMS05MDYwOQ_937f0c40-aa52-43ea-9ad7-f705cc193d62">0.50</ix:nonFraction><ix:nonNumeric contextRef="i98b54305564e42f9abfa073cb3e4947b_I20211231" name="us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjEvZnJhZzo5YmUwNGU3MmU1NWE0MTU1ODRkNzBjYjQyZDBiOTk1MS90YWJsZToyMjZkNDY4ODk1NDg0Nzg3OWIwOWJkNWRlMjk2OWViNS90YWJsZXJhbmdlOjIyNmQ0Njg4OTU0ODQ3ODc5YjA5YmQ1ZGUyOTY5ZWI1XzEtMS0xLTEtOTA2MDk_28197a07-64ce-40a2-ba82-1434c5c3b4b8">http://fasb.org/us-gaap/2022#SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares</ix:nonNumeric><ix:nonNumeric contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231" name="us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjEvZnJhZzo5YmUwNGU3MmU1NWE0MTU1ODRkNzBjYjQyZDBiOTk1MS90YWJsZTo4Y2M1ZDc0OGRmY2Q0NzlhOTUyYTEzODI3NWZiZjkwOC90YWJsZXJhbmdlOjhjYzVkNzQ4ZGZjZDQ3OWE5NTJhMTM4Mjc1ZmJmOTA4XzItMS0xLTEtOTA2MDk_c186d0df-d278-4109-bc8f-f2fe4c8c94ec">http://fasb.org/us-gaap/2022#FairValueAdjustmentOfWarrants</ix:nonNumeric><ix:nonNumeric contextRef="i6e7545b455184e6c8f1133a56f5e689c_D20220101-20220930" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzEyNjQ0MzgzNzI0Mzkx_1f5323c0-bbe0-45e6-bfd6-3ba4780f1116">P2Y</ix:nonNumeric><ix:nonFraction unitRef="usdPerShare" contextRef="i1dfc06d3caf74e879b017b7ba4bccc6c_I20220930" decimals="INF" name="amci:TemporaryEquityIssuePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMzU5L2ZyYWc6MmNkMjU2Mjk3N2NhNDVmNWE1YjBmZGRiODFlODhmZmMvdGV4dHJlZ2lvbjoyY2QyNTYyOTc3Y2E0NWY1YTViMGZkZGI4MWU4OGZmY181NDk3NTU4MTM5MjU_8c325cde-957c-43bc-a33f-3e7c1be91fc8">1.75</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i9b90ee4e94cb439f99b65328a21b6c23_I20220930" decimals="INF" name="amci:TemporaryEquityIssuePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMzU5L2ZyYWc6MmNkMjU2Mjk3N2NhNDVmNWE1YjBmZGRiODFlODhmZmMvdGV4dHJlZ2lvbjoyY2QyNTYyOTc3Y2E0NWY1YTViMGZkZGI4MWU4OGZmY181NDk3NTU4MTM5MzI_18840379-ed0b-4a02-8cf7-ad4d4e4cb5ea">3.94</ix:nonFraction><ix:nonNumeric contextRef="i51da7734998e408b9fefa2e716945170_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTA0_78de1c22-d3ad-43ae-a899-19a74e1b2357">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="i05590867d0ee4d609cfc35f801b2bfb0_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk3OTk5_761df305-309f-4903-a23c-ce62ac3f485c">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="i7ec6ce83073a4b3dbe1336fd4cb6ec9a_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEwOTk1MTE2Mjg0Mzgw_848b9b44-6118-41f1-9447-548b3ddf83fb">P2Y</ix:nonNumeric><ix:nonFraction unitRef="usdPerShare" contextRef="i8a9c59f1273542b8ab3e8255d224f529_I20211231" decimals="INF" name="amci:TemporaryEquityIssuePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMzUwL2ZyYWc6ZTY1ZmEzZGFlMzVmNDQ5MThmZjE5YjJlYjZjNzBkZmMvdGV4dHJlZ2lvbjplNjVmYTNkYWUzNWY0NDkxOGZmMTliMmViNmM3MGRmY181NDk3NTU4MTQwODg_a18cc782-38b5-48b8-81e7-0ce4e087259e">1.75</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i1b658f2ff91349b3beaa5d4bd56ba109_I20211231" decimals="INF" name="amci:TemporaryEquityIssuePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMzUwL2ZyYWc6ZTY1ZmEzZGFlMzVmNDQ5MThmZjE5YjJlYjZjNzBkZmMvdGV4dHJlZ2lvbjplNjVmYTNkYWUzNWY0NDkxOGZmMTliMmViNmM3MGRmY181NDk3NTU4MTQwOTk_e53f1854-8446-4f0f-9aaa-00a1d60c9cc4">3.94</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="icbd1a0745c954062aab7bb0d81157304_I20201231" decimals="INF" name="amci:TemporaryEquityIssuePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMzUwL2ZyYWc6ZTY1ZmEzZGFlMzVmNDQ5MThmZjE5YjJlYjZjNzBkZmMvdGV4dHJlZ2lvbjplNjVmYTNkYWUzNWY0NDkxOGZmMTliMmViNmM3MGRmY181NDk3NTU4MTQxMTE_ecd1a6fe-0a1d-4bc1-addc-b3100fc0276d">1.75</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="ice5b7039b91e4ef49110749cb0d4f41b_I20201231" decimals="INF" name="amci:TemporaryEquityIssuePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMzUwL2ZyYWc6ZTY1ZmEzZGFlMzVmNDQ5MThmZjE5YjJlYjZjNzBkZmMvdGV4dHJlZ2lvbjplNjVmYTNkYWUzNWY0NDkxOGZmMTliMmViNmM3MGRmY181NDk3NTU4MTQxMDU_dfa80275-6209-4617-b37a-91174371c608">3.94</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="amci-20230213.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idae72aba29fc40268c267b6f3b0eff28_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if090e35b3ace4abc92ca72a48339ebd7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amci:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39b3f93aa3714933b05800e10c00a387_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amci:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a9d6acf0a3443b8a9bfd210dcef6a0e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amci:CommonClassaNotSubjectToRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib763267d74d64b8fbe45ac357a9f8f08_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amci:CommonClassaNotSubjectToRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28b4565471d542708454f455b422d119_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id57512e5cedd4b74bc2f1786d35220d2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i456af52614a84b9987f0558f3c9d3476_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a8ff7f453974014b00746e89fa737d3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80972ef154634fbfa900d162f556ef03_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ec1172d9fda413997c83cfd78da69a8_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6e8e0bf44ba47628681fa0a2b0c4d8e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54e04e92a2f745c79145378982854e9d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia80b8151be5a4bbda59a9bd0f4d2f0d4_D20210128-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c83b432fed543cdbb0ae452750d8666_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0792dc9052f4435aec8f1746381b495_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie106d118b90b4570a0b940a2a0611875_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14e0883a4b7e4c05850198fa191fd751_D20210128-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i561b8e9c306343cbaa06d16947928777_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0df54c9e466f4cee877df6ba1a2a8b5c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d10e6b77d0f437bb89153397dd47b71_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i331e64d7b36f44f3a66c631e0f8eeddb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccfd9da1f9504cf29912dc80db305fc8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7947124f41844b0939436b1a8f133ad_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d0aee75172442178da88056a9989307_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida7b05626e374502819328077c492d48_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie90832410d85447aa964ca438ac09c5f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c3171eddba54a6b8c58c3219dea0549_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c13bbdaf19b4cd897fbbb738aa40bdb_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf261b46a23c49b4a762205835c271ab_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85ee8ec1448f491faaa8d5f1b8a40824_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34104a0f3a774be48e18d60b95cb9e34_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie631ef4e3c7041e688921b3859fca7f5_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d521767d60745fd9681006b5cd0f52f_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bb75187403d4c7096a2ecce94a1cfe2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic24c8091c8be4348b39159f1dd9591dc_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54638a76c0754184ad34989edb55bad0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc67725111024800a8fe8de4f7e18d06_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0513771cd0245b88eec6099822e8d74_I20210127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i763e0a3dbecb4e3795d7f408cf8a20d5_I20210127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec832394a7514357811e3f793e5b673f_I20210127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc4dbb45fe26489b9bca7b77497e7ca7_I20210127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib90981c31c9b45a98ded9929aeaa406e_I20210127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacb1cd84cde241edbd72d0fcbd87e137_D20210128-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68b075b25b0c44f6a65dc37835ddacab_D20210128-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60a5cae9cdab4813bb1586b3eb4d1453_D20210128-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic78d5d5e9dab4e66927c72ef3a01cffb_D20210128-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia238c2a996b14c81929dd59e484951e5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f0fcd477eed4404a2b0dc7ab62aec98_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79b3bc37e87346618fe34e2a23526ca7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44e48778017342f3ab0160bb5770cda2_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97e926931d264729ab7aaa14e1843a88_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie687fdc1ee234a2686233327949a762b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8155dd44f1cf44b6963742cb3e993f91_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3756d2ccfa146a8b4a56cd8bc84e1d6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1634b21bc004766bd5719101e1d1b9a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cd57aeb02fe49d7ab3297670b39a5ec_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5e9fb5e65ac48fcaf2c511cdde6838a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bd791fd96c546dbb9c9ea8bb1d75555_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i872f016ca939404ab1d0fbc4771bc03a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bef5324e72a48db9ebecc0f92eacda1_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ef0abc6bb5e4c13a1e3275c01c2d9be_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54a9911fbd55474198f366931f8bbeda_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c5914aab6b6409fa89292f8b33f2d63_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cfc7a3d369645768bf19279957b83f3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if96f4a11922442b08faec4138ba298eb_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89b183b3eb6542b0870815f5da77659b_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc418deb7a554f8e82e462f5270ec4fe_D20210917-20210917"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-17</xbrli:startDate><xbrli:endDate>2021-09-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6689ad9df05044c9b7cca157156ac7d3_I20220514"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="item"><xbrli:measure>amci:item</xbrli:measure></xbrli:unit><xbrli:context id="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-06</xbrli:startDate><xbrli:endDate>2021-08-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie730d94e9acc40f48d227ce51539c50b_I20210806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba67ebbc3e2147e2a5a1f7dbbeab0ccd_I20210806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PrivatePlacementWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98ebad46078d44259754e031d9c5bd6d_D20210806-20210806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PrivatePlacementWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-06</xbrli:startDate><xbrli:endDate>2021-08-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60c2802479f2421e81d073c740ec38f5_D20210806-20210806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-06</xbrli:startDate><xbrli:endDate>2021-08-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43e0774f1b034661961530c2cf95f99f_D20220308-20220308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amci:LanzatechGlobalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-08</xbrli:startDate><xbrli:endDate>2022-03-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f2a2868033e4660a17c0f7ba45d4aad_I20220308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amci:LanzatechGlobalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib38307702eee44f3b72af83f31e3cf7d_I20220308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amci:LanzatechGlobalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8883929afdf94d6986448173f1858e61_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:SponsorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf1a938c139d435097214ed3b23c295f_I20210806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cdb37bb224f48e29779bad54f3033b8_D20220328-20220328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:SponsorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-28</xbrli:startDate><xbrli:endDate>2022-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67af9d98434f4635b3c35ea4fd55d5c2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:WorkingCapitalLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5afd526069b8462e9de75a0d249417cf_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:WorkingCapitalLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i450b257d15c4448cabb4fa176b9c5882_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b4c8d7ac58e4e2586992b9fe74034be_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amci:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i759728e90602443f941d8e14893c6860_D20210128-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i950a5ff168a044a0ba3702bafec5a66a_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4878d88c1b144a42922da4d1a6220176_D20210201-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id018cdbc6e7243f8a9576d62630018fd_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70621bbf47964eb1927c544e539a3b0c_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id42184778b03400da7d8ae8bccfeca9b_D20210128-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia10b0438b73b4dd5bf7658eb1d2482c7_D20210201-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8294868a1493467a83fbece546a36f63_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99c308a1e70a4da386ff5a6632f478d0_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42d79bd723cf48078269f4e2acf3b597_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7e0d5966ac7479ebfa164e10daa1272_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7d75b9f8f1c40e39fde71392a72ee04_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40a66b571894495b9172904623c3020a_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17dcd8e30cd643c885ad894b1240e01c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8be3aafc5054f04afe2e590fba42def_D20210128-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fb60d41143f4f3d991562590f0fe6af_D20210128-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id44a938156574d23a69f5f980c896774_I20210806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9caa935ece004b9ab6c6caa6377836b9_D20210803-20210803"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-03</xbrli:startDate><xbrli:endDate>2021-08-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d95a7ae67054cae98cfee5d7bdc74d0_D20210917-20210917"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-17</xbrli:startDate><xbrli:endDate>2021-09-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d5d9aae93c24a62a9caf5acab5abecc_D20210129-20210129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:FounderSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-29</xbrli:startDate><xbrli:endDate>2021-01-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2ebc1a8b07f4d3391509c2584f8f003_I20210129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:FounderSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08b6b03fda3a43f2bcbde1101ee39ff8_D20210129-20210129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:FounderSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-29</xbrli:startDate><xbrli:endDate>2021-01-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74ee1ef3f5f34200a3a86559aefbe48d_I20210129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:FounderSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ba6d4f2129048179fa2e9c2275582f2_I20210514"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:FounderSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea24dbc94fdc4dc58f170b69b6c3e2de_D20210514-20210514"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:FounderSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-14</xbrli:startDate><xbrli:endDate>2021-05-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife30827df02148faa72d404a20bb4270_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:FounderSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e2866880e0e48c8bbbc428a81262e75_I20210917"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:FounderSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib652946365cc4c8c967e8a2df8bcdc17_D20210129-20210129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:AnchorInvestorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:FounderSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-29</xbrli:startDate><xbrli:endDate>2021-01-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2674980052ce4cc69be120b4e40c0013_I20210129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:AnchorInvestorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:FounderSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f5a155717274afab3d521dfbf34a269_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:FounderSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="d"><xbrli:measure>amci:D</xbrli:measure></xbrli:unit><xbrli:context id="i75f3392af70e4d85aac3d65a530d4294_I20210129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartyLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4acc15b7c694e09ba13c24b2db16e14_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:WorkingCapitalLoansWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90361d85f46242c1b15c6d1084c691cc_D20220328-20220328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:WorkingCapitalLoansWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-28</xbrli:startDate><xbrli:endDate>2022-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86b1870170ac4b14af116725cbaa1dfb_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:AdministrativeSupportAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4fffab42a2f49dd80ac77b6fa45c8a1_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:AdministrativeSupportAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3924e9e376c84b7a875190639f24cc1f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:AdministrativeSupportAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida667f998b1d43e1b6a919463e190674_D20210128-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:AdministrativeSupportAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52caac5a377e45b8b201f83962c02a8e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:AdministrativeSupportAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcd72b5b1194408cba4cb6838372ac02_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:AdministrativeSupportAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d2f9128cbf246cd945ae4ac218c0a51_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:AdministrativeSupportAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i383980889531482c9add5e621b85e027_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d8e8fd5c9a54f1994bb8cd3e7be4dfb_I20210917"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff3bcef644df441dabded615618c965f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:EvercoreGroupL.l.c.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65896feef8e64216b26c18f33b966b64_D20220929-20220929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">amci:CoplacementAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:EvercoreGroupL.l.c.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-29</xbrli:startDate><xbrli:endDate>2022-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib81de9f71a844a21bb8c1a0d4ae5b6ab_D20220929-20220929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">amci:FinancialAdvisoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:EvercoreGroupL.l.c.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-29</xbrli:startDate><xbrli:endDate>2022-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if178c64ffcb14c83b95a35515433f700_D20220929-20220929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">amci:DeferredUnderwritingFeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:EvercoreGroupL.l.c.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-29</xbrli:startDate><xbrli:endDate>2022-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie50e9e7d91b842cf814d5cfc02ae90f3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="vote"><xbrli:measure>amci:vote</xbrli:measure></xbrli:unit><xbrli:context id="i525804f64fa24dab94c10a95e9c90289_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amci:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a43243fe73e4e0982e02d8804f9029b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amci:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c002aa5301d41eea4dcb66a8e84489d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amci:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55de68debcc94bafbd57bd3a38c3cfbd_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amci:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i246d06060759490897b705c5ed7fc8f0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i291fade0df2b465aa82cd6d5ea3294af_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9b91be3831b484da13cf601329f6dbe_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i451ff43e2c50495caaa75e2af24f295d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PublicWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98b54305564e42f9abfa073cb3e4947b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PublicWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i850b9630ce17489eb80c21a6da12ee2f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PrivatePlacementWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c30db48f9bb482b9cb45b5c2227dd57_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PrivatePlacementWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1836ec53dd484e9b9bf84ece3ddced78_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PublicWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie30c1da2c5304363b3b61cf5bb114865_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PublicWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="amci:WarrantConditionAxis">amci:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5a60bdcc4a4477db94a694066392510_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PublicWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="amci:WarrantConditionAxis">amci:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2e834c4b7e54fd3806cd19f77045daa_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PublicWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa1f55ccc0e14b588cf21c809f2ea5b3_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PublicWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if81ad5ca3f944114a295b408d90c868d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc3169776a3543fb889330eb5abfe41d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PublicWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i417fef00be594681ab5912d70872db7e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PrivatePlacementWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i946a08fcd3a04e65862611981f20e270_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i818e11a86037425d8b4e148caf3f101c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PublicWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if33c5b343220431f8fa1664c765aaf71_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PrivatePlacementWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9894e2c3dc734f0b880e510f21ccd046_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5b0bb5d02764693b9a25febf0a6032b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2be463ef022149f1913c72172ac44e78_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9712786e3d6e4293bfa543a7f4306d3d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i179691d9e1bf479b916db187d97d10bc_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10a81d94cb444487a1305e090e7ac9f0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibda8175b82524bcc9e6f7f7496388515_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="y"><xbrli:measure>amci:Y</xbrli:measure></xbrli:unit><xbrli:context id="i0b029e7f84ba49809517714b945d453d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib01d619804214c1ba4cf7f01250d2ac3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b3852e6684e45c08ebac5f6a1cb253d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa37f22ae2644299a4ab468acaa968cd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f13d0d3a95c4cdaa0dc91deeb0264b3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i402c8e15d0b54a389ec05f6fe78c92c5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ff6463cfe5f4c1b946bb36d0cac2871_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if29e2998f81b49e2b4637ccd72f330be_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfba6a12780447a3b8b33ecd046d9a4b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if64ccb69704247c689ad8abffde913e9_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i974a103ab76f4dfebf71b623a294979d_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1bafc618d6f473f9a793bbc10bcd6dc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i902dff4aa68147929f6d78320ff652e0_D20221018-20221018"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">amci:October2022SubscriptionAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-18</xbrli:startDate><xbrli:endDate>2022-10-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i697f9a8b07d74a73b684f9ec2bc17566_I20221018"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">amci:October2022SubscriptionAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64c9dd51c7c74824810ac9d20592fd6b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amci:CommonClassaNotSubjectToRedemptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5052ad254932443fa86d172a353e56b2_D20210128-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib213ebc10b6a466a909031c9bd976e11_D20210128-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfc521f27ebb491f8864b3a6e6a87d0b_D20210128-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i471e72d2c86b4efaaf8080c12ecaa577_D20210128-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd535064e945451eb2cc6d863ed461a9_D20210128-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0abd6277c4d4571a894945f36707ca5_D20210128-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:SponsorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia93b17d361a84b54b833904249951429_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib178386587034322a4ea05a95f29a04c_D20210128-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i717f3c096f124e38aff5fad8440a91a2_D20210128-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa0df75fa4824897be8997ed124b9bdc_D20210128-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfb1e8d076954c04a1dbf3023d0849d7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:FounderSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia65ba84b6b954a5385d3241cfcb6736d_I20210917"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7e91bd1f75d4961a01179e9753dc8da_D20210128-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:FounderSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic448f6ee37eb44f9ac584c6527e1d94e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:WorkingCapitalLoansWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie077d272226547f6a11f29862ca333d6_D20210128-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:AdministrativeSupportAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c60188ae1f64a00af376413ca3e4b68_D20210128-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefc421e312514841a1adc71514c3bb9a_D20210128-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77e83a23de6644e3be03c1d9c1e36370_D20210128-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PublicWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cb1ba206598437fb974dd69c2b87e0f_D20210128-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PublicWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="amci:WarrantConditionAxis">amci:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if77b5c86cfcc4c03a7007e9a9266feb2_D20210128-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PublicWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="amci:WarrantConditionAxis">amci:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i182c81dada5746a896432e0206ca7183_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PublicWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87ed9aa6359e4e9da28c6fd65b021373_D20210128-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PublicWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11685a5fe8fb4e7580ffa0ca743f0062_I20210806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64bb7db0f547412db51fb298ab7f1eb1_I20210806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib14d34f779324c98acee7371373d9927_I20210806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie04573b29e10454392fcd1c7a4d28cb2_I20210806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i531831f23f064c698db5bd956d8f7662_I20210806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i832a10c8d035443c86f96cddb14c1741_D20210128-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1031eb2976d644cfbbf5cce499b8af89_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6a395c8f57c4345b9c5c1927223b563_I20220308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amci:LanzatechGlobalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b9add4019654e2d87f0e463effed72f_I20220308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amci:LanzatechGlobalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fa285a120cf4338a950b439d1496dd7_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb733d9b6c67432ab5a278cc8f9ae7e7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic032ce31175f4c45b33f9642339eab9b_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="amci:RelatedAndNonrelatedPartyStatusAxis">amci:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6752cd0319b04183b8e6481ee3e75964_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="amci:RelatedAndNonrelatedPartyStatusAxis">amci:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia996051c39e14c1c956460fb2675ae34_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34364739f4c64be69f7a57e53ecbd751_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78e21c830827492786035892daf32e0d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20c42717ddd94c808b501ab8475516e6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0898c763893444f8318ba806e5872af_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6fb523d0475453fbb376be661a6c994_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1f4bcf8b20140f296bf2a34009e0064_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98880ce312ba4017b552dd89dc664bb1_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0a0ddb6c93245558effec1f57e566ba_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13b3497fdd1e496ba1fa077592599faf_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38e737447613466db8a474885460ec95_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i758897248ac340d7bb20c3abbe6a9817_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id15fe476907046a7b6b9b51738bf5917_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4e845950e88489fa5590b0035aa2dea_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d49e0cbdb6445f7b88d97d435a55770_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c18fa0bbec84bdcb7e52c35f80ede0a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18eedd573381425c8c989e260801dafe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e70eaff18414dc4b12fb6d52ddce0d0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86b1d28db14d4ccea94e00a84975ab9a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dfcd7c6d97d4ad18dc9629f6bf4066c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a0614f9ac2b45cca8e106cb399680b8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55f893214d234b679544f44bd054f770_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib72b5d999a244a2ca01c9b4f197493e7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7959fab1f2c4a659a441b16211f26c0_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4980eb4213814e27a8b8df2fb28468ac_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63802ab78f814062927f14d9e2bb6b67_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76d10658df3b4e6bad3f7a990812f829_D20220308-20220308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-08</xbrli:startDate><xbrli:endDate>2022-03-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e4ce82bb6ca465b8f60e74f553154c0_I20220308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia00417eab54343e78db23ff7c39f19cc_I20221207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>amci:segment</xbrli:measure></xbrli:unit><xbrli:context id="i9e0585e1e90d4bfcaf7ee5c271d12b05_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c9ab1e0b29947a7a657a947fe20cbe7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d1fe9a7bf25419cb084a70d94fcaf1d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2e8db82a9c84e61945251a17b875f00_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3449ace90ec469a8b933bce0d62a372_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i315f432e066e42e392096344bb252b66_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67acca9fc71147e489123a8f993fe8b2_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12519dc7dd4148c380c0b8e7e6b17007_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47d9518ef3cd492aa38b19f292383c71_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65b51113d1c84fe482ce3387414ff062_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d26440e551243a091345a8db5c10bd8_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89150b1561bc43ecbec2f1adb044c3f0_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia54c798db359416fb9d69e6545adde53_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f5fbd11e5eb48dba2314084aadf7c9f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5424171a95fe47638686ad26cd8b4504_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26fc510abd7a4c3b8c924af0c3ded993_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ae7957cd9f6426986d2a7924166bbe8_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5741c6b90ae94985b512b131a7c7a8f1_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0abb7a85949a40588f25eea015f597df_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ce64b99bdea417c846661dbfe732b7e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafde522813d645e4811e7040d7545b79_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9418ed0ad4f411e9f9d5e0c27663f80_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i762c119593394e9dab80370e5fe11b8f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:JointDevelopmentAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c521e9c446743728abb9bb381113c58_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:JointDevelopmentAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7cfe038e19c5406ab72b862c3e2c4a7c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:OtherContractResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib55995d927ac49f2b032b95862ccebc3_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:OtherContractResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifffd25e8f7474755a9cbbfa56a92b938_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:ResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1cd36f9560344a4a3455d63ec431e88_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:ResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44a9fd092f5b4aaaa519e060a4d1a0bb_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2ce93d60685463eacfcc8cdabd7567c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a377b78b6e24777830917170e5b1313_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:CarbonSmartMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8409be642f8c496ca120218eb6fbf890_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:CarbonSmartMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdff94687942421eaaf5757d75c7f1c2_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:EngineeringAndOtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2013e6baeeb243468ee04296b2f2e7b8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:EngineeringAndOtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1a1013d2add4d6090c80d57a0f917aa_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:CarbonCaptureAndTransformationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i266d893e21e44dd69a6f838fef0c5262_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:CarbonCaptureAndTransformationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5573ff2e43a4c498f3126b9f6dfd70f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8145859fe60a449a937d2ca309df194f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b913fb20765432a923bd689fe670302_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdb81a8598ac482d9b8beedc98026777_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i782abe270873419eb029c509a796cfe0_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if05bbbf98c144ad8aa72922f1d64e7e2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48ba258d15f74288bf5398c05269bbf6_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e768c2b952146e1955ab2593a5abd0b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i285bf14114324cc3b2c392b9b984d16e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:LanzaJetIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie926aa19bc694f0586f296dab820baf8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3508735d501341a2badcc0f6a6be0770_D20200513-20200513"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:LanzaJetIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-13</xbrli:startDate><xbrli:endDate>2020-05-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabbdb50d80c247b39bf74f30bb6e2aa1_I20200513"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:LanzaJetIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfcdf3126a1c413992b29dabc55a78ee_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:LanzaJetIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6b123fcece94433b4a72c6716d59ddf_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:LanzaJetIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifaeb71870a2f4f65bef7abad49932d71_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:LanzaJetIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic197136819df4f3d91e14be688674014_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:LanzaJetIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7c2c8dee6434965a0e89d9311bf370e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:LanzaJetIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65fec460822f43acb02e40736b3b8a79_D20210201-20210404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="invesstment_round"><xbrli:measure>amci:invesstment_round</xbrli:measure></xbrli:unit><xbrli:context id="i0953d2d09b0e4116b4f9972716c60d69_I20210404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:LanzaJetIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f16003c0fce46c997e3bcde7fa19188_D20210201-20210404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:LanzaJetIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f76a4903dee46c7a36a3359dafca0c1_D20110928-20110928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2011-09-28</xbrli:startDate><xbrli:endDate>2011-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="cny"><xbrli:measure>iso4217:CNY</xbrli:measure></xbrli:unit><xbrli:context id="ibea6cef92fd440f0849af4b7e43ac9d0_I20110928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2011-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia16a7b02d1334a8c8712b104eafb3d0e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic62d084cb3144cc2a7041bace85abb24_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c67702cd8234f33a60771751ce65fbe_D20220429-20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-29</xbrli:startDate><xbrli:endDate>2022-04-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa61d655eb524064963927b0d13c1a26_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16f9490902b14332975939591b56c0ce_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b8a832fa95e40dd8e00caad65e8fc91_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i890286f3ce6f403f85f12ab3e67b6b6e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7329eb228fb439b8a66213456cd7cd2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i102ea5a4d307404c84aab38c52f1411f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i379c9b036151404ba5af5925388baa54_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ed25cf6aa114e57a8dac87f70ade94d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84a93d4537e04f79aeb456018d0705ee_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia33dc2132bbc4f94ad2a656f9bd29ecb_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9ef9ee81e0d436bae0f3213e39b62ea_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f43e380d2624479993e527bb1c21058_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if25caf19e5b840e88f4735e4136a603a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i541e2e9fe4644a20b8b1b376f83dee9d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0624bd72b2cf4ede8ec463949522ea9a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd5ccd73a28c47ebac5c69568150935f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia692081523eb4eeab727c1fc860a7079_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18d637000e084883bc89386915d6aae9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8345fcb8c9f147978a79d376aea1f2aa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9bb8758e465423fb3bbebe9bcea3ef7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e8c018a77ea44b685797703d8a62a43_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b34bf4c7df9425fa69de07cc96a2ac9_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida50a4aa7f4047c9a5bf3fcef6f2d36d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2dae0c39f39546cdbbe879b2a2245fe6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80812ae1293f45978d4c5ec6ccb77d63_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i350b1ab261cb4e4db6e8558ad63e36ba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i255bc9e0c6fd4f8a8cfcde46d7515d42_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07186a2d797e4458bf8d9a94dc91a2d0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36aa3c86e8874dec967acf37511c6479_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia859bc758ac345ea9093ab9e82ff0731_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04cf9359671d402dba7a452b2672fb05_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43750276631c4e1ba6fc6ef8f398254e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f2cde5be60544bbb0bd73ff5aef0cad_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5088a09b2ff24bc9bfba62c1ce63d419_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia52cfe0290ea4a978f3254d197b6c758_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55050b0de34747fbba14961fb9a1e9be_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e47b12b058d42d9b8a8500645afac39_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputProbabilityWeightingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis">amci:SecuritiesSubjectToMandatoryRedemptionNearTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd94d602b126443bb0f923d41ad8c7a1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputProbabilityWeightingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis">amci:SecuritiesSubjectToMandatoryRedemptionLongTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec52bedc36d740b58bbc9ba1b8a983fe_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputTimeToConversionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis">amci:SecuritiesSubjectToMandatoryRedemptionNearTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ce1629b93bf43a19b229d4d55f31882_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputTimeToConversionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis">amci:SecuritiesSubjectToMandatoryRedemptionLongTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie070efbfc7bb4781b963dadb0a382d58_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis">amci:SecuritiesSubjectToMandatoryRedemptionNearTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputLiquidityPriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49e4803247b0402587b5096b129d9f31_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputLiquidityPriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis">amci:SecuritiesSubjectToMandatoryRedemptionLongTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09800e6ff5ef4478927f317abe6e7fb7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis">amci:SecuritiesSubjectToMandatoryRedemptionNearTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c63b562f14d44b9952abb1eea623813_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis">amci:SecuritiesSubjectToMandatoryRedemptionLongTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib14e5758f2a840a3b657e5dd9d422ebe_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputProbabilityWeightingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantNearTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i192c0e38323342ae9304ab84b0debe13_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantLongTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputProbabilityWeightingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37123c3b7a85495b95dd4d8511fc0442_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantNearTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fa6834bd2214eff8b934f7fdaa67fbf_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantLongTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0172ec8bd8ce4a22879fb349fbbafc56_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantNearTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9d5899a57c54d7990cac2605e65ebd3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantLongTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0aa6805e2b1149559fbad18c590187ff_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantNearTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icda6841801c24b74be59d169bb943c1a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantLongTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ca319150c654f32ae12b5fe4314342e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputTimeToConversionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantNearTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7fb1eeb489e46439a3c7f8c3a135d2b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantLongTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputTimeToConversionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50591f4e8c7a4c87a18ff51b7460e5d8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantNearTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32c536245c9a49b0a6be57c612f69c6d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantLongTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb39bfc330164ff6ba59e1d2825cd61d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantNearTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i114b807366e64e039876ae4814999f64_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantLongTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0945a26d694b428d8419686bb048d18d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fb53208afd74e9483b23d0e4041d555_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFELiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i079f7d69cf684156b67ee6553c8b6aad_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFEWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24da02763da74b0a98ebfa8693930419_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e2cb48d3fed408fb6bf572cd6d907a7_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFELiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i339b33ace04542deabf468483e22dd7b_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFEWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcbb421dbd8a47549b523344e6362ae3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c5b2e7ef7394f83aafc18d6214bf674_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFELiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9af2492b6f554a0eb3fc32f72a1bb287_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFEWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5618649df5e5458fa3e4d03670a6f48b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icce53a5d10814231a163555304304500_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFELiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iceff32fcb2af47c7981043c476b7ae54_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFEWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68ebbca494b448ef875e3b5a750be5f7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i578deee2fa2d4d7bb7f94e488eeef63f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFELiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e9a8a61ba8846269b1f093403d0655f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFEWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dcdacedd7b3425b94c3894b1d80e349_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic04f0a1ede324c85b72039cfd7feb0b7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFELiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78b91d141eb346fc856035c2b7e19205_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFEWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a79cdf54f8341f5939209c59107cddb_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">amci:InlandRevenueNewZealandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="scheme"><xbrli:measure>amci:scheme</xbrli:measure></xbrli:unit><xbrli:context id="i6e7545b455184e6c8f1133a56f5e689c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd4d0f3725b743bb9a13d0e7f76a6680_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id580de21b42b4e398c7373ee2244ec4a_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b4e3fd1f02f47b5a39f57e583f20233_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64009d0294a6447cbb23d3d0c5282ca7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e411fa8a71f41a3b345b23c815aba64_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c25a29e3caa42e99299fc9c41c7bac1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:TransactionsWithEquityMethodInvesteesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id33f2498c7aa4d4ba897810160258324_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:TransactionsWithEquityMethodInvesteesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i578fdaf743b64320848f4efd3fbff206_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartyTransitionServicesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68abf404f20a4c66a39987d6172c4179_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartyTransitionServicesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e23e5276e6d4282a2e9f97732511ff8_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartyInvestmentAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8acbdb690ad34c79ba365f582f00b5da_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartyInvestmentAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85c0c3423aa7412ca1b42997ac78fe99_I20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartyLeaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="renewal_option"><xbrli:measure>amci:renewal_option</xbrli:measure></xbrli:unit><xbrli:context id="i82d95c66ecd54340a53c89c11d9122a0_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartySupplyAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica64ee13842e4d87b58d8e0776c87382_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartySupplyAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idce0b2fa8b1948daac1bdd0c26b6d051_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dfc06d3caf74e879b017b7ba4bccc6c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b90ee4e94cb439f99b65328a21b6c23_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7233a4b0cd54bc9b9d31a1fda4e4f29_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f16b3d33a074e1ba14330da0255fa2f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab3c900d2c4e4b2a91220c825b2d6956_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4c4d87c859840cc99ff35a606293d63_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d3aaae919f443669873c0b2494eb950_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f67793938594975ad7e63e3f8a4f312_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e83a5ed9e3a42fbb38d656ae52b386c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife262e1009764f0ebe3fdfe5ad4fb494_I20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8afc523d3a4c48d79839de0f31b51d9c_D20200501-20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-01</xbrli:startDate><xbrli:endDate>2020-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i274fc7fa467b4dfca60a8caf5ff1ce05_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i119eb57b7e1540229b6f3479667c5786_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d01e01ebc9943c18b155b63bbd4d023_I20221002"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82842e075dc846f3a2e003e61f072850_D20221002-20221002"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-02</xbrli:startDate><xbrli:endDate>2022-10-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e9aa0cf9cf540058d33cfcb743c1b90_I20221109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:LanzaJetFreedomPinesFuelsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11190b90fcdd4adb805e60aa7b5e6559_I20221109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:LanzaJetFreedomPinesFuelsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">amci:SeniorSecuredNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i841691236bcc4a358b07eb492c06d80c_I20221109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:LanzaJetFreedomPinesFuelsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">amci:SubordinatedSecuredNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfc212252c93424d9125b3ea9c058464_I20221109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13deb916e76344f39ef3aa84463dff11_I20221109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">amci:OneTrancheOfNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45c8b69ce7724ca09fcd2a0e03378434_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31c5c6ff291e4bfbaecc0f0138bbdc9b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cd0c82523ad48cfbd1bd9a5c47959b6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="amci:RelatedAndNonrelatedPartyStatusAxis">amci:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i960c81aa420d4215ad749484380fb1d3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="amci:RelatedAndNonrelatedPartyStatusAxis">amci:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i946f64f7009a4a2082ea5e8ea9ae0377_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if07a33149ab34a4fbdf400d0fabf37f6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia22c1bdd47434793a0dc37fce48a996d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94e27674b4054eeb8e5f88cdfd303c29_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00591629b1be427aa8c0009cf1fb6f6e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifeb17f8540b2472cbe4d74587d5ad4aa_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d56d77913a14f86a6d7945e10f160c2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5eb0c8c36cbc470dbddae10e948288a4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05ec61c49dc34bc69ccd60b0af98c42e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45b464fc79c145a2a521d5dd55876280_D20210401-20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68c741fd42694f06bc7e2689ea444d6a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied8cd34c75144efca4224b616436546e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9a4fe64e8384eb1ac82e12eceb516c9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie594942781b24073905212d61c4895df_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib670cc288d804b0da674a966573402b6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">amci:ErrorCorrectionEquityMethodInvestmentsIntangiblesAndFixedAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f626d763fea4f03b5c54c8fd030b350_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">amci:ErrorCorrectionEquityMethodInvestmentsIntangiblesAndFixedAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic75b0e764db44a3ea1a1199da6c4795b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">amci:ErrorCorrectionEquityMethodInvestmentsIntangiblesAndFixedAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ddd84d3244a4e469b4d90c6789d9b85_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">amci:ErrorCorrectionEquityMethodInvestmentsIntangiblesAndFixedAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icea6a4eaa3fa47bc9fd500d0e0e53a13_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">amci:ErrorCorrectionEquityMethodInvestmentContributedIntellectualAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5437a811e196420794bdd75c799bf19b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">amci:ErrorCorrectionEquityMethodInvestmentContributedIntellectualAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6272a6a1b0f14bc1a60665228d4ff94d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">amci:ErrorCorrectionEquityMethodInvestmentContributedIntellectualAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89d112338dda40d0b977e99b3737e024_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">amci:ErrorCorrectionEquityMethodInvestmentContributedIntellectualAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7dbd0916f2f407fbf3b88496fe98376_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">amci:ErrorCorrectionEquityMethodInvestmentGainOnDilutionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9f5902630fa415a8d71cc63925f4a89_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">amci:ErrorCorrectionEquityMethodInvestmentGainOnDilutionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i142b45d688a94040896bab9c453fa022_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i475ef0e1c62c4e2194e47d2dab3b2b37_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartySupplyAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84e5c0f8b51d4b4ea1203de397661f35_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartySupplyAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idccad26b9b674e58874df0b2f95fbd38_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8987593ef9dd4097a8751ede87870612_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief2dc30089664149a39ac740dc44fcd1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i313f0012493b4bbbb3009a5a1bf811eb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ba67557e60f4d1c9ab04d369b4a98b9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0727c1578ba4d70a8b82b043575d5a6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22ad32b2cf2844b38ba63af045e6e421_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa2024ac8ce64a4cb2c146b06249fdb9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5fbf727115a466bbef562191f56b933_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i979244b8b15f4cdba6249d9a452d49e9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaeab5bba9ba24bbab921cc565da5880c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4715c3e771cb49659b7d7d1edf71bd81_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:LanzaJetIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7a001a92c1048529f1d70f282ef5979_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:LanzaJetIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51da7734998e408b9fefa2e716945170_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8253259ad4874f5a9b674506631abe14_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05590867d0ee4d609cfc35f801b2bfb0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id306802fd9ee409aab98820719190d6a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf64231b10064ce9b86e185225060418_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i831d5d72289e4ecebda264860e6ddb01_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib84e916b214e40bb9503c00b519d9b19_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ad0ccd0af184ac4a13f4b4276bb623e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3806badc445d44dd82e2c5a6b9e25bfb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7c702b96a6f4df9b250877d0384b508_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2179adde8d304d8280bfbc5ee18bc488_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bcb50c289e34d1482c2e928125d7fde_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f54a9cc2417463291611fdfdeedb0d2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i743ecbc9e30043a599d588f612598339_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56b52dbeac4d4479bfb65e79f892fff0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb494d52ad624b01abe6e93490255650_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icaaa8522aec94f1aa360a0050053d993_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfee3a338b794d7d95cda90ba4dd2425_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2678f5a65b234d35a12ce212238a1276_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifac9f30a87864eb3ac5fa0f54dde723a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i358ff5b6e3854374ba1d7d0c7d0343e5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85c99d1acfdb4854a6eeb001415fd1fc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bcdbff1e49a4f7893b55aef5e3383b0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d734da8c6d54d6394aafbc36ef97fe0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2e7fdecab214154afe7ef716788fbb0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:JointDevelopmentAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic848ff8d5c6f468b8ef166100477c3d3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:JointDevelopmentAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5a5c7a4013b40f996deb5caeadbee89_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:OtherContractResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25000550374347d98ff4260b0fe8fcc1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:OtherContractResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcca0034fe6a4d0990224e5b8a5dd449_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:ResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i841b3eaf08c64e929bd5d8c3b5550936_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:ResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84f5e809f9504f9aa1546f38557476d3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i941766ba89044c74b5ec672aca6c1610_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i339e323267704b6397de8db0f758c601_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:EngineeringAndOtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d8cebd2641f4bcd972a34fb2e86777c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:EngineeringAndOtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i028a5508763345629acfb45969fb4396_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:CarbonCaptureAndTransformationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb183fb29c764617802fbb8f9cc6ef0a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:CarbonCaptureAndTransformationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d133fe090bf40acb6e27f45ba8c513d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41997fda0c884eaeb59b9fa43fb3f3b5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84559e50cc784ae4947d2762750bee39_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1b898530c2c4589a32c8d8d907dc09f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68d2069e34784ebfbc6b06f1d0168f28_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f366cdc85054777b0fbbe8b243bd6b1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f54cf1501b448c0a13761e8ce9c4f33_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i395f2b2b0888423698fc8b4613a0c7a8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d2c4854af1c4ad183efa288b7c84140_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:LanzaJetIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4448ea0f5e794cccaf623e81ad622af0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7da793980258460bb178e447b22bf4df_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:LanzaJetIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa162be01a7e42838d798ac77c1e8764_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:LanzaJetIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie466fa6065e24c99b35c9b349c76a551_D20110928-20110928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2011-09-28</xbrli:startDate><xbrli:endDate>2011-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if87506a2fe1e44eea4a6cc3fad0ec2be_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c210a255c684636bb39fa23a2370b08_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a7398a2daa84714af0a8aedf56e44db_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i429f6f8a96604c7ebb57f635a19670fb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb56e9df9e8a4d3fb130ee2ff3f1a588_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7779ec82a944d5989685ea5c473b325_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9677cfd1c23149c39d4d453a38d4b6f4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:TransactionsWithEquityMethodInvesteesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4dc568acac614adb953dfdedc71d98b5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:TransactionsWithEquityMethodInvesteesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62a14169b57143bbada3e671e8a86ea6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:TransactionsWithEquityMethodInvesteesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5cf4398c3d547eaa80b15bf808fd8c5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80fc94b127ec4857ab5aacd4d3b22f07_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice7ea95c9fb84d36a4857e2a761cf72f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0c8f06ff99246cdb46b4b9b0600f524_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22bd73e99737495a9bc32803b0a38fcb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if52a74eff3e34ea7bd679e63aa269811_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida1349a04a004301b22372e88994a9b7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43d8664385d6443a97bd2baa7945074d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i496bb986b9154962b5941a9ef4c15f9a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84be5f6d8d7b4fb09cf5f8067275b5e2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2572a9b98e9a4c54ae3bd8e69a273beb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">amci:DerivativeNearTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputProbabilityWeightingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf22b55e0fed4e0c81de5bef50d3013a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputProbabilityWeightingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">amci:DerivativeLongTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib114abec90f74932b5c8531cce6dc917_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">amci:DerivativeNearTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputTimeToConversionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i367f5f8cece445cfb46f812a669bcd7d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputTimeToConversionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">amci:DerivativeLongTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccef67c1c54d4161a5720eded9695c69_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">amci:DerivativeNearTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputLiquidityPriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib085f020f9a848ccb3533923ee8aafcf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputLiquidityPriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">amci:DerivativeLongTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica26df06c0a34ccf8742113f8a95570d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">amci:DerivativeNearTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie99d17fd90cb4d7987c8af1f52716253_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">amci:DerivativeLongTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic732fa66399e46eb8f8f50bfe6a6b35c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputProbabilityWeightingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantNearTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3318e30ec98146f5915d9bdc540724bb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantLongTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputProbabilityWeightingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9db1cfd579a04d91b7516eeb7322d953_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantNearTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdd52c0f69244ffea4e30e908a904220_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantLongTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f66a327ce0b49c890e6a99fa7f9fbaf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantNearTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ca4d63251324696875efe201490b263_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantLongTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82cb4f4ddcf64c0191fa7d4c0cb0521e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantNearTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7905b9a8c9624fa98a477251487eac0d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantLongTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91c4e209e7064892a5423ab903a240cc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputTimeToConversionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantNearTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57bff8b3d92f4c7cb9038273d4bf242f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantLongTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputTimeToConversionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i187fcf7aff144ee2ab2ff0d1b8136024_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantNearTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c38034324df4a3dab4243d7adcb1f21_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantLongTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64eaa8be4efb4867bb9b47e16fac72d7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantNearTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie146e5c775d746339943039ce5e4a6dd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantLongTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9596a7ff3bea42e58dcd39b0f38a74fa_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10f6a1f2d1324379935392c475073764_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFELiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e89877de092491fa0ce31158a83134f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFEWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8096c15e999498da5d65ca68368db35_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if06480e1451e4cb3931502d5a16df7c6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFELiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2859bc5f912d48f8a7b394269608ca11_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFEWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0741139789474a10a1ce163a9a98a470_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbd46d99a3b44e778776bac9d32b613b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFELiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b348afbe5de43b8843f3c23b5497e45_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFEWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e7e83e30c3d44fdb6bc2da913857f3f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89df8c332f124e06ace60a1e9c5cab82_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if03679d2c8874922bb5588f668eb7d35_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic580d984d78b4b299abd56ff167e37d7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4d0329f226943faa5580463c870698c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb3aa04cd5e7479082b4f9014ca3e18c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if23e5af08c304d4997948a7aa3740d0c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fa3bebd5c07454880ff014ca7706dc5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf4b1adda3834411b36d3d632f21e01c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6165c558d2a64bd2ba478d320a293753_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76b729f3daf846f681967ad7e92f649b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentOtherTypesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39d2cbb02f9e4ba9b23e10f13e34d417_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentOtherTypesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8a470f3b214430bbb7075de4c3b1041_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacdef9e753d8416790fee52e2ac18e18_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c4c3289f5c34d4b9daf93c4456e999f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amci:WTILoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc118da157274cfdb66d08ffff284787_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amci:WTILoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45b11649159e4d9ea0d390a541b073d1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amci:PPPLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30198db7c24e48949cc55680e9933f73_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amci:PPPLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i404699cd00694919a171cbd57221125e_I20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amci:WTILoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i593657e076c3432fa7ca2b295b005b97_D20160101-20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amci:WTILoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-01-01</xbrli:startDate><xbrli:endDate>2016-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idee985caefbc450c8367961aff024380_D20160101-20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amci:WTILoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-01-01</xbrli:startDate><xbrli:endDate>2016-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9219179a97ab4a4b82c9454bafb8d9fe_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amci:WTILoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic037a70c12df457680d3fb392aa182f3_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amci:PPPLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i066afad72e9d4b139078a273831e92d4_I20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amci:PPPLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e518f168d1f463d87802b9ada1450e7_D20210928-20210928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amci:PPPLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-28</xbrli:startDate><xbrli:endDate>2021-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3c4ceff701e45aabe297c3d9da57706_I20210928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amci:PPPLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8aafbe30b7bb4fd68e9bf6b7a590d428_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bc03a6bd4624cafb93bad1d3f537cdc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie93366da59b6430ca421d5c1bbe96fbe_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">amci:InlandRevenueNewZealandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i674eabcf32014cbbbafe71136b7607fc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">amci:InlandRevenueNewZealandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7126fac96e634ad0af8988b83b1e7593_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04acfe14cd6f4c0da7448253e2c86947_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43158a95b30f4aaab73e7597bb3c2a77_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bc2ae3cc9a8471192b73d09b8c4196c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14808e8f9df64a649044715542143c00_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied52ef89a5c14dea943af84ca5eee65e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i180c304002694f86a2cf308b957c10a8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">amci:InlandRevenueNewZealandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46667c1000434c14a56ef64c99eb3a8c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">amci:InlandRevenueNewZealandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie04b19809090466ab84ebbe80fe42718_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5a23afc7674452e9cdd8908a9228efd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ec6ce83073a4b3dbe1336fd4cb6ec9a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a3ce2d4285046a28faff5151642a219_D20201101-20201130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2020-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i573b811889c3495891ffd2a6cb11821d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8edc4dc10f9f4f9bbe7fde8514cd754b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i213ef7ccde724ea7afd07d3e7e86daa8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03b32e37b4f7484ea3c2ae0cc21ee87c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8891a21b42fd46edae0f2cb767f54ab4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11fb672b3c844ef88abb79b5adf6a2f6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d8b29d6eda64dde944469b96c9e6f69_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i803b263ea3554c628c2b2cd7af31afde_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4de62ab3a564461880c512002a30b250_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartyTransitionServicesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75c056609d254c53af9c29c67d99d60b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartyTransitionServicesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id905c833627b4121b886db6e813419df_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartyInvestmentAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae076a6656ae43ecb5bd532f5ce42d8c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartyInvestmentAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcbed162e9304111b3a8a6214d89a1d1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartySupplyAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28298076d77146a590f9bd3e1debbf12_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartySupplyAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac85d16334474caf87d510d9eb18ff97_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a9c59f1273542b8ab3e8255d224f529_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b658f2ff91349b3beaa5d4bd56ba109_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i579053a3cd4d442382bdb8ffa9a87db6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51d874e0b5b94c329952825293416b35_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6147091081d14d69be73064143508062_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75249f1eb69a41749449ae454de51fed_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c54836fffa1449f85209e9cddadc72d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icae471cb37e8404291aadc66b866dff7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbd1a0745c954062aab7bb0d81157304_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice5b7039b91e4ef49110749cb0d4f41b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0affa519b5d4e0aae8d04132534645a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74eaaed6f417404bb146455ed9642f5a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea72673f89f344d5a288193ba7de0128_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie65b1b4339964ae0830003a7a95f3358_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90db5fda8f064408a48fcdc8d953f421_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i203a431eb37944ba9970e49c1a8973a0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice29ee32562f4fbcacd93b5434eb9059_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60f5e9b899c3402e921d693b6d34e7db_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3639631deb4141b89e868bff198a8abe_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27b40d5ba4e24322ad9e1de0fd9901c5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i274b66feb9f24726acba535a568e1b1c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2fd472d035b4442864a247790745af2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i004d3d6d81544e698359c68c43fc61d0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i306c9af6b46045cb8fca7a2fca95e245_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d11321cc3a942239572275fcf381918_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c8efec04d224fbaa59158d2f94edd4d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i909eedca48974777b86ab5582898a5a8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70266a51f6fd4149be790adbf96c3a30_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76b836230c434467ac363b81bab66632_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i695b4941729c41e48e97d09ddc96d4ac_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabb8b1ba7cc04a52a91d508fcb565f43_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idad7341fd7894a348248ac1892d2d548_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65a85eee2f814026a7777b50ae141b0b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia53cc2675c474ab094ee86871334ac6e_D20200201-20200229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001843724</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-02-29</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ib82e114cd19f45afae73e7a64e42f208_1"></div><div style="min-height:18pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As filed with the Securities and Exchange Commission on February 13, 2023</span></div><div style="margin-bottom:6pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Registration No:</span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.869%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:2pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xL2ZyYWc6MjhlYTM5MzQ0OWY4NDFmYTg2MTUyMDgwYTFlNGI3NzIvdGV4dHJlZ2lvbjoyOGVhMzkzNDQ5Zjg0MWZhODYxNTIwODBhMWU0Yjc3Ml8xMDk5NTExNjMwMzczOQ_b9dc31a4-de0d-45ae-994d-1d4f118cfed7">S-1</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REGISTRATION STATEMENT </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNDER</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE SECURITIES ACT OF 1933 </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xL2ZyYWc6MjhlYTM5MzQ0OWY4NDFmYTg2MTUyMDgwYTFlNGI3NzIvdGV4dHJlZ2lvbjoyOGVhMzkzNDQ5Zjg0MWZhODYxNTIwODBhMWU0Yjc3Ml8xMDk5NTExNjMwMzc3Ng_ad374cfd-9e8b-4867-8790-27870042e196">LanzaTech Global, Inc.</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.348%"><tr><td style="width:1.0%"></td><td style="width:30.485%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.421%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.485%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.421%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.488%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Delaware</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">8731</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">92-2018969</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Primary Standard Industrial<br/>Classification Code Number)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(I.R.S. Employer<br/>Identification Number)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">8045 Lamon Avenue, Suite 400</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Skokie, Illinois 60077</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Tel: (847) 324-2400</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Address, including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices)</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Joe Blasko</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">8045 Lamon Avenue, Suite 400</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Skokie, Illinois 60077</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Tel: (847) 324-2400</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Name, address, including zip code, and telephone number, including area code, of agent for service)</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Copies to:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.937%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Kerry S. Burke<br/>Brian Rosenzweig<br/>Covington &amp; Burling LLP<br/>One CityCenter<br/>Washington, D.C. 20001<br/>Tel: (202) 662-6000</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Approximate date of commencement of proposed sale to the public: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">As soon as practicable after this Registration Statement becomes effective. </span></div><div style="margin-bottom:3pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. &#9744; </span></div><div style="margin-bottom:3pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744; </span></div><div style="margin-bottom:3pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744; </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744; </span></div><div style="margin-bottom:3pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. (Check one): </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.404%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.941%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.915%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.634%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.406%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Large accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xL2ZyYWc6MjhlYTM5MzQ0OWY4NDFmYTg2MTUyMDgwYTFlNGI3NzIvdGFibGU6NmQ1MmFkYmQ5YjVkNDkxODkyYTY1Yjg5NWM1Mjg4M2QvdGFibGVyYW5nZTo2ZDUyYWRiZDliNWQ0OTE4OTJhNjViODk1YzUyODgzZF8xLTAtMS0xLTkwNjA5_04965d5b-b796-4c7c-8447-27736c1d7a57">Non-accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xL2ZyYWc6MjhlYTM5MzQ0OWY4NDFmYTg2MTUyMDgwYTFlNGI3NzIvdGFibGU6NmQ1MmFkYmQ5YjVkNDkxODkyYTY1Yjg5NWM1Mjg4M2QvdGFibGVyYW5nZTo2ZDUyYWRiZDliNWQ0OTE4OTJhNjViODk1YzUyODgzZF8xLTMtMS0xLTkwNjA5_5daa4453-1424-47af-b7cd-bb0de943d8e3">&#9746;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xL2ZyYWc6MjhlYTM5MzQ0OWY4NDFmYTg2MTUyMDgwYTFlNGI3NzIvdGFibGU6NmQ1MmFkYmQ5YjVkNDkxODkyYTY1Yjg5NWM1Mjg4M2QvdGFibGVyYW5nZTo2ZDUyYWRiZDliNWQ0OTE4OTJhNjViODk1YzUyODgzZF8yLTMtMS0xLTkwNjA5_f162a3ed-91cf-4e39-9b7a-c36eed35ab1d">&#9746;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:3pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. <ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="dei:EntityExTransitionPeriod" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xL2ZyYWc6MjhlYTM5MzQ0OWY4NDFmYTg2MTUyMDgwYTFlNGI3NzIvdGV4dHJlZ2lvbjoyOGVhMzkzNDQ5Zjg0MWZhODYxNTIwODBhMWU0Yjc3Ml8xMDk5NTExNjMwMzc0MA_dff1e791-751a-4ab2-ab21-46502e982353">&#9744;</ix:nonNumeric> </span></div><div style="margin-bottom:9pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine. </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.869%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_1387"></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:3pt"><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#f1665f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The information in this preliminary prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is declared effective. This preliminary prospectus is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted. </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#f1665f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUBJECT TO COMPLETION, DATED FEBRUARY 13, 2023 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRELIMINARY PROSPECTUS </span></div><div style="text-align:center"><img src="amci-20230213_g1.jpg" alt="amci-20230213_g1.jpg" style="height:54px;margin-bottom:5pt;vertical-align:text-bottom;width:357px"/></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Up to 218,067,996 Shares of Common Stock </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">4,774,276 Warrants to Purchase Common Stock </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">This prospectus relates to the issuance by us of an aggregate of up to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,249,473</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> shares of our common stock, $0.0001 par value per share (&#8220;common stock&#8221;), which consists of (i) up to 4,774,276 shares of common stock that are issuable upon the exercise of private placement warrants (the &#8220;Private Placement Warrants&#8221;) originally issued in a private placement to AMCI Sponsor II LLC (the &#8220;Sponsor&#8221;) in connection with the initial public offering (&#8220;IPO&#8221;) of AMCI Acquisition Corp. II (&#8220;AMCI&#8221;) a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">nd upon the conversion of certain working capital loans of the Sponsor, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">at a price of $1.00 per warrant, (ii) up to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,494,514</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> shares of common stock that are issuable upon the exercise of public warrants (the &#8220;Public Warrants&#8221; and, together with the Private Placement Warrants, the &#8220;warrants&#8221;) originally issued in connection with the AMCI IPO as units of AMCI at a price of $10.00 per unit, with each unit consisting of one ordinary share and one-half of one warrant, (iii) up to 5,000,000 shares of common stock that are issuable upon the conversion of that certain Simple Agreement for Future Equity between BGTF LT Aggregator LP (&#8220;Brookfield&#8221;) and LanzaTech NZ, Inc., dated October 3, 2022 (the &#8220;Brookfield SAFE&#8221;) at the equivalent to a price of $10.00 per share, (iv) up to 300,000 shares of common stock that are issuable under a warrant held by ArcelorMittal XCarb S. &#224; r.l. (&#8220;ArcelorMittal&#8221;), dated December 8, 2021 (the &#8220;AM Warrant&#8221;) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">at the equivalent to a price of $10.00 per share, and (v) up to 1,680,683 shares of common stock underlying options issued to certain holders under our incentive plans (the &#8220;Options&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> and together with the warrants, the AM Warrant and the Brookfield SAFE, the &#8220;Convertible Securities&#8221;) held by certain selling stockholders. We will receive the proceeds from the exercise of any warrants, the AM Warrant or the Options for cash. </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">This prospectus also relates to the offer and sale from time to time by the selling stockholders named in this prospectus or their permitted transferees (the &#8220;selling stockholders&#8221;) of up to 4,774,276 Private Placement Warrants and up to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,818,523</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> shares of common stock, which consists of (i) up to 18,500,000 shares of common stock issued on February 8, 2023 in a private placement pursuant to subscription agreements, dated March 8, 2022, October 18, 2022, February 1, 2023, and February 6, 2023 (each as amended, as applicable), at a price of $10.00 per share (the &#8220;PIPE Shares&#8221;), (ii) up to 4,774,276 shares of common stock that are issuable upon the exercise of the Private Placement Warrants, (iii) up to 5,000,000 shares of common stock that are issuable upon the conversion of the Brookfield SAFE, (iv) up to 300,000 shares of common stock that are issuable upon the exercise of the AM Warrant, (v) up to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,164,839</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> shares of common stock held by certain selling stockholders, (vi) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">up to 1,680,683 shares of common stock underlying the Options held by certain selling stockholders, (vii) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">up to 5,916,514 shares of common stock purchased by certain selling stockholders subject to that certain forward purchase agreement by and between the Company, ACM ARRT H LLC (&#8220;ACM&#8221;), and the other parties thereto (the &#8220;Forward Purchase Agreement&#8221;), and (viii) up to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,482,211</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> shares of common stock, required to be registered pursuant to that certain Registration Rights Agreement, dated February 8, 2023 (the &#8220;Registration Rights Agreement&#8221;), by and among us and certain of the selling stockholders. We will not receive any proceeds from the sale of the Private Placement Warrants or of the common stock by the selling stockholders pursuant to this prospectus. </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The selling stockholders may offer, sell or distribute all or a portion of the securities hereby registered publicly or through private transactions at prevailing market prices or at negotiated prices. We are required to pay certain costs, expenses and fees in connection with the registration of these securities, including with regard to compliance with state securities or &#8220;blue sky&#8221; laws. The selling stockholders will bear all commissions and discounts, if any, attributable to their sale of Private Placement Warrants or shares of common stock. See the section titled &#8220;Plan of Distribution.&#8221; </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Our common stock and warrants are listed on the Nasdaq Capital Market (&#8220;Nasdaq&#8221;) under the symbols &#8220;LNZA&#8221; and &#8220;LNZAW,&#8221; respectively. On February 10, 2023, the last reported sales price of the common stock was $7.30 per share.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The common stock and the common stock issuable upon exercise of the resale securities noted above represent a substantial percentage of the total outstanding shares of our common stock as of the date of this prospectus. Additionally, if all of the Convertible Securities were converted, or exercised, as applicable, the selling stockholders would own </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,818,523</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> shares of common stock, representing approximately 92.3% of the total outstanding common stock. So long as the registration statement of which this prospectus forms a part is effective, the sales of the securities being offered in this prospectus could result in a significant decline in the public trading price of the common stock. The sales of certain such securities are subject to lock-up restrictions. Furthermore, if the market price for shares of common stock is less than the exercise price of a holder&#8217;s warrant or of the AM Warrant, such holder may be less likely to exercise the warrants, the AM Warrant or the Options, as the case may be, as such holder would be selling at a loss if they sold their common stock. Subject to adjustment, the exercise price of the warrants is $11.50 per share and the exercise price of the AM Warrant is $10.00 per share.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The exercise prices of the Options range from $1.07 per share to $3.15 per share. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">On February 10, 2023 the last reported sales price of the common stock was $7.30 per share. Additionally, if the market price for shares of common stock is less than $10.00 per share, holders of shares of common stock would be selling at a loss if they purchased the shares of common stock at $10.00 per share. Because certain selling stockholders purchased shares privately at a price below the current market price, they may have an incentive to sell shares of their common stock because they could profit despite the market price of common stock falling below $10.00 per share. While these selling stockholders may, on average, experience a positive rate of return based on the current market price, public securityholders may not experience a similar rate of return on the securities they purchased due to differences in the purchase prices and the current market price.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">We are an &#8220;emerging growth company&#8221; and a &#8220;smaller reporting company&#8221; as defined under the U.S. federal securities laws. See &#8220;Prospectus Summary&#8201;&#8212;&#8201;Implications of Being an Emerging Growth Company and a Smaller Reporting Company.&#8221; This prospectus complies with the requirements that apply to an issuer that is an emerging growth company and a smaller reporting company. </span></div><div style="margin-bottom:3pt;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investing in the common stock involves risks. See &#8220;<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#ib82e114cd19f45afae73e7a64e42f208_1575">Risk Factors</a>&#8221; beginning on page <a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#ib82e114cd19f45afae73e7a64e42f208_1575">7</a> of this prospectus to read about factors you should consider before investing in the common stock. </span></div><div style="margin-bottom:9pt;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The date of this prospectus is&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2023.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.969%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_1390"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Table of Contents</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:92.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.311%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1444">ABOUT THIS PROSPECTUS </a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1444">ii</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1470">MARKET AND INDUSTRY DATA </a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1470">iii</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1491">TRADEMARKS </a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1491">iii</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1512">FORWARD-LOOKING STATEMENTS </a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1512">iv</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1533">PROSPECTUS SUMMARY </a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1533">1</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1554">THE OFFERING </a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1554">4</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1575">RISK FACTORS </a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1575">7</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1597">USE OF PROCEEDS </a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1597">47</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1618">DETERMINATION OF OFFERING PRICE </a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1618">48</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1639">MARKET INFORMATION FOR COMMON STOCK AND DIVIDEND POLICY </a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1639">49</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1660">UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION </a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1660">50</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1681">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS </a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1681">66</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1702">BUSINESS</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1702">85</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1723">MANAGEMENT</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1723">115</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1744">EXECUTIVE COMPENSATION </a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1744">123</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1765">BENEFICIAL OWNERSHIP </a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1765">136</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1786">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS </a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1786">138</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1807">DESCRIPTION OF SECURITIES </a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1807">144</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1828">SELLING STOCKHOLDERS </a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1828">156</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1849">MATERIAL U.S. FEDERAL INCOME AND ESTATE TAX CONSIDERATIONS </a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1849">162</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1870">PLAN OF DISTRIBUTION </a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1870">166</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1891">LEGAL MATTERS </a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1891">169</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1912">EXPERTS </a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1912">169</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1933">CHANGE IN THE REGISTRANT'S CERTIFYING ACCOUNTANT </a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1933">169</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1954">WHERE YOU CAN FIND MORE INFORMATION </a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1954">170</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1268">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS </a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1268">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1268">1</a></span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_1444"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ABOUT THIS PROSPECTUS </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus is part of a registration statement on Form S-1 that we filed with the SEC using the &#8220;shelf&#8221; registration process. This prospectus relates to the issuance by us of the shares of common stock issuable upon the exercise of any Convertible Securities. Under this shelf registration process, the selling stockholders may, from time to time, sell the securities offered by them described in this prospectus. We will not receive any proceeds from the sale by such selling stockholders of the securities offered by them described in this prospectus. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neither we nor the selling stockholders have authorized anyone to provide you with information that is different from or in addition to the information contained in this prospectus or in any applicable prospectus supplement or in any related free writing prospectus prepared by or on behalf of us or to which we have referred you. Accordingly, neither we nor any selling stockholder takes any responsibility for, or can provide any assurance as to the reliability of, any information that others may give. Neither we nor any selling stockholder will make any offers to sell or seek any offers to buy these securities in any jurisdiction where the offer or sale is not permitted. You should assume that the information contained in this prospectus, any applicable prospectus supplement, and any related free writing prospectus is accurate only as of the respective dates of such documents, regardless of the time of delivery of the respective documents or any sale of securities offered hereby. Our business, financial condition, results of operations and prospects may have changed materially since those dates. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also provide a prospectus supplement or post-effective amendment to the registration statement to add information to, or update or change information contained in, this prospectus. You should read this prospectus and any applicable prospectus supplement or post-effective amendment to the registration statement together with the additional information to which we refer you in the section of this prospectus titled &#8220;Where You Can Find More Information.&#8221; </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 8, 2023 (the &#8220;Closing Date&#8221;), LanzaTech NZ, Inc. (&#8220;Legacy LanzaTech&#8221;) and AMCI consummated the previously announced business combination pursuant to that certain Merger Agreement, as amended on December 7, 2022 (the &#8220;Merger Agreement&#8221;), by and among Legacy LanzaTech, AMCI and AMCI Merger Sub (&#8220;Merger Sub&#8221;), a Delaware corporation and wholly owned subsidiary of AMCI. As contemplated by the Merger Agreement, Merger Sub merged with and into Legacy LanzaTech, with Legacy LanzaTech continuing as the surviving corporation and as a wholly owned subsidiary of AMCI (the &#8220;Business Combination&#8221;). On the Closing Date, AMCI changed its name to LanzaTech Global, Inc. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context indicates otherwise, references in this prospectus to the &#8220;Company,&#8221; &#8220;LanzaTech,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and similar terms refer to LanzaTech Global, Inc. (formerly known as AMCI Acquisition Corp. II) and its consolidated subsidiaries (including LanzaTech NZ, Inc.) following the Business Combination. References to &#8220;AMCI&#8221; refer to AMCI Acquisition Corp. II prior to the Business Combination and references to &#8220;Legacy LanzaTech&#8221; refer to LanzaTech NZ, Inc. prior to the Business Combination. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">References to &#8220;PRC&#8221; or &#8220;China&#8221; refer to the People&#8217;s Republic of China, which, solely for the purpose of this prospectus, exclude Taiwan and the special administrative regions of Hong Kong and Macau.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the legal form of the Business Combination pursuant to the Merger Agreement, the Business Combination will be accounted for as a reverse recapitalization in accordance with accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;). Under this method of accounting, AMCI will be treated as the acquired company for financial reporting purposes, whereas Legacy LanzaTech will be treated as the accounting acquirer. In accordance with this accounting method, the Business Combination will be treated as the equivalent of Legacy LanzaTech issuing stock for the net assets of AMCI, accompanied by a recapitalization. The net assets of AMCI will be stated at historical cost, with no goodwill or other intangible assets recorded, and operations prior to the Business Combination will be those of LanzaTech. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_1470"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MARKET AND INDUSTRY DATA </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information contained in this document relates to or is based on studies, publications, surveys and other data obtained from third-party sources and LanzaTech&#8217;s own internal estimates and research. While we believe these third-party sources to be reliable as of the date of this prospectus, we have not independently verified the market and industry data contained in this prospectus or the underlying assumptions relied on therein. Finally, while we believe our own internal research is reliable, such research has not been verified by any independent source. </span></div><div id="ib82e114cd19f45afae73e7a64e42f208_1491"></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRADEMARKS </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This document contains references to trademarks, trade names and service marks belonging to other entities. Solely for convenience, trademarks, trade names and service marks referred to in this prospectus may appear without the &#174; or TM symbols, but such references are not intended to indicate, in any way, that the applicable licensor will not assert, to the fullest extent under applicable law, its rights to these trademarks and trade names. We do not intend our use or display of other companies&#8217; trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of us by, any other companies. </span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_1512"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORWARD-LOOKING STATEMENTS </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus contains statements that are forward-looking and as such are not historical facts. This includes, without limitation, statements regarding the financial position, business strategy and the plans and objectives of management for future operations. These statements constitute projections, forecasts and forward-looking statements, and are not guarantees of performance. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. When used in this prospectus, words such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;possible,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;strive,&#8221; &#8220;would&#8221; and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. When we discusses our strategies or plans, we are making projections, forecasts or forward-looking statements. Such statements are based on the beliefs of, as well as assumptions made by and information currently available to, LanzaTech&#8217;s management. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements in this prospectus may include, for example, statements about: </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our anticipated growth rate and market opportunities; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to maintain the listing of our securities on Nasdaq; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the potential liquidity and trading of our securities; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to raise financing in the future; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our assessment of the competitive landscape; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to comply with laws and regulations applicable to our business;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to enter into, successfully maintain and manage relationships with industry partners;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our receipt of substantial additional financing to fund our operations and complete the development and commercialization of our process technologies;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the availability of governmental programs designed to incentivize the production and consumption of low-carbon fuels and carbon capture and utilization; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to adequately protect our intellectual property rights;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to attract, retain and motivate qualified personnel and to manage our growth effectively; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our future financial performance and capital requirements; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to implement and maintain effective internal controls; and </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of the COVID-19 pandemic on our business. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We caution you that the foregoing list may not contain all of the forward-looking statements made in this prospectus. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These forward-looking statements are only predictions based on our current expectations and projections about future events and are subject to a number of risks, uncertainties and assumptions, including those described in &#8220;Risk Factors&#8221; and elsewhere in this prospectus. Moreover, we operate in a competitive industry, and new risks emerge from time to time. It is not possible for the management of LanzaTech to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this prospectus may not occur, and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements in this prospectus. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The forward-looking statements included in this prospectus are made only as of the date hereof. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we cannot guarantee that the future results, levels of activity, performance or events and circumstances reflected in the forward-looking statements will be achieved or occur. LanzaTech does not undertake any obligation to update publicly any forward-looking statements for any reason after the date of this prospectus to conform these statements to actual results or to changes in expectations, except as required by law. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should read this prospectus, the documents that have been filed as exhibits to the registration statement of which this prospectus forms a part, and any accompanying prospectus supplement with the understanding that the actual future results, levels of activity, performance, events and circumstances of LanzaTech may be materially different from what is expected.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">v</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_1533"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROSPECTUS SUMMARY</span></div><div style="margin-bottom:9pt;padding-right:1pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This summary highlights selected information contained in this prospectus. This summary does not contain all the information that you should consider before investing in our warrants or common stock. You should read the entire prospectus carefully, including the &#8220;Risk Factors,&#8221; &#8220;Forward-Looking Statements&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; sections, and our historical financial statements and the accompanying notes included elsewhere in this prospectus.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company Overview </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech is a nature-based carbon refining company that transforms waste carbon into the chemical building blocks for consumer goods such as sustainable fuels, fabrics, and packaging that people use in their daily lives. Using LanzaTech&#8217;s process technology, LanzaTech&#8217;s partners launched the world&#8217;s first commercial carbon refining plant in 2018 in China. Since then, LanzaTech&#8217;s partners have launched an additional two commercial plants operating in China, one in April 2021 and the other in September 2022. LanzaTech has numerous projects in construction, under development and in the pipeline globally. LanzaTech&#8217;s technology platform is designed to use a variety of waste feedstocks, from waste industrial gases to biomass residues and municipal solid waste. LanzaTech&#8217;s technology platform is designed to capitalize on the demand for sustainable fuels and chemicals, which can be used in multiple sectors such as aviation, automotive, textiles, home goods, consumer goods and others, to address the growing preference among major companies for environmentally conscious products and manufacturing processes.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Combination </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On the Closing Date, Legacy LanzaTech and AMCI consummated the previously announced Business Combination pursuant to the Merger Agreement, by and among Legacy LanzaTech, AMCI and Merger Sub. As contemplated by the Merger Agreement, Merger Sub merged with and into Legacy LanzaTech, with Legacy LanzaTech continuing as the surviving corporation and as a wholly owned subsidiary of AMCI. On the Closing Date, AMCI changed its name to LanzaTech Global, Inc. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immediately prior to the Business Combination, all issued and outstanding shares of preferred stock of Legacy LanzaTech were automatically converted into shares of common stock based on the applicable conversion ratio.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares of the common stock payable in the Business Combination in respect of each share of Legacy LanzaTech capital stock were determined based on the applicable exchange ratio of 4.374677 (the &#8220;Exchange Ratio&#8221;). In addition, the accumulated dividends payable to the holders of Legacy LanzaTech preferred shares were settled by delivery of the common stock, as part of the merger consideration.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, at the effective time of the Business Combination (the &#8220;Effective Time&#8221;):</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">each warrant to purchase Legacy LanzaTech common stock that was outstanding and unexercised immediately prior to the Effective Time and would automatically be exercised or exchanged in full in accordance with its terms by virtue of the occurrence of the Business Combination, was automatically exercised or exchanged in full for the applicable shares of Legacy LanzaTech capital stock, and each such share of Legacy LanzaTech common stock was treated as being issued and outstanding immediately prior to the Effective Time and was cancelled and converted into the right to receive the applicable number of shares of common stock;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">each LanzaTech warrant that was outstanding and unexercised prior to the Effective Time and was not automatically exercised in full as described above was converted into a warrant to purchase shares of common stock, in which case (a) the number of shares underlying such warrant was determined by multiplying the number of shares of Legacy LanzaTech capital stock subject to such warrant immediately prior to the Effective Time, by the Exchange Ratio, and (b) the per share exercise price of such warrant was determined by dividing the per share exercise price of such warrant immediately prior to the Effective Time by the Exchange Ratio, except that in the case of the AM Warrant, such exercise price is $10.00; </span></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent not converted in full immediately prior to the Effective Time, the Brookfield SAFE was assumed by LanzaTech and convertible into shares of common stock; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">each option to purchase shares of Legacy LanzaTech common stock outstanding as of the Effective Time was converted into an option to purchase a number of shares of common stock (rounded down to the nearest whole share) equal to the product of (i) the number of shares of Legacy LanzaTech common stock subject to such option multiplied by (ii) the Exchange Ratio. The exercise price of such options is equal to the quotient of (a) the exercise price per share of such option in effect immediately prior to the Effective Time divided by (b) the Exchange Ratio.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the execution of the Merger Agreement, AMCI entered into subscription agreements (as amended on December 7, 2022, the &#8220;Initial Subscription Agreements&#8221;) with certain investors (the &#8220;Initial PIPE Investors&#8221;). AMCI entered into additional subscription agreements with certain institutional and accredited investors (the &#8220;PIPE Investors&#8221;) on October 8, 2022 (as amended on December 7, 2022) and February 6, 2022 (collectively, the &#8220;PIPE Subscription Agreements&#8221; and together with the subscription agreement between AMCI and ArcelorMittal, the &#8220;Subscription Agreements&#8221;). Pursuant to the Subscription Agreements, the PIPE Investors purchased an aggregate of 18,500,000 shares of common stock (the &#8220;PIPE Shares&#8221;) in a private placement at a price of $10.00 per share for an aggregate purchase price of $185 million (the &#8220;PIPE Investment&#8221;). Such aggregate number of shares and aggregate purchase price include 3,000,000 shares of common stock issued to ArcelorMittal pursuant to the AM SAFE with Legacy LanzaTech, as a result of which such PIPE Investor entered into a Subscription Agreement prior to the closing of the Business Combination.  The PIPE Investment was consummated in connection with the consummation of the Business Combination.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Information</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were incorporated in Delaware on January 28, 2021, under the name AMCI Acquisition Corp. II, in order to effectuate a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities. AMCI completed its initial public offering on August 6, 2021. On February 8, 2023, AMCI and Legacy LanzaTech consummated the transactions contemplated by the Merger Agreement. On the Closing Date, AMCI changed its name to LanzaTech Global, Inc. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The mailing address of our principal executive office is 8045 Lamon Avenue, Suite 400, Skokie, Illinois 60077, and our telephone number is (847) 324-2400. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Implications of Being an Emerging Growth Company and a Smaller Reporting Company </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012, and therefore we intend to take advantage of certain exemptions from various public company reporting requirements, including not being required to have our internal control over financial reporting audited by our independent registered public accounting firm pursuant to Section 404(b) of the Sarbanes-Oxley Act of 2002 (the &#8220;Sarbanes-Oxley Act&#8221;), reduced disclosure obligations regarding executive compensation in this prospectus, our periodic reports and our proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and any golden parachute payments not previously approved. We will remain an emerging growth company until the earlier of (1) December 31, 2026 (the last day of the fiscal year following the fifth anniversary of the consummation of AMCI&#8217;s initial public offering), (2) the last day of the fiscal year in which we have total annual gross revenues of at least $1.235 billion, (3) the last day of the fiscal year in which we are deemed to be a &#8220;large accelerated filer,&#8221; as defined in the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and (4) the date on which we have issued more than $1.0 billion in nonconvertible debt securities during the prior three-year period. </span></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also a smaller reporting company as defined in the Exchange Act. We may continue to be a smaller reporting company even after we are no longer an emerging growth company. We may take advantage of certain of the scaled disclosures available to smaller reporting companies including, among other things, providing only two years of audited financial statements. We will remain a smaller reporting company for so long as (1) the market value of common stock held by non-affiliates is less than $250 million as of the last business day of the second fiscal quarter, or (2) our annual revenues in our most recent fiscal year completed before the last business day of our second fiscal quarter are less than $100 million and the market value of common stock held by non-affiliates is less than $700 million as of the last business day of the second fiscal quarter. </span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_1554"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE OFFERING </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.015%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.785%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuance of common stock</span></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:3.45pt;text-indent:18pt"><span><br/></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of common stock offered by us</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Up to 19,249,473 shares of common stock, which consists of (i) up to 4,774,276 shares of common stock that are issuable upon the exercise of Private Placement Warrants, (ii) up to 7,494,514 shares of common stock that are issuable upon the exercise of Public Warrants, (iii) up to 5,000,000 shares of common stock that are issuable upon the conversion of the Brookfield SAFE, (iv) up to 300,000 shares of common stock that are issuable upon exercise of the AM Warrant, and (v) up to 1,680,683 shares of common stock underlying the Options held by certain selling stockholders.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of common stock outstanding prior to the exercise or conversion of all Convertible Securities</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196,222,737 shares (as of February 8, 2023)</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of common stock outstanding assuming exercise or conversion of all Convertible Securities</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215,472,210 shares (based on total shares outstanding as of February 8, 2023)</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price of the Private Placement Warrants</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$11.50 per share, subject to adjustment as described herein.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price of the Public Warrants</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$11.50 per share, subject to adjustment as described herein.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price of the AM Warrant</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.00 per share, subject to adjustment.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise prices of the Options</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Options have exercise prices ranging between $1.07 per share and $3.15 per share.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Use of Proceeds</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We will receive up to an aggregate of approximately $145 million from the exercise of all of the warrants, the AM Warrant and the Options, assuming the exercise in full of all of the warrants, the AM Warrant and the Options for cash. There is no exercise price that must be paid in connection with the conversion of the Brookfield SAFE.  We expect to use the net proceeds from the exercise of the warrants, the AM Warrant and the Options for general corporate purposes. See the section titled &#8220;Use of Proceeds.&#8221;</span></td></tr></table></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.015%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.785%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If the market price for shares of common stock is less than the exercise price of a holder&#8217;s warrant, the AM Warrant or the Options, such holder may be less likely to exercise the warrants, the AM Warrant or the Options, as applicable, as such holder would be selling at a loss if they sold their common stock. Subject to adjustment, the exercise price of the warrants is $11.50 per share and the exercise price of the AM Warrant is $10.00 per share.  The exercise prices of the Options range from $1.07 per share to $3.15 per share. Additionally, on February 10, 2023 the last reported sales price of the common stock was $7.30 per share. If the market price for shares of common stock is less than $10.00 per share, holders of shares of common stock would be selling at a loss if they purchased the shares of common stock at $10.00 per share. Because certain selling stockholders purchased shares privately at a price below the current market price, they may have an incentive to sell shares of their common stock because they could profit despite the market price of common stock falling below $10.00 per share. While these selling stockholders may, on average, experience a positive rate of return based on the current market price, public securityholders may not experience a similar rate of return on the securities they purchased due to differences in the purchase prices and the current market price. For example, based on the closing price of our common stock of $7.30 on February 10, 2023, the Sponsor and the former holders of all of the shares of AMCI Class B common stock (which converted into our common stock at the closing of the Business Combination), including certain former AMCI directors and officers (all of the foregoing, the &#8220;AMCI Insiders&#8221;) would have a potential profit of up to approximately $7.29 per share that they purchased prior to the initial public offering of AMCI, or up to approximately $14.8 million in the aggregate (not giving effect to the issuance of common stock issuable upon exercise of the warrants held by them).</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Resale of common stock and warrants</span></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:3.75pt;text-indent:18pt"><span><br/></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of common stock offered by the selling stockholders</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Up to (i) 18,500,000 PIPE Shares, (ii) up to 4,774,276 shares of common stock exercisable on the Private Placement Warrants, (iii) up to 5,000,000 shares of common stock pursuant to the Brookfield SAFE, (iv) up to 300,000 shares of common stock that are issuable upon exercise of the AM Warrant, (v) up to 2,164,839 shares of common stock held by certain selling stockholders, (vi) up to 1,680,683 shares of common stock underlying the Options held by certain selling stockholders, (vii) up to 5,916,514 shares of common stock purchased by certain selling stockholders subject to the Forward Purchase Agreement, and (viii) up to 160,482,211 shares of common stock required to be registered pursuant to the Registration Rights Agreement.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants offered by the selling stockholders</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Up to 4,774,276 Private Placement Warrants</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Private Placement Warrants are redeemable in certain circumstances. See &#8220;Description of Securities&#8221; for further discussion.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Use of Proceeds</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We will not receive any proceeds from the sale of the Private Placement Warrants or of the common stock by the selling stockholders pursuant to this prospectus.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.015%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.785%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lock-up Restrictions</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain of the shares of common stock issued in connection with the Business Combination are subject to restrictions on transfer until the termination of applicable lock-up periods. See &#8220;Certain Relationships and Related Party Transactions&#8201;&#8212; LanzaTech Related Party Transactions&#8221; for further discussion.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk Factors</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Before investing in our securities, you should carefully read and consider the information set forth in the section titled &#8220;<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ib82e114cd19f45afae73e7a64e42f208_1575">Risk Factors</a>&#8221; of this prospectus.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nasdaq Ticker Symbol</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The common stock and Public Warrants are listed on Nasdaq under &#8220;LNZA&#8221; and &#8220;LNZAW&#8221;, respectively.</span></div></td></tr></table></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_1575"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISK FACTORS</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">An investment in our equity securities involves a high degree of risk. Before you make a decision to buy our equity securities, in addition to the risks and uncertainties discussed in the section titled &#8220;Forward-Looking Statements,&#8221; you should carefully consider the risks and uncertainties described below, together with all of the other information contained in this prospectus, including our financial statements and related notes appearing at the end of this prospectus and in the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221; If any of the events or developments described below were to occur, our business, prospects, operating results and financial condition could suffer materially, the trading price of our equity securities could decline and you could lose all or part of your investment. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently believe to be immaterial may also adversely affect our business. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Risk Factors </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of principal risk to which our business, operations and financial performance are subject. Each of these risks is more fully described in the individual risk factors immediately following this summary. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have incurred losses and anticipate continuing to incur losses, and have not yet generated material revenues from marketing of CarbonSmart&#8482; products and sale of equipment.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The success of our plant operations is significantly dependent upon the strong execution and operation of each project by the respective industry partner as we rely, and expect to continue to rely, heavily on industry partners to effect our growth strategy and to execute our business plan, and our failure to successfully maintain and manage these relationships and enter into new relationships could prevent us from achieving or sustaining profitability.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Fluctuations in the prices of waste-based feedstocks used to manufacture the products produced using our process technologies, the price of fossil feedstocks relative to the price of our waste-based feedstocks, and the availability of the waste-based feedstocks may affect our or our industry partners&#8217; cost structure, gross margin and ability to compete.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We compete in an industry characterized by rapidly advancing technologies, intense competition and a complex intellectual property landscape, and our failure to successfully compete with other companies in our industry may have a material adverse effect on our business, financial condition and results of operations and market share.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may require substantial additional financing to fund our operations and complete the development and commercialization of the process technologies that produce each of our products or new aspects of our existing process technologies that produce each of our products, and we may not be able to do so on favorable terms.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Even if we successfully develop process technologies that produce products meeting our industry partners&#8217; specifications, the adoption of such process technologies by our industry partners may be delayed or reduced, or our costs may increase.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Failure of LanzaJet to complete its initial facility or failure of third parties to adopt the LanzaJet process in their commercial facilities for the production of sustainable aviation fuel (&#8220;SAF&#8221;) could result in us never owning a majority stake in LanzaJet and may severely impact our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Governmental programs designed to incentivize the production and consumption of low-carbon fuels and carbon capture and utilization, may be implemented in a way that does not include products produced using our novel technology platform and process technologies or could be repealed, curtailed or otherwise </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">changed, which would have a material adverse effect on our business, results of operations and financial condition.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Political and economic uncertainty, including changes in policies of the Chinese government or in relations between China and the United States, may impact our revenue and materially and adversely affect our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability or the ability of our partners to operate in China may be impaired by changes in Chinese laws and regulations, including those relating to taxation, environmental regulation, restrictions on foreign investment, and other matters, which can change quickly with little advance notice.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our operations and financial results may be impacted if the PRC government determines that the contractual arrangements constituting part of the Shougang Joint Venture variable interest entity (&#8220;VIE&#8221;) structure do not comply with PRC regulations, or if these regulations change or are interpreted differently in the future.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We and our partners may be subject to regulatory actions by the Chinese government targeting concerns related to data security and monopolistic behavior.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in China&#8217;s economic, political or social conditions or legal system or government policies could have a material adverse effect on our business and operations.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be subject to risks that the Chinese government may intervene or influence our operations at any time.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We and our industry partners are subject to extensive international, national and regional laws and regulations, and any changes in laws or regulations, or failure to comply with these laws and regulations, could have a material adverse effect on our business.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business, results of operations and financial condition have been, and could continue to be, adversely affected by the COVID-19 pandemic. Causes of supply chain challenges, including COVID-19, could result in delays or increased costs for us and our partners deploying our technologies.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Market prices for more sustainable, waste-based products that our process technologies enable are subject to volatility and there is a limited referenceable market for such products.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our patent rights and trade secrets protections may not provide commercially meaningful protection against competition, and we may not be able to operate our business without infringing the proprietary rights of third parties.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">There can be no assurance that our warrants will be in the money at the time they become exercisable, and they may expire worthless.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Business and Industry</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business, results of operations and financial condition have been, and could continue to be, adversely affected by the COVID-19 pandemic.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ongoing COVID-19 pandemic has impacted our business and we expect it to continue to do so. Governments and businesses have taken, and may continue to take, unprecedented measures in response to the COVID-19 pandemic. Such measures have included restrictions on travel and business operations, temporary closures of businesses, and quarantines and shelter-in-place orders. The COVID-19 pandemic has caused significant volatility and disruption in global financial markets.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic and the measures taken by many countries in response have had an adverse impact on, and could continue to adversely impact, our business, results of operations and financial condition. These actions include:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disruption in demand for the products produced using our process technologies, which has resulted and may continue to result in a decline in the prices we and our industry partners have been able to charge for the sale of such products;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">effects on our industry partners&#8217; and potential industry partners&#8217; ability or willingness to invest in new technologies or to work with us;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a slow-down in the construction of manufacturing facilities for our technology platform;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays in the delivery of the products produced using our process technologies;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a reduction in government grants and related funding for research and development;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limitations on our ability to operate our business as a result of federal, state or local regulations imposed as a result of COVID-19; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limitations on our industry partners&#8217; ability to conduct partnering activities in a timely manner.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the aforementioned factors impact our revenues directly in instances where we participate in projects with industry partners under our co-development model, and indirectly in instances where we are party to licensing agreements with industry partners and collect lower royalty fees.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The full extent of the impact of the COVID-19 pandemic on our operational and current and future financial performance is currently uncertain and will depend on many factors outside our control, including, without limitation, the timing, extent, trajectory and duration of the pandemic, the availability of effective treatments and vaccines, the emergence, severity and spread of potential variants of the virus that causes COVID-19, the imposition of and compliance with protective public safety measures, and the impact of the pandemic on the global economy and on the demand for the products produced using our process technologies and our ability to maintain current and foster new relationships with our industry partners. We are continuing to monitor the situation and take appropriate actions in accordance with the recommendations and requirements of relevant authorities. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have incurred losses and anticipate continuing to incur losses.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not achieved operating profitability in any quarter since our formation. Our net losses after tax were approximately $55.0 million for the nine months ended September 30, 2022, and $30.6 million for the nine months ended September 30, 2021. As of September 30, 2022, we had an accumulated deficit of $434.9 million. We anticipate that we will continue to incur losses until we can sufficiently commercialize our process technologies. We cannot guarantee when we will operate profitably, if ever. The profitability of products produced using our process technologies depends largely on manufacturing costs and the market prices of the products produced using our process technologies. In the case of the partners with which we have entered licensing agreements, the prices they are able to charge impact the royalty fees we derive from their revenues. We must sustain the relationships we have developed with our current partners and successfully establish relationships with new partners to which we can license our proprietary technologies or with whom we can co-develop plants, and we must continue to find ways to further enhance our technology platform and product portfolio. If we are unable to successfully take these steps, we may never operate profitably, and, even if we do achieve profitability, we may be unable to sustain or increase our profitability in the future.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The success of our plant operations is significantly dependent upon the strong execution and operation of each project by the respective industry partner as we rely, and expect to continue to rely, heavily on industry partners to effect our growth strategy and to execute our business plan. Our failure to successfully maintain and manage these relationships and enter into new relationships could delay our anticipated timelines, prevent the successful development and commercialization of products produced using our process technologies, negatively impact our financial results and prevent us from achieving or sustaining profitability.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to successfully maintain and manage partnering arrangements and enter into new partnering arrangements are critical factors to the success of our business and growth. We rely, and expect to continue to rely, heavily on such arrangements. We have limited or no control over the amount or timing of resources that any third party commits to negotiating a partnering arrangement with us or, if negotiated and entered into, the timing or amount of resources that a third party will commit to our projects. Any third party with which we are in negotiations may experience a change of policy or priorities and may discontinue negotiations with us. Any of our industry partners may fail to perform their obligations as expected. These industry partners may breach or terminate their agreements with us or otherwise fail to conduct their partnering activities successfully and in a timely manner. Further, our industry partners may not develop commercially viable products in connection with our partnering arrangements or devote sufficient resources to the development, manufacture, marketing and sale of products produced using our process technologies. Moreover, disagreements with an industry partner could develop, and any such conflict could reduce our ability to enter into future partnering agreements and negatively impact our relationships with one or more existing industry partners. Any of these events could delay our anticipated timelines, prevent the successful development and commercialization of products produced using our process technologies, negatively impact our financial results, and prevent us from ever achieving or sustaining profitability. These negative consequences could be augmented in the event that we are forced to seek replacement partners.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current and future partnering opportunities could be harmed if:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we do not achieve our objectives under our arrangements in a timely manner, or at all;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we disagree with our industry partners as to rights to intellectual property we jointly develop or that they must license from us, or as to their research programs or commercialization activities;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we are unable to successfully manage multiple partnering arrangements occurring at the same time;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">applicable laws, regulations or state actors, domestic or foreign, impede our ability to enter into strategic arrangements;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we develop processes or enter into additional partnering arrangements that conflict with the business objectives of our other arrangements;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our industry partners become competitors of ours or enter into agreements with our competitors; or</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">consolidation in our target markets limits the number of potential industry partners.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, because we have entered into exclusive arrangements with industry partners, other potential partners in our industry may choose to compete against us, rather than partner with us. This may limit our partnering opportunities and harm our business and prospects. Our business also could be negatively impacted if any of our industry partners undergoes a change of control or assigns the rights or obligations under any of our agreements. If any of our industry partners were to assign these agreements to our competitors or to a third party who is not willing to work with us on the same terms or commit the same resources as the current industry partner, our business and prospects could be adversely affected.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Even if we are successful in entering into strategic partnering arrangements, there are a number of different arrangements that we can pursue, and there are no assurances that we will select and negotiate the best arrangements for us and our stockholders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek to commercialize our process technologies by pursuing licensing arrangements in some markets and seek arrangements to co-develop projects in others. Our business strategy is based on a wide variety of factors, </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">including the size and competitive environment in each market, and our perceived ability to best monetize our proprietary technology. The types of arrangements we enter into with our industry partners will be significant in determining the amount of risk and control that we maintain with respect to the development and commercialization of products produced using our process technologies. The contractual arrangements with our industry partners will also determine the amount of capital we need to contribute to a particular project, as well as the revenue we may receive and the margins associated with any sale of products produced using our process technologies. We will need to analyze these issues properly and negotiate corresponding arrangements with our industry partners to efficiently balance the amount of risk we take, the level of control we maintain and the amount of revenues and margins we obtain with respect to the products produced using our process technologies. There are no assurances that we will select and negotiate the best arrangements for us and our stockholders. Failure to choose optimal arrangements could result in delays or failures in the commercial development of certain products produced using our process technologies, sub-optimal economic returns and capital commitments that negatively impact our business, and our ability to successfully pursue multiple opportunities in parallel.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have entered into and anticipate entering into non-binding letters of intent, side letters, memoranda of understanding, term sheets and other arrangements with potential industry partners and cannot assure you that such arrangements will lead to definitive agreements. If we are unable to complete these arrangements in a timely manner and on terms favorable to us, our business will be adversely affected.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have engaged in negotiations with a number of companies and have agreed to preliminary terms regarding the development and commercialization of certain products produced using our process technologies. We may be unable to negotiate final terms in a timely manner, or at all, and there is no guarantee that the terms of any final, definitive, binding agreement will be the same or similar to those currently contemplated in a preliminary agreement. Final terms may be less favorable to us than those set forth in the preliminary agreements. Delays in negotiating final, definitive, binding agreements could slow the development and commercialization of products produced using our process technologies. Failure to agree to final terms for the development and commercialization of such products could prevent us from growing our business, result in wasted resources and cause us to consume capital significantly faster than we currently anticipate.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We continue to face significant risks associated with our international expansion strategy.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are continuing to seek new opportunities to produce and commercialize products using our process technologies outside the United States through entering into licensing and co-development arrangements with new and existing industry partners. Our international business operations are subject to a variety of risks, including:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">challenges associated with operating in diverse cultural and legal environments, including legal restrictions that impact our ability to enter into strategic partnering arrangements;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the need to comply with a variety of U.S. laws applicable to the conduct of overseas operations, including export control laws and the Foreign Corrupt Practices Act and local law requirements;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability, or reduced ability, to protect our intellectual property in certain countries;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential for longer sales cycles in certain countries;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in or interpretations of foreign rules and regulations that may adversely affect our or our industry partners&#8217; ability to produce or sell products manufactured using our process technologies or repatriate profits to the United States;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">economic, political or social instability in foreign countries;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in demand for products produced using our process technologies in international markets;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the imposition of tariffs and other foreign taxes;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the imposition of limitations on, or increase of, withholding and other taxes on remittances and other payments by foreign subsidiaries or joint ventures;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limitations on the production or movement of genetically engineered products or processes and the production or sale of products or processes manufactured using genetically engineered products, into, out of and within foreign countries; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the availability of government subsidies or other incentives that benefit competitors in their local markets that are not available to us.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our inability to overcome these obstacles could harm our business, financial condition and operating results. Even if we are successful in managing these obstacles, our industry partners internationally are subject to these same risks and may not be able to manage these obstacles effectively.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Construction of our or our partners&#8217; plants may not be completed in the expected timeframe or in a cost-effective manner. Any delays in the construction of plants could severely impact our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our projected financial performance and results of operations depend on our ability and our partners&#8217; abilities to construct several commercial scale plants. With respect to these future plants, we and our partners also do not have agreements with engineering, procurement or construction firms. Consequently, we cannot predict on what terms such firms may agree to design and construct future plants.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we and our partners are unable to construct these plants within the planned timeframes, in a cost-effective manner or at all due to a variety of factors, including, but not limited to, a failure to acquire or lease land on which to build plants, a stoppage of construction as a result of the COVID-19 pandemic, the imposition or heightening of sanctions or other economic or military measures in relation to the current Russia-Ukraine conflict, unexpected construction problems, permitting and other regulatory issues, severe weather, labor disputes, and issues with subcontractors or vendors, including payment disputes, our business, financial condition, results of operations and prospects could be severely impacted.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The construction and commission of any new project is dependent on a number of contingencies some of which are beyond our and our partners&#8217; control. There is a risk that significant unanticipated costs or delays could arise due to, among other things, errors or omissions, unanticipated or concealed project site conditions, including subsurface conditions and changes to such conditions, unforeseen technical issues or increases in plant and equipment costs, insufficiency of water supply and other utility infrastructure, or inadequate contractual arrangements. Should these or other significant unanticipated costs arise, this could have a material adverse impact on our business, financial condition, results of operations and prospects. No assurance can be given that construction will be completed on time or at all, or as to whether we and our partners will have sufficient funds available to complete construction.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to continuously reduce operating and capital costs for our and our partners&#8217; facilities that deploy our process technologies may impact adoption of our process technologies and could severely impact our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the date of this prospectus, 12 commercial facilities are either in engineering or under construction utilizing our technology. We anticipate the deployment of numerous commercial facilities to accelerate the commercialization of our process. If we are unable to adequately reduce and control the operating and capital costs of our and our partners&#8217; facilities that deploy our process technologies, we will be unable to realize manufacturing volume and cost targets. We and our partners may have to significantly reduce our spending, delay or cancel our planned activities or substantially change our current business model. This could reduce the market adoption of our process technologies and products, damage our reputation with current or prospective industry partners and investors, and harm our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Maintenance, expansion and refurbishment of our and our partners&#8217; facilities, the construction of new facilities and the development and implementation of our new process technologies or new aspects of our existing process technologies involve significant risks.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our facilities and our partners&#8217; facilities may require regular or periodic maintenance, upgrading, expansion, refurbishment or improvement. Any unexpected operational or mechanical failure, including failure associated with </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">breakdowns and forced outages, could reduce the facilities&#8217; production capacity below expected levels, which would reduce our and our partners&#8217; production capabilities and ultimately our revenues. Unanticipated capital expenditures associated with maintaining, upgrading, expanding, repairing, refurbishing, or improving facilities may also reduce our profitability. Our facilities and our partners&#8217; facilities may also be subject to unanticipated damage as a result of natural disasters, terrorist attacks or other events.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we or our partners make any major modifications to facilities, such modifications likely would result in substantial additional capital expenditures and could prolong the time necessary to bring the facility online. We or our partners may also choose to refurbish or upgrade facilities based on our assessment that such activity will provide adequate financial returns. However, such activities require time for development and capital expenditures before commencement of commercial operations, and key assumptions underpinning a decision to make such an investment may prove incorrect, including assumptions regarding construction costs and timing, which could harm our business, financial condition, results of operations and cash flows.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The construction of new manufacturing facilities entails a number of risks and assumptions, including the ability to begin production within the cost and timeframe estimated and to attract a sufficient number of skilled workers to meet the needs of the new facility. Additionally, our and our partners&#8217; assessment of the projected benefits associated with the construction of new manufacturing facilities is subject to a number of estimates and assumptions, which in turn are subject to significant economic, competitive and other uncertainties that are beyond our control. If we or our partners experience delays or increased costs, our estimates and assumptions are incorrect, or other unforeseen events occur, our business, ability to supply our industry partners, financial condition, results of operations and cash flows could be adversely impacted.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, we may not be successful or efficient in developing or implementing new processes technologies or new aspects of our existing process technologies. Innovation in production processes involves significant expense and carries inherent risks, including difficulties in designing and developing new process technologies, development and production timing delays, lower than anticipated manufacturing yields, and product defects. Disruptions in the production process can also result from errors, defects in materials, delays in obtaining or revising operating permits and licenses, returns of product from our industry partners, interruption in our supply of materials or resources, and disruptions at our or our partners&#8217; facilities due to accidents, maintenance issues, or unsafe working conditions, all of which could affect the timing of production ramps and yields. Production issues can lead to increased costs and may affect our and our partners&#8217; ability to meet product demand, which could adversely impact our business and results from operations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our commercial success may be influenced by the price of fossil feedstocks relative to the price of our waste-based feedstocks.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial success may be influenced by the cost of our and our partners&#8217; products produced using our process technologies relative to fossil feedstock-based products. The cost of fossil feedstock-based products is in part based on the price of fossil feedstocks, which are subject to historically fluctuating prices. If the price of waste-based feedstocks increases and/or the price of fossil feedstocks decreases, products produced using our process technologies may be less competitive relative to fossil feedstock-based products. A material decrease in the cost of conventional fossil feedstock-based products may require a reduction in the prices of products produced using our process technologies for them to remain attractive in the marketplace and may negatively impact our revenues.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fluctuations in the prices of waste-based feedstocks used to manufacture the products produced using our process technologies may affect our or our industry partners&#8217; cost structure, gross margin and ability to compete.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost to produce the products we commercialize with our industry partners is highly dependent on the cost and usage of various waste-based feedstocks. The prices of many of these feedstocks are cyclical and volatile. An increase in the price of the waste-based feedstocks used to manufacture the products produced using our process technologies would likely change our or our industry partners&#8217; cost structure and impact our gross margin. At certain levels, waste-based feedstock prices may make the products produced using our process technologies uneconomical to manufacture.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although there may be indices that show the pricing of the feedstock used for production that closely track to products produced using our process technologies, there are no assurances that these indices will be valid or, if valid, that current prices will not later change. In addition, we may underestimate the volume of feedstock required to operate at commercial scale. For example, although the feedstock usage quantities are based on predictable chemical reactions, the actual consumption required to produce SAF on a commercial scale may be greater, affecting production cost and impacting production volumes. We cannot control the cost of these feedstocks, and we could underestimate feedstock pricing and volume requirements. These uncertainties could affect our costs, or the costs of our industry partners, and our gross margin. Although we believe that our process technologies can operate on multiple feedstocks in the event that prices of specific feedstocks fluctuate, we have not tested this on a commercial scale and cannot guarantee that feedstocks are interchangeable without requiring significant alterations to our process technologies.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Declines in the prices of feedstocks our competitors use to produce their products could allow them to reduce the prices of their products, which could cause us or our industry partners to reduce the prices of the products produced using our process technologies. This could make it uneconomical for our partners to produce products using our process technologies.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost to produce the products our competitors and our industry partners&#8217; competitors are commercializing and attempting to commercialize is highly dependent on the cost and usage of various feedstocks. The cost to produce ethanol by our competitors is highly dependent on the prices of corn, sorghum, barley, sugar cane and sugar beets. The prices of many of these feedstocks are cyclical and volatile. Declines in the prices of the feedstocks our competitors use to produce their products could allow our competitors to reduce the prices of their products. This in turn could cause our industry partners to have to reduce the prices of any competing products that are commercialized using our process technologies, or make it uneconomical for our partners to produce products using our process technologies, which would reduce the revenues we generate in connection with our partners&#8217; sale of such products. Even the perception of future declines in the feedstocks our competitors utilize may adversely affect the prices our industry partners can obtain from our industry partners or prevent potential industry partners from entering into agreements to buy products produced using our process technologies.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If the availability of the waste-based feedstocks used in our process technologies declines or competition for them increases, we or our business partners may experience delayed or reduced production or be required to raise the prices of the products produced using our process technologies, either of which could reduce the demand for the products produced using our process technologies and our revenue.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The production of products using our process technologies will require large volumes of waste-based feedstocks. We cannot predict the future availability of any waste-based feedstock necessary to produce products using our process technologies. The supply of waste-based feedstocks might be impacted by a wide range of factors, including increased competition, weather conditions, natural disasters, droughts, floods, changes in the waste-producing industries, the imposition or heightening of sanctions or other economic or military measures in relation to the current Russia-Ukraine conflict, or government policies and subsidies. Declines in the availability of the waste-based feedstocks used to produce products using our process technologies could cause delays or reductions in production, increases in the prices of products produced using our process technologies, and reductions in demand for products produced using our process technologies, resulting in reduced revenue for us.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We compete in an industry characterized by rapidly advancing technologies, intense competition and a complex intellectual property landscape, and our failure to successfully compete with other companies in our industry may have a material adverse effect on our business, financial condition and results of operations and market share.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we do not believe we have any direct competitors, there can be no assurance that we will not have direct competition in the future, that such competitors will not substantially increase the resources devoted to the development and marketing of their products and services that compete with us, or that new or existing competitors will not enter the market in which we are active.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face substantial indirect competition from many different sources, including companies that enjoy competitive advantages over us, such as greater financial, research and development, manufacturing, personnel and </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">marketing resources, greater brand recognition, stronger historical relationships with their customers and more experience and expertise in intellectual property rights and operating within certain international locations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These competitors may introduce competing products without our prior knowledge and without our ability to take preemptive measures in anticipation of their commercial launch. Competition may increase further as a result of greater availability of capital for investment and increased interest in our industry as more companies seek to facilitate the development of a circular carbon economy. Our competitors may succeed in developing, acquiring or licensing on an exclusive or non-exclusive basis technologies that are more effective or less costly than those we have developed. Our failure to successfully compete may have a material adverse effect on our business, financial condition and results of operations and diminish our market share.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Technological innovation by others could render our technology and the products produced using our process technologies obsolete or uneconomical.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fuel and chemical industries are characterized by rapid and significant technological change. Our success will depend on our ability to maintain a competitive position with respect to technological advances. Our technology and the products derived from our technology may be rendered obsolete or uneconomical by technological advances by others, more efficient and cost-effective products, or entirely different approaches developed by one or more of our competitors or other third parties. Though we plan to continue to expend significant resources to enhance our technology platform and processes, there are no assurances we will be able to keep pace with technological change.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our financial results could vary significantly from quarter to quarter and are difficult to predict.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial results could vary significantly from quarter to quarter because of a variety of factors, many of which are outside of our control and are difficult to predict. As a result, comparing our results of operations on a period-to-period basis may not be meaningful. In addition to the risk factors stated herein, other factors that could cause our quarterly results of operations to fluctuate include:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">achievement of, or failure to achieve, technology or product development milestones needed to allow us to enter identified markets on a timely and cost-effective basis;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays or greater than anticipated expenses associated with the scale-up and the commercialization of process technologies to produce new products;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the amount that we invest to develop, acquire or license new technologies and processes;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully enter into partnering arrangements, and the terms of those relationships (including levels of related capital contributions);</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fluctuations in the prices or availability of the feedstocks required to produce products using our process technologies or those of our competitors;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the size and complexity of our organization, including our expanded operations as a public company;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in general economic, industry and market conditions, both domestically and in our foreign markets;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">business interruptions, including disruptions in the production process at any facility where products produced using our process technologies are manufactured;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">departure of executives or other key management employees;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the needs for the products produced using our process technologies;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the development of new competitive technologies or products by others and competitive pricing pressures;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing, size and mix of sales to our industry partners for products produced using our process technologies;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seasonal production and the sale of products produced using our process technologies; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in governmental, accounting and tax rules and regulations, environmental, health and safety requirements, and other rules and regulations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to these and other factors, our financial results for any quarterly or annual period may not meet our expectations or the expectations of our investors and may not be meaningful indications of our future performance.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our financial projections may differ materially from actual results.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial projections are based on our estimates and assumptions concerning various factors which are subject to significant risks and uncertainties, many of which are beyond our control, and therefore actual results may differ materially. These estimates and assumptions include, among others: estimates of the total addressable market for products produced using our process technologies; assumptions regarding industry partner demand and performance under existing agreements and industry partner agreements currently under negotiation; estimates of the rate at which project starts can be achieved; assumptions regarding our ability to identify and convert new customers; estimates of our ability to retain and add capacity with existing customers; assumptions regarding our ability to negotiate and structure product offtake; estimates of the rate and timelines at which certain project development milestones can be achieved; assumptions regarding our ability to scale production to meet current and future demand; and assumptions regarding research, product development, product timelines, operational execution and demand. These estimates and assumptions are subject to various factors beyond our control, including, for example, changes in industry partner demand, changes in the supply of feedstock, increased construction costs for our plants, changes in the regulatory environment, the impact of global health crises (including the COVID-19 pandemic), the imposition or heightening of sanctions or other economic or military measures in relation to the current Russia-Ukraine conflict, and changes in our executive team. Notably, our financial projections reflect assumptions regarding contracts that are currently under negotiation with, as well as indications of interest from, potential industry partners who may withdraw at any time. Accordingly, our future financial condition and results of operations may differ materially from our projections and expectations. Our failure to achieve our projected results could harm the trading price of our securities and our financial position.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may require substantial additional financing to fund our operations and complete the development and commercialization of the process technologies that produce each of our products or new aspects of our existing process technologies that produce each of our products, and we may not be able to do so on favorable terms.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations have consumed substantial amounts of cash since inception, and we expect to substantially increase our spending, in particular, as we:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">enter into and engage in strategic partnering arrangements to produce products cost-effectively at acceptable quality levels and price points, including making capital contributions for the construction of certain plants;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">invest in developments with respect to our existing process technologies in order to increase their effectiveness or reduce related capital expenditures;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expand our research and development efforts;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">grow our business organization;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pursue select co-development opportunities;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seek to identify additional market opportunities for the products produced using our process technologies; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pursue partnering arrangements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our existing cash and cash equivalents will be sufficient to fund our operations for at least 12 months from the date of this prospectus. However, changing circumstances may cause us to consume capital significantly faster than we currently anticipate, and we may need to spend more money than currently expected because of circumstances beyond our control. Moreover, we and our industry partners may experience delays in the production of commercial quantities of products, in a manner that is cost-effective and at suitable quality levels, which would postpone our ability to generate revenue associated with the sale of such products. Securing additional financing could require a substantial amount of time and attention from our management and may divert a disproportionate amount of its attention away from our business activities, which may adversely affect our ability to conduct our day-to-day operations. In addition, we cannot guarantee that future financing will be available in sufficient amounts or on terms acceptable to us, if at all. If we are unable to raise additional capital when required or on acceptable terms, we may be required to:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delay or suspend some or all of our commercialization efforts;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">decrease or abandon some or all of our research and development efforts;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">decrease the financial resources dedicated to our partnering efforts, which may substantially postpone the development, manufacture, marketing or sale of existing and future products produced using our process technologies; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">suspend the growth of our organization.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To raise additional funds to support our business operations, we may sell additional equity, or convertible debt securities, which would result in the issuance of additional shares of our capital stock and dilution to our stockholders. The incurrence of indebtedness would result in increased fixed payment obligations and could also result in certain restrictive covenants, such as limitations on our ability to incur additional debt, limitations on our ability to acquire, sell or license intellectual property rights and other operating restrictions that could adversely impact our ability to conduct our business. If we are unable to raise additional capital in sufficient amounts or on terms acceptable to us, we will be prevented from pursuing discovery, development and commercialization efforts and our ability to generate revenues and achieve or sustain profitability will be substantially harmed.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to manage our growth and expand our operations successfully, our reputation and brand may be damaged and our business and results of operations may be harmed.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the past several years, we have experienced significant expansion of our business. We expect this growth to continue and accelerate in the future in connection with our commercialization efforts, expanded research and development activities, and as we transition to operating as a public company. Our ability to effectively manage our anticipated growth and expansion of our operations will require us to do, among other things, the following:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">enhance our operational, financial and management controls and infrastructure, human resource policies, and reporting systems and procedures;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">effectively scale our operations;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">successfully identify, recruit, hire, train, maintain, motivate and integrate additional employees;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expand our facilities and equipment; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">effectively manage and maintain our corporate culture.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These enhancements and improvements will require significant capital expenditures and allocation of valuable management and employee resources, and our growth will continue to place a strain on our operational, financial and management infrastructure. Our future financial performance and our ability to execute on our business plan will depend, in part, on our ability to effectively manage any future growth and expansion. There are no guarantees we will be able to do so in an efficient or timely manner, or at all. Our failure to effectively manage growth and expansion could have a material adverse effect on our business, results of operations, financial condition, prospects and reputation.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we lose key personnel or are unable to attract, integrate and retain additional key personnel, it could harm our research and development efforts, delay the commercialization of the new process technologies or the new aspects of our existing process technologies, delay the launch of process technologies in our development pipeline and impair our ability to meet our business objectives.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business involves complex operations spanning a variety of disciplines and demanding a management team and employee workforce that is knowledgeable in the many areas necessary for our operations. The loss of any key member of our management team or key research and development or operational employees, or the failure to attract and retain such employees, could prevent us from developing and commercializing new process technologies or the new aspects of our existing process technologies, delay the launch of process technologies in our development pipeline and impair our ability to meet our business objectives.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be able to attract or retain qualified employees due to the intense competition for qualified personnel among technology-based businesses, or due to the scarcity of personnel with the qualifications or experience necessary for our business. Hiring, training and successfully integrating qualified personnel into our operations can be a lengthy and expensive process, and efforts to integrate such personnel may not be successful. The market for qualified personnel is very competitive because of the limited number of people available with the necessary technical skills and understanding of our technology, and given the number of companies in this industry seeking this type of personnel. If we are not able to attract, integrate and retain the necessary personnel to accomplish our business objectives, we may experience staffing constraints that will adversely affect our ability to support our internal research and development programs. In particular, our production process development, process engineering, research and development, and plant operations programs are dependent on our ability to attract, integrate and retain highly skilled scientific, technical and operational personnel. Competition for such personnel from numerous companies and academic and other research institutions may limit our ability to do so on acceptable terms, or at all. As we continue to expand our international operations, these personnel-related risks will increase and we will face additional geography-specific challenges, such as challenges hiring, training, and relocating employees to specific regions or countries and differing tax and regulatory regimes.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Even if we successfully develop process technologies that produce products meeting our industry partners&#8217; specifications, the adoption of such process technologies by our industry partners may be delayed or reduced, or our costs may increase, due to customer qualification, negative life cycle assessment or capital investment procedures.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if the products produced using our process technologies are produced at contractual or targeted specifications, as the case may be, we or our industry partners may face delays or reduced demand for such products related to current or future customer qualification trials that could take several months, complicated life cycle assessments, or capital investment procedures. For the products produced using our process technologies to be accepted, our industry partners may need to test and certify them for use in their processes and, in some cases, determine whether products that contain the products produced using our process technologies satisfy additional third-party specifications. We may need to demonstrate to our industry partners that the products produced using our process technologies do not contain impurities that cause such products to behave differently than their traditional equivalents in a way that impacts their end-product quality. Our industry partners, in turn, may need to validate the use of the products produced using our process technologies for third parties. Our products may require lengthy and complex life cycle assessments to evaluate the potential environmental impacts of the products through their entire life cycles, covering all relevant inputs from, and emissions into, the environment. Our industry partners&#8217; customers may need to engage in capital investment procedures to assess their abilities to invest in our products, which may result in those customers determining not to allocate their resources to purchasing our products. Meeting these suitability standards could be a time-consuming and expensive process, and our industry partners may invest substantial time and resources into such qualification efforts without ultimately securing approval by their customers. This could materially and adversely impact our revenues until customer qualification, positive life cycle assessment or capital investment procedures are achieved and maintained.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure of LanzaJet to complete its initial facility or failure of third parties to adopt the LanzaJet process in their commercial facilities for the production of SAF could result in us never owning a majority stake in LanzaJet and may severely impact our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the LanzaJet Investment Agreement, described in more detail in the section entitled &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business &#8212;&#8201;Key Collaboration Agreements &#8212; LanzaJet Agreements &#8212; LanzaJet Amended and Restated Investment Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; Mitsui, Suncor Energy Inc. (&#8220;Suncor&#8221;), British Airways PLC, a subsidiary of International Consolidated Airlines Group (&#8220;British Airways&#8221;) and Shell Ventures LLC (&#8220;Shell&#8221;) have committed to invest in LanzaJet a total of up to $120 million in second tranche investments upon the achievement of certain development milestones relating to an initial demonstration facility located at the LanzaTech Freedom Pines Biorefinery in Soperton, Georgia (the &#8220;Soperton facility&#8221;). Pursuant to the LanzaJet Investment Agreement, $45 million has already been invested in setting up LanzaJet and in constructing the Soperton facility. Our partners have likewise agreed to determine the feasibility of developing additional potential facilities for the commercial scale production of alcohol-to-jet (&#8220;ATJ&#8221;) fuel.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although LanzaJet is currently working with the partners mentioned above to confirm project locations and solidify the appropriate project structures, and we are developing projects ourselves to construct and operate facilities that would use the LanzaJet process, there is no guarantee that these facilities will be completed or that third parties will adopt the LanzaJet process in their commercial facilities for the production of SAF. The failure of LanzaJet to complete its initial facility or of third parties to adopt the LanzaJet process in their commercial facilities could severely impact our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, we currently have a 25% voting interest in LanzaJet and are not currently able to make decisions on behalf of LanzaJet without support from other shareholders. We will remain a minority shareholder in LanzaJet unless we are issued shares pursuant to the LanzaJet Amended and Restated Investment Agreement upon the closing of at least two of the second tranche investments by any of Mitsui, Suncor, British Airways and Shell. The conditions for these second tranche investments include performance requirements at the Soperton facility, regulatory approvals, the negotiation of additional agreements and other conditions which are outside our control. These conditions have not been, and may never be, met. As such, we cannot guarantee when or whether we will become majority shareholders in, or exercise control over, LanzaJet at any time in the future.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LanzaJet has an exclusive license to some of our intellectual property related to SAF.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the LanzaJet Investment Agreement, we entered into an intellectual property and technology license agreement (the &#8220;LanzaJet License Agreement&#8221;) with LanzaJet. Pursuant to the LanzaJet License Agreement, we granted to LanzaJet a perpetual, worldwide, non-transferrable, irrevocable, royalty-free, sublicensable, exclusive license to certain intellectual property related to the conversion of ethanol to fuel. This license is exclusive including as to us. With the exception of certain pre-existing SAF obligations and development projects for which we have already been granted sublicenses, we are unable to undertake new SAF production opportunities using the licensed intellectual property, or otherwise use such intellectual property for the conversion of ethanol to fuel, without the prior consent of LanzaJet while the LanzaJet License Agreement is in effect. We cannot guarantee that LanzaJet would grant such consent or otherwise agree to grant to us a license of intellectual property and our receipt thereof would depend on negotiations with our fellow shareholders of LanzaJet.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the LanzaJet Shareholder Loan described in more detail in the section entitled &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain Relationships and Related Party Transactions &#8212; Legacy LanzaTech Related Party Transactions &#8212; LanzaJet Shareholder Loan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; LanzaJet collaterally assigned its license from LanzaTech to secure the LanzaJet Freedom Pines Fuels LLC (&#8220;FPF&#8221;) shareholder debt. In the event of a default by FPF, LanzaJet shareholders could prevent LanzaJet from funding FPF to cure its default and ultimately foreclose on LanzaJet&#8217;s license.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our and our industry partners&#8217; failure to accurately forecast demand for any product produced using our process technologies could result in an unexpected shortfall or surplus that could negatively affect our results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the length of time it takes to develop and commercialize the products produced using our process technologies, we and our industry partners must make development and production decisions well in advance of </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">commercial production and sale of such products. Our and our industry partners&#8217; ability to accurately forecast demand for any of the products produced using our process technologies that are commercialized can be adversely affected by a number of factors, many of which are outside of our control, including actions by our competitors, changes in market conditions, environmental factors and adverse weather conditions. A shortfall or surplus in the supply of products produced using our process technologies may reduce our revenues, damage our reputation and adversely affect industry partner relationships, which could harm our business, results of operations and financial condition.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our success is highly dependent on our ability to maintain and efficiently utilize our technology platform, and to effectively identify potential products for which to develop and commercialize new process technologies, and problems related to our technology platform could harm our business and result in wasted research and development efforts.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are highly dependent on our technology platform for the development and commercialization of products and new process technologies. If we experience challenges in our technology platform, such as problems with engineering new microbes, or if we encounter problems interpreting and analyzing data using our process technologies, our business and ability to compete may be harmed and our financial condition negatively affected.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be successful in identifying new market opportunities and needs and developing our technology platform, or process technologies to produce products to meet those needs, which would limit our prospects and lead to greater dependency on the success of a smaller number of target products.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our business model depends in part on our ability to identify new market opportunities and needs for our technology platform, or process technologies to produce products to meet those needs. The manufacturing technologies we research and develop are new and continuously changing and advancing. The products that are derived from these technologies may not be applicable or compatible with demands in existing or future markets. Furthermore, we may not be able to identify new opportunities as they arise for products since future applications of any given product may not be readily determinable, and we cannot reasonably estimate the size of any markets that may develop. If we are not able to successfully identify new market opportunities and needs and develop new technologies, processes or products to meet those needs beyond those we currently develop, we may be unable to expand our business and will therefore be highly dependent on the revenues related to the products that can currently be produced using our process technologies.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our failure or the failure of our industry partners to realize expected economies of scale could limit our or our partners&#8217; ability to sell products produced using our process technologies at competitive prices, negatively impact our ability to enter into other strategic arrangements and the potential for other industry partners to adopt our process technologies, and materially and adversely affect our business and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our industry partners may be unable to realize expected economies of scale in connection with scale up and commercialization efforts. The failure to achieve these efficiencies or realize these expected benefits could negatively impact our or our industry partners&#8217; ability to sell products produced using our process technologies at competitive prices, negatively impact our ability to enter into other strategic arrangements and the potential for other industry partners to adopt our process technologies, and materially and adversely affect our business and prospects.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our microbial protein products business, which allows for the extraction of spent microbes that contain protein and other valuable nutrients which can then be used in numerous applications, may not develop as currently expected.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Microbial protein is composed of spent microbes from LanzaTech commercial facilities. These microbes are comprised of proteins and other valuable nutrients and have performed the task of gas fermentation, have been extracted from the relevant commercial unit and are no longer viable. These materials can be isolated and used in numerous applications, including feed products for livestock and fish, fertilizers for agricultural applications, and protein extract-based products. While we believe many of these markets are large and diverse, with stakeholders actively seeking sustainable and nutritious inputs, we cannot be certain that these markets will materialize or that customers will purchase our protein products in sufficient quantities. With only one commercial customer that is currently selling residual microbial protein as a component in fish and livestock feed products, this business has a </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">limited commercial history. Our protein products business may not develop to the extent currently expected, which may adversely affect our business and prospects.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Natural or man-made disasters, social, economic and political instability, and other similar events may significantly disrupt our and our industry partners&#8217; businesses, and negatively impact our results of operations and financial condition.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate headquarters are located in Skokie, Illinois and we work with industry partners in multiple other locations, including in China, Japan, India, Canada, Australia, Italy, Spain, UK, Netherlands and South Africa. These locations, in particular a number of our current and potential non-U.S. locations, may be subject to social, economic and political instability, such as social uprisings. Any of our or our industry partners&#8217; facilities may be harmed or rendered inoperable by natural or man-made disasters, including earthquakes, tornadoes, hurricanes, wildfires, floods, tsunamis, nuclear disasters, acts of terrorism or other criminal activities, the imposition or heightening of sanctions or other economic or military measures in relation to the current Russia-Ukraine conflict, infectious disease outbreaks and power outages, which may render it difficult or impossible for us or our industry partners to operate our businesses for some period of time. Our and our industry partners&#8217; facilities would likely be costly to repair or replace, and any such efforts would likely require substantial time. Any disruptions in our or our industry partners&#8217; operations could negatively impact our business and results of operations, and harm our reputation. Our or our industry partners&#8217; disaster recovery plans may not be sufficient to address an actual disaster, in particular any events that negatively impact our or our industry partners&#8217; physical infrastructures. In addition, we and our industry partners may not carry sufficient business insurance to compensate for losses that may occur. Any such losses or damages could have a material adverse effect on our results of operations and financial condition, and success as an overall business.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Governmental programs designed to incentivize the production and consumption of low-carbon fuels and carbon capture and utilization, may be implemented in a way that does not include products produced using our novel technology platform and process technologies or could be repealed, curtailed or otherwise changed, which would have a material adverse effect on our business, results of operations and financial condition.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and other participants in the biomass-based and low-carbon fuel industry rely on governmental programs requiring or incentivizing the production and consumption of fuels with lower carbon intensity than conventional fossil fuels and carbon capture and utilization. Biomass-based and low-carbon fuel has historically been more expensive to produce than petroleum-based fuel and these governmental programs support a market for biomass-based and low-carbon fuel that might not otherwise exist.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One of the most important of these programs is the Renewable Fuel Standard II (&#8220;RFS II&#8221;), a Federal law which requires that transportation fuels in the United States contain a minimum amount of renewable fuel. This program is administered by the Environmental Protection Agency (&#8220;EPA&#8221;). The EPA&#8217;s authority includes setting annual minimum aggregate levels of consumption in four &#8220;nested&#8221; renewable fuel categories, including categories in which our fuel competes (including advanced biofuel, biomass-based diesel and cellulo biofuel). The parties obligated to comply with this renewable volume obligation (&#8220;RVO&#8221;), are petroleum refiners and petroleum fuel importers. The petroleum industry is strongly opposed to the RFS II program and can be expected to continue to press for changes both in the RFS II program itself and in the way that it is administered by the EPA. The EPA has not approved LanzaTech-derived ethanol from industrial emissions as a Renewable Identification Number (&#8220;RIN&#8221;) generating fuel (i.e., a fuel that generates credits) under the RFS II program.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United States Congress could repeal, curtail or otherwise change the RFS II program in a manner adverse to us, such as by excluding products produced using our novel technology platform and process technologies. Similarly, the EPA could curtail or otherwise change its administration of the RFS II program in a manner adverse to us, including by not increasing or even decreasing the RVO, by waiving compliance with the RVO or otherwise. Furthermore, judicial review of the EPA&#8217;s actions, including any judicial decisions that the EPA failed to adequately evaluate the environmental impacts of RFS II, could create uncertainty in the administration of the RFS II program. In addition, while Congress specified RFS II volume requirements through 2022 (subject to adjustment in the rulemaking process), beginning in 2023 required volumes of renewable fuel will be largely at the discretion of the EPA (in coordination with the Secretary of Energy and Secretary of Agriculture), which must set the volumes after </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">evaluating a set of particular statutory factors. We cannot predict what changes, if any, will be instituted or the impact of any changes on our business, although adverse changes could seriously harm our business, results of operations and financial condition.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The California Low Carbon Fuel Standard (&#8220;LCFS&#8221;), is another program that provides a strong incentive for production of renewable diesel and alternative jet fuel, and fuels produced through methods involving carbon capture and utilization. The LCFS could be repealed or amended in a manner that eliminates or reduces this incentive, or could be implemented in a way that excludes or negatively affects products produced using our novel technology platform, such as by assigning a lower carbon intensity to a fuel pathway produced using a competitor&#8217;s technology.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, while the efforts of other jurisdictions to mitigate climate change are expected to result in the adoption of similar programs as the RFS II program or LCFS, increasing stakeholder scrutiny of the greenhouse gas (&#8220;GHG&#8221;), reduction benefits attributable to low-carbon fuels production and consumption could dampen interest in the adoption of similar programs. While the products produced using our process technologies generally compare favorably with conventional low-carbon fuels, public sentiment against reliance upon low-carbon fuels or carbon capture and utilization as pathways to deep decarbonization could adversely affect our market opportunities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any decline in the value of carbon credits or other incentives associated with products produced using our process technologies could harm our results of operations, cash flow and financial condition.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The value of products produced using our process technologies may be dependent on the value of carbon credits, programs relating to low-carbon materials and products standards and other similar regulatory regimes or the implicit value of decarbonized materials. The value of these credits fluctuates based on market and regulatory forces outside of our control. There is a risk that the supply of low-carbon alternative materials and products outstrips demand, resulting in the value of carbon credits declining. Any such declines could mean that the economic benefits from our industry partners&#8217; efforts to de-carbonize their operations might not be realized. Any decline in the value of carbon credits or other incentives associated with products produced using our process technologies could harm our results of operations, cash flow and financial condition. The value of carbon credits and other incentives may also be adversely effected by legislative, agency, or judicial determinations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We expect to rely on a limited number of industry partners for a significant portion of our near-term revenue.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently have agreements with a limited number of industry partners, including Suncor, IndianOil Corporation Limited (&#8220;IndianOil&#8221;), Mitsui, Sekisui Chemical Co., Ltd. (&#8220;Sekisui&#8221;) and the Shougang Joint Venture, from which we expect to generate most of our revenues through the end of 2023. Entities in which the Shougang Joint Venture holds a controlling interest operate the three currently operating commercial scale facilities that produce low carbon ethanol using our process technology. In addition, a commercial scale facility is in advanced stages of construction by our partner ArcelorMittal. The facility is expected to begin commissioning in the coming months. The loss of one or more of our industry partners, a substantial reduction in the scope of their projects, their failure to exercise customer options, their unwillingness to extend contractual deadlines if we are unable to meet production requirements, their inability to perform under their contracts or a significant deterioration in their financial condition could harm our business, results of operations and financial condition. If we fail to perform under the terms of these agreements, the industry partners could seek to terminate these agreements or pursue damages against us, including liquidated damages in certain instances, which could harm our business.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We and our industry partners are subject to extensive international, national and subnational laws and regulations, and any changes in relevant laws or regulations, or failure to comply with these laws and regulations, could have a material adverse effect on our business and could substantially hinder our and our partners&#8217; ability to manufacture and commercialize products produced using our process technologies.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our industry partners are subject to extensive international, national and subnational laws and regulations relating to the production of renewable fuels, the protection of the environment and in support of the </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ethanol industry at large. These laws, their regulatory requirements and their implementation and enforcement impact our existing and potential business operations by imposing restrictions on our and our industry partners&#8217;:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">existing and proposed business operations or the need to install enhanced or additional controls&#894;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">need to obtain and comply with permits and authorizations&#894;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">liability for exceeding applicable permit limits or legal requirements&#894;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">specifications related to the ethanol and other products we or our industry partners market and produce using our process technologies;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">criteria for assessing the carbon intensity and GHG emissions attributable to fuels produced using our process technologies.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we and our industry partners may be involved in administrative or legal proceedings under the Comprehensive Environmental Response, Compensation, and Liability Act of 1980, the Resource Conservation and Recovery Act of 1976 (&#8220;RCRA&#8221;) in the United States, and similar environmental laws across the globe relating to the designation of certain sites for investigation or remediation with respect to environmental risks, the disposal of hazardous waste, and reduction of the hazards associated with storage, handling and transportation of the products we and our industrial partners produce. Potential consequences of these proceedings can include the need to pay for remediation of contaminated sites, the costs of which can be significant and uncertain.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Likewise, in the normal course of business, we and our industry partners may need to obtain and comply with air emissions permits pursuant to the Clean Air Act of 1963 and water discharge permits pursuant to the Clean Water Act of 1972 in the United States, and similar environmental permits and authorizations across the globe relating to air and water emissions. Potential changes to regulatory, permit and authorization standards, requirements or processes may result in uncertainty and additional costs for us and our industry partners.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, GHG emissions are subject to environmental laws and regulations in the various jurisdictions in which we and our industry partners have operations. Some of our and our industry partners&#8217; operations are within jurisdictions that have or are developing regulatory regimes governing emissions of GHGs, including carbon dioxide (&#8220;CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). These include existing coverage under the European Union Emission Trading System, the California cap and trade scheme, India&#8217;s Performance, Achieve and Trade scheme, South Africa&#8217;s Trade Exposure and Greenhouse Gas Benchmark Regulations, the Tokyo Cap-and-Trade Program, China&#8217;s Emission Trading Scheme, related subnational programs and any potential expansions of these policies or related policies. In addition, the EPA requires mandatory reporting of GHG emissions and is regulating GHG emissions for new construction and major modifications to existing facilities. The EPA and California also regulate the amount of GHGs that may be emitted by new motor vehicles, including passenger cars, and new commercial airplanes. These and related regulations could be implemented and developed in ways that reduce or eliminate reliance on carbon-based fuels in transportation, for example, by hastening the widespread adoption of electricity or hydrogen as a fuel source, in lieu of low-carbon fuels, for certain categories of transportation vehicles.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increased public concern surrounding the emission of GHGs may result in more international, national or subnational requirements to reduce or mitigate the effects of GHG emissions. Although uncertain, these developments could increase the costs related to the application of our fermentation technology. Additionally, although governmental policies to reduce GHG emissions may continue to incentivize the production of low-carbon fuels and carbon capture, it is also possible that such policies could be altered in a way that may negatively impact our growth, increase our and our industry partners&#8217; operating costs, or reduce demand for our technology. We cannot predict the manner or extent to which such policy or legislation may affect our industry partners and ultimately harm or help our business or the carbon capture industry in general.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business could be affected in the future by additional international, national and subnational regulation, pricing of GHG emissions or other climate change legislation, regulation or agreements. It is difficult at this time to estimate the likelihood of passage, or predict the potential impact, of any additional legislation, regulations or </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">agreements. Potential consequences of new obligations could include increased technology, transportation, material, and administrative costs and may require us to make additional investments in our operations. As we continue distributing our technology to our target markets, international, national or subnational government entities may seek to impose regulations or competitors may seek to influence regulations through lobbying efforts.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any changes in laws or regulations or failure by us or our industry partners to comply with applicable regulatory laws and regulations could have a material adverse effect on our reputation as well as our business, results of operations and financial condition and could substantially hinder our and our partners&#8217; ability to manufacture and commercialize products produced using our process technologies.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our success may be dependent on popular, government and corporate sentiment regarding the production of carbon-based fuels and chemicals and the development and deployment of carbon capture and utilization technology.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At present, we believe that popular, government and corporate sentiment largely favors the production of carbon-based fuels and chemicals and the development and deployment of carbon capture and utilization technology, which has led to many national governments&#8217; enactment of policies and incentives that favor the production of the fuels and chemicals we manufacture and the processes we have developed to create them. However, there are a number of scientists, policy makers and other actors who believe carbon capture and utilization technologies will simply prolong the life of high-carbon sectors and impede the transition to renewable energy sources. Such individuals believe that using the carbon capture and utilization process to produce fuels, such as ethanol, simply defers the emission of CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> into the atmosphere and that anything that promotes the adoption of low-carbon fuels and advanced liquid fuels (other than hydrogen produced via electrolysis) will result in &#8220;locking in&#8221; a carbon economy from which the world should be moving away. These scientists, policy makers and other actors advocate for the adoption of regulations and incentives that would reduce or eliminate reliance on carbon-based fuels in favor of the adoption of electricity and hydrogen as fuel sources.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If scientists, policy makers and other actors are successful in convincing governments and corporations to enact policies that disfavor, or changes in government administrations result in shifts in policy that disincentivize, the production of carbon-based fuels and the development and deployment of carbon capture and utilization technology, it could negatively impact the demand for products produced using our process technologies and our ability to maintain and develop relationships with our strategic partners, which would harm our business, results of operations and financial condition. The viability of our business model also could be impacted if, over time, popular, government and corporate support gravitates significantly away from the use of carbon-based fuels toward the predominant use of electricity and hydrogen as fuel sources.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We and our industry partners use hazardous materials and must comply with applicable environmental, health and safety laws and regulations. Any claims relating to improper handling, storage or disposal of these materials or noncompliance with applicable laws and regulations could be time consuming and costly and could adversely affect our business and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our industry partners use hazardous chemicals and biological materials and are subject to a variety of international, national and subnational laws and regulations governing the use, generation, manufacture, storage, handling and disposal of these materials, including RCRA and the Occupational Safety and Health Act of 1970. Although we and our industry partners have implemented safety procedures for handling and disposing of these materials and waste products, we cannot be sure that our safety measures are compliant with legal requirements or adequate to eliminate the risk of accidental injury or contamination. In the event of contamination or injury, we could be held liable for any resulting damages, and any liability could exceed our insurance coverage. There can be no assurance that neither we nor any of our industry partners will not violate environmental, health and safety laws as a result of human error, accident, equipment failure or other causes.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compliance with applicable environmental, health and safety laws and regulations is expensive and time consuming, and the failure to comply with past, present or future laws or regulations could result in the imposition of fines, third-party property damage, product liability and personal injury claims, investigation and remediation costs, the suspension of production or a cessation of operations. Our liability in such an event may exceed our total </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">assets. Liability under environmental laws can be joint and several and without regard to comparative fault. Environmental laws and regulations could become more stringent over time, imposing greater compliance costs and increasing risks and penalties associated with violations, which could impair our research, development or production efforts and harm our business. Accordingly, violations of present and future environmental laws or regulations by us or any of our industry partners could restrict our ability to develop and commercialize products using our process technologies, build out or expand facilities, or pursue certain technologies, and could require us and our industry partners to acquire equipment or incur potentially significant costs to comply with environmental regulations. In addition, our hazardous materials and environmental laws and regulations-related risks may augment as we expand our international operations, including imposition of laws and regulations impacting our ability to transfer hazardous chemicals and biological materials between countries.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to product liability claims, which could result in material expense, diversion of management time and attention and damage to our business, reputation and brand.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The products produced using our process technologies that we and our industry partners commercialize may contain undetected defects or impurities that are not discovered until after the products have been used by customers or incorporated into products for end-users. This could result in claims from customers or others, damage to our business and reputation and brand or significant costs to correct the defect or impurity. Therefore, the sale of products produced using our process technologies entails the risk of product liability claims. Any product liability claim brought against us, regardless of its merit, could result in material expense, diversion of management time and attention, damage to our business, reputation and brand and cause us to fail to retain existing industry partners or to fail to attract new industry partners.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ethical, legal and social concerns about genetically engineered products and process technologies that use genetically engineered supplies could limit or prevent the use of products produced using our process technologies and could limit our revenues.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The use of genetically engineered products and process technologies that use genetically engineered supplies is subject to laws and regulations in many countries, including by the EPA under the Toxic Substances Control Act of 1976, some of which are new or still evolving. Public attitudes about the safety and environmental hazards of genetically engineered products and processes, and ethical concerns over genetic research, could influence public acceptance of our technology, processes and products produced using our process technologies that use genetically engineered supplies.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to develop and commercialize one or more of our technologies or process technologies could be limited by additional factors, including:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">public attitudes regarding, and potential changes to laws governing, ownership of genetic material, which could harm our intellectual property rights with respect to our genetic material and discourage others from supporting, developing or commercializing products produced using our process technologies; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">governmental reaction to negative publicity concerning genetically engineered organisms, which could result in greater government regulation of genetic research, greater government regulation of genetic-related feedstock sources, or other adverse governmental regulatory restrictions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The subject of genetically engineered organisms has received negative publicity, which has aroused public debate. This adverse publicity could lead to greater regulation and trade restrictions on imports of genetically engineered products. These trends could result in increased expenses, delays or other impediments to our programs or the public acceptance and commercialization of the products produced using our process technologies.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our genetically engineered microbes may be subject to regulatory scrutiny and may face future development and regulatory difficulties. Additionally, failure to obtain import permits for all relevant microbes in jurisdictions with our industry partners could adversely affect our business and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our genetically engineered microbes may have significantly altered characteristics compared to those found in the wild and may be subject to regulatory scrutiny. As a result, we may be required to implement additional </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">costly measures to obtain and maintain our regulatory permits, licenses, authorizations and approvals. To the extent such regulatory scrutiny or changes impact our ability to execute on existing or new programs for our industry partners, or make doing so more costly or difficult, our business, financial condition, or results of operations may be adversely affected. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because the use of genetically engineered products and process technologies that use genetically engineered supplies is subject to laws and regulations in many countries, some of which are new or still evolving, regulatory requirements, including those related to import permits, may continue to change in various jurisdictions. If such regulatory requirements prevent us from obtaining import permits for jurisdictions where we have industry partners, such changes may impact our ability to execute on existing or new programs for our industry partners, or make doing so more costly or difficult, which may adversely affect our business, financial condition, results of operations, market share and prospects.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our government grants are subject to uncertainty, which could harm our business and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have sought and may continue to seek to obtain government grants in the future to offset a portion of the costs of our research and development, commercialization and other activities. We cannot be certain that we will be able to secure any such government grants in a timely fashion, or at all. Moreover, any of our existing grants or new grants that we may obtain may be terminated, modified or recovered by the granting governmental body. If such grant funding is discontinued, our revenue and cash received from grants will decrease. If we do not receive grants we are counting on, our liquidity will be impacted, which will impact our ability to grow or maintain our business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also be subject to additional regulations and audits by government agencies as part of routine audits of our activities funded by our government grants. As part of an audit, these agencies may review our performance, cost structures and compliance with applicable laws, regulations and standards. Funds available under grants must be applied by us toward the research and development programs specified by the granting agencies, rather than for all of our programs generally. If any of our costs are found to be allocated improperly, the costs may not be reimbursed and any costs already reimbursed may have to be refunded. Accordingly, an audit could result in an adjustment to our revenues and results of operations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The requirements of being a public company may strain our resources and divert management&#8217;s attention, and the increases in legal, accounting and compliance expenses that will result from being a public company may be greater than we anticipate.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Business Combination, we have become a public company, and as such, we have and will continue to incur significant legal, accounting and other expenses that we did not incur as a private company. We are subject to the reporting requirements of the Exchange Act, and we are also required to comply with the applicable requirements of the Sarbanes-Oxley Act and the Dodd-Frank Wall Street Reform and Consumer Protection Act, as well as the rules and regulations subsequently implemented by the SEC and the listing standards of Nasdaq, including changes in corporate governance practices and the establishment and maintenance of effective disclosure and financial controls. Compliance with these rules and regulations can be burdensome. Our management and other personnel have recently devoted and will continue to devote a substantial amount of time to these compliance initiatives. Moreover, these rules and regulations will increase our historical legal and financial compliance costs and will make some activities more time-consuming and costly. For example, these rules and regulations may make it more difficult and more expensive for us to obtain director and officer liability insurance than we obtained as a private company, and could also make it more difficult for us to attract and retain qualified members of the LanzaTech Board as compared to when we were a private company. In particular, we expect to incur significant expenses and devote substantial management effort toward ensuring compliance with the requirements of Section 404 of the Sarbanes-Oxley Act. We are hiring additional accounting and financial staff, and engaging outside consultants, all with appropriate public company experience and technical accounting knowledge and maintaining an internal audit function, which will increase our operating expenses. Moreover, we could incur additional compensation costs in the event that we decide to pay cash compensation closer to that of other public companies, which would increase our general and administrative expenses and could materially and adversely affect our profitability.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our management has limited experience in operating a public company.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our executive officers and directors have limited experience in the management of a publicly traded company subject to significant regulatory oversight and reporting obligations under federal securities laws. Our management team may not successfully or effectively manage our transition to a public company following the Business Combination. Their limited experience in dealing with the increasingly complex laws pertaining to public companies could be a significant disadvantage in that it is likely that an increasing amount of their time may be devoted to these activities, which will result in less time being devoted to our management and growth. We may not have adequate personnel with the appropriate level of knowledge, experience and training in the accounting policies, practices or internal controls over financial reporting required of public companies in the United States. It is possible that we will be required to expand our employee base and hire additional employees to support our operations as a public company, which will increase our operating costs in future periods. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we experience a significant disruption in our information technology systems, including security breaches, or if we fail to implement new systems and software successfully, our business operations and financial condition could be adversely affected.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend on information technology systems to, among other functions, control our manufacturing processes, process orders and invoices, collect and make payments, interact with industry partners and suppliers, manage inventory and otherwise conduct our business. We also depend on these systems to respond to inquiries, contribute to our overall internal control processes, maintain records of our property, plant and equipment and record and pay amounts due to vendors and other creditors. The failure of our information technology systems to perform as we anticipate could disrupt our business and could result in transaction errors, processing inefficiencies and the loss of sales and industry partners. As we implement planned upgrades or changes to systems, we may also experience interruptions in service, loss of data or reduced functionality and other unforeseen material issues which could adversely impact our ability to provide quotes, take orders and otherwise run our business in a timely manner. In addition, if our new systems fail to provide accurate and increased visibility into pricing and cost structures, it may be difficult to improve or maximize our profit margins. As a result, our results of operations could be adversely affected.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, cyber-attacks or security breaches could compromise our trade secrets or other confidential, business critical information, cause a disruption in our operations, or harm our reputation. Our information technology systems are subject to potential disruptions, including significant network or power outages, service disruptions or interruptions from third-party information technology service providers, software or hardware errors, cyberattacks, computer viruses, malware, ransomware events, other malicious codes and/or unauthorized access attempts, denial-of-service attacks, phishing schemes, fraud, or other disruptive problems, any of which, if successful, could result in data leaks or otherwise compromise our confidential or proprietary information and disrupt our operations. Despite our efforts to protect sensitive information and comply with and implement data security measures, there can be no assurance that any controls and procedures that we have in place will be sufficient to protect us. Further, as cyber threats are continually evolving, our controls and procedures may become inadequate and we may be required to devote additional resources to modify or enhance our systems in the future. We may also be required to expend resources to monitor for and remediate cyber-related incidents or to enhance and strengthen our cyber security, including by deployment of additional personnel and technical protection measures, further training of employees, changing vendor control and monitoring practices, and engaging third-party experts and consultants. Any such disruptions to our information technology systems, breaches or compromises of data, or misappropriation of information could result in violation of privacy and other laws, litigation, fines, negative publicity, lost sales or business delays, any of which could have a material adverse effect on our business, financial condition or results of operations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International sales by us and our industry partners expose us and our industry partners to the risk of fluctuation in currency exchange rates and rates of foreign inflation, which could adversely affect our results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we and our industry partners commercialize and sell products produced using our process technologies outside of the United States, a portion of our and our industry partners&#8217; revenues is generated outside of the United States and we derive some of our revenues from our industry partners in their local currencies. As a result, our </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">revenues and results of operations are subject to foreign exchange fluctuations, which we may not be able to manage successfully. We bear the risk that the rate of inflation in the foreign countries where we and our industry partners incur costs and expenses or the decline in value of the U.S. dollar compared to those foreign currencies, will increase our costs as expressed in U.S. dollars. The prices of the products produced using our process technologies may not be adjusted to offset the effects of inflation on our or our industry partners&#8217; cost structure, which could increase costs and reduce net operating margins. If we do not successfully manage these risks through hedging or other mechanisms, our revenues and results of operations could be adversely affected.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in interest rates and capital availability may impact investment and financing decisions by our industry partners, which could adversely affect our results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend on partnering, licensing, and contractual relationships with our industry partners that implement our process technologies, as well as investments by such partners, as a significant source of financing. Changes in credit and capital market conditions, including changes in interest rates and capital availability, may increase the cost of financing for our industry partners, which may limit their ability or willingness to enter into partnering agreements with us or to further invest in their facilities that implement our process technologies. Such changes may also make it more difficult for us to obtain favorable terms for any future partnership arrangements. To the extent that these changes impact investment and financing decisions by our industry partners in a manner that is adverse to us, such changes could adversely affect our results of operations. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any failure by us to manage acquisitions and other significant transactions successfully may have a material adverse effect on our results of operations, financial condition, and cash flows.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may consider opportunities to acquire other companies, products or technologies that may enhance our capabilities, expand the breadth of our markets or partner base, or advance our business strategies. Potential acquisitions involve numerous risks, including: problems assimilating the acquired service offerings, products or technologies, issues maintaining uniform standards, procedures, quality control and policies, unanticipated costs associated with acquisitions, diversion of management&#8217;s attention from our existing business, risks associated with entering new markets in which we have limited or no experience, increased legal and accounting costs relating to the acquisitions or compliance with regulatory matters, and unanticipated or undisclosed liabilities of any target.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have no current commitments with respect to any acquisition. We do not know if we will be able to identify acquisitions we deem suitable, whether we will be able to successfully complete any such acquisitions on favorable terms or at all, or whether we will be able to successfully integrate any acquired service offerings, products or technologies. Our potential inability to manage acquisitions and other significant transactions successfully or to integrate any acquired business, products or technologies effectively may adversely affect our business, results of operations and financial condition.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We believe our company culture has contributed to our success, and if we cannot maintain this culture as we grow and, in particular, become a public company, our business could be harmed.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our culture has contributed to our success to date. We have invested in building a strong corporate culture and believe it is one of our most important and sustainable sources of competitive advantage. Our corporate culture is team-oriented, community-based and rooted in company values to promote close alignment between employees throughout the organization. Community strengthening events and team activities encourage cross-team and cross-location interactions. This foundation promotes an understanding of our organizational values and ensures that our team members stand for and contribute to the vision and objectives of the company. Any failure to maintain our culture could negatively affect our ability to retain and recruit personnel, which is critical to our growth, and to effectively focus on and pursue our corporate objectives. In addition, as we develop the systems and processes associated with being a public company, we may find it difficult to maintain these important aspects of our culture. Furthermore, as we grow and evolve on an international scale, we may find it increasingly difficult to maintain these beneficial aspects of our corporate culture throughout our global footprint. If we fail to maintain our corporate culture, or if we are unable to retain or hire key personnel that contribute positively to our corporate culture, our business and competitive position may be harmed.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Causes of supply chain challenges, including COVID-19, could result in delays or increased costs for us and our partners deploying our technologies.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The products that we and our partners produce using our process technologies must be delivered to our industry partners and involve a variety of inputs which must be procured and delivered to our facilities. Our suppliers, sub-contractors and industry partners have been disrupted by certain issues related to the COVID-19 pandemic, including worker absenteeism, quarantines, restrictions on employees&#8217; ability to work, office and factory closures, disruptions to ports and other shipping infrastructure, border closures or other travel or health-related restrictions. Supply chain disruptions may also occur from time to time due to a range of factors beyond our control, including, but not limited to, climate change, increased costs of labor, freight costs and raw material prices along with a shortage of qualified workers. Such issues may cause delays in the delivery of, or increases in the cost of, the inputs used in our process technologies, potentially resulting in delays or increased costs for us and our partners deploying our technologies or for our industry partners purchasing our products, which may materially impact our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We and our industry partners have a limited operating history utilizing our technology and different feedstocks, which may make it difficult to evaluate our future viability and predict our future performance.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our partners have a limited operating history utilizing our process technologies and different feed stocks on which to base an evaluation of our business and prospects. Our operating results are not predictable and our historical results may not be indicative of our future results. Few peer companies with our business model exist and none have yet established long-term track records at scale that might assist us in predicting whether our business model and strategy can be implemented and sustained over an extended period of time. It may be difficult for you to evaluate our potential future performance without the benefit of established long-term track records from companies implementing a similar business model. We may encounter unanticipated problems as we continue to refine our business model and process technologies, and may be forced to make significant changes to our anticipated sales and revenue models to compete with our competitors&#8217; offerings, which may adversely affect our results of operations and profitability. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have not yet generated material revenues from marketing of CarbonSmart products and our revenue forecast must be considered in light of the uncertainty and risks frequently encountered by companies in their early stage of development.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not yet generated material revenues from marketing CarbonSmart products or the sale of our equipment. We are subject to the risks inherent to early-stage companies seeking to develop, market and distribute new products, particularly companies in evolving markets such as renewable energy and technology. The likelihood of our success must be considered in light of the problems, expenses, difficulties, complications and delays frequently encountered in connection with the development, introduction, marketing and distribution of new products in a competitive environment.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Such risks include dependence on the success and acceptance of our products, the ability to attract and retain a suitable partner base, and the management of growth. To address these risks, we must, among other things, further develop and enhance our process technologies, generate increased demand for our products, attract a sufficient partner base, collaborate with partners, respond to competitive developments, and attract, retain and motivate qualified personnel. We are thus subject to many of the risks common to companies in their early stage of development, including under-capitalization, cash shortages, limitations with respect to personnel, financial, and other resources and lack of revenues.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to use our net operating loss carryforwards and certain other tax attributes may be limited.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred losses during our history. To the extent that we continue to generate taxable losses, unused losses will carry forward to offset future taxable income, if any, until such unused losses expire, if at all. As of December 31, 2021, we had U.S. federal NOL carryforwards of approximately $236.3 million.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Tax Act (as defined below), as modified by the CARES Act (as defined below), U.S. federal NOL carryforwards generated in taxable periods beginning after December 31, 2017, may be carried forward indefinitely, </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">but the deductibility of such net operating loss carryforwards in taxable years beginning after December 31, 2020, is limited to 80% of taxable income. It is uncertain if and to what extent various states will conform to the Tax Act or the CARES Act.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our NOL carryforwards are subject to review and possible adjustment by the IRS, and state tax authorities. Under Sections 382 and 383 of the Code, our federal net operating loss carryforwards and other tax attributes may become subject to an annual limitation in the event of certain cumulative changes in the ownership of our stock. An &#8220;ownership change&#8221; pursuant to Section 382 of the Code generally occurs if one or more stockholders or groups of stockholders who own at least 5% of a company&#8217;s stock increase their ownership (as measured by value) by more than 50 percentage points over their lowest ownership percentage within a rolling three-year period. Our ability to utilize our NOL carryforwards and other tax attributes to offset future taxable income or tax liabilities may be limited as a result of ownership changes, including potential changes in connection with our migration from New Zealand to the United States, the Business Combination or other transactions. Similar rules may apply under state tax laws. We have not yet determined the amount of the cumulative change in our ownership resulting from the Business Combination or other transactions, or any resulting limitations on our ability to utilize our net operating loss carryforwards and other tax attributes. If we earn taxable income, such limitations could result in increased future income tax liability to us and our future cash flows could be adversely affected. We have recorded a valuation allowance related to our NOL carryforwards and other deferred tax assets due to the uncertainty of the ultimate realization of the future benefits of those assets.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in U.S. and foreign tax laws could have a material adverse effect on our business, cash flow, results of operations or financial conditions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax regimes we are subject to or operate under, including income and non-income taxes, are unsettled and may be subject to significant change. Changes in tax laws, regulations, or rulings, or changes in interpretations of existing laws and regulations, could materially affect our financial position and results of operations. For example, the 2017 Tax Cuts and Jobs Act, or Tax Act, made broad and complex changes to the U.S. tax code, including changes to U.S. federal tax rates, additional limitations on the deductibility of interest, both positive and negative changes to the utilization of future NOL carryforwards, and allowing for the expensing of certain capital expenditures. The Coronavirus Aid, Relief, and Economic Security Act, or CARES Act, has already modified certain provisions of the Tax Act and the United States Congress is considering new proposed tax legislation. The exact impact of the Tax Act and the CARES Act for future years is difficult to quantify, but these changes could materially affect our effective tax rate in future periods, in addition to any changes made by new tax legislation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Organization for Economic Cooperation and Development has been working on a Base Erosion and Profit Shifting Project and is expected to continue to issue guidelines and proposals that may change various aspects of the existing framework under which our tax obligations are determined in many of the countries in which we do business. Similarly, the European Commission and several countries have issued proposals that would change various aspects of the current tax framework under which we are taxed. These proposals include changes to the existing framework to calculate income tax, as well as proposals to change or impose new types of non-income taxes, including taxes based on a percentage of revenue.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we expand the scale of our international business activities, these types of changes to the taxation of our activities could increase our worldwide effective tax rate, increase the amount of taxes imposed on our business, and harm our financial position. Such changes may also apply retroactively to our historical operations and result in taxes greater than the amounts estimated and recorded in our financial statements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Political and economic uncertainty, including changes in policies of the Chinese government or in relations between China and the United States, may impact our revenue and materially and adversely affect our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our partners operate facilities and do business on an international scale, including in China. Political and economic uncertainty, including changes in policies of the Chinese government or relations between China and the United States, may impact us adversely. There is significant uncertainty about the future relationship between China and the United States with respect to trade policy, government relations and treaties. Political uncertainty </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">surrounding Chinese government policies, international trade disputes between China and the United States, and protectionist measures could result in increased trade controls and regulations. Heightened tensions resulting in restrictions and additional regulations may negatively impact our ability to send our microbes and other supplies to our plants in China, to purchase and ship ethanol out of China, or to gain ethanol-related licenses in China.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The implementation of sanctions on certain Chinese individuals or entities may result in complications for our interactions with LanzaTech China Limited, the Shougang Joint Venture and our joint venture partners in China, or with certain of our strategic investors located in China, including Sinopec. Sinopec is a Chinese investment platform that was jointly established in 2018 by China Petrochemical Corporation (&#8220;Sinopec Group&#8221;) and China Petroleum &amp; Chemical Corporation (&#8220;Sinopec Corp&#8221;). Sinopec Corp is a majority-owned subsidiary of Sinopec Group, which is controlled by the State-owned Assets Supervision and Administration Commission of the State Council of the People&#8217;s Republic of China. Based on publicly available information provided by China Petroleum &amp; Chemical Corporation, as of August 2022, the China Petroleum &amp; Chemical Corporation holds, directly or indirectly, 49% of the equity/voting rights of Sinopec. As a result of potential trade and investment restrictions, we may be unable to complete an investment in any joint venture that we may enter into with Sinopec, or to protect our interests in our existing or potential future joint ventures by nominating a non-Chinese director to the board of directors of any such joint venture. Sanctions also may negatively impact our ability to repatriate dividends from a Chinese joint venture and may result in further costs or delays as a result of currency controls. These increased costs and restrictions may reduce our margins or reduce demand for our products if prices increase for our industry partners, and could adversely affect our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability or the ability of our partners to operate in China may be impaired by changes in Chinese laws and regulations, including those relating to taxation, environmental regulation, restrictions on foreign investment, and other matters, which can change quickly with little advance notice.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we are headquartered in Skokie, Illinois, we have business operations in China. This includes a minority ownership stake in the Shougang Joint Venture, several strategic investors located in China, including Sinopec, and a core team of technical, business and administrative professionals at a LanzaTech office in Shanghai, which support the ongoing operations and further growth of the business in China. We license our technology in China to the Shougang Joint Venture. Entities in which the Shougang Joint Venture holds a controlling interest currently produce low carbon ethanol at three commercial scale facilities using our process technology, which, in addition to its use as fuel, is transported and processed for use in consumer products.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Chinese government has exercised and continues to exercise substantial control over every sector of the Chinese economy through regulation and state ownership. The central Chinese government or local governments having jurisdiction within China may impose new, stricter regulations, or interpretations of existing regulations, that would require additional expenditures and efforts on our part to ensure our compliance with such regulations or interpretations. For example, regulations in the PRC applicable to LanzaTech China Limited, a WFOE, may change. As such, our operations and the operations of our joint venture partners and our sales and licenses to partners located in China may be subject to governmental and regulatory interference in the provinces in which they operate. We, our joint venture and other partners could also be subject to regulation by various political and regulatory entities, including local and municipal agencies and other governmental subdivisions. Regulations may be imposed or change quickly with little advance notice. Our ability, and the ability of our joint venture and other partners, to operate in China may be impaired by any such laws or regulations, or any changes in laws and regulations in China. We and our joint venture and other partners may incur increased costs necessary to comply with existing and future laws and regulations or penalties for any failure to comply.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our operations and financial results may be impacted if the PRC government determines that the contractual arrangements constituting part of the Shougang Joint Venture VIE structure do not comply with PRC regulations, or if these regulations change or are interpreted differently in the future.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have business operations in China, several strategic investors located in China, including Sinopec, and a core team of technical, business and administrative professionals at a LanzaTech office in Shanghai, which support the ongoing operations and further growth of the business in China. We also hold a minority ownership stake in the Shougang Joint Venture. We have determined the Shougang Joint Venture to be a VIE for which we are not the </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">primary beneficiary. The VIE structure was implemented in order to effectuate the intellectual property licensing arrangement between us and the Shougang Joint Venture and is not used to provide investors with exposure to foreign investment in China-based companies where Chinese law prohibits direct foreign investment in the operating companies. If the PRC government determines that the contractual arrangements constituting part of the VIE structure do not comply with PRC regulations, or if these regulations change or are interpreted differently in the future, it could result in a material change to our operations. This could result in our inability to assert contractual control over our intellectual property and other assets in the Shougang Joint Venture, or cause a material change in the value of the shares of the common stock.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We and our partners may be subject to regulatory actions by the Chinese government targeting concerns related to data security and monopolistic behavior.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recent statements and regulatory actions by the Chinese government have targeted companies whose operations involves cross-border data security or anti-monopoly concerns. Although we are incorporated and headquartered in the United States, we may still be subject to certain PRC laws due to our business operations in China. These operations include several strategic investors located in China, including Sinopec, a core team of technical, business and administrative professionals at our office in Shanghai, and our minority ownership stake in, and contractual commitments with, the Shougang Joint Venture.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 10, 2021, China promulgated the PRC Data Security Law (the &#8220;DSL&#8221;), which became effective on September 1, 2021. The DSL intends to regulate data processing activities, ensure data security, promote data development and utilization, protect the data-related rights and interests of individuals and organizations, and safeguard Chinese sovereignty, security and development interests. Article 36 of the DSL provides that any Chinese entity that provides data to foreign judicial or law enforcement agencies (regardless of whether directly or through a foreign entity) without approval from a Chinese authority would likely be deemed to be in violation of the DSL. In addition, pursuant to Article 2 of Measures for Cybersecurity Reviews (the &#8220;Measures&#8221;) issued by the CAC, the procurement of any network product or service by an operator of critical information infrastructure that affects or may affect national security will be subjected to a cybersecurity review. Pursuant to Article 35 of Cybersecurity Law of the PRC, &#8220;critical information infrastructure operators&#8221; that purchase network products and services which may influence national security will be subject to cybersecurity review by the CAC. With respect to LanzaTech China Limited, the Shougang Joint Venture and our operational partners in China, the exact scope of the term &#8220;critical information infrastructure operator&#8221; remains unclear, so there can be no assurance that we, the Shougang Joint Venture or our partners will not be subjected to critical information infrastructure operator review in the future. Furthermore, in the event that we, the Shougang Joint Venture or our partners become operators of critical information infrastructure in the future, they may be subject to the DSL, the Measures and cybersecurity review by the CAC.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Article 3 of Anti-Monopoly Law of the PRC (the &#8220;Anti-Monopoly Law&#8221;) prohibits &#8220;monopolistic practices,&#8221; which include: (a) the conclusion of monopoly agreements between operators&#894; (b) the abuse of dominant market position by operators&#894; and (c) concentration of undertakings which has or may have the effect of eliminating or restricting market competition. Furthermore, according to Article 19 of the Anti-Monopoly Law, the operator will be assumed to have a dominant market position if the following apply: (a) an operator has 50% or higher market share in a relevant market&#894; (b) two operators have 66% or higher market share in a relevant market&#894; or (c) three operators have 75% or higher market share in a relevant market. We believe that neither we nor any of our partners in China have engaged in any monopolistic practices in China, and that recent statements and regulatory actions by the Chinese government do not impact our ability to conduct business, accept foreign investments, or list on a U.S. or other foreign stock exchange. However, there can be no assurance that regulators in China will not promulgate new laws and regulations or adopt new series of interpretations or regulatory actions which may require us and our partners to satisfy new requirements related to these concerns. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in China&#8217;s economic, political or social conditions or legal system or government policies could have a material adverse effect on our business and operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business operations in China include the Shougang Joint Venture, several strategic investors located in China, including Sinopec, and a core team of technical, business and administrative professionals at a LanzaTech </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">office in Shanghai, which support the ongoing operations and further growth of the business in China. We license our technology in China to the Shougang Joint Venture. Entities in which the Shougang Joint Venture holds a controlling interest currently produce low carbon ethanol at three commercial scale facilities using our process technology, which, in addition to its use as fuel, is transported and processed for use in consumer products. Meanwhile, several additional facilities are being engineered and constructed. Accordingly, our business, financial condition, results of operations and prospects may be influenced to a significant degree by political, economic and social conditions in China generally and by the significant discretion of Chinese governmental authorities. The Chinese government continues to play a significant role in regulating industry development by imposing industrial policies. The Chinese government also exercises significant control over China&#8217;s economic growth through allocating resources, controlling payment of foreign currency-denominated obligations, setting monetary policy, and providing preferential treatment to particular industries or companies. The increased global focus on environmental and social issues and China&#8217;s potential adoption of more stringent standards in these areas may adversely impact us or our suppliers.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, the Chinese legal system is based in part on government policies and internal rules, some of which are not published on a timely basis or at all and may have a retroactive effect. As a result, we or our suppliers may not be aware of our violation of any of these policies and rules until sometime after the alleged violation. In addition, any administrative and court proceedings in China may be protracted, resulting in substantial costs and diversion of resources and management attention. Further, such evolving laws and regulations and the inconsistent enforcement thereof could also lead to failure to obtain or maintain licenses and permits to do business in China, which would adversely affect us or our suppliers in China. Any such disruption, or if one or more of our Chinese suppliers was prevented from operating, could have an adverse impact on our results of operations and financial condition.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to risks that the Chinese government may intervene or influence our operations at any time.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we have employees located in China and conduct some operations in China, including through our China-based joint venture and at the facilities in China operated by entities in which the Shougang Joint Venture holds a controlling interest using our process technology, we are subject to the risk that the Chinese government may intervene or influence our operations at any time. However, because our operations in China are largely limited to technology licenses and the production of our low carbon ethanol, we do not expect that such intervention or influence would result in a material change in our operations. Nonetheless, in the event that the Chinese government were to intervene in our operations, we might experience a disruption at the three facilities in China operated by entities in which the Shougang Joint Venture holds a controlling interest using our process technology, or at the facilities in construction, to our joint venture and joint venture partners, to our licenses to partners in China and to our low carbon ethanol production, which could have a material adverse effect on our results of operations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Products produced by our process technologies compete with or are intended to displace comparable products produced using fossil resources. The market prices for these alternatively produced products and commodities are subject to volatility and there is a limited referenceable market for the more sustainable, waste-based products that our process technologies enable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Products produced by our process technologies compete with or are intended to displace comparable products produced using fossil resources. The market prices for these alternatively produced products and commodities are subject to volatility and may depend on uncertain consumer demand as well as changing supply of feedstocks. In particular, demand for our products may depend on changing attitudes toward, and the price and availability of, fossil resources.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe we have any direct competitors that produce products with similar attributes to ours. Due to the limited competition we face, there is a limited referenceable market for the more sustainable, waste-based products that our process technologies enable. It may be difficult to evaluate our potential future performance without the benefit of established long-term track records from companies developing similar sustainable, waste-based products.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Process performance at LanzaTech plants is dependent on the quality and quantity of the feedstock supplied from the host facility.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We design the parameters to best process the feedstock we expect to receive from the host facility. Although we rigorously test feedgas when a project is being designed in order to determine the expected composition of the feedstock there is no guarantee that the quality and quantity of the feedstock will be identical to the test conditions. Feedstock changes based on day-to-day variability in host company process conditions can be anticipated to some extent, but cannot be fully mitigated.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced variability in the quality and quantity of feedstock supplied from our operating facilities, and although it is typically in the facilities&#8217; best interest to provide consistent and good quality feedstock, which help maintain the high utilization of our process, there is no guarantee that it will be supplied.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The deployment of the technology for alternative waste gas feedstocks can lead to unforeseen issues due to the change in the upstream industrial process.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we have designed our reactor and process to minimize the amount of mechanical and operational adjustments required for the utilization of different waste gas feedstocks, there is no guarantee that performance will be as expected. Our microbe has proven to be flexible to different feed gas compositions, with tests conducted at pilot-scale using a wide range of CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, hydrogen (&#8220;H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and carbon monoxide (&#8220;CO&#8221;)-containing gases.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scale-up and commercialization of process technologies for alternative feedstocks without first conducting tests at demonstration scale can introduce some risk. Performance related improvements may not be as fungible as anticipated in scaling up alternative feedstocks.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Intellectual Property</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our patent rights may not provide commercially meaningful protection against competition, and we may be unable to detect infringement of our patents.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends, in part, on our ability to obtain and maintain patent protection and other intellectual property rights to protect our technology from competition. We have adopted a strategy of seeking patents and patent licenses in the United States and in certain foreign countries with respect to certain technologies used in, or relating to, our process technology for developing products. As of December 31, 2022, our overall owned and in-licensed patent portfolio included 1,264 granted patents and 588 pending patent applications across 141 patent families in the United States and in various foreign jurisdictions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The strength of patents involves complex legal and scientific questions and can be uncertain. The patent applications that we own or license may fail to result in issued patents in the United States or in other foreign countries. Even with regard to the patents that have been issued to us, it is possible that third parties could challenge the validity, enforceability, ownership or scope thereof, which could result in such patents being narrowed, invalidated or held unenforceable. There is a substantial amount of litigation involving patent and other intellectual property rights, including interference and reexamination proceedings before the U.S. Patent and Trademark Office, or oppositions or comparable proceedings in foreign jurisdictions. Furthermore, even if they are unchallenged, our patents and patent applications may not adequately protect our technology or prevent others from designing around our patent claims. In addition, patent laws may change over time, and such changes may impair our ability to maintain, protect or enforce our patents. Moreover, we may not be able to detect unauthorized use of, or take appropriate steps to enforce, our patents rights against third parties. For example, third parties could practice our inventions without authorization, in secret and in territories where we do not have patent protection. Furthermore, despite our efforts and precautions, we may be unable to prevent a third party from copying or otherwise obtaining and using our inventions or other proprietary information or technology without authorization, or from infringing our patents. Such third parties may then try to sell or import products made using our inventions in and into the United States or other territories. We may be unable to prove that such products were made using our inventions, and any legal and contractual remedies available to us may not adequately compensate us.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional uncertainty may result from patent reform legislation proposed by the U.S. Congress and other national governments and from legal precedent handed down by the U.S. Court of Appeals for the Federal Circuit, the U.S. Supreme Court and the courts of foreign countries, as they determine legal issues concerning the scope, validity and construction of patent claims. Because patent applications in the United States and many foreign jurisdictions are typically not published until 18 months after filing, or in some cases not at all, and because publication of discoveries in the scientific literature often lags behind the actual discoveries, there is additional uncertainty as to validity of any issued patent. Accordingly, we cannot be certain that any of our patent applications will result in issued patents, or even if issued, be sure of their validity or enforceability. Additionally we cannot predict whether any of our patent rights will be broad enough in scope to provide commercial advantage and prevent circumvention. Also, it may be difficult for us to trace chemicals imported into the United States that are produced by others using microorganisms or processes covered by our patents without our authorization, which will limit our ability to enforce our patent rights against potential infringers. In any event, patents are enforceable only for a limited term.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Differences and uncertainties with respect to legal systems outside the United States could adversely affect the legal protection available to us.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have and plan to continue partnering with others in building manufacturing facilities using our process technologies in countries other than the United States. However, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the United States. Many companies have encountered significant problems, including delays, in protecting and enforcing intellectual property rights in certain foreign jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents and other intellectual property protection, particularly those relating to bio-industrial technologies. This could make it difficult for us to stop the misappropriation of our trade secrets or the infringement of our patents or other intellectual property rights. Proceedings to enforce our patents and other proprietary rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business. Such proceedings could also be met with defenses, counterclaims and countersuits attacking the validity, enforceability, ownership and scope of our intellectual property rights, and if such defenses, counterclaims or countersuits are successful, we could lose valuable intellectual property rights in certain jurisdictions. Accordingly, our efforts to enforce our intellectual property rights in such countries could be inadequate to obtain a significant commercial advantage from the intellectual property that we develop. Moreover, the registration of intellectual property is costly and subject to complex rules, regulations and local laws. Outside the United States, we only file our patent applications in selected foreign jurisdictions and therefore will have no patent protection against potential infringers in jurisdictions where we have not applied for patent protection.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to operate our business without infringing the proprietary rights of third parties.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability and the ability of our partners to commercialize the products produced using our technology platform depends on the ability to develop, manufacture, market and sell such products without infringing the proprietary rights of third parties. Numerous U.S. and foreign patents and pending patent applications owned by third parties, including parties with whom we may compete, exist in fields including processes that relate to our technology platform and the processes derived using our technology platform. These third parties may allege that our technology platform or the processes derived using our technology platform, or even the methods and organisms themselves, infringe their intellectual property rights, and we may be subject to legal proceedings relating to these claims.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are found to infringe the intellectual property rights of a third party, we or our partners could be prohibited from commercializing the product produced using the infringing technology, or from licensing our technology, unless we obtain a license to use the technology covered by the third-party intellectual property rights or are able to design around the relevant third party intellectual property rights. We may be unable to obtain a license on terms acceptable to us, if at all, and we may not be able to redesign our technology or processes to avoid infringement. Even if we are able to redesign technology or processes to avoid an infringement claim, our efforts to design around the third-party intellectual property rights may lead to a less effective or more costly product. In addition, we may be subject to legal proceedings alleging the infringement, misappropriation or other violation of the intellectual property of third parties, which could result in substantial costs and divert our efforts and attention from other </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">aspects of our business. A court could also order us to pay compensatory damages for any infringement, plus prejudgment interest and could, in addition, treble the compensatory damages and award attorney fees. These damages could be substantial and could harm our reputation, business, financial condition and results of operations. A court also could enter orders that temporarily, preliminarily or permanently prohibit us and our partners from making, using, selling or offering to sell one or more of the products that may be produced using our technology platform and processes, or could enter an order mandating that we undertake certain remedial activities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade secrets can be difficult to protect and enforce, and our inability to do so could adversely affect our competitive position.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on trade secrets and confidentiality agreements to protect some of our technology and proprietary know-how that is not patentable, processes for which patents are difficult to enforce, and any other elements of our technology platform that involve proprietary know-how, information or technology that is not covered by patents, particularly where we do not believe patent protection is appropriate or obtainable. However, trade secrets are difficult to maintain and protect. Our strategy for scale-up of production requires us to share confidential information with our business partners and other parties. Our business partners&#8217; employees, consultants, contractors or scientific and other advisors may unintentionally or willfully disclose our proprietary information to competitors. Enforcement of claims that a third party has illegally obtained and is using trade secrets is an expensive, time-consuming and uncertain process. In addition, foreign courts are sometimes less willing than U.S. courts to protect trade secrets. If our competitors independently develop equivalent knowledge, methods and know-how, we would not be able to assert our trade secrets against them. Our failure to obtain or maintain trade secret protection could adversely affect our competitive business position.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have taken measures to protect our trade secrets and proprietary information, but these measures may not be effective. We require new employees and consultants to execute confidentiality agreements upon the commencement of an employment or consulting arrangement with us. These agreements generally require that all confidential information developed by the individual or made known to the individual by us during the course of the individual&#8217;s relationship with us be kept confidential and not disclosed to third parties. Nevertheless, our proprietary information may be disclosed, third parties could reverse engineer our systems, and others may independently develop substantially equivalent proprietary information and techniques or otherwise gain access to our trade secrets. Costly and time-consuming litigation could be necessary to enforce and determine the scope of our proprietary rights, and failure to obtain or maintain trade secret protection could adversely affect our competitive business position.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If trade secrets are stolen, misappropriated or reverse engineered, others could use these designs to produce competing products.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of third parties, including various industry partners, plant operators, university scientists and researchers, and those involved in the shipping and handling of products produced using our technology platform, have or may have access in the future to our proprietary technology. If the proprietary technology covered by our trade secrets were stolen, misappropriated or reverse engineered based on unauthorized use or based on extrapolation from our disclosures in our patent applications, it could be used by other parties for their own commercial gain. If this were to occur, it could be difficult, time consuming and costly for us to discover or challenge this type of use, especially in countries with limited intellectual property protection.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to prevent third parties from adopting, registering or using trademarks or otherwise violating our trademark rights, our business could be materially adversely affected.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently hold issued trademark registrations and have trademark applications pending, any of which may be the subject of a governmental or third-party objection, which could prevent the issuance or maintenance of the same and thus create the potential need to rebrand or relabel one or more of our services. As our business matures, our reliance on our trademarks to differentiate us from our competitors increases and as a result, if we are unable to prevent third parties from adopting, registering or using trademarks, trade dress, or other source indicators that infringe, dilute or otherwise violate our trademark rights, our business could be materially adversely affected.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not retain exclusive rights to intellectual property created as a result of our strategic partnering arrangements which could limit our prospects and result in costly and time-consuming disputes.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a party to joint development agreements with a number of parties and are seeking to enter into agreements with others, each of which involve research and development efforts. We expect to enter into additional strategic partnering arrangements in the future. Under our existing agreements, we share, and would share, to various degrees, intellectual property we jointly develop. Any disputes as to ownership with a partner that may arise could encumber or prevent our use of the disputed technology, could harm our relationship with the relevant partner and would likely negatively affect our commercialization plans with respect to that technology. Additionally, litigation may be necessary to resolve disputes as to the ownership of intellectual property rights as between us and our industry partners, which can be costly, distracting to management and can harm our reputation and the value of our company. Further, we may not be successful in defending our intellectual property rights in any such litigation, and if we are unsuccessful, the value of our company could be seriously harmed.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Some of our intellectual property may be subject to federal regulation such as &#8220;march-in&#8221; rights, reporting requirements and a preference for U.S. industry, and any such regulations could negatively impact our business and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the intellectual property that protects our technology platform has been funded by grants from U.S. government agencies and is subject to certain federal regulations. For example, under the &#8220;march-in&#8221; provisions of the Bayh-Dole Act, the government may have the right under limited circumstances to require us to grant exclusive, partially exclusive or non-exclusive rights to third parties under any intellectual property discovered through the government-funded programs. March-in rights can be triggered if the government determines that we have failed to work sufficiently towards achieving practical application of a technology or if action is necessary to alleviate health or safety needs, to meet requirements for public use specified by federal regulations or to give preference to U.S. industry. Specifically, certain of our granted and pending patents that cover recombinant and other microorganisms, cell-free protein synthesis platforms, protein expression vectors, fermentative production pathways, and microbial and ethanol conversion pathways may be subject to march-in-rights. These patents account for less than one percent of our granted and pending patents. We are also subject to certain reporting requirements as well as a preference for U.S. industry relating to manufacturing of products under the Bayh-Dole Act. Any such regulations could negatively impact our business and prospects.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend on certain technologies that are licensed to us. We do not control these technologies and any loss of our rights to them could prevent us from developing or selling our process technologies.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on licenses in order to be able to use various proprietary technologies that are material to our business, including a license with the Battelle Memorial Institute (&#8220;Battelle&#8221;). We do not own the patents that underlie these licenses. Our rights to use the technology we license are subject to the continuation of and compliance with the terms of those licenses. We do not always control the prosecution, maintenance or filing of the patents to which we hold licenses. Thus, some of these patents and patent applications were not written by us or our attorneys, and we did not have control over their drafting and prosecution. Our licensors might not have given the same attention to the drafting and prosecution of these patents and applications as we would have if we had been the owners of the patents and applications and had control over the drafting and prosecution. We cannot be certain that drafting or prosecution of the licensed patents and patent applications by the licensors have been or will be conducted in compliance with applicable laws and regulations or will result in valid and enforceable patents and other intellectual property rights.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our rights to use the technology we license are subject to the validity of the owners&#8217; intellectual property rights. Enforcement of our licensed patents or defense or any claims asserting the invalidity of these patents is often subject to the control or cooperation of our licensors and/or interpretation of the license agreements. We cannot be certain that we will have control of the enforcement of these patents against third parties. Legal action could be initiated against the owners of the intellectual property that we license. Even if we are not a party to these legal actions, an adverse outcome could harm our business because it might prevent our licensors from continuing to license the intellectual property that we may need to operate our business.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our licenses contain provisions that allow the licensor to terminate the license upon specific conditions, including breach or insolvency. Our rights under the licenses are subject to our continued compliance with the terms of the license, including the payment of royalties due under the license. Termination of these licenses could prevent us from developing or marketing some or all of our process technologies. Because of the complexity of our technologies underlying our process technologies and the patents we have licensed, determining the scope of the license and related royalty obligation can be difficult and can lead to disputes between us and the licensor. An unfavorable resolution of such a dispute could lead to an increase in the royalties payable pursuant to the license. If a licensor believed we were not paying the royalties due under the license or were otherwise not in compliance with the terms of the license, the licensor might attempt to revoke the license. If such an attempt were successful, we might be barred from developing and selling some or all of our process technologies.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any strategic partnering arrangement that involves the licensing of any of our intellectual property may increase our risks, harm our competitive position and increase our costs.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to partnering with industry leaders through our co-development model, we may enter into licensing arrangements aimed to accelerate commercialization of our production process pipeline. Licensing any of our intellectual property increases the number of people who have access to some of our proprietary information. The scope of any such license may not be sufficiently narrow to adequately protect our interests. Moreover, contractual obligations of our licensees not to disclose or misuse our intellectual property may not be sufficient to prevent such disclosure or misuse. The costs of enforcing contractual rights could substantially increase our operating costs and may not be cost-effective, reasonable under the circumstances or ultimately succeed in protecting our proprietary rights. If our competitors access our intellectual property, they may gain further insight into the technology and design of our process technologies, which would harm our competitive position.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be involved in lawsuits to protect or enforce our patents or the patents of our licensors, or lawsuits asserted by a third party, which could be expensive, time consuming and unsuccessful.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competitors may infringe our patents or the patents of our licensors. To counter infringement or unauthorized use, we may need to file infringement claims, which can be expensive and time-consuming. In addition, in an infringement proceeding, a court may decide that a patent of ours or our licensors is not valid or is unenforceable, or may refuse to stop the other party from using the technology at issue on the grounds that our patents do not cover the technology in question. An adverse result in any litigation or defense proceedings could put one or more of our patents at risk of being invalidated or interpreted narrowly and could put our patent applications at risk of not issuing. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interference proceedings provoked by third parties or brought by the U.S. Patent and Trademark Office may be necessary to determine the priority of inventions with respect to our patents or patent applications or those of our collaborators or licensors. An unfavorable outcome could require us to cease using the related technology or to attempt to license rights to it from the prevailing party. Our business could be harmed if the prevailing party does not offer us a license on commercially reasonable terms. Litigation or interference proceedings may fail and, even if successful, may result in substantial costs and distract our management and other employees. We may not be able to prevent, alone or with our licensors, misappropriation of our proprietary rights, particularly in countries where the laws may not protect those rights as fully as in the United States.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the uncertainties involved in the issuance and enforcement of patents, and the value of a patent, patent disputes and litigations are common. We may become involved in patent disputes relating to infringement of our technology, with third-parties asserting their patents, with our licensors or licensees, with industry partners and with employees, among others. Patent disputes can take years to resolve, can be very costly and can result in loss of rights, injunctions and substantial penalties. Moreover, patent disputes and related proceedings can distract management&#8217;s attention and interfere with running the business.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Ownership of Our Securities</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The price of the common stock may be volatile.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the Business Combination, fluctuations in the price of New LanzaTech&#8217;s securities could contribute to the loss of all or part of your investment. Prior to the Business Combination, there was not a public market for the stock of LanzaTech and trading in the shares of AMCI&#8217;s common stock was not active. If an active market for our securities develops and continues, the trading price of New LanzaTech securities following the Business Combination could be volatile and subject to wide fluctuations in response to various factors, some of which are beyond our control. Any of the factors listed below could have a material adverse effect on your investment in our securities and New LanzaTech securities may trade at prices significantly below the price you paid for them. In such circumstances, the trading price of our securities may not recover and may experience a further decline. Factors affecting the trading price of New LanzaTech&#8217;s securities may include:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actual or anticipated fluctuations in our quarterly financial results or the quarterly financial results of companies perceived to be similar to us;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the market&#8217;s expectations about New LanzaTech&#8217;s operating results;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the development of new plants;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">success of competitors;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">operating results failing to meet the expectations of securities analysts or investors in a particular period;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">entering into new agreements with partners;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in financial estimates and recommendations by securities analysts concerning New LanzaTech or the industry in which New LanzaTech operates in general;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">operating and stock price performance of other companies that investors deem comparable to New LanzaTech;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ability to market new and enhanced products and services on a timely basis;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in laws and regulations affecting our business;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">commencement of, or involvement in, litigation involving New LanzaTech;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in New LanzaTech&#8217;s capital structure, such as future issuances of securities or the incurrence of additional debt;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the volume of shares of common stock available for public sale;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any major change in New LanzaTech&#8217;s board or management;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sales of substantial amounts of common stock by our or New LanzaTech&#8217;s directors, executive officers or significant stockholders or the perception that such sales could occur; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic and political conditions such as recessions, interest rates, fuel prices, international currency fluctuations and acts of war or terrorism.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Broad market and industry factors may materially harm the market price of our securities irrespective of our operating performance. The stock market in general, and Nasdaq specifically, have experienced extreme volatility that has often been unrelated to the operating performance of particular companies. As a result of this volatility, you may not be able to sell your securities at or above the price at which it was acquired. A loss of investor confidence in the market for the stocks of other companies which investors perceive to be similar to New LanzaTech could depress our stock price regardless of our business, prospects, financial conditions or results of operations. A decline in the </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">market price of our securities also could adversely affect our ability to issue additional securities and our ability to obtain additional financing in the future.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, the common stock and the common stock issuable upon exercise of the resale securities described in this prospectus represent a substantial percentage of the total outstanding shares of our common stock as of the date of this prospectus. Additionally, if all of the Convertible Securities were converted, the selling stockholders would own 198,818,523 shares of common stock, representing approximately 92.3% of the total outstanding common stock. So long as the registration statement of which this prospectus forms a part is effective, the sales of the securities being offered in this prospectus could result in a significant decline in the public trading price of the common stock.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reports published by analysts, including projections in those reports that differ from our actual results, could adversely affect the price and trading volume of the common stock.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that securities research analysts will establish and publish their own periodic projections for the business of LanzaTech. These projections may vary widely and may not accurately predict the results we actually achieve. Our stock price may decline if our actual results do not match the projections of these securities research analysts. Similarly, if one or more of the analysts who write reports on LanzaTech downgrades our stock or publishes inaccurate or unfavorable research about our business, our stock price could decline. If one or more of these analysts ceases coverage of LanzaTech or fails to publish reports on LanzaTech regularly, our stock price or trading volume could decline.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may issue additional shares of common stock or other equity securities without your approval, which would dilute your ownership interests and may depress the market price of the common stock.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the consummation of the Business Combination, we had warrants (including the AM Warrant) outstanding to purchase up to an aggregate of 12,574,276 shares of common stock and options (including the Options) outstanding to purchase up to an aggregate of 14,310,025 shares of common stock. Under the LanzaTech 2023 Long-Term Incentive Plan (the &#8220;2023 Plan&#8221;), we also have the ability to issue 19,622,273 shares of our common stock, and the Brookfield SAFE may convert into up to 5,000,000 shares of our common stock. The 2023 Plan is required to provide for the ability to grant and recycle the common stock (including any shares subject to forfeited options or restricted stock awards), and to initially reserve a number of shares of the common stock constituting 10% of the total number of shares of the common stock outstanding on a fully diluted basis, as determined at the closing of the Business Combination, and include an &#8220;evergreen&#8221; provision pursuant to which the number of shares reserved for issuance under the 2023 Plan will be increased automatically each year by 3% of the aggregate number of shares of the common stock then outstanding on a fully diluted basis. We may also issue additional shares of common stock or other equity securities of equal or senior rank in the future in connection with, among other things, future acquisitions or repayment of outstanding indebtedness, without stockholder approval, in a number of circumstances.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our issuance of additional shares of common stock or other equity securities of equal or senior rank would have the following effects:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our existing stockholders&#8217; proportionate ownership interest in LanzaTech will decrease;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the amount of cash available per share, including for payment of dividends in the future, may decrease;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the relative voting strength of each previously outstanding share of common stock may be diminished; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the market price of shares of the common stock may decline.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our actual financial position and results of operations may differ materially from the unaudited pro forma condensed combined financial information included in this prospectus, which may not be indicative of what our actual financial position or results of operations would have been.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma condensed combined financial information in this prospectus is presented for illustrative purposes only and is not necessarily indicative of what our actual financial position or results of </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">operations would have been had the Business Combination been completed on the dates indicated. See the section titled &#8220;Unaudited Pro Forma Condensed Combined Financial Information&#8221; for more information.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Because we do not anticipate paying any cash dividends on the common stock in the foreseeable future, capital appreciation, if any, will be your sole source of gains and you may never receive a return on your investment.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may retain future earnings, if any, for future operations, expansion and debt repayment and have no current plans to pay any cash dividends for the foreseeable future. Any decision to declare and pay dividends as a public company in the future will be made at the discretion of the Board and will depend on, among other things, our results of operations, financial condition, cash requirements, contractual restrictions and other factors that the Board may deem relevant. In addition, our ability to pay dividends may be limited by covenants of any existing and future outstanding indebtedness we or our subsidiaries incur. As a result, you may not receive any return on an investment in our securities unless you sell your securities for a price greater than that which you paid for it.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Public Warrants are identical to the Private Placement Warrants in material terms and provisions, except in certain circumstances, and are materially different from the LanzaTech warrants.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Public Warrants are identical to the Private Placement Warrants in material terms and provisions, except that the Private Placement Warrants are not transferable, assignable or salable until 30 days after the closing of the Business Combination (except in limited circumstances) and are not redeemable by us so long as they are held by the Sponsor or its permitted transferees. If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, they will be redeemable by us and exercisable by the holders on the same basis as the Public Warrants. The Sponsor agreed not to transfer, assign or sell any of the Private Placement Warrants until 30 days after the closing of the business combination.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may redeem the Public Warrants prior to their exercise at a time that is disadvantageous to holders of Public Warrants. We have the ability to redeem outstanding Public Warrants at any time after they become exercisable and prior to their expiration, at a price of $0.01 per Public Warrant, provided that the closing price of the common stock equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any 20 trading days within a 30 trading day period commencing once the Public Warrants become exercisable and ending three days before we send the notice of redemption to Public Warrant holders. If and when the Public Warrants become redeemable by us, we may exercise the redemption right even if we are unable to register or qualify the underlying securities for sale under all applicable state securities laws. As a result, we may redeem the warrants as set forth above even if the holders are otherwise unable to exercise the warrants. Redemption of the outstanding Public Warrants could force holders of the Public Warrants (i) to exercise their Public Warrants and pay the exercise price therefor at a time when it may be disadvantageous for them to do so, (ii) to sell their Public Warrants at the then-current market price when they might otherwise wish to hold their Public Warrants or (iii) to accept the nominal redemption price which, at the time the outstanding Public Warrants are called for redemption, is likely to be substantially less than the market value of their Public Warrants. As noted above, none of the Private Placement Warrants will be redeemable by us so long as they are held by the Sponsor or its permitted transferees.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of the Legacy LanzaTech warrants that were converted into New LanzaTech warrants at the closing of the Business Combination are materially different from those of the Public Warrants. The AM Warrant entitles its holder to purchase up to 300,000 shares of common stock at an exercise price equal to $10.00, and will expire on the fifth anniversary of the consummation of the Business Combination. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">You may only be able to exercise your Public Warrants on a &#8220;cashless basis&#8221; under certain circumstances, and if you do so, you will receive fewer shares of the common stock from such exercise than if you were to exercise such warrants for cash.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Warrant Agreement provides that in the following circumstances holders of warrants who seek to exercise their Public Warrants will not be permitted to do so for cash and will, instead, be required to do so on a cashless basis in accordance with Section 3(a)(9) of the Securities Act: (i) if the shares of common stock issuable upon exercise of the warrants are not registered under the Securities Act in accordance with the terms of the Warrant Agreement; (ii) if we have so elected and the shares of common stock is at the time of any exercise of a warrant not </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">listed on a national securities exchange such that they satisfy the definition of &#8220;covered securities&#8221; under Section 18(b)(1) of the Securities Act; and (iii) if we have so elected and we call the Public Warrants for redemption. If you exercise your Public Warrants on a cashless basis, you would pay the warrant exercise price by surrendering the warrants for that number of shares of common stock equal to the quotient obtained by dividing (x) the product of the number of shares of common stock underlying the warrants, multiplied by the excess of the &#8220;fair market value&#8221; of our shares of common stock (as defined in the next sentence) over the exercise price of the warrants by (y) the fair market value. The &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">fair market value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is the average closing price of the shares of the common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of exercise is received by the warrant agent or on which the notice of redemption is sent to the holders of warrants, as applicable. As a result, you would receive fewer shares of the common stock from such exercise than if you were to exercise such warrants for cash.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our warrant agreement designates the courts of the State of New York or the United States District Court for the Southern District of New York as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by holders of our warrants, which could limit the ability of warrant holders to obtain a favorable judicial forum for disputes with our company.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our warrant agreement provides that, subject to applicable law, (i) any action, proceeding or claim against us arising out of or relating in any way to the Warrant Agreement, including under the Securities Act, will be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and (ii) that we irrevocably submit to such jurisdiction, which jurisdiction will be the exclusive forum for any such action, proceeding or claim. We will waive any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, these provisions of the Warrant Agreement will not apply to suits brought to enforce any liability or duty created by the Exchange Act or any other claim for which the federal district courts of the United States of America are the sole and exclusive forum. Any person or entity purchasing or otherwise acquiring any interest in any of our warrants will be deemed to have notice of and to have consented to the forum provisions in our Warrant Agreement. If any action, the subject matter of which is within the scope the forum provisions of the Warrant Agreement, is filed in a court other than a court of the State of New York or the United States District Court for the Southern District of New York (a &#8220;foreign action&#8221;) in the name of any holder of our warrants, such holder will be deemed to have consented to: (x) the personal jurisdiction of the state and federal courts located in the State of New York in connection with any action brought in any such court to enforce the forum provisions (an &#8220;enforcement action&#8221;), and (y) having service of process made upon such warrant holder in any such enforcement action by service upon such warrant holder&#8217;s counsel in the foreign action as agent for such warrant holder.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This choice-of-forum provision may limit a warrant holder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with our company, which may discourage such lawsuits against us and our directors, officers, or other employees and may result in increased litigation costs for our stockholders. Alternatively, if a court were to find this provision of the Warrant Agreement inapplicable or unenforceable with respect to one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could materially and adversely affect our business, financial condition and results of operations and result in a diversion of the time and resources of our management and board of directors.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may amend the terms of the Public Warrants in a manner that may be adverse to holders with the approval by the holders of at least 50% of the then-outstanding Public Warrants. As a result, the exercise price of a holder&#8217;s Public Warrants could be increased, the exercise period could be shortened and the number of shares of the common stock purchasable upon exercise of a Public Warrant could be decreased, all without the approval of that warrant holder.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Public Warrants were issued in registered form under the Warrant Agreement between Continental Stock Transfer &amp; Trust Company, as warrant agent, and us. The Warrant Agreement provides that the terms of the Public Warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision, but requires the approval by the holders of at least 50% of the then-outstanding Public Warrants to make </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any change that adversely affects the interests of the registered holders. Accordingly, we may amend the terms of the Public Warrants in a manner adverse to a holder if holders of at least 50% of the then-outstanding Public Warrants approve of such amendment. Although our ability to amend the terms of the Public Warrants with the consent of at least 50% of the then-outstanding Public Warrants is unlimited, examples of such amendments could be amendments to, among other things, increase the exercise price of the Public Warrants, convert the Public Warrants into cash or stock, shorten the exercise period or decrease the number of shares of common stock purchasable upon exercise of a Public Warrant.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We and Legacy LanzaTech have identified material weaknesses in our internal control over financial reporting. While some of these material weaknesses have been remediated, they could continue to adversely affect our ability to report our results of operations and financial condition accurately and in a timely manner.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with US GAAP. Our management is likewise required, on a quarterly basis, to evaluate the effectiveness of our internal controls and to disclose any changes and material weaknesses identified through such evaluation of those internal controls. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AMCI previously identified a material weakness in its internal control over financial reporting related to the accounting for certain complex financial instruments issued by AMCI that were not effectively designed or maintained. This material weakness resulted in the restatement of AMCI&#8217;s balance sheet as of August 6, 2021. Additionally, this material weakness could have resulted in a misstatement of complex financial instruments and related accounts and disclosures that would result in an additional material misstatement of AMCI&#8217;s financial statements that would not be prevented or detected on a timely basis. As of September 30, 2022, this material weakness was remediated. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, AMCI has identified a quantitative and qualitative material weakness in its internal control over financial reporting related to the accounting of certain fees of Evercore related to advisory and placement agent services, which Evercore waived in connection with its resignation. Pursuant to an advisory agreement and a placement agency agreement that AMCI entered into with Evercore, AMCI agreed to pay Evercore an aggregate fee of approximately $8.0 million in connection with AMCI&#8217;s initial business combination that was wholly contingent on the closing of its initial business combination. On or about October 11, 2022, AMCI determined that disclosure regarding such arrangements and aggregate fees of $8.0 million, which were reasonably estimable and reasonably possible, had been omitted from the footnotes contained in its previously-issued financial statements. AMCI&#8217;s management evaluated the impact of the error on its internal control over financial reporting, and although the error had no impact to its condensed consolidated balance sheets, statements of cash flows or operations because such amount was never probable in accordance with the guidance set forth in ASC 450-20, the omission of such contingent payment from the footnotes to its financial statements was significant and therefore was determined to be a material error. Based on the above, AMCI&#8217;s management concluded that the nondisclosure represented a material weakness in AMCI&#8217;s internal control over financial reporting.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is possible that we may identify other material weaknesses in the future. Our management has expended, and will continue to expend, a substantial amount of effort and resources for the improvement of our internal control over financial reporting. While we have processes to properly identify and evaluate the appropriate accounting technical pronouncements and other literature for all significant or unusual transactions, we have expanded and will continue to improve these processes to ensure that the nuances of such transactions are effectively evaluated in the context of the increasingly complex accounting standards. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legacy LanzaTech has also identified material weaknesses in its internal control over financial reporting. The material weaknesses relate to the segregation of duties over manual journal entries and account reconciliations due to finance team size limitations; the design of formal accounting policies to analyze, account for, and disclose complex transactions; and the design, implementation, and documentation of internal controls at the entity level and </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">certain reporting processes. During 2022, Legacy LanzaTech restated its previously issued 2020 and 2021 financial statements. The restatement resulted from certain material weaknesses, as described above. For additional information on the restatement, see Note 2 &#8212; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to Legacy LanzaTech&#8217;s 2020 and 2021 restated financial statements. LanzaTech is implementing measures designed to improve its internal control over financial reporting to remediate these material weaknesses, including hiring of additional accounting personnel. We believe the measures described above should remediate the material weaknesses identified and strengthen our internal control over financial reporting. While we continue the challenging and costly process to remediate the material weaknesses, we cannot predict the success of such plan or the outcome of our assessment of this plan until the remediation initiatives have been completed and have been operating effectively for a sufficient period of time. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We can give no assurance that these measures will remediate the deficiencies in internal control or that additional material weaknesses or significant deficiencies in internal control over financial reporting will not be identified in the future. Failure to implement and maintain effective internal control over financial reporting could result in material misstatements of our consolidated financial statements that may require us to restate our financial statements or cause us to fail to meet our periodic reporting obligations. As a result, we could be subject to sanctions or investigations by the stock exchange on which the common stock is listed, the SEC or other regulatory authorities. Failure to timely file will cause us to be ineligible to utilize short form registration statements on Form S-3 or Form S-4, which may impair our ability to obtain capital in a timely fashion to execute our business strategies or issue shares to effect an acquisition. In either case, there could result a material adverse effect on our business. The existence of material weaknesses or significant deficiencies in internal control over financial reporting could adversely affect our reputation or investor perceptions of LanzaTech, which could have a negative effect on the trading price of the common stock. In addition, we would incur additional costs to remediate material weaknesses in our internal control over financial reporting.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required, pursuant to Section 404 of the Sarbanes-Oxley Act, to furnish a report by management on, among other things, the effectiveness of our internal control over financial reporting for future annual reports on Form 10-K to be filed with the SEC. Failure to comply with the Sarbanes-Oxley Act could potentially subject us to sanctions or investigations by the SEC, Nasdaq or other regulatory authorities, which would require additional financial and management resources. However, for as long as we are an emerging growth company under the Jumpstart Our Business Startups Act of 2012, our independent registered public accounting firm will not be required to attest to the effectiveness of our internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act. We could be an emerging growth company for up to five years from the last day of the fiscal year of AMCI&#8217;s IPO.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may face litigation and other risks as a result of the material weaknesses in our internal control over financial reporting.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described elsewhere herein, we have identified a material weakness in our internal control over financial reporting related to the accounting for certain complex financial instruments issued by AMCI that were not effectively designed or maintained, which material weakness resulted in the restatement of AMCI&#8217;s balance sheet as of August 6, 2021, and a material weakness in our internal control over financial reporting related to the accounting of certain fees of Evercore.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of such material weaknesses, the restatement, the change in accounting for the financial instruments, and other matters raised or that may in the future be raised by the SEC, we face potential for litigation or other disputes which may include, among others, claims invoking the federal and state securities laws, contractual claims or other claims arising from the restatement and material weaknesses in our internal control over financial reporting and the preparation of our financial statements. As of the date hereof, we have no knowledge of any such litigation or dispute. However, we can provide no assurance that such litigation or dispute will not arise in the future. Any such litigation or dispute, whether successful or not, could have a material adverse effect on our business, results of operations and financial condition or our ability to complete a business combination.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Delaware law and provisions in our certificate of incorporation and bylaws could make a takeover proposal more difficult.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our organizational documents are governed by Delaware law. Certain provisions of Delaware law and of our certificate of incorporation and bylaws could discourage, delay, defer or prevent a merger, tender offer, proxy contest or other change of control transaction that a stockholder might consider in its best interest, including those attempts that might result in a premium over the market price for the shares of the common stock held by our stockholders. These provisions include the ability of the Board to designate the terms of and issue new series of preference shares, supermajority voting requirements to amend certain provisions of our certificate of incorporation, the classification of the Board, and a prohibition on stockholder actions by written consent, which may make more difficult the removal of management and may discourage transactions that otherwise could involve payment of a premium over prevailing market prices for our securities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These anti-takeover provisions as well as certain provisions of Delaware law could make it more difficult for a third party to acquire us, even if the third party&#8217;s offer may be considered beneficial by many of our stockholders. As a result, our stockholders may be limited in their ability to obtain a premium for their shares. If prospective takeovers are not consummated for any reason, we may experience negative reactions from the financial markets, including negative impacts on the price of the common stock. These provisions could also discourage proxy contests and make it more difficult for stockholders to elect directors of their choosing and to cause us to take other corporate actions that our stockholders desire.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our certificate of incorporation designates the Court of Chancery of the State of Delaware as the sole and exclusive forum for certain types of actions and proceedings and the federal district courts as the sole and exclusive forum for other types of actions and proceedings, in each case, that may be initiated by our stockholders, which could limit our stockholders&#8217; ability to obtain what such stockholders believe to be a favorable judicial forum for disputes with Lus or our directors, officers or other employees or increase our stockholders&#8217; costs in bringing such a claim.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our certificate of incorporation provides that, unless we consents to the selection of an alternative forum, the Court of Chancery of the State of Delaware will be the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of LanzaTech; (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or employee of LanzaTech to LanzaTech or its stockholders; (iii) any action asserting a claim against LanzaTech or any director, officer or employee arising pursuant to any provision of the DGCL or our certificate of incorporation or bylaws; or (iv) any action asserting a claim against LanzaTech or any director, officer or employee of LanzaTech governed by the internal affairs doctrine, and, if brought outside of Delaware, the stockholder bringing the suit will be deemed to have consented to (A) the personal jurisdiction of the state and federal courts within Delaware and (B) service of process on such stockholder&#8217;s counsel. The provision described in the immediately preceding sentence will not apply to (i) suits brought to enforce a duty or liability created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction and (ii) any complaint asserting a cause of action arising under the Securities Act of 1933, as amended, or the rules and regulations promulgated thereunder, for which the federal courts will be the exclusive forum. Any person or entity purchasing or otherwise acquiring an interest in any shares of our capital stock will be deemed to have notice of and to have consented to the forum provisions in our certificate of incorporation. These choice-of-forum provisions may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that he, she or it believes to be favorable for disputes with us or our directors, officers or other employees, which may discourage such lawsuits against us and our directors, officers, or other employees and may result in increased litigation costs for our stockholders. We note that there is uncertainty as to whether a court would enforce these provisions and that investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder. Section 22 of the Securities Act creates concurrent jurisdiction for state and federal courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alternatively, if a court were to find these provisions of our certificate of incorporation inapplicable or unenforceable with respect to one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could materially adversely affect our </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">business, financial condition and results of operations and result in a diversion of the time and resources of our management and the Board.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our actual financial position and results of operations may differ materially from the unaudited pro forma financial information included in this prospectus.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma condensed combined financial information included in this prospectus is presented for illustrative purposes only and is not necessarily indicative of what our actual financial position or results of operations would have been had the Business Combination been completed on the dates indicated. See &#8220;Unaudited Pro Forma Condensed Combined Financial Information&#8221; for more information.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There can be no assurance that our warrants or the AM Warrant will be in the money at the time they become exercisable, and they may expire worthless.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to adjustment, the exercise price for the outstanding Public Warrants and Private Placement Warrants is $11.50 per share of common stock and the exercise price for the AM Warrant is $10.00 per share of common stock. If the market price for shares of common stock is less than the exercise price of a holder&#8217;s warrant or AM Warrant, such holder may be less likely to exercise the warrants or the AM Warrant, as applicable, as such holder would be selling at a loss if they sold their common stock. There can be no assurance that such warrants or the AM Warrant will be in the money following the time they become exercisable and prior to their expiration, and as such, the warrants and the AM Warrant may expire worthless.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The holders of the shares of common stock registered hereby may be willing to sell their shares at a price lower than the public market price.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 10, 2023 the last reported sales price of the common stock was $7.30 per share. If the market price for shares of common stock is less than $10.00 per share, holders of shares of common stock would be selling at a loss if they purchased the shares of common stock at $10.00 per share. Because certain selling stockholders purchased shares privately at a price below the current market price, they may have an incentive to sell shares of their common stock because they could profit despite the market price of common stock falling below $10.00 per share. While these selling stockholders may, on average, experience a positive rate of return based on the current market price, public securityholders may not experience a similar rate of return on the securities they purchased due to differences in the purchase prices and the current market price. For example, based on the closing price of our common stock of $7.30 on February 10, 2023, the Sponsor and the AMCI Insiders would have a potential profit of up to approximately $7.295 per share that they purchased prior to the initial public offering of AMCI, or up to approximately $14.8 million in the aggregate (not giving effect to the issuance of common stock issuable upon exercise of the warrants held by them).</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_1597"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">USE OF PROCEEDS </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will not receive any proceeds from the sale of the Private Placement Warrants or of the common stock by the selling stockholders pursuant to this prospectus. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will receive up to an aggregate of approximately $145 million from the exercise of the warrants, the AM Warrant and the Options, assuming the exercise in full of all of the warrants, the AM Warrant and the Options for cash. To the extent that the warrants, the AM Warrant and the Options are exercised on a &#8220;cashless basis,&#8221; the amount of cash we would receive from the exercise of the warrants, the AM Warrant and the Options will decrease. We expect to use the net proceeds from the exercise of the warrants, the AM Warrant and the Options for general corporate purposes. We will have broad discretion over the use of proceeds from the exercise of the warrants, the AM Warrant and the Options.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is no assurance that the holders of the warrants or the AM Warrant will elect to exercise any or all of such warrant, or that the holders of Options will elect to exercise any or all of such Optionss. If the market price for shares of common stock is less than the exercise price of a holder&#8217;s warrant,the AM Warrant or the Options, such holder may be less likely to exercise the warrants, the AM Warrant or the Options, as applicable, as such holder would be selling at a loss if they sold their common stock. Subject to adjustment, the exercise price of the warrants is $11.50 per share and the exercise price of the AM Warrant is $10.00 per share. Subject to adjustment, the exercise prices of the Options range from $1.07 per share to $3.15 per share. On February 10, 2023 the last reported sales price of the common stock was $7.30 per share. Additionally, if the market price for shares of common stock is less than $10.00 per share, holders of shares of common stock would be selling at a loss if they purchased the shares of common stock at $10.00 per share. Because certain selling stockholders purchased shares privately at a price below the current market price, they may have an incentive to sell shares of their common stock because they could profit despite the market price of common stock falling below $10.00 per share. While these selling stockholders may, on average, experience a positive rate of return based on the current market price, public securityholders may not experience a similar rate of return on the securities they purchased due to differences in the purchase prices and the current market price. For example, based on the closing price of our common stock of $7.30 on February 10, 2023, the Sponsor and AMCI Insiders would have a potential profit of up to approximately $7.295 per share that they purchased prior to the initial public offering of AMCI, or up to approximately $14.8 million in the aggregate (not giving effect to the issuance of common stock issuable upon exercise of the warrants held by them).</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_1618"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DETERMINATION OF OFFERING PRICE </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The offering price of the shares of common stock underlying the warrants offered hereby is determined by reference to the exercise price of the warrants of $11.50 per share. The Public Warrants are listed on Nasdaq under the symbol &#8220;LNZAW.&#8221; The offering price of the shares of common stock underlying the Brookfield SAFE offered hereby is determined by reference to the conversion price of the Brookfield SAFE of $10.00 per share. The offering price of the shares of common stock underlying the AM Warrant is determined by reference to the exercise price of the AM Warrant of $10.00 per share.  The offering price of shares of common stock underlying the Options is determined by reference to the exercise price of the Options, which ranges between $1.07 per share and $3.15 per share.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot currently determine the price or prices at which shares of common stock or the Private Placement Warrants may be sold by the selling stockholders under this prospectus. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_1639"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MARKET INFORMATION FOR COMMON STOCK AND DIVIDEND POLICY </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market Information </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is currently listed on Nasdaq under the symbol &#8220;LNZA.&#8221; Prior to the consummation of the Business Combination, our common shares were listed on Nasdaq under the symbol &#8220;AMCI.&#8221; As of February 10, 2023, there were 182 holders of record of common stock. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividend Policy </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have never declared or paid any dividends on shares of common stock. We anticipate that we will retain all of our future earnings, if any, for use in the operation and expansion of our business and do not anticipate paying cash dividends in the foreseeable future. Any decision to declare and pay dividends in the future will be made at the sole discretion of our Board will depend on, among other things, our results of operations, cash requirements, financial condition, contractual restrictions and other factors that our board of directors may deem relevant.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_1660"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In this section, unless otherwise indicated or the context otherwise requires, references in this section to &#8220;New LanzaTech,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and other similar terms refer to LanzaTech Global, Inc. and its consolidated subsidiaries, including LanzaTech NZ, Inc. and its consolidated subsidiaries subsequent to the Business Combination. References to &#8220;LanzaTech&#8221; and &#8220;Legacy LanzaTech&#8221; refer to LanzaTech NZ, Inc. and its consolidated subsidiaries prior to the Business Combination and references to &#8220;AMCI&#8221; refer to AMCI Acquisition Corp. II prior to the Business Combination.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Introduction</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New LanzaTech is providing the following unaudited pro forma condensed combined financial information to aid you in your analysis of the financial aspects of the Business Combination.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AMCI was a blank check company formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registration statement for AMCI&#8217;s IPO became effective on August 3, 2021. On August 6, 2021, AMCI consummated its IPO of 15,000,000 units. Each unit consists of one share of Class A common stock, and one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one share of Class A common stock for $11.50 per share. The units were sold at $10.00 per unit, generating gross proceeds to AMCI of $150.0 million, and incurring offering costs of approximately $7.3 million, inclusive of approximately $5.3 million in deferred underwriting commissions. The underwriters were granted a 45-day option from the date of the underwriting agreement (August 3, 2021) to purchase up to 2,250,000 additional units to cover over-allotments, at $10.00 per unit. On September 17, 2021, the over-allotment option expired, resulting in the forfeiture of 562,500 founder shares.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Simultaneously with the closing of the IPO, AMCI consummated the sale of an aggregate of 3,500,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, generating gross proceeds to AMCI of $3.5 million. No underwriting discounts or commissions were paid with respect to such sales. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon closing of the IPO and sale of Private Placement Warrants, $150.0 million was placed in the trust account established in connection with the IPO (the &#8220;Trust Account&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AMCI had 24 months from the closing of the IPO (by August 6, 2023) to complete an initial business combination.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech was founded in 2005 in New Zealand and was headquartered in Skokie, Illinois. LanzaTech is a nature-based carbon refining company that transforms waste carbon into materials such as sustainable fuels, fabrics, and packaging that people use in their daily lives. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma condensed combined balance sheet as of September 30, 2022 combines the unaudited condensed balance sheet of AMCI and the unaudited condensed consolidated balance sheet of LanzaTech on a pro forma basis as if the Business Combination and the related transactions contemplated by the Merger Agreement, summarized below, had been consummated on September 30, 2022. The unaudited pro forma condensed combined statements of operations for the nine months ended September 30, 2022 and for the year-ended December 31, 2021 combine the historical statements of operation of AMCI and LanzaTech for such periods on a pro forma basis as if the Business Combination and related transactions, summarized below, had been consummated on January 1, 2021, the beginning of the earliest period presented. The related transactions that are given pro forma effect include:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the reverse recapitalization between AMCI and LanzaTech;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the net proceeds from the issuance of 18,500,000 shares of New LanzaTech common stock in connection with the Private Placement;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the net proceeds from the issuance of the Brookfield SAFE; and</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Forward Purchase Agreement between AMCI, LanzaTech and ACM.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma condensed combined financial information may not be useful in predicting the future financial condition and results of operations of New LanzaTech. The actual financial position and results of operations of New LanzaTech may differ significantly from the pro forma amounts reflected herein due to a variety of factors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The historical financial information of AMCI was derived from the unaudited financial statements of AMCI as of and for the nine months ended September 30, 2022 and the audited financial statements of AMCI as of December 31, 2021 and for the period from August 3, 2021 (inception) through December 31, 2021, which are included elsewhere in this prospectus. The historical financial information of LanzaTech was derived from the unaudited condensed consolidated financial statements of LanzaTech as of and for the nine months ended September 30, 2022 and the audited consolidated financial statements of LanzaTech as of and for the year ended December 31, 2021, which are included elsewhere in this prospectus. This information should be read together with AMCI&#8217;s and LanzaTech&#8217;s audited financial statements and related notes, the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and other financial information included elsewhere in this prospectus.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech, AMCI and ACM executed the Forward Purchase Agreement on February 3, 2023. Pursuant to the Forward Purchase Agreement, ACM obtained 5,916,514 Recycled Shares on the open market for approximately $10.16 per share (&#8220;Redemption Price&#8221;), and such purchase price of $60.1 million was funded by the use of Trust Account proceeds as a prepayment (&#8220;Prepayment Amount&#8221;) for the Forward Purchase Agreement redemption at the end of three years (&#8220;Maturity Date&#8221;). ACM has the right at the end of three years to return the shares and keep the Prepayment Amount plus the fees described below, or may, at ACM&#8217;s sole discretion, to partially or fully terminate this transaction over the course of the three year term by returning cash in an amount equal to the number of shares terminated from time to time (&#8220;Terminated Shares&#8221;) multiplied by the Redemption Price, which price may be reduced in the case of certain dilutive events (&#8220;Reset Price&#8221;). </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the end of the three-year term, New LanzaTech is obligated to pay ACM an amount equal to the product of (1) 7,500,000 less (b) the number of Terminated Shares multiplied by (2) $2.00 (the &#8220;Maturity Consideration&#8221;). In addition to the Prepayment Amount and the Maturity Consideration, on the Maturity Date, New LanzaTech shall pay to ACM an amount equal to the product of (x) 500,000 and (y) the Redemption Price, totalling $5.1 million (the &#8220;Share Consideration&#8221;). </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, ACM may request, at its sole discretion, warrants of New LanzaTech exercisable for shares in an amount equal to 10,000,000 less the number of Recycled Shares (&#8220;Shortfall Warrants&#8221;). The Shortfall Warrants warrants have an exercise price equal to the Reset Price. The form of the Shortfall Warrants shall be agreed upon by LanzaTech, AMCI and ACM within 45 days of the executed Forward Purchase Agreement. ACM has requested 4,083,486 Shortfall Warrants based on the number of Recycled Shares purchased. In connection with the Forward Purchase Agreement, ACM assigned its rights, duties and obligations with respect to a portion of the shares purchased under the Forward Purchase Agreement to Vellar Opportunity Fund SPV LLC - Series 10.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Business Combination closed on February 8, 2023 and was accounted for as a reverse recapitalization, in accordance with US GAAP. Under this method of accounting, AMCI was treated as the &#8220;acquired&#8221; company for financial reporting purposes. Accordingly, the Business Combination was treated as the equivalent of LanzaTech issuing stock for the net assets of AMCI, accompanied by a recapitalization. The net assets of AMCI were stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Business Combination are those of LanzaTech.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech was determined to be the accounting acquirer based on evaluation of the following facts and circumstances:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">LanzaTech stockholders have the largest portion of voting rights (85.3%) in New LanzaTech;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">LanzaTech&#8217;s existing senior management team comprise senior management of New LanzaTech;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The operations of New LanzaTech primarily represent operations of LanzaTech; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In comparison with AMCI, LanzaTech has significantly more revenues and total assets.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description of the Business Combination</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate consideration for the Business Combination will be payable in the form of shares of New LanzaTech common stock.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the purchase consideration:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.355%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.804%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shares transferred</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,324,363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value per share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total share consideration</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,673,243,630</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exchanged</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,756,370&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total equity value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,817,000,000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total shares transferred include the conversion of LanzaTech RSAs to New LanzaTech RSAs in accordance with the Merger Agreement. Total shares transferred do not include LanzaTech options. See note (3) for further information on these instruments.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total share consideration is calculated using a $10.00 per-share reference price. The closing share price of the Business Combination was determined on the Closing Date. As the Business Combination was accounted for as a reverse recapitalization, the value per share is disclosed for informational purposes only in order to indicate the fair value of shares transferred.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Options exchanged represents the conversion of LanzaTech options into New LanzaTech options in accordance with the Merger Agreement. These options are not assumed to be exercised for the purposes of the unaudited pro forma condensed combined financial information and, therefore, have not been included in Total share consideration. The value of the options represents the number of shares that would be issued under the option agreements assuming full cash exercise. Those shares are valued at the $10.00 per-share reference price.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total equity value includes the value of the exchanged options assuming full cash exercise of all such instruments. The total equity value is equal to the equity value of $1,817.0 million outlined in the Merger Agreement. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the pro forma shares of New LanzaTech Common Stock outstanding:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMCI Public Stockholders</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,981,860&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMCI Shares subject to Forward Purchase Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,916,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMCI Insiders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total AMCI Shares</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,398,374&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legacy LanzaTech stockholders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,324,363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PIPE Investors</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,500,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pro Forma New LanzaTech Common Stock at September 30, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196,222,737&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents shares purchased by ACM as part of the Forward Purchase Agreement described in Footnote N below. These shares are redeemable at the option of ACM and have been classified as redeemable common stock.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">1,250,000 AMCI Insider shares were cancelled and re-issued to public shareholders whereby those public shareholders agreed not to redeem their Class A common stock in connection with the Business Combination. The transfer of AMCI Insider shares served as an incentive for public shareholders to not redeem. These shares remain outstanding following the Closing and are reflected in this table as part of the AMCI Public Stockholders share count.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts and percentages exclude all LanzaTech options (including vested LanzaTech options) as they are not outstanding common stock at the time of Closing. Further, these amounts also exclude the 11,000,000 warrants outstanding to acquire AMCI Class A common stock as these were outstanding at the closing of the Business Combination. Additionally, amounts and percentages reflect no election by Brookfield or ArcelorMittal to convert any portion of the Brookfield SAFE or AM Warrant into shares of New LanzaTech common stock following the Closing.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following unaudited pro forma condensed combined balance sheet as of September 30, 2022 and the unaudited pro forma condensed combined statement of operations for the nine months ended September 30, 2022 and the year ended December 31, 2021 are based on the historical financial statements of AMCI and LanzaTech. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma adjustments are based on information currently available, and assumptions and estimates underlying the unaudited pro forma adjustments are described in the accompanying notes. Actual results may differ materially from the assumptions used to present the accompanying the unaudited condensed combined pro forma financial information.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_2352"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET AS OF September 30, 2022 (in thousands)</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.906%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">As of September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">AMCI Acquisition Corp. II (Historical)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">LanzaTech NZ, Inc. (Historical)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Transaction Accounting Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Pro Forma Combined</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(B)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">248,991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(200)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(C)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11,778)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(D)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">155,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(E)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(F)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(60,547)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(N)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade and other receivables, net of allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses - current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(278)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(A)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(A)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(D)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Current Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88,815&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">197,364&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">286,464&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investments held in Trust Account</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150,969&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(150,969)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(B)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forward purchase agreement derivative asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(N)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">151,254</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">135,590</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">59,418</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">346,262</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LIABILITIES, CONTINGENTLY REDEEMABLE PREFERRED EQUITY, AND SHAREHOLDERS' EQUITY (DEFICIT)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,688&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,488&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,625)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(D)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Capital based tax payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Franchise tax payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(A)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(A)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(D)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,572)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(H)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AM SAFE liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(27,221)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(E)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AM Warrant</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,022)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(K)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,357)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(A)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Due to related party</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued salaries and wages</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,079&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,079&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,316&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49,047&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(34,602)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,761&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred underwriting commissions payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(200)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(C)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Brookfield SAFE liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(F)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivative warrant liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25,576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(O)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-current lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.906%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-current contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">823&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">823&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,059&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62,599&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,774&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">109,432&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Class A common stock subject to possible redemption</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150,294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(65,464)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(L)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60,096&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(84,831)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(B)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60,096&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(N)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingently Redeemable Preferred Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redeemable convertible preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">480,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">241,529&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(G)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(722,160)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(H)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shareholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Class A common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Class B common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(E)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(H)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(L)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(N)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12,330)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(D)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">928,409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">184,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(E)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">723,715&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(H)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(J)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(K)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(L)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,010)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(M)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(60,095)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(N)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated (deficit) equity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,099)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(434,863)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(D)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(755,116)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,779)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(E)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(241,529)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(G)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,741)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(J)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,010&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(M)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(47,524)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(N)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25,576)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(O)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total shareholders' (deficit) equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,099)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(407,640)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">589,473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">176,734&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TOTAL LIABILITIES, CONTINGENTLY REDEEMABLE PREFERRED EQUITY, AND SHAREHOLDERS' EQUITY (DEFICIT)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">151,254</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">135,590</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">59,418</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">346,262</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to the unaudited pro forma condensed combined financial information.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_2374"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unaudited Pro Forma Condensed Combined Statement of Operations For the nine months Ended September 30, 2022 (in thousands, except share and per share amounts)</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.778%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.639%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">AMCI Acquisition Corp. II (Historical)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">LanzaTech NZ, Inc. (Historical)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Transaction Accounting Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Pro Forma Combined</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenue from contracts with customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenue from collaborative arrangements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenue from related party transactions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25,781&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25,781&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost and operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of revenues from contracts with customers (exclusive of depreciation shown below)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of revenue from collaborative arrangements (exclusive of depreciation shown below)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(727)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(727)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of revenue from related party transactions (exclusive of depreciation shown below)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(342)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(342)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(39,858)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(39,858)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,433)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,433)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19,482)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,011)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(AA)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(20,404)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(II)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,677)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(AA)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative expenses - related party</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Capital based tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(AA)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Franchise tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(AA)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total cost and operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,101)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(82,004)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,089&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(83,016)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Loss) income from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,101)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(56,223)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,089&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(57,235)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other (expense) income, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,067&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(AA)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,637&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(FF)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,050)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(GG)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(HH)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in fair value of derivative warrant liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,067&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,067)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(AA)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain from settlement of deferred underwriting commissions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(BB)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income from investments held in Trust Account</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(972)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(BB)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other income (loss), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,211&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,097)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,474)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,640&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(57,320)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,615&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(54,595)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax (expense) benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(LL)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,056&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(54,974)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,669&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(52,249)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unpaid cumulative dividends on preferred stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28,925)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(MM)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss) allocated to common shareholders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,056&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(83,899)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,594&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(52,249)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average shares outstanding of Class A common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic and diluted net income per share, Class A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average shares outstanding of Class B common stock, basic and diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,750,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic and diluted net income per share, Class B common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.778%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.639%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding - basic and diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,108,472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">196,222,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss per common share - basic and diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(39.79)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to the unaudited pro forma condensed combined financial information.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_2395"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unaudited Pro Forma Condensed Combined Statement of Operations For the Year Ended December 31, 2021 (in thousands, except share and per share amounts)</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.639%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">AMCI Acquisition Corp. II (Historical)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">LanzaTech NZ, Inc. (Historical as restated)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Transaction Accounting Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Pro Forma Combined</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenue from contracts with customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenue from collaborative arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenue from related party transactions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25,461&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25,461&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost and operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of revenues from contracts with customers (exclusive of depreciation shown below)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13,167)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13,167)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of revenue from collaborative arrangements (exclusive of depreciation shown below)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of revenue from related party transactions (exclusive of depreciation shown below)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(808)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(808)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(44,229)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(CC)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(45,476)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,201)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(DD)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,806)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,806)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13,216)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,337)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(AA)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16,602)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(CC)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,540)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(DD)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(451)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(JJ)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(951)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(AA)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative expenses - related party</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Capital based tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(198)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(AA)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Franchise tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(AA)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total cost and operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,387)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(76,480)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,296)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(81,163)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,387)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(51,019)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,296)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(55,702)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other (expense) income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(673)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(AA)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(74,109)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,779)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(EE)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(HH)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(47,073)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(JJ)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25,576)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(KK)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in fair value of derivative warrant liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,905)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(AA)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Offering costs allocated to derivative warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(476)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(AA)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income from investments held in Trust Account</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(BB)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other income (loss), net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,435&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,385&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(74,871)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(71,051)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (Loss) before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(48,634)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(78,167)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(126,753)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(LL)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(46,689)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(78,167)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(124,808)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unpaid cumulative dividends on preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(36,758)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(MM)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss) allocated to common shareholders</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(83,447)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(41,409)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(124,808)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.639%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average shares outstanding of Class A common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,690,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic and diluted net income per share, Class A</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average shares outstanding of Class B common stock, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic and diluted net income per share, Class B common stock</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding - basic and diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,959,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">196,222,737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss per common share - basic and diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(42.59)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.64)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to the unaudited pro forma condensed combined financial information.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_2304"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. Basis of Presentation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Business Combination was accounted for as a reverse recapitalization in accordance with US GAAP. Under this method of accounting, AMCI was treated as the &#8220;acquired&#8221; company for financial reporting purposes. Accordingly, the Business Combination was treated as the equivalent of LanzaTech issuing stock for the net assets of AMCI, accompanied by a recapitalization. The net assets of AMCI were stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Business Combination are those of LanzaTech.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma condensed combined balance sheet as of September 30, 2022 assumes that the Business Combination occurred on September 30, 2022. The unaudited pro forma condensed combined statements of operations for the nine months ended September 30, 2022 and the year ended December 31, 2021 give pro forma effect to the Business Combination as if it had been completed on January 1, 2021. These periods are presented on the basis of LanzaTech as the accounting acquirer.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma condensed combined balance sheet as of September 30, 2022 has been prepared using, and should be read in conjunction with, the following:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">AMCI&#8217;s unaudited condensed balance sheet as of September 30, 2022 and the related notes as of and for the period ended September 30, 2022, included elsewhere in this prospectus; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">LanzaTech&#8217;s unaudited condensed consolidated balance sheet as of September 30, 2022 and the related notes as of and for the period ended September 30, 2022, included elsewhere in this prospectus.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma condensed combined statements of operations for the nine months ended September 30, 2022 and for the year ended December 31, 2021 have been prepared using, and should be read in conjunction with, the following:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">AMCI&#8217;s unaudited condensed statement of operations for the nine months ended September 30, 2022 and the audited statement of operations for the period from August 6, 2021 (inception) through December 31, 2021 included elsewhere in this prospectus; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">LanzaTech&#8217;s unaudited condensed consolidated statement of operations and comprehensive loss for the nine months ended September 30, 2022 and the audited consolidated statement of operations and comprehensive loss for the year ended December 31, 2021 included elsewhere in this prospectus.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management has made significant estimates and assumptions in its determination of the pro forma adjustments. As the unaudited pro forma condensed combined financial information has been prepared based on these preliminary estimates, the final amounts recorded may differ materially from the information presented.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma condensed combined financial information does not give effect to any anticipated synergies, operating efficiencies, tax savings, or cost savings that may be associated with the Business Combination.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pro forma adjustments reflecting the consummation of the Business Combination are based on certain currently available information and certain assumptions and methodologies that management believes are reasonable under the circumstances. The unaudited combined pro forma adjustments, which are described in the accompanying notes, may be revised as additional information becomes available and is evaluated. Therefore, it is likely that the actual adjustments will differ from the pro forma adjustments and it is possible the differences may be material. Management believes that its assumptions and methodologies provide a reasonable basis for presenting all of the significant effects of the Business Combination based on information available to management at this time and that the pro forma adjustments give appropriate effect to those assumptions and are properly applied in the unaudited pro forma condensed combined financial information.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. Adjustments to Unaudited Pro Forma Condensed Combined Financial Information</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma condensed combined financial information has been prepared to illustrate the effect of the Business Combination and has been prepared for informational purposes only.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma information has been prepared in accordance with Article 11 of Regulation S-X as amended by the final rule, Release No. 33-10786, &#8220;Amendments to Financial Disclosures about Acquired and Disposed Businesses.&#8221; Release No. 33-10786 replaces the existing pro forma adjustment criteria with simplified requirements to depict the accounting for the transaction (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transaction Accounting Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and present the reasonably estimable synergies and other transaction effects that have occurred or are reasonably expected to occur (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Adjustments&#8221;). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management has elected not to present Management&#8217;s Adjustments and will only be presenting Transaction Accounting Adjustments in the unaudited pro forma condensed combined financial information.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pro forma basic and diluted loss per share amounts presented in the unaudited pro forma combined statements of operations are based upon the number of shares of New LanzaTech common stock outstanding, assuming the Business Combination occurred on January 1, 2021.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjustments to Unaudited Pro Forma Condensed Combined Balance Sheet</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adjustments included in the unaudited pro forma condensed combined balance sheet as of September 30, 2022 are as follows:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.12pt">Reflects the following reclassifications on the balance sheet to align presentation:</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reflects the reclassification of $0.3 million of prepaid expenses - current into $0.3 million of other current assets.</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reflects the reclassification of $1.4 million of accrued expenses and $0.2 million of franchise tax payable to other accrued liabilities.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.68pt">Reflects the reclassification of $151.0 million of marketable securities held in the Trust Account at the balance sheet date that becomes available at the closing of the Business Combination. This amount is reduced by the $84.8 million in cash that was paid to redeeming shareholders for the 8,351,626 shares of Class A common stock subject to redemption that were redeemed at a per share redemption price of $10.16.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.68pt">Reflects the payment of $0.2 million of deferred underwriting fees payable that were incurred in connection with the IPO. The fees were paid at the close of the Business Combination. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.12pt">Represents the settlement of transaction costs of both AMCI and LanzaTech related to the Business Combination of $12.2 million, in addition to the $0.2 million of deferred underwriting fees noted above, inclusive of advisory, banking, printing, legal and accounting fees that are capitalized into additional paid-in capital as a reduction to proceeds. The unaudited pro forma condensed combined balance sheet reflects these costs as a reduction of cash of $11.8 million as $0.4 million have been paid as of September 30, 2022. $2.2 million in other accrued liabilities and $1.6 million in accounts payable  was accrued between both AMCI and LanzaTech as of September 30, 2022. $1.2 million was capitalized on LanzaTech&#8217;s balance sheet as of September 30, 2022. Adjustment to accumulated deficit of $3.1 million represents the capitalization of transaction costs expensed by AMCI through September 30, 2022.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.24pt">Represents the net proceeds from the Private Placement of 18,500,000 shares of Class A common stock, par value $0.0001, at $10.00 per share. Proceeds from the Private Placement totaled $155.0 million as 3,000,000 shares of Class A common stock were issued under the AM SAFE in satisfaction of the related liability recorded on LanzaTech&#8217;s balance sheet. Additionally, the AM SAFE is effectively adjusted to $30.0 million immediately prior to its conversion to shares through an entry to accumulated deficit for $2.8 million. See footnote EE for further details.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(F)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">Represents the issuance of the Brookfield SAFE for $50.0 million. At the time of issuance, none of the Brookfield SAFE automatically converts to New LanzaTech common stock as a result of the Business Combination. Conversion only occurs at the option of Brookfield as no equity funding has occurred. As a result, the Brookfield SAFE is reflected as a mark-to-market liability on the pro forma balance sheet. There is no associated pro forma income statement impact as the Brookfield SAFE was not outstanding in the periods presented where a mark-to-market adjustment could be calculated. Management is still assessing the full accounting impact of this arrangement.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(G)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.12pt">Represents the implied declaration of the $241.5 million unpaid cumulative dividends immediately prior to the conversion of LanzaTech preferred shares into LanzaTech common shares. As required by the Merger Agreement, all unpaid cumulative dividends on LanzaTech preferred shares are converted to shares of New LanzaTech common stock by dividing the total cumulative dividends by $10.00. This conversion occurs in footnote H. The dividend accrual was calculated through February 8, 2023, the Closing Date.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(H)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.12pt">Represents recapitalization of LanzaTech through the issuance of 167,324,363 shares of New LanzaTech common stock to LanzaTech shareholders as consideration for the reverse recapitalization, including the settlement of LanzaTech preferred shares into shares of New LanzaTech common stock and the settlement of the cumulative unpaid dividend on the LanzaTech preferred shares into shares of New LanzaTech common stock as discussed in footnote G. LanzaTech preferred shares were converted into LanzaTech common shares prior to the reverse recapitalization on a one for one basis. </span></div><div style="margin-bottom:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, this adjustment reflects the net exercise of all outstanding warrants to purchase up to an aggregate of 225,223 shares of LanzaTech common stock granted by LanzaTech to Venture Lending and Leasing VI, Inc. in September 2012, and to Venture Lending and Leasing VII, Inc. and Venture Lending and Leasing VIII, Inc. in November 2016 (collectively, the &#8220;VLL Warrants&#8221;) into LanzaTech common shares immediately prior to the reverse capitalization. The $1.6 million liability for these warrants is derecognized as a result of the exercise.</span></div><div style="margin-bottom:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of LanzaTech common shares received per share consideration of 4.37 shares of New LanzaTech common stock. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(I)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.01pt">Represents the conversion and accelerated vesting of LanzaTech options into New LanzaTech options where the option agreement includes a performance condition that accelerated vesting as a result of the Business Combination. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(J)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.45pt">Represents the conversion and accelerated vesting of LanzaTech RSAs into the New LanzaTech RSAs.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(K)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.12pt">Reflects the reclassification of the AM Warrant from liability to equity upon close of the Business Combination as the warrant became exercisable for a fixed number of shares at a fixed exercise price at the time of the Business Combination. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(L)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.24pt">Reflects the reclassification of $65.5 million of Class A common stock subject to possible redemption that were ultimately not redeemed to permanent equity.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(M)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:2.45pt">Reflects the elimination of AMCI&#8217;s historical accumulated deficit to additional paid-in capital. The amount eliminated is adjusted for the amount of AMCI historical accumulated deficit already reclassified in footnote D.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(N)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.12pt">Reflects the Forward Purchase Agreement. The combination of the Prepayment Amount (reflected as a cash outflow of $60.5 million, inclusive of $0.4 million in stock acquisition fees in this adjustment) and ACM&#8217;s optional early termination economically result in the arrangement being akin to a prepaid written put option on 5,916,514 Class A common shares. Because prepaid, New LanzaTech is entitled over the 36 month maturity period to either a return of cash or a return of shares, which ACM will determine at its sole discretion. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Forward Purchase Agreement is therefore evaluated as a prepaid redemption contract that meets the definition of a derivative and is initially valued at an estimated closing date fair value of $13.0 million. The value of the derivative is comprised of the Prepayment Amount, and is reduced by the economics of the downside protection provided to ACM, the Maturity Consideration on non-terminated shares and the Share Consideration, reducing the value of the Prepayment Amount by $47.1 million. The derivative will be remeasured to fair value with changes reflected in earnings in future periods. The accounting for the forward purchase agreement asset, as well as the final valuation, are still under evaluation and may be subject to change. </span></div><div style="margin-bottom:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expensed transaction costs in the amount of $0.5 million are reflected as an adjustment to accumulated deficit.</span></div><div style="margin-bottom:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The difference between the Prepayment Amount and fair value of the derivative is recorded through accumulated deficit as a one-time charge reflecting the cost of entering the Forward Purchase Agreement.</span></div><div style="margin-bottom:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 5,916,514 Class A common shares purchased by ACM are classified as redeemable common shares as such shares may be redeemed with the settlement of the derivative asset solely at ACM&#8217;s election. These shares are reclassified to Class A common stock subject to possible redemption from Class A common stock and recorded at their maximum redemption value of $60.1 million on the unaudited pro forma condensed combined balance sheet. The reclassification of shares is recorded through additional paid-in capital.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(O)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.12pt">Reflects the issuance of 4,083,486 Shortfall Warrants to ACM in connection with the Forward Purchase Agreement. The form of these warrants will be negotiated between ACM and New LanzaTech within 45 days of the executed Forward Purchase Agreement. For the purpose of the pro forma financial information, these warrants are assumed to be liability classified and have a 3 year term. The Shortfall Warrant value is recorded to derivative warrant liabilities, with an offsetting entry to accumulated deficit. As the form of the warrant has not yet been determined, the classification and valuation of these warrants is subject to change based on the final form agreed between the parties.  </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjustments to Unaudited Pro Forma Condensed Combined Statements of Operations</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pro forma adjustments included in the unaudited pro forma condensed combined statements of operations for the nine months ended September 30, 2022 and year ended December 31, 2021 are as follows:</span></div><div style="margin-bottom:9pt;padding-left:40.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(AA)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.4pt">Reflects the following reclassifications on the combined statement of operations to align presentation:</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reflects the reclassification of general and administrative expense, franchise tax expense and capital-based tax expense into selling, general and administrative expense.</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reflects the reclassification of change in fair value of derivative warrant liabilities into other (expense) income, net.</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reflects the reclassification of offering costs allocated to derivative warrant liabilities into other (expense) income, net. This reclassification only applies to the year ended December 31, 2021.</span></div><div style="margin-bottom:9pt;padding-left:40.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(BB)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:2.52pt">Reflects the elimination of investment income on the Trust Account and the gain from the settlement of deferred underwriting fees resulting from the resignation of Evercore. As this gain resulting from Evercore's resignation occurred prior to Closing and is recorded by AMCI, the gain is reversed.</span></div><div style="margin-bottom:9pt;padding-left:40.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(CC)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:2.52pt">Reflects the expense related to the conversion and accelerated vesting of LanzaTech options into New LanzaTech options where the option agreement includes a performance condition that accelerated vesting as a result of the Business Combination. This expense is split between selling, general and administrative expense and research and development expense based on where the related employees&#8217; compensation expense is recorded.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;padding-left:40.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(DD)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.4pt">Reflects the expense related to the conversion and accelerated vesting of LanzaTech RSAs into New LanzaTech RSAs.  This expense is split between selling, general and administrative expense and research and development expense based on where the related employees&#8217; compensation expense is recorded.</span></div><div style="margin-bottom:9pt;padding-left:40.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(EE)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.64pt">Reflects the mark-to-market adjustment on the AM SAFE liability to increase the value of the liability to $30.0 million at the time of settlement as 3,000,000 shares of New LanzaTech common stock valued at $10.00 per share are to be issued in satisfaction of the SAFE liability.</span></div><div style="margin-bottom:9pt;padding-left:40.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(FF)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.72pt">Reflects the reversal of the fair value adjustment on the AM Warrant as the AM Warrant is equity classified upon close of the Business Combination (see footnote K above). As the AM Warrant was issued in December 2021, there is no associated mark-to-market adjustment on the statement of operations for the year-ending December 31, 2021.</span></div><div style="margin-bottom:9pt;padding-left:40.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(GG)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.4pt">Reflects the reversal of the fair value adjustment on the AM SAFE as the AM SAFE is satisfied upon close of the Business Combination (see footnote E above).</span></div><div style="margin-bottom:9pt;padding-left:40.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(HH)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.4pt">Reflects the reversal of the fair value adjustment on the VLL Warrants, which were exercised immediately prior to the close of the Business Combination (see Footnote H above).</span></div><div style="margin-bottom:9pt;padding-left:40.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(II)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.18pt">Reflects the reversal of capitalizable transaction costs which would not have been expensed had the transaction taken place on January 1, 2021.</span></div><div style="margin-bottom:9pt;padding-left:40.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(JJ)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.06pt">Reflects the transaction costs related to the issuance of the Forward Purchase Agreement as if the transaction had taken place on January 1, 2021. These transaction costs are included in selling, general and administrative expense. Lastly, this reflects the one-time, non-cash charge of entering into the Forward Purchase Agreement, which are included in other (expense) income, net. See Footnote N for further details.</span></div><div style="margin-bottom:9pt;padding-left:40.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(KK)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.4pt">Represents the expense on the Shortfall Warrants issued in connection with the Forward Purchase Agreement (see Footnote O above).</span></div><div style="margin-bottom:9pt;padding-left:40.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(LL)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.64pt">LanzaTech has significant deferred tax assets in the jurisdictions in which it operates. The ability to realize deferred tax assets depends on LanzaTech&#8217;s ability to generate sufficient taxable income within the carryforward periods provided for in the tax law for each tax jurisdiction. The valuation allowances recorded against deferred tax assets generated by taxable losses in certain jurisdictions will affect the provision for income taxes until the valuation allowances are released. </span></div><div style="margin-bottom:9pt;padding-left:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma condensed combined financial information assumes these deferred tax assets and the related valuation allowance will transfer to New LanzaTech, so New LanzaTech's provision for income taxes will include no tax benefit for losses incurred in these jurisdictions until the respective valuation allowance is eliminated. As a result, there has been no tax effect applied to any of the pro forma adjustments detailed above as the valuation allowances remain outstanding during the period of the unaudited pro forma condensed combined statement of operations.</span></div><div style="margin-bottom:9pt;padding-left:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2022, the income tax expense recorded by AMCI has been reversed from the unaudited pro forma condensed combined statement of operations due to the expectations noted here. The associated current tax liability on the unaudited pro forma condensed combined balance sheet as of September 30, 2022 has not been reversed as the Business Combination does not trigger its settlement.</span></div><div style="padding-left:40.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(MM)Reflects the elimination of the unpaid cumulative dividend on LanzaTech preferred shares as all LanzaTech preferred shares were converted into New LanzaTech common stock at the closing of the Business Combination. New LanzaTech did not have any outstanding preferred shares at the closing of the Business Combination.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. Loss per Share</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Represents the net loss per share calculated using the historical weighted average shares outstanding, and the issuance of additional shares in connection with the Business Combination, assuming the shares were outstanding since January 1, 2021. As the Business Combination and related equity transactions are being reflected as if they had occurred at the beginning of the period presented, the calculation of weighted average shares outstanding for basic and diluted net income (loss) per share assumes that the shares issued relating to the Business Combination have been outstanding for the entirety of the period presented. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in thousands except per share data)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the nine months ended September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the year ended December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52,249)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124,808)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding of common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196,222,737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196,222,737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share (basic and diluted) attributable to common stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.64)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">As LanzaTech had a net loss on a pro forma combined basis, the outstanding New LanzaTech options and the outstanding New LanzaTech warrants have no impact to diluted net loss per share as they are considered anti-dilutive.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">If Brookfield were to convert the Brookfield SAFE to 5,000,000 shares of New LanzaTech common stock, the pro forma loss per share would be as follows:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12.45pt">For the nine months ended September 30, 2022: $(0.26)</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">For the year ended December 31, 2021: $(0.62)</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_1681"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis should be read in conjunction with LanzaTech&#8217;s financial statements and related notes included elsewhere in this prospectus. This discussion and analysis and other parts of this prospectus contain forward-looking statements based upon current beliefs, plans and expectations that involve risks, uncertainties, and assumptions. LanzaTech&#8217;s actual results and the timing of selected events could differ materially from those anticipated in these forward-looking statements as a result of several factors, including those set forth under &#8220;Risk Factors&#8221; and elsewhere in this prospectus. You should carefully read the &#8220;Risk Factors&#8221; section of this prospectus to gain an understanding of the important factors that could cause actual results to differ materially from any such forward-looking statements. Please also see &#8220;Forward-Looking Statements.&#8221; In this section, unless otherwise indicated or the context otherwise requires, references in this section to &#8220;New LanzaTech,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and other similar terms refer to LanzaTech Global,&#160;Inc. and its consolidated subsidiaries, including LanzaTech NZ, Inc. and its consolidated subsidiaries subsequent to the Business Combination. References to &#8220;LanzaTech&#8221; and &#8220;Legacy LanzaTech&#8221; refer to LanzaTech NZ, Inc. and its consolidated subsidiaries prior to the Business Combination and references to &#8220;AMCI&#8221; refer to AMCI Acquisition Corp. II prior to the Business Combination.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a nature-based carbon refining company that transforms waste carbon into the chemical building blocks for consumer goods such as sustainable fuels, fabrics, and packaging that people use in their daily lives. Our customers leverage our proven proprietary gas fermentation technology platform to convert certain feedstock, including waste carbon gases, into sustainable fuels and chemicals such as ethanol. We are focused on taking advantage of the many uses of ethanol while capitalizing on the growing preference among major companies for renewable products and environmentally-conscious manufacturing processes.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech performs research and development (&#8220;R&amp;D&#8221;) services related to novel technologies and development of biocatalysts for commercial applications, mainly to produce fuels and chemicals. We primarily employ a licensing business model whereby our customers build, own and operate facilities that use our technology, and in return, we are paid a royalty fee based on the revenue generated by the customer from the use of our technology. We began operations in 2005 and in 2018, we established the world&#8217;s first commercial waste gas to ethanol plant in China, followed by a second and a third one in 2021 and 2022, respectively, also in China, with others currently in development in various countries around the world.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not achieved operating profitability since our formation. Our net losses after tax were $(55.0) million for the nine&#160;months ended September&#160;30, 2022 and $(30.6) million for the nine&#160;months ended September&#160;30, 2021. As of September&#160;30, 2022 we had an accumulated deficit of $(434.9) million compared to an accumulated deficit of $(379.9) million as of December&#160;31, 2021. We anticipate that we will continue to incur losses until we sufficiently commercialize our technology.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Business Combination</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;8, 2022, AMCI entered into the Merger Agreement with Legacy LanzaTech and Merger Sub. On February 8, 2023, upon the terms and subject to the satisfaction or waiver of the conditions described in the Merger Agreement, including approval of the transaction by the AMCI Stockholders and LanzaTech stockholders, Merger Sub merged with and into LanzaTech. Upon consummation of the Business Combination, the separate corporate existence of Merger Sub ceased, and LanzaTech survived the Business Combination and became a wholly owned subsidiary of AMCI. In addition, in connection with the consummation of the Business Combination, the combined company was renamed &#8220;LanzaTech Global,&#160;Inc.&#8221; and is referred to in this section as &#8220;New LanzaTech.&#8221;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Impact of the Business Combination</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Business Combination is being accounted for as a reverse recapitalization. LanzaTech is the accounting predecessor and New LanzaTech is the successor SEC registrant, meaning that LanzaTech&#8217;s financial statements for previous periods will be disclosed in New LanzaTech&#8217;s periodic reports filed with the SEC.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under this method of accounting, AMCI is treated as the acquired company for financial statement reporting purposes. For accounting purposes, LanzaTech is deemed to be the accounting acquirer in the transaction and, consequently, the transaction is treated as a recapitalization of LanzaTech (i.e., a capital transaction involving the issuance of stock by AMCI for the stock of LanzaTech). Accordingly, the condensed consolidated balance sheets and results of operations of LanzaTech are the historical financial statements of New LanzaTech, and AMCI&#8217;s assets, liabilities and results of operations have been consolidated with LanzaTech&#8217;s as of the acquisition date. Operations prior to the Business Combination are presented as those of LanzaTech. The net assets of LanzaTech are recognized at carrying value, with no goodwill or other intangible assets recorded.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most significant change in New LanzaTech&#8217;s financial position and results is a $198.6 million net increase in cash and cash equivalents and a $584.4 million net increase in total stockholders&#8217; equity, in each case as compared to LanzaTech&#8217;s condensed consolidated balance sheet as of September&#160;30, 2022. See&#8220;Unaudited Pro Forma Condensed Combined Financial Information&#8221; for additional information.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restatement of Previously Issued Consolidated Financial Statements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations gives effect to the restatement adjustments made to the previously reported consolidated financial statements of Legacy LanzaTech as of and for the years ended December 31, 2021 and 2020. For additional information and a detailed discussion of the restatement, see Note 2, &#8220;Summary of Significant Accounting Policies&#8212;Restatement&#8221; in our consolidated financial statements, which are included elsewhere in this proxy prospectus.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Factors Affecting Our Performance</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our performance and future success depend on several factors that present significant opportunities for New LanzaTech but also pose risks and challenges.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to New LanzaTech&#8217;s business, we have identified several potential risk factors, including (i)&#160;the history of LanzaTech&#8217;s net losses and the fact that New LanzaTech anticipates incurring further losses going forward; (ii)&#160;New LanzaTech&#8217;s reliance upon industry partners to effect our growth strategy and to execute our business plan; (iii)&#160;New LanzaTech owns and anticipates acquiring additional equity interests in several of our customers&#8217; plants and has exposure to the volatility and liquidity risks inherent in holding such equity; (iv)&#160;the concentration of New LanzaTech&#8217;s revenue in a limited number of customers and the fact that our growth will depend on expanding that customer base; (v)&#160;rapidly changing technology and extensive competition for technologies addressing decarbonization; (vi)&#160;the protection of New LanzaTech&#8217;s intellectual property; (vii)&#160;construction risks, including failure to complete projects on time or in a cost effective manner; (viii)&#160;potential requirements for additional financing to fund operations and complete the development and commercialization of new products or new aspects of existing process technologies; (ix)&#160;the fluctuating availability and cost of waste based feedstocks used in New LanzaTech&#8217;s process; (x)&#160;volatility in commodity chemicals prices and the associated impact on New LanzaTech&#8217;s royalty revenue and CarbonSmart revenues and (xi) market conditions and geopolitical factors. For additional information regarding risks facing our business, see &#8220;Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech&#8217;s condensed consolidated financial statements were prepared in accordance with US GAAP. See Note&#160;2 to our condensed consolidated financial statements, included elsewhere in this prospectus, for a full description of our basis of presentation.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Operational and Business Metrics</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the measures presented in our condensed consolidated financial statements, we review the following key business metrics to measure our performance, identify trends affecting our business, formulate business plans, and make strategic decisions that will impact the future operational results of New LanzaTech. Increases or decreases in our key business metrics may not correspond with increases or decreases in our revenue.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Key Financial Metrics:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The key elements of LanzaTech&#8217;s performance for the nine&#160;month periods ended September&#160;30, 2022 and September&#160;30, 2021 are summarized in the tables below:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine&#160;months ended<br/>September&#160;30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except for percentages)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">US GAAP Measures:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,781&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,974)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,591)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,383)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Key Performance Indicators:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One-Time Revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recurring Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(562)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,781&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,327&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of Revenues (ex. Depreciation)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,231)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,990)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,241)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general &amp; administrative and other expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,482)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,595)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,887)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52,153)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,770)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,383)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">___________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes revenue from licensing and sales of microbes and media.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Consists of costs of revenues from contracts with customers (exclusive of depreciation), cost of revenue from collaboration agreements (exclusive of depreciation) and cost of revenue from related party transactions (exclusive of depreciation).</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Adjusted EBITDA is calculated as net loss, excluding the impact of depreciation, interest income (expense), net, gain on extinguishment of debt, stock-based compensation and change in fair value of warrants liability, and loss/(gain) from equity method investees, net. Adjusted EBITDA is a supplemental measure that is not a substitute for, or superior to, measures of financial performance prepared in accordance with US GAAP. Adjusted EBITDA does not represent, and should not be considered, an alternative to net income (loss), as determined in accordance with US GAAP. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Non-GAAP Financial Measures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221; for additional information and reconciliation of Adjusted EBITDA to net loss, its most directly comparable US GAAP measure.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Key Financial Metrics:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The key elements of LanzaTech&#8217;s performance for the fiscal&#160;years ended December&#160;31, 2021 and December&#160;31, 2020 are summarized in the tables below:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except for percentages)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">US GAAP Measures:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,689)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,713)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,976)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Key Performance Indicators:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One-Time Revenue</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recurring Revenue </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,949&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,461&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,353&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,108&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of Revenues (ex. Depreciation)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,592)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,637)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general &amp; administrative and other expense</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,216)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,029)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,187)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,792)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,263)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,529)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">___________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes revenue from licensing and sales of microbes and media.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Consists of cost of revenue from contracts with customers (exclusive of depreciation), cost of revenue from collaboration agreements (exclusive of depreciation), and cost of revenue from related party transactions (exclusive of depreciation).</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Adjusted EBITDA is calculated as net loss, excluding the impact of depreciation, interest income (expense), net, loss/(gain) on extinguishment of debt, stock-based compensation and change in fair value of warrants liability, and gain from equity method investees. Adjusted EBITDA is a supplemental measure that is not a substitute for, or superior to, measures of financial performance prepared in accordance with US GAAP. Adjusted EBITDA does not represent, and should not be considered an alternative to net income (loss) as determined in accordance with US GAAP. See &#8220;Non-GAAP Financial Measures&#8221; for additional information and reconciliation of Adjusted EBITDA to net income (loss), its most directly comparable US GAAP measure.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA, a non-GAAP measure, is an addition to, and not a substitute for or superior to, measures of financial performance prepared in accordance with US GAAP and should not be considered as an alternative to net income, operating income or any other performance measure derived in accordance with US GAAP or as alternative to cash flows from operating activities as a measure of liquidity. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-GAAP Financial Measures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for additional information and reconciliation of this measure.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Key Non-Financial Metrics:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September&#160;30,</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands of tonnes per annum)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></div></td><td colspan="3" style="border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 vs. 2021</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Capacity Additions</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative Capacity Additions</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech&#8217;s installed capacity, which includes capacity by equity method investees and customers, is one of the key drivers for the Company&#8217;s licensing revenues given that they are usually contracted on a&#160;percentage-of-revenue or a dollars-per-tonne basis.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands of tonnes per annum)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></div></td><td colspan="3" style="border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 vs. 2020</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Capacity Additions</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative Capacity Additions</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Components of Operating Results</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we have offerings in multiple market segments and operate in multiple countries, we operate and manage our business as one reportable operating segment. Nearly all of our service offerings are delivered and supported on a global basis. Additionally, most of our service offerings are deployed in a nearly identical way, and we evaluate our financial information and resources and assesses the performance of these resources on a consolidated basis.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, we have financed our operations primarily through equity financing, joint development R&amp;D agreements, U.S. government R&amp;D contracts, engineering and other services contracts, licensing agreements, and joint venture agreements. We derive all revenues from a single operating segment. Revenues can be viewed as a combination of the following:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Feasibility studies and engineering services related to basic design of commercial plants utilizing our technologies;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Licensing of intellectual property when customers deploy our carbon capture and transformation technology;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Research and development services related to novel technologies and microbial strains; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Sale of CarbonSmart ethanol to customers.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is measured based on the consideration specified in customer contracts and excludes amounts collected on behalf of third parties.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Carbon Capture and Transformation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide feasibility studies and basic design and engineering services used for detailed design, procurement, and construction of commercial plants that utilize our technologies, along with the sale of equipment and microbes. The services provided are recognized as a performance obligation satisfied over time. Revenue is recognized using the output method based on milestone completion, the cost-to-cost input method for certain engineering services, or the&#160;percentage of completion method when certain revenue recognition requirements are met. Management has determined that the milestone completion and the associated contractual payment amounts are an appropriate measure of progress toward complete satisfaction of the performance obligations under Accounting Standards Codification (&#8220;ASC&#8221;) 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 606&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We license intellectual property to generate recurring revenue when our customers deploy carbon capture and transformation plants. When licenses are considered to be distinct performance obligations, the recognition of revenue is dependent on the terms of the contract, which may include fixed consideration or royalties based on sales or usage, in which case, the revenue is recognized when the subsequent sale or usage occurs or when the performance obligation to which some or all of the sales or usage-based royalty is allocated or has been satisfied, whichever is later.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Services</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We perform R&amp;D services related to novel technologies and the development of biocatalysts for commercial applications, mainly to produce fuels and chemicals. We engage in two main types of R&amp;D services&#160;&#8211; joint development agreements, and other contract research, including projects with the U.S. Department of Energy. Such services are recognized as a performance obligation satisfied over time. Revenue is recognized based on milestone completion, when payments are contingent upon the achievement of such milestones, or based on stage of contract or phase completion method when enforceable rights to payment exist. When no milestones or stages are clearly defined, management has determined that the cost incurred, input method, is an appropriate measure of progress toward complete satisfaction of the performance obligations under ASC 606 and estimates its variable consideration under the expected value method. Accordingly, we record a contract liability for these performance obligations based on milestones achieved and the expected repayment of the development costs.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is not recognized in advance of customer acceptance of a milestone, when such acceptance is contractually required. Payments for R&amp;D services with no contractual payments are not due from customers until a technical report is submitted; therefore, a contract asset is recognized at milestone completion but prior to the submission of a technical report. The contract asset represents our right to consideration for the services performed at milestone completion. Occasionally, customers provide payments in advance of us providing services which creates a contract liability for the Company. The contract liability represents our obligation to provide services to a customer.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collaboration Arrangements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have certain partnership agreements that are within the scope of ASC 808, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 808&#8221;), which provides guidance on the presentation and disclosure of collaborative arrangements. Generally, the classification of the transactions as collaborative arrangements is determined based on the nature of the contractual terms of the arrangement, along with the nature of the operations of the participants. Our collaborative agreements generally include provision of R&amp;D services related to novel technologies and biocatalysts. Amounts received for these services are classified as Revenue from collaborative arrangements in the consolidated statements of operations and comprehensive loss. New LanzaTech&#8217;s R&amp;D services are a major part of our ongoing operations and therefore ASC 606 was applied to recognize revenue.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenues</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our R&amp;D, engineering, and other direct costs of services are related to revenue agreements with customers, related parties, and collaborative partners, and represent cost of revenue. Costs include both internal and third-party fixed and variable costs and include materials, supplies, labor, and fringe benefits.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenses</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expenses consist of personnel costs and the cost of consultants, materials and supplies associated with R&amp;D projects as well as various laboratory studies. Indirect R&amp;D costs include depreciation and other indirect overhead expenses. We expect our R&amp;D activities to increase substantially as we continue to invest in improving our technology and developing new products.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, General and Administrative Expenses</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses (&#8220;SG&amp;A&#8221;) consist primarily of personnel costs, costs of general marketing activities and promotional activities, travel-related expenses, and other indirect overhead costs. We expect that our sales and marketing expenses will increase as we expand our sales and marketing efforts, commercial capability, brand awareness and customer base through targeted marketing initiatives.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our general and administrative expenses consist primarily of personnel costs for our executive, finance, corporate and other administrative functions, intellectual property and patent costs, facilities and other allocated expenses, other expenses for outside professional services, including legal, human resources, audit and accounting services and insurance costs. We expect our general and administrative expenses to increase as a result of operating as a public company, including additional costs relating to compliance with the rules&#160;and regulations of the SEC and stock exchange rules, legal and auditing services, additional insurance, investor relations activities, and other administrative and professional services. We also expect our intellectual property expenses to increase as we expand and increase protection of our intellectual property portfolio.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other (Expense) Income, Net</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other (expense) income, net relates to miscellaneous other income and expense and foreign currency gains and losses. Interest income consists of income earned from our cash, cash equivalents and short-term investments. We expect our interest income to increase following completion of the Business Combination as we invest the net proceeds in a variety of capital preservation investments, including short-term, investment-grade, interest-bearing obligations of the U.S. government and its agencies.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gain from Equity Investees, Net</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold interests in LanzaJet located in the United States, and the Shougang Joint Venture located in China, which we have determined to be VIEs for which it has been determined we are not the primary beneficiary. Our variable interests primarily relate to entities in which we have a non-controlling equity interest. Although these financial arrangements resulted in holding variable interests in these entities, they did not empower us to direct the activities of the VIEs that most significantly impact the VIEs&#8217; economic performance. However, through our holdings in LanzaJet, our representation on the board of directors and participation in the policy-making process, as well as the material intra-entity transactions, we have determined that we can exercise significant influence over the activities of LanzaJet. Our interest in LanzaJet is accounted for under the equity method of accounting, with income (loss) from equity method investees, net recognized in our consolidated statements of operations and comprehensive loss and equity method investments recognized on our consolidated balance sheets. As of September&#160;30, 2022, we no longer have significant influence over the activities of the Shougang Joint Venture and as a result, our investment is accounted for at cost with impairment (if any) recognized in our consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company currently has a license agreement with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the Shougang Joint Venture</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and a letter agreement with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the Shougang Joint Venture</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Sinopec. These agreements do not provide LanzaTech with the power to direct the </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">activities that are most significant to the economic performance of these entities, therefore LanzaTech has determined it is not the primary beneficiary and does not currently consolidate any VIEs.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Expense (Benefit)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current and deferred taxes are calculated based on tax rates enacted or substantively enacted at the reporting date and are recognized in profit or loss except when the tax relates to items charged or credited to other comprehensive income, in which case the tax is also recognized in other comprehensive income. Deferred tax is recognized in respect of temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements. Deferred tax assets and unused tax losses are only recognized to the extent that it is probable that future taxable amounts will be available to utilize temporary differences and losses. These losses are subject to shareholder continuity rules, and may be impacted by future fundraising activities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a valuation allowance against the full value of our net deferred tax assets because management believes the recoverability of the tax assets is not more likely than not. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations&#160;&#8212; Nine&#160;Months Ended September&#160;30, 2022 Compared to Nine&#160;Months Ended September&#160;30, 2021 (Unaudited)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations presented below should be reviewed in conjunction with our condensed consolidated financial statements and notes included elsewhere in this prospectus. The following table sets forth our condensed consolidated results of operations for the periods indicated:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:9pt"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine&#160;months&#160;ended&#160;September&#160;30,</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except for per share amounts)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></div></td><td colspan="3" style="border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 vs. 2021</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="text-align:center"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,231)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,990)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,241)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Profit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,550</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,337</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,787)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(21)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="padding-left:9pt;text-indent:-9pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating expenses:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,858)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,223)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,635)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,433)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,763)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(670)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,482)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,595)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,887)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:33pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(62,773)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(43,581)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(19,192)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">44</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="padding-left:9pt;text-indent:-9pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56,223)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,244)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,979)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:33pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other (expense) income, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,097)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,379)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(148)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss before income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(57,320)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(32,962)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(24,358)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">74</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(54,974)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(30,591)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(24,383)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">80</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(767)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(738)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,545&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(55,741)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(30,620)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(25,121)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">82</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="padding-left:9pt;text-indent:-9pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"></span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2.5pt double #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2.5pt double #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2.5pt double #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share - basic and diluted</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding - basic and diluted</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,108,472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,909,635&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue increased $7.5 million, or 41%, in the first nine&#160;months of 2022 compared to the same period in 2021. Engineering and other services increased revenues by $7.9 million, consisting of an increase of $1.2 million from projects with new customers and a $6.7 million increase from contracts with existing customers. Revenue from the sale of CarbonSmart ethanol generated an increase in revenues of $3.4 million, revenue from other contract research increased revenues by $2.7 million and revenue from licensing increased revenues by $0.1 million. This increase in revenue was partially offset by a decrease of $(6.6) million in revenue from joint development agreements as a result of the completion and near-completion of certain joint development projects.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenues</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue increased $9.2 million, or 93%, in the first nine&#160;months of 2022 compared to the same period in 2021. Cost of revenue from engineering and other services increased by $8.0 million mainly due to an increase in the number of customer projects and a shift in sales mix with certain projects generating higher cost of revenue. Additional changes in cost of revenue resulted from increases in CarbonSmart ethanol sales which generated       $2.9 million in cost of revenue and increases in cost of revenue of $1.7 million from other contract research. These increases were partially offset by decreases of $(3.4) million of cost of revenue from joint development agreements. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expense increased $10.6 million, or 36%, in the first nine&#160;months of 2022 compared to the same period in 2021. This was due to an increase of $5.1 million in headcount and related costs to accelerate growth, a $2.3 million increase in general R&amp;D spend, and an increase of $3.2 million in external R&amp;D services to expand R&amp;D capabilities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, General and Administrative Expense</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SG&amp;A expense increased $7.9 million, or 68%, in the first nine&#160;months of 2022 as compared to the same period in 2021. The increase was primarily related to a $4.6 million increase in personnel costs as we scaled up non-R&amp;D-related functions, and a $3.3 million increase in external consulting fees related to the proposed Business Combination. See Note&#160;1 to our condensed consolidated financial statements included elsewhere in this prospectus for more information regarding the proposed Business Combination.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gain from Equity Method Investees, Net</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first nine&#160;months of 2022, gain from equity method investees, net remained relatively consistent with the same period in 2021, primarily due to net loss attributable to Legacy LanzaTech of $1.1 million for each of the nine&#160;month periods ended September&#160;30, 2022 and September&#160;30, 2021, offset by gain from the dilution of our equity method interests of $3.4 million for the nine&#160;months ended September&#160;30, 2022, and $3.5 million for the nine&#160;months ended September&#160;30, 2021.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations&#160;&#8212;&#160;Year ended December&#160;31, 2021 Compared to&#160;Year Ended December&#160;31, 2020</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 5.5pt;text-indent:-9pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 5.5pt;text-indent:-9pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except for per share amounts)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,461&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,353&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,108&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,592)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,637)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Profit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,232</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,761</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,471</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="padding-left:9pt;text-indent:-9pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating expenses:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,454)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,775)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation Expense</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,806)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,979)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(827)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,216)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,029)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,187)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:33pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(61,251)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(46,462)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(14,789)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="padding-left:9pt;text-indent:-9pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,019)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,701)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,318)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:33pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income (expense), net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1432)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss before income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(48,634)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(39,880)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8,754)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(222)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(46,689)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(37,713)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8,976)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(530)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(46,594)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(37,088)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,506)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="padding-left:9pt;text-indent:-9pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"></span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2.5pt double #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2.5pt double #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2.5pt double #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share &#8211; basic and diluted</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.59)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding - basic and diluted</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,959,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,629,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue increased $7.1 million, or 39%, in the&#160;year ended December&#160;31, 2021 compared to the&#160;year ended December&#160;31, 2020. During the&#160;year ended December&#160;31, 2021, the net impact of joint development agreements increased revenues by $4.8 million due to $1.5 million in collaborative arrangements from new customers and $3.3&#160;million in continued collaborations with existing customers.Other contract research increased by $0.2 million. Engineering and other services increased revenues by $1.1 million, primarily due to an increase in the number of customers and revenue-generating projects net of a decrease of $(1.9) million due to a reduction in the volume of services provided to LanzaJet. Revenue from licensing from related parties increased by $1.0 million for the&#160;year ended December&#160;31, 2021.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenues</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue increased $3.6 million, or 31%, in the&#160;year ended December&#160;31, 2021, compared to December&#160;31, 2020. This increase is in line with the increase in revenues: cost of revenue from engineering and other services increased by $1.6 million mainly due to an increase in the number of customers, net of a decrease of $(1.9) million in cost of revenue for engineering services with a related party. Cost of revenue from joint development agreements increased by $2.0 million due to continuing collaboration with existing customers.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expense increased $9.8 million, or 28%, in the&#160;year ended December&#160;31, 2021 compared to the&#160;year ended December&#160;31, 2020. The increase in R&amp;D expense, in the&#160;year ended December&#160;31, 2021 was due to an increase of $5.9 million in personnel and related costs to accelerate growth, a $1.8 million increase in general R&amp;D spend from 2020 when COVID-19 lockdowns halted R&amp;D, an increase of $1.4 million in external R&amp;D services, and an increase of $0.7 million to expand R&amp;D capabilities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, General and Administrative Expense</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SG&amp;A expense increased $4.2 million, or 46%, in the&#160;year ended December&#160;31, 2021, compared to the&#160;year ended December&#160;31, 2020. The increase in SG&amp;A expense was primarily related to a $1.8 million increase in personnel costs as we scaled up non-R&amp;D-related functions and a $1.2 million increase in external consulting fees related to the proposed Business Combination. See Note&#160;20 to our consolidated financial statements included elsewhere in this prospectus for more information regarding the proposed Business Combination. The remaining increase of $1.2 million in SG&amp;A expense is related to various other non-R&amp;D services.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense), Net</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows our other income (expense), net for the&#160;years ended December&#160;31, 2021, and 2020, and related period-over-period changes:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year&#160;ended&#160;December&#160;31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except for percentages)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(351)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on extinguishment of debt</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income, net</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(673)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(845)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(491)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income (expense), net</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,385&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,564&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1432)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net increased $2.6 million, or (1,432)%, in the&#160;year ended December&#160;31, 2021 compared to the&#160;year ended December&#160;31, 2020. The increase is primarily due to the forgiveness of $3.1 million in principal outstanding under the PPP Loan (as defined below) and a decrease in interest expense of $0.3 million, partially offset by a $(0.7) million fluctuation,&#160;year-over-year, in the change in fair value of the warrant liability and a $(0.1) million increase in foreign exchange losses.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gain from Equity Method Investees, Net</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021 compared to 2020, gain from equity method investees, net decreased $(0.2) million, or (10)%, primarily due to lower gain from the dilution of our equity method interests recognized in the&#160;year ended December&#160;31, 2021, as compared to the&#160;year ended December&#160;31, 2020, partially offset by lower losses incurred by the two equity method investees during 2021, as compared to 2020, as they continued to scale up operations. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents comprise cash on hand, demand deposits at banks, and other short-term, highly liquid investments with original maturity of three&#160;months or less that are readily convertible to known amounts of cash and which are subject to an insignificant risk of changes in value. The following table shows the balances of our cash, cash equivalents and restricted cash as of September&#160;30, 2022 and September&#160;30, 2021:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September&#160;30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except for percentages)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022&#160;vs.&#160;2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,034&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,666)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 as compared to September&#160;30, 2021, Legacy LanzaTech&#8217;s cash, cash equivalents, and restricted cash decreased $(64.7) million, or (56)%, primarily due to increased cash used to fund working capital and an increase in the net loss adjusted for non-cash charges, partially offset by the proceeds from the issuance of a $30.0 million SAFE and warrant instruments in December&#160;2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows balances of our cash and cash equivalents as of December&#160;31, 2021, and 2020:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except for percentages)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,732&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,909&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,823&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 as compared to December&#160;30, 2020, Legacy LanzaTech&#8217;s cash, cash equivalents, and restricted cash increased $67.8 million, or 111%, primarily due to the proceeds from the issuance of equity instruments of Legacy LanzaTech and the proceeds from the issuance of the SAFE and warrant instruments, partially offset by the cash used to fund operations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources and Uses of Capital</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since inception, we have financed our operations primarily through equity financing, joint development R&amp;D agreements, U.S. government R&amp;D contracts, engineering and other services contracts, licensing agreements, and joint venture agreements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to successfully develop products and expand our business depends on many factors, including our ability to meet working capital needs, the availability of equity or debt financing and, over time, our ability to generate cash flows from operations. We manage our capital to ensure that LanzaTech can continue as a going concern while maximizing the return to stakeholders through the optimization of debt and equity balances. Our overall capital risk strategy remains unchanged from prior&#160;years. Following completion of the Business Combination, the Company may change its capital risk strategy related to use of capital proceeds from the Business Combination to increase its product offerings or for business growth purposes.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, our capital structure consists of equity (comprising issued capital, reserves and accumulated deficit). We are not subject to any externally imposed capital requirements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech had six outstanding series of redeemable preferred stock. LanzaTech preferred shares were convertible at the holder&#8217;s option into shares of common stock, on a share-for-share basis, using a conversion rate determined by dividing the original issue price by the conversion price. Each LanzaTech preferred share was automatically converted into a common share of LanzaTech upon the closing of the Business Combination. In April&#160;2021, Legacy LanzaTech issued 3,634,210 Series&#160;F preferred shares for gross proceeds of $83.1 million ($22.86 per share).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 2, 2022, LanzaTech entered in the Brookfield SAFE with Brookfield and received a cash payment of $50,000,000 as the Initial Purchase Amount. In exchange, the Company granted to Brookfield the right to certain shares of the Company&#8217;s capital stock upon a Liquidity Event. If no Liquidity Event occurs beforehand, on the fifth anniversary of the Brookfield SAFE, LanzaTech will repay in cash any remaining unconverted portion of the Initial Purchase Amount less any Non-Repayable Amount, plus interest in the high single digits, compounded annually. Brookfield has the option to extend the repayment date to the tenth anniversary of the date of the Brookfield SAFE if certain events do not occur.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regarding indebtedness, LanzaTech does not have any outstanding debt on its condensed consolidated balance sheet as of September&#160;30, 2022. During fiscal&#160;year 2021, LanzaTech repaid the outstanding amount of $(0.6) million of its loan facility with Venture Lending and Leasing VII&#160;Inc. and Venture Lending and Leasing VIII,&#160;Inc. Additionally, LanzaTech&#8217;s $3.1 million Paycheck Protection Program loan (the &#8220;PPP Loan&#8221;) outstanding as of December&#160;31, 2020 was fully forgiven by the Small Business Administration in September&#160;2021. Consequently, LanzaTech recognized a gain on debt extinguishment of $(3.1) million related to the PPP Loan, in other income in the statement of operations and comprehensive loss for the&#160;year ended December&#160;31, 2021.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 9, 2022, LanzaTech committed to purchase $5.5 million of Subordinated Secured Notes in a funding for LanzaJet&#8217;s subsidiary, FPF, expected to occur on May 1, 2023. The Subordinated Secured Notes are secured by a security interest over the intellectual property owned or in-licensed by LanzaJet. LanzaJet also provides a guarantee of any costs and expenses required to complete the initial facility and achieve commercial operation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of our business, we also enter into purchase commitments or other transactions in which we make representations and warranties that relate to the performance of our goods and services. We do not expect material losses related to these transactions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our existing cash and cash equivalents will be sufficient to fund our operations for at least the next 12&#160;months from the date of this prospectus. However, our liquidity assumptions may prove to be incorrect, and we could utilize our available financial resources sooner than we currently expect. In addition, we may elect to raise funds within this period of time through equity or debt financing arrangements or collaborations. Our future capital requirements and the adequacy of available funds will depend on many factors, including those set forth under &#8220;Risk Factors&#8221; elsewhere in this prospectus.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will receive up to an aggregate of approximately $145 million from the exercise of all of the warrants and AM Warrant, assuming the exercise in full of all of the warrants and the AM Warrant for cash. However, if the market price for shares of common stock is less than the exercise price of a holder&#8217;s warrant or AM Warrant, as applicable, such holder may be less likely to exercise the warrants as such holder would be selling at a loss if they sold their common stock. Subject to adjustment, the exercise price of the warrants is $11.50 per share and the exercise price of the AM Warrant is $10.00 per share.  On February 10, 2023 the last reported sales price of the common stock was $7.30 per share. Additionally, if the market price for shares of common stock is less than $10.00 per share, holders of shares of common stock would be selling at a loss if they purchased the shares of common stock at $10.00 per share. Because certain selling stockholders purchased shares privately at a price below the current market price, they may have an incentive to sell shares of their common stock because they could profit despite the market price of common stock falling below $10.00 per share. While these selling stockholders may, on average, experience a positive rate of return based on the current market price, public securityholders may not experience a similar rate of return on the securities they purchased due to differences in the purchase prices and the current market price. For example, based on the closing price of our common stock of $7.30 on February 10, 2023, the Sponsor and the AMCI Insiders would have a potential profit of up to approximately $7.295 per share that they purchased prior to the initial public offering of AMCI, or up to approximately $14.8 million in the aggregate (not giving effect to the issuance of common stock issuable upon exercise of the warrants held by them).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be able to secure additional financing to meet our operating requirements on acceptable terms, or at all. If we raise additional funds by issuing equity and/or convertible debt securities, dilution to our existing stockholders will result. If we raise additional financing and incur indebtedness, we would be subject to increased fixed payment obligations and could also be subject to certain restrictive covenants, such as limitations on our ability to incur additional debt, limitations on our ability to acquire, sell or license intellectual property rights and other operating restrictions that could adversely impact our ability to conduct our business. If we are unable to obtain additional funds, we will have to reduce our operating costs, which will cause a delay or reduction in our technology development and commercialization programs.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The common stock and the common stock issuable upon exercise of the resale securities noted above represent a substantial percentage of the total outstanding shares of our common stock as of the date of this prospectus. Additionally, if all of the Convertible Securities were converted, the selling stockholders would own 198,818,523 shares of common stock, representing approximately 92.3% of the total outstanding common stock. So long as the registration statement of which this prospectus forms a part is effective, the sales of the securities being offered in this prospectus could result in a significant decline in the public trading price of the common stock.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">For the Nine&#160;Months Ended September&#160;30, 2022 and 2021</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of our cash flow for the nine&#160;months ended September&#160;30, 2022 and September&#160;30, 2021:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine&#160;months&#160;ended<br/>September&#160;30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except for&#160;percentages)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Net cash provided by (used in):</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71,336)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,718)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,618)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,530)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,201)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,329)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85,936)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of currency translation</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(249)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (decrease) increase in cash, cash equivalents, and restricted cash</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77,698)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,791&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows Used in Operating Activities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine&#160;months ended September&#160;30, 2022, net cash used in operating activities was $(71.3) million. This was primarily driven by a net loss of $(55.0) million, adjusted for share-based compensation expense of $2.1 million, depreciation of property, plant and equipment of $3.4 million, and non-cash lease expense of $1.3 million. Additional contributions of the net cash usage are related to the decrease in net cash provided by operating assets and liabilities of $(20.2) million, the non-cash gain from equity method investees, net of $(2.3) million, the gain on change in fair value of warrant liabilities of $(0.3) million, the non-cash recognition of licensing revenue of $(1.6)&#160;million and non-cash foreign currency exchange losses of $1.3 million.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine&#160;months ended September&#160;30, 2021, net cash used in operating activities was $(26.7) million. This was primarily driven by a net loss of $(30.6) million, adjusted for net cash provided by operating assets and liabilities of $4.3 million, share-based compensation expense of $1.8 million, depreciation of property, plant and equipment of $2.8 million, loss on change in fair value of warrant liabilities of $0.7 million, and non-cash lease expense of $1.2 million. This was partially offset by non-cash recognition of licensing revenue of $(1.5) million, the forgiveness of LanzaTech&#8217;s $(3.1) million aggregate principal amount PPP Loan, and the gain from equity method investees, net of $(2.4) million.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows Used in Investing Activities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine&#160;months ended September&#160;30, 2022, net cash used in investing activities was $(6.5) million, driven by the purchase of property, plant and equipment of $(6.5) million.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine&#160;months ended September&#160;30, 2021, net cash used in investing activities was $(4.2) million, driven by the purchase of property, plant and equipment of $(4.2) million.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Financing Activities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine&#160;months ended September&#160;30, 2022, net cash provided by financing activities was not significant.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine&#160;months ended September&#160;30, 2021, net cash provided by financing activities was $86.0 million. This was driven by $83.1 million in proceeds from the issuance of equity instruments of LanzaTech, proceeds of $0.7 million from the exercise of options to acquire shares of common stock of LanzaTech, and the proceeds from the exercise of warrants of $3.2 million. This was partially offset by the repayment of borrowings of $(0.6) million and the repurchase of equity instruments of LanzaTech of $(0.4) million.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">For the&#160;Years Ended December&#160;31, 2021 and 2020</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of our cash flow for the&#160;years ended December&#160;31, 2021, and 2020:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December&#160;31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except for percentages)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Net cash provided by (used in):</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,591)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,320)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,747)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,593)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">846&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of currency translation</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents, and restricted cash</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,823&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,208)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows Used in Operating Activities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the&#160;year ended December&#160;31, 2021, net cash used in operating activities was $(42.6) million. This was primarily driven by a net loss of $(46.7) million, adjusted for stock-based compensation expense of $2.5 million, loss on change in fair value of warrant liabilities of $0.6 million, depreciation of property, plant and equipment of $3.8 million, non-cash lease expense of $1.7 million, a change in operating assets and liabilities of $2.5 million, and a net foreign exchange gain of $0.1 million. This was partially offset by non-cash recognition of licensing revenue of $(2.0) million, the forgiveness of LanzaTech&#8217;s $(3.1) million aggregate principal amount PPP Loan, and the gain from equity method investees, net of $(1.9) million.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the&#160;year ended December&#160;31, 2020, net cash used in operating activities was $(39.3) million. This was primarily driven by a net loss of $(37.7) million, as well as stock-based compensation expense of $2.4 million, a change to the provision for bad debt of $0.9 million, depreciation of property, plant and equipment of $3.0 million, and non-cash lease expense of $1.6 million. This was partially offset by non-cash recognition of licensing revenue of $(1.0) million, gain on change in fair value of warrant liabilities of $(0.1) million, net cash used by operating assets and liabilities of $(6.1) million, and the gain from equity method investees, net of $(2.2) million.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows Used in Investing Activities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the&#160;year ended December&#160;31, 2021, net cash used in investing activities was $(5.7) million, driven by the purchase of property, plant and equipment.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the&#160;year ended December&#160;31, 2020, net cash used in investing activities was $(6.6) million, primarily driven by the purchase of property, plant and equipment of $(7.1) million, partially offset by the $0.5 million in proceeds from the disposal of investment property.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Financing Activities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the&#160;year ended December&#160;31, 2021, net cash provided by financing activities was $116.0 million. This was primarily driven by the proceeds from the issue of equity instruments of LanzaTech of $83.1 million, proceeds of $0.7 million from the exercise of options to acquire shares of common stock of LanzaTech, the proceeds from the issue of SAFE and warrant instruments of $30.0 million, and the proceeds from the exercise of a warrant of $3.2&#160;million. This was partially offset by the repayment of borrowings of $(0.6) million and the repurchase of equity instruments of LanzaTechof $(0.4) million.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the&#160;year ended December&#160;31, 2020, net cash provided by financing activities was $44.7 million. This was primarily driven by the proceeds from the issue of equity instruments of LanzaTech of $46.6 million and the proceeds from borrowings of $3.1 million. This was partially offset by the repayment of borrowings of $(4.9)&#160;million.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021, we did not engage in any off-balance sheet arrangements, including the use of structured finance, special purpose entities or variable interest entities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Significant Management Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management&#8217;s discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements included elsewhere in this prospectus that have been prepared in accordance with US GAAP. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and related disclosures. We consider an accounting estimate to be critical to the consolidated financial statements if the estimate is complex in nature or requires a high degree of judgment and actual results may differ from these estimates with any such differences being potentially material. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances. We evaluate our estimates and assumptions on an ongoing basis. While our significant accounting policies are more fully described in Note&#160;2 to our consolidated financial statements, we believe that the accounting policies discussed below are critical to understanding our historical and future performance:</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue from our contracts with customers in accordance with ASC 606. The Company also has certain partnership agreements that are within the scope of ASC 808. We primarily earn revenue from services related to feasibility studies and basic engineering design of commercial plants, joint development, and contract R&amp;D activities to develop novel biocatalysts and related technologies. When accounting for these arrangements, we must develop assumptions that require judgment such as determining the performance obligations in the contract, determining the transaction price for the contract and stand-alone selling price for each performance obligation identified, and measuring progress towards satisfaction of the performance obligations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The determination of whether goods and services qualify as distinct performance obligations is based on the contract terms and our view of the business. Typically, our goods and services provided under a contract with a customer are viewed as a single performance obligation. Most of our arrangements provide fixed consideration, however, when there are variable consideration elements, we estimate the transaction price and whether revenue should be constrained. Significant estimates and judgments are also used when a material right is provided to the customer. In these instances, management estimates the stand-alone selling price and apportions the total transaction price to this material right.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most performance obligations on our non-governmental arrangements are recognized over time. We typically use the output method to measure the satisfaction of such performance based on milestone completion or&#160;percentage completion when certain revenue recognition requirements are met. We exercise judgment when determining the&#160;percentage of completion against the total transaction price initially estimated. For arrangements with government agencies, we measure the satisfaction of performance obligations over time using the input method which requires judgment when selecting the most indicative measure of such performance.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measure stock-based awards granted to employees and directors based on their fair value on the date of grant. We have elected not to estimate forfeitures which means compensation expenses may be reversed in the period in which the forfeiture occurs.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We mostly apply judgment for stock-based awards with performance conditions, because compensation expense is recognized only when it is probable the performance conditions will be met (i.e. occurrence of a liquidity event). Management determined that the occurrence of the liquidity event is probable when the event is consummated, as such, no compensation expenses have been recognized.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair value of each stock option grant on the date of grant using the Black-Scholes option-pricing model, which requires the use of highly subjective assumptions including:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected Term - We have opted to use the &#8220;simplified method&#8221; for estimating the expected term of plain-vanilla options, whereby the expected term equals the arithmetic average of the vesting term and LanzaTech&#8217;s contractual term of the option (generally 10 years).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-Free Interest Rate - The risk-free rate assumption is based on the U.S. Treasury zero-coupon instruments with maturities similar to the expected term of LanzaTech&#8217;s stock options.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected Dividend - We have not issued any dividends and do not anticipate issuing dividends on LanzaTech&#8217;s common stock. As a result, we have estimated the dividend yield to be zero.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected Volatility - Due to our limited operating history and a lack of company-specific historical and implied volatility data, we have based our estimate of expected volatility on the historical volatility of a group of similar companies that are publicly traded. The historical volatility data was computed using the daily closing prices for the various companies&#8217; shares during the equivalent period of the calculated expected term of the stock-based awards.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair value of the RSAs using the fair value of common stock. Please refer to the Common Stock Valuation section below.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrant Liabilities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warrants to purchase shares of redeemable convertible preferred stock are classified as liabilities under Other accrued liabilities and under SAFE warrant on our consolidated balance sheets. These warrants are recognized at fair value with subsequent changes recorded in other income (expense), net, in the statements of operations and comprehensive loss. We will continue to adjust for changes in fair value until the earlier of the exercise of the warrants, at which time the liability will be reclassified as redeemable convertible preferred stock, or the expiration of the warrants, at which time the entire amount will be reversed and reflected in the statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilized the Black-Scholes option-pricing model, which incorporates management&#8217;s assumptions and estimates, to value the preferred stock warrants. Estimates and assumptions impacting the fair value measurement include the fair value per share of the underlying redeemable convertible preferred stock, the remaining contractual term of the warrants, risk-free interest rate, expected dividend yield and expected volatility of the price of the underlying preferred stock. We determined the fair value per share of the underlying preferred stock by taking into consideration our most recent issuance of our preferred stock with additional factors deemed relevant, because we are a private company and lack company-specific historical and implied volatility information of our stock. We determined the remaining contractual term based on the contract term of the warrants adjusted for the probability of a liquidity event. Expected stock volatility was based on the historical volatility of publicly traded peer companies for a similar remaining contractual term.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock Valuation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As there has been no public market for our equity instruments to date, the estimated fair value of our shares of common stock has been determined by management and approved by the LanzaTech Board as of the grant date. The LanzaTech Board considered our most recently available independent third-party valuation of the common stock and additional objective and subjective factors that it believed were relevant at the date of the grant.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The independent third-party valuations of the common stock have been performed in accordance with the guidance outlined in the AICPA Practice Aid, Valuation of Privately-Held Company Equity Securities Issued as Compensation (&#8220;AICPA&#8217;s Practice Aid&#8221;). The specialist considered all objective and subjective factors, including management&#8217;s best estimate of our business condition, prospects, and operating performance at each valuation date. Other significant factors included:</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the rights, preferences, and privileges of our preferred stock as compared to those of the common stock, including the liquidation preferences of our preferred stock;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our results of operations, and financial position;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">arms-length transactions involving recent rounds of preferred stock financings;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the lack of liquidity of the common stock;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our stage of development and business strategy and the material risks related to our business and industry;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the valuation of publicly traded companies in relevant industry sectors, as well as recently completed mergers and acquisitions of peer companies;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the likelihood of achieving a liquidity event, such as an initial public offering or a sale of our company, given prevailing market conditions; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In valuing the common stock, the fair value of our business was determined using an option pricing model to backsolve the value of the security from our most recent round of financing which implies a total equity value as well as a per-share common stock value at the valuation date. In August&#160;2021, LanzaTech used a weighted-average methodology for valuing its common stock that included a probability-adjusted liquidity event.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the Business Combination, the fair market value of the common stock will be determined based on the quoted market price of the common stock.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New LanzaTech is subject to the income tax laws in the jurisdictions in which we operate. New LanzaTech makes significant estimates and judgments to determine the provision for income taxes, taxes payables, and deferred tax assets and liabilities. We record a valuation allowance to reduce deferred tax assets to the amount that is more likely than not to be realized. The ability to realize deferred tax assets depends on our ability to generate sufficient taxable income within the carryback or carryforward periods provided for in the tax law for each tax jurisdiction. In determining whether deferred tax asset can be realized based on the provisions of the applicable accounting guidance, management considers the historical operating results, known or planned operating developments, the period of time over which certain temporary differences will reverse, consideration of the utilization of certain deferred income tax liabilities, tax law carryback capability in a particular country, prudent and feasible tax planning strategies, changes in tax laws, and estimates of future earnings and taxable income.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record uncertain tax positions on the basis of a two-step process whereby it is determined whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position, and for those tax positions that meet the more likely than not criteria, the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority is recognized. The Company evaluates and adjusts the amount of unrecognized income tax benefits based on changes in law, facts and circumstances.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Emerging Growth Company Status</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;102(b)(1)&#160;of the JOBS Act exempts &#8220;emerging growth companies&#8221; (as defined in Section&#160;2(a)&#160;of the Securities Act) from being required to comply with new or revised financial accounting standards until private companies are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can choose not to take advantage of the extended transition period and comply with the requirements that apply to non-emerging growth companies, but any such election to not take advantage of the extended transition period is irrevocable. New LanzaTech has elected not to opt out of the extended transition period for new or revised financial accounting standards. This may make it difficult or impossible to compare New LanzaTech&#8217;s financial results with the financial results of another public company that is either not an emerging growth company or is an emerging growth company that has chosen not to take advantage of the extended transition period exemptions because of the potential differences in accounting standards used.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New LanzaTech will remain an emerging growth company until the earliest of (i)&#160;the last day of the fiscal&#160;year in which the market value of common stock that is held by non-affiliates equals or exceeds $700 million as of the end of that&#160;year&#8217;s second fiscal quarter, (ii)&#160;the last day of the fiscal&#160;year in which New LanzaTech has total annual gross revenue of $1.235 billion or more during such fiscal&#160;year (as indexed for inflation), (iii)&#160;the date on which New LanzaTech has issued more than $1 billion in non-convertible debt in the prior three-year period or (iv)&#160;December&#160;31, 2026, which is the last day of the fiscal&#160;year following the fifth anniversary of AMCI&#8217;s IPO.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Implications of being a Smaller Reporting Company</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, New LanzaTech is a &#8220;smaller reporting company&#8221; as defined in Item&#160;10(f)(1)&#160;of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two&#160;years of audited financial statements. New LanzaTech will remain a smaller reporting company until the last day of the fiscal&#160;year in which (i)&#160;the market value of common stock held by non-affiliates exceeds $250 million as of the end of that&#160;year&#8217;s second fiscal quarter, or (ii)&#160;New LanzaTech&#8217;s annual revenues exceeded $100 million during such completed fiscal&#160;year and the market value of common stock held by non-affiliates equals or exceeds $700 million as of the end of that&#160;year&#8217;s second fiscal quarter. To the extent New LanzaTech takes advantage of such reduced disclosure obligations, it may also make comparison of its financial statements with other public companies difficult or impossible.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued and Adopted Accounting Standards</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note&#160;2 to our condensed consolidated financial statements, included elsewhere in this prospectus, for a full description of recent accounting pronouncements, including the actual and expected dates of adoption and estimate effects on our consolidated results of operations and financial condition, which is incorporated herein by reference.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To supplement our financial statements presented in accordance with US GAAP and to provide investors with additional information regarding our financial results, we have presented in this prospectus adjusted EBITDA, a non-GAAP financial measure. Adjusted EBITDA is not based on any standardized methodology prescribed by US GAAP and is not necessarily comparable to similarly titled measures presented by other companies.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We define adjusted EBITDA as our net loss, excluding the impact of depreciation and amortization, interest income (expense), income tax benefit (expense), gain on extinguishment of debt, stock-based compensation, and loss/(gain) from equity method investees. We monitor and have presented in this prospectus adjusted EBITDA because it is a key measure used by our management and the Board to understand and evaluate our operating performance, to establish budgets, and to develop operational goals for managing our business. We believe adjusted EBITDA helps identify underlying trends in our business that could otherwise be masked by the effect of certain expenses that we include in net loss. Accordingly, we believe adjusted EBITDA provides useful information to investors, analysts, and others in understanding and evaluating our operating results and enhancing the overall understanding of our past performance and future prospects. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA is not prepared in accordance with US GAAP and should not be considered in isolation of, or as an alternative to, measures prepared in accordance with US GAAP. There are a number of limitations related to the use of adjusted EBITDA rather than net loss, which is the most directly comparable financial measure calculated and presented in accordance with US GAAP. For example, adjusted EBITDA: (i)&#160;excludes stock-based compensation expense as it recently has been, and will continue to be for the foreseeable future, an excess significant non-cash expense for our business beyond our normative operating environment in consideration of the proposed Business Combination and subsequent transition to a publicly-traded company; (ii)&#160;excludes depreciation expense and, although this is a non-cash expense, the assets being depreciated and amortized may have to be replaced in the future; and (iii)&#160;does not reflect the cash requirements necessary to service interest on our debt, which affects the cash available to us; and (iv)&#160;certain income or expense items that do not provide a comparable measure of our business performance. In addition, the expenses and other items that we exclude in our calculations of adjusted EBITDA may differ from the expenses and other items, if any, that other companies may exclude from adjusted EBITDA when they report their operating results. In addition, other companies may use other measures to </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">evaluate their performance, all of which could reduce the usefulness of our non-GAAP financial measures as tools for comparison.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles adjusted EBITDA to net loss, the most directly comparable financial measure calculated and presented in accordance with US GAAP.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reconciliation of Net loss to Adjusted EBITDA</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:9pt;text-indent:-9pt"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine&#160;months ended</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September&#160;30,</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021<br/>as Restated</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020<br/>as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,974)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,591)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,689)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,713)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and Amortization</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,763&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest (income) expense</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on extinguishment of debt</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,065)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,065)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense and change in fair value of warrant liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,094&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,346)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,371)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,945)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,167)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(52,153)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(30,770)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(44,792)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(34,263)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Stock-based compensation expense represents expense related to equity compensation plans.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_1702"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BUSINESS</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Overview </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Founded in 2005 in New Zealand and headquartered today in Skokie, Illinois, we are a nature-based carbon refining company that transforms waste carbon into the chemical building blocks for consumer goods such as sustainable fuels, fabrics, and packaging that people use in their daily lives. Our goal is to reduce the need for virgin fossil fuels by challenging and striving to change the way the world uses carbon. We aim to accomplish this through the creation of a circular economy where carbon can be reused rather than wasted. Through technology and applications that are designed to touch multiple points of carbon use such as converting industrial, municipal, and agricultural waste into products, developing sustainable products to change the supply chain, and having systems to reuse the waste once consumers are done with the products, we believe we can offer a solution to help alleviate the global carbon crisis. Our economically viable and scalable technology is designed to enable emitters to reduce their environmental impact and potentially to replace materials made from virgin fossil resources with recycled carbon, supporting their climate goals, meeting mandated targets, and creating a more sustainable future.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Using our process technology, our partners launched the world&#8217;s first commercial carbon refining plant in 2018 in China and have subsequently added two commercial plants operating in China. LanzaTech has numerous projects in construction, under development and in the pipeline globally. Our technology platform is designed to use a variety of waste feedstocks, from waste industrial gases to biomass residues and municipal solid waste. Our technology platform is designed to capitalize on the demand for sustainable fuels and chemicals, which can be used in multiple sectors such as aviation, automotive, textiles, home goods, consumer goods and others, to address the growing preference among major companies for environmentally conscious products and manufacturing processes. We believe LanzaTech&#8217;s proven commercialized technology can enable global scale decarbonization and initiate a circular and climate positive carbon economy.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gas fermentation is a robust form of carbon capture and transformation that enhances the value of waste streams and reduces environmental pollution. Additionally, our technology platform utilizes existing industrial land and recycled process water, further reducing the environmental impact of producing our low carbon ethanol on land and biodiversity. Gas fermentation is a key part of our technology offering and we license this capability to customers to develop their own gas fermentation facilities, accelerating the spread of our technology across a variety of feedstocks and geographies.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our novel technology platform is like brewing, but instead of using yeast that eat sugar to make alcohol, our biocatalysts, or microbes, eat waste carbon to produce ethanol, ethanol derivatives, and ethanol co-products. Because our system is biological and can grow in dynamic environments and react in real-time to changing conditions, it is much more tolerant of variability in feedstock composition and supply than systems based on catalytic chemistry and is therefore highly customizable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our low carbon ethanol is being produced at commercial scale at three separate locations in China, with production of over 50 million gallons of fuel grade ethanol, resulting in the mitigation of over 250,000 tons of CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and keeping the equivalent of an estimated 23 million gallons of oil in the ground since May&#160;2018. Used microorganisms from our commercial facilities are protein-rich and can be sold in China as animal feed.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also developing biocatalysts and processes to produce a vast suite of additional products utilizing novel biocatalysts, including acetone and isopropanol (&#8220;IPA&#8221;) and important industrial solvents used in multiple applications including production of polymers from IPA. Products generated through the application of downstream catalytic chemistry of ethanol include SAF, sustainable diesel, ethylene, polyethylene, polyethylene terephthalate (&#8220;PET&#8221;), surfactants and glycols. Sustainable diesel can be blended with conventional diesel fuels as &#8220;drop in fuel&#8221; without any blending wall set by engine technology and offers reduced emissions, improving local air quality. Ethylene is widely used in the chemical industry, mostly for production of polyethylene, a plastic&#160;containing polymer&#160;chains of ethylene units in various chain lengths. Polyethylene is primarily used to make films and for packaging applications. Ethylene glycol is another product that can be used for production of surfactants, a key ingredient for detergents and liquid soap production. Ethanol can be further&#160;converted&#160;to monoethylene&#160;glycol (&#8220;MEG&#8221;), an important&#160;precursor&#160;to&#160;PET for use in packaging and textiles applications.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, we helped launch LanzaJet, a SAF company, and maintain approximately a 25% ownership stake in the business. LanzaJet has secured funding for a 10 million gallon commercial-scale production facility that we expect will begin producing SAF in 2023. We developed and scaled the production facility in Soperton, Georgia using our platform technology, which enables the conversion of ethanol to sustainable jet and diesel fuels, in collaboration with the Pacific Northwest National Lab and the U.S. Department of Energy. Using our platform technology, we have converted ethanol produced from steel mill emissions to SAF and have powered flights by Virgin Atlantic in 2018 and All Nippon Airways in 2019.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a complete depiction of our organizational structure, please refer to the structure chart below.</span></div><div style="margin-bottom:9pt;text-align:center"><img src="amci-20230213_g2.jpg" alt="amci-20230213_g2.jpg" style="height:318px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We aim to maximize revenue through the selective deployment of both our licensing and co-development models. Our licensing model focuses on generating licensing, royalty, and services fees from our commercialization efforts, while our partners own and operate the gas fermentation plants. This capital-light model enables us to concurrently partner with a significant number of partners to build customer &#8208; owned gas fermentation facilities in parallel, accelerating the spread of our technology platform. Our licensing model typically generates stable, recurring revenues which we anticipate will compound as more customer plants are built and validated by our pipeline of customers. As a licensor and services provider, we structure our agreements to provide engineering and startup services and key components of the overall equipment package that are based on our proprietary designs and integrations. Once fully operational, recurring revenues are generated from royalties on the offtake, ongoing supply of microbes and media, as well as software, monitoring and analytics support.  In certain more limited cases, we will act as co-developer on projects, allowing us to leverage our existing relationships and engineering and project development expertise in a financial sponsor role for select projects where we believe we can participate in the ownership, either directly or by arranging and deploying third-party capital, and operation of the gas fermentation plant. In the select instances where we will participate directly in the project ownership, we expect to be a minority investor in those projects&#8217; capital requirements, accounting for approximately 5% of the total capital. We believe that the co-development model has the potential to allow for the acceleration of the development and integration of new feedstocks and products while also allowing us to capture additional potential value from the individual project&#8217;s performance. In each instance of co-development, we intend to license our technology directly to the project, which we expect will enable us to capture the same revenue streams of licensing, royalty, and services fees generated through the licensing model with customer-owned facilities. To maximize revenue from each project, whether via licensing or co-development, we sell supplies and equipment to our projects and customers. Additionally, we provide advisory, research and engineering services to develop new chemicals, use new feedstocks, and advance new fermentation or synthetic biology capabilities.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management team has more than 150&#160;years of combined research and development, engineering and scale up, operations, partnering and licensing experience in the energy industry. Our company was co-founded in 2005 by our advisor and former Chief Scientific Officer, Dr.&#160;Sean Simpson, and the late molecular biology expert, Dr.&#160;Richard Forster. Dr.&#160;Jennifer Holmgren, our Chief Executive Officer since 2010, has over 30&#160;years of experience in the energy sector, including a proven track record in the development and commercialization of renewable jet fuel and chemical technologies. We are led by a diverse management team and board of directors with deep experience in leading energy companies and major financial institutions. We believe the expertise of our leadership team and the strength of our relationships within the industry are critical to our strategy as we continue to deploy our technology and expand our business.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market Opportunity</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GHG</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">emissions are rampant in major economic areas across the globe. In Asia, the largest emitter of GHGs, approximately 10 billion metric tons of CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are emitted per&#160;year, with almost 30% of the global territorial fossil fuel CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> emissions occurring in China alone. In the United States, approximately six billion metric tons of CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> have been emitted annually for over 30&#160;years. In Europe, nearly five billion metric tons of CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are emitted per&#160;year. GHGs from human activities are the most significant driver of observed climate change, which is taking on greater importance and urgency throughout the world.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2016, the Paris Agreement was signed by a consortium of countries committing to limit the increase of global average temperatures to 2&#176;C or less compared to pre-industrial levels. Such initiatives have placed an increased emphasis on monitoring and mitigating the effects of climate change and generally promoting environmentally friendly behavior. In 2017, the International Energy Agency (&#8220;IEA&#8221;) estimated that an annual $3.5 trillion in energy-sector investments would be required through 2050 to achieve the 2&#176;C target. In 2019, the European Union released the Green Deal Communication, a package of measures and policies ranging from ambitiously cutting emissions, to investing in cutting-edge research and innovation, to preserving Europe&#8217;s natural environment and achieving a carbon neutral economy by 2050. The roadmap includes a comprehensive plan to increase the European Union&#8217;s GHG reduction target for 2030 to at least 50% and toward 55% as compared to 1990, compared to the current target of 40%. In the United States, President Biden re-committed to the Paris Agreement, pledging 50-52% GHG reductions by 2030 compared to 2005 levels. In 2021, the U.S. Congress passed the Infrastructure Investment and Jobs Act, which included over $62 billion for the U.S. Department of Energy to use for clean energy technology deployment. In August 2021, President Biden signed the Inflation Reduction Act, which provided approximately $369 billion for clean energy deployment and climate change mitigation and adaptation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alongside potential government mandates for aviation and industrial emitters, regional governments, companies and investors have announced their own emissions and waste reduction targets. According to the RE100 initiative, nearly 350 global companies spanning a broad array of sectors have pledged to transition to 100% renewable electricity by 2050 with an average target date of 2030. Outside of the RE100, many more companies are facing consumer and shareholder pressure to increase their environmental disclosures and join the transition to cleaner energy sources. For example, the members of the International Air Transport Association, which includes nearly 300 airlines responsible for over 80% of the world&#8217;s air traffic, have committed to cut their emissions in half by 2050 compared to 2005 levels. In addition, in March&#160;2021, Airlines for America, the industry trade organization representing the leading U.S. airlines, announced the commitment of its member carriers to work to achieve net-zero carbon emissions by 2050. The carriers also committed to work toward a rapid expansion of the production and deployment of commercially viable SAF, specifically to make two billion gallons of SAF available to U.S. aircraft operators in 2030.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that carbon capture and transformation technologies will be used increasingly within industrial sectors of the economy as one of the primary methods to reduce GHG emissions and meet mandates and climate goals. The two options for dealing with captured carbon today are sequestering it in the ground, or carbon capture and sequestration (&#8220;CCS&#8221;), and recycling it into products, or carbon capture and utilization or transformation (&#8220;CCU&#8221; or &#8220;CCT&#8221;).</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe LanzaTech can provide a profitable pathway to solving an emitter&#8217;s carbon problem. For example, today in Europe, a steel mill can pay penalties for their emissions, purchase offsets, or invest in a CCS facility and reduce their emissions at site under an Emissions Trading System. In each case, we believe the cost of the emissions, offsets or investment in a CCS facility are less cost effective than building a LanzaTech CCT facility to decrease carbon emissions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While reducing the carbon intensity of fuels is important, it does not address the carbon contained in physical goods. Sustainability-marketed products grew 7.1 times faster than conventionally marketed products from 2015 to 2019. Further, eco-conscious customers now make up roughly 80% of a consumer market worth over $1.8 trillion. Many companies have already pledged to achieve carbon neutral or net zero carbon targets, with some aiming to achieve that target within the next decade.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently, we recycle carbon to produce ethanol that can be used for SAF production, the global addressable market for which is estimated at $180 billion. Our customers also operate our carbon refining technology in the single-cell protein market, estimated at $16 billion in 2019, because our process makes high protein biomass as a byproduct. Ethanol can also be converted to MEG and PET, with markets worth an estimated $28 billion for MEG and $44 billion for PET packaging at the end of 2021. We have a portfolio of existing recycled carbon and soon-to-be commercialized CarbonSmart&#160;products that we believe have the potential to penetrate more chemicals markets in the coming&#160;years as more commercial facilities begin operations. CarbonSmart is a concept where we see carbon waste transformed into many products that we use in our daily lives. Approximately two tons of CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are removed per ton of CarbonSmart product made.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our customers and partners are brand owners who have made strong sustainability commitments and endeavor to connect their customers with low carbon products that do not compete with food production for feedstock, land, or water.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Ethanol Market</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ethanol can be used directly as fuel but can also serve as a feedstock to produce a broad range of products, including cosmetics and beauty products, hand hygiene products, paint, food additives, tires, children&#8217;s toys, plastic products, rubber, clothing and upholstery. The United States is responsible for over half of ethanol production globally and has produced an average of nearly 15 billion gallons of ethanol annually since 2015, while the ethanol output for the rest of the world has increased by over 20% during the same period. Meanwhile, most governments have instituted caps on food-derived ethanol. The focus of most ethanol growth in the future is expected to be waste-based, non-food ethanol.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Fuel Market</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, global fuel ethanol production reached 30 billion gallons. We believe the demand for renewable fuels and related infrastructure will rise substantially over the next decade driven by strong demand from both consumers and sustainability-focused suppliers. We also believe that the federal regulatory framework in the United States, including the Renewable Fuel standard, will drive production of ethanol for the liquid transportation fuel market. We believe the production of ethanol from recycled carbon, such as from industrial emissions, will also have a market in the European Union through the Renewable Energy Directive and at the state level in the United States with the California Low Carbon Fuel Standard. Other states in the Northeast United States, as well as Canada, have signaled they will institute such policies in the coming&#160;years.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sustainable Aviation Fuel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Mandated global SAF demand is expected to hit 61 billion gallons per&#160;year by 2040. The Biden Administration has a goal of replacing all jet fuel with sustainable alternatives by 2050. The global market for aviation fuel is estimated to be nearly $250 billion by 2026. Airlines and aviation sector coalitions, including companies addressing Scope 3 emissions are making corporate commitments to increase SAF use. To reach expected 2030 SAF demand, global SAF capacity must achieve an 87% CAGR.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Chemicals and Protein Markets</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">According to the IEA, the chemicals sector is the largest industrial consumer of both oil and gas. Petrochemical feedstock accounts for 12% of global oil demand, a share that is expected to increase because of increasing demand for plastics, fertilizers, and other products. With the growth in demand for petrochemical products, petrochemicals are expected to account for over a third of the growth in oil demand to 2030, and nearly half to 2050, ahead of trucks, aviation, and shipping. Petrochemicals are also poised to consume an additional 56 billion cubic meters of natural gas by 2030. Currently, organic chemicals are predominantly derived from fossil sources such as petroleum. These chemicals are used to produce a wide array of materials. More than 10 million barrels of oil are consumed daily to create these materials, releasing massive quantities of new carbon into the atmosphere in the process.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Protein demand is outpacing supply. Today&#8217;s alternatives are dominated by crop-based feedstocks. It is currently estimated that the plant-based protein market will be valued at $162 billion in 2030 and would make up an estimated 7.7% of the global protein market.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Competitive Advantages</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the following combination of capabilities and strengths distinguishes us from our potential competitors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proven, Differentiated, Adaptable Proprietary Technology Platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leader in gas fermentation and have developed economically attractive, commercial-scale carbon recycling technology and end products. Our proprietary technology platform allows us to produce different products and chemicals from multiple feedstocks utilizing the same process at the same plant. Our biological system ensures stable performance despite fluctuating gas feedstock compositions, unlike thermocatalytic processes, which require consistent gas feedstock compositions. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New high-value chemical intermediates can be used to make materials such as acrylics, fibers, plastics and synthetic rubber and a wide variety of chemicals including alcohols, acids, esters, and ketones. LanzaTech has demonstrated this with several partners who have used chemical intermediates to make fabrics, packaging, detergent, cleaning agents and fragrances. This process can lock waste carbon into durable goods, creating a circular carbon economy where carbon is refined and re-used instead of emitted as harmful greenhouse gases.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our technology enables a circular carbon economy, which keeps carbon in the material cycle instead of allowing it to be emitted into the atmosphere as pollution. By locking carbon into chemical building blocks used to make every-day goods, we are reducing the need to extract virgin fossil resources to make the same products. We believe this could have a game changing impact on the chemical industry and its supply chain, shifting the way the industry considers commodity sourcing and supply.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Low Carbon, Enabling Technology</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our technology is designed for use across the supply chain, from emitters of waste carbon to those who want to develop products from waste carbon. Industrial emitters can implement LanzaTech&#8217;s carbon capture solution onto their existing facility and derive revenue from used carbon. As an example, the first commercial facility in China to utilize our technology platform has sold over 38 million gallons of ethanol into the market, displacing fossil gasoline for road transport use, and avoiding the equivalent of over 195,000 tons of CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> emissions at source. Our technology platform allows emitters to play a role in the circular carbon economy by generating products from waste carbon that would otherwise come from virgin fossil resources and selling these products to end users who want to reduce their environmental impact.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our platform technology is highly customizable and we believe it will provide flexibility to respond to market demand</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through the use of synthetic biology, microorganisms can be engineered to produce different chemicals directly from gases using the same process and production hardware. By changing the microorganism in a commercial facility, we have developed the capability to switch the product focus of commercial plants within a matter of&#160;days. We believe this will enable production of different product targets in campaigns at the same commercial facility. We believe this capability will enable partners and customers to rapidly respond to fluctuating market conditions and maximize the value of their assets, by producing the highest value product at any given time.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Platform Validated Through Partnerships with Industry Leaders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have demonstrated the commercial success of gas fermentation on feedstocks from a broad array of waste streams. Three commercial scale facilities in China utilizing steel off-gas and ferroalloy off-gas emission are currently being operated by entities in which the Shougang Joint Venture holds a controlling interest. In addition, a commercial scale facility in Ghent, Belgium is in advanced stages of construction by our partner ArcelorMittal. The facility is expected to begin commissioning in the coming months.The pilot-scale plant in Japan developed with Sekisui has been producing ethanol from gasified municipal solid waste since 2017. Construction on a next scale 1/10th commercial sized facility with Sekisui was completed in April 2022 and the facility is in the commissioning stage. Additionally, a demonstration-scale facility in Alberta, Canada, with partner Suncor, utilizing waste-based feedstocks, including municipal waste and forestry-residues, has produced ethanol in test runs since July 2022  Commercial projects using refinery off-gases, industrial and biorefinery CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ferroalloy off-gases, gasified biomass, and gasified mixed plastic wastes are under development. We have worked with several partners on the integration of the gasification and gas fermentation processes to convert solid feedstocks to fermentation products, culminating in over 50,000 hours of pilot and demonstration scale operations on live synthesis gas (&#8220;syngas&#8221;) produced from gasification.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of our ability to deliver a sustainable, economically advantaged solution to produce fuels chemicals and products using waste feedstocks, we have been able to attract key industry partners in our markets such as Mitsui, ArcelorMittal, Suncor, BASF, IndianOil, and Sinopec.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, the Shougang Joint Venture plant that has been using our technology platform on a commercial scale received Roundtable&#160;on&#160;Sustainable Biomaterials (&#8220;RSB&#8221;)&#160;certification. RSB certification is awarded to facilities that ensure the&#160;sustainability of their products and promote the health of their employee and the&#160;welfare of their local communities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Strong Intellectual Property Position</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, we owned or had licensed rights to 1,264 granted patents and 588 pending patent applications across 141 patent families in the United States, Europe, Asia and additional jurisdictions, in addition to our trade secrets. These issued patents and pending patent applications cover not only the upstream (such as gasification and gas conditioning), gas fermentation, and downstream (such as product separations and catalytic conversions) production systems that we are developing or may pursue in the future, but also certain of the underlying technologies used to develop our systems. Our intellectual property portfolio contains patent families spanning the entire platform, from the feedstock to the gas fermentation to the product recovery. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following chart summarizes the breadth of our IP portfolio:</span></div><div style="margin-bottom:9pt;text-align:center"><img src="amci-20230213_g3.jpg" alt="amci-20230213_g3.jpg" style="height:341px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Extensive Industry Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have over 17&#160;years of experience developing, testing, scaling, and optimizing gas fermentation and integrating gas fermentation with upstream and downstream technologies, culminating in the world&#8217;s first commercial gas fermentation plant in 2018. Our management team brings over 150&#160;years of combined research and development, engineering and scale up, operations, partnering and licensing experience in the energy industry.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Technology Platform</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have developed, scaled, and deployed an adaptable proprietary technology platform that integrates core gas fermentation with upstream processes, such as gasification and gas conditioning, and downstream processes, such as product separations and catalytic conversions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our technology platform is like brewing, but instead of using yeast that eat sugar to make alcohol, our biocatalysts, or microbes, eat waste carbon to make end products. Because our system is biological, and biological systems grow in dynamic environments and react in real time to changing conditions, it is much more tolerant of variability in feedstock composition and supply than systems based on catalytic chemistry and is, therefore, highly customizable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our technology platform can use feedstocks containing CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and CO, including waste emissions from steel, oil refining, and ferroalloy industries, gasified municipal solid waste (&#8220;MSW&#8221;), agricultural wastes, and reformed biogas. We have demonstrated this with partners globally and have shown conversion of these input streams at various scales, including at three commercial facilities in China being operated by entities in which the Shougang Joint Venture holds a controlling interest using industrial emissions. Our commercial partners will be able to </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">combine our gas fermentation system with different engineered biocatalysts to produce different products, allowing them to leverage their existing capital investment and to calibrate production to market conditions.</span></div><div style="margin-bottom:9pt;text-align:center"><img src="amci-20230213_g4.jpg" alt="amci-20230213_g4.jpg" style="height:328px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Step 1: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The process begins by receiving off-gas or waste gas streams comprising gases that contain various mixtures of CO, CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, such as from steelmaking emissions or gasified waste.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Step 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: These gases are compressed, conditioned, and transferred into fermentation bioreactors containing LanzaTech&#8217;s proprietary biocatalysts (microorganism) and a liquid media.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Step 3: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The biocatalysts ferment the gases and, as part of their natural biology, they produce ethanol and other chemicals as a result of this fermentation. This is a continuous process that can run without shutting down for extended periods.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LanzaTech&#8217;s Biocatalyst</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Clostridium autoethanogenum</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is an Acetogen, a chemolithoautotrophic microorganism that uses certain gases for both carbon and energy. Acetogens naturally produce acetate, and a select subset of Acetogens, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">autoethanogenum</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, natively synthesize ethanol. Acetogens are ubiquitous in anaerobic environments, such as soil, animal and human guts, sediments, the deep sea, and hot springs. For biotechnological applications, acetogenic clostridia are among the fastest growing acetogens and have been used industrially for more than 100&#160;years.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our technology platform relies on gas-consuming biocatalysts that use an ancient biological pathway known as the acetyl coenzyme-A biochemical pathway for autotrophic growth (the &#8220;Wood-Ljungdahl Pathway&#8221;). The Wood-Ljungdahl Pathway is the most energetically efficient carbon fixation pathway and enables our proprietary biocatalyst to transform the carbon and energy in gas streams into valuable products. In addition to being highly energy efficient, the Wood-Ljungdahl Pathway also allows high levels of dynamic flexibility in the composition of the gas streams (and therefore resources) that can be converted into valuable products. The pathway allows the LanzaTech process to use both CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and CO as sources of carbon and H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and CO as sources of energy. The application of this pathway with this biocatalyst enables a significant range of sustainable, high volume, and globally available waste resources for commercial deployment and product manufacture. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Feedstock Diversity for Resilience</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current manufacture of essential goods results in an abundance of waste carbon in the form of polluting gases or solid wastes in the air, landfills, and waterways. The LanzaTech gas fermentation platform can utilize feedstocks ranging from CO to CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-rich waste streams, including industrial and refinery off-gas, reformed biogas, gasified biomass and MSW, and CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt;text-align:center"><img src="amci-20230213_g5.jpg" alt="amci-20230213_g5.jpg" style="height:371px;margin-bottom:5pt;vertical-align:text-bottom;width:465px"/></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CO can provide both carbon and energy for our proprietary microbes. In contrast, CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> only provides carbon, which means a source of chemical energy, H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, must be added for a CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> conversion. In a CO-rich stream, the microbe can make the H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> it needs from water via a biological water gas shift reaction, creating CO waste streams of various compositions ideal for gas fermentation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Waste carbon feedstocks generally have low cost, global availability with regional abundance, low carbon intensity, and are non-competitive with food production. If the entirety of the potential feedstocks could be accessed, up to 6.5 billion metric tons annually of gas fermentation products, primarily ethanol, could be produced</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compared to other catalytic conversion processes, LanzaTech&#8217;s gas fermentation process is uniquely tolerant to the inherent variability of waste gas composition, enabling a wide diversity of feedstocks and high variety of products. Upstream catalysis technology focuses on identification and removal of fermentation inhibitors before fermentation feedstock gases are introduced into the bioreactors. LanzaTech has developed and optimized its proprietary gas treatment system to remove more than four classes of fermentation inhibitors from the broad spectrum of feedstocks, gasified biomass to steel off-gasses, in a simple process that substantially decreases capital and operating expenses while providing increased flexibility.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Potential Feedstocks</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following feedstocks could be used with our platform technology:</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Industrial Emissions</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Steel, ferroalloy, or refinery off-gases are point-sourced. CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-rich off-gases, which are produced by the cement and sugar ethanol industries, can also be used to feed gas fermentation alongside a hydrogen source as explained in subsequent sections.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Steel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Energy-intensive manufacturing processes, such as steel production, inevitably result in gaseous emissions, which cannot be stored and which are emitted by the steel maker. As an environmental liability rich in CO, these emissions are an ideal feedstock for our process. We have been working with these readily available, abundant gases since 2008.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Ferroalloy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Ferroalloy gases are also rich in CO, making this another ideal emission source. We are developing projects using ferroalloy gases in target regions such as China, Norway and India.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Refining</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Certain refinery off-gases are ideal feedstocks for our process. A unique feature of processing refinery gases is that most of the carbon in the ethanol produced is derived directly from CO2, rather than from CO. Oil and gas companies also have extensive experience producing and handling liquid fuels, gas processing, engineering, and chemical catalysis.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solid Wastes and Reformed Landfill Gas</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biomass and agricultural residues offer the largest potential sources of feedstock for gasification. In contrast to other methods of converting biomass feedstocks into fuels, gasification and gas fermentation have the potential to utilize all carbon in the feedstock. This includes carbon contained in the natural polymer lignin, which is typically not accessible in current cellulosic biomass fermentation processes. Gasified non-recyclable MSW, mixed plastic waste, and reformed biogas such as landfill gas (&#8220;LFG&#8221;) are abundant waste streams that we believe are currently underutilized sources of carbon for conversion into CarbonSmart&#160;fuels, chemicals, and materials using our technology platform.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Biomass: Biomass, such as agricultural and forestry residues, can be gasified into syngas. Syngas contains CO and H2 and is well suited for our process. While higher in capital costs due to the addition of one or more gasifiers, these projects typically benefit from significant renewable policy incentives, and can be deployed as smaller modular systems.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">MSW and Refuse Derived Fuel (&#8220;RDF&#8221;): As with biomass, MSW and RDF can also be gasified into syngas for use in our process, which can accept unsorted waste, ideally with mechanically recyclable items removed. The current alternatives are landfilling or incineration, which are increasingly falling out of favor globally, and so waste management companies are seeking alternative sustainable solutions. These projects benefit from tipping fees, or fees generated by the disposal and processing of waste on a per ton basis, on the waste, and in certain locations, can be deployed as smaller modular systems.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reformed LFG: Only 32% of landfills in the United States collect methane, and the collection efficiency can range from 35% to 90% for modern landfills that do collect. As a result, landfills are responsible for more than 15% of the anthropogenic methane released in the U.S. Many landfills flare the LFG or operate older power generation units that emit large volumes of carcinogens and micro particles. LanzaTech believes it can utilize this gas stream. Capturing this feedstock for CarbonSmart materials has the potential to clean the air and improve human and environmental health surrounding landfills while reducing dependence on fresh fossil resources.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As modern industries transition to more sustainable feedstocks, we believe industrial and refinery waste gases will ultimately transition as well. To enable this transition, LanzaTech is developing the ability to pivot to CO2 from biorefineries and direct air capture (&#8220;DAC&#8221;) for continued, sustained, low carbon materials and fuels.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Future Proofing Feedstock Capability </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> sourced from biorefineries, industrial emissions, and DAC technologies can be coupled with H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to produce products with extremely high carbon conversion efficiency of over 90% carbon utilization. Since H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> can be produced from renewable power via water electrolysis (&#8220;green&#8221;) or by steam methane reforming with carbon capture (&#8220;blue&#8221;), the carbon footprint of the products made will be a fraction of that relative to petroleum refining. As more hydrogen is present in the feedstock, more carbon is captured into the ethanol product. We believe CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as a feedstock has the potential to disrupt the fuel and chemical supply chains by substituting CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for conventional fossil resources. By developing and integrating these approaches, we believe our technology platform is positioned to take advantage of the expected continued price reductions and capacity increases for renewable electricity, maximizing utilization of CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> streams.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integrating bioindustrial CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and eventually DAC technologies with LanzaTech&#8217;s gas fermentation platform creates an opportunity for renewable fuel production from low-cost CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> feedstock. Integrating with LanzaJet&#8217;s Alcohol to Jet (&#8220;ATJ-SPK&#8221;) process can produce SAF from each of ethanol derived from CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> produced by water electrolysis. DAC CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to SAF is estimated to have a 94% emissions reduction when compared to the fossil counterpart at 94 g-CO2e/MJ of ATJ-SPK. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Steel Industry Transition</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech&#8217;s gas fermentation technology can utilize the evolving off-gases from iron and steelmaking processes through the transition from carbon to hydrogen feedstocks. The LanzaTech system can remain in place, utilizing existing assets at iron and steel mills to take advantage of available hydrogen, coupled with carbon from other on-site sources including electric arc furnaces, or further transition to gasification of waste carbon resources (solid waste or biomass) or utilize direct air capture. We believe that our early investments in GHG emission reduction technology positions us to continue to be a leader in carbon recycling in other hard-to-abate sectors.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Technology Platform Development</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout our 17-year history, LanzaTech has consistently developed and scaled innovative gas fermentation technology solutions and is now deploying them commercially. Our team has designed and developed equipment necessary to enable the biocatalyst that functions in a 3-liter benchtop reactor to operate equivalently in a 750,000-liter fermentation reactor.</span></div><div style="margin-bottom:9pt;text-align:center"><img src="amci-20230213_g6.jpg" alt="amci-20230213_g6.jpg" style="height:282px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech&#8217;s gas fermentation process has been demonstrated at four sites with 50,000 hours of operation in the field using steel mill waste gases plus another 50,000 hours of operating in the field integrating gasification, gas treatment and gas fermentation. The success of these 100,000 hours of experience at pilot and demonstration scales </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">led to the May 2018 startup of the first operating commercial gas fermentation facility in the world, at the Jingtang Steel Mill in Caofeidian in Hebei Province, China. A second commercial plant, the Shoulang Jiyuan plant in Ningxia, China, of the same capacity and utilizing ferroalloy off-gas come online in April 2021. The third commercial plant, the Ningxia Binze plant in Ningxia, China, with an annual capacity of 60,000 tons and utilizing ferroalloy off-gas, came online in September 2022. Together these facilities have produced over 50 million gallons of fuel-grade ethanol and mitigated over 250,000 tons of CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. There are 14 additional plants being developed worldwide, 12 of which are commercial-scale and two are demo-scale or 1/10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> commercial-scale. Four of the 12 commercial plants are in construction and the remaining eight plants are in engineering phases. The demo-scale facility and the 1/10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> commercial-scale facility are in startup test run and commissioning phases, respectively. The 14 additional plants will use a mix of feedstocks including steel off-gas, ferroalloy off-gas, refinery off-gas, gasified biomass, gasified municipal solid waste, CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and green H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and ethanol in instances where the plant will produce sustainable aviation fuel from the ATJ process.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech is continuously developing and advancing its technology platform, and in late October 2022, announced that its next-generation bioreactor, currently utilized in a demonstration-scale facility in Alberta, Canada with partner Suncor, is expected to run additional test campaigns for ethanol production on a wide range of waste-based feedstocks. This next generation bioreactor is expected to improve the economic viability of LanzaTech&#8217;s integrated biorefinery offering. The demonstration-scale facility has produced ethanol in test runs since July 2022 and converts waste-based feedstocks, including municipal waste and forestry-residues, into ethanol. Additional test campaigns are expected over the next several months along with full construction completion of the facility. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Applications of Our Technology Platform</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our technology platform enables companies around the world to generate revenue from transformed carbon in waste resources. Across the supply chain, we promote a CarbonSmart circular economy, where both resource providers and end users can choose to be carbon-efficient by recycling or &#8220;locking&#8221; carbon into new products rather than making them from new fossil resources. Current and proposed applications of our technology platform include ethanol products, which can serve as the chemical building blocks for consumer goods, such as household cleaners and sustainable fuels, including sustainable aviation fuel, as well as protein products, such as animal/fish feed and fertilizer. These applications are discussed further below.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date we have partnered with several consumer-facing companies to demonstrate the market value of our CarbonSmart products. This includes leveraging our technology to make the chemical intermediates for the production of a new range of cleaning products, packaging for cosmetics, fibers for clothing, and as an input for fragrances. The ethanol used in these first CarbonSmart products originates in China at our commercial facilities, but we expect that over the longer term, the input ethanol will be made in our facilities across the globe.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ethanol Products</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our customers and partners already have used our technology platform to produce ethanol, ethanol derivatives and ethanol co-products from steel mills, ferroalloy plants, and refineries, as well as gasified biomass and municipal waste.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, LanzaTech has produced over 1,000 metric tons of finished CarbonSmart products for consumer brands. Examples of CarbonSmart product launches are as follows:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Purified ethanol in home cleaning products: LanzaTech&#8217;s purified ethanol from steel mill off gas is utilized in a line of household cleaners.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Purified ethanol in fine fragrances: High purity ethanol is one of the major ingredients in fine fragrances. LanzaTech&#8217;s high purity ethanol will be used in one of the world&#8217;s largest fragrance and beauty company&#8217;s fragrance formulations.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Ethanol as a feedstock for polyethylene production: LanzaTech ethanol was utilized for conversion to ethylene and then polyethylene, for use in manufacturing the world&#8217;s first cosmetic bottle from steel mill emissions.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Ethanol as a feedstock for surfactant production: LanzaTech&#8217;s partner launched a line of laundry detergents utilizing CarbonSmart ethanol as input for surfactants production.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Ethanol as a feedstock for polyester production: LanzaTech ethanol was utilized for conversion to ethylene and then monoethylene glycol (MEG) a building block for PET production. This was used to make yarns and fabric for lululemon and Zara apparel collections.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the date of this prospectus, 12 commercial-scale facilities are either under construction or in engineering utilizing our technology, as outlined in the graphic in the section titled &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business &#8212; Market Opportunity &#8212; Overview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221; The first commercial facility to use our technology was the Shougang Joint Venture in 2018, a joint venture between us and Shougang Group and TangMing formed in 2011. This gas fermentation plant was the world&#8217;s first commercial facility to convert industrial emissions into sustainable ethanol. This plant has an annual production capacity of approximately 46,000 tons of ethanol.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sustainable Aviation Fuel Products</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ethanol produced by us can be blended into road transport fuels or can be converted through the LanzaJet&#8482; ATJ process to an ethanol-based ATJ-SPK and to sustainable diesel, both of which can be blended with their fossil equivalents. LanzaJet ATJ-SPK from our ethanol can demonstrate up to 80% GHG reduction compared to fossil alternatives depending on circumstances, including feedstock, geography and methodology. ATJ-SPK is qualified for use at up to a 50% blend level with conventional jet fuel for all commercial flights. This process is poised for commercial deployment. The process has a high potential jet yield of 90%.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our first ATJ demonstration unit produced approximately 4,000 gallons of jet fuel and 600 gallons of diesel fuel. A portion of this fuel was used to power a commercial passenger 747-jet flight operated by Virgin Atlantic from Orlando, Florida to London, UK in 2018. The fuel was also used for a 2019 Trans-Pacific flight to deliver a new Boeing aircraft to All Nippon Airways in Tokyo from Everett, Washington.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have designed our technology platform to convert ethanol to SAF, which is of strategic importance to airlines for meeting their commitments to reduce emissions.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaJet</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the goal of accelerating commercialization of the ATJ process, we helped launch LanzaJet in June 2020 and became shareholders along with Suncor and Mitsui, with British Airways and Shell joining as shareholders in 2021. LanzaJet received financing from the Microsoft Climate Fund in 2022. We currently hold a 25% stake in LanzaJet. Mitsui, Suncor, British Airways and Shell have committed to invest a total of up to $165 million. This initial facility is currently under construction in Soperton, Georgia and will have the capacity to produce 10 million gallons per year of SAF and renewable diesel from sustainable ethanol sources. In December 2022, installation of key equipment for the novel process technology that converts ethanol to drop-in replacement SAF began and construction at the facility is expected to be completed in 2023. Pursuant to the LanzaJet License Agreement, we granted to LanzaJet a perpetual, worldwide, non-transferrable, irrevocable, royalty-free, sublicensable, exclusive license to certain patents related to the conversion of ethanol to fuel. This license is exclusive including as to us. The primary waste biomass to be used for ethanol feedstocks is cellulosic wastes from sugar cane or other agricultural activities in Brazil. Additional, longer-term waste-based biomass-derived feedstocks for SAF include waste starch slurry from conventional fermentation and biogas derived from biomass degradation in landfills. Waste-based industrial off-gases can also be used to produce ethanol as a feedstock for the process.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This plant, located at the LanzaTech Freedom Pines Biorefinery in Soperton, Georgia, is also supported by participation from All Nippon Airways and a US Department of Energy grant of $14 million. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate deployment of numerous commercial ATJ facilities above the 10 million gallons per&#160;year capacity of the LanzaTech Freedom Pines Biorefinery. We are currently working with partners to confirm project locations and solidify the appropriate project structures. Locations for these facilities include Asia, mainland Europe, the United Kingdom, and the United States. We expect these facilities will be funded by LanzaJet shareholders as well as other sources, including government grants and loan guarantees depending on the project structure and partners, location, and other factors.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DRAGON</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, Project DRAGON (Decarbonising and Reimagining Aviation for the Goal of Net Zero) was formally initiated. This waste-to-SAF project received GBP &#163;3.15 million in grant funding from the UK Secretary of State for Transport (the &#8220;UK Authority&#8221;) Green Fuels Green Skies program and &#163;1 million from Innovate UK as part of the South Wales Industrial Cluster deployment program. LanzaTech is responsible for front-end engineering design and associated project development activities for the UK Authority to achieve a final investment decision for both the LanzaTech Gas Fermentation unit and the adjacent LanzaJet ATJ unit in Port Talbot, South Wales, United Kingdom. These activities, further supported in December 2022 by a &#163;24.9 million grant from the UK Authority's Advanced Fuels Fund, are underway with a view to achieving a final investment decision in 2024 and full operations in 2026-2027 to produce 100 million liters per year of SAF for two major UK airlines. Overall the project is expected to play a significant role in meeting the UK government&#8217;s target of 10% SAF by 2030, as well as resulting in significant carbon emissions reductions compared to fossil kerosene, and to also reduce emissions of particulate matter and sulfur.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FLITE</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December&#160;2020, the Fuel via Low Carbon Integrated Technology from Ethanol, or FLITE, project was formally initiated. This project received EUR 20 million in grant funding from the EU Horizon 2020. LanzaTech is responsible for plant design, construction and operations using LanzaJet&#8217;s ATJ technology. Project development has been initiated and we expect the FLITE facility to be fully operational in 2024 and to produce SAF using waste-based ethanol sourced from multiple European producers. In addition, the SAF expected to be produced at the facility is anticipated to result in a significant carbon emission reduction relative to fossil kerosene and to also reduce emissions of particulate matter and sulfur.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaJet&#8217;s ATJ technology is leveraging existing low-carbon intensity ethanol and is enabling a transition to new sources of waste-based ethanol. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Project LOTUS</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, SkyNRG Americas in partnership with LanzaTech was awarded $1 million in funding for Project LOTUS (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">L</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">andfill </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ff-gas </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ltra-low carbon intensity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AF) to design, build, operate, and maintain a production facility that will convert raw LFG into SAF. The project is expected to leverage green hydrogen and LanzaTech&#8217;s gas fermentation technology to convert LFG to ethanol at an operating landfill. The ethanol will be converted to SAF using the LanzaJet ATJ technology developed by LanzaTech and Pacific Northwest National Laboratory and subsequently licensed to LanzaJet. SkyNRG Americas has numerous contractual partners, including </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boeing and Alaska Airlines, who are committed to advancing use of the fuel in flight once it is produced through project LOTUS.</span></div><div style="margin-bottom:9pt;text-align:center"><img src="amci-20230213_g7.jpg" alt="amci-20230213_g7.jpg" style="height:238px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe Project LOTUS has the potential to provide a new U.S.-produced regional supply chain for producing SAF that meets international ASTM specifications while reducing methane emissions and improving air quality. The SAF is expected to be high quality, low soot forming, and sustainably derived, with the potential to reduce up to 110% of GHG emissions over traditional jet fuels. The $1 million in funding from the Department of Energy, awarded in September 2021, is expected to accelerate the commercial rollout of this SAF production path from LFG by reducing the technical and financial risks for future integrated commercial plants across the United States.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Protein Products</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An additional application of our technology platform is the production of protein products. Microbial protein is composed of lysed, spent microbes from LanzaTech commercial facilities. These microbes contain proteins and other valuable nutrients and have performed the task of gas fermentation, have been extracted from the relevant commercial unit and are no longer viable. These materials can be extracted and used in numerous applications, including feed products for livestock and fish, fertilizers for agricultural applications, and protein extract-based products. LanzaTech&#8217;s first commercial customer is currently selling residual microbial protein as a component in fish and livestock feed products. Many of these markets are large and diverse, with stakeholders actively seeking sustainable and nutritious inputs. We believe our technology offers improved overall plant economics and environmental performance.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant composition testing on LanzaTech microbial protein has already been completed and detailed materials characterizations have been developed. These tests have shown that LanzaTech microbial protein products contain very high protein content, typically exceeding 85 weight&#160;percent of the overall material mass. In addition, LanzaTech&#8217;s microbial protein product for fertilizer and feed applications contains high concentrations of B vitamins and other minerals. These materials are beneficial in certain end-use applications such as animal feeds.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that animal feed is the most profitable application for microbial protein. Fertilizer and biogas applications currently provide alternatives where feed applications are impractical. The nearest term applications for LanzaTech microbial protein include:</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Animal/Fish Feed</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Using LanzaTech microbial protein as a key ingredient in fish and animal feed represents a significant opportunity for LanzaTech. Global fishmeal production alone is six to seven million tons annually. Separation and drying of microbial protein for feed applications is similar to that of fertilizers, leading to potentially higher margins for LanzaTech and its customers. Studies have demonstrated that LanzaTech microbial protein is effective as a </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">partial replacement for fish meal and corn gluten meal in Atlantic Salmon at levels up to 15 weight&#160;percent in the diet. Nutrient digestibility and safety were demonstrated up to 30 weight&#160;percent in feed. Depending on region, regulatory approval may be required prior to marketing. Also, sufficient feed gas treatment is required for feed applications to ensure any detrimental gas contaminants do not enter the food chain.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fertilizer</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global fertilizer market is roughly $150 billion and consists of approximately 187 million tons of materials sold annually. Fertilizer products draw widely different prices based on their compositions and availability. LanzaTech believes that its microbial protein has strong potential as a fertilizer that is easy to apply and low maintenance. Use as a fertilizer may require regional or local approval.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Biogas</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some markets, including the European Union, it is economically advantageous to anaerobically digest the residual microbial protein to produce biogas. This biogas can be used in a cogen unit to produce power, steam, and hot water for use in the industrial facility. In regions where there are strong government incentives promoting biogas production, this may be a profitable use of residual microbial protein.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Synthetic Biology and Chemical Products</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our synthetic biology platform we can develop new microbes to produce additional chemical products.Our platform technology enables rapid scale-up of new microbes once they are developed. Beyond ethanol, we have demonstrated the ability to produce ethylene, isopropanol, and acetone directly from gases.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, LanzaTech demonstrated direct continuous production of ethylene from CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, creating a new non- fossil fuel pathway to this widely used commodity chemical. With a projected global market value of $170 billion by 2030, ethylene is widely used in the chemical industry, and its worldwide production capacity (estimated over 200 million tons per annum in 2021) is one of the largest of any chemical. Using oil or natural gas as feedstock, petrochemical plants use the cracking process to extract ethylene, which is then transformed into chemical compounds and plastics, which manufacturers use to produce many of the products used every day, including:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Polyethylene (Plastics) &#8211; used to make food packaging, bottles, bags, and other plastics-based goods.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Ethylene Oxide / Ethylene Glycol &#8211; can become polyester for textiles, as well as antifreeze for airplane engines and wings.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Ethylene Dichloride &#8211; this, in turn, can become a vinyl product used in PVC pipes, siding, medical devices, and clothing.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Styrene &#8211; synthetic rubber found in tires, as well as foam insulation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech has previously produced ethylene via the indirect ethanol pathway, taking ethanol produced from carbon emissions and then converting this ethanol to ethylene. This latest development bypasses the conversion step, making the process less energy intensive and more efficient. With this, LanzaTech estimates that the ability to directly produce ethylene from a waste feedstock will offer a lower cost and lower carbon product, which is anticipated to enable greater market penetration than via the indirect ethanol pathway.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech is scaling up the process to make these molecules. We have provided high-purity fermentation products (e.g. ethanol) and upgraded products (e.g., PET) to over 20 customers. Because this capability is unique to gas fermenting microbes, we have several collaborations with end users targeting the production of new molecules. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech has achieved the direct synthesis of over 50 target products, molecules spanning from two-carbon up to 20+ carbon molecules and varying functional classes. LanzaTech has also demonstrated control over stereospecificity of the molecules, as well as the production of entirely novel compounds that cannot be produced in nature. In addition, LanzaTech has identified over 500 pathways for the production of an extensive spectrum of molecules using our proprietary predictive microbial modelling capability. Computer modelling simulations confirm </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the feasibility of producing these molecules from gas while providing accurate projections of achievable yields and therefore the economic case for each. Direct production of chemicals that today are produced via the ethanol conversion pathway, will make the process less energy intensive and more efficient. With this, LanzaTech estimates that the ability to directly produce chemicals from a waste feedstock will offer a lower cost and lower carbon product which will enable greater market penetration than via the indirect ethanol pathway.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our demonstrated ability to genetically modify our proprietary gas-fermenting microbe acetogen Clostridium autoethanogenum, is a competitive differentiator. While in recent&#160;years a number of rudimentary tools for gas fermenting organisms have been described in the public domain, these have low efficiency and are not amenable for use in high-throughput workflows. We have developed a complete suite of high-throughput capabilities essential for development of optimized production strains or application of iterative, machine learning-based screening strategies employed by the pharmaceutical or natural product industries. Specifically, we have assembled a fully automated strain fabrication facility capable of designing, engineering and delivering several thousand genetically re-programmed strains per&#160;month. This &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">BioFab</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; facility leverages the advanced computational biology, characterized libraries of genetic regulators, as well as tools and protocols to enable precise and predictable genetic re-programming of our proprietary gas-fermenting microbe. The combination of the capabilities and technologies that comprise the BioFab were developed in-house and are proprietary to us. Data from iterative cycles of design, construction, and analysis of engineered microbial strains within the BioFab is captured computationally and used to further refine our genetic modelling and strain design programs. Thus, over time these models and programs become increasingly accurate, minimizing the time required to deliver new commercial strains producing valuable chemical products.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe we can further expand our product portfolio through the industrial microbiology capabilities we have pioneered and use our technology to produce high-value chemical intermediates used to make materials such as acrylics, fibers, plastics, and synthetic rubber. In the future, once fully developed, we believe these new microbes will have the potential to be dropped into any existing industrial gas fermentation facility to make new products from established transformed carbon feedstocks, in many cases leading to carbon capture and sequestration in durable goods. We believe synthetic biology could enable the production of a wide variety of chemicals including alcohols, acids, esters, and ketones.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete in industries characterized by rapidly advancing technologies and a complex intellectual property landscape. We face competition from many different sources, including companies that enjoy competitive advantages over us, such as greater financial, research and development, manufacturing, personnel and marketing resources, greater brand recognition, and more experience and expertise.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we do not believe we have any direct competitors, there are some companies with alignment in feedstock usage, products, synthetic biology, process design or commercial scale. While competing companies may be able to deliver some of these capabilities, we believe that no other company can currently deliver all of them in an integrated way.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These competitors may introduce competing products without our prior knowledge and without our ability to take preemptive measures in anticipation of their commercial launch. Competition may increase further as a result of greater availability of capital for investment and increased interest in our industry as more companies seek to facilitate the development of a carbon circular economy.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual Property</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech is a technology company which protects its intellectual property across an entire platform through a combination of trade secrets, confidential information, patents, trademarks, copyrights, nondisclosure agreements, material transfer agreements, employee agreements, and strong intellectual property and confidentiality clauses in collaboration and other agreements. We do not consider any individual patent, patent family or trademark to be material to our overall business. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Patents</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, we had owned or in-licensed 1,264 granted patents globally and 588 pending patent applications globally reflecting 141 patent families. We have filed patent applications continuously every year from 2007 to 2022, demonstrating continued innovation and establishing a steady patent estate viewed from a patent term perspective. As earlier filed patents reach their 20-year patent term, later filed patents remain enforceable thus providing a rolling patent estate of enforceable patents. Our patent estate is global in nature with patents or patent applications in over 50 individual countries and several pending applications in the International Patent System established by The Patent Cooperation Treaty.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade Secrets and Confidential Information</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a large body of intellectual property that is maintained, not as patents, but as trade secrets and confidential information. Such intellectual property is protected by appropriate measures to maintain the secrecy and confidentiality of the intellectual property, including for example, contractual measures with confidentially and security obligations, physical security measures and digital security measures.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trademarks</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain trademark rights and registrations in its name and brands in several global jurisdictions. Examples include &#8220;LanzaTech&#8221; and &#8220;CarbonSmart.&#8221;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Domains</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have registered a number of domain names for website used in our business. For example, we have registered the domain name for &#8220;LanzaTech.com.&#8221;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intellectual Property Overview and Risks</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of our intellectual property assets were developed and are owned solely by us, a few have been developed via collaboration, some of which are jointly owned with third parties, and a small number have been acquired or licensed from third parties. We expect that we will continue to make additional patent application filings and that we will continue to pursue opportunities to acquire and license additional intellectual property assets, technologies, platforms or products as developments arise or are identified.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regardless, we cannot be certain that any of the patent filings or other intellectual property rights that we have pursued or obtained will provide the protection we seek. Our future commercial success depends, in part, on our ability to obtain and maintain patent and other proprietary protection for commercially important technology, inventions and know-how related to our business; defend and enforce our patents and other intellectual property; preserve the confidentiality of our trade secrets; and operate without infringing, misappropriating or violating the valid and enforceable patents and other intellectual property rights of third parties. Our ability to stop third parties from making, using, selling, offering to sell or importing our products may depend on the extent to which we have rights under valid and enforceable patents, trade secrets or other intellectual property rights that cover these activities. With respect to both our owned and licensed intellectual property, we cannot be sure that patents will issue with respect to any of the owned or licensed pending patent applications or with respect to any patent applications that we, our co-owners or our licensors may file in the future, nor can we be sure that any of our owned or licensed patents or any patents that may be issued in the future to us or our licensors will be commercially useful in protecting any products that we ultimately attempt to commercialize, or any method of making or using such products.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the &#8220;march-in&#8221; provisions of the Bayh-Dole Act, the government may have the right under limited circumstances to require us to grant exclusive, partially exclusive or non-exclusive rights to third parties under any intellectual property discovered through the government-funded programs. March-in rights can be triggered if the government determines that we have failed to work sufficiently towards achieving practical application of a technology or if action is necessary to alleviate health or safety needs, to meet requirements for public use specified by federal regulations or to give preference to U.S. industry. Specifically, certain of our granted and pending patents </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that cover recombinant and other microorganisms, cell-free protein synthesis platforms, protein expression vectors, fermentative production pathways, and microbial and ethanol conversion pathways may be subject to march-in-rights. These patents account for less than one percent of our granted and pending patents. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Collaboration Agreements</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">License Agreement with Battelle Memorial Institute</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September&#160;2018, we entered into a license agreement with Battelle, which was subsequently amended in January&#160;and April&#160;2020 (as amended, the &#8220;Battelle License Agreement&#8221;). Under the Battelle License Agreement, Battelle granted to us an exclusive sublicensable commercial license to certain patents related to the conversion of ethanol to fuels (the &#8220;Battelle patent rights&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Battelle License Agreement, we must meet certain development milestones, including producing and selling products and sublicensing the Battelle patent rights to others within certain timeframes. The agreement also requires that any products manufactured using the Battelle patent rights and sold within the United States will be substantially manufactured in the United States. Battelle retains the right to practice or license the Battelle patents to nonprofit institutions for research, development, or demonstration purposes. We licensed our rights and obligations under the Battelle License Agreement exclusively to LanzaJet. As such, we may only exercise these rights through a sublicense from LanzaJet.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our entry into the Battelle License Agreement, we paid an initial fee of $5,000 and agreed to pay Battelle a royalty of less than one percent of net sales of products involving the Battelle patent rights and a 10% royalty on all sublicense revenues and royalties. As of the date of this prospectus, we have not been required to make any royalty payments under the Battelle License Agreement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Battelle License Agreement remains effective until the last of the Battelle patent rights expires, is abandoned or is adjudicated invalid, unless the agreement is earlier terminated. The last of the Battelle patent rights are currently scheduled to expire in approximately October&#160;2035. Battelle may terminate the agreement if we become insolvent or if we fail to meet certain reporting or payment requirements under the agreement. Battelle may also terminate the agreement or convert the license into a non-exclusive license if we fail to reach certain of the abovementioned development milestones within the applicable time periods. We may terminate the Battelle License Agreement upon 60&#160;days&#8217; prior notice to Battelle, and either party may terminate the agreement if the other party breaches the agreement and fails to cure such breach after 60&#160;days&#8217; notice. We agreed to indemnify Battelle against certain third-party claims related to the Battelle patents.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LanzaJet&#160;Agreements</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LanzaJet Amended and Restated Investment&#160;Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2021, we entered into an amended and restated investment agreement with LanzaJet, Mitsui, Suncor, British Airways and Shell. We refer to this agreement as the &#8220;LanzaJet Investment Agreement.&#8221; The LanzaJet Investment Agreement was entered into in order to facilitate the production of SAF by designing, constructing and operating a demonstration facility located at the LanzaTech Freedom Pines Biorefinery in Soperton, Georgia (the &#8220;LanzaJet Freedom Pines Demonstration Facility&#8221;), and to determine the feasibility of developing additional potential facilities for commercial scale production of fuel.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the LanzaJet Investment Agreement, we received shares of common stock of LanzaJet (&#8220;LanzaJet shares&#8221;), in exchange for a license to our rights and obligations under the Battelle License Agreement (discussed further below under &#8220;&#8212; License Agreement with LanzaJet&#8221;). Pursuant to the LanzaJet Investment Agreement, Mitsui, Shell, British Airways and Suncor each contributed an initial cash investment in exchange for shares of common stock of LanzaJet.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of Mitsui, Shell, British Airways and Suncor agreed to make an additional cash investment following the achievement of certain development milestones relating to the demonstration facility, which payments we refer to as second tranche investments. If made, the second tranche investments would fund the development and operation of </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">commercial facilities by Mitsui, Shell, British Airways and Suncor, respectively. These commercial facilities would sublicense the relevant fuel production technology from LanzaJet. Upon the closing of each of the first three of these second tranche investments and no later than the sublicensing of the relevant facility, LanzaJet is required to issue additional LanzaJet shares to us. We currently hold approximately 25% of the outstanding shares of LanzaJet. Upon the issuance of additional shares to us in connection with the closing of each of the first three potential second tranche investments, we would hold approximately 40%, 50% and 57% of the outstanding shares of LanzaJet, respectively. Unless and until two second tranche investments are made and assuming none of the employee equity incentive pool is issued as shares, LanzaJet undertakes an initial public offering or a sale of LanzaJet occurs under certain circumstances, we would remain a minority shareholder of LanzaJet.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LanzaJet Investment Agreement may be terminated by the mutual consent of the parties at any time or automatically as to the second tranche obligations of any party if LanzaJet has not called for such party to make a second tranche investment by December 31, 2025. Each party to the LanzaJet Investment Agreement agreed to indemnify the other parties for all claims arising from such party&#8217;s breach of the agreement or from fraud, gross negligence, or willful misconduct with regard to the agreement.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">License&#160;Agreement&#160;with&#160;LanzaJet</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, in connection with the LanzaJet Investment Agreement, we entered into the LanzaJet License Agreement. Under the LanzaJet License Agreement, we granted to LanzaJet a perpetual, worldwide, non-transferrable, irrevocable, royalty-free, sublicensable, exclusive license to all of our intellectual property rights under the Battelle License Agreement, as well as other intellectual property owned by us relating to the conversion of ethanol to fuels. LanzaJet assumed all of our obligations under the Battelle License Agreement, including development, reporting, royalty payment and sublicensing obligations. LanzaJet assumed all of our rights under the Battelle License Agreement except for our rights, in certain circumstances, to terminate the agreement, to amend the agreement or to assign our rights thereunder, provided that we may not exercise these rights without LanzaJet&#8217;s prior consent.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The license granted by us to LanzaJet is exclusive, including as against us, with the exception of certain development projects we are undertaking in collaboration with the U.S. Department of Energy or pursuant to certain grants from the U.S. Department of Energy, for which LanzaJet granted us a worldwide, non- transferable, non-sublicensable, non-exclusive, royalty-free sublicense to the relevant intellectual property rights. LanzaJet also agreed to grant us a non-exclusive sublicense at most-favored nation pricing to fulfill certain pre-existing SAF obligations if we are unable to fulfill these obligations through other off-take agreements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LanzaJet License Agreement has an indefinite term. If LanzaJet fails to perform its obligations under the Battelle License Agreement, we may continue to perform our obligations under such agreement. LanzaJet may terminate the LanzaJet License Agreement immediately upon notice to us if a material portion of the licensed subject matter is determined by a court to be invalid. We may terminate the agreement upon 30 days&#8217; written notice if LanzaJet materially breaches the agreement and fails to cure after receiving notice of the breach. If certain commercial facility development milestones are not met under the LanzaJet Investment Agreement, we may terminate the LanzaJet License Agreement and after such termination, the agreement will survive solely with respect to the LanzaJet Freedom Pines Demonstration Facility. If the agreement is terminated for any other reason, LanzaJet&#8217;s license will cease immediately but any sublicenses granted by LanzaJet prior to termination of the agreement will survive, subject to their terms. We and LanzaJet agreed to indemnify the other against certain third-party claims.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LanzaJet&#160;Amended&#160;and&#160;Restated&#160;Stockholders&#8217;&#160;Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the LanzaJet Investment Agreement, on April 1, 2021, we entered into an amended and restated stockholders&#8217; agreement with LanzaJet, Shell, Mitsui, British Airways and Suncor (the &#8220;LanzaJet Stockholders&#8217; Agreement&#8221;). Under the LanzaJet Stockholders&#8217; Agreement, each party is required to hold and vote its shares of LanzaJet stock to ensure that LanzaJet&#8217;s board of directors (the &#8220;LanzaJet board&#8221;) is composed of eight directors: one designee from each of British Airways, Mitsui, Suncor and Shell, two LanzaTech designees (one of which will be the chairperson), LanzaJet&#8217;s chief executive officer, and one independent director. Each party must </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hold a certain number of shares of LanzaJet common stock in order to maintain their respective designated board seats. Pursuant to the agreement, if a party votes to remove its designated director from the LanzaJet board, the other parties must also vote in favor of removal. If a party fails to comply with its obligations under the second tranche investments provided for in the LanzaJet Investment Agreement, the other parties may vote to remove that party&#8217;s designee, and such party will forfeit its designated LanzaJet board seat in exchange for the right to designate a non-voting observer to the LanzaJet board.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreement also provides that the parties must vote their shares in favor of a proposed change of control transaction and take all reasonable steps necessary to execute the transaction if it meets certain standards and is approved by us, the LanzaJet board, and any investor holding a certain number of LanzaJet shares.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The parties to the LanzaJet Stockholders&#8217; Agreement may not transfer their LanzaJet shares until 2026, except for permitted transfers to affiliates. LanzaJet has a right of first refusal with regard to all transfers of LanzaJet shares to third parties and if LanzaJet declines to exercise this right, the other parties to the agreement are entitled to a pro rata right of first refusal. We and the other parties will also have a pro rata right of first refusal with regard to new LanzaJet shares issued as well as a put right with respect to LanzaJet shares that we and such parties hold upon the occurrence of certain conditions. The LanzaJet Stockholders&#8217; Agreement also provides registration rights in connection with an initial public offering of or other registration of LanzaJet shares.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each party to the LanzaJet Stockholders&#8217; Agreement agrees to indemnify the other parties for all claims arising from such party&#8217;s breach of the agreement or from fraud, gross negligence, or willful misconduct with regard to the agreement. The LanzaJet Stockholders&#8217;&#160;Agreement will terminate either with the consent of all of the parties or upon an initial public offering of LanzaJet shares or a specified liquidation event.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LanzaJet Note Purchase Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 9, 2022, we and the other LanzaJet shareholders entered into the LanzaJet Note Purchase Agreement, pursuant to which FPF, a wholly owned subsidiary of LanzaJet, will issue, from time to time, notes in an aggregate principal amount of up to $147.0 million (the &#8220;LanzaJet Notes&#8221;), comprised of approximately $113.5&#160;million aggregate principal amount of 6.00% Senior Secured Notes due December 31, 2043 and $33.5&#160;million aggregate principal amount of 6.00% Subordinated Secured Notes due December 31, 2043. We have committed to purchase $5.5 million of Subordinated Secured Notes in a funding expected to occur on May 1,2023. The Senior Secured Notes are secured by a security interest over substantially all assets of FPF, and both the Senior Secured Notes and the Subordinated Secured Notes are secured by a security interest over all intellectual property owned or in-licensed by LanzaJet. LanzaJet also provides a guarantee of any costs and expenses required to complete the LanzaJet Freedom Pines Demonstration Facility and achieve commercial operation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each purchaser of LanzaJet Notes under the LanzaJet Note Purchase Agreement is also entitled to receive a warrant for the right to purchase 575 shares of common stock of LanzaJet for each $10,000 of LanzaJet Notes purchased by such purchaser (which, in the case of LanzaTech, will be equal to a right to purchase 316,250 shares of common stock of LanzaJet).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the LanzaJet Note Purchase Agreement, FPF must provide periodic progress reports and financial information to the noteholders, in addition to providing notice of certain significant events. Additionally, FPF is restricted from undertaking certain transactions or making certain restricted payments while the LanzaJet Notes are outstanding. The LanzaJet Note Purchase Agreement may be amended with the approval of FPF and all noteholders. Upon an event of default under the Note Purchase Agreement, each purchaser may accelerate its own LanzaJet Notes. Enforcement against the collateral securing the LanzaJet Notes requires the approval of certain holders as specified in the LanzaJet Notes. Under the LanzaJet Note Purchase Agreement, FPF has agreed to indemnify the noteholders for certain liabilities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mitsui Alliance Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;15, 2022, we entered into an amended and restated collaboration agreement with Mitsui which was further amended on March 24, 2022 and October 2, 2022 (as amended, the &#8220;Mitsui Alliance Agreement&#8221;). Under the Mitsui Alliance Agreement, Mitsui must use commercially reasonable efforts to promote our gasification, waste-to-</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ethanol and CarbonSmart technology and establish commercial facilities using this technology in Japan. In exchange, we agreed to exclusively promote and designate Mitsui as our preferred provider of investment and off-take services worldwide, as well as our preferred provider of engineering, procurement and construction services in Japan, subject to exceptions for certain of our existing commercial partnerships that allow us to recommend Brookfield as a provider of investment services in specified circumstances, including the Brookfield Framework Agreement. We and Mitsui agreed to share prospective customer information and to structure package offerings of our combined services through either a joint venture or royalty payment structure.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Mitsui Alliance Agreement, we may not recommend any alternative provider of the aforementioned services without the advance written consent of Mitsui. In addition, we agreed to provide Mitsui with the right to first offer its services to any customer who requires or requests these services. We must obtain written consent from Mitsui before soliciting customers or marketing or recommending our waste-to-ethanol technology in Japan.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Mitsui Alliance Agreement may be terminated by Mitsui without cause with three&#160;months&#8217; notice. The agreement may be terminated by us or Mitsui if the other party becomes insolvent or if the agreement is materially breached and the breaching party fails to cure within 30&#160;days after receiving notice of the breach. We and Mitsui have agreed to indemnify each other against certain third-party claims.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shougang Joint Venture</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Articles of Association of Beijing Shougang LanzaTech Technology Co., Ltd</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our subsidiary LanzaTech Hong Kong Limited, a limited liability company organized in Hong Kong, we hold approximately 9.3% of the outstanding shares of Beijing Shougang LanzaTech Technology Co., Ltd (the &#8220;Shougang Joint Venture&#8221;) as a result of our contribution of certain intellectual property rights (see &#8220; &#8212; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shougang Joint Venture License Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; below). Our rights and responsibilities as a holder of such shares are set forth in the Shougang Joint Venture&#8217;s Articles of Association,effective in November 2021. Because our shares were issued before an initial public offering of the Shougang Joint Venture, our shares may not be transferred within one&#160;year from the date on which the Shougang Joint Venture&#8217;s shares are publicly listed. The Shougang Joint Venture has an indefinite duration.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the general meeting of shareholders of the Shougang Joint Venture, shareholders have the authority to determine the Shougang Joint Venture&#8217;s business plan, elect and replace directors, increase or decrease the registered capital of the Shougang Joint Venture, amend the Shougang Joint Venture, dissolve the Shougang Joint Venture, and approve certain transactions, among other functions. As a holder of more than 3% of the shares of the Shougang Joint Venture, we have the right to submit proposals to the Shougang Joint Venture at general meetings.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise provided, and in accordance with accounting provisions of the Shougang Joint Venture, when a distribution of Shougang Joint Venture profits is approved, the Shougang Joint Venture&#8217;s after-tax profits are distributed in proportion to the shares held by shareholders. In the event of a liquidation, the Shougang Joint Venture&#8217;s property must be distributed in proportion to the shares held by shareholders after liquidation expenses, wages of employees, statutory compensation, owed tax and Shougang Joint Venture debts are paid. If we object to a resolution on merger and division of the Shougang Joint Venture, we can request the Shougang Joint Venture acquire our shares.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shougang Joint Venture Letter Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November&#160;3, 2021, LanzaTech Hong Kong Limited entered into a side letter of agreement (the &#8220;Shougang Joint Venture Letter Agreement&#8221;) with the Shougang Joint Venture and Mitsui. The Shougang Joint Venture Letter Agreement sets forth the parties&#8217; mutual understanding that if the Shougang Joint Venture decides not to pursue an initial public offering of its securities in China or if an initial public offering does not take place by the end of 2024, the Shougang Joint Venture will make commercially reasonable efforts and discuss in good faith with shareholders the possibility of restoring certain provisions from a previous version of the Shougang Joint Venture Articles, including provisions granting shareholders rights to financial records, board composition provisions, and provisions requiring unanimous consent of the board to make certain decisions.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shougang Joint Venture License Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;6, 2021, we entered into an Intellectual Property Rights License Agreement with the Shougang Joint Venture, which was subsequently amended in January&#160;2022 (as amended, the &#8220;Shougang Joint Venture License Agreement&#8221;). Under the Shougang Joint Venture License Agreement, we granted the Shougang Joint Venture a license to certain of our intellectual property rights, including certain patented fermentation processes, alcohol production processes, novel bacteria and trademarks. The license we granted to the Shougang Joint Venture is a non-transferable (except with our written consent), exclusive, sublicensable commercial license under the licensed subject matter, to utilize gas fermentation technology to produce ethanol and by-products at commercial facilities in China. The Shougang Joint Venture may sublicense its rights to third-party contractors acting on its behalf, subject to certain conditions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In consideration for the licenses we granted to the Shougang Joint Venture, the Shougang Joint Venture agreed to pay us a royalty on a graduated scale from 10% to 20% of all sublicensing revenues received by the Shougang Joint Venture in connection with the establishment and sublicensing of certain commercial facilities by the Shougang Joint Venture after the first commercial facility. As of the date of this prospectus, we have not received any royalty payments from the Shougang Joint Venture. Because our shareholding ratio in the Shougang Joint Venture has fallen below 10% due to a financing prior to the submission of an application by the Shougang Joint Venture for an initial public offering on a securities exchange in China, we have the right to request an adjustment to the royalty rates payable to us by the Shougang Joint Venture. This right will automatically terminate upon the submission of an application by the Shougang Joint Venture for an initial public offering on a securities exchange in China. If such application is subsequently terminated, our right to request an adjustment to the royalty rates will resume. The Shougang Joint Venture License Agreement provides that we will solely own all developed technology that results from, is based on, or uses the licensed subject matter in the operation of the Shougang Joint Venture, and all such technology will be subject to the license granted to the Shougang Joint Venture.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Shougang Joint Venture has a right to cooperate with third parties regarding any commercial license under the licensed subject matter, subject to certain conditions. We agreed not to enter into any agreement with any third party preventing the Shougang Joint Venture&#8217;s rights on the licensed subject matter in China. If the Shougang Joint Venture has not entered negotiations or signed an agreement with a third party for commencement of a project within a certain period of time, we will be free to engage with such third party ourselves.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon submission of an application by the Shougang Joint Venture for an initial public offering on a securities exchange in China, if we enter liquidation and as a result the Shougang Joint Venture License Agreement is terminated, the Shougang Joint Venture will be granted an option to call for an assignment of patents that are licensed pursuant to the agreement at that time, provided we first receive a written irrevocable, non-exclusive sublicense for the surviving term of such patents. If the Shougang Joint Venture&#8217;s application for an initial public offering is revoked or otherwise terminated, this call option will automatically become void. If the Shougang Joint Venture&#8217;s right to the licensed subject matter is prohibited or restricted by operation of United States export controls, the Shougang Joint Venture has the right to continue to use the licensed subject matter as provided in the agreement. In such event, so long as the Shougang Joint Venture&#8217;s continued use of the licensed subject matter complies with the agreement, we agreed not to initiate patent infringement claims against the Shougang Joint Venture.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Shougang Joint Venture License Agreement will continue until the earlier of (a)&#160;the date the final licensed intellectual property right expires or terminates, (b)&#160;the date the last commercial facility is permanently decommissioned and (c)&#160;termination of the agreement. The agreement will terminate automatically in the event that the Shougang Joint Venture dissolves or is liquidated, institutes or actively participates in any action, suit or proceeding to invalidate or limit the scope of the licensed subject matter, or breaches certain provisions of the agreement. We may terminate the Shougang Joint Venture License Agreement upon default by the Shougang Joint Venture if the Shougang Joint Venture does not remedy the default within 60&#160;days. We agreed to indemnify the Shougang Joint Venture, its affiliates and their current and former representatives from claims resulting from our material breach of the representations and warranties of the Shougang Joint Venture License Agreement. We have the first right to enforce and defend against infringement of the intellectual property licensed under the Shougang Joint Venture License Agreement and to recover any monetary compensation awarded in any litigation proceedings. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to do so, the Shougang Joint Venture may enforce and defend the licensed intellectual property against infringement.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Letter Agreement with Sinopec</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;12, 2021, we entered into a letter agreement with Sinopec and the Shougang Joint Venture (the &#8220;Sinopec Letter Agreement&#8221;). The parties to the Sinopec Letter Agreement agreed that the Shougang Joint Venture has exclusive rights to use our gas fermentation technology in commercial projects in China to produce fuel ethanol using steel mill and ferroalloy off-gas as described in the Shougang Joint Venture License Agreement. The Shougang Joint Venture agreed to notify Sinopec and us if it enters into a term sheet or equivalent preliminary agreement with respect to the use of our gas fermentation technology in commercial projects in China falling outside the scope of the Shougang Joint Venture License Agreement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sinopec and the Shougang Joint Venture have the right to cooperate with us on commercial projects outside the scope of the Shougang Joint Venture License Agreement and to provide technical and engineering services.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Grant&#160;Agreement&#160;with&#160;the&#160;European&#160;Climate,&#160;Infrastructure&#160;and&#160;Environment&#160;Executive&#160;Agency</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our subsidiary LanzaTech BV, on October 7, 2020, we entered into a Grant Agreement (the &#8220;CINEA Grant Agreement&#8221;) with the European Climate, Infrastructure and Environment Executive Agency (formerly the Innovation and Networks Executive Agency of the European Union) (&#8220;CINEA&#8221;), along with SkyNRG BV (&#8220;SkyNRG&#8221;), RSB Roundtable on Sustainable Biomaterials Assocation, E4tech (UK) Ltd and Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung E.V. The CINEA Grant Agreement provides for the award of a grant from CINEA to the parties to the CINEA Grant Agreement to fund the &#8220;Fuel via Low Carbon Integrated Technology from Ethanol&#8221; program, which we refer to as the FLITE program, to expand the supply of low carbon jet fuel in Europe by designing, building, and demonstrating an innovative ethanol-based ATJ technology in an ATJ Advanced Production Unit. Pursuant to the CINEA Grant Agreement, LanzaTech is responsible for plant design, construction and operations using ATJ technology. The CINEA Grant Agreement contemplates that FLITE will occur for a period of 48 months ending on November 30, 2024.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maximum grant amount under the CINEA Grant Agreement is EUR 20,000,000. The grant is applied to 100% of non-profit eligible costs and 70% of for-profit eligible costs. The estimated eligible costs of implementing the FLITE program are approximately EUR 54,500,000. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the CINEA Grant Agreement, we own any intellectual property generated as a result of our participation in the program. If we do not protect, exploit and disseminate such intellectual property rights, to the extent reasonable and possible, CINEA may assume ownership thereof.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The parties must compensate CINEA for any damage it sustains as a result of the parties&#8217; implementation of the FLITE program or because the FLITE program was not implemented in full compliance with the CINEA Grant Agreement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The participation of a party may be terminated by the coordinator of the CINEA Grant Agreement, designated as SkyNRG, upon request of the concerned party or on behalf of the other parties, subject to certain notice requirements and based upon reasons that must be approved by CINEA. CINEA may independently terminate the CINEA Grant Agreement or the participation of one or more parties in certain enumerated situations, including a party&#8217;s change in financial or organization situation likely to affect the program, substantial errors or serious breach of obligations under the agreement, systemic errors or fraud in other similar agreements, and force majeure.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreement may be amended by request of any of the parties subject to the procedural guidelines therein. The agreement may be terminated by the parties with cause, or without cause subject to a potential reduction of the grant amount.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Agreements with Sekisui Chemical Co.,&#160;Ltd.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Memorandum of Understanding with Sekisui</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;20, 2018 we entered into a Memorandum of Understanding with Sekisui with respect to the business of producing ethanol converted by microbes from syngas generated from municipal solid waste, industrial solid waste, and other waste materials (the &#8220;Sekisui MOU&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Sekisui MOU, we and Sekisui agreed to notify each other of any new projects or opportunities anywhere in the world relating to waste-to-ethanol production, to the extent legally permissible, and to inform relevant third parties of the other party&#8217;s intent to participate in such new projects. If Sekisui notifies us of a business project in Japan, we agreed not to grant or license our technology or provide media, microbes, or technical support to the project without Sekisui&#8217;s consent. Sekisui will manage developing and establishing appropriate structures related to the waste to ethanol production, collection of license fees, providing main and non-specialized technical support of operations, and media and microbe distribution following our manufacture thereof.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sekisui MOU expires on June&#160;20, 2028, at which point we and Sekisui must engage in good faith discussions on whether to extend the term. We also must engage in good faith discussions to determine whether the Sekisui MOU should be terminated or amended if there is a substantial change for either party relating to the performance of or responsibility for waste to ethanol production, including changes in control or ownership of either party.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sekisui Term Sheet</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;21, 2020, we entered into a term sheet with Sekisui (the &#8220;Sekisui Term Sheet&#8221;) in connection with the development of a waste-to-ethanol commercial facility. The Sekisui Term Sheet addresses the provision of engineering services by LanzaTech to the future operator of the commercial facility, and the granting of a license by LanzaTech to Sekisui for certain information, technology and intellectual property necessary to design, operate, and maintain the fermentation processes, microbes, and ethanol by-products of the commercial facility. The Sekisui Term Sheet governs the terms of operation of the first commercial facility and any future facilities contemplated under the Sekisui Memorandum, including with respect to performance targets and guarantees and engineering fees.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Sekisui Term Sheet, we are expected to provide, sell or distribute microbes and trace media for the operation of the commercial facility for a fixed fee, subject to mutually agreed price adjustments for future facilities. For any additional facility that is constructed in accordance with the terms of the Sekisui Memorandum, we would not provide trace media or microbes without Sekisui&#8217;s consent.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a certain date, the fixed fee arrangement is expected to end and we expect to charge our standard price for the microbes and trace media. At that point, Sekisui may choose which type of microbes and trace media it would like to purchase from us, and we must carry stock of the same microbes sold to Sekisui for at least one&#160;year from the last delivery. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The entity operating the commercial facility is required to pay to us and Sekisui a license fee consisting of a&#160;percentage of gross sales of all products which utilize our licensed subject matter. Our portion of the licensing fee is a single-digit percentage of gross sales of all products which utilize our licensed subject matter. As of the date of this prospectus, we have not received any payments under the Sekisui Term Sheet. The provisions of the Sekisui Term Sheet relating to the license and supply of media and microbes continue in effect as long as the commercial facility is operating. Once in effect, we may terminate the license for uncured material breach, if the licensee becomes insolvent, or if there is a change of control or assignment without our consent.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Grant Agreement between LanzaTech UK Limited and UK Secretary of State for Transport</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 12, 2022, LanzaTech UK Limited (&#8220;LanzaTech UK&#8221;), a wholly owned subsidiary of LanzaTech, was awarded a grant from the UK Authority in connection with Project DRAGON. The grant was awarded to fund LanzaTech UK&#8217;s front-end engineering design and associated project development activities for the UK Authority to achieve a final investment decision for a proposed facility in Port Talbot, South Wales, United Kingdom. The </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">proposed facility would use LanzaTech&#8217;s process technology to convert a variety of waste sources into waste-based low-carbon ethanol. This ethanol would then be converted to SAF and diesel fuel using LanzaJet's ATJ technology.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the grant agreement between LanzaTech UK and the UK Authority (the &#8220;DRAGON Grant Agreement&#8221;), the UK Authority agreed to provide to LanzaTech UK up to &#163;24,961,000 upon the achievement of certain milestones related to Project DRAGON. In return, LanzaTech UK agreed to provide regular progress reports, audit reports, and documentation of its expenses to the UK Authority. In the event that LanzaTech UK defaults on its obligations under the DRAGON Grant Agreement, the UK Authority may suspend payments under the agreement, reduce the amount of the grant, require LanzaTech UK to repay amounts paid under the grant with interest, or terminate the agreement. All intellectual property rights owned by each of the parties prior to the date of the DRAGON Grant Agreement or developed by either party during the period of the grant will remain the property of such party. However, any intellectual property rights developed in the course of the activities funded by the grant and included in LanzaTech&#8217;s periodic progress reports to the UK Authority will belong to the UK Authority.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Either party may terminate the DRAGON Grant Agreement for convenience upon 28 days&#8217; written notice. Upon termination of the DRAGON Grant Agreement, LanzaTech UK must return any unspent funds issued under the grant and promptly prepare a plan to terminate funded activities. If the UK Authority terminates the agreement for convenience, it will be obligated to pay to LanzaTech UK a reasonable amount in respect of any activities completed in furtherance of Project DRAGON at the time of termination, but will not be liable for any expenses related to any transfer or termination of any of LanzaTech UK&#8217;s employees engaged in activities related to Project DRAGON. The period for which the grant is awarded expires on March 31, 2025.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech UK has agreed to indemnify and hold harmless the UK Authority and its representatives with respect to all actions, claims, charges, demands, losses and/or proceedings arising from or incurred by reason of the actions or omissions of LanzaTech UK in connection with Project DRAGON. To the extent permitted under applicable law, the UK Authority&#8217;s liability to LanzaTech UK under the DRAGON Grant Agreement will be limited to its obligation to make payment of grant funds when due and payable.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Agreements with Brookfield</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Brookfield Framework Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;2, 2022 we entered into a framework agreement with BGTF LT Aggregator LP, an affiliate of Brookfield Asset Management Inc. (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Brookfield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and such agreement, the &#8220;Brookfield Framework Agreement&#8221;). Under the Brookfield Framework Agreement, we agreed to exclusively offer Brookfield the opportunity to acquire or invest in certain projects to construct commercial production facilities employing CCT technology in the U.S., the European Union, the United Kingdom, Canada or Mexico for which we are solely or jointly responsible for obtaining or providing equity financing, subject to certain exceptions. We agreed to present Brookfield with projects that over the term of the agreement require equity funding of at least $500,000,000 in the aggregate. With respect to projects acquired by Brookfield, we are entitled to a&#160;percentage of free cash flow generated by such projects determined in accordance with a hurdle-based return waterfall. Brookfield has no obligation under the Brookfield Framework Agreement to invest in any of the projects. Additionally, we agreed to recommend Brookfield to customers that, in our reasonable judgment, are likely to need third-party funding to develop, construct and own projects subject to the Brookfield Framework Agreement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Brookfield&#8217;s exclusivity will terminate upon the earliest of (a)&#160;the aggregate equity funding by Brookfield in projects acquired by Brookfield of at least $500,000,000, along with Brookfield&#8217;s written notice that it will no longer maintain access to at least $500,000,000 to fund new projects, (b)&#160;Brookfield&#8217;s rejection of a specified number of projects that otherwise meet certain criteria over a specified time period, and (c)&#160;October&#160;2, 2027, which is the date the Brookfield Framework Agreement is set to terminate. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Brookfield SAFE</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;2, 2022, concurrently with entry into the Brookfield Framework Agreement, we entered into a Simple Agreement for Future Equity with Brookfield (the &#8220;Brookfield SAFE&#8221;). Under the Brookfield SAFE, we agreed to issue to Brookfield the right to certain shares of Legacy LanzaTech&#8217;s capital stock, in exchange for the </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">payment of $50,000,000 (the &#8220;Initial Purchase Amount&#8221;). Following the completion of the Business Combination, Brookfield may, at any time at its option, convert all or a portion of the Initial Purchase Amount less any amount that has already been converted or repaid (the &#8220;Purchase Amount&#8221;) into shares of the common stock. The number of shares into which the Purchase Amount and the Non-Repayable Amount (as defined below) are convertible is determined by dividing such amount by the price per share paid by the PIPE Investors ($10.00).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On the fifth anniversary of the Brookfield SAFE, we will repay in cash any remaining unconverted portion of the Initial Purchase Amount (the &#8220;Remaining Amount&#8221;), plus interest in the high single digits, compounded annually. For each $50,000,000 of aggregate equity funding required for qualifying projects acquired by Brookfield in accordance with the Brookfield Framework Agreement, the Remaining Amount would be reduced by $5,000,000 (such reduction, the &#8220;Non-Repayable Amount&#8221;). Equity funding for any one or more projects in excess of $50,000,000 in the aggregate will be counted towards the next $50,000,000 of equity funding required for qualifying projects. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be required to repay the Brookfield SAFE prior to the fifth anniversary if upon a conversion event, if we take certain actions that would cause us to be unable to satisfy our obligations under the Brookfield SAFE, including failure to provide for certain rights to Brookfield in an Equity Financing or taking any action that would reasonably be expected to cause the fair market value of LanzaTech to fall below $200,000,000. LanzaTech, Inc. provided a guarantee for LanzaTech to repay its obligations under the Brookfield SAFE, including any expenses incurred by Brookfield in enforcing or exercising its rights under such guarantee.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the case of a liquidation or dissolution of LanzaTech, Brookfield would be entitled to receive a portion of the proceeds equal to the Purchase Amount plus interest in the high single digits, compounded annually, and such right would be on par with unsecured indebtedness of LanzaTech, and rank senior to any outstanding common stock, preferred stock and other SAFEs. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Brookfield SAFE will automatically terminate following the earliest occurrence of (A)&#160;the Initial Purchase Amount having been fully repaid and/or converted and (B)&#160;the payment of amounts due to Brookfield in the event of a liquidation or dissolution of LanzaTech. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Brookfield Cooperation Letter Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;2, 2022, in connection with our entry into the Brookfield Framework Agreement, we entered into a letter agreement with Suncor and Brookfield (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Brookfield Cooperation Letter Agreement&#8221;). Under the Brookfield Cooperation Letter Agreement, we agreed to simultaneously notify Suncor upon the submission of any notice to Brookfield that a project is construction-ready under the Brookfield Framework Agreement for any equity investment opportunity in Canada or Colorado. For any of such investment opportunities Brookfield pursues, Brookfield has agreed under the Brookfield Cooperation Letter Agreement to grant Suncor the right to invest up to a certain percentage that lies between 15 &#8211; 25% of the required equity capital on economic terms at least as favorable as those granted to Brookfield and any other third-party investors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Brookfield Cooperation Letter Agreement, Suncor agreed to notify Brookfield of any projects using our technology that Suncor establishes which require equity capital from a third-party. Suncor has also agreed to consider any investment proposal presented to it by Brookfield pursuant to such notification prior to the execution of agreements with other third parties.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Letter Agreement with IndianOil</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December&#160;4, 2017, we entered into a letter of agreement (the &#8220;IndianOil Letter Agreement&#8221;) with IndianOil. The IndianOil Letter Agreement sets forth a framework for the development of a plant utilizing our technology to produce ethanol from waste gas at IndianOil&#8217;s Panipat refinery in Haryana, India, as well as terms for future agreements for the development of additional plants by IndianOil or other third parties. In connection with the IndianOil Letter Agreement, we licensed to IndianOil certain technology used to produce ethanol from waste gas in exchange for royalties in the range of $13 to $14 per metric ton of ethanol, net of any applicable tax, by the first plant. For each additional plant developed by IndianOil, IndianOil has agreed to a royalty between $28 and $31 per metric ton of ethanol for a period of five years or alternatively, a lump sum license fee of $8 million for an ethanol </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unit with a capacity of 40,000 metric tons per year, or on a proportionate basis predicated on the actual size of the future unit. As of the date of this prospectus, we have not received any royalty or lump sum license fees under the IndianOil Letter Agreement. IndianOil agreed to purchase design and engineering services, proprietary microbes and trace media mix from us to facilitate the construction and operation of the first IndianOil plant. Additionally, we agreed to provide IndianOil with terms for commercial deployment of our waste gas to ethanol process that are at least as favorable as those that we may grant to third parties (other than parties in which we have ownership or co-development projects we may undertake with third parties) in addition to an exclusivity period during which we have agreed to engage IndianOil as our engineering partner for commercial plants developed by third parties using the oil refinery technology we licensed to IndianOil. The IndianOil Letter Agreement terminates on December&#160;4,&#160;2027, unless earlier terminated by mutual agreement.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Suncor License Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;6, 2020, we entered into a Master Licensing Agreement with Suncor, which was amended and supplemented on October 2, 2022 by the Brookfield Cooperation Letter Agreement (as amended, the &#8220;Suncor License Agreement&#8221;). Pursuant to the Suncor License Agreement we granted Suncor a worldwide, non-exclusive, license to certain of our intellectual property related to our gas fermentation technology, which is sub-licensable only to joint ventures affiliated with Suncor and transferable only with our consent.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This license is conditional on Suncor&#8217;s fulfillment of certain obligations including the provision of financing, engineering, and other project support services reasonably required for us to accomplish certain developmental and funding targets. Suncor paid us an initial license fee of $5 million Canadian and has agreed to pay us a royalty of up to 10% of net revenue from excess ethanol produced at the first four commercial facilities developed under our joint development plans with Suncor above a certain daily quota and on all ethanol produced at additional facilities developed under our joint development plans with Suncor. Alternatively, Suncor may pay a one-time royalty fee for any licensed facility, which would be calculated based on the potential capacity of such facility. As of the date of this prospectus, we have not received any royalty payments under the Suncor License Agreement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Suncor License Agreement, we granted most favored customer pricing to Suncor with regard to our engineering services, supply of equipment and microbes, and royalties from commercial facilities. Additionally, we granted Suncor a right of first refusal with regard to any investment in or off-take from any future commercial gas fermentation plants in Canada and Colorado, other than investment opportunities offered to Brookfield or its affiliates under the Brookfield Framework Agreement which would be subject to the provisions of the Brookfield Framework Agreement described above.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Suncor License Agreement may be terminated by agreement of both parties if either party becomes insolvent, commits a material breach and fails to remedy such breach within a certain timeframe or if no commercial facilities have been completed under our joint development plans by 2031. We may terminate the agreement if Suncor fails to make required payments under the Suncor License Agreement. Suncor may terminate the agreement for convenience upon 90&#160;days&#8217; notice.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Regulation</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Environmental Regulation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business and the businesses of the customers who license our technology are subject to various international, national, and regional laws and regulations relating to the production of renewable fuels, the protection of the environment and in support of the ethanol industry at large. These laws, their underlying regulatory requirements, and their enforcement, some of which are described below, impact our existing and potential business operations by imposing restrictions on our, our customers&#8217; and our partners&#8217;:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">existing and proposed business operations or the need to install enhanced or additional pollution controls&#894;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">need to obtain and comply with permits and authorizations&#894;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">liability for exceeding applicable permit limits or legal requirements&#894; and</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">specifications related to the ethanol we market and produce.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GHG emissions are subject to environmental laws and regulations in the various jurisdictions in which we and our customers have operations. In the normal course of business, we and our customers and partners may be involved in legal proceedings under the Comprehensive Environmental Response, Compensation, and Liability Act, the Resource Conservation and Recovery Act, and similar environmental laws across the globe relating to the designation of certain sites for investigation or remediation with respect to environmental risks.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our and our customers&#8217; operations are within jurisdictions that have or are developing regulatory regimes governing emissions of GHGs, including CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. These include existing coverage under the European Union Emission Trading System, the California cap and trade scheme, India&#8217;s Performance, Achieve and Trade scheme, South Africa&#8217;s Trade Exposure and Greenhouse Gas Benchmark Regulations, the Tokyo Cap-and-Trade Program, China&#8217;s Emission Trading Scheme and any potential expansions of these policies or related policies. In addition, the EPA requires mandatory reporting of GHG emissions and is regulating GHG emissions for new construction and major modifications to existing facilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increased public concern surrounding the emission of GHGs may result in more international, national, or regional requirements to reduce or mitigate the effects of GHG emissions. While carbon reduction legislation will support the business case for implementing carbon capture technology, we cannot predict the manner or extent to which such legislation may affect our customers and partners and ultimately help or harm our business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business could be affected in the future by additional international, national, and regional regulation, pricing of GHG emissions or other climate change legislation, regulation, or agreements. It is difficult at this time to estimate the likelihood of passage, or predict the potential impact, of any additional legislation, regulations or agreements. Potential consequences of new obligations could include increased technology, transportation, material, and administrative costs and may require us to make additional investments in our operations. As we continue distributing our technology to our target markets, international, national, or regional government entities may seek to impose regulations or competitors may seek to influence regulations through lobbying efforts. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fuel Ethanol Regulation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are various governmental programs and policies across the world that affect the supply and demand for ethanol and to which a significant&#160;percentage of our customers and partners are sensitive. For instance, in the United States, the federal government mandates the use of a certain amount of renewable fuels under the Renewable Fuel Standard II, or RFS II, and the Environmental Protection Agency has the authority to take measures with respect to RFS II that can have the effect of increasing or decreasing the overall volume of ethanol in the U.S. Currently, LanzaTech-derived ethanol from industrial emissions does not qualify as a Renewable Identification Number generating fuel under the US RFS II program. Furthermore, the recent United States-Mexico-Canada Agreement maintains the duty-free access of U.S. agricultural commodities, including ethanol, into Canada and Mexico and may have the effect of increasing the trading volume of ethanol throughout North America more broadly. Comparable international, U.S. federal and state regulatory and trading policies will affect the supply of ethanol for potential customers and partners within our target markets.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Chemical Regulation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are important regulatory issues related to approval of chemicals from new pathways and approvals for import and use of genetically modified microorganisms (&#8220;GMM&#8221;). While specific requirements differ by jurisdiction, there are common elements across countries and regions such as chemical safety in production and end-use; required testing and data; process characterization; and following proper notification procedures. While chemically identical to existing and regulated chemicals, governments often require similar approval processes for new production routes such as those prescribed by the US Toxic Substances Control Act and the EU Registration, Evaluation, Authorisation and Restriction of Chemicals program. Further, the import and use of GMM such as biocatalysts in chemical production is governed by many of these same, as well as additional, laws and regulations. So far, we have received approximately 20 approvals or exemptions for use of our biocatalysts in the USA, China, India, Canada, Austria, Belgium, and Japan. As each jurisdiction has their own unique requirements for approval, our overall strategy for approval has included the use of external experts and consultants to accelerate our approval </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">processes. Chemicals from new pathways is still an emerging area in legislation, where regulations are evolving to align with global best practices.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our People&#160;&amp; Culture</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech is a woman-led company. The core of who we are is based on a strong foundation of values. All team members are trained on how these fit into our day-to-day operations with our teammates and customers.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, we had over 365 full-time equivalent employees working for LanzaTech in the United States, China, India, the United Kingdom, the European Union and New Zealand. None of our employees has engaged in any labor strikes. We have no collective bargaining agreements with our employees. We consider our relationship with our employees to be positive and have not experienced any major labor disputes.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Facilities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech&#8217;s global headquarters and R&amp;D center are co-located at the Illinois Science + Technology Park research campus in Skokie, Illinois. The facility houses LanzaTech&#8217;s state-of-the-art laboratories dedicated to synthetic biology, product synthesis, and analytics. In addition to its R&amp;D center, the LanzaTech&#160;Freedom Pines Biorefinery located&#160;in Soperton, Georgia&#160;is&#160;used&#160;for scaling up&#160;and production. The site includes multiple &gt;100 L gas fermentation systems emulating commercial designs and supporting laboratory facilities and is also the site of LanzaTech&#8217;s scale up of the&#160;ATJ&#160;process.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_1723"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MANAGEMENT</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth certain information regarding our executive officers and directors as of the date of this prospectus. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.868%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Age</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Position(s)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Executive Officers:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jennifer Holmgren, Ph.D.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Geoff Trukenbrod</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Steven Stanley, Ph.D.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Commercial Officer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carl Wolf</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Operating Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Freya Burton</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Sustainability Officer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joseph Blasko</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General Counsel</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Julie Zarraga</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Engineering</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Johanna Haggstrom, Ph. D.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Chemicals &amp; Hydrocarbon Fuels Technology</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Robert Conrado, Ph.D.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Engineering Design and Development</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Non-Employee Directors:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barbara Byrne</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nigel Gormly</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dorri McWhorter</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jim Messina</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nimesh Patel</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gary Rieschel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Member of the audit committee. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) Member of the nominating and governance committee. </span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3) Member of the compensation committee. </span></div><div style="margin-bottom:9pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Officers</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Jennifer Holmgren, Ph.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our Chief Executive Officer and as a director since the Business Combination, and previously served as Chief Executive Officer and as a director of Legacy LanzaTech from 2010 until the Business Combination. Previously, she served as Vice President and General Manager of the Renewable Energy and Chemicals business unit at UOP LLC, a Honeywell Company, where she held various commercial and technical leadership positions from 1987-2010. In 2003, she was the first woman awarded the Malcolm E. Pruitt Award from the Council for Chemical Research (CCR). In 2010, she was the recipient of the Leadership Award from the Commercial Aviation Alternative Fuels Initiative (CAAFI) for her work in establishing the technical and commercial viability of sustainable aviation biofuels. In 2015, Dr.&#160;Holmgren and her team at LanzaTech were awarded the U.S. Environmental Protection Agency Presidential Green Chemistry Award, and Dr.&#160;Holmgren was awarded the BIO Rosalind Franklin Award for Leadership in Industrial Biotechnology. Sustainability magazine, Salt, named Dr.&#160;Holmgren as the world&#8217;s most compassionate businesswoman in 2015. In October&#160;2015, Dr.&#160;Holmgren was awarded the Outstanding Leader Award in Corporate Social Innovation from the YWCA Metropolitan Chicago. The Digest named Dr.&#160;Holmgren #1 of the 100 most influential leaders in the Bioeconomy in 2017 and awarded her the Global Bioenergy Leadership Award in 2018 and the 2020 William C. Holmberg Award for Lifetime Achievement in the Advanced Bioeconomy. Dr.&#160;Holmgren was also the 2018 recipient of the AIChE Fuels&#160;&amp; Petrochemicals Division Award. In 2021, she received the Edison Achievement Award for making a significant and lasting contribution to the world of innovation, and the Prix Voltaire Award, awarded by the Prix Voltaire International Foundation, which award is based on the 17 sustainable development goals initiated by the United Nations. In 2022, she was included in ICIS&#8217;s Top 40 Power Players ranking. Dr.&#160;Holmgren has an honorary doctorate from Delft University of Technology. Dr.&#160;Holmgren is the author or co-author of 50 U.S. patents and more than 30 scientific publications and is a member of the National Academy of Engineering. She is on the Governing </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Council for the Bio Energy Research Institute in India, which was established by the Department of Biotechnology, Indian Government, and IndianOil Corporation. Dr.&#160;Holmgren also sits on the Advisory Council for the Andlinger Center for Energy and the Environment at Princeton University, the Halliburton Labs Advisory Board, the Universiti Teknologi PETRONAS International Advisory Council, and the Founder Advisory for The Engine, a venture capital fund built by MIT that invests in early-stage science and engineering companies. Dr.&#160;Holmgren holds a Ph.D. from the University of Illinois at Urbana-Champaign in Inorganic Materials Synthesis, an M.B.A. from the Booth School of Business at the University of Chicago and a B.Sc. from Harvey Mudd College in Chemistry.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that Dr.&#160;Holmgren is qualified to serve as a director based on her extensive industry experience and her status as an internationally recognized expert in the development and commercialization of fuels and chemical technologies in the energy sector.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Geoff Trukenbrod</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our Chief Financial Officer since the Business Combination, and previously served as Chief Financial Officer of Legacy LanzaTech from August&#160;2020 until the Business Combination. Mr.&#160;Trukenbrod has over 25&#160;years of experience building and leading companies through rapid expansions, turnarounds, and exits as an operating executive, equity and debt investor, and director. He led finance and corporate development for multiple venture and private equity backed businesses in the analytics, biotech, financial services, and social impact industries, including as the Interim Chief Financial Officer and Strategic Advisor for Pangea, a financial technology company, earlier in 2020; Chief Financial and Chief Operating Officer of Aginity, a data analytics software company, from 2017 to 2020; Chief Capital Officer and Co-Founder of social impact technology and capital advisory company Timshel from 2013 to 2016; and Chief Financial and Budget Officer for President Barack Obama&#8217;s 2012 re-election campaign. Mr.&#160;Trukenbrod holds an M.B.A. with Honors from the Booth School of Business at the University of Chicago and a B.A. from Hamilton College.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Steven Stanley, Ph.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our Chief Commercial Officer since the Business Combination, and previously served as Chief Commercial Officer of Legacy LanzaTech from May 2022 until the Business Combination. He has more than 30 years of technical and business experience in the global petrochemicals industry, having successfully conducted business in nearly 50 countries and maintaining profit and loss responsibility for eight global businesses. After beginning his career as a research engineer at Shell Chemical Company in Houston, Texas, Dr. Stanley joined Union Carbide Corporation as Product Manager of UNIPOL&#8482; PP Catalysts. Dr. Stanley was later appointed Business Manager of UNIPOL&#8482; Polyethylene and PP Catalysts and relocated to Union Carbide&#8217;s headquarters in Danbury, Connecticut. In 2001, Dr. Stanley became Senior Business Director of UNIPOL&#8482; PP Licensing &amp; Catalyst for The Dow Chemical Company upon their acquisition of Union Carbide. In 2005, Dr. Stanley was appointed Global Business Director of Dow Performance Fluids, Epoxy &amp; Specialty Chemicals business group, leading a portfolio of six global businesses. Dr. Stanley was subsequently recruited by Dow leadership to become Vice President, Commercial of Univation Technologies LLC, a global UNIPOL&#8482; PE process technology licensing and catalyst joint venture company between Dow and ExxonMobil Chemical in Houston, Texas. He served from January 2015 to December 2021 as President of Univation Technologies and thereafter as a consultant in the polymers and petrochemical industry until he joined LanzaTech. Dr. Stanley holds a Ph.D. in Chemical Engineering from the University of Houston and a B.S. in Chemical Engineering from the University of Minnesota.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Carl Wolf </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has served as our Chief Operating Officer since the Business Combination, and previously served as Chief Operating Officer of Legacy LanzaTech from June 2022 until the Business Combination. From 2011 through June 2022 Mr. Wolf held numerous positions at Legacy LanzaTech including in operations, government relations, and business development and strategy. Before joining LanzaTech, Mr. Wolf was a consultant at BCS LLC where he worked with environmental and energy sector clients, including the U.S. Department of Energy. Mr. Wolf holds an M.B.A. from The Kellogg School of Management at Northwestern University, an M.Sc. from the New York Institute of Technology and a B.A. from the University of Maryland-Baltimore County.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Freya Burton</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our Chief Sustainability Officer since the Business Combination, and previously served as Chief Sustainability Officer of Legacy LanzaTech since 2016. Ms.&#160;Burton served in various other roles at Legacy LanzaTech from 2007 through 2016, including roles in communications, government relations, human resources and research and development. Ms.&#160;Burton holds an M.A. from Corpus Christi College at the University of Cambridge.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joseph Blasko </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has served as our General Counsel and Corporate Secretary since the Business Combination, and previously served as General Counsel and Corporate Secretary of Legacy LanzaTech since January 2023. From 2011 through 2022, Mr. Blasko led the global legal and compliance department at James Hardie Industries plc, an Irish-domiciled, NYSE/ASX-listed global building materials company. Prior to joining James Hardie Industries, Mr. Blasko served as General Counsel of Liebert Corporation, a wholly-owned subsidiary of industrial conglomerate Emerson Electric Co., held senior roles within the legal department at The Scotts Miracle-Gro Company and practiced law at Vorys Sater Seymour and Pease LLP, with a broad focus on regulatory, commercial and products liability litigation. Mr. Blasko holds a B.S.F.S. from The Walsh School of Foreign Service at Georgetown University and a J.D. from the Case Western Reserve School of Law.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Julie Zarraga</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as Executive Vice President of Engineering at LanzaTech since the Business Combination, and previously served as Legacy LanzaTech&#8217;s Executive Vice President of Engineering since September 2022 until the Business Combination and as Vice President of Engineering from 2015 until September 2022. Previously, she held various leadership roles at Merichem Gas Technologies, including Director of Process Technology. Ms.&#160;Zarraga started her career at UOP LLC, a Honeywell Company, where she spent nearly 20&#160;years focused on engineering, project management, construction, commissioning, startup and testing of commercial plants globally. Ms.&#160;Zarraga holds a B.S. in Chemical Engineering from Northwestern University.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Robert Conrado, Ph.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as Vice President of Engineering Design and Development at LanzaTech since the Business Combination, and previously served as Legacy LanzaTech&#8217;s Vice President of Engineering Design and Development from October&#160;2018 until the Business Combination. Dr.&#160;Conrado has held various engineering leadership roles at LanzaTech since joining the company in 2013, serving as Director of Engineering Design and Development from 2016 to October&#160;2018 and Manager of Engineering Design and Development from 2015 to 2016. Prior to his tenure at Legacy LanzaTech, Dr.&#160;Conrado was a founding Senior Fellow at the Advanced Research Projects Agency&#160;&#8212; Energy (ARPA-E) within the U.S. Department of Energy. Dr.&#160;Conrado holds a Ph.D. from Cornell University in Chemical and Biomolecular Engineering and a B.E. from Dartmouth College in Biochemical Engineering.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Johanna Haggstrom, Ph.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as Vice President, Chemicals &amp; Hydrocarbon Fuels Technology at LanzaTech since the Business Combination, and previously served as Legacy LanzaTech&#8217;s Vice President, Chemicals &amp; Hydrocarbon Fuels Technology from 2020 until the Business Combination. In this role, she leads LanzaTech&#8217;s research and development efforts and is responsible for chemical and fuels technology products, processes, measurements and tools, project management, quality, budget, and organizational development. In May 2022 she became responsible for the LanzaTech Freedom Pines Biorefinery, including the scale-up of technologies and LanzaTech biomanufacturing. Prior to joining LanzaTech, Dr. Haggstrom spent more than 12 years in the energy industry at Halliburton Co., including most recently as a Director of Technology. Dr. Haggstrom holds a B.S. in chemical engineering from M&#228;lardalen University in Sweden and a Ph.D. in chemistry from Kansas State University.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Employee Directors</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Barbara Byrne</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as a director of LanzaTech since the Business Combination. Ms. Byrne is the former Vice Chairman, Investment Banking at Barclays PLC, where she worked until 2018. During her more than 35 years of financial services experience, Ms. Byrne served as team leader for some of Barclays' most important multinational corporate clients and was the primary architect of several of Barclays' marquee transactions. She is a member of various industry councils and participates as a forum leader on strategic issues and trends facing the financial services sector and global markets. Ms. Byrne has served as a director of Paramount Global since 2018, and as a director of Hennessy Capital Investment Corp. V, Slam Corp. and PowerSchool, Inc. since 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Byrne holds a B.A. in Economics from Mount Holyoke College. We believe that Ms. Byrne is qualified to serve as a director based on her extensive experience in the investment banking industry and her business and financial expertise.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nigel Gormly</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as a director of LanzaTech since the Business Combination and previously served as a director of Legacy LanzaTech from 2014 until the Business Combination. Mr. Gormly has served as the Founder </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Director of Waihou Capital since 2019. Since 2020, he has also served as Chief Investment Officer of Toha Foundry, a fin-tech company creating a global marketplace with climate and environmental impact at its heart to enable the true value of impact to be recognized and traded in the market, enabling impact investment to be unleashed at scale. Mr. Gormly previously served as Head of International Direct Investment for the New Zealand Superannuation Fund, New Zealand&#8217;s sovereign wealth fund, from 2013 to 2019, where he was primarily responsible for the Fund&#8217;s direct investments in energy, infrastructure and expansion capital as well as leading the Fund&#8217;s collaboration efforts with global investment partners. Prior to joining the Super Fund, Mr. Gormly spent 10 years with Fonterra, where he held a number of strategic development and commercial leadership roles, most recently as General Manager of Commercial Ventures. Mr. Gormly&#8217;s early career was focused on M&amp;A and corporate finance advisory based in London, with assignments throughout Asia, Latin America and Europe. He has also served on the board of View, Inc. (Nasdaq: VIEW) since 2015. A Chartered Financial Analyst, Mr. Gormly holds a Graduate Diploma in Finance, and a B.Sc. and a B.Com. from the University of Auckland.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that Mr.&#160;Gormly is qualified to serve as a director based on his extensive experience in the venture capital and investment banking industries. Mr. Gormly was nominated as a director on the board of directors of Legacy LanzaTech by New Zealand Superannuation Fund.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dorri McWhorter</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as a director of LanzaTech since the Business Combination. Ms. McWhorter has served as the President and Chief Executive Officer of YMCA of Metropolitan Chicago since 2021. From 2011 to 2021, Ms. McWhorter served as the chief executive officer of YWCA of Metropolitan Chicago. Prior to joining the YWCA, she was a partner at Crowe Horwath, LLP, and also held senior positions with Snap-on Incorporated and Booz Allen Hamilton. Ms. McWhorter is a former licensed certified public accountant and currently sits on the Financial Accounting Standards Advisory Council. Ms. McWhorter has served as a director of Lifeway Foods, Inc. since 2020, and also serves on the boards of William Blair Funds and Skyway Concession Company.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. McWhorter holds a Bachelor of Business Administration degree from the University of Wisconsin- Madison, an M.B.A. from Northwestern University's Kellogg School of Management, and an honorary Doctor of Humane Letters from Lake Forest College. We believe that Ms. McWhorter is qualified to serve as a director based on her experience as a chief executive officer and her business and financial expertise.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Jim Messina </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has served as a director of LanzaTech since the Business Combination and previously served as a director of Legacy LanzaTech from 2013 until the Business Combination. Mr. Messina has served as the President and CEO of The Messina Group, a strategic consulting firm specializing in advising political leaders, corporations, and advocacy organizations, since 2013. Jim Messina has served as a director of Ontrak, Inc. since August 2022. Previously, Mr. Messina served as White House Deputy Chief of Staff to President Barack Obama from 2009 to 2011 and was Campaign Manager for President Obama&#8217;s 2012 re-election campaign. Previously, Mr. Messina served as Chief of Staff for various Senate and House offices on Capitol Hill where he worked to pass key legislation. Mr. Messina serves on the boards of several private companies including Blockchain.com, Fortera, Vectra.ai, the United States Soccer Foundation, and the Montana Land Reliance. Mr. Messina is a graduate of the University of Montana where he earned a B.A. in political science and journalism.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that Mr.&#160;Messina is qualified to serve as a director based on his corporate advisory expertise and his extensive experience in executive management.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nimesh Patel </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has served as a director of LanzaTech since January 2021, and previously served as AMCI&#8217;s Chief Executive Officer from January&#160;2021 until the Business Combination. Mr.&#160;Patel is a Managing Director, Co-head of Investments and a member of the Investment Committee for AMCI Group. Mr.&#160;Patel has served as a key member of AMCI&#8217;s senior management team since January&#160;2008 and has helped lead the investment business for AMCI. Mr.&#160;Patel was an officer of AMCI Acquisition Corp., a SPAC that successfully completed a business combination with Advent Technologies,&#160;Inc. in February&#160;2021. Mr.&#160;Patel has served on the Boards of Directors or represented AMCI&#8217;s equity interests in eight companies during his time at AMCI and has served on the Board of Directors for Conuma Resources Ltd since April&#160;2017. Prior to joining AMCI, Mr.&#160;Patel was with Great Hill Partners where he focused on private equity investments in technology-enabled services companies. Previously Mr.&#160;Patel was with ChrysCapital, where he focused on private equity investments in the technology-enabled services, business process outsourcing and renewable energy sectors. Mr.&#160;Patel graduated cum laude from Princeton </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">University with an A.B. in Economics and with an M.B.A. from the Wharton School of the University of Pennsylvania.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that Mr.&#160;Patel is qualified to serve as a director because of his depth of experience in the investment sector.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gary Rieschel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as a director of LanzaTech since the Business Combination, and previously served as a director of Legacy LanzaTech from 2010 until the Business Combination. Mr. Rieschel has served as the Founder and Managing Partner of Qiming Venture Partners since 2005, when he founded the venture capital firm. Qiming Venture Partners primarily invests in the technology and consumer and healthcare industries, and has over $9 billion in assets under management. Prior to founding Qiming Venture Partners, Mr. Rieschel was a senior executive at Intel, Sequent Computer, Cisco Systems, and Softbank Corporation. Mr. Rieschel has in total 27 years of experience as a venture capital investor.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Rieschel holds a B.A. in Biology from Reed College and an M.B.A. from Harvard Business School. We believe that Mr. Rieschel is qualified to serve as a director based on his business experience and 27 years of experience in the venture capital industry. Mr. Rieschel was nominated as a director on the board of directors of Legacy LanzaTech by Qiming Venture Partners.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Composition</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LanzaTech Board directs the management of LanzaTech&#8217;s business and affairs, as provided by Delaware law, and conducts its business through meetings of the Board and its standing committees. The LanzaTech Board consists of seven members. Dr. Holmgren serves as chair of the Board. The primary responsibilities of the Board are to provide risk oversight and strategic guidance to LanzaTech and to counsel and direct LanzaTech&#8217;s management. The Board meets on a regular basis and will convene additional meetings, as required.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LanzaTech Board is divided into three classes, with only one class of directors being elected in each year and each class serving a three-year term. Nigel Gormly, Jennifer Holmgren and Nimesh Patel are currently Class I drectors; Barbara Byrne and Gary Rieschel are currently Class II directors; and Jim Messina and Dorri McWhorter are currently Class III directors. Each Class I director has a term that expires at LanzaTech&#8217;s 2024 annual meeting of stockholders, each Class II director has a term that expires at LanzaTech&#8217;s 2025 annual meeting of stockholders, and each Class III director has a term that expires at LanzaTech&#8217;s 2026 annual meeting of stockholders, or in each case until their respective successors are duly elected and qualified, or until their earlier resignation, removal or death.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Independence of Directors</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech adheres to the rules of Nasdaq in determining whether a director is independent. The Nasdaq listing standards generally define an &#8220;independent director&#8221; as a person who is not an executive officer or employee, or who does not have a relationship which, in the opinion of the company&#8217;s board of directors, would interfere with the exercise of independent judgment in carrying out his or her responsibilities as a director. Our board of directors has determined that Nigel Gormly, Barbara Byrne, Jim Messina, Dorri McWhorter and Gary Rieschel are independent directors of LanzaTech. LanzaTech&#8217;s independent directors have regularly scheduled meetings at which only independent directors are present. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The board recognizes the importance of appointing a strong lead independent director to maintain a counterbalancing structure to ensure the board functions in an appropriately independent manner.  Jim Messina serves as our lead independent director.  Our lead independent director&#8217;s responsibilities include, among other things:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">presiding at all meetings of the board in the absence of, or upon the request of, the Chairperson of the board;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lead regular executive sessions of the independent members of the board;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">call special meetings of the New LanzaTech Board as necessary to address important or urgent LanzaTech issues;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">call meetings of the non-employee or independent members of the board, with appropriate notice;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">advise the Nominating and Governance Committee and the Chairperson of the board on the membership of the various board committees and the selection of committee chairpersons;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">serve as principal liaison between the non-employee and independent members of the board, as a group, the Chief Executive Officer of New LanzaTech, and the Chairperson of the board, as necessary;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">engage when necessary and appropriate, after consultation with the Chairperson of the board and the Chief Executive Officer, as the liaison between the board and the New LanzaTech shareholders and other stakeholders; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">foster open dialogue and constructive feedback among the independent directors.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Leadership Structure and Role in Risk Oversight</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board recognizes that the leadership structure and combination or separation of the Chief Executive Officer and chairperson roles is driven by the needs of LanzaTech at any point in time. As a result, no policy exists requiring combination or separation of leadership roles, and our governing documents do not mandate a particular structure. This has allowed the Board the flexibility to establish the most appropriate structure for LanzaTech at any given time. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LanzaTech Board oversees the risk management activities designed and implemented by its management. The LanzaTech Board does not have a standing risk management committee, but rather executes its oversight responsibility both directly and through its standing committees. The LanzaTech Board also considers specific risk topics, including risks associated with LanzaTech&#8217;s strategic initiatives, business plans and capital structure. LanzaTech&#8217;s management, including its executive officers, are primarily responsible for managing the risks associated with operation and business of the company and providing appropriate updates to the LanzaTech Board and the audit committee. The LanzaTech Board delegates to the audit committee oversight of its risk management process, and LanzaTech&#8217;s other board committees also consider risks as they perform their respective committee responsibilities. All board committees report to the LanzaTech Board as appropriate, including, but not limited to, when a matter rises to the level of a material or enterprise risk.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Committees of LanzaTech&#8217;s Board of Directors</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech has an audit committee, a nominating and governance committee and a compensation committee. In addition, from time to time, special committees may be established under the direction of the LanzaTech Board when necessary to address specific issues. Copies of each board committee&#8217;s charter are posted on our website. Our website and the information contained on, or that can be accessed through, such website are not deemed to be incorporated by reference in, and are not considered part of, this prospectus.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Audit Committee</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech&#8217;s audit committee consists of Barbara Byrne, Nigel Gormly and Dorri McWhorter. Dorri McWhorter serves as the chairperson of LanzaTech&#8217;s audit committee. Each of Barbara Byrne, Nigel Gormly and Dorri McWhorter is independent under Nasdaq listing standards and Rule&#160;10A-3 of the Exchange Act. Each member of the audit committee is financially literate. Dorri McWhorter is an &#8220;audit committee financial expert&#8221; within the meaning of SEC regulations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The audit committee has the following responsibilities, among others, as set forth in the audit committee charter:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">selecting a firm to serve as the independent registered public accounting firm to audit LanzaTech&#8217;s financial statements;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ensuring the independence of the independent registered public accounting firm;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">discussing the scope and results of the audit with the independent registered public accounting firm and reviewing, with management and that firm, LanzaTech&#8217;s interim and year-end operating results;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establishing procedures for employees to anonymously submit concerns about questionable accounting or audit matters;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">considering the adequacy of LanzaTech&#8217;s internal controls;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing material related party transactions or those that require disclosure; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-approving audit and non-audit services to be performed by the independent registered public accounting firm.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nominating and Governance Committee</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech&#8217;s nominating and governance committee consists of Nigel Gormly, Dorri McWhorter and Jim Messina. Jim Messina serves as the chairperson of LanzaTech&#8217;s nominating and governance committee. Each of Nigel Gormly, Dorri McWhorter and Jim Messina is independent under Nasdaq listing standards.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The nominating and governance committee has the following responsibilities, among others, as set forth in the nominating and governance committee&#8217;s charter:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">identifying and recommending candidates for membership on the Board;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing and recommending LanzaTech&#8217;s corporate governance guidelines and policies;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">overseeing the process of evaluating the performance of the Board;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">assisting the Board on corporate governance matters; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing proposed waivers of our Code of Conduct and Ethics for directors and executive officers.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Committee</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech&#8217;s compensation committee consists of Barbara Byrne, Jim Messina and Gary Rieschel. Gary Rieschel will serve as the chairperson of LanzaTech&#8217;s compensation committee. Each of Barbara Byrne, Jim Messina and Gary Rieschel is independent under applicable SEC rules&#160;and Nasdaq listing standards and a &#8220;non-employee director&#8221; as defined in Rule&#160;16b-3 promulgated under the Exchange Act.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The compensation committee has the following responsibilities, among others, as set forth in the compensation committee&#8217;s charter:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing and approving, or recommending that the Board approve, the compensation of executive officers;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing and recommending to the Board the compensation of its directors;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">administering LanzaTech&#8217;s stock and equity incentive plans;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing and approving, or making recommendations to the Board with respect to, incentive compensation and equity plans; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing LanzaTech&#8217;s overall compensation philosophy.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Code of Ethics and Code of Conduct and Ethics</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech has adopted a Code of Conduct and Ethics that applies to all officers, directors and employees. The Code of Conduct and Ethics codifies the business and ethical principles that govern all aspects of our business, reflecting our commitment to this culture of honesty, integrity and accountability. In addition to following the Code </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of Conduct and Ethics, officers, directors and employees are expected to seek guidance in situations where there is a question regarding compliance issues, whether with the letter or the spirit of our policies and applicable laws. LanzaTech&#8217;s Code of Conduct and Ethics applies to all of the executive officers, directors and employees of LanzaTech and its subsidiaries. We will provide, without charge, upon request, copies of the Code of Ethics. Our Code of Conduct and Ethics is available on our website. LanzaTech&#8217;s website and the information contained on, or that can be accessed through, such website is not deemed to be incorporated by reference in, and are not considered part of, this prospectus. For copies of our Code of Conduct and Ethics, please see the section entitled &#8220;Where You Can Find More Information.&#8221; </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Committee Interlocks and Insider Participation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of the members of the compensation committee is currently one of LanzaTech&#8217;s officers or employees. None of LanzaTech&#8217;s executive officers currently serves, or has served during the last completed fiscal&#160;year, as a member of the board of directors or compensation committee of any entity that has one or more executive officers who is serving as a member of LanzaTech&#8217;s board of directors or compensation committee.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_1744"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE COMPENSATION</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As used in this section, &#8220;LanzaTech&#8221; refers to Legacy LanzaTech prior to the closing of the Business Combination and LanzaTech Global, Inc. after the closing of the Business Combination; and the &#8220;Board&#8221; refers to the board of directors of Legacy LanzaTech prior to the closing of the Business Combination and to the board of directors of LanzaTech Global, Inc. after the closing of the Business Combination. Upon the closing of the Business Combination, the executive officers of Legacy LanzaTech became executive officers of LanzaTech Global, Inc.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Compensation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This section provides an overview of LanzaTech&#8217;s executive compensation programs as they relate to the executive officers named below (the &#8220;named executive officers&#8221;), including a narrative description of the material factors necessary to understand the information disclosed in the summary compensation table below. LanzaTech&#8217;s board of directors (the &#8220;LanzaTech Board&#8221;), upon the recommendation of its compensation committee, has historically determined the compensation of LanzaTech&#8217;s Chief Executive Officer. The Chief Executive Officer has historically determined the compensation for LanzaTech&#8217;s Chief Financial Officer and Chief Scientific Officer, except that all bonus awards, stock options and restricted stock awards are approved by the LanzaTech Board upon the recommendation of the compensation committee. For the&#160;year ended December&#160;31, 2022, LanzaTech&#8217;s named executive officers were:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Dr. Jennifer Holmgren, LanzaTech&#8217;s Chief Executive Officer and a member of the LanzaTech Board;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Geoff Trukenbrod, LanzaTech&#8217;s Chief Financial Officer; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Dr. Sean Simpson, LanzaTech&#8217;s former Chief Scientific Officer and a former member of the LanzaTech Board.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required by SEC rules, our named executive officers also include the following individuals who were former officers of AMCI until the closing of the Business Combination: Nimesh Patel, who served as Chief Executive Officer, and Patrick Murphy, who served as Chief Financial Officer. Neither of them received any employee compensation during the fiscal year ended December 31, 2022 and, as a result, this section is focused on the compensation of our current named executive officers.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2022 Summary Compensation Table</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the named executive officers became an executive officer of New LanzaTech, except for Dr. Simpson, who is an advisor to the company. The following table presents information regarding the compensation awarded by, earned by or paid to LanzaTech&#8217;s named executive officers during the fiscal&#160;year ended December&#160;31, 2022.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.756%"><tr><td style="width:1.0%"></td><td style="width:20.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.506%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.670%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.916%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.916%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.867%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.893%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name and Principal Position</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Salary<br/>($)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Bonus<br/>($)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock<br/>Awards<br/>($)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Option<br/>Awards<br/>($)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-qualified </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Compensation </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Earnings ($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr.&#160;Jennifer Holmgren</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">908,202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Geoff Trukenbrod</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388,269&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,637&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533,907&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr.&#160;Sean Simpson</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Former Chief Scientific Officer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434,903&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects matching contributions under LanzaTech&#8217;s 401(k)&#160;retirement savings plan.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects an increase in Mr. Trukenbrod&#8217;s annual base salary that became effective on February 6, 2022.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Dr. Simpson served as LanzaTech&#8217;s Chief Scientific Officer beginning in 2010 through December 2022.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects an increase in Dr. Simpson&#8217;s annual base salary that was effective from February 6, 2022 through December 31, 2022.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes a bonus of $30,000, $15,000 of which was paid in connection with the execution of Mr. Trukenbrod&#8217;s employment agreement on May 29, 2021 and $15,000 of which was paid six months thereafter.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Narrative to Summary Compensation Table</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Base Salaries</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr.&#160;Holmgren&#8217;s annual base salary for 2022 was $525,000.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr.&#160;Trukenbrod&#8217;s annual base salary for 2022 was initially $375,000, and was increased to $390,000 effective as of February 6, 2022. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr.&#160;Simpson&#8217;s annual base salary for 2022 was $325,000, and was increased to $338,000, effective from February 6, 2022 to December 31, 2022.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bonuses</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, Dr.&#160;Holmgren, Mr.&#160;Trukenbrod and Dr.&#160;Simpson each earned a discretionary bonus. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Compensation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although LanzaTech does not have a formal policy with respect to the grant of equity incentive awards to its executive officers, or any formal equity ownership guidelines applicable to them, LanzaTech generally uses equity incentive awards to compensate its executive officers in the form of initial grants in connection with the commencement of employment and also at various other times during their employment. Accordingly, the LanzaTech Board, upon the recommendation of its compensation committee, periodically reviews the equity incentive compensation of LanzaTech&#8217;s executive officers and from time to time has granted equity incentive awards to them in the form of stock options and restricted stock awards. No equity incentive awards were granted to Lanza Tech&#8217;s named executive officers in 2022.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Executive Employment Agreements and Other Arrangements</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dr.&#160;Jennifer Holmgren</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech entered into an employment agreement with Dr.&#160;Holmgren in April&#160;2010, which was subsequently amended. The employment agreement provides for Dr.&#160;Holmgren&#8217;s at-will employment as LanzaTech&#8217;s Chief Executive Officer and provides for an initial base salary, bonus target and equity award. Dr.&#160;Holmgren&#8217;s salary and bonus target were revised most recently as of May&#160;17, 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of her employment agreement, in the event Dr.&#160;Holmgren&#8217;s employment is terminated without &#8220;Cause&#8221; (as defined in Dr.&#160;Holmgren&#8217;s employment agreement), LanzaTech will be obligated to pay her an amount equal to six&#160;months of her then-current base salary, payable in substantially equal installments in accordance with LanzaTech&#8217;s standard payroll practices. Notwithstanding the foregoing, in the event that such severance constitutes &#8220;nonqualified deferred compensation&#8221; within the meaning of Section&#160;409A of the Code, then such severance shall not commence payment until the 60th day following Dr.&#160;Holmgren&#8217;s &#8220;separation from service&#8221; within the meaning of Section&#160;409A of the Code. The severance payments, and accelerated vesting terms described above in connection with a termination without Cause following a Change in Control, are subject to Dr.&#160;Holmgren&#8217;s timely execution of a release agreement in form and content commercially reasonable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 20, 2022, LanzaTech entered into an employment agreement with Dr. Holmgren, which became effective as of the Closing of the Business Combination (the &#8220;Holmgren Agreement&#8221;). The Holmgren Agreement provides for Dr. Holmgren&#8217;s at-will employment as New LanzaTech&#8217;s Chief Executive Officer and provides for an annual base salary of $750,000 and an initial annual bonus target of 100% of Dr. Holmgren&#8217;s base salary. Pursuant to the agreement, LanzaTech granted Dr. Holmgren an initial equity award following the Closing consisting of (i) restricted stock units with a targeted value of $1,500,000 at grant, and (ii) a stock option to purchase a number of shares with a targeted value of $1,500,000 at grant and with a per share exercise price no less than the fair market </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">value of a share on the date of grant. Subject to Dr. Holmgren&#8217;s continued service, the initial equity award will vest in substantially equal installments over three years and will be subject to the terms of the 2023 Plan. Contingent upon the Closing, Dr. Holmgren will also be eligible for a one-time award of restricted stock units with a targeted value of $13,000,000 at grant. This award will be subject to both (i) a time-based vesting component (annual vesting over three years) and (ii) a performance-based vesting component (the 20-day average closing price of a share of New LanzaTech&#8217;s common stock must reach $11.50 on or after the 151st day following, and within five years of, the Closing), and will vest on the first date both requirements are satisfied.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Holmgren Agreement, in the event Dr. Holmgren&#8217;s employment is terminated without &#8220;Cause&#8221; or Dr. Holmgren resigns for &#8220;Good Reason&#8221; (in each case as defined in the Holmgren Agreement), New LanzaTech is obligated to pay Dr. Holmgren (i) a lump sum payment equal to 18 months of her then-current base salary; (ii) an annual bonus (if any) for the year in which the termination occurs, equal to the annual bonus Dr. Holmgren would have received for that year based on actual performance and pro-rated based on the number of days she was employed during the relevant year; and (iii) if Dr. Holmgren is eligible for and timely elects COBRA coverage, up to 18 months of the portion of Dr. Holmgren&#8217;s COBRA premium attributable to the employer contributions LanzaTech would have paid had Dr. Holmgren remained employed. Additionally, if Dr. Holmgren&#8217;s employment is terminated without Cause or for Good Reason during the period beginning 30 days prior to a &#8220;Corporate Transaction&#8221; (as defined in the Holmgren Agreement) and ending 24 months following a Corporate Transaction, the amount of the lump sum payment described in clause (i) will be increased from 18 months to 24&#160;months of her then-current base salary, and 50% of Dr. Holmgren&#8217;s stock options which are outstanding as of the Closing will immediately vest.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The severance payments and accelerated vesting terms described above are subject to Dr. Holmgren&#8217;s execution of a release agreement in a form provided by LanzaTech. Upon the adoption of the Severance Plan (as defined below), the terms of that plan will override the severance described above in clauses (i) through (iii) to the extent that plan&#8217;s benefit is at least equal to the severance described above in clauses (i) through (iii). Dr. Holmgren&#8217;s severance benefit under the Severance Plan is expected to be identical to what is described in clauses (i) through (iii) above.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Geoff Trukenbrod</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech entered into an employment agreement with Mr. Trukenbrod, effective as of May 29, 2021. The employment agreement provides for Mr. Trukenbrod&#8217;s at-will employment as LanzaTech&#8217;s Chief Financial Officer and provides for an annual base salary of $375,000 and an annual bonus of up to 40% of his then-current base salary. Mr. Trukenbrod was also awarded a $30,000 bonus in connection with the execution of his employment agreement, $15,000 of which was paid at the time of execution of such agreement and $15,000 of which was paid six months thereafter. In addition, LanzaTech awarded Mr. Trukenbrod an option to purchase 1,006,176 shares of common stock.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of his employment agreement, in the event Mr.&#160;Trukenbrod&#8217;s employment is terminated without &#8220;Cause&#8221; (as defined in Mr.&#160;Trukenbrod&#8217;s employment agreement) or he resigns for &#8220;Good Reason&#8221; (as defined in Mr.&#160;Trukenbrod&#8217;s employment agreement), LanzaTech will be obligated to (i)&#160;pay Mr.&#160;Trukenbrod an amount equal to six&#160;months of his then-current base salary, payable on LanzaTech&#8217;s normal payroll schedule, (ii)&#160;subsidize Mr.&#160;Trukenbrod&#8217;s continuation coverage under the Consolidated Omnibus Budget Reconciliation Act for a period of six&#160;months, and (iii) accelerate the vesting of any outstanding equity that would have vested in the 24-month period following Mr. Trukenbrod&#8217;s termination. The severance payments and accelerated vesting terms described above are subject to Mr.&#160;Trukenbrod&#8217;s execution of a waiver and release agreement in a form acceptable to LanzaTech for its senior executives.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 21, 2022, LanzaTech entered into a new employment agreement with Mr. Trukenbrod, which became effective as of the Closing of the Business Combination (the &#8220;Trukenbrod Agreement&#8221;). The Trukenbrod Agreement provides for Mr. Trukenbrod&#8217;s at-will employment as LanzaTech&#8217;s Chief Financial Officer and provides for an annual base salary of $425,000 and an initial annual bonus target of 70% of Mr. Trukenbrod&#8217;s base salary. Pursuant to the agreement, LanzaTech granted Mr. Trukenbrod an initial equity award following the Closing consisting of (i) restricted stock units with a targeted value of $350,000 at grant, and (ii) a stock option to purchase a </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">number of shares with a targeted value of $350,000 at grant and with a per share exercise price no less than the fair market value of a share on the date of grant. Subject to Mr. Trukenbrod&#8217;s continued service, the initial equity award will vest in substantially equal installments over three years and will be subject to the terms of the 2023 Plan. Contingent upon the Closing, Mr. Trukenbrod will also be eligible for a one-time award of restricted stock units with a targeted value of $1,400,000 at grant. This award will be subject to both (i) a time-based vesting component (annual vesting over three years) and (ii) a performance-based vesting component (the 20-day average closing price of a share of common stock must reach $11.50 on or after the 151st day following, and within five years of, the Closing), and will vest on the first date both requirements are satisfied.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Trukenbrod Agreement, in the event Mr. Trukenbrod&#8217;s employment is terminated without &#8220;Cause&#8221; or Mr. Trukenbrod resigns for &#8220;Good Reason&#8221; (in each case, as defined in the Trukenbrod Agreement), LanzaTech will be obligated to pay Mr. Trukenbrod (i) a lump sum payment equal to 12 months of his then-current base salary; (ii) an annual bonus (if any) for the year in which the termination occurs, equal to the annual bonus Mr. Trukenbrod would have received for that year based on actual performance and pro-rated based on the number of days he was employed during the relevant year; and (iii) if Mr. Trukenbrod is eligible for and timely elects COBRA coverage, up to 12 months of the portion of Mr. Trukenbrod&#8217;s COBRA premium attributable to the employer contributions LanzaTech would have paid had Mr. Trukenbrod remained employed. In addition, following a termination without &#8220;Cause&#8221; or a resignation for &#8220;Good Reason&#8221;, the number of shares subject to stock options that remain outstanding as of immediately prior to the Closing, that would have vested in the 24-month period following such a termination, shall immediately vest. Notwithstanding the foregoing, if Mr. Trukenbrod&#8217;s employment is terminated without Cause or for Good Reason during the period beginning 30 days prior to a &#8220;Corporate Transaction&#8221; (as defined in the Trukenbrod Agreement) and ending 24 months following a Corporate Transaction, the amount of the lump sum payment described in clause (i) will be increased from 12 months to 18&#160;months of his then-current base salary. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The severance payments and accelerated vesting terms described above are subject to Mr. Trukenbrod&#8217;s execution of a release agreement in a form provided by LanzaTech. Upon the adoption of the Severance Plan, the terms of that plan will override the severance described above in clauses (i) through (iii) to the extent that plan&#8217;s benefit is at least equal to the severance described above in clauses (i) through (iii). Mr. Trukenbrod&#8217;s severance benefit under the Severance Plan is expected to be identical to what is described in clauses (i) through (iii) above.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dr.&#160;Sean Simpson</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We entered into an offer letter with Dr.&#160;Simpson in November&#160;2013, which was subsequently amended. The offer letter provided for Dr.&#160;Simpson&#8217;s at-will&#160;employment as LanzaTech&#8217;s Chief Science Officer and provided for an initial base salary and bonus target.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 2, 2023, we entered into a Transition Letter with Dr. Simpson (the &#8220;Transition Letter&#8221;), pursuant to which Dr. Simpson resigned from his positions as Chief Scientific Officer and as a member of the LanzaTech Board, effective as of January 1, 2023. In connection with Dr. Simpson&#8217;s resignation and subject to Dr. Simpson complying with all other terms of the Transition Letter (including executing and not revoking the release of certain claims), he will receive a $1,500,000 payment in a single lump sum within 45 days of the Closing.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As provided by the terms of the Transition Agreement, LanzaTech and Dr. Simpson entered into a consulting agreement (the &#8220;Consulting Agreement&#8221;), pursuant to which Dr. Simpson will serve as a consultant to LanzaTech from January 1, 2023, through January 1, 2025, unless terminated by us or Dr. Simpson pursuant to the terms of the Consulting Agreement. Dr. Simpson&#8217;s unvested equity awards will continue to vest so long as he remains a consultant to LanzaTech.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Outstanding Equity Awards as of December&#160;31, 2022</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding outstanding stock options held by LanzaTech&#8217;s named executive officers as of December 31, 2022. All awards in the table below that were granted prior to July 29, 2019 were granted under one of the following LanzaTech equity plans: 2006 Scheme, 2011 Plan, 2013 Plan, or 2015 Plan (each as defined below, and collectively the &#8220;Legacy LanzaTech Plans&#8221;), and awards granted subsequent to such </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">date were granted under the LanzaTech NZ, Inc. 2019 Stock Plan (the &#8220;2019 Plan&#8221;), each as described in more detail under &#8220;&#8212; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Incentive and Other Compensation Plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; below.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.329%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.156%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.800%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Option Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock&#160;Awards</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Grant&#160;date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of securities underlying unexercised options&#160;(#) exercisable</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of securities underlying unexercised options&#160;(#) unexercisable</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Option exercise <br/>price<br/>($)</span></td><td colspan="3" style="border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Option<br/>expiration<br/>date</span></td><td colspan="3" style="border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of <br/>shares&#160;or units&#160;of <br/>stock&#160;that have <br/>not&#160;vested&#160;(#)</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Market&#160;value of&#160;shares&#160;or units&#160;of&#160;stock that&#160;have&#160;not vested&#160;($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Jennifer Holmgren</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/14/2013</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,474&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.60&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/14/2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/20/2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">984,302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/20/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/26/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354,768&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/26/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/20/2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,227,228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,168,676&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Geoff Trukenbrod</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/19/2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/19/2031</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Sean Simpson</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/14/2013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/14/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/20/2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">874,935&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/20/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/26/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/26/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/9/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192,652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,010&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/9/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/9/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592,904&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,013,991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">___________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Based on the November 18, 2022 value of $14.86 per share, which was the latest appraisal received by LanzaTech for purposes of administering its equity incentive plans. This appraised value is subject to certain limitations, qualifications and assumptions and may not reflect the fair value of LanzaTech's common stock, is presented for illustrative purposes only and should not be relied on for any reason.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Dr. Simpson&#8217;s unvested equity awards will continue to vest so long as he remains a consultant to LanzaTech.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Incentive and Other Compensation Plans</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Incentive Plan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 23, 2022, the AMCI Board approved the 2023 Plan, which was approved by the AMCI stockholders on February 6, 2023, and became effective as of the consummation of the Business Combination.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AMCI initially reserved 19,622,273 shares of common stock for issuance under the 2023 Plan (the &#8220;Share Reserve&#8221;). In addition, such aggregate number of shares will automatically increase on January 1 of each year commencing on January 1, 2024, before the expiration of the 2023 Plan, in an amount equal to 3% of the total number of shares of New LanzaTech&#8217;s capital stock outstanding on December 31 of the preceding year, unless the Board acts prior to January 1st of a given year to provide that the increase for such year will be a lesser number. The maximum aggregate number of shares which may be issued thereunder pursuant to incentive stock options (&#8220;ISOs&#8221;) is 760,000,000 shares.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares issued under the 2023 Plan include authorized but unissued or reacquired shares of common stock. Any shares of common stock underlying any awards that are forfeited, cancelled, reacquired by New LanzaTech prior to vesting, expired (whether voluntarily or involuntarily), satisfied without the issuance of shares, withheld upon exercise of a stock option or settlement of an award to cover the exercise price or tax withholding, surrendered pursuant to an exchange, or otherwise terminated (other than by exercise) shall again be available for grant and issuance under the 2023 Plan; shall be deemed not to have been issued for purposes of determining the maximum aggregate number of shares that may be issued under the 2023 Plan; and shall not reduce the Share Reserve. With respect to awards that will or may be settled in cash, only shares actually issued pursuant to such awards are not available under the 2023 Plan; all remaining shares under such awards are available for future grant under the 2023 Plan. If any shares that actually have been issued under the 2023 Plan pursuant to an award are forfeited back to or reacquired by New LanzaTech pursuant to the failure to meet a contingency or condition required to vest such shares in the grantee, a right of first refusal, a forfeiture provision, or repurchase by New LanzaTech, then the shares that are forfeited or reacquired will revert to and again become available for future grant and issuance under the 2023 </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plan. Shares underlying any substitute awards that New LanzaTech grants to employees, directors or consultants of a business that is acquired by New LanzaTech do not count against the Share Reserve.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plan Administration</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board administers the 2023 Plan, and is authorized to delegate any or all of its powers under the 2023 Plan to one or more committees. The Board or committee(s) administering the 2023 Plan are referred to herein as the &#8220;Administrator.&#8221; The Board is permitted to delegate to one or more officers the power to grant awards to its employees and officers and to exercise such other powers under the 2023 Plan as theBoard or committee(s) may determine, subject to certain limitations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2023 Plan, the Administrator has the authority to award nonstatutory stock options (&#8220;NSOs&#8221;), ISOs, stock appreciation rights (&#8220;SARs&#8221;), restricted stock, restricted stock units (&#8220;RSUs&#8221;), unrestricted stock, performance awards and other stock-based awards or cash incentives. All awards are granted pursuant to an award agreement. Awards other than ISOs can be granted to employees, directors and consultants, but ISOs can be granted only to employees.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator has the authority to set the terms of all awards, including the vesting schedule, restrictions and restriction periods, repurchase provisions, rights of first refusal, forfeiture provisions, form of payment (cash, shares, or other consideration) upon exercise or settlement of the award, payment contingencies, and satisfaction of any performance goals. Each award agreement must specify any circumstances under which awards may be forfeited.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options and SARs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. With respect to stock options and SARs, the Administrator determines the exercise price applicable thereto within the terms and conditions of the 2023 Plan; provided that, the exercise price per share subject to a stock option or SAR cannot be less than 100% of the fair market value of the common stock on the date of grant, unless the Board expressly determines otherwise and such stock option or SAR complies with applicable law, including Section 409A of the Code to the extent applicable. Notwithstanding the foregoing, stock options may be granted with a per share exercise price, other than as required above, as a substitution for a stock option or SAR in accordance with and pursuant to Section 424 of the Code, in the case of an ISO, and pursuant to Section 409A of the Code, in the case of a NSO. The Administrator also has authority to determine the term of stock options and SARs granted under the 2023 Plan, up to a maximum period of 10 years. The Administrator may, but is not required to, permit a grantee to exercise any part or all of his or her stock options prior to full vesting. In no event may a stock option be exercised beyond the expiration of its term. Payment for shares issued upon the exercise of a stock option may be made by (1) cash; (2) check; (3) to the extent permitted under applicable law, delivery of a promissory note with such recourse, interest, security, redemption, and other provisions as the Administrator determines to be appropriate (subject to the provisions of Section 153 of the Delaware General Corporation Law and any other applicable law); (4) cancellation of indebtedness; (5) other previously owned shares that have a fair market value on the date of surrender equal to the aggregate exercise price of the shares as to which the stock option is exercised; (6) a cashless exercise; (7) such other consideration and method of payment permitted under applicable law; or (8) any combination of the foregoing methods of payment. The 2023 Plan does not permit the repricing of options or SARs without shareholder approval.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tax Limitations on ISOs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The aggregate fair market value, determined at the time of grant, of shares of common stock with respect to ISOs that are exercisable for the first time by an optionholder during any calendar year under all stock plans maintained by New LanzaTech may not exceed $100,000. Options or portions thereof that exceed such limit are generally treated as NSOs. No ISO may be granted to any person who, at the time of the grant, owns or is deemed to own more than 10% of the total combined voting power of all classes of New LanzaTech&#8217;s stock or any affiliates of New LanzaTech unless (1) the option exercise price is at least 110% of the fair market value of the stock subject to the option on the date of grant, and (2) the option is not exercisable after the expiration of five years from the date of grant.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise provided in an award agreement, if a grantee of restricted stock terminates employment or service during the applicable restriction period, New LanzaTech has the right to repurchase all or </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">part of the shares of restricted stock still subject to restriction from the grantee at the issue price or at another stated or formula price (or to require forfeiture if such shares of restricted stock were issued at no cost). Additionally, unless otherwise determined by the Administrator, grantees of restricted stock are entitled to receive all dividends and other distributions paid with respect to their shares of restricted stock, subject to such terms and conditions as the Administrator may determine.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. An RSU may be settled in any form specified by the Administrator in the award agreement, including delivery of stock, cash, or a combination of cash and stock as deemed appropriate by the Administrator. The Administrator may, but need not, provide that grantees of RSUs are paid or accrue dividend equivalent payments on each date that dividends are paid with respect to New LanzaTech&#8217;s common stock prior to the settlement of their RSUs, subject to such terms and conditions as the Administrator may determine. The treatment of any dividends or dividend equivalents shall be set forth in the award agreement at the time the award is granted.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The 2023 Plan permits the grant of performance-based stock and cash awards that may vest or become earned and paid contingent upon the attainment of performance goals during a designated performance period, as determined by the Administrator and set forth in the applicable award agreement. Performance goals may be based on a company-wide basis, with respect to one or more business units, divisions, subsidiaries, or business segments, and in either absolute terms or relative to the performance of one or more comparable companies or the performance of one or more relevant indices, and may be based on financial performance, achievement of strategic objectives, or any other organizational goals, all as determined by the Administrator. At the expiration of the performance period, the Administrator shall evaluate the performance award holder&#8217;s and/or New LanzaTech&#8217;s performance in light of any performance goals for such performance award, and shall determine the number of shares (or other applicable payment measures) which have been earned.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board may issue other forms of awards, which may, but are not required to be, valued in whole or in part by reference to, or otherwise based on, New LanzaTech common stock. The Board hassole and complete discretion to determine the persons to whom and the time or times at which such other awards are granted, the number of shares of New LanzaTech common stock (or the cash equivalent thereof) to be granted and all other terms and conditions of such other awards. Such awards may be granted either alone or in conjunction with other awards granted under the 2023 Plan.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transferability</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2023 Plan, awards generally are not transferable, but the Administrator may provide that an award is transferable by will, by the laws of descent and distribution, or as permitted by applicable law. A grantee must satisfy all applicable federal, state and local or other income and employment tax withholding obligations before New LanzaTech recognizes ownership of shares under an award (or other consideration payable pursuant to the award).</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate Transactions and Recapitalizations</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of a &#8220;Corporate Transaction&#8221; (as defined in the 2023 Plan), each outstanding award is treated as the Administrator determines. The Administrator has the right to (1) accelerate the vesting of any or all outstanding stock options and SARs, in whole or in part; (2) make non-forfeitable any or all outstanding restricted stock or RSUs, in whole or in part; (3) cancel for no consideration any stock option or SAR that is not exercised as of the effective time of the Corporate Transaction; or (4) cancel or redeem awards in exchange for cash or another form of consideration, including substitute awards in respect of the capital stock of a successor corporation, all subject to any limitations imposed by applicable law and provided that, if the fair market value of common stock on the date of the Corporate Transaction does not exceed the exercise price of any option or SAR, the Administrator may cancel that stock option or SAR without any payment of consideration. The Administrator is not obligated to treat all stock awards or portions of stock awards in the same manner and is not obligated to take the same actions with respect to all participants.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event a successor or acquiring corporation (if any) refuses to assume, convert, replace, or substitute awards pursuant to a Corporate Transaction, such awards will have their vesting accelerate as to all shares subject to </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">129</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">such awards (and any applicable right of repurchase fully lapse) immediately prior to the Corporate Transaction. In addition, in the event a successor or acquiring corporation (if any) refuses to assume, convert, replace, or substitute awards pursuant to a Corporate Transaction, the Administrator will notify the grantee that such award will be exercisable for a period of time determined by the Administrator in its sole discretion, and such award will terminate upon the expiration of such period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separately, in the event of a stock split or other change in the capital structure of New LanzaTech, the 2023 Plan provides for appropriate adjustments, as applicable, to the maximum number and class of shares reserved for issuance under the 2023 Plan, the ISO limit, and the class and number of shares and exercise price or purchase price of outstanding awards under the 2023 Plan.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plan Amendment or Termination</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has the authority to amend, suspend, or terminate the 2023 Plan, although certain material amendments require the approval of New LanzaTech&#8217;s stockholders. In no event will any amendment increase the maximum number of shares of common stock with respect to which awards may be granted under the 2023 Plan without stockholder approval. No awards are permitted to be granted after the tenth anniversary of the earlier of (i) the date the Board adopts the 2023 Plan and (ii) the date New LanzaTech&#8217;s stockholders approve the 2023 Plan, unless sooner terminated.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator has the authority to amend, modify or terminate any outstanding award, but the grantee will be required to consent to such action unless the amendment, modification or termination would not materially and adversely affect the grantee&#8217;s rights under the 2023 Plan, the change is permitted in connection with specified corporate transactions or capitalization adjustments, or the change is required or advisable for New LanzaTech, the 2023 Plan or the award to satisfy applicable law or accounting standards.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Annual Bonus Plan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 8, 2023, the Board adopted an annual bonus plan which became effective upon the completion of the Business Combination. The form of annual bonus plan is attached as Exhibit 10.30 to the registration statement of which this prospectus forms a part.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Severance Plan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 8, 2023, the Board adopted an executive severance plan (the &#8220;Severance Plan&#8221;) which became effective upon the completion of the Business Combination. Under the Severance Plan, qualifying employees who satisfy conditions set forth in the plan (other than Ms. Holmgren) will be entitled to receive 12 months&#8217; base salary, in the case of a Qualifying Termination, or 18 months&#8217; base salary, in the case of a Corporate Transaction Termination (in each case, as defined in the Severance Plan). Ms. Holmgren will be entitled to receive 18 months&#8217; base salary or 24 months&#8217; base salary in the case of a Qualifying Termination or a Corporate Transaction Termination, respectively. Employees having a seniority level of vice president or higher who are designated in writing by the compensation committee of the Board, and who also meet certain other specified criteria will be eligible to participate in the Severance Plan. The Severance Plan is attached as Exhibit 10.35 to the registration statement of which this prospectus forms a part.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2019 Plan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2019 Plan was adopted by the LanzaTech Board and approved by LanzaTech&#8217;s stockholders on July&#160;29,&#160;2019, and amended and restated on October&#160;28, 2021. The 2019 Plan replaced the LanzaTech NZ,&#160;Inc. 2015 Stock Plan (the &#8220;2015 Plan&#8221;) on the date the 2019 Plan was approved by LanzaTech&#8217;s stockholders, except that any awards previously granted under the 2015 Plan remained in effect pursuant to their terms. The 2019 Plan allowed the LanzaTech Board to make equity incentive awards to LanzaTech&#8217;s employees, directors, and consultants. No further awards will be made under the 2019 Plan.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Authorized Shares</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maximum aggregate number of shares of common stock that may be issued under the 2019 Plan is 5,906,033 shares, plus any shares returned to the 2019 Plan, and shares returned from a prior plan (up to 5,074,626 shares), as described below. Shares issued under the 2019 Plan include authorized but unissued or reacquired shares of common stock. If (1) an outstanding award for any reason expires or is terminated or cancelled, (2) shares of common stock are acquired pursuant to an award subject to forfeiture or repurchase and are forfeited or repurchased by LanzaTech, or (3) shares of common stock are withheld upon exercise of an option or settlement of an award to cover the exercise price or tax withholding, then the shares of common stock allocable to the terminated portion of such award, such forfeited or repurchased shares of common stock or such shares of common stock used to pay the exercise price or tax withholding shall generally again be available for issuance under the 2019 Plan. If a stock option under the LanzaTech 2006 Share Option Scheme, LanzaTech 2008 Share Option Scheme or LanzaTech NZ, Inc. 2011 Stock Plan expires or is cancelled or terminated (in whole or in part), or if shares of common stock are withheld upon exercise of a stock option under the LanzaTech NZ, Inc. 2011 Stock Plan to cover the exercise price or tax withholding, in each case during the period beginning on October 1, 2020 and ending on October 31, 2021, then the shares of common stock subject to such stock options (which amount shall not exceed 5,074,626 shares of common stock) shall become available for issuance under the 2019 Plan. The maximum number of shares of common stock that may be issued pursuant to the exercise of ISOs shall not exceed 5,906,033 shares, including, to the extent permitted by Section 422 of the Code, any shares that return to the 2019 Plan as described above.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plan Administration</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LanzaTech Board administers the 2019 Plan and may delegate any or all of its powers under the plan to one or more of its committees. Subject to the terms of the 2019 Plan, the LanzaTech Board had the authority to set the terms of all awards.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LanzaTech Board may grant awards of nonstatutory and incentive stock options and restricted stock under the 2019 Plan. All awards are granted pursuant to an award agreement. Awards other than ISOs may be granted to employees, directors, and consultants. ISOs may be granted only to employees. The LanzaTech Board determines the exercise price for a stock option within the terms and conditions of the 2019 Plan; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that the exercise price per share subject to an option cannot be less than 100% of the fair market value of common stock on the date of grant. Options granted under the 2019 Plan become exercisable at the rate specified by the LanzaTech Board in the award agreement. The award agreement specifies circumstances under which awards may be forfeited. The LanzaTech Board determines the term of stock options granted under the 2019 Plan, generally, up to a maximum of 10&#160;years.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any shares of LanzaTech&#8217;s common stock awarded under any restricted stock award agreement may be subject to forfeiture to LanzaTech in accordance with a vesting schedule determined by the LanzaTech Board and award agreements for restricted stock will be subject to restrictions imposed by the LanzaTech Board, as it deems appropriate. Generally, if a grantee of restricted stock terminates employment or service during the applicable restriction period, LanzaTech has the right to repurchase from the grantee all or part of the shares of restricted stock still subject to restriction at the issue price or at another stated or formula price. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate Transactions</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2019 Plan provides that in the event of a &#8220;Change in Control&#8221; (as defined in the 2019 Plan), each outstanding award will be treated as the LanzaTech Board determines. The LanzaTech Board may (1)&#160;accelerate the vesting and/or exercisability of any or all outstanding stock options, in whole or in part&#894; (2)&#160;make non-forfeitable any or all outstanding restricted stock awards, in whole or in part&#894; (3)&#160;cancel or redeem awards in exchange for cash or another form of consideration, including cancelling for no consideration the portion of an option for which the fair market value on the date of the &#8220;Change in Control&#8221; does not exceed the exercise price; or (4)&#160;provide that the acquiring corporation will assume or continue the awards or substitute the awards for awards with respect to the acquiror&#8217;s shares.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number and class of securities available under the 2019 Plan, the exercise price per share of each stock option, and the repurchase price per share for each restricted stock award is subject to adjustment in the event of any stock split, reverse stock split, stock dividend, recapitalization, combination or exchange of shares, reclassification of shares, spin-off or other similar change in capitalization.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain stock options and restricted stock awards granted in November&#160;of 2020, and one restricted stock award granted in April&#160;of 2021, provide for accelerated vesting upon certain events that qualify as a &#8220;Liquidity Event&#8221; (as defined in the applicable award agreements, with respect to stock options and restricted stock awards respectively), unless the LanzaTech Board determines that such event is not a Liquidity Event.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plan Amendment or Termination</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LanzaTech Board has the authority to alter, amend, suspend or terminate the 2019 Plan in whole or in part; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that the LanzaTech Board will obtain stockholder approval of any plan amendment to the extent necessary to comply with applicable law, rule, or regulation. In no event will any amendment increase the maximum number of shares of common stock with respect to which awards may be granted under the 2019 Plan without stockholder approval. The LanzaTech Board may amend, modify, or terminate any outstanding award, but the grantee will be required to consent to such action unless the amendment, modification, or termination would not adversely affect the grantee&#8217;s rights under the 2019 Plan or the change is permitted in connection with a Change in Control or capitalization adjustments.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2015 Plan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2015 Plan was adopted by the LanzaTech Board on April&#160;1, 2015, and approved by LanzaTech&#8217;s stockholders on August&#160;3, 2015. The 2015 Plan replaced the LanzaTech NZ,&#160;Inc. 2013 Stock Plan (the &#8220;2013 Plan&#8221;) on the date the 2015 Plan was approved by LanzaTech&#8217;s stockholders, except that any awards previously granted under the 2013 Plan remained in effect pursuant to their terms. The 2015 Plan allowed the LanzaTech Board to make equity incentive awards to LanzaTech&#8217;s employees, directors, and consultants.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plan Administration</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LanzaTech Board administers the 2015 Plan and may delegate any or all of its powers under the plan to one or more of its committees. Subject to the terms of the 2015 Plan, the LanzaTech Board had the authority to set the terms of all awards.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Awards</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LanzaTech Board made grants of awards of nonstatutory and incentive stock options under the 2015 Plan. All awards were granted pursuant to an award agreement. Awards other than ISOs were granted to employees, directors, and consultants. ISOs were granted only to employees. The LanzaTech Board determined the exercise price for a stock option within the terms and conditions of the 2015 Plan; provided, that the exercise price per share subject to an option could not be less than 100% of the fair market value of common stock on the date of grant. Options granted under the 2015 Plan become exercisable at the rate specified by the LanzaTech Board in the award agreement. The award agreement specifies circumstances under which awards may be forfeited. The LanzaTech Board determined the term of stock options granted under the 2015 Plan, generally, up to a maximum of 10&#160;years.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate Transactions</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2015 Plan provided that in the event of a &#8220;Change in Control&#8221; (as defined in the 2015 Plan), each outstanding award would be treated as the LanzaTech Board determines. The LanzaTech Board could (1)&#160;accelerate the vesting and/or exercisability of any or all outstanding awards, in whole or in part&#894; (2)&#160;cancel or redeem awards in exchange for cash or another form of consideration; or (3)&#160;provide that the acquiring corporation will assume or continue the awards or substitute the awards for awards with respect to the acquiror&#8217;s shares.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number and class of securities available under the 2015 Plan and the exercise price per share of each stock option granted pursuant to the 2015 Plan is subject to adjustment in the event of any stock split, reverse stock split, </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">stock dividend, recapitalization, combination or exchange of shares, reclassification of shares, spin-off or other similar change in capitalization.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2013 Plan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2013 Plan was adopted by the LanzaTech Board on August&#160;23, 2013, and approved by LanzaTech&#8217;s stockholders on August&#160;23, 2013. The 2013 Plan replaced the LanzaTech NZ,&#160;Inc. 2011 Stock Plan (the&#8220;2011&#160;Plan&#8221;) on the date the 2013 Plan was approved by LanzaTech&#8217;s stockholders, except that any awards previously granted under the 2011 Plan remained in effect pursuant to their terms. The 2013 Plan allowed the LanzaTech Board to make equity incentive awards to LanzaTech&#8217;s employees, directors, and consultants.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plan Administration</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LanzaTech Board administers the 2013 Plan and may delegate any or all of its powers under the plan to one or more of its committees. Subject to the terms of the 2013 Plan, the LanzaTech Board had the authority to set the terms of all awards.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LanzaTech Board made grants of awards of nonstatutory and incentive stock options under the 2013 Plan. All awards were granted pursuant to an award agreement. Awards other than ISOs were granted to employees, directors, and consultants. ISOs were granted only to employees. The LanzaTech Board determined the exercise price for a stock option within the terms and conditions of the 2013 Plan; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that the exercise price per share subject to an option could not be less than 100% of the fair market value of common stock on the date of grant. Options granted under the 2013 Plan become exercisable at the rate specified by the LanzaTech Board in the award agreement. The award agreement specifies circumstances under which awards may be forfeited. The LanzaTech Board determined the term of stock options granted under the 2013 Plan, generally, up to a maximum of 10&#160;years.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate Transactions</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2013 Plan provided that in the event of a &#8220;Change in Control&#8221; (as defined in the 2013 Plan), each outstanding award would be treated as the LanzaTech Board determines. The LanzaTech Board could (1)&#160;accelerate the vesting and/or exercisability of any or all outstanding awards, in whole or in part&#894; (2)&#160;cancel or redeem awards in exchange for cash or another form of consideration; or (3)&#160;provide that the acquiring corporation will assume or continue the awards or substitute the awards for awards with respect to the acquiror&#8217;s shares.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number and class of securities available under the 2013 Plan and the exercise price per share of each stock option granted pursuant to the 2013 Plan is subject to adjustment in the event of any stock split, reverse stock split, stock dividend, recapitalization, combination or exchange of shares, reclassification of shares, spin-off or other similar change in capitalization.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2011 Plan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2011 Plan was adopted by the LanzaTech Board on April&#160;30, 2011, and approved by LanzaTech&#8217;s stockholders on April&#160;30, 2011. The 2011 Plan replaced all prior share option schemes on the date the 2011 Plan was approved by LanzaTech&#8217;s stockholders, except that any awards previously granted under such share options schemes remained in effect pursuant to their terms. The 2011 Plan allowed the LanzaTech Board to make equity incentive awards to LanzaTech&#8217;s employees, directors, and consultants.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plan Administration</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LanzaTech Board administers the 2011 Plan and may delegate any or all of its powers under the plan to one or more of its committees. Subject to the terms of the 2011 Plan, the LanzaTech Board has the authority to set the terms of all awards. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LanzaTech Board made grants of awards of nonstatutory and incentive stock options under the 2011 Plan. All awards were granted pursuant to an award agreement. Awards other than ISOs were granted to employees, directors, and consultants. ISOs were granted only to employees. The LanzaTech Board determined the exercise price for a stock option within the terms and conditions of the 2011 Plan; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that the exercise price per share subject to an option could not be less than 100% of the fair market value of common stock on the date of grant. Options granted under the 2011 Plan become exercisable at the rate specified by the LanzaTech Board in the award agreement. The award agreement specifies circumstances under which awards may be forfeited. The LanzaTech Board determined the term of stock options granted under the 2011 Plan, generally, up to a maximum of 10&#160;years.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate Transactions</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2011 Plan provided that in the event of a &#8220;Change in Control&#8221; (as defined in the 2011 Plan), each outstanding award would be treated as the LanzaTech Board determines. The LanzaTech Board could (1)&#160;accelerate the vesting and/or exercisability of any or all outstanding awards, in whole or in part&#894; (2)&#160;cancel or redeem awards in exchange for cash or another form of consideration; or (3)&#160;provide that the acquiring corporation will assume or continue the awards or substitute the awards for awards with respect to the acquiror&#8217;s shares.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number and class of securities available under the 2011 Plan and the exercise price per share of each stock option granted pursuant to the 2011 Plan is subject to adjustment in the event of any stock split, reverse stock split, stock dividend, recapitalization, combination or exchange of shares, reclassification of shares, spin-off or other similar change in capitalization.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LanzaTech 2006 Share Option Scheme (the &#8220;2006 Scheme&#8221;)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2006 Scheme was adopted by the LanzaTech Board in 2006. The 2006 Scheme allowed the LanzaTech Board to grant stock options to LanzaTech&#8217;s employees, directors, and consultants.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plan Administration</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LanzaTech Board administers the 2006 Scheme. Subject to the terms of the 2006 Scheme, the LanzaTech Board has the authority to set the terms of all awards.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LanzaTech Board made grants of option awards under the 2006 Scheme. All stock options were granted pursuant to a scheme member undertaking. The LanzaTech Board determined the exercise price for a stock option. Options granted under the 2006 Scheme become exercisable at the rate specified by the LanzaTech Board. The LanzaTech Board determined the terms of stock options granted under the 2006 Scheme.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate Transactions</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2006 Scheme provided that the LanzaTech Board may require that all &#8220;Scheme Members&#8221; (as that term is defined in the Rules&#160;Relating to the LanzaTech 2006 Share Option Scheme) exercise any then outstanding awards if shares of LanzaTech are listed on a stock exchange or market, or if a person (or group of persons) acquire 50% or more of the total voting rights of LanzaTech.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number and class of securities available under the 2006 Scheme and the exercise price per share of each stock option is subject to adjustment in the event of any consolidation, subdivision, or similar proportionate reconstruction of the shares of LanzaTech.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Options Deed Poll</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2006, the LanzaTech Board adopted the Deed Poll Relating to Option Schemes Established by LanzaTech New Zealand Limited (the &#8220;Options Deed Poll&#8221;) pursuant to New Zealand law. The Options Deed Poll provides administrative and other governing terms for each of the aforementioned equity plans. The Options Deed Poll </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">applies to all grants under the 2006 Scheme, the 2011 Plan, the 2013 Plan, the 2015 Plan, and the 2019 Plan that occurred before October&#160;28, 2021. The Options Deed Poll does not apply to grants made after October&#160;28, 2021, the date on which LanzaTech redomiciled under Delaware law.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Benefit Plans</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech maintains the LanzaTech Retirement Savings 401(k)&#160;Plan (the &#8220;401(k)&#160;Plan&#8221;) for its U.S.-based employees, including the named executive officers, who satisfy certain eligibility requirements. The 401(k)&#160;Plan is intended to qualify as a tax-qualified plan under Section&#160;401(k)&#160;of the Code. The named executive officers are eligible to participate in the 401(k)&#160;Plan on the same basis as LanzaTech&#8217;s other employees. The Code allows eligible employees to contribute, on a pre-tax basis, a portion of their salary, within prescribed limits, through contributions to the 401(k)&#160;Plan. Contributions are allocated to each participant&#8217;s account and are then invested in selected investment alternatives according to each participant&#8217;s directions. LanzaTech provides for a discretionary matching contribution. In 2021, LanzaTech matched 100% of eligible deferrals up to 3.5% of the participant&#8217;s compensation for participants with 1,000 hours of service who were actively employed on December&#160;31, 2021. LanzaTech also participates in certain statutory benefit plans outside of the United States.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Employee Director Compensation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-employee directors of LanzaTech did not receive any compensation for their services as directors during 2022.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the completion of the Business Combination, the Board adopted a non-employee director compensation plan pursuant to which each non-employee director is entitled to receive annual cash compensation of $60,000 for his or her service on the Board. Additionally, the lead independent director is entitled to additional annual cash compensation of $30,000, and each member of the audit committee of the Board, the compensation committee of the Board, and the nominating and governance committee of the Board is entitled to annual cash compensation of $10,000, $7,500, and $5,000, respectively. The chairperson of each such committee is entitled to additional annual cash compensation of $10,000, $7,500, and $5,000, respectively.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">135</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_1765"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BENEFICIAL OWNERSHIP</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information regarding the beneficial ownership of shares of common stock as of February 8, 2023, after giving effect to the Business Combination: </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">each person known by us to be the beneficial owner of more than 5% of common stock; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">each of our named executive officers and directors; and </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">all of our executive officers and directors as a group. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beneficial ownership is determined in accordance with the rules and regulations of the SEC. A person is a &#8220;beneficial owner&#8221; of a security if that person has or shares &#8220;voting power,&#8221; which includes the power to vote or to direct the voting of the security, or &#8220;investment power,&#8221; which includes the power to dispose of or to direct the disposition of the security, or has the right to acquire such powers within 60 days. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The beneficial ownership of shares of common stock is calculated based on 196,222,737 shares of common stock outstanding as of February 8, 2023. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise noted in the footnotes to the following table, and subject to applicable community property laws, the persons and entities named in the table have sole voting and investment power with respect to their beneficially owned common stock. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise noted in the footnotes to the following table, and subject to applicable community property laws, the persons and entities named in the table have sole voting and investment power with respect to their beneficially owned common stock. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name and Address <br/>of Beneficial Owner</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of&#160;<br/>shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of&#160;<br/>Total&#160;<br/>Voting<br/>Power</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Directors and Named Executive Officers of LanzaTech </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:9pt;padding-right:2.9pt;text-indent:18pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Jennifer Holmgren </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,353,856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Geoff Trukenbrod </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barbara Byrne</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nigel Gormly</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dorri McWhorter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James Messina </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071,848&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nimesh Patel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gary Rieschel</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patrick Murphy</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sean Simpson </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,703,982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">All Directors and Executive Officers of LanzaTech as a Group (17 individuals)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,737,067</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.75</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Five Percent Holders:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Khosla Ventures </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,839,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Guardians of New Zealand Superannuation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,263,337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sinopec Capital Co., Ltd. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,112,976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Novo Holdings A/S </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(10)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,814,845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14pt">Less than one&#160;percent.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Unless otherwise noted, the business address of each of the following individuals is 8045 Lamon Avenue, Suite 400, Skokie, Illinois 60077.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Consists of (i) 3,683,163 shares of Common Stock and (ii) 1,670,693 shares of Common Stock subject to options exercisable within 60 days of the Closing Date.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Consists of 28,706 shares of Common Stock subject to options exercisable within 60 days of the Closing Date.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Consists of 341,224 shares of Common Stock subject to options exercisable within 60 days of the Closing Date.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Consists of 1,071,848 shares of Common Stock subject to options exercisable within 60 days of the Closing Date.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Consists of (i) 1,081,801 shares of New LanzaTech Common Stock held by the Shikine Onsen Investment Trust, (ii) 1,083,038 shares of New LanzaTech Common Stock held by Dr. Simpson, and (iii) 1,240,202 shares of New LanzaTech Common Stock subject to options exercisable within 60 days of the Closing Date. Dr. Simpson and his spouse are trustees of the Shikine Onsen Investment Trust and Dr. Simpson may be deemed to have shared voting and dispositive power over the shares held by the Shikine Onsen Investment Trust.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Consists of (i) 13,875,332 shares of LanzaTech common stock held by KV III, (ii) 28,992,029 shares of LanzaTech common stock held by entities owned or controlled by Vinod Khosla, and (iii) 972,539 shares of LanzaTech common stock held by limited partners of KV II not affiliated with Vinod Khosla. Khosla Ventures Associates III, LLC (&#8220;KVA III&#8221;) is the general partner of KV III. VK Services, LLC (&#8220;VK Services&#8221;) is the Manager of KVA III. Vinod Khosla is the Managing Member of VK Services. As such, (i) each of KVA III and VK Services may be deemed to be the beneficial owners having shared voting power and shared investment power over 13,875,332 shares of LanzaTech common stock, and (ii) Vinod Khosla may be deemed to be the beneficial owner having shared voting power and shared investment power over 42,867,361 shares of LanzaTech common stock, and each disclaims beneficial ownership of such securities except to the extent of his or its pecuniary interest therein. The business address of Vinod Khosla and each of the other entities listed in this footnote is 2128 Sand Hill Road, Menlo Park, CA 94025.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Consists of shares of Common Stock held by Guardians of New Zealand Superannuation, as the manager and administrator of the New Zealand Superannuation Fund. Matt Whineray, Chief Executive Officer, has direct voting and investment power over these shares. The business address of Guardians of New Zealand Superannuation is 21 Queen Street Level 12, Auckland 1010, New Zealand.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Any action by Sinopec Capital Co., Ltd. with respect to its shares, including voting and dispositive decisions, requires a vote of three out of the five members of its investment team. Under the so-called &#8220;rule of three,&#8221; because voting and dispositive decisions are made by three out of the five members of the investment team, none of the members is deemed to be a beneficial owner of securities held by Sinopec Capital Co., Ltd. Accordingly, none of the members of the investment team is deemed to have or share beneficial ownership of the shares held by Sinopec Capital Co., Ltd. The business address of Sinopec Capital Co., Ltd. is 22nd Floor, World Financial Center East Tower, 1 East 3rd Ring Middle Road, Chaoyang District, Beijing, China.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Novo Holdings A/S has the sole power to vote and dispose of the shares, and no individual or other entity is deemed to hold any beneficial ownership in the shares. The business address of Novo Holdings A/S is Tuborg Havnevej 19, 2900 Hellerup, Denmark. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">137</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_1786"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Policies and Procedures for Related Party Transactions </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon consummation of the Business Combination, the Board adopted a written Related Party Transactions Policy that sets forth LanzaTech&#8217;s policies and procedures regarding the notification, review, approval, ratification and disclosure of &#8220;related party transactions.&#8221; For purposes of LanzaTech&#8217;s policy, a &#8220;related party transaction&#8221; is a transaction, arrangement or relationship (or any series of similar transactions, arrangements or relationships) in which LanzaTech or any of its subsidiaries are participants involving an amount that exceeds $120,000, in which any &#8220;related person&#8221; has or will have a direct or indirect material interest. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transactions involving compensation for services provided to LanzaTech as an employee or director will not be considered related party transactions under this policy. A &#8220;related person&#8221; is any executive officer, director, nominee to become a director, a holder of more than 5% of any class of LanzaTech&#8217;s voting securities, including any of their immediate family members and affiliates, including entities owned or controlled by such persons, and any entity that employs any of the foregoing persons, of which any of the foregoing persons is a general partner, officer or serves in a similar position, or in which any of the foregoing persons has a 10% percent or greater beneficial ownership interest. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the policy, the related person in question or, in the case of transactions with a holder of more than 5% of any class of LanzaTech&#8217;s voting securities, any director or employee with knowledge of a proposed transaction, must present information regarding the proposed related party transaction to the audit committee of the Board for review. To identify related party transactions in advance, LanzaTech will rely on information supplied by its executive officers, directors and certain significant stockholders. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The audit committee will approve only those transactions that it determines are in LanzaTech&#8217;s best interests. The transactions described below under the subheadings &#8220;Pre-Business Combination AMCI Related Party Transactions&#8221; and &#8220;Legacy LanzaTech Related Party Transactions&#8221; were entered into prior to the adoption of the Related Party Transactions Policy. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LanzaTech Related Party Transactions </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lock-up Agreements </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Directors, officers and employees of Legacy LanzaTech are subject to certain restrictions on transfer as set forth in the lock-up agreements between LanzaTech and each such director, officer or employee (the &#8220;Lock-Up Agreements&#8221;) with respect to shares of common stock and related securities held by such persons or affiliates of such persons immediately following the closing of the Business Combination, issuable to such persons or such persons&#8217; affiliates in the Merger, or issuable to such persons upon settlement or exercise of equity awards or warrants.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The restrictions on transfer for directors and officers of Legacy LanzaTech will end on the earlier of (i) the date that is one year following the Closing Date, (ii) such date upon which the closing price per share of common stock equals or exceeds $12.00 per share for any 20 trading days within any 30-day trading period commencing at least 150 days after the Closing and (iii) the date on which LanzaTech completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction after the Business Combination that results in all of LanzaTech&#8217;s stockholders having the right to exchange their shares of common stock for cash, securities or other property. The restrictions on transfer for Legacy LanzaTech employees that are not directors or officers will end on the date that is six months following the Closing.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, AMCI, the Sponsor and the AMCI Insiders have agreed that the lock-up period applicable to the 3,750,000 shares of common stock held by the AMCI Insiders will end on the earlier of (i) the date that is one year following the Closing, (ii) the date on which AMCI consummates a liquidation, merger, capital stock exchange or other similar transaction after the Closing that results in all of AMCI&#8217;s stockholders having the right to exchange their common stock for cash, securities or other property, (iii) the valid termination of the Sponsor Support Agreement entered into in connection with AMCI&#8217;s IPO, and (iv) the date on which the volume weighted average </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">closing sale price of the shares of common stock is equal to or greater than $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Closing.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing description of the Lock-up Agreements are subject to and qualified in their entirety by reference to the full text of the form of Lock-up Agreement, a copy of which is attached as Exhibit 10.1 to the registration statement of which this prospectus forms a part, and the terms of which are incorporated herein by reference. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Registration Rights Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the consummation of the Business Combination, AMCI and Legacy LanzaTech entered into a Registration Rights Agreement that AMCI, the Sponsor, certain stockholders of AMCI, Legacy LanzaTech, and certain stockholders of Legacy LanzaTech. Pursuant to the Registration Rights Agreement, we granted the parties thereto certain customary registration rights with respect to certain shares of common stock and warrants.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Registration Rights Agreement provides that the Sponsor, then-holders of all outstanding shares of AMCI Class&#160;B common stock, and certain holders of shares of Legacy LanzaTech capital stock will be subject to certain restrictions on transfer with respect to their shares of common stock and LanzaTech warrants. Such restrictions will end (i)&#160;with respect to the Sponsor and the holders of AMCI Class&#160;B common stock, on the earlier of (a)&#160;the date that is one&#160;year following the closing of the Business Combination, (b)&#160;such date upon which the closing price per share of common stock equals or exceeds $12.00 per share for any 20 trading&#160;days within any 30&#160;day trading period commencing at least 150&#160;days after the closing of the Business Combination and (c)&#160;the date on which LanzaTech completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction after the Business Combination that results in all of LanzaTech&#8217;s stockholders having the right to exchange their shares of common stock for cash, securities or other property, and (ii)&#160;with respect to the holders of shares of Legacy LanzaTech capital stock, on the date that is six&#160;months following the closing of the Business Combination.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification Agreements </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with consummating the Business Combination, LanzaTech entered into customary indemnification agreements with the directors and executive officers of LanzaTech following the Business Combination. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pre-Business Combination AMCI Related Party Transactions </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Founder Shares</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;29, 2021, the Sponsor paid $25,000, or approximately $0.005 per share, to cover certain offering costs in consideration for 5,031,250 shares common stock. In March&#160;2021, the Sponsor transferred all of the founder shares held by it to members of the AMCI Board, management team and persons or entities affiliated with AMCI Group. Such shares are fully paid. On May&#160;14, 2021, certain of AMCI&#8217;s initial stockholders forfeited an aggregate of 718,750 founder shares, resulting in an aggregate of 4,312,500 founder shares outstanding. On September&#160;17, 2021, the over-allotment option granted in connection with AMCI&#8217;s IPO expired unexercised, resulting in the 562,500 additional founder shares being forfeited.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Agreements with Anchor Investors</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the terms of the letter agreements entered into between AMCI and certain qualified institutional buyers or institutional accredited investors who purchased units in the IPO, including entities affiliated with Apollo Capital Management, L.P., Adage Capital Partners, L.P., Shaolin Capital Management, LLC and Aristeia Capital, LLC, (the &#8220;Anchor Investors&#8221;), certain of AMCI&#8217;s initial stockholders agreed to sell an aggregate of 780,000 founder shares to the Anchor Investors concurrently with the Closing. The Anchor Investors were introduced to AMCI through Evercore, in Evercore&#8217;s capacity as underwriter of AMCI&#8217;s IPO. AMCI determined that the fair value of these founder shares was approximately $6.5 million (or approximately $8.35 per share) using a Monte Carlo simulation. AMCI recognized the excess fair value of these founder shares, over the price sold to the </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">139</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anchor Investors, as an expense of the IPO resulting in a charge against the carrying value of AMCI Class A common stock subject to possible redemption. None of the Anchor Investors are &#8220;related persons&#8221; with respect to AMCI or LanzaTech as such term is defined in Item 404(a) of Regulation S-K.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Private Placement Warrants</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of 3,500,000 Private Placement Warrants, each exercisable to purchase one share of AMCI Class A common stock at $11.50 per share, at a price of $1.00 per warrant, or $3,500,000 in the aggregate.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Private Placement Warrants are not redeemable by AMCI so long as they are held by the initial purchasers or their permitted transferees. The initial purchasers, or their permitted transferees, have the option to exercise the Private Placement Warrants on a cashless basis. If the Private Placement Warrants are held by holders other than initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable and exercisable by the holders on the same basis as the warrants included in the units sold in the IPO. Otherwise, the Private Placement Warrants have terms and provisions that are identical to those of the warrants sold as part of the units in the IPO.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the units sold in the IPO.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Private Placement </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Private Placement, AMCI Group, LLC Series&#160;35, an entity in which Hans Mende, a director of AMCI, holds voting and investment control, subscribed for 1,700,000 shares of AMCI Class A common stock for an aggregate purchase price of $17,000,000. In connection with the consummation of the Business Combination, all of the issued and outstanding shares of AMCI Class A common stock, including the shares of AMCI Class A common stock issued to AMCI Group, LLC Series&#160;35, became shares of common stock. AMCI Group, LLC Series 35 is a member of the Sponsor and a beneficial owner of more than 5% of AMCI&#8217;s currently outstanding securities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sponsor Support Agreement and Sponsor Letter Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the IPO, the Sponsor and the other AMCI Insiders entered into a letter agreement with AMCI, pursuant to which they agreed to (i)&#160;waive their redemption rights with respect to any founder shares and public shares they hold in connection with the completion of AMCI&#8217;s initial business combination, (ii)&#160;waive their redemption rights with respect to any founder shares and public shares they hold in connection with a stockholder vote to approve an amendment to AMCI&#8217;s amended and restated certificate of incorporation to modify the substance or timing of its obligation to redeem 100% of its public shares if AMCI had not consummated an initial business combination within 24&#160;months from the closing of the IPO or with respect to any other material provisions relating to stockholders&#8217; rights or pre-initial business combination activity and (iii)&#160;waive their rights to liquidating distributions from the Trust Account with respect to any founder shares they hold if AMCI failed to complete an initial business combination within 24&#160;months from the closing of the IPO or during any extended period of time as a result of an amendment to our amended and restated certificate of incorporation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the execution of the Merger Agreement, the Sponsor and the holders of all of the shares of AMCI Class B common stock, including the AMCI Insiders, entered into the Sponsor Support Agreement with AMCI and Legacy LanzaTech, pursuant to which each AMCI Insider agreed, among other things, to: (i)&#160;vote all the AMCI Shares held by such AMCI Insider (a)&#160;in favor of each of the condition precedent proposals and (b)&#160;against a business combination not relating to the Business Combination and any other action that would reasonably be expected to (x)&#160;materially impede, interfere with, delay, postpone or adversely affect the Business Combination or any of the other transactions contemplated by the Merger Agreement, (y)&#160;to the knowledge of such AMCI Insider, result in a material breach of any covenant, representation or warranty or other obligation or agreement of AMCI under the Merger Agreement or (z)&#160;result in a material breach of any covenant, representation or warranty or other obligation or agreement contained in the Sponsor Support Agreement; (ii)&#160;irrevocably waive any anti-dilution right or other protection with respect to the shares of AMCI Class B common stock that would result in the AMCI Class </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B common stock converting into AMCI Class A common stock at a ratio greater than one-for-one; and (iii)&#160;not to elect to redeem their respective shares of common stock of AMCI in connection with the Business Combination. In addition, under the Sponsor Support Agreement, the AMCI Insiders agreed to forfeit, on a pro rata basis, the at-risk founder shares in the event that there was an excess redemption&#160;percentage of the issued and outstanding shares of AMCI Class A common stock.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Administrative Service Fee</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the closing of the IPO, AMCI agreed to pay its Sponsor $10,000 per month for office space and secretarial and administrative services provided to members of the management team. For the three months ended September 30, 2022 and 2021, AMCI incurred $30,000 and $20,000 of such fees, respectively, which are included as general and administrative fees &#8212; related party on AMCI&#8217;s unaudited condensed statements of operations included elsewhere in this prospectus. For the nine months ended September 30, 2022 and for the period from January 28 (inception) through September 30, 2021, AMCI incurred $90,000 and $20,000 of such fees, respectively, which are included as general and administrative fees &#8212; related party on AMCI&#8217;s unaudited condensed statements of operations included elsewhere in this prospectus.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legacy LanzaTech Related Party Transactions </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Private Placement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the execution of the Merger Agreement, AMCI entered into the Initial Subscription Agreements with certain PIPE Investors, pursuant to which such PIPE Investors agreed to purchase, and AMCI agreed to sell to such PIPE Investors, an aggregate of 12,500,000 shares of common stock, for a purchase price of $10.00 per share and an aggregate purchase price of $125,000,000, in the Private Placement. Such aggregate number of shares and aggregate purchase price include 3,000,000 shares of common stock to be issued to ArcelorMittal pursuant to the AM SAFE with Legacy LanzaTech, as a result of which such PIPE Investor entered into an Initial Subscription Agreement prior to the closing.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AMCI also entered into the Additional Subscription Agreements with certain PIPE Investors pursuant to which AMCI agreed to issue and sell in a private placement an aggregate of 5,500,000 shares of common stock to such PIPE Investors for $10.00 per share and an aggregate purchase price of $55,000,000. PIPE Investors agreed to purchase shares of common stock for an aggregate purchase price of $185,000,000 in the Private Placement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech and Mitsui are party to certain collaboration and investment agreements described in the section entitled &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Key Collaboration Agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mitsui, ArcelorMittal, BASF, Primetals, Oxy, SHV and Trafigura are commercial partners of LanzaTech.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below sets forth the number of shares of common stock purchased by LanzaTech&#8217;s related parties:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Person</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares&#160;of <br/>Class A<br/>Common <br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash&#160;Purchase<br/>Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Guardians of New Zealand Superannuation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Khosla Ventures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">K One W One</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Guardians of New Zealand Superannuation is the manager and administrator of the New Zealand Superannuation Fund.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) Represents 1,000,000 shares of common stock purchased by Future Solutions Investments, LLC for an aggregate purchase price of $10,000,000.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3) Represents 200,000 shares of common stock purchased by K One W One (No. 3) Ltd. for an aggregate purchase price of $2,000,000.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LanzaTech Stockholder Support Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the execution of the Merger Agreement, holders of 69.56% of the LanzaTech voting shares in the aggregate entered into the LanzaTech Stockholder Support Agreement, pursuant to which, among other </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">things, they agreed to vote in favor of the adoption of the Merger Agreement and any other matters necessary or reasonably requested by AMCI or Legacy LanzaTech for consummation of the Business Combination.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Financings</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Series&#160;E Preferred Financing</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July&#160;2019, Legacy LanzaTech issued and sold an aggregate of 3,149,745 shares of its Series&#160;E preferred stock (the &#8220;Series&#160;E Preferred&#8221;) at a purchase price of $22.859 per share, for an aggregate purchase price of $72.0 million.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Series&#160;E-1 Preferred Financing</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February&#160;2020, Legacy LanzaTech issued and sold an aggregate of 2,034,212 shares of its Series&#160;E-1 preferred stock (the &#8220;Series&#160;E-1 Preferred&#8221;) at a purchase price of $22.859 per share, for an aggregate purchase price of $46.5 million.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Series&#160;F Preferred Financing</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December&#160;2020, Legacy LanzaTech issued and sold an aggregate of 3,634,210 shares of its Series&#160;F preferred stock (the &#8220;Series&#160;F Preferred&#8221;) at a purchase price of $22.859 per share, for an aggregate purchase price of $83.1 million. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the shares of Series&#160;E Preferred, Series&#160;E-1 Preferred and Series&#160;F Preferred acquired by Legacy LanzaTech&#8217;s directors, executive officers, or holders of more than 5% of LanzaTech&#8217;s capital stock, or any member of the immediate family of the foregoing persons, in the financing transactions described above.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.596%"><tr><td style="width:1.0%"></td><td style="width:41.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.036%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.036%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.036%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.176%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Person</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Series&#160;E<br/>Preferred</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Series&#160;E-1<br/>Preferred</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Series&#160;F<br/>Preferred</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash<br/>Purchase&#160;Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Guardians of New Zealand Superannuation</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,312,394&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,000,014.45&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sinopec Capital Co., Ltd.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,074,406.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LanzaJet Shareholder Loan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 9, 2022, Legacy LanzaTech and the other LanzaJet shareholders entered into the LanzaJet Note Purchase Agreement, pursuant to which FPF, a wholly owned subsidiary of LanzaJet, will issue, from time to time, the LanzaJet Notes in an aggregate principal amount of up to $147.0 million, comprised of approximately $113.5&#160;million aggregate principal amount of 6.00% Senior Secured Notes due December 31, 2043 and $33.5&#160;million aggregate principal amount of 6.00% Subordinated Secured Notes due December 31, 2043. Legacy LanzaTech has committed to purchase $5.5 million of Subordinated Secured Notes in a funding expected to occur on May 1, 2023. The Senior Secured Notes are secured by a security interest over substantially all assets of FPF, and both the Senior Secured Notes and the Subordinated Secured Notes are secured by a security interest over all intellectual property owned or in-licensed by LanzaJet. LanzaJet also provides a guarantee of any costs and expenses required to complete the LanzaJet Freedom Pines Demonstration Facility and achieve commercial operation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each purchaser of LanzaJet Notes under the LanzaJet Note Purchase Agreement is also entitled to receive a warrant for the right to purchase 575 shares of common stock of LanzaJet for each $10,000 of Notes purchased by such purchaser (which, in the case of the Company, will be equal to a right to purchase 316,250 shares of common stock of LanzaJet). </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LanzaJet Note Purchase Agreement may be amended with the approval of holders of FPF and all of the holders of the LanzaJet Notes. Upon an event of default under the LanzaJet Note Purchase Agreement, each purchaser may accelerate its own LanzaJet Notes. Enforcement against the collateral securing the LanzaJet Notes requires the approval of certain holders as specified in the LanzaJet Notes.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">142</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employment Agreements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech has entered into employment agreements with each of its executive officers. These agreements provide for at-will employment for no specified period, and provide for an initial base salary and bonus target. LanzaTech has also entered into customary confidentiality, non-competition, and assignment of inventions agreements with each executive officer. Additional information regarding employment agreements with LanzaTech&#8217;s named executive officers is discussed above under the section entitled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Executive Compensation &#8212; Executive Employment Agreements and Other Arrangements.&#8221;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_1807"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DESCRIPTION OF SECURITIES </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following summary of the material terms of the common stock, preferred stock and our Private Placement Warrants is not intended to be a complete summary of the rights and preferences of such securities, and is qualified by reference to the applicable warrant agreement and to our Charter and Bylaws, which are exhibits to the registration statement of which this prospectus forms a part. We urge you to read the applicable warrant agreement and our Charter and Bylaws in their entirety for a complete description of the rights and preferences of our securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Authorized and Outstanding Stock</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Charter authorizes the issuance of 420,000,000 shares, consisting of 400,000,000 shares of common stock, $0.0001 par value per share, and 20,000,000 shares of preferred stock, $0.0001 par value per share. As of the date of this prospectus, there were 196,222,737 shares of common stock outstanding. No shares of preferred stock are currently outstanding.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Charter provides the following with respect to the rights, powers, preferences and privileges of the common stock.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Voting Power</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise required by law or as otherwise provided in any certificate of designation for any series of preferred stock, the holders of shares of common stock possess all voting power for the election of LanzaTech&#8217;s directors and all other matters requiring stockholder action. Holders of shares of common stock are entitled to one vote for each share held on all matters to be voted on by stockholders.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividends</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of shares of common stock will be entitled to receive such dividends, if any, as may be declared from time to time by the Board in its discretion out of funds legally available therefor. AMCI has not historically paid any cash dividends on the common stock to date and we do not intend to pay cash dividends in the foreseeable future. Any payment of cash dividends in the future will be dependent upon LanzaTech&#8217;s revenues and earnings, if any, capital requirements and general financial conditions. In no event will any stock dividends or stock splits or combinations of stock be declared or made on shares of common stock unless the shares of common stock at the time outstanding are treated equally and identically.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidation, Dissolution and Winding Up</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of LanzaTech&#8217;s voluntary or involuntary liquidation, dissolution, distribution of assets or winding-up, the holders of shares of common stock will be entitled to receive an equal amount per share of all of LanzaTech&#8217;s assets of whatever kind available for distribution to stockholders, after the rights of the holders of the preferred stock have been satisfied.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Preemptive or Other Rights</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LanzaTech stockholders have no preemptive or other subscription rights. No sinking fund provisions are applicable to the common stock. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Charter provides that shares of preferred stock may be issued from time to time in one or more series. The Board is authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. The Board will be able to, without stockholder approval, issue shares of preferred stock with voting and other rights that could adversely affect the voting power and other rights of the holders of the shares of common </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">144</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">stock and could have anti-takeover&#160;effects. The ability of the Board to issue shares of preferred stock without stockholder approval could have the effect of delaying, deferring or preventing a change of control of LanzaTech or the removal of existing management. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Registration Rights</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AMCI, certain of the Legacy LanzaTech stockholders and AMCI Stockholders entered into a Registration Rights Agreement, pursuant to which, among other things, such stockholders were granted certain registration rights with respect to certain shares of securities held by them. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anti-Takeover Provisions</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Charter and Bylaws</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among other things, the Charter and Bylaws:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">permit the Board to issue up to 20,000,000 shares of preferred stock, with any rights, preferences and privileges as they may designate, including the right to approve an acquisition or other change of control;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide that the number of directors of LanzaTech may be changed only by resolution of the Board;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide that, subject to the rights of any series of preferred stock to elect directors, directors may be removed only with cause by the holders of at least 66&#8532;% of all of LanzaTech&#8217;s then-outstanding shares of the capital stock entitled to vote generally at an election of directors;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide that all vacancies, including newly created directorships, may, except as otherwise required by law, be filled by the affirmative vote of a majority of directors then in office, even if less than a quorum;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide that stockholders seeking to present proposals before a meeting of stockholders or to nominate candidates for election as directors at a meeting of stockholders must provide advance notice in writing, and also specify requirements as to the form and content of a stockholder&#8217;s notice;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide that special meetings of LanzaTech&#8217;s stockholders may be called by the Board pursuant to a resolution adopted by a majority of the Board;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide that the Board will be divided into three classes of directors, with the classes to be as nearly equal as possible, and with the directors serving three-year terms, therefore making it more difficult for stockholders to change the composition of the Board; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">do not provide for cumulative voting rights, therefore allowing the holders of a majority of the shares of common stock entitled to vote in any election of directors to elect all of the directors standing for election, if they should so choose. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The combination of these provisions will make it more difficult for the existing stockholders to replace the Board as well as for another party to obtain control of LanzaTech by replacing the Board. Because the </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Board has the power to retain and discharge its officers, these provisions could also make it more difficult for existing stockholders or another party to effect a change in management. In addition, the authorization of undesignated preferred stock makes it possible for the Board to issue shares of preferred stock with voting or other rights or preferences that could impede the success of any attempt to change the control of LanzaTech.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These provisions are intended to enhance the likelihood of continued stability in the composition of the Board and its policies and to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to reduce LanzaTech&#8217;s vulnerability to hostile takeovers and to discourage certain tactics that may be used in proxy fights. However, such provisions could have the effect of discouraging others from making tender offers for LanzaTech&#8217;s shares and may have the effect of delaying changes in its control or management. As a consequence, these provisions may also inhibit fluctuations in the market price of LanzaTech&#8217;s Common Stock.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain Anti-Takeover Provisions of Delaware Law</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech is subject to the provisions of Section&#160;203 of the DGCL, which prevents certain Delaware corporations, under certain circumstances, from engaging in a &#8220;business combination&#8221; with:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a stockholder who owns 15% or more of our outstanding voting stock (otherwise known as an &#8220;interested stockholder&#8221;);</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an affiliate of an interested stockholder; or</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an associate of an interested stockholder, for three years following the date that the stockholder became an interested stockholder.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A &#8220;business combination&#8221; includes a merger or sale of more than 10% of a corporation&#8217;s assets.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">However, the above provisions of Section 203 would not apply if:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the relevant board of directors approves the transaction that made the stockholder an interested stockholder prior to the date of the transaction;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">after the completion of the transaction that resulted in the stockholder becoming an interested stockholder, that stockholder owned at least 85% of the corporation&#8217;s voting stock outstanding at the time the transaction commenced, other than statutorily excluded shares of common stock; or</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">on or subsequent to the date of the transaction, the initial business combination is approved by the board of directors and authorized at a meeting of the corporation&#8217;s stockholders, and not by written consent, by an affirmative vote of at least two-thirds of the outstanding voting stock not owned by the interested stockholder.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These provisions may have the effect of delaying, deferring, or preventing changes in control of LanzaTech.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Warrants</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Public Warrants</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Public Warrant entitles the registered holder to purchase one share of common stock at a price of $11.50&#160;per share, subject to adjustment as discussed below, at any time commencing 30&#160;days after the completion of the Business Combination. Pursuant to the warrant agreement, a Public Warrant holder may exercise its Public Warrants only for a whole number of shares of common stock. This means that only a whole Public Warrant may be exercised at any given time by a Public Warrant holder. No fractional Public Warrants were issued upon separation of AMCI&#8217;s units and only whole Public Warrants will trade. The Public Warrants will expire five&#160;years after the Closing, at 5:00&#160;p.m., New York City time, or earlier upon redemption or liquidation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not obligated to deliver any shares of common stock pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the&#160;Securities Act&#160;with respect to the shares of common stock underlying the Public Warrants is then effective and a prospectus relating thereto is current, subject to satisfaction of our obligations described below with respect to registration. No Public Warrant will be exercisable and we will not be obligated to issue shares of common stock upon exercise of a Public Warrant unless the common stock issuable upon such Public Warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the Public Warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a Public Warrant, the holder of such Public Warrant will not be entitled to exercise such Public Warrant and such Public Warrant may have no value and expire worthless. In no event will we be required to net cash settle any warrant. In the event that a registration statement is not effective for the exercised Public Warrants, the purchaser of a unit containing such Public Warrant will have paid the full purchase price for the unit solely for the share of common stock underlying such unit.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have agreed that as soon as practicable, but in no event later than 15 business&#160;days after the Closing, we will use our best efforts to file with the SEC a registration statement covering the shares of common stock issuable upon exercise of the Public Warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those shares of common stock until the Public Warrants expire or are redeemed, as specified in the warrant agreement. We cannot assure you that we will be able to do so if, for example, any facts or events arise which represent a fundamental change in the information set forth in the registration statement or prospectus, the financial statements contained or incorporated by reference therein are not current or correct or the SEC issues a stop order. If a registration statement covering the shares of common stock issuable upon exercise of the Public Warrants is not effective by the 60th business day after the Closing, Public Warrant holders may, until such time as there is an effective registration statement and during any period when we have failed to maintain an effective registration statement, exercise warrants on a &#8220;cashless basis&#8221; in accordance with Section&#160;3(a)(9)&#160;of the Securities Act or another exemption. Notwithstanding the above, if common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a &#8220;covered security&#8221; under Section&#160;18(b)(1)&#160;of the Securities Act, we may, at our option, require holders of Public Warrants who exercise their warrants to do so on a &#8220;cashless basis&#8221; in accordance with Section&#160;3(a)(9)&#160;of the Securities Act and, in the event we so elect, we will not be required to file or maintain in effect a registration statement, and in the event we do not so elect, we will use our best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. In such event, each holder would pay the exercise price by surrendering the Public Warrants for that number of shares of common stock equal to the lesser of (A)&#160;the quotient obtained by dividing (x)&#160;the product of the number of shares of common stock underlying the warrants, multiplied by the excess of the &#8220;fair market value&#8221; (defined below) less the exercise price of the warrants by (y)&#160;the fair market value and (B)&#160;0.361. The &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">fair market value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; as used in this paragraph shall mean the volume weighted average price of the common stock for the 10 trading&#160;days ending on the trading day prior to the date on which the notice of exercise is received by the warrant agent.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redemption of Public Warrant when the price per share of common stock equals or exceeds $18.00.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once the Public Warrants become exercisable, we may call the Public Warrants for redemption:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in whole and not in part;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at a price of $0.01 per warrant;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">upon a minimum of 30 days&#8217; prior written notice of redemption to each Public Warrant holder; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if, and only if, the closing price of common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing once the Public Warrants become exercisable and ending three trading days before we send the notice of redemption to the Public Warrant holders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not redeem the Public Warrants as described above unless a registration statement under the Securities Act covering the issuance of the common stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of common stock is available throughout the 30-day redemption period. If and when the Public Warrants become redeemable by us, we may exercise our redemption right even if we are unable to register or qualify the underlying securities for sale under all applicable state securities laws. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established the last of the redemption criteria discussed above to prevent a redemption call unless there is at the time of the call a significant premium to the Public Warrant exercise price. If the foregoing conditions are satisfied and we issue a notice of redemption of the Public Warrants, each Public Warrant holder will be entitled to exercise its Public Warrant prior to the scheduled redemption date. However, the price of the common stock may fall below the $18.00 redemption trigger price (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) as well as the $11.50 (for whole shares) warrant exercise price after the redemption notice is issued.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redemption of Public Warrants when the price per share of common stock equals or exceeds $10.00.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once the Public Warrants become exercisable, we may redeem the outstanding Public Warrants:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in whole and not in part&#894;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at $0.10 per warrant upon a minimum of 30 days&#8217; prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table below, based on the redemption date and the &#8220;fair market value&#8221; of the common stock except as otherwise described below&#894; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if, and only if, the closing price of the common stock equals or exceeds $10.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described below under the heading &#8220;&#8212; Anti-Dilution Adjustments&#8221;) for any 20 trading days within the 30-trading day period ending three trading days before we send the notice of redemption to the Public Warrant holders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning on the date the notice of redemption is given until the Public Warrants are redeemed or exercised, holders may elect to exercise their Public Warrants on a cashless basis. The numbers in the table below represent the number of shares of common stock that a Public Warrant holder will receive upon such cashless exercise in connection with a redemption by New LanzaTech pursuant to this redemption feature, based on the &#8220;fair market value&#8221; of common stock on the corresponding redemption date (assuming holders elect to exercise their Public Warrants and such warrants are not redeemed for $0.10 per warrant), determined for these purposes based on volume weighted average price of common stock during the 10 trading&#160;days immediately following the date on which the notice of redemption is sent to the holders of Public Warrants, and the number of&#160;months that the corresponding redemption date precedes the expiration date of the warrants, each as set forth in the table below. We will provide the Public Warrant holders with the final fair market value no later than one business day after the 10-trading day period described above ends. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The share prices set forth in the column headings of the table below will be adjusted as of any date on which the number of shares issuable upon exercise of a Public Warrant or the exercise price of a Public Warrant is adjusted as set forth under the heading &#8220;&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Anti-Dilution Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; below. If the number of shares issuable upon exercise of a Public Warrant is adjusted, the adjusted share prices in the column headings will equal the share prices immediately prior to such adjustment, multiplied by a fraction, the numerator of which is the number of shares deliverable upon exercise of a Public Warrant immediately prior to such adjustment and the denominator of which is the number of shares deliverable upon exercise of a Public Warrant as so adjusted. The number of shares in the table below shall be adjusted in the same manner and at the same time as the number of shares issuable upon exercise of a Public Warrant. If the exercise price of a Public Warrant is adjusted, (a)&#160;in the case of an adjustment pursuant to the second paragraph under the heading &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212; Other Terms</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; below, the adjusted share prices in the column headings will equal the unadjusted share price multiplied by a fraction, the numerator of which is the higher of the Market Value and the Newly Issued Price as set forth under the heading &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212; Other Terms</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and the denominator of which is $10.00 and (b)&#160;in the case of an adjustment pursuant to the second paragraph under the heading &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;Anti-Dilution </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">148</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; below, the adjusted share prices in the column headings will equal the unadjusted share price less the decrease in the exercise price of a public warrant pursuant to such exercise price adjustment.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.688%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.399%"></td><td style="width:0.1%"></td></tr><tr style="height:16pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redemption Date (period to expiration of Public Warrants)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Market Value of common stock</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&lt;10.00</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11.00</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12.00</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">13.00</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">14.00</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15.00</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16.00</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">17.00</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&gt;18.00</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 months</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.261</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.281</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.297</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.311</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.324</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.337</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.348</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.358</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.361</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 months</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.257</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.277</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.294</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.310</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.324</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.337</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.348</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.358</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.361</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 months</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.252</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.272</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.291</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.307</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.322</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.335</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.347</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.357</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.361</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 months</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.246</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.268</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.287</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.304</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.320</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.333</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.346</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.357</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.361</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48 months</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.241</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.263</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.283</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.301</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.317</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.332</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.344</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.356</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.361</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 months</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.235</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.258</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.279</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.298</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.315</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.330</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.343</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.356</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.361</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 months</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.228</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.252</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.274</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.294</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.312</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.328</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.342</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.355</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.361</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39 months</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.221</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.246</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.269</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.290</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.309</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.325</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.340</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.354</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.361</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 months</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.213</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.239</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.263</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.285</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.305</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.323</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.339</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.353</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.361</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 months</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.205</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.232</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.257</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.280</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.301</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.320</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.337</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.352</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.361</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 months</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.196</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.224</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.250</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.274</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.297</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.316</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.335</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.351</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.361</span></div></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.688%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.399%"></td><td style="width:0.1%"></td></tr><tr style="height:16pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redemption Date (period to expiration of Public Warrants)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Market&#160;Value&#160;of&#160;common stock</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&lt;10.00</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11.00</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12.00</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">13.00</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">14.00</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15.00</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16.00</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">17.00</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&gt;18.00</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 months</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.185</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.214</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.242</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.268</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.291</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.313</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.332</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.350</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.361</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 months</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.173</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.204</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.233</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.260</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.285</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.308</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.329</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.348</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.361</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 months</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.161</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.193</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.223</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.252</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.279</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.304</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.326</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.347</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.361</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 months</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.146</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.179</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.211</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.242</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.271</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.298</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.322</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.345</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.361</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 months</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.130</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.164</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.197</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.230</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.262</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.291</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.317</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.342</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.361</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 months</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.111</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.146</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.181</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.216</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.250</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.282</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.312</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.339</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.361</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 months</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.090</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.125</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.162</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.199</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.237</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.272</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.305</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.336</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.361</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 months</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.065</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.099</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.137</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.178</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.219</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.259</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.296</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.331</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.361</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 months</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.034</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.065</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.104</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.150</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.197</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.243</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.286</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.326</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.361</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0 months</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.042</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.115</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.179</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.233</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.281</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.323</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.361</span></div></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exact fair market value and redemption date may not be set forth in the table above, in which case, if the fair market value is between two values in the table or the redemption date is between two redemption dates in the table, the number of shares of common stock to be issued for each Public Warrant exercised will be determined by a straight-line interpolation between the number of shares set forth for the higher and lower fair market values and the earlier and later redemption dates, as applicable, based on a 365 or 366-day&#160;year, as applicable. For example, if the volume weighted average price of common stock during the 10 trading&#160;days immediately following the date on which the notice of redemption is sent to the holders of the Public Warrants is $11.00 per share, and at such time there are 57&#160;months until the expiration of the warrants, holders may choose to, in connection with this redemption feature, exercise their Public Warrants for 0.277 shares of common stock for each whole public warrant. For an example where the exact fair market value and redemption date are not as set forth in the table above, if the volume weighted average price of common stock during the 10 trading&#160;days immediately following the date on which the notice of redemption is sent to the holders of the Public Warrants is $13.50 per share, and at such time there are 38&#160;months until the expiration of the Public Warrants, holders may choose to, in connection with this redemption feature, exercise their Public Warrants for 0.298 shares of common stock for each whole Public Warrant. In no event will the Public Warrants be exercisable on a cashless basis in connection with this redemption feature for more than 0.361 shares of common stock per warrant (subject to adjustment). Finally, as reflected in the table above, if the Public Warrants are out of the money and about to expire, they cannot be exercised on a cashless basis in connection </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with a redemption by us pursuant to this redemption feature, since they will not be exercisable for any shares of common stock.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This redemption feature differs from the typical warrant redemption features used in other blank check offerings, which typically only provide for a redemption of warrants for cash (other than the Private Placement Warrants) when the trading price for the underlying common stock exceeds $18.00 per share for a specified period of time. This redemption feature is structured to allow for all of the outstanding Public Warrants to be redeemed when the common stock is trading at or above $10.00 per share, which may be at a time when the trading price of the common stock is below the exercise price of the Public Warrants. We have established this redemption feature to provide us with the flexibility to redeem the Public Warrants without the warrants having to reach the $18.00 per share threshold set forth above under &#8220;&#8212;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redemption of Public Warrants when the price per share of the common stock equals or exceeds $18</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">00</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221; Holders choosing to exercise their Public Warrants in connection with a redemption pursuant to this feature will, in effect, receive a number of shares for their Public Warrants based on an</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">option pricing model with a fixed volatility input. This redemption right provides us with an additional mechanism by which to redeem all of the outstanding Public Warrants, and therefore have certainty as to our capital structure as the Public Warrants would no longer be outstanding and would have been exercised or redeemed and we will be required to pay the redemption price to Public Warrant holders if we choose to exercise this redemption right and it will allow us to quickly proceed with a redemption of the Public Warrants if we determine it is in our best interest to do so. As such, we would redeem the Public Warrants in this manner when we believes it is in our best interest to update our capital structure to remove the Public Warrants and pay the redemption price to the Public Warrant holders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As stated above, we can redeem the Public Warrants when the common stock is trading at a price starting at $10.00, which is below the exercise price of $11.50, because it will provide certainty with respect to our capital structure and cash position while providing Public Warrant holders with the opportunity to exercise their warrants on a cashless basis for the applicable number of shares. If we choose to redeem the Public Warrant when the common stock is trading at a price below the exercise price of the Public Warrants, this could result in the Public Warrant holders receiving fewer shares of common stock than they would have received if they had chosen to wait to exercise their Public Warrants for Common Stock if and when such Common Stock was trading at a price higher than the exercise price of $11.50.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No fractional shares of common stock will be issued upon exercise. If, upon exercise, a holder would be entitled to receive a fractional interest in a share, we will round down to the nearest whole number of the number of shares of common stock to be issued to the holder. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redemption Procedures</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A holder of a Public Warrant may notify us in writing in the event it elects to be subject to a requirement that such holder will not have the right to exercise such Public Warrant, to the extent that after giving effect to such exercise, such person (together with such person&#8217;s affiliates), to the warrant agent&#8217;s actual knowledge, would beneficially own in excess of 4.9% or 9.8% (as specified by the holder) of the common stock outstanding immediately after giving effect to such exercise.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anti-Dilution Adjustments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the number of outstanding shares of common stock is increased by a capitalization or share dividend payable in Common Stock, or by a split-up&#160;of shares of common stock or other similar event, then, on the effective date of such stock dividend, split-up&#160;or similar event, the number of shares of common stock issuable on exercise of each whole Public Warrant will be increased in proportion to such increase in the outstanding ordinary stock. A rights offering made to all or substantially all holders of common stock entitling holders to purchase common stock at a price less than the &#8220;historical fair market value&#8221; (as defined below) will be deemed a share dividend of a number of shares of common stock equal to the product of (i)&#160;the number of shares of common stock actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for common stock) and (ii)&#160;one minus the quotient of (x)&#160;the price per share of common stock paid in such rights offering and (y)&#160;the historical fair market value. For these purposes, (a)&#160;if the rights offering is for </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">150</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">securities convertible into or exercisable for common stock, in determining the price payable for Common Stock, there will be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (b)&#160;&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">historical fair market value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the volume weighted average price of common stock as reported during the 10 trading day period ending on the trading day prior to the first date on which the common stock trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if we, at any time while the warrants are outstanding and unexpired, pay a dividend or make a distribution in cash, securities or other assets to the holders of shares of common stock on account of such shares (or other securities into which the warrants are convertible), other than (a)&#160;as described above, or (b)&#160;any cash dividends or cash distributions which, when combined on a per share basis with all other cash dividends and cash distributions paid on the common stock during the 365-day period ending on the date of declaration of such dividend or distribution does not exceed $0.50 (as adjusted to appropriately reflect any other adjustments and excluding cash dividends or cash distributions that resulted in an adjustment to the exercise price or to the number of shares of common stock issuable on exercise of each Public Warrant) but only with respect to the amount of the aggregate cash dividends or cash distributions equal to or less than $0.50 per share, then the warrant exercise price will be decreased, effective immediately after the effective date of such event, by the amount of cash and/or the fair market value of any securities or other assets paid on each share of common stock in respect of such event.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the number of outstanding shares of common stock is decreased by a consolidation, combination, reverse stock split or reclassification of shares of common stock or other similar event, then, on the effective date of such consolidation, combination, reverse stock split, reclassification or similar event, the number of shares of common stock issuable on exercise of each Public Warrant will be decreased in proportion to such decrease in outstanding shares of common stock.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Whenever the number of shares of common stock purchasable upon the exercise of the Public Warrants is adjusted, as described above, the Public Warrant exercise price will be adjusted by multiplying the Public Warrant exercise price immediately prior to such adjustment by a fraction (x)&#160;the numerator of which will be the number of shares of common stock purchasable upon the exercise of the Public Warrants immediately prior to such adjustment, and (y)&#160;the denominator of which will be the number of shares of common stock so purchasable immediately thereafter.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In case of any reclassification or reorganization of the outstanding shares of common stock (other than those described above or that solely affects the par value of such shares of common stock), or in the case of any merger or consolidation of LanzaTech with or into another corporation (other than a consolidation or merger in which we are the continuing corporation and that does not result in any reclassification or reorganization of the outstanding shares of common stock), or in the case of any sale or conveyance to another corporation or entity of the assets or other property of LanzaTech as an entirety or substantially as an entirety in connection with which we are dissolved, the holders of the Public Warrants will thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the Public Warrants and in lieu of the common stock immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of common stock or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the Public Warrants would have received if such holder had exercised their Public Warrants immediately prior to such event. However, if less than 70% of the consideration receivable by the holders of common stock in such a transaction is payable in the form of common stock in the successor entity that is listed for trading on a national securities exchange or is quoted in an established over-the-counter&#160;market, or is to be so listed for trading or quoted immediately following such event, and if the registered holder of the Public Warrant properly exercises the Public Warrant within 30&#160;days following public disclosure of such transaction, the Public Warrant exercise price will be reduced as specified in the warrant agreement based on the Black-Scholes&#160;value (as defined in the warrant agreement) of the Public Warrant. The purpose of such exercise price reduction is to provide additional value to holders of the Public Warrants when an extraordinary transaction occurs during the exercise period of the Public Warrants pursuant to which the holders of the warrants otherwise do not receive the full potential value of the Public Warrants in order to determine and realize the option value component of the Public Warrant. This formula is to compensate the Public Warrant holder for the loss of the option value portion of the Public Warrant due to the </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">151</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">requirement that the Public Warrant holder exercise the Public Warrant within 30&#160;days of the event. The Black-Scholes&#160;model is an accepted pricing model for estimating fair market value where no quoted market price for an instrument is available.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Terms</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Public Warrants are issued in registered form under a warrant agreement between Continental Stock Transfer&#160;&amp; Trust Company, as warrant agent, and us. The warrant agreement provides that the terms of the Public Warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision, and that all other modifications or amendments will require the vote or written consent of the holders of at least 50% of the then outstanding Public Warrants, and, solely with respect to any amendment to the terms of the Private Placement Warrants, a majority of the then outstanding Private Placement Warrants.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Public Warrants may be exercised upon surrender of the warrant certificate on or prior to the expiration date at the offices of the warrant agent, with the exercise form on the reverse side of the warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price (or on a cashless basis, if applicable), by certified or official bank check payable to us, for the number of Public Warrants being exercised. The Public Warrant holders do not have the rights or privileges of holders of common stock and any voting rights until they exercise their Public Warrants and receive Common Stock. After the issuance of common stock upon exercise of the Public Warrants, each holder will be entitled to one vote for each share held of record on all matters to be voted on by stockholders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No fractional shares will be issued upon exercise of the Public Warrants. If, upon exercise of the Public Warrants, a holder would be entitled to receive a fractional interest in a share, we will, upon exercise, round down to the nearest whole number of shares of common stock to be issued to the warrant holder.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Private Placement Warrants</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as described below, the Private Placement Warrants have terms and provisions that are identical to those of the Public Warrants. The Private Placement Warrants (including the common stock issuable upon exercise of the Private Placement Warrants) will not be transferable, assignable or salable until 30&#160;days after the Closing (except pursuant to limited exceptions to AMCI&#8217;s officers and directors and other persons or entities affiliated with the initial purchasers of the Private Placement Warrants) and they will not be redeemable by us so long as they are held by the Sponsor or its permitted transferees. The Sponsor, or its permitted transferees, has the option to exercise the Private Placement Warrants on a cashless basis. If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by us in all redemption scenarios and exercisable by the holders on the same basis as the Public Warrants.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If holders of the Private Placement Warrants elect to exercise them on a cashless basis, they would pay the exercise price by surrendering their warrants for that number of shares of common stock equal to the quotient obtained by dividing (x)&#160;the product of the number of shares of common stock underlying the warrants, multiplied by the excess of the &#8220;Sponsor fair market value&#8221; (defined below) over the exercise price of the warrants by (y)&#160;the Sponsor fair market value. For these purposes, the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sponsor fair market value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean the average reported closing price of the common stock for the 10 trading&#160;days ending on the third trading day prior to the date on which the notice of warrant exercise is sent to the warrant agent. The reason that these warrants will be exercisable on a cashless basis so long as they are held by the Sponsor and its permitted transferees is because if they remain affiliated with us, their ability to sell our securities in the open market will be significantly limited. We have policies in place that restrict insiders from selling our securities except during specific periods of time. Even during such periods of time when insiders will be permitted to sell our securities, an insider cannot trade in our securities if he or she is in possession of material non-public information. Accordingly, unlike public stockholders who could exercise their warrants and sell the common stock received upon such exercise freely in the open market in order to recoup the cost of such exercise, the insiders could be significantly restricted from selling such securities. As a result, we believe that allowing the holders to exercise such warrants on a cashless basis is appropriate.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AMCI&#8217;s initial stockholders have agreed not to transfer, assign or sell any of the Private Placement Warrants (including the common stock issuable upon exercise of any of these warrants) until the date that is 30&#160;days after the </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">152</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Closing, except that, among other limited exceptions, transfers can be made to AMCI&#8217;s officers and directors and other persons or entities affiliated with the Sponsor.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward Purchase Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 3, 2023, AMCI, Legacy LanzaTech and ACM entered into the Forward Purchase Agreement for an over-the-counter Equity Prepaid Forward Transaction (the &#8220;Forward Purchase Transaction&#8221;). For purposes of the Forward Purchase Agreement, ACM is referred to as the &#8220;Seller&#8221; and AMCI and LanzaTech are referred to as the &#8220;Counterparty&#8221; prior to and after the Business Combination, respectively. Pursuant to the terms of the Forward Purchase Agreement, the Seller purchased through a broker in the open market 5,916,514 shares of AMCI&#8217;s common stock before the closing of the Business Combination (the &#8220;Closing&#8221;) from holders of AMCI&#8217;s common shares (other than AMCI), including from holders who had previously elected to redeem their shares (such purchased shares, and the successor shares following the Closing, the &#8220;Recycled Shares&#8221;) in connection with the Business Combination pursuant to the redemption rights set forth in AMCI&#8217;s Amended and Restated Certificate of Incorporation (such holders, &#8220;Redeeming Holders&#8221;). The aggregate total number of shares subject to the Forward Purchase Agreement (the &#8220;Number of Shares&#8221;) is 10,000,000. The Number of Shares is subject to reduction following termination of the Forward Purchase Agreement with respect to the Recycled Shares as described under &#8220;Optional Early Termination&#8221; in the Forward Purchase Agreement. Unless in connection with an optional early termination, the Seller has agreed to hold the Recycled Shares in a bankruptcy remote special purpose vehicle for the benefit of the Counterparty. The Seller also may not beneficially own greater than 9.9% of our outstanding common shares.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the Forward Purchase Agreement, the Seller was paid directly, out of the funds held in the Trust Account $60.1 million (the &#8220;Prepayment Amount&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We agreed to file a registration statement with the SEC registering the resale of the Recycled Shares and the Share Consideration (as defined below) (the &#8220;Registration Statement&#8221;) under the Securities Act of 1933, within 45 days following the request of the Seller. From time to time following the Closing and only after the effectiveness of the Registration Statement (the &#8220;Registration Statement Effective Date&#8221;), the Seller may, at its discretion, provide a shortfall sale notice to the Counterparty without a payment obligation to the Counterparty (the &#8220;Shortfall Sales&#8221;) until such time as the aggregate amount indicated on such shortfall sale notices equals $2,500,000 (the &#8220;Prepayment Shortfall&#8221;). The Prepayment Shortfall will increase by $7,500,000 if the Counterparty fails to repay to the Seller the Prepayment Shortfall in full within 30 days from the Closing. For 30 days following the Closing, the Seller will not sell any Recycled Shares at a price below $10.00 per share. The Counterparty has agreed that it will not issue any shares, or securities or debt that is convertible, exercisable or exchangeable into shares until the gross proceeds indicated in the shortfall sales notices equal the Prepayment Shortfall, except under certain circumstances as further described in the Forward Purchase Agreement. The Seller in its sole discretion may request warrants of the Counterparty exercisable for shares in an amount equal to (i) 10,000,000 shares less (ii) (a) the number of Recycled Shares at the outset of the Forward Purchase Transaction plus (b) the number of shares indicated on the shortfall sale notice by the Seller that reduces the Prepayment Shortfall (the &#8220;Shortfall Warrants&#8221;). The Shortfall Warrants will have an exercise price equal to the Reset Price.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Seller may also, at its discretion and at any time, provide a notice under &#8220;OET Sales.&#8221; The Seller may deliver an OET notice and return to the Counterparty the product of the Reset Price and the number of shares listed on the OET notice. Following the Closing, the reset price (the &#8220;Reset Price&#8221;) will initially be the per share Redemption Price; provided, however, that the Reset Price may be reduced to any lower price at which the Counterparty sells, issues or grants any shares or securities convertible or exchangeable into shares (other than grants or issuances under the Counterparty&#8217;s equity compensation plans or shares underlying warrants issued in connection with the Business Combination), subject to certain exceptions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity date will be the third anniversary of the Closing (the &#8220;Maturity Date&#8221;). Upon the occurrence of the Maturity Date, the Counterparty is obligated to pay to Seller an amount equal to the product of (1) (a) the lesser of the Maximum Number of Shares and 7,500,000 less (b) the number of Terminated Shares multiplied by (2) $2.00, or $3.25 if the Counterparty fails to repay to the Seller the Prepayment Shortfall in full within 30 days of the closing of the Business Combination (the &#8220;Maturity Consideration&#8221;). At the Maturity Date, the Counterparty will be entitled to </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">153</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">deliver the Maturity Consideration to the Seller in cash or shares calculated based on the average daily VWAP Price over 30 trading days ending on the later of the Maturity Date and the date on which such shares are registered. The Maturity Date may be accelerated by Seller, at its discretion, if, among other termination events, following the Closing, the VWAP Price is below (i) if the Counterparty has not repaid the Prepayment Shortfall in full, then (a) $3.00 per Share for any 20 trading days during a 30 consecutive trading day-period that ends during the first 90 days after the date of the Forward Purchase Agreement, and (b) $6.00 per Share thereafter, and (b) if the Counterparty has repaid the Prepayment Shortfall in full, then (1) $2.00 per Share for any 50 trading days during a 60 consecutive trading day-period that ends during the first 90 days after the date of the Forward Purchase Agreement, and (2) $3.00 per share thereafter. In addition to the Prepayment Amount and the Maturity Consideration, on the Maturity Date, the Counterparty has agreed to pay to the Seller an amount equal to the product of (x) 500,000 and (y) the Redemption Price (the &#8220;Share Consideration&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Forward Purchase Agreement may be terminated by any of the parties thereto if the resale registration statement is not declared effective within 105 days of the registration request (such event, an &#8220;Additional Termination Event&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Counterparty has agreed to indemnify and hold harmless the Seller, its affiliates, assignees and other parties described therein (the &#8220;Indemnified Parties&#8221;) from and against all losses, claims, damages and liabilities under the Forward Purchase Agreement (excluding liabilities relating to the manner in which Seller sells any shares it owns) and reimburse the Indemnified Parties for their reasonable expenses incurred in connection with such liabilities, subject to certain exceptions described therein, and has agreed to contribute to any amounts required to be paid by any Indemnified Parties if such indemnification is unavailable or insufficient to hold such party harmless.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Seller waived any redemption rights with respect to any Recycled Shares in connection with the Business Combination. In connection with the Forward Purchase Agreement, ACM assigned its rights, duties and obligations with respect to a portion of the shares purchased under the Forward Purchase Agreement to Vellar Opportunity Fund SPV LLC - Series 10. In connection with the Forward Purchase Agreement, the Seller assigned its rights, duties and obligations with respect to a portion of the shares purchased under the Forward Purchase Agreement to Vellar Opportunity Fund SPV LLC - Series 10.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Limitations on Liability and Indemnification of Officers and Directors</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The DGCL authorizes corporations to limit or eliminate the personal liability of directors of corporations and their stockholders for monetary damages for breaches of directors&#8217; fiduciary duties, subject to certain exceptions. The Charter includes a provision that eliminates the personal liability of directors for damages for any breach of fiduciary duty as a director where, in civil proceedings, the person acted in good faith and in a manner that person reasonably believed to be in or not opposed to the best interests of LanzaTech or, in criminal proceedings, where the person had no reasonable cause to believe that his or her conduct was unlawful.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Bylaws provide that we must indemnify and advance expenses to our directors and officers to the fullest extent authorized by the DGCL. We are also expressly authorized to carry directors&#8217; and officers&#8217; liability insurance providing indemnification for our directors, officers, and certain employees for some liabilities. We believe that these indemnification and advancement provisions and insurance are useful to attract and retain qualified directors and executive officers.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The limitation of liability, advancement and indemnification provisions in the Charter and Bylaws may discourage stockholders from bringing lawsuits against directors for breaches of their fiduciary duties. These provisions also may have the effect of reducing the likelihood of derivative litigation against directors and officers, even though such an action, if successful, might otherwise benefit us and our stockholders. In addition, your investment may be adversely affected to the extent we pay the costs of settlement and damage awards against directors and officer pursuant to these indemnification provisions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is currently no pending material litigation or proceeding involving any of our directors, officers, or employees for which indemnification is sought.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">154</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dissenters&#8217; Rights of Appraisal and Payment</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the DGCL, with certain exceptions, stockholders will have appraisal rights in connection with a merger or consolidation of LanzaTech. Pursuant to the DGCL, stockholders who properly request and perfect appraisal rights in connection with such merger or consolidation will have the right to receive payment of the fair value of their shares as determined by the Delaware Court of Chancery.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stockholders&#8217; Derivative Actions</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the DGCL, any of our stockholders may bring an action in LanzaTech&#8217;s name to procure a judgment in LanzaTech&#8217;s favor, also known as a derivative action, provided that the stockholder bringing the action is a holder of our shares at the time of the transaction to which the action relates or such stockholder&#8217;s stock thereafter devolved by operation of law.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transfer Agent and Registrar</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transfer agent for our capital stock is Continental Stock Transfer &amp; Trust Company.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Listing of common stock</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock and Public Warrants are listed on Nasdaq under the symbols &#8220;LNZA&#8221; and &#8220;LNZAW,&#8221; respectively.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">155</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_1828"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SELLING STOCKHOLDERS </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus relates to the resale by the selling stockholders from time to time of up to 4,774,276 Private Placement Warrants and up to 198,818,523 shares of common stock, which consists of (i) up to 18,500,000 PIPE Shares issued in the PIPE Investment, (ii) up to 4,774,276 shares of common stock issuable upon the exercise of the Private Placement Warrants, (iii) up to 5,000,000 shares of common stock issuable to Brookfield upon the conversion of the Brookfield SAFE, (iv) up to 300,000 shares of common stock issuable upon the exercise of the AM Warrant, (v) up to 2,164,839 shares of common stock held by certain selling stockholders, (vi) up to 1,680,683 shares of common stock underlying the Options held by certain selling stockholders, (vii) up to 5,916,514 shares of common stock purchased by certain selling stockholders subject to the Forward Purchase Agreement, and (viii) up to 160,482,211 shares of common stock pursuant to the Registration Rights Agreement. We will not receive any proceeds from the sale of the Private Placement Warrants or of the common stock by the selling stockholders pursuant to this prospectus.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The selling stockholders may from time to time offer and sell any or all of the Private Placement Warrants and common stock set forth below pursuant to this prospectus and any accompanying prospectus supplement. As used in this prospectus, the term &#8220;selling stockholders&#8221; includes the persons listed in the table below, together with any additional selling stockholders listed in a subsequent amendment to this prospectus, and their pledgees, donees, transferees, assignees, successors, designees and others who later come to hold any of the selling stockholders&#8217; interests in the common stock, other than through a public sale. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling stockholders holding 160,482,211 shares of common stock set forth below are subject to the terms of the Registration Rights Agreement, which includes restrictions on transfer until the termination of applicable lock-up periods. Under the Registration Rights Agreement, such selling stockholders (i) agreed to certain restrictions on transfer with respect to their shares of common stock and warrants and (ii) were granted certain registration rights with respect to certain equity securities held by them. See &#8220;Certain Relationships and Related Party Transactions - LanzaTech Related Party Transactions&#8221; for further discussion. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as set forth in the footnotes below, the following table sets forth certain information as of February 8, 2023 regarding the beneficial ownership of Private Placement Warrants and common stock by the selling stockholders and the Private Placement Warrants and shares of common stock being offered by the selling stockholders. The applicable percentage ownership of the Private Placement Warrants is based on 4,774,276 Private Placement Warrants outstanding as of February 8, 2023. The applicable percentage ownership of common stock is based on 213,825,577 shares of common stock outstanding as of February 8, 2023. Information with respect to the Private Placement Warrants and shares of common stock owned beneficially after the offering assumes the sale of all of the Private Placement Warrants and shares of common stock registered hereby. The selling stockholders may offer and sell some, all or none of their Private Placement Warrants and shares of common stock. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beneficial ownership is determined in accordance with the rules and regulations of the SEC. A person is a &#8220;beneficial owner&#8221; of a security if that person has or shares &#8220;voting power,&#8221; which includes the power to vote or to direct the voting of the security, or &#8220;investment power,&#8221; which includes the power to dispose of or to direct the disposition of the security, or has the right to acquire such powers within 60 days. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise noted in the footnotes to the following table, and subject to applicable community property laws, the persons and entities named in the table have sole voting and investment power with respect to their beneficially owned Private Placement Warrants and common stock. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">156</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_2329"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please see the section titled &#8220;Plan of Distribution&#8221; in this prospectus for further information regarding the selling stockholders&#8217; method of distributing these securities.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.073%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.874%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.874%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.874%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.878%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Name of Selling Stockholder</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Shares of Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Warrants to Purchase Common Stock</span></td></tr><tr style="height:38pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Number Beneficially Owned Prior to Offering</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Number Registered for Sale Hereby</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.22pt;font-weight:700;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Number Beneficially Owned After Offering</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Percent Owned After Offering</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Number Beneficially Owned Prior to Offering</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Number Registered for Sale Hereby</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.22pt;font-weight:700;line-height:100%;position:relative;top:-2.27pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Number Beneficially Owned After Offering</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Percent Owned After Offering</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Activant Capital IV, LP </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,212,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,212,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ACM ARRT H LLC </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,926,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,926,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AMCI Group, LLC Series 35 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,799,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,799,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AMCI Sponsor II LLC </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,774,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,774,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ArcelorMittal XCarb S.&#224; r.l. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,300,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,300,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,774,276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,774,276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Baowu Clean Energy Co., Ltd.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,920,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,920,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">BASF Venture Capital GmbH </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,335,877&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,335,877&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">BGTF LT Aggregator LP </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(8)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Boat Harbour Limited</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (9)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,803,619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,803,619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CCSRF Fuel (HK) Investment Limited </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(10)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,103,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,103,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dialog (Labuan) Ltd</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">773,063&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">773,063&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gothic Corporation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(11)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">596,486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">596,486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gothic ERP LLC </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(12)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">113,114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">113,114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gothic HSP Corporation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (13)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">113,114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">113,114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Guardians of New Zealand Superannuation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(14)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,263,337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,263,337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IOCL Singapore Pte Ltd </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(15)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,025,762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,025,762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">K One W One (No. 2) Ltd </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(16)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,365,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,365,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">K One W One (No. 3) Ltd </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(17)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,413,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,413,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Entities affiliated with Khosla Ventures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (18)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43,839,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43,839,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Land Noble Investments Limited </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(19)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,452,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,452,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">LCP Extension Fund, LLC </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(20)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">147,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">147,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mitsui &amp; Co. Ltd. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(21)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,310,884&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,310,884&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Novo Holdings A/S </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(22)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,814,845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,814,845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Oxy Low Carbon Ventures, LLC </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(23)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,800,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,800,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pescadero Capital, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PETRONAS Technology Ventures SDN BHD </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(24)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,865,329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,865,329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Primetals Technologies Austria GmbH </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(25)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,362,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,362,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Puig International SA </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(26)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Qiming Managing Directors Fund II, LP </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(27)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66,007&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66,007&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Qiming Venture Partners II, LP </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(28)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,536,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,536,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Qiming Venture Partners II-C, LP </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(29)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">397,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">397,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Saints Ventures II, L.P. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(30)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150,855&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150,855&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sandia Investment Management, LP </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(31)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">187,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">187,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SBCVC Fund III Company Limited </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(32)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104,852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104,852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sekisui Chemical Co., Ltd.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (33)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">967,621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">967,621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">157</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.073%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.874%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.874%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.874%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.878%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SHV Energy N.V. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(34)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sinopec Capital Co., Ltd. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(35)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,112,976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,112,976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Suncor Energy, Inc. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(36)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,899,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,899,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Board of Trustees of the Leland Stanford Junior University (SEVF II)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Duke Endowment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(37)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">226,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">226,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trafigura US Holdings, Inc. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(38)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vellar Opportunity Fund SPV LLC - Series 10 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(39)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,990,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,990,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Woodside Energy Technologies Pty, Ltd. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(40)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Brian Beem </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(41)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">298,148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">298,148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Kate Burson </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(42)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,968&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,968&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Henry Copses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(43)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Morgan Holmes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(44)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patrick Murphy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(45)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">177,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">177,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nimesh Patel </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(46)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">318,148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">318,148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adrian Paterson </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(47)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mark Pinho </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(48)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,968&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,968&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sean Simpson </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(49)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,473,674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,473,674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jill Watz </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(50)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,968&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,968&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Walker Woodson </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(51)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Roger Wyse </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(52)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">371,848&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">371,848&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TOTAL</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">198,818,523</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">198,818,523</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,774,276</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,774,276</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The amounts set forth in this column are the number of shares of common stock that may be offered by each selling stockholder using this prospectus. These amounts do not represent any other shares of our common stock that the selling stockholder may own beneficially or otherwise.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Steve Sarracino has voting and/or investment power over the shares held by Activant Capital IV, LP.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">On February 3, 2023, AMCI, Legacy LanzaTech and ACM entered into the Forward Purchase Transaction, as described in the section entitled &#8220;Description of Securities &#8212; Forward Purchase Agreement.&#8221; The securities are held directly by ACM ARRT H LLC, of which Atalaya Capital Management LP (&#8220;ACM&#8221;) is the Manager and has investment and dispositive power over the shares. Ivan Zinn is the Chief Investment Officer of ACM and has voting and dispositive power over the shares. The business address of ACM ARRT H LLC and ACM is One Rockefeller Plaza, 32nd Floor New York, NY 10020.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">AMCI Group, LLC Series 35 is a member of AMCI Sponsor II LLC. Hans Mende, former non-executive chairman of the board of directors of AMCI, predecessor registrant prior to the consummation of the Business Combination, is the chairman of AMCI Group LLC, Series 35 and may be deemed to have voting or investment power with respect to all shares of common stock held by AMCI Group LLC, Series 35.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Consists of (i) 4,774,276 shares of common stock that are issuable upon the exercise of Private Placement Warrants, and (ii) 4,774,276 Private Placement Warrants. Brian Beem is the sole managing member of AMCI Sponsor II LLC. Mr. Beem is the former president and a member of the board of directors of AMCI, predecessor registrant prior to the consummation of the Business Combination. Mr. Beem may be deemed to have voting or investment power with respect to the securities held by AMCI Sponsor II LLC.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Consists of 3,000,000 shares of common stock held by ArcelorMittal XCarb S.&#224; r.l. (&#8220;XCarb&#8221;) and 300,000 shares of common stock subject to warrants that are exercisable within 60 days of February 8, 2023. XCarb is a commercial partner of LanzaTech. XCarb is a direct wholly-owned subsidiary of AM Global Holding S.&#224; r.l. and an indirect wholly-owned subsidiary of ArcelorMittal, a publicly traded company, each of which may be deemed to have beneficial ownership of the shares held by XCarb. The address for XCarb is 24-26, boulevard d&#8217;Avranches, L-1160 Luxembourg, Grand Duchy of Luxembourg.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">BASF Venture Capital GmbH is a commercial partner of LanzaTech. Markus Solibieda, managing director, has direct voting and investment power over the shares held by BASF Venture Capital GmbH.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">BGTF LT Aggregator LP is an affiliate of Brookfield Renewable Power Inc., a commercial partner of LanzaTech. The general partner of BGTF LT Aggregator LP is BGTF Bermuda GP Limited, an affiliate of Brookfield Corporation. BAM Partners Trust (&#8220;BAM Partnership&#8221;) owns all of Brookfield Corporation&#8217;s class B limited voting shares entitling it to appoint one-half of the board of directors of Brookfield Corporation. The beneficial interests in the BAM Partnership, and the voting interests in its trustee (&#8220;BAM Partners&#8221;), are held as follows: one-third by Jack L. Cockwell, one-third by Bruce Flatt, and one-third jointly by Brian W. Kingston, Brian D. Lawson, Cyrus Madon, Samuel J.B. Pollock and Sachin G. Shah in equal parts. No single individual or entity controls the BAM Partnership.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Voting and investment decisions with respect to the shares held by Boat Harbour are made by its board of directors, and none of the directors are deemed to have or share beneficial ownership of the shares held by Boat Harbour Limited.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">158</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Prior to the consummation of the Business Combination, CCSRF Fuel (HK) Investment Limited had the right to appoint and elect, and did appoint and elect, one director to Legacy LanzaTech&#8217;s board of directors. This appointment right terminated upon the consummation of the Business Combination. Any action by CCSRF Fuel (HK) Investment Limited with respect to its shares, including voting and dispositive decisions, requires a unanimous vote by the investment committee, which consists of more than one member. Because voting and dispositive decisions must be unanimous, none of the investment committee members is deemed to be a beneficial owner of securities held by CCSRF Fuel (HK) Investment Limited. Accordingly, none of the members of the investment committee is deemed to have or share beneficial ownership of the shares held by CCSRF Fuel (HK) Investment Limited. The business address of CCSRF Fuel (HK) Investment Limited is 8/F Capital Mansion, No. 6 Xinyuan South Road, Chaoyang District, Beijing, China.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(11)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">DUMAC, Inc., as the investment manager of Gothic Corporation, may be deemed to beneficially own the shares of common stock of the issuer held by Gothic Corporation. Neal F. Triplett, as the President of DUMAC, Inc., may be deemed to beneficially own the shares of common stock of the issuer held by Gothic Corporation. The address of each of the persons referenced in this footnote is 280 S. Mangum Street, Suite 210, Durham, NC 27701.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(12)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">DUMAC, Inc., as the investment manager of Gothic ERP LLC, may be deemed to beneficially own the shares of common stock of the issuer held by Gothic ERP LLC. Neal F. Triplett, as the President of DUMAC, Inc., may be deemed to beneficially own the shares of common stock of the issuer held by Gothic ERP LLC. The address of each of the persons referenced in this footnote is 280 S. Mangum Street, Suite 210, Durham, NC 27701.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(13)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">DUMAC, Inc., as the investment manager of Gothic HSP Corporation, may be deemed to beneficially own the shares of common stock of the issuer held by Gothic HSP Corporation. Neal F. Triplett, as the President of DUMAC, Inc., may be deemed to beneficially own the shares of common stock of the issuer held by Gothic HSP Corporation. The address of each of the persons referenced in this footnote is 280 S. Mangum Street, Suite 210, Durham, NC 27701.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(14)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Shares of common stock held by Guardians of New Zealand Superannuation, as the manager and administrator of the New Zealand Superannuation Fund. Prior to the consummation of the Business Combination, Guardians of New Zealand Superannuation had the right to appoint and elect, and did appoint and elect, one director to Legacy LanzaTech&#8217;s board of directors. This appointment right terminated upon the consummation of the Business Combination. Matt Whineray, Chief Executive Officer, has direct voting and investment power over the shares held by Guardians of New Zealand Superannuation. The business address of Guardians of New Zealand Superannuation is Level 12, 21 Queen Street, Auckland 1010, New Zealand.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(15)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Prior to the consummation of the Business Combination, IOCL Singapore Pte Ltd had the right to appoint and elect, and did appoint and elect, one director to Legacy LanzaTech&#8217;s board of directors. This appointment right terminated upon the consummation of the Business Combination.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(16)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Stephen Robert Tindall has voting and/or investment control over the shares held by K One W One (No. 2) Ltd.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(17)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Stephen Robert Tindall has voting and/or investment control over the shares held by K One W One (No. 3) Ltd.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(18)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Prior to the consummation of the Business Combination, certain affiliates of Khosla Ventures II, LP (&#8220;KV II&#8221;) and Khosla Ventures III, LP (&#8220;KV III&#8221;) had the right to appoint and elect, and did appoint and elect, two directors to Legacy LanzaTech&#8217;s board of directors. This appointment right terminated upon the consummation of the Business Combination. Consists of (i) 13,875,332 shares of LanzaTech common stock held by KV III, (ii) 28,992,029 shares of LanzaTech common stock held by entities owned or controlled by Vinod Khosla, and (iii) 972,539 shares of LanzaTech common stock held by limited partners of KV II not affiliated with Vinod Khosla. Khosla Ventures Associates III, LLC (&#8220;KVA III&#8221;) is the general partner of KV III. VK Services, LLC (&#8220;VK Services&#8221;) is the Manager of KVA III. Vinod Khosla is the Managing Member of VK Services. As such, (i) each of KVA III and VK Services may be deemed to be the beneficial owners having shared voting power and shared investment power over 13,875,332 shares of LanzaTech common stock, and (ii) Vinod Khosla may be deemed to be the beneficial owner having shared voting power and shared investment power over 42,867,361 shares of LanzaTech common stock, and each disclaims beneficial ownership of such securities except to the extent of his or its pecuniary interest therein. The business address of Vinod Khosla and each of the other entities listed in this footnote is 2128 Sand Hill Road, Menlo Park, CA 94025.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(19)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Land Noble Investments Limited (&#8220;Land Noble&#8221;) is the registered owner of the shares and is governed by a three member board of directors. Land Noble is wholly owned by CICC Growth Capital Fund I, L.P. (&#8220;CICC Fund&#8221;), which is controlled by its general partner, CICC Growth Capital Fund GP, Ltd. (&#8220;CICC GP&#8221;). CICC GP is governed by a three member board of directors. Additionally, the consent of a majority of the three-member investment committee of CICC Investment Management Co. Ltd. (&#8220;CICC Manager&#8221;), is required for any disposal of the shares by Land Noble. Land Noble, CICC Fund and CICC GP may be deemed to share beneficial ownership of the shares, but under the so-called &#8220;rule of three&#8221;, neither the members of the boards of directors of Land Noble and CICC GP, nor the members of the investment committee of CICC Manager, are deemed beneficial owners of the shares. The business address of all of the foregoing entities is 35th Floor, SK Tower, No.6A Jianguomenwai Avenue, Chaoyang District, Beijing, China.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(20)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Saints Ventures II, LLC (&#8220;SVII LLC&#8221;) is the manager of LCP Extension Fund, LLC. Any investment decision by SVII LLC requires the approval of two out of three of its managing members. Under the so-called &#8220;rule of three,&#8221; because voting and dispositive decisions are made by two out of the three managing members of SVII LLC, none of the managing members is deemed to be a beneficial owner of securities held.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(21)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">LanzaTech and Mitsui are party to certain collaboration and investment agreements described in the section entitled &#8220;Business &#8212; Key Collaboration Agreements.&#8221; Prior to the consummation of the Business Combination, Mitsui had the right to appoint and elect, and did appoint and elect, one director to Legacy LanzaTech&#8217;s board of directors. This appointment right terminated upon the consummation of the Business Combination. No natural person has voting and/or investment power over the shares held by Mitsui &amp; Co. Ltd.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(22)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Prior to the consummation of the Business Combination, Novo Holdings A/S had the right to appoint and elect, and did appoint and elect, one director to Legacy LanzaTech&#8217;s board of directors. This appointment right terminated upon the consummation of the Business Combination. Novo Holdings A/S has the sole power to vote and dispose of the shares, and no individual or other entity is deemed to hold any beneficial ownership in the shares. The business address of Novo Holdings A/S is Tuborg Havnevej 19, 2900 Hellerup, Denmark.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(23)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Oxy Low Carbon Ventures, LLC is a commercial partner of LanzaTech.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(24)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Prior to the consummation of the Business Combination, PETRONAS Technology Ventures SDN BHD had the right to appoint and elect, and did appoint and elect, one director to Legacy LanzaTech&#8217;s board of directors. This appointment right terminated upon the consummation of the Business Combination. PETRONAS Technology Ventures SDN BHD has the sole power to vote and dispose of the shares, and no individual or other entity is deemed to hold any beneficial ownership in the shares.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">159</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(25)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Primetals Technologies Austria GmbH is a commercial partner of LanzaTech. Etsuro Hirai, Andreas Weinhengst, Alexander Fleischanderl, Michael Kienberger, Miljenko Solje, Jeremy Hamon, and Rainer Oberleitner, each may be deemed to have shared voting and dispositive power with respect to the shares.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(26)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Puig International SA is a wholly-owned subsidiary of the Spanish entity JORBA PERFUMES, S.L., which in turn is a wholly-owned subsidiary of the Spanish entity PUIG, S.L. Voting and dispositive decisions with respect to the shares held by Puig International SA are made by PUIG, S.L. The business address of Puig International SA is Business Park Terre Bonne - (B&#226;timent A4), Route de Crassier 17, CH - 1262 Eysins, Switzerland.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(27)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Prior to the consummation of the Business Combination, Qiming Venture Partners II, L.P., Qiming Venture Partners II-C, L.P. and Qiming Managing Directors Fund II, L.P. (collectively, &#8220;Qiming Venture Partners&#8221;) jointly had the right to appoint and elect, and did appoint and elect, one director to Legacy LanzaTech&#8217;s board of directors. This appointment right terminated upon the consummation of the Business Combination. The general partner of Qiming Venture Partners II, L.P. and Qiming Venture Partners II-C, L.P. is Qiming GP II, L.P., a Cayman Islands exempted limited partnership, whose general partner is Qiming Corporate GP II, Ltd., a Cayman Islands exempted company. The general partner of Qiming Managing Directors Fund II, L.P. is Qiming Corporate GP II, Ltd. The voting and investment power of shares held by Qiming Venture Partners is exercised by Qiming Corporate GP II, Ltd., which is beneficially owned by Duane Kuang, Gary Rieschel, Nisa Leung and Robert Headley.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(28)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Prior to the consummation of the Business Combination Qiming Venture Partners jointly had the right to appoint and elect, and did appoint and elect, one director to Legacy LanzaTech&#8217;s board of directors. This appointment right terminated upon the consummation of the Business Combination. The general partner of Qiming Venture Partners II, L.P. and Qiming Venture Partners II-C, L.P. is Qiming GP II, L.P., a Cayman Islands exempted limited partnership, whose general partner is Qiming Corporate GP II, Ltd., a Cayman Islands exempted company. The general partner of Qiming Managing Directors Fund II, L.P. is Qiming Corporate GP II, Ltd. The voting and investment power of shares held by Qiming Venture Partners is exercised by Qiming Corporate GP II, Ltd., which is beneficially owned by Duane Kuang, Gary Rieschel, Nisa Leung and Robert Headley.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(29)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Prior to the consummation of the Business Combination Qiming Venture Partners jointly had the right to appoint and elect, and did appoint and elect, one director to Legacy LanzaTech&#8217;s board of directors. This appointment right terminated upon the consummation of the Business Combination. The general partner of Qiming Venture Partners II, L.P. and Qiming Venture Partners II-C, L.P. is Qiming GP II, L.P., a Cayman Islands exempted limited partnership, whose general partner is Qiming Corporate GP II, Ltd., a Cayman Islands exempted company. The general partner of Qiming Managing Directors Fund II, L.P. is Qiming Corporate GP II, Ltd. The voting and investment power of shares held by Qiming Venture Partners is exercised by Qiming Corporate GP II, Ltd., which is beneficially owned by Duane Kuang, Gary Rieschel, Nisa Leung and Robert Headley.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(30)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">SVII LLC is the manager of LCP Extension Fund, LLC. Any investment decision by SVII LLC requires the approval of two out of three of its managing members. Under the so-called &#8220;rule of three,&#8221; because voting and dispositive decisions are made by two out of the three managing members of SVII LLC, none of the managing members is deemed to be a beneficial owner of securities held.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(31)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Consists of shares of LanzaTech common stock allocated to investors managed by Sandia Investment Management LP (&#8220;Sandia&#8221;). Sandia Investment Management LLC is the general partner of Sandia. Tim Sichler serves as Founder &amp; CIO of the general partner of Sandia, and in such capacity may be deemed to be the beneficial owner having shared voting power and shared investment power over the securities described in this footnote.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(32)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">SBCVC Fund III Company Limited is an investment vehicle under SBCVC Fund III L.P. which is an investment fund in a form of a limited partnership incorporated and existing under the laws of the Cayman Island. Chauncey Shey, Peter Hua and Alan Song, members of the investment committee of SBCVC Fund III L.P., have shared voting and investment power with respect to the shares held by SBCVC Fund III Company Limited.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(33)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">LanzaTech and Sekisui are party to certain collaboration agreements described in the section entitled &#8220;Business &#8212; Key Collaboration Agreements.&#8221;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(34)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">SHV Energy N.V. is a commercial partner of LanzaTech. The board of directors has the sole power to vote and dispose of the shares. The board of directors is jointly represented by its two members, Mr. Abraham A. Graber and Mr. Paulo F. Rodrigues. No individual or other entity has any specific rights over the shares nor holds any beneficial ownership of the shares.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(35)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Prior to the consummation of the Business Combination, Sinopec Capital Co., Ltd. had the right to appoint and elect, and did appoint and elect, one director to Legacy LanzaTech&#8217;s board of directors. This appointment right terminated upon the consummation of the Business Combination. Any action by Sinopec Capital Co., Ltd. with respect to its shares, including voting and dispositive decisions, requires a vote of three out of the five members of its investment team. Under the so-called &#8220;rule of three,&#8221; because voting and dispositive decisions are made by three out of the five members of the investment team, none of the members is deemed to be a beneficial owner of securities held by Sinopec Capital Co., Ltd. Accordingly, none of the members of the investment team is deemed to have or share beneficial ownership of the shares held by Sinopec Capital Co., Ltd. The business address of Sinopec Capital Co., Ltd. is 22nd Floor, World Financial Center East Tower, 1 East 3rd Ring Middle Road, Chaoyang District, Beijing, China.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(36)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">LanzaTech and Suncor are party to certain collaboration and investment agreements described in the section entitled &#8220;Business &#8212; Key Collaboration Agreements.&#8221;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(37)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">DUMAC, Inc., as the investment manager of The Duke Endowment, may be deemed to beneficially own the shares of common stock of the issuer held by The Duke Endowment. Neal F. Triplett, as the President of DUMAC, Inc., may be deemed to beneficially own the shares of common stock of the issuer held by The Duke Endowment. The address of each of the persons referenced in this footnote is 280 S. Mangum Street, Suite 210, Durham, NC 27701.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(38)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Trafigura US Holdings Inc. is a direct wholly-owned subsidiary of Trafigura US Inc., which in turn is an indirect wholly-owned subsidiary of Trafigura Group Pte. Ltd. The business address of Trafigura US Holdings, Inc. is 1209, Orange Street, Wilmington, Delaware. Trafigura Trading LLC, another direct wholly-owned subsidiary of Trafigura US Inc., is a commercial partner of LanzaTech.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(39)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Consists of 2,990,000 shares of common stock held directly by Vellar Opportunity Fund SPV LLC - Series 10 (&#8220;Vellar&#8221;). AMCI, Legacy LanzaTech, ACM and Vellar entered into an Assignment and Novation Agreement, as described in the section entitled &#8220;Description of Securities &#8212; Forward Purchase Agreement.&#8221; Cohen &amp; Company Financial Management, LLC (&#8220;CCFM&#8221;) is the investment manager for Vellar, and Mr. Daniel Cohen is the Chief Investment Officer of CCFM.  CCFM is a controlled subsidiary of Dekania Investors, LLC, which in turn is a controlled subsidiary of Cohen &amp; Company LLC, which in turn is a controlled subsidiary of Cohen &amp; Company Inc. Mr. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">160</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Cohen disclaims any beneficial ownership of the shares held by these entities.  The business address of Vellar Opportunity Fund SPV LLC &#8211; Series 10 is c/o Mourant Governance Services (Cayman) Limited 94, Solaris Avenue, Camana Bay, PO Box 1348 Grand Cayman KY1-1108, Cayman Islands.  The business address for each of Cohen &amp; Company Financial Management, LLC; Dekania Investors, LLC; Cohen &amp; Company LLC; Cohen &amp; Company Inc.; and Mr. Daniel Cohen is 3 Columbus Circle, 24th Floor, New York NY 10019.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">There are no natural persons who have voting and/or investment power over the shares held by Woodside Energy Technologies Pty Ltd.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(41)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Mr. Beem is the former president and a member of the board of directors of AMCI, predecessor registrant prior to the consummation of the Business Combination.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(42)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Ms. Burson is a former member of the board of directors of AMCI, predecessor registrant prior to the consummation of the Business Combination.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(43)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Mr. Copses is the former Vice President of AMCI, predecessor registrant prior to the consummation of the Business Combination</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(44)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Mr. Holmes is the former Vice President of AMCI, predecessor registrant prior to the consummation of the Business Combination.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(45)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Mr. Murphy is the former chief financial officer of AMCI, predecessor registrant prior to the consummation of the Business Combination.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(46)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Mr. Patel is the former chief executive officer and a member of the board of directors of AMCI, predecessor registrant prior to the consummation of the Business Combination, and is a member of the board of directors of LanzaTech.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(47)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Mr. Paterson is a former member of the board of directors of AMCI, predecessor registrant prior to the consummation of the Business Combination.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(48)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Mr. Pinho is a former member of the board of directors of AMCI, predecessor registrant prior to the consummation of the Business Combination.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(49)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Dr. Simpson is the former chief scientific officer and a member of the board of directors of Legacy LanzaTech. Consists of 2,164,839 shares of common stock and 1,308,835 shares of common stock underlying stock options.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(50)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Ms. Watz is a former member of the board of directors of AMCI, predecessor registrant prior to the consummation of the Business Combination.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(51)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Mr. Woodson is an affiliate of AMCI, predecessor registrant prior to the consummation of the Business Combination.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(52)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Dr. Wyse is a former member of the board of directors of Legacy LanzaTech. Consists of 371,848 shares of common stock underlying stock options.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">161</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_1849"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MATERIAL U.S. FEDERAL INCOME AND ESTATE TAX CONSIDERATIONS</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion describes material United States federal income and estate tax considerations relating to the acquisition, ownership, and disposition of shares by a a non-U.S. holder (as defined below) that acquires our shares in this offering and holds them as a capital asset. This discussion is based on the tax laws of the United States, including the Code, Treasury regulations promulgated or proposed thereunder, and administrative and judicial interpretations thereof, all as in effect on the date hereof. These tax laws are subject to change, possibly with retroactive effect, and subject to differing interpretations that could affect the tax consequences described herein. This section does not address the treatment of a non-U.S. holder under the laws of any state, local or foreign taxing jurisdiction. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of this discussion, a &#8220;non-U.S. holder&#8221; is a beneficial owner of our shares that, for United States federal income tax purposes, is: </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a non-resident alien individual; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a foreign corporation; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">an estate the income of which is not subject to United States federal income taxation regardless of its source; or </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a trust that does not have in effect a valid election under the Treasury regulations to be treated as a United States person and either (1) no court within the United States is able to exercise primary supervision over the trust&#8217;s administration or (2) no United States person has the authority to control all substantial decisions of that trust. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This discussion does not address all aspects of United States federal income taxation that may be applicable to holders in light of their particular circumstances or status (including, for example, banks and other financial institutions, insurance companies, brokers and dealers in securities or currencies, traders that have elected to mark securities to market, partnerships or other pass-through entities, corporations that accumulate earnings to avoid United States federal income tax, tax-exempt organizations, pension plans, persons that hold our shares as part of a straddle, hedge or other integrated investment, persons subject to alternative minimum tax, certain United States expatriates, and foreign governments or agencies). </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a partnership (including any entity or arrangement treated as a partnership for United States federal income tax purposes) holds our shares, the tax treatment of a person treated as a partner in the partnership for United States federal income tax purposes generally will depend on the status of the partner and the activities of the partnership. Partnerships (and other entities or arrangements so treated for United States federal income tax purposes) and their partners should consult their own tax advisors. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">This discussion addresses only non-U.S. holders and does not discuss any tax considerations other than United States federal income tax and certain United States federal estate tax considerations. Prospective investors are urged to consult their own tax advisors regarding the United States federal, state, and local, and foreign tax consequences of the purchase, ownership, and disposition of our shares, including the effect of any applicable income or estate tax treaty.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed above, we have not paid and do not currently expect to pay dividends. If we do make a distribution of cash or property with respect to our shares, any such distribution generally will constitute a dividend for United States federal income tax purposes except as described below. Subject to the discussion below under &#8220;&#8212; FATCA Withholding&#8221; and &#8220;&#8212; Information Reporting and Backup Withholding,&#8221; and except as described below, any such dividends paid to a non-U.S. holder generally will be subject to withholding tax at a 30% rate or at a lower rate under an applicable income tax treaty between the United States and the non-U.S. holder&#8217;s country of residence. In order to receive a reduced treaty withholding tax rate, a non-U.S. holder must furnish to us or our paying agent a properly executed Internal Revenue Service </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">162</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Form W-8BEN or Form W-8BEN-E (or other applicable form) prior to payment of the dividend, certifying under penalties of perjury that the non-U.S. holder is entitled to a reduction in withholding under an applicable income tax treaty. A non-U.S. holder that holds our shares through a financial institution or other agent will be required to provide appropriate documentation to the financial institution or other agent, which then will be required to provide certification to us or our paying agent either directly or through other intermediaries. A non-U.S. holder that is eligible for a reduced rate of withholding tax pursuant to an income tax treaty may obtain a refund of any excess amounts withheld by filing a refund claim with the Internal Revenue Service. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a dividend is &#8220;effectively connected&#8221; with the conduct of a trade or business in the United States of the non-U.S. holder (and, if an applicable income tax treaty so provides, attributable to a permanent establishment or fixed base maintained by the non-U.S. holder in the United States), the non-U.S. holder is exempt from the withholding tax described above provided that the holder has furnished to us or our paying agent an Internal Revenue Service Form W-8ECI (or applicable successor form), certifying under penalties of perjury that the dividend is effectively connected with the non-U.S. holder&#8217;s conduct of a trade or business in the United States (and, if an applicable income tax treaty so provides, attributable to a permanent establishment or fixed base maintained in the United States). &#8220;Effectively connected&#8221; dividends will generally be subject to United States federal income tax at the rates that also apply to U.S. persons. A corporate non-U.S. holder may, under certain circumstances, be subject to an additional branch profits tax at a 30% rate (or at a lower rate under an applicable income tax treaty) with respect to its &#8220;effectively connected&#8221; dividends. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent a distribution with respect to our shares exceeds our current or accumulated earnings and profits, as determined under United States federal income tax principles, the distribution will be treated, first, as a tax-free return of the non-U.S. holder&#8217;s investment, up to the holder&#8217;s adjusted tax basis in its shares, and, thereafter, as capital gain, which is subject to the tax treatment described below in &#8220;- Gain on Sale, Exchange or Other Taxable Disposition.&#8221; </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gain On Sale, Exchange or Other Taxable Disposition </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the discussion below under &#8220;- FATCA Withholding&#8221; and &#8220;- Information Reporting and Backup Withholding,&#8221; a non-U.S. holder generally will not be subject to United States federal income tax or withholding tax on gain realized upon a sale, exchange or other taxable disposition of shares (including a redemption, but only if the redemption would be treated as a sale or exchange rather than a distribution for United States federal income tax purposes) unless: </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the gain is &#8220;effectively connected&#8221; with the conduct of a trade or business of the non-U.S. holder in the United States (and, if required by an applicable income tax treaty, the gain is attributable to a permanent establishment or fixed base maintained in the United States), in which case the non-U.S. holder generally will be subject to United States federal income tax on a net income basis with respect to such gain in the same manner as if such holder were a resident of the United States and, if the non-U.S. holder is a corporation for United States federal income tax purposes, may, under certain circumstances, be subject to an additional &#8220;branch profits tax&#8221; at a 30% rate (or at a lower rate under an applicable income tax treaty) on its &#8220;effectively connected&#8221; gains; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the non-U.S. holder is an individual who is present in the United States for 183 or more days in the taxable year of the disposition and meets certain other conditions, in which case the non-U.S. holder generally will be subject to United States federal income tax at a 30% rate (or at a lower rate under an applicable income tax treaty) on the gain derived from the sale, which gain may be offset by U.S.-source capital losses for the year; or </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we are or have been a &#8220;United States real property holding corporation&#8221; or USRPHC (as described below) at any time within the shorter of the five-year period preceding the disposition and the non-U.S. holder&#8217;s holding period for our shares (the &#8220;relevant period&#8221;) and the non-U.S. holder (i) disposes of our shares during a calendar year when our shares are no longer regularly traded on an established securities market or (ii) owned (directly, indirectly, and constructively) more than 5% of our shares at any time during the relevant period, in which case such a non-U.S. holder will be subject to tax on the gain on the disposition of </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">163</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares generally as if the gain were effectively connected with the conduct of a trade or business in the United States, except that the &#8220;branch profits tax&#8221; will not apply. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe we currently are not, and we do not anticipate becoming, a USRPHC for United States federal income tax purposes. Generally, a corporation is a USRPHC only if the fair market value of its United States real property interests (as defined in the Code) equals or exceeds 50% of the sum of the fair market value of its worldwide real property interests and its other assets used or held for use in a trade or business. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FATCA Withholding </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sections 1471 through 1474 of the Code and the Treasury regulations issued thereunder (commonly referred to as the Foreign Account Tax Compliance Act, or FATCA) impose a 30% withholding tax on dividends paid on our shares to, and (subject to the proposed Treasury Regulations discussed below) the gross proceeds derived from the sale or other disposition of our shares by, a foreign entity if the foreign entity is: </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a &#8220;foreign financial institution&#8221; (as defined under FATCA) that does not furnish proper documentation, typically on IRS Form W-8BEN-E, evidencing either (i) an exemption from FATCA withholding or (ii) its compliance (or deemed compliance) with specified due diligence, reporting, withholding and certification obligations under FATCA or (iii) residence in a jurisdiction that has entered into an intergovernmental agreement with the United States relating to FATCA and compliance with the diligence and reporting requirements of the intergovernmental agreement and local implementing rules; or </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a &#8220;non-financial foreign entity&#8221; (as defined under FATCA) that does not provide sufficient documentation, typically on IRS Form W-8BEN-E, evidencing either (i) an exemption from FATCA or (ii) adequate information regarding substantial United States beneficial owners of such entity (if any). </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Withholding under FATCA generally applies to payments of dividends on our shares and to payments of gross proceeds from a sale or other disposition of our shares. Withholding agents may, however, rely on proposed U.S. Treasury Regulations that would no longer require FATCA withholding on payments of gross proceeds. A withholding agent such as a broker, and not LanzaTech, will determine whether or not to implement gross proceeds FATCA withholding. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a dividend payment is subject to withholding both under FATCA and the withholding tax rules discussed above under &#8220;- Dividends,&#8221; the withholding under FATCA may be credited against, and therefore reduce, such other withholding tax. Holders of shares should consult their own tax advisors regarding these requirements and whether they may be relevant to their ownership and disposition of the shares. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under certain circumstances, a non-U.S. holder will be eligible for refunds or credits of withholding taxes imposed under FATCA by filing a United States federal income tax return. Prospective investors should consult their tax advisors regarding the effect of FATCA on their ownership and disposition of our shares. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Information Reporting and Backup Withholding </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as described below, a non-U.S. holder generally will be exempt from backup withholding and information reporting requirements with respect to dividend payments and the payment of the proceeds from the sale of our shares effected at a United States office of a broker, as long as the payor or broker does not have actual knowledge or reason to know that the holder is a United States person and the holder has furnished to the payor or broker: </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a valid Internal Revenue Service Form W-8BEN or Form W-8BEN-E on which the non-U.S. holder certifies, under penalties of perjury, that it is a non-United States person; or </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other documentation upon which it may rely to treat the payments as made to a non-United States person in accordance with Treasury regulations, </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or the non-U.S. holder otherwise establishes an exemption. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">164</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, we must report annually to the Internal Revenue Service and to non-U.S. holders the amount of dividends paid to them and the tax withheld with respect to such dividends, regardless of whether withholding was required. Copies of the information returns reporting such dividends and withholding may also be made available to the tax authorities in the country in which the respective non-U.S. holder resides under the provisions of an applicable income tax treaty. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment of the proceeds from the sale of our shares effected at a foreign office of a broker generally will not be subject to information reporting or backup withholding. However, a sale of our shares by a non-U.S. holder that is effected at a foreign office of a broker will be subject to information reporting and backup withholding if: </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the proceeds are transferred to an account maintained by the non-U.S. holder in the United States; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the payment of proceeds or the confirmation of the sale is mailed to the non-U.S. holder at a United States address; or </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the sale has some other specified connection with the United States as provided in the Treasury regulations, </span></div><div style="margin-bottom:9pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unless the broker does not have actual knowledge or reason to know that the holder is a United States person and the documentation requirements described above are met or the non-U.S. holder otherwise establishes an exemption. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, a sale of shares will be subject to information reporting if it is effected at a foreign office of a broker that is: </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a United States person; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a &#8220;controlled foreign corporation&#8221; for United States federal income tax purposes; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a foreign person 50% or more of whose gross income is effectively connected with the conduct of a United States trade or business for a specified three-year period; or </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a foreign partnership, if at any time during its tax year (a) one or more of its partners are &#8220;U.S. persons&#8221;, as defined in U.S. Treasury regulations, who in the aggregate hold more than 50% of the income or capital interest in the partnership, or (b) such foreign partnership is engaged in the conduct of a trade or business in the United States, </span></div><div style="margin-bottom:9pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unless the broker does not have actual knowledge or reason to know that the holder is a United States person and the documentation requirements described above are met or an exemption is otherwise established. Backup withholding will apply if the sale is subject to information reporting and the broker has actual knowledge that the holder is a United States person. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Backup withholding is not an additional tax. A non-U.S. holder generally may obtain a refund of any amounts withheld under the backup withholding rules that exceed the non-U.S. holder&#8217;s income tax liability by timely filing a refund claim with the Internal Revenue Service. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Federal Estate Taxes </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estates of nonresident alien decedents generally are subject to United States federal estate tax on property with a United States situs. Because we are a United States corporation, our shares will be United States situs property and therefore will be included in the taxable estate of a nonresident alien decedent at the time of the decedent&#8217;s death, unless an applicable estate tax treaty between the United States and the decedent&#8217;s country of residence provides otherwise. An estate tax credit is available to reduce the net tax liability of a nonresident alien&#8217;s estate, but the estate tax credit for a nonresident alien is generally much smaller than the applicable credit for computing the estate tax of a United States resident. Nonresident aliens should consult their personal tax advisors regarding the United States federal estate tax consequences of owning our shares.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">165</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_1870"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PLAN OF DISTRIBUTION </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are registering the issuance by us of up to 19,249,473 shares of common stock, which consists of (i) up to 4,774,276 shares of common stock that are issuable upon the exercise of Private Placement Warrants, (ii) up to 7,494,514 shares of common stock that are issuable upon the exercise of Public Warrants, (iii) up to 5,000,000 shares of common stock that are issuable upon the conversion of the Brookfield SAFE, (iv) up to 300,000 shares of common stock that are issuable upon exercise of the AM Warrant, and (v) up to 1,680,683 shares of common stock underlying the Options held by certain selling stockholders. We are also registering the resale by the selling stockholders of up to 4,774,276 Private Placement Warrants and up to 198,818,523 shares of common stock, which consists of (i) up to 18,500,000 PIPE Shares issued in the PIPE Investment, (ii) up to 5,000,000 shares of common stock that are issuable upon the conversion of the Brookfield SAFE, (iii) up to 4,774,276 shares of common stock that are issuable upon the exercise of Private Placement Warrants, (iv) up to 300,000 shares of common stock that are issuable upon exercise of the AM Warrant, (v) up to 2,164,839 shares of common stock held by certain selling stockholders, (vi) up to 1,680,683 shares of common stock underlying the Options held by certain selling stockholders, (vii) up to 5,916,514 shares of common stock purchased by certain selling stockholders subject to the Forward Purchase Agreement, and (viii) up to 160,482,211 shares of common stock issued pursuant to the Registration Rights Agreement. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will bear all costs, expenses and fees in connection with the registration of these securities, including with regard to compliance with state securities or &#8220;blue sky&#8221; laws. The selling stockholders will bear all commissions and discounts, if any, attributable to their sale of warrants or shares of common stock (as applicable). </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will not receive any proceeds from the sale of the Private Placement Warrants or of the common stock by the selling stockholders pursuant to this prospectus. The aggregate proceeds to the selling stockholders will be the purchase price of the common stock or warrants (as applicable) less any discounts and commissions borne by the selling stockholders. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Private Placement Warrants and shares of common stock beneficially owned by the selling stockholders covered by this prospectus may be offered and sold from time to time by the selling stockholders. The term &#8220;selling stockholders&#8221; includes donees, pledgees, transferees or other successors in interest selling securities received after the date of this prospectus from a selling stockholder as a gift, pledge, partnership distribution or other transfer. The selling stockholders will act independently of us in making decisions with respect to the timing, manner and size of each sale. Such sales may be made on one or more exchanges or in the over-the-counter market or otherwise, at prices and under terms then prevailing or at prices related to the then current market price or in negotiated transactions. The selling stockholders may sell their shares of common stock or Private Placement Warrants by one or more of, or a combination of, the following methods: </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">purchases by a broker-dealer as principal and resale by such broker-dealer for its own account pursuant to this prospectus; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ordinary brokerage transactions and transactions in which the broker solicits purchasers; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">block trades in which the broker-dealer so engaged will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an over-the-counter distribution in accordance with the rules of Nasdaq; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">through trading plans entered into by a selling stockholder pursuant to Rule 10b5-1 under the Exchange Act, that are in place at the time of an offering pursuant to this prospectus and any applicable prospectus supplement hereto that provide for periodic sales of their securities on the basis of parameters described in such trading plans; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to or through underwriters, agents or broker-dealers; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;at the market&#8221; offerings, as defined in Rule 415 under the Securities Act, at negotiated prices, at prices prevailing at the time of sale or at prices related to such prevailing market prices, including sales made </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">166</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">directly on a national securities exchange or sales made through a market maker other than on an exchange or other similar offerings through sales agents; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">privately negotiated transactions </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">options transactions; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">through a combination of any of the above methods of sale; or </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any other method permitted pursuant to applicable law. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, any securities that qualify for sale pursuant to Rule 144 may be sold under Rule 144 rather than pursuant to this prospectus. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent required, this prospectus may be amended or supplemented from time to time to describe a specific plan of distribution. In connection with distributions of the common stock, Private Placement Warrants or otherwise, the selling stockholders may enter into hedging transactions with broker-dealers or other financial institutions. In connection with such transactions, broker-dealers or other financial institutions may engage in short sales of common stock or Private Placement Warrants in the course of hedging the positions they assume with selling stockholders. The selling stockholders may also sell shares of common stock or Private Placement Warrants short and redeliver the shares to close out such short positions. The selling stockholders may also enter into option or other transactions with broker-dealers or other financial institutions which require the delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction). The selling stockholders may also pledge shares of common stock or Private Placement Warrants to a broker-dealer or other financial institution, and, upon a default, such broker-dealer or other financial institution may effect sales of the pledged securities pursuant to this prospectus (as supplemented or amended to reflect such transaction). </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A selling stockholder may enter into derivative transactions with third parties, or sell securities not covered by this prospectus to third parties in privately negotiated transactions. If an applicable prospectus supplement indicates, in connection with those derivatives, the third parties may sell shares of common stock or Private Placement Warrants covered by this prospectus and the applicable prospectus supplement, including in short sale transactions. If so, the third party may use securities pledged by any selling stockholder or borrowed from any selling stockholder or others to settle those sales or to close out any related open borrowings of stock or Private Placement Warrants, and may use securities received from any selling stockholder in settlement of those derivatives to close out any related open borrowings of stock or warrants. If treated as so under applicable securities laws, the third party in such sale transactions will be an underwriter and will be identified in the applicable prospectus supplement (or a post-effective amendment). In addition, any selling stockholder may otherwise loan or pledge shares of common stock or Private Placement Warrants to a financial institution or other third party that in turn may sell the securities short using this prospectus. Such financial institution or other third party may transfer its economic short position to investors in our securities or in connection with a concurrent offering of other securities. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In effecting sales, broker-dealers or agents engaged by the selling stockholders may arrange for other broker-dealers to participate. Broker-dealers or agents may receive commissions, discounts or concessions from the selling stockholders in amounts to be negotiated immediately prior to the sale. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In offering the shares of common stock or Private Placement Warrants covered by this prospectus, the selling stockholders and any broker-dealers who execute sales for them may be deemed to be &#8220;underwriters&#8221; within the meaning of the Securities Act in connection with such sales. Any profits realized by selling stockholders who are &#8220;underwriters,&#8221; and the compensation of any broker-dealer who executes sales for them, may be deemed to be underwriting discounts and commissions. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to comply with the securities laws of certain states, if applicable, the common stock and Private Placement Warrants must be sold in such jurisdictions only through registered or licensed brokers or dealers. In addition, in certain states the shares of common stock and Private Placement Warrants may not be sold unless they </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">167</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have advised the selling stockholders that the anti-manipulation rules of Regulation M under the Exchange Act may apply to sales of common stock or Private Placement Warrants in the market and to the activities of the selling and their affiliates. In addition, we will make copies of this prospectus available to the selling stockholders for the purpose of satisfying the prospectus delivery requirements of the Securities Act. The selling stockholders may indemnify any broker-dealer that participates in transactions involving the sale of the common stock or warrants against certain liabilities, including liabilities arising under the Securities Act. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the time a particular offer of shares of common stock or Private Placement Warrants is made, if required, a prospectus supplement will be distributed that will set forth the number of securities being offered and the terms of the offering, including the name of any underwriter, dealer or agent, the purchase price paid by any underwriter, any discount, commission and other item constituting compensation, any discount, commission or concession allowed or reallowed or paid to any dealer, and the proposed selling price to the public. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have agreed to indemnify certain of the selling stockholders against certain liabilities, including liabilities under the Securities Act and state securities laws, relating to the registration of the shares of common stock offered by this prospectus.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">168</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_1891"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LEGAL MATTERS</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The validity of the securities offered by this prospectus will be passed upon by Covington &amp; Burling LLP. </span></div><div id="ib82e114cd19f45afae73e7a64e42f208_1912"></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXPERTS</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of AMCI Acquisition Corp. II as of December 31, 2021 and for the period from January 28, 2021 (inception) through December 31, 2021 appearing in this prospectus have been audited by Marcum LLP, independent registered public accounting firm, as set forth in their report thereon (which contains an explanatory paragraph relating to substantial doubt about the ability of AMCI Acquisition Corp. II to continue as a going concern as described in Note 1 to the financial statements), appearing elsewhere in this prospectus, and are included in reliance on such report given on the authority of such firm as experts in auditing and accounting. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of LanzaTech NZ, Inc. as of December 31, 2021 and 2020 and for the years then ended included in this prospectus have been audited by Deloitte &amp; Touche LLP, an independent registered public accounting firm, as stated in their report. Such financial statements are included in reliance on the report of such firm given their authority as experts in auditing and accounting. </span></div><div id="ib82e114cd19f45afae73e7a64e42f208_1933"></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CHANGE IN THE REGISTRANT&#8217;S CERTIFYING ACCOUNTANT </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 8, 2023, the Board approved a resolution appointing Deloitte as LanzaTech&#8217;s independent registered public accounting firm to audit LanzaTech&#8217;s consolidated financial statements for the fiscal year ending December 31, 2023. Deloitte serves as the independent registered public accounting firm of Legacy LanzaTech through the issuance of its December 31, 2022 financial statements. Accordingly, Marcum, AMCI&#8217;s independent registered public accounting firm prior to the Business Combination, was informed on February 8, 2023 that it was dismissed as LanzaTech&#8217;s independent registered public accounting firm, effective upon completion of Marcum&#8217;s audit of AMCI&#8217;s consolidated financial statements as of and for the year ended December 31, 2022, and the issuance of their report thereon.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The report of Marcum on AMCI&#8217;s financial statements as of and for the most recent fiscal year ended December 31, 2021 did not contain an adverse opinion or a disclaimer of opinion, and were not qualified or modified as to uncertainties, audit scope or accounting principles, except as follows: Marcum&#8217;s report on AMCI&#8217;s financial statements as of and for the fiscal year ended December 31, 2021 contained a separate paragraph expressing substantial doubt about the AMCI&#8217;s ability to continue as a going concern.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During AMCI&#8217;s fiscal year ended December 31, 2021 and the subsequent interim period through September 30, 2022, there were no disagreements between AMCI and Marcum on any matter of accounting principles or practices, financial disclosure or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of Marcum, would have caused it to make reference to the subject matter of the disagreements in its reports on AMCI&#8217;s financial statements for such year. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During AMCI&#8217;s fiscal year ended December 31, 2021 and the subsequent interim period through September 30, 2022, there were no &#8220;reportable events&#8221; (as defined in Item 304(a)(1)(v) of Regulation S-K (&#8220;Regulation S-K&#8221;) under the Exchange Act, except that Marcum advised AMCI of the following material weaknesses related to: (i) the accounting for certain complex financial instruments and (ii) the accounting of certain fees related to financial advisory and placement agent services. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech provided Marcum with a copy of the foregoing disclosures and has requested that Marcum furnish LanzaTech with a letter addressed to the SEC stating whether it agrees with the statements made by LanzaTech set forth above. A copy of Marcum&#8217;s letter, dated February 13, 2023, is filed as Exhibit 16.1 to the registration statement of which this prospectus forms a part. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal year ended December 31, 2021 and the subsequent interim period through September 30, 2022, neither LanzaTech, nor any party on behalf of LanzaTech, consulted with Deloitte with respect to either (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of the audit opinion that might be rendered with respect to LanzaTech&#8217;s consolidated financial statements, and no written report </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">169</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1390">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or oral advice was provided to LanzaTech by Deloitte that was an important factor considered by LanzaTech in reaching a decision as to any accounting, auditing or financial reporting issue, or (ii) any matter that was subject to any disagreement (as that term is defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions) or a reportable event (as that term is defined in Item 304(a)(1)(v) of Regulation S-K). </span></div><div id="ib82e114cd19f45afae73e7a64e42f208_1954"></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WHERE YOU CAN FIND MORE INFORMATION </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have filed with the SEC a registration statement on Form S-1 under the Securities Act with respect to the securities being offered by this prospectus. This prospectus, which constitutes part of the registration statement, does not contain all of the information in the registration statement and its exhibits. For further information with respect to us and our securities offered by this prospectus, we refer you to the registration statement and its exhibits. Statements contained in this prospectus as to the contents of any contract or any other document referred to are not necessarily complete, and in each instance, we refer you to the copy of the contract or other document filed as an exhibit to the registration statement. Each of these statements is qualified in all respects by this reference. You can read our SEC filings, including the registration statement, over the internet at the SEC&#8217;s website at www.sec.gov. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the information reporting requirements of the Exchange Act, and we file reports, proxy statements and other information with the SEC. These reports, proxy statements and other information will be available for review at the SEC&#8217;s website at www.sec.gov. We also maintain a website at www.lanzatech.com, at which you may access these materials free of charge as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC. LanzaTech&#8217;s website and the information contained on, or that can be accessed through, such website are not deemed to be incorporated by reference in, and are not considered part of, this prospectus.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">170</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_1268"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO FINANCIAL STATEMENTS</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:92.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.311%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unaudited Condensed Financial Statements</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_10">Condensed Balance Sheets as of September 30, 2022 (Unaudited) and December 31, 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_10">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_10">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_16">Unaudited Condensed Statements of Operations for the three months ended September 30, 2022 and 2021, for the nine months ended September 30, 2022 and for the period from January 28, 2021 (inception) through September 30, 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_16">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_19">Unaudited Condensed Statements of Changes in Stockholders&#8217; Equity (Deficit) for the three and nine months ended September 30, 2022, for the three months ended September 30, 2021 and for the period from January 28, 2021 (inception) through September 30, 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_19">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_25">Unaudited Condensed Statements of Cash Flows for the nine months ended September 30, 2022 and for the period from January 28, 2021 (inception) through September 30, 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_25">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_25">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_28">Notes to Unaudited Condensed Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_28">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_28">6</a></span></div></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:92.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.311%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Audited Financial Statements</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_70">Report of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_70">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_70">23</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_73">Balance Sheet as of December 31, 2021 (audited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_73">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_73">24</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_79">Statement of Operations for the period from January 28, 2021 (inception) through December 31, 2021 (audited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_79">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_79">25</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_82">Statement of Changes in Stockholder&#8217;s Deficit for the period from January 28, 2021 (inception) through December 31, 2021 (audited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_82">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_82">26</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_85">Statement of Cash Flows for the period from January 28, 2021 (inception) through December 31, 2021 (audited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_85">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_85">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_88">Notes to Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_88">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_88">28</a></span></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LANZATECH NZ, INC. </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:92.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.311%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unaudited Condensed Financial Statements</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_643">Condensed Consolidated Balance Sheets (Unaudited) as of September 30, 2022 and December 31, 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_643">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_643">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_654">Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) for the nine months ended September 30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_654">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_654">45</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_664">Condensed Consolidated Statements of Cash Flows (Unaudited) for the nine months ended September 30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_664">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_664">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_671">Condensed Consolidated Statements of Changes in Redeemable Convertible Preferred Stock and Shareholders&#8217; Deficit (Unaudited) for the nine months ended September 30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_671">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_671">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_681">Notes to Condensed Consolidated Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_681">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_681">48</a></span></div></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:92.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.311%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Audited Financial Statements</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1302">Report of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1302">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_1302">66</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_370">Consolidated Balance Sheets as of December 31, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_370">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_370">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_379">Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_379">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_379">68</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_388">Consolidated Statements of Changes in Redeemable Convertible Preferred Stock and Shareholders&#8217; Equity (Deficit) for the years ended December 31, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_388">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_388">69</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_397">Consolidated Statements of Cash Flows for the years ended December 31, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_397">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_397">70</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_403">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_403">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_403">71</a></span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-1</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_10"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED BALANCE SHEETS</span></div></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930" decimals="0" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfNC0xLTEtMS05MDYwOQ_2ed69704-d6e8-4bda-ab41-643906196024">7,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfNC0zLTEtMS05MDYwOQ_7b8d55a0-5b63-4bc8-8904-436fb1df02ca">343,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses &#8211; current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930" decimals="0" name="us-gaap:PrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfNS0xLTEtMS05MDYwOQ_e7b04999-c5c8-45c1-86af-4c1691bc0b9e">277,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:PrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfNS0zLTEtMS05MDYwOQ_cbb8d26b-af61-44bb-871e-cf312a0864c3">337,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930" decimals="0" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfNi0xLTEtMS05MDYwOQ_547407d4-4182-4195-af89-32029b1ef223">285,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfNi0zLTEtMS05MDYwOQ_65d21260-35b1-4ea3-ad68-29a33c28404b">680,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses &#8211; long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="amci:PrepaidExpensesLongTerm" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfNy0zLTEtMS05MDYwOQ_3b4156ca-c3db-41bb-9475-e2602c34a0d8">184,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held in trust account</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930" decimals="0" name="us-gaap:AssetsHeldInTrustNoncurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfOC0xLTEtMS05MDYwOQ_b34438ef-d062-420b-ad85-c9d6b13a3179">150,969,468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:AssetsHeldInTrustNoncurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfOC0zLTEtMS05MDYwOQ_0f4561df-2917-42ca-a6a4-f9f2a58aefa1">150,006,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930" decimals="0" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfOS0xLTEtMS05MDYwOQ_75570294-d044-4564-a086-a86fbec96407">151,254,582</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfOS0zLTEtMS05MDYwOQ_5e16ded8-eb93-40a6-b653-f9d95d05fd4c">150,871,760</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders&#8217; Deficit:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930" decimals="0" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMTMtMS0xLTEtOTA2MDk_cc3390cb-571b-40df-8386-744afe7e740f">1,687,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMTMtMy0xLTEtOTA2MDk_6111f828-e4a3-4d81-9aac-8345c1d2b3cd">85,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930" decimals="0" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMTQtMS0xLTEtOTA2MDk_dcbe55b9-050a-43e3-8ce5-66c58f35f99b">1,356,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMTQtMy0xLTEtOTA2MDk_bf9d0a4a-dc5c-4290-9993-d8d7a96a48b8">229,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to related party</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930" decimals="0" name="us-gaap:DueToRelatedPartiesCurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMTUtMS0xLTEtOTA2MDk_20768516-1b8b-4b1f-9904-55d266072350">736,123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:DueToRelatedPartiesCurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMTUtMy0xLTEtOTA2MDk_f992dc01-e4a8-4772-a247-2dfcf5073b28">49,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital based tax payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930" decimals="0" name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMTYtMS0xLTEtOTA2MDk_6aca43dc-6f05-4c2a-a05e-57a8feebf120">331,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMTYtMy0xLTEtOTA2MDk_185a106d-db63-4399-a0bc-93354edffe34">198,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Franchise tax payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930" decimals="0" name="amci:FranchiseTaxPayableCurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMTctMS0xLTEtOTA2MDk_4f667e8a-8386-4035-a2fa-5e77ea83a295">149,639</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="amci:FranchiseTaxPayableCurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMTctMy0xLTEtOTA2MDk_0c993451-1ce5-473e-88e9-ca98ffe0cd85">188,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930" decimals="0" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMTgtMS0xLTEtOTA2MDk_5c1c216f-5ad2-4520-916a-0ac6ece63c68">54,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current liabilities </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930" decimals="0" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMTktMS0xLTEtOTA2MDk_c38a505c-f0b8-4c6c-a2aa-ddbecedcdca6">4,316,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMTktMy0xLTEtOTA2MDk_5380f83d-3e5a-4547-b727-887d46a693f0">751,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred underwriting commissions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930" decimals="0" name="amci:DeferredUnderwritingCompensationNoncurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMjAtMS0xLTEtOTA2MDk_f2d4ddd1-80c3-4d0b-9c74-6f695ccf3842">200,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="amci:DeferredUnderwritingCompensationNoncurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMjAtMy0xLTEtOTA2MDk_cf1b9128-5d58-4831-b1e0-d2312641b356">5,250,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930" decimals="0" name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMjEtMS0xLTEtOTA2MDk_5ce32fcf-37c3-4fb8-8c47-6fa6ca90d283">1,543,280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMjEtMy0xLTEtOTA2MDk_4454e0d4-d702-4f7b-be31-236fb0b8de67">5,610,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930" decimals="0" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMjItMS0xLTEtOTA2MDk_d06f3e70-4e3b-49fb-a183-ed695c9a373d">6,059,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMjItMy0xLTEtOTA2MDk_869d6d6a-7681-4792-817b-707d998189f4">11,611,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitments and Contingencies (Note 5)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMjQtMS0xLTEtOTA2MDk_5004390f-588a-44a3-ba53-b44305f3643a"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMjQtMy0xLTEtOTA2MDk_5ccb5fce-4dc8-42a9-9ca0-653d920d7310"></ix:nonFraction></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock subject to possible redemption, $0.0001 par value; 15,000,000 shares issued and outstanding at $10.00 per share at redemption as of September 30, 2022 and December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if090e35b3ace4abc92ca72a48339ebd7_I20220930" decimals="0" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMjYtMS0xLTEtOTA2MDk_2cd82cc5-d9bb-4198-b065-2bf3cc7d4534">150,293,649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39b3f93aa3714933b05800e10c00a387_I20211231" decimals="0" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMjYtMy0xLTEtOTA2MDk_08745514-cabb-488c-ab19-44b466822a61">150,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stockholders&#8217; Deficit:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $0.0001 par value&#894; 1,000,000 shares authorized&#894; no shares issued or outstanding as of September 30, 2022 and December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930" decimals="0" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMjktMS0xLTEtOTA2MDk_d373fc66-e885-4ba6-81fd-ae0c5634028b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMjktMy0xLTEtOTA2MDk_e4be30b9-8767-4e67-9b7e-1722fece0b1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock, $0.0001 par value; 280,000,000 shares authorized; no non-redeemable shares issued or outstanding as of September 30, 2022 and December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a9d6acf0a3443b8a9bfd210dcef6a0e_I20220930" decimals="0" name="us-gaap:CommonStockValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMzAtMS0xLTEtOTA2MDk_a43f5e80-5c03-4b37-a38e-cbf3cb7d224c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib763267d74d64b8fbe45ac357a9f8f08_I20211231" decimals="0" name="us-gaap:CommonStockValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMzAtMy0xLTEtOTA2MDk_d28487ac-8dfb-4633-982f-c085b65979dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 3,750,000 shares issued and outstanding as of September 30, 2022 and December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28b4565471d542708454f455b422d119_I20220930" decimals="0" name="us-gaap:CommonStockValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMzEtMS0xLTEtOTA2MDk_3df73ba7-f733-4009-980b-d68354aec3e0">375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id57512e5cedd4b74bc2f1786d35220d2_I20211231" decimals="0" name="us-gaap:CommonStockValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMzEtMy0xLTEtOTA2MDk_8a0ce581-d78e-49fc-afd3-a8c9164d40ed">375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930" decimals="0" name="us-gaap:AdditionalPaidInCapital" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMzItMS0xLTEtOTA2MDk_e6c12ebd-440b-4798-8607-e77b04a16025">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:AdditionalPaidInCapital" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMzItMy0xLTEtOTA2MDk_2461198c-44b8-4e1b-9758-84c86daff406">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930" decimals="0" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMzMtMS0xLTEtOTA2MDk_4003378a-edb1-498f-86df-1e747b74c90c">5,099,235</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMzMtMy0xLTEtOTA2MDk_06764561-dffb-4526-a866-e3f98e4bf315">10,739,971</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total stockholders&#8217; deficit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMzQtMS0xLTEtOTA2MDk_137c6e43-506b-4a12-bb15-53bc388053e1">5,098,860</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMzQtMy0xLTEtOTA2MDk_c145527f-2e45-4d38-bc2e-1aabbc68772d">10,739,596</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders&#8217; Deficit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930" decimals="0" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMzUtMS0xLTEtOTA2MDk_b11b73c9-056e-4e6e-8302-84579ed8b573">151,254,582</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMzUtMy0xLTEtOTA2MDk_2869497c-7883-4eba-9626-c4b3fac9f40d">150,871,760</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-2</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_16"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNAUDITED CONDENSED STATEMENTS OF OPERATIONS</span></div></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three<br/>Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three<br/>Months Ended <br/>September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Nine<br/>Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the<br/>Period from<br/>January 28,<br/>2021<br/>(inception)<br/>through<br/>September 30, <br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930" decimals="0" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMS0xLTEtMS05MDYwOQ_ad48e93e-1adf-49d1-9989-602472d0f58c">876,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930" decimals="0" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMS0zLTEtMS05MDYwOQ_880846db-f6f2-4e2f-98c3-0627adba83de">284,686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930" decimals="0" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMS01LTEtMS05MDYwOQ_74109254-c1ca-41d1-bc52-b117471c987d">3,677,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMS03LTEtMS05MDYwOQ_5b9ad450-4da6-49f2-89e4-cd86f5a3f14a">286,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses &#8211; related party</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930" decimals="0" name="us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMi0xLTEtMS05MDYwOQ_7f1517f9-29db-4bb8-90d7-01fecd3d4cf4">30,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930" decimals="0" name="us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMi0zLTEtMS05MDYwOQ_461b088a-758f-4de8-8bb4-4f5b4b3e35a0">20,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930" decimals="0" name="us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMi01LTEtMS05MDYwOQ_d8512674-ac8c-422b-926b-dac3329f9ec0">90,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" name="us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMi03LTEtMS05MDYwOQ_2ff127bf-1e26-42e5-be65-35a75ab845f2">20,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital base tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930" decimals="0" name="amci:CapitalBaseTaxExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMy0xLTEtMS05MDYwOQ_59dbe8ab-e560-495a-853a-0512ab9c4c06">75,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930" decimals="0" name="amci:CapitalBaseTaxExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMy01LTEtMS05MDYwOQ_13e3834d-3b33-4151-8514-ea5d64612dce">183,578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Franchise tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930" decimals="0" name="us-gaap:ProductionTaxExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfNC0xLTEtMS05MDYwOQ_74041c60-f2b4-4914-8b75-69ffab5b22a4">50,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930" decimals="0" name="us-gaap:ProductionTaxExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfNC0zLTEtMS05MDYwOQ_4481562f-fc27-47f8-a776-9ef7e3cfaef5">134,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930" decimals="0" name="us-gaap:ProductionTaxExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfNC01LTEtMS05MDYwOQ_316ec4be-91f1-45db-b038-3e823e3b7993">149,639</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" name="us-gaap:ProductionTaxExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfNC03LTEtMS05MDYwOQ_59c7e584-d51c-4f81-965c-0d14b7dbb269">134,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930" decimals="0" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfNS0xLTEtMS05MDYwOQ_465b5760-d02d-4f7a-b0ee-08dea17dbba7">1,032,551</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930" decimals="0" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfNS0zLTEtMS05MDYwOQ_c40ff9cc-e0c1-44d4-aaa0-37b63102bbf1">439,531</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930" decimals="0" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfNS01LTEtMS05MDYwOQ_d4a86e9f-f30d-4649-a43f-6908bed64293">4,100,422</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfNS03LTEtMS05MDYwOQ_613fb58f-51c7-4e20-9c3c-898aada41a86">441,100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expenses):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930" decimals="0" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfNy0xLTEtMS05MDYwOQ_2b028052-4f17-4b57-8289-5f774fa5467c">1,426,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930" decimals="0" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfNy0zLTEtMS05MDYwOQ_c299dcd7-4093-49f6-8440-617a996f7606">1,382,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930" decimals="0" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfNy01LTEtMS05MDYwOQ_fc84d293-a905-4f95-ab09-7c7267e15676">4,066,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfNy03LTEtMS05MDYwOQ_2ffa446d-0610-406f-8ecb-3bdb2f7b80f1">1,382,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from extinguishment of deferred underwriting commissions on public warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930" decimals="0" name="amci:GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfOC0xLTEtMS05MDYwOQ_726c342f-f597-4825-9c7e-8e09a72cfbf8">171,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930" decimals="0" name="amci:GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfOC01LTEtMS05MDYwOQ_c1837017-9cfd-45fe-9a5c-d8c6af86cf8c">171,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Offering costs allocated to derivative warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930" decimals="0" name="amci:OfferingCostsAllocatedToDerivativeWarrantLiabilities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfOS0zLTEtMS05MDYwOQ_6b67d525-faee-430c-a4a2-028d75b754a4">476,450</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" name="amci:OfferingCostsAllocatedToDerivativeWarrantLiabilities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfOS03LTEtMS05MDYwOQ_2253877b-3686-4d44-8aac-82f95278ba64">476,450</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from investments held in trust account</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930" decimals="0" name="amci:IncomeFromInvestmentsHeldInTrustAccount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTAtMS0xLTEtOTA2MDk_80c0ce7c-8224-4230-9bcd-1d6949de14e9">733,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930" decimals="0" name="amci:IncomeFromInvestmentsHeldInTrustAccount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTAtMy0xLTEtOTA2MDk_2d6a6ba4-8fd2-4aac-9df8-c6c2199a6b64">2,178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930" decimals="0" name="amci:IncomeFromInvestmentsHeldInTrustAccount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTAtNS0xLTEtOTA2MDk_48d3c546-8e69-4727-bc47-39c2e95d7532">972,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" name="amci:IncomeFromInvestmentsHeldInTrustAccount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTAtNy0xLTEtOTA2MDk_7130b32f-484c-44d7-906f-1315fe0f0d07">2,178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income tax expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930" decimals="0" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTEtMS0xLTEtOTA2MDk_4604b14f-75bc-47aa-a0ad-b81d11e14fe3">1,298,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930" decimals="0" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTEtMy0xLTEtOTA2MDk_8da824e1-de6b-4a3f-ae04-79211afc53bc">469,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930" decimals="0" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTEtNS0xLTEtOTA2MDk_0a95ffab-2ca7-4644-8237-0037031a644e">1,110,451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTEtNy0xLTEtOTA2MDk_78b095f5-2202-4050-aeab-b62cd9946dee">467,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930" decimals="0" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTItMS0xLTEtOTA2MDk_2df7ba50-c60c-42a5-9923-5d0b0f6fee0c">54,366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930" decimals="0" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTItNS0xLTEtOTA2MDk_5410277d-8081-41d4-a2ed-7757a797cb2c">54,366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930" decimals="0" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTMtMS0xLTEtOTA2MDk_58d8e922-0e56-4332-91a3-a64e27bedccf">1,244,545</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930" decimals="0" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTMtMy0xLTEtOTA2MDk_292bcb37-f14a-4c16-9930-e8d8805ba1fa">469,097</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930" decimals="0" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTMtNS0xLTEtOTA2MDk_6666b3d8-e41e-4080-b1c8-d03f6ae15c10">1,056,085</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTMtNy0xLTEtOTA2MDk_84325c71-9904-4704-9770-7a710ea0da75">467,528</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average shares outstanding of Class A common stock, basic and diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7ec1172d9fda413997c83cfd78da69a8_D20220701-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTUtMS0xLTEtOTA2MDk_c0b9da0a-2858-4a80-96e1-bc36c7ea8ac8"><ix:nonFraction unitRef="shares" contextRef="i7ec1172d9fda413997c83cfd78da69a8_D20220701-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTUtMS0xLTEtOTA2MDk_c43d3ea0-baec-4af3-b87b-946e48b66bb9">15,000,000</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia6e8e0bf44ba47628681fa0a2b0c4d8e_D20210701-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTUtMy0xLTEtOTA2MDk_338f46a2-a749-4bfb-a482-fab22e34803d"><ix:nonFraction unitRef="shares" contextRef="ia6e8e0bf44ba47628681fa0a2b0c4d8e_D20210701-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTUtMy0xLTEtOTA2MDk_6bff9245-0e84-49c5-abe0-dbb9f3cecd6f">9,130,435</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i54e04e92a2f745c79145378982854e9d_D20220101-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTUtNS0xLTEtOTA2MDk_1fc4fe8d-f7a5-495b-a931-83035ed3511d"><ix:nonFraction unitRef="shares" contextRef="i54e04e92a2f745c79145378982854e9d_D20220101-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTUtNS0xLTEtOTA2MDk_ab4413ff-356c-43a1-a259-dcb1b4c4b76c">15,000,000</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia80b8151be5a4bbda59a9bd0f4d2f0d4_D20210128-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTUtNy0xLTEtOTA2MDk_3bd8277a-a0ed-4b64-b816-0c852ea47e65"><ix:nonFraction unitRef="shares" contextRef="ia80b8151be5a4bbda59a9bd0f4d2f0d4_D20210128-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTUtNy0xLTEtOTA2MDk_978013b4-79f2-484c-9416-ca750773c4fd">3,428,571</ix:nonFraction></ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic and diluted net income (loss) per share, Class A common stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7ec1172d9fda413997c83cfd78da69a8_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTYtMS0xLTEtOTA2MDk_6bac8f29-f587-4948-9bdd-bab9345de1cf"><ix:nonFraction unitRef="usdPerShare" contextRef="i7ec1172d9fda413997c83cfd78da69a8_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTYtMS0xLTEtOTA2MDk_91c2bc70-adc1-4e02-8adc-856bf06f3f6b">0.07</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia6e8e0bf44ba47628681fa0a2b0c4d8e_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTYtMy0xLTEtOTA2MDk_016a37eb-1435-4fd1-9493-626969d90139"><ix:nonFraction unitRef="usdPerShare" contextRef="ia6e8e0bf44ba47628681fa0a2b0c4d8e_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTYtMy0xLTEtOTA2MDk_f8c929d6-7f0e-45d2-b32e-5803e03592db">0.04</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i54e04e92a2f745c79145378982854e9d_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTYtNS0xLTEtOTA2MDk_874cba48-848c-4822-a872-c2ae644843eb"><ix:nonFraction unitRef="usdPerShare" contextRef="i54e04e92a2f745c79145378982854e9d_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTYtNS0xLTEtOTA2MDk_c1cdc175-bc63-48c8-8fcb-923a9f4d353e">0.06</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia80b8151be5a4bbda59a9bd0f4d2f0d4_D20210128-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTYtNy0xLTEtOTA2MDk_b37bbde1-f735-468d-b50f-1584ea42656d"><ix:nonFraction unitRef="usdPerShare" contextRef="ia80b8151be5a4bbda59a9bd0f4d2f0d4_D20210128-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTYtNy0xLTEtOTA2MDk_c2764a6a-f7ef-4383-86ae-2c8f8edd5b38">0.07</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average shares outstanding of Class B common stock, basic and diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5c83b432fed543cdbb0ae452750d8666_D20220701-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTctMS0xLTEtOTA2MDk_10011bb1-915b-49c0-8858-302ff37c7a49"><ix:nonFraction unitRef="shares" contextRef="i5c83b432fed543cdbb0ae452750d8666_D20220701-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTctMS0xLTEtOTA2MDk_dba84638-a64a-413d-aefb-2da14d8be922">3,750,000</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib0792dc9052f4435aec8f1746381b495_D20210701-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTctMy0xLTEtOTA2MDk_4408f2d8-8315-4d88-8adc-aeaed6b7ecc5"><ix:nonFraction unitRef="shares" contextRef="ib0792dc9052f4435aec8f1746381b495_D20210701-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTctMy0xLTEtOTA2MDk_dbbebf20-0cda-4882-95c8-af6badd2d824">3,750,000</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie106d118b90b4570a0b940a2a0611875_D20220101-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTctNS0xLTEtOTA2MDk_0fc39d83-0e4e-471e-9064-89126f7fc961"><ix:nonFraction unitRef="shares" contextRef="ie106d118b90b4570a0b940a2a0611875_D20220101-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTctNS0xLTEtOTA2MDk_920ce994-7640-4ff6-b2be-241e461be604">3,750,000</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i14e0883a4b7e4c05850198fa191fd751_D20210128-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTctNy0xLTEtOTA2MDk_5e0d264a-c9e2-4db8-ac4f-7c63288b43a8"><ix:nonFraction unitRef="shares" contextRef="i14e0883a4b7e4c05850198fa191fd751_D20210128-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTctNy0xLTEtOTA2MDk_a9096d44-010d-416c-bc6a-86ce0352a9e3">3,750,000</ix:nonFraction></ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic and diluted net income (loss) per share, Class B common stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5c83b432fed543cdbb0ae452750d8666_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTgtMS0xLTEtOTA2MDk_144b7e08-1564-41c3-a876-e89513b56556"><ix:nonFraction unitRef="usdPerShare" contextRef="i5c83b432fed543cdbb0ae452750d8666_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTgtMS0xLTEtOTA2MDk_178d7683-ba47-456d-9295-906c5b22d5dd">0.07</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib0792dc9052f4435aec8f1746381b495_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTgtMy0xLTEtOTA2MDk_68c28f90-16ec-43d8-831a-f749cec949af"><ix:nonFraction unitRef="usdPerShare" contextRef="ib0792dc9052f4435aec8f1746381b495_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTgtMy0xLTEtOTA2MDk_75ae0364-c050-4f34-acfd-83effc2d9e1b">0.04</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie106d118b90b4570a0b940a2a0611875_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTgtNS0xLTEtOTA2MDk_1bcefe41-4e92-42b4-8281-fefa28036792"><ix:nonFraction unitRef="usdPerShare" contextRef="ie106d118b90b4570a0b940a2a0611875_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTgtNS0xLTEtOTA2MDk_b39ca7c5-216d-4d96-acba-7118d02df5a1">0.06</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i14e0883a4b7e4c05850198fa191fd751_D20210128-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTgtNy0xLTEtOTA2MDk_0e2c0e55-cbed-48c1-9a08-eac5328fbf4a"><ix:nonFraction unitRef="usdPerShare" contextRef="i14e0883a4b7e4c05850198fa191fd751_D20210128-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTgtNy0xLTEtOTA2MDk_c5531584-8d7b-4ff7-95bb-f6639b4136ea">0.07</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-3</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_19"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; EQUITY (DEFICIT)</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022</span></div></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.641%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Deficit</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance &#8211; December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i561b8e9c306343cbaa06d16947928777_I20211231" decimals="INF" name="us-gaap:SharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMy0xLTEtMS05MDYwOQ_8e7c76e5-414b-4abb-9755-55b47b30bd93">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561b8e9c306343cbaa06d16947928777_I20211231" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMy0zLTEtMS05MDYwOQ_1ac29fbc-572e-42c7-a8dd-eba02ba56228">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0df54c9e466f4cee877df6ba1a2a8b5c_I20211231" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMy01LTEtMS05MDYwOQ_a6d00d93-4369-4f08-87b1-8fc23686ec5e">3,750,000</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0df54c9e466f4cee877df6ba1a2a8b5c_I20211231" decimals="0" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMy03LTEtMS05MDYwOQ_714683c2-863c-47ab-94c2-bdc02e6c2dbd">375</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d10e6b77d0f437bb89153397dd47b71_I20211231" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMy05LTEtMS05MDYwOQ_6a711e0b-99f5-472d-ac27-0b473b495ccc">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i331e64d7b36f44f3a66c631e0f8eeddb_I20211231" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMy0xMS0xLTEtOTA2MDk_e93e44e3-2b39-4e63-9f19-e3a1de1af59a">10,739,971</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMy0xMy0xLTEtOTA2MDk_ca3340c9-ff41-4caa-bf3a-4714dcbdb3ac">10,739,596</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iccfd9da1f9504cf29912dc80db305fc8_D20220101-20220331" decimals="0" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfNC0xMS0xLTEtOTA2MDk_0ea731a3-257c-4832-b7e2-ccd66e008400">3,542,722</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7947124f41844b0939436b1a8f133ad_D20220101-20220331" decimals="0" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfNC0xMy0xLTEtOTA2MDk_2317d8d6-1cc0-4f41-b25b-f6b6857642f0">3,542,722</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance &#8211; March 31, 2022 (unaudited)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0d0aee75172442178da88056a9989307_I20220331" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfNS01LTEtMS05MDYwOQ_6f1bcee4-5163-449d-a859-1c15effb357a">3,750,000</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d0aee75172442178da88056a9989307_I20220331" decimals="0" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfNS03LTEtMS05MDYwOQ_5c045fce-4d7d-40d9-9e62-188c92005bed">375</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida7b05626e374502819328077c492d48_I20220331" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfNS0xMS0xLTEtOTA2MDk_bb4b1fc5-f502-45cb-b514-b6c324c1108f">14,282,693</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie90832410d85447aa964ca438ac09c5f_I20220331" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfNS0xMy0xLTEtOTA2MDk_11e7821a-a5fd-4e5b-a3b4-07d69c18fc64">14,282,318</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c3171eddba54a6b8c58c3219dea0549_D20220401-20220630" decimals="0" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfNi0xMS0xLTEtOTA2MDk_e46aba94-029d-40b3-8c63-adcb836e35c6">3,354,262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c13bbdaf19b4cd897fbbb738aa40bdb_D20220401-20220630" decimals="0" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfNi0xMy0xLTEtOTA2MDk_f7e04d16-83a4-4931-9f87-94bab145e6fe">3,354,262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance &#8211; June 30, 2022 (unaudited)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaf261b46a23c49b4a762205835c271ab_I20220630" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfNy01LTEtMS05MDYwOQ_c2c5ecbd-6bfa-4619-a730-10894f68ec88">3,750,000</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf261b46a23c49b4a762205835c271ab_I20220630" decimals="0" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfNy03LTEtMS05MDYwOQ_40a6e66b-bc6e-48c2-8907-7774272cf11f">375</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i85ee8ec1448f491faaa8d5f1b8a40824_I20220630" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfNy0xMS0xLTEtOTA2MDk_572a2c0f-5e53-4658-82dd-be9c0de8208c">10,928,431</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i34104a0f3a774be48e18d60b95cb9e34_I20220630" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfNy0xMy0xLTEtOTA2MDk_26328b7f-04b7-43e3-87d8-31298f19ce88">10,928,056</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Extinguishment of deferred underwriting commissions on public shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie631ef4e3c7041e688921b3859fca7f5_D20220701-20220930" decimals="0" name="amci:AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfOC05LTEtMS05MDYwOQ_d194c861-0864-44aa-b3c0-593c08e314c6">4,878,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930" decimals="0" name="amci:AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfOC0xMy0xLTEtOTA2MDk_d795fb90-302d-4323-a50a-0599e1b54eb7">4,878,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reclass from additional paid-in capital to retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie631ef4e3c7041e688921b3859fca7f5_D20220701-20220930" decimals="0" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfOS05LTEtMS05MDYwOQ_73e054e0-6b8f-44b6-9e76-923650fa1172">4,878,300</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d521767d60745fd9681006b5cd0f52f_D20220701-20220930" decimals="0" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfOS0xMS0xLTEtOTA2MDk_5404fb44-84e5-4cf5-8e11-c7374ca05e9a">4,878,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Subsequent remeasurement of Class A common stock subject to possible redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d521767d60745fd9681006b5cd0f52f_D20220701-20220930" decimals="0" sign="-" name="amci:IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMTAtMTEtMS0xLTkwNjA5_941828e3-1f7b-4749-a15e-8b7e296e0f48">293,649</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930" decimals="0" sign="-" name="amci:IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMTAtMTMtMS0xLTkwNjA5_02483270-035b-4b67-bea3-6e122a801d13">293,649</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d521767d60745fd9681006b5cd0f52f_D20220701-20220930" decimals="0" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMTEtMTEtMS0xLTkwNjA5_122ea289-a932-4c3d-a9a9-0f47c79f8fc1">1,244,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930" decimals="0" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMTEtMTMtMS0xLTkwNjA5_0f063875-756f-43e8-b9cf-710253dbc021">1,244,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance &#8211; September 30, 2022 (unaudited)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0bb75187403d4c7096a2ecce94a1cfe2_I20220930" decimals="INF" name="us-gaap:SharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMTItMS0xLTEtOTA2MDk_37435952-21e3-4439-9aec-412fd3c8b5f0">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bb75187403d4c7096a2ecce94a1cfe2_I20220930" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMTItMy0xLTEtOTA2MDk_4ae20d00-e0e9-4b8b-938d-5a7e2984d06d">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic24c8091c8be4348b39159f1dd9591dc_I20220930" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMTItNS0xLTEtOTA2MDk_31a82efc-713f-427b-92f9-88c320ae3df6">3,750,000</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic24c8091c8be4348b39159f1dd9591dc_I20220930" decimals="0" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMTItNy0xLTEtOTA2MDk_4108af23-a212-4912-8d9a-d3de5a2b2c76">375</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54638a76c0754184ad34989edb55bad0_I20220930" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMTItOS0xLTEtOTA2MDk_1cfee17e-48e1-4e34-b6f7-59e227595be9">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc67725111024800a8fe8de4f7e18d06_I20220930" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMTItMTEtMS0xLTkwNjA5_1da54b12-4cc5-4dbd-9cd0-8c99a7769485">5,099,235</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMTItMTMtMS0xLTkwNjA5_22963c06-10d7-4935-9793-9da243bef4db">5,098,860</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2021 AND FOR THE PERIOD FROM JANUARY 28, 2021 (INCEPTION) THROUGH SEPTEMBER 30, 2021</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.641%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity (Deficit)</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance &#8211; January 28, 2021 (inception) </span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic0513771cd0245b88eec6099822e8d74_I20210127" decimals="INF" name="us-gaap:SharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMy0xLTEtMS05MDYwOQ_be5905d5-ce0d-4733-9830-920ff496649d">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0513771cd0245b88eec6099822e8d74_I20210127" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMy0zLTEtMS05MDYwOQ_41a0c083-d260-4670-b6f3-7fa0d2b7eb76">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i763e0a3dbecb4e3795d7f408cf8a20d5_I20210127" decimals="INF" name="us-gaap:SharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMy01LTEtMS05MDYwOQ_046fc7f9-e92c-4215-8bc0-44581c93a078">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i763e0a3dbecb4e3795d7f408cf8a20d5_I20210127" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMy03LTEtMS05MDYwOQ_c5ec1aff-ac20-4298-8567-59992221aa62">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec832394a7514357811e3f793e5b673f_I20210127" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMy05LTEtMS05MDYwOQ_823c7014-c71a-44d0-8a92-07abe2949ee4">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc4dbb45fe26489b9bca7b77497e7ca7_I20210127" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMy0xMS0xLTEtOTA2MDk_6cc7afb8-2dcd-4bb7-b050-3b1aba658d46">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib90981c31c9b45a98ded9929aeaa406e_I20210127" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMy0xMy0xLTEtOTA2MDk_1104efbb-4951-4776-873d-f08ff0bcce1e">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of Class B common stock to Sponsor</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iacb1cd84cde241edbd72d0fcbd87e137_D20210128-20210331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfNC01LTEtMS05MDYwOQ_50fe5d28-a220-4eb1-be83-31c5d31294db">4,312,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacb1cd84cde241edbd72d0fcbd87e137_D20210128-20210331" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfNC03LTEtMS05MDYwOQ_1f7e8abf-a1ea-4c9a-9607-d4c5a5f3c535">431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68b075b25b0c44f6a65dc37835ddacab_D20210128-20210331" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfNC05LTEtMS05MDYwOQ_57632a2b-2dd0-4366-87ec-eb4652ce5a00">24,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60a5cae9cdab4813bb1586b3eb4d1453_D20210128-20210331" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfNC0xMy0xLTEtOTA2MDk_4a98a8ec-270a-4bb6-b5fe-1601c539ab91">25,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic78d5d5e9dab4e66927c72ef3a01cffb_D20210128-20210331" decimals="0" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfNS0xMS0xLTEtOTA2MDk_699a5701-eb9f-4a44-99b3-f3641fe53058">1,126</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i60a5cae9cdab4813bb1586b3eb4d1453_D20210128-20210331" decimals="0" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfNS0xMy0xLTEtOTA2MDk_dba78a6f-805a-48c6-b14e-cdc04482e15c">1,126</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance &#8211; March 31, 2021 (unaudited)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia238c2a996b14c81929dd59e484951e5_I20210331" decimals="INF" name="us-gaap:SharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfNi0xLTEtMS05MDYwOQ_24e1bc97-de9d-4ba7-a086-1b8e33881b44">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia238c2a996b14c81929dd59e484951e5_I20210331" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfNi0zLTEtMS05MDYwOQ_beb44767-6b75-48d2-8fad-5f9bb7d6639d">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5f0fcd477eed4404a2b0dc7ab62aec98_I20210331" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfNi01LTEtMS05MDYwOQ_cc158baa-cc54-402c-8206-3ef434708707">4,312,500</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f0fcd477eed4404a2b0dc7ab62aec98_I20210331" decimals="0" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfNi03LTEtMS05MDYwOQ_aa00a1ff-e175-467f-b0a3-d895dfde03a6">431</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79b3bc37e87346618fe34e2a23526ca7_I20210331" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfNi05LTEtMS05MDYwOQ_72a838f4-6e2f-4f1f-9dc9-71a5eebb77c5">24,569</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i44e48778017342f3ab0160bb5770cda2_I20210331" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfNi0xMS0xLTEtOTA2MDk_1482f512-0e01-49dc-827d-fa6d80ef67e2">1,126</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97e926931d264729ab7aaa14e1843a88_I20210331" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfNi0xMy0xLTEtOTA2MDk_2777d9d4-a62c-4de9-b75b-229ef5b1c251">23,874</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie687fdc1ee234a2686233327949a762b_D20210401-20210630" decimals="0" sign="-" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfNy0xMS0xLTEtOTA2MDk_6799ac80-9a74-4747-930a-4da9f5953122">443</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8155dd44f1cf44b6963742cb3e993f91_D20210401-20210630" decimals="0" sign="-" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfNy0xMy0xLTEtOTA2MDk_8376991a-f744-4623-9121-3f4bd5a8c501">443</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance &#8211; June 30, 2021 (unaudited)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic3756d2ccfa146a8b4a56cd8bc84e1d6_I20210630" decimals="INF" name="us-gaap:SharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfOC0xLTEtMS05MDYwOQ_6f4a65b6-cd5f-4f90-96ed-00d496be8ad9">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3756d2ccfa146a8b4a56cd8bc84e1d6_I20210630" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfOC0zLTEtMS05MDYwOQ_88e6420f-abe8-4f57-96e6-7f74f21ebae9">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib1634b21bc004766bd5719101e1d1b9a_I20210630" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfOC01LTEtMS05MDYwOQ_39af1f34-9cae-4a7b-8c42-b6cc9f427096">4,312,500</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1634b21bc004766bd5719101e1d1b9a_I20210630" decimals="0" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfOC03LTEtMS05MDYwOQ_3c189e79-8cfb-4908-b54a-85e33cf189e8">431</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cd57aeb02fe49d7ab3297670b39a5ec_I20210630" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfOC05LTEtMS05MDYwOQ_f8d209ab-7ee9-446f-8ea1-262c1496674e">24,569</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5e9fb5e65ac48fcaf2c511cdde6838a_I20210630" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfOC0xMS0xLTEtOTA2MDk_c8f3c07c-109c-4f96-8b95-85fdd4685af1">1,569</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bd791fd96c546dbb9c9ea8bb1d75555_I20210630" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfOC0xMy0xLTEtOTA2MDk_d322be7c-ab14-40d6-aae8-5e561b27d0cf">23,431</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Excess cash received over the fair value of the private warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i872f016ca939404ab1d0fbc4771bc03a_D20210701-20210930" decimals="0" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfOS05LTEtMS05MDYwOQ_03cbb36b-1c1a-4aed-9bdb-94ec653e2dd2">1,085,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930" decimals="0" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfOS0xMy0xLTEtOTA2MDk_5dda3c9f-483c-435e-9d2f-feeca1228770">1,085,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forfeited shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i7bef5324e72a48db9ebecc0f92eacda1_D20210701-20210930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTAtNS0xLTEtOTA2MDk_e7ad7e59-4cd9-4688-bdf3-29bc37ca4339">562,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bef5324e72a48db9ebecc0f92eacda1_D20210701-20210930" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTAtNy0xLTEtOTA2MDk_b5f6c6d2-8ab5-4465-a5cb-cb53e01f7718">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i872f016ca939404ab1d0fbc4771bc03a_D20210701-20210930" decimals="0" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTAtOS0xLTEtOTA2MDk_a3720688-ef12-415f-8953-200d6afcd9c4">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contribution from Sponsor upon sale of founder shares to Anchor Investors</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i872f016ca939404ab1d0fbc4771bc03a_D20210701-20210930" decimals="0" name="amci:ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTEtOS0xLTEtOTA2MDk_530deeee-4df9-4e56-8d55-d4317d0e8d74">6,509,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930" decimals="0" name="amci:ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTEtMTMtMS0xLTkwNjA5_195fc3aa-bd4a-44cf-9883-b0aa74f66d80">6,509,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accretion of Class A common stock subject to possible redemption amount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i872f016ca939404ab1d0fbc4771bc03a_D20210701-20210930" decimals="0" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTItOS0xLTEtOTA2MDk_fb272d73-549c-4376-a8ab-4b335996de38">7,619,383</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ef0abc6bb5e4c13a1e3275c01c2d9be_D20210701-20210930" decimals="0" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTItMTEtMS0xLTkwNjA5_16bcb312-f38d-4d3e-b5d4-9e7ad980329d">10,786,709</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930" decimals="0" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTItMTMtMS0xLTkwNjA5_75f5690a-b147-4452-a10f-fb91ff255cfd">18,406,092</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ef0abc6bb5e4c13a1e3275c01c2d9be_D20210701-20210930" decimals="0" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTMtMTEtMS0xLTkwNjA5_e73573d1-44a4-4d13-a7d7-22968e1b5679">469,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930" decimals="0" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTMtMTMtMS0xLTkwNjA5_f5e360d2-2637-485d-8259-d57dc52ca4ef">469,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance &#8211; September 30, 2021 (unaudited)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i54a9911fbd55474198f366931f8bbeda_I20210930" decimals="INF" name="us-gaap:SharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTQtMS0xLTEtOTA2MDk_39375110-dbed-43f6-a4aa-c74089ed1337">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54a9911fbd55474198f366931f8bbeda_I20210930" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTQtMy0xLTEtOTA2MDk_47b4c867-f03d-48eb-90ce-4a1de5c90369">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6c5914aab6b6409fa89292f8b33f2d63_I20210930" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTQtNS0xLTEtOTA2MDk_17bc6eaf-f282-47e4-8bb7-10250d7048c7">3,750,000</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c5914aab6b6409fa89292f8b33f2d63_I20210930" decimals="0" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTQtNy0xLTEtOTA2MDk_bf0e2fc0-187e-426b-b9c3-f9f8640da066">375</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1cfc7a3d369645768bf19279957b83f3_I20210930" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTQtMTEtMS0xLTkwNjA5_682c613f-366f-48dd-9e5c-61cd91625a1a">10,319,181</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if96f4a11922442b08faec4138ba298eb_I20210930" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTQtMTMtMS0xLTkwNjA5_07045090-6b80-4f7a-b43e-c99ed72e000a">10,318,806</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">This number includes up to 562,500 shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5). On May 14, 2021, the Sponsor forfeited 718,750 shares of Class B common stock, resulting in the sponsor continuing to hold 4,312,500 shares of Class B common stock. All share and per-share amounts have been retroactively restated to reflect the share surrender.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-4</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_25"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS</span></div></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">For the Nine<br/>Months Ended<br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">For the Period<br/>from January 28,<br/>2021 (inception)<br/>through September 30,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flows from Operating Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930" decimals="0" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMi0xLTEtMS05MDYwOQ_c32800d3-9c17-4437-a4d0-54945dec77d4">1,056,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMi0zLTEtMS05MDYwOQ_8ee7f3b4-4f8d-4e22-a8d1-f71ff1f06c7f">467,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative expenses paid by Sponsor in exchange for issuance of Class B common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" name="amci:GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfNC0zLTEtMS05MDYwOQ_47711072-5767-46fe-a2a7-d2483b5a7236">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in fair value of derivative warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930" decimals="0" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfNS0xLTEtMS05MDYwOQ_19d3f13a-a4bc-47b4-8991-e5bc26874f95">4,066,720</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfNS0zLTEtMS05MDYwOQ_287f52df-211d-4801-bcd9-55624e5a33fc">1,382,900</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain from extinguishment of deferred underwriting commission on public warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930" decimals="0" name="amci:GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfNi0xLTEtMS05MDYwOQ_ca2ed25d-f419-4f1d-9574-57517a6ef5ef">171,700</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Offering costs allocated to derivative warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" name="amci:OfferingCostsAllocatedToDerivativeWarrantLiabilities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfNy0zLTEtMS05MDYwOQ_a211f24b-d927-47af-8470-fd8479fdb95c">476,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income from investments held in the trust account</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930" decimals="0" name="amci:IncomeFromInvestmentsHeldInTrustAccount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfOC0xLTEtMS05MDYwOQ_ca03f775-7819-4a36-ac0c-eadfe8d1a16f">972,453</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" name="amci:IncomeFromInvestmentsHeldInTrustAccount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfOC0zLTEtMS05MDYwOQ_0724d90a-3c7f-4d8c-a4b0-8f900c746172">2,178</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930" decimals="0" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMTAtMS0xLTEtOTA2MDk_ca7e12c9-1b9e-4554-a172-d1b093902829">244,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMTAtMy0xLTEtOTA2MDk_cb818a0c-161a-44d2-a741-fad244829515">49,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930" decimals="0" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMTEtMS0xLTEtOTA2MDk_3d037858-e462-494f-be9a-0280b717bf31">1,602,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMTEtMy0xLTEtOTA2MDk_3195a0aa-41d9-41de-b285-78cbd588084c">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Due to related party</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930" decimals="0" name="amci:IncreaseDecreaseInDueToRelatedParties." format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMTItMS0xLTEtOTA2MDk_d42fa0e7-0608-400b-b12f-18fa8ab6d6fa">686,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" name="amci:IncreaseDecreaseInDueToRelatedParties." format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMTItMy0xLTEtOTA2MDk_68423b72-8911-49a9-b578-377ff1fccad5">19,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930" decimals="0" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMTMtMS0xLTEtOTA2MDk_7198266c-7058-4ede-b998-b6506a1d79df">1,127,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMTMtMy0xLTEtOTA2MDk_3adb603e-512e-47f5-90db-404dcd4ccff0">138,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Capital base tax payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930" decimals="0" name="amci:IncreaseDecreaseInCapitalBaseTaxPayable" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMTQtMS0xLTEtOTA2MDk_8bc83ddc-be83-412a-83d9-4218c4d34af5">133,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Franchise tax payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930" decimals="0" sign="-" name="amci:IncreaseDecreaseFranchiseTaxPayable" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMTUtMS0xLTEtOTA2MDk_aa326f6a-03a5-4d59-82b0-9bb2459e1d74">38,598</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" name="amci:IncreaseDecreaseFranchiseTaxPayable" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMTUtMy0xLTEtOTA2MDk_1b6e1ae6-8846-42bf-9d96-816655db1f7a">134,845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930" decimals="0" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMTYtMS0xLTEtOTA2MDk_75dd9845-20c6-45b2-9a8a-fbb256881da7">54,366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash used in operating activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930" decimals="0" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMTctMS0xLTEtOTA2MDk_67be43c7-257e-4459-be7f-2ecc839d12dc">345,097</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMTctMy0xLTEtOTA2MDk_3be58d7e-c0e7-4769-b044-ab6be495689c">95,325</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flows from Investing Activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash deposited in trust account</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" name="us-gaap:PaymentsToAcquireTrustPreferredInvestments" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMjAtMy0xLTEtOTA2MDk_75f06b58-2358-400a-97d9-a826a30812f9">150,000,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment income released from Trust Account</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930" decimals="0" sign="-" name="amci:PaymentsForInvestmentOfCashInTrustAccount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMjEtMS0xLTEtOTA2MDk_c9c9f7ff-d2f7-4347-92c6-12ad79880a2f">9,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash provided by investing activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930" decimals="0" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMjItMS0xLTEtOTA2MDk_ccfd6832-4ad2-4d4b-9ddf-8a34e4db70fa">9,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMjItMy0xLTEtOTA2MDk_4263a845-7ad8-43cc-bc6e-5bb332a5162c">150,000,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flows from Financing Activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from note payable to related party</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" name="us-gaap:ProceedsFromRelatedPartyDebt" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMjUtMy0xLTEtOTA2MDk_b68aaf6a-d025-438f-a77b-8494c690265c">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds received from initial public offering, gross</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMjYtMy0xLTEtOTA2MDk_8ffe1e0f-5548-4545-b82e-cd8b94aa5754">150,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds received from private placement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" name="us-gaap:ProceedsFromIssuanceOfWarrants" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMjctMy0xLTEtOTA2MDk_64654f1c-a025-4165-ac63-39ceb99dcd32">852,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash provided by financing activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMjgtMy0xLTEtOTA2MDk_104a9357-2f38-4cbe-93d6-4c05a0e52cb6">150,853,416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net change in cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930" decimals="0" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMzAtMS0xLTEtOTA2MDk_f16d8177-b772-4aa1-97d9-86a85b5fdf1c">336,097</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMzAtMy0xLTEtOTA2MDk_1a24bfeb-a9d2-4baa-b904-027413c14c7c">758,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash &#8211; beginning of the period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMzItMS0xLTEtOTA2MDk_016ddb9f-bf62-41c9-9a93-9f718ccc67a3">343,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash &#8211; end of the period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930" decimals="0" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMzMtMS0xLTEtOTA2MDk_55ae8f0b-3342-443a-8851-61ad60814b1e">7,302</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96f4a11922442b08faec4138ba298eb_I20210930" decimals="0" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMzMtMy0xLTEtOTA2MDk_485fe2a5-6a65-40a4-b958-a1220190c8a1">758,091</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental disclosure of noncash activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Offering costs included in notes payable </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" name="amci:DeferredOfferingCostsIncludedInNotesPayable" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMzYtMy0xLTEtOTA2MDk_23b66971-0def-4c64-9bdc-5eaee79b6b39">1,968,784</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Offering costs included in accrued expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" name="amci:OfferingCostsIncludedInAccountsPayableAccruedExpenses" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMzctMy0xLTEtOTA2MDk_f02d6446-bae3-4309-ab59-fc954db233b0">30,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Offering costs paid by Sponsor in exchange for issuance of Class B common stock</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" name="amci:DeferredUnderwritingFeePayable" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMzgtMy0xLTEtOTA2MDk_2eede8fa-3d70-4389-8e9d-af7eb3127bd8">24,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses paid by related party under note payable and advances</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" name="amci:NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMzktMy0xLTEtOTA2MDk_76a23594-c540-4faa-9e9b-01b2fc720cff">677,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayment of note payable and advances by Sponsor in exchange for issuance of private placement warrants</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" name="amci:NoncashRepaymentOfNotePayableAndAdvances" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfNDAtMy0xLTEtOTA2MDk_18046cb8-2018-404c-aeb7-cfd9e087c071">2,647,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred underwriting commissions in connection with the initial public offering</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" name="amci:NoncashDeferredUnderwritingCommissions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfNDEtMy0xLTEtOTA2MDk_84b43cb8-fd07-49ae-8859-cb549622cd00">5,250,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Value of Class B common stock transferred to Anchor Investors at initial public offering</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="0" name="amci:ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfNDItMy0xLTEtOTA2MDk_b544350b-4493-4309-b98e-b8a51391e7c5">6,509,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Extinguishment of deferred underwriting commissions on public shares</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930" decimals="0" name="amci:NoncashExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfNDMtMS0xLTEtOTA2MDk_49ed7b9c-6e7c-411e-a7d1-5e17509f3991">4,878,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-5</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_28"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS</span></div></div><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_31"></div><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjY1NzM_e7e70661-1026-4b4c-92b5-4e2c6cb6c688" continuedAt="i352bc49383aa4edd8e1a038b89d0d8d0" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1 &#8212; Description of Organization and Business Operations</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AMCI Acquisition Corp. II (the &#8220;Company&#8221;) is a blank check company incorporated as a Delaware corporation on January 28, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with <ix:nonFraction unitRef="item" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="INF" name="amci:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMzY2_c3e67605-b0fe-4fda-b933-5a510e719062">one</ix:nonFraction> or more businesses (the &#8220;business combination&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, the Company has neither engaged in any operations nor generated any revenues. All activity to date relates to the Company&#8217;s formation and the initial public offering (as defined below), described below and since the initial public offering, its search for a business combination target. The Company will not generate any operating revenues until after the completion of its initial business combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the initial public offering and from changes in the fair value of its derivative warrant liabilities, if applicable. The Company has selected December 31 as its fiscal year end.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s sponsor is AMCI Sponsor II LLC, a Delaware limited liability company (the &#8220;Sponsor&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registration statement for the Company&#8217;s initial public offering was declared effective on August 3, 2021 (the &#8220;effective date&#8221;). On August 6, 2021, the Company consummated its initial public offering (the &#8220;initial public offering&#8221;) of <ix:nonFraction unitRef="shares" contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806" decimals="INF" name="amci:UnitsIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMTUyMQ_e825bf47-2cf7-4533-8ade-254db4d1f23d">15,000,000</ix:nonFraction> units (the &#8220;units&#8221;). Each unit consists of <ix:nonFraction unitRef="shares" contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806" decimals="INF" name="amci:NumberOfSharesIssuedPerUnit" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMTU2Nw_cf5f6cd6-2d44-4085-b5b1-54d3bea4c781">one</ix:nonFraction> Class A common stock of the Company, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="ie730d94e9acc40f48d227ce51539c50b_I20210806" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMTYxNw_008057fd-0c35-42ac-8e0d-7a4fb0734c15">0.0001</ix:nonFraction> per share (the &#8220;Class A common stock&#8221;), and one-half of one redeemable warrant of the Company (the &#8220;warrant&#8221;), each whole warrant entitling the holder thereof to purchase <ix:nonFraction unitRef="shares" contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMTc5MQ_ac75825c-ad7f-4fd8-9037-fcdfb30ec6d7">one</ix:nonFraction> Class A common stock for $<ix:nonFraction unitRef="usdPerShare" contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMTgxOQ_8a38af25-eb9d-4c8d-8fb8-3e4f2b00a89f">11.50</ix:nonFraction> per share. The units were sold at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMTg2Nw_b88cb605-4929-4259-9c16-1e6b92ee7b7c">10.00</ix:nonFraction> per unit, generating gross proceeds to the Company of $<ix:nonFraction unitRef="usd" contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806" decimals="0" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMTkyNA_f7635828-6121-4c2f-9f22-0a14458db9f9">150,000,000</ix:nonFraction> which is discussed in Note 3.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Simultaneously with the closing of the initial public offering, the Company completed the private sale of an aggregate of <ix:nonFraction unitRef="shares" contextRef="iba67ebbc3e2147e2a5a1f7dbbeab0ccd_I20210806" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjA3OQ_1872ee73-bdbb-4e76-b1f1-9f1d37eb98f9">3,500,000</ix:nonFraction> warrants (the &#8220;private placement warrants&#8221;) to the Sponsor at a purchase price of $<ix:nonFraction unitRef="usdPerShare" contextRef="iba67ebbc3e2147e2a5a1f7dbbeab0ccd_I20210806" decimals="2" name="amci:ClassOfWarrantOrRightPriceOfWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjE2NA_af37c0cb-3da5-4927-a0cf-65c36f5d1273">1.00</ix:nonFraction> per private placement warrant, generating gross proceeds to the Company of $<ix:nonFraction unitRef="usd" contextRef="i98ebad46078d44259754e031d9c5bd6d_D20210806-20210806" decimals="0" name="us-gaap:ProceedsFromIssuanceOfWarrants" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjI0Mg_92185aca-eb79-4531-8884-cac29be444d5">3,500,000</ix:nonFraction>. The private placement warrants are identical to the warrants sold in the initial public offering, except that the private placement warrants, so long as they are held by the Sponsor or its permitted transferees, (i) are not redeemable by the Company, (ii) may not (including the Class A common stock issuable upon exercise of such private placement warrants), subject to certain limited exceptions, be transferred, assigned or sold by such holders until <ix:nonNumeric contextRef="i98ebad46078d44259754e031d9c5bd6d_D20210806-20210806" name="amci:RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjcwMA_e3d49d52-8564-48d8-b483-75f1bf86b536">30</ix:nonNumeric> days after the completion of the Company&#8217;s initial business combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights. No underwriting discounts or commissions were paid with respect to such sales.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the initial public offering includes two instruments, Class A common stock and warrants, and as the warrants are classified as a financial liability, it is necessary to allocate the gross proceeds between Class A common stock and warrants. The Company adopted the residual method to allocate the gross proceeds between Class A common stock and warrants based on their relative fair values. The gross proceeds were first allocated to the fair value of the warrants and the residual amount was allocated to the Class A common stock. The percentage derived from this allocation was used to allocate the deferred offering costs between Class A common stock and warrants. Issuance costs allocated to the warrants were expensed to the Company&#8217;s unaudited condensed statements of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction costs of the initial public offering amounted to $<ix:nonFraction unitRef="usd" contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806" decimals="0" name="amci:TransactionCosts" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMzgwNw_eae44901-16ec-43e6-aa4f-1b53f76cd126">13,782,542</ix:nonFraction> and consisted of $<ix:nonFraction unitRef="usd" contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806" decimals="0" name="amci:SaleOfStockUnderwritingDiscounts" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMzgyNw_947a5257-50e7-493c-828d-18a56d36cb16">1,500,000</ix:nonFraction> of underwriting discount, $<ix:nonFraction unitRef="usd" contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806" decimals="0" name="amci:DeferredUnderwritingDiscounts" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMzg1Ng_d9922010-57e4-4a2c-ab8f-bfa30f542d5e">5,250,000</ix:nonFraction> of deferred underwriting discount, $<ix:nonFraction unitRef="usd" contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806" decimals="0" name="amci:ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMzg5NA_4694959e-20bb-4c39-98c3-b8fbfe89b507">6,509,758</ix:nonFraction> in fair value of Class B common stock issued to Anchor Investors, and $<ix:nonFraction unitRef="usd" contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806" decimals="0" name="amci:SaleOfStockOtherOfferingCosts" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMzk2Nw_4d9b43f6-9b3b-47cf-8d19-8ecc9edcfb30">522,784</ix:nonFraction> of other offering costs.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A total of $<ix:nonFraction unitRef="usd" contextRef="i60c2802479f2421e81d073c740ec38f5_D20210806-20210806" decimals="0" name="amci:PaymentsForInvestmentOfCashInTrustAccount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfNDAwNg_c1b4cfc0-aa9b-4fd3-b13c-ade4955c3250">150,000,000</ix:nonFraction> was placed in a U.S.-based trust account maintained by Continental Stock Transfer &amp; Trust Company, acting as trustee (the &#8220;trust account&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company must complete <ix:nonFraction unitRef="item" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="INF" name="amci:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfNDE3NQ_7412166a-fe7c-4098-a3bf-c0190506af33">one</ix:nonFraction> or more initial business combination having an aggregate fair market value of at least <ix:nonFraction unitRef="number" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="INF" name="amci:ConditionForFutureBusinessCombinationUseOfProceedsPercentage" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfNDI2NQ_714ee95d-ace5-4f8d-9169-0eae13048cd9">80</ix:nonFraction>% of the value of the assets held in the trust account (excluding the amount of deferred underwriting discounts held in trust and taxes payable on the income earned on the trust account) at the time of the signing a definitive agreement in connection with the initial business combination. However, the Company will only complete a business combination if the post-transaction company owns or acquires <ix:nonFraction unitRef="number" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="INF" name="amci:ConditionForFutureBusinessCombinationThresholdPercentageOwnership" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfNDY2OQ_f2bf36ed-0d1a-4ffe-bbd8-d3bfabe7eef6">50</ix:nonFraction>% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to </span></div></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="i352bc49383aa4edd8e1a038b89d0d8d0" continuedAt="iab4ed8c0ac614db5a9978f819edde66f"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">register as an investment company under the Investment Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;). There is no assurance that the Company will be able to complete a business combination successfully.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the closing of the initial public offering, management has agreed that an amount equal to at least $<ix:nonFraction unitRef="usdPerShare" contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfNTE1NQ_05e48242-5b7d-4223-8bf9-99e75a15b2a0">10.00</ix:nonFraction> per unit sold in the initial public offering, including the proceeds of the private placement warrants, will be held in a trust account, located in the United States with Continental Stock Transfer &amp; Trust Company acting as trustee, and will invest only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect to interest earned on the funds held in the trust account that may be released to the Company to pay taxes, if any, the proceeds from the initial public offering and the sale of the private placement warrants will not be released from the trust account until the earliest of (i) the completion of initial business combination, (ii) the redemption of the Company&#8217;s public shares if the Company is unable to complete an initial business combination by August 6, 2023, subject to applicable law, or (iii) the redemption of the Company&#8217;s public shares properly submitted in connection with a stockholder vote to amend its amended and restated certificate of incorporation to modify the substance or timing of the Company&#8217;s obligation to redeem <ix:nonFraction unitRef="number" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="INF" name="amci:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfNjUwMA_49bed0c6-6a68-4efb-9335-b6e145e55187">100</ix:nonFraction>% of its public shares if the Company has not consummated an initial business combination by August 6, 2023 or with respect to any other material provisions relating to stockholders&#8217; rights or pre-initial business combination activity. The proceeds deposited in the trust account could become subject to the claims of the Company&#8217;s creditors, if any, which could have priority over the claims of the Company&#8217;s public stockholders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will provide its public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial business combination either (i) in connection with a stockholder meeting called to approve the business combination or (ii) without a stockholder vote by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed business combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem all or a portion of their public shares upon the completion of the initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account calculated as of two business days prior to the consummation of the initial business combination, including interest earned on the funds held in the trust account (which interest shall be net of taxes payable), divided by the number of then outstanding public shares, subject to the limitations and on the conditions described herein. The amount in the trust account is initially anticipated to be $<ix:nonFraction unitRef="usdPerShare" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="2" name="amci:FundHeldInTrustAccountPerPublicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfODA5Ng_905b7f3c-0da5-4dd7-9920-a3da05af3595">10.00</ix:nonFraction> per public share. The per share amount the Company will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the representative of the underwriters.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares of common stock subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the initial public offering, in accordance with Financial Accounting Standards Board&#8217;s (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480, &#8220;Distinguishing Liabilities from Equity.&#8221; In such case, the Company will proceed with a business combination if the Company has net tangible assets of at least $<ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="0" name="amci:ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfODc4OQ_a24095f4-033c-46fd-9b68-077f759432c6">5,000,001</ix:nonFraction> upon such consummation of a business combination and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the business combination.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will have only <ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="amci:MonthsToCompleteAcquisition" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfOTAxOA_034dadea-563d-44be-8c4b-a4aa43206c65">24</ix:nonNumeric> months from the closing of the initial public offering to complete the initial business combination (the &#8220;Combination Period&#8221;). However, if the Company is unable to complete the initial business combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfOTM5MA_6b8b7a9b-cdb9-4964-a6c2-9088a7366feb">ten</span> business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (which interest shall be net of taxes payable and up to $<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="0" name="amci:MaximumAllowedDissolutionExpenses" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfOTY3Mw_c12b3efb-8a66-4cef-bd10-78521d99e36d">100,000</ix:nonFraction> of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company&#8217;s remaining stockholders and the Company&#8217;s board of </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="iab4ed8c0ac614db5a9978f819edde66f" continuedAt="i7b35976ea4f04aaaa8545c396187d107"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">directors, liquidate and dissolve, subject, in each case, to the Company&#8217;s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sponsor, officers and directors have agreed to (i) waive their redemption rights with respect to any founder shares and public shares they hold in connection with the completion of the initial business combination, (ii) waive their redemption rights with respect to any founder shares and public shares they hold in connection with a stockholder vote to approve an amendment to the Company&#8217;s amended and restated certificate of incorporation, (iii) waive their rights to liquidating distributions from the trust account with respect to any founder shares they hold if the Company fails to complete the initial business combination within the Combination Period, and (iv) vote their founder shares and any public shares purchased during or after the initial public offering in favor of the initial business combination.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $<ix:nonFraction unitRef="usdPerShare" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="2" name="amci:FundHeldInTrustAccountPerPublicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMTE1MzE_2041902b-a92b-4883-85e8-843d52c434dd">10.00</ix:nonFraction> per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $<ix:nonFraction unitRef="usdPerShare" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="2" name="amci:FundHeldInTrustAccountPerPublicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMTE2OTA_4fcac67e-5011-48fb-830f-8231a626f1b9">10.00</ix:nonFraction> per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party (other than the Company&#8217;s independent registered public accounting firm) or prospective target business who executed a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is enforceable), nor will it apply to any claims under the Company&#8217;s indemnity of the underwriters of the initial public offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor&#8217;s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would be able to satisfy those obligations. None of the Company&#8217;s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Emerging Growth Company Status</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities and Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s unaudited condensed financial statements with those of another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="i7b35976ea4f04aaaa8545c396187d107" continuedAt="iae1f8878035b4ab490d61f6d0a90b088"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is continuing to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company&#8217;s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these unaudited condensed financial statements. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 16, 2022, President Biden signed into law the Inflation Reduction Act of 2022 (the &#8220;IR Act&#8221;), which, among other things, imposes a new 1% U.S. federal excise tax on certain repurchases of stock by &#8220;covered corporations&#8221; (which include publicly traded domestic (i.e., U.S.) corporations) beginning in 2023, with certain exceptions (the &#8220;Excise Tax&#8221;). The Excise Tax is imposed on the repurchasing corporation itself, not its stockholders from which the stock is repurchased. Because we are a Delaware corporation and our securities are trading on Nasdaq, we are a &#8220;covered corporation&#8221; for this purpose. The amount of the Excise Tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the Excise Tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the Excise Tax. The U.S. Department of the Treasury has authority to provide regulations and other guidance to carry out, and prevent the abuse or avoidance of the Excise Tax; however, no guidance has been issued to date. It is uncertain whether, and/or to what extent, the Excise Tax could apply to any repurchase by us of our common stock or in the event of our liquidation, in each instance after December 31, 2022, including any redemptions in connection with an initial business combination or in the event we do not consummate an initial business combination by August 6, 2023.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposed Business Combination</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2022, the Company entered into an agreement and plan of merger (the &#8220;Merger Agreement&#8221;) with AMCI Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (&#8220;Merger Sub&#8221;), and LanzaTech NZ, Inc., a Delaware corporation (&#8220;LanzaTech&#8221;). The transactions contemplated by the Merger Agreement are referred to herein as the &#8220;Proposed Business Combination.&#8221; The time of the closing of the Proposed Business Combination is referred to herein as the &#8220;Closing.&#8221;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Proposed Business Combination is approved by the Company&#8217;s stockholders and LanzaTech&#8217;s stockholders, and the closing conditions in the Merger Agreement are satisfied or waived, then, among other things, upon the terms and subject to the conditions of the Merger Agreement and in accordance with Delaware General Corporation Law, Merger Sub will merge with and into LanzaTech, with LanzaTech surviving the Merger as the Company&#8217;s wholly owned subsidiary (the &#8220;Merger&#8221;). In connection with the consummation of the Merger, the Company will be renamed &#8220;LanzaTech Global, Inc.&#8221; and is referred to herein as &#8220;New LanzaTech&#8221; as of the time following such change of name.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Merger Agreement, the Company has agreed to acquire all of the outstanding equity interests of LanzaTech for consideration consisting of equity interests of New LanzaTech valued at $<ix:nonFraction unitRef="usd" contextRef="i43e0774f1b034661961530c2cf95f99f_D20220308-20220308" decimals="0" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMTg3MTQ_0241b268-c893-4ec9-8dd2-631bf565144b">1,817,000,000</ix:nonFraction> in the aggregate. The consideration to be paid to holders of shares of LanzaTech capital stock will be shares of common stock of New LanzaTech (&#8220;New LanzaTech Common Stock&#8221;), valued at $<ix:nonFraction unitRef="usdPerShare" contextRef="i0f2a2868033e4660a17c0f7ba45d4aad_I20220308" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMTg5MDI_35254d1f-245f-4d8d-8d84-0cd3c27553d7">10.00</ix:nonFraction> per share, to be paid at the closing of the Merger. The number of shares of New LanzaTech Common Stock payable in the Merger in respect of each share of LanzaTech capital stock (each, a &#8220;LanzaTech Share&#8221;) will be determined based on the exchange ratio (the &#8220;Exchange Ratio&#8221;), and certain corresponding adjustments, in each case as set forth in the Merger Agreement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, at Closing: (i) each warrant to purchase LanzaTech Shares (each, a &#8220;LanzaTech Warrant&#8221;) that is outstanding and unexercised immediately prior to Closing and would automatically be exercised or exchanged in full in accordance with its terms by virtue of the occurrence of the Merger, will be so automatically exercised or exchanged in full for the applicable LanzaTech Shares, and each such LanzaTech Share will be treated as being issued and outstanding immediately prior to Closing and will be canceled and converted into the right to receive the applicable shares of New LanzaTech Common Stock; and (ii) each LanzaTech Warrant that is outstanding and unexercised immediately prior to the Closing and is not automatically exercised in full as </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="iae1f8878035b4ab490d61f6d0a90b088" continuedAt="i9c3e1eaa847847398fee3ff3cad39f05"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">described in clause (i) will be converted into a warrant to purchase shares of New LanzaTech Common Stock, in which case (a) the number of shares underlying such New LanzaTech warrant (each, a &#8220;New LanzaTech Warrant&#8221;) will be determined by multiplying the number of LanzaTech Shares subject to such warrant immediately prior to Closing, by the Exchange Ratio and (b) the per share exercise price of such New LanzaTech Warrant will be determined by dividing the per share exercise price of such LanzaTech Warrant immediately prior to the Effective Time by the Exchange Ratio, except that in the case of certain warrants specified in the Merger Agreement, such exercise price will be $<ix:nonFraction unitRef="usdPerShare" contextRef="i0f2a2868033e4660a17c0f7ba45d4aad_I20220308" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjA3MzE_93bd10c5-ddf1-43ce-bee1-7aa11b0a7021">10.00</ix:nonFraction>.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, at Closing, each option to purchase LanzaTech Shares (each, a &#8220;LanzaTech Option&#8221;) will be converted into an option to purchase a number of shares of New LanzaTech Common Stock (rounded down to the nearest whole share) equal to the product of (i) the number of LanzaTech Shares subject to such LanzaTech Option multiplied by (ii) the Exchange Ratio. The exercise price of such New LanzaTech option will be equal to the quotient of (a) the exercise price per share of such LanzaTech Option in effect immediately prior to the Effective Time divided by (b) the Exchange Ratio (and as so determined, this exercise price will be rounded up to the nearest full cent).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, at Closing, each award of restricted shares of LanzaTech common stock (each, a &#8220;LanzaTech RSA&#8221;) that is outstanding immediately prior to the Effective Time will be converted into an award of restricted shares of New LanzaTech Common Stock (each, a &#8220;New LanzaTech RSA&#8221;) on the same terms and conditions as were applicable to such LanzaTech RSA immediately prior to the Effective Time, except that such New LanzaTech RSA will relate to a number of shares of New LanzaTech Common Stock equal to the number of LanzaTech Shares subject to such LanzaTech RSA, multiplied by the Exchange Ratio.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The closing of the Merger is subject to certain customary conditions, including, among others, (i) adoption by AMCI&#8217;s stockholders and LanzaTech&#8217;s stockholders of the Merger Agreement and their approval of certain other actions related to the Proposed Business Combination, (ii) the expiration or termination of the waiting period (or any extension thereof) applicable to the transactions contemplated by the Merger Agreement and any ancillary agreements, in each case under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, (iii) the effectiveness of a registration statement on Form S-4 (the &#8220;Registration Statement&#8221;) under the Securities Act with respect to the shares of New LanzaTech Common Stock to be paid as consideration in the Merger, (iv) there being no government order or law enjoining, prohibiting or making illegal the consummation of the Merger or the transactions contemplated by the Merger Agreement, (v) AMCI having at least $<ix:nonFraction unitRef="usd" contextRef="ib38307702eee44f3b72af83f31e3cf7d_I20220308" decimals="0" name="us-gaap:AssetsNet" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjMwMDQ_4ca36b26-af10-405f-b78b-b435c3bdd76f">5,000,001</ix:nonFraction> of net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) under the Exchange Act) after giving effect to any payments required to be made in connection with the redemption of AMCI&#8217;s public shares and the proceeds from the Subscription Agreements described below, (vi) AMCI having at least $<ix:nonFraction unitRef="usd" contextRef="i0f2a2868033e4660a17c0f7ba45d4aad_I20220308" decimals="0" name="us-gaap:AssetsHeldInTrustCurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjMzMTM_d320f3dd-7867-4754-9192-fa110613490e">230,000,000</ix:nonFraction> of cash at the closing of the Merger, consisting of cash held in AMCI&#8217;s trust account after taking into account any redemption of AMCI&#8217;s public shares, and the proceeds from the Subscription Agreements described below, net of transaction expenses of AMCI and LanzaTech, and (vii) the listing on Nasdaq of the shares of New LanzaTech Common Stock issued in connection with the Proposed Business Combination.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Going Concern</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, the Company had approximately $<ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="0" name="amci:ProceedsHeldInOperatingAccountForWorkingCapitalPurpose" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjM4MDc_31037c91-6ef6-4ba1-84a2-2173a105b992">7,000</ix:nonFraction> in its operating bank account and a working capital deficit of approximately $<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-5" name="amci:WorkingCapitalDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjM4ODc_d963e54b-7b8b-4cc5-a53a-39c9179fcc4b">3.5</ix:nonFraction> million , not taking into account tax obligations of approximately $<ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="0" name="amci:TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjM5NDk_86c3b82f-3285-445a-9116-9aaff006b183">536,000</ix:nonFraction> that may be paid from income from investments held in the trust account.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s liquidity needs up to September 30, 2022 have been satisfied through a contribution of $<ix:nonFraction unitRef="usd" contextRef="i8883929afdf94d6986448173f1858e61_D20220101-20220930" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjQxMjY_be831398-c046-4fe0-b442-9c745ac0fb50">25,000</ix:nonFraction> from the Sponsor to cover for certain offering costs in exchange for the issuance of Founder Shares, and a loan and advances from the Sponsor pursuant to the Note (as defined in Note 4). Subsequent to the initial public offering, net proceeds from the private placement of $<ix:nonFraction unitRef="usd" contextRef="ibf1a938c139d435097214ed3b23c295f_I20210806" decimals="-5" name="amci:ProceedsHeldInOperatingAccountForWorkingCapitalPurpose" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjQ0MDI_c939b8a9-6f44-4960-8b96-a022b10b87b1">0.9</ix:nonFraction> million were placed in the operating account for working capital purposes. In addition, in order to finance transaction costs in connection with a business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#8217;s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 4). On March 28, 2022, the Company entered into a noninterest-bearing Working Capital Loan with its Sponsor for the principal amount of up to $<ix:nonFraction unitRef="usd" contextRef="i6cdb37bb224f48e29779bad54f3033b8_D20220328-20220328" decimals="-5" name="amci:WorkingCapitalLoan" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjQ4OTY_44cc37d8-ae01-4a7d-be07-a77a2fafe1af">1.5</ix:nonFraction> million. As of September 30, 2022 and December 31, 2021, there were <ix:nonFraction unitRef="usd" contextRef="i67af9d98434f4635b3c35ea4fd55d5c2_I20211231" decimals="0" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjQ5NTk_a9a3fffc-45c0-42b6-a08c-9c0d978cee06"><ix:nonFraction unitRef="usd" contextRef="i5afd526069b8462e9de75a0d249417cf_I20220930" decimals="0" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjQ5NTk_ad010e4f-d9f7-42cc-a966-84c2d130560d">no</ix:nonFraction></ix:nonFraction> amounts outstanding under any Working Capital Loan.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS</span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9c3e1eaa847847398fee3ff3cad39f05" continuedAt="i09aafe3e3ad94fddadbece5ec79656ae">In connection with the Company&#8217;s assessment of going concern considerations in accordance with FASB Accounting Standards Update (&#8220;ASU&#8221;) 2014-15, &#8220;Disclosures of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern,&#8221; management has determined that the liquidity condition, and the mandatory liquidation and subsequent dissolution that will be required if the Company does not complete a business combination before August 6, 2023 raises substantial doubt about the Company&#8217;s ability to continue as a going concern. Although Management expects that it will be able to raise additional capital to support its planned activities and complete a business combination on or prior to August 6, 2023, it is uncertain whether it will be able to do so. No adjustments have been made to the carrying amounts of assets or liabilities should we be required to liquidate after August 6, 2023. The condensed financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern. The Company intends to complete a business combination before the mandatory liquidation date. Over this time period, the Company will be using the funds outside of the trust account for paying existing accounts payable, identifying and evaluating prospective initial business combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the business combination.</ix:continuation></span></div><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_37"></div><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTU0MDU_8c219329-b9ab-4242-9cc6-290d8a72d8c9" continuedAt="i412c086b7ca94085856fcc6f4315b857" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2 &#8212; Basis of Presentation and Summary of Significant Accounting Policies</span></div><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTU0MDY_80223e17-87ab-49e5-85fd-0edcfee32acb" continuedAt="ia59d28068eec4051b60bb378fd3e4c39" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) for interim financial information and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022 or any future period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K filed by the Company with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on March 25, 2022.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTUzOTg_0068ae3b-4409-499b-995c-1ae01c906004" continuedAt="ia344cb76006a4cc7ba49a2096b388551" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of September 30, 2022 and December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTU0MDM_4d195c44-3693-4d46-ab0b-e17eb368ad4a" continuedAt="iafb8c1bd22464c98a8f13eb1b230d190" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had <ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="0" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTcxMw_d0d990fd-86bc-4905-9c0b-54732926d110"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="0" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTcxMw_d5d25ee2-e8c4-4953-84a3-d0b863c5192b">no</ix:nonFraction></ix:nonFraction> cash equivalents as of September 30, 2022 and December 31, 2021.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTU0MDc_5da5e2b7-bc84-4b0e-840c-9ea9b5ee393a" continuedAt="i89f8ab05fdff489bbedabad70a7381aa" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></div></ix:nonNumeric></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="i412c086b7ca94085856fcc6f4315b857" continuedAt="i847a765ded3842b58142ea0b13395f8e"><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="amci:InvestmentsHeldInTrustAccountPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTU0MDg_95f7201a-b7fa-445e-b5cb-4c56d891d75b" continuedAt="ia4417ae1655443c58b32531793e69bab" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments Held in the Trust Account</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company&#8217;s investments held in the trust account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company&#8217;s investments held in the trust account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the trust account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the trust account are determined using available market information.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTUzOTk_2d2f34a4-1105-4ef7-8293-597078f5a443" continuedAt="ica1158bf61aa4e79a8a1549d5ddcd3ac" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities which qualify as financial instruments under the FASB ASC 820, &#8220;Fair Value Measurement,&#8221; equal or approximate the carrying amounts represented in the condensed balance sheets.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTU0MTE_b33f652b-57c0-421e-b3dd-772714c4d25f" continuedAt="i55ce36de169e4bd3b8b833b00e06a629" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="amci:OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTU0MDk_48a0f13c-a513-41c0-8868-77ffd14d1f0d" continuedAt="ic1e7e51e3575493c9b9766493cad3fe5" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Offering Costs Associated With Initial Public Offering</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the initial public offering that were directly related to the initial public offering. Offering costs were allocated to the separable financial instruments issued in the initial public offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and presented as non-operating expenses in the unaudited condensed statements of operations. Offering costs associated with the Class A common stock issued were charged against the carrying value of the shares of Class A common stock upon the completion of the initial public offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="i847a765ded3842b58142ea0b13395f8e" continuedAt="ic48ccf0ec5d246798cb936602769d3d9"><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTU0MTI_b0529009-8ffb-4cf8-808c-de8ae6645922" continuedAt="i63c860a400c84add8f802bfdaf186314" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Class A Common Stock Shares Subject to Possible Redemption </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, &#8220;Distinguishing Liabilities from Equity.&#8221; Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders&#8217; equity. The Company&#8217;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of uncertain future events. Accordingly, as of the initial public offering, <ix:nonFraction unitRef="shares" contextRef="i4b4c8d7ac58e4e2586992b9fe74034be_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfNzY1MQ_4c60d91f-b906-4aec-a065-7ab238577574">15,000,000</ix:nonFraction> shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders&#8217; equity (deficit) section of the Company&#8217;s condensed balance sheets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 480-10-S99, the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of the reporting period. This method would view the end of the reporting period as if it were also the redemption date of the security. Effective with the closing of the initial public offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTU0MDA_05c45c16-7e4c-4d72-a411-da94f63f99bb" continuedAt="i33167ef5167e4893b8bfa684da3542ed" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The public warrants and the private placement warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The initial fair value of the public warrants issued in connection with the initial public offering was estimated using a Monte-Carlo simulation model. The fair value of the public warrants as of September 30, 2022 and as of December 31, 2021 is based on observable listed prices for such warrants. The fair value of the private placement warrants as of September 30, 2022 and as of December 31, 2021 is determined using a Black-Scholes option pricing model. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTU0MTA_906a4ab4-2048-48ce-9846-3be40f694c05" continuedAt="ibaad48e26c454b7ea1f1c5355d957d0d" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also </span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="ic48ccf0ec5d246798cb936602769d3d9" continuedAt="i43d36c17770942c7aa0efacaa5827bed"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibaad48e26c454b7ea1f1c5355d957d0d" continuedAt="ia04949aa7dd640e19ba61ea7fec3d57b">provides guidance on derecognition, classification, interest and penalties, accounting in period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company&#8217;s effective tax rate was <ix:nonFraction unitRef="number" contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930" decimals="4" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTE5OTM_9f3c4a93-d8fb-40af-a57a-ed6c83126df6">0.88</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930" decimals="4" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTIwMDA_e881ca05-5c28-40fb-957c-92b2b199f7ab">0.91</ix:nonFraction>% for the three and nine months ended September 30, 2022, respectively, and <ix:nonFraction unitRef="number" contextRef="i759728e90602443f941d8e14893c6860_D20210128-20210131" decimals="4" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTIwNzc_34786fcf-b777-4eff-92a1-6ad38fffa85a"><ix:nonFraction unitRef="number" contextRef="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930" decimals="4" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTIwNzc_7340d238-5d53-4188-84dc-ec4e8f099c5d"><ix:nonFraction unitRef="number" contextRef="i950a5ff168a044a0ba3702bafec5a66a_D20210401-20210930" decimals="4" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTIwNzc_8d0be041-8f56-4846-904b-f3589bf59879"><ix:nonFraction unitRef="number" contextRef="i4878d88c1b144a42922da4d1a6220176_D20210201-20210331" decimals="4" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTIwNzc_e483c2e8-45cc-47a7-94e4-ef111600a0de">0.00</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>% for the three months ended September 30, 2021 and the period from January 28, 2021 (inception) through September 30, 2021. The effective tax rate differs from the statutory tax rate of <ix:nonFraction unitRef="number" contextRef="id018cdbc6e7243f8a9576d62630018fd_D20220701-20220930" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTIyNjU_00dccf80-a00f-4dfa-a7bd-e0ae2a0d4f34"><ix:nonFraction unitRef="number" contextRef="i70621bbf47964eb1927c544e539a3b0c_D20210401-20210930" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTIyNjU_3763ed26-2d05-4f21-8461-e04a78478673"><ix:nonFraction unitRef="number" contextRef="id42184778b03400da7d8ae8bccfeca9b_D20210128-20210131" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTIyNjU_61f98752-21d2-493b-a046-588913f68cda"><ix:nonFraction unitRef="number" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTIyNjU_6fc0e67a-8c9b-453b-bf3d-60259e0c938e"><ix:nonFraction unitRef="number" contextRef="ia10b0438b73b4dd5bf7658eb1d2482c7_D20210201-20210331" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTIyNjU_74e195d3-9f04-45d3-87b4-4501c2d1f58d">21</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>% for the three and nine months ended September 30, 2022, the three months ended September 30, 2021 and the period from January 28, 2021 (inception) through September 30, 2021 due primarily to changes in fair value of derivative warrant liabilities, non-taxable gains on the settlement of deferred underwriting commissions, and the valuation allowance on the deferred tax assets.</ix:continuation></span></div><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTU0MDQ_72131a40-0fed-4536-95d0-4ba1ae757b68" continuedAt="i69f1811ea3ec4785b21a0ffa6524fd89" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Per Share Of Common Stock</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share.&#8221; The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the units sold in the initial public offering and the private placement warrants to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="i8294868a1493467a83fbece546a36f63_D20220101-20220930" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTMzNjM_989ef914-8b9a-40fb-8623-e42dd05d926b">11,000,000</ix:nonFraction> shares of Class A common stock in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the three and nine months ended September 30, 2022 and for the three months ended September 30, 2021 and for the period from January 28, 2021 (inception) through September 30, 2021. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock:</span></div><div style="margin-bottom:9pt"><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTU0MTM_1ca8bff9-4375-44a2-bc5a-36fe2bc530f4" continuedAt="i3f66db4aa0424eeb9e0a784a703d900e" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended <br/>September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99c308a1e70a4da386ff5a6632f478d0_D20220701-20220930" decimals="0" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfNC0xLTEtMS05MDYwOQ_799cced8-07e2-4bf6-9a78-ad89ec154542">995,636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42d79bd723cf48078269f4e2acf3b597_D20220701-20220930" decimals="0" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfNC0zLTEtMS05MDYwOQ_2c4f174a-975a-428a-92ba-0e46d28c4239">248,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e0d5966ac7479ebfa164e10daa1272_D20210701-20210930" decimals="0" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfNC01LTEtMS05MDYwOQ_1ed83c00-6dcf-4897-8365-13556d7eafec">332,524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d75b9f8f1c40e39fde71392a72ee04_D20210701-20210930" decimals="0" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfNC03LTEtMS05MDYwOQ_7cf06308-fe0c-4732-bc26-8038572c0bb5">136,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99c308a1e70a4da386ff5a6632f478d0_D20220701-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfNy0xLTEtMS05MDYwOQ_61ce089d-55e6-45a0-a039-22328dde8313"><ix:nonFraction unitRef="shares" contextRef="i99c308a1e70a4da386ff5a6632f478d0_D20220701-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfNy0xLTEtMS05MDYwOQ_cfd4b0b2-420f-429f-a32e-df83c15b34b4">15,000,000</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i42d79bd723cf48078269f4e2acf3b597_D20220701-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfNy0zLTEtMS05MDYwOQ_91408058-3fce-456d-b3c4-130e91e45323"><ix:nonFraction unitRef="shares" contextRef="i42d79bd723cf48078269f4e2acf3b597_D20220701-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfNy0zLTEtMS05MDYwOQ_ce1a504f-0d65-4723-803c-7ab9a42cd46f">3,750,000</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic7e0d5966ac7479ebfa164e10daa1272_D20210701-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfNy01LTEtMS05MDYwOQ_970d15b4-e5fc-4ccf-9c00-790fb18b8c95"><ix:nonFraction unitRef="shares" contextRef="ic7e0d5966ac7479ebfa164e10daa1272_D20210701-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfNy01LTEtMS05MDYwOQ_c4fc7f0e-eccf-4031-be65-ada3a2e361d6">9,130,435</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie7d75b9f8f1c40e39fde71392a72ee04_D20210701-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfNy03LTEtMS05MDYwOQ_93937af7-3cd8-428b-91f5-80ceb37ed1c8"><ix:nonFraction unitRef="shares" contextRef="ie7d75b9f8f1c40e39fde71392a72ee04_D20210701-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfNy03LTEtMS05MDYwOQ_f526f844-f6c1-4377-8f3e-23e3db5ebeac">3,750,000</ix:nonFraction></ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i99c308a1e70a4da386ff5a6632f478d0_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfOC0xLTEtMS05MDYwOQ_5aa81add-8faa-45e7-9c3a-feb6ae061016"><ix:nonFraction unitRef="usdPerShare" contextRef="i99c308a1e70a4da386ff5a6632f478d0_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfOC0xLTEtMS05MDYwOQ_df840ca5-8b40-4195-9c00-ef595f803e44">0.07</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i42d79bd723cf48078269f4e2acf3b597_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfOC0zLTEtMS05MDYwOQ_09f1a3f6-a626-42d1-8729-fb66f47cc6c3"><ix:nonFraction unitRef="usdPerShare" contextRef="i42d79bd723cf48078269f4e2acf3b597_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfOC0zLTEtMS05MDYwOQ_0ee03c1f-a5af-4f8f-83ac-193e4488bb33">0.07</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic7e0d5966ac7479ebfa164e10daa1272_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfOC01LTEtMS05MDYwOQ_552ca31e-578a-46ba-a453-70ae5f7dde82"><ix:nonFraction unitRef="usdPerShare" contextRef="ic7e0d5966ac7479ebfa164e10daa1272_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfOC01LTEtMS05MDYwOQ_82d324b9-5f51-41da-9f1f-451187a9cd9a">0.04</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie7d75b9f8f1c40e39fde71392a72ee04_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfOC03LTEtMS05MDYwOQ_124b09be-c431-442a-bd68-615e9c6c9d9b"><ix:nonFraction unitRef="usdPerShare" contextRef="ie7d75b9f8f1c40e39fde71392a72ee04_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfOC03LTEtMS05MDYwOQ_f988bae6-a923-4514-b87e-7ff70ee5d280">0.04</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="i43d36c17770942c7aa0efacaa5827bed" continuedAt="ic6c429b5f76641a5bbf03b6a626ac366"><div style="margin-bottom:9pt"><ix:continuation id="i69f1811ea3ec4785b21a0ffa6524fd89" continuedAt="i9690f8c911fd4fdfab9ea4388e14e9dd"><ix:continuation id="i3f66db4aa0424eeb9e0a784a703d900e" continuedAt="ie4988b69c857416ba83346fe7fea7045"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.887%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.004%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Nine Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Period from January 28, 2021 <br/>(inception) through <br/>September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40a66b571894495b9172904623c3020a_D20220101-20220930" decimals="0" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfNC0xLTEtMS05MDYwOQ_8e4285ad-9d2d-4194-a72e-611ca2a47440">844,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17dcd8e30cd643c885ad894b1240e01c_D20220101-20220930" decimals="0" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfNC0zLTEtMS05MDYwOQ_880fe067-c677-4a01-a228-fabd8e9f85f7">211,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8be3aafc5054f04afe2e590fba42def_D20210128-20210930" decimals="0" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfNC01LTEtMS05MDYwOQ_e544907e-840f-4909-b478-b2f840a6ce11">223,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fb60d41143f4f3d991562590f0fe6af_D20210128-20210930" decimals="0" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfNC03LTEtMS05MDYwOQ_be1abf9c-9068-4756-8ca5-14062774aedb">244,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i40a66b571894495b9172904623c3020a_D20220101-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfNy0xLTEtMS05MDYwOQ_bf99afef-b4ba-4ac2-86b5-b80e979c7732"><ix:nonFraction unitRef="shares" contextRef="i40a66b571894495b9172904623c3020a_D20220101-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfNy0xLTEtMS05MDYwOQ_fe8003dd-2615-41fe-a2d5-507f659d1822">15,000,000</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i17dcd8e30cd643c885ad894b1240e01c_D20220101-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfNy0zLTEtMS05MDYwOQ_7fa9a89c-7b05-42a5-9d2c-f43dada02c5c"><ix:nonFraction unitRef="shares" contextRef="i17dcd8e30cd643c885ad894b1240e01c_D20220101-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfNy0zLTEtMS05MDYwOQ_b6f9b7e9-ecb5-4051-a2c5-625802b6ad63">3,750,000</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie8be3aafc5054f04afe2e590fba42def_D20210128-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfNy01LTEtMS05MDYwOQ_5edefea0-2ff0-47c9-9f87-8aa18d0add47"><ix:nonFraction unitRef="shares" contextRef="ie8be3aafc5054f04afe2e590fba42def_D20210128-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfNy01LTEtMS05MDYwOQ_7cf90125-013f-435b-b298-5925d7877326">3,428,571</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5fb60d41143f4f3d991562590f0fe6af_D20210128-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfNy03LTEtMS05MDYwOQ_6bc482a3-154e-4f98-9a93-6876822e956b"><ix:nonFraction unitRef="shares" contextRef="i5fb60d41143f4f3d991562590f0fe6af_D20210128-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfNy03LTEtMS05MDYwOQ_b0778646-fe31-4ad3-9a5c-4cf5cb7022b2">3,750,000</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i40a66b571894495b9172904623c3020a_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfOC0xLTEtMS05MDYwOQ_82f777f8-96ce-4291-af6c-ef5125afa324"><ix:nonFraction unitRef="usdPerShare" contextRef="i40a66b571894495b9172904623c3020a_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfOC0xLTEtMS05MDYwOQ_f2b3fee6-a9e8-41d1-ac04-36d0e89f727d">0.06</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i17dcd8e30cd643c885ad894b1240e01c_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfOC0zLTEtMS05MDYwOQ_0fa7f5a2-e3c4-4960-99f3-998d37f4f52a"><ix:nonFraction unitRef="usdPerShare" contextRef="i17dcd8e30cd643c885ad894b1240e01c_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfOC0zLTEtMS05MDYwOQ_e723aae7-f860-4a03-a741-7d568334206b">0.06</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie8be3aafc5054f04afe2e590fba42def_D20210128-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfOC01LTEtMS05MDYwOQ_924e98ad-7d6b-4551-9a5f-bbadd87fe49e"><ix:nonFraction unitRef="usdPerShare" contextRef="ie8be3aafc5054f04afe2e590fba42def_D20210128-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfOC01LTEtMS05MDYwOQ_9316f18e-1c12-48d7-86aa-1b7e08767682">0.07</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5fb60d41143f4f3d991562590f0fe6af_D20210128-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfOC03LTEtMS05MDYwOQ_2d25c3a7-3567-47db-beaf-cc5ca59eebc4"><ix:nonFraction unitRef="usdPerShare" contextRef="i5fb60d41143f4f3d991562590f0fe6af_D20210128-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfOC03LTEtMS05MDYwOQ_dce29936-a876-46b1-99c8-67d7a3bc4aee">0.07</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTU0MDE_c06aa8a3-3330-4a3a-9f71-2579ad2b8d33" continuedAt="if2d13293fb4046dd997303549baa7456" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FASB issued ASU 2022-03, ASC Subtopic 820 &#8220;Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions&#8221;. The ASU amends ASC 820 to clarify that a contractual sales restriction is not considered in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. The ASU applies to both holders and issuers of equity and equity-linked securities measured at fair value. The amendments in this ASU are effective for the Company in fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is still evaluating the impact of this pronouncement on the condensed financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company&#8217;s unaudited condensed financial statements.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_40"></div><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="amci:InitialPublicOfferingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MC9mcmFnOjM5NzE2ZmRkNzc0YjRhYjM4MzVkY2UzODBmNWI0ZTU4L3RleHRyZWdpb246Mzk3MTZmZGQ3NzRiNGFiMzgzNWRjZTM4MGY1YjRlNThfMTE5NQ_7f07d1fd-e4cb-4aff-88d9-01b59c8eaf92" continuedAt="i43be93d6dd254a3287f970806daf278c" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3 &#8212; Initial Public Offering</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 6, 2021, the Company consummated its initial public offering of <ix:nonFraction unitRef="shares" contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806" decimals="INF" name="amci:UnitsIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MC9mcmFnOjM5NzE2ZmRkNzc0YjRhYjM4MzVkY2UzODBmNWI0ZTU4L3RleHRyZWdpb246Mzk3MTZmZGQ3NzRiNGFiMzgzNWRjZTM4MGY1YjRlNThfMTEy_aee6daff-51a7-49a9-aa66-bc9eec85f9b6">15,000,000</ix:nonFraction> units, at an offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MC9mcmFnOjM5NzE2ZmRkNzc0YjRhYjM4MzVkY2UzODBmNWI0ZTU4L3RleHRyZWdpb246Mzk3MTZmZGQ3NzRiNGFiMzgzNWRjZTM4MGY1YjRlNThfMTQ2_4d82f9f6-0d75-4a8f-b77b-a663cbff2567">10.00</ix:nonFraction> per unit, generating gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806" decimals="-5" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MC9mcmFnOjM5NzE2ZmRkNzc0YjRhYjM4MzVkY2UzODBmNWI0ZTU4L3RleHRyZWdpb246Mzk3MTZmZGQ3NzRiNGFiMzgzNWRjZTM4MGY1YjRlNThfMTg4_a04295f0-c6cb-42ae-8870-1ae5589e270c">150.0</ix:nonFraction> million, and incurring offering costs of approximately $<ix:nonFraction unitRef="usd" contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806" decimals="-5" name="us-gaap:DeferredOfferingCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MC9mcmFnOjM5NzE2ZmRkNzc0YjRhYjM4MzVkY2UzODBmNWI0ZTU4L3RleHRyZWdpb246Mzk3MTZmZGQ3NzRiNGFiMzgzNWRjZTM4MGY1YjRlNThfMjM4_8e016718-5081-4989-9042-ebc510b9546c">13.8</ix:nonFraction> million, inclusive of $<ix:nonFraction unitRef="usd" contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806" decimals="-5" name="amci:SaleOfStockUnderwritingDiscounts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MC9mcmFnOjM5NzE2ZmRkNzc0YjRhYjM4MzVkY2UzODBmNWI0ZTU4L3RleHRyZWdpb246Mzk3MTZmZGQ3NzRiNGFiMzgzNWRjZTM4MGY1YjRlNThfMjU1_582718f3-855e-4989-9e70-07b13527bad1">1.5</ix:nonFraction> million of underwriting discount, approximately $<ix:nonFraction unitRef="usd" contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806" decimals="-5" name="amci:DeferredUnderwritingCompensationNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MC9mcmFnOjM5NzE2ZmRkNzc0YjRhYjM4MzVkY2UzODBmNWI0ZTU4L3RleHRyZWdpb246Mzk3MTZmZGQ3NzRiNGFiMzgzNWRjZTM4MGY1YjRlNThfMjk4_e199f500-bce0-4781-814a-4758bd254c66">5.3</ix:nonFraction> million in deferred underwriting commissions, approximately $<ix:nonFraction unitRef="usd" contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806" decimals="-5" name="amci:ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MC9mcmFnOjM5NzE2ZmRkNzc0YjRhYjM4MzVkY2UzODBmNWI0ZTU4L3RleHRyZWdpb246Mzk3MTZmZGQ3NzRiNGFiMzgzNWRjZTM4MGY1YjRlNThfMzUz_33ef2661-453f-4d48-8fa3-d1d966a38f0e">6.5</ix:nonFraction> million in fair value of Class B common stock issued to Anchor Investors, and approximately $<ix:nonFraction unitRef="usd" contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806" decimals="-5" name="amci:SaleOfStockOtherOfferingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MC9mcmFnOjM5NzE2ZmRkNzc0YjRhYjM4MzVkY2UzODBmNWI0ZTU4L3RleHRyZWdpb246Mzk3MTZmZGQ3NzRiNGFiMzgzNWRjZTM4MGY1YjRlNThfNDQw_014f3be6-ca28-4934-a44a-3cf2f0ec8d20">0.5</ix:nonFraction> million in other offering costs. Each whole warrant entitles the holder to purchase <ix:nonFraction unitRef="shares" contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MC9mcmFnOjM5NzE2ZmRkNzc0YjRhYjM4MzVkY2UzODBmNWI0ZTU4L3RleHRyZWdpb246Mzk3MTZmZGQ3NzRiNGFiMzgzNWRjZTM4MGY1YjRlNThfNTI3_da11c9c1-f55c-4f77-a95b-4346e6c187f7">one</ix:nonFraction> share of Class A common stock at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="id44a938156574d23a69f5f980c896774_I20210806" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MC9mcmFnOjM5NzE2ZmRkNzc0YjRhYjM4MzVkY2UzODBmNWI0ZTU4L3RleHRyZWdpb246Mzk3MTZmZGQ3NzRiNGFiMzgzNWRjZTM4MGY1YjRlNThfNTc0_e25cb108-6087-4c4f-b936-cd4e94b6244f">11.50</ix:nonFraction> per share, subject to adjustment (see Note 8). Certain qualified institutional buyers or institutional accredited investors (the &#8220;Anchor Investors&#8221;) purchased <ix:nonFraction unitRef="shares" contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806" decimals="INF" name="amci:OptionToPurchaseAdditionalUnitsGivenToInvestors" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MC9mcmFnOjM5NzE2ZmRkNzc0YjRhYjM4MzVkY2UzODBmNWI0ZTU4L3RleHRyZWdpb246Mzk3MTZmZGQ3NzRiNGFiMzgzNWRjZTM4MGY1YjRlNThfNzM2_493f5010-2639-4bb6-a4db-76664b75abb6">15,480,000</ix:nonFraction> units in the initial public offering. None of the Anchor Investors are affiliated with any member of the Company&#8217;s management.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters had a <ix:nonNumeric contextRef="i9caa935ece004b9ab6c6caa6377836b9_D20210803-20210803" name="amci:OptionVestingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MC9mcmFnOjM5NzE2ZmRkNzc0YjRhYjM4MzVkY2UzODBmNWI0ZTU4L3RleHRyZWdpb246Mzk3MTZmZGQ3NzRiNGFiMzgzNWRjZTM4MGY1YjRlNThfMTE5Ng_452c3a7a-ab39-480b-a88e-bb8994fb1a33">45-day</ix:nonNumeric> option from the date of the underwriting agreement (August 3, 2021) to purchase up to an additional <ix:nonFraction unitRef="shares" contextRef="i9caa935ece004b9ab6c6caa6377836b9_D20210803-20210803" decimals="INF" name="amci:OptionToPurchaseAdditionalUnitsGivenToInvestors" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MC9mcmFnOjM5NzE2ZmRkNzc0YjRhYjM4MzVkY2UzODBmNWI0ZTU4L3RleHRyZWdpb246Mzk3MTZmZGQ3NzRiNGFiMzgzNWRjZTM4MGY1YjRlNThfOTk2_42e77af3-29cf-4796-8cdb-3da13f11970f">2,250,000</ix:nonFraction> units to cover over-allotments. On September 17, 2021, the over-allotment option expired unexercised, resulting in <ix:nonFraction unitRef="shares" contextRef="i0d95a7ae67054cae98cfee5d7bdc74d0_D20210917-20210917" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MC9mcmFnOjM5NzE2ZmRkNzc0YjRhYjM4MzVkY2UzODBmNWI0ZTU4L3RleHRyZWdpb246Mzk3MTZmZGQ3NzRiNGFiMzgzNWRjZTM4MGY1YjRlNThfMTExNA_f2746955-9719-4786-b6a2-2f747d4c1be5">562,500</ix:nonFraction> shares of Class B common stock that were subject to forfeiture to be forfeited.</span></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_43"></div><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNzg2MQ_1bb3f816-df3d-49c6-b28a-8c793fc15bfb" continuedAt="i234c34a64a2d4259b622c42451710fbf" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4 &#8212; Related Party Transactions</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Founder Shares</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2021, the Sponsor paid $<ix:nonFraction unitRef="usd" contextRef="i1d5d9aae93c24a62a9caf5acab5abecc_D20210129-20210129" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfOTQ_2c8334ec-5e80-4a93-ab9c-945f239606b6">25,000</ix:nonFraction>, or approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="if2ebc1a8b07f4d3391509c2584f8f003_I20210129" decimals="3" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMTE1_d919dd19-1a0e-4d23-ae96-504b8f3fc155">0.005</ix:nonFraction> per share, to cover certain offering costs in consideration for <ix:nonFraction unitRef="shares" contextRef="i08b6b03fda3a43f2bcbde1101ee39ff8_D20210129-20210129" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMTgy_20bd27f0-d7ab-49c8-b607-68684e03db07">5,031,250</ix:nonFraction> shares of Class B common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i74ee1ef3f5f34200a3a86559aefbe48d_I20210129" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMjI3_9463bb68-d4d3-4796-bb65-075242680977">0.0001</ix:nonFraction>. In March 2021, the Sponsor transferred all of the founder shares it held to members of the Company&#8217;s board of directors, management </span></div></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="i234c34a64a2d4259b622c42451710fbf" continuedAt="ia76b39759197417bbadf6bce8aaa26aa"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">team, and persons or entities affiliated with AMCI Group (the &#8220;initial shareholders&#8221;). Such shares were fully paid. On May 14, 2021, the Sponsor surrendered <ix:nonFraction unitRef="shares" contextRef="i8ba6d4f2129048179fa2e9c2275582f2_I20210514" decimals="INF" name="amci:NumberOfSharesSurrendered" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNTIw_fffe6006-68c5-4d00-b6b7-030fcb9c7cf2">718,750</ix:nonFraction> founder shares to the Company for <ix:nonFraction unitRef="usd" contextRef="iea24dbc94fdc4dc58f170b69b6c3e2de_D20210514-20210514" decimals="0" name="amci:SharesSurrenderedFairValueOfShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNTU3_148ef400-d84e-412a-93ef-271b0274ad14">no</ix:nonFraction> consideration, resulting in the Sponsor owning <ix:nonFraction unitRef="shares" contextRef="i8ba6d4f2129048179fa2e9c2275582f2_I20210514" decimals="INF" name="amci:AggregateNumberOfSharesOwned" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNjA3_fc1b30ba-679e-4fa6-88bf-1b64dc81f217">4,312,500</ix:nonFraction> founder shares. Up to <ix:nonFraction unitRef="shares" contextRef="ife30827df02148faa72d404a20bb4270_I20220930" decimals="INF" name="amci:NumberOfSharesSubjectToForfeiture" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNjMy_ef489890-7a72-415e-812c-98ac147ba9a4">562,500</ix:nonFraction> of the founder shares will be forfeited depending on the extent to which the underwriters&#8217; over-allotment is exercised. On September 17, 2021, the over-allotment option expired unexercised, resulting in <ix:nonFraction unitRef="shares" contextRef="i0e2866880e0e48c8bbbc428a81262e75_I20210917" decimals="INF" name="amci:NumberOfSharesSubjectToForfeiture" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfODM4_57d08c9b-6c4c-45a1-83ec-b63f63a7a329">562,500</ix:nonFraction> of the founder shares being forfeited.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In exchange for the Anchor Investors&#8217; participation in the initial public offering as described in Note 3, the Sponsor sold a total of <ix:nonFraction unitRef="shares" contextRef="ib652946365cc4c8c967e8a2df8bcdc17_D20210129-20210129" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMTAxNQ_ebc25146-e423-4a9a-a98d-f6a1cde7a1d1">780,000</ix:nonFraction> founder shares to the Anchor Investors. The Company determined that the fair value of these founder shares was approximately $<ix:nonFraction unitRef="usd" contextRef="ib652946365cc4c8c967e8a2df8bcdc17_D20210129-20210129" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMTE0Mw_1506cb16-1274-4a0f-9182-b663b1472180">6.5</ix:nonFraction> million (or approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="i2674980052ce4cc69be120b4e40c0013_I20210129" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMTE2NA_ab89ed0f-edd5-422e-a304-bb2c4380b9d6">8.35</ix:nonFraction> per share) using a Monte Carlo simulation. The Company recognized the excess fair value of these founder shares, over the price sold to the Anchor Investors, as an expense of the initial public offering resulting in a charge against the carrying value of Class A common stock subject to possible redemption.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial stockholders have agreed not to transfer, assign or sell any of their founder shares and any Class A common stocks issuable upon conversion thereof until the earlier to occur of: (A) <ix:nonNumeric contextRef="i7f5a155717274afab3d521dfbf34a269_D20220101-20220930" name="amci:RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMTY3MA_c36223b5-aabe-4a8b-b3df-70c278771f36">one year</ix:nonNumeric> after the completion of the initial business combination and (B) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction after the Company&#8217;s initial business combination that results in all of the Company&#8217;s stockholders having the right to exchange their Class A common stock for cash, securities or other property; except to certain permitted transferees and under certain circumstances (the &#8220;Lock-up&#8221;). Any permitted transferees will be subject to the same restrictions and other agreements of the company&#8217;s initial stockholders with respect to any founder shares. Notwithstanding the foregoing, the founder shares will be released from the Lock-up if the closing price of the Company&#8217;s Class A common stock equals or exceeds $<ix:nonFraction unitRef="usdPerShare" contextRef="i7f5a155717274afab3d521dfbf34a269_D20220101-20220930" decimals="2" name="amci:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMjQ2MA_a1721919-5735-4de7-a51c-62e58b7da6c8">12.00</ix:nonFraction> per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any <ix:nonFraction unitRef="d" contextRef="i7f5a155717274afab3d521dfbf34a269_D20220101-20220930" decimals="INF" name="amci:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMjU4NA_c0909f5f-42c8-4a2b-807f-df0e9c6df319">20</ix:nonFraction> trading days within any <ix:nonFraction unitRef="d" contextRef="i7f5a155717274afab3d521dfbf34a269_D20220101-20220930" decimals="INF" name="amci:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMjYxMQ_ff4dfde7-f340-4550-a19d-cde226cca019">30</ix:nonFraction>-trading day period commencing at least <ix:nonNumeric contextRef="i7f5a155717274afab3d521dfbf34a269_D20220101-20220930" name="amci:ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMjY1Mw_dccb2432-151d-4bb9-9af9-96b8379895af">150</ix:nonNumeric> days after the company&#8217;s initial business combination.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Private Placement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Simultaneously with the closing of the initial public offering, the Company&#8217;s Sponsor has purchased an aggregate of <ix:nonFraction unitRef="shares" contextRef="iba67ebbc3e2147e2a5a1f7dbbeab0ccd_I20210806" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMjg0MA_274e41fb-dffe-4425-8f83-150cdd3f73f5">3,500,000</ix:nonFraction> private placement warrants, each exercisable to purchase <ix:nonFraction unitRef="shares" contextRef="iba67ebbc3e2147e2a5a1f7dbbeab0ccd_I20210806" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMjkwMA_e656b88c-f838-48ff-9f13-3e76ec89010a">one</ix:nonFraction> Class A common stock at $<ix:nonFraction unitRef="usdPerShare" contextRef="iba67ebbc3e2147e2a5a1f7dbbeab0ccd_I20210806" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMjkyNw_11f3b296-11e5-40f0-8284-950609662739">11.50</ix:nonFraction> per share, at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="iba67ebbc3e2147e2a5a1f7dbbeab0ccd_I20210806" decimals="2" name="amci:ClassOfWarrantOrRightPriceOfWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMjk1NQ_c0d4b5a3-fcff-4b2e-8a4b-ad4865de3145">1.00</ix:nonFraction> per warrant, or $<ix:nonFraction unitRef="usd" contextRef="i98ebad46078d44259754e031d9c5bd6d_D20210806-20210806" decimals="0" name="us-gaap:ProceedsFromIssuanceOfWarrants" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMjk3NA_cdb58e08-4544-4fef-a4a9-915f023a1858">3,500,000</ix:nonFraction> in the aggregate.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The private placement warrants will not be redeemable by the Company so long as they are held by the initial purchasers or their permitted transferees. The initial purchasers, or their permitted transferees, have the option to exercise the private placement warrants on a cashless basis. If the private placement warrants are held by holders other than initial purchasers or their permitted transferees, the private placement warrants will be redeemable by the Company and exercisable by the holders on the same basis as the warrants included in the units being sold in the initial public offering. Otherwise, the private placement warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in the initial public offering.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the private placement warrants are held by holders other than the Sponsor or its permitted transferees, the private placement warrants will be redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the units being sold in the initial public offering.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Loans and Advances</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2021, the Sponsor agreed to loan the Company up to $<ix:nonFraction unitRef="usd" contextRef="i75f3392af70e4d85aac3d65a530d4294_I20210129" decimals="0" name="amci:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNDE5OQ_35af23b2-11ef-4d1f-a9a2-26c7ed2215fc">300,000</ix:nonFraction> to be used for a portion of the expenses of the initial public offering (&#8220;Note&#8221;). This loan was non-interest bearing, unsecured and payable upon the closing of the initial public offering. In addition to the Note, the Sponsor of the Company also paid certain administrative expenses and offering costs on behalf of the Company. These advances were due on demand and were non-interest bearing. The Company repaid the note payable and advances in exchange for the issuance of private placement warrants.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Working Capital Loans</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in order to finance transaction costs in connection with an intended business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#8217;s officers and directors may, but are not obligated </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="ia76b39759197417bbadf6bce8aaa26aa" continuedAt="id85398d8d2084f2d96b474ba28122b81"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to, loan the Company funds as may be required on a non-interest basis (&#8220;Working Capital Loans&#8221;). If the Company completes the initial business combination, it will repay the Working Capital Loans. In the event that the initial business combination does not close, the Company may use a portion of the working capital held outside the trust account to repay the Working Capital Loans but no proceeds from the trust account would be used to repay the Working Capital Loans. Up to $<ix:nonFraction unitRef="usd" contextRef="ic4acc15b7c694e09ba13c24b2db16e14_I20220930" decimals="0" name="amci:MaximumLoansConvertibleIntoWarrants" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNTQzMA_e3bd5251-7ea6-4f91-88d7-199de8b537a8">1,500,000</ix:nonFraction> of such Working Capital Loans may be convertible into warrants of the post-business combination entity at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic4acc15b7c694e09ba13c24b2db16e14_I20220930" decimals="2" name="amci:ClassOfWarrantOrRightPriceOfWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNTU1MA_0fcb03b3-2187-4c33-a65c-2ccffd45359a">1.00</ix:nonFraction> per warrant at the option of the lender. Such warrants would be identical to the private placement warrants. Except as set forth above, the terms of Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. On March 28, 2022, the Company entered into a noninterest-bearing Working Capital Loan with its Sponsor for the principal amount of up to $<ix:nonFraction unitRef="usd" contextRef="i90361d85f46242c1b15c6d1084c691cc_D20220328-20220328" decimals="-5" name="amci:WorkingCapitalLoan" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNTk1Ng_273fc780-ff40-46d7-acb0-41ae86cf29fa">1.5</ix:nonFraction> million. As of September 30, 2022 and December 31, 2021, the Company had <ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="0" name="amci:OutstandingWorkingCapitalLoans" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNjAyNA_3aba9188-dbd0-4991-b422-d790eef5750c"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="0" name="amci:OutstandingWorkingCapitalLoans" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNjAyNA_6cdcece2-7677-405a-87d1-cd4b4b623e0c">no</ix:nonFraction></ix:nonFraction> borrowings under the Working Capital Loans.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Administrative Service Fee</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the closing of the initial public offering, the Company will pay its Sponsor $<ix:nonFraction unitRef="usd" contextRef="i86b1870170ac4b14af116725cbaa1dfb_D20220101-20220930" decimals="0" name="amci:RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNjE4OQ_12252aac-0be0-44d7-bb23-e395d5107698">10,000</ix:nonFraction> per month for office space, secretarial and administrative services provided to members of the management team. Upon completion of the initial business combination or the Company&#8217;s liquidation, the Company will cease paying these monthly fees. For the three months ended September 30, 2022 and 2021, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="ic4fffab42a2f49dd80ac77b6fa45c8a1_D20220701-20220930" decimals="0" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNjUxMw_334c398d-c9a0-4f33-9096-6d20f31e7258">30,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i3924e9e376c84b7a875190639f24cc1f_D20210701-20210930" decimals="0" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNjUyMA_a0223daa-87de-4f37-b57d-f14f7d741797">20,000</ix:nonFraction>, respectively, of such fees, included as general and administrative fees &#8212; related party on the accompanying unaudited condensed statements of operations. For the nine months ended September 30, 2022 and for the period from January 28, 2021 (inception) through September 30, 2021, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="i86b1870170ac4b14af116725cbaa1dfb_D20220101-20220930" decimals="0" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNjgyNQ_b475c710-b233-48f1-bd1a-f391e107ee02">90,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ida667f998b1d43e1b6a919463e190674_D20210128-20210930" decimals="0" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNjgzMg_c262ef83-0f65-43c3-895a-9ae21ea7f07b">20,000</ix:nonFraction>, respectively, of such fees, included as general and administrative fees &#8212; related party on the accompanying unaudited condensed statements of operations. As of September 30, 2022 and December 31, 2021, approximately $<ix:nonFraction unitRef="usd" contextRef="i52caac5a377e45b8b201f83962c02a8e_I20220930" decimals="0" name="us-gaap:DueToRelatedPartiesCurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNzA1Mg_c748e9e6-bee8-4f02-8340-747579e83f48">90,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ifcd72b5b1194408cba4cb6838372ac02_I20211231" decimals="0" name="us-gaap:DueToRelatedPartiesCurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNzA1OQ_0880f6d8-91a8-4ff7-bf33-17b6711719a1">50,000</ix:nonFraction>, respectively, of such fees were included in due to related party on the accompanying condensed balance sheets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sponsor, officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on the Company&#8217;s behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. The Company&#8217;s audit committee will review on a quarterly basis all payments that were made by the Company to the Sponsor, directors, officers or directors of the Company, or any of their affiliates. As of September 30, 2022 and December 31, 2021, there were approximately $<ix:nonFraction unitRef="usd" contextRef="i86b1870170ac4b14af116725cbaa1dfb_D20220101-20220930" decimals="0" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNzc0Ng_229d19a4-2fbd-4dcf-b929-a29c69e46e4c">596,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i8d2f9128cbf246cd945ae4ac218c0a51_D20210101-20211231" decimals="0" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNzc1Mw_ba48ee39-f1a5-456b-aa86-c608fced49e7">0</ix:nonFraction>, respectively, of such fees included as due to related party on the accompanying condensed balance sheets.</span></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_46"></div><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80Ni9mcmFnOjFhNTk2MTYyYmNiOTQ2ZDU4YjNlNjc3MmJhNTgwZjE1L3RleHRyZWdpb246MWE1OTYxNjJiY2I5NDZkNThiM2U2NzcyYmE1ODBmMTVfMzk3OA_12a30fc1-25d8-46eb-8c21-17900b95b94a" continuedAt="i3c2486989e1949aa870288b6d875b1a5" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5 &#8212; Commitments and Contingencies</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Registration Rights</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of the (i) founder shares, which were issued in a private placement prior to the closing of the initial public offering, (ii) private placement warrants, which were issued in a private placement simultaneously with the closing of the initial public offering and the shares of Class A common stock underlying such private placement warrants and (iii) private placement warrants that may be issued upon conversion of Working Capital Loans will have registration rights to require the Company to register a sale of any of its securities held by them prior to the consummation of the initial business combination pursuant to a registration rights agreement to be signed prior to or on the effective date of the initial public offering. The holders of these securities are entitled to make up to <ix:nonFraction unitRef="item" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="INF" name="amci:MaximumNumberOfDemandsForRegistrationOfSecurities" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80Ni9mcmFnOjFhNTk2MTYyYmNiOTQ2ZDU4YjNlNjc3MmJhNTgwZjE1L3RleHRyZWdpb246MWE1OTYxNjJiY2I5NDZkNThiM2U2NzcyYmE1ODBmMTVfODY3_4b52ebdd-244e-46d0-b1c1-58149733fffd">three</ix:nonFraction> demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent to the Company&#8217;s completion of its initial business combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. In addition, the Anchor Investors will, upon receipt of their founder shares, execute a registration rights agreement with respect to their founder shares.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Underwriting Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted the underwriters a <ix:nonNumeric contextRef="i383980889531482c9add5e621b85e027_D20220101-20220930" name="amci:OptionVestingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80Ni9mcmFnOjFhNTk2MTYyYmNiOTQ2ZDU4YjNlNjc3MmJhNTgwZjE1L3RleHRyZWdpb246MWE1OTYxNjJiY2I5NDZkNThiM2U2NzcyYmE1ODBmMTVfMzk3OQ_839ccdbc-8e22-4333-b8eb-393b364ff187">45-day</ix:nonNumeric> option from the date of the underwriting agreement to purchase up to an additional <ix:nonFraction unitRef="shares" contextRef="i383980889531482c9add5e621b85e027_D20220101-20220930" decimals="INF" name="amci:OptionToPurchaseAdditionalUnitsGivenToUnderwriters" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80Ni9mcmFnOjFhNTk2MTYyYmNiOTQ2ZDU4YjNlNjc3MmJhNTgwZjE1L3RleHRyZWdpb246MWE1OTYxNjJiY2I5NDZkNThiM2U2NzcyYmE1ODBmMTVfMTU2NQ_7b113c33-d026-42fe-8a33-e60b3f1cc36f">2,250,000</ix:nonFraction> units to cover over-allotments, if any. On September 17, 2021, the over-allotment option expired unexercised, resulting in the forfeiture of <ix:nonFraction unitRef="shares" contextRef="i2d8e8fd5c9a54f1994bb8cd3e7be4dfb_I20210917" decimals="INF" name="amci:NumberOfSharesSubjectToForfeiture" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80Ni9mcmFnOjFhNTk2MTYyYmNiOTQ2ZDU4YjNlNjc3MmJhNTgwZjE1L3RleHRyZWdpb246MWE1OTYxNjJiY2I5NDZkNThiM2U2NzcyYmE1ODBmMTVfMTcwOQ_c18c634d-041d-4dfb-b384-ae99f2cb106e">562,500</ix:nonFraction> shares of founder shares. </span></div></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="i3c2486989e1949aa870288b6d875b1a5" continuedAt="i1966a5c37d3543f9921cfb34ea76605f"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters were paid an underwriting discount of one percent (<ix:nonFraction unitRef="number" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="2" name="amci:UnderwritingDiscountPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80Ni9mcmFnOjFhNTk2MTYyYmNiOTQ2ZDU4YjNlNjc3MmJhNTgwZjE1L3RleHRyZWdpb246MWE1OTYxNjJiY2I5NDZkNThiM2U2NzcyYmE1ODBmMTVfMTgwNw_8efda7ec-68a0-4823-a722-38b72f02cc15">1</ix:nonFraction>%) of the gross proceeds of the initial public offering, or $<ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="0" name="amci:SaleOfStockUnderwritingDiscounts" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80Ni9mcmFnOjFhNTk2MTYyYmNiOTQ2ZDU4YjNlNjc3MmJhNTgwZjE1L3RleHRyZWdpb246MWE1OTYxNjJiY2I5NDZkNThiM2U2NzcyYmE1ODBmMTVfMTg2OA_d972eb9a-1890-46f4-85f4-097a375ee45a">1,500,000</ix:nonFraction>. Additionally, in connection with the initial public offering, the Company agreed to pay the underwriters a deferred underwriting fee of <ix:nonFraction unitRef="number" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="3" name="amci:DeferredUnderwritingDiscountPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80Ni9mcmFnOjFhNTk2MTYyYmNiOTQ2ZDU4YjNlNjc3MmJhNTgwZjE1L3RleHRyZWdpb246MWE1OTYxNjJiY2I5NDZkNThiM2U2NzcyYmE1ODBmMTVfMjAwOA_09982a70-57b8-4f9c-b10d-1bb0ac1c9e08">3.5</ix:nonFraction>% of the gross proceeds, or $<ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="0" name="amci:DeferredUnderwritingDiscounts" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80Ni9mcmFnOjFhNTk2MTYyYmNiOTQ2ZDU4YjNlNjc3MmJhNTgwZjE1L3RleHRyZWdpb246MWE1OTYxNjJiY2I5NDZkNThiM2U2NzcyYmE1ODBmMTVfMjAzNw_5fa2af6e-f444-471f-abb9-7b7a6b9008ad">5,250,000</ix:nonFraction>, of the initial public offering upon the completion of the Company&#8217;s initial business combination. On September 29, 2022, as discussed further below, Evercore Group L.L.C., (&#8220;Evercore&#8221;) the representative of the underwriters of the initial public offering, waived its deferred underwriting fee that accrued from its participation in the initial public offering. The Company recognized approximately $<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-5" name="amci:AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80Ni9mcmFnOjFhNTk2MTYyYmNiOTQ2ZDU4YjNlNjc3MmJhNTgwZjE1L3RleHRyZWdpb246MWE1OTYxNjJiY2I5NDZkNThiM2U2NzcyYmE1ODBmMTVfMjQzOQ_59dea2b5-b037-4434-9e30-ca00e55cf75b"><ix:nonFraction unitRef="usd" contextRef="id018cdbc6e7243f8a9576d62630018fd_D20220701-20220930" decimals="-5" name="amci:AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80Ni9mcmFnOjFhNTk2MTYyYmNiOTQ2ZDU4YjNlNjc3MmJhNTgwZjE1L3RleHRyZWdpb246MWE1OTYxNjJiY2I5NDZkNThiM2U2NzcyYmE1ODBmMTVfMjQzOQ_c1afb6e7-cc69-4d9d-b4e4-1db78d10403e">4.9</ix:nonFraction></ix:nonFraction> million of the commissions waiver as a reduction to additional paid-in capital in the condensed statements of changes in stockholders&#8217; deficit for the three and nine months ended September 30, 2022, as this portion represents an extinguishment of deferred underwriting commissions on public shares which was originally recognized in accumulated deficit. The remaining balance of approximately $172,000 is recognized as a gain from extinguishment of deferred underwriting commissions on public warrants in the condensed statements of operations, which represents the original amount expensed in the Company&#8217;s initial public offering.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 27, 2022 and September 29, 2022, the Company received notice and a formal letter, respectively, from Evercore Group, L.L.C., an underwriter in the Company&#8217;s initial public offering, advising that it had, among other things, (i) resigned from and ceased or refused to act in, its roles as co-placement agent, co-capital markets advisor and exclusive financial advisor to the Company in connection with the Merger and as underwriter in the Company&#8217;s initial public offering and (ii) waived its right to receive an aggregate of $<ix:nonFraction unitRef="usd" contextRef="iff3bcef644df441dabded615618c965f_D20220101-20220930" decimals="0" name="us-gaap:ProceedsFromFeesReceived" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80Ni9mcmFnOjFhNTk2MTYyYmNiOTQ2ZDU4YjNlNjc3MmJhNTgwZjE1L3RleHRyZWdpb246MWE1OTYxNjJiY2I5NDZkNThiM2U2NzcyYmE1ODBmMTVfMzYwNQ_73a4b4e2-89cf-4599-b06f-ee4d3f7193d8">13,050,000</ix:nonFraction> in fees, all of which were contingent upon and payable upon the closing of the Merger, consisting of $<ix:nonFraction unitRef="usd" contextRef="i65896feef8e64216b26c18f33b966b64_D20220929-20220929" decimals="0" name="us-gaap:ProceedsFromFeesReceived" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80Ni9mcmFnOjFhNTk2MTYyYmNiOTQ2ZDU4YjNlNjc3MmJhNTgwZjE1L3RleHRyZWdpb246MWE1OTYxNjJiY2I5NDZkNThiM2U2NzcyYmE1ODBmMTVfMzcwOQ_25992c1b-e08d-4a7b-9487-58e411a1fb46">500,000</ix:nonFraction> for its role as co-placement agent, $<ix:nonFraction unitRef="usd" contextRef="ib81de9f71a844a21bb8c1a0d4ae5b6ab_D20220929-20220929" decimals="0" name="us-gaap:ProceedsFromFeesReceived" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80Ni9mcmFnOjFhNTk2MTYyYmNiOTQ2ZDU4YjNlNjc3MmJhNTgwZjE1L3RleHRyZWdpb246MWE1OTYxNjJiY2I5NDZkNThiM2U2NzcyYmE1ODBmMTVfMzc0OA_7d4c63c0-0817-47f7-8c7b-c84a3fd5c25a">7,500,000</ix:nonFraction> for its role as exclusive financial advisor and $<ix:nonFraction unitRef="usd" contextRef="if178c64ffcb14c83b95a35515433f700_D20220929-20220929" decimals="0" name="us-gaap:ProceedsFromFeesReceived" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80Ni9mcmFnOjFhNTk2MTYyYmNiOTQ2ZDU4YjNlNjc3MmJhNTgwZjE1L3RleHRyZWdpb246MWE1OTYxNjJiY2I5NDZkNThiM2U2NzcyYmE1ODBmMTVfMzc5OQ_25a9cf14-8cf4-4670-8a0d-491f787a1ef9">5,050,000</ix:nonFraction> of deferred underwriting fees accrued from its participation in the Company&#8217;s initial public offering, as well as any expense reimbursements owed to it under those arrangements.</span></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_49"></div><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="amci:TemporaryEquityDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OS9mcmFnOjg5MzRhOTk3NzlkZTQxNjRhZGZlMTg0MDhiMmI0OGIwL3RleHRyZWdpb246ODkzNGE5OTc3OWRlNDE2NGFkZmUxODQwOGIyYjQ4YjBfNzgz_0cb6b806-bca3-4f06-891c-f0dae291802e" continuedAt="i3b902bfdc27d48969c2107019ea73a06" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6 &#8212; Class A Common Stock Subject to Possible Redemption</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of future events. The Company is authorized to issue <ix:nonFraction unitRef="shares" contextRef="ie50e9e7d91b842cf814d5cfc02ae90f3_I20220930" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OS9mcmFnOjg5MzRhOTk3NzlkZTQxNjRhZGZlMTg0MDhiMmI0OGIwL3RleHRyZWdpb246ODkzNGE5OTc3OWRlNDE2NGFkZmUxODQwOGIyYjQ4YjBfMjc3_a5e7e350-eaab-472c-aa55-6efc12662de3">280,000,000</ix:nonFraction> shares of Class A common stock with a par value of $<ix:nonFraction unitRef="usdPerShare" contextRef="ie50e9e7d91b842cf814d5cfc02ae90f3_I20220930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OS9mcmFnOjg5MzRhOTk3NzlkZTQxNjRhZGZlMTg0MDhiMmI0OGIwL3RleHRyZWdpb246ODkzNGE5OTc3OWRlNDE2NGFkZmUxODQwOGIyYjQ4YjBfMzMx_1bc4375f-5f74-466f-9ef0-e83fb363e9d8">0.0001</ix:nonFraction> per share. Holders of the Company&#8217;s Class A common stock are entitled to <ix:nonFraction unitRef="vote" contextRef="ie50e9e7d91b842cf814d5cfc02ae90f3_I20220930" decimals="INF" name="amci:CommonStockNumberOfVotesPerShare" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OS9mcmFnOjg5MzRhOTk3NzlkZTQxNjRhZGZlMTg0MDhiMmI0OGIwL3RleHRyZWdpb246ODkzNGE5OTc3OWRlNDE2NGFkZmUxODQwOGIyYjQ4YjBfNDA3_349ec297-fa06-4283-862f-75f578e22895">one</ix:nonFraction> vote for each share. As of September 30, 2022 and December 31, 2021, there were <ix:nonFraction unitRef="shares" contextRef="i525804f64fa24dab94c10a95e9c90289_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OS9mcmFnOjg5MzRhOTk3NzlkZTQxNjRhZGZlMTg0MDhiMmI0OGIwL3RleHRyZWdpb246ODkzNGE5OTc3OWRlNDE2NGFkZmUxODQwOGIyYjQ4YjBfNDkw_00cf380e-6cd4-4973-9bf9-02c9a1bbf32a"><ix:nonFraction unitRef="shares" contextRef="i0a43243fe73e4e0982e02d8804f9029b_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OS9mcmFnOjg5MzRhOTk3NzlkZTQxNjRhZGZlMTg0MDhiMmI0OGIwL3RleHRyZWdpb246ODkzNGE5OTc3OWRlNDE2NGFkZmUxODQwOGIyYjQ4YjBfNDkw_1c8fa93b-ab99-4963-98b9-87070421dac7">15,000,000</ix:nonFraction></ix:nonFraction> shares of Class A common stock outstanding subject to possible redemption and are classified outside of permanent equity in the condensed balance sheets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Class A common stock subject to possible redemption reflected on the condensed balance sheets is reconciled in the following table:</span></div><div style="margin-bottom:9pt"><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:TemporaryEquityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OS9mcmFnOjg5MzRhOTk3NzlkZTQxNjRhZGZlMTg0MDhiMmI0OGIwL3RleHRyZWdpb246ODkzNGE5OTc3OWRlNDE2NGFkZmUxODQwOGIyYjQ4YjBfNzg0_c409f20b-71f7-4efa-9cad-77d5fa953837" continuedAt="ie12c87e42f5140d980b3c07ffa527540" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross proceeds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c002aa5301d41eea4dcb66a8e84489d_D20210101-20211231" decimals="0" name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OS9mcmFnOjg5MzRhOTk3NzlkZTQxNjRhZGZlMTg0MDhiMmI0OGIwL3RhYmxlOmJjOWNmMjQ3MzZmNTRmN2U5OTljMTU0ZDk5M2ViZWNjL3RhYmxlcmFuZ2U6YmM5Y2YyNDczNmY1NGY3ZTk5OWMxNTRkOTkzZWJlY2NfMC0xLTEtMS05MDYwOQ_8f7c3d34-e1b4-4a48-8ff7-8b7459124230">150,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount allocated to public warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c002aa5301d41eea4dcb66a8e84489d_D20210101-20211231" decimals="0" sign="-" name="amci:TemporaryEquityProceedsAllocatedToWarrants" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OS9mcmFnOjg5MzRhOTk3NzlkZTQxNjRhZGZlMTg0MDhiMmI0OGIwL3RhYmxlOmJjOWNmMjQ3MzZmNTRmN2U5OTljMTU0ZDk5M2ViZWNjL3RhYmxlcmFuZ2U6YmM5Y2YyNDczNmY1NGY3ZTk5OWMxNTRkOTkzZWJlY2NfMi0xLTEtMS05MDYwOQ_6f16be67-2c4f-4ae7-a0e4-10c6eb743a16">5,100,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c002aa5301d41eea4dcb66a8e84489d_D20210101-20211231" decimals="0" sign="-" name="amci:TemporaryEquityIssuanceCosts" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OS9mcmFnOjg5MzRhOTk3NzlkZTQxNjRhZGZlMTg0MDhiMmI0OGIwL3RhYmxlOmJjOWNmMjQ3MzZmNTRmN2U5OTljMTU0ZDk5M2ViZWNjL3RhYmxlcmFuZ2U6YmM5Y2YyNDczNmY1NGY3ZTk5OWMxNTRkOTkzZWJlY2NfMy0xLTEtMS05MDYwOQ_0bdab388-dbcc-44ac-8cbb-584004864069">13,306,092</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of carrying value to redemption value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c002aa5301d41eea4dcb66a8e84489d_D20210101-20211231" decimals="0" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OS9mcmFnOjg5MzRhOTk3NzlkZTQxNjRhZGZlMTg0MDhiMmI0OGIwL3RhYmxlOmJjOWNmMjQ3MzZmNTRmN2U5OTljMTU0ZDk5M2ViZWNjL3RhYmxlcmFuZ2U6YmM5Y2YyNDczNmY1NGY3ZTk5OWMxNTRkOTkzZWJlY2NfNS0xLTEtMS05MDYwOQ_d76a1475-f4fa-425e-b5bd-cca8cf3bc501">18,406,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock subject to possible redemption, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a43243fe73e4e0982e02d8804f9029b_I20211231" decimals="0" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OS9mcmFnOjg5MzRhOTk3NzlkZTQxNjRhZGZlMTg0MDhiMmI0OGIwL3RhYmxlOmJjOWNmMjQ3MzZmNTRmN2U5OTljMTU0ZDk5M2ViZWNjL3RhYmxlcmFuZ2U6YmM5Y2YyNDczNmY1NGY3ZTk5OWMxNTRkOTkzZWJlY2NfNi0xLTEtMS05MDYwOQ_d89afa10-f049-4c8d-928c-8cf16f320572">150,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subsequent remeasurement of Class A common stock subject to possible redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55de68debcc94bafbd57bd3a38c3cfbd_D20220101-20220930" decimals="0" name="amci:IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OS9mcmFnOjg5MzRhOTk3NzlkZTQxNjRhZGZlMTg0MDhiMmI0OGIwL3RhYmxlOmJjOWNmMjQ3MzZmNTRmN2U5OTljMTU0ZDk5M2ViZWNjL3RhYmxlcmFuZ2U6YmM5Y2YyNDczNmY1NGY3ZTk5OWMxNTRkOTkzZWJlY2NfNy0xLTEtMS05MDYwOQ_0ce1e578-e563-4eeb-906b-45eb97867a7b">293,649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock subject to possible redemption, September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i525804f64fa24dab94c10a95e9c90289_I20220930" decimals="0" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OS9mcmFnOjg5MzRhOTk3NzlkZTQxNjRhZGZlMTg0MDhiMmI0OGIwL3RhYmxlOmJjOWNmMjQ3MzZmNTRmN2U5OTljMTU0ZDk5M2ViZWNjL3RhYmxlcmFuZ2U6YmM5Y2YyNDczNmY1NGY3ZTk5OWMxNTRkOTkzZWJlY2NfOC0xLTEtMS05MDYwOQ_b4d9f236-9515-463d-a4fa-7f5c56c8f7cd">150,293,649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:nonNumeric><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib82e114cd19f45afae73e7a64e42f208_52"></div><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfMzQxOQ_c2f6d55c-8691-4023-9cf6-f930be7b7425" continuedAt="ic977458973c74913828906f74109cce6" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7 &#8212; Stockholders&#8217; Equity (Deficit)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Preferred Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The Company is authorized to issue <ix:nonFraction unitRef="shares" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfOTg_3529f7cf-bebb-46fd-9b97-4ee89733be2b"><ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfOTg_361ded67-2c4c-4266-a27b-5a86e3b85858">1,000,000</ix:nonFraction></ix:nonFraction> shares of preferred stock with a par value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfMTQ3_5a6803fe-d329-45b4-8976-553733024ff0"><ix:nonFraction unitRef="usdPerShare" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfMTQ3_f2702886-2a51-45f4-922a-70e7acc9516b">0.0001</ix:nonFraction></ix:nonFraction> and provides that shares of preferred stock may be issued from time to time in one or more series. The Company&#8217;s board of directors will be authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, </span></div></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="ic977458973c74913828906f74109cce6" continuedAt="i527e400e859b485d947a6e128cb5d50a"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">applicable to the shares of each series. As of September 30, 2022 and December 31, 2021, there were <ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfNTk0_05f24216-ceb4-40b5-a16d-6387d113a5f9"><ix:nonFraction unitRef="shares" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfNTk0_09ef2793-29d4-4353-a2c7-6908d403ab89">no</ix:nonFraction></ix:nonFraction> shares of preferred stock issued or outstanding.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Class A Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The Company is authorized to issue <ix:nonFraction unitRef="shares" contextRef="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfNzA0_0ec255f1-787d-43b9-b310-3b7935f88a23"><ix:nonFraction unitRef="shares" contextRef="ie50e9e7d91b842cf814d5cfc02ae90f3_I20220930" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfNzA0_606711b3-a4f7-4c9d-9b5b-3ac77240e43f">280,000,000</ix:nonFraction></ix:nonFraction> shares of Class A common stock with a par value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfNzU4_55185e3e-d93a-4b05-908a-4a549edf47ba"><ix:nonFraction unitRef="usdPerShare" contextRef="ie50e9e7d91b842cf814d5cfc02ae90f3_I20220930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfNzU4_8ca3cb4a-3d76-4f4d-9041-c3ec7d4dc2d5">0.0001</ix:nonFraction></ix:nonFraction> per share. As of September 30, 2022 and December 31, 2021, there were <ix:nonFraction unitRef="shares" contextRef="i525804f64fa24dab94c10a95e9c90289_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfODMx_01aa148b-d110-4151-8fac-9e59b90e5f5c"><ix:nonFraction unitRef="shares" contextRef="i0a43243fe73e4e0982e02d8804f9029b_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfODMx_e3712b99-a4b2-46f1-9bbc-8334ac1fb4bf">15,000,000</ix:nonFraction></ix:nonFraction> shares of Class A common stock issued and outstanding, all of which were subject to possible redemption and are classified as temporary equity (see Note 6).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Class B Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The Company is authorized to issue <ix:nonFraction unitRef="shares" contextRef="i246d06060759490897b705c5ed7fc8f0_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfMTA0OQ_44c86ba4-b61f-4a78-b6ca-d3077183700b"><ix:nonFraction unitRef="shares" contextRef="i291fade0df2b465aa82cd6d5ea3294af_I20220930" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfMTA0OQ_6d6c6439-20cd-4993-94de-e905a3b81fa7">20,000,000</ix:nonFraction></ix:nonFraction> Class B common stock with a par value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i246d06060759490897b705c5ed7fc8f0_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfMTA5Mw_882d08b1-47b8-45f7-973d-aae8ac83d07a"><ix:nonFraction unitRef="usdPerShare" contextRef="i291fade0df2b465aa82cd6d5ea3294af_I20220930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfMTA5Mw_dae42586-73da-4e78-a60b-cd83a7b7896f">0.0001</ix:nonFraction></ix:nonFraction> per share. As of September 30, 2022 and December 31, 2021, there were <ix:nonFraction unitRef="shares" contextRef="i291fade0df2b465aa82cd6d5ea3294af_I20220930" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfMTE2Ng_11159f4c-7069-4f0f-9f43-512408c88a84"><ix:nonFraction unitRef="shares" contextRef="i246d06060759490897b705c5ed7fc8f0_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfMTE2Ng_469a6cee-b175-40a2-a49c-682962c5a127">3,750,000</ix:nonFraction></ix:nonFraction> shares of Class B common stock issued and outstanding (see Note 4).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of the Company&#8217;s stockholders except as required by law. Unless specified in the Company&#8217;s amended and restated certificate of incorporation, or as required by applicable provisions of the Delaware General Corporation Law (&#8220;DGCL&#8221;) or applicable stock exchange rules, the affirmative vote of a majority of the Company&#8217;s shares of common stock that are voted is required to approve any such matter voted on by its stockholders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Class B common stock will automatically convert into shares of Class A common stock concurrently with or immediately following the consummation of the initial business combination on a <ix:nonFraction unitRef="shares" contextRef="ie9b91be3831b484da13cf601329f6dbe_D20220101-20220930" decimals="INF" name="us-gaap:ConversionOfStockSharesIssued1" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfMTk5Mg_9b960e85-873d-4699-92d3-888a74848941">one</ix:nonFraction>-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in connection with the initial business combination, the number of shares of Class A common stock issuable upon conversion of all founder shares will equal, in the aggregate, on an as-converted basis, <ix:nonFraction unitRef="number" contextRef="ie9b91be3831b484da13cf601329f6dbe_D20220101-20220930" decimals="0" name="amci:ConvertibleStockConversionRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfMjQ4Ng_5a2467f8-0c4a-4638-872b-40127a616885">20</ix:nonFraction>% of the total number of shares of Class A common stock outstanding after such conversion (after giving effect to any redemptions of shares of Class A common stock by public stockholders), including the total number of shares of Class A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial business combination, excluding any shares of Class A common stock or equity-linked securities or rights exercisable for or convertible into shares of Class A common stock issued, or to be issued, to any seller in the initial business combination and any private placement warrants issued to the Sponsor, officers or directors upon conversion of working capital loans, provided that such conversion of founder shares will never occur on a less than <ix:nonFraction unitRef="shares" contextRef="ie9b91be3831b484da13cf601329f6dbe_D20220101-20220930" decimals="INF" name="us-gaap:ConversionOfStockSharesIssued1" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfMzQwMw_892fea6e-3ef4-4a05-9445-49bdd3dac6e1">one</ix:nonFraction>-for-one basis.</span></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_55"></div><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="amci:WarrantsTextBlockTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNjc5NA_2708d9de-7e04-4214-a69f-b0e57c67a59c" continuedAt="i217855279c29474ea1128f843cf57e30" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8 &#8212; Warrants</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022 and December 31, 2021, in connection with the initial public offering, the Company has <ix:nonFraction unitRef="shares" contextRef="i451ff43e2c50495caaa75e2af24f295d_I20220930" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMTM1_2d2501f8-f775-4085-8f2b-fc632e6e3f60"><ix:nonFraction unitRef="shares" contextRef="i98b54305564e42f9abfa073cb3e4947b_I20211231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMTM1_a16c0d7a-d00e-4619-bcb0-47e0a30185c3">7,500,000</ix:nonFraction></ix:nonFraction> public warrants and <ix:nonFraction unitRef="shares" contextRef="i850b9630ce17489eb80c21a6da12ee2f_I20220930" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMTU4_41b9688a-010d-47d6-9e37-76a2eca9dc25"><ix:nonFraction unitRef="shares" contextRef="i9c30db48f9bb482b9cb45b5c2227dd57_I20211231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMTU4_9489fbd2-186b-4239-85ba-ca49f542cc5e">3,500,000</ix:nonFraction></ix:nonFraction> private placement warrants outstanding.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each whole warrant entitles the registered holder to purchase <ix:nonFraction unitRef="shares" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMjYz_87dfbf06-f921-4da7-91fd-9fc5457ab68f">one</ix:nonFraction> share of Class A common stock at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="2" name="amci:ClassOfWarrantOrRightPriceOfWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMzEw_6eeb9f7f-a076-49b7-b026-c2a9186b889c">11.50</ix:nonFraction> per share, subject to adjustment as discussed below, at any time commencing <ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="amci:WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMzg5_08cba45c-721c-4ef1-b4ea-c5ea232565c7">30</ix:nonNumeric> days after the completion of the initial business combination, provided that the Company has an effective registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement) and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder. The warrants will expire <ix:nonNumeric contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfOTk0_eeb759cb-d0c2-4727-96f4-1a552b871870">five years</ix:nonNumeric> after the completion of the Company&#8217;s initial business combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreed that as soon as practicable, but in no event later than fifteen (<ix:nonNumeric contextRef="i1836ec53dd484e9b9bf84ece3ddced78_D20220101-20220930" name="amci:PeriodForFillingRegistrationStatementAfterBusinessCombination" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMTIzMA_ad6b7454-bb5f-4a21-8749-a14f4268b41d">15</ix:nonNumeric>) business days after the closing of the initial business combination, it will use its best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A common stock issuable upon exercise of the warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the shares of Class A </span></div></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="i217855279c29474ea1128f843cf57e30" continuedAt="i45d62c447c2f47b5b706a04a023db69b"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">common stock issuable upon exercise of the warrants is not effective by the sixtieth (<ix:nonNumeric contextRef="i1836ec53dd484e9b9bf84ece3ddced78_D20220101-20220930" name="amci:PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMTkyMQ_30ea98dc-f312-4cd5-8c0b-6494d6285b74">60</ix:nonNumeric>th) business day after the closing of the initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Company&#8217;s Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a &#8220;covered security&#8221; under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of public warrants who exercise their warrants to do so on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, it will not be required to file or maintain in effect a registration statement, and in the event the Company do not so elect, it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redemption of warrants when the price per share of Class A common stock equals or exceeds $<ix:nonFraction unitRef="usdPerShare" contextRef="ie30c1da2c5304363b3b61cf5bb114865_D20220101-20220930" decimals="2" name="amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMzE0NQ_0964dde3-7d60-4ff8-be4d-4fa663434478">18.00</ix:nonFraction>.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once the warrants become exercisable, the Company may redeem the outstanding warrants:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in whole and not in part;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ie30c1da2c5304363b3b61cf5bb114865_D20220101-20220930" decimals="2" name="amci:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMzI3Ng_e8127131-ff32-4159-b694-24717b4a1c67">0.01</ix:nonFraction> per warrant;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">upon a minimum of <ix:nonNumeric contextRef="ie30c1da2c5304363b3b61cf5bb114865_D20220101-20220930" name="amci:RedemptionPeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMzMxMA_0586c461-3dd9-4934-a548-8c5823c7d454">30</ix:nonNumeric> days&#8217; prior written notice of redemption to each warrant holder; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if, and only if, the closing price of the Class A common stock equals or exceeds $<ix:nonFraction unitRef="usdPerShare" contextRef="ie30c1da2c5304363b3b61cf5bb114865_D20220101-20220930" decimals="2" name="amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMzQ1OA_ae4d39b3-237c-46bf-b29b-8f56e2267326">18.00</ix:nonFraction> per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading &#8220;&#8212; Warrants&#8201;&#8212;&#8201;Public Stockholders&#8217; Warrants&#8201;&#8212;&#8201;Anti-Dilution Adjustments&#8221;) for any <ix:nonNumeric contextRef="ie30c1da2c5304363b3b61cf5bb114865_D20220101-20220930" name="amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMzY5NQ_9616086f-34a3-4514-bb75-114e9894b8ea">20</ix:nonNumeric> trading days within a <ix:nonNumeric contextRef="ie30c1da2c5304363b3b61cf5bb114865_D20220101-20220930" name="amci:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMzcyMA_864a4768-1a49-4b04-8884-ebbb38c71296">30</ix:nonNumeric>-trading day period ending three trading days before we send the notice of redemption to the warrant holders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redemption of warrants when the price per share of Class A common stock equals or exceeds $<ix:nonFraction unitRef="usdPerShare" contextRef="ia5a60bdcc4a4477db94a694066392510_D20220101-20220930" decimals="2" name="amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMzkyMg_d35141ff-f1e9-42a4-85a0-8cb643d63625">10.00</ix:nonFraction>.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once the warrants become exercisable, the Company may redeem the outstanding warrants:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in whole and not in part;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at $<ix:nonFraction unitRef="usdPerShare" contextRef="ia5a60bdcc4a4477db94a694066392510_D20220101-20220930" decimals="2" name="amci:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNDA0Mg_381330aa-d7b3-43d1-a21b-de660866d0e3">0.10</ix:nonFraction> per warrant upon a minimum of <ix:nonNumeric contextRef="ia5a60bdcc4a4477db94a694066392510_D20220101-20220930" name="amci:RedemptionPeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNDA3NQ_ce20302a-b810-4717-b6af-b2585f9c9e57">30</ix:nonNumeric> days&#8217; prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table below, based on the redemption date and the &#8220;fair market value&#8221; (as defined below) of our Class A common stock except as otherwise described below; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if, and only if, the closing price of our Class A common stock equals or exceeds $<ix:nonFraction unitRef="usdPerShare" contextRef="ia5a60bdcc4a4477db94a694066392510_D20220101-20220930" decimals="2" name="amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNDUyMA_5ff2fa22-de9c-4abe-a387-103104723ae2">10.00</ix:nonFraction> per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading &#8220;&#8212; Warrants&#8201;&#8212;&#8201;Public Stockholders&#8217; Warrants&#8201;&#8212;&#8201;Anti-Dilution Adjustments&#8221;) for any <ix:nonNumeric contextRef="ia5a60bdcc4a4477db94a694066392510_D20220101-20220930" name="amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNDc2NA_78f24a5b-3eae-4793-b29f-413e093967fc">20</ix:nonNumeric> trading days within the <ix:nonNumeric contextRef="ia5a60bdcc4a4477db94a694066392510_D20220101-20220930" name="amci:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNDc5MQ_2f66cebc-8583-47e5-8c01-afd92bbb1155">30</ix:nonNumeric>-trading day period ending three trading days before we send the notice of redemption to the warrant holders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if (x) the Company issue additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of our initial business combination at an issue price or effective issue price of less than $<ix:nonFraction unitRef="usdPerShare" contextRef="if2e834c4b7e54fd3806cd19f77045daa_I20220930" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNTE2Mw_2fbe88a9-7e47-418e-8faf-0bfe39f3c742">9.20</ix:nonFraction> per share (with such issue price or effective issue price to be determined in good faith by the Company&#8217;s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any founder shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the &#8220;Newly Issued Price&#8221;), (y) the aggregate gross proceeds from such issuances represent more than <ix:nonFraction unitRef="number" contextRef="ifa1f55ccc0e14b588cf21c809f2ea5b3_D20220101-20220930" decimals="2" name="amci:PercentageOfGrossProceedsOnTotalEquityProceed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNTU5MA_91b3f2ae-644a-43b5-a8a7-509507dfe7e5">60</ix:nonFraction>% of the total equity proceeds, and interest thereon, available for the funding of our initial business combination on the date of the consummation of the initial business combination (net of redemptions), and (z) the volume weighted average trading price of the Company&#8217;s Class A common stock during the <ix:nonNumeric contextRef="ifa1f55ccc0e14b588cf21c809f2ea5b3_D20220101-20220930" name="amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNTg5Ng_058e1812-a28a-4cfd-a867-b46757cdc1cd">20</ix:nonNumeric> trading day period starting on the trading day prior to the day on which the Company consummate the initial business combination (such price, the &#8220;Market Value&#8221;) is below $<ix:nonFraction unitRef="usdPerShare" contextRef="if2e834c4b7e54fd3806cd19f77045daa_I20220930" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNjA3MA_7fac2243-fb86-46ea-ae4b-2bc7aa0fb78a">9.20</ix:nonFraction> per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to <ix:nonFraction unitRef="number" contextRef="ie30c1da2c5304363b3b61cf5bb114865_D20220101-20220930" decimals="2" name="amci:ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNjE3Mw_675d228a-ad74-4619-927f-3af1dfc17520">115</ix:nonFraction>% of the higher of the Market Value and the Newly Issued Price, the $<ix:nonFraction unitRef="usdPerShare" contextRef="ie30c1da2c5304363b3b61cf5bb114865_D20220101-20220930" decimals="2" name="amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNjI0Mg_1a9d0544-d13d-4c76-ba08-e5752fc3876b">18.00</ix:nonFraction> per share redemption </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i45d62c447c2f47b5b706a04a023db69b" continuedAt="ia56ff02ffa214c2c919cd2896adbf7c6">trigger price described above under &#8220;&#8212; Redemption of warrants when the price per share of Class A common stock equals or exceeds $<ix:nonFraction unitRef="usdPerShare" contextRef="ie30c1da2c5304363b3b61cf5bb114865_D20220101-20220930" decimals="2" name="amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNjM5NQ_e86c20a4-a113-4b96-bf2b-604c1b6d06a3">18.00</ix:nonFraction>&#8221; will be adjusted (to the nearest cent) to be equal to <ix:nonFraction unitRef="number" contextRef="ia5a60bdcc4a4477db94a694066392510_D20220101-20220930" decimals="2" name="amci:ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNjQ1Mw_765d1019-6313-4b0f-8bef-5bc1effd1ff2">180</ix:nonFraction>% of the higher of the Market Value and the Newly Issued Price, and the $<ix:nonFraction unitRef="usdPerShare" contextRef="ia5a60bdcc4a4477db94a694066392510_D20220101-20220930" decimals="2" name="amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNjUyNg_025edc5d-f30e-4abf-8c41-b7a107b37097">10.00</ix:nonFraction> per share redemption trigger price described above under &#8220;&#8212; Redemption of warrants when the price per share of Class A common stock equals or exceeds $<ix:nonFraction unitRef="usdPerShare" contextRef="ia5a60bdcc4a4477db94a694066392510_D20220101-20220930" decimals="2" name="amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNjY3OQ_be99d9eb-4039-49cc-a718-87391c5e57b7">10.00</ix:nonFraction>&#8221; will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.</ix:continuation></span></div><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_58"></div><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RleHRyZWdpb246Nzg4ODJlYWMzMGYyNDFhMDhmNDJkNWU0YjhmOTkxNmFfMzYxMQ_2fb6a4ab-8486-4567-b170-16e399504618" continuedAt="ia71b8b5e51a3424a93900a052aba3d35" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9 &#8212; Fair Value Measurements </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information about the Company&#8217;s financial assets and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy:</span></div><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RleHRyZWdpb246Nzg4ODJlYWMzMGYyNDFhMDhmNDJkNWU0YjhmOTkxNmFfMzYwOA_4024adb6-20e2-4c00-93ea-c03dacefc1f0" continuedAt="i0a5a6478df8a4fb1b8d683dbdac7e152" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September 30, 2022</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other <br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held in trust account</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if81ad5ca3f944114a295b408d90c868d_I20220930" decimals="0" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOjk0ODgwNzc2OWFkMDQ3MDI4YmM4Y2Y2NjVjMTRkMzI1L3RhYmxlcmFuZ2U6OTQ4ODA3NzY5YWQwNDcwMjhiYzhjZjY2NWMxNGQzMjVfMi0yLTEtMS05MDYwOQ_392c19e0-d07a-4431-abec-f30cce9cd4f7">150,969,468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201;public warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc3169776a3543fb889330eb5abfe41d_I20220930" decimals="0" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOjk0ODgwNzc2OWFkMDQ3MDI4YmM4Y2Y2NjVjMTRkMzI1L3RhYmxlcmFuZ2U6OTQ4ODA3NzY5YWQwNDcwMjhiYzhjZjY2NWMxNGQzMjVfNC0yLTEtMS05MDYwOQ_a9942e42-f3f6-4713-bdf1-f0799f726850">1,050,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201;private placement warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i417fef00be594681ab5912d70872db7e_I20220930" decimals="0" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOjk0ODgwNzc2OWFkMDQ3MDI4YmM4Y2Y2NjVjMTRkMzI1L3RhYmxlcmFuZ2U6OTQ4ODA3NzY5YWQwNDcwMjhiYzhjZjY2NWMxNGQzMjVfNS02LTEtMS05MDYwOQ_e4b8c6c3-e64f-46f9-ab5e-a6595f947b82">493,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2021</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held in trust account</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i946a08fcd3a04e65862611981f20e270_I20211231" decimals="0" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOmZhOTkwMTE3YWU1NzQ4ZGRhZDA3ZDU5NDc4NzM2MjJmL3RhYmxlcmFuZ2U6ZmE5OTAxMTdhZTU3NDhkZGFkMDdkNTk0Nzg3MzYyMmZfMi0yLTEtMS05MDYwOQ_b993c50f-43a9-4258-ba9d-67ffaa1ed279">150,006,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201; public warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i818e11a86037425d8b4e148caf3f101c_I20211231" decimals="0" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOmZhOTkwMTE3YWU1NzQ4ZGRhZDA3ZDU5NDc4NzM2MjJmL3RhYmxlcmFuZ2U6ZmE5OTAxMTdhZTU3NDhkZGFkMDdkNTk0Nzg3MzYyMmZfNC0yLTEtMS05MDYwOQ_9886944c-ebd3-405a-8f5a-c5b3d12db1f2">3,825,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201;private placement warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if33c5b343220431f8fa1664c765aaf71_I20211231" decimals="0" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOmZhOTkwMTE3YWU1NzQ4ZGRhZDA3ZDU5NDc4NzM2MjJmL3RhYmxlcmFuZ2U6ZmE5OTAxMTdhZTU3NDhkZGFkMDdkNTk0Nzg3MzYyMmZfNS02LTEtMS05MDYwOQ_ad56df1f-3f08-4674-9a64-1f8e0843d16a">1,785,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transfers to/from Levels 1, 2 and 3 are recognized at the beginning of the reporting period. The estimated fair value of public warrants was transferred from a Level 3 fair value measurement to a Level 1 measurement, when the public warrants were separately listed and traded in September 2021. There were no other transfers between levels in the nine months ended September 30, 2022 and in the period from January 28, 2021 (inception) through December 31, 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 assets include investments in mutual funds invested in U.S. government securities and derivative warrant liabilities (public warrants). The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For periods where no observable traded price is available, the fair value of the public warrants has been estimated using a Monte-Carlo simulation model and the private placement warrants has been estimated using a Black-Scholes option pricing model. For periods subsequent to the detachment of the public warrants from the units, the fair value of the public warrants is based on the observable listed price for such warrants. The estimated fair value of the public and private placement warrants, prior to the public warrants being traded in an active market, was determined using Level 3 inputs. Inherent in a Monte-Carlo simulation and Black-Scholes option pricing model are assumptions related to the unit price, expected volatility, risk-free interest rate, term to expiration, and dividend yield. The unit price is based on the publicly traded price of the units as of the measurement date. The Company estimated the volatility for the public and private placement warrants based on the implied volatility from the traded prices of warrants issued by other special purpose acquisition companies. The risk-free interest rate is based on </span></div></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="ia71b8b5e51a3424a93900a052aba3d35" continuedAt="i547feb09bd32410d983903bbe842cd41"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">interpolated U.S. Treasury rates, commensurate with a similar term to the public and private placement warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. Finally, the Company does not anticipate paying a dividend. Any changes in these assumptions can change the valuation significantly.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2022 and 2021, the Company recognized a change to the statement of operations resulting from a decrease (increase) in the fair value of liabilities of approximately $<ix:nonFraction unitRef="usd" contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930" decimals="-5" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RleHRyZWdpb246Nzg4ODJlYWMzMGYyNDFhMDhmNDJkNWU0YjhmOTkxNmFfMjc0MQ_607d0ae2-2eff-4a5a-bb72-7f230a839aca">1.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930" decimals="-5" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RleHRyZWdpb246Nzg4ODJlYWMzMGYyNDFhMDhmNDJkNWU0YjhmOTkxNmFfMjc0OA_d6c28225-6f76-4a2e-babc-054097f4b9a1">1.4</ix:nonFraction> million, respectively, presented as change in fair value of derivative warrant liabilities on the accompanying statements of operations. For the nine months ended September 30, 2022 and for the period from January 28, 2021 (inception) through September 30, 2021, the Company recognized a change to the statement of operations resulting from a decrease (increase) in the fair value of liabilities of approximately $<ix:nonFraction unitRef="usd" contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930" decimals="-5" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RleHRyZWdpb246Nzg4ODJlYWMzMGYyNDFhMDhmNDJkNWU0YjhmOTkxNmFfMzE1Ng_1f773683-964f-4b18-a18d-6f5ed6f332cd">4.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930" decimals="-5" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RleHRyZWdpb246Nzg4ODJlYWMzMGYyNDFhMDhmNDJkNWU0YjhmOTkxNmFfMzE2Mw_e30450bb-624a-4934-8406-4a620ef70476">1.4</ix:nonFraction> million, respectively, presented as change in fair value of derivative warrant liabilities on the accompanying statements of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates:</span></div><div style="margin-bottom:9pt"><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RleHRyZWdpb246Nzg4ODJlYWMzMGYyNDFhMDhmNDJkNWU0YjhmOTkxNmFfMzYwOQ_3c0e3823-82a1-49ff-934c-08c957bd2d10" continuedAt="i8c293ebfd4044fd8a2923a4e43b474b0" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30, 2022 </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2021 </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9894e2c3dc734f0b880e510f21ccd046_I20220930" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOjYwZjM2ZTFlMGY0MjRmY2VhYjQzMWVkODIwZDEzMGU3L3RhYmxlcmFuZ2U6NjBmMzZlMWUwZjQyNGZjZWFiNDMxZWQ4MjBkMTMwZTdfMS0xLTEtMS05MDYwOQ_a8692485-9b8a-46b4-825d-512e482145cb">11.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia5b0bb5d02764693b9a25febf0a6032b_I20211231" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOjYwZjM2ZTFlMGY0MjRmY2VhYjQzMWVkODIwZDEzMGU3L3RhYmxlcmFuZ2U6NjBmMzZlMWUwZjQyNGZjZWFiNDMxZWQ4MjBkMTMwZTdfMS0zLTEtMS05MDYwOQ_0a839927-1eda-4920-af78-01408ed5217f">11.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="item" contextRef="i2be463ef022149f1913c72172ac44e78_I20220930" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOjYwZjM2ZTFlMGY0MjRmY2VhYjQzMWVkODIwZDEzMGU3L3RhYmxlcmFuZ2U6NjBmMzZlMWUwZjQyNGZjZWFiNDMxZWQ4MjBkMTMwZTdfMi0xLTEtMS05MDYwOQ_00c3facd-df79-4c8b-9c30-fd2511eae647">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="item" contextRef="i9712786e3d6e4293bfa543a7f4306d3d_I20211231" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOjYwZjM2ZTFlMGY0MjRmY2VhYjQzMWVkODIwZDEzMGU3L3RhYmxlcmFuZ2U6NjBmMzZlMWUwZjQyNGZjZWFiNDMxZWQ4MjBkMTMwZTdfMi0zLTEtMS05MDYwOQ_a2a946c6-6882-4c67-acc6-8d97e8f62b9f">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i179691d9e1bf479b916db187d97d10bc_I20220930" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOjYwZjM2ZTFlMGY0MjRmY2VhYjQzMWVkODIwZDEzMGU3L3RhYmxlcmFuZ2U6NjBmMzZlMWUwZjQyNGZjZWFiNDMxZWQ4MjBkMTMwZTdfMy0xLTEtMS05MDYwOQ_3ca34311-7ce4-4a15-8552-c2f3b3a113b7">9.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i10a81d94cb444487a1305e090e7ac9f0_I20211231" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOjYwZjM2ZTFlMGY0MjRmY2VhYjQzMWVkODIwZDEzMGU3L3RhYmxlcmFuZ2U6NjBmMzZlMWUwZjQyNGZjZWFiNDMxZWQ4MjBkMTMwZTdfMy0zLTEtMS05MDYwOQ_494eedfe-2f47-4f89-8e4c-8ee4c5f2d94b">9.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="y" contextRef="ibda8175b82524bcc9e6f7f7496388515_I20220930" decimals="INF" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOjYwZjM2ZTFlMGY0MjRmY2VhYjQzMWVkODIwZDEzMGU3L3RhYmxlcmFuZ2U6NjBmMzZlMWUwZjQyNGZjZWFiNDMxZWQ4MjBkMTMwZTdfNC0xLTEtMS05MDYwOQ_58880635-de41-4f76-9b4c-e5f6efe8100e">5.19</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="y" contextRef="i0b029e7f84ba49809517714b945d453d_I20211231" decimals="INF" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOjYwZjM2ZTFlMGY0MjRmY2VhYjQzMWVkODIwZDEzMGU3L3RhYmxlcmFuZ2U6NjBmMzZlMWUwZjQyNGZjZWFiNDMxZWQ4MjBkMTMwZTdfNC0zLTEtMS05MDYwOQ_41b044f7-711f-4b2f-b835-18eeff0abeb0">5.75</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="item" contextRef="ib01d619804214c1ba4cf7f01250d2ac3_I20220930" decimals="4" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOjYwZjM2ZTFlMGY0MjRmY2VhYjQzMWVkODIwZDEzMGU3L3RhYmxlcmFuZ2U6NjBmMzZlMWUwZjQyNGZjZWFiNDMxZWQ4MjBkMTMwZTdfNS0xLTEtMS05MDYwOQ_bb75b720-a815-4e63-9098-5b4a4ec741b7">3.97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="item" contextRef="i0b3852e6684e45c08ebac5f6a1cb253d_I20211231" decimals="4" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOjYwZjM2ZTFlMGY0MjRmY2VhYjQzMWVkODIwZDEzMGU3L3RhYmxlcmFuZ2U6NjBmMzZlMWUwZjQyNGZjZWFiNDMxZWQ4MjBkMTMwZTdfNS0zLTEtMS05MDYwOQ_338f7913-dd2a-41a9-9a2f-d1906259f2f6">1.32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the fair value of the derivative warrant liabilities, measured using Level 3 inputs, for the three and nine months ended September 30, 2022 is summarized as follows:</span></div><div style="margin-bottom:9pt"><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RleHRyZWdpb246Nzg4ODJlYWMzMGYyNDFhMDhmNDJkNWU0YjhmOTkxNmFfMzYxMA_06c087e7-5075-4d91-9ba8-5f4e5e343bb9" continuedAt="i08b2dad0534d4927ad8b331459eb64f5" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa37f22ae2644299a4ab468acaa968cd_I20211231" decimals="0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOmVjMGJlNWVkNzlmYTQ1MTQ5NWEzOTMyZGM5M2E3NDg0L3RhYmxlcmFuZ2U6ZWMwYmU1ZWQ3OWZhNDUxNDk1YTM5MzJkYzkzYTc0ODRfMC0xLTEtMS05MDYwOQ_09be21fd-35e7-4ca6-90a9-c5069abf0f0a">1,785,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f13d0d3a95c4cdaa0dc91deeb0264b3_D20220101-20220331" decimals="0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOmVjMGJlNWVkNzlmYTQ1MTQ5NWEzOTMyZGM5M2E3NDg0L3RhYmxlcmFuZ2U6ZWMwYmU1ZWQ3OWZhNDUxNDk1YTM5MzJkYzkzYTc0ODRfMS0xLTEtMS05MDYwOQ_6409570c-a417-4d7f-b263-1a18f472a751">245,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i402c8e15d0b54a389ec05f6fe78c92c5_I20220331" decimals="0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOmVjMGJlNWVkNzlmYTQ1MTQ5NWEzOTMyZGM5M2E3NDg0L3RhYmxlcmFuZ2U6ZWMwYmU1ZWQ3OWZhNDUxNDk1YTM5MzJkYzkzYTc0ODRfMi0xLTEtMS05MDYwOQ_06787f78-d36c-49ab-b3cf-b8eaf479571f">2,030,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ff6463cfe5f4c1b946bb36d0cac2871_D20220401-20220630" decimals="0" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOmVjMGJlNWVkNzlmYTQ1MTQ5NWEzOTMyZGM5M2E3NDg0L3RhYmxlcmFuZ2U6ZWMwYmU1ZWQ3OWZhNDUxNDk1YTM5MzJkYzkzYTc0ODRfMy0xLTEtMS05MDYwOQ_85c64131-d424-4b6a-880f-38889905966d">1,085,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if29e2998f81b49e2b4637ccd72f330be_I20220630" decimals="0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOmVjMGJlNWVkNzlmYTQ1MTQ5NWEzOTMyZGM5M2E3NDg0L3RhYmxlcmFuZ2U6ZWMwYmU1ZWQ3OWZhNDUxNDk1YTM5MzJkYzkzYTc0ODRfNC0xLTEtMS05MDYwOQ_39e873a7-afaa-4697-95e4-c35c94a673e5">945,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfba6a12780447a3b8b33ecd046d9a4b_D20220701-20220930" decimals="0" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOmVjMGJlNWVkNzlmYTQ1MTQ5NWEzOTMyZGM5M2E3NDg0L3RhYmxlcmFuZ2U6ZWMwYmU1ZWQ3OWZhNDUxNDk1YTM5MzJkYzkzYTc0ODRfNS0xLTEtMS05MDYwOQ_53d94fd1-8a68-44ae-b2a6-240206435286">451,720</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if64ccb69704247c689ad8abffde913e9_I20220930" decimals="0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOmVjMGJlNWVkNzlmYTQ1MTQ5NWEzOTMyZGM5M2E3NDg0L3RhYmxlcmFuZ2U6ZWMwYmU1ZWQ3OWZhNDUxNDk1YTM5MzJkYzkzYTc0ODRfNi0xLTEtMS05MDYwOQ_8a19a703-6c6f-4db7-a159-aa41072c53d7">493,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_64"></div><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NC9mcmFnOjNiMTk0YmIzNTJmZjRmNTFiMGEzNmM4YzE4ZDQ4OTdjL3RleHRyZWdpb246M2IxOTRiYjM1MmZmNGY1MWIwYTM2YzhjMThkNDg5N2NfODYx_ade7ea84-07d3-44d6-bb7b-6b65a3fc3b35" continuedAt="ic37fd39382d24186aa483133061d33e3" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10 &#8212; Subsequent Events</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 18, 2022, the Company entered into additional subscription agreements (the &#8220;Subscription Agreements&#8221;) with certain accredited investors (collectively, the &#8220;Additional PIPE Investors&#8221;), pursuant to which, among other things, the Company agreed to issue and sell, in a private placement to close immediately prior to the closing of the Merger, an aggregate of <ix:nonFraction unitRef="shares" contextRef="i902dff4aa68147929f6d78320ff652e0_D20221018-20221018" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NC9mcmFnOjNiMTk0YmIzNTJmZjRmNTFiMGEzNmM4YzE4ZDQ4OTdjL3RleHRyZWdpb246M2IxOTRiYjM1MmZmNGY1MWIwYTM2YzhjMThkNDg5N2NfNDAy_62969dfa-ada7-4f10-b66b-4e07c125dcf8">5,500,000</ix:nonFraction> shares of Class A common stock at a purchase price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i697f9a8b07d74a73b684f9ec2bc17566_I20221018" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NC9mcmFnOjNiMTk0YmIzNTJmZjRmNTFiMGEzNmM4YzE4ZDQ4OTdjL3RleHRyZWdpb246M2IxOTRiYjM1MmZmNGY1MWIwYTM2YzhjMThkNDg5N2NfNDU4_c0545a9a-b16c-40e0-9169-36339cfc4126">10.00</ix:nonFraction> per share to the Additional PIPE Investors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated subsequent events and transactions that occurred up to the date the unaudited condensed financial statements were issued. Based upon this review and except in the case of the foregoing, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.</span></div></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-22</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_70"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Shareholders and Board of Directors of</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AMCI Acquisition Corp. II</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying balance sheet of AMCI Acquisition Corp. II (the &#8220;Company&#8221;) as of December 31, 2021, the related statements of operations, changes in stockholders&#8217; deficit and cash flows for the period from January 28, 2021 (inception) through December 31, 2021, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021, and the results of its operations and its cash flows for the period from January 28, 2021 (inception) through December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Explanatory Paragraph &#8211; Going Concern</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As more fully described in Note 1 to the financial statements, the Company&#8217;s business plan is dependent on the completion of a business combination and the Company&#8217;s cash and working capital as of December 31, 2021 are not sufficient to complete its planned activities for a reasonable period of time, which is considered to be one year from the issuance date of the financial statements. These conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern. Management&#8217;s plans with regard to these matters are also described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:47.435%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Marcum LLP</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marcum LLP</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We have served as the Company&#8217;s auditor since 2021.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York, NY</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 25, 2022</span></td></tr></table></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-23</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_73"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BALANCE SHEET</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DECEMBER 31, 2021</span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMi0xLTEtMS05MDYwOQ_73041914-6ba4-47c6-83e2-51c61da2d0cd">343,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses &#8211; current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:PrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMy0xLTEtMS05MDYwOQ_3b790c50-a125-49f6-963a-2e72168a55a0">337,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfNC0xLTEtMS05MDYwOQ_48843f6c-2c6e-4fda-8c57-2e5f914a61a6">680,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses &#8211; long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="amci:PrepaidExpensesLongTerm" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfNS0xLTEtMS05MDYwOQ_fed717b5-b17f-40cb-8187-7d96528e7840">184,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held in trust account</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:AssetsHeldInTrustNoncurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfNi0xLTEtMS05MDYwOQ_885cf4bf-062f-4ccd-9a1a-a73e6ee51627">150,006,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfNy0xLTEtMS05MDYwOQ_85f29e46-2bc0-45d7-b4d4-3343bb557c62">150,871,760</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders&#8217; Deficit:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMTEtMS0xLTEtOTA2MDk_89cff7aa-e0f2-4788-81c3-3d0661837cf8">85,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMTItMS0xLTEtOTA2MDk_5ee39c2e-29b6-48a2-b7b0-c6406c0abd48">229,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to related party</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:DueToRelatedPartiesCurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMTMtMS0xLTEtOTA2MDk_2cc16b17-60bb-4ede-89ab-b1a289e0ca5c">49,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital based tax payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMTQtMS0xLTEtOTA2MDk_5f54701c-44b7-471e-9402-2d436395191f">198,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Franchise tax payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="amci:FranchiseTaxPayableCurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMTUtMS0xLTEtOTA2MDk_c7ce7bdf-3f93-40b4-bf11-fd86728ca3a9">188,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMTYtMS0xLTEtOTA2MDk_6aa0e1ee-93f9-4346-8179-ea8a8f7b5cfa">751,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred underwriting commissions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="amci:DeferredUnderwritingCompensationNoncurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMTctMS0xLTEtOTA2MDk_389bf53d-c41d-48ad-b5f1-d2d8f35b2043">5,250,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMTgtMS0xLTEtOTA2MDk_75179c1b-5e4f-4a37-acaf-c823458ec2ce">5,610,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMTktMS0xLTEtOTA2MDk_f5fa079e-4a69-4842-b670-67af0542995e">11,611,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitments and Contingencies (Note 5)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMjEtMS0xLTEtOTA2MDk_6fce97f4-ca15-4e4c-9d6e-0f6e682f14fd"></ix:nonFraction>&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock subject to possible redemption, $0.0001 par value; 15,000,000 shares issued and outstanding at $10.00 per share at redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMjMtMS0xLTEtOTA2MDk_f16e8e82-9bb4-417f-ad73-212a30f3caea">150,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stockholders&#8217; Deficit:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $0.0001 par value&#894; 1,000,000 shares authorized&#894; no shares issued or outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMjYtMS0xLTEtOTA2MDk_08555ab8-2906-4037-bf08-4c64941c31d4"><ix:nonFraction unitRef="usd" contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930" decimals="0" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMjYtMS0xLTEtOTA2MDk_75c284b6-f8c9-4edb-9777-b71271be399f">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock, $0.0001 par value; 280,000,000 shares authorized; no non-redeemable shares issued or outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a8ff7f453974014b00746e89fa737d3_I20211231" decimals="0" name="us-gaap:CommonStockValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMjctMS0xLTEtOTA2MDk_461128f5-8409-461c-bf9c-e264dc26415b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 3,750,000 shares issued and outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id57512e5cedd4b74bc2f1786d35220d2_I20211231" decimals="0" name="us-gaap:CommonStockValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMjgtMS0xLTEtOTA2MDk_54463d5e-f1fb-4b3e-bc3c-9d228a3a3562">375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="INF" name="us-gaap:AdditionalPaidInCapital" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMjktMS0xLTEtOTA2MDk_0ab6624f-1201-4f58-96a7-12351d51cf1e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMzAtMS0xLTEtOTA2MDk_ffba3de2-40a2-4232-a3c1-e1f2c99605fa">10,739,971</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total stockholders&#8217; deficit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMzEtMS0xLTEtOTA2MDk_88047e9d-0b34-47c9-847b-018b235a9695">10,739,596</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders&#8217; Deficit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMzItMS0xLTEtOTA2MDk_671f9ae9-803c-4842-8f4a-5a2310f8a711">150,871,760</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-24</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_79"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STATEMENT OF OPERATIONS</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE PERIOD FROM JANUARY 28, 2021 (INCEPTION) THROUGH DECEMBER 31, 2021</span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfMC0xLTEtMS05MDYwOQ_9882a6db-95ef-4b5f-bd9d-ea781d3b7220">951,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses &#8211; related party</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfMS0xLTEtMS05MDYwOQ_b3883834-46ea-4c10-8d5a-cc859c70e37e">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital based tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="amci:CapitalBaseTaxExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfMi0xLTEtMS05MDYwOQ_99702829-d4f9-446c-9c44-afdbe0cb01f0">198,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Franchise tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="us-gaap:ProductionTaxExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfMy0xLTEtMS05MDYwOQ_04ee8193-45a5-4fc6-8926-17b7c1f76d32">188,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfNC0xLTEtMS05MDYwOQ_ff863cb4-e341-46f0-ad67-55f7da484290">1,387,827</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expenses):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfNi0xLTEtMS05MDYwOQ_f9d1d165-4f3c-464d-8320-8084c8d3b0d9">1,905,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Offering costs allocated to derivative warrant liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="amci:OfferingCostsAllocatedToDerivativeWarrantLiabilities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfNy0xLTEtMS05MDYwOQ_51c19d17-ca89-4c89-828f-1d2f0f2d1a8d">476,450</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from investments held in trust account</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="amci:IncomeFromInvestmentsHeldInTrustAccount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfOC0xLTEtMS05MDYwOQ_f5c092db-22fe-414b-bb4a-f5a3651f56c0">6,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfOS0xLTEtMS05MDYwOQ_6ebbf9c2-16a3-45ef-8303-df4a622f9408">46,738</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average shares outstanding of Class A common stock, basic and diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5052ad254932443fa86d172a353e56b2_D20210128-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfMTEtMS0xLTEtOTA2MDk_8797735a-75e4-4f3c-b2f6-86f507207f6e"><ix:nonFraction unitRef="shares" contextRef="i5052ad254932443fa86d172a353e56b2_D20210128-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfMTEtMS0xLTEtOTA2MDk_c4fe4f03-712d-4b1c-89d2-966b29febe5d">4,690,909</ix:nonFraction></ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic and diluted net income per share, Class A common stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5052ad254932443fa86d172a353e56b2_D20210128-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfMTItMS0xLTEtOTA2MDk_1403d029-2622-4707-9070-1f9cd31fbd5e"><ix:nonFraction unitRef="usdPerShare" contextRef="i5052ad254932443fa86d172a353e56b2_D20210128-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfMTItMS0xLTEtOTA2MDk_8ea3b9a3-7e07-4361-955e-6adc0426b6f2">0.01</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average shares outstanding of Class B common stock, basic and diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib213ebc10b6a466a909031c9bd976e11_D20210128-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfMTMtMS0xLTEtOTA2MDk_263b0f7c-1b68-4ff0-af9d-06123e06731d"><ix:nonFraction unitRef="shares" contextRef="ib213ebc10b6a466a909031c9bd976e11_D20210128-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfMTMtMS0xLTEtOTA2MDk_52875b2d-c2ee-4ade-bbe3-e780a95b8bd3">3,750,000</ix:nonFraction></ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic and diluted net income per share, Class B common stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib213ebc10b6a466a909031c9bd976e11_D20210128-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfMTQtMS0xLTEtOTA2MDk_1e031cad-7d56-4fd3-88e3-c581df3519e7"><ix:nonFraction unitRef="usdPerShare" contextRef="ib213ebc10b6a466a909031c9bd976e11_D20210128-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfMTQtMS0xLTEtOTA2MDk_66dad396-23b3-4985-9ca2-c3d1f19e83de">0.01</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-25</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_82"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STATEMENT OF CHANGES IN STOCKHOLDERS&#8217; DEFICIT</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE PERIOD FROM JANUARY 28, 2021 (INCEPTION) THROUGH DECEMBER 31, 2021</span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Deficit</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Deficit</span></td></tr><tr style="height:12pt"><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance &#8211; January 28, 2021 (inception)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic0513771cd0245b88eec6099822e8d74_I20210127" decimals="INF" name="us-gaap:SharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfMy0xLTEtMS05MDYwOQ_797fb4d1-1285-420b-909b-f4f20001d654">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0513771cd0245b88eec6099822e8d74_I20210127" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfMy0zLTEtMS05MDYwOQ_50a6b2be-ad1c-4e50-8776-9f1fb435e58b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i763e0a3dbecb4e3795d7f408cf8a20d5_I20210127" decimals="INF" name="us-gaap:SharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfMy01LTEtMS05MDYwOQ_4febeb70-e1a4-4afe-b62a-f2f870e37f35">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i763e0a3dbecb4e3795d7f408cf8a20d5_I20210127" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfMy03LTEtMS05MDYwOQ_3cb2b53e-53aa-4eda-8582-24b69e866bf2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec832394a7514357811e3f793e5b673f_I20210127" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfMy05LTEtMS05MDYwOQ_e662f1d9-24cd-4595-9971-080e4f0c4faa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc4dbb45fe26489b9bca7b77497e7ca7_I20210127" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfMy0xMS0xLTEtOTA2MDk_b8f545ee-e8ae-4a97-b92a-f1ce7257e282">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib90981c31c9b45a98ded9929aeaa406e_I20210127" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfMy0xMy0xLTEtOTA2MDk_13253921-cc3a-4d93-be0a-77c7358ca099">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of Class B common stock to Sponsor</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icfc521f27ebb491f8864b3a6e6a87d0b_D20210128-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfNC01LTEtMS05MDYwOQ_04b96086-bc30-4ad5-84d2-b0fc3d3b7f17">4,312,500</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfc521f27ebb491f8864b3a6e6a87d0b_D20210128-20211231" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfNC03LTEtMS05MDYwOQ_1d55eef4-0ea4-4386-bc86-7ce4f9d56828">431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471e72d2c86b4efaaf8080c12ecaa577_D20210128-20211231" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfNC05LTEtMS05MDYwOQ_8ceb63a2-519a-4d10-af4c-8c6a0211048f">24,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfNC0xMy0xLTEtOTA2MDk_4096a9f8-9d9e-4924-8e15-92d80f327f30">25,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Excess cash received over the fair value of the private warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471e72d2c86b4efaaf8080c12ecaa577_D20210128-20211231" decimals="0" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfNS05LTEtMS05MDYwOQ_9b569a39-956e-4d95-8142-a7aa07d84dec">1,085,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfNS0xMy0xLTEtOTA2MDk_d58b4543-fc3c-4cbd-ab09-e07d5172ab44">1,085,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited shares</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="icfc521f27ebb491f8864b3a6e6a87d0b_D20210128-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfNi01LTEtMS05MDYwOQ_8464e29e-7f33-4b02-9925-c20db3969e17">562,500</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icfc521f27ebb491f8864b3a6e6a87d0b_D20210128-20211231" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfNi03LTEtMS05MDYwOQ_306415f0-e7cb-4fa4-8ef5-b7c499b5ff22">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471e72d2c86b4efaaf8080c12ecaa577_D20210128-20211231" decimals="0" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfNi05LTEtMS05MDYwOQ_c45d159e-4452-40d9-94d6-13e247e038a6">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contribution from Sponsor upon sale of founder shares to Anchor Investors</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471e72d2c86b4efaaf8080c12ecaa577_D20210128-20211231" decimals="0" name="amci:ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfNy05LTEtMS05MDYwOQ_78dc728c-421a-4a86-8503-415ae7497f72">6,509,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="amci:ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfNy0xMy0xLTEtOTA2MDk_1739e79b-e9b0-4680-9d73-16e578da400f">6,509,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accretion of Class A common stock subject to possible redemption amount</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i471e72d2c86b4efaaf8080c12ecaa577_D20210128-20211231" decimals="0" sign="-" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfOC05LTEtMS05MDYwOQ_62514f6d-6709-4161-83dc-d5ba683c0a55">7,619,383</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd535064e945451eb2cc6d863ed461a9_D20210128-20211231" decimals="0" sign="-" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfOC0xMS0xLTEtOTA2MDk_2867a873-02ad-4030-8c9e-99ff273a0ac1">10,786,709</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" sign="-" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfOC0xMy0xLTEtOTA2MDk_11df518d-7ae8-4210-ab1b-2a48fb5e6d08">18,406,092</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd535064e945451eb2cc6d863ed461a9_D20210128-20211231" decimals="0" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfOS0xMS0xLTEtOTA2MDk_f807320c-f044-4ded-912d-7fc97796cbef">46,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfOS0xMy0xLTEtOTA2MDk_d526e1ec-1279-411f-bdb5-b9120a35fda4">46,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance &#8211; December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i561b8e9c306343cbaa06d16947928777_I20211231" decimals="INF" name="us-gaap:SharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfMTAtMS0xLTEtOTA2MDk_ca261fde-eda2-4d7c-a22f-b1f28771a7a0">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561b8e9c306343cbaa06d16947928777_I20211231" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfMTAtMy0xLTEtOTA2MDk_fab67f5e-8b45-4486-9ae0-e994de09622c">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0df54c9e466f4cee877df6ba1a2a8b5c_I20211231" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfMTAtNS0xLTEtOTA2MDk_53b3fe3b-f466-4091-a08a-83fae5afc55f">3,750,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0df54c9e466f4cee877df6ba1a2a8b5c_I20211231" decimals="0" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfMTAtNy0xLTEtOTA2MDk_5bf78088-6708-45af-a445-5b63da694f5e">375</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d10e6b77d0f437bb89153397dd47b71_I20211231" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfMTAtOS0xLTEtOTA2MDk_fc3f41d1-56dd-4756-a580-1c6a84e6571f">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i331e64d7b36f44f3a66c631e0f8eeddb_I20211231" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfMTAtMTEtMS0xLTkwNjA5_f0f3aea3-0a90-4e30-9286-9d705980d144">10,739,971</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfMTAtMTMtMS0xLTkwNjA5_bf177288-8bd9-4acd-9bb2-288d5cc28b19">10,739,596</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-26</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_85"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STATEMENT OF CASH FLOWS</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE PERIOD FROM JANUARY 28, 2021 (INCEPTION) THROUGH DECEMBER 31, 2021</span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flows from Operating Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMS0xLTEtMS05MDYwOQ_f6581450-c81b-4be5-b9a1-61cc5261b5e0">46,738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative expenses paid by Sponsor in exchange for issuance of Class B common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="amci:GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMy0xLTEtMS05MDYwOQ_012ef73c-1943-438b-a60e-8305b2012925">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of derivative warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfNC0xLTEtMS05MDYwOQ_0ba36467-6f6d-40c9-b4fe-19e914002546">1,905,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Offering costs allocated to derivative warrant liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="amci:OfferingCostsAllocatedToDerivativeWarrantLiabilities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfNS0xLTEtMS05MDYwOQ_4cba809a-a6d2-439b-a71b-39c21489c2de">476,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from investments held in the trust account</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="amci:IncomeFromInvestmentsHeldInTrustAccount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfNi0xLTEtMS05MDYwOQ_dfa83dbf-385a-43a8-adf4-6b041e4f84a5">6,015</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfOC0xLTEtMS05MDYwOQ_38ffaadb-8f51-4b5d-9e70-77cb7aab8e6d">155,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfOS0xLTEtMS05MDYwOQ_512d6683-3e6c-47a1-b9d5-63df8d7d16f2">85,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Due to related party</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="amci:DueToRelatedParty" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMTAtMS0xLTEtOTA2MDk_b741b58a-09b0-4372-87f5-a0af35345f32">49,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMTEtMS0xLTEtOTA2MDk_b5616f9a-f67a-4e78-8aee-8b32d5129f13">199,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital based tax payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="amci:IncreaseDecreaseInCapitalBaseTaxPayable" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMTItMS0xLTEtOTA2MDk_6efd4859-8353-4588-8eb3-3b321c45ce57">198,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Franchise tax payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="amci:IncreaseDecreaseFranchiseTaxPayable" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMTMtMS0xLTEtOTA2MDk_e4cab3fb-263a-4b3b-b5dc-10f34a2ed565">188,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash used in operating activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMTQtMS0xLTEtOTA2MDk_3dbf082d-9aeb-42d8-96c3-bc6c87ea428f">510,017</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flows from Investing Activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash deposited in trust account</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="amci:PaymentsForInvestmentOfCashInTrustAccount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMTctMS0xLTEtOTA2MDk_6143a93a-016c-48aa-93d2-4c02c84574c1">150,000,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash used in investing activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMTgtMS0xLTEtOTA2MDk_869af83f-480a-43ad-97a6-27773d1036e8">150,000,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flows from Financing Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from note payable to related party</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="us-gaap:ProceedsFromRelatedPartyDebt" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMjEtMS0xLTEtOTA2MDk_346132c9-7fe9-47c6-8ada-01ce35cbadad">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds received from initial public offering, gross</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMjItMS0xLTEtOTA2MDk_b1659c8d-7490-42ec-a00d-782406ef74be">150,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds received from private placement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="us-gaap:ProceedsFromIssuanceOfWarrants" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMjMtMS0xLTEtOTA2MDk_f4f183f0-418c-482a-92a1-374b38052fef">852,416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash provided by financing activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMjQtMS0xLTEtOTA2MDk_04b34572-a1e5-43a6-9146-4a433ea76225">150,853,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net change in cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMjYtMS0xLTEtOTA2MDk_2421601f-7ff6-4ff5-a5af-62a6d125f125">343,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash &#8211; beginning of the period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib90981c31c9b45a98ded9929aeaa406e_I20210127" decimals="0" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMjgtMS0xLTEtOTA2MDk_3398dd5c-7999-43e6-afe9-1d20a2e62669">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash &#8211; end of the period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMjktMS0xLTEtOTA2MDk_f41fcadc-5fa9-4ced-abf2-0bd97e3fcaf2">343,399</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supplemental disclosure of noncash activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Offering costs paid by related party under note payable and advances</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="amci:StockIssuanceCostsNoncash" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMzItMS0xLTEtOTA2MDk_84b6db88-c525-4903-8df2-c1938ab118b3">1,968,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Offering costs included in accrued expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="amci:OfferingCostsIncludedInAccountsPayableAccruedExpenses" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMzMtMS0xLTEtOTA2MDk_466c841a-ebfd-4e0f-85f3-bf405cbc3e6a">30,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Offering costs paid by Sponsor in exchange for issuance of Class B common stock</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="amci:DeferredUnderwritingFeePayable" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMzQtMS0xLTEtOTA2MDk_d9e2c3fd-8a33-4648-be21-40b1af13d679">24,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses paid by related party under note payable and advances</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="amci:NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMzUtMS0xLTEtOTA2MDk_0c6da33f-f7d4-4570-8a90-ec48be2331a4">677,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of note payable and advances by Sponsor in exchange for issuance of private placement warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="amci:NoncashRepaymentOfNotePayableAndAdvances" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMzYtMS0xLTEtOTA2MDk_3b5a34a3-974f-435b-b336-384baf429101">2,647,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred underwriting commissions in connection with the initial public offering</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="amci:NoncashDeferredUnderwritingCommissions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMzctMS0xLTEtOTA2MDk_23105c6b-59f9-49aa-9022-0670de7f4543">5,250,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Value of Class B common stock transferred to Anchor Investors at initial public offering</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231" decimals="0" name="amci:ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMzgtMS0xLTEtOTA2MDk_1be21642-e06d-42a5-acbd-200319a00f03">6,509,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-27</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_88"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the period from January 28, 2021 (inception) through December 31, 2021</span></div></div><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_91"></div><ix:continuation id="i09aafe3e3ad94fddadbece5ec79656ae" continuedAt="i24755db1cb9c4d0185ca3372eae6afeb"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1 &#8212; Description of Organization and Business Operations</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AMCI Acquisition Corp. II (the &#8220;Company&#8221;) is a blank check company incorporated as a Delaware corporation on January 28, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with <ix:nonFraction unitRef="item" contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231" decimals="INF" name="amci:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMzY2_2286dc58-62a2-4ab2-8c0b-9fef74713252">one</ix:nonFraction> or more businesses (the &#8220;business combination&#8221;). </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the Company has neither engaged in any operations nor generated any revenues. All activity for the period from January 28, 2021 (inception) through December 31, 2021 relates to the Company&#8217;s formation and the initial public offering (&#8220;initial public offering&#8221;), described below. The Company will not generate any operating revenues until after the completion of its initial business combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the initial public offering and from changes in the fair value of its derivative warrant liabilities, if applicable. The Company has selected December 31 as its fiscal year end.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s sponsor is AMCI Sponsor II LLC, a Delaware limited liability company (the &#8220;Sponsor&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registration statement for the Company&#8217;s initial public offering was declared effective on August 3, 2021 (the &#8220;effective date&#8221;). On August 6, 2021, the Company consummated its initial public offering of <ix:nonFraction unitRef="shares" contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806" decimals="INF" name="amci:UnitsIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMTQ4MQ_e0534989-b78c-4663-9014-39fe73786945">15,000,000</ix:nonFraction> units (the &#8220;units&#8221;). Each unit consists of <ix:nonFraction unitRef="shares" contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806" decimals="INF" name="amci:NumberOfSharesIssuedPerUnit" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMTUyNw_df87d620-f23b-4c13-89ab-2f5fb5a93c2a">one</ix:nonFraction> Class A common stock of the Company, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="ie730d94e9acc40f48d227ce51539c50b_I20210806" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMTU3Nw_d4b3da32-fd25-40b6-8ffb-48b7283cdf73">0.0001</ix:nonFraction> per share (the &#8220;Class A common stock&#8221;), and one-half of one redeemable warrant of the Company (the &#8220;warrant&#8221;), each whole warrant entitling the holder thereof to purchase <ix:nonFraction unitRef="shares" contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMTc1MQ_df490069-a510-40a6-ac2f-f457b61d19d4">one</ix:nonFraction> Class A common stock for $<ix:nonFraction unitRef="usdPerShare" contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMTc3OQ_d9b90c57-a956-4589-b770-b116791c0eb1">11.50</ix:nonFraction> per share. The units were sold at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMTgyNw_85850a0a-7fc9-4e2f-b88c-c351f49568be">10.00</ix:nonFraction> per unit, generating gross proceeds to the Company of $<ix:nonFraction unitRef="usd" contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806" decimals="0" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMTg4NA_b2fd2cf8-a157-40c1-b641-5c98124a0c8c">150,000,000</ix:nonFraction>, which is discussed in Note 3.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Simultaneously with the closing of the initial public offering, the Company completed the private sale of an aggregate of <ix:nonFraction unitRef="shares" contextRef="iba67ebbc3e2147e2a5a1f7dbbeab0ccd_I20210806" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMjA0MA_24c39fc9-c54c-47a7-b972-343f5ed8fd4d">3,500,000</ix:nonFraction> warrants (the &#8220;private placement warrants&#8221;) to the Sponsor at a purchase price of $<ix:nonFraction unitRef="usdPerShare" contextRef="iba67ebbc3e2147e2a5a1f7dbbeab0ccd_I20210806" decimals="2" name="amci:ClassOfWarrantOrRightPriceOfWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMjEyNQ_922a94d9-49f5-4484-83e2-45c6d5ece14a">1.00</ix:nonFraction> per private placement warrant, generating gross proceeds to the Company of $<ix:nonFraction unitRef="usd" contextRef="i98ebad46078d44259754e031d9c5bd6d_D20210806-20210806" decimals="0" name="us-gaap:ProceedsFromIssuanceOfWarrants" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMjIwMw_4a25e55d-e5ed-4fae-a0de-3f99e7838b82">3,500,000</ix:nonFraction>. The private placement warrants are identical to the warrants sold in the initial public offering, except that the private placement warrants, so long as they are held by the Sponsor or its permitted transferees, (i) are not redeemable by the Company, (ii) may not (including the Class A common stock issuable upon exercise of such private placement warrants), subject to certain limited exceptions, be transferred, assigned or sold by such holders until <ix:nonNumeric contextRef="i98ebad46078d44259754e031d9c5bd6d_D20210806-20210806" name="amci:RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMjY2MQ_e0657ad2-fd13-404b-af6e-cd642cc9a93c">30</ix:nonNumeric> days after the completion of the Company&#8217;s initial business combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights. No underwriting discounts or commissions were paid with respect to such sales.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the initial public offering includes two instruments, Class A common stock and warrants, and as the warrants are classified as a financial liability, it is necessary to allocate the gross proceeds between Class A common stock and warrants. The Company adopted the residual method to allocate the gross proceeds between Class A common stock and warrants based on their relative fair values. The gross proceeds were first allocated to the fair value of the warrants and the residual amount was allocated to the Class A common stock. The percentage derived from this allocation was used to allocate the deferred offering costs between Class A common stock and warrants. Issuance costs allocated to the warrants were expensed to the Company&#8217;s statement of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction costs of the initial public offering amounted to $<ix:nonFraction unitRef="usd" contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806" decimals="0" name="amci:TransactionCosts" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMzc0Nw_e9ea48f3-da8f-4c31-8c44-71d8f3e87a07">13,782,542</ix:nonFraction> and consisted of $<ix:nonFraction unitRef="usd" contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806" decimals="0" name="amci:SaleOfStockUnderwritingDiscounts" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMzc2Nw_6fad1d73-ca5e-4337-b89d-d8621d4d23a3">1,500,000</ix:nonFraction> of underwriting discount, $<ix:nonFraction unitRef="usd" contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806" decimals="0" name="amci:DeferredUnderwritingDiscounts" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMzc5Ng_ef28e91d-43c1-476c-a93e-90a29f25bfea">5,250,000</ix:nonFraction> of deferred underwriting discount, $<ix:nonFraction unitRef="usd" contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806" decimals="0" name="amci:ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMzgzNA_a5cab3ab-de04-4d4e-8a12-5092b6628bac">6,509,758</ix:nonFraction> in fair value of Class B common stock issued to Anchor Investors, and $<ix:nonFraction unitRef="usd" contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806" decimals="0" name="amci:SaleOfStockOtherOfferingCosts" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMzkwNw_5c4d0548-b451-43dc-ad99-d6e396d2502e">522,784</ix:nonFraction> of other offering costs.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A total of $<ix:nonFraction unitRef="usd" contextRef="i60c2802479f2421e81d073c740ec38f5_D20210806-20210806" decimals="0" name="amci:PaymentsForInvestmentOfCashInTrustAccount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMzk0Ng_f2ac49ad-1ee6-48c7-81b0-50acfb1cb4c1">150,000,000</ix:nonFraction> was placed in a U.S.-based trust account maintained by Continental Stock Transfer &amp; Trust Company, acting as trustee.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company must complete <ix:nonFraction unitRef="item" contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231" decimals="INF" name="amci:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfNDA5Mw_c92b8634-4d15-44d2-aa90-2a458831cf59">one</ix:nonFraction> or more initial business combination having an aggregate fair market value of at least <ix:nonFraction unitRef="number" contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231" decimals="0" name="amci:ConditionForFutureBusinessCombinationUseOfProceedsPercentage" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfNDE4Mw_65fd8a4d-bdb0-470c-9ca5-cfafe5f5b49d">80</ix:nonFraction>% of the value of the assets held in the trust account (excluding the amount of deferred underwriting discounts held in trust and taxes payable on the income earned on the trust account) at the time of the signing a definitive agreement in connection with the initial business combination. However, the Company will only complete a business combination if the post-transaction company owns or acquires <ix:nonFraction unitRef="number" contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231" decimals="0" name="amci:ConditionForFutureBusinessCombinationThresholdPercentageOwnership" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfNDU4Nw_3a34b452-942f-4499-bd8d-83cc58c02fec">50</ix:nonFraction>% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the period from January 28, 2021 (inception) through December 31, 2021</span></div></div><ix:continuation id="i24755db1cb9c4d0185ca3372eae6afeb" continuedAt="i493dc27be795434088cb2f1cbb518a5e"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">register as an investment company under the Investment Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;). There is no assurance that the Company will be able to complete a business combination successfully.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the closing of the initial public offering, management has agreed that an amount equal to at least $<ix:nonFraction unitRef="usdPerShare" contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfNTA3Mw_02c7686a-f5c1-4c0a-a182-0e2b28d9b40c">10.00</ix:nonFraction> per unit sold in the initial public offering, including the proceeds of the private placement warrants, will be held in a trust account (the &#8220;trust account&#8221;), located in the United States with Continental Stock Transfer &amp; Trust Company acting as trustee, and will invest only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect to interest earned on the funds held in the trust account that may be released to the Company to pay taxes, if any, the proceeds from the initial public offering and the sale of the private placement warrants will not be released from the trust account until the earliest of (i) the completion of initial business combination, (ii) the redemption of the Company&#8217;s public shares if the Company is unable to complete an initial business combination by August 6, 2023, subject to applicable law, or (iii) the redemption of the Company&#8217;s public shares properly submitted in connection with a stockholder vote to amend its amended and restated certificate of incorporation to modify the substance or timing of the Company&#8217;s obligation to redeem <ix:nonFraction unitRef="number" contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231" decimals="2" name="amci:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfNjQ0MA_ecb66a6a-6b95-47d4-a1e0-49e317d24426">100</ix:nonFraction>% of its public shares if the Company has not consummated an initial business combination by August 6, 2023 or with respect to any other material provisions relating to stockholders&#8217; rights or pre-initial business combination activity. The proceeds deposited in the trust account could become subject to the claims of the Company&#8217;s creditors, if any, which could have priority over the claims of the Company&#8217;s public stockholders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will provide its public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial business combination either (i) in connection with a stockholder meeting called to approve the business combination or (ii) without a stockholder vote by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed business combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem all or a portion of their public shares upon the completion of the initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account calculated as of two business days prior to the consummation of the initial business combination, including interest earned on the funds held in the trust account (which interest shall be net of taxes payable), divided by the number of then outstanding public shares, subject to the limitations and on the conditions described herein. The amount in the trust account is initially anticipated to be $<ix:nonFraction unitRef="usdPerShare" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="2" name="amci:FundHeldInTrustAccountPerPublicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfODAzNg_34f406bd-4ead-4f2c-8c51-8540e1fb1d44">10.00</ix:nonFraction> per public share. The per share amount the Company will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the representative of the underwriters.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares of common stock subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the initial public offering, in accordance with Financial Accounting Standards Board&#8217;s (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480, &#8220;Distinguishing Liabilities from Equity.&#8221; In such case, the Company will proceed with a business combination if the Company has net tangible assets of at least $<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="0" name="amci:ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfODcyOQ_37324c9b-59d0-455d-96b1-3baec80e6e27">5,000,001</ix:nonFraction> upon such consummation of a business combination and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the business combination.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will have only <ix:nonNumeric contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231" name="amci:MonthsToCompleteAcquisition" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfODk1OA_4a402796-b87f-44f1-9856-5c1a1b702ea0">24</ix:nonNumeric> months from the closing of the initial public offering to complete the initial business combination (the &#8220;Combination Period&#8221;). However, if the Company is unable to complete the initial business combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfOTMzMA_80eea167-68dd-4f47-a97c-0adf8eb467f8">ten</span> business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (which interest shall be net of taxes payable and up to $<ix:nonFraction unitRef="usd" contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231" decimals="0" name="amci:MaximumAllowedDissolutionExpenses" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfOTYxMw_c168c4fc-f8ef-41ff-9f62-9dbeead32ee9">100,000</ix:nonFraction> of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company&#8217;s remaining stockholders and the Company&#8217;s board of </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the period from January 28, 2021 (inception) through December 31, 2021</span></div></div><ix:continuation id="i493dc27be795434088cb2f1cbb518a5e" continuedAt="i38524d77732c409e8989843daed55b59"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">directors, liquidate and dissolve, subject, in each case, to the Company&#8217;s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sponsor, officers and directors have agreed to (i) waive their redemption rights with respect to any founder shares and public shares they hold in connection with the completion of the initial business combination, (ii) waive their redemption rights with respect to any founder shares and public shares they hold in connection with a stockholder vote to approve an amendment to the Company&#8217;s amended and restated certificate of incorporation, (iii) waive their rights to liquidating distributions from the trust account with respect to any founder shares they hold if the Company fails to complete the initial business combination within the Combination Period, and (iv) vote their founder shares and any public shares purchased during or after the initial public offering in favor of the initial business combination.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $<ix:nonFraction unitRef="usdPerShare" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="2" name="amci:FundHeldInTrustAccountPerPublicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMTE0NzE_1ba1bb37-b562-4551-a28b-7358ecc27ae7">10.00</ix:nonFraction> per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $<ix:nonFraction unitRef="usdPerShare" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="2" name="amci:FundHeldInTrustAccountPerPublicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMTE2MzA_4036875b-14f8-4a92-beda-453ab45761da">10.00</ix:nonFraction> per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party (other than the Company&#8217;s independent registered public accounting firm) or prospective target business who executed a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is enforceable), nor will it apply to any claims under the Company&#8217;s indemnity of the underwriters of the initial public offering against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor&#8217;s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would be able to satisfy those obligations. None of the Company&#8217;s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Emerging Growth Company Status</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the period from January 28, 2021 (inception) through December 31, 2021</span></div></div><ix:continuation id="i38524d77732c409e8989843daed55b59" continuedAt="i95232bd264bf4f159ee9dbeb2fb7f807"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is continuing to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company&#8217;s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposed Business Combination</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As more fully described in Note 11, on March 8, 2022, the Company entered into an agreement and plan of merger (the &#8220;Merger Agreement&#8221;) with AMCI Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (&#8220;Merger Sub&#8221;), and LanzaTech NZ, Inc., a Delaware corporation (&#8220;LanzaTech&#8221;). Upon consummation of the transactions, the Company will change its name to &#8220;LanzaTech Global, Inc.&#8221;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Going Concern</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the Company had approximately $<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-5" name="amci:ProceedsHeldInOperatingAccountForWorkingCapitalPurpose" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMTYwMjQ_ca50ba98-c367-4041-924d-414be6654194">0.3</ix:nonFraction> million in its operating bank account and a working capital deficit of approximately $<ix:nonFraction unitRef="usd" contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231" decimals="-5" name="amci:WorkingCapitalDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMTYxMDQ_8d8a76cd-57d7-4c09-8f07-0ee9708d7f90">0.1</ix:nonFraction> million.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s liquidity needs up to December 31, 2021 have been satisfied through a contribution of $<ix:nonFraction unitRef="usd" contextRef="id0abd6277c4d4571a894945f36707ca5_D20210128-20211231" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMTYyMDg_8b4ad65d-b74f-4930-b4b1-1fae3f242ed1">25,000</ix:nonFraction> from the Sponsor to cover for certain offering costs in exchange for the issuance of founder shares, and a loan and advances from the Sponsor pursuant to the Note (as defined in Note 4). Subsequent to the initial public offering, net proceeds from the private placement of $<ix:nonFraction unitRef="usd" contextRef="ibf1a938c139d435097214ed3b23c295f_I20210806" decimals="-5" name="amci:ProceedsHeldInOperatingAccountForWorkingCapitalPurpose" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMTY0ODQ_d5ce28b0-d51b-444b-afa9-20f7bc4871af">0.9</ix:nonFraction> million were placed in the operating account for working capital purposes. In addition, in order to finance transaction costs in connection with a business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#8217;s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 4). As of December 31, 2021, there were <ix:nonFraction unitRef="usd" contextRef="i67af9d98434f4635b3c35ea4fd55d5c2_I20211231" decimals="0" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMTY4NzY_24406358-7141-4973-8adb-0dc2816fb62c">no</ix:nonFraction> amounts outstanding under any Working Capital Loan.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company&#8217;s assessment of going concern considerations in accordance with Financial Accounting Standard Board&#8217;s Accounting Standards Update (&#8220;ASU&#8221;) 2014-15, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosures of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; management has determined that the Company would not be able to meet its obligations as they become due within one year after the date that the financial statements are available to be issued. As such, management has determined that the liquidity condition raises substantial doubt about the Company&#8217;s ability to continue as a going concern. As of December 31, 2021, no adjustments have been made to the carrying amounts of assets or liabilities.</span></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_97"></div><ix:continuation id="ic6c429b5f76641a5bbf03b6a626ac366" continuedAt="i7b8f6f4597754c0489c1637764af36f9"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2 &#8212; Basis of Presentation and Summary of Significant Accounting Policies</span></div><ix:continuation id="ia59d28068eec4051b60bb378fd3e4c39" continuedAt="id93b75853a924368982b7ccd90ee4322"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;).</span></div></ix:continuation><ix:continuation id="ia344cb76006a4cc7ba49a2096b388551" continuedAt="i6a1aedda86154155a15af2c6e0818f44"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="0" name="us-gaap:CashFDICInsuredAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85Ny9mcmFnOjIyZmU4NmQ4ZDBiMTQ4NTQ4ZjA1NjBhMTRiZTJlMDg1L3RleHRyZWdpb246MjJmZTg2ZDhkMGIxNDg1NDhmMDU2MGExNGJlMmUwODVfNjI1_c1152eb2-22b7-4040-a63c-5cd6e01649f5">250,000</ix:nonFraction>. As of December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></div></ix:continuation><ix:continuation id="iafb8c1bd22464c98a8f13eb1b230d190" continuedAt="i09484847551142418cdffc3c9c5affa7"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had <ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="0" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85Ny9mcmFnOjIyZmU4NmQ4ZDBiMTQ4NTQ4ZjA1NjBhMTRiZTJlMDg1L3RleHRyZWdpb246MjJmZTg2ZDhkMGIxNDg1NDhmMDU2MGExNGJlMmUwODVfOTgx_0247369e-7384-449e-8b0d-2a5e84dd78ad">no</ix:nonFraction> cash equivalents as of December 31, 2021.</span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the period from January 28, 2021 (inception) through December 31, 2021</span></div></div><ix:continuation id="i7b8f6f4597754c0489c1637764af36f9" continuedAt="ie8bcd26123544b0995e65ce92dd44aea"><ix:continuation id="i89f8ab05fdff489bbedabad70a7381aa" continuedAt="iacd73ac48aa2490896023096807762ff"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></div></ix:continuation><ix:continuation id="ia4417ae1655443c58b32531793e69bab"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments Held in the Trust Account</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company&#8217;s investments held in the trust account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company&#8217;s investments held in the trust account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the trust account in the accompanying statement of operations. The estimated fair values of investments held in the trust account are determined using available market information.</span></div></ix:continuation><ix:continuation id="ica1158bf61aa4e79a8a1549d5ddcd3ac"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities which qualify as financial instruments under the FASB ASC 820, &#8220;Fair Value Measurement,&#8221; equal or approximate the carrying amounts represented in the balance sheet.</span></div></ix:continuation><ix:continuation id="i55ce36de169e4bd3b8b833b00e06a629" continuedAt="id55ae49f030e4e16b38d2d4f116feed9"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</span></div></ix:continuation><ix:continuation id="ic1e7e51e3575493c9b9766493cad3fe5" continuedAt="i55de32efe1ba4756b28172afdff9c44d"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Offering Costs Associated with Initial Public Offering</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the initial public offering that were directly related to the initial public offering. Offering costs were allocated to the separable financial instruments issued in the initial public offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and </span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the period from January 28, 2021 (inception) through December 31, 2021</span></div></div><ix:continuation id="ie8bcd26123544b0995e65ce92dd44aea" continuedAt="ib1a244dbeb4144da94c5d70b2de03d89"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i55de32efe1ba4756b28172afdff9c44d">presented as non-operating expenses in the statement of operations. Offering costs associated with the Class A common stock issued were charged against the carrying value of the shares of Class A common stock upon the completion of the initial public offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</ix:continuation></span></div><ix:continuation id="i63c860a400c84add8f802bfdaf186314"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Class A Common Stock Subject to Possible Redemption </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, &#8220;Distinguishing Liabilities from Equity.&#8221; Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders&#8217; equity. The Company&#8217;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of uncertain future events. Accordingly, as of the initial public offering, <ix:nonFraction unitRef="shares" contextRef="ia93b17d361a84b54b833904249951429_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85Ny9mcmFnOjIyZmU4NmQ4ZDBiMTQ4NTQ4ZjA1NjBhMTRiZTJlMDg1L3RleHRyZWdpb246MjJmZTg2ZDhkMGIxNDg1NDhmMDU2MGExNGJlMmUwODVfNjc2NQ_18cb2d1e-9d5b-4dd7-8c39-59d2f91407b8">15,000,000</ix:nonFraction> shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders&#8217; equity (deficit) section of the Company&#8217;s balance sheet.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 480-10-S99, the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of the reporting period. This method would view the end of the reporting period as if it were also the redemption date of the security. Effective with the closing of the initial public offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.</span></div></ix:continuation><ix:continuation id="i33167ef5167e4893b8bfa684da3542ed" continuedAt="i2dc6fe64c1684e768f6e1a73a4ab0fc7"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The public warrants and the private placement warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The initial fair value of the public warrants issued in connection with the initial public offering was estimated using a Monte-Carlo simulation model. The fair value of the public warrants as of December 31, 2021 is based on observable listed prices for such warrants. The fair value of the private placement warrants as of December 31, 2021 is determined using a Black-Scholes option pricing model. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</span></div></ix:continuation><ix:continuation id="ia04949aa7dd640e19ba61ea7fec3d57b" continuedAt="ib95de1b59ea045c2bfd569806af85747"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the </span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the period from January 28, 2021 (inception) through December 31, 2021</span></div></div><ix:continuation id="ib1a244dbeb4144da94c5d70b2de03d89" continuedAt="i67512cdb0b9745f0af6676f6adc72e49"><ix:continuation id="ib95de1b59ea045c2bfd569806af85747" continuedAt="i340fee7a2b184bada29aa1cba8c4aa8c"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</span></div></ix:continuation><ix:continuation id="i9690f8c911fd4fdfab9ea4388e14e9dd" continuedAt="i9e9ce477821b47c5af03edda1fe184f5"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Per Share of Common Stock</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share.&#8221; The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the units sold in the initial public offering and the private placement warrants to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="ib178386587034322a4ea05a95f29a04c_D20210128-20211231" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85Ny9mcmFnOjIyZmU4NmQ4ZDBiMTQ4NTQ4ZjA1NjBhMTRiZTJlMDg1L3RleHRyZWdpb246MjJmZTg2ZDhkMGIxNDg1NDhmMDU2MGExNGJlMmUwODVfMTE3MTk_d1909f62-551c-483a-b19d-6f0ae42090b4">11,000,000</ix:nonFraction> shares of Class A common stock in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the period from January 28, 2021 (inception) through December 31, 2021. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock:</span></div><div style="margin-bottom:9pt"><ix:continuation id="ie4988b69c857416ba83346fe7fea7045" continuedAt="i1595af8a85a2479d91848a09431a3489"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.451%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.805%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the period from January 28, 2021<br/>(inception) through December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income (loss) per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i717f3c096f124e38aff5fad8440a91a2_D20210128-20211231" decimals="0" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85Ny9mcmFnOjIyZmU4NmQ4ZDBiMTQ4NTQ4ZjA1NjBhMTRiZTJlMDg1L3RhYmxlOjM4NmZhYmFmYzI2MzQ0MDE5NzVkZjMxMGI4YTdkY2RhL3RhYmxlcmFuZ2U6Mzg2ZmFiYWZjMjYzNDQwMTk3NWRmMzEwYjhhN2RjZGFfNC0xLTEtMS05MDYwOQ_bfd155bd-839f-45cd-829d-56d29307ea53">25,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa0df75fa4824897be8997ed124b9bdc_D20210128-20211231" decimals="0" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85Ny9mcmFnOjIyZmU4NmQ4ZDBiMTQ4NTQ4ZjA1NjBhMTRiZTJlMDg1L3RhYmxlOjM4NmZhYmFmYzI2MzQ0MDE5NzVkZjMxMGI4YTdkY2RhL3RhYmxlcmFuZ2U6Mzg2ZmFiYWZjMjYzNDQwMTk3NWRmMzEwYjhhN2RjZGFfNC0zLTEtMS05MDYwOQ_7ef945cd-5c06-47bf-953f-ae6f3cc51e66">20,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i717f3c096f124e38aff5fad8440a91a2_D20210128-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85Ny9mcmFnOjIyZmU4NmQ4ZDBiMTQ4NTQ4ZjA1NjBhMTRiZTJlMDg1L3RhYmxlOjM4NmZhYmFmYzI2MzQ0MDE5NzVkZjMxMGI4YTdkY2RhL3RhYmxlcmFuZ2U6Mzg2ZmFiYWZjMjYzNDQwMTk3NWRmMzEwYjhhN2RjZGFfNy0xLTEtMS05MDYwOQ_5b4b9350-4582-4bdb-929a-5f6b6d359e6b"><ix:nonFraction unitRef="shares" contextRef="i717f3c096f124e38aff5fad8440a91a2_D20210128-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85Ny9mcmFnOjIyZmU4NmQ4ZDBiMTQ4NTQ4ZjA1NjBhMTRiZTJlMDg1L3RhYmxlOjM4NmZhYmFmYzI2MzQ0MDE5NzVkZjMxMGI4YTdkY2RhL3RhYmxlcmFuZ2U6Mzg2ZmFiYWZjMjYzNDQwMTk3NWRmMzEwYjhhN2RjZGFfNy0xLTEtMS05MDYwOQ_efbeb947-a039-45f4-90b2-32503f6ee99e">4,690,909</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa0df75fa4824897be8997ed124b9bdc_D20210128-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85Ny9mcmFnOjIyZmU4NmQ4ZDBiMTQ4NTQ4ZjA1NjBhMTRiZTJlMDg1L3RhYmxlOjM4NmZhYmFmYzI2MzQ0MDE5NzVkZjMxMGI4YTdkY2RhL3RhYmxlcmFuZ2U6Mzg2ZmFiYWZjMjYzNDQwMTk3NWRmMzEwYjhhN2RjZGFfNy0zLTEtMS05MDYwOQ_483513d9-8a2a-4f56-828c-1ab677f7fa3e"><ix:nonFraction unitRef="shares" contextRef="iaa0df75fa4824897be8997ed124b9bdc_D20210128-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85Ny9mcmFnOjIyZmU4NmQ4ZDBiMTQ4NTQ4ZjA1NjBhMTRiZTJlMDg1L3RhYmxlOjM4NmZhYmFmYzI2MzQ0MDE5NzVkZjMxMGI4YTdkY2RhL3RhYmxlcmFuZ2U6Mzg2ZmFiYWZjMjYzNDQwMTk3NWRmMzEwYjhhN2RjZGFfNy0zLTEtMS05MDYwOQ_966f99f2-b0a5-4cb0-a311-19bb6232333a">3,750,000</ix:nonFraction></ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income (loss) per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i717f3c096f124e38aff5fad8440a91a2_D20210128-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85Ny9mcmFnOjIyZmU4NmQ4ZDBiMTQ4NTQ4ZjA1NjBhMTRiZTJlMDg1L3RhYmxlOjM4NmZhYmFmYzI2MzQ0MDE5NzVkZjMxMGI4YTdkY2RhL3RhYmxlcmFuZ2U6Mzg2ZmFiYWZjMjYzNDQwMTk3NWRmMzEwYjhhN2RjZGFfOC0xLTEtMS05MDYwOQ_4d081ec1-6748-4d82-8c61-f250b4f59bbe"><ix:nonFraction unitRef="usdPerShare" contextRef="i717f3c096f124e38aff5fad8440a91a2_D20210128-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85Ny9mcmFnOjIyZmU4NmQ4ZDBiMTQ4NTQ4ZjA1NjBhMTRiZTJlMDg1L3RhYmxlOjM4NmZhYmFmYzI2MzQ0MDE5NzVkZjMxMGI4YTdkY2RhL3RhYmxlcmFuZ2U6Mzg2ZmFiYWZjMjYzNDQwMTk3NWRmMzEwYjhhN2RjZGFfOC0xLTEtMS05MDYwOQ_9b583eea-3c47-4821-9870-2186f62d5c79">0.01</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaa0df75fa4824897be8997ed124b9bdc_D20210128-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85Ny9mcmFnOjIyZmU4NmQ4ZDBiMTQ4NTQ4ZjA1NjBhMTRiZTJlMDg1L3RhYmxlOjM4NmZhYmFmYzI2MzQ0MDE5NzVkZjMxMGI4YTdkY2RhL3RhYmxlcmFuZ2U6Mzg2ZmFiYWZjMjYzNDQwMTk3NWRmMzEwYjhhN2RjZGFfOC0zLTEtMS05MDYwOQ_e4a84ca5-e275-4135-a4eb-0865a2358845"><ix:nonFraction unitRef="usdPerShare" contextRef="iaa0df75fa4824897be8997ed124b9bdc_D20210128-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85Ny9mcmFnOjIyZmU4NmQ4ZDBiMTQ4NTQ4ZjA1NjBhMTRiZTJlMDg1L3RhYmxlOjM4NmZhYmFmYzI2MzQ0MDE5NzVkZjMxMGI4YTdkY2RhL3RhYmxlcmFuZ2U6Mzg2ZmFiYWZjMjYzNDQwMTk3NWRmMzEwYjhhN2RjZGFfOC0zLTEtMS05MDYwOQ_e866ea24-ebad-4f4a-ae4b-f5127aebc3c8">0.01</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><ix:continuation id="if2d13293fb4046dd997303549baa7456" continuedAt="id8f3e62a06924ee7bdf61970f4b2c270"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2020-06, &#8220;Debt &#8212; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8212; Contracts in an Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity&#8221; (&#8220;ASU 2020-06&#8221;), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. ASU 2020-06 also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 on August 2, 2021 using the modified retrospective method for transition. Adoption of ASU 2020-06 did not impact the Company&#8217;s financial position, results of operations or cash flows.</span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the period from January 28, 2021 (inception) through December 31, 2021</span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i67512cdb0b9745f0af6676f6adc72e49" continuedAt="i1145a981771c4b53b99e9d85b31bf8ee"><ix:continuation id="id8f3e62a06924ee7bdf61970f4b2c270" continuedAt="i637a1bd411944a4eb691ac3278ac3d67">The Company&#8217;s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company&#8217;s financial statements.</ix:continuation></ix:continuation></span></div><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_100"></div><ix:continuation id="i43be93d6dd254a3287f970806daf278c"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3 &#8212; Initial Public Offering</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 6, 2021, the Company consummated its initial public offering of <ix:nonFraction unitRef="shares" contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806" decimals="INF" name="amci:UnitsIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDAvZnJhZzowNTQwNTVmNWFlNTY0MTU0YTExMWE4ZDIwYTc1Y2M3Ny90ZXh0cmVnaW9uOjA1NDA1NWY1YWU1NjQxNTRhMTExYThkMjBhNzVjYzc3XzExMg_1621b5f9-a267-4a92-bdf5-6e63c0cb0c8b">15,000,000</ix:nonFraction> units, at an offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDAvZnJhZzowNTQwNTVmNWFlNTY0MTU0YTExMWE4ZDIwYTc1Y2M3Ny90ZXh0cmVnaW9uOjA1NDA1NWY1YWU1NjQxNTRhMTExYThkMjBhNzVjYzc3XzE0Ng_7ac3fb2b-f7b6-4db3-89eb-4a3ea0bb2b39">10.00</ix:nonFraction> per unit, generating gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806" decimals="-5" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDAvZnJhZzowNTQwNTVmNWFlNTY0MTU0YTExMWE4ZDIwYTc1Y2M3Ny90ZXh0cmVnaW9uOjA1NDA1NWY1YWU1NjQxNTRhMTExYThkMjBhNzVjYzc3XzE4OA_d8449cc6-9e8f-4521-8bea-7f10f395854f">150.0</ix:nonFraction> million, and incurring offering costs of approximately $<ix:nonFraction unitRef="usd" contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806" decimals="-5" name="us-gaap:DeferredOfferingCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDAvZnJhZzowNTQwNTVmNWFlNTY0MTU0YTExMWE4ZDIwYTc1Y2M3Ny90ZXh0cmVnaW9uOjA1NDA1NWY1YWU1NjQxNTRhMTExYThkMjBhNzVjYzc3XzIzOA_a4569ee5-c632-43a4-a118-33a0cac9d134">13.8</ix:nonFraction> million, inclusive of $<ix:nonFraction unitRef="usd" contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806" decimals="-5" name="amci:SaleOfStockUnderwritingDiscounts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDAvZnJhZzowNTQwNTVmNWFlNTY0MTU0YTExMWE4ZDIwYTc1Y2M3Ny90ZXh0cmVnaW9uOjA1NDA1NWY1YWU1NjQxNTRhMTExYThkMjBhNzVjYzc3XzI1NQ_d03a30c5-a492-41c1-be1c-db1cc3df8c77">1.5</ix:nonFraction> million of underwriting discount, approximately $<ix:nonFraction unitRef="usd" contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806" decimals="-5" name="amci:DeferredUnderwritingCompensationNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDAvZnJhZzowNTQwNTVmNWFlNTY0MTU0YTExMWE4ZDIwYTc1Y2M3Ny90ZXh0cmVnaW9uOjA1NDA1NWY1YWU1NjQxNTRhMTExYThkMjBhNzVjYzc3XzI5OA_e7855184-4fa8-44f2-a501-8cf7587202f0">5.3</ix:nonFraction> million in deferred underwriting commissions, approximately $<ix:nonFraction unitRef="usd" contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806" decimals="-5" name="amci:ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDAvZnJhZzowNTQwNTVmNWFlNTY0MTU0YTExMWE4ZDIwYTc1Y2M3Ny90ZXh0cmVnaW9uOjA1NDA1NWY1YWU1NjQxNTRhMTExYThkMjBhNzVjYzc3XzM1Mw_189418b0-bd39-4787-a430-04588f29456a">6.5</ix:nonFraction> million in fair value of Class B common stock issued to Anchor Investors, and approximately $<ix:nonFraction unitRef="usd" contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806" decimals="-5" name="amci:SaleOfStockOtherOfferingCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDAvZnJhZzowNTQwNTVmNWFlNTY0MTU0YTExMWE4ZDIwYTc1Y2M3Ny90ZXh0cmVnaW9uOjA1NDA1NWY1YWU1NjQxNTRhMTExYThkMjBhNzVjYzc3XzQ0MA_2aade448-41d6-4ed4-bc8c-88b8d9c17a4c">0.5</ix:nonFraction> million in other offering costs. Each whole warrant entitles the holder to purchase <ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDAvZnJhZzowNTQwNTVmNWFlNTY0MTU0YTExMWE4ZDIwYTc1Y2M3Ny90ZXh0cmVnaW9uOjA1NDA1NWY1YWU1NjQxNTRhMTExYThkMjBhNzVjYzc3XzUxOQ_92cdb5a5-50cb-4ad6-9a25-e1127897be92">one</ix:nonFraction> share of Class A common stock at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="id44a938156574d23a69f5f980c896774_I20210806" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDAvZnJhZzowNTQwNTVmNWFlNTY0MTU0YTExMWE4ZDIwYTc1Y2M3Ny90ZXh0cmVnaW9uOjA1NDA1NWY1YWU1NjQxNTRhMTExYThkMjBhNzVjYzc3XzU2Ng_259f5bc0-3929-464f-9714-c2004db717a8">11.50</ix:nonFraction> per share, subject to adjustment (see Note 8). Certain qualified institutional buyers or institutional accredited investors (the &#8220;Anchor Investors&#8221;) purchased <ix:nonFraction unitRef="shares" contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806" decimals="INF" name="amci:OptionToPurchaseAdditionalUnitsGivenToInvestors" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDAvZnJhZzowNTQwNTVmNWFlNTY0MTU0YTExMWE4ZDIwYTc1Y2M3Ny90ZXh0cmVnaW9uOjA1NDA1NWY1YWU1NjQxNTRhMTExYThkMjBhNzVjYzc3XzcyOA_7967bc05-4117-46df-ac1d-30fe2faa47b4">15,480,000</ix:nonFraction> units in the initial public offering. None of the Anchor Investors are affiliated with any member of the Company&#8217;s management.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters had a <ix:nonNumeric contextRef="i9caa935ece004b9ab6c6caa6377836b9_D20210803-20210803" name="amci:OptionVestingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDAvZnJhZzowNTQwNTVmNWFlNTY0MTU0YTExMWE4ZDIwYTc1Y2M3Ny90ZXh0cmVnaW9uOjA1NDA1NWY1YWU1NjQxNTRhMTExYThkMjBhNzVjYzc3XzExODg_9004b6a6-621b-487a-a96a-77f8214311ff">45-day</ix:nonNumeric> option from the date of the underwriting agreement (August 3, 2021) to purchase up to an additional <ix:nonFraction unitRef="shares" contextRef="i9caa935ece004b9ab6c6caa6377836b9_D20210803-20210803" decimals="INF" name="amci:OptionToPurchaseAdditionalUnitsGivenToUnderwriters" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDAvZnJhZzowNTQwNTVmNWFlNTY0MTU0YTExMWE4ZDIwYTc1Y2M3Ny90ZXh0cmVnaW9uOjA1NDA1NWY1YWU1NjQxNTRhMTExYThkMjBhNzVjYzc3Xzk4OA_2a281dbc-94fd-45ea-b8bc-c8dbef01c41c">2,250,000</ix:nonFraction> units to cover over-allotments. On September 17, 2021, the over-allotment option expired unexercised, resulting in <ix:nonFraction unitRef="shares" contextRef="i0d95a7ae67054cae98cfee5d7bdc74d0_D20210917-20210917" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDAvZnJhZzowNTQwNTVmNWFlNTY0MTU0YTExMWE4ZDIwYTc1Y2M3Ny90ZXh0cmVnaW9uOjA1NDA1NWY1YWU1NjQxNTRhMTExYThkMjBhNzVjYzc3XzExMDY_bc7cd97d-ec67-44c8-b219-2094c266907a">562,500</ix:nonFraction> shares of Class B common stock that were subject to forfeiture to be forfeited.</span></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_103"></div><ix:continuation id="id85398d8d2084f2d96b474ba28122b81" continuedAt="if5ce1b243177422d8f1206533cad423f"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4 &#8212; Related Party Transactions</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Founder Shares</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2021, the Sponsor paid $<ix:nonFraction unitRef="usd" contextRef="i1d5d9aae93c24a62a9caf5acab5abecc_D20210129-20210129" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzk0_97f253e0-58e2-48b9-b8c0-57ed77a05e29">25,000</ix:nonFraction>, or approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="if2ebc1a8b07f4d3391509c2584f8f003_I20210129" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzExNQ_f89f3d98-0cda-4f80-82a9-3e14d67cbcc9">0.005</ix:nonFraction> per share, to cover certain offering costs in consideration for <ix:nonFraction unitRef="shares" contextRef="i08b6b03fda3a43f2bcbde1101ee39ff8_D20210129-20210129" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzE4Mg_2820bd45-d179-42aa-9f0a-6379ddb4a3ce">5,031,250</ix:nonFraction> shares of Class B common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i74ee1ef3f5f34200a3a86559aefbe48d_I20210129" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzIyNw_eb9ade99-8dc5-4d3a-bd53-98f34f987430">0.0001</ix:nonFraction>. In March 2021, the Sponsor transferred all of the founder shares it held to members of the Company&#8217;s board of directors, management team, and persons or entities affiliated with AMCI Group (the &#8220;initial shareholders&#8221;). Such shares were fully paid. On May 14, 2021, the Sponsor surrendered <ix:nonFraction unitRef="shares" contextRef="i8ba6d4f2129048179fa2e9c2275582f2_I20210514" decimals="INF" name="amci:NumberOfSharesSurrendered" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzUyMA_4df1a45c-003b-468a-956a-bee61505634d">718,750</ix:nonFraction> founder shares to the Company for no consideration, resulting in the Sponsor owning <ix:nonFraction unitRef="shares" contextRef="i8ba6d4f2129048179fa2e9c2275582f2_I20210514" decimals="INF" name="amci:AggregateNumberOfSharesOwned" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzYwNw_33434c7d-db51-4d7f-a71a-37b8d1017b72">4,312,500</ix:nonFraction> founder shares. Up to <ix:nonFraction unitRef="shares" contextRef="ibfb1e8d076954c04a1dbf3023d0849d7_I20211231" decimals="INF" name="amci:NumberOfSharesSubjectToForfeiture" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzYzMg_e9409684-db8d-4406-bf21-9998dc504ebc">562,500</ix:nonFraction> of the founder shares will be forfeited depending on the extent to which the underwriters&#8217; over-allotment is exercised. On September 17, 2021, the over-allotment option expired unexercised, resulting in <ix:nonFraction unitRef="shares" contextRef="ia65ba84b6b954a5385d3241cfcb6736d_I20210917" decimals="INF" name="amci:NumberOfSharesSubjectToForfeiture" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzgzOA_0f41b7d7-7186-45dd-9268-5525247e191a">562,500</ix:nonFraction> of the founder shares being forfeited.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In exchange for the Anchor Investors&#8217; participation in the initial public offering as described in Note 3, the Sponsor sold a total of <ix:nonFraction unitRef="shares" contextRef="ib652946365cc4c8c967e8a2df8bcdc17_D20210129-20210129" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzEwMTU_446b303f-cdd7-4de1-b364-3e2b97671821">780,000</ix:nonFraction> founder shares to the Anchor Investors. The Company determined that the fair value of these founder shares was approximately $<ix:nonFraction unitRef="usd" contextRef="ib652946365cc4c8c967e8a2df8bcdc17_D20210129-20210129" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzExNDM_b07a6b9f-f1ab-47c2-b8b4-5d428ed2cb25">6.5</ix:nonFraction> million (or approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="i2674980052ce4cc69be120b4e40c0013_I20210129" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzExNjQ_e27c9ead-b45d-4327-b8bb-a078207f2ed6">8.35</ix:nonFraction> per share) using a Monte Carlo simulation. The Company recognized the excess fair value of these founder shares, over the price sold to the Anchor Investors, as an expense of the initial public offering resulting in a charge against the carrying value of Class A common stock subject to possible redemption.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial stockholders have agreed not to transfer, assign or sell any of their founder shares and any Class A common stocks issuable upon conversion thereof until the earlier to occur of: (A) <ix:nonNumeric contextRef="ie7e91bd1f75d4961a01179e9753dc8da_D20210128-20211231" name="amci:RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzE2NzA_11fd7302-4bf0-4c6f-8078-ebd2c35aab4e">one year</ix:nonNumeric> after the completion of the initial business combination and (B) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction after the Company&#8217;s initial business combination that results in all of the Company&#8217;s stockholders having the right to exchange their Class A common stock for cash, securities or other property; except to certain permitted transferees and under certain circumstances (the &#8220;Lock-up&#8221;). Any permitted transferees will be subject to the same restrictions and other agreements of the company&#8217;s initial stockholders with respect to any founder shares. Notwithstanding the foregoing, the founder shares will be released from the Lock-up if the closing price of the Company&#8217;s Class A common stock equals or exceeds $<ix:nonFraction unitRef="usdPerShare" contextRef="ie7e91bd1f75d4961a01179e9753dc8da_D20210128-20211231" decimals="2" name="amci:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzI0NjA_6b63d458-c502-4baf-a8d7-bae61127add9">12.00</ix:nonFraction> per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any <ix:nonFraction unitRef="d" contextRef="ie7e91bd1f75d4961a01179e9753dc8da_D20210128-20211231" decimals="INF" name="amci:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzI1ODQ_00cb2590-a67a-4591-821e-a4c074ba6bef">20</ix:nonFraction> trading days within any <ix:nonFraction unitRef="d" contextRef="ie7e91bd1f75d4961a01179e9753dc8da_D20210128-20211231" decimals="INF" name="amci:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzI2MTE_23df0edf-ec7b-4f55-9ae6-09be9ebee70a">30</ix:nonFraction>-trading day period commencing at least <ix:nonNumeric contextRef="ie7e91bd1f75d4961a01179e9753dc8da_D20210128-20211231" name="amci:ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzI2NTM_a4ff6dfa-4f07-4f36-84eb-4e0594ec817b">150</ix:nonNumeric> days after the company&#8217;s initial business combination.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the period from January 28, 2021 (inception) through December 31, 2021</span></div></div><ix:continuation id="if5ce1b243177422d8f1206533cad423f" continuedAt="idd04b12f135b4963bc1413276d123ff2"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Private Placement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Simultaneously with the closing of the initial public offering, the Company&#8217;s Sponsor has purchased an aggregate of <ix:nonFraction unitRef="shares" contextRef="iba67ebbc3e2147e2a5a1f7dbbeab0ccd_I20210806" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzI4NDA_9e5c28ff-3e1d-4f43-ad73-3b480d2a32a7">3,500,000</ix:nonFraction> private placement warrants, each exercisable to purchase <ix:nonFraction unitRef="shares" contextRef="iba67ebbc3e2147e2a5a1f7dbbeab0ccd_I20210806" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzI5MDA_847e74bd-714b-4997-88b4-ecb5c1233340">one</ix:nonFraction> Class A common stock at $<ix:nonFraction unitRef="usdPerShare" contextRef="iba67ebbc3e2147e2a5a1f7dbbeab0ccd_I20210806" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzI5Mjc_5bc093cf-6963-4565-8b91-3de1b1e9e7aa">11.50</ix:nonFraction> per share, at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="iba67ebbc3e2147e2a5a1f7dbbeab0ccd_I20210806" decimals="2" name="amci:ClassOfWarrantOrRightPriceOfWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzI5NTU_506884db-1135-49c1-9adc-3db8e7642c6a">1.00</ix:nonFraction> per warrant, or $<ix:nonFraction unitRef="usd" contextRef="i98ebad46078d44259754e031d9c5bd6d_D20210806-20210806" decimals="0" name="us-gaap:ProceedsFromIssuanceOfWarrants" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzI5NzQ_f50187ba-7a85-4101-869f-c1a68e67b05b">3,500,000</ix:nonFraction> in the aggregate.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The private placement warrants will not be redeemable by the Company so long as they are held by the initial purchasers or their permitted transferees. The initial purchasers, or their permitted transferees, have the option to exercise the private placement warrants on a cashless basis. If the private placement warrants are held by holders other than initial purchasers or their permitted transferees, the private placement warrants will be redeemable by the Company and exercisable by the holders on the same basis as the warrants included in the units being sold in the initial public offering. Otherwise, the private placement warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in the initial public offering.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the private placement warrants are held by holders other than the Sponsor or its permitted transferees, the private placement warrants will be redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the units being sold in the initial public offering.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Loans and Advances</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2021, the Sponsor agreed to loan the Company up to $<ix:nonFraction unitRef="usd" contextRef="i75f3392af70e4d85aac3d65a530d4294_I20210129" decimals="0" name="amci:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzQxOTk_f303dd41-0924-48d8-abac-78bdd4d11c4d">300,000</ix:nonFraction> to be used for a portion of the expenses of the initial public offering (&#8220;Note&#8221;). This loan was non-interest bearing, unsecured and payable upon the closing of the initial public offering. In addition to the Note, the Sponsor of the Company also paid certain administrative expenses and offering costs on behalf of the Company. These advances were due on demand and were non-interest bearing. The Company repaid the note payable and advances in exchange for the issuance of private placement warrants.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in order to finance transaction costs in connection with an intended business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#8217;s officers and directors may, but are not obligated to, loan the Company funds as may be required on a non-interest basis (&#8220;Working Capital Loans&#8221;). If the Company completes the initial business combination, it will repay the Working Capital Loans. In the event that the initial business combination does not close, the Company may use a portion of the working capital held outside the trust account to repay the Working Capital Loans but no proceeds from the trust account would be used to repay the Working Capital Loans. Up to $<ix:nonFraction unitRef="usd" contextRef="ic448f6ee37eb44f9ac584c6527e1d94e_I20211231" decimals="0" name="amci:MaximumLoansConvertibleIntoWarrants" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzU0MDg_1666bd50-21a7-48d5-b39f-7013d57b6a02">1,500,000</ix:nonFraction> of such Working Capital Loans may be convertible into warrants of the post-business combination entity at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic448f6ee37eb44f9ac584c6527e1d94e_I20211231" decimals="2" name="amci:ClassOfWarrantOrRightPriceOfWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzU1Mjg_19c58e08-4228-4433-b348-98e817e1a789">1.00</ix:nonFraction> per warrant at the option of the lender. Such warrants would be identical to the private placement warrants. Except as set forth above, the terms of Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of December 31, 2021, the Company had <ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="0" name="amci:OutstandingWorkingCapitalLoans" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzU4Mzc_0b9da650-0ee5-4148-8694-5ab2e95ee4e2">no</ix:nonFraction> borrowings under the Working Capital Loans.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Administrative Service Fee</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the closing of the initial public offering, the Company will pay its Sponsor $<ix:nonFraction unitRef="usd" contextRef="ie077d272226547f6a11f29862ca333d6_D20210128-20211231" decimals="0" name="amci:RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzYwMDI_fc74b9d9-d5a6-43c1-abb8-8de5f1040869">10,000</ix:nonFraction> per month for office space, secretarial and administrative services provided to members of the management team. Upon completion of the initial business combination or the Company&#8217;s liquidation, the Company will cease paying these monthly fees. For the period from January 28, 2021 (inception) through December 31, 2021, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="ie077d272226547f6a11f29862ca333d6_D20210128-20211231" decimals="0" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzYzNDY_c1861287-670b-4334-8e10-33a553006753">50,000</ix:nonFraction> of such fees, included as general and administrative fees &#8212; related party on the accompanying statement of operations. As of December 31, 2021, approximately $<ix:nonFraction unitRef="usd" contextRef="ifcd72b5b1194408cba4cb6838372ac02_I20211231" decimals="0" name="us-gaap:DueToRelatedPartiesCurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzY1MDc_52d7807b-d61f-4cb3-ade2-6d5373d66723">50,000</ix:nonFraction> of such fees are included as due to related party on the accompanying balance sheet.</span></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_106"></div><ix:continuation id="i1966a5c37d3543f9921cfb34ea76605f" continuedAt="i26f05b6ea1a34c478e34883380cfc30b"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5 &#8212; Commitments and Contingencies</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Registration Rights</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of the (i) founder shares, which were issued in a private placement prior to the closing of the initial public offering, (ii) private placement warrants, which were issued in a private placement simultaneously with the closing of the initial public offering and the shares of Class A common stock underlying such private placement </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the period from January 28, 2021 (inception) through December 31, 2021</span></div></div><ix:continuation id="i26f05b6ea1a34c478e34883380cfc30b" continuedAt="ia2e46c1b322c4113b5462415c9a4e55a"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">warrants and (iii) private placement warrants that may be issued upon conversion of Working Capital Loans will have registration rights to require the Company to register a sale of any of its securities held by them prior to the consummation of the initial business combination pursuant to a registration rights agreement to be signed prior to or on the effective date of the initial public offering. The holders of these securities are entitled to make up to <ix:nonFraction unitRef="item" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="amci:MaximumNumberOfDemandsForRegistrationOfSecurities" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDYvZnJhZzoyYTQ2OTAwZGUyNzM0MDhiODZlN2RiYWE5YWQwZmVmOS90ZXh0cmVnaW9uOjJhNDY5MDBkZTI3MzQwOGI4NmU3ZGJhYTlhZDBmZWY5Xzg2Nw_61fd37fc-0508-45ec-9f05-e622685f1989">three</ix:nonFraction> demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent to the Company&#8217;s completion of its initial business combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. In addition, the Anchor Investors will, upon receipt of their founder shares, execute a registration rights agreement with respect to their founder shares.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Underwriting Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted the underwriters a <ix:nonNumeric contextRef="i5c60188ae1f64a00af376413ca3e4b68_D20210128-20211231" name="amci:OptionVestingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDYvZnJhZzoyYTQ2OTAwZGUyNzM0MDhiODZlN2RiYWE5YWQwZmVmOS90ZXh0cmVnaW9uOjJhNDY5MDBkZTI3MzQwOGI4NmU3ZGJhYTlhZDBmZWY5XzIwODg_cb6a484c-631c-47f3-83aa-6db32dc823c9">45-day</ix:nonNumeric> option from the date of the underwriting agreement to purchase up to an additional <ix:nonFraction unitRef="shares" contextRef="i5c60188ae1f64a00af376413ca3e4b68_D20210128-20211231" decimals="INF" name="amci:OptionToPurchaseAdditionalUnitsGivenToUnderwriters" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDYvZnJhZzoyYTQ2OTAwZGUyNzM0MDhiODZlN2RiYWE5YWQwZmVmOS90ZXh0cmVnaW9uOjJhNDY5MDBkZTI3MzQwOGI4NmU3ZGJhYTlhZDBmZWY5XzE1NjU_97ba6ac9-e271-4e86-be6a-a43d9358ec0a">2,250,000</ix:nonFraction> units to cover over-allotments, if any. On September 17, 2021, the over-allotment option expired unexercised, resulting in the forfeiture of <ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="amci:NumberOfSharesSubjectToForfeiture" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDYvZnJhZzoyYTQ2OTAwZGUyNzM0MDhiODZlN2RiYWE5YWQwZmVmOS90ZXh0cmVnaW9uOjJhNDY5MDBkZTI3MzQwOGI4NmU3ZGJhYTlhZDBmZWY5XzE3MDk_2a71fc0e-fafc-4fa1-8e49-22a027c1b803">562,500</ix:nonFraction> shares of founder shares.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters were paid an underwriting discount of one percent (<ix:nonFraction unitRef="number" contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231" decimals="2" name="amci:UnderwritingDiscountPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDYvZnJhZzoyYTQ2OTAwZGUyNzM0MDhiODZlN2RiYWE5YWQwZmVmOS90ZXh0cmVnaW9uOjJhNDY5MDBkZTI3MzQwOGI4NmU3ZGJhYTlhZDBmZWY5XzE4MDY_812d3e75-50eb-48f8-9bc6-b82c7c5203c4">1</ix:nonFraction>%) of the gross proceeds of the initial public offering, or $<ix:nonFraction unitRef="usd" contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231" decimals="0" name="amci:UnderwriterCashDiscount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDYvZnJhZzoyYTQ2OTAwZGUyNzM0MDhiODZlN2RiYWE5YWQwZmVmOS90ZXh0cmVnaW9uOjJhNDY5MDBkZTI3MzQwOGI4NmU3ZGJhYTlhZDBmZWY5XzE4Njc_485c661b-c150-4472-a1a4-e23b01869dc4">1,500,000</ix:nonFraction>. Additionally, the underwriters will be entitled to a deferred underwriting discount of <ix:nonFraction unitRef="number" contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231" decimals="3" name="amci:DeferredUnderwritingDiscountPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDYvZnJhZzoyYTQ2OTAwZGUyNzM0MDhiODZlN2RiYWE5YWQwZmVmOS90ZXh0cmVnaW9uOjJhNDY5MDBkZTI3MzQwOGI4NmU3ZGJhYTlhZDBmZWY5XzE5NTg_83e3330c-404b-4881-814e-6a758cafc556">3.5</ix:nonFraction>% of the gross proceeds, or $<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="0" name="amci:DeferredUnderwritingDiscounts" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDYvZnJhZzoyYTQ2OTAwZGUyNzM0MDhiODZlN2RiYWE5YWQwZmVmOS90ZXh0cmVnaW9uOjJhNDY5MDBkZTI3MzQwOGI4NmU3ZGJhYTlhZDBmZWY5XzE5ODc_fb7ff77c-d02f-4b9b-a010-a5db7fadfbfd">5,250,000</ix:nonFraction>, of the initial public offering upon the completion of the Company&#8217;s initial business combination.</span></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_109"></div><ix:continuation id="i3b902bfdc27d48969c2107019ea73a06" continuedAt="i485fc60867a94f65b9cfe6199d00f687"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6 &#8212; Class A Common Stock Subject to Possible Redemption</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of future events. The Company is authorized to issue <ix:nonFraction unitRef="shares" contextRef="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDkvZnJhZzo2MWVmOGFmNjBmNDg0NTM4YWI1OWZlMWRmZDU5NmFhZi90ZXh0cmVnaW9uOjYxZWY4YWY2MGY0ODQ1MzhhYjU5ZmUxZGZkNTk2YWFmXzI3Nw_cb32a20a-a0ce-4160-873b-cf047aa529d4">280,000,000</ix:nonFraction> shares of Class A common stock with a par value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231" decimals="INF" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDkvZnJhZzo2MWVmOGFmNjBmNDg0NTM4YWI1OWZlMWRmZDU5NmFhZi90ZXh0cmVnaW9uOjYxZWY4YWY2MGY0ODQ1MzhhYjU5ZmUxZGZkNTk2YWFmXzMzMQ_10591853-17e7-4573-95a5-802c12a91ebc">0.0001</ix:nonFraction> per share. Holders of the Company&#8217;s Class A common stock are entitled to <ix:nonFraction unitRef="vote" contextRef="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231" decimals="INF" name="amci:TemporaryEquityNumberOfVotesPerShare" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDkvZnJhZzo2MWVmOGFmNjBmNDg0NTM4YWI1OWZlMWRmZDU5NmFhZi90ZXh0cmVnaW9uOjYxZWY4YWY2MGY0ODQ1MzhhYjU5ZmUxZGZkNTk2YWFmXzQwNw_739434d1-8362-420d-88cb-4ddc86819d1b">one</ix:nonFraction> vote for each share. As of December 31, 2021, there were <ix:nonFraction unitRef="shares" contextRef="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDkvZnJhZzo2MWVmOGFmNjBmNDg0NTM4YWI1OWZlMWRmZDU5NmFhZi90ZXh0cmVnaW9uOjYxZWY4YWY2MGY0ODQ1MzhhYjU5ZmUxZGZkNTk2YWFmXzQ2Nw_da267036-7070-4b6e-9fc9-da49eaef76d9">15,000,000</ix:nonFraction> shares of Class A common stock outstanding subject to possible redemption and are classified outside of permanent equity in the balance sheet.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Class A common stock subject to possible redemption reflected on the balance sheet is reconciled in the following table:</span></div><div style="margin-bottom:9pt"><ix:continuation id="ie12c87e42f5140d980b3c07ffa527540" continuedAt="ib6eb98b7687747308c8ffe8975871220"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross proceeds from Initial Public Offering</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib178386587034322a4ea05a95f29a04c_D20210128-20211231" decimals="0" name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDkvZnJhZzo2MWVmOGFmNjBmNDg0NTM4YWI1OWZlMWRmZDU5NmFhZi90YWJsZToxYzNkMGRjMDdkMzc0NTQyYjE4N2VlMzAxMDIyOWQ3MC90YWJsZXJhbmdlOjFjM2QwZGMwN2QzNzQ1NDJiMTg3ZWUzMDEwMjI5ZDcwXzAtMS0xLTEtOTA2MDk_399dd35f-19d7-40e4-9f92-2af87aef6946">150,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of Public Warrants at issuance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib178386587034322a4ea05a95f29a04c_D20210128-20211231" decimals="0" sign="-" name="amci:TemporaryEquityProceedsAllocatedToWarrants" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDkvZnJhZzo2MWVmOGFmNjBmNDg0NTM4YWI1OWZlMWRmZDU5NmFhZi90YWJsZToxYzNkMGRjMDdkMzc0NTQyYjE4N2VlMzAxMDIyOWQ3MC90YWJsZXJhbmdlOjFjM2QwZGMwN2QzNzQ1NDJiMTg3ZWUzMDEwMjI5ZDcwXzItMS0xLTEtOTA2MDk_288fd6b4-c4e9-47b9-9e15-c4a2fd345f5d">5,100,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Offering costs allocated to Class A common stock subject to possible redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib178386587034322a4ea05a95f29a04c_D20210128-20211231" decimals="0" sign="-" name="amci:TemporaryEquityIssuanceCosts" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDkvZnJhZzo2MWVmOGFmNjBmNDg0NTM4YWI1OWZlMWRmZDU5NmFhZi90YWJsZToxYzNkMGRjMDdkMzc0NTQyYjE4N2VlMzAxMDIyOWQ3MC90YWJsZXJhbmdlOjFjM2QwZGMwN2QzNzQ1NDJiMTg3ZWUzMDEwMjI5ZDcwXzMtMS0xLTEtOTA2MDk_61f89360-b017-4b67-9893-a023da1b16dc">13,306,092</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion on Class A common stock subject to possible redemption amount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib178386587034322a4ea05a95f29a04c_D20210128-20211231" decimals="0" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDkvZnJhZzo2MWVmOGFmNjBmNDg0NTM4YWI1OWZlMWRmZDU5NmFhZi90YWJsZToxYzNkMGRjMDdkMzc0NTQyYjE4N2VlMzAxMDIyOWQ3MC90YWJsZXJhbmdlOjFjM2QwZGMwN2QzNzQ1NDJiMTg3ZWUzMDEwMjI5ZDcwXzUtMS0xLTEtOTA2MDk_b90b13e7-94c8-4165-8f9d-dfe9bdd19d28">18,406,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock subject to possible redemption</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231" decimals="0" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDkvZnJhZzo2MWVmOGFmNjBmNDg0NTM4YWI1OWZlMWRmZDU5NmFhZi90YWJsZToxYzNkMGRjMDdkMzc0NTQyYjE4N2VlMzAxMDIyOWQ3MC90YWJsZXJhbmdlOjFjM2QwZGMwN2QzNzQ1NDJiMTg3ZWUzMDEwMjI5ZDcwXzYtMS0xLTEtOTA2MDk_e8e1ab87-e788-4f7b-aae8-8f5dce5ef68e">150,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib82e114cd19f45afae73e7a64e42f208_112"></div><ix:continuation id="i527e400e859b485d947a6e128cb5d50a" continuedAt="i2ff16c5bf5ba44dfb389d55d473e309e"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7 &#8212; Stockholders&#8217; Deficit</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Preferred Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; The Company is authorized to issue <ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTIvZnJhZzpkYTgxZjE4NWVjOTA0M2M4YmRiM2ZiOWE0Nzg3YzYxMy90ZXh0cmVnaW9uOmRhODFmMTg1ZWM5MDQzYzhiZGIzZmI5YTQ3ODdjNjEzXzg5_9dab5856-d98d-4d42-a24c-724e07a82917">1,000,000</ix:nonFraction> shares of preferred stock with a par value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTIvZnJhZzpkYTgxZjE4NWVjOTA0M2M4YmRiM2ZiOWE0Nzg3YzYxMy90ZXh0cmVnaW9uOmRhODFmMTg1ZWM5MDQzYzhiZGIzZmI5YTQ3ODdjNjEzXzEzOA_6bec9ee1-7732-4cf7-811b-0a024d512436">0.0001</ix:nonFraction> and provides that shares of preferred stock may be issued from time to time in one or more series. The Company&#8217;s board of directors will be authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. As of December 31, 2021, there were <ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTIvZnJhZzpkYTgxZjE4NWVjOTA0M2M4YmRiM2ZiOWE0Nzg3YzYxMy90ZXh0cmVnaW9uOmRhODFmMTg1ZWM5MDQzYzhiZGIzZmI5YTQ3ODdjNjEzXzU2Mg_2f083aa9-2469-4b1b-8b9d-673273724734">no</ix:nonFraction> shares of preferred stock issued or outstanding.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Class A Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The Company is authorized to issue <ix:nonFraction unitRef="shares" contextRef="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTIvZnJhZzpkYTgxZjE4NWVjOTA0M2M4YmRiM2ZiOWE0Nzg3YzYxMy90ZXh0cmVnaW9uOmRhODFmMTg1ZWM5MDQzYzhiZGIzZmI5YTQ3ODdjNjEzXzY3Mg_1e2a3d24-ceeb-4ffb-a902-d2a76401f01b">280,000,000</ix:nonFraction> shares of Class A common stock with a par value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTIvZnJhZzpkYTgxZjE4NWVjOTA0M2M4YmRiM2ZiOWE0Nzg3YzYxMy90ZXh0cmVnaW9uOmRhODFmMTg1ZWM5MDQzYzhiZGIzZmI5YTQ3ODdjNjEzXzcyNg_2d6bef78-6c23-41bf-9eae-b34b11518902">0.0001</ix:nonFraction> per share. As of December 31, 2021, there were <ix:nonFraction unitRef="shares" contextRef="i0a43243fe73e4e0982e02d8804f9029b_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTIvZnJhZzpkYTgxZjE4NWVjOTA0M2M4YmRiM2ZiOWE0Nzg3YzYxMy90ZXh0cmVnaW9uOmRhODFmMTg1ZWM5MDQzYzhiZGIzZmI5YTQ3ODdjNjEzXzc3Ng_ab08940d-ac4f-4068-ad2e-844ad77ef95b">15,000,000</ix:nonFraction> shares of Class A common stock issued and outstanding, all of which were subject to possible redemption and are classified as temporary equity (see Note 6).</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the period from January 28, 2021 (inception) through December 31, 2021</span></div></div><ix:continuation id="i2ff16c5bf5ba44dfb389d55d473e309e" continuedAt="if2a76b57f6cd4956945dbce262155f09"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Class B Common Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; The Company is authorized to issue <ix:nonFraction unitRef="shares" contextRef="i246d06060759490897b705c5ed7fc8f0_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTIvZnJhZzpkYTgxZjE4NWVjOTA0M2M4YmRiM2ZiOWE0Nzg3YzYxMy90ZXh0cmVnaW9uOmRhODFmMTg1ZWM5MDQzYzhiZGIzZmI5YTQ3ODdjNjEzXzk5NA_d615b093-b044-4fdd-ac14-1b7f6e282a3e">20,000,000</ix:nonFraction> Class B common stock with a par value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i246d06060759490897b705c5ed7fc8f0_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTIvZnJhZzpkYTgxZjE4NWVjOTA0M2M4YmRiM2ZiOWE0Nzg3YzYxMy90ZXh0cmVnaW9uOmRhODFmMTg1ZWM5MDQzYzhiZGIzZmI5YTQ3ODdjNjEzXzEwMzg_3bd025c5-1073-4629-95cd-0df48ef00832">0.0001</ix:nonFraction> per share. As of December 31, 2021, there were <ix:nonFraction unitRef="shares" contextRef="i246d06060759490897b705c5ed7fc8f0_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTIvZnJhZzpkYTgxZjE4NWVjOTA0M2M4YmRiM2ZiOWE0Nzg3YzYxMy90ZXh0cmVnaW9uOmRhODFmMTg1ZWM5MDQzYzhiZGIzZmI5YTQ3ODdjNjEzXzEwODg_dae399c9-1e14-4c55-9889-cf3bfbf0f16a">3,750,000</ix:nonFraction> shares of Class B common stock issued and outstanding (see Note 4).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of the Company&#8217;s stockholders except as required by law. Unless specified in the Company&#8217;s amended and restated certificate of incorporation, or as required by applicable provisions of the Delaware General Corporation Law (&#8220;DGCL&#8221;) or applicable stock exchange rules, the affirmative vote of a majority of the Company&#8217;s shares of common stock that are voted is required to approve any such matter voted on by its stockholders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Class B common stock will automatically convert into shares of Class A common stock concurrently with or immediately following the consummation of the initial business combination on a <ix:nonFraction unitRef="shares" contextRef="iefc421e312514841a1adc71514c3bb9a_D20210128-20211231" decimals="INF" name="us-gaap:ConversionOfStockSharesIssued1" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTIvZnJhZzpkYTgxZjE4NWVjOTA0M2M4YmRiM2ZiOWE0Nzg3YzYxMy90ZXh0cmVnaW9uOmRhODFmMTg1ZWM5MDQzYzhiZGIzZmI5YTQ3ODdjNjEzXzE5MTQ_83d93f16-749e-4e9a-b8a0-22225b53dfde">one</ix:nonFraction>-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in connection with the initial business combination, the number of shares of Class A common stock issuable upon conversion of all founder shares will equal, in the aggregate, on an as-converted basis, <ix:nonFraction unitRef="number" contextRef="iefc421e312514841a1adc71514c3bb9a_D20210128-20211231" decimals="0" name="amci:ConvertibleStockConversionRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTIvZnJhZzpkYTgxZjE4NWVjOTA0M2M4YmRiM2ZiOWE0Nzg3YzYxMy90ZXh0cmVnaW9uOmRhODFmMTg1ZWM5MDQzYzhiZGIzZmI5YTQ3ODdjNjEzXzI0MDg_f75f0457-fc32-450f-9ff5-02ee0fcf906e">20</ix:nonFraction>% of the total number of shares of Class A common stock outstanding after such conversion (after giving effect to any redemptions of shares of Class A common stock by public stockholders), including the total number of shares of Class A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial business combination, excluding any shares of Class A common stock or equity-linked securities or rights exercisable for or convertible into shares of Class A common stock issued, or to be issued, to any seller in the initial business combination and any private placement warrants issued to the Sponsor, officers or directors upon conversion of working capital loans, provided that such conversion of founder shares will never occur on a less than <ix:nonFraction unitRef="shares" contextRef="iefc421e312514841a1adc71514c3bb9a_D20210128-20211231" decimals="INF" name="us-gaap:ConversionOfStockSharesIssued1" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTIvZnJhZzpkYTgxZjE4NWVjOTA0M2M4YmRiM2ZiOWE0Nzg3YzYxMy90ZXh0cmVnaW9uOmRhODFmMTg1ZWM5MDQzYzhiZGIzZmI5YTQ3ODdjNjEzXzMzMjU_c2504a81-7ccd-4710-9f24-7cd4599eec2e">one</ix:nonFraction>-for-one basis.</span></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_115"></div><ix:continuation id="ia56ff02ffa214c2c919cd2896adbf7c6" continuedAt="i58f8862fd5b14322a39dd1587d877a89"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8 &#8212; Warrants</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, in connection with the initial public offering, the Company has <ix:nonFraction unitRef="shares" contextRef="i98b54305564e42f9abfa073cb3e4947b_I20211231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzExMg_3698ec48-aa2b-4f0f-beca-6d02fa6accce">7,500,000</ix:nonFraction> public warrants and <ix:nonFraction unitRef="shares" contextRef="i9c30db48f9bb482b9cb45b5c2227dd57_I20211231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzEzNQ_10574a47-36e7-4c80-9822-162ebe33723b">3,500,000</ix:nonFraction> private placement warrants outstanding.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each whole warrant entitles the registered holder to purchase <ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzI0MA_1471caca-7776-44ee-9cf3-65fc5f9a2cf6">one</ix:nonFraction> share of Class A common stock at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="2" name="amci:ClassOfWarrantOrRightPriceOfWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzI4Nw_5b638a48-b98d-4c3a-be97-0e3118d16bb0">11.50</ix:nonFraction> per share, subject to adjustment as discussed below, at any time commencing <ix:nonNumeric contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231" name="amci:WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzM2Ng_0622eb0e-f3c6-4053-b77b-779a68d2dfba">30</ix:nonNumeric> days after the completion of the initial business combination, provided that the Company has an effective registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement) and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder. The warrants will expire <ix:nonNumeric contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231" name="amci:MaximumThresholdPeriodForFilingRegistrationStatementAfterBusinessCombination" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2Xzk3MQ_32515392-b4d9-48af-9e20-1e04870aaca5">five years</ix:nonNumeric> after the completion of the Company&#8217;s initial business combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreed that as soon as practicable, but in no event later than fifteen (<ix:nonNumeric contextRef="i77e83a23de6644e3be03c1d9c1e36370_D20210128-20211231" name="amci:PeriodForFillingRegistrationStatementAfterBusinessCombination" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzEyMDc_dfef4d29-51b7-4122-9116-11dd3dfb28a6">15</ix:nonNumeric>) business days after the closing of the initial business combination, it will use its best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A common stock issuable upon exercise of the warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the sixtieth (<ix:nonNumeric contextRef="i77e83a23de6644e3be03c1d9c1e36370_D20210128-20211231" name="amci:PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzE4OTg_f7e3c3ce-e919-48c2-9ab4-cce99c5d2dae">60</ix:nonNumeric>th) business day after the closing of the initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Company&#8217;s Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a &#8220;covered security&#8221; under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of public warrants who </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the period from January 28, 2021 (inception) through December 31, 2021</span></div></div><ix:continuation id="i58f8862fd5b14322a39dd1587d877a89"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">exercise their warrants to do so on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, it will not be required to file or maintain in effect a registration statement, and in the event the Company do not so elect, it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redemption of warrants when the price per share of Class A common stock equals or exceeds $<ix:nonFraction unitRef="usdPerShare" contextRef="i3cb1ba206598437fb974dd69c2b87e0f_D20210128-20211231" decimals="2" name="amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzMxMjI_44019d24-d32d-4cab-b9ac-28922a2fc7ce">18.00</ix:nonFraction>.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once the warrants become exercisable, the Company may redeem the outstanding warrants:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in whole and not in part;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i3cb1ba206598437fb974dd69c2b87e0f_D20210128-20211231" decimals="2" name="amci:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzMyNTM_530eb54b-f8c7-4da4-9c7e-85c0554a3515">0.01</ix:nonFraction> per warrant;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">upon a minimum of <ix:nonNumeric contextRef="i3cb1ba206598437fb974dd69c2b87e0f_D20210128-20211231" name="amci:RedemptionPeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzMyODc_60100c42-e0f1-4bd4-a21b-c1465cd2edf7">30</ix:nonNumeric> days&#8217; prior written notice of redemption to each warrant holder; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if, and only if, the closing price of the Class A common stock equals or exceeds $<ix:nonFraction unitRef="usdPerShare" contextRef="i3cb1ba206598437fb974dd69c2b87e0f_D20210128-20211231" decimals="2" name="amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzM0MzU_9cc9a2c9-18e3-4364-bb85-898d297e9676">18.00</ix:nonFraction> per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading &#8220;&#8212; Warrants &#8212; Public Stockholders&#8217; Warrants &#8212; Anti-Dilution Adjustments&#8221;) for any <ix:nonNumeric contextRef="i3cb1ba206598437fb974dd69c2b87e0f_D20210128-20211231" name="amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzM2NzI_13365139-9389-42f7-8dcc-1e52f18b3f2e">20</ix:nonNumeric> trading days within a <ix:nonNumeric contextRef="i3cb1ba206598437fb974dd69c2b87e0f_D20210128-20211231" name="amci:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzM2OTc_5353c83a-7eb6-4da5-a581-1ac10f304a0e">30</ix:nonNumeric>-trading day period ending three trading days before we send the notice of redemption to the warrant holders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redemption of warrants when the price per share of Class A common stock equals or exceeds $<ix:nonFraction unitRef="usdPerShare" contextRef="if77b5c86cfcc4c03a7007e9a9266feb2_D20210128-20211231" decimals="2" name="amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzM4OTk_0185f904-7ebf-4083-9575-42125ea51cf7">10.00</ix:nonFraction>.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once the warrants become exercisable, the Company may redeem the outstanding warrants:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in whole and not in part;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at $<ix:nonFraction unitRef="usdPerShare" contextRef="if77b5c86cfcc4c03a7007e9a9266feb2_D20210128-20211231" decimals="2" name="amci:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzQwMTk_d59b0d47-ea9e-4f73-9bfd-2aba13c90c1e">0.10</ix:nonFraction> per warrant upon a minimum of <ix:nonNumeric contextRef="if77b5c86cfcc4c03a7007e9a9266feb2_D20210128-20211231" name="amci:RedemptionPeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzQwNTI_9f068794-5924-4f79-a92d-a0cce4b88b75">30</ix:nonNumeric> days&#8217; prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table below, based on the redemption date and the &#8220;fair market value&#8221; (as defined below) of our Class A common stock except as otherwise described below; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if, and only if, the closing price of our Class A common stock equals or exceeds $<ix:nonFraction unitRef="usdPerShare" contextRef="if77b5c86cfcc4c03a7007e9a9266feb2_D20210128-20211231" decimals="2" name="amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzQ0OTc_e0e68020-dd30-49e8-8425-a5a5883c9818">10.00</ix:nonFraction> per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading &#8220;&#8212; Warrants &#8212; Public Stockholders&#8217; Warrants &#8212; Anti-Dilution Adjustments&#8221;) for any <ix:nonNumeric contextRef="if77b5c86cfcc4c03a7007e9a9266feb2_D20210128-20211231" name="amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzQ3NDE_a8689e54-7fdc-4961-8c1b-b110c01ae1f7">20</ix:nonNumeric> trading days within the <ix:nonNumeric contextRef="if77b5c86cfcc4c03a7007e9a9266feb2_D20210128-20211231" name="amci:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzQ3Njg_80fd0e8f-5477-4c95-a1c9-aa4ae9c5989a">30</ix:nonNumeric>-trading day period ending three trading days before we send the notice of redemption to the warrant holders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if (x) the Company issue additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of our initial business combination at an issue price or effective issue price of less than $<ix:nonFraction unitRef="usdPerShare" contextRef="i182c81dada5746a896432e0206ca7183_I20211231" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzUxNDA_d94f9ddd-8c84-47a8-8ea9-1a6ec848c081">9.20</ix:nonFraction> per share (with such issue price or effective issue price to be determined in good faith by the Company&#8217;s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any founder shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the &#8220;Newly Issued Price&#8221;), (y) the aggregate gross proceeds from such issuances represent more than <ix:nonFraction unitRef="number" contextRef="i87ed9aa6359e4e9da28c6fd65b021373_D20210128-20211231" decimals="2" name="amci:PercentageOfGrossProceedsOnTotalEquityProceed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzU1Njc_4cf41e73-12ad-4e4c-befe-00cf9a2da874">60</ix:nonFraction>% of the total equity proceeds, and interest thereon, available for the funding of our initial business combination on the date of the consummation of the initial business combination (net of redemptions), and (z) the volume weighted average trading price of the Company&#8217;s Class A common stock during the <ix:nonFraction unitRef="d" contextRef="i87ed9aa6359e4e9da28c6fd65b021373_D20210128-20211231" decimals="INF" name="amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDaysSource2" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzU4NzM_9b13b6ff-f6da-470e-b325-864e497ea907">20</ix:nonFraction> trading day period starting on the trading day prior to the day on which the Company consummate the initial business combination (such price, the &#8220;Market Value&#8221;) is below $<ix:nonFraction unitRef="usdPerShare" contextRef="i182c81dada5746a896432e0206ca7183_I20211231" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzYwNDc_e865d953-90e2-4e27-bd19-1f890b4d8a95">9.20</ix:nonFraction> per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to <ix:nonFraction unitRef="number" contextRef="i3cb1ba206598437fb974dd69c2b87e0f_D20210128-20211231" decimals="2" name="amci:ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzYxNTA_26a9dbda-cd58-400d-a463-31c8da138e2d">115</ix:nonFraction>% of the higher of the Market Value and the Newly Issued Price, the $<ix:nonFraction unitRef="usdPerShare" contextRef="i3cb1ba206598437fb974dd69c2b87e0f_D20210128-20211231" decimals="2" name="amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzYyMTk_474ed319-df46-4721-b3c4-d7fed8dadf38">18.00</ix:nonFraction> per share redemption trigger price described above under &#8220;&#8212; Redemption of warrants when the price per share of Class A common stock equals or exceeds $<ix:nonFraction unitRef="usdPerShare" contextRef="i3cb1ba206598437fb974dd69c2b87e0f_D20210128-20211231" decimals="2" name="amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzYzNzI_580b4e05-e854-479b-8d53-a2113e0d1ec0">18.00</ix:nonFraction>&#8221; will be adjusted (to the nearest cent) to be equal to <ix:nonFraction unitRef="number" contextRef="if77b5c86cfcc4c03a7007e9a9266feb2_D20210128-20211231" decimals="2" name="amci:ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzY0MzA_aa2191da-7eb2-427a-8521-6ba27ab474be">180</ix:nonFraction>% of the higher of the Market Value and the Newly Issued Price, and the $<ix:nonFraction unitRef="usdPerShare" contextRef="if77b5c86cfcc4c03a7007e9a9266feb2_D20210128-20211231" decimals="2" name="amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzY1MDM_a306ab78-eecf-4e14-9084-3d92092902fe">10.00</ix:nonFraction> per share redemption trigger price described above under &#8220;&#8212; Redemption of warrants when the price per share of Class A common stock equals or exceeds $<ix:nonFraction unitRef="usdPerShare" contextRef="if77b5c86cfcc4c03a7007e9a9266feb2_D20210128-20211231" decimals="2" name="amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzY2NTY_31068f17-1130-410b-9afd-c22ba3cb4dff">10.00</ix:nonFraction>&#8221; will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-39</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_118"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the period from January 28, 2021 (inception) through December 31, 2021</span></div></div><ix:continuation id="i547feb09bd32410d983903bbe842cd41" continuedAt="ia6ea627c6b12436384c96984bb4052a2"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9 &#8212; Fair Value Measurement </span></div><ix:continuation id="i0a5a6478df8a4fb1b8d683dbdac7e152" continuedAt="id5a89e767fcc4a0aa63ef36831754f3e"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information as of December 31, 2021 about the Company&#8217;s financial assets and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held in Trust Account</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i946a08fcd3a04e65862611981f20e270_I20211231" decimals="0" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZToxMzVmMjM0MDk3NzM0MjIzYjg4ODM3NzkzNDk2MGZhYi90YWJsZXJhbmdlOjEzNWYyMzQwOTc3MzQyMjNiODg4Mzc3OTM0OTYwZmFiXzMtMi0xLTEtOTA2MDk_0f22c5bf-225d-4b52-83b1-928d66f881fd">150,006,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities &#8211; Public Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i818e11a86037425d8b4e148caf3f101c_I20211231" decimals="0" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZToxMzVmMjM0MDk3NzM0MjIzYjg4ODM3NzkzNDk2MGZhYi90YWJsZXJhbmdlOjEzNWYyMzQwOTc3MzQyMjNiODg4Mzc3OTM0OTYwZmFiXzUtMi0xLTEtOTA2MDk_9358140b-71bc-4b76-b62c-bc01c7f82fde">3,825,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities &#8211; Private Placement Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if33c5b343220431f8fa1664c765aaf71_I20211231" decimals="0" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZToxMzVmMjM0MDk3NzM0MjIzYjg4ODM3NzkzNDk2MGZhYi90YWJsZXJhbmdlOjEzNWYyMzQwOTc3MzQyMjNiODg4Mzc3OTM0OTYwZmFiXzYtNi0xLTEtOTA2MDk_b08822b7-0fd9-451f-968d-6ad9e73de630">1,785,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transfers to/from Levels 1, 2 and 3 are recognized at the beginning of the reporting period. The estimated fair value of public warrants was transferred from a Level 3 fair value measurement to a Level 1 measurement, when the public warrants were separately listed and traded in September 2021. There were no other transfers between levels in the period from January 28, 2021 (inception) through December 31, 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 assets include investments in mutual funds invested in U.S. government securities and derivative warrant liabilities (public warrants). The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For periods where no observable traded price is available, the fair value of the public warrants has been estimated using a Monte-Carlo simulation model and the private placement warrants has been estimated using a Black-Scholes option pricing model. For periods subsequent to the detachment of the public warrants from the units, the fair value of the public warrants is based on the observable listed price for such warrants. The estimated fair value of the public and private placement warrants, prior to the public warrants being traded in an active market, was determined using Level 3 inputs. Inherent in a Monte-Carlo simulation and Black-Scholes option pricing model are assumptions related to the unit price, expected volatility, risk-free interest rate, term to expiration, and dividend yield. The unit price is based on the publicly traded price of the units as of the measurement date. The Company estimated the volatility for the public and private placement warrants based on the implied volatility from the traded prices of warrants issued by other special purpose acquisition companies. The risk-free interest rate is based on interpolated U.S. Treasury rates, commensurate with a similar term to the public and private placement warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. Finally, the Company does not anticipate paying a dividend. Any changes in these assumptions can change the valuation significantly.</span></div><ix:continuation id="i8c293ebfd4044fd8a2923a4e43b474b0" continuedAt="i9be795be447041c0a402bcedbee506dc"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of <br/>December 31, 2021 </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of <br/>August 6, 2021 </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia5b0bb5d02764693b9a25febf0a6032b_I20211231" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZToxNDAxMGQ4NWY0ZTQ0ZjVjYWUxYjc0Yzg5ZjVjYTNmYS90YWJsZXJhbmdlOjE0MDEwZDg1ZjRlNDRmNWNhZTFiNzRjODlmNWNhM2ZhXzEtMS0xLTEtOTA2MDk_53208eea-da05-4e48-8a03-9dc64d04ceb7">11.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i11685a5fe8fb4e7580ffa0ca743f0062_I20210806" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZToxNDAxMGQ4NWY0ZTQ0ZjVjYWUxYjc0Yzg5ZjVjYTNmYS90YWJsZXJhbmdlOjE0MDEwZDg1ZjRlNDRmNWNhZTFiNzRjODlmNWNhM2ZhXzEtMy0xLTEtOTA2MDk_ae58f824-7d8f-426a-907c-1f3dd0497fd3">11.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9712786e3d6e4293bfa543a7f4306d3d_I20211231" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZToxNDAxMGQ4NWY0ZTQ0ZjVjYWUxYjc0Yzg5ZjVjYTNmYS90YWJsZXJhbmdlOjE0MDEwZDg1ZjRlNDRmNWNhZTFiNzRjODlmNWNhM2ZhXzItMS0xLTEtOTA2MDk_8b79369b-9371-426a-af92-82f97846f5a8">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i64bb7db0f547412db51fb298ab7f1eb1_I20210806" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZToxNDAxMGQ4NWY0ZTQ0ZjVjYWUxYjc0Yzg5ZjVjYTNmYS90YWJsZXJhbmdlOjE0MDEwZDg1ZjRlNDRmNWNhZTFiNzRjODlmNWNhM2ZhXzItMy0xLTEtOTA2MDk_8ed93242-184c-43fe-b6e2-fb91bbf2553c">11.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i10a81d94cb444487a1305e090e7ac9f0_I20211231" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZToxNDAxMGQ4NWY0ZTQ0ZjVjYWUxYjc0Yzg5ZjVjYTNmYS90YWJsZXJhbmdlOjE0MDEwZDg1ZjRlNDRmNWNhZTFiNzRjODlmNWNhM2ZhXzMtMS0xLTEtOTA2MDk_0badb415-4adc-4b08-8359-4d5d54f51512">9.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib14d34f779324c98acee7371373d9927_I20210806" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZToxNDAxMGQ4NWY0ZTQ0ZjVjYWUxYjc0Yzg5ZjVjYTNmYS90YWJsZXJhbmdlOjE0MDEwZDg1ZjRlNDRmNWNhZTFiNzRjODlmNWNhM2ZhXzMtMy0xLTEtOTA2MDk_c8b750b7-53d0-478d-a2f2-39d77aed0e2e">9.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining term (yrs)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="y" contextRef="i0b029e7f84ba49809517714b945d453d_I20211231" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZToxNDAxMGQ4NWY0ZTQ0ZjVjYWUxYjc0Yzg5ZjVjYTNmYS90YWJsZXJhbmdlOjE0MDEwZDg1ZjRlNDRmNWNhZTFiNzRjODlmNWNhM2ZhXzQtMS0xLTEtOTA2MDk_191c82a7-91fa-499e-812d-b46e4ed6a811">5.75</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="y" contextRef="ie04573b29e10454392fcd1c7a4d28cb2_I20210806" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZToxNDAxMGQ4NWY0ZTQ0ZjVjYWUxYjc0Yzg5ZjVjYTNmYS90YWJsZXJhbmdlOjE0MDEwZDg1ZjRlNDRmNWNhZTFiNzRjODlmNWNhM2ZhXzQtMy0xLTEtOTA2MDk_bab501fe-4c53-4169-9084-275114e0420a">6.51</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0b3852e6684e45c08ebac5f6a1cb253d_I20211231" decimals="4" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZToxNDAxMGQ4NWY0ZTQ0ZjVjYWUxYjc0Yzg5ZjVjYTNmYS90YWJsZXJhbmdlOjE0MDEwZDg1ZjRlNDRmNWNhZTFiNzRjODlmNWNhM2ZhXzUtMS0xLTEtOTA2MDk_66916457-4899-45e7-91c5-76fcaa456495">1.32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i531831f23f064c698db5bd956d8f7662_I20210806" decimals="4" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZToxNDAxMGQ4NWY0ZTQ0ZjVjYWUxYjc0Yzg5ZjVjYTNmYS90YWJsZXJhbmdlOjE0MDEwZDg1ZjRlNDRmNWNhZTFiNzRjODlmNWNhM2ZhXzUtMy0xLTEtOTA2MDk_f0bc8508-1acd-43cd-a2d9-a0e25dc74e8a">0.99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the period from January 28, 2021 (inception) through December 31, 2021</span></div></div><ix:continuation id="ia6ea627c6b12436384c96984bb4052a2" continuedAt="ib3c46206c3384fffb5548bd2adc416dd"><ix:continuation id="i08b2dad0534d4927ad8b331459eb64f5" continuedAt="icd30a0a20d034472bae0fd85868df018"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the fair value of the derivative warrant liabilities, measured using Level 3 inputs, for the period from January 28, 2021 (inception) through December 31, 2021 is summarized as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at January 28, 2021 (inception)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of Public and Private Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i832a10c8d035443c86f96cddb14c1741_D20210128-20211231" decimals="0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZTo1MzY0ZWVhYzc3ZTY0ODEyODVmZDU2NmJlMjI5MTY1MS90YWJsZXJhbmdlOjUzNjRlZWFjNzdlNjQ4MTI4NWZkNTY2YmUyMjkxNjUxXzEtMS0xLTEtOTA2MDk_7f32f6a0-d02b-4c41-b581-8c31ee93c747">7,515,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer of Public Warrants to Level 1</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i832a10c8d035443c86f96cddb14c1741_D20210128-20211231" decimals="0" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZTo1MzY0ZWVhYzc3ZTY0ODEyODVmZDU2NmJlMjI5MTY1MS90YWJsZXJhbmdlOjUzNjRlZWFjNzdlNjQ4MTI4NWZkNTY2YmUyMjkxNjUxXzItMS0xLTEtOTA2MDk_89468125-23c7-4ce6-b358-3d6d606ae1f1">5,100,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i832a10c8d035443c86f96cddb14c1741_D20210128-20211231" decimals="0" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZTo1MzY0ZWVhYzc3ZTY0ODEyODVmZDU2NmJlMjI5MTY1MS90YWJsZXJhbmdlOjUzNjRlZWFjNzdlNjQ4MTI4NWZkNTY2YmUyMjkxNjUxXzMtMS0xLTEtOTA2MDk_686c9b30-7e45-4010-bf49-5c30e532faca">630,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa37f22ae2644299a4ab468acaa968cd_I20211231" decimals="0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZTo1MzY0ZWVhYzc3ZTY0ODEyODVmZDU2NmJlMjI5MTY1MS90YWJsZXJhbmdlOjUzNjRlZWFjNzdlNjQ4MTI4NWZkNTY2YmUyMjkxNjUxXzQtMS0xLTEtOTA2MDk_90186d3a-8cf1-474a-b034-ee36ecbc963f">1,785,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib82e114cd19f45afae73e7a64e42f208_124"></div><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90ZXh0cmVnaW9uOjVmYjc0NjhhMWViNjRlNmNhYTk3MWQ2NzM3M2E1MmZmXzE5ODg_7bad12e9-3afc-4473-bb7f-3d748d71a00e" continuedAt="ie04d21523f9247beb399ddd75b73033d" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10 &#8212; Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal and Connecticut jurisdictions and are subject to examination. The income tax provision consists of the following:</span></div><div style="margin-bottom:9pt"><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90ZXh0cmVnaW9uOjVmYjc0NjhhMWViNjRlNmNhYTk3MWQ2NzM3M2E1MmZmXzE5ODk_ce3cac7e-f92b-4ee2-a7cf-38aa1fada581" continuedAt="i914588d7f8f04abba97ec9edc4c23520" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Period from January 28, 2021<br/>(inception) through December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231" decimals="0" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90YWJsZTo4NWRjZDZjY2VhMDE0ZGY1ODMyMzA5ODYwMmUzYmRlMS90YWJsZXJhbmdlOjg1ZGNkNmNjZWEwMTRkZjU4MzIzMDk4NjAyZTNiZGUxXzItMS0xLTEtOTA2MDk_a7a207a9-dbba-4987-bcff-943c91ccb3e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231" decimals="0" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90YWJsZTo4NWRjZDZjY2VhMDE0ZGY1ODMyMzA5ODYwMmUzYmRlMS90YWJsZXJhbmdlOjg1ZGNkNmNjZWEwMTRkZjU4MzIzMDk4NjAyZTNiZGUxXzMtMS0xLTEtOTA2MDk_2d56e2cb-7966-49d8-8971-af09ce8e880f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231" decimals="0" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90YWJsZTo4NWRjZDZjY2VhMDE0ZGY1ODMyMzA5ODYwMmUzYmRlMS90YWJsZXJhbmdlOjg1ZGNkNmNjZWEwMTRkZjU4MzIzMDk4NjAyZTNiZGUxXzUtMS0xLTEtOTA2MDk_30f499da-3a3a-4a29-8fef-f4c4d7fa75c4">290,181</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231" xsi:nil="true" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90YWJsZTo4NWRjZDZjY2VhMDE0ZGY1ODMyMzA5ODYwMmUzYmRlMS90YWJsZXJhbmdlOjg1ZGNkNmNjZWEwMTRkZjU4MzIzMDk4NjAyZTNiZGUxXzYtMS0xLTEtOTA2MDk_454fa62f-c8b7-49d8-ba30-63a3e518dc64"></ix:nonFraction>&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231" decimals="0" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90YWJsZTo4NWRjZDZjY2VhMDE0ZGY1ODMyMzA5ODYwMmUzYmRlMS90YWJsZXJhbmdlOjg1ZGNkNmNjZWEwMTRkZjU4MzIzMDk4NjAyZTNiZGUxXzctMS0xLTEtOTA2MDk_de068258-33f5-4846-ba36-b71fada20cd2">290,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231" decimals="0" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90YWJsZTo4NWRjZDZjY2VhMDE0ZGY1ODMyMzA5ODYwMmUzYmRlMS90YWJsZXJhbmdlOjg1ZGNkNmNjZWEwMTRkZjU4MzIzMDk4NjAyZTNiZGUxXzgtMS0xLTEtOTA2MDk_51db61c4-11b2-4b03-83c4-aab2d4cbbc73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s net deferred tax assets are as follows:</span></div><div style="margin-bottom:9pt"><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90ZXh0cmVnaW9uOjVmYjc0NjhhMWViNjRlNmNhYTk3MWQ2NzM3M2E1MmZmXzE5OTA_d9c342b9-f63e-49a1-97c8-0370495dd798" continuedAt="ide653d35c1ac44b68a689059132f8f33" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Start-up/Organization costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="amci:DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90YWJsZTo1ZWVmOTI3Yzk2NmY0MGJhYWFkMjgzMmNiYmQ2NGE2OS90YWJsZXJhbmdlOjVlZWY5MjdjOTY2ZjQwYmFhYWQyODMyY2JiZDY0YTY5XzItMS0xLTEtOTA2MDk_f4ae6ee8-9f8d-4027-9477-5c62c68f7ce6">210,307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90YWJsZTo1ZWVmOTI3Yzk2NmY0MGJhYWFkMjgzMmNiYmQ2NGE2OS90YWJsZXJhbmdlOjVlZWY5MjdjOTY2ZjQwYmFhYWQyODMyY2JiZDY0YTY5XzMtMS0xLTEtOTA2MDk_2001f559-1c2d-419b-9d5a-92600f22358f">79,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90YWJsZTo1ZWVmOTI3Yzk2NmY0MGJhYWFkMjgzMmNiYmQ2NGE2OS90YWJsZXJhbmdlOjVlZWY5MjdjOTY2ZjQwYmFhYWQyODMyY2JiZDY0YTY5XzQtMS0xLTEtOTA2MDk_0a453e4f-2bcf-4add-a600-74e6dcf9965f">290,181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90YWJsZTo1ZWVmOTI3Yzk2NmY0MGJhYWFkMjgzMmNiYmQ2NGE2OS90YWJsZXJhbmdlOjVlZWY5MjdjOTY2ZjQwYmFhYWQyODMyY2JiZDY0YTY5XzUtMS0xLTEtOTA2MDk_6df78da7-cd53-4f2a-89e0-bec1ccccd3e9">290,181</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax asset, net of allowance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax assets, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the period from January 28, 2021 (inception) through December 31, 2021, the valuation allowance was $<ix:nonFraction unitRef="usd" contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231" decimals="0" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90ZXh0cmVnaW9uOjVmYjc0NjhhMWViNjRlNmNhYTk3MWQ2NzM3M2E1MmZmXzExNTA_548394a9-7cc0-4952-8f2e-f4e100a3b88b">290,181</ix:nonFraction>. As of December 31, 2021, the Company had $<ix:nonFraction unitRef="usd" contextRef="i1031eb2976d644cfbbf5cce499b8af89_I20211231" decimals="0" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90ZXh0cmVnaW9uOjVmYjc0NjhhMWViNjRlNmNhYTk3MWQ2NzM3M2E1MmZmXzExOTU_881b967b-d7b5-49f2-9c77-5d75f2fa80b4">380,351</ix:nonFraction> of U.S. federal net operating loss carryovers, which do not expire, available to offset future taxable income.</span></div></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the period from January 28, 2021 (inception) through December 31, 2021</span></div></div><ix:continuation id="ie04d21523f9247beb399ddd75b73033d" continuedAt="i4ecce717eb6a4849bd55e9e5ac7be9ce"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="0" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90ZXh0cmVnaW9uOjVmYjc0NjhhMWViNjRlNmNhYTk3MWQ2NzM3M2E1MmZmXzEzMjA_3b238f48-613e-4d0d-a57e-3429e99eb3f1">no</ix:nonFraction> unrecognized tax benefits as of December 31, 2021. <ix:nonFraction unitRef="usd" contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231" decimals="0" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90ZXh0cmVnaW9uOjVmYjc0NjhhMWViNjRlNmNhYTk3MWQ2NzM3M2E1MmZmXzEzNzQ_e39fa352-d56c-4b7e-ba7b-1572a7b39ad9">No</ix:nonFraction> amounts were accrued for the payment of interest and penalties as of December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company&#8217;s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the statutory federal income tax rate (benefit) to the Company&#8217;s effective tax rate (benefit) is as follows:</span></div><div style="margin-bottom:9pt"><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90ZXh0cmVnaW9uOjVmYjc0NjhhMWViNjRlNmNhYTk3MWQ2NzM3M2E1MmZmXzE5OTE_2e637002-10d3-4919-9d0d-197e3f8ceaf7" continuedAt="i059ddb4036db47439d1ef89ee1fa7fc3" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Period from January 28, 2021 (inception) through December 31, 2021 </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory federal income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90YWJsZTplMzk2OWJkOWM3NTE0MTc3ODhmMDc1ZmNmYmIzOGJhNy90YWJsZXJhbmdlOmUzOTY5YmQ5Yzc1MTQxNzc4OGYwNzVmY2ZiYjM4YmE3XzEtMS0xLTEtOTA2MDk_ed8f8bd5-cfbb-4a5a-ab8d-92c0d8746c5a">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative warrant liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90YWJsZTplMzk2OWJkOWM3NTE0MTc3ODhmMDc1ZmNmYmIzOGJhNy90YWJsZXJhbmdlOmUzOTY5YmQ5Yzc1MTQxNzc4OGYwNzVmY2ZiYjM4YmE3XzItMS0xLTEtOTA2MDk_a8bda234-1dd0-406d-addd-853d504750e2">855.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Offering costs allocated to derivative warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90YWJsZTplMzk2OWJkOWM3NTE0MTc3ODhmMDc1ZmNmYmIzOGJhNy90YWJsZXJhbmdlOmUzOTY5YmQ5Yzc1MTQxNzc4OGYwNzVmY2ZiYjM4YmE3XzMtMS0xLTEtOTA2MDk_0c3c48eb-aa89-4c2c-b62a-cecde9bbbad0">214.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90YWJsZTplMzk2OWJkOWM3NTE0MTc3ODhmMDc1ZmNmYmIzOGJhNy90YWJsZXJhbmdlOmUzOTY5YmQ5Yzc1MTQxNzc4OGYwNzVmY2ZiYjM4YmE3XzQtMS0xLTEtOTA2MDk_4684cb06-0d0a-47d5-9333-6ce1a45f0d94">620.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90YWJsZTplMzk2OWJkOWM3NTE0MTc3ODhmMDc1ZmNmYmIzOGJhNy90YWJsZXJhbmdlOmUzOTY5YmQ5Yzc1MTQxNzc4OGYwNzVmY2ZiYjM4YmE3XzUtMS0xLTEtOTA2MDk_c5b4d4c2-22e9-4036-a867-be6ac58f4401">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_127"></div><ix:continuation id="ic37fd39382d24186aa483133061d33e3" continuedAt="i0514f1fa32d94c3ca9e14a65b7c9600c"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11 &#8212; Subsequent Events</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated subsequent events and transactions that occurred up to the date financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2022, the Company entered into the Merger Agreement with Merger Sub and LanzaTech. The transactions contemplated by the Merger Agreement are referred to herein as the &#8220;Business Combination.&#8221; The time of the closing of the Business Combination is referred to herein as the &#8220;Closing.&#8221; The date of the Closing of the Business Combination is referred to herein as the &#8220;Closing Date.&#8221;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposed Business Combination</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Business Combination is approved by the Company&#8217;s stockholders and LanzaTech&#8217;s stockholders, and the closing conditions in the Merger Agreement are satisfied or waived, then, among other things, upon the terms and subject to the conditions of the Merger Agreement and in accordance with Delaware General Corporation Law, Merger Sub will merge with and into LanzaTech, with LanzaTech surviving the merger as the Company&#8217;s wholly owned subsidiary (the &#8220;Merger&#8221;). In connection with the consummation of the Merger, the Company will be renamed &#8220;LanzaTech Global, Inc.&#8221; and is referred to herein as &#8220;New LanzaTech&#8221; as of the time following such change of name.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Merger Agreement, the Company has agreed to acquire all of the outstanding equity interests of LanzaTech for consideration consisting of equity interests of New LanzaTech valued at $<ix:nonFraction unitRef="usd" contextRef="ia6a395c8f57c4345b9c5c1927223b563_I20220308" decimals="0" name="us-gaap:BusinessCombinationContingentConsiderationAssetCurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjcvZnJhZzpkODdkZjEzZGM1MWE0NmFjOTAyYjA5NTJhZmM4M2NjZS90ZXh0cmVnaW9uOmQ4N2RmMTNkYzUxYTQ2YWM5MDJiMDk1MmFmYzgzY2NlXzE1ODM_a45a7d0b-1740-4763-b404-234989ecf73e">1,817,000,000</ix:nonFraction> in the aggregate. The consideration to be paid to holders of shares of LanzaTech capital stock will be shares of common stock of New LanzaTech (&#8220;New LanzaTech Common Stock&#8221;), valued at $<ix:nonFraction unitRef="usdPerShare" contextRef="ia6a395c8f57c4345b9c5c1927223b563_I20220308" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjcvZnJhZzpkODdkZjEzZGM1MWE0NmFjOTAyYjA5NTJhZmM4M2NjZS90ZXh0cmVnaW9uOmQ4N2RmMTNkYzUxYTQ2YWM5MDJiMDk1MmFmYzgzY2NlXzE3NzE_4007679a-9d77-4c63-8f6f-2de767839b0a">10.00</ix:nonFraction> per share, to be paid at the closing of the Merger. The number of shares of New LanzaTech Common Stock payable in the Merger in respect of each share of LanzaTech capital stock (each, a &#8220;LanzaTech Share&#8221;) will be determined based on the exchange ratio (the &#8220;Exchange Ratio&#8221;), and certain corresponding adjustments, in each case as set forth in the Merger Agreement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, at Closing: (i) each warrant to purchase LanzaTech Shares (each, a &#8220;LanzaTech Warrant&#8221;) that is outstanding and unexercised immediately prior to Closing and would automatically be exercised or exchanged in full in accordance with its terms by virtue of the occurrence of the Merger, will be so automatically exercised or exchanged in full for the applicable LanzaTech Shares, and each such LanzaTech Share will be treated as being issued and outstanding immediately prior to Closing and will be canceled and converted into the right to receive the applicable shares of New LanzaTech Common Stock; and (ii) each LanzaTech Warrant that </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMCI ACQUISITION CORP. II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the period from January 28, 2021 (inception) through December 31, 2021</span></div></div><ix:continuation id="i0514f1fa32d94c3ca9e14a65b7c9600c" continuedAt="i0b4e10a9549e473c939a7869953dcacb"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is outstanding and unexercised immediately prior to the Closing and is not automatically exercised in full as described in clause (i) will be converted into a warrant to purchase shares of New LanzaTech Common Stock, in which case (a) the number of shares underlying such New LanzaTech warrant (each, a &#8220;New LanzaTech Warrant&#8221;) will be determined by multiplying the number of LanzaTech Shares subject to such warrant immediately prior to Closing, by the Exchange Ratio and (b) the per share exercise price of such New LanzaTech Warrant will be determined by dividing the per share exercise price of such LanzaTech Warrant immediately prior to the Effective Time by the Exchange Ratio, except that in the case of certain warrants specified in the Merger Agreement, such exercise price will be $<ix:nonFraction unitRef="usdPerShare" contextRef="ia6a395c8f57c4345b9c5c1927223b563_I20220308" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjcvZnJhZzpkODdkZjEzZGM1MWE0NmFjOTAyYjA5NTJhZmM4M2NjZS90ZXh0cmVnaW9uOmQ4N2RmMTNkYzUxYTQ2YWM5MDJiMDk1MmFmYzgzY2NlXzM2MDA_4328ef0c-9307-4c9f-8745-000b5aadc550">10.00</ix:nonFraction>.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, at Closing, each option to purchase LanzaTech Shares (each, a &#8220;LanzaTech Option&#8221;) will be converted into an option to purchase a number of shares of New LanzaTech Common Stock (rounded down to the nearest whole share) equal to the product of (i) the number of LanzaTech Shares subject to such LanzaTech Option multiplied by (ii) the Exchange Ratio. The exercise price of such New LanzaTech option will be equal to the quotient of (a) the exercise price per share of such LanzaTech Option in effect immediately prior to the Effective Time divided by (b) the Exchange Ratio (and as so determined, this exercise price will be rounded up to the nearest full cent).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, at Closing, each award of restricted shares of LanzaTech common stock (each, a &#8220;LanzaTech RSA&#8221;) that is outstanding immediately prior to the Effective Time will be converted into an award of restricted shares of New LanzaTech Common Stock (each, a &#8220;New LanzaTech RSA&#8221;) on the same terms and conditions as were applicable to such LanzaTech RSA immediately prior to the Effective Time, except that such New LanzaTech RSA will relate to a number of shares of New LanzaTech Common Stock equal to the number of LanzaTech Shares subject to such LanzaTech RSA, multiplied by the Exchange Ratio.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The closing of the Merger is subject to certain customary conditions, including, among others, (i) adoption by AMCI&#8217;s stockholders and LanzaTech&#8217;s stockholders of the Merger Agreement and their approval of certain other actions related to the Business Combination, (ii) the expiration or termination of the waiting period (or any extension thereof) applicable to the transactions contemplated by the Merger Agreement and any ancillary agreements, in each case under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, (iii) the effectiveness of a registration statement on Form S-4 (the &#8220;Registration Statement&#8221;) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) with respect to the shares of New LanzaTech Common Stock to be paid as consideration in the Merger, (iv) there being no government order or law enjoining, prohibiting or making illegal the consummation of the Merger or the transactions contemplated by the Merger Agreement, (v) AMCI having at least $<ix:nonFraction unitRef="usd" contextRef="i1b9add4019654e2d87f0e463effed72f_I20220308" decimals="0" name="us-gaap:AssetsNet" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjcvZnJhZzpkODdkZjEzZGM1MWE0NmFjOTAyYjA5NTJhZmM4M2NjZS90ZXh0cmVnaW9uOmQ4N2RmMTNkYzUxYTQ2YWM5MDJiMDk1MmFmYzgzY2NlXzU5MDc_4f4e4f3a-9516-4c26-8660-7bf3c6b47b21">5,000,001</ix:nonFraction> of net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) under the Exchange Act) after giving effect to any payments required to be made in connection with the redemption of AMCI&#8217;s public shares and the proceeds from the Subscription Agreements described below, (vi) AMCI having at least $<ix:nonFraction unitRef="usd" contextRef="i1b9add4019654e2d87f0e463effed72f_I20220308" decimals="0" name="us-gaap:AssetsHeldInTrustCurrent" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjcvZnJhZzpkODdkZjEzZGM1MWE0NmFjOTAyYjA5NTJhZmM4M2NjZS90ZXh0cmVnaW9uOmQ4N2RmMTNkYzUxYTQ2YWM5MDJiMDk1MmFmYzgzY2NlXzYyMTY_db578b5a-2e25-4b40-b5e8-d7800ef2be3c">230,000,000</ix:nonFraction> of cash at the closing of the Merger, consisting of cash held in AMCI&#8217;s trust account after taking into account any redemption of AMCI&#8217;s public shares, and the proceeds from the Subscription Agreements described below, net of transaction expenses of AMCI and LanzaTech, and (vii) the listing on Nasdaq of the shares of New LanzaTech Common Stock issued in connection with the Business Combination.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-43</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_643"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LANZATECH NZ, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except share and per share data)</span></div></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021 <br/>as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzQtMS0xLTEtOTA3MDc_4be7a95c-ef8f-4aca-bda6-684d62c2c62f">50,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzQtMy0xLTEtOTA3MDc_e9d1675a-a926-4452-b5fa-4588c28c201e">128,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade and other receivables, net of allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:AccountsAndOtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzUtMS0xLTEtOTA3MDc_e008ddfc-f5be-4c70-86d3-d5af181a6391">11,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:AccountsAndOtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzUtMy0xLTEtOTA3MDc_8d4c4640-c5af-4a80-a12d-93b7de86b197">2,878</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzYtMS0xLTEtOTA3MDc_2afd77ce-bb33-4117-ab43-ff9188f3598f">14,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzYtMy0xLTEtOTA3MDc_bfaa2a3d-6f8d-4a50-afe5-77a5a8c87ce7">11,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzctMS0xLTEtOTA3MDc_00cba1f5-e791-4cf6-8726-c7109625dd46">12,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzctMy0xLTEtOTA3MDc_58b305ca-9447-41bd-b713-67f8997d5ebf">5,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzgtMS0xLTEtOTkxODE_d5d6e0dd-5da8-42b2-82d5-2909f58a403c">88,815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzgtMy0xLTEtOTkyNjM_1d0c92ae-9b17-485f-8c01-cc70ae5f4ca4">148,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzktMS0xLTEtOTA3MDc_b89328c3-6cca-411e-9688-9ca742196626">16,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzktMy0xLTEtOTA3MDc_66c942ba-bda8-4ef2-963c-6d8ac426ff72">14,148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzEwLTEtMS0xLTkwNzA3_c1b3c833-00d6-457f-8448-22f4292d4567">3,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzEwLTMtMS0xLTkwNzA3_765fe67a-5ca7-49c6-9650-7f63dd1b3ab0">4,686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity Method Investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzExLTEtMS0xLTkwNzA3_9f180717-bcff-4503-a17d-cb684a849ca2">11,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzExLTMtMS0xLTkwNzA3_f279425a-3533-4046-ab59-56df85eaa96f">24,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity Security Investment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzEyLTEtMS0xLTkwNzA3_13ce506f-dd15-446a-bb05-1f84c34a4b15">14,990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzEyLTMtMS0xLTkwNzA3_c94e3780-2505-45c2-a167-89bab141ba79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzEzLTEtMS0xLTkwNzA3_c5ef134a-a779-41a8-a475-32b0eeb48481">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzEzLTMtMS0xLTkwNzA3_720a91fb-4279-4220-9b50-d16b67fd526a">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzE0LTEtMS0xLTk5MjY2_1b7bfad9-c942-4ca1-b722-bfcdc74c155d">135,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzE0LTMtMS0xLTkwNzA3_c4ddde92-449f-4948-bd66-606d1a49ea1b">193,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities, Contingently Redeemable Preferred Stock, and Shareholders&#8217; Deficit</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzE3LTEtMS0xLTkwNzA3_e72203d0-6959-44a9-ae6b-f726457a7aef">1,488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzE3LTMtMS0xLTkwNzA3_e50688f6-1b1b-4a17-a66a-d6f5c0ec3cdc">2,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzE4LTEtMS0xLTkwNzA3_0c21dc31-9fe0-4ad3-8957-78de4532d824">8,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzE4LTMtMS0xLTkwNzA3_b4314c31-c6b7-4bbb-9889-74887b36fb22">7,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="amci:SimpleAgreementForFutureEquityLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzE5LTEtMS0xLTkwNzA3_35d9ac4e-0b55-4c2a-a0ef-5075294a75c7">27,221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="amci:SimpleAgreementForFutureEquityLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzE5LTMtMS0xLTkwNzA3_e83f7da0-5093-4b82-af9a-11e90236fa69">28,271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SAFE warrant</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzIwLTEtMS0xLTkwNzA3_c3877934-087d-4e53-9a07-78a3e38dbe99">2,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzIwLTMtMS0xLTkwNzA3_0c71e64b-112f-4d72-8934-9dc71d71c198">1,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzIxLTEtMS0xLTkwNzA3_1f00fe2c-faa3-4247-af1b-0a8336188fff">2,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzIxLTMtMS0xLTkwNzA3_74655878-1a34-42fc-ad06-f982a5a688d0">3,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued salaries and wages</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzIyLTEtMS0xLTkwNzA3_f14ee44d-331b-4787-ab1e-a23638cb38a8">5,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzIyLTMtMS0xLTkwNzA3_93f283d4-0aa2-42d7-bb89-bbf81d927175">4,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzIzLTEtMS0xLTkwNzA3_1205ff09-5c22-4ebf-8506-ffb183fbd807">2,205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzIzLTMtMS0xLTkwNzA3_70fd09cf-3821-4adf-9260-e07fae07b935">2,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzI0LTEtMS0xLTk5Mjk5_2cd7829b-3983-4ac0-967a-f71c9f9475ac">49,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzI0LTMtMS0xLTk5MzAy_e250afff-8303-4071-a73a-aa61739540c1">49,290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzI1LTEtMS0xLTkwNzA3_b0c87482-79fc-4084-8919-a8b2c53b37cf">1,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzI1LTMtMS0xLTkwNzA3_f720371a-92ea-4c92-810e-2e092585a063">3,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current contract liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzI2LTEtMS0xLTkwNzA3_eef7e1f1-a039-4f80-92fa-ce826f439c58">11,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzI2LTMtMS0xLTkwNzA3_59d993e5-e480-405d-9bdd-842577db5c6e">13,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzI3LTEtMS0xLTkwNzA3_a75b6a5d-71ff-4b1b-8ffc-5684a2b3373f">823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzI3LTMtMS0xLTkwNzA3_d996ab44-1501-43dc-a192-809852b94fb4">823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzI4LTEtMS0xLTk5Mjk5_0a587c5d-978c-44ac-b958-024e9567ce64">62,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzI4LTMtMS0xLTk5MzAy_7b498885-cabe-4683-90ac-08ae79bb549b">67,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Commitments and Contingencies (see note 11)</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzI5LTEtMS0xLTk5MzYw_93b84215-85bd-42b2-ba5b-936d475af0fe"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzI5LTMtMS0xLTk5MzYw_c0b6d7cf-af10-46f7-9850-64707c360f1f"></ix:nonFraction></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingently Redeemable Preferred Stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Redeemable convertible preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="INF" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzMyLTAtMS0xLTkwNzA3L3RleHRyZWdpb246ZDNmYTQ4NmNjYmQ2NDY0NTk3OTZlMDVlM2RlN2M1ODZfNDU_b14c31d6-0582-4dd1-9527-4560d8788747"><ix:nonFraction unitRef="usdPerShare" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzMyLTAtMS0xLTkwNzA3L3RleHRyZWdpb246ZDNmYTQ4NmNjYmQ2NDY0NTk3OTZlMDVlM2RlN2M1ODZfNDU_c2db7f73-9b00-4c5c-9a47-e807e2341f68">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzMyLTAtMS0xLTkwNzA3L3RleHRyZWdpb246ZDNmYTQ4NmNjYmQ2NDY0NTk3OTZlMDVlM2RlN2M1ODZfNTk_77f63a85-7448-4b8a-86b9-17e4adc27e17"><ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzMyLTAtMS0xLTkwNzA3L3RleHRyZWdpb246ZDNmYTQ4NmNjYmQ2NDY0NTk3OTZlMDVlM2RlN2M1ODZfNTk_b5c0536b-a201-4898-b32e-8df3171156ca">29,747,033</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzMyLTAtMS0xLTkwNzA3L3RleHRyZWdpb246ZDNmYTQ4NmNjYmQ2NDY0NTk3OTZlMDVlM2RlN2M1ODZfODE_9e872197-94e0-4129-ac82-6a14cbf36648"><ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzMyLTAtMS0xLTkwNzA3L3RleHRyZWdpb246ZDNmYTQ4NmNjYmQ2NDY0NTk3OTZlMDVlM2RlN2M1ODZfODE_b0aeceda-ef75-4d48-97a0-fff5a1b4662f"><ix:nonFraction unitRef="shares" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzMyLTAtMS0xLTkwNzA3L3RleHRyZWdpb246ZDNmYTQ4NmNjYmQ2NDY0NTk3OTZlMDVlM2RlN2M1ODZfODE_c8050675-d814-4276-a944-d08393b23d4d"><ix:nonFraction unitRef="shares" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzMyLTAtMS0xLTkwNzA3L3RleHRyZWdpb246ZDNmYTQ4NmNjYmQ2NDY0NTk3OTZlMDVlM2RlN2M1ODZfODE_d3aab95a-a376-4ddb-884c-ad50a4e51a58">29,521,810</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding as of September&#160;30, 2022 and December&#160;31, 2021.</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzMyLTEtMS0xLTkwNzA3_0a2514d9-6750-4ec3-8e77-0b7ec08f74fb">480,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzMyLTMtMS0xLTkwNzA3_1faf0950-d3ee-40f8-8c55-1ddf8d52958c">480,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shareholders&#8217; Deficit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM0LTAtMS0xLTkwNzA3L3RleHRyZWdpb246NWQ2MjcxZmQ4NjEyNDhkNmExNzJlNzhlYzU1YWVkMjVfMTk_a2e817c6-e701-44e8-bdb6-0eecdd6b12dc"><ix:nonFraction unitRef="usdPerShare" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM0LTAtMS0xLTkwNzA3L3RleHRyZWdpb246NWQ2MjcxZmQ4NjEyNDhkNmExNzJlNzhlYzU1YWVkMjVfMTk_b4e43c07-2ac5-4ab4-a446-13de29026d99">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM0LTAtMS0xLTkwNzA3L3RleHRyZWdpb246NWQ2MjcxZmQ4NjEyNDhkNmExNzJlNzhlYzU1YWVkMjVfMzM_01109a43-b8ed-4d00-a577-88865c822825"><ix:nonFraction unitRef="shares" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM0LTAtMS0xLTkwNzA3L3RleHRyZWdpb246NWQ2MjcxZmQ4NjEyNDhkNmExNzJlNzhlYzU1YWVkMjVfMzM_750abc69-0804-4296-8fe3-7201d8392445">36,326,815</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM0LTAtMS0xLTkwNzA3L3RleHRyZWdpb246NWQ2MjcxZmQ4NjEyNDhkNmExNzJlNzhlYzU1YWVkMjVfNTU_2405acb9-a192-4c66-a2d8-18796a7edb66"><ix:nonFraction unitRef="shares" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM0LTAtMS0xLTkwNzA3L3RleHRyZWdpb246NWQ2MjcxZmQ4NjEyNDhkNmExNzJlNzhlYzU1YWVkMjVfNTU_425d3f5a-e640-48eb-9302-073dcc6e53bd">2,110,346</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM0LTAtMS0xLTkwNzA3L3RleHRyZWdpb246NWQ2MjcxZmQ4NjEyNDhkNmExNzJlNzhlYzU1YWVkMjVfNjI_69820550-c349-4199-ae64-af0c0189c632"><ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM0LTAtMS0xLTkwNzA3L3RleHRyZWdpb246NWQ2MjcxZmQ4NjEyNDhkNmExNzJlNzhlYzU1YWVkMjVfNjI_83c30b22-dbde-4192-b470-8f638d59bd31">2,106,934</ix:nonFraction></ix:nonFraction> shares issued and outstanding as September&#160;30, 2022 and December&#160;31, 2021, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM0LTEtMS0xLTkwNzA3_08837169-2961-4af3-b3a0-f4c7da877a10">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM0LTMtMS0xLTkwNzA3_79651307-3f7e-4ce1-8dab-304837e40994">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM1LTEtMS0xLTkwNzA3_9ecb0774-252b-4f00-b372-bfdc4cc5c8f1">23,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM1LTMtMS0xLTkwNzA3_38b1b185-6b6b-4bfa-8157-029915f228c3">21,711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM2LTEtMS0xLTkwNzA3_c36d0e89-41f5-4098-9042-9a5e7c22f602">3,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM2LTMtMS0xLTkwNzA3_5e833418-512f-483c-ad0b-4c2e5fc476b9">3,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM3LTEtMS0xLTkwNzA3_b941e408-2a16-403f-97b4-363fadc266b1">434,863</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM3LTMtMS0xLTkwNzA3_96f7aa7c-09d0-4318-99c6-404941c5656a">379,889</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM4LTEtMS0xLTk5MzA1_d00502ac-2eec-4bea-80b5-3f84da83fa9b">407,640</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM4LTMtMS0xLTk5MzEw_49d60a0d-5a2c-490e-af08-4389885517dc">354,917</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities, contingently redeemable preferred stock, and shareholders' deficit</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM5LTEtMS0xLTk5MzA1_ea269387-8aa2-4c66-af24-75192f2ef688">135,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM5LTMtMS0xLTk5MzEw_8cd4fabb-4a7b-4777-add7-b9f0061e3f10">193,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the accompanying Notes to the Condensed Consolidated Financial Statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-44</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_654"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LANZATECH NZ, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPREHENSIVE LOSS (UNAUDITED)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except share and per share data)</span></div></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.015%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.521%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from contracts with customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzQtMS0xLTEtOTA3MTA_576d605f-d478-477b-a7de-927782680876">21,932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzQtMy0xLTEtOTA3MTA_b7f3a625-21ba-4890-b367-997f3dc49b4f">13,317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from collaborative arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzUtMS0xLTEtOTA3MTA_9a8b17fe-3a8a-4d4a-b77f-ebdd448db6d6">1,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzUtMy0xLTEtOTA3MTA_663c52eb-b4fc-4af6-ad31-709bee93131d">2,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from related party transactions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzYtMS0xLTEtOTA3MTA_ebb93582-da5a-46e6-891a-b714dfc92b18">2,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzYtMy0xLTEtOTA3MTA_20470455-fabb-40f5-9e02-d2d818565972">2,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzctMS0xLTEtOTk1NzQ_a95deb6c-3856-4ad0-9238-0fa1af661a84">25,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzctMy0xLTEtOTA3MTA_71f95f28-c40c-415a-93cc-9beb125a5557">18,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost and operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues from contracts with customers (exclusive of depreciation shown below)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzEwLTEtMS0xLTkwNzEw_7acf49d0-f1ba-4fce-8825-d3a439a925bb">18,162</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzEwLTMtMS0xLTkwNzEw_371009d2-8fdd-4051-bc0a-0bd0eed521ce">8,480</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue from collaborative arrangements (exclusive of depreciation shown below)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fa285a120cf4338a950b439d1496dd7_D20220101-20220930" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzExLTEtMS0xLTkwNzEw_369f9824-7d72-4bfc-8893-0076d5d609af">727</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb733d9b6c67432ab5a278cc8f9ae7e7_D20210101-20210930" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzExLTMtMS0xLTkwNzEw_0d2ce464-f26f-44d2-9bca-d509f8fbc388">935</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue from related party transactions (exclusive of depreciation shown below)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic032ce31175f4c45b33f9642339eab9b_D20220101-20220930" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzEyLTEtMS0xLTkwNzEw_adba5501-a16d-4557-8463-146f7f396033">342</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6752cd0319b04183b8e6481ee3e75964_D20210101-20210930" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzEyLTMtMS0xLTkwNzEw_647e2352-6481-46d2-a1d9-ae30440ae338">575</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzEzLTEtMS0xLTkwNzEw_e809d846-8f83-40d2-96b5-057e66fbc4d2">39,858</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzEzLTMtMS0xLTkwNzEw_46dca58a-c506-4e0c-90f4-1e846c90eccb">29,223</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzE0LTEtMS0xLTkwNzEw_75112d74-99ce-45fc-849d-0f9e570fbbdc">3,433</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzE0LTMtMS0xLTkwNzEw_796a23ce-2ee1-4e7b-91e0-972ec4a380e8">2,763</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzE1LTEtMS0xLTkwNzEw_47e6e106-9d9c-4379-b72f-a17852efd48e">19,482</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzE1LTMtMS0xLTkwNzEw_a7d0da62-bfe8-4c6d-8389-44f977b27ff7">11,595</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost and operating expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzE2LTEtMS0xLTk5NTc4_1ad5482b-d1b8-4908-922d-fb4036bf55af">82,004</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzE2LTMtMS0xLTkwNzEw_d23b1bbe-f11e-48de-8573-337ed3df37d8">53,571</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzE3LTEtMS0xLTk5NTc4_ead8d0d2-fae3-4256-9ec4-0096e3774c88">56,223</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzE3LTMtMS0xLTkwNzEw_830987e9-5860-42b5-8a8f-cd54e1794672">35,244</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzE5LTEtMS0xLTkwNzEw_78eb1e19-b8a1-4ef5-a10a-7f483f8b4969">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzE5LTMtMS0xLTkwNzEw_0599cca7-0887-4dc7-879f-4697ddeecad2">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzIwLTEtMS0xLTkwNzEw_e0ac5871-86a3-481d-9475-ebd02a653882">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzIwLTMtMS0xLTkwNzEw_d444afc7-c8d1-49f9-a230-cfa68e7e7854">3,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzIxLTEtMS0xLTkwNzEw_36ef1e91-d446-4fa5-b8bc-a5b0abdbc51b">1,100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzIxLTMtMS0xLTkwNzEw_12bdb33b-b412-4820-af65-4f825bf3fbf9">778</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other (expense) income, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzIyLTEtMS0xLTk5NTgx_20893fed-efa6-42ce-adde-971fed439a88">1,097</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzIyLTMtMS0xLTk5NTg1_9d97701d-0b43-4f6b-9560-17295e8a98d0">2,282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzIzLTEtMS0xLTk5NTgx_82c09984-2344-47c4-932b-870f86c01320">57,320</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzIzLTMtMS0xLTk5NTg1_5b9c069a-53e7-4903-8900-092c4b87fee5">32,962</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzI0LTEtMS0xLTkwNzEw_d1cbf149-6d92-4f89-a4c3-ebc0d757d28f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzI0LTMtMS0xLTkwNzEw_1a1ba826-7c70-4321-9286-8eaaecc2cc0f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzI1LTEtMS0xLTkwNzEw_a37ab943-c334-4fd5-a853-60ddc855e6cf">2,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzI1LTMtMS0xLTkwNzEw_13820b58-a4d2-43fe-93b7-e0f9486ec73a">2,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzI2LTEtMS0xLTk5NTgx_0269c412-fc29-4432-83d2-d0ff6d29860d">54,974</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzI2LTMtMS0xLTkwNzEw_8eb19940-a52c-4c49-aa67-2548899e0537">30,591</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid cumulative dividends on preferred stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:PreferredStockDividendsIncomeStatementImpact" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzI4LTEtMS0xLTkwNzEw_2d089ff3-c271-487a-804a-b05c5c804a9e">28,925</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:PreferredStockDividendsIncomeStatementImpact" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzI4LTMtMS0xLTkwNzEw_c1b2000d-f8c6-42e6-b7e6-0bbe9fcec20e">27,068</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss allocated to common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzI5LTEtMS0xLTkwNzEw_f67e847b-18ca-47de-beb8-54bc1b9212c7">83,899</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzI5LTMtMS0xLTk5NTg4_958097a3-d10e-4a49-960d-8c78b812e04c">57,659</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzMyLTEtMS0xLTkwNzEw_274efbd5-1640-46ec-8d17-a4afcfb5ddf7">767</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzMyLTMtMS0xLTkwNzEw_3a1fa224-8b3b-4fa4-bc74-4ab974713068">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzMzLTEtMS0xLTk5NTk2_94090f2e-40f2-4254-b0d7-286c0eafa1c1">55,741</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzMzLTMtMS0xLTkwNzEw_783af38e-add1-436b-9fa3-096b29fcf776">30,620</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share - basic and diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzM1LTEtMS0xLTkwNzEw_4cc13ab2-86f1-4ada-9dd2-3b4f26110ea5"><ix:nonFraction unitRef="usdPerShare" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzM1LTEtMS0xLTkwNzEw_8c2cb863-b14d-480b-ba1d-451e1d089909">39.79</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzM1LTMtMS0xLTkwNzEw_946673d5-f332-4531-82f1-f5338e53b6e5"><ix:nonFraction unitRef="usdPerShare" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzM1LTMtMS0xLTkwNzEw_c7a8539f-a0f1-4c59-b03e-6394bc735e97">30.19</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding - basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzM2LTEtMS0xLTkwNzEw_30ef1d57-910b-4b89-9f0c-359113d3d40e"><ix:nonFraction unitRef="shares" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzM2LTEtMS0xLTkwNzEw_4e26ab3a-7ce9-48fc-817a-f4a09b55c5ab">2,108,472</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzM2LTMtMS0xLTkwNzEw_75f71a28-7c68-4e34-921a-c3014d787de1"><ix:nonFraction unitRef="shares" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzM2LTMtMS0xLTkwNzEw_fc6976f2-61da-48e1-814d-3eeaa95e8ac8">1,909,635</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the accompanying Notes to the Condensed Consolidated Financial Statements. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-45</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_664"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LANZATECH NZ, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands) </span></div></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows From Operating Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzMtMS0xLTEtOTA3MTI_75e75683-052d-49b1-a313-fb4cde2afdd3">54,974</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzMtMy0xLTEtOTA3MTI_f1e4ad83-e20e-48b1-a5eb-24fd8734a18a">30,591</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzUtMS0xLTEtOTA3MTI_d6c240ea-bebe-4218-b2a2-643d3f4cbf17">2,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzUtMy0xLTEtOTA3MTI_3e52b56d-db4d-46a8-90fa-552369d3779c">1,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on change in fair value of SAFE and warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" sign="-" name="amci:FairValueAdjustmentOfWarrantsAndUnrealizedGainLossOnDerivatives" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzYtMS0xLTEtOTA3MTI_52acac58-6597-4ad6-a7fd-d997b6df43c0">330</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="amci:FairValueAdjustmentOfWarrantsAndUnrealizedGainLossOnDerivatives" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzYtMy0xLTEtOTA3MTI_30bafa3f-4b90-4acb-b7cc-afd0f555354b">699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzctMS0xLTEtOTA3MTI_d1f6b60d-79c9-48f1-b099-1fc96e6db645">3,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzctMy0xLTEtOTA3MTI_8733272e-246b-4ad6-9dc2-20c6d174b807">2,763</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzgtMS0xLTEtOTA3MTI_a9f8ade7-8040-46cf-b09f-4b89b12ad888">1,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzgtMy0xLTEtOTA3MTI_49211779-1715-4789-9526-59df833616c0">1,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash recognition of licensing revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="amci:NoncashRecognitionOfLicensingRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzktMS0xLTEtOTA3MTI_3dda1ab1-56cf-4576-b935-feb13d5e4c93">1,620</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="amci:NoncashRecognitionOfLicensingRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzktMy0xLTEtOTA3MTI_2c51b5d3-c6ff-4177-8dc1-cbf84e454129">1,516</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzEwLTEtMS0xLTkwNzEy_adb2ff02-fabb-4488-8ad9-4e99f8e694e5">2,346</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzEwLTMtMS0xLTkwNzEy_9b9ae180-4083-49b6-8996-aa7de7bfd94d">2,371</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPP loan forgiveness</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzExLTEtMS0xLTkwNzEy_30133795-9faf-4840-a6a6-186d0f4668eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzExLTMtMS0xLTkwNzEy_95d52f3e-1b73-4e23-984b-14a15b070c91">3,065</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net foreign exchange loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzEyLTEtMS0xLTkwNzEy_4cf29eef-66e7-493c-8558-4763c2fa7758">1,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzEyLTMtMS0xLTkwNzEy_1b850324-6d93-4e22-9c29-3a7290491e22">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzE0LTEtMS0xLTkwNzEy_97734b86-f51e-43c9-9941-7540861aad3e">8,710</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzE0LTMtMS0xLTkwNzEy_a4c3a945-cc9d-4fe5-b8ce-0d26496c7e04">3,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzE1LTEtMS0xLTkwNzEy_df4b8b79-ec8d-4f2b-af5a-ed1394b80c75">3,270</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzE1LTMtMS0xLTkwNzEy_02907d7f-083d-4f94-aa52-360d54f4923a">3,838</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzE2LTEtMS0xLTkwNzEy_0e4751e8-fbb5-406e-bf30-84cd6583b41c">5,981</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzE2LTMtMS0xLTkwNzEy_6525cfe6-d7d9-48b6-9eea-9d3ab9c4a49c">558</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued salaries and wages</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzE3LTEtMS0xLTkwNzEy_3a345f4b-0541-4d1e-a7e3-a7f3219740f3">463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzE3LTMtMS0xLTkwNzEy_44a8095e-714f-4025-b4eb-830b1f614f31">717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzE4LTEtMS0xLTkwNzEy_7e3dfb69-f415-44bd-b8e9-2808e5637277">471</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzE4LTMtMS0xLTkwNzEy_7fcefeec-7cd1-41bf-99d4-b4d39fec5695">4,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzE5LTEtMS0xLTkwNzEy_05569863-0ed4-4887-8e11-c406476a90d6">1,518</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzE5LTMtMS0xLTkwNzEy_a29e311c-78b6-4eec-9652-ebce068739d6">1,389</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzIwLTEtMS0xLTkwNzEy_0d9ec78f-378e-4d62-ab3d-612f3976c4ec">733</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzIwLTMtMS0xLTkwNzEy_393a54f2-0015-42cd-ab82-358bc095b89f">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzIxLTEtMS0xLTk5ODE3_4212ed9d-574d-40d1-bcbf-019ba3eecd63">71,336</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzIxLTMtMS0xLTk5ODEy_14bce2e3-5200-47ab-9555-52f15fa4c3a4">26,718</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows From Investing Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzIzLTEtMS0xLTkwNzEy_39ba6381-6121-4176-bfda-5784e7e634a2">6,530</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzIzLTMtMS0xLTkwNzEy_0df81d56-b341-4646-afd7-74d928e7c14d">4,201</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzI0LTEtMS0xLTk5ODI4_4daaa322-6499-4957-ae25-7b89775f015b">6,530</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzI0LTMtMS0xLTk5ODI4_5429ee0e-5e02-4100-ac38-abf59fd86a82">4,201</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows From Financing Activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issue of equity instruments of the Company</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="amci:ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzI2LTEtMS0xLTkwNzEy_d746b00c-51f8-4c2b-a027-2a917ac457a6">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="amci:ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzI2LTMtMS0xLTkwNzEy_50a70339-0349-4a45-b477-d773bf577ce1">83,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of a warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzI3LTEtMS0xLTkwNzEy_26f4c66f-44fa-402c-b774-0b51d7dc78bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzI3LTMtMS0xLTkwNzEy_8c3bda6a-e007-466c-b49d-eee3efd099d0">3,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of equity instruments of the Company</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzI4LTEtMS0xLTkwNzEy_c14b1592-0ae3-44d5-91ae-eeb7316df97f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzI4LTMtMS0xLTkwNzEy_39919e06-60e3-440c-9b5f-496ae1a6046f">396</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:RepaymentsOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzI5LTEtMS0xLTkwNzEy_5ec19ed3-9d14-4aa5-9e68-56fbed3a8107">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:RepaymentsOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzI5LTMtMS0xLTkwNzEy_dae40cd3-c009-4da7-a021-f98c3bdaf223">570</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzMwLTEtMS0xLTk5ODMy_7715d86b-0474-4b91-af0a-f9876539e67c">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzMwLTMtMS0xLTk5ODMx_7ed39236-291d-4b2b-ad92-94b6dd5ab952">85,959</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (decrease) increase in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzMxLTEtMS0xLTk5ODMy_6cd35d47-6a77-49e4-bf99-f379e0bca948">77,843</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzMxLTMtMS0xLTkwNzEy_fa30dd25-64ed-4541-b1a2-d05287575f39">55,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzMyLTEtMS0xLTkwNzEy_0fff2acc-9835-49b1-9c81-2f3fea210f50">128,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzMyLTMtMS0xLTkwNzEy_4c061cf2-81d4-4bcb-9356-77d261079a75">60,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of currency translation on cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzMzLTEtMS0xLTkwNzEy_4aef9530-ffd1-4128-bd79-672bbb12b52f">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzMzLTMtMS0xLTkwNzEy_1507b220-b4ee-48cb-8b3c-e7d4904836f7">249</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzM0LTEtMS0xLTk5ODMy_3e4a0a76-aa93-4dfa-8762-a28c8f5424ec">51,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34364739f4c64be69f7a57e53ecbd751_I20210930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzM0LTMtMS0xLTk5ODMx_d983cf5c-1ef9-4c67-80b1-a79929eac2d1">115,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental disclosure of non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition of property, plant and equipment under accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzM2LTEtMS0xLTkwNzEy_9c313323-212b-4ac7-bebb-11227f3b0a04">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzM2LTMtMS0xLTkwNzEy_ebfaf472-ecfb-4b95-995f-8cbac7cd4937">346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receipt of common shares as payment for option exercises</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:ConversionOfStockAmountConverted1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzM3LTEtMS0xLTkwNzEy_79cfebc4-aa64-4b4d-9637-e5e7499eff9f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:ConversionOfStockAmountConverted1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzM3LTMtMS0xLTkwNzEy_18e5be34-8ae7-4a1a-8467-68f67a7fa103">938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPP loan forgiveness</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="amci:NoncashLoanForgiveness" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzM4LTEtMS0xLTkwNzEy_27ca5cb7-7a9c-4aed-9af4-aa8d2ca69591">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="amci:NoncashLoanForgiveness" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzM4LTMtMS0xLTkwNzEy_69f4aff9-ee87-462b-88b8-f071849fdae1">3,065</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the accompanying Notes to the Condensed Consolidated Financial Statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-46</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_671"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LANZATECH NZ, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND SHAREHOLDERS&#8217; DEFICIT (UNAUDITED)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(all amounts in thousands, except share data) </span></div></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.726%"><tr><td style="width:1.0%"></td><td style="width:24.808%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.754%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.268%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.754%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.754%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.623%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.469%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable Convertible Preferred Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shareholders' Deficit</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at January 1, 2022, as Restated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzgtMS0xLTEtOTA3MTQ_aae21c98-321c-4524-b1c1-e93c64bf9468">29,521,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzgtMy0xLTEtOTA3MTQ_48cd4831-bb5d-4c0f-84a8-e362912d0a2d">480,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i78e21c830827492786035892daf32e0d_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzgtNi0xLTEtOTA3MTQ_60b2fa77-7af7-4864-a250-24d08f4c6612">2,106,934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78e21c830827492786035892daf32e0d_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzgtOC0xLTEtOTA3MTQ_164f2e08-efb5-4a20-b36c-2ff58ee00dd5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20c42717ddd94c808b501ab8475516e6_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzgtMTAtMS0xLTkwNzE0_9abc4b1c-7055-4aaf-8ecd-823989661b5f">21,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0898c763893444f8318ba806e5872af_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzgtMTItMS0xLTkwNzE0_e3a677af-df70-4c95-b3af-7fbdb51f3595">379,889</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6fb523d0475453fbb376be661a6c994_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzgtMTQtMS0xLTkwNzE0_ac122f4e-8ebe-4d28-bedb-be78288dd63b">3,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzgtMTYtMS0xLTkwNzE0_776255ab-6cf7-44d2-b024-ddd882e180d7">354,917</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1f4bcf8b20140f296bf2a34009e0064_D20220101-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzEwLTEwLTEtMS05MDcxNA_5daf6295-442c-4995-8944-920ff0e2869f">2,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzEwLTE2LTEtMS05MDcxNA_31e66e40-8734-4928-8372-29031fe6d6b0">2,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98880ce312ba4017b552dd89dc664bb1_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzExLTEyLTEtMS05MDcxNA_a2c2d905-9029-4ae7-9b35-b9575077d315">54,974</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzExLTE2LTEtMS05MDcxNA_f7fbd35d-f75c-481c-a9b9-d6e9528437aa">54,974</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic0a0ddb6c93245558effec1f57e566ba_D20220101-20220930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzEyLTYtMS0xLTkwNzE0_b893b993-8178-4006-822b-a32f161168a5">3,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1f4bcf8b20140f296bf2a34009e0064_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzEyLTEwLTEtMS05MDcxNA_6cf43a8f-ed6e-4f0f-8ab8-29b0314d344b">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzEyLTE2LTEtMS05MDcxNA_41cb08dd-f8a8-4418-bc9b-00081503fc12">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer from foreign currency translation to equity security investment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13b3497fdd1e496ba1fa077592599faf_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzEzLTE0LTEtMS05MDcxNA_4ab67200-44fb-4226-a3e0-d41b7982bd5e">928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzEzLTE2LTEtMS05MDcxNA_7a90a4a7-8cc7-48a5-a93d-848f006d0583">928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13b3497fdd1e496ba1fa077592599faf_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzE0LTE0LTEtMS05MDcxNA_85afc25f-b58f-4191-a0c8-1415fd1e584c">767</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzE0LTE2LTEtMS05MDcxNA_deb93d03-dee4-4a4d-ac6a-1e345ba57864">767</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September&#160;30, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzE1LTEtMS0xLTEwMDIyOQ_ba14e279-4a34-436e-bee4-62bfd8528c09">29,521,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzE1LTMtMS0xLTEwMDIyOQ_4d6ed53f-ec00-49d8-bb1c-61a51becdde6">480,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i38e737447613466db8a474885460ec95_I20220930" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzE1LTYtMS0xLTEwMDIyOQ_ac273511-3dd3-41ca-9826-3d7388999357">2,110,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38e737447613466db8a474885460ec95_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzE1LTgtMS0xLTEwMDIyOQ_d4489092-3aa2-48dd-9bca-706d4cb5d285">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i758897248ac340d7bb20c3abbe6a9817_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzE1LTEwLTEtMS0xMDAyMjY_cca52f3f-1518-4777-884f-a6e2fd0ffde7">23,801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id15fe476907046a7b6b9b51738bf5917_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzE1LTEyLTEtMS0xMDAyMjY_5a424570-3dfe-4d0e-a838-ed3fafe5b10a">434,863</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4e845950e88489fa5590b0035aa2dea_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzE1LTE0LTEtMS0xMDAyMjM_87ab1c66-dec2-4d30-89c0-1cf6a4fa7f1b">3,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzE1LTE2LTEtMS0xMDAyMTM_2d0a1e96-4e31-49e8-ba69-dab6fc5ce4ea">407,640</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.751%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.349%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.159%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.349%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.474%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.360%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable Convertible Preferred Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shareholders' Deficit</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at January 1, 2021, as Restated </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzgtMS0xLTEtOTA3MTQ_3ac72db6-0b23-4fa7-8aea-c49240282193">25,729,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzgtMy0xLTEtOTA3MTQ_04c1bd2c-70f2-4e4f-8b2a-1b14de951fcc">394,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4d49e0cbdb6445f7b88d97d435a55770_I20201231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzgtNi0xLTEtOTA3MTQ_ae95a750-4887-46dd-9532-c612ca4213b4">1,656,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d49e0cbdb6445f7b88d97d435a55770_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzgtOC0xLTEtOTA3MTQ_edf73803-053d-45c8-8f31-2822810a5b51">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c18fa0bbec84bdcb7e52c35f80ede0a_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzgtMTAtMS0xLTkwNzE0_333d7efd-e111-4915-8f53-274cd2bf8852">18,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i18eedd573381425c8c989e260801dafe_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzgtMTItMS0xLTkwNzE0_c98585f8-a48d-4ce4-b6ab-0317f55a32d6">333,200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e70eaff18414dc4b12fb6d52ddce0d0_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzgtMTQtMS0xLTkwNzE0_1cabb4fd-e2d6-4bed-acc2-b7d209f3f232">3,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzgtMTYtMS0xLTkwNzE0_267cd072-534b-47f0-890b-35fe098c5d24">311,216</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of Series F Preferred Stock, net of issuance cost of $<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="INF" name="amci:TemporaryEquityStockIssuanceCost" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzktMC0xLTEtOTA3MTQvdGV4dHJlZ2lvbjo0N2M0ZTdlYTJmM2Y0OWRmOGZlNmFhZjliZjY3MTNjOF8xNDI5MzY1MTE2MTE1Ng_7eb8da91-e01f-45a7-94df-14a230d404c9">0</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="INF" name="amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzktMS0xLTEtOTA3MTQ_982ba8f4-72a6-4206-9f17-9f18f1dd3e1a">3,634,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzktMy0xLTEtOTA3MTQ_c88d97fe-7738-40bb-940b-d77c5bb041ae">83,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="INF" name="amci:TemporaryEquitySharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzEwLTEtMS0xLTkwNzE0_119d3e1a-8c75-4097-b1a4-dba6db262018">158,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="amci:TemporaryEquityValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzEwLTMtMS0xLTkwNzE0_8426c3cf-80c4-4c3b-a143-59a3f1bbbefe">3,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86b1d28db14d4ccea94e00a84975ab9a_D20210101-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzExLTEwLTEtMS05MDcxNA_c9c47b1e-0211-4f7b-9160-17e5d1946be1">1,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzExLTE2LTEtMS05MDcxNA_2ccdcbc1-492e-4cd6-b490-61266e179e5e">1,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of equity instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86b1d28db14d4ccea94e00a84975ab9a_D20210101-20210930" decimals="-3" name="amci:AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzEyLTEwLTEtMS05MDcxNA_bb259cb9-7f69-4085-91ec-14c82b314bd5">396</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="amci:AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzEyLTE2LTEtMS05MDcxNA_5b203e66-1029-4f52-ab1a-4605f9165a71">396</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6dfcd7c6d97d4ad18dc9629f6bf4066c_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzEzLTEyLTEtMS05MDcxNA_d5505aec-966b-47ba-a7ec-8cce26b24c57">30,591</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzEzLTE2LTEtMS05MDcxNA_84558695-f1d4-48f1-8ee7-efa9036a34cd">30,591</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9a0614f9ac2b45cca8e106cb399680b8_D20210101-20210930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzE0LTYtMS0xLTkwNzE0_fa4ddf73-d05e-4994-8a3c-492253fa96df">448,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86b1d28db14d4ccea94e00a84975ab9a_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzE0LTEwLTEtMS05MDcxNA_6725daaa-976f-4968-b42c-016e0852fedb">702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzE0LTE2LTEtMS05MDcxNA_13e1664e-1e53-4959-aa91-d0acb2b01430">702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55f893214d234b679544f44bd054f770_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzE1LTE0LTEtMS05MDcxNA_b19a8096-a319-4d76-8782-f9a9389dc1eb">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzE1LTE2LTEtMS05MDcxNA_aedee15a-5e29-4907-9bf8-8799098233dd">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September&#160;30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i34364739f4c64be69f7a57e53ecbd751_I20210930" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzE2LTEtMS0xLTkwNzE0_a7d41d39-7a19-40dc-a9bd-53b3e2413652">29,521,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34364739f4c64be69f7a57e53ecbd751_I20210930" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzE2LTMtMS0xLTEwMDIzMg_3b53c4b3-fefe-416b-86ac-70065f2918c8">480,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib72b5d999a244a2ca01c9b4f197493e7_I20210930" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzE2LTYtMS0xLTEwMDI0OQ_77093263-0cd4-4f33-aac7-6768097b2dd9">2,104,434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib72b5d999a244a2ca01c9b4f197493e7_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzE2LTgtMS0xLTEwMDI0OQ_8478040f-d09c-4da8-bebb-6a442da95cbd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7959fab1f2c4a659a441b16211f26c0_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzE2LTEwLTEtMS0xMDAyNDY_3eea6cf0-ebfa-4602-8029-db9cdedd8a6c">20,914</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4980eb4213814e27a8b8df2fb28468ac_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzE2LTEyLTEtMS0xMDAyNDM_de51993c-e7f7-4b68-92b5-6f7ba9042f8c">363,791</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63802ab78f814062927f14d9e2bb6b67_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzE2LTE0LTEtMS0xMDAyNDA_476325be-6cdb-458b-b4f1-bd78cfb6fcf0">3,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i34364739f4c64be69f7a57e53ecbd751_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzE2LTE2LTEtMS0xMDAyMzc_de91f235-083c-4db9-b878-627ee30d8ee0">339,740</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the accompanying Notes to the Condensed Consolidated&#160;Financial Statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-47</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_681"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LANZATECH NZ, INC.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</span></div></div><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_689"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1 &#8212; <ix:continuation id="i95232bd264bf4f159ee9dbeb2fb7f807" continuedAt="i9ae1ee4e24eb473b824b27d5068704b6">Description of the Business</ix:continuation></span></div><ix:continuation id="i9ae1ee4e24eb473b824b27d5068704b6" continuedAt="i2d893bd07ddb49439a544951e735756b"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reporting entity is LanzaTech NZ, Inc. (formerly known as LanzaTech New Zealand Limited) and its subsidiaries (collectively, &#8220;the Company&#8221; or "LanzaTech"). LanzaTech NZ, Inc. is a profit-oriented entity previously incorporated in New Zealand. Effective October 28, 2021, LanzaTech New Zealand Limited filed a Certificate of Incorporation to migrate its country of domicile from New Zealand to Delaware, in the United States, and change its corporate name to &#8220;LanzaTech NZ, Inc.&#8221; The amendment was approved by the Board of Directors of LanzaTech and was effected by the filing of a Certificate of Incorporation with the Delaware Secretary of State. The registered office location is c/o The Corporation Trust Company, Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware, 19801. The Company licenses its technology to customers, performs research and development in biotechnology, and provides engineering and other related services for commercial and government customers. Using the Company&#8217;s proprietary fermentation technology, the Company&#8217;s customers can convert certain carbon-rich waste gases into fuels and chemicals. The Company employs a licensing business model whereby its customers build, own and operate facilities that use the Company's technology, and in return, the Company is paid royalties based on the revenue generated from the use of its technology. In 2018, the Company, through its partners, launched the world&#8217;s first commercial waste gas to ethanol plant in China, followed by a second one in 2021, also in China, with others currently in development in various countries.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposed Merger</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2022, the Company entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with AMCI Acquisition Corp. II, a Delaware corporation (&#8220;AMCI&#8221;) and AMCI Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of AMCI (&#8220;Merger Sub&#8221;). Under the Merger Agreement, Merger Sub will merge with and into LanzaTech, with LanzaTech surviving the Merger as a wholly-owned subsidiary of AMCI (&#8220;the Business Combination&#8221;). In connection with the Business Combination, AMCI will be renamed LanzaTech Global, Inc. (&#8220;New LanzaTech&#8221;). AMCI has agreed to acquire all of the outstanding equity interests of LanzaTech for consideration consisting of an equity interest of New LanzaTech valued at approximately $<ix:nonFraction unitRef="usd" contextRef="i76d10658df3b4e6bad3f7a990812f829_D20220308-20220308" decimals="-8" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82ODkvZnJhZzo0M2YwMTI1ZGY5YjU0YmVhOTBjNWVmYjEwODg5ZDQyMi90ZXh0cmVnaW9uOjQzZjAxMjVkZjliNTRiZWE5MGM1ZWZiMTA4ODlkNDIyXzEyNjQ0MzgzNzI4NTg4_143aa043-927c-4c82-8a32-381a9683455b">1.8</ix:nonFraction>&#160;billion. Completion of the transaction is subject to certain customary regulatory consents and approval by stockholders of AMCI and the Company. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Merger Agreement was amended on December 7, 2022, to provide for, among other things, (i) the inclusion of the aggregate net proceeds from each of the AM SAFE Note and Brookfield SAFE in the Acquiror Closing Cash Amount, (ii) the reduction of the Minimum Closing Cash Condition from $<ix:nonFraction unitRef="usd" contextRef="i3e4ce82bb6ca465b8f60e74f553154c0_I20220308" decimals="INF" name="amci:ReverseCapitalizationClosingCashCondition" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82ODkvZnJhZzo0M2YwMTI1ZGY5YjU0YmVhOTBjNWVmYjEwODg5ZDQyMi90ZXh0cmVnaW9uOjQzZjAxMjVkZjliNTRiZWE5MGM1ZWZiMTA4ODlkNDIyXzEwOTk1MTE2Mjg2ODg4_0c0282a5-8578-41ce-b8e1-b37852b76e39">250,000,000</ix:nonFraction> to $<ix:nonFraction unitRef="usd" contextRef="ia00417eab54343e78db23ff7c39f19cc_I20221207" decimals="INF" name="amci:ReverseCapitalizationClosingCashCondition" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82ODkvZnJhZzo0M2YwMTI1ZGY5YjU0YmVhOTBjNWVmYjEwODg5ZDQyMi90ZXh0cmVnaW9uOjQzZjAxMjVkZjliNTRiZWE5MGM1ZWZiMTA4ODlkNDIyXzEwOTk1MTE2Mjg2OTAy_fca78457-1fc6-427d-b072-30e6289484a7">230,000,000</ix:nonFraction>, (iii) the clarification that, to the extent that the Brookfield SAFE remains unexercised at Closing, it will be assumed by AMCI, remain in effect on the same terms and conditions as are in effect prior to the Closing and thereafter entitle the holder thereof to be issued shares of common stock in AMCI after the Closing, (iv) the clarification that, in the event that it becomes reasonably apparent to the parties that the Acquiror Closing Cash Amount will be less than the Minimum Closing Cash Condition, AMCI will use commercially reasonable efforts to enter into non-redemption agreements, or similar agreements, as may be necessary to satisfy the Minimum Closing Cash Condition, (v) the extension of the outside date applicable to the Closing from December 7, 2022 to February 28, 2023 and (vi) the elimination of LanzaTech's right to terminate the agreement in the event that we fail to, on or prior to July 7, 2022, enter into one or more additional subscription agreements or non-redemption agreements as a result of which the sum of the PIPE Investment Amount (including net proceeds under the AM SAFE Note to LanzaTech) and the aggregate number of shares of Class A common stock subject to non-redemption agreements multiplied by $<ix:nonFraction unitRef="usdPerShare" contextRef="ia00417eab54343e78db23ff7c39f19cc_I20221207" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82ODkvZnJhZzo0M2YwMTI1ZGY5YjU0YmVhOTBjNWVmYjEwODg5ZDQyMi90ZXh0cmVnaW9uOjQzZjAxMjVkZjliNTRiZWE5MGM1ZWZiMTA4ODlkNDIyXzEyNjQ0MzgzNzI4NTgw_be62af44-8bb4-4d3f-a131-1254568a1b4a">10.00</ix:nonFraction>, minus certain transaction expenses and other liabilities at Closing, would be equal to at least the Minimum Closing Cash Condition.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger Agreement, AMCI entered into subscription agreements with certain investors pursuant to which AMCI agreed to issue and sell a private placement to close immediately prior to the Business Combination.</span></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-48</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_695"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2 &#8212; <ix:continuation id="i1145a981771c4b53b99e9d85b31bf8ee" continuedAt="ib099cbda83ca49b1abf3ac3c0075387e">Summary of Significant Accounting Policies </ix:continuation></span></div><ix:continuation id="ib099cbda83ca49b1abf3ac3c0075387e" continuedAt="ibaee9f03de4c41208b15a1ecbf93400b"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id93b75853a924368982b7ccd90ee4322" continuedAt="i9334404a4b6b4bcfbe949931fc737113">The accompanying unaudited condensed consolidated financial statements of LanzaTech NZ Inc. have been prepared in accordance with generally accepted accounting principles for interim financial information, and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America ("US GAAP"), the accounting principles, standards, and procedures adopted by the U.S. Securities and Exchange Commission, for complete financial statements. However, in the opinion of management, all adjustments (consisting of normal recurring accruals) have been made that are necessary for a fair presentation of the condensed consolidated financial statements for the interim periods. For further information refer to the Consolidated Financial Statements and Footnotes thereto included in the Company's Annual Report for the year ended December 31, 2021.</ix:continuation></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a qualitative approach in assessing the consolidation requirement for variable interest entities ("VIEs"). This approach focuses on determining whether the Company has the power to direct the activities of the VIE that most significantly affect the VIE&#8217;s economic performance and whether the Company has the obligation to absorb losses, or the right to receive benefits, that could potentially be significant to the VIE.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds interests in certain VIEs for which it has been determined the Company is not the primary beneficiary. The Company's variable interests primarily relate to entities in which the Company has a non-controlling equity interest. Although these financial arrangements resulted in holding variable interests in these entities, they did not empower the Company to direct the activities of the VIEs that most significantly impact the VIEs' economic performance. The Company's interests in the VIEs are, therefore, accounted for under the equity method of accounting or alternative measurement. Refer to Note 5,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further information. The Company is exposed to the VIEs' losses and other impairment indicators up to the carrying value of each investment and any amounts receivable from the VIE, less amounts payable. Refer to Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further details on the transactions with VIEs.</span></div><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="amci:GoingConcernPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzEyNjQ0MzgzNzYwNTAy_49c1a415-2d28-48a6-960c-c97e0f51e636" continuedAt="i9ec98792a5364d40aabaf745d4892aca" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Going Concern</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements of the Company have been prepared assuming the Company will continue as a going concern and in accordance with accounting principles generally accepted in the United States of America ("US GAAP"). The going concern basis of presentation assumes that the Company will continue in operation one year after the date these financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. The Company had cash and cash equivalents of $<ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzMwMzI_4be7a95c-ef8f-4aca-bda6-684d62c2c62f">50,370</ix:nonFraction> and an accumulated deficit of $(<ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzMwNjc_b941e408-2a16-403f-97b4-363fadc266b1">434,863</ix:nonFraction>) at September&#160;30, 2022 and cash outflows from operations of $(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzEwOTk1MTE2MzE4ODYz_c5d36cc5-741e-43a2-b0fa-d2164e66e3d6">71,336</ix:nonFraction>) and a net loss of $(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzMxMzU_4c8900a3-ad17-45ef-864a-9bf0cff99e89">54,974</ix:nonFraction>) for the nine months ended September&#160;30, 2022. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has historically funded its operations through debt financing and issuance of equity securities. Based on the Company&#8217;s financial position as of the date these condensed consolidated financial statements were available to be issued, the Company projects that it will be able to cover its liquidity needs for the next twelve months with cash on hand. Accordingly, the Company&#8217;s condensed consolidated financial statements have been prepared on the basis that it will continue as a going concern.</span></div></ix:nonNumeric><ix:continuation id="iacd73ac48aa2490896023096807762ff" continuedAt="i1b90b58153154b5695a111deb3fb35e1"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates include fair value of equity awards granted to both employees and non-employees, the SAFE and the SAFE warrants.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in facts and circumstances or additional information may result in revised estimates, and actual results may differ from these estimates.</span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="ibaee9f03de4c41208b15a1ecbf93400b" continuedAt="i19dd88ec288d4f809c18d7e11b3356c7"><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzEyNjQ0MzgzNzYwNTAz_5dba1736-faf0-4a37-b969-d2c1df1594bd" continuedAt="i95dfebb5484c4cb6b011f7c75a41e26d" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates as <ix:nonFraction unitRef="segment" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzEwOTk1MTE2MzE4ODgy_6efbdcf3-c216-4d2a-b246-0e238996b17b">one</ix:nonFraction> operating segment which is the licensing of its technologies and related services such as research and development and engineering. The Chief Executive Officer who is the chief operating decision maker, reviews financial information on an aggregate basis for allocating resources and evaluating financial performance. Substantially all of the Company's long-lived assets are maintained in the United States. </span></div></ix:nonNumeric><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzEyNjQ0MzgzNzYwNTA0_445633bb-1116-4d7b-aa32-cab16fb0270e" continuedAt="i77a09598a51c423180f1bbf63da96c67" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currencies</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reporting currency is the U.S. Dollar. The Company has certain foreign subsidiaries where the functional currency is the local currency. All of the assets and liabilities of these subsidiaries are converted to U.S. dollars at the exchange rate in effect at the balance sheet date, income and expense accounts are translated at average rates for the period, and shareholder&#8217;s equity accounts are translated at historical rates. The effects of translating financial statements of foreign operations into our reporting currency are recognized as an adjustment in accumulated other comprehensive income (loss).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has foreign subsidiaries that have a functional currency of the U.S. dollar. Purchases and sales of assets and income and expense items denominated in foreign currencies are remeasured into U.S. dollar amounts on the respective dates of such transactions. Net realized foreign currency gains or losses relating to the differences between these recorded amounts and the U.S. dollar equivalent actually received or paid are included within Other (expense) income, net in the condensed consolidated statements of operations and comprehensive loss.</span></div></ix:nonNumeric><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:continuation id="i09484847551142418cdffc3c9c5affa7" continuedAt="ib5e7619c56474b4c90f85433a00af9e1">Cash and Cash Equivalents</ix:continuation></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib5e7619c56474b4c90f85433a00af9e1">The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents.</ix:continuation> As of September&#160;30, 2022 and December&#160;31, 2021, the Company had $<ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzYyMTU_4be7a95c-ef8f-4aca-bda6-684d62c2c62f">50,370</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzYyMjI_e9d1675a-a926-4452-b5fa-4588c28c201e">128,318</ix:nonFraction> of cash and cash equivalents, respectively.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzEyNjQ0MzgzNzYwNTA1_37c5a75a-91cb-4037-8a86-e00c0cefa119" continuedAt="ia1c6ca72bba34c95bcaabf3b72214096" escape="true">Restricted Cash and Other Cash Flows from Operating Activities</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia1c6ca72bba34c95bcaabf3b72214096" continuedAt="i2db626d1882f40dd84be53b5847b813d">The Company is required to maintain a cash deposit with a bank which consists of collateral on certain travel and expense programs maintained by the bank. </ix:continuation><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzEyNjQ0MzgzNzYwNTA2_14be1a80-0763-4159-a69a-18646913aa12" continuedAt="i9690259a73dd4b618afb3c9ea85ee003" escape="true">The following represents a reconciliation of cash and cash equivalents in the condensed consolidated balance sheets to total cash, cash equivalents and restricted cash in the condensed consolidated statements of cash flows as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands).</ix:nonNumeric></span></div><div style="margin-bottom:9pt"><ix:continuation id="i9690259a73dd4b618afb3c9ea85ee003" continuedAt="i79861692e30244c5b89cea291c63d8bd"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTpkOTkyMWE0ZDU1MGY0NjJkODliYWNhODliNmQ0OTkwMi90YWJsZXJhbmdlOmQ5OTIxYTRkNTUwZjQ2MmQ4OWJhY2E4OWI2ZDQ5OTAyXzItMS0xLTEtOTA3MTc_54ad6417-3e90-44b3-bad9-fa826203f99b">50,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTpkOTkyMWE0ZDU1MGY0NjJkODliYWNhODliNmQ0OTkwMi90YWJsZXJhbmdlOmQ5OTIxYTRkNTUwZjQ2MmQ4OWJhY2E4OWI2ZDQ5OTAyXzItMy0xLTEtOTA3MTc_f62aa66b-42fc-4129-a73f-10db6c3c9005">128,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (presented within Other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:RestrictedCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTpkOTkyMWE0ZDU1MGY0NjJkODliYWNhODliNmQ0OTkwMi90YWJsZXJhbmdlOmQ5OTIxYTRkNTUwZjQ2MmQ4OWJhY2E4OWI2ZDQ5OTAyXzMtMS0xLTEtOTA3MTc_101f4207-dee3-4d5f-80c9-b1463bb5eae2">664</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:RestrictedCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTpkOTkyMWE0ZDU1MGY0NjJkODliYWNhODliNmQ0OTkwMi90YWJsZXJhbmdlOmQ5OTIxYTRkNTUwZjQ2MmQ4OWJhY2E4OWI2ZDQ5OTAyXzMtMy0xLTEtOTA3MTc_51244441-1acd-466a-9a23-9bfa40691a5a">414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTpkOTkyMWE0ZDU1MGY0NjJkODliYWNhODliNmQ0OTkwMi90YWJsZXJhbmdlOmQ5OTIxYTRkNTUwZjQ2MmQ4OWJhY2E4OWI2ZDQ5OTAyXzQtMS0xLTEtMTAzOTkw_d5012947-df1e-4920-b403-93fd312d2f76">51,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTpkOTkyMWE0ZDU1MGY0NjJkODliYWNhODliNmQ0OTkwMi90YWJsZXJhbmdlOmQ5OTIxYTRkNTUwZjQ2MmQ4OWJhY2E4OWI2ZDQ5OTAyXzQtMy0xLTEtMTAzOTkw_b13f6818-6532-4612-b248-a3e6d41c7384">128,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzEyNjQ0MzgzNzYwNTA3_2ae97da4-14ef-4461-b43c-3905da4a9344" continuedAt="i17b92520167d4edabb4f1fd31b9d9460" escape="true">Trade and Other Receivables </ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i17b92520167d4edabb4f1fd31b9d9460" continuedAt="ic7572311be3e498cbe8c782ef360f2c1">Receivables are reported net of allowances for doubtful accounts. The Company maintains allowances for doubtful accounts for estimated losses resulting from the inability of customers to make required payments. The Company estimates the allowance for doubtful accounts based on a variety of factors including the length of time receivables are past due, the financial health of customers, unusual macroeconomic conditions, and historical experience. </ix:continuation>As of September&#160;30, 2022 and December&#160;31, 2021, the Company recognized an allowance for doubtful accounts of $<ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzczMDM_40a0eeb9-9238-4194-ae37-de91afbc7d93">1,051</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzczMTA_9958e039-0384-4885-b0d3-707db7252a34">1,235</ix:nonFraction>, respectively.</span></div><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzEyNjQ0MzgzNzYwNTA4_79c0d118-cf48-4d73-a848-bc3e061a9c39" continuedAt="if45177b0b529496fa1b94d46a364a09b" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with Accounting Standards Codification ("ASC") 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company primarily earns revenue from services related to feasibility studies and basic engineering design of commercial plants, licensing of technologies, joint development and contract </span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i19dd88ec288d4f809c18d7e11b3356c7" continuedAt="i8310019c3b634671abe4abf28c133778"><ix:continuation id="if45177b0b529496fa1b94d46a364a09b" continuedAt="if153fbae7d304fa79c6bf5f2d9d2344b"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">research activities to develop novel biocatalysts and related technologies, and sale of CarbonSmart ethanol produced using the Company's proprietary technologies.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is measured based on the consideration specified in a contract with a customer. The Company records taxes collected from customers and remitted to governmental authorities on a net basis. The Company&#8217;s payment terms are between 30-60 days and can vary by customer type and products offered. Management has evaluated the terms of our arrangements and determined that they do not contain significant financing components.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Carbon Capture and Transformation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides feasibility studies and basic design and engineering services used for detailed design, procurement, and construction of commercial plants that utilize the Company&#8217;s technologies, along with the sale of equipment and microbes. The services provided are recognized as a performance obligation satisfied over time. Revenue is recognized using the output method based on milestone completion, the cost-to-cost input method for certain engineering services, or the percentage of completion method as performance obligations are satisfied. Management has determined that the milestone completion and the associated contractual payment amounts are an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company licenses intellectual property to generate recurring revenue when its customers deploy carbon capture and transformation plants. When licenses are considered to be distinct performance obligations, the recognition of revenue is dependent on the terms of the contract, which may include fixed consideration or royalties based on sales or usage, in which case, the revenue is recognized when the subsequent sale or usage occurs or when the performance obligation to which some or all of the sales or usage-based royalty is allocated has been satisfied, whichever is later.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Services</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs research and development (&#8220;R&amp;D&#8221;) services related to novel technologies and development of biocatalysts for commercial applications, mainly to produce fuels and chemicals. The Company engages in two main types of R&amp;D services &#8211; joint development agreements, and other contract research, including projects with the U.S. Department of Energy. Such services are recognized as a performance obligation satisfied over time. Revenue is recognized based on milestone completion, when payments are contingent upon the achievement of such milestones, or based on percentage-completion method when enforceable rights to payment exist. When no milestones or phases are clearly defined, management has determined that the cost incurred, input method, is an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and estimates its variable consideration under the expected value method. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is not recognized in advance of customer acceptance of a milestone when such acceptance is contractually required. Payments for R&amp;D services with no contractual payments are not due from customers until a technical report is submitted; therefore, a contract asset is recognized at milestone completion but prior to the submission of a technical report. The contract asset represents the Company&#8217;s right to consideration for the services performed at milestone completion. Occasionally, customers provide payments in advance of the Company providing services which creates a contract liability for the Company. The contract liability represents the Company's obligation to provide services to a customer. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collaboration Arrangements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain partnership agreements that are within the scope of ASC 808, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides guidance on the presentation and disclosure of collaborative arrangements. Generally, the classification of the transactions under the collaborative arrangements is determined based on the nature of the contractual terms of the arrangement, along with the nature of the operations of the participants. The Company&#8217;s collaborative agreements generally include a provision of R&amp;D services related to novel technologies and biocatalysts. Amounts received for these services are classified as Revenue from collaborative arrangements in the condensed consolidated statements of operations and comprehensive loss. The Company's R&amp;D services are a major part of the Company's ongoing operations and therefore ASC 606 is applied to recognize revenue.</span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i8310019c3b634671abe4abf28c133778" continuedAt="i0e03f3ec7cf045b1ade35642851de707"><ix:continuation id="if153fbae7d304fa79c6bf5f2d9d2344b"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CarbonSmart</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's CarbonSmart business, initially CarbonSmart ethanol, is produced by LanzaTech licensed plants using the Company's proprietary technologies. Customers can buy CarbonSmart ethanol directly from LanzaTech, which the Company sources from these partnering plants. Revenue is recognized at a point in time when control transfers to the customer, which varies depending on the shipping terms. The Company acts as the principal in such transactions and accordingly, recognizes revenue and cost of revenues on a gross basis.</span></div></ix:continuation><ix:continuation id="id55ae49f030e4e16b38d2d4f116feed9" continuedAt="ic134ef192e0d4485a314607ad44035c0"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily due to their short-term nature, except for the warrant liability. </span></div></ix:continuation><ix:continuation id="i6a1aedda86154155a15af2c6e0818f44" continuedAt="ib05d87a8c0394d27b06a4e113a31ab02"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue generated from the Company&#8217;s customers outside of the United States for the nine months ended September&#160;30, 2022 and 2021 was approximately <ix:nonFraction unitRef="number" contextRef="i9e0585e1e90d4bfcaf7ee5c271d12b05_D20220101-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzE0Njkx_5ecba68c-a103-4835-b271-c8adaf82ab62">61</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i1c9ab1e0b29947a7a657a947fe20cbe7_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzE0Njk4_4ad09a72-545e-4cd0-8719-0c2c57b127d3">65</ix:nonFraction>%, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021, approximately <ix:nonFraction unitRef="number" contextRef="i9d1fe9a7bf25419cb084a70d94fcaf1d_D20220101-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzE0NzQ3_d48841c2-13c7-4c98-99e0-a9526ffa6288">35</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ie2e8db82a9c84e61945251a17b875f00_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzE0NzU0_0c9825e1-4f47-4b8f-988e-3bbbf198e42e">35</ix:nonFraction>%, respectively, of trade accounts receivable and unbilled accounts receivable was due from customers located outside the United States. At September&#160;30, 2022 and December&#160;31, 2021, the value of property, plant, and equipment outside the United States was immaterial.</span></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib05d87a8c0394d27b06a4e113a31ab02" continuedAt="i11242f18cce5452f88a1ba2f3b3e4c03">The Company&#8217;s revenue by geographic region based on the customer&#8217;s location</ix:continuation> is presented in Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i0e03f3ec7cf045b1ade35642851de707" continuedAt="ie13506f5f5ed412189f70da16928770a"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customers</span></div><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzE1OTQyOTE4NjQzODM4_7ec3719b-c8d3-491b-9082-d205fe9fe218" continuedAt="i652f6205f2ab42d1a83cf7e4321865af" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers representing 10% or greater of revenue were as follows for the nine months ended September&#160;30, 2022 and 2021:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia3449ace90ec469a8b933bce0d62a372_D20220101-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTo5ZGIwYTQxZmI4MDI0YTY2OWUwOTc0ZGMyMDE5Mzk5Yy90YWJsZXJhbmdlOjlkYjBhNDFmYjgwMjRhNjY5ZTA5NzRkYzIwMTkzOTljXzItMS0xLTEtOTA3MTc_a2df08be-d2cb-44a3-a4a1-d28b2c7fe87d">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i315f432e066e42e392096344bb252b66_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTo5ZGIwYTQxZmI4MDI0YTY2OWUwOTc0ZGMyMDE5Mzk5Yy90YWJsZXJhbmdlOjlkYjBhNDFmYjgwMjRhNjY5ZTA5NzRkYzIwMTkzOTljXzItMy0xLTEtOTA3MTc_083478f8-39cf-4b8a-8656-bfdb6a1fa074">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i67acca9fc71147e489123a8f993fe8b2_D20220101-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTo5ZGIwYTQxZmI4MDI0YTY2OWUwOTc0ZGMyMDE5Mzk5Yy90YWJsZXJhbmdlOjlkYjBhNDFmYjgwMjRhNjY5ZTA5NzRkYzIwMTkzOTljXzMtMS0xLTEtOTA3MTc_e319c743-150b-48fc-a05b-93fbfe1b65fa">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i12519dc7dd4148c380c0b8e7e6b17007_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTo5ZGIwYTQxZmI4MDI0YTY2OWUwOTc0ZGMyMDE5Mzk5Yy90YWJsZXJhbmdlOjlkYjBhNDFmYjgwMjRhNjY5ZTA5NzRkYzIwMTkzOTljXzMtMy0xLTEtOTA3MTc_6e865643-83b3-430f-bdd4-f98766d7a6b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i47d9518ef3cd492aa38b19f292383c71_D20220101-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTo5ZGIwYTQxZmI4MDI0YTY2OWUwOTc0ZGMyMDE5Mzk5Yy90YWJsZXJhbmdlOjlkYjBhNDFmYjgwMjRhNjY5ZTA5NzRkYzIwMTkzOTljXzQtMS0xLTEtOTA3MTc_09332514-2ec9-4697-ab45-4be5ae4cc5fd">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i65b51113d1c84fe482ce3387414ff062_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTo5ZGIwYTQxZmI4MDI0YTY2OWUwOTc0ZGMyMDE5Mzk5Yy90YWJsZXJhbmdlOjlkYjBhNDFmYjgwMjRhNjY5ZTA5NzRkYzIwMTkzOTljXzQtMy0xLTEtOTA3MTc_7c9555b5-58fd-4c11-b279-bcfc200c3cb5">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5d26440e551243a091345a8db5c10bd8_D20220101-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTo5ZGIwYTQxZmI4MDI0YTY2OWUwOTc0ZGMyMDE5Mzk5Yy90YWJsZXJhbmdlOjlkYjBhNDFmYjgwMjRhNjY5ZTA5NzRkYzIwMTkzOTljXzUtMS0xLTEtOTA3MTc_69a97167-e733-40d9-ac92-40b1890f3899">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i89150b1561bc43ecbec2f1adb044c3f0_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTo5ZGIwYTQxZmI4MDI0YTY2OWUwOTc0ZGMyMDE5Mzk5Yy90YWJsZXJhbmdlOjlkYjBhNDFmYjgwMjRhNjY5ZTA5NzRkYzIwMTkzOTljXzUtMy0xLTEtOTA3MTc_b0806a22-86f6-4c28-905e-b667e63bc963">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia54c798db359416fb9d69e6545adde53_D20220101-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTo5ZGIwYTQxZmI4MDI0YTY2OWUwOTc0ZGMyMDE5Mzk5Yy90YWJsZXJhbmdlOjlkYjBhNDFmYjgwMjRhNjY5ZTA5NzRkYzIwMTkzOTljXzYtMS0xLTEtOTA3MTc_47d8b801-d0bd-4415-9395-ad7d7d806597">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9f5fbd11e5eb48dba2314084aadf7c9f_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTo5ZGIwYTQxZmI4MDI0YTY2OWUwOTc0ZGMyMDE5Mzk5Yy90YWJsZXJhbmdlOjlkYjBhNDFmYjgwMjRhNjY5ZTA5NzRkYzIwMTkzOTljXzYtMy0xLTEtOTA3MTc_862147dc-40ed-4236-8fae-df4b6c339224">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><ix:continuation id="i637a1bd411944a4eb691ac3278ac3d67" continuedAt="i2d3760be1d784b8490cdffc94b92f2e8"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Announced Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Financial Accounting Standard Board ("FASB") issued an Accounting Standard Update ("ASU") No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2020-10&#8221;). The standard contains improvements to the FASB Accounting Standards Codification (the &#8220;Codification&#8221;) by ensuring that all guidance that requires or provides an option for an entity to provide information in the notes to financial statements is codified in the disclosure section of the Codification. The standard also improves various topics in the Codification so that entities can apply guidance more consistently on codifications that are varied in nature where the original guidance may have been unclear. The amendments in ASU 2020-10 were effective for the Company for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption was permitted. There were no material impacts upon the adoption of ASU 2020-10, on its consolidated financial statements and related disclosures. </span></div></ix:continuation></ix:continuation><div id="ib82e114cd19f45afae73e7a64e42f208_701"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3 &#8212; <ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90ZXh0cmVnaW9uOmFmZjIwZTcyOGQyZjQ1YmFiZTdkMjU1NWJhOWVkNGIxXzEzNzQzODk1MzUzNTY1_7ec9160f-e2c6-4a81-9f9a-fdcf51049c8f" continuedAt="id3fc3f4716c544c9aa37fec881da1d65" escape="true">Net Loss Per Share</ix:nonNumeric></span></div><ix:continuation id="id3fc3f4716c544c9aa37fec881da1d65" continuedAt="i40ad6870773e48dd8d64ff90588ff1cb"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is computed by dividing net loss by the weighted-average number of shares of common stock of the Company outstanding during the period. Diluted net loss per share is computed by giving effect to all potential shares of common stock of the Company, including outstanding stock options, warrants, and contingently redeemable preferred stock, to the extent dilutive.</span></div><ix:continuation id="i1595af8a85a2479d91848a09431a3489" continuedAt="i832bfb2710404c6280e30a31db035fac"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of basic and diluted net loss per share for the Company&#8217;s common stock (in thousands, except shares and per share amounts):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss for basic and diluted earnings per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTphMDljODYyZGZkMDU0MzdlOWE2MzExNmJmODc0NjgxZC90YWJsZXJhbmdlOmEwOWM4NjJkZmQwNTQzN2U5YTYzMTE2YmY4NzQ2ODFkXzMtMS0xLTEtOTA3MTc_bd4888b6-d1ff-4400-a81a-b047a2b1499f">54,974</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTphMDljODYyZGZkMDU0MzdlOWE2MzExNmJmODc0NjgxZC90YWJsZXJhbmdlOmEwOWM4NjJkZmQwNTQzN2U5YTYzMTE2YmY4NzQ2ODFkXzMtMy0xLTEtOTA3MTc_ded3efb6-b883-4f89-9010-587c27522a65">30,591</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid cumulative dividends on preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:PreferredStockDividendsIncomeStatementImpact" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTphMDljODYyZGZkMDU0MzdlOWE2MzExNmJmODc0NjgxZC90YWJsZXJhbmdlOmEwOWM4NjJkZmQwNTQzN2U5YTYzMTE2YmY4NzQ2ODFkXzQtMS0xLTEtOTA3MTc_6709117e-10e5-43ed-9310-c17adedc0989">28,925</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:PreferredStockDividendsIncomeStatementImpact" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTphMDljODYyZGZkMDU0MzdlOWE2MzExNmJmODc0NjgxZC90YWJsZXJhbmdlOmEwOWM4NjJkZmQwNTQzN2U5YTYzMTE2YmY4NzQ2ODFkXzQtMy0xLTEtOTA3MTc_44615719-d6b0-4ab0-9c3e-f0f971b95c15">27,068</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss allocated to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTphMDljODYyZGZkMDU0MzdlOWE2MzExNmJmODc0NjgxZC90YWJsZXJhbmdlOmEwOWM4NjJkZmQwNTQzN2U5YTYzMTE2YmY4NzQ2ODFkXzUtMS0xLTEtMTA1Mjc4_8b9d9aab-e297-4bec-b875-d8bc1c815488">83,899</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTphMDljODYyZGZkMDU0MzdlOWE2MzExNmJmODc0NjgxZC90YWJsZXJhbmdlOmEwOWM4NjJkZmQwNTQzN2U5YTYzMTE2YmY4NzQ2ODFkXzUtMy0xLTEtMTA1Mjgx_086539ae-59b0-4a8b-a061-b82e85656f6d">57,659</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares used in calculating net loss per share, basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTphMDljODYyZGZkMDU0MzdlOWE2MzExNmJmODc0NjgxZC90YWJsZXJhbmdlOmEwOWM4NjJkZmQwNTQzN2U5YTYzMTE2YmY4NzQ2ODFkXzgtMS0xLTEtOTA3MTc_55818624-cc38-4ddf-a20d-2e4bae0eb20a"><ix:nonFraction unitRef="shares" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTphMDljODYyZGZkMDU0MzdlOWE2MzExNmJmODc0NjgxZC90YWJsZXJhbmdlOmEwOWM4NjJkZmQwNTQzN2U5YTYzMTE2YmY4NzQ2ODFkXzgtMS0xLTEtOTA3MTc_5bb9e8ad-92aa-4633-bbc3-d4c948120f9c">2,108,472</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTphMDljODYyZGZkMDU0MzdlOWE2MzExNmJmODc0NjgxZC90YWJsZXJhbmdlOmEwOWM4NjJkZmQwNTQzN2U5YTYzMTE2YmY4NzQ2ODFkXzgtMy0xLTEtOTA3MTc_4ad0362e-8dba-476a-b3cc-3f44e46057d4"><ix:nonFraction unitRef="shares" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTphMDljODYyZGZkMDU0MzdlOWE2MzExNmJmODc0NjgxZC90YWJsZXJhbmdlOmEwOWM4NjJkZmQwNTQzN2U5YTYzMTE2YmY4NzQ2ODFkXzgtMy0xLTEtOTA3MTc_77845e31-3cc3-4d2a-978c-3d0808ae8f75">1,909,635</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share, basic and diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTphMDljODYyZGZkMDU0MzdlOWE2MzExNmJmODc0NjgxZC90YWJsZXJhbmdlOmEwOWM4NjJkZmQwNTQzN2U5YTYzMTE2YmY4NzQ2ODFkXzEwLTEtMS0xLTkwNzE3_17122848-ee6a-4635-b91b-19f1d00dd5ea"><ix:nonFraction unitRef="usdPerShare" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTphMDljODYyZGZkMDU0MzdlOWE2MzExNmJmODc0NjgxZC90YWJsZXJhbmdlOmEwOWM4NjJkZmQwNTQzN2U5YTYzMTE2YmY4NzQ2ODFkXzEwLTEtMS0xLTkwNzE3_fe4ba0aa-28cf-4dac-85df-a920e3ce4f28">39.79</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTphMDljODYyZGZkMDU0MzdlOWE2MzExNmJmODc0NjgxZC90YWJsZXJhbmdlOmEwOWM4NjJkZmQwNTQzN2U5YTYzMTE2YmY4NzQ2ODFkXzEwLTMtMS0xLTkwNzE3_1d9de965-fa02-4f4f-bb83-a411b6d20965"><ix:nonFraction unitRef="usdPerShare" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTphMDljODYyZGZkMDU0MzdlOWE2MzExNmJmODc0NjgxZC90YWJsZXJhbmdlOmEwOWM4NjJkZmQwNTQzN2U5YTYzMTE2YmY4NzQ2ODFkXzEwLTMtMS0xLTkwNzE3_4d67c3c9-6b9e-42df-a9cb-e524c2259927">30.19</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In periods in which the Company reports a net loss, all share-based compensation awards are excluded from the calculation of diluted weighted average shares outstanding because of their anti-dilutive effect on earnings (loss) per share.</span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i40ad6870773e48dd8d64ff90588ff1cb" continuedAt="i6a24746baef8458985b1bcbf028ee8f4"><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90ZXh0cmVnaW9uOmFmZjIwZTcyOGQyZjQ1YmFiZTdkMjU1NWJhOWVkNGIxXzEzNzQzODk1MzUzNTY5_4e898582-80d9-40ca-8e9f-66b9898220ec" continuedAt="idc7940672ae9482f9ff7cb656b063e08" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and 2021, potential shares of common stock not included in the computation of loss per share because their effect would be antidilutive include the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable convertible preferred stock (if converted)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5424171a95fe47638686ad26cd8b4504_D20220101-20220930" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTo1ZTQxYjA0Mjc1ODE0MTU3YTNjNDMzNDhkNWQzNmE5Zi90YWJsZXJhbmdlOjVlNDFiMDQyNzU4MTQxNTdhM2M0MzM0OGQ1ZDM2YTlmXzItMS0xLTEtOTA3MTc_cde20063-2087-467d-8d80-19a8ed20e5e3">29,521,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i26fc510abd7a4c3b8c924af0c3ded993_D20210101-20210930" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTo1ZTQxYjA0Mjc1ODE0MTU3YTNjNDMzNDhkNWQzNmE5Zi90YWJsZXJhbmdlOjVlNDFiMDQyNzU4MTQxNTdhM2M0MzM0OGQ1ZDM2YTlmXzItMy0xLTEtOTA3MTc_b66e2085-beb7-429f-b46c-619dc9b0e570">29,521,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7ae7957cd9f6426986d2a7924166bbe8_D20220101-20220930" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTo1ZTQxYjA0Mjc1ODE0MTU3YTNjNDMzNDhkNWQzNmE5Zi90YWJsZXJhbmdlOjVlNDFiMDQyNzU4MTQxNTdhM2M0MzM0OGQ1ZDM2YTlmXzMtMS0xLTEtOTA3MTc_0280a094-3264-4ae1-b3ec-9672639538ec">3,790,978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5741c6b90ae94985b512b131a7c7a8f1_D20210101-20210930" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTo1ZTQxYjA0Mjc1ODE0MTU3YTNjNDMzNDhkNWQzNmE5Zi90YWJsZXJhbmdlOjVlNDFiMDQyNzU4MTQxNTdhM2M0MzM0OGQ1ZDM2YTlmXzMtMy0xLTEtOTA3MTc_fb7c5020-3d67-48b9-9cf0-19b592a03c4c">3,540,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSAs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0abb7a85949a40588f25eea015f597df_D20220101-20220930" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTo1ZTQxYjA0Mjc1ODE0MTU3YTNjNDMzNDhkNWQzNmE5Zi90YWJsZXJhbmdlOjVlNDFiMDQyNzU4MTQxNTdhM2M0MzM0OGQ1ZDM2YTlmXzQtMS0xLTEtOTA3MTc_05b5a04b-2dc2-43f3-8628-8f5aa55ef222">579,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2ce64b99bdea417c846661dbfe732b7e_D20210101-20210930" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTo1ZTQxYjA0Mjc1ODE0MTU3YTNjNDMzNDhkNWQzNmE5Zi90YWJsZXJhbmdlOjVlNDFiMDQyNzU4MTQxNTdhM2M0MzM0OGQ1ZDM2YTlmXzQtMy0xLTEtOTA3MTc_957e2144-2fc1-4b65-b3ca-87b46abfcb7a">579,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iafde522813d645e4811e7040d7545b79_D20220101-20220930" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTo1ZTQxYjA0Mjc1ODE0MTU3YTNjNDMzNDhkNWQzNmE5Zi90YWJsZXJhbmdlOjVlNDFiMDQyNzU4MTQxNTdhM2M0MzM0OGQ1ZDM2YTlmXzUtMS0xLTEtOTA3MTc_8e33b9c8-1be2-48be-9c78-c452648894d6">225,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia9418ed0ad4f411e9f9d5e0c27663f80_D20210101-20210930" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTo1ZTQxYjA0Mjc1ODE0MTU3YTNjNDMzNDhkNWQzNmE5Zi90YWJsZXJhbmdlOjVlNDFiMDQyNzU4MTQxNTdhM2M0MzM0OGQ1ZDM2YTlmXzUtMy0xLTEtOTA3MTc_edd58592-ff85-4a28-b703-485c9a3b163b">225,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTo1ZTQxYjA0Mjc1ODE0MTU3YTNjNDMzNDhkNWQzNmE5Zi90YWJsZXJhbmdlOjVlNDFiMDQyNzU4MTQxNTdhM2M0MzM0OGQ1ZDM2YTlmXzctMS0xLTEtMTA1MzI2_4f9a6d61-c530-4707-9784-505299a75aa0">34,117,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTo1ZTQxYjA0Mjc1ODE0MTU3YTNjNDMzNDhkNWQzNmE5Zi90YWJsZXJhbmdlOjVlNDFiMDQyNzU4MTQxNTdhM2M0MzM0OGQ1ZDM2YTlmXzctMy0xLTEtMTA1MzI5_a4151249-6bc3-4685-a7dc-7936808b0a1e">33,867,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the organizational documents of the Company, the preferred shares are convertible by the holder at any time at their option. In addition, the preferred shares will automatically convert into common shares upon either (i) the determination of the holders of certain requisite preferred shares of the Company (which determination will be submitted for approval by such stockholders in connection with the Business Combination described in Note 1, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Description of the Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), or (ii) a firmly underwritten initial public offering of the Company&#8217;s shares that satisfies certain requirements (but not, for the avoidance of doubt, upon a business combination with a special purpose acquisition company, such as the Business Combination, unless such conversion is otherwise effected pursuant to clause (i) above). Such conversion would be at a <ix:nonFraction unitRef="number" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="INF" name="us-gaap:PreferredStockConvertibleConversionRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90ZXh0cmVnaW9uOmFmZjIwZTcyOGQyZjQ1YmFiZTdkMjU1NWJhOWVkNGIxXzEwOTk1MTE2Mjg0MTMx_03bcc109-bbaa-4200-9381-045bac4ef156">1</ix:nonFraction>:1 ratio, adjusted for certain corporate events. Upon conversion of the preferred shares, the cumulative accrued and declared dividends will become payable. The additional <ix:nonFraction unitRef="shares" contextRef="i5424171a95fe47638686ad26cd8b4504_D20220101-20220930" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90ZXh0cmVnaW9uOmFmZjIwZTcyOGQyZjQ1YmFiZTdkMjU1NWJhOWVkNGIxXzIwMjM_cde20063-2087-467d-8d80-19a8ed20e5e3">29,521,810</ix:nonFraction> of potential shares of common stock resulting from any such conversion are not included in the computation of diluted net loss per share in the nine months ended September&#160;30, 2022 and 2021, respectively, because doing so would be anti-dilutive. In connection with the SAFE, see Note 6 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company could issue additional potential shares of common stock upon closing of the Business Combination. Further, under the Simple Agreement for Future Equity ("SAFE") warrant, additional potential shares of common stock could be issued upon closing of the Business Combination and exercise of the warrant. These potential shares of common stock have not been issued as of September 30, 2022. The per share issuance price for the SAFE and SAFE warrant upon closing of the Business Combination is <ix:nonFraction unitRef="number" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="INF" name="amci:LiquidityPriceOfSAFEAndSAFEWarrants" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90ZXh0cmVnaW9uOmFmZjIwZTcyOGQyZjQ1YmFiZTdkMjU1NWJhOWVkNGIxXzEyNjQ0MzgzNzI1Nzc5_8c5b3f4b-6e1b-4387-8c2a-33faae080a5c">100</ix:nonFraction>% of the liquidity price. If another qualified liquidity event occurs instead, the issuance price is <ix:nonFraction unitRef="number" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="2" name="amci:LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90ZXh0cmVnaW9uOmFmZjIwZTcyOGQyZjQ1YmFiZTdkMjU1NWJhOWVkNGIxXzEyNjQ0MzgzNzI1Nzg1_788a3e95-13a2-4767-883f-0997754aff29">90</ix:nonFraction>% of the liquidity price.</span></div></ix:continuation><div id="ib82e114cd19f45afae73e7a64e42f208_707"></div><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90ZXh0cmVnaW9uOjJlOWYyNWYwNmY2ZDQzOWVhY2NhMGQxYmMyMjVjMDFiXzEzNzQzODk1MzUxOTU3_c0315e9c-96a9-4663-b372-4fbcc4c7b559" continuedAt="ie0d99f63469b44cfb2041695e2a051b6" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4 &#8212; Revenues</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregated Revenue</span></div><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90ZXh0cmVnaW9uOjJlOWYyNWYwNmY2ZDQzOWVhY2NhMGQxYmMyMjVjMDFiXzEzNzQzODk1MzUxOTU4_63c9a93f-2474-4ac5-8a25-99f82b2c70f8" continuedAt="i33cddc672f3a4eca99d24f292f8cdf61" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents disaggregated revenue in the following categories (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Types:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joint development agreements</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i762c119593394e9dab80370e5fe11b8f_D20220101-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzMtMS0xLTEtOTA3MTc_6f0af3b6-591a-4234-ae43-ab874fb4d1ec">4,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c521e9c446743728abb9bb381113c58_D20210101-20210930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzMtMy0xLTEtOTA3MTc_38c6a9ea-873d-421d-86a6-709f3bdde10c">10,660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other contract research</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cfe038e19c5406ab72b862c3e2c4a7c_D20220101-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzQtMS0xLTEtOTA3MTc_d64e73b2-deeb-4d3b-b423-8024200df38a">4,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib55995d927ac49f2b032b95862ccebc3_D20210101-20210930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzQtMy0xLTEtOTA3MTc_9af36ac2-a0f3-466d-ae8c-6ff322f15e4a">1,393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifffd25e8f7474755a9cbbfa56a92b938_D20220101-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzUtMS0xLTEtOTA3MTc_99d8a78e-9d06-45b9-9b36-229f178add68">8,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1cd36f9560344a4a3455d63ec431e88_D20210101-20210930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzUtMy0xLTEtOTA3MTc_7e136c2e-a5c1-4b83-ba31-2c756e4e8d66">12,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a9fd092f5b4aaaa519e060a4d1a0bb_D20220101-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzctMS0xLTEtOTA3MTc_f6a750b7-77a9-49c8-9173-9d14568ed5a5">1,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2ce93d60685463eacfcc8cdabd7567c_D20210101-20210930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzctMy0xLTEtOTA3MTc_192df2dc-a3ce-48af-bbcb-3aaa1e53c982">1,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CarbonSmart</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a377b78b6e24777830917170e5b1313_D20220101-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzgtMS0xLTEtOTA3MTc_ff57cf55-b13f-45a0-a305-e790e0b6714d">3,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8409be642f8c496ca120218eb6fbf890_D20210101-20210930" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzgtMy0xLTEtOTA3MTc_b9e348a8-bf3e-4e62-8726-8aaba1bc4240">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Engineering and other services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdff94687942421eaaf5757d75c7f1c2_D20220101-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzktMS0xLTEtOTA3MTc_45932519-653c-40b2-b319-7070ada8e6c4">12,630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2013e6baeeb243468ee04296b2f2e7b8_D20210101-20210930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzktMy0xLTEtOTA3MTc_85a60493-9493-4a91-8b81-70c531a8d477">4,756</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carbon capture and transformation revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1a1013d2add4d6090c80d57a0f917aa_D20220101-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzEwLTEtMS0xLTkwNzE3_f8edd3e1-5825-4325-9b4b-d6d11084fd25">17,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i266d893e21e44dd69a6f838fef0c5262_D20210101-20210930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzEwLTMtMS0xLTkwNzE3_5fd1c11b-495e-481b-89cc-8f04fc8e47cd">6,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzEyLTEtMS0xLTkwNzE3_93dc3635-b6c3-4a1e-a1d0-77a67110acb9">25,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzEyLTMtMS0xLTkwNzE3_fb980201-15b8-44bf-8414-7a38c5cc2d15">18,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="ie0d99f63469b44cfb2041695e2a051b6" continuedAt="ibd61fc2302cb480280916cf51fd070dd"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from collaborative partners of $<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90ZXh0cmVnaW9uOjJlOWYyNWYwNmY2ZDQzOWVhY2NhMGQxYmMyMjVjMDFiXzE4MQ_9a8b17fe-3a8a-4d4a-b77f-ebdd448db6d6">1,733</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90ZXh0cmVnaW9uOjJlOWYyNWYwNmY2ZDQzOWVhY2NhMGQxYmMyMjVjMDFiXzE4OA_663c52eb-b4fc-4af6-ad31-709bee93131d">2,662</ix:nonFraction> for the nine months ended September&#160;30, 2022 and 2021, is included in the table above within joint development agreements. Revenue from related parties is included in licensing for $<ix:nonFraction unitRef="usd" contextRef="i44a9fd092f5b4aaaa519e060a4d1a0bb_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90ZXh0cmVnaW9uOjJlOWYyNWYwNmY2ZDQzOWVhY2NhMGQxYmMyMjVjMDFiXzEwOTk1MTE2MjgyNTQ1_fdd73c5e-f987-4226-9f1b-fd9ad6498eee">1,620</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ic2ce93d60685463eacfcc8cdabd7567c_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90ZXh0cmVnaW9uOjJlOWYyNWYwNmY2ZDQzOWVhY2NhMGQxYmMyMjVjMDFiXzEwOTk1MTE2MjgyNTU3_6e70d105-9d65-4720-a28e-73868419273a">1,518</ix:nonFraction> with the remaining revenue of $<ix:nonFraction unitRef="usd" contextRef="icdff94687942421eaaf5757d75c7f1c2_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90ZXh0cmVnaW9uOjJlOWYyNWYwNmY2ZDQzOWVhY2NhMGQxYmMyMjVjMDFiXzEyNjQ0MzgzNzI0MTcw_2a81f027-008b-43a8-8ce4-4cf7ec8a967f">496</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i2013e6baeeb243468ee04296b2f2e7b8_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90ZXh0cmVnaW9uOjJlOWYyNWYwNmY2ZDQzOWVhY2NhMGQxYmMyMjVjMDFiXzEyNjQ0MzgzNzI0MTc2_3fae5227-c062-495a-8e8e-2fce4caac370">830</ix:nonFraction> in Engineering and other services, for the nine months ended September&#160;30, 2022 and 2021, respectively.</span></div><ix:continuation id="i33cddc672f3a4eca99d24f292f8cdf61" continuedAt="ie27f23b9cd4a4f5fb450a3ee933e108f"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents disaggregation of the Company&#8217;s revenues by customer location for the nine months ended September&#160;30, 2022 and 2021 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5573ff2e43a4c498f3126b9f6dfd70f_D20220101-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTowZDdjY2ZmMzQ1ODE0NTg3YjM2ZDZiMWYyZjFlODFlOC90YWJsZXJhbmdlOjBkN2NjZmYzNDU4MTQ1ODdiMzZkNmIxZjJmMWU4MWU4XzItMS0xLTEtOTA3MTc_75f2c455-e9c8-406b-bd59-fcc741e6a224">12,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8145859fe60a449a937d2ca309df194f_D20210101-20210930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTowZDdjY2ZmMzQ1ODE0NTg3YjM2ZDZiMWYyZjFlODFlOC90YWJsZXJhbmdlOjBkN2NjZmYzNDU4MTQ1ODdiMzZkNmIxZjJmMWU4MWU4XzItMy0xLTEtOTA3MTc_35ce2b3e-de2e-4b68-9eaa-78c19f0a2084">12,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Middle East, Africa (EMEA)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b913fb20765432a923bd689fe670302_D20220101-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTowZDdjY2ZmMzQ1ODE0NTg3YjM2ZDZiMWYyZjFlODFlOC90YWJsZXJhbmdlOjBkN2NjZmYzNDU4MTQ1ODdiMzZkNmIxZjJmMWU4MWU4XzMtMS0xLTEtOTA3MTc_19b9bc8b-7619-4d69-af36-dbb9f197d784">7,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdb81a8598ac482d9b8beedc98026777_D20210101-20210930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTowZDdjY2ZmMzQ1ODE0NTg3YjM2ZDZiMWYyZjFlODFlOC90YWJsZXJhbmdlOjBkN2NjZmYzNDU4MTQ1ODdiMzZkNmIxZjJmMWU4MWU4XzMtMy0xLTEtOTA3MTc_e2589a09-6f72-421b-9d9c-2134214f7248">5,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i782abe270873419eb029c509a796cfe0_D20220101-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTowZDdjY2ZmMzQ1ODE0NTg3YjM2ZDZiMWYyZjFlODFlOC90YWJsZXJhbmdlOjBkN2NjZmYzNDU4MTQ1ODdiMzZkNmIxZjJmMWU4MWU4XzQtMS0xLTEtOTA3MTc_5f77cbe5-5488-4e05-a47c-6329acfde7d6">4,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if05bbbf98c144ad8aa72922f1d64e7e2_D20210101-20210930" decimals="-3" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTowZDdjY2ZmMzQ1ODE0NTg3YjM2ZDZiMWYyZjFlODFlOC90YWJsZXJhbmdlOjBkN2NjZmYzNDU4MTQ1ODdiMzZkNmIxZjJmMWU4MWU4XzQtMy0xLTEtOTA3MTc_2b52d7fa-cd38-4c30-a51e-b08164a718b9">242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48ba258d15f74288bf5398c05269bbf6_D20220101-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTowZDdjY2ZmMzQ1ODE0NTg3YjM2ZDZiMWYyZjFlODFlOC90YWJsZXJhbmdlOjBkN2NjZmYzNDU4MTQ1ODdiMzZkNmIxZjJmMWU4MWU4XzUtMS0xLTEtOTA3MTc_16bf8807-b5f0-4738-b34b-38328fbccb5a">1,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e768c2b952146e1955ab2593a5abd0b_D20210101-20210930" decimals="-3" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTowZDdjY2ZmMzQ1ODE0NTg3YjM2ZDZiMWYyZjFlODFlOC90YWJsZXJhbmdlOjBkN2NjZmYzNDU4MTQ1ODdiMzZkNmIxZjJmMWU4MWU4XzUtMy0xLTEtOTA3MTc_e6cd24dd-52f0-4037-9d3d-6e7d137ee814">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTowZDdjY2ZmMzQ1ODE0NTg3YjM2ZDZiMWYyZjFlODFlOC90YWJsZXJhbmdlOjBkN2NjZmYzNDU4MTQ1ODdiMzZkNmIxZjJmMWU4MWU4XzYtMS0xLTEtMTAyODQ4_647a64ae-aa15-4e3c-958f-679926724718">25,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTowZDdjY2ZmMzQ1ODE0NTg3YjM2ZDZiMWYyZjFlODFlOC90YWJsZXJhbmdlOjBkN2NjZmYzNDU4MTQ1ODdiMzZkNmIxZjJmMWU4MWU4XzYtMy0xLTEtMTAyODQ4_e0b35b07-93af-4f17-ad0c-dbdb41226825">18,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract balances</span></div><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90ZXh0cmVnaW9uOjJlOWYyNWYwNmY2ZDQzOWVhY2NhMGQxYmMyMjVjMDFiXzEzNzQzODk1MzUxOTYw_caaa6e1a-25be-44f0-9cf3-7f8c07bbcf93" continuedAt="i62662af451f54664944fe209802b7be0" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides changes in contract assets and liabilities (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Contract Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Contract Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-current Contract Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022 as Restated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTozZDMwYjFhM2FiYWU0ZTQ2YTgxNjdmNzg2MjE0MGYyZC90YWJsZXJhbmdlOjNkMzBiMWEzYWJhZTRlNDZhODE2N2Y3ODYyMTQwZjJkXzEtMS0xLTEtOTA3MTc_cfd43cc6-7f45-48dd-879f-46aed905f893">11,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTozZDMwYjFhM2FiYWU0ZTQ2YTgxNjdmNzg2MjE0MGYyZC90YWJsZXJhbmdlOjNkMzBiMWEzYWJhZTRlNDZhODE2N2Y3ODYyMTQwZjJkXzEtMy0xLTEtOTA3MTc_f7bc87b0-d075-44fc-80f6-d3c2fa2d4fe7">3,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTozZDMwYjFhM2FiYWU0ZTQ2YTgxNjdmNzg2MjE0MGYyZC90YWJsZXJhbmdlOjNkMzBiMWEzYWJhZTRlNDZhODE2N2Y3ODYyMTQwZjJkXzEtNS0xLTEtOTA3MTc_33535710-976d-4be4-af07-a44b3d4d523e">13,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to unbilled accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="amci:ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTozZDMwYjFhM2FiYWU0ZTQ2YTgxNjdmNzg2MjE0MGYyZC90YWJsZXJhbmdlOjNkMzBiMWEzYWJhZTRlNDZhODE2N2Y3ODYyMTQwZjJkXzItMS0xLTEtOTA3MTc_e3f9b858-42c7-46cf-b15d-ce07e2377593">19,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases due to cash received</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="amci:ContractWithCustomerLiabilityCurrentAmountsCollected" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTozZDMwYjFhM2FiYWU0ZTQ2YTgxNjdmNzg2MjE0MGYyZC90YWJsZXJhbmdlOjNkMzBiMWEzYWJhZTRlNDZhODE2N2Y3ODYyMTQwZjJkXzMtMy0xLTEtOTA3MTc_2bfc5379-8387-408f-89d4-842489e125cd">775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="amci:ContractWithCustomerLiabilityNoncurrentAmountsCollected" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTozZDMwYjFhM2FiYWU0ZTQ2YTgxNjdmNzg2MjE0MGYyZC90YWJsZXJhbmdlOjNkMzBiMWEzYWJhZTRlNDZhODE2N2Y3ODYyMTQwZjJkXzMtNS0xLTEtOTA3MTc_6b9f20dc-47d5-4588-9746-93741c4d0f4b">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled accounts receivable recognized in trade receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="amci:ContractWithCustomerAssetCurrentReclassifiedToReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTozZDMwYjFhM2FiYWU0ZTQ2YTgxNjdmNzg2MjE0MGYyZC90YWJsZXJhbmdlOjNkMzBiMWEzYWJhZTRlNDZhODE2N2Y3ODYyMTQwZjJkXzQtMS0xLTEtOTA3MTc_c7834261-3504-48fc-bbab-a71855b2b4bd">16,085</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease on revaluation on currency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" sign="-" name="amci:ContractWithCustomerAssetCurrentForeignCurrencyTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTozZDMwYjFhM2FiYWU0ZTQ2YTgxNjdmNzg2MjE0MGYyZC90YWJsZXJhbmdlOjNkMzBiMWEzYWJhZTRlNDZhODE2N2Y3ODYyMTQwZjJkXzUtMS0xLTEtOTA3MTc_96f95811-4327-4363-a1d1-8e29d67cd1cb">122</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" sign="-" name="amci:ContractWithCustomerLiabilityNoncurrentForeignCurrencyTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTozZDMwYjFhM2FiYWU0ZTQ2YTgxNjdmNzg2MjE0MGYyZC90YWJsZXJhbmdlOjNkMzBiMWEzYWJhZTRlNDZhODE2N2Y3ODYyMTQwZjJkXzUtNS0xLTEtOTA3MTc_adbdd106-a29a-4201-8f13-0b9dbe64bd5a">804</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification from non-current to current contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="amci:ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTozZDMwYjFhM2FiYWU0ZTQ2YTgxNjdmNzg2MjE0MGYyZC90YWJsZXJhbmdlOjNkMzBiMWEzYWJhZTRlNDZhODE2N2Y3ODYyMTQwZjJkXzYtMy0xLTEtOTA3MTc_77ad9fc0-5655-4369-803c-65f1d978cd83">2,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="amci:ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTozZDMwYjFhM2FiYWU0ZTQ2YTgxNjdmNzg2MjE0MGYyZC90YWJsZXJhbmdlOjNkMzBiMWEzYWJhZTRlNDZhODE2N2Y3ODYyMTQwZjJkXzYtNS0xLTEtOTA3MTc_d33b3c1f-6cfd-4d83-bd54-cc3e74e136d7">2,015</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification to revenue as a result of performance obligations satisfied</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="amci:ContractWithCustomerLiabilityCurrentRevenueRecognized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTozZDMwYjFhM2FiYWU0ZTQ2YTgxNjdmNzg2MjE0MGYyZC90YWJsZXJhbmdlOjNkMzBiMWEzYWJhZTRlNDZhODE2N2Y3ODYyMTQwZjJkXzctMy0xLTEtOTA3MTc_091fd8f7-2613-4172-90c5-2ef95708a4bd">3,298</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTozZDMwYjFhM2FiYWU0ZTQ2YTgxNjdmNzg2MjE0MGYyZC90YWJsZXJhbmdlOjNkMzBiMWEzYWJhZTRlNDZhODE2N2Y3ODYyMTQwZjJkXzgtMS0xLTEtMTAyODYw_f25f9782-8315-4a8f-9d72-1ae154002ca2">14,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTozZDMwYjFhM2FiYWU0ZTQ2YTgxNjdmNzg2MjE0MGYyZC90YWJsZXJhbmdlOjNkMzBiMWEzYWJhZTRlNDZhODE2N2Y3ODYyMTQwZjJkXzgtMy0xLTEtMTAyODYw_72d3a6b7-656c-4f88-b904-566ae5e8023e">2,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTozZDMwYjFhM2FiYWU0ZTQ2YTgxNjdmNzg2MjE0MGYyZC90YWJsZXJhbmdlOjNkMzBiMWEzYWJhZTRlNDZhODE2N2Y3ODYyMTQwZjJkXzgtNS0xLTEtMTAyODYw_7986b276-d626-4bdf-bf8d-bce253dd3205">11,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in contract assets was mostly due to unbilled accounts receivables from contracts with customers where the Company performed engineering and other services, while the decrease in contract liabilities was primarily due to the recognition of revenue during the period related to advance payments previously received by the Company for engineering and other services contracts with customers. As of September&#160;30, 2022 and December&#160;31, 2021 the Company had $<ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:BilledContractReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90ZXh0cmVnaW9uOjJlOWYyNWYwNmY2ZDQzOWVhY2NhMGQxYmMyMjVjMDFiXzExODQ_756327a0-d0ed-41e9-93bf-982a4599442a">11,588</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:BilledContractReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90ZXh0cmVnaW9uOjJlOWYyNWYwNmY2ZDQzOWVhY2NhMGQxYmMyMjVjMDFiXzExOTE_e563cbab-3a1a-4563-abed-7890ce9d1dbb">2,878</ix:nonFraction>, respectively, of billed accounts receivable, net of allowance.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contract liability balance is comprised of unconditional payments received from the Company&#8217;s customers prior to the satisfaction of the related performance obligations. Such amounts are anticipated to be recorded as revenues when services are performed in subsequent periods. The Company expects to recognize the amounts classified as current contract liabilities, in revenue within one year or less and those classified as non-current within two to three years. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Remaining performance obligations</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction price allocated to the remaining performance obligation represents contracted revenue that has not yet been recognized, which includes unearned revenue that will be recognized as revenue in future periods. Transaction price allocated to remaining performance obligations is influenced by several factors, including the length of the contract term compared to the research term and the existence of customer specific acceptance rights. </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="ibd61fc2302cb480280916cf51fd070dd" continuedAt="i4751e95fa9b24e258ed569087ba220a5"><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90ZXh0cmVnaW9uOjJlOWYyNWYwNmY2ZDQzOWVhY2NhMGQxYmMyMjVjMDFiXzEzNzQzODk1MzUxOTYx_6bd0a197-5593-4c42-a13e-6e6384f29bdc" continuedAt="i64e273c2cbf04d44a07ecffd3908f33a" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remaining performance obligations consisted of the following (in thousands): </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="amci:RevenueRemainingPerformanceObligationCurrentAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTphNjk4ZmY2NGQxM2I0NjBmODA4ZWYwMDllODMzNzEzYS90YWJsZXJhbmdlOmE2OThmZjY0ZDEzYjQ2MGY4MDhlZjAwOWU4MzM3MTNhXzItMS0xLTEtOTA3MTc_7378990f-e35d-422a-b703-9426f2b2b096">2,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="amci:RevenueRemainingPerformanceObligationCurrentAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTphNjk4ZmY2NGQxM2I0NjBmODA4ZWYwMDllODMzNzEzYS90YWJsZXJhbmdlOmE2OThmZjY0ZDEzYjQ2MGY4MDhlZjAwOWU4MzM3MTNhXzItMy0xLTEtOTA3MTc_5a3628a9-517a-42f6-9da6-ebf4bfdd9353">3,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="amci:RevenueRemainingPerformanceObligationNoncurrentAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTphNjk4ZmY2NGQxM2I0NjBmODA4ZWYwMDllODMzNzEzYS90YWJsZXJhbmdlOmE2OThmZjY0ZDEzYjQ2MGY4MDhlZjAwOWU4MzM3MTNhXzMtMS0xLTEtOTA3MTc_626b9cfd-2a8a-488f-b521-e7be877e0708">11,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="amci:RevenueRemainingPerformanceObligationNoncurrentAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTphNjk4ZmY2NGQxM2I0NjBmODA4ZWYwMDllODMzNzEzYS90YWJsZXJhbmdlOmE2OThmZjY0ZDEzYjQ2MGY4MDhlZjAwOWU4MzM3MTNhXzMtMy0xLTEtOTA3MTc_047996da-60e8-4a7d-9308-534965559538">13,901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTphNjk4ZmY2NGQxM2I0NjBmODA4ZWYwMDllODMzNzEzYS90YWJsZXJhbmdlOmE2OThmZjY0ZDEzYjQ2MGY4MDhlZjAwOWU4MzM3MTNhXzQtMS0xLTEtMTAyOTIw_6b574e9c-1c27-49f0-a50e-ab1d9928a840">14,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTphNjk4ZmY2NGQxM2I0NjBmODA4ZWYwMDllODMzNzEzYS90YWJsZXJhbmdlOmE2OThmZjY0ZDEzYjQ2MGY4MDhlZjAwOWU4MzM3MTNhXzQtMy0xLTEtMTAyOTIw_9e4f2f1c-471e-4f02-be19-1b8430bb8084">17,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_713"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5 &#8212; <ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:InvestmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzE1OTQyOTE4NjEyMzM0_e7fb4e97-d03c-474c-b6fe-0c53ec4f2cf3" continuedAt="id7319d7a070a4a7889e01a6cb7ce4a0a" escape="true">Investments</ix:nonNumeric></span></div><ix:continuation id="id7319d7a070a4a7889e01a6cb7ce4a0a" continuedAt="idcdaf0fcd33c4d1ead4ea8db777a5d93"><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:InvestmentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzE1OTQyOTE4NjEyMzM1_2236459d-3621-4afe-abdc-a6e396546679" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investments consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Category</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021 as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Method Investment in LanzaJet</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90YWJsZTo2YmZhNjJlNjYyMTM0NGM1YTMyZmZhMjdmMmRmMmY4ZC90YWJsZXJhbmdlOjZiZmE2MmU2NjIxMzQ0YzVhMzJmZmEyN2YyZGYyZjhkXzMtMS0xLTEtOTA3MTc_e90744ed-a634-4247-bf36-76543108a1b4">11,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i285bf14114324cc3b2c392b9b984d16e_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90YWJsZTo2YmZhNjJlNjYyMTM0NGM1YTMyZmZhMjdmMmRmMmY4ZC90YWJsZXJhbmdlOjZiZmE2MmU2NjIxMzQ0YzVhMzJmZmEyN2YyZGYyZjhkXzMtMy0xLTEtOTA3MTc_2c83c773-53f4-44cf-bcbb-0a5f6994dcc0">12,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Security Investment in SGLT</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90YWJsZTo2YmZhNjJlNjYyMTM0NGM1YTMyZmZhMjdmMmRmMmY4ZC90YWJsZXJhbmdlOjZiZmE2MmU2NjIxMzQ0YzVhMzJmZmEyN2YyZGYyZjhkXzQtMS0xLTEtOTA3MTc_ecd9e435-7754-436c-ad0b-477905f32976">14,990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie926aa19bc694f0586f296dab820baf8_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90YWJsZTo2YmZhNjJlNjYyMTM0NGM1YTMyZmZhMjdmMmRmMmY4ZC90YWJsZXJhbmdlOjZiZmE2MmU2NjIxMzQ0YzVhMzJmZmEyN2YyZGYyZjhkXzQtMy0xLTEtOTA3MTc_27263d9b-1562-40a2-977a-8f754225f2ba">12,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Investment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90YWJsZTo2YmZhNjJlNjYyMTM0NGM1YTMyZmZhMjdmMmRmMmY4ZC90YWJsZXJhbmdlOjZiZmE2MmU2NjIxMzQ0YzVhMzJmZmEyN2YyZGYyZjhkXzUtMS0xLTEtOTA3MTc_e0284e2c-3b46-432a-8f0e-5f914d69a273">26,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90YWJsZTo2YmZhNjJlNjYyMTM0NGM1YTMyZmZhMjdmMmRmMmY4ZC90YWJsZXJhbmdlOjZiZmE2MmU2NjIxMzQ0YzVhMzJmZmEyN2YyZGYyZjhkXzUtMy0xLTEtOTA3MTc_d9f7b924-0b4d-4aae-9135-964d3edfa8c9">24,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LanzaJet</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 13, 2020, the Company contributed $<ix:nonFraction unitRef="usd" contextRef="i3508735d501341a2badcc0f6a6be0770_D20200513-20200513" decimals="-3" name="us-gaap:ContributionOfProperty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzE0OQ_59e0a865-5dea-4a27-a7a7-ee4c03fc278b">15,000</ix:nonFraction> in intellectual property in exchange for a <ix:nonFraction unitRef="number" contextRef="iabbdb50d80c247b39bf74f30bb6e2aa1_I20200513" decimals="3" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzE5NQ_1d8eaf7a-9530-47bf-8f2c-391ca616ed52">37.5</ix:nonFraction>% interest (&#8220;Original Interest&#8221;) of LanzaJet, Inc. (&#8220;LanzaJet&#8221;) in connection with an investment agreement (&#8220;Investment Agreement&#8221;). The Company accounts for the transaction as a revenue transaction with a customer under ASC 606 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The licensing and technical support services provided are recognized as a single combined performance obligation satisfied over the expected period of those services, beginning May 2020 through December 2025. During the nine months ended September&#160;30, 2022 and 2021, the Company has recognized revenue from this arrangement of $<ix:nonFraction unitRef="usd" contextRef="ibfcdf3126a1c413992b29dabc55a78ee_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzc3Mw_537f6fe9-bf94-4f38-871c-687bd960abe1">1,620</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ib6b123fcece94433b4a72c6716d59ddf_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzc4MA_d620fe4b-3cc7-45cd-8f24-e64131e62636">1,516</ix:nonFraction> respectively, net of intra-entity profit elimination. As of  September&#160;30, 2022 and December&#160;31, 2021, the Company has recorded deferred revenue of $<ix:nonFraction unitRef="usd" contextRef="ifaeb71870a2f4f65bef7abad49932d71_I20220930" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzg3NA_4914cc61-5cb5-4c73-b631-891fa8d258bc">8,734</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i285bf14114324cc3b2c392b9b984d16e_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzg4MQ_f6be441e-f48c-4d14-b428-563ee3064148">10,746</ix:nonFraction>, respectively. Intra-entity profits related to revenue contracts with LanzaJet are $<ix:nonFraction unitRef="usd" contextRef="ic197136819df4f3d91e14be688674014_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzk4Mw_2495db85-8d70-42c9-ada4-8da080b0ca15">395</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="id7c2c8dee6434965a0e89d9311bf370e_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzk5MA_7e2fc3cb-6711-42b5-9b0b-96ef934baee6">497</ix:nonFraction> as of September&#160;30, 2022, and 2021, respectively. Intra-entity profit is amortized over the <ix:nonNumeric contextRef="ibfcdf3126a1c413992b29dabc55a78ee_D20220101-20220930" name="amci:RevenueFromContractWithCustomerAmortizationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzE1OTQyOTE4NjEyMzQ4_b598eca3-6fd1-4be8-bd60-d1fdea57fadc">15-year</ix:nonNumeric> amortization period through 2034. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between February 1, 2021 and April 4, 2021, LanzaJet closed <ix:nonFraction unitRef="invesstment_round" contextRef="i65fec460822f43acb02e40736b3b8a79_D20210201-20210404" decimals="INF" name="amci:NumberOfRoundsOfInvestments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzEwOTk1MTE2Mjg3Mzkw_a3d39608-123b-48f7-9a23-48e1b39a9671">two</ix:nonFraction> additional rounds of investment which reduced the Original Interest to <ix:nonFraction unitRef="number" contextRef="i0953d2d09b0e4116b4f9972716c60d69_I20210404" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzEyNjQ0MzgzNzI4OTc5_0215ec19-acd3-407d-abf3-7a9c7e9c89bf">25</ix:nonFraction>%. As a result, the Company recognized a gain on dilution of $<ix:nonFraction unitRef="usd" contextRef="i3f16003c0fce46c997e3bcde7fa19188_D20210201-20210404" decimals="-3" name="amci:EquityMethodInvestmentGainOnDilutionOfInvestment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzEzMTE_73b074ed-a92e-4d64-8026-68e817a81977">503</ix:nonFraction>. The Company retained its contingent right to receive an additional interest in LanzaJet of up to <ix:nonFraction unitRef="shares" contextRef="i0953d2d09b0e4116b4f9972716c60d69_I20210404" decimals="INF" name="amci:EquityMethodInvestmentContingentRightToReceiveAdditionalInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzEyNjQ0MzgzNzI4OTg0_cf76e815-6ca9-4108-994b-fcf71433babf">45</ix:nonFraction>&#160;million shares for <ix:nonFraction unitRef="usd" contextRef="i3f16003c0fce46c997e3bcde7fa19188_D20210201-20210404" decimals="INF" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzEwOTk1MTE2Mjg3Mzkx_5ff08a23-5aed-4c4d-b183-ea39bb5ba50b">no</ix:nonFraction> additional consideration. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of our equity method investment in LanzaJet as of September&#160;30, 2022 and December&#160;31, 2021 was approximately $<ix:nonFraction unitRef="usd" contextRef="ifaeb71870a2f4f65bef7abad49932d71_I20220930" decimals="-3" name="us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzE1NjA_bc4c9a36-f9b9-4c43-985f-06fd0d2b7c7b">3,600</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i285bf14114324cc3b2c392b9b984d16e_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzE1Njg_a165c7e1-5464-411f-8465-db2c33e54311">3,100</ix:nonFraction> less than our proportionate share of our equity method investees&#8217; book values, respectively. The basis differences are largely the result of a difference in the timing of recognition of variable consideration to which we may become entitled in exchange for our contribution of intellectual property to LanzaJet. The variable consideration we may receive will be in the form of additional ownership interests and the majority of the basis difference will reverse in connection with recognition of that variable consideration. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with a sublicense agreement to LanzaJet under our license agreement with Battelle Memorial Institute (&#8220;Battelle&#8221;), LanzaTech remains responsible for any failure by LanzaJet to pay royalties due to Battelle. The fair value of LanzaTech&#8217;s obligation under this guarantee was immaterial as of September&#160;30, 2022 and December 31, 2021.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="idcdaf0fcd33c4d1ead4ea8db777a5d93" continuedAt="ic4854af5a0714e4f96177639b1ecf3f7"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SGLT</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2011, the Company contributed RMB <ix:nonFraction unitRef="cny" contextRef="i9f76a4903dee46c7a36a3359dafca0c1_D20110928-20110928" decimals="-3" name="us-gaap:ContributionOfProperty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzI0ODc_950f0822-5896-4b4a-b1fc-f44eb2e6dad1">25,800</ix:nonFraction> (approx. $<ix:nonFraction unitRef="usd" contextRef="i9f76a4903dee46c7a36a3359dafca0c1_D20110928-20110928" decimals="-3" name="us-gaap:ContributionOfProperty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzI0OTk_c5e0f6d5-0c32-48fb-ac82-5a96a81f8899">4,000</ix:nonFraction>) in intellectual property in exchange for <ix:nonFraction unitRef="number" contextRef="ibea6cef92fd440f0849af4b7e43ac9d0_I20110928" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzI1NDQ_93604c93-578e-439a-9b17-d4b7c41b01a3">30</ix:nonFraction>% of the registered capital of Beijing ShouGang LanzaTech Technology Co., LTD (&#8220;SGLT&#8221;). </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company&#8217;s interest in SGLT&#8217;s registered capital is approximately <ix:nonFraction unitRef="number" contextRef="ie926aa19bc694f0586f296dab820baf8_I20211231" decimals="4" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzI3MTM_16e8f094-1592-4fbc-8d5c-51495cee8304">10.01</ix:nonFraction>%. As the result of the admittance of new investors, the Company recognized a gain from dilution of $<ix:nonFraction unitRef="usd" contextRef="ia16a7b02d1334a8c8712b104eafb3d0e_D20210101-20210930" decimals="-3" name="amci:EquityMethodInvestmentGainOnDilutionOfInvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzI4MTQ_d446038b-64a1-4b0c-8480-a4dc9643b90f">3,014</ix:nonFraction> during the nine months ended September&#160;30, 2021. On April 29, 2022, SGLT closed a round of financing which reduced the Company's ownership to <ix:nonFraction unitRef="number" contextRef="ic62d084cb3144cc2a7041bace85abb24_I20220429" decimals="4" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzI5NDM_cac3c96e-5d23-435e-92f8-56d53f19335a">9.31</ix:nonFraction>% and resulted in the recognition of gain from dilution of $<ix:nonFraction unitRef="usd" contextRef="i7c67702cd8234f33a60771751ce65fbe_D20220429-20220429" decimals="-3" name="amci:EquityMethodInvestmentGainOnDilutionOfInvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzMwMDM_8e2cbe75-3bb6-4928-afa7-46d4c1c2fe65">3,368</ix:nonFraction>. On September 30, 2022, management of the Company determined that the Company no longer had significant influence over the operating and financial policies of SGLT due to the significant and sustained decrease in SGLT's technological dependence on LanzaTech. As such, as of September 30, 2022, the Company ceased applying the equity method and reclassified cumulative currency translation adjustments associated with its investment in SGLT of $<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="amci:TransferFromForeignCurrencyTranslationToEquitySecurityInvestment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzEyNjQ0MzgzNzI5MDAx_115b1849-43a8-43ab-8e28-fd718c24a15b">928</ix:nonFraction> to include those adjustments in the carrying value of its investment. Prospectively, the Company will account for its investment in the equity security of SGLT using the alternative measurement principals as permitted under ASC 321, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments - Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, because SGLT's fair value is not readily determinable. As the change is effective on September 30, 2022, the Company recorded SGLT's attributable net loss of $<ix:nonFraction unitRef="usd" contextRef="iaa61d655eb524064963927b0d13c1a26_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzEyNjQ0MzgzNzI4OTk2_0543a7de-c7cb-474f-a9db-7b1892c83a1c">76</ix:nonFraction>, for the nine months ended September&#160;30, 2022, on the condensed consolidated statements of operations. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequently, under the alternative measurement method, LanzaTech will adjust the carrying value for observable changes in price and will reassess whether its investment in SGLT continues to qualify for such method. Additionally, LanzaTech will perform a qualitative assessment and recognize an impairment if their are sufficient indicators that the fair value of the SGLT investment is less than its carrying value. The changes in value and impairment charges (if any), are recorded in other (expense) income, net in the condensed consolidated statement of operations.</span></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic4854af5a0714e4f96177639b1ecf3f7">As of September&#160;30, 2022 and December&#160;31, 2021, there were <ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="INF" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzEwOTk1MTE2Mjg3Mzcy_0e9773a8-c667-4446-be45-d247eb240caa"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzEwOTk1MTE2Mjg3Mzcy_c317dda4-9505-4d02-8907-63a78350aadd">no</ix:nonFraction></ix:nonFraction> impairments of either equity investees. During the nine months ended September&#160;30, 2022 and the year ended December&#160;31, 2021, the Company received <ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="INF" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzEwOTk1MTE2Mjg3Mzgw_711cec94-9397-4217-9b0a-ae1b8341bced"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="INF" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzEwOTk1MTE2Mjg3Mzgw_9b8c4a4e-f2bb-4e9c-82be-3e303b48d977">no</ix:nonFraction></ix:nonFraction> dividends from equity investments.</ix:continuation> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib82e114cd19f45afae73e7a64e42f208_719"></div><ix:continuation id="ib3c46206c3384fffb5548bd2adc416dd" continuedAt="i9d9e7ef582374066bbab7c62a93fcfda"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6 &#8212; Fair Value</span></div><ix:continuation id="id5a89e767fcc4a0aa63ef36831754f3e" continuedAt="ib8e78e925bfb407d9232f336593e2bf5"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value hierarchy for its assets and liabilities measured at fair value as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if81ad5ca3f944114a295b408d90c868d_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzQtMS0xLTEtOTA3MTc_267c43fb-7099-48e5-9008-6a30c1f23ef8">519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b8a832fa95e40dd8e00caad65e8fc91_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzQtMy0xLTEtOTA3MTc_081ceca8-18ba-4d2a-ab60-dad425ec3fa9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i890286f3ce6f403f85f12ab3e67b6b6e_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzQtNS0xLTEtOTA3MTc_7203df67-7869-4b3a-a02b-4b8a5ec428ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7329eb228fb439b8a66213456cd7cd2_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzQtNy0xLTEtMTAzNDI2_957312d4-8323-40ba-8479-6bdaf11e9bf5">519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i102ea5a4d307404c84aab38c52f1411f_I20220930" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzctMS0xLTEtOTA3MTc_a2465503-cba0-4883-8d9f-b75958814025">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i379c9b036151404ba5af5925388baa54_I20220930" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzctMy0xLTEtOTA3MTc_fc333e17-f9d1-40df-a596-f067fca887b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ed25cf6aa114e57a8dac87f70ade94d_I20220930" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzctNS0xLTEtOTA3MTc_93741a35-1ed1-4d0c-9bd8-b8d393c3cbc1">1,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84a93d4537e04f79aeb456018d0705ee_I20220930" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzctNy0xLTEtMTAzNDI2_2a639001-2040-4c83-a7d4-cb64bf4e6035">1,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33dc2132bbc4f94ad2a656f9bd29ecb_I20220930" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzgtMS0xLTEtOTA3MTc_d707f99c-8d91-4f6c-ae9c-f51ba8b36a68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9ef9ee81e0d436bae0f3213e39b62ea_I20220930" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzgtMy0xLTEtOTA3MTc_6404bb18-f4b1-405a-aab1-dc0bfb1fb5ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f43e380d2624479993e527bb1c21058_I20220930" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzgtNS0xLTEtOTA3MTc_b1a4ed67-bd13-4510-9aa6-512bac660474">2,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if25caf19e5b840e88f4735e4136a603a_I20220930" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzgtNy0xLTEtMTAzNDI2_e37b20cb-c61a-4338-8fd9-dd22c4191945">2,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if81ad5ca3f944114a295b408d90c868d_I20220930" decimals="-3" name="amci:SimpleAgreementForFutureEquityLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzktMS0xLTEtOTA3MTc_b5196d03-a4a7-4f71-9bfa-00315087435d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b8a832fa95e40dd8e00caad65e8fc91_I20220930" decimals="-3" name="amci:SimpleAgreementForFutureEquityLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzktMy0xLTEtOTA3MTc_f0ddca9e-3501-4c21-9d0f-1579577833cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i890286f3ce6f403f85f12ab3e67b6b6e_I20220930" decimals="-3" name="amci:SimpleAgreementForFutureEquityLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzktNS0xLTEtOTA3MTc_36d7c02b-c894-461d-b0ba-b2043d66d7eb">27,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7329eb228fb439b8a66213456cd7cd2_I20220930" decimals="-3" name="amci:SimpleAgreementForFutureEquityLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzktNy0xLTEtMTAzNDI2_726d08a8-cdc3-4f34-a317-8021e3f66b16">27,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if81ad5ca3f944114a295b408d90c868d_I20220930" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzEwLTEtMS0xLTEwMzQyNg_a95241ec-5dd0-4771-9872-a2d5ecb9f017">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b8a832fa95e40dd8e00caad65e8fc91_I20220930" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzEwLTMtMS0xLTEwMzQyNg_d5e0e91c-8c9f-4e77-8511-493f5d15793c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i890286f3ce6f403f85f12ab3e67b6b6e_I20220930" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzEwLTUtMS0xLTEwMzQyNg_3190f0c3-c370-4470-a008-4a2c9e2107ba">30,815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7329eb228fb439b8a66213456cd7cd2_I20220930" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzEwLTctMS0xLTEwMzQyNg_a0956a9f-d94a-43ab-a5ba-8723b4483a8a">30,815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i9d9e7ef582374066bbab7c62a93fcfda" continuedAt="i596dd3dc196b42f5a3aa9991cb75c7c1"><div style="margin-bottom:9pt"><ix:continuation id="ib8e78e925bfb407d9232f336593e2bf5" continuedAt="i24990ad74b5f4f09ad68ea531bb2677d"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i946a08fcd3a04e65862611981f20e270_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzQtMS0xLTEtMTAzNDE0_908f6e92-159b-458f-874f-00224d8e41b4">516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i541e2e9fe4644a20b8b1b376f83dee9d_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzQtMy0xLTEtMTAzNDE0_c9a3c721-784d-415f-aa45-7b092ac9e29c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0624bd72b2cf4ede8ec463949522ea9a_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzQtNS0xLTEtMTAzNDE0_4d063c17-d79b-42bb-aa0e-f4a6db199e45">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd5ccd73a28c47ebac5c69568150935f_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzQtNy0xLTEtMTAzNDE0_ac6e0774-f59f-4149-b832-5013d3c78007">516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i946a08fcd3a04e65862611981f20e270_I20211231" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzctMS0xLTEtOTA3MTc_fa91582c-9dfd-4557-9b07-e0249d6b7591">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i541e2e9fe4644a20b8b1b376f83dee9d_I20211231" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzctMy0xLTEtOTA3MTc_5e5d7714-4eb8-4278-876a-ba36f9898985">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0624bd72b2cf4ede8ec463949522ea9a_I20211231" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzctNS0xLTEtOTA3MTc_220c52d4-4b02-49d9-8882-63704e062677">1,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd5ccd73a28c47ebac5c69568150935f_I20211231" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzctNy0xLTEtMTAzNDE0_7caebe61-fd36-4f4f-879a-b35624104295">1,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia692081523eb4eeab727c1fc860a7079_I20211231" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzgtMS0xLTEtOTA3MTc_d3b810f3-40a1-4a9e-bae1-c7f82213be7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d637000e084883bc89386915d6aae9_I20211231" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzgtMy0xLTEtOTA3MTc_03c8d225-9256-4cbd-b82f-f03c326f2114">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8345fcb8c9f147978a79d376aea1f2aa_I20211231" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzgtNS0xLTEtOTA3MTc_80da59ea-7d02-43f2-bb9d-ec77b7a5d9be">1,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9bb8758e465423fb3bbebe9bcea3ef7_I20211231" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzgtNy0xLTEtMTAzNDE0_1e04762a-098b-49a5-bf53-c6ffe7bed45b">1,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i946a08fcd3a04e65862611981f20e270_I20211231" decimals="-3" name="amci:SimpleAgreementForFutureEquityLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzktMS0xLTEtOTA3MTc_2d106706-abe2-4bf4-9a2f-109421c263ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i541e2e9fe4644a20b8b1b376f83dee9d_I20211231" decimals="-3" name="amci:SimpleAgreementForFutureEquityLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzktMy0xLTEtOTA3MTc_56bb4e94-dcac-4696-b4ca-91b79c68f2ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0624bd72b2cf4ede8ec463949522ea9a_I20211231" decimals="-3" name="amci:SimpleAgreementForFutureEquityLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzktNS0xLTEtOTA3MTc_79d74fb3-13c1-42f6-95d8-3974015bc6aa">28,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd5ccd73a28c47ebac5c69568150935f_I20211231" decimals="-3" name="amci:SimpleAgreementForFutureEquityLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzktNy0xLTEtMTAzNDE0_9a3851b1-c7c6-4cbe-a209-5afcb2501b0b">28,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i946a08fcd3a04e65862611981f20e270_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzEwLTEtMS0xLTEwMzQxNA_25ae9d72-cc0a-442c-a2c0-9284921ebf61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i541e2e9fe4644a20b8b1b376f83dee9d_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzEwLTMtMS0xLTEwMzQxNA_b1adf403-408f-4b5a-8cf4-ee144bd190f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0624bd72b2cf4ede8ec463949522ea9a_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzEwLTUtMS0xLTEwMzQxNA_7e28c1e8-fb66-45ff-9264-9b6bbe36b868">31,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd5ccd73a28c47ebac5c69568150935f_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzEwLTctMS0xLTEwMzQxNA_08239dbd-88b8-4951-add6-60a2c042c192">31,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has warrants to purchase preferred shares outstanding as of September&#160;30, 2022 and December&#160;31, 2021 representing <ix:nonFraction unitRef="shares" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90ZXh0cmVnaW9uOjk0ODAwMjlkMTliZjRlMWQ4ZGQ4OTU0ZTgzODk0ODQ5XzI4Mw_903ce5f7-1718-47f9-a5c3-96d104128a60">225,223</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90ZXh0cmVnaW9uOjk0ODAwMjlkMTliZjRlMWQ4ZGQ4OTU0ZTgzODk0ODQ5XzEwOTk1MTE2Mjg2NDEz_d400d76b-a03a-40f6-8fb7-b85f54c921c8">225,223</ix:nonFraction> preferred shares, respectively, which warrants expire at various dates through December 31, 2027. The exercise prices of the warrants range from $<ix:nonFraction unitRef="usdPerShare" contextRef="i0e8c018a77ea44b685797703d8a62a43_I20211231" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90ZXh0cmVnaW9uOjk0ODAwMjlkMTliZjRlMWQ4ZGQ4OTU0ZTgzODk0ODQ5XzQzOA_d383ec08-7fc6-4486-aa3a-e92640b8a088"><ix:nonFraction unitRef="usdPerShare" contextRef="i1b34bf4c7df9425fa69de07cc96a2ac9_I20220930" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90ZXh0cmVnaW9uOjk0ODAwMjlkMTliZjRlMWQ4ZGQ4OTU0ZTgzODk0ODQ5XzQzOA_d862fc0f-e1fa-44af-b792-2bfc3768013b">14.69</ix:nonFraction></ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="ida50a4aa7f4047c9a5bf3fcef6f2d36d_I20220930" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90ZXh0cmVnaW9uOjk0ODAwMjlkMTliZjRlMWQ4ZGQ4OTU0ZTgzODk0ODQ5XzQ0NA_0d9f6cdf-a912-4cab-90a7-518ff0e6bfef"><ix:nonFraction unitRef="usdPerShare" contextRef="i2dae0c39f39546cdbbe879b2a2245fe6_I20211231" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90ZXh0cmVnaW9uOjk0ODAwMjlkMTliZjRlMWQ4ZGQ4OTU0ZTgzODk0ODQ5XzQ0NA_51f4dcff-4d7c-4086-a805-e3d0b7de959d">19.93</ix:nonFraction></ix:nonFraction> as of each of September&#160;30, 2022 and December&#160;31, 2021. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The warrants are accounted for as liabilities in accordance with ASC 480, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distinguishing Liability from Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and are presented within other accrued liabilities on the condensed consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the condensed consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The fair value of the warrants was calculated using the Black-Scholes Option Pricing Model. For the nine months ended September&#160;30, 2022 and 2021, the Company recognized a change in the fair value of liabilities of approximately $(<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90ZXh0cmVnaW9uOjk0ODAwMjlkMTliZjRlMWQ4ZGQ4OTU0ZTgzODk0ODQ5XzExMDY_6a5fe816-8b8f-4556-baf6-b068e4ba366c">427</ix:nonFraction>) and $(<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90ZXh0cmVnaW9uOjk0ODAwMjlkMTliZjRlMWQ4ZGQ4OTU0ZTgzODk0ODQ5XzExMTM_3ed9f528-a8ff-43af-ba23-78127723683d">699</ix:nonFraction>), respectively, on the condensed consolidated statements of operations and comprehensive loss within other (expense) income, net.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the warrants is determined using Level 3 inputs. Inherent in the Black-Scholes Option Pricing Model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its warrants based on implied volatility from the Company&#8217;s warrants and from historical volatility of select peer companies that match the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.</span></div><ix:continuation id="i9be795be447041c0a402bcedbee506dc" continuedAt="iae573c0f9efa4766801e50aff487bff2"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the weighted average inputs used in calculating the fair value of the preferred share warrants outstanding as of September&#160;30, 2022 and December&#160;31, 2021:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i80812ae1293f45978d4c5ec6ccb77d63_I20220930" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpjMmVmZTU2ZWUwYmQ0ZWU2OTY4ZjIzZjgwZDNlOTE0Ny90YWJsZXJhbmdlOmMyZWZlNTZlZTBiZDRlZTY5NjhmMjNmODBkM2U5MTQ3XzEtMS0xLTEtOTA3MTc_0885110c-f268-42d7-826d-e522694de168">15.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i350b1ab261cb4e4db6e8558ad63e36ba_I20211231" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpjMmVmZTU2ZWUwYmQ0ZWU2OTY4ZjIzZjgwZDNlOTE0Ny90YWJsZXJhbmdlOmMyZWZlNTZlZTBiZDRlZTY5NjhmMjNmODBkM2U5MTQ3XzEtMy0xLTEtOTA3MTc_14f72355-82cb-4b9a-a224-0e4ced58e02f">13.77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i255bc9e0c6fd4f8a8cfcde46d7515d42_I20220930" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpjMmVmZTU2ZWUwYmQ0ZWU2OTY4ZjIzZjgwZDNlOTE0Ny90YWJsZXJhbmdlOmMyZWZlNTZlZTBiZDRlZTY5NjhmMjNmODBkM2U5MTQ3XzItMS0xLTEtOTA3MTc_21972f8d-ea1c-4c31-8858-b368b96e7d68">17.31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i07186a2d797e4458bf8d9a94dc91a2d0_I20211231" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpjMmVmZTU2ZWUwYmQ0ZWU2OTY4ZjIzZjgwZDNlOTE0Ny90YWJsZXJhbmdlOmMyZWZlNTZlZTBiZDRlZTY5NjhmMjNmODBkM2U5MTQ3XzItMy0xLTEtOTA3MTc_c347a686-6b96-4d7e-9d4b-7dac8232af78">17.32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i36aa3c86e8874dec967acf37511c6479_I20220930" decimals="1" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpjMmVmZTU2ZWUwYmQ0ZWU2OTY4ZjIzZjgwZDNlOTE0Ny90YWJsZXJhbmdlOmMyZWZlNTZlZTBiZDRlZTY5NjhmMjNmODBkM2U5MTQ3XzMtMS0xLTEtOTA3MTc_9353e15b-dbaf-49a6-908d-80e24c1ebeba">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia859bc758ac345ea9093ab9e82ff0731_I20211231" decimals="1" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpjMmVmZTU2ZWUwYmQ0ZWU2OTY4ZjIzZjgwZDNlOTE0Ny90YWJsZXJhbmdlOmMyZWZlNTZlZTBiZDRlZTY5NjhmMjNmODBkM2U5MTQ3XzMtMy0xLTEtOTA3MTc_fd992d18-072c-49e2-a71f-5c63c7d8efcf">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i04cf9359671d402dba7a452b2672fb05_I20220930" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpjMmVmZTU2ZWUwYmQ0ZWU2OTY4ZjIzZjgwZDNlOTE0Ny90YWJsZXJhbmdlOmMyZWZlNTZlZTBiZDRlZTY5NjhmMjNmODBkM2U5MTQ3XzQtMS0xLTEtOTA3MTc_f5cf5d9f-63cd-4ea4-a213-e045a76a30fc">76.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i43750276631c4e1ba6fc6ef8f398254e_I20211231" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpjMmVmZTU2ZWUwYmQ0ZWU2OTY4ZjIzZjgwZDNlOTE0Ny90YWJsZXJhbmdlOmMyZWZlNTZlZTBiZDRlZTY5NjhmMjNmODBkM2U5MTQ3XzQtMy0xLTEtOTA3MTc_55a35914-10c3-41f2-84ba-d2385293e03d">70.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2f2cde5be60544bbb0bd73ff5aef0cad_I20220930" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpjMmVmZTU2ZWUwYmQ0ZWU2OTY4ZjIzZjgwZDNlOTE0Ny90YWJsZXJhbmdlOmMyZWZlNTZlZTBiZDRlZTY5NjhmMjNmODBkM2U5MTQ3XzUtMS0xLTEtOTA3MTc_4a9e0d71-601a-4d17-8457-9abaf608a293">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5088a09b2ff24bc9bfba62c1ce63d419_I20211231" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpjMmVmZTU2ZWUwYmQ0ZWU2OTY4ZjIzZjgwZDNlOTE0Ny90YWJsZXJhbmdlOmMyZWZlNTZlZTBiZDRlZTY5NjhmMjNmODBkM2U5MTQ3XzUtMy0xLTEtOTA3MTc_85f1d499-694d-4cc4-9cc9-5ba1bb22e87c">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia52cfe0290ea4a978f3254d197b6c758_I20220930" decimals="0" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpjMmVmZTU2ZWUwYmQ0ZWU2OTY4ZjIzZjgwZDNlOTE0Ny90YWJsZXJhbmdlOmMyZWZlNTZlZTBiZDRlZTY5NjhmMjNmODBkM2U5MTQ3XzYtMS0xLTEtOTA3MTc_0cab51d9-3dd9-45a6-886f-9185d0452609">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i55050b0de34747fbba14961fb9a1e9be_I20211231" decimals="0" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpjMmVmZTU2ZWUwYmQ0ZWU2OTY4ZjIzZjgwZDNlOTE0Ny90YWJsZXJhbmdlOmMyZWZlNTZlZTBiZDRlZTY5NjhmMjNmODBkM2U5MTQ3XzYtMy0xLTEtOTA3MTc_7f1e35d7-7534-4743-94e9-a6907267b574">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i596dd3dc196b42f5a3aa9991cb75c7c1" continuedAt="i4921c4fbd7a64607b8e4090d8d68218d"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SAFE Liability and SAFE Warrant</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company issued a SAFE that allowed an investor to participate in future equity financings through a share-settled redemption of the amount invested (such notional being the &#8220;invested amount&#8221;). The SAFE had not yet converted as a qualifying financing had not yet occurred as of September&#160;30, 2022. At September&#160;30, 2022, the SAFE had a fair value of $<ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="amci:SimpleAgreementForFutureEquityLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90ZXh0cmVnaW9uOjk0ODAwMjlkMTliZjRlMWQ4ZGQ4OTU0ZTgzODk0ODQ5XzI2MTE_35d9ac4e-0b55-4c2a-a0ef-5075294a75c7">27,221</ix:nonFraction> and was recorded within current liabilities on the condensed consolidated balance sheet. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, the warrant related to the SAFE of $<ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90ZXh0cmVnaW9uOjk0ODAwMjlkMTliZjRlMWQ4ZGQ4OTU0ZTgzODk0ODQ5XzI3NDg_c3877934-087d-4e53-9a07-78a3e38dbe99">2,022</ix:nonFraction> as of September&#160;30, 2022 is accounted for as a liability. This liability is recorded in current liabilities on the Company's condensed consolidated balance sheets at fair value on the date of issuance and will be revalued each subsequent reporting period until such instrument is exercised or expires. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in fair value between reporting periods for both the SAFE liability and SAFE warrant is included in other (expense) income, net in the condensed consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s SAFE liability and SAFE warrant are mark-to-market liabilities pursuant to ASC 480 and are classified within Level 3 of the fair value hierarchy as the Company is using a scenario-based approach which allowed the Company to estimate the implied value of the business based on the terms of the SAFE. Significant unobservable inputs included probability and expected term. Probability is based upon the likelihood of the Company closing a transaction with a special purpose acquisition company. The expected term was based on the anticipated time until the SAFE investments would have a conversion event. </span></div><ix:continuation id="iae573c0f9efa4766801e50aff487bff2" continuedAt="i8811170c4ff7433ea97edc11c9acb299"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE liability fair value measurement at September&#160;30, 2022 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4e47b12b058d42d9b8a8500645afac39_I20220930" decimals="2" name="amci:SAFELiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpmNjkwMWI4OTAxODY0Y2ZmOTNiZjg0MzIxZGYwZmVmMy90YWJsZXJhbmdlOmY2OTAxYjg5MDE4NjRjZmY5M2JmODQzMjFkZjBmZWYzXzItMS0xLTEtOTA3MTc_52cbc599-38c8-43a6-bdac-38e2d7d51026">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibd94d602b126443bb0f923d41ad8c7a1_I20220930" decimals="2" name="amci:SAFELiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpmNjkwMWI4OTAxODY0Y2ZmOTNiZjg0MzIxZGYwZmVmMy90YWJsZXJhbmdlOmY2OTAxYjg5MDE4NjRjZmY5M2JmODQzMjFkZjBmZWYzXzItMy0xLTEtOTA3MTc_3b67345c-493f-4abd-a946-288926a92f9b">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iec52bedc36d740b58bbc9ba1b8a983fe_I20220930" decimals="1" name="amci:SAFELiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpmNjkwMWI4OTAxODY0Y2ZmOTNiZjg0MzIxZGYwZmVmMy90YWJsZXJhbmdlOmY2OTAxYjg5MDE4NjRjZmY5M2JmODQzMjFkZjBmZWYzXzMtMS0xLTEtOTA3MTc_0e86975a-bfbd-46cf-9ad1-50d1060d3ae3">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9ce1629b93bf43a19b229d4d55f31882_I20220930" decimals="1" name="amci:SAFELiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpmNjkwMWI4OTAxODY0Y2ZmOTNiZjg0MzIxZGYwZmVmMy90YWJsZXJhbmdlOmY2OTAxYjg5MDE4NjRjZmY5M2JmODQzMjFkZjBmZWYzXzMtMy0xLTEtOTA3MTc_5b039636-4495-4ca5-a313-605d08e58484">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liquidity price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie070efbfc7bb4781b963dadb0a382d58_I20220930" decimals="INF" name="amci:SAFELiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpmNjkwMWI4OTAxODY0Y2ZmOTNiZjg0MzIxZGYwZmVmMy90YWJsZXJhbmdlOmY2OTAxYjg5MDE4NjRjZmY5M2JmODQzMjFkZjBmZWYzXzQtMS0xLTEtOTA3MTc_2b854dcf-b4a2-45ce-9ffd-5750bf48352c">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i49e4803247b0402587b5096b129d9f31_I20220930" decimals="2" name="amci:SAFELiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpmNjkwMWI4OTAxODY0Y2ZmOTNiZjg0MzIxZGYwZmVmMy90YWJsZXJhbmdlOmY2OTAxYjg5MDE4NjRjZmY5M2JmODQzMjFkZjBmZWYzXzQtMy0xLTEtOTA3MTc_0b4968ac-00b1-481e-a334-c490b7cc727e">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i09800e6ff5ef4478927f317abe6e7fb7_I20220930" decimals="3" name="amci:SAFELiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpmNjkwMWI4OTAxODY0Y2ZmOTNiZjg0MzIxZGYwZmVmMy90YWJsZXJhbmdlOmY2OTAxYjg5MDE4NjRjZmY5M2JmODQzMjFkZjBmZWYzXzUtMS0xLTEtOTA3MTc_7916d42e-4c32-4562-a7e0-e3eb887c1147">26.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6c63b562f14d44b9952abb1eea623813_I20220930" decimals="3" name="amci:SAFELiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpmNjkwMWI4OTAxODY0Y2ZmOTNiZjg0MzIxZGYwZmVmMy90YWJsZXJhbmdlOmY2OTAxYjg5MDE4NjRjZmY5M2JmODQzMjFkZjBmZWYzXzUtMy0xLTEtOTA3MTc_9420224a-fba6-4ce8-ae4e-269d12958e50">26.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE warrant fair value measurement at September&#160;30, 2022 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib14e5758f2a840a3b657e5dd9d422ebe_I20220930" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTphMmU3MGY5YTI4NjA0ZmZlYjIzZGU5NWRkNzg2MjBlNS90YWJsZXJhbmdlOmEyZTcwZjlhMjg2MDRmZmViMjNkZTk1ZGQ3ODYyMGU1XzItMS0xLTEtOTA3MTc_343b1f55-061d-4cfb-9c28-fb9e371361c4">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i192c0e38323342ae9304ab84b0debe13_I20220930" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTphMmU3MGY5YTI4NjA0ZmZlYjIzZGU5NWRkNzg2MjBlNS90YWJsZXJhbmdlOmEyZTcwZjlhMjg2MDRmZmViMjNkZTk1ZGQ3ODYyMGU1XzItMy0xLTEtOTA3MTc_012306f7-8e2e-4926-9ac3-aa282fd68b40">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining life (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37123c3b7a85495b95dd4d8511fc0442_I20220930" decimals="1" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTphMmU3MGY5YTI4NjA0ZmZlYjIzZGU5NWRkNzg2MjBlNS90YWJsZXJhbmdlOmEyZTcwZjlhMjg2MDRmZmViMjNkZTk1ZGQ3ODYyMGU1XzMtMS0xLTEtOTA3MTc_0d083398-cdcf-4c31-9510-f31819ff2c99">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0fa6834bd2214eff8b934f7fdaa67fbf_I20220930" decimals="1" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTphMmU3MGY5YTI4NjA0ZmZlYjIzZGU5NWRkNzg2MjBlNS90YWJsZXJhbmdlOmEyZTcwZjlhMjg2MDRmZmViMjNkZTk1ZGQ3ODYyMGU1XzMtMy0xLTEtOTA3MTc_8f620e6d-db97-4c32-8948-f6b8d78c6968">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0172ec8bd8ce4a22879fb349fbbafc56_I20220930" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTphMmU3MGY5YTI4NjA0ZmZlYjIzZGU5NWRkNzg2MjBlNS90YWJsZXJhbmdlOmEyZTcwZjlhMjg2MDRmZmViMjNkZTk1ZGQ3ODYyMGU1XzQtMS0xLTEtOTA3MTc_259d5594-3622-4f27-aed4-5d7a22bd03b3">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic9d5899a57c54d7990cac2605e65ebd3_I20220930" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTphMmU3MGY5YTI4NjA0ZmZlYjIzZGU5NWRkNzg2MjBlNS90YWJsZXJhbmdlOmEyZTcwZjlhMjg2MDRmZmViMjNkZTk1ZGQ3ODYyMGU1XzQtMy0xLTEtOTA3MTc_1aaf75b9-fd80-4b5f-b6b3-0288b04b24f8">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0aa6805e2b1149559fbad18c590187ff_I20220930" decimals="4" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTphMmU3MGY5YTI4NjA0ZmZlYjIzZGU5NWRkNzg2MjBlNS90YWJsZXJhbmdlOmEyZTcwZjlhMjg2MDRmZmViMjNkZTk1ZGQ3ODYyMGU1XzUtMS0xLTEtOTA3MTc_38a98a93-c76b-493c-9afa-ce744cf73ad0">4.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icda6841801c24b74be59d169bb943c1a_I20220930" decimals="4" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTphMmU3MGY5YTI4NjA0ZmZlYjIzZGU5NWRkNzg2MjBlNS90YWJsZXJhbmdlOmEyZTcwZjlhMjg2MDRmZmViMjNkZTk1ZGQ3ODYyMGU1XzUtMy0xLTEtOTA3MTc_e974c56d-94ea-41af-b992-5f432a533ab8">4.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5ca319150c654f32ae12b5fe4314342e_I20220930" decimals="1" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTphMmU3MGY5YTI4NjA0ZmZlYjIzZGU5NWRkNzg2MjBlNS90YWJsZXJhbmdlOmEyZTcwZjlhMjg2MDRmZmViMjNkZTk1ZGQ3ODYyMGU1XzYtMS0xLTEtOTA3MTc_4f4e2a59-9770-4e2b-aee2-a5d8f864fdb2">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie7fb1eeb489e46439a3c7f8c3a135d2b_I20220930" decimals="1" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTphMmU3MGY5YTI4NjA0ZmZlYjIzZGU5NWRkNzg2MjBlNS90YWJsZXJhbmdlOmEyZTcwZjlhMjg2MDRmZmViMjNkZTk1ZGQ3ODYyMGU1XzYtMy0xLTEtOTA3MTc_d5fe7fb3-e3c7-427b-b8e1-3c923a6e3a7b">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i50591f4e8c7a4c87a18ff51b7460e5d8_I20220930" decimals="4" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTphMmU3MGY5YTI4NjA0ZmZlYjIzZGU5NWRkNzg2MjBlNS90YWJsZXJhbmdlOmEyZTcwZjlhMjg2MDRmZmViMjNkZTk1ZGQ3ODYyMGU1XzctMS0xLTEtOTA3MTc_770d2d0d-a1c6-4009-bffa-f5d0ee232f0a">3.33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i32c536245c9a49b0a6be57c612f69c6d_I20220930" decimals="4" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTphMmU3MGY5YTI4NjA0ZmZlYjIzZGU5NWRkNzg2MjBlNS90YWJsZXJhbmdlOmEyZTcwZjlhMjg2MDRmZmViMjNkZTk1ZGQ3ODYyMGU1XzctMy0xLTEtOTA3MTc_3c5c8b70-9236-45fe-aacd-dbdd64f76650">4.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ieb39bfc330164ff6ba59e1d2825cd61d_I20220930" decimals="0" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTphMmU3MGY5YTI4NjA0ZmZlYjIzZGU5NWRkNzg2MjBlNS90YWJsZXJhbmdlOmEyZTcwZjlhMjg2MDRmZmViMjNkZTk1ZGQ3ODYyMGU1XzgtMS0xLTEtOTA3MTc_cc4731da-b2eb-46e7-835e-d886a542a3d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i114b807366e64e039876ae4814999f64_I20220930" decimals="0" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTphMmU3MGY5YTI4NjA0ZmZlYjIzZGU5NWRkNzg2MjBlNS90YWJsZXJhbmdlOmEyZTcwZjlhMjg2MDRmZmViMjNkZTk1ZGQ3ODYyMGU1XzgtMy0xLTEtOTA3MTc_1bf76296-170e-4a2c-86e0-dfd58b7cf10e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation><ix:continuation id="icd30a0a20d034472bae0fd85868df018" continuedAt="ib49e9ea9387a4d09b4154b30bef248f6"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables represents a reconciliation of the contingent shares issuance liabilities fair value measurements using the significant unobservable inputs (Level 3) (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrants</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE liability</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE warrant</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0945a26d694b428d8419686bb048d18d_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTo4N2E5ODg1MzlhMTg0OWNjYWFhYWRkNzk4NWViOGYwYS90YWJsZXJhbmdlOjg3YTk4ODUzOWExODQ5Y2NhYWFhZGQ3OTg1ZWI4ZjBhXzEtMS0xLTEtOTA3MTc_79504280-67f7-4a1b-b120-bb4df56e4ecc">1,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb53208afd74e9483b23d0e4041d555_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTo4N2E5ODg1MzlhMTg0OWNjYWFhYWRkNzk4NWViOGYwYS90YWJsZXJhbmdlOjg3YTk4ODUzOWExODQ5Y2NhYWFhZGQ3OTg1ZWI4ZjBhXzEtMi0xLTEtOTA3MTc_aa50dcc0-e9ef-4cc3-88dc-171952e9a2e0">28,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i079f7d69cf684156b67ee6553c8b6aad_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTo4N2E5ODg1MzlhMTg0OWNjYWFhYWRkNzk4NWViOGYwYS90YWJsZXJhbmdlOjg3YTk4ODUzOWExODQ5Y2NhYWFhZGQ3OTg1ZWI4ZjBhXzEtMy0xLTEtOTA3MTc_63955c1e-0865-48af-8919-e7fc5ecd9408">1,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss / (gain) recognized in condensed statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24da02763da74b0a98ebfa8693930419_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTo4N2E5ODg1MzlhMTg0OWNjYWFhYWRkNzk4NWViOGYwYS90YWJsZXJhbmdlOjg3YTk4ODUzOWExODQ5Y2NhYWFhZGQ3OTg1ZWI4ZjBhXzItMS0xLTEtOTA3MTc_ec7e42d7-2354-4b80-ad4e-750ecf6eed95">427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e2cb48d3fed408fb6bf572cd6d907a7_D20220101-20220930" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTo4N2E5ODg1MzlhMTg0OWNjYWFhYWRkNzk4NWViOGYwYS90YWJsZXJhbmdlOjg3YTk4ODUzOWExODQ5Y2NhYWFhZGQ3OTg1ZWI4ZjBhXzItMi0xLTEtOTA3MTc_b45c640b-0199-4b27-82cb-abda4f5c9ffb">1,050</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i339b33ace04542deabf468483e22dd7b_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTo4N2E5ODg1MzlhMTg0OWNjYWFhYWRkNzk4NWViOGYwYS90YWJsZXJhbmdlOjg3YTk4ODUzOWExODQ5Y2NhYWFhZGQ3OTg1ZWI4ZjBhXzItMy0xLTEtOTA3MTc_22401323-0955-4b4b-99b3-4323d111e6f8">293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcbb421dbd8a47549b523344e6362ae3_I20220930" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTo4N2E5ODg1MzlhMTg0OWNjYWFhYWRkNzk4NWViOGYwYS90YWJsZXJhbmdlOjg3YTk4ODUzOWExODQ5Y2NhYWFhZGQ3OTg1ZWI4ZjBhXzMtMS0xLTEtOTA3MTc_3166743e-ab40-4a2d-a55d-a8a8ffba7a3d">1,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c5b2e7ef7394f83aafc18d6214bf674_I20220930" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTo4N2E5ODg1MzlhMTg0OWNjYWFhYWRkNzk4NWViOGYwYS90YWJsZXJhbmdlOjg3YTk4ODUzOWExODQ5Y2NhYWFhZGQ3OTg1ZWI4ZjBhXzMtMi0xLTEtOTA3MTc_2b687400-06c0-4dc8-9cda-67160facdf10">27,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af2492b6f554a0eb3fc32f72a1bb287_I20220930" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTo4N2E5ODg1MzlhMTg0OWNjYWFhYWRkNzk4NWViOGYwYS90YWJsZXJhbmdlOjg3YTk4ODUzOWExODQ5Y2NhYWFhZGQ3OTg1ZWI4ZjBhXzMtMy0xLTEtOTA3MTc_592565c3-c6e5-4a28-bed1-aa482c981950">2,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i4921c4fbd7a64607b8e4090d8d68218d" continuedAt="iba91deced8854759b9b386753a4438b9"><div style="margin-bottom:9pt"><ix:continuation id="ib49e9ea9387a4d09b4154b30bef248f6" continuedAt="i95a2054d31a740af8146bec4ca1c39e6"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrants</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE liability</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE warrant</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5618649df5e5458fa3e4d03670a6f48b_I20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTozNGU4YzdkNzk2MmQ0YWMwYTkzMDI1YTUxNmI4OTliYS90YWJsZXJhbmdlOjM0ZThjN2Q3OTYyZDRhYzBhOTMwMjVhNTE2Yjg5OWJhXzEtMS0xLTEtOTA3MTc_d6930405-3d43-44ee-b817-c0011b9a6db2">582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce53a5d10814231a163555304304500_I20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTozNGU4YzdkNzk2MmQ0YWMwYTkzMDI1YTUxNmI4OTliYS90YWJsZXJhbmdlOjM0ZThjN2Q3OTYyZDRhYzBhOTMwMjVhNTE2Yjg5OWJhXzEtMi0xLTEtOTA3MTc_5ecae1dd-1d73-42ed-ae1b-b90dee1811d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iceff32fcb2af47c7981043c476b7ae54_I20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTozNGU4YzdkNzk2MmQ0YWMwYTkzMDI1YTUxNmI4OTliYS90YWJsZXJhbmdlOjM0ZThjN2Q3OTYyZDRhYzBhOTMwMjVhNTE2Yjg5OWJhXzEtMy0xLTEtOTA3MTc_080926f3-bc41-41bc-ad61-c0534c5fee58">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of SAFE liability and warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ebbca494b448ef875e3b5a750be5f7_D20210101-20210930" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTozNGU4YzdkNzk2MmQ0YWMwYTkzMDI1YTUxNmI4OTliYS90YWJsZXJhbmdlOjM0ZThjN2Q3OTYyZDRhYzBhOTMwMjVhNTE2Yjg5OWJhXzItMS0xLTEtOTA3MTc_7d576e77-60da-4913-9219-561f3b20ebac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578deee2fa2d4d7bb7f94e488eeef63f_D20210101-20210930" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTozNGU4YzdkNzk2MmQ0YWMwYTkzMDI1YTUxNmI4OTliYS90YWJsZXJhbmdlOjM0ZThjN2Q3OTYyZDRhYzBhOTMwMjVhNTE2Yjg5OWJhXzItMi0xLTEtOTA3MTc_af5dbdc5-100f-4c7a-8089-207f96404f25">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e9a8a61ba8846269b1f093403d0655f_D20210101-20210930" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTozNGU4YzdkNzk2MmQ0YWMwYTkzMDI1YTUxNmI4OTliYS90YWJsZXJhbmdlOjM0ZThjN2Q3OTYyZDRhYzBhOTMwMjVhNTE2Yjg5OWJhXzItMy0xLTEtOTA3MTc_7d43e709-c155-4963-95d2-53d959fa292a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss recognized in condensed statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ebbca494b448ef875e3b5a750be5f7_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTozNGU4YzdkNzk2MmQ0YWMwYTkzMDI1YTUxNmI4OTliYS90YWJsZXJhbmdlOjM0ZThjN2Q3OTYyZDRhYzBhOTMwMjVhNTE2Yjg5OWJhXzMtMS0xLTEtOTA3MTc_0d6fe7fb-1798-42e6-adf9-22869d230ce1">699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578deee2fa2d4d7bb7f94e488eeef63f_D20210101-20210930" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTozNGU4YzdkNzk2MmQ0YWMwYTkzMDI1YTUxNmI4OTliYS90YWJsZXJhbmdlOjM0ZThjN2Q3OTYyZDRhYzBhOTMwMjVhNTE2Yjg5OWJhXzMtMi0xLTEtOTA3MTc_262481ec-f3ad-4f1f-9f7c-f438d26c9c28">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e9a8a61ba8846269b1f093403d0655f_D20210101-20210930" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTozNGU4YzdkNzk2MmQ0YWMwYTkzMDI1YTUxNmI4OTliYS90YWJsZXJhbmdlOjM0ZThjN2Q3OTYyZDRhYzBhOTMwMjVhNTE2Yjg5OWJhXzMtMy0xLTEtOTA3MTc_90a1dfcd-f25b-4ad7-99c7-f729f09d5449">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dcdacedd7b3425b94c3894b1d80e349_I20210930" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTozNGU4YzdkNzk2MmQ0YWMwYTkzMDI1YTUxNmI4OTliYS90YWJsZXJhbmdlOjM0ZThjN2Q3OTYyZDRhYzBhOTMwMjVhNTE2Yjg5OWJhXzQtMS0xLTEtOTA3MTc_e2255602-3bf5-44ee-bd1d-7db58bd1d70b">1,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic04f0a1ede324c85b72039cfd7feb0b7_I20210930" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTozNGU4YzdkNzk2MmQ0YWMwYTkzMDI1YTUxNmI4OTliYS90YWJsZXJhbmdlOjM0ZThjN2Q3OTYyZDRhYzBhOTMwMjVhNTE2Yjg5OWJhXzQtMi0xLTEtOTA3MTc_94999727-27ac-4dc1-a9b6-70bf3be736f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78b91d141eb346fc856035c2b7e19205_I20210930" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTozNGU4YzdkNzk2MmQ0YWMwYTkzMDI1YTUxNmI4OTliYS90YWJsZXJhbmdlOjM0ZThjN2Q3OTYyZDRhYzBhOTMwMjVhNTE2Yjg5OWJhXzQtMy0xLTEtOTA3MTc_ded479d0-6187-4286-880f-2026c41de29a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div id="ib82e114cd19f45afae73e7a64e42f208_758"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7 &#8212; <ix:continuation id="i4ecce717eb6a4849bd55e9e5ac7be9ce" continuedAt="i31c1e679013e4217b7c40c4e5bc07f9c">Income Taxes</ix:continuation></span></div><ix:continuation id="i31c1e679013e4217b7c40c4e5bc07f9c" continuedAt="i8f9f3f6a434342f48795de3cf5e528df"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to federal state income taxes in the United States, as well as income taxes in foreign jurisdictions in which it conducts business. The Company does not provide for federal income taxes on the undistributed earnings of its foreign subsidiaries as such earnings are reinvested indefinitely. The Company and its foreign subsidiaries have historically been loss generating entities that have resulted in <ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="INF" name="us-gaap:ForeignEarningsRepatriated" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NTgvZnJhZzo0NWFhNzEzMGQ4ODM0YWI2YThkZjJkNmVjYTkyODdkMy90ZXh0cmVnaW9uOjQ1YWE3MTMwZDg4MzRhYjZhOGRmMmQ2ZWNhOTI4N2QzXzEwOTk1MTE2MjgyNzY4_5ef7f81c-4b44-4cfc-b46e-33027aea4800"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="INF" name="us-gaap:ForeignEarningsRepatriated" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NTgvZnJhZzo0NWFhNzEzMGQ4ODM0YWI2YThkZjJkNmVjYTkyODdkMy90ZXh0cmVnaW9uOjQ1YWE3MTMwZDg4MzRhYjZhOGRmMmQ2ZWNhOTI4N2QzXzEwOTk1MTE2MjgyNzY4_623b2974-7fb6-4827-aacc-c50a8576abd4">no</ix:nonFraction></ix:nonFraction> excess earnings to consider for repatriation and accordingly there are <ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="INF" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NTgvZnJhZzo0NWFhNzEzMGQ4ODM0YWI2YThkZjJkNmVjYTkyODdkMy90ZXh0cmVnaW9uOjQ1YWE3MTMwZDg4MzRhYjZhOGRmMmQ2ZWNhOTI4N2QzXzEwOTk1MTE2MjgyNzc2_0c102a5e-5578-44f4-8330-863792a60a95"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="INF" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NTgvZnJhZzo0NWFhNzEzMGQ4ODM0YWI2YThkZjJkNmVjYTkyODdkMy90ZXh0cmVnaW9uOjQ1YWE3MTMwZDg4MzRhYjZhOGRmMmQ2ZWNhOTI4N2QzXzEwOTk1MTE2MjgyNzc2_790540e5-9b34-45b6-836a-cdb509edfae4">no</ix:nonFraction></ix:nonFraction> deferred income taxes recognized for the nine months ended September&#160;30, 2022 and 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded an income tax expense of $<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NTgvZnJhZzo0NWFhNzEzMGQ4ODM0YWI2YThkZjJkNmVjYTkyODdkMy90ZXh0cmVnaW9uOjQ1YWE3MTMwZDg4MzRhYjZhOGRmMmQ2ZWNhOTI4N2QzXzEwOTk1MTE2MjgyNzY1_4026b52d-7dd0-47cf-9617-8525486b1c07"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NTgvZnJhZzo0NWFhNzEzMGQ4ODM0YWI2YThkZjJkNmVjYTkyODdkMy90ZXh0cmVnaW9uOjQ1YWE3MTMwZDg4MzRhYjZhOGRmMmQ2ZWNhOTI4N2QzXzEwOTk1MTE2MjgyNzY1_ee060e2e-7a31-4e65-96dd-90ef339f43b0">0</ix:nonFraction></ix:nonFraction> for the nine months ended September&#160;30, 2022 and 2021, representing an effective tax rate of <ix:nonFraction unitRef="number" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NTgvZnJhZzo0NWFhNzEzMGQ4ODM0YWI2YThkZjJkNmVjYTkyODdkMy90ZXh0cmVnaW9uOjQ1YWE3MTMwZDg4MzRhYjZhOGRmMmQ2ZWNhOTI4N2QzXzEyNjQ0MzgzNzI0NDIw_5d3edb14-7dd3-467e-afe0-8cc6ce51f5d4"><ix:nonFraction unitRef="number" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NTgvZnJhZzo0NWFhNzEzMGQ4ODM0YWI2YThkZjJkNmVjYTkyODdkMy90ZXh0cmVnaW9uOjQ1YWE3MTMwZDg4MzRhYjZhOGRmMmQ2ZWNhOTI4N2QzXzEyNjQ0MzgzNzI0NDIw_88f65c56-d69a-4f97-957f-2df19f1428e6">0</ix:nonFraction></ix:nonFraction>%. The difference between the U.S. federal statutory rate of 21% and the Company's effective tax rate in the first nine months ended September&#160;30, 2022 is primarily due to a full valuation allowance related to the Company's U.S. deferred tax assets and tax benefits in the Company's foreign jurisdictions. For the first nine months ended September 30, 2021, the Company's effective tax rate was computed based on income tax rate in New Zealand of <ix:nonFraction unitRef="number" contextRef="i8a79cdf54f8341f5939209c59107cddb_D20210101-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NTgvZnJhZzo0NWFhNzEzMGQ4ODM0YWI2YThkZjJkNmVjYTkyODdkMy90ZXh0cmVnaW9uOjQ1YWE3MTMwZDg4MzRhYjZhOGRmMmQ2ZWNhOTI4N2QzXzExNTU_2faead93-4fe9-45b5-a4b0-f69759985e3e">28.0</ix:nonFraction>% as the Company was still domiciled in New Zealand. The Company reassesses the need for a valuation allowance on a quarterly basis. If it is determined that a portion or all of the valuation allowance is not required, it will generally be a benefit to the income tax provision in the period such determination is made.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts business in multiple jurisdictions within and outside the United States. Consequently, the Company is subject to periodic income tax examinations by domestic and foreign income tax authorities. The Company is subject to audits for tax years 2009 and onward for federal purposes. There are tax years which remain subject to examination in various other state and foreign jurisdictions that are not material to the Company's financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, the Company migrated its country of domicile from New Zealand to Delaware in the United States. On migration, the Company was deemed to have disposed of all its assets and liabilities to a third-party at market value which resulted in taxable income to the Company for New Zealand income tax purposes which was fully offset by net operating loss carryforwards and deferred R&amp;D credits in New Zealand. The migration to Delaware is classified as a tax-free reorganization for U.S. federal income tax purposes.</span></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_765"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8 &#8212; <ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzEzNzQzODk1MzUyMjEx_8f0f3727-34f2-453c-9381-01643e30a207" continuedAt="i7ec896a9844242b99caed2eb2ec42f15" escape="true">Share-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="i7ec896a9844242b99caed2eb2ec42f15" continuedAt="i272264ea97bd46f1ae0d5eb130ba805b"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers share option plans to employees, directors, and others providing similar employee-related services, which meet the definition of an equity-settled share-based payment.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="scheme" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="amci:NumberOfShareBasedStockSchemes" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzEwOTk1MTE2MjgyNzg1_058a1350-8b17-4355-9766-2df0c815688a">five</ix:nonFraction> ownership-based participation rights schemes for employees, directors, and certain third-party providers. In accordance with the provisions of the schemes, as approved by the directors and shareholders, grantees have been granted options to purchase common shares at an exercise price based on the fair value price of the Company&#8217;s common shares on the date of grant as approved by the directors. The stock options generally have a service condition of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzEyNjQ0MzgzNzI0Mzkx_1f5323c0-bbe0-45e6-bfd6-3ba4780f1116">two</span> to <ix:nonNumeric contextRef="ibd4d0f3725b743bb9a13d0e7f76a6680_D20220101-20220930" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzEyNjQ0MzgzNzI0NDAx_775b83b1-d5c4-4a00-adf7-622503806752">five years</ix:nonNumeric> and vest over time as the service condition is being satisfied. Upon termination of employment, unvested stock options are evaluated for forfeiture or modifications, subject to the terms of the awards and Company's policies.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i272264ea97bd46f1ae0d5eb130ba805b" continuedAt="ia985096254434cec9408d660883bdfb0"><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzEzNzQzODk1MzUyMjEz_245539e9-9434-4f0f-85af-c855bc39d18e" continuedAt="i4c15e8f1d8d1408095a1035a360e3c36" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option awards outstanding as of September&#160;30, 2022 and changes during the period ended September&#160;30, 2022 were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares under option (thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average remaining contractual term (years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate intrinsic value (thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzEtMS0xLTEtOTA3MTc_ca49e918-ae00-489b-af55-b54d591b40e0">3,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzEtMy0xLTEtOTA3MTc_40107fe1-3161-41bf-8256-163471a0dab5">6.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzEtNS0xLTEtOTA3MTc_b6d020b8-97c8-4d43-99b1-7a876e067cb0">6.16</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzEtNy0xLTEtOTA3MTc_fee98050-af1e-413d-b2e8-770a25acdd8a">27,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expecting to vest at January 1, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzItMS0xLTEtOTA3MTc_6cf76058-8183-4c58-a646-d46085f9952a">3,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzItMy0xLTEtOTA3MTc_56cd5b9b-3bd9-4263-be51-991e46fd83f5">6.55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzItNS0xLTEtOTA3MTc_979be31b-92a1-43aa-9222-701e0706a563">6.16</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzItNy0xLTEtOTA3MTc_f854138a-6619-4785-b847-b6a2cc3961c1">27,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzMtMS0xLTEtOTA3MTc_4b124198-0039-4cee-b350-a8bfce975028">2,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzMtMy0xLTEtOTA3MTc_24ae6db1-e3a3-49e9-ad58-431e4f727586">6.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzMtNS0xLTEtOTA3MTc_a2fab849-153d-4d4f-a704-7c83a5510251">4.85</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzMtNy0xLTEtOTA3MTc_2d8705f8-b6b6-4852-8287-92b7153c4e88">18,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzQtMS0xLTEtOTA3MTc_abc1315c-d5cb-470f-b6c6-b9f0339b39e4">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzQtMy0xLTEtOTA3MTc_a8e6d36b-61e8-47e5-a487-a25d8e3b4dfb">6.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzQtNy0xLTEtOTA3MTc_594ad8fa-a982-4681-9170-856adaa03d4f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzUtMS0xLTEtOTA3MTc_307d66c5-92ca-4923-bd41-03b78ba3c550">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzUtMy0xLTEtOTA3MTc_b0476843-94fb-4570-b20d-77a2d00be2a8">9.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="amci:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzUtNy0xLTEtOTA3MTc_d5a1c51f-3c49-4e3d-8026-94ae0692877f">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzYtMS0xLTEtOTA3MTc_1d63206c-27c2-426c-af75-a466adb607e2">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzYtMy0xLTEtOTA3MTc_854d721e-c1e7-45fe-86a8-a16ba0f840bb">6.61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="amci:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzYtNy0xLTEtOTA3MTc_e71d31f2-ce29-47c5-9655-f054a0a3a3f7">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzctMS0xLTEtOTA3MTc_8840b6e3-4a2e-45c0-8f43-4089897a8d23">3,806</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzctMy0xLTEtOTA3MTc_d4585a78-83cf-40a3-863b-d5b5c2d76feb">6.52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzctNS0xLTEtOTA3MTc_97c08d4d-7d8b-4aa1-91d0-33366bff08b9">5.39</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzctNy0xLTEtOTA3MTc_56935bc3-9bde-4aed-bb82-56c8de73cb0d">42,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expecting to vest at September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzgtMS0xLTEtOTA3MTc_f79c4a24-4bf9-4c3c-9cfd-37ca5e255d1d">3,806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzgtMy0xLTEtOTA3MTc_eb344375-e6c9-4f66-9240-e43c0222380a">6.52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzgtNS0xLTEtOTA3MTc_c7090c6d-6076-40d4-9750-60d25de57cc4">5.39</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzgtNy0xLTEtOTA3MTc_2b9178a8-bcb3-43b2-bf7d-e87b5b310276">42,032</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzktMS0xLTEtOTA3MTc_d3ccd9a2-94e5-46b9-bfc8-67c7d23e13f6">2,918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzktMy0xLTEtOTA3MTc_9eb92e7f-7a86-4c06-8208-d906e435f0c7">6.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzktNS0xLTEtOTA3MTc_0a081f18-2061-49d3-b5d1-070d2ac14640">4.56</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzktNy0xLTEtOTA3MTc_698de498-11ba-48e9-80e9-94b9bdc9d868">32,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded compensation expense of $<ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzExMDQ_888ba1d1-fbc5-41d0-9a3d-104c7d8b0de6">2,067</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzExMTE_3614c777-7902-4bd5-bb0a-c2bc56ba1eb0">1,790</ix:nonFraction> for the nine months ended September&#160;30, 2022 and September&#160;30, 2021, respectively. Unrecognized compensation costs as of September&#160;30, 2022 was $<ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzEyMTA_5e8eb45e-7d32-4cac-8369-ae0b69afc8c8">3,835</ix:nonFraction> and will be recognized over a weighted average of <ix:nonNumeric contextRef="id580de21b42b4e398c7373ee2244ec4a_D20220101-20220930" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzEwOTk1MTE2MjgyNzc0_075c25e1-bde5-455a-b7ce-9113b2c7cef9">2.27</ix:nonNumeric> years. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Awards (&#8220;RSAs&#8221;)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSAs become eligible to vest upon the satisfaction of a time-based service condition. However, in order to vest, a liquidity event, defined as acquisition, asset transfer, or initial listing, must occur within <ix:nonNumeric contextRef="i5b4e3fd1f02f47b5a39f57e583f20233_D20220101-20220930" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzEyNjQ0MzgzNzI0NDE5_cccdd4f8-4833-43c2-8338-6f36cb1ae731">10</ix:nonNumeric> years from the grant date. Upon a liquidity event, if the participant&#8217;s service has not terminated, the entire RSA award vests in full, whether or not previously eligible for vesting. If the participant&#8217;s service has terminated and they have satisfied the time-based service condition, the RSAs that are outstanding and eligible for vesting shall immediately vest in full. The time-based service requirements of the RSAs have a maximum term of <ix:nonNumeric contextRef="i5b4e3fd1f02f47b5a39f57e583f20233_D20220101-20220930" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzEwOTk1MTE2MjgyNzk0_483ea750-2f04-4179-b2e4-d1d1f3c0abf0">three years</ix:nonNumeric> from the date of grant.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, there were <ix:nonFraction unitRef="shares" contextRef="i64009d0294a6447cbb23d3d0c5282ca7_I20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzIwMjI_212e5337-c586-4d24-bb64-7b66abfd0956">579,660</ix:nonFraction> outstanding unvested shares for a weighted average fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i64009d0294a6447cbb23d3d0c5282ca7_I20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzIwOTE_4dec10ac-3039-439f-bcc6-1bb881c7d36a">4.72</ix:nonFraction>. There were no changes during the nine months ended September&#160;30, 2022.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, and September&#160;30, 2021 the Company concluded that the liquidity event performance condition described above for the RSAs was not probable of being satisfied at such time. As a result, the Company did <ix:nonFraction unitRef="usd" contextRef="i9e411fa8a71f41a3b345b23c815aba64_D20210101-20210930" decimals="INF" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzEwOTk1MTE2MjgyNzc2_82d4152a-9b37-433a-8f10-d806522e973a"><ix:nonFraction unitRef="usd" contextRef="i5b4e3fd1f02f47b5a39f57e583f20233_D20220101-20220930" decimals="INF" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzEwOTk1MTE2MjgyNzc2_a63a8e48-d9ad-4af1-896e-9f4e05b3e244">not</ix:nonFraction></ix:nonFraction> recognize any compensation cost during the nine months ended September&#160;30, 2022 and September&#160;30, 2021 for any RSAs granted.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-61</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_773"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="idd04b12f135b4963bc1413276d123ff2" continuedAt="i92c5a640d9be41da898efbc6e01b12ad"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9 &#8212; Related Party Transactions</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021, the Company had an equity ownership in LanzaJet and SGLT with an aggregate carrying value of $<ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90ZXh0cmVnaW9uOmNmNDZjNGQ4MWIwZjRkNWQ5ZTMwMzRiZjBjOGRjOGNlXzE1MA_e0284e2c-3b46-432a-8f0e-5f914d69a273">26,037</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90ZXh0cmVnaW9uOmNmNDZjNGQ4MWIwZjRkNWQ5ZTMwMzRiZjBjOGRjOGNlXzE1Nw_d9f7b924-0b4d-4aae-9135-964d3edfa8c9">24,752</ix:nonFraction>, respectively. <ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90ZXh0cmVnaW9uOmNmNDZjNGQ4MWIwZjRkNWQ5ZTMwMzRiZjBjOGRjOGNlXzEzNzQzODk1MzUzNzMz_582e6c4d-7037-4798-820b-0e5520fe0f68" continuedAt="i1d559b47269e468090522797f2691f66" escape="true">The table below summarizes amounts related to transactions with these related parties (in thousands):</ix:nonNumeric></span></div><div style="margin-bottom:9pt"><ix:continuation id="i1d559b47269e468090522797f2691f66"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90YWJsZToxYWNiYjg1NzgzZDc0Y2I5YTYyZjI0NzYyNzUyNGRiYS90YWJsZXJhbmdlOjFhY2JiODU3ODNkNzRjYjlhNjJmMjQ3NjI3NTI0ZGJhXzItMS0xLTEtOTA3MTc_51141796-7690-4de4-94b4-c251b37b43a8">2,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90YWJsZToxYWNiYjg1NzgzZDc0Y2I5YTYyZjI0NzYyNzUyNGRiYS90YWJsZXJhbmdlOjFhY2JiODU3ODNkNzRjYjlhNjJmMjQ3NjI3NTI0ZGJhXzItMy0xLTEtOTA3MTc_7fc9fdae-edd5-4ee0-99b7-4791485469e3">2,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c25a29e3caa42e99299fc9c41c7bac1_I20220930" decimals="-3" name="us-gaap:AccountsReceivableNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90YWJsZToxYWNiYjg1NzgzZDc0Y2I5YTYyZjI0NzYyNzUyNGRiYS90YWJsZXJhbmdlOjFhY2JiODU3ODNkNzRjYjlhNjJmMjQ3NjI3NTI0ZGJhXzYtMS0xLTEtOTA3MTc_6c2724f9-d426-4846-aaac-70120887ea95">1,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id33f2498c7aa4d4ba897810160258324_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90YWJsZToxYWNiYjg1NzgzZDc0Y2I5YTYyZjI0NzYyNzUyNGRiYS90YWJsZXJhbmdlOjFhY2JiODU3ODNkNzRjYjlhNjJmMjQ3NjI3NTI0ZGJhXzYtMy0xLTEtOTA3MTc_c8bd1f41-7a6b-4fc1-abb4-ae4e65e89156">1,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c25a29e3caa42e99299fc9c41c7bac1_I20220930" decimals="-3" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90YWJsZToxYWNiYjg1NzgzZDc0Y2I5YTYyZjI0NzYyNzUyNGRiYS90YWJsZXJhbmdlOjFhY2JiODU3ODNkNzRjYjlhNjJmMjQ3NjI3NTI0ZGJhXzctMS0xLTEtOTA3MTc_ea88b0f7-cad3-4a82-8978-cf8adea80083">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id33f2498c7aa4d4ba897810160258324_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90YWJsZToxYWNiYjg1NzgzZDc0Y2I5YTYyZjI0NzYyNzUyNGRiYS90YWJsZXJhbmdlOjFhY2JiODU3ODNkNzRjYjlhNjJmMjQ3NjI3NTI0ZGJhXzctMy0xLTEtOTA3MTc_a3fa96fd-69cb-42b9-a071-25667561a634">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases and open accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c25a29e3caa42e99299fc9c41c7bac1_I20220930" decimals="-3" name="amci:PurchasesAndOpenAccountsPayableRelatedParties" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90YWJsZToxYWNiYjg1NzgzZDc0Y2I5YTYyZjI0NzYyNzUyNGRiYS90YWJsZXJhbmdlOjFhY2JiODU3ODNkNzRjYjlhNjJmMjQ3NjI3NTI0ZGJhXzgtMS0xLTEtOTA3MTc_78c8679c-1e57-49ec-aabf-7f793f9851f3">1,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id33f2498c7aa4d4ba897810160258324_I20211231" decimals="-3" name="amci:PurchasesAndOpenAccountsPayableRelatedParties" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90YWJsZToxYWNiYjg1NzgzZDc0Y2I5YTYyZjI0NzYyNzUyNGRiYS90YWJsZXJhbmdlOjFhY2JiODU3ODNkNzRjYjlhNjJmMjQ3NjI3NTI0ZGJhXzgtMy0xLTEtOTA3MTc_63a10f3b-5f06-42a4-bc3e-77cceb36f635">2,575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounts payable balance is for work that LanzaJet performed as a subcontractor to the Company. Refer to Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for more information. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the formation of LanzaJet, the Company entered into a transition services agreement with LanzaJet. The transition services agreement generally sets out the respective rights, responsibilities and obligations of the Company and LanzaJet with respect to R&amp;D services, access to office and laboratory space, business development and other administrative support services. The transition services agreement may be terminated by mutual consent of the Company and LanzaJet, by LanzaJet at any time, and by the Company upon breach or non-payment by LanzaJet. There are no substantive termination penalties in the event the Company terminates. For the nine months ended September&#160;30, 2022 and September&#160;30, 2021, the Company recognized revenue from related parties of approximately $<ix:nonFraction unitRef="usd" contextRef="i578fdaf743b64320848f4efd3fbff206_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90ZXh0cmVnaW9uOmNmNDZjNGQ4MWIwZjRkNWQ5ZTMwMzRiZjBjOGRjOGNlXzExOTY_23f94841-a53f-4399-8d41-e5260d78c354">148</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i68abf404f20a4c66a39987d6172c4179_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90ZXh0cmVnaW9uOmNmNDZjNGQ4MWIwZjRkNWQ5ZTMwMzRiZjBjOGRjOGNlXzEyMDM_64cb5f78-4e5b-4b8b-beb8-523ce526b902">355</ix:nonFraction>, respectively, under the transition services agreement. The Company also provides certain engineering and other services related to a gas-to-jet demonstration plant currently in development by LanzaJet pursuant to the Investment Agreement described in Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In connection with these services, the Company recognized revenue from LanzaJet of approximately $<ix:nonFraction unitRef="usd" contextRef="i3e23e5276e6d4282a2e9f97732511ff8_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90ZXh0cmVnaW9uOmNmNDZjNGQ4MWIwZjRkNWQ5ZTMwMzRiZjBjOGRjOGNlXzE1NzY_986a5c2a-f22a-45c4-90cf-87c84ec3f45c">170</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i8acbdb690ad34c79ba365f582f00b5da_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90ZXh0cmVnaW9uOmNmNDZjNGQ4MWIwZjRkNWQ5ZTMwMzRiZjBjOGRjOGNlXzE1ODM_7d603ec1-d1df-47c6-8a83-198af78361bd">403</ix:nonFraction>, for the nine months ended September&#160;30, 2022 and September&#160;30, 2021, respectively. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, the Company executed an agreement to lease certain land to a subsidiary of LanzaJet for a period of <ix:nonNumeric contextRef="i85c0c3423aa7412ca1b42997ac78fe99_I20200531" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90ZXh0cmVnaW9uOmNmNDZjNGQ4MWIwZjRkNWQ5ZTMwMzRiZjBjOGRjOGNlXzEyNjQ0MzgzNzI1OTQw_26139f3c-aaec-4d1a-b6b8-c846bdd6c984">10</ix:nonNumeric> years with an option to renew this lease for <ix:nonFraction unitRef="renewal_option" contextRef="i85c0c3423aa7412ca1b42997ac78fe99_I20200531" decimals="INF" name="amci:LesseeOperatingLeaseNumberOfRenewalTerms" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90ZXh0cmVnaW9uOmNmNDZjNGQ4MWIwZjRkNWQ5ZTMwMzRiZjBjOGRjOGNlXzE1OTQyOTE4NjA5Mjky_5ad92fc8-4739-4eff-a082-e0e70cf79fa9">five</ix:nonFraction> additional periods of <ix:nonNumeric contextRef="i85c0c3423aa7412ca1b42997ac78fe99_I20200531" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90ZXh0cmVnaW9uOmNmNDZjNGQ4MWIwZjRkNWQ5ZTMwMzRiZjBjOGRjOGNlXzE1OTQyOTE4NjA5MzA3_c384846c-f7ad-43ca-a277-f68ab207dc4f">one year</ix:nonNumeric> with minimum annual rent due to the Company of $<ix:nonFraction unitRef="usd" contextRef="i85c0c3423aa7412ca1b42997ac78fe99_I20200531" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90ZXh0cmVnaW9uOmNmNDZjNGQ4MWIwZjRkNWQ5ZTMwMzRiZjBjOGRjOGNlXzEyNjQ0MzgzNzI1OTM2_ca3e8d68-71c1-4c56-8196-fbd5f6714614">24</ix:nonFraction>. The lease commenced upon execution of the lease agreement and was subsequently amended in 2022 to extend the Pre-Development Term and annual rent amount. Refer to Note 12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for more information.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company supplies SGLT with certain water-soluble organic compounds required in the Company's proprietary gas fermentation process, and small-size equipment. As a result, for the nine months ended September&#160;30, 2022 and September&#160;30, 2021, the Company recognized revenue from related parties of approximately $<ix:nonFraction unitRef="usd" contextRef="i82d95c66ecd54340a53c89c11d9122a0_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90ZXh0cmVnaW9uOmNmNDZjNGQ4MWIwZjRkNWQ5ZTMwMzRiZjBjOGRjOGNlXzIzNzE_ee896a0a-532a-4272-a0af-1e34befd0f3b">151</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ica64ee13842e4d87b58d8e0776c87382_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90ZXh0cmVnaW9uOmNmNDZjNGQ4MWIwZjRkNWQ5ZTMwMzRiZjBjOGRjOGNlXzIzNzg_6a4eb452-06b9-438e-b3d9-46e8c14255f9">69</ix:nonFraction>, respectively. The Company also provided engineering services and incurred costs of $$<ix:nonFraction unitRef="usd" contextRef="i82d95c66ecd54340a53c89c11d9122a0_D20220101-20220930" decimals="-3" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90ZXh0cmVnaW9uOmNmNDZjNGQ4MWIwZjRkNWQ5ZTMwMzRiZjBjOGRjOGNlXzI0NjY_6f13e134-b2c7-44bb-b546-4d5eef37c3f4">893</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ica64ee13842e4d87b58d8e0776c87382_D20210101-20210930" decimals="-3" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90ZXh0cmVnaW9uOmNmNDZjNGQ4MWIwZjRkNWQ5ZTMwMzRiZjBjOGRjOGNlXzI0NzM_b2383ea6-950c-4cff-ab87-a86b51b3e406">1,171</ix:nonFraction> for the nine months ended September&#160;30, 2022 and September&#160;30, 2021, respectively. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, LanzaTech and SGLT entered into a license agreement in 2019, subsequently amended in 2021, to provide SGLT with the right to sublicense the intellectual property that LanzaTech previously licensed to SGLT. In exchange, the Company is entitled to receive licensing consideration, calculated as a percentage of the royalties received by SGLT from the sublicenses. Currently, SGLT sublicenses to certain of its subsidiaries that use LanzaTech's proprietary technology. The royalties received by SGLT are based on sales-and-usage of the sublicensed technology. For the nine months ended September&#160;30, 2022, and September&#160;30, 2021, the Company did not earn any sublicensing revenue as no royalties were received by SGLT.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-62</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_785"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10 &#8212; <ix:continuation id="i485fc60867a94f65b9cfe6199d00f687" continuedAt="ia47b7737e9b2416ba186f021e3660c51">Redeemable, Convertible Preferred Stock</ix:continuation></span></div><ix:continuation id="ia47b7737e9b2416ba186f021e3660c51" continuedAt="ie7ed36e1afb04dac9cfc695d88382f14"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has six outstanding series of contingently redeemable convertible preferred stock. <ix:continuation id="ib6eb98b7687747308c8ffe8975871220" continuedAt="if5bde5279a0447c1b91c559d5ee6bb32">The authorized, issued and outstanding shares, issue price, and carrying value as of September&#160;30, 2022, are as follows (in thousands, except share and per share amounts):</ix:continuation></span></div><div style="margin-bottom:9pt"><ix:continuation id="if5bde5279a0447c1b91c559d5ee6bb32" continuedAt="i22954257b28841cba2013f7f5f4c8653"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.287%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares Authorized</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idce0b2fa8b1948daac1bdd0c26b6d051_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzEtMS0xLTEtOTA3MTc_d6bfd1e6-b72f-4baa-9114-dc9f3522c5ed">4,666,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idce0b2fa8b1948daac1bdd0c26b6d051_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzEtMy0xLTEtOTA3MTc_bfc21d00-d498-47b9-ac62-e5d7ad89a098"><ix:nonFraction unitRef="shares" contextRef="idce0b2fa8b1948daac1bdd0c26b6d051_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzEtMy0xLTEtOTA3MTc_d1f43b1f-4f1b-48e3-aba3-45c9a26f478f">4,666,503</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i1dfc06d3caf74e879b017b7ba4bccc6c_I20220930" decimals="INF" name="amci:TemporaryEquityIssuePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzEtNS0xLTEtOTA3MTcvdGV4dHJlZ2lvbjo2MDI0NzlkMDhiNDc0MmRkODAzOTk5NmRmZTQ4MTEzNV81NDk3NTU4MTM5MDk_8c325cde-957c-43bc-a33f-3e7c1be91fc8">1.75</ix:nonFraction> - <ix:nonFraction unitRef="usdPerShare" contextRef="i9b90ee4e94cb439f99b65328a21b6c23_I20220930" decimals="INF" name="amci:TemporaryEquityIssuePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzEtNS0xLTEtOTA3MTcvdGV4dHJlZ2lvbjo2MDI0NzlkMDhiNDc0MmRkODAzOTk5NmRmZTQ4MTEzNV81NDk3NTU4MTM5MTY_18840379-ed0b-4a02-8cf7-ad4d4e4cb5ea">3.94</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idce0b2fa8b1948daac1bdd0c26b6d051_I20220930" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzEtNy0xLTEtOTA3MTc_35397cc3-d4a7-42c2-9a6a-a998421152e2">12,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib7233a4b0cd54bc9b9d31a1fda4e4f29_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzItMS0xLTEtOTA3MTc_e820fad7-9b77-4a8d-a57e-589863ee5cb4">1,733,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib7233a4b0cd54bc9b9d31a1fda4e4f29_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzItMy0xLTEtOTA3MTc_8ea52767-5690-4746-8d2d-f7230edbed10"><ix:nonFraction unitRef="shares" contextRef="ib7233a4b0cd54bc9b9d31a1fda4e4f29_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzItMy0xLTEtOTA3MTc_c7baf515-a9b1-417b-933e-82068209a9fa">1,733,370</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib7233a4b0cd54bc9b9d31a1fda4e4f29_I20220930" decimals="INF" name="amci:TemporaryEquityIssuePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzItNS0xLTEtOTA3MTc_1e19e36a-f1f6-4254-95da-fbe19e8bbfca">10.38</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7233a4b0cd54bc9b9d31a1fda4e4f29_I20220930" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzItNy0xLTEtOTA3MTc_f6788442-1ea2-4c8a-b2c8-548075b4a20c">18,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1f16b3d33a074e1ba14330da0255fa2f_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzMtMS0xLTEtOTA3MTc_803fdf6e-d6c5-494a-8952-23a2f9625545">4,254,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1f16b3d33a074e1ba14330da0255fa2f_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzMtMy0xLTEtOTA3MTc_31ded89c-36cb-419e-a5af-16a2f885c82c"><ix:nonFraction unitRef="shares" contextRef="i1f16b3d33a074e1ba14330da0255fa2f_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzMtMy0xLTEtOTA3MTc_efc3c2f1-eb5d-439b-9980-91e4a7a8aaa9">4,142,408</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1f16b3d33a074e1ba14330da0255fa2f_I20220930" decimals="INF" name="amci:TemporaryEquityIssuePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzMtNS0xLTEtOTA3MTc_912fe16e-9e83-4660-8635-156020b2b88c">14.69</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f16b3d33a074e1ba14330da0255fa2f_I20220930" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzMtNy0xLTEtOTA3MTc_a55d53fb-6537-4482-b66a-5c8814e27d6c">60,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab3c900d2c4e4b2a91220c825b2d6956_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzQtMS0xLTEtOTA3MTc_5dc6cfb9-e8fc-4ae9-80c8-3238434e08f7">10,274,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab3c900d2c4e4b2a91220c825b2d6956_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzQtMy0xLTEtOTA3MTc_96eb25e5-bdb4-4684-b388-a5050ba27615"><ix:nonFraction unitRef="shares" contextRef="iab3c900d2c4e4b2a91220c825b2d6956_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzQtMy0xLTEtOTA3MTc_b53a1568-1227-44f0-90ef-ab8fa0815669">10,161,362</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab3c900d2c4e4b2a91220c825b2d6956_I20220930" decimals="INF" name="amci:TemporaryEquityIssuePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzQtNS0xLTEtOTA3MTc_10e12ed8-f7c6-4e58-b450-f4d91fda6827">19.93</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3c900d2c4e4b2a91220c825b2d6956_I20220930" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzQtNy0xLTEtOTA3MTc_32a41864-ab01-4427-b42c-bf777b1971f2">188,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie4c4d87c859840cc99ff35a606293d63_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzUtMS0xLTEtOTA3MTc_ed0bf039-d01e-4f24-ac15-ec9a3582de0d">5,183,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie4c4d87c859840cc99ff35a606293d63_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzUtMy0xLTEtOTA3MTc_bb90b170-30b7-46d4-a8ce-71e3230efed1"><ix:nonFraction unitRef="shares" contextRef="ie4c4d87c859840cc99ff35a606293d63_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzUtMy0xLTEtOTA3MTc_e57fcd0c-211b-47ba-b93d-e9ee7b84db8b">5,183,957</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie4c4d87c859840cc99ff35a606293d63_I20220930" decimals="INF" name="amci:TemporaryEquityIssuePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzUtNS0xLTEtOTA3MTc_9876f389-f177-4cd4-a81a-14f26138514a">22.86</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4c4d87c859840cc99ff35a606293d63_I20220930" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzUtNy0xLTEtOTA3MTc_60d635fe-aba2-4aa4-b26f-78f37ac4973d">118,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series F</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1d3aaae919f443669873c0b2494eb950_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzYtMS0xLTEtOTA3MTc_89fe3b53-4a51-41ed-8de5-3035253ff7ec">3,634,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1d3aaae919f443669873c0b2494eb950_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzYtMy0xLTEtOTA3MTc_58e6d317-990c-487f-865a-97e278f66da1"><ix:nonFraction unitRef="shares" contextRef="i1d3aaae919f443669873c0b2494eb950_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzYtMy0xLTEtOTA3MTc_b8ffac56-3d6e-449d-aa2e-a39c3ad4aab4">3,634,210</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1d3aaae919f443669873c0b2494eb950_I20220930" decimals="INF" name="amci:TemporaryEquityIssuePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzYtNS0xLTEtOTA3MTc_725f45a4-e3dc-4402-9758-26dadb26eb37">22.86</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d3aaae919f443669873c0b2494eb950_I20220930" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzYtNy0xLTEtOTA3MTc_c7637558-f52a-4b69-a895-ece8d2969dd5">83,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzctMS0xLTEtMTAzNTIz_fba0096b-225a-4e61-9f77-6e9ca8e93fa5">29,747,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzctMy0xLTEtMTAzNTIz_7c1c1aba-4479-4c1e-b4c9-9463a49b7871"><ix:nonFraction unitRef="shares" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzctMy0xLTEtMTAzNTIz_e22cbe58-d101-464a-9208-939135bf053b">29,521,810</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzctNy0xLTEtMTAzNTIz_df66dc74-4a56-4c0d-9afe-a7be43829238">480,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in redeemable convertible preferred stock issued and outstanding during the nine months ended September&#160;30, 2022. The holders of preferred shares are entitled to receive dividends on an as converted to common shares basis as if all preferred shares had been converted into common shares on the date of such event. Dividends are cumulative and are payable in arrears at the rate of <ix:nonFraction unitRef="number" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="2" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90ZXh0cmVnaW9uOmNmODQzZTk3ZjA2MDQ4MTY5ZTE0NDFlOWQ0M2QzYjFhXzEyNjQ0MzgzNzIyMjg5_56f147d4-0648-4c97-9d91-58a60458b1fa">8</ix:nonFraction>% of the original issue price.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, a warrant was exercised for a total issuance of <ix:nonFraction unitRef="shares" contextRef="i9f67793938594975ad7e63e3f8a4f312_D20210301-20210331" decimals="INF" name="amci:TemporaryEquitySharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90ZXh0cmVnaW9uOmNmODQzZTk3ZjA2MDQ4MTY5ZTE0NDFlOWQ0M2QzYjFhXzc5MA_7a61295e-3800-40ca-9b0e-7f99dc33386a">158,058</ix:nonFraction> Series D preferred shares which led to an increase in redeemable convertible preferred stock of $<ix:nonFraction unitRef="usd" contextRef="i0e83a5ed9e3a42fbb38d656ae52b386c_D20210101-20210930" decimals="-3" name="amci:TemporaryEquityExerciseOfWarrants" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90ZXh0cmVnaW9uOmNmODQzZTk3ZjA2MDQ4MTY5ZTE0NDFlOWQ0M2QzYjFhXzg4OQ_1399e738-a5e6-478c-8cbb-629ff8ae0015">3,150</ix:nonFraction> during the nine months ended September&#160;30, 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redemption features of preferred shares are not fixed and do not have a determinable price on fixed or determinable dates. As of September&#160;30, 2022, the preferred shares are not currently redeemable, and it is not probable that the preferred shares will become redeemable, since it is uncertain whether or when circumstances exist that would constitute a deemed liquidation event. Accordingly, the Company has not adjusted the carrying value of the preferred shares to their redemption values.</span></div></ix:continuation><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib82e114cd19f45afae73e7a64e42f208_789"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11 &#8212; <ix:continuation id="ia2e46c1b322c4113b5462415c9a4e55a" continuedAt="if0442ad0bf2f476a88533955e6b4f374">Commitments and Contingencies</ix:continuation></span></div><ix:continuation id="if0442ad0bf2f476a88533955e6b4f374" continuedAt="ic41f9b49aa2042b399bfd2d93e8096d4"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may be involved in legal proceedings and exposed to potential claims in the normal course of business. As of September&#160;30, 2022 and December&#160;31, 2021, the Company does <ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:LossContingencyEstimateOfPossibleLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODkvZnJhZzo5YjA1YTA5OWZmMTc0Mjk4ODFlYzA2YzUxNDE4Y2Q1Zi90ZXh0cmVnaW9uOjliMDVhMDk5ZmYxNzQyOTg4MWVjMDZjNTE0MThjZDVmXzEyNjQ0MzgzNzIwMDI3_e8ad006d-1c80-462c-add7-c446719a194b"><ix:nonFraction unitRef="usd" contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930" decimals="INF" name="us-gaap:LossContingencyEstimateOfPossibleLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODkvZnJhZzo5YjA1YTA5OWZmMTc0Mjk4ODFlYzA2YzUxNDE4Y2Q1Zi90ZXh0cmVnaW9uOjliMDVhMDk5ZmYxNzQyOTg4MWVjMDZjNTE0MThjZDVmXzEyNjQ0MzgzNzIwMDI3_ec89333c-0a38-4707-b2c0-df830bcc25f9">not</ix:nonFraction></ix:nonFraction> have any reasonable possible or probable losses from such claims. </span></div></ix:continuation><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib82e114cd19f45afae73e7a64e42f208_796"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 12 &#8212; <ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:OperatingLeasesOfLessorDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OTYvZnJhZzpkNTZhODA0MDAzYTQ0ZDZjOWQ1NDNkZTFkYTdjMTk1ZC90ZXh0cmVnaW9uOmQ1NmE4MDQwMDNhNDRkNmM5ZDU0M2RlMWRhN2MxOTVkXzEwOTk1MTE2Mjc5NTk0_ae96a430-9041-4765-acd0-0f41a474d624" continuedAt="i079e43459f6848afa8f044a5ae771cf6" escape="true">Leases </ix:nonNumeric></span></div><ix:continuation id="i079e43459f6848afa8f044a5ae771cf6" continuedAt="i9dc6f14aefb3401e8cdf6f22782e8c4f"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, the Company executed an agreement to lease certain land to a subsidiary of LanzaJet for a period of <ix:nonNumeric contextRef="ife262e1009764f0ebe3fdfe5ad4fb494_I20200531" name="us-gaap:LessorOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OTYvZnJhZzpkNTZhODA0MDAzYTQ0ZDZjOWQ1NDNkZTFkYTdjMTk1ZC90ZXh0cmVnaW9uOmQ1NmE4MDQwMDNhNDRkNmM5ZDU0M2RlMWRhN2MxOTVkXzEyNjQ0MzgzNzIxMjE1_d7909957-7f56-4cc2-a08f-ea21a5fcda30">10</ix:nonNumeric> years with an option to renew this lease for <ix:nonFraction unitRef="renewal_option" contextRef="i8afc523d3a4c48d79839de0f31b51d9c_D20200501-20200531" decimals="INF" name="amci:LesssorOperatingLeaseNumberOfRenewalOptions" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OTYvZnJhZzpkNTZhODA0MDAzYTQ0ZDZjOWQ1NDNkZTFkYTdjMTk1ZC90ZXh0cmVnaW9uOmQ1NmE4MDQwMDNhNDRkNmM5ZDU0M2RlMWRhN2MxOTVkXzEyNjQ0MzgzNzIxMjMw_0f62e767-c37f-49cc-be6a-94d320e30d94">five</ix:nonFraction> additional periods of <ix:nonNumeric contextRef="ife262e1009764f0ebe3fdfe5ad4fb494_I20200531" name="us-gaap:LessorOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OTYvZnJhZzpkNTZhODA0MDAzYTQ0ZDZjOWQ1NDNkZTFkYTdjMTk1ZC90ZXh0cmVnaW9uOmQ1NmE4MDQwMDNhNDRkNmM5ZDU0M2RlMWRhN2MxOTVkXzEyNjQ0MzgzNzIxMjQz_79265e4c-6fa6-464d-95d4-c0c68f2016d0">one year</ix:nonNumeric> with minimum annual rent due. This agreement is accounted for as an operating lease. In February 2022, the lease agreement with LanzaJet was amended to extend the pre-development term of the lease until the earlier of commencement of construction of the alcohol-to-jet fuel facility on the leased land or December 31, 2023 and increased the annual base rent amount. The Company recognizes lease revenue on a straight-line basis over the life of the lease agreement. </span></div><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:OperatingLeaseLeaseIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OTYvZnJhZzpkNTZhODA0MDAzYTQ0ZDZjOWQ1NDNkZTFkYTdjMTk1ZC90ZXh0cmVnaW9uOmQ1NmE4MDQwMDNhNDRkNmM5ZDU0M2RlMWRhN2MxOTVkXzEwOTk1MTE2Mjc5NTk1_04cf309e-d576-4ff2-9753-2b360ad4e13b" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents amounts included in Revenue from related party transactions in the Condensed Consolidated Statement of Operations related to lessor activity (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease income from operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i274fc7fa467b4dfca60a8caf5ff1ce05_D20220101-20220930" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OTYvZnJhZzpkNTZhODA0MDAzYTQ0ZDZjOWQ1NDNkZTFkYTdjMTk1ZC90YWJsZToxOWUyNjM5ODNiZDQ0MWQ4OTdiMzM0YjhiOThlOWU2YS90YWJsZXJhbmdlOjE5ZTI2Mzk4M2JkNDQxZDg5N2IzMzRiOGI5OGU5ZTZhXzItMS0xLTEtOTA3MTc_366f7789-15eb-47b1-a919-27882dfffeeb">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119eb57b7e1540229b6f3479667c5786_D20210101-20210930" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OTYvZnJhZzpkNTZhODA0MDAzYTQ0ZDZjOWQ1NDNkZTFkYTdjMTk1ZC90YWJsZToxOWUyNjM5ODNiZDQ0MWQ4OTdiMzM0YjhiOThlOWU2YS90YWJsZXJhbmdlOjE5ZTI2Mzk4M2JkNDQxZDg5N2IzMzRiOGI5OGU5ZTZhXzItMy0xLTEtOTA3MTc_31de8e57-d15c-4bdb-9bfb-6ac6bc7a66ef">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib82e114cd19f45afae73e7a64e42f208_801"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 13 &#8212;<ix:continuation id="i0b4e10a9549e473c939a7869953dcacb" continuedAt="i6dd8d80c8f6443c68c2911f3205a384a"> Subsequent Events</ix:continuation></span></div><ix:continuation id="i6dd8d80c8f6443c68c2911f3205a384a" continuedAt="i60e0d72d01144a27ac8a4b1566c8787f"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated events occurring subsequent to September&#160;30, 2022 through December 12, 2022, the date the condensed consolidated financial statements were available to be issued. The Company has identified two transactions with BGTF LT Aggregator LP (&#8220;Brookfield&#8221;), an affiliate of Brookfield Asset Management Inc, and a transaction with LanzaJet, described as follows:</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Brookfield Framework Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 2, 2022, LanzaTech entered into a framework agreement with Brookfield (the &#8220;Brookfield Framework Agreement&#8221;). Under such agreement, LanzaTech agreed to exclusively offer Brookfield the opportunity to acquire or invest in certain projects to construct commercial production facilities employing carbon capture and transformation technology in the U.S., the European Union, the United Kingdom, Canada or Mexico for which LanzaTech is solely or jointly responsible for obtaining or providing equity financing, subject to certain exceptions. LanzaTech agreed to present Brookfield with projects that over the term of the agreement require equity funding of at least $<ix:nonFraction unitRef="usd" contextRef="i4d01e01ebc9943c18b155b63bbd4d023_I20221002" decimals="INF" name="amci:FrameworkAgreementRequiredEquityFunding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzE1OTQyOTE4NjE4MTA2_65694e7f-fa8a-4483-a0d7-1aceb95b73bb">500,000,000</ix:nonFraction> in the aggregate. With respect to projects acquired by Brookfield, LanzaTech is entitled to a percentage of free cash flow generated by such projects determined in accordance with a hurdle-based return waterfall. Brookfield has no obligation under the Brookfield Framework Agreement to invest in any of the projects.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Brookfield SAFE</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 2, 2022, LanzaTech entered into a Simple Agreement for Future Equity (the &#8220;Brookfield SAFE&#8221;) with Brookfield. Under the Brookfield SAFE, LanzaTech agreed to issue to Brookfield the right to certain shares of its capital stock, the issuance of which is conditional upon LanzaTech obtaining certain necessary stockholder approvals and waivers, in exchange for the payment of $<ix:nonFraction unitRef="usd" contextRef="i82842e075dc846f3a2e003e61f072850_D20221002-20221002" decimals="INF" name="amci:SimpleAgreementForFutureEquityInitialPurchaseAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzEyNjQ0MzgzNzM0NzM5_f5f33273-c868-44b7-863f-cf48d363bc44">50,000,000</ix:nonFraction> (the &#8220;Initial Purchase Amount&#8221;). On the fifth anniversary of the Brookfield SAFE, LanzaTech will repay in cash any remaining unconverted portion of the Initial Purchase Amount (the &#8220;Remaining Amount&#8221;) less any Non-Repayable Amount (as described below), plus interest in the high single digits, compounded annually. Brookfield has the option to extend the repayment date to the tenth anniversary of the date of the Brookfield SAFE if certain events do not occur.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the first of either (a) a transaction with the principal purpose of raising capital, pursuant to which LanzaTech issues and sells preferred stock at a fixed valuation (an &#8220;Equity Financing&#8221;), or (b) the completion of an initial public offering, a direct listing, or a merger of LanzaTech with a special purpose acquisition company, which includes the Business Combination (such a merger, a &#8220;de-SPAC Transaction&#8221; and such event described in (b), a &#8220;Liquidity Event&#8221;), Brookfield may, at any time at its option, convert all or a portion of the Initial Purchase Amount less any amount that has already been converted or repaid into shares of LanzaTech capital stock or, in the case of a de-SPAC Transaction, shares of common stock of the surviving public company in such de-SPAC Transaction (including, in the case of the Business Combination, New LanzaTech Common Stock). </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each $<ix:nonFraction unitRef="usd" contextRef="i4d01e01ebc9943c18b155b63bbd4d023_I20221002" decimals="-7" name="amci:FrameworkAgreementRequiredEquityFundingForQualifyingProjects" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzEyNjQ0MzgzNzM0NzUy_6d7e9c75-7fa3-485a-b470-77165fe598a9">50,000,000</ix:nonFraction> of aggregate equity funding required for qualifying projects acquired by Brookfield in accordance with the Brookfield Framework Agreement, the Remaining Amount will be reduced by $<ix:nonFraction unitRef="usd" contextRef="i4d01e01ebc9943c18b155b63bbd4d023_I20221002" decimals="-6" name="amci:FrameworkAgreementRequiredEquityFundingForQualifyingProjectsRemainingAmountReduction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzEyNjQ0MzgzNzM0NzY1_05bc8d7c-9e41-4c17-b528-dd1c01447a29">5,000,000</ix:nonFraction> (such cumulative reductions the &#8220;Non-Repayable Amount&#8221;). Upon the first Equity Financing or Liquidity Event, the Non-Repayable Amount would convert automatically into shares of LanzaTech capital stock or, in the case of a de-SPAC Transaction, shares of common stock of the surviving public company in such de-SPAC Transaction (including, in the case of the Business Combination, New LanzaTech Common Stock), and thereafter, the Non-Repayable Amount will convert automatically on an as accrued basis.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LanzaJet Shareholder Loan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 9, 2022, the Company and the other LanzaJet shareholders entered into a Note Purchase Agreement (the &#8220;Note Purchase Agreement&#8221;), pursuant to which LanzaJet Freedom Pines Fuels LLC (&#8220;FPF&#8221;), a wholly owned subsidiary of LanzaJet, will issue, from time to time, notes in an aggregate principal amount of up to $<ix:nonFraction unitRef="usd" contextRef="i8e9aa0cf9cf540058d33cfcb743c1b90_I20221109" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzEyNjQ0MzgzNzM0NzIz_d69d0a42-f0e4-4513-97d4-66686261d2b3">147.0</ix:nonFraction>&#160;million (the &#8220;Notes&#8221;), comprised of approximately $<ix:nonFraction unitRef="usd" contextRef="i11190b90fcdd4adb805e60aa7b5e6559_I20221109" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzEyNjQ0MzgzNzM0NzAw_faac5577-97fa-4be7-9fed-c91004d54b75">113.5</ix:nonFraction>&#160;million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i11190b90fcdd4adb805e60aa7b5e6559_I20221109" decimals="2" name="amci:LineOfCreditFacilityInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzEyNjQ0MzgzNzM0NzE2_98c0a522-7b45-46df-9f39-1e81ccfa9aa4">6.00</ix:nonFraction>% Senior Secured Notes due December 31, 2043 and $<ix:nonFraction unitRef="usd" contextRef="i841691236bcc4a358b07eb492c06d80c_I20221109" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzEyNjQ0MzgzNzM0Njg1_e6f1bac0-7b4c-4dc3-92e9-f9bc88849ecb">33.5</ix:nonFraction>&#160;million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i841691236bcc4a358b07eb492c06d80c_I20221109" decimals="2" name="amci:LineOfCreditFacilityInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzEyNjQ0MzgzNzM0Njc4_02e537c7-0cbb-47f4-8f0b-8a2685bbde25">6.00</ix:nonFraction>% Subordinated Secured Notes due December 31, 2043. The Company has committed to purchase $<ix:nonFraction unitRef="usd" contextRef="icfc212252c93424d9125b3ea9c058464_I20221109" decimals="-5" name="amci:NoteReceivableCommitmentToPurchase" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzEyNjQ0MzgzNzM0NjY0_244ec4ef-760a-4779-b99a-43372894687d">5.5</ix:nonFraction>&#160;million of Subordinated Secured Notes in a funding scheduled to occur on May 1, 2023. The Senior Secured Notes are secured by a security </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i60e0d72d01144a27ac8a4b1566c8787f" continuedAt="i940aee07aeb84dd4ad3cfc26961e85f4"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">interest over substantially all assets of FPF, and both the Senior Secured Notes and the Subordinated Secured Notes are secured by a security interest over all intellectual property owned or in-licensed by LanzaJet. LanzaJet also provides a guarantee of any costs and expenses required to complete the LanzaJet Freedom Pines Demonstration Facility and achieve commercial operation. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each purchaser of Notes under the Note Purchase Agreement is also entitled to receive a warrant for the right to purchase <ix:nonFraction unitRef="shares" contextRef="i13deb916e76344f39ef3aa84463dff11_I20221109" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzEyNjQ0MzgzNzM0NjUw_6b10ff68-8358-491f-a350-3a3d0693be05">575</ix:nonFraction> shares of common stock of LanzaJet for each $<ix:nonFraction unitRef="usd" contextRef="i13deb916e76344f39ef3aa84463dff11_I20221109" decimals="-3" name="amci:ClassOfWarrantOrRightAmountOfNotesPurchased" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzEyNjQ0MzgzNzM0NjQx_2df417aa-8d04-416c-b6fc-23f6c9f07f49">10,000</ix:nonFraction> of Notes purchased by such purchaser (which, in the case of the Company, will be equal to a right to purchase <ix:nonFraction unitRef="shares" contextRef="icfc212252c93424d9125b3ea9c058464_I20221109" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzEyNjQ0MzgzNzM0NjU1_6f3b668a-9428-4660-a73b-821c69ec4afd">316,250</ix:nonFraction> shares of common stock of LanzaJet).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LanzaJet Note Purchase Agreement may be amended with the approval of holders of FPF and all holders of the LanzaJet Notes.  Upon an event of default under the Note Purchase Agreement, each purchaser may accelerate its own Notes. Enforcement against the collateral securing the Notes requires the approval of certain holders as specified in the Notes.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amended Merger Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Merger Agreement was amended on December 7, 2022, to provide for, among other things, (i) the inclusion of the aggregate net proceeds from each of the AM SAFE Note and Brookfield SAFE in the Acquiror Closing Cash Amount, (ii) the reduction of the Minimum Closing Cash Condition from $<ix:nonFraction unitRef="usd" contextRef="i3e4ce82bb6ca465b8f60e74f553154c0_I20220308" decimals="INF" name="amci:ReverseCapitalizationClosingCashCondition" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzEyNjQ0MzgzNzM0NjA1_7a0957ab-e997-467c-a67e-abe53f87c375">250,000,000</ix:nonFraction> to $<ix:nonFraction unitRef="usd" contextRef="ia00417eab54343e78db23ff7c39f19cc_I20221207" decimals="INF" name="amci:ReverseCapitalizationClosingCashCondition" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzEyNjQ0MzgzNzM0NjE5_093d1057-72fd-4818-8108-6fe5f26a0a11">230,000,000</ix:nonFraction>, (iii) the clarification that, to the extent that the Brookfield SAFE remains unexercised at Closing, it will be assumed by AMCI, remain in effect on the same terms and conditions as are in effect prior to the Closing and thereafter entitle the holder thereof to be issued shares of common stock in AMCI after the Closing, (iv) the clarification that, in the event that it becomes reasonably apparent to the parties that the Acquiror Closing Cash Amount will be less than the Minimum Closing Cash Condition, AMCI will use commercially reasonable efforts to enter into non-redemption agreements, or similar agreements, as may be necessary to satisfy the Minimum Closing Cash Condition, (v) the extension of the outside date applicable to the Closing from December 7, 2022 to February 28, 2023 and (vi) the elimination of LanzaTech's right to terminate the agreement in the event that we fail to, on or prior to July 7, 2022, enter into one or more additional subscription agreements or non-redemption agreements as a result of which the sum of the PIPE Investment Amount (including net proceeds under the AM SAFE Note to LanzaTech) and the aggregate number of shares of Class A common stock subject to non-redemption agreements multiplied by $<ix:nonFraction unitRef="usdPerShare" contextRef="ia00417eab54343e78db23ff7c39f19cc_I20221207" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzEyNjQ0MzgzNzM0NjMz_031c790b-d692-4570-8efd-e9b50f8bd402">10.00</ix:nonFraction>, minus certain transaction expenses and other liabilities at Closing, would be equal to at least the Minimum Closing Cash Condition.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-65</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_1302"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of LanzaTech NZ, Inc.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of LanzaTech NZ, Inc. and subsidiaries (the &#8220;Company&#8221;) as of December 31, 2021 and 2020, the related consolidated statements of operations and comprehensive loss, consolidated statement of cash flows, and consolidated statements of changes in redeemable convertible preferred stock and shareholders&#8217; equity (deficit) for each of the two years in the period ended December 31, 2021, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Material Restatement of the 2021 and 2020 Financial Statements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 2 to the financial statements, the accompanying 2021 and 2020 financial statements have been restated to correct material misstatements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB and in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.275%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Deloitte &amp; Touche LLP</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chicago, Illinois</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2022 (October 11, 2022 as to the effects of the restatement to the 2021 and 2020 financial statements discussed above and in Note 2 of the financial statements)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We have served as the Company&#8217;s auditor since 2021.</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-66</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_370"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LANZATECH NZ, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS (RESTATED)</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except share and per share data)</span></div></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzUtMS0xLTEtOTA2MTg_eeef63a0-d6f1-4f00-a84e-80ba462c1ca7">128,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzUtMy0xLTEtOTA2MTg_5e0796c0-5938-41d5-8adf-dfde7a897c23">60,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade and other receivables, net of allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:AccountsAndOtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzYtMS0xLTEtOTA2MTg_ebeaea22-4903-4268-a18c-7542bc7eef04">2,878</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:AccountsAndOtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzYtMy0xLTEtOTA2MTg_5208a64c-070f-47f2-a346-07bcc808406b">5,521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzctMS0xLTEtOTA2MTg_1f366894-d382-4d98-bd78-895c0dab1ac5">11,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzctMy0xLTEtOTA2MTg_36065a00-d6dd-45fe-8834-cd4557deedf7">6,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzgtMS0xLTEtOTA2MTg_ae544e8b-7634-49eb-a531-73dbecd2b2f1">5,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzgtMy0xLTEtOTA2MTg_f3191170-6d76-4d08-98c9-66d4e034a7fc">4,387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzktMS0xLTEtMTAwMDM0_f45ae89e-374f-4dde-9dac-19820bf9cf72">148,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzktMy0xLTEtMTAwMDM0_cf36f115-4254-45f3-a70f-3290a69b9f33">76,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzEwLTEtMS0xLTkwNjE4_d3556e6f-c694-4e3b-966c-f45eb25c4161">14,148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzEwLTMtMS0xLTkwNjE4_1eca5388-3fea-48a5-9af2-c8717b5b5daa">11,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzExLTEtMS0xLTkwNjE4_1ea64747-d5ba-4547-9a83-046e06564b2d">4,686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzExLTMtMS0xLTkwNjE4_1ab7a265-861f-4bbf-84d9-b1141075fecd">6,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzEyLTEtMS0xLTkwNjE4_06dd6c9c-9a8d-46eb-8519-859fe3b9321e">24,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzEyLTMtMS0xLTkwNjE4_3f21b6a2-b02e-45b1-9ba9-b0b464c13ecd">23,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzEzLTEtMS0xLTkwNjE4_4d1b5a99-cf92-4dda-8710-57c27f386e7e">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzEzLTMtMS0xLTkwNjE4_d3ca67c4-1c72-4e5a-a3a7-7eedb6c8e506">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzE0LTEtMS0xLTEwMDAzNA_6bd80eaa-da5c-4c45-975f-eda1f9d40154">193,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzE0LTMtMS0xLTkwNjE4_1ec0e5ab-d374-4a97-a411-eba8e3a2e5e8">118,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities, Contingently Redeemable Preferred Stock, and Shareholders&#8217; Deficit</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzE3LTEtMS0xLTkwNjE4_4dd88c53-d5f5-4ecb-a54c-9427d9e377dd">2,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzE3LTMtMS0xLTkwNjE4_3b7ce1bb-7339-41f2-8924-03428c5fa70f">1,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzE4LTEtMS0xLTkwNjE4_f6796160-c7c9-4da0-a95e-82f9781146b3">7,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzE4LTMtMS0xLTkwNjE4_bea734e6-b894-44aa-9b29-b8925bd38194">2,897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="amci:SimpleAgreementForFutureEquityLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzE5LTEtMS0xLTkwNjE4_100a6ead-a1e9-425a-8ab5-05f7cc4ff5f2">28,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="amci:SimpleAgreementForFutureEquityLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzE5LTMtMS0xLTkwNjE4_3f7cbbb0-e973-4ca1-b235-05a90ede7538">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SAFE warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzIwLTEtMS0xLTkwNjE4_32370669-7205-47f9-8b4e-4b01571f5d24">1,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzIwLTMtMS0xLTkwNjE4_3262c62a-7634-4dbb-8313-2e0322d885d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzIxLTEtMS0xLTkwNjE4_8a4d6d18-711d-4056-816f-3f29b6e11fc8">3,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzIxLTMtMS0xLTkwNjE4_68260e99-ccff-4b6d-8257-45f9c8d2f2e4">5,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued salaries and wages</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzIyLTEtMS0xLTkwNjE4_84f68a43-c903-47ba-8c44-43f6e01c269c">4,261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzIyLTMtMS0xLTkwNjE4_8cd24b54-0e63-4102-a51f-b39d70a1d04f">3,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzIzLTEtMS0xLTkwNjE4_5c1d8bb3-1b20-45ab-ab8d-e60e7d080768">2,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzIzLTMtMS0xLTkwNjE4_f4130a79-8bf6-4b99-aeab-9b5be4df08b3">1,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzI0LTEtMS0xLTkwNjE4_ca71cf4d-95c7-41ab-909a-c00664f57393">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:LongTermDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzI0LTMtMS0xLTkwNjE4_00900c16-9c8f-4aae-998d-9eda5dd54391">570</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzI1LTEtMS0xLTEwMDAzNA_33c96333-92b3-47a7-89d4-dd83f0e0ff56">49,290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzI1LTMtMS0xLTEwMDAzNA_b40925ef-9507-425f-87b5-a206ef12b831">15,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzI2LTEtMS0xLTkwNjE4_6e0502d7-32c6-4340-8d70-4c1e4100be85">3,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzI2LTMtMS0xLTkwNjE4_78754351-0d53-43e7-a1cb-dc9e92e2d17f">5,334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current contract liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzI3LTEtMS0xLTkwNjE4_8eae18a2-2e48-4582-bc67-bc892cda6f10">13,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzI3LTMtMS0xLTkwNjE4_020f023c-7757-402f-9f11-0559ed68fb92">11,291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzI4LTEtMS0xLTkwNjE4_10e53d8b-9d19-4904-909c-d9ebb54a97bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzI4LTMtMS0xLTkwNjE4_52d0d1d8-c1b8-49c4-ae5e-fa21c7808f39">3,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzI5LTEtMS0xLTkwNjE4_147a253b-d810-47e4-8a30-9d68e1c1ffc9">823</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzI5LTMtMS0xLTkwNjE4_56c0bd08-eadd-42ac-bf6c-d028a4cac82a">894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzMwLTEtMS0xLTEwMDAzNA_747cf831-e930-442c-8d5d-b77fd93cffd7">67,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzMwLTMtMS0xLTEwMDAzNA_83c19ec9-0cbd-476b-b89a-ba967d8a4de9">35,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Commitments and Contingencies (see note 18)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzMxLTEtMS0xLTEwMDA3Mw_30c73755-6798-476b-8804-a1e54e27d14d"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzMxLTMtMS0xLTEwMDA3MA_691e241e-6005-47eb-a977-654476c1b334"></ix:nonFraction></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingently Redeemable Preferred Stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Redeemable convertible preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="INF" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM0LTAtMS0xLTkwNjE4L3RleHRyZWdpb246ZTAyYzNiZmI5Y2M1NDk5M2FiYjQyNTk3YTdiOTlmNjZfNDU_28c0f2ac-8575-4c75-b09e-60be838ff3e2"><ix:nonFraction unitRef="usdPerShare" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM0LTAtMS0xLTkwNjE4L3RleHRyZWdpb246ZTAyYzNiZmI5Y2M1NDk5M2FiYjQyNTk3YTdiOTlmNjZfNDU_51423a24-69ec-4984-a548-076f60c64239">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM0LTAtMS0xLTkwNjE4L3RleHRyZWdpb246ZTAyYzNiZmI5Y2M1NDk5M2FiYjQyNTk3YTdiOTlmNjZfNTk_08b17727-6323-4015-9db3-4c87264488b8">29,747,033</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM0LTAtMS0xLTkwNjE4L3RleHRyZWdpb246ZTAyYzNiZmI5Y2M1NDk5M2FiYjQyNTk3YTdiOTlmNjZfNjY_c3e57ba9-87f0-4c58-9042-5f220fd69184">26,112,823</ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM0LTAtMS0xLTkwNjE4L3RleHRyZWdpb246ZTAyYzNiZmI5Y2M1NDk5M2FiYjQyNTk3YTdiOTlmNjZfODg_d1280e21-ab82-41c6-968e-0ad8675b6aee"><ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM0LTAtMS0xLTkwNjE4L3RleHRyZWdpb246ZTAyYzNiZmI5Y2M1NDk5M2FiYjQyNTk3YTdiOTlmNjZfODg_ffa85e89-1c63-4120-8051-38d6969036dd">29,521,810</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM0LTAtMS0xLTkwNjE4L3RleHRyZWdpb246ZTAyYzNiZmI5Y2M1NDk5M2FiYjQyNTk3YTdiOTlmNjZfOTU_00c18d1b-e8eb-4944-9669-85e17463f623"><ix:nonFraction unitRef="shares" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM0LTAtMS0xLTkwNjE4L3RleHRyZWdpb246ZTAyYzNiZmI5Y2M1NDk5M2FiYjQyNTk3YTdiOTlmNjZfOTU_c07c9700-55a9-4983-80d2-d682d4a43499">25,729,542</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of December&#160;31, 2021 and 2020, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM0LTEtMS0xLTkwNjE4_79172363-c892-48ce-aa25-cec9227a60f8">480,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM0LTMtMS0xLTkwNjE4_4e60710b-982f-4f50-b189-aa411fc99cc0">394,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shareholders&#8217; Deficit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM2LTAtMS0xLTkwNjE4L3RleHRyZWdpb246NzRmYWQzNDAzMjcwNDcwNzljYzllYjFkZmEzZTYzZjJfMTk_221c5847-09c8-4ac5-b97f-3a057c216f0f"><ix:nonFraction unitRef="usdPerShare" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM2LTAtMS0xLTkwNjE4L3RleHRyZWdpb246NzRmYWQzNDAzMjcwNDcwNzljYzllYjFkZmEzZTYzZjJfMTk_8f598eb1-3018-4f3c-b71f-196dce453160">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM2LTAtMS0xLTkwNjE4L3RleHRyZWdpb246NzRmYWQzNDAzMjcwNDcwNzljYzllYjFkZmEzZTYzZjJfMzM_c1edda4e-f7df-40e9-a5ba-3efc96b3806e"><ix:nonFraction unitRef="shares" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM2LTAtMS0xLTkwNjE4L3RleHRyZWdpb246NzRmYWQzNDAzMjcwNDcwNzljYzllYjFkZmEzZTYzZjJfMzM_c987e00c-f8e5-433a-9a03-12b684e2a765">36,326,815</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM2LTAtMS0xLTkwNjE4L3RleHRyZWdpb246NzRmYWQzNDAzMjcwNDcwNzljYzllYjFkZmEzZTYzZjJfNTU_1f4ebde1-abb7-4570-9c81-c3c9fc9db0a8"><ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM2LTAtMS0xLTkwNjE4L3RleHRyZWdpb246NzRmYWQzNDAzMjcwNDcwNzljYzllYjFkZmEzZTYzZjJfNTU_e8aa24d9-9082-4e7c-9a84-d326585471cb">2,106,934</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM2LTAtMS0xLTkwNjE4L3RleHRyZWdpb246NzRmYWQzNDAzMjcwNDcwNzljYzllYjFkZmEzZTYzZjJfNjI_5ca1e5cb-08fc-4a85-b403-7ba0b5249733"><ix:nonFraction unitRef="shares" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM2LTAtMS0xLTkwNjE4L3RleHRyZWdpb246NzRmYWQzNDAzMjcwNDcwNzljYzllYjFkZmEzZTYzZjJfNjI_7707e025-3af8-4018-84f0-fa71918093c0">1,656,415</ix:nonFraction></ix:nonFraction> shares issued and outstanding as December&#160;31, 2021 and 2020, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM2LTEtMS0xLTkwNjE4_9abe4844-f808-4472-8233-9c69ca33746e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM2LTMtMS0xLTkwNjE4_cce7ee32-3177-46bb-816e-be0e46c4be05">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM3LTEtMS0xLTkwNjE4_8dd83afd-21bc-4937-9366-0df26b35128d">21,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM3LTMtMS0xLTkwNjE4_e002affb-c8ab-4172-9b0b-bb938a0b6c8f">18,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM4LTEtMS0xLTkwNjE4_9fa9c1fc-f31d-4302-b7fc-9480d76551c5">3,261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM4LTMtMS0xLTkwNjE4_00ec0ca8-45ff-4194-b222-47fa62fdcacb">3,166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM5LTEtMS0xLTkwNjE4_1c4e878d-dcbe-4a40-9f8d-dfe130f8b8bf">379,889</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM5LTMtMS0xLTkwNjE4_367f8596-685e-4265-9721-27722fa7f5cd">333,200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzQwLTEtMS0xLTEwMDAzNA_57c4598b-f8f0-48c0-b09f-b4df4440ecbf">354,917</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzQwLTMtMS0xLTEwMDAzNA_e0c1b79e-ae71-4a48-8507-7cfe752dd4f1">311,216</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities, contingently redeemable preferred stock, and shareholders' deficit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzQxLTEtMS0xLTEwMDAzNA_8abba99e-59b5-4e5c-8a7f-8e12a44b6d9d">193,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzQxLTMtMS0xLTEwMDAzNA_0dd91a99-1364-415d-8b76-1e0ed791bd19">118,980</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See the accompanying Notes to the Consolidated Financial Statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-67</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_379"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LANZATECH NZ, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS AND</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPREHENSIVE LOSS (RESTATED)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except share and per share data)</span></div></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:70.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.866%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from contracts with customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzQtMS0xLTEtOTA2MTg_b4cce1df-ceca-4db5-a3a3-c87c930070aa">18,871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzQtMy0xLTEtOTA2MTg_660cda08-f37f-47ec-869b-43c5acc12438">12,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from collaborative arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzUtMS0xLTEtOTA2MTg_13d326e6-3aff-446d-acc4-c059ef461bf0">3,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzUtMy0xLTEtOTA2MTg_4fdd4784-bb52-4c25-8eef-3a77274d00f8">1,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from related party transactions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzYtMS0xLTEtOTA2MTg_5f91fba1-8c8e-468d-ae93-2e1718ca2deb">3,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzYtMy0xLTEtOTA2MTg_dff092ac-66bd-48cd-af42-365d4f62c659">4,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzctMS0xLTEtMTAwMDA2_afc8d549-ec3f-4ba1-9b20-7563d3c128d6">25,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzctMy0xLTEtOTA2MTg_4e35fc25-388e-4ebf-b06d-57b5af23e4a3">18,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost and operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue from contracts with customers (exclusive of depreciation shown below)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzEwLTEtMS0xLTkwNjE4_0eaf0586-cd78-40ec-9182-c839a1447dfd">13,167</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzEwLTMtMS0xLTkwNjE4_1f8ad7f4-6065-4e92-9ba3-1904104d0b11">8,185</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue from collaborative arrangements (exclusive of depreciation shown below)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45c8b69ce7724ca09fcd2a0e03378434_D20210101-20211231" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzExLTEtMS0xLTkwNjE4_1d26a4ef-7c37-4c62-8bc6-d28aceb5c94a">1,254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31c5c6ff291e4bfbaecc0f0138bbdc9b_D20200101-20201231" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzExLTMtMS0xLTkwNjE4_fbe40e9b-8919-43af-9190-42e833a84d93">743</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue from related party transactions (exclusive of depreciation shown below)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1cd0c82523ad48cfbd1bd9a5c47959b6_D20210101-20211231" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzEyLTEtMS0xLTkwNjE4_f9a1e9a8-270c-468d-9e31-986d4e41b8f4">808</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i960c81aa420d4215ad749484380fb1d3_D20200101-20201231" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzEyLTMtMS0xLTkwNjE4_233a9240-2df3-4b9f-a082-d237710bc4bb">2,664</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzEzLTEtMS0xLTkwNjE4_1e3c9a71-7f4d-454c-a4e6-154620b0f4f8">44,229</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzEzLTMtMS0xLTkwNjE4_14490cda-8b80-4889-972c-286da3319bc0">34,454</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzE0LTEtMS0xLTkwNjE4_5414e862-0cfd-4bff-a8da-1fd7769514b6">3,806</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzE0LTMtMS0xLTkwNjE4_721e852e-1059-49a5-b3d6-ff5e7180a979">2,979</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzE1LTEtMS0xLTkwNjE4_032d6280-bb4c-4284-a92f-6cd84195aec8">13,216</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzE1LTMtMS0xLTkwNjE4_84d1b0a6-8928-48b6-919f-3b944b535382">9,029</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost and operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzE2LTEtMS0xLTEwMDAwOA_c50f6a3c-e8d1-4c9f-a2c4-cfab0bc79bd6">76,480</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzE2LTMtMS0xLTkwNjE4_51ecd52c-be6d-4762-97a2-1d9c417d3176">58,054</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzE3LTEtMS0xLTEwMDAwOA_9a201a98-edb6-4d7f-80df-7a5d3854f4b4">51,019</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzE3LTMtMS0xLTkwNjE4_d9bbb0f9-cb82-40a0-ae39-e67e98dad6dc">39,701</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzE5LTEtMS0xLTkwNjE4_7321e4f9-5799-49de-8a03-7e296d21baa1">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzE5LTMtMS0xLTkwNjE4_41ef98af-65f2-4560-9070-1640a92a64e6">351</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzIwLTEtMS0xLTEwMDAxMQ_47425913-a158-45bb-a060-1889d4e09135">3,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzIwLTMtMS0xLTEwMDAxMQ_383dcbc3-883e-461a-a099-78e464b85839">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzIxLTEtMS0xLTkwNjE4_0a267b3b-20ac-434b-901f-86d2d669c23b">673</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzIxLTMtMS0xLTkwNjE4_cb52ea9b-ce1d-4185-9670-d31fbb190b3f">172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzIyLTEtMS0xLTEwMDAxMQ_2790ea14-fdcb-404b-af7c-e21d62aa1c31">2,385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzIyLTMtMS0xLTEwMDAxMQ_43f53694-6fe4-42a5-ab5d-5740f458bb8e">179</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzIzLTEtMS0xLTEwMDAxMQ_de03b610-38a9-4a93-b4ce-4c0316b9e581">48,634</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzIzLTMtMS0xLTEwMDAxMQ_3857ff1d-ae08-471f-8df6-1a8cba47d226">39,880</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzI0LTEtMS0xLTEwMDAxMQ_e1416e1f-313d-4181-869d-e6012b9ead76">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzI0LTMtMS0xLTkwNjE4_a9c78d71-2ee8-418e-bd60-90c485a547dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzI1LTEtMS0xLTkwNjE4_ca3a4b6a-a37a-418b-a095-1bf3e9cf0de9">1,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzI1LTMtMS0xLTkwNjE4_64ecc3a5-73b4-4ade-ac4d-4596102ac7f6">2,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzI2LTEtMS0xLTEwMDAxMQ_73fd9b7b-9bb4-4633-9611-b64e0727f741">46,689</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzI2LTMtMS0xLTkwNjE4_7dae49c5-6e96-4959-adc5-6888d80e563e">37,713</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid cumulative dividends on preferred stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:PreferredStockDividendsIncomeStatementImpact" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzI4LTEtMS0xLTkwNjE4_67331bb7-302b-4546-a16f-6b9cfd22665c">36,758</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:PreferredStockDividendsIncomeStatementImpact" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzI4LTMtMS0xLTEwMDAxNQ_64d699fd-ec5a-47ef-87ad-3715fe86799c">31,291</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss allocated to common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzI5LTEtMS0xLTkwNjE4_6e418212-f618-47b3-9340-3f460881fb02">83,447</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzI5LTMtMS0xLTEwMDAxNQ_3abf0611-6fd7-4213-b851-36601ae85acb">69,004</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzMyLTEtMS0xLTkwNjE4_de8b3341-5adc-429d-a4ab-f270800de1e5">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzMyLTMtMS0xLTkwNjE4_a8423fdf-4794-4b05-86cf-9208c88780b6">625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzMzLTEtMS0xLTEwMDAxNQ_2eb1757c-da0e-4f23-88a5-2d1bef9b9b3d">46,594</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzMzLTMtMS0xLTkwNjE4_c5f2791d-95fa-410c-a794-c4a64f727233">37,088</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share - basic and diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzM1LTEtMS0xLTkwNjE4_7a6d9e8f-6154-4f5f-9e0c-75831b2912d5"><ix:nonFraction unitRef="usdPerShare" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzM1LTEtMS0xLTkwNjE4_8a8d08a3-5164-46f2-b6c3-2e4fa2d36871">42.59</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzM1LTMtMS0xLTkwNjE4_5c9c0b5e-f842-4990-8921-b5591d5cdc78"><ix:nonFraction unitRef="usdPerShare" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzM1LTMtMS0xLTkwNjE4_893cf890-89e4-4775-8333-b07ac4e21b3d">42.34</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding - basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzM2LTEtMS0xLTkwNjE4_0a2734a5-9881-4cf6-bdf1-239005a4a1a3"><ix:nonFraction unitRef="shares" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzM2LTEtMS0xLTkwNjE4_237b9631-b3b4-4d9e-918f-267e61e0ff6b">1,959,165</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzM2LTMtMS0xLTkwNjE4_d2141d30-19d0-40af-beab-a6bc57fe7b8d"><ix:nonFraction unitRef="shares" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzM2LTMtMS0xLTkwNjE4_d9a75a13-35c0-4a8b-a2b7-9c808a698d92">1,629,821</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the accompanying Notes to the Consolidated Financial Statements. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-68</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_388"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LANZATECH NZ, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND SHAREHOLDERS&#8217; EQUITY (DEFICIT) (RESTATED)</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(all amounts in thousands, except share data) </span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.962%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.970%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable Convertible Preferred Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shareholders' Equity (Deficit)</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at January 1, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i946f64f7009a4a2082ea5e8ea9ae0377_I20191231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzItMS0xLTEtOTA2MTg_8f726e2c-a614-4d5c-b591-b676a623f7d9">23,695,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i946f64f7009a4a2082ea5e8ea9ae0377_I20191231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzItMy0xLTEtOTA2MTg_eca8dac2-503d-40d2-a423-eff6747cc990">347,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if07a33149ab34a4fbdf400d0fabf37f6_I20191231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzItNi0xLTEtOTA2MTg_ef6af4f6-17b6-4cee-801e-eed2a0d967a9">1,622,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if07a33149ab34a4fbdf400d0fabf37f6_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzItOC0xLTEtOTA2MTg_8c013d6c-7947-44a5-ac07-2918a9125649">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia22c1bdd47434793a0dc37fce48a996d_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzItMTAtMS0xLTkwNjE4_30042851-5004-4f20-9f80-bda97bda5aad">16,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94e27674b4054eeb8e5f88cdfd303c29_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzItMTItMS0xLTkwNjE4_0d8be6e1-64c1-4d61-9141-ec8fd4850fc8">295,487</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00591629b1be427aa8c0009cf1fb6f6e_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzItMTQtMS0xLTkwNjE4_63ac087a-2b28-4c64-870f-6c05303a1021">2,541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i946f64f7009a4a2082ea5e8ea9ae0377_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzItMTYtMS0xLTEwMDM0Mw_46ce2c06-e376-4932-ad80-71e088993269">276,592</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of Series E Preferred Stock, net of issuance cost of $$<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="amci:TemporaryEquityStockIssuanceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzMtMC0xLTEtOTA2MTgvdGV4dHJlZ2lvbjoyYWEwZTEwYzUwZGY0MTA2YTdlNzFlZGM3YTQ1ZGU1OF8xMDk5NTExNjI3NzgzMQ_743a4dcc-2bc6-4478-b8c5-266a1143fe94">30</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="INF" name="amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzMtMS0xLTEtOTA2MTg_02b61ac7-05ec-4e40-9962-4f31e8f3dd0e">2,034,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzMtMy0xLTEtOTA2MTg_d3116525-f1f9-44e5-8523-350cb656d7db">46,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifeb17f8540b2472cbe4d74587d5ad4aa_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzQtMTAtMS0xLTkwNjE4_77347821-4f0f-497c-85d4-8d2d4870d9f3">2,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzQtMTYtMS0xLTEwMDM0Mw_066d1b73-8547-490a-992e-feafd42e194f">2,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss, as Restated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d56d77913a14f86a6d7945e10f160c2_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzUtMTItMS0xLTkwNjE4_85c6b985-a070-42a4-a724-543694cb0c9e">37,713</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzUtMTYtMS0xLTEwMDM0Mw_e15f5f3a-8c51-4cf8-b83d-9e30cd62cc48">37,713</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5eb0c8c36cbc470dbddae10e948288a4_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzYtNi0xLTEtOTA2MTg_0ef44b5b-0048-4148-8d19-5428d5c6ff1b">33,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifeb17f8540b2472cbe4d74587d5ad4aa_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzYtMTAtMS0xLTkwNjE4_a5a47c99-7be2-4e4d-82a8-124a6bcf19af">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzYtMTYtMS0xLTEwMDM0Mw_c6dd3f48-1c25-4593-b709-865d8a648f31">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05ec61c49dc34bc69ccd60b0af98c42e_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzctMTQtMS0xLTkwNjE4_067a82d8-07bf-4e57-88ec-af96d4291b0e">625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzctMTYtMS0xLTEwMDM0Mw_357cdc41-03e1-4ef7-9f83-9afae2ba021f">625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2020 as Restated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzgtMS0xLTEtMTAwMzIz_f24b64dd-8069-4d12-8022-daede5aea988">25,729,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzgtMy0xLTEtMTAwMzIz_4208c034-3e66-4971-8ad0-81ef8868a74c">394,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4d49e0cbdb6445f7b88d97d435a55770_I20201231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzgtNi0xLTEtMTAwMzMx_8c1f81f6-d933-436f-b9a6-a1bb4f63b651">1,656,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d49e0cbdb6445f7b88d97d435a55770_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzgtOC0xLTEtMTAwMzMx_9e50ab09-2c29-4eb7-9f85-ca3476e932b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c18fa0bbec84bdcb7e52c35f80ede0a_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzgtMTAtMS0xLTEwMDMzNA_cf450e11-7afc-4be0-9d9b-0cd26fb674c4">18,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i18eedd573381425c8c989e260801dafe_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzgtMTItMS0xLTEwMDMzNw_2a1bf98f-bc42-4e44-9969-10e8dce408b0">333,200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e70eaff18414dc4b12fb6d52ddce0d0_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzgtMTQtMS0xLTEwMDM0MA_9e167ca3-3082-44f8-a550-564197531917">3,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzgtMTYtMS0xLTEwMDM0Mw_810449ee-9198-4d7e-9b85-ed6c99ec8034">311,216</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of Series F Preferred Stock, net of issuance cost of $<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="INF" name="amci:TemporaryEquityStockIssuanceCost" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzktMC0xLTEtOTA2MTgvdGV4dHJlZ2lvbjpmZjIwY2E2ZTBiNTQ0M2Y0OThhNTNlZGNiNjhjZWMxZF82Ng_22029cf0-d1a5-4bea-bdff-3529eee0ed2f">0</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i45b464fc79c145a2a521d5dd55876280_D20210401-20210430" decimals="INF" name="amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzktMS0xLTEtOTA2MTg_4649de70-6da7-4a9b-960b-f4f5d6c67ec6">3,634,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45b464fc79c145a2a521d5dd55876280_D20210401-20210430" decimals="-3" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzktMy0xLTEtOTA2MTg_967c829c-e99b-4cbb-aa8a-c4def402c379">83,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of a warrant, Series D Preferred Stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9f67793938594975ad7e63e3f8a4f312_D20210301-20210331" decimals="INF" name="amci:TemporaryEquitySharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzEwLTEtMS0xLTkwNjE4_8525332d-3170-4341-83b7-390b93b4670d">158,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="amci:TemporaryEquityExerciseOfWarrants" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzEwLTMtMS0xLTkwNjE4_6403d042-2785-4eec-8cad-33f5f24af997">3,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c741fd42694f06bc7e2689ea444d6a_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzExLTEwLTEtMS05MDYxOA_913edd57-53c9-41db-89b5-129dcf296c80">2,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzExLTE2LTEtMS05MDYxOA_965e58a9-8c6a-4e03-8a4f-95f7119a3754">2,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of equity instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68c741fd42694f06bc7e2689ea444d6a_D20210101-20211231" decimals="-3" name="amci:AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzEyLTEwLTEtMS05MDYxOA_721d5bcc-ca99-4328-a924-e7f123f9c9bb">396</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="amci:AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzEyLTE2LTEtMS05MDYxOA_37234046-44ac-4165-aac6-653004379d47">396</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss, as Restated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied8cd34c75144efca4224b616436546e_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzEzLTEyLTEtMS05MDYxOA_b18e300b-88cd-4ad9-b4a4-04b1eb3e30c8">46,689</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzEzLTE2LTEtMS0xMDAzNDM_d5a5e1ef-5a13-4e60-9e5b-ba548fadb288">46,689</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia9a4fe64e8384eb1ac82e12eceb516c9_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzE0LTYtMS0xLTkwNjE4_f132d57f-f7fc-4087-a400-4370d328570c">450,519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c741fd42694f06bc7e2689ea444d6a_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzE0LTEwLTEtMS05MDYxOA_5e0f2fdd-b5bf-478e-98f0-fb2250c13441">758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzE0LTE2LTEtMS05MDYxOA_26bbc367-d4f0-482d-b214-0e6371f8c938">758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594942781b24073905212d61c4895df_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzE1LTE0LTEtMS05MDYxOA_88e9183a-8030-4325-84f7-e8a6f005f405">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzE1LTE2LTEtMS05MDYxOA_1d980cc5-6284-406f-ae83-c76c44f9c0b5">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021 as Restated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzE2LTEtMS0xLTEwMDMyNw_ffa9f4e5-c4d1-4df9-8295-76ab17d13a51">29,521,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzE2LTMtMS0xLTEwMDMyNw_9fd9ea47-9e3b-4a34-a5d2-0b84587d5660">480,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i78e21c830827492786035892daf32e0d_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzE2LTYtMS0xLTEwMDMzMQ_61a9903a-d40c-4938-9691-b01819859c12">2,106,934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78e21c830827492786035892daf32e0d_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzE2LTgtMS0xLTEwMDMzMQ_6e91a306-8f0d-4559-86c5-181ad9073560">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20c42717ddd94c808b501ab8475516e6_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzE2LTEwLTEtMS0xMDAzMzQ_5de0bc70-102d-4e63-b037-e6c879f4c71c">21,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0898c763893444f8318ba806e5872af_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzE2LTEyLTEtMS0xMDAzMzc_26489eb7-41da-4087-8869-7e8017baf263">379,889</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6fb523d0475453fbb376be661a6c994_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzE2LTE0LTEtMS0xMDAzNDA_5c9d9723-2c20-445d-81fc-32b4381535cd">3,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzE2LTE2LTEtMS0xMDAzNDM_80568e35-6b81-4deb-a547-1cac4d4623d5">354,917</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of the consolidated&#160;financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-69</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_397"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LANZATECH NZ, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS (RESTATED)</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands) </span></div></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Cash Flows From Operating Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQtMS0xLTEtOTA2MTg_2deeca7e-70e2-4fa8-b509-9b4a2ad950ea">46,689</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQtMy0xLTEtOTA2MTg_7880da65-e801-45b2-b981-896eefaae81e">37,713</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzYtMS0xLTEtOTA2MTg_f3cc3f80-6f6e-4a76-92ff-2f571853de0d">2,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzYtMy0xLTEtOTA2MTg_809340e8-7d52-4484-95b9-8bc39c42d4c3">2,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Loss/(gain) on change in fair value of warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzctMS0xLTEtOTA2MTg_8314ad76-3a3c-4077-90bd-3f5ab3bf5266">563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzctMy0xLTEtOTA2MTg_83ac635d-4fa4-4c68-bd87-e5959ceb0fde">105</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Bad debt expense and recoveries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzgtMS0xLTEtOTA2MTg_ff88c173-5058-4fc6-8bde-7cd7a1f82039">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzgtMy0xLTEtOTA2MTg_7bf8e3d7-e3d0-4736-962c-0c422f217c5e">877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Depreciation of property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzktMS0xLTEtOTA2MTg_75f24d91-4fb0-4387-a963-a785951724d6">3,806</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzktMy0xLTEtOTA2MTg_99b05299-338e-4064-b070-66460abf3fee">2,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzEwLTEtMS0xLTkwNjE4_51d21668-7715-423b-80a0-a15394099db6">1,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzEwLTMtMS0xLTkwNjE4_93c75923-1a5f-4175-a92a-9f9228729316">1,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-cash recognition of licensing revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="amci:NoncashRecognitionOfLicensingRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzExLTEtMS0xLTkwNjE4_2d46e931-c7e1-4dfb-a629-47db87654797">2,022</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="amci:NoncashRecognitionOfLicensingRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzExLTMtMS0xLTkwNjE4_8b61f4a3-f175-4168-97ec-be0b79c9b08b">1,018</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">PPP loan forgiveness</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzEyLTEtMS0xLTkwNjE4_d5c78837-22d7-445e-9013-1f725df3f4ba">3,065</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzEyLTMtMS0xLTkwNjE4_15eb0bb3-2939-439a-b6e2-38cd60ea9f51">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzEzLTEtMS0xLTkwNjE4_56f6d0f3-b521-4c2c-9623-7e5e1a066498">1,945</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzEzLTMtMS0xLTkwNjE4_d76ebb77-7fd9-49f1-839f-646f7d346fa1">2,167</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net foreign exchange gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzE0LTEtMS0xLTkwNjE4_b4f1a810-ac58-47f3-b5aa-180c8577f889">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzE0LTMtMS0xLTkwNjE4_e0da67aa-e3cb-4d4d-93de-89de3d36bef1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzE2LTEtMS0xLTkwNjE4_b552ad6f-ce07-45e5-898c-fcdb7c5bacdb">2,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzE2LTMtMS0xLTkwNjE4_d8a75871-c7bd-4a81-8489-b7670ab20706">4,470</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzE3LTEtMS0xLTkwNjE4_3c3388c1-51dd-43f2-b51b-05b357c77e7b">5,514</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzE3LTMtMS0xLTkwNjE4_7a497488-8c7a-4d4c-a86b-6266cd6ed737">5,605</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzE4LTEtMS0xLTkwNjE4_afd6aee8-2f4f-4715-bc44-1f38594b6134">941</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzE4LTMtMS0xLTkwNjE4_626915e1-13b1-4b09-8909-30da7430bbb5">364</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accounts payable and accrued salaries and wages</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzE5LTEtMS0xLTkwNjE4_45cb5612-c9c6-4288-b093-e2c25df17061">1,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzE5LTMtMS0xLTkwNjE4_ddbc996c-d36c-4186-b640-7d356c4c5c95">690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzIwLTEtMS0xLTkwNjE4_2c0c9cc8-9f7a-4585-a3cd-1b5e0c5c5e5f">5,762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzIwLTMtMS0xLTkwNjE4_d3a47522-9353-4596-8639-e621c3dec4e9">3,167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzIxLTEtMS0xLTkwNjE4_eb2a2b77-66c5-4614-bd88-6bd901d007f8">1,618</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzIxLTMtMS0xLTkwNjE4_07331ac3-1087-479c-8208-03e418f657d4">1,204</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzIyLTEtMS0xLTkwNjE4_3d6ccbf7-16bb-4157-80f7-754cc5503532">908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzIyLTMtMS0xLTkwNjE4_ec22d5e7-f216-4d90-ba30-8f1434ebb99d">1,705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzIzLTEtMS0xLTEwMDE4MQ_0f195c09-c083-45bb-a9e5-af52fd3c1d08">42,591</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzIzLTMtMS0xLTEwMDE4MQ_6994ae70-dfb8-4505-be5f-d627f1e42897">39,271</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Cash Flows From Investing Activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzI1LTEtMS0xLTkwNjE4_950c8111-3280-4bfb-ad7c-cef4caab9456">5,752</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzI1LTMtMS0xLTkwNjE4_d7e546b2-5a3c-492e-a78c-d2ff8fac78f6">7,110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Proceeds from disposal of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzI2LTEtMS0xLTkwNjE4_0bd5e4c6-ca1e-4fa2-9fcb-547a6d48de37">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzI2LTMtMS0xLTkwNjE4_f878f65a-e29c-4ecb-8c4c-168e591c9d2d">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Proceeds from disposal of investment property</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromSaleOfOtherRealEstate" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzI3LTEtMS0xLTkwNjE4_dab5a426-c8c4-46e2-8f04-fb2252ed61b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromSaleOfOtherRealEstate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzI3LTMtMS0xLTkwNjE4_8dd483be-4b40-414e-aad6-86c8b80b763e">513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzI4LTEtMS0xLTEwMDE4NQ_550c6df7-e5c4-47ad-a06c-a4ef0fd96deb">5,747</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzI4LTMtMS0xLTEwMDE4NQ_8987a114-45cb-45c6-ac56-13e78dfaa381">6,593</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Cash Flows From Financing Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Proceeds from issue of equity instruments of the Company</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="amci:ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzMwLTEtMS0xLTkwNjE4_c98cf063-58fc-4718-af99-6220e54eee91">83,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="amci:ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzMwLTMtMS0xLTkwNjE4_ba074f6c-0ed8-47b8-be06-917c6b50d916">46,572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Proceeds from exercise of a warrant</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzMxLTEtMS0xLTkwNjE4_6b085ff2-5684-4e42-a38c-0422fb9b2777">3,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzMxLTMtMS0xLTkwNjE4_6375e478-d673-4fad-8973-ee08ae0bb778">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Proceeds from issue of SAFE and warrant instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfWarrants" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzMyLTEtMS0xLTkwNjE4_cc483307-e56b-4250-ab01-c91ad33a2007">30,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfWarrants" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzMyLTMtMS0xLTkwNjE4_b2ff1602-09c9-470f-b884-10ba372e3925">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Payment for share issue costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzMzLTEtMS0xLTkwNjE4_0c551e99-fe06-4502-92d3-943d88c4a67b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzMzLTMtMS0xLTkwNjE4_d89c2748-aef4-434e-b417-5828fd97cc3d">30</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Proceeds from borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzM0LTEtMS0xLTkwNjE4_8e5dc630-f70b-4d45-9700-521ae6d632ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzM0LTMtMS0xLTkwNjE4_19a0eb8a-cffe-47a8-80bc-abcae7ffdbf1">3,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Repurchase of equity instruments of the Company</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzM1LTEtMS0xLTkwNjE4_dae8b7d4-9dc5-443e-9d40-caf1d1755790">396</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzM1LTMtMS0xLTkwNjE4_707bd8b0-ec4e-436b-b82f-30aba8e279ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Repayment of borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:RepaymentsOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzM2LTEtMS0xLTkwNjE4_145b4158-6356-44bd-8af4-53883b687fc6">570</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzM2LTMtMS0xLTkwNjE4_a17c85af-a908-45a8-96bd-314a51a52408">4,880</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzM3LTEtMS0xLTEwMDE5Mg_98785849-8815-4a1e-9b44-0f0825848dac">116,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzM3LTMtMS0xLTEwMDE5Mg_d1db09e1-3881-476d-9875-b32c37964b9c">44,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzM4LTEtMS0xLTEwMDIwMA_03055c1b-97e6-4070-9cce-b231a92baf77">67,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzM4LTMtMS0xLTkwNjE4_a6c716a3-fab5-470f-8e5b-bf5f891b3ffd">1,137</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzM5LTEtMS0xLTkwNjE4_1d51bd0c-e75e-4b99-b561-96b492ebc647">60,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i946f64f7009a4a2082ea5e8ea9ae0377_I20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzM5LTMtMS0xLTkwNjE4_b63cb6f3-a6b8-4bed-8049-b4f37935bc1e">62,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Effects of currency translation on cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQwLTEtMS0xLTkwNjE4_caa6fdf4-c470-4f2d-92f0-e0f7d1a933b8">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQwLTMtMS0xLTkwNjE4_6dac7797-ee80-4181-afbe-af19c44b135f">71</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQxLTEtMS0xLTkwNjE4_e58ff2a4-4c76-4517-a3d2-1e35cbceb59e">128,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQxLTMtMS0xLTkwNjE4_41d6a5be-b2c3-40bc-a6a2-122630dd4ba9">60,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Supplemental disclosure of cash flow information:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQzLTEtMS0xLTkwNjE4_df6d95e7-1b40-4bf3-95e3-8994686f2034">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQzLTMtMS0xLTkwNjE4_aaf2c4a4-7be2-466a-92cb-578b443af80a">356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash paid for income taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQ0LTEtMS0xLTkwNjE4_46d5ff8d-4266-4adb-8b80-6bc82ab0af9e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQ0LTMtMS0xLTkwNjE4_94872c8c-c2bd-4fae-82c8-84ac8a7a6e01">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Supplemental disclosure of non-cash investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Acquisition of equity method investment in LanzaJet through contribution of license</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionInvestmentsAcquired1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQ2LTEtMS0xLTkwNjE4_84b3ec7b-2bd8-46bb-bf57-326b4a27f97f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionInvestmentsAcquired1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQ2LTMtMS0xLTkwNjE4_122b787e-0639-42ae-8353-c13c8bfe293d">15,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Acquisition of property, plant and equipment under accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQ3LTEtMS0xLTkwNjE4_e3da3f11-a503-49c6-8d68-2d8494a8e47c">708</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQ3LTMtMS0xLTkwNjE4_08c30ab6-1cd3-4a2f-8c6b-1584d40fcd4b">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Supplemental disclosure of non-cash financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">PPP loan forgiveness</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="amci:NoncashLoanForgiveness" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQ5LTEtMS0xLTkwNjE4_ef168628-b73c-4c53-8cbb-9454bbd48f66">3,065</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="amci:NoncashLoanForgiveness" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQ5LTMtMS0xLTEwMDIwNQ_8633d529-1a78-473d-a47a-c15a2c7cf959">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Receipt of common shares as payment for option exercises</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:ConversionOfStockAmountConverted1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzUwLTEtMS0xLTkwNjE4_415fa49f-0d3f-4851-b807-2c1c24a66e0d">938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:ConversionOfStockAmountConverted1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzUwLTMtMS0xLTkwNjE4_f3faf4a3-2889-44fd-bb45-1f957bb4e597">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See the accompanying Notes to the Consolidated Financial Statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-70</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_403"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LANZATECH NZ, INC.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Restated)</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib82e114cd19f45afae73e7a64e42f208_410"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1 &#8212; <ix:continuation id="i2d893bd07ddb49439a544951e735756b" continuedAt="i6192e5fdaa79406991c74298feb4737e">Description of the Business</ix:continuation></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6192e5fdaa79406991c74298feb4737e">The reporting entity is LanzaTech NZ, Inc. (formerly known as LanzaTech New Zealand Limited) and its subsidiaries (collectively, &#8220;the Company&#8221;). LanzaTech NZ, Inc. is a profit-oriented entity previously incorporated in New Zealand. Effective October 28, 2021, LanzaTech New Zealand Limited filed a Certificate of Incorporation to migrate its country of domicile from New Zealand to Delaware, in the United States, and change its corporate name to &#8220;LanzaTech NZ, Inc.&#8221; The amendment was approved by the Board of Directors of LanzaTech and was effected by the filing of a Certificate of Incorporation with the Delaware Secretary of State. All necessary adjustments have been recorded to present fairly the Company's financial position as of December&#160;31, 2021 and 2020 and the results of operations and cash flows for the years then ended. The registered office location is c/o The Corporation Trust Company, Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware, 19801. The Company licenses its technology to customers, performs research and development in biotechnology, and provides engineering and other related services for commercial and government customers. Using the Company&#8217;s proprietary fermentation technology, the Company&#8217;s customers can convert certain carbon-rich waste gases into fuels and chemicals. The Company employs a licensing business model whereby its customers build, own and operate facilities that use the Company's technology, and in return, the Company is paid royalties based on the revenue generated from the use of its technology. In 2018, the Company, through its equity method investee, launched the world&#8217;s first commercial waste gas to ethanol plant in China, followed by a second one in 2021, also in China, with others currently in development in various countries around the world.</ix:continuation></span></div><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_416"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2 &#8212; <ix:continuation id="ie13506f5f5ed412189f70da16928770a" continuedAt="i16a30740aa0149c8829685e26b2364ab">Summary of Significant Accounting Policies </ix:continuation></span></div><ix:continuation id="i16a30740aa0149c8829685e26b2364ab" continuedAt="if8f020f96a264e0bb70e98f53d6b0c19"><ix:continuation id="i9334404a4b6b4bcfbe949931fc737113"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;US GAAP"). The consolidated financial statements include the accounts of LanzaTech NZ, Inc. and its wholly-owned consolidated subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation.</span></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of its evaluation, the Company makes judgments in determining whether an entity is a variable interest entity (&#8220;VIE&#8221;) and, if so, whether it is the primary beneficiary of the VIE and is thus required to consolidate the entity. A VIE is a legal entity that has a total equity investment that is insufficient to finance its activities without additional subordinated financial support or whose equity investors lack the characteristics of a controlling financial interest. Our variable interest arises from contractual, ownership or other monetary interests in the entity, which change with fluctuations in the fair value of the entity&#8217;s net assets. A VIE is consolidated by its primary beneficiary, the party that has both the power to direct the activities that most significantly impact the VIE&#8217;s economic performance, and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE. We consolidate a VIE when we are deemed to be the primary beneficiary. We assess whether or not we are the primary beneficiary of a VIE on an ongoing basis. If we are not deemed to be the primary beneficiary in a VIE, we account for the investment or other variable interests in a VIE in accordance with applicable US GAAP.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds interests in certain VIEs for which it has been determined the Company is not the primary beneficiary. The Company's variable interests primarily relate to entities in which the Company has a non-controlling equity interest. Although these financial arrangements resulted in holding variable interests in these entities, they did not empower the Company to direct the activities of the VIEs that most significantly impact the VIEs' economic performance. The Company's interests in the VIEs are, therefore, accounted for under the equity method of accounting. Refer to Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further information. The Company's maximum exposure to loss in connection with its interest in VIEs is its equity method investment and any amounts receivable from the VIE, less amounts payable. Refer to Note 14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further details on the transactions with VIEs.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restatement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 16, 2022, the Audit Committee of the Board of Directors of LanzaTech, after discussion with management of LanzaTech and LanzaTech&#8217;s independent registered public accounting firm, Deloitte &amp; Touche, </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="if8f020f96a264e0bb70e98f53d6b0c19" continuedAt="i2d817d4c2d12467ebf3798f8beb0b6eb"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LLP, concluded that LanzaTech&#8217;s previously issued audited consolidated financial statements as of and for the fiscal years ended December 31, 2021 and December 31, 2020 should no longer be relied upon. The errors leading to restatement were communicated to and discussed with AMCI upon their discovery. The AMCI Board considered the circumstances surrounding the restatement and concluded that it did not negatively impact its decision to proceed with the Business Combination primarily because of the individually immaterial adjustments. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined that its recorded share of equity method earnings amounts from an unconsolidated affiliate for the years ended December 31, 2021 and 2020 and its gain on dilution amount for the year ended December 31, 2021 were incorrect following the completion of LanzaJet, Inc's ("LanzaJet") financial statement audit. Additionally, the Company identified that it was not properly eliminating intra-entity profits related to revenue contracts with LanzaJet. As a result of the adjustments recorded by the unconsolidated affiliate and the identification of the error related to the elimination of intra-entity profits, the Company made the decision to restate its consolidated financial statements as of and for the years ended December 31, 2021 and 2020, on or around the completion of the audit of LanzaJet's financial statements for the years ended December 31, 2021 and 2020, on August 23, 2022. The Company also determined it was not properly accounting for its licensing arrangement with LanzaJet, and had not disclosed all significant related party transactions with its equity method investees. The Company has also revised these disclosures.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 250, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Changes and Error Corrections</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company evaluated the materiality of the adjustments, considering both quantitative and qualitative factors, and determined that the related aggregate impact was material to its consolidated financial statements as of and for the years ended December 31, 2021 and 2020. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Description of Errors Corrected</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Accounting for Equity Method Investments: </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The previously reported equity method investment in LanzaJet, Inc. (&#8220;LanzaJet&#8221;), as described in Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, contained errors in the Company's recorded share of LanzaJet losses for the years ended 2021 and 2020 as a result of adjustments made by LanzaJet to its financial statements in connection with the audit of LanzaJet's financial statements for the years ended December 31, 2021 and 2020. The adjustments primarily were comprised of (1) an adjustment to correct an error relating to the measurement of the intangible asset associated with the intellectual property contributed by the Company as described in Note 5 &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the related amortization; and (2), an adjustment to reclassify as a reduction to fixed assets certain government grants received by LanzaJet that it originally recorded as revenue. Other less significant adjustments were also identified and corrected in connection with the audit of LanzaJet's financial statements for the years ended December 31, 2021 and 2020. The net impact of these adjustments on the equity method investment's balance and accumulated deficit in the Company's Consolidated Balance Sheets was a decrease of $<ix:nonFraction unitRef="usd" contextRef="ib670cc288d804b0da674a966573402b6_I20211231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NjE2_568b7b56-0cef-4fb2-9cc1-f4082a4137dd"><ix:nonFraction unitRef="usd" contextRef="ib670cc288d804b0da674a966573402b6_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NjE2_c3872c20-a737-46d5-9f7e-b0a51cba21f8">580</ix:nonFraction></ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i8f626d763fea4f03b5c54c8fd030b350_I20201231" decimals="-3" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NjIy_3d5a88a3-7ec5-439e-b666-9541ed3a3c05"><ix:nonFraction unitRef="usd" contextRef="i8f626d763fea4f03b5c54c8fd030b350_I20201231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NjIy_6b5e0c98-e312-4313-be39-6d46d549d023">257</ix:nonFraction></ix:nonFraction> as of December 31, 2021 and 2020, respectively. The net impact of these adjustments on the gain from equity method investees in the Company&#8217;s Consolidated Statements of Operations and Comprehensive Loss was a decrease of $<ix:nonFraction unitRef="usd" contextRef="ic75b0e764db44a3ea1a1199da6c4795b_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NjA0_7553a497-34df-452b-aec2-9b6f6839fb9d">580</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i1ddd84d3244a4e469b4d90c6789d9b85_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NjEw_ccd5e483-a9f1-4edb-922d-25da02a66594">257</ix:nonFraction> for the years ended December 31, 2021 and 2020, respectively. </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The previously reported revenue from related parties related to contributed intellectual property contained errors for intra-entity profit that was not previously eliminated, as described in Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The impact of these errors on the equity method investment's balance and accumulated deficit in the Consolidated Balance Sheets was $<ix:nonFraction unitRef="usd" contextRef="icea6a4eaa3fa47bc9fd500d0e0e53a13_I20211231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTky_455b0540-74c4-4062-8b44-c16b8020f49a"><ix:nonFraction unitRef="usd" contextRef="icea6a4eaa3fa47bc9fd500d0e0e53a13_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTky_71c00ec1-797f-4bdd-94ba-f28001002047">662</ix:nonFraction></ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i5437a811e196420794bdd75c799bf19b_I20201231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTk4_a162734b-f7ed-445b-b4b5-77fcc04d69c8"><ix:nonFraction unitRef="usd" contextRef="i5437a811e196420794bdd75c799bf19b_I20201231" decimals="-3" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTk4_bf80199d-4311-4bb0-af62-bd65e634477a">549</ix:nonFraction></ix:nonFraction> as of December 31, 2021 and 2020, respectively and $<ix:nonFraction unitRef="usd" contextRef="i6272a6a1b0f14bc1a60665228d4ff94d_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:RevenueFromRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTgw_8dcfceb6-30e6-4c71-98ef-49fdbdf81475">662</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i89d112338dda40d0b977e99b3737e024_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:RevenueFromRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTg2_96947d5a-51c4-40e9-bd1c-2b5c6f7970d4">549</ix:nonFraction> on revenue from related party transactions in the Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2021 and 2020, respectively.</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The previously reported gain on dilution, as described in Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, was not correctly calculated for the year ended December 31, 2021. The impact of these errors on the equity method investment's balance and accumulated deficit in the Consolidated Balance Sheets as of December 31, </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i2d817d4c2d12467ebf3798f8beb0b6eb" continuedAt="i9daf1947194d4cf4a35592f4f3ef6d29"><div style="margin-bottom:9pt;padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021 was $<ix:nonFraction unitRef="usd" contextRef="ie7dbd0916f2f407fbf3b88496fe98376_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTc0_c5c4ec26-e7d1-47f0-adc6-b235c2d121eb"><ix:nonFraction unitRef="usd" contextRef="ie7dbd0916f2f407fbf3b88496fe98376_I20211231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTc0_fd9ba952-a01c-4ede-8593-6709b2c6c7bc">322</ix:nonFraction></ix:nonFraction>; and the impact on gain from equity method investees in the Consolidated Statements of Operations and Comprehensive Loss was $<ix:nonFraction unitRef="usd" contextRef="id9f5902630fa415a8d71cc63925f4a89_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTY4_e9df5444-3850-4045-9df4-dfdfbe1edc07">322</ix:nonFraction> for the year ended December 31, 2021.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Additional Misstatements:</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The previously reported contract assets and other accrued liabilities included revenue and related cost of revenue amounts that was recorded in an inappropriate period. These amounts were recorded in 2021, however, the performance obligation was actually satisfied in 2020.. The impact of these errors on the contract assets and other accrued liabilities in the Consolidated Balance Sheet as of December 31, 2020 was $<ix:nonFraction unitRef="usd" contextRef="i142b45d688a94040896bab9c453fa022_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTYy_05e1a422-f32d-4d83-9fa3-8d541cfb0659"><ix:nonFraction unitRef="usd" contextRef="i142b45d688a94040896bab9c453fa022_I20201231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTYy_1804b876-f72d-4a20-8ae5-2f852db202aa">122</ix:nonFraction></ix:nonFraction>; and the impact on revenue from contracts with customers and cost of revenue from contracts with customers in the Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2021 and 2020 was  $<ix:nonFraction unitRef="usd" contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231" decimals="-3" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEwOTk1MTE2MzcyNzkz_6828adcd-ac57-407e-b152-e09116ec4b82"><ix:nonFraction unitRef="usd" contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEwOTk1MTE2MzcyNzkz_c9ef5cc5-92f3-4c34-b395-0240e72b95ba">122</ix:nonFraction></ix:nonFraction>.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Disclosure errors:</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company determined its licensing arrangement with LanzaJet, described in Note 5 &#8211; Investments, should have been accounted for as a transaction with a customer solely within the scope of Accounting Standards Codification 606 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from contracts with customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 606") rather than akin to an operating lease under Accounting Standards Codification 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 842"). The licensing arrangement is a contract with our customer, LanzaJet, that conveys to LanzaJet the right to use an intangible asset (IP). Contracts with customers are accounted for under ASC 606 unless they are within the scope of other accounting literature. Because the licensing arrangement conveys the right to use an intangible asset, it is not within the scope of ASC 842. Under limited circumstances, ASC 606 requires certain arrangements that do not, in substance, transfer control of an asset (i.e., when the arrangement contains certain repurchase rights or obligations) to be accounted for as leases. However, those limited circumstances are not present in our licensing arrangement with LanzaJet. Therefore, the Company concluded accounting for the arrangement under ASC 606 is required. Because the period over which the Company determined it was required to recognize revenue under ASC 606 was the same as the period of time over which it had been recognizing revenue, there was no effect on the amounts recorded in the consolidated financial statements. Additionally, the difference in timing of recognition of the variable consideration resulted in a difference between the carrying value of our equity method investment in LanzaJet and our proportionate share LanzaJet's book values, that was not previously disclosed. However, the disclosures in Note 5 &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, have been revised accordingly.</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company did not disclose in Note 5 &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, its obligation under a guarantee with sublicensing agreement between LanzaJet and a third party. The fair value of this guarantee was deemed immaterial as of December 31, 2021 and 2020.</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company did not include in its disclosure for related party transactions in Note 14 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that it also provided engineering services to one of its equity method investees, Beijing ShouGang LanzaTech Technology Co., LTD ("SGLT"), for which costs of $<ix:nonFraction unitRef="usd" contextRef="i475ef0e1c62c4e2194e47d2dab3b2b37_D20210101-20211231" decimals="-3" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTQw_27eb92a7-eaa2-4a15-bf57-3bc4ac19be82">1,223</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i84e5c0f8b51d4b4ea1203de397661f35_D20200101-20201231" decimals="-3" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTQ4_8df34b04-6196-4be1-9470-f1f444e74d59">242</ix:nonFraction> were incurred during the years ended December 31, 2021 and 2020. The Company also did not disclose that in 2019 it entered into a licensing agreement to receive licensing consideration from SGLT. </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i9daf1947194d4cf4a35592f4f3ef6d29" continuedAt="i0b1be86ecd644f83aadd62f4cae8117c"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of the errors discussed above were individually material to the financial statements, however, their cumulative impact was material and resulted in a restatement of the 2021 and 2020 financial statements. <ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk4MDQy_87d2ecea-ecba-4823-a532-e39d309f5065" continuedAt="if0477314df334abfa475f37219f20d01" escape="true">The effects of the correction of these errors on the relevant financial statement line items is as follows:</ix:nonNumeric></span></div><ix:continuation id="if0477314df334abfa475f37219f20d01" continuedAt="if2df199a67214766973c2a6a019adbe3"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Balance Sheet</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idccad26b9b674e58874df0b2f95fbd38_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpmMzc5ZmY4ZDMyNGE0YjJiOGQ1NTAxZWE4OGM4NDQxYS90YWJsZXJhbmdlOmYzNzlmZjhkMzI0YTRiMmI4ZDU1MDFlYTg4Yzg0NDFhXzMtMS0xLTEtOTA2MTg_af807c2d-398f-44fb-9ce8-31fb28d75fd5">26,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8987593ef9dd4097a8751ede87870612_I20211231" decimals="-3" sign="-" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpmMzc5ZmY4ZDMyNGE0YjJiOGQ1NTAxZWE4OGM4NDQxYS90YWJsZXJhbmdlOmYzNzlmZjhkMzI0YTRiMmI4ZDU1MDFlYTg4Yzg0NDFhXzMtMi0xLTEtOTA2MTg_6b45b833-747d-4d47-b9a7-9d2126fa7b72">1,727</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpmMzc5ZmY4ZDMyNGE0YjJiOGQ1NTAxZWE4OGM4NDQxYS90YWJsZXJhbmdlOmYzNzlmZjhkMzI0YTRiMmI4ZDU1MDFlYTg4Yzg0NDFhXzMtMy0xLTEtOTA2MTg_286b4618-814a-4978-a3bf-2cf4fa19beca">24,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idccad26b9b674e58874df0b2f95fbd38_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpmMzc5ZmY4ZDMyNGE0YjJiOGQ1NTAxZWE4OGM4NDQxYS90YWJsZXJhbmdlOmYzNzlmZjhkMzI0YTRiMmI4ZDU1MDFlYTg4Yzg0NDFhXzQtMS0xLTEtOTA2MTg_2eaf51b1-6b17-42a4-984e-1d5452c82634">194,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8987593ef9dd4097a8751ede87870612_I20211231" decimals="-3" sign="-" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpmMzc5ZmY4ZDMyNGE0YjJiOGQ1NTAxZWE4OGM4NDQxYS90YWJsZXJhbmdlOmYzNzlmZjhkMzI0YTRiMmI4ZDU1MDFlYTg4Yzg0NDFhXzQtMi0xLTEtOTA2MTg_b1832a1b-4227-4057-8e1b-8b24001b424b">1,727</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpmMzc5ZmY4ZDMyNGE0YjJiOGQ1NTAxZWE4OGM4NDQxYS90YWJsZXJhbmdlOmYzNzlmZjhkMzI0YTRiMmI4ZDU1MDFlYTg4Yzg0NDFhXzQtMy0xLTEtOTA2MTg_f32d79b4-c6a1-4601-9783-2e3273d417a2">193,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idccad26b9b674e58874df0b2f95fbd38_I20211231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpmMzc5ZmY4ZDMyNGE0YjJiOGQ1NTAxZWE4OGM4NDQxYS90YWJsZXJhbmdlOmYzNzlmZjhkMzI0YTRiMmI4ZDU1MDFlYTg4Yzg0NDFhXzUtMS0xLTEtOTA2MTg_b2bfab66-dbb5-4758-a5c0-4bac32405236">378,162</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8987593ef9dd4097a8751ede87870612_I20211231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpmMzc5ZmY4ZDMyNGE0YjJiOGQ1NTAxZWE4OGM4NDQxYS90YWJsZXJhbmdlOmYzNzlmZjhkMzI0YTRiMmI4ZDU1MDFlYTg4Yzg0NDFhXzUtMi0xLTEtOTA2MTg_b792793a-7d61-4e63-b807-81142b184ebe">1,727</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpmMzc5ZmY4ZDMyNGE0YjJiOGQ1NTAxZWE4OGM4NDQxYS90YWJsZXJhbmdlOmYzNzlmZjhkMzI0YTRiMmI4ZDU1MDFlYTg4Yzg0NDFhXzUtMy0xLTEtOTA2MTg_970cb0d9-d366-4cbf-82b9-9c5139df1f3c">379,889</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idccad26b9b674e58874df0b2f95fbd38_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpmMzc5ZmY4ZDMyNGE0YjJiOGQ1NTAxZWE4OGM4NDQxYS90YWJsZXJhbmdlOmYzNzlmZjhkMzI0YTRiMmI4ZDU1MDFlYTg4Yzg0NDFhXzYtMS0xLTEtOTA2MTg_71f7a841-3bc0-4d54-8645-286f2528a65b">353,190</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8987593ef9dd4097a8751ede87870612_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpmMzc5ZmY4ZDMyNGE0YjJiOGQ1NTAxZWE4OGM4NDQxYS90YWJsZXJhbmdlOmYzNzlmZjhkMzI0YTRiMmI4ZDU1MDFlYTg4Yzg0NDFhXzYtMi0xLTEtOTA2MTg_0eab9560-896f-4d91-80f3-31bdac6b890e">1,727</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpmMzc5ZmY4ZDMyNGE0YjJiOGQ1NTAxZWE4OGM4NDQxYS90YWJsZXJhbmdlOmYzNzlmZjhkMzI0YTRiMmI4ZDU1MDFlYTg4Yzg0NDFhXzYtMy0xLTEtOTA2MTg_2226f8b4-3b38-4fd8-a0cd-4ccaa92d105c">354,917</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, contingently redeemable preferred equity, and shareholders' deficit</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idccad26b9b674e58874df0b2f95fbd38_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpmMzc5ZmY4ZDMyNGE0YjJiOGQ1NTAxZWE4OGM4NDQxYS90YWJsZXJhbmdlOmYzNzlmZjhkMzI0YTRiMmI4ZDU1MDFlYTg4Yzg0NDFhXzctMS0xLTEtOTA2MTg_7f10212d-da47-4782-9813-26e8cf4c19d6">194,738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8987593ef9dd4097a8751ede87870612_I20211231" decimals="-3" sign="-" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpmMzc5ZmY4ZDMyNGE0YjJiOGQ1NTAxZWE4OGM4NDQxYS90YWJsZXJhbmdlOmYzNzlmZjhkMzI0YTRiMmI4ZDU1MDFlYTg4Yzg0NDFhXzctMi0xLTEtOTA2MTg_fac99856-00bf-4ab7-9766-2628e4b43b65">1,727</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpmMzc5ZmY4ZDMyNGE0YjJiOGQ1NTAxZWE4OGM4NDQxYS90YWJsZXJhbmdlOmYzNzlmZjhkMzI0YTRiMmI4ZDU1MDFlYTg4Yzg0NDFhXzctMy0xLTEtOTA2MTg_2a8614df-ac72-4b53-a9c0-f34c090b1c8b">193,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Balance Sheet</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief2dc30089664149a39ac740dc44fcd1_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzMtMS0xLTEtOTA2MTg_604135fb-34f3-42d5-92ae-dff6cb3362f8">6,064</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i142b45d688a94040896bab9c453fa022_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzMtMi0xLTEtOTA2MTg_f5ccde99-4cb8-4890-bf12-30a52813130c">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzMtMy0xLTEtOTA2MTg_04d4cd26-b387-42ca-8f7d-fbe04706b37a">6,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief2dc30089664149a39ac740dc44fcd1_I20201231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzQtMS0xLTEtOTA2MTg_b33e5469-9c8b-4f67-9b0a-ee7ee4abbc98">76,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i142b45d688a94040896bab9c453fa022_I20201231" decimals="-3" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzQtMi0xLTEtOTA2MTg_5cbb464b-0dd1-4647-8d0d-3c82d0220519">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzQtMy0xLTEtOTA2MTg_1a3a6baa-2c50-4537-9b15-6bebf089adec">76,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief2dc30089664149a39ac740dc44fcd1_I20201231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzUtMS0xLTEtOTA2MTg_761d9967-d2ba-4f15-bfcd-91e6696509e0">24,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i142b45d688a94040896bab9c453fa022_I20201231" decimals="-3" sign="-" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzUtMi0xLTEtOTA2MTg_dd77cdad-9bc5-4958-8f4e-79f6a610478d">806</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzUtMy0xLTEtOTA2MTg_ee8ffd38-3a7a-4936-988c-3d5940733eca">23,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief2dc30089664149a39ac740dc44fcd1_I20201231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzYtMS0xLTEtOTA2MTg_5dc7fad2-978e-46dd-972b-a2dd113a6b9b">119,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i142b45d688a94040896bab9c453fa022_I20201231" decimals="-3" sign="-" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzYtMi0xLTEtOTA2MTg_d68b5119-6fed-4714-9614-df64672f96df">684</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzYtMy0xLTEtOTA2MTg_000d896b-3b17-4591-b612-8332dd148d60">118,980</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief2dc30089664149a39ac740dc44fcd1_I20201231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzctMS0xLTEtOTA2MTg_e866eeab-cbcd-4179-9d38-bc42e3c7f0ec">2,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i142b45d688a94040896bab9c453fa022_I20201231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzctMi0xLTEtOTA2MTg_c1911a96-112f-4d41-b944-46f018d5acf9">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzctMy0xLTEtOTA2MTg_4d60dc2d-1754-4524-8568-3780882662c8">2,897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief2dc30089664149a39ac740dc44fcd1_I20201231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzgtMS0xLTEtOTA2MTg_1d86b3e1-58f8-4c7c-b4cb-e03e691d3346">15,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i142b45d688a94040896bab9c453fa022_I20201231" decimals="-3" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzgtMi0xLTEtOTA2MTg_9097bfa9-0004-4275-9268-e4d4c19fd837">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzgtMy0xLTEtOTA2MTg_4dcd0bb1-8bdd-4594-8124-7755106b7f63">15,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief2dc30089664149a39ac740dc44fcd1_I20201231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzktMS0xLTEtOTA2MTg_3f264050-df9e-4ed2-a617-f99171bf5560">35,666</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i142b45d688a94040896bab9c453fa022_I20201231" decimals="-3" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzktMi0xLTEtOTA2MTg_6ccf222c-6673-4430-9650-796d982acee6">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzktMy0xLTEtOTA2MTg_7b6c1119-9860-4fc2-a155-46245acab801">35,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief2dc30089664149a39ac740dc44fcd1_I20201231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzEwLTEtMS0xLTkwNjE4_5bd3c9f9-401e-4ab1-aa9f-3f62967c2593">332,394</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i142b45d688a94040896bab9c453fa022_I20201231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzEwLTItMS0xLTkwNjE4_11273836-a35f-4e99-a574-f5da0bed6522">806</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzEwLTMtMS0xLTkwNjE4_b498ae3c-bacd-4226-b7e7-0f1eae4b5391">333,200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief2dc30089664149a39ac740dc44fcd1_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzExLTEtMS0xLTkwNjE4_8c1f8015-fe28-4f7f-87eb-ab69f2fe198d">310,410</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i142b45d688a94040896bab9c453fa022_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzExLTItMS0xLTkwNjE4_80f2e8d0-73ec-466f-95e7-e90693468637">806</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzExLTMtMS0xLTkwNjE4_d6b13137-0fba-4734-a55b-57e6d978c6f1">311,216</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, contingently redeemable preferred equity, and shareholders' deficit</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief2dc30089664149a39ac740dc44fcd1_I20201231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzEyLTEtMS0xLTkwNjE4_2f7e976e-1fc9-40b4-abd9-75624faf877b">119,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i142b45d688a94040896bab9c453fa022_I20201231" decimals="-3" sign="-" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzEyLTItMS0xLTkwNjE4_b7954321-1daf-4480-aa64-ab16a1fa3a4d">684</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzEyLTMtMS0xLTkwNjE4_5edafbf0-b725-4059-9149-154a25427eff">118,980</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i0b1be86ecd644f83aadd62f4cae8117c" continuedAt="i0ab446b792a04182804f3b711e0b860c"><ix:continuation id="if2df199a67214766973c2a6a019adbe3" continuedAt="i2d46636584f14ed8b0a31e5411f1b750"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Operations and Comprehensive Loss</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from contracts with customers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzMtMS0xLTEtOTA2MTg_a5b1e917-4f01-4151-8b96-c7a343969759">18,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzMtMi0xLTEtOTA2MTg_536b9281-52d3-44e0-bcfd-9667c2565c02">122</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzMtMy0xLTEtOTA2MTg_4fcec587-2a40-42ac-800e-6771d872ad4f">18,871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from related party transactions</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzQtMS0xLTEtOTA2MTg_debba524-8380-40f1-8a87-de55a89b10f9">3,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:RevenueFromRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzQtMi0xLTEtOTA2MTg_2503d78e-aac5-441c-9867-d12df477d295">662</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzQtMy0xLTEtOTA2MTg_075dea97-40a3-4874-b0c7-bcfb09f9043a">3,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzUtMS0xLTEtOTA2MTg_d08934e0-4c6d-4b90-9dff-8f8baf18d345">26,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzUtMi0xLTEtOTA2MTg_aa05db9b-af0c-4a94-bded-22ba66a4bab3">784</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzUtMy0xLTEtOTA2MTg_1ef6cef5-30fd-4990-aa67-b085d791744a">25,461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue from contracts with customers (exclusive of depreciation shown below)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231" decimals="-3" name="amci:CostOfRevenueFromContractsWithCustomersExcludingDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzYtMS0xLTEtOTA2MTg_9bbf3da1-da5f-45df-8329-e99af942e070">13,289</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231" decimals="-3" sign="-" name="amci:CostOfRevenueFromContractsWithCustomersExcludingDepreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzYtMi0xLTEtOTA2MTg_2b067f2f-c7fe-4a49-9ef0-58914430fc87">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="amci:CostOfRevenueFromContractsWithCustomersExcludingDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzYtMy0xLTEtOTA2MTg_f4948059-5bab-42e3-b620-66f01c066096">13,167</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost and operating expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzctMS0xLTEtOTA2MTg_a40612a8-f0cb-4d54-b5a5-19918fbfec19">76,602</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzctMi0xLTEtOTA2MTg_e4c7e737-e3fa-47ff-8a79-af3ba2335311">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzctMy0xLTEtOTA2MTg_97cc8d47-e14a-441f-955a-3b6470c8eefa">76,480</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzgtMS0xLTEtOTA2MTg_b6261a5a-3c09-4d4e-828c-99f5129b92fa">50,357</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzgtMi0xLTEtOTA2MTg_0b697aae-6347-4e53-bb90-5fec2e617d67">662</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzgtMy0xLTEtOTA2MTg_4dc23c4a-34fa-4cb3-9a29-1a63ec3ab1d6">51,019</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzktMS0xLTEtOTA2MTg_7f6dcd90-f1fb-42ce-a6bd-2a5d1c6ac258">47,972</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzktMi0xLTEtOTA2MTg_68a9407a-d1eb-4020-b1e9-6e72c987a5f2">662</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzktMy0xLTEtOTA2MTg_3b3e6a07-8fe4-49ad-9971-748150cf0430">48,634</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231" decimals="-3" name="amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzEwLTEtMS0xLTkwNjE4_0318061d-f94a-4096-81a5-05f3d4ae8624">2,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231" decimals="-3" sign="-" name="amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzEwLTItMS0xLTkwNjE4_ef2a149c-bc58-4278-8ab8-fe85cf206210">259</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzEwLTMtMS0xLTkwNjE4_df615396-f3c0-486a-b61b-b1382dcd48a2">1,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzExLTEtMS0xLTkwNjE4_3a207f14-5718-4afc-a38b-5ac272f409f9">45,768</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzExLTItMS0xLTkwNjE4_f2e53261-0aec-4561-97c0-64077fc8e220">921</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzExLTMtMS0xLTkwNjE4_8d4c46fc-126d-44dd-9983-c161cc29d5f7">46,689</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss allocated to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzEyLTEtMS0xLTkwNjE4_45b7a812-1bfb-426c-9b05-2f484255e21c"><ix:nonFraction unitRef="usd" contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzEyLTEtMS0xLTkwNjE4_7c21b2b8-299c-4c90-aa11-9774c483319f">82,526</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzEyLTItMS0xLTkwNjE4_ea3ea404-f82c-4dbd-b72c-8d9bac09d7a2"><ix:nonFraction unitRef="usd" contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzEyLTItMS0xLTkwNjE4_f2b15ea9-0e42-4dfc-b31d-9021db79d1b1">921</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzEyLTMtMS0xLTkwNjE4_40c41d80-a98c-4884-9428-3348f6f19da5"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzEyLTMtMS0xLTkwNjE4_c36c853c-308a-4073-be59-9cebbe27f3f2">83,447</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzEzLTEtMS0xLTkwNjE4_610223e4-df34-4ed3-9a3d-d2cafd0b1b5a">45,673</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzEzLTItMS0xLTkwNjE4_b3deb2c5-b51c-4853-8089-8caab5dfcdfb">921</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzEzLTMtMS0xLTkwNjE4_6357882f-dcc5-42a6-9ea9-2463b1251766">46,594</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share - basic and diluted</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzE1LTEtMS0xLTkwNjE4_8b51293d-7318-474a-a6b6-bc485e6fa2a2"><ix:nonFraction unitRef="usdPerShare" contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzE1LTEtMS0xLTkwNjE4_fa6b7b66-0d80-4f7a-8aa5-b5e1340461fd">42.12</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzE1LTItMS0xLTkwNjE4_8e4c825b-3f09-431f-84b5-b48fd343b175"><ix:nonFraction unitRef="usdPerShare" contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzE1LTItMS0xLTkwNjE4_a8dbf8b1-f7ae-4b01-a320-6184a8e4c1f6">0.47</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzE1LTMtMS0xLTkwNjE4_614d7c92-6c06-413d-9219-f7854cd98ba7"><ix:nonFraction unitRef="usdPerShare" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzE1LTMtMS0xLTkwNjE4_c6be22d3-564c-4f24-99d0-ce6f9ac0bd87">42.59</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Operations and Comprehensive Loss</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from contracts with customers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzMtMS0xLTEtOTA2MTg_1c7cdd16-472f-42da-9891-30db0578b47c">12,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzMtMi0xLTEtOTA2MTg_4bf03ec1-248a-4302-a424-deaee3eff4ac">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzMtMy0xLTEtOTA2MTg_dc441720-3209-4455-8446-f33edc0e4b28">12,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from related party transactions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzQtMS0xLTEtOTA2MTg_dafb549d-6952-4420-9823-c79665eba221">4,752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:RevenueFromRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzQtMi0xLTEtOTA2MTg_e61b7a86-f8ba-4c75-8af1-c70e7ae54d9f">549</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzQtMy0xLTEtOTA2MTg_0ede6b80-1f56-4295-99b2-aadcb77cd337">4,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzUtMS0xLTEtOTA2MTg_f117a3da-c5a6-4abd-bf6f-fa44e1527174">18,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzUtMi0xLTEtOTA2MTg_349d46b5-58df-4579-8ab6-d54a113a2cf8">427</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzUtMy0xLTEtOTA2MTg_fac029eb-8f8f-4a9d-83ed-1f9d33d71636">18,353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue from contracts with customers (exclusive of depreciation shown below)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231" decimals="-3" name="amci:CostOfRevenueFromContractsWithCustomersExcludingDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzYtMS0xLTEtOTA2MTg_3d9e0a04-5bf7-439b-af6d-f277be9f20c4">8,063</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231" decimals="-3" name="amci:CostOfRevenueFromContractsWithCustomersExcludingDepreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzYtMi0xLTEtOTA2MTg_01c3d8e1-5c10-458e-b272-9455cf42e112">122</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="amci:CostOfRevenueFromContractsWithCustomersExcludingDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzYtMy0xLTEtOTA2MTg_6aa17882-7ca0-4c95-81e8-6b7f14eed8a3">8,185</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost and operating expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzctMS0xLTEtOTA2MTg_ff470f85-9aac-4ec0-80d6-773b41b1c7d6">57,932</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231" decimals="-3" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzctMi0xLTEtOTA2MTg_6c215048-22f9-427d-9faf-4f9afbd643db">122</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzctMy0xLTEtOTA2MTg_7c6db7af-85cc-4c6a-b47f-fe002598afd8">58,054</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzgtMS0xLTEtOTA2MTg_1fdad722-4dfc-4f40-90af-31a59db3af94">39,152</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzgtMi0xLTEtOTA2MTg_977990b1-865f-4be6-9d0f-b4a1ac4228d7">549</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzgtMy0xLTEtOTA2MTg_a7cc5a97-7969-4043-afcb-a331e03398d7">39,701</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzktMS0xLTEtOTA2MTg_96651436-fde4-4713-b18a-bf00bfe595ba">39,331</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzktMi0xLTEtOTA2MTg_b96530e2-435b-4b93-8206-8f99af070576">549</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzktMy0xLTEtOTA2MTg_69a30fd9-3c87-4a7c-ba0f-a87c11c5bcbd">39,880</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231" decimals="-3" name="amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzEwLTEtMS0xLTkwNjE4_10ec46d0-9a1c-42e1-928b-73f6b75a5753">2,424</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231" decimals="-3" sign="-" name="amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzEwLTItMS0xLTkwNjE4_fc888f6f-e6a2-4896-b6c3-dadb913a4391">257</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzEwLTMtMS0xLTkwNjE4_476fc1dc-2970-4554-914c-efce47256afc">2,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzExLTEtMS0xLTkwNjE4_2ad30d6d-7b49-420e-b31a-d4fc4bba003d">36,907</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzExLTItMS0xLTkwNjE4_0c06ed8d-be39-4dc8-8868-5ec914eb613e">806</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzExLTMtMS0xLTkwNjE4_144213bd-74b7-4c18-8d1e-7ab44c81fd4f">37,713</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss allocated to common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzEyLTEtMS0xLTkwNjE4_262312ff-01d2-448d-88a0-cdfa067b654e"><ix:nonFraction unitRef="usd" contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzEyLTEtMS0xLTkwNjE4_2ad93a58-f365-4a92-b9c9-76ffc2c578e2">68,198</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzEyLTItMS0xLTkwNjE4_837f6362-490b-44d5-b331-618266821824"><ix:nonFraction unitRef="usd" contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzEyLTItMS0xLTkwNjE4_a23fca93-047e-4a1e-92ac-612db8c6aaf6">806</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzEyLTMtMS0xLTkwNjE4_4bbead41-6b93-49ef-9aad-d14d0f3a6539"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzEyLTMtMS0xLTkwNjE4_7247a72c-cf6b-49e8-9f5c-92ba8b83b573">69,004</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzEzLTEtMS0xLTkwNjE4_9cec75f9-ae7c-47d3-af49-bc21f893b7b0">36,282</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzEzLTItMS0xLTkwNjE4_344a8e6d-25dd-4339-88e8-f3c58d97fad3">806</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzEzLTMtMS0xLTkwNjE4_694b05e4-82ab-47df-a52e-e97b9a92a799">37,088</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share - basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzE1LTEtMS0xLTkwNjE4_7f2d6fe3-3aa4-4a3d-9714-304522e5ea1c"><ix:nonFraction unitRef="usdPerShare" contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzE1LTEtMS0xLTkwNjE4_cb28fd04-1039-497d-9a20-ff36267c01b9">41.84</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzE1LTItMS0xLTkwNjE4_9ae533d1-0c11-4ed0-a2c0-a5ad3b344c64"><ix:nonFraction unitRef="usdPerShare" contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzE1LTItMS0xLTkwNjE4_d319d7ae-8ecc-4024-b603-3de0b24a895d">0.50</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzE1LTMtMS0xLTkwNjE4_6fea7826-1fe3-4a6e-951d-8674bd093bb2"><ix:nonFraction unitRef="usdPerShare" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzE1LTMtMS0xLTkwNjE4_c077357b-02ec-4aac-a2d4-ed8538ed3c0c">42.34</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i0ab446b792a04182804f3b711e0b860c" continuedAt="i719632369d164889801e68f915fce438"><ix:continuation id="i2d46636584f14ed8b0a31e5411f1b750" continuedAt="icad7eb5117594689b88fa404799a8580"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Changes in Redeemable Convertible Preferred Stock and Shareholders&#8217; Equity (Deficit)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit - Balance at December 31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i313f0012493b4bbbb3009a5a1bf811eb_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTphZjNmMTA2MjRhZTA0ZGQxYjJhNTZkZDFjNDk3YjI5Yi90YWJsZXJhbmdlOmFmM2YxMDYyNGFlMDRkZDFiMmE1NmRkMWM0OTdiMjliXzMtMS0xLTEtOTA2MTg_a19676c8-7957-4bc1-8f8b-79722e6f9efd">332,394</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ba67557e60f4d1c9ab04d369b4a98b9_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTphZjNmMTA2MjRhZTA0ZGQxYjJhNTZkZDFjNDk3YjI5Yi90YWJsZXJhbmdlOmFmM2YxMDYyNGFlMDRkZDFiMmE1NmRkMWM0OTdiMjliXzMtMi0xLTEtOTA2MTg_85d6c961-a7bc-4d9e-bb8f-bf8202dd8869">806</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i18eedd573381425c8c989e260801dafe_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTphZjNmMTA2MjRhZTA0ZGQxYjJhNTZkZDFjNDk3YjI5Yi90YWJsZXJhbmdlOmFmM2YxMDYyNGFlMDRkZDFiMmE1NmRkMWM0OTdiMjliXzMtMy0xLTEtOTA2MTg_17ed0d90-61b4-419b-b210-f799af00cfb9">333,200</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit &#8211; balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief2dc30089664149a39ac740dc44fcd1_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTphZjNmMTA2MjRhZTA0ZGQxYjJhNTZkZDFjNDk3YjI5Yi90YWJsZXJhbmdlOmFmM2YxMDYyNGFlMDRkZDFiMmE1NmRkMWM0OTdiMjliXzQtMS0xLTEtOTA2MTg_fa56c6da-e16b-4c00-b898-7afe58ca73e5">310,410</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i142b45d688a94040896bab9c453fa022_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTphZjNmMTA2MjRhZTA0ZGQxYjJhNTZkZDFjNDk3YjI5Yi90YWJsZXJhbmdlOmFmM2YxMDYyNGFlMDRkZDFiMmE1NmRkMWM0OTdiMjliXzQtMi0xLTEtOTA2MTg_5dcc0389-5bc9-41ca-b43a-b4a4109621f9">806</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTphZjNmMTA2MjRhZTA0ZGQxYjJhNTZkZDFjNDk3YjI5Yi90YWJsZXJhbmdlOmFmM2YxMDYyNGFlMDRkZDFiMmE1NmRkMWM0OTdiMjliXzQtMy0xLTEtOTA2MTg_ec089af0-e352-4d34-b327-f26d714f9506">311,216</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTphZjNmMTA2MjRhZTA0ZGQxYjJhNTZkZDFjNDk3YjI5Yi90YWJsZXJhbmdlOmFmM2YxMDYyNGFlMDRkZDFiMmE1NmRkMWM0OTdiMjliXzUtMS0xLTEtOTA2MTg_1c66b56b-3d08-47a6-9c90-3696a9788b85">45,768</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTphZjNmMTA2MjRhZTA0ZGQxYjJhNTZkZDFjNDk3YjI5Yi90YWJsZXJhbmdlOmFmM2YxMDYyNGFlMDRkZDFiMmE1NmRkMWM0OTdiMjliXzUtMi0xLTEtOTA2MTg_ae03e10d-befc-43d0-abaa-aa4fb7f8c912">921</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTphZjNmMTA2MjRhZTA0ZGQxYjJhNTZkZDFjNDk3YjI5Yi90YWJsZXJhbmdlOmFmM2YxMDYyNGFlMDRkZDFiMmE1NmRkMWM0OTdiMjliXzUtMy0xLTEtOTA2MTg_aab2cee3-ccbc-41b9-aef9-e789c686c47a">46,689</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit - balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0727c1578ba4d70a8b82b043575d5a6_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTphZjNmMTA2MjRhZTA0ZGQxYjJhNTZkZDFjNDk3YjI5Yi90YWJsZXJhbmdlOmFmM2YxMDYyNGFlMDRkZDFiMmE1NmRkMWM0OTdiMjliXzYtMS0xLTEtOTA2MTg_56d12ce1-bafa-47ba-a3b3-68cdb90174a2">378,162</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22ad32b2cf2844b38ba63af045e6e421_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTphZjNmMTA2MjRhZTA0ZGQxYjJhNTZkZDFjNDk3YjI5Yi90YWJsZXJhbmdlOmFmM2YxMDYyNGFlMDRkZDFiMmE1NmRkMWM0OTdiMjliXzYtMi0xLTEtOTA2MTg_6a32bb72-b6a1-49e4-bdb8-5a55f1a9592c">1,727</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0898c763893444f8318ba806e5872af_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTphZjNmMTA2MjRhZTA0ZGQxYjJhNTZkZDFjNDk3YjI5Yi90YWJsZXJhbmdlOmFmM2YxMDYyNGFlMDRkZDFiMmE1NmRkMWM0OTdiMjliXzYtMy0xLTEtOTA2MTg_b63517e5-aff4-46b8-8dca-922b3490b1aa">379,889</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit &#8211; balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idccad26b9b674e58874df0b2f95fbd38_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTphZjNmMTA2MjRhZTA0ZGQxYjJhNTZkZDFjNDk3YjI5Yi90YWJsZXJhbmdlOmFmM2YxMDYyNGFlMDRkZDFiMmE1NmRkMWM0OTdiMjliXzctMS0xLTEtOTA2MTg_ae8abbe0-3739-44f1-8bef-372decb57639">353,190</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8987593ef9dd4097a8751ede87870612_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTphZjNmMTA2MjRhZTA0ZGQxYjJhNTZkZDFjNDk3YjI5Yi90YWJsZXJhbmdlOmFmM2YxMDYyNGFlMDRkZDFiMmE1NmRkMWM0OTdiMjliXzctMi0xLTEtOTA2MTg_2f74c73a-df25-4482-af91-c6cc5a5a4df0">1,727</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTphZjNmMTA2MjRhZTA0ZGQxYjJhNTZkZDFjNDk3YjI5Yi90YWJsZXJhbmdlOmFmM2YxMDYyNGFlMDRkZDFiMmE1NmRkMWM0OTdiMjliXzctMy0xLTEtOTA2MTg_a38b7a4e-29ca-44f3-98ce-0c75b5db1219">354,917</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Changes in Redeemable Convertible Preferred Stock and Shareholders&#8217; Equity (Deficit)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit - Balance at December 31, 2019</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa2024ac8ce64a4cb2c146b06249fdb9_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNGJjNjJjMzE5MGY0YTcxODU4YWVlOGE5M2JkMzQwYi90YWJsZXJhbmdlOmU0YmM2MmMzMTkwZjRhNzE4NThhZWU4YTkzYmQzNDBiXzMtMS0xLTEtOTA2MTg_a4169aab-dd8f-4328-9e7b-ab54744c7841">295,487</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5fbf727115a466bbef562191f56b933_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNGJjNjJjMzE5MGY0YTcxODU4YWVlOGE5M2JkMzQwYi90YWJsZXJhbmdlOmU0YmM2MmMzMTkwZjRhNzE4NThhZWU4YTkzYmQzNDBiXzMtMi0xLTEtOTA2MTg_fde8caaf-aae7-412a-9c2e-1016e62234fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94e27674b4054eeb8e5f88cdfd303c29_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNGJjNjJjMzE5MGY0YTcxODU4YWVlOGE5M2JkMzQwYi90YWJsZXJhbmdlOmU0YmM2MmMzMTkwZjRhNzE4NThhZWU4YTkzYmQzNDBiXzMtMy0xLTEtOTA2MTg_0d3fb525-7833-4a07-bc41-1057d00607bb">295,487</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit &#8211; balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i979244b8b15f4cdba6249d9a452d49e9_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNGJjNjJjMzE5MGY0YTcxODU4YWVlOGE5M2JkMzQwYi90YWJsZXJhbmdlOmU0YmM2MmMzMTkwZjRhNzE4NThhZWU4YTkzYmQzNDBiXzQtMS0xLTEtOTA2MTg_6fa6db95-4e61-4419-9297-e969211b37d8">276,592</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaeab5bba9ba24bbab921cc565da5880c_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNGJjNjJjMzE5MGY0YTcxODU4YWVlOGE5M2JkMzQwYi90YWJsZXJhbmdlOmU0YmM2MmMzMTkwZjRhNzE4NThhZWU4YTkzYmQzNDBiXzQtMi0xLTEtOTA2MTg_3e15baef-c59c-4591-924f-6c1e8b88ceae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i946f64f7009a4a2082ea5e8ea9ae0377_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNGJjNjJjMzE5MGY0YTcxODU4YWVlOGE5M2JkMzQwYi90YWJsZXJhbmdlOmU0YmM2MmMzMTkwZjRhNzE4NThhZWU4YTkzYmQzNDBiXzQtMy0xLTEtOTA2MTg_1d467545-0362-4b05-aace-b993ab4647df">276,592</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNGJjNjJjMzE5MGY0YTcxODU4YWVlOGE5M2JkMzQwYi90YWJsZXJhbmdlOmU0YmM2MmMzMTkwZjRhNzE4NThhZWU4YTkzYmQzNDBiXzUtMS0xLTEtOTA2MTg_f3673dfe-71a7-43a1-a11f-7dbf8770a8b8">36,907</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNGJjNjJjMzE5MGY0YTcxODU4YWVlOGE5M2JkMzQwYi90YWJsZXJhbmdlOmU0YmM2MmMzMTkwZjRhNzE4NThhZWU4YTkzYmQzNDBiXzUtMi0xLTEtOTA2MTg_c690d1ef-faa2-4f8d-b461-27d1992c6444">806</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNGJjNjJjMzE5MGY0YTcxODU4YWVlOGE5M2JkMzQwYi90YWJsZXJhbmdlOmU0YmM2MmMzMTkwZjRhNzE4NThhZWU4YTkzYmQzNDBiXzUtMy0xLTEtOTA2MTg_e9b039a3-202b-4743-92ef-9ac1e3b66e4a">37,713</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit - balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i313f0012493b4bbbb3009a5a1bf811eb_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNGJjNjJjMzE5MGY0YTcxODU4YWVlOGE5M2JkMzQwYi90YWJsZXJhbmdlOmU0YmM2MmMzMTkwZjRhNzE4NThhZWU4YTkzYmQzNDBiXzYtMS0xLTEtOTA2MTg_833dda64-c47d-4ff5-9feb-f3fb80a6fc38">332,394</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ba67557e60f4d1c9ab04d369b4a98b9_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNGJjNjJjMzE5MGY0YTcxODU4YWVlOGE5M2JkMzQwYi90YWJsZXJhbmdlOmU0YmM2MmMzMTkwZjRhNzE4NThhZWU4YTkzYmQzNDBiXzYtMi0xLTEtOTA2MTg_ceabccf8-6a61-4ccd-96bb-0d09e60cd883">806</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i18eedd573381425c8c989e260801dafe_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNGJjNjJjMzE5MGY0YTcxODU4YWVlOGE5M2JkMzQwYi90YWJsZXJhbmdlOmU0YmM2MmMzMTkwZjRhNzE4NThhZWU4YTkzYmQzNDBiXzYtMy0xLTEtOTA2MTg_3e2ebe59-28e5-4881-a24d-798c2f923a5b">333,200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit &#8211; balance at December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief2dc30089664149a39ac740dc44fcd1_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNGJjNjJjMzE5MGY0YTcxODU4YWVlOGE5M2JkMzQwYi90YWJsZXJhbmdlOmU0YmM2MmMzMTkwZjRhNzE4NThhZWU4YTkzYmQzNDBiXzctMS0xLTEtOTA2MTg_76e5671f-a841-4e05-8693-917fb39924c5">310,410</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i142b45d688a94040896bab9c453fa022_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNGJjNjJjMzE5MGY0YTcxODU4YWVlOGE5M2JkMzQwYi90YWJsZXJhbmdlOmU0YmM2MmMzMTkwZjRhNzE4NThhZWU4YTkzYmQzNDBiXzctMi0xLTEtOTA2MTg_37a10ac0-b1ca-4fa6-b005-bb357f4a6a2f">806</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNGJjNjJjMzE5MGY0YTcxODU4YWVlOGE5M2JkMzQwYi90YWJsZXJhbmdlOmU0YmM2MmMzMTkwZjRhNzE4NThhZWU4YTkzYmQzNDBiXzctMy0xLTEtOTA2MTg_be5fd46a-b3ed-416c-967a-26d11063e3e8">311,216</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Cash Flows</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzMtMS0xLTEtOTA2MTg_37695cb8-47c4-4504-b3bf-cb83c9c4cb5a">45,768</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzMtMi0xLTEtOTA2MTg_6aa68811-a174-453a-b508-387ce24565ce">921</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzMtMy0xLTEtOTA2MTg_8899e8ca-3a3b-4656-8a59-27ae2c47178f">46,689</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash recognition of licensing revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231" decimals="-3" name="amci:NoncashRecognitionOfLicensingRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzUtMS0xLTEtOTA2MTg_1b4dd543-6bcb-4bfe-b553-22a28bdbd585">2,684</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231" decimals="-3" sign="-" name="amci:NoncashRecognitionOfLicensingRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzUtMi0xLTEtOTA2MTg_d0dbb9d9-9e9a-49fb-b57a-e7a3307d238b">662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="amci:NoncashRecognitionOfLicensingRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzUtMy0xLTEtOTA2MTg_99e1d8cf-5665-404a-a5ca-c02648b6bea1">2,022</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231" decimals="-3" name="amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzYtMS0xLTEtOTA2MTg_1516b691-90f3-4ac9-8a08-7f35b03ae22f">2,204</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231" decimals="-3" sign="-" name="amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzYtMi0xLTEtOTA2MTg_644c30c5-6ee6-4834-9fee-ff14c340a2b3">259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzYtMy0xLTEtOTA2MTg_a6cf7b0c-1e08-498c-b860-8849d3776ebd">1,945</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzgtMS0xLTEtOTA2MTg_9b830c5e-a009-465b-ae2d-5608f6a7d8c6">5,636</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzgtMi0xLTEtOTA2MTg_b6dd629f-662f-4988-b9e0-da8c14365beb">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzgtMy0xLTEtOTA2MTg_a0bf7414-5114-4f56-aa8f-2850e34aa991">5,514</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued salaries and wages</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzktMS0xLTEtOTA2MTg_5c3bbe09-6181-4fb1-bc2a-39d2731e6b87">1,378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzktMi0xLTEtOTA2MTg_197e17c8-a38b-44b0-9aa3-004edc1e4fbc">122</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzktMy0xLTEtOTA2MTg_62bc47b6-5831-4643-badb-922c12a968b9">1,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzEwLTEtMS0xLTkwNjE4_c6937d46-6090-4d05-8bd4-16b94ac7d948">42,591</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzEwLTItMS0xLTkwNjE4_cc5d42a5-da0e-4a36-a0cf-93ae9ed2549b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzEwLTMtMS0xLTkwNjE4_95af01e0-def0-48e2-91c0-3d0243ed0280">42,591</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i719632369d164889801e68f915fce438" continuedAt="i2faca0f267be493184503a925cf2a40a"><div style="margin-bottom:9pt"><ix:continuation id="icad7eb5117594689b88fa404799a8580" continuedAt="ia7e02bd19b704982af243c5e2fc3c728"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Cash Flows</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzMtMS0xLTEtOTA2MTg_9765639d-b8f0-42e8-9ea3-19e0ad84bfbc">36,907</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzMtMi0xLTEtOTA2MTg_ccbf9ae0-9e03-4975-b7d0-d039a0bf8e0f">806</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzMtMy0xLTEtOTA2MTg_ae924edb-60ef-4a23-95f6-30137e38d177">37,713</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash recognition of licensing revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231" decimals="-3" name="amci:NoncashRecognitionOfLicensingRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzUtMS0xLTEtOTA2MTg_625cacb9-cd1f-4d9d-b49a-266e3bfa39ac">1,567</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231" decimals="-3" sign="-" name="amci:NoncashRecognitionOfLicensingRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzUtMi0xLTEtOTA2MTg_76e126a4-3410-4a1c-8a63-4608e48d1c8e">549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="amci:NoncashRecognitionOfLicensingRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzUtMy0xLTEtOTA2MTg_2013263d-facf-402f-9980-4a73439888e0">1,018</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231" decimals="-3" name="amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzYtMS0xLTEtOTA2MTg_8f5fc5e3-968f-4757-ac44-134cfa41bc66">2,424</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231" decimals="-3" sign="-" name="amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzYtMi0xLTEtOTA2MTg_b2894806-63be-4d7d-a0f6-4488ac2e8eb7">257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzYtMy0xLTEtOTA2MTg_2f57ba85-52e4-415e-aaf9-93e970ef4087">2,167</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzgtMS0xLTEtOTA2MTg_d766fcb4-8d02-4722-97d4-f166a25bf505">5,483</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzgtMi0xLTEtOTA2MTg_9bbcfc0a-1099-4237-b1cd-f047d45378ce">122</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzgtMy0xLTEtOTA2MTg_a79c242d-b87f-4db7-99cd-48d4734dbf15">5,605</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued salaries and wages</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzktMS0xLTEtOTA2MTg_b33da788-860d-472f-bba4-23eed6390e9c">568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzktMi0xLTEtOTA2MTg_a5a6dd69-1564-41e8-9fd9-1a2d63a27006">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzktMy0xLTEtOTA2MTg_559f3851-08c3-49bb-becf-bfd44466ec22">690</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzEwLTEtMS0xLTkwNjE4_2d143e25-56e4-4e0c-8621-3e3b79d790ce">39,271</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzEwLTItMS0xLTkwNjE4_925dab67-eadf-4626-9ebc-5eedbed3c36d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzEwLTMtMS0xLTkwNjE4_ea6bfb5e-bae4-43ca-a961-874ad56d3129">39,271</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Other Disclosure Errors: </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 5 - Investments: The Company did not disclose intra-entity profits elimination amounts related to revenue contracts with LanzaJet of $<ix:nonFraction unitRef="usd" contextRef="i4715c3e771cb49659b7d7d1edf71bd81_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzExMTk4_2c0ac6d9-312b-4bd7-97a8-a310024c235b">662</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ia7a001a92c1048529f1d70f282ef5979_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzExMjA1_b6c2e032-cb3a-4b55-9f63-101e95489eef">549</ix:nonFraction> as of December 31, 2021, and 2020, respectively as they were not eliminated. The previously disclosed gain on dilution was incorrect as of and for the year ended December 31, 2021.</span></div><div style="margin-bottom:9pt"><ix:continuation id="ia7e02bd19b704982af243c5e2fc3c728"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on dilution</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231" decimals="-3" name="amci:EquityMethodInvestmentGainOnDilutionOfInvestment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTowMzkwZjI1OGE3ZDk0Y2MwOGYwYjFlNGE1ZDY3ZTljOC90YWJsZXJhbmdlOjAzOTBmMjU4YTdkOTRjYzA4ZjBiMWU0YTVkNjdlOWM4XzItMS0xLTEtOTA2MTg_dc7aa9fb-912b-41f4-8d75-e27c11566e2a">181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="amci:EquityMethodInvestmentGainOnDilutionOfInvestment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTowMzkwZjI1OGE3ZDk0Y2MwOGYwYjFlNGE1ZDY3ZTljOC90YWJsZXJhbmdlOjAzOTBmMjU4YTdkOTRjYzA4ZjBiMWU0YTVkNjdlOWM4XzItMi0xLTEtOTA2MTg_7390010a-5e60-4b6f-ac9a-e208c49b6e08">503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><ix:continuation id="i95dfebb5484c4cb6b011f7c75a41e26d"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates as <ix:nonFraction unitRef="segment" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTMz_c938a68d-ef71-446d-a957-4f900cf1ad20">one</ix:nonFraction> operating segment. Operating segments are defined as components of an enterprise for which separate financial information is evaluated regularly by the chief operating decision maker (&#8220;CODM&#8221;), in deciding how to allocate resources and assess performance.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company offers a variety of services and operates in multiple countries, the Company&#8217;s business operates in <ix:nonFraction unitRef="segment" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEwOTk1MTE2MzczMTE5_13032edc-e6d3-4fcf-a4a1-12248b4ed8eb">one</ix:nonFraction> operating segment because most of the Company&#8217;s service offerings are delivered and supported on a global basis, most of the Company&#8217;s service offerings are deployed in a nearly identical way, and the Company&#8217;s CODM evaluates the Company&#8217;s financial information and resources and assesses the performance of these resources on a consolidated basis. There are no segment managers who are held accountable by the CODM, or anyone else, for operations, operating results, and planning for components below the consolidated level. Accordingly, the Company has determined that it has a single reportable and operating segment. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for disaggregation of the Company&#8217;s revenues by customer location.</span></div></ix:continuation><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="amci:CoronavirusPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NjMx_dc28a29a-3598-4ca0-a086-3779910c67d4" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Coronavirus (COVID-19)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the World Health Organization declared the viral strain of coronavirus ("COVID-19") a global pandemic and recommended containment and mitigation measures worldwide. The spread of COVID-19 and the resulting economic contraction has resulted in increased business uncertainty. The consequences of a prolonged economic decline could include, but are not limited to, reduced revenues, increased instances of uncollectible customer receivables, and increased asset impairments in future periods. Accordingly, the Company cannot reasonably estimate the length or severity of this pandemic, or the extent to which the disruption may materially impact its consolidated balance sheets, consolidated statements of operations and comprehensive loss or statements of cash flows for future periods.</span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i2faca0f267be493184503a925cf2a40a" continuedAt="i6a21aa6c46494d169e28341c538f6773"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:continuation id="i9ec98792a5364d40aabaf745d4892aca" continuedAt="i81a0be728e9940c28ec626dcd60ea75d">Going Concern</ix:continuation></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i81a0be728e9940c28ec626dcd60ea75d">The accompanying consolidated financial statements of the Company have been prepared assuming the Company will continue as a going concern and in accordance with US GAAP. The going concern basis of presentation assumes that the Company will continue in operation one year after the date these financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business.</ix:continuation> The Company had cash and cash equivalents of $<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEzODU0_eeef63a0-d6f1-4f00-a84e-80ba462c1ca7">128,318</ix:nonFraction> and an accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEzODg4_1c4e878d-dcbe-4a40-9f8d-dfe130f8b8bf">379,889</ix:nonFraction> at December&#160;31, 2021 and cash outflows from operations of $<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEzOTM0_4d2c388e-3d4d-41a4-aceb-587dcdff03a2">42,591</ix:nonFraction> and a net loss of $<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEzOTU1_f6496454-eb77-4fa9-b2c1-9006c9ee67f6">46,689</ix:nonFraction> for the year ended December&#160;31, 2021. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has historically funded its operations through debt financing and issuance of equity securities. Based on the Company&#8217;s financial position as of the date these consolidated financial statements were issued, the Company projects that it will be able to cover its liquidity needs for the next twelve months with cash on hand. Accordingly, the Company&#8217;s consolidated financial statements have been prepared on the basis that it will continue as a going concern.</span></div><ix:continuation id="i1b90b58153154b5695a111deb3fb35e1"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates include fair value of equity awards granted to both employees and non-employees.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in facts and circumstances or additional information may result in revised estimates, and actual results may differ from these estimates.</span></div></ix:continuation><ix:continuation id="i77a09598a51c423180f1bbf63da96c67"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currencies</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reporting currency is the U.S. Dollar. The Company has certain foreign subsidiaries where the functional currency is the local currency. All of the assets and liabilities of these subsidiaries are converted to U.S. dollars at the exchange rate in effect at the balance sheet date, income and expense accounts are translated at average rates for the period, and shareholder&#8217;s equity accounts are translated at historical rates. The effects of translating financial statements of foreign operations into our reporting currency are recognized as an adjustment in accumulated other comprehensive income (loss).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has foreign subsidiaries that have a functional currency of the U.S. dollar. Purchases and sales of assets and income and expense items denominated in foreign currencies are remeasured into U.S. dollar amounts on the respective dates of such transactions. Net realized foreign currency gains or losses relating to the differences between these recorded amounts and the U.S. dollar equivalent actually received or paid are included within Other income, net in the consolidated statements of operations and comprehensive loss.</span></div></ix:continuation><ix:continuation id="i2db626d1882f40dd84be53b5847b813d" continuedAt="i01b453fb601a4a41a6d551b6cc0d1668"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. As of December&#160;31, 2021 and 2020, the Company had $<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE2NDk1_eeef63a0-d6f1-4f00-a84e-80ba462c1ca7">128,318</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE2NTAy_5e0796c0-5938-41d5-8adf-dfde7a897c23">60,495</ix:nonFraction> of cash and cash equivalents, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to maintain a cash deposit with a bank which consists of collateral on a travel and expense program maintained by the bank. <ix:continuation id="i79861692e30244c5b89cea291c63d8bd" continuedAt="iee01df3cea60409782ff55d693b6c608">The following represents a reconciliation of cash and cash equivalents in </ix:continuation></span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i6a21aa6c46494d169e28341c538f6773" continuedAt="ia6c0318e50ac4efe83e238abc098a2a6"><ix:continuation id="i01b453fb601a4a41a6d551b6cc0d1668"><ix:continuation id="iee01df3cea60409782ff55d693b6c608"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the consolidated balance sheets to total cash, cash equivalents and restricted cash in the consolidated statement of cash flows as of December 31, 2021 and December 31, 2020.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTozNjc1MDRkZDlkNjY0ZDUwYTRiMzgyNzYxM2E5OGFmYS90YWJsZXJhbmdlOjM2NzUwNGRkOWQ2NjRkNTBhNGIzODI3NjEzYTk4YWZhXzItMS0xLTEtOTA2MTg_8cdb2635-fa3d-44ff-96e5-a509d0349ebf">128,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTozNjc1MDRkZDlkNjY0ZDUwYTRiMzgyNzYxM2E5OGFmYS90YWJsZXJhbmdlOjM2NzUwNGRkOWQ2NjRkNTBhNGIzODI3NjEzYTk4YWZhXzItMy0xLTEtOTA2MTg_2360910d-a822-446d-b91f-e85001a3a322">60,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (presented within Other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:RestrictedCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTozNjc1MDRkZDlkNjY0ZDUwYTRiMzgyNzYxM2E5OGFmYS90YWJsZXJhbmdlOjM2NzUwNGRkOWQ2NjRkNTBhNGIzODI3NjEzYTk4YWZhXzMtMS0xLTEtOTA2MTg_2f4026da-dd91-431d-837a-60466b2286e0">414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:RestrictedCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTozNjc1MDRkZDlkNjY0ZDUwYTRiMzgyNzYxM2E5OGFmYS90YWJsZXJhbmdlOjM2NzUwNGRkOWQ2NjRkNTBhNGIzODI3NjEzYTk4YWZhXzMtMy0xLTEtOTA2MTg_a795be53-afcc-4728-b9d7-0fa5d5053830">414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTozNjc1MDRkZDlkNjY0ZDUwYTRiMzgyNzYxM2E5OGFmYS90YWJsZXJhbmdlOjM2NzUwNGRkOWQ2NjRkNTBhNGIzODI3NjEzYTk4YWZhXzQtMS0xLTEtOTA2MTg_42c54b7f-fb05-4b7f-896e-67b938eb7212">128,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTozNjc1MDRkZDlkNjY0ZDUwYTRiMzgyNzYxM2E5OGFmYS90YWJsZXJhbmdlOjM2NzUwNGRkOWQ2NjRkNTBhNGIzODI3NjEzYTk4YWZhXzQtMy0xLTEtOTA2MTg_2db59a05-985d-43c9-9d4a-2825e92c590a">60,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:continuation id="ic7572311be3e498cbe8c782ef360f2c1" continuedAt="i4fcfabd5efb344629cc4a669e44cd72d">Trade and Other Receivables </ix:continuation></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4fcfabd5efb344629cc4a669e44cd72d">Receivables are reported net of allowances for doubtful accounts. The Company maintains allowances for doubtful accounts for estimated losses resulting from the inability of customers to make required payments. The Company estimates the allowance for doubtful accounts based on a variety of factors including the length of time receivables are past due, the financial health of customers, unusual macroeconomic conditions, and historical experience.</ix:continuation> As of December&#160;31, 2021 and 2020, the Company recognized an allowance for doubtful accounts of $<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE3NTA4_6bbfec4d-1f4c-4c09-8055-06c1e77bb0f9">1,235</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE3NTE1_2d7d0958-4ad3-4e55-b72d-7177f67c5b08">1,325</ix:nonFraction>, respectively.</span></div><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="amci:OtherCurrentAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NjM4_4ab97cc7-cd0c-4397-a5e2-ee73a78e13c0" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Current Assets</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current assets consist of prepaid expenses, materials and supplies, and other assets. Material and supplies consist of spare parts and consumables used for research and research equipment and is stated at the weighted average cost.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NjM5_6f2079d6-9a8d-44d8-aad9-694ccfa5aa1a" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment, net</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost and include improvements that significantly increase capacities or extend the useful lives of existing plant and equipment.&#160;Depreciation is calculated using the straight-line method over the estimated useful life of the assets. Useful lives range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTA0_78de1c22-d3ad-43ae-a899-19a74e1b2357">three</span> to <ix:nonNumeric contextRef="i8253259ad4874f5a9b674506631abe14_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTE2_fa398fb4-70f5-4423-861b-236c205b81bc">five years</ix:nonNumeric> for instruments and equipment, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk3OTk5_761df305-309f-4903-a23c-ce62ac3f485c">three</span> to <ix:nonNumeric contextRef="id306802fd9ee409aab98820719190d6a_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk4MDE4_9ba8b725-f7c6-4087-a62d-6aeb6efa7c6b">five years</ix:nonNumeric> for office equipment and furniture and software, <ix:nonNumeric contextRef="idf64231b10064ce9b86e185225060418_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk4MDM3_6d54f517-5c70-46b6-8b15-00ef745a181b">five years</ix:nonNumeric> for vehicles and, for leasehold improvements, the shorter of the life of the improvement or the remaining term of the lease. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews the remaining useful life of its assets on a regular basis to determine whether changes have taken place that would suggest that a change to depreciation policies is warranted.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon retirement or disposal of property, plant and equipment, the cost and related accumulated depreciation are removed from the account, and the resulting gains or losses, if any, are recorded in the consolidated statements of operations and comprehensive loss. Net gains or losses related to asset dispositions are recognized in earnings in the period in which dispositions occur. Routine maintenance, repairs and replacements are expensed as incurred.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:LessorLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NjQw_dc731ab2-5d38-4e34-b245-c448d5582746" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines&#160;if an arrangement is a lease at inception.&#160;Lease agreements are evaluated to classify the lease as a finance or operating&#160;lease.&#160;Operating lease assets and liabilities are recognized at the commencement date of the lease based on the present value of lease payments over the lease term. Lease assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. As most&#160;leases&#160;do not provide an implicit interest rate,&#160;the Company&#160;uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. Leases with an initial term of 12 months or less are not recorded on the Company&#8217;s consolidated balance sheets. The Company recognizes lease expense for these leases on a straight-line basis over the lease term.&#160;The Company accounts for lease components and non-lease components as a single lease component.</span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="ia6c0318e50ac4efe83e238abc098a2a6" continuedAt="i8fd37c33a26e4cce8faa7a1d3b9db708"><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk3OTY5_2091368a-00e5-4aaf-bde8-8496595d061c" continuedAt="ib698dea69dfe49c8864b07846868466a" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs a recoverability assessment of each of its long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indicators may include, but are not limited to, adverse changes in the regulatory environment in a jurisdiction where the Company operates, a decision to discontinue the development of a long-lived asset, early termination of a significant customer contract, or the introduction of newer technology.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When performing a recoverability assessment, the Company measures whether the estimated future undiscounted net cash flows expected to be generated by the asset exceeds its carrying value. In the event that an asset does not meet the recoverability test, the carrying value of the asset will be adjusted to fair value resulting in an impairment charge.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib698dea69dfe49c8864b07846868466a">Management develops the assumptions used in the recoverability assessment based on active contracts as well as information received from third-party industry sources.</ix:continuation> The Company did not record an impairment during the years ended December&#160;31, 2021 and 2020. </span></div><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk3OTcw_356b952a-07de-4e4c-8bc5-370e74b4a398" continuedAt="ibc6728a651d94a5d9a4f09b9028818ef" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Method Investments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in entities over which the Company has significant influence, but not control, are accounted for using the&#160;equity method&#160;of accounting. Gain from&#160;equity method&#160;investees, net represents the Company&#8217;s proportionate share of net income or loss of its equity method investees and any gains or losses from the dilution of such investments.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibc6728a651d94a5d9a4f09b9028818ef">Equity method&#160;investments are assessed for impairment whenever changes in the facts and circumstances indicate a loss in value may have occurred. When a loss is deemed to have occurred and is other than temporary, the carrying value of the&#160;equity method&#160;investment is written down to fair value. In evaluating whether a loss is other than temporary, the Company considers the length of time for which the conditions have existed and its intent and ability to hold the investment.</ix:continuation> </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:continuation id="i2dc6fe64c1684e768f6e1a73a4ab0fc7" continuedAt="i52fdca89ecb14cd496c587f6d0da27e1">Simple Agreement for Future Equity (SAFE)</ix:continuation></span></div><div style="margin-bottom:9pt;text-indent:18pt"><ix:continuation id="i52fdca89ecb14cd496c587f6d0da27e1"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company issued a SAFE that allowed an investor to participate in future equity financings through a share-settled redemption of the amount invested (such notional being the &#8220;invested amount&#8221;). The Company determined that the SAFE was not legal form debt (i.e., no creditors&#8217; rights). The SAFE includes a provision allowing for cash redemption upon the occurrence of a change of control, the occurrence of which is outside the control of the Company. Therefore, the SAFE is classified as mark-to-market liability pursuant to Accounting Standards Codification (&#8220;ASC&#8221;) 480, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distinguishing Liability from Equity</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="amci:WarrantsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk3OTcy_c44c5ba1-063e-4eab-8244-219a00a6e305" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has warrants to purchase preferred shares outstanding as of December&#160;31, 2021 and 2020 representing <ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzIyODI4_e892d144-1090-4936-90cb-2e609259e814">225,223</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzIyODM1_996db12c-946a-470c-9339-9674b9498ed0">383,281</ix:nonFraction> preferred shares, respectively, which warrants expire at various dates through December 31, 2027. The exercise prices of the warrants range from $<ix:nonFraction unitRef="usdPerShare" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzIyOTgz_22b99194-1a30-4761-9c73-95c7dd880ed7">14.69</ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzIyOTg5_d3590132-9eef-4a60-8120-93e449de3a52">19.93</ix:nonFraction> as of each of December&#160;31, 2021 and 2020. The Company accounts for its warrants as liabilities based upon the characteristics and provisions of each instrument. The liabilities are included in other accrued liabilities on the Company's consolidated balance sheets at their fair value on the date of issuance and are revalued in each subsequent reporting period until such instruments are exercised or expire. The change in fair value between reporting periods is included in other (expense) income, net in the consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further the warrant related to the SAFE of $<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzIzNTkw_32370669-7205-47f9-8b4e-4b01571f5d24">1,729</ix:nonFraction> is accounted for as a liability. This liability is recorded in current liabilities on the Company's consolidated balance sheets at fair value on the date of issuance and will be revalued each subsequent reporting period until such instrument is exercised or expire. The change in fair value between reporting periods is included in other (expense) income, net in the consolidated statements of operations and comprehensive loss.</span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i8fd37c33a26e4cce8faa7a1d3b9db708" continuedAt="ifd24132be64440eca7be3588d4f64914"><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:DebtPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk3OTcz_bfa7408a-94ce-431f-a6f3-1c9ab25e51e8" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Term Debt and Debt Issuance Costs</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s debt consists of credit facilities with financial institutions. Costs directly related to the issuance of debt are reported on the consolidated balance sheets as a reduction from the carrying amount of the recognized debt liability and amortized over the term of the debt using the effective interest method.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk3OTc0_941ef884-56e5-4738-9427-77b0998f94ec" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal and Contingencies</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may be involved in legal actions in the ordinary course of business, inquiries and proceedings concerning employment, labor, environmental, and other claims. The Company will recognize a loss contingency in the consolidated financial statements when it is probable a liability has been incurred and the amount of the loss can be reasonably estimated. The Company will disclose any loss contingencies that do not meet both conditions if there is a reasonable possibility that a loss may have been incurred. Gain contingencies are not recorded until realized.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk3OTc1_99425717-4d08-44fa-9d84-d44bfa319e93" continuedAt="if8dc654d0bb345668389d24965768ddd" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company primarily earns revenue from services related to feasibility studies and basic engineering design of commercial plants, licensing of technologies, joint development and contract research activities to develop novel biocatalysts and related technologies.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is measured based on the consideration specified in a contract with a customer. The Company records taxes collected from customers and remitted to governmental authorities on a net basis. The Company&#8217;s payment terms are between 30-60 days and can vary by customer type and products offered. We have evaluated the terms of our arrangements and determined that they do not contain significant financing components.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Carbon Capture and Transformation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides feasibility studies and basic design and engineering services used for detailed design, procurement, and construction of commercial plants that utilize the Company&#8217;s technologies, along with the sale of equipment and microbes. The services provided are recognized as a performance obligation satisfied over time. Revenue is recognized using the output method based on milestone completion, the cost-to-cost input method for certain engineering services, or the percentage of completion method when certain revenue recognition requirements are met. Management has determined that the milestone completion and the associated contractual payment amounts are an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company licenses intellectual property to generate recurring revenue when its customers deploy carbon capture and transformation plants. When licenses are considered to be distinct performance obligations, the recognition of revenue is dependent on the terms of the contract, which may include fixed consideration or royalties based on sales or usage, in which case, the revenue is recognized when the subsequent sale or usage occurs or when the performance obligation to which some or all of the sales or usage-based royalty is allocated has been satisfied, whichever is later.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Services</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs research and development (&#8220;R&amp;D&#8221;) services related to novel technologies and development of biocatalysts for commercial applications, mainly to produce fuels and chemicals. The Company engages in two main types of R&amp;D services &#8211; joint development agreements, and other contract research, including projects with the U.S. Department of Energy. Such services are recognized as a performance obligation satisfied over time. Revenue is recognized based on milestone completion, when such milestones are contractually defined, or based on stage of contract completion when not defined. For the latter, management has determined that the cost incurred, input method, is an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and estimates its variable consideration under the expected value method. Accordingly, the Company records a liability based on milestones achieved and the expected repayment of the development costs. </span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="ifd24132be64440eca7be3588d4f64914" continuedAt="i5bbce15a57374d55a9dd06a390e59e64"><ix:continuation id="if8dc654d0bb345668389d24965768ddd"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s joint development agreements may utilize the cost-to-cost method of revenue recognition or may include well defined payment milestones, dependent on the contract, both of which the Company evaluates against work completed prior to revenue recognition. For other contract research, the Company utilizes the cost-to-cost method of revenue recognition. These contracts have a fixed dollar amount which is based on the Company&#8217;s estimate of total costs to be incurred over the life of each contract. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is not recognized in advance of customer acceptance of a milestone, when such acceptance is contractually required. Payments for R&amp;D services with no contractual payments are not due from customers until a technical report is submitted; therefore, a contract asset is recognized at milestone completion but prior to the submission of a technical report. The contract asset represents the Company&#8217;s right to consideration for the services performed at milestone completion. Occasionally, customers provide payments in advance of the Company providing services which creates a contract liability for the Company. The contract liability represents the Company's obligation to provide services to a customer. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collaboration Arrangements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain partnership agreements that are within the scope of ASC 808, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides guidance on the presentation and disclosure of collaborative arrangements. Generally, the classification of the transactions under the collaborative arrangements is determined based on the nature of the contractual terms of the arrangement, along with the nature of the operations of the participants. The Company&#8217;s collaborative agreements generally include a provision of R&amp;D services related to novel technologies and biocatalysts. Amounts received for these services are classified as Revenue from collaborative arrangements in the consolidated statements of operations and comprehensive loss. The Company's R&amp;D services are a major part of the Company's ongoing operations and therefore ASC 606 is applied to recognize revenue.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenues</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s R&amp;D, engineering, and other direct costs of services related to revenue agreements with customers, related parties, and collaborative partners represent cost of revenue. Costs include both internal and third-party fixed and variable costs and include materials, supplies, labor, and fringe benefits.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incur research and development costs associated with various R&amp;D activities and expense these costs as incurred.</span></div></ix:continuation><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk3OTc2_65ca9fe6-40e5-4a01-a950-c437ccd46b73" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for equity-based compensation in accordance with ASC 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation &#8211; Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Accordingly, in exchange for employee and director services, compensation is given in the form of equity awards. The equity awards are recorded based on the grant date fair value and expensed over the requisite service period for the respective award.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s equity-based awards include stock option awards and restricted stock issued by the Company, which vest based on either time or the achievement of certain performance conditions. The Company records forfeitures as they occur. Compensation expense resulting from time-vesting-based awards is recognized in the Company&#8217;s consolidated statements of operations and comprehensive loss, primarily within research and development expenses, at the grant date fair value over the requisite service period. Compensation expense resulting from performance awards recognized over the requisite service period when it is probable that the performance condition will be met. The calculated compensation expense for performance awards is adjusted based on an estimate of awards ultimately expected to vest. The Company estimates grant date fair value using a Black-Scholes option pricing model that uses assumptions including expected volatility, expected term, and the expected risk-free rate of return. The Company has determined that the Black-Scholes option pricing model, as well as the underlying assumptions used in its application, is appropriate in estimating the fair value of its award grants.</span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i5bbce15a57374d55a9dd06a390e59e64" continuedAt="i5a427d74621546f089f526b5a866f2e4"><ix:continuation id="i340fee7a2b184bada29aa1cba8c4aa8c"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows the asset and liability method of accounting for income taxes under ASC 740, Income Taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income tax assets are evaluated to determine if valuation allowances are required or should be adjusted. Valuation allowances are established based on a more likely than not standard. The ability to realize deferred tax assets depends on the Company&#8217;s ability to generate sufficient taxable income within the carryback or carryforward periods provided for in the tax law for each tax jurisdiction. The Company considers the various possible sources of taxable income when assessing the realization of its deferred tax assets. The valuation allowances recorded against deferred tax assets generated by taxable losses in certain jurisdictions will affect the provision for income taxes until the valuation allowances are released. The Company&#8217;s provision for income taxes will include no tax benefit for losses incurred and no tax expense with respect to income generated in these jurisdictions until the respective valuation allowance is eliminated.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records uncertain tax positions on the basis of a two-step process whereby it is determined whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position, and for those tax positions that meet the more likely than not criteria, the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority is recognized. The Company recognizes accrued interest and penalties related to unrecognized tax benefits in income tax expense.</span></div></ix:continuation><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="amci:RelatedPartyTransactionsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk3OTc4_9e149c09-f857-45f9-9d94-8c9f4e079327" continuedAt="i1906e1d984cb47fca806954c9dfdd1fd" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Transactions</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows ASC 850-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for the identification of related parties and disclosure of related party transactions.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1906e1d984cb47fca806954c9dfdd1fd">Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.</ix:continuation> Refer to Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Note 14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further information.</span></div><ix:continuation id="i9e9ce477821b47c5af03edda1fe184f5" continuedAt="i785f60608e6048d7a65eb175e191c5fb"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss Per Share</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is computed by dividing net loss attributable to participating stock by the weighted average number of shares of participating stock outstanding during the period. </span></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i785f60608e6048d7a65eb175e191c5fb">Diluted net loss per share reflects potential dilution and is computed by dividing net loss attributable to participating stock by the weighted average number of shares of participating stock outstanding during the period. The dilutive effect of outstanding awards, if any, is reflected in diluted earnings per share by application of the treasury stock method or if-converted method, as applicable.</ix:continuation> Refer to Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Loss Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i5a427d74621546f089f526b5a866f2e4" continuedAt="i359309bf9e2f408197478e7c470ef5dd"><ix:continuation id="ic134ef192e0d4485a314607ad44035c0"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-term nature, except for the warrant liability. Refer to Note 11, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrant Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for more information.</span></div></ix:continuation><ix:continuation id="i11242f18cce5452f88a1ba2f3b3e4c03" continuedAt="id709cb74ea8b4b2787ad3af5afe1d9f6"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties (Restated)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue generated from the Company&#8217;s customers outside of the United States for the years ended December&#160;31, 2021 and 2020 was approximately <ix:nonFraction unitRef="number" contextRef="i831d5d72289e4ecebda264860e6ddb01_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzM4ODI2_6367ec26-769b-49c9-9ae6-d02ec5367a3e">38</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ib84e916b214e40bb9503c00b519d9b19_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzM4ODMz_5ca75fc2-edca-4d59-abb6-2bfb537a7921">14</ix:nonFraction>%, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, approximately <ix:nonFraction unitRef="number" contextRef="ie2e8db82a9c84e61945251a17b875f00_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzM4ODgy_3626e304-1c04-4321-a4d5-721feb0789a9">35</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i2ad0ccd0af184ac4a13f4b4276bb623e_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzM4ODg5_a441b973-e9d2-4a36-bf54-d363623bb4c3">27</ix:nonFraction>%, respectively, of trade accounts receivable and unbilled accounts receivable was due from customers located outside the United States. At December&#160;31, 2021 and 2020, the value of property, plant, and equipment outside the United States was immaterial.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue by geographic region based on the customer&#8217;s location is presented in Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customers</span></div><ix:continuation id="i652f6205f2ab42d1a83cf7e4321865af"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers representing 10% or greater of revenue were as follows for the years ended December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3806badc445d44dd82e2c5a6b9e25bfb_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpiODAwN2ZjMTBkYjM0ZTU3OTRmOTU0NWFjNzQ0ZmVkZS90YWJsZXJhbmdlOmI4MDA3ZmMxMGRiMzRlNTc5NGY5NTQ1YWM3NDRmZWRlXzMtMS0xLTEtOTA2MTg_4e6808ab-7c3a-45c3-a94e-59186c7d5399">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia7c702b96a6f4df9b250877d0384b508_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpiODAwN2ZjMTBkYjM0ZTU3OTRmOTU0NWFjNzQ0ZmVkZS90YWJsZXJhbmdlOmI4MDA3ZmMxMGRiMzRlNTc5NGY5NTQ1YWM3NDRmZWRlXzMtMy0xLTEtOTA2MTg_eb0390f1-19ca-41fe-9489-1ec642e35c52">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2179adde8d304d8280bfbc5ee18bc488_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpiODAwN2ZjMTBkYjM0ZTU3OTRmOTU0NWFjNzQ0ZmVkZS90YWJsZXJhbmdlOmI4MDA3ZmMxMGRiMzRlNTc5NGY5NTQ1YWM3NDRmZWRlXzQtMS0xLTEtOTA2MTg_a5d8e431-8ecc-4346-90a8-6a551120e316">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3bcb50c289e34d1482c2e928125d7fde_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpiODAwN2ZjMTBkYjM0ZTU3OTRmOTU0NWFjNzQ0ZmVkZS90YWJsZXJhbmdlOmI4MDA3ZmMxMGRiMzRlNTc5NGY5NTQ1YWM3NDRmZWRlXzQtMy0xLTEtOTA2MTg_64254793-df10-4d24-9023-12722cb445f8">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9f54a9cc2417463291611fdfdeedb0d2_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpiODAwN2ZjMTBkYjM0ZTU3OTRmOTU0NWFjNzQ0ZmVkZS90YWJsZXJhbmdlOmI4MDA3ZmMxMGRiMzRlNTc5NGY5NTQ1YWM3NDRmZWRlXzUtMS0xLTEtOTA2MTg_78a3e8f6-d157-4ba8-b80a-9087bb2a61fa">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i743ecbc9e30043a599d588f612598339_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpiODAwN2ZjMTBkYjM0ZTU3OTRmOTU0NWFjNzQ0ZmVkZS90YWJsZXJhbmdlOmI4MDA3ZmMxMGRiMzRlNTc5NGY5NTQ1YWM3NDRmZWRlXzUtMy0xLTEtOTA2MTg_8c008db4-d0d7-4276-a03c-307e1215fefb">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id709cb74ea8b4b2787ad3af5afe1d9f6">As of December&#160;31, 2021, two of the Company's customers separately represented <ix:nonFraction unitRef="number" contextRef="i56b52dbeac4d4479bfb65e79f892fff0_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NDY2_9c737571-adcc-49a2-a357-9c60a9ff4887">49</ix:nonFraction>% (Customer B) and <ix:nonFraction unitRef="number" contextRef="idb494d52ad624b01abe6e93490255650_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NDcx_905dde0a-a6c8-4e84-8a18-23bc381968a9">15</ix:nonFraction>% (Customer D) of total accounts receivable and contract assets on the consolidated balance sheet.</ix:continuation> </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i359309bf9e2f408197478e7c470ef5dd"><ix:continuation id="i2d3760be1d784b8490cdffc94b92f2e8"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses (Topic 326): Disclosure Framework &#8211; Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2016-13&#8221;), which requires financial assets measured at amortized cost basis, including trade receivables, to be presented net of the amount expected to be collected. The measurement of all expected credit losses will be based on historical experience, current conditions, and reasonable and supportable forecasts. The Company adopted the new standard effective January 1, 2020, using a modified retrospective transition method, which requires a cumulative-effect adjustment, if any, to the opening balance of retained earnings to be recognized on the date of adoption with prior periods not restated. The adoption did not have a material impact on the Company&#8217;s financial position or results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles &#8211; Goodwill and Other &#8211; Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2018-15&#8221;), which requires a customer in a cloud computing arrangement that is a service contract to follow the internal-use software guidance in ASC 350-40 to determine which implementation costs to capitalize as assets. A customer&#8217;s accounting for the costs of the hosting component of the arrangement is not affected by the new guidance. The Company adopted ASU 2018-15 as of January 1, 2020 with no material impact on its consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2018, the FASB issued ASU 2018-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Stock Compensation Improvements to Non-employee Share-Based Payment Accounting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2018-07&#8221;), which simplifies the accounting for stock-based payments granted to non-employees for goods and services. Under ASU 2018-07, most of the guidance on such payments to non-employees will be aligned with the requirements for stock-based payments granted to employees. The Company early adopted ASU 2018-07 as of January 1, 2020 and its adoption did not have a material impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2019-12&#8221;), as part of its simplification initiative to reduce the cost and complexity in accounting for income taxes. ASU 2019-12 removes certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. ASU 2019-12 also amends other aspects of the guidance to help simplify and promote consistent application of US GAAP. The Company adopted ASU 2019-12 as of January 1, 2021 with no material impact on its consolidated financial statements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Announced Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2020-10&#8221;). The standard contains improvements to the FASB Accounting Standards Codification (the &#8220;Codification&#8221;) by ensuring that all guidance that requires or provides an option for an entity to provide information in the notes to financial statements is codified in the disclosure section of the Codification. The standard also improves various topics in the Codification so that entities can apply guidance more consistently on codifications that are varied in nature where the original guidance may have been unclear. The amendments in ASU 2020-10 are effective for the Company for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption is permitted. The Company does not expect the adoption of ASU 2020-10 to have a material impact on its consolidated financial statements and related disclosures.</span></div></ix:continuation></ix:continuation><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib82e114cd19f45afae73e7a64e42f208_422"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3 &#8212; <ix:continuation id="i6a24746baef8458985b1bcbf028ee8f4" continuedAt="i1cc7336c419d43efae5099f71b0bc47e">Net Loss Per Share</ix:continuation></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1cc7336c419d43efae5099f71b0bc47e" continuedAt="i4330022771c54f7a9c5e412b3fea927b">Basic net loss per share is computed by dividing net loss by the weighted-average number of shares of common stock of the Company outstanding during the period. Diluted net loss per share is computed by giving effect to all potential shares of common stock of the Company, including outstanding stock options, warrants, and contingently redeemable preferred stock, to the extent dilutive.</ix:continuation></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i4330022771c54f7a9c5e412b3fea927b"><ix:continuation id="i832bfb2710404c6280e30a31db035fac"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of basic and diluted net loss per share for the Company&#8217;s common stock (in thousands, except shares and per share amounts):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss for basic and diluted earnings per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZToyMmQzM2Q4MWExYjY0MjFhOGUwMjdlNDQyYjE0NGRjZS90YWJsZXJhbmdlOjIyZDMzZDgxYTFiNjQyMWE4ZTAyN2U0NDJiMTQ0ZGNlXzQtMS0xLTEtOTA2MTg_fed67763-e872-4be3-8299-0ebe0a8c4b77">46,689</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZToyMmQzM2Q4MWExYjY0MjFhOGUwMjdlNDQyYjE0NGRjZS90YWJsZXJhbmdlOjIyZDMzZDgxYTFiNjQyMWE4ZTAyN2U0NDJiMTQ0ZGNlXzQtMy0xLTEtOTA2MTg_1be9c2f4-1833-49eb-b570-82e4fc6a9e2a">37,713</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid cumulative dividends on preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:PreferredStockDividendsIncomeStatementImpact" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZToyMmQzM2Q4MWExYjY0MjFhOGUwMjdlNDQyYjE0NGRjZS90YWJsZXJhbmdlOjIyZDMzZDgxYTFiNjQyMWE4ZTAyN2U0NDJiMTQ0ZGNlXzUtMS0xLTEtOTA2MTg_5ac9ceb4-c10c-4f8d-af99-e8d6fa3cb010">36,758</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:PreferredStockDividendsIncomeStatementImpact" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZToyMmQzM2Q4MWExYjY0MjFhOGUwMjdlNDQyYjE0NGRjZS90YWJsZXJhbmdlOjIyZDMzZDgxYTFiNjQyMWE4ZTAyN2U0NDJiMTQ0ZGNlXzUtMy0xLTEtOTA2MTg_1e9c22c4-4a9f-4324-8dba-acfbd0601235">31,291</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss allocated to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZToyMmQzM2Q4MWExYjY0MjFhOGUwMjdlNDQyYjE0NGRjZS90YWJsZXJhbmdlOjIyZDMzZDgxYTFiNjQyMWE4ZTAyN2U0NDJiMTQ0ZGNlXzYtMS0xLTEtMTA1MzY5_a0b9b7f1-8a28-424b-974f-65e635a4f2f0">83,447</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZToyMmQzM2Q4MWExYjY0MjFhOGUwMjdlNDQyYjE0NGRjZS90YWJsZXJhbmdlOjIyZDMzZDgxYTFiNjQyMWE4ZTAyN2U0NDJiMTQ0ZGNlXzYtMy0xLTEtMTA1MzU4_4cc1215b-683e-4c1a-a1f3-77ba959054e8">69,004</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares used in calculating net loss per share, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZToyMmQzM2Q4MWExYjY0MjFhOGUwMjdlNDQyYjE0NGRjZS90YWJsZXJhbmdlOjIyZDMzZDgxYTFiNjQyMWE4ZTAyN2U0NDJiMTQ0ZGNlXzktMS0xLTEtOTA2MTg_85dda7ab-7ed4-48dc-b99e-049e6bde6fdd"><ix:nonFraction unitRef="shares" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZToyMmQzM2Q4MWExYjY0MjFhOGUwMjdlNDQyYjE0NGRjZS90YWJsZXJhbmdlOjIyZDMzZDgxYTFiNjQyMWE4ZTAyN2U0NDJiMTQ0ZGNlXzktMS0xLTEtOTA2MTg_ae625271-4af5-4ec3-a1ed-de34de7e8306">1,959,165</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZToyMmQzM2Q4MWExYjY0MjFhOGUwMjdlNDQyYjE0NGRjZS90YWJsZXJhbmdlOjIyZDMzZDgxYTFiNjQyMWE4ZTAyN2U0NDJiMTQ0ZGNlXzktMy0xLTEtOTA2MTg_02894df7-c492-433d-a7fe-e5e2c6d65bd2"><ix:nonFraction unitRef="shares" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZToyMmQzM2Q4MWExYjY0MjFhOGUwMjdlNDQyYjE0NGRjZS90YWJsZXJhbmdlOjIyZDMzZDgxYTFiNjQyMWE4ZTAyN2U0NDJiMTQ0ZGNlXzktMy0xLTEtOTA2MTg_20851da3-be2d-43f8-a486-89bf69965dcb">1,629,821</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share, basic and diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZToyMmQzM2Q4MWExYjY0MjFhOGUwMjdlNDQyYjE0NGRjZS90YWJsZXJhbmdlOjIyZDMzZDgxYTFiNjQyMWE4ZTAyN2U0NDJiMTQ0ZGNlXzExLTEtMS0xLTkwNjE4_76523769-8874-4261-abff-190b9e9ef324"><ix:nonFraction unitRef="usdPerShare" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZToyMmQzM2Q4MWExYjY0MjFhOGUwMjdlNDQyYjE0NGRjZS90YWJsZXJhbmdlOjIyZDMzZDgxYTFiNjQyMWE4ZTAyN2U0NDJiMTQ0ZGNlXzExLTEtMS0xLTkwNjE4_dc729dff-3327-469f-9afa-84e911774d77">42.59</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZToyMmQzM2Q4MWExYjY0MjFhOGUwMjdlNDQyYjE0NGRjZS90YWJsZXJhbmdlOjIyZDMzZDgxYTFiNjQyMWE4ZTAyN2U0NDJiMTQ0ZGNlXzExLTMtMS0xLTkwNjE4_11cb4b0e-f074-411e-b978-42a16dcd956b"><ix:nonFraction unitRef="usdPerShare" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZToyMmQzM2Q4MWExYjY0MjFhOGUwMjdlNDQyYjE0NGRjZS90YWJsZXJhbmdlOjIyZDMzZDgxYTFiNjQyMWE4ZTAyN2U0NDJiMTQ0ZGNlXzExLTMtMS0xLTkwNjE4_fe59b5c6-6008-4ac8-bacd-40bb74acb889">42.34</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In periods in which the Company reports a net loss, all stock-based compensation awards are excluded from the calculation of diluted weighted average shares outstanding because of their anti-dilutive effect on earnings (loss) per share.</span></div></ix:continuation><ix:continuation id="idc7940672ae9482f9ff7cb656b063e08"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, potential shares of common stock not included in the computation of earnings per share because their effect would be antidilutive include the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable convertible preferred stock (if converted)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icaaa8522aec94f1aa360a0050053d993_D20210101-20211231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZTo4ODAxOTMyNjkzZjg0NWMyYjAyMGRiNjMxZWQ1N2JiMC90YWJsZXJhbmdlOjg4MDE5MzI2OTNmODQ1YzJiMDIwZGI2MzFlZDU3YmIwXzItMS0xLTEtOTA2MTg_fb92a09b-a9a9-4b0b-b4a0-ee608d155393">29,521,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icfee3a338b794d7d95cda90ba4dd2425_D20200101-20201231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZTo4ODAxOTMyNjkzZjg0NWMyYjAyMGRiNjMxZWQ1N2JiMC90YWJsZXJhbmdlOjg4MDE5MzI2OTNmODQ1YzJiMDIwZGI2MzFlZDU3YmIwXzItMy0xLTEtOTA2MTg_51fc46bd-3c2a-4e06-9e9c-db125e2c700e">25,729,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2678f5a65b234d35a12ce212238a1276_D20210101-20211231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZTo4ODAxOTMyNjkzZjg0NWMyYjAyMGRiNjMxZWQ1N2JiMC90YWJsZXJhbmdlOjg4MDE5MzI2OTNmODQ1YzJiMDIwZGI2MzFlZDU3YmIwXzMtMS0xLTEtOTA2MTg_974949bd-a1ef-42e4-9277-c9c07a1dc2ff">3,848,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifac9f30a87864eb3ac5fa0f54dde723a_D20200101-20201231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZTo4ODAxOTMyNjkzZjg0NWMyYjAyMGRiNjMxZWQ1N2JiMC90YWJsZXJhbmdlOjg4MDE5MzI2OTNmODQ1YzJiMDIwZGI2MzFlZDU3YmIwXzMtMy0xLTEtOTA2MTg_6f3a08be-5735-43de-b81c-c77894dc6739">4,283,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSAs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i358ff5b6e3854374ba1d7d0c7d0343e5_D20210101-20211231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZTo4ODAxOTMyNjkzZjg0NWMyYjAyMGRiNjMxZWQ1N2JiMC90YWJsZXJhbmdlOjg4MDE5MzI2OTNmODQ1YzJiMDIwZGI2MzFlZDU3YmIwXzQtMS0xLTEtOTA2MTg_86f26717-169b-4312-9125-0dc0d53df63b">579,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i85c99d1acfdb4854a6eeb001415fd1fc_D20200101-20201231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZTo4ODAxOTMyNjkzZjg0NWMyYjAyMGRiNjMxZWQ1N2JiMC90YWJsZXJhbmdlOjg4MDE5MzI2OTNmODQ1YzJiMDIwZGI2MzFlZDU3YmIwXzQtMy0xLTEtOTA2MTg_caee94d2-c715-497e-ab07-1e622f1126b0">324,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1bcdbff1e49a4f7893b55aef5e3383b0_D20210101-20211231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZTo4ODAxOTMyNjkzZjg0NWMyYjAyMGRiNjMxZWQ1N2JiMC90YWJsZXJhbmdlOjg4MDE5MzI2OTNmODQ1YzJiMDIwZGI2MzFlZDU3YmIwXzUtMS0xLTEtOTA2MTg_28714bf2-a3ab-4f36-9a3d-848457b3eeb7">225,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6d734da8c6d54d6394aafbc36ef97fe0_D20200101-20201231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZTo4ODAxOTMyNjkzZjg0NWMyYjAyMGRiNjMxZWQ1N2JiMC90YWJsZXJhbmdlOjg4MDE5MzI2OTNmODQ1YzJiMDIwZGI2MzFlZDU3YmIwXzUtMy0xLTEtOTA2MTg_274972cc-736b-4aa7-9a88-c704caf8219d">383,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZTo4ODAxOTMyNjkzZjg0NWMyYjAyMGRiNjMxZWQ1N2JiMC90YWJsZXJhbmdlOjg4MDE5MzI2OTNmODQ1YzJiMDIwZGI2MzFlZDU3YmIwXzYtMS0xLTEtMTA1MzYx_f7bac6d4-2308-49e9-90a9-84317f651ad3">34,175,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZTo4ODAxOTMyNjkzZjg0NWMyYjAyMGRiNjMxZWQ1N2JiMC90YWJsZXJhbmdlOjg4MDE5MzI2OTNmODQ1YzJiMDIwZGI2MzFlZDU3YmIwXzYtMy0xLTEtMTA1MzY2_4705f548-f086-4a88-89f8-6b2f19c4cd42">30,720,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the organizational documents of the Company, the preferred shares will automatically convert into common shares upon either (i) the determination of the holders of certain requisite preferred shares of the Company (which determination will be submitted for approval by such stockholders in connection with the Merger described below in Note 20) or (ii) a firmly underwritten initial public offering of the Company&#8217;s shares that satisfies certain requirements (but not, for the avoidance of doubt, upon a business combination with a special purpose acquisition company, such as the Merger, unless such conversion is otherwise effected pursuant to clause (i) above). Such conversion would be at a <ix:nonFraction unitRef="number" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:PreferredStockConvertibleConversionRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90ZXh0cmVnaW9uOjFiYzk2Mjk3ZjBiMTQwNzU5MTJlYWRkYTIyMGI5N2ZjXzEwOTk1MTE2MjgzOTE3_132ec162-8f6e-4799-9b87-b40a677cfefc">1</ix:nonFraction>:1 ratio, adjusted for certain corporate events.Upon conversion of the preferred shares, the cumulative accrued and declared dividends will become payable.  The additional <ix:nonFraction unitRef="shares" contextRef="icaaa8522aec94f1aa360a0050053d993_D20210101-20211231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90ZXh0cmVnaW9uOjFiYzk2Mjk3ZjBiMTQwNzU5MTJlYWRkYTIyMGI5N2ZjXzE3NzI_a5b1c017-4d39-46d2-a294-66f93e8d20cd">29,521,810</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="icfee3a338b794d7d95cda90ba4dd2425_D20200101-20201231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90ZXh0cmVnaW9uOjFiYzk2Mjk3ZjBiMTQwNzU5MTJlYWRkYTIyMGI5N2ZjXzE3Nzk_981c30fc-8e9c-4fab-9064-78b881bfca4f">25,729,542</ix:nonFraction> of potential shares of common stock resulting from any such conversion are not included in the computation of diluted net loss per share in 2021 and 2020, respectively, because neither an initial public offering nor a stockholder determination of such conversion had occurred at the end of the period. In connection with the SAFE, see Note 10 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simple Agreement for Future Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company could issue additional potential shares of common stock upon closing of the Merger. Further, under the SAFE warrant, see Note 6 &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Note 11 &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrants Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, additional potential shares of common stock could be issued upon closing of the Merger and exercise of the warrant. These potential shares of common stock have not been issued as of December 31, 2021. The per share issuance price for the SAFE and SAFE warrant upon closing of the Merger is <ix:nonFraction unitRef="number" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="amci:LiquidityPriceOfSAFEAndSAFEWarrants" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90ZXh0cmVnaW9uOjFiYzk2Mjk3ZjBiMTQwNzU5MTJlYWRkYTIyMGI5N2ZjXzEyNjQ0MzgzNzI1NTYy_9fa7cada-b161-488c-919e-efbc7b0964fb">100</ix:nonFraction>% of the liquidity price. If another qualified liquidity event occurs instead, the issuance price is <ix:nonFraction unitRef="number" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="2" name="amci:LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90ZXh0cmVnaW9uOjFiYzk2Mjk3ZjBiMTQwNzU5MTJlYWRkYTIyMGI5N2ZjXzEyNjQ0MzgzNzI1NTU3_5c806afe-ca49-4de0-a922-c82e6cdd846f">90</ix:nonFraction>% of the liquidity price.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-86</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_428"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4 &#8212; <ix:continuation id="i4751e95fa9b24e258ed569087ba220a5" continuedAt="i366cfe2234f142f4a2f1eaaca203a17e">Revenues</ix:continuation></span></div><ix:continuation id="i366cfe2234f142f4a2f1eaaca203a17e" continuedAt="ieea298b9d41a402ea0fe51994127033c"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregated Revenue</span></div><ix:continuation id="ie27f23b9cd4a4f5fb450a3ee933e108f" continuedAt="ib463dde3a5aa4930bd1c04bc7ace237b"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents disaggregated revenue in the following categories (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 5.5pt;text-align:center;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 5.5pt;text-align:center;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Types:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joint development agreements</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2e7fdecab214154afe7ef716788fbb0_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTo3ZjQ1MzFlYWI3MGQ0MmExODQxMDYzOTBlZmMxNDM1My90YWJsZXJhbmdlOjdmNDUzMWVhYjcwZDQyYTE4NDEwNjM5MGVmYzE0MzUzXzQtMS0xLTEtOTA2MTg_3e51e3ac-3f8a-4201-8fe0-15b2dee54f9c">11,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic848ff8d5c6f468b8ef166100477c3d3_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTo3ZjQ1MzFlYWI3MGQ0MmExODQxMDYzOTBlZmMxNDM1My90YWJsZXJhbmdlOjdmNDUzMWVhYjcwZDQyYTE4NDEwNjM5MGVmYzE0MzUzXzQtMy0xLTEtOTA2MTg_36198028-3fe6-4c2c-99b5-99b5caf5286a">6,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other contract research</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5a5c7a4013b40f996deb5caeadbee89_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTo3ZjQ1MzFlYWI3MGQ0MmExODQxMDYzOTBlZmMxNDM1My90YWJsZXJhbmdlOjdmNDUzMWVhYjcwZDQyYTE4NDEwNjM5MGVmYzE0MzUzXzUtMS0xLTEtOTA2MTg_345174e2-85df-4450-b681-4804e41a2664">2,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25000550374347d98ff4260b0fe8fcc1_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTo3ZjQ1MzFlYWI3MGQ0MmExODQxMDYzOTBlZmMxNDM1My90YWJsZXJhbmdlOjdmNDUzMWVhYjcwZDQyYTE4NDEwNjM5MGVmYzE0MzUzXzUtMy0xLTEtOTA2MTg_471b9ab0-7c33-4625-b54e-ff4c78de1102">1,982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcca0034fe6a4d0990224e5b8a5dd449_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTo3ZjQ1MzFlYWI3MGQ0MmExODQxMDYzOTBlZmMxNDM1My90YWJsZXJhbmdlOjdmNDUzMWVhYjcwZDQyYTE4NDEwNjM5MGVmYzE0MzUzXzYtMS0xLTEtOTA2MTg_aaf49218-95d2-47ea-bdb3-a26fb6517554">13,897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841b3eaf08c64e929bd5d8c3b5550936_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTo3ZjQ1MzFlYWI3MGQ0MmExODQxMDYzOTBlZmMxNDM1My90YWJsZXJhbmdlOjdmNDUzMWVhYjcwZDQyYTE4NDEwNjM5MGVmYzE0MzUzXzYtMy0xLTEtOTA2MTg_1e7ee98f-a9c1-43f8-b43e-cca4d9999ec4">8,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f5e809f9504f9aa1546f38557476d3_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTo3ZjQ1MzFlYWI3MGQ0MmExODQxMDYzOTBlZmMxNDM1My90YWJsZXJhbmdlOjdmNDUzMWVhYjcwZDQyYTE4NDEwNjM5MGVmYzE0MzUzXzgtMS0xLTEtOTA2MTg_b9d765f6-d9c4-4ac5-ac07-08c43ba8bae8">2,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i941766ba89044c74b5ec672aca6c1610_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTo3ZjQ1MzFlYWI3MGQ0MmExODQxMDYzOTBlZmMxNDM1My90YWJsZXJhbmdlOjdmNDUzMWVhYjcwZDQyYTE4NDEwNjM5MGVmYzE0MzUzXzgtMy0xLTEtOTA2MTg_6a1b9b05-1e04-4af5-a271-90c6e888382a">1,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Engineering and other services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i339e323267704b6397de8db0f758c601_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTo3ZjQ1MzFlYWI3MGQ0MmExODQxMDYzOTBlZmMxNDM1My90YWJsZXJhbmdlOjdmNDUzMWVhYjcwZDQyYTE4NDEwNjM5MGVmYzE0MzUzXzktMS0xLTEtOTA2MTg_04509d9a-05bd-4642-99f6-180ace1f8822">9,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d8cebd2641f4bcd972a34fb2e86777c_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTo3ZjQ1MzFlYWI3MGQ0MmExODQxMDYzOTBlZmMxNDM1My90YWJsZXJhbmdlOjdmNDUzMWVhYjcwZDQyYTE4NDEwNjM5MGVmYzE0MzUzXzktMy0xLTEtOTA2MTg_5e3aa1cf-22c7-427f-99da-7c8a6cb401f5">8,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carbon capture and transformation revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i028a5508763345629acfb45969fb4396_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTo3ZjQ1MzFlYWI3MGQ0MmExODQxMDYzOTBlZmMxNDM1My90YWJsZXJhbmdlOjdmNDUzMWVhYjcwZDQyYTE4NDEwNjM5MGVmYzE0MzUzXzEwLTEtMS0xLTkwNjE4_45e1bbac-3471-4e43-b645-d3165bb3607e">11,564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb183fb29c764617802fbb8f9cc6ef0a_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTo3ZjQ1MzFlYWI3MGQ0MmExODQxMDYzOTBlZmMxNDM1My90YWJsZXJhbmdlOjdmNDUzMWVhYjcwZDQyYTE4NDEwNjM5MGVmYzE0MzUzXzEwLTMtMS0xLTkwNjE4_814c14b7-0577-4809-816c-cc61a40a04b8">9,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:33pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTo3ZjQ1MzFlYWI3MGQ0MmExODQxMDYzOTBlZmMxNDM1My90YWJsZXJhbmdlOjdmNDUzMWVhYjcwZDQyYTE4NDEwNjM5MGVmYzE0MzUzXzEyLTEtMS0xLTkwNjE4_83fea5f9-f960-4cbe-ad4a-b832297633f5">25,461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTo3ZjQ1MzFlYWI3MGQ0MmExODQxMDYzOTBlZmMxNDM1My90YWJsZXJhbmdlOjdmNDUzMWVhYjcwZDQyYTE4NDEwNjM5MGVmYzE0MzUzXzEyLTMtMS0xLTkwNjE4_248958b9-5ebc-41f1-9081-395e002af04a">18,353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from collaborative partners is included in the table above within joint development agreements. </span></div><ix:continuation id="ib463dde3a5aa4930bd1c04bc7ace237b"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents disaggregation of the Company&#8217;s revenues by customer location for the years ended December&#160;31, 2021 and 2020 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d133fe090bf40acb6e27f45ba8c513d_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTozZjMyMjQ1Njg1Nzc0YzFjODIzZWVhNzgxZTgxMDA0Mi90YWJsZXJhbmdlOjNmMzIyNDU2ODU3NzRjMWM4MjNlZWE3ODFlODEwMDQyXzMtMS0xLTEtOTA2MTg_32d89fb3-38ac-4a5a-ba4d-5cd229b4fa7d">15,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41997fda0c884eaeb59b9fa43fb3f3b5_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTozZjMyMjQ1Njg1Nzc0YzFjODIzZWVhNzgxZTgxMDA0Mi90YWJsZXJhbmdlOjNmMzIyNDU2ODU3NzRjMWM4MjNlZWE3ODFlODEwMDQyXzMtMy0xLTEtOTA2MTg_62ab5839-1c7d-49e6-814c-f4cda1f0a5aa">15,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84559e50cc784ae4947d2762750bee39_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTozZjMyMjQ1Njg1Nzc0YzFjODIzZWVhNzgxZTgxMDA0Mi90YWJsZXJhbmdlOjNmMzIyNDU2ODU3NzRjMWM4MjNlZWE3ODFlODEwMDQyXzQtMS0xLTEtOTA2MTg_b3333326-ba4a-4283-b809-c737f7938591">7,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b898530c2c4589a32c8d8d907dc09f_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTozZjMyMjQ1Njg1Nzc0YzFjODIzZWVhNzgxZTgxMDA0Mi90YWJsZXJhbmdlOjNmMzIyNDU2ODU3NzRjMWM4MjNlZWE3ODFlODEwMDQyXzQtMy0xLTEtOTA2MTg_18eeed54-31c5-479c-a411-3a0624051553">2,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68d2069e34784ebfbc6b06f1d0168f28_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTozZjMyMjQ1Njg1Nzc0YzFjODIzZWVhNzgxZTgxMDA0Mi90YWJsZXJhbmdlOjNmMzIyNDU2ODU3NzRjMWM4MjNlZWE3ODFlODEwMDQyXzUtMS0xLTEtOTA2MTg_a8958f1a-775f-42c8-9095-bd6e43355561">1,477</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f366cdc85054777b0fbbe8b243bd6b1_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTozZjMyMjQ1Njg1Nzc0YzFjODIzZWVhNzgxZTgxMDA0Mi90YWJsZXJhbmdlOjNmMzIyNDU2ODU3NzRjMWM4MjNlZWE3ODFlODEwMDQyXzUtMy0xLTEtOTA2MTg_74ca16e2-d68d-44c3-a63a-ce578e7def84">504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f54cf1501b448c0a13761e8ce9c4f33_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTozZjMyMjQ1Njg1Nzc0YzFjODIzZWVhNzgxZTgxMDA0Mi90YWJsZXJhbmdlOjNmMzIyNDU2ODU3NzRjMWM4MjNlZWE3ODFlODEwMDQyXzYtMS0xLTEtOTA2MTg_521178f6-adeb-49d9-bb7f-e9363a8d6933">637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i395f2b2b0888423698fc8b4613a0c7a8_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTozZjMyMjQ1Njg1Nzc0YzFjODIzZWVhNzgxZTgxMDA0Mi90YWJsZXJhbmdlOjNmMzIyNDU2ODU3NzRjMWM4MjNlZWE3ODFlODEwMDQyXzYtMy0xLTEtOTA2MTg_323df867-6c8b-4470-8066-b33a6c7d01ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTozZjMyMjQ1Njg1Nzc0YzFjODIzZWVhNzgxZTgxMDA0Mi90YWJsZXJhbmdlOjNmMzIyNDU2ODU3NzRjMWM4MjNlZWE3ODFlODEwMDQyXzctMS0xLTEtOTA2MTg_03dc7b0b-b0ff-4750-a463-4242f795c94f">25,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTozZjMyMjQ1Njg1Nzc0YzFjODIzZWVhNzgxZTgxMDA0Mi90YWJsZXJhbmdlOjNmMzIyNDU2ODU3NzRjMWM4MjNlZWE3ODFlODEwMDQyXzctMy0xLTEtMTAzNTgz_fb9851cd-62be-4bd2-a3d0-167a75d0213d">18,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract balances</span></div><ix:continuation id="i62662af451f54664944fe209802b7be0"><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides changes in contract assets and liabilities during the year ended December 31, 2021.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Contract Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Contract Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-current Contract Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020 as Restated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTpmZTYzZTMyMmVkMzI0YjNkOGM1NjhkYWNmMmRjYjRjYi90YWJsZXJhbmdlOmZlNjNlMzIyZWQzMjRiM2Q4YzU2OGRhY2YyZGNiNGNiXzEtMS0xLTEtOTA2MTg_7f1d2bd8-4f2a-4327-98ef-128abe281cab">6,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTpmZTYzZTMyMmVkMzI0YjNkOGM1NjhkYWNmMmRjYjRjYi90YWJsZXJhbmdlOmZlNjNlMzIyZWQzMjRiM2Q4YzU2OGRhY2YyZGNiNGNiXzEtMy0xLTEtOTA2MTg_a7339fad-3fa2-4d81-9aa3-aa7e2eb164be">5,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTpmZTYzZTMyMmVkMzI0YjNkOGM1NjhkYWNmMmRjYjRjYi90YWJsZXJhbmdlOmZlNjNlMzIyZWQzMjRiM2Q4YzU2OGRhY2YyZGNiNGNiXzEtNS0xLTEtOTA2MTg_318dd8fe-1591-46e1-9499-e2cc1546b3dd">11,291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to unbilled accounts receivable as Restated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="amci:ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTpmZTYzZTMyMmVkMzI0YjNkOGM1NjhkYWNmMmRjYjRjYi90YWJsZXJhbmdlOmZlNjNlMzIyZWQzMjRiM2Q4YzU2OGRhY2YyZGNiNGNiXzItMS0xLTEtOTA2MTg_1cf24101-9e19-4d76-861b-d4ed7084c006">8,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases due to cash received</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="amci:ContractWithCustomerLiabilityCurrentAmountsCollected" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTpmZTYzZTMyMmVkMzI0YjNkOGM1NjhkYWNmMmRjYjRjYi90YWJsZXJhbmdlOmZlNjNlMzIyZWQzMjRiM2Q4YzU2OGRhY2YyZGNiNGNiXzMtMy0xLTEtOTA2MTg_fd4ea8d7-f565-465a-b0a4-0bb27e8311de">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="amci:ContractWithCustomerLiabilityNoncurrentAmountsCollected" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTpmZTYzZTMyMmVkMzI0YjNkOGM1NjhkYWNmMmRjYjRjYi90YWJsZXJhbmdlOmZlNjNlMzIyZWQzMjRiM2Q4YzU2OGRhY2YyZGNiNGNiXzMtNS0xLTEtOTA2MTg_49b001aa-32b9-4f49-9237-26f715268043">5,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled accounts receivable recognized in trade receivables as Restated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="amci:ContractWithCustomerAssetCurrentReclassifiedToReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTpmZTYzZTMyMmVkMzI0YjNkOGM1NjhkYWNmMmRjYjRjYi90YWJsZXJhbmdlOmZlNjNlMzIyZWQzMjRiM2Q4YzU2OGRhY2YyZGNiNGNiXzQtMS0xLTEtOTA2MTg_ff2db7f5-b03b-4b93-8cf1-4f1c7fd28d50">3,002</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification from long-term to short-term</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="amci:ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTpmZTYzZTMyMmVkMzI0YjNkOGM1NjhkYWNmMmRjYjRjYi90YWJsZXJhbmdlOmZlNjNlMzIyZWQzMjRiM2Q4YzU2OGRhY2YyZGNiNGNiXzUtMy0xLTEtOTA2MTg_0065a5d3-f814-4268-8e2b-fd868c2b2df6">3,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="amci:ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTpmZTYzZTMyMmVkMzI0YjNkOGM1NjhkYWNmMmRjYjRjYi90YWJsZXJhbmdlOmZlNjNlMzIyZWQzMjRiM2Q4YzU2OGRhY2YyZGNiNGNiXzUtNS0xLTEtOTA2MTg_ddc8aa96-5c5e-4956-96b9-f27a2486ba89">3,080</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification to revenue as a result of performance obligations satisfied</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="amci:ContractWithCustomerLiabilityCurrentRevenueRecognized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTpmZTYzZTMyMmVkMzI0YjNkOGM1NjhkYWNmMmRjYjRjYi90YWJsZXJhbmdlOmZlNjNlMzIyZWQzMjRiM2Q4YzU2OGRhY2YyZGNiNGNiXzYtMy0xLTEtOTA2MTg_2638c183-55df-4a68-8c56-5503cd1de72e">5,104</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTpmZTYzZTMyMmVkMzI0YjNkOGM1NjhkYWNmMmRjYjRjYi90YWJsZXJhbmdlOmZlNjNlMzIyZWQzMjRiM2Q4YzU2OGRhY2YyZGNiNGNiXzctMS0xLTEtMTAzNTkz_c55fd091-3081-4044-9ade-6023f4175b02">11,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTpmZTYzZTMyMmVkMzI0YjNkOGM1NjhkYWNmMmRjYjRjYi90YWJsZXJhbmdlOmZlNjNlMzIyZWQzMjRiM2Q4YzU2OGRhY2YyZGNiNGNiXzctMy0xLTEtMTAzNTkz_8d6f08e6-1673-4da8-a475-cfa7ee300432">3,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTpmZTYzZTMyMmVkMzI0YjNkOGM1NjhkYWNmMmRjYjRjYi90YWJsZXJhbmdlOmZlNjNlMzIyZWQzMjRiM2Q4YzU2OGRhY2YyZGNiNGNiXzctNS0xLTEtMTAzNTkz_1796bff5-d977-48ee-a7cb-20a3d55e7b96">13,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="ieea298b9d41a402ea0fe51994127033c"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in contract assets was mostly due to unbilled accounts receivables from contracts with customers where the Company performed engineering and other services, while the increase in contract liabilities was primarily due to advance payments received under engineering and other services. As of December&#160;31, 2021 and 2020 the Company had $<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:BilledContractReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90ZXh0cmVnaW9uOjFmMjdlMTc1NzliYjQxNmJhMjdkNjI3MDZhNDQ4ZjJmXzg1Mg_53e4fb71-0d66-4553-821d-1fdde11f7be1">2,878</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:BilledContractReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90ZXh0cmVnaW9uOjFmMjdlMTc1NzliYjQxNmJhMjdkNjI3MDZhNDQ4ZjJmXzg1OQ_abf5daeb-73a0-4b31-9456-2347e6f3210c">5,521</ix:nonFraction>, respectively, of billed accounts receivable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contract liability balance is comprised of unconditional payments received from the Company&#8217;s customers prior to the satisfaction of the related performance obligations. Such amounts are anticipated to be recorded as revenues when services are performed in subsequent periods. The Company expects to recognize the amounts classified as current contract liabilities, in revenue within one year or less and those classified as non-current within two and three years. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Remaining performance obligations</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction price allocated to the remaining performance obligation represents contracted revenue that has not yet been recognized, which includes unearned revenue that will be recognized as revenue in future periods. Transaction price allocated to remaining performance obligations is influenced by several factors, including the length of the contract term compared to the research term and the existence of customer specific acceptance rights. </span></div><ix:continuation id="i64e273c2cbf04d44a07ecffd3908f33a"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remaining performance obligations consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="amci:RevenueRemainingPerformanceObligationCurrentAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTphMzQ0ODMxMzg2NGM0ZjM4YjI0YTcxY2FmMTRlNTZjZC90YWJsZXJhbmdlOmEzNDQ4MzEzODY0YzRmMzhiMjRhNzFjYWYxNGU1NmNkXzItMS0xLTEtOTA2MTg_fc549038-2b27-424f-b8bf-02e1c61ac989">3,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="amci:RevenueRemainingPerformanceObligationCurrentAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTphMzQ0ODMxMzg2NGM0ZjM4YjI0YTcxY2FmMTRlNTZjZC90YWJsZXJhbmdlOmEzNDQ4MzEzODY0YzRmMzhiMjRhNzFjYWYxNGU1NmNkXzItMy0xLTEtOTA2MTg_1802684a-be6f-453c-883a-68018cc82e21">5,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="amci:RevenueRemainingPerformanceObligationNoncurrentAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTphMzQ0ODMxMzg2NGM0ZjM4YjI0YTcxY2FmMTRlNTZjZC90YWJsZXJhbmdlOmEzNDQ4MzEzODY0YzRmMzhiMjRhNzFjYWYxNGU1NmNkXzMtMS0xLTEtOTA2MTg_f4b63380-5e0c-47b9-9339-53f3bffa20df">13,901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="amci:RevenueRemainingPerformanceObligationNoncurrentAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTphMzQ0ODMxMzg2NGM0ZjM4YjI0YTcxY2FmMTRlNTZjZC90YWJsZXJhbmdlOmEzNDQ4MzEzODY0YzRmMzhiMjRhNzFjYWYxNGU1NmNkXzMtMy0xLTEtOTA2MTg_2b936e17-2fa7-460b-99df-2551cae19d1d">11,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTphMzQ0ODMxMzg2NGM0ZjM4YjI0YTcxY2FmMTRlNTZjZC90YWJsZXJhbmdlOmEzNDQ4MzEzODY0YzRmMzhiMjRhNzFjYWYxNGU1NmNkXzQtMS0xLTEtMTAzNjAz_3048df72-917d-4e15-9cb7-e68dd7eb2d7d">17,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTphMzQ0ODMxMzg2NGM0ZjM4YjI0YTcxY2FmMTRlNTZjZC90YWJsZXJhbmdlOmEzNDQ4MzEzODY0YzRmMzhiMjRhNzFjYWYxNGU1NmNkXzQtMy0xLTEtMTAzNjAz_9e5a3036-a270-4ef9-bf14-2273e68096c6">16,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_434"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5 &#8212; <ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:EquityMethodInvestmentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzE1OTQyOTE4NjEwNTU1_7e801bf9-1c5d-4084-a08e-63e4f7b03e94" continuedAt="i9ad8dfff515d4cc2a41d510b7a8d240c" escape="true">Investments</ix:nonNumeric></span></div><ix:continuation id="i9ad8dfff515d4cc2a41d510b7a8d240c" continuedAt="i9a53554cadcf4af3a92f9487fbb64089"><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzE1OTQyOTE4NjEwNTU2_43fceb24-6b53-4cc4-b79e-c22073c5cb97" continuedAt="if1c7275d18eb4eb3b51dd5363661adef" escape="true"><div style="margin-bottom:9pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investments consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Category</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in LanzaJet</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i285bf14114324cc3b2c392b9b984d16e_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo4ZGVmMzhhOWZkYTY0YmUxYmYxMGI4ZGFiYzhlYTM4OC90YWJsZXJhbmdlOjhkZWYzOGE5ZmRhNjRiZTFiZjEwYjhkYWJjOGVhMzg4XzQtMi0xLTEtOTA2MTg_66ec5e7a-50e8-4a98-866f-b132877b443f">12,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d2c4854af1c4ad183efa288b7c84140_I20201231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo4ZGVmMzhhOWZkYTY0YmUxYmYxMGI4ZGFiYzhlYTM4OC90YWJsZXJhbmdlOjhkZWYzOGE5ZmRhNjRiZTFiZjEwYjhkYWJjOGVhMzg4XzQtNC0xLTEtOTA2MTg_f3553f9b-11cc-41f7-a1bf-a1a9c5edde3e">13,651</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in SGLT</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie926aa19bc694f0586f296dab820baf8_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo4ZGVmMzhhOWZkYTY0YmUxYmYxMGI4ZGFiYzhlYTM4OC90YWJsZXJhbmdlOjhkZWYzOGE5ZmRhNjRiZTFiZjEwYjhkYWJjOGVhMzg4XzUtMi0xLTEtOTA2MTg_aa9c64ef-1367-460f-8267-735dbbef97a0">12,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4448ea0f5e794cccaf623e81ad622af0_I20201231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo4ZGVmMzhhOWZkYTY0YmUxYmYxMGI4ZGFiYzhlYTM4OC90YWJsZXJhbmdlOjhkZWYzOGE5ZmRhNjRiZTFiZjEwYjhkYWJjOGVhMzg4XzUtNC0xLTEtOTA2MTg_5f1f7ae0-f3eb-4daa-b3e5-abbfd4f69d99">9,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Investment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo4ZGVmMzhhOWZkYTY0YmUxYmYxMGI4ZGFiYzhlYTM4OC90YWJsZXJhbmdlOjhkZWYzOGE5ZmRhNjRiZTFiZjEwYjhkYWJjOGVhMzg4XzYtNC0xLTEtMTAzNjE5_5b9604b7-5b22-43d7-a768-0d4d68b09b4b">24,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo4ZGVmMzhhOWZkYTY0YmUxYmYxMGI4ZGFiYzhlYTM4OC90YWJsZXJhbmdlOjhkZWYzOGE5ZmRhNjRiZTFiZjEwYjhkYWJjOGVhMzg4XzYtNi0xLTEtMTAzNjE5_06c13aaa-87b7-42f5-b681-64f9ac7158f7">23,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Method Investments</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LanzaJet</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 13, 2020, the Company contributed $<ix:nonFraction unitRef="usd" contextRef="i3508735d501341a2badcc0f6a6be0770_D20200513-20200513" decimals="-3" name="us-gaap:ContributionOfProperty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzE3Ng_db2fbade-1bbb-4cc4-946a-1b76689e1026">15,000</ix:nonFraction> in intellectual property in exchange for a <ix:nonFraction unitRef="number" contextRef="iabbdb50d80c247b39bf74f30bb6e2aa1_I20200513" decimals="3" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzIyMg_2a8a185b-1db7-44ee-9b82-89df186c9b26">37.5</ix:nonFraction>% interest (&#8220;Original Interest&#8221;) of LanzaJet, Inc. (&#8220;LanzaJet&#8221;) and the right to future increase in ownership whereby LanzaTech could become a majority owner of LanzaJet if the intellectual property is used commercially in connection with an investment agreement (&#8220;Investment Agreement&#8221;). The Company also agreed to perform certain technical and administrative support services. LanzaJet is a sustainable fuels technology company dedicated to expanding sustainable aviation fuels (&#8220;SAF&#8221;) to reduce greenhouse gas emissions and the decarbonization of the aviation and transportation industries. LanzaJet&#8217;s access to the license is in perpetuity if certain key performance indicators (&#8220;KPI&#8217;s&#8221;) are met in accordance with the Investment Agreement. If these KPI&#8217;s are not met by December 31, 2025, the Company may terminate the license. The Company accounts for the transaction in accordance with ASC 606. The licensing and support services provided are recognized as a performance obligation satisfied over the expected period of those services, beginning May 2020 through December 2025. During the years ended December&#160;31, 2021 </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i9a53554cadcf4af3a92f9487fbb64089" continuedAt="i7cd8ec8ef29140e2b6efdac7709b3f5b"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and 2020, the Company has recognized revenue from this arrangement of $<ix:nonFraction unitRef="usd" contextRef="i7da793980258460bb178e447b22bf4df_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzE0MDI_da879107-fb8a-4577-b570-9b328b3872be">2,025</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="iaa162be01a7e42838d798ac77c1e8764_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzE0MDk_23375173-4b8f-49fb-b932-3e82baf35e6e">1,018</ix:nonFraction> and has recorded deferred revenue of $<ix:nonFraction unitRef="usd" contextRef="i285bf14114324cc3b2c392b9b984d16e_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzE0NDk_db609870-92ae-4c09-85c9-36dd5a1cfbca">10,746</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i5d2c4854af1c4ad183efa288b7c84140_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzE0NTY_44b16308-1bc8-453f-991a-cf20b8cbe92f">13,433</ix:nonFraction> respectively. Further, the Company has eliminated intra-entity profits related to revenue contracts with LanzaJet of $<ix:nonFraction unitRef="usd" contextRef="i4715c3e771cb49659b7d7d1edf71bd81_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzE1Nzc_2c0ac6d9-312b-4bd7-97a8-a310024c235b">662</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ia7a001a92c1048529f1d70f282ef5979_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzE1ODQ_b6c2e032-cb3a-4b55-9f63-101e95489eef">549</ix:nonFraction> as of December 31, 2021, and 2020, respectively. Intra-entity profit is amortized over the <ix:nonNumeric contextRef="i7da793980258460bb178e447b22bf4df_D20210101-20211231" name="amci:RevenueFromContractWithCustomerAmortizationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzEwOTk1MTE2Mjg1Njkz_8d21437e-5087-4b39-9829-aa4895be3a9b">15-year</ix:nonNumeric> amortization period through 2034.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the Original Interest, the Investment Agreement allows at the option of the other investors party thereto to contribute additional funds towards building commercial plants and to receive a technology sublicense if certain KPI&#8217;s are met. At such point, the Company would receive an additional interest in LanzaJet of up to <ix:nonFraction unitRef="shares" contextRef="i0953d2d09b0e4116b4f9972716c60d69_I20210404" decimals="INF" name="amci:EquityMethodInvestmentContingentRightToReceiveAdditionalInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzIwNTc_fb88a7c3-b532-4284-8d2d-c3b61e09e2ef">45</ix:nonFraction>&#160;million shares for <ix:nonFraction unitRef="usd" contextRef="i3f16003c0fce46c997e3bcde7fa19188_D20210201-20210404" decimals="INF" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzEwOTk1MTE2Mjg1NjI4_843c8ec0-3514-4fda-b57e-d8a855ace5dc">no</ix:nonFraction> additional consideration at that time. There would be no additional LanzaJet Board of Director representation with the potential increased interest. The additional tranches of interests in LanzaJet received upon the achievement of certain KPIs represent non-monetary variable consideration. The Company has applied the variable consideration constraint per ASC 606 and recognized no variable consideration as of December 31, 2021 as the Company has determined that it is not probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. The Company regularly reviews and updates its estimates. Any changes made are recorded as a cumulative adjustment in the period identified and revenue for future periods is recognized using the new adjusted estimate.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between February 1, and April 4, 2021, LanzaJet closed <ix:nonFraction unitRef="invesstment_round" contextRef="i65fec460822f43acb02e40736b3b8a79_D20210201-20210404" decimals="INF" name="amci:NumberOfRoundsOfInvestments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzEwOTk1MTE2Mjg1NjMw_b495b88d-aae0-4c6b-add5-464bc4c6eaae">two</ix:nonFraction> additional rounds of investment which reduced the Company's Original Interest to <ix:nonFraction unitRef="number" contextRef="i0953d2d09b0e4116b4f9972716c60d69_I20210404" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzEyNjQ0MzgzNzI3MTk2_68f4ba4d-4402-41ef-ab39-c858a048be87">25</ix:nonFraction>%. As a result, the Company recognized a gain on dilution of $<ix:nonFraction unitRef="usd" contextRef="i3f16003c0fce46c997e3bcde7fa19188_D20210201-20210404" decimals="-3" name="amci:EquityMethodInvestmentGainOnDilutionOfInvestment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzEwOTk1MTE2Mjg1NTg3_82385278-742f-4ef4-9747-479f73a6bfed">503</ix:nonFraction>. The Company retained its right to receive additional interest in LanzaJet of up to <ix:nonFraction unitRef="shares" contextRef="i0953d2d09b0e4116b4f9972716c60d69_I20210404" decimals="INF" name="amci:EquityMethodInvestmentContingentRightToReceiveAdditionalInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzEyNjQ0MzgzNzI3MjAx_07cc009e-3838-40c6-b11e-377a039c155a">45</ix:nonFraction>&#160;million shares for <ix:nonFraction unitRef="usd" contextRef="i3f16003c0fce46c997e3bcde7fa19188_D20210201-20210404" decimals="INF" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzEwOTk1MTE2Mjg1NjI5_cb4756f8-f6ea-43a9-a54c-7613f5e13a4d">no</ix:nonFraction> additional consideration. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of our equity method investments as of December&#160;31, 2021 and 2020 was approximately $<ix:nonFraction unitRef="usd" contextRef="i285bf14114324cc3b2c392b9b984d16e_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzEyNjQ0MzgzNzI3MTgw_3258513a-0d39-4f66-8394-d919fdd8e157">3,100</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i5d2c4854af1c4ad183efa288b7c84140_I20201231" decimals="-3" name="us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzEyNjQ0MzgzNzI3MTg4_9d6ac856-d92b-4171-846b-097dc3a08e75">3,800</ix:nonFraction> less than our proportionate share of our equity method investees&#8217; book values, respectively. The basis differences relate primarily to our equity method investment in LanzaJet and are largely the result of a difference in the timing of recognition of variable consideration to which we may become entitled in exchange for our contribution of IP to LanzaJet. The variable consideration we may receive will be in the form of additional ownership interests and the majority of the basis difference will reverse in connection with recognition of that variable consideration. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with a sublicense agreement to LanzaJet under our license agreement with Battelle Memorial Institute (&#8220;Battelle&#8221;), LanzaTech remains responsible for any failure by LanzaJet to pay royalties due to Battelle. The fair value of LanzaTech&#8217;s obligation under this guarantee was immaterial as of December&#160;31, 2021 and 2020.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SGLT</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2011, the Company contributed RMB <ix:nonFraction unitRef="cny" contextRef="ie466fa6065e24c99b35c9b349c76a551_D20110928-20110928" decimals="-3" name="us-gaap:ContributionOfProperty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzQzNDg_8b356f20-bc7e-41e5-ad86-a455cdb79a3d">25,800</ix:nonFraction> (approx. $<ix:nonFraction unitRef="usd" contextRef="ie466fa6065e24c99b35c9b349c76a551_D20110928-20110928" decimals="-3" name="us-gaap:ContributionOfProperty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzQzNjA_f9de3106-eaef-4685-bd9d-9a2b909783aa">4,000</ix:nonFraction>) in intellectual property in exchange for <ix:nonFraction unitRef="number" contextRef="ibea6cef92fd440f0849af4b7e43ac9d0_I20110928" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzQ0MDU_5743c8d2-9612-4bf6-be06-dc2ecf9dec0d">30</ix:nonFraction>% of the registered capital of SGLT. SGLT utilizes and develops technologies and know-how in connection with the production of anhydrous ethanol from steel mill waste gases. The contribution was recognized as revenue in 2011.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, as the result of the admittance of new investors, the Company&#8217;s interest in SGLT&#8217;s registered capital is approximately <ix:nonFraction unitRef="number" contextRef="ie926aa19bc694f0586f296dab820baf8_I20211231" decimals="4" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzQ3Njg_39c0e0a6-37d2-4707-ac2a-56e5974dc07e">10.01</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i4448ea0f5e794cccaf623e81ad622af0_I20201231" decimals="4" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzQ3NzU_625bbb8a-0839-417d-a3d1-bbfc55dd5eaf">11.14</ix:nonFraction>%, respectively. The Company recognized a gain from the dilution of $<ix:nonFraction unitRef="usd" contextRef="if87506a2fe1e44eea4a6cc3fad0ec2be_D20210101-20211231" decimals="-3" name="amci:EquityMethodInvestmentGainOnDilutionOfInvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzQ4NDQ_bb015e91-1774-4628-b312-dfe662d6d7e5">3,048</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i9c210a255c684636bb39fa23a2370b08_D20200101-20201231" decimals="-3" name="amci:EquityMethodInvestmentGainOnDilutionOfInvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzQ4NTE_3f65ac35-6015-42b3-a8e2-26404abb4355">3,811</ix:nonFraction> during the years ended December 31, 2021 and December 31, 2020, respectively. The Company has continued to apply the equity method of accounting to the investment as the Company maintains significant influence via representation on SGLT&#8217;s Board of Directors and SGLT's significant dependency on the intellectual property the Company contributed.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i7cd8ec8ef29140e2b6efdac7709b3f5b"><ix:continuation id="if1c7275d18eb4eb3b51dd5363661adef" continuedAt="i1d3a3d15d384475aa34854717e9ed6e4"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents summarized aggregated financial information of the equity method investments:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selected Statement of Operations Information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a7398a2daa84714af0a8aedf56e44db_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzQtMS0xLTEtOTA2MTg_55e04238-c2c5-4fe4-8477-dfaec5ba09d9">40,244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i429f6f8a96604c7ebb57f635a19670fb_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzQtMy0xLTEtOTA2MTg_c929a864-0cb5-4e80-b5ad-b138b48efc41">26,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a7398a2daa84714af0a8aedf56e44db_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzUtMS0xLTEtOTA2MTg_214ed423-f316-4812-83ab-0876d8d11c80">5,703</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i429f6f8a96604c7ebb57f635a19670fb_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzUtMy0xLTEtOTA2MTg_3ccb2b1a-c6a2-436d-908f-f3b52817f9f0">5,510</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a7398a2daa84714af0a8aedf56e44db_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzYtMS0xLTEtOTA2MTg_a841048a-cad9-4dd3-9f34-563a2bcb12e8">9,695</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i429f6f8a96604c7ebb57f635a19670fb_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzYtMy0xLTEtOTA2MTg_1f73109c-85b0-43ed-8169-5ecdff6f916e">9,729</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to the Company</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzctMS0xLTEtOTA2MTg_c3430abb-e89d-45a5-ad66-06dcf37693e8">1,606</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzctMy0xLTEtOTA2MTg_3cf6d7c2-7a25-47e5-a0a8-ef5e048e1d98">1,644</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selected Balance Sheet Information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb56e9df9e8a4d3fb130ee2ff3f1a588_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzEzLTEtMS0xLTkwNjE4_202c9088-5eef-40c4-8811-1069e31e2c12">56,204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7779ec82a944d5989685ea5c473b325_I20201231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzEzLTMtMS0xLTkwNjE4_0682570b-0f28-4622-9524-d4d533ad4eb1">55,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb56e9df9e8a4d3fb130ee2ff3f1a588_I20211231" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzE0LTEtMS0xLTkwNjE4_130dbb26-4772-4e9e-b744-ac4a48c6f1e3">270,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7779ec82a944d5989685ea5c473b325_I20201231" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzE0LTMtMS0xLTkwNjE4_84df0683-ad7c-4b14-a953-91a4456500ba">133,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb56e9df9e8a4d3fb130ee2ff3f1a588_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzE1LTEtMS0xLTkwNjE4_3e1b6968-53e6-47a2-ba3d-22d4a75741d6">64,499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7779ec82a944d5989685ea5c473b325_I20201231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzE1LTMtMS0xLTkwNjE4_0c1f591d-c4fb-4441-8628-59c41e0f73d1">33,540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb56e9df9e8a4d3fb130ee2ff3f1a588_I20211231" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzE2LTEtMS0xLTkwNjE4_c4b55ce6-7822-4183-9a54-7c23abc398b3">58,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7779ec82a944d5989685ea5c473b325_I20201231" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzE2LTMtMS0xLTkwNjE4_5b7bd7d8-eaa5-4795-a4d3-d225599eae4d">21,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, there were <ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="INF" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzEwOTk1MTE2Mjg1NjE3_b0b07a60-18d0-4051-8b54-4e38c4b5894b"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="INF" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzEwOTk1MTE2Mjg1NjE3_b3ee6690-f98d-439d-a6d2-de92f91087d2">no</ix:nonFraction></ix:nonFraction> impairments of equity method investees. During 2021 and 2020, the Company received <ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="INF" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzEwOTk1MTE2Mjg1NjUz_5f09c4d1-f33d-4aa1-9faa-000d6020d74c"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="INF" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzEwOTk1MTE2Mjg1NjUz_7b44d892-534b-494e-a846-7d05048a790c">no</ix:nonFraction></ix:nonFraction> dividends from equity method investments. <ix:continuation id="i1d3a3d15d384475aa34854717e9ed6e4" continuedAt="i91486c0694bc4d72add8a614036ec06c">As of and for the years ended December 31, 2021 and December 31, 2020, sales, accounts receivable, and purchases and open accounts payable with equity method investees were as follows (in thousands):</ix:continuation></span></div><div style="margin-bottom:9pt"><ix:continuation id="i91486c0694bc4d72add8a614036ec06c"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9677cfd1c23149c39d4d453a38d4b6f4_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZToyOThhZmE1MDdlOTg0NTNiODBlYjk0NzVkMWNkMGU0YS90YWJsZXJhbmdlOjI5OGFmYTUwN2U5ODQ1M2I4MGViOTQ3NWQxY2QwZTRhXzMtMS0xLTEtOTA2MTg_6912a520-8dfa-4079-9596-ed4f21cf6d7f">3,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dc568acac614adb953dfdedc71d98b5_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZToyOThhZmE1MDdlOTg0NTNiODBlYjk0NzVkMWNkMGU0YS90YWJsZXJhbmdlOjI5OGFmYTUwN2U5ODQ1M2I4MGViOTQ3NWQxY2QwZTRhXzMtMy0xLTEtOTA2MTg_341af267-e98a-497d-997d-96a321b7b9f3">4,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id33f2498c7aa4d4ba897810160258324_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZToyOThhZmE1MDdlOTg0NTNiODBlYjk0NzVkMWNkMGU0YS90YWJsZXJhbmdlOjI5OGFmYTUwN2U5ODQ1M2I4MGViOTQ3NWQxY2QwZTRhXzQtMS0xLTEtOTA2MTg_699f6b91-eeda-4836-bcbf-6ce47e02152b">1,071</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a14169b57143bbada3e671e8a86ea6_I20201231" decimals="-3" name="us-gaap:AccountsReceivableNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZToyOThhZmE1MDdlOTg0NTNiODBlYjk0NzVkMWNkMGU0YS90YWJsZXJhbmdlOjI5OGFmYTUwN2U5ODQ1M2I4MGViOTQ3NWQxY2QwZTRhXzQtMy0xLTEtOTA2MTg_96dbde6e-af31-4c48-b8c7-f49144ea9410">3,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases and open accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id33f2498c7aa4d4ba897810160258324_I20211231" decimals="-3" name="amci:PurchasesAndOpenAccountsPayableRelatedParties" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZToyOThhZmE1MDdlOTg0NTNiODBlYjk0NzVkMWNkMGU0YS90YWJsZXJhbmdlOjI5OGFmYTUwN2U5ODQ1M2I4MGViOTQ3NWQxY2QwZTRhXzUtMS0xLTEtOTA2MTg_f0d7a542-d1c1-4071-8fa3-494eadae48ec">2,575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a14169b57143bbada3e671e8a86ea6_I20201231" decimals="-3" name="amci:PurchasesAndOpenAccountsPayableRelatedParties" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZToyOThhZmE1MDdlOTg0NTNiODBlYjk0NzVkMWNkMGU0YS90YWJsZXJhbmdlOjI5OGFmYTUwN2U5ODQ1M2I4MGViOTQ3NWQxY2QwZTRhXzUtMy0xLTEtOTA2MTg_821d20ae-992b-4e06-b748-716ba8baa0c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-90</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_440"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6 &#8212; <ix:continuation id="iba91deced8854759b9b386753a4438b9" continuedAt="ied418172eae244e9a0f7c333316c6761">Fair Value</ix:continuation></span></div><ix:continuation id="ied418172eae244e9a0f7c333316c6761" continuedAt="i8db47b015dde4c49853e5fa63795fe75"><ix:continuation id="i24990ad74b5f4f09ad68ea531bb2677d"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value hierarchy for its assets and liabilities measured at fair value as of December&#160;31, 2021 and 2020 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i946a08fcd3a04e65862611981f20e270_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzQtMS0xLTEtMTAzNjg1_65333c6d-6849-4a32-8296-03b6b5de746a">516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i541e2e9fe4644a20b8b1b376f83dee9d_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzQtMy0xLTEtMTAzNjg1_c06fc672-0c16-48e0-910d-7434bb328a90">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0624bd72b2cf4ede8ec463949522ea9a_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzQtNS0xLTEtMTAzNjg1_b403d1dc-9661-43c5-a3ee-768f4ac4f6cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd5ccd73a28c47ebac5c69568150935f_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzQtNy0xLTEtMTAzNjg1_fa709c45-73e7-497a-b66e-77664ff79134">516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:13pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i946a08fcd3a04e65862611981f20e270_I20211231" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzctMS0xLTEtOTA2MTg_11b9cbf1-0c9c-4fb6-b665-e80624e8423c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i541e2e9fe4644a20b8b1b376f83dee9d_I20211231" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzctMy0xLTEtOTA2MTg_f08e59de-b904-4b50-abb1-08472ab1fcda">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0624bd72b2cf4ede8ec463949522ea9a_I20211231" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzctNS0xLTEtOTA2MTg_db19570e-29c2-4b23-b446-c165f75c27b9">1,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd5ccd73a28c47ebac5c69568150935f_I20211231" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzctNy0xLTEtMTAzNjg1_f4defbda-2133-419a-a79b-6ddbc5e9892b">1,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia692081523eb4eeab727c1fc860a7079_I20211231" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzgtMS0xLTEtMTAzNjg1_302c7a74-3f45-49f9-925f-3e8e3ed56019">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d637000e084883bc89386915d6aae9_I20211231" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzgtMy0xLTEtMTAzNjg1_1b8d304f-9107-4470-ac39-4403f0467e67">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8345fcb8c9f147978a79d376aea1f2aa_I20211231" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzgtNS0xLTEtMTAzNjg1_30aec2c1-cf60-4cc6-968a-5bde3c552b38">1,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9bb8758e465423fb3bbebe9bcea3ef7_I20211231" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzgtNy0xLTEtMTAzNjg1_0445a1a7-162a-4bdc-95de-583e89951b98">1,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i946a08fcd3a04e65862611981f20e270_I20211231" decimals="-3" name="amci:SimpleAgreementForFutureEquityLiability" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzktMS0xLTEtMTAzNjg1_cd58af5c-ff99-4125-98ac-a0cc876612c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i541e2e9fe4644a20b8b1b376f83dee9d_I20211231" decimals="-3" name="amci:SimpleAgreementForFutureEquityLiability" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzktMy0xLTEtMTAzNjg1_0c54095a-45e8-47e6-8c78-c8da72bc15d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0624bd72b2cf4ede8ec463949522ea9a_I20211231" decimals="-3" name="amci:SimpleAgreementForFutureEquityLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzktNS0xLTEtMTAzNjg1_928d9e82-3102-47a0-80ed-72f37de107c8">28,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd5ccd73a28c47ebac5c69568150935f_I20211231" decimals="-3" name="amci:SimpleAgreementForFutureEquityLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzktNy0xLTEtMTAzNjg1_5d2d4da2-494c-411d-bbdd-cc08dd89923f">28,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i946a08fcd3a04e65862611981f20e270_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzEwLTEtMS0xLTEwMzY4NQ_a80993c7-9ff8-48f8-b967-904d5f56cb87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i541e2e9fe4644a20b8b1b376f83dee9d_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzEwLTMtMS0xLTEwMzY4NQ_1e8453b4-9578-4444-a19c-feb610333334">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0624bd72b2cf4ede8ec463949522ea9a_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzEwLTUtMS0xLTEwMzY4NQ_56ef9c20-0a3b-44e5-95c8-67efb630807a">31,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd5ccd73a28c47ebac5c69568150935f_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzEwLTctMS0xLTEwMzY4NQ_3d25e6c3-3693-4d67-9e00-a10db7e2c700">31,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5cf4398c3d547eaa80b15bf808fd8c5_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3MjFjMDZhOGNiODc0NDA4YTUxY2FjMmFhNTcwMTY1OC90YWJsZXJhbmdlOjcyMWMwNmE4Y2I4NzQ0MDhhNTFjYWMyYWE1NzAxNjU4XzQtMS0xLTEtMTAzNjg5_09cd4b14-03f2-467d-8847-b19090e91ee7">516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80fc94b127ec4857ab5aacd4d3b22f07_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3MjFjMDZhOGNiODc0NDA4YTUxY2FjMmFhNTcwMTY1OC90YWJsZXJhbmdlOjcyMWMwNmE4Y2I4NzQ0MDhhNTFjYWMyYWE1NzAxNjU4XzQtMy0xLTEtMTAzNjg5_54beb3b9-e5bb-4fb0-b973-6cfc3b74c88c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice7ea95c9fb84d36a4857e2a761cf72f_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3MjFjMDZhOGNiODc0NDA4YTUxY2FjMmFhNTcwMTY1OC90YWJsZXJhbmdlOjcyMWMwNmE4Y2I4NzQ0MDhhNTFjYWMyYWE1NzAxNjU4XzQtNS0xLTEtMTAzNjg5_8bb4d04a-d2a8-4940-bf38-a59b19dd79f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0c8f06ff99246cdb46b4b9b0600f524_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3MjFjMDZhOGNiODc0NDA4YTUxY2FjMmFhNTcwMTY1OC90YWJsZXJhbmdlOjcyMWMwNmE4Y2I4NzQ0MDhhNTFjYWMyYWE1NzAxNjU4XzQtNy0xLTEtMTAzNjg5_c0f3b7f4-2ec5-4cb1-b0fc-154c2e00d63c">516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5cf4398c3d547eaa80b15bf808fd8c5_I20201231" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3MjFjMDZhOGNiODc0NDA4YTUxY2FjMmFhNTcwMTY1OC90YWJsZXJhbmdlOjcyMWMwNmE4Y2I4NzQ0MDhhNTFjYWMyYWE1NzAxNjU4XzctMS0xLTEtOTA2MTg_2ab12c3f-08fb-40bd-9248-cc0df5cb74a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80fc94b127ec4857ab5aacd4d3b22f07_I20201231" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3MjFjMDZhOGNiODc0NDA4YTUxY2FjMmFhNTcwMTY1OC90YWJsZXJhbmdlOjcyMWMwNmE4Y2I4NzQ0MDhhNTFjYWMyYWE1NzAxNjU4XzctMy0xLTEtOTA2MTg_e28a806d-af1a-442d-8cc0-bcf9ad78a79e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice7ea95c9fb84d36a4857e2a761cf72f_I20201231" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3MjFjMDZhOGNiODc0NDA4YTUxY2FjMmFhNTcwMTY1OC90YWJsZXJhbmdlOjcyMWMwNmE4Y2I4NzQ0MDhhNTFjYWMyYWE1NzAxNjU4XzctNS0xLTEtOTA2MTg_2381a6b4-6fb5-48cf-9212-5733364b4d70">582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0c8f06ff99246cdb46b4b9b0600f524_I20201231" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3MjFjMDZhOGNiODc0NDA4YTUxY2FjMmFhNTcwMTY1OC90YWJsZXJhbmdlOjcyMWMwNmE4Y2I4NzQ0MDhhNTFjYWMyYWE1NzAxNjU4XzctNy0xLTEtMTAzNjky_c5d12be3-d7f9-49b6-ab54-57ba31a2ee18">582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The warrants are accounted for as liabilities in accordance with ASC 480 and are presented within other accrued liabilities on the consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the warrants was calculated using the Black-Scholes Option Pricing Model. For the years ended December&#160;31, 2021 and 2020, the Company recognized a change in the fair value of liabilities of approximately $(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90ZXh0cmVnaW9uOmE0NWFkYmNmYzUwZTQwYjlhYmQ3MmNmMzJlOWU5YmJlXzc0NQ_4713a589-f622-4786-b727-08d236012cc9">563</ix:nonFraction>) and $<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90ZXh0cmVnaW9uOmE0NWFkYmNmYzUwZTQwYjlhYmQ3MmNmMzJlOWU5YmJlXzc1Mg_757a46c2-5193-48ad-b159-15722b180b32">105</ix:nonFraction>, respectively, on the statements of operations and comprehensive loss within other income (expense), net.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the warrants is determined using Level 3 inputs. Inherent in the Black-Scholes Option Pricing Model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its warrants based on implied volatility from the Company&#8217;s warrants and from historical volatility of select peer companies that match the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i8db47b015dde4c49853e5fa63795fe75" continuedAt="i12216c26fb6c4293b5d41c142af5d730"><ix:continuation id="i8811170c4ff7433ea97edc11c9acb299" continuedAt="i668e250f3f7643c8b8ab7632d4680939"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the weighted average inputs used in calculating the fair value of the preferred share warrants outstanding as of December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i350b1ab261cb4e4db6e8558ad63e36ba_I20211231" decimals="INF" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTpmODhlMmY4NzEyMGI0ZjZmYjM2ZGZiYjMxMTUzNmJhMy90YWJsZXJhbmdlOmY4OGUyZjg3MTIwYjRmNmZiMzZkZmJiMzExNTM2YmEzXzEtMS0xLTEtOTA2MTg_a316a007-786e-4f89-9083-9c4be608e404">13.77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i22bd73e99737495a9bc32803b0a38fcb_I20201231" decimals="INF" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTpmODhlMmY4NzEyMGI0ZjZmYjM2ZGZiYjMxMTUzNmJhMy90YWJsZXJhbmdlOmY4OGUyZjg3MTIwYjRmNmZiMzZkZmJiMzExNTM2YmEzXzEtMy0xLTEtOTA2MTg_caf68faa-da66-42ae-b81c-e23975acd701">4.68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i07186a2d797e4458bf8d9a94dc91a2d0_I20211231" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTpmODhlMmY4NzEyMGI0ZjZmYjM2ZGZiYjMxMTUzNmJhMy90YWJsZXJhbmdlOmY4OGUyZjg3MTIwYjRmNmZiMzZkZmJiMzExNTM2YmEzXzItMS0xLTEtOTA2MTg_ad8f51b8-6e8a-4e2c-84ab-7cb9174da8ba">17.32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if52a74eff3e34ea7bd679e63aa269811_I20201231" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTpmODhlMmY4NzEyMGI0ZjZmYjM2ZGZiYjMxMTUzNmJhMy90YWJsZXJhbmdlOmY4OGUyZjg3MTIwYjRmNmZiMzZkZmJiMzExNTM2YmEzXzItMy0xLTEtOTA2MTg_6961e632-db8e-4f0c-9fac-d3c9a1fb2cd5">18.39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia859bc758ac345ea9093ab9e82ff0731_I20211231" decimals="1" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTpmODhlMmY4NzEyMGI0ZjZmYjM2ZGZiYjMxMTUzNmJhMy90YWJsZXJhbmdlOmY4OGUyZjg3MTIwYjRmNmZiMzZkZmJiMzExNTM2YmEzXzMtMS0xLTEtOTA2MTg_a5d9b960-2f55-4031-83e3-67363ca7f30e">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ida1349a04a004301b22372e88994a9b7_I20201231" decimals="1" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTpmODhlMmY4NzEyMGI0ZjZmYjM2ZGZiYjMxMTUzNmJhMy90YWJsZXJhbmdlOmY4OGUyZjg3MTIwYjRmNmZiMzZkZmJiMzExNTM2YmEzXzMtMy0xLTEtOTA2MTg_e0eb10b5-59ce-4970-b123-a89019688d58">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i43750276631c4e1ba6fc6ef8f398254e_I20211231" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTpmODhlMmY4NzEyMGI0ZjZmYjM2ZGZiYjMxMTUzNmJhMy90YWJsZXJhbmdlOmY4OGUyZjg3MTIwYjRmNmZiMzZkZmJiMzExNTM2YmEzXzQtMS0xLTEtOTA2MTg_c7e0563b-ff50-43fa-94df-dabdbef45296">70.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i43d8664385d6443a97bd2baa7945074d_I20201231" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTpmODhlMmY4NzEyMGI0ZjZmYjM2ZGZiYjMxMTUzNmJhMy90YWJsZXJhbmdlOmY4OGUyZjg3MTIwYjRmNmZiMzZkZmJiMzExNTM2YmEzXzQtMy0xLTEtOTA2MTg_05f6819d-ed8e-49df-93da-9b348e4a2e14">88.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5088a09b2ff24bc9bfba62c1ce63d419_I20211231" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTpmODhlMmY4NzEyMGI0ZjZmYjM2ZGZiYjMxMTUzNmJhMy90YWJsZXJhbmdlOmY4OGUyZjg3MTIwYjRmNmZiMzZkZmJiMzExNTM2YmEzXzUtMS0xLTEtOTA2MTg_c16e934a-f6df-4d3f-a7ca-d66635d9e02c">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i496bb986b9154962b5941a9ef4c15f9a_I20201231" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTpmODhlMmY4NzEyMGI0ZjZmYjM2ZGZiYjMxMTUzNmJhMy90YWJsZXJhbmdlOmY4OGUyZjg3MTIwYjRmNmZiMzZkZmJiMzExNTM2YmEzXzUtMy0xLTEtOTA2MTg_70a69156-995f-4205-97b1-6cadbe679ce9">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i55050b0de34747fbba14961fb9a1e9be_I20211231" decimals="0" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTpmODhlMmY4NzEyMGI0ZjZmYjM2ZGZiYjMxMTUzNmJhMy90YWJsZXJhbmdlOmY4OGUyZjg3MTIwYjRmNmZiMzZkZmJiMzExNTM2YmEzXzYtMS0xLTEtOTA2MTg_289c0462-aa8e-4049-b779-b8c0084a26c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i84be5f6d8d7b4fb09cf5f8067275b5e2_I20201231" decimals="0" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTpmODhlMmY4NzEyMGI0ZjZmYjM2ZGZiYjMxMTUzNmJhMy90YWJsZXJhbmdlOmY4OGUyZjg3MTIwYjRmNmZiMzZkZmJiMzExNTM2YmEzXzYtMy0xLTEtOTA2MTg_1eef60e1-c57f-41aa-a2d7-bdaf80b0bb59">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s SAFE liability and SAFE warrant are mark-to-market liabilities pursuant to ASC 480 and are classified within Level 3 of the fair value hierarchy as the Company is using a scenario-based approach which allowed the Company to estimate the implied value of the business based on the terms of the SAFE. Significant unobservable inputs included probability and expected term. Probability is based upon the likelihood of the Company closing a transaction with a special purpose acquisition company. The expected term was based on the anticipated time until the SAFE investments would have a conversion event. </span></div><ix:continuation id="i668e250f3f7643c8b8ab7632d4680939"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE liability fair value measurement at December 31, 2021 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2572a9b98e9a4c54ae3bd8e69a273beb_I20211231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTplYzQ1NTU4ZTQyNTQ0YWU0YTI3MjkyOWI0OGNmMWI5MS90YWJsZXJhbmdlOmVjNDU1NThlNDI1NDRhZTRhMjcyOTI5YjQ4Y2YxYjkxXzItMS0xLTEtOTA2MTg_a31cc5be-fb48-46c1-80df-96605b28457f">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idf22b55e0fed4e0c81de5bef50d3013a_I20211231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTplYzQ1NTU4ZTQyNTQ0YWU0YTI3MjkyOWI0OGNmMWI5MS90YWJsZXJhbmdlOmVjNDU1NThlNDI1NDRhZTRhMjcyOTI5YjQ4Y2YxYjkxXzItMy0xLTEtOTA2MTg_bce32899-e0cd-46d3-920f-34ca13183097">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib114abec90f74932b5c8531cce6dc917_I20211231" decimals="1" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTplYzQ1NTU4ZTQyNTQ0YWU0YTI3MjkyOWI0OGNmMWI5MS90YWJsZXJhbmdlOmVjNDU1NThlNDI1NDRhZTRhMjcyOTI5YjQ4Y2YxYjkxXzMtMS0xLTEtOTA2MTg_1e8295ca-ea81-48f3-ae08-1fc21b17df58">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i367f5f8cece445cfb46f812a669bcd7d_I20211231" decimals="1" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTplYzQ1NTU4ZTQyNTQ0YWU0YTI3MjkyOWI0OGNmMWI5MS90YWJsZXJhbmdlOmVjNDU1NThlNDI1NDRhZTRhMjcyOTI5YjQ4Y2YxYjkxXzMtMy0xLTEtOTA2MTg_c755823c-0579-4775-a78a-e4e8c5c8bd14">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liquidity price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iccef67c1c54d4161a5720eded9695c69_I20211231" decimals="INF" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTplYzQ1NTU4ZTQyNTQ0YWU0YTI3MjkyOWI0OGNmMWI5MS90YWJsZXJhbmdlOmVjNDU1NThlNDI1NDRhZTRhMjcyOTI5YjQ4Y2YxYjkxXzQtMS0xLTEtOTA2MTg_84cbbdbe-72a8-4ce3-9f8b-b7b5666909ff">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib085f020f9a848ccb3533923ee8aafcf_I20211231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTplYzQ1NTU4ZTQyNTQ0YWU0YTI3MjkyOWI0OGNmMWI5MS90YWJsZXJhbmdlOmVjNDU1NThlNDI1NDRhZTRhMjcyOTI5YjQ4Y2YxYjkxXzQtMy0xLTEtOTA2MTg_567a5330-4603-4b13-9b12-2a5dd7b086a9">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ica26df06c0a34ccf8742113f8a95570d_I20211231" decimals="3" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTplYzQ1NTU4ZTQyNTQ0YWU0YTI3MjkyOWI0OGNmMWI5MS90YWJsZXJhbmdlOmVjNDU1NThlNDI1NDRhZTRhMjcyOTI5YjQ4Y2YxYjkxXzUtMS0xLTEtOTA2MTg_db0dd0ac-2ddc-4c8b-a544-eb41e6c3ca21">17.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie99d17fd90cb4d7987c8af1f52716253_I20211231" decimals="3" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTplYzQ1NTU4ZTQyNTQ0YWU0YTI3MjkyOWI0OGNmMWI5MS90YWJsZXJhbmdlOmVjNDU1NThlNDI1NDRhZTRhMjcyOTI5YjQ4Y2YxYjkxXzUtMy0xLTEtOTA2MTg_75b0952b-1833-4077-8d08-bb556eb6bc94">17.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE warrant fair value measurement at December 31, 2021 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic732fa66399e46eb8f8f50bfe6a6b35c_I20211231" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo1OGM5OGVjNjhlYWQ0Zjg3OWY1MDUyOTgzYWI3MzNjOC90YWJsZXJhbmdlOjU4Yzk4ZWM2OGVhZDRmODc5ZjUwNTI5ODNhYjczM2M4XzItMS0xLTEtOTA2MTg_0d1bde8d-560c-4ab4-bfc5-cb1d28546eb2">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3318e30ec98146f5915d9bdc540724bb_I20211231" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo1OGM5OGVjNjhlYWQ0Zjg3OWY1MDUyOTgzYWI3MzNjOC90YWJsZXJhbmdlOjU4Yzk4ZWM2OGVhZDRmODc5ZjUwNTI5ODNhYjczM2M4XzItMy0xLTEtOTA2MTg_3dde7723-5551-46d2-a7ff-eb1fcc42bed2">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining life (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9db1cfd579a04d91b7516eeb7322d953_I20211231" decimals="1" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo1OGM5OGVjNjhlYWQ0Zjg3OWY1MDUyOTgzYWI3MzNjOC90YWJsZXJhbmdlOjU4Yzk4ZWM2OGVhZDRmODc5ZjUwNTI5ODNhYjczM2M4XzMtMS0xLTEtOTA2MTg_8b153db3-00c8-4297-8fd2-07e19e26d86e">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibdd52c0f69244ffea4e30e908a904220_I20211231" decimals="1" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo1OGM5OGVjNjhlYWQ0Zjg3OWY1MDUyOTgzYWI3MzNjOC90YWJsZXJhbmdlOjU4Yzk4ZWM2OGVhZDRmODc5ZjUwNTI5ODNhYjczM2M4XzMtMy0xLTEtOTA2MTg_a93d611c-c704-4487-9a5c-1375bc4499e1">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0f66a327ce0b49c890e6a99fa7f9fbaf_I20211231" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo1OGM5OGVjNjhlYWQ0Zjg3OWY1MDUyOTgzYWI3MzNjOC90YWJsZXJhbmdlOjU4Yzk4ZWM2OGVhZDRmODc5ZjUwNTI5ODNhYjczM2M4XzQtMS0xLTEtOTA2MTg_5bda4efd-6097-4915-b99a-e479118d6fff">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1ca4d63251324696875efe201490b263_I20211231" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo1OGM5OGVjNjhlYWQ0Zjg3OWY1MDUyOTgzYWI3MzNjOC90YWJsZXJhbmdlOjU4Yzk4ZWM2OGVhZDRmODc5ZjUwNTI5ODNhYjczM2M4XzQtMy0xLTEtOTA2MTg_82326126-55c2-4edb-b716-bdb6631209fc">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i82cb4f4ddcf64c0191fa7d4c0cb0521e_I20211231" decimals="4" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo1OGM5OGVjNjhlYWQ0Zjg3OWY1MDUyOTgzYWI3MzNjOC90YWJsZXJhbmdlOjU4Yzk4ZWM2OGVhZDRmODc5ZjUwNTI5ODNhYjczM2M4XzUtMS0xLTEtOTA2MTg_5c3fa68c-9ec0-4cca-b652-e8fffb611e56">1.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7905b9a8c9624fa98a477251487eac0d_I20211231" decimals="4" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo1OGM5OGVjNjhlYWQ0Zjg3OWY1MDUyOTgzYWI3MzNjOC90YWJsZXJhbmdlOjU4Yzk4ZWM2OGVhZDRmODc5ZjUwNTI5ODNhYjczM2M4XzUtMy0xLTEtOTA2MTg_615b6fa5-b22f-488b-be50-6a66c4b278ef">1.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i91c4e209e7064892a5423ab903a240cc_I20211231" decimals="1" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo1OGM5OGVjNjhlYWQ0Zjg3OWY1MDUyOTgzYWI3MzNjOC90YWJsZXJhbmdlOjU4Yzk4ZWM2OGVhZDRmODc5ZjUwNTI5ODNhYjczM2M4XzYtMS0xLTEtOTA2MTg_f7527333-c7d5-49b9-98ec-a18a84b3f247">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i57bff8b3d92f4c7cb9038273d4bf242f_I20211231" decimals="1" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo1OGM5OGVjNjhlYWQ0Zjg3OWY1MDUyOTgzYWI3MzNjOC90YWJsZXJhbmdlOjU4Yzk4ZWM2OGVhZDRmODc5ZjUwNTI5ODNhYjczM2M4XzYtMy0xLTEtOTA2MTg_756f6e69-ec62-41c7-bef1-458f51aa9780">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i187fcf7aff144ee2ab2ff0d1b8136024_I20211231" decimals="4" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo1OGM5OGVjNjhlYWQ0Zjg3OWY1MDUyOTgzYWI3MzNjOC90YWJsZXJhbmdlOjU4Yzk4ZWM2OGVhZDRmODc5ZjUwNTI5ODNhYjczM2M4XzctMS0xLTEtOTA2MTg_88cd8914-6c48-439a-8f35-3ad9ffe96aca">0.19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4c38034324df4a3dab4243d7adcb1f21_I20211231" decimals="4" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo1OGM5OGVjNjhlYWQ0Zjg3OWY1MDUyOTgzYWI3MzNjOC90YWJsZXJhbmdlOjU4Yzk4ZWM2OGVhZDRmODc5ZjUwNTI5ODNhYjczM2M4XzctMy0xLTEtOTA2MTg_f22e19de-1870-4225-8e8d-8e79fca56458">0.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i64eaa8be4efb4867bb9b47e16fac72d7_I20211231" decimals="0" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo1OGM5OGVjNjhlYWQ0Zjg3OWY1MDUyOTgzYWI3MzNjOC90YWJsZXJhbmdlOjU4Yzk4ZWM2OGVhZDRmODc5ZjUwNTI5ODNhYjczM2M4XzgtMS0xLTEtOTA2MTg_147202cd-dcba-4739-8e78-76c84a74bc6f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie146e5c775d746339943039ce5e4a6dd_I20211231" decimals="0" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo1OGM5OGVjNjhlYWQ0Zjg3OWY1MDUyOTgzYWI3MzNjOC90YWJsZXJhbmdlOjU4Yzk4ZWM2OGVhZDRmODc5ZjUwNTI5ODNhYjczM2M4XzgtMy0xLTEtOTA2MTg_0e9e1e8c-9a42-485b-af1d-e0d8bb5e8fd8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i12216c26fb6c4293b5d41c142af5d730"><ix:continuation id="i95a2054d31a740af8146bec4ca1c39e6"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents a reconciliation of the contingent shares issuance liabilities fair value measurements using the significant unobservable inputs (Level 3) (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9596a7ff3bea42e58dcd39b0f38a74fa_I20191231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzEtMS0xLTEtOTA2MTg_eeaee7e6-fb46-499e-922d-eceb83427372">687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10f6a1f2d1324379935392c475073764_I20191231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzEtMy0xLTEtMTAzNzIz_b6b0c41c-6489-4d10-9675-c2d56e5061af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e89877de092491fa0ce31158a83134f_I20191231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzEtNS0xLTEtMTAzNzIz_15c3c423-a073-4de0-97a3-84f7ad38fecf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain recognized in statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8096c15e999498da5d65ca68368db35_D20200101-20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzItMS0xLTEtOTA2MTg_54de8044-e95c-4e04-9d46-384c571def87">105</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if06480e1451e4cb3931502d5a16df7c6_D20200101-20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzItMy0xLTEtMTAzNzIz_af0a0310-4f9f-4679-953c-dfbe6cf68abc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2859bc5f912d48f8a7b394269608ca11_D20200101-20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzItNS0xLTEtMTAzNzIz_0c4cdf89-4363-4816-8c4a-fb3613b0b703">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5618649df5e5458fa3e4d03670a6f48b_I20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzMtMS0xLTEtMTAzNzIz_db27a6d9-19cc-4a60-83de-a6fb36039bd1">582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce53a5d10814231a163555304304500_I20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzMtMy0xLTEtMTAzNzIz_819fb6b9-1e1e-44f0-9e4c-b5c24ddc1545">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iceff32fcb2af47c7981043c476b7ae54_I20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzMtNS0xLTEtMTAzNzIz_b94bcf18-e52d-4cf9-b006-5ca431331ba1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of SAFE liability and warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0741139789474a10a1ce163a9a98a470_D20210101-20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzQtMS0xLTEtMTAzNzI3_0ad55d97-411c-4049-a9c5-aae547e6350f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbd46d99a3b44e778776bac9d32b613b_D20210101-20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzQtMy0xLTEtMTAzNzI3_ff5cd3df-c5b8-4b82-aecd-44abf8bfca49">28,271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b348afbe5de43b8843f3c23b5497e45_D20210101-20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzQtNS0xLTEtMTAzNzI3_fda5d9ed-e253-49cc-ba60-de7b418c12a4">1,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss recognized in statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0741139789474a10a1ce163a9a98a470_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzUtMS0xLTEtOTA2MTg_25108e3e-67ae-473e-b123-f9d58e55a3db">563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbd46d99a3b44e778776bac9d32b613b_D20210101-20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzUtMy0xLTEtMTAzNzI3_763cd95a-d586-411a-a81e-8383db08ca8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b348afbe5de43b8843f3c23b5497e45_D20210101-20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzUtNS0xLTEtMTAzNzI3_1ff52c01-9bbd-49ac-97e7-123d5d55fb44">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0945a26d694b428d8419686bb048d18d_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzYtMS0xLTEtMTAzNzI3_56b8fe9a-1dba-447d-b149-0481a1161857">1,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb53208afd74e9483b23d0e4041d555_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzYtMy0xLTEtMTAzNzI3_64e1b1f2-f896-4a09-9234-f091036d387f">28,271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i079f7d69cf684156b67ee6553c8b6aad_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzYtNS0xLTEtMTAzNzI3_a5912993-bc77-4903-a38d-c06738cd3329">1,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, a warrant was exercised for a total issuance of <ix:nonFraction unitRef="shares" contextRef="i9f67793938594975ad7e63e3f8a4f312_D20210301-20210331" decimals="INF" name="amci:TemporaryEquitySharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90ZXh0cmVnaW9uOmE0NWFkYmNmYzUwZTQwYjlhYmQ3MmNmMzJlOWU5YmJlXzEyNjQ0MzgzNzMwNjk5_7b774582-92de-4764-a6c0-4a0405180f05">158,058</ix:nonFraction> Series D preferred shares. The fair value of this warrant was $<ix:nonFraction unitRef="usd" contextRef="i946f64f7009a4a2082ea5e8ea9ae0377_I20191231" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90ZXh0cmVnaW9uOmE0NWFkYmNmYzUwZTQwYjlhYmQ3MmNmMzJlOWU5YmJlXzEyNjQ0MzgzNzMwNzA4_eda6a868-79b5-468a-ad22-19410007f1e1">107</ix:nonFraction> as of January 1, 2020 and was remeasured to <ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="INF" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90ZXh0cmVnaW9uOmE0NWFkYmNmYzUwZTQwYjlhYmQ3MmNmMzJlOWU5YmJlXzE1OTQyOTE4NjE0MDUy_93853490-dd70-4728-a61d-8f3eb150d2e3">zero</ix:nonFraction> as of December 31, 2020. As a result, the exercise had no impact on the consolidated statement of operations and comprehensive loss as of and for the year ended December 31, 2021.</span></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_446"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7 &#8212; <ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:OtherCurrentAssetsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDYvZnJhZzoyNjNmY2MyY2NhMzg0MjEzYjFkYTI4Y2FjNDk4YzVlNS90ZXh0cmVnaW9uOjI2M2ZjYzJjY2EzODQyMTNiMWRhMjhjYWM0OThjNWU1XzEwOTk1MTE2Mjc4MDE4_4d2f8870-25ec-4fa8-bd22-d17fdcb74f4b" continuedAt="id07ee85f3285471a8a0672f25472ff21" escape="true">Other Current Assets </ix:nonNumeric></span></div><ix:continuation id="id07ee85f3285471a8a0672f25472ff21"><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDYvZnJhZzoyNjNmY2MyY2NhMzg0MjEzYjFkYTI4Y2FjNDk4YzVlNS90ZXh0cmVnaW9uOjI2M2ZjYzJjY2EzODQyMTNiMWRhMjhjYWM0OThjNWU1XzEwOTk1MTE2Mjc4MDE5_2bd0eee3-5936-4cd5-88b3-d58ca7adc471" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020 other current assets consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Materials and supplies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:MaterialsSuppliesAndOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDYvZnJhZzoyNjNmY2MyY2NhMzg0MjEzYjFkYTI4Y2FjNDk4YzVlNS90YWJsZTowYmE1YTI1MDcwY2I0NTM5YWM5YjdmZjA5OTcwNGRkMC90YWJsZXJhbmdlOjBiYTVhMjUwNzBjYjQ1MzlhYzliN2ZmMDk5NzA0ZGQwXzItMS0xLTEtOTA2MTg_a27ba717-5ae2-4af5-87a2-dae08e590c14">2,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:MaterialsSuppliesAndOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDYvZnJhZzoyNjNmY2MyY2NhMzg0MjEzYjFkYTI4Y2FjNDk4YzVlNS90YWJsZTowYmE1YTI1MDcwY2I0NTM5YWM5YjdmZjA5OTcwNGRkMC90YWJsZXJhbmdlOjBiYTVhMjUwNzBjYjQ1MzlhYzliN2ZmMDk5NzA0ZGQwXzItMy0xLTEtOTA2MTg_54f8aa60-004a-45bb-bf94-9f80e71f0d19">1,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDYvZnJhZzoyNjNmY2MyY2NhMzg0MjEzYjFkYTI4Y2FjNDk4YzVlNS90YWJsZTowYmE1YTI1MDcwY2I0NTM5YWM5YjdmZjA5OTcwNGRkMC90YWJsZXJhbmdlOjBiYTVhMjUwNzBjYjQ1MzlhYzliN2ZmMDk5NzA0ZGQwXzMtMS0xLTEtOTA2MTg_57e465de-3615-43b1-a710-51b943178333">1,503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:PrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDYvZnJhZzoyNjNmY2MyY2NhMzg0MjEzYjFkYTI4Y2FjNDk4YzVlNS90YWJsZTowYmE1YTI1MDcwY2I0NTM5YWM5YjdmZjA5OTcwNGRkMC90YWJsZXJhbmdlOjBiYTVhMjUwNzBjYjQ1MzlhYzliN2ZmMDk5NzA0ZGQwXzMtMy0xLTEtOTA2MTg_0b61f80d-4e09-4a27-8991-54e53251f312">1,419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:OtherAssetsMiscellaneousCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDYvZnJhZzoyNjNmY2MyY2NhMzg0MjEzYjFkYTI4Y2FjNDk4YzVlNS90YWJsZTowYmE1YTI1MDcwY2I0NTM5YWM5YjdmZjA5OTcwNGRkMC90YWJsZXJhbmdlOjBiYTVhMjUwNzBjYjQ1MzlhYzliN2ZmMDk5NzA0ZGQwXzQtMS0xLTEtOTA2MTg_e6741f08-71af-4e0c-b484-6b847118c968">1,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:OtherAssetsMiscellaneousCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDYvZnJhZzoyNjNmY2MyY2NhMzg0MjEzYjFkYTI4Y2FjNDk4YzVlNS90YWJsZTowYmE1YTI1MDcwY2I0NTM5YWM5YjdmZjA5OTcwNGRkMC90YWJsZXJhbmdlOjBiYTVhMjUwNzBjYjQ1MzlhYzliN2ZmMDk5NzA0ZGQwXzQtMy0xLTEtOTA2MTg_65360af9-d206-4912-9ce4-1bbf490f2b4b">1,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDYvZnJhZzoyNjNmY2MyY2NhMzg0MjEzYjFkYTI4Y2FjNDk4YzVlNS90YWJsZTowYmE1YTI1MDcwY2I0NTM5YWM5YjdmZjA5OTcwNGRkMC90YWJsZXJhbmdlOjBiYTVhMjUwNzBjYjQ1MzlhYzliN2ZmMDk5NzA0ZGQwXzQtMS0xLTEtMTAwNTM0_1a6f9d7e-d7a2-4488-aec9-4e4abbe6a4a1">5,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDYvZnJhZzoyNjNmY2MyY2NhMzg0MjEzYjFkYTI4Y2FjNDk4YzVlNS90YWJsZTowYmE1YTI1MDcwY2I0NTM5YWM5YjdmZjA5OTcwNGRkMC90YWJsZXJhbmdlOjBiYTVhMjUwNzBjYjQ1MzlhYzliN2ZmMDk5NzA0ZGQwXzQtMy0xLTEtMTAwNTM3_68b167a6-a399-47b6-918c-5b342059a941">4,387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_452"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8 &#8212; <ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90ZXh0cmVnaW9uOmU1ZDE0ZmNiZWU1YTQ0OWQ5OWUxZjllYjllMzJmNmQ3XzEwOTk1MTE2Mjc4MTAw_cbe102c9-a435-4526-bfa4-7f193b9e960e" continuedAt="i7495987f06074c76ac7edd8151c0d782" escape="true">Property, Plant and Equipment</ix:nonNumeric></span></div><ix:continuation id="i7495987f06074c76ac7edd8151c0d782"><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90ZXh0cmVnaW9uOmU1ZDE0ZmNiZWU1YTQ0OWQ5OWUxZjllYjllMzJmNmQ3XzEwOTk1MTE2Mjc4MTAx_04180521-20a3-4a46-88e6-51ab83974bfa" escape="true"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, the Company&#8217;s property, plant and equipment, net consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e7e83e30c3d44fdb6bc2da913857f3f_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzItMS0xLTEtOTA2MTg_553cf9c5-ed64-459f-a1c9-44ced906dbb4">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89df8c332f124e06ace60a1e9c5cab82_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzItMy0xLTEtOTA2MTg_7d58267f-b54f-4fd8-ba13-58d41034d1e4">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if03679d2c8874922bb5588f668eb7d35_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzMtMS0xLTEtOTA2MTg_0b7d78a2-3c8a-4c0c-8fe3-f1ffebe56419">4,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic580d984d78b4b299abd56ff167e37d7_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzMtMy0xLTEtOTA2MTg_54f26a0a-f0e4-461d-9dde-d71796f203c3">4,187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4d0329f226943faa5580463c870698c_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzQtMS0xLTEtOTA2MTg_9b0399c8-b7d2-4cdd-af6d-c1bb9a4fa698">26,627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb3aa04cd5e7479082b4f9014ca3e18c_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzQtMy0xLTEtOTA2MTg_0029ccd3-a1a2-4880-b994-6039c00cd5cb">21,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vehicles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if23e5af08c304d4997948a7aa3740d0c_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzUtMS0xLTEtOTA2MTg_2e56ff1a-8980-41e1-a336-8b08e5125b23">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fa3bebd5c07454880ff014ca7706dc5_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzUtMy0xLTEtOTA2MTg_71ea4923-61f2-4e4b-9764-39568b44c413">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office Equipment and furniture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf4b1adda3834411b36d3d632f21e01c_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzYtMS0xLTEtOTA2MTg_e6e0560b-12cd-4992-a01b-a18c1904b76a">1,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6165c558d2a64bd2ba478d320a293753_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzYtMy0xLTEtOTA2MTg_27a31d4e-703c-43d4-ab37-abfed8d2968f">1,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76b729f3daf846f681967ad7e92f649b_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzctMS0xLTEtOTA2MTg_dd1c993a-ed4f-4b88-bc36-5203f037f255">728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39d2cbb02f9e4ba9b23e10f13e34d417_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzctMy0xLTEtOTA2MTg_48203ab4-81d2-4aeb-ae31-32b8fd32d3cb">544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8a470f3b214430bbb7075de4c3b1041_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzgtMS0xLTEtOTA2MTg_30aaf7f9-3ec9-413f-9dd7-2a28d48c4007">3,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacdef9e753d8416790fee52e2ac18e18_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzgtMy0xLTEtOTA2MTg_92d9cd92-4647-4c75-9522-bc3eb3ea57d2">2,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzgtMS0xLTEtMTAwNTU3_f172b777-6ae7-4dcb-bcf2-f445a4084615">36,521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzgtMy0xLTEtMTAwNTYw_5e3c4f2b-9894-4e89-9f3f-83dbe7509e27">30,298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzExLTEtMS0xLTkwNjE4_ea14775b-94cb-4f1f-bd02-08b30f9c79fd">22,373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzExLTMtMS0xLTkwNjE4_f1dec1d9-39ab-4f14-a902-0be51b653587">18,689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment, net</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzEyLTEtMS0xLTEwMDU2Mw_1446ba35-e6f3-4b97-bcf2-193894031e05">14,148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzEyLTMtMS0xLTEwMDU2Mw_84299ad5-e9d9-41c2-b902-770c9a81bf7d">11,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:9pt;padding-right:33.2pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation for the years ended December&#160;31, 2021 and 2020 totaled $<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90ZXh0cmVnaW9uOmU1ZDE0ZmNiZWU1YTQ0OWQ5OWUxZjllYjllMzJmNmQ3XzIwNg_5ef667f9-ecf5-4ffc-b23e-d0b0d747754c">3,806</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90ZXh0cmVnaW9uOmU1ZDE0ZmNiZWU1YTQ0OWQ5OWUxZjllYjllMzJmNmQ3XzIxMw_fcdf9442-2417-42cd-8674-e6dd7d976091">2,979</ix:nonFraction>, respectively.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_458"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9 &#8212; <ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90ZXh0cmVnaW9uOjQ3MDdlMzY3NDU1ODQ4NmE4NjM5NzJmNzYyNzY2MjI1XzE1OTQyOTE4NjA1Mjg2_183f109b-23fb-48fb-b96b-c685f14a18af" continuedAt="iedc9fadc34154cc98bf4ab9e50021c53" escape="true">Debt</ix:nonNumeric></span></div><ix:continuation id="iedc9fadc34154cc98bf4ab9e50021c53" continuedAt="i5987619df1934386a4a55ed7bd373ee1"><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90ZXh0cmVnaW9uOjQ3MDdlMzY3NDU1ODQ4NmE4NjM5NzJmNzYyNzY2MjI1XzE1OTQyOTE4NjA1Mjg3_726347a9-caa2-40c8-9805-88fed152480f" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, the Company&#8217;s debt consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 WTI Loan</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c4c3289f5c34d4b9daf93c4456e999f_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90YWJsZTphZDUzYmI0M2VkNmY0NDMzOWNhYmQ1ZDFhODRlMzQ5NC90YWJsZXJhbmdlOmFkNTNiYjQzZWQ2ZjQ0MzM5Y2FiZDVkMWE4NGUzNDk0XzItMS0xLTEtOTA2MTg_724a444c-cae7-420c-addc-3abaf8ab3fab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc118da157274cfdb66d08ffff284787_I20201231" decimals="-3" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90YWJsZTphZDUzYmI0M2VkNmY0NDMzOWNhYmQ1ZDFhODRlMzQ5NC90YWJsZXJhbmdlOmFkNTNiYjQzZWQ2ZjQ0MzM5Y2FiZDVkMWE4NGUzNDk0XzItMy0xLTEtOTA2MTg_c057e9c4-f39b-4458-ab5a-e26034888d63">570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPP Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45b11649159e4d9ea0d390a541b073d1_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90YWJsZTphZDUzYmI0M2VkNmY0NDMzOWNhYmQ1ZDFhODRlMzQ5NC90YWJsZXJhbmdlOmFkNTNiYjQzZWQ2ZjQ0MzM5Y2FiZDVkMWE4NGUzNDk0XzMtMS0xLTEtOTA2MTg_1c907713-d969-416b-b357-b1c0039e6ce4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30198db7c24e48949cc55680e9933f73_I20201231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90YWJsZTphZDUzYmI0M2VkNmY0NDMzOWNhYmQ1ZDFhODRlMzQ5NC90YWJsZXJhbmdlOmFkNTNiYjQzZWQ2ZjQ0MzM5Y2FiZDVkMWE4NGUzNDk0XzMtMy0xLTEtOTA2MTg_eabc40df-963c-4445-a3dd-a76aecbcb9f1">3,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90YWJsZTphZDUzYmI0M2VkNmY0NDMzOWNhYmQ1ZDFhODRlMzQ5NC90YWJsZXJhbmdlOmFkNTNiYjQzZWQ2ZjQ0MzM5Y2FiZDVkMWE4NGUzNDk0XzMtMS0xLTEtMTAzNzQy_79dae61d-9c0a-4b10-b01d-c062d3c3986e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90YWJsZTphZDUzYmI0M2VkNmY0NDMzOWNhYmQ1ZDFhODRlMzQ5NC90YWJsZXJhbmdlOmFkNTNiYjQzZWQ2ZjQ0MzM5Y2FiZDVkMWE4NGUzNDk0XzMtMy0xLTEtMTAzNzQy_bd375d30-1066-44a4-815b-3495c22215ac">3,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less amount due within one year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90YWJsZTphZDUzYmI0M2VkNmY0NDMzOWNhYmQ1ZDFhODRlMzQ5NC90YWJsZXJhbmdlOmFkNTNiYjQzZWQ2ZjQ0MzM5Y2FiZDVkMWE4NGUzNDk0XzUtMS0xLTEtOTA2MTg_a7fc4e72-5ca5-45f2-a12b-ce42367ba904">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:LongTermDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90YWJsZTphZDUzYmI0M2VkNmY0NDMzOWNhYmQ1ZDFhODRlMzQ5NC90YWJsZXJhbmdlOmFkNTNiYjQzZWQ2ZjQ0MzM5Y2FiZDVkMWE4NGUzNDk0XzUtMy0xLTEtOTA2MTg_d4737846-60f2-43ad-bd1a-436557bf0a36">570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt due after one year, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90YWJsZTphZDUzYmI0M2VkNmY0NDMzOWNhYmQ1ZDFhODRlMzQ5NC90YWJsZXJhbmdlOmFkNTNiYjQzZWQ2ZjQ0MzM5Y2FiZDVkMWE4NGUzNDk0XzUtMS0xLTEtMTAzNzQy_7bc5b827-7010-4b57-bcaa-96382d09e199">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90YWJsZTphZDUzYmI0M2VkNmY0NDMzOWNhYmQ1ZDFhODRlMzQ5NC90YWJsZXJhbmdlOmFkNTNiYjQzZWQ2ZjQ0MzM5Y2FiZDVkMWE4NGUzNDk0XzUtMy0xLTEtMTAzNzQy_0bd9ebe2-e098-48e9-a8d9-58dfe403ab53">3,065</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2016, a loan facility was entered into with Venture Lending and Leasing VII, Inc. and Venture Lending and Leasing VIII, Inc. (the &#8220;2016 WTI Loan&#8221;) for a total of $<ix:nonFraction unitRef="usd" contextRef="i404699cd00694919a171cbd57221125e_I20161231" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90ZXh0cmVnaW9uOjQ3MDdlMzY3NDU1ODQ4NmE4NjM5NzJmNzYyNzY2MjI1XzI2NQ_e6ff3d00-43dc-463c-b48b-01426134717e">17,500</ix:nonFraction> available in three tranches, all of which have been drawn. Tranches one and two were fully repaid as of December&#160;31, 2020. The coupon interest rate for each tranche is the WSJ prime rate, at the time of each drawdown, plus <ix:nonFraction unitRef="number" contextRef="i593657e076c3432fa7ca2b295b005b97_D20160101-20161231" decimals="2" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90ZXh0cmVnaW9uOjQ3MDdlMzY3NDU1ODQ4NmE4NjM5NzJmNzYyNzY2MjI1XzQ3Ng_de3525f1-0780-41ff-b1a4-6f1042c242a5">9.0</ix:nonFraction>%, but not less than <ix:nonFraction unitRef="number" contextRef="i404699cd00694919a171cbd57221125e_I20161231" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90ZXh0cmVnaW9uOjQ3MDdlMzY3NDU1ODQ4NmE4NjM5NzJmNzYyNzY2MjI1XzQ5OA_589820dd-fa69-40ac-a584-2787caac1585">12.5</ix:nonFraction>%. The term of each drawdown is <ix:nonNumeric contextRef="idee985caefbc450c8367961aff024380_D20160101-20161231" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90ZXh0cmVnaW9uOjQ3MDdlMzY3NDU1ODQ4NmE4NjM5NzJmNzYyNzY2MjI1XzE1OTQyOTE4NjA1MzAy_64d1ce5f-6ff1-4fb7-99bd-fea2cc29d13c">39</ix:nonNumeric> months, including nine months of interest-only payments. The loan facility was secured by all of the Company&#8217;s assets. In March 2021, the Company repaid $<ix:nonFraction unitRef="usd" contextRef="i9219179a97ab4a4b82c9454bafb8d9fe_D20210301-20210331" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90ZXh0cmVnaW9uOjQ3MDdlMzY3NDU1ODQ4NmE4NjM5NzJmNzYyNzY2MjI1XzEyNjQ0MzgzNzIxOTUz_479cda92-8c2e-4a83-9e49-9663842e1cb2">570</ix:nonFraction> on outstanding amounts owed on the 2016 WTI loan facility. As of December&#160;31, 2021, tranche three was fully repaid and the Company has no outstanding debt under this facility. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was required to meet certain non-financial covenants in its loan facility agreement. In 2021 and 2020, the Company was in compliance with all non-financial covenants. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Paycheck Protection Program Loan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, the Company was granted a loan in the amount of $<ix:nonFraction unitRef="usd" contextRef="ic037a70c12df457680d3fb392aa182f3_D20200401-20200430" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90ZXh0cmVnaW9uOjQ3MDdlMzY3NDU1ODQ4NmE4NjM5NzJmNzYyNzY2MjI1XzExMjY_0b47eb60-5656-418e-a43a-8b27c9f52cde">3,065</ix:nonFraction> pursuant to the Paycheck Protection Program (the &#8220;PPP Loan&#8221;) under the Coronavirus Aid, Relief and Economic Security Act. The PPP Loan has a two-year term and bears interest at a rate of <ix:nonFraction unitRef="number" contextRef="i066afad72e9d4b139078a273831e92d4_I20200430" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90ZXh0cmVnaW9uOjQ3MDdlMzY3NDU1ODQ4NmE4NjM5NzJmNzYyNzY2MjI1XzEzMTY_f87adf00-be28-4f84-87e9-db7522ea5a4f">0.98</ix:nonFraction>% per annum. Monthly principal and interest payments are deferred for six months after the date of disbursement. The PPP Loan may be prepaid at any time prior to maturity with no prepayment penalties. The PPP Loan contains events of default and other provisions customary for a loan of this type. The PPP Loan may be forgiven if used under program parameters for payroll, mortgage interest, and rent expenses. During 2021 and 2020, the Company was in compliance with the terms of the PPP Loan.</span></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5987619df1934386a4a55ed7bd373ee1">On September 28, 2021, the Company received notice that the obligation of $<ix:nonFraction unitRef="usd" contextRef="i9e518f168d1f463d87802b9ada1450e7_D20210928-20210928" decimals="-3" name="us-gaap:DebtInstrumentDecreaseForgiveness" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90ZXh0cmVnaW9uOjQ3MDdlMzY3NDU1ODQ4NmE4NjM5NzJmNzYyNzY2MjI1XzEwOTk1MTE2MjgwMzI0_0bae7892-c568-4acd-85a8-4147581f1ec5">3,065</ix:nonFraction> had been forgiven, and the Company has <ix:nonFraction unitRef="usd" contextRef="ia3c4ceff701e45aabe297c3d9da57706_I20210928" decimals="INF" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90ZXh0cmVnaW9uOjQ3MDdlMzY3NDU1ODQ4NmE4NjM5NzJmNzYyNzY2MjI1XzEyNjQ0MzgzNzIxOTQ0_712f8707-9046-4b71-8ba5-6728dfb235ff">no</ix:nonFraction> outstanding debt under this program. The Company recorded the gain on extinguishment in the 2021 consolidated statement of operations and comprehensive loss.</ix:continuation> </span></div><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_464"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10 &#8212; <ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="amci:SimpleAgreementForFutureEquityLiabilityDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NjQvZnJhZzpkNDE3NzAwNmY2OTQ0NWYyYjdmMjllNzg0ZGMwZDkxNS90ZXh0cmVnaW9uOmQ0MTc3MDA2ZjY5NDQ1ZjJiN2YyOWU3ODRkYzBkOTE1XzE1OTQyOTE4NjA1MDQ5_a9da5f51-bf6a-47fb-99d3-ac7872e21042" continuedAt="i065fb2e50f7f4ff9914d3273f28a5077" escape="true">SAFE</ix:nonNumeric></span></div><ix:continuation id="i065fb2e50f7f4ff9914d3273f28a5077" continuedAt="idadf30b1c2a846468029db9ae5b49c32"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company issued a SAFE that allows an investor to participate in future equity financings through a share-settled redemption of the amount invested (such notional being the &#8220;invested amount&#8221;). Upon the occurrence of a change of control, the investor has the right to receive the greater of (i) a cash payment equal to the invested amount under such SAFE, or (ii) the consideration payable in such change of control in respect of the number of common shares equal to the invested amount divided by the liquidity price set forth in the applicable SAFE. Upon an initial public offering or a business combination with a special purpose acquisition company, the investor has the right to receive a number of common shares equal to the invested amount divided by the liquidity price set forth in the applicable SAFE, except that if a business combination with a special purpose acquisition company involves a private placement of newly issued shares, the invested amount will be treated as participating in such private placement and exchanged for a number of common shares equal to the invested amount divided by the price per share applicable in such private placement (subject to a discount upon certain circumstances).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SAFE also contains change of control and initial public offering settlement alternatives described above, that settle differently upon a next round financing such that it allows the investor to participate in future equity </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="idadf30b1c2a846468029db9ae5b49c32" continuedAt="i20c21a7f8fa14829b74220bbeb8bdbe5">financings through a share-settled redemption at a discounted price to the price paid by other investors. That is, upon a future equity financing involving preferred shares, the SAFE would be settled into a number of preferred shares equal to the invested amount of the SAFE divided by a percentage of the discounted price investors paid to purchase preferred shares in the financing, with such discounted price calculated as a percentage of the price investors paid to purchase preferred shares in the financing.</ix:continuation></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i20c21a7f8fa14829b74220bbeb8bdbe5">The SAFE had not yet converted to equity as a qualifying financing event had not occurred as of December 31, 2021. At December 31, 2021, the SAFE had a fair value of $<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="amci:SimpleAgreementForFutureEquityLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NjQvZnJhZzpkNDE3NzAwNmY2OTQ0NWYyYjdmMjllNzg0ZGMwZDkxNS90ZXh0cmVnaW9uOmQ0MTc3MDA2ZjY5NDQ1ZjJiN2YyOWU3ODRkYzBkOTE1XzIxNjY_100a6ead-a1e9-425a-8ab5-05f7cc4ff5f2">28,271</ix:nonFraction> and was recorded within current liabilities on the consolidated balance sheet.</ix:continuation> </span></div><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_468"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11 &#8212; <ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:DerivativesAndFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NjgvZnJhZzoxMjcyNGM3MjNlZTc0NWNjYmQzMjc3MTFlM2UzMDE3OS90ZXh0cmVnaW9uOjEyNzI0YzcyM2VlNzQ1Y2NiZDMyNzcxMWUzZTMwMTc5XzEwOTk1MTE2Mjc4Njkw_99614d62-6132-4200-a8c6-17b86ff5b2be" continuedAt="i5362f15fad504b0ebff9401d5c887f32" escape="true">Warrant Liabilities</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-indent:18pt"><ix:continuation id="i5362f15fad504b0ebff9401d5c887f32"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with certain loan borrowing agreements and equity raises, the Company issues warrants to purchase preferred shares. The Company evaluated the accounting treatment for the preferred share warrants issued and concluded pursuant to its evaluation of ASC 480, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distinguishing Liabilities From Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and determined that there is an obligation to issue a variable number of shares and as such, were considered a liability in the consolidated balance sheets. The warrant liability requires the Company to remeasure the value of the underlying warrants and report the effect of the changes on the Company&#8217;s operations until the warrants are exercised or expired. The primary underlying risk exposure pertaining to the warrants is the change in fair value of the underlying preferred shares for each reporting period.</span></ix:continuation></div><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_474"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 12 &#8212; <ix:continuation id="i8f9f3f6a434342f48795de3cf5e528df" continuedAt="ib76df21bd80b493994d63a360c9be0a9">Income Taxes</ix:continuation></span></div><ix:continuation id="ib76df21bd80b493994d63a360c9be0a9" continuedAt="i924a084020a74becb7f7be7b84f19ef4"><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzE1OTQyOTE4NjA3MzQy_a4950562-2991-4731-a1da-216f5f74e0de" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of (loss) income before income taxes and gain from equity method investees, net are as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8aafbe30b7bb4fd68e9bf6b7a590d428_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo1ZjNkNDdhZmEwOTk0YTFlODdiOTA3NTEzZTdjYjg5My90YWJsZXJhbmdlOjVmM2Q0N2FmYTA5OTRhMWU4N2I5MDc1MTNlN2NiODkzXzMtMS0xLTEtOTA2MTg_2fabe8bf-1acc-4d6b-804c-8c97c606d832">39,860</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc03a6bd4624cafb93bad1d3f537cdc_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo1ZjNkNDdhZmEwOTk0YTFlODdiOTA3NTEzZTdjYjg5My90YWJsZXJhbmdlOjVmM2Q0N2FmYTA5OTRhMWU4N2I5MDc1MTNlN2NiODkzXzMtMy0xLTEtOTA2MTg_b1f6af01-36fc-4094-a1ec-343b50ca7195">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Zealand</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie93366da59b6430ca421d5c1bbe96fbe_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo1ZjNkNDdhZmEwOTk0YTFlODdiOTA3NTEzZTdjYjg5My90YWJsZXJhbmdlOjVmM2Q0N2FmYTA5OTRhMWU4N2I5MDc1MTNlN2NiODkzXzQtMS0xLTEtOTA2MTg_18fcb163-8d14-40b2-b872-827779d932f7">7,551</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i674eabcf32014cbbbafe71136b7607fc_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo1ZjNkNDdhZmEwOTk0YTFlODdiOTA3NTEzZTdjYjg5My90YWJsZXJhbmdlOjVmM2Q0N2FmYTA5OTRhMWU4N2I5MDc1MTNlN2NiODkzXzQtMy0xLTEtOTA2MTg_825f1b93-172d-421a-aee6-81a113a8646f">40,651</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo1ZjNkNDdhZmEwOTk0YTFlODdiOTA3NTEzZTdjYjg5My90YWJsZXJhbmdlOjVmM2Q0N2FmYTA5OTRhMWU4N2I5MDc1MTNlN2NiODkzXzUtMS0xLTEtOTA2MTg_be77ec53-d871-4305-97d3-9e8b3511cecf">722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo1ZjNkNDdhZmEwOTk0YTFlODdiOTA3NTEzZTdjYjg5My90YWJsZXJhbmdlOjVmM2Q0N2FmYTA5OTRhMWU4N2I5MDc1MTNlN2NiODkzXzUtMy0xLTEtOTA2MTg_fa880a6b-1e70-4f30-a250-7a75971d019d">2,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo1ZjNkNDdhZmEwOTk0YTFlODdiOTA3NTEzZTdjYjg5My90YWJsZXJhbmdlOjVmM2Q0N2FmYTA5OTRhMWU4N2I5MDc1MTNlN2NiODkzXzYtMS0xLTEtOTA2MTg_9cc31a22-bf6e-44c6-ab69-bda7a1014c3d">46,689</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo1ZjNkNDdhZmEwOTk0YTFlODdiOTA3NTEzZTdjYjg5My90YWJsZXJhbmdlOjVmM2Q0N2FmYTA5OTRhMWU4N2I5MDc1MTNlN2NiODkzXzYtMy0xLTEtOTA2MTg_f0b225dc-a0e4-4114-a02d-61e241c2a9c0">37,713</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:continuation id="i914588d7f8f04abba97ec9edc4c23520"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of income tax expense were as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aafbe30b7bb4fd68e9bf6b7a590d428_D20210101-20211231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzMtMS0xLTEtOTA2MTg_8f0eb65a-b8d3-4740-b15b-118fa8677d0a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc03a6bd4624cafb93bad1d3f537cdc_D20200101-20201231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzMtMy0xLTEtOTA2MTg_440987b4-38ea-4a58-91ed-01763a9e883c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Zealand</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie93366da59b6430ca421d5c1bbe96fbe_D20210101-20211231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzQtMS0xLTEtMTA2NTY2_d5270eb1-9cf2-4abb-8fee-0bc44b83f08c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i674eabcf32014cbbbafe71136b7607fc_D20200101-20201231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzQtMy0xLTEtMTA2NTY2_4d30cd8d-949d-4d6c-85a9-0c377c855d8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzUtMS0xLTEtOTA2MTg_d289a7a5-b221-4e2a-83b4-3daf5b1daf6f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzUtMy0xLTEtOTA2MTg_5e0d1802-91f5-432c-9c20-d667a48802e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzYtMS0xLTEtMTAzODA5_c54b9acc-4fe3-476d-af27-d9554d060b2d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzYtMy0xLTEtMTAzODA5_10034237-96f8-4a9e-88f1-8275f4ca2d06">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aafbe30b7bb4fd68e9bf6b7a590d428_D20210101-20211231" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzgtMS0xLTEtOTA2MTg_e8f5fd06-a519-4aa4-a5e8-70ff75143d71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc03a6bd4624cafb93bad1d3f537cdc_D20200101-20201231" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzgtMy0xLTEtOTA2MTg_f9ad4456-b4fa-4624-bfb0-fc0d7cc06ffd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Zealand</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie93366da59b6430ca421d5c1bbe96fbe_D20210101-20211231" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzktMS0xLTEtMTAzODA5_31cb6a41-8297-457a-ab61-c952b641bdae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i674eabcf32014cbbbafe71136b7607fc_D20200101-20201231" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzktMy0xLTEtMTAzODA5_46ee91ef-81a0-4e92-a027-6be3d339738d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzEwLTEtMS0xLTkwNjE4_cb2b31e7-3804-4949-9c48-c479342a8a3a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzEwLTMtMS0xLTkwNjE4_8fe0ec4a-13da-4f1b-9da6-18c3b2858bdb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzExLTEtMS0xLTEwMzgwOQ_eb56fd2e-f390-435d-b4b2-b086051916e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzExLTMtMS0xLTEwMzgwOQ_4d6b76a5-819f-4015-8481-794aaeff87fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i059ddb4036db47439d1ef89ee1fa7fc3" continuedAt="i79607d70bdde42b6a1e52d05edc234fc">The following table is a reconciliation of income taxes computed at the statutory federal income tax rate (<ix:nonFraction unitRef="number" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzMzNg_bd30c525-b933-44d8-a79a-b23af15cad91">21.0</ix:nonFraction>% federal income tax rate in the United States for 2021 and <ix:nonFraction unitRef="number" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzM5NQ_987aa55c-61b5-4c36-ba87-9faf2ee05be8">28.0</ix:nonFraction>% federal income tax rate in the New Zealand for </ix:continuation></span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i924a084020a74becb7f7be7b84f19ef4" continuedAt="i6b1c762794ec4c12b25bd2eb42f8bc6c"><ix:continuation id="i79607d70bdde42b6a1e52d05edc234fc"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020, respectively) to the income tax expense (benefit) reflected in the consolidated statement of operations and comprehensive loss (in thousands, except percentages):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit) at the statutory federal income tax rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzMtMS0xLTEtOTA2MTg_ad2f8d6d-11c6-4d56-b208-83ca591942d7">9,805</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzMtMi0xLTEtOTA2MTg_bd30c525-b933-44d8-a79a-b23af15cad91">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzMtNC0xLTEtOTA2MTg_b0269dc3-2782-4d4d-94d6-3eab7539569a">10,560</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzMtNS0xLTEtOTA2MTg_987aa55c-61b5-4c36-ba87-9faf2ee05be8">28.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax rate differential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzQtMS0xLTEtOTA2MTg_a7f05575-097d-4f14-90fb-6970660bd2c6">605</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzQtMi0xLTEtOTA2MTg_b7bdef8e-3cfa-4688-a8cb-189fffb8573b">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzQtNC0xLTEtOTA2MTg_3c4a67ca-2bbc-4f70-9cbd-172337d96039">1,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzQtNS0xLTEtOTA2MTg_9b676220-acde-4c3e-9f7d-462bd3e437c7">3.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzUtMS0xLTEtOTA2MTg_a0b250e6-4028-47c7-8ad3-c1333ceefaa9">4,068</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzUtMi0xLTEtOTA2MTg_c5ccf8f1-cf81-43a3-ba52-6dea192f4aa0">8.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzUtNC0xLTEtOTA2MTg_9d3eb903-5bf1-4c7e-be03-27e8683036e4">2,429</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzUtNS0xLTEtOTA2MTg_831e066e-62c6-487d-8fad-fe1aad95fbb5">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzYtMS0xLTEtOTA2MTg_783c1684-caec-432b-86c5-96bd1691d09e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzYtMi0xLTEtOTA2MTg_c2ba4497-32fe-4063-9530-901e4fe766d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzYtNC0xLTEtOTA2MTg_3675a987-9ad9-4ca5-9268-64db5e8de950">10,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzYtNS0xLTEtOTA2MTg_6ee7761a-0ebe-4436-9056-2d27701c9ae0">27.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="amci:EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzctMS0xLTEtOTA2MTg_4c50a2c9-c9df-4a45-bb80-5c58670d2c3d">143</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="3" name="amci:EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzctMi0xLTEtOTA2MTg_3d14d962-36c7-429a-845e-10a71b371f60">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="amci:EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzctNC0xLTEtOTA2MTg_f553fe5d-578e-4ee7-afdb-5f824abc533f">5,892</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="3" name="amci:EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzctNS0xLTEtOTA2MTg_5eb690b8-1e8d-4d2f-8902-ef0049f12ed7">16.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzgtMS0xLTEtOTA2MTg_ba7ad18e-540e-4a25-aa1a-6fb4c57f3061">501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzgtMi0xLTEtOTA2MTg_ba72f760-46df-4024-b68b-8b860e6df5cc">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzgtNC0xLTEtOTA2MTg_90b0b97b-8827-48c8-8227-3f79af923531">670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzgtNS0xLTEtOTA2MTg_d3bee6f7-1b83-4af4-89c9-bd180c1ca395">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income on receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="amci:EffectiveIncomeTaxRateReconciliationInterestIncomeAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzktMS0xLTEtOTA2MTg_b6d22f89-4613-4755-b7a6-4cf57174b1b1">882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="3" sign="-" name="amci:EffectiveIncomeTaxRateReconciliationInterestIncomePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzktMi0xLTEtOTA2MTg_f55017f4-4050-489e-9c1c-0f45cf79d94a">1.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="amci:EffectiveIncomeTaxRateReconciliationInterestIncomeAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzktNC0xLTEtOTA2MTg_44b81ef4-4e6f-41fa-a10c-45e2fc891f03">2,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="3" sign="-" name="amci:EffectiveIncomeTaxRateReconciliationInterestIncomePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzktNS0xLTEtOTA2MTg_73fbd9c4-d9b0-4a96-a498-cc3c3969213a">5.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" sign="-" name="amci:EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzEwLTEtMS0xLTkwNjE4_2259cf90-6a8e-4606-adcf-d136f06db8bc">443</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="3" name="amci:EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzEwLTItMS0xLTkwNjE4_0e5ab231-8975-42af-b5bc-397fcdc71ece">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="amci:EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzEwLTQtMS0xLTkwNjE4_1c17bd6f-8e03-4134-99f3-2cf77d95221c">679</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="3" name="amci:EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzEwLTUtMS0xLTkwNjE4_bdab59e1-6b34-43bc-b001-373706afa834">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible legal costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="amci:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzExLTEtMS0xLTkwNjE4_42e78396-6792-47fc-8fa5-53864ec75432">1,291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="3" sign="-" name="amci:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzExLTItMS0xLTkwNjE4_91edd467-cba8-45fa-a14b-8c230565ec8e">2.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="amci:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzExLTQtMS0xLTkwNjE4_4e2ac24a-e4f6-4133-97da-8a78d253e4e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="3" name="amci:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzExLTUtMS0xLTkwNjE4_d40dd0c6-17bb-455b-bcf3-2b8b46e7c2aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from redomiciliation of intellectual property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="amci:EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzEyLTEtMS0xLTkwNjE4_e13624f5-c7e5-47cf-b2ac-573c0b2729b1">4,890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="3" sign="-" name="amci:EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzEyLTItMS0xLTkwNjE4_d1b5431c-0770-4859-b003-d2230b7046c2">10.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="amci:EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzEyLTUtMS0xLTEwMzgyNg_6944b8b7-d4b5-4774-abfe-d6da70eb0f86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="3" name="amci:EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzEyLTctMS0xLTEwMzgyNg_70c762bb-9db5-44f2-9706-1233c08ae21c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzEzLTEtMS0xLTkwNjE4_cf91be70-9036-4d0a-a805-bf14085984df">7,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzEzLTItMS0xLTkwNjE4_07010753-f59e-4805-bd2b-8f25546df7a6">17.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzEzLTQtMS0xLTkwNjE4_11e9b286-956c-4f48-9047-f5d478218b61">5,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzEzLTUtMS0xLTkwNjE4_29279f90-58a0-4e50-b600-987f6dc6638f">14.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPP loan forgiveness</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="amci:EffectiveIncomeTaxRateReconciliationDebtForgivenessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzE0LTEtMS0xLTkwNjE4_4219f644-2722-4cf0-92e5-16a0ab5ffca2">644</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="3" sign="-" name="amci:EffectiveIncomeTaxRateReconciliationDebtForgivenessPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzE0LTItMS0xLTkwNjE4_eb76abaa-3f3e-43c8-b406-34af5bf4a7b9">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="amci:EffectiveIncomeTaxRateReconciliationDebtForgivenessAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzE0LTQtMS0xLTkwNjE4_3fb376b7-5928-4edd-9f71-b480eb0e7f80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="3" name="amci:EffectiveIncomeTaxRateReconciliationDebtForgivenessPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzE0LTUtMS0xLTkwNjE4_8d28bf71-3a34-4d94-9744-4665346fb0eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzE1LTEtMS0xLTkwNjE4_a8bdc6b0-f0b6-40ae-95af-402620bfa1d8">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzE1LTItMS0xLTkwNjE4_984deeb4-4e0a-42e9-9d65-08d004c04b09">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzE1LTQtMS0xLTkwNjE4_f8fab86f-8778-4ab8-a813-c3b9d8bb4663">196</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzE1LTUtMS0xLTkwNjE4_34f48e35-d7d1-4791-8c44-ba469b0fe2be">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax benefit</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzE2LTEtMS0xLTEwMzgyNg_458feac6-207a-4f3f-a39a-dea74a97df0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzE2LTMtMS0xLTEwMzgyNg_48be2175-746c-4718-86dc-194123e43caf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzE2LTUtMS0xLTEwMzgyNg_5841875a-1548-4e24-b244-024c69840556">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzE2LTctMS0xLTEwMzgyNg_1c4beeb3-19d2-44e8-b6c2-6689bc419312">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i6b1c762794ec4c12b25bd2eb42f8bc6c" continuedAt="ife62ddd6759343b0b0221b4ff1d66dcc"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Taxes</span></div><ix:continuation id="ide653d35c1ac44b68a689059132f8f33"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of deferred tax assets and liabilities as of December&#160;31, 2021 and 2020, were as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss and credit carryforwards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzMtMS0xLTEtOTA2MTg_0ddfd107-cb16-45b4-8e51-db58b57012e8">107,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzMtMy0xLTEtOTA2MTg_4f823864-5d5b-4c50-9c55-4779231602ba">104,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="amci:DeferredTaxAssetsLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzQtMS0xLTEtOTA2MTg_42cb086c-621c-4f33-aef2-0b73d8366cd5">1,878</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="amci:DeferredTaxAssetsLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzQtMy0xLTEtOTA2MTg_6295ded2-f0f1-4eb5-afdc-207726e5eb11">2,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued bonus</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzUtMS0xLTEtOTA2MTg_5e334046-2367-4fc8-94d4-9493ec7d23c0">981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzUtMy0xLTEtOTA2MTg_0807419d-f9f9-418b-94da-6d1d191a99c5">850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzYtMS0xLTEtOTA2MTg_386ef617-6e14-483e-92e7-f34e7a44b000">1,566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzYtMy0xLTEtOTA2MTg_5345820e-3b4e-4df8-9476-3107a65e08d4">429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsDeferredIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzctMS0xLTEtOTA2MTg_4ad87bb8-9140-4845-a51d-5eb43b7939a8">309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsDeferredIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzctMy0xLTEtOTA2MTg_0ce8daf2-f806-460f-8d07-9ba34687afe2">1,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzgtMS0xLTEtOTA2MTg_5d41037c-c199-4bc2-8992-1654e7fae65f">1,243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzgtMy0xLTEtOTA2MTg_c2703a6f-a557-4b51-8139-00cfcf9033e6">1,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzktMS0xLTEtOTA2MTg_f8d671ae-f2fc-41c7-a6c0-af81a58a1811">925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzktMy0xLTEtOTA2MTg_414cadd0-8638-4237-b79c-6b6d71f719b3">394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzEwLTItMS0xLTEwMzg1OA_27417e59-c0bf-4ade-9e45-019c35fb3cc3">114,881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzEwLTQtMS0xLTEwMzg1OA_98964e74-e8b1-469c-b6e1-a099b1208f0f">110,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzExLTEtMS0xLTkwNjE4_91e95bfd-852f-49e1-ad83-80cd0125b832">113,276</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzExLTMtMS0xLTkwNjE4_fc9756b2-f758-4262-99fb-daa23ba118c5">108,300</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax asset</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzEyLTItMS0xLTEwMzg1OA_ba61881f-6fb3-4d99-b3cd-ffc8868ef44b">1,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzEyLTQtMS0xLTEwMzg1OA_15dbba94-9a6d-4163-95db-3de2f4cc2170">2,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease asset</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzE0LTEtMS0xLTkwNjE4_e6eec02e-4814-4229-9486-e2f1b5fa3537">1,429</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzE0LTMtMS0xLTkwNjE4_f3ae3032-b5f6-47f3-acac-5ec041b64d28">1,941</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzE1LTEtMS0xLTkwNjE4_e848d44b-60b1-4413-a257-b12d52cce60d">176</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzE1LTMtMS0xLTkwNjE4_28bd6842-0f78-4a98-b1c7-4397231df7bf">176</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzE2LTItMS0xLTEwMzg1OA_0df82fcf-c9e8-4ad7-849d-426b90f5ce9b">1,605</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzE2LTQtMS0xLTEwMzg1OA_75364d7e-1ebc-4c7e-a8bd-b0e8941fe47a">2,117</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net deferred income tax assets and liabilities:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzE4LTItMS0xLTEwMzg1OA_2577df8f-664b-42d8-b762-6f1c3171db7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzE4LTQtMS0xLTEwMzg1OA_95e17fc8-dc94-4031-988a-1bc5ba6e1e60">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021 and 2020, the Company had $<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="amci:OperatingLossAndTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2Xzc3Mw_bd4344ff-dd30-4ce9-8d74-ff4ed271c0a7">299,194</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="amci:OperatingLossAndTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2Xzc4MA_fcea64ed-d279-4cf8-a66c-2bfd11f8460b">271,390</ix:nonFraction>, respectively, of tax losses and credits carried forward subject to shareholder continuity and acceptance in the countries where the Company has tax losses carried forward. R&amp;D tax credits included within these amounts are $<ix:nonFraction unitRef="usd" contextRef="i7126fac96e634ad0af8988b83b1e7593_I20211231" decimals="-3" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEwMDY_11fb7005-1afc-45ea-9adb-377daf953d94">35,147</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i04acfe14cd6f4c0da7448253e2c86947_I20201231" decimals="-3" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEwMTM_8369a140-a854-47b5-a577-cecc24d89be9">40,556</ix:nonFraction>, respectively, which may be available to offset future income tax liabilities. At December&#160;31, 2021 and 2020, the net operating loss and credit carryforwards are comprised of $<ix:nonFraction unitRef="usd" contextRef="i43158a95b30f4aaab73e7597bb3c2a77_I20211231" decimals="-3" name="amci:OperatingLossAndTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzExNzQ_5a601b14-1056-428c-9c25-550934683357">239,559</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i1bc2ae3cc9a8471192b73d09b8c4196c_I20201231" decimals="-3" name="amci:OperatingLossAndTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzExODE_691c4090-1ff2-4c77-82f5-6366c7abe237">196,442</ix:nonFraction> in the United States, $<ix:nonFraction unitRef="usd" contextRef="i14808e8f9df64a649044715542143c00_I20211231" decimals="-3" name="amci:OperatingLossAndTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEyMDY_95b5b1d3-a114-41b6-8fe4-177c7d98e54b">22,203</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ied52ef89a5c14dea943af84ca5eee65e_I20201231" decimals="-3" name="amci:OperatingLossAndTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEyMTM_a70ac59e-c813-4a53-980d-e220ce62e353">18,104</ix:nonFraction> in state and local, $<ix:nonFraction unitRef="usd" contextRef="i180c304002694f86a2cf308b957c10a8_I20211231" decimals="-3" name="amci:OperatingLossAndTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEyMzY_da9be9a8-183c-493d-a8c9-f677f36dc96b">35,116</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i46667c1000434c14a56ef64c99eb3a8c_I20201231" decimals="-3" name="amci:OperatingLossAndTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEyNDM_9a879170-9cff-433d-8db4-4d92c31e7dfe">54,334</ix:nonFraction> in New Zealand, and $<ix:nonFraction unitRef="usd" contextRef="ie04b19809090466ab84ebbe80fe42718_I20211231" decimals="-3" name="amci:OperatingLossAndTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEyNjY_36b6597d-7f18-486a-abf7-fe7522567d76">4,589</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ib5a23afc7674452e9cdd8908a9228efd_I20201231" decimals="-3" name="amci:OperatingLossAndTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEyNzM_00ac3426-6131-440c-a12d-16b80a399dc7">2,510</ix:nonFraction> in other foreign jurisdictions, respectively. At December&#160;31, 2021 and 2020, the Company had net operating loss carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="amci:OperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzE0MDI_0693b6bc-05b8-431a-a04e-ec3387c64fa5">136,454</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="amci:OperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzE0MDk_16749047-8898-4910-b33d-c91417f0a110">132,373</ix:nonFraction>, respectively, that expire in various years from 2022 through 2037, plus $<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="amci:OperatingLossCarryforwardsNotSubjectToExpiration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzE0ODU_1c8ac200-51d2-4262-a7ba-b66c7e50c6d4">127,593</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="amci:OperatingLossCarryforwardsNotSubjectToExpiration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzE0OTI_85a9c25b-540f-4a84-8c46-b88398bc9b23">98,462</ix:nonFraction>, respectively, for which there is no expiration date. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 382 of the Internal Revenue Code imposes an annual limitation on the utilization of net operating loss carryforwards based on a statutory rate of return and the value of the corporation at the time of a &#8220;change of ownership&#8221; as defined by Section 382. The Company had a change in ownership</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in November 2014. T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">herefore, the Company&#8217;s ability to utilize its net operating loss carryforwards incurred prior to the 2014 ownership change, will be subject in future periods to annual limitations. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In assessing the realizability of deferred tax assets, the Company assesses whether it is more-likely-than-not that a portion or all of the deferred tax assets will not be realized. The Company considers the scheduled reversal of deferred tax liabilities, tax planning strategies and projected future taxable income in making this assessment. At December&#160;31, 2021 and 2020, a valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzI0MzI_0137224b-3e90-4e73-a380-c7e7b6263c98">113,276</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzI0Mzk_e628183c-20bb-4ef6-9ce2-c4064f6dd621">108,300</ix:nonFraction>, respectively, was recorded against certain deferred tax assets based on this assessment. The Company believes it is more-likely-than-not that the tax benefit of the remaining net deferred tax assets will be realized. The amount of net deferred tax assets considered realizable could be increased or reduced in the future if the Company&#8217;s assessment of future taxable income or tax planning strategies changes.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="ife62ddd6759343b0b0221b4ff1d66dcc"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its foreign subsidiaries have historically been loss generating entities that have resulted in <ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="INF" name="us-gaap:ForeignEarningsRepatriated" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEwOTk1MTE2MjgyMzcy_4a6d7663-3094-4bcb-a265-f972922b035e"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="INF" name="us-gaap:ForeignEarningsRepatriated" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEwOTk1MTE2MjgyMzcy_624a85cf-7de9-454a-a803-41d9a4e38f4d">no</ix:nonFraction></ix:nonFraction> excess earnings to consider for repatriation and accordingly there are <ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="INF" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEwOTk1MTE2MjgyMzgx_3eaad12f-6cd7-4f76-ac1d-89a6ae00f867"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="INF" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEwOTk1MTE2MjgyMzgx_de4ab60d-5ec5-4858-b19d-01c95a468c5f">no</ix:nonFraction></ix:nonFraction> deferred income taxes recognized as of December&#160;31, 2021 and 2020.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021 and 2020, the Company had <ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEwOTk1MTE2MjgyMzg5_8be8ec18-65af-457b-8c01-8a5ebe77470a"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEwOTk1MTE2MjgyMzg5_d7f28bca-5665-409f-bde6-de815528c0f3">no</ix:nonFraction></ix:nonFraction> tax liability or benefit related to uncertain tax positions. <ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="INF" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEwOTk1MTE2MjgyMzk3_3b6e8709-90cf-472f-98dd-e89368f745fa"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="INF" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEwOTk1MTE2MjgyMzk3_89c376be-0cd1-484a-8513-e688dbe61fa1">No</ix:nonFraction></ix:nonFraction> interest or penalties related to uncertain taxes have been recognized on the accompanying consolidated statements of operations. Management does not expect a significant change in uncertain tax positions during the twelve months subsequent to December 31, 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts business in multiple jurisdictions within and outside the United States. Consequently, the Company is subject to periodic income tax examinations by domestic and foreign income tax authorities. During December 2021, the Internal Revenue Service completed an income tax examination of the Company&#8217;s U.S. federal income tax return for the year ended December 31, 2016, which resulted in no impact to the Company&#8217;s consolidated financial statements. The Company has no other ongoing tax examinations with domestic or foreign taxing authorities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, the Company migrated its country of domicile from New Zealand to Delaware in the United States. On migration, the Company was deemed to have disposed of all its assets and liabilities to a third-party at market value which resulted in taxable income to the Company for New Zealand income tax purposes. The migration to Delaware is classified as a tax-free reorganization for U.S. federal income tax purposes.</span></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_481"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 13 &#8212; <ix:continuation id="ia985096254434cec9408d660883bdfb0" continuedAt="i6a057179cfef464aacb41ce6b6331df8">Stock-Based Compensation</ix:continuation></span></div><ix:continuation id="i6a057179cfef464aacb41ce6b6331df8" continuedAt="if756f4cbd63c45c0b9b9c01b45c38bb3"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers share option plans to employees, directors, and others providing consulting services, which meet the definition of an equity-settled stock-based payment.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="scheme" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="amci:NumberOfShareBasedStockSchemes" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEwOTk1MTE2Mjg0NDA0_2744e875-2af2-4c3b-83a1-4159ad843f5f">five</ix:nonFraction> ownership-based participation rights schemes for employees, directors, and certain third-party providers. In accordance with the provisions of the schemes, as approved by the directors and shareholders, grantees have been granted options to purchase common shares at an exercise price based on the fair value price of the Company&#8217;s common shares on the date of grant as approved by the directors. The stock options generally have a service condition of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEwOTk1MTE2Mjg0Mzgw_848b9b44-6118-41f1-9447-548b3ddf83fb">two</span> to <ix:nonNumeric contextRef="ibd4d0f3725b743bb9a13d0e7f76a6680_D20220101-20220930" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEwOTk1MTE2Mjg0Mzg4_3508be3a-ff3d-4b84-a7e6-bf8940faef01">five years</ix:nonNumeric> and vest over time as the service condition is being satisfied. In November 2020, the Company granted <ix:nonFraction unitRef="shares" contextRef="i3a3ce2d4285046a28faff5151642a219_D20201101-20201130" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEyNjQ0MzgzNzI2MDE1_ca72cf36-2108-4206-941c-b249b9797095">151,068</ix:nonFraction> options which have a performance condition that accelerates vesting on liquidity event. All stock options have a term of <ix:nonNumeric contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEyNjQ0MzgzNzI2MDIz_3df6a6af-69d6-4adf-8ff8-bb1595b5028b">10</ix:nonNumeric> years from the date of grant. Upon termination of employment, unvested stock options are evaluated for forfeiture or modifications, subject to the terms of the awards and Company's policies.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="if756f4cbd63c45c0b9b9c01b45c38bb3" continuedAt="i8310adec275b4e71b1397ffd0c291aee"><ix:continuation id="i4c15e8f1d8d1408095a1035a360e3c36"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option awards outstanding as of December&#160;31, 2021 and changes during the year ended December&#160;31, 2021 were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares under option (thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average remaining contractual term (years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate intrinsic value (thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at January 1, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzEtMS0xLTEtOTA2MTg_e6ebcba5-bafd-4f0b-b18f-5397988e40f5">4,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzEtMy0xLTEtOTA2MTg_b1f9bc3b-4001-4619-a090-948d8813b1da">5.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzEtNS0xLTEtOTA2MTg_c9f9894e-883a-443a-9d20-c94a76a45ba0">5.09</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzEtNy0xLTEtOTA2MTg_fde8cb66-5920-4cf5-8370-68f0f7c25adf">2,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expecting to vest at January 1, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzItMS0xLTEtOTA2MTg_3cc1e9a9-2bfd-4875-957e-e94f41285f24">4,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzItMy0xLTEtOTA2MTg_bf29fd65-c8ac-4e50-a52c-725050fe07cb">5.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzItNS0xLTEtOTA2MTg_1aa77258-13b9-4c39-8d96-5265c5c71e13">5.09</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzItNy0xLTEtOTA2MTg_c29cfdcb-9d98-4459-b6f8-e5a08ec84e5c">2,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable at January 1, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzMtMS0xLTEtOTA2MTg_54e94a70-7ad6-4ae3-aab1-c65c5b94c12e">2,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzMtMy0xLTEtOTA2MTg_90340d9e-ae3e-4aeb-97e0-6034d2110b24">5.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzMtNS0xLTEtOTA2MTg_9543d9fc-c60a-421d-96ab-fd189a17185a">3.47</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzMtNy0xLTEtOTA2MTg_95e56246-d78e-4447-ab4b-6b9deda65efb">2,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzQtMS0xLTEtOTA2MTg_42df3c2d-c86b-43a4-9a23-bc4af0bdae4f">620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzQtMy0xLTEtOTA2MTg_efab4132-24cf-4eac-822e-d71e51475427">9.33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzQtNy0xLTEtOTA2MTg_99cfb7e8-9e55-44cd-ae7a-91f58cb747b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzUtMS0xLTEtOTA2MTg_096738cc-de54-4e71-9ac9-acdf21d0c0c5">721</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzUtMy0xLTEtOTA2MTg_5df55e8a-67fc-4f9b-9d60-f1cfff4969c8">2.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="amci:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzUtNy0xLTEtOTA2MTg_e4e31f28-ca48-40b3-868d-0562088b9b1f">1,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited/expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzYtMS0xLTEtOTA2MTg_ce6cdaf9-75a8-44bb-bc7c-33c35b939dbb">334</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzYtMy0xLTEtOTA2MTg_6f7cdb50-58e0-4676-af03-719528e8b767">2.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="amci:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzYtNy0xLTEtOTA2MTg_00a23a63-bf1d-4563-8dc5-48437665a384">755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzctMS0xLTEtOTA2MTg_8a7ec6f9-5428-4d6d-b93e-dac70a41bde5">3,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzctMy0xLTEtOTA2MTg_3e55e338-4ae6-4c06-ac5c-e889902df5f8">6.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzctNS0xLTEtOTA2MTg_5827ef19-80e9-4e3b-94d7-99fbb1388494">6.16</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzctNy0xLTEtOTA2MTg_cfb0187d-3be3-44e8-93ee-d2bc24ba87dc">27,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expecting to vest at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzgtMS0xLTEtOTA2MTg_348ac829-f154-46a0-a920-2a0bef743386">3,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzgtMy0xLTEtOTA2MTg_118e2664-53a3-40c8-ad8c-912847a7a52b">6.55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzgtNS0xLTEtOTA2MTg_01850e65-0919-45e5-96c6-ee827033fa12">6.16</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzgtNy0xLTEtOTA2MTg_4d83f52a-36b0-4e10-b2f6-9dcf35b0851c">27,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable at December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzktMS0xLTEtOTA2MTg_4d3a8a0f-884e-49cf-9910-d5d1cb997775">2,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzktMy0xLTEtOTA2MTg_8cd0f31e-456a-4097-a333-be79fe9e77bc">6.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzktNS0xLTEtOTA2MTg_35c724d6-ebad-4188-88ec-9174147148e1">4.85</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzktNy0xLTEtOTA2MTg_abe71e51-9ecb-4d56-ba0e-0c79a3dbe734">18,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded compensation expense of $<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEyODg_3fd66100-f91b-483a-9fd3-190aff3b4352">2,531</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEyOTU_117d56aa-b330-4286-85ba-a4352b346a06">2,392</ix:nonFraction> for the years ended December&#160;31, 2021 and 2020, respectively. Unrecognized compensation costs as of December&#160;31, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEzODg_e340967e-646f-420b-8373-7f056cff81b3">6,120</ix:nonFraction> and will be recognized over a weighted average of <ix:nonNumeric contextRef="i573b811889c3495891ffd2a6cb11821d_D20210101-20211231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEwOTk1MTE2Mjg0NDEz_5e84cddf-0da2-4c7d-9ad7-381de3ccbb62">2.7</ix:nonNumeric> years. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each stock option award was estimated on each grant date using the Black-Scholes option pricing model. The following assumptions were used and required significant judgment to determine:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Expected Term</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; the Company used the &#8220;simplified method&#8221; for estimating the expected term of plain-vanilla options, whereby the expected term equals the arithmetic average of the vesting term and LanzaTech&#8217;s contractual term of the option. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Risk-Free Interest Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The risk-free interest rate is based on the U.S. Treasury zero-coupon instruments with maturities similar to the expected term of LanzaTech&#8217;s stock options. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Expected Dividend</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; the expected dividend yield is based on the Company's expectation of future dividend payouts to common stockholders. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Expected Volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Due to the Company's limited historical data, a group of similar companies that are publicly traded was used to estimate the expected volatility. The historical volatility data was computed using the daily closing prices for the various companies' shares during the equivalent period of the calculated expected term of the stock-based awards.</span></div><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEwOTk1MTE2Mjg0Mzc5_92627356-2b9b-4e36-ab45-3d6849cc7264" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the weighted-average assumptions applied in the Black-Scholes valuation of options for awards subject to expense recognition for the first time in the period, for the years ended December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8edc4dc10f9f4f9bbe7fde8514cd754b_I20211231" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZToxNTE5YjNlMjA4MmY0ODkwODdiODQwOWVjNmQxMzY3ZS90YWJsZXJhbmdlOjE1MTliM2UyMDgyZjQ4OTA4N2I4NDA5ZWM2ZDEzNjdlXzItMS0xLTEtOTA2MTg_1840e45b-424e-47d3-943f-bd016f770330">9.33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i213ef7ccde724ea7afd07d3e7e86daa8_I20201231" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZToxNTE5YjNlMjA4MmY0ODkwODdiODQwOWVjNmQxMzY3ZS90YWJsZXJhbmdlOjE1MTliM2UyMDgyZjQ4OTA4N2I4NDA5ZWM2ZDEzNjdlXzItMy0xLTEtOTA2MTg_4de46539-edf9-4d7e-938c-e03b021f9c8c">4.68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8edc4dc10f9f4f9bbe7fde8514cd754b_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZToxNTE5YjNlMjA4MmY0ODkwODdiODQwOWVjNmQxMzY3ZS90YWJsZXJhbmdlOjE1MTliM2UyMDgyZjQ4OTA4N2I4NDA5ZWM2ZDEzNjdlXzMtMS0xLTEtOTA2MTg_ca26b58d-c112-4545-8828-ffc6a5ef138c">9.33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i213ef7ccde724ea7afd07d3e7e86daa8_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZToxNTE5YjNlMjA4MmY0ODkwODdiODQwOWVjNmQxMzY3ZS90YWJsZXJhbmdlOjE1MTliM2UyMDgyZjQ4OTA4N2I4NDA5ZWM2ZDEzNjdlXzMtMy0xLTEtOTA2MTg_77606d16-d3ac-485f-923d-5531dc0d6d7c">4.68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i573b811889c3495891ffd2a6cb11821d_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZToxNTE5YjNlMjA4MmY0ODkwODdiODQwOWVjNmQxMzY3ZS90YWJsZXJhbmdlOjE1MTliM2UyMDgyZjQ4OTA4N2I4NDA5ZWM2ZDEzNjdlXzQtMS0xLTEtOTA2MTg_2706778a-fa25-4474-8a53-7f630af6df23">6.1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i03b32e37b4f7484ea3c2ae0cc21ee87c_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZToxNTE5YjNlMjA4MmY0ODkwODdiODQwOWVjNmQxMzY3ZS90YWJsZXJhbmdlOjE1MTliM2UyMDgyZjQ4OTA4N2I4NDA5ZWM2ZDEzNjdlXzQtMy0xLTEtOTA2MTg_fedee1a0-16ca-4373-a143-991d27a6657e">6.4</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i573b811889c3495891ffd2a6cb11821d_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZToxNTE5YjNlMjA4MmY0ODkwODdiODQwOWVjNmQxMzY3ZS90YWJsZXJhbmdlOjE1MTliM2UyMDgyZjQ4OTA4N2I4NDA5ZWM2ZDEzNjdlXzUtMS0xLTEtOTA2MTg_a6acfbd2-02a6-455d-aa58-7de831ce0298">98.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i03b32e37b4f7484ea3c2ae0cc21ee87c_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZToxNTE5YjNlMjA4MmY0ODkwODdiODQwOWVjNmQxMzY3ZS90YWJsZXJhbmdlOjE1MTliM2UyMDgyZjQ4OTA4N2I4NDA5ZWM2ZDEzNjdlXzUtMy0xLTEtOTA2MTg_8658c6a2-3a79-4ef4-a0f5-886c0c36370d">100.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i573b811889c3495891ffd2a6cb11821d_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZToxNTE5YjNlMjA4MmY0ODkwODdiODQwOWVjNmQxMzY3ZS90YWJsZXJhbmdlOjE1MTliM2UyMDgyZjQ4OTA4N2I4NDA5ZWM2ZDEzNjdlXzYtMS0xLTEtOTA2MTg_8055367b-d168-4fe5-a80c-6895cc000b26">1.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i03b32e37b4f7484ea3c2ae0cc21ee87c_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZToxNTE5YjNlMjA4MmY0ODkwODdiODQwOWVjNmQxMzY3ZS90YWJsZXJhbmdlOjE1MTliM2UyMDgyZjQ4OTA4N2I4NDA5ZWM2ZDEzNjdlXzYtMy0xLTEtOTA2MTg_8b1294ce-2e11-4df6-9700-d41489fefa26">0.56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i573b811889c3495891ffd2a6cb11821d_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZToxNTE5YjNlMjA4MmY0ODkwODdiODQwOWVjNmQxMzY3ZS90YWJsZXJhbmdlOjE1MTliM2UyMDgyZjQ4OTA4N2I4NDA5ZWM2ZDEzNjdlXzctMS0xLTEtOTA2MTg_f056a3cd-2148-4b1d-ad32-43fdc19a4d15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i03b32e37b4f7484ea3c2ae0cc21ee87c_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZToxNTE5YjNlMjA4MmY0ODkwODdiODQwOWVjNmQxMzY3ZS90YWJsZXJhbmdlOjE1MTliM2UyMDgyZjQ4OTA4N2I4NDA5ZWM2ZDEzNjdlXzctMy0xLTEtOTA2MTg_be30f48f-b321-4491-bfad-5d551a98bcca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i8310adec275b4e71b1397ffd0c291aee"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant date fair value of options granted during 2021 and 2020 was $<ix:nonFraction unitRef="usdPerShare" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzI4OTQ_3499dcec-2f31-4a1c-858f-a12994c81b09">6.29</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzI5MDE_437754a1-7965-48fc-ad21-1b0743bc0d26">3.99</ix:nonFraction> per option, respectively.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Awards (&#8220;RSAs&#8221;)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSAs become eligible to vest upon the satisfaction of a time-based service condition. However, in order to vest, a liquidity event, defined as acquisition, asset transfer, or initial listing, must occur within <ix:nonNumeric contextRef="i8891a21b42fd46edae0f2cb767f54ab4_D20210101-20211231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEwOTk1MTE2Mjg0NDE2_2952282e-d94d-4c92-a2c7-4255049ffd5a">10</ix:nonNumeric> years from the grant date. Upon a liquidity event, if the participant&#8217;s service has not terminated, the entire RSA award vests in full, whether or not previously eligible for vesting. If the participant&#8217;s service has terminated and they have satisfied the time-based service condition, the RSAs that are outstanding and eligible for vesting shall immediately vest in full. The time-based service requirements of the RSAs have a maximum term of <ix:nonNumeric contextRef="i8891a21b42fd46edae0f2cb767f54ab4_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEwOTk1MTE2Mjg0NDI5_15ea1398-383b-4e7e-9db7-2c83055582d2">three years</ix:nonNumeric> from the date of grant.</span></div><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEwOTk1MTE2Mjg0Mzc4_84561739-c71b-4128-969f-6680d2a692b3" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSAs as of December&#160;31, 2021 and changes during the year ended December&#160;31, 2021 were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nonvested Shares (thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at January 1, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i11fb672b3c844ef88abb79b5adf6a2f6_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpjMzhhN2RlZmE0Nzg0NmU1YWFhMjY0ZTkyMDI1NWRiOC90YWJsZXJhbmdlOmMzOGE3ZGVmYTQ3ODQ2ZTVhYWEyNjRlOTIwMjU1ZGI4XzEtMS0xLTEtOTA2MTg_62979af0-9fed-401d-b8e4-3f04e6e10095">325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i11fb672b3c844ef88abb79b5adf6a2f6_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpjMzhhN2RlZmE0Nzg0NmU1YWFhMjY0ZTkyMDI1NWRiOC90YWJsZXJhbmdlOmMzOGE3ZGVmYTQ3ODQ2ZTVhYWEyNjRlOTIwMjU1ZGI4XzEtMy0xLTEtOTA2MTg_aae6e742-8fd2-4ef6-8ef4-28e9d966ec06">4.68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8891a21b42fd46edae0f2cb767f54ab4_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpjMzhhN2RlZmE0Nzg0NmU1YWFhMjY0ZTkyMDI1NWRiOC90YWJsZXJhbmdlOmMzOGE3ZGVmYTQ3ODQ2ZTVhYWEyNjRlOTIwMjU1ZGI4XzItMS0xLTEtOTA2MTg_9a0f6eb5-cae1-427d-b094-3140c172f7b6">281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8891a21b42fd46edae0f2cb767f54ab4_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpjMzhhN2RlZmE0Nzg0NmU1YWFhMjY0ZTkyMDI1NWRiOC90YWJsZXJhbmdlOmMzOGE3ZGVmYTQ3ODQ2ZTVhYWEyNjRlOTIwMjU1ZGI4XzItMy0xLTEtOTA2MTg_8f48d20e-a8d6-4564-bd00-3fa4ffe505e4">4.76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8891a21b42fd46edae0f2cb767f54ab4_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpjMzhhN2RlZmE0Nzg0NmU1YWFhMjY0ZTkyMDI1NWRiOC90YWJsZXJhbmdlOmMzOGE3ZGVmYTQ3ODQ2ZTVhYWEyNjRlOTIwMjU1ZGI4XzMtMS0xLTEtOTA2MTg_9c4ff371-a1ba-4985-875b-c4501093a63a">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8891a21b42fd46edae0f2cb767f54ab4_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpjMzhhN2RlZmE0Nzg0NmU1YWFhMjY0ZTkyMDI1NWRiOC90YWJsZXJhbmdlOmMzOGE3ZGVmYTQ3ODQ2ZTVhYWEyNjRlOTIwMjU1ZGI4XzMtMy0xLTEtOTA2MTg_aa35a09a-7689-4449-8a9f-7fcd3fac2d43">4.68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9d8b29d6eda64dde944469b96c9e6f69_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpjMzhhN2RlZmE0Nzg0NmU1YWFhMjY0ZTkyMDI1NWRiOC90YWJsZXJhbmdlOmMzOGE3ZGVmYTQ3ODQ2ZTVhYWEyNjRlOTIwMjU1ZGI4XzQtMS0xLTEtOTA2MTg_1663d632-06ab-4e85-908a-bbe59abac6da">580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9d8b29d6eda64dde944469b96c9e6f69_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpjMzhhN2RlZmE0Nzg0NmU1YWFhMjY0ZTkyMDI1NWRiOC90YWJsZXJhbmdlOmMzOGE3ZGVmYTQ3ODQ2ZTVhYWEyNjRlOTIwMjU1ZGI4XzQtMy0xLTEtOTA2MTg_c193b501-6da0-46fe-bf82-6f072515ad0b">4.72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, the Company concluded that the liquidity event performance condition described above for the RSAs was not probable of being satisfied at such time. As a result, the Company did <ix:nonFraction unitRef="usd" contextRef="i803b263ea3554c628c2b2cd7af31afde_D20200101-20201231" decimals="INF" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEwOTk1MTE2Mjg0NDcz_14a14f19-b859-47f7-848d-487050247b90"><ix:nonFraction unitRef="usd" contextRef="i8891a21b42fd46edae0f2cb767f54ab4_D20210101-20211231" decimals="INF" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEwOTk1MTE2Mjg0NDcz_73bd7ec2-62eb-4364-963a-5bad5eaf0f12">no</ix:nonFraction></ix:nonFraction>t recognize any compensation cost during the years ended December&#160;31, 2021 and 2020 for any RSAs granted.</span></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_488"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 14 &#8212; <ix:continuation id="i92c5a640d9be41da898efbc6e01b12ad" continuedAt="i59e0683e8e0c46248144ee7a71788fb7">Related Party Transactions</ix:continuation></span></div><ix:continuation id="i59e0683e8e0c46248144ee7a71788fb7" continuedAt="iccef3fc124d544b2b0358e1fd0a76705"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, the Company had an equity ownership in LanzaJet and SGLT with an aggregate carrying value of $<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODgvZnJhZzo2ZmQ2MWFmNTE5ODA0OTcwOWE2NWMxNjM0ZGZkMjNiOS90ZXh0cmVnaW9uOjZmZDYxYWY1MTk4MDQ5NzA5YTY1YzE2MzRkZmQyM2I5XzE1Mg_01521cfc-301d-4e22-97a0-180f07e0d52a">24,752</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODgvZnJhZzo2ZmQ2MWFmNTE5ODA0OTcwOWE2NWMxNjM0ZGZkMjNiOS90ZXh0cmVnaW9uOjZmZDYxYWY1MTk4MDQ5NzA5YTY1YzE2MzRkZmQyM2I5XzE1OQ_0755ea81-bdeb-4546-a332-3e1ebbf772fe">23,217</ix:nonFraction>, respectively. Trade receivables and contract assets of $<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODgvZnJhZzo2ZmQ2MWFmNTE5ODA0OTcwOWE2NWMxNjM0ZGZkMjNiOS90ZXh0cmVnaW9uOjZmZDYxYWY1MTk4MDQ5NzA5YTY1YzE2MzRkZmQyM2I5XzIxOA_e1e0e8d5-5118-4933-bef3-26cda7900629">1,071</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:AccountsReceivableNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODgvZnJhZzo2ZmQ2MWFmNTE5ODA0OTcwOWE2NWMxNjM0ZGZkMjNiOS90ZXh0cmVnaW9uOjZmZDYxYWY1MTk4MDQ5NzA5YTY1YzE2MzRkZmQyM2I5XzIyNQ_9406913e-5ae2-4db7-b13a-8ebe8d32b966">3,257</ix:nonFraction>, from these equity method investees are included in accounts receivable, respectively. The Company made purchases and had open accounts payable of $<ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODgvZnJhZzo2ZmQ2MWFmNTE5ODA0OTcwOWE2NWMxNjM0ZGZkMjNiOS90ZXh0cmVnaW9uOjZmZDYxYWY1MTk4MDQ5NzA5YTY1YzE2MzRkZmQyM2I5XzM3NQ_4a903ee4-b0b6-4678-b57f-1250afd4dad6"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODgvZnJhZzo2ZmQ2MWFmNTE5ODA0OTcwOWE2NWMxNjM0ZGZkMjNiOS90ZXh0cmVnaW9uOjZmZDYxYWY1MTk4MDQ5NzA5YTY1YzE2MzRkZmQyM2I5XzM3NQ_5f4bba26-e211-4a5d-8f3d-35c3e9a54bb3">2,575</ix:nonFraction></ix:nonFraction> as of and for the year ended December&#160;31, 2021. The accounts payable balance is for work that LanzaJet performed as a subcontractor to the Company. Refer to Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s, for more information.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the formation of LanzaJet, the Company entered into a transition services agreement with LanzaJet. The transition services agreement generally sets out the respective rights, responsibilities and obligations of the Company and LanzaJet with respect to R&amp;D services, business development and other administrative support services. The transition services agreement may be terminated by mutual consent of the Company and LanzaJet, by LanzaJet at any time, and by the Company upon breach or non-payment by LanzaJet. There are no substantive termination penalties in the event the Company terminates. During the years ended December&#160;31, 2021 and 2020, the Company recognized revenue from related parties of approximately $<ix:nonFraction unitRef="usd" contextRef="i4de62ab3a564461880c512002a30b250_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODgvZnJhZzo2ZmQ2MWFmNTE5ODA0OTcwOWE2NWMxNjM0ZGZkMjNiOS90ZXh0cmVnaW9uOjZmZDYxYWY1MTk4MDQ5NzA5YTY1YzE2MzRkZmQyM2I5XzEyODQ_1197bd07-9dfd-4c29-a9fc-bdd5500767a8">495</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i75c056609d254c53af9c29c67d99d60b_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODgvZnJhZzo2ZmQ2MWFmNTE5ODA0OTcwOWE2NWMxNjM0ZGZkMjNiOS90ZXh0cmVnaW9uOjZmZDYxYWY1MTk4MDQ5NzA5YTY1YzE2MzRkZmQyM2I5XzEyOTE_7eb9893c-c78b-411d-b644-f03ace062610">285</ix:nonFraction>, respectively, under the transition services agreement. The Company provides certain engineering and other services related to a gas-to-jet demonstration plant currently in development by LanzaJet pursuant to the Investment Agreement described in Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As a result, during the years ended December&#160;31, 2021 and 2020, the Company recognized revenue from related parties of approximately $<ix:nonFraction unitRef="usd" contextRef="id905c833627b4121b886db6e813419df_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODgvZnJhZzo2ZmQ2MWFmNTE5ODA0OTcwOWE2NWMxNjM0ZGZkMjNiOS90ZXh0cmVnaW9uOjZmZDYxYWY1MTk4MDQ5NzA5YTY1YzE2MzRkZmQyM2I5XzE2Nzk_6eed7976-f772-452a-9b01-7eea8d65adf7">428</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="iae076a6656ae43ecb5bd532f5ce42d8c_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODgvZnJhZzo2ZmQ2MWFmNTE5ODA0OTcwOWE2NWMxNjM0ZGZkMjNiOS90ZXh0cmVnaW9uOjZmZDYxYWY1MTk4MDQ5NzA5YTY1YzE2MzRkZmQyM2I5XzE2ODY_e84f4214-8749-4148-ac7d-0c3907f4f063">2,740</ix:nonFraction>, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company supplies SGLT with its biocatalyst, certain water-soluble organic compounds required in the Company's proprietary gas fermentation process, and small-size equipment. As a result, during 2021 and 2020 the Company recognized revenue from related parties of approximately $<ix:nonFraction unitRef="usd" contextRef="ifcbed162e9304111b3a8a6214d89a1d1_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODgvZnJhZzo2ZmQ2MWFmNTE5ODA0OTcwOWE2NWMxNjM0ZGZkMjNiOS90ZXh0cmVnaW9uOjZmZDYxYWY1MTk4MDQ5NzA5YTY1YzE2MzRkZmQyM2I5XzEyNjQ0MzgzNzIyMzcy_24f7acf4-08ed-434d-bf95-4da094be4d97">282</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i28298076d77146a590f9bd3e1debbf12_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODgvZnJhZzo2ZmQ2MWFmNTE5ODA0OTcwOWE2NWMxNjM0ZGZkMjNiOS90ZXh0cmVnaW9uOjZmZDYxYWY1MTk4MDQ5NzA5YTY1YzE2MzRkZmQyM2I5XzEyNjQ0MzgzNzIyMzc4_7cdedf47-a972-435d-a218-38be9bae9c42">156</ix:nonFraction>, respectively. The Company also provided engineering services and incurred costs of $<ix:nonFraction unitRef="usd" contextRef="ifcbed162e9304111b3a8a6214d89a1d1_D20210101-20211231" decimals="-3" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODgvZnJhZzo2ZmQ2MWFmNTE5ODA0OTcwOWE2NWMxNjM0ZGZkMjNiOS90ZXh0cmVnaW9uOjZmZDYxYWY1MTk4MDQ5NzA5YTY1YzE2MzRkZmQyM2I5XzEyNjQ0MzgzNzIyMzU4_acc1be3c-87b5-4a02-9ff8-9047fe0bb483">1,223</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i28298076d77146a590f9bd3e1debbf12_D20200101-20201231" decimals="-3" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODgvZnJhZzo2ZmQ2MWFmNTE5ODA0OTcwOWE2NWMxNjM0ZGZkMjNiOS90ZXh0cmVnaW9uOjZmZDYxYWY1MTk4MDQ5NzA5YTY1YzE2MzRkZmQyM2I5XzEyNjQ0MzgzNzIyMzY2_078481bb-b04a-4a6b-a082-8bb70ec9735e">242</ix:nonFraction> during the years ended December&#160;31, 2021 and 2020, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, LanzaTech and SGLT entered into a license agreement in 2019, subsequently amended in 2021, to provide SGLT with the right to sublicense the intellectual property that LanzaTech previously licensed to SGLT. In </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iccef3fc124d544b2b0358e1fd0a76705">exchange, the Company is entitled to receive licensing consideration, calculated as a percentage of the royalties received by SGLT from the sublicenses. Currently, SGLT sublicenses to certain of its subsidiaries that use LanzaTech's proprietary technology. The royalties to be received by SGLT are based on sales-and-usage of the sublicensed technology. For the years ended December&#160;31, 2021 and 2020, the Company did not earn any sublicensing revenue as no royalties were received by SGLT.</ix:continuation></span></div><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_492"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 15 &#8212; <ix:continuation id="if2a76b57f6cd4956945dbce262155f09" continuedAt="i6260cbb3f0ea409c8f8fc261b95428e8">Shareholders&#8217; Equity</ix:continuation></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6260cbb3f0ea409c8f8fc261b95428e8">The securities of the Company are represented by common shares, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTIvZnJhZzpkMzY5MTUzZDU1ODM0MzY2OWRmYzI3YjRmNzUyMTFhZC90ZXh0cmVnaW9uOmQzNjkxNTNkNTU4MzQzNjY5ZGZjMjdiNGY3NTIxMWFkXzExMA_221c5847-09c8-4ac5-b97f-3a057c216f0f"><ix:nonFraction unitRef="usdPerShare" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTIvZnJhZzpkMzY5MTUzZDU1ODM0MzY2OWRmYzI3YjRmNzUyMTFhZC90ZXh0cmVnaW9uOmQzNjkxNTNkNTU4MzQzNjY5ZGZjMjdiNGY3NTIxMWFkXzExMA_8f598eb1-3018-4f3c-b71f-196dce453160">0.0001</ix:nonFraction></ix:nonFraction> per share. Each common share is entitled to <ix:nonFraction unitRef="vote" contextRef="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231" decimals="INF" name="amci:TemporaryEquityNumberOfVotesPerShare" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTIvZnJhZzpkMzY5MTUzZDU1ODM0MzY2OWRmYzI3YjRmNzUyMTFhZC90ZXh0cmVnaW9uOmQzNjkxNTNkNTU4MzQzNjY5ZGZjMjdiNGY3NTIxMWFkXzEwOTk1MTE2Mjc4Mzg4_d824e453-a833-4b18-a323-b832be745ae3">one</ix:nonFraction> vote. With respect to payment of dividends and distribution of assets upon liquidation, dissolution or winding up of the Company, whether voluntary or involuntary, all common shares shall participate pro rata in such payment whenever funds are legally available and when declared by the Board of Directors of the Company, subject to the prior rights of holders of all classes of stock outstanding.</ix:continuation></span></div><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_499"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 16 &#8212; <ix:continuation id="ie7ed36e1afb04dac9cfc695d88382f14" continuedAt="iae61c644e3664736ba0c2a86e8a0c95d">Redeemable, Convertible Preferred Stock</ix:continuation></span></div><ix:continuation id="iae61c644e3664736ba0c2a86e8a0c95d" continuedAt="id24d912c799f4df89dea689194137b41"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has six outstanding series of contingently redeemable convertible preferred stock. <ix:continuation id="i22954257b28841cba2013f7f5f4c8653" continuedAt="ia8386c9f1ad2456e833d812dd4749701">The authorized, issued and outstanding shares, issue price, and carrying value as of December&#160;31, 2021 and 2020 are as follows (in thousands, except share and per share amounts):</ix:continuation></span></div><ix:continuation id="ia8386c9f1ad2456e833d812dd4749701" continuedAt="i37acaad6344b461db59c82794d3207c5"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares Authorized</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac85d16334474caf87d510d9eb18ff97_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzItMS0xLTEtOTA2MTg_e7d6899c-3f0e-47ce-93d5-6574ff5f2450">4,666,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac85d16334474caf87d510d9eb18ff97_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzItMy0xLTEtOTA2MTg_0dcb58b4-463e-47b0-91e0-7f270a23ed07"><ix:nonFraction unitRef="shares" contextRef="iac85d16334474caf87d510d9eb18ff97_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzItMy0xLTEtOTA2MTg_7f21e596-96c3-4951-9152-41bfc2d4f553">4,666,503</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i8a9c59f1273542b8ab3e8255d224f529_I20211231" decimals="INF" name="amci:TemporaryEquityIssuePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzItNS0xLTEtOTA2MTgvdGV4dHJlZ2lvbjpiZmFjNzM4MWYzZDU0YWJhYjJhNzMyYWI3NzM5MWFmMl81NDk3NTU4MTM5MDk_a18cc782-38b5-48b8-81e7-0ce4e087259e">1.75</ix:nonFraction> - <ix:nonFraction unitRef="usdPerShare" contextRef="i1b658f2ff91349b3beaa5d4bd56ba109_I20211231" decimals="INF" name="amci:TemporaryEquityIssuePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzItNS0xLTEtOTA2MTgvdGV4dHJlZ2lvbjpiZmFjNzM4MWYzZDU0YWJhYjJhNzMyYWI3NzM5MWFmMl81NDk3NTU4MTM5MTY_e53f1854-8446-4f0f-9aaa-00a1d60c9cc4">3.94</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac85d16334474caf87d510d9eb18ff97_I20211231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzItNy0xLTEtOTA2MTg_99fb48f7-4c3f-4f96-b96f-f2c169fc3f58">12,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i579053a3cd4d442382bdb8ffa9a87db6_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzMtMS0xLTEtOTA2MTg_2a562577-4099-4dfe-af41-3357100b55aa">1,733,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i579053a3cd4d442382bdb8ffa9a87db6_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzMtMy0xLTEtOTA2MTg_8105e51b-1daa-488d-9d33-646f92bc149c"><ix:nonFraction unitRef="shares" contextRef="i579053a3cd4d442382bdb8ffa9a87db6_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzMtMy0xLTEtOTA2MTg_9ce462da-6894-43d6-ad43-a4d5577a2860">1,733,370</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i579053a3cd4d442382bdb8ffa9a87db6_I20211231" decimals="INF" name="amci:TemporaryEquityIssuePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzMtNS0xLTEtOTA2MTg_6c810dda-5c8d-4c01-99fa-e1b4b7fb9990">10.38</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i579053a3cd4d442382bdb8ffa9a87db6_I20211231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzMtNy0xLTEtOTA2MTg_5767f11b-0119-495c-a5fa-0b4881bc4945">18,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i51d874e0b5b94c329952825293416b35_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzQtMS0xLTEtOTA2MTg_7f3f0fd5-b475-44f4-b6f0-147f7d56a8c4">4,254,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i51d874e0b5b94c329952825293416b35_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzQtMy0xLTEtOTA2MTg_005d8e48-8e93-444a-aa9b-cd31e589c4fa"><ix:nonFraction unitRef="shares" contextRef="i51d874e0b5b94c329952825293416b35_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzQtMy0xLTEtOTA2MTg_31419515-79d2-4561-99fb-93ee0ac06ee8">4,142,408</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i51d874e0b5b94c329952825293416b35_I20211231" decimals="INF" name="amci:TemporaryEquityIssuePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzQtNS0xLTEtOTA2MTg_a2cf795f-2f59-449b-86bf-3dd5adbf31c1">14.69</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51d874e0b5b94c329952825293416b35_I20211231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzQtNy0xLTEtOTA2MTg_e6db881f-d94b-4dfa-afec-1c4eb9f42aad">60,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6147091081d14d69be73064143508062_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzUtMS0xLTEtOTA2MTg_b52daf12-dcc8-419e-a5b3-f780568c426c">10,274,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6147091081d14d69be73064143508062_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzUtMy0xLTEtOTA2MTg_0458a0ed-7b35-4ab5-98a3-4bad49deb5f4"><ix:nonFraction unitRef="shares" contextRef="i6147091081d14d69be73064143508062_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzUtMy0xLTEtOTA2MTg_83f5241d-e3e7-4d90-aa35-2006f2192479">10,161,362</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6147091081d14d69be73064143508062_I20211231" decimals="INF" name="amci:TemporaryEquityIssuePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzUtNS0xLTEtOTA2MTg_76b2ce9f-923f-49c4-be2d-55cd1a2c6e17">19.93</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6147091081d14d69be73064143508062_I20211231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzUtNy0xLTEtOTA2MTg_8d367a9f-9d2b-4da5-858e-ffa53b9b95c5">188,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i75249f1eb69a41749449ae454de51fed_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzYtMS0xLTEtOTA2MTg_8e171d4f-7892-4703-853e-bfe40056183a">5,183,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i75249f1eb69a41749449ae454de51fed_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzYtMy0xLTEtOTA2MTg_0f6817c9-9656-4a55-a4c9-fe1274e85749"><ix:nonFraction unitRef="shares" contextRef="i75249f1eb69a41749449ae454de51fed_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzYtMy0xLTEtOTA2MTg_b7f88a60-f154-47a1-abe2-c3eee374bcce">5,183,957</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i75249f1eb69a41749449ae454de51fed_I20211231" decimals="INF" name="amci:TemporaryEquityIssuePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzYtNS0xLTEtOTA2MTg_fbe4f73d-81fd-4ccd-a2eb-61d41cd6e226">22.86</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75249f1eb69a41749449ae454de51fed_I20211231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzYtNy0xLTEtOTA2MTg_7fc2595e-742e-444e-9e01-2d2d05b25227">118,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series F</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9c54836fffa1449f85209e9cddadc72d_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzctMS0xLTEtOTA2MTg_d712eed9-189a-4322-958f-a11556360e22">3,634,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9c54836fffa1449f85209e9cddadc72d_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzctMy0xLTEtOTA2MTg_dba7ac8b-7417-4a03-a358-8058b3ab8865"><ix:nonFraction unitRef="shares" contextRef="i9c54836fffa1449f85209e9cddadc72d_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzctMy0xLTEtOTA2MTg_f32731f4-4078-4063-8d69-2109b3129af7">3,634,210</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9c54836fffa1449f85209e9cddadc72d_I20211231" decimals="INF" name="amci:TemporaryEquityIssuePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzctNS0xLTEtOTA2MTg_675198ab-14c4-4786-8f32-b65adf8bc96d">22.86</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c54836fffa1449f85209e9cddadc72d_I20211231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzctNy0xLTEtOTA2MTg_69095c12-7771-44d1-ad4d-a0c8318ff6d1">83,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzgtMS0xLTEtMTAzOTMx_6433ca6e-ed26-4420-b32d-7ae16245a737">29,747,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzgtMy0xLTEtMTAzOTM1_36a6fe36-c042-4eff-974c-84f767bd7b27"><ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzgtMy0xLTEtMTAzOTM1_ab7b9c99-b388-402c-a45c-93c6d8f8b849">29,521,810</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzgtNy0xLTEtMTAzOTM4_6132638c-ccdf-42f5-a95b-1079331e78da">480,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares Authorized</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Issue Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="icae471cb37e8404291aadc66b866dff7_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzItMS0xLTEtOTA2MTg_a123593c-ae60-40f8-a08b-c580b07ed266">4,666,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="icae471cb37e8404291aadc66b866dff7_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzItMy0xLTEtOTA2MTg_5494fc29-f8dc-49c9-8033-26ba2b198427"><ix:nonFraction unitRef="shares" contextRef="icae471cb37e8404291aadc66b866dff7_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzItMy0xLTEtOTA2MTg_d707c45b-0510-4a98-b6c1-d708442fece0">4,666,503</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="icbd1a0745c954062aab7bb0d81157304_I20201231" decimals="INF" name="amci:TemporaryEquityIssuePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzItNS0xLTEtOTA2MTgvdGV4dHJlZ2lvbjphZjczYTdjYTVjZTg0ZTA4YjVjODA1Yzg1ODg2YjUwM181NDk3NTU4MTM5MDk_ecd1a6fe-0a1d-4bc1-addc-b3100fc0276d">1.75</ix:nonFraction> - <ix:nonFraction unitRef="usdPerShare" contextRef="ice5b7039b91e4ef49110749cb0d4f41b_I20201231" decimals="INF" name="amci:TemporaryEquityIssuePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzItNS0xLTEtOTA2MTgvdGV4dHJlZ2lvbjphZjczYTdjYTVjZTg0ZTA4YjVjODA1Yzg1ODg2YjUwM181NDk3NTU4MTM5MTY_dfa80275-6209-4617-b37a-91174371c608">3.94</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icae471cb37e8404291aadc66b866dff7_I20201231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzItNy0xLTEtOTA2MTg_d300e775-93a4-4509-a551-e4d778dd9a5e">12,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="if0affa519b5d4e0aae8d04132534645a_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzMtMS0xLTEtOTA2MTg_5d942941-fca0-438f-bb6a-e58d7c434953">1,733,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="if0affa519b5d4e0aae8d04132534645a_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzMtMy0xLTEtOTA2MTg_782408eb-16da-435f-88c1-e0dd8a368be3"><ix:nonFraction unitRef="shares" contextRef="if0affa519b5d4e0aae8d04132534645a_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzMtMy0xLTEtOTA2MTg_fe16c32f-484b-4723-990b-f29fab7f4852">1,733,370</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="if0affa519b5d4e0aae8d04132534645a_I20201231" decimals="INF" name="amci:TemporaryEquityIssuePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzMtNS0xLTEtOTA2MTg_d96bae44-4ce1-4e08-82ca-6722cba1fb03">10.38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if0affa519b5d4e0aae8d04132534645a_I20201231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzMtNy0xLTEtOTA2MTg_1b4438cd-f542-48c6-a103-6fbbede451fc">18,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i74eaaed6f417404bb146455ed9642f5a_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzQtMS0xLTEtOTA2MTg_88ec5197-aa4d-48b8-8d14-ef73aaabe892">4,254,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i74eaaed6f417404bb146455ed9642f5a_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzQtMy0xLTEtOTA2MTg_5e4783dc-f20c-4606-bd41-0807f1a2ef6c"><ix:nonFraction unitRef="shares" contextRef="i74eaaed6f417404bb146455ed9642f5a_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzQtMy0xLTEtOTA2MTg_8797e2c7-94f0-48c2-ae78-c17faaa9fb03">4,142,408</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i74eaaed6f417404bb146455ed9642f5a_I20201231" decimals="INF" name="amci:TemporaryEquityIssuePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzQtNS0xLTEtOTA2MTg_960ae2a2-3ca3-4b53-be49-4a399db46328">14.69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i74eaaed6f417404bb146455ed9642f5a_I20201231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzQtNy0xLTEtOTA2MTg_a9a5f7c3-f0d5-4022-87be-2857a1f531c4">60,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="iea72673f89f344d5a288193ba7de0128_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzUtMS0xLTEtOTA2MTg_366cf9e6-c409-4fef-96ac-0cc347d0d14d">10,274,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="iea72673f89f344d5a288193ba7de0128_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzUtMy0xLTEtOTA2MTg_6cda9385-fec9-4b59-b0c5-7116c596a778"><ix:nonFraction unitRef="shares" contextRef="iea72673f89f344d5a288193ba7de0128_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzUtMy0xLTEtOTA2MTg_cd10460c-07ec-4acc-b331-068bf536b475">10,003,304</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="iea72673f89f344d5a288193ba7de0128_I20201231" decimals="INF" name="amci:TemporaryEquityIssuePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzUtNS0xLTEtOTA2MTg_d0243d75-deea-40cf-b6d0-0f9c525c639d">19.93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iea72673f89f344d5a288193ba7de0128_I20201231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzUtNy0xLTEtOTA2MTg_adf0e7ac-befd-4b69-bd74-7f0a4eb2a73f">185,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ie65b1b4339964ae0830003a7a95f3358_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzYtMS0xLTEtOTA2MTg_e209d18c-2613-4f58-9e1f-5192fa1967d3">5,183,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ie65b1b4339964ae0830003a7a95f3358_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzYtMy0xLTEtOTA2MTg_76bf0950-4f64-4a00-877a-a90e2311f970"><ix:nonFraction unitRef="shares" contextRef="ie65b1b4339964ae0830003a7a95f3358_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzYtMy0xLTEtOTA2MTg_7b1fb6af-6d4a-4b5e-8345-dcf7f17402ff">5,183,957</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie65b1b4339964ae0830003a7a95f3358_I20201231" decimals="INF" name="amci:TemporaryEquityIssuePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzYtNS0xLTEtOTA2MTg_e978b490-b95c-4e8e-ba1a-c42a5d7fb1dd">22.86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie65b1b4339964ae0830003a7a95f3358_I20201231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzYtNy0xLTEtOTA2MTg_1cee6207-785f-4b14-a1a8-e56d2b89b50c">118,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzctMS0xLTEtMTAzOTQ2_06c80540-0906-4949-aa32-2e714864966a">26,112,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzctMy0xLTEtMTAzOTQ4_235f836e-901d-4560-b770-050e54ad0c92"><ix:nonFraction unitRef="shares" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzctMy0xLTEtMTAzOTQ4_58786c75-857f-41fc-95cd-b3adfc82c3f4">25,729,542</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzctNy0xLTEtMTAzOTUx_1b87007f-fed5-4849-9e29-cbb8131b1406">394,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="id24d912c799f4df89dea689194137b41" continuedAt="ief9b20cb50fa4485ab64080ea3b26d6e"><ix:continuation id="i37acaad6344b461db59c82794d3207c5"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable convertible preferred stock issued and outstanding as of December&#160;31, 2021 and 2020, and changes during the years ended December&#160;31, 2021 and 2020, were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.989%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.989%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.470%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.989%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.989%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.310%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.997%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="81" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Redeemable Convertible Preferred Stock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series B</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series C</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series D</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series E</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series F</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i90db5fda8f064408a48fcdc8d953f421_I20191231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzMtMS0xLTEtMTAzOTU3_96196587-39aa-400b-983b-b785d54926c2">4,666,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90db5fda8f064408a48fcdc8d953f421_I20191231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzMtMy0xLTEtMTAzOTU3_dc80ce45-bde6-40fe-a76a-429d358ad0fb">12,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i203a431eb37944ba9970e49c1a8973a0_I20191231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzMtNS0xLTEtMTAzOTYx_0e1a4494-344d-405d-b618-97aab898e55b">1,733,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i203a431eb37944ba9970e49c1a8973a0_I20191231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzMtNy0xLTEtMTAzOTYx_9edeba73-ead8-4435-9753-e813ed6ffa9a">18,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ice29ee32562f4fbcacd93b5434eb9059_I20191231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzMtOS0xLTEtMTAzOTYz_4c9bcfe3-c7da-4c95-88be-24fbf1d20d1e">4,142,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice29ee32562f4fbcacd93b5434eb9059_I20191231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzMtMTEtMS0xLTEwMzk2Mw_fd329b72-f318-4183-9796-ef0d839b5222">60,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i60f5e9b899c3402e921d693b6d34e7db_I20191231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzMtMTMtMS0xLTEwMzk2Nw_b806fb35-a654-439a-a57b-f55ce41e5f17">10,003,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60f5e9b899c3402e921d693b6d34e7db_I20191231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzMtMTUtMS0xLTEwMzk2Nw_17c27544-d5b3-4ffa-9708-472072196510">185,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3639631deb4141b89e868bff198a8abe_I20191231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzMtMTctMS0xLTEwMzk3MA_85153eaf-2922-451d-be3c-e0e4e289bc3a">3,149,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3639631deb4141b89e868bff198a8abe_I20191231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzMtMTktMS0xLTEwMzk3MA_a728b6ba-e6c5-49ca-9803-47cae70a8ceb">71,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27b40d5ba4e24322ad9e1de0fd9901c5_I20191231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzMtMjEtMS0xLTEwMzk3Mg_38b3ebf3-4d82-4671-a40a-0512916989f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b40d5ba4e24322ad9e1de0fd9901c5_I20191231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzMtMjMtMS0xLTEwMzk3Mg_7455d014-dd24-4efe-bce0-9a864f9dbf32">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i946f64f7009a4a2082ea5e8ea9ae0377_I20191231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzMtMjUtMS0xLTEwMzk3Ng_fc356742-e503-4d33-83ca-e5f5af23d088">23,695,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i946f64f7009a4a2082ea5e8ea9ae0377_I20191231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzMtMjctMS0xLTEwMzk3Ng_c35a2ffd-3fce-435f-934c-91c54e80909a">347,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Preferred stock issuance, net of costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i274b66feb9f24726acba535a568e1b1c_D20200101-20201231" decimals="INF" name="amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzQtMS0xLTEtMTAzOTU3_5cfb9f39-c0fa-4d8a-97f6-c0667699d371">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i274b66feb9f24726acba535a568e1b1c_D20200101-20201231" decimals="-3" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzQtMy0xLTEtMTAzOTU3_20aaa251-926a-4e64-8cbf-bc33ac9d3805">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id2fd472d035b4442864a247790745af2_D20200101-20201231" decimals="INF" name="amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzQtNS0xLTEtMTAzOTYx_8488f30b-4192-4031-bd89-0edfa9f89244">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2fd472d035b4442864a247790745af2_D20200101-20201231" decimals="-3" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzQtNy0xLTEtMTAzOTYx_e8753823-2e7d-4ee7-8222-18be0ee600a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i004d3d6d81544e698359c68c43fc61d0_D20200101-20201231" decimals="INF" name="amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzQtOS0xLTEtMTAzOTYz_7913eaa4-2365-40a4-91b2-4e21a8235de5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i004d3d6d81544e698359c68c43fc61d0_D20200101-20201231" decimals="-3" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzQtMTEtMS0xLTEwMzk2Mw_e9de6a59-23e4-4e8f-8b45-3ddf687a3c34">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i306c9af6b46045cb8fca7a2fca95e245_D20200101-20201231" decimals="INF" name="amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzQtMTMtMS0xLTEwMzk2Nw_13b65a1b-dc45-4466-9a07-489e4e2669c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i306c9af6b46045cb8fca7a2fca95e245_D20200101-20201231" decimals="-3" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzQtMTUtMS0xLTEwMzk2Nw_1b088ee8-67c4-48c7-9997-ea8b4472fe53">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4d11321cc3a942239572275fcf381918_D20200101-20201231" decimals="INF" name="amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzQtMTctMS0xLTEwMzk3MA_9ddfdda5-54e8-4df9-b1a1-505e89cd87bc">2,034,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d11321cc3a942239572275fcf381918_D20200101-20201231" decimals="-3" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzQtMTktMS0xLTEwMzk3MA_6e0a4b0a-802a-4557-846c-1e4384d41bf5">46,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5c8efec04d224fbaa59158d2f94edd4d_D20200101-20201231" decimals="INF" name="amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzQtMjEtMS0xLTEwMzk3Mg_29cefd93-ba2e-448e-aedc-cfc69dd916ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c8efec04d224fbaa59158d2f94edd4d_D20200101-20201231" decimals="-3" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzQtMjMtMS0xLTEwMzk3Mg_86fab3c9-30a5-4a89-a89d-a188b0ff91df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="INF" name="amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzQtMjUtMS0xLTEwMzk3Ng_5f99b6d6-cb13-4ba7-a8b7-da69b301016a">2,034,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzQtMjctMS0xLTEwMzk3Ng_52db0a17-153c-4d95-9ffc-a8c1965cfc92">46,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icae471cb37e8404291aadc66b866dff7_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzUtMS0xLTEtMTAzOTU3_22842f6f-0a7f-4564-a733-bd05951d608b">4,666,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae471cb37e8404291aadc66b866dff7_I20201231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzUtMy0xLTEtMTAzOTU3_76494529-c09f-4ae7-aad6-696b44d777fa">12,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if0affa519b5d4e0aae8d04132534645a_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzUtNS0xLTEtMTAzOTYx_6b6d9236-a9a0-4762-9950-fdd12930e94a">1,733,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0affa519b5d4e0aae8d04132534645a_I20201231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzUtNy0xLTEtMTAzOTYx_e321e629-a3c3-4ab7-8956-0ff7b8a2434b">18,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i74eaaed6f417404bb146455ed9642f5a_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzUtOS0xLTEtMTAzOTYz_0e1c9f2f-bd7f-4e36-b48a-b54a59463978">4,142,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74eaaed6f417404bb146455ed9642f5a_I20201231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzUtMTEtMS0xLTEwMzk2Mw_e5990720-e68b-474d-9696-18b0f53f2efb">60,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iea72673f89f344d5a288193ba7de0128_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzUtMTMtMS0xLTEwMzk2Nw_a1898ee0-45e7-4535-ac71-1b47ab9bd02d">10,003,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea72673f89f344d5a288193ba7de0128_I20201231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzUtMTUtMS0xLTEwMzk2Nw_7dd3f318-146a-49f3-8946-8e409a4abc3e">185,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie65b1b4339964ae0830003a7a95f3358_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzUtMTctMS0xLTEwMzk3MA_b8fea4c3-7d45-41ee-b1cd-db7eaa42b76e">5,183,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie65b1b4339964ae0830003a7a95f3358_I20201231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzUtMTktMS0xLTEwMzk3MA_4c4baf0d-2ac8-4b4f-9aa3-aab53cfcca06">118,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i909eedca48974777b86ab5582898a5a8_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzUtMjEtMS0xLTEwMzk3Mg_3ac7e9b5-7bb0-442c-8981-34bf4e51456f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i909eedca48974777b86ab5582898a5a8_I20201231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzUtMjMtMS0xLTEwMzk3Mg_9ccaac41-edd3-4de5-a230-22455ae9191e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzUtMjUtMS0xLTEwMzk3Ng_33b941a6-8ccc-4ae1-a1f8-86e77dbde46e">25,729,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzUtMjctMS0xLTEwMzk3Ng_4d62e153-5c87-478e-9f5a-42d2e6facae1">394,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Preferred stock issuance, net of costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70266a51f6fd4149be790adbf96c3a30_D20210101-20211231" decimals="INF" name="amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzYtMS0xLTEtOTA2MTg_419aa2d3-ef27-4258-a296-b82d3c5ef8bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70266a51f6fd4149be790adbf96c3a30_D20210101-20211231" decimals="-3" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzYtMy0xLTEtOTA2MTg_5fcd54cc-8ff1-4051-ac3b-1b9e600b18b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i76b836230c434467ac363b81bab66632_D20210101-20211231" decimals="INF" name="amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzYtNS0xLTEtOTA2MTg_ee0dea95-d7b9-4ea2-ae0d-47269ea0be7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76b836230c434467ac363b81bab66632_D20210101-20211231" decimals="-3" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzYtNy0xLTEtOTA2MTg_91e5d214-fe7b-4b29-b394-5c94927e9c8d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i695b4941729c41e48e97d09ddc96d4ac_D20210101-20211231" decimals="INF" name="amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzYtOS0xLTEtOTA2MTg_4fc34525-f9e9-452b-8e3d-2836387ef3e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i695b4941729c41e48e97d09ddc96d4ac_D20210101-20211231" decimals="-3" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzYtMTEtMS0xLTkwNjE4_7f8a2e7d-4110-4e51-a834-6236cdcf950c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iabb8b1ba7cc04a52a91d508fcb565f43_D20210101-20211231" decimals="INF" name="amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzYtMTMtMS0xLTkwNjE4_e6aa8cfe-bebc-4b7e-aae7-6a6c053af00c">158,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabb8b1ba7cc04a52a91d508fcb565f43_D20210101-20211231" decimals="-3" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzYtMTUtMS0xLTkwNjE4_4a797d38-494a-473d-a4b6-04f9645a6004">3,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idad7341fd7894a348248ac1892d2d548_D20210101-20211231" decimals="INF" name="amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzYtMTctMS0xLTkwNjE4_61451b5b-1de2-4feb-9055-e1d65b39693e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idad7341fd7894a348248ac1892d2d548_D20210101-20211231" decimals="-3" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzYtMTktMS0xLTkwNjE4_d9f1b336-3a98-4f5e-9c06-3387d7183b8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i65a85eee2f814026a7777b50ae141b0b_D20210101-20211231" decimals="INF" name="amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzYtMjEtMS0xLTkwNjE4_e50edadb-90c3-4b24-b054-d91979c823e7">3,634,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a85eee2f814026a7777b50ae141b0b_D20210101-20211231" decimals="-3" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzYtMjMtMS0xLTkwNjE4_82a85272-5a78-4072-9571-d8ec26e94613">83,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="INF" name="amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzYtMjUtMS0xLTEwMzk3Ng_2998f694-f1f2-46ae-a55a-c760298a069a">3,792,268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzYtMjctMS0xLTEwMzk3Ng_cee73ad1-3ab0-430c-86c1-a46df64a8f1c">86,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac85d16334474caf87d510d9eb18ff97_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzctMS0xLTEtMTAzOTU3_4f1a162b-cc4d-4532-9d1a-a9060df3e07b">4,666,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac85d16334474caf87d510d9eb18ff97_I20211231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzctMy0xLTEtMTAzOTU3_d3d29862-b3ad-482d-85cd-c65bddb0d241">12,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i579053a3cd4d442382bdb8ffa9a87db6_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzctNS0xLTEtMTAzOTYx_9efc3afb-45a7-40e5-a083-c93d7b81ec48">1,733,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i579053a3cd4d442382bdb8ffa9a87db6_I20211231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzctNy0xLTEtMTAzOTYx_c3b07b02-b0a4-4c1d-9abb-dfebf74a98f8">18,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i51d874e0b5b94c329952825293416b35_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzctOS0xLTEtMTAzOTYz_34cfaaad-7711-4238-b605-357e29db66da">4,142,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51d874e0b5b94c329952825293416b35_I20211231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzctMTEtMS0xLTEwMzk2Mw_f0b0a936-074e-49a5-9d2e-860e83e3169b">60,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6147091081d14d69be73064143508062_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzctMTMtMS0xLTEwMzk2Nw_96e7ce60-1822-4e4f-bac8-d15742b89c50">10,161,362</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6147091081d14d69be73064143508062_I20211231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzctMTUtMS0xLTEwMzk2Nw_dfe0d866-0623-4082-ada2-957a8936698d">188,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i75249f1eb69a41749449ae454de51fed_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzctMTctMS0xLTEwMzk3MA_b33b3a3a-53aa-406f-a7b0-f3e7eb131e05">5,183,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75249f1eb69a41749449ae454de51fed_I20211231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzctMTktMS0xLTEwMzk3MA_9eb25c21-c994-4267-a3d1-07311ff35009">118,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9c54836fffa1449f85209e9cddadc72d_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzctMjEtMS0xLTkwNjE4_56d73ba1-e7f2-4227-b291-9267025f3a02">3,634,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c54836fffa1449f85209e9cddadc72d_I20211231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzctMjMtMS0xLTkwNjE4_ed552657-87ca-4016-b6ad-27ac8dd0a7fa">83,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzctMjUtMS0xLTEwMzk3Ng_6aca8400-5cee-45dd-bf49-0dabc470e6c6">29,521,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzctMjctMS0xLTEwMzk3Ng_d0a80d7a-b30a-4cf6-adb2-54f15ef74a60">480,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records all preferred shares net of offering costs at their respective fair values on the dates of issuance. The preferred shares are classified outside of shareholders&#8217; (deficit) equity in the consolidated financial statements, as the preferred shares are redeemable under circumstances that qualify as a deemed liquidation event, which are outside the control of the Company. Upon the occurrence of a liquidation event, such as a voluntary or involuntary liquidation, dissolution or winding up of the Company, merger, consolidation, or change in control, the holders of Series E preferred stock are entitled, on a pari passu basis, to be paid out of the assets of the Company available for distribution before any payment is made to the holders of Series A, B, C, and D preferred shares and then to holders of common shares. In February 2020, the Company closed a Series E follow-on round with the issuance of <ix:nonFraction unitRef="shares" contextRef="ia53cc2675c474ab094ee86871334ac6e_D20200201-20200229" decimals="INF" name="amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90ZXh0cmVnaW9uOjRjN2Y5MDQwMTVkODRiZDdiNGFiOTU4MGQwYjdhOTYwXzEzODc_fc6de623-aa44-4a67-ad9d-d7ff572a8b6a">2,034,212</ix:nonFraction> Series E preferred shares for net proceeds of $<ix:nonFraction unitRef="usd" contextRef="ia53cc2675c474ab094ee86871334ac6e_D20200201-20200229" decimals="-3" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90ZXh0cmVnaW9uOjRjN2Y5MDQwMTVkODRiZDdiNGFiOTU4MGQwYjdhOTYwXzE0MzY_e9d6c13f-02f9-4ee8-a2b8-e8c8ec79da83">46,470</ix:nonFraction> ($<ix:nonFraction unitRef="usdPerShare" contextRef="ia53cc2675c474ab094ee86871334ac6e_D20200201-20200229" decimals="2" name="amci:TemporaryEquityStockIssuedDuringPeriodPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90ZXh0cmVnaW9uOjRjN2Y5MDQwMTVkODRiZDdiNGFiOTU4MGQwYjdhOTYwXzE0NDA_ee1b8f07-59ef-4267-ba1d-66b263bdc650">22.86</ix:nonFraction> per share). In March 2021, a warrant was exercised for a total issuance of <ix:nonFraction unitRef="shares" contextRef="i9f67793938594975ad7e63e3f8a4f312_D20210301-20210331" decimals="INF" name="amci:TemporaryEquitySharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90ZXh0cmVnaW9uOjRjN2Y5MDQwMTVkODRiZDdiNGFiOTU4MGQwYjdhOTYwXzE1MTg_8525332d-3170-4341-83b7-390b93b4670d">158,058</ix:nonFraction> Series D preferred shares and net proceeds of $<ix:nonFraction unitRef="usd" contextRef="i9f67793938594975ad7e63e3f8a4f312_D20210301-20210331" decimals="-3" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90ZXh0cmVnaW9uOjRjN2Y5MDQwMTVkODRiZDdiNGFiOTU4MGQwYjdhOTYwXzE3MDQyNDMwMjM0ODYx_e6ba6be5-da57-4702-836a-309edafcfa57">3,150</ix:nonFraction> ($<ix:nonFraction unitRef="usdPerShare" contextRef="i9f67793938594975ad7e63e3f8a4f312_D20210301-20210331" decimals="2" name="amci:TemporaryEquityStockIssuedDuringPeriodPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90ZXh0cmVnaW9uOjRjN2Y5MDQwMTVkODRiZDdiNGFiOTU4MGQwYjdhOTYwXzEwOTk1MTE2MjgyMDc4_69cc02a9-2322-44ca-85e0-8e94cb6e0e8a">19.93</ix:nonFraction> per share). In April 2021, the Company closed a Series F round with the issuance of <ix:nonFraction unitRef="shares" contextRef="i45b464fc79c145a2a521d5dd55876280_D20210401-20210430" decimals="INF" name="amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90ZXh0cmVnaW9uOjRjN2Y5MDQwMTVkODRiZDdiNGFiOTU4MGQwYjdhOTYwXzE2NjI_4649de70-6da7-4a9b-960b-f4f5d6c67ec6">3,634,210</ix:nonFraction> Series F preferred shares for the net proceeds of $<ix:nonFraction unitRef="usd" contextRef="i45b464fc79c145a2a521d5dd55876280_D20210401-20210430" decimals="-3" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90ZXh0cmVnaW9uOjRjN2Y5MDQwMTVkODRiZDdiNGFiOTU4MGQwYjdhOTYwXzE3MTU_967c829c-e99b-4cbb-aa8a-c4def402c379">83,073</ix:nonFraction> ($<ix:nonFraction unitRef="usdPerShare" contextRef="i45b464fc79c145a2a521d5dd55876280_D20210401-20210430" decimals="2" name="amci:TemporaryEquityStockIssuedDuringPeriodPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90ZXh0cmVnaW9uOjRjN2Y5MDQwMTVkODRiZDdiNGFiOTU4MGQwYjdhOTYwXzE3MTk_605c39de-53b1-4a6e-9fef-f7e9c9c74690">22.86</ix:nonFraction> per share).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of preferred shares are entitled to cast the number of votes equal to the number of whole common shares into which the preferred shares are convertible. The holders of preferred shares also have consent rights, including in a number of cases subject to a separate class vote and a supermajority requirement, over certain actions including, among others (i) alterations or changes to the terms of the preferred shares, (ii) the election of a certain number of directors, including the designation of directors by holders of a specified series of preferred shares or by certain specified individual stockholders, and (iii) repurchases of shares, the authorization or designation of more senior class or series of shares, or certain issuances of new shares.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preferred shares are convertible at the holder&#8217;s option into common shares generally on a share-for-share basis. Each preferred share will be automatically converted into common stock upon either (i) the determination of the holders of certain requisite preferred shares or (ii) a firmly underwritten initial public offering of the Company&#8217;s shares that satisfies certain requirements (but not, for the avoidance of doubt, upon a business combination with a special purpose acquisition company, unless such conversion is otherwise effected pursuant to clause (i) above).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of preferred shares are entitled to receive dividends on an as converted to common shares basis as if all preferred shares had been converted into common shares on the date of such event. Dividends are cumulative and are payable in arrears at the rate of <ix:nonFraction unitRef="number" contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" decimals="2" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90ZXh0cmVnaW9uOjRjN2Y5MDQwMTVkODRiZDdiNGFiOTU4MGQwYjdhOTYwXzEyNjQ0MzgzNzIzNzIx_3f5afd6c-1fb9-424b-b5ef-71db1b1d4cd3">8</ix:nonFraction>% of the original issue price. If dividends are payable on common shares, preferred shareholders also receive those dividends as if the preferred shares had been converted to common shares. Series D, E, and F preferred shareholders are entitled to be paid dividends prior to Series A, B, and C, on a pari passu basis. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redemption features of preferred shares are not fixed and do not have a determinable price on fixed or determinable dates. As of December&#160;31, 2021 and 2020, preferred shares are not currently redeemable, and it is not probable that preferred shares will become redeemable, since it is uncertain whether or when circumstances exist </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ief9b20cb50fa4485ab64080ea3b26d6e">that would constitute a deemed liquidation event. Accordingly, the Company has not adjusted the carrying value of the preferred shares to their redemption values.</ix:continuation></span></div><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_503"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 17 &#8211; <ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:DefinedBenefitPlanTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MDMvZnJhZzpiMGE2NjgxODAyNmY0NWUyOGY3MTk4ZTRmM2M5MzY2OS90ZXh0cmVnaW9uOmIwYTY2ODE4MDI2ZjQ1ZTI4ZjcxOThlNGYzYzkzNjY5XzE1OTQyOTE4NjAzMzg5_d62c9e4d-1b35-4f9d-94cf-c5b7e612ff24" continuedAt="i9cdd8f4b345747e781ea1b1756248bb9" escape="true">Benefit Plans</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9cdd8f4b345747e781ea1b1756248bb9">The Company sponsors a 401(k) defined contribution retirement plan for the benefit of its employees, substantially all of whom are eligible to participate after meeting minimum qualifying requirements. Contributions to the plan are at the discretion of the Company. For the years ended December&#160;31, 2021 and 2020, the Company contributed $<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:DefinedContributionPlanCostRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MDMvZnJhZzpiMGE2NjgxODAyNmY0NWUyOGY3MTk4ZTRmM2M5MzY2OS90ZXh0cmVnaW9uOmIwYTY2ODE4MDI2ZjQ1ZTI4ZjcxOThlNGYzYzkzNjY5XzM1MA_a4547216-c10e-46fc-8e03-955c98a94c90">720</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:DefinedContributionPlanCostRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MDMvZnJhZzpiMGE2NjgxODAyNmY0NWUyOGY3MTk4ZTRmM2M5MzY2OS90ZXh0cmVnaW9uOmIwYTY2ODE4MDI2ZjQ1ZTI4ZjcxOThlNGYzYzkzNjY5XzM1Nw_29536b44-6e7a-462c-b8a9-e5ad9defee2b">548</ix:nonFraction>, respectively, to the plan, which contributions are included within research and development expense in the consolidated statements of operations and comprehensive loss.</ix:continuation></span></div><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_507"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 18 &#8212; <ix:continuation id="ic41f9b49aa2042b399bfd2d93e8096d4" continuedAt="ib4ed2e6f6e154419a73d69d92bdf8657">Commitments and Contingencies</ix:continuation></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:continuation id="ib4ed2e6f6e154419a73d69d92bdf8657" continuedAt="i1c8adaa335c74d35978c9c72146e36bf">Litigation</ix:continuation></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1c8adaa335c74d35978c9c72146e36bf">The Company may be involved in legal proceedings and exposed to potential claims in the normal course of business. As of December 31, 2021 and December 31, 2020, it is not probable that the Company has incurred any losses from such claims.</ix:continuation> </span></div><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_514"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 19 &#8212; <ix:continuation id="i9dc6f14aefb3401e8cdf6f22782e8c4f" continuedAt="i42090ebe1d49440bbaf5238d716d253f"><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzEwOTk1MTE2Mjc5Njc0_ba1b5d92-7ca1-4584-a6ad-e2737757af8f" continuedAt="ic78ea3ef102641188391c0da1d839a9a" escape="true">Leases </ix:nonNumeric></ix:continuation></span></div><ix:continuation id="i42090ebe1d49440bbaf5238d716d253f" continuedAt="i8da61ec7833c4e5e8aea2a7dbfce9eb5"><ix:continuation id="ic78ea3ef102641188391c0da1d839a9a" continuedAt="ifbbd546a44e54aed9d207ace0b762764"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases certain office space and laboratory facilities. The Company&#8217;s lease agreements typically do not contain any significant guarantees of asset values at the end of a lease, renewal options or restrictive covenants. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s adoption of ASC 842, Leases, all leases were classified as operating leases. During </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021 and 2020, t</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he discount rate used in the calculation of lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was <ix:nonFraction unitRef="number" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzEwOTk1MTE2Mjc5NzEx_1f93508d-288b-493c-b9ec-d7aff22276cd"><ix:nonFraction unitRef="number" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzEwOTk1MTE2Mjc5NzEx_cd90eb9d-32d9-4f9e-a70f-26c30e2901a7">7.5</ix:nonFraction></ix:nonFraction>%, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which is the estimate of the rate of interest that the Company would have to pay to borrow on a collateralized basis over a similar term.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating lease costs and variable lease costs for the years ended December&#160;31, 2021 and 2020 were $<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzY3Mw_3deb38e4-8d3d-4418-b2a0-d62fcc741582">2,126</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzY4MA_ee51c574-5dcb-453c-a6f2-c4b365338eb2">2,077</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzY4Nw_db161f28-993f-4f74-8353-b3e81b8bf94e">2,575</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzY5NA_9e3647a7-0797-4a5a-b8c0-ee61209da4b9">1,813</ix:nonFraction>, respectively. Cash paid for amounts included in the measurement of operating lease liabilities for the years ended December&#160;31, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzgyNw_669ada02-7507-4724-94e0-b2ceabecce18">2,059</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzgzNA_a73c5c93-f2bc-4375-ba2e-aec126bce4fa">1,765</ix:nonFraction>, respectively.</span></div><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzEwOTk1MTE2Mjc5NjY5_3f5133d0-f011-4435-9553-cb7b847c02d8" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, lease payments for operating leases for the Company&#8217;s office facility and laboratories are shown below (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.279%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTpiMDFkZjYzNWIyM2Y0YWY0OTYxMDhlODM4ODNmMTA2Ni90YWJsZXJhbmdlOmIwMWRmNjM1YjIzZjRhZjQ5NjEwOGU4Mzg4M2YxMDY2XzEtMS0xLTEtOTA2MTg_730122be-3137-4a92-a1ab-5bfcc62a8119">2,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTpiMDFkZjYzNWIyM2Y0YWY0OTYxMDhlODM4ODNmMTA2Ni90YWJsZXJhbmdlOmIwMWRmNjM1YjIzZjRhZjQ5NjEwOGU4Mzg4M2YxMDY2XzItMS0xLTEtOTA2MTg_573ef46c-f3e3-420e-8c1f-346812359759">2,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTpiMDFkZjYzNWIyM2Y0YWY0OTYxMDhlODM4ODNmMTA2Ni90YWJsZXJhbmdlOmIwMWRmNjM1YjIzZjRhZjQ5NjEwOGU4Mzg4M2YxMDY2XzMtMS0xLTEtOTA2MTg_8a219a6b-1feb-4d17-81b9-b0d67ad438ec">1,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTpiMDFkZjYzNWIyM2Y0YWY0OTYxMDhlODM4ODNmMTA2Ni90YWJsZXJhbmdlOmIwMWRmNjM1YjIzZjRhZjQ5NjEwOGU4Mzg4M2YxMDY2XzQtMS0xLTEtOTA2MTg_737b9553-4156-463c-a7f9-b3d5c84ff5bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTpiMDFkZjYzNWIyM2Y0YWY0OTYxMDhlODM4ODNmMTA2Ni90YWJsZXJhbmdlOmIwMWRmNjM1YjIzZjRhZjQ5NjEwOGU4Mzg4M2YxMDY2XzUtMS0xLTEtOTA2MTg_7a3a7204-bb69-420c-8b50-8c3c2687463a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTpiMDFkZjYzNWIyM2Y0YWY0OTYxMDhlODM4ODNmMTA2Ni90YWJsZXJhbmdlOmIwMWRmNjM1YjIzZjRhZjQ5NjEwOGU4Mzg4M2YxMDY2XzYtMS0xLTEtOTA2MTg_4dee4893-c22c-4bd4-b8a7-65b83b737bd1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTpiMDFkZjYzNWIyM2Y0YWY0OTYxMDhlODM4ODNmMTA2Ni90YWJsZXJhbmdlOmIwMWRmNjM1YjIzZjRhZjQ5NjEwOGU4Mzg4M2YxMDY2XzctMi0xLTEtMTA1NTQ1_12168446-512b-4f54-8fa6-55d20f6eac3d">5,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTpiMDFkZjYzNWIyM2Y0YWY0OTYxMDhlODM4ODNmMTA2Ni90YWJsZXJhbmdlOmIwMWRmNjM1YjIzZjRhZjQ5NjEwOGU4Mzg4M2YxMDY2XzgtMS0xLTEtOTA2MTg_17af482e-1ea1-47e9-a2f4-548eb672aa77">485</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTpiMDFkZjYzNWIyM2Y0YWY0OTYxMDhlODM4ODNmMTA2Ni90YWJsZXJhbmdlOmIwMWRmNjM1YjIzZjRhZjQ5NjEwOGU4Mzg4M2YxMDY2XzktMi0xLTEtMTA1NTQ1_651266c3-ca15-479f-b4b3-a5a84fc0502a">5,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="amci:AssetsAndLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzEwOTk1MTE2Mjc5Njcw_4536995a-e033-4876-b6d6-782205cba4ef" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of weighted average remaining lease term and discount rate for all of the Company&#8217;s operating leases:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTowMjY2YTVjYjA3ODA0OWVkOTgwMjU1OTYxZGJjZTRlYi90YWJsZXJhbmdlOjAyNjZhNWNiMDc4MDQ5ZWQ5ODAyNTU5NjFkYmNlNGViXzItMS0xLTEtOTA2MTg_672c7a4a-cc0d-4413-96fe-58d00bf91e36">2.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTowMjY2YTVjYjA3ODA0OWVkOTgwMjU1OTYxZGJjZTRlYi90YWJsZXJhbmdlOjAyNjZhNWNiMDc4MDQ5ZWQ5ODAyNTU5NjFkYmNlNGViXzItMy0xLTEtOTA2MTg_9c8ec383-d115-401b-8d8b-ae0402f80b5c">3.4</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTowMjY2YTVjYjA3ODA0OWVkOTgwMjU1OTYxZGJjZTRlYi90YWJsZXJhbmdlOjAyNjZhNWNiMDc4MDQ5ZWQ5ODAyNTU5NjFkYmNlNGViXzMtMS0xLTEtOTA2MTg_d3715867-1953-4e16-a737-3c4512de75e0">7.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTowMjY2YTVjYjA3ODA0OWVkOTgwMjU1OTYxZGJjZTRlYi90YWJsZXJhbmdlOjAyNjZhNWNiMDc4MDQ5ZWQ5ODAyNTU5NjFkYmNlNGViXzMtMy0xLTEtOTA2MTg_e609f3ea-4dc4-4cd4-a349-9d5a3109b665">7.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><ix:continuation id="i8da61ec7833c4e5e8aea2a7dbfce9eb5" continuedAt="icc7514fd870e487c994fb5601c51b09f"><ix:continuation id="ifbbd546a44e54aed9d207ace0b762764" continuedAt="i851eb500d3954360849f3b5a1f650aa0"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor Accounting</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, the Company executed an agreement to lease certain land to a subsidiary of LanzaJet for a period of <ix:nonNumeric contextRef="ife262e1009764f0ebe3fdfe5ad4fb494_I20200531" name="us-gaap:LessorOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzEyNjQ0MzgzNzIxMzE3_a52f441a-d449-449e-86db-75b05e0bcda0">10</ix:nonNumeric> years with an option to renew this lease for <ix:nonFraction unitRef="renewal_option" contextRef="i8afc523d3a4c48d79839de0f31b51d9c_D20200501-20200531" decimals="INF" name="amci:LesssorOperatingLeaseNumberOfRenewalOptions" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzEwOTk1MTE2Mjc5Njkw_07fa8d93-85cd-4a7b-a540-283eca314d19">five</ix:nonFraction> additional periods of <ix:nonNumeric contextRef="ife262e1009764f0ebe3fdfe5ad4fb494_I20200531" name="us-gaap:LessorOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzEwOTk1MTE2Mjc5Njc2_d54ea6b7-da00-47ed-bf1c-50e99897506f">one year</ix:nonNumeric> with minimum annual rent due. This agreement is accounted for as an operating lease. We recognize lease revenue on a straight-line basis over the life of the lease agreement. <ix:nonNumeric contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzEwOTk1MTE2Mjc5Njcx_0d3a91f3-bde1-41a1-90aa-2962212e8082" continuedAt="i447f20d9f16541f998317b55b0c7e17f" escape="true">The following future minimum lease payments due to us from the lease agreement at December 31, 2021, is as follows (in thousands)</ix:nonNumeric></span></div><div style="margin-bottom:9pt"><ix:continuation id="i447f20d9f16541f998317b55b0c7e17f"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTo0ZWEzNWY4NGZiNTk0NTIzYmU3ZjIwMzI4ZGYwYTYzZC90YWJsZXJhbmdlOjRlYTM1Zjg0ZmI1OTQ1MjNiZTdmMjAzMjhkZjBhNjNkXzEtMS0xLTEtOTA2MTg_a58adc9c-afdb-4b15-8683-6827b0513360">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTo0ZWEzNWY4NGZiNTk0NTIzYmU3ZjIwMzI4ZGYwYTYzZC90YWJsZXJhbmdlOjRlYTM1Zjg0ZmI1OTQ1MjNiZTdmMjAzMjhkZjBhNjNkXzItMS0xLTEtOTA2MTg_a887936f-e47f-419a-ad4e-f94c67dfe43a">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedThreeYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTo0ZWEzNWY4NGZiNTk0NTIzYmU3ZjIwMzI4ZGYwYTYzZC90YWJsZXJhbmdlOjRlYTM1Zjg0ZmI1OTQ1MjNiZTdmMjAzMjhkZjBhNjNkXzMtMS0xLTEtOTA2MTg_4d3c4969-256b-49b5-8227-230e13467490">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedFourYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTo0ZWEzNWY4NGZiNTk0NTIzYmU3ZjIwMzI4ZGYwYTYzZC90YWJsZXJhbmdlOjRlYTM1Zjg0ZmI1OTQ1MjNiZTdmMjAzMjhkZjBhNjNkXzQtMS0xLTEtOTA2MTg_087ad943-2464-4c41-9ea8-f795df3f7306">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedFiveYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTo0ZWEzNWY4NGZiNTk0NTIzYmU3ZjIwMzI4ZGYwYTYzZC90YWJsZXJhbmdlOjRlYTM1Zjg0ZmI1OTQ1MjNiZTdmMjAzMjhkZjBhNjNkXzUtMS0xLTEtOTA2MTg_24ba9eaf-d05b-432b-a007-05e2a00c2717">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedThereafter" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTo0ZWEzNWY4NGZiNTk0NTIzYmU3ZjIwMzI4ZGYwYTYzZC90YWJsZXJhbmdlOjRlYTM1Zjg0ZmI1OTQ1MjNiZTdmMjAzMjhkZjBhNjNkXzYtMS0xLTEtOTA2MTg_e92cb201-82d6-4088-9bd6-0b8900976cf1">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTo0ZWEzNWY4NGZiNTk0NTIzYmU3ZjIwMzI4ZGYwYTYzZC90YWJsZXJhbmdlOjRlYTM1Zjg0ZmI1OTQ1MjNiZTdmMjAzMjhkZjBhNjNkXzctMS0xLTEtOTA2MTg_a2d1b23d-f7c7-496f-a658-343601a8e48b">288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icc7514fd870e487c994fb5601c51b09f"><ix:continuation id="i851eb500d3954360849f3b5a1f650aa0">Lease revenue totaled $<ix:nonFraction unitRef="usd" contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzEyNjQ0MzgzNzIxMzA4_6fd04359-15da-483e-bfa1-d0eed8760424">24</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzEyNjQ0MzgzNzIxMzEz_84e8144c-fb83-446f-9caa-19c327012dc6">14</ix:nonFraction> for the years ended December 31, 2021 and 2020.</ix:continuation></ix:continuation> </span></div><div style="text-align:center"><span><br/></span></div><div id="ib82e114cd19f45afae73e7a64e42f208_518"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 20 &#8212; <ix:continuation id="i940aee07aeb84dd4ad3cfc26961e85f4" continuedAt="ibf39a54c440d4f50856eeb830adde6c3">Subsequent Events</ix:continuation></span></div><ix:continuation id="ibf39a54c440d4f50856eeb830adde6c3"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated events occurring subsequent to December&#160;31, 2021 through May 9, 2022, the date the consolidated financial statements were available to be issued. The Company is not aware of any significant or material subsequent event that would require disclosure.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposed Merger</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2022, the Company entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with AMCI Acquisition Corp. II, a Delaware corporation (&#8220;AMCI&#8221;) and AMCI Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of AMCI (&#8220;Merger Sub&#8221;). Under the Merger Agreement, Merger Sub will merge with and into LanzaTech, with LanzaTech surviving the Merger as a wholly-owned subsidiary of AMCI (&#8220;the Merger&#8221;). In connection with the Merger, AMCI will be renamed LanzaTech Global, Inc (&#8220;New LanzaTech&#8221;). AMCI has agreed to acquire all of the outstanding equity interests of LanzaTech for consideration consisting of an equity interest of New LanzaTech valued at approximately $<ix:nonFraction unitRef="usd" contextRef="i3e4ce82bb6ca465b8f60e74f553154c0_I20220308" decimals="-8" name="us-gaap:BusinessCombinationContingentConsiderationAssetCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTgvZnJhZzo2ZDhmODMyMGU2NDU0MDgxYWE1NDZlODI0NjFjOGZmOS90ZXh0cmVnaW9uOjZkOGY4MzIwZTY0NTQwODFhYTU0NmU4MjQ2MWM4ZmY5XzEyNjQ0MzgzNzIwOTEw_2d3fc55d-f471-4a63-9d42-7ed89de08916">1.8</ix:nonFraction>&#160;billion. Completion of the transaction is subject to certain customary regulatory consents and approval by stockholders of AMCI and the Company.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger Agreement, on March 8, 2022, AMCI entered into subscription agreements with certain investors pursuant to which AMCI agreed to issue and sell a private placement to close immediately prior to the Merger.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-104</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_1975"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:center"><img src="amci-20230213_g8.jpg" alt="amci-20230213_g8.jpg" style="height:77px;margin-bottom:5pt;vertical-align:text-bottom;width:357px"/></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_1997"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INFORMATION NOT REQUIRED IN PROSPECTUS</span></div><div id="ib82e114cd19f45afae73e7a64e42f208_2018"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 13.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Expenses of Issuance and Distribution</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth all expenses to be paid by us in connection with the issuance and distribution of the securities being registered hereby. All amounts shown are estimates except for the SEC registration fee. </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SEC registration fee</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196,965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal fees and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounting fees and expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Printing fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Miscellaneous</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465,965&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib82e114cd19f45afae73e7a64e42f208_2040"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 14.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Indemnification of Directors and Officers</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our second amended and restated certificate of incorporation (our &#8220;Charter&#8221;) provides that all of our directors, officers, employees and agents shall be entitled to be indemnified by us to the fullest extent permitted by Section 145 of the Delaware General Corporation Law (&#8220;DGCL&#8221;). Section 145 of the DGCL concerning indemnification of officers, directors, employees and agents is set forth below. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 145. Indemnification of officers, directors, employees and agents; insurance. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">A corporation shall have power to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the corporation) by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys&#8217; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with such action, suit or proceeding if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe the person&#8217;s conduct was unlawful. The termination of any action, suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption that the person did not act in good faith and in a manner which the person reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had reasonable cause to believe that the person&#8217;s conduct was unlawful. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">A corporation shall have power to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against expenses (including attorneys&#8217; fees) actually and reasonably incurred by the person in connection with the defense or settlement of such action or suit if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation and except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">To the extent that a present or former director or officer of a corporation has been successful on the merits or otherwise in defense of any action, suit or proceeding referred to in subsections (a) and (b) of this section, or in defense of any claim, issue or matter therein, such person shall be indemnified against expenses (including attorneys&#8217; fees) actually and reasonably incurred by such person in connection therewith. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any indemnification under subsections (a) and (b) of this section (unless ordered by a court) shall be made by the corporation only as authorized in the specific case upon a determination that indemnification of the present or former director, officer, employee or agent is proper in the circumstances because the person has met the applicable standard of conduct set forth in subsections (a) and (b) of this section. Such determination shall be made, with respect to a person who is a director or officer at the time of such determination, (1) by a majority vote of the directors who are not parties to such action, suit or proceeding, even though less than a quorum, or (2) by a committee of such directors designated by majority vote of such directors, even though less than a quorum, or (3) if there are no such directors, or if such directors so direct, by independent legal counsel in a written opinion, or (4) by the stockholders. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Expenses (including attorneys&#8217; fees) incurred by an officer or director in defending any civil, criminal, administrative or investigative action, suit or proceeding may be paid by the corporation in advance of the final disposition of such action, suit or proceeding upon receipt of an undertaking by or on behalf of such director or officer to repay such amount if it shall ultimately be determined that such person is not entitled to be indemnified by the corporation as authorized in this section. Such expenses (including attorneys&#8217; fees) incurred by former officers and directors or other employees and agents may be so paid upon such terms and conditions, if any, as the corporation deems appropriate. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.01pt">The indemnification and advancement of expenses provided by, or granted pursuant to, the other subsections of this section shall not be deemed exclusive of any other rights to which those seeking indemnification or advancement of expenses may be entitled under any bylaw, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in such person&#8217;s official capacity and as to action in another capacity while holding such office. A right to indemnification or to advancement of expenses arising under a provision of the certificate of incorporation or a bylaw shall not be eliminated or impaired by an amendment to such provision after the occurrence of the act or omission that is the subject of the civil, criminal, administrative or investigative action, suit or proceeding for which indemnification or advancement of expenses is sought, unless the provision in effect at the time of such act or omission explicitly authorizes such elimination or impairment after such action or omission has occurred. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">A corporation shall have power to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any liability asserted against such person and incurred by such person in any such capacity, or arising out of such person&#8217;s status as such, whether or not the corporation would have the power to indemnify such person against such liability under this section. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">For purposes of this section, references to &#8220;the corporation&#8221; shall include, in addition to the resulting corporation, any constituent corporation (including any constituent of a constituent) absorbed in a consolidation or merger which, if its separate existence had continued, would have had power and authority to indemnify its directors, officers, and employees or agents, so that any person who is or was a director, officer, employee or agent of such constituent corporation, or is or was serving at the request of such constituent corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, shall stand in the same position under this section with respect to the resulting or surviving corporation as such person would have with respect to such constituent corporation if its separate existence had continued. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">For purposes of this section, references to &#8220;other enterprises&#8221; shall include employee benefit plans; references to &#8220;fines&#8221; shall include any excise taxes assessed on a person with respect to any employee benefit plan; and references to &#8220;serving at the request of the corporation&#8221; shall include any service as a director, officer, employee or agent of the corporation which imposes duties on, or involves services by, such director, officer, employee or agent with respect to an employee benefit plan, its participants or beneficiaries; and a person who acted in good faith and in a manner such person reasonably believed to be in the interest of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner &#8220;not opposed to the best interests of the corporation&#8221; as referred to in this section. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">The indemnification and advancement of expenses provided by, or granted pursuant to, this section shall, unless otherwise provided when authorized or ratified, continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the benefit of the heirs, executors and administrators of such a person. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Court of Chancery is hereby vested with exclusive jurisdiction to hear and determine all actions for advancement of expenses or indemnification brought under this section or under any by law, agreement, vote of stockholders or disinterested directors, or otherwise. The Court of Chancery may summarily determine a corporation&#8217;s obligation to advance expenses (including attorneys&#8217; fees). </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers, and controlling persons pursuant to the foregoing provisions, or otherwise, we have been advised that, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment of expenses incurred or paid by a director, officer or controlling person in a successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, we will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to the court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with Section 102(b)(7) of the DGCL, our Charter provides that no director shall be personally liable to us or any of our stockholders for monetary damages resulting from breaches of their fiduciary duty as directors, except to the extent such limitation on or exemption from liability is not permitted under the DGCL. The effect of this provision of our Charter is to eliminate our rights and those of our stockholders (through stockholders&#8217; derivative suits on our behalf) to recover monetary damages against a director for breach of the fiduciary duty of care as a director, including breaches resulting from negligent or grossly negligent behavior, except, as restricted by Section 102(b)(7) of the DGCL. However, this provision does not limit or eliminate our rights or the rights of any stockholder to seek non-monetary relief, such as an injunction or rescission, in the event of a breach of a director&#8217;s duty of care. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the DGCL is amended to authorize corporate action further eliminating or limiting the liability of directors, then, in accordance with our Charter, the liability of our directors to us or our stockholders will be eliminated or limited to the fullest extent authorized by the DGCL, as so amended. Any repeal or amendment of provisions of our Charter limiting or eliminating the liability of directors, whether by our stockholders or by changes in law, or the adoption of any other provisions inconsistent therewith, will (unless otherwise required by law) be prospective only, except to the extent such amendment or change in law permits us to further limit or eliminate the liability of directors on a retroactive basis. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Charter also provides that we will, to the fullest extent authorized or permitted by applicable law, indemnify our current and former officers and directors, as well as those persons who, while directors or officers of our corporation, are or were serving as directors, officers, employees or agents of another entity, trust or other enterprise, including service with respect to an employee benefit plan, in connection with any threatened, pending or completed proceeding, whether civil, criminal, administrative or investigative, against all expense, liability and loss (including, without limitation, attorney&#8217;s fees, judgments, fines, ERISA excise taxes and penalties and amounts paid in settlement) reasonably incurred or suffered by any such person in connection with any such proceeding. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, a person eligible for indemnification pursuant to our Charter will be indemnified by us in connection with a proceeding initiated by such person only if such proceeding was authorized by our board of directors, except for proceedings to enforce rights to indemnification. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The right to indemnification which is conferred by our Charter is a contract right that includes the right to be paid by us the expenses incurred in defending or otherwise participating in any proceeding referenced above in advance of its final disposition, provided, however, that if the DGCL requires, an advancement of expenses incurred by our officer or director (solely in the capacity as an officer or director of our corporation) will be made only upon delivery to us of an undertaking, by or on behalf of such officer or director, to repay all amounts so advanced if it is ultimately determined that such person is not entitled to be indemnified for such expenses under our Charter or otherwise. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rights to indemnification and advancement of expenses will not be deemed exclusive of any other rights which any person covered by our Charter may have or hereafter acquire under law, our Charter, our amended and restated bylaws (the &#8220;Bylaws&#8221;), an agreement, vote of stockholders or disinterested directors, or otherwise. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any repeal or amendment of provisions of our Charter affecting indemnification rights, whether by our stockholders or by changes in law, or the adoption of any other provisions inconsistent therewith, will (unless otherwise required by law) be prospective only, except to the extent such amendment or change in law permits us to provide broader indemnification rights on a retroactive basis, and will not in any way diminish or adversely affect any right or protection existing at the time of such repeal or amendment or adoption of such inconsistent provision with respect to any act or omission occurring prior to such repeal or amendment or adoption of such inconsistent provision. Our Charter will also permit us, to the extent and in the manner authorized or permitted by law, to indemnify and to advance expenses to persons other that those specifically covered by our Charter. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Bylaws include the provisions relating to advancement of expenses and indemnification rights consistent with those which are set forth in our Charter. In addition, our Bylaws provide for a right of indemnity to bring a suit in the event a claim for indemnification or advancement of expenses is not paid in full by us within a specified period of time. Our Bylaws also permit us to purchase and maintain insurance, at our expense, to protect us and/or any director, officer, employee or agent of our corporation or another entity, trust or other enterprise against any expense, liability or loss, whether or not we would have the power to indemnify such person against such expense, liability or loss under the DGCL. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any repeal or amendment of provisions of our Bylaws affecting indemnification rights, whether by our board of directors, stockholders or by changes in applicable law, or the adoption of any other provisions inconsistent therewith, will (unless otherwise required by law) be prospective only, except to the extent such amendment or change in law permits us to provide broader indemnification rights on a retroactive basis, and will not in any way diminish or adversely affect any right or protection existing thereunder with respect to any act or omission occurring prior to such repeal or amendment or adoption of such inconsistent provision. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our consummation of the Business Combination, we entered into customary indemnification agreements with our directors and executive officers. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib82e114cd19f45afae73e7a64e42f208_2063"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 15. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Sale of Unregistered Securities </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following list sets forth information regarding all unregistered securities sold by us since inception:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">On January 29, 2021, the Sponsor subscribed for an aggregate 5,031,250 shares of AMCI Class B common stock, par value $0.0001 per share (the &#8220;Founder Shares&#8221;) for a total subscription price of $25,000, or approximately $0.005 per share. In March 2021, the Sponsor transferred all of the Founder Shares held by it to members of the AMCI&#8217;s board of directors, its management team and persons or entities affiliated with AMCI Group. On May 14, 2021, certain of AMCI&#8217;s initial stockholders forfeited an aggregate of 718,750 Founder Shares, resulting in an aggregate of 4,312,500 Founder Shares outstanding. On September 17, </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021, the over-allotment option expired and therefore, the initial stockholders forfeited 562,500 Founder Shares, resulting in an aggregate of 3,750,000 Founder Shares outstanding.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2)</span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Simultaneous with the consummation of AMCI&#8217;s Initial Public Offering, the Sponsor purchased 3,500,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, generating gross proceeds of $3.5 million. No underwriting discounts or commissions were paid with respect to such sales. This issuance was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">On February 8, 2023, pursuant to certain non-redemption agreements dated February 3, 2023 and February 6, 2023, AMCI issued and sold 1,250,000 shares of AMCI Class A common stock to certain qualified institutional buyers and accredited investors.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">On February 8, concurrently with the closing of the Business Combination, we issued 18,500,000 shares of common stock for an aggregate purchase price of $185.0 million to certain qualified institutional buyers and accredited investors, at a price of $10.00 per share. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">On February 8, AMCI issued and sold 469,052 shares of AMCI Class A common stock to certain Anchor Investors.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6)</span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the closing of the Business Combination, unvested options to purchase an aggregate of 3,271,104 shares of Legacy LanzaTech common stock at exercise prices of approximately $0.70 to $43.60 per share under the Legacy LanzaTech Plans were automatically and without any required action on the part of any holder or beneficiary thereof, assumed by us and converted into options to purchase an aggregate of 14,310,025 shares of common stock at exercise prices of approximately $0.16 to $9.97. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of the foregoing transactions involved any underwriters, underwriting discounts or commissions, or any public offering. We believe each of these transactions was exempt from registration under the Securities Act in reliance on Section 4(a)(2) of the Securities Act (and Regulation D promulgated thereunder) as transactions by an issuer not involving any public offering or Rule 701 promulgated under Section 3(b) of the Securities Act as transactions by an issuer under benefit plans and contracts relating to compensation as provided under Rule 701. The recipients of the securities in each of these transactions represented their intentions to acquire the securities for investment only and not with a view to or for sale in connection with any distribution thereof, and appropriate legends were placed on the share certificates issued in these transactions. All recipients had adequate access, through their relationships with us, to information about us. The sales of these securities were made without any general solicitation or advertising. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib82e114cd19f45afae73e7a64e42f208_2084"></div><div style="-sec-extract:summary;margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibits </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.434%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#8224;**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1843724/000110465923002389/amci-20220930xs4a.htm#AnnexA">Merger Agreement, dated as of March 8, 2022, by and among AMCI Acquisition Corp. II, AMCI Merger Sub, Inc. and LanzaTech NZ, Inc. (incorporated by reference to Exhibit 2.1 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1843724/000110465923002389/amci-20220930xs4a.htm#ANNEXH_986203">Amendment No. 1 to Merger Agreement, dated as of December 7, 2022, by and among AMCI Acquisition Corp. II, AMCI Merger Sub, Inc. and LanzaTech NZ, Inc. (incorporated by reference to Exhibit 2.2 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1843724/000110465923002389/amci-20220930xs4a.htm#ANNEXH_986203">January 10,</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1843724/000110465923002389/amci-20220930xs4a.htm#ANNEXH_986203"> 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Certificate of Incorporation of LanzaTech Global, Inc., (incorporated by reference to Exhibit 3.1 of LanzaTech Global Inc.&#8217;s Current Report on Form 8-K, filed with the SEC on February 13, 2023).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Bylaws of LanzaTech Global, Inc. (incorporated by reference to Exhibit 3.3 of LanzaTech Global Inc.&#8217;s Current Report on Form 8-K, filed with the SEC on February 13, 2023).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465921101453/tm215219d18_ex4-1.htm">Warrant Agreement, dated as of August 3, 2021, between AMCI Acquisition Corp. II and Continental Stock Transfer &amp; Trust Company (incorporated by reference to Exhibit 4.1 of AMCI Acquisition Corp. II&#8217;s Current Report on Form 8-K (File No. 001-40282), filed with the SEC on August 6, 2021).</a></span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.434%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1843724/000110465923002389/amci-20220930xs4a.htm#ANNEXC_962800">Form</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1843724/000110465923002389/amci-20220930xs4a.htm#ANNEXC_962800"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1843724/000110465923002389/amci-20220930xs4a.htm#ANNEXC_962800">of Initial Subscription Agreement (incorporated by reference to Exhibit 10.1 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1843724/000110465923002389/amci-20220930xs4a.htm#ANNEXC_962800">January 10,</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1843724/000110465923002389/amci-20220930xs4a.htm#ANNEXC_962800"> 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1843724/000110465923002389/amci-20220930xs4a.htm#ANNEXJ_766651">Form of Amendment and Consent of Initial PIPE Investors (incorporated by reference to Exhibit 10.1.1 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1843724/000110465923002389/amci-20220930xs4a.htm#ANNEXJ_766651">January 10,</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1843724/000110465923002389/amci-20220930xs4a.htm#ANNEXJ_766651"> 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1843724/000110465923002389/amci-20220930xs4a.htm#ANNEXG_973062">Form of Additional Subscription Agreement (incorporated by reference to Exhibit 10.40 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1843724/000110465923002389/amci-20220930xs4a.htm#ANNEXG_973062">January 10,</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1843724/000110465923002389/amci-20220930xs4a.htm#ANNEXG_973062"> 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1843724/000110465923002389/amci-20220930xs4a.htm#ANNEXK_173813">Form of Amendment and Consent of Additional PIPE Investors (incorporated by reference to Exhibit 10.40.1 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1843724/000110465923002389/amci-20220930xs4a.htm#ANNEXK_173813">January 10,</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1843724/000110465923002389/amci-20220930xs4a.htm#ANNEXK_173813"> 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465923011412/tm235711d1_ex10-1.htm">Subscription Agreement between AMCI Acquisition Corp. II and Oxy Low Carbon Ventures, LLC. (incorporated by reference</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465923011412/tm235711d1_ex10-1.htm"> to </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465923011412/tm235711d1_ex10-1.htm">Exhibit 10.1 of AMCI Acquisition Corp. II.&#8217;s Current Report on Form 8-K, filed with the SEC on February 7, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465923011412/tm235711d1_ex10-2.htm">Subscription Agreement between AMCI Acquisition Corp. II and Pescadero Capital, LLC. (incorporated by reference to Exhibit 10.2 of AMCI Acquisition Corp. II.&#8217;s Current Report on Form 8-K, filed with the SEC on February 7, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Simple Agreement for Future Equity, dated as of December 8, 2021, by and between LanzaTech NZ, Inc. and ArcelorMittal XCarb S.&#224; r.l. (incorporated by reference to Exhibit 10.37 of LanzaTech Global Inc.&#8217;s Current Report on Form 8-K, filed with the SEC on February 13, 2023).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE Warrant, dated as of December 7, 2021, from LanzaTech NZ, Inc. to ArcelorMittal XCarb S.&#224; r.l. (incorporated by reference to Exhibit 4.2 of LanzaTech Global Inc.&#8217;s Current Report on Form 8-K, filed with the SEC on February 13, 2023).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.10**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465923010845/tm235567d1_ex10-1.htm">Forward Purchase Agreement, dated February 3, 2023 (incorporated by reference to Exhibit 10.1 of AMCI&#8217;s Current Report on Form 8-K (File No. 001-40282), filed with the SEC on February 6, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.11**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span id="i0248ffc9ab6b407f8d904608c32e2658_15-2-1-1-123184"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assignment and Novation Agreement, dated February 3, 2023, by and among AMCI Acquisition Corp. II, LanzaTech NZ, Inc., ACM ARRT H LLC, and and Vellar Opportunity Fund SPV LLC - Series 10. (incorporated by reference to Exhibit 4.3 of LanzaTech Global Inc.&#8217;s Current Report on Form 8-K, filed with the SEC on February 13, 2023).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit51-resalesx1.htm">Opinion of Covington &amp; Burling LLP</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922031257/tm228241d1_ex10-5.htm">Form&#160;of Lock-Up Agreement (incorporated by reference to Exhibit&#160;10.5 of AMCI&#8217;s Current Report on Form&#160;8-K (File No.&#160;001-40282), filed with the SEC on March&#160;8, 2022).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LanzaTech 2023 Long-Term Incentive Plan  (incorporated by reference to Exhibit 3.3 of LanzaTech Global Inc.&#8217;s Current Report on Form 8-K, filed with the SEC on February 13, 2023).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2.1+**</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922126132/amci-20220630xex10d4d1.htm">Form of Stock Option Agreement under the LanzaTech 2023 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.4.1 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2.2+**</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922126132/amci-20220630xex10d4d2.htm">Form of Time-Vested Restricted Stock Unit Agreement under the LanzaTech 2023 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.4.2 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2.3+**</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922126132/amci-20220630xex10d4d3.htm">Form of Director Restricted Stock Unit Agreement under the LanzaTech 2023 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.4.3 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2.4+**</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922126132/amci-20220630xex10d4d4.htm">Form of Time- and Performance-Vested Restricted Stock Unit Agreement under the LanzaTech 2023 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.4.4 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465923002389/amci-20220930xs4a.htm#AnnexA">Registration Rights Agreement, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465923002389/amci-20220930xs4a.htm#AnnexA">by and among LanzaTech Global, Inc., LanzaTech NZ, Inc., AMCI Sponsor II LLC, and the holders identified on Schedule I </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465923002389/amci-20220930xs4a.htm#AnnexA">thereto (incorporated by reference to Exhibit 2.1 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4#**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922118586/amci-20220630xex10d12.htm">Exclusive Patent License Agreement, dated September 13, 2018, by and between Battelle Memorial Institute and LanzaTech, Inc.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922118586/amci-20220630xex10d12.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922118586/amci-20220630xex10d12.htm">(incorporated by reference to Exhibit 10.12 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.434%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6#**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922118586/amci-20220630xex10d12d1.htm">Letter Amendment 1, dated January 13, 2020, between Battelle Memorial Institute and LanzaTech, Inc (incorporated by reference to Exhibit 10.12.1 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7#**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922118586/amci-20220630xex10d12d2.htm">Clarification Letter, dated April 24, 2020, between Battelle Memorial Institute and LanzaTech, Inc. (incorporated by reference to Exhibit 10.12.2 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8#&#8224;**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922118586/amci-20220630xex10d13.htm">Amended and Restated Investment Agreement, dated April 2, 2021, by and among LanzaTech, Inc., LanzaJet, Inc., Mitsui &amp; Co., Ltd., Suncor Energy Inc., British Airways PLC and Shell Ventures LLC (incorporated by reference to Exhibit 10.13 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9#&#8224;**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922118586/amci-20220630xex10d14.htm">Intellectual Property and Technology License Agreement, dated May 28, 2020, between LanzaTech, Inc. and LanzaJet, Inc. (incorporated by reference to Exhibit 10.14 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10#&#8224;**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922118586/amci-20220630xex10d15.htm">Amended and Restated Stockholders&#8217; Agreement, dated April 2, 2021, by and among LanzaJet, Inc., LanzaTech, Inc., Mitsui &amp; Co., Ltd., Suncor Energy Inc., British Airways PLC, and Shell Ventures LLC. (incorporated by reference to Exhibit 10.15 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11#**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922118586/amci-20220630xex10d16.htm">Amended and Restated Alliance Agreement, dated February 15, 2022, by and between LanzaTech NZ, Inc. and Mitsui &amp; Co., Ltd. (incorporated by reference to Exhibit 10.16 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11.1#**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922118586/amci-20220630xex10d16d1.htm">Amendment No. 1 to Amended and Restated Alliance Agreement, dated March 24, 2022, by and between LanzaTech NZ, Inc. and Mitsui &amp; Co., Ltd. (incorporated by reference to Exhibit 10.16.1 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11.2#**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922118586/amci-20220630xex10d16d2.htm">Amendment No. 2 to Amended and Restated Alliance Agreement, dated October 2, 2022, by and between LanzaTech NZ, Inc. and Mitsui &amp; Co.,Ltd. (incorporated by reference to Exhibit 10.16.2 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12#**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922118586/amci-20220630xex10d17.htm">Articles of Association of Beijing Shougang LanzaTech Technology Co., Ltd. (incorporated by reference to Exhibit 10.17 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922057803/amci-20220228xex10d18.htm">Side Letter Agreement, dated November 3, 2021, by and among Beijing Shougang LanzaTech Technology Co., Ltd., Mitsui &amp; Co., Ltd., and LanzaTech Hong Kong Limited (incorporated by reference to Exhibit 10.18 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14#**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922118586/amci-20220630xex10d19.htm">2021 Intellectual Property Rights License Agreement, dated September 6, 2021, between Beijing Shougang LanzaTech Technology Co., Ltd. and LanzaTech Hong Kong Limited (incorporated by reference to Exhibit 10.19 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14.1**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922107852/amci-20220331xex10d19d1.htm">Amendment No. 1 to 2021 Intellectual Property License Agreement, dated January 14, 2022, between Beijing Shougang LanzaTech Technology Co., Ltd. and LanzaTech Hong Kong Limited (incorporated by reference to Exhibit 10.19.1 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15#**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922118586/amci-20220630xex10d20.htm">Letter Agreement, dated April 12, 2021, among LanzaTech New Zealand Limited, LanzaTech Hong Kong Limited, Sinopec Capital Co, Ltd and Beijing Shougang-LanzaTech Technology Co., Ltd. (incorporated by reference to Exhibit 10.20 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16#&#8224;**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922118586/amci-20220630xex10d21.htm">Grant Agreement, dated October 7, 2020, among the European Climate, Infrastructure and Environmental Executive Agency, SkyNRG BV, RSB Roundtable on Sustainable Biomaterials Association, LanzaTech BV, E4tech UK Ltd, and Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung E.V. (incorporated by reference to Exhibit 10.21 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17#**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922118586/amci-20220630xex10d22.htm">Memorandum of Understanding, dated June 20, 2018, between Sekisui Chemical Co., Ltd. and LanzaTech, Inc. (incorporated by reference to Exhibit 10.22 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.434%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18#**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922118586/amci-20220630xex10d23.htm">Term Sheet, dated February 21, 2020, between Sekisui Chemical Co., Ltd. and LanzaTech, Inc. (incorporated by reference to Exhibit 10.23 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19#**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922118586/amci-20220630xex10d24.htm">Letter of Agreement, dated December 4, 2017, between LanzaTech, Inc. and IndianOil Corporation Limited (incorporated by reference to Exhibit 10.24 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20#**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922118586/amci-20220630xex10d25.htm">Master Licensing Agreement, dated October 6, 2020, between Suncor Energy Inc. and LanzaTech, Inc. (incorporated by reference to Exhibit 10.25 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20.1**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922107852/amci-20220331xex10d25d1.htm">Amendment No. 1 to Master Licensing Agreement, dated October 2, 2022, between Suncor Energy Inc. and LanzaTech, Inc. (incorporated by reference to Exhibit 10.25.1 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21+**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922057803/amci-20220228xex10d26.htm">Executive Employment Agreement, dated April 20, 2010, between Dr. Jennifer Holmgren and LanzaTech, Inc. (incorporated by reference to Exhibit 10.26 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21.1+**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922057803/amci-20220228xex10d26d1.htm">Letter from LanzaTech, Inc. to Dr. Jennifer Holmgren, dated May 17, 2021. (incorporated by reference to Exhibit 10.26.1 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21.2+&#8224;**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922129481/tm225496d16_ex10-26d2.htm">Executive Employment Agreement, dated December 20, 2022, between Dr. Jennifer Holmgren and LanzaTech Global, Inc. (incorporated by reference to Exhibit 10.26.2 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22+**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922057803/amci-20220228xex10d27.htm">Employment Agreement, dated October 21, 2013, between Dr. Sean Simpson and LanzaTech, Inc. (incorporated by reference to Exhibit 10.27 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22.1+**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922057803/amci-20220228xex10d27d1.htm">Letter from LanzaTech, Inc. to Dr. Sean Simpson, dated January 6, 2020 (incorporated by reference to Exhibit 10.27.1 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023). </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22.2+&#8224;**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465923000238/amci-20220930xex10d27d2.htm">Transition Letter, entered into on January 2, 2023, between Dr. Sean Simpson and LanzaTech, Inc. (incorporated by reference to Exhibit 10.27.2 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22.3+&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465923000238/amci-20220930xex10d27d3.htm">Consulting Agreement, entered into on January 2, 2023, between Dr. Sean Simpson and LanzaTech, Inc. (incorporated by reference to Exhibit 10.27.3 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23+**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922057803/amci-20220228xex10d28.htm">Employment Agreement, dated May 28, 2021, between Geoff Trukenbrod and LanzaTech, Inc. (incorporated by reference to Exhibit 10.28 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23.1+&#8224;**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922129481/tm225496d16_ex10-28d1.htm">Executive Employment Agreement, dated December 21. 2022, between Geoff Trukenbrod and LanzaTech Global, Inc. (incorporated by reference to Exhibit 10.28.1 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24+**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922057803/amci-20220228xex10d29.htm">Deed Poll Relating to Option Schemes Established by LanzaTech New Zealand Limited and LanzaTech New Zealand Limited 2006 Share Option Scheme (incorporated by reference to Exhibit 10.29 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023). </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24.1+**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922057803/amci-20220228xex10d29d1.htm">Deed of Amendment to Deed Poll Relating to Option Schemes Established by LanzaTech New Zealand Limited, dated September 12, 2011 (incorporated by reference to Exhibit 10.29.1 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24.2+**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922057803/amci-20220228xex10d29d2.htm">Deed of Amendment to Deed Poll Relating to Option Schemes Established by LanzaTech New Zealand Limited, dated January 8, 2016 (incorporated by reference to Exhibit 10.29.2 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24.3+**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922057803/amci-20220228xex10d29d3.htm">Deed of Amendment to Deed Poll Relating to Option Schemes Established by LanzaTech New Zealand Limited, dated October 28, 2021 (incorporated by reference to Exhibit 10.29.3 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25+**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922057803/amci-20220228xex10d30.htm">LanzaTech New Zealand Limited 2011 Stock Plan. (incorporated by reference to Exhibit 10.30 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.434%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25.1+**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922057803/amci-20220228xex10d30d1.htm">Form of Stock Option Agreement under the LanzaTech New Zealand Limited 2011 Stock Plan (incorporated by reference to Exhibit 10.30.1 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25.2+**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922057803/amci-20220228xex10d30d2.htm">Form of Stock Option Agreement under the LanzaTech New Zealand Limited 2011 Stock Plan (New Zealand employees) (incorporated by reference to Exhibit 10.30.2 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26+**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922057803/amci-20220228xex10d31.htm">LanzaTech New Zealand Limited 2013 Stock Plan (incorporated by reference to Exhibit 10.31 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26.1+**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922057803/amci-20220228xex10d31d1.htm">Form of Stock Option Agreement under the LanzaTech New Zealand Limited 2013 Stock Plan (incorporated by reference to Exhibit 10.31.1 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26.2+**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922057803/amci-20220228xex10d31d2.htm">Form of Stock Option Agreement under the LanzaTech New Zealand Limited 2013 Stock Plan (New Zealand employees) (incorporated by reference to Exhibit 10.31.2 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27+**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922057803/amci-20220228xex10d32.htm">LanzaTech New Zealand Limited 2015 Stock Plan (incorporated by reference to Exhibit 10.32 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27.1+**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922057803/amci-20220228xex10d32d1.htm">Form of Stock Option Agreement under the LanzaTech New Zealand Limited 2015 Stock Plan (incorporated by reference to Exhibit 10.32.1 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28+**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922057803/amci-20220228xex10d33.htm">LanzaTech NZ, Inc. 2019 Stock Plan (incorporated by reference to Exhibit 10.33 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28.1+&#8224;**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922057803/amci-20220228xex10d33d1.htm">Form of Notice of Grant and Subscription for Stock Option under the LanzaTech NZ, Inc. 2019 Stock Plan (incorporated by reference to Exhibit 10.33.1 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28.2+&#8224;**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922057803/amci-20220228xex10d33d2.htm">Form of Notice of Restricted Stock Grant under the LanzaTech NZ, Inc. 2019 Stock Plan (incorporated by reference to Exhibit 10.33.2 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28.3+**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922057803/amci-20220228xex10d33d3.htm">Form of Stock Option Agreement under the LanzaTech NZ, Inc. 2019 Stock Plan (incorporated by reference to Exhibit 10.33.3 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29+**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922057803/amci-20220228xex10d34.htm">Amendment to LanzaTech New Zealand Limited Stock Option Award Agreements, dated October 28, 2021 (incorporated by reference to Exhibit 10.34 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.30+**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922107852/amci-20220331xex10d35.htm">Annual Bonus Plan (incorporated by reference to Exhibit 10.35 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31+**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922129481/tm225496d16_ex10-36.htm">Form of indemnification agreement between LanzaTech Global, Inc. and each of its directors and officers (incorporated by reference to Exhibit 10.36 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.32#&#8224;**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922118586/amci-20220630xex10d37.htm">Framework Agreement, dated as of October 2, 2022, by and between LanzaTech, Inc. and BGTF LT Aggregator LP (incorporated by reference to Exhibit 10.37 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.33#&#8224;**</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922118586/amci-20220630xex10d38.htm">Simple Agreement for Future Equity, dated as of October 2, 2022, by and between LanzaTech NZ, Inc. and BGTF LT Aggregator LP (incorporated by reference to Exhibit 10.38 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.33.1**</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465923000238/amci-20220930xex10d38d1.htm">Amendment No. 1 to Simple Agreement for Future Equity, dated as of December 30, 2022, by and between LanzaTech NZ, Inc. and BGTF LT Aggregator LP (incorporated by reference to Exhibit 10.38.1 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.34#**</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922118586/amci-20220630xex10d39.htm">Cooperation Letter Agreement, dated as of October 2, 2022, by and between LanzaTech, Inc., Suncor Energy, Inc. and BGTF LT Aggregator LP (incorporated by reference to Exhibit 10.39 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.35+**</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922126132/amci-20220630xex10d41.htm">LanzaTech U.S. Executive Severance Plan (incorporated by reference to Exhibit 10.41 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.434%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.36&#8224;#**</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922127871/tm2232769d1_ex10-1.htm">Grant Agreement, by and between LanzaTech UK Limited and the Secretary of State for Transport, dated December 12, 2022 (incorporated by reference to Exhibit 10.1 of AMCI Acquisition Corp. II's Current Report on Form 8-K (File No. 001-40282), filed with the SEC on December 16, 2022).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.37&#8224;#**</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1843724/000110465922129481/tm225496d16_ex10-43.htm">Note Purchase Agreement, dated November 9, 2022, by and among LanzaJet Freedom Pines Fuels LLC, LanzaTech, Inc. and the other purchasers named therein (incorporated by reference to Exhibit 10.43 of AMCI Acquisition Corp. II.&#8217;s Registration Statement on S-4/A, filed with the SEC on January 10, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1**</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Letter re: Change in certifying accountant (incorporated by reference to Exhibit 16.1 to LanzaTech Global Inc.&#8217;s Current Report on Form 8-K, filed with the SEC on February 13, 2023).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1**</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subsidiaries of the Registrant  (incorporated by reference to Exhibit 21.1 to LanzaTech Global Inc.&#8217;s Current Report on Form 8-K, filed with the SEC on February 13, 2023).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit231-resalesx1.htm">Consent of Marcum LLP, independent registered public accounting firm of AMCI Acquisition Corp. II.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.2</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit232-resalesx1.htm">Consent of Deloitte &amp; Touche LLP, independent registered public accounting firm to LanzaTech NZ, Inc.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit51-resalesx1.htm">Consent of Covington &amp; Burling LLP (included in Exhibit 5.1 hereto).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib82e114cd19f45afae73e7a64e42f208_2126">Power of Attorney (included on signature page).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit107-resalesx1.htm">Calculation of Filing Fee</a></span></div></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8224;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14pt">Certain of the exhibits and schedules to this exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Registrant agrees to furnish a copy of all omitted exhibits and schedules to the SEC upon its request.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14pt">To be filed by amendment.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">**</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10pt">Previously filed.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">#</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14pt">Certain confidential information contained in this exhibit, marked by brackets, has been redacted in accordance with Regulation S-K Item 601(b) because the information (i) is not material and (ii) would be competitively harmful if disclosed.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.49pt">Management contract or compensatory plan or arrangement. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ib82e114cd19f45afae73e7a64e42f208_2105"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 17.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Undertakings. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The undersigned registrant hereby undertakes: </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933 (the &#8220;Securities Act&#8221;); </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.8pt">To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement; and </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.03pt">To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement; </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided, however</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that the undertakings set forth in paragraphs (1)(i), (1)(ii) and (1)(iii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), that are incorporated by reference in this registration statement or are contained in a form of prospectus filed pursuant to Rule 424(b) that is part of this registration statement. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">That, for the purpose of determining liability under the Securities Act to any purchaser, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Provided, however</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">That, for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424; </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.8pt">Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.03pt">The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.57pt">Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-11</span></div></div></div><div id="ib82e114cd19f45afae73e7a64e42f208_2126"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Skokie, State of Illinois, on February 13, 2023. </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:38.301%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LANZATECH GLOBAL, INC. </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By: /s/ Jennifer Holmgren, Ph.D.</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name: Jennifer Holmgren, Ph.D.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title: Chief Executive Officer and Director</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">POWER OF ATTORNEY</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Geoff Trukenbrod and Joseph Blasko his true and lawful attorney-in-fact, with full power of substitution and resubstitution for him and in his name, place and stead, in any and all capacities to sign any and all amendments including post-effective amendments to this registration statement and any and all registration statements filed pursuant to Rule 462 under the Securities Act of 1933, as amended, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the SEC, hereby ratifying and confirming all that said attorney-in-fact or his substitute, each acting alone, may lawfully do or cause to be done by virtue thereof.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated: </span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.387%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.215%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Position</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jennifer Holmgren, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and Director </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer) </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 13, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jennifer Holmgren, Ph.D. </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Geoff Trukenbrod</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer) </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 13, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Geoff Trukenbrod</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/George Dimitrov</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Accounting Officer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 13, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">George Dimitrov</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Barbara Byrne</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 13, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barbara Byrne</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Nigel Gormly </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 13, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nigel Gormly</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Dorri McWhorter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 13, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dorri McWhorter</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jim Messina</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 13, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jim Messina </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Nimesh Patel</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 13, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nimesh Patel</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Gary Rieschel</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 13, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gary Rieschel</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-12</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>exhibit107-resalesx1.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="id7ac29ae7d264234be0d3f3be363d489_38"></div><div style="min-height:36pt;width:100%"><div style="padding-right:72pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 107</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Calculation of Filing Fee Tables</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Form S-1</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Form Type)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LanzaTech Global Inc.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact Name of Registrant as Specified in its Charter)</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Table 1&#58; Newly Registered and Carry Forward Securities</font></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.479%"><tr><td style="width:1.0%"></td><td style="width:5.575%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.790%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.360%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.454%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.837%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.051%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.677%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Security Type</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Security Class Title</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:6.55pt;padding-right:6.55pt;text-align:center;text-indent:-0.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Fee Calculation or Carry Forward Rule</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Amount Registered</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.87pt;font-weight:700;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Proposed Maximum Offering Price Per Share</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Maximum Aggregate Offering Price</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Fee Rate</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Amount of Registration Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.87pt;font-weight:700;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Carry Forward Form Type</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Carry Forward File Number</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Carry Forward Initial effective date</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward</font></div></td></tr><tr><td colspan="39" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.15pt;padding-right:0.15pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Primary Offering</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.1pt;padding-right:6.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Fees to Be</font></div><div style="padding-left:6.1pt;padding-right:6.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Paid</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.25pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.35pt;padding-right:0.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock underlying AM Warrant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">457(g)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">300,000</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$10.00</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(4)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.45pt;padding-right:0.45pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$3,000,000</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.00011020</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.42pt;padding-right:0.42pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$331</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.1pt;padding-right:6.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Fees to Be</font></div><div style="padding-left:6.1pt;padding-right:6.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Paid</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.25pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.35pt;padding-right:0.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock underlying Brookfield SAFE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(5)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">457(g)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,000,000</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$10.00</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(6)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.45pt;padding-right:0.45pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$50,000,000</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.00011020</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.42pt;padding-right:0.42pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$5,510</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.1pt;padding-right:6.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Fees to Be</font></div><div style="padding-left:6.1pt;padding-right:6.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Paid</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.25pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.35pt;padding-right:0.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock underlying Private Placement Warrants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(7)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">457(g)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,774,276</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$11.50</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(8)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.45pt;padding-right:0.45pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$54,904,174</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.00011020</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.42pt;padding-right:0.42pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$6,051</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.1pt;padding-right:6.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Fees to Be</font></div><div style="padding-left:6.1pt;padding-right:6.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Paid</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.25pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.35pt;padding-right:0.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock underlying Public Warrants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(9)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">457(g)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,494,514</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$11.50</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(10)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.45pt;padding-right:0.45pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$86,186,911</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.00011020</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.42pt;padding-right:0.42pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$9,498</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.1pt;padding-right:6.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Fees to Be</font></div><div style="padding-left:6.1pt;padding-right:6.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Paid</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.25pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.35pt;padding-right:0.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock, par value $0.0001 per share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(11)</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">457(c)</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,680,683</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$7.80</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(12)</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.45pt;padding-right:0.45pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$13,109,328</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.00011020</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.42pt;padding-right:0.42pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$1,445</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="39" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Secondary Offering</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.1pt;padding-right:6.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Fees to Be</font></div><div style="padding-left:6.1pt;padding-right:6.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Paid</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.35pt;padding-right:0.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock underlying AM Warrant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">457(g)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">300,000</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$10.00</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(4)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.45pt;padding-right:0.45pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$3,000,000</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.00011020</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.42pt;padding-right:0.42pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$331</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.1pt;padding-right:6.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Fees to Be</font></div><div style="padding-left:6.1pt;padding-right:6.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Paid</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.35pt;padding-right:0.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock underlying Brookfield SAFE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(5)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">457(g)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,000,000</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$10.00</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(6)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.45pt;padding-right:0.45pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$50,000,000</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.00011020</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.42pt;padding-right:0.42pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$5,510</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.1pt;padding-right:6.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Fees to Be</font></div><div style="padding-left:6.1pt;padding-right:6.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Paid</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.35pt;padding-right:0.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock underlying Private Placement Warrants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(7)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">457(g)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,774,276</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$11.50</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(8)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.45pt;padding-right:0.45pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$54,904,174</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.00011020</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.42pt;padding-right:0.42pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$6,051</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.1pt;padding-right:6.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Fees to Be</font></div><div style="padding-left:6.1pt;padding-right:6.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Paid</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.35pt;padding-right:0.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Private Placement Warrants to purchase  common stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(13)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">457(g)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,774,276</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$11.50</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(8)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.45pt;padding-right:0.45pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.00011020</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.42pt;padding-right:0.42pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.1pt;padding-right:6.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Fees to Be</font></div><div style="padding-left:6.1pt;padding-right:6.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Paid</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.35pt;padding-right:0.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock, par value $0.0001 per share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(14)</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">457(c)</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">188,744,247</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$7.80</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(12)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.45pt;padding-right:0.45pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$1,472,205,127</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.00011020</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.42pt;padding-right:0.42pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$162,238</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="12" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:-0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total Offering Amounts</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"><div style="padding-left:0.45pt;padding-right:0.45pt;text-align:center"><font><br></font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.42pt;padding-right:0.42pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$1,787,309,714</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="12" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:-0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total Fees Previously Paid</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.42pt;padding-right:0.42pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="12" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:-0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total Fee Offsets</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.42pt;padding-right:0.42pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="12" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:-0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net Fee Due</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.35pt;padding-right:0.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$196,965</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="id7ac29ae7d264234be0d3f3be363d489_77"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.34pt">Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from stock splits, stock dividends or similar transactions.</font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.34pt">Calculated pursuant to Rule 457 under the Securities Act by multiplying the proposed maximum aggregate offering price of securities to be registered by 0.00011020.</font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.34pt">Represents 300,000 shares of common stock issuable upon the exercise of a warrant held by ArcelorMittal XCarb S. &#224; r.l., dated December 8, 2021 (the &#8220;AM Warrant&#8221;) at the equivalent to a price of $10.00 per share.</font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.34pt">Estimated solely for purposes of calculating the registration fee pursuant to Rule 457(g) under the Securities Act, based on the exercise price applicable to shares issuable upon the exercise of the AM Warrant.</font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.34pt">Represents 5,000,000 shares of common stock issuable upon the conversion of that certain Simple Agreement for Future Equity between BGTF LT Aggregator LP and LanzaTech NZ, Inc., dated October 3, 2022 (the &#8220;Brookfield SAFE&#8221;) at the equivalent to a price of $10.00 per share.</font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.34pt">Estimated solely for purposes of calculating the registration fee pursuant to Rule 457(g) under the Securities Act, based on the equivalent to the conversion price applicable to shares issuable upon the conversion of the Brookfield SAFE.</font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.34pt">Represents 4,774,276 shares of common stock issuable upon the exercise of private placement warrants (the &#8220;Private Placement Warrants&#8221;) originally issued in a private placement to AMCI Sponsor II LLC in connection with the initial public offering (&#8220;IPO&#8221;) of AMCI Acquisition Corp. II (&#8220;AMCI&#8221;) or thereafter at a price of $1.00 per warrant.</font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.34pt">Estimated solely for purposes of calculating the registration fee pursuant to Rule 457(g) under the Securities Act, based on the exercise price applicable to shares issuable upon the exercise of the Private Placement Warrants.</font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.34pt">Represents 7,494,514 shares of common stock that are issuable upon the exercise of public warrants (the &#8220;Public Warrants) originally issued in connection with the AMCI IPO as units of AMCI at a price of $10.00 per unit, with each unit consisting of one ordinary share and one-half of one warrant.</font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:1.34pt">Estimated solely for purposes of calculating the registration fee pursuant to Rule 457(g) under the Securities Act, based on the exercise price applicable to shares issuable upon the exercise of the Public Warrants.</font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:1.34pt">Represents 1,680,683 shares of common stock underlying options issued to certain holders under our incentive plans (the &#8220;Options&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:1.34pt">Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457 of the Securities Act, based on the average of the high and low prices of the Common Stock on The Nasdaq Capital Market on February 10, 2023. </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:1.34pt">Represents 4,774,276 Private Placement Warrants.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:1.34pt">Represents 188,744,247 shares of common stock offered for resale, which consists of (i) up to 18,500,000 shares of common stock issued on February 8, 2023 in a private placement pursuant to subscription agreements, dated March 8, 2022, October 18, 2022, February 1, 2023, and February 6, 2023 (each as amended, as applicable), at a price of $10.00 per share, (ii) up to 2,164,839 shares of common stock held by certain selling stockholders, (iii) up to 1,680,683 shares of common stock underlying the Options held by certain selling stockholders, (iv) up to 5,916,514 shares of common stock purchased by certain selling stockholders subject to that certain forward purchase agreement by and between the Company, ACM ARRT H LLC, and the other parties thereto, and (v) up to 160,482,211 shares of common stock, required to be registered pursuant to that certain Registration Rights Agreement, dated February 8, 2023, by and among us and certain of the selling stockholders.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>exhibit51-resalesx1.htm
<DESCRIPTION>EX-5.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="iacb436f9cbf4497b837e6b6e360b7f48_41"></div><div style="min-height:90pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 5.1</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.435%"><tr><td style="width:1.0%"></td><td style="width:73.077%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.723%"></td><td style="width:0.1%"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"><div><img alt="logo1aa.jpg" src="logo1aa.jpg" style="height:21px;margin-bottom:5pt;vertical-align:text-bottom;width:154px"></div></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Covington &#38; Burling LLP</font></div><div style="margin-bottom:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">One CityCenter</font></div><div style="margin-bottom:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">850 Tenth Street, NW</font></div><div style="margin-bottom:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Washington, DC 20001-4956</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">T&#160;&#160;&#160;+1 202 662 6000</font></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">BEIJING&#160;&#160;&#160;&#160;&#160;BRUSSELS&#160;&#160;&#160;&#160;&#160;DUBAI&#160;&#160;&#160;&#160;&#160;&#160;FRANKFURT&#160;&#160;&#160;&#160;&#160;JOHANNESBURG</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">LONDON&#160;&#160;&#160;&#160;&#160;LOS ANGELES&#160;&#160;&#160;&#160;&#160;NEW YORK&#160;&#160;&#160;&#160;&#160;SAN FRANCISCO</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">SEOUL&#160;&#160;&#160;&#160;&#160;SHANGHAI&#160;&#160;&#160;&#160;&#160;SILICON VALLEY&#160;&#160;&#160;&#160;&#160;WASHINGTON</font></td></tr></table></div></div><div style="margin-bottom:9pt;padding-left:288pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">February 13, 2023</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">LanzaTech Global, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8045 Lamon Avenue, Suite 400</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Skokie, Illinois 60077</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Ladies &#38; Gentlemen&#58;</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We have acted as counsel to LanzaTech Global, Inc., a Delaware corporation (the &#8220;Company&#8221;), in connection with the registration by the Company under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), pursuant to the Company&#8217;s Registration Statement on Form S-1, which was filed with the Securities and Exchange Commission (the &#8220;Commission&#8221;) on February 13, 2023 (the &#8220;Registration Statement&#8221;), of (a) the issuance of shares of the Company&#8217;s common stock, $0.0001 par value per share (&#8220;common stock&#8221;), (b) the resale of common stock held by certain stockholders of the Company and (c) the resale of certain warrants of the Company held by the holders thereof, as follows&#58;</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;the issuance of up to 4,774,276 shares of common stock that are issuable upon the exercise of private placement warrants (the &#8220;Private Placement Warrants&#8221;) by the holders thereof (the &#8220;Private Warrant Shares&#8221;), issued pursuant to the Warrant Agreement by and between AMCI and Continental Stock Transfer &#38; Trust Company, dated August 3, 2021 (the &#8220;Warrant Agreement&#8221;),</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;the issuance of up to 7,494,514 shares of common stock that are issuable upon the exercise of certain public warrants by the holders thereof (the &#8220;Public Warrant Shares&#8221; and together with the Private Warrant Shares, the &#8220;Warrant Shares&#8221;), issued pursuant to the Warrant Agreement,</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;the issuance of up to 5,000,000 shares of common stock that are issuable upon the conversion of that certain Simple Agreement for Future Equity between BGTF LT Aggregator LP and LanzaTech NZ, Inc., dated October 3, 2022 (the &#8220;Brookfield SAFE&#8221;), upon conversion by the holder thereof (the &#8220;SAFE Shares&#8221;), </font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;the issuance of up to 300,000 shares of common stock that are issuable under the SAFE Warrant by and between ArcelorMittal XCarb S.&#224; r.l. and LanzaTech NZ, Inc., dated December 8, 2021 (the &#8220;AM Warrant&#8221;) upon the exercise by the holder thereof (the &#8220;AM Shares&#8221;),</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;the issuance of up to 1,680,683 shares of common stock (the &#8220;Plan Shares&#8221; and together with the Private Warrant Shares, the Public Warrant Shares, the SAFE Shares and the AM Shares, the &#8220;Convertible Security Shares&#8221;) underlying options to purchase common stock issued pursuant to the Company&#8217;s 2006 Deed Poll Relating to Options Scheme, 2008 Stock Plan, 2011 Stock Plan, 2013 Stock Plan, 2015 Stock Plan, and 2019 Stock Plan, (collectively the &#8220;Plans&#8221;), </font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(vi)&#160;&#160;&#160;&#160;the resale of the Convertible Security Shares (other than the Public Warrant Shares),</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="iacb436f9cbf4497b837e6b6e360b7f48_60"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><img alt="logo1aa.jpg" src="logo1aa.jpg" style="height:16px;margin-bottom:5pt;vertical-align:text-bottom;width:114px"></div></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(vii)&#160;&#160;&#160;&#160;the resale of up to 179,569,050 shares of common stock (the &#8220;Resale Shares&#8221;) and</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(viii)&#160;&#160;&#160;&#160;the resale of up to 4,774,276 Private Placement Warrants (the &#8220;Resale Warrants&#8221;).</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We have reviewed&#58;</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;the Warrant Agreement, </font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;the Brookfield SAFE, </font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;the AM Warrant, </font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;the Registration Rights Agreement by and among the Company, LanzaTech NZ, Inc., AMCI Sponsor II LLC, and the Holders (as defined therein), dated February 8, 2023,</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;the Forward Purchase Agreement by and among ACM ARRT H LLC, the Company and LanzaTech NZ, Inc., dated February 3, 2023,</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(vi)&#160;&#160;&#160;&#160;the Assignment and Novation Agreement, by and among AMCI Acquisition Corp. II, LanzaTech NZ, Inc., ACM ARRT H LLC, and and Vellar Opportunity Fund SPV LLC - Series 10, dated February 3, 2023,</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(vii)&#160;&#160;&#160;&#160;the Plans and</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(viii)&#160;&#160;&#160;&#160;such other corporate records, certificates and other documents, and such questions of law, as we have considered necessary or appropriate for the purposes of this opinion. </font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We have assumed that all signatures are genuine, that all documents submitted to us as originals are authentic and that all copies of documents submitted to us conform to the originals.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We have relied as to certain matters on information obtained from public officials, officers of the Company and other sources believed by us to be responsible.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">With respect to the Convertible Security Shares, we express no opinion to the extent that, notwithstanding the Company&#8217;s current reservation of shares of common stock, future issuances of securities of the Company, including the Convertible Security Shares, and anti-dilution adjustments to outstanding securities of the Company, including the Warrants, the Brookfield SAFE and the AM Warrant, may cause any of the foregoing to be exercisable for more shares of common stock than the number that remain authorized but unissued. We also have assumed that the Warrant Price (as defined in each of the Private Warrants, the Public Warrants) and the Exercise Price (as defined in the AM Warrant) will not be adjusted to an amount below the par value per share of the common stock.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Based upon the foregoing, and subject to the qualifications set forth below, we are of the opinion that&#58;</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The Warrant Shares have been duly authorized and, when issued and paid for upon exercise of the Warrants,  in accordance with the terms of the Warrants, will be validly issued, fully paid and non-assessable.</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;The SAFE Shares have been duly authorized and, when issued upon conversion of the Brookfield SAFE,  in accordance with the terms of the Brookfield SAFE, will be validly issued, fully paid and non-assessable.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><img alt="logo1aa.jpg" src="logo1aa.jpg" style="height:16px;margin-bottom:5pt;vertical-align:text-bottom;width:114px"></div></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;The AM Shares have been duly authorized and, when issued and paid for upon exercise of the AM Warrant,  in accordance with the terms of the AM Warrant, will be validly issued, fully paid and non-assessable.</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;The Plan Shares have been duly authorized and, when issued and paid for in accordance with the terms of the Plan upon the exercise thereof, will be validly issued, fully paid and non-assessable.</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(5)&#160;&#160;&#160;&#160;The Resale Shares have been duly authorized and are validly issued, fully paid and non-assessable.</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(6)&#160;&#160;&#160;&#160;The Resale Warrants have been duly authorized and constitute the valid and binding obligations of the Company, enforceable against the Company in accordance with their terms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other laws of general applicability relating to or affecting creditors&#8217; rights and to general equity principles.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The foregoing opinion is subject to the following qualifications. We express no opinion as to&#58; (i) waivers of defenses, subrogation and related rights, rights to trial by jury, rights to object to venue, or other rights or benefits bestowed by operation of law&#59; (ii) releases or waivers of unmatured claims or rights&#59; (iii) indemnification, contribution, or exculpation provisions, or provisions for the non-survival of representations, to the extent they purport to indemnify any party against, or release or limit any party&#8217;s liability for, its own breach or failure to comply with statutory obligations, or to the extent such provisions are contrary to public policy&#59; (iv) provisions for liquidated damages and penalties, penalty interest and interest on interest&#59; (v) provisions requiring amendments and waivers to be in writing&#59; (vi) provisions making notices effective even if not actually received&#59; (vii) exclusive jurisdiction or venue provisions or (viii) provisions purporting to make a party&#8217;s determination conclusive.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We are members of the bar of the District of Columbia and the State of New York. We do not express any opinion herein on any laws other than the Delaware General Corporation Law and the State of New York.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We hereby consent to the filing of this opinion as Exhibit 5.1 to the Registration Statement. We also hereby consent to the reference to our firm under the heading &#8220;Legal Matters&#8221; in the prospectus constituting part of the Registration Statement. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act.</font></div><div style="margin-bottom:9pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.897%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Very truly yours,</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Covington &#38; Burling LLP</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>exhibit231-resalesx1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i4842e373b66549e58f7b6c22a2cf9342_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 23.1</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM&#8217;S CONSENT</font></div><div style="margin-bottom:20pt;padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We consent to the inclusion in this Registration Statement of LanzaTech Global, Inc. (formerly known as AMCI Acquisition Corp. II) on Form S-1 of our report dated March 25, 2022, which includes an explanatory paragraph as to the ability of AMCI Acquisition Corp. II (now known as LanzaTech Global, Inc.) to continue as a going concern, with respect to our audit of the financial statements of AMCI Acquisition Corp. II (now known as LanzaTech Global, Inc.) as of December 31, 2021 and for the period from January 28, 2021 (inception) through December 31, 2021, which report appears in the Prospectus, which is part of this Registration Statement. We will be dismissed as auditors effective upon completion of the audit of the financial statements of AMCI Acquisition Corp. II (now known as LanzaTech Global, Inc.) as of and for the year ended December 31, 2022 and the issuance of the report thereon and accordingly, we have not performed any audit or review procedures with respect to any financial statements appearing in such Prospectus for the period after December 31, 2022.  We also consent to the reference to our Firm under the heading &#8220;Experts&#8221; in such Prospectus.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:27.724%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Marcum LLP</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Marcum LLP</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">New York, NY</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">February 13, 2023</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>5
<FILENAME>exhibit232-resalesx1.htm
<DESCRIPTION>EX-23.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="if186e1a594034886a9ecf6de662df602_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23.2</font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="margin-bottom:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We consent to the use in this Registration Statement on Form S-1 of our report dated May 9, 2022, (October 11, 2022, as to the effects of the restatement discussed in Note 2), relating to the consolidated financial statements of LanzaTech NZ, Inc. and subsidiaries. We also consent to the reference to us under the heading &#8220;Experts&#8221; in such Registration Statement.</font></div><div style="margin-bottom:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:28.685%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Deloitte &#38; Touche LLP</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Chicago, Illinois</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">February 13, 2023</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>amci-20230213.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:1f450268-e321-4330-aadf-815e69af2b4b,g:fe19691a-e2ec-4bc1-af0c-c42cfd4d1d7c-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:amci="http://amciacquisitioncorp/20230213" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://amciacquisitioncorp/20230213">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.org/2006/xbrldi" schemaLocation="http://www.xbrl.org/2006/xbrldi-2006.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="amci-20230213_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="amci-20230213_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="amci-20230213_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="amci-20230213_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://amciacquisitioncorp/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDBALANCESHEETS" roleURI="http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS">
        <link:definition>0000002 - Statement - CONDENSED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDBALANCESHEETSParenthetical" roleURI="http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETSParenthetical">
        <link:definition>0000003 - Statement - CONDENSED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS" roleURI="http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS">
        <link:definition>0000004 - Statement - UNAUDITED CONDENSED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT" roleURI="http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT">
        <link:definition>0000005 - Statement - UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICITParenthetical" roleURI="http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICITParenthetical">
        <link:definition>0000006 - Statement - UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS" roleURI="http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000007 - Statement - UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BALANCESHEET" roleURI="http://amciacquisitioncorp/role/BALANCESHEET">
        <link:definition>0000008 - Statement - BALANCE SHEET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BALANCESHEETParenthetical" roleURI="http://amciacquisitioncorp/role/BALANCESHEETParenthetical">
        <link:definition>0000009 - Statement - BALANCE SHEET (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STATEMENTOFOPERATIONS" roleURI="http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS">
        <link:definition>0000010 - Statement - STATEMENT OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT" roleURI="http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT">
        <link:definition>0000011 - Statement - STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STATEMENTOFCASHFLOWS" roleURI="http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS">
        <link:definition>0000012 - Statement - STATEMENT OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" roleURI="http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED">
        <link:definition>0000013 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" roleURI="http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical">
        <link:definition>0000014 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED" roleURI="http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED">
        <link:definition>0000015 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" roleURI="http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED">
        <link:definition>0000016 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED" roleURI="http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED">
        <link:definition>0000017 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND SHAREHOLDERS&#8217; DEFICIT (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>0000018 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>0000019 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" roleURI="http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS">
        <link:definition>0000020 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT" roleURI="http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT">
        <link:definition>0000021 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND SHAREHOLDERS&#8217; EQUITY (DEFICIT)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000022 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofOrganizationandBusinessOperations" roleURI="http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperations">
        <link:definition>0000023 - Disclosure - Description of Organization and Business Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPolicies" roleURI="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPolicies">
        <link:definition>0000024 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InitialPublicOffering" roleURI="http://amciacquisitioncorp/role/InitialPublicOffering">
        <link:definition>0000025 - Disclosure - Initial Public Offering</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions" roleURI="http://amciacquisitioncorp/role/RelatedPartyTransactions">
        <link:definition>0000026 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://amciacquisitioncorp/role/CommitmentsandContingencies">
        <link:definition>0000027 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ClassACommonStockSubjecttoPossibleRedemption" roleURI="http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemption">
        <link:definition>0000028 - Disclosure - Class A Common Stock Subject to Possible Redemption</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficit" roleURI="http://amciacquisitioncorp/role/StockholdersEquityDeficit">
        <link:definition>0000029 - Disclosure - Stockholders' Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Warrants" roleURI="http://amciacquisitioncorp/role/Warrants">
        <link:definition>0000030 - Disclosure - Warrants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://amciacquisitioncorp/role/FairValueMeasurements">
        <link:definition>0000031 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://amciacquisitioncorp/role/SubsequentEvents">
        <link:definition>0000032 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofOrganizationandBusinessOperations_1" roleURI="http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperations_1">
        <link:definition>0000033 - Disclosure - Description of Organization and Business Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPolicies_1" roleURI="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPolicies_1">
        <link:definition>0000034 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InitialPublicOffering_1" roleURI="http://amciacquisitioncorp/role/InitialPublicOffering_1">
        <link:definition>0000035 - Disclosure - Initial Public Offering</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions_1" roleURI="http://amciacquisitioncorp/role/RelatedPartyTransactions_1">
        <link:definition>0000036 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies_1" roleURI="http://amciacquisitioncorp/role/CommitmentsandContingencies_1">
        <link:definition>0000037 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ClassACommonStockSubjecttoPossibleRedemption_1" roleURI="http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemption_1">
        <link:definition>0000038 - Disclosure - Class A Common Stock Subject to Possible Redemption</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersDeficit" roleURI="http://amciacquisitioncorp/role/StockholdersDeficit">
        <link:definition>0000039 - Disclosure - Stockholders' Deficit</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Warrants_1" roleURI="http://amciacquisitioncorp/role/Warrants_1">
        <link:definition>0000040 - Disclosure - Warrants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements_1" roleURI="http://amciacquisitioncorp/role/FairValueMeasurements_1">
        <link:definition>0000041 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://amciacquisitioncorp/role/IncomeTaxes">
        <link:definition>0000042 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents_1" roleURI="http://amciacquisitioncorp/role/SubsequentEvents_1">
        <link:definition>0000043 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionoftheBusiness" roleURI="http://amciacquisitioncorp/role/DescriptionoftheBusiness">
        <link:definition>0000044 - Disclosure - Description of the Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPolicies">
        <link:definition>0000045 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShare" roleURI="http://amciacquisitioncorp/role/NetLossPerShare">
        <link:definition>0000046 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenues" roleURI="http://amciacquisitioncorp/role/Revenues">
        <link:definition>0000047 - Disclosure - Revenues</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://amciacquisitioncorp/role/Investments">
        <link:definition>0000048 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValue" roleURI="http://amciacquisitioncorp/role/FairValue">
        <link:definition>0000049 - Disclosure - Fair Value</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes_1" roleURI="http://amciacquisitioncorp/role/IncomeTaxes_1">
        <link:definition>0000050 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensation" roleURI="http://amciacquisitioncorp/role/ShareBasedCompensation">
        <link:definition>0000051 - Disclosure - Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions_2" roleURI="http://amciacquisitioncorp/role/RelatedPartyTransactions_2">
        <link:definition>0000052 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableConvertiblePreferredStock" roleURI="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStock">
        <link:definition>0000053 - Disclosure - Redeemable, Convertible Preferred Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies_2" roleURI="http://amciacquisitioncorp/role/CommitmentsandContingencies_2">
        <link:definition>0000054 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://amciacquisitioncorp/role/Leases">
        <link:definition>0000055 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents_2" roleURI="http://amciacquisitioncorp/role/SubsequentEvents_2">
        <link:definition>0000056 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionoftheBusiness_1" roleURI="http://amciacquisitioncorp/role/DescriptionoftheBusiness_1">
        <link:definition>0000057 - Disclosure - Description of the Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies_1" roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPolicies_1">
        <link:definition>0000058 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShare_1" roleURI="http://amciacquisitioncorp/role/NetLossPerShare_1">
        <link:definition>0000059 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenues_1" roleURI="http://amciacquisitioncorp/role/Revenues_1">
        <link:definition>0000060 - Disclosure - Revenues</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments_1" roleURI="http://amciacquisitioncorp/role/Investments_1">
        <link:definition>0000061 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValue_1" roleURI="http://amciacquisitioncorp/role/FairValue_1">
        <link:definition>0000062 - Disclosure - Fair Value</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherCurrentAssets" roleURI="http://amciacquisitioncorp/role/OtherCurrentAssets">
        <link:definition>0000063 - Disclosure - Other Current Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipment" roleURI="http://amciacquisitioncorp/role/PropertyPlantandEquipment">
        <link:definition>0000064 - Disclosure - Property, Plant, and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://amciacquisitioncorp/role/Debt">
        <link:definition>0000065 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SAFE" roleURI="http://amciacquisitioncorp/role/SAFE">
        <link:definition>0000066 - Disclosure - SAFE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantLiabilities" roleURI="http://amciacquisitioncorp/role/WarrantLiabilities">
        <link:definition>0000067 - Disclosure - Warrant Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes_2" roleURI="http://amciacquisitioncorp/role/IncomeTaxes_2">
        <link:definition>0000068 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://amciacquisitioncorp/role/StockBasedCompensation">
        <link:definition>0000069 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions_3" roleURI="http://amciacquisitioncorp/role/RelatedPartyTransactions_3">
        <link:definition>0000070 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquity" roleURI="http://amciacquisitioncorp/role/ShareholdersEquity">
        <link:definition>0000071 - Disclosure - Shareholders&#8217; Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableConvertiblePreferredStock_1" roleURI="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStock_1">
        <link:definition>0000072 - Disclosure - Redeemable, Convertible Preferred Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlans" roleURI="http://amciacquisitioncorp/role/BenefitPlans">
        <link:definition>0000073 - Disclosure - Benefit Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies_3" roleURI="http://amciacquisitioncorp/role/CommitmentsandContingencies_3">
        <link:definition>0000074 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases_1" roleURI="http://amciacquisitioncorp/role/Leases_1">
        <link:definition>0000075 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents_3" roleURI="http://amciacquisitioncorp/role/SubsequentEvents_3">
        <link:definition>0000076 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" roleURI="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>9954701 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies_1" roleURI="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies_1">
        <link:definition>9954702 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>9954703 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies_1" roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies_1">
        <link:definition>9954704 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" roleURI="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables">
        <link:definition>9954705 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ClassACommonStockSubjecttoPossibleRedemptionTables" roleURI="http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionTables">
        <link:definition>9954706 - Disclosure - Class A Common Stock Subject to Possible Redemption (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://amciacquisitioncorp/role/FairValueMeasurementsTables">
        <link:definition>9954707 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesTables_1" roleURI="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables_1">
        <link:definition>9954708 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ClassACommonStockSubjecttoPossibleRedemptionTables_1" roleURI="http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionTables_1">
        <link:definition>9954709 - Disclosure - Class A Common Stock Subject to Possible Redemption (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables_1" roleURI="http://amciacquisitioncorp/role/FairValueMeasurementsTables_1">
        <link:definition>9954710 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://amciacquisitioncorp/role/IncomeTaxesTables">
        <link:definition>9954711 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>9954712 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareTables" roleURI="http://amciacquisitioncorp/role/NetLossPerShareTables">
        <link:definition>9954713 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesTables" roleURI="http://amciacquisitioncorp/role/RevenuesTables">
        <link:definition>9954714 - Disclosure - Revenues (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables" roleURI="http://amciacquisitioncorp/role/InvestmentsTables">
        <link:definition>9954715 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueTables" roleURI="http://amciacquisitioncorp/role/FairValueTables">
        <link:definition>9954716 - Disclosure - Fair Value (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationTables" roleURI="http://amciacquisitioncorp/role/ShareBasedCompensationTables">
        <link:definition>9954717 - Disclosure - Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsTables" roleURI="http://amciacquisitioncorp/role/RelatedPartyTransactionsTables">
        <link:definition>9954718 - Disclosure - Related Party Transactions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableConvertiblePreferredStockTables" roleURI="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockTables">
        <link:definition>9954719 - Disclosure - Redeemable, Convertible Preferred Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://amciacquisitioncorp/role/LeasesTables">
        <link:definition>9954720 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables_1" roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesTables_1">
        <link:definition>9954721 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareTables_1" roleURI="http://amciacquisitioncorp/role/NetLossPerShareTables_1">
        <link:definition>9954722 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesTables_1" roleURI="http://amciacquisitioncorp/role/RevenuesTables_1">
        <link:definition>9954723 - Disclosure - Revenues (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables_1" roleURI="http://amciacquisitioncorp/role/InvestmentsTables_1">
        <link:definition>9954724 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueTables_1" roleURI="http://amciacquisitioncorp/role/FairValueTables_1">
        <link:definition>9954725 - Disclosure - Fair Value (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherCurrentAssetsTables" roleURI="http://amciacquisitioncorp/role/OtherCurrentAssetsTables">
        <link:definition>9954726 - Disclosure - Other Current Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentTables" roleURI="http://amciacquisitioncorp/role/PropertyPlantandEquipmentTables">
        <link:definition>9954727 - Disclosure - Property, Plant, and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://amciacquisitioncorp/role/DebtTables">
        <link:definition>9954728 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables_1" roleURI="http://amciacquisitioncorp/role/IncomeTaxesTables_1">
        <link:definition>9954729 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://amciacquisitioncorp/role/StockBasedCompensationTables">
        <link:definition>9954730 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableConvertiblePreferredStockTables_1" roleURI="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockTables_1">
        <link:definition>9954731 - Disclosure - Redeemable, Convertible Preferred Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables_1" roleURI="http://amciacquisitioncorp/role/LeasesTables_1">
        <link:definition>9954732 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofOrganizationandBusinessOperationsDetails" roleURI="http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails">
        <link:definition>9954733 - Disclosure - Description of Organization and Business Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" roleURI="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails">
        <link:definition>9954734 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails" roleURI="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails">
        <link:definition>9954735 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Net Income (Loss) Per Share of Common Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InitialPublicOfferingDetails" roleURI="http://amciacquisitioncorp/role/InitialPublicOfferingDetails">
        <link:definition>9954736 - Disclosure - Initial Public Offering (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsFounderSharesDetails" roleURI="http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails">
        <link:definition>9954737 - Disclosure - Related Party Transactions - Founder Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsAdditionalInformationDetails" roleURI="http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails">
        <link:definition>9954738 - Disclosure - Related Party Transactions - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails">
        <link:definition>9954739 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ClassACommonStockSubjecttoPossibleRedemptionDetails" roleURI="http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails">
        <link:definition>9954740 - Disclosure - Class A Common Stock Subject to Possible Redemption (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficitPreferredStockSharesDetails" roleURI="http://amciacquisitioncorp/role/StockholdersEquityDeficitPreferredStockSharesDetails">
        <link:definition>9954741 - Disclosure - Stockholders' Equity (Deficit) - Preferred Stock Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficitCommonStockSharesDetails" roleURI="http://amciacquisitioncorp/role/StockholdersEquityDeficitCommonStockSharesDetails">
        <link:definition>9954742 - Disclosure - Stockholders' Equity (Deficit) - Common Stock Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantsDetails" roleURI="http://amciacquisitioncorp/role/WarrantsDetails">
        <link:definition>9954743 - Disclosure - Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantsAdditionalInformationDetails" roleURI="http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails">
        <link:definition>9954744 - Disclosure - Warrants Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails" roleURI="http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails">
        <link:definition>9954745 - Disclosure - Fair Value Measurements - Company's financial assets and liabilities that are measured at fair value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsLevel3fairvaluemeasurementsDetails" roleURI="http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails">
        <link:definition>9954746 - Disclosure - Fair Value Measurements - Level 3 fair value measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails" roleURI="http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails">
        <link:definition>9954747 - Disclosure - Fair Value Measurements - Change in the fair value of the derivative warrant liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://amciacquisitioncorp/role/SubsequentEventsDetails">
        <link:definition>9954748 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofOrganizationandBusinessOperationsDetails_1" roleURI="http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1">
        <link:definition>9954749 - Disclosure - Description of Organization and Business Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails_1" roleURI="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails_1">
        <link:definition>9954750 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails_1" roleURI="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails_1">
        <link:definition>9954751 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Net Income (Loss) Per Share of Common Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InitialPublicOfferingDetails_1" roleURI="http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1">
        <link:definition>9954752 - Disclosure - Initial Public Offering (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsFounderSharesDetails_1" roleURI="http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails_1">
        <link:definition>9954753 - Disclosure - Related Party Transactions - Founder Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsAdditionalInformationDetails_1" roleURI="http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1">
        <link:definition>9954754 - Disclosure - Related Party Transactions - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails_1" roleURI="http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails_1">
        <link:definition>9954755 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ClassACommonStockSubjecttoPossibleRedemptionDetails_1" roleURI="http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails_1">
        <link:definition>9954756 - Disclosure - Class A Common Stock Subject to Possible Redemption (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersDeficitPreferredStockSharesDetails" roleURI="http://amciacquisitioncorp/role/StockholdersDeficitPreferredStockSharesDetails">
        <link:definition>9954757 - Disclosure - Stockholders' Deficit - Preferred Stock Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersDeficitCommonStockSharesDetails" roleURI="http://amciacquisitioncorp/role/StockholdersDeficitCommonStockSharesDetails">
        <link:definition>9954758 - Disclosure - Stockholders' Deficit - Common Stock Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantsDetails_1" roleURI="http://amciacquisitioncorp/role/WarrantsDetails_1">
        <link:definition>9954759 - Disclosure - Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantsAdditionalInformationDetails_1" roleURI="http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1">
        <link:definition>9954760 - Disclosure - Warrants - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails_1" roleURI="http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails_1">
        <link:definition>9954761 - Disclosure - Fair Value Measurements - Company's financial assets and liabilities that are measured at fair value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsLevel3fairvaluemeasurementsDetails_1" roleURI="http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails_1">
        <link:definition>9954762 - Disclosure - Fair Value Measurements - Level 3 fair value measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails_1" roleURI="http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails_1">
        <link:definition>9954763 - Disclosure - Fair Value Measurements - Change in the fair value of the derivative warrant liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncometaxprovisionDetails" roleURI="http://amciacquisitioncorp/role/IncomeTaxesIncometaxprovisionDetails">
        <link:definition>9954764 - Disclosure - Income Taxes - Income tax provision (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDeferredtaxassetsDetails" roleURI="http://amciacquisitioncorp/role/IncomeTaxesDeferredtaxassetsDetails">
        <link:definition>9954765 - Disclosure - Income Taxes - Deferred tax assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationofthestatutoryfederalincometaxratebenefitDetails" roleURI="http://amciacquisitioncorp/role/IncomeTaxesReconciliationofthestatutoryfederalincometaxratebenefitDetails">
        <link:definition>9954766 - Disclosure - Income Taxes - Reconciliation of the statutory federal income tax rate (benefit) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails_1" roleURI="http://amciacquisitioncorp/role/SubsequentEventsDetails_1">
        <link:definition>9954767 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionoftheBusinessDetails" roleURI="http://amciacquisitioncorp/role/DescriptionoftheBusinessDetails">
        <link:definition>9954768 - Disclosure - Description of the Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesGoingConcernandSegmentInformationDetails" roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesGoingConcernandSegmentInformationDetails">
        <link:definition>9954769 - Disclosure - Summary of Significant Accounting Policies - Going Concern and Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails" roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails">
        <link:definition>9954770 - Disclosure - Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashReconciliationDetails" roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashReconciliationDetails">
        <link:definition>9954771 - Disclosure - Summary of Significant Accounting Policies - Cash, Cash Equivalents and Restricted Cash Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTradeandOtherReceivablesDetails" roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesTradeandOtherReceivablesDetails">
        <link:definition>9954772 - Disclosure - Summary of Significant Accounting Policies - Trade and Other Receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails" roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails">
        <link:definition>9954773 - Disclosure - Summary of Significant Accounting Policies - Concentration of Credit Risk and Other Risks and Uncertainties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails" roleURI="http://amciacquisitioncorp/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails">
        <link:definition>9954774 - Disclosure - Net Loss Per Share - Schedule of Calculation of Basic and Diluted Net Loss per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LanzaTech10QNetLossPerShareAntidilutiveSharesDetails" roleURI="http://amciacquisitioncorp/role/LanzaTech10QNetLossPerShareAntidilutiveSharesDetails">
        <link:definition>9954775 - Disclosure - LanzaTech 10Q Net Loss Per Share - Antidilutive Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesDisaggregatedRevenueDetails" roleURI="http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails">
        <link:definition>9954776 - Disclosure - Revenues - Disaggregated Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesAdditionalInformationDetails" roleURI="http://amciacquisitioncorp/role/RevenuesAdditionalInformationDetails">
        <link:definition>9954777 - Disclosure - Revenues - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesDisaggregationbyCustomerLocationDetails" roleURI="http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails">
        <link:definition>9954778 - Disclosure - Revenues - Disaggregation by Customer Location (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesContractBalancesDetails" roleURI="http://amciacquisitioncorp/role/RevenuesContractBalancesDetails">
        <link:definition>9954779 - Disclosure - Revenues - Contract Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesRemainingPerformanceObligationsDetails" roleURI="http://amciacquisitioncorp/role/RevenuesRemainingPerformanceObligationsDetails">
        <link:definition>9954780 - Disclosure - Revenues - Remaining Performance Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsScheduleofInvestmentsDetails" roleURI="http://amciacquisitioncorp/role/InvestmentsScheduleofInvestmentsDetails">
        <link:definition>9954781 - Disclosure - Investments - Schedule of Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNarrativeDetails" roleURI="http://amciacquisitioncorp/role/InvestmentsNarrativeDetails">
        <link:definition>9954782 - Disclosure - Investments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueFinancialAssetsandLiabilitiesDetails" roleURI="http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails">
        <link:definition>9954783 - Disclosure - Fair Value - Financial Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueNarrativeDetails" roleURI="http://amciacquisitioncorp/role/FairValueNarrativeDetails">
        <link:definition>9954784 - Disclosure - Fair Value - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueLevel3FairValueMeasurementsDetails" roleURI="http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails">
        <link:definition>9954785 - Disclosure - Fair Value - Level 3 Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails" roleURI="http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails">
        <link:definition>9954786 - Disclosure - Fair Value - Change in Fair Value of Derivative Warrant Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://amciacquisitioncorp/role/IncomeTaxesDetails">
        <link:definition>9954787 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationNarrativeDetails" roleURI="http://amciacquisitioncorp/role/ShareBasedCompensationNarrativeDetails">
        <link:definition>9954788 - Disclosure - Share-Based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationStockOptionAwardActivityDetails" roleURI="http://amciacquisitioncorp/role/ShareBasedCompensationStockOptionAwardActivityDetails">
        <link:definition>9954789 - Disclosure - Share-Based Compensation - Stock Option Award Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsDetails" roleURI="http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails">
        <link:definition>9954790 - Disclosure - Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails" roleURI="http://amciacquisitioncorp/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails">
        <link:definition>9954791 - Disclosure - Related Party Transactions - Schedule of Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableConvertiblePreferredStockDetails" roleURI="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockDetails">
        <link:definition>9954792 - Disclosure - Redeemable, Convertible Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails_2" roleURI="http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails_2">
        <link:definition>9954793 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesDetails" roleURI="http://amciacquisitioncorp/role/LeasesDetails">
        <link:definition>9954794 - Disclosure - Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails_2" roleURI="http://amciacquisitioncorp/role/SubsequentEventsDetails_2">
        <link:definition>9954795 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesRestatementDetails" roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails">
        <link:definition>9954796 - Disclosure - Summary of Significant Accounting Policies - Restatement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesSegmentInformationDetails" roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails">
        <link:definition>9954797 - Disclosure - Summary of Significant Accounting Policies - Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesGoingConcernDetails" roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesGoingConcernDetails">
        <link:definition>9954798 - Disclosure - Summary of Significant Accounting Policies - Going Concern (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails_1" roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails_1">
        <link:definition>9954799 - Disclosure - Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashReconciliationDetails_1" roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashReconciliationDetails_1">
        <link:definition>9954800 - Disclosure - Summary of Significant Accounting Policies - Cash, Cash Equivalents and Restricted Cash Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTradeandOtherReceivablesDetails_1" roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesTradeandOtherReceivablesDetails_1">
        <link:definition>9954801 - Disclosure - Summary of Significant Accounting Policies - Trade and Other Receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentnetDetails" roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentnetDetails">
        <link:definition>9954802 - Disclosure - Summary of Significant Accounting Policies - Property, Plant and Equipment, net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesWarrantsDetails" roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesWarrantsDetails">
        <link:definition>9954803 - Disclosure - Summary of Significant Accounting Policies - Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails_1" roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails_1">
        <link:definition>9954804 - Disclosure - Summary of Significant Accounting Policies - Concentration of Credit Risk and Other Risks and Uncertainties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails_1" roleURI="http://amciacquisitioncorp/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails_1">
        <link:definition>9954805 - Disclosure - Net Loss Per Share - Schedule of Calculation of Basic and Diluted Net Loss per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareAntidilutiveSharesDetails" roleURI="http://amciacquisitioncorp/role/NetLossPerShareAntidilutiveSharesDetails">
        <link:definition>9954806 - Disclosure - Net Loss Per Share - Antidilutive Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesDisaggregatedRevenueDetails_1" roleURI="http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails_1">
        <link:definition>9954807 - Disclosure - Revenues - Disaggregated Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesDisaggregationbyCustomerLocationDetails_1" roleURI="http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails_1">
        <link:definition>9954808 - Disclosure - Revenues - Disaggregation by Customer Location (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesContractBalancesDetails_1" roleURI="http://amciacquisitioncorp/role/RevenuesContractBalancesDetails_1">
        <link:definition>9954809 - Disclosure - Revenues - Contract Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesAdditionalInformationDetails_1" roleURI="http://amciacquisitioncorp/role/RevenuesAdditionalInformationDetails_1">
        <link:definition>9954810 - Disclosure - Revenues - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesRemainingPerformanceObligationsDetails_1" roleURI="http://amciacquisitioncorp/role/RevenuesRemainingPerformanceObligationsDetails_1">
        <link:definition>9954811 - Disclosure - Revenues - Remaining Performance Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsEquityMethodInvestmentsDetails" roleURI="http://amciacquisitioncorp/role/InvestmentsEquityMethodInvestmentsDetails">
        <link:definition>9954812 - Disclosure - Investments - Equity Method Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNarrativeDetails_1" roleURI="http://amciacquisitioncorp/role/InvestmentsNarrativeDetails_1">
        <link:definition>9954813 - Disclosure - Investments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsSummarizedFinancialInformationDetails" roleURI="http://amciacquisitioncorp/role/InvestmentsSummarizedFinancialInformationDetails">
        <link:definition>9954814 - Disclosure - Investments - Summarized Financial Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTransactionsDetails" roleURI="http://amciacquisitioncorp/role/InvestmentsTransactionsDetails">
        <link:definition>9954815 - Disclosure - Investments - Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueFinancialAssetsandLiabilitiesDetails_1" roleURI="http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails_1">
        <link:definition>9954816 - Disclosure - Fair Value - Financial Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueNarrativeDetails_1" roleURI="http://amciacquisitioncorp/role/FairValueNarrativeDetails_1">
        <link:definition>9954817 - Disclosure - Fair Value - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueLevel3FairValueMeasurementsDetails_1" roleURI="http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1">
        <link:definition>9954818 - Disclosure - Fair Value - Level 3 Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails_1" roleURI="http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails_1">
        <link:definition>9954819 - Disclosure - Fair Value - Change in Fair Value of Derivative Warrant Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherCurrentAssetsDetails" roleURI="http://amciacquisitioncorp/role/OtherCurrentAssetsDetails">
        <link:definition>9954820 - Disclosure - Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentDetails" roleURI="http://amciacquisitioncorp/role/PropertyPlantandEquipmentDetails">
        <link:definition>9954821 - Disclosure - Property, Plant, and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentNarrativeDetails" roleURI="http://amciacquisitioncorp/role/PropertyPlantandEquipmentNarrativeDetails">
        <link:definition>9954822 - Disclosure - Property, Plant, and Equipment - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtDetails" roleURI="http://amciacquisitioncorp/role/DebtDetails">
        <link:definition>9954823 - Disclosure - Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtNarrativeDetails" roleURI="http://amciacquisitioncorp/role/DebtNarrativeDetails">
        <link:definition>9954824 - Disclosure - Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SAFEDetails" roleURI="http://amciacquisitioncorp/role/SAFEDetails">
        <link:definition>9954825 - Disclosure - SAFE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsofLossIncomeDetails" roleURI="http://amciacquisitioncorp/role/IncomeTaxesComponentsofLossIncomeDetails">
        <link:definition>9954826 - Disclosure - Income Taxes - Components of (Loss) Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeTaxProvisionDetails" roleURI="http://amciacquisitioncorp/role/IncomeTaxesIncomeTaxProvisionDetails">
        <link:definition>9954827 - Disclosure - Income Taxes - Income Tax Provision (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationDetails" roleURI="http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails">
        <link:definition>9954828 - Disclosure - Income Taxes - Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>9954829 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://amciacquisitioncorp/role/IncomeTaxesNarrativeDetails">
        <link:definition>9954830 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationNarrativeDetails" roleURI="http://amciacquisitioncorp/role/StockBasedCompensationNarrativeDetails">
        <link:definition>9954831 - Disclosure - Stock-Based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationStockOptionAwardActivityDetails" roleURI="http://amciacquisitioncorp/role/StockBasedCompensationStockOptionAwardActivityDetails">
        <link:definition>9954832 - Disclosure - Stock-Based Compensation - Stock Option Award Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationFairValueAssumptionsDetails" roleURI="http://amciacquisitioncorp/role/StockBasedCompensationFairValueAssumptionsDetails">
        <link:definition>9954833 - Disclosure - Stock-Based Compensation - Fair Value Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationRestrictedStockAwardsActivityDetails" roleURI="http://amciacquisitioncorp/role/StockBasedCompensationRestrictedStockAwardsActivityDetails">
        <link:definition>9954834 - Disclosure - Stock-Based Compensation - Restricted Stock Awards Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsDetails_1" roleURI="http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails_1">
        <link:definition>9954835 - Disclosure - Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityDetails" roleURI="http://amciacquisitioncorp/role/ShareholdersEquityDetails">
        <link:definition>9954836 - Disclosure - Shareholders&#8217; Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableConvertiblePreferredStockAuthorizedIssuedandOutstandingSharesIssuePriceandCarryingValueDetails" roleURI="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockAuthorizedIssuedandOutstandingSharesIssuePriceandCarryingValueDetails">
        <link:definition>9954837 - Disclosure - Redeemable, Convertible Preferred Stock - Authorized, Issued and Outstanding Shares, Issue Price, and Carrying Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableConvertiblePreferredStockChangesDetails" roleURI="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockChangesDetails">
        <link:definition>9954838 - Disclosure - Redeemable, Convertible Preferred Stock - Changes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableConvertiblePreferredStockNarrativeDetails" roleURI="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockNarrativeDetails">
        <link:definition>9954839 - Disclosure - Redeemable, Convertible Preferred Stock - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansDetails" roleURI="http://amciacquisitioncorp/role/BenefitPlansDetails">
        <link:definition>9954840 - Disclosure - Benefit Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://amciacquisitioncorp/role/LeasesNarrativeDetails">
        <link:definition>9954841 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseMaturitiesDetails" roleURI="http://amciacquisitioncorp/role/LeasesLeaseMaturitiesDetails">
        <link:definition>9954842 - Disclosure - Leases - Lease Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseMaturitiesDetails_1" roleURI="http://amciacquisitioncorp/role/LeasesLeaseMaturitiesDetails_1">
        <link:definition>9954842 - Disclosure - Leases - Lease Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLessorOperatingLeasePaymentstobeReceivedDetails" roleURI="http://amciacquisitioncorp/role/LeasesLessorOperatingLeasePaymentstobeReceivedDetails">
        <link:definition>9954843 - Disclosure - Leases - Lessor, Operating Lease, Payments to be Received (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalInformationDetails" roleURI="http://amciacquisitioncorp/role/LeasesSupplementalInformationDetails">
        <link:definition>9954844 - Disclosure - Leases - Supplemental Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails_3" roleURI="http://amciacquisitioncorp/role/SubsequentEventsDetails_3">
        <link:definition>9954845 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="amci_ContractWithCustomerAssetCurrentForeignCurrencyTranslationAdjustment" abstract="false" name="ContractWithCustomerAssetCurrentForeignCurrencyTranslationAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_CoronavirusPolicyTextBlock" abstract="false" name="CoronavirusPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="amci_TemporaryEquityNumberOfVotesPerShare" abstract="false" name="TemporaryEquityNumberOfVotesPerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="amci_SAFELiabilityMeasurementInput" abstract="false" name="SAFELiabilityMeasurementInput" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="amci_RevenueRemainingPerformanceObligationNoncurrentAmount" abstract="false" name="RevenueRemainingPerformanceObligationNoncurrentAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable" abstract="false" name="ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" abstract="true" name="RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_WarrantsTextBlockTextBlock" abstract="false" name="WarrantsTextBlockTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="amci_AdministrativeSupportAgreementMember" abstract="true" name="AdministrativeSupportAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_LanzatechGlobalMember" abstract="true" name="LanzatechGlobalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="amci_ContractWithCustomerAssetCurrentReclassifiedToReceivable" abstract="false" name="ContractWithCustomerAssetCurrentReclassifiedToReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_RelatedPartyInvestmentAgreementMember" abstract="true" name="RelatedPartyInvestmentAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_NumberOfWarrantsIssuedPerUnit" abstract="false" name="NumberOfWarrantsIssuedPerUnit" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_CarbonSmartMember" abstract="true" name="CarbonSmartMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_UnderwriterCashDiscount" abstract="false" name="UnderwriterCashDiscount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_DueToRelatedParty" abstract="false" name="DueToRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_DeferredUnderwritingCompensationNoncurrent" abstract="false" name="DeferredUnderwritingCompensationNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjects" abstract="false" name="FrameworkAgreementRequiredEquityFundingForQualifyingProjects" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" abstract="false" name="RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="amci_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" abstract="false" name="RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise" abstract="false" name="PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="amci_WarrantConditionDomain" abstract="true" name="WarrantConditionDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_ContractWithCustomerLiabilityNoncurrentAmountsCollected" abstract="false" name="ContractWithCustomerLiabilityNoncurrentAmountsCollected" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_NoteReceivableCommitmentToPurchase" abstract="false" name="NoteReceivableCommitmentToPurchase" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_NoncashLoanForgiveness" abstract="false" name="NoncashLoanForgiveness" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_CustomerDMember" abstract="true" name="CustomerDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_NoncashRepaymentOfNotePayableAndAdvances" abstract="false" name="NoncashRepaymentOfNotePayableAndAdvances" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_ContractWithCustomerLiabilityCurrentAmountsCollected" abstract="false" name="ContractWithCustomerLiabilityCurrentAmountsCollected" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_WarrantConditionAxis" abstract="true" name="WarrantConditionAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="amci_MeasurementInputInterestRateMember" abstract="true" name="MeasurementInputInterestRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_WorkingCapitalDeficit" abstract="false" name="WorkingCapitalDeficit" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_CommonStockNumberOfVotesPerShare" abstract="false" name="CommonStockNumberOfVotesPerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="amci_RedemptionPeriodUponClosure" abstract="false" name="RedemptionPeriodUponClosure" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="amci_OptionToPurchaseAdditionalUnitsGivenToInvestors" abstract="false" name="OptionToPurchaseAdditionalUnitsGivenToInvestors" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="amci_DeferredUnderwritingDiscountPercentage" abstract="false" name="DeferredUnderwritingDiscountPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="amci_OperatingLossCarryforwardsSubjectToExpiration" abstract="false" name="OperatingLossCarryforwardsSubjectToExpiration" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" abstract="false" name="ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_NumberOfRoundsOfInvestments" abstract="false" name="NumberOfRoundsOfInvestments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="amci_WorkingCapitalLoansWarrantMember" abstract="true" name="WorkingCapitalLoansWarrantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts" abstract="false" name="DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDaysSource2" abstract="false" name="ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDaysSource2" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="amci_MaximumNumberOfDemandsForRegistrationOfSecurities" abstract="false" name="MaximumNumberOfDemandsForRegistrationOfSecurities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="amci_TransactionsWithEquityMethodInvesteesMember" abstract="true" name="TransactionsWithEquityMethodInvesteesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" abstract="false" name="ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="amci_MeasurementInputProbabilityWeightingMember" abstract="true" name="MeasurementInputProbabilityWeightingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_PercentageOfGrossProceedsOnTotalEquityProceed" abstract="false" name="PercentageOfGrossProceedsOnTotalEquityProceed" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="amci_DerivativeNearTermMember" abstract="true" name="DerivativeNearTermMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares" abstract="false" name="GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount" abstract="false" name="TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_SeniorSecuredNotesReceivableMember" abstract="true" name="SeniorSecuredNotesReceivableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption" abstract="false" name="IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" abstract="false" name="TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="amci_PeriodForFillingRegistrationStatementAfterBusinessCombination" abstract="false" name="PeriodForFillingRegistrationStatementAfterBusinessCombination" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="amci_AggregateNumberOfSharesOwned" abstract="false" name="AggregateNumberOfSharesOwned" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="amci_LineOfCreditFacilityInterestRate" abstract="false" name="LineOfCreditFacilityInterestRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities" abstract="false" name="OfferingCostsAllocatedToDerivativeWarrantLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_OperatingLossAndTaxCreditCarryforwards" abstract="false" name="OperatingLossAndTaxCreditCarryforwards" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_ScheduleOfReverseCapitalizationTable" abstract="true" name="ScheduleOfReverseCapitalizationTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember" abstract="true" name="BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_InvestmentsLineItems" abstract="true" name="InvestmentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="amci_InvestmentsHeldInTrustAccountPolicyTextBlock" abstract="false" name="InvestmentsHeldInTrustAccountPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="amci_CoplacementAgentMember" abstract="true" name="CoplacementAgentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_SAFELiabilityMember" abstract="true" name="SAFELiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationDebtForgivenessAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_EquityMethodInvestmentContingentRightToReceiveAdditionalInterest" abstract="false" name="EquityMethodInvestmentContingentRightToReceiveAdditionalInterest" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="amci_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" abstract="false" name="MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" abstract="false" name="ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors" abstract="false" name="ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_WTILoanMember" abstract="true" name="WTILoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises" abstract="false" name="ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_NumberOfShareBasedStockSchemes" abstract="false" name="NumberOfShareBasedStockSchemes" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_SaleOfStockUnderwritingDiscounts" abstract="false" name="SaleOfStockUnderwritingDiscounts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_PlusAbstract" abstract="true" name="PlusAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="amci_PPPLoanMember" abstract="true" name="PPPLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_InitialPublicOfferingTextBlock" abstract="false" name="InitialPublicOfferingTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="amci_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="amci_NumberOfSharesSubjectToForfeiture" abstract="false" name="NumberOfSharesSubjectToForfeiture" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="amci_IncreaseDecreaseInDueToRelatedParties." abstract="false" name="IncreaseDecreaseInDueToRelatedParties." nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" abstract="false" name="ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="amci_SecuritiesSubjectToMandatoryRedemptionLongTermMember" abstract="true" name="SecuritiesSubjectToMandatoryRedemptionLongTermMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_EffectiveIncomeTaxRateReconciliationInterestIncomeAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationInterestIncomeAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_SAFEWarrantNearTermMember" abstract="true" name="SAFEWarrantNearTermMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_NoncashRecognitionOfLicensingRevenue" abstract="false" name="NoncashRecognitionOfLicensingRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_DeferredTaxAssetsLeasingArrangements" abstract="false" name="DeferredTaxAssetsLeasingArrangements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_LesssorOperatingLeaseNumberOfRenewalOptions" abstract="false" name="LesssorOperatingLeaseNumberOfRenewalOptions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="amci_RelatedAndNonrelatedPartyStatusAxis" abstract="true" name="RelatedAndNonrelatedPartyStatusAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationDebtForgivenessPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="amci_NoncashDeferredUnderwritingCommissions" abstract="false" name="NoncashDeferredUnderwritingCommissions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_RelatedPartyMember" abstract="true" name="RelatedPartyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_LesseeOperatingLeaseNumberOfRenewalTerms" abstract="false" name="LesseeOperatingLeaseNumberOfRenewalTerms" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose" abstract="false" name="ProceedsHeldInOperatingAccountForWorkingCapitalPurpose" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_DeferredUnderwritingDiscounts" abstract="false" name="DeferredUnderwritingDiscounts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_CustomerCMember" abstract="true" name="CustomerCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_October2022SubscriptionAgreementsMember" abstract="true" name="October2022SubscriptionAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_ClassOfWarrantOrRightAmountOfNotesPurchased" abstract="false" name="ClassOfWarrantOrRightAmountOfNotesPurchased" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_NumberOfSharesIssuedPerUnit" abstract="false" name="NumberOfSharesIssuedPerUnit" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="amci_LessAbstract" abstract="true" name="LessAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="amci_TemporaryEquityIssuanceCosts" abstract="false" name="TemporaryEquityIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_ContractWithCustomerLiabilityCurrentRevenueRecognized" abstract="false" name="ContractWithCustomerLiabilityCurrentRevenueRecognized" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_ErrorCorrectionEquityMethodInvestmentGainOnDilutionMember" abstract="true" name="ErrorCorrectionEquityMethodInvestmentGainOnDilutionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants" abstract="false" name="GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" abstract="true" name="RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_IncreaseDecreaseFranchiseTaxPayable" abstract="false" name="IncreaseDecreaseFranchiseTaxPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_SponsorMember" abstract="true" name="SponsorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" abstract="false" name="TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="amci_UnderwritingDiscountPercentage" abstract="false" name="UnderwritingDiscountPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="amci_WorkingCapitalLoansMember" abstract="true" name="WorkingCapitalLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_WarrantsPolicyPolicyTextBlock" abstract="false" name="WarrantsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="amci_NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties" abstract="false" name="NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_GoingConcernPolicyTextBlock" abstract="false" name="GoingConcernPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="amci_StockIssuanceCostsNoncash" abstract="false" name="StockIssuanceCostsNoncash" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent" abstract="false" name="ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_TemporaryEquityValueConversionOfConvertibleSecurities" abstract="false" name="TemporaryEquityValueConversionOfConvertibleSecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_TransferFromForeignCurrencyTranslationToEquitySecurityInvestment" abstract="false" name="TransferFromForeignCurrencyTranslationToEquitySecurityInvestment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters" abstract="false" name="OptionToPurchaseAdditionalUnitsGivenToUnderwriters" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="amci_PrivatePlacementWarrantsMember" abstract="true" name="PrivatePlacementWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_FinancialAdvisoryMember" abstract="true" name="FinancialAdvisoryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_PublicWarrantsMember" abstract="true" name="PublicWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_SharesSurrenderedFairValueOfShares" abstract="false" name="SharesSurrenderedFairValueOfShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_WorkingCapitalLoan" abstract="false" name="WorkingCapitalLoan" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_ReverseCapitalizationClosingCashCondition" abstract="false" name="ReverseCapitalizationClosingCashCondition" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_FairValueAdjustmentOfWarrantsAndUnrealizedGainLossOnDerivatives" abstract="false" name="FairValueAdjustmentOfWarrantsAndUnrealizedGainLossOnDerivatives" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_ContractWithCustomerLiabilityCurrentAbstract" abstract="true" name="ContractWithCustomerLiabilityCurrentAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="amci_CustomerAMember" abstract="true" name="CustomerAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_DerivativeLongTermMember" abstract="true" name="DerivativeLongTermMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_MeasurementInputLiquidityPriceMember" abstract="true" name="MeasurementInputLiquidityPriceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_MonthsToCompleteAcquisition" abstract="false" name="MonthsToCompleteAcquisition" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="amci_CommonClassaNotSubjectToRedemptionMember" abstract="true" name="CommonClassaNotSubjectToRedemptionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne" abstract="false" name="LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="amci_InvestmentsTable" abstract="true" name="InvestmentsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="amci_IncomeFromInvestmentsHeldInTrustAccount" abstract="false" name="IncomeFromInvestmentsHeldInTrustAccount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_OptionVestingPeriod" abstract="false" name="OptionVestingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="amci_CustomerEMember" abstract="true" name="CustomerEMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_SubordinatedSecuredNotesReceivableMember" abstract="true" name="SubordinatedSecuredNotesReceivableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_SimpleAgreementForFutureEquityLiability" abstract="false" name="SimpleAgreementForFutureEquityLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_OperatingLossCarryforwardsNotSubjectToExpiration" abstract="false" name="OperatingLossCarryforwardsNotSubjectToExpiration" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_TransactionCosts" abstract="false" name="TransactionCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" abstract="false" name="ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="amci_RelatedAndNonrelatedPartyStatusDomain" abstract="true" name="RelatedAndNonrelatedPartyStatusDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent" abstract="false" name="ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_JointDevelopmentAgreementsMember" abstract="true" name="JointDevelopmentAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment" abstract="false" name="IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_ConditionForFutureBusinessCombinationThresholdPercentageOwnership" abstract="false" name="ConditionForFutureBusinessCombinationThresholdPercentageOwnership" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="amci_OfferingCostsIncludedInAccountsPayableAccruedExpenses" abstract="false" name="OfferingCostsIncludedInAccountsPayableAccruedExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" abstract="false" name="ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="amci_RelatedPartyTransitionServicesAgreementMember" abstract="true" name="RelatedPartyTransitionServicesAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_FundHeldInTrustAccountPerPublicShare" abstract="false" name="FundHeldInTrustAccountPerPublicShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="amci_AMCIACQUISITIONCORPIIMember" abstract="true" name="AMCIACQUISITIONCORPIIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_DeferredUnderwritingFeePayable" abstract="false" name="DeferredUnderwritingFeePayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_ScheduleOfReverseCapitalizationLineItems" abstract="true" name="ScheduleOfReverseCapitalizationLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="amci_TemporaryEquityProceedsAllocatedToWarrants" abstract="false" name="TemporaryEquityProceedsAllocatedToWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_IncreaseDecreaseInCapitalBaseTaxPayable" abstract="false" name="IncreaseDecreaseInCapitalBaseTaxPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_SAFEWarrantLongTermMember" abstract="true" name="SAFEWarrantLongTermMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_EarningPerShareBasicAndDilutedAbstract" abstract="true" name="EarningPerShareBasicAndDilutedAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="amci_RelatedPartyLoansMember" abstract="true" name="RelatedPartyLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_MaximumLoansConvertibleIntoWarrants" abstract="false" name="MaximumLoansConvertibleIntoWarrants" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_ConvertibleStockConversionRatio" abstract="false" name="ConvertibleStockConversionRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="amci_TemporaryEquityStockIssuanceCost" abstract="false" name="TemporaryEquityStockIssuanceCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_TemporaryEquityStockIssuedDuringPeriodPricePerShare" abstract="false" name="TemporaryEquityStockIssuedDuringPeriodPricePerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="amci_ConditionForFutureBusinessCombinationUseOfProceedsPercentage" abstract="false" name="ConditionForFutureBusinessCombinationUseOfProceedsPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="amci_TemporaryEquityDisclosureTextBlock" abstract="false" name="TemporaryEquityDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="amci_RelatedPartySupplyAgreementMember" abstract="true" name="RelatedPartySupplyAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_CommonClassaSubjectToRedemptionMember" abstract="true" name="CommonClassaSubjectToRedemptionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_AnchorInvestorsMember" abstract="true" name="AnchorInvestorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_ErrorCorrectionEquityMethodInvestmentsIntangiblesAndFixedAssetsMember" abstract="true" name="ErrorCorrectionEquityMethodInvestmentsIntangiblesAndFixedAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_OneTrancheOfNotesMember" abstract="true" name="OneTrancheOfNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_ContractWithCustomerLiabilityNoncurrentAbstract" abstract="true" name="ContractWithCustomerLiabilityNoncurrentAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="amci_RedemptionPeriod" abstract="false" name="RedemptionPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="amci_ResearchAndDevelopmentMember" abstract="true" name="ResearchAndDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_OtherContractResearchMember" abstract="true" name="OtherContractResearchMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_SimpleAgreementForFutureEquityLiabilityDisclosureTextBlock" abstract="false" name="SimpleAgreementForFutureEquityLiabilityDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="amci_FranchiseTaxPayableCurrent" abstract="false" name="FranchiseTaxPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_PaymentsForInvestmentOfCashInTrustAccount" abstract="false" name="PaymentsForInvestmentOfCashInTrustAccount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_DenominatorForCalculationOfEarningsPerShareAbstract" abstract="true" name="DenominatorForCalculationOfEarningsPerShareAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="amci_MeasurementInputTimeToConversionMember" abstract="true" name="MeasurementInputTimeToConversionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_EffectiveIncomeTaxRateReconciliationInterestIncomePercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationInterestIncomePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="amci_RelatedPartyLeaseAgreementMember" abstract="true" name="RelatedPartyLeaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" abstract="false" name="PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" abstract="false" name="TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="amci_InlandRevenueNewZealandMember" abstract="true" name="InlandRevenueNewZealandMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_MaximumThresholdPeriodForFilingRegistrationStatementAfterBusinessCombination" abstract="false" name="MaximumThresholdPeriodForFilingRegistrationStatementAfterBusinessCombination" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="amci_EquityMethodInvestmentGainOnDilutionOfInvestment" abstract="false" name="EquityMethodInvestmentGainOnDilutionOfInvestment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_CostOfRevenueFromContractsWithCustomersExcludingDepreciation" abstract="false" name="CostOfRevenueFromContractsWithCustomersExcludingDepreciation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_LanzaJetFreedomPinesFuelsLLCMember" abstract="true" name="LanzaJetFreedomPinesFuelsLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_CapitalBaseTaxExpense" abstract="false" name="CapitalBaseTaxExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_RevenueRemainingPerformanceObligationCurrentAmount" abstract="false" name="RevenueRemainingPerformanceObligationCurrentAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_NoncashExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares" abstract="false" name="NoncashExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_IncomeTaxesLineItems" abstract="true" name="IncomeTaxesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="amci_SecuritiesSubjectToMandatoryRedemptionNearTermMember" abstract="true" name="SecuritiesSubjectToMandatoryRedemptionNearTermMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering" abstract="false" name="ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_InitialPublicOfferingAbstract" abstract="true" name="InitialPublicOfferingAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="amci_MaximumAllowedDissolutionExpenses" abstract="false" name="MaximumAllowedDissolutionExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices" abstract="false" name="ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="amci_LanzaJetIncMember" abstract="true" name="LanzaJetIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_NumberOfSharesSurrendered" abstract="false" name="NumberOfSharesSurrendered" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares" abstract="false" name="AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights" abstract="false" name="ClassOfWarrantOrRightPriceOfWarrantsOrRights" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="amci_TemporaryEquityIssuePricePerShare" abstract="false" name="TemporaryEquityIssuePricePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="amci_TemporaryEquitySharesConversionOfConvertibleSecurities" abstract="false" name="TemporaryEquitySharesConversionOfConvertibleSecurities" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="amci_ContractWithCustomerLiabilityNoncurrentForeignCurrencyTranslationAdjustment" abstract="false" name="ContractWithCustomerLiabilityNoncurrentForeignCurrencyTranslationAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_FrameworkAgreementRequiredEquityFunding" abstract="false" name="FrameworkAgreementRequiredEquityFunding" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_LiquidityPriceOfSAFEAndSAFEWarrants" abstract="false" name="LiquidityPriceOfSAFEAndSAFEWarrants" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="amci_UnitsIssuedDuringPeriodSharesNewIssues" abstract="false" name="UnitsIssuedDuringPeriodSharesNewIssues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="amci_FounderSharesMember" abstract="true" name="FounderSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_PrepaidExpensesLongTerm" abstract="false" name="PrepaidExpensesLongTerm" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_NumeratorAbstract" abstract="true" name="NumeratorAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="amci_EngineeringAndOtherServicesMember" abstract="true" name="EngineeringAndOtherServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_RevenueFromContractWithCustomerAmortizationPeriod" abstract="false" name="RevenueFromContractWithCustomerAmortizationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="amci_ErrorCorrectionEquityMethodInvestmentContributedIntellectualAssetMember" abstract="true" name="ErrorCorrectionEquityMethodInvestmentContributedIntellectualAssetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_CarbonCaptureAndTransformationMember" abstract="true" name="CarbonCaptureAndTransformationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_DeferredOfferingCostsIncludedInNotesPayable" abstract="false" name="DeferredOfferingCostsIncludedInNotesPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" abstract="false" name="ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="amci_OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock" abstract="false" name="OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" abstract="false" name="ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="amci_WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering" abstract="false" name="WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="amci_SAFEWarrantMember" abstract="true" name="SAFEWarrantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_DeferredUnderwritingFeesMember" abstract="true" name="DeferredUnderwritingFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_RelatedPartyTransactionsPolicyPolicyTextBlock" abstract="false" name="RelatedPartyTransactionsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="amci_SaleOfStockOtherOfferingCosts" abstract="false" name="SaleOfStockOtherOfferingCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_OutstandingWorkingCapitalLoans" abstract="false" name="OutstandingWorkingCapitalLoans" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_OtherCurrentAssetsPolicyTextBlock" abstract="false" name="OtherCurrentAssetsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="amci_SimpleAgreementForFutureEquityInitialPurchaseAmount" abstract="false" name="SimpleAgreementForFutureEquityInitialPurchaseAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_CustomerBMember" abstract="true" name="CustomerBMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjectsRemainingAmountReduction" abstract="false" name="FrameworkAgreementRequiredEquityFundingForQualifyingProjectsRemainingAmountReduction" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_IncomeTaxesTable" abstract="true" name="IncomeTaxesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" abstract="false" name="TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="amci_PurchasesAndOpenAccountsPayableRelatedParties" abstract="false" name="PurchasesAndOpenAccountsPayableRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_EvercoreGroupL.l.c.Member" abstract="true" name="EvercoreGroupL.l.c.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amci_TemporaryEquityExerciseOfWarrants" abstract="false" name="TemporaryEquityExerciseOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>amci-20230213_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:1f450268-e321-4330-aadf-815e69af2b4b,g:fe19691a-e2ec-4bc1-af0c-c42cfd4d1d7c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS" xlink:type="simple" xlink:href="amci-20230213.xsd#CONDENSEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_13724ae3-b290-466a-84fa-407e898a86e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_92de4379-860e-4acb-9852-f755154bee70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_13724ae3-b290-466a-84fa-407e898a86e8" xlink:to="loc_us-gaap_LiabilitiesCurrent_92de4379-860e-4acb-9852-f755154bee70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_fef7e62e-3592-43d8-bfaf-3d1412c00c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_13724ae3-b290-466a-84fa-407e898a86e8" xlink:to="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_fef7e62e-3592-43d8-bfaf-3d1412c00c9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingCompensationNoncurrent_9fbfc403-0c7a-4906-8f04-17cee25e7255" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingCompensationNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_13724ae3-b290-466a-84fa-407e898a86e8" xlink:to="loc_amci_DeferredUnderwritingCompensationNoncurrent_9fbfc403-0c7a-4906-8f04-17cee25e7255" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_79007049-8f43-466e-a27d-ac46cc66a616" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_c97afc41-8a21-491e-9485-56493af2fb17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_79007049-8f43-466e-a27d-ac46cc66a616" xlink:to="loc_us-gaap_CommitmentsAndContingencies_c97afc41-8a21-491e-9485-56493af2fb17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_3e002619-9865-428a-9784-7e38a9f146f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_79007049-8f43-466e-a27d-ac46cc66a616" xlink:to="loc_us-gaap_Liabilities_3e002619-9865-428a-9784-7e38a9f146f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9b8eaaaf-fd0e-4242-a640-9f8ff6cc6ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_79007049-8f43-466e-a27d-ac46cc66a616" xlink:to="loc_us-gaap_StockholdersEquity_9b8eaaaf-fd0e-4242-a640-9f8ff6cc6ac5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_ba1337f0-f69e-4321-ae35-2aee9117b83d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_79007049-8f43-466e-a27d-ac46cc66a616" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_ba1337f0-f69e-4321-ae35-2aee9117b83d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ba13299c-4cca-47b3-9502-d16e3a893aff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_76f2e4d8-a2a7-4398-88b8-c46701d8788c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ba13299c-4cca-47b3-9502-d16e3a893aff" xlink:to="loc_us-gaap_PreferredStockValue_76f2e4d8-a2a7-4398-88b8-c46701d8788c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_53d78a2d-f11f-40ce-bdae-687ec4935c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ba13299c-4cca-47b3-9502-d16e3a893aff" xlink:to="loc_us-gaap_AdditionalPaidInCapital_53d78a2d-f11f-40ce-bdae-687ec4935c9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_50f12415-ae07-4f4e-95ac-2402755d117f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ba13299c-4cca-47b3-9502-d16e3a893aff" xlink:to="loc_us-gaap_CommonStockValue_50f12415-ae07-4f4e-95ac-2402755d117f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b33c744b-1d6f-4842-ba30-e421e010e0b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ba13299c-4cca-47b3-9502-d16e3a893aff" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b33c744b-1d6f-4842-ba30-e421e010e0b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_068f0d4c-34a8-463f-ae5e-4b2ae6a97e93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_FranchiseTaxPayableCurrent_0df352cc-4006-44c4-b5c1-0fac8ee75a56" xlink:href="amci-20230213.xsd#amci_FranchiseTaxPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_068f0d4c-34a8-463f-ae5e-4b2ae6a97e93" xlink:to="loc_amci_FranchiseTaxPayableCurrent_0df352cc-4006-44c4-b5c1-0fac8ee75a56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_b65cbdb8-5912-489d-91e4-526667d2233d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_068f0d4c-34a8-463f-ae5e-4b2ae6a97e93" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrent_b65cbdb8-5912-489d-91e4-526667d2233d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_4f20b25a-b8a3-49a6-97a4-37dda582de4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_068f0d4c-34a8-463f-ae5e-4b2ae6a97e93" xlink:to="loc_us-gaap_AccountsPayableCurrent_4f20b25a-b8a3-49a6-97a4-37dda582de4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent_04fdde04-c67b-4d0e-86fd-cce23eb0e168" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_068f0d4c-34a8-463f-ae5e-4b2ae6a97e93" xlink:to="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent_04fdde04-c67b-4d0e-86fd-cce23eb0e168" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_1e9bbfce-2118-4d86-8fba-892eb73d4071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_068f0d4c-34a8-463f-ae5e-4b2ae6a97e93" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_1e9bbfce-2118-4d86-8fba-892eb73d4071" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_951269b3-bc3f-48b1-baa7-cdf46849fd52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_068f0d4c-34a8-463f-ae5e-4b2ae6a97e93" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_951269b3-bc3f-48b1-baa7-cdf46849fd52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_0822c1bc-da18-47eb-b270-7fd1d16e8912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_a22c500c-1076-4d25-99a2-958bb143b239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0822c1bc-da18-47eb-b270-7fd1d16e8912" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_a22c500c-1076-4d25-99a2-958bb143b239" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_61a9df2c-d46b-452c-9ebb-1d8195eaee0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0822c1bc-da18-47eb-b270-7fd1d16e8912" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_61a9df2c-d46b-452c-9ebb-1d8195eaee0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b704aa68-13ca-4180-8118-69dc1db9e602" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PrepaidExpensesLongTerm_3eeef77c-770b-4b8c-97a8-e2cc3f67c8e6" xlink:href="amci-20230213.xsd#amci_PrepaidExpensesLongTerm"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b704aa68-13ca-4180-8118-69dc1db9e602" xlink:to="loc_amci_PrepaidExpensesLongTerm_3eeef77c-770b-4b8c-97a8-e2cc3f67c8e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrustNoncurrent_7be2801e-322c-4ba4-a89d-9b89ff3ec24f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b704aa68-13ca-4180-8118-69dc1db9e602" xlink:to="loc_us-gaap_AssetsHeldInTrustNoncurrent_7be2801e-322c-4ba4-a89d-9b89ff3ec24f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3e32702b-c233-4de5-ad8a-e1cfa4f18088" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b704aa68-13ca-4180-8118-69dc1db9e602" xlink:to="loc_us-gaap_AssetsCurrent_3e32702b-c233-4de5-ad8a-e1cfa4f18088" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="amci-20230213.xsd#UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8860456c-44ac-4681-9c43-4fe22ccd6d43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f02af8fd-eaea-48ca-8464-3d11a74b291f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_8860456c-44ac-4681-9c43-4fe22ccd6d43" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f02af8fd-eaea-48ca-8464-3d11a74b291f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a19f4643-2a03-4b5f-b718-ea02ddb3cb3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_8860456c-44ac-4681-9c43-4fe22ccd6d43" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a19f4643-2a03-4b5f-b718-ea02ddb3cb3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a0739bfd-bd14-4615-971c-bc302352006e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_edb013a4-0842-4248-b864-f266f714f6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a0739bfd-bd14-4615-971c-bc302352006e" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_edb013a4-0842-4248-b864-f266f714f6d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants_ae713daa-0b1a-497b-abe5-ec484f0a804c" xlink:href="amci-20230213.xsd#amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a0739bfd-bd14-4615-971c-bc302352006e" xlink:to="loc_amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants_ae713daa-0b1a-497b-abe5-ec484f0a804c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities_3523b23a-c2e3-42cd-afe2-c7f436c51ae1" xlink:href="amci-20230213.xsd#amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a0739bfd-bd14-4615-971c-bc302352006e" xlink:to="loc_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities_3523b23a-c2e3-42cd-afe2-c7f436c51ae1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeFromInvestmentsHeldInTrustAccount_0245e1ca-8da4-40d9-95b0-ea897d8630f8" xlink:href="amci-20230213.xsd#amci_IncomeFromInvestmentsHeldInTrustAccount"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a0739bfd-bd14-4615-971c-bc302352006e" xlink:to="loc_amci_IncomeFromInvestmentsHeldInTrustAccount_0245e1ca-8da4-40d9-95b0-ea897d8630f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_51c300ed-9c79-40f0-b89f-c169c25d8c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a0739bfd-bd14-4615-971c-bc302352006e" xlink:to="loc_us-gaap_OperatingIncomeLoss_51c300ed-9c79-40f0-b89f-c169c25d8c5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_269ef67c-2a24-47b8-9712-5e6da07d4a75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductionTaxExpense_e18c4797-446d-4bbb-b7ac-513a34c8dba4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductionTaxExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_269ef67c-2a24-47b8-9712-5e6da07d4a75" xlink:to="loc_us-gaap_ProductionTaxExpense_e18c4797-446d-4bbb-b7ac-513a34c8dba4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_db0788b6-d298-4c24-8c2e-91c6db69ebca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_269ef67c-2a24-47b8-9712-5e6da07d4a75" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_db0788b6-d298-4c24-8c2e-91c6db69ebca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_87bcffc0-fc7d-46a5-9e43-4b5adfccdf55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_269ef67c-2a24-47b8-9712-5e6da07d4a75" xlink:to="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_87bcffc0-fc7d-46a5-9e43-4b5adfccdf55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CapitalBaseTaxExpense_30e8beaf-3dc1-4be8-8ce2-c2cd85150c42" xlink:href="amci-20230213.xsd#amci_CapitalBaseTaxExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_269ef67c-2a24-47b8-9712-5e6da07d4a75" xlink:to="loc_amci_CapitalBaseTaxExpense_30e8beaf-3dc1-4be8-8ce2-c2cd85150c42" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="amci-20230213.xsd#UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ddde9e1b-9d0a-41d7-8a6c-d1f04d78b8a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireTrustPreferredInvestments_89f40e8a-edc5-4c27-8da8-73df40cf4e40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireTrustPreferredInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ddde9e1b-9d0a-41d7-8a6c-d1f04d78b8a1" xlink:to="loc_us-gaap_PaymentsToAcquireTrustPreferredInvestments_89f40e8a-edc5-4c27-8da8-73df40cf4e40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PaymentsForInvestmentOfCashInTrustAccount_c9270ada-3796-414e-adf3-aa99073734f8" xlink:href="amci-20230213.xsd#amci_PaymentsForInvestmentOfCashInTrustAccount"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ddde9e1b-9d0a-41d7-8a6c-d1f04d78b8a1" xlink:to="loc_amci_PaymentsForInvestmentOfCashInTrustAccount_c9270ada-3796-414e-adf3-aa99073734f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2e58bdda-6998-40aa-9602-6cd3ea9c869d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_fbdc20e3-f107-419f-8a52-b9cbf991344d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2e58bdda-6998-40aa-9602-6cd3ea9c869d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_fbdc20e3-f107-419f-8a52-b9cbf991344d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_e9be4647-ef68-433d-92e8-b975fcb40f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2e58bdda-6998-40aa-9602-6cd3ea9c869d" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_e9be4647-ef68-433d-92e8-b975fcb40f2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt_80b50ad1-6336-4931-bd39-dcc7e2fde45d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2e58bdda-6998-40aa-9602-6cd3ea9c869d" xlink:to="loc_us-gaap_ProceedsFromRelatedPartyDebt_80b50ad1-6336-4931-bd39-dcc7e2fde45d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b89abf14-dac5-4352-8f7f-858f7a0bb44c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d52c684a-971c-4277-8eb0-09c074b8585c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b89abf14-dac5-4352-8f7f-858f7a0bb44c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d52c684a-971c-4277-8eb0-09c074b8585c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3491bf6c-fdc2-4b38-be11-aecd235100dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b89abf14-dac5-4352-8f7f-858f7a0bb44c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3491bf6c-fdc2-4b38-be11-aecd235100dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_52f9e4e8-a72c-411c-8861-27d7781e27fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b89abf14-dac5-4352-8f7f-858f7a0bb44c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_52f9e4e8-a72c-411c-8861-27d7781e27fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9f687f3b-79fa-48a0-ad39-ad170a6dfcc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_5afe59ce-a4ce-451c-ad58-5a724ac1ce6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9f687f3b-79fa-48a0-ad39-ad170a6dfcc5" xlink:to="loc_us-gaap_ProfitLoss_5afe59ce-a4ce-451c-ad58-5a724ac1ce6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares_86f90dcf-4c0d-4b55-8e90-32f459ddd545" xlink:href="amci-20230213.xsd#amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9f687f3b-79fa-48a0-ad39-ad170a6dfcc5" xlink:to="loc_amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares_86f90dcf-4c0d-4b55-8e90-32f459ddd545" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_b2c61e00-1880-45ac-a476-ada5e99eb57c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9f687f3b-79fa-48a0-ad39-ad170a6dfcc5" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_b2c61e00-1880-45ac-a476-ada5e99eb57c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants_1a98abf7-f098-4a4c-acde-705b77da75db" xlink:href="amci-20230213.xsd#amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9f687f3b-79fa-48a0-ad39-ad170a6dfcc5" xlink:to="loc_amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants_1a98abf7-f098-4a4c-acde-705b77da75db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities_4a54f2fd-9c77-4433-b140-f53f15c79814" xlink:href="amci-20230213.xsd#amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9f687f3b-79fa-48a0-ad39-ad170a6dfcc5" xlink:to="loc_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities_4a54f2fd-9c77-4433-b140-f53f15c79814" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeFromInvestmentsHeldInTrustAccount_f756d084-a2c0-4f99-b7ca-5cb6b49cf3f1" xlink:href="amci-20230213.xsd#amci_IncomeFromInvestmentsHeldInTrustAccount"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9f687f3b-79fa-48a0-ad39-ad170a6dfcc5" xlink:to="loc_amci_IncomeFromInvestmentsHeldInTrustAccount_f756d084-a2c0-4f99-b7ca-5cb6b49cf3f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_d069a183-56d8-429b-a20e-51ae9bf4e0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9f687f3b-79fa-48a0-ad39-ad170a6dfcc5" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_d069a183-56d8-429b-a20e-51ae9bf4e0e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_21e3ccb2-5a51-4c56-8e4b-f08255a46008" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9f687f3b-79fa-48a0-ad39-ad170a6dfcc5" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_21e3ccb2-5a51-4c56-8e4b-f08255a46008" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncreaseDecreaseInDueToRelatedParties._bfb2000a-05b6-435f-a17b-77144e151ea2" xlink:href="amci-20230213.xsd#amci_IncreaseDecreaseInDueToRelatedParties."/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9f687f3b-79fa-48a0-ad39-ad170a6dfcc5" xlink:to="loc_amci_IncreaseDecreaseInDueToRelatedParties._bfb2000a-05b6-435f-a17b-77144e151ea2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_9f52b8e1-7b2e-4226-abbd-29da1e47a814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9f687f3b-79fa-48a0-ad39-ad170a6dfcc5" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_9f52b8e1-7b2e-4226-abbd-29da1e47a814" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncreaseDecreaseInCapitalBaseTaxPayable_8a3a16a2-21d1-4dc1-bc80-78ed75c1c017" xlink:href="amci-20230213.xsd#amci_IncreaseDecreaseInCapitalBaseTaxPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9f687f3b-79fa-48a0-ad39-ad170a6dfcc5" xlink:to="loc_amci_IncreaseDecreaseInCapitalBaseTaxPayable_8a3a16a2-21d1-4dc1-bc80-78ed75c1c017" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncreaseDecreaseFranchiseTaxPayable_f9375a74-d1b0-44d4-8066-08e86eb413fe" xlink:href="amci-20230213.xsd#amci_IncreaseDecreaseFranchiseTaxPayable"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9f687f3b-79fa-48a0-ad39-ad170a6dfcc5" xlink:to="loc_amci_IncreaseDecreaseFranchiseTaxPayable_f9375a74-d1b0-44d4-8066-08e86eb413fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_ff1fd5ce-f97d-4949-9369-37b0582eb9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9f687f3b-79fa-48a0-ad39-ad170a6dfcc5" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_ff1fd5ce-f97d-4949-9369-37b0582eb9ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DueToRelatedParty_5ab0acf0-8143-4644-ac36-c2d829373113" xlink:href="amci-20230213.xsd#amci_DueToRelatedParty"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9f687f3b-79fa-48a0-ad39-ad170a6dfcc5" xlink:to="loc_amci_DueToRelatedParty_5ab0acf0-8143-4644-ac36-c2d829373113" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS" xlink:type="simple" xlink:href="amci-20230213.xsd#STATEMENTOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_656eaf6b-31ec-4200-89e8-6f50ffc90137" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_3ed1fbd0-dd9f-4c30-a1cb-3f8f1444f421" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_656eaf6b-31ec-4200-89e8-6f50ffc90137" xlink:to="loc_us-gaap_OperatingIncomeLoss_3ed1fbd0-dd9f-4c30-a1cb-3f8f1444f421" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_66e59060-a603-40e1-a7dd-c54aed93772e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_656eaf6b-31ec-4200-89e8-6f50ffc90137" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_66e59060-a603-40e1-a7dd-c54aed93772e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeFromInvestmentsHeldInTrustAccount_6c877ea1-5a42-412d-a4b4-21b44bf43c13" xlink:href="amci-20230213.xsd#amci_IncomeFromInvestmentsHeldInTrustAccount"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_656eaf6b-31ec-4200-89e8-6f50ffc90137" xlink:to="loc_amci_IncomeFromInvestmentsHeldInTrustAccount_6c877ea1-5a42-412d-a4b4-21b44bf43c13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities_8a1854c4-642d-4c17-80dc-58d970d146a6" xlink:href="amci-20230213.xsd#amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_656eaf6b-31ec-4200-89e8-6f50ffc90137" xlink:to="loc_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities_8a1854c4-642d-4c17-80dc-58d970d146a6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="simple" xlink:href="amci-20230213.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"/>
  <link:calculationLink xlink:role="http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_2dc93489-1d59-4fd1-a39e-f16f276afacf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_8ac533f9-844d-4e2b-b965-d7f3b94fd5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2dc93489-1d59-4fd1-a39e-f16f276afacf" xlink:to="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_8ac533f9-844d-4e2b-b965-d7f3b94fd5f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_c843543f-43a1-4220-a3ad-fdba4c3ce0db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2dc93489-1d59-4fd1-a39e-f16f276afacf" xlink:to="loc_us-gaap_OtherAssetsCurrent_c843543f-43a1-4220-a3ad-fdba4c3ce0db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1bcfb3ba-9457-45fb-b36b-a85d9ddb164f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2dc93489-1d59-4fd1-a39e-f16f276afacf" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1bcfb3ba-9457-45fb-b36b-a85d9ddb164f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_d3f32d4a-3d34-4052-a5dd-6a04a4ceebaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2dc93489-1d59-4fd1-a39e-f16f276afacf" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_d3f32d4a-3d34-4052-a5dd-6a04a4ceebaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2563d5b5-cef4-40cb-a614-a35c847a8fab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_0c8bf824-fccb-4ab2-86fc-1d506cc6ab9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2563d5b5-cef4-40cb-a614-a35c847a8fab" xlink:to="loc_us-gaap_AdditionalPaidInCapital_0c8bf824-fccb-4ab2-86fc-1d506cc6ab9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_6a4225ac-1527-4dad-a2c6-6b1c91d2a487" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2563d5b5-cef4-40cb-a614-a35c847a8fab" xlink:to="loc_us-gaap_CommonStockValue_6a4225ac-1527-4dad-a2c6-6b1c91d2a487" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4fd3ee47-6af1-474e-9af3-8dd2c68cfac1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2563d5b5-cef4-40cb-a614-a35c847a8fab" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4fd3ee47-6af1-474e-9af3-8dd2c68cfac1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e5252e04-1013-4e6f-8575-9ab3638d9d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2563d5b5-cef4-40cb-a614-a35c847a8fab" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e5252e04-1013-4e6f-8575-9ab3638d9d0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_609ab397-62cb-4ae4-a1e2-ef8005decfcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_3649ea1c-2693-4b83-b284-287708282b67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_609ab397-62cb-4ae4-a1e2-ef8005decfcf" xlink:to="loc_us-gaap_AccountsPayableCurrent_3649ea1c-2693-4b83-b284-287708282b67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_b9e2df8c-827c-44c3-ba66-00888d566d88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_609ab397-62cb-4ae4-a1e2-ef8005decfcf" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_b9e2df8c-827c-44c3-ba66-00888d566d88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_49a40faf-3e80-4256-bd81-3fc5963371ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_609ab397-62cb-4ae4-a1e2-ef8005decfcf" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_49a40faf-3e80-4256-bd81-3fc5963371ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SimpleAgreementForFutureEquityLiability_713859e8-5a5e-410d-86c0-4147e6f826e5" xlink:href="amci-20230213.xsd#amci_SimpleAgreementForFutureEquityLiability"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_609ab397-62cb-4ae4-a1e2-ef8005decfcf" xlink:to="loc_amci_SimpleAgreementForFutureEquityLiability_713859e8-5a5e-410d-86c0-4147e6f826e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_cf54d768-4cf1-40fd-9253-d53564071902" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_609ab397-62cb-4ae4-a1e2-ef8005decfcf" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_cf54d768-4cf1-40fd-9253-d53564071902" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_de171219-dfd7-4c11-8f27-29672fd74cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_609ab397-62cb-4ae4-a1e2-ef8005decfcf" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_de171219-dfd7-4c11-8f27-29672fd74cc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_4484257f-64a0-43bf-a3c2-2069efecdcc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_609ab397-62cb-4ae4-a1e2-ef8005decfcf" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_4484257f-64a0-43bf-a3c2-2069efecdcc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_6806c44c-4793-48dd-a719-f64f34d963bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_609ab397-62cb-4ae4-a1e2-ef8005decfcf" xlink:to="loc_us-gaap_LongTermDebtCurrent_6806c44c-4793-48dd-a719-f64f34d963bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_29ae55d5-2a9d-49a7-8825-cb05307721c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_9527a1a0-9f35-4484-a72b-ab6253d852c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_29ae55d5-2a9d-49a7-8825-cb05307721c2" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_9527a1a0-9f35-4484-a72b-ab6253d852c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f6243c42-a17f-4f85-9b70-e887a987be0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_29ae55d5-2a9d-49a7-8825-cb05307721c2" xlink:to="loc_us-gaap_AssetsCurrent_f6243c42-a17f-4f85-9b70-e887a987be0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_32eefa9b-e71f-4bdd-ab63-5399b6daf575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_29ae55d5-2a9d-49a7-8825-cb05307721c2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_32eefa9b-e71f-4bdd-ab63-5399b6daf575" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_24543bfb-9982-4811-8f27-ceed3a8d2402" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_29ae55d5-2a9d-49a7-8825-cb05307721c2" xlink:to="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_24543bfb-9982-4811-8f27-ceed3a8d2402" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e700eaf5-3961-4199-9d00-36f3c50f5831" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_29ae55d5-2a9d-49a7-8825-cb05307721c2" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e700eaf5-3961-4199-9d00-36f3c50f5831" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_2f4e03be-c354-4c67-9288-9a529a2a6491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_29ae55d5-2a9d-49a7-8825-cb05307721c2" xlink:to="loc_us-gaap_EquityMethodInvestments_2f4e03be-c354-4c67-9288-9a529a2a6491" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_4a6a5864-9a0c-42ce-8497-49ac7a59af39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_ebeaacb0-e8ff-4637-a134-b14d23e75397" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4a6a5864-9a0c-42ce-8497-49ac7a59af39" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_ebeaacb0-e8ff-4637-a134-b14d23e75397" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_7fa14ff6-2bdd-4b6d-87c2-5f0678a73636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4a6a5864-9a0c-42ce-8497-49ac7a59af39" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_7fa14ff6-2bdd-4b6d-87c2-5f0678a73636" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_dbd482d6-c3f2-496d-b242-91b2c8d68a74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4a6a5864-9a0c-42ce-8497-49ac7a59af39" xlink:to="loc_us-gaap_LiabilitiesCurrent_dbd482d6-c3f2-496d-b242-91b2c8d68a74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_168fa2dc-71d1-4f91-b8ee-40f4b76d277d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4a6a5864-9a0c-42ce-8497-49ac7a59af39" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_168fa2dc-71d1-4f91-b8ee-40f4b76d277d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_f5c70d28-18b6-4fa1-b417-f16d82c32bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4a6a5864-9a0c-42ce-8497-49ac7a59af39" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_f5c70d28-18b6-4fa1-b417-f16d82c32bb5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED" xlink:type="simple" xlink:href="amci-20230213.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED"/>
  <link:calculationLink xlink:role="http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_2449b758-2eeb-42dc-ad04-c818313006cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_a580ff7c-a58b-45ca-a618-fa409350cb2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_2449b758-2eeb-42dc-ad04-c818313006cd" xlink:to="loc_us-gaap_CostsAndExpenses_a580ff7c-a58b-45ca-a618-fa409350cb2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_85c7f227-f437-4069-b068-adcbc31f4283" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_2449b758-2eeb-42dc-ad04-c818313006cd" xlink:to="loc_us-gaap_Revenues_85c7f227-f437-4069-b068-adcbc31f4283" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_42ea6fa2-a1e3-4bda-83ed-7fee62b89a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_ce574849-11cd-4360-9ec1-57576c7fb0dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_42ea6fa2-a1e3-4bda-83ed-7fee62b89a2b" xlink:to="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_ce574849-11cd-4360-9ec1-57576c7fb0dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_cb5a6825-90b0-4e89-b37f-ad12c7d03703" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_42ea6fa2-a1e3-4bda-83ed-7fee62b89a2b" xlink:to="loc_us-gaap_RevenueFromRelatedParties_cb5a6825-90b0-4e89-b37f-ad12c7d03703" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_86cff3a3-31b2-4185-8fd8-53a5405d0255" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_42ea6fa2-a1e3-4bda-83ed-7fee62b89a2b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_86cff3a3-31b2-4185-8fd8-53a5405d0255" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_cac3bc52-7a45-42dd-b548-25c3493198f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_50740574-5d3e-4346-a28e-d83f71b3f077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_cac3bc52-7a45-42dd-b548-25c3493198f6" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_50740574-5d3e-4346-a28e-d83f71b3f077" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_226ccbe6-a4a1-4e17-9392-22d7cf7fa227" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_cac3bc52-7a45-42dd-b548-25c3493198f6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_226ccbe6-a4a1-4e17-9392-22d7cf7fa227" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_3de26a2f-4fb8-427a-ae9d-58ab6f413758" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_0a74d1f1-6ca5-453d-9cf7-5b0d216e4ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_3de26a2f-4fb8-427a-ae9d-58ab6f413758" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_0a74d1f1-6ca5-453d-9cf7-5b0d216e4ea1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_39e12ea1-1169-4da0-bd61-c6f3018cc1ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_3de26a2f-4fb8-427a-ae9d-58ab6f413758" xlink:to="loc_us-gaap_Depreciation_39e12ea1-1169-4da0-bd61-c6f3018cc1ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_3c0c69c3-685c-4554-8e53-bb5cad746cb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_3de26a2f-4fb8-427a-ae9d-58ab6f413758" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_3c0c69c3-685c-4554-8e53-bb5cad746cb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_7987231d-2217-46d7-af59-2bea5eed52d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_3de26a2f-4fb8-427a-ae9d-58ab6f413758" xlink:to="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_7987231d-2217-46d7-af59-2bea5eed52d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_93f23211-58f4-4b04-9250-736269cc8d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_48d6a0a2-bc72-442f-bc83-0827742beab9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_93f23211-58f4-4b04-9250-736269cc8d7c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_48d6a0a2-bc72-442f-bc83-0827742beab9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0ad35c58-e7aa-4c1c-bbd8-e9c7435eaf88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_93f23211-58f4-4b04-9250-736269cc8d7c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0ad35c58-e7aa-4c1c-bbd8-e9c7435eaf88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment_7e11d0ef-e806-4b14-b717-4b37e6fc10d4" xlink:href="amci-20230213.xsd#amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_93f23211-58f4-4b04-9250-736269cc8d7c" xlink:to="loc_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment_7e11d0ef-e806-4b14-b717-4b37e6fc10d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_f0b5ce01-6e8a-4457-ac0b-2c8bf24d4c48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_c66c6ad0-2a51-4e5c-9437-33251e4ad889" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_f0b5ce01-6e8a-4457-ac0b-2c8bf24d4c48" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_c66c6ad0-2a51-4e5c-9437-33251e4ad889" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f2789dc5-2da4-45b9-98bb-2a9b25b6bd3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_f0b5ce01-6e8a-4457-ac0b-2c8bf24d4c48" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f2789dc5-2da4-45b9-98bb-2a9b25b6bd3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_0da3ac7d-0e11-40f7-ac50-2a20162269b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_f0b5ce01-6e8a-4457-ac0b-2c8bf24d4c48" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_0da3ac7d-0e11-40f7-ac50-2a20162269b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b312b150-34ad-4f4a-97c5-d289ee093813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_08c0fd78-a6bd-4424-9f83-966cc7e078c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b312b150-34ad-4f4a-97c5-d289ee093813" xlink:to="loc_us-gaap_OperatingIncomeLoss_08c0fd78-a6bd-4424-9f83-966cc7e078c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_7801ff4f-4f8f-40e2-9414-e3af4de2b661" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b312b150-34ad-4f4a-97c5-d289ee093813" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_7801ff4f-4f8f-40e2-9414-e3af4de2b661" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_91265ea8-00d7-49ff-afb6-fbeeaefc4a17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d56e9a9e-1a60-4f97-92af-042d71cf1a09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_91265ea8-00d7-49ff-afb6-fbeeaefc4a17" xlink:to="loc_us-gaap_NetIncomeLoss_d56e9a9e-1a60-4f97-92af-042d71cf1a09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact_0afc2d00-fd2a-43b7-a000-ebe344fa2d54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_91265ea8-00d7-49ff-afb6-fbeeaefc4a17" xlink:to="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact_0afc2d00-fd2a-43b7-a000-ebe344fa2d54" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="simple" xlink:href="amci-20230213.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"/>
  <link:calculationLink xlink:role="http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_67257109-a55c-4f6f-b0a7-51fd849ccfe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_416fe684-d2b8-4715-9673-e37404f7cfc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_67257109-a55c-4f6f-b0a7-51fd849ccfe8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_416fe684-d2b8-4715-9673-e37404f7cfc6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6c686359-dd69-4087-a424-0084430124f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_67257109-a55c-4f6f-b0a7-51fd849ccfe8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6c686359-dd69-4087-a424-0084430124f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_338ca228-00bc-46f6-b115-5134c8fad6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_67257109-a55c-4f6f-b0a7-51fd849ccfe8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_338ca228-00bc-46f6-b115-5134c8fad6bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4c6a175e-a6fc-4022-876d-ecf357834241" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_e79a3265-7ec4-430a-95d2-9b0b8ab8ce20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4c6a175e-a6fc-4022-876d-ecf357834241" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_e79a3265-7ec4-430a-95d2-9b0b8ab8ce20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfEquity_dfc1b383-b0bf-46ca-bb21-508ffb5e0470" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfEquity"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4c6a175e-a6fc-4022-876d-ecf357834241" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfEquity_dfc1b383-b0bf-46ca-bb21-508ffb5e0470" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_452abe3f-f3c4-47f5-aace-f9b10ba0f766" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4c6a175e-a6fc-4022-876d-ecf357834241" xlink:to="loc_us-gaap_RepaymentsOfDebt_452abe3f-f3c4-47f5-aace-f9b10ba0f766" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises_a092638a-556f-42d4-add5-f5c77f312228" xlink:href="amci-20230213.xsd#amci_ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4c6a175e-a6fc-4022-876d-ecf357834241" xlink:to="loc_amci_ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises_a092638a-556f-42d4-add5-f5c77f312228" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_8f36c607-c614-4957-bb0e-ec09b376cc43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4c6a175e-a6fc-4022-876d-ecf357834241" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_8f36c607-c614-4957-bb0e-ec09b376cc43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_2d9c756b-a76f-4ba3-87ba-1483cc6ff670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4c6a175e-a6fc-4022-876d-ecf357834241" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_2d9c756b-a76f-4ba3-87ba-1483cc6ff670" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_18f9079c-4352-4454-8764-3f643d7e8117" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4c6a175e-a6fc-4022-876d-ecf357834241" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_18f9079c-4352-4454-8764-3f643d7e8117" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_07479a38-c804-4ed0-ae94-54f6fc0926b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_08a62ff7-5443-47af-94ff-881c75762424" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_07479a38-c804-4ed0-ae94-54f6fc0926b7" xlink:to="loc_us-gaap_ShareBasedCompensation_08a62ff7-5443-47af-94ff-881c75762424" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_b07779cf-0baa-468e-a16c-c31769178d32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_07479a38-c804-4ed0-ae94-54f6fc0926b7" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_b07779cf-0baa-468e-a16c-c31769178d32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_63282be1-8d27-4711-8f8a-1329e1087caa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_07479a38-c804-4ed0-ae94-54f6fc0926b7" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_63282be1-8d27-4711-8f8a-1329e1087caa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_aeb476f6-f523-4d23-ac39-247137e6ab59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_07479a38-c804-4ed0-ae94-54f6fc0926b7" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_aeb476f6-f523-4d23-ac39-247137e6ab59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_508a56fb-d47a-4b5c-95fe-43a48a43c3b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_07479a38-c804-4ed0-ae94-54f6fc0926b7" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_508a56fb-d47a-4b5c-95fe-43a48a43c3b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_FairValueAdjustmentOfWarrantsAndUnrealizedGainLossOnDerivatives_dddcfafc-f367-47c5-894f-94c360548d5d" xlink:href="amci-20230213.xsd#amci_FairValueAdjustmentOfWarrantsAndUnrealizedGainLossOnDerivatives"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_07479a38-c804-4ed0-ae94-54f6fc0926b7" xlink:to="loc_amci_FairValueAdjustmentOfWarrantsAndUnrealizedGainLossOnDerivatives_dddcfafc-f367-47c5-894f-94c360548d5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_d3494047-0b7b-4d96-b272-834272f2d789" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_07479a38-c804-4ed0-ae94-54f6fc0926b7" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_d3494047-0b7b-4d96-b272-834272f2d789" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_9aad22c3-58e2-4d3b-b6b3-b08b24ccff4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_07479a38-c804-4ed0-ae94-54f6fc0926b7" xlink:to="loc_us-gaap_Depreciation_9aad22c3-58e2-4d3b-b6b3-b08b24ccff4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NoncashRecognitionOfLicensingRevenue_4da85510-3141-4d9b-8b8b-8c4964c072e3" xlink:href="amci-20230213.xsd#amci_NoncashRecognitionOfLicensingRevenue"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_07479a38-c804-4ed0-ae94-54f6fc0926b7" xlink:to="loc_amci_NoncashRecognitionOfLicensingRevenue_4da85510-3141-4d9b-8b8b-8c4964c072e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_ab82200e-60f4-4456-ab20-69121913ba5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_07479a38-c804-4ed0-ae94-54f6fc0926b7" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_ab82200e-60f4-4456-ab20-69121913ba5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a994a68c-271d-4588-90cb-deaa9e865369" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_07479a38-c804-4ed0-ae94-54f6fc0926b7" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a994a68c-271d-4588-90cb-deaa9e865369" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_8824daf2-0ae5-4425-b866-13141db48998" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_07479a38-c804-4ed0-ae94-54f6fc0926b7" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_8824daf2-0ae5-4425-b866-13141db48998" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_6012fe02-1496-4de4-806f-91bd4902020b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_07479a38-c804-4ed0-ae94-54f6fc0926b7" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_6012fe02-1496-4de4-806f-91bd4902020b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_64114dbb-7ca2-4cdc-8619-7d3a5cfc0567" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_07479a38-c804-4ed0-ae94-54f6fc0926b7" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_64114dbb-7ca2-4cdc-8619-7d3a5cfc0567" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_85e70401-1bab-47c0-b117-814c7e1de79a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_07479a38-c804-4ed0-ae94-54f6fc0926b7" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_85e70401-1bab-47c0-b117-814c7e1de79a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3d53df02-7ec0-4730-b4f2-66e83fdf3158" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_07479a38-c804-4ed0-ae94-54f6fc0926b7" xlink:to="loc_us-gaap_NetIncomeLoss_3d53df02-7ec0-4730-b4f2-66e83fdf3158" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_3bca924b-61c7-4eff-8e2f-25868a2e87a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_07479a38-c804-4ed0-ae94-54f6fc0926b7" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_3bca924b-61c7-4eff-8e2f-25868a2e87a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_2999dcdf-d4bc-4b3f-93e5-ab2caaec6b02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_07479a38-c804-4ed0-ae94-54f6fc0926b7" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_2999dcdf-d4bc-4b3f-93e5-ab2caaec6b02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment_d97f7522-0aaa-4de3-8d78-d90210161469" xlink:href="amci-20230213.xsd#amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment"/>
    <link:calculationArc order="19" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_07479a38-c804-4ed0-ae94-54f6fc0926b7" xlink:to="loc_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment_d97f7522-0aaa-4de3-8d78-d90210161469" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_81bb3f35-23bb-4357-92d2-a57a506071bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_2240199d-0e4b-44fd-b75f-c972f18fad48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_81bb3f35-23bb-4357-92d2-a57a506071bd" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_2240199d-0e4b-44fd-b75f-c972f18fad48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7d7c9da8-e269-4860-845b-a6304caf67f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_81bb3f35-23bb-4357-92d2-a57a506071bd" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7d7c9da8-e269-4860-845b-a6304caf67f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfOtherRealEstate_02afd317-2259-4455-ae79-968b014a3e11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfOtherRealEstate"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_81bb3f35-23bb-4357-92d2-a57a506071bd" xlink:to="loc_us-gaap_ProceedsFromSaleOfOtherRealEstate_02afd317-2259-4455-ae79-968b014a3e11" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/IncomeTaxesDeferredtaxassetsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#IncomeTaxesDeferredtaxassetsDetails"/>
  <link:calculationLink xlink:role="http://amciacquisitioncorp/role/IncomeTaxesDeferredtaxassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1c3bacfa-2a63-4261-8d69-e8112da069ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_59cfb1c1-79bc-42d5-9ac3-a1a28a468750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1c3bacfa-2a63-4261-8d69-e8112da069ad" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_59cfb1c1-79bc-42d5-9ac3-a1a28a468750" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_32aa724c-9e6f-42a4-afbc-8466f93ebea8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1c3bacfa-2a63-4261-8d69-e8112da069ad" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_32aa724c-9e6f-42a4-afbc-8466f93ebea8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_8502eb3c-5290-4878-8032-a3353df6743f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1c3bacfa-2a63-4261-8d69-e8112da069ad" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_8502eb3c-5290-4878-8032-a3353df6743f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2a1b3907-c142-476a-8511-431fa57924e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1c3bacfa-2a63-4261-8d69-e8112da069ad" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2a1b3907-c142-476a-8511-431fa57924e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_e4e9559c-62e6-4155-b670-22d6923e6a51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1c3bacfa-2a63-4261-8d69-e8112da069ad" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_e4e9559c-62e6-4155-b670-22d6923e6a51" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashReconciliationDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashReconciliationDetails"/>
  <link:calculationLink xlink:role="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1cb6be36-c404-4856-ac55-285cc9da5417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_74307650-aa5a-4539-a47e-0d1c1e3af0ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1cb6be36-c404-4856-ac55-285cc9da5417" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_74307650-aa5a-4539-a47e-0d1c1e3af0ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_f51ce133-5a31-45ef-9aac-3747b32e9b40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1cb6be36-c404-4856-ac55-285cc9da5417" xlink:to="loc_us-gaap_RestrictedCash_f51ce133-5a31-45ef-9aac-3747b32e9b40" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RevenuesRemainingPerformanceObligationsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#RevenuesRemainingPerformanceObligationsDetails"/>
  <link:calculationLink xlink:role="http://amciacquisitioncorp/role/RevenuesRemainingPerformanceObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_98c59dce-1623-489a-bcf2-90999273797d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RevenueRemainingPerformanceObligationCurrentAmount_78575847-1731-4388-b8e3-b6d5f49e01c1" xlink:href="amci-20230213.xsd#amci_RevenueRemainingPerformanceObligationCurrentAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation_98c59dce-1623-489a-bcf2-90999273797d" xlink:to="loc_amci_RevenueRemainingPerformanceObligationCurrentAmount_78575847-1731-4388-b8e3-b6d5f49e01c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RevenueRemainingPerformanceObligationNoncurrentAmount_8a3c6c5d-72c8-4391-9e5e-e34ac8eeb4e8" xlink:href="amci-20230213.xsd#amci_RevenueRemainingPerformanceObligationNoncurrentAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation_98c59dce-1623-489a-bcf2-90999273797d" xlink:to="loc_amci_RevenueRemainingPerformanceObligationNoncurrentAmount_8a3c6c5d-72c8-4391-9e5e-e34ac8eeb4e8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/InvestmentsScheduleofInvestmentsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#InvestmentsScheduleofInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://amciacquisitioncorp/role/InvestmentsScheduleofInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_6893309b-9fd4-4d54-9572-5cee59c8fded" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_1dec4786-d8c1-4eb1-af72-6ec61facbcbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_6893309b-9fd4-4d54-9572-5cee59c8fded" xlink:to="loc_us-gaap_EquityMethodInvestments_1dec4786-d8c1-4eb1-af72-6ec61facbcbc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_66b4932f-6038-4001-94b4-96224cbd80a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_6893309b-9fd4-4d54-9572-5cee59c8fded" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_66b4932f-6038-4001-94b4-96224cbd80a8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueFinancialAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_8ba6db0f-118b-4e61-8d7c-fbd603ca74c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SimpleAgreementForFutureEquityLiability_3e5338dc-5a7d-49cb-9600-59278511d0c5" xlink:href="amci-20230213.xsd#amci_SimpleAgreementForFutureEquityLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_8ba6db0f-118b-4e61-8d7c-fbd603ca74c7" xlink:to="loc_amci_SimpleAgreementForFutureEquityLiability_3e5338dc-5a7d-49cb-9600-59278511d0c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_2a54f34e-faae-4d1a-8a0b-b70eca975529" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_8ba6db0f-118b-4e61-8d7c-fbd603ca74c7" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_2a54f34e-faae-4d1a-8a0b-b70eca975529" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/OtherCurrentAssetsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#OtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://amciacquisitioncorp/role/OtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_a62f49b5-69a0-413b-b98e-2b79921dffd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_3630b950-3e0a-4777-9ad4-1d36af473834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_a62f49b5-69a0-413b-b98e-2b79921dffd7" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_3630b950-3e0a-4777-9ad4-1d36af473834" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialsSuppliesAndOther_37344c18-9e79-4e31-9701-67132790a85a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialsSuppliesAndOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_a62f49b5-69a0-413b-b98e-2b79921dffd7" xlink:to="loc_us-gaap_MaterialsSuppliesAndOther_37344c18-9e79-4e31-9701-67132790a85a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_811c1745-ae9e-4029-b023-efedb685d060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_a62f49b5-69a0-413b-b98e-2b79921dffd7" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_811c1745-ae9e-4029-b023-efedb685d060" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/PropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#PropertyPlantandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://amciacquisitioncorp/role/PropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_50bc7587-7d44-438d-9284-8c3f368340d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5cfd4fb6-a242-49a6-a135-0192232ed2c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_50bc7587-7d44-438d-9284-8c3f368340d4" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5cfd4fb6-a242-49a6-a135-0192232ed2c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_c3d8e76b-e65f-4d5f-b93b-4a9fb0ba77c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_50bc7587-7d44-438d-9284-8c3f368340d4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_c3d8e76b-e65f-4d5f-b93b-4a9fb0ba77c7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/DebtDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#DebtDetails"/>
  <link:calculationLink xlink:role="http://amciacquisitioncorp/role/DebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_9aa649d3-de01-44d9-9811-8371f01d8040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_6176e622-c1d4-4bfc-a695-30657142cc03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_9aa649d3-de01-44d9-9811-8371f01d8040" xlink:to="loc_us-gaap_LongTermDebtCurrent_6176e622-c1d4-4bfc-a695-30657142cc03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_1c5d21c0-4700-423f-b085-50c9519002d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_9aa649d3-de01-44d9-9811-8371f01d8040" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_1c5d21c0-4700-423f-b085-50c9519002d2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/IncomeTaxesComponentsofLossIncomeDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#IncomeTaxesComponentsofLossIncomeDetails"/>
  <link:calculationLink xlink:role="http://amciacquisitioncorp/role/IncomeTaxesComponentsofLossIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6e58c176-414c-4252-b340-d009e4263273" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_53da9056-14bb-4d49-b392-6d7a88d7c988" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6e58c176-414c-4252-b340-d009e4263273" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_53da9056-14bb-4d49-b392-6d7a88d7c988" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_e8a61e1f-4a15-4ab2-84d6-4e8249272f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6e58c176-414c-4252-b340-d009e4263273" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_e8a61e1f-4a15-4ab2-84d6-4e8249272f9b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/IncomeTaxesIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#IncomeTaxesIncomeTaxProvisionDetails"/>
  <link:calculationLink xlink:role="http://amciacquisitioncorp/role/IncomeTaxesIncomeTaxProvisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c491e817-2539-4c2c-b21f-b754360d7a13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_91ad9d89-61a4-4ebc-b585-a10ded99449b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c491e817-2539-4c2c-b21f-b754360d7a13" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_91ad9d89-61a4-4ebc-b585-a10ded99449b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_b15742c5-454d-468b-ab16-47bd9f93e1e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c491e817-2539-4c2c-b21f-b754360d7a13" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_b15742c5-454d-468b-ab16-47bd9f93e1e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_4184679f-8567-472e-8c4c-ec7083fa7da2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_ab1b46fd-7857-4947-be81-4f160706381f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_4184679f-8567-472e-8c4c-ec7083fa7da2" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_ab1b46fd-7857-4947-be81-4f160706381f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_a5520d03-bfbb-4d6f-8ef7-fd5e590b737c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_4184679f-8567-472e-8c4c-ec7083fa7da2" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_a5520d03-bfbb-4d6f-8ef7-fd5e590b737c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#IncomeTaxesReconciliationDetails"/>
  <link:calculationLink xlink:role="http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ca64ed5d-b1bd-466b-b672-316b5de76403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationInterestIncomePercent_6e060608-b839-4967-a3c5-83b3d0d4266b" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationInterestIncomePercent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ca64ed5d-b1bd-466b-b672-316b5de76403" xlink:to="loc_amci_EffectiveIncomeTaxRateReconciliationInterestIncomePercent_6e060608-b839-4967-a3c5-83b3d0d4266b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_4ec29b27-35a5-41c4-8da4-0797ed586996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ca64ed5d-b1bd-466b-b672-316b5de76403" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_4ec29b27-35a5-41c4-8da4-0797ed586996" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_f66899ce-55b1-4b3c-a2d3-e8d6e269d893" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ca64ed5d-b1bd-466b-b672-316b5de76403" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_f66899ce-55b1-4b3c-a2d3-e8d6e269d893" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_ebc54976-9063-46ec-bb7b-43f3813863de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ca64ed5d-b1bd-466b-b672-316b5de76403" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_ebc54976-9063-46ec-bb7b-43f3813863de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentPercent_115d1554-f665-4044-8e0d-6d7a04e0906d" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentPercent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ca64ed5d-b1bd-466b-b672-316b5de76403" xlink:to="loc_amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentPercent_115d1554-f665-4044-8e0d-6d7a04e0906d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalPercent_f416a9e2-7705-47d5-98b5-e66025d81cb8" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalPercent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ca64ed5d-b1bd-466b-b672-316b5de76403" xlink:to="loc_amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalPercent_f416a9e2-7705-47d5-98b5-e66025d81cb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_c67b9d2b-0c3f-4be4-ac57-f0cb89c15a55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ca64ed5d-b1bd-466b-b672-316b5de76403" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_c67b9d2b-0c3f-4be4-ac57-f0cb89c15a55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesPercent_89f5beba-7f02-4ccc-88e2-30040279d327" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesPercent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ca64ed5d-b1bd-466b-b672-316b5de76403" xlink:to="loc_amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesPercent_89f5beba-7f02-4ccc-88e2-30040279d327" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessPercent_4261ec31-a592-4f88-bbcf-db0f8bdd4121" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessPercent"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ca64ed5d-b1bd-466b-b672-316b5de76403" xlink:to="loc_amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessPercent_4261ec31-a592-4f88-bbcf-db0f8bdd4121" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_acd8c3e8-938c-4088-a2e1-bbe75ff5bbfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ca64ed5d-b1bd-466b-b672-316b5de76403" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_acd8c3e8-938c-4088-a2e1-bbe75ff5bbfb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyPercent_2c16d1e3-2573-4128-a1fb-783abfdbfc65" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyPercent"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ca64ed5d-b1bd-466b-b672-316b5de76403" xlink:to="loc_amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyPercent_2c16d1e3-2573-4128-a1fb-783abfdbfc65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_d658282c-3063-4aa7-87c4-48a72be8cb81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ca64ed5d-b1bd-466b-b672-316b5de76403" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_d658282c-3063-4aa7-87c4-48a72be8cb81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_baef8854-659e-4144-a0fb-ada3ef5f60bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ca64ed5d-b1bd-466b-b672-316b5de76403" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_baef8854-659e-4144-a0fb-ada3ef5f60bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_aa7ef502-2f60-4a42-b2ac-482368f34124" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyAmount_98a3d0d5-8ba2-4b8d-9cd8-e5074c7999b2" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_aa7ef502-2f60-4a42-b2ac-482368f34124" xlink:to="loc_amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyAmount_98a3d0d5-8ba2-4b8d-9cd8-e5074c7999b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesAmount_f5d665c4-4c32-4d8c-83f4-18eb3a33c20f" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_aa7ef502-2f60-4a42-b2ac-482368f34124" xlink:to="loc_amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesAmount_f5d665c4-4c32-4d8c-83f4-18eb3a33c20f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_038fc0db-2b8a-4f20-9d9d-286864e08012" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_aa7ef502-2f60-4a42-b2ac-482368f34124" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_038fc0db-2b8a-4f20-9d9d-286864e08012" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_95391bc8-a16f-4cf4-ae09-915d9cc6405f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_aa7ef502-2f60-4a42-b2ac-482368f34124" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_95391bc8-a16f-4cf4-ae09-915d9cc6405f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationInterestIncomeAmount_18bb7f89-250c-407d-8b48-99e3f2aa766c" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationInterestIncomeAmount"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_aa7ef502-2f60-4a42-b2ac-482368f34124" xlink:to="loc_amci_EffectiveIncomeTaxRateReconciliationInterestIncomeAmount_18bb7f89-250c-407d-8b48-99e3f2aa766c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_6cb6f752-cc5b-4ebb-a66a-81ad5929efe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_aa7ef502-2f60-4a42-b2ac-482368f34124" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_6cb6f752-cc5b-4ebb-a66a-81ad5929efe9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_948b64e9-5f0b-49ac-8bd7-86f192e9ae88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_aa7ef502-2f60-4a42-b2ac-482368f34124" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_948b64e9-5f0b-49ac-8bd7-86f192e9ae88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_2ef62a22-7e4a-40cb-9af8-5d9e244479fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_aa7ef502-2f60-4a42-b2ac-482368f34124" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_2ef62a22-7e4a-40cb-9af8-5d9e244479fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessAmount_4de4a084-a5a9-47f9-8358-bca6af7f8e4d" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessAmount"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_aa7ef502-2f60-4a42-b2ac-482368f34124" xlink:to="loc_amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessAmount_4de4a084-a5a9-47f9-8358-bca6af7f8e4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_3e60736b-6332-49f6-bfef-f7e1a9327a82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_aa7ef502-2f60-4a42-b2ac-482368f34124" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_3e60736b-6332-49f6-bfef-f7e1a9327a82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentAmount_3a17764b-b258-4d83-89c7-010abed97509" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentAmount"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_aa7ef502-2f60-4a42-b2ac-482368f34124" xlink:to="loc_amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentAmount_3a17764b-b258-4d83-89c7-010abed97509" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_297ca6ea-aa32-465b-be33-5bc4a26a387d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_aa7ef502-2f60-4a42-b2ac-482368f34124" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_297ca6ea-aa32-465b-be33-5bc4a26a387d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalAmount_804eaa32-b0ad-464f-ab9d-70adef8b3cb6" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalAmount"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_aa7ef502-2f60-4a42-b2ac-482368f34124" xlink:to="loc_amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalAmount_804eaa32-b0ad-464f-ab9d-70adef8b3cb6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_7c479390-77d6-456f-a44c-7ce8b75810ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_bfdb7367-e409-404e-94bb-42427a21203c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_7c479390-77d6-456f-a44c-7ce8b75810ff" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_bfdb7367-e409-404e-94bb-42427a21203c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_e583400b-4a13-4537-9f61-1c299233fff2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_7c479390-77d6-456f-a44c-7ce8b75810ff" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_e583400b-4a13-4537-9f61-1c299233fff2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses_934369e3-619d-48ad-adab-34dd6aaf55d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_7c479390-77d6-456f-a44c-7ce8b75810ff" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses_934369e3-619d-48ad-adab-34dd6aaf55d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredTaxAssetsLeasingArrangements_d967f70b-1e4d-4672-9213-296826765f85" xlink:href="amci-20230213.xsd#amci_DeferredTaxAssetsLeasingArrangements"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_7c479390-77d6-456f-a44c-7ce8b75810ff" xlink:to="loc_amci_DeferredTaxAssetsLeasingArrangements_d967f70b-1e4d-4672-9213-296826765f85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_901a28fc-0e07-4a69-bd62-5bc1166d6b64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_7c479390-77d6-456f-a44c-7ce8b75810ff" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_901a28fc-0e07-4a69-bd62-5bc1166d6b64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsEquityMethodInvestments_56004534-da6f-440d-a4d0-f72d2882aa9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsEquityMethodInvestments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_7c479390-77d6-456f-a44c-7ce8b75810ff" xlink:to="loc_us-gaap_DeferredTaxAssetsEquityMethodInvestments_56004534-da6f-440d-a4d0-f72d2882aa9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_7cb1b1d8-75e9-447b-adab-850fab3e58ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_7c479390-77d6-456f-a44c-7ce8b75810ff" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_7cb1b1d8-75e9-447b-adab-850fab3e58ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_e142c92c-4ec0-4d44-9d27-a3f89ce1911a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_0652fcc9-4b4e-4b9d-b374-0fd0ddc54ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_e142c92c-4ec0-4d44-9d27-a3f89ce1911a" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_0652fcc9-4b4e-4b9d-b374-0fd0ddc54ea7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_316c94a2-a38d-432e-845e-490f53b6d8e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_e142c92c-4ec0-4d44-9d27-a3f89ce1911a" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_316c94a2-a38d-432e-845e-490f53b6d8e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_c172dd47-390b-40e3-ae48-b8fd9a7fee9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_85359863-c69f-4dc6-b896-18865d0e6623" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_c172dd47-390b-40e3-ae48-b8fd9a7fee9f" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_85359863-c69f-4dc6-b896-18865d0e6623" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_036ce73b-16a0-4398-b322-a197534e731f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_c172dd47-390b-40e3-ae48-b8fd9a7fee9f" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_036ce73b-16a0-4398-b322-a197534e731f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_244f1490-9699-4da6-a076-99a13a8605d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_17a2fc3c-89de-46b8-a7b2-2c3b2e9d3996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_244f1490-9699-4da6-a076-99a13a8605d2" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_17a2fc3c-89de-46b8-a7b2-2c3b2e9d3996" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_8f225df0-f1e1-496b-973f-415d005ce3b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_244f1490-9699-4da6-a076-99a13a8605d2" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_8f225df0-f1e1-496b-973f-415d005ce3b2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/LeasesLeaseMaturitiesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#LeasesLeaseMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://amciacquisitioncorp/role/LeasesLeaseMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_047c14f7-9cab-4e76-8f30-2ff9a71e8dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_ba857c0d-fe5a-4c4f-86be-d07b07a9b9f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_047c14f7-9cab-4e76-8f30-2ff9a71e8dd3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_ba857c0d-fe5a-4c4f-86be-d07b07a9b9f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b4389246-0ed2-486b-a605-0a377a7da3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_047c14f7-9cab-4e76-8f30-2ff9a71e8dd3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b4389246-0ed2-486b-a605-0a377a7da3c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_d0681e22-eec2-4f57-8568-e6860470a4be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_047c14f7-9cab-4e76-8f30-2ff9a71e8dd3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_d0681e22-eec2-4f57-8568-e6860470a4be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_3a51d444-d544-4ddb-a4a6-c90a07b99b1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_047c14f7-9cab-4e76-8f30-2ff9a71e8dd3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_3a51d444-d544-4ddb-a4a6-c90a07b99b1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_64ec82d4-15d0-48a9-9f96-e68e15cf4bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_047c14f7-9cab-4e76-8f30-2ff9a71e8dd3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_64ec82d4-15d0-48a9-9f96-e68e15cf4bf2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_413c6fe0-3f60-4a2c-af59-0a8fb42f85b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_047c14f7-9cab-4e76-8f30-2ff9a71e8dd3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_413c6fe0-3f60-4a2c-af59-0a8fb42f85b5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/LeasesLeaseMaturitiesDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#LeasesLeaseMaturitiesDetails_1"/>
  <link:calculationLink xlink:role="http://amciacquisitioncorp/role/LeasesLeaseMaturitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_cb8fb364-e7d9-4e8e-a8f2-53ee0c737596" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_88083c4e-5389-4d08-9169-22341a29ec22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_cb8fb364-e7d9-4e8e-a8f2-53ee0c737596" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_88083c4e-5389-4d08-9169-22341a29ec22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_970b6c3d-b6c2-4076-9c58-f0f5fb06f78d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_cb8fb364-e7d9-4e8e-a8f2-53ee0c737596" xlink:to="loc_us-gaap_OperatingLeaseLiability_970b6c3d-b6c2-4076-9c58-f0f5fb06f78d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/LeasesLessorOperatingLeasePaymentstobeReceivedDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#LeasesLessorOperatingLeasePaymentstobeReceivedDetails"/>
  <link:calculationLink xlink:role="http://amciacquisitioncorp/role/LeasesLessorOperatingLeasePaymentstobeReceivedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_44307179-76bd-4edc-b8b1-a0272401b6dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter_cdc76870-a94a-441b-bd04-a7ce9401d59b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_44307179-76bd-4edc-b8b1-a0272401b6dd" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter_cdc76870-a94a-441b-bd04-a7ce9401d59b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_be19dd1a-23d0-4596-a814-36f19ba3e3c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_44307179-76bd-4edc-b8b1-a0272401b6dd" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_be19dd1a-23d0-4596-a814-36f19ba3e3c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears_1c1ce70f-6dcb-422a-ad59-cdb790923473" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_44307179-76bd-4edc-b8b1-a0272401b6dd" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears_1c1ce70f-6dcb-422a-ad59-cdb790923473" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_54ba2943-58d8-4fbb-8731-4e1394ecfc49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_44307179-76bd-4edc-b8b1-a0272401b6dd" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_54ba2943-58d8-4fbb-8731-4e1394ecfc49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_45b4bd36-4962-4073-a2b1-ac178796c945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_44307179-76bd-4edc-b8b1-a0272401b6dd" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_45b4bd36-4962-4073-a2b1-ac178796c945" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_73c44c4a-c737-414e-ae38-bc6ae494f2bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_44307179-76bd-4edc-b8b1-a0272401b6dd" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_73c44c4a-c737-414e-ae38-bc6ae494f2bd" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>amci-20230213_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:1f450268-e321-4330-aadf-815e69af2b4b,g:fe19691a-e2ec-4bc1-af0c-c42cfd4d1d7c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS" xlink:type="simple" xlink:href="amci-20230213.xsd#CONDENSEDBALANCESHEETS"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS" xlink:type="extended" id="i8ca44624f64440d1a968c7ab01d875e6_CONDENSEDBALANCESHEETS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e1e84abb-4010-4af1-b38b-66f344b2dcd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_02796abe-e2d5-44c0-8175-3a87a3386c21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e1e84abb-4010-4af1-b38b-66f344b2dcd6" xlink:to="loc_us-gaap_AssetsAbstract_02796abe-e2d5-44c0-8175-3a87a3386c21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_c6d996c9-e161-42fe-b103-8db926422a74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_02796abe-e2d5-44c0-8175-3a87a3386c21" xlink:to="loc_us-gaap_AssetsCurrentAbstract_c6d996c9-e161-42fe-b103-8db926422a74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a9b9052d-7ec6-498c-8d09-687c037ec097" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c6d996c9-e161-42fe-b103-8db926422a74" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a9b9052d-7ec6-498c-8d09-687c037ec097" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_1287821b-cc29-4940-8f30-0ee8914c7086" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c6d996c9-e161-42fe-b103-8db926422a74" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_1287821b-cc29-4940-8f30-0ee8914c7086" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_0c4c6423-4db4-4de5-ba90-7721ca01daac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c6d996c9-e161-42fe-b103-8db926422a74" xlink:to="loc_us-gaap_AssetsCurrent_0c4c6423-4db4-4de5-ba90-7721ca01daac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PrepaidExpensesLongTerm_6921d00b-709d-40ae-ab9c-87c320a43f59" xlink:href="amci-20230213.xsd#amci_PrepaidExpensesLongTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_02796abe-e2d5-44c0-8175-3a87a3386c21" xlink:to="loc_amci_PrepaidExpensesLongTerm_6921d00b-709d-40ae-ab9c-87c320a43f59" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrustNoncurrent_1a082574-3391-415b-b30c-05873a48c502" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_02796abe-e2d5-44c0-8175-3a87a3386c21" xlink:to="loc_us-gaap_AssetsHeldInTrustNoncurrent_1a082574-3391-415b-b30c-05873a48c502" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b7d807d5-3569-4aec-9b82-830dc3192bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_02796abe-e2d5-44c0-8175-3a87a3386c21" xlink:to="loc_us-gaap_Assets_b7d807d5-3569-4aec-9b82-830dc3192bb6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6480f33d-e8d3-4e86-a815-d370788bd2a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e1e84abb-4010-4af1-b38b-66f344b2dcd6" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6480f33d-e8d3-4e86-a815-d370788bd2a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_c84f0667-06b1-467a-8377-26d16a755689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6480f33d-e8d3-4e86-a815-d370788bd2a3" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_c84f0667-06b1-467a-8377-26d16a755689" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_2eecff8f-e2be-4a1b-b22b-c3c7ef35b824" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c84f0667-06b1-467a-8377-26d16a755689" xlink:to="loc_us-gaap_AccountsPayableCurrent_2eecff8f-e2be-4a1b-b22b-c3c7ef35b824" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_02d40a45-785f-45fa-a7f9-b22c0197c773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c84f0667-06b1-467a-8377-26d16a755689" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_02d40a45-785f-45fa-a7f9-b22c0197c773" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_6b47bbf7-9843-41f9-832e-0481254dbb56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c84f0667-06b1-467a-8377-26d16a755689" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrent_6b47bbf7-9843-41f9-832e-0481254dbb56" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent_6cfcb7a2-d59b-475f-8743-da7d51bc804d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c84f0667-06b1-467a-8377-26d16a755689" xlink:to="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent_6cfcb7a2-d59b-475f-8743-da7d51bc804d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_FranchiseTaxPayableCurrent_b39c3c6d-b515-4466-b0e6-06446540e4ae" xlink:href="amci-20230213.xsd#amci_FranchiseTaxPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c84f0667-06b1-467a-8377-26d16a755689" xlink:to="loc_amci_FranchiseTaxPayableCurrent_b39c3c6d-b515-4466-b0e6-06446540e4ae" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_1bdb6d9c-7fa6-44ef-95cd-c759e7d47b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c84f0667-06b1-467a-8377-26d16a755689" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_1bdb6d9c-7fa6-44ef-95cd-c759e7d47b6c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_25d49b26-aaf1-4a80-8595-62ccfbcaf2dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c84f0667-06b1-467a-8377-26d16a755689" xlink:to="loc_us-gaap_LiabilitiesCurrent_25d49b26-aaf1-4a80-8595-62ccfbcaf2dd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingCompensationNoncurrent_cdc5d7ce-490a-4288-9eae-19c9bd9213fc" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingCompensationNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6480f33d-e8d3-4e86-a815-d370788bd2a3" xlink:to="loc_amci_DeferredUnderwritingCompensationNoncurrent_cdc5d7ce-490a-4288-9eae-19c9bd9213fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_44cf6904-3cb0-4ea5-8895-c951d78e00ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6480f33d-e8d3-4e86-a815-d370788bd2a3" xlink:to="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_44cf6904-3cb0-4ea5-8895-c951d78e00ae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_d9a35385-0021-4a4c-84a3-e8489fb3f209" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6480f33d-e8d3-4e86-a815-d370788bd2a3" xlink:to="loc_us-gaap_Liabilities_d9a35385-0021-4a4c-84a3-e8489fb3f209" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_2627aed0-e395-443c-b1dc-e58caac93817" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6480f33d-e8d3-4e86-a815-d370788bd2a3" xlink:to="loc_us-gaap_CommitmentsAndContingencies_2627aed0-e395-443c-b1dc-e58caac93817" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_865e44ee-b107-43f4-aa13-bcb863b6fa2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6480f33d-e8d3-4e86-a815-d370788bd2a3" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_865e44ee-b107-43f4-aa13-bcb863b6fa2f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_8644fc90-8655-40c6-bcbc-2b26027a676b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6480f33d-e8d3-4e86-a815-d370788bd2a3" xlink:to="loc_us-gaap_StockholdersEquityAbstract_8644fc90-8655-40c6-bcbc-2b26027a676b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_91848054-8773-4869-a797-a530934c445a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8644fc90-8655-40c6-bcbc-2b26027a676b" xlink:to="loc_us-gaap_PreferredStockValue_91848054-8773-4869-a797-a530934c445a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_3cfedeb2-0452-43a6-8ea8-605375df6418" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8644fc90-8655-40c6-bcbc-2b26027a676b" xlink:to="loc_us-gaap_CommonStockValue_3cfedeb2-0452-43a6-8ea8-605375df6418" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_bab365f8-9277-4481-bd94-370ea4633642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8644fc90-8655-40c6-bcbc-2b26027a676b" xlink:to="loc_us-gaap_AdditionalPaidInCapital_bab365f8-9277-4481-bd94-370ea4633642" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1e344672-33be-4a6d-9ad8-35d6764bde6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8644fc90-8655-40c6-bcbc-2b26027a676b" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1e344672-33be-4a6d-9ad8-35d6764bde6f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b3a1b5bc-6753-4e42-a853-f3531dd8e76c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8644fc90-8655-40c6-bcbc-2b26027a676b" xlink:to="loc_us-gaap_StockholdersEquity_b3a1b5bc-6753-4e42-a853-f3531dd8e76c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_d105359e-4b48-42de-98be-8624771f8cae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6480f33d-e8d3-4e86-a815-d370788bd2a3" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_d105359e-4b48-42de-98be-8624771f8cae" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_dc9195cc-5545-4f92-a897-2e21ef4ec16e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e1e84abb-4010-4af1-b38b-66f344b2dcd6" xlink:to="loc_us-gaap_StatementTable_dc9195cc-5545-4f92-a897-2e21ef4ec16e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_eb4622c9-cdbd-40c6-8a1c-11b09e5b3e4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_dc9195cc-5545-4f92-a897-2e21ef4ec16e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_eb4622c9-cdbd-40c6-8a1c-11b09e5b3e4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_eb4622c9-cdbd-40c6-8a1c-11b09e5b3e4d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_eb4622c9-cdbd-40c6-8a1c-11b09e5b3e4d" xlink:to="loc_us-gaap_ClassOfStockDomain_eb4622c9-cdbd-40c6-8a1c-11b09e5b3e4d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_378bb9fc-740e-4952-a2b5-047df624764f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_eb4622c9-cdbd-40c6-8a1c-11b09e5b3e4d" xlink:to="loc_us-gaap_ClassOfStockDomain_378bb9fc-740e-4952-a2b5-047df624764f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_532c4f2b-d1e2-44a0-a8a4-0889567ee7b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_378bb9fc-740e-4952-a2b5-047df624764f" xlink:to="loc_us-gaap_CommonClassAMember_532c4f2b-d1e2-44a0-a8a4-0889567ee7b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CommonClassaSubjectToRedemptionMember_ecac95fa-4ac8-458e-b942-bc132bc8ea7f" xlink:href="amci-20230213.xsd#amci_CommonClassaSubjectToRedemptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CommonClassAMember_532c4f2b-d1e2-44a0-a8a4-0889567ee7b7" xlink:to="loc_amci_CommonClassaSubjectToRedemptionMember_ecac95fa-4ac8-458e-b942-bc132bc8ea7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CommonClassaNotSubjectToRedemptionMember_dd42ddb1-6ac6-4503-a479-29f299be59b1" xlink:href="amci-20230213.xsd#amci_CommonClassaNotSubjectToRedemptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CommonClassAMember_532c4f2b-d1e2-44a0-a8a4-0889567ee7b7" xlink:to="loc_amci_CommonClassaNotSubjectToRedemptionMember_dd42ddb1-6ac6-4503-a479-29f299be59b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_c1a60e54-1acf-49a3-a037-5f2d805b0fee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_378bb9fc-740e-4952-a2b5-047df624764f" xlink:to="loc_us-gaap_CommonClassBMember_c1a60e54-1acf-49a3-a037-5f2d805b0fee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_21923800-30c0-4c34-8b1e-0859c60c1ac5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_dc9195cc-5545-4f92-a897-2e21ef4ec16e" xlink:to="loc_dei_LegalEntityAxis_21923800-30c0-4c34-8b1e-0859c60c1ac5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_21923800-30c0-4c34-8b1e-0859c60c1ac5_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_21923800-30c0-4c34-8b1e-0859c60c1ac5" xlink:to="loc_dei_EntityDomain_21923800-30c0-4c34-8b1e-0859c60c1ac5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_6cf5a461-3e45-4ca5-a244-1d3474cf9350" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_21923800-30c0-4c34-8b1e-0859c60c1ac5" xlink:to="loc_dei_EntityDomain_6cf5a461-3e45-4ca5-a244-1d3474cf9350" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AMCIACQUISITIONCORPIIMember_3194b4c5-585a-4b00-ae69-02bd8d74e3d2" xlink:href="amci-20230213.xsd#amci_AMCIACQUISITIONCORPIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_6cf5a461-3e45-4ca5-a244-1d3474cf9350" xlink:to="loc_amci_AMCIACQUISITIONCORPIIMember_3194b4c5-585a-4b00-ae69-02bd8d74e3d2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="amci-20230213.xsd#CONDENSEDBALANCESHEETSParenthetical"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETSParenthetical" xlink:type="extended" id="icb2d66c5b80a4b53bf16ab3d67409344_CONDENSEDBALANCESHEETSParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_477fa7e4-5013-48ea-8a79-4463a2ad1973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_2f6d4224-b929-4fc1-9dab-ce955082ed9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_477fa7e4-5013-48ea-8a79-4463a2ad1973" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_2f6d4224-b929-4fc1-9dab-ce955082ed9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_5774eac9-7677-4f6c-9aac-6de9f7590a23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_477fa7e4-5013-48ea-8a79-4463a2ad1973" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_5774eac9-7677-4f6c-9aac-6de9f7590a23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_5d14a709-53d8-4e58-8113-1072155ba824" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_477fa7e4-5013-48ea-8a79-4463a2ad1973" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_5d14a709-53d8-4e58-8113-1072155ba824" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityRedemptionPricePerShare_36f48c14-5f20-4ef4-a913-27fd3539a109" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_477fa7e4-5013-48ea-8a79-4463a2ad1973" xlink:to="loc_us-gaap_TemporaryEquityRedemptionPricePerShare_36f48c14-5f20-4ef4-a913-27fd3539a109" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_ee70679b-97e7-4784-a91c-5d85afbc116e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_477fa7e4-5013-48ea-8a79-4463a2ad1973" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_ee70679b-97e7-4784-a91c-5d85afbc116e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_a0aaa86a-8ed8-4d82-835d-91f7ecb39394" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_477fa7e4-5013-48ea-8a79-4463a2ad1973" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_a0aaa86a-8ed8-4d82-835d-91f7ecb39394" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_04f2b087-da0b-40c6-b7c2-d0a0137a321e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_477fa7e4-5013-48ea-8a79-4463a2ad1973" xlink:to="loc_us-gaap_PreferredStockSharesIssued_04f2b087-da0b-40c6-b7c2-d0a0137a321e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_670dd7b5-4be8-4404-a498-fe8ba334dbd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_477fa7e4-5013-48ea-8a79-4463a2ad1973" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_670dd7b5-4be8-4404-a498-fe8ba334dbd3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_73e73130-847f-4d89-811b-31169d8e267a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding_670dd7b5-4be8-4404-a498-fe8ba334dbd3" xlink:to="loc_us-gaap_CommonStockSharesIssued_73e73130-847f-4d89-811b-31169d8e267a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_b2a56f46-4664-4aa4-950a-1bed0f2813fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_477fa7e4-5013-48ea-8a79-4463a2ad1973" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_b2a56f46-4664-4aa4-950a-1bed0f2813fa" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_7627e271-f433-4f9b-a38e-c3a0fcae7151" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_477fa7e4-5013-48ea-8a79-4463a2ad1973" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_7627e271-f433-4f9b-a38e-c3a0fcae7151" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_8d9679b6-a728-4fd1-8040-0b3efef9675e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_477fa7e4-5013-48ea-8a79-4463a2ad1973" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_8d9679b6-a728-4fd1-8040-0b3efef9675e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_93470851-3014-477c-ba67-c10bd3b7f3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_477fa7e4-5013-48ea-8a79-4463a2ad1973" xlink:to="loc_us-gaap_StatementTable_93470851-3014-477c-ba67-c10bd3b7f3cf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1ae64b6c-ffea-42c7-8015-3d29028836a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_93470851-3014-477c-ba67-c10bd3b7f3cf" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1ae64b6c-ffea-42c7-8015-3d29028836a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_1ae64b6c-ffea-42c7-8015-3d29028836a0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1ae64b6c-ffea-42c7-8015-3d29028836a0" xlink:to="loc_us-gaap_ClassOfStockDomain_1ae64b6c-ffea-42c7-8015-3d29028836a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_410d9261-2bfd-4df0-94b5-750c363d3297" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1ae64b6c-ffea-42c7-8015-3d29028836a0" xlink:to="loc_us-gaap_ClassOfStockDomain_410d9261-2bfd-4df0-94b5-750c363d3297" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_30917b05-92ee-4a75-9d79-42cdbfcb4c58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_410d9261-2bfd-4df0-94b5-750c363d3297" xlink:to="loc_us-gaap_CommonClassAMember_30917b05-92ee-4a75-9d79-42cdbfcb4c58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CommonClassaSubjectToRedemptionMember_7df541d6-32dd-4480-8eca-f04b447997e9" xlink:href="amci-20230213.xsd#amci_CommonClassaSubjectToRedemptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CommonClassAMember_30917b05-92ee-4a75-9d79-42cdbfcb4c58" xlink:to="loc_amci_CommonClassaSubjectToRedemptionMember_7df541d6-32dd-4480-8eca-f04b447997e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CommonClassaNotSubjectToRedemptionMember_b1858cfd-4047-4b58-94da-c4deba163fa4" xlink:href="amci-20230213.xsd#amci_CommonClassaNotSubjectToRedemptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CommonClassAMember_30917b05-92ee-4a75-9d79-42cdbfcb4c58" xlink:to="loc_amci_CommonClassaNotSubjectToRedemptionMember_b1858cfd-4047-4b58-94da-c4deba163fa4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_e63bcdc1-0a4f-4e0f-a950-014e0d99626e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_410d9261-2bfd-4df0-94b5-750c363d3297" xlink:to="loc_us-gaap_CommonClassBMember_e63bcdc1-0a4f-4e0f-a950-014e0d99626e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_e52aa498-1bf7-4285-afb3-f2e6fe79e9b4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_93470851-3014-477c-ba67-c10bd3b7f3cf" xlink:to="loc_dei_LegalEntityAxis_e52aa498-1bf7-4285-afb3-f2e6fe79e9b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e52aa498-1bf7-4285-afb3-f2e6fe79e9b4_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_e52aa498-1bf7-4285-afb3-f2e6fe79e9b4" xlink:to="loc_dei_EntityDomain_e52aa498-1bf7-4285-afb3-f2e6fe79e9b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_3e687032-ca7c-45de-b1dc-ea578cfc2a2d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_e52aa498-1bf7-4285-afb3-f2e6fe79e9b4" xlink:to="loc_dei_EntityDomain_3e687032-ca7c-45de-b1dc-ea578cfc2a2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AMCIACQUISITIONCORPIIMember_4be42f52-bbc8-4c3a-88d7-d39b61d464d4" xlink:href="amci-20230213.xsd#amci_AMCIACQUISITIONCORPIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_3e687032-ca7c-45de-b1dc-ea578cfc2a2d" xlink:to="loc_amci_AMCIACQUISITIONCORPIIMember_4be42f52-bbc8-4c3a-88d7-d39b61d464d4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="amci-20230213.xsd#UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS" xlink:type="extended" id="i961fde5750d64bd9bfc7fe6fef5a269f_UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_bdee3776-0373-48f6-aed7-6900df31c090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_162611fe-2fad-4951-a6eb-0db6f0b83fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bdee3776-0373-48f6-aed7-6900df31c090" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_162611fe-2fad-4951-a6eb-0db6f0b83fdc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_cf37d87c-b54c-40f0-9c0a-a2499860cdcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bdee3776-0373-48f6-aed7-6900df31c090" xlink:to="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_cf37d87c-b54c-40f0-9c0a-a2499860cdcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CapitalBaseTaxExpense_dc9b6a90-ffdd-4f6b-a061-09fed46d7762" xlink:href="amci-20230213.xsd#amci_CapitalBaseTaxExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bdee3776-0373-48f6-aed7-6900df31c090" xlink:to="loc_amci_CapitalBaseTaxExpense_dc9b6a90-ffdd-4f6b-a061-09fed46d7762" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductionTaxExpense_e6cea964-2886-4755-bcc7-0fb52c5d463a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductionTaxExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bdee3776-0373-48f6-aed7-6900df31c090" xlink:to="loc_us-gaap_ProductionTaxExpense_e6cea964-2886-4755-bcc7-0fb52c5d463a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_36874785-9ea0-4a5b-b4c6-23088209e82a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bdee3776-0373-48f6-aed7-6900df31c090" xlink:to="loc_us-gaap_OperatingIncomeLoss_36874785-9ea0-4a5b-b4c6-23088209e82a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_bbf665d5-985a-4f56-b702-9bb307e9faa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bdee3776-0373-48f6-aed7-6900df31c090" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_bbf665d5-985a-4f56-b702-9bb307e9faa2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_5e649bba-5945-47c9-8d37-7ed4f01b7562" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_bbf665d5-985a-4f56-b702-9bb307e9faa2" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_5e649bba-5945-47c9-8d37-7ed4f01b7562" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants_6f63e3b2-7f05-42c6-960c-043e1969fa41" xlink:href="amci-20230213.xsd#amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_bbf665d5-985a-4f56-b702-9bb307e9faa2" xlink:to="loc_amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants_6f63e3b2-7f05-42c6-960c-043e1969fa41" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities_8b0e48ff-8afa-423d-a702-2f0ab51e57a5" xlink:href="amci-20230213.xsd#amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_bbf665d5-985a-4f56-b702-9bb307e9faa2" xlink:to="loc_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities_8b0e48ff-8afa-423d-a702-2f0ab51e57a5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeFromInvestmentsHeldInTrustAccount_87b6997f-068a-432e-a43a-892d4cb4b36d" xlink:href="amci-20230213.xsd#amci_IncomeFromInvestmentsHeldInTrustAccount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_bbf665d5-985a-4f56-b702-9bb307e9faa2" xlink:to="loc_amci_IncomeFromInvestmentsHeldInTrustAccount_87b6997f-068a-432e-a43a-892d4cb4b36d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_09e6e0be-7dea-4555-8fd9-47df499180d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bdee3776-0373-48f6-aed7-6900df31c090" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_09e6e0be-7dea-4555-8fd9-47df499180d4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e1aec2c2-422b-47b5-8447-7e655787de61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bdee3776-0373-48f6-aed7-6900df31c090" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e1aec2c2-422b-47b5-8447-7e655787de61" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b41b7419-6453-4b4b-92b2-01381d0ebdce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bdee3776-0373-48f6-aed7-6900df31c090" xlink:to="loc_us-gaap_NetIncomeLoss_b41b7419-6453-4b4b-92b2-01381d0ebdce" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_faafc819-e4fa-40e4-adce-2d3f670945a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bdee3776-0373-48f6-aed7-6900df31c090" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_faafc819-e4fa-40e4-adce-2d3f670945a1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b094118d-ecf6-414b-abf9-9c6f5e6aa089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bdee3776-0373-48f6-aed7-6900df31c090" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b094118d-ecf6-414b-abf9-9c6f5e6aa089" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_dc6ab005-bd7f-48a4-aae2-87aa0a05ca0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bdee3776-0373-48f6-aed7-6900df31c090" xlink:to="loc_us-gaap_EarningsPerShareBasic_dc6ab005-bd7f-48a4-aae2-87aa0a05ca0a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_4de1cec2-6f1d-4c2d-94be-55b2bb7720cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bdee3776-0373-48f6-aed7-6900df31c090" xlink:to="loc_us-gaap_EarningsPerShareDiluted_4de1cec2-6f1d-4c2d-94be-55b2bb7720cd" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1f3d29bf-8051-4a6f-8a46-d39c415a07cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_bdee3776-0373-48f6-aed7-6900df31c090" xlink:to="loc_us-gaap_StatementTable_1f3d29bf-8051-4a6f-8a46-d39c415a07cb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_04ad1522-4d0d-47cc-91e9-009847feeee5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1f3d29bf-8051-4a6f-8a46-d39c415a07cb" xlink:to="loc_us-gaap_StatementClassOfStockAxis_04ad1522-4d0d-47cc-91e9-009847feeee5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_04ad1522-4d0d-47cc-91e9-009847feeee5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_04ad1522-4d0d-47cc-91e9-009847feeee5" xlink:to="loc_us-gaap_ClassOfStockDomain_04ad1522-4d0d-47cc-91e9-009847feeee5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_022003aa-7ef4-4c15-96be-329d0bf36293" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_04ad1522-4d0d-47cc-91e9-009847feeee5" xlink:to="loc_us-gaap_ClassOfStockDomain_022003aa-7ef4-4c15-96be-329d0bf36293" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_3e9b3810-93a0-4c2a-ad89-2eec41050ee4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_022003aa-7ef4-4c15-96be-329d0bf36293" xlink:to="loc_us-gaap_CommonClassAMember_3e9b3810-93a0-4c2a-ad89-2eec41050ee4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_34bb1ec4-9a62-48cc-9e79-38eb68baddef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_022003aa-7ef4-4c15-96be-329d0bf36293" xlink:to="loc_us-gaap_CommonClassBMember_34bb1ec4-9a62-48cc-9e79-38eb68baddef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_8443f5ff-ffb3-4c8f-b958-f94718c1d9c3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1f3d29bf-8051-4a6f-8a46-d39c415a07cb" xlink:to="loc_dei_LegalEntityAxis_8443f5ff-ffb3-4c8f-b958-f94718c1d9c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8443f5ff-ffb3-4c8f-b958-f94718c1d9c3_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_8443f5ff-ffb3-4c8f-b958-f94718c1d9c3" xlink:to="loc_dei_EntityDomain_8443f5ff-ffb3-4c8f-b958-f94718c1d9c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_89286be9-c989-4e34-a579-cdeeb02c2a8e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_8443f5ff-ffb3-4c8f-b958-f94718c1d9c3" xlink:to="loc_dei_EntityDomain_89286be9-c989-4e34-a579-cdeeb02c2a8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AMCIACQUISITIONCORPIIMember_4912ce48-bffe-45be-97a4-6d510a40c86f" xlink:href="amci-20230213.xsd#amci_AMCIACQUISITIONCORPIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_89286be9-c989-4e34-a579-cdeeb02c2a8e" xlink:to="loc_amci_AMCIACQUISITIONCORPIIMember_4912ce48-bffe-45be-97a4-6d510a40c86f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="amci-20230213.xsd#UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended" id="i7d92708e46e54ffbb7f2396c102fb30e_UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4cd846f4-4447-4c97-9487-e6194b597ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4cd846f4-4447-4c97-9487-e6194b597ae4" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1deecb76-55bc-4c87-8e8a-f9110549d51b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:to="loc_us-gaap_StockholdersEquity_1deecb76-55bc-4c87-8e8a-f9110549d51b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_8ff43a4f-5ccf-4008-998e-af2a2f5f17fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:to="loc_us-gaap_SharesIssued_8ff43a4f-5ccf-4008-998e-af2a2f5f17fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_0542e663-1271-41a1-a0a8-fe2fd13280c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_0542e663-1271-41a1-a0a8-fe2fd13280c4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_36c8a4f2-6ac1-48af-a3ea-2f95a824b57e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_36c8a4f2-6ac1-48af-a3ea-2f95a824b57e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares_ae976ed1-aef4-4a7e-8e9b-11095abfb9ef" xlink:href="amci-20230213.xsd#amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:to="loc_amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares_ae976ed1-aef4-4a7e-8e9b-11095abfb9ef" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_7b75d776-3976-472d-906c-31a8045e1ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_7b75d776-3976-472d-906c-31a8045e1ed4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption_e9b00c16-3c37-41fd-89ff-aaa01fc9e636" xlink:href="amci-20230213.xsd#amci_IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:to="loc_amci_IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption_e9b00c16-3c37-41fd-89ff-aaa01fc9e636" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_88f96a84-4301-4238-bf02-1d362f30bac6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_88f96a84-4301-4238-bf02-1d362f30bac6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_3bdbe266-6974-42d0-864a-681537e14020" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_3bdbe266-6974-42d0-864a-681537e14020" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_13a14fe7-23f0-453a-a497-1936c2a3b2a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_13a14fe7-23f0-453a-a497-1936c2a3b2a3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors_7994b0b7-0b18-46ca-a126-04ac8e5bb1d2" xlink:href="amci-20230213.xsd#amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:to="loc_amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors_7994b0b7-0b18-46ca-a126-04ac8e5bb1d2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_7e6beccc-e8ab-4362-a489-41db4a77a4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_7e6beccc-e8ab-4362-a489-41db4a77a4ce" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_76c3b6d2-1c0f-4c2f-b122-537eb456cd97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:to="loc_us-gaap_NetIncomeLoss_76c3b6d2-1c0f-4c2f-b122-537eb456cd97" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7e19feeb-3955-4f51-9e7a-df370fdefff7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_a0e8ce21-5eee-4a26-a43d-f0973f1573d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2130ac5b-5501-49fd-ba42-eeee6e9fd2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_4cd846f4-4447-4c97-9487-e6194b597ae4" xlink:to="loc_us-gaap_StatementTable_2130ac5b-5501-49fd-ba42-eeee6e9fd2ad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_d479328f-7b06-4db1-b986-357fdceb1bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2130ac5b-5501-49fd-ba42-eeee6e9fd2ad" xlink:to="loc_us-gaap_StatementClassOfStockAxis_d479328f-7b06-4db1-b986-357fdceb1bc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d479328f-7b06-4db1-b986-357fdceb1bc2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d479328f-7b06-4db1-b986-357fdceb1bc2" xlink:to="loc_us-gaap_ClassOfStockDomain_d479328f-7b06-4db1-b986-357fdceb1bc2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_7c4cd42e-a5ec-4cb0-bcda-fa6425b142bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d479328f-7b06-4db1-b986-357fdceb1bc2" xlink:to="loc_us-gaap_ClassOfStockDomain_7c4cd42e-a5ec-4cb0-bcda-fa6425b142bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_828e2fe2-26f9-45f8-b8f9-40ebed503060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7c4cd42e-a5ec-4cb0-bcda-fa6425b142bb" xlink:to="loc_us-gaap_CommonClassAMember_828e2fe2-26f9-45f8-b8f9-40ebed503060" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_b5bc83e7-e676-4344-b9c9-efb78ca272cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7c4cd42e-a5ec-4cb0-bcda-fa6425b142bb" xlink:to="loc_us-gaap_CommonClassBMember_b5bc83e7-e676-4344-b9c9-efb78ca272cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ff3feba9-dd51-4fd3-9a54-a3e983cc5794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2130ac5b-5501-49fd-ba42-eeee6e9fd2ad" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ff3feba9-dd51-4fd3-9a54-a3e983cc5794" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ff3feba9-dd51-4fd3-9a54-a3e983cc5794_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ff3feba9-dd51-4fd3-9a54-a3e983cc5794" xlink:to="loc_us-gaap_EquityComponentDomain_ff3feba9-dd51-4fd3-9a54-a3e983cc5794_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_29117070-6709-42f2-b588-202a168cd37d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ff3feba9-dd51-4fd3-9a54-a3e983cc5794" xlink:to="loc_us-gaap_EquityComponentDomain_29117070-6709-42f2-b588-202a168cd37d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_64d474b0-b740-42d6-8ad5-077ecccdd11b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_29117070-6709-42f2-b588-202a168cd37d" xlink:to="loc_us-gaap_CommonStockMember_64d474b0-b740-42d6-8ad5-077ecccdd11b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_79165033-cbd6-45d9-bf0d-235d1f0e7b60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_29117070-6709-42f2-b588-202a168cd37d" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_79165033-cbd6-45d9-bf0d-235d1f0e7b60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_50a0909a-6e77-4c63-af67-041785cb4bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_29117070-6709-42f2-b588-202a168cd37d" xlink:to="loc_us-gaap_RetainedEarningsMember_50a0909a-6e77-4c63-af67-041785cb4bc8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_cef96a7a-2a2f-4721-8865-6286ea4b68c6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2130ac5b-5501-49fd-ba42-eeee6e9fd2ad" xlink:to="loc_dei_LegalEntityAxis_cef96a7a-2a2f-4721-8865-6286ea4b68c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_cef96a7a-2a2f-4721-8865-6286ea4b68c6_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_cef96a7a-2a2f-4721-8865-6286ea4b68c6" xlink:to="loc_dei_EntityDomain_cef96a7a-2a2f-4721-8865-6286ea4b68c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_0a135783-d172-4400-bb8d-74d5a3844ca1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_cef96a7a-2a2f-4721-8865-6286ea4b68c6" xlink:to="loc_dei_EntityDomain_0a135783-d172-4400-bb8d-74d5a3844ca1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AMCIACQUISITIONCORPIIMember_aeed2247-6f85-4d24-b361-5a8151ae9602" xlink:href="amci-20230213.xsd#amci_AMCIACQUISITIONCORPIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_0a135783-d172-4400-bb8d-74d5a3844ca1" xlink:to="loc_amci_AMCIACQUISITIONCORPIIMember_aeed2247-6f85-4d24-b361-5a8151ae9602" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICITParenthetical" xlink:type="simple" xlink:href="amci-20230213.xsd#UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICITParenthetical"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICITParenthetical" xlink:type="extended" id="ib67f3f0f7046405c8f8c69a64e431a42_UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICITParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_37c30a5f-88b6-4718-9d62-25f7615725c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_aa1a44d3-0bd0-4177-b4bb-130c37947531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_37c30a5f-88b6-4718-9d62-25f7615725c2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_aa1a44d3-0bd0-4177-b4bb-130c37947531" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfSharesSurrendered_9aa9e322-2426-4188-9f3d-5cb5595bae24" xlink:href="amci-20230213.xsd#amci_NumberOfSharesSurrendered"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_37c30a5f-88b6-4718-9d62-25f7615725c2" xlink:to="loc_amci_NumberOfSharesSurrendered_9aa9e322-2426-4188-9f3d-5cb5595bae24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AggregateNumberOfSharesOwned_826c3577-47ef-421d-9d88-6377e712f6d7" xlink:href="amci-20230213.xsd#amci_AggregateNumberOfSharesOwned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_37c30a5f-88b6-4718-9d62-25f7615725c2" xlink:to="loc_amci_AggregateNumberOfSharesOwned_826c3577-47ef-421d-9d88-6377e712f6d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5027cb8c-2240-49ae-8124-ea29f2e2da29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_37c30a5f-88b6-4718-9d62-25f7615725c2" xlink:to="loc_us-gaap_StatementTable_5027cb8c-2240-49ae-8124-ea29f2e2da29" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_fb7cb0ae-248f-4ac3-90c4-cff65ac59a26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5027cb8c-2240-49ae-8124-ea29f2e2da29" xlink:to="loc_us-gaap_StatementClassOfStockAxis_fb7cb0ae-248f-4ac3-90c4-cff65ac59a26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_fb7cb0ae-248f-4ac3-90c4-cff65ac59a26_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fb7cb0ae-248f-4ac3-90c4-cff65ac59a26" xlink:to="loc_us-gaap_ClassOfStockDomain_fb7cb0ae-248f-4ac3-90c4-cff65ac59a26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b5c7e992-fa82-4e18-b999-fadfc62ef5df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fb7cb0ae-248f-4ac3-90c4-cff65ac59a26" xlink:to="loc_us-gaap_ClassOfStockDomain_b5c7e992-fa82-4e18-b999-fadfc62ef5df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_211af367-b6eb-4c28-975b-261bb0cd5f87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_b5c7e992-fa82-4e18-b999-fadfc62ef5df" xlink:to="loc_us-gaap_CommonClassBMember_211af367-b6eb-4c28-975b-261bb0cd5f87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_adeefcb8-d474-4dcf-93da-3578ceba504f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5027cb8c-2240-49ae-8124-ea29f2e2da29" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_adeefcb8-d474-4dcf-93da-3578ceba504f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_adeefcb8-d474-4dcf-93da-3578ceba504f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_adeefcb8-d474-4dcf-93da-3578ceba504f" xlink:to="loc_us-gaap_RelatedPartyDomain_adeefcb8-d474-4dcf-93da-3578ceba504f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_b76cf85b-9fe1-4e3f-a601-3ce7985b745f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_adeefcb8-d474-4dcf-93da-3578ceba504f" xlink:to="loc_us-gaap_RelatedPartyDomain_b76cf85b-9fe1-4e3f-a601-3ce7985b745f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SponsorMember_5f4b7250-368b-4439-b839-c472dad6dbfd" xlink:href="amci-20230213.xsd#amci_SponsorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_b76cf85b-9fe1-4e3f-a601-3ce7985b745f" xlink:to="loc_amci_SponsorMember_5f4b7250-368b-4439-b839-c472dad6dbfd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_6e890416-42b0-4a72-9b28-f0eef30a0e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5027cb8c-2240-49ae-8124-ea29f2e2da29" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_6e890416-42b0-4a72-9b28-f0eef30a0e8c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6e890416-42b0-4a72-9b28-f0eef30a0e8c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_6e890416-42b0-4a72-9b28-f0eef30a0e8c" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6e890416-42b0-4a72-9b28-f0eef30a0e8c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b2229c4e-ef91-4e99-9b30-ab1ff2c65c18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_6e890416-42b0-4a72-9b28-f0eef30a0e8c" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b2229c4e-ef91-4e99-9b30-ab1ff2c65c18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_516fe906-05f5-4007-88d3-bdd6b119987d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b2229c4e-ef91-4e99-9b30-ab1ff2c65c18" xlink:to="loc_us-gaap_OverAllotmentOptionMember_516fe906-05f5-4007-88d3-bdd6b119987d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_428ae195-c34c-4646-9eaf-c1cd2aaec960" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5027cb8c-2240-49ae-8124-ea29f2e2da29" xlink:to="loc_dei_LegalEntityAxis_428ae195-c34c-4646-9eaf-c1cd2aaec960" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_428ae195-c34c-4646-9eaf-c1cd2aaec960_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_428ae195-c34c-4646-9eaf-c1cd2aaec960" xlink:to="loc_dei_EntityDomain_428ae195-c34c-4646-9eaf-c1cd2aaec960_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_cdb94253-34e7-476d-9cee-f87176355ae9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_428ae195-c34c-4646-9eaf-c1cd2aaec960" xlink:to="loc_dei_EntityDomain_cdb94253-34e7-476d-9cee-f87176355ae9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AMCIACQUISITIONCORPIIMember_9db284e7-7250-4167-be0c-33747f42eb11" xlink:href="amci-20230213.xsd#amci_AMCIACQUISITIONCORPIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_cdb94253-34e7-476d-9cee-f87176355ae9" xlink:to="loc_amci_AMCIACQUISITIONCORPIIMember_9db284e7-7250-4167-be0c-33747f42eb11" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="amci-20230213.xsd#UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS" xlink:type="extended" id="i7c87597de67c4d5e9004f5a7ace6ab9d_UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1ba60755-a7bf-416e-8c76-5ba4900b4881" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8a6c6f6a-20f8-41c4-bcd5-3b1749eed9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1ba60755-a7bf-416e-8c76-5ba4900b4881" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8a6c6f6a-20f8-41c4-bcd5-3b1749eed9a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_4b0fbb4c-21c4-4b62-ad64-8a6d0b04ed77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8a6c6f6a-20f8-41c4-bcd5-3b1749eed9a1" xlink:to="loc_us-gaap_ProfitLoss_4b0fbb4c-21c4-4b62-ad64-8a6d0b04ed77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2e353793-064d-4dfa-b1a8-e25ae53f6d46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8a6c6f6a-20f8-41c4-bcd5-3b1749eed9a1" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2e353793-064d-4dfa-b1a8-e25ae53f6d46" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares_59a4f7bb-a27e-4fdc-a819-c1937c54e04b" xlink:href="amci-20230213.xsd#amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2e353793-064d-4dfa-b1a8-e25ae53f6d46" xlink:to="loc_amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares_59a4f7bb-a27e-4fdc-a819-c1937c54e04b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_0122ba53-e131-421b-94b8-fc3674f61046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2e353793-064d-4dfa-b1a8-e25ae53f6d46" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_0122ba53-e131-421b-94b8-fc3674f61046" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants_012409c8-35f0-4ac9-8a01-472cba969ff1" xlink:href="amci-20230213.xsd#amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2e353793-064d-4dfa-b1a8-e25ae53f6d46" xlink:to="loc_amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants_012409c8-35f0-4ac9-8a01-472cba969ff1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities_049d1e49-db24-4236-b742-3ef326889021" xlink:href="amci-20230213.xsd#amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2e353793-064d-4dfa-b1a8-e25ae53f6d46" xlink:to="loc_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities_049d1e49-db24-4236-b742-3ef326889021" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeFromInvestmentsHeldInTrustAccount_05f438e1-d334-406d-a912-bbbbbe8b1153" xlink:href="amci-20230213.xsd#amci_IncomeFromInvestmentsHeldInTrustAccount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2e353793-064d-4dfa-b1a8-e25ae53f6d46" xlink:to="loc_amci_IncomeFromInvestmentsHeldInTrustAccount_05f438e1-d334-406d-a912-bbbbbe8b1153" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4dad2a15-f91e-4a34-be70-a71b5b8beae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2e353793-064d-4dfa-b1a8-e25ae53f6d46" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4dad2a15-f91e-4a34-be70-a71b5b8beae4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_5df06ad9-eaef-42c9-8fbc-dca98762c622" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4dad2a15-f91e-4a34-be70-a71b5b8beae4" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_5df06ad9-eaef-42c9-8fbc-dca98762c622" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_28c43207-4a16-4421-80bf-dc652e3099f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4dad2a15-f91e-4a34-be70-a71b5b8beae4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_28c43207-4a16-4421-80bf-dc652e3099f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncreaseDecreaseInDueToRelatedParties._1ea7bc86-6669-4530-9252-2c295ab8a715" xlink:href="amci-20230213.xsd#amci_IncreaseDecreaseInDueToRelatedParties."/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4dad2a15-f91e-4a34-be70-a71b5b8beae4" xlink:to="loc_amci_IncreaseDecreaseInDueToRelatedParties._1ea7bc86-6669-4530-9252-2c295ab8a715" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_3d451016-c824-419f-a9e5-2adc51f272ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4dad2a15-f91e-4a34-be70-a71b5b8beae4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_3d451016-c824-419f-a9e5-2adc51f272ca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncreaseDecreaseInCapitalBaseTaxPayable_e2733c93-99d8-497f-b7fc-4fbc6a11476b" xlink:href="amci-20230213.xsd#amci_IncreaseDecreaseInCapitalBaseTaxPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4dad2a15-f91e-4a34-be70-a71b5b8beae4" xlink:to="loc_amci_IncreaseDecreaseInCapitalBaseTaxPayable_e2733c93-99d8-497f-b7fc-4fbc6a11476b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncreaseDecreaseFranchiseTaxPayable_7e17cc72-c06c-4602-a055-5558072d8be3" xlink:href="amci-20230213.xsd#amci_IncreaseDecreaseFranchiseTaxPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4dad2a15-f91e-4a34-be70-a71b5b8beae4" xlink:to="loc_amci_IncreaseDecreaseFranchiseTaxPayable_7e17cc72-c06c-4602-a055-5558072d8be3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_feb4a9df-2466-4051-a0a5-dd9b7f864a88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4dad2a15-f91e-4a34-be70-a71b5b8beae4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_feb4a9df-2466-4051-a0a5-dd9b7f864a88" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_86d2e3df-3356-41b8-b3ff-417cedf40fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8a6c6f6a-20f8-41c4-bcd5-3b1749eed9a1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_86d2e3df-3356-41b8-b3ff-417cedf40fdc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_650b37a4-a910-47cd-b053-4726b5c31306" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1ba60755-a7bf-416e-8c76-5ba4900b4881" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_650b37a4-a910-47cd-b053-4726b5c31306" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireTrustPreferredInvestments_f90174e5-74f7-461c-8d07-8cb37192260e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireTrustPreferredInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_650b37a4-a910-47cd-b053-4726b5c31306" xlink:to="loc_us-gaap_PaymentsToAcquireTrustPreferredInvestments_f90174e5-74f7-461c-8d07-8cb37192260e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PaymentsForInvestmentOfCashInTrustAccount_2833d5a5-eb44-4dae-8378-660b2b958030" xlink:href="amci-20230213.xsd#amci_PaymentsForInvestmentOfCashInTrustAccount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_650b37a4-a910-47cd-b053-4726b5c31306" xlink:to="loc_amci_PaymentsForInvestmentOfCashInTrustAccount_2833d5a5-eb44-4dae-8378-660b2b958030" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3346860f-ecbc-42dd-87d5-ef876fa71028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_650b37a4-a910-47cd-b053-4726b5c31306" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3346860f-ecbc-42dd-87d5-ef876fa71028" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7491fc7d-97b2-49c8-b572-4a8b2804c7fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1ba60755-a7bf-416e-8c76-5ba4900b4881" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7491fc7d-97b2-49c8-b572-4a8b2804c7fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt_e186ed71-40b1-4adb-99ba-81f4bf783760" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7491fc7d-97b2-49c8-b572-4a8b2804c7fd" xlink:to="loc_us-gaap_ProceedsFromRelatedPartyDebt_e186ed71-40b1-4adb-99ba-81f4bf783760" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_ac849eae-dd60-4c12-8ba5-3c7a5f1fbfc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7491fc7d-97b2-49c8-b572-4a8b2804c7fd" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_ac849eae-dd60-4c12-8ba5-3c7a5f1fbfc6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_ee1e9ae2-a085-4ae4-9bb9-e62d2a4d5bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7491fc7d-97b2-49c8-b572-4a8b2804c7fd" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_ee1e9ae2-a085-4ae4-9bb9-e62d2a4d5bb0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f6862162-280d-4fb2-a7c7-be30e909e315" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7491fc7d-97b2-49c8-b572-4a8b2804c7fd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f6862162-280d-4fb2-a7c7-be30e909e315" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_75b69740-5388-4121-8306-8ba4344ead49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1ba60755-a7bf-416e-8c76-5ba4900b4881" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_75b69740-5388-4121-8306-8ba4344ead49" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5316e1b3-4db4-47cd-856f-008556166e04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1ba60755-a7bf-416e-8c76-5ba4900b4881" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5316e1b3-4db4-47cd-856f-008556166e04" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_db4ccd7e-6c8d-4952-9c17-26f21bea317b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_f61fe553-f9e8-4cf4-8dd1-fbf15cec49dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1ba60755-a7bf-416e-8c76-5ba4900b4881" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_f61fe553-f9e8-4cf4-8dd1-fbf15cec49dd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredOfferingCostsIncludedInNotesPayable_390b8f45-81fb-4e0c-a44d-ae6fe052d542" xlink:href="amci-20230213.xsd#amci_DeferredOfferingCostsIncludedInNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_f61fe553-f9e8-4cf4-8dd1-fbf15cec49dd" xlink:to="loc_amci_DeferredOfferingCostsIncludedInNotesPayable_390b8f45-81fb-4e0c-a44d-ae6fe052d542" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OfferingCostsIncludedInAccountsPayableAccruedExpenses_f03a56a6-85cd-4502-b155-03a6db2ff4f7" xlink:href="amci-20230213.xsd#amci_OfferingCostsIncludedInAccountsPayableAccruedExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_f61fe553-f9e8-4cf4-8dd1-fbf15cec49dd" xlink:to="loc_amci_OfferingCostsIncludedInAccountsPayableAccruedExpenses_f03a56a6-85cd-4502-b155-03a6db2ff4f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingFeePayable_887bb67f-b7c7-4fe6-b530-69d19afa73bc" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingFeePayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_f61fe553-f9e8-4cf4-8dd1-fbf15cec49dd" xlink:to="loc_amci_DeferredUnderwritingFeePayable_887bb67f-b7c7-4fe6-b530-69d19afa73bc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties_f0d3f398-928a-4d27-ab42-a94aff57feea" xlink:href="amci-20230213.xsd#amci_NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_f61fe553-f9e8-4cf4-8dd1-fbf15cec49dd" xlink:to="loc_amci_NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties_f0d3f398-928a-4d27-ab42-a94aff57feea" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NoncashRepaymentOfNotePayableAndAdvances_c6de6fe9-5203-4cae-b8f1-dba34e0275b6" xlink:href="amci-20230213.xsd#amci_NoncashRepaymentOfNotePayableAndAdvances"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_f61fe553-f9e8-4cf4-8dd1-fbf15cec49dd" xlink:to="loc_amci_NoncashRepaymentOfNotePayableAndAdvances_c6de6fe9-5203-4cae-b8f1-dba34e0275b6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NoncashDeferredUnderwritingCommissions_cc257c14-e9d4-4d41-bb91-a17e6e38b637" xlink:href="amci-20230213.xsd#amci_NoncashDeferredUnderwritingCommissions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_f61fe553-f9e8-4cf4-8dd1-fbf15cec49dd" xlink:to="loc_amci_NoncashDeferredUnderwritingCommissions_cc257c14-e9d4-4d41-bb91-a17e6e38b637" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering_791d4b4b-19c3-4877-985e-48d57020ac6f" xlink:href="amci-20230213.xsd#amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_f61fe553-f9e8-4cf4-8dd1-fbf15cec49dd" xlink:to="loc_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering_791d4b4b-19c3-4877-985e-48d57020ac6f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NoncashExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares_6d12f406-e028-4a88-8b31-91dcbe6e7d83" xlink:href="amci-20230213.xsd#amci_NoncashExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_f61fe553-f9e8-4cf4-8dd1-fbf15cec49dd" xlink:to="loc_amci_NoncashExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares_6d12f406-e028-4a88-8b31-91dcbe6e7d83" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_cbbc28b1-f52c-4a68-bdde-506fb18f065c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1ba60755-a7bf-416e-8c76-5ba4900b4881" xlink:to="loc_us-gaap_StatementTable_cbbc28b1-f52c-4a68-bdde-506fb18f065c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_bce28936-24ba-4ea9-92b4-f2c926f95f44" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_cbbc28b1-f52c-4a68-bdde-506fb18f065c" xlink:to="loc_dei_LegalEntityAxis_bce28936-24ba-4ea9-92b4-f2c926f95f44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_bce28936-24ba-4ea9-92b4-f2c926f95f44_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_bce28936-24ba-4ea9-92b4-f2c926f95f44" xlink:to="loc_dei_EntityDomain_bce28936-24ba-4ea9-92b4-f2c926f95f44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f379dc99-5a8f-4517-b3f9-c91a91f4db8f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_bce28936-24ba-4ea9-92b4-f2c926f95f44" xlink:to="loc_dei_EntityDomain_f379dc99-5a8f-4517-b3f9-c91a91f4db8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AMCIACQUISITIONCORPIIMember_8d38792d-587d-47e8-853e-058feda1a908" xlink:href="amci-20230213.xsd#amci_AMCIACQUISITIONCORPIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_f379dc99-5a8f-4517-b3f9-c91a91f4db8f" xlink:to="loc_amci_AMCIACQUISITIONCORPIIMember_8d38792d-587d-47e8-853e-058feda1a908" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/BALANCESHEET" xlink:type="simple" xlink:href="amci-20230213.xsd#BALANCESHEET"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/BALANCESHEET" xlink:type="extended" id="i04b0e8022d7e4a52a82693f64e0bfdee_BALANCESHEET">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a38a2f73-cbe4-4faf-8b73-ab5807185c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_c24d7a95-1df3-4259-9734-3751f0479bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a38a2f73-cbe4-4faf-8b73-ab5807185c9b" xlink:to="loc_us-gaap_AssetsAbstract_c24d7a95-1df3-4259-9734-3751f0479bf1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_cd4d09a6-fa30-41db-90db-631927249add" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_c24d7a95-1df3-4259-9734-3751f0479bf1" xlink:to="loc_us-gaap_AssetsCurrentAbstract_cd4d09a6-fa30-41db-90db-631927249add" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_09f3e502-785d-46ba-b4cd-da849b46e94f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cd4d09a6-fa30-41db-90db-631927249add" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_09f3e502-785d-46ba-b4cd-da849b46e94f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_fb35ff66-3854-4a81-906a-00b393f2176f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cd4d09a6-fa30-41db-90db-631927249add" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_fb35ff66-3854-4a81-906a-00b393f2176f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_e7ed2cc8-5eef-43f8-9822-8327f29aae34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cd4d09a6-fa30-41db-90db-631927249add" xlink:to="loc_us-gaap_AssetsCurrent_e7ed2cc8-5eef-43f8-9822-8327f29aae34" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PrepaidExpensesLongTerm_07a5d250-139f-4873-8c8c-bb0ea4578cbf" xlink:href="amci-20230213.xsd#amci_PrepaidExpensesLongTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_c24d7a95-1df3-4259-9734-3751f0479bf1" xlink:to="loc_amci_PrepaidExpensesLongTerm_07a5d250-139f-4873-8c8c-bb0ea4578cbf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrustNoncurrent_f60fae47-84fd-4f50-8044-cc8abf16afec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_c24d7a95-1df3-4259-9734-3751f0479bf1" xlink:to="loc_us-gaap_AssetsHeldInTrustNoncurrent_f60fae47-84fd-4f50-8044-cc8abf16afec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_050e6dd9-e5f2-4e7f-a1a2-59c1968508b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_c24d7a95-1df3-4259-9734-3751f0479bf1" xlink:to="loc_us-gaap_Assets_050e6dd9-e5f2-4e7f-a1a2-59c1968508b4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40f86f7b-3942-4af2-a0d6-1192c2e5b760" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a38a2f73-cbe4-4faf-8b73-ab5807185c9b" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40f86f7b-3942-4af2-a0d6-1192c2e5b760" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_75554c4b-cea1-4085-8abb-47906e58d187" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40f86f7b-3942-4af2-a0d6-1192c2e5b760" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_75554c4b-cea1-4085-8abb-47906e58d187" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_2f69eb89-a111-4440-80f6-b9c392aaec48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_75554c4b-cea1-4085-8abb-47906e58d187" xlink:to="loc_us-gaap_AccountsPayableCurrent_2f69eb89-a111-4440-80f6-b9c392aaec48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_93d89a90-437e-4b4c-b8ce-b902d62e7895" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_75554c4b-cea1-4085-8abb-47906e58d187" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_93d89a90-437e-4b4c-b8ce-b902d62e7895" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_a09b2ab3-a679-4522-9f25-36e25138b134" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_75554c4b-cea1-4085-8abb-47906e58d187" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrent_a09b2ab3-a679-4522-9f25-36e25138b134" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent_9906c206-1e6b-435d-99aa-07ff31a2896a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_75554c4b-cea1-4085-8abb-47906e58d187" xlink:to="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent_9906c206-1e6b-435d-99aa-07ff31a2896a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_FranchiseTaxPayableCurrent_8c4677cf-74ec-41c3-84db-51a9006dc52d" xlink:href="amci-20230213.xsd#amci_FranchiseTaxPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_75554c4b-cea1-4085-8abb-47906e58d187" xlink:to="loc_amci_FranchiseTaxPayableCurrent_8c4677cf-74ec-41c3-84db-51a9006dc52d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_bc9e588b-86a4-4af5-bc0c-e716da1a302f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_75554c4b-cea1-4085-8abb-47906e58d187" xlink:to="loc_us-gaap_LiabilitiesCurrent_bc9e588b-86a4-4af5-bc0c-e716da1a302f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingCompensationNoncurrent_bcc46429-90f6-4f35-8b2e-89312eacbc65" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingCompensationNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40f86f7b-3942-4af2-a0d6-1192c2e5b760" xlink:to="loc_amci_DeferredUnderwritingCompensationNoncurrent_bcc46429-90f6-4f35-8b2e-89312eacbc65" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_347abce6-23dc-4388-9945-a084c5452abb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40f86f7b-3942-4af2-a0d6-1192c2e5b760" xlink:to="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_347abce6-23dc-4388-9945-a084c5452abb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_8cb5af0a-c1e6-4429-b8b4-d92ea97578df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40f86f7b-3942-4af2-a0d6-1192c2e5b760" xlink:to="loc_us-gaap_Liabilities_8cb5af0a-c1e6-4429-b8b4-d92ea97578df" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_7f424c0b-d5a9-44f9-a417-4b0cb035c2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40f86f7b-3942-4af2-a0d6-1192c2e5b760" xlink:to="loc_us-gaap_CommitmentsAndContingencies_7f424c0b-d5a9-44f9-a417-4b0cb035c2c0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_7f980e4d-5943-4608-a543-bf6e134c5950" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40f86f7b-3942-4af2-a0d6-1192c2e5b760" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_7f980e4d-5943-4608-a543-bf6e134c5950" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_b55135b8-83d8-41d9-b783-b58802c9117f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40f86f7b-3942-4af2-a0d6-1192c2e5b760" xlink:to="loc_us-gaap_StockholdersEquityAbstract_b55135b8-83d8-41d9-b783-b58802c9117f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_41403410-1801-408c-9f8b-e6fab38b7396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b55135b8-83d8-41d9-b783-b58802c9117f" xlink:to="loc_us-gaap_PreferredStockValue_41403410-1801-408c-9f8b-e6fab38b7396" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_710ebb0e-a481-4760-bb0a-a3502428c582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b55135b8-83d8-41d9-b783-b58802c9117f" xlink:to="loc_us-gaap_CommonStockValue_710ebb0e-a481-4760-bb0a-a3502428c582" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_4d181e7d-39b8-4b65-b70d-59e6a0cde1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b55135b8-83d8-41d9-b783-b58802c9117f" xlink:to="loc_us-gaap_AdditionalPaidInCapital_4d181e7d-39b8-4b65-b70d-59e6a0cde1d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d7119c47-2301-4779-8091-4afb56d1e6a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b55135b8-83d8-41d9-b783-b58802c9117f" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d7119c47-2301-4779-8091-4afb56d1e6a6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4f5bfc36-f864-423b-a9a0-2a5feb1985a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b55135b8-83d8-41d9-b783-b58802c9117f" xlink:to="loc_us-gaap_StockholdersEquity_4f5bfc36-f864-423b-a9a0-2a5feb1985a9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_fae08bb9-4c96-414f-8f28-27332aa81fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40f86f7b-3942-4af2-a0d6-1192c2e5b760" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_fae08bb9-4c96-414f-8f28-27332aa81fdc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_47fa0cd7-e2f2-471d-af73-8eb77eb3d408" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_a38a2f73-cbe4-4faf-8b73-ab5807185c9b" xlink:to="loc_us-gaap_StatementTable_47fa0cd7-e2f2-471d-af73-8eb77eb3d408" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_e98d9c82-9c61-4a22-9d1a-58bbd6da7da4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_47fa0cd7-e2f2-471d-af73-8eb77eb3d408" xlink:to="loc_us-gaap_StatementClassOfStockAxis_e98d9c82-9c61-4a22-9d1a-58bbd6da7da4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e98d9c82-9c61-4a22-9d1a-58bbd6da7da4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_e98d9c82-9c61-4a22-9d1a-58bbd6da7da4" xlink:to="loc_us-gaap_ClassOfStockDomain_e98d9c82-9c61-4a22-9d1a-58bbd6da7da4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_2d3a94c8-f1a7-47c2-bbf3-62e023752546" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_e98d9c82-9c61-4a22-9d1a-58bbd6da7da4" xlink:to="loc_us-gaap_ClassOfStockDomain_2d3a94c8-f1a7-47c2-bbf3-62e023752546" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_97435b99-266c-41f8-8523-9f0e255fe7e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_2d3a94c8-f1a7-47c2-bbf3-62e023752546" xlink:to="loc_us-gaap_CommonClassAMember_97435b99-266c-41f8-8523-9f0e255fe7e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CommonClassaSubjectToRedemptionMember_a41ce87c-7843-4956-911b-e18d348f5604" xlink:href="amci-20230213.xsd#amci_CommonClassaSubjectToRedemptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CommonClassAMember_97435b99-266c-41f8-8523-9f0e255fe7e9" xlink:to="loc_amci_CommonClassaSubjectToRedemptionMember_a41ce87c-7843-4956-911b-e18d348f5604" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CommonClassaNotSubjectToRedemptionMember_9115df03-f9fd-46df-8838-0b1cd640347a" xlink:href="amci-20230213.xsd#amci_CommonClassaNotSubjectToRedemptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CommonClassAMember_97435b99-266c-41f8-8523-9f0e255fe7e9" xlink:to="loc_amci_CommonClassaNotSubjectToRedemptionMember_9115df03-f9fd-46df-8838-0b1cd640347a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_d3d1fd70-b3fa-42c1-b24d-70151df4fb97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_2d3a94c8-f1a7-47c2-bbf3-62e023752546" xlink:to="loc_us-gaap_CommonClassBMember_d3d1fd70-b3fa-42c1-b24d-70151df4fb97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_3e3e7865-2630-444f-a875-c3aace11d581" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_47fa0cd7-e2f2-471d-af73-8eb77eb3d408" xlink:to="loc_dei_LegalEntityAxis_3e3e7865-2630-444f-a875-c3aace11d581" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_3e3e7865-2630-444f-a875-c3aace11d581_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_3e3e7865-2630-444f-a875-c3aace11d581" xlink:to="loc_dei_EntityDomain_3e3e7865-2630-444f-a875-c3aace11d581_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_0217676b-8da3-42fa-83ba-2a4cdadd5567" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_3e3e7865-2630-444f-a875-c3aace11d581" xlink:to="loc_dei_EntityDomain_0217676b-8da3-42fa-83ba-2a4cdadd5567" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AMCIACQUISITIONCORPIIMember_1660a6d3-b070-4a15-b8fd-52ed5c2b73a3" xlink:href="amci-20230213.xsd#amci_AMCIACQUISITIONCORPIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_0217676b-8da3-42fa-83ba-2a4cdadd5567" xlink:to="loc_amci_AMCIACQUISITIONCORPIIMember_1660a6d3-b070-4a15-b8fd-52ed5c2b73a3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/BALANCESHEETParenthetical" xlink:type="simple" xlink:href="amci-20230213.xsd#BALANCESHEETParenthetical"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/BALANCESHEETParenthetical" xlink:type="extended" id="ic50e9616a5654f41b272672e497bba9a_BALANCESHEETParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_47f3a210-3509-4407-9997-6bc861818af3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_54e1a3df-4d9b-4fcc-a51f-32d07af502d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_47f3a210-3509-4407-9997-6bc861818af3" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_54e1a3df-4d9b-4fcc-a51f-32d07af502d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_801805d2-bfe2-425b-80cd-9348177f9dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_47f3a210-3509-4407-9997-6bc861818af3" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_801805d2-bfe2-425b-80cd-9348177f9dd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_20fe033f-c155-4252-bea3-fe93eec7f66f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_47f3a210-3509-4407-9997-6bc861818af3" xlink:to="loc_us-gaap_PreferredStockSharesIssued_20fe033f-c155-4252-bea3-fe93eec7f66f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_dad2b630-7620-4f26-b1c2-10a4f8e434a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_47f3a210-3509-4407-9997-6bc861818af3" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_dad2b630-7620-4f26-b1c2-10a4f8e434a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_4f80e20f-5d97-4556-a955-c26d9a14db06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_47f3a210-3509-4407-9997-6bc861818af3" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_4f80e20f-5d97-4556-a955-c26d9a14db06" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_e8318032-560f-4062-954f-8b814082fde8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_47f3a210-3509-4407-9997-6bc861818af3" xlink:to="loc_us-gaap_CommonStockSharesIssued_e8318032-560f-4062-954f-8b814082fde8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_440034d8-7659-4ba1-9d1f-464eb7284070" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_47f3a210-3509-4407-9997-6bc861818af3" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_440034d8-7659-4ba1-9d1f-464eb7284070" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityRedemptionPricePerShare_28394c67-391e-4211-ae40-68915fa4822e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_47f3a210-3509-4407-9997-6bc861818af3" xlink:to="loc_us-gaap_TemporaryEquityRedemptionPricePerShare_28394c67-391e-4211-ae40-68915fa4822e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_8072dab2-656e-474a-a827-e987e64a56f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_47f3a210-3509-4407-9997-6bc861818af3" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_8072dab2-656e-474a-a827-e987e64a56f3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_4bd66da9-7b29-4aba-a566-4ad57bd05bda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_47f3a210-3509-4407-9997-6bc861818af3" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_4bd66da9-7b29-4aba-a566-4ad57bd05bda" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_15de97d1-6edf-40f7-a0c5-d7e0d61d6250" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_47f3a210-3509-4407-9997-6bc861818af3" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_15de97d1-6edf-40f7-a0c5-d7e0d61d6250" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_ba53cf0c-3743-4f7e-a34c-c2529daa039d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_47f3a210-3509-4407-9997-6bc861818af3" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_ba53cf0c-3743-4f7e-a34c-c2529daa039d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2c407f2c-faa3-4e3e-b280-17c0d15d4f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_47f3a210-3509-4407-9997-6bc861818af3" xlink:to="loc_us-gaap_StatementTable_2c407f2c-faa3-4e3e-b280-17c0d15d4f4a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_e9141058-0071-4c32-9b45-9d6ff8d8aa78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2c407f2c-faa3-4e3e-b280-17c0d15d4f4a" xlink:to="loc_us-gaap_StatementClassOfStockAxis_e9141058-0071-4c32-9b45-9d6ff8d8aa78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e9141058-0071-4c32-9b45-9d6ff8d8aa78_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_e9141058-0071-4c32-9b45-9d6ff8d8aa78" xlink:to="loc_us-gaap_ClassOfStockDomain_e9141058-0071-4c32-9b45-9d6ff8d8aa78_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6a4ec719-92d5-4746-a746-fc383f990a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_e9141058-0071-4c32-9b45-9d6ff8d8aa78" xlink:to="loc_us-gaap_ClassOfStockDomain_6a4ec719-92d5-4746-a746-fc383f990a4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_35bbd81d-6cee-48a3-9f7b-a60fe73bbdee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6a4ec719-92d5-4746-a746-fc383f990a4d" xlink:to="loc_us-gaap_CommonClassAMember_35bbd81d-6cee-48a3-9f7b-a60fe73bbdee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CommonClassaSubjectToRedemptionMember_03bc4c5d-08b6-4bb4-af25-15c3d17dee09" xlink:href="amci-20230213.xsd#amci_CommonClassaSubjectToRedemptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CommonClassAMember_35bbd81d-6cee-48a3-9f7b-a60fe73bbdee" xlink:to="loc_amci_CommonClassaSubjectToRedemptionMember_03bc4c5d-08b6-4bb4-af25-15c3d17dee09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CommonClassaNotSubjectToRedemptionMember_c2db6ce1-5482-4809-819d-c89cb75243c8" xlink:href="amci-20230213.xsd#amci_CommonClassaNotSubjectToRedemptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CommonClassAMember_35bbd81d-6cee-48a3-9f7b-a60fe73bbdee" xlink:to="loc_amci_CommonClassaNotSubjectToRedemptionMember_c2db6ce1-5482-4809-819d-c89cb75243c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_dec1b552-9d90-4a3b-9108-369766435435" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6a4ec719-92d5-4746-a746-fc383f990a4d" xlink:to="loc_us-gaap_CommonClassBMember_dec1b552-9d90-4a3b-9108-369766435435" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS" xlink:type="simple" xlink:href="amci-20230213.xsd#STATEMENTOFOPERATIONS"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS" xlink:type="extended" id="i4ae2b418d0724b61aabebbe752520ba6_STATEMENTOFOPERATIONS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e3976cc7-362a-4b09-b88b-83946527bb87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_33c22b7e-52cf-4176-8f92-b90b540be56b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e3976cc7-362a-4b09-b88b-83946527bb87" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_33c22b7e-52cf-4176-8f92-b90b540be56b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_6f748948-594a-4d47-b23e-708019880317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e3976cc7-362a-4b09-b88b-83946527bb87" xlink:to="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_6f748948-594a-4d47-b23e-708019880317" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CapitalBaseTaxExpense_756b3d87-5df7-4805-8ba9-6a459098940f" xlink:href="amci-20230213.xsd#amci_CapitalBaseTaxExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e3976cc7-362a-4b09-b88b-83946527bb87" xlink:to="loc_amci_CapitalBaseTaxExpense_756b3d87-5df7-4805-8ba9-6a459098940f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductionTaxExpense_b02c6244-650b-4d18-83a6-8ef7bc133d81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductionTaxExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e3976cc7-362a-4b09-b88b-83946527bb87" xlink:to="loc_us-gaap_ProductionTaxExpense_b02c6244-650b-4d18-83a6-8ef7bc133d81" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6f780719-9c88-4812-8a20-3b855caa98b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e3976cc7-362a-4b09-b88b-83946527bb87" xlink:to="loc_us-gaap_OperatingIncomeLoss_6f780719-9c88-4812-8a20-3b855caa98b5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_eec3938f-7dd0-479c-a2aa-b15639d8b613" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e3976cc7-362a-4b09-b88b-83946527bb87" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_eec3938f-7dd0-479c-a2aa-b15639d8b613" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_7270dbdc-720d-4da6-b745-720416b0892b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_eec3938f-7dd0-479c-a2aa-b15639d8b613" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_7270dbdc-720d-4da6-b745-720416b0892b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities_51d9cab4-440f-4164-b304-a0cfe4b144fd" xlink:href="amci-20230213.xsd#amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_eec3938f-7dd0-479c-a2aa-b15639d8b613" xlink:to="loc_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities_51d9cab4-440f-4164-b304-a0cfe4b144fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeFromInvestmentsHeldInTrustAccount_bfff92c3-8f27-44c5-8a93-d6b62f37a27f" xlink:href="amci-20230213.xsd#amci_IncomeFromInvestmentsHeldInTrustAccount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_eec3938f-7dd0-479c-a2aa-b15639d8b613" xlink:to="loc_amci_IncomeFromInvestmentsHeldInTrustAccount_bfff92c3-8f27-44c5-8a93-d6b62f37a27f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_42cd8f1c-32be-49ae-b229-377a881a4d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e3976cc7-362a-4b09-b88b-83946527bb87" xlink:to="loc_us-gaap_NetIncomeLoss_42cd8f1c-32be-49ae-b229-377a881a4d6a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a99ef95c-f053-44e9-94b6-d275e722c459" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e3976cc7-362a-4b09-b88b-83946527bb87" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a99ef95c-f053-44e9-94b6-d275e722c459" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_256ce803-7aac-417d-b655-233c7e860115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e3976cc7-362a-4b09-b88b-83946527bb87" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_256ce803-7aac-417d-b655-233c7e860115" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_0f826ef6-ab52-47ca-a0e1-89d1ba0ccfd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e3976cc7-362a-4b09-b88b-83946527bb87" xlink:to="loc_us-gaap_EarningsPerShareBasic_0f826ef6-ab52-47ca-a0e1-89d1ba0ccfd4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_584c4ad3-6e92-4245-8a5c-031a4c0f424e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e3976cc7-362a-4b09-b88b-83946527bb87" xlink:to="loc_us-gaap_EarningsPerShareDiluted_584c4ad3-6e92-4245-8a5c-031a4c0f424e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1c630c2f-baea-4361-93df-5796fa2c77a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e3976cc7-362a-4b09-b88b-83946527bb87" xlink:to="loc_us-gaap_StatementTable_1c630c2f-baea-4361-93df-5796fa2c77a2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_cbac23f2-dd02-441c-932b-6adce17da3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1c630c2f-baea-4361-93df-5796fa2c77a2" xlink:to="loc_us-gaap_StatementClassOfStockAxis_cbac23f2-dd02-441c-932b-6adce17da3ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_cbac23f2-dd02-441c-932b-6adce17da3ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_cbac23f2-dd02-441c-932b-6adce17da3ce" xlink:to="loc_us-gaap_ClassOfStockDomain_cbac23f2-dd02-441c-932b-6adce17da3ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_5ea59af4-d74b-4260-812e-ad7f65a54af8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_cbac23f2-dd02-441c-932b-6adce17da3ce" xlink:to="loc_us-gaap_ClassOfStockDomain_5ea59af4-d74b-4260-812e-ad7f65a54af8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_2982151c-a966-40eb-815b-dea7651b3bda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_5ea59af4-d74b-4260-812e-ad7f65a54af8" xlink:to="loc_us-gaap_CommonClassAMember_2982151c-a966-40eb-815b-dea7651b3bda" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_b3569d2c-de72-4c40-b2c7-c58443c4f5ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_5ea59af4-d74b-4260-812e-ad7f65a54af8" xlink:to="loc_us-gaap_CommonClassBMember_b3569d2c-de72-4c40-b2c7-c58443c4f5ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_921e4aa8-8be3-4f5d-b0e5-6ee1b2465605" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1c630c2f-baea-4361-93df-5796fa2c77a2" xlink:to="loc_dei_LegalEntityAxis_921e4aa8-8be3-4f5d-b0e5-6ee1b2465605" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_921e4aa8-8be3-4f5d-b0e5-6ee1b2465605_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_921e4aa8-8be3-4f5d-b0e5-6ee1b2465605" xlink:to="loc_dei_EntityDomain_921e4aa8-8be3-4f5d-b0e5-6ee1b2465605_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c49ca2a9-743e-4692-9526-e85707bcef8a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_921e4aa8-8be3-4f5d-b0e5-6ee1b2465605" xlink:to="loc_dei_EntityDomain_c49ca2a9-743e-4692-9526-e85707bcef8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AMCIACQUISITIONCORPIIMember_1e642f8c-89eb-455a-bda2-3b9e15c40c78" xlink:href="amci-20230213.xsd#amci_AMCIACQUISITIONCORPIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_c49ca2a9-743e-4692-9526-e85707bcef8a" xlink:to="loc_amci_AMCIACQUISITIONCORPIIMember_1e642f8c-89eb-455a-bda2-3b9e15c40c78" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT" xlink:type="simple" xlink:href="amci-20230213.xsd#STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT" xlink:type="extended" id="icf66e4288bfa4d14a0585e5971146e01_STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1ed4927e-a484-4189-8b83-c1b6d7bb0599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_dee19823-5d4d-4ec0-82df-0ffc67ea5e11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1ed4927e-a484-4189-8b83-c1b6d7bb0599" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_dee19823-5d4d-4ec0-82df-0ffc67ea5e11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c6f422f6-bf12-4152-bd6a-98d56b67e372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_dee19823-5d4d-4ec0-82df-0ffc67ea5e11" xlink:to="loc_us-gaap_StockholdersEquity_c6f422f6-bf12-4152-bd6a-98d56b67e372" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_85f75661-4c9e-4dc8-942e-fef90ea4993e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_dee19823-5d4d-4ec0-82df-0ffc67ea5e11" xlink:to="loc_us-gaap_SharesIssued_85f75661-4c9e-4dc8-942e-fef90ea4993e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_3646171a-c207-4f82-847a-7bf76690a773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_dee19823-5d4d-4ec0-82df-0ffc67ea5e11" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_3646171a-c207-4f82-847a-7bf76690a773" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_f38989ab-16f8-4394-ac20-96527cfbaa1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_dee19823-5d4d-4ec0-82df-0ffc67ea5e11" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_f38989ab-16f8-4394-ac20-96527cfbaa1c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_e10e133e-8068-4015-a5d8-256c7d23c380" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_dee19823-5d4d-4ec0-82df-0ffc67ea5e11" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_e10e133e-8068-4015-a5d8-256c7d23c380" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_c77ceb5b-2827-444c-8188-dacbe6d45d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_dee19823-5d4d-4ec0-82df-0ffc67ea5e11" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_c77ceb5b-2827-444c-8188-dacbe6d45d3c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_93217f54-98b7-49b3-bf30-420a2e2ed82b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_dee19823-5d4d-4ec0-82df-0ffc67ea5e11" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_93217f54-98b7-49b3-bf30-420a2e2ed82b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors_50c2316a-5e96-4017-9bf7-394da44a0f64" xlink:href="amci-20230213.xsd#amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_dee19823-5d4d-4ec0-82df-0ffc67ea5e11" xlink:to="loc_amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors_50c2316a-5e96-4017-9bf7-394da44a0f64" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_dab0cbc9-049d-4683-8872-1029750a12af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_dee19823-5d4d-4ec0-82df-0ffc67ea5e11" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_dab0cbc9-049d-4683-8872-1029750a12af" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5608002b-19d0-4d66-b978-1a40599315eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_dee19823-5d4d-4ec0-82df-0ffc67ea5e11" xlink:to="loc_us-gaap_NetIncomeLoss_5608002b-19d0-4d66-b978-1a40599315eb" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_fc40bc0a-a94c-4a1b-91ad-b39306cd24f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_0da2c5f6-349e-43d6-8ca0-99eb0da76262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_18fa2598-9baa-4c81-bf0c-b51ba23046cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1ed4927e-a484-4189-8b83-c1b6d7bb0599" xlink:to="loc_us-gaap_StatementTable_18fa2598-9baa-4c81-bf0c-b51ba23046cd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_bcf2216d-a9c1-4b93-87e9-901cfedc4ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_18fa2598-9baa-4c81-bf0c-b51ba23046cd" xlink:to="loc_us-gaap_StatementClassOfStockAxis_bcf2216d-a9c1-4b93-87e9-901cfedc4ba9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_bcf2216d-a9c1-4b93-87e9-901cfedc4ba9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_bcf2216d-a9c1-4b93-87e9-901cfedc4ba9" xlink:to="loc_us-gaap_ClassOfStockDomain_bcf2216d-a9c1-4b93-87e9-901cfedc4ba9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8a58a504-f33a-4ce5-8fc0-b37896bfbe09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_bcf2216d-a9c1-4b93-87e9-901cfedc4ba9" xlink:to="loc_us-gaap_ClassOfStockDomain_8a58a504-f33a-4ce5-8fc0-b37896bfbe09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_b15d6005-6234-4eea-b5ea-ff347935fc72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_8a58a504-f33a-4ce5-8fc0-b37896bfbe09" xlink:to="loc_us-gaap_CommonClassAMember_b15d6005-6234-4eea-b5ea-ff347935fc72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_4963cf04-a965-4cfe-bcf2-a2cead8f1c60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_8a58a504-f33a-4ce5-8fc0-b37896bfbe09" xlink:to="loc_us-gaap_CommonClassBMember_4963cf04-a965-4cfe-bcf2-a2cead8f1c60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2581647f-f875-4621-97c1-df2750c5fe74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_18fa2598-9baa-4c81-bf0c-b51ba23046cd" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2581647f-f875-4621-97c1-df2750c5fe74" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2581647f-f875-4621-97c1-df2750c5fe74_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2581647f-f875-4621-97c1-df2750c5fe74" xlink:to="loc_us-gaap_EquityComponentDomain_2581647f-f875-4621-97c1-df2750c5fe74_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1f28a26b-63ab-4bd3-a515-0a952ada0ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2581647f-f875-4621-97c1-df2750c5fe74" xlink:to="loc_us-gaap_EquityComponentDomain_1f28a26b-63ab-4bd3-a515-0a952ada0ae6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_1b95749f-d356-49e4-b8df-e95af8d6d967" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1f28a26b-63ab-4bd3-a515-0a952ada0ae6" xlink:to="loc_us-gaap_CommonStockMember_1b95749f-d356-49e4-b8df-e95af8d6d967" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_a0850f3c-d251-4ba4-8c5c-96118b42fd6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1f28a26b-63ab-4bd3-a515-0a952ada0ae6" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_a0850f3c-d251-4ba4-8c5c-96118b42fd6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_84dcd4af-605e-49a2-bb2c-f8a20b927e02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1f28a26b-63ab-4bd3-a515-0a952ada0ae6" xlink:to="loc_us-gaap_RetainedEarningsMember_84dcd4af-605e-49a2-bb2c-f8a20b927e02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_0c1c3cf2-074e-4e70-8922-404a603c4594" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_18fa2598-9baa-4c81-bf0c-b51ba23046cd" xlink:to="loc_dei_LegalEntityAxis_0c1c3cf2-074e-4e70-8922-404a603c4594" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_0c1c3cf2-074e-4e70-8922-404a603c4594_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_0c1c3cf2-074e-4e70-8922-404a603c4594" xlink:to="loc_dei_EntityDomain_0c1c3cf2-074e-4e70-8922-404a603c4594_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ab6bd045-d833-4b39-b34e-8c41771b1158" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_0c1c3cf2-074e-4e70-8922-404a603c4594" xlink:to="loc_dei_EntityDomain_ab6bd045-d833-4b39-b34e-8c41771b1158" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AMCIACQUISITIONCORPIIMember_3ee0ffae-da01-4714-9357-6244ab233788" xlink:href="amci-20230213.xsd#amci_AMCIACQUISITIONCORPIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_ab6bd045-d833-4b39-b34e-8c41771b1158" xlink:to="loc_amci_AMCIACQUISITIONCORPIIMember_3ee0ffae-da01-4714-9357-6244ab233788" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS" xlink:type="simple" xlink:href="amci-20230213.xsd#STATEMENTOFCASHFLOWS"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS" xlink:type="extended" id="i9fc891461b834337aa76cb07e2f00a9c_STATEMENTOFCASHFLOWS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5e5515e0-0d25-47ed-a036-6e4ee7f4bac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8f1e97f8-21f5-47ed-b08f-a167403fcd6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5e5515e0-0d25-47ed-a036-6e4ee7f4bac3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8f1e97f8-21f5-47ed-b08f-a167403fcd6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_420d21b2-b335-4249-a10b-beae61fc0851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8f1e97f8-21f5-47ed-b08f-a167403fcd6b" xlink:to="loc_us-gaap_ProfitLoss_420d21b2-b335-4249-a10b-beae61fc0851" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a666a007-9f60-4c09-a57f-662548fb317a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8f1e97f8-21f5-47ed-b08f-a167403fcd6b" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a666a007-9f60-4c09-a57f-662548fb317a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares_4b4dff33-fa50-45bf-8577-525e656ebedd" xlink:href="amci-20230213.xsd#amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a666a007-9f60-4c09-a57f-662548fb317a" xlink:to="loc_amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares_4b4dff33-fa50-45bf-8577-525e656ebedd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_d9c5a121-1837-4d4d-9340-242d23b8d78d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a666a007-9f60-4c09-a57f-662548fb317a" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_d9c5a121-1837-4d4d-9340-242d23b8d78d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities_619a65c0-aa30-4b97-8e8f-44410a385a40" xlink:href="amci-20230213.xsd#amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a666a007-9f60-4c09-a57f-662548fb317a" xlink:to="loc_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities_619a65c0-aa30-4b97-8e8f-44410a385a40" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeFromInvestmentsHeldInTrustAccount_011e02a0-3c2b-459e-804f-62ee51a4ee2a" xlink:href="amci-20230213.xsd#amci_IncomeFromInvestmentsHeldInTrustAccount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a666a007-9f60-4c09-a57f-662548fb317a" xlink:to="loc_amci_IncomeFromInvestmentsHeldInTrustAccount_011e02a0-3c2b-459e-804f-62ee51a4ee2a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42628b7d-fc96-4d43-9e04-f7849854e0c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a666a007-9f60-4c09-a57f-662548fb317a" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42628b7d-fc96-4d43-9e04-f7849854e0c4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_c636c678-540b-4016-9f93-c4cec60716c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42628b7d-fc96-4d43-9e04-f7849854e0c4" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_c636c678-540b-4016-9f93-c4cec60716c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_ea41768b-1eca-4e10-b5fe-893e18c2c9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42628b7d-fc96-4d43-9e04-f7849854e0c4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_ea41768b-1eca-4e10-b5fe-893e18c2c9d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DueToRelatedParty_326c954b-2be3-4998-8858-d010ed54a0f6" xlink:href="amci-20230213.xsd#amci_DueToRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42628b7d-fc96-4d43-9e04-f7849854e0c4" xlink:to="loc_amci_DueToRelatedParty_326c954b-2be3-4998-8858-d010ed54a0f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireTrustPreferredInvestments_0c24ac06-e556-436c-b4d5-326cadad1f10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireTrustPreferredInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42628b7d-fc96-4d43-9e04-f7849854e0c4" xlink:to="loc_us-gaap_PaymentsToAcquireTrustPreferredInvestments_0c24ac06-e556-436c-b4d5-326cadad1f10" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_72614b1c-055c-461c-bfb6-cf045f15f669" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42628b7d-fc96-4d43-9e04-f7849854e0c4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_72614b1c-055c-461c-bfb6-cf045f15f669" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncreaseDecreaseInCapitalBaseTaxPayable_f9477f0f-c8bb-45ac-9c98-f856f01b6a90" xlink:href="amci-20230213.xsd#amci_IncreaseDecreaseInCapitalBaseTaxPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42628b7d-fc96-4d43-9e04-f7849854e0c4" xlink:to="loc_amci_IncreaseDecreaseInCapitalBaseTaxPayable_f9477f0f-c8bb-45ac-9c98-f856f01b6a90" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncreaseDecreaseFranchiseTaxPayable_1022e373-aaad-4bb4-98ba-24750e81bcbe" xlink:href="amci-20230213.xsd#amci_IncreaseDecreaseFranchiseTaxPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42628b7d-fc96-4d43-9e04-f7849854e0c4" xlink:to="loc_amci_IncreaseDecreaseFranchiseTaxPayable_1022e373-aaad-4bb4-98ba-24750e81bcbe" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dccf2755-e650-4753-a514-9e2d331de5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8f1e97f8-21f5-47ed-b08f-a167403fcd6b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dccf2755-e650-4753-a514-9e2d331de5f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_499de0e7-2af6-4ed6-b6b0-204d282be86c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5e5515e0-0d25-47ed-a036-6e4ee7f4bac3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_499de0e7-2af6-4ed6-b6b0-204d282be86c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PaymentsForInvestmentOfCashInTrustAccount_3bf501f2-ef15-4bab-bdcc-a2b7169389e7" xlink:href="amci-20230213.xsd#amci_PaymentsForInvestmentOfCashInTrustAccount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_499de0e7-2af6-4ed6-b6b0-204d282be86c" xlink:to="loc_amci_PaymentsForInvestmentOfCashInTrustAccount_3bf501f2-ef15-4bab-bdcc-a2b7169389e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9a477875-a4f1-4c44-b224-89e8504bde38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_499de0e7-2af6-4ed6-b6b0-204d282be86c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9a477875-a4f1-4c44-b224-89e8504bde38" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_54ec4d1a-96ab-4fc7-8f0e-3f6c2f087540" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5e5515e0-0d25-47ed-a036-6e4ee7f4bac3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_54ec4d1a-96ab-4fc7-8f0e-3f6c2f087540" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt_b51a441f-df78-4b9b-83a5-3a92c449b665" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_54ec4d1a-96ab-4fc7-8f0e-3f6c2f087540" xlink:to="loc_us-gaap_ProceedsFromRelatedPartyDebt_b51a441f-df78-4b9b-83a5-3a92c449b665" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_6451110d-6bb8-4ed1-9abd-4c4bfbf1979d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_54ec4d1a-96ab-4fc7-8f0e-3f6c2f087540" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_6451110d-6bb8-4ed1-9abd-4c4bfbf1979d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_d7913063-572c-4061-b997-3daaf8ac7eca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_54ec4d1a-96ab-4fc7-8f0e-3f6c2f087540" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_d7913063-572c-4061-b997-3daaf8ac7eca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6c7bedf0-0e40-4be3-8ab9-9d89e3c49596" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_54ec4d1a-96ab-4fc7-8f0e-3f6c2f087540" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6c7bedf0-0e40-4be3-8ab9-9d89e3c49596" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7e018cbd-7ca0-47a8-8243-fa5b30eb4b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5e5515e0-0d25-47ed-a036-6e4ee7f4bac3" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7e018cbd-7ca0-47a8-8243-fa5b30eb4b4a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3500f740-dcab-44d5-84a4-37f387d4e192" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5e5515e0-0d25-47ed-a036-6e4ee7f4bac3" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3500f740-dcab-44d5-84a4-37f387d4e192" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dd1f576e-96e1-435e-9dff-dab47c43122f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_3dc9938f-face-41a2-8427-e0e6dba3d34e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5e5515e0-0d25-47ed-a036-6e4ee7f4bac3" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_3dc9938f-face-41a2-8427-e0e6dba3d34e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredOfferingCostsIncludedInNotesPayable_28285b70-c65a-4bab-8cb3-cb1d6e28ba13" xlink:href="amci-20230213.xsd#amci_DeferredOfferingCostsIncludedInNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_3dc9938f-face-41a2-8427-e0e6dba3d34e" xlink:to="loc_amci_DeferredOfferingCostsIncludedInNotesPayable_28285b70-c65a-4bab-8cb3-cb1d6e28ba13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OfferingCostsIncludedInAccountsPayableAccruedExpenses_9cc53e46-6079-49b6-a1e6-55f87fb4568f" xlink:href="amci-20230213.xsd#amci_OfferingCostsIncludedInAccountsPayableAccruedExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_3dc9938f-face-41a2-8427-e0e6dba3d34e" xlink:to="loc_amci_OfferingCostsIncludedInAccountsPayableAccruedExpenses_9cc53e46-6079-49b6-a1e6-55f87fb4568f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingFeePayable_18b0e515-1c68-4b42-b1f1-0545e522aba1" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingFeePayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_3dc9938f-face-41a2-8427-e0e6dba3d34e" xlink:to="loc_amci_DeferredUnderwritingFeePayable_18b0e515-1c68-4b42-b1f1-0545e522aba1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_StockIssuanceCostsNoncash_5f9dc2e0-aaf0-43aa-b34d-6ae36891ec17" xlink:href="amci-20230213.xsd#amci_StockIssuanceCostsNoncash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_3dc9938f-face-41a2-8427-e0e6dba3d34e" xlink:to="loc_amci_StockIssuanceCostsNoncash_5f9dc2e0-aaf0-43aa-b34d-6ae36891ec17" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties_253fb604-949a-48e3-a19d-7478c996922f" xlink:href="amci-20230213.xsd#amci_NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_3dc9938f-face-41a2-8427-e0e6dba3d34e" xlink:to="loc_amci_NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties_253fb604-949a-48e3-a19d-7478c996922f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NoncashRepaymentOfNotePayableAndAdvances_d7fb5b0e-852e-49c2-863f-4fdf87bc163c" xlink:href="amci-20230213.xsd#amci_NoncashRepaymentOfNotePayableAndAdvances"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_3dc9938f-face-41a2-8427-e0e6dba3d34e" xlink:to="loc_amci_NoncashRepaymentOfNotePayableAndAdvances_d7fb5b0e-852e-49c2-863f-4fdf87bc163c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NoncashDeferredUnderwritingCommissions_7f0618f8-a01d-4391-9f82-916172f3719e" xlink:href="amci-20230213.xsd#amci_NoncashDeferredUnderwritingCommissions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_3dc9938f-face-41a2-8427-e0e6dba3d34e" xlink:to="loc_amci_NoncashDeferredUnderwritingCommissions_7f0618f8-a01d-4391-9f82-916172f3719e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering_9ddbd602-d3e8-47fd-9da4-7b1e710538d8" xlink:href="amci-20230213.xsd#amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_3dc9938f-face-41a2-8427-e0e6dba3d34e" xlink:to="loc_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering_9ddbd602-d3e8-47fd-9da4-7b1e710538d8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_19c98fa6-588a-47bf-9111-767b5c68bf8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_5e5515e0-0d25-47ed-a036-6e4ee7f4bac3" xlink:to="loc_us-gaap_StatementTable_19c98fa6-588a-47bf-9111-767b5c68bf8f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_44f31e63-62bb-4b49-846d-42af608eb908" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_19c98fa6-588a-47bf-9111-767b5c68bf8f" xlink:to="loc_dei_LegalEntityAxis_44f31e63-62bb-4b49-846d-42af608eb908" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_44f31e63-62bb-4b49-846d-42af608eb908_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_44f31e63-62bb-4b49-846d-42af608eb908" xlink:to="loc_dei_EntityDomain_44f31e63-62bb-4b49-846d-42af608eb908_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_0c0afd72-c1fd-4a47-8c98-a99e18b38de5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_44f31e63-62bb-4b49-846d-42af608eb908" xlink:to="loc_dei_EntityDomain_0c0afd72-c1fd-4a47-8c98-a99e18b38de5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AMCIACQUISITIONCORPIIMember_ea2449b3-185e-4c40-b85e-fc4460fd2c98" xlink:href="amci-20230213.xsd#amci_AMCIACQUISITIONCORPIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_0c0afd72-c1fd-4a47-8c98-a99e18b38de5" xlink:to="loc_amci_AMCIACQUISITIONCORPIIMember_ea2449b3-185e-4c40-b85e-fc4460fd2c98" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED" xlink:type="simple" xlink:href="amci-20230213.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED" xlink:type="extended" id="ic51c40e398314c398765057a345d34b0_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_acf0ecf3-e665-47cc-a3e5-77c84aa4ff5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:to="loc_us-gaap_RevenuesAbstract_acf0ecf3-e665-47cc-a3e5-77c84aa4ff5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_2746b5b6-3efa-45ce-9c4c-96510eaa4a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_acf0ecf3-e665-47cc-a3e5-77c84aa4ff5e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_2746b5b6-3efa-45ce-9c4c-96510eaa4a8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_d688eca5-92be-4ad1-a8ed-5041a23bfbda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_acf0ecf3-e665-47cc-a3e5-77c84aa4ff5e" xlink:to="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_d688eca5-92be-4ad1-a8ed-5041a23bfbda" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_e924d784-86fb-4f15-ac16-e284c6470bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_acf0ecf3-e665-47cc-a3e5-77c84aa4ff5e" xlink:to="loc_us-gaap_RevenueFromRelatedParties_e924d784-86fb-4f15-ac16-e284c6470bbb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_8e6ad674-99e6-41a0-b5b5-ca7187794477" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_acf0ecf3-e665-47cc-a3e5-77c84aa4ff5e" xlink:to="loc_us-gaap_Revenues_8e6ad674-99e6-41a0-b5b5-ca7187794477" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_9becdb41-626b-48fb-a39d-613a57d702b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_9becdb41-626b-48fb-a39d-613a57d702b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_9fac1064-7bfd-41d2-a89a-e311f498bc46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9becdb41-626b-48fb-a39d-613a57d702b7" xlink:to="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_9fac1064-7bfd-41d2-a89a-e311f498bc46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_15aef306-dc06-4d24-a3fb-447f9378efc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9becdb41-626b-48fb-a39d-613a57d702b7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_15aef306-dc06-4d24-a3fb-447f9378efc3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_1a1fdfd5-70ab-4300-ae37-250abefc215a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9becdb41-626b-48fb-a39d-613a57d702b7" xlink:to="loc_us-gaap_Depreciation_1a1fdfd5-70ab-4300-ae37-250abefc215a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4cbf772b-33c2-4acf-a767-02c4733d6253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9becdb41-626b-48fb-a39d-613a57d702b7" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4cbf772b-33c2-4acf-a767-02c4733d6253" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_975a260d-e0db-4ca7-91d5-12b89486ceae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9becdb41-626b-48fb-a39d-613a57d702b7" xlink:to="loc_us-gaap_CostsAndExpenses_975a260d-e0db-4ca7-91d5-12b89486ceae" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b0b3e25f-1432-4625-943a-30c0e57c177a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:to="loc_us-gaap_OperatingIncomeLoss_b0b3e25f-1432-4625-943a-30c0e57c177a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e11bf529-f34c-4af9-b9c5-f38659a57cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e11bf529-f34c-4af9-b9c5-f38659a57cfb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_fc64eb3f-825e-4c07-9311-dc2fa7c826cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e11bf529-f34c-4af9-b9c5-f38659a57cfb" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_fc64eb3f-825e-4c07-9311-dc2fa7c826cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_11aaa23d-a208-4ced-860b-ad223f559f93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e11bf529-f34c-4af9-b9c5-f38659a57cfb" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_11aaa23d-a208-4ced-860b-ad223f559f93" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ce0d9bb0-6074-43e7-bc95-5b89c92edc7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e11bf529-f34c-4af9-b9c5-f38659a57cfb" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ce0d9bb0-6074-43e7-bc95-5b89c92edc7c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_39213f71-3cb5-42ce-9595-24963c0672bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e11bf529-f34c-4af9-b9c5-f38659a57cfb" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_39213f71-3cb5-42ce-9595-24963c0672bd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ed9b2fc7-5627-4120-8fa4-6918dd9a6b17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ed9b2fc7-5627-4120-8fa4-6918dd9a6b17" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_04288034-5382-434d-9c77-599693c8e56a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_04288034-5382-434d-9c77-599693c8e56a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment_b04c919a-7d94-40c5-9629-0ffb866323d7" xlink:href="amci-20230213.xsd#amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:to="loc_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment_b04c919a-7d94-40c5-9629-0ffb866323d7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_71e251c6-60cc-46c2-8df5-cdd9f04d1731" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:to="loc_us-gaap_NetIncomeLoss_71e251c6-60cc-46c2-8df5-cdd9f04d1731" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact_15269f91-a186-424c-a746-4efafd685917" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:to="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact_15269f91-a186-424c-a746-4efafd685917" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_77841741-38fb-4086-91b6-cff3fe06a367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_77841741-38fb-4086-91b6-cff3fe06a367" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_8170d51c-1589-4f45-bf4d-f1086e88da0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_8170d51c-1589-4f45-bf4d-f1086e88da0a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_f667eabd-17de-47ae-9264-f59f235af05c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_8170d51c-1589-4f45-bf4d-f1086e88da0a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_f667eabd-17de-47ae-9264-f59f235af05c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_e4301a84-eb34-4066-8126-cfcb4dc8b709" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_8170d51c-1589-4f45-bf4d-f1086e88da0a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_e4301a84-eb34-4066-8126-cfcb4dc8b709" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_533a1bfe-a28b-4d16-8138-8943ce36658e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:to="loc_us-gaap_EarningsPerShareBasic_533a1bfe-a28b-4d16-8138-8943ce36658e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_52940994-ae9d-43ca-942a-d55e01b02db8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:to="loc_us-gaap_EarningsPerShareDiluted_52940994-ae9d-43ca-942a-d55e01b02db8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1b6fd420-197f-4236-a24f-4cd35d248f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1b6fd420-197f-4236-a24f-4cd35d248f2e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_830d6b65-57d6-48b5-8604-2bc779b400fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_830d6b65-57d6-48b5-8604-2bc779b400fb" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7175a5a7-a2df-4cb1-b94d-d5e08fb68bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:to="loc_us-gaap_StatementTable_7175a5a7-a2df-4cb1-b94d-d5e08fb68bd0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedAndNonrelatedPartyStatusAxis_b2a7f35a-54c4-4f5c-af12-32e71ce07bb2" xlink:href="amci-20230213.xsd#amci_RelatedAndNonrelatedPartyStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7175a5a7-a2df-4cb1-b94d-d5e08fb68bd0" xlink:to="loc_amci_RelatedAndNonrelatedPartyStatusAxis_b2a7f35a-54c4-4f5c-af12-32e71ce07bb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedAndNonrelatedPartyStatusDomain_b2a7f35a-54c4-4f5c-af12-32e71ce07bb2_default" xlink:href="amci-20230213.xsd#amci_RelatedAndNonrelatedPartyStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_amci_RelatedAndNonrelatedPartyStatusAxis_b2a7f35a-54c4-4f5c-af12-32e71ce07bb2" xlink:to="loc_amci_RelatedAndNonrelatedPartyStatusDomain_b2a7f35a-54c4-4f5c-af12-32e71ce07bb2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedAndNonrelatedPartyStatusDomain_dbbde72a-3353-41e9-ab3b-b1642f83bf1d" xlink:href="amci-20230213.xsd#amci_RelatedAndNonrelatedPartyStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_amci_RelatedAndNonrelatedPartyStatusAxis_b2a7f35a-54c4-4f5c-af12-32e71ce07bb2" xlink:to="loc_amci_RelatedAndNonrelatedPartyStatusDomain_dbbde72a-3353-41e9-ab3b-b1642f83bf1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartyMember_b49cf4cf-a585-452b-bae4-69a920710267" xlink:href="amci-20230213.xsd#amci_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_RelatedAndNonrelatedPartyStatusDomain_dbbde72a-3353-41e9-ab3b-b1642f83bf1d" xlink:to="loc_amci_RelatedPartyMember_b49cf4cf-a585-452b-bae4-69a920710267" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_df554e44-c75a-45fc-9d7e-f9d8cc102b01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7175a5a7-a2df-4cb1-b94d-d5e08fb68bd0" xlink:to="loc_us-gaap_TypeOfArrangementAxis_df554e44-c75a-45fc-9d7e-f9d8cc102b01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_df554e44-c75a-45fc-9d7e-f9d8cc102b01_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_df554e44-c75a-45fc-9d7e-f9d8cc102b01" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_df554e44-c75a-45fc-9d7e-f9d8cc102b01_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_52977176-79d7-48a3-adbd-d402bc4e1560" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_df554e44-c75a-45fc-9d7e-f9d8cc102b01" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_52977176-79d7-48a3-adbd-d402bc4e1560" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_032a4f7e-b27a-40b3-a42d-fea5b39a88bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_52977176-79d7-48a3-adbd-d402bc4e1560" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_032a4f7e-b27a-40b3-a42d-fea5b39a88bd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED" xlink:type="simple" xlink:href="amci-20230213.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED" xlink:type="extended" id="i412cd6c2980a43ea865fd9eae00bc436_CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ef60ae80-222a-4e16-a623-42e65db71746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3361fd3d-7387-49db-8067-2e650b1095a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ef60ae80-222a-4e16-a623-42e65db71746" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3361fd3d-7387-49db-8067-2e650b1095a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_22c8c46b-2115-4068-b005-b66967a8549a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3361fd3d-7387-49db-8067-2e650b1095a7" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_22c8c46b-2115-4068-b005-b66967a8549a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6a1d7bcf-c33f-45bf-8fbd-00ba51314820" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3361fd3d-7387-49db-8067-2e650b1095a7" xlink:to="loc_us-gaap_StockholdersEquity_6a1d7bcf-c33f-45bf-8fbd-00ba51314820" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4687f0db-f147-423d-81d1-546df72b1978" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3361fd3d-7387-49db-8067-2e650b1095a7" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4687f0db-f147-423d-81d1-546df72b1978" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments_a124aa8e-26f7-408e-8724-b5880aaafea6" xlink:href="amci-20230213.xsd#amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3361fd3d-7387-49db-8067-2e650b1095a7" xlink:to="loc_amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments_a124aa8e-26f7-408e-8724-b5880aaafea6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b6811ab0-8d23-4798-b257-1f18faccd520" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3361fd3d-7387-49db-8067-2e650b1095a7" xlink:to="loc_us-gaap_NetIncomeLoss_b6811ab0-8d23-4798-b257-1f18faccd520" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c8d7eec3-5c17-417b-8a5e-d4150df8b814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3361fd3d-7387-49db-8067-2e650b1095a7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c8d7eec3-5c17-417b-8a5e-d4150df8b814" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_c49bf888-2f5e-4a17-b452-8134c4f90fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3361fd3d-7387-49db-8067-2e650b1095a7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_c49bf888-2f5e-4a17-b452-8134c4f90fa4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_746c9227-dac5-4324-ac25-cde70413b37e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3361fd3d-7387-49db-8067-2e650b1095a7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_746c9227-dac5-4324-ac25-cde70413b37e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2b52e5d5-3fb1-4181-b57d-0d9b7c247927" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3361fd3d-7387-49db-8067-2e650b1095a7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2b52e5d5-3fb1-4181-b57d-0d9b7c247927" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_7a600743-66da-435d-a659-a133acc5a1b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_94bc1b6a-1786-4591-89ab-71ba5ec6eca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_db9b9e34-a9ed-4598-b437-29948fde2fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ef60ae80-222a-4e16-a623-42e65db71746" xlink:to="loc_us-gaap_StatementTable_db9b9e34-a9ed-4598-b437-29948fde2fc7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d1b8777c-797e-4dba-b76c-cfb16cb41d67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_db9b9e34-a9ed-4598-b437-29948fde2fc7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d1b8777c-797e-4dba-b76c-cfb16cb41d67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d1b8777c-797e-4dba-b76c-cfb16cb41d67_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d1b8777c-797e-4dba-b76c-cfb16cb41d67" xlink:to="loc_us-gaap_EquityComponentDomain_d1b8777c-797e-4dba-b76c-cfb16cb41d67_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2208b8f4-9074-49d5-9c0b-afe8f1c9001a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d1b8777c-797e-4dba-b76c-cfb16cb41d67" xlink:to="loc_us-gaap_EquityComponentDomain_2208b8f4-9074-49d5-9c0b-afe8f1c9001a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7b47bfd7-8307-48e9-ac3e-ef607e94a565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2208b8f4-9074-49d5-9c0b-afe8f1c9001a" xlink:to="loc_us-gaap_CommonStockMember_7b47bfd7-8307-48e9-ac3e-ef607e94a565" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_cab8327d-5067-4554-be49-4bf1e47cf82d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2208b8f4-9074-49d5-9c0b-afe8f1c9001a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_cab8327d-5067-4554-be49-4bf1e47cf82d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_20b610a5-26c4-4b80-bb50-0a4cdbf64ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2208b8f4-9074-49d5-9c0b-afe8f1c9001a" xlink:to="loc_us-gaap_RetainedEarningsMember_20b610a5-26c4-4b80-bb50-0a4cdbf64ea0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a0d83642-eb1b-474b-8d83-29117fe0d802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2208b8f4-9074-49d5-9c0b-afe8f1c9001a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a0d83642-eb1b-474b-8d83-29117fe0d802" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="amci-20230213.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="extended" id="i59eaea011a2142f6a0edbf7f16fab9db_CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_7b431d38-17fa-4e27-acf0-5825ddc89706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:to="loc_us-gaap_RevenuesAbstract_7b431d38-17fa-4e27-acf0-5825ddc89706" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_3de8faaa-c93d-4e1c-a492-5b594f35d51f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_7b431d38-17fa-4e27-acf0-5825ddc89706" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_3de8faaa-c93d-4e1c-a492-5b594f35d51f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_27a713ea-f6e9-4c81-b45b-4169cabed164" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_7b431d38-17fa-4e27-acf0-5825ddc89706" xlink:to="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_27a713ea-f6e9-4c81-b45b-4169cabed164" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_525cace1-fe48-4284-933f-6dbfad495311" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_7b431d38-17fa-4e27-acf0-5825ddc89706" xlink:to="loc_us-gaap_RevenueFromRelatedParties_525cace1-fe48-4284-933f-6dbfad495311" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_37c63081-cd00-4923-b8c6-e1d69c0a6a53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_7b431d38-17fa-4e27-acf0-5825ddc89706" xlink:to="loc_us-gaap_Revenues_37c63081-cd00-4923-b8c6-e1d69c0a6a53" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_c459f12f-f6e4-4677-a8ee-015704b4972e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_c459f12f-f6e4-4677-a8ee-015704b4972e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_5d08ee59-976e-4fd9-a567-1b55878cc001" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_c459f12f-f6e4-4677-a8ee-015704b4972e" xlink:to="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_5d08ee59-976e-4fd9-a567-1b55878cc001" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_c72bde8f-5c35-4508-a84e-ed7f8c379f63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_c459f12f-f6e4-4677-a8ee-015704b4972e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_c72bde8f-5c35-4508-a84e-ed7f8c379f63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_8a251fe6-32ed-4da1-a8cc-d8bbbf172e43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_c459f12f-f6e4-4677-a8ee-015704b4972e" xlink:to="loc_us-gaap_Depreciation_8a251fe6-32ed-4da1-a8cc-d8bbbf172e43" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_85180d5a-4b46-4113-bf38-aa52cf097208" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_c459f12f-f6e4-4677-a8ee-015704b4972e" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_85180d5a-4b46-4113-bf38-aa52cf097208" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_b7fee8df-d2b4-4b6c-b893-b3564aca1496" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_c459f12f-f6e4-4677-a8ee-015704b4972e" xlink:to="loc_us-gaap_CostsAndExpenses_b7fee8df-d2b4-4b6c-b893-b3564aca1496" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_2cbec3fc-c8ee-43d9-a53b-17ff80c13f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:to="loc_us-gaap_OperatingIncomeLoss_2cbec3fc-c8ee-43d9-a53b-17ff80c13f4a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_7a1df2af-1514-4a64-9852-bed97cc9ea73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_7a1df2af-1514-4a64-9852-bed97cc9ea73" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_549e7485-cf54-43fe-a48a-02078ef53d03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_7a1df2af-1514-4a64-9852-bed97cc9ea73" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_549e7485-cf54-43fe-a48a-02078ef53d03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f96908cf-1d3f-4eeb-b775-a1d417691017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_7a1df2af-1514-4a64-9852-bed97cc9ea73" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f96908cf-1d3f-4eeb-b775-a1d417691017" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_1417ed12-2f4f-4a61-b65d-3ecf91fd1827" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_7a1df2af-1514-4a64-9852-bed97cc9ea73" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_1417ed12-2f4f-4a61-b65d-3ecf91fd1827" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_b2546adb-f57d-49b6-a723-a3c0ed1fd2b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_7a1df2af-1514-4a64-9852-bed97cc9ea73" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_b2546adb-f57d-49b6-a723-a3c0ed1fd2b7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_459a9384-774a-4647-8b1f-3352343c0a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_459a9384-774a-4647-8b1f-3352343c0a4a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_742ee07a-7155-4a1a-8a75-5166ff78623a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_742ee07a-7155-4a1a-8a75-5166ff78623a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment_d901682e-712f-47d3-a58f-5a32f5b0a08a" xlink:href="amci-20230213.xsd#amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:to="loc_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment_d901682e-712f-47d3-a58f-5a32f5b0a08a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0d3d3358-dddb-43a4-822e-1399e613e6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:to="loc_us-gaap_NetIncomeLoss_0d3d3358-dddb-43a4-822e-1399e613e6b8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact_68d5ded3-e204-438d-a4ac-0a4f5c39bad9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:to="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact_68d5ded3-e204-438d-a4ac-0a4f5c39bad9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_583427cb-9e8e-43ad-92cc-8e0c0d3cb583" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_583427cb-9e8e-43ad-92cc-8e0c0d3cb583" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_33cd4e2f-f8a2-451c-9ce6-55487c0ef944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_33cd4e2f-f8a2-451c-9ce6-55487c0ef944" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3907877a-8771-4614-84df-8d60af74c31f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_33cd4e2f-f8a2-451c-9ce6-55487c0ef944" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3907877a-8771-4614-84df-8d60af74c31f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_1cf28efc-96b3-4f6f-8023-e021fae2002c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_33cd4e2f-f8a2-451c-9ce6-55487c0ef944" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_1cf28efc-96b3-4f6f-8023-e021fae2002c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_eef5d0ab-228c-4d3f-b0bc-8f56d94b7637" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:to="loc_us-gaap_EarningsPerShareBasic_eef5d0ab-228c-4d3f-b0bc-8f56d94b7637" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_d8cbd96e-2858-46e0-bba4-db54fd258680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:to="loc_us-gaap_EarningsPerShareDiluted_d8cbd96e-2858-46e0-bba4-db54fd258680" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2f5872ff-a404-4c6d-bfe3-e0bf51f04473" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2f5872ff-a404-4c6d-bfe3-e0bf51f04473" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_96bf93f5-a8ac-4a94-82f4-bebdeaee3865" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_96bf93f5-a8ac-4a94-82f4-bebdeaee3865" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_13255535-0854-4a04-9039-80b46b9622fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:to="loc_us-gaap_StatementTable_13255535-0854-4a04-9039-80b46b9622fa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedAndNonrelatedPartyStatusAxis_a5cf4f4e-fa82-4c9c-aeac-99833cb36bfe" xlink:href="amci-20230213.xsd#amci_RelatedAndNonrelatedPartyStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_13255535-0854-4a04-9039-80b46b9622fa" xlink:to="loc_amci_RelatedAndNonrelatedPartyStatusAxis_a5cf4f4e-fa82-4c9c-aeac-99833cb36bfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedAndNonrelatedPartyStatusDomain_a5cf4f4e-fa82-4c9c-aeac-99833cb36bfe_default" xlink:href="amci-20230213.xsd#amci_RelatedAndNonrelatedPartyStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_amci_RelatedAndNonrelatedPartyStatusAxis_a5cf4f4e-fa82-4c9c-aeac-99833cb36bfe" xlink:to="loc_amci_RelatedAndNonrelatedPartyStatusDomain_a5cf4f4e-fa82-4c9c-aeac-99833cb36bfe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedAndNonrelatedPartyStatusDomain_65fea499-f6b1-4d3e-9958-88731bca141c" xlink:href="amci-20230213.xsd#amci_RelatedAndNonrelatedPartyStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_amci_RelatedAndNonrelatedPartyStatusAxis_a5cf4f4e-fa82-4c9c-aeac-99833cb36bfe" xlink:to="loc_amci_RelatedAndNonrelatedPartyStatusDomain_65fea499-f6b1-4d3e-9958-88731bca141c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartyMember_f526c74d-97a5-44ce-b140-3e96054817b5" xlink:href="amci-20230213.xsd#amci_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_RelatedAndNonrelatedPartyStatusDomain_65fea499-f6b1-4d3e-9958-88731bca141c" xlink:to="loc_amci_RelatedPartyMember_f526c74d-97a5-44ce-b140-3e96054817b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_9893acbe-dba6-4147-a174-9e0b9a68da64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_13255535-0854-4a04-9039-80b46b9622fa" xlink:to="loc_us-gaap_TypeOfArrangementAxis_9893acbe-dba6-4147-a174-9e0b9a68da64" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_9893acbe-dba6-4147-a174-9e0b9a68da64_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_9893acbe-dba6-4147-a174-9e0b9a68da64" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_9893acbe-dba6-4147-a174-9e0b9a68da64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4bc9c99b-278d-4e15-8e85-10575cbed670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_9893acbe-dba6-4147-a174-9e0b9a68da64" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4bc9c99b-278d-4e15-8e85-10575cbed670" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_7fec58cf-fecd-426b-888b-453edc06bee9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4bc9c99b-278d-4e15-8e85-10575cbed670" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_7fec58cf-fecd-426b-888b-453edc06bee9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="amci-20230213.xsd#CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT" xlink:type="extended" id="ib1ae2335df924b9b9a80ebe33c2a8c49_CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ff156a9a-37a8-4719-b914-38e6c6888b40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_be557772-094e-412d-9f3b-27652677c28c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ff156a9a-37a8-4719-b914-38e6c6888b40" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_be557772-094e-412d-9f3b-27652677c28c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_849df79d-1425-44e5-964f-dbfde9346aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_be557772-094e-412d-9f3b-27652677c28c" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_849df79d-1425-44e5-964f-dbfde9346aa7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3088ecfc-6974-44e4-88b1-829e398287c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_be557772-094e-412d-9f3b-27652677c28c" xlink:to="loc_us-gaap_StockholdersEquity_3088ecfc-6974-44e4-88b1-829e398287c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_ade8c1e2-1c04-481d-96cf-1fd209aae11d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_be557772-094e-412d-9f3b-27652677c28c" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_ade8c1e2-1c04-481d-96cf-1fd209aae11d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments_fab2cc9c-dd73-41e4-97db-f74aee708a98" xlink:href="amci-20230213.xsd#amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_be557772-094e-412d-9f3b-27652677c28c" xlink:to="loc_amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments_fab2cc9c-dd73-41e4-97db-f74aee708a98" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_914046e5-bdff-4708-b381-d19186c958be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_be557772-094e-412d-9f3b-27652677c28c" xlink:to="loc_us-gaap_NetIncomeLoss_914046e5-bdff-4708-b381-d19186c958be" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_96568cf0-b2ba-4b0b-9535-d8f35e4e5711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_be557772-094e-412d-9f3b-27652677c28c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_96568cf0-b2ba-4b0b-9535-d8f35e4e5711" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_fd8506dc-5780-43a1-8885-9bc5a6776598" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_be557772-094e-412d-9f3b-27652677c28c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_fd8506dc-5780-43a1-8885-9bc5a6776598" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_fd26f13b-9b70-4771-b2b2-00c2334eb258" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_be557772-094e-412d-9f3b-27652677c28c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_fd26f13b-9b70-4771-b2b2-00c2334eb258" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_fe74db8d-ec7b-493e-bc67-be397d388d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_04a0304b-5822-43a2-9108-b22b728bec26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_bc2de6f7-6a7e-42d2-a802-a26dab3bd22f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ff156a9a-37a8-4719-b914-38e6c6888b40" xlink:to="loc_us-gaap_StatementTable_bc2de6f7-6a7e-42d2-a802-a26dab3bd22f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e95bd905-7b41-4828-9099-c7d61eab6770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_bc2de6f7-6a7e-42d2-a802-a26dab3bd22f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e95bd905-7b41-4828-9099-c7d61eab6770" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e95bd905-7b41-4828-9099-c7d61eab6770_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e95bd905-7b41-4828-9099-c7d61eab6770" xlink:to="loc_us-gaap_EquityComponentDomain_e95bd905-7b41-4828-9099-c7d61eab6770_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a6e2f0c6-05ec-4af4-896b-4ea325c8f8cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e95bd905-7b41-4828-9099-c7d61eab6770" xlink:to="loc_us-gaap_EquityComponentDomain_a6e2f0c6-05ec-4af4-896b-4ea325c8f8cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6f971af9-99ab-4956-8d6a-ee64284d8578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a6e2f0c6-05ec-4af4-896b-4ea325c8f8cd" xlink:to="loc_us-gaap_CommonStockMember_6f971af9-99ab-4956-8d6a-ee64284d8578" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_2add8e70-38a9-47c1-b5f0-845725128d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a6e2f0c6-05ec-4af4-896b-4ea325c8f8cd" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_2add8e70-38a9-47c1-b5f0-845725128d3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_46774186-6194-4f7b-8058-bcd686735eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a6e2f0c6-05ec-4af4-896b-4ea325c8f8cd" xlink:to="loc_us-gaap_RetainedEarningsMember_46774186-6194-4f7b-8058-bcd686735eeb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7997418e-9530-4ec8-a7ab-44f129fa0b22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a6e2f0c6-05ec-4af4-896b-4ea325c8f8cd" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7997418e-9530-4ec8-a7ab-44f129fa0b22" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#DescriptionofOrganizationandBusinessOperationsDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails" xlink:type="extended" id="ifec5c093bd164b298264dface4e82f1b_DescriptionofOrganizationandBusinessOperationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum_f0c8a8ed-f5bb-47ad-8c4b-b405fba46ad9" xlink:href="amci-20230213.xsd#amci_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum_f0c8a8ed-f5bb-47ad-8c4b-b405fba46ad9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_UnitsIssuedDuringPeriodSharesNewIssues_936aaf7a-72e7-4bf1-b5a9-ba11ec7199f6" xlink:href="amci-20230213.xsd#amci_UnitsIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_UnitsIssuedDuringPeriodSharesNewIssues_936aaf7a-72e7-4bf1-b5a9-ba11ec7199f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_3c079317-b6b2-4872-93a8-05dd088f9ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_3c079317-b6b2-4872-93a8-05dd088f9ce9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights_58b24ac9-a224-405a-836d-97da7e1a47bc" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights_58b24ac9-a224-405a-836d-97da7e1a47bc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_a05d5756-92f7-4c37-8a6e-75d9e7ca611b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_a05d5756-92f7-4c37-8a6e-75d9e7ca611b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_44bd403f-17ee-4ed0-946c-6cc78596b890" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_44bd403f-17ee-4ed0-946c-6cc78596b890" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_56d87219-79be-4368-8bb0-24971278adae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_56d87219-79be-4368-8bb0-24971278adae" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_e16a0c31-d88d-4aa2-856a-b0bf1f1d56fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_e16a0c31-d88d-4aa2-856a-b0bf1f1d56fc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TransactionCosts_cfc34899-738e-41df-998e-9e01150b12ab" xlink:href="amci-20230213.xsd#amci_TransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_TransactionCosts_cfc34899-738e-41df-998e-9e01150b12ab" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering_ce1fb3e4-97a4-481c-95a0-84247a0acf27" xlink:href="amci-20230213.xsd#amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_TransactionCosts_cfc34899-738e-41df-998e-9e01150b12ab" xlink:to="loc_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering_ce1fb3e4-97a4-481c-95a0-84247a0acf27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SaleOfStockUnderwritingDiscounts_bf5d09f0-d5e1-4770-91e3-379a29d0a798" xlink:href="amci-20230213.xsd#amci_SaleOfStockUnderwritingDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_TransactionCosts_cfc34899-738e-41df-998e-9e01150b12ab" xlink:to="loc_amci_SaleOfStockUnderwritingDiscounts_bf5d09f0-d5e1-4770-91e3-379a29d0a798" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingDiscounts_bd1002a3-1242-49d1-a9ba-bf78114feadf" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_TransactionCosts_cfc34899-738e-41df-998e-9e01150b12ab" xlink:to="loc_amci_DeferredUnderwritingDiscounts_bd1002a3-1242-49d1-a9ba-bf78114feadf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SaleOfStockOtherOfferingCosts_5201c840-b679-4d18-847f-ca22fa7baf6c" xlink:href="amci-20230213.xsd#amci_SaleOfStockOtherOfferingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_TransactionCosts_cfc34899-738e-41df-998e-9e01150b12ab" xlink:to="loc_amci_SaleOfStockOtherOfferingCosts_5201c840-b679-4d18-847f-ca22fa7baf6c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PaymentsForInvestmentOfCashInTrustAccount_b5b8fde1-b1cb-400b-9ef0-8bd27deb3f44" xlink:href="amci-20230213.xsd#amci_PaymentsForInvestmentOfCashInTrustAccount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_PaymentsForInvestmentOfCashInTrustAccount_b5b8fde1-b1cb-400b-9ef0-8bd27deb3f44" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ConditionForFutureBusinessCombinationUseOfProceedsPercentage_fc82c614-89ef-4789-8e71-7e106658b321" xlink:href="amci-20230213.xsd#amci_ConditionForFutureBusinessCombinationUseOfProceedsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_ConditionForFutureBusinessCombinationUseOfProceedsPercentage_fc82c614-89ef-4789-8e71-7e106658b321" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ConditionForFutureBusinessCombinationThresholdPercentageOwnership_25285574-43b0-454c-bbe9-821df810314a" xlink:href="amci-20230213.xsd#amci_ConditionForFutureBusinessCombinationThresholdPercentageOwnership"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_ConditionForFutureBusinessCombinationThresholdPercentageOwnership_25285574-43b0-454c-bbe9-821df810314a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_43efded9-5057-42d0-950c-466b1904711e" xlink:href="amci-20230213.xsd#amci_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_43efded9-5057-42d0-950c-466b1904711e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets_99bb052c-4817-4002-b9eb-4fc5a417a9e5" xlink:href="amci-20230213.xsd#amci_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets_99bb052c-4817-4002-b9eb-4fc5a417a9e5" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MonthsToCompleteAcquisition_ee2a2326-b8f7-4263-a848-0bbf197e13dd" xlink:href="amci-20230213.xsd#amci_MonthsToCompleteAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_MonthsToCompleteAcquisition_ee2a2326-b8f7-4263-a848-0bbf197e13dd" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RedemptionPeriodUponClosure_9f7fcd36-fbba-444b-869a-8a8f9f9db42a" xlink:href="amci-20230213.xsd#amci_RedemptionPeriodUponClosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_RedemptionPeriodUponClosure_9f7fcd36-fbba-444b-869a-8a8f9f9db42a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MaximumAllowedDissolutionExpenses_5dd12829-0817-4a13-aa40-3277ec34a4f8" xlink:href="amci-20230213.xsd#amci_MaximumAllowedDissolutionExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_MaximumAllowedDissolutionExpenses_5dd12829-0817-4a13-aa40-3277ec34a4f8" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount_2d35a79a-ebf1-45ac-b7c0-bac8f29f6cd7" xlink:href="amci-20230213.xsd#amci_TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount_2d35a79a-ebf1-45ac-b7c0-bac8f29f6cd7" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WorkingCapitalDeficit_2d756eea-a382-4c13-9c61-3c3be7a19d43" xlink:href="amci-20230213.xsd#amci_WorkingCapitalDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_WorkingCapitalDeficit_2d756eea-a382-4c13-9c61-3c3be7a19d43" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_cc0bbe28-451f-4c8a-bfba-ae9890e03bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_cc0bbe28-451f-4c8a-bfba-ae9890e03bfa" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_aaa90dc1-f08b-4f5b-b438-bb735347f93f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNet_69410b18-1df0-4151-9686-e8fe7aa03dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_us-gaap_AssetsNet_69410b18-1df0-4151-9686-e8fe7aa03dd8" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrustCurrent_9f4c9d91-e1ef-4286-9add-a023f6d538a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_us-gaap_AssetsHeldInTrustCurrent_9f4c9d91-e1ef-4286-9add-a023f6d538a9" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_c869f921-18d4-4111-93f1-07994e955ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_c869f921-18d4-4111-93f1-07994e955ab1" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_58e4b035-dd6d-4515-8488-2f1baa8f97dc" xlink:href="amci-20230213.xsd#amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_58e4b035-dd6d-4515-8488-2f1baa8f97dc" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1f5991fb-e8ff-4b83-98df-6ae4f93fc7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1f5991fb-e8ff-4b83-98df-6ae4f93fc7ef" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_d68f67cc-317a-44b9-a4c2-95db8dbb7e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_d68f67cc-317a-44b9-a4c2-95db8dbb7e4b" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfSharesIssuedPerUnit_7e140c8e-7327-477d-92d0-9e3ed7e39225" xlink:href="amci-20230213.xsd#amci_NumberOfSharesIssuedPerUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_NumberOfSharesIssuedPerUnit_7e140c8e-7327-477d-92d0-9e3ed7e39225" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfWarrantsIssuedPerUnit_c0f9ef5a-25fd-4aac-8d97-f823f0c96790" xlink:href="amci-20230213.xsd#amci_NumberOfWarrantsIssuedPerUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_NumberOfWarrantsIssuedPerUnit_c0f9ef5a-25fd-4aac-8d97-f823f0c96790" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_FundHeldInTrustAccountPerPublicShare_10ec0a5e-155e-4b18-8a9e-83b0d12f7243" xlink:href="amci-20230213.xsd#amci_FundHeldInTrustAccountPerPublicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_FundHeldInTrustAccountPerPublicShare_10ec0a5e-155e-4b18-8a9e-83b0d12f7243" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose_d3b9c9e1-af19-4968-a88b-27c5846ed399" xlink:href="amci-20230213.xsd#amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose_d3b9c9e1-af19-4968-a88b-27c5846ed399" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_9d475f8e-7126-4d44-b19a-e9af88d58774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_us-gaap_ShortTermBorrowings_9d475f8e-7126-4d44-b19a-e9af88d58774" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WorkingCapitalLoan_56592bc4-65a7-4794-8f15-2a6e89d095d1" xlink:href="amci-20230213.xsd#amci_WorkingCapitalLoan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_WorkingCapitalLoan_56592bc4-65a7-4794-8f15-2a6e89d095d1" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_835a426e-aa7b-4391-a034-110c4158c650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_835a426e-aa7b-4391-a034-110c4158c650" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2530d8a9-de3c-4396-8847-1268ac3f95a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_835a426e-aa7b-4391-a034-110c4158c650" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2530d8a9-de3c-4396-8847-1268ac3f95a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_2530d8a9-de3c-4396-8847-1268ac3f95a9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2530d8a9-de3c-4396-8847-1268ac3f95a9" xlink:to="loc_us-gaap_RelatedPartyDomain_2530d8a9-de3c-4396-8847-1268ac3f95a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_5bd94865-3579-4c78-a95c-d772bfad8dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2530d8a9-de3c-4396-8847-1268ac3f95a9" xlink:to="loc_us-gaap_RelatedPartyDomain_5bd94865-3579-4c78-a95c-d772bfad8dbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SponsorMember_1dabb120-dea3-4329-835a-ba59f584c285" xlink:href="amci-20230213.xsd#amci_SponsorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_5bd94865-3579-4c78-a95c-d772bfad8dbe" xlink:to="loc_amci_SponsorMember_1dabb120-dea3-4329-835a-ba59f584c285" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_546ea855-bf03-424f-92d8-2dbe4fafdb3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_835a426e-aa7b-4391-a034-110c4158c650" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_546ea855-bf03-424f-92d8-2dbe4fafdb3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_546ea855-bf03-424f-92d8-2dbe4fafdb3e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_546ea855-bf03-424f-92d8-2dbe4fafdb3e" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_546ea855-bf03-424f-92d8-2dbe4fafdb3e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e5dc0220-6629-4cd3-86e9-2d55ef090568" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_546ea855-bf03-424f-92d8-2dbe4fafdb3e" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e5dc0220-6629-4cd3-86e9-2d55ef090568" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_40c6cb18-e1e1-4c59-aa40-1dbf66f06ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e5dc0220-6629-4cd3-86e9-2d55ef090568" xlink:to="loc_us-gaap_IPOMember_40c6cb18-e1e1-4c59-aa40-1dbf66f06ca1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_b0d5386c-5764-4d47-aeb0-e3828818d213" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e5dc0220-6629-4cd3-86e9-2d55ef090568" xlink:to="loc_us-gaap_PrivatePlacementMember_b0d5386c-5764-4d47-aeb0-e3828818d213" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_f41f6f05-f2e3-4355-ac5b-2ccd8aae22fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_835a426e-aa7b-4391-a034-110c4158c650" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_f41f6f05-f2e3-4355-ac5b-2ccd8aae22fd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_f41f6f05-f2e3-4355-ac5b-2ccd8aae22fd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_f41f6f05-f2e3-4355-ac5b-2ccd8aae22fd" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_f41f6f05-f2e3-4355-ac5b-2ccd8aae22fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_fca87ae5-93bd-41fd-b248-56bf5a9b6fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_f41f6f05-f2e3-4355-ac5b-2ccd8aae22fd" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_fca87ae5-93bd-41fd-b248-56bf5a9b6fa4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_14e66f10-bc17-4136-ae0b-b22b9636804f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_fca87ae5-93bd-41fd-b248-56bf5a9b6fa4" xlink:to="loc_us-gaap_WarrantMember_14e66f10-bc17-4136-ae0b-b22b9636804f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PrivatePlacementWarrantsMember_b41e680c-ad5b-4653-89ec-0b4299f1238a" xlink:href="amci-20230213.xsd#amci_PrivatePlacementWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WarrantMember_14e66f10-bc17-4136-ae0b-b22b9636804f" xlink:to="loc_amci_PrivatePlacementWarrantsMember_b41e680c-ad5b-4653-89ec-0b4299f1238a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_cee072c1-b291-4a49-876c-aaad333c81a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_835a426e-aa7b-4391-a034-110c4158c650" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_cee072c1-b291-4a49-876c-aaad333c81a1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_cee072c1-b291-4a49-876c-aaad333c81a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_cee072c1-b291-4a49-876c-aaad333c81a1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_cee072c1-b291-4a49-876c-aaad333c81a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_52f59937-edd7-417c-aa9b-11f35a06cbfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_cee072c1-b291-4a49-876c-aaad333c81a1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_52f59937-edd7-417c-aa9b-11f35a06cbfc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_74801853-0a6f-44eb-8ae2-b2124c9192f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_52f59937-edd7-417c-aa9b-11f35a06cbfc" xlink:to="loc_us-gaap_SubsequentEventMember_74801853-0a6f-44eb-8ae2-b2124c9192f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_702be989-4051-4b00-b19f-52090b63cb42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_835a426e-aa7b-4391-a034-110c4158c650" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_702be989-4051-4b00-b19f-52090b63cb42" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_702be989-4051-4b00-b19f-52090b63cb42_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_702be989-4051-4b00-b19f-52090b63cb42" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_702be989-4051-4b00-b19f-52090b63cb42_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_09eccf02-a80a-49f8-9c8a-81c6ae2289d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_702be989-4051-4b00-b19f-52090b63cb42" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_09eccf02-a80a-49f8-9c8a-81c6ae2289d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WorkingCapitalLoansMember_06065880-19f1-4bf7-89a8-dbd389cb6c1a" xlink:href="amci-20230213.xsd#amci_WorkingCapitalLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_09eccf02-a80a-49f8-9c8a-81c6ae2289d9" xlink:to="loc_amci_WorkingCapitalLoansMember_06065880-19f1-4bf7-89a8-dbd389cb6c1a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_0fa1f18b-e232-4166-a7b8-7bbf649ec9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_835a426e-aa7b-4391-a034-110c4158c650" xlink:to="loc_us-gaap_StatementClassOfStockAxis_0fa1f18b-e232-4166-a7b8-7bbf649ec9ed" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_0fa1f18b-e232-4166-a7b8-7bbf649ec9ed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0fa1f18b-e232-4166-a7b8-7bbf649ec9ed" xlink:to="loc_us-gaap_ClassOfStockDomain_0fa1f18b-e232-4166-a7b8-7bbf649ec9ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_31a628c9-10b6-47f5-928d-547a1da094df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0fa1f18b-e232-4166-a7b8-7bbf649ec9ed" xlink:to="loc_us-gaap_ClassOfStockDomain_31a628c9-10b6-47f5-928d-547a1da094df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_3ce506d2-2e96-4db4-a8bf-81509df937a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_31a628c9-10b6-47f5-928d-547a1da094df" xlink:to="loc_us-gaap_CommonClassAMember_3ce506d2-2e96-4db4-a8bf-81509df937a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_413a9339-4c81-4d5d-9bbe-9203cc5a1a7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_835a426e-aa7b-4391-a034-110c4158c650" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_413a9339-4c81-4d5d-9bbe-9203cc5a1a7e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_413a9339-4c81-4d5d-9bbe-9203cc5a1a7e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_413a9339-4c81-4d5d-9bbe-9203cc5a1a7e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_413a9339-4c81-4d5d-9bbe-9203cc5a1a7e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dc268c6c-41b0-445e-9d53-b9f9e6fe9d51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_413a9339-4c81-4d5d-9bbe-9203cc5a1a7e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dc268c6c-41b0-445e-9d53-b9f9e6fe9d51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LanzatechGlobalMember_291d4eea-8b7b-4571-8b2a-1a0c1a459974" xlink:href="amci-20230213.xsd#amci_LanzatechGlobalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dc268c6c-41b0-445e-9d53-b9f9e6fe9d51" xlink:to="loc_amci_LanzatechGlobalMember_291d4eea-8b7b-4571-8b2a-1a0c1a459974" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d17566be-e5b9-40f6-96ef-861780209ca0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_835a426e-aa7b-4391-a034-110c4158c650" xlink:to="loc_srt_RangeAxis_d17566be-e5b9-40f6-96ef-861780209ca0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d17566be-e5b9-40f6-96ef-861780209ca0_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d17566be-e5b9-40f6-96ef-861780209ca0" xlink:to="loc_srt_RangeMember_d17566be-e5b9-40f6-96ef-861780209ca0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4130e301-9a38-4da4-b6d4-2168538ce859" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d17566be-e5b9-40f6-96ef-861780209ca0" xlink:to="loc_srt_RangeMember_4130e301-9a38-4da4-b6d4-2168538ce859" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e5619d78-14cd-42aa-adae-221a28997adf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4130e301-9a38-4da4-b6d4-2168538ce859" xlink:to="loc_srt_MinimumMember_e5619d78-14cd-42aa-adae-221a28997adf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_88b1a476-f346-428f-9511-978cda3a082b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_835a426e-aa7b-4391-a034-110c4158c650" xlink:to="loc_dei_LegalEntityAxis_88b1a476-f346-428f-9511-978cda3a082b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_88b1a476-f346-428f-9511-978cda3a082b_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_88b1a476-f346-428f-9511-978cda3a082b" xlink:to="loc_dei_EntityDomain_88b1a476-f346-428f-9511-978cda3a082b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_bd7c8032-576a-4291-9db3-0c494964c32d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_88b1a476-f346-428f-9511-978cda3a082b" xlink:to="loc_dei_EntityDomain_bd7c8032-576a-4291-9db3-0c494964c32d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" xlink:type="extended" id="i1a028e7493c44edc8d35cafc4e858802_BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5e6c802b-a9de-4d52-a44b-36f4022e33ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_bf37ae0d-3114-43cb-9449-126a65ef68a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5e6c802b-a9de-4d52-a44b-36f4022e33ff" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_bf37ae0d-3114-43cb-9449-126a65ef68a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_891c03f5-d6cc-4000-bb6c-c7ddc945685b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5e6c802b-a9de-4d52-a44b-36f4022e33ff" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_891c03f5-d6cc-4000-bb6c-c7ddc945685b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2c0690c9-509e-4f75-82b1-8138bbd5b9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5e6c802b-a9de-4d52-a44b-36f4022e33ff" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2c0690c9-509e-4f75-82b1-8138bbd5b9e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_070bd5fd-39c3-4a7d-bb0a-305ba1174f05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5e6c802b-a9de-4d52-a44b-36f4022e33ff" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_070bd5fd-39c3-4a7d-bb0a-305ba1174f05" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3d782982-a055-4975-a9c6-34bfd91adf6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5e6c802b-a9de-4d52-a44b-36f4022e33ff" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3d782982-a055-4975-a9c6-34bfd91adf6c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_9e1805a5-f895-4658-b1d2-88aa05eeb4a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5e6c802b-a9de-4d52-a44b-36f4022e33ff" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_9e1805a5-f895-4658-b1d2-88aa05eeb4a8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_eaccfc69-eeac-48d3-9a1f-b7f43909c0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_5e6c802b-a9de-4d52-a44b-36f4022e33ff" xlink:to="loc_us-gaap_StatementTable_eaccfc69-eeac-48d3-9a1f-b7f43909c0f7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_fc208ac2-ba70-4046-a9f4-1f084f6507ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_eaccfc69-eeac-48d3-9a1f-b7f43909c0f7" xlink:to="loc_us-gaap_StatementClassOfStockAxis_fc208ac2-ba70-4046-a9f4-1f084f6507ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_fc208ac2-ba70-4046-a9f4-1f084f6507ff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fc208ac2-ba70-4046-a9f4-1f084f6507ff" xlink:to="loc_us-gaap_ClassOfStockDomain_fc208ac2-ba70-4046-a9f4-1f084f6507ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_60eec158-b8ef-4a81-80a8-93cdb3bf075b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fc208ac2-ba70-4046-a9f4-1f084f6507ff" xlink:to="loc_us-gaap_ClassOfStockDomain_60eec158-b8ef-4a81-80a8-93cdb3bf075b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_07437987-4a92-4439-89a0-97b5b1dcf5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_60eec158-b8ef-4a81-80a8-93cdb3bf075b" xlink:to="loc_us-gaap_CommonClassAMember_07437987-4a92-4439-89a0-97b5b1dcf5b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CommonClassaSubjectToRedemptionMember_d5e04a03-1da3-44c8-b4bb-baa97454532b" xlink:href="amci-20230213.xsd#amci_CommonClassaSubjectToRedemptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_60eec158-b8ef-4a81-80a8-93cdb3bf075b" xlink:to="loc_amci_CommonClassaSubjectToRedemptionMember_d5e04a03-1da3-44c8-b4bb-baa97454532b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_9c924c1e-6c05-4ab0-9166-939ea80522ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_eaccfc69-eeac-48d3-9a1f-b7f43909c0f7" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_9c924c1e-6c05-4ab0-9166-939ea80522ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9c924c1e-6c05-4ab0-9166-939ea80522ff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_9c924c1e-6c05-4ab0-9166-939ea80522ff" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9c924c1e-6c05-4ab0-9166-939ea80522ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5ae9c8a7-43e9-4d3a-8dd0-7d65c6615e24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_9c924c1e-6c05-4ab0-9166-939ea80522ff" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5ae9c8a7-43e9-4d3a-8dd0-7d65c6615e24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_7ca95c40-e7e8-4e6e-b20c-dd0b47decb74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5ae9c8a7-43e9-4d3a-8dd0-7d65c6615e24" xlink:to="loc_us-gaap_IPOMember_7ca95c40-e7e8-4e6e-b20c-dd0b47decb74" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_b7fff5db-7918-4b09-be46-db1cb4d7cbf6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_eaccfc69-eeac-48d3-9a1f-b7f43909c0f7" xlink:to="loc_dei_LegalEntityAxis_b7fff5db-7918-4b09-be46-db1cb4d7cbf6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b7fff5db-7918-4b09-be46-db1cb4d7cbf6_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_b7fff5db-7918-4b09-be46-db1cb4d7cbf6" xlink:to="loc_dei_EntityDomain_b7fff5db-7918-4b09-be46-db1cb4d7cbf6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_7c8f1a70-3607-4770-82f7-6f1e8200d9dc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_b7fff5db-7918-4b09-be46-db1cb4d7cbf6" xlink:to="loc_dei_EntityDomain_7c8f1a70-3607-4770-82f7-6f1e8200d9dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AMCIACQUISITIONCORPIIMember_020233e8-cdad-4fc1-ad16-ee7876f41c57" xlink:href="amci-20230213.xsd#amci_AMCIACQUISITIONCORPIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_7c8f1a70-3607-4770-82f7-6f1e8200d9dc" xlink:to="loc_amci_AMCIACQUISITIONCORPIIMember_020233e8-cdad-4fc1-ad16-ee7876f41c57" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails" xlink:type="extended" id="ifd92a62061a54ed69bbf364caefdf19e_BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7db61d6f-99d1-4d29-a0ac-dea07600642e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EarningPerShareBasicAndDilutedAbstract_cd243423-eaff-4802-99e1-3c7e68d3867c" xlink:href="amci-20230213.xsd#amci_EarningPerShareBasicAndDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7db61d6f-99d1-4d29-a0ac-dea07600642e" xlink:to="loc_amci_EarningPerShareBasicAndDilutedAbstract_cd243423-eaff-4802-99e1-3c7e68d3867c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumeratorAbstract_edfffc9e-71e3-4a68-b498-7445c31bc8dc" xlink:href="amci-20230213.xsd#amci_NumeratorAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_EarningPerShareBasicAndDilutedAbstract_cd243423-eaff-4802-99e1-3c7e68d3867c" xlink:to="loc_amci_NumeratorAbstract_edfffc9e-71e3-4a68-b498-7445c31bc8dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_8579a650-4d6c-462c-a562-31a9df9cce97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_NumeratorAbstract_edfffc9e-71e3-4a68-b498-7445c31bc8dc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_8579a650-4d6c-462c-a562-31a9df9cce97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DenominatorForCalculationOfEarningsPerShareAbstract_b9304b5a-964e-40cf-aa85-792409812cba" xlink:href="amci-20230213.xsd#amci_DenominatorForCalculationOfEarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_EarningPerShareBasicAndDilutedAbstract_cd243423-eaff-4802-99e1-3c7e68d3867c" xlink:to="loc_amci_DenominatorForCalculationOfEarningsPerShareAbstract_b9304b5a-964e-40cf-aa85-792409812cba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0bba52a0-9f1d-4927-a836-187bf0641646" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_DenominatorForCalculationOfEarningsPerShareAbstract_b9304b5a-964e-40cf-aa85-792409812cba" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0bba52a0-9f1d-4927-a836-187bf0641646" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1f95c99a-0b12-488f-96c1-81a30323f37f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_DenominatorForCalculationOfEarningsPerShareAbstract_b9304b5a-964e-40cf-aa85-792409812cba" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1f95c99a-0b12-488f-96c1-81a30323f37f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_49f64466-cd53-4581-b3a0-db45b3e5fd1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_DenominatorForCalculationOfEarningsPerShareAbstract_b9304b5a-964e-40cf-aa85-792409812cba" xlink:to="loc_us-gaap_EarningsPerShareBasic_49f64466-cd53-4581-b3a0-db45b3e5fd1b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_729a08da-c3f4-4821-896b-76ea983d0c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_DenominatorForCalculationOfEarningsPerShareAbstract_b9304b5a-964e-40cf-aa85-792409812cba" xlink:to="loc_us-gaap_EarningsPerShareDiluted_729a08da-c3f4-4821-896b-76ea983d0c1f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_301e24d2-a705-4c73-a278-5c3842593e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_7db61d6f-99d1-4d29-a0ac-dea07600642e" xlink:to="loc_us-gaap_StatementTable_301e24d2-a705-4c73-a278-5c3842593e9d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_a4fb1e03-ebb3-4b13-9a72-e9a70b9492fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_301e24d2-a705-4c73-a278-5c3842593e9d" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_a4fb1e03-ebb3-4b13-9a72-e9a70b9492fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a4fb1e03-ebb3-4b13-9a72-e9a70b9492fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_a4fb1e03-ebb3-4b13-9a72-e9a70b9492fa" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a4fb1e03-ebb3-4b13-9a72-e9a70b9492fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_debdff50-ec87-4b4b-8361-d86c4bab70d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_a4fb1e03-ebb3-4b13-9a72-e9a70b9492fa" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_debdff50-ec87-4b4b-8361-d86c4bab70d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_ba6f2ffe-f564-497a-a9bd-450ed0d7926f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_debdff50-ec87-4b4b-8361-d86c4bab70d7" xlink:to="loc_us-gaap_CommonClassAMember_ba6f2ffe-f564-497a-a9bd-450ed0d7926f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_2364cfb9-2dd3-4be6-b318-44f7d50baf85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_debdff50-ec87-4b4b-8361-d86c4bab70d7" xlink:to="loc_us-gaap_CommonClassBMember_2364cfb9-2dd3-4be6-b318-44f7d50baf85" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/InitialPublicOfferingDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#InitialPublicOfferingDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/InitialPublicOfferingDetails" xlink:type="extended" id="id247fd3bc2de491fadaae8fb99ee7ef9_InitialPublicOfferingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_UnitsIssuedDuringPeriodSharesNewIssues_115c52b3-6426-4302-99bf-3d67d15b2b5b" xlink:href="amci-20230213.xsd#amci_UnitsIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:to="loc_amci_UnitsIssuedDuringPeriodSharesNewIssues_115c52b3-6426-4302-99bf-3d67d15b2b5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_f8640123-acf3-4bf8-9fca-a5a208003f38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_f8640123-acf3-4bf8-9fca-a5a208003f38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_65ed336d-9d19-4e7b-b47a-8c48b949b8de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_65ed336d-9d19-4e7b-b47a-8c48b949b8de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts_361ecaa5-1f33-4411-a6ca-5751394bd911" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:to="loc_us-gaap_DeferredOfferingCosts_361ecaa5-1f33-4411-a6ca-5751394bd911" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SaleOfStockUnderwritingDiscounts_61fff495-1755-405f-9190-852fb5f74e5e" xlink:href="amci-20230213.xsd#amci_SaleOfStockUnderwritingDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:to="loc_amci_SaleOfStockUnderwritingDiscounts_61fff495-1755-405f-9190-852fb5f74e5e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering_e018b597-4608-4c1d-b840-7a73b05c6592" xlink:href="amci-20230213.xsd#amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:to="loc_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering_e018b597-4608-4c1d-b840-7a73b05c6592" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SaleOfStockOtherOfferingCosts_0b5d2e0a-c46d-4c2f-a1dc-9683951d78f6" xlink:href="amci-20230213.xsd#amci_SaleOfStockOtherOfferingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:to="loc_amci_SaleOfStockOtherOfferingCosts_0b5d2e0a-c46d-4c2f-a1dc-9683951d78f6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_8f602268-f334-44d7-8176-c30dc39a5ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_8f602268-f334-44d7-8176-c30dc39a5ce5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingCompensationNoncurrent_10923e0c-246c-47fd-83e1-a1a3276717eb" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingCompensationNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:to="loc_amci_DeferredUnderwritingCompensationNoncurrent_10923e0c-246c-47fd-83e1-a1a3276717eb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OptionVestingPeriod_647a222f-1084-4895-b219-48ff76471b15" xlink:href="amci-20230213.xsd#amci_OptionVestingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:to="loc_amci_OptionVestingPeriod_647a222f-1084-4895-b219-48ff76471b15" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters_86db4fdd-b3e5-4c2a-b37f-ad9150caac1b" xlink:href="amci-20230213.xsd#amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:to="loc_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters_86db4fdd-b3e5-4c2a-b37f-ad9150caac1b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_9b571df3-2e78-47a0-9c18-303413905cef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_9b571df3-2e78-47a0-9c18-303413905cef" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OptionToPurchaseAdditionalUnitsGivenToInvestors_404f7d04-d2ea-4fb4-af85-7b836bee010c" xlink:href="amci-20230213.xsd#amci_OptionToPurchaseAdditionalUnitsGivenToInvestors"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:to="loc_amci_OptionToPurchaseAdditionalUnitsGivenToInvestors_404f7d04-d2ea-4fb4-af85-7b836bee010c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_0e9179a9-f90c-432e-9ace-c306b96481cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_0e9179a9-f90c-432e-9ace-c306b96481cb" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_04a48104-b824-495b-813d-cdff3f610879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_04a48104-b824-495b-813d-cdff3f610879" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_7e9e493e-f7b3-497d-9335-b67a017d091f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_04a48104-b824-495b-813d-cdff3f610879" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_7e9e493e-f7b3-497d-9335-b67a017d091f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7e9e493e-f7b3-497d-9335-b67a017d091f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_7e9e493e-f7b3-497d-9335-b67a017d091f" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7e9e493e-f7b3-497d-9335-b67a017d091f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ea699391-8e0a-4212-a8d2-5806f605c7eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_7e9e493e-f7b3-497d-9335-b67a017d091f" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ea699391-8e0a-4212-a8d2-5806f605c7eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_7d4ac979-0bc2-4668-991c-121a9ab1f023" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ea699391-8e0a-4212-a8d2-5806f605c7eb" xlink:to="loc_us-gaap_CommonClassAMember_7d4ac979-0bc2-4668-991c-121a9ab1f023" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_cfb85461-f83c-4a27-a1fa-cd747653fbab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ea699391-8e0a-4212-a8d2-5806f605c7eb" xlink:to="loc_us-gaap_IPOMember_cfb85461-f83c-4a27-a1fa-cd747653fbab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_41f71c98-d1ad-4bf9-8760-4d9195c43047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ea699391-8e0a-4212-a8d2-5806f605c7eb" xlink:to="loc_us-gaap_OverAllotmentOptionMember_41f71c98-d1ad-4bf9-8760-4d9195c43047" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_0620c83c-3a92-4bc6-af7f-2750b3897afe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_04a48104-b824-495b-813d-cdff3f610879" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_0620c83c-3a92-4bc6-af7f-2750b3897afe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_0620c83c-3a92-4bc6-af7f-2750b3897afe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_0620c83c-3a92-4bc6-af7f-2750b3897afe" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_0620c83c-3a92-4bc6-af7f-2750b3897afe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_861197ea-4e75-4bcd-962d-b8bcf4f04441" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_0620c83c-3a92-4bc6-af7f-2750b3897afe" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_861197ea-4e75-4bcd-962d-b8bcf4f04441" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_12545d31-b783-49d3-9e8c-081a3986faa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_861197ea-4e75-4bcd-962d-b8bcf4f04441" xlink:to="loc_us-gaap_WarrantMember_12545d31-b783-49d3-9e8c-081a3986faa3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_ca91f874-2b4b-477f-b035-40246d1aec7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_04a48104-b824-495b-813d-cdff3f610879" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_ca91f874-2b4b-477f-b035-40246d1aec7d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ca91f874-2b4b-477f-b035-40246d1aec7d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ca91f874-2b4b-477f-b035-40246d1aec7d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ca91f874-2b4b-477f-b035-40246d1aec7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_835864d4-0f6b-49ba-b3b7-c99bbfb08aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ca91f874-2b4b-477f-b035-40246d1aec7d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_835864d4-0f6b-49ba-b3b7-c99bbfb08aa6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_62a63154-9a29-41ed-a5f2-85e03d6bffec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_835864d4-0f6b-49ba-b3b7-c99bbfb08aa6" xlink:to="loc_us-gaap_SubsequentEventMember_62a63154-9a29-41ed-a5f2-85e03d6bffec" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#RelatedPartyTransactionsFounderSharesDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails" xlink:type="extended" id="ic29539bbbe7946edae9192ad29e4d9a6_RelatedPartyTransactionsFounderSharesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_e8194cfa-e801-4342-b51a-1fff868d8ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6b5dd6f0-6f51-4263-8616-240cedd4eb1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e8194cfa-e801-4342-b51a-1fff868d8ad3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6b5dd6f0-6f51-4263-8616-240cedd4eb1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_b68cf1cc-1ed0-4032-b1d6-f3461ef09563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e8194cfa-e801-4342-b51a-1fff868d8ad3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_b68cf1cc-1ed0-4032-b1d6-f3461ef09563" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_afc32434-e2f5-4102-8c96-60c75faf5185" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e8194cfa-e801-4342-b51a-1fff868d8ad3" xlink:to="loc_us-gaap_SharePrice_afc32434-e2f5-4102-8c96-60c75faf5185" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfSharesSurrendered_b775dc38-2f37-4309-844e-df055c78d25d" xlink:href="amci-20230213.xsd#amci_NumberOfSharesSurrendered"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e8194cfa-e801-4342-b51a-1fff868d8ad3" xlink:to="loc_amci_NumberOfSharesSurrendered_b775dc38-2f37-4309-844e-df055c78d25d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SharesSurrenderedFairValueOfShares_d2d84bea-358a-4eeb-8ed9-88d830e298a6" xlink:href="amci-20230213.xsd#amci_SharesSurrenderedFairValueOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e8194cfa-e801-4342-b51a-1fff868d8ad3" xlink:to="loc_amci_SharesSurrenderedFairValueOfShares_d2d84bea-358a-4eeb-8ed9-88d830e298a6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AggregateNumberOfSharesOwned_0f7263e2-c526-4f1f-b7e3-9511813d3bb3" xlink:href="amci-20230213.xsd#amci_AggregateNumberOfSharesOwned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e8194cfa-e801-4342-b51a-1fff868d8ad3" xlink:to="loc_amci_AggregateNumberOfSharesOwned_0f7263e2-c526-4f1f-b7e3-9511813d3bb3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfSharesSubjectToForfeiture_25ddf885-aa9e-4768-892f-190218f38986" xlink:href="amci-20230213.xsd#amci_NumberOfSharesSubjectToForfeiture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e8194cfa-e801-4342-b51a-1fff868d8ad3" xlink:to="loc_amci_NumberOfSharesSubjectToForfeiture_25ddf885-aa9e-4768-892f-190218f38986" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_fa8427ee-1d96-433a-88f1-24455f94e1be" xlink:href="amci-20230213.xsd#amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e8194cfa-e801-4342-b51a-1fff868d8ad3" xlink:to="loc_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_fa8427ee-1d96-433a-88f1-24455f94e1be" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_ab7a7398-63cc-427c-bed4-308959bdd94a" xlink:href="amci-20230213.xsd#amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e8194cfa-e801-4342-b51a-1fff868d8ad3" xlink:to="loc_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_ab7a7398-63cc-427c-bed4-308959bdd94a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_2af93e2f-a87d-4fb6-90dd-d091279bcb41" xlink:href="amci-20230213.xsd#amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e8194cfa-e801-4342-b51a-1fff868d8ad3" xlink:to="loc_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_2af93e2f-a87d-4fb6-90dd-d091279bcb41" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_87e20e92-da07-4f23-8202-364a00417674" xlink:href="amci-20230213.xsd#amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e8194cfa-e801-4342-b51a-1fff868d8ad3" xlink:to="loc_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_87e20e92-da07-4f23-8202-364a00417674" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences_98fbca3b-4442-4e44-b33a-0f43543ded64" xlink:href="amci-20230213.xsd#amci_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e8194cfa-e801-4342-b51a-1fff868d8ad3" xlink:to="loc_amci_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences_98fbca3b-4442-4e44-b33a-0f43543ded64" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_e9bb2635-8034-4c94-adec-5ce20c949c54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e8194cfa-e801-4342-b51a-1fff868d8ad3" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_e9bb2635-8034-4c94-adec-5ce20c949c54" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_4a500366-036d-4b2a-8ac8-9bc90bbd7aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_e9bb2635-8034-4c94-adec-5ce20c949c54" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_4a500366-036d-4b2a-8ac8-9bc90bbd7aa3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_4a500366-036d-4b2a-8ac8-9bc90bbd7aa3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_4a500366-036d-4b2a-8ac8-9bc90bbd7aa3" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_4a500366-036d-4b2a-8ac8-9bc90bbd7aa3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_b8b0fd13-2f6d-4955-82ba-c864a0542af6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_4a500366-036d-4b2a-8ac8-9bc90bbd7aa3" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_b8b0fd13-2f6d-4955-82ba-c864a0542af6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_FounderSharesMember_01f6c120-290a-4bb5-adf2-7cdd5e33a5cd" xlink:href="amci-20230213.xsd#amci_FounderSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_b8b0fd13-2f6d-4955-82ba-c864a0542af6" xlink:to="loc_amci_FounderSharesMember_01f6c120-290a-4bb5-adf2-7cdd5e33a5cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7d91d1bf-5176-4b06-b388-c84237804bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_e9bb2635-8034-4c94-adec-5ce20c949c54" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7d91d1bf-5176-4b06-b388-c84237804bcc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_7d91d1bf-5176-4b06-b388-c84237804bcc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7d91d1bf-5176-4b06-b388-c84237804bcc" xlink:to="loc_us-gaap_RelatedPartyDomain_7d91d1bf-5176-4b06-b388-c84237804bcc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_87066bc7-7ba4-43cf-8d81-564ec2979587" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7d91d1bf-5176-4b06-b388-c84237804bcc" xlink:to="loc_us-gaap_RelatedPartyDomain_87066bc7-7ba4-43cf-8d81-564ec2979587" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SponsorMember_0bdf14c2-831c-485f-bbfe-9e5bf4fe9ca0" xlink:href="amci-20230213.xsd#amci_SponsorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_87066bc7-7ba4-43cf-8d81-564ec2979587" xlink:to="loc_amci_SponsorMember_0bdf14c2-831c-485f-bbfe-9e5bf4fe9ca0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AnchorInvestorsMember_7fcb756c-e73f-4058-9b73-d4b6974341a6" xlink:href="amci-20230213.xsd#amci_AnchorInvestorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_87066bc7-7ba4-43cf-8d81-564ec2979587" xlink:to="loc_amci_AnchorInvestorsMember_7fcb756c-e73f-4058-9b73-d4b6974341a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_d7b719bd-5aa4-41af-a0d0-3abadf37e9f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_e9bb2635-8034-4c94-adec-5ce20c949c54" xlink:to="loc_us-gaap_StatementClassOfStockAxis_d7b719bd-5aa4-41af-a0d0-3abadf37e9f3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d7b719bd-5aa4-41af-a0d0-3abadf37e9f3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d7b719bd-5aa4-41af-a0d0-3abadf37e9f3" xlink:to="loc_us-gaap_ClassOfStockDomain_d7b719bd-5aa4-41af-a0d0-3abadf37e9f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_0893270d-8498-4879-aec7-ff5105f64b63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d7b719bd-5aa4-41af-a0d0-3abadf37e9f3" xlink:to="loc_us-gaap_ClassOfStockDomain_0893270d-8498-4879-aec7-ff5105f64b63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_e93d15f2-a14b-436b-a216-f9b7c703b8e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0893270d-8498-4879-aec7-ff5105f64b63" xlink:to="loc_us-gaap_CommonClassBMember_e93d15f2-a14b-436b-a216-f9b7c703b8e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_52303ecb-8849-47c8-acf9-69bbd127fdc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_e9bb2635-8034-4c94-adec-5ce20c949c54" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_52303ecb-8849-47c8-acf9-69bbd127fdc1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_52303ecb-8849-47c8-acf9-69bbd127fdc1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_52303ecb-8849-47c8-acf9-69bbd127fdc1" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_52303ecb-8849-47c8-acf9-69bbd127fdc1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_bca14e86-2724-4514-9014-46cea3a55174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_52303ecb-8849-47c8-acf9-69bbd127fdc1" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_bca14e86-2724-4514-9014-46cea3a55174" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_5e4d2546-6778-47d0-a5bf-703615102c43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_bca14e86-2724-4514-9014-46cea3a55174" xlink:to="loc_us-gaap_OverAllotmentOptionMember_5e4d2546-6778-47d0-a5bf-703615102c43" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#RelatedPartyTransactionsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails" xlink:type="extended" id="i10b8c586074948f084490b466c8504d7_RelatedPartyTransactionsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_c7b9e6d9-583f-43a4-95cd-4a66a228a528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_dd06fb29-7af6-4923-8c32-bec83248275f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b9e6d9-583f-43a4-95cd-4a66a228a528" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_dd06fb29-7af6-4923-8c32-bec83248275f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_bba8aaac-05de-4aee-9f6c-eea4a7f987a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b9e6d9-583f-43a4-95cd-4a66a228a528" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_bba8aaac-05de-4aee-9f6c-eea4a7f987a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights_9cea3d45-0abe-4a5c-a5e1-64f69edc1f54" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b9e6d9-583f-43a4-95cd-4a66a228a528" xlink:to="loc_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights_9cea3d45-0abe-4a5c-a5e1-64f69edc1f54" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3d530c05-efee-4364-88c4-af88bdca4e70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b9e6d9-583f-43a4-95cd-4a66a228a528" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3d530c05-efee-4364-88c4-af88bdca4e70" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_8fc7c7c1-a953-440c-b3c2-2003b5c3c00f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b9e6d9-583f-43a4-95cd-4a66a228a528" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_8fc7c7c1-a953-440c-b3c2-2003b5c3c00f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_857c813a-d964-4994-8a87-2453a8169bdb" xlink:href="amci-20230213.xsd#amci_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b9e6d9-583f-43a4-95cd-4a66a228a528" xlink:to="loc_amci_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_857c813a-d964-4994-8a87-2453a8169bdb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MaximumLoansConvertibleIntoWarrants_c30ae5a0-708c-49c6-b273-c23e0bb936aa" xlink:href="amci-20230213.xsd#amci_MaximumLoansConvertibleIntoWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b9e6d9-583f-43a4-95cd-4a66a228a528" xlink:to="loc_amci_MaximumLoansConvertibleIntoWarrants_c30ae5a0-708c-49c6-b273-c23e0bb936aa" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OutstandingWorkingCapitalLoans_82ef05b4-afbc-4afe-b433-565567c41df1" xlink:href="amci-20230213.xsd#amci_OutstandingWorkingCapitalLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b9e6d9-583f-43a4-95cd-4a66a228a528" xlink:to="loc_amci_OutstandingWorkingCapitalLoans_82ef05b4-afbc-4afe-b433-565567c41df1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_f0bbe974-1e16-4c2a-b227-677b0be8d6dc" xlink:href="amci-20230213.xsd#amci_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b9e6d9-583f-43a4-95cd-4a66a228a528" xlink:to="loc_amci_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_f0bbe974-1e16-4c2a-b227-677b0be8d6dc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_a232eae2-5cae-4a08-802b-df1391d40243" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b9e6d9-583f-43a4-95cd-4a66a228a528" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_a232eae2-5cae-4a08-802b-df1391d40243" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_cc8b3532-0991-4417-8a0e-2541c67da846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b9e6d9-583f-43a4-95cd-4a66a228a528" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_cc8b3532-0991-4417-8a0e-2541c67da846" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_ab42eda1-7fd7-42c7-9ac4-f92b0442067d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b9e6d9-583f-43a4-95cd-4a66a228a528" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrent_ab42eda1-7fd7-42c7-9ac4-f92b0442067d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WorkingCapitalLoan_5a7e479b-4c24-4aab-91ea-42469c0d77b4" xlink:href="amci-20230213.xsd#amci_WorkingCapitalLoan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b9e6d9-583f-43a4-95cd-4a66a228a528" xlink:to="loc_amci_WorkingCapitalLoan_5a7e479b-4c24-4aab-91ea-42469c0d77b4" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ed821746-1d2e-403a-8fae-36687fd3d44e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b9e6d9-583f-43a4-95cd-4a66a228a528" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ed821746-1d2e-403a-8fae-36687fd3d44e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_6b111f83-e9b0-48a8-8474-159026a8c977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ed821746-1d2e-403a-8fae-36687fd3d44e" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_6b111f83-e9b0-48a8-8474-159026a8c977" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_6b111f83-e9b0-48a8-8474-159026a8c977_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_6b111f83-e9b0-48a8-8474-159026a8c977" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_6b111f83-e9b0-48a8-8474-159026a8c977_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_4ff1f188-e274-4f9e-a3a0-d72e703a47f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_6b111f83-e9b0-48a8-8474-159026a8c977" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_4ff1f188-e274-4f9e-a3a0-d72e703a47f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AdministrativeSupportAgreementMember_e6582682-8460-4479-a5b5-9dbe2751b01d" xlink:href="amci-20230213.xsd#amci_AdministrativeSupportAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_4ff1f188-e274-4f9e-a3a0-d72e703a47f9" xlink:to="loc_amci_AdministrativeSupportAgreementMember_e6582682-8460-4479-a5b5-9dbe2751b01d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartyLoansMember_a2bfa4b3-6a2b-47c8-9b10-751601373799" xlink:href="amci-20230213.xsd#amci_RelatedPartyLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_4ff1f188-e274-4f9e-a3a0-d72e703a47f9" xlink:to="loc_amci_RelatedPartyLoansMember_a2bfa4b3-6a2b-47c8-9b10-751601373799" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_ae8e2a21-1930-432e-9563-ecaeed0c1736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ed821746-1d2e-403a-8fae-36687fd3d44e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_ae8e2a21-1930-432e-9563-ecaeed0c1736" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_ae8e2a21-1930-432e-9563-ecaeed0c1736_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_ae8e2a21-1930-432e-9563-ecaeed0c1736" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_ae8e2a21-1930-432e-9563-ecaeed0c1736_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_3d0f4bd7-17e5-4b68-a67e-37c58350d46f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_ae8e2a21-1930-432e-9563-ecaeed0c1736" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_3d0f4bd7-17e5-4b68-a67e-37c58350d46f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WorkingCapitalLoansWarrantMember_c8c76826-307f-46f6-a374-7f12212ab93c" xlink:href="amci-20230213.xsd#amci_WorkingCapitalLoansWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3d0f4bd7-17e5-4b68-a67e-37c58350d46f" xlink:to="loc_amci_WorkingCapitalLoansWarrantMember_c8c76826-307f-46f6-a374-7f12212ab93c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PrivatePlacementWarrantsMember_1ea3b51a-2b04-46a9-bbdc-1abdb04da060" xlink:href="amci-20230213.xsd#amci_PrivatePlacementWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3d0f4bd7-17e5-4b68-a67e-37c58350d46f" xlink:to="loc_amci_PrivatePlacementWarrantsMember_1ea3b51a-2b04-46a9-bbdc-1abdb04da060" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_6e399ff1-911d-458c-9e0d-31f4ad5c8d21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ed821746-1d2e-403a-8fae-36687fd3d44e" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_6e399ff1-911d-458c-9e0d-31f4ad5c8d21" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6e399ff1-911d-458c-9e0d-31f4ad5c8d21_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_6e399ff1-911d-458c-9e0d-31f4ad5c8d21" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6e399ff1-911d-458c-9e0d-31f4ad5c8d21_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ab5e4ee6-4ead-4b99-9c85-0567a4a1f78a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_6e399ff1-911d-458c-9e0d-31f4ad5c8d21" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ab5e4ee6-4ead-4b99-9c85-0567a4a1f78a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_c2c55eca-292f-41e2-a57d-38741d532f75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ab5e4ee6-4ead-4b99-9c85-0567a4a1f78a" xlink:to="loc_us-gaap_PrivatePlacementMember_c2c55eca-292f-41e2-a57d-38741d532f75" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ea75088e-ce9a-4b77-a2f3-beaa97746489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ed821746-1d2e-403a-8fae-36687fd3d44e" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ea75088e-ce9a-4b77-a2f3-beaa97746489" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_ea75088e-ce9a-4b77-a2f3-beaa97746489_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ea75088e-ce9a-4b77-a2f3-beaa97746489" xlink:to="loc_us-gaap_RelatedPartyDomain_ea75088e-ce9a-4b77-a2f3-beaa97746489_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_ab621efb-5242-457f-be60-2f3b89dabf04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ea75088e-ce9a-4b77-a2f3-beaa97746489" xlink:to="loc_us-gaap_RelatedPartyDomain_ab621efb-5242-457f-be60-2f3b89dabf04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SponsorMember_9cd2660c-4704-41c7-a65f-081e9a3723c5" xlink:href="amci-20230213.xsd#amci_SponsorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_ab621efb-5242-457f-be60-2f3b89dabf04" xlink:to="loc_amci_SponsorMember_9cd2660c-4704-41c7-a65f-081e9a3723c5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="i15bde29c0c1b41f2b0455e472cdb0020_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_3aa1081c-cf5b-4310-8834-8747c4689289" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MaximumNumberOfDemandsForRegistrationOfSecurities_3fa30737-a857-43bf-b6cb-c9de1c274925" xlink:href="amci-20230213.xsd#amci_MaximumNumberOfDemandsForRegistrationOfSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_3aa1081c-cf5b-4310-8834-8747c4689289" xlink:to="loc_amci_MaximumNumberOfDemandsForRegistrationOfSecurities_3fa30737-a857-43bf-b6cb-c9de1c274925" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OptionVestingPeriod_1396040f-047d-49c5-af32-1dbcdb29ec6f" xlink:href="amci-20230213.xsd#amci_OptionVestingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_3aa1081c-cf5b-4310-8834-8747c4689289" xlink:to="loc_amci_OptionVestingPeriod_1396040f-047d-49c5-af32-1dbcdb29ec6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters_84ab91fb-5ee1-416c-b654-b0214b9a9887" xlink:href="amci-20230213.xsd#amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_3aa1081c-cf5b-4310-8834-8747c4689289" xlink:to="loc_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters_84ab91fb-5ee1-416c-b654-b0214b9a9887" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_UnderwritingDiscountPercentage_04234913-1d6b-4417-8f9e-ab852d34c219" xlink:href="amci-20230213.xsd#amci_UnderwritingDiscountPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_3aa1081c-cf5b-4310-8834-8747c4689289" xlink:to="loc_amci_UnderwritingDiscountPercentage_04234913-1d6b-4417-8f9e-ab852d34c219" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SaleOfStockUnderwritingDiscounts_d81a2149-f1aa-422e-bf32-4c39bf537aab" xlink:href="amci-20230213.xsd#amci_SaleOfStockUnderwritingDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_3aa1081c-cf5b-4310-8834-8747c4689289" xlink:to="loc_amci_SaleOfStockUnderwritingDiscounts_d81a2149-f1aa-422e-bf32-4c39bf537aab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingDiscounts_78aa804f-0f59-4546-9a99-b9723b892e69" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_3aa1081c-cf5b-4310-8834-8747c4689289" xlink:to="loc_amci_DeferredUnderwritingDiscounts_78aa804f-0f59-4546-9a99-b9723b892e69" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingDiscountPercentage_2ceefc0d-b159-40a1-809c-58dc01fed7c8" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingDiscountPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_3aa1081c-cf5b-4310-8834-8747c4689289" xlink:to="loc_amci_DeferredUnderwritingDiscountPercentage_2ceefc0d-b159-40a1-809c-58dc01fed7c8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfSharesSubjectToForfeiture_cb273b7f-1d4a-4ccd-8a46-c8fd0aa537b8" xlink:href="amci-20230213.xsd#amci_NumberOfSharesSubjectToForfeiture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_3aa1081c-cf5b-4310-8834-8747c4689289" xlink:to="loc_amci_NumberOfSharesSubjectToForfeiture_cb273b7f-1d4a-4ccd-8a46-c8fd0aa537b8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromFeesReceived_4a4a4619-f94a-459d-b884-f7563a08ba0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromFeesReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_3aa1081c-cf5b-4310-8834-8747c4689289" xlink:to="loc_us-gaap_ProceedsFromFeesReceived_4a4a4619-f94a-459d-b884-f7563a08ba0e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares_dc7b771e-7289-470a-bbca-2dee80a0e665" xlink:href="amci-20230213.xsd#amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_3aa1081c-cf5b-4310-8834-8747c4689289" xlink:to="loc_amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares_dc7b771e-7289-470a-bbca-2dee80a0e665" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants_8ca6d680-2028-4826-99c6-0f4997e1d1e7" xlink:href="amci-20230213.xsd#amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_3aa1081c-cf5b-4310-8834-8747c4689289" xlink:to="loc_amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants_8ca6d680-2028-4826-99c6-0f4997e1d1e7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_3acee5c0-2bc7-4dc4-9bff-256b9b2426fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_3aa1081c-cf5b-4310-8834-8747c4689289" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_3acee5c0-2bc7-4dc4-9bff-256b9b2426fb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_6cfbdd5c-6d71-41ff-9eec-906e6f8a3cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_3acee5c0-2bc7-4dc4-9bff-256b9b2426fb" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_6cfbdd5c-6d71-41ff-9eec-906e6f8a3cf2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6cfbdd5c-6d71-41ff-9eec-906e6f8a3cf2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_6cfbdd5c-6d71-41ff-9eec-906e6f8a3cf2" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6cfbdd5c-6d71-41ff-9eec-906e6f8a3cf2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_eac3e71e-658e-4bc7-981f-832bcb343217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_6cfbdd5c-6d71-41ff-9eec-906e6f8a3cf2" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_eac3e71e-658e-4bc7-981f-832bcb343217" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_aa1b93cf-6938-40b1-9032-cfd20c906cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_eac3e71e-658e-4bc7-981f-832bcb343217" xlink:to="loc_us-gaap_OverAllotmentOptionMember_aa1b93cf-6938-40b1-9032-cfd20c906cfc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingFeesMember_f5f0fd4d-bc99-4804-94c5-6e0f68ac7373" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_eac3e71e-658e-4bc7-981f-832bcb343217" xlink:to="loc_amci_DeferredUnderwritingFeesMember_f5f0fd4d-bc99-4804-94c5-6e0f68ac7373" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_840d3d53-b3c4-4363-8c23-560992bedf24" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_3acee5c0-2bc7-4dc4-9bff-256b9b2426fb" xlink:to="loc_dei_LegalEntityAxis_840d3d53-b3c4-4363-8c23-560992bedf24" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_840d3d53-b3c4-4363-8c23-560992bedf24_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_840d3d53-b3c4-4363-8c23-560992bedf24" xlink:to="loc_dei_EntityDomain_840d3d53-b3c4-4363-8c23-560992bedf24_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_57b56199-be81-4d9f-821c-989e53b9f281" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_840d3d53-b3c4-4363-8c23-560992bedf24" xlink:to="loc_dei_EntityDomain_57b56199-be81-4d9f-821c-989e53b9f281" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EvercoreGroupL.l.c.Member_d9e721c9-d626-47ce-801a-7ed90330dfff" xlink:href="amci-20230213.xsd#amci_EvercoreGroupL.l.c.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_57b56199-be81-4d9f-821c-989e53b9f281" xlink:to="loc_amci_EvercoreGroupL.l.c.Member_d9e721c9-d626-47ce-801a-7ed90330dfff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_7e2d1134-8bba-41b4-b03e-c0e92f0a940d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_3acee5c0-2bc7-4dc4-9bff-256b9b2426fb" xlink:to="loc_srt_TitleOfIndividualAxis_7e2d1134-8bba-41b4-b03e-c0e92f0a940d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7e2d1134-8bba-41b4-b03e-c0e92f0a940d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_7e2d1134-8bba-41b4-b03e-c0e92f0a940d" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7e2d1134-8bba-41b4-b03e-c0e92f0a940d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_34fda081-5eff-4070-bfd4-1abc77413510" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_7e2d1134-8bba-41b4-b03e-c0e92f0a940d" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_34fda081-5eff-4070-bfd4-1abc77413510" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CoplacementAgentMember_f976c122-952a-4982-9fbd-5c9f6fda451e" xlink:href="amci-20230213.xsd#amci_CoplacementAgentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_34fda081-5eff-4070-bfd4-1abc77413510" xlink:to="loc_amci_CoplacementAgentMember_f976c122-952a-4982-9fbd-5c9f6fda451e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_FinancialAdvisoryMember_0e879e3f-a386-4570-acf8-b05c087c66e5" xlink:href="amci-20230213.xsd#amci_FinancialAdvisoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_34fda081-5eff-4070-bfd4-1abc77413510" xlink:to="loc_amci_FinancialAdvisoryMember_0e879e3f-a386-4570-acf8-b05c087c66e5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#ClassACommonStockSubjecttoPossibleRedemptionDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails" xlink:type="extended" id="ia3ae6bb6cfc5442c86801b15134579ed_ClassACommonStockSubjecttoPossibleRedemptionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_b8a161d1-cc3f-4317-980e-515d61eb37c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_1a24e4df-5904-494e-b711-86a84608494a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_b8a161d1-cc3f-4317-980e-515d61eb37c7" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_1a24e4df-5904-494e-b711-86a84608494a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_d7cfee3c-ac03-461f-93fb-0577ba8ed12c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_b8a161d1-cc3f-4317-980e-515d61eb37c7" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_d7cfee3c-ac03-461f-93fb-0577ba8ed12c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CommonStockNumberOfVotesPerShare_5a4ee8c9-c68c-4565-b817-8e72559bb2a8" xlink:href="amci-20230213.xsd#amci_CommonStockNumberOfVotesPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_b8a161d1-cc3f-4317-980e-515d61eb37c7" xlink:to="loc_amci_CommonStockNumberOfVotesPerShare_5a4ee8c9-c68c-4565-b817-8e72559bb2a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_bc1cae89-3d7b-4397-ba8b-f679ffa5d0b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_b8a161d1-cc3f-4317-980e-515d61eb37c7" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_bc1cae89-3d7b-4397-ba8b-f679ffa5d0b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_a9738f51-9ad3-4ae4-8bb6-cc81610ea656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_b8a161d1-cc3f-4317-980e-515d61eb37c7" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_a9738f51-9ad3-4ae4-8bb6-cc81610ea656" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LessAbstract_dee913fd-7f80-4faf-951e-cb73db62f24d" xlink:href="amci-20230213.xsd#amci_LessAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_b8a161d1-cc3f-4317-980e-515d61eb37c7" xlink:to="loc_amci_LessAbstract_dee913fd-7f80-4faf-951e-cb73db62f24d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityProceedsAllocatedToWarrants_dc744e8d-0ec6-4ce8-9433-388e17d093ab" xlink:href="amci-20230213.xsd#amci_TemporaryEquityProceedsAllocatedToWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_LessAbstract_dee913fd-7f80-4faf-951e-cb73db62f24d" xlink:to="loc_amci_TemporaryEquityProceedsAllocatedToWarrants_dc744e8d-0ec6-4ce8-9433-388e17d093ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityIssuanceCosts_b479770d-7fd6-4540-8cba-00e2e9d71159" xlink:href="amci-20230213.xsd#amci_TemporaryEquityIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_LessAbstract_dee913fd-7f80-4faf-951e-cb73db62f24d" xlink:to="loc_amci_TemporaryEquityIssuanceCosts_b479770d-7fd6-4540-8cba-00e2e9d71159" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PlusAbstract_2b6cc841-57d2-464c-b1af-b2ca5f7d29a0" xlink:href="amci-20230213.xsd#amci_PlusAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_b8a161d1-cc3f-4317-980e-515d61eb37c7" xlink:to="loc_amci_PlusAbstract_2b6cc841-57d2-464c-b1af-b2ca5f7d29a0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_c4e19979-048e-4be5-86d4-37787e090b21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_PlusAbstract_2b6cc841-57d2-464c-b1af-b2ca5f7d29a0" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_c4e19979-048e-4be5-86d4-37787e090b21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption_f1602b0c-ade8-4150-abd0-8a4be0815910" xlink:href="amci-20230213.xsd#amci_IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_PlusAbstract_2b6cc841-57d2-464c-b1af-b2ca5f7d29a0" xlink:to="loc_amci_IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption_f1602b0c-ade8-4150-abd0-8a4be0815910" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_e9f4353f-55fb-46d5-97d2-4859be94e166" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_PlusAbstract_2b6cc841-57d2-464c-b1af-b2ca5f7d29a0" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_e9f4353f-55fb-46d5-97d2-4859be94e166" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_5ae3d0b2-151f-4292-b103-762033b73b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TemporaryEquityLineItems_b8a161d1-cc3f-4317-980e-515d61eb37c7" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_5ae3d0b2-151f-4292-b103-762033b73b3b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b638fdbc-a68a-47e6-92bd-81926bd1077b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_5ae3d0b2-151f-4292-b103-762033b73b3b" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b638fdbc-a68a-47e6-92bd-81926bd1077b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b638fdbc-a68a-47e6-92bd-81926bd1077b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b638fdbc-a68a-47e6-92bd-81926bd1077b" xlink:to="loc_us-gaap_ClassOfStockDomain_b638fdbc-a68a-47e6-92bd-81926bd1077b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b673e447-4267-4e8f-ae23-2c6adc836d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b638fdbc-a68a-47e6-92bd-81926bd1077b" xlink:to="loc_us-gaap_ClassOfStockDomain_b673e447-4267-4e8f-ae23-2c6adc836d3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_bfaea8c6-4b72-46cc-9688-70df33934fda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_b673e447-4267-4e8f-ae23-2c6adc836d3a" xlink:to="loc_us-gaap_CommonClassAMember_bfaea8c6-4b72-46cc-9688-70df33934fda" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CommonClassaSubjectToRedemptionMember_f369e75b-a3b9-44df-a32b-779cdfe88387" xlink:href="amci-20230213.xsd#amci_CommonClassaSubjectToRedemptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CommonClassAMember_bfaea8c6-4b72-46cc-9688-70df33934fda" xlink:to="loc_amci_CommonClassaSubjectToRedemptionMember_f369e75b-a3b9-44df-a32b-779cdfe88387" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/StockholdersEquityDeficitCommonStockSharesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#StockholdersEquityDeficitCommonStockSharesDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/StockholdersEquityDeficitCommonStockSharesDetails" xlink:type="extended" id="i5e36df74666a442f985de915751a3dbc_StockholdersEquityDeficitCommonStockSharesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_ff36a3d0-a6f0-4e80-9efe-5f3de711e127" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_ecdb5a8e-1b36-4688-a289-878c3fd75ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_ff36a3d0-a6f0-4e80-9efe-5f3de711e127" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_ecdb5a8e-1b36-4688-a289-878c3fd75ebe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_4a63a917-1427-41f2-9a18-468ff9ea4c31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_ff36a3d0-a6f0-4e80-9efe-5f3de711e127" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_4a63a917-1427-41f2-9a18-468ff9ea4c31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_1d124d7b-3669-467f-b1e1-ab0be477852c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_ff36a3d0-a6f0-4e80-9efe-5f3de711e127" xlink:to="loc_us-gaap_CommonStockSharesIssued_1d124d7b-3669-467f-b1e1-ab0be477852c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_9e986c4f-4668-4e2a-b538-c5847ee866b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_ff36a3d0-a6f0-4e80-9efe-5f3de711e127" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_9e986c4f-4668-4e2a-b538-c5847ee866b0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_9451c68d-df3b-4cf1-8f77-f09da9bdc28e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_ff36a3d0-a6f0-4e80-9efe-5f3de711e127" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_9451c68d-df3b-4cf1-8f77-f09da9bdc28e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_5b2906d8-1d92-49a6-86f5-ec097b507923" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_ff36a3d0-a6f0-4e80-9efe-5f3de711e127" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_5b2906d8-1d92-49a6-86f5-ec097b507923" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1_21c77c9b-342e-4902-ab06-bdd2d4af8743" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_ff36a3d0-a6f0-4e80-9efe-5f3de711e127" xlink:to="loc_us-gaap_ConversionOfStockSharesIssued1_21c77c9b-342e-4902-ab06-bdd2d4af8743" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ConvertibleStockConversionRatio_462687d9-ef9c-4cd4-97bc-db6fb4253f52" xlink:href="amci-20230213.xsd#amci_ConvertibleStockConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_ff36a3d0-a6f0-4e80-9efe-5f3de711e127" xlink:to="loc_amci_ConvertibleStockConversionRatio_462687d9-ef9c-4cd4-97bc-db6fb4253f52" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_5bab40fd-4728-4f47-8061-dcf6eec61b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_ff36a3d0-a6f0-4e80-9efe-5f3de711e127" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_5bab40fd-4728-4f47-8061-dcf6eec61b7e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_da6dcc9a-6ed1-4c2c-8f7e-02e753a2f319" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_5bab40fd-4728-4f47-8061-dcf6eec61b7e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_da6dcc9a-6ed1-4c2c-8f7e-02e753a2f319" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_da6dcc9a-6ed1-4c2c-8f7e-02e753a2f319_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_da6dcc9a-6ed1-4c2c-8f7e-02e753a2f319" xlink:to="loc_us-gaap_ClassOfStockDomain_da6dcc9a-6ed1-4c2c-8f7e-02e753a2f319_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_406957b4-abda-43fe-8fa7-571eec6adaf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_da6dcc9a-6ed1-4c2c-8f7e-02e753a2f319" xlink:to="loc_us-gaap_ClassOfStockDomain_406957b4-abda-43fe-8fa7-571eec6adaf4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_dfcb59cb-8c72-4c26-a215-e7635bde48b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_406957b4-abda-43fe-8fa7-571eec6adaf4" xlink:to="loc_us-gaap_CommonClassAMember_dfcb59cb-8c72-4c26-a215-e7635bde48b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CommonClassaSubjectToRedemptionMember_b0a1452c-847d-439d-b8ae-4695148018c1" xlink:href="amci-20230213.xsd#amci_CommonClassaSubjectToRedemptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CommonClassAMember_dfcb59cb-8c72-4c26-a215-e7635bde48b0" xlink:to="loc_amci_CommonClassaSubjectToRedemptionMember_b0a1452c-847d-439d-b8ae-4695148018c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_e143f35c-4dbe-469f-a4d0-96684d4177d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_406957b4-abda-43fe-8fa7-571eec6adaf4" xlink:to="loc_us-gaap_CommonClassBMember_e143f35c-4dbe-469f-a4d0-96684d4177d2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/WarrantsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#WarrantsDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/WarrantsDetails" xlink:type="extended" id="i84c55bb149904931b4b902084fa347fa_WarrantsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_603fea72-69be-40c8-87ac-8bb4b2c0d84c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_db499b86-8ebe-4dda-841b-dd2b08785cea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_603fea72-69be-40c8-87ac-8bb4b2c0d84c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_db499b86-8ebe-4dda-841b-dd2b08785cea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_995eaedf-2931-4990-bd3c-bf664bc69d62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_603fea72-69be-40c8-87ac-8bb4b2c0d84c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_995eaedf-2931-4990-bd3c-bf664bc69d62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights_09a292ef-d6fb-4454-a8ed-05d45500fbaa" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_603fea72-69be-40c8-87ac-8bb4b2c0d84c" xlink:to="loc_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights_09a292ef-d6fb-4454-a8ed-05d45500fbaa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering_b9cf9f87-b70b-42be-8589-c70c2fabedc8" xlink:href="amci-20230213.xsd#amci_WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_603fea72-69be-40c8-87ac-8bb4b2c0d84c" xlink:to="loc_amci_WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering_b9cf9f87-b70b-42be-8589-c70c2fabedc8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_29dce198-3634-417d-8353-944c4f504db4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_603fea72-69be-40c8-87ac-8bb4b2c0d84c" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_29dce198-3634-417d-8353-944c4f504db4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PeriodForFillingRegistrationStatementAfterBusinessCombination_dda64794-93c7-4ee3-a984-d180aecec862" xlink:href="amci-20230213.xsd#amci_PeriodForFillingRegistrationStatementAfterBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_603fea72-69be-40c8-87ac-8bb4b2c0d84c" xlink:to="loc_amci_PeriodForFillingRegistrationStatementAfterBusinessCombination_dda64794-93c7-4ee3-a984-d180aecec862" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise_8a4321fb-090e-421c-8f1d-0923ef454cf7" xlink:href="amci-20230213.xsd#amci_PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_603fea72-69be-40c8-87ac-8bb4b2c0d84c" xlink:to="loc_amci_PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise_8a4321fb-090e-421c-8f1d-0923ef454cf7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_42ff24c7-3197-4fdc-94ab-aecd8f2872be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_603fea72-69be-40c8-87ac-8bb4b2c0d84c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_42ff24c7-3197-4fdc-94ab-aecd8f2872be" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_06de9eb2-bc52-409e-a764-4d7909f1fd09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_42ff24c7-3197-4fdc-94ab-aecd8f2872be" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_06de9eb2-bc52-409e-a764-4d7909f1fd09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_06de9eb2-bc52-409e-a764-4d7909f1fd09_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_06de9eb2-bc52-409e-a764-4d7909f1fd09" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_06de9eb2-bc52-409e-a764-4d7909f1fd09_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_6f925e87-c08a-4274-96d8-192dbec65ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_06de9eb2-bc52-409e-a764-4d7909f1fd09" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_6f925e87-c08a-4274-96d8-192dbec65ac9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PublicWarrantsMember_4e5803c8-8028-4ae8-92f5-f5c85fc24a4d" xlink:href="amci-20230213.xsd#amci_PublicWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_6f925e87-c08a-4274-96d8-192dbec65ac9" xlink:to="loc_amci_PublicWarrantsMember_4e5803c8-8028-4ae8-92f5-f5c85fc24a4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PrivatePlacementWarrantsMember_96026862-cfc8-4dda-a9d5-3f897485a0fe" xlink:href="amci-20230213.xsd#amci_PrivatePlacementWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_6f925e87-c08a-4274-96d8-192dbec65ac9" xlink:to="loc_amci_PrivatePlacementWarrantsMember_96026862-cfc8-4dda-a9d5-3f897485a0fe" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#WarrantsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails" xlink:type="extended" id="ifa94a0b633a54877990b744e045e77d8_WarrantsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_2b027379-0477-418b-a223-e76f42fb5051" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_eb05eebe-b16b-4898-bfcf-6c5fcd482f49" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_2b027379-0477-418b-a223-e76f42fb5051" xlink:to="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_eb05eebe-b16b-4898-bfcf-6c5fcd482f49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_0138de82-1375-4fd0-8d9e-8786fa33933a" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_2b027379-0477-418b-a223-e76f42fb5051" xlink:to="loc_amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_0138de82-1375-4fd0-8d9e-8786fa33933a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RedemptionPeriod_0af54c37-3944-4abe-863a-9623b0e0e3a1" xlink:href="amci-20230213.xsd#amci_RedemptionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_2b027379-0477-418b-a223-e76f42fb5051" xlink:to="loc_amci_RedemptionPeriod_0af54c37-3944-4abe-863a-9623b0e0e3a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_b787a683-8bf5-4503-87f5-b1a7a9d604e9" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_2b027379-0477-418b-a223-e76f42fb5051" xlink:to="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_b787a683-8bf5-4503-87f5-b1a7a9d604e9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants_00fa3705-ec0a-44c4-b4ef-53ee1c364665" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_2b027379-0477-418b-a223-e76f42fb5051" xlink:to="loc_amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants_00fa3705-ec0a-44c4-b4ef-53ee1c364665" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_efd5dff9-fd26-4a16-8213-5d28584c4440" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_2b027379-0477-418b-a223-e76f42fb5051" xlink:to="loc_us-gaap_SharePrice_efd5dff9-fd26-4a16-8213-5d28584c4440" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PercentageOfGrossProceedsOnTotalEquityProceed_5beb6563-cae0-43a3-81ab-67bba3839913" xlink:href="amci-20230213.xsd#amci_PercentageOfGrossProceedsOnTotalEquityProceed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_2b027379-0477-418b-a223-e76f42fb5051" xlink:to="loc_amci_PercentageOfGrossProceedsOnTotalEquityProceed_5beb6563-cae0-43a3-81ab-67bba3839913" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_8f8112f0-3ad1-4950-a027-38fefbfbf84b" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_2b027379-0477-418b-a223-e76f42fb5051" xlink:to="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_8f8112f0-3ad1-4950-a027-38fefbfbf84b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices_a41c5e55-aaac-4110-a35a-1b996f1b846c" xlink:href="amci-20230213.xsd#amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_2b027379-0477-418b-a223-e76f42fb5051" xlink:to="loc_amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices_a41c5e55-aaac-4110-a35a-1b996f1b846c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_702d3479-f924-40ef-8544-03a0131eb132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_2b027379-0477-418b-a223-e76f42fb5051" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_702d3479-f924-40ef-8544-03a0131eb132" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_b35bd8c8-e010-42a1-bfc8-c2e060711280" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_2b027379-0477-418b-a223-e76f42fb5051" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_b35bd8c8-e010-42a1-bfc8-c2e060711280" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_4b1bff85-4208-425d-bb12-4d15ec102ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_b35bd8c8-e010-42a1-bfc8-c2e060711280" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_4b1bff85-4208-425d-bb12-4d15ec102ce0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_4b1bff85-4208-425d-bb12-4d15ec102ce0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_4b1bff85-4208-425d-bb12-4d15ec102ce0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_4b1bff85-4208-425d-bb12-4d15ec102ce0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_9060aa84-9b54-49af-9b41-d0d8c7433575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_4b1bff85-4208-425d-bb12-4d15ec102ce0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_9060aa84-9b54-49af-9b41-d0d8c7433575" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PublicWarrantsMember_b42c3f97-b87b-4fa4-a7ba-a68432fb3d9d" xlink:href="amci-20230213.xsd#amci_PublicWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_9060aa84-9b54-49af-9b41-d0d8c7433575" xlink:to="loc_amci_PublicWarrantsMember_b42c3f97-b87b-4fa4-a7ba-a68432fb3d9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a6e7807c-9fb4-48f1-ae34-963d4fbb1ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_b35bd8c8-e010-42a1-bfc8-c2e060711280" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a6e7807c-9fb4-48f1-ae34-963d4fbb1ca8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a6e7807c-9fb4-48f1-ae34-963d4fbb1ca8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a6e7807c-9fb4-48f1-ae34-963d4fbb1ca8" xlink:to="loc_us-gaap_ClassOfStockDomain_a6e7807c-9fb4-48f1-ae34-963d4fbb1ca8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6752f5c1-70b9-4963-b438-472d239e5c13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a6e7807c-9fb4-48f1-ae34-963d4fbb1ca8" xlink:to="loc_us-gaap_ClassOfStockDomain_6752f5c1-70b9-4963-b438-472d239e5c13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_4473488f-264e-40e7-b462-8470d51b51b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6752f5c1-70b9-4963-b438-472d239e5c13" xlink:to="loc_us-gaap_CommonClassAMember_4473488f-264e-40e7-b462-8470d51b51b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WarrantConditionAxis_67557f60-0c4b-4576-b578-9c0523b7fc17" xlink:href="amci-20230213.xsd#amci_WarrantConditionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_b35bd8c8-e010-42a1-bfc8-c2e060711280" xlink:to="loc_amci_WarrantConditionAxis_67557f60-0c4b-4576-b578-9c0523b7fc17" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WarrantConditionDomain_67557f60-0c4b-4576-b578-9c0523b7fc17_default" xlink:href="amci-20230213.xsd#amci_WarrantConditionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_amci_WarrantConditionAxis_67557f60-0c4b-4576-b578-9c0523b7fc17" xlink:to="loc_amci_WarrantConditionDomain_67557f60-0c4b-4576-b578-9c0523b7fc17_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WarrantConditionDomain_b9abe891-d675-41e0-9492-2f763b7b608c" xlink:href="amci-20230213.xsd#amci_WarrantConditionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_amci_WarrantConditionAxis_67557f60-0c4b-4576-b578-9c0523b7fc17" xlink:to="loc_amci_WarrantConditionDomain_b9abe891-d675-41e0-9492-2f763b7b608c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_29668417-e47d-448b-8cdc-a51171743007" xlink:href="amci-20230213.xsd#amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_WarrantConditionDomain_b9abe891-d675-41e0-9492-2f763b7b608c" xlink:to="loc_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_29668417-e47d-448b-8cdc-a51171743007" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_efbc2319-b59d-4bf7-9288-4a46e73e9f70" xlink:href="amci-20230213.xsd#amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_WarrantConditionDomain_b9abe891-d675-41e0-9492-2f763b7b608c" xlink:to="loc_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_efbc2319-b59d-4bf7-9288-4a46e73e9f70" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails" xlink:type="extended" id="i7174bf97cd2d43bd89fa22988ac153ee_FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_06008f66-9008-4607-8958-f783cbe23a44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_ec8ff52b-a43a-4b03-a222-49b4650bb8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_06008f66-9008-4607-8958-f783cbe23a44" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_ec8ff52b-a43a-4b03-a222-49b4650bb8cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_bc13bd31-357b-4f5b-a4fc-d01584df65ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_ec8ff52b-a43a-4b03-a222-49b4650bb8cf" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_bc13bd31-357b-4f5b-a4fc-d01584df65ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_9bb1f9cd-ceea-4c3a-a2e8-621fb1794b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_06008f66-9008-4607-8958-f783cbe23a44" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_9bb1f9cd-ceea-4c3a-a2e8-621fb1794b8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_822a92e9-ef97-41d6-88ff-2a3b0c405483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_9bb1f9cd-ceea-4c3a-a2e8-621fb1794b8a" xlink:to="loc_us-gaap_DerivativeLiabilities_822a92e9-ef97-41d6-88ff-2a3b0c405483" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_01cec613-793a-468f-ae03-7c20e85e015f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_9bb1f9cd-ceea-4c3a-a2e8-621fb1794b8a" xlink:to="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_01cec613-793a-468f-ae03-7c20e85e015f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_c9fd1667-3562-4afa-a9a6-9e1a0112d284" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_06008f66-9008-4607-8958-f783cbe23a44" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_c9fd1667-3562-4afa-a9a6-9e1a0112d284" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_412546e0-d74d-4992-bcf9-855acdba9713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_06008f66-9008-4607-8958-f783cbe23a44" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_412546e0-d74d-4992-bcf9-855acdba9713" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bad5c375-2435-4075-83d5-f0780c5bd803" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_412546e0-d74d-4992-bcf9-855acdba9713" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bad5c375-2435-4075-83d5-f0780c5bd803" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_bad5c375-2435-4075-83d5-f0780c5bd803_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bad5c375-2435-4075-83d5-f0780c5bd803" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_bad5c375-2435-4075-83d5-f0780c5bd803_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_b12fc9ff-6785-4091-b683-bf2952cdbe0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bad5c375-2435-4075-83d5-f0780c5bd803" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_b12fc9ff-6785-4091-b683-bf2952cdbe0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_858641af-3df7-426e-9872-e66240dedda9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_b12fc9ff-6785-4091-b683-bf2952cdbe0d" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_858641af-3df7-426e-9872-e66240dedda9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_54af9af7-3ce7-4210-83d5-7a67115c5a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_412546e0-d74d-4992-bcf9-855acdba9713" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_54af9af7-3ce7-4210-83d5-7a67115c5a1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_54af9af7-3ce7-4210-83d5-7a67115c5a1c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_54af9af7-3ce7-4210-83d5-7a67115c5a1c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_54af9af7-3ce7-4210-83d5-7a67115c5a1c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eb154cf4-fe5e-4caf-97cb-810baf5f3a43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_54af9af7-3ce7-4210-83d5-7a67115c5a1c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eb154cf4-fe5e-4caf-97cb-810baf5f3a43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_5808f3da-a427-4b01-ae66-9b8440b2a382" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eb154cf4-fe5e-4caf-97cb-810baf5f3a43" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_5808f3da-a427-4b01-ae66-9b8440b2a382" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_189bbaef-c0b1-441a-b249-3cc3d1e333b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eb154cf4-fe5e-4caf-97cb-810baf5f3a43" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_189bbaef-c0b1-441a-b249-3cc3d1e333b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_22f4192a-f18f-44e9-8b8f-ccea4436740b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_412546e0-d74d-4992-bcf9-855acdba9713" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_22f4192a-f18f-44e9-8b8f-ccea4436740b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_22f4192a-f18f-44e9-8b8f-ccea4436740b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_22f4192a-f18f-44e9-8b8f-ccea4436740b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_22f4192a-f18f-44e9-8b8f-ccea4436740b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_a9f6d96a-e442-4999-9c80-d53448204f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_22f4192a-f18f-44e9-8b8f-ccea4436740b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_a9f6d96a-e442-4999-9c80-d53448204f4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PublicWarrantsMember_2efa28af-3467-4166-8200-d162f0900d2a" xlink:href="amci-20230213.xsd#amci_PublicWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_a9f6d96a-e442-4999-9c80-d53448204f4c" xlink:to="loc_amci_PublicWarrantsMember_2efa28af-3467-4166-8200-d162f0900d2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PrivatePlacementWarrantsMember_b57f6d9a-ff71-4e9a-adce-6a8e3d1860a8" xlink:href="amci-20230213.xsd#amci_PrivatePlacementWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_a9f6d96a-e442-4999-9c80-d53448204f4c" xlink:to="loc_amci_PrivatePlacementWarrantsMember_b57f6d9a-ff71-4e9a-adce-6a8e3d1860a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_80314774-5279-45b1-bb4e-cc8eed77cb7d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_412546e0-d74d-4992-bcf9-855acdba9713" xlink:to="loc_dei_LegalEntityAxis_80314774-5279-45b1-bb4e-cc8eed77cb7d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_80314774-5279-45b1-bb4e-cc8eed77cb7d_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_80314774-5279-45b1-bb4e-cc8eed77cb7d" xlink:to="loc_dei_EntityDomain_80314774-5279-45b1-bb4e-cc8eed77cb7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_abd2ff6d-06cb-4f26-acfa-e8f373d80873" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_80314774-5279-45b1-bb4e-cc8eed77cb7d" xlink:to="loc_dei_EntityDomain_abd2ff6d-06cb-4f26-acfa-e8f373d80873" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AMCIACQUISITIONCORPIIMember_8759678d-f806-4c1b-9cb1-3060d5d39932" xlink:href="amci-20230213.xsd#amci_AMCIACQUISITIONCORPIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_abd2ff6d-06cb-4f26-acfa-e8f373d80873" xlink:to="loc_amci_AMCIACQUISITIONCORPIIMember_8759678d-f806-4c1b-9cb1-3060d5d39932" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueMeasurementsLevel3fairvaluemeasurementsDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails" xlink:type="extended" id="i575ef054b45448cf875f97d8a0247714_FairValueMeasurementsLevel3fairvaluemeasurementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_92e3753f-8fa3-4f18-ac35-99ac94520acf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_d79e1ba7-2ce0-46d6-944a-450c3fa9bef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_92e3753f-8fa3-4f18-ac35-99ac94520acf" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_d79e1ba7-2ce0-46d6-944a-450c3fa9bef5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_3b44f11d-4edb-49e8-b0a6-0db407cc6871" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_92e3753f-8fa3-4f18-ac35-99ac94520acf" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_3b44f11d-4edb-49e8-b0a6-0db407cc6871" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_0acd5f1f-bc3e-4315-82df-21388e1698ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_3b44f11d-4edb-49e8-b0a6-0db407cc6871" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_0acd5f1f-bc3e-4315-82df-21388e1698ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_0acd5f1f-bc3e-4315-82df-21388e1698ae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_0acd5f1f-bc3e-4315-82df-21388e1698ae" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_0acd5f1f-bc3e-4315-82df-21388e1698ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_9de0848b-32ce-4c3c-8b86-2daa203ab74b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_0acd5f1f-bc3e-4315-82df-21388e1698ae" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_9de0848b-32ce-4c3c-8b86-2daa203ab74b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExercisePriceMember_7544e836-f603-4a8d-a957-7999acc855a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExercisePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_9de0848b-32ce-4c3c-8b86-2daa203ab74b" xlink:to="loc_us-gaap_MeasurementInputExercisePriceMember_7544e836-f603-4a8d-a957-7999acc855a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_5385b988-6de1-4345-b661-232255fbf3a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_9de0848b-32ce-4c3c-8b86-2daa203ab74b" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_5385b988-6de1-4345-b661-232255fbf3a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_a6cff8cb-3fe1-493d-a72d-931ada24736c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_9de0848b-32ce-4c3c-8b86-2daa203ab74b" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_a6cff8cb-3fe1-493d-a72d-931ada24736c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_e0e209d7-b449-43f2-a654-0e71b47b0b65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_9de0848b-32ce-4c3c-8b86-2daa203ab74b" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_e0e209d7-b449-43f2-a654-0e71b47b0b65" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1e3bd8ff-091c-4cd5-81c4-e60b5ec9d77d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_9de0848b-32ce-4c3c-8b86-2daa203ab74b" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1e3bd8ff-091c-4cd5-81c4-e60b5ec9d77d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_26187533-6d61-40ab-8efe-2375d6cc7621" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_3b44f11d-4edb-49e8-b0a6-0db407cc6871" xlink:to="loc_dei_LegalEntityAxis_26187533-6d61-40ab-8efe-2375d6cc7621" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_26187533-6d61-40ab-8efe-2375d6cc7621_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_26187533-6d61-40ab-8efe-2375d6cc7621" xlink:to="loc_dei_EntityDomain_26187533-6d61-40ab-8efe-2375d6cc7621_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_0b414506-d964-4096-b770-78df7373e843" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_26187533-6d61-40ab-8efe-2375d6cc7621" xlink:to="loc_dei_EntityDomain_0b414506-d964-4096-b770-78df7373e843" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AMCIACQUISITIONCORPIIMember_fc402b49-5de7-437c-b911-031eec01af04" xlink:href="amci-20230213.xsd#amci_AMCIACQUISITIONCORPIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_0b414506-d964-4096-b770-78df7373e843" xlink:to="loc_amci_AMCIACQUISITIONCORPIIMember_fc402b49-5de7-437c-b911-031eec01af04" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails" xlink:type="extended" id="i807bc84f64ef4986a88b62c4573c9c09_FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_26d6e6ba-d1f9-4300-9604-72d2aa48a2af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_869f7b9b-bf17-4810-bc91-ef4d3db549d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_26d6e6ba-d1f9-4300-9604-72d2aa48a2af" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_869f7b9b-bf17-4810-bc91-ef4d3db549d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3a319a89-9f7d-417c-9d52-febd1dc1c660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_869f7b9b-bf17-4810-bc91-ef4d3db549d1" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3a319a89-9f7d-417c-9d52-febd1dc1c660" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_333e0542-467f-4768-b531-c1a18155ea73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_869f7b9b-bf17-4810-bc91-ef4d3db549d1" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_333e0542-467f-4768-b531-c1a18155ea73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_bc5de0f2-bdd5-4a6b-84cc-4074131baaab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_333e0542-467f-4768-b531-c1a18155ea73" xlink:to="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_bc5de0f2-bdd5-4a6b-84cc-4074131baaab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b6a54be2-27ce-45bf-8a84-c56cfd179d86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ddbb4878-c2ac-4648-be2f-bedc190bf77c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_26d6e6ba-d1f9-4300-9604-72d2aa48a2af" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ddbb4878-c2ac-4648-be2f-bedc190bf77c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_50924c43-a0b4-46f5-9090-903ae56701ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ddbb4878-c2ac-4648-be2f-bedc190bf77c" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_50924c43-a0b4-46f5-9090-903ae56701ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_50924c43-a0b4-46f5-9090-903ae56701ed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_50924c43-a0b4-46f5-9090-903ae56701ed" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_50924c43-a0b4-46f5-9090-903ae56701ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_a1be14e1-b65d-46c5-a1f4-1e816ecd217c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_50924c43-a0b4-46f5-9090-903ae56701ed" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_a1be14e1-b65d-46c5-a1f4-1e816ecd217c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_6e08efe0-3d32-4557-b2ff-71afbce89279" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_a1be14e1-b65d-46c5-a1f4-1e816ecd217c" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_6e08efe0-3d32-4557-b2ff-71afbce89279" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/SubsequentEventsDetails" xlink:type="extended" id="i327d1e2f06cb4d649a7bb75d3b3b1d54_SubsequentEventsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_8d0edc14-8684-40fd-8c8a-10a4218e27f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_be138c88-380c-46ea-915c-bb5d4ed7d20e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_8d0edc14-8684-40fd-8c8a-10a4218e27f0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_be138c88-380c-46ea-915c-bb5d4ed7d20e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_163936e3-2b19-4275-861c-187566216530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_8d0edc14-8684-40fd-8c8a-10a4218e27f0" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_163936e3-2b19-4275-861c-187566216530" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_cf1ef23f-30f1-4d6f-9979-0f60ce9e3ae0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_8d0edc14-8684-40fd-8c8a-10a4218e27f0" xlink:to="loc_us-gaap_SubsequentEventTable_cf1ef23f-30f1-4d6f-9979-0f60ce9e3ae0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_ccc0ad2a-619e-4510-a549-610c348a26a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_cf1ef23f-30f1-4d6f-9979-0f60ce9e3ae0" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_ccc0ad2a-619e-4510-a549-610c348a26a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ccc0ad2a-619e-4510-a549-610c348a26a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ccc0ad2a-619e-4510-a549-610c348a26a1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ccc0ad2a-619e-4510-a549-610c348a26a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_52a02182-43ca-41dc-b418-fab45098e863" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ccc0ad2a-619e-4510-a549-610c348a26a1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_52a02182-43ca-41dc-b418-fab45098e863" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_843c5bb3-f1e7-48ac-acee-50ba9f896433" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_52a02182-43ca-41dc-b418-fab45098e863" xlink:to="loc_us-gaap_SubsequentEventMember_843c5bb3-f1e7-48ac-acee-50ba9f896433" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_f5a1bbd9-e847-4b2d-9038-9cb1f0e55439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_cf1ef23f-30f1-4d6f-9979-0f60ce9e3ae0" xlink:to="loc_us-gaap_StatementClassOfStockAxis_f5a1bbd9-e847-4b2d-9038-9cb1f0e55439" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f5a1bbd9-e847-4b2d-9038-9cb1f0e55439_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_f5a1bbd9-e847-4b2d-9038-9cb1f0e55439" xlink:to="loc_us-gaap_ClassOfStockDomain_f5a1bbd9-e847-4b2d-9038-9cb1f0e55439_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9e567789-e087-41bd-b061-b69750c0ec31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_f5a1bbd9-e847-4b2d-9038-9cb1f0e55439" xlink:to="loc_us-gaap_ClassOfStockDomain_9e567789-e087-41bd-b061-b69750c0ec31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_4075b45d-a593-4588-adb9-459722b32a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_9e567789-e087-41bd-b061-b69750c0ec31" xlink:to="loc_us-gaap_CommonClassAMember_4075b45d-a593-4588-adb9-459722b32a1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_47f91f79-7cef-4f93-ae3e-91e481c0a5e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_cf1ef23f-30f1-4d6f-9979-0f60ce9e3ae0" xlink:to="loc_us-gaap_TypeOfArrangementAxis_47f91f79-7cef-4f93-ae3e-91e481c0a5e5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_47f91f79-7cef-4f93-ae3e-91e481c0a5e5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_47f91f79-7cef-4f93-ae3e-91e481c0a5e5" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_47f91f79-7cef-4f93-ae3e-91e481c0a5e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a66d699b-50a2-47ca-badf-fdfd18746afb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_47f91f79-7cef-4f93-ae3e-91e481c0a5e5" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a66d699b-50a2-47ca-badf-fdfd18746afb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_October2022SubscriptionAgreementsMember_ed8d850b-898d-463a-a454-5bd69211d385" xlink:href="amci-20230213.xsd#amci_October2022SubscriptionAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a66d699b-50a2-47ca-badf-fdfd18746afb" xlink:to="loc_amci_October2022SubscriptionAgreementsMember_ed8d850b-898d-463a-a454-5bd69211d385" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#DescriptionofOrganizationandBusinessOperationsDetails_1"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1" xlink:type="extended" id="i1d626b3e4e86441590aa6d5b555158d5_DescriptionofOrganizationandBusinessOperationsDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum_15c91bc1-0d32-4ca8-a60a-acb50e291104" xlink:href="amci-20230213.xsd#amci_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum_15c91bc1-0d32-4ca8-a60a-acb50e291104" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_UnitsIssuedDuringPeriodSharesNewIssues_ca98ac2c-96bb-4921-9d3a-9e963ecb1b95" xlink:href="amci-20230213.xsd#amci_UnitsIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_UnitsIssuedDuringPeriodSharesNewIssues_ca98ac2c-96bb-4921-9d3a-9e963ecb1b95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_fc38173f-00dd-48c7-b85e-7888abd33257" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_fc38173f-00dd-48c7-b85e-7888abd33257" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights_598a943f-aed6-4df6-bf06-3c0af671f23c" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights_598a943f-aed6-4df6-bf06-3c0af671f23c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_a6249e89-f14e-48cb-a494-778d9db7bdcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_a6249e89-f14e-48cb-a494-778d9db7bdcd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_bcf85891-9695-41a5-8850-632ebf014207" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_bcf85891-9695-41a5-8850-632ebf014207" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_28e40c80-0f35-4d95-a570-1a4e63558eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_28e40c80-0f35-4d95-a570-1a4e63558eb3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_5f2988f5-cc2f-43f0-bac6-993cccfb8506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_5f2988f5-cc2f-43f0-bac6-993cccfb8506" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_27d329b4-337c-4716-984a-6e302f727500" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_27d329b4-337c-4716-984a-6e302f727500" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TransactionCosts_97981b7b-b14d-4d04-b172-a59be0bb7951" xlink:href="amci-20230213.xsd#amci_TransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_TransactionCosts_97981b7b-b14d-4d04-b172-a59be0bb7951" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering_fb3953ba-2234-4df3-93ee-08824703f2f4" xlink:href="amci-20230213.xsd#amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_TransactionCosts_97981b7b-b14d-4d04-b172-a59be0bb7951" xlink:to="loc_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering_fb3953ba-2234-4df3-93ee-08824703f2f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SaleOfStockUnderwritingDiscounts_576992aa-5003-479e-8413-a2130b6d8a9d" xlink:href="amci-20230213.xsd#amci_SaleOfStockUnderwritingDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_TransactionCosts_97981b7b-b14d-4d04-b172-a59be0bb7951" xlink:to="loc_amci_SaleOfStockUnderwritingDiscounts_576992aa-5003-479e-8413-a2130b6d8a9d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingDiscounts_f55d8090-85e4-4d8e-8ebf-112d7a3c1736" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_TransactionCosts_97981b7b-b14d-4d04-b172-a59be0bb7951" xlink:to="loc_amci_DeferredUnderwritingDiscounts_f55d8090-85e4-4d8e-8ebf-112d7a3c1736" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SaleOfStockOtherOfferingCosts_f6ed6c6e-6c07-4ab6-8ace-774dd3f8c5de" xlink:href="amci-20230213.xsd#amci_SaleOfStockOtherOfferingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_TransactionCosts_97981b7b-b14d-4d04-b172-a59be0bb7951" xlink:to="loc_amci_SaleOfStockOtherOfferingCosts_f6ed6c6e-6c07-4ab6-8ace-774dd3f8c5de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PaymentsForInvestmentOfCashInTrustAccount_369b046d-4d7c-42f6-998e-c896493a93c2" xlink:href="amci-20230213.xsd#amci_PaymentsForInvestmentOfCashInTrustAccount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_PaymentsForInvestmentOfCashInTrustAccount_369b046d-4d7c-42f6-998e-c896493a93c2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ConditionForFutureBusinessCombinationUseOfProceedsPercentage_4a37485d-8ad2-4ffb-8dd6-c7ff953dd8d8" xlink:href="amci-20230213.xsd#amci_ConditionForFutureBusinessCombinationUseOfProceedsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_ConditionForFutureBusinessCombinationUseOfProceedsPercentage_4a37485d-8ad2-4ffb-8dd6-c7ff953dd8d8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ConditionForFutureBusinessCombinationThresholdPercentageOwnership_af6defb6-39ce-4e54-a717-63e20325f79d" xlink:href="amci-20230213.xsd#amci_ConditionForFutureBusinessCombinationThresholdPercentageOwnership"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_ConditionForFutureBusinessCombinationThresholdPercentageOwnership_af6defb6-39ce-4e54-a717-63e20325f79d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_9bc8a15c-0408-47a1-8afb-0a809143ec58" xlink:href="amci-20230213.xsd#amci_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_9bc8a15c-0408-47a1-8afb-0a809143ec58" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets_caf1cc15-1198-472e-bd29-42dd9b549a28" xlink:href="amci-20230213.xsd#amci_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets_caf1cc15-1198-472e-bd29-42dd9b549a28" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MonthsToCompleteAcquisition_e4956c31-ee3c-4f72-8b39-471dbc36f18a" xlink:href="amci-20230213.xsd#amci_MonthsToCompleteAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_MonthsToCompleteAcquisition_e4956c31-ee3c-4f72-8b39-471dbc36f18a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RedemptionPeriodUponClosure_017bbf46-9259-4d53-b21f-0d269840ab40" xlink:href="amci-20230213.xsd#amci_RedemptionPeriodUponClosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_RedemptionPeriodUponClosure_017bbf46-9259-4d53-b21f-0d269840ab40" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MaximumAllowedDissolutionExpenses_c4d0b8be-fdbc-44d5-9a7b-dcf1a403d59d" xlink:href="amci-20230213.xsd#amci_MaximumAllowedDissolutionExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_MaximumAllowedDissolutionExpenses_c4d0b8be-fdbc-44d5-9a7b-dcf1a403d59d" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount_af7b8ddc-e5db-48a7-8c6b-76d31831148c" xlink:href="amci-20230213.xsd#amci_TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount_af7b8ddc-e5db-48a7-8c6b-76d31831148c" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WorkingCapitalDeficit_06f2ab50-e178-4579-a2bb-d3a0f32443ab" xlink:href="amci-20230213.xsd#amci_WorkingCapitalDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_WorkingCapitalDeficit_06f2ab50-e178-4579-a2bb-d3a0f32443ab" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_435460a6-ccea-4d35-a259-4a29da4b5847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_435460a6-ccea-4d35-a259-4a29da4b5847" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_1c127ea7-edbd-4e27-8407-4a3e8b815a95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_5b6b7d50-bae0-4f87-9e59-e6e938de9ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNet_ba4e00f7-28e3-4351-bd86-f63bd7cab182" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_us-gaap_AssetsNet_ba4e00f7-28e3-4351-bd86-f63bd7cab182" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrustCurrent_169d285b-cd9a-4484-bbc7-22408aa1ec6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_us-gaap_AssetsHeldInTrustCurrent_169d285b-cd9a-4484-bbc7-22408aa1ec6b" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_55104e0b-a730-406f-9949-5c7114473f61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_55104e0b-a730-406f-9949-5c7114473f61" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_d08df402-5e24-4fae-8a2e-26f0f1d448a0" xlink:href="amci-20230213.xsd#amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_d08df402-5e24-4fae-8a2e-26f0f1d448a0" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_f8eb0a95-4cfa-4eea-b387-867706629da0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_4190d2fc-07aa-4c85-8b89-da2adebde2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_4190d2fc-07aa-4c85-8b89-da2adebde2d6" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfSharesIssuedPerUnit_22f175a5-6769-4911-91ae-9cd04baff910" xlink:href="amci-20230213.xsd#amci_NumberOfSharesIssuedPerUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_NumberOfSharesIssuedPerUnit_22f175a5-6769-4911-91ae-9cd04baff910" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfWarrantsIssuedPerUnit_c8355b4a-f26c-4c4b-ba20-8361993d1e2a" xlink:href="amci-20230213.xsd#amci_NumberOfWarrantsIssuedPerUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_NumberOfWarrantsIssuedPerUnit_c8355b4a-f26c-4c4b-ba20-8361993d1e2a" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_FundHeldInTrustAccountPerPublicShare_afb9a4c0-9f00-43f6-a353-1a6fb2c991e6" xlink:href="amci-20230213.xsd#amci_FundHeldInTrustAccountPerPublicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_FundHeldInTrustAccountPerPublicShare_afb9a4c0-9f00-43f6-a353-1a6fb2c991e6" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose_2ea91e66-dc91-46f1-9630-73dfa4aa21e2" xlink:href="amci-20230213.xsd#amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose_2ea91e66-dc91-46f1-9630-73dfa4aa21e2" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_7e3bc4de-7c70-4860-95ec-52b7d092eee7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_us-gaap_ShortTermBorrowings_7e3bc4de-7c70-4860-95ec-52b7d092eee7" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WorkingCapitalLoan_8967e7dc-ccda-46f6-ada9-e6892cb5ca60" xlink:href="amci-20230213.xsd#amci_WorkingCapitalLoan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_WorkingCapitalLoan_8967e7dc-ccda-46f6-ada9-e6892cb5ca60" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_7aa4c02c-fda4-499d-a116-307cc86fd54b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_7aa4c02c-fda4-499d-a116-307cc86fd54b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_da7ee473-32de-44fa-9ac8-de0fe7b270cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_7aa4c02c-fda4-499d-a116-307cc86fd54b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_da7ee473-32de-44fa-9ac8-de0fe7b270cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_da7ee473-32de-44fa-9ac8-de0fe7b270cd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_da7ee473-32de-44fa-9ac8-de0fe7b270cd" xlink:to="loc_us-gaap_RelatedPartyDomain_da7ee473-32de-44fa-9ac8-de0fe7b270cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_7f9ca51e-c02a-413f-8998-92fd719d613c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_da7ee473-32de-44fa-9ac8-de0fe7b270cd" xlink:to="loc_us-gaap_RelatedPartyDomain_7f9ca51e-c02a-413f-8998-92fd719d613c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SponsorMember_bc90bfda-4ded-43c2-b1ec-3747167eeb7e" xlink:href="amci-20230213.xsd#amci_SponsorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_7f9ca51e-c02a-413f-8998-92fd719d613c" xlink:to="loc_amci_SponsorMember_bc90bfda-4ded-43c2-b1ec-3747167eeb7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_feea4219-d05a-4c89-8203-f6232ea45430" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_7aa4c02c-fda4-499d-a116-307cc86fd54b" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_feea4219-d05a-4c89-8203-f6232ea45430" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_feea4219-d05a-4c89-8203-f6232ea45430_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_feea4219-d05a-4c89-8203-f6232ea45430" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_feea4219-d05a-4c89-8203-f6232ea45430_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_15f37be4-ae8d-40be-a689-b2531208cb67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_feea4219-d05a-4c89-8203-f6232ea45430" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_15f37be4-ae8d-40be-a689-b2531208cb67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_a6d5d254-844a-4e73-a1a1-67aa543ed462" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_15f37be4-ae8d-40be-a689-b2531208cb67" xlink:to="loc_us-gaap_IPOMember_a6d5d254-844a-4e73-a1a1-67aa543ed462" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_bc60b59a-b206-46dd-98bc-3fc46473f538" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_15f37be4-ae8d-40be-a689-b2531208cb67" xlink:to="loc_us-gaap_PrivatePlacementMember_bc60b59a-b206-46dd-98bc-3fc46473f538" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_4fa455b3-d05e-4145-a205-22ec6ab0d9d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_7aa4c02c-fda4-499d-a116-307cc86fd54b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_4fa455b3-d05e-4145-a205-22ec6ab0d9d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_4fa455b3-d05e-4145-a205-22ec6ab0d9d8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_4fa455b3-d05e-4145-a205-22ec6ab0d9d8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_4fa455b3-d05e-4145-a205-22ec6ab0d9d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_127791f0-8495-470a-8ed7-c0a94933fb0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_4fa455b3-d05e-4145-a205-22ec6ab0d9d8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_127791f0-8495-470a-8ed7-c0a94933fb0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_e85c91c1-2a63-460b-8ec2-dde0a88e491e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_127791f0-8495-470a-8ed7-c0a94933fb0d" xlink:to="loc_us-gaap_WarrantMember_e85c91c1-2a63-460b-8ec2-dde0a88e491e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PrivatePlacementWarrantsMember_e05642d0-d143-455b-8008-621e7e8bfac2" xlink:href="amci-20230213.xsd#amci_PrivatePlacementWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WarrantMember_e85c91c1-2a63-460b-8ec2-dde0a88e491e" xlink:to="loc_amci_PrivatePlacementWarrantsMember_e05642d0-d143-455b-8008-621e7e8bfac2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c9066e3b-d59a-4978-ba4b-bb128a1fbd38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_7aa4c02c-fda4-499d-a116-307cc86fd54b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c9066e3b-d59a-4978-ba4b-bb128a1fbd38" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c9066e3b-d59a-4978-ba4b-bb128a1fbd38_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c9066e3b-d59a-4978-ba4b-bb128a1fbd38" xlink:to="loc_us-gaap_EquityComponentDomain_c9066e3b-d59a-4978-ba4b-bb128a1fbd38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9756db90-e74f-4453-aa78-de7a0c3024ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c9066e3b-d59a-4978-ba4b-bb128a1fbd38" xlink:to="loc_us-gaap_EquityComponentDomain_9756db90-e74f-4453-aa78-de7a0c3024ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_e1ed1bd5-abf9-466c-a334-75317a2449c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9756db90-e74f-4453-aa78-de7a0c3024ef" xlink:to="loc_us-gaap_RetainedEarningsMember_e1ed1bd5-abf9-466c-a334-75317a2449c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_8ce35ddf-586f-4af4-9e1d-fb04a656b19e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9756db90-e74f-4453-aa78-de7a0c3024ef" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_8ce35ddf-586f-4af4-9e1d-fb04a656b19e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_34bc521c-2c8e-426f-93e0-181c8f716da9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_7aa4c02c-fda4-499d-a116-307cc86fd54b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_34bc521c-2c8e-426f-93e0-181c8f716da9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_34bc521c-2c8e-426f-93e0-181c8f716da9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_34bc521c-2c8e-426f-93e0-181c8f716da9" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_34bc521c-2c8e-426f-93e0-181c8f716da9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_90d57eae-a15e-4f7f-8561-b98b61125345" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_34bc521c-2c8e-426f-93e0-181c8f716da9" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_90d57eae-a15e-4f7f-8561-b98b61125345" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_65ea6fca-34da-4a29-988c-f3085e84eab1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_90d57eae-a15e-4f7f-8561-b98b61125345" xlink:to="loc_us-gaap_SubsequentEventMember_65ea6fca-34da-4a29-988c-f3085e84eab1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_73a78aa9-49ce-47c9-a42b-c92eb4a272d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_7aa4c02c-fda4-499d-a116-307cc86fd54b" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_73a78aa9-49ce-47c9-a42b-c92eb4a272d6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_73a78aa9-49ce-47c9-a42b-c92eb4a272d6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_73a78aa9-49ce-47c9-a42b-c92eb4a272d6" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_73a78aa9-49ce-47c9-a42b-c92eb4a272d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_c738ebca-a8f2-4cf0-8d39-d19b91fe784f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_73a78aa9-49ce-47c9-a42b-c92eb4a272d6" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_c738ebca-a8f2-4cf0-8d39-d19b91fe784f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WorkingCapitalLoansMember_bb9210fa-9e1f-4b92-a840-a2adfbb385d4" xlink:href="amci-20230213.xsd#amci_WorkingCapitalLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_c738ebca-a8f2-4cf0-8d39-d19b91fe784f" xlink:to="loc_amci_WorkingCapitalLoansMember_bb9210fa-9e1f-4b92-a840-a2adfbb385d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_4c755822-2724-4194-9d76-5f7bc4b8edbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_7aa4c02c-fda4-499d-a116-307cc86fd54b" xlink:to="loc_us-gaap_StatementClassOfStockAxis_4c755822-2724-4194-9d76-5f7bc4b8edbb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4c755822-2724-4194-9d76-5f7bc4b8edbb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4c755822-2724-4194-9d76-5f7bc4b8edbb" xlink:to="loc_us-gaap_ClassOfStockDomain_4c755822-2724-4194-9d76-5f7bc4b8edbb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f818b171-9c26-4fb1-80e1-8cacb5b4aba0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4c755822-2724-4194-9d76-5f7bc4b8edbb" xlink:to="loc_us-gaap_ClassOfStockDomain_f818b171-9c26-4fb1-80e1-8cacb5b4aba0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_9aa98549-a064-476a-b132-d7a7dab7f0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_f818b171-9c26-4fb1-80e1-8cacb5b4aba0" xlink:to="loc_us-gaap_CommonClassAMember_9aa98549-a064-476a-b132-d7a7dab7f0cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_acb9b11b-c19f-4851-bf71-33458294f3e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_7aa4c02c-fda4-499d-a116-307cc86fd54b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_acb9b11b-c19f-4851-bf71-33458294f3e4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_acb9b11b-c19f-4851-bf71-33458294f3e4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_acb9b11b-c19f-4851-bf71-33458294f3e4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_acb9b11b-c19f-4851-bf71-33458294f3e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_780d78ba-d19c-4761-9c23-d116cd02c61d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_acb9b11b-c19f-4851-bf71-33458294f3e4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_780d78ba-d19c-4761-9c23-d116cd02c61d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LanzatechGlobalMember_2aadbe74-6f15-4392-a702-dca0dd2774d2" xlink:href="amci-20230213.xsd#amci_LanzatechGlobalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_780d78ba-d19c-4761-9c23-d116cd02c61d" xlink:to="loc_amci_LanzatechGlobalMember_2aadbe74-6f15-4392-a702-dca0dd2774d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2143e65c-b89b-43a2-bcfd-2623818ae03d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_7aa4c02c-fda4-499d-a116-307cc86fd54b" xlink:to="loc_srt_RangeAxis_2143e65c-b89b-43a2-bcfd-2623818ae03d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2143e65c-b89b-43a2-bcfd-2623818ae03d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_2143e65c-b89b-43a2-bcfd-2623818ae03d" xlink:to="loc_srt_RangeMember_2143e65c-b89b-43a2-bcfd-2623818ae03d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_048a9512-0959-4fb5-b35a-6c24dd3a1467" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_2143e65c-b89b-43a2-bcfd-2623818ae03d" xlink:to="loc_srt_RangeMember_048a9512-0959-4fb5-b35a-6c24dd3a1467" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d0300676-1d6c-4de9-9317-be5638f17d68" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_048a9512-0959-4fb5-b35a-6c24dd3a1467" xlink:to="loc_srt_MinimumMember_d0300676-1d6c-4de9-9317-be5638f17d68" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails_1"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails_1" xlink:type="extended" id="i1c050a172a6347c0b80a23ee2b4d175b_BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_11a944ed-7338-4a45-bc87-8840a1b8676e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFDICInsuredAmount_d39f4265-f30b-473f-8502-6bc852f69238" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFDICInsuredAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_11a944ed-7338-4a45-bc87-8840a1b8676e" xlink:to="loc_us-gaap_CashFDICInsuredAmount_d39f4265-f30b-473f-8502-6bc852f69238" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_06fdf701-8bcf-46df-8d05-8e15252f0f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_11a944ed-7338-4a45-bc87-8840a1b8676e" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_06fdf701-8bcf-46df-8d05-8e15252f0f9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_401a488a-ea28-4797-92fb-0fdf60ae0ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_11a944ed-7338-4a45-bc87-8840a1b8676e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_401a488a-ea28-4797-92fb-0fdf60ae0ca6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_097a2c98-cca4-4766-98f9-b97feed0f588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_11a944ed-7338-4a45-bc87-8840a1b8676e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_097a2c98-cca4-4766-98f9-b97feed0f588" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_2c779c81-42d5-416f-a42d-ba88adcfee31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_11a944ed-7338-4a45-bc87-8840a1b8676e" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_2c779c81-42d5-416f-a42d-ba88adcfee31" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_728eff13-3bb1-4f8a-b08e-9e1aa55e2740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_11a944ed-7338-4a45-bc87-8840a1b8676e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_728eff13-3bb1-4f8a-b08e-9e1aa55e2740" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_9ab2b88a-a5b4-463d-8fd8-a28758009e54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_11a944ed-7338-4a45-bc87-8840a1b8676e" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_9ab2b88a-a5b4-463d-8fd8-a28758009e54" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_139b2749-e680-4014-8079-e03a16adbd30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_11a944ed-7338-4a45-bc87-8840a1b8676e" xlink:to="loc_us-gaap_StatementTable_139b2749-e680-4014-8079-e03a16adbd30" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_9e565b72-63be-4e3d-8513-41a77fe50554" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_139b2749-e680-4014-8079-e03a16adbd30" xlink:to="loc_us-gaap_StatementClassOfStockAxis_9e565b72-63be-4e3d-8513-41a77fe50554" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9e565b72-63be-4e3d-8513-41a77fe50554_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9e565b72-63be-4e3d-8513-41a77fe50554" xlink:to="loc_us-gaap_ClassOfStockDomain_9e565b72-63be-4e3d-8513-41a77fe50554_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4b670743-7a56-4b7c-8ebb-daa52a9b11e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9e565b72-63be-4e3d-8513-41a77fe50554" xlink:to="loc_us-gaap_ClassOfStockDomain_4b670743-7a56-4b7c-8ebb-daa52a9b11e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_26f3a6d8-ff44-4915-a7fd-8a822ab51d28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_4b670743-7a56-4b7c-8ebb-daa52a9b11e4" xlink:to="loc_us-gaap_CommonClassAMember_26f3a6d8-ff44-4915-a7fd-8a822ab51d28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CommonClassaSubjectToRedemptionMember_5f5327f5-a9b1-4d75-a7a9-08ae93c9eabf" xlink:href="amci-20230213.xsd#amci_CommonClassaSubjectToRedemptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_4b670743-7a56-4b7c-8ebb-daa52a9b11e4" xlink:to="loc_amci_CommonClassaSubjectToRedemptionMember_5f5327f5-a9b1-4d75-a7a9-08ae93c9eabf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_b2f417d5-5f79-401f-a2bf-d23fc156bdaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_139b2749-e680-4014-8079-e03a16adbd30" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_b2f417d5-5f79-401f-a2bf-d23fc156bdaf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b2f417d5-5f79-401f-a2bf-d23fc156bdaf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_b2f417d5-5f79-401f-a2bf-d23fc156bdaf" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b2f417d5-5f79-401f-a2bf-d23fc156bdaf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d7bb0813-c1b6-459a-802e-1184e6880dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_b2f417d5-5f79-401f-a2bf-d23fc156bdaf" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d7bb0813-c1b6-459a-802e-1184e6880dcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_88d531c5-5aaa-4931-a756-d8a71144970d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d7bb0813-c1b6-459a-802e-1184e6880dcb" xlink:to="loc_us-gaap_IPOMember_88d531c5-5aaa-4931-a756-d8a71144970d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails_1"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails_1" xlink:type="extended" id="i517556761fa34a2a8c521951fca07fbd_BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_02226b4f-dfd5-4a5a-9ea2-6b4f5074ecde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EarningPerShareBasicAndDilutedAbstract_ee4261ac-0e46-4fb2-99db-31a7a966feca" xlink:href="amci-20230213.xsd#amci_EarningPerShareBasicAndDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_02226b4f-dfd5-4a5a-9ea2-6b4f5074ecde" xlink:to="loc_amci_EarningPerShareBasicAndDilutedAbstract_ee4261ac-0e46-4fb2-99db-31a7a966feca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumeratorAbstract_fc939d97-6dc1-4fe0-957a-4a0e08d5eae4" xlink:href="amci-20230213.xsd#amci_NumeratorAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_EarningPerShareBasicAndDilutedAbstract_ee4261ac-0e46-4fb2-99db-31a7a966feca" xlink:to="loc_amci_NumeratorAbstract_fc939d97-6dc1-4fe0-957a-4a0e08d5eae4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_1de91cb6-083b-49ec-a669-1a3d4fb8eb9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_NumeratorAbstract_fc939d97-6dc1-4fe0-957a-4a0e08d5eae4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_1de91cb6-083b-49ec-a669-1a3d4fb8eb9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DenominatorForCalculationOfEarningsPerShareAbstract_14d14aa1-cecf-4231-beca-f7505477ccbf" xlink:href="amci-20230213.xsd#amci_DenominatorForCalculationOfEarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_EarningPerShareBasicAndDilutedAbstract_ee4261ac-0e46-4fb2-99db-31a7a966feca" xlink:to="loc_amci_DenominatorForCalculationOfEarningsPerShareAbstract_14d14aa1-cecf-4231-beca-f7505477ccbf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_64caa038-02f0-4582-b872-46fa7c8e6da1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_DenominatorForCalculationOfEarningsPerShareAbstract_14d14aa1-cecf-4231-beca-f7505477ccbf" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_64caa038-02f0-4582-b872-46fa7c8e6da1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5a1e542c-2925-4f3c-9719-b66fea6eeb61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_DenominatorForCalculationOfEarningsPerShareAbstract_14d14aa1-cecf-4231-beca-f7505477ccbf" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5a1e542c-2925-4f3c-9719-b66fea6eeb61" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_6167de40-dfaf-45f5-ba20-eec279e0c8bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_DenominatorForCalculationOfEarningsPerShareAbstract_14d14aa1-cecf-4231-beca-f7505477ccbf" xlink:to="loc_us-gaap_EarningsPerShareBasic_6167de40-dfaf-45f5-ba20-eec279e0c8bb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_766a0040-ce50-40ae-a8bb-b9d8f62c70b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_DenominatorForCalculationOfEarningsPerShareAbstract_14d14aa1-cecf-4231-beca-f7505477ccbf" xlink:to="loc_us-gaap_EarningsPerShareDiluted_766a0040-ce50-40ae-a8bb-b9d8f62c70b5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1004a647-319e-410a-9baf-bf5b4536e07d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_02226b4f-dfd5-4a5a-9ea2-6b4f5074ecde" xlink:to="loc_us-gaap_StatementTable_1004a647-319e-410a-9baf-bf5b4536e07d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_7fa5d1d6-af82-492b-b271-71489289e847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1004a647-319e-410a-9baf-bf5b4536e07d" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_7fa5d1d6-af82-492b-b271-71489289e847" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7fa5d1d6-af82-492b-b271-71489289e847_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_7fa5d1d6-af82-492b-b271-71489289e847" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7fa5d1d6-af82-492b-b271-71489289e847_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_bd5bdc5d-af4f-4f9a-8c86-da5886609bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_7fa5d1d6-af82-492b-b271-71489289e847" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_bd5bdc5d-af4f-4f9a-8c86-da5886609bf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_bbfe69c8-6de7-4d03-b9a7-cde6def7e601" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_bd5bdc5d-af4f-4f9a-8c86-da5886609bf0" xlink:to="loc_us-gaap_CommonClassAMember_bbfe69c8-6de7-4d03-b9a7-cde6def7e601" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_afb77c5d-21b9-4b57-b943-2ffb78118d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_bd5bdc5d-af4f-4f9a-8c86-da5886609bf0" xlink:to="loc_us-gaap_CommonClassBMember_afb77c5d-21b9-4b57-b943-2ffb78118d5e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#InitialPublicOfferingDetails_1"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1" xlink:type="extended" id="i022af6bf2fc04d9abb9864edb924416f_InitialPublicOfferingDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_UnitsIssuedDuringPeriodSharesNewIssues_2f6b5999-2eb9-4512-8a4e-7df5817d3860" xlink:href="amci-20230213.xsd#amci_UnitsIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:to="loc_amci_UnitsIssuedDuringPeriodSharesNewIssues_2f6b5999-2eb9-4512-8a4e-7df5817d3860" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_676ffd84-438f-4c65-a6a0-d9abde6b0f14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_676ffd84-438f-4c65-a6a0-d9abde6b0f14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_0f9eea6e-3306-4736-b36c-02898ff33332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_0f9eea6e-3306-4736-b36c-02898ff33332" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts_76aa0545-86cc-4acc-bff8-0af7616f83eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:to="loc_us-gaap_DeferredOfferingCosts_76aa0545-86cc-4acc-bff8-0af7616f83eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SaleOfStockUnderwritingDiscounts_22c3507f-da20-45a6-95eb-910e5890507c" xlink:href="amci-20230213.xsd#amci_SaleOfStockUnderwritingDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:to="loc_amci_SaleOfStockUnderwritingDiscounts_22c3507f-da20-45a6-95eb-910e5890507c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering_d871cbb4-1861-408d-9898-329f748c9515" xlink:href="amci-20230213.xsd#amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:to="loc_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering_d871cbb4-1861-408d-9898-329f748c9515" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SaleOfStockOtherOfferingCosts_c36e427b-7c4d-4273-ba43-33bb9db661b5" xlink:href="amci-20230213.xsd#amci_SaleOfStockOtherOfferingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:to="loc_amci_SaleOfStockOtherOfferingCosts_c36e427b-7c4d-4273-ba43-33bb9db661b5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingCompensationNoncurrent_ac2a344d-d532-433c-80af-30f258a37f12" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingCompensationNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:to="loc_amci_DeferredUnderwritingCompensationNoncurrent_ac2a344d-d532-433c-80af-30f258a37f12" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OptionVestingPeriod_76f1eaf1-b07f-479d-aaee-1cd17f9fb4a7" xlink:href="amci-20230213.xsd#amci_OptionVestingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:to="loc_amci_OptionVestingPeriod_76f1eaf1-b07f-479d-aaee-1cd17f9fb4a7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters_95c60086-76f3-484b-ad1b-f98030912150" xlink:href="amci-20230213.xsd#amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:to="loc_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters_95c60086-76f3-484b-ad1b-f98030912150" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_1b885dee-6b31-40c5-94f8-700c8ec5fccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_1b885dee-6b31-40c5-94f8-700c8ec5fccf" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_99292f23-f581-498c-886e-9978334a9d51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_99292f23-f581-498c-886e-9978334a9d51" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OptionToPurchaseAdditionalUnitsGivenToInvestors_fc6848cf-4d7c-4538-bc65-94542fce8d9d" xlink:href="amci-20230213.xsd#amci_OptionToPurchaseAdditionalUnitsGivenToInvestors"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:to="loc_amci_OptionToPurchaseAdditionalUnitsGivenToInvestors_fc6848cf-4d7c-4538-bc65-94542fce8d9d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_122d7b45-4829-429c-b320-5d516735f55b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_122d7b45-4829-429c-b320-5d516735f55b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_b097dbe5-d72d-4c31-8013-aae0fd24a11a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_b097dbe5-d72d-4c31-8013-aae0fd24a11a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_1abd08b1-d45e-434f-9169-9d9e132b87ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_b097dbe5-d72d-4c31-8013-aae0fd24a11a" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_1abd08b1-d45e-434f-9169-9d9e132b87ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1abd08b1-d45e-434f-9169-9d9e132b87ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_1abd08b1-d45e-434f-9169-9d9e132b87ef" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1abd08b1-d45e-434f-9169-9d9e132b87ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5e47573f-4607-4e56-80bc-72fa1e557383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_1abd08b1-d45e-434f-9169-9d9e132b87ef" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5e47573f-4607-4e56-80bc-72fa1e557383" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_791507c0-ee0f-4eaf-9f06-fc5604caede4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5e47573f-4607-4e56-80bc-72fa1e557383" xlink:to="loc_us-gaap_CommonClassAMember_791507c0-ee0f-4eaf-9f06-fc5604caede4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_b7b68806-ff44-4b6e-a64d-feb2a4533a90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5e47573f-4607-4e56-80bc-72fa1e557383" xlink:to="loc_us-gaap_IPOMember_b7b68806-ff44-4b6e-a64d-feb2a4533a90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_066af362-b984-422d-b331-9e33cbed8bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5e47573f-4607-4e56-80bc-72fa1e557383" xlink:to="loc_us-gaap_OverAllotmentOptionMember_066af362-b984-422d-b331-9e33cbed8bf6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_70921261-0907-470a-a4ae-2f0b2ae655ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_b097dbe5-d72d-4c31-8013-aae0fd24a11a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_70921261-0907-470a-a4ae-2f0b2ae655ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_70921261-0907-470a-a4ae-2f0b2ae655ac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_70921261-0907-470a-a4ae-2f0b2ae655ac" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_70921261-0907-470a-a4ae-2f0b2ae655ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_163bbe01-4cb3-48d0-bd8a-0ba924824db5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_70921261-0907-470a-a4ae-2f0b2ae655ac" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_163bbe01-4cb3-48d0-bd8a-0ba924824db5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_cc3e5406-92dd-45b0-83bb-79a176b41b58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_163bbe01-4cb3-48d0-bd8a-0ba924824db5" xlink:to="loc_us-gaap_WarrantMember_cc3e5406-92dd-45b0-83bb-79a176b41b58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_3c71802e-e355-4ca3-8cd9-443bea518b89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_b097dbe5-d72d-4c31-8013-aae0fd24a11a" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_3c71802e-e355-4ca3-8cd9-443bea518b89" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3c71802e-e355-4ca3-8cd9-443bea518b89_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_3c71802e-e355-4ca3-8cd9-443bea518b89" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3c71802e-e355-4ca3-8cd9-443bea518b89_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_829c4b56-c73d-4e5f-9841-9b36c4c08bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_3c71802e-e355-4ca3-8cd9-443bea518b89" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_829c4b56-c73d-4e5f-9841-9b36c4c08bf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_e02b0f47-bac9-4d2e-9c9e-96c883c60a29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_829c4b56-c73d-4e5f-9841-9b36c4c08bf6" xlink:to="loc_us-gaap_SubsequentEventMember_e02b0f47-bac9-4d2e-9c9e-96c883c60a29" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#RelatedPartyTransactionsFounderSharesDetails_1"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails_1" xlink:type="extended" id="i6ab2df0a618944a08b2abea48d62ac41_RelatedPartyTransactionsFounderSharesDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_2b38a898-7d66-4f49-b2c1-51991045588c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_7c5f33f8-9461-4cc2-9d20-7e7670158748" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2b38a898-7d66-4f49-b2c1-51991045588c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_7c5f33f8-9461-4cc2-9d20-7e7670158748" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_b42f7c8b-d93c-454a-b9b2-1e29a266f030" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2b38a898-7d66-4f49-b2c1-51991045588c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_b42f7c8b-d93c-454a-b9b2-1e29a266f030" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_b077ca0a-a89d-4e37-b302-f3da8efe1a04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2b38a898-7d66-4f49-b2c1-51991045588c" xlink:to="loc_us-gaap_SharePrice_b077ca0a-a89d-4e37-b302-f3da8efe1a04" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfSharesSurrendered_76e425fc-0265-4d1b-990d-c277c3f24ada" xlink:href="amci-20230213.xsd#amci_NumberOfSharesSurrendered"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2b38a898-7d66-4f49-b2c1-51991045588c" xlink:to="loc_amci_NumberOfSharesSurrendered_76e425fc-0265-4d1b-990d-c277c3f24ada" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AggregateNumberOfSharesOwned_424da5e5-3ee6-4d59-98c9-cac2afea8e61" xlink:href="amci-20230213.xsd#amci_AggregateNumberOfSharesOwned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2b38a898-7d66-4f49-b2c1-51991045588c" xlink:to="loc_amci_AggregateNumberOfSharesOwned_424da5e5-3ee6-4d59-98c9-cac2afea8e61" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfSharesSubjectToForfeiture_5279524c-5a26-4ef3-bdd9-77f74f7f0481" xlink:href="amci-20230213.xsd#amci_NumberOfSharesSubjectToForfeiture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2b38a898-7d66-4f49-b2c1-51991045588c" xlink:to="loc_amci_NumberOfSharesSubjectToForfeiture_5279524c-5a26-4ef3-bdd9-77f74f7f0481" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_2ed8b038-8f3c-4668-afb9-b97b3573ef60" xlink:href="amci-20230213.xsd#amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2b38a898-7d66-4f49-b2c1-51991045588c" xlink:to="loc_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_2ed8b038-8f3c-4668-afb9-b97b3573ef60" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_4a7f8b6f-274b-46fe-aa66-08447ae03e38" xlink:href="amci-20230213.xsd#amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2b38a898-7d66-4f49-b2c1-51991045588c" xlink:to="loc_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_4a7f8b6f-274b-46fe-aa66-08447ae03e38" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_3a85e767-213b-4d60-9b5c-1c46141c8174" xlink:href="amci-20230213.xsd#amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2b38a898-7d66-4f49-b2c1-51991045588c" xlink:to="loc_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_3a85e767-213b-4d60-9b5c-1c46141c8174" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_57dfe31e-325d-40b6-b04f-86f16dc62faf" xlink:href="amci-20230213.xsd#amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2b38a898-7d66-4f49-b2c1-51991045588c" xlink:to="loc_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_57dfe31e-325d-40b6-b04f-86f16dc62faf" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences_ae7bacab-85c5-4f7b-8969-a8cc893215b7" xlink:href="amci-20230213.xsd#amci_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2b38a898-7d66-4f49-b2c1-51991045588c" xlink:to="loc_amci_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences_ae7bacab-85c5-4f7b-8969-a8cc893215b7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_42144c07-bb95-4efa-a144-03f76fa212a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2b38a898-7d66-4f49-b2c1-51991045588c" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_42144c07-bb95-4efa-a144-03f76fa212a0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_8aac4915-1c8e-4740-9e29-7f797b930f57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_42144c07-bb95-4efa-a144-03f76fa212a0" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_8aac4915-1c8e-4740-9e29-7f797b930f57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_8aac4915-1c8e-4740-9e29-7f797b930f57_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_8aac4915-1c8e-4740-9e29-7f797b930f57" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_8aac4915-1c8e-4740-9e29-7f797b930f57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_5a19b159-b1ac-4fc2-8537-2c7bee90f117" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_8aac4915-1c8e-4740-9e29-7f797b930f57" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_5a19b159-b1ac-4fc2-8537-2c7bee90f117" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_FounderSharesMember_049f3a18-a345-4e6c-8ada-eb273945923f" xlink:href="amci-20230213.xsd#amci_FounderSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_5a19b159-b1ac-4fc2-8537-2c7bee90f117" xlink:to="loc_amci_FounderSharesMember_049f3a18-a345-4e6c-8ada-eb273945923f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_d1a5a645-90d1-40e8-9dbe-f2d7c4a76b44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_42144c07-bb95-4efa-a144-03f76fa212a0" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_d1a5a645-90d1-40e8-9dbe-f2d7c4a76b44" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_d1a5a645-90d1-40e8-9dbe-f2d7c4a76b44_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_d1a5a645-90d1-40e8-9dbe-f2d7c4a76b44" xlink:to="loc_us-gaap_RelatedPartyDomain_d1a5a645-90d1-40e8-9dbe-f2d7c4a76b44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_157c23d6-6436-4730-9e37-22e72e33ddf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_d1a5a645-90d1-40e8-9dbe-f2d7c4a76b44" xlink:to="loc_us-gaap_RelatedPartyDomain_157c23d6-6436-4730-9e37-22e72e33ddf4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SponsorMember_b8909d4f-e9f4-42d5-b391-a621904a26f1" xlink:href="amci-20230213.xsd#amci_SponsorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_157c23d6-6436-4730-9e37-22e72e33ddf4" xlink:to="loc_amci_SponsorMember_b8909d4f-e9f4-42d5-b391-a621904a26f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AnchorInvestorsMember_17edc89c-cbf7-47e4-abaf-bf785ea43565" xlink:href="amci-20230213.xsd#amci_AnchorInvestorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_157c23d6-6436-4730-9e37-22e72e33ddf4" xlink:to="loc_amci_AnchorInvestorsMember_17edc89c-cbf7-47e4-abaf-bf785ea43565" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_cdba1205-7e8f-4061-ac3c-d2f2e8db06bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_42144c07-bb95-4efa-a144-03f76fa212a0" xlink:to="loc_us-gaap_StatementClassOfStockAxis_cdba1205-7e8f-4061-ac3c-d2f2e8db06bb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_cdba1205-7e8f-4061-ac3c-d2f2e8db06bb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_cdba1205-7e8f-4061-ac3c-d2f2e8db06bb" xlink:to="loc_us-gaap_ClassOfStockDomain_cdba1205-7e8f-4061-ac3c-d2f2e8db06bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a1196921-7fe0-4afe-b23e-d142434388d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_cdba1205-7e8f-4061-ac3c-d2f2e8db06bb" xlink:to="loc_us-gaap_ClassOfStockDomain_a1196921-7fe0-4afe-b23e-d142434388d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_c61cd6e7-076d-4f15-a4b6-89a56517e198" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_a1196921-7fe0-4afe-b23e-d142434388d2" xlink:to="loc_us-gaap_CommonClassBMember_c61cd6e7-076d-4f15-a4b6-89a56517e198" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#RelatedPartyTransactionsAdditionalInformationDetails_1"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1" xlink:type="extended" id="i45d3e1daa01e408ea4222e2654cd1cac_RelatedPartyTransactionsAdditionalInformationDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_e4beaa29-e215-43be-a465-125a0c472767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_7c9ef227-faaf-4402-ae81-a38233af56bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e4beaa29-e215-43be-a465-125a0c472767" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_7c9ef227-faaf-4402-ae81-a38233af56bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_7bca2d53-a120-4397-adf9-aea94fff4c79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e4beaa29-e215-43be-a465-125a0c472767" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_7bca2d53-a120-4397-adf9-aea94fff4c79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights_d1720d68-a0cc-45c6-bd7f-e9057c1a84a9" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e4beaa29-e215-43be-a465-125a0c472767" xlink:to="loc_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights_d1720d68-a0cc-45c6-bd7f-e9057c1a84a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_cb585564-ad80-467f-adbf-006de669dc58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e4beaa29-e215-43be-a465-125a0c472767" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_cb585564-ad80-467f-adbf-006de669dc58" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_3f1529e5-ef33-47d1-b272-351ba900ff55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e4beaa29-e215-43be-a465-125a0c472767" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_3f1529e5-ef33-47d1-b272-351ba900ff55" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_b0ca3a0b-18a6-40a0-9abb-6254fe8bb8e7" xlink:href="amci-20230213.xsd#amci_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e4beaa29-e215-43be-a465-125a0c472767" xlink:to="loc_amci_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_b0ca3a0b-18a6-40a0-9abb-6254fe8bb8e7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MaximumLoansConvertibleIntoWarrants_d890335d-b3ec-4e1d-b165-4216f7c92aba" xlink:href="amci-20230213.xsd#amci_MaximumLoansConvertibleIntoWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e4beaa29-e215-43be-a465-125a0c472767" xlink:to="loc_amci_MaximumLoansConvertibleIntoWarrants_d890335d-b3ec-4e1d-b165-4216f7c92aba" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OutstandingWorkingCapitalLoans_4644991b-6030-4aa2-8458-edd07547915d" xlink:href="amci-20230213.xsd#amci_OutstandingWorkingCapitalLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e4beaa29-e215-43be-a465-125a0c472767" xlink:to="loc_amci_OutstandingWorkingCapitalLoans_4644991b-6030-4aa2-8458-edd07547915d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_60199878-2629-43e4-9b8d-c820624b521d" xlink:href="amci-20230213.xsd#amci_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e4beaa29-e215-43be-a465-125a0c472767" xlink:to="loc_amci_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_60199878-2629-43e4-9b8d-c820624b521d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_b751fff8-4e07-4d17-8e22-e190319bbb00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e4beaa29-e215-43be-a465-125a0c472767" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_b751fff8-4e07-4d17-8e22-e190319bbb00" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_13396fd6-e6ec-487b-8e1f-d289325f4837" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e4beaa29-e215-43be-a465-125a0c472767" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_13396fd6-e6ec-487b-8e1f-d289325f4837" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_0f085e94-983e-475c-9b21-cfa95b5a150e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e4beaa29-e215-43be-a465-125a0c472767" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrent_0f085e94-983e-475c-9b21-cfa95b5a150e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WorkingCapitalLoan_13ef090d-1520-4b25-8c42-a7421d3fbaa3" xlink:href="amci-20230213.xsd#amci_WorkingCapitalLoan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e4beaa29-e215-43be-a465-125a0c472767" xlink:to="loc_amci_WorkingCapitalLoan_13ef090d-1520-4b25-8c42-a7421d3fbaa3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c7a67ddf-e72c-45a7-a1c2-94d8604baaa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e4beaa29-e215-43be-a465-125a0c472767" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c7a67ddf-e72c-45a7-a1c2-94d8604baaa6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_85f3b641-c883-4255-a076-d974455a9d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c7a67ddf-e72c-45a7-a1c2-94d8604baaa6" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_85f3b641-c883-4255-a076-d974455a9d6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_85f3b641-c883-4255-a076-d974455a9d6f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_85f3b641-c883-4255-a076-d974455a9d6f" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_85f3b641-c883-4255-a076-d974455a9d6f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_96ea2cdb-0949-49e3-bb43-93b3bf72a03c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_85f3b641-c883-4255-a076-d974455a9d6f" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_96ea2cdb-0949-49e3-bb43-93b3bf72a03c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AdministrativeSupportAgreementMember_4f5073a9-d5dc-4789-a6ee-80d8fec06de8" xlink:href="amci-20230213.xsd#amci_AdministrativeSupportAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_96ea2cdb-0949-49e3-bb43-93b3bf72a03c" xlink:to="loc_amci_AdministrativeSupportAgreementMember_4f5073a9-d5dc-4789-a6ee-80d8fec06de8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartyLoansMember_9ad40c6d-9af4-489f-820f-244294532734" xlink:href="amci-20230213.xsd#amci_RelatedPartyLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_96ea2cdb-0949-49e3-bb43-93b3bf72a03c" xlink:to="loc_amci_RelatedPartyLoansMember_9ad40c6d-9af4-489f-820f-244294532734" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_2a5ae534-578b-451e-9dfd-d88b7dccff46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c7a67ddf-e72c-45a7-a1c2-94d8604baaa6" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_2a5ae534-578b-451e-9dfd-d88b7dccff46" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_2a5ae534-578b-451e-9dfd-d88b7dccff46_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_2a5ae534-578b-451e-9dfd-d88b7dccff46" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_2a5ae534-578b-451e-9dfd-d88b7dccff46_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_3588b828-4261-4a64-a825-b2244acb76f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_2a5ae534-578b-451e-9dfd-d88b7dccff46" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_3588b828-4261-4a64-a825-b2244acb76f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WorkingCapitalLoansWarrantMember_c21421dc-8264-4cd7-8f4b-42320b1791b9" xlink:href="amci-20230213.xsd#amci_WorkingCapitalLoansWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3588b828-4261-4a64-a825-b2244acb76f2" xlink:to="loc_amci_WorkingCapitalLoansWarrantMember_c21421dc-8264-4cd7-8f4b-42320b1791b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PrivatePlacementWarrantsMember_a879c526-1c64-445e-a154-6b843f8167e9" xlink:href="amci-20230213.xsd#amci_PrivatePlacementWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3588b828-4261-4a64-a825-b2244acb76f2" xlink:to="loc_amci_PrivatePlacementWarrantsMember_a879c526-1c64-445e-a154-6b843f8167e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_3b49303d-e2f1-495e-845a-9501c6c53adf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c7a67ddf-e72c-45a7-a1c2-94d8604baaa6" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_3b49303d-e2f1-495e-845a-9501c6c53adf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3b49303d-e2f1-495e-845a-9501c6c53adf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_3b49303d-e2f1-495e-845a-9501c6c53adf" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3b49303d-e2f1-495e-845a-9501c6c53adf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e4d1dbc9-6afe-402e-b9e3-36fdb054e0ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_3b49303d-e2f1-495e-845a-9501c6c53adf" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e4d1dbc9-6afe-402e-b9e3-36fdb054e0ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_ce9216cf-0bf6-4cff-87f1-b034ad273d12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e4d1dbc9-6afe-402e-b9e3-36fdb054e0ef" xlink:to="loc_us-gaap_PrivatePlacementMember_ce9216cf-0bf6-4cff-87f1-b034ad273d12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_5027c353-a245-48f1-9e5b-7801890ad3cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c7a67ddf-e72c-45a7-a1c2-94d8604baaa6" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_5027c353-a245-48f1-9e5b-7801890ad3cb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5027c353-a245-48f1-9e5b-7801890ad3cb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5027c353-a245-48f1-9e5b-7801890ad3cb" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5027c353-a245-48f1-9e5b-7801890ad3cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_6cb2ce6b-166a-4df3-a3ef-ef0181d4bc7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5027c353-a245-48f1-9e5b-7801890ad3cb" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_6cb2ce6b-166a-4df3-a3ef-ef0181d4bc7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_ad6fa048-dcfb-49fe-9cb0-f2ee464b9036" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_6cb2ce6b-166a-4df3-a3ef-ef0181d4bc7b" xlink:to="loc_us-gaap_SubsequentEventMember_ad6fa048-dcfb-49fe-9cb0-f2ee464b9036" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c4753fc2-3569-4853-8e8b-f07114cab444" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c7a67ddf-e72c-45a7-a1c2-94d8604baaa6" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c4753fc2-3569-4853-8e8b-f07114cab444" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_c4753fc2-3569-4853-8e8b-f07114cab444_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c4753fc2-3569-4853-8e8b-f07114cab444" xlink:to="loc_us-gaap_RelatedPartyDomain_c4753fc2-3569-4853-8e8b-f07114cab444_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_19627290-96db-4c56-8894-273eb5da3139" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c4753fc2-3569-4853-8e8b-f07114cab444" xlink:to="loc_us-gaap_RelatedPartyDomain_19627290-96db-4c56-8894-273eb5da3139" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SponsorMember_0e5bd329-5e55-42f0-a7ca-04043f64c57b" xlink:href="amci-20230213.xsd#amci_SponsorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_19627290-96db-4c56-8894-273eb5da3139" xlink:to="loc_amci_SponsorMember_0e5bd329-5e55-42f0-a7ca-04043f64c57b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#CommitmentsandContingenciesDetails_1"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails_1" xlink:type="extended" id="i1a0a3fe18ca149d08fe6ee051d33fb9f_CommitmentsandContingenciesDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_4da68dde-dbed-4e9d-9af0-0115c5782c97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MaximumNumberOfDemandsForRegistrationOfSecurities_eac94de3-45f1-48ea-87c7-02ef6bed9a0b" xlink:href="amci-20230213.xsd#amci_MaximumNumberOfDemandsForRegistrationOfSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_4da68dde-dbed-4e9d-9af0-0115c5782c97" xlink:to="loc_amci_MaximumNumberOfDemandsForRegistrationOfSecurities_eac94de3-45f1-48ea-87c7-02ef6bed9a0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OptionVestingPeriod_77e8a116-018e-42bb-9991-b04831c6771e" xlink:href="amci-20230213.xsd#amci_OptionVestingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_4da68dde-dbed-4e9d-9af0-0115c5782c97" xlink:to="loc_amci_OptionVestingPeriod_77e8a116-018e-42bb-9991-b04831c6771e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters_334cc09e-880f-4ebc-acd7-d75e1092fd6c" xlink:href="amci-20230213.xsd#amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_4da68dde-dbed-4e9d-9af0-0115c5782c97" xlink:to="loc_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters_334cc09e-880f-4ebc-acd7-d75e1092fd6c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfSharesSubjectToForfeiture_835debaa-cca0-4597-ab74-1c73d89d1bfe" xlink:href="amci-20230213.xsd#amci_NumberOfSharesSubjectToForfeiture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_4da68dde-dbed-4e9d-9af0-0115c5782c97" xlink:to="loc_amci_NumberOfSharesSubjectToForfeiture_835debaa-cca0-4597-ab74-1c73d89d1bfe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_UnderwritingDiscountPercentage_c6f5f777-bc06-4a92-bdba-ff8d8f7d4d90" xlink:href="amci-20230213.xsd#amci_UnderwritingDiscountPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_4da68dde-dbed-4e9d-9af0-0115c5782c97" xlink:to="loc_amci_UnderwritingDiscountPercentage_c6f5f777-bc06-4a92-bdba-ff8d8f7d4d90" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_UnderwriterCashDiscount_ea5565f1-6bb3-4f67-bd9c-1b7f72cd3019" xlink:href="amci-20230213.xsd#amci_UnderwriterCashDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_4da68dde-dbed-4e9d-9af0-0115c5782c97" xlink:to="loc_amci_UnderwriterCashDiscount_ea5565f1-6bb3-4f67-bd9c-1b7f72cd3019" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingDiscountPercentage_901c80a7-d85a-488c-b065-e554c0c77780" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingDiscountPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_4da68dde-dbed-4e9d-9af0-0115c5782c97" xlink:to="loc_amci_DeferredUnderwritingDiscountPercentage_901c80a7-d85a-488c-b065-e554c0c77780" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingDiscounts_a2cd7c2d-b1cc-4dc0-9a58-f391b256ac0d" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_4da68dde-dbed-4e9d-9af0-0115c5782c97" xlink:to="loc_amci_DeferredUnderwritingDiscounts_a2cd7c2d-b1cc-4dc0-9a58-f391b256ac0d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_aa69ceea-6983-444c-972f-bc362d4500a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_4da68dde-dbed-4e9d-9af0-0115c5782c97" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_aa69ceea-6983-444c-972f-bc362d4500a3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_c10a4aa5-6146-45ae-870b-28a1f5ad76fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_aa69ceea-6983-444c-972f-bc362d4500a3" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_c10a4aa5-6146-45ae-870b-28a1f5ad76fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c10a4aa5-6146-45ae-870b-28a1f5ad76fb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_c10a4aa5-6146-45ae-870b-28a1f5ad76fb" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c10a4aa5-6146-45ae-870b-28a1f5ad76fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0dbf0a95-459f-41f5-ab2b-6a8f8dc0ce85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_c10a4aa5-6146-45ae-870b-28a1f5ad76fb" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0dbf0a95-459f-41f5-ab2b-6a8f8dc0ce85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_da0aad13-2ada-432f-ad30-1764a3c05976" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0dbf0a95-459f-41f5-ab2b-6a8f8dc0ce85" xlink:to="loc_us-gaap_OverAllotmentOptionMember_da0aad13-2ada-432f-ad30-1764a3c05976" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#ClassACommonStockSubjecttoPossibleRedemptionDetails_1"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails_1" xlink:type="extended" id="iff805d7bacaf43d0bd43ebad71fc6b12_ClassACommonStockSubjecttoPossibleRedemptionDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_25d50226-eb0e-42ac-bf55-79e8d29a9da0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_526d0cd4-ef1c-41ce-9e7c-e05847f4f91b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_25d50226-eb0e-42ac-bf55-79e8d29a9da0" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_526d0cd4-ef1c-41ce-9e7c-e05847f4f91b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_2e0b741f-c035-4915-bf9e-b163ba507384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_25d50226-eb0e-42ac-bf55-79e8d29a9da0" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_2e0b741f-c035-4915-bf9e-b163ba507384" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityNumberOfVotesPerShare_53ddf5cc-c07b-406a-bdf7-fb94fe41a281" xlink:href="amci-20230213.xsd#amci_TemporaryEquityNumberOfVotesPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_25d50226-eb0e-42ac-bf55-79e8d29a9da0" xlink:to="loc_amci_TemporaryEquityNumberOfVotesPerShare_53ddf5cc-c07b-406a-bdf7-fb94fe41a281" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_5644f054-f2d4-4fcc-906d-1c24005322f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_25d50226-eb0e-42ac-bf55-79e8d29a9da0" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_5644f054-f2d4-4fcc-906d-1c24005322f4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_88265bad-3a44-4d0e-b268-7f02c147a01f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_25d50226-eb0e-42ac-bf55-79e8d29a9da0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_88265bad-3a44-4d0e-b268-7f02c147a01f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LessAbstract_046eaf39-7c97-44c1-bdf0-cfe757d7d0e8" xlink:href="amci-20230213.xsd#amci_LessAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_25d50226-eb0e-42ac-bf55-79e8d29a9da0" xlink:to="loc_amci_LessAbstract_046eaf39-7c97-44c1-bdf0-cfe757d7d0e8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityProceedsAllocatedToWarrants_70edd542-76b5-48b1-bb8c-bc413b79e3e7" xlink:href="amci-20230213.xsd#amci_TemporaryEquityProceedsAllocatedToWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_LessAbstract_046eaf39-7c97-44c1-bdf0-cfe757d7d0e8" xlink:to="loc_amci_TemporaryEquityProceedsAllocatedToWarrants_70edd542-76b5-48b1-bb8c-bc413b79e3e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityIssuanceCosts_ac1c22eb-9d16-498f-8634-e0ad66c0ab02" xlink:href="amci-20230213.xsd#amci_TemporaryEquityIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_LessAbstract_046eaf39-7c97-44c1-bdf0-cfe757d7d0e8" xlink:to="loc_amci_TemporaryEquityIssuanceCosts_ac1c22eb-9d16-498f-8634-e0ad66c0ab02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PlusAbstract_1c80b241-6060-4965-bbbc-9412a80ebe47" xlink:href="amci-20230213.xsd#amci_PlusAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_25d50226-eb0e-42ac-bf55-79e8d29a9da0" xlink:to="loc_amci_PlusAbstract_1c80b241-6060-4965-bbbc-9412a80ebe47" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_bcd087b3-1103-4e05-9935-1b6836fd489d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_PlusAbstract_1c80b241-6060-4965-bbbc-9412a80ebe47" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_bcd087b3-1103-4e05-9935-1b6836fd489d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_5cf1d2fc-1e9b-4940-8ad1-d1a3142fc7d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_PlusAbstract_1c80b241-6060-4965-bbbc-9412a80ebe47" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_5cf1d2fc-1e9b-4940-8ad1-d1a3142fc7d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_5327910c-ccdb-4a5e-8c10-38627e8e834d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TemporaryEquityLineItems_25d50226-eb0e-42ac-bf55-79e8d29a9da0" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_5327910c-ccdb-4a5e-8c10-38627e8e834d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_7111d986-14da-4767-a5c6-dbfea618ba46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_5327910c-ccdb-4a5e-8c10-38627e8e834d" xlink:to="loc_us-gaap_StatementClassOfStockAxis_7111d986-14da-4767-a5c6-dbfea618ba46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_7111d986-14da-4767-a5c6-dbfea618ba46_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7111d986-14da-4767-a5c6-dbfea618ba46" xlink:to="loc_us-gaap_ClassOfStockDomain_7111d986-14da-4767-a5c6-dbfea618ba46_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a478a914-124b-4f4c-8197-371df81947e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7111d986-14da-4767-a5c6-dbfea618ba46" xlink:to="loc_us-gaap_ClassOfStockDomain_a478a914-124b-4f4c-8197-371df81947e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_a4778b6c-1de1-48e2-98b3-c58071263400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_a478a914-124b-4f4c-8197-371df81947e1" xlink:to="loc_us-gaap_CommonClassAMember_a4778b6c-1de1-48e2-98b3-c58071263400" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/StockholdersDeficitCommonStockSharesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#StockholdersDeficitCommonStockSharesDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/StockholdersDeficitCommonStockSharesDetails" xlink:type="extended" id="ia7f3f20662ef4af3b0814b15a95c69a3_StockholdersDeficitCommonStockSharesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_ba1ccfa9-1671-4837-91f9-9541f4a7b460" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_7cc145f6-a6a2-44a5-bcf3-eecefbe8a389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_ba1ccfa9-1671-4837-91f9-9541f4a7b460" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_7cc145f6-a6a2-44a5-bcf3-eecefbe8a389" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_b9b967aa-3a6b-4aab-9f96-c4517216040a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_ba1ccfa9-1671-4837-91f9-9541f4a7b460" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_b9b967aa-3a6b-4aab-9f96-c4517216040a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_4cfb02f9-ca39-44a7-9df4-1701539fcba2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_ba1ccfa9-1671-4837-91f9-9541f4a7b460" xlink:to="loc_us-gaap_CommonStockSharesIssued_4cfb02f9-ca39-44a7-9df4-1701539fcba2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_7712d476-5788-4155-b47a-1c6b8b1ff155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_ba1ccfa9-1671-4837-91f9-9541f4a7b460" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_7712d476-5788-4155-b47a-1c6b8b1ff155" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_02a49cb7-9e73-49f0-9530-e9c097c7309e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_ba1ccfa9-1671-4837-91f9-9541f4a7b460" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_02a49cb7-9e73-49f0-9530-e9c097c7309e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_b9464bad-2c35-4b71-bd61-2edb988543b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_ba1ccfa9-1671-4837-91f9-9541f4a7b460" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_b9464bad-2c35-4b71-bd61-2edb988543b1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1_bec6d527-295d-4ef8-8eac-8eeae630d5b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_ba1ccfa9-1671-4837-91f9-9541f4a7b460" xlink:to="loc_us-gaap_ConversionOfStockSharesIssued1_bec6d527-295d-4ef8-8eac-8eeae630d5b5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ConvertibleStockConversionRatio_031fe511-cbd0-4244-af51-50f27f8962d8" xlink:href="amci-20230213.xsd#amci_ConvertibleStockConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_ba1ccfa9-1671-4837-91f9-9541f4a7b460" xlink:to="loc_amci_ConvertibleStockConversionRatio_031fe511-cbd0-4244-af51-50f27f8962d8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_0a1e5536-7d69-4038-8b17-90604d94037a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_ba1ccfa9-1671-4837-91f9-9541f4a7b460" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_0a1e5536-7d69-4038-8b17-90604d94037a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_92b9a361-14a6-43c9-bf53-cc254c96885f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_0a1e5536-7d69-4038-8b17-90604d94037a" xlink:to="loc_us-gaap_StatementClassOfStockAxis_92b9a361-14a6-43c9-bf53-cc254c96885f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_92b9a361-14a6-43c9-bf53-cc254c96885f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_92b9a361-14a6-43c9-bf53-cc254c96885f" xlink:to="loc_us-gaap_ClassOfStockDomain_92b9a361-14a6-43c9-bf53-cc254c96885f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_ab0bb292-f2bb-4140-ada3-da8c6828ee48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_92b9a361-14a6-43c9-bf53-cc254c96885f" xlink:to="loc_us-gaap_ClassOfStockDomain_ab0bb292-f2bb-4140-ada3-da8c6828ee48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_b91fd885-53b2-49a7-a2ad-38273a521336" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_ab0bb292-f2bb-4140-ada3-da8c6828ee48" xlink:to="loc_us-gaap_CommonClassAMember_b91fd885-53b2-49a7-a2ad-38273a521336" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CommonClassaSubjectToRedemptionMember_d29fb6e5-651c-4229-a76b-73112e69e79a" xlink:href="amci-20230213.xsd#amci_CommonClassaSubjectToRedemptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CommonClassAMember_b91fd885-53b2-49a7-a2ad-38273a521336" xlink:to="loc_amci_CommonClassaSubjectToRedemptionMember_d29fb6e5-651c-4229-a76b-73112e69e79a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_eed0810b-cd6c-407d-a969-48be86e9cad7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_ab0bb292-f2bb-4140-ada3-da8c6828ee48" xlink:to="loc_us-gaap_CommonClassBMember_eed0810b-cd6c-407d-a969-48be86e9cad7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/WarrantsDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#WarrantsDetails_1"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/WarrantsDetails_1" xlink:type="extended" id="i0171416c2baa4dd2866e3887036e091b_WarrantsDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_06d023b9-1fa3-4156-b358-501eff38d214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_524d3dbb-cf99-43be-98cd-b7ae8ee760b8" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_06d023b9-1fa3-4156-b358-501eff38d214" xlink:to="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_524d3dbb-cf99-43be-98cd-b7ae8ee760b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants_9f2a1cea-9805-43d6-8be7-064dfe0f553d" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_06d023b9-1fa3-4156-b358-501eff38d214" xlink:to="loc_amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants_9f2a1cea-9805-43d6-8be7-064dfe0f553d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_fc49f683-ce16-48bb-a7c3-2f5b7b30983a" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_06d023b9-1fa3-4156-b358-501eff38d214" xlink:to="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_fc49f683-ce16-48bb-a7c3-2f5b7b30983a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices_0ecac309-a909-49cc-85ea-b4c184d12ab9" xlink:href="amci-20230213.xsd#amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_06d023b9-1fa3-4156-b358-501eff38d214" xlink:to="loc_amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices_0ecac309-a909-49cc-85ea-b4c184d12ab9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_dc6c7a95-5e99-4765-b611-ecfbcb7a9067" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_06d023b9-1fa3-4156-b358-501eff38d214" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_dc6c7a95-5e99-4765-b611-ecfbcb7a9067" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_00edf6e7-b8a7-41de-b5e8-db678580d355" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_06d023b9-1fa3-4156-b358-501eff38d214" xlink:to="loc_amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_00edf6e7-b8a7-41de-b5e8-db678580d355" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RedemptionPeriod_b79ca11f-5595-45ff-85e5-8ebb7500d5c9" xlink:href="amci-20230213.xsd#amci_RedemptionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_06d023b9-1fa3-4156-b358-501eff38d214" xlink:to="loc_amci_RedemptionPeriod_b79ca11f-5595-45ff-85e5-8ebb7500d5c9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_65842cf8-b341-4857-af1f-67c85f3d4167" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_06d023b9-1fa3-4156-b358-501eff38d214" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_65842cf8-b341-4857-af1f-67c85f3d4167" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_10dfb356-e506-4b8b-aea3-9c76e22be7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_65842cf8-b341-4857-af1f-67c85f3d4167" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_10dfb356-e506-4b8b-aea3-9c76e22be7ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_10dfb356-e506-4b8b-aea3-9c76e22be7ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_10dfb356-e506-4b8b-aea3-9c76e22be7ef" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_10dfb356-e506-4b8b-aea3-9c76e22be7ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_4f9f749f-745e-4b33-915a-59de2ad082b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_10dfb356-e506-4b8b-aea3-9c76e22be7ef" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_4f9f749f-745e-4b33-915a-59de2ad082b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_a629f69b-70cc-413e-80d5-a10d4a7de0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_4f9f749f-745e-4b33-915a-59de2ad082b9" xlink:to="loc_us-gaap_WarrantMember_a629f69b-70cc-413e-80d5-a10d4a7de0cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PublicWarrantsMember_bf6c1339-542a-495e-92da-a655f360d2e3" xlink:href="amci-20230213.xsd#amci_PublicWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WarrantMember_a629f69b-70cc-413e-80d5-a10d4a7de0cb" xlink:to="loc_amci_PublicWarrantsMember_bf6c1339-542a-495e-92da-a655f360d2e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WarrantConditionAxis_948273a4-8caa-4070-ad07-c8b712a6e95b" xlink:href="amci-20230213.xsd#amci_WarrantConditionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_65842cf8-b341-4857-af1f-67c85f3d4167" xlink:to="loc_amci_WarrantConditionAxis_948273a4-8caa-4070-ad07-c8b712a6e95b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WarrantConditionDomain_948273a4-8caa-4070-ad07-c8b712a6e95b_default" xlink:href="amci-20230213.xsd#amci_WarrantConditionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_amci_WarrantConditionAxis_948273a4-8caa-4070-ad07-c8b712a6e95b" xlink:to="loc_amci_WarrantConditionDomain_948273a4-8caa-4070-ad07-c8b712a6e95b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WarrantConditionDomain_48ea59f1-b4d1-4cc0-9224-c1b83322c206" xlink:href="amci-20230213.xsd#amci_WarrantConditionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_amci_WarrantConditionAxis_948273a4-8caa-4070-ad07-c8b712a6e95b" xlink:to="loc_amci_WarrantConditionDomain_48ea59f1-b4d1-4cc0-9224-c1b83322c206" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_e912d944-44fc-49b9-a6a0-d7695a72df7d" xlink:href="amci-20230213.xsd#amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_WarrantConditionDomain_48ea59f1-b4d1-4cc0-9224-c1b83322c206" xlink:to="loc_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_e912d944-44fc-49b9-a6a0-d7695a72df7d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_4c0bd206-7053-4e70-bd6d-de79f366d15c" xlink:href="amci-20230213.xsd#amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_WarrantConditionDomain_48ea59f1-b4d1-4cc0-9224-c1b83322c206" xlink:to="loc_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_4c0bd206-7053-4e70-bd6d-de79f366d15c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#WarrantsAdditionalInformationDetails_1"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1" xlink:type="extended" id="i02c2dd1d733f4d0a83560143d20d2b06_WarrantsAdditionalInformationDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_9741ed5c-fd97-4d07-a88f-6da49f7075fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_421b1dc0-8261-40ad-a10b-edae00944bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_9741ed5c-fd97-4d07-a88f-6da49f7075fb" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_421b1dc0-8261-40ad-a10b-edae00944bd2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_7a046823-e04c-46a3-8a1d-ad234e0bfcec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_9741ed5c-fd97-4d07-a88f-6da49f7075fb" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_7a046823-e04c-46a3-8a1d-ad234e0bfcec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights_824dbc32-a719-4122-8af6-91708df71a21" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_9741ed5c-fd97-4d07-a88f-6da49f7075fb" xlink:to="loc_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights_824dbc32-a719-4122-8af6-91708df71a21" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering_efb4380a-961e-4f52-80b0-fe240531e10a" xlink:href="amci-20230213.xsd#amci_WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_9741ed5c-fd97-4d07-a88f-6da49f7075fb" xlink:to="loc_amci_WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering_efb4380a-961e-4f52-80b0-fe240531e10a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MaximumThresholdPeriodForFilingRegistrationStatementAfterBusinessCombination_ed1df239-a4de-45f1-b5bb-a894e6784848" xlink:href="amci-20230213.xsd#amci_MaximumThresholdPeriodForFilingRegistrationStatementAfterBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_9741ed5c-fd97-4d07-a88f-6da49f7075fb" xlink:to="loc_amci_MaximumThresholdPeriodForFilingRegistrationStatementAfterBusinessCombination_ed1df239-a4de-45f1-b5bb-a894e6784848" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_88064f0d-9018-4902-9882-70662d254c96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_9741ed5c-fd97-4d07-a88f-6da49f7075fb" xlink:to="loc_us-gaap_SharePrice_88064f0d-9018-4902-9882-70662d254c96" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PercentageOfGrossProceedsOnTotalEquityProceed_33444bde-04aa-4faf-839a-08c841ea238d" xlink:href="amci-20230213.xsd#amci_PercentageOfGrossProceedsOnTotalEquityProceed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_9741ed5c-fd97-4d07-a88f-6da49f7075fb" xlink:to="loc_amci_PercentageOfGrossProceedsOnTotalEquityProceed_33444bde-04aa-4faf-839a-08c841ea238d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDaysSource2_aa2228d8-91a4-4f56-bea6-a3ab50969be2" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDaysSource2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_9741ed5c-fd97-4d07-a88f-6da49f7075fb" xlink:to="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDaysSource2_aa2228d8-91a4-4f56-bea6-a3ab50969be2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices_127d1b7d-7b96-49a9-be01-0a4fd16dda3b" xlink:href="amci-20230213.xsd#amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_9741ed5c-fd97-4d07-a88f-6da49f7075fb" xlink:to="loc_amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices_127d1b7d-7b96-49a9-be01-0a4fd16dda3b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_d5796239-6492-458b-a5a5-9048aeeb8268" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_9741ed5c-fd97-4d07-a88f-6da49f7075fb" xlink:to="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_d5796239-6492-458b-a5a5-9048aeeb8268" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PeriodForFillingRegistrationStatementAfterBusinessCombination_4fd4224a-c0cd-44e9-8cf8-511b9f2a2a4e" xlink:href="amci-20230213.xsd#amci_PeriodForFillingRegistrationStatementAfterBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_9741ed5c-fd97-4d07-a88f-6da49f7075fb" xlink:to="loc_amci_PeriodForFillingRegistrationStatementAfterBusinessCombination_4fd4224a-c0cd-44e9-8cf8-511b9f2a2a4e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise_06cda81e-c75d-4fda-a5b3-e7895af9f93c" xlink:href="amci-20230213.xsd#amci_PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_9741ed5c-fd97-4d07-a88f-6da49f7075fb" xlink:to="loc_amci_PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise_06cda81e-c75d-4fda-a5b3-e7895af9f93c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_094fa258-0f93-426e-81c4-ec3f2c608017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_9741ed5c-fd97-4d07-a88f-6da49f7075fb" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_094fa258-0f93-426e-81c4-ec3f2c608017" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_4dcedc17-4867-4305-b65b-104798e3e24a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_094fa258-0f93-426e-81c4-ec3f2c608017" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_4dcedc17-4867-4305-b65b-104798e3e24a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_4dcedc17-4867-4305-b65b-104798e3e24a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_4dcedc17-4867-4305-b65b-104798e3e24a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_4dcedc17-4867-4305-b65b-104798e3e24a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_066c44e1-e50d-417e-9ba5-927fe99ec3c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_4dcedc17-4867-4305-b65b-104798e3e24a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_066c44e1-e50d-417e-9ba5-927fe99ec3c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PublicWarrantsMember_5cae2c82-0cbd-4748-9a66-c84dd333de52" xlink:href="amci-20230213.xsd#amci_PublicWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_066c44e1-e50d-417e-9ba5-927fe99ec3c9" xlink:to="loc_amci_PublicWarrantsMember_5cae2c82-0cbd-4748-9a66-c84dd333de52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PrivatePlacementWarrantsMember_f1caa473-ee76-4c59-a3c5-3b43df2fc0c0" xlink:href="amci-20230213.xsd#amci_PrivatePlacementWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_066c44e1-e50d-417e-9ba5-927fe99ec3c9" xlink:to="loc_amci_PrivatePlacementWarrantsMember_f1caa473-ee76-4c59-a3c5-3b43df2fc0c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_9f7229ba-1c01-4aee-be62-13c487e16cb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_094fa258-0f93-426e-81c4-ec3f2c608017" xlink:to="loc_us-gaap_StatementClassOfStockAxis_9f7229ba-1c01-4aee-be62-13c487e16cb1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9f7229ba-1c01-4aee-be62-13c487e16cb1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9f7229ba-1c01-4aee-be62-13c487e16cb1" xlink:to="loc_us-gaap_ClassOfStockDomain_9f7229ba-1c01-4aee-be62-13c487e16cb1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_699853f2-4b4f-48b2-8237-6a386a261adc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9f7229ba-1c01-4aee-be62-13c487e16cb1" xlink:to="loc_us-gaap_ClassOfStockDomain_699853f2-4b4f-48b2-8237-6a386a261adc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_f7184929-052f-4577-9328-1cb3bac383bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_699853f2-4b4f-48b2-8237-6a386a261adc" xlink:to="loc_us-gaap_CommonClassAMember_f7184929-052f-4577-9328-1cb3bac383bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WarrantConditionAxis_bb24f23c-cab4-40a3-8078-a56a4fd92aef" xlink:href="amci-20230213.xsd#amci_WarrantConditionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_094fa258-0f93-426e-81c4-ec3f2c608017" xlink:to="loc_amci_WarrantConditionAxis_bb24f23c-cab4-40a3-8078-a56a4fd92aef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WarrantConditionDomain_bb24f23c-cab4-40a3-8078-a56a4fd92aef_default" xlink:href="amci-20230213.xsd#amci_WarrantConditionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_amci_WarrantConditionAxis_bb24f23c-cab4-40a3-8078-a56a4fd92aef" xlink:to="loc_amci_WarrantConditionDomain_bb24f23c-cab4-40a3-8078-a56a4fd92aef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WarrantConditionDomain_6364e875-f47f-4616-b088-2e6cc3cf8d94" xlink:href="amci-20230213.xsd#amci_WarrantConditionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_amci_WarrantConditionAxis_bb24f23c-cab4-40a3-8078-a56a4fd92aef" xlink:to="loc_amci_WarrantConditionDomain_6364e875-f47f-4616-b088-2e6cc3cf8d94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_53a2cf90-ef3e-4636-9436-4cf546e15807" xlink:href="amci-20230213.xsd#amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_WarrantConditionDomain_6364e875-f47f-4616-b088-2e6cc3cf8d94" xlink:to="loc_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_53a2cf90-ef3e-4636-9436-4cf546e15807" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_c11738e6-dc89-428e-b844-17c77a7ca741" xlink:href="amci-20230213.xsd#amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_WarrantConditionDomain_6364e875-f47f-4616-b088-2e6cc3cf8d94" xlink:to="loc_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_c11738e6-dc89-428e-b844-17c77a7ca741" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails_1"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails_1" xlink:type="extended" id="ie52147c2f45945c88bebea27b6a81c85_FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eba0e873-ed6f-4acb-97bc-95f464c25713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_4721b638-0bd5-4f66-bd01-0bb5d601af8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eba0e873-ed6f-4acb-97bc-95f464c25713" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_4721b638-0bd5-4f66-bd01-0bb5d601af8b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_5f7319a3-2d15-4598-9d86-9c31d00d5640" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_4721b638-0bd5-4f66-bd01-0bb5d601af8b" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_5f7319a3-2d15-4598-9d86-9c31d00d5640" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_33de9596-7d01-48ec-9162-e68517bc1e25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eba0e873-ed6f-4acb-97bc-95f464c25713" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_33de9596-7d01-48ec-9162-e68517bc1e25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_a653a3c9-b4b0-4c63-ae3c-cee1b3f9979a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_33de9596-7d01-48ec-9162-e68517bc1e25" xlink:to="loc_us-gaap_DerivativeLiabilities_a653a3c9-b4b0-4c63-ae3c-cee1b3f9979a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_47f4cdbc-9f4d-4a3e-8754-f55699f4c813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_33de9596-7d01-48ec-9162-e68517bc1e25" xlink:to="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_47f4cdbc-9f4d-4a3e-8754-f55699f4c813" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7b52c479-5140-4edf-b32a-b88ed4ac1ac8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eba0e873-ed6f-4acb-97bc-95f464c25713" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7b52c479-5140-4edf-b32a-b88ed4ac1ac8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_61109597-defa-4ae9-81ac-8ce0e74d4764" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7b52c479-5140-4edf-b32a-b88ed4ac1ac8" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_61109597-defa-4ae9-81ac-8ce0e74d4764" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_61109597-defa-4ae9-81ac-8ce0e74d4764_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_61109597-defa-4ae9-81ac-8ce0e74d4764" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_61109597-defa-4ae9-81ac-8ce0e74d4764_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_a0316df4-e6e6-413f-9bc9-e766b6cf1012" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_61109597-defa-4ae9-81ac-8ce0e74d4764" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_a0316df4-e6e6-413f-9bc9-e766b6cf1012" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_85ea9d19-b76e-4d0d-8cc7-57db36219d93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_a0316df4-e6e6-413f-9bc9-e766b6cf1012" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_85ea9d19-b76e-4d0d-8cc7-57db36219d93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_33ad746d-6e90-4208-af65-029f68957af7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7b52c479-5140-4edf-b32a-b88ed4ac1ac8" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_33ad746d-6e90-4208-af65-029f68957af7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_33ad746d-6e90-4208-af65-029f68957af7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_33ad746d-6e90-4208-af65-029f68957af7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_33ad746d-6e90-4208-af65-029f68957af7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f2d20f2f-b8d7-4ce4-8437-1337b0c8ba0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_33ad746d-6e90-4208-af65-029f68957af7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f2d20f2f-b8d7-4ce4-8437-1337b0c8ba0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_0c498ffb-0607-484f-b3e7-371f62e03a91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f2d20f2f-b8d7-4ce4-8437-1337b0c8ba0c" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_0c498ffb-0607-484f-b3e7-371f62e03a91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_c9759be5-15f0-4705-8b2b-6237ac668af0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f2d20f2f-b8d7-4ce4-8437-1337b0c8ba0c" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_c9759be5-15f0-4705-8b2b-6237ac668af0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_8a0d3a61-64dc-423d-a5a3-700d36097ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7b52c479-5140-4edf-b32a-b88ed4ac1ac8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_8a0d3a61-64dc-423d-a5a3-700d36097ef9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_8a0d3a61-64dc-423d-a5a3-700d36097ef9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_8a0d3a61-64dc-423d-a5a3-700d36097ef9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_8a0d3a61-64dc-423d-a5a3-700d36097ef9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_8fc2b457-9874-458f-ae0b-db03cc7929dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_8a0d3a61-64dc-423d-a5a3-700d36097ef9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_8fc2b457-9874-458f-ae0b-db03cc7929dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PublicWarrantsMember_d9d28ec8-43d3-4d27-82e9-b2f3a888dfdc" xlink:href="amci-20230213.xsd#amci_PublicWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_8fc2b457-9874-458f-ae0b-db03cc7929dc" xlink:to="loc_amci_PublicWarrantsMember_d9d28ec8-43d3-4d27-82e9-b2f3a888dfdc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PrivatePlacementWarrantsMember_1a353563-6fdc-415d-bca2-bf5969dd9835" xlink:href="amci-20230213.xsd#amci_PrivatePlacementWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_8fc2b457-9874-458f-ae0b-db03cc7929dc" xlink:to="loc_amci_PrivatePlacementWarrantsMember_1a353563-6fdc-415d-bca2-bf5969dd9835" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueMeasurementsLevel3fairvaluemeasurementsDetails_1"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails_1" xlink:type="extended" id="if865aa6d546f42c2a87bd2a6b518de91_FairValueMeasurementsLevel3fairvaluemeasurementsDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1d3db642-a943-4452-bead-f2402387674b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_afdb6a72-8bc6-4696-9388-225d17eeaa62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1d3db642-a943-4452-bead-f2402387674b" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_afdb6a72-8bc6-4696-9388-225d17eeaa62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_560fe087-7a21-4434-b82e-336df05c45ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1d3db642-a943-4452-bead-f2402387674b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_560fe087-7a21-4434-b82e-336df05c45ad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_571438ed-a02d-40c6-91b4-78ecadd1a932" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_560fe087-7a21-4434-b82e-336df05c45ad" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_571438ed-a02d-40c6-91b4-78ecadd1a932" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_571438ed-a02d-40c6-91b4-78ecadd1a932_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_571438ed-a02d-40c6-91b4-78ecadd1a932" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_571438ed-a02d-40c6-91b4-78ecadd1a932_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_4081ba0e-a9a9-476f-9fb8-03cc15337611" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_571438ed-a02d-40c6-91b4-78ecadd1a932" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_4081ba0e-a9a9-476f-9fb8-03cc15337611" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExercisePriceMember_4b481541-4c95-4d8e-8c00-01f8d8fb2c86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExercisePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_4081ba0e-a9a9-476f-9fb8-03cc15337611" xlink:to="loc_us-gaap_MeasurementInputExercisePriceMember_4b481541-4c95-4d8e-8c00-01f8d8fb2c86" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_33cfd1ef-e248-4b65-83af-afaff287a22a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_4081ba0e-a9a9-476f-9fb8-03cc15337611" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_33cfd1ef-e248-4b65-83af-afaff287a22a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_0e747ab2-97f5-49a8-80d5-14a8f14ca268" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_4081ba0e-a9a9-476f-9fb8-03cc15337611" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_0e747ab2-97f5-49a8-80d5-14a8f14ca268" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_00843266-f3fa-45f9-8d9b-71cf5029961a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_4081ba0e-a9a9-476f-9fb8-03cc15337611" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_00843266-f3fa-45f9-8d9b-71cf5029961a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_6a3c56de-8e52-4210-8850-4836b0278aac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_4081ba0e-a9a9-476f-9fb8-03cc15337611" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_6a3c56de-8e52-4210-8850-4836b0278aac" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_1cab0524-15a6-40cd-9e14-2d0615400196" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_560fe087-7a21-4434-b82e-336df05c45ad" xlink:to="loc_dei_LegalEntityAxis_1cab0524-15a6-40cd-9e14-2d0615400196" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_1cab0524-15a6-40cd-9e14-2d0615400196_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1cab0524-15a6-40cd-9e14-2d0615400196" xlink:to="loc_dei_EntityDomain_1cab0524-15a6-40cd-9e14-2d0615400196_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_7cd271a2-b608-43ff-9157-797fd6ee300d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1cab0524-15a6-40cd-9e14-2d0615400196" xlink:to="loc_dei_EntityDomain_7cd271a2-b608-43ff-9157-797fd6ee300d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AMCIACQUISITIONCORPIIMember_fbc4f033-072d-4f05-8d27-e183bbbc9bba" xlink:href="amci-20230213.xsd#amci_AMCIACQUISITIONCORPIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_7cd271a2-b608-43ff-9157-797fd6ee300d" xlink:to="loc_amci_AMCIACQUISITIONCORPIIMember_fbc4f033-072d-4f05-8d27-e183bbbc9bba" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails_1"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails_1" xlink:type="extended" id="ib3a65c600c0c4b98980b81e4a9c9b024_FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_98169117-fe48-453d-99a2-eac38165dbab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1f39a9ad-6e3e-4631-9e6a-7539c70248d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_98169117-fe48-453d-99a2-eac38165dbab" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1f39a9ad-6e3e-4631-9e6a-7539c70248d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ebb36662-6ce4-4011-ae58-56a3b7ac5d23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1f39a9ad-6e3e-4631-9e6a-7539c70248d4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ebb36662-6ce4-4011-ae58-56a3b7ac5d23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_37ddc941-917e-42ac-adce-5f81761f9fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1f39a9ad-6e3e-4631-9e6a-7539c70248d4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_37ddc941-917e-42ac-adce-5f81761f9fe5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_eb48b37c-3fdf-46ff-afd1-23e0c9ca8f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1f39a9ad-6e3e-4631-9e6a-7539c70248d4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_eb48b37c-3fdf-46ff-afd1-23e0c9ca8f7f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_7712b432-6585-4ebc-a76d-4521ed894025" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1f39a9ad-6e3e-4631-9e6a-7539c70248d4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_7712b432-6585-4ebc-a76d-4521ed894025" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_72a786c8-8a2d-4d3f-8e80-20b461b87632" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_7712b432-6585-4ebc-a76d-4521ed894025" xlink:to="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_72a786c8-8a2d-4d3f-8e80-20b461b87632" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b20fc0c9-7b57-4c2d-bf86-d6321e3cdde6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_0af888c3-702a-4016-b920-1db750527b35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_98169117-fe48-453d-99a2-eac38165dbab" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_0af888c3-702a-4016-b920-1db750527b35" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_a0cd681d-363e-4341-b7e1-bbb5746680ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_0af888c3-702a-4016-b920-1db750527b35" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_a0cd681d-363e-4341-b7e1-bbb5746680ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_a0cd681d-363e-4341-b7e1-bbb5746680ea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_a0cd681d-363e-4341-b7e1-bbb5746680ea" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_a0cd681d-363e-4341-b7e1-bbb5746680ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2e6f2df8-de30-4802-81c0-76b252f3d756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_a0cd681d-363e-4341-b7e1-bbb5746680ea" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2e6f2df8-de30-4802-81c0-76b252f3d756" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_e6bfffa1-03bd-432a-98a1-92baede37e93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2e6f2df8-de30-4802-81c0-76b252f3d756" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_e6bfffa1-03bd-432a-98a1-92baede37e93" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/IncomeTaxesDeferredtaxassetsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#IncomeTaxesDeferredtaxassetsDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/IncomeTaxesDeferredtaxassetsDetails" xlink:type="extended" id="ib6e8551b0a33457dbb25906f17721ad5_IncomeTaxesDeferredtaxassetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_9d30c61b-be0f-48da-b74a-d1ea9bd9eee9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_a6807c27-0695-4a82-b8f0-69bfbec99e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_9d30c61b-be0f-48da-b74a-d1ea9bd9eee9" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_a6807c27-0695-4a82-b8f0-69bfbec99e9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts_a56a6ad9-14d4-4909-9365-5f30aebe8b41" xlink:href="amci-20230213.xsd#amci_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_a6807c27-0695-4a82-b8f0-69bfbec99e9b" xlink:to="loc_amci_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts_a56a6ad9-14d4-4909-9365-5f30aebe8b41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_dd0b9c1a-0cf8-4084-9bab-0aba17f61910" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_a6807c27-0695-4a82-b8f0-69bfbec99e9b" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_dd0b9c1a-0cf8-4084-9bab-0aba17f61910" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_cc1c9ef9-67d3-44ee-85a5-7b0f70e89d72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_a6807c27-0695-4a82-b8f0-69bfbec99e9b" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_cc1c9ef9-67d3-44ee-85a5-7b0f70e89d72" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_9c5ffc7a-81a6-46db-a433-b10117583e38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_a6807c27-0695-4a82-b8f0-69bfbec99e9b" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_9c5ffc7a-81a6-46db-a433-b10117583e38" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_13f411a9-053b-4c9d-b2c2-c56b9ad33cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_a6807c27-0695-4a82-b8f0-69bfbec99e9b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_13f411a9-053b-4c9d-b2c2-c56b9ad33cf3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_1d6f1f05-6163-4d27-9dff-31744f45e0ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_a6807c27-0695-4a82-b8f0-69bfbec99e9b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_1d6f1f05-6163-4d27-9dff-31744f45e0ea" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_fc8b6634-63b1-4d47-a130-ceb3ec73316c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_9d30c61b-be0f-48da-b74a-d1ea9bd9eee9" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_fc8b6634-63b1-4d47-a130-ceb3ec73316c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_3db61465-c1eb-4797-b3d0-a70141e3bec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_fc8b6634-63b1-4d47-a130-ceb3ec73316c" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_3db61465-c1eb-4797-b3d0-a70141e3bec7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_3db61465-c1eb-4797-b3d0-a70141e3bec7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_3db61465-c1eb-4797-b3d0-a70141e3bec7" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_3db61465-c1eb-4797-b3d0-a70141e3bec7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_457644b8-1fa3-4237-b0cc-e0fb0fe964b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_3db61465-c1eb-4797-b3d0-a70141e3bec7" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_457644b8-1fa3-4237-b0cc-e0fb0fe964b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_405b6c5e-d376-473d-8445-3db0d50192e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_457644b8-1fa3-4237-b0cc-e0fb0fe964b0" xlink:to="loc_us-gaap_DomesticCountryMember_405b6c5e-d376-473d-8445-3db0d50192e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_ad6c963d-45d2-4bb7-a9ae-163773844127" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_fc8b6634-63b1-4d47-a130-ceb3ec73316c" xlink:to="loc_dei_LegalEntityAxis_ad6c963d-45d2-4bb7-a9ae-163773844127" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ad6c963d-45d2-4bb7-a9ae-163773844127_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_ad6c963d-45d2-4bb7-a9ae-163773844127" xlink:to="loc_dei_EntityDomain_ad6c963d-45d2-4bb7-a9ae-163773844127_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8bd5d0de-7dfb-4a6a-9846-71ed73ed9464" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_ad6c963d-45d2-4bb7-a9ae-163773844127" xlink:to="loc_dei_EntityDomain_8bd5d0de-7dfb-4a6a-9846-71ed73ed9464" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AMCIACQUISITIONCORPIIMember_1914bd85-d8e0-40bd-900a-da4c609fa4fa" xlink:href="amci-20230213.xsd#amci_AMCIACQUISITIONCORPIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_8bd5d0de-7dfb-4a6a-9846-71ed73ed9464" xlink:to="loc_amci_AMCIACQUISITIONCORPIIMember_1914bd85-d8e0-40bd-900a-da4c609fa4fa" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SubsequentEventsDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#SubsequentEventsDetails_1"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/SubsequentEventsDetails_1" xlink:type="extended" id="iabfad95e7510441e81cdc194faec9a63_SubsequentEventsDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_a79859ec-a34b-4491-95fd-9fc1bbf2d5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationAssetCurrent_07f58aa7-51ee-47c7-b85a-3c9fff103ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationAssetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_a79859ec-a34b-4491-95fd-9fc1bbf2d5f9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationAssetCurrent_07f58aa7-51ee-47c7-b85a-3c9fff103ea0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_1c1663a1-65d8-4ae0-8906-f9457f8a37dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_a79859ec-a34b-4491-95fd-9fc1bbf2d5f9" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_1c1663a1-65d8-4ae0-8906-f9457f8a37dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_5c013b54-5c34-4a11-a5f1-5be5efdae0b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_a79859ec-a34b-4491-95fd-9fc1bbf2d5f9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_5c013b54-5c34-4a11-a5f1-5be5efdae0b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNet_3a3c53d2-c934-4af6-9b0e-5257c6a353d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_a79859ec-a34b-4491-95fd-9fc1bbf2d5f9" xlink:to="loc_us-gaap_AssetsNet_3a3c53d2-c934-4af6-9b0e-5257c6a353d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrustCurrent_cc7fb71f-c7cf-462c-87ed-8618960bb8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_a79859ec-a34b-4491-95fd-9fc1bbf2d5f9" xlink:to="loc_us-gaap_AssetsHeldInTrustCurrent_cc7fb71f-c7cf-462c-87ed-8618960bb8cb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_a5080629-59ff-42e4-8951-0d999082fd21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_a79859ec-a34b-4491-95fd-9fc1bbf2d5f9" xlink:to="loc_us-gaap_SubsequentEventTable_a5080629-59ff-42e4-8951-0d999082fd21" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e35f0ef1-7c26-421b-894b-a435a4e14e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_a5080629-59ff-42e4-8951-0d999082fd21" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e35f0ef1-7c26-421b-894b-a435a4e14e7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e35f0ef1-7c26-421b-894b-a435a4e14e7c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e35f0ef1-7c26-421b-894b-a435a4e14e7c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e35f0ef1-7c26-421b-894b-a435a4e14e7c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9955463c-5935-404b-a7b4-375f33ad06a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e35f0ef1-7c26-421b-894b-a435a4e14e7c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9955463c-5935-404b-a7b4-375f33ad06a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LanzatechGlobalMember_2537c931-33ca-4bb9-a21c-d22902d7b85d" xlink:href="amci-20230213.xsd#amci_LanzatechGlobalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9955463c-5935-404b-a7b4-375f33ad06a8" xlink:to="loc_amci_LanzatechGlobalMember_2537c931-33ca-4bb9-a21c-d22902d7b85d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_936a8c3d-d768-4d53-8fef-01b133057b9c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_a5080629-59ff-42e4-8951-0d999082fd21" xlink:to="loc_srt_RangeAxis_936a8c3d-d768-4d53-8fef-01b133057b9c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_936a8c3d-d768-4d53-8fef-01b133057b9c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_936a8c3d-d768-4d53-8fef-01b133057b9c" xlink:to="loc_srt_RangeMember_936a8c3d-d768-4d53-8fef-01b133057b9c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2fc5e521-87ca-4a06-a52f-f00a5e59d9e1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_936a8c3d-d768-4d53-8fef-01b133057b9c" xlink:to="loc_srt_RangeMember_2fc5e521-87ca-4a06-a52f-f00a5e59d9e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_897720b6-f6bc-469e-900c-9922e5032f56" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2fc5e521-87ca-4a06-a52f-f00a5e59d9e1" xlink:to="loc_srt_MinimumMember_897720b6-f6bc-469e-900c-9922e5032f56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_aaf4c946-adfe-4e8e-b211-d3a1fd70c180" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_a5080629-59ff-42e4-8951-0d999082fd21" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_aaf4c946-adfe-4e8e-b211-d3a1fd70c180" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_aaf4c946-adfe-4e8e-b211-d3a1fd70c180_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_aaf4c946-adfe-4e8e-b211-d3a1fd70c180" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_aaf4c946-adfe-4e8e-b211-d3a1fd70c180_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_100aff10-8d7e-4591-a785-33083425462a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_aaf4c946-adfe-4e8e-b211-d3a1fd70c180" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_100aff10-8d7e-4591-a785-33083425462a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_ec86211f-246c-44d9-8bbe-6b181a9a7c1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_100aff10-8d7e-4591-a785-33083425462a" xlink:to="loc_us-gaap_SubsequentEventMember_ec86211f-246c-44d9-8bbe-6b181a9a7c1e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/DescriptionoftheBusinessDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#DescriptionoftheBusinessDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/DescriptionoftheBusinessDetails" xlink:type="extended" id="ic180921f825c4c948beb907b12a86566_DescriptionoftheBusinessDetails">
    <link:loc xlink:type="locator" xlink:label="loc_amci_ScheduleOfReverseCapitalizationLineItems_c140a6d9-281c-4f43-aa64-f01f3e900687" xlink:href="amci-20230213.xsd#amci_ScheduleOfReverseCapitalizationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_d4de3e9b-202d-4ac8-a7c1-b5b9868afcbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_ScheduleOfReverseCapitalizationLineItems_c140a6d9-281c-4f43-aa64-f01f3e900687" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_d4de3e9b-202d-4ac8-a7c1-b5b9868afcbc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ReverseCapitalizationClosingCashCondition_a87600a6-1df3-4770-be5c-e23cfce553b1" xlink:href="amci-20230213.xsd#amci_ReverseCapitalizationClosingCashCondition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_ScheduleOfReverseCapitalizationLineItems_c140a6d9-281c-4f43-aa64-f01f3e900687" xlink:to="loc_amci_ReverseCapitalizationClosingCashCondition_a87600a6-1df3-4770-be5c-e23cfce553b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_27054c58-a093-4270-9052-5b8ac2a3efc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_ScheduleOfReverseCapitalizationLineItems_c140a6d9-281c-4f43-aa64-f01f3e900687" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_27054c58-a093-4270-9052-5b8ac2a3efc3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ScheduleOfReverseCapitalizationTable_c878226f-5929-43cc-b64c-c06c8c15f67c" xlink:href="amci-20230213.xsd#amci_ScheduleOfReverseCapitalizationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_amci_ScheduleOfReverseCapitalizationLineItems_c140a6d9-281c-4f43-aa64-f01f3e900687" xlink:to="loc_amci_ScheduleOfReverseCapitalizationTable_c878226f-5929-43cc-b64c-c06c8c15f67c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_518badbc-4395-4bea-a126-361b101c19f1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_amci_ScheduleOfReverseCapitalizationTable_c878226f-5929-43cc-b64c-c06c8c15f67c" xlink:to="loc_srt_RangeAxis_518badbc-4395-4bea-a126-361b101c19f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_518badbc-4395-4bea-a126-361b101c19f1_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_518badbc-4395-4bea-a126-361b101c19f1" xlink:to="loc_srt_RangeMember_518badbc-4395-4bea-a126-361b101c19f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_923567b9-097b-4840-89e6-2cc60a842e6a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_518badbc-4395-4bea-a126-361b101c19f1" xlink:to="loc_srt_RangeMember_923567b9-097b-4840-89e6-2cc60a842e6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_32dd861e-95b5-4b08-b1a3-278399907be5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_923567b9-097b-4840-89e6-2cc60a842e6a" xlink:to="loc_srt_MinimumMember_32dd861e-95b5-4b08-b1a3-278399907be5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6d77349a-b774-41f8-93fe-8893dabef303" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_923567b9-097b-4840-89e6-2cc60a842e6a" xlink:to="loc_srt_MaximumMember_6d77349a-b774-41f8-93fe-8893dabef303" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_d85fe2b7-846f-43c0-b6f5-e45bd6d23131" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_amci_ScheduleOfReverseCapitalizationTable_c878226f-5929-43cc-b64c-c06c8c15f67c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_d85fe2b7-846f-43c0-b6f5-e45bd6d23131" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_d85fe2b7-846f-43c0-b6f5-e45bd6d23131_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_d85fe2b7-846f-43c0-b6f5-e45bd6d23131" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_d85fe2b7-846f-43c0-b6f5-e45bd6d23131_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9c30d4f1-4318-4557-b320-06f62207180e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_d85fe2b7-846f-43c0-b6f5-e45bd6d23131" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9c30d4f1-4318-4557-b320-06f62207180e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_2f8a6b57-ac74-4c5c-836b-c125e01aea21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_9c30d4f1-4318-4557-b320-06f62207180e" xlink:to="loc_us-gaap_SubsequentEventMember_2f8a6b57-ac74-4c5c-836b-c125e01aea21" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails" xlink:type="extended" id="if7a850da8b4f4468b427eb2c27010510_SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_27773c39-9eac-4a84-94bb-e5f9e6b39b72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_ff03adfa-b640-4793-8a36-c49bd1cc844f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_27773c39-9eac-4a84-94bb-e5f9e6b39b72" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_ff03adfa-b640-4793-8a36-c49bd1cc844f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_7434e94f-6938-4cd3-86ba-e5a4098e82b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_27773c39-9eac-4a84-94bb-e5f9e6b39b72" xlink:to="loc_us-gaap_ConcentrationRiskTable_7434e94f-6938-4cd3-86ba-e5a4098e82b6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c4ce5d67-5ae0-4228-893d-144a010ac007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_7434e94f-6938-4cd3-86ba-e5a4098e82b6" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c4ce5d67-5ae0-4228-893d-144a010ac007" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c4ce5d67-5ae0-4228-893d-144a010ac007_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c4ce5d67-5ae0-4228-893d-144a010ac007" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c4ce5d67-5ae0-4228-893d-144a010ac007_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2f0fd9a9-392e-4966-88fb-3e9f38916851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c4ce5d67-5ae0-4228-893d-144a010ac007" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2f0fd9a9-392e-4966-88fb-3e9f38916851" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_55b932c7-07bf-4f82-8919-9b0e543dff64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2f0fd9a9-392e-4966-88fb-3e9f38916851" xlink:to="loc_us-gaap_SalesRevenueNetMember_55b932c7-07bf-4f82-8919-9b0e543dff64" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_0a69ed67-4c1d-426b-a6fa-ba5f32cc03eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2f0fd9a9-392e-4966-88fb-3e9f38916851" xlink:to="loc_us-gaap_AccountsReceivableMember_0a69ed67-4c1d-426b-a6fa-ba5f32cc03eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_c7838422-4fe7-4fc7-9257-c5a7ab96dc2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_7434e94f-6938-4cd3-86ba-e5a4098e82b6" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_c7838422-4fe7-4fc7-9257-c5a7ab96dc2e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_c7838422-4fe7-4fc7-9257-c5a7ab96dc2e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_c7838422-4fe7-4fc7-9257-c5a7ab96dc2e" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_c7838422-4fe7-4fc7-9257-c5a7ab96dc2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_de46362b-80f1-41c9-b780-eb52ffce5829" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_c7838422-4fe7-4fc7-9257-c5a7ab96dc2e" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_de46362b-80f1-41c9-b780-eb52ffce5829" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_dbcd99a5-2d44-4c43-8b8b-6fd9988f5a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_de46362b-80f1-41c9-b780-eb52ffce5829" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_dbcd99a5-2d44-4c43-8b8b-6fd9988f5a9a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_2f54c2aa-454e-4710-9201-f5cb05b582a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_de46362b-80f1-41c9-b780-eb52ffce5829" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_2f54c2aa-454e-4710-9201-f5cb05b582a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_64e2040e-820e-4577-baf6-6b727bb01358" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_7434e94f-6938-4cd3-86ba-e5a4098e82b6" xlink:to="loc_srt_StatementGeographicalAxis_64e2040e-820e-4577-baf6-6b727bb01358" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_64e2040e-820e-4577-baf6-6b727bb01358_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_64e2040e-820e-4577-baf6-6b727bb01358" xlink:to="loc_srt_SegmentGeographicalDomain_64e2040e-820e-4577-baf6-6b727bb01358_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_af41e5ce-10f2-4704-9766-90c92608acaf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_64e2040e-820e-4577-baf6-6b727bb01358" xlink:to="loc_srt_SegmentGeographicalDomain_af41e5ce-10f2-4704-9766-90c92608acaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_321ad319-6ec1-4fa4-9197-a2fbd0d5d949" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_af41e5ce-10f2-4704-9766-90c92608acaf" xlink:to="loc_us-gaap_NonUsMember_321ad319-6ec1-4fa4-9197-a2fbd0d5d949" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_c19a6247-e4ef-4bc5-8c69-f95f29457b18" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_7434e94f-6938-4cd3-86ba-e5a4098e82b6" xlink:to="loc_srt_MajorCustomersAxis_c19a6247-e4ef-4bc5-8c69-f95f29457b18" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_c19a6247-e4ef-4bc5-8c69-f95f29457b18_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_c19a6247-e4ef-4bc5-8c69-f95f29457b18" xlink:to="loc_srt_NameOfMajorCustomerDomain_c19a6247-e4ef-4bc5-8c69-f95f29457b18_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_cf1bd91e-e446-46f2-8b7c-9afb50151434" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_c19a6247-e4ef-4bc5-8c69-f95f29457b18" xlink:to="loc_srt_NameOfMajorCustomerDomain_cf1bd91e-e446-46f2-8b7c-9afb50151434" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CustomerAMember_9567f82f-7f2c-4c5a-8496-303aa72450e4" xlink:href="amci-20230213.xsd#amci_CustomerAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_cf1bd91e-e446-46f2-8b7c-9afb50151434" xlink:to="loc_amci_CustomerAMember_9567f82f-7f2c-4c5a-8496-303aa72450e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CustomerBMember_e7944bb1-604d-44ba-9700-83cc23eac6ae" xlink:href="amci-20230213.xsd#amci_CustomerBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_cf1bd91e-e446-46f2-8b7c-9afb50151434" xlink:to="loc_amci_CustomerBMember_e7944bb1-604d-44ba-9700-83cc23eac6ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CustomerCMember_6501a2df-e564-4275-992a-d8cee521db3d" xlink:href="amci-20230213.xsd#amci_CustomerCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_cf1bd91e-e446-46f2-8b7c-9afb50151434" xlink:to="loc_amci_CustomerCMember_6501a2df-e564-4275-992a-d8cee521db3d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CustomerDMember_635276af-be4c-4fd5-acb6-2e155a270a86" xlink:href="amci-20230213.xsd#amci_CustomerDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_cf1bd91e-e446-46f2-8b7c-9afb50151434" xlink:to="loc_amci_CustomerDMember_635276af-be4c-4fd5-acb6-2e155a270a86" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CustomerEMember_dbec7925-9ab5-457e-b49c-849a4c35151c" xlink:href="amci-20230213.xsd#amci_CustomerEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_cf1bd91e-e446-46f2-8b7c-9afb50151434" xlink:to="loc_amci_CustomerEMember_dbec7925-9ab5-457e-b49c-849a4c35151c" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/LanzaTech10QNetLossPerShareAntidilutiveSharesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#LanzaTech10QNetLossPerShareAntidilutiveSharesDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/LanzaTech10QNetLossPerShareAntidilutiveSharesDetails" xlink:type="extended" id="id94cb4de342a422cac459ecba2914c63_LanzaTech10QNetLossPerShareAntidilutiveSharesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_cb61deb2-333f-46c1-beed-4ba8d27c7576" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_28d2a8b9-e574-450b-85bf-415e7ccd98d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_cb61deb2-333f-46c1-beed-4ba8d27c7576" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_28d2a8b9-e574-450b-85bf-415e7ccd98d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleConversionRatio_8ab904e8-5321-46a4-aa7a-b543dfc4cafa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockConvertibleConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_cb61deb2-333f-46c1-beed-4ba8d27c7576" xlink:to="loc_us-gaap_PreferredStockConvertibleConversionRatio_8ab904e8-5321-46a4-aa7a-b543dfc4cafa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LiquidityPriceOfSAFEAndSAFEWarrants_b58906e7-081f-452c-82f5-f6a79aa31291" xlink:href="amci-20230213.xsd#amci_LiquidityPriceOfSAFEAndSAFEWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_cb61deb2-333f-46c1-beed-4ba8d27c7576" xlink:to="loc_amci_LiquidityPriceOfSAFEAndSAFEWarrants_b58906e7-081f-452c-82f5-f6a79aa31291" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne_b9deed10-7cf2-4d98-85d8-c60213e2d771" xlink:href="amci-20230213.xsd#amci_LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_cb61deb2-333f-46c1-beed-4ba8d27c7576" xlink:to="loc_amci_LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne_b9deed10-7cf2-4d98-85d8-c60213e2d771" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_27b2393a-0392-44c7-b9d0-420142014a54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_cb61deb2-333f-46c1-beed-4ba8d27c7576" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_27b2393a-0392-44c7-b9d0-420142014a54" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_da8a1684-aaed-4002-9033-be00e8997b54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_27b2393a-0392-44c7-b9d0-420142014a54" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_da8a1684-aaed-4002-9033-be00e8997b54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_da8a1684-aaed-4002-9033-be00e8997b54_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_da8a1684-aaed-4002-9033-be00e8997b54" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_da8a1684-aaed-4002-9033-be00e8997b54_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bbc6adc9-65e6-4c6d-a1a6-9f3af3f57e53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_da8a1684-aaed-4002-9033-be00e8997b54" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bbc6adc9-65e6-4c6d-a1a6-9f3af3f57e53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_0f72eafb-bf90-48ef-8123-8426b321afb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bbc6adc9-65e6-4c6d-a1a6-9f3af3f57e53" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_0f72eafb-bf90-48ef-8123-8426b321afb6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_f600349d-b5a7-488a-b7fb-a3d86de15c04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bbc6adc9-65e6-4c6d-a1a6-9f3af3f57e53" xlink:to="loc_us-gaap_EmployeeStockOptionMember_f600349d-b5a7-488a-b7fb-a3d86de15c04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_06e8c791-79f3-40c1-a16c-be9ef823c0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bbc6adc9-65e6-4c6d-a1a6-9f3af3f57e53" xlink:to="loc_us-gaap_RestrictedStockMember_06e8c791-79f3-40c1-a16c-be9ef823c0cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_b51fa1be-a34c-46fb-b525-8e979abce068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bbc6adc9-65e6-4c6d-a1a6-9f3af3f57e53" xlink:to="loc_us-gaap_WarrantMember_b51fa1be-a34c-46fb-b525-8e979abce068" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#RevenuesDisaggregatedRevenueDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails" xlink:type="extended" id="i3829db7c0d6d4a6f9e735754d6a1039d_RevenuesDisaggregatedRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_d154f728-83bf-4a9c-a784-cf210b87ba44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_50915808-a1bc-4c1a-995d-1d01a3130ffd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d154f728-83bf-4a9c-a784-cf210b87ba44" xlink:to="loc_us-gaap_Revenues_50915808-a1bc-4c1a-995d-1d01a3130ffd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_7f37f525-2421-4c43-82c2-bb092a45408b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d154f728-83bf-4a9c-a784-cf210b87ba44" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_7f37f525-2421-4c43-82c2-bb092a45408b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_1601a8d6-7d4a-417f-9b0f-a9eef1ce9e44" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_7f37f525-2421-4c43-82c2-bb092a45408b" xlink:to="loc_srt_ProductOrServiceAxis_1601a8d6-7d4a-417f-9b0f-a9eef1ce9e44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1601a8d6-7d4a-417f-9b0f-a9eef1ce9e44_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_1601a8d6-7d4a-417f-9b0f-a9eef1ce9e44" xlink:to="loc_srt_ProductsAndServicesDomain_1601a8d6-7d4a-417f-9b0f-a9eef1ce9e44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9a715959-7e1d-45f2-9f44-c62f9c329bd2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_1601a8d6-7d4a-417f-9b0f-a9eef1ce9e44" xlink:to="loc_srt_ProductsAndServicesDomain_9a715959-7e1d-45f2-9f44-c62f9c329bd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ResearchAndDevelopmentMember_954cb40b-c223-4102-8122-a758d284692a" xlink:href="amci-20230213.xsd#amci_ResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9a715959-7e1d-45f2-9f44-c62f9c329bd2" xlink:to="loc_amci_ResearchAndDevelopmentMember_954cb40b-c223-4102-8122-a758d284692a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_JointDevelopmentAgreementsMember_d0a6a8e8-0e97-4ed5-8df8-60b2653abbbc" xlink:href="amci-20230213.xsd#amci_JointDevelopmentAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_ResearchAndDevelopmentMember_954cb40b-c223-4102-8122-a758d284692a" xlink:to="loc_amci_JointDevelopmentAgreementsMember_d0a6a8e8-0e97-4ed5-8df8-60b2653abbbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OtherContractResearchMember_8a7ffe74-59b0-4d14-a6f8-935aab4fae94" xlink:href="amci-20230213.xsd#amci_OtherContractResearchMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_ResearchAndDevelopmentMember_954cb40b-c223-4102-8122-a758d284692a" xlink:to="loc_amci_OtherContractResearchMember_8a7ffe74-59b0-4d14-a6f8-935aab4fae94" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CarbonCaptureAndTransformationMember_951a61b5-857a-4b91-a9a0-428683d25510" xlink:href="amci-20230213.xsd#amci_CarbonCaptureAndTransformationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9a715959-7e1d-45f2-9f44-c62f9c329bd2" xlink:to="loc_amci_CarbonCaptureAndTransformationMember_951a61b5-857a-4b91-a9a0-428683d25510" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAndServiceMember_0fd489cf-49ad-4401-a16f-aafcebc09aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicenseAndServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_CarbonCaptureAndTransformationMember_951a61b5-857a-4b91-a9a0-428683d25510" xlink:to="loc_us-gaap_LicenseAndServiceMember_0fd489cf-49ad-4401-a16f-aafcebc09aa5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CarbonSmartMember_9343bfef-5c0d-4008-ab2e-7e339440aa0a" xlink:href="amci-20230213.xsd#amci_CarbonSmartMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_CarbonCaptureAndTransformationMember_951a61b5-857a-4b91-a9a0-428683d25510" xlink:to="loc_amci_CarbonSmartMember_9343bfef-5c0d-4008-ab2e-7e339440aa0a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EngineeringAndOtherServicesMember_44eb2712-3ec4-46e5-9989-138b4d11ac20" xlink:href="amci-20230213.xsd#amci_EngineeringAndOtherServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_CarbonCaptureAndTransformationMember_951a61b5-857a-4b91-a9a0-428683d25510" xlink:to="loc_amci_EngineeringAndOtherServicesMember_44eb2712-3ec4-46e5-9989-138b4d11ac20" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RevenuesAdditionalInformationDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#RevenuesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/RevenuesAdditionalInformationDetails" xlink:type="extended" id="i28fdeaa4f2f847e7937524fde128c84f_RevenuesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_1fcb3123-95b0-47a3-8d60-096cc26daa3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_cf3810d0-6d8d-4b48-b052-0103096532b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1fcb3123-95b0-47a3-8d60-096cc26daa3f" xlink:to="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_cf3810d0-6d8d-4b48-b052-0103096532b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_d24535e1-ff9a-4043-aa65-957ad8c9d7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1fcb3123-95b0-47a3-8d60-096cc26daa3f" xlink:to="loc_us-gaap_RevenueFromRelatedParties_d24535e1-ff9a-4043-aa65-957ad8c9d7cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BilledContractReceivables_c164a3e8-97e4-4782-96c0-da96582089da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BilledContractReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1fcb3123-95b0-47a3-8d60-096cc26daa3f" xlink:to="loc_us-gaap_BilledContractReceivables_c164a3e8-97e4-4782-96c0-da96582089da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_882b956d-61c2-450a-8ec3-bc0571d744ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1fcb3123-95b0-47a3-8d60-096cc26daa3f" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_882b956d-61c2-450a-8ec3-bc0571d744ce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_beb9f3dd-8e3f-4d52-8b5f-d388e608c04a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_882b956d-61c2-450a-8ec3-bc0571d744ce" xlink:to="loc_srt_ProductOrServiceAxis_beb9f3dd-8e3f-4d52-8b5f-d388e608c04a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_beb9f3dd-8e3f-4d52-8b5f-d388e608c04a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_beb9f3dd-8e3f-4d52-8b5f-d388e608c04a" xlink:to="loc_srt_ProductsAndServicesDomain_beb9f3dd-8e3f-4d52-8b5f-d388e608c04a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_179fd5c9-ceaa-4175-9925-9b939e6dec98" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_beb9f3dd-8e3f-4d52-8b5f-d388e608c04a" xlink:to="loc_srt_ProductsAndServicesDomain_179fd5c9-ceaa-4175-9925-9b939e6dec98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAndServiceMember_cca5eeba-4850-4051-8fd9-ae229082a6cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicenseAndServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_179fd5c9-ceaa-4175-9925-9b939e6dec98" xlink:to="loc_us-gaap_LicenseAndServiceMember_cca5eeba-4850-4051-8fd9-ae229082a6cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EngineeringAndOtherServicesMember_14516721-38ca-4368-9051-613f8441bfaf" xlink:href="amci-20230213.xsd#amci_EngineeringAndOtherServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_179fd5c9-ceaa-4175-9925-9b939e6dec98" xlink:to="loc_amci_EngineeringAndOtherServicesMember_14516721-38ca-4368-9051-613f8441bfaf" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#RevenuesDisaggregationbyCustomerLocationDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails" xlink:type="extended" id="i041ba02cca3c403797e99291a865299b_RevenuesDisaggregationbyCustomerLocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_49660965-113f-499f-8287-4cdbec451b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_5dc7a6ed-3c45-4898-9c04-11ac25dea679" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_49660965-113f-499f-8287-4cdbec451b7a" xlink:to="loc_us-gaap_Revenues_5dc7a6ed-3c45-4898-9c04-11ac25dea679" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_225e0623-021f-4b51-840f-2624efa06a54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_49660965-113f-499f-8287-4cdbec451b7a" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_225e0623-021f-4b51-840f-2624efa06a54" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ebfc83ee-1c82-4b86-befe-f94590ba8de6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_225e0623-021f-4b51-840f-2624efa06a54" xlink:to="loc_srt_StatementGeographicalAxis_ebfc83ee-1c82-4b86-befe-f94590ba8de6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ebfc83ee-1c82-4b86-befe-f94590ba8de6_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_ebfc83ee-1c82-4b86-befe-f94590ba8de6" xlink:to="loc_srt_SegmentGeographicalDomain_ebfc83ee-1c82-4b86-befe-f94590ba8de6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b57353ec-6cb4-4190-adb6-4f2e8c988ca6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_ebfc83ee-1c82-4b86-befe-f94590ba8de6" xlink:to="loc_srt_SegmentGeographicalDomain_b57353ec-6cb4-4190-adb6-4f2e8c988ca6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NorthAmericaMember_0681ed4e-6e0f-477d-9aa5-f3a849bad165" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NorthAmericaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b57353ec-6cb4-4190-adb6-4f2e8c988ca6" xlink:to="loc_srt_NorthAmericaMember_0681ed4e-6e0f-477d-9aa5-f3a849bad165" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_9ae0100d-2074-45ea-a3d9-cc2c1b5a199f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b57353ec-6cb4-4190-adb6-4f2e8c988ca6" xlink:to="loc_us-gaap_EMEAMember_9ae0100d-2074-45ea-a3d9-cc2c1b5a199f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaMember_55ac936e-6dee-4234-b2be-ae9c80b3408a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b57353ec-6cb4-4190-adb6-4f2e8c988ca6" xlink:to="loc_srt_AsiaMember_55ac936e-6dee-4234-b2be-ae9c80b3408a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_AU_0b5e8d04-589a-4122-8ea3-185729001cb3" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_AU"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b57353ec-6cb4-4190-adb6-4f2e8c988ca6" xlink:to="loc_country_AU_0b5e8d04-589a-4122-8ea3-185729001cb3" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/InvestmentsScheduleofInvestmentsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#InvestmentsScheduleofInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/InvestmentsScheduleofInvestmentsDetails" xlink:type="extended" id="i3e56ddf340aa4cd780ed56127fb2ed5a_InvestmentsScheduleofInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_amci_InvestmentsLineItems_354e51fa-786f-466a-bed7-8ebf126fdcc9" xlink:href="amci-20230213.xsd#amci_InvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_87cc7c1b-d826-44b3-b96c-6c10ab7a472e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_InvestmentsLineItems_354e51fa-786f-466a-bed7-8ebf126fdcc9" xlink:to="loc_us-gaap_EquityMethodInvestments_87cc7c1b-d826-44b3-b96c-6c10ab7a472e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_1637db7c-d03f-44bc-94b7-1e9b7bd3ff7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_InvestmentsLineItems_354e51fa-786f-466a-bed7-8ebf126fdcc9" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_1637db7c-d03f-44bc-94b7-1e9b7bd3ff7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_2d25d91f-9efb-422e-8796-d3093cc39e99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_InvestmentsLineItems_354e51fa-786f-466a-bed7-8ebf126fdcc9" xlink:to="loc_us-gaap_Investments_2d25d91f-9efb-422e-8796-d3093cc39e99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_InvestmentsTable_47cf546e-4244-4f61-a601-94836ea71f58" xlink:href="amci-20230213.xsd#amci_InvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_amci_InvestmentsLineItems_354e51fa-786f-466a-bed7-8ebf126fdcc9" xlink:to="loc_amci_InvestmentsTable_47cf546e-4244-4f61-a601-94836ea71f58" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_707444db-b084-44be-8506-73df38d63d18" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_amci_InvestmentsTable_47cf546e-4244-4f61-a601-94836ea71f58" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_707444db-b084-44be-8506-73df38d63d18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_707444db-b084-44be-8506-73df38d63d18_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_707444db-b084-44be-8506-73df38d63d18" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_707444db-b084-44be-8506-73df38d63d18_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_302e059a-5b16-4cf8-80cf-230af1d86eb1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_707444db-b084-44be-8506-73df38d63d18" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_302e059a-5b16-4cf8-80cf-230af1d86eb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember_25feef42-65e6-43f1-9c70-b5de46149b84" xlink:href="amci-20230213.xsd#amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_302e059a-5b16-4cf8-80cf-230af1d86eb1" xlink:to="loc_amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember_25feef42-65e6-43f1-9c70-b5de46149b84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LanzaJetIncMember_7646f0d8-f2a8-47aa-9899-d0e9289025d0" xlink:href="amci-20230213.xsd#amci_LanzaJetIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_302e059a-5b16-4cf8-80cf-230af1d86eb1" xlink:to="loc_amci_LanzaJetIncMember_7646f0d8-f2a8-47aa-9899-d0e9289025d0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#InvestmentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/InvestmentsNarrativeDetails" xlink:type="extended" id="i5c691087679541f0b3a0eeeb15d5e0df_InvestmentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:href="amci-20230213.xsd#amci_InvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContributionOfProperty_54092028-8cdf-4468-947b-f53c97af350a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContributionOfProperty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:to="loc_us-gaap_ContributionOfProperty_54092028-8cdf-4468-947b-f53c97af350a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_683b157a-b66e-4eac-8f98-2e3c16be7e63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_683b157a-b66e-4eac-8f98-2e3c16be7e63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2a971a85-b18c-400e-9137-e53c8115a754" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2a971a85-b18c-400e-9137-e53c8115a754" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_1187ba30-2c86-4e4d-bd3e-43e46bf3f151" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:to="loc_us-gaap_ContractWithCustomerLiability_1187ba30-2c86-4e4d-bd3e-43e46bf3f151" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RevenueFromContractWithCustomerAmortizationPeriod_1502524b-75cf-4dca-b4ec-8827586e2b2e" xlink:href="amci-20230213.xsd#amci_RevenueFromContractWithCustomerAmortizationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:to="loc_amci_RevenueFromContractWithCustomerAmortizationPeriod_1502524b-75cf-4dca-b4ec-8827586e2b2e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfRoundsOfInvestments_c6834fd4-1232-49a4-b1c4-7dbdf7626875" xlink:href="amci-20230213.xsd#amci_NumberOfRoundsOfInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:to="loc_amci_NumberOfRoundsOfInvestments_c6834fd4-1232-49a4-b1c4-7dbdf7626875" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EquityMethodInvestmentGainOnDilutionOfInvestment_31a3a02c-aa30-49b8-80ab-7e077c3724fb" xlink:href="amci-20230213.xsd#amci_EquityMethodInvestmentGainOnDilutionOfInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:to="loc_amci_EquityMethodInvestmentGainOnDilutionOfInvestment_31a3a02c-aa30-49b8-80ab-7e077c3724fb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EquityMethodInvestmentContingentRightToReceiveAdditionalInterest_6429c8ba-c4e4-4d01-a76f-a72fd6e727e2" xlink:href="amci-20230213.xsd#amci_EquityMethodInvestmentContingentRightToReceiveAdditionalInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:to="loc_amci_EquityMethodInvestmentContingentRightToReceiveAdditionalInterest_6429c8ba-c4e4-4d01-a76f-a72fd6e727e2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_53a306af-105a-491f-9b8f-373772901e40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_53a306af-105a-491f-9b8f-373772901e40" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_ba9dac76-a6a1-4822-a969-d549c10fcb3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_ba9dac76-a6a1-4822-a969-d549c10fcb3f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TransferFromForeignCurrencyTranslationToEquitySecurityInvestment_0de3f727-9f2d-4c94-90b7-dca94c45acc3" xlink:href="amci-20230213.xsd#amci_TransferFromForeignCurrencyTranslationToEquitySecurityInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:to="loc_amci_TransferFromForeignCurrencyTranslationToEquitySecurityInvestment_0de3f727-9f2d-4c94-90b7-dca94c45acc3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_8b390cd6-2be8-4661-9c58-703b9a4065c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_8b390cd6-2be8-4661-9c58-703b9a4065c9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_78358c72-ab84-428a-aa21-1db2a9f1efda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_78358c72-ab84-428a-aa21-1db2a9f1efda" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_73173729-5057-4134-b331-7f34cc8c994d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_73173729-5057-4134-b331-7f34cc8c994d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_InvestmentsTable_f303dee1-5937-47f5-b761-b66aae7a2324" xlink:href="amci-20230213.xsd#amci_InvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:to="loc_amci_InvestmentsTable_f303dee1-5937-47f5-b761-b66aae7a2324" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_fe3e5723-9fe3-4874-9b64-5d19e7786df3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_amci_InvestmentsTable_f303dee1-5937-47f5-b761-b66aae7a2324" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_fe3e5723-9fe3-4874-9b64-5d19e7786df3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_fe3e5723-9fe3-4874-9b64-5d19e7786df3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_fe3e5723-9fe3-4874-9b64-5d19e7786df3" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_fe3e5723-9fe3-4874-9b64-5d19e7786df3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_52d98fbc-8f1b-4cff-bda9-7790329c8b5b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_fe3e5723-9fe3-4874-9b64-5d19e7786df3" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_52d98fbc-8f1b-4cff-bda9-7790329c8b5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LanzaJetIncMember_d7fbaec5-7a2d-47a9-a23a-ec8c1c59bc79" xlink:href="amci-20230213.xsd#amci_LanzaJetIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_52d98fbc-8f1b-4cff-bda9-7790329c8b5b" xlink:to="loc_amci_LanzaJetIncMember_d7fbaec5-7a2d-47a9-a23a-ec8c1c59bc79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember_d68604da-3c77-49c3-8505-700061924b4e" xlink:href="amci-20230213.xsd#amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_52d98fbc-8f1b-4cff-bda9-7790329c8b5b" xlink:to="loc_amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember_d68604da-3c77-49c3-8505-700061924b4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_8100fbe3-63a1-4dd4-9295-51123d8e47a5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_amci_InvestmentsTable_f303dee1-5937-47f5-b761-b66aae7a2324" xlink:to="loc_srt_ConsolidationItemsAxis_8100fbe3-63a1-4dd4-9295-51123d8e47a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_8100fbe3-63a1-4dd4-9295-51123d8e47a5_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_8100fbe3-63a1-4dd4-9295-51123d8e47a5" xlink:to="loc_srt_ConsolidationItemsDomain_8100fbe3-63a1-4dd4-9295-51123d8e47a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_8b3b46d4-39b5-4b9a-9137-d4105fffb11d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_8100fbe3-63a1-4dd4-9295-51123d8e47a5" xlink:to="loc_srt_ConsolidationItemsDomain_8b3b46d4-39b5-4b9a-9137-d4105fffb11d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_35a35e91-0de9-4129-ab97-2e95312ef112" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_8b3b46d4-39b5-4b9a-9137-d4105fffb11d" xlink:to="loc_us-gaap_IntersegmentEliminationMember_35a35e91-0de9-4129-ab97-2e95312ef112" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueFinancialAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails" xlink:type="extended" id="i7a99ec17b2f94c10ada72939d825de8e_FairValueFinancialAssetsandLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_cb457104-c200-4e31-8c9e-9f063355eef3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_9b02b330-0458-4b0e-9e87-45063a5c474f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_cb457104-c200-4e31-8c9e-9f063355eef3" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_9b02b330-0458-4b0e-9e87-45063a5c474f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_158eae75-c77a-4388-845d-47c92ba23733" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_9b02b330-0458-4b0e-9e87-45063a5c474f" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_158eae75-c77a-4388-845d-47c92ba23733" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e269bc7c-7f84-4fa0-8b59-fe6baf625a8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_cb457104-c200-4e31-8c9e-9f063355eef3" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e269bc7c-7f84-4fa0-8b59-fe6baf625a8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_85a319a8-ad4f-4953-a57f-56a97e2d55f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e269bc7c-7f84-4fa0-8b59-fe6baf625a8b" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_85a319a8-ad4f-4953-a57f-56a97e2d55f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SimpleAgreementForFutureEquityLiability_23dbf7aa-b9d3-447e-b665-50605ecab058" xlink:href="amci-20230213.xsd#amci_SimpleAgreementForFutureEquityLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e269bc7c-7f84-4fa0-8b59-fe6baf625a8b" xlink:to="loc_amci_SimpleAgreementForFutureEquityLiability_23dbf7aa-b9d3-447e-b665-50605ecab058" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_39708f67-91eb-47ec-85b8-65bedd8a0e50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e269bc7c-7f84-4fa0-8b59-fe6baf625a8b" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_39708f67-91eb-47ec-85b8-65bedd8a0e50" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3b7ba9e0-316e-4a82-bb1f-3ceebffe27b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_cb457104-c200-4e31-8c9e-9f063355eef3" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3b7ba9e0-316e-4a82-bb1f-3ceebffe27b8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_dd6e4089-f9f3-4d1f-a6cb-886d5e5c1c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3b7ba9e0-316e-4a82-bb1f-3ceebffe27b8" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_dd6e4089-f9f3-4d1f-a6cb-886d5e5c1c5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_dd6e4089-f9f3-4d1f-a6cb-886d5e5c1c5b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_dd6e4089-f9f3-4d1f-a6cb-886d5e5c1c5b" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_dd6e4089-f9f3-4d1f-a6cb-886d5e5c1c5b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_7e1ed6f3-429a-4671-af12-d19c85fb3595" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_dd6e4089-f9f3-4d1f-a6cb-886d5e5c1c5b" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_7e1ed6f3-429a-4671-af12-d19c85fb3595" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_b5ecc242-83c0-4e62-9686-79853a74cfee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_7e1ed6f3-429a-4671-af12-d19c85fb3595" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_b5ecc242-83c0-4e62-9686-79853a74cfee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ce15d46a-0d49-43a8-b1f4-4c6e53cbf99d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3b7ba9e0-316e-4a82-bb1f-3ceebffe27b8" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ce15d46a-0d49-43a8-b1f4-4c6e53cbf99d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ce15d46a-0d49-43a8-b1f4-4c6e53cbf99d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ce15d46a-0d49-43a8-b1f4-4c6e53cbf99d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ce15d46a-0d49-43a8-b1f4-4c6e53cbf99d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4b264ddd-4a25-4b50-92e1-a44fcbfc10fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ce15d46a-0d49-43a8-b1f4-4c6e53cbf99d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4b264ddd-4a25-4b50-92e1-a44fcbfc10fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_c267f7e3-6fa4-4420-8545-2b07c62009d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4b264ddd-4a25-4b50-92e1-a44fcbfc10fc" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_c267f7e3-6fa4-4420-8545-2b07c62009d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_fd49602b-f1d6-4472-8822-e413d69c4ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4b264ddd-4a25-4b50-92e1-a44fcbfc10fc" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_fd49602b-f1d6-4472-8822-e413d69c4ebf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_25f0dbf8-ada9-410e-8598-4209fee0d8d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4b264ddd-4a25-4b50-92e1-a44fcbfc10fc" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_25f0dbf8-ada9-410e-8598-4209fee0d8d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_c6f97b68-ebbd-4416-80e9-5a75a93ed784" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3b7ba9e0-316e-4a82-bb1f-3ceebffe27b8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_c6f97b68-ebbd-4416-80e9-5a75a93ed784" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_c6f97b68-ebbd-4416-80e9-5a75a93ed784_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_c6f97b68-ebbd-4416-80e9-5a75a93ed784" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_c6f97b68-ebbd-4416-80e9-5a75a93ed784_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_2aa1bba7-6212-4ce8-9ff3-455a74d25a89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_c6f97b68-ebbd-4416-80e9-5a75a93ed784" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_2aa1bba7-6212-4ce8-9ff3-455a74d25a89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_36ad3f63-d367-4426-9196-e5ceb56e8ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2aa1bba7-6212-4ce8-9ff3-455a74d25a89" xlink:to="loc_us-gaap_WarrantMember_36ad3f63-d367-4426-9196-e5ceb56e8ef2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SAFEWarrantMember_2a755666-8dab-4698-990f-15d37dd04d30" xlink:href="amci-20230213.xsd#amci_SAFEWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2aa1bba7-6212-4ce8-9ff3-455a74d25a89" xlink:to="loc_amci_SAFEWarrantMember_2a755666-8dab-4698-990f-15d37dd04d30" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueNarrativeDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueNarrativeDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/FairValueNarrativeDetails" xlink:type="extended" id="i12a3617e50ca41839d6244dbe8cbd6ce_FairValueNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b83e3a99-a663-414d-ada3-225779f4645c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2a4f8233-f0e4-4dda-b3d4-ff24592d1b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b83e3a99-a663-414d-ada3-225779f4645c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2a4f8233-f0e4-4dda-b3d4-ff24592d1b5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_6ef1bcfd-e205-4609-96b8-db301ece9ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b83e3a99-a663-414d-ada3-225779f4645c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_6ef1bcfd-e205-4609-96b8-db301ece9ff1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_0beeccd0-4957-4c51-bfb2-1fb5ee5806c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b83e3a99-a663-414d-ada3-225779f4645c" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_0beeccd0-4957-4c51-bfb2-1fb5ee5806c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SimpleAgreementForFutureEquityLiability_e0f8d684-cbad-4f69-9fac-7e87da36c065" xlink:href="amci-20230213.xsd#amci_SimpleAgreementForFutureEquityLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b83e3a99-a663-414d-ada3-225779f4645c" xlink:to="loc_amci_SimpleAgreementForFutureEquityLiability_e0f8d684-cbad-4f69-9fac-7e87da36c065" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_d9583f90-bae9-476e-bfd2-05acf276319e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b83e3a99-a663-414d-ada3-225779f4645c" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_d9583f90-bae9-476e-bfd2-05acf276319e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_de3d4536-9edf-4d73-9790-ade86e26f86e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b83e3a99-a663-414d-ada3-225779f4645c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_de3d4536-9edf-4d73-9790-ade86e26f86e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_946e24bb-a6ad-4960-9d37-8eeb71e3031e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_de3d4536-9edf-4d73-9790-ade86e26f86e" xlink:to="loc_srt_RangeAxis_946e24bb-a6ad-4960-9d37-8eeb71e3031e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_946e24bb-a6ad-4960-9d37-8eeb71e3031e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_946e24bb-a6ad-4960-9d37-8eeb71e3031e" xlink:to="loc_srt_RangeMember_946e24bb-a6ad-4960-9d37-8eeb71e3031e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_667bc230-1fe0-4a06-893b-4f58720b721e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_946e24bb-a6ad-4960-9d37-8eeb71e3031e" xlink:to="loc_srt_RangeMember_667bc230-1fe0-4a06-893b-4f58720b721e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_bf0fdd02-f754-4ed7-b4db-da950e7f68d8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_667bc230-1fe0-4a06-893b-4f58720b721e" xlink:to="loc_srt_MinimumMember_bf0fdd02-f754-4ed7-b4db-da950e7f68d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_489040dd-ff23-451b-8e20-0129a2d7de61" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_667bc230-1fe0-4a06-893b-4f58720b721e" xlink:to="loc_srt_MaximumMember_489040dd-ff23-451b-8e20-0129a2d7de61" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueLevel3FairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails" xlink:type="extended" id="i7c0b3b2c404e48e6bdcf64982820fa32_FairValueLevel3FairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1d89fd94-4e59-4a0b-af8e-3fcc2d091992" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SAFELiabilityMeasurementInput_9e36319b-a5f2-4131-a71a-fb36a2da24f6" xlink:href="amci-20230213.xsd#amci_SAFELiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1d89fd94-4e59-4a0b-af8e-3fcc2d091992" xlink:to="loc_amci_SAFELiabilityMeasurementInput_9e36319b-a5f2-4131-a71a-fb36a2da24f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_403c8504-3bcb-490f-a811-1e22aef7f6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1d89fd94-4e59-4a0b-af8e-3fcc2d091992" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_403c8504-3bcb-490f-a811-1e22aef7f6c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_6a4bceb7-252b-4004-ac81-1b6b3b138ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1d89fd94-4e59-4a0b-af8e-3fcc2d091992" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_6a4bceb7-252b-4004-ac81-1b6b3b138ed1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_df5e3f44-d9dd-4d17-8c08-ddeaf7cd835a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_6a4bceb7-252b-4004-ac81-1b6b3b138ed1" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_df5e3f44-d9dd-4d17-8c08-ddeaf7cd835a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_df5e3f44-d9dd-4d17-8c08-ddeaf7cd835a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_df5e3f44-d9dd-4d17-8c08-ddeaf7cd835a" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_df5e3f44-d9dd-4d17-8c08-ddeaf7cd835a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_6da678c7-9c86-41be-a8aa-09f55d827274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_df5e3f44-d9dd-4d17-8c08-ddeaf7cd835a" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_6da678c7-9c86-41be-a8aa-09f55d827274" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_549ae470-d772-4118-828e-6ef55caa8c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6da678c7-9c86-41be-a8aa-09f55d827274" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_549ae470-d772-4118-828e-6ef55caa8c2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExercisePriceMember_668b2a04-8d11-40e9-b3a7-1a9f31676ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExercisePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6da678c7-9c86-41be-a8aa-09f55d827274" xlink:to="loc_us-gaap_MeasurementInputExercisePriceMember_668b2a04-8d11-40e9-b3a7-1a9f31676ca1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_e54c05a5-3b3c-411c-81af-f46eb89c5f04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6da678c7-9c86-41be-a8aa-09f55d827274" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_e54c05a5-3b3c-411c-81af-f46eb89c5f04" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_a5d074f9-9896-4880-b16e-53fe175c8a49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6da678c7-9c86-41be-a8aa-09f55d827274" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_a5d074f9-9896-4880-b16e-53fe175c8a49" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_23bb9595-5072-4efe-8b0c-3911944f7ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6da678c7-9c86-41be-a8aa-09f55d827274" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_23bb9595-5072-4efe-8b0c-3911944f7ecc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MeasurementInputProbabilityWeightingMember_3edba0fb-6428-45f4-8a8e-cb2aa993313c" xlink:href="amci-20230213.xsd#amci_MeasurementInputProbabilityWeightingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6da678c7-9c86-41be-a8aa-09f55d827274" xlink:to="loc_amci_MeasurementInputProbabilityWeightingMember_3edba0fb-6428-45f4-8a8e-cb2aa993313c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MeasurementInputInterestRateMember_50a54f28-efd1-4a42-bedc-facc822435a5" xlink:href="amci-20230213.xsd#amci_MeasurementInputInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6da678c7-9c86-41be-a8aa-09f55d827274" xlink:to="loc_amci_MeasurementInputInterestRateMember_50a54f28-efd1-4a42-bedc-facc822435a5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MeasurementInputTimeToConversionMember_be165e8f-45f2-419b-8e51-d2c192e8011d" xlink:href="amci-20230213.xsd#amci_MeasurementInputTimeToConversionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6da678c7-9c86-41be-a8aa-09f55d827274" xlink:to="loc_amci_MeasurementInputTimeToConversionMember_be165e8f-45f2-419b-8e51-d2c192e8011d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MeasurementInputLiquidityPriceMember_3408d71d-9af5-4e9a-b3d0-1fd7a29e3853" xlink:href="amci-20230213.xsd#amci_MeasurementInputLiquidityPriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6da678c7-9c86-41be-a8aa-09f55d827274" xlink:to="loc_amci_MeasurementInputLiquidityPriceMember_3408d71d-9af5-4e9a-b3d0-1fd7a29e3853" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_cf355b15-f6b4-4f98-b93a-77b64aa97680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6da678c7-9c86-41be-a8aa-09f55d827274" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_cf355b15-f6b4-4f98-b93a-77b64aa97680" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_001854f5-9106-4f76-8af0-954c2be65d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6da678c7-9c86-41be-a8aa-09f55d827274" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_001854f5-9106-4f76-8af0-954c2be65d8e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1098abe6-8dc0-4834-9ada-f22bd83dd4fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_6a4bceb7-252b-4004-ac81-1b6b3b138ed1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1098abe6-8dc0-4834-9ada-f22bd83dd4fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1098abe6-8dc0-4834-9ada-f22bd83dd4fe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1098abe6-8dc0-4834-9ada-f22bd83dd4fe" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1098abe6-8dc0-4834-9ada-f22bd83dd4fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_d032f91d-41e1-4c03-ad27-7a8e133ef5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1098abe6-8dc0-4834-9ada-f22bd83dd4fe" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_d032f91d-41e1-4c03-ad27-7a8e133ef5f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SAFEWarrantNearTermMember_1b411fe4-2e09-4a33-91be-3e594a036b04" xlink:href="amci-20230213.xsd#amci_SAFEWarrantNearTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_d032f91d-41e1-4c03-ad27-7a8e133ef5f8" xlink:to="loc_amci_SAFEWarrantNearTermMember_1b411fe4-2e09-4a33-91be-3e594a036b04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SAFEWarrantLongTermMember_7c469296-8af6-40e4-85ad-a20fcaa9a510" xlink:href="amci-20230213.xsd#amci_SAFEWarrantLongTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_d032f91d-41e1-4c03-ad27-7a8e133ef5f8" xlink:to="loc_amci_SAFEWarrantLongTermMember_7c469296-8af6-40e4-85ad-a20fcaa9a510" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis_4053075e-3fd0-4d8c-a4c7-d7abe6ea033f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_6a4bceb7-252b-4004-ac81-1b6b3b138ed1" xlink:to="loc_us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis_4053075e-3fd0-4d8c-a4c7-d7abe6ea033f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain_4053075e-3fd0-4d8c-a4c7-d7abe6ea033f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis_4053075e-3fd0-4d8c-a4c7-d7abe6ea033f" xlink:to="loc_us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain_4053075e-3fd0-4d8c-a4c7-d7abe6ea033f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain_c0eb8c04-d6e2-4d17-bd9d-25621c95505a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis_4053075e-3fd0-4d8c-a4c7-d7abe6ea033f" xlink:to="loc_us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain_c0eb8c04-d6e2-4d17-bd9d-25621c95505a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SecuritiesSubjectToMandatoryRedemptionNearTermMember_73ac9392-c846-4b4f-b878-864ed03f5599" xlink:href="amci-20230213.xsd#amci_SecuritiesSubjectToMandatoryRedemptionNearTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain_c0eb8c04-d6e2-4d17-bd9d-25621c95505a" xlink:to="loc_amci_SecuritiesSubjectToMandatoryRedemptionNearTermMember_73ac9392-c846-4b4f-b878-864ed03f5599" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SecuritiesSubjectToMandatoryRedemptionLongTermMember_8b8bf5fa-5475-4f51-889d-d05b26d01add" xlink:href="amci-20230213.xsd#amci_SecuritiesSubjectToMandatoryRedemptionLongTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain_c0eb8c04-d6e2-4d17-bd9d-25621c95505a" xlink:to="loc_amci_SecuritiesSubjectToMandatoryRedemptionLongTermMember_8b8bf5fa-5475-4f51-889d-d05b26d01add" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails" xlink:type="extended" id="i4488a6b0568f4be9b5887c7d713ee70b_FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_cd2d9a85-2a61-4ac3-a8dc-22916799a164" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_52dcd283-d084-40f3-a906-e5d57b965e71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_cd2d9a85-2a61-4ac3-a8dc-22916799a164" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_52dcd283-d084-40f3-a906-e5d57b965e71" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_66acf4fe-ce0e-41ec-ae19-8b39bc5c41f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_52dcd283-d084-40f3-a906-e5d57b965e71" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_66acf4fe-ce0e-41ec-ae19-8b39bc5c41f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_7ed555b1-a673-4da8-a87e-61d9396709f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_52dcd283-d084-40f3-a906-e5d57b965e71" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_7ed555b1-a673-4da8-a87e-61d9396709f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_0db48777-3a37-4c74-a514-9addb9ecf074" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_52dcd283-d084-40f3-a906-e5d57b965e71" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_0db48777-3a37-4c74-a514-9addb9ecf074" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3a6d1c3c-edbe-44c0-b8c8-048bcb26a947" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_d68cb897-7b10-409d-a388-f6796a203ece" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_cd2d9a85-2a61-4ac3-a8dc-22916799a164" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_d68cb897-7b10-409d-a388-f6796a203ece" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_2cd53da9-8d89-4baa-921e-092e9b54fc20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_d68cb897-7b10-409d-a388-f6796a203ece" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_2cd53da9-8d89-4baa-921e-092e9b54fc20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2cd53da9-8d89-4baa-921e-092e9b54fc20_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_2cd53da9-8d89-4baa-921e-092e9b54fc20" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2cd53da9-8d89-4baa-921e-092e9b54fc20_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_fa583aec-b2e9-4c31-bbc6-2391c839e6e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_2cd53da9-8d89-4baa-921e-092e9b54fc20" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_fa583aec-b2e9-4c31-bbc6-2391c839e6e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_61ab63d4-f6d4-46b7-be74-978c81dae7cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_fa583aec-b2e9-4c31-bbc6-2391c839e6e1" xlink:to="loc_us-gaap_WarrantMember_61ab63d4-f6d4-46b7-be74-978c81dae7cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SAFELiabilityMember_b96b9e88-bc44-49a5-ba7d-8351cfabb88a" xlink:href="amci-20230213.xsd#amci_SAFELiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_fa583aec-b2e9-4c31-bbc6-2391c839e6e1" xlink:to="loc_amci_SAFELiabilityMember_b96b9e88-bc44-49a5-ba7d-8351cfabb88a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SAFEWarrantMember_5edd37b4-f8cf-471c-a775-f13613c57d3f" xlink:href="amci-20230213.xsd#amci_SAFEWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_fa583aec-b2e9-4c31-bbc6-2391c839e6e1" xlink:to="loc_amci_SAFEWarrantMember_5edd37b4-f8cf-471c-a775-f13613c57d3f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#IncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/IncomeTaxesDetails" xlink:type="extended" id="ibeb1e36b83d843149bb698c131f26681_IncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeTaxesLineItems_b2a03771-32cb-4a55-8c51-1fba60d0b734" xlink:href="amci-20230213.xsd#amci_IncomeTaxesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignEarningsRepatriated_913b52bd-b9f3-4199-b204-7b8a9b66306a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignEarningsRepatriated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_IncomeTaxesLineItems_b2a03771-32cb-4a55-8c51-1fba60d0b734" xlink:to="loc_us-gaap_ForeignEarningsRepatriated_913b52bd-b9f3-4199-b204-7b8a9b66306a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_cecd9d51-eb69-4788-a6c2-922218d5892c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_IncomeTaxesLineItems_b2a03771-32cb-4a55-8c51-1fba60d0b734" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_cecd9d51-eb69-4788-a6c2-922218d5892c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2c17adbc-5da2-4f49-8531-cec3eae8ae2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_IncomeTaxesLineItems_b2a03771-32cb-4a55-8c51-1fba60d0b734" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_2c17adbc-5da2-4f49-8531-cec3eae8ae2d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2094b39c-b93a-4fe4-85cc-a457fe993f23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_IncomeTaxesLineItems_b2a03771-32cb-4a55-8c51-1fba60d0b734" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2094b39c-b93a-4fe4-85cc-a457fe993f23" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeTaxesTable_9f5a93a5-d871-4d05-8999-2a67f87ac80c" xlink:href="amci-20230213.xsd#amci_IncomeTaxesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_amci_IncomeTaxesLineItems_b2a03771-32cb-4a55-8c51-1fba60d0b734" xlink:to="loc_amci_IncomeTaxesTable_9f5a93a5-d871-4d05-8999-2a67f87ac80c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_e45d3ab1-fb71-4ed2-82aa-e2edfc9f60ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_amci_IncomeTaxesTable_9f5a93a5-d871-4d05-8999-2a67f87ac80c" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_e45d3ab1-fb71-4ed2-82aa-e2edfc9f60ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_e45d3ab1-fb71-4ed2-82aa-e2edfc9f60ad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_e45d3ab1-fb71-4ed2-82aa-e2edfc9f60ad" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_e45d3ab1-fb71-4ed2-82aa-e2edfc9f60ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_262fe449-0c19-4113-a37a-f67cae018651" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_e45d3ab1-fb71-4ed2-82aa-e2edfc9f60ad" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_262fe449-0c19-4113-a37a-f67cae018651" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_c73dcc38-0b27-4b30-a9d3-fcdeedf739eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_262fe449-0c19-4113-a37a-f67cae018651" xlink:to="loc_us-gaap_ForeignCountryMember_c73dcc38-0b27-4b30-a9d3-fcdeedf739eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_f96ca4e2-7bec-4e0c-b510-f777dc3bcb34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_amci_IncomeTaxesTable_9f5a93a5-d871-4d05-8999-2a67f87ac80c" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_f96ca4e2-7bec-4e0c-b510-f777dc3bcb34" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_f96ca4e2-7bec-4e0c-b510-f777dc3bcb34_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_f96ca4e2-7bec-4e0c-b510-f777dc3bcb34" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_f96ca4e2-7bec-4e0c-b510-f777dc3bcb34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_e3bd2cec-8500-4b23-b3fc-71cecb65e96a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_f96ca4e2-7bec-4e0c-b510-f777dc3bcb34" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_e3bd2cec-8500-4b23-b3fc-71cecb65e96a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_InlandRevenueNewZealandMember_fc18a023-9756-4bee-a3fb-e9de9856efab" xlink:href="amci-20230213.xsd#amci_InlandRevenueNewZealandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_e3bd2cec-8500-4b23-b3fc-71cecb65e96a" xlink:to="loc_amci_InlandRevenueNewZealandMember_fc18a023-9756-4bee-a3fb-e9de9856efab" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended" id="ifce44e0a06ad4af59813320e9c87c8ec_ShareBasedCompensationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16ae9acb-551a-40fd-8a3c-f654ae36e1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfShareBasedStockSchemes_7e3e6fb2-9262-409c-905c-4c21e8c9ed88" xlink:href="amci-20230213.xsd#amci_NumberOfShareBasedStockSchemes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16ae9acb-551a-40fd-8a3c-f654ae36e1fe" xlink:to="loc_amci_NumberOfShareBasedStockSchemes_7e3e6fb2-9262-409c-905c-4c21e8c9ed88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_891c9e22-2459-4b9a-86aa-5e76b1d5f264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16ae9acb-551a-40fd-8a3c-f654ae36e1fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_891c9e22-2459-4b9a-86aa-5e76b1d5f264" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_829cc7f8-3d4d-494b-9e4e-7dc990a44040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16ae9acb-551a-40fd-8a3c-f654ae36e1fe" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_829cc7f8-3d4d-494b-9e4e-7dc990a44040" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_e50efedf-5761-49ec-911f-bdf0a3dc6ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16ae9acb-551a-40fd-8a3c-f654ae36e1fe" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_e50efedf-5761-49ec-911f-bdf0a3dc6ebc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_12d494c5-309e-4ea5-8109-3228a868d65b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16ae9acb-551a-40fd-8a3c-f654ae36e1fe" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_12d494c5-309e-4ea5-8109-3228a868d65b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_539c5360-2e86-4290-ab24-ce1133ba3631" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16ae9acb-551a-40fd-8a3c-f654ae36e1fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_539c5360-2e86-4290-ab24-ce1133ba3631" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_491facc2-1dbd-4d0a-9c80-309fbb49948a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16ae9acb-551a-40fd-8a3c-f654ae36e1fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_491facc2-1dbd-4d0a-9c80-309fbb49948a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4b442d5e-5052-4233-a04e-1f4509eb4b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16ae9acb-551a-40fd-8a3c-f654ae36e1fe" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4b442d5e-5052-4233-a04e-1f4509eb4b9d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fa9cfd51-8a4b-4ca2-8519-9563ca6ca448" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4b442d5e-5052-4233-a04e-1f4509eb4b9d" xlink:to="loc_srt_RangeAxis_fa9cfd51-8a4b-4ca2-8519-9563ca6ca448" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fa9cfd51-8a4b-4ca2-8519-9563ca6ca448_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_fa9cfd51-8a4b-4ca2-8519-9563ca6ca448" xlink:to="loc_srt_RangeMember_fa9cfd51-8a4b-4ca2-8519-9563ca6ca448_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ae09eeed-4190-4bf5-be35-c2b510fb1469" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_fa9cfd51-8a4b-4ca2-8519-9563ca6ca448" xlink:to="loc_srt_RangeMember_ae09eeed-4190-4bf5-be35-c2b510fb1469" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a5211925-ed4e-4f00-8200-e45363c60369" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ae09eeed-4190-4bf5-be35-c2b510fb1469" xlink:to="loc_srt_MinimumMember_a5211925-ed4e-4f00-8200-e45363c60369" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4ef8cc14-adfb-4209-bbc2-81847893f55d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ae09eeed-4190-4bf5-be35-c2b510fb1469" xlink:to="loc_srt_MaximumMember_4ef8cc14-adfb-4209-bbc2-81847893f55d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2b2ffbff-82c7-4dde-817e-4b10632d0a85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4b442d5e-5052-4233-a04e-1f4509eb4b9d" xlink:to="loc_us-gaap_AwardTypeAxis_2b2ffbff-82c7-4dde-817e-4b10632d0a85" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2b2ffbff-82c7-4dde-817e-4b10632d0a85_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_2b2ffbff-82c7-4dde-817e-4b10632d0a85" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2b2ffbff-82c7-4dde-817e-4b10632d0a85_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d20e343f-b738-4954-9870-a2121f401017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_2b2ffbff-82c7-4dde-817e-4b10632d0a85" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d20e343f-b738-4954-9870-a2121f401017" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d9609a12-e7eb-4377-91ff-3020aa22b733" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d20e343f-b738-4954-9870-a2121f401017" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d9609a12-e7eb-4377-91ff-3020aa22b733" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_3ffbdd4d-0062-4f84-9b19-a925c5700271" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d20e343f-b738-4954-9870-a2121f401017" xlink:to="loc_us-gaap_RestrictedStockMember_3ffbdd4d-0062-4f84-9b19-a925c5700271" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#RelatedPartyTransactionsDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails" xlink:type="extended" id="ia138e10bd82049bf995014d80c28e235_RelatedPartyTransactionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_4ff7e4ac-c549-42ff-9bd5-2221f047d9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_6efb008a-9c08-4918-8e22-ad150bd68e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ff7e4ac-c549-42ff-9bd5-2221f047d9e5" xlink:to="loc_us-gaap_Investments_6efb008a-9c08-4918-8e22-ad150bd68e5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_201888a1-173b-453b-a1fe-de7c295b2bde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ff7e4ac-c549-42ff-9bd5-2221f047d9e5" xlink:to="loc_us-gaap_RevenueFromRelatedParties_201888a1-173b-453b-a1fe-de7c295b2bde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_ffb1b4fa-ab7c-417b-9b97-52fe58b54084" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ff7e4ac-c549-42ff-9bd5-2221f047d9e5" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_ffb1b4fa-ab7c-417b-9b97-52fe58b54084" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LesseeOperatingLeaseNumberOfRenewalTerms_fe3c5454-3e1d-4f3c-896a-0976501cc744" xlink:href="amci-20230213.xsd#amci_LesseeOperatingLeaseNumberOfRenewalTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ff7e4ac-c549-42ff-9bd5-2221f047d9e5" xlink:to="loc_amci_LesseeOperatingLeaseNumberOfRenewalTerms_fe3c5454-3e1d-4f3c-896a-0976501cc744" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_f3870bec-47f9-4e0c-8108-2ef65b06fb71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ff7e4ac-c549-42ff-9bd5-2221f047d9e5" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_f3870bec-47f9-4e0c-8108-2ef65b06fb71" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_b261947d-2ad9-41f8-9cad-aa6debbb6aac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ff7e4ac-c549-42ff-9bd5-2221f047d9e5" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_b261947d-2ad9-41f8-9cad-aa6debbb6aac" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_d8e7c984-58ce-402f-822a-e943d7f921ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ff7e4ac-c549-42ff-9bd5-2221f047d9e5" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_d8e7c984-58ce-402f-822a-e943d7f921ba" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_244aba86-e871-4e78-87a7-a7df1b56cbea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ff7e4ac-c549-42ff-9bd5-2221f047d9e5" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_244aba86-e871-4e78-87a7-a7df1b56cbea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_6067dc2f-60a6-47db-b58e-48051bb1f965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_244aba86-e871-4e78-87a7-a7df1b56cbea" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_6067dc2f-60a6-47db-b58e-48051bb1f965" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_6067dc2f-60a6-47db-b58e-48051bb1f965_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_6067dc2f-60a6-47db-b58e-48051bb1f965" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_6067dc2f-60a6-47db-b58e-48051bb1f965_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_3d668435-28e7-4691-a729-9d7ec4623aab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_6067dc2f-60a6-47db-b58e-48051bb1f965" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_3d668435-28e7-4691-a729-9d7ec4623aab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartyTransitionServicesAgreementMember_2a8fe926-bea9-43be-a663-854541d5a95d" xlink:href="amci-20230213.xsd#amci_RelatedPartyTransitionServicesAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_3d668435-28e7-4691-a729-9d7ec4623aab" xlink:to="loc_amci_RelatedPartyTransitionServicesAgreementMember_2a8fe926-bea9-43be-a663-854541d5a95d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartyInvestmentAgreementMember_99cdaae8-a67b-43c6-8fbd-ee99bc1e84de" xlink:href="amci-20230213.xsd#amci_RelatedPartyInvestmentAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_3d668435-28e7-4691-a729-9d7ec4623aab" xlink:to="loc_amci_RelatedPartyInvestmentAgreementMember_99cdaae8-a67b-43c6-8fbd-ee99bc1e84de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartyLeaseAgreementMember_259543b2-d108-4f91-95b4-4a9bac064d76" xlink:href="amci-20230213.xsd#amci_RelatedPartyLeaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_3d668435-28e7-4691-a729-9d7ec4623aab" xlink:to="loc_amci_RelatedPartyLeaseAgreementMember_259543b2-d108-4f91-95b4-4a9bac064d76" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartySupplyAgreementMember_2949a828-eb9c-4f39-9e71-d65c55967e3f" xlink:href="amci-20230213.xsd#amci_RelatedPartySupplyAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_3d668435-28e7-4691-a729-9d7ec4623aab" xlink:to="loc_amci_RelatedPartySupplyAgreementMember_2949a828-eb9c-4f39-9e71-d65c55967e3f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7e63a17d-236d-464b-8c0a-ccf8ce27e2df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_244aba86-e871-4e78-87a7-a7df1b56cbea" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7e63a17d-236d-464b-8c0a-ccf8ce27e2df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_7e63a17d-236d-464b-8c0a-ccf8ce27e2df_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7e63a17d-236d-464b-8c0a-ccf8ce27e2df" xlink:to="loc_us-gaap_RelatedPartyDomain_7e63a17d-236d-464b-8c0a-ccf8ce27e2df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_0bc0e6f2-dcad-4e41-aebd-8ca569945589" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7e63a17d-236d-464b-8c0a-ccf8ce27e2df" xlink:to="loc_us-gaap_RelatedPartyDomain_0bc0e6f2-dcad-4e41-aebd-8ca569945589" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_711f68e2-38e2-4732-a511-89caf650d224" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_0bc0e6f2-dcad-4e41-aebd-8ca569945589" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_711f68e2-38e2-4732-a511-89caf650d224" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails" xlink:type="extended" id="i59705b9345274a30b1fd19963b4b3d24_RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_d1f377ff-edfe-4e0a-b455-fc16a15eed43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_64c4b9e5-09d4-446d-8f38-52c3e8cbf0ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d1f377ff-edfe-4e0a-b455-fc16a15eed43" xlink:to="loc_us-gaap_AccountsReceivableNet_64c4b9e5-09d4-446d-8f38-52c3e8cbf0ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_115e5f78-5be9-4890-bd12-489d655b4ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d1f377ff-edfe-4e0a-b455-fc16a15eed43" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_115e5f78-5be9-4890-bd12-489d655b4ebf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PurchasesAndOpenAccountsPayableRelatedParties_43f85312-5796-46e7-b1e6-b573d5eb134d" xlink:href="amci-20230213.xsd#amci_PurchasesAndOpenAccountsPayableRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d1f377ff-edfe-4e0a-b455-fc16a15eed43" xlink:to="loc_amci_PurchasesAndOpenAccountsPayableRelatedParties_43f85312-5796-46e7-b1e6-b573d5eb134d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ccf69834-1be7-4255-bc8e-4fe22afedbf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d1f377ff-edfe-4e0a-b455-fc16a15eed43" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ccf69834-1be7-4255-bc8e-4fe22afedbf4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a786ae1e-0039-41f2-8a0f-be390f4e1e99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ccf69834-1be7-4255-bc8e-4fe22afedbf4" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a786ae1e-0039-41f2-8a0f-be390f4e1e99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_a786ae1e-0039-41f2-8a0f-be390f4e1e99_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a786ae1e-0039-41f2-8a0f-be390f4e1e99" xlink:to="loc_us-gaap_RelatedPartyDomain_a786ae1e-0039-41f2-8a0f-be390f4e1e99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_046c714c-4127-4b8a-a0c8-dcedf05a3a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a786ae1e-0039-41f2-8a0f-be390f4e1e99" xlink:to="loc_us-gaap_RelatedPartyDomain_046c714c-4127-4b8a-a0c8-dcedf05a3a3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_f7e86e3a-7bc9-47ad-a2df-4fcce256789f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_046c714c-4127-4b8a-a0c8-dcedf05a3a3e" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_f7e86e3a-7bc9-47ad-a2df-4fcce256789f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_00891f3c-bca8-4d8f-9e50-4830a4f6993b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ccf69834-1be7-4255-bc8e-4fe22afedbf4" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_00891f3c-bca8-4d8f-9e50-4830a4f6993b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_00891f3c-bca8-4d8f-9e50-4830a4f6993b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_00891f3c-bca8-4d8f-9e50-4830a4f6993b" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_00891f3c-bca8-4d8f-9e50-4830a4f6993b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_48e6bc74-efbc-4b27-abb3-d5b3b237e0d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_00891f3c-bca8-4d8f-9e50-4830a4f6993b" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_48e6bc74-efbc-4b27-abb3-d5b3b237e0d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TransactionsWithEquityMethodInvesteesMember_0d3a92a1-bf54-491a-a31a-9d43a43c5dff" xlink:href="amci-20230213.xsd#amci_TransactionsWithEquityMethodInvesteesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_48e6bc74-efbc-4b27-abb3-d5b3b237e0d9" xlink:to="loc_amci_TransactionsWithEquityMethodInvesteesMember_0d3a92a1-bf54-491a-a31a-9d43a43c5dff" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#RedeemableConvertiblePreferredStockDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockDetails" xlink:type="extended" id="i822655a9b04b4d47af57e304529e011d_RedeemableConvertiblePreferredStockDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_68f48d78-6caf-4fea-8d04-4609ebfa0388" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_e7335ae4-c2d8-40bf-a6d3-ee6f13edeb89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_68f48d78-6caf-4fea-8d04-4609ebfa0388" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_e7335ae4-c2d8-40bf-a6d3-ee6f13edeb89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_8deb2295-2c72-403f-b772-d7c455ac78f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_68f48d78-6caf-4fea-8d04-4609ebfa0388" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_8deb2295-2c72-403f-b772-d7c455ac78f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_2e686001-9126-4553-a048-fc7dead47a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_68f48d78-6caf-4fea-8d04-4609ebfa0388" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_2e686001-9126-4553-a048-fc7dead47a9e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityIssuePricePerShare_41308491-6aa6-4d84-ad9a-deda731c44f0" xlink:href="amci-20230213.xsd#amci_TemporaryEquityIssuePricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_68f48d78-6caf-4fea-8d04-4609ebfa0388" xlink:to="loc_amci_TemporaryEquityIssuePricePerShare_41308491-6aa6-4d84-ad9a-deda731c44f0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_d3eac69a-35e3-45b8-b6eb-7f8b2f5cb13b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_68f48d78-6caf-4fea-8d04-4609ebfa0388" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_d3eac69a-35e3-45b8-b6eb-7f8b2f5cb13b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_0c412200-96ae-4a22-b789-46899ccb1fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_68f48d78-6caf-4fea-8d04-4609ebfa0388" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_0c412200-96ae-4a22-b789-46899ccb1fc6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquitySharesConversionOfConvertibleSecurities_ca9535d4-cc22-4d7c-b474-f0bc2ae4c41a" xlink:href="amci-20230213.xsd#amci_TemporaryEquitySharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_68f48d78-6caf-4fea-8d04-4609ebfa0388" xlink:to="loc_amci_TemporaryEquitySharesConversionOfConvertibleSecurities_ca9535d4-cc22-4d7c-b474-f0bc2ae4c41a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityExerciseOfWarrants_0e316981-6a7b-4361-b6f9-3def1084b541" xlink:href="amci-20230213.xsd#amci_TemporaryEquityExerciseOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_68f48d78-6caf-4fea-8d04-4609ebfa0388" xlink:to="loc_amci_TemporaryEquityExerciseOfWarrants_0e316981-6a7b-4361-b6f9-3def1084b541" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_21d5f830-44b8-4d52-b085-36c6a9f73f12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TemporaryEquityLineItems_68f48d78-6caf-4fea-8d04-4609ebfa0388" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_21d5f830-44b8-4d52-b085-36c6a9f73f12" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_25335d25-35cf-4b3d-8f82-5eaabbe391ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_21d5f830-44b8-4d52-b085-36c6a9f73f12" xlink:to="loc_us-gaap_StatementClassOfStockAxis_25335d25-35cf-4b3d-8f82-5eaabbe391ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_25335d25-35cf-4b3d-8f82-5eaabbe391ff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_25335d25-35cf-4b3d-8f82-5eaabbe391ff" xlink:to="loc_us-gaap_ClassOfStockDomain_25335d25-35cf-4b3d-8f82-5eaabbe391ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d415c96a-a4b6-4493-8a0f-176f2b307c6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_25335d25-35cf-4b3d-8f82-5eaabbe391ff" xlink:to="loc_us-gaap_ClassOfStockDomain_d415c96a-a4b6-4493-8a0f-176f2b307c6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_f3fe6368-2cf1-4d41-8c5a-bb4e709d1def" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d415c96a-a4b6-4493-8a0f-176f2b307c6f" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_f3fe6368-2cf1-4d41-8c5a-bb4e709d1def" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_ef31616e-3089-4952-8344-d9c87e1b6686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d415c96a-a4b6-4493-8a0f-176f2b307c6f" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_ef31616e-3089-4952-8344-d9c87e1b6686" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_0d855b0f-93a7-4dc9-bb95-d27abc21560c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d415c96a-a4b6-4493-8a0f-176f2b307c6f" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_0d855b0f-93a7-4dc9-bb95-d27abc21560c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_1a98258b-7d7f-465b-8846-8a7bf38fc523" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d415c96a-a4b6-4493-8a0f-176f2b307c6f" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_1a98258b-7d7f-465b-8846-8a7bf38fc523" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_d0217291-76bb-4812-84cf-b10013d51717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d415c96a-a4b6-4493-8a0f-176f2b307c6f" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_d0217291-76bb-4812-84cf-b10013d51717" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember_9e5efadb-1655-4f1a-9d2d-9cd854c9c336" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d415c96a-a4b6-4493-8a0f-176f2b307c6f" xlink:to="loc_us-gaap_SeriesFPreferredStockMember_9e5efadb-1655-4f1a-9d2d-9cd854c9c336" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_74fc200a-f5fa-4673-8247-39f7d604e218" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_21d5f830-44b8-4d52-b085-36c6a9f73f12" xlink:to="loc_srt_RangeAxis_74fc200a-f5fa-4673-8247-39f7d604e218" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_74fc200a-f5fa-4673-8247-39f7d604e218_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_74fc200a-f5fa-4673-8247-39f7d604e218" xlink:to="loc_srt_RangeMember_74fc200a-f5fa-4673-8247-39f7d604e218_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ea56d26b-350c-4c12-a668-f65ce8e6a5d5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_74fc200a-f5fa-4673-8247-39f7d604e218" xlink:to="loc_srt_RangeMember_ea56d26b-350c-4c12-a668-f65ce8e6a5d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_bc910218-afde-4622-9473-87e7f6969851" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ea56d26b-350c-4c12-a668-f65ce8e6a5d5" xlink:to="loc_srt_MinimumMember_bc910218-afde-4622-9473-87e7f6969851" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1041c5f1-22eb-4659-9d7b-d40a66fae2b1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ea56d26b-350c-4c12-a668-f65ce8e6a5d5" xlink:to="loc_srt_MaximumMember_1041c5f1-22eb-4659-9d7b-d40a66fae2b1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/LeasesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#LeasesDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/LeasesDetails" xlink:type="extended" id="i055b3cff958d4650b455b9287884da59_LeasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_71818f4f-ad60-460f-9db5-a34f62b7c704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_cbf4ae50-1100-496c-9204-1281fabceef8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_71818f4f-ad60-460f-9db5-a34f62b7c704" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_cbf4ae50-1100-496c-9204-1281fabceef8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c207d64e-8872-47c7-8530-68c75cedd56d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_71818f4f-ad60-460f-9db5-a34f62b7c704" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c207d64e-8872-47c7-8530-68c75cedd56d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_53180eb5-6291-4244-8981-9459786ee04a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c207d64e-8872-47c7-8530-68c75cedd56d" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_53180eb5-6291-4244-8981-9459786ee04a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_53180eb5-6291-4244-8981-9459786ee04a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_53180eb5-6291-4244-8981-9459786ee04a" xlink:to="loc_us-gaap_RelatedPartyDomain_53180eb5-6291-4244-8981-9459786ee04a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_3379464e-44af-4543-8306-7e8abe05677d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_53180eb5-6291-4244-8981-9459786ee04a" xlink:to="loc_us-gaap_RelatedPartyDomain_3379464e-44af-4543-8306-7e8abe05677d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_ac52ef73-8e4d-47d2-8559-4b2ba5145862" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3379464e-44af-4543-8306-7e8abe05677d" xlink:to="loc_srt_AffiliatedEntityMember_ac52ef73-8e4d-47d2-8559-4b2ba5145862" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SubsequentEventsDetails_2" xlink:type="simple" xlink:href="amci-20230213.xsd#SubsequentEventsDetails_2"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/SubsequentEventsDetails_2" xlink:type="extended" id="i29622f95d9f743989179f0009b05269a_SubsequentEventsDetails_2">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_14dbd671-b818-48dc-b679-ddbe52fd3a50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_FrameworkAgreementRequiredEquityFunding_be474ba4-7389-42c2-a814-0be4e90fb137" xlink:href="amci-20230213.xsd#amci_FrameworkAgreementRequiredEquityFunding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_14dbd671-b818-48dc-b679-ddbe52fd3a50" xlink:to="loc_amci_FrameworkAgreementRequiredEquityFunding_be474ba4-7389-42c2-a814-0be4e90fb137" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SimpleAgreementForFutureEquityInitialPurchaseAmount_447385e2-3c84-47b4-adf0-43eb9d69934b" xlink:href="amci-20230213.xsd#amci_SimpleAgreementForFutureEquityInitialPurchaseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_14dbd671-b818-48dc-b679-ddbe52fd3a50" xlink:to="loc_amci_SimpleAgreementForFutureEquityInitialPurchaseAmount_447385e2-3c84-47b4-adf0-43eb9d69934b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjects_6b2f2a9f-434d-4820-81a5-06226e9f3d1d" xlink:href="amci-20230213.xsd#amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjects"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_14dbd671-b818-48dc-b679-ddbe52fd3a50" xlink:to="loc_amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjects_6b2f2a9f-434d-4820-81a5-06226e9f3d1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjectsRemainingAmountReduction_5f42c802-ce44-45f6-8c13-76c3e95c61bc" xlink:href="amci-20230213.xsd#amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjectsRemainingAmountReduction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_14dbd671-b818-48dc-b679-ddbe52fd3a50" xlink:to="loc_amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjectsRemainingAmountReduction_5f42c802-ce44-45f6-8c13-76c3e95c61bc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_db53916a-db14-4cc1-a4c9-6c33eb13403c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_14dbd671-b818-48dc-b679-ddbe52fd3a50" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_db53916a-db14-4cc1-a4c9-6c33eb13403c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LineOfCreditFacilityInterestRate_82430e0c-c923-4fff-bcdc-a8a11d99fee5" xlink:href="amci-20230213.xsd#amci_LineOfCreditFacilityInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_14dbd671-b818-48dc-b679-ddbe52fd3a50" xlink:to="loc_amci_LineOfCreditFacilityInterestRate_82430e0c-c923-4fff-bcdc-a8a11d99fee5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NoteReceivableCommitmentToPurchase_c2fdd277-65ac-48bb-84ee-3845dcb749f5" xlink:href="amci-20230213.xsd#amci_NoteReceivableCommitmentToPurchase"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_14dbd671-b818-48dc-b679-ddbe52fd3a50" xlink:to="loc_amci_NoteReceivableCommitmentToPurchase_c2fdd277-65ac-48bb-84ee-3845dcb749f5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_223d3d56-9086-4e11-ada3-f6692e7102cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_14dbd671-b818-48dc-b679-ddbe52fd3a50" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_223d3d56-9086-4e11-ada3-f6692e7102cd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightAmountOfNotesPurchased_9be1b3a8-709f-4892-bf56-a959bbcc8cd5" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightAmountOfNotesPurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_14dbd671-b818-48dc-b679-ddbe52fd3a50" xlink:to="loc_amci_ClassOfWarrantOrRightAmountOfNotesPurchased_9be1b3a8-709f-4892-bf56-a959bbcc8cd5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ReverseCapitalizationClosingCashCondition_ec565aba-cc90-4cd1-9ff5-1b9781f6d26a" xlink:href="amci-20230213.xsd#amci_ReverseCapitalizationClosingCashCondition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_14dbd671-b818-48dc-b679-ddbe52fd3a50" xlink:to="loc_amci_ReverseCapitalizationClosingCashCondition_ec565aba-cc90-4cd1-9ff5-1b9781f6d26a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_69da888f-4cc0-4b35-b1a3-77228fe19806" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_14dbd671-b818-48dc-b679-ddbe52fd3a50" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_69da888f-4cc0-4b35-b1a3-77228fe19806" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_7196ff1d-3991-4f29-aabf-1a291210bd40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_14dbd671-b818-48dc-b679-ddbe52fd3a50" xlink:to="loc_us-gaap_SubsequentEventTable_7196ff1d-3991-4f29-aabf-1a291210bd40" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_83a1d8a2-7564-41dc-8206-78a30839eb93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_7196ff1d-3991-4f29-aabf-1a291210bd40" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_83a1d8a2-7564-41dc-8206-78a30839eb93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_83a1d8a2-7564-41dc-8206-78a30839eb93_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_83a1d8a2-7564-41dc-8206-78a30839eb93" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_83a1d8a2-7564-41dc-8206-78a30839eb93_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3da869a7-d601-42cb-ad30-90a491b8d0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_83a1d8a2-7564-41dc-8206-78a30839eb93" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3da869a7-d601-42cb-ad30-90a491b8d0b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_dd64c125-d969-4bf8-9d35-50557fb9bf78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3da869a7-d601-42cb-ad30-90a491b8d0b1" xlink:to="loc_us-gaap_SubsequentEventMember_dd64c125-d969-4bf8-9d35-50557fb9bf78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_2d1f9d5e-660e-4b21-8d78-15874d57b229" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_7196ff1d-3991-4f29-aabf-1a291210bd40" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_2d1f9d5e-660e-4b21-8d78-15874d57b229" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_2d1f9d5e-660e-4b21-8d78-15874d57b229_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_2d1f9d5e-660e-4b21-8d78-15874d57b229" xlink:to="loc_us-gaap_ReceivableTypeDomain_2d1f9d5e-660e-4b21-8d78-15874d57b229_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_0c587682-970d-4356-98fe-025bc6997ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_2d1f9d5e-660e-4b21-8d78-15874d57b229" xlink:to="loc_us-gaap_ReceivableTypeDomain_0c587682-970d-4356-98fe-025bc6997ea5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SeniorSecuredNotesReceivableMember_406c1050-6cd6-45da-9181-5b86a70c4204" xlink:href="amci-20230213.xsd#amci_SeniorSecuredNotesReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_0c587682-970d-4356-98fe-025bc6997ea5" xlink:to="loc_amci_SeniorSecuredNotesReceivableMember_406c1050-6cd6-45da-9181-5b86a70c4204" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SubordinatedSecuredNotesReceivableMember_0c617a32-58a9-4247-9d49-9173f994667b" xlink:href="amci-20230213.xsd#amci_SubordinatedSecuredNotesReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_0c587682-970d-4356-98fe-025bc6997ea5" xlink:to="loc_amci_SubordinatedSecuredNotesReceivableMember_0c617a32-58a9-4247-9d49-9173f994667b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OneTrancheOfNotesMember_e05d6449-2491-4092-b131-47d3d1581233" xlink:href="amci-20230213.xsd#amci_OneTrancheOfNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_0c587682-970d-4356-98fe-025bc6997ea5" xlink:to="loc_amci_OneTrancheOfNotesMember_e05d6449-2491-4092-b131-47d3d1581233" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_ec1c7f9e-eca4-4e08-9cd5-b0b069879fcb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_7196ff1d-3991-4f29-aabf-1a291210bd40" xlink:to="loc_dei_LegalEntityAxis_ec1c7f9e-eca4-4e08-9cd5-b0b069879fcb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ec1c7f9e-eca4-4e08-9cd5-b0b069879fcb_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_ec1c7f9e-eca4-4e08-9cd5-b0b069879fcb" xlink:to="loc_dei_EntityDomain_ec1c7f9e-eca4-4e08-9cd5-b0b069879fcb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_9ce1024c-07f7-4838-aae4-68a94675c4ce" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_ec1c7f9e-eca4-4e08-9cd5-b0b069879fcb" xlink:to="loc_dei_EntityDomain_9ce1024c-07f7-4838-aae4-68a94675c4ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LanzaJetFreedomPinesFuelsLLCMember_3e868701-58c0-456a-837d-25d3fc57edad" xlink:href="amci-20230213.xsd#amci_LanzaJetFreedomPinesFuelsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_9ce1024c-07f7-4838-aae4-68a94675c4ce" xlink:to="loc_amci_LanzaJetFreedomPinesFuelsLLCMember_3e868701-58c0-456a-837d-25d3fc57edad" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#SummaryofSignificantAccountingPoliciesRestatementDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails" xlink:type="extended" id="i41824681c65c4db3afbfc443d496fa9c_SummaryofSignificantAccountingPoliciesRestatementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_e95a9f3b-50da-4e2e-b8f0-1b722c586dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:to="loc_us-gaap_EquityMethodInvestments_e95a9f3b-50da-4e2e-b8f0-1b722c586dc3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2a73b764-4bd2-4dc4-8f4b-052e8d21f2ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2a73b764-4bd2-4dc4-8f4b-052e8d21f2ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_16e5f4d2-d3c4-4d21-b9a2-578c76cc7a92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_16e5f4d2-d3c4-4d21-b9a2-578c76cc7a92" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_5a56d59c-f50d-49a9-8552-a6cec3a35933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:to="loc_us-gaap_RevenueFromRelatedParties_5a56d59c-f50d-49a9-8552-a6cec3a35933" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_73b659c6-4cf7-4000-a108-49169d7b74e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_73b659c6-4cf7-4000-a108-49169d7b74e0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_eac22738-9688-4276-8527-46d92dfe81ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_eac22738-9688-4276-8527-46d92dfe81ef" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9e0da47b-a39d-4658-a4e0-d025742bb953" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9e0da47b-a39d-4658-a4e0-d025742bb953" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_9fee692c-63eb-4878-9213-d4c23fdcdd75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:to="loc_us-gaap_CostOfRevenue_9fee692c-63eb-4878-9213-d4c23fdcdd75" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_a1032f36-0463-49ca-8cda-be76dbb9de62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_a1032f36-0463-49ca-8cda-be76dbb9de62" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b86f0425-5abc-4d4f-8a05-2b4990d3eb6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:to="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b86f0425-5abc-4d4f-8a05-2b4990d3eb6e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_cceae2fc-9d94-4658-8b49-64a662fd0d89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8e2b8442-966a-4599-a4f9-ca141f39d6de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b86f0425-5abc-4d4f-8a05-2b4990d3eb6e" xlink:to="loc_us-gaap_AssetsCurrent_8e2b8442-966a-4599-a4f9-ca141f39d6de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_48f5de03-877a-4819-960e-89fb14afe107" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e8a6551e-bdc1-4d04-b9aa-5e9c1f4e42f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b86f0425-5abc-4d4f-8a05-2b4990d3eb6e" xlink:to="loc_us-gaap_Assets_e8a6551e-bdc1-4d04-b9aa-5e9c1f4e42f9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_ce8bcf01-1d91-4586-9fc3-38ac8d93ce45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_0b4869b7-94bd-4b7d-ba23-651146ceb02e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b86f0425-5abc-4d4f-8a05-2b4990d3eb6e" xlink:to="loc_us-gaap_LiabilitiesCurrent_0b4869b7-94bd-4b7d-ba23-651146ceb02e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_53ea54e5-8635-4a52-8936-fdbc63eb8605" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b86f0425-5abc-4d4f-8a05-2b4990d3eb6e" xlink:to="loc_us-gaap_Liabilities_53ea54e5-8635-4a52-8936-fdbc63eb8605" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c75a4841-26be-4cb0-a495-984bbd18fb4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_debc201e-970e-43bc-b3c9-789de71d7d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b86f0425-5abc-4d4f-8a05-2b4990d3eb6e" xlink:to="loc_us-gaap_StockholdersEquity_debc201e-970e-43bc-b3c9-789de71d7d8a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_08ee9d47-4919-466e-8f18-c98eafb6759c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b86f0425-5abc-4d4f-8a05-2b4990d3eb6e" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_08ee9d47-4919-466e-8f18-c98eafb6759c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_c0d41b5d-639d-4fb1-82f3-359971bc7c20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:to="loc_us-gaap_IncomeStatementAbstract_c0d41b5d-639d-4fb1-82f3-359971bc7c20" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fc8541c8-f994-4ec9-9cfc-3c0676f6bb6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_967be624-4747-4f2a-a0bb-cc25a049bc28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_558c2eb8-1438-458c-b2c0-3b7d7d80dd36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_c0d41b5d-639d-4fb1-82f3-359971bc7c20" xlink:to="loc_us-gaap_Revenues_558c2eb8-1438-458c-b2c0-3b7d7d80dd36" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CostOfRevenueFromContractsWithCustomersExcludingDepreciation_802add1b-b6ed-49a5-8e8d-5c4ae073825b" xlink:href="amci-20230213.xsd#amci_CostOfRevenueFromContractsWithCustomersExcludingDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_c0d41b5d-639d-4fb1-82f3-359971bc7c20" xlink:to="loc_amci_CostOfRevenueFromContractsWithCustomersExcludingDepreciation_802add1b-b6ed-49a5-8e8d-5c4ae073825b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_ce76d455-6ac9-4234-9e64-c5de54134f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_c0d41b5d-639d-4fb1-82f3-359971bc7c20" xlink:to="loc_us-gaap_OperatingExpenses_ce76d455-6ac9-4234-9e64-c5de54134f6b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_55870a47-bf09-4832-944f-a6d3d648d665" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_c0d41b5d-639d-4fb1-82f3-359971bc7c20" xlink:to="loc_us-gaap_OperatingIncomeLoss_55870a47-bf09-4832-944f-a6d3d648d665" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_73300547-b0d7-4bb8-b4c7-f2772a4871d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_c0d41b5d-639d-4fb1-82f3-359971bc7c20" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_73300547-b0d7-4bb8-b4c7-f2772a4871d4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment_8bf4d8d6-3610-436d-981e-aeed04557509" xlink:href="amci-20230213.xsd#amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_c0d41b5d-639d-4fb1-82f3-359971bc7c20" xlink:to="loc_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment_8bf4d8d6-3610-436d-981e-aeed04557509" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_83582993-241b-4680-b931-314eb7dbdfba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_c0d41b5d-639d-4fb1-82f3-359971bc7c20" xlink:to="loc_us-gaap_NetIncomeLoss_83582993-241b-4680-b931-314eb7dbdfba" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_73cb1646-c9bf-4adc-873d-04a952aa55ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_c0d41b5d-639d-4fb1-82f3-359971bc7c20" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_73cb1646-c9bf-4adc-873d-04a952aa55ef" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_bbb853c8-79ef-4630-bb3a-4bf7cf2a46e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_c0d41b5d-639d-4fb1-82f3-359971bc7c20" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_bbb853c8-79ef-4630-bb3a-4bf7cf2a46e6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_3b1648cf-2abc-4058-9b04-ee1fb6583379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_c0d41b5d-639d-4fb1-82f3-359971bc7c20" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_3b1648cf-2abc-4058-9b04-ee1fb6583379" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_9d030b4b-f579-4ab2-853e-4b2bf63c7e70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_c0d41b5d-639d-4fb1-82f3-359971bc7c20" xlink:to="loc_us-gaap_EarningsPerShareBasic_9d030b4b-f579-4ab2-853e-4b2bf63c7e70" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_b390b658-6905-4c21-86ec-af6c4ea627a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_c0d41b5d-639d-4fb1-82f3-359971bc7c20" xlink:to="loc_us-gaap_EarningsPerShareDiluted_b390b658-6905-4c21-86ec-af6c4ea627a3" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_e4b1f51e-f902-47ec-b9e3-346ddbf8e706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:to="loc_us-gaap_StatementOfStockholdersEquityAbstract_e4b1f51e-f902-47ec-b9e3-346ddbf8e706" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_202dd34b-d5b1-4d7a-98c3-2ed9286938b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_83368446-e73f-497c-9898-c4d22bc38da7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_51660052-5490-4484-ace5-4f22e8c82eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_ff0498ca-21a3-46c2-a876-cdc5541903f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:to="loc_us-gaap_StatementOfCashFlowsAbstract_ff0498ca-21a3-46c2-a876-cdc5541903f6" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6b19d8ad-ec90-448e-a0b4-3fabadeb9803" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NoncashRecognitionOfLicensingRevenue_7d8de20c-db1d-45f3-ac9e-414ee9f792bb" xlink:href="amci-20230213.xsd#amci_NoncashRecognitionOfLicensingRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ff0498ca-21a3-46c2-a876-cdc5541903f6" xlink:to="loc_amci_NoncashRecognitionOfLicensingRevenue_7d8de20c-db1d-45f3-ac9e-414ee9f792bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment_31561c4b-9fd9-423b-9be5-f2244cf4e369" xlink:href="amci-20230213.xsd#amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_01d97984-c8a2-4513-bdfd-e0f902c77f22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ff0498ca-21a3-46c2-a876-cdc5541903f6" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_01d97984-c8a2-4513-bdfd-e0f902c77f22" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9713c2f9-fb2d-40f7-8ee6-323ae993c170" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ff0498ca-21a3-46c2-a876-cdc5541903f6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9713c2f9-fb2d-40f7-8ee6-323ae993c170" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a1b1cb04-11d8-43a3-bcff-0467f30ee8e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ff0498ca-21a3-46c2-a876-cdc5541903f6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a1b1cb04-11d8-43a3-bcff-0467f30ee8e4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EquityMethodInvestmentGainOnDilutionOfInvestment_2b6566f8-29a3-4f4e-8c9a-dbe1b7dc2611" xlink:href="amci-20230213.xsd#amci_EquityMethodInvestmentGainOnDilutionOfInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:to="loc_amci_EquityMethodInvestmentGainOnDilutionOfInvestment_2b6566f8-29a3-4f4e-8c9a-dbe1b7dc2611" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_a5ce2833-5ed2-4ef7-afe0-4af6ea20ed6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:to="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_a5ce2833-5ed2-4ef7-afe0-4af6ea20ed6e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_659a3593-fd87-420e-8f12-71d35817470c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_a5ce2833-5ed2-4ef7-afe0-4af6ea20ed6e" xlink:to="loc_srt_RestatementAxis_659a3593-fd87-420e-8f12-71d35817470c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_659a3593-fd87-420e-8f12-71d35817470c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_659a3593-fd87-420e-8f12-71d35817470c" xlink:to="loc_srt_RestatementDomain_659a3593-fd87-420e-8f12-71d35817470c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_f5645697-470f-4c07-9a2c-d97755bfaebf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_659a3593-fd87-420e-8f12-71d35817470c" xlink:to="loc_srt_RestatementDomain_f5645697-470f-4c07-9a2c-d97755bfaebf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_9081b480-1e61-49df-93aa-75e4a86f9939" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_f5645697-470f-4c07-9a2c-d97755bfaebf" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_9081b480-1e61-49df-93aa-75e4a86f9939" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_88c985f1-65c6-4dd0-9c97-798ae70ef892" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_f5645697-470f-4c07-9a2c-d97755bfaebf" xlink:to="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_88c985f1-65c6-4dd0-9c97-798ae70ef892" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_cfb7a99c-265a-419d-b2ee-835018beb0dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_a5ce2833-5ed2-4ef7-afe0-4af6ea20ed6e" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_cfb7a99c-265a-419d-b2ee-835018beb0dd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_cfb7a99c-265a-419d-b2ee-835018beb0dd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_cfb7a99c-265a-419d-b2ee-835018beb0dd" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_cfb7a99c-265a-419d-b2ee-835018beb0dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_96c227f1-f1ea-438a-aa44-7b23cf77a8f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_cfb7a99c-265a-419d-b2ee-835018beb0dd" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_96c227f1-f1ea-438a-aa44-7b23cf77a8f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ErrorCorrectionEquityMethodInvestmentsIntangiblesAndFixedAssetsMember_6101c4d9-f0b2-4582-a633-5b10e3b2ccff" xlink:href="amci-20230213.xsd#amci_ErrorCorrectionEquityMethodInvestmentsIntangiblesAndFixedAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_96c227f1-f1ea-438a-aa44-7b23cf77a8f1" xlink:to="loc_amci_ErrorCorrectionEquityMethodInvestmentsIntangiblesAndFixedAssetsMember_6101c4d9-f0b2-4582-a633-5b10e3b2ccff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ErrorCorrectionEquityMethodInvestmentContributedIntellectualAssetMember_f165cd1b-0609-4f4b-83d5-e5e0848092e8" xlink:href="amci-20230213.xsd#amci_ErrorCorrectionEquityMethodInvestmentContributedIntellectualAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_96c227f1-f1ea-438a-aa44-7b23cf77a8f1" xlink:to="loc_amci_ErrorCorrectionEquityMethodInvestmentContributedIntellectualAssetMember_f165cd1b-0609-4f4b-83d5-e5e0848092e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ErrorCorrectionEquityMethodInvestmentGainOnDilutionMember_ff4853ef-e36a-403c-be0d-0e7666a88042" xlink:href="amci-20230213.xsd#amci_ErrorCorrectionEquityMethodInvestmentGainOnDilutionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_96c227f1-f1ea-438a-aa44-7b23cf77a8f1" xlink:to="loc_amci_ErrorCorrectionEquityMethodInvestmentGainOnDilutionMember_ff4853ef-e36a-403c-be0d-0e7666a88042" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_2d6d2482-84ff-4c80-b95d-fafaf2c6fbda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_a5ce2833-5ed2-4ef7-afe0-4af6ea20ed6e" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_2d6d2482-84ff-4c80-b95d-fafaf2c6fbda" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_2d6d2482-84ff-4c80-b95d-fafaf2c6fbda_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_2d6d2482-84ff-4c80-b95d-fafaf2c6fbda" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_2d6d2482-84ff-4c80-b95d-fafaf2c6fbda_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_66ef4793-4558-4598-9707-841028437dda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_2d6d2482-84ff-4c80-b95d-fafaf2c6fbda" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_66ef4793-4558-4598-9707-841028437dda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartySupplyAgreementMember_0ec85ba7-da3f-4ff5-8852-5db1fa1a4a2f" xlink:href="amci-20230213.xsd#amci_RelatedPartySupplyAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_66ef4793-4558-4598-9707-841028437dda" xlink:to="loc_amci_RelatedPartySupplyAgreementMember_0ec85ba7-da3f-4ff5-8852-5db1fa1a4a2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d0466734-67c0-4c3b-b4a2-72bb07798279" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_a5ce2833-5ed2-4ef7-afe0-4af6ea20ed6e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d0466734-67c0-4c3b-b4a2-72bb07798279" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d0466734-67c0-4c3b-b4a2-72bb07798279_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d0466734-67c0-4c3b-b4a2-72bb07798279" xlink:to="loc_us-gaap_EquityComponentDomain_d0466734-67c0-4c3b-b4a2-72bb07798279_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_751d69e1-5472-4123-bb74-390404120633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d0466734-67c0-4c3b-b4a2-72bb07798279" xlink:to="loc_us-gaap_EquityComponentDomain_751d69e1-5472-4123-bb74-390404120633" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_a9b360b5-1e04-4d5a-8165-d4a6a0169497" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_751d69e1-5472-4123-bb74-390404120633" xlink:to="loc_us-gaap_RetainedEarningsMember_a9b360b5-1e04-4d5a-8165-d4a6a0169497" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_6710fbd7-3c7f-44a3-ae1c-f37681dfdcc9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_a5ce2833-5ed2-4ef7-afe0-4af6ea20ed6e" xlink:to="loc_srt_ConsolidationItemsAxis_6710fbd7-3c7f-44a3-ae1c-f37681dfdcc9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_6710fbd7-3c7f-44a3-ae1c-f37681dfdcc9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_6710fbd7-3c7f-44a3-ae1c-f37681dfdcc9" xlink:to="loc_srt_ConsolidationItemsDomain_6710fbd7-3c7f-44a3-ae1c-f37681dfdcc9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a9e1b789-f22d-41be-8311-9701d4d9efd5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_6710fbd7-3c7f-44a3-ae1c-f37681dfdcc9" xlink:to="loc_srt_ConsolidationItemsDomain_a9e1b789-f22d-41be-8311-9701d4d9efd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_b827a09f-45e8-45f4-82c4-ee5902b40cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a9e1b789-f22d-41be-8311-9701d4d9efd5" xlink:to="loc_us-gaap_IntersegmentEliminationMember_b827a09f-45e8-45f4-82c4-ee5902b40cf2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ba23234c-afe9-4326-9331-115216504640" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_a5ce2833-5ed2-4ef7-afe0-4af6ea20ed6e" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ba23234c-afe9-4326-9331-115216504640" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ba23234c-afe9-4326-9331-115216504640_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ba23234c-afe9-4326-9331-115216504640" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ba23234c-afe9-4326-9331-115216504640_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_7aab5ada-0852-4ec7-bbaf-298d17734a37" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ba23234c-afe9-4326-9331-115216504640" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_7aab5ada-0852-4ec7-bbaf-298d17734a37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LanzaJetIncMember_890ec803-fd72-4262-aaaa-24c6c1826ee5" xlink:href="amci-20230213.xsd#amci_LanzaJetIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_7aab5ada-0852-4ec7-bbaf-298d17734a37" xlink:to="loc_amci_LanzaJetIncMember_890ec803-fd72-4262-aaaa-24c6c1826ee5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentnetDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentnetDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentnetDetails" xlink:type="extended" id="i67c5d79736d34aec93c11960212f58a6_SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentnetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_25ddaca1-8814-462b-a109-f81f56a5ecff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_99d7200f-cb8f-4172-81f3-846675e47f63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_25ddaca1-8814-462b-a109-f81f56a5ecff" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_99d7200f-cb8f-4172-81f3-846675e47f63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b2cde381-830e-4e9c-9a91-3da96cfe9829" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_25ddaca1-8814-462b-a109-f81f56a5ecff" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b2cde381-830e-4e9c-9a91-3da96cfe9829" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fc88f4e3-3a51-45ad-95f8-3ef41ca65aff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b2cde381-830e-4e9c-9a91-3da96cfe9829" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fc88f4e3-3a51-45ad-95f8-3ef41ca65aff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_fc88f4e3-3a51-45ad-95f8-3ef41ca65aff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fc88f4e3-3a51-45ad-95f8-3ef41ca65aff" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_fc88f4e3-3a51-45ad-95f8-3ef41ca65aff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d4f1537c-e97a-47c1-bf1b-dd74dc0a7f13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fc88f4e3-3a51-45ad-95f8-3ef41ca65aff" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d4f1537c-e97a-47c1-bf1b-dd74dc0a7f13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_1d23c3f8-1616-489e-859b-f4007378c634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d4f1537c-e97a-47c1-bf1b-dd74dc0a7f13" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_1d23c3f8-1616-489e-859b-f4007378c634" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_b2fc36b8-3676-44af-8168-2823192b8efd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d4f1537c-e97a-47c1-bf1b-dd74dc0a7f13" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_b2fc36b8-3676-44af-8168-2823192b8efd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_bf7686a8-8056-42bd-a4d4-12210968f9da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VehiclesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d4f1537c-e97a-47c1-bf1b-dd74dc0a7f13" xlink:to="loc_us-gaap_VehiclesMember_bf7686a8-8056-42bd-a4d4-12210968f9da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_12abe3d7-176a-46c6-a8da-c621f5c08f85" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b2cde381-830e-4e9c-9a91-3da96cfe9829" xlink:to="loc_srt_RangeAxis_12abe3d7-176a-46c6-a8da-c621f5c08f85" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_12abe3d7-176a-46c6-a8da-c621f5c08f85_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_12abe3d7-176a-46c6-a8da-c621f5c08f85" xlink:to="loc_srt_RangeMember_12abe3d7-176a-46c6-a8da-c621f5c08f85_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e069c5dd-ab1d-4121-a6bc-048b812d2bb5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_12abe3d7-176a-46c6-a8da-c621f5c08f85" xlink:to="loc_srt_RangeMember_e069c5dd-ab1d-4121-a6bc-048b812d2bb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e47cdedb-7b95-4497-b8ca-a69de9c640d2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e069c5dd-ab1d-4121-a6bc-048b812d2bb5" xlink:to="loc_srt_MinimumMember_e47cdedb-7b95-4497-b8ca-a69de9c640d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2ae4bfd2-2d54-478e-9671-3ea36ea8503c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e069c5dd-ab1d-4121-a6bc-048b812d2bb5" xlink:to="loc_srt_MaximumMember_2ae4bfd2-2d54-478e-9671-3ea36ea8503c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails_1"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails_1" xlink:type="extended" id="i8cfd5014e5534bdcbba94ee681671b66_SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_aae44aef-cff6-4371-ab25-f63f8c6c89c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_0674d98c-e43d-4e90-852f-fe6a52e032fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_aae44aef-cff6-4371-ab25-f63f8c6c89c9" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_0674d98c-e43d-4e90-852f-fe6a52e032fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_28b27546-e380-4427-af30-eb3495db5804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_aae44aef-cff6-4371-ab25-f63f8c6c89c9" xlink:to="loc_us-gaap_ConcentrationRiskTable_28b27546-e380-4427-af30-eb3495db5804" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_32918114-b31d-42fc-8139-1aac66048c66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_28b27546-e380-4427-af30-eb3495db5804" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_32918114-b31d-42fc-8139-1aac66048c66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_32918114-b31d-42fc-8139-1aac66048c66_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_32918114-b31d-42fc-8139-1aac66048c66" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_32918114-b31d-42fc-8139-1aac66048c66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2abcc1c8-8232-4f73-abab-0651baac3df5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_32918114-b31d-42fc-8139-1aac66048c66" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2abcc1c8-8232-4f73-abab-0651baac3df5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_1195b712-91e9-44f2-a48b-3836088859c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2abcc1c8-8232-4f73-abab-0651baac3df5" xlink:to="loc_us-gaap_SalesRevenueNetMember_1195b712-91e9-44f2-a48b-3836088859c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_53904858-3678-4eb9-aa4a-8d4e3ba0f65a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2abcc1c8-8232-4f73-abab-0651baac3df5" xlink:to="loc_us-gaap_AccountsReceivableMember_53904858-3678-4eb9-aa4a-8d4e3ba0f65a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_59e237e5-1e0c-400b-bf20-bc2991c358a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_28b27546-e380-4427-af30-eb3495db5804" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_59e237e5-1e0c-400b-bf20-bc2991c358a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_59e237e5-1e0c-400b-bf20-bc2991c358a0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_59e237e5-1e0c-400b-bf20-bc2991c358a0" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_59e237e5-1e0c-400b-bf20-bc2991c358a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_a6f08780-38ce-421b-b1af-f11379732796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_59e237e5-1e0c-400b-bf20-bc2991c358a0" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_a6f08780-38ce-421b-b1af-f11379732796" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_119f84f8-b3e6-4c5a-92e0-07fd56b3e440" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_a6f08780-38ce-421b-b1af-f11379732796" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_119f84f8-b3e6-4c5a-92e0-07fd56b3e440" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_6bde93d3-cc4c-4493-bd15-f42a9d8d13ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_a6f08780-38ce-421b-b1af-f11379732796" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_6bde93d3-cc4c-4493-bd15-f42a9d8d13ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_95441c91-f8e5-42e3-b0fc-e438c88de1be" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_28b27546-e380-4427-af30-eb3495db5804" xlink:to="loc_srt_StatementGeographicalAxis_95441c91-f8e5-42e3-b0fc-e438c88de1be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_95441c91-f8e5-42e3-b0fc-e438c88de1be_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_95441c91-f8e5-42e3-b0fc-e438c88de1be" xlink:to="loc_srt_SegmentGeographicalDomain_95441c91-f8e5-42e3-b0fc-e438c88de1be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6d22a47c-ab11-4f03-bee4-14f987402fc8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_95441c91-f8e5-42e3-b0fc-e438c88de1be" xlink:to="loc_srt_SegmentGeographicalDomain_6d22a47c-ab11-4f03-bee4-14f987402fc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_31c20e22-5a9a-4850-aec7-9658f8b3f715" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_6d22a47c-ab11-4f03-bee4-14f987402fc8" xlink:to="loc_us-gaap_NonUsMember_31c20e22-5a9a-4850-aec7-9658f8b3f715" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_e03f5f9b-c47d-4df4-b39e-f4790026a497" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_28b27546-e380-4427-af30-eb3495db5804" xlink:to="loc_srt_MajorCustomersAxis_e03f5f9b-c47d-4df4-b39e-f4790026a497" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_e03f5f9b-c47d-4df4-b39e-f4790026a497_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_e03f5f9b-c47d-4df4-b39e-f4790026a497" xlink:to="loc_srt_NameOfMajorCustomerDomain_e03f5f9b-c47d-4df4-b39e-f4790026a497_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_4da873b3-2c5b-4da1-93ca-dc252f6d8122" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_e03f5f9b-c47d-4df4-b39e-f4790026a497" xlink:to="loc_srt_NameOfMajorCustomerDomain_4da873b3-2c5b-4da1-93ca-dc252f6d8122" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CustomerAMember_0d0fa4f4-3ce9-4133-8e4d-b7dcabe23866" xlink:href="amci-20230213.xsd#amci_CustomerAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_4da873b3-2c5b-4da1-93ca-dc252f6d8122" xlink:to="loc_amci_CustomerAMember_0d0fa4f4-3ce9-4133-8e4d-b7dcabe23866" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CustomerBMember_f1e8fa5f-8f7c-4777-9812-df528215a9ae" xlink:href="amci-20230213.xsd#amci_CustomerBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_4da873b3-2c5b-4da1-93ca-dc252f6d8122" xlink:to="loc_amci_CustomerBMember_f1e8fa5f-8f7c-4777-9812-df528215a9ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CustomerCMember_4a235fa1-3443-4d76-878a-3825050d0dc1" xlink:href="amci-20230213.xsd#amci_CustomerCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_4da873b3-2c5b-4da1-93ca-dc252f6d8122" xlink:to="loc_amci_CustomerCMember_4a235fa1-3443-4d76-878a-3825050d0dc1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CustomerDMember_2cfc12bd-6502-46f0-8bd5-ffa365f286b9" xlink:href="amci-20230213.xsd#amci_CustomerDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_4da873b3-2c5b-4da1-93ca-dc252f6d8122" xlink:to="loc_amci_CustomerDMember_2cfc12bd-6502-46f0-8bd5-ffa365f286b9" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/NetLossPerShareAntidilutiveSharesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#NetLossPerShareAntidilutiveSharesDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/NetLossPerShareAntidilutiveSharesDetails" xlink:type="extended" id="iacb3e345c0514eed8be44c60f279dd87_NetLossPerShareAntidilutiveSharesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_18cb625b-ecfc-4a08-a0a8-6c8e058188c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b8292252-e5f3-4750-807b-780f25e8d874" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_18cb625b-ecfc-4a08-a0a8-6c8e058188c0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b8292252-e5f3-4750-807b-780f25e8d874" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleConversionRatio_49b999d1-865b-457b-ab5d-ae7589220814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockConvertibleConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_18cb625b-ecfc-4a08-a0a8-6c8e058188c0" xlink:to="loc_us-gaap_PreferredStockConvertibleConversionRatio_49b999d1-865b-457b-ab5d-ae7589220814" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LiquidityPriceOfSAFEAndSAFEWarrants_5f139b9b-02a1-4386-b88e-383deb584378" xlink:href="amci-20230213.xsd#amci_LiquidityPriceOfSAFEAndSAFEWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_18cb625b-ecfc-4a08-a0a8-6c8e058188c0" xlink:to="loc_amci_LiquidityPriceOfSAFEAndSAFEWarrants_5f139b9b-02a1-4386-b88e-383deb584378" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne_4f693514-1c6d-4a24-8fbc-226eb90b6cc7" xlink:href="amci-20230213.xsd#amci_LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_18cb625b-ecfc-4a08-a0a8-6c8e058188c0" xlink:to="loc_amci_LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne_4f693514-1c6d-4a24-8fbc-226eb90b6cc7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5bd86ab9-6f02-4dfc-816f-b92d4e05605a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_18cb625b-ecfc-4a08-a0a8-6c8e058188c0" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5bd86ab9-6f02-4dfc-816f-b92d4e05605a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_8b405278-4868-4779-a8a2-ae29cc7468e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5bd86ab9-6f02-4dfc-816f-b92d4e05605a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_8b405278-4868-4779-a8a2-ae29cc7468e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8b405278-4868-4779-a8a2-ae29cc7468e1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_8b405278-4868-4779-a8a2-ae29cc7468e1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8b405278-4868-4779-a8a2-ae29cc7468e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_24978e2d-bb21-409a-bd67-d7f72b9ff7de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_8b405278-4868-4779-a8a2-ae29cc7468e1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_24978e2d-bb21-409a-bd67-d7f72b9ff7de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_a10e2338-5350-48a7-a905-77aa776bff5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_24978e2d-bb21-409a-bd67-d7f72b9ff7de" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_a10e2338-5350-48a7-a905-77aa776bff5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_fe4341b2-96b1-4eba-8862-5e0e41f7eb57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_24978e2d-bb21-409a-bd67-d7f72b9ff7de" xlink:to="loc_us-gaap_EmployeeStockOptionMember_fe4341b2-96b1-4eba-8862-5e0e41f7eb57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_44071837-ebad-41d8-a51b-c3f7e1f6aaf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_24978e2d-bb21-409a-bd67-d7f72b9ff7de" xlink:to="loc_us-gaap_RestrictedStockMember_44071837-ebad-41d8-a51b-c3f7e1f6aaf4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_0630aadc-f7d6-41c3-95a5-020aa6fe1334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_24978e2d-bb21-409a-bd67-d7f72b9ff7de" xlink:to="loc_us-gaap_WarrantMember_0630aadc-f7d6-41c3-95a5-020aa6fe1334" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#RevenuesDisaggregatedRevenueDetails_1"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails_1" xlink:type="extended" id="i6cc27dee653e42cdabab4a3232b2f566_RevenuesDisaggregatedRevenueDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_677fd964-80e7-4b25-b830-70471edbac40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_216923c2-fd7b-49aa-9858-fafd2dc598ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_677fd964-80e7-4b25-b830-70471edbac40" xlink:to="loc_us-gaap_Revenues_216923c2-fd7b-49aa-9858-fafd2dc598ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_b540b356-5700-4dbb-b06e-4bf69e77dd9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_677fd964-80e7-4b25-b830-70471edbac40" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_b540b356-5700-4dbb-b06e-4bf69e77dd9f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f72d1110-46e4-403e-bac4-1b8bb0c54280" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b540b356-5700-4dbb-b06e-4bf69e77dd9f" xlink:to="loc_srt_ProductOrServiceAxis_f72d1110-46e4-403e-bac4-1b8bb0c54280" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f72d1110-46e4-403e-bac4-1b8bb0c54280_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_f72d1110-46e4-403e-bac4-1b8bb0c54280" xlink:to="loc_srt_ProductsAndServicesDomain_f72d1110-46e4-403e-bac4-1b8bb0c54280_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_92b8bbfe-4750-4507-a6ca-d0bb8a3dd33d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_f72d1110-46e4-403e-bac4-1b8bb0c54280" xlink:to="loc_srt_ProductsAndServicesDomain_92b8bbfe-4750-4507-a6ca-d0bb8a3dd33d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ResearchAndDevelopmentMember_21d570d0-bbe9-4a3e-ac8e-36d50c10ed26" xlink:href="amci-20230213.xsd#amci_ResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_92b8bbfe-4750-4507-a6ca-d0bb8a3dd33d" xlink:to="loc_amci_ResearchAndDevelopmentMember_21d570d0-bbe9-4a3e-ac8e-36d50c10ed26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_JointDevelopmentAgreementsMember_8f0b8526-5ba6-4b7b-a2fc-d7b407ba9404" xlink:href="amci-20230213.xsd#amci_JointDevelopmentAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_ResearchAndDevelopmentMember_21d570d0-bbe9-4a3e-ac8e-36d50c10ed26" xlink:to="loc_amci_JointDevelopmentAgreementsMember_8f0b8526-5ba6-4b7b-a2fc-d7b407ba9404" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OtherContractResearchMember_a9f9d374-50cb-458c-94c2-4c830c9d9ec1" xlink:href="amci-20230213.xsd#amci_OtherContractResearchMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_ResearchAndDevelopmentMember_21d570d0-bbe9-4a3e-ac8e-36d50c10ed26" xlink:to="loc_amci_OtherContractResearchMember_a9f9d374-50cb-458c-94c2-4c830c9d9ec1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CarbonCaptureAndTransformationMember_15a8b63b-03ba-4acf-90fd-da687543c377" xlink:href="amci-20230213.xsd#amci_CarbonCaptureAndTransformationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_92b8bbfe-4750-4507-a6ca-d0bb8a3dd33d" xlink:to="loc_amci_CarbonCaptureAndTransformationMember_15a8b63b-03ba-4acf-90fd-da687543c377" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAndServiceMember_13a464f1-e5e6-489c-8828-b582b56061a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicenseAndServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_CarbonCaptureAndTransformationMember_15a8b63b-03ba-4acf-90fd-da687543c377" xlink:to="loc_us-gaap_LicenseAndServiceMember_13a464f1-e5e6-489c-8828-b582b56061a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CarbonSmartMember_3a8f940b-ad01-44aa-a833-402e52c34b3f" xlink:href="amci-20230213.xsd#amci_CarbonSmartMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_CarbonCaptureAndTransformationMember_15a8b63b-03ba-4acf-90fd-da687543c377" xlink:to="loc_amci_CarbonSmartMember_3a8f940b-ad01-44aa-a833-402e52c34b3f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EngineeringAndOtherServicesMember_465ade6c-393d-42ad-814c-179c4bf7ad74" xlink:href="amci-20230213.xsd#amci_EngineeringAndOtherServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_CarbonCaptureAndTransformationMember_15a8b63b-03ba-4acf-90fd-da687543c377" xlink:to="loc_amci_EngineeringAndOtherServicesMember_465ade6c-393d-42ad-814c-179c4bf7ad74" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#RevenuesDisaggregationbyCustomerLocationDetails_1"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails_1" xlink:type="extended" id="i3b86863835bc4293b606fc0d898242e4_RevenuesDisaggregationbyCustomerLocationDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_a5a5b89f-96d7-45e0-bee1-a9b447504278" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_99d1b550-2309-40b6-8ec1-68f631011c97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a5a5b89f-96d7-45e0-bee1-a9b447504278" xlink:to="loc_us-gaap_Revenues_99d1b550-2309-40b6-8ec1-68f631011c97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_f35e77e1-0481-44cb-aa78-86af2f60d79a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a5a5b89f-96d7-45e0-bee1-a9b447504278" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_f35e77e1-0481-44cb-aa78-86af2f60d79a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_1959904b-17a7-44e8-a8f3-081ec6ba8820" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f35e77e1-0481-44cb-aa78-86af2f60d79a" xlink:to="loc_srt_StatementGeographicalAxis_1959904b-17a7-44e8-a8f3-081ec6ba8820" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1959904b-17a7-44e8-a8f3-081ec6ba8820_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_1959904b-17a7-44e8-a8f3-081ec6ba8820" xlink:to="loc_srt_SegmentGeographicalDomain_1959904b-17a7-44e8-a8f3-081ec6ba8820_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7b647736-e17d-43c1-8f41-245f45616e4d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_1959904b-17a7-44e8-a8f3-081ec6ba8820" xlink:to="loc_srt_SegmentGeographicalDomain_7b647736-e17d-43c1-8f41-245f45616e4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NorthAmericaMember_7e97b8f6-333c-47e1-b8bd-47241edb0d16" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NorthAmericaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7b647736-e17d-43c1-8f41-245f45616e4d" xlink:to="loc_srt_NorthAmericaMember_7e97b8f6-333c-47e1-b8bd-47241edb0d16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_f25b0f15-7bd6-4843-bffd-806bc11e5aed" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7b647736-e17d-43c1-8f41-245f45616e4d" xlink:to="loc_srt_EuropeMember_f25b0f15-7bd6-4843-bffd-806bc11e5aed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaMember_232e414e-61c3-4ebd-b66d-87048f46d4e2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7b647736-e17d-43c1-8f41-245f45616e4d" xlink:to="loc_srt_AsiaMember_232e414e-61c3-4ebd-b66d-87048f46d4e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_AU_2948f984-254a-4f0e-8628-9eec39a88db0" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_AU"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7b647736-e17d-43c1-8f41-245f45616e4d" xlink:to="loc_country_AU_2948f984-254a-4f0e-8628-9eec39a88db0" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/InvestmentsEquityMethodInvestmentsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#InvestmentsEquityMethodInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/InvestmentsEquityMethodInvestmentsDetails" xlink:type="extended" id="i3a7118c1bf2e4c8ba202a85ddad001cf_InvestmentsEquityMethodInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_654c2f7f-e21d-4448-aeb0-6878104651e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_b39b7b93-5200-49ec-9b8e-ba914f9dc2ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_654c2f7f-e21d-4448-aeb0-6878104651e5" xlink:to="loc_us-gaap_EquityMethodInvestments_b39b7b93-5200-49ec-9b8e-ba914f9dc2ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f19f59cf-1793-4091-8b82-02f7fde0c0a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_654c2f7f-e21d-4448-aeb0-6878104651e5" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f19f59cf-1793-4091-8b82-02f7fde0c0a1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1bf2ffc8-12cc-468e-b13c-292898bec23a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f19f59cf-1793-4091-8b82-02f7fde0c0a1" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1bf2ffc8-12cc-468e-b13c-292898bec23a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_1bf2ffc8-12cc-468e-b13c-292898bec23a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1bf2ffc8-12cc-468e-b13c-292898bec23a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_1bf2ffc8-12cc-468e-b13c-292898bec23a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_59d7e56d-fd81-424f-a7a6-df6e4f02c7e1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1bf2ffc8-12cc-468e-b13c-292898bec23a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_59d7e56d-fd81-424f-a7a6-df6e4f02c7e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LanzaJetIncMember_72601285-505a-468f-b731-f385ba3ce96f" xlink:href="amci-20230213.xsd#amci_LanzaJetIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_59d7e56d-fd81-424f-a7a6-df6e4f02c7e1" xlink:to="loc_amci_LanzaJetIncMember_72601285-505a-468f-b731-f385ba3ce96f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember_8d22cf81-646d-47ca-bdf7-c90ef1f619f4" xlink:href="amci-20230213.xsd#amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_59d7e56d-fd81-424f-a7a6-df6e4f02c7e1" xlink:to="loc_amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember_8d22cf81-646d-47ca-bdf7-c90ef1f619f4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/InvestmentsNarrativeDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#InvestmentsNarrativeDetails_1"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/InvestmentsNarrativeDetails_1" xlink:type="extended" id="i9ecbbbef7cb940549fd6784e4b30eb2f_InvestmentsNarrativeDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3e7309c6-3d23-441f-a7f3-24c0c2c35698" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContributionOfProperty_652300b5-f4aa-4745-9f42-0bbc9e5e17ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContributionOfProperty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3e7309c6-3d23-441f-a7f3-24c0c2c35698" xlink:to="loc_us-gaap_ContributionOfProperty_652300b5-f4aa-4745-9f42-0bbc9e5e17ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_0ed7ea75-b774-445d-8f43-340f9c47a080" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3e7309c6-3d23-441f-a7f3-24c0c2c35698" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_0ed7ea75-b774-445d-8f43-340f9c47a080" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_efbd78d4-ed7b-4d99-876f-760fee0a027e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3e7309c6-3d23-441f-a7f3-24c0c2c35698" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_efbd78d4-ed7b-4d99-876f-760fee0a027e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_e39fb988-9f91-4d9d-a53d-0919592cec6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3e7309c6-3d23-441f-a7f3-24c0c2c35698" xlink:to="loc_us-gaap_ContractWithCustomerLiability_e39fb988-9f91-4d9d-a53d-0919592cec6a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RevenueFromContractWithCustomerAmortizationPeriod_e52c2466-8730-4ed7-ad45-dec727eb3aac" xlink:href="amci-20230213.xsd#amci_RevenueFromContractWithCustomerAmortizationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3e7309c6-3d23-441f-a7f3-24c0c2c35698" xlink:to="loc_amci_RevenueFromContractWithCustomerAmortizationPeriod_e52c2466-8730-4ed7-ad45-dec727eb3aac" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EquityMethodInvestmentContingentRightToReceiveAdditionalInterest_2518a859-cf32-4fd6-a473-283be42a633b" xlink:href="amci-20230213.xsd#amci_EquityMethodInvestmentContingentRightToReceiveAdditionalInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3e7309c6-3d23-441f-a7f3-24c0c2c35698" xlink:to="loc_amci_EquityMethodInvestmentContingentRightToReceiveAdditionalInterest_2518a859-cf32-4fd6-a473-283be42a633b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_ad1b38ac-c0a2-4896-99fd-1fa3ee85b801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3e7309c6-3d23-441f-a7f3-24c0c2c35698" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_ad1b38ac-c0a2-4896-99fd-1fa3ee85b801" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EquityMethodInvestmentGainOnDilutionOfInvestment_e031030f-d76f-4620-bdff-7e130df9afae" xlink:href="amci-20230213.xsd#amci_EquityMethodInvestmentGainOnDilutionOfInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3e7309c6-3d23-441f-a7f3-24c0c2c35698" xlink:to="loc_amci_EquityMethodInvestmentGainOnDilutionOfInvestment_e031030f-d76f-4620-bdff-7e130df9afae" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_e87e20ad-e386-4e2e-9eac-0a30cdc01c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3e7309c6-3d23-441f-a7f3-24c0c2c35698" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_e87e20ad-e386-4e2e-9eac-0a30cdc01c0d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_c2ae9624-72fa-4eab-820f-c129e35b246f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3e7309c6-3d23-441f-a7f3-24c0c2c35698" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_c2ae9624-72fa-4eab-820f-c129e35b246f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_c5b03700-374e-494a-81d1-80429fe00fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3e7309c6-3d23-441f-a7f3-24c0c2c35698" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_c5b03700-374e-494a-81d1-80429fe00fbd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8d463a2a-8d91-4622-96bd-8e391bc6092a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3e7309c6-3d23-441f-a7f3-24c0c2c35698" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8d463a2a-8d91-4622-96bd-8e391bc6092a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c5285669-a31f-4af9-892d-60f256d462dc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8d463a2a-8d91-4622-96bd-8e391bc6092a" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c5285669-a31f-4af9-892d-60f256d462dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_c5285669-a31f-4af9-892d-60f256d462dc_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c5285669-a31f-4af9-892d-60f256d462dc" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_c5285669-a31f-4af9-892d-60f256d462dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_af75611e-f3f8-41ad-883f-71ab668ba154" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c5285669-a31f-4af9-892d-60f256d462dc" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_af75611e-f3f8-41ad-883f-71ab668ba154" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LanzaJetIncMember_c18bf726-8767-4a07-995a-177e62449fd2" xlink:href="amci-20230213.xsd#amci_LanzaJetIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_af75611e-f3f8-41ad-883f-71ab668ba154" xlink:to="loc_amci_LanzaJetIncMember_c18bf726-8767-4a07-995a-177e62449fd2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember_47f57589-066c-43e5-b8d5-6315a1b4eab7" xlink:href="amci-20230213.xsd#amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_af75611e-f3f8-41ad-883f-71ab668ba154" xlink:to="loc_amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember_47f57589-066c-43e5-b8d5-6315a1b4eab7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_453117cc-a844-4a1c-b925-e436096f8e57" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8d463a2a-8d91-4622-96bd-8e391bc6092a" xlink:to="loc_srt_ConsolidationItemsAxis_453117cc-a844-4a1c-b925-e436096f8e57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_453117cc-a844-4a1c-b925-e436096f8e57_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_453117cc-a844-4a1c-b925-e436096f8e57" xlink:to="loc_srt_ConsolidationItemsDomain_453117cc-a844-4a1c-b925-e436096f8e57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_76124291-b8be-40d3-8e60-3f101dd0ea4c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_453117cc-a844-4a1c-b925-e436096f8e57" xlink:to="loc_srt_ConsolidationItemsDomain_76124291-b8be-40d3-8e60-3f101dd0ea4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_8d56b6e1-f4a6-44b0-8e4b-94bcf52e75cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_76124291-b8be-40d3-8e60-3f101dd0ea4c" xlink:to="loc_us-gaap_IntersegmentEliminationMember_8d56b6e1-f4a6-44b0-8e4b-94bcf52e75cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_895bb86e-c401-4328-a4a0-3d5965e405c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8d463a2a-8d91-4622-96bd-8e391bc6092a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_895bb86e-c401-4328-a4a0-3d5965e405c8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_895bb86e-c401-4328-a4a0-3d5965e405c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_895bb86e-c401-4328-a4a0-3d5965e405c8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_895bb86e-c401-4328-a4a0-3d5965e405c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f5e934a5-456b-4d17-8b85-773635bce409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_895bb86e-c401-4328-a4a0-3d5965e405c8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f5e934a5-456b-4d17-8b85-773635bce409" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntellectualPropertyMember_674abc35-956c-45ba-be60-07c827d839a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntellectualPropertyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f5e934a5-456b-4d17-8b85-773635bce409" xlink:to="loc_us-gaap_IntellectualPropertyMember_674abc35-956c-45ba-be60-07c827d839a8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/InvestmentsSummarizedFinancialInformationDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#InvestmentsSummarizedFinancialInformationDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/InvestmentsSummarizedFinancialInformationDetails" xlink:type="extended" id="i8de5bfbad1e64afaa88839fc4d130365_InvestmentsSummarizedFinancialInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_db490cc5-d522-42b3-9b20-5398e6f0703a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_ab4726e7-9555-438a-96a4-0bbadfb499dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_db490cc5-d522-42b3-9b20-5398e6f0703a" xlink:to="loc_us-gaap_Revenues_ab4726e7-9555-438a-96a4-0bbadfb499dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_82eca11f-069f-45b5-8679-6203747ab89e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_db490cc5-d522-42b3-9b20-5398e6f0703a" xlink:to="loc_us-gaap_GrossProfit_82eca11f-069f-45b5-8679-6203747ab89e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7f215a94-039d-4496-ad33-0c8ab3f01fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_db490cc5-d522-42b3-9b20-5398e6f0703a" xlink:to="loc_us-gaap_NetIncomeLoss_7f215a94-039d-4496-ad33-0c8ab3f01fe2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5f017bfa-770e-407e-9661-50e82847384c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_db490cc5-d522-42b3-9b20-5398e6f0703a" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5f017bfa-770e-407e-9661-50e82847384c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_1667ce46-fb46-47e5-9a42-e033d75895a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_db490cc5-d522-42b3-9b20-5398e6f0703a" xlink:to="loc_us-gaap_AssetsCurrent_1667ce46-fb46-47e5-9a42-e033d75895a6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_f0248569-6948-4bff-9450-d32d44517a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_db490cc5-d522-42b3-9b20-5398e6f0703a" xlink:to="loc_us-gaap_AssetsNoncurrent_f0248569-6948-4bff-9450-d32d44517a9d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_676e51eb-17f8-4206-b6db-57100f998635" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_db490cc5-d522-42b3-9b20-5398e6f0703a" xlink:to="loc_us-gaap_LiabilitiesCurrent_676e51eb-17f8-4206-b6db-57100f998635" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_8ac21ba6-b115-4416-8e9b-df2ff9c92b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_db490cc5-d522-42b3-9b20-5398e6f0703a" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_8ac21ba6-b115-4416-8e9b-df2ff9c92b6d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_86cef5b4-73fd-4771-aef5-eb7c1853cfb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_db490cc5-d522-42b3-9b20-5398e6f0703a" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_86cef5b4-73fd-4771-aef5-eb7c1853cfb3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_f1100966-6d07-45b8-a382-e751b3cd691e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_86cef5b4-73fd-4771-aef5-eb7c1853cfb3" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_f1100966-6d07-45b8-a382-e751b3cd691e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_f1100966-6d07-45b8-a382-e751b3cd691e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_f1100966-6d07-45b8-a382-e751b3cd691e" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_f1100966-6d07-45b8-a382-e751b3cd691e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_232364a7-2b62-48d8-b668-7220c2d9c1dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_f1100966-6d07-45b8-a382-e751b3cd691e" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_232364a7-2b62-48d8-b668-7220c2d9c1dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_708cb6e8-1721-437e-a8c5-021ddd1a1664" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_232364a7-2b62-48d8-b668-7220c2d9c1dd" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_708cb6e8-1721-437e-a8c5-021ddd1a1664" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/InvestmentsTransactionsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#InvestmentsTransactionsDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/InvestmentsTransactionsDetails" xlink:type="extended" id="ic39731b37ab34e0eb579027ce09113b3_InvestmentsTransactionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_5e82ff31-907e-4a61-883d-395e10f699d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_bc358419-5240-4865-b1fa-4f484e64377e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_5e82ff31-907e-4a61-883d-395e10f699d2" xlink:to="loc_us-gaap_RevenueFromRelatedParties_bc358419-5240-4865-b1fa-4f484e64377e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_fa9f5f75-9f4f-4627-a980-5c2dc14cfb57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_5e82ff31-907e-4a61-883d-395e10f699d2" xlink:to="loc_us-gaap_AccountsReceivableNet_fa9f5f75-9f4f-4627-a980-5c2dc14cfb57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PurchasesAndOpenAccountsPayableRelatedParties_75b3a94a-a09e-41d7-8978-a05cf22d0942" xlink:href="amci-20230213.xsd#amci_PurchasesAndOpenAccountsPayableRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_5e82ff31-907e-4a61-883d-395e10f699d2" xlink:to="loc_amci_PurchasesAndOpenAccountsPayableRelatedParties_75b3a94a-a09e-41d7-8978-a05cf22d0942" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_0572abe6-30fa-4b01-b843-af149ef19530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_5e82ff31-907e-4a61-883d-395e10f699d2" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_0572abe6-30fa-4b01-b843-af149ef19530" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_47bc1de6-cab9-4692-97f5-64c82fde0567" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_0572abe6-30fa-4b01-b843-af149ef19530" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_47bc1de6-cab9-4692-97f5-64c82fde0567" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_47bc1de6-cab9-4692-97f5-64c82fde0567_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_47bc1de6-cab9-4692-97f5-64c82fde0567" xlink:to="loc_us-gaap_RelatedPartyDomain_47bc1de6-cab9-4692-97f5-64c82fde0567_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_9990a789-7acc-4ac0-9556-96fbac574ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_47bc1de6-cab9-4692-97f5-64c82fde0567" xlink:to="loc_us-gaap_RelatedPartyDomain_9990a789-7acc-4ac0-9556-96fbac574ef9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_49e27318-33c3-4c8f-b4b8-0d9f91447790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_9990a789-7acc-4ac0-9556-96fbac574ef9" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_49e27318-33c3-4c8f-b4b8-0d9f91447790" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_81c80b30-c656-4ea9-ba58-44561bed088d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_0572abe6-30fa-4b01-b843-af149ef19530" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_81c80b30-c656-4ea9-ba58-44561bed088d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_81c80b30-c656-4ea9-ba58-44561bed088d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_81c80b30-c656-4ea9-ba58-44561bed088d" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_81c80b30-c656-4ea9-ba58-44561bed088d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_c4ab963b-2361-4028-be4d-5e3b96722862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_81c80b30-c656-4ea9-ba58-44561bed088d" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_c4ab963b-2361-4028-be4d-5e3b96722862" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TransactionsWithEquityMethodInvesteesMember_153604cc-0ee5-4367-81a3-25afd0254af4" xlink:href="amci-20230213.xsd#amci_TransactionsWithEquityMethodInvesteesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_c4ab963b-2361-4028-be4d-5e3b96722862" xlink:to="loc_amci_TransactionsWithEquityMethodInvesteesMember_153604cc-0ee5-4367-81a3-25afd0254af4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueFinancialAssetsandLiabilitiesDetails_1"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails_1" xlink:type="extended" id="i6e60a7c9835142c4b3ffd02e0c47bb09_FairValueFinancialAssetsandLiabilitiesDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_68148fc6-3d13-4c13-8869-febcdad03b68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_415469f3-6651-46d3-a719-7aff87fbbec5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_68148fc6-3d13-4c13-8869-febcdad03b68" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_415469f3-6651-46d3-a719-7aff87fbbec5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_7deef2d8-5bc4-4889-aead-89d19ddb1a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_415469f3-6651-46d3-a719-7aff87fbbec5" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_7deef2d8-5bc4-4889-aead-89d19ddb1a5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e668c71f-ad94-439a-baec-d5683a7650e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_68148fc6-3d13-4c13-8869-febcdad03b68" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e668c71f-ad94-439a-baec-d5683a7650e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_c596ffab-c60c-4664-9a75-511ecd552ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e668c71f-ad94-439a-baec-d5683a7650e3" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_c596ffab-c60c-4664-9a75-511ecd552ed7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SimpleAgreementForFutureEquityLiability_d35d5588-7f65-426a-b788-09758418b89c" xlink:href="amci-20230213.xsd#amci_SimpleAgreementForFutureEquityLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e668c71f-ad94-439a-baec-d5683a7650e3" xlink:to="loc_amci_SimpleAgreementForFutureEquityLiability_d35d5588-7f65-426a-b788-09758418b89c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_ffe90ce4-0f4c-46b1-b3e9-e34767256ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e668c71f-ad94-439a-baec-d5683a7650e3" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_ffe90ce4-0f4c-46b1-b3e9-e34767256ce4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09f5f470-f825-4251-81be-3ed143236fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_68148fc6-3d13-4c13-8869-febcdad03b68" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09f5f470-f825-4251-81be-3ed143236fc5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_85780d2f-b1e9-4ab2-b126-2051e289ae9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09f5f470-f825-4251-81be-3ed143236fc5" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_85780d2f-b1e9-4ab2-b126-2051e289ae9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_85780d2f-b1e9-4ab2-b126-2051e289ae9a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_85780d2f-b1e9-4ab2-b126-2051e289ae9a" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_85780d2f-b1e9-4ab2-b126-2051e289ae9a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_e932dfc9-3049-4aec-825a-5dad4c947647" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_85780d2f-b1e9-4ab2-b126-2051e289ae9a" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_e932dfc9-3049-4aec-825a-5dad4c947647" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_7f44df46-0f59-4824-b95c-357df457e5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_e932dfc9-3049-4aec-825a-5dad4c947647" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_7f44df46-0f59-4824-b95c-357df457e5f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0022b06a-173e-498f-88eb-83d1867623ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09f5f470-f825-4251-81be-3ed143236fc5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0022b06a-173e-498f-88eb-83d1867623ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0022b06a-173e-498f-88eb-83d1867623ff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0022b06a-173e-498f-88eb-83d1867623ff" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0022b06a-173e-498f-88eb-83d1867623ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6cea754f-4c5b-44b4-9613-397b7e627862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0022b06a-173e-498f-88eb-83d1867623ff" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6cea754f-4c5b-44b4-9613-397b7e627862" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_26122e94-d076-4698-b90a-b3900136a400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6cea754f-4c5b-44b4-9613-397b7e627862" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_26122e94-d076-4698-b90a-b3900136a400" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_6b7be07d-3632-44ea-b38b-4283f6288873" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6cea754f-4c5b-44b4-9613-397b7e627862" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_6b7be07d-3632-44ea-b38b-4283f6288873" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_7b00180c-a977-496f-b6f3-8850910b2df8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6cea754f-4c5b-44b4-9613-397b7e627862" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_7b00180c-a977-496f-b6f3-8850910b2df8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_30948ce3-ed24-4269-960e-b477392ec04c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09f5f470-f825-4251-81be-3ed143236fc5" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_30948ce3-ed24-4269-960e-b477392ec04c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_30948ce3-ed24-4269-960e-b477392ec04c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_30948ce3-ed24-4269-960e-b477392ec04c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_30948ce3-ed24-4269-960e-b477392ec04c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_3381f6f0-c95e-474f-b5c3-524ccb0e2bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_30948ce3-ed24-4269-960e-b477392ec04c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_3381f6f0-c95e-474f-b5c3-524ccb0e2bf3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SAFEWarrantMember_0d5c81b4-ab79-483f-81dc-a73f50d13e06" xlink:href="amci-20230213.xsd#amci_SAFEWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3381f6f0-c95e-474f-b5c3-524ccb0e2bf3" xlink:to="loc_amci_SAFEWarrantMember_0d5c81b4-ab79-483f-81dc-a73f50d13e06" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueNarrativeDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueNarrativeDetails_1"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/FairValueNarrativeDetails_1" xlink:type="extended" id="i9f95812b73de4623bdbced766e04ba88_FairValueNarrativeDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b314cd96-d72d-4e84-a69c-a3a0f9220a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_cb501457-e8e2-48f7-b0d0-5eaf7d804275" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b314cd96-d72d-4e84-a69c-a3a0f9220a0c" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_cb501457-e8e2-48f7-b0d0-5eaf7d804275" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquitySharesConversionOfConvertibleSecurities_cf3f2e4d-cfb3-4c78-8d37-35bcabfef40b" xlink:href="amci-20230213.xsd#amci_TemporaryEquitySharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b314cd96-d72d-4e84-a69c-a3a0f9220a0c" xlink:to="loc_amci_TemporaryEquitySharesConversionOfConvertibleSecurities_cf3f2e4d-cfb3-4c78-8d37-35bcabfef40b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_5917740b-7b36-4f63-806f-8780b23ddf36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b314cd96-d72d-4e84-a69c-a3a0f9220a0c" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_5917740b-7b36-4f63-806f-8780b23ddf36" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4bf409d6-f953-4e21-87d2-272332dbfed4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b314cd96-d72d-4e84-a69c-a3a0f9220a0c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4bf409d6-f953-4e21-87d2-272332dbfed4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_385c3eae-8092-4c07-b293-22d16b621656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4bf409d6-f953-4e21-87d2-272332dbfed4" xlink:to="loc_us-gaap_StatementClassOfStockAxis_385c3eae-8092-4c07-b293-22d16b621656" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_385c3eae-8092-4c07-b293-22d16b621656_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_385c3eae-8092-4c07-b293-22d16b621656" xlink:to="loc_us-gaap_ClassOfStockDomain_385c3eae-8092-4c07-b293-22d16b621656_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6c5fd09a-9cca-467e-bf5c-74abe109b6dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_385c3eae-8092-4c07-b293-22d16b621656" xlink:to="loc_us-gaap_ClassOfStockDomain_6c5fd09a-9cca-467e-bf5c-74abe109b6dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_0df7c4ec-7a71-48a8-b36b-fec216f10583" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6c5fd09a-9cca-467e-bf5c-74abe109b6dc" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_0df7c4ec-7a71-48a8-b36b-fec216f10583" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueLevel3FairValueMeasurementsDetails_1"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1" xlink:type="extended" id="i7c772217d89f47d8b759af07af91c716_FairValueLevel3FairValueMeasurementsDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_acf573eb-519c-4a14-983f-fdd2f047b21c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_dcf84fcc-8f3c-47e0-a849-0205d4fa0e26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_acf573eb-519c-4a14-983f-fdd2f047b21c" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_dcf84fcc-8f3c-47e0-a849-0205d4fa0e26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityMeasurementInput_a13ebe17-42d4-4ea1-96df-981994c10843" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_acf573eb-519c-4a14-983f-fdd2f047b21c" xlink:to="loc_us-gaap_DerivativeLiabilityMeasurementInput_a13ebe17-42d4-4ea1-96df-981994c10843" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8e76b180-8721-4ba9-93bb-3056ab9539ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_acf573eb-519c-4a14-983f-fdd2f047b21c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8e76b180-8721-4ba9-93bb-3056ab9539ac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_527383fa-58e3-4765-987b-226b429e3067" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8e76b180-8721-4ba9-93bb-3056ab9539ac" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_527383fa-58e3-4765-987b-226b429e3067" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_527383fa-58e3-4765-987b-226b429e3067_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_527383fa-58e3-4765-987b-226b429e3067" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_527383fa-58e3-4765-987b-226b429e3067_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_ff16be64-0f82-48f0-9229-f05aa99c5338" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_527383fa-58e3-4765-987b-226b429e3067" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_ff16be64-0f82-48f0-9229-f05aa99c5338" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_db28ef60-003f-4c90-be07-c7b34087fe58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ff16be64-0f82-48f0-9229-f05aa99c5338" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_db28ef60-003f-4c90-be07-c7b34087fe58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExercisePriceMember_47f314d8-aceb-45ba-97f0-0bd2dc57f933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExercisePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ff16be64-0f82-48f0-9229-f05aa99c5338" xlink:to="loc_us-gaap_MeasurementInputExercisePriceMember_47f314d8-aceb-45ba-97f0-0bd2dc57f933" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_ca3e9b5c-1895-4a98-84e1-fba6f4e2e14a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ff16be64-0f82-48f0-9229-f05aa99c5338" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_ca3e9b5c-1895-4a98-84e1-fba6f4e2e14a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_2745cbc2-0c06-4d37-aee5-b9701b9b71c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ff16be64-0f82-48f0-9229-f05aa99c5338" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_2745cbc2-0c06-4d37-aee5-b9701b9b71c8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_2be7eee4-10da-4e29-a8e5-525c6aad0b40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ff16be64-0f82-48f0-9229-f05aa99c5338" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_2be7eee4-10da-4e29-a8e5-525c6aad0b40" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MeasurementInputProbabilityWeightingMember_e30e6fa2-106d-4c9e-b7d6-b217fe984c19" xlink:href="amci-20230213.xsd#amci_MeasurementInputProbabilityWeightingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ff16be64-0f82-48f0-9229-f05aa99c5338" xlink:to="loc_amci_MeasurementInputProbabilityWeightingMember_e30e6fa2-106d-4c9e-b7d6-b217fe984c19" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MeasurementInputInterestRateMember_ed738a2a-78f1-4638-8c51-409efb3476f7" xlink:href="amci-20230213.xsd#amci_MeasurementInputInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ff16be64-0f82-48f0-9229-f05aa99c5338" xlink:to="loc_amci_MeasurementInputInterestRateMember_ed738a2a-78f1-4638-8c51-409efb3476f7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MeasurementInputTimeToConversionMember_afea1bb5-c08d-41f4-9575-161ed1dee711" xlink:href="amci-20230213.xsd#amci_MeasurementInputTimeToConversionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ff16be64-0f82-48f0-9229-f05aa99c5338" xlink:to="loc_amci_MeasurementInputTimeToConversionMember_afea1bb5-c08d-41f4-9575-161ed1dee711" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MeasurementInputLiquidityPriceMember_2faaca17-8978-4656-8595-8c8c8e05517c" xlink:href="amci-20230213.xsd#amci_MeasurementInputLiquidityPriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ff16be64-0f82-48f0-9229-f05aa99c5338" xlink:to="loc_amci_MeasurementInputLiquidityPriceMember_2faaca17-8978-4656-8595-8c8c8e05517c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_d6cae5c0-9b4b-4dda-aaf4-aff00ff98b01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ff16be64-0f82-48f0-9229-f05aa99c5338" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_d6cae5c0-9b4b-4dda-aaf4-aff00ff98b01" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_aed2aa98-fe68-46ba-b976-297ec7beeffa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ff16be64-0f82-48f0-9229-f05aa99c5338" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_aed2aa98-fe68-46ba-b976-297ec7beeffa" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_622ebd62-25cb-4967-b25f-410c71c5d245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8e76b180-8721-4ba9-93bb-3056ab9539ac" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_622ebd62-25cb-4967-b25f-410c71c5d245" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_622ebd62-25cb-4967-b25f-410c71c5d245_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_622ebd62-25cb-4967-b25f-410c71c5d245" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_622ebd62-25cb-4967-b25f-410c71c5d245_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8072605d-5a6f-4bac-9737-75e11efe5308" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_622ebd62-25cb-4967-b25f-410c71c5d245" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8072605d-5a6f-4bac-9737-75e11efe5308" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DerivativeNearTermMember_c180c9eb-3ad0-4b64-b571-79c91cc75a9d" xlink:href="amci-20230213.xsd#amci_DerivativeNearTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8072605d-5a6f-4bac-9737-75e11efe5308" xlink:to="loc_amci_DerivativeNearTermMember_c180c9eb-3ad0-4b64-b571-79c91cc75a9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DerivativeLongTermMember_1ad48db0-8a39-4d8e-a318-73d65b856004" xlink:href="amci-20230213.xsd#amci_DerivativeLongTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8072605d-5a6f-4bac-9737-75e11efe5308" xlink:to="loc_amci_DerivativeLongTermMember_1ad48db0-8a39-4d8e-a318-73d65b856004" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_22580edc-9736-4e8d-a9d3-03848b0a1d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8e76b180-8721-4ba9-93bb-3056ab9539ac" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_22580edc-9736-4e8d-a9d3-03848b0a1d3b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_22580edc-9736-4e8d-a9d3-03848b0a1d3b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_22580edc-9736-4e8d-a9d3-03848b0a1d3b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_22580edc-9736-4e8d-a9d3-03848b0a1d3b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_2fe7eca9-4b07-4ef0-9188-120e8e99b976" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_22580edc-9736-4e8d-a9d3-03848b0a1d3b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_2fe7eca9-4b07-4ef0-9188-120e8e99b976" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SAFEWarrantNearTermMember_5b924cff-f062-47ea-a12a-4a78477a160c" xlink:href="amci-20230213.xsd#amci_SAFEWarrantNearTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2fe7eca9-4b07-4ef0-9188-120e8e99b976" xlink:to="loc_amci_SAFEWarrantNearTermMember_5b924cff-f062-47ea-a12a-4a78477a160c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SAFEWarrantLongTermMember_4308830c-733b-4755-9ef0-b18a47474ee3" xlink:href="amci-20230213.xsd#amci_SAFEWarrantLongTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2fe7eca9-4b07-4ef0-9188-120e8e99b976" xlink:to="loc_amci_SAFEWarrantLongTermMember_4308830c-733b-4755-9ef0-b18a47474ee3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails_1"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails_1" xlink:type="extended" id="i40dff0a0d9b14a9f96867a0f626736e3_FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_c7d8c0e2-203b-405f-9302-b6910f733e62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_887d655c-6e6b-4021-b2b6-bc8924bd84dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_c7d8c0e2-203b-405f-9302-b6910f733e62" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_887d655c-6e6b-4021-b2b6-bc8924bd84dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_f1c5396b-222c-4621-907d-1afc10024363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_887d655c-6e6b-4021-b2b6-bc8924bd84dd" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_f1c5396b-222c-4621-907d-1afc10024363" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_443a89f2-2700-4646-a913-427b123602ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_887d655c-6e6b-4021-b2b6-bc8924bd84dd" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_443a89f2-2700-4646-a913-427b123602ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_feafd0ff-04fe-44af-a49e-1631bf4e259d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_887d655c-6e6b-4021-b2b6-bc8924bd84dd" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_feafd0ff-04fe-44af-a49e-1631bf4e259d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_a92f7d8b-8014-42f1-890b-1a3e011e148a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_58edcd02-4755-412b-a604-1719327fcd1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_c7d8c0e2-203b-405f-9302-b6910f733e62" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_58edcd02-4755-412b-a604-1719327fcd1b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_32cdbe9a-e2e4-441a-af7f-30d098e27986" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_58edcd02-4755-412b-a604-1719327fcd1b" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_32cdbe9a-e2e4-441a-af7f-30d098e27986" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_32cdbe9a-e2e4-441a-af7f-30d098e27986_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_32cdbe9a-e2e4-441a-af7f-30d098e27986" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_32cdbe9a-e2e4-441a-af7f-30d098e27986_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c8ba6a4f-b2cc-4973-93d5-cc88cd9d27e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_32cdbe9a-e2e4-441a-af7f-30d098e27986" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c8ba6a4f-b2cc-4973-93d5-cc88cd9d27e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_a8666fda-2457-4362-a034-50ae2c2a704e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c8ba6a4f-b2cc-4973-93d5-cc88cd9d27e1" xlink:to="loc_us-gaap_WarrantMember_a8666fda-2457-4362-a034-50ae2c2a704e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SAFELiabilityMember_2f6b7e5c-de2c-445f-88e0-a7b8311e27f9" xlink:href="amci-20230213.xsd#amci_SAFELiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c8ba6a4f-b2cc-4973-93d5-cc88cd9d27e1" xlink:to="loc_amci_SAFELiabilityMember_2f6b7e5c-de2c-445f-88e0-a7b8311e27f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SAFEWarrantMember_ec55f8d3-e475-4ec5-8478-6da1eea96bf1" xlink:href="amci-20230213.xsd#amci_SAFEWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c8ba6a4f-b2cc-4973-93d5-cc88cd9d27e1" xlink:to="loc_amci_SAFEWarrantMember_ec55f8d3-e475-4ec5-8478-6da1eea96bf1" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/PropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#PropertyPlantandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/PropertyPlantandEquipmentDetails" xlink:type="extended" id="ie8c5a59938624a3db5b9ea6e2e7f5070_PropertyPlantandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b92be7d1-a870-42e1-95f7-901429f3e39f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_da509181-0a00-45b3-bb24-71b712ab4449" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b92be7d1-a870-42e1-95f7-901429f3e39f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_da509181-0a00-45b3-bb24-71b712ab4449" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3e305bc7-3977-4893-a125-4198769d3b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b92be7d1-a870-42e1-95f7-901429f3e39f" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3e305bc7-3977-4893-a125-4198769d3b8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_825aa643-c269-4086-a0cf-2015bab92c50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b92be7d1-a870-42e1-95f7-901429f3e39f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_825aa643-c269-4086-a0cf-2015bab92c50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79357d81-b22e-4132-97a7-f4b269e83add" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b92be7d1-a870-42e1-95f7-901429f3e39f" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79357d81-b22e-4132-97a7-f4b269e83add" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7282c13b-3f99-46d4-85db-99b5d5f945f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79357d81-b22e-4132-97a7-f4b269e83add" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7282c13b-3f99-46d4-85db-99b5d5f945f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7282c13b-3f99-46d4-85db-99b5d5f945f2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7282c13b-3f99-46d4-85db-99b5d5f945f2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7282c13b-3f99-46d4-85db-99b5d5f945f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0098ac62-85f9-4dd9-91f2-f72017445901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7282c13b-3f99-46d4-85db-99b5d5f945f2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0098ac62-85f9-4dd9-91f2-f72017445901" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_00d26591-2283-4746-8276-b57ac73ba551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0098ac62-85f9-4dd9-91f2-f72017445901" xlink:to="loc_us-gaap_LandMember_00d26591-2283-4746-8276-b57ac73ba551" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_6a315964-4df8-4e1c-ba65-a76ac060988f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0098ac62-85f9-4dd9-91f2-f72017445901" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_6a315964-4df8-4e1c-ba65-a76ac060988f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_4b2b7330-e297-4a71-a2d6-c60e8868fa64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0098ac62-85f9-4dd9-91f2-f72017445901" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_4b2b7330-e297-4a71-a2d6-c60e8868fa64" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AutomobilesMember_ff78be49-35ec-40c8-91cb-a71d090e4df3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AutomobilesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0098ac62-85f9-4dd9-91f2-f72017445901" xlink:to="loc_us-gaap_AutomobilesMember_ff78be49-35ec-40c8-91cb-a71d090e4df3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_89ee1bc0-d6cb-4ccf-ba73-625566e72fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0098ac62-85f9-4dd9-91f2-f72017445901" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_89ee1bc0-d6cb-4ccf-ba73-625566e72fc4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOtherTypesMember_0f6c6914-f7b9-43ec-8024-6fb5bb0a68d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentOtherTypesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0098ac62-85f9-4dd9-91f2-f72017445901" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentOtherTypesMember_0f6c6914-f7b9-43ec-8024-6fb5bb0a68d9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_e69340e6-ff4e-464f-8f2c-1d2833289457" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0098ac62-85f9-4dd9-91f2-f72017445901" xlink:to="loc_us-gaap_ConstructionInProgressMember_e69340e6-ff4e-464f-8f2c-1d2833289457" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/DebtDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#DebtDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/DebtDetails" xlink:type="extended" id="ifa4aad42dfef4c0885a1051058de2e46_DebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a9789556-dfe2-4955-8468-20edd3f6e9f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_debcdecf-d874-4607-8e5c-1941059eef03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9789556-dfe2-4955-8468-20edd3f6e9f8" xlink:to="loc_us-gaap_LongTermDebt_debcdecf-d874-4607-8e5c-1941059eef03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_40fc08e2-dd78-4a29-881c-fca74b354f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9789556-dfe2-4955-8468-20edd3f6e9f8" xlink:to="loc_us-gaap_LongTermDebtCurrent_40fc08e2-dd78-4a29-881c-fca74b354f9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_efdc4677-b0f7-4091-9d1f-d391ce18815e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9789556-dfe2-4955-8468-20edd3f6e9f8" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_efdc4677-b0f7-4091-9d1f-d391ce18815e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ab23c67b-d8b2-4540-a1aa-95e9cbb8d325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9789556-dfe2-4955-8468-20edd3f6e9f8" xlink:to="loc_us-gaap_DebtInstrumentTable_ab23c67b-d8b2-4540-a1aa-95e9cbb8d325" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_427955f2-0f0d-43c6-b7c1-25f4e0e0bc92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ab23c67b-d8b2-4540-a1aa-95e9cbb8d325" xlink:to="loc_us-gaap_DebtInstrumentAxis_427955f2-0f0d-43c6-b7c1-25f4e0e0bc92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_427955f2-0f0d-43c6-b7c1-25f4e0e0bc92_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_427955f2-0f0d-43c6-b7c1-25f4e0e0bc92" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_427955f2-0f0d-43c6-b7c1-25f4e0e0bc92_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bf11bfd9-4906-4175-ac9f-1e6ddba612c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_427955f2-0f0d-43c6-b7c1-25f4e0e0bc92" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bf11bfd9-4906-4175-ac9f-1e6ddba612c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WTILoanMember_e6a2597b-f827-494b-9a12-59f318a8a024" xlink:href="amci-20230213.xsd#amci_WTILoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bf11bfd9-4906-4175-ac9f-1e6ddba612c1" xlink:to="loc_amci_WTILoanMember_e6a2597b-f827-494b-9a12-59f318a8a024" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PPPLoanMember_ff4dd4a4-47a6-4c69-a99f-faf7dcf3d850" xlink:href="amci-20230213.xsd#amci_PPPLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bf11bfd9-4906-4175-ac9f-1e6ddba612c1" xlink:to="loc_amci_PPPLoanMember_ff4dd4a4-47a6-4c69-a99f-faf7dcf3d850" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#DebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/DebtNarrativeDetails" xlink:type="extended" id="ie73174cff88c4fd1b6d2fff25184bd64_DebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_02e31ac2-e12b-4f79-80ad-7e5218f0bc44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_a79f4b41-a52a-40d1-bf97-a4886e4344e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02e31ac2-e12b-4f79-80ad-7e5218f0bc44" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_a79f4b41-a52a-40d1-bf97-a4886e4344e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_25990a60-d2b3-4d2f-83ba-7d50f817c6d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02e31ac2-e12b-4f79-80ad-7e5218f0bc44" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_25990a60-d2b3-4d2f-83ba-7d50f817c6d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a4b88278-0d0e-4bd5-a13a-e039417a1618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02e31ac2-e12b-4f79-80ad-7e5218f0bc44" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a4b88278-0d0e-4bd5-a13a-e039417a1618" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_4b560b2f-5e57-45eb-9be8-7b3a25f54ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02e31ac2-e12b-4f79-80ad-7e5218f0bc44" xlink:to="loc_us-gaap_DebtInstrumentTerm_4b560b2f-5e57-45eb-9be8-7b3a25f54ff0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_cde48d2e-9337-42e3-a798-04a06e2258c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02e31ac2-e12b-4f79-80ad-7e5218f0bc44" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_cde48d2e-9337-42e3-a798-04a06e2258c3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_b9a73aad-d03f-4746-85ee-72f210ac0367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02e31ac2-e12b-4f79-80ad-7e5218f0bc44" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_b9a73aad-d03f-4746-85ee-72f210ac0367" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDecreaseForgiveness_6b5b58a1-c612-42a8-9312-42a2f72af9fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDecreaseForgiveness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02e31ac2-e12b-4f79-80ad-7e5218f0bc44" xlink:to="loc_us-gaap_DebtInstrumentDecreaseForgiveness_6b5b58a1-c612-42a8-9312-42a2f72af9fc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_4a31b029-58b1-41e0-a6a1-addea3ea7a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02e31ac2-e12b-4f79-80ad-7e5218f0bc44" xlink:to="loc_us-gaap_LongTermDebt_4a31b029-58b1-41e0-a6a1-addea3ea7a3c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_bdc77ce2-20ae-4a01-bce3-d3994d8c2d00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02e31ac2-e12b-4f79-80ad-7e5218f0bc44" xlink:to="loc_us-gaap_DebtInstrumentTable_bdc77ce2-20ae-4a01-bce3-d3994d8c2d00" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_54e2b618-b963-4c8c-8115-b870641ae24d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_bdc77ce2-20ae-4a01-bce3-d3994d8c2d00" xlink:to="loc_us-gaap_DebtInstrumentAxis_54e2b618-b963-4c8c-8115-b870641ae24d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_54e2b618-b963-4c8c-8115-b870641ae24d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_54e2b618-b963-4c8c-8115-b870641ae24d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_54e2b618-b963-4c8c-8115-b870641ae24d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5989e1ca-702f-4f09-8004-dc40d71fef57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_54e2b618-b963-4c8c-8115-b870641ae24d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5989e1ca-702f-4f09-8004-dc40d71fef57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WTILoanMember_c13b8494-dfa9-4520-9865-4940db245845" xlink:href="amci-20230213.xsd#amci_WTILoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5989e1ca-702f-4f09-8004-dc40d71fef57" xlink:to="loc_amci_WTILoanMember_c13b8494-dfa9-4520-9865-4940db245845" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PPPLoanMember_8f6c588f-9275-4f11-938c-67830b6ba418" xlink:href="amci-20230213.xsd#amci_PPPLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5989e1ca-702f-4f09-8004-dc40d71fef57" xlink:to="loc_amci_PPPLoanMember_8f6c588f-9275-4f11-938c-67830b6ba418" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_4cd6da2e-aabf-4021-ae8f-99b8183dace3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_bdc77ce2-20ae-4a01-bce3-d3994d8c2d00" xlink:to="loc_us-gaap_VariableRateAxis_4cd6da2e-aabf-4021-ae8f-99b8183dace3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_4cd6da2e-aabf-4021-ae8f-99b8183dace3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_4cd6da2e-aabf-4021-ae8f-99b8183dace3" xlink:to="loc_us-gaap_VariableRateDomain_4cd6da2e-aabf-4021-ae8f-99b8183dace3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_b237d3e7-a47c-42b6-89bd-dcaec46989fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_4cd6da2e-aabf-4021-ae8f-99b8183dace3" xlink:to="loc_us-gaap_VariableRateDomain_b237d3e7-a47c-42b6-89bd-dcaec46989fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_828914a3-4934-47be-9d50-541a76500c15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrimeRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_b237d3e7-a47c-42b6-89bd-dcaec46989fa" xlink:to="loc_us-gaap_PrimeRateMember_828914a3-4934-47be-9d50-541a76500c15" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/IncomeTaxesComponentsofLossIncomeDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#IncomeTaxesComponentsofLossIncomeDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/IncomeTaxesComponentsofLossIncomeDetails" xlink:type="extended" id="i664f27bd407345c5be036b2460d68ea7_IncomeTaxesComponentsofLossIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeTaxesLineItems_fd44bc1e-4839-4b8e-92dd-ba662520b825" xlink:href="amci-20230213.xsd#amci_IncomeTaxesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_23fdf7a5-893d-47b8-baf1-bcbaf7c1a62a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_IncomeTaxesLineItems_fd44bc1e-4839-4b8e-92dd-ba662520b825" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_23fdf7a5-893d-47b8-baf1-bcbaf7c1a62a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_fb1e75d9-0f63-4e33-b432-9d2e290cff91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_IncomeTaxesLineItems_fd44bc1e-4839-4b8e-92dd-ba662520b825" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_fb1e75d9-0f63-4e33-b432-9d2e290cff91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_441fe825-8a69-4285-93ed-827b5eb73a66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_IncomeTaxesLineItems_fd44bc1e-4839-4b8e-92dd-ba662520b825" xlink:to="loc_us-gaap_NetIncomeLoss_441fe825-8a69-4285-93ed-827b5eb73a66" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeTaxesTable_4f660339-fdb9-4437-a64b-8e5e4d1ad128" xlink:href="amci-20230213.xsd#amci_IncomeTaxesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_amci_IncomeTaxesLineItems_fd44bc1e-4839-4b8e-92dd-ba662520b825" xlink:to="loc_amci_IncomeTaxesTable_4f660339-fdb9-4437-a64b-8e5e4d1ad128" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_f8336f54-b248-4cf0-90f4-69001b277b95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_amci_IncomeTaxesTable_4f660339-fdb9-4437-a64b-8e5e4d1ad128" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_f8336f54-b248-4cf0-90f4-69001b277b95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_f8336f54-b248-4cf0-90f4-69001b277b95_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_f8336f54-b248-4cf0-90f4-69001b277b95" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_f8336f54-b248-4cf0-90f4-69001b277b95_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_984bb842-f6da-4b1f-82ab-74238ab2bbe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_f8336f54-b248-4cf0-90f4-69001b277b95" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_984bb842-f6da-4b1f-82ab-74238ab2bbe5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_9af69f2b-d862-413c-b532-1642eab77f68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_984bb842-f6da-4b1f-82ab-74238ab2bbe5" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_9af69f2b-d862-413c-b532-1642eab77f68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_InlandRevenueNewZealandMember_06300732-8d5f-42dc-ad6d-3b9661356f77" xlink:href="amci-20230213.xsd#amci_InlandRevenueNewZealandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_984bb842-f6da-4b1f-82ab-74238ab2bbe5" xlink:to="loc_amci_InlandRevenueNewZealandMember_06300732-8d5f-42dc-ad6d-3b9661356f77" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/IncomeTaxesIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#IncomeTaxesIncomeTaxProvisionDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/IncomeTaxesIncomeTaxProvisionDetails" xlink:type="extended" id="i1fa3b893a5d24a4080e0e2f9ce9cceb1_IncomeTaxesIncomeTaxProvisionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeTaxesLineItems_92e805ba-1346-4bec-a998-2cef7d9807cb" xlink:href="amci-20230213.xsd#amci_IncomeTaxesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_81e9e8d6-edbe-414c-9d1a-bf75186c0f23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_IncomeTaxesLineItems_92e805ba-1346-4bec-a998-2cef7d9807cb" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_81e9e8d6-edbe-414c-9d1a-bf75186c0f23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_784e1de0-21e6-4e28-9cbb-e543acd2b537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_81e9e8d6-edbe-414c-9d1a-bf75186c0f23" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_784e1de0-21e6-4e28-9cbb-e543acd2b537" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_bc274077-3c96-400b-ab96-3cb3532d863a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_81e9e8d6-edbe-414c-9d1a-bf75186c0f23" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_bc274077-3c96-400b-ab96-3cb3532d863a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_b36aad99-c73a-4457-a794-4d28b882bc21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_81e9e8d6-edbe-414c-9d1a-bf75186c0f23" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_b36aad99-c73a-4457-a794-4d28b882bc21" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_09c0a2d5-3294-4aba-a401-0d67d97696e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_IncomeTaxesLineItems_92e805ba-1346-4bec-a998-2cef7d9807cb" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_09c0a2d5-3294-4aba-a401-0d67d97696e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_0ba17cb0-9651-4cb4-a5c6-109944447d82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_09c0a2d5-3294-4aba-a401-0d67d97696e8" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_0ba17cb0-9651-4cb4-a5c6-109944447d82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_4c297b9c-1b03-4b9a-aedf-cfc3c9471faf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_09c0a2d5-3294-4aba-a401-0d67d97696e8" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_4c297b9c-1b03-4b9a-aedf-cfc3c9471faf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_54db3e58-05ae-4b7e-bce2-012c9e51ecbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_09c0a2d5-3294-4aba-a401-0d67d97696e8" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_54db3e58-05ae-4b7e-bce2-012c9e51ecbf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeTaxesTable_c771eb70-b828-4d22-9db0-fb33e5b867c7" xlink:href="amci-20230213.xsd#amci_IncomeTaxesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_amci_IncomeTaxesLineItems_92e805ba-1346-4bec-a998-2cef7d9807cb" xlink:to="loc_amci_IncomeTaxesTable_c771eb70-b828-4d22-9db0-fb33e5b867c7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_b218de76-0484-496b-8fb9-e4c45ac6c773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_amci_IncomeTaxesTable_c771eb70-b828-4d22-9db0-fb33e5b867c7" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_b218de76-0484-496b-8fb9-e4c45ac6c773" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_b218de76-0484-496b-8fb9-e4c45ac6c773_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_b218de76-0484-496b-8fb9-e4c45ac6c773" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_b218de76-0484-496b-8fb9-e4c45ac6c773_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_fc9ed223-4d63-4550-809d-3384443d62a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_b218de76-0484-496b-8fb9-e4c45ac6c773" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_fc9ed223-4d63-4550-809d-3384443d62a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_2f1d3edc-a406-49f0-9cb4-e694f6da5c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_fc9ed223-4d63-4550-809d-3384443d62a6" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_2f1d3edc-a406-49f0-9cb4-e694f6da5c9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_InlandRevenueNewZealandMember_b44bc324-2a7d-4c4f-be69-663e32c1162c" xlink:href="amci-20230213.xsd#amci_InlandRevenueNewZealandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_fc9ed223-4d63-4550-809d-3384443d62a6" xlink:to="loc_amci_InlandRevenueNewZealandMember_b44bc324-2a7d-4c4f-be69-663e32c1162c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="i2f2b292a093e4bd5b902ba48801ad34a_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeTaxesLineItems_8c0bb472-0dd9-4522-9286-6a7f943cdd68" xlink:href="amci-20230213.xsd#amci_IncomeTaxesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_95e7a445-604e-4c91-8fc4-b6f86d5a6a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_IncomeTaxesLineItems_8c0bb472-0dd9-4522-9286-6a7f943cdd68" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_95e7a445-604e-4c91-8fc4-b6f86d5a6a0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OperatingLossAndTaxCreditCarryforwards_6c808b1e-323d-47e1-a8e6-9fb7633855a7" xlink:href="amci-20230213.xsd#amci_OperatingLossAndTaxCreditCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_IncomeTaxesLineItems_8c0bb472-0dd9-4522-9286-6a7f943cdd68" xlink:to="loc_amci_OperatingLossAndTaxCreditCarryforwards_6c808b1e-323d-47e1-a8e6-9fb7633855a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_6d07920a-6df4-41bd-8ff2-d3f951bedb4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_IncomeTaxesLineItems_8c0bb472-0dd9-4522-9286-6a7f943cdd68" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_6d07920a-6df4-41bd-8ff2-d3f951bedb4e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OperatingLossCarryforwardsSubjectToExpiration_d421f1c9-d846-42d1-ad4e-5694aedb4281" xlink:href="amci-20230213.xsd#amci_OperatingLossCarryforwardsSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_IncomeTaxesLineItems_8c0bb472-0dd9-4522-9286-6a7f943cdd68" xlink:to="loc_amci_OperatingLossCarryforwardsSubjectToExpiration_d421f1c9-d846-42d1-ad4e-5694aedb4281" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OperatingLossCarryforwardsNotSubjectToExpiration_6a0b4b84-0883-4852-9130-6a21e09ca8c5" xlink:href="amci-20230213.xsd#amci_OperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_IncomeTaxesLineItems_8c0bb472-0dd9-4522-9286-6a7f943cdd68" xlink:to="loc_amci_OperatingLossCarryforwardsNotSubjectToExpiration_6a0b4b84-0883-4852-9130-6a21e09ca8c5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ba9d9a82-72c3-4261-ab63-e9c6941e58cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_IncomeTaxesLineItems_8c0bb472-0dd9-4522-9286-6a7f943cdd68" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ba9d9a82-72c3-4261-ab63-e9c6941e58cb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignEarningsRepatriated_8a839053-6c54-43d4-8675-c64e488707cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignEarningsRepatriated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_IncomeTaxesLineItems_8c0bb472-0dd9-4522-9286-6a7f943cdd68" xlink:to="loc_us-gaap_ForeignEarningsRepatriated_8a839053-6c54-43d4-8675-c64e488707cf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3c781734-e316-47b0-bb44-e1c7748d65cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_IncomeTaxesLineItems_8c0bb472-0dd9-4522-9286-6a7f943cdd68" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3c781734-e316-47b0-bb44-e1c7748d65cf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_fdafbb01-113d-46d7-88c1-98c3c6b4d157" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_IncomeTaxesLineItems_8c0bb472-0dd9-4522-9286-6a7f943cdd68" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_fdafbb01-113d-46d7-88c1-98c3c6b4d157" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_0af7cae8-8202-4ad5-8485-c0a521a44db2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_amci_IncomeTaxesLineItems_8c0bb472-0dd9-4522-9286-6a7f943cdd68" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_0af7cae8-8202-4ad5-8485-c0a521a44db2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeTaxesTable_7364abd1-3934-4e33-8754-213aeb5659e5" xlink:href="amci-20230213.xsd#amci_IncomeTaxesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_amci_IncomeTaxesLineItems_8c0bb472-0dd9-4522-9286-6a7f943cdd68" xlink:to="loc_amci_IncomeTaxesTable_7364abd1-3934-4e33-8754-213aeb5659e5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_ef3ff305-11ce-4151-b3b9-cbb72befa23f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_amci_IncomeTaxesTable_7364abd1-3934-4e33-8754-213aeb5659e5" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_ef3ff305-11ce-4151-b3b9-cbb72befa23f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_ef3ff305-11ce-4151-b3b9-cbb72befa23f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_ef3ff305-11ce-4151-b3b9-cbb72befa23f" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_ef3ff305-11ce-4151-b3b9-cbb72befa23f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_70ff8a18-03be-4d1a-bfa3-ac2edd64ecec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_ef3ff305-11ce-4151-b3b9-cbb72befa23f" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_70ff8a18-03be-4d1a-bfa3-ac2edd64ecec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_3b6579f5-12c7-4fbc-9ea2-fdd21b718ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_70ff8a18-03be-4d1a-bfa3-ac2edd64ecec" xlink:to="loc_us-gaap_ResearchMember_3b6579f5-12c7-4fbc-9ea2-fdd21b718ffc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_5b1ee23e-d50a-4807-a1b9-4f56add5f210" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_amci_IncomeTaxesTable_7364abd1-3934-4e33-8754-213aeb5659e5" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_5b1ee23e-d50a-4807-a1b9-4f56add5f210" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_5b1ee23e-d50a-4807-a1b9-4f56add5f210_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_5b1ee23e-d50a-4807-a1b9-4f56add5f210" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_5b1ee23e-d50a-4807-a1b9-4f56add5f210_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_9622d0cc-4338-48e8-82ae-fb758e5fd56c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_5b1ee23e-d50a-4807-a1b9-4f56add5f210" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_9622d0cc-4338-48e8-82ae-fb758e5fd56c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_f82f69eb-3c60-4d47-bf5c-37e6b97f7f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_9622d0cc-4338-48e8-82ae-fb758e5fd56c" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_f82f69eb-3c60-4d47-bf5c-37e6b97f7f69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_InlandRevenueNewZealandMember_442c35d8-f365-4cef-844d-7eb82b3e7bb2" xlink:href="amci-20230213.xsd#amci_InlandRevenueNewZealandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_9622d0cc-4338-48e8-82ae-fb758e5fd56c" xlink:to="loc_amci_InlandRevenueNewZealandMember_442c35d8-f365-4cef-844d-7eb82b3e7bb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_3eb8ce8a-da09-468f-b0e3-98ff72ec88f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_amci_IncomeTaxesTable_7364abd1-3934-4e33-8754-213aeb5659e5" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_3eb8ce8a-da09-468f-b0e3-98ff72ec88f1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_3eb8ce8a-da09-468f-b0e3-98ff72ec88f1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_3eb8ce8a-da09-468f-b0e3-98ff72ec88f1" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_3eb8ce8a-da09-468f-b0e3-98ff72ec88f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_291ab73b-da3f-4f7f-a7f1-582580a9781d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_3eb8ce8a-da09-468f-b0e3-98ff72ec88f1" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_291ab73b-da3f-4f7f-a7f1-582580a9781d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_e3dee2d6-fd01-4c62-a40e-0e19450d7e15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_291ab73b-da3f-4f7f-a7f1-582580a9781d" xlink:to="loc_us-gaap_DomesticCountryMember_e3dee2d6-fd01-4c62-a40e-0e19450d7e15" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_ac24bb4e-e10f-41bb-9cad-918695fbf46a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_291ab73b-da3f-4f7f-a7f1-582580a9781d" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_ac24bb4e-e10f-41bb-9cad-918695fbf46a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_6fe1142d-7747-4cf5-a59a-ae36fc4c4ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_291ab73b-da3f-4f7f-a7f1-582580a9781d" xlink:to="loc_us-gaap_ForeignCountryMember_6fe1142d-7747-4cf5-a59a-ae36fc4c4ccf" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/StockBasedCompensationNarrativeDetails" xlink:type="extended" id="i5c1f7c9249594dabbcb6ad38f333363a_StockBasedCompensationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e7c355f9-a2e3-4a4c-bb0e-6442a14eeb7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfShareBasedStockSchemes_4bc1442e-34d4-468d-902c-b437b5815652" xlink:href="amci-20230213.xsd#amci_NumberOfShareBasedStockSchemes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e7c355f9-a2e3-4a4c-bb0e-6442a14eeb7f" xlink:to="loc_amci_NumberOfShareBasedStockSchemes_4bc1442e-34d4-468d-902c-b437b5815652" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_4bcc7f12-f524-4f3c-ac05-4866158cc5ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e7c355f9-a2e3-4a4c-bb0e-6442a14eeb7f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_4bcc7f12-f524-4f3c-ac05-4866158cc5ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4b1870bf-19bc-40c4-bc2a-60ec5c15ee18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e7c355f9-a2e3-4a4c-bb0e-6442a14eeb7f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4b1870bf-19bc-40c4-bc2a-60ec5c15ee18" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_497cd31a-c879-4cb2-b61c-c4a653a02f89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e7c355f9-a2e3-4a4c-bb0e-6442a14eeb7f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_497cd31a-c879-4cb2-b61c-c4a653a02f89" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_6da0da0b-b1f0-49da-b465-e12e6d7352e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e7c355f9-a2e3-4a4c-bb0e-6442a14eeb7f" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_6da0da0b-b1f0-49da-b465-e12e6d7352e7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_59613c3e-d483-4ee1-b333-f61dfd2a4aba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e7c355f9-a2e3-4a4c-bb0e-6442a14eeb7f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_59613c3e-d483-4ee1-b333-f61dfd2a4aba" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f07c951a-929f-4698-9421-e66a4a9279e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e7c355f9-a2e3-4a4c-bb0e-6442a14eeb7f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f07c951a-929f-4698-9421-e66a4a9279e1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5f9c1877-2896-4bd0-83ed-447b2db5fd34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e7c355f9-a2e3-4a4c-bb0e-6442a14eeb7f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5f9c1877-2896-4bd0-83ed-447b2db5fd34" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_673f1e21-0c4e-454c-b665-3d58990e0e58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e7c355f9-a2e3-4a4c-bb0e-6442a14eeb7f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_673f1e21-0c4e-454c-b665-3d58990e0e58" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_2f40502b-ba87-4210-8613-739ba900695c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e7c355f9-a2e3-4a4c-bb0e-6442a14eeb7f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_2f40502b-ba87-4210-8613-739ba900695c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7797a858-7ab3-4469-be75-e9499410eba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e7c355f9-a2e3-4a4c-bb0e-6442a14eeb7f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7797a858-7ab3-4469-be75-e9499410eba8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3544d690-d641-452a-b8f2-4f35ccf471cd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7797a858-7ab3-4469-be75-e9499410eba8" xlink:to="loc_srt_RangeAxis_3544d690-d641-452a-b8f2-4f35ccf471cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3544d690-d641-452a-b8f2-4f35ccf471cd_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_3544d690-d641-452a-b8f2-4f35ccf471cd" xlink:to="loc_srt_RangeMember_3544d690-d641-452a-b8f2-4f35ccf471cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d9792b32-5e99-4faf-bbd7-c4096cca1a31" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_3544d690-d641-452a-b8f2-4f35ccf471cd" xlink:to="loc_srt_RangeMember_d9792b32-5e99-4faf-bbd7-c4096cca1a31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_aaf2135c-e170-4e65-9d0e-2a358699224e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d9792b32-5e99-4faf-bbd7-c4096cca1a31" xlink:to="loc_srt_MinimumMember_aaf2135c-e170-4e65-9d0e-2a358699224e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9e74cb6d-d035-4b52-80e2-5f4ad28969cb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d9792b32-5e99-4faf-bbd7-c4096cca1a31" xlink:to="loc_srt_MaximumMember_9e74cb6d-d035-4b52-80e2-5f4ad28969cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b6e18b91-5b68-4bcc-b9cc-523cfdfd073b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7797a858-7ab3-4469-be75-e9499410eba8" xlink:to="loc_us-gaap_AwardTypeAxis_b6e18b91-5b68-4bcc-b9cc-523cfdfd073b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b6e18b91-5b68-4bcc-b9cc-523cfdfd073b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_b6e18b91-5b68-4bcc-b9cc-523cfdfd073b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b6e18b91-5b68-4bcc-b9cc-523cfdfd073b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e867f3f6-420e-419c-8aef-e97a90fb89ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_b6e18b91-5b68-4bcc-b9cc-523cfdfd073b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e867f3f6-420e-419c-8aef-e97a90fb89ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_b3604efc-d630-46ae-a6b8-0f1d21571bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e867f3f6-420e-419c-8aef-e97a90fb89ec" xlink:to="loc_us-gaap_EmployeeStockOptionMember_b3604efc-d630-46ae-a6b8-0f1d21571bf9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_85eb06d6-9369-463c-bd04-09f1c1e42fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e867f3f6-420e-419c-8aef-e97a90fb89ec" xlink:to="loc_us-gaap_RestrictedStockMember_85eb06d6-9369-463c-bd04-09f1c1e42fb5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/StockBasedCompensationFairValueAssumptionsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#StockBasedCompensationFairValueAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/StockBasedCompensationFairValueAssumptionsDetails" xlink:type="extended" id="i55add050c4e5408792515c858a4cf9e0_StockBasedCompensationFairValueAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a30e1f8-8a85-42bc-9275-3f4651e5fc04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_8a7e9cbb-ee91-40ad-b82b-c01973b5dfc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a30e1f8-8a85-42bc-9275-3f4651e5fc04" xlink:to="loc_us-gaap_SharePrice_8a7e9cbb-ee91-40ad-b82b-c01973b5dfc6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_e818dec0-ccf6-4aaf-a8e4-fe1a93532f99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a30e1f8-8a85-42bc-9275-3f4651e5fc04" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_e818dec0-ccf6-4aaf-a8e4-fe1a93532f99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_d09bdef3-a3a5-498a-8016-40e31b78e7af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a30e1f8-8a85-42bc-9275-3f4651e5fc04" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_d09bdef3-a3a5-498a-8016-40e31b78e7af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_489512a1-f316-4a30-9c43-6e5e4affcef1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a30e1f8-8a85-42bc-9275-3f4651e5fc04" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_489512a1-f316-4a30-9c43-6e5e4affcef1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7ed06be5-2551-40fe-833e-c58afac08c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a30e1f8-8a85-42bc-9275-3f4651e5fc04" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7ed06be5-2551-40fe-833e-c58afac08c8a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c9714e5a-9166-40cd-aed9-465f49d976f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a30e1f8-8a85-42bc-9275-3f4651e5fc04" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c9714e5a-9166-40cd-aed9-465f49d976f3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_98068630-4f10-40ab-b7b7-37cdabafa781" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a30e1f8-8a85-42bc-9275-3f4651e5fc04" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_98068630-4f10-40ab-b7b7-37cdabafa781" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_952164c8-9e20-4f93-9d1e-aa3013339f08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_98068630-4f10-40ab-b7b7-37cdabafa781" xlink:to="loc_us-gaap_AwardTypeAxis_952164c8-9e20-4f93-9d1e-aa3013339f08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_952164c8-9e20-4f93-9d1e-aa3013339f08_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_952164c8-9e20-4f93-9d1e-aa3013339f08" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_952164c8-9e20-4f93-9d1e-aa3013339f08_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c0023a40-0841-4e2e-88c7-badc24b75d74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_952164c8-9e20-4f93-9d1e-aa3013339f08" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c0023a40-0841-4e2e-88c7-badc24b75d74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4d5bfc3f-1512-485e-af3d-5be8ee38b88c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c0023a40-0841-4e2e-88c7-badc24b75d74" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4d5bfc3f-1512-485e-af3d-5be8ee38b88c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/StockBasedCompensationRestrictedStockAwardsActivityDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#StockBasedCompensationRestrictedStockAwardsActivityDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/StockBasedCompensationRestrictedStockAwardsActivityDetails" xlink:type="extended" id="i43cdb1fc9464409ba3063e55e7ce8880_StockBasedCompensationRestrictedStockAwardsActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aba192ce-95cb-4310-a787-80c7bc75ea35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e62ae742-a0da-467a-9e69-663655155a15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aba192ce-95cb-4310-a787-80c7bc75ea35" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e62ae742-a0da-467a-9e69-663655155a15" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7aae5001-64ac-4115-846d-cf6a570ded79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e62ae742-a0da-467a-9e69-663655155a15" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7aae5001-64ac-4115-846d-cf6a570ded79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_65a46d28-19b3-429b-b40c-a35100f4bbc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e62ae742-a0da-467a-9e69-663655155a15" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_65a46d28-19b3-429b-b40c-a35100f4bbc5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_7f2136f5-fd8d-4e99-bf0a-d9f8daf6d8af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e62ae742-a0da-467a-9e69-663655155a15" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_7f2136f5-fd8d-4e99-bf0a-d9f8daf6d8af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c808225b-1b9e-4c24-aec0-5f5302549c63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4c0477cd-861f-4344-9f49-282e42b6b937" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aba192ce-95cb-4310-a787-80c7bc75ea35" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4c0477cd-861f-4344-9f49-282e42b6b937" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_eff902dc-fd44-44d4-99d1-58796518fda4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4c0477cd-861f-4344-9f49-282e42b6b937" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_eff902dc-fd44-44d4-99d1-58796518fda4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e587decf-2a96-47de-94d9-2a052db0ac7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4c0477cd-861f-4344-9f49-282e42b6b937" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e587decf-2a96-47de-94d9-2a052db0ac7f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_45a126c5-dcd9-4a73-9a76-81fc75020c04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4c0477cd-861f-4344-9f49-282e42b6b937" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_45a126c5-dcd9-4a73-9a76-81fc75020c04" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3efb80c4-1e5e-4df7-bdfc-77b33272f0ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_25c928f5-a4f2-4fc3-b2cd-190f8c03f5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aba192ce-95cb-4310-a787-80c7bc75ea35" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_25c928f5-a4f2-4fc3-b2cd-190f8c03f5c0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6505ade0-ce5c-4280-884d-3839ea510256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_25c928f5-a4f2-4fc3-b2cd-190f8c03f5c0" xlink:to="loc_us-gaap_AwardTypeAxis_6505ade0-ce5c-4280-884d-3839ea510256" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6505ade0-ce5c-4280-884d-3839ea510256_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6505ade0-ce5c-4280-884d-3839ea510256" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6505ade0-ce5c-4280-884d-3839ea510256_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f276f50-b961-4519-8bea-e3e0df436964" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6505ade0-ce5c-4280-884d-3839ea510256" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f276f50-b961-4519-8bea-e3e0df436964" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_db0fc0a1-23d6-4295-94b5-ab8264a7f60d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f276f50-b961-4519-8bea-e3e0df436964" xlink:to="loc_us-gaap_RestrictedStockMember_db0fc0a1-23d6-4295-94b5-ab8264a7f60d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#RelatedPartyTransactionsDetails_1"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails_1" xlink:type="extended" id="i5c5fe46f14ef496ea2cc2ab3084d52af_RelatedPartyTransactionsDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_824a3409-b69e-404f-af52-f752060badff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_9049c9e0-ba89-4ff1-b3df-164e2427055a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_824a3409-b69e-404f-af52-f752060badff" xlink:to="loc_us-gaap_EquityMethodInvestments_9049c9e0-ba89-4ff1-b3df-164e2427055a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_e8e751e8-4d2d-4360-b4ad-22f561df04da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_824a3409-b69e-404f-af52-f752060badff" xlink:to="loc_us-gaap_AccountsReceivableNet_e8e751e8-4d2d-4360-b4ad-22f561df04da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_15dd20cc-e65a-4c42-9f0f-8d6bc2128d17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_824a3409-b69e-404f-af52-f752060badff" xlink:to="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_15dd20cc-e65a-4c42-9f0f-8d6bc2128d17" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_2f4650ea-1618-4f3f-92b5-ee22774fdf55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_824a3409-b69e-404f-af52-f752060badff" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_2f4650ea-1618-4f3f-92b5-ee22774fdf55" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_2bc805be-554d-4cca-9e16-5b22ce76972f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_824a3409-b69e-404f-af52-f752060badff" xlink:to="loc_us-gaap_RevenueFromRelatedParties_2bc805be-554d-4cca-9e16-5b22ce76972f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_0d89e291-7584-481a-9524-89c4491a81e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_824a3409-b69e-404f-af52-f752060badff" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_0d89e291-7584-481a-9524-89c4491a81e0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d33dd4d6-202f-4116-b889-6d874a02d1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_824a3409-b69e-404f-af52-f752060badff" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d33dd4d6-202f-4116-b889-6d874a02d1fc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_dec29975-2310-403a-927d-24ffa7a73e53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d33dd4d6-202f-4116-b889-6d874a02d1fc" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_dec29975-2310-403a-927d-24ffa7a73e53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_dec29975-2310-403a-927d-24ffa7a73e53_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_dec29975-2310-403a-927d-24ffa7a73e53" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_dec29975-2310-403a-927d-24ffa7a73e53_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_3b4bfc2d-4be0-4987-9d49-6698a9b11b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_dec29975-2310-403a-927d-24ffa7a73e53" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_3b4bfc2d-4be0-4987-9d49-6698a9b11b3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartyTransitionServicesAgreementMember_c2384b82-0959-462f-90f5-c3d2ff4359f4" xlink:href="amci-20230213.xsd#amci_RelatedPartyTransitionServicesAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_3b4bfc2d-4be0-4987-9d49-6698a9b11b3b" xlink:to="loc_amci_RelatedPartyTransitionServicesAgreementMember_c2384b82-0959-462f-90f5-c3d2ff4359f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartyInvestmentAgreementMember_e474fcef-4953-41bc-a2bb-e078f37e2f79" xlink:href="amci-20230213.xsd#amci_RelatedPartyInvestmentAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_3b4bfc2d-4be0-4987-9d49-6698a9b11b3b" xlink:to="loc_amci_RelatedPartyInvestmentAgreementMember_e474fcef-4953-41bc-a2bb-e078f37e2f79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartySupplyAgreementMember_6ef0dbd3-3802-4ff2-95e6-6f22e31097ef" xlink:href="amci-20230213.xsd#amci_RelatedPartySupplyAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_3b4bfc2d-4be0-4987-9d49-6698a9b11b3b" xlink:to="loc_amci_RelatedPartySupplyAgreementMember_6ef0dbd3-3802-4ff2-95e6-6f22e31097ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_740bac47-ef37-4a7f-919a-53fc0e239518" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d33dd4d6-202f-4116-b889-6d874a02d1fc" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_740bac47-ef37-4a7f-919a-53fc0e239518" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_740bac47-ef37-4a7f-919a-53fc0e239518_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_740bac47-ef37-4a7f-919a-53fc0e239518" xlink:to="loc_us-gaap_RelatedPartyDomain_740bac47-ef37-4a7f-919a-53fc0e239518_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_64cf256d-bf6c-496e-aed2-1462493ca78c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_740bac47-ef37-4a7f-919a-53fc0e239518" xlink:to="loc_us-gaap_RelatedPartyDomain_64cf256d-bf6c-496e-aed2-1462493ca78c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_8a544c66-9903-4e43-a48b-36e0f02b7aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_64cf256d-bf6c-496e-aed2-1462493ca78c" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_8a544c66-9903-4e43-a48b-36e0f02b7aea" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockAuthorizedIssuedandOutstandingSharesIssuePriceandCarryingValueDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#RedeemableConvertiblePreferredStockAuthorizedIssuedandOutstandingSharesIssuePriceandCarryingValueDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockAuthorizedIssuedandOutstandingSharesIssuePriceandCarryingValueDetails" xlink:type="extended" id="i7b7098104df24e1499fd469a29f43bd6_RedeemableConvertiblePreferredStockAuthorizedIssuedandOutstandingSharesIssuePriceandCarryingValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_27c1645f-2bb5-44e8-96c1-b92e7469da72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_a7e0fb6b-8830-4018-b294-c4ad8fde8489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_27c1645f-2bb5-44e8-96c1-b92e7469da72" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_a7e0fb6b-8830-4018-b294-c4ad8fde8489" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_3b2241f8-73c1-453a-824f-40aafee40fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_27c1645f-2bb5-44e8-96c1-b92e7469da72" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_3b2241f8-73c1-453a-824f-40aafee40fbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_822de676-5dd5-4026-a081-ccc26090f972" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_27c1645f-2bb5-44e8-96c1-b92e7469da72" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_822de676-5dd5-4026-a081-ccc26090f972" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityIssuePricePerShare_05f68bd6-6606-45ea-aa84-4620e802015d" xlink:href="amci-20230213.xsd#amci_TemporaryEquityIssuePricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_27c1645f-2bb5-44e8-96c1-b92e7469da72" xlink:to="loc_amci_TemporaryEquityIssuePricePerShare_05f68bd6-6606-45ea-aa84-4620e802015d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_26d25ffd-5766-45e1-8147-cb47d9f96d90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_27c1645f-2bb5-44e8-96c1-b92e7469da72" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_26d25ffd-5766-45e1-8147-cb47d9f96d90" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_c5f1d3db-5337-458a-8a45-524a00b8e3d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TemporaryEquityLineItems_27c1645f-2bb5-44e8-96c1-b92e7469da72" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_c5f1d3db-5337-458a-8a45-524a00b8e3d0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1379bde6-dd4b-4509-bcd8-fe32533d0f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_c5f1d3db-5337-458a-8a45-524a00b8e3d0" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1379bde6-dd4b-4509-bcd8-fe32533d0f6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_1379bde6-dd4b-4509-bcd8-fe32533d0f6b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1379bde6-dd4b-4509-bcd8-fe32533d0f6b" xlink:to="loc_us-gaap_ClassOfStockDomain_1379bde6-dd4b-4509-bcd8-fe32533d0f6b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6b15e8b4-4038-4526-83b3-cff14c53824e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1379bde6-dd4b-4509-bcd8-fe32533d0f6b" xlink:to="loc_us-gaap_ClassOfStockDomain_6b15e8b4-4038-4526-83b3-cff14c53824e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_415a3323-026e-451f-a2f6-eb175bb6a737" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6b15e8b4-4038-4526-83b3-cff14c53824e" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_415a3323-026e-451f-a2f6-eb175bb6a737" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_453248fe-b8a7-4e74-81c5-aff4bab3260b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6b15e8b4-4038-4526-83b3-cff14c53824e" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_453248fe-b8a7-4e74-81c5-aff4bab3260b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_a48ca6f1-5302-4616-acde-509bb6c7d45d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6b15e8b4-4038-4526-83b3-cff14c53824e" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_a48ca6f1-5302-4616-acde-509bb6c7d45d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_c98162d1-f61e-4bd5-bb43-c9557e267660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6b15e8b4-4038-4526-83b3-cff14c53824e" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_c98162d1-f61e-4bd5-bb43-c9557e267660" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_9bd4d6c9-9133-40df-880e-6b572b99103f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6b15e8b4-4038-4526-83b3-cff14c53824e" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_9bd4d6c9-9133-40df-880e-6b572b99103f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember_22cc61ad-59b7-4a63-974c-e79e9f918c51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6b15e8b4-4038-4526-83b3-cff14c53824e" xlink:to="loc_us-gaap_SeriesFPreferredStockMember_22cc61ad-59b7-4a63-974c-e79e9f918c51" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_37b93e9f-3eb7-4c10-b574-80547e535ec5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_c5f1d3db-5337-458a-8a45-524a00b8e3d0" xlink:to="loc_srt_RangeAxis_37b93e9f-3eb7-4c10-b574-80547e535ec5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_37b93e9f-3eb7-4c10-b574-80547e535ec5_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_37b93e9f-3eb7-4c10-b574-80547e535ec5" xlink:to="loc_srt_RangeMember_37b93e9f-3eb7-4c10-b574-80547e535ec5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_afea1b11-06fd-4067-b05a-461a5a5d520d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_37b93e9f-3eb7-4c10-b574-80547e535ec5" xlink:to="loc_srt_RangeMember_afea1b11-06fd-4067-b05a-461a5a5d520d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_28ab2932-0fb4-4c96-bb93-32203ed13797" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_afea1b11-06fd-4067-b05a-461a5a5d520d" xlink:to="loc_srt_MinimumMember_28ab2932-0fb4-4c96-bb93-32203ed13797" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e1d05acc-4b7f-42b1-ac62-ca1c655124b3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_afea1b11-06fd-4067-b05a-461a5a5d520d" xlink:to="loc_srt_MaximumMember_e1d05acc-4b7f-42b1-ac62-ca1c655124b3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockChangesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#RedeemableConvertiblePreferredStockChangesDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockChangesDetails" xlink:type="extended" id="i842b59cb5e7145f784c0a441294e0775_RedeemableConvertiblePreferredStockChangesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_3b25a73c-97de-4b3f-9951-f4765d44a876" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d50fc952-97cc-4f52-8989-1580220b2593" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_3b25a73c-97de-4b3f-9951-f4765d44a876" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d50fc952-97cc-4f52-8989-1580220b2593" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_880639c1-da8c-48bf-8a2d-752a96ecc9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d50fc952-97cc-4f52-8989-1580220b2593" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_880639c1-da8c-48bf-8a2d-752a96ecc9d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_d327aeae-37c1-43fe-b59e-064bef766455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d50fc952-97cc-4f52-8989-1580220b2593" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_d327aeae-37c1-43fe-b59e-064bef766455" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_23ce97dd-829d-44d4-b344-818b65c89a0f" xlink:href="amci-20230213.xsd#amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d50fc952-97cc-4f52-8989-1580220b2593" xlink:to="loc_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_23ce97dd-829d-44d4-b344-818b65c89a0f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_b7dbe3d5-8720-495e-85da-e2f1e4577f45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d50fc952-97cc-4f52-8989-1580220b2593" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_b7dbe3d5-8720-495e-85da-e2f1e4577f45" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_7f241a1c-2c5e-4ec5-af98-49c4da420263" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_a5452a53-e5dc-4a6d-ae91-67c3bc632ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_cd7c3ded-35d2-4042-aea8-efbb7dc24f14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TemporaryEquityLineItems_3b25a73c-97de-4b3f-9951-f4765d44a876" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_cd7c3ded-35d2-4042-aea8-efbb7dc24f14" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1fdf40f2-a0c3-4cea-b1cf-25c6f35a3d71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_cd7c3ded-35d2-4042-aea8-efbb7dc24f14" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1fdf40f2-a0c3-4cea-b1cf-25c6f35a3d71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_1fdf40f2-a0c3-4cea-b1cf-25c6f35a3d71_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1fdf40f2-a0c3-4cea-b1cf-25c6f35a3d71" xlink:to="loc_us-gaap_ClassOfStockDomain_1fdf40f2-a0c3-4cea-b1cf-25c6f35a3d71_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_827a47ac-32b4-4539-b2ea-59e03bbea104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1fdf40f2-a0c3-4cea-b1cf-25c6f35a3d71" xlink:to="loc_us-gaap_ClassOfStockDomain_827a47ac-32b4-4539-b2ea-59e03bbea104" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_0c9cb7e6-ea54-4036-a733-0cf73443db43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_827a47ac-32b4-4539-b2ea-59e03bbea104" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_0c9cb7e6-ea54-4036-a733-0cf73443db43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_a39aacb9-368f-4fb0-9348-9c43e324afc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_827a47ac-32b4-4539-b2ea-59e03bbea104" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_a39aacb9-368f-4fb0-9348-9c43e324afc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_e79ec7f9-1d20-41dd-a0a4-6cbb36de8ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_827a47ac-32b4-4539-b2ea-59e03bbea104" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_e79ec7f9-1d20-41dd-a0a4-6cbb36de8ddd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_65daf9a2-fe6b-4bb3-8368-ea95e4ee8578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_827a47ac-32b4-4539-b2ea-59e03bbea104" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_65daf9a2-fe6b-4bb3-8368-ea95e4ee8578" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_dee5c003-2839-4603-9987-8ddb83c6d373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_827a47ac-32b4-4539-b2ea-59e03bbea104" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_dee5c003-2839-4603-9987-8ddb83c6d373" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember_0b8d19a2-f46f-40d7-b02b-233514107916" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_827a47ac-32b4-4539-b2ea-59e03bbea104" xlink:to="loc_us-gaap_SeriesFPreferredStockMember_0b8d19a2-f46f-40d7-b02b-233514107916" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockNarrativeDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#RedeemableConvertiblePreferredStockNarrativeDetails"/>
  <link:definitionLink xlink:role="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockNarrativeDetails" xlink:type="extended" id="ic99da8a946c54f8b8225eb8bc0942174_RedeemableConvertiblePreferredStockNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_318d8ca0-5917-4479-97fc-89d701849593" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_ce0eae0c-6de2-4cb2-93de-95c676a25e2f" xlink:href="amci-20230213.xsd#amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_318d8ca0-5917-4479-97fc-89d701849593" xlink:to="loc_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_ce0eae0c-6de2-4cb2-93de-95c676a25e2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_a22bb5d7-a8e2-42cb-b34e-2c98acc421c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_318d8ca0-5917-4479-97fc-89d701849593" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_a22bb5d7-a8e2-42cb-b34e-2c98acc421c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityStockIssuedDuringPeriodPricePerShare_3904cb88-d038-4cf1-8d87-f362e067e6ad" xlink:href="amci-20230213.xsd#amci_TemporaryEquityStockIssuedDuringPeriodPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_318d8ca0-5917-4479-97fc-89d701849593" xlink:to="loc_amci_TemporaryEquityStockIssuedDuringPeriodPricePerShare_3904cb88-d038-4cf1-8d87-f362e067e6ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquitySharesConversionOfConvertibleSecurities_344f2d9b-ce75-47e7-8007-a508af60d9aa" xlink:href="amci-20230213.xsd#amci_TemporaryEquitySharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_318d8ca0-5917-4479-97fc-89d701849593" xlink:to="loc_amci_TemporaryEquitySharesConversionOfConvertibleSecurities_344f2d9b-ce75-47e7-8007-a508af60d9aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_9fda3839-7db4-440e-bae9-1182f4aa7320" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_318d8ca0-5917-4479-97fc-89d701849593" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_9fda3839-7db4-440e-bae9-1182f4aa7320" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_c4fc6ede-93e7-4783-8ad6-a07ca24c7291" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TemporaryEquityLineItems_318d8ca0-5917-4479-97fc-89d701849593" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_c4fc6ede-93e7-4783-8ad6-a07ca24c7291" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b02a24b6-f913-4e62-b006-82f6a85af061" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_c4fc6ede-93e7-4783-8ad6-a07ca24c7291" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b02a24b6-f913-4e62-b006-82f6a85af061" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b02a24b6-f913-4e62-b006-82f6a85af061_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b02a24b6-f913-4e62-b006-82f6a85af061" xlink:to="loc_us-gaap_ClassOfStockDomain_b02a24b6-f913-4e62-b006-82f6a85af061_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_792a58fa-9b99-485b-a1b3-96af0d7b9846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b02a24b6-f913-4e62-b006-82f6a85af061" xlink:to="loc_us-gaap_ClassOfStockDomain_792a58fa-9b99-485b-a1b3-96af0d7b9846" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_45f23bc1-58db-47e7-bdc0-027721dec528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_792a58fa-9b99-485b-a1b3-96af0d7b9846" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_45f23bc1-58db-47e7-bdc0-027721dec528" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_9f617756-60e3-4b2b-957e-ad6f4e82c270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_792a58fa-9b99-485b-a1b3-96af0d7b9846" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_9f617756-60e3-4b2b-957e-ad6f4e82c270" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember_c8013cc0-0384-4f95-9a33-0150dda4624a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_792a58fa-9b99-485b-a1b3-96af0d7b9846" xlink:to="loc_us-gaap_SeriesFPreferredStockMember_c8013cc0-0384-4f95-9a33-0150dda4624a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>amci-20230213_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:1f450268-e321-4330-aadf-815e69af2b4b,g:fe19691a-e2ec-4bc1-af0c-c42cfd4d1d7c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_96d6830d-4d30-42c7-a73a-4835bd0548dc_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentration Risk</link:label>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicConcentrationRiskMember" xlink:to="lab_us-gaap_GeographicConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_d1286b1c-eec8-46e7-867f-3b255ac40cc8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ClassOfWarrantOrRightAmountOfNotesPurchased_c628f9ee-03d1-4dee-b23e-1d8172ab2437_terseLabel_en-US" xlink:label="lab_amci_ClassOfWarrantOrRightAmountOfNotesPurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Notes purchased</link:label>
    <link:label id="lab_amci_ClassOfWarrantOrRightAmountOfNotesPurchased_label_en-US" xlink:label="lab_amci_ClassOfWarrantOrRightAmountOfNotesPurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Amount Of Notes Purchased</link:label>
    <link:label id="lab_amci_ClassOfWarrantOrRightAmountOfNotesPurchased_documentation_en-US" xlink:label="lab_amci_ClassOfWarrantOrRightAmountOfNotesPurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Amount Of Notes Purchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightAmountOfNotesPurchased" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightAmountOfNotesPurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ClassOfWarrantOrRightAmountOfNotesPurchased" xlink:to="lab_amci_ClassOfWarrantOrRightAmountOfNotesPurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_e46df4bf-d3c6-4703-ac50-d76d24d3b057_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_7bc9ebbc-8b7f-4bcf-8d06-8a89a785aeef_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease income from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:to="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_20f475ff-4e88-4dd9-bfae-2d720eeecb1e_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_4fcacdce-16b8-45be-a607-b0b078fef791_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_ad16d2f9-9ada-4320-bbc8-5edd92de18db_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currencies</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_4b9bce49-d253-469d-be3d-6059a00acce0_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_13234e6d-f5f7-4114-a1f7-1e3b201c39e0_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bad debt expense and recoveries</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent_0a10b2c8-accc-4cd7-9566-77e2102a7371_terseLabel_en-US" xlink:label="lab_amci_ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from non-current to current contract liabilities</link:label>
    <link:label id="lab_amci_ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent_label_en-US" xlink:label="lab_amci_ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Current, Reclassification From Noncurrent</link:label>
    <link:label id="lab_amci_ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent_documentation_en-US" xlink:label="lab_amci_ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Current, Reclassification From Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent" xlink:href="amci-20230213.xsd#amci_ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent" xlink:to="lab_amci_ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_e63252e4-d6d5-41bb-baae-fb5502e6ea5f_terseLabel_en-US" xlink:label="lab_amci_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses per month</link:label>
    <link:label id="lab_amci_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_label_en-US" xlink:label="lab_amci_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party Per Month</link:label>
    <link:label id="lab_amci_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_documentation_en-US" xlink:label="lab_amci_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The contractual monthly amount to be paid for support services.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" xlink:href="amci-20230213.xsd#amci_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" xlink:to="lab_amci_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ContractWithCustomerLiabilityCurrentAbstract_5d9028b3-4f41-485a-a04d-3c777fee3c53_terseLabel_en-US" xlink:label="lab_amci_ContractWithCustomerLiabilityCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Contract Liabilities</link:label>
    <link:label id="lab_amci_ContractWithCustomerLiabilityCurrentAbstract_label_en-US" xlink:label="lab_amci_ContractWithCustomerLiabilityCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Current [Abstract]</link:label>
    <link:label id="lab_amci_ContractWithCustomerLiabilityCurrentAbstract_documentation_en-US" xlink:label="lab_amci_ContractWithCustomerLiabilityCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContractWithCustomerLiabilityCurrentAbstract" xlink:href="amci-20230213.xsd#amci_ContractWithCustomerLiabilityCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ContractWithCustomerLiabilityCurrentAbstract" xlink:to="lab_amci_ContractWithCustomerLiabilityCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ErrorCorrectionEquityMethodInvestmentContributedIntellectualAssetMember_84af65dc-c172-4a4d-9c24-a7fbd4a9ebe2_terseLabel_en-US" xlink:label="lab_amci_ErrorCorrectionEquityMethodInvestmentContributedIntellectualAssetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Equity Method Investment, Contributed Intellectual Asset</link:label>
    <link:label id="lab_amci_ErrorCorrectionEquityMethodInvestmentContributedIntellectualAssetMember_label_en-US" xlink:label="lab_amci_ErrorCorrectionEquityMethodInvestmentContributedIntellectualAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Equity Method Investment, Contributed Intellectual Asset [Member]</link:label>
    <link:label id="lab_amci_ErrorCorrectionEquityMethodInvestmentContributedIntellectualAssetMember_documentation_en-US" xlink:label="lab_amci_ErrorCorrectionEquityMethodInvestmentContributedIntellectualAssetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Equity Method Investment, Contributed Intellectual Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ErrorCorrectionEquityMethodInvestmentContributedIntellectualAssetMember" xlink:href="amci-20230213.xsd#amci_ErrorCorrectionEquityMethodInvestmentContributedIntellectualAssetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ErrorCorrectionEquityMethodInvestmentContributedIntellectualAssetMember" xlink:to="lab_amci_ErrorCorrectionEquityMethodInvestmentContributedIntellectualAssetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_896b2ea2-0f50-4271-a73b-5907353a7d62_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_247b4d2c-96bf-4f85-a8bc-d3a002a1a53c_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_7814c270-6b0c-4b55-9726-3b3821a8c223_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, shares outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_MaximumLoansConvertibleIntoWarrants_28cb98c1-9e01-4ebb-99a6-348a998cf677_terseLabel_en-US" xlink:label="lab_amci_MaximumLoansConvertibleIntoWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan conversion agreement warrant</link:label>
    <link:label id="lab_amci_MaximumLoansConvertibleIntoWarrants_label_en-US" xlink:label="lab_amci_MaximumLoansConvertibleIntoWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">maximum Loans Convertible Into Warrants</link:label>
    <link:label id="lab_amci_MaximumLoansConvertibleIntoWarrants_documentation_en-US" xlink:label="lab_amci_MaximumLoansConvertibleIntoWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The maximum amount which a potential loan could have repaid through issuance of warrants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MaximumLoansConvertibleIntoWarrants" xlink:href="amci-20230213.xsd#amci_MaximumLoansConvertibleIntoWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_MaximumLoansConvertibleIntoWarrants" xlink:to="lab_amci_MaximumLoansConvertibleIntoWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments_a9df9a89-4628-4fee-8b4a-f0f7b0c8b184_negatedTerseLabel_en-US" xlink:label="lab_amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of equity instruments</link:label>
    <link:label id="lab_amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments_label_en-US" xlink:label="lab_amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Repurchase of Equity Instruments</link:label>
    <link:label id="lab_amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments_documentation_en-US" xlink:label="lab_amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Repurchase of Equity Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments" xlink:href="amci-20230213.xsd#amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments" xlink:to="lab_amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_03d19db5-41c7-4ab1-b09e-6f3de9951f33_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_90198074-fa21-49e0-b1f7-e81067cab16c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_82cbd0e1-32e2-48bf-b4a4-edece087fea9_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of impairment</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_InitialPublicOfferingTextBlock_13839c47-c3fc-4b8d-b570-dd6776b07d1b_terseLabel_en-US" xlink:label="lab_amci_InitialPublicOfferingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Public Offering</link:label>
    <link:label id="lab_amci_InitialPublicOfferingTextBlock_label_en-US" xlink:label="lab_amci_InitialPublicOfferingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Public Offering [Text Block]</link:label>
    <link:label id="lab_amci_InitialPublicOfferingTextBlock_documentation_en-US" xlink:label="lab_amci_InitialPublicOfferingTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure on information about initial public offering.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_InitialPublicOfferingTextBlock" xlink:href="amci-20230213.xsd#amci_InitialPublicOfferingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_InitialPublicOfferingTextBlock" xlink:to="lab_amci_InitialPublicOfferingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_f8322785-9fbc-4f33-bdde-5112bca3b857_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTextBlock_3ecedf79-b82a-43f9-8c07-0ab5b6b18d7a_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTextBlock" xlink:to="lab_us-gaap_InvestmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_c8b81c89-021a-4ba0-a737-5a07bf0c7c1d_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentAmount_80a9dcbc-f662-4144-b4a9-6d04f92803dd_terseLabel_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment</link:label>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentAmount_label_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Equity Method Investment, Amount</link:label>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentAmount_documentation_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Equity Method Investment, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentAmount" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentAmount" xlink:to="lab_amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses_bdbd6bdd-eb04-4659-aab5-b2fa9c10da4a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued bonus</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Bonuses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_5d632f6e-5297-4db6-b02e-6355030f95c7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesDPreferredStockMember_0de2d255-edb6-4d29-adaf-68cb88974b51_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesDPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series D</link:label>
    <link:label id="lab_us-gaap_SeriesDPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesDPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series D Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesDPreferredStockMember" xlink:to="lab_us-gaap_SeriesDPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_LesseeOperatingLeaseNumberOfRenewalTerms_8fe94d0c-cb8b-47f8-9e36-ea1ef456b098_terseLabel_en-US" xlink:label="lab_amci_LesseeOperatingLeaseNumberOfRenewalTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease number of renewal terms</link:label>
    <link:label id="lab_amci_LesseeOperatingLeaseNumberOfRenewalTerms_label_en-US" xlink:label="lab_amci_LesseeOperatingLeaseNumberOfRenewalTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Number Of Renewal Terms</link:label>
    <link:label id="lab_amci_LesseeOperatingLeaseNumberOfRenewalTerms_documentation_en-US" xlink:label="lab_amci_LesseeOperatingLeaseNumberOfRenewalTerms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Number Of Renewal Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LesseeOperatingLeaseNumberOfRenewalTerms" xlink:href="amci-20230213.xsd#amci_LesseeOperatingLeaseNumberOfRenewalTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_LesseeOperatingLeaseNumberOfRenewalTerms" xlink:to="lab_amci_LesseeOperatingLeaseNumberOfRenewalTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_UnderwriterCashDiscount_6fca7bf9-2c1b-4b25-b6fe-868cb4e1c2e5_terseLabel_en-US" xlink:label="lab_amci_UnderwriterCashDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underwriter cash discount</link:label>
    <link:label id="lab_amci_UnderwriterCashDiscount_label_en-US" xlink:label="lab_amci_UnderwriterCashDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underwriter cash discount</link:label>
    <link:label id="lab_amci_UnderwriterCashDiscount_documentation_en-US" xlink:label="lab_amci_UnderwriterCashDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the cash underwriting discount per unit.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_UnderwriterCashDiscount" xlink:href="amci-20230213.xsd#amci_UnderwriterCashDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_UnderwriterCashDiscount" xlink:to="lab_amci_UnderwriterCashDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_1c6443f0-ce03-4111-9a3a-979dbe1e95a6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_0551ae73-d2f0-490e-b964-d960430ccdf9_verboseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_Depreciation_7e8be9f0-5c0a-4020-8b0b-349ce653b97e_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c7d578fc-72c0-43f3-a258-a36d92b1cc77_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon exercise of options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_96448793-84da-4590-933e-84a4a8f7c140_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0ac7581f-24a7-49a2-ada6-d5b233fc0d94_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_f2c3c151-6ca3-4572-a219-14b89560e147_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred income tax assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_d3181c22-4ca1-4207-a5b6-b23c031736ea_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_29d450f1-36de-4cbf-90a9-a73e44e36247_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights_624ed527-7fc3-4906-80bc-cd9d5155db76_terseLabel_en-US" xlink:label="lab_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Price of warrant</link:label>
    <link:label id="lab_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights_label_en-US" xlink:label="lab_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Price of Warrants or Rights</link:label>
    <link:label id="lab_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights_documentation_en-US" xlink:label="lab_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Price per share or per unit of warrants or rights outstanding.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:to="lab_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_ee153bae-921b-458f-ae06-2a79b4918825_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_LesssorOperatingLeaseNumberOfRenewalOptions_4c5effb4-e219-4f8e-a685-0c604f5e0e7e_terseLabel_en-US" xlink:label="lab_amci_LesssorOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of renewal options</link:label>
    <link:label id="lab_amci_LesssorOperatingLeaseNumberOfRenewalOptions_label_en-US" xlink:label="lab_amci_LesssorOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lesssor, Operating Lease, Number Of Renewal Options</link:label>
    <link:label id="lab_amci_LesssorOperatingLeaseNumberOfRenewalOptions_documentation_en-US" xlink:label="lab_amci_LesssorOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lesssor, Operating Lease, Number Of Renewal Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LesssorOperatingLeaseNumberOfRenewalOptions" xlink:href="amci-20230213.xsd#amci_LesssorOperatingLeaseNumberOfRenewalOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_LesssorOperatingLeaseNumberOfRenewalOptions" xlink:to="lab_amci_LesssorOperatingLeaseNumberOfRenewalOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_39351824-1de9-4450-9238-b9f9ac4acd74_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_90aca5c2-c033-4a75-bbf4-cdb3c9d56750_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_fb065a6e-05c4-4e50-b78b-09507305a876_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_8a9eca0f-58a5-4fbf-bf2d-7e3a5674bb1a_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, Redeemable Convertible Preferred Stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_24c88e4e-6be8-4f4b-a7aa-c15763cc24ce_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, Redeemable Convertible Preferred Stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_0e46caa8-3779-46f9-8907-e4a34a6894c6_verboseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock subject to possible redemption, outstanding</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_ba2589f4-9a76-4134-8bf0-2344537feeb6_netLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:to="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_159263f0-8a56-485b-aa46-28cf09f4bb07_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b904eec-7f8a-423b-b75d-9a061be2a3d9_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c013ada4-14ed-4c51-ad4d-278f7550a394_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate purchase of stock</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a01a5926-401d-437e-b12b-a061717b1234_verboseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive shares</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_768f5a74-d432-4c0c-a39b-7a71f81c8add_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_600651df-dd69-4c9f-99d5-c1af674d4e67_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering costs allocated to derivative warrant liabilities (in percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_b2681c6e-873f-479b-8cdc-8790349ce8df_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_aeaa45f5-0bde-4305-a579-53a322a6a888_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ErrorCorrectionEquityMethodInvestmentsIntangiblesAndFixedAssetsMember_bcc44d01-1ff4-44fa-a2ed-51aa5217857b_terseLabel_en-US" xlink:label="lab_amci_ErrorCorrectionEquityMethodInvestmentsIntangiblesAndFixedAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Equity Method Investments, Intangibles And Fixed Assets</link:label>
    <link:label id="lab_amci_ErrorCorrectionEquityMethodInvestmentsIntangiblesAndFixedAssetsMember_label_en-US" xlink:label="lab_amci_ErrorCorrectionEquityMethodInvestmentsIntangiblesAndFixedAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Equity Method Investments, Intangibles And Fixed Assets [Member]</link:label>
    <link:label id="lab_amci_ErrorCorrectionEquityMethodInvestmentsIntangiblesAndFixedAssetsMember_documentation_en-US" xlink:label="lab_amci_ErrorCorrectionEquityMethodInvestmentsIntangiblesAndFixedAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Equity Method Investments, Intangibles And Fixed Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ErrorCorrectionEquityMethodInvestmentsIntangiblesAndFixedAssetsMember" xlink:href="amci-20230213.xsd#amci_ErrorCorrectionEquityMethodInvestmentsIntangiblesAndFixedAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ErrorCorrectionEquityMethodInvestmentsIntangiblesAndFixedAssetsMember" xlink:to="lab_amci_ErrorCorrectionEquityMethodInvestmentsIntangiblesAndFixedAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_2d45f1df-0c10-49e5-9e34-5b66391a1a74_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_f0592127-8e00-454b-9c05-be48e4429521_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_ed4dd239-3c58-4ca7-b3b7-d19d2fc947be_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_4f9de73a-25d2-4845-ac85-87499976b188_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of possible loss</link:label>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_label_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:to="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_c364ae58-062f-4878-98b9-788bf16d6e57_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_2cfaf89a-6534-422d-a510-553ba9f3458c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_582b84f3-1c6e-4bec-abdc-857346b2ba67_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_573fa234-3ae2-47d9-8de2-e5005cdd1f2e_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_MonthsToCompleteAcquisition_a4cd597e-050d-4274-9ed8-18e7401c2229_terseLabel_en-US" xlink:label="lab_amci_MonthsToCompleteAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Months to complete acquisition</link:label>
    <link:label id="lab_amci_MonthsToCompleteAcquisition_label_en-US" xlink:label="lab_amci_MonthsToCompleteAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Months To Complete Acquisition</link:label>
    <link:label id="lab_amci_MonthsToCompleteAcquisition_documentation_en-US" xlink:label="lab_amci_MonthsToCompleteAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the anticipated business timeline in months for completing a business combination.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MonthsToCompleteAcquisition" xlink:href="amci-20230213.xsd#amci_MonthsToCompleteAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_MonthsToCompleteAcquisition" xlink:to="lab_amci_MonthsToCompleteAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_CustomerAMember_7b0bad67-1d04-44a7-86f7-58dfa0b61f5c_terseLabel_en-US" xlink:label="lab_amci_CustomerAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer A</link:label>
    <link:label id="lab_amci_CustomerAMember_label_en-US" xlink:label="lab_amci_CustomerAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer A [Member]</link:label>
    <link:label id="lab_amci_CustomerAMember_documentation_en-US" xlink:label="lab_amci_CustomerAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer A</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CustomerAMember" xlink:href="amci-20230213.xsd#amci_CustomerAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_CustomerAMember" xlink:to="lab_amci_CustomerAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_ca12f471-7571-4f96-9c50-599356cd634f_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_PublicWarrantsMember_681536bf-ca2f-442f-9734-ec7c48291a82_terseLabel_en-US" xlink:label="lab_amci_PublicWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">public warrants</link:label>
    <link:label id="lab_amci_PublicWarrantsMember_label_en-US" xlink:label="lab_amci_PublicWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Warrants</link:label>
    <link:label id="lab_amci_PublicWarrantsMember_documentation_en-US" xlink:label="lab_amci_PublicWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents a redeemable warrant (Public Warrant) that entitles the holder to purchase shares of common stock subject to adjustment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PublicWarrantsMember" xlink:href="amci-20230213.xsd#amci_PublicWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_PublicWarrantsMember" xlink:to="lab_amci_PublicWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputExpectedDividendRateMember_321f0de0-d5dc-4beb-99f0-1287b48626b6_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_MeasurementInputExpectedDividendRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_6524afd0-0153-44ed-9031-aeae2dfc995d_terseLabel_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards Activity</link:label>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested Restricted Stock Shares Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_73f105ee-8610-4c3e-93c2-4eabfb53c1a1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled/forfeited (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_9072b63b-6b5e-4297-8d62-acf62895cc50_terseLabel_en-US" xlink:label="lab_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of preferred stock (in shares)</link:label>
    <link:label id="lab_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Shares, New Issues</link:label>
    <link:label id="lab_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_documentation_en-US" xlink:label="lab_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:href="amci-20230213.xsd#amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_40dc15da-f61b-4855-b666-adb5a69172e5_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent" xlink:to="lab_us-gaap_LiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_d3de8303-4c5e-468d-9c42-7a18aa3bf277_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, Weighted average remaining contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_29e23560-2f94-4a72-abf0-623637748788_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price, per unit</link:label>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_a64bbf8b-b506-404b-a0d5-a1e7fc1098ab_verboseLabel_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Price per share</link:label>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_label_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_RevenueFromContractWithCustomerAmortizationPeriod_92613f24-f237-4440-a361-0e819b3ed252_terseLabel_en-US" xlink:label="lab_amci_RevenueFromContractWithCustomerAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Profit amortization period</link:label>
    <link:label id="lab_amci_RevenueFromContractWithCustomerAmortizationPeriod_label_en-US" xlink:label="lab_amci_RevenueFromContractWithCustomerAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Amortization Period</link:label>
    <link:label id="lab_amci_RevenueFromContractWithCustomerAmortizationPeriod_documentation_en-US" xlink:label="lab_amci_RevenueFromContractWithCustomerAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RevenueFromContractWithCustomerAmortizationPeriod" xlink:href="amci-20230213.xsd#amci_RevenueFromContractWithCustomerAmortizationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_RevenueFromContractWithCustomerAmortizationPeriod" xlink:to="lab_amci_RevenueFromContractWithCustomerAmortizationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_2c166940-8dd4-4582-9d95-88dc3ef4326e_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_6b1115b7-a6e8-4698-8706-69977d76f1f7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_RelatedAndNonrelatedPartyStatusDomain_ef67a65a-a19e-420c-b4e2-ea477913fe9d_terseLabel_en-US" xlink:label="lab_amci_RelatedAndNonrelatedPartyStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related and Nonrelated Party Status [Domain]</link:label>
    <link:label id="lab_amci_RelatedAndNonrelatedPartyStatusDomain_label_en-US" xlink:label="lab_amci_RelatedAndNonrelatedPartyStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related and Nonrelated Party Status [Domain]</link:label>
    <link:label id="lab_amci_RelatedAndNonrelatedPartyStatusDomain_documentation_en-US" xlink:label="lab_amci_RelatedAndNonrelatedPartyStatusDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related and Nonrelated Party Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedAndNonrelatedPartyStatusDomain" xlink:href="amci-20230213.xsd#amci_RelatedAndNonrelatedPartyStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_RelatedAndNonrelatedPartyStatusDomain" xlink:to="lab_amci_RelatedAndNonrelatedPartyStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_EquityMethodInvestmentContingentRightToReceiveAdditionalInterest_7f0cbfe2-50fb-4f3b-85b6-afc7e1770abf_terseLabel_en-US" xlink:label="lab_amci_EquityMethodInvestmentContingentRightToReceiveAdditionalInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent right to receive additional interest</link:label>
    <link:label id="lab_amci_EquityMethodInvestmentContingentRightToReceiveAdditionalInterest_label_en-US" xlink:label="lab_amci_EquityMethodInvestmentContingentRightToReceiveAdditionalInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Contingent Right To Receive Additional Interest</link:label>
    <link:label id="lab_amci_EquityMethodInvestmentContingentRightToReceiveAdditionalInterest_documentation_en-US" xlink:label="lab_amci_EquityMethodInvestmentContingentRightToReceiveAdditionalInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Contingent Right To Receive Additional Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EquityMethodInvestmentContingentRightToReceiveAdditionalInterest" xlink:href="amci-20230213.xsd#amci_EquityMethodInvestmentContingentRightToReceiveAdditionalInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_EquityMethodInvestmentContingentRightToReceiveAdditionalInterest" xlink:to="lab_amci_EquityMethodInvestmentContingentRightToReceiveAdditionalInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_1ef2131d-f82a-4d4b-9c0e-150b5064be06_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount_468c08c8-c5f6-484e-8816-dd531662c7a9_terseLabel_en-US" xlink:label="lab_amci_TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax obligations</link:label>
    <link:label id="lab_amci_TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount_label_en-US" xlink:label="lab_amci_TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax obligations paid from income from investments held in the trust account</link:label>
    <link:label id="lab_amci_TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount_documentation_en-US" xlink:label="lab_amci_TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">It represents tax obligations paid from income from investments held in the trust account.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount" xlink:href="amci-20230213.xsd#amci_TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount" xlink:to="lab_amci_TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_CostOfRevenueFromContractsWithCustomersExcludingDepreciation_d0f00d54-9c7e-4523-98e2-1661fd14b2a7_negatedTerseLabel_en-US" xlink:label="lab_amci_CostOfRevenueFromContractsWithCustomersExcludingDepreciation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenues from contracts with customers (exclusive of depreciation shown below)</link:label>
    <link:label id="lab_amci_CostOfRevenueFromContractsWithCustomersExcludingDepreciation_label_en-US" xlink:label="lab_amci_CostOfRevenueFromContractsWithCustomersExcludingDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue From Contracts with Customers, Excluding Depreciation</link:label>
    <link:label id="lab_amci_CostOfRevenueFromContractsWithCustomersExcludingDepreciation_documentation_en-US" xlink:label="lab_amci_CostOfRevenueFromContractsWithCustomersExcludingDepreciation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue From Contracts with Customers, Excluding Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CostOfRevenueFromContractsWithCustomersExcludingDepreciation" xlink:href="amci-20230213.xsd#amci_CostOfRevenueFromContractsWithCustomersExcludingDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_CostOfRevenueFromContractsWithCustomersExcludingDepreciation" xlink:to="lab_amci_CostOfRevenueFromContractsWithCustomersExcludingDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c5804cea-d2cb-4b1f-926f-f5cdbfa8e28c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_ec92a0bf-5725-49cd-b2b8-11ff4b192b53_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost and operating expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityRedemptionPricePerShare_58af9cd3-4a9c-4519-8249-83eb69ae6ab5_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Redemption Price Per Share</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityRedemptionPricePerShare_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Redemption Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:to="lab_us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_de0948a7-8be4-458e-8308-e9dfca90191d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_DerivativeLongTermMember_c322dc70-2794-47a9-a963-2c6a4a435ca3_terseLabel_en-US" xlink:label="lab_amci_DerivativeLongTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term</link:label>
    <link:label id="lab_amci_DerivativeLongTermMember_label_en-US" xlink:label="lab_amci_DerivativeLongTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Long Term [Member]</link:label>
    <link:label id="lab_amci_DerivativeLongTermMember_documentation_en-US" xlink:label="lab_amci_DerivativeLongTermMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Long Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DerivativeLongTermMember" xlink:href="amci-20230213.xsd#amci_DerivativeLongTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_DerivativeLongTermMember" xlink:to="lab_amci_DerivativeLongTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_1a40cc6d-fb1c-4e5b-999b-1c6598d620d5_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_321fcd00-ef0b-4037-b81c-1920d09193ba_terseLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_e0e3a12d-7abb-4b27-99f7-24aba959ea38_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6183a06-d736-4b70-a722-c1ef98de16e0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose_c40fbead-2b54-4660-b466-b8f54a7e0641_terseLabel_en-US" xlink:label="lab_amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds held in operating account for working capital purpose</link:label>
    <link:label id="lab_amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose_label_en-US" xlink:label="lab_amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds Held In Operating Account For Working Capital Purpose</link:label>
    <link:label id="lab_amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose_documentation_en-US" xlink:label="lab_amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of proceeds held in operating account for working capital purpose.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose" xlink:href="amci-20230213.xsd#amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose" xlink:to="lab_amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3393d3d2-e589-4e95-9474-ee3e7a9d7670_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows From Investing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_SAFELiabilityMember_073cc185-abe5-45c1-ba1d-19dff896a006_terseLabel_en-US" xlink:label="lab_amci_SAFELiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SAFE Liability</link:label>
    <link:label id="lab_amci_SAFELiabilityMember_label_en-US" xlink:label="lab_amci_SAFELiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SAFE Liability [Member]</link:label>
    <link:label id="lab_amci_SAFELiabilityMember_documentation_en-US" xlink:label="lab_amci_SAFELiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SAFE Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SAFELiabilityMember" xlink:href="amci-20230213.xsd#amci_SAFELiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_SAFELiabilityMember" xlink:to="lab_amci_SAFELiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9d60e9f9-0214-4592-8ed9-aa9e36f51fa4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2fbbcb98-8901-4097-aed6-44b1254742da_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsHeldInTrustNoncurrent_66f4081f-f82e-4f5a-9580-4f38449a9202_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsHeldInTrustNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments held in trust account</link:label>
    <link:label id="lab_us-gaap_AssetsHeldInTrustNoncurrent_label_en-US" xlink:label="lab_us-gaap_AssetsHeldInTrustNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held-in-trust, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrustNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsHeldInTrustNoncurrent" xlink:to="lab_us-gaap_AssetsHeldInTrustNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_03ca41b0-d245-4ed0-9699-874bdc90ee39_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_fb46da09-b8dc-40bd-887c-8d41947b57a8_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_d4c09d05-5df5-449c-b85b-5101c07d940b_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ec657073-eb2e-4fd9-b2c1-170b9d8d7973_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_3067e733-8c69-40c6-92c0-c33f46c0b9c4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue_525ac709-1d58-4965-8631-aa071c50d328_terseLabel_en-US" xlink:label="lab_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled/forfeited, Aggregate intrinsic value</link:label>
    <link:label id="lab_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue_label_en-US" xlink:label="lab_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue_documentation_en-US" xlink:label="lab_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue" xlink:href="amci-20230213.xsd#amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue" xlink:to="lab_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessAmount_6a225129-a1ea-4b64-b254-29577aab3e4e_negatedTerseLabel_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PPP loan forgiveness</link:label>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessAmount_label_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Debt Forgiveness, Amount</link:label>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessAmount_documentation_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Debt Forgiveness, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessAmount" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessAmount" xlink:to="lab_amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_e7692aac-e14e-44d8-9b5d-ce73728b1eb2_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjects_70fb1c72-ac28-41f9-b6e1-0552994690de_terseLabel_en-US" xlink:label="lab_amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjects" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Required equity funding for qualifying projects</link:label>
    <link:label id="lab_amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjects_label_en-US" xlink:label="lab_amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjects" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Framework Agreement, Required Equity Funding For Qualifying Projects</link:label>
    <link:label id="lab_amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjects_documentation_en-US" xlink:label="lab_amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjects" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Framework Agreement, Required Equity Funding For Qualifying Projects</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjects" xlink:href="amci-20230213.xsd#amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjects"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjects" xlink:to="lab_amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjects" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9935eda6-329b-4305-9eba-0052d8695efc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested shares weighted average fair value (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ce79ac48-1e4f-465b-a6bc-cf9343455277_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, weighted average fair value (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f24cefee-adc2-4cfb-96f4-64429d9984b5_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, weighted average fair value (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_RelatedPartyTransitionServicesAgreementMember_a526f0ae-3067-45f9-aa92-f1e8fd3b725d_terseLabel_en-US" xlink:label="lab_amci_RelatedPartyTransitionServicesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transition Services Agreement</link:label>
    <link:label id="lab_amci_RelatedPartyTransitionServicesAgreementMember_label_en-US" xlink:label="lab_amci_RelatedPartyTransitionServicesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transition Services Agreement [Member]</link:label>
    <link:label id="lab_amci_RelatedPartyTransitionServicesAgreementMember_documentation_en-US" xlink:label="lab_amci_RelatedPartyTransitionServicesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transition Services Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartyTransitionServicesAgreementMember" xlink:href="amci-20230213.xsd#amci_RelatedPartyTransitionServicesAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_RelatedPartyTransitionServicesAgreementMember" xlink:to="lab_amci_RelatedPartyTransitionServicesAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_42f94295-2d52-421c-a1ae-39e77532bfe1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_dfea399d-299d-4828-b56b-dead5f06a9ff_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_EquityMethodInvestmentGainOnDilutionOfInvestment_08b363e8-0468-4246-bca7-26e537839ed7_terseLabel_en-US" xlink:label="lab_amci_EquityMethodInvestmentGainOnDilutionOfInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on dilution</link:label>
    <link:label id="lab_amci_EquityMethodInvestmentGainOnDilutionOfInvestment_label_en-US" xlink:label="lab_amci_EquityMethodInvestmentGainOnDilutionOfInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Gain On Dilution Of Investment</link:label>
    <link:label id="lab_amci_EquityMethodInvestmentGainOnDilutionOfInvestment_documentation_en-US" xlink:label="lab_amci_EquityMethodInvestmentGainOnDilutionOfInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Gain On Dilution Of Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EquityMethodInvestmentGainOnDilutionOfInvestment" xlink:href="amci-20230213.xsd#amci_EquityMethodInvestmentGainOnDilutionOfInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_EquityMethodInvestmentGainOnDilutionOfInvestment" xlink:to="lab_amci_EquityMethodInvestmentGainOnDilutionOfInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_735ca7b2-9356-439e-a7da-a85dc3c85f6d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of a warrant</link:label>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_label_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Warrant Exercises</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromWarrantExercises" xlink:to="lab_us-gaap_ProceedsFromWarrantExercises" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_75bf0050-4f58-48ba-af04-49dc518b7d04_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in contract assets and liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductionTaxExpense_a1e562e9-bb61-4b73-a6c5-8dbbbeb0307b_terseLabel_en-US" xlink:label="lab_us-gaap_ProductionTaxExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Franchise tax expense</link:label>
    <link:label id="lab_us-gaap_ProductionTaxExpense_label_en-US" xlink:label="lab_us-gaap_ProductionTaxExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Production Tax Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductionTaxExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductionTaxExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductionTaxExpense" xlink:to="lab_us-gaap_ProductionTaxExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_CarbonCaptureAndTransformationMember_78a73d8a-309b-441a-8e6e-1c38c69b9215_terseLabel_en-US" xlink:label="lab_amci_CarbonCaptureAndTransformationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carbon capture and transformation</link:label>
    <link:label id="lab_amci_CarbonCaptureAndTransformationMember_label_en-US" xlink:label="lab_amci_CarbonCaptureAndTransformationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carbon Capture And Transformation [Member]</link:label>
    <link:label id="lab_amci_CarbonCaptureAndTransformationMember_documentation_en-US" xlink:label="lab_amci_CarbonCaptureAndTransformationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carbon Capture And Transformation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CarbonCaptureAndTransformationMember" xlink:href="amci-20230213.xsd#amci_CarbonCaptureAndTransformationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_CarbonCaptureAndTransformationMember" xlink:to="lab_amci_CarbonCaptureAndTransformationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_RedemptionPeriod_25f53cd9-9404-496c-990b-a375d2f895c5_terseLabel_en-US" xlink:label="lab_amci_RedemptionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption period</link:label>
    <link:label id="lab_amci_RedemptionPeriod_label_en-US" xlink:label="lab_amci_RedemptionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption Period</link:label>
    <link:label id="lab_amci_RedemptionPeriod_documentation_en-US" xlink:label="lab_amci_RedemptionPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RedemptionPeriod" xlink:href="amci-20230213.xsd#amci_RedemptionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_RedemptionPeriod" xlink:to="lab_amci_RedemptionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_3622da2d-1d07-4293-9df0-df013f55f6e7_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_43bbb4c5-1f38-42e0-830e-85d415937fb2_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_2ad2eb68-dd08-48f5-81ab-1e5015747feb_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_abae350d-42ca-4c2a-ac38-551bf79a9e0c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaterialsSuppliesAndOther_a6ec0c69-b001-4d18-8a6c-a19fc5414750_terseLabel_en-US" xlink:label="lab_us-gaap_MaterialsSuppliesAndOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Materials and supplies</link:label>
    <link:label id="lab_us-gaap_MaterialsSuppliesAndOther_label_en-US" xlink:label="lab_us-gaap_MaterialsSuppliesAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Materials, Supplies, and Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialsSuppliesAndOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialsSuppliesAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaterialsSuppliesAndOther" xlink:to="lab_us-gaap_MaterialsSuppliesAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_6ed4f4ed-b131-4375-9b08-5c16f7b9d605_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_5df6c6ff-d946-45cb-a216-0c3c3c39b4ad_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited shares (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_7451425d-0f07-45a3-ba1c-fec8a26d0115_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited shares (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_8e3370d9-e4b4-4a19-923c-2b607bd884fb_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock forfeited</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_4c244b3a-79cd-4bbb-aad9-744ab7a2e8d9_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease, cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_5d266174-01f2-4463-887b-a9c9f6bafbaa_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class A common stock subject to possible redemption</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_31237453-7f0a-4901-9147-c82f90b32dd4_netLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable convertible preferred stock, $0.0001 par value</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_a518a792-02f2-41d0-a747-91ffdd74af9e_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, temporary equity</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_c00ea450-c71d-42fd-8bbd-d83b6ae39ee0_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, temporary equity</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_9b6620fd-b2ba-4aa8-9236-ff3ef8890823_verboseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_5d24de8e-bbb4-429c-b1f9-b03179d64fc7_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; Deficit</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_52d5d8fb-a2c4-41b6-81c0-e6a6c7225c43_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign tax rate differential</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_14dedb91-191d-40de-8cf0-37f5b602a169_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy_13b87375-a402-4aca-b2b9-2d97b7e198bf_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade and Other Receivables</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade and Other Accounts Receivable, Unbilled Receivables, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_96d1abfe-a7b2-4006-83a3-a92a0268accb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Stock Options Valuation Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_f8438671-7173-46bc-af3b-460b8689be97_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_403552da-21ab-4032-aab6-06504eeb18eb_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_bba46a8e-a919-498d-845f-d924ab641798_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_7901b292-e2ee-4598-a101-25ffa503a592_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in valuation allowance (in percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_8da7bfe0-cfdc-4453-a60f-25403c72315a_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_6faa9b5e-6045-440f-97ea-8dfd52c150bc_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of private placement warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1b1abd18-af9c-480e-a8d2-40394d6e2ade_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of warrants to purchase shares issued</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_999edbcf-3359-4a55-a9ae-fd1396d5c6e0_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized cost, recognition period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_TemporaryEquityStockIssuedDuringPeriodPricePerShare_3094dca2-e779-4667-8eac-45d5a3bd7763_terseLabel_en-US" xlink:label="lab_amci_TemporaryEquityStockIssuedDuringPeriodPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of preferred stock (in dollars per share)</link:label>
    <link:label id="lab_amci_TemporaryEquityStockIssuedDuringPeriodPricePerShare_label_en-US" xlink:label="lab_amci_TemporaryEquityStockIssuedDuringPeriodPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Price Per Share</link:label>
    <link:label id="lab_amci_TemporaryEquityStockIssuedDuringPeriodPricePerShare_documentation_en-US" xlink:label="lab_amci_TemporaryEquityStockIssuedDuringPeriodPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityStockIssuedDuringPeriodPricePerShare" xlink:href="amci-20230213.xsd#amci_TemporaryEquityStockIssuedDuringPeriodPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_TemporaryEquityStockIssuedDuringPeriodPricePerShare" xlink:to="lab_amci_TemporaryEquityStockIssuedDuringPeriodPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_77da500f-aee5-43cc-841b-5931b3ee27c4_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases and open accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_a1c44836-22e8-441e-a8df-6745705b2e56_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, Weighted average remaining contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesCPreferredStockMember_6c82bb4d-aa2b-4dcf-88f7-69e7646ff9fa_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesCPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series C</link:label>
    <link:label id="lab_us-gaap_SeriesCPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesCPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series C Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesCPreferredStockMember" xlink:to="lab_us-gaap_SeriesCPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_4a3c8adb-3a2d-491a-a7e8-abb69db014df_terseLabel_en-US" xlink:label="lab_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00</link:label>
    <link:label id="lab_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_label_en-US" xlink:label="lab_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00</link:label>
    <link:label id="lab_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_documentation_en-US" xlink:label="lab_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This member stands for the scenario, where redemption of warrants when the price per share of class a common stock equals or exceeds $10.00.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" xlink:href="amci-20230213.xsd#amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" xlink:to="lab_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_103f2cab-4295-4c32-bd73-3e43f2e1ebb5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_3846e236-ffde-47a4-87b2-6f15f7094d09_terseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_f1b0f1dd-86fe-4054-9764-4cf2ec658f1f_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_f720f29f-a8f7-4a0e-b36a-4e29a27c5c52_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_07c67312-17ff-4b41-aea5-7b88b6166528_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_cba9c446-9531-4f86-8eb3-17f653e85e6e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross proceeds from Initial Public Offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Redeemable Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets_796d8299-57e3-4cb4-9c51-d766d5988ecd_terseLabel_en-US" xlink:label="lab_amci_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condition For Future Business Combination Threshold Net Tangible Assets</link:label>
    <link:label id="lab_amci_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets_label_en-US" xlink:label="lab_amci_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condition for future business combination threshold Net Tangible Assets</link:label>
    <link:label id="lab_amci_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets_documentation_en-US" xlink:label="lab_amci_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The threshold net tangible assets which the reporting entity must maintain in order to proceed with a business combination utilizing the proceeds of the offering.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" xlink:href="amci-20230213.xsd#amci_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" xlink:to="lab_amci_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_StockIssuanceCostsNoncash_6a0d8371-0fa4-4d33-8301-5d59ec348ca5_terseLabel_en-US" xlink:label="lab_amci_StockIssuanceCostsNoncash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering costs included in notes payable</link:label>
    <link:label id="lab_amci_StockIssuanceCostsNoncash_label_en-US" xlink:label="lab_amci_StockIssuanceCostsNoncash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issuance Costs Noncash</link:label>
    <link:label id="lab_amci_StockIssuanceCostsNoncash_documentation_en-US" xlink:label="lab_amci_StockIssuanceCostsNoncash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issuance costs noncash.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_StockIssuanceCostsNoncash" xlink:href="amci-20230213.xsd#amci_StockIssuanceCostsNoncash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_StockIssuanceCostsNoncash" xlink:to="lab_amci_StockIssuanceCostsNoncash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_ad7c74ba-f0ba-4246-8eb6-14b0c62d6148_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe, Middle East, Africa (EMEA)</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_NoncashExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares_68d45861-f626-460a-a845-7a4979f3489b_terseLabel_en-US" xlink:label="lab_amci_NoncashExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of deferred underwriting commissions on public shares</link:label>
    <link:label id="lab_amci_NoncashExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares_label_en-US" xlink:label="lab_amci_NoncashExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Extinguishment Of Deferred Underwriting Commissions On Public Shares</link:label>
    <link:label id="lab_amci_NoncashExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares_documentation_en-US" xlink:label="lab_amci_NoncashExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of value of noncash extinguishment of deferred underwriting commissions on public shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NoncashExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares" xlink:href="amci-20230213.xsd#amci_NoncashExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_NoncashExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares" xlink:to="lab_amci_NoncashExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputExpectedTermMember_55a77d46-c003-4c7e-8183-ac79c972712f_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term</link:label>
    <link:label id="lab_us-gaap_MeasurementInputExpectedTermMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Term [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedTermMember" xlink:to="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember_5c9bc730-463a-42fb-8d3f-8a363108b4db_terseLabel_en-US" xlink:label="lab_amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SGLT</link:label>
    <link:label id="lab_amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember_label_en-US" xlink:label="lab_amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beijing ShouGang LanzaTech Technology Co., LTD (SGLT) [Member]</link:label>
    <link:label id="lab_amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember_documentation_en-US" xlink:label="lab_amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beijing ShouGang LanzaTech Technology Co., LTD (SGLT)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember" xlink:href="amci-20230213.xsd#amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember" xlink:to="lab_amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_02e38072-ee8f-4189-934b-b6008323d36d_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforward</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_0f1b8fda-c02f-498e-ae70-e9ad98c5571f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss and credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_e49b5cf5-546f-4e93-a197-a2cbf45b2406_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of error corrections</link:label>
    <link:label id="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_SponsorMember_972bcd28-663c-4005-ab77-81dcb98cca2a_terseLabel_en-US" xlink:label="lab_amci_SponsorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sponsor</link:label>
    <link:label id="lab_amci_SponsorMember_label_en-US" xlink:label="lab_amci_SponsorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sponsor</link:label>
    <link:label id="lab_amci_SponsorMember_documentation_en-US" xlink:label="lab_amci_SponsorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This member stands for sponsor.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SponsorMember" xlink:href="amci-20230213.xsd#amci_SponsorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_SponsorMember" xlink:to="lab_amci_SponsorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_IncomeTaxesTable_7a6c7780-fa67-48e7-9403-ef75fe9d5bf8_terseLabel_en-US" xlink:label="lab_amci_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:label id="lab_amci_IncomeTaxesTable_label_en-US" xlink:label="lab_amci_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:label id="lab_amci_IncomeTaxesTable_documentation_en-US" xlink:label="lab_amci_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeTaxesTable" xlink:href="amci-20230213.xsd#amci_IncomeTaxesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_IncomeTaxesTable" xlink:to="lab_amci_IncomeTaxesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_018f0eb6-46d1-4d0a-8f26-ca551bc11b2f_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_5a461d64-b000-472f-817e-e2278c1cda8e_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_834297cf-0c7d-47d4-a15f-ce925238cc31_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares, par value (usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_2ba22f13-c40b-4474-a251-f82d186a59c5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6c0cd4ee-4f88-4ffb-9769-d70e3d38a34e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_eb62a039-fff3-4e7f-96b2-b39c834f984c_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_0764d3af-d34f-4eb1-acec-4fcff41c6208_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_eba1f16d-e547-4f3b-bd2f-689ac96f5978_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_7fa4d76f-1838-4ecf-8ab0-b7549832773c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer from foreign currency translation to equity security investment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_DeferredTaxAssetsLeasingArrangements_ec67bda3-0f50-4c74-879d-ea643a24e319_terseLabel_en-US" xlink:label="lab_amci_DeferredTaxAssetsLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_amci_DeferredTaxAssetsLeasingArrangements_label_en-US" xlink:label="lab_amci_DeferredTaxAssetsLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Leasing Arrangements</link:label>
    <link:label id="lab_amci_DeferredTaxAssetsLeasingArrangements_documentation_en-US" xlink:label="lab_amci_DeferredTaxAssetsLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredTaxAssetsLeasingArrangements" xlink:href="amci-20230213.xsd#amci_DeferredTaxAssetsLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_DeferredTaxAssetsLeasingArrangements" xlink:to="lab_amci_DeferredTaxAssetsLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_9a7d4eb1-1083-448f-a050-e8731f12459a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_cc3e0e4d-8895-4b0d-8966-a89bec2a1b9f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_121473ab-744a-4a7a-9ca5-369639b53a33_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_PercentageOfGrossProceedsOnTotalEquityProceed_a9e581bf-bcf0-470c-ae97-b3b56cbad7ae_terseLabel_en-US" xlink:label="lab_amci_PercentageOfGrossProceedsOnTotalEquityProceed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of gross proceeds on total equity proceeds</link:label>
    <link:label id="lab_amci_PercentageOfGrossProceedsOnTotalEquityProceed_bc17d728-c4ff-4f45-8042-ddfb0f24a001_verboseLabel_en-US" xlink:label="lab_amci_PercentageOfGrossProceedsOnTotalEquityProceed" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of gross proceeds on total equity proceeds</link:label>
    <link:label id="lab_amci_PercentageOfGrossProceedsOnTotalEquityProceed_label_en-US" xlink:label="lab_amci_PercentageOfGrossProceedsOnTotalEquityProceed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Gross Proceeds On Total Equity Proceed</link:label>
    <link:label id="lab_amci_PercentageOfGrossProceedsOnTotalEquityProceed_documentation_en-US" xlink:label="lab_amci_PercentageOfGrossProceedsOnTotalEquityProceed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the percentage of gross proceeds on total equity proceeds.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PercentageOfGrossProceedsOnTotalEquityProceed" xlink:href="amci-20230213.xsd#amci_PercentageOfGrossProceedsOnTotalEquityProceed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_PercentageOfGrossProceedsOnTotalEquityProceed" xlink:to="lab_amci_PercentageOfGrossProceedsOnTotalEquityProceed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_0beaf56c-82eb-4055-8f5b-29466eff5335_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_fc2e0ef9-6198-409b-a7eb-bf81f257402f_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simple Agreement for Future Equity (SAFE)</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_73959178-a083-4f9f-b2b7-89d8017c2e10_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_97deee70-061a-4f5a-9f28-921cd9ec686a_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_af049921-bbfa-4a32-8564-0054fac61385_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total income tax benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesEPreferredStockMember_ade2fee2-d153-4816-8ac5-2125f33a5a94_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesEPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series E</link:label>
    <link:label id="lab_us-gaap_SeriesEPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesEPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series E Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesEPreferredStockMember" xlink:to="lab_us-gaap_SeriesEPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_d6b7951b-2b71-4e66-9aaf-c36fbfa76f69_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_NoncashRepaymentOfNotePayableAndAdvances_fce1ee4c-b4e0-4400-9678-5708d1d7cb13_terseLabel_en-US" xlink:label="lab_amci_NoncashRepaymentOfNotePayableAndAdvances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of note payable and advances by Sponsor in exchange for issuance of private placement warrants</link:label>
    <link:label id="lab_amci_NoncashRepaymentOfNotePayableAndAdvances_533ea2dc-1bb9-469f-93ab-04efa1f4280b_verboseLabel_en-US" xlink:label="lab_amci_NoncashRepaymentOfNotePayableAndAdvances" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of note payable and advances by Sponsor in exchange for issuance of private placement warrants</link:label>
    <link:label id="lab_amci_NoncashRepaymentOfNotePayableAndAdvances_label_en-US" xlink:label="lab_amci_NoncashRepaymentOfNotePayableAndAdvances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Repayment Of Note Payable And Advances</link:label>
    <link:label id="lab_amci_NoncashRepaymentOfNotePayableAndAdvances_documentation_en-US" xlink:label="lab_amci_NoncashRepaymentOfNotePayableAndAdvances" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash repayment of note payable and advances.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NoncashRepaymentOfNotePayableAndAdvances" xlink:href="amci-20230213.xsd#amci_NoncashRepaymentOfNotePayableAndAdvances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_NoncashRepaymentOfNotePayableAndAdvances" xlink:to="lab_amci_NoncashRepaymentOfNotePayableAndAdvances" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_6316c668-df2e-4e8e-a0ed-8deb98c383c5_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_NumberOfRoundsOfInvestments_5cf5e3f2-3aed-4670-b204-6c059cebd1cd_terseLabel_en-US" xlink:label="lab_amci_NumberOfRoundsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of rounds of investments</link:label>
    <link:label id="lab_amci_NumberOfRoundsOfInvestments_label_en-US" xlink:label="lab_amci_NumberOfRoundsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Rounds of Investments</link:label>
    <link:label id="lab_amci_NumberOfRoundsOfInvestments_documentation_en-US" xlink:label="lab_amci_NumberOfRoundsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Rounds of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfRoundsOfInvestments" xlink:href="amci-20230213.xsd#amci_NumberOfRoundsOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_NumberOfRoundsOfInvestments" xlink:to="lab_amci_NumberOfRoundsOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_4a2a111c-1464-4638-88c3-8337aae06b88_terseLabel_en-US" xlink:label="lab_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments</link:label>
    <link:label id="lab_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_label_en-US" xlink:label="lab_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Error Correction, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:to="lab_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_dcb5e398-722e-4297-9144-e24fe5317569_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_1a3b28ec-e360-4149-b7d8-34193766f0b6_terseLabel_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Corrections and Prior Period Adjustments Restatement [Line Items]</link:label>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_label_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Corrections and Prior Period Adjustments Restatement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_9cdf6abd-4c34-415d-b582-fcd17ccf74c1_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative warrant liabilities as expense</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_fffbbe02-e189-474a-a442-3fa6cac56dd1_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative warrant liabilities at the beginning</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_dd4af38d-60d6-4b0c-af6b-0abaeb9272e7_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative warrant liabilities at the end</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrimeRateMember_8ba98152-2ad1-40cb-afee-b96eb9022ce2_terseLabel_en-US" xlink:label="lab_us-gaap_PrimeRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prime Rate</link:label>
    <link:label id="lab_us-gaap_PrimeRateMember_label_en-US" xlink:label="lab_us-gaap_PrimeRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prime Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrimeRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrimeRateMember" xlink:to="lab_us-gaap_PrimeRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_b4e95403-0be0-4eea-8624-09f087727ad5_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1e10fb44-2e00-4ebc-b269-26ad5245eac6_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued salaries and wages</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_255bb1b8-03c2-470b-8f1d-f85e89f49fe4_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_f6a5cf70-f29f-441a-9164-843e61fe355e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_ea188af7-fdd2-4275-af58-2f2d1db0ee74_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from related party transactions</link:label>
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_04600360-11b8-4487-91f6-7d75ffdafa4c_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_dce360a3-efb8-44f4-9f33-0816040fbb54_netLabel_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_label_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromRelatedParties" xlink:to="lab_us-gaap_RevenueFromRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_aafaef87-f0e0-45be-ac37-cca724929544_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income (loss) per common share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_e8ece1a6-73fe-4a55-88d6-27b7f8f89325_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per common share - basic (usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_824de5c0-7e8f-4f89-975a-c5495505f29c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award requisite service period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_OperatingLossCarryforwardsNotSubjectToExpiration_58d4106f-1046-445c-a7ec-bb6c9961e0a8_terseLabel_en-US" xlink:label="lab_amci_OperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards, not subject to expiration</link:label>
    <link:label id="lab_amci_OperatingLossCarryforwardsNotSubjectToExpiration_label_en-US" xlink:label="lab_amci_OperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Not Subject To Expiration</link:label>
    <link:label id="lab_amci_OperatingLossCarryforwardsNotSubjectToExpiration_documentation_en-US" xlink:label="lab_amci_OperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Not Subject To Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OperatingLossCarryforwardsNotSubjectToExpiration" xlink:href="amci-20230213.xsd#amci_OperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_OperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="lab_amci_OperatingLossCarryforwardsNotSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_0ca5828d-593a-45c7-b867-b8cdf1a23218_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_LanzaJetFreedomPinesFuelsLLCMember_10503f43-ae76-4495-843a-9bfd3b545845_terseLabel_en-US" xlink:label="lab_amci_LanzaJetFreedomPinesFuelsLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LanzaJet Freedom Pines Fuels LLC</link:label>
    <link:label id="lab_amci_LanzaJetFreedomPinesFuelsLLCMember_label_en-US" xlink:label="lab_amci_LanzaJetFreedomPinesFuelsLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LanzaJet Freedom Pines Fuels LLC [Member]</link:label>
    <link:label id="lab_amci_LanzaJetFreedomPinesFuelsLLCMember_documentation_en-US" xlink:label="lab_amci_LanzaJetFreedomPinesFuelsLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LanzaJet Freedom Pines Fuels LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LanzaJetFreedomPinesFuelsLLCMember" xlink:href="amci-20230213.xsd#amci_LanzaJetFreedomPinesFuelsLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_LanzaJetFreedomPinesFuelsLLCMember" xlink:to="lab_amci_LanzaJetFreedomPinesFuelsLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_66b59728-70a3-48b0-a35a-33c7f6074853_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_ca4f680d-9545-4f82-9d21-24aca6f9a688_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5b52d502-a0ec-444c-b1c3-db0e30fc0a67_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_592e381d-2cce-4683-ad14-d1175c2171d9_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_FundHeldInTrustAccountPerPublicShare_4196390a-4dd5-4ca6-9c6b-2c1b3c7ae5fc_terseLabel_en-US" xlink:label="lab_amci_FundHeldInTrustAccountPerPublicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funds in Trust Account per public share</link:label>
    <link:label id="lab_amci_FundHeldInTrustAccountPerPublicShare_label_en-US" xlink:label="lab_amci_FundHeldInTrustAccountPerPublicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fund Held In Trust Account Per Public Share</link:label>
    <link:label id="lab_amci_FundHeldInTrustAccountPerPublicShare_documentation_en-US" xlink:label="lab_amci_FundHeldInTrustAccountPerPublicShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Per share amount of funds held in trust account per public share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_FundHeldInTrustAccountPerPublicShare" xlink:href="amci-20230213.xsd#amci_FundHeldInTrustAccountPerPublicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_FundHeldInTrustAccountPerPublicShare" xlink:to="lab_amci_FundHeldInTrustAccountPerPublicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_34b7cc81-fdeb-41f2-8904-658124a62a1e_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFDICInsuredAmount_8945ac6c-b429-410e-8aca-1840c703da1a_terseLabel_en-US" xlink:label="lab_us-gaap_CashFDICInsuredAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, FDIC Insured Amount</link:label>
    <link:label id="lab_us-gaap_CashFDICInsuredAmount_label_en-US" xlink:label="lab_us-gaap_CashFDICInsuredAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, FDIC Insured Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFDICInsuredAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFDICInsuredAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFDICInsuredAmount" xlink:to="lab_us-gaap_CashFDICInsuredAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_2d5306d7-7674-4b98-b688-e601ad6dd015_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_label_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfEquity_7a7dd37c-5224-4b3f-ad02-2743b4682a5d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfEquity" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of equity instruments of the Company</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfEquity_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfEquity" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_df614ef2-3cc3-4a49-a203-2d311006ece3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_3505f4ef-e4bb-464a-babd-841e124bbd1a_terseLabel_en-US" xlink:label="lab_amci_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)</link:label>
    <link:label id="lab_amci_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_label_en-US" xlink:label="lab_amci_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Obligation To Redeem Public Shares If Entity Does Not Complete A Business Combination</link:label>
    <link:label id="lab_amci_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_documentation_en-US" xlink:label="lab_amci_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the percentage of shares which the reporting entity is obligated to redeem if a business combination is not consummated using the offering proceeds within a specified period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" xlink:href="amci-20230213.xsd#amci_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" xlink:to="lab_amci_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_a01c041e-f61e-4eaa-9655-96f7edcee442_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ConditionForFutureBusinessCombinationThresholdPercentageOwnership_c51f3cbf-05f5-42ce-92d0-cab9efea6515_terseLabel_en-US" xlink:label="lab_amci_ConditionForFutureBusinessCombinationThresholdPercentageOwnership" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condition For Future Business Combination Threshold Percentage Ownership</link:label>
    <link:label id="lab_amci_ConditionForFutureBusinessCombinationThresholdPercentageOwnership_label_en-US" xlink:label="lab_amci_ConditionForFutureBusinessCombinationThresholdPercentageOwnership" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condition for future business combination threshold Percentage Ownership</link:label>
    <link:label id="lab_amci_ConditionForFutureBusinessCombinationThresholdPercentageOwnership_documentation_en-US" xlink:label="lab_amci_ConditionForFutureBusinessCombinationThresholdPercentageOwnership" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The threshold percentage of voting interest to be acquired in a future business combination as specified for the use of proceeds from the offering.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ConditionForFutureBusinessCombinationThresholdPercentageOwnership" xlink:href="amci-20230213.xsd#amci_ConditionForFutureBusinessCombinationThresholdPercentageOwnership"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ConditionForFutureBusinessCombinationThresholdPercentageOwnership" xlink:to="lab_amci_ConditionForFutureBusinessCombinationThresholdPercentageOwnership" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_1cd9d27e-d41e-479d-8cd4-7246d4c0681e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_LanzatechGlobalMember_4895cc6d-efaa-4ba6-bd63-e143c8377753_terseLabel_en-US" xlink:label="lab_amci_LanzatechGlobalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LanzaTech Global</link:label>
    <link:label id="lab_amci_LanzatechGlobalMember_label_en-US" xlink:label="lab_amci_LanzatechGlobalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LanzaTech Global</link:label>
    <link:label id="lab_amci_LanzatechGlobalMember_documentation_en-US" xlink:label="lab_amci_LanzatechGlobalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents about LanzaTech Global.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LanzatechGlobalMember" xlink:href="amci-20230213.xsd#amci_LanzatechGlobalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_LanzatechGlobalMember" xlink:to="lab_amci_LanzatechGlobalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_MeasurementInputTimeToConversionMember_2fae0d65-c7ea-4259-a16e-cac5228a3b7c_terseLabel_en-US" xlink:label="lab_amci_MeasurementInputTimeToConversionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time to conversion</link:label>
    <link:label id="lab_amci_MeasurementInputTimeToConversionMember_label_en-US" xlink:label="lab_amci_MeasurementInputTimeToConversionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Time To Conversion [Member]</link:label>
    <link:label id="lab_amci_MeasurementInputTimeToConversionMember_documentation_en-US" xlink:label="lab_amci_MeasurementInputTimeToConversionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Time To Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MeasurementInputTimeToConversionMember" xlink:href="amci-20230213.xsd#amci_MeasurementInputTimeToConversionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_MeasurementInputTimeToConversionMember" xlink:to="lab_amci_MeasurementInputTimeToConversionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_TemporaryEquityExerciseOfWarrants_c5678637-c177-4437-95bc-8aef447bf7a9_terseLabel_en-US" xlink:label="lab_amci_TemporaryEquityExerciseOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of warrants</link:label>
    <link:label id="lab_amci_TemporaryEquityExerciseOfWarrants_label_en-US" xlink:label="lab_amci_TemporaryEquityExerciseOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Exercise of Warrants</link:label>
    <link:label id="lab_amci_TemporaryEquityExerciseOfWarrants_documentation_en-US" xlink:label="lab_amci_TemporaryEquityExerciseOfWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Exercise of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityExerciseOfWarrants" xlink:href="amci-20230213.xsd#amci_TemporaryEquityExerciseOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_TemporaryEquityExerciseOfWarrants" xlink:to="lab_amci_TemporaryEquityExerciseOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_0a5e0459-bbbe-47e2-aa6a-3aa60c006900_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_1d27057f-5bb3-426d-871a-aae49dc7b6b4_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_b730ad5d-cf26-4ca4-a50c-727aab86b849_verboseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock subject to possible redemption, issued</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_642d67fe-8b17-4d51-b4e2-c8a1dbb168be_netLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesIssued" xlink:to="lab_us-gaap_TemporaryEquitySharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_1caca24e-40da-49b5-9539-21a0a732d7b1_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_a2d840fb-f0df-4ce3-bd35-de1a7a00df44_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest and penalties</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTableTextBlock_97e7578e-d2ed-4aa3-a8cb-db5112e25ad0_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTableTextBlock" xlink:to="lab_us-gaap_InvestmentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare_fcb8104f-6c78-4835-b84c-0b45756a7e29_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock subject to possible redemption, par value</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare_870c9bed-3741-4f32-9870-ff99dbae6d0b_verboseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity par value (usd per share)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_DeferredUnderwritingDiscounts_be0b4099-c730-4cbf-8f52-e68444a7aa2a_terseLabel_en-US" xlink:label="lab_amci_DeferredUnderwritingDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred underwriting discount</link:label>
    <link:label id="lab_amci_DeferredUnderwritingDiscounts_label_en-US" xlink:label="lab_amci_DeferredUnderwritingDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Underwriting Discounts</link:label>
    <link:label id="lab_amci_DeferredUnderwritingDiscounts_documentation_en-US" xlink:label="lab_amci_DeferredUnderwritingDiscounts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The carrying value as of balance sheet date of underwriting discounts deferred, classified as noncurrent.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingDiscounts" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_DeferredUnderwritingDiscounts" xlink:to="lab_amci_DeferredUnderwritingDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_edb10109-2c99-4bd8-9a44-eb0523451f55_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_02c75d03-5f3d-4efe-823e-c9fc9589afe6_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_AMCIACQUISITIONCORPIIMember_4b2a7fca-d8a1-495a-9594-9c369dced77c_terseLabel_en-US" xlink:label="lab_amci_AMCIACQUISITIONCORPIIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AMCI ACQUISITION CORP. II</link:label>
    <link:label id="lab_amci_AMCIACQUISITIONCORPIIMember_label_en-US" xlink:label="lab_amci_AMCIACQUISITIONCORPIIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AMCI ACQUISITION CORP. II [Member]</link:label>
    <link:label id="lab_amci_AMCIACQUISITIONCORPIIMember_documentation_en-US" xlink:label="lab_amci_AMCIACQUISITIONCORPIIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AMCI ACQUISITION CORP. II</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AMCIACQUISITIONCORPIIMember" xlink:href="amci-20230213.xsd#amci_AMCIACQUISITIONCORPIIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_AMCIACQUISITIONCORPIIMember" xlink:to="lab_amci_AMCIACQUISITIONCORPIIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_4d24d2f3-0215-4c76-a710-8affb582d81c_terseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_OperatingLossAndTaxCreditCarryforwards_73c19112-1fd9-4ff2-8e6e-4a1e93e64fe2_terseLabel_en-US" xlink:label="lab_amci_OperatingLossAndTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax losses and credits carried forward</link:label>
    <link:label id="lab_amci_OperatingLossAndTaxCreditCarryforwards_label_en-US" xlink:label="lab_amci_OperatingLossAndTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss And Tax Credit Carryforwards</link:label>
    <link:label id="lab_amci_OperatingLossAndTaxCreditCarryforwards_documentation_en-US" xlink:label="lab_amci_OperatingLossAndTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss And Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OperatingLossAndTaxCreditCarryforwards" xlink:href="amci-20230213.xsd#amci_OperatingLossAndTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_OperatingLossAndTaxCreditCarryforwards" xlink:to="lab_amci_OperatingLossAndTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_21f69d6a-70b5-402e-8a5a-c67c3dfb0094_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_36074e2e-b1c1-40b0-b4cb-8bee76ba102d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_b026f4bd-364b-40ee-a362-35c4b0c09de5_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_9067057f-cffb-43d1-bb0c-b16fa1d3b6df_terseLabel_en-US" xlink:label="lab_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination</link:label>
    <link:label id="lab_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_label_en-US" xlink:label="lab_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer, Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination, Threshold Trading Days</link:label>
    <link:label id="lab_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_documentation_en-US" xlink:label="lab_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">When determining the condition for transfer of shares without restriction after a business combination, the number of days in which the share price must exceed the specified amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xlink:href="amci-20230213.xsd#amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xlink:to="lab_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_JointDevelopmentAgreementsMember_5acc9358-dbd0-47b3-be12-a347e13718e3_terseLabel_en-US" xlink:label="lab_amci_JointDevelopmentAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint development agreements</link:label>
    <link:label id="lab_amci_JointDevelopmentAgreementsMember_label_en-US" xlink:label="lab_amci_JointDevelopmentAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Development Agreements [Member]</link:label>
    <link:label id="lab_amci_JointDevelopmentAgreementsMember_documentation_en-US" xlink:label="lab_amci_JointDevelopmentAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Development Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_JointDevelopmentAgreementsMember" xlink:href="amci-20230213.xsd#amci_JointDevelopmentAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_JointDevelopmentAgreementsMember" xlink:to="lab_amci_JointDevelopmentAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_53f0233d-4428-4d35-9ba9-bfd00a338450_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenues from contracts with customers (exclusive of depreciation shown below)</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0d7a1c14-9f14-4da3-9590-fef59784db78_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_799ca3aa-9434-43d0-bf26-b06a76b917a6_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Warrants expiration term</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Outstanding, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_953298f9-e108-45c0-af3e-f4297fdebbf3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_MaximumThresholdPeriodForFilingRegistrationStatementAfterBusinessCombination_f6498541-b79e-4f72-b0fc-e0d863695605_terseLabel_en-US" xlink:label="lab_amci_MaximumThresholdPeriodForFilingRegistrationStatementAfterBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold period for filling registration statement after business combination</link:label>
    <link:label id="lab_amci_MaximumThresholdPeriodForFilingRegistrationStatementAfterBusinessCombination_label_en-US" xlink:label="lab_amci_MaximumThresholdPeriodForFilingRegistrationStatementAfterBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Threshold Period For Filing Registration Statement After Business Combination</link:label>
    <link:label id="lab_amci_MaximumThresholdPeriodForFilingRegistrationStatementAfterBusinessCombination_documentation_en-US" xlink:label="lab_amci_MaximumThresholdPeriodForFilingRegistrationStatementAfterBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The maximum threshold period for filing registration statement after business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MaximumThresholdPeriodForFilingRegistrationStatementAfterBusinessCombination" xlink:href="amci-20230213.xsd#amci_MaximumThresholdPeriodForFilingRegistrationStatementAfterBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_MaximumThresholdPeriodForFilingRegistrationStatementAfterBusinessCombination" xlink:to="lab_amci_MaximumThresholdPeriodForFilingRegistrationStatementAfterBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_938a4d49-7c8b-469b-a3db-5c01d1a15ffc_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments, Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments, Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:to="lab_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_17c23494-52d7-48df-b321-7c60c5f08895_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_40cf7b23-64f2-4f72-8daa-0c9f0a8505cc_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_24aa14e2-b9a4-444c-b46c-c26f52df2f37_terseLabel_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_label_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:to="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_TemporaryEquityNumberOfVotesPerShare_dc940bfc-5120-4675-883f-81ebbb5ff58c_terseLabel_en-US" xlink:label="lab_amci_TemporaryEquityNumberOfVotesPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of votes per common stock subject to possible redemption</link:label>
    <link:label id="lab_amci_TemporaryEquityNumberOfVotesPerShare_label_en-US" xlink:label="lab_amci_TemporaryEquityNumberOfVotesPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Number of Votes Per Share</link:label>
    <link:label id="lab_amci_TemporaryEquityNumberOfVotesPerShare_documentation_en-US" xlink:label="lab_amci_TemporaryEquityNumberOfVotesPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the number of votes per common stock subject to possible redemption.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityNumberOfVotesPerShare" xlink:href="amci-20230213.xsd#amci_TemporaryEquityNumberOfVotesPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_TemporaryEquityNumberOfVotesPerShare" xlink:to="lab_amci_TemporaryEquityNumberOfVotesPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_6283e581-b72e-4856-bbec-cffca21d7941_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_RevenueRemainingPerformanceObligationNoncurrentAmount_f2f8edbc-32f3-4856-adb3-b9b480de13bf_terseLabel_en-US" xlink:label="lab_amci_RevenueRemainingPerformanceObligationNoncurrentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current</link:label>
    <link:label id="lab_amci_RevenueRemainingPerformanceObligationNoncurrentAmount_label_en-US" xlink:label="lab_amci_RevenueRemainingPerformanceObligationNoncurrentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Noncurrent, Amount</link:label>
    <link:label id="lab_amci_RevenueRemainingPerformanceObligationNoncurrentAmount_documentation_en-US" xlink:label="lab_amci_RevenueRemainingPerformanceObligationNoncurrentAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Noncurrent, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RevenueRemainingPerformanceObligationNoncurrentAmount" xlink:href="amci-20230213.xsd#amci_RevenueRemainingPerformanceObligationNoncurrentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_RevenueRemainingPerformanceObligationNoncurrentAmount" xlink:to="lab_amci_RevenueRemainingPerformanceObligationNoncurrentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_5228680a-51b8-4215-a372-77b7a4d2fdf9_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares per warrant</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_bb4f519f-e6f5-47c7-b580-d8fa32e26477_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expecting to vest (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_CustomerEMember_a402621b-ca86-42d6-ada7-ff01498e7b29_terseLabel_en-US" xlink:label="lab_amci_CustomerEMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer E</link:label>
    <link:label id="lab_amci_CustomerEMember_label_en-US" xlink:label="lab_amci_CustomerEMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer E [Member]</link:label>
    <link:label id="lab_amci_CustomerEMember_documentation_en-US" xlink:label="lab_amci_CustomerEMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer E</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CustomerEMember" xlink:href="amci-20230213.xsd#amci_CustomerEMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_CustomerEMember" xlink:to="lab_amci_CustomerEMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_c7b1bcc4-b8ee-4255-92e0-b5ff87da305d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_e0a99764-41fc-47e8-b220-f0b48ba64469_negatedLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of derivative warrant liabilities (in percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_dc9bd8c2-cc34-4501-84dd-88c13fd7778d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value less than proportionate share of book value</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Difference Between Carrying Amount and Underlying Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:to="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_OperatingLossCarryforwardsSubjectToExpiration_314c35b2-ec26-4899-a579-c3f9908d2d65_terseLabel_en-US" xlink:label="lab_amci_OperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards, subject to expiration</link:label>
    <link:label id="lab_amci_OperatingLossCarryforwardsSubjectToExpiration_label_en-US" xlink:label="lab_amci_OperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Subject To Expiration</link:label>
    <link:label id="lab_amci_OperatingLossCarryforwardsSubjectToExpiration_documentation_en-US" xlink:label="lab_amci_OperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Subject To Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OperatingLossCarryforwardsSubjectToExpiration" xlink:href="amci-20230213.xsd#amci_OperatingLossCarryforwardsSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_OperatingLossCarryforwardsSubjectToExpiration" xlink:to="lab_amci_OperatingLossCarryforwardsSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_bcc537be-57b8-4b57-b0b9-91181e49c233_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Security Investment in SGLT</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_CapitalBaseTaxExpense_ba9a4feb-eaf7-45b1-8866-50eca9a327ea_terseLabel_en-US" xlink:label="lab_amci_CapitalBaseTaxExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital base tax expense</link:label>
    <link:label id="lab_amci_CapitalBaseTaxExpense_label_en-US" xlink:label="lab_amci_CapitalBaseTaxExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Base Tax Expense</link:label>
    <link:label id="lab_amci_CapitalBaseTaxExpense_documentation_en-US" xlink:label="lab_amci_CapitalBaseTaxExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of capital base tax expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CapitalBaseTaxExpense" xlink:href="amci-20230213.xsd#amci_CapitalBaseTaxExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_CapitalBaseTaxExpense" xlink:to="lab_amci_CapitalBaseTaxExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_864e7d6b-221b-45e5-b7b4-5c594d22c98f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares, shares outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_66040af3-6465-4f23-9408-493f5ceadd9a_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_0d002973-a40d-4681-96a4-5cc2e3d0a072_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_210d8fa7-0d0c-45e8-b3a9-be1bb2bd8c86_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_0212718a-bbea-4b7e-aabe-6cc31b979d16_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Balance Sheet</link:label>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7f84383f-a217-4374-870b-d868b8041290_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_UnderwritingDiscountPercentage_0fd45868-1bea-4085-a5d3-f7dc31bec1fc_terseLabel_en-US" xlink:label="lab_amci_UnderwritingDiscountPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underwriting Discount Percentage</link:label>
    <link:label id="lab_amci_UnderwritingDiscountPercentage_label_en-US" xlink:label="lab_amci_UnderwritingDiscountPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underwriting Discount Percentage</link:label>
    <link:label id="lab_amci_UnderwritingDiscountPercentage_documentation_en-US" xlink:label="lab_amci_UnderwritingDiscountPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to Underwriting Discount Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_UnderwritingDiscountPercentage" xlink:href="amci-20230213.xsd#amci_UnderwritingDiscountPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_UnderwritingDiscountPercentage" xlink:to="lab_amci_UnderwritingDiscountPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_791d61d6-0312-409f-8024-95dd00e5cd40_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative expenses - related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_9f92d15b-6709-4d36-80ff-c7d6c966f90f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_762e1f86-c3de-41ab-8f6e-8d55c3c14add_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_31d6e12a-adb6-4ed2-90df-6403760c06ef_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_19c2c347-8edb-47f1-9520-daa587d9ad18_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_5f354445-0e37-4dec-8e5e-715e2748daf4_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_50723402-c974-40bc-9921-dd14e783b9e0_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_68176e37-866d-454f-9739-5aa805fcfc27_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_d531691e-0c39-4d0b-b70d-374c81854e51_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_763cc7ca-a8d5-4092-8321-f534fad9b8b8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_b7863c20-2b80-4bf3-be79-5540c02f183c_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B</link:label>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesBPreferredStockMember" xlink:to="lab_us-gaap_SeriesBPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_LessAbstract_364ad0c9-eac5-4857-8191-25e6dfb08726_terseLabel_en-US" xlink:label="lab_amci_LessAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less:</link:label>
    <link:label id="lab_amci_LessAbstract_label_en-US" xlink:label="lab_amci_LessAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less [Abstract]</link:label>
    <link:label id="lab_amci_LessAbstract_documentation_en-US" xlink:label="lab_amci_LessAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">No definition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LessAbstract" xlink:href="amci-20230213.xsd#amci_LessAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_LessAbstract" xlink:to="lab_amci_LessAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ScheduleOfReverseCapitalizationTable_4843f2b2-e7ce-44a4-9546-7b1430d69580_terseLabel_en-US" xlink:label="lab_amci_ScheduleOfReverseCapitalizationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reverse Capitalization [Table]</link:label>
    <link:label id="lab_amci_ScheduleOfReverseCapitalizationTable_label_en-US" xlink:label="lab_amci_ScheduleOfReverseCapitalizationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reverse Capitalization [Table]</link:label>
    <link:label id="lab_amci_ScheduleOfReverseCapitalizationTable_documentation_en-US" xlink:label="lab_amci_ScheduleOfReverseCapitalizationTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reverse Capitalization [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ScheduleOfReverseCapitalizationTable" xlink:href="amci-20230213.xsd#amci_ScheduleOfReverseCapitalizationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ScheduleOfReverseCapitalizationTable" xlink:to="lab_amci_ScheduleOfReverseCapitalizationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_09dc9ad0-4884-46a0-bff3-ac55c1cc5af0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_b65b794f-2159-4518-b053-acb8c94ca07c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities_abb8d075-b515-45b8-89e6-2745f85a67f4_negatedLabel_en-US" xlink:label="lab_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering costs allocated to derivative warrant liabilities</link:label>
    <link:label id="lab_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities_1eb8b255-63ea-4c72-88d1-3cfc61f3ba98_terseLabel_en-US" xlink:label="lab_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering costs allocated to derivative warrant liabilities</link:label>
    <link:label id="lab_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities_label_en-US" xlink:label="lab_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering Costs Allocated To Derivative Warrant Liabilities</link:label>
    <link:label id="lab_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities_documentation_en-US" xlink:label="lab_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of offering costs allocated to derivative warrant liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities" xlink:href="amci-20230213.xsd#amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities" xlink:to="lab_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BilledContractReceivables_8a3fa01c-693c-476d-8ac6-298ec252acb7_terseLabel_en-US" xlink:label="lab_us-gaap_BilledContractReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Billed accounts receivable, net of allowance</link:label>
    <link:label id="lab_us-gaap_BilledContractReceivables_label_en-US" xlink:label="lab_us-gaap_BilledContractReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Billed Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BilledContractReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BilledContractReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BilledContractReceivables" xlink:to="lab_us-gaap_BilledContractReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_SecuritiesSubjectToMandatoryRedemptionLongTermMember_f674581b-b049-4a9c-a465-e941e00c6cc0_terseLabel_en-US" xlink:label="lab_amci_SecuritiesSubjectToMandatoryRedemptionLongTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term</link:label>
    <link:label id="lab_amci_SecuritiesSubjectToMandatoryRedemptionLongTermMember_label_en-US" xlink:label="lab_amci_SecuritiesSubjectToMandatoryRedemptionLongTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Subject to Mandatory Redemption, Long Term [Member]</link:label>
    <link:label id="lab_amci_SecuritiesSubjectToMandatoryRedemptionLongTermMember_documentation_en-US" xlink:label="lab_amci_SecuritiesSubjectToMandatoryRedemptionLongTermMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Subject to Mandatory Redemption, Long Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SecuritiesSubjectToMandatoryRedemptionLongTermMember" xlink:href="amci-20230213.xsd#amci_SecuritiesSubjectToMandatoryRedemptionLongTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_SecuritiesSubjectToMandatoryRedemptionLongTermMember" xlink:to="lab_amci_SecuritiesSubjectToMandatoryRedemptionLongTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_41caeedd-323a-46ca-9ab1-67b5f93a3328_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_57138f77-d170-4c00-8a21-cd8c7747a1cf_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises_3e854a3b-ebf0-4b60-be9b-3b3f028c0699_terseLabel_en-US" xlink:label="lab_amci_ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issue of equity instruments of the Company</link:label>
    <link:label id="lab_amci_ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises_label_en-US" xlink:label="lab_amci_ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Issuance Or Sale Of Equity, Excluding Warrant Exercises</link:label>
    <link:label id="lab_amci_ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises_documentation_en-US" xlink:label="lab_amci_ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Issuance Or Sale Of Equity, Excluding Warrant Exercises</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises" xlink:href="amci-20230213.xsd#amci_ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises" xlink:to="lab_amci_ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_cff54535-4bd1-4e2b-86c7-4af6f395b36e_totalLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investment</link:label>
    <link:label id="lab_us-gaap_Investments_06c5f295-64f3-4b8c-a616-142d0969b044_terseLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_e781a45b-08d6-45d9-adfa-fceea00a9daf_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_ba9e6066-85e1-440e-be34-9154fb77cf2f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_d867ed37-d95a-4ba8-8ab0-0ae1bed64d90_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment_7cb9dfa8-1be6-4624-8a2d-2df168dc6aba_terseLabel_en-US" xlink:label="lab_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from equity method investees, net</link:label>
    <link:label id="lab_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment_1d790f6c-804f-469c-968c-ff207a29deee_negatedTerseLabel_en-US" xlink:label="lab_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from equity method investees, net</link:label>
    <link:label id="lab_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment_label_en-US" xlink:label="lab_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments and Gain On Dilution Of Investment</link:label>
    <link:label id="lab_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment_documentation_en-US" xlink:label="lab_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments and Gain On Dilution Of Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment" xlink:href="amci-20230213.xsd#amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment" xlink:to="lab_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_3dfcd8e6-16b1-4f01-82b9-0e4da39aa94b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_a9de566c-5aa5-4174-b67a-caa7e561337f_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_EarningPerShareBasicAndDilutedAbstract_24c5f794-6a6b-4128-9904-44e2f9008f1a_verboseLabel_en-US" xlink:label="lab_amci_EarningPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic and diluted net income (loss) per common share:</link:label>
    <link:label id="lab_amci_EarningPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_amci_EarningPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earning Per Share Basic And Diluted [Abstract]</link:label>
    <link:label id="lab_amci_EarningPerShareBasicAndDilutedAbstract_documentation_en-US" xlink:label="lab_amci_EarningPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">No definition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EarningPerShareBasicAndDilutedAbstract" xlink:href="amci-20230213.xsd#amci_EarningPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_EarningPerShareBasicAndDilutedAbstract" xlink:to="lab_amci_EarningPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_NoteReceivableCommitmentToPurchase_2f7e6af3-3d3c-4da6-b780-3a366c3a332a_terseLabel_en-US" xlink:label="lab_amci_NoteReceivableCommitmentToPurchase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes receivable, commitment to purchase</link:label>
    <link:label id="lab_amci_NoteReceivableCommitmentToPurchase_label_en-US" xlink:label="lab_amci_NoteReceivableCommitmentToPurchase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Receivable, Commitment To Purchase</link:label>
    <link:label id="lab_amci_NoteReceivableCommitmentToPurchase_documentation_en-US" xlink:label="lab_amci_NoteReceivableCommitmentToPurchase" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Receivable, Commitment To Purchase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NoteReceivableCommitmentToPurchase" xlink:href="amci-20230213.xsd#amci_NoteReceivableCommitmentToPurchase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_NoteReceivableCommitmentToPurchase" xlink:to="lab_amci_NoteReceivableCommitmentToPurchase" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_61d3b37f-3e21-4d7b-b677-d10766dca3d4_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1a533f7e-46d8-4a81-9b8a-2705a25e34a7_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0fa91fa4-d0db-4926-82d7-f401087751cf_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_809822a4-5756-4769-afe4-b5ac218f2a1e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_645b3ded-32bf-456b-9d7c-334b0c92ea91_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_fa6087c7-ace4-4583-85e8-4dc0d37fa33c_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, measurement input</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Outstanding, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputSharePriceMember_d5d02fcb-2cad-48e1-a42c-d99a90426078_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputSharePriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock price</link:label>
    <link:label id="lab_us-gaap_MeasurementInputSharePriceMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputSharePriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Share Price [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputSharePriceMember" xlink:to="lab_us-gaap_MeasurementInputSharePriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_ccb4197c-b819-414c-8fdd-3f3c6b6b0692_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_OneTrancheOfNotesMember_09713c4b-5fd1-4cd3-bc92-56b117c024e7_terseLabel_en-US" xlink:label="lab_amci_OneTrancheOfNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Tranche Of Notes</link:label>
    <link:label id="lab_amci_OneTrancheOfNotesMember_label_en-US" xlink:label="lab_amci_OneTrancheOfNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Tranche Of Notes [Member]</link:label>
    <link:label id="lab_amci_OneTrancheOfNotesMember_documentation_en-US" xlink:label="lab_amci_OneTrancheOfNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Tranche Of Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OneTrancheOfNotesMember" xlink:href="amci-20230213.xsd#amci_OneTrancheOfNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_OneTrancheOfNotesMember" xlink:to="lab_amci_OneTrancheOfNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_35927baa-d3a0-4b6d-bbfc-87eec423af17_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_16a610e5-007b-40ab-8ddd-a2f8ad09f3f8_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expecting, Weighted average remaining contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_5176d5bd-d922-417b-b621-229d86aa10e0_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_96d0ac83-1673-47ed-96af-f863ad27557a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_66e5cf58-3f32-42e9-9d71-5fe10b3d39a4_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_SAFELiabilityMeasurementInput_9542705d-1fe0-4192-a54b-f46fec70deb4_terseLabel_en-US" xlink:label="lab_amci_SAFELiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SAFE liability, measurement input</link:label>
    <link:label id="lab_amci_SAFELiabilityMeasurementInput_label_en-US" xlink:label="lab_amci_SAFELiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SAFE Liability, Measurement Input</link:label>
    <link:label id="lab_amci_SAFELiabilityMeasurementInput_documentation_en-US" xlink:label="lab_amci_SAFELiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SAFE Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SAFELiabilityMeasurementInput" xlink:href="amci-20230213.xsd#amci_SAFELiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_SAFELiabilityMeasurementInput" xlink:to="lab_amci_SAFELiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstanding_29690a5f-b9ad-4e59-b059-4d1fe647f5c4_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstanding_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:to="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_e5666724-f984-43bd-a1f2-b2a63a33f52d_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_065f4eb8-8d52-4c36-ab50-16261d13f61a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesFPreferredStockMember_75f8eae5-bf3c-4be7-9864-326093591858_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesFPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series F</link:label>
    <link:label id="lab_us-gaap_SeriesFPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesFPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series F Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesFPreferredStockMember" xlink:to="lab_us-gaap_SeriesFPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_1284821a-57f7-4319-b232-7d83d9cef8eb_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_ccc6ad45-214d-490e-9626-d7336ae8bedb_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockDividendsIncomeStatementImpact_03e6facf-6f16-41d2-b0d4-ac9a06e2238c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid cumulative dividends on preferred stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockDividendsIncomeStatementImpact_label_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock Dividends, Income Statement Impact</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:to="lab_us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_NumberOfWarrantsIssuedPerUnit_e2a3e97b-9fc9-47f1-a633-6c92a54d3089_terseLabel_en-US" xlink:label="lab_amci_NumberOfWarrantsIssuedPerUnit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of warrants in a unit</link:label>
    <link:label id="lab_amci_NumberOfWarrantsIssuedPerUnit_label_en-US" xlink:label="lab_amci_NumberOfWarrantsIssuedPerUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Warrants Issued Per Unit</link:label>
    <link:label id="lab_amci_NumberOfWarrantsIssuedPerUnit_documentation_en-US" xlink:label="lab_amci_NumberOfWarrantsIssuedPerUnit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the number of warrants in a unit.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfWarrantsIssuedPerUnit" xlink:href="amci-20230213.xsd#amci_NumberOfWarrantsIssuedPerUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_NumberOfWarrantsIssuedPerUnit" xlink:to="lab_amci_NumberOfWarrantsIssuedPerUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_29827b5b-e9ee-4845-bd1c-46a877aa1a80_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_cea112be-b098-423f-82bb-cdebcca62c59_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ContractWithCustomerLiabilityCurrentRevenueRecognized_04ad3190-4998-4f25-9457-c34a6fa79170_negatedTerseLabel_en-US" xlink:label="lab_amci_ContractWithCustomerLiabilityCurrentRevenueRecognized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification to revenue as a result of performance obligations satisfied</link:label>
    <link:label id="lab_amci_ContractWithCustomerLiabilityCurrentRevenueRecognized_label_en-US" xlink:label="lab_amci_ContractWithCustomerLiabilityCurrentRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Current, Revenue Recognized</link:label>
    <link:label id="lab_amci_ContractWithCustomerLiabilityCurrentRevenueRecognized_documentation_en-US" xlink:label="lab_amci_ContractWithCustomerLiabilityCurrentRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Current, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContractWithCustomerLiabilityCurrentRevenueRecognized" xlink:href="amci-20230213.xsd#amci_ContractWithCustomerLiabilityCurrentRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ContractWithCustomerLiabilityCurrentRevenueRecognized" xlink:to="lab_amci_ContractWithCustomerLiabilityCurrentRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_a0dd6438-76a9-4942-9520-73d27d30efa0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_SeniorSecuredNotesReceivableMember_ba29b295-2649-4986-8d65-d87cb99413ac_terseLabel_en-US" xlink:label="lab_amci_SeniorSecuredNotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Notes Receivable</link:label>
    <link:label id="lab_amci_SeniorSecuredNotesReceivableMember_label_en-US" xlink:label="lab_amci_SeniorSecuredNotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Notes Receivable [Member]</link:label>
    <link:label id="lab_amci_SeniorSecuredNotesReceivableMember_documentation_en-US" xlink:label="lab_amci_SeniorSecuredNotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SeniorSecuredNotesReceivableMember" xlink:href="amci-20230213.xsd#amci_SeniorSecuredNotesReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_SeniorSecuredNotesReceivableMember" xlink:to="lab_amci_SeniorSecuredNotesReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_9b6cdf72-228b-422e-8489-bc792a18e70c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts related to transactions with related parties</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_21b9fe94-5736-4fc6-b6bc-b66900d1da8d_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_OptionVestingPeriod_984cd910-03eb-4a24-84a0-23adcc21c0fe_terseLabel_en-US" xlink:label="lab_amci_OptionVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option vesting period</link:label>
    <link:label id="lab_amci_OptionVestingPeriod_label_en-US" xlink:label="lab_amci_OptionVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Vesting Period</link:label>
    <link:label id="lab_amci_OptionVestingPeriod_documentation_en-US" xlink:label="lab_amci_OptionVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option vesting period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OptionVestingPeriod" xlink:href="amci-20230213.xsd#amci_OptionVestingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_OptionVestingPeriod" xlink:to="lab_amci_OptionVestingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_3bf26951-d3a5-4b4d-b085-27e92b7ed61a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_3fef8675-76de-4568-8c03-74696944712e_terseLabel_en-US" xlink:label="lab_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00</link:label>
    <link:label id="lab_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_label_en-US" xlink:label="lab_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00</link:label>
    <link:label id="lab_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_documentation_en-US" xlink:label="lab_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This member stands for the scenario, where redemption of warrants when the price per share of class a common stock equals or exceeds $18.00.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" xlink:href="amci-20230213.xsd#amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" xlink:to="lab_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PostemploymentBenefitsAbstract_label_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postemployment Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract" xlink:to="lab_us-gaap_PostemploymentBenefitsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_12b58d55-08ae-4c0c-815c-09f99fb56eda_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_c109738e-e93f-4971-af2f-fd2b0b4c6b6e_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_RelatedPartyLoansMember_3637ea4f-d25e-4467-b40e-b17149389b3e_terseLabel_en-US" xlink:label="lab_amci_RelatedPartyLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Loans</link:label>
    <link:label id="lab_amci_RelatedPartyLoansMember_label_en-US" xlink:label="lab_amci_RelatedPartyLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Loans</link:label>
    <link:label id="lab_amci_RelatedPartyLoansMember_documentation_en-US" xlink:label="lab_amci_RelatedPartyLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This member stands for related party loans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartyLoansMember" xlink:href="amci-20230213.xsd#amci_RelatedPartyLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_RelatedPartyLoansMember" xlink:to="lab_amci_RelatedPartyLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_f08615d3-1c73-4e12-8c85-8099bcf96724_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon exercise of options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_f094f380-1bf1-471c-a85f-275a3f0f33ce_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_de2a96b5-7ba2-4e2f-b129-c4c68a5de22a_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent_0b7f0baf-402d-4d3d-b06c-19bb3c9309d7_terseLabel_en-US" xlink:label="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital based tax payable</link:label>
    <link:label id="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent_93d0b8b4-d7d4-4fce-b2e5-55cc80973d1b_verboseLabel_en-US" xlink:label="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital based tax payable</link:label>
    <link:label id="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for Taxes Other than Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_06b8fa07-d3af-419b-99b1-3f7e303c28df_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_41d14d6d-edbf-4b2d-bb9d-021f5fcc96b1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cost and operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_62e066e7-0b89-45a7-a92f-1d085bde3541_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationInterestIncomeAmount_e00750e9-e793-4472-b386-941ec7606051_terseLabel_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationInterestIncomeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income on receivable</link:label>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationInterestIncomeAmount_label_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationInterestIncomeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Interest Income, Amount</link:label>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationInterestIncomeAmount_documentation_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationInterestIncomeAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Interest Income, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationInterestIncomeAmount" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationInterestIncomeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_EffectiveIncomeTaxRateReconciliationInterestIncomeAmount" xlink:to="lab_amci_EffectiveIncomeTaxRateReconciliationInterestIncomeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_NumberOfSharesIssuedPerUnit_85c33289-4106-4cb5-a1d2-4edee8186552_terseLabel_en-US" xlink:label="lab_amci_NumberOfSharesIssuedPerUnit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares in a unit</link:label>
    <link:label id="lab_amci_NumberOfSharesIssuedPerUnit_label_en-US" xlink:label="lab_amci_NumberOfSharesIssuedPerUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares Issued Per Unit</link:label>
    <link:label id="lab_amci_NumberOfSharesIssuedPerUnit_documentation_en-US" xlink:label="lab_amci_NumberOfSharesIssuedPerUnit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the number of shares in a unit.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfSharesIssuedPerUnit" xlink:href="amci-20230213.xsd#amci_NumberOfSharesIssuedPerUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_NumberOfSharesIssuedPerUnit" xlink:to="lab_amci_NumberOfSharesIssuedPerUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent_80413533-225a-444c-a615-7aba080a150d_negatedTerseLabel_en-US" xlink:label="lab_amci_ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from non-current to current contract liabilities</link:label>
    <link:label id="lab_amci_ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent_label_en-US" xlink:label="lab_amci_ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Noncurrent, Reclassification To Current</link:label>
    <link:label id="lab_amci_ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent_documentation_en-US" xlink:label="lab_amci_ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Noncurrent, Reclassification To Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent" xlink:href="amci-20230213.xsd#amci_ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent" xlink:to="lab_amci_ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ContractWithCustomerAssetCurrentForeignCurrencyTranslationAdjustment_bef89ac4-6c15-4fc7-b916-a2b0cb5ebea2_terseLabel_en-US" xlink:label="lab_amci_ContractWithCustomerAssetCurrentForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease on revaluation on currency</link:label>
    <link:label id="lab_amci_ContractWithCustomerAssetCurrentForeignCurrencyTranslationAdjustment_label_en-US" xlink:label="lab_amci_ContractWithCustomerAssetCurrentForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Asset, Current, Foreign Currency Translation Adjustment</link:label>
    <link:label id="lab_amci_ContractWithCustomerAssetCurrentForeignCurrencyTranslationAdjustment_documentation_en-US" xlink:label="lab_amci_ContractWithCustomerAssetCurrentForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Asset, Current, Foreign Currency Translation Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContractWithCustomerAssetCurrentForeignCurrencyTranslationAdjustment" xlink:href="amci-20230213.xsd#amci_ContractWithCustomerAssetCurrentForeignCurrencyTranslationAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ContractWithCustomerAssetCurrentForeignCurrencyTranslationAdjustment" xlink:to="lab_amci_ContractWithCustomerAssetCurrentForeignCurrencyTranslationAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_e5ffe6f5-e158-4864-b895-feffe97baf90_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_RelatedPartySupplyAgreementMember_6ba8830f-6892-4f54-8fd0-8e4fd35079fc_terseLabel_en-US" xlink:label="lab_amci_RelatedPartySupplyAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Supply Agreement</link:label>
    <link:label id="lab_amci_RelatedPartySupplyAgreementMember_label_en-US" xlink:label="lab_amci_RelatedPartySupplyAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Supply Agreement [Member]</link:label>
    <link:label id="lab_amci_RelatedPartySupplyAgreementMember_documentation_en-US" xlink:label="lab_amci_RelatedPartySupplyAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Supply Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartySupplyAgreementMember" xlink:href="amci-20230213.xsd#amci_RelatedPartySupplyAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_RelatedPartySupplyAgreementMember" xlink:to="lab_amci_RelatedPartySupplyAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_7b9ed1b1-4cd3-4d3c-8e2c-9403dde04438_negatedLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities loss</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_8b09dd82-c73e-4073-94cd-5584e0819cb3_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_67229d46-fd81-4201-acf1-896db9dbbb9a_terseLabel_en-US" xlink:label="lab_amci_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity of related party promissory note</link:label>
    <link:label id="lab_amci_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_label_en-US" xlink:label="lab_amci_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Borrowing Capacity of Related Party Promissory Note</link:label>
    <link:label id="lab_amci_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_documentation_en-US" xlink:label="lab_amci_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of maximum borrowing capacity of related party promissory note.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" xlink:href="amci-20230213.xsd#amci_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" xlink:to="lab_amci_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_61bdfeb4-a659-414f-b70f-444c3fb331f0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_f9480505-446c-4579-a77a-ee9d7db25dce_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity (Deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_b29016fb-cdc7-408a-808f-6529749e16fa_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_OtherCurrentAssetsPolicyTextBlock_b6a17677-cb3c-4a05-8636-271e43653a32_terseLabel_en-US" xlink:label="lab_amci_OtherCurrentAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets</link:label>
    <link:label id="lab_amci_OtherCurrentAssetsPolicyTextBlock_label_en-US" xlink:label="lab_amci_OtherCurrentAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Policy Text Block]</link:label>
    <link:label id="lab_amci_OtherCurrentAssetsPolicyTextBlock_documentation_en-US" xlink:label="lab_amci_OtherCurrentAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OtherCurrentAssetsPolicyTextBlock" xlink:href="amci-20230213.xsd#amci_OtherCurrentAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_OtherCurrentAssetsPolicyTextBlock" xlink:to="lab_amci_OtherCurrentAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock_431d1963-df86-4649-bece-29f7bc5cb4d0_terseLabel_en-US" xlink:label="lab_amci_OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering Costs Associated with Initial Public Offering</link:label>
    <link:label id="lab_amci_OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock_label_en-US" xlink:label="lab_amci_OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering Costs Associated With The Initial Public Offering [Policy Text Block]</link:label>
    <link:label id="lab_amci_OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock_documentation_en-US" xlink:label="lab_amci_OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The disclosure of offering costs associated with the initial public offering.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock" xlink:href="amci-20230213.xsd#amci_OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock" xlink:to="lab_amci_OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_3e2634e6-4d19-4562-8754-8632a3f82bc8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_LanzaJetIncMember_e360316b-a081-45d2-9b31-bc01872ce1d4_terseLabel_en-US" xlink:label="lab_amci_LanzaJetIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LanzaJet</link:label>
    <link:label id="lab_amci_LanzaJetIncMember_label_en-US" xlink:label="lab_amci_LanzaJetIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LanzaJet, Inc. [Member]</link:label>
    <link:label id="lab_amci_LanzaJetIncMember_documentation_en-US" xlink:label="lab_amci_LanzaJetIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LanzaJet, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LanzaJetIncMember" xlink:href="amci-20230213.xsd#amci_LanzaJetIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_LanzaJetIncMember" xlink:to="lab_amci_LanzaJetIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_InvestmentsLineItems_1ef814a0-1ddd-402d-adde-654591e381e1_terseLabel_en-US" xlink:label="lab_amci_InvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Line Items]</link:label>
    <link:label id="lab_amci_InvestmentsLineItems_label_en-US" xlink:label="lab_amci_InvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Line Items]</link:label>
    <link:label id="lab_amci_InvestmentsLineItems_documentation_en-US" xlink:label="lab_amci_InvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_InvestmentsLineItems" xlink:href="amci-20230213.xsd#amci_InvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_InvestmentsLineItems" xlink:to="lab_amci_InvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_f0130096-3921-4d7c-a7ac-d852812e3975_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding balance</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_88028249-8e8f-4c09-90c8-c49717b67365_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_8512e6b0-424c-4ed0-b65b-b36d20935839_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclass from additional paid-in capital to retained earnings</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_SimpleAgreementForFutureEquityInitialPurchaseAmount_95c2dc89-864f-499d-99e7-1cd31ce29739_terseLabel_en-US" xlink:label="lab_amci_SimpleAgreementForFutureEquityInitialPurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial purchase amount</link:label>
    <link:label id="lab_amci_SimpleAgreementForFutureEquityInitialPurchaseAmount_label_en-US" xlink:label="lab_amci_SimpleAgreementForFutureEquityInitialPurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simple Agreement For Future Equity, Initial Purchase Amount</link:label>
    <link:label id="lab_amci_SimpleAgreementForFutureEquityInitialPurchaseAmount_documentation_en-US" xlink:label="lab_amci_SimpleAgreementForFutureEquityInitialPurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simple Agreement For Future Equity, Initial Purchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SimpleAgreementForFutureEquityInitialPurchaseAmount" xlink:href="amci-20230213.xsd#amci_SimpleAgreementForFutureEquityInitialPurchaseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_SimpleAgreementForFutureEquityInitialPurchaseAmount" xlink:to="lab_amci_SimpleAgreementForFutureEquityInitialPurchaseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_MeasurementInputLiquidityPriceMember_9bd41944-91d9-49f7-971b-a5176c23b7a0_terseLabel_en-US" xlink:label="lab_amci_MeasurementInputLiquidityPriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liquidity price</link:label>
    <link:label id="lab_amci_MeasurementInputLiquidityPriceMember_label_en-US" xlink:label="lab_amci_MeasurementInputLiquidityPriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Liquidity Price [Member]</link:label>
    <link:label id="lab_amci_MeasurementInputLiquidityPriceMember_documentation_en-US" xlink:label="lab_amci_MeasurementInputLiquidityPriceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Liquidity Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MeasurementInputLiquidityPriceMember" xlink:href="amci-20230213.xsd#amci_MeasurementInputLiquidityPriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_MeasurementInputLiquidityPriceMember" xlink:to="lab_amci_MeasurementInputLiquidityPriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_79750857-1f03-4830-8b96-eb40ebe6be21_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_DenominatorForCalculationOfEarningsPerShareAbstract_a03925a5-fb36-479a-bf57-df651ebfc9ca_terseLabel_en-US" xlink:label="lab_amci_DenominatorForCalculationOfEarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_amci_DenominatorForCalculationOfEarningsPerShareAbstract_label_en-US" xlink:label="lab_amci_DenominatorForCalculationOfEarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator For Calculation Of Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_amci_DenominatorForCalculationOfEarningsPerShareAbstract_documentation_en-US" xlink:label="lab_amci_DenominatorForCalculationOfEarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">No definition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DenominatorForCalculationOfEarningsPerShareAbstract" xlink:href="amci-20230213.xsd#amci_DenominatorForCalculationOfEarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_DenominatorForCalculationOfEarningsPerShareAbstract" xlink:to="lab_amci_DenominatorForCalculationOfEarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_f2e35e08-6a5f-43a6-8c38-d0827fb059bd_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_ad7661f7-603f-492e-9f23-ff529cbfc100_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_667defb7-d177-46fa-9330-aee6b87b1ead_terseLabel_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">As Previously Reported</link:label>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_label_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously Reported [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioPreviouslyReportedMember" xlink:to="lab_srt_ScenarioPreviouslyReportedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_EvercoreGroupL.l.c.Member_0c32fa16-17eb-43b9-a44d-d45625b8ee10_terseLabel_en-US" xlink:label="lab_amci_EvercoreGroupL.l.c.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evercore Group, L.L.C.</link:label>
    <link:label id="lab_amci_EvercoreGroupL.l.c.Member_label_en-US" xlink:label="lab_amci_EvercoreGroupL.l.c.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evercore Group, L.L.C.</link:label>
    <link:label id="lab_amci_EvercoreGroupL.l.c.Member_documentation_en-US" xlink:label="lab_amci_EvercoreGroupL.l.c.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This member represents Evercore Group LLC.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EvercoreGroupL.l.c.Member" xlink:href="amci-20230213.xsd#amci_EvercoreGroupL.l.c.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_EvercoreGroupL.l.c.Member" xlink:to="lab_amci_EvercoreGroupL.l.c.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fd48f7a3-ebfa-4f0f-a7fa-fb3deb901567_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders' Deficit:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ef96e4a2-0738-4bb6-8877-e7809ce958c8_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Contingently Redeemable Preferred Stock, and Shareholders&#8217; Deficit</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_75eae175-249d-4c55-a546-9d7a0471f393_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3336c235-e0f8-4048-aa3d-89b49fe64838_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants_24547f1b-4ff0-4271-8b02-2ea9db0c66eb_terseLabel_en-US" xlink:label="lab_amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum threshold written notice period for redemption of public warrants</link:label>
    <link:label id="lab_amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants_label_en-US" xlink:label="lab_amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Minimum Threshold Written Notice Period For Redemption Of Warrants</link:label>
    <link:label id="lab_amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants_documentation_en-US" xlink:label="lab_amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The minimum threshold period during which a written notice is required for redemption of warrants, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" xlink:to="lab_amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanTextBlock_1325d133-6430-4a2c-831a-330e8f336907_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit Plans</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanTextBlock_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanTextBlock" xlink:to="lab_us-gaap_DefinedBenefitPlanTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_SAFEWarrantNearTermMember_d9ff14b9-b170-4658-a703-28f0b5e3d4e5_terseLabel_en-US" xlink:label="lab_amci_SAFEWarrantNearTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Near Term</link:label>
    <link:label id="lab_amci_SAFEWarrantNearTermMember_label_en-US" xlink:label="lab_amci_SAFEWarrantNearTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SAFE Warrant, Near Term [Member]</link:label>
    <link:label id="lab_amci_SAFEWarrantNearTermMember_documentation_en-US" xlink:label="lab_amci_SAFEWarrantNearTermMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SAFE Warrant, Near Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SAFEWarrantNearTermMember" xlink:href="amci-20230213.xsd#amci_SAFEWarrantNearTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_SAFEWarrantNearTermMember" xlink:to="lab_amci_SAFEWarrantNearTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract_6b5989ef-22ba-4761-bfc4-b2e4aa0c15b0_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Cash Flow Elements, Investing Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Cash Flow Elements, Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract" xlink:to="lab_us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_IncomeFromInvestmentsHeldInTrustAccount_a5e3de32-5e96-4d02-b22a-984e54804291_terseLabel_en-US" xlink:label="lab_amci_IncomeFromInvestmentsHeldInTrustAccount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from investments held in trust account</link:label>
    <link:label id="lab_amci_IncomeFromInvestmentsHeldInTrustAccount_e0608f2c-f80d-4775-87cf-20ce4791c085_negatedLabel_en-US" xlink:label="lab_amci_IncomeFromInvestmentsHeldInTrustAccount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from investments held in the trust account</link:label>
    <link:label id="lab_amci_IncomeFromInvestmentsHeldInTrustAccount_label_en-US" xlink:label="lab_amci_IncomeFromInvestmentsHeldInTrustAccount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income From Investments Held In Trust Account</link:label>
    <link:label id="lab_amci_IncomeFromInvestmentsHeldInTrustAccount_documentation_en-US" xlink:label="lab_amci_IncomeFromInvestmentsHeldInTrustAccount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of income from investments held in Trust Account.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeFromInvestmentsHeldInTrustAccount" xlink:href="amci-20230213.xsd#amci_IncomeFromInvestmentsHeldInTrustAccount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_IncomeFromInvestmentsHeldInTrustAccount" xlink:to="lab_amci_IncomeFromInvestmentsHeldInTrustAccount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_c341d7e9-0f50-4306-9f46-c40df2b4ff7f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee or Group of Investees</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_42df096b-99a4-4b9a-a689-62ef37432559_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_18f3ed6c-99e4-4c42-8a1b-c16edb1118b0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_FounderSharesMember_5fb78e87-f550-49d3-bc5d-df15de31b355_terseLabel_en-US" xlink:label="lab_amci_FounderSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Founder Shares</link:label>
    <link:label id="lab_amci_FounderSharesMember_label_en-US" xlink:label="lab_amci_FounderSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Founder Shares</link:label>
    <link:label id="lab_amci_FounderSharesMember_documentation_en-US" xlink:label="lab_amci_FounderSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This member stands for Founder Shares Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_FounderSharesMember" xlink:href="amci-20230213.xsd#amci_FounderSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_FounderSharesMember" xlink:to="lab_amci_FounderSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties_1f3fe333-5782-4d48-8dc0-b5746c90fe45_terseLabel_en-US" xlink:label="lab_amci_NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses paid by related party under note payable and advances</link:label>
    <link:label id="lab_amci_NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties_label_en-US" xlink:label="lab_amci_NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Prepaid Expenses And Other Assets Paid By Related Parties</link:label>
    <link:label id="lab_amci_NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties_documentation_en-US" xlink:label="lab_amci_NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash prepaid expenses and other assets paid by related parties.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties" xlink:href="amci-20230213.xsd#amci_NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties" xlink:to="lab_amci_NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_d720213c-ac64-42a4-9749-c1c420cd9128_terseLabel_en-US" xlink:label="lab_amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption price per public warrant (in dollars per share)</link:label>
    <link:label id="lab_amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_label_en-US" xlink:label="lab_amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Redemption Price Of Warrants Or Rights</link:label>
    <link:label id="lab_amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_documentation_en-US" xlink:label="lab_amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption price per share or per unit of warrants or rights outstanding.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xlink:to="lab_amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_1fa7be81-16ca-42d3-82ae-a774b2f35617_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expecting to vest, Aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_RelatedPartyInvestmentAgreementMember_753a1067-36f2-4dd6-b96c-9dca16384c50_terseLabel_en-US" xlink:label="lab_amci_RelatedPartyInvestmentAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Investment Agreement</link:label>
    <link:label id="lab_amci_RelatedPartyInvestmentAgreementMember_label_en-US" xlink:label="lab_amci_RelatedPartyInvestmentAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Investment Agreement [Member]</link:label>
    <link:label id="lab_amci_RelatedPartyInvestmentAgreementMember_documentation_en-US" xlink:label="lab_amci_RelatedPartyInvestmentAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Investment Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartyInvestmentAgreementMember" xlink:href="amci-20230213.xsd#amci_RelatedPartyInvestmentAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_RelatedPartyInvestmentAgreementMember" xlink:to="lab_amci_RelatedPartyInvestmentAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_DeferredUnderwritingDiscountPercentage_42dae920-6f70-45da-9f21-929d76788bd7_terseLabel_en-US" xlink:label="lab_amci_DeferredUnderwritingDiscountPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred underwriting fee percentage</link:label>
    <link:label id="lab_amci_DeferredUnderwritingDiscountPercentage_label_en-US" xlink:label="lab_amci_DeferredUnderwritingDiscountPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Underwriting Discount Percentage</link:label>
    <link:label id="lab_amci_DeferredUnderwritingDiscountPercentage_documentation_en-US" xlink:label="lab_amci_DeferredUnderwritingDiscountPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to Deferred Underwriting Discount Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingDiscountPercentage" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingDiscountPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_DeferredUnderwritingDiscountPercentage" xlink:to="lab_amci_DeferredUnderwritingDiscountPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering_4fe23b09-ded4-4dfc-9346-62fbf8a9bfb2_terseLabel_en-US" xlink:label="lab_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of Class B common stock transferred to Anchor Investors at initial public offering</link:label>
    <link:label id="lab_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering_label_en-US" xlink:label="lab_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of Class B common stock transferred to Anchor Investors at Initial Public Offering</link:label>
    <link:label id="lab_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering_documentation_en-US" xlink:label="lab_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of value of Class B common stock transferred to anchor investors at initial public offering.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering" xlink:href="amci-20230213.xsd#amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering" xlink:to="lab_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c18e7960-0fb9-41ed-ba77-c47f7997b52d_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding of common stock, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_dd88b03d-1c28-4b62-9679-eb1b247a6188_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average number of common shares outstanding - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a2746b24-1dbf-4f45-8555-fe2a1f9918f0_netLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares used in calculating net loss per share, basic and diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationAssetCurrent_6171c7a3-9082-49a2-b2a0-5e4064329eae_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationAssetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationAssetCurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationAssetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Asset, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationAssetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationAssetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationAssetCurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationAssetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_1d2badf1-f34c-4f9d-acbb-874266109670_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise_09deec4f-5cff-4704-80ae-a59a23eaa102_terseLabel_en-US" xlink:label="lab_amci_PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period of time after which warrant holder may do cashless exercise</link:label>
    <link:label id="lab_amci_PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise_label_en-US" xlink:label="lab_amci_PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period Of Time After Which Warrant Holder May Do Cashless Exercise</link:label>
    <link:label id="lab_amci_PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise_documentation_en-US" xlink:label="lab_amci_PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">period of time after which warrant holder may do cashless exercise.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise" xlink:href="amci-20230213.xsd#amci_PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise" xlink:to="lab_amci_PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_90d83e79-9846-43c0-84a7-a7aa40809c04_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNet_857ed220-f66a-4745-aaff-409d75fb454f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNet_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNet" xlink:to="lab_us-gaap_AccountsReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_6ae1a85c-1898-4a8d-9ab2-9644aa639359_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.0001 par value 1,000,000 shares authorized no shares issued or outstanding as of June 30, 2022 and December 31, 2021</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_9c415b2b-6d72-401a-b506-7f0a61750242_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.0001 par value 1,000,000 shares authorized no shares issued or outstanding as of June 30, 2022 and December 31, 2021</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_4d98b309-de1f-426e-a072-1ba8016deddd_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSAs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_OutstandingWorkingCapitalLoans_579bbbe1-ea90-4ac7-a7f8-619b2b9dd70a_terseLabel_en-US" xlink:label="lab_amci_OutstandingWorkingCapitalLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding working capital loans</link:label>
    <link:label id="lab_amci_OutstandingWorkingCapitalLoans_label_en-US" xlink:label="lab_amci_OutstandingWorkingCapitalLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Working Capital Loans</link:label>
    <link:label id="lab_amci_OutstandingWorkingCapitalLoans_documentation_en-US" xlink:label="lab_amci_OutstandingWorkingCapitalLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to Outstanding Working Capital Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OutstandingWorkingCapitalLoans" xlink:href="amci-20230213.xsd#amci_OutstandingWorkingCapitalLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_OutstandingWorkingCapitalLoans" xlink:to="lab_amci_OutstandingWorkingCapitalLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_c470daa1-abed-45cd-b690-3bfa1c2b645f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_7c0e3766-6ea8-4245-b357-28deb851b8ba_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain_1d949977-6d4c-47a0-9569-b00d0718dc42_terseLabel_en-US" xlink:label="lab_us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments Subject to Mandatory Redemption, Financial Instrument [Domain]</link:label>
    <link:label id="lab_us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain_label_en-US" xlink:label="lab_us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments Subject to Mandatory Redemption, Financial Instrument [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain" xlink:to="lab_us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_d3cf343b-09db-4376-94a7-916a3c85f8d9_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_OfferingCostsIncludedInAccountsPayableAccruedExpenses_9b1d5849-234b-47a4-8410-618c4e267d33_terseLabel_en-US" xlink:label="lab_amci_OfferingCostsIncludedInAccountsPayableAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering costs included in accrued expenses</link:label>
    <link:label id="lab_amci_OfferingCostsIncludedInAccountsPayableAccruedExpenses_label_en-US" xlink:label="lab_amci_OfferingCostsIncludedInAccountsPayableAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering Costs Included In Accounts Payable Accrued Expenses</link:label>
    <link:label id="lab_amci_OfferingCostsIncludedInAccountsPayableAccruedExpenses_documentation_en-US" xlink:label="lab_amci_OfferingCostsIncludedInAccountsPayableAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of offering costs included in accounts payable or accrued expenses that were incurred during a noncash or partial noncash transaction.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OfferingCostsIncludedInAccountsPayableAccruedExpenses" xlink:href="amci-20230213.xsd#amci_OfferingCostsIncludedInAccountsPayableAccruedExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_OfferingCostsIncludedInAccountsPayableAccruedExpenses" xlink:to="lab_amci_OfferingCostsIncludedInAccountsPayableAccruedExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_257743fc-b3cb-468b-af2d-acae30a576b3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrent_7819de0a-beec-4515-8d79-9be24882e686_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current assets</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent" xlink:to="lab_us-gaap_AssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_f00de6b6-44e7-43a7-b55e-562c8dd6a5dc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_SimpleAgreementForFutureEquityLiabilityDisclosureTextBlock_9149ba30-c031-4698-83fe-d418e93c20dc_terseLabel_en-US" xlink:label="lab_amci_SimpleAgreementForFutureEquityLiabilityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SAFE</link:label>
    <link:label id="lab_amci_SimpleAgreementForFutureEquityLiabilityDisclosureTextBlock_label_en-US" xlink:label="lab_amci_SimpleAgreementForFutureEquityLiabilityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simple Agreement for Future Equity Liability Disclosure [Text Block]</link:label>
    <link:label id="lab_amci_SimpleAgreementForFutureEquityLiabilityDisclosureTextBlock_documentation_en-US" xlink:label="lab_amci_SimpleAgreementForFutureEquityLiabilityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simple Agreement for Future Equity Liability Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SimpleAgreementForFutureEquityLiabilityDisclosureTextBlock" xlink:href="amci-20230213.xsd#amci_SimpleAgreementForFutureEquityLiabilityDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_SimpleAgreementForFutureEquityLiabilityDisclosureTextBlock" xlink:to="lab_amci_SimpleAgreementForFutureEquityLiabilityDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d41e8019-5bba-408d-bf0a-adb1806bef1d_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3ac43d15-3d02-41ad-85de-28ed1baeca97_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_b3966f65-b405-4155-99b5-4853cfee8f2b_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_6626246b-74b5-4b73-ba94-0409475c6548_verboseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_68ccab08-1f61-49e4-bc59-6d11b014222c_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ContractWithCustomerLiabilityNoncurrentAbstract_9d42a4fc-a592-43ec-8c3a-316fdce921d5_terseLabel_en-US" xlink:label="lab_amci_ContractWithCustomerLiabilityNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current Contract Liabilities</link:label>
    <link:label id="lab_amci_ContractWithCustomerLiabilityNoncurrentAbstract_label_en-US" xlink:label="lab_amci_ContractWithCustomerLiabilityNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Noncurrent [Abstract]</link:label>
    <link:label id="lab_amci_ContractWithCustomerLiabilityNoncurrentAbstract_documentation_en-US" xlink:label="lab_amci_ContractWithCustomerLiabilityNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContractWithCustomerLiabilityNoncurrentAbstract" xlink:href="amci-20230213.xsd#amci_ContractWithCustomerLiabilityNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ContractWithCustomerLiabilityNoncurrentAbstract" xlink:to="lab_amci_ContractWithCustomerLiabilityNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_WarrantConditionDomain_5a522aea-650d-42a9-ac4e-4e4817849fab_terseLabel_en-US" xlink:label="lab_amci_WarrantConditionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant Condition [Domain]</link:label>
    <link:label id="lab_amci_WarrantConditionDomain_label_en-US" xlink:label="lab_amci_WarrantConditionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant Condition [Domain]</link:label>
    <link:label id="lab_amci_WarrantConditionDomain_documentation_en-US" xlink:label="lab_amci_WarrantConditionDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant Condition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WarrantConditionDomain" xlink:href="amci-20230213.xsd#amci_WarrantConditionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_WarrantConditionDomain" xlink:to="lab_amci_WarrantConditionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_44c4caf3-b0ed-4b62-a5f1-be152c214e53_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_f356c9b7-86b4-45b3-8a3b-e05ef3cb8d7d_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of significant components of the Company's deferred tax assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_134643a0-506b-4d59-b099-0a4c5e3a3949_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant components of deferred tax assets and liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_de8445c5-93aa-4d2a-9be1-5203face70e5_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0553fe82-196f-4364-9eaa-0eafc25934ee_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_aa670da0-0061-4bd7-805e-5bd9d085bb71_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_75aba9c0-8cc2-4759-96fe-92f975ad69c0_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_NoncashLoanForgiveness_c213da3f-9d1e-43c7-8851-833c547dd8ef_terseLabel_en-US" xlink:label="lab_amci_NoncashLoanForgiveness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PPP loan forgiveness</link:label>
    <link:label id="lab_amci_NoncashLoanForgiveness_label_en-US" xlink:label="lab_amci_NoncashLoanForgiveness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Loan Forgiveness</link:label>
    <link:label id="lab_amci_NoncashLoanForgiveness_documentation_en-US" xlink:label="lab_amci_NoncashLoanForgiveness" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Loan Forgiveness</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NoncashLoanForgiveness" xlink:href="amci-20230213.xsd#amci_NoncashLoanForgiveness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_NoncashLoanForgiveness" xlink:to="lab_amci_NoncashLoanForgiveness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_0594332b-59cc-43e4-8fe4-aaa7ce2fdd42_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of SAFE liability and warrant</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_40f0bdf4-5906-489d-a93b-b6da33af8602_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_c997e3df-197d-4d40-9f17-1a8fadb25465_terseLabel_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Debt Issuance Costs</link:label>
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtPolicyTextBlock" xlink:to="lab_us-gaap_DebtPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ResearchAndDevelopmentMember_32c23ae3-66b6-4c60-9949-d5de99abfa24_terseLabel_en-US" xlink:label="lab_amci_ResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_amci_ResearchAndDevelopmentMember_label_en-US" xlink:label="lab_amci_ResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development [Member]</link:label>
    <link:label id="lab_amci_ResearchAndDevelopmentMember_documentation_en-US" xlink:label="lab_amci_ResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ResearchAndDevelopmentMember" xlink:href="amci-20230213.xsd#amci_ResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ResearchAndDevelopmentMember" xlink:to="lab_amci_ResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_October2022SubscriptionAgreementsMember_b99880dc-c3ef-4e0e-829c-dc12339def32_terseLabel_en-US" xlink:label="lab_amci_October2022SubscriptionAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription Agreements</link:label>
    <link:label id="lab_amci_October2022SubscriptionAgreementsMember_label_en-US" xlink:label="lab_amci_October2022SubscriptionAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2022 Subscription Agreements</link:label>
    <link:label id="lab_amci_October2022SubscriptionAgreementsMember_documentation_en-US" xlink:label="lab_amci_October2022SubscriptionAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This member represents October 2022 subscription agreements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_October2022SubscriptionAgreementsMember" xlink:href="amci-20230213.xsd#amci_October2022SubscriptionAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_October2022SubscriptionAgreementsMember" xlink:to="lab_amci_October2022SubscriptionAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireTrustPreferredInvestments_f97b8982-9763-4345-9cd2-5d00c90641a7_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireTrustPreferredInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash deposited in trust account</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireTrustPreferredInvestments_5d4a24c1-d40e-4263-8f57-838e23d25d50_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireTrustPreferredInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash deposited in Trust Account</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireTrustPreferredInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireTrustPreferredInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Trust Preferred Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireTrustPreferredInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireTrustPreferredInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireTrustPreferredInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireTrustPreferredInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d25ce995-d705-4beb-a7e7-b14dc4b30b62_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_590ed316-9ce3-4f2a-8d27-6f9c94e16913_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of derivative warrant liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_ad98371a-3a7a-4833-8719-fe7791d88c40_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) loss on change in fair value of SAFE and warrant liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_0648c7ad-53b1-4f18-ab34-a725b9131156_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of derivative warrant liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_label_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Adjustment of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAdjustmentOfWarrants" xlink:to="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_CommonClassaSubjectToRedemptionMember_ab361456-4b5e-40bb-8e88-a8a2ef22a41c_terseLabel_en-US" xlink:label="lab_amci_CommonClassaSubjectToRedemptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class A Common Stock Subject to Redemption</link:label>
    <link:label id="lab_amci_CommonClassaSubjectToRedemptionMember_label_en-US" xlink:label="lab_amci_CommonClassaSubjectToRedemptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class A Common Stock Subject to Redemption</link:label>
    <link:label id="lab_amci_CommonClassaSubjectToRedemptionMember_documentation_en-US" xlink:label="lab_amci_CommonClassaSubjectToRedemptionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Classification of common stock representing ownership interest in a corporation that is subject to redemption.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CommonClassaSubjectToRedemptionMember" xlink:href="amci-20230213.xsd#amci_CommonClassaSubjectToRedemptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_CommonClassaSubjectToRedemptionMember" xlink:to="lab_amci_CommonClassaSubjectToRedemptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_fd570d5d-5695-468e-a410-331c1bf30129_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_7612c355-4971-48f5-b53c-5d6361256a0f_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_0f8fdc0d-84f4-4b23-b922-f155ced86dc0_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_3e2a464c-78ae-4448-ab5d-5165edb24bd3_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_efc897c3-d058-46a8-b0f5-c74e220d540d_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_5e23b407-27d2-4367-b914-e3e8029ac57f_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_MeasurementInputProbabilityWeightingMember_ec4c6ceb-47f7-41bb-9d5f-ed30322f2b00_terseLabel_en-US" xlink:label="lab_amci_MeasurementInputProbabilityWeightingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Probability weighting</link:label>
    <link:label id="lab_amci_MeasurementInputProbabilityWeightingMember_label_en-US" xlink:label="lab_amci_MeasurementInputProbabilityWeightingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Probability Weighting [Member]</link:label>
    <link:label id="lab_amci_MeasurementInputProbabilityWeightingMember_documentation_en-US" xlink:label="lab_amci_MeasurementInputProbabilityWeightingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Probability Weighting</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MeasurementInputProbabilityWeightingMember" xlink:href="amci-20230213.xsd#amci_MeasurementInputProbabilityWeightingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_MeasurementInputProbabilityWeightingMember" xlink:to="lab_amci_MeasurementInputProbabilityWeightingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_IncreaseDecreaseFranchiseTaxPayable_6a228e24-a762-4bdb-82e6-241903cf61d9_terseLabel_en-US" xlink:label="lab_amci_IncreaseDecreaseFranchiseTaxPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Franchise tax payable</link:label>
    <link:label id="lab_amci_IncreaseDecreaseFranchiseTaxPayable_label_en-US" xlink:label="lab_amci_IncreaseDecreaseFranchiseTaxPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease Franchise Tax Payable</link:label>
    <link:label id="lab_amci_IncreaseDecreaseFranchiseTaxPayable_documentation_en-US" xlink:label="lab_amci_IncreaseDecreaseFranchiseTaxPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The increase (decrease) during the reporting period of franchise tax payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncreaseDecreaseFranchiseTaxPayable" xlink:href="amci-20230213.xsd#amci_IncreaseDecreaseFranchiseTaxPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_IncreaseDecreaseFranchiseTaxPayable" xlink:to="lab_amci_IncreaseDecreaseFranchiseTaxPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_1134ce4f-0649-4888-9912-2bc2dd244cb4_totalLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_CoronavirusPolicyTextBlock_85bc16c5-cd24-4a44-8e16-74c4e0dcccdf_terseLabel_en-US" xlink:label="lab_amci_CoronavirusPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coronavirus</link:label>
    <link:label id="lab_amci_CoronavirusPolicyTextBlock_label_en-US" xlink:label="lab_amci_CoronavirusPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coronavirus [Policy Text Block]</link:label>
    <link:label id="lab_amci_CoronavirusPolicyTextBlock_documentation_en-US" xlink:label="lab_amci_CoronavirusPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coronavirus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CoronavirusPolicyTextBlock" xlink:href="amci-20230213.xsd#amci_CoronavirusPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_CoronavirusPolicyTextBlock" xlink:to="lab_amci_CoronavirusPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesAndFairValueTextBlock_1233d723-8713-4583-8b62-07d2c8cac2e0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativesAndFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives and Fair Value [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesAndFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesAndFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesAndFairValueTextBlock" xlink:to="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_cb03eb49-bdac-44e5-834e-4c728dd7910e_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (expense) income:</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ContractWithCustomerLiabilityCurrentAmountsCollected_6aadb548-cb96-467f-b5f8-f526c2944b02_terseLabel_en-US" xlink:label="lab_amci_ContractWithCustomerLiabilityCurrentAmountsCollected" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increases due to cash received</link:label>
    <link:label id="lab_amci_ContractWithCustomerLiabilityCurrentAmountsCollected_label_en-US" xlink:label="lab_amci_ContractWithCustomerLiabilityCurrentAmountsCollected" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Current, Amounts Collected</link:label>
    <link:label id="lab_amci_ContractWithCustomerLiabilityCurrentAmountsCollected_documentation_en-US" xlink:label="lab_amci_ContractWithCustomerLiabilityCurrentAmountsCollected" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Current, Amounts Collected</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContractWithCustomerLiabilityCurrentAmountsCollected" xlink:href="amci-20230213.xsd#amci_ContractWithCustomerLiabilityCurrentAmountsCollected"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ContractWithCustomerLiabilityCurrentAmountsCollected" xlink:to="lab_amci_ContractWithCustomerLiabilityCurrentAmountsCollected" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent_867f2d8c-59e9-4f0a-92ee-9d1153c06f20_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade and other receivables, net of allowance</link:label>
    <link:label id="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts and Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:to="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_54845185-109f-47e7-bcdd-9bb49a7de1d9_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_6cee37d9-f049-4b44-816d-4af74d72de70_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ConvertibleStockConversionRatio_3c216158-11c1-49db-9755-d3c19449789b_terseLabel_en-US" xlink:label="lab_amci_ConvertibleStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ratio to be applied to the stock in the conversion</link:label>
    <link:label id="lab_amci_ConvertibleStockConversionRatio_label_en-US" xlink:label="lab_amci_ConvertibleStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Stock Conversion Ratio</link:label>
    <link:label id="lab_amci_ConvertibleStockConversionRatio_documentation_en-US" xlink:label="lab_amci_ConvertibleStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The ratio to be applied to the stock in a conversion of convertible stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ConvertibleStockConversionRatio" xlink:href="amci-20230213.xsd#amci_ConvertibleStockConversionRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ConvertibleStockConversionRatio" xlink:to="lab_amci_ConvertibleStockConversionRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_4c87b3d2-d373-429f-a955-16f9aab88293_terseLabel_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over-allotment option</link:label>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_label_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over-Allotment Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OverAllotmentOptionMember" xlink:to="lab_us-gaap_OverAllotmentOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationInterestIncomePercent_cc997a00-22f9-42ed-ae8e-1f562b468e46_terseLabel_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationInterestIncomePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income on receivable</link:label>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationInterestIncomePercent_label_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationInterestIncomePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Interest Income, Percent</link:label>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationInterestIncomePercent_documentation_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationInterestIncomePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Interest Income, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationInterestIncomePercent" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationInterestIncomePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_EffectiveIncomeTaxRateReconciliationInterestIncomePercent" xlink:to="lab_amci_EffectiveIncomeTaxRateReconciliationInterestIncomePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_2eed577c-8252-4f07-af9f-b79901460f9a_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_a8cf3ad4-6863-4b1a-9798-b07257037742_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_d8ea836b-6a52-4cbb-950d-a33b2a21391f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Organization and Business Operations</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_0757d539-e81e-41d5-aa93-254fe47ced0a_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of preferred stock</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_ab8f80f5-96a8-4782-84ca-7d67ead89485_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, Aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts_9df6e685-d40b-458b-a84a-0a8d124c422d_terseLabel_en-US" xlink:label="lab_amci_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Start-up/Organization costs</link:label>
    <link:label id="lab_amci_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts_label_en-US" xlink:label="lab_amci_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Capitalized Start Up And Organization Costs</link:label>
    <link:label id="lab_amci_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts_documentation_en-US" xlink:label="lab_amci_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">" Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from capitalized start up and organization costs."</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts" xlink:href="amci-20230213.xsd#amci_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts" xlink:to="lab_amci_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_SAFEWarrantMember_392e3aa3-fb70-4705-a58f-cae80e6d9d8c_terseLabel_en-US" xlink:label="lab_amci_SAFEWarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SAFE warrant</link:label>
    <link:label id="lab_amci_SAFEWarrantMember_label_en-US" xlink:label="lab_amci_SAFEWarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SAFE Warrant [Member]</link:label>
    <link:label id="lab_amci_SAFEWarrantMember_documentation_en-US" xlink:label="lab_amci_SAFEWarrantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SAFE Warrant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SAFEWarrantMember" xlink:href="amci-20230213.xsd#amci_SAFEWarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_SAFEWarrantMember" xlink:to="lab_amci_SAFEWarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsEquityMethodInvestments_80626f07-d1df-417e-a0e6-3081a77f844e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsEquityMethodInvestments" xlink:to="lab_us-gaap_DeferredTaxAssetsEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction_3bfa0e75-ba67-4cba-a60e-bfe9e749f98c_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount incurred</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Amounts of Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum_f429a153-920c-4150-97b4-e114dd71d4eb_terseLabel_en-US" xlink:label="lab_amci_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condition for future business combination number of businesses minimum</link:label>
    <link:label id="lab_amci_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum_label_en-US" xlink:label="lab_amci_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condition for future business combination number of businesses minimum</link:label>
    <link:label id="lab_amci_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum_documentation_en-US" xlink:label="lab_amci_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The minimum number of businesses which the reporting entity must acquire with the net proceeds of the offering.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" xlink:href="amci-20230213.xsd#amci_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" xlink:to="lab_amci_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_e27f212f-7ae1-4986-a07b-007b4bc88862_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_c4abc818-9a8f-4beb-928f-df639a8c71fc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_label_en-US" xlink:label="lab_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:to="lab_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_SaleOfStockOtherOfferingCosts_eb934b69-fd18-4b89-9718-5ce003c5da1e_terseLabel_en-US" xlink:label="lab_amci_SaleOfStockOtherOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other offering costs</link:label>
    <link:label id="lab_amci_SaleOfStockOtherOfferingCosts_label_en-US" xlink:label="lab_amci_SaleOfStockOtherOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Other Offering Costs</link:label>
    <link:label id="lab_amci_SaleOfStockOtherOfferingCosts_documentation_en-US" xlink:label="lab_amci_SaleOfStockOtherOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of other offering costs incurred.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SaleOfStockOtherOfferingCosts" xlink:href="amci-20230213.xsd#amci_SaleOfStockOtherOfferingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_SaleOfStockOtherOfferingCosts" xlink:to="lab_amci_SaleOfStockOtherOfferingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares_358416e1-7078-465c-a820-608b731df33e_terseLabel_en-US" xlink:label="lab_amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative expenses paid by Sponsor in exchange for issuance of Class B common stock</link:label>
    <link:label id="lab_amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares_label_en-US" xlink:label="lab_amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General And Administrative Expenses Paid By Sponsor In Exchange For Shares</link:label>
    <link:label id="lab_amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares_documentation_en-US" xlink:label="lab_amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of general and administrative expenses paid by Sponsor in exchange for shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares" xlink:href="amci-20230213.xsd#amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares" xlink:to="lab_amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_730164aa-0a62-4537-b390-bf6eb7d55fc7_negatedLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion of Class A common stock subject to possible redemption amount</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_b9fa9c98-f680-46e4-b1bd-061fb309ddcb_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion of Class A common stock subject to possible redemption amount</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_6833269e-032f-490b-9fcb-bc1dde1ed9f6_verboseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion of carrying value to redemption value</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Accretion to Redemption Value, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:to="lab_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_5b3cb2c7-d0e6-450c-a00b-7dbd5e311680_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of reconciliation of the total income tax provision tax rate to the statutory federal income tax rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_52e62714-7716-46d4-b257-5b39e2977eed_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of income taxes computed at statutory federal income tax rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaMember_4a9d4a3d-dea9-47d9-b264-ebc0bd35d5da_terseLabel_en-US" xlink:label="lab_srt_AsiaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia</link:label>
    <link:label id="lab_srt_AsiaMember_label_en-US" xlink:label="lab_srt_AsiaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaMember" xlink:to="lab_srt_AsiaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_041dc2a2-16d3-44ab-9429-1388a2f1b5ab_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (decrease) increase in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering_2af262e2-a3c4-4999-b927-c628db5b114c_terseLabel_en-US" xlink:label="lab_amci_WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold period days after the completion of the initial Business Combination for exercise of warrants</link:label>
    <link:label id="lab_amci_WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering_label_en-US" xlink:label="lab_amci_WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants And Rights Outstanding Exercisable Term From Closing Of Initial Public Offering</link:label>
    <link:label id="lab_amci_WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering_documentation_en-US" xlink:label="lab_amci_WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The warrants exercisable term from the closing of the initial public offering, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering" xlink:href="amci-20230213.xsd#amci_WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering" xlink:to="lab_amci_WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_8f409dfe-103b-4012-a695-1a2cdf3bd895_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_8ac0b7a2-a1cd-476c-aafe-8d2a51177a64_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_6589f109-e8d0-4059-abb9-e78bfacd4e23_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a65707fb-53f5-4e9e-8ab9-309af887fff8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityMeasurementInput_1da8867d-7cd8-4d11-aa86-9f30b59210e0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, measurement input</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityMeasurementInput" xlink:to="lab_us-gaap_DerivativeLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_a00f6be8-4c2e-45ec-a052-040072721fbe_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_eb4009f8-cd71-4365-af3c-2ffefbc58331_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_5d3e1eab-70f5-4901-98fd-70b545dd250d_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_09fb548f-6d98-40ae-b68b-d7f255b4fcca_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_e6a911e1-2307-43c3-9f69-714a55d8e314_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentOtherTypesMember_bad19b26-f812-4756-ab44-a9f87d2beceb_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentOtherTypesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentOtherTypesMember_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentOtherTypesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Other Types [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOtherTypesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentOtherTypesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentOtherTypesMember" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentOtherTypesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_DerivativeNearTermMember_316bfcf3-24c3-42fd-a1c2-a04fe14072ba_terseLabel_en-US" xlink:label="lab_amci_DerivativeNearTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Near Term</link:label>
    <link:label id="lab_amci_DerivativeNearTermMember_label_en-US" xlink:label="lab_amci_DerivativeNearTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Near Term [Member]</link:label>
    <link:label id="lab_amci_DerivativeNearTermMember_documentation_en-US" xlink:label="lab_amci_DerivativeNearTermMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Near Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DerivativeNearTermMember" xlink:href="amci-20230213.xsd#amci_DerivativeNearTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_DerivativeNearTermMember" xlink:to="lab_amci_DerivativeNearTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_4531f34a-f9f7-403f-bad9-1d089d3ba294_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Per Share of Common Stock</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_4a8da8f7-cecc-4f43-9acb-dcd1c069a895_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_e49338a9-d2ff-4ba7-9bd3-9da175981679_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_71d05bc2-bf89-439a-acef-1cc9b9776ff6_verboseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of noncash activities:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_0c641492-1d7e-4c43-b30f-c83a79132e86_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of non-cash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_650c0177-b630-480f-8d78-8038f94aaaa6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments cost</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_b18b909a-a1c5-46f5-b60b-c2e519c00b09_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments cost</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_RedemptionPeriodUponClosure_0f4f0ba6-a8ed-438e-90f7-880238892649_terseLabel_en-US" xlink:label="lab_amci_RedemptionPeriodUponClosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption period upon closure</link:label>
    <link:label id="lab_amci_RedemptionPeriodUponClosure_label_en-US" xlink:label="lab_amci_RedemptionPeriodUponClosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption Period Upon Closure</link:label>
    <link:label id="lab_amci_RedemptionPeriodUponClosure_documentation_en-US" xlink:label="lab_amci_RedemptionPeriodUponClosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The period of time in which the reporting entity must redeem shares issued pursuant to the offering.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RedemptionPeriodUponClosure" xlink:href="amci-20230213.xsd#amci_RedemptionPeriodUponClosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_RedemptionPeriodUponClosure" xlink:to="lab_amci_RedemptionPeriodUponClosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_16381754-947f-4f60-8b5b-d5d225432c90_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_17fa1d0f-650f-426c-8016-2c505a66419b_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of warrants outstanding</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_db6e750a-5f9d-4faf-8878-97d89492d4ad_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_SAFEWarrantLongTermMember_9f7905c1-bba3-4da5-b5fd-f3e04c909484_terseLabel_en-US" xlink:label="lab_amci_SAFEWarrantLongTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term</link:label>
    <link:label id="lab_amci_SAFEWarrantLongTermMember_label_en-US" xlink:label="lab_amci_SAFEWarrantLongTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SAFE Warrant, Long Term [Member]</link:label>
    <link:label id="lab_amci_SAFEWarrantLongTermMember_documentation_en-US" xlink:label="lab_amci_SAFEWarrantLongTermMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SAFE Warrant, Long Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SAFEWarrantLongTermMember" xlink:href="amci-20230213.xsd#amci_SAFEWarrantLongTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_SAFEWarrantLongTermMember" xlink:to="lab_amci_SAFEWarrantLongTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_4063ca42-4e35-4da7-a938-682505a5fe0c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesOfLessorDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:to="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_4e11c1f0-c327-47b3-9884-41622d68b82d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from equity method investees, net</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_08f81ad3-19f5-47ae-a15b-a95eaa7e9872_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from equity method investees, net</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_c09d4bf9-a6ff-4378-8e17-079877e4ca0b_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ReverseCapitalizationClosingCashCondition_5541a0b3-211f-4314-b3e1-ebfbd16d6f3a_terseLabel_en-US" xlink:label="lab_amci_ReverseCapitalizationClosingCashCondition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum closing cash condition</link:label>
    <link:label id="lab_amci_ReverseCapitalizationClosingCashCondition_label_en-US" xlink:label="lab_amci_ReverseCapitalizationClosingCashCondition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Capitalization, Closing Cash Condition</link:label>
    <link:label id="lab_amci_ReverseCapitalizationClosingCashCondition_documentation_en-US" xlink:label="lab_amci_ReverseCapitalizationClosingCashCondition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Capitalization, Closing Cash Condition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ReverseCapitalizationClosingCashCondition" xlink:href="amci-20230213.xsd#amci_ReverseCapitalizationClosingCashCondition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ReverseCapitalizationClosingCashCondition" xlink:to="lab_amci_ReverseCapitalizationClosingCashCondition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_6819883e-6179-4484-a2cf-3aa5bb7fc849_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_adb58fc6-2b60-4751-bb22-4bdfd0205b11_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyAmount_8d0fd4be-513b-41f0-94bf-87edb8566853_terseLabel_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from redomiciliation of intellectual property</link:label>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyAmount_label_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Gain From Redomicilation Of Intellectual Property, Amount</link:label>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyAmount_documentation_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Gain From Redomicilation Of Intellectual Property, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyAmount" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyAmount" xlink:to="lab_amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices_2c4dadf0-eea8-4de0-ac0b-ba7523af6e10_verboseLabel_en-US" xlink:label="lab_amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)</link:label>
    <link:label id="lab_amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices_label_en-US" xlink:label="lab_amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class O fWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrices</link:label>
    <link:label id="lab_amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices_documentation_en-US" xlink:label="lab_amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of adjustment of exercise price of warrants based on market value and newly issued price.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices" xlink:href="amci-20230213.xsd#amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices" xlink:to="lab_amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_355a4a17-a93f-4112-b890-3abddaeef55b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Calculation of Basic and Diluted Net Loss per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRelatedPartyDebt_a32641f9-fb2b-4908-9db5-ff2c3b3c31b0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRelatedPartyDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from note payable to related party</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRelatedPartyDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRelatedPartyDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Related Party Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="lab_us-gaap_ProceedsFromRelatedPartyDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AutomobilesMember_4b547dae-a3e5-48e5-81e1-abc932d4adae_terseLabel_en-US" xlink:label="lab_us-gaap_AutomobilesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vehicles</link:label>
    <link:label id="lab_us-gaap_AutomobilesMember_label_en-US" xlink:label="lab_us-gaap_AutomobilesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Automobiles [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AutomobilesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AutomobilesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AutomobilesMember" xlink:to="lab_us-gaap_AutomobilesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_23299ba3-1b2a-4192-a2ff-6c2f7a9606f0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_3d99bebc-597c-4b81-8685-365aa938798d_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_OptionToPurchaseAdditionalUnitsGivenToInvestors_7b82e2db-5cdd-4700-a768-6412100c4e4f_terseLabel_en-US" xlink:label="lab_amci_OptionToPurchaseAdditionalUnitsGivenToInvestors" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to purchase additional units given to investors</link:label>
    <link:label id="lab_amci_OptionToPurchaseAdditionalUnitsGivenToInvestors_label_en-US" xlink:label="lab_amci_OptionToPurchaseAdditionalUnitsGivenToInvestors" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option To Purchase Additional Units Given To Investors</link:label>
    <link:label id="lab_amci_OptionToPurchaseAdditionalUnitsGivenToInvestors_documentation_en-US" xlink:label="lab_amci_OptionToPurchaseAdditionalUnitsGivenToInvestors" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to purchase additional units given to investors.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OptionToPurchaseAdditionalUnitsGivenToInvestors" xlink:href="amci-20230213.xsd#amci_OptionToPurchaseAdditionalUnitsGivenToInvestors"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_OptionToPurchaseAdditionalUnitsGivenToInvestors" xlink:to="lab_amci_OptionToPurchaseAdditionalUnitsGivenToInvestors" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6f474c7b-250b-40f7-86c8-cbfdaf3a2982_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_74c9a353-b52e-425c-b1cc-4715c3d0fb7d_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_6528bc07-d340-4c79-a9c6-87c585c1abb5_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_NumeratorAbstract_1da49818-00cc-4612-a809-80c2b0c79c16_terseLabel_en-US" xlink:label="lab_amci_NumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_amci_NumeratorAbstract_label_en-US" xlink:label="lab_amci_NumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator [Abstract]</link:label>
    <link:label id="lab_amci_NumeratorAbstract_documentation_en-US" xlink:label="lab_amci_NumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">No definition available.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumeratorAbstract" xlink:href="amci-20230213.xsd#amci_NumeratorAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_NumeratorAbstract" xlink:to="lab_amci_NumeratorAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_WorkingCapitalLoan_178607cc-9675-4755-9dcd-d12d85adf796_terseLabel_en-US" xlink:label="lab_amci_WorkingCapitalLoan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Working Capital Loan</link:label>
    <link:label id="lab_amci_WorkingCapitalLoan_label_en-US" xlink:label="lab_amci_WorkingCapitalLoan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Working Capital Loan</link:label>
    <link:label id="lab_amci_WorkingCapitalLoan_documentation_en-US" xlink:label="lab_amci_WorkingCapitalLoan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to Working Capital Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WorkingCapitalLoan" xlink:href="amci-20230213.xsd#amci_WorkingCapitalLoan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_WorkingCapitalLoan" xlink:to="lab_amci_WorkingCapitalLoan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfOtherRealEstate_dddb4438-40e7-4ad4-b69f-f49a9d067687_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfOtherRealEstate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from disposal of investment property</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfOtherRealEstate_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfOtherRealEstate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Other Real Estate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfOtherRealEstate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfOtherRealEstate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfOtherRealEstate" xlink:to="lab_us-gaap_ProceedsFromSaleOfOtherRealEstate" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors_87d1b35e-69f8-4344-bad0-48b9b47d6494_terseLabel_en-US" xlink:label="lab_amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution from Sponsor upon sale of founder shares to Anchor Investors</link:label>
    <link:label id="lab_amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors_label_en-US" xlink:label="lab_amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution from Sponsor upon sale of Founder Shares to Anchor Investors</link:label>
    <link:label id="lab_amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors_documentation_en-US" xlink:label="lab_amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents amount of Contribution from Sponsor upon sale of Founder Shares to Anchor Investors.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors" xlink:href="amci-20230213.xsd#amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors" xlink:to="lab_amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_32c4bfe3-1689-4e42-a3bd-ba7d315bdfba_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments held in trust account</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_9d8d7ee5-e19b-4a74-a371-5af710b14c06_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments held in Trust Account</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_NumberOfSharesSurrendered_fbd2e57b-6ae4-4805-b025-5422981f27a8_terseLabel_en-US" xlink:label="lab_amci_NumberOfSharesSurrendered" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares surrendered</link:label>
    <link:label id="lab_amci_NumberOfSharesSurrendered_label_en-US" xlink:label="lab_amci_NumberOfSharesSurrendered" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Shares Surrendered</link:label>
    <link:label id="lab_amci_NumberOfSharesSurrendered_documentation_en-US" xlink:label="lab_amci_NumberOfSharesSurrendered" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to Number Of Shares Surrendered</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfSharesSurrendered" xlink:href="amci-20230213.xsd#amci_NumberOfSharesSurrendered"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_NumberOfSharesSurrendered" xlink:to="lab_amci_NumberOfSharesSurrendered" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockDividendRatePercentage_b9734366-16a0-4384-a7b4-8e52b8a8e752_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend rate</link:label>
    <link:label id="lab_us-gaap_PreferredStockDividendRatePercentage_label_en-US" xlink:label="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividend Rate, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockDividendRatePercentage" xlink:to="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c71182c8-f019-486c-9b78-825b7c4b21af_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes receivable, aggregate principal amount</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_92c55f1d-f610-4def-a959-3f1f301e0fcb_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_label_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableTypeDomain" xlink:to="lab_us-gaap_ReceivableTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_e91e1f81-9efd-42ee-a2f7-99a2fc982f20_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party fees</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_8226d68d-02e2-41e2-875b-d9cceb3a909d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_TransferFromForeignCurrencyTranslationToEquitySecurityInvestment_f81ab799-f8e9-40f2-84a0-7ed1bfcf5486_terseLabel_en-US" xlink:label="lab_amci_TransferFromForeignCurrencyTranslationToEquitySecurityInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer from foreign currency translation to equity security investment</link:label>
    <link:label id="lab_amci_TransferFromForeignCurrencyTranslationToEquitySecurityInvestment_label_en-US" xlink:label="lab_amci_TransferFromForeignCurrencyTranslationToEquitySecurityInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer from Foreign Currency Translation to Equity Security Investment</link:label>
    <link:label id="lab_amci_TransferFromForeignCurrencyTranslationToEquitySecurityInvestment_documentation_en-US" xlink:label="lab_amci_TransferFromForeignCurrencyTranslationToEquitySecurityInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer from Foreign Currency Translation to Equity Security Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TransferFromForeignCurrencyTranslationToEquitySecurityInvestment" xlink:href="amci-20230213.xsd#amci_TransferFromForeignCurrencyTranslationToEquitySecurityInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_TransferFromForeignCurrencyTranslationToEquitySecurityInvestment" xlink:to="lab_amci_TransferFromForeignCurrencyTranslationToEquitySecurityInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_MaximumAllowedDissolutionExpenses_3e8c78b0-6756-48d1-ae64-65e34fbc93cb_terseLabel_en-US" xlink:label="lab_amci_MaximumAllowedDissolutionExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum allowed dissolution expenses</link:label>
    <link:label id="lab_amci_MaximumAllowedDissolutionExpenses_label_en-US" xlink:label="lab_amci_MaximumAllowedDissolutionExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Allowed Dissolution Expenses</link:label>
    <link:label id="lab_amci_MaximumAllowedDissolutionExpenses_documentation_en-US" xlink:label="lab_amci_MaximumAllowedDissolutionExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The maximum amount permitted to be paid for dissolution expenses if a business combination is not completed within the specified period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MaximumAllowedDissolutionExpenses" xlink:href="amci-20230213.xsd#amci_MaximumAllowedDissolutionExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_MaximumAllowedDissolutionExpenses" xlink:to="lab_amci_MaximumAllowedDissolutionExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_9641d2b5-c812-454f-be35-92d8752a32c0_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_ee4e9074-16f0-4d46-8e8d-5b6c1445e7cd_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_SecuritiesSubjectToMandatoryRedemptionNearTermMember_484b0a44-05a6-4f65-a354-a9a384f323d6_terseLabel_en-US" xlink:label="lab_amci_SecuritiesSubjectToMandatoryRedemptionNearTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Near Term</link:label>
    <link:label id="lab_amci_SecuritiesSubjectToMandatoryRedemptionNearTermMember_label_en-US" xlink:label="lab_amci_SecuritiesSubjectToMandatoryRedemptionNearTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Subject to Mandatory Redemption, Near Term [Member]</link:label>
    <link:label id="lab_amci_SecuritiesSubjectToMandatoryRedemptionNearTermMember_documentation_en-US" xlink:label="lab_amci_SecuritiesSubjectToMandatoryRedemptionNearTermMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Subject to Mandatory Redemption, Near Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SecuritiesSubjectToMandatoryRedemptionNearTermMember" xlink:href="amci-20230213.xsd#amci_SecuritiesSubjectToMandatoryRedemptionNearTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_SecuritiesSubjectToMandatoryRedemptionNearTermMember" xlink:to="lab_amci_SecuritiesSubjectToMandatoryRedemptionNearTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_e39fca24-8909-441d-a229-4caf9da4ca4c_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_7b63d80a-890c-459e-a4f9-1ac203d957e8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of borrowings</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalAmount_c9f016b7-a1aa-4e97-a60b-e5073ff0515e_terseLabel_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible legal costs</link:label>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalAmount_label_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Legal, Amount</link:label>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalAmount_documentation_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Legal, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalAmount" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalAmount" xlink:to="lab_amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_e74a8882-7d8a-4e42-b05f-a0eb3f845f30_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_ee5677be-a643-4cac-9d48-8cb5d7653572_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_207591c0-c1e3-4f3b-8a47-3c991b9ec2e6_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_4cf57056-95fe-4a01-88bc-b199e3b7315b_netLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss for basic and diluted earnings per common share</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_SaleOfStockUnderwritingDiscounts_ff96ffe0-5f7d-4883-9db7-2530750bbc4d_terseLabel_en-US" xlink:label="lab_amci_SaleOfStockUnderwritingDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underwriting discount</link:label>
    <link:label id="lab_amci_SaleOfStockUnderwritingDiscounts_label_en-US" xlink:label="lab_amci_SaleOfStockUnderwritingDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Underwriting Discounts</link:label>
    <link:label id="lab_amci_SaleOfStockUnderwritingDiscounts_documentation_en-US" xlink:label="lab_amci_SaleOfStockUnderwritingDiscounts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of offering fees discounts for underwriters.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SaleOfStockUnderwritingDiscounts" xlink:href="amci-20230213.xsd#amci_SaleOfStockUnderwritingDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_SaleOfStockUnderwritingDiscounts" xlink:to="lab_amci_SaleOfStockUnderwritingDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_189bf108-afb0-4e21-a22b-e67c6535b886_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityLineItems_1d9a98fa-5056-490e-939a-9ba764b6483d_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Line Items]</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityLineItems_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityLineItems" xlink:to="lab_us-gaap_TemporaryEquityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_8ac677e7-94d3-4cd3-aa99-eddf467b4bdc_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, Forfeited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c934dfb2-c99c-487f-b09d-0967fd7eb0c7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_86c690d2-cc42-4ee0-bdf8-0102b28a9bb3_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_FairValueAdjustmentOfWarrantsAndUnrealizedGainLossOnDerivatives_c2ca39ca-7a89-4368-824a-879e67bb356f_terseLabel_en-US" xlink:label="lab_amci_FairValueAdjustmentOfWarrantsAndUnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) loss on change in fair value of SAFE and warrant liabilities</link:label>
    <link:label id="lab_amci_FairValueAdjustmentOfWarrantsAndUnrealizedGainLossOnDerivatives_label_en-US" xlink:label="lab_amci_FairValueAdjustmentOfWarrantsAndUnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Adjustment Of Warrants And Unrealized Gain (Loss) On Derivatives</link:label>
    <link:label id="lab_amci_FairValueAdjustmentOfWarrantsAndUnrealizedGainLossOnDerivatives_documentation_en-US" xlink:label="lab_amci_FairValueAdjustmentOfWarrantsAndUnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Adjustment Of Warrants And Unrealized Gain (Loss) On Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_FairValueAdjustmentOfWarrantsAndUnrealizedGainLossOnDerivatives" xlink:href="amci-20230213.xsd#amci_FairValueAdjustmentOfWarrantsAndUnrealizedGainLossOnDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_FairValueAdjustmentOfWarrantsAndUnrealizedGainLossOnDerivatives" xlink:to="lab_amci_FairValueAdjustmentOfWarrantsAndUnrealizedGainLossOnDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_15b7db3b-4f57-412a-8711-2688d48b558c_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_3b2341e4-a323-4c06-a4e6-7e4b6c164476_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_ad549dca-23f0-4638-b6ba-5d1326c043d7_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesAmount_e75b1162-1957-494a-a49f-994b74c82057_terseLabel_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange differences</link:label>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesAmount_label_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Exchange Differences, Amount</link:label>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesAmount_documentation_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Exchange Differences, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesAmount" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesAmount" xlink:to="lab_amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_85ea98b8-016f-47a9-835a-4e9faa7f17ff_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_cb978694-75d7-4ebf-bc1a-f055c93b028c_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_947decad-021f-4112-a3ae-7de8e5765251_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Statement of Cash Flows</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_e856d4c1-404b-4788-a340-b197ba10b39f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters_a42b735f-ee72-4ac9-a38c-a9fdb67ff0f4_terseLabel_en-US" xlink:label="lab_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to purchase additional Units</link:label>
    <link:label id="lab_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters_label_en-US" xlink:label="lab_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to Purchase Additional Units Given to Underwriters</link:label>
    <link:label id="lab_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters_documentation_en-US" xlink:label="lab_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the option to purchase additional Units.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters" xlink:href="amci-20230213.xsd#amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters" xlink:to="lab_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_96673fb7-beff-40d9-9ef4-795f21e01032_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_14261d0b-56fb-46cd-b950-b8d2e3db9c95_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_00317df4-9784-4b53-b9bb-0e57077bb28d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_d271ee96-b2f6-4c3c-8d13-751760527626_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_0b5bf9ff-5c93-4ba3-848c-2a43c73c4471_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_6d1c6d80-616f-4ae4-9196-137751212b92_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_6fc210e6-72d9-4983-881d-8ff37528ab2c_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled/forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_5d66f328-4cd5-4e43-abc5-609f9de02759_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_11e8565e-3cde-475b-a9bb-d1ea90c67996_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesPercent_cfbb2b8c-821f-46ae-a6fa-50556b466df9_terseLabel_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange differences</link:label>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesPercent_label_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Exchange Differences, Percent</link:label>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesPercent_documentation_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Exchange Differences, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesPercent" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesPercent" xlink:to="lab_amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_d9dbaf74-2c63-4c0b-94d4-d9d2c3223931_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_41173ca2-135e-479e-b310-6219d8c726c2_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of Class B common stock to Sponsor</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_1f802cd2-e3da-4957-a633-a21dddcc0730_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate purchase price</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption_748651bd-23c9-494c-ab23-7633eff3cda2_terseLabel_en-US" xlink:label="lab_amci_IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent remeasurement of Class A common stock subject to possible redemption</link:label>
    <link:label id="lab_amci_IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption_label_en-US" xlink:label="lab_amci_IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase or Decrease in Equity Due to Re-measurement of Common Stock Subject to Possible Redemption</link:label>
    <link:label id="lab_amci_IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption_documentation_en-US" xlink:label="lab_amci_IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of increase or decrease in equity due to re-measurement of common stock subject to possible redemption.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption" xlink:href="amci-20230213.xsd#amci_IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption" xlink:to="lab_amci_IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_TemporaryEquityIssuePricePerShare_b672f1c6-d27c-43b6-be99-51cdc8ef3d1b_terseLabel_en-US" xlink:label="lab_amci_TemporaryEquityIssuePricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issue price (in dollars per share)</link:label>
    <link:label id="lab_amci_TemporaryEquityIssuePricePerShare_label_en-US" xlink:label="lab_amci_TemporaryEquityIssuePricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Issue Price Per Share</link:label>
    <link:label id="lab_amci_TemporaryEquityIssuePricePerShare_documentation_en-US" xlink:label="lab_amci_TemporaryEquityIssuePricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Issue Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityIssuePricePerShare" xlink:href="amci-20230213.xsd#amci_TemporaryEquityIssuePricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_TemporaryEquityIssuePricePerShare" xlink:to="lab_amci_TemporaryEquityIssuePricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_045bb8a3-9760-4d3d-ae9c-7bac6dbb02b1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_d7ba0dc1-fa6e-4e0f-97d0-e1e2d8fa7961_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_fdb7918b-7cfc-44ac-ad3b-9a6ccbececed_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_4ea1d19b-2b02-4e05-af97-3121c6ea71c1_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, shares issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_UnitsIssuedDuringPeriodSharesNewIssues_b87588fa-e751-41a0-9682-ceb66e2cb0a9_verboseLabel_en-US" xlink:label="lab_amci_UnitsIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of units sold</link:label>
    <link:label id="lab_amci_UnitsIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_amci_UnitsIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Units Issued During Period, Shares, New Issues</link:label>
    <link:label id="lab_amci_UnitsIssuedDuringPeriodSharesNewIssues_documentation_en-US" xlink:label="lab_amci_UnitsIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of new units issued during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_UnitsIssuedDuringPeriodSharesNewIssues" xlink:href="amci-20230213.xsd#amci_UnitsIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_UnitsIssuedDuringPeriodSharesNewIssues" xlink:to="lab_amci_UnitsIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5b939ea4-7a17-4afd-ac71-33246f0edf2f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested Shares (thousands)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_abbab5ed-83b6-4a6b-97fa-6f1bf64d5b7f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_71ffdddc-a23a-4981-ae10-56b9315784b3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_92d15561-e137-4570-9448-570c342d2f6b_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassBMember_22dbb318-3523-4c17-a187-cb1bc6dd0265_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class B Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonClassBMember_label_en-US" xlink:label="lab_us-gaap_CommonClassBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class B [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassBMember" xlink:to="lab_us-gaap_CommonClassBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_29882ecc-2415-47c8-a127-c6cfe49c881d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_92b71f50-9712-4831-a7bd-c59d7d6e92b8_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_174eb31f-7f21-4bf1-af88-a14abc3aa1ca_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VehiclesMember_a5470100-4d00-42d4-a4e8-39cf4b0270a0_terseLabel_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vehicles</link:label>
    <link:label id="lab_us-gaap_VehiclesMember_label_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vehicles [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VehiclesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VehiclesMember" xlink:to="lab_us-gaap_VehiclesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_RelatedPartyLeaseAgreementMember_d9279aa8-0aed-4624-8330-12bd86479e9d_terseLabel_en-US" xlink:label="lab_amci_RelatedPartyLeaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Lease Agreement</link:label>
    <link:label id="lab_amci_RelatedPartyLeaseAgreementMember_label_en-US" xlink:label="lab_amci_RelatedPartyLeaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Lease Agreement [Member]</link:label>
    <link:label id="lab_amci_RelatedPartyLeaseAgreementMember_documentation_en-US" xlink:label="lab_amci_RelatedPartyLeaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Lease Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartyLeaseAgreementMember" xlink:href="amci-20230213.xsd#amci_RelatedPartyLeaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_RelatedPartyLeaseAgreementMember" xlink:to="lab_amci_RelatedPartyLeaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AffiliatedEntityMember_bc2793e5-a9e6-4b90-b858-3186186fcdaf_terseLabel_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Entity</link:label>
    <link:label id="lab_srt_AffiliatedEntityMember_label_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Entity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AffiliatedEntityMember" xlink:to="lab_srt_AffiliatedEntityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_NumberOfSharesSubjectToForfeiture_0f6ad419-1f3c-4eb2-ac1e-ada3245c6b2f_terseLabel_en-US" xlink:label="lab_amci_NumberOfSharesSubjectToForfeiture" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares subject to forfeiture</link:label>
    <link:label id="lab_amci_NumberOfSharesSubjectToForfeiture_label_en-US" xlink:label="lab_amci_NumberOfSharesSubjectToForfeiture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Shares Subject To Forfeiture</link:label>
    <link:label id="lab_amci_NumberOfSharesSubjectToForfeiture_documentation_en-US" xlink:label="lab_amci_NumberOfSharesSubjectToForfeiture" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of shares owned by the founders subject to forfeiture if the underwriter overallotment option is not exercised in the proposed public offering.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfSharesSubjectToForfeiture" xlink:href="amci-20230213.xsd#amci_NumberOfSharesSubjectToForfeiture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_NumberOfSharesSubjectToForfeiture" xlink:to="lab_amci_NumberOfSharesSubjectToForfeiture" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_2be55752-d8a3-4543-9915-90834592a806_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_bca5c1ff-b85a-430c-aa3e-411a8744177a_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_93d45b8c-66f9-48f4-8e8a-23424fd262c0_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears_90bc04ca-457c-4e4b-9810-cd974cde4c63_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignEarningsRepatriated_c5c5fcfc-85af-47cb-9a64-729940f18b01_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignEarningsRepatriated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign earnings repatriated</link:label>
    <link:label id="lab_us-gaap_ForeignEarningsRepatriated_label_en-US" xlink:label="lab_us-gaap_ForeignEarningsRepatriated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Earnings Repatriated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignEarningsRepatriated" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignEarningsRepatriated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignEarningsRepatriated" xlink:to="lab_us-gaap_ForeignEarningsRepatriated" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentAssetsTextBlock_d24e4ff3-b9b3-469c-8e8e-bd22e575964d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets</link:label>
    <link:label id="lab_us-gaap_OtherCurrentAssetsTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentAssetsTextBlock" xlink:to="lab_us-gaap_OtherCurrentAssetsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_195711f0-ac70-403c-96be-067b1ceb3c03_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_4893c2ed-aea4-46d2-bd85-6b86fa74b7b6_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_2dd92751-979a-4125-8b08-d44b59214c9e_verboseLabel_en-US" xlink:label="lab_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative warrant liabilities</link:label>
    <link:label id="lab_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_label_en-US" xlink:label="lab_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Fair Value of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" xlink:to="lab_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjectsRemainingAmountReduction_006b7c0e-fa20-40fa-bba4-47e81642c37a_terseLabel_en-US" xlink:label="lab_amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjectsRemainingAmountReduction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Required equity funding for qualifying projects, remaining amount reduction</link:label>
    <link:label id="lab_amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjectsRemainingAmountReduction_label_en-US" xlink:label="lab_amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjectsRemainingAmountReduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Framework Agreement, Required Equity Funding For Qualifying Projects, Remaining Amount Reduction</link:label>
    <link:label id="lab_amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjectsRemainingAmountReduction_documentation_en-US" xlink:label="lab_amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjectsRemainingAmountReduction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Framework Agreement, Required Equity Funding For Qualifying Projects, Remaining Amount Reduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjectsRemainingAmountReduction" xlink:href="amci-20230213.xsd#amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjectsRemainingAmountReduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjectsRemainingAmountReduction" xlink:to="lab_amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjectsRemainingAmountReduction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis_b5c757a3-239e-4d4a-8bf8-414a5102844b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Axis]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis" xlink:to="lab_us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7505516b-971b-4190-9640-0c49be320509_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_CarbonSmartMember_161cdc9c-e5a7-4030-82f3-b57b80b93b85_terseLabel_en-US" xlink:label="lab_amci_CarbonSmartMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CarbonSmart</link:label>
    <link:label id="lab_amci_CarbonSmartMember_label_en-US" xlink:label="lab_amci_CarbonSmartMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CarbonSmart [Member]</link:label>
    <link:label id="lab_amci_CarbonSmartMember_documentation_en-US" xlink:label="lab_amci_CarbonSmartMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CarbonSmart</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CarbonSmartMember" xlink:href="amci-20230213.xsd#amci_CarbonSmartMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_CarbonSmartMember" xlink:to="lab_amci_CarbonSmartMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_a15e1858-9d3a-4921-b0cd-079b3ce6b0c4_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the beginning (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_fde09b92-10e2-407f-b34c-eec3e8fee466_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the end (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_b2f85167-3749-4871-8085-7487db639113_terseLabel_en-US" xlink:label="lab_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination</link:label>
    <link:label id="lab_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_label_en-US" xlink:label="lab_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer, Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination, Threshold Consecutive Trading Days</link:label>
    <link:label id="lab_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_documentation_en-US" xlink:label="lab_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">When determining the condition for transfer of shares without restriction after a business combination, the number of consecutive trading days used to observe the share price.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xlink:href="amci-20230213.xsd#amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xlink:to="lab_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_525a1156-dcfb-4054-a020-50fdb85efc94_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_dd83eab7-dc7a-40f0-8c39-301bc173f8d9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_MeasurementInputInterestRateMember_a0975ff5-9c93-49ef-935a-8f436ee0c3af_terseLabel_en-US" xlink:label="lab_amci_MeasurementInputInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_amci_MeasurementInputInterestRateMember_label_en-US" xlink:label="lab_amci_MeasurementInputInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Interest Rate [Member]</link:label>
    <link:label id="lab_amci_MeasurementInputInterestRateMember_documentation_en-US" xlink:label="lab_amci_MeasurementInputInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MeasurementInputInterestRateMember" xlink:href="amci-20230213.xsd#amci_MeasurementInputInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_MeasurementInputInterestRateMember" xlink:to="lab_amci_MeasurementInputInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsHeldInTrustCurrent_22559ca1-5f73-4852-b0d9-e64c82e93b61_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsHeldInTrustCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash held in AMCI's trust account</link:label>
    <link:label id="lab_us-gaap_AssetsHeldInTrustCurrent_1f423fb4-5a51-4f84-8542-8c5a0eb2fece_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsHeldInTrustCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash held in AMCI's trust account</link:label>
    <link:label id="lab_us-gaap_AssetsHeldInTrustCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsHeldInTrustCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held-in-trust, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrustCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsHeldInTrustCurrent" xlink:to="lab_us-gaap_AssetsHeldInTrustCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_287ebe1a-a079-42cd-bdc4-bc840451ea5f_terseLabel_en-US" xlink:label="lab_us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class A Common Stock Shares Subject to Possible Redemption</link:label>
    <link:label id="lab_us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_c739e0c8-0381-4e9d-b413-4d77fae79058_verboseLabel_en-US" xlink:label="lab_us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class A Common Stock Subject to Possible Redemption</link:label>
    <link:label id="lab_us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Subject to Mandatory Redemption, Changes in Redemption Value, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" xlink:to="lab_us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_d9d2ab75-a063-4bad-b39d-2beb95e886d3_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_680ec05b-abb7-4251-ac2e-8288ec801f2f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued salaries and wages</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_AggregateNumberOfSharesOwned_9b360962-87ea-4c73-9db2-3f37512b29e9_terseLabel_en-US" xlink:label="lab_amci_AggregateNumberOfSharesOwned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate number of shares owned</link:label>
    <link:label id="lab_amci_AggregateNumberOfSharesOwned_label_en-US" xlink:label="lab_amci_AggregateNumberOfSharesOwned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Number Of Shares Owned</link:label>
    <link:label id="lab_amci_AggregateNumberOfSharesOwned_documentation_en-US" xlink:label="lab_amci_AggregateNumberOfSharesOwned" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of shares owned by the founders after the impact of the stock dividend.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AggregateNumberOfSharesOwned" xlink:href="amci-20230213.xsd#amci_AggregateNumberOfSharesOwned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_AggregateNumberOfSharesOwned" xlink:to="lab_amci_AggregateNumberOfSharesOwned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f530556c-d4e5-43d5-b210-c3bc10432c77_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_779d5c66-f0ab-46de-967f-f0132b4656f5_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_81cac91a-4710-481c-81a0-2eb7ccb4b425_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_CustomerDMember_22cac237-aef8-4ef1-98b5-27b11ff01a9e_terseLabel_en-US" xlink:label="lab_amci_CustomerDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer D</link:label>
    <link:label id="lab_amci_CustomerDMember_label_en-US" xlink:label="lab_amci_CustomerDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer D [Member]</link:label>
    <link:label id="lab_amci_CustomerDMember_documentation_en-US" xlink:label="lab_amci_CustomerDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer D</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CustomerDMember" xlink:href="amci-20230213.xsd#amci_CustomerDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_CustomerDMember" xlink:to="lab_amci_CustomerDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_TemporaryEquitySharesConversionOfConvertibleSecurities_a25f8a3c-afc6-44e3-8758-bfdade778c34_terseLabel_en-US" xlink:label="lab_amci_TemporaryEquitySharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of warrants (in shares)</link:label>
    <link:label id="lab_amci_TemporaryEquitySharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_amci_TemporaryEquitySharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares, Conversion of Convertible Securities</link:label>
    <link:label id="lab_amci_TemporaryEquitySharesConversionOfConvertibleSecurities_documentation_en-US" xlink:label="lab_amci_TemporaryEquitySharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquitySharesConversionOfConvertibleSecurities" xlink:href="amci-20230213.xsd#amci_TemporaryEquitySharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_TemporaryEquitySharesConversionOfConvertibleSecurities" xlink:to="lab_amci_TemporaryEquitySharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_AssetsAndLiabilitiesLesseeTableTextBlock_d3a6ce59-5fcf-4493-90f8-adf252a04cc1_terseLabel_en-US" xlink:label="lab_amci_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee</link:label>
    <link:label id="lab_amci_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_amci_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_amci_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_amci_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="amci-20230213.xsd#amci_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_amci_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_de3b024c-9eff-4107-a059-4610a3bcd4c7_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ead39fbf-40b8-4461-a7af-cecf545d0b12_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorLeasesPolicyTextBlock_b3d501df-290b-48e4-b339-0de359614a02_terseLabel_en-US" xlink:label="lab_us-gaap_LessorLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LessorLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LessorLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LessorLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_25c93dbf-3042-4cfa-afb5-680270fd1255_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_49816a09-a14b-4090-9dcd-43d7328c67cc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_PaymentsForInvestmentOfCashInTrustAccount_d709866b-c2f7-4ee7-a171-e6fb3ba46bbb_negatedTerseLabel_en-US" xlink:label="lab_amci_PaymentsForInvestmentOfCashInTrustAccount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment income released from Trust Account</link:label>
    <link:label id="lab_amci_PaymentsForInvestmentOfCashInTrustAccount_064a593f-6c47-4078-9590-fdf6cb8edfaa_terseLabel_en-US" xlink:label="lab_amci_PaymentsForInvestmentOfCashInTrustAccount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for investment of cash in trust account</link:label>
    <link:label id="lab_amci_PaymentsForInvestmentOfCashInTrustAccount_label_en-US" xlink:label="lab_amci_PaymentsForInvestmentOfCashInTrustAccount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for investment of cash in Trust Account</link:label>
    <link:label id="lab_amci_PaymentsForInvestmentOfCashInTrustAccount_documentation_en-US" xlink:label="lab_amci_PaymentsForInvestmentOfCashInTrustAccount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of cash outflow for investment of cash in trust account.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PaymentsForInvestmentOfCashInTrustAccount" xlink:href="amci-20230213.xsd#amci_PaymentsForInvestmentOfCashInTrustAccount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_PaymentsForInvestmentOfCashInTrustAccount" xlink:to="lab_amci_PaymentsForInvestmentOfCashInTrustAccount" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentPercent_e6b00238-f72e-4529-b0ca-578802e56046_terseLabel_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment</link:label>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentPercent_label_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Equity Method Investment, Percent</link:label>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentPercent_documentation_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Equity Method Investment, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentPercent" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentPercent" xlink:to="lab_amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_55d5abae-006c-4d4b-9663-d8525ce6add3_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from contracts with customers</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockConvertibleConversionRatio_1c8d95d5-38f6-453c-b895-953e5ff7a70f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockConvertibleConversionRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion ratio</link:label>
    <link:label id="lab_us-gaap_PreferredStockConvertibleConversionRatio_label_en-US" xlink:label="lab_us-gaap_PreferredStockConvertibleConversionRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleConversionRatio" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockConvertibleConversionRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockConvertibleConversionRatio" xlink:to="lab_us-gaap_PreferredStockConvertibleConversionRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6f679db4-3ee8-4be3-a759-7d30613473ce_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of Class B common stock to Sponsor (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_a7903495-4b06-4a07-b41e-602a402edaad_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issued</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesAuthorized_5b4bf27f-ebd2-4c8f-918f-99da8213a722_verboseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesAuthorized_734d02d2-9259-4d97-859c-e553e5a74c2b_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock subject to possible redemption, shares authorized</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesAuthorized_e59c2ccf-aa3e-4b84-b7c4-628f325ede5f_netLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesAuthorized_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesAuthorized" xlink:to="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_InitialPublicOfferingAbstract_51efcae5-3249-487c-9c02-ea258b1e7d68_terseLabel_en-US" xlink:label="lab_amci_InitialPublicOfferingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Public Offering</link:label>
    <link:label id="lab_amci_InitialPublicOfferingAbstract_label_en-US" xlink:label="lab_amci_InitialPublicOfferingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Public Offering</link:label>
    <link:label id="lab_amci_InitialPublicOfferingAbstract_documentation_en-US" xlink:label="lab_amci_InitialPublicOfferingAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">No definition available.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_InitialPublicOfferingAbstract" xlink:href="amci-20230213.xsd#amci_InitialPublicOfferingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_InitialPublicOfferingAbstract" xlink:to="lab_amci_InitialPublicOfferingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_IncreaseDecreaseInCapitalBaseTaxPayable_cdf3c935-f1d9-4431-b034-f29ba91b0f71_terseLabel_en-US" xlink:label="lab_amci_IncreaseDecreaseInCapitalBaseTaxPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital base tax payable</link:label>
    <link:label id="lab_amci_IncreaseDecreaseInCapitalBaseTaxPayable_label_en-US" xlink:label="lab_amci_IncreaseDecreaseInCapitalBaseTaxPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Capital Base Tax Payable</link:label>
    <link:label id="lab_amci_IncreaseDecreaseInCapitalBaseTaxPayable_documentation_en-US" xlink:label="lab_amci_IncreaseDecreaseInCapitalBaseTaxPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The of increase (decrease) during the reporting period of capital base tax payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncreaseDecreaseInCapitalBaseTaxPayable" xlink:href="amci-20230213.xsd#amci_IncreaseDecreaseInCapitalBaseTaxPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_IncreaseDecreaseInCapitalBaseTaxPayable" xlink:to="lab_amci_IncreaseDecreaseInCapitalBaseTaxPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_RelatedPartyTransactionsPolicyPolicyTextBlock_400ce082-937b-4df0-b929-227e18e39120_terseLabel_en-US" xlink:label="lab_amci_RelatedPartyTransactionsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_amci_RelatedPartyTransactionsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_amci_RelatedPartyTransactionsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions, Policy [Policy Text Block]</link:label>
    <link:label id="lab_amci_RelatedPartyTransactionsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_amci_RelatedPartyTransactionsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartyTransactionsPolicyPolicyTextBlock" xlink:href="amci-20230213.xsd#amci_RelatedPartyTransactionsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_RelatedPartyTransactionsPolicyPolicyTextBlock" xlink:to="lab_amci_RelatedPartyTransactionsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_DeferredUnderwritingFeesMember_ffc8e1dc-9d10-4409-b563-8a3555ada4f6_terseLabel_en-US" xlink:label="lab_amci_DeferredUnderwritingFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Underwriting Fees</link:label>
    <link:label id="lab_amci_DeferredUnderwritingFeesMember_label_en-US" xlink:label="lab_amci_DeferredUnderwritingFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Underwriting Fees</link:label>
    <link:label id="lab_amci_DeferredUnderwritingFeesMember_documentation_en-US" xlink:label="lab_amci_DeferredUnderwritingFeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This member stands for deferred underwritingfees member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingFeesMember" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_DeferredUnderwritingFeesMember" xlink:to="lab_amci_DeferredUnderwritingFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_RevenueRemainingPerformanceObligationCurrentAmount_6ba3172c-43df-46d9-ae27-ad20bced399d_terseLabel_en-US" xlink:label="lab_amci_RevenueRemainingPerformanceObligationCurrentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current</link:label>
    <link:label id="lab_amci_RevenueRemainingPerformanceObligationCurrentAmount_label_en-US" xlink:label="lab_amci_RevenueRemainingPerformanceObligationCurrentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Current, Amount</link:label>
    <link:label id="lab_amci_RevenueRemainingPerformanceObligationCurrentAmount_documentation_en-US" xlink:label="lab_amci_RevenueRemainingPerformanceObligationCurrentAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Current, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RevenueRemainingPerformanceObligationCurrentAmount" xlink:href="amci-20230213.xsd#amci_RevenueRemainingPerformanceObligationCurrentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_RevenueRemainingPerformanceObligationCurrentAmount" xlink:to="lab_amci_RevenueRemainingPerformanceObligationCurrentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_cb9e0782-bd62-44b9-819b-b529e198516c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of impairment</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_357eac7d-0520-4c7f-92d9-4c981940238a_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intra-entity</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_b33b144e-7c86-4030-a1d1-4bceb4729075_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from collaborative arrangements</link:label>
    <link:label id="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_label_en-US" xlink:label="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:to="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ContractWithCustomerLiabilityNoncurrentAmountsCollected_63dbf9b9-f4d0-4776-a2e1-a1ac1eaf2680_terseLabel_en-US" xlink:label="lab_amci_ContractWithCustomerLiabilityNoncurrentAmountsCollected" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increases due to cash received</link:label>
    <link:label id="lab_amci_ContractWithCustomerLiabilityNoncurrentAmountsCollected_label_en-US" xlink:label="lab_amci_ContractWithCustomerLiabilityNoncurrentAmountsCollected" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Noncurrent, Amounts Collected</link:label>
    <link:label id="lab_amci_ContractWithCustomerLiabilityNoncurrentAmountsCollected_documentation_en-US" xlink:label="lab_amci_ContractWithCustomerLiabilityNoncurrentAmountsCollected" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Noncurrent, Amounts Collected</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContractWithCustomerLiabilityNoncurrentAmountsCollected" xlink:href="amci-20230213.xsd#amci_ContractWithCustomerLiabilityNoncurrentAmountsCollected"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ContractWithCustomerLiabilityNoncurrentAmountsCollected" xlink:to="lab_amci_ContractWithCustomerLiabilityNoncurrentAmountsCollected" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_ba11a87f-a0c1-448b-8a91-25d78b02ef28_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_a5ad92f6-788a-4076-a0c7-9aeef876f0e6_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1_2312a17d-c27c-487f-ac1b-edad31656cc8_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of equity method investment in LanzaJet through contribution of license</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Investments Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_7c902901-0427-4807-92cb-ddcb5e967ce3_verboseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price</link:label>
    <link:label id="lab_us-gaap_SharePrice_3dac5445-5e51-47d7-a264-fbd10361aa26_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock price (usd per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_RelatedPartyMember_08daddc6-7cff-4372-8954-cebb84a73321_terseLabel_en-US" xlink:label="lab_amci_RelatedPartyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party</link:label>
    <link:label id="lab_amci_RelatedPartyMember_label_en-US" xlink:label="lab_amci_RelatedPartyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Member]</link:label>
    <link:label id="lab_amci_RelatedPartyMember_documentation_en-US" xlink:label="lab_amci_RelatedPartyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartyMember" xlink:href="amci-20230213.xsd#amci_RelatedPartyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_RelatedPartyMember" xlink:to="lab_amci_RelatedPartyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_SharesSurrenderedFairValueOfShares_1df916d2-fa2b-4029-9c81-38d8fefade9e_terseLabel_en-US" xlink:label="lab_amci_SharesSurrenderedFairValueOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of shares surrendered</link:label>
    <link:label id="lab_amci_SharesSurrenderedFairValueOfShares_label_en-US" xlink:label="lab_amci_SharesSurrenderedFairValueOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Surrendered, Fair Value Of Shares</link:label>
    <link:label id="lab_amci_SharesSurrenderedFairValueOfShares_documentation_en-US" xlink:label="lab_amci_SharesSurrenderedFairValueOfShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of value of shares surrendered during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SharesSurrenderedFairValueOfShares" xlink:href="amci-20230213.xsd#amci_SharesSurrenderedFairValueOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_SharesSurrenderedFairValueOfShares" xlink:to="lab_amci_SharesSurrenderedFairValueOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_c018682a-a7d7-4821-ab6a-a2ad70058fc9_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_ba06f97b-b12b-4dbc-9190-7512317b6090_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_5497cbf3-2245-4789-ab90-ce9f8d4c522f_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_c93ca28b-85ff-4b5e-aa16-9ffcf0f12d38_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ErrorCorrectionEquityMethodInvestmentGainOnDilutionMember_d7b69d11-4ff8-4acb-9147-168856c7ff00_terseLabel_en-US" xlink:label="lab_amci_ErrorCorrectionEquityMethodInvestmentGainOnDilutionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Equity Method Investment, Gain On Dilution</link:label>
    <link:label id="lab_amci_ErrorCorrectionEquityMethodInvestmentGainOnDilutionMember_label_en-US" xlink:label="lab_amci_ErrorCorrectionEquityMethodInvestmentGainOnDilutionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Equity Method Investment, Gain On Dilution [Member]</link:label>
    <link:label id="lab_amci_ErrorCorrectionEquityMethodInvestmentGainOnDilutionMember_documentation_en-US" xlink:label="lab_amci_ErrorCorrectionEquityMethodInvestmentGainOnDilutionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Equity Method Investment, Gain On Dilution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ErrorCorrectionEquityMethodInvestmentGainOnDilutionMember" xlink:href="amci-20230213.xsd#amci_ErrorCorrectionEquityMethodInvestmentGainOnDilutionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ErrorCorrectionEquityMethodInvestmentGainOnDilutionMember" xlink:to="lab_amci_ErrorCorrectionEquityMethodInvestmentGainOnDilutionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchMember_0543b2a0-3c97-4955-84de-2d0b69d3a1b3_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D tax credits</link:label>
    <link:label id="lab_us-gaap_ResearchMember_label_en-US" xlink:label="lab_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Tax Credit Carryforward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchMember" xlink:to="lab_us-gaap_ResearchMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_2b901d7d-6b27-4213-bb12-6e36d17aa9e2_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_fdfff254-565b-4ae3-833a-99009620f390_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_d9ccbbb8-471e-4195-9d86-698aa9610ac3_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_7d6fc7be-ec96-4150-b5aa-209cdea6686a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ContractWithCustomerAssetCurrentReclassifiedToReceivable_04c88e97-019a-44e9-8d97-bb82d6d4d9e6_negatedTerseLabel_en-US" xlink:label="lab_amci_ContractWithCustomerAssetCurrentReclassifiedToReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled accounts receivable recognized in trade receivables</link:label>
    <link:label id="lab_amci_ContractWithCustomerAssetCurrentReclassifiedToReceivable_label_en-US" xlink:label="lab_amci_ContractWithCustomerAssetCurrentReclassifiedToReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Asset, Current, Reclassified To Receivable</link:label>
    <link:label id="lab_amci_ContractWithCustomerAssetCurrentReclassifiedToReceivable_documentation_en-US" xlink:label="lab_amci_ContractWithCustomerAssetCurrentReclassifiedToReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Asset, Current, Reclassified To Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContractWithCustomerAssetCurrentReclassifiedToReceivable" xlink:href="amci-20230213.xsd#amci_ContractWithCustomerAssetCurrentReclassifiedToReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ContractWithCustomerAssetCurrentReclassifiedToReceivable" xlink:to="lab_amci_ContractWithCustomerAssetCurrentReclassifiedToReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_country_AU_0d303a3e-c0e5-44f3-b695-c894967372e3_terseLabel_en-US" xlink:label="lab_country_AU" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australia</link:label>
    <link:label id="lab_country_AU_label_en-US" xlink:label="lab_country_AU" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AUSTRALIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_AU" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_AU"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_AU" xlink:to="lab_country_AU" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_ea516085-e88c-4807-97a7-17c72027cb8e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_fd611039-64aa-475e-a271-745550d00974_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_dec1dba7-484e-4a8c-bcc6-2af55d86f58d_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_WorkingCapitalLoansWarrantMember_d6363534-cd66-4d1e-b329-7046a17e314e_terseLabel_en-US" xlink:label="lab_amci_WorkingCapitalLoansWarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Working capital loans warrant</link:label>
    <link:label id="lab_amci_WorkingCapitalLoansWarrantMember_label_en-US" xlink:label="lab_amci_WorkingCapitalLoansWarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Working capital loans warrant</link:label>
    <link:label id="lab_amci_WorkingCapitalLoansWarrantMember_documentation_en-US" xlink:label="lab_amci_WorkingCapitalLoansWarrantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This member represents working capital loans warrant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WorkingCapitalLoansWarrantMember" xlink:href="amci-20230213.xsd#amci_WorkingCapitalLoansWarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_WorkingCapitalLoansWarrantMember" xlink:to="lab_amci_WorkingCapitalLoansWarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_3fc8676e-e73d-49e2-a38b-38a71f0071d0_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocation of net income (loss)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_dabdb0f1-20e5-4553-bc83-9ab993f67c91_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocation of net loss</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares_1008b478-0ad7-4075-8dcd-86c76c22e9e4_terseLabel_en-US" xlink:label="lab_amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of deferred underwriting commissions on public shares</link:label>
    <link:label id="lab_amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares_a859bad6-3e93-4356-a479-419da658dcf3_verboseLabel_en-US" xlink:label="lab_amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commissions waiver as reduction to additional paid-in capital</link:label>
    <link:label id="lab_amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares_label_en-US" xlink:label="lab_amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To Additional Paid In Capital Extinguishment Of Deferred Underwriting Commissions On Public Shares</link:label>
    <link:label id="lab_amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares_documentation_en-US" xlink:label="lab_amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of adjustment to additional paid in capital extinguishment of deferred underwriting commissions on public shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares" xlink:href="amci-20230213.xsd#amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares" xlink:to="lab_amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_1066d918-1070-470f-89f4-4ea9684a6f9a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State.</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_f0ee5bee-fd30-464f-a7b2-4c930cd620b1_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price of warrant</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_09995df3-3fe8-4982-8976-6fce4c6d1cae_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of warrant or right, exercise price of warrants or rights (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_50ca904e-77aa-4277-8c8c-f0668bd2377f_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_b2c780c0-4c81-4608-8139-05b85a524c6a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_cfa55e7f-c1a5-4faa-9a48-bf3b72cd34dd_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_c15d54f3-e1b8-47db-97e7-168af43cd8fb_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; deficit</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_264089b9-8d75-4ce8-bec0-e8c2db972642_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the beginning</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_d9315692-4dfe-45af-9dbb-4c3409ac8f2d_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the end</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_7b6e8f42-5c98-46b6-bf58-bf2fc0ee76ba_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; deficit</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_a188685a-64d4-43b7-a918-d6472524f95f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining performance obligations</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_235a5410-1f8a-43cc-9618-93f98ed25a24_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credits</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_8855e68f-be73-41c3-8a4c-510b91ce6718_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited, weighted average fair value (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_MaximumNumberOfDemandsForRegistrationOfSecurities_500628e0-f1d2-491c-9c12-97ab2c08acdf_terseLabel_en-US" xlink:label="lab_amci_MaximumNumberOfDemandsForRegistrationOfSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Number Of Demands For Registration Of Securities</link:label>
    <link:label id="lab_amci_MaximumNumberOfDemandsForRegistrationOfSecurities_label_en-US" xlink:label="lab_amci_MaximumNumberOfDemandsForRegistrationOfSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Number Of Demands For Registration Of Securities</link:label>
    <link:label id="lab_amci_MaximumNumberOfDemandsForRegistrationOfSecurities_documentation_en-US" xlink:label="lab_amci_MaximumNumberOfDemandsForRegistrationOfSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the maximum number of demands for registration of securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MaximumNumberOfDemandsForRegistrationOfSecurities" xlink:href="amci-20230213.xsd#amci_MaximumNumberOfDemandsForRegistrationOfSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_MaximumNumberOfDemandsForRegistrationOfSecurities" xlink:to="lab_amci_MaximumNumberOfDemandsForRegistrationOfSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_3263bde4-3ff1-400b-83d4-c8aa567f8846_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_a0cff1fd-ce70-4000-92aa-1d16fc64b9e1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of change in the fair value of the derivative warrant liabilities, measured using Level 3 inputs</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_TemporaryEquityValueConversionOfConvertibleSecurities_922b6987-e6a6-4056-a507-5ccddef4340c_terseLabel_en-US" xlink:label="lab_amci_TemporaryEquityValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of warrants</link:label>
    <link:label id="lab_amci_TemporaryEquityValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_amci_TemporaryEquityValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Value, Conversion of Convertible Securities</link:label>
    <link:label id="lab_amci_TemporaryEquityValueConversionOfConvertibleSecurities_documentation_en-US" xlink:label="lab_amci_TemporaryEquityValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityValueConversionOfConvertibleSecurities" xlink:href="amci-20230213.xsd#amci_TemporaryEquityValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_TemporaryEquityValueConversionOfConvertibleSecurities" xlink:to="lab_amci_TemporaryEquityValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_52f2b2e6-d517-4670-bef7-747c303a5f13_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_559d1d70-e2ac-4588-9017-48ef0c7713b6_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation costs</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentDecreaseForgiveness_4d9d2349-5293-4e33-8fb4-438a39fc65c5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentDecreaseForgiveness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt forgiveness</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentDecreaseForgiveness_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentDecreaseForgiveness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Decrease, Forgiveness</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDecreaseForgiveness" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDecreaseForgiveness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentDecreaseForgiveness" xlink:to="lab_us-gaap_DebtInstrumentDecreaseForgiveness" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_CustomerCMember_bdb866e9-2b32-431d-8916-9edbb8a1e6f8_terseLabel_en-US" xlink:label="lab_amci_CustomerCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer C</link:label>
    <link:label id="lab_amci_CustomerCMember_label_en-US" xlink:label="lab_amci_CustomerCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer C [Member]</link:label>
    <link:label id="lab_amci_CustomerCMember_documentation_en-US" xlink:label="lab_amci_CustomerCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer C</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CustomerCMember" xlink:href="amci-20230213.xsd#amci_CustomerCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_CustomerCMember" xlink:to="lab_amci_CustomerCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_adbcbfa3-0afb-4034-b57b-4424e6d08395_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_3eaf2df6-deed-4d69-ae0b-fd9a1301f9be_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_46f950e4-e539-4adc-83ba-423d63a93433_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_52dbf606-836c-4b52-997d-3462c9d7f73c_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_CommonStockNumberOfVotesPerShare_5f49e3aa-193f-45f5-91b5-f96f59d77a61_terseLabel_en-US" xlink:label="lab_amci_CommonStockNumberOfVotesPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of votes per common stock</link:label>
    <link:label id="lab_amci_CommonStockNumberOfVotesPerShare_label_en-US" xlink:label="lab_amci_CommonStockNumberOfVotesPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Number of Votes Per Share</link:label>
    <link:label id="lab_amci_CommonStockNumberOfVotesPerShare_documentation_en-US" xlink:label="lab_amci_CommonStockNumberOfVotesPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the number of votes issued per common stock share.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CommonStockNumberOfVotesPerShare" xlink:href="amci-20230213.xsd#amci_CommonStockNumberOfVotesPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_CommonStockNumberOfVotesPerShare" xlink:to="lab_amci_CommonStockNumberOfVotesPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_64ffc454-173b-4eaf-876f-22b62301d451_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_83438bf6-4ecf-49a3-aaf0-1f3371d64960_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_db2e00d7-17fa-450d-be83-3f0bbb776ec5_terseLabel_en-US" xlink:label="lab_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share)</link:label>
    <link:label id="lab_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_label_en-US" xlink:label="lab_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer, Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination, Stock Price Trigger</link:label>
    <link:label id="lab_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_documentation_en-US" xlink:label="lab_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The share price threshold that must be achieved in order to waive the restriction on transfer of shares during a restricted period after a business combination.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xlink:href="amci-20230213.xsd#amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xlink:to="lab_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_FrameworkAgreementRequiredEquityFunding_438b9585-e307-4147-9dc4-a90950dba5da_terseLabel_en-US" xlink:label="lab_amci_FrameworkAgreementRequiredEquityFunding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Required equity funding</link:label>
    <link:label id="lab_amci_FrameworkAgreementRequiredEquityFunding_label_en-US" xlink:label="lab_amci_FrameworkAgreementRequiredEquityFunding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Framework Agreement, Required Equity Funding</link:label>
    <link:label id="lab_amci_FrameworkAgreementRequiredEquityFunding_documentation_en-US" xlink:label="lab_amci_FrameworkAgreementRequiredEquityFunding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Framework Agreement, Required Equity Funding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_FrameworkAgreementRequiredEquityFunding" xlink:href="amci-20230213.xsd#amci_FrameworkAgreementRequiredEquityFunding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_FrameworkAgreementRequiredEquityFunding" xlink:to="lab_amci_FrameworkAgreementRequiredEquityFunding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_f0b31394-4ad6-4488-b345-c0297964c87d_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Equipment and furniture</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_74e8d3a7-37d5-4e3b-aefc-dd2b7d88ba8e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_5c7333fb-1e2b-4638-a9f4-3799e2ad1498_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of quantitative information regarding Level 3 fair value measurement inputs</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_88d1ff6c-7e30-4425-9ab9-97a52a43f75b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions to plan</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_1216e3ba-c701-4a42-b4b2-e050ab48c8fd_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_640beae8-6c2b-4236-ba0d-59921de89fc4_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_20695382-2100-4af6-9d00-21193f400291_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_GoingConcernPolicyTextBlock_2798694b-4cfa-4c7b-b632-1557d5ebf974_terseLabel_en-US" xlink:label="lab_amci_GoingConcernPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Going Concern</link:label>
    <link:label id="lab_amci_GoingConcernPolicyTextBlock_label_en-US" xlink:label="lab_amci_GoingConcernPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Going Concern [Policy Text Block]</link:label>
    <link:label id="lab_amci_GoingConcernPolicyTextBlock_documentation_en-US" xlink:label="lab_amci_GoingConcernPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Going Concern</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_GoingConcernPolicyTextBlock" xlink:href="amci-20230213.xsd#amci_GoingConcernPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_GoingConcernPolicyTextBlock" xlink:to="lab_amci_GoingConcernPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_0f7663b2-42f1-4bc7-9b79-16f00babf870_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_WTILoanMember_d6b93c71-56bb-454e-ab23-0ef2d1b5bfa3_terseLabel_en-US" xlink:label="lab_amci_WTILoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 WTI Loan</link:label>
    <link:label id="lab_amci_WTILoanMember_label_en-US" xlink:label="lab_amci_WTILoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WTI Loan [Member]</link:label>
    <link:label id="lab_amci_WTILoanMember_documentation_en-US" xlink:label="lab_amci_WTILoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WTI Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WTILoanMember" xlink:href="amci-20230213.xsd#amci_WTILoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_WTILoanMember" xlink:to="lab_amci_WTILoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_NumberOfShareBasedStockSchemes_49693f57-41c7-4038-a12b-53b9b910fe28_terseLabel_en-US" xlink:label="lab_amci_NumberOfShareBasedStockSchemes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of share based stock schemes</link:label>
    <link:label id="lab_amci_NumberOfShareBasedStockSchemes_label_en-US" xlink:label="lab_amci_NumberOfShareBasedStockSchemes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Share Based Stock Schemes</link:label>
    <link:label id="lab_amci_NumberOfShareBasedStockSchemes_documentation_en-US" xlink:label="lab_amci_NumberOfShareBasedStockSchemes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Share Based Stock Schemes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfShareBasedStockSchemes" xlink:href="amci-20230213.xsd#amci_NumberOfShareBasedStockSchemes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_NumberOfShareBasedStockSchemes" xlink:to="lab_amci_NumberOfShareBasedStockSchemes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_c889bcfe-7544-4fbc-a92f-3134fe28814a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_332aff9b-53df-40ef-b72a-c716427baf17_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c7502a49-121b-4d5e-9735-0e6484ffb8a3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_37ff59bf-f60e-4701-ae29-a99728c2a087_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income (expense), net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_3b80781d-ac54-426a-aab3-2b03e799d150_terseLabel_en-US" xlink:label="lab_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold consecutive trading days for redemption of public warrants</link:label>
    <link:label id="lab_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_label_en-US" xlink:label="lab_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Redemption Of Warrants Or Rights, , Threshold Consecutive Trading Days</link:label>
    <link:label id="lab_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_documentation_en-US" xlink:label="lab_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold number of specified consecutive trading days for stock price trigger considered for redemption of warrants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" xlink:to="lab_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_146de703-8740-4669-925e-6a4e9bd2c6c1_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_1e700b40-d4cc-407d-8932-2f1f37b6b8a8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_TemporaryEquityStockIssuanceCost_94a8eab4-b058-4dab-9c60-f35acbe1bbeb_terseLabel_en-US" xlink:label="lab_amci_TemporaryEquityStockIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issuance cost</link:label>
    <link:label id="lab_amci_TemporaryEquityStockIssuanceCost_label_en-US" xlink:label="lab_amci_TemporaryEquityStockIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issuance Cost</link:label>
    <link:label id="lab_amci_TemporaryEquityStockIssuanceCost_documentation_en-US" xlink:label="lab_amci_TemporaryEquityStockIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityStockIssuanceCost" xlink:href="amci-20230213.xsd#amci_TemporaryEquityStockIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_TemporaryEquityStockIssuanceCost" xlink:to="lab_amci_TemporaryEquityStockIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_74b14334-0301-490c-903b-7c41c7363694_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_dccdf4e9-aa85-428c-87b4-faea5c36495f_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_aa522e19-2894-48be-bc27-9f76d3803ebf_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_339ec4b1-033f-423d-a690-baf1d0ebf5fa_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other (expense) income, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_73f6e1ff-a57f-42a8-ba9f-440b93c9aad7_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_0a46f636-3f7e-4f11-becc-40c1abbe3cbd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expense</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_e19c99f6-f93b-4d2d-94df-1e1432fa7e2a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLeaseIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:to="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityTableTextBlock_48dfb2c5-8293-4c73-8e22-892c730ae1a9_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of reconciliation of common stock subject to possible redemption</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityTableTextBlock_7cbaceb8-f19a-435b-9665-7bd8c82e53e0_verboseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized, issued and outstanding shares, issue price, and carrying value</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityTableTextBlock_28df0d07-4132-48ae-8fe6-424907942469_netLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable convertible preferred stock</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityTableTextBlock" xlink:to="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_9bbc233b-808d-4230-a4ce-97e147b63ac7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ac1957ff-f840-49ab-80a3-dbcdf4398d19_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_ab6cd4d7-892b-43a4-bc8c-3d1b1118dbd3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Public Warrants to Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_7e6955ec-ba67-4744-ad90-6f45adea3973_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A</link:label>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesAPreferredStockMember" xlink:to="lab_us-gaap_SeriesAPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_DueToRelatedParty_8c116be4-6cde-46f2-802b-3f1685190989_terseLabel_en-US" xlink:label="lab_amci_DueToRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to related party</link:label>
    <link:label id="lab_amci_DueToRelatedParty_label_en-US" xlink:label="lab_amci_DueToRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Related Party</link:label>
    <link:label id="lab_amci_DueToRelatedParty_documentation_en-US" xlink:label="lab_amci_DueToRelatedParty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of increase (decrease) in related party payables classified as other, due within one year or operating cycle, if longer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DueToRelatedParty" xlink:href="amci-20230213.xsd#amci_DueToRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_DueToRelatedParty" xlink:to="lab_amci_DueToRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_add54ff2-2688-4c60-9c6a-752829cd3221_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_NoncashRecognitionOfLicensingRevenue_2c080418-63b4-4481-8ae1-83ead3e7d564_negatedTerseLabel_en-US" xlink:label="lab_amci_NoncashRecognitionOfLicensingRevenue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash recognition of licensing revenue</link:label>
    <link:label id="lab_amci_NoncashRecognitionOfLicensingRevenue_label_en-US" xlink:label="lab_amci_NoncashRecognitionOfLicensingRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Recognition of Licensing Revenue</link:label>
    <link:label id="lab_amci_NoncashRecognitionOfLicensingRevenue_documentation_en-US" xlink:label="lab_amci_NoncashRecognitionOfLicensingRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Recognition of Licensing Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NoncashRecognitionOfLicensingRevenue" xlink:href="amci-20230213.xsd#amci_NoncashRecognitionOfLicensingRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_NoncashRecognitionOfLicensingRevenue" xlink:to="lab_amci_NoncashRecognitionOfLicensingRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredOfferingCosts_23f2a485-36b0-4a00-ba31-476238d57106_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering costs</link:label>
    <link:label id="lab_us-gaap_DeferredOfferingCosts_label_en-US" xlink:label="lab_us-gaap_DeferredOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Offering Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredOfferingCosts" xlink:to="lab_us-gaap_DeferredOfferingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_aaaa2cb5-1ee5-48f8-b1ce-fca30b47e431_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_22691647-4d99-4b35-881d-773902d38d80_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_0b7b07ba-491e-4398-a63d-71a4900d9d01_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_InvestmentsTable_a15e7542-dffb-405e-90bd-c109c81c77b7_terseLabel_en-US" xlink:label="lab_amci_InvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Table]</link:label>
    <link:label id="lab_amci_InvestmentsTable_label_en-US" xlink:label="lab_amci_InvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Table]</link:label>
    <link:label id="lab_amci_InvestmentsTable_documentation_en-US" xlink:label="lab_amci_InvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_InvestmentsTable" xlink:href="amci-20230213.xsd#amci_InvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_InvestmentsTable" xlink:to="lab_amci_InvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0c6335e9-52c1-4546-9bf1-3d5e92e05202_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_c01a56f0-0160-4188-9e2d-0770e2e35add_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_29b02e67-05c6-4227-8c48-fd3a4e217453_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ConditionForFutureBusinessCombinationUseOfProceedsPercentage_33a2ccb5-ee43-43bd-bb47-04f59f2b007d_terseLabel_en-US" xlink:label="lab_amci_ConditionForFutureBusinessCombinationUseOfProceedsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condition for future business combination use of proceeds percentage</link:label>
    <link:label id="lab_amci_ConditionForFutureBusinessCombinationUseOfProceedsPercentage_label_en-US" xlink:label="lab_amci_ConditionForFutureBusinessCombinationUseOfProceedsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condition for future business combination use of proceeds percentage</link:label>
    <link:label id="lab_amci_ConditionForFutureBusinessCombinationUseOfProceedsPercentage_documentation_en-US" xlink:label="lab_amci_ConditionForFutureBusinessCombinationUseOfProceedsPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The threshold percentage of the assets held in the trust account funded by proceeds from the offering which must be used for purposes of consummating a business combination.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ConditionForFutureBusinessCombinationUseOfProceedsPercentage" xlink:href="amci-20230213.xsd#amci_ConditionForFutureBusinessCombinationUseOfProceedsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ConditionForFutureBusinessCombinationUseOfProceedsPercentage" xlink:to="lab_amci_ConditionForFutureBusinessCombinationUseOfProceedsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_PurchasesAndOpenAccountsPayableRelatedParties_196a12cc-da34-4a73-97f0-4db0ad8d3f5a_terseLabel_en-US" xlink:label="lab_amci_PurchasesAndOpenAccountsPayableRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases and open accounts payable</link:label>
    <link:label id="lab_amci_PurchasesAndOpenAccountsPayableRelatedParties_label_en-US" xlink:label="lab_amci_PurchasesAndOpenAccountsPayableRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases and Open Accounts Payable, Related Parties</link:label>
    <link:label id="lab_amci_PurchasesAndOpenAccountsPayableRelatedParties_documentation_en-US" xlink:label="lab_amci_PurchasesAndOpenAccountsPayableRelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases and Open Accounts Payable, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PurchasesAndOpenAccountsPayableRelatedParties" xlink:href="amci-20230213.xsd#amci_PurchasesAndOpenAccountsPayableRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_PurchasesAndOpenAccountsPayableRelatedParties" xlink:to="lab_amci_PurchasesAndOpenAccountsPayableRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_ff67901d-92d5-4cd4-87de-d79da6dfbb93_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_6b57b7c9-251e-471d-a279-275756b2dafd_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvesteeMember_cefb1d04-3be4-4e6f-b467-ade091acb4f3_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvesteeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investee</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvesteeMember_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvesteeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvesteeMember" xlink:to="lab_us-gaap_EquityMethodInvesteeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_a5096cad-8a9b-467b-895c-778f4ba83c69_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign tax rate differential</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_048a2f8e-b0d6-4daf-a494-87f408b008d1_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_667975cc-7619-4247-8f2b-6b748c184933_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_9ee5de93-c0e4-4265-8f03-991c63860402_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_06edd04e-7bbd-4fe6-841b-afdc448d59f5_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_a121c9b6-fb7c-4126-8469-aeb681b78f0b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_bbd82e1a-53b0-43be-b2f8-def27eabcb31_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value, (per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_094142f2-c023-459c-b30d-8cc4a39437f0_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8b1a07d7-31e9-476c-a907-21e9678a7058_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_ed7ba63e-39ed-4868-987f-0fa33cbf9e4f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Statement of Operations and Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_af6b305b-adac-47d1-a632-0c8c4610ca05_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares granted in period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_9bb078d5-d4d6-4cca-bd29-96c66caadd86_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_4a75cffb-a507-447f-8a63-39b42a7c61e3_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_PrepaidExpensesLongTerm_afaa3b13-0d3d-4851-ad35-69edbd44eb5d_terseLabel_en-US" xlink:label="lab_amci_PrepaidExpensesLongTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses - long-term</link:label>
    <link:label id="lab_amci_PrepaidExpensesLongTerm_label_en-US" xlink:label="lab_amci_PrepaidExpensesLongTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses - long-term</link:label>
    <link:label id="lab_amci_PrepaidExpensesLongTerm_documentation_en-US" xlink:label="lab_amci_PrepaidExpensesLongTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Prepaid expenses - long-term.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PrepaidExpensesLongTerm" xlink:href="amci-20230213.xsd#amci_PrepaidExpensesLongTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_PrepaidExpensesLongTerm" xlink:to="lab_amci_PrepaidExpensesLongTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_346b1c9e-6a39-45af-aa9c-421f1b764948_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised, Aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fa0c53c0-4f63-4dba-8413-fe011885a575_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding of common stock, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_99f1049a-4a45-447e-9146-7009fb50aea5_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares used in calculating net loss per share, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_facdb012-4c3d-4e26-8af0-6acb960d5fc1_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term (years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue_9d03fd4d-25c9-4cdc-ae2b-a2f836fe0da6_terseLabel_en-US" xlink:label="lab_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired, Aggregate intrinsic value</link:label>
    <link:label id="lab_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue_label_en-US" xlink:label="lab_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue_documentation_en-US" xlink:label="lab_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue" xlink:href="amci-20230213.xsd#amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue" xlink:to="lab_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_WorkingCapitalDeficit_74896288-7911-4d55-8b67-63c09b837bbb_terseLabel_en-US" xlink:label="lab_amci_WorkingCapitalDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Working capital deficit</link:label>
    <link:label id="lab_amci_WorkingCapitalDeficit_label_en-US" xlink:label="lab_amci_WorkingCapitalDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Working Capital Deficit</link:label>
    <link:label id="lab_amci_WorkingCapitalDeficit_documentation_en-US" xlink:label="lab_amci_WorkingCapitalDeficit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount represents the information about working capital deficit.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WorkingCapitalDeficit" xlink:href="amci-20230213.xsd#amci_WorkingCapitalDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_WorkingCapitalDeficit" xlink:to="lab_amci_WorkingCapitalDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ContractWithCustomerLiabilityNoncurrentForeignCurrencyTranslationAdjustment_b379b7b8-ac05-41a3-b977-b23d21fba2ac_terseLabel_en-US" xlink:label="lab_amci_ContractWithCustomerLiabilityNoncurrentForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease on revaluation on currency</link:label>
    <link:label id="lab_amci_ContractWithCustomerLiabilityNoncurrentForeignCurrencyTranslationAdjustment_label_en-US" xlink:label="lab_amci_ContractWithCustomerLiabilityNoncurrentForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Noncurrent, Foreign Currency Translation Adjustment</link:label>
    <link:label id="lab_amci_ContractWithCustomerLiabilityNoncurrentForeignCurrencyTranslationAdjustment_documentation_en-US" xlink:label="lab_amci_ContractWithCustomerLiabilityNoncurrentForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Noncurrent, Foreign Currency Translation Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContractWithCustomerLiabilityNoncurrentForeignCurrencyTranslationAdjustment" xlink:href="amci-20230213.xsd#amci_ContractWithCustomerLiabilityNoncurrentForeignCurrencyTranslationAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ContractWithCustomerLiabilityNoncurrentForeignCurrencyTranslationAdjustment" xlink:to="lab_amci_ContractWithCustomerLiabilityNoncurrentForeignCurrencyTranslationAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_SimpleAgreementForFutureEquityLiability_0f4e1221-c0c6-4e97-a78b-d872f84d2e34_terseLabel_en-US" xlink:label="lab_amci_SimpleAgreementForFutureEquityLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SAFE liability</link:label>
    <link:label id="lab_amci_SimpleAgreementForFutureEquityLiability_b9b1b262-d089-42b4-94a3-ab8921a5e6f7_verboseLabel_en-US" xlink:label="lab_amci_SimpleAgreementForFutureEquityLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SAFE liability</link:label>
    <link:label id="lab_amci_SimpleAgreementForFutureEquityLiability_label_en-US" xlink:label="lab_amci_SimpleAgreementForFutureEquityLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simple Agreement for Future Equity Liability</link:label>
    <link:label id="lab_amci_SimpleAgreementForFutureEquityLiability_documentation_en-US" xlink:label="lab_amci_SimpleAgreementForFutureEquityLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simple Agreement for Future Equity Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SimpleAgreementForFutureEquityLiability" xlink:href="amci-20230213.xsd#amci_SimpleAgreementForFutureEquityLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_SimpleAgreementForFutureEquityLiability" xlink:to="lab_amci_SimpleAgreementForFutureEquityLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_WarrantsTextBlockTextBlock_b0a51b6d-78f8-4b44-9ae5-7751d948a28b_terseLabel_en-US" xlink:label="lab_amci_WarrantsTextBlockTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_amci_WarrantsTextBlockTextBlock_label_en-US" xlink:label="lab_amci_WarrantsTextBlockTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Text Block [Text Block]</link:label>
    <link:label id="lab_amci_WarrantsTextBlockTextBlock_documentation_en-US" xlink:label="lab_amci_WarrantsTextBlockTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the entire disclosure of warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WarrantsTextBlockTextBlock" xlink:href="amci-20230213.xsd#amci_WarrantsTextBlockTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_WarrantsTextBlockTextBlock" xlink:to="lab_amci_WarrantsTextBlockTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5537f72a-31f8-46e7-b407-411d09bfe2b0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted, weighted average fair value (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_51417916-9167-4e1a-80fe-f099aa70e8ed_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of assets and liabilities that are measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_8b01cc6f-3bd1-49ef-941a-14017c70c3cc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrivatePlacementMember_b827afe5-856c-45a7-95fb-1ec018077864_terseLabel_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Placement</link:label>
    <link:label id="lab_us-gaap_PrivatePlacementMember_label_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Placement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrivatePlacementMember" xlink:to="lab_us-gaap_PrivatePlacementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_21580ba6-ba77-4ae0-b5a3-93ca67d0b241_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_22747221-ed8f-4afd-9e68-e5496d9f4121_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, shares authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_CustomerBMember_169a6d25-327a-436e-ac2f-66a023a207fb_terseLabel_en-US" xlink:label="lab_amci_CustomerBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer B</link:label>
    <link:label id="lab_amci_CustomerBMember_label_en-US" xlink:label="lab_amci_CustomerBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer B [Member]</link:label>
    <link:label id="lab_amci_CustomerBMember_documentation_en-US" xlink:label="lab_amci_CustomerBMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer B</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CustomerBMember" xlink:href="amci-20230213.xsd#amci_CustomerBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_CustomerBMember" xlink:to="lab_amci_CustomerBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_TemporaryEquityProceedsAllocatedToWarrants_c18af108-abb6-4206-a9fd-81d230b0a1ba_verboseLabel_en-US" xlink:label="lab_amci_TemporaryEquityProceedsAllocatedToWarrants" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount allocated to public warrants</link:label>
    <link:label id="lab_amci_TemporaryEquityProceedsAllocatedToWarrants_346caae9-539a-48b1-9ee2-5cf08fda8f10_terseLabel_en-US" xlink:label="lab_amci_TemporaryEquityProceedsAllocatedToWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of Public Warrants at issuance</link:label>
    <link:label id="lab_amci_TemporaryEquityProceedsAllocatedToWarrants_label_en-US" xlink:label="lab_amci_TemporaryEquityProceedsAllocatedToWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity , Proceeds Allocated To Warrants</link:label>
    <link:label id="lab_amci_TemporaryEquityProceedsAllocatedToWarrants_documentation_en-US" xlink:label="lab_amci_TemporaryEquityProceedsAllocatedToWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of gross proceeds allocated from temporary equity to warrants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityProceedsAllocatedToWarrants" xlink:href="amci-20230213.xsd#amci_TemporaryEquityProceedsAllocatedToWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_TemporaryEquityProceedsAllocatedToWarrants" xlink:to="lab_amci_TemporaryEquityProceedsAllocatedToWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5ba29240-a14b-4a7c-9ef5-3eebce516edd_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_bd8167b2-2c2f-4a73-8957-a8b36aa007b0_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess cash received over the fair value of the private warrants</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_16f1289b-2cb5-4d4a-918a-10dd87659c4a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e0e43ca2-4ff4-4cc2-af5e-4b8fe0a171bd_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss allocated to common shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e26e6ceb-65a9-4a61-acce-e8d30641fb9c_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss allocated to common shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDaysSource2_3b15d737-a0e0-4cb5-92e0-bac1253446d0_terseLabel_en-US" xlink:label="lab_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDaysSource2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold consecutive trading days for redemption of public warrants</link:label>
    <link:label id="lab_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDaysSource2_label_en-US" xlink:label="lab_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDaysSource2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Redemption Of Warrants Or Rights, , Threshold Consecutive Trading Days Source2</link:label>
    <link:label id="lab_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDaysSource2_documentation_en-US" xlink:label="lab_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDaysSource2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold number of specified consecutive trading days for stock price trigger considered for redemption of warrants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDaysSource2" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDaysSource2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDaysSource2" xlink:to="lab_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDaysSource2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_1d57f47c-8f70-4c2a-80f9-1d6513893ac0_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_2243d634-2fc2-4cf6-9fb0-f82a8562d17d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_1e18a020-38ab-4916-afd8-55aa68506244_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_57ff450e-7d78-40cb-b21c-fa2685099ffa_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_7d3b9c17-4eeb-4153-a72d-0b9bf286a79e_netLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_c5558b14-1f4c-46b3-8f80-6b00b50a98ec_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_7b94580c-1a09-4576-82b3-b51545257882_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of property, plant and equipment under accounts payable</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_7429be53-6cb5-4c68-b03e-042e2d92499e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net foreign exchange loss</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5ff84ce3-dd85-455e-a0f6-77b3d2fb8619_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_14f3110c-8f07-42e8-9257-5a38b6fd6030_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputExercisePriceMember_353e8338-6e0b-49c7-8610-e0a399dbd236_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputExercisePriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price</link:label>
    <link:label id="lab_us-gaap_MeasurementInputExercisePriceMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputExercisePriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Exercise Price [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExercisePriceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExercisePriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExercisePriceMember" xlink:to="lab_us-gaap_MeasurementInputExercisePriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_03724358-fdc4-4c07-8417-2c3ca5455426_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityByClassOfStockTable_69961d2b-c502-4a15-bd70-742e922fa6cb_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityByClassOfStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, by Class of Stock [Table]</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityByClassOfStockTable_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityByClassOfStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, by Class of Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="lab_us-gaap_TemporaryEquityByClassOfStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_994c7272-565d-448e-9d3a-f371573a32dc_terseLabel_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_label_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:to="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_9bd1574b-d5e1-4694-b481-3b229cab025b_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_e25666c4-6295-4292-8a11-82ecfc1ca520_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_LineOfCreditFacilityInterestRate_1dbb7e86-409c-4c54-9bbf-01c4503d5a95_terseLabel_en-US" xlink:label="lab_amci_LineOfCreditFacilityInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, interest rate</link:label>
    <link:label id="lab_amci_LineOfCreditFacilityInterestRate_label_en-US" xlink:label="lab_amci_LineOfCreditFacilityInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate</link:label>
    <link:label id="lab_amci_LineOfCreditFacilityInterestRate_documentation_en-US" xlink:label="lab_amci_LineOfCreditFacilityInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LineOfCreditFacilityInterestRate" xlink:href="amci-20230213.xsd#amci_LineOfCreditFacilityInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_LineOfCreditFacilityInterestRate" xlink:to="lab_amci_LineOfCreditFacilityInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_TemporaryEquityDisclosureTextBlock_7efbe880-f3bd-4c15-8415-711dd0af953b_terseLabel_en-US" xlink:label="lab_amci_TemporaryEquityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class A Common Stock Subject to Possible Redemption</link:label>
    <link:label id="lab_amci_TemporaryEquityDisclosureTextBlock_785fd344-2bc2-435c-996e-97bd46435d19_verboseLabel_en-US" xlink:label="lab_amci_TemporaryEquityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable, Convertible Preferred Stock</link:label>
    <link:label id="lab_amci_TemporaryEquityDisclosureTextBlock_label_en-US" xlink:label="lab_amci_TemporaryEquityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity Disclosure [Text Block]</link:label>
    <link:label id="lab_amci_TemporaryEquityDisclosureTextBlock_documentation_en-US" xlink:label="lab_amci_TemporaryEquityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure on temporary equity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityDisclosureTextBlock" xlink:href="amci-20230213.xsd#amci_TemporaryEquityDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_TemporaryEquityDisclosureTextBlock" xlink:to="lab_amci_TemporaryEquityDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_f57a77e5-a72f-4ddd-94cd-a61aa38a8766_verboseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Purchases from Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_IncreaseDecreaseInDueToRelatedParties._dfe226dc-37c3-4e11-8848-c9033714f60d_terseLabel_en-US" xlink:label="lab_amci_IncreaseDecreaseInDueToRelatedParties." xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to related party</link:label>
    <link:label id="lab_amci_IncreaseDecreaseInDueToRelatedParties._label_en-US" xlink:label="lab_amci_IncreaseDecreaseInDueToRelatedParties." xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Due To Related Parties.</link:label>
    <link:label id="lab_amci_IncreaseDecreaseInDueToRelatedParties._documentation_en-US" xlink:label="lab_amci_IncreaseDecreaseInDueToRelatedParties." xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of increase (decrease) in related party payables classified as other,</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncreaseDecreaseInDueToRelatedParties." xlink:href="amci-20230213.xsd#amci_IncreaseDecreaseInDueToRelatedParties."/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_IncreaseDecreaseInDueToRelatedParties." xlink:to="lab_amci_IncreaseDecreaseInDueToRelatedParties." xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_25dc8f95-9eeb-47a4-9015-753f18d41ed8_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_PrivatePlacementWarrantsMember_7877b9cc-3235-413a-aaac-252d67075716_verboseLabel_en-US" xlink:label="lab_amci_PrivatePlacementWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">private placement warrants</link:label>
    <link:label id="lab_amci_PrivatePlacementWarrantsMember_8bf95131-e963-4546-b6a1-94faaa0f766f_terseLabel_en-US" xlink:label="lab_amci_PrivatePlacementWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Placement Warrants</link:label>
    <link:label id="lab_amci_PrivatePlacementWarrantsMember_label_en-US" xlink:label="lab_amci_PrivatePlacementWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Placement Warrants</link:label>
    <link:label id="lab_amci_PrivatePlacementWarrantsMember_documentation_en-US" xlink:label="lab_amci_PrivatePlacementWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents a redeemable warrant (Private Placement Warrant) that entitles the holder to purchase shares of common stock if the underwriter's option is exercised in full.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PrivatePlacementWarrantsMember" xlink:href="amci-20230213.xsd#amci_PrivatePlacementWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_PrivatePlacementWarrantsMember" xlink:to="lab_amci_PrivatePlacementWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_d896472f-596f-4028-931c-e75e16c40e8c_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory tax rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_b0c613e1-4c53-4736-b747-be1a57296085_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory federal income tax rate (in percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_c0e049d5-667a-44c0-bf13-d8bc6321493a_netLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax (benefit) at the statutory federal income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_RelatedAndNonrelatedPartyStatusAxis_fc753a9b-1120-47e7-9d7f-3a47856faced_terseLabel_en-US" xlink:label="lab_amci_RelatedAndNonrelatedPartyStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related and Nonrelated Party Status [Axis]</link:label>
    <link:label id="lab_amci_RelatedAndNonrelatedPartyStatusAxis_label_en-US" xlink:label="lab_amci_RelatedAndNonrelatedPartyStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related and Nonrelated Party Status [Axis]</link:label>
    <link:label id="lab_amci_RelatedAndNonrelatedPartyStatusAxis_documentation_en-US" xlink:label="lab_amci_RelatedAndNonrelatedPartyStatusAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related and Nonrelated Party Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedAndNonrelatedPartyStatusAxis" xlink:href="amci-20230213.xsd#amci_RelatedAndNonrelatedPartyStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_RelatedAndNonrelatedPartyStatusAxis" xlink:to="lab_amci_RelatedAndNonrelatedPartyStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_DeferredUnderwritingFeePayable_0e7aa7dd-0c46-466a-a65c-97c5d7e68563_terseLabel_en-US" xlink:label="lab_amci_DeferredUnderwritingFeePayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering costs paid by Sponsor in exchange for issuance of Class B common stock</link:label>
    <link:label id="lab_amci_DeferredUnderwritingFeePayable_label_en-US" xlink:label="lab_amci_DeferredUnderwritingFeePayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Underwriting Fee Payable.</link:label>
    <link:label id="lab_amci_DeferredUnderwritingFeePayable_documentation_en-US" xlink:label="lab_amci_DeferredUnderwritingFeePayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of underwriting fee payable deferred during the period, classified as non-cash investing and financing activity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingFeePayable" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingFeePayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_DeferredUnderwritingFeePayable" xlink:to="lab_amci_DeferredUnderwritingFeePayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0fe0abf0-7f98-4141-af44-53f3e42dc99d_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e84d81c1-a15d-4c6c-88aa-a3b88004861f_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_7c459306-39ca-4f77-a99d-0e809cfccc6b_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_LiquidityPriceOfSAFEAndSAFEWarrants_813f6f11-f0e0-4f22-8d8a-40f74fcfbb9b_terseLabel_en-US" xlink:label="lab_amci_LiquidityPriceOfSAFEAndSAFEWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liquidity price of SAFE and SAFE warrants</link:label>
    <link:label id="lab_amci_LiquidityPriceOfSAFEAndSAFEWarrants_label_en-US" xlink:label="lab_amci_LiquidityPriceOfSAFEAndSAFEWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liquidity Price of SAFE and SAFE Warrants</link:label>
    <link:label id="lab_amci_LiquidityPriceOfSAFEAndSAFEWarrants_documentation_en-US" xlink:label="lab_amci_LiquidityPriceOfSAFEAndSAFEWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liquidity Price of SAFE and SAFE Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LiquidityPriceOfSAFEAndSAFEWarrants" xlink:href="amci-20230213.xsd#amci_LiquidityPriceOfSAFEAndSAFEWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_LiquidityPriceOfSAFEAndSAFEWarrants" xlink:to="lab_amci_LiquidityPriceOfSAFEAndSAFEWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_e23636cc-9de4-4e67-b65c-706504816a33_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IPOMember_1fda1c1c-ea29-47eb-9923-8a8cfb0b9fec_terseLabel_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO [Member]</link:label>
    <link:label id="lab_us-gaap_IPOMember_label_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IPOMember" xlink:to="lab_us-gaap_IPOMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_437afc0a-08f9-4312-a1bf-d7ac3dc354f8_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local taxes</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_IncomeTaxesLineItems_eab68e3d-b7f9-4787-975a-3a6198e4c277_terseLabel_en-US" xlink:label="lab_amci_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:label id="lab_amci_IncomeTaxesLineItems_label_en-US" xlink:label="lab_amci_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:label id="lab_amci_IncomeTaxesLineItems_documentation_en-US" xlink:label="lab_amci_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeTaxesLineItems" xlink:href="amci-20230213.xsd#amci_IncomeTaxesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_IncomeTaxesLineItems" xlink:to="lab_amci_IncomeTaxesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_4b117a80-7ddf-49b9-b5f4-38177c1d4be2_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_202b11b1-8fec-42f9-a347-ccb0e341601e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of currency translation on cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_2e6a57c9-182b-4244-98f0-49f60a32f407_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_9015d1f5-2eeb-4729-b4b2-5e1eb0840a02_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_1ec954f6-1064-4def-b3bd-0c7631ed77e6_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of derivative liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_81e0f05a-e6a2-4963-ade2-f440a3efd175_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of derivative liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_107d291f-c45e-4a6e-8e0b-b4df38733b84_terseLabel_en-US" xlink:label="lab_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions on transfer period of time after business combination completion</link:label>
    <link:label id="lab_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_label_en-US" xlink:label="lab_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions On Transfer Period Of Time After Business Combination Completion</link:label>
    <link:label id="lab_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_documentation_en-US" xlink:label="lab_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The period of time after completion of a business combination during which the shares or warrant may not be transferred.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" xlink:href="amci-20230213.xsd#amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" xlink:to="lab_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_WorkingCapitalLoansMember_f0c86b75-a042-4181-9ee7-b8b6f1854ab4_terseLabel_en-US" xlink:label="lab_amci_WorkingCapitalLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Working Capital Loans</link:label>
    <link:label id="lab_amci_WorkingCapitalLoansMember_label_en-US" xlink:label="lab_amci_WorkingCapitalLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Working Capital Loans</link:label>
    <link:label id="lab_amci_WorkingCapitalLoansMember_documentation_en-US" xlink:label="lab_amci_WorkingCapitalLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to working capital loans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WorkingCapitalLoansMember" xlink:href="amci-20230213.xsd#amci_WorkingCapitalLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_WorkingCapitalLoansMember" xlink:to="lab_amci_WorkingCapitalLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_f8b54dbc-780a-4dc9-b2d9-16d745b2dc96_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants_d8eb441d-3fe9-47fb-a3e9-e11749d0c9dc_terseLabel_en-US" xlink:label="lab_amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from extinguishment of deferred underwriting commissions on public warrants</link:label>
    <link:label id="lab_amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants_84b745e8-4f37-44a5-b095-432c97fc15bf_negatedLabel_en-US" xlink:label="lab_amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from extinguishment of deferred underwriting commission on public warrants</link:label>
    <link:label id="lab_amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants_label_en-US" xlink:label="lab_amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Loss From Extinguishment Of Deferred Underwriting Commissions On Public Warrants</link:label>
    <link:label id="lab_amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants_documentation_en-US" xlink:label="lab_amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of gain (loss) from extinguishment of deferred underwriting commissions on public warrants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants" xlink:href="amci-20230213.xsd#amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants" xlink:to="lab_amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_629815d8-e138-4de8-b99b-608804b20f4b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_989678c0-969a-42be-bcec-4dc013f64ea2_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_b32751c6-5ebf-42ef-809d-c0c83a19a760_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_a7d95bcb-700a-4126-9f39-b4963e19d323_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (expense) income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_b33a302e-9193-4e59-8d80-45fd88d1e2aa_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock price (usd per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalPercent_837c9690-b7db-4365-99fc-7a941b7d5d56_terseLabel_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible legal costs</link:label>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalPercent_label_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Legal, Percent</link:label>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalPercent_documentation_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Legal, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalPercent" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalPercent" xlink:to="lab_amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_88d9afa3-138c-4216-b4ac-3412a728ae4c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_66920b7e-c6d4-4aad-b043-ba23474b8876_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6e8c9dc0-82d8-4d09-b46d-214aa3c9130e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassAMember_0ba74ac1-a718-4c7c-ae89-f7a567a4df2a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class A Common stock</link:label>
    <link:label id="lab_us-gaap_CommonClassAMember_label_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class A [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassAMember" xlink:to="lab_us-gaap_CommonClassAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_9a35637a-c2dd-4698-b53d-ab8c3ceb167b_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Other Cash Flows from Operating Activities</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_c4a4cecf-64ac-4b14-b0fa-b04d54edfc55_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Cash Equivalents, and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_07f99ddb-e2f7-4448-9150-d14e8af87673_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_b1fdee9a-d0b2-4806-a110-950041979936_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_3d82ecd8-2c51-457c-acda-98a31c5fe10a_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_ef7ee7a2-16f5-4f9b-b0dd-750850684d70_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences_1f5ca94e-acd9-432e-8533-a8d3f1779815_terseLabel_en-US" xlink:label="lab_amci_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences</link:label>
    <link:label id="lab_amci_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences_label_en-US" xlink:label="lab_amci_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold Period After Business Combination In Which Specified Trading Days Within Any Specified Trading Day Period Commences</link:label>
    <link:label id="lab_amci_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences_documentation_en-US" xlink:label="lab_amci_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The period of time after a business combination which must elapse before consideration of the share price condition for transfer of shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" xlink:href="amci-20230213.xsd#amci_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" xlink:to="lab_amci_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_a580f257-9bca-48c5-803a-fdd6a0376471_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_059da0de-11c1-4857-95c5-2cd8ef375719_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_322427fe-51b4-4b55-b520-d9134ca56597_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_075ebcde-d078-4dab-91e4-cf7bed572522_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Note Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Note Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_edf4fb02-7ead-4397-83dd-368110af621d_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash (presented within Other current assets)</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_InlandRevenueNewZealandMember_c50f2ac7-673c-4ce9-bc91-5a1fc84e1f4b_terseLabel_en-US" xlink:label="lab_amci_InlandRevenueNewZealandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Zealand</link:label>
    <link:label id="lab_amci_InlandRevenueNewZealandMember_label_en-US" xlink:label="lab_amci_InlandRevenueNewZealandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inland Revenue, New Zealand [Member]</link:label>
    <link:label id="lab_amci_InlandRevenueNewZealandMember_documentation_en-US" xlink:label="lab_amci_InlandRevenueNewZealandMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inland Revenue, New Zealand</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_InlandRevenueNewZealandMember" xlink:href="amci-20230213.xsd#amci_InlandRevenueNewZealandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_InlandRevenueNewZealandMember" xlink:to="lab_amci_InlandRevenueNewZealandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b6ba2937-e17b-4807-8f61-ab148bae350d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares under option (thousands)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_ff809ae6-33f3-4bc7-b6c0-734eac69cdca_terseLabel_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer concentration risk</link:label>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_label_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedules of Concentration of Risk, by Risk Factor [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_f6eafab5-1a9a-4c17-9ff8-8e28aef9e1dd_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_86df268e-582a-4d92-8560-8a08c64cfb00_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, Aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_165d63dd-8305-457f-965c-6c8098307bfb_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_WarrantsPolicyPolicyTextBlock_b3a27b38-4b2b-4999-aa6e-7249215143cc_terseLabel_en-US" xlink:label="lab_amci_WarrantsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_amci_WarrantsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_amci_WarrantsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Policy [Policy Text Block]</link:label>
    <link:label id="lab_amci_WarrantsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_amci_WarrantsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WarrantsPolicyPolicyTextBlock" xlink:href="amci-20230213.xsd#amci_WarrantsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_WarrantsPolicyPolicyTextBlock" xlink:to="lab_amci_WarrantsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForErrorCorrectionDomain_39fc15fd-2f76-4b7d-942c-097fb06ed4b6_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForErrorCorrectionDomain_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:to="lab_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_a0c0657b-f0b3-4355-b862-09105074d713_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends from equity investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Equity Method Investment, Distribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:to="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_9b017330-7a10-470e-83c5-ca9831b348ba_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cost and operating expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_WarrantConditionAxis_7a7f2e33-0a1f-4b5b-9194-9efe9714efff_terseLabel_en-US" xlink:label="lab_amci_WarrantConditionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant Condition [Axis]</link:label>
    <link:label id="lab_amci_WarrantConditionAxis_label_en-US" xlink:label="lab_amci_WarrantConditionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant Condition [Axis]</link:label>
    <link:label id="lab_amci_WarrantConditionAxis_documentation_en-US" xlink:label="lab_amci_WarrantConditionAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant Condition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WarrantConditionAxis" xlink:href="amci-20230213.xsd#amci_WarrantConditionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_WarrantConditionAxis" xlink:to="lab_amci_WarrantConditionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockSharesIssued1_f14f0809-a74d-43a3-a14f-0c8f29f98738_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Class A common stock issued upon conversion of each share (in shares)</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockSharesIssued1_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockSharesIssued1" xlink:to="lab_us-gaap_ConversionOfStockSharesIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockAmountConverted1_142f37ba-c861-47c2-8d75-d38833eb2118_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receipt of common shares as payment for option exercises</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockAmountConverted1_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Amount Converted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockAmountConverted1" xlink:to="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_6b87eebe-d8c7-4138-81d2-06305f7f6e63_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_cfe7c1c4-468f-4f8a-afb0-c61e591e9977_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:to="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_415d15b5-1ed1-4ebd-8822-ef38d4e7d254_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity (Deficit)</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_2f6a0d8f-eee0-4238-a682-330dfdb2e4be_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_008b06d2-6194-4db3-8a0f-9eccb5c8fece_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeaseTermOfContract_6d589c26-2cde-45dc-934a-3350e0608c75_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of contract</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LessorOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_9f9991f4-adda-473f-874e-aff1f0cd588d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_4618b29c-178b-4714-ab87-69a84d82eb55_terseLabel_en-US" xlink:label="lab_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold trading days for redemption of public warrants</link:label>
    <link:label id="lab_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_label_en-US" xlink:label="lab_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Redemption Of Warrants Or Rights, , Threshold Trading Days</link:label>
    <link:label id="lab_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_documentation_en-US" xlink:label="lab_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold number of specified trading days for stock price trigger considered for redemption of warrants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" xlink:to="lab_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_DeferredOfferingCostsIncludedInNotesPayable_104d7967-26e9-49fb-a632-c4ea2207d93b_terseLabel_en-US" xlink:label="lab_amci_DeferredOfferingCostsIncludedInNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering costs included in notes payable</link:label>
    <link:label id="lab_amci_DeferredOfferingCostsIncludedInNotesPayable_5845d000-e2dd-4cb7-bcb3-8c731e3640d3_verboseLabel_en-US" xlink:label="lab_amci_DeferredOfferingCostsIncludedInNotesPayable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering costs included in notes payable</link:label>
    <link:label id="lab_amci_DeferredOfferingCostsIncludedInNotesPayable_label_en-US" xlink:label="lab_amci_DeferredOfferingCostsIncludedInNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Offering Costs Included in Notes Payable</link:label>
    <link:label id="lab_amci_DeferredOfferingCostsIncludedInNotesPayable_documentation_en-US" xlink:label="lab_amci_DeferredOfferingCostsIncludedInNotesPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of deferred offering costs included in notes payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredOfferingCostsIncludedInNotesPayable" xlink:href="amci-20230213.xsd#amci_DeferredOfferingCostsIncludedInNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_DeferredOfferingCostsIncludedInNotesPayable" xlink:to="lab_amci_DeferredOfferingCostsIncludedInNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived_4a9d7d82-6cc4-45e4-a91e-3034a1f9024f_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease income receivable</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived_bec612e4-ebbe-4ef7-b490-d6f9899756b0_totalLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payments to be Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_DeferredUnderwritingCompensationNoncurrent_f48bb692-a451-4b56-800a-174fcc09d1cf_verboseLabel_en-US" xlink:label="lab_amci_DeferredUnderwritingCompensationNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred underwriting commissions</link:label>
    <link:label id="lab_amci_DeferredUnderwritingCompensationNoncurrent_label_en-US" xlink:label="lab_amci_DeferredUnderwritingCompensationNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Underwriting Compensation, Noncurrent</link:label>
    <link:label id="lab_amci_DeferredUnderwritingCompensationNoncurrent_documentation_en-US" xlink:label="lab_amci_DeferredUnderwritingCompensationNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The carrying value as of balance sheet date of underwriting compensation deferred, classified as noncurrent.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingCompensationNoncurrent" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingCompensationNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_DeferredUnderwritingCompensationNoncurrent" xlink:to="lab_amci_DeferredUnderwritingCompensationNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_b7b7c27c-e1d2-4064-95a2-40eeaf275d7e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromFeesReceived_e5ace75a-3cf0-4046-ad7c-d46983d4c72e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromFeesReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate fees received</link:label>
    <link:label id="lab_us-gaap_ProceedsFromFeesReceived_label_en-US" xlink:label="lab_us-gaap_ProceedsFromFeesReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Fees Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromFeesReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromFeesReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromFeesReceived" xlink:to="lab_us-gaap_ProceedsFromFeesReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_81f83e31-d5ea-4303-875b-d982a20583a4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_b4844dc2-2b23-469e-9906-8795593bab41_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_AdministrativeSupportAgreementMember_8a836d39-8cf7-4fe0-b041-299b693f658e_terseLabel_en-US" xlink:label="lab_amci_AdministrativeSupportAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Administrative Support Agreement</link:label>
    <link:label id="lab_amci_AdministrativeSupportAgreementMember_label_en-US" xlink:label="lab_amci_AdministrativeSupportAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Administrative Support Agreement</link:label>
    <link:label id="lab_amci_AdministrativeSupportAgreementMember_documentation_en-US" xlink:label="lab_amci_AdministrativeSupportAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This member stands for Administrative Support Agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AdministrativeSupportAgreementMember" xlink:href="amci-20230213.xsd#amci_AdministrativeSupportAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_AdministrativeSupportAgreementMember" xlink:to="lab_amci_AdministrativeSupportAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_407e9239-0c8b-48bf-8d0a-5d2e52c5cdac_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_3cafb613-7704-42d6-bd22-364d3064b45d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_9102c5ae-adb8-4038-86f7-a61e009c3593_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Organization and Business Operations</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_1d4de31b-49a5-4a63-8d1b-b41cc8acb289_verboseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of the Business</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_54a3ae4d-20a3-49e7-8e63-e76a501788c3_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_a3dd2e7d-a87c-4534-a292-94665ec6f522_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ScheduleOfReverseCapitalizationLineItems_86950a22-ed17-4917-91ae-0a5c55737782_terseLabel_en-US" xlink:label="lab_amci_ScheduleOfReverseCapitalizationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reverse Capitalization [Line Items]</link:label>
    <link:label id="lab_amci_ScheduleOfReverseCapitalizationLineItems_label_en-US" xlink:label="lab_amci_ScheduleOfReverseCapitalizationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reverse Capitalization [Line Items]</link:label>
    <link:label id="lab_amci_ScheduleOfReverseCapitalizationLineItems_documentation_en-US" xlink:label="lab_amci_ScheduleOfReverseCapitalizationLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reverse Capitalization [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ScheduleOfReverseCapitalizationLineItems" xlink:href="amci-20230213.xsd#amci_ScheduleOfReverseCapitalizationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ScheduleOfReverseCapitalizationLineItems" xlink:to="lab_amci_ScheduleOfReverseCapitalizationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_7cf74f25-67c2-422d-9e84-99b8ae21c76a_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_b841c200-1cfc-4708-ab95-9d883583af5e_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_5d290b04-849e-4821-af4f-e0e9d5edfb68_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_OtherContractResearchMember_d31b14e8-aa75-4502-ab3f-28ccd37e735a_terseLabel_en-US" xlink:label="lab_amci_OtherContractResearchMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other contract research</link:label>
    <link:label id="lab_amci_OtherContractResearchMember_label_en-US" xlink:label="lab_amci_OtherContractResearchMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Contract Research [Member]</link:label>
    <link:label id="lab_amci_OtherContractResearchMember_documentation_en-US" xlink:label="lab_amci_OtherContractResearchMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Contract Research</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OtherContractResearchMember" xlink:href="amci-20230213.xsd#amci_OtherContractResearchMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_OtherContractResearchMember" xlink:to="lab_amci_OtherContractResearchMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_e5815bd5-8856-473a-8c64-7a78620c5904_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_93148364-dbae-4dfa-9e37-bc5d9471b54d_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e62b9797-a489-4b6e-b3bb-8126c759fc72_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_AnchorInvestorsMember_cd5b458d-b7f0-4b05-8ba2-90d6c5070851_terseLabel_en-US" xlink:label="lab_amci_AnchorInvestorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anchor Investors</link:label>
    <link:label id="lab_amci_AnchorInvestorsMember_label_en-US" xlink:label="lab_amci_AnchorInvestorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anchor Investors</link:label>
    <link:label id="lab_amci_AnchorInvestorsMember_documentation_en-US" xlink:label="lab_amci_AnchorInvestorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information about Anchor Investors.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AnchorInvestorsMember" xlink:href="amci-20230213.xsd#amci_AnchorInvestorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_AnchorInvestorsMember" xlink:to="lab_amci_AnchorInvestorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNet_30bfae93-406e-4d7c-ad5d-a245e6a2d5e3_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net tangible assets</link:label>
    <link:label id="lab_us-gaap_AssetsNet_label_en-US" xlink:label="lab_us-gaap_AssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNet" xlink:to="lab_us-gaap_AssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_NoncashDeferredUnderwritingCommissions_099629fb-afa8-4ba7-ada1-5769e7e92d92_terseLabel_en-US" xlink:label="lab_amci_NoncashDeferredUnderwritingCommissions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred underwriting commissions in connection with the initial public offering</link:label>
    <link:label id="lab_amci_NoncashDeferredUnderwritingCommissions_label_en-US" xlink:label="lab_amci_NoncashDeferredUnderwritingCommissions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Deferred Underwriting Commissions</link:label>
    <link:label id="lab_amci_NoncashDeferredUnderwritingCommissions_documentation_en-US" xlink:label="lab_amci_NoncashDeferredUnderwritingCommissions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash deferred underwriting commissions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NoncashDeferredUnderwritingCommissions" xlink:href="amci-20230213.xsd#amci_NoncashDeferredUnderwritingCommissions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_NoncashDeferredUnderwritingCommissions" xlink:to="lab_amci_NoncashDeferredUnderwritingCommissions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e52227b9-62d1-4d4a-854f-3aa551c4e569_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from contracts with customers</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e4a0e4ed-843c-441a-8d3e-ae542cb78b0d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from contracts with customers</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e8626000-39d3-4d19-a9f3-60c3060b983e_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from contracts with customers</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_00523f97-b537-42a3-898b-4e953875dcd7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration consisting of equity interests</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_SubordinatedSecuredNotesReceivableMember_07cd27aa-8ddf-40ed-90c1-c75f67db3b5d_terseLabel_en-US" xlink:label="lab_amci_SubordinatedSecuredNotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subordinated Secured Notes Receivable</link:label>
    <link:label id="lab_amci_SubordinatedSecuredNotesReceivableMember_label_en-US" xlink:label="lab_amci_SubordinatedSecuredNotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subordinated Secured Notes Receivable [Member]</link:label>
    <link:label id="lab_amci_SubordinatedSecuredNotesReceivableMember_documentation_en-US" xlink:label="lab_amci_SubordinatedSecuredNotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subordinated Secured Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SubordinatedSecuredNotesReceivableMember" xlink:href="amci-20230213.xsd#amci_SubordinatedSecuredNotesReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_SubordinatedSecuredNotesReceivableMember" xlink:to="lab_amci_SubordinatedSecuredNotesReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_4775d934-8e34-4b8a-adee-62cfca316c34_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_TemporaryEquityIssuanceCosts_be768383-dc4b-4ae2-bf64-06d9abe5fc53_verboseLabel_en-US" xlink:label="lab_amci_TemporaryEquityIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class A common stock issuance costs</link:label>
    <link:label id="lab_amci_TemporaryEquityIssuanceCosts_87dc77b3-b8f9-4e94-8fa0-7f5ae502e26c_terseLabel_en-US" xlink:label="lab_amci_TemporaryEquityIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering costs allocated to Class A common stock subject to possible redemption</link:label>
    <link:label id="lab_amci_TemporaryEquityIssuanceCosts_label_en-US" xlink:label="lab_amci_TemporaryEquityIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Issuance Costs</link:label>
    <link:label id="lab_amci_TemporaryEquityIssuanceCosts_documentation_en-US" xlink:label="lab_amci_TemporaryEquityIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of issuance costs related to temporary equity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityIssuanceCosts" xlink:href="amci-20230213.xsd#amci_TemporaryEquityIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_TemporaryEquityIssuanceCosts" xlink:to="lab_amci_TemporaryEquityIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_0f8fa10b-36c4-40df-9fe6-4b1aafde231b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_91bec502-2303-4ea1-8326-b1e4542056e9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_228fc800-41af-425c-9c2f-5461f7549692_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsDeferredIncome_20488966-2ae8-4ea9-9d67-677e7bd424e3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsDeferredIncome_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Deferred Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_76dd5937-68da-4349-a51e-ab4d8f8f5d3d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_4bcec843-3e7b-4dd6-b9e9-306638f98e53_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities, contingently redeemable preferred stock, and shareholders' deficit</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_0093a35c-14b6-4c44-9ed6-46f913c9b12a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities, contingently redeemable preferred stock, and shareholders' deficit</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_878892bc-46eb-45ab-be59-79183761e6d8_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_f29b84b1-70fc-48ab-ac4d-352b56af038b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_8534b76b-1664-48d4-be17-039c50070dd5_netLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, gross</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_c90d0635-d81a-46bd-9d76-8ecfa11429b1_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross deferred tax asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_8933f9be-dc5c-4938-9563-bb75b262129f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of (loss) income before income taxes and gain from equity method investees, net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_TransactionCosts_ab38b48c-a798-4db6-a874-89a81c72c5c4_terseLabel_en-US" xlink:label="lab_amci_TransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction Costs</link:label>
    <link:label id="lab_amci_TransactionCosts_a3e6b8f8-2a00-4a71-8acd-e2b635f01ba4_verboseLabel_en-US" xlink:label="lab_amci_TransactionCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction Costs</link:label>
    <link:label id="lab_amci_TransactionCosts_label_en-US" xlink:label="lab_amci_TransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction Costs</link:label>
    <link:label id="lab_amci_TransactionCosts_documentation_en-US" xlink:label="lab_amci_TransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of transaction costs incurred.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TransactionCosts" xlink:href="amci-20230213.xsd#amci_TransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_TransactionCosts" xlink:to="lab_amci_TransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_TransactionsWithEquityMethodInvesteesMember_d66e3be8-c03d-4d49-9d6f-eb971d2284c8_terseLabel_en-US" xlink:label="lab_amci_TransactionsWithEquityMethodInvesteesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transactions with Equity Method Investees</link:label>
    <link:label id="lab_amci_TransactionsWithEquityMethodInvesteesMember_label_en-US" xlink:label="lab_amci_TransactionsWithEquityMethodInvesteesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transactions with Equity Method Investees [Member]</link:label>
    <link:label id="lab_amci_TransactionsWithEquityMethodInvesteesMember_documentation_en-US" xlink:label="lab_amci_TransactionsWithEquityMethodInvesteesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transactions with Equity Method Investees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TransactionsWithEquityMethodInvesteesMember" xlink:href="amci-20230213.xsd#amci_TransactionsWithEquityMethodInvesteesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_TransactionsWithEquityMethodInvesteesMember" xlink:to="lab_amci_TransactionsWithEquityMethodInvesteesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_8b61ac2f-664d-4fa5-85fe-a6c078c38f3c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_f624b0a0-d12c-406e-b4b5-abac8eff3d73_verboseLabel_en-US" xlink:label="lab_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock price trigger for redemption of public warrants (in dollars per share)</link:label>
    <link:label id="lab_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_label_en-US" xlink:label="lab_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right Redemption Of Warrants Or Rights Stock Price Trigger</link:label>
    <link:label id="lab_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_documentation_en-US" xlink:label="lab_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Price of the entity's common stock which would be required to be attained to trigger the redemption of warrants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" xlink:to="lab_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_d91259db-6521-49fd-b3fc-8e57c62a3538_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss allocated to common shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_5b2c0737-8d1e-4407-80d8-88d2aa3db1c2_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income (loss) per common share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_9dc5b71a-d849-49bb-ae27-c2250281a637_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per common share - diluted (usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_b99ebbec-0d56-4840-baea-b3400d6d0dcc_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicenseAndServiceMember_3010e64a-7480-4b3e-a8ba-6148ac7366ed_terseLabel_en-US" xlink:label="lab_us-gaap_LicenseAndServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing</link:label>
    <link:label id="lab_us-gaap_LicenseAndServiceMember_label_en-US" xlink:label="lab_us-gaap_LicenseAndServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License and Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAndServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicenseAndServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicenseAndServiceMember" xlink:to="lab_us-gaap_LicenseAndServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_PeriodForFillingRegistrationStatementAfterBusinessCombination_216c55c8-3125-4a1a-8eb4-02eb4868b16b_terseLabel_en-US" xlink:label="lab_amci_PeriodForFillingRegistrationStatementAfterBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period for filling registration statement after business combination</link:label>
    <link:label id="lab_amci_PeriodForFillingRegistrationStatementAfterBusinessCombination_label_en-US" xlink:label="lab_amci_PeriodForFillingRegistrationStatementAfterBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period For Filling Registration Statement After Business Combination</link:label>
    <link:label id="lab_amci_PeriodForFillingRegistrationStatementAfterBusinessCombination_documentation_en-US" xlink:label="lab_amci_PeriodForFillingRegistrationStatementAfterBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents period for filling registration statement after business combination.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PeriodForFillingRegistrationStatementAfterBusinessCombination" xlink:href="amci-20230213.xsd#amci_PeriodForFillingRegistrationStatementAfterBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_PeriodForFillingRegistrationStatementAfterBusinessCombination" xlink:to="lab_amci_PeriodForFillingRegistrationStatementAfterBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityDisclosureAbstract_09317894-f634-45e5-83cd-f4301bd26887_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="lab_us-gaap_TemporaryEquityDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContributionOfProperty_bf4d6f3e-70a4-455b-bf42-e021c97b94b2_terseLabel_en-US" xlink:label="lab_us-gaap_ContributionOfProperty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution of intellectual property</link:label>
    <link:label id="lab_us-gaap_ContributionOfProperty_label_en-US" xlink:label="lab_us-gaap_ContributionOfProperty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution of Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContributionOfProperty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContributionOfProperty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContributionOfProperty" xlink:to="lab_us-gaap_ContributionOfProperty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_d5f429d0-02ed-4c98-a945-8b83cf9769a9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from disposal of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_86ac83f8-4fbd-4263-914a-f8bf772707e7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_014b163c-9242-40f7-9fbe-70812524cd8b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_bbe8d669-d4aa-47af-a7f0-ad337b5d59c1_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_CommonClassaNotSubjectToRedemptionMember_c7564196-fde4-46ad-9a76-f27307a72bf6_terseLabel_en-US" xlink:label="lab_amci_CommonClassaNotSubjectToRedemptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class A Common Stock Not Subject to Redemption</link:label>
    <link:label id="lab_amci_CommonClassaNotSubjectToRedemptionMember_label_en-US" xlink:label="lab_amci_CommonClassaNotSubjectToRedemptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class A Common Stock Not Subject to Redemption</link:label>
    <link:label id="lab_amci_CommonClassaNotSubjectToRedemptionMember_documentation_en-US" xlink:label="lab_amci_CommonClassaNotSubjectToRedemptionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Classification of common stock representing ownership interest in a corporation that is not subject to redemption.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CommonClassaNotSubjectToRedemptionMember" xlink:href="amci-20230213.xsd#amci_CommonClassaNotSubjectToRedemptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_CommonClassaNotSubjectToRedemptionMember" xlink:to="lab_amci_CommonClassaNotSubjectToRedemptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_e23711c7-7557-486b-9e7e-5008ac878f6d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_2d75c98a-1f4b-4384-b351-d79caea6d3b0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_fca8cc8b-9e8b-49c1-823c-c48a7aee69e0_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntellectualPropertyMember_cb91e56b-472b-40ae-858f-6b04ebdd4dbc_terseLabel_en-US" xlink:label="lab_us-gaap_IntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intellectual Property</link:label>
    <link:label id="lab_us-gaap_IntellectualPropertyMember_label_en-US" xlink:label="lab_us-gaap_IntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intellectual Property [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntellectualPropertyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntellectualPropertyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntellectualPropertyMember" xlink:to="lab_us-gaap_IntellectualPropertyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_459445e0-d260-40fa-81a6-4f9c5dad782f_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_9eb21ae2-38c1-4616-b440-2e56f548fee3_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax position</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_6f03b8c9-ccae-4837-ae27-c5f60567cb49_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Security Investment</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI and without Readily Determinable Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:to="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter_c847901f-7466-45ec-903c-6f7cd69cfb90_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_PlusAbstract_3173e730-c500-4e63-beef-badb600b323b_terseLabel_en-US" xlink:label="lab_amci_PlusAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plus:</link:label>
    <link:label id="lab_amci_PlusAbstract_label_en-US" xlink:label="lab_amci_PlusAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plus [Abstract]</link:label>
    <link:label id="lab_amci_PlusAbstract_documentation_en-US" xlink:label="lab_amci_PlusAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">No definition available.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PlusAbstract" xlink:href="amci-20230213.xsd#amci_PlusAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_PlusAbstract" xlink:to="lab_amci_PlusAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_8060a067-e1fc-484f-817d-16e65f406775_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeaseRenewalTerm_55f834b8-e5d2-488a-ae40-b3e58b6fdc08_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renewal term</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LessorOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_5d81ff12-2ca3-4f3d-9c2d-4214b5fa0a5a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_894a0696-9f12-453e-b485-d837d4d7fbc7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_71217d82-69e4-4964-844a-67230d51d7d2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_db46533e-d77b-4c8f-87bc-61778342dc5a_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_96eb2d8d-0a87-41d6-8de8-a646ab23ed9a_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract_2610ddfe-3eec-442f-8581-5a910250eea1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_8f4912e5-d468-4c53-97c7-62b01e8dc1d3_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_4a7e2ae2-269f-46a9-ae3a-396f0a7fff67_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment on equity method investments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_f21501d1-1277-4375-8fe4-572f6c6ed6f2_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_FranchiseTaxPayableCurrent_35976fd6-994b-43dc-a631-0f6a1572b4e1_terseLabel_en-US" xlink:label="lab_amci_FranchiseTaxPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Franchise tax payable</link:label>
    <link:label id="lab_amci_FranchiseTaxPayableCurrent_label_en-US" xlink:label="lab_amci_FranchiseTaxPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Franchise Tax Payable Current</link:label>
    <link:label id="lab_amci_FranchiseTaxPayableCurrent_documentation_en-US" xlink:label="lab_amci_FranchiseTaxPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of franchise tax payable current.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_FranchiseTaxPayableCurrent" xlink:href="amci-20230213.xsd#amci_FranchiseTaxPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_FranchiseTaxPayableCurrent" xlink:to="lab_amci_FranchiseTaxPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_9e0e7fc5-815f-4bee-b48b-846a79612203_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant date fair value of options granted (usd per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable_25494aad-c479-4aca-8a8b-543591301fad_terseLabel_en-US" xlink:label="lab_amci_ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to unbilled accounts receivable</link:label>
    <link:label id="lab_amci_ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable_label_en-US" xlink:label="lab_amci_ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Asset, Current, Additions To Unbilled Accounts Receivable</link:label>
    <link:label id="lab_amci_ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable_documentation_en-US" xlink:label="lab_amci_ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Asset, Current, Additions To Unbilled Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable" xlink:href="amci-20230213.xsd#amci_ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable" xlink:to="lab_amci_ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_3e5534c9-ac4c-4eaa-b816-be6bfe258b9c_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_3611b73b-a79a-453f-9065-7bda4cc70f34_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_8a73f9ae-44c5-42ff-8b7c-41d0a93748b7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds received from private placement</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_546d1662-6de9-4fb0-9242-a011f473b87b_netLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issue of SAFE and warrant instruments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_e30d070a-997b-404c-b288-4a18b6141602_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate purchase price</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_1c082636-1227-412c-84d4-3c3fb82c7640_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment on equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Other than Temporary Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:to="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_94f1ff87-9112-4e6d-91a2-1ce658840503_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_InvestmentsHeldInTrustAccountPolicyTextBlock_dbbaff53-3952-497f-9441-b04c1f10583f_terseLabel_en-US" xlink:label="lab_amci_InvestmentsHeldInTrustAccountPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Held in the Trust Account</link:label>
    <link:label id="lab_amci_InvestmentsHeldInTrustAccountPolicyTextBlock_label_en-US" xlink:label="lab_amci_InvestmentsHeldInTrustAccountPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Held In Trust Account [Policy Text Block]</link:label>
    <link:label id="lab_amci_InvestmentsHeldInTrustAccountPolicyTextBlock_documentation_en-US" xlink:label="lab_amci_InvestmentsHeldInTrustAccountPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of accounting policy for investments held trust account.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_InvestmentsHeldInTrustAccountPolicyTextBlock" xlink:href="amci-20230213.xsd#amci_InvestmentsHeldInTrustAccountPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_InvestmentsHeldInTrustAccountPolicyTextBlock" xlink:to="lab_amci_InvestmentsHeldInTrustAccountPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_23b749e8-8f2b-411f-a7e3-afb8f9f5cca0_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_c8ace72c-9689-436c-b6e9-b08af4501d68_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_6a1cf2fb-478e-4797-b1e6-9eb17a2c014d_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_19e4a842-7d14-4c73-acfa-0e635a3d45ff_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_cf79ca5d-bb44-4440-9ccb-619d70e404b3_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_f456958f-9d57-48ab-9cb0-ebb5aa7691ec_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyPercent_4e86492c-2d1b-4ca4-8218-cb3fd6c82263_terseLabel_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from redomiciliation of intellectual property</link:label>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyPercent_label_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Gain From Redomicilation Of Intellectual Property, Percent</link:label>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyPercent_documentation_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Gain From Redomicilation Of Intellectual Property, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyPercent" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyPercent" xlink:to="lab_amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrentAbstract_18867fe2-cdcf-4c05-a3d8-0611d5889c43_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Contract Assets</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrentAbstract" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_05d4f295-57c4-4d2e-a4dc-bbb7851ed362_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousCurrent_e2a6ae01-2b21-428b-8455-a19fefb0c952_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:to="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_8e24acd9-a475-4985-bc59-ffda056f9adc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_27848b34-00e4-44a8-8c39-af6b6e49b18e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_27bfbc95-273f-4dde-afb8-5c81ed206260_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_5a111705-04ee-4185-a7bc-bb3c67a8d140_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_910a3b4f-7cf0-49ca-a077-c1376d14a7b5_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative expenses</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_9eef1265-93d6-41fc-84ba-7dc9a2452769_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Statement of Changes in Redeemable Convertible Preferred Stock and Shareholders&#8217; Equity (Deficit)</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_177b239d-761f-4358-a0c5-6c6bd0fb5054_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax (benefit) at the statutory federal income tax rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_16043d29-7150-46fb-8a6d-9172782884e7_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows From Financing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueToRelatedPartiesCurrent_0fe35363-2739-42c8-ba3c-e8f315d71af2_terseLabel_en-US" xlink:label="lab_us-gaap_DueToRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to related party</link:label>
    <link:label id="lab_us-gaap_DueToRelatedPartiesCurrent_label_en-US" xlink:label="lab_us-gaap_DueToRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Related Parties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToRelatedPartiesCurrent" xlink:to="lab_us-gaap_DueToRelatedPartiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_EngineeringAndOtherServicesMember_9481a0ac-fd07-4fb3-96aa-d49f8960ed63_terseLabel_en-US" xlink:label="lab_amci_EngineeringAndOtherServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engineering and other services</link:label>
    <link:label id="lab_amci_EngineeringAndOtherServicesMember_label_en-US" xlink:label="lab_amci_EngineeringAndOtherServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engineering And Other Services [Member]</link:label>
    <link:label id="lab_amci_EngineeringAndOtherServicesMember_documentation_en-US" xlink:label="lab_amci_EngineeringAndOtherServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engineering And Other Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EngineeringAndOtherServicesMember" xlink:href="amci-20230213.xsd#amci_EngineeringAndOtherServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_EngineeringAndOtherServicesMember" xlink:to="lab_amci_EngineeringAndOtherServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne_e7adb5fc-1e47-41c2-b216-92eef74d5f36_terseLabel_en-US" xlink:label="lab_amci_LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liquidity price of SAFE and SAFE warrants, condition one</link:label>
    <link:label id="lab_amci_LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne_label_en-US" xlink:label="lab_amci_LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liquidity Price of SAFE and SAFE Warrants, Condition One</link:label>
    <link:label id="lab_amci_LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne_documentation_en-US" xlink:label="lab_amci_LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liquidity Price of SAFE and SAFE Warrants, Condition One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne" xlink:href="amci-20230213.xsd#amci_LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne" xlink:to="lab_amci_LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_FinancialAdvisoryMember_bab3eba4-f27d-4498-b559-5a429ba5bf6e_terseLabel_en-US" xlink:label="lab_amci_FinancialAdvisoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Advisory</link:label>
    <link:label id="lab_amci_FinancialAdvisoryMember_label_en-US" xlink:label="lab_amci_FinancialAdvisoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Advisory</link:label>
    <link:label id="lab_amci_FinancialAdvisoryMember_documentation_en-US" xlink:label="lab_amci_FinancialAdvisoryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This member represents financial advisory member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_FinancialAdvisoryMember" xlink:href="amci-20230213.xsd#amci_FinancialAdvisoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_FinancialAdvisoryMember" xlink:to="lab_amci_FinancialAdvisoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_071fea00-ed16-4391-816c-82f0d1291c87_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds received from initial public offering, gross</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_83274811-93c9-487c-a50b-9fc1163da201_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NorthAmericaMember_e92de932-f637-4507-939e-cc753f1ff9d0_terseLabel_en-US" xlink:label="lab_srt_NorthAmericaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America</link:label>
    <link:label id="lab_srt_NorthAmericaMember_label_en-US" xlink:label="lab_srt_NorthAmericaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NorthAmericaMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NorthAmericaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NorthAmericaMember" xlink:to="lab_srt_NorthAmericaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_PPPLoanMember_5f4d65d5-6f73-4334-9e30-b2424129d910_terseLabel_en-US" xlink:label="lab_amci_PPPLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PPP Loan</link:label>
    <link:label id="lab_amci_PPPLoanMember_label_en-US" xlink:label="lab_amci_PPPLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PPP Loan [Member]</link:label>
    <link:label id="lab_amci_PPPLoanMember_documentation_en-US" xlink:label="lab_amci_PPPLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PPP Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PPPLoanMember" xlink:href="amci-20230213.xsd#amci_PPPLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_PPPLoanMember" xlink:to="lab_amci_PPPLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_CoplacementAgentMember_c778f1da-c9ed-4d64-b2b2-e818defd0f04_terseLabel_en-US" xlink:label="lab_amci_CoplacementAgentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coplacement Agent</link:label>
    <link:label id="lab_amci_CoplacementAgentMember_label_en-US" xlink:label="lab_amci_CoplacementAgentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coplacement Agent</link:label>
    <link:label id="lab_amci_CoplacementAgentMember_documentation_en-US" xlink:label="lab_amci_CoplacementAgentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This member represents Coplacement Agent Member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CoplacementAgentMember" xlink:href="amci-20230213.xsd#amci_CoplacementAgentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_CoplacementAgentMember" xlink:to="lab_amci_CoplacementAgentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessPercent_bdadaf54-c344-424e-996d-615e1b60fd2e_negatedTerseLabel_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessPercent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PPP loan forgiveness</link:label>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessPercent_label_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Debt Forgiveness, Percent</link:label>
    <link:label id="lab_amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessPercent_documentation_en-US" xlink:label="lab_amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Debt Forgiveness, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessPercent" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessPercent" xlink:to="lab_amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_03bdbe6c-4227-4ed7-a20f-7d655e2ba6e6_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableConvertiblePreferredStockMember_ee3f7cde-0270-473b-be10-b10fe1963fb4_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable convertible preferred stock (if converted)</link:label>
    <link:label id="lab_us-gaap_RedeemableConvertiblePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Convertible Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:to="lab_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>amci-20230213_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:1f450268-e321-4330-aadf-815e69af2b4b,g:fe19691a-e2ec-4bc1-af0c-c42cfd4d1d7c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CoverPage" xlink:type="simple" xlink:href="amci-20230213.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_9e2addf5-38ca-4693-9280-7a761449fa64" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_6cc72304-3b71-4da8-b0a3-6c854315dbd4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9e2addf5-38ca-4693-9280-7a761449fa64" xlink:to="loc_dei_DocumentType_6cc72304-3b71-4da8-b0a3-6c854315dbd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_9fbe99b0-b297-4937-a770-33e6acedc8d2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9e2addf5-38ca-4693-9280-7a761449fa64" xlink:to="loc_dei_EntityRegistrantName_9fbe99b0-b297-4937-a770-33e6acedc8d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_23a32e21-2478-4b32-bafd-8c45637090b5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9e2addf5-38ca-4693-9280-7a761449fa64" xlink:to="loc_dei_EntityFilerCategory_23a32e21-2478-4b32-bafd-8c45637090b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_6c55e60d-e4dc-4d2e-bfbf-3b2aff1d2d38" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9e2addf5-38ca-4693-9280-7a761449fa64" xlink:to="loc_dei_EntitySmallBusiness_6c55e60d-e4dc-4d2e-bfbf-3b2aff1d2d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_77e44725-0da0-4805-bbca-a01484c66567" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9e2addf5-38ca-4693-9280-7a761449fa64" xlink:to="loc_dei_EntityEmergingGrowthCompany_77e44725-0da0-4805-bbca-a01484c66567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_747da4e6-9037-4eb9-a789-d2bfcbc67d64" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9e2addf5-38ca-4693-9280-7a761449fa64" xlink:to="loc_dei_EntityExTransitionPeriod_747da4e6-9037-4eb9-a789-d2bfcbc67d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_8318e678-34b2-4a22-80f0-9da5312c1357" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9e2addf5-38ca-4693-9280-7a761449fa64" xlink:to="loc_dei_EntityCentralIndexKey_8318e678-34b2-4a22-80f0-9da5312c1357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_ad75275e-0458-4e40-ac78-8a076093e6cc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9e2addf5-38ca-4693-9280-7a761449fa64" xlink:to="loc_dei_AmendmentFlag_ad75275e-0458-4e40-ac78-8a076093e6cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS" xlink:type="simple" xlink:href="amci-20230213.xsd#CONDENSEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_e70933d7-c9a4-44de-93e5-924c6a39a8bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_dc9195cc-5545-4f92-a897-2e21ef4ec16e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e70933d7-c9a4-44de-93e5-924c6a39a8bf" xlink:to="loc_us-gaap_StatementTable_dc9195cc-5545-4f92-a897-2e21ef4ec16e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_eb4622c9-cdbd-40c6-8a1c-11b09e5b3e4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_dc9195cc-5545-4f92-a897-2e21ef4ec16e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_eb4622c9-cdbd-40c6-8a1c-11b09e5b3e4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_378bb9fc-740e-4952-a2b5-047df624764f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_eb4622c9-cdbd-40c6-8a1c-11b09e5b3e4d" xlink:to="loc_us-gaap_ClassOfStockDomain_378bb9fc-740e-4952-a2b5-047df624764f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_532c4f2b-d1e2-44a0-a8a4-0889567ee7b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_378bb9fc-740e-4952-a2b5-047df624764f" xlink:to="loc_us-gaap_CommonClassAMember_532c4f2b-d1e2-44a0-a8a4-0889567ee7b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CommonClassaSubjectToRedemptionMember_ecac95fa-4ac8-458e-b942-bc132bc8ea7f" xlink:href="amci-20230213.xsd#amci_CommonClassaSubjectToRedemptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonClassAMember_532c4f2b-d1e2-44a0-a8a4-0889567ee7b7" xlink:to="loc_amci_CommonClassaSubjectToRedemptionMember_ecac95fa-4ac8-458e-b942-bc132bc8ea7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CommonClassaNotSubjectToRedemptionMember_dd42ddb1-6ac6-4503-a479-29f299be59b1" xlink:href="amci-20230213.xsd#amci_CommonClassaNotSubjectToRedemptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonClassAMember_532c4f2b-d1e2-44a0-a8a4-0889567ee7b7" xlink:to="loc_amci_CommonClassaNotSubjectToRedemptionMember_dd42ddb1-6ac6-4503-a479-29f299be59b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_c1a60e54-1acf-49a3-a037-5f2d805b0fee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_378bb9fc-740e-4952-a2b5-047df624764f" xlink:to="loc_us-gaap_CommonClassBMember_c1a60e54-1acf-49a3-a037-5f2d805b0fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_21923800-30c0-4c34-8b1e-0859c60c1ac5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_dc9195cc-5545-4f92-a897-2e21ef4ec16e" xlink:to="loc_dei_LegalEntityAxis_21923800-30c0-4c34-8b1e-0859c60c1ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_6cf5a461-3e45-4ca5-a244-1d3474cf9350" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_21923800-30c0-4c34-8b1e-0859c60c1ac5" xlink:to="loc_dei_EntityDomain_6cf5a461-3e45-4ca5-a244-1d3474cf9350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AMCIACQUISITIONCORPIIMember_3194b4c5-585a-4b00-ae69-02bd8d74e3d2" xlink:href="amci-20230213.xsd#amci_AMCIACQUISITIONCORPIIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_6cf5a461-3e45-4ca5-a244-1d3474cf9350" xlink:to="loc_amci_AMCIACQUISITIONCORPIIMember_3194b4c5-585a-4b00-ae69-02bd8d74e3d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e1e84abb-4010-4af1-b38b-66f344b2dcd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_dc9195cc-5545-4f92-a897-2e21ef4ec16e" xlink:to="loc_us-gaap_StatementLineItems_e1e84abb-4010-4af1-b38b-66f344b2dcd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_02796abe-e2d5-44c0-8175-3a87a3386c21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e1e84abb-4010-4af1-b38b-66f344b2dcd6" xlink:to="loc_us-gaap_AssetsAbstract_02796abe-e2d5-44c0-8175-3a87a3386c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_c6d996c9-e161-42fe-b103-8db926422a74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_02796abe-e2d5-44c0-8175-3a87a3386c21" xlink:to="loc_us-gaap_AssetsCurrentAbstract_c6d996c9-e161-42fe-b103-8db926422a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a9b9052d-7ec6-498c-8d09-687c037ec097" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c6d996c9-e161-42fe-b103-8db926422a74" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a9b9052d-7ec6-498c-8d09-687c037ec097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_1287821b-cc29-4940-8f30-0ee8914c7086" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c6d996c9-e161-42fe-b103-8db926422a74" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_1287821b-cc29-4940-8f30-0ee8914c7086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_0c4c6423-4db4-4de5-ba90-7721ca01daac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c6d996c9-e161-42fe-b103-8db926422a74" xlink:to="loc_us-gaap_AssetsCurrent_0c4c6423-4db4-4de5-ba90-7721ca01daac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PrepaidExpensesLongTerm_6921d00b-709d-40ae-ab9c-87c320a43f59" xlink:href="amci-20230213.xsd#amci_PrepaidExpensesLongTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_02796abe-e2d5-44c0-8175-3a87a3386c21" xlink:to="loc_amci_PrepaidExpensesLongTerm_6921d00b-709d-40ae-ab9c-87c320a43f59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrustNoncurrent_1a082574-3391-415b-b30c-05873a48c502" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_02796abe-e2d5-44c0-8175-3a87a3386c21" xlink:to="loc_us-gaap_AssetsHeldInTrustNoncurrent_1a082574-3391-415b-b30c-05873a48c502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b7d807d5-3569-4aec-9b82-830dc3192bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_02796abe-e2d5-44c0-8175-3a87a3386c21" xlink:to="loc_us-gaap_Assets_b7d807d5-3569-4aec-9b82-830dc3192bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6480f33d-e8d3-4e86-a815-d370788bd2a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e1e84abb-4010-4af1-b38b-66f344b2dcd6" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6480f33d-e8d3-4e86-a815-d370788bd2a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_c84f0667-06b1-467a-8377-26d16a755689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6480f33d-e8d3-4e86-a815-d370788bd2a3" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_c84f0667-06b1-467a-8377-26d16a755689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_2eecff8f-e2be-4a1b-b22b-c3c7ef35b824" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c84f0667-06b1-467a-8377-26d16a755689" xlink:to="loc_us-gaap_AccountsPayableCurrent_2eecff8f-e2be-4a1b-b22b-c3c7ef35b824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_02d40a45-785f-45fa-a7f9-b22c0197c773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c84f0667-06b1-467a-8377-26d16a755689" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_02d40a45-785f-45fa-a7f9-b22c0197c773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_6b47bbf7-9843-41f9-832e-0481254dbb56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c84f0667-06b1-467a-8377-26d16a755689" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrent_6b47bbf7-9843-41f9-832e-0481254dbb56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent_6cfcb7a2-d59b-475f-8743-da7d51bc804d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c84f0667-06b1-467a-8377-26d16a755689" xlink:to="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent_6cfcb7a2-d59b-475f-8743-da7d51bc804d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_FranchiseTaxPayableCurrent_b39c3c6d-b515-4466-b0e6-06446540e4ae" xlink:href="amci-20230213.xsd#amci_FranchiseTaxPayableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c84f0667-06b1-467a-8377-26d16a755689" xlink:to="loc_amci_FranchiseTaxPayableCurrent_b39c3c6d-b515-4466-b0e6-06446540e4ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_1bdb6d9c-7fa6-44ef-95cd-c759e7d47b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c84f0667-06b1-467a-8377-26d16a755689" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_1bdb6d9c-7fa6-44ef-95cd-c759e7d47b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_25d49b26-aaf1-4a80-8595-62ccfbcaf2dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c84f0667-06b1-467a-8377-26d16a755689" xlink:to="loc_us-gaap_LiabilitiesCurrent_25d49b26-aaf1-4a80-8595-62ccfbcaf2dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingCompensationNoncurrent_cdc5d7ce-490a-4288-9eae-19c9bd9213fc" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingCompensationNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6480f33d-e8d3-4e86-a815-d370788bd2a3" xlink:to="loc_amci_DeferredUnderwritingCompensationNoncurrent_cdc5d7ce-490a-4288-9eae-19c9bd9213fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_44cf6904-3cb0-4ea5-8895-c951d78e00ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6480f33d-e8d3-4e86-a815-d370788bd2a3" xlink:to="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_44cf6904-3cb0-4ea5-8895-c951d78e00ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_d9a35385-0021-4a4c-84a3-e8489fb3f209" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6480f33d-e8d3-4e86-a815-d370788bd2a3" xlink:to="loc_us-gaap_Liabilities_d9a35385-0021-4a4c-84a3-e8489fb3f209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_2627aed0-e395-443c-b1dc-e58caac93817" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6480f33d-e8d3-4e86-a815-d370788bd2a3" xlink:to="loc_us-gaap_CommitmentsAndContingencies_2627aed0-e395-443c-b1dc-e58caac93817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_865e44ee-b107-43f4-aa13-bcb863b6fa2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6480f33d-e8d3-4e86-a815-d370788bd2a3" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_865e44ee-b107-43f4-aa13-bcb863b6fa2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_8644fc90-8655-40c6-bcbc-2b26027a676b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6480f33d-e8d3-4e86-a815-d370788bd2a3" xlink:to="loc_us-gaap_StockholdersEquityAbstract_8644fc90-8655-40c6-bcbc-2b26027a676b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_91848054-8773-4869-a797-a530934c445a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8644fc90-8655-40c6-bcbc-2b26027a676b" xlink:to="loc_us-gaap_PreferredStockValue_91848054-8773-4869-a797-a530934c445a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_3cfedeb2-0452-43a6-8ea8-605375df6418" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8644fc90-8655-40c6-bcbc-2b26027a676b" xlink:to="loc_us-gaap_CommonStockValue_3cfedeb2-0452-43a6-8ea8-605375df6418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_bab365f8-9277-4481-bd94-370ea4633642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8644fc90-8655-40c6-bcbc-2b26027a676b" xlink:to="loc_us-gaap_AdditionalPaidInCapital_bab365f8-9277-4481-bd94-370ea4633642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1e344672-33be-4a6d-9ad8-35d6764bde6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8644fc90-8655-40c6-bcbc-2b26027a676b" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1e344672-33be-4a6d-9ad8-35d6764bde6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b3a1b5bc-6753-4e42-a853-f3531dd8e76c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8644fc90-8655-40c6-bcbc-2b26027a676b" xlink:to="loc_us-gaap_StockholdersEquity_b3a1b5bc-6753-4e42-a853-f3531dd8e76c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_d105359e-4b48-42de-98be-8624771f8cae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6480f33d-e8d3-4e86-a815-d370788bd2a3" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_d105359e-4b48-42de-98be-8624771f8cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="amci-20230213.xsd#CONDENSEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_a5d23887-a48c-414b-a099-728357ede0af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_93470851-3014-477c-ba67-c10bd3b7f3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a5d23887-a48c-414b-a099-728357ede0af" xlink:to="loc_us-gaap_StatementTable_93470851-3014-477c-ba67-c10bd3b7f3cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1ae64b6c-ffea-42c7-8015-3d29028836a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_93470851-3014-477c-ba67-c10bd3b7f3cf" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1ae64b6c-ffea-42c7-8015-3d29028836a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_410d9261-2bfd-4df0-94b5-750c363d3297" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1ae64b6c-ffea-42c7-8015-3d29028836a0" xlink:to="loc_us-gaap_ClassOfStockDomain_410d9261-2bfd-4df0-94b5-750c363d3297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_30917b05-92ee-4a75-9d79-42cdbfcb4c58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_410d9261-2bfd-4df0-94b5-750c363d3297" xlink:to="loc_us-gaap_CommonClassAMember_30917b05-92ee-4a75-9d79-42cdbfcb4c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CommonClassaSubjectToRedemptionMember_7df541d6-32dd-4480-8eca-f04b447997e9" xlink:href="amci-20230213.xsd#amci_CommonClassaSubjectToRedemptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonClassAMember_30917b05-92ee-4a75-9d79-42cdbfcb4c58" xlink:to="loc_amci_CommonClassaSubjectToRedemptionMember_7df541d6-32dd-4480-8eca-f04b447997e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CommonClassaNotSubjectToRedemptionMember_b1858cfd-4047-4b58-94da-c4deba163fa4" xlink:href="amci-20230213.xsd#amci_CommonClassaNotSubjectToRedemptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonClassAMember_30917b05-92ee-4a75-9d79-42cdbfcb4c58" xlink:to="loc_amci_CommonClassaNotSubjectToRedemptionMember_b1858cfd-4047-4b58-94da-c4deba163fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_e63bcdc1-0a4f-4e0f-a950-014e0d99626e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_410d9261-2bfd-4df0-94b5-750c363d3297" xlink:to="loc_us-gaap_CommonClassBMember_e63bcdc1-0a4f-4e0f-a950-014e0d99626e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_e52aa498-1bf7-4285-afb3-f2e6fe79e9b4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_93470851-3014-477c-ba67-c10bd3b7f3cf" xlink:to="loc_dei_LegalEntityAxis_e52aa498-1bf7-4285-afb3-f2e6fe79e9b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_3e687032-ca7c-45de-b1dc-ea578cfc2a2d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_e52aa498-1bf7-4285-afb3-f2e6fe79e9b4" xlink:to="loc_dei_EntityDomain_3e687032-ca7c-45de-b1dc-ea578cfc2a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AMCIACQUISITIONCORPIIMember_4be42f52-bbc8-4c3a-88d7-d39b61d464d4" xlink:href="amci-20230213.xsd#amci_AMCIACQUISITIONCORPIIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_3e687032-ca7c-45de-b1dc-ea578cfc2a2d" xlink:to="loc_amci_AMCIACQUISITIONCORPIIMember_4be42f52-bbc8-4c3a-88d7-d39b61d464d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_477fa7e4-5013-48ea-8a79-4463a2ad1973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_93470851-3014-477c-ba67-c10bd3b7f3cf" xlink:to="loc_us-gaap_StatementLineItems_477fa7e4-5013-48ea-8a79-4463a2ad1973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_2f6d4224-b929-4fc1-9dab-ce955082ed9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_477fa7e4-5013-48ea-8a79-4463a2ad1973" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_2f6d4224-b929-4fc1-9dab-ce955082ed9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_5774eac9-7677-4f6c-9aac-6de9f7590a23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_477fa7e4-5013-48ea-8a79-4463a2ad1973" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_5774eac9-7677-4f6c-9aac-6de9f7590a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_5d14a709-53d8-4e58-8113-1072155ba824" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_477fa7e4-5013-48ea-8a79-4463a2ad1973" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_5d14a709-53d8-4e58-8113-1072155ba824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityRedemptionPricePerShare_36f48c14-5f20-4ef4-a913-27fd3539a109" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_477fa7e4-5013-48ea-8a79-4463a2ad1973" xlink:to="loc_us-gaap_TemporaryEquityRedemptionPricePerShare_36f48c14-5f20-4ef4-a913-27fd3539a109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_ee70679b-97e7-4784-a91c-5d85afbc116e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_477fa7e4-5013-48ea-8a79-4463a2ad1973" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_ee70679b-97e7-4784-a91c-5d85afbc116e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_a0aaa86a-8ed8-4d82-835d-91f7ecb39394" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_477fa7e4-5013-48ea-8a79-4463a2ad1973" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_a0aaa86a-8ed8-4d82-835d-91f7ecb39394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_04f2b087-da0b-40c6-b7c2-d0a0137a321e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_477fa7e4-5013-48ea-8a79-4463a2ad1973" xlink:to="loc_us-gaap_PreferredStockSharesIssued_04f2b087-da0b-40c6-b7c2-d0a0137a321e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_670dd7b5-4be8-4404-a498-fe8ba334dbd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_477fa7e4-5013-48ea-8a79-4463a2ad1973" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_670dd7b5-4be8-4404-a498-fe8ba334dbd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_73e73130-847f-4d89-811b-31169d8e267a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding_670dd7b5-4be8-4404-a498-fe8ba334dbd3" xlink:to="loc_us-gaap_CommonStockSharesIssued_73e73130-847f-4d89-811b-31169d8e267a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_b2a56f46-4664-4aa4-950a-1bed0f2813fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_477fa7e4-5013-48ea-8a79-4463a2ad1973" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_b2a56f46-4664-4aa4-950a-1bed0f2813fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_7627e271-f433-4f9b-a38e-c3a0fcae7151" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_477fa7e4-5013-48ea-8a79-4463a2ad1973" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_7627e271-f433-4f9b-a38e-c3a0fcae7151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_8d9679b6-a728-4fd1-8040-0b3efef9675e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_477fa7e4-5013-48ea-8a79-4463a2ad1973" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_8d9679b6-a728-4fd1-8040-0b3efef9675e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="amci-20230213.xsd#UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_224a092f-d288-4e33-9cae-eb6710b87537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1f3d29bf-8051-4a6f-8a46-d39c415a07cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_224a092f-d288-4e33-9cae-eb6710b87537" xlink:to="loc_us-gaap_StatementTable_1f3d29bf-8051-4a6f-8a46-d39c415a07cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_04ad1522-4d0d-47cc-91e9-009847feeee5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1f3d29bf-8051-4a6f-8a46-d39c415a07cb" xlink:to="loc_us-gaap_StatementClassOfStockAxis_04ad1522-4d0d-47cc-91e9-009847feeee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_022003aa-7ef4-4c15-96be-329d0bf36293" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_04ad1522-4d0d-47cc-91e9-009847feeee5" xlink:to="loc_us-gaap_ClassOfStockDomain_022003aa-7ef4-4c15-96be-329d0bf36293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_3e9b3810-93a0-4c2a-ad89-2eec41050ee4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_022003aa-7ef4-4c15-96be-329d0bf36293" xlink:to="loc_us-gaap_CommonClassAMember_3e9b3810-93a0-4c2a-ad89-2eec41050ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_34bb1ec4-9a62-48cc-9e79-38eb68baddef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_022003aa-7ef4-4c15-96be-329d0bf36293" xlink:to="loc_us-gaap_CommonClassBMember_34bb1ec4-9a62-48cc-9e79-38eb68baddef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_8443f5ff-ffb3-4c8f-b958-f94718c1d9c3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1f3d29bf-8051-4a6f-8a46-d39c415a07cb" xlink:to="loc_dei_LegalEntityAxis_8443f5ff-ffb3-4c8f-b958-f94718c1d9c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_89286be9-c989-4e34-a579-cdeeb02c2a8e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_8443f5ff-ffb3-4c8f-b958-f94718c1d9c3" xlink:to="loc_dei_EntityDomain_89286be9-c989-4e34-a579-cdeeb02c2a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AMCIACQUISITIONCORPIIMember_4912ce48-bffe-45be-97a4-6d510a40c86f" xlink:href="amci-20230213.xsd#amci_AMCIACQUISITIONCORPIIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_89286be9-c989-4e34-a579-cdeeb02c2a8e" xlink:to="loc_amci_AMCIACQUISITIONCORPIIMember_4912ce48-bffe-45be-97a4-6d510a40c86f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_bdee3776-0373-48f6-aed7-6900df31c090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1f3d29bf-8051-4a6f-8a46-d39c415a07cb" xlink:to="loc_us-gaap_StatementLineItems_bdee3776-0373-48f6-aed7-6900df31c090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_162611fe-2fad-4951-a6eb-0db6f0b83fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bdee3776-0373-48f6-aed7-6900df31c090" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_162611fe-2fad-4951-a6eb-0db6f0b83fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_cf37d87c-b54c-40f0-9c0a-a2499860cdcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bdee3776-0373-48f6-aed7-6900df31c090" xlink:to="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_cf37d87c-b54c-40f0-9c0a-a2499860cdcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CapitalBaseTaxExpense_dc9b6a90-ffdd-4f6b-a061-09fed46d7762" xlink:href="amci-20230213.xsd#amci_CapitalBaseTaxExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bdee3776-0373-48f6-aed7-6900df31c090" xlink:to="loc_amci_CapitalBaseTaxExpense_dc9b6a90-ffdd-4f6b-a061-09fed46d7762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductionTaxExpense_e6cea964-2886-4755-bcc7-0fb52c5d463a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductionTaxExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bdee3776-0373-48f6-aed7-6900df31c090" xlink:to="loc_us-gaap_ProductionTaxExpense_e6cea964-2886-4755-bcc7-0fb52c5d463a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_36874785-9ea0-4a5b-b4c6-23088209e82a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bdee3776-0373-48f6-aed7-6900df31c090" xlink:to="loc_us-gaap_OperatingIncomeLoss_36874785-9ea0-4a5b-b4c6-23088209e82a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_bbf665d5-985a-4f56-b702-9bb307e9faa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bdee3776-0373-48f6-aed7-6900df31c090" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_bbf665d5-985a-4f56-b702-9bb307e9faa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_5e649bba-5945-47c9-8d37-7ed4f01b7562" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_bbf665d5-985a-4f56-b702-9bb307e9faa2" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_5e649bba-5945-47c9-8d37-7ed4f01b7562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants_6f63e3b2-7f05-42c6-960c-043e1969fa41" xlink:href="amci-20230213.xsd#amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_bbf665d5-985a-4f56-b702-9bb307e9faa2" xlink:to="loc_amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants_6f63e3b2-7f05-42c6-960c-043e1969fa41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities_8b0e48ff-8afa-423d-a702-2f0ab51e57a5" xlink:href="amci-20230213.xsd#amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_bbf665d5-985a-4f56-b702-9bb307e9faa2" xlink:to="loc_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities_8b0e48ff-8afa-423d-a702-2f0ab51e57a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeFromInvestmentsHeldInTrustAccount_87b6997f-068a-432e-a43a-892d4cb4b36d" xlink:href="amci-20230213.xsd#amci_IncomeFromInvestmentsHeldInTrustAccount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_bbf665d5-985a-4f56-b702-9bb307e9faa2" xlink:to="loc_amci_IncomeFromInvestmentsHeldInTrustAccount_87b6997f-068a-432e-a43a-892d4cb4b36d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_09e6e0be-7dea-4555-8fd9-47df499180d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bdee3776-0373-48f6-aed7-6900df31c090" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_09e6e0be-7dea-4555-8fd9-47df499180d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e1aec2c2-422b-47b5-8447-7e655787de61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bdee3776-0373-48f6-aed7-6900df31c090" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e1aec2c2-422b-47b5-8447-7e655787de61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b41b7419-6453-4b4b-92b2-01381d0ebdce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bdee3776-0373-48f6-aed7-6900df31c090" xlink:to="loc_us-gaap_NetIncomeLoss_b41b7419-6453-4b4b-92b2-01381d0ebdce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_faafc819-e4fa-40e4-adce-2d3f670945a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bdee3776-0373-48f6-aed7-6900df31c090" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_faafc819-e4fa-40e4-adce-2d3f670945a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b094118d-ecf6-414b-abf9-9c6f5e6aa089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bdee3776-0373-48f6-aed7-6900df31c090" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b094118d-ecf6-414b-abf9-9c6f5e6aa089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_dc6ab005-bd7f-48a4-aae2-87aa0a05ca0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bdee3776-0373-48f6-aed7-6900df31c090" xlink:to="loc_us-gaap_EarningsPerShareBasic_dc6ab005-bd7f-48a4-aae2-87aa0a05ca0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_4de1cec2-6f1d-4c2d-94be-55b2bb7720cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bdee3776-0373-48f6-aed7-6900df31c090" xlink:to="loc_us-gaap_EarningsPerShareDiluted_4de1cec2-6f1d-4c2d-94be-55b2bb7720cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="amci-20230213.xsd#UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_6ef152c7-b6f9-487b-888d-fa8ae9b92ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2130ac5b-5501-49fd-ba42-eeee6e9fd2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_6ef152c7-b6f9-487b-888d-fa8ae9b92ca7" xlink:to="loc_us-gaap_StatementTable_2130ac5b-5501-49fd-ba42-eeee6e9fd2ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_d479328f-7b06-4db1-b986-357fdceb1bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2130ac5b-5501-49fd-ba42-eeee6e9fd2ad" xlink:to="loc_us-gaap_StatementClassOfStockAxis_d479328f-7b06-4db1-b986-357fdceb1bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_7c4cd42e-a5ec-4cb0-bcda-fa6425b142bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d479328f-7b06-4db1-b986-357fdceb1bc2" xlink:to="loc_us-gaap_ClassOfStockDomain_7c4cd42e-a5ec-4cb0-bcda-fa6425b142bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_828e2fe2-26f9-45f8-b8f9-40ebed503060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7c4cd42e-a5ec-4cb0-bcda-fa6425b142bb" xlink:to="loc_us-gaap_CommonClassAMember_828e2fe2-26f9-45f8-b8f9-40ebed503060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_b5bc83e7-e676-4344-b9c9-efb78ca272cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7c4cd42e-a5ec-4cb0-bcda-fa6425b142bb" xlink:to="loc_us-gaap_CommonClassBMember_b5bc83e7-e676-4344-b9c9-efb78ca272cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ff3feba9-dd51-4fd3-9a54-a3e983cc5794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2130ac5b-5501-49fd-ba42-eeee6e9fd2ad" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ff3feba9-dd51-4fd3-9a54-a3e983cc5794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_29117070-6709-42f2-b588-202a168cd37d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ff3feba9-dd51-4fd3-9a54-a3e983cc5794" xlink:to="loc_us-gaap_EquityComponentDomain_29117070-6709-42f2-b588-202a168cd37d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_64d474b0-b740-42d6-8ad5-077ecccdd11b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_29117070-6709-42f2-b588-202a168cd37d" xlink:to="loc_us-gaap_CommonStockMember_64d474b0-b740-42d6-8ad5-077ecccdd11b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_79165033-cbd6-45d9-bf0d-235d1f0e7b60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_29117070-6709-42f2-b588-202a168cd37d" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_79165033-cbd6-45d9-bf0d-235d1f0e7b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_50a0909a-6e77-4c63-af67-041785cb4bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_29117070-6709-42f2-b588-202a168cd37d" xlink:to="loc_us-gaap_RetainedEarningsMember_50a0909a-6e77-4c63-af67-041785cb4bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_cef96a7a-2a2f-4721-8865-6286ea4b68c6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2130ac5b-5501-49fd-ba42-eeee6e9fd2ad" xlink:to="loc_dei_LegalEntityAxis_cef96a7a-2a2f-4721-8865-6286ea4b68c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_0a135783-d172-4400-bb8d-74d5a3844ca1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_cef96a7a-2a2f-4721-8865-6286ea4b68c6" xlink:to="loc_dei_EntityDomain_0a135783-d172-4400-bb8d-74d5a3844ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AMCIACQUISITIONCORPIIMember_aeed2247-6f85-4d24-b361-5a8151ae9602" xlink:href="amci-20230213.xsd#amci_AMCIACQUISITIONCORPIIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_0a135783-d172-4400-bb8d-74d5a3844ca1" xlink:to="loc_amci_AMCIACQUISITIONCORPIIMember_aeed2247-6f85-4d24-b361-5a8151ae9602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4cd846f4-4447-4c97-9487-e6194b597ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2130ac5b-5501-49fd-ba42-eeee6e9fd2ad" xlink:to="loc_us-gaap_StatementLineItems_4cd846f4-4447-4c97-9487-e6194b597ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4cd846f4-4447-4c97-9487-e6194b597ae4" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1deecb76-55bc-4c87-8e8a-f9110549d51b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:to="loc_us-gaap_StockholdersEquity_1deecb76-55bc-4c87-8e8a-f9110549d51b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_8ff43a4f-5ccf-4008-998e-af2a2f5f17fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:to="loc_us-gaap_SharesIssued_8ff43a4f-5ccf-4008-998e-af2a2f5f17fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_0542e663-1271-41a1-a0a8-fe2fd13280c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_0542e663-1271-41a1-a0a8-fe2fd13280c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_36c8a4f2-6ac1-48af-a3ea-2f95a824b57e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_36c8a4f2-6ac1-48af-a3ea-2f95a824b57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares_ae976ed1-aef4-4a7e-8e9b-11095abfb9ef" xlink:href="amci-20230213.xsd#amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:to="loc_amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares_ae976ed1-aef4-4a7e-8e9b-11095abfb9ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_7b75d776-3976-472d-906c-31a8045e1ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_7b75d776-3976-472d-906c-31a8045e1ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption_e9b00c16-3c37-41fd-89ff-aaa01fc9e636" xlink:href="amci-20230213.xsd#amci_IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:to="loc_amci_IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption_e9b00c16-3c37-41fd-89ff-aaa01fc9e636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_88f96a84-4301-4238-bf02-1d362f30bac6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_88f96a84-4301-4238-bf02-1d362f30bac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_3bdbe266-6974-42d0-864a-681537e14020" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_3bdbe266-6974-42d0-864a-681537e14020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_13a14fe7-23f0-453a-a497-1936c2a3b2a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_13a14fe7-23f0-453a-a497-1936c2a3b2a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors_7994b0b7-0b18-46ca-a126-04ac8e5bb1d2" xlink:href="amci-20230213.xsd#amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:to="loc_amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors_7994b0b7-0b18-46ca-a126-04ac8e5bb1d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_7e6beccc-e8ab-4362-a489-41db4a77a4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_7e6beccc-e8ab-4362-a489-41db4a77a4ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_76c3b6d2-1c0f-4c2f-b122-537eb456cd97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:to="loc_us-gaap_NetIncomeLoss_76c3b6d2-1c0f-4c2f-b122-537eb456cd97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7e19feeb-3955-4f51-9e7a-df370fdefff7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:to="loc_us-gaap_StockholdersEquity_7e19feeb-3955-4f51-9e7a-df370fdefff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_a0e8ce21-5eee-4a26-a43d-f0973f1573d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98872bfd-7de1-462d-b211-9f738a4f47cd" xlink:to="loc_us-gaap_SharesIssued_a0e8ce21-5eee-4a26-a43d-f0973f1573d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICITParenthetical" xlink:type="simple" xlink:href="amci-20230213.xsd#UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICITParenthetical"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICITParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_4b8ccdd6-bb0e-4af3-8c64-c5eb0bff2858" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5027cb8c-2240-49ae-8124-ea29f2e2da29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_4b8ccdd6-bb0e-4af3-8c64-c5eb0bff2858" xlink:to="loc_us-gaap_StatementTable_5027cb8c-2240-49ae-8124-ea29f2e2da29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_fb7cb0ae-248f-4ac3-90c4-cff65ac59a26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5027cb8c-2240-49ae-8124-ea29f2e2da29" xlink:to="loc_us-gaap_StatementClassOfStockAxis_fb7cb0ae-248f-4ac3-90c4-cff65ac59a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b5c7e992-fa82-4e18-b999-fadfc62ef5df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fb7cb0ae-248f-4ac3-90c4-cff65ac59a26" xlink:to="loc_us-gaap_ClassOfStockDomain_b5c7e992-fa82-4e18-b999-fadfc62ef5df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_211af367-b6eb-4c28-975b-261bb0cd5f87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_b5c7e992-fa82-4e18-b999-fadfc62ef5df" xlink:to="loc_us-gaap_CommonClassBMember_211af367-b6eb-4c28-975b-261bb0cd5f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_adeefcb8-d474-4dcf-93da-3578ceba504f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5027cb8c-2240-49ae-8124-ea29f2e2da29" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_adeefcb8-d474-4dcf-93da-3578ceba504f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_b76cf85b-9fe1-4e3f-a601-3ce7985b745f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_adeefcb8-d474-4dcf-93da-3578ceba504f" xlink:to="loc_us-gaap_RelatedPartyDomain_b76cf85b-9fe1-4e3f-a601-3ce7985b745f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SponsorMember_5f4b7250-368b-4439-b839-c472dad6dbfd" xlink:href="amci-20230213.xsd#amci_SponsorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_b76cf85b-9fe1-4e3f-a601-3ce7985b745f" xlink:to="loc_amci_SponsorMember_5f4b7250-368b-4439-b839-c472dad6dbfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_6e890416-42b0-4a72-9b28-f0eef30a0e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5027cb8c-2240-49ae-8124-ea29f2e2da29" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_6e890416-42b0-4a72-9b28-f0eef30a0e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b2229c4e-ef91-4e99-9b30-ab1ff2c65c18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_6e890416-42b0-4a72-9b28-f0eef30a0e8c" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b2229c4e-ef91-4e99-9b30-ab1ff2c65c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_516fe906-05f5-4007-88d3-bdd6b119987d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b2229c4e-ef91-4e99-9b30-ab1ff2c65c18" xlink:to="loc_us-gaap_OverAllotmentOptionMember_516fe906-05f5-4007-88d3-bdd6b119987d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_428ae195-c34c-4646-9eaf-c1cd2aaec960" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5027cb8c-2240-49ae-8124-ea29f2e2da29" xlink:to="loc_dei_LegalEntityAxis_428ae195-c34c-4646-9eaf-c1cd2aaec960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_cdb94253-34e7-476d-9cee-f87176355ae9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_428ae195-c34c-4646-9eaf-c1cd2aaec960" xlink:to="loc_dei_EntityDomain_cdb94253-34e7-476d-9cee-f87176355ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AMCIACQUISITIONCORPIIMember_9db284e7-7250-4167-be0c-33747f42eb11" xlink:href="amci-20230213.xsd#amci_AMCIACQUISITIONCORPIIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_cdb94253-34e7-476d-9cee-f87176355ae9" xlink:to="loc_amci_AMCIACQUISITIONCORPIIMember_9db284e7-7250-4167-be0c-33747f42eb11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_37c30a5f-88b6-4718-9d62-25f7615725c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5027cb8c-2240-49ae-8124-ea29f2e2da29" xlink:to="loc_us-gaap_StatementLineItems_37c30a5f-88b6-4718-9d62-25f7615725c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_aa1a44d3-0bd0-4177-b4bb-130c37947531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_37c30a5f-88b6-4718-9d62-25f7615725c2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_aa1a44d3-0bd0-4177-b4bb-130c37947531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfSharesSurrendered_9aa9e322-2426-4188-9f3d-5cb5595bae24" xlink:href="amci-20230213.xsd#amci_NumberOfSharesSurrendered"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_37c30a5f-88b6-4718-9d62-25f7615725c2" xlink:to="loc_amci_NumberOfSharesSurrendered_9aa9e322-2426-4188-9f3d-5cb5595bae24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AggregateNumberOfSharesOwned_826c3577-47ef-421d-9d88-6377e712f6d7" xlink:href="amci-20230213.xsd#amci_AggregateNumberOfSharesOwned"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_37c30a5f-88b6-4718-9d62-25f7615725c2" xlink:to="loc_amci_AggregateNumberOfSharesOwned_826c3577-47ef-421d-9d88-6377e712f6d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="amci-20230213.xsd#UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_c0ecd953-09fc-4d60-a7dc-af817216cc39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_cbbc28b1-f52c-4a68-bdde-506fb18f065c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c0ecd953-09fc-4d60-a7dc-af817216cc39" xlink:to="loc_us-gaap_StatementTable_cbbc28b1-f52c-4a68-bdde-506fb18f065c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_bce28936-24ba-4ea9-92b4-f2c926f95f44" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_cbbc28b1-f52c-4a68-bdde-506fb18f065c" xlink:to="loc_dei_LegalEntityAxis_bce28936-24ba-4ea9-92b4-f2c926f95f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f379dc99-5a8f-4517-b3f9-c91a91f4db8f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_bce28936-24ba-4ea9-92b4-f2c926f95f44" xlink:to="loc_dei_EntityDomain_f379dc99-5a8f-4517-b3f9-c91a91f4db8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AMCIACQUISITIONCORPIIMember_8d38792d-587d-47e8-853e-058feda1a908" xlink:href="amci-20230213.xsd#amci_AMCIACQUISITIONCORPIIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_f379dc99-5a8f-4517-b3f9-c91a91f4db8f" xlink:to="loc_amci_AMCIACQUISITIONCORPIIMember_8d38792d-587d-47e8-853e-058feda1a908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1ba60755-a7bf-416e-8c76-5ba4900b4881" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_cbbc28b1-f52c-4a68-bdde-506fb18f065c" xlink:to="loc_us-gaap_StatementLineItems_1ba60755-a7bf-416e-8c76-5ba4900b4881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8a6c6f6a-20f8-41c4-bcd5-3b1749eed9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1ba60755-a7bf-416e-8c76-5ba4900b4881" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8a6c6f6a-20f8-41c4-bcd5-3b1749eed9a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_4b0fbb4c-21c4-4b62-ad64-8a6d0b04ed77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8a6c6f6a-20f8-41c4-bcd5-3b1749eed9a1" xlink:to="loc_us-gaap_ProfitLoss_4b0fbb4c-21c4-4b62-ad64-8a6d0b04ed77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2e353793-064d-4dfa-b1a8-e25ae53f6d46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8a6c6f6a-20f8-41c4-bcd5-3b1749eed9a1" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2e353793-064d-4dfa-b1a8-e25ae53f6d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares_59a4f7bb-a27e-4fdc-a819-c1937c54e04b" xlink:href="amci-20230213.xsd#amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2e353793-064d-4dfa-b1a8-e25ae53f6d46" xlink:to="loc_amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares_59a4f7bb-a27e-4fdc-a819-c1937c54e04b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_0122ba53-e131-421b-94b8-fc3674f61046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2e353793-064d-4dfa-b1a8-e25ae53f6d46" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_0122ba53-e131-421b-94b8-fc3674f61046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants_012409c8-35f0-4ac9-8a01-472cba969ff1" xlink:href="amci-20230213.xsd#amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2e353793-064d-4dfa-b1a8-e25ae53f6d46" xlink:to="loc_amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants_012409c8-35f0-4ac9-8a01-472cba969ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities_049d1e49-db24-4236-b742-3ef326889021" xlink:href="amci-20230213.xsd#amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2e353793-064d-4dfa-b1a8-e25ae53f6d46" xlink:to="loc_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities_049d1e49-db24-4236-b742-3ef326889021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeFromInvestmentsHeldInTrustAccount_05f438e1-d334-406d-a912-bbbbbe8b1153" xlink:href="amci-20230213.xsd#amci_IncomeFromInvestmentsHeldInTrustAccount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2e353793-064d-4dfa-b1a8-e25ae53f6d46" xlink:to="loc_amci_IncomeFromInvestmentsHeldInTrustAccount_05f438e1-d334-406d-a912-bbbbbe8b1153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4dad2a15-f91e-4a34-be70-a71b5b8beae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2e353793-064d-4dfa-b1a8-e25ae53f6d46" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4dad2a15-f91e-4a34-be70-a71b5b8beae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_5df06ad9-eaef-42c9-8fbc-dca98762c622" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4dad2a15-f91e-4a34-be70-a71b5b8beae4" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_5df06ad9-eaef-42c9-8fbc-dca98762c622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_28c43207-4a16-4421-80bf-dc652e3099f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4dad2a15-f91e-4a34-be70-a71b5b8beae4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_28c43207-4a16-4421-80bf-dc652e3099f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncreaseDecreaseInDueToRelatedParties._1ea7bc86-6669-4530-9252-2c295ab8a715" xlink:href="amci-20230213.xsd#amci_IncreaseDecreaseInDueToRelatedParties."/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4dad2a15-f91e-4a34-be70-a71b5b8beae4" xlink:to="loc_amci_IncreaseDecreaseInDueToRelatedParties._1ea7bc86-6669-4530-9252-2c295ab8a715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_3d451016-c824-419f-a9e5-2adc51f272ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4dad2a15-f91e-4a34-be70-a71b5b8beae4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_3d451016-c824-419f-a9e5-2adc51f272ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncreaseDecreaseInCapitalBaseTaxPayable_e2733c93-99d8-497f-b7fc-4fbc6a11476b" xlink:href="amci-20230213.xsd#amci_IncreaseDecreaseInCapitalBaseTaxPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4dad2a15-f91e-4a34-be70-a71b5b8beae4" xlink:to="loc_amci_IncreaseDecreaseInCapitalBaseTaxPayable_e2733c93-99d8-497f-b7fc-4fbc6a11476b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncreaseDecreaseFranchiseTaxPayable_7e17cc72-c06c-4602-a055-5558072d8be3" xlink:href="amci-20230213.xsd#amci_IncreaseDecreaseFranchiseTaxPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4dad2a15-f91e-4a34-be70-a71b5b8beae4" xlink:to="loc_amci_IncreaseDecreaseFranchiseTaxPayable_7e17cc72-c06c-4602-a055-5558072d8be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_feb4a9df-2466-4051-a0a5-dd9b7f864a88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4dad2a15-f91e-4a34-be70-a71b5b8beae4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_feb4a9df-2466-4051-a0a5-dd9b7f864a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_86d2e3df-3356-41b8-b3ff-417cedf40fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8a6c6f6a-20f8-41c4-bcd5-3b1749eed9a1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_86d2e3df-3356-41b8-b3ff-417cedf40fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_650b37a4-a910-47cd-b053-4726b5c31306" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1ba60755-a7bf-416e-8c76-5ba4900b4881" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_650b37a4-a910-47cd-b053-4726b5c31306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireTrustPreferredInvestments_f90174e5-74f7-461c-8d07-8cb37192260e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireTrustPreferredInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_650b37a4-a910-47cd-b053-4726b5c31306" xlink:to="loc_us-gaap_PaymentsToAcquireTrustPreferredInvestments_f90174e5-74f7-461c-8d07-8cb37192260e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PaymentsForInvestmentOfCashInTrustAccount_2833d5a5-eb44-4dae-8378-660b2b958030" xlink:href="amci-20230213.xsd#amci_PaymentsForInvestmentOfCashInTrustAccount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_650b37a4-a910-47cd-b053-4726b5c31306" xlink:to="loc_amci_PaymentsForInvestmentOfCashInTrustAccount_2833d5a5-eb44-4dae-8378-660b2b958030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3346860f-ecbc-42dd-87d5-ef876fa71028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_650b37a4-a910-47cd-b053-4726b5c31306" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3346860f-ecbc-42dd-87d5-ef876fa71028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7491fc7d-97b2-49c8-b572-4a8b2804c7fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1ba60755-a7bf-416e-8c76-5ba4900b4881" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7491fc7d-97b2-49c8-b572-4a8b2804c7fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt_e186ed71-40b1-4adb-99ba-81f4bf783760" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7491fc7d-97b2-49c8-b572-4a8b2804c7fd" xlink:to="loc_us-gaap_ProceedsFromRelatedPartyDebt_e186ed71-40b1-4adb-99ba-81f4bf783760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_ac849eae-dd60-4c12-8ba5-3c7a5f1fbfc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7491fc7d-97b2-49c8-b572-4a8b2804c7fd" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_ac849eae-dd60-4c12-8ba5-3c7a5f1fbfc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_ee1e9ae2-a085-4ae4-9bb9-e62d2a4d5bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7491fc7d-97b2-49c8-b572-4a8b2804c7fd" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_ee1e9ae2-a085-4ae4-9bb9-e62d2a4d5bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f6862162-280d-4fb2-a7c7-be30e909e315" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7491fc7d-97b2-49c8-b572-4a8b2804c7fd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f6862162-280d-4fb2-a7c7-be30e909e315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_75b69740-5388-4121-8306-8ba4344ead49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1ba60755-a7bf-416e-8c76-5ba4900b4881" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_75b69740-5388-4121-8306-8ba4344ead49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5316e1b3-4db4-47cd-856f-008556166e04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1ba60755-a7bf-416e-8c76-5ba4900b4881" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5316e1b3-4db4-47cd-856f-008556166e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_db4ccd7e-6c8d-4952-9c17-26f21bea317b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1ba60755-a7bf-416e-8c76-5ba4900b4881" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_db4ccd7e-6c8d-4952-9c17-26f21bea317b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_f61fe553-f9e8-4cf4-8dd1-fbf15cec49dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1ba60755-a7bf-416e-8c76-5ba4900b4881" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_f61fe553-f9e8-4cf4-8dd1-fbf15cec49dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredOfferingCostsIncludedInNotesPayable_390b8f45-81fb-4e0c-a44d-ae6fe052d542" xlink:href="amci-20230213.xsd#amci_DeferredOfferingCostsIncludedInNotesPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_f61fe553-f9e8-4cf4-8dd1-fbf15cec49dd" xlink:to="loc_amci_DeferredOfferingCostsIncludedInNotesPayable_390b8f45-81fb-4e0c-a44d-ae6fe052d542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OfferingCostsIncludedInAccountsPayableAccruedExpenses_f03a56a6-85cd-4502-b155-03a6db2ff4f7" xlink:href="amci-20230213.xsd#amci_OfferingCostsIncludedInAccountsPayableAccruedExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_f61fe553-f9e8-4cf4-8dd1-fbf15cec49dd" xlink:to="loc_amci_OfferingCostsIncludedInAccountsPayableAccruedExpenses_f03a56a6-85cd-4502-b155-03a6db2ff4f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingFeePayable_887bb67f-b7c7-4fe6-b530-69d19afa73bc" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingFeePayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_f61fe553-f9e8-4cf4-8dd1-fbf15cec49dd" xlink:to="loc_amci_DeferredUnderwritingFeePayable_887bb67f-b7c7-4fe6-b530-69d19afa73bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties_f0d3f398-928a-4d27-ab42-a94aff57feea" xlink:href="amci-20230213.xsd#amci_NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_f61fe553-f9e8-4cf4-8dd1-fbf15cec49dd" xlink:to="loc_amci_NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties_f0d3f398-928a-4d27-ab42-a94aff57feea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NoncashRepaymentOfNotePayableAndAdvances_c6de6fe9-5203-4cae-b8f1-dba34e0275b6" xlink:href="amci-20230213.xsd#amci_NoncashRepaymentOfNotePayableAndAdvances"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_f61fe553-f9e8-4cf4-8dd1-fbf15cec49dd" xlink:to="loc_amci_NoncashRepaymentOfNotePayableAndAdvances_c6de6fe9-5203-4cae-b8f1-dba34e0275b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NoncashDeferredUnderwritingCommissions_cc257c14-e9d4-4d41-bb91-a17e6e38b637" xlink:href="amci-20230213.xsd#amci_NoncashDeferredUnderwritingCommissions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_f61fe553-f9e8-4cf4-8dd1-fbf15cec49dd" xlink:to="loc_amci_NoncashDeferredUnderwritingCommissions_cc257c14-e9d4-4d41-bb91-a17e6e38b637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering_791d4b4b-19c3-4877-985e-48d57020ac6f" xlink:href="amci-20230213.xsd#amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_f61fe553-f9e8-4cf4-8dd1-fbf15cec49dd" xlink:to="loc_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering_791d4b4b-19c3-4877-985e-48d57020ac6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NoncashExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares_6d12f406-e028-4a88-8b31-91dcbe6e7d83" xlink:href="amci-20230213.xsd#amci_NoncashExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_f61fe553-f9e8-4cf4-8dd1-fbf15cec49dd" xlink:to="loc_amci_NoncashExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares_6d12f406-e028-4a88-8b31-91dcbe6e7d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/BALANCESHEET" xlink:type="simple" xlink:href="amci-20230213.xsd#BALANCESHEET"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/BALANCESHEET" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_edd22bbd-1061-42e1-9591-11c2b25c1601" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_47fa0cd7-e2f2-471d-af73-8eb77eb3d408" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_edd22bbd-1061-42e1-9591-11c2b25c1601" xlink:to="loc_us-gaap_StatementTable_47fa0cd7-e2f2-471d-af73-8eb77eb3d408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_e98d9c82-9c61-4a22-9d1a-58bbd6da7da4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_47fa0cd7-e2f2-471d-af73-8eb77eb3d408" xlink:to="loc_us-gaap_StatementClassOfStockAxis_e98d9c82-9c61-4a22-9d1a-58bbd6da7da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_2d3a94c8-f1a7-47c2-bbf3-62e023752546" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_e98d9c82-9c61-4a22-9d1a-58bbd6da7da4" xlink:to="loc_us-gaap_ClassOfStockDomain_2d3a94c8-f1a7-47c2-bbf3-62e023752546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_97435b99-266c-41f8-8523-9f0e255fe7e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_2d3a94c8-f1a7-47c2-bbf3-62e023752546" xlink:to="loc_us-gaap_CommonClassAMember_97435b99-266c-41f8-8523-9f0e255fe7e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CommonClassaSubjectToRedemptionMember_a41ce87c-7843-4956-911b-e18d348f5604" xlink:href="amci-20230213.xsd#amci_CommonClassaSubjectToRedemptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonClassAMember_97435b99-266c-41f8-8523-9f0e255fe7e9" xlink:to="loc_amci_CommonClassaSubjectToRedemptionMember_a41ce87c-7843-4956-911b-e18d348f5604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CommonClassaNotSubjectToRedemptionMember_9115df03-f9fd-46df-8838-0b1cd640347a" xlink:href="amci-20230213.xsd#amci_CommonClassaNotSubjectToRedemptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonClassAMember_97435b99-266c-41f8-8523-9f0e255fe7e9" xlink:to="loc_amci_CommonClassaNotSubjectToRedemptionMember_9115df03-f9fd-46df-8838-0b1cd640347a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_d3d1fd70-b3fa-42c1-b24d-70151df4fb97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_2d3a94c8-f1a7-47c2-bbf3-62e023752546" xlink:to="loc_us-gaap_CommonClassBMember_d3d1fd70-b3fa-42c1-b24d-70151df4fb97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_3e3e7865-2630-444f-a875-c3aace11d581" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_47fa0cd7-e2f2-471d-af73-8eb77eb3d408" xlink:to="loc_dei_LegalEntityAxis_3e3e7865-2630-444f-a875-c3aace11d581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_0217676b-8da3-42fa-83ba-2a4cdadd5567" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_3e3e7865-2630-444f-a875-c3aace11d581" xlink:to="loc_dei_EntityDomain_0217676b-8da3-42fa-83ba-2a4cdadd5567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AMCIACQUISITIONCORPIIMember_1660a6d3-b070-4a15-b8fd-52ed5c2b73a3" xlink:href="amci-20230213.xsd#amci_AMCIACQUISITIONCORPIIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_0217676b-8da3-42fa-83ba-2a4cdadd5567" xlink:to="loc_amci_AMCIACQUISITIONCORPIIMember_1660a6d3-b070-4a15-b8fd-52ed5c2b73a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a38a2f73-cbe4-4faf-8b73-ab5807185c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_47fa0cd7-e2f2-471d-af73-8eb77eb3d408" xlink:to="loc_us-gaap_StatementLineItems_a38a2f73-cbe4-4faf-8b73-ab5807185c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_c24d7a95-1df3-4259-9734-3751f0479bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a38a2f73-cbe4-4faf-8b73-ab5807185c9b" xlink:to="loc_us-gaap_AssetsAbstract_c24d7a95-1df3-4259-9734-3751f0479bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_cd4d09a6-fa30-41db-90db-631927249add" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c24d7a95-1df3-4259-9734-3751f0479bf1" xlink:to="loc_us-gaap_AssetsCurrentAbstract_cd4d09a6-fa30-41db-90db-631927249add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_09f3e502-785d-46ba-b4cd-da849b46e94f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cd4d09a6-fa30-41db-90db-631927249add" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_09f3e502-785d-46ba-b4cd-da849b46e94f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_fb35ff66-3854-4a81-906a-00b393f2176f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cd4d09a6-fa30-41db-90db-631927249add" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_fb35ff66-3854-4a81-906a-00b393f2176f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_e7ed2cc8-5eef-43f8-9822-8327f29aae34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cd4d09a6-fa30-41db-90db-631927249add" xlink:to="loc_us-gaap_AssetsCurrent_e7ed2cc8-5eef-43f8-9822-8327f29aae34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PrepaidExpensesLongTerm_07a5d250-139f-4873-8c8c-bb0ea4578cbf" xlink:href="amci-20230213.xsd#amci_PrepaidExpensesLongTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c24d7a95-1df3-4259-9734-3751f0479bf1" xlink:to="loc_amci_PrepaidExpensesLongTerm_07a5d250-139f-4873-8c8c-bb0ea4578cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrustNoncurrent_f60fae47-84fd-4f50-8044-cc8abf16afec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c24d7a95-1df3-4259-9734-3751f0479bf1" xlink:to="loc_us-gaap_AssetsHeldInTrustNoncurrent_f60fae47-84fd-4f50-8044-cc8abf16afec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_050e6dd9-e5f2-4e7f-a1a2-59c1968508b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c24d7a95-1df3-4259-9734-3751f0479bf1" xlink:to="loc_us-gaap_Assets_050e6dd9-e5f2-4e7f-a1a2-59c1968508b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40f86f7b-3942-4af2-a0d6-1192c2e5b760" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a38a2f73-cbe4-4faf-8b73-ab5807185c9b" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40f86f7b-3942-4af2-a0d6-1192c2e5b760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_75554c4b-cea1-4085-8abb-47906e58d187" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40f86f7b-3942-4af2-a0d6-1192c2e5b760" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_75554c4b-cea1-4085-8abb-47906e58d187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_2f69eb89-a111-4440-80f6-b9c392aaec48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_75554c4b-cea1-4085-8abb-47906e58d187" xlink:to="loc_us-gaap_AccountsPayableCurrent_2f69eb89-a111-4440-80f6-b9c392aaec48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_93d89a90-437e-4b4c-b8ce-b902d62e7895" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_75554c4b-cea1-4085-8abb-47906e58d187" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_93d89a90-437e-4b4c-b8ce-b902d62e7895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_a09b2ab3-a679-4522-9f25-36e25138b134" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_75554c4b-cea1-4085-8abb-47906e58d187" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrent_a09b2ab3-a679-4522-9f25-36e25138b134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent_9906c206-1e6b-435d-99aa-07ff31a2896a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_75554c4b-cea1-4085-8abb-47906e58d187" xlink:to="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent_9906c206-1e6b-435d-99aa-07ff31a2896a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_FranchiseTaxPayableCurrent_8c4677cf-74ec-41c3-84db-51a9006dc52d" xlink:href="amci-20230213.xsd#amci_FranchiseTaxPayableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_75554c4b-cea1-4085-8abb-47906e58d187" xlink:to="loc_amci_FranchiseTaxPayableCurrent_8c4677cf-74ec-41c3-84db-51a9006dc52d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_bc9e588b-86a4-4af5-bc0c-e716da1a302f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_75554c4b-cea1-4085-8abb-47906e58d187" xlink:to="loc_us-gaap_LiabilitiesCurrent_bc9e588b-86a4-4af5-bc0c-e716da1a302f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingCompensationNoncurrent_bcc46429-90f6-4f35-8b2e-89312eacbc65" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingCompensationNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40f86f7b-3942-4af2-a0d6-1192c2e5b760" xlink:to="loc_amci_DeferredUnderwritingCompensationNoncurrent_bcc46429-90f6-4f35-8b2e-89312eacbc65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_347abce6-23dc-4388-9945-a084c5452abb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40f86f7b-3942-4af2-a0d6-1192c2e5b760" xlink:to="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_347abce6-23dc-4388-9945-a084c5452abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_8cb5af0a-c1e6-4429-b8b4-d92ea97578df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40f86f7b-3942-4af2-a0d6-1192c2e5b760" xlink:to="loc_us-gaap_Liabilities_8cb5af0a-c1e6-4429-b8b4-d92ea97578df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_7f424c0b-d5a9-44f9-a417-4b0cb035c2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40f86f7b-3942-4af2-a0d6-1192c2e5b760" xlink:to="loc_us-gaap_CommitmentsAndContingencies_7f424c0b-d5a9-44f9-a417-4b0cb035c2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_7f980e4d-5943-4608-a543-bf6e134c5950" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40f86f7b-3942-4af2-a0d6-1192c2e5b760" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_7f980e4d-5943-4608-a543-bf6e134c5950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_b55135b8-83d8-41d9-b783-b58802c9117f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40f86f7b-3942-4af2-a0d6-1192c2e5b760" xlink:to="loc_us-gaap_StockholdersEquityAbstract_b55135b8-83d8-41d9-b783-b58802c9117f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_41403410-1801-408c-9f8b-e6fab38b7396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b55135b8-83d8-41d9-b783-b58802c9117f" xlink:to="loc_us-gaap_PreferredStockValue_41403410-1801-408c-9f8b-e6fab38b7396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_710ebb0e-a481-4760-bb0a-a3502428c582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b55135b8-83d8-41d9-b783-b58802c9117f" xlink:to="loc_us-gaap_CommonStockValue_710ebb0e-a481-4760-bb0a-a3502428c582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_4d181e7d-39b8-4b65-b70d-59e6a0cde1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b55135b8-83d8-41d9-b783-b58802c9117f" xlink:to="loc_us-gaap_AdditionalPaidInCapital_4d181e7d-39b8-4b65-b70d-59e6a0cde1d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d7119c47-2301-4779-8091-4afb56d1e6a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b55135b8-83d8-41d9-b783-b58802c9117f" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d7119c47-2301-4779-8091-4afb56d1e6a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4f5bfc36-f864-423b-a9a0-2a5feb1985a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b55135b8-83d8-41d9-b783-b58802c9117f" xlink:to="loc_us-gaap_StockholdersEquity_4f5bfc36-f864-423b-a9a0-2a5feb1985a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_fae08bb9-4c96-414f-8f28-27332aa81fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_40f86f7b-3942-4af2-a0d6-1192c2e5b760" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_fae08bb9-4c96-414f-8f28-27332aa81fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/BALANCESHEETParenthetical" xlink:type="simple" xlink:href="amci-20230213.xsd#BALANCESHEETParenthetical"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/BALANCESHEETParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_ff7bf236-d9fd-465e-b970-442bc52b4dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2c407f2c-faa3-4e3e-b280-17c0d15d4f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ff7bf236-d9fd-465e-b970-442bc52b4dcd" xlink:to="loc_us-gaap_StatementTable_2c407f2c-faa3-4e3e-b280-17c0d15d4f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_e9141058-0071-4c32-9b45-9d6ff8d8aa78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2c407f2c-faa3-4e3e-b280-17c0d15d4f4a" xlink:to="loc_us-gaap_StatementClassOfStockAxis_e9141058-0071-4c32-9b45-9d6ff8d8aa78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6a4ec719-92d5-4746-a746-fc383f990a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_e9141058-0071-4c32-9b45-9d6ff8d8aa78" xlink:to="loc_us-gaap_ClassOfStockDomain_6a4ec719-92d5-4746-a746-fc383f990a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_35bbd81d-6cee-48a3-9f7b-a60fe73bbdee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6a4ec719-92d5-4746-a746-fc383f990a4d" xlink:to="loc_us-gaap_CommonClassAMember_35bbd81d-6cee-48a3-9f7b-a60fe73bbdee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CommonClassaSubjectToRedemptionMember_03bc4c5d-08b6-4bb4-af25-15c3d17dee09" xlink:href="amci-20230213.xsd#amci_CommonClassaSubjectToRedemptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonClassAMember_35bbd81d-6cee-48a3-9f7b-a60fe73bbdee" xlink:to="loc_amci_CommonClassaSubjectToRedemptionMember_03bc4c5d-08b6-4bb4-af25-15c3d17dee09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CommonClassaNotSubjectToRedemptionMember_c2db6ce1-5482-4809-819d-c89cb75243c8" xlink:href="amci-20230213.xsd#amci_CommonClassaNotSubjectToRedemptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonClassAMember_35bbd81d-6cee-48a3-9f7b-a60fe73bbdee" xlink:to="loc_amci_CommonClassaNotSubjectToRedemptionMember_c2db6ce1-5482-4809-819d-c89cb75243c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_dec1b552-9d90-4a3b-9108-369766435435" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6a4ec719-92d5-4746-a746-fc383f990a4d" xlink:to="loc_us-gaap_CommonClassBMember_dec1b552-9d90-4a3b-9108-369766435435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_47f3a210-3509-4407-9997-6bc861818af3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2c407f2c-faa3-4e3e-b280-17c0d15d4f4a" xlink:to="loc_us-gaap_StatementLineItems_47f3a210-3509-4407-9997-6bc861818af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_54e1a3df-4d9b-4fcc-a51f-32d07af502d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_47f3a210-3509-4407-9997-6bc861818af3" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_54e1a3df-4d9b-4fcc-a51f-32d07af502d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_801805d2-bfe2-425b-80cd-9348177f9dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_47f3a210-3509-4407-9997-6bc861818af3" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_801805d2-bfe2-425b-80cd-9348177f9dd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_20fe033f-c155-4252-bea3-fe93eec7f66f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_47f3a210-3509-4407-9997-6bc861818af3" xlink:to="loc_us-gaap_PreferredStockSharesIssued_20fe033f-c155-4252-bea3-fe93eec7f66f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_dad2b630-7620-4f26-b1c2-10a4f8e434a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_47f3a210-3509-4407-9997-6bc861818af3" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_dad2b630-7620-4f26-b1c2-10a4f8e434a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_4f80e20f-5d97-4556-a955-c26d9a14db06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_47f3a210-3509-4407-9997-6bc861818af3" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_4f80e20f-5d97-4556-a955-c26d9a14db06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_e8318032-560f-4062-954f-8b814082fde8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_47f3a210-3509-4407-9997-6bc861818af3" xlink:to="loc_us-gaap_CommonStockSharesIssued_e8318032-560f-4062-954f-8b814082fde8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_440034d8-7659-4ba1-9d1f-464eb7284070" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_47f3a210-3509-4407-9997-6bc861818af3" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_440034d8-7659-4ba1-9d1f-464eb7284070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityRedemptionPricePerShare_28394c67-391e-4211-ae40-68915fa4822e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_47f3a210-3509-4407-9997-6bc861818af3" xlink:to="loc_us-gaap_TemporaryEquityRedemptionPricePerShare_28394c67-391e-4211-ae40-68915fa4822e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_8072dab2-656e-474a-a827-e987e64a56f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_47f3a210-3509-4407-9997-6bc861818af3" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_8072dab2-656e-474a-a827-e987e64a56f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_4bd66da9-7b29-4aba-a566-4ad57bd05bda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_47f3a210-3509-4407-9997-6bc861818af3" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_4bd66da9-7b29-4aba-a566-4ad57bd05bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_15de97d1-6edf-40f7-a0c5-d7e0d61d6250" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_47f3a210-3509-4407-9997-6bc861818af3" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_15de97d1-6edf-40f7-a0c5-d7e0d61d6250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_ba53cf0c-3743-4f7e-a34c-c2529daa039d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_47f3a210-3509-4407-9997-6bc861818af3" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_ba53cf0c-3743-4f7e-a34c-c2529daa039d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS" xlink:type="simple" xlink:href="amci-20230213.xsd#STATEMENTOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_16005142-f471-408e-a13c-cac308d5e163" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1c630c2f-baea-4361-93df-5796fa2c77a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_16005142-f471-408e-a13c-cac308d5e163" xlink:to="loc_us-gaap_StatementTable_1c630c2f-baea-4361-93df-5796fa2c77a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_cbac23f2-dd02-441c-932b-6adce17da3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1c630c2f-baea-4361-93df-5796fa2c77a2" xlink:to="loc_us-gaap_StatementClassOfStockAxis_cbac23f2-dd02-441c-932b-6adce17da3ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_5ea59af4-d74b-4260-812e-ad7f65a54af8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_cbac23f2-dd02-441c-932b-6adce17da3ce" xlink:to="loc_us-gaap_ClassOfStockDomain_5ea59af4-d74b-4260-812e-ad7f65a54af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_2982151c-a966-40eb-815b-dea7651b3bda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_5ea59af4-d74b-4260-812e-ad7f65a54af8" xlink:to="loc_us-gaap_CommonClassAMember_2982151c-a966-40eb-815b-dea7651b3bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_b3569d2c-de72-4c40-b2c7-c58443c4f5ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_5ea59af4-d74b-4260-812e-ad7f65a54af8" xlink:to="loc_us-gaap_CommonClassBMember_b3569d2c-de72-4c40-b2c7-c58443c4f5ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_921e4aa8-8be3-4f5d-b0e5-6ee1b2465605" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1c630c2f-baea-4361-93df-5796fa2c77a2" xlink:to="loc_dei_LegalEntityAxis_921e4aa8-8be3-4f5d-b0e5-6ee1b2465605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c49ca2a9-743e-4692-9526-e85707bcef8a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_921e4aa8-8be3-4f5d-b0e5-6ee1b2465605" xlink:to="loc_dei_EntityDomain_c49ca2a9-743e-4692-9526-e85707bcef8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AMCIACQUISITIONCORPIIMember_1e642f8c-89eb-455a-bda2-3b9e15c40c78" xlink:href="amci-20230213.xsd#amci_AMCIACQUISITIONCORPIIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_c49ca2a9-743e-4692-9526-e85707bcef8a" xlink:to="loc_amci_AMCIACQUISITIONCORPIIMember_1e642f8c-89eb-455a-bda2-3b9e15c40c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e3976cc7-362a-4b09-b88b-83946527bb87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1c630c2f-baea-4361-93df-5796fa2c77a2" xlink:to="loc_us-gaap_StatementLineItems_e3976cc7-362a-4b09-b88b-83946527bb87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_33c22b7e-52cf-4176-8f92-b90b540be56b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e3976cc7-362a-4b09-b88b-83946527bb87" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_33c22b7e-52cf-4176-8f92-b90b540be56b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_6f748948-594a-4d47-b23e-708019880317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e3976cc7-362a-4b09-b88b-83946527bb87" xlink:to="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_6f748948-594a-4d47-b23e-708019880317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CapitalBaseTaxExpense_756b3d87-5df7-4805-8ba9-6a459098940f" xlink:href="amci-20230213.xsd#amci_CapitalBaseTaxExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e3976cc7-362a-4b09-b88b-83946527bb87" xlink:to="loc_amci_CapitalBaseTaxExpense_756b3d87-5df7-4805-8ba9-6a459098940f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductionTaxExpense_b02c6244-650b-4d18-83a6-8ef7bc133d81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductionTaxExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e3976cc7-362a-4b09-b88b-83946527bb87" xlink:to="loc_us-gaap_ProductionTaxExpense_b02c6244-650b-4d18-83a6-8ef7bc133d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6f780719-9c88-4812-8a20-3b855caa98b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e3976cc7-362a-4b09-b88b-83946527bb87" xlink:to="loc_us-gaap_OperatingIncomeLoss_6f780719-9c88-4812-8a20-3b855caa98b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_eec3938f-7dd0-479c-a2aa-b15639d8b613" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e3976cc7-362a-4b09-b88b-83946527bb87" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_eec3938f-7dd0-479c-a2aa-b15639d8b613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_7270dbdc-720d-4da6-b745-720416b0892b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_eec3938f-7dd0-479c-a2aa-b15639d8b613" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_7270dbdc-720d-4da6-b745-720416b0892b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities_51d9cab4-440f-4164-b304-a0cfe4b144fd" xlink:href="amci-20230213.xsd#amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_eec3938f-7dd0-479c-a2aa-b15639d8b613" xlink:to="loc_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities_51d9cab4-440f-4164-b304-a0cfe4b144fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeFromInvestmentsHeldInTrustAccount_bfff92c3-8f27-44c5-8a93-d6b62f37a27f" xlink:href="amci-20230213.xsd#amci_IncomeFromInvestmentsHeldInTrustAccount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_eec3938f-7dd0-479c-a2aa-b15639d8b613" xlink:to="loc_amci_IncomeFromInvestmentsHeldInTrustAccount_bfff92c3-8f27-44c5-8a93-d6b62f37a27f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_42cd8f1c-32be-49ae-b229-377a881a4d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e3976cc7-362a-4b09-b88b-83946527bb87" xlink:to="loc_us-gaap_NetIncomeLoss_42cd8f1c-32be-49ae-b229-377a881a4d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a99ef95c-f053-44e9-94b6-d275e722c459" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e3976cc7-362a-4b09-b88b-83946527bb87" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a99ef95c-f053-44e9-94b6-d275e722c459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_256ce803-7aac-417d-b655-233c7e860115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e3976cc7-362a-4b09-b88b-83946527bb87" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_256ce803-7aac-417d-b655-233c7e860115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_0f826ef6-ab52-47ca-a0e1-89d1ba0ccfd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e3976cc7-362a-4b09-b88b-83946527bb87" xlink:to="loc_us-gaap_EarningsPerShareBasic_0f826ef6-ab52-47ca-a0e1-89d1ba0ccfd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_584c4ad3-6e92-4245-8a5c-031a4c0f424e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e3976cc7-362a-4b09-b88b-83946527bb87" xlink:to="loc_us-gaap_EarningsPerShareDiluted_584c4ad3-6e92-4245-8a5c-031a4c0f424e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT" xlink:type="simple" xlink:href="amci-20230213.xsd#STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_f01f433f-00e0-4ead-80ed-37c2079b19bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_18fa2598-9baa-4c81-bf0c-b51ba23046cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_f01f433f-00e0-4ead-80ed-37c2079b19bc" xlink:to="loc_us-gaap_StatementTable_18fa2598-9baa-4c81-bf0c-b51ba23046cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_bcf2216d-a9c1-4b93-87e9-901cfedc4ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_18fa2598-9baa-4c81-bf0c-b51ba23046cd" xlink:to="loc_us-gaap_StatementClassOfStockAxis_bcf2216d-a9c1-4b93-87e9-901cfedc4ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8a58a504-f33a-4ce5-8fc0-b37896bfbe09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_bcf2216d-a9c1-4b93-87e9-901cfedc4ba9" xlink:to="loc_us-gaap_ClassOfStockDomain_8a58a504-f33a-4ce5-8fc0-b37896bfbe09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_b15d6005-6234-4eea-b5ea-ff347935fc72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_8a58a504-f33a-4ce5-8fc0-b37896bfbe09" xlink:to="loc_us-gaap_CommonClassAMember_b15d6005-6234-4eea-b5ea-ff347935fc72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_4963cf04-a965-4cfe-bcf2-a2cead8f1c60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_8a58a504-f33a-4ce5-8fc0-b37896bfbe09" xlink:to="loc_us-gaap_CommonClassBMember_4963cf04-a965-4cfe-bcf2-a2cead8f1c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2581647f-f875-4621-97c1-df2750c5fe74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_18fa2598-9baa-4c81-bf0c-b51ba23046cd" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2581647f-f875-4621-97c1-df2750c5fe74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1f28a26b-63ab-4bd3-a515-0a952ada0ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2581647f-f875-4621-97c1-df2750c5fe74" xlink:to="loc_us-gaap_EquityComponentDomain_1f28a26b-63ab-4bd3-a515-0a952ada0ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_1b95749f-d356-49e4-b8df-e95af8d6d967" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1f28a26b-63ab-4bd3-a515-0a952ada0ae6" xlink:to="loc_us-gaap_CommonStockMember_1b95749f-d356-49e4-b8df-e95af8d6d967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_a0850f3c-d251-4ba4-8c5c-96118b42fd6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1f28a26b-63ab-4bd3-a515-0a952ada0ae6" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_a0850f3c-d251-4ba4-8c5c-96118b42fd6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_84dcd4af-605e-49a2-bb2c-f8a20b927e02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1f28a26b-63ab-4bd3-a515-0a952ada0ae6" xlink:to="loc_us-gaap_RetainedEarningsMember_84dcd4af-605e-49a2-bb2c-f8a20b927e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_0c1c3cf2-074e-4e70-8922-404a603c4594" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_18fa2598-9baa-4c81-bf0c-b51ba23046cd" xlink:to="loc_dei_LegalEntityAxis_0c1c3cf2-074e-4e70-8922-404a603c4594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ab6bd045-d833-4b39-b34e-8c41771b1158" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_0c1c3cf2-074e-4e70-8922-404a603c4594" xlink:to="loc_dei_EntityDomain_ab6bd045-d833-4b39-b34e-8c41771b1158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AMCIACQUISITIONCORPIIMember_3ee0ffae-da01-4714-9357-6244ab233788" xlink:href="amci-20230213.xsd#amci_AMCIACQUISITIONCORPIIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_ab6bd045-d833-4b39-b34e-8c41771b1158" xlink:to="loc_amci_AMCIACQUISITIONCORPIIMember_3ee0ffae-da01-4714-9357-6244ab233788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1ed4927e-a484-4189-8b83-c1b6d7bb0599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_18fa2598-9baa-4c81-bf0c-b51ba23046cd" xlink:to="loc_us-gaap_StatementLineItems_1ed4927e-a484-4189-8b83-c1b6d7bb0599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_dee19823-5d4d-4ec0-82df-0ffc67ea5e11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1ed4927e-a484-4189-8b83-c1b6d7bb0599" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_dee19823-5d4d-4ec0-82df-0ffc67ea5e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c6f422f6-bf12-4152-bd6a-98d56b67e372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_dee19823-5d4d-4ec0-82df-0ffc67ea5e11" xlink:to="loc_us-gaap_StockholdersEquity_c6f422f6-bf12-4152-bd6a-98d56b67e372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_85f75661-4c9e-4dc8-942e-fef90ea4993e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_dee19823-5d4d-4ec0-82df-0ffc67ea5e11" xlink:to="loc_us-gaap_SharesIssued_85f75661-4c9e-4dc8-942e-fef90ea4993e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_3646171a-c207-4f82-847a-7bf76690a773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_dee19823-5d4d-4ec0-82df-0ffc67ea5e11" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_3646171a-c207-4f82-847a-7bf76690a773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_f38989ab-16f8-4394-ac20-96527cfbaa1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_dee19823-5d4d-4ec0-82df-0ffc67ea5e11" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_f38989ab-16f8-4394-ac20-96527cfbaa1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_e10e133e-8068-4015-a5d8-256c7d23c380" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_dee19823-5d4d-4ec0-82df-0ffc67ea5e11" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_e10e133e-8068-4015-a5d8-256c7d23c380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_c77ceb5b-2827-444c-8188-dacbe6d45d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_dee19823-5d4d-4ec0-82df-0ffc67ea5e11" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_c77ceb5b-2827-444c-8188-dacbe6d45d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_93217f54-98b7-49b3-bf30-420a2e2ed82b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_dee19823-5d4d-4ec0-82df-0ffc67ea5e11" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_93217f54-98b7-49b3-bf30-420a2e2ed82b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors_50c2316a-5e96-4017-9bf7-394da44a0f64" xlink:href="amci-20230213.xsd#amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_dee19823-5d4d-4ec0-82df-0ffc67ea5e11" xlink:to="loc_amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors_50c2316a-5e96-4017-9bf7-394da44a0f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_dab0cbc9-049d-4683-8872-1029750a12af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_dee19823-5d4d-4ec0-82df-0ffc67ea5e11" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_dab0cbc9-049d-4683-8872-1029750a12af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5608002b-19d0-4d66-b978-1a40599315eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_dee19823-5d4d-4ec0-82df-0ffc67ea5e11" xlink:to="loc_us-gaap_NetIncomeLoss_5608002b-19d0-4d66-b978-1a40599315eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_fc40bc0a-a94c-4a1b-91ad-b39306cd24f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_dee19823-5d4d-4ec0-82df-0ffc67ea5e11" xlink:to="loc_us-gaap_StockholdersEquity_fc40bc0a-a94c-4a1b-91ad-b39306cd24f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_0da2c5f6-349e-43d6-8ca0-99eb0da76262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_dee19823-5d4d-4ec0-82df-0ffc67ea5e11" xlink:to="loc_us-gaap_SharesIssued_0da2c5f6-349e-43d6-8ca0-99eb0da76262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS" xlink:type="simple" xlink:href="amci-20230213.xsd#STATEMENTOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_9b344ad2-3562-410d-8ee0-39bcf2db8beb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_19c98fa6-588a-47bf-9111-767b5c68bf8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9b344ad2-3562-410d-8ee0-39bcf2db8beb" xlink:to="loc_us-gaap_StatementTable_19c98fa6-588a-47bf-9111-767b5c68bf8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_44f31e63-62bb-4b49-846d-42af608eb908" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_19c98fa6-588a-47bf-9111-767b5c68bf8f" xlink:to="loc_dei_LegalEntityAxis_44f31e63-62bb-4b49-846d-42af608eb908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_0c0afd72-c1fd-4a47-8c98-a99e18b38de5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_44f31e63-62bb-4b49-846d-42af608eb908" xlink:to="loc_dei_EntityDomain_0c0afd72-c1fd-4a47-8c98-a99e18b38de5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AMCIACQUISITIONCORPIIMember_ea2449b3-185e-4c40-b85e-fc4460fd2c98" xlink:href="amci-20230213.xsd#amci_AMCIACQUISITIONCORPIIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_0c0afd72-c1fd-4a47-8c98-a99e18b38de5" xlink:to="loc_amci_AMCIACQUISITIONCORPIIMember_ea2449b3-185e-4c40-b85e-fc4460fd2c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5e5515e0-0d25-47ed-a036-6e4ee7f4bac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_19c98fa6-588a-47bf-9111-767b5c68bf8f" xlink:to="loc_us-gaap_StatementLineItems_5e5515e0-0d25-47ed-a036-6e4ee7f4bac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8f1e97f8-21f5-47ed-b08f-a167403fcd6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5e5515e0-0d25-47ed-a036-6e4ee7f4bac3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8f1e97f8-21f5-47ed-b08f-a167403fcd6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_420d21b2-b335-4249-a10b-beae61fc0851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8f1e97f8-21f5-47ed-b08f-a167403fcd6b" xlink:to="loc_us-gaap_ProfitLoss_420d21b2-b335-4249-a10b-beae61fc0851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a666a007-9f60-4c09-a57f-662548fb317a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8f1e97f8-21f5-47ed-b08f-a167403fcd6b" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a666a007-9f60-4c09-a57f-662548fb317a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares_4b4dff33-fa50-45bf-8577-525e656ebedd" xlink:href="amci-20230213.xsd#amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a666a007-9f60-4c09-a57f-662548fb317a" xlink:to="loc_amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares_4b4dff33-fa50-45bf-8577-525e656ebedd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_d9c5a121-1837-4d4d-9340-242d23b8d78d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a666a007-9f60-4c09-a57f-662548fb317a" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_d9c5a121-1837-4d4d-9340-242d23b8d78d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities_619a65c0-aa30-4b97-8e8f-44410a385a40" xlink:href="amci-20230213.xsd#amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a666a007-9f60-4c09-a57f-662548fb317a" xlink:to="loc_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities_619a65c0-aa30-4b97-8e8f-44410a385a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeFromInvestmentsHeldInTrustAccount_011e02a0-3c2b-459e-804f-62ee51a4ee2a" xlink:href="amci-20230213.xsd#amci_IncomeFromInvestmentsHeldInTrustAccount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a666a007-9f60-4c09-a57f-662548fb317a" xlink:to="loc_amci_IncomeFromInvestmentsHeldInTrustAccount_011e02a0-3c2b-459e-804f-62ee51a4ee2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42628b7d-fc96-4d43-9e04-f7849854e0c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a666a007-9f60-4c09-a57f-662548fb317a" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42628b7d-fc96-4d43-9e04-f7849854e0c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_c636c678-540b-4016-9f93-c4cec60716c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42628b7d-fc96-4d43-9e04-f7849854e0c4" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_c636c678-540b-4016-9f93-c4cec60716c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_ea41768b-1eca-4e10-b5fe-893e18c2c9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42628b7d-fc96-4d43-9e04-f7849854e0c4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_ea41768b-1eca-4e10-b5fe-893e18c2c9d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DueToRelatedParty_326c954b-2be3-4998-8858-d010ed54a0f6" xlink:href="amci-20230213.xsd#amci_DueToRelatedParty"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42628b7d-fc96-4d43-9e04-f7849854e0c4" xlink:to="loc_amci_DueToRelatedParty_326c954b-2be3-4998-8858-d010ed54a0f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireTrustPreferredInvestments_0c24ac06-e556-436c-b4d5-326cadad1f10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireTrustPreferredInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42628b7d-fc96-4d43-9e04-f7849854e0c4" xlink:to="loc_us-gaap_PaymentsToAcquireTrustPreferredInvestments_0c24ac06-e556-436c-b4d5-326cadad1f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_72614b1c-055c-461c-bfb6-cf045f15f669" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42628b7d-fc96-4d43-9e04-f7849854e0c4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_72614b1c-055c-461c-bfb6-cf045f15f669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncreaseDecreaseInCapitalBaseTaxPayable_f9477f0f-c8bb-45ac-9c98-f856f01b6a90" xlink:href="amci-20230213.xsd#amci_IncreaseDecreaseInCapitalBaseTaxPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42628b7d-fc96-4d43-9e04-f7849854e0c4" xlink:to="loc_amci_IncreaseDecreaseInCapitalBaseTaxPayable_f9477f0f-c8bb-45ac-9c98-f856f01b6a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncreaseDecreaseFranchiseTaxPayable_1022e373-aaad-4bb4-98ba-24750e81bcbe" xlink:href="amci-20230213.xsd#amci_IncreaseDecreaseFranchiseTaxPayable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42628b7d-fc96-4d43-9e04-f7849854e0c4" xlink:to="loc_amci_IncreaseDecreaseFranchiseTaxPayable_1022e373-aaad-4bb4-98ba-24750e81bcbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dccf2755-e650-4753-a514-9e2d331de5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8f1e97f8-21f5-47ed-b08f-a167403fcd6b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dccf2755-e650-4753-a514-9e2d331de5f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_499de0e7-2af6-4ed6-b6b0-204d282be86c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5e5515e0-0d25-47ed-a036-6e4ee7f4bac3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_499de0e7-2af6-4ed6-b6b0-204d282be86c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PaymentsForInvestmentOfCashInTrustAccount_3bf501f2-ef15-4bab-bdcc-a2b7169389e7" xlink:href="amci-20230213.xsd#amci_PaymentsForInvestmentOfCashInTrustAccount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_499de0e7-2af6-4ed6-b6b0-204d282be86c" xlink:to="loc_amci_PaymentsForInvestmentOfCashInTrustAccount_3bf501f2-ef15-4bab-bdcc-a2b7169389e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9a477875-a4f1-4c44-b224-89e8504bde38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_499de0e7-2af6-4ed6-b6b0-204d282be86c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9a477875-a4f1-4c44-b224-89e8504bde38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_54ec4d1a-96ab-4fc7-8f0e-3f6c2f087540" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5e5515e0-0d25-47ed-a036-6e4ee7f4bac3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_54ec4d1a-96ab-4fc7-8f0e-3f6c2f087540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt_b51a441f-df78-4b9b-83a5-3a92c449b665" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_54ec4d1a-96ab-4fc7-8f0e-3f6c2f087540" xlink:to="loc_us-gaap_ProceedsFromRelatedPartyDebt_b51a441f-df78-4b9b-83a5-3a92c449b665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_6451110d-6bb8-4ed1-9abd-4c4bfbf1979d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_54ec4d1a-96ab-4fc7-8f0e-3f6c2f087540" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_6451110d-6bb8-4ed1-9abd-4c4bfbf1979d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_d7913063-572c-4061-b997-3daaf8ac7eca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_54ec4d1a-96ab-4fc7-8f0e-3f6c2f087540" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_d7913063-572c-4061-b997-3daaf8ac7eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6c7bedf0-0e40-4be3-8ab9-9d89e3c49596" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_54ec4d1a-96ab-4fc7-8f0e-3f6c2f087540" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6c7bedf0-0e40-4be3-8ab9-9d89e3c49596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7e018cbd-7ca0-47a8-8243-fa5b30eb4b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5e5515e0-0d25-47ed-a036-6e4ee7f4bac3" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7e018cbd-7ca0-47a8-8243-fa5b30eb4b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3500f740-dcab-44d5-84a4-37f387d4e192" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5e5515e0-0d25-47ed-a036-6e4ee7f4bac3" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3500f740-dcab-44d5-84a4-37f387d4e192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dd1f576e-96e1-435e-9dff-dab47c43122f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5e5515e0-0d25-47ed-a036-6e4ee7f4bac3" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dd1f576e-96e1-435e-9dff-dab47c43122f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_3dc9938f-face-41a2-8427-e0e6dba3d34e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5e5515e0-0d25-47ed-a036-6e4ee7f4bac3" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_3dc9938f-face-41a2-8427-e0e6dba3d34e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredOfferingCostsIncludedInNotesPayable_28285b70-c65a-4bab-8cb3-cb1d6e28ba13" xlink:href="amci-20230213.xsd#amci_DeferredOfferingCostsIncludedInNotesPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_3dc9938f-face-41a2-8427-e0e6dba3d34e" xlink:to="loc_amci_DeferredOfferingCostsIncludedInNotesPayable_28285b70-c65a-4bab-8cb3-cb1d6e28ba13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OfferingCostsIncludedInAccountsPayableAccruedExpenses_9cc53e46-6079-49b6-a1e6-55f87fb4568f" xlink:href="amci-20230213.xsd#amci_OfferingCostsIncludedInAccountsPayableAccruedExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_3dc9938f-face-41a2-8427-e0e6dba3d34e" xlink:to="loc_amci_OfferingCostsIncludedInAccountsPayableAccruedExpenses_9cc53e46-6079-49b6-a1e6-55f87fb4568f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingFeePayable_18b0e515-1c68-4b42-b1f1-0545e522aba1" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingFeePayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_3dc9938f-face-41a2-8427-e0e6dba3d34e" xlink:to="loc_amci_DeferredUnderwritingFeePayable_18b0e515-1c68-4b42-b1f1-0545e522aba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_StockIssuanceCostsNoncash_5f9dc2e0-aaf0-43aa-b34d-6ae36891ec17" xlink:href="amci-20230213.xsd#amci_StockIssuanceCostsNoncash"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_3dc9938f-face-41a2-8427-e0e6dba3d34e" xlink:to="loc_amci_StockIssuanceCostsNoncash_5f9dc2e0-aaf0-43aa-b34d-6ae36891ec17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties_253fb604-949a-48e3-a19d-7478c996922f" xlink:href="amci-20230213.xsd#amci_NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_3dc9938f-face-41a2-8427-e0e6dba3d34e" xlink:to="loc_amci_NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties_253fb604-949a-48e3-a19d-7478c996922f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NoncashRepaymentOfNotePayableAndAdvances_d7fb5b0e-852e-49c2-863f-4fdf87bc163c" xlink:href="amci-20230213.xsd#amci_NoncashRepaymentOfNotePayableAndAdvances"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_3dc9938f-face-41a2-8427-e0e6dba3d34e" xlink:to="loc_amci_NoncashRepaymentOfNotePayableAndAdvances_d7fb5b0e-852e-49c2-863f-4fdf87bc163c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NoncashDeferredUnderwritingCommissions_7f0618f8-a01d-4391-9f82-916172f3719e" xlink:href="amci-20230213.xsd#amci_NoncashDeferredUnderwritingCommissions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_3dc9938f-face-41a2-8427-e0e6dba3d34e" xlink:to="loc_amci_NoncashDeferredUnderwritingCommissions_7f0618f8-a01d-4391-9f82-916172f3719e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering_9ddbd602-d3e8-47fd-9da4-7b1e710538d8" xlink:href="amci-20230213.xsd#amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_3dc9938f-face-41a2-8427-e0e6dba3d34e" xlink:to="loc_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering_9ddbd602-d3e8-47fd-9da4-7b1e710538d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="simple" xlink:href="amci-20230213.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_eddc233e-dcfc-4e48-a631-c14eb3babf1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_cdd20bab-6ecf-48f8-abd5-10eb6453b777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_eddc233e-dcfc-4e48-a631-c14eb3babf1f" xlink:to="loc_us-gaap_AssetsAbstract_cdd20bab-6ecf-48f8-abd5-10eb6453b777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_0c8dfd0e-0635-4ec0-9960-7197adbaa3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cdd20bab-6ecf-48f8-abd5-10eb6453b777" xlink:to="loc_us-gaap_AssetsCurrentAbstract_0c8dfd0e-0635-4ec0-9960-7197adbaa3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d25a6915-4572-4c37-93de-ff48db801e66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0c8dfd0e-0635-4ec0-9960-7197adbaa3e0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d25a6915-4572-4c37-93de-ff48db801e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_de42cc07-b02b-4e12-95c7-45f4338014f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0c8dfd0e-0635-4ec0-9960-7197adbaa3e0" xlink:to="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_de42cc07-b02b-4e12-95c7-45f4338014f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_d27e1b97-b01f-442b-809b-92e1be5372f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0c8dfd0e-0635-4ec0-9960-7197adbaa3e0" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_d27e1b97-b01f-442b-809b-92e1be5372f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_eddf893c-cd1e-4cb8-85f3-7ccadd128864" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0c8dfd0e-0635-4ec0-9960-7197adbaa3e0" xlink:to="loc_us-gaap_OtherAssetsCurrent_eddf893c-cd1e-4cb8-85f3-7ccadd128864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_1d9b2698-475c-4f73-bfaf-be9c6869040d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0c8dfd0e-0635-4ec0-9960-7197adbaa3e0" xlink:to="loc_us-gaap_AssetsCurrent_1d9b2698-475c-4f73-bfaf-be9c6869040d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_81e08ec2-84e4-4934-ac1d-10951de31622" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cdd20bab-6ecf-48f8-abd5-10eb6453b777" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_81e08ec2-84e4-4934-ac1d-10951de31622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_6e176ca5-00ce-4fb7-8583-aea6e3ee423a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cdd20bab-6ecf-48f8-abd5-10eb6453b777" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_6e176ca5-00ce-4fb7-8583-aea6e3ee423a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_020601e8-656b-4cc7-a37e-b9a45339a699" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cdd20bab-6ecf-48f8-abd5-10eb6453b777" xlink:to="loc_us-gaap_EquityMethodInvestments_020601e8-656b-4cc7-a37e-b9a45339a699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_e8162315-894a-4982-9520-b9e636f59ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cdd20bab-6ecf-48f8-abd5-10eb6453b777" xlink:to="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_e8162315-894a-4982-9520-b9e636f59ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_8f996066-187c-45e4-8d29-6bc4840e3f55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cdd20bab-6ecf-48f8-abd5-10eb6453b777" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_8f996066-187c-45e4-8d29-6bc4840e3f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_3e78657e-ac4f-47ff-bc78-1dac0e6f8dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cdd20bab-6ecf-48f8-abd5-10eb6453b777" xlink:to="loc_us-gaap_Assets_3e78657e-ac4f-47ff-bc78-1dac0e6f8dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b2e1420c-a757-4435-8caa-fc3f18046d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_eddc233e-dcfc-4e48-a631-c14eb3babf1f" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b2e1420c-a757-4435-8caa-fc3f18046d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_cabf574d-f273-48b6-9a26-cd057090d9b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b2e1420c-a757-4435-8caa-fc3f18046d7a" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_cabf574d-f273-48b6-9a26-cd057090d9b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_01c0923b-2154-41fc-849c-288940a19f31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_cabf574d-f273-48b6-9a26-cd057090d9b3" xlink:to="loc_us-gaap_AccountsPayableCurrent_01c0923b-2154-41fc-849c-288940a19f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_173889ce-7aa4-4fc1-bf5e-8a3040895806" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_cabf574d-f273-48b6-9a26-cd057090d9b3" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_173889ce-7aa4-4fc1-bf5e-8a3040895806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SimpleAgreementForFutureEquityLiability_1e015b19-6004-47e5-9cf3-6f7375942a10" xlink:href="amci-20230213.xsd#amci_SimpleAgreementForFutureEquityLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_cabf574d-f273-48b6-9a26-cd057090d9b3" xlink:to="loc_amci_SimpleAgreementForFutureEquityLiability_1e015b19-6004-47e5-9cf3-6f7375942a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_87ab091f-5e77-40be-ae7a-3087d3ca7f24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_cabf574d-f273-48b6-9a26-cd057090d9b3" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_87ab091f-5e77-40be-ae7a-3087d3ca7f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_b9621503-ceed-4cd7-95b4-31ba33eacc30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_cabf574d-f273-48b6-9a26-cd057090d9b3" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_b9621503-ceed-4cd7-95b4-31ba33eacc30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_bdacc6c3-b60a-4f05-8fb0-376b26487f14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_cabf574d-f273-48b6-9a26-cd057090d9b3" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_bdacc6c3-b60a-4f05-8fb0-376b26487f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_95cfdaae-e281-4ca3-bf6d-6251d5dd786e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_cabf574d-f273-48b6-9a26-cd057090d9b3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_95cfdaae-e281-4ca3-bf6d-6251d5dd786e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b77fc82c-3f8c-4a3d-a31a-f35f8840d9ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_cabf574d-f273-48b6-9a26-cd057090d9b3" xlink:to="loc_us-gaap_LiabilitiesCurrent_b77fc82c-3f8c-4a3d-a31a-f35f8840d9ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e067910a-235f-4122-a5ee-160dfa0f2059" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b2e1420c-a757-4435-8caa-fc3f18046d7a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e067910a-235f-4122-a5ee-160dfa0f2059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_a7f4c23a-168f-4831-80c3-68daf9a72d03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b2e1420c-a757-4435-8caa-fc3f18046d7a" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_a7f4c23a-168f-4831-80c3-68daf9a72d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_c0d0d159-41fd-4a7d-9e1f-cc28f2f2c553" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b2e1420c-a757-4435-8caa-fc3f18046d7a" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_c0d0d159-41fd-4a7d-9e1f-cc28f2f2c553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_4886fe3a-370f-4b18-b068-0a32192182c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b2e1420c-a757-4435-8caa-fc3f18046d7a" xlink:to="loc_us-gaap_Liabilities_4886fe3a-370f-4b18-b068-0a32192182c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_d4f8ab9f-1f90-4d5a-8f0a-2cb9561fbc8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b2e1420c-a757-4435-8caa-fc3f18046d7a" xlink:to="loc_us-gaap_CommitmentsAndContingencies_d4f8ab9f-1f90-4d5a-8f0a-2cb9561fbc8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_a8e38017-f5d2-403c-b3dc-3f4ce3db6b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b2e1420c-a757-4435-8caa-fc3f18046d7a" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_a8e38017-f5d2-403c-b3dc-3f4ce3db6b8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_79dde508-730d-495c-8f19-5d289368d8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b2e1420c-a757-4435-8caa-fc3f18046d7a" xlink:to="loc_us-gaap_StockholdersEquityAbstract_79dde508-730d-495c-8f19-5d289368d8cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_fb91aacf-09bd-45c0-b61c-c851748780e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_79dde508-730d-495c-8f19-5d289368d8cb" xlink:to="loc_us-gaap_CommonStockValue_fb91aacf-09bd-45c0-b61c-c851748780e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_3baf7f2f-6cb6-4d74-95b2-91ac7c69953f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_79dde508-730d-495c-8f19-5d289368d8cb" xlink:to="loc_us-gaap_AdditionalPaidInCapital_3baf7f2f-6cb6-4d74-95b2-91ac7c69953f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_bbd3e398-1722-47d8-bf99-5a36194b68f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_79dde508-730d-495c-8f19-5d289368d8cb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_bbd3e398-1722-47d8-bf99-5a36194b68f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1b74f503-db2a-4364-b60c-85a604520f23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_79dde508-730d-495c-8f19-5d289368d8cb" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1b74f503-db2a-4364-b60c-85a604520f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_cdff4d0c-8171-4a45-8985-eeed86d471d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_79dde508-730d-495c-8f19-5d289368d8cb" xlink:to="loc_us-gaap_StockholdersEquity_cdff4d0c-8171-4a45-8985-eeed86d471d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_322163e4-4c90-4c29-a978-0819bd6cd6e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b2e1420c-a757-4435-8caa-fc3f18046d7a" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_322163e4-4c90-4c29-a978-0819bd6cd6e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" xlink:type="simple" xlink:href="amci-20230213.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_711413d1-5aa3-40fd-8ba9-0b78fbb0a635" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_5ee5b857-891e-4096-ab68-338bb23fa92f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_711413d1-5aa3-40fd-8ba9-0b78fbb0a635" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_5ee5b857-891e-4096-ab68-338bb23fa92f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_a03476cf-bf2a-4177-966d-a77c07e2535b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_711413d1-5aa3-40fd-8ba9-0b78fbb0a635" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_a03476cf-bf2a-4177-966d-a77c07e2535b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_92335cc5-8f26-4d6c-aab4-f74d429cc4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_711413d1-5aa3-40fd-8ba9-0b78fbb0a635" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_92335cc5-8f26-4d6c-aab4-f74d429cc4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_62d09789-4921-4906-8a0a-23886c6ad2cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_711413d1-5aa3-40fd-8ba9-0b78fbb0a635" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_62d09789-4921-4906-8a0a-23886c6ad2cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_35f223f6-6fc0-4e34-9d55-7ebb1e7ed970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_711413d1-5aa3-40fd-8ba9-0b78fbb0a635" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_35f223f6-6fc0-4e34-9d55-7ebb1e7ed970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_0676cced-3b5f-4cbb-b9a9-fd5e221682c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_711413d1-5aa3-40fd-8ba9-0b78fbb0a635" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_0676cced-3b5f-4cbb-b9a9-fd5e221682c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_16950700-680d-480e-91a9-0ca300279f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_711413d1-5aa3-40fd-8ba9-0b78fbb0a635" xlink:to="loc_us-gaap_CommonStockSharesIssued_16950700-680d-480e-91a9-0ca300279f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_3cb17e43-d566-44e5-84d4-541edcf2c467" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_711413d1-5aa3-40fd-8ba9-0b78fbb0a635" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_3cb17e43-d566-44e5-84d4-541edcf2c467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED" xlink:type="simple" xlink:href="amci-20230213.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_ff12a524-8430-42ec-8cc9-f5c760d64b18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7175a5a7-a2df-4cb1-b94d-d5e08fb68bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ff12a524-8430-42ec-8cc9-f5c760d64b18" xlink:to="loc_us-gaap_StatementTable_7175a5a7-a2df-4cb1-b94d-d5e08fb68bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedAndNonrelatedPartyStatusAxis_b2a7f35a-54c4-4f5c-af12-32e71ce07bb2" xlink:href="amci-20230213.xsd#amci_RelatedAndNonrelatedPartyStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7175a5a7-a2df-4cb1-b94d-d5e08fb68bd0" xlink:to="loc_amci_RelatedAndNonrelatedPartyStatusAxis_b2a7f35a-54c4-4f5c-af12-32e71ce07bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedAndNonrelatedPartyStatusDomain_dbbde72a-3353-41e9-ab3b-b1642f83bf1d" xlink:href="amci-20230213.xsd#amci_RelatedAndNonrelatedPartyStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_RelatedAndNonrelatedPartyStatusAxis_b2a7f35a-54c4-4f5c-af12-32e71ce07bb2" xlink:to="loc_amci_RelatedAndNonrelatedPartyStatusDomain_dbbde72a-3353-41e9-ab3b-b1642f83bf1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartyMember_b49cf4cf-a585-452b-bae4-69a920710267" xlink:href="amci-20230213.xsd#amci_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_RelatedAndNonrelatedPartyStatusDomain_dbbde72a-3353-41e9-ab3b-b1642f83bf1d" xlink:to="loc_amci_RelatedPartyMember_b49cf4cf-a585-452b-bae4-69a920710267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_df554e44-c75a-45fc-9d7e-f9d8cc102b01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7175a5a7-a2df-4cb1-b94d-d5e08fb68bd0" xlink:to="loc_us-gaap_TypeOfArrangementAxis_df554e44-c75a-45fc-9d7e-f9d8cc102b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_52977176-79d7-48a3-adbd-d402bc4e1560" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_df554e44-c75a-45fc-9d7e-f9d8cc102b01" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_52977176-79d7-48a3-adbd-d402bc4e1560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_032a4f7e-b27a-40b3-a42d-fea5b39a88bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_52977176-79d7-48a3-adbd-d402bc4e1560" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_032a4f7e-b27a-40b3-a42d-fea5b39a88bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7175a5a7-a2df-4cb1-b94d-d5e08fb68bd0" xlink:to="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_acf0ecf3-e665-47cc-a3e5-77c84aa4ff5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:to="loc_us-gaap_RevenuesAbstract_acf0ecf3-e665-47cc-a3e5-77c84aa4ff5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_2746b5b6-3efa-45ce-9c4c-96510eaa4a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_acf0ecf3-e665-47cc-a3e5-77c84aa4ff5e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_2746b5b6-3efa-45ce-9c4c-96510eaa4a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_d688eca5-92be-4ad1-a8ed-5041a23bfbda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_acf0ecf3-e665-47cc-a3e5-77c84aa4ff5e" xlink:to="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_d688eca5-92be-4ad1-a8ed-5041a23bfbda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_e924d784-86fb-4f15-ac16-e284c6470bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_acf0ecf3-e665-47cc-a3e5-77c84aa4ff5e" xlink:to="loc_us-gaap_RevenueFromRelatedParties_e924d784-86fb-4f15-ac16-e284c6470bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_8e6ad674-99e6-41a0-b5b5-ca7187794477" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_acf0ecf3-e665-47cc-a3e5-77c84aa4ff5e" xlink:to="loc_us-gaap_Revenues_8e6ad674-99e6-41a0-b5b5-ca7187794477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_9becdb41-626b-48fb-a39d-613a57d702b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_9becdb41-626b-48fb-a39d-613a57d702b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_9fac1064-7bfd-41d2-a89a-e311f498bc46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9becdb41-626b-48fb-a39d-613a57d702b7" xlink:to="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_9fac1064-7bfd-41d2-a89a-e311f498bc46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_15aef306-dc06-4d24-a3fb-447f9378efc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9becdb41-626b-48fb-a39d-613a57d702b7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_15aef306-dc06-4d24-a3fb-447f9378efc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_1a1fdfd5-70ab-4300-ae37-250abefc215a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9becdb41-626b-48fb-a39d-613a57d702b7" xlink:to="loc_us-gaap_Depreciation_1a1fdfd5-70ab-4300-ae37-250abefc215a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4cbf772b-33c2-4acf-a767-02c4733d6253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9becdb41-626b-48fb-a39d-613a57d702b7" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4cbf772b-33c2-4acf-a767-02c4733d6253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_975a260d-e0db-4ca7-91d5-12b89486ceae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9becdb41-626b-48fb-a39d-613a57d702b7" xlink:to="loc_us-gaap_CostsAndExpenses_975a260d-e0db-4ca7-91d5-12b89486ceae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b0b3e25f-1432-4625-943a-30c0e57c177a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:to="loc_us-gaap_OperatingIncomeLoss_b0b3e25f-1432-4625-943a-30c0e57c177a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e11bf529-f34c-4af9-b9c5-f38659a57cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e11bf529-f34c-4af9-b9c5-f38659a57cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_fc64eb3f-825e-4c07-9311-dc2fa7c826cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e11bf529-f34c-4af9-b9c5-f38659a57cfb" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_fc64eb3f-825e-4c07-9311-dc2fa7c826cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_11aaa23d-a208-4ced-860b-ad223f559f93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e11bf529-f34c-4af9-b9c5-f38659a57cfb" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_11aaa23d-a208-4ced-860b-ad223f559f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ce0d9bb0-6074-43e7-bc95-5b89c92edc7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e11bf529-f34c-4af9-b9c5-f38659a57cfb" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ce0d9bb0-6074-43e7-bc95-5b89c92edc7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_39213f71-3cb5-42ce-9595-24963c0672bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e11bf529-f34c-4af9-b9c5-f38659a57cfb" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_39213f71-3cb5-42ce-9595-24963c0672bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ed9b2fc7-5627-4120-8fa4-6918dd9a6b17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ed9b2fc7-5627-4120-8fa4-6918dd9a6b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_04288034-5382-434d-9c77-599693c8e56a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_04288034-5382-434d-9c77-599693c8e56a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment_b04c919a-7d94-40c5-9629-0ffb866323d7" xlink:href="amci-20230213.xsd#amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:to="loc_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment_b04c919a-7d94-40c5-9629-0ffb866323d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_71e251c6-60cc-46c2-8df5-cdd9f04d1731" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:to="loc_us-gaap_NetIncomeLoss_71e251c6-60cc-46c2-8df5-cdd9f04d1731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact_15269f91-a186-424c-a746-4efafd685917" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:to="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact_15269f91-a186-424c-a746-4efafd685917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_77841741-38fb-4086-91b6-cff3fe06a367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_77841741-38fb-4086-91b6-cff3fe06a367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_8170d51c-1589-4f45-bf4d-f1086e88da0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_8170d51c-1589-4f45-bf4d-f1086e88da0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_f667eabd-17de-47ae-9264-f59f235af05c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_8170d51c-1589-4f45-bf4d-f1086e88da0a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_f667eabd-17de-47ae-9264-f59f235af05c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_e4301a84-eb34-4066-8126-cfcb4dc8b709" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_8170d51c-1589-4f45-bf4d-f1086e88da0a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_e4301a84-eb34-4066-8126-cfcb4dc8b709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_533a1bfe-a28b-4d16-8138-8943ce36658e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:to="loc_us-gaap_EarningsPerShareBasic_533a1bfe-a28b-4d16-8138-8943ce36658e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_52940994-ae9d-43ca-942a-d55e01b02db8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:to="loc_us-gaap_EarningsPerShareDiluted_52940994-ae9d-43ca-942a-d55e01b02db8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1b6fd420-197f-4236-a24f-4cd35d248f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1b6fd420-197f-4236-a24f-4cd35d248f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_830d6b65-57d6-48b5-8604-2bc779b400fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_270c9fdb-1d63-4fe5-a9a0-c6d7d7090fb8" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_830d6b65-57d6-48b5-8604-2bc779b400fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="simple" xlink:href="amci-20230213.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_21cad839-f0de-4a85-a526-36020f5559c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9d39820f-d35b-436b-bb5d-ac7cd7e5d691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_21cad839-f0de-4a85-a526-36020f5559c3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9d39820f-d35b-436b-bb5d-ac7cd7e5d691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_720e0e49-a4d7-409a-acf8-352e436feae9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9d39820f-d35b-436b-bb5d-ac7cd7e5d691" xlink:to="loc_us-gaap_NetIncomeLoss_720e0e49-a4d7-409a-acf8-352e436feae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b2be53b0-704f-4b17-9908-20df2b6535cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9d39820f-d35b-436b-bb5d-ac7cd7e5d691" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b2be53b0-704f-4b17-9908-20df2b6535cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_d9c351b4-d3d7-48e8-bb0c-d311d356faca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b2be53b0-704f-4b17-9908-20df2b6535cf" xlink:to="loc_us-gaap_ShareBasedCompensation_d9c351b4-d3d7-48e8-bb0c-d311d356faca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_FairValueAdjustmentOfWarrantsAndUnrealizedGainLossOnDerivatives_07f65d33-bf40-465b-a364-f3fdc1c799c7" xlink:href="amci-20230213.xsd#amci_FairValueAdjustmentOfWarrantsAndUnrealizedGainLossOnDerivatives"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b2be53b0-704f-4b17-9908-20df2b6535cf" xlink:to="loc_amci_FairValueAdjustmentOfWarrantsAndUnrealizedGainLossOnDerivatives_07f65d33-bf40-465b-a364-f3fdc1c799c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_54644eab-57cc-494e-a21a-1ec20a4363de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b2be53b0-704f-4b17-9908-20df2b6535cf" xlink:to="loc_us-gaap_Depreciation_54644eab-57cc-494e-a21a-1ec20a4363de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_5657ce11-859d-47b9-be9c-841c78d33068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b2be53b0-704f-4b17-9908-20df2b6535cf" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_5657ce11-859d-47b9-be9c-841c78d33068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NoncashRecognitionOfLicensingRevenue_d0497b50-0f21-4c92-9847-d4555c247fb5" xlink:href="amci-20230213.xsd#amci_NoncashRecognitionOfLicensingRevenue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b2be53b0-704f-4b17-9908-20df2b6535cf" xlink:to="loc_amci_NoncashRecognitionOfLicensingRevenue_d0497b50-0f21-4c92-9847-d4555c247fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_ae4c2008-4c96-4a81-a956-7e42d92dee8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b2be53b0-704f-4b17-9908-20df2b6535cf" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_ae4c2008-4c96-4a81-a956-7e42d92dee8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1778e086-379a-4f4f-9ffd-351e0650643d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b2be53b0-704f-4b17-9908-20df2b6535cf" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1778e086-379a-4f4f-9ffd-351e0650643d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_2bc7866d-9096-4460-8382-f3726df57314" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b2be53b0-704f-4b17-9908-20df2b6535cf" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_2bc7866d-9096-4460-8382-f3726df57314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0f185afc-13fd-4088-a128-9be221e60941" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b2be53b0-704f-4b17-9908-20df2b6535cf" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0f185afc-13fd-4088-a128-9be221e60941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b77858ec-575a-4af3-84a3-a98131810a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0f185afc-13fd-4088-a128-9be221e60941" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b77858ec-575a-4af3-84a3-a98131810a6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_91f2ba24-478d-4711-8f2a-cf30f2050039" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0f185afc-13fd-4088-a128-9be221e60941" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_91f2ba24-478d-4711-8f2a-cf30f2050039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_b139a9e3-5871-4581-ac94-0722bd02f7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0f185afc-13fd-4088-a128-9be221e60941" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_b139a9e3-5871-4581-ac94-0722bd02f7ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_ac7e8efb-2cf2-4d70-8df8-4c438cd7f118" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0f185afc-13fd-4088-a128-9be221e60941" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_ac7e8efb-2cf2-4d70-8df8-4c438cd7f118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_967d6708-d662-470f-bc4f-1f95cd7b16cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0f185afc-13fd-4088-a128-9be221e60941" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_967d6708-d662-470f-bc4f-1f95cd7b16cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_877f5d6d-bea9-4efa-975e-71d3866d5b07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0f185afc-13fd-4088-a128-9be221e60941" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_877f5d6d-bea9-4efa-975e-71d3866d5b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_9fa03fff-ea95-4469-9f21-365fc933b0c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0f185afc-13fd-4088-a128-9be221e60941" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_9fa03fff-ea95-4469-9f21-365fc933b0c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_50e7ffce-cd3e-47cf-b636-e2b4d1413ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9d39820f-d35b-436b-bb5d-ac7cd7e5d691" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_50e7ffce-cd3e-47cf-b636-e2b4d1413ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b293fed0-7471-483f-a841-f1718ca6d38c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_21cad839-f0de-4a85-a526-36020f5559c3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b293fed0-7471-483f-a841-f1718ca6d38c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c9f4e604-f9ec-4916-8e1e-312dee3f7c86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b293fed0-7471-483f-a841-f1718ca6d38c" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c9f4e604-f9ec-4916-8e1e-312dee3f7c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_970ac6af-d2e6-4f2a-92e7-17d213e56ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b293fed0-7471-483f-a841-f1718ca6d38c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_970ac6af-d2e6-4f2a-92e7-17d213e56ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ac745c87-25b4-4ff9-90b7-596630babe15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_21cad839-f0de-4a85-a526-36020f5559c3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ac745c87-25b4-4ff9-90b7-596630babe15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises_6e3f6f6e-4d45-4363-9429-44d023ad10bf" xlink:href="amci-20230213.xsd#amci_ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ac745c87-25b4-4ff9-90b7-596630babe15" xlink:to="loc_amci_ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises_6e3f6f6e-4d45-4363-9429-44d023ad10bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_f1c9e803-b27d-4856-9726-0696bc86243c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ac745c87-25b4-4ff9-90b7-596630babe15" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_f1c9e803-b27d-4856-9726-0696bc86243c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfEquity_c9263d57-f17c-4159-9d14-23cbd96ea7b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ac745c87-25b4-4ff9-90b7-596630babe15" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfEquity_c9263d57-f17c-4159-9d14-23cbd96ea7b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_fcc6f700-e033-44f8-b6fb-764e1d24fc85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ac745c87-25b4-4ff9-90b7-596630babe15" xlink:to="loc_us-gaap_RepaymentsOfDebt_fcc6f700-e033-44f8-b6fb-764e1d24fc85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_16d32595-5d57-4610-a2ad-6bfaf33f157f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ac745c87-25b4-4ff9-90b7-596630babe15" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_16d32595-5d57-4610-a2ad-6bfaf33f157f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_544fca44-da04-414a-8c34-5fd35fb97feb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_21cad839-f0de-4a85-a526-36020f5559c3" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_544fca44-da04-414a-8c34-5fd35fb97feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4a579f24-b2be-4c5a-83c2-51f87121b34c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_21cad839-f0de-4a85-a526-36020f5559c3" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4a579f24-b2be-4c5a-83c2-51f87121b34c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_112d7027-ba05-4e51-b668-5a77c786589d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_21cad839-f0de-4a85-a526-36020f5559c3" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_112d7027-ba05-4e51-b668-5a77c786589d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0e9d56d4-2f3c-4030-86ab-de12216b327f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_21cad839-f0de-4a85-a526-36020f5559c3" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0e9d56d4-2f3c-4030-86ab-de12216b327f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_a59db290-d36d-4440-8b01-78b70ba8d466" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_21cad839-f0de-4a85-a526-36020f5559c3" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_a59db290-d36d-4440-8b01-78b70ba8d466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_54a88d61-2099-4fd6-bc1f-09458c13ef69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_a59db290-d36d-4440-8b01-78b70ba8d466" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_54a88d61-2099-4fd6-bc1f-09458c13ef69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1_275ea0b7-b353-4a9f-bc54-dde606e87581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_a59db290-d36d-4440-8b01-78b70ba8d466" xlink:to="loc_us-gaap_ConversionOfStockAmountConverted1_275ea0b7-b353-4a9f-bc54-dde606e87581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NoncashLoanForgiveness_0183cddc-ce2c-45f0-b96c-99061803b02d" xlink:href="amci-20230213.xsd#amci_NoncashLoanForgiveness"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_a59db290-d36d-4440-8b01-78b70ba8d466" xlink:to="loc_amci_NoncashLoanForgiveness_0183cddc-ce2c-45f0-b96c-99061803b02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED" xlink:type="simple" xlink:href="amci-20230213.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_c93069bf-22f1-45aa-9f1f-3a981c846bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a633fc37-7c0d-413a-9e14-b05825f2074f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_c93069bf-22f1-45aa-9f1f-3a981c846bfc" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a633fc37-7c0d-413a-9e14-b05825f2074f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_1819a58d-43ee-4a8f-8446-e0aa2839ae87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a633fc37-7c0d-413a-9e14-b05825f2074f" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_1819a58d-43ee-4a8f-8446-e0aa2839ae87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_3256d227-b3c9-42f7-8187-310463aabba2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a633fc37-7c0d-413a-9e14-b05825f2074f" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_3256d227-b3c9-42f7-8187-310463aabba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_1e06d545-4661-456b-bcdc-e34ca82d8ff0" xlink:href="amci-20230213.xsd#amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a633fc37-7c0d-413a-9e14-b05825f2074f" xlink:to="loc_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_1e06d545-4661-456b-bcdc-e34ca82d8ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_a21d1f89-f379-4a1b-8952-c4531b4e0bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a633fc37-7c0d-413a-9e14-b05825f2074f" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_a21d1f89-f379-4a1b-8952-c4531b4e0bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquitySharesConversionOfConvertibleSecurities_fc139565-482c-4d7b-9782-896a2afde777" xlink:href="amci-20230213.xsd#amci_TemporaryEquitySharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a633fc37-7c0d-413a-9e14-b05825f2074f" xlink:to="loc_amci_TemporaryEquitySharesConversionOfConvertibleSecurities_fc139565-482c-4d7b-9782-896a2afde777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityValueConversionOfConvertibleSecurities_4bd5cb5f-a7d4-46bd-9ece-bbb0a5c908ee" xlink:href="amci-20230213.xsd#amci_TemporaryEquityValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a633fc37-7c0d-413a-9e14-b05825f2074f" xlink:to="loc_amci_TemporaryEquityValueConversionOfConvertibleSecurities_4bd5cb5f-a7d4-46bd-9ece-bbb0a5c908ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_a0ffe2c3-a714-455d-a987-2df2b2004990" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a633fc37-7c0d-413a-9e14-b05825f2074f" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_a0ffe2c3-a714-455d-a987-2df2b2004990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_b34f6d39-ec2f-4a59-a1dc-0c041ec3a274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a633fc37-7c0d-413a-9e14-b05825f2074f" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_b34f6d39-ec2f-4a59-a1dc-0c041ec3a274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityStockIssuanceCost_e28a08d2-7c96-4172-b053-b391ccba1440" xlink:href="amci-20230213.xsd#amci_TemporaryEquityStockIssuanceCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_c93069bf-22f1-45aa-9f1f-3a981c846bfc" xlink:to="loc_amci_TemporaryEquityStockIssuanceCost_e28a08d2-7c96-4172-b053-b391ccba1440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_db9b9e34-a9ed-4598-b437-29948fde2fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_c93069bf-22f1-45aa-9f1f-3a981c846bfc" xlink:to="loc_us-gaap_StatementTable_db9b9e34-a9ed-4598-b437-29948fde2fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d1b8777c-797e-4dba-b76c-cfb16cb41d67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_db9b9e34-a9ed-4598-b437-29948fde2fc7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d1b8777c-797e-4dba-b76c-cfb16cb41d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2208b8f4-9074-49d5-9c0b-afe8f1c9001a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d1b8777c-797e-4dba-b76c-cfb16cb41d67" xlink:to="loc_us-gaap_EquityComponentDomain_2208b8f4-9074-49d5-9c0b-afe8f1c9001a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7b47bfd7-8307-48e9-ac3e-ef607e94a565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2208b8f4-9074-49d5-9c0b-afe8f1c9001a" xlink:to="loc_us-gaap_CommonStockMember_7b47bfd7-8307-48e9-ac3e-ef607e94a565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_cab8327d-5067-4554-be49-4bf1e47cf82d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2208b8f4-9074-49d5-9c0b-afe8f1c9001a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_cab8327d-5067-4554-be49-4bf1e47cf82d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_20b610a5-26c4-4b80-bb50-0a4cdbf64ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2208b8f4-9074-49d5-9c0b-afe8f1c9001a" xlink:to="loc_us-gaap_RetainedEarningsMember_20b610a5-26c4-4b80-bb50-0a4cdbf64ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a0d83642-eb1b-474b-8d83-29117fe0d802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2208b8f4-9074-49d5-9c0b-afe8f1c9001a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a0d83642-eb1b-474b-8d83-29117fe0d802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ef60ae80-222a-4e16-a623-42e65db71746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_db9b9e34-a9ed-4598-b437-29948fde2fc7" xlink:to="loc_us-gaap_StatementLineItems_ef60ae80-222a-4e16-a623-42e65db71746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3361fd3d-7387-49db-8067-2e650b1095a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ef60ae80-222a-4e16-a623-42e65db71746" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3361fd3d-7387-49db-8067-2e650b1095a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_22c8c46b-2115-4068-b005-b66967a8549a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3361fd3d-7387-49db-8067-2e650b1095a7" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_22c8c46b-2115-4068-b005-b66967a8549a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6a1d7bcf-c33f-45bf-8fbd-00ba51314820" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3361fd3d-7387-49db-8067-2e650b1095a7" xlink:to="loc_us-gaap_StockholdersEquity_6a1d7bcf-c33f-45bf-8fbd-00ba51314820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4687f0db-f147-423d-81d1-546df72b1978" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3361fd3d-7387-49db-8067-2e650b1095a7" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4687f0db-f147-423d-81d1-546df72b1978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments_a124aa8e-26f7-408e-8724-b5880aaafea6" xlink:href="amci-20230213.xsd#amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3361fd3d-7387-49db-8067-2e650b1095a7" xlink:to="loc_amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments_a124aa8e-26f7-408e-8724-b5880aaafea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b6811ab0-8d23-4798-b257-1f18faccd520" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3361fd3d-7387-49db-8067-2e650b1095a7" xlink:to="loc_us-gaap_NetIncomeLoss_b6811ab0-8d23-4798-b257-1f18faccd520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c8d7eec3-5c17-417b-8a5e-d4150df8b814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3361fd3d-7387-49db-8067-2e650b1095a7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c8d7eec3-5c17-417b-8a5e-d4150df8b814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_c49bf888-2f5e-4a17-b452-8134c4f90fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3361fd3d-7387-49db-8067-2e650b1095a7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_c49bf888-2f5e-4a17-b452-8134c4f90fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_746c9227-dac5-4324-ac25-cde70413b37e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3361fd3d-7387-49db-8067-2e650b1095a7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_746c9227-dac5-4324-ac25-cde70413b37e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2b52e5d5-3fb1-4181-b57d-0d9b7c247927" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3361fd3d-7387-49db-8067-2e650b1095a7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2b52e5d5-3fb1-4181-b57d-0d9b7c247927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_7a600743-66da-435d-a659-a133acc5a1b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3361fd3d-7387-49db-8067-2e650b1095a7" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_7a600743-66da-435d-a659-a133acc5a1b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_94bc1b6a-1786-4591-89ab-71ba5ec6eca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3361fd3d-7387-49db-8067-2e650b1095a7" xlink:to="loc_us-gaap_StockholdersEquity_94bc1b6a-1786-4591-89ab-71ba5ec6eca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="amci-20230213.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_58199111-eb16-4230-8f15-7f144e70d92b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_189e5603-d70e-4350-b143-e850399f6da9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_58199111-eb16-4230-8f15-7f144e70d92b" xlink:to="loc_us-gaap_AssetsAbstract_189e5603-d70e-4350-b143-e850399f6da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_6fe89e1e-ab85-40fd-a5a6-7b1e1a77b41a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_189e5603-d70e-4350-b143-e850399f6da9" xlink:to="loc_us-gaap_AssetsCurrentAbstract_6fe89e1e-ab85-40fd-a5a6-7b1e1a77b41a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9a4ab1a7-e268-49ee-8526-1ca68b798a77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6fe89e1e-ab85-40fd-a5a6-7b1e1a77b41a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9a4ab1a7-e268-49ee-8526-1ca68b798a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_e22e3fdc-5cf2-48d9-b1b1-1f786e1fb1ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6fe89e1e-ab85-40fd-a5a6-7b1e1a77b41a" xlink:to="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_e22e3fdc-5cf2-48d9-b1b1-1f786e1fb1ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_c2a395a5-3e04-42ba-bea4-2391daab4734" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6fe89e1e-ab85-40fd-a5a6-7b1e1a77b41a" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_c2a395a5-3e04-42ba-bea4-2391daab4734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_49399bbe-7f09-4386-8eaa-a816f84428c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6fe89e1e-ab85-40fd-a5a6-7b1e1a77b41a" xlink:to="loc_us-gaap_OtherAssetsCurrent_49399bbe-7f09-4386-8eaa-a816f84428c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_2622898c-29b6-4fa7-be10-bd46aa586131" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6fe89e1e-ab85-40fd-a5a6-7b1e1a77b41a" xlink:to="loc_us-gaap_AssetsCurrent_2622898c-29b6-4fa7-be10-bd46aa586131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_83054632-91fd-4e81-bb42-2ca86afee430" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_189e5603-d70e-4350-b143-e850399f6da9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_83054632-91fd-4e81-bb42-2ca86afee430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_55685b5f-e3a2-4887-8984-44b78768f2a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_189e5603-d70e-4350-b143-e850399f6da9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_55685b5f-e3a2-4887-8984-44b78768f2a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_45177500-025e-4287-968a-a3c6fba1fa14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_189e5603-d70e-4350-b143-e850399f6da9" xlink:to="loc_us-gaap_EquityMethodInvestments_45177500-025e-4287-968a-a3c6fba1fa14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_eca5db20-c7ea-4aa5-8250-30d25e6e53ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_189e5603-d70e-4350-b143-e850399f6da9" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_eca5db20-c7ea-4aa5-8250-30d25e6e53ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e36a79a0-e7c2-4119-8491-3478245a2d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_189e5603-d70e-4350-b143-e850399f6da9" xlink:to="loc_us-gaap_Assets_e36a79a0-e7c2-4119-8491-3478245a2d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a073beb-d824-486c-a0fd-9daba1279d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_58199111-eb16-4230-8f15-7f144e70d92b" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a073beb-d824-486c-a0fd-9daba1279d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_40157d01-86e6-4328-b4c5-cf74908a1ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a073beb-d824-486c-a0fd-9daba1279d8f" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_40157d01-86e6-4328-b4c5-cf74908a1ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_76931323-a56c-481c-b1db-f3ec7cb4ff5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_40157d01-86e6-4328-b4c5-cf74908a1ae7" xlink:to="loc_us-gaap_AccountsPayableCurrent_76931323-a56c-481c-b1db-f3ec7cb4ff5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_c8441e8d-4a57-4e10-8489-0dbb57873e11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_40157d01-86e6-4328-b4c5-cf74908a1ae7" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_c8441e8d-4a57-4e10-8489-0dbb57873e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SimpleAgreementForFutureEquityLiability_136479fb-16de-4337-8003-e0d0105c2e6f" xlink:href="amci-20230213.xsd#amci_SimpleAgreementForFutureEquityLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_40157d01-86e6-4328-b4c5-cf74908a1ae7" xlink:to="loc_amci_SimpleAgreementForFutureEquityLiability_136479fb-16de-4337-8003-e0d0105c2e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_e7d2fa7e-5f1e-4d60-a383-ac713ddf694a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_40157d01-86e6-4328-b4c5-cf74908a1ae7" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_e7d2fa7e-5f1e-4d60-a383-ac713ddf694a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_553fa047-3c7c-4b08-a655-7fe62b93246e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_40157d01-86e6-4328-b4c5-cf74908a1ae7" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_553fa047-3c7c-4b08-a655-7fe62b93246e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_a8d5dd8b-e779-45cf-a3c4-1138b4ffa6a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_40157d01-86e6-4328-b4c5-cf74908a1ae7" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_a8d5dd8b-e779-45cf-a3c4-1138b4ffa6a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_dca8ac78-6943-42fb-b905-154adf59055a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_40157d01-86e6-4328-b4c5-cf74908a1ae7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_dca8ac78-6943-42fb-b905-154adf59055a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_039b3a67-762b-4571-b389-7aacae356770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_40157d01-86e6-4328-b4c5-cf74908a1ae7" xlink:to="loc_us-gaap_LongTermDebtCurrent_039b3a67-762b-4571-b389-7aacae356770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_408a1cc7-acd7-408e-9292-92651d07401f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_40157d01-86e6-4328-b4c5-cf74908a1ae7" xlink:to="loc_us-gaap_LiabilitiesCurrent_408a1cc7-acd7-408e-9292-92651d07401f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_df31ce7c-843a-4032-8703-217e823da75f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a073beb-d824-486c-a0fd-9daba1279d8f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_df31ce7c-843a-4032-8703-217e823da75f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_d6c40851-d07f-4113-916a-9622b8e141f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a073beb-d824-486c-a0fd-9daba1279d8f" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_d6c40851-d07f-4113-916a-9622b8e141f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_66477271-38bd-4039-88aa-f5d1422cf9bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a073beb-d824-486c-a0fd-9daba1279d8f" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_66477271-38bd-4039-88aa-f5d1422cf9bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_a05d9265-c82e-400d-aa7a-9c1e267d62f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a073beb-d824-486c-a0fd-9daba1279d8f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_a05d9265-c82e-400d-aa7a-9c1e267d62f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_ab8bcc43-34dc-4b65-bc27-5cc6b91c7005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a073beb-d824-486c-a0fd-9daba1279d8f" xlink:to="loc_us-gaap_Liabilities_ab8bcc43-34dc-4b65-bc27-5cc6b91c7005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_0ca211f3-8a9e-4274-967c-43d88a28ea8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a073beb-d824-486c-a0fd-9daba1279d8f" xlink:to="loc_us-gaap_CommitmentsAndContingencies_0ca211f3-8a9e-4274-967c-43d88a28ea8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_9d9c200c-3e6d-4daa-a349-72bd9769057a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a073beb-d824-486c-a0fd-9daba1279d8f" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_9d9c200c-3e6d-4daa-a349-72bd9769057a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_bb785ba3-25ad-4c37-b3ed-1f00d9be251c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a073beb-d824-486c-a0fd-9daba1279d8f" xlink:to="loc_us-gaap_StockholdersEquityAbstract_bb785ba3-25ad-4c37-b3ed-1f00d9be251c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_56e0526b-2056-4068-a063-c70acac4acb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bb785ba3-25ad-4c37-b3ed-1f00d9be251c" xlink:to="loc_us-gaap_CommonStockValue_56e0526b-2056-4068-a063-c70acac4acb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_8092ac57-7a07-42b3-a7c5-7492dab92002" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bb785ba3-25ad-4c37-b3ed-1f00d9be251c" xlink:to="loc_us-gaap_AdditionalPaidInCapital_8092ac57-7a07-42b3-a7c5-7492dab92002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_48675c4b-9bae-45f0-947b-5bf40a2ea43d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bb785ba3-25ad-4c37-b3ed-1f00d9be251c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_48675c4b-9bae-45f0-947b-5bf40a2ea43d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f2737039-fd47-4eaa-84c0-b68dfc3a599a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bb785ba3-25ad-4c37-b3ed-1f00d9be251c" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f2737039-fd47-4eaa-84c0-b68dfc3a599a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5c4bc1f9-30bc-46cb-b026-80d4683cdd41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bb785ba3-25ad-4c37-b3ed-1f00d9be251c" xlink:to="loc_us-gaap_StockholdersEquity_5c4bc1f9-30bc-46cb-b026-80d4683cdd41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_5a3de140-9de3-4525-bcd9-f5280c81bb49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a073beb-d824-486c-a0fd-9daba1279d8f" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_5a3de140-9de3-4525-bcd9-f5280c81bb49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="amci-20230213.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_dc23d80c-b558-4e57-88cb-d1a882294f77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_d24ce72b-90c3-498e-9919-25aee65631c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dc23d80c-b558-4e57-88cb-d1a882294f77" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_d24ce72b-90c3-498e-9919-25aee65631c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_f02cd1b4-f039-46fa-8d5e-7ee671201d41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dc23d80c-b558-4e57-88cb-d1a882294f77" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_f02cd1b4-f039-46fa-8d5e-7ee671201d41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_eb951cd5-991e-4099-bd6b-4a0d43f238c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dc23d80c-b558-4e57-88cb-d1a882294f77" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_eb951cd5-991e-4099-bd6b-4a0d43f238c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_995e01b2-8c5b-4ef5-80b3-d461650fedee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dc23d80c-b558-4e57-88cb-d1a882294f77" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_995e01b2-8c5b-4ef5-80b3-d461650fedee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_b8c591b6-32e3-4845-a8e8-9c4c81483336" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dc23d80c-b558-4e57-88cb-d1a882294f77" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_b8c591b6-32e3-4845-a8e8-9c4c81483336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_945816ba-7a45-4240-b95a-f26eeb2c810c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dc23d80c-b558-4e57-88cb-d1a882294f77" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_945816ba-7a45-4240-b95a-f26eeb2c810c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_6c558e99-d5e5-4961-9d1c-8ab1ecebc375" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dc23d80c-b558-4e57-88cb-d1a882294f77" xlink:to="loc_us-gaap_CommonStockSharesIssued_6c558e99-d5e5-4961-9d1c-8ab1ecebc375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_60c33805-f712-4562-8644-9bf3de675a47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dc23d80c-b558-4e57-88cb-d1a882294f77" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_60c33805-f712-4562-8644-9bf3de675a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="amci-20230213.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_cc640eae-e1ec-4dde-a1f9-384a4e40492f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_13255535-0854-4a04-9039-80b46b9622fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cc640eae-e1ec-4dde-a1f9-384a4e40492f" xlink:to="loc_us-gaap_StatementTable_13255535-0854-4a04-9039-80b46b9622fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedAndNonrelatedPartyStatusAxis_a5cf4f4e-fa82-4c9c-aeac-99833cb36bfe" xlink:href="amci-20230213.xsd#amci_RelatedAndNonrelatedPartyStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_13255535-0854-4a04-9039-80b46b9622fa" xlink:to="loc_amci_RelatedAndNonrelatedPartyStatusAxis_a5cf4f4e-fa82-4c9c-aeac-99833cb36bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedAndNonrelatedPartyStatusDomain_65fea499-f6b1-4d3e-9958-88731bca141c" xlink:href="amci-20230213.xsd#amci_RelatedAndNonrelatedPartyStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_RelatedAndNonrelatedPartyStatusAxis_a5cf4f4e-fa82-4c9c-aeac-99833cb36bfe" xlink:to="loc_amci_RelatedAndNonrelatedPartyStatusDomain_65fea499-f6b1-4d3e-9958-88731bca141c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartyMember_f526c74d-97a5-44ce-b140-3e96054817b5" xlink:href="amci-20230213.xsd#amci_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_RelatedAndNonrelatedPartyStatusDomain_65fea499-f6b1-4d3e-9958-88731bca141c" xlink:to="loc_amci_RelatedPartyMember_f526c74d-97a5-44ce-b140-3e96054817b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_9893acbe-dba6-4147-a174-9e0b9a68da64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_13255535-0854-4a04-9039-80b46b9622fa" xlink:to="loc_us-gaap_TypeOfArrangementAxis_9893acbe-dba6-4147-a174-9e0b9a68da64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4bc9c99b-278d-4e15-8e85-10575cbed670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_9893acbe-dba6-4147-a174-9e0b9a68da64" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4bc9c99b-278d-4e15-8e85-10575cbed670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_7fec58cf-fecd-426b-888b-453edc06bee9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4bc9c99b-278d-4e15-8e85-10575cbed670" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_7fec58cf-fecd-426b-888b-453edc06bee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_13255535-0854-4a04-9039-80b46b9622fa" xlink:to="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_7b431d38-17fa-4e27-acf0-5825ddc89706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:to="loc_us-gaap_RevenuesAbstract_7b431d38-17fa-4e27-acf0-5825ddc89706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_3de8faaa-c93d-4e1c-a492-5b594f35d51f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_7b431d38-17fa-4e27-acf0-5825ddc89706" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_3de8faaa-c93d-4e1c-a492-5b594f35d51f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_27a713ea-f6e9-4c81-b45b-4169cabed164" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_7b431d38-17fa-4e27-acf0-5825ddc89706" xlink:to="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_27a713ea-f6e9-4c81-b45b-4169cabed164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_525cace1-fe48-4284-933f-6dbfad495311" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_7b431d38-17fa-4e27-acf0-5825ddc89706" xlink:to="loc_us-gaap_RevenueFromRelatedParties_525cace1-fe48-4284-933f-6dbfad495311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_37c63081-cd00-4923-b8c6-e1d69c0a6a53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_7b431d38-17fa-4e27-acf0-5825ddc89706" xlink:to="loc_us-gaap_Revenues_37c63081-cd00-4923-b8c6-e1d69c0a6a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_c459f12f-f6e4-4677-a8ee-015704b4972e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_c459f12f-f6e4-4677-a8ee-015704b4972e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_5d08ee59-976e-4fd9-a567-1b55878cc001" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_c459f12f-f6e4-4677-a8ee-015704b4972e" xlink:to="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_5d08ee59-976e-4fd9-a567-1b55878cc001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_c72bde8f-5c35-4508-a84e-ed7f8c379f63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_c459f12f-f6e4-4677-a8ee-015704b4972e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_c72bde8f-5c35-4508-a84e-ed7f8c379f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_8a251fe6-32ed-4da1-a8cc-d8bbbf172e43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_c459f12f-f6e4-4677-a8ee-015704b4972e" xlink:to="loc_us-gaap_Depreciation_8a251fe6-32ed-4da1-a8cc-d8bbbf172e43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_85180d5a-4b46-4113-bf38-aa52cf097208" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_c459f12f-f6e4-4677-a8ee-015704b4972e" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_85180d5a-4b46-4113-bf38-aa52cf097208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_b7fee8df-d2b4-4b6c-b893-b3564aca1496" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_c459f12f-f6e4-4677-a8ee-015704b4972e" xlink:to="loc_us-gaap_CostsAndExpenses_b7fee8df-d2b4-4b6c-b893-b3564aca1496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_2cbec3fc-c8ee-43d9-a53b-17ff80c13f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:to="loc_us-gaap_OperatingIncomeLoss_2cbec3fc-c8ee-43d9-a53b-17ff80c13f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_7a1df2af-1514-4a64-9852-bed97cc9ea73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_7a1df2af-1514-4a64-9852-bed97cc9ea73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_549e7485-cf54-43fe-a48a-02078ef53d03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_7a1df2af-1514-4a64-9852-bed97cc9ea73" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_549e7485-cf54-43fe-a48a-02078ef53d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f96908cf-1d3f-4eeb-b775-a1d417691017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_7a1df2af-1514-4a64-9852-bed97cc9ea73" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f96908cf-1d3f-4eeb-b775-a1d417691017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_1417ed12-2f4f-4a61-b65d-3ecf91fd1827" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_7a1df2af-1514-4a64-9852-bed97cc9ea73" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_1417ed12-2f4f-4a61-b65d-3ecf91fd1827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_b2546adb-f57d-49b6-a723-a3c0ed1fd2b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_7a1df2af-1514-4a64-9852-bed97cc9ea73" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_b2546adb-f57d-49b6-a723-a3c0ed1fd2b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_459a9384-774a-4647-8b1f-3352343c0a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_459a9384-774a-4647-8b1f-3352343c0a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_742ee07a-7155-4a1a-8a75-5166ff78623a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_742ee07a-7155-4a1a-8a75-5166ff78623a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment_d901682e-712f-47d3-a58f-5a32f5b0a08a" xlink:href="amci-20230213.xsd#amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:to="loc_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment_d901682e-712f-47d3-a58f-5a32f5b0a08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0d3d3358-dddb-43a4-822e-1399e613e6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:to="loc_us-gaap_NetIncomeLoss_0d3d3358-dddb-43a4-822e-1399e613e6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact_68d5ded3-e204-438d-a4ac-0a4f5c39bad9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:to="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact_68d5ded3-e204-438d-a4ac-0a4f5c39bad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_583427cb-9e8e-43ad-92cc-8e0c0d3cb583" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_583427cb-9e8e-43ad-92cc-8e0c0d3cb583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_33cd4e2f-f8a2-451c-9ce6-55487c0ef944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_33cd4e2f-f8a2-451c-9ce6-55487c0ef944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3907877a-8771-4614-84df-8d60af74c31f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_33cd4e2f-f8a2-451c-9ce6-55487c0ef944" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3907877a-8771-4614-84df-8d60af74c31f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_1cf28efc-96b3-4f6f-8023-e021fae2002c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_33cd4e2f-f8a2-451c-9ce6-55487c0ef944" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_1cf28efc-96b3-4f6f-8023-e021fae2002c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_eef5d0ab-228c-4d3f-b0bc-8f56d94b7637" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:to="loc_us-gaap_EarningsPerShareBasic_eef5d0ab-228c-4d3f-b0bc-8f56d94b7637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_d8cbd96e-2858-46e0-bba4-db54fd258680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:to="loc_us-gaap_EarningsPerShareDiluted_d8cbd96e-2858-46e0-bba4-db54fd258680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2f5872ff-a404-4c6d-bfe3-e0bf51f04473" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2f5872ff-a404-4c6d-bfe3-e0bf51f04473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_96bf93f5-a8ac-4a94-82f4-bebdeaee3865" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3b22461b-2f31-47f8-a99a-8928e07e5fdd" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_96bf93f5-a8ac-4a94-82f4-bebdeaee3865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="amci-20230213.xsd#CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_527e0c12-7806-4cf9-8107-40a7cb8612e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b9c0f3ed-3bfe-4f21-b281-2dfe44e80829" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_527e0c12-7806-4cf9-8107-40a7cb8612e3" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b9c0f3ed-3bfe-4f21-b281-2dfe44e80829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_841ae830-170f-484b-b1fa-e947b11cd840" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b9c0f3ed-3bfe-4f21-b281-2dfe44e80829" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_841ae830-170f-484b-b1fa-e947b11cd840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_2b7afe2e-2c94-40ed-a401-e6c97d97b1fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b9c0f3ed-3bfe-4f21-b281-2dfe44e80829" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_2b7afe2e-2c94-40ed-a401-e6c97d97b1fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_d4c37f27-162c-4666-9d01-58979a622804" xlink:href="amci-20230213.xsd#amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b9c0f3ed-3bfe-4f21-b281-2dfe44e80829" xlink:to="loc_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_d4c37f27-162c-4666-9d01-58979a622804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_5871c8aa-23c1-46db-aee9-9e1d28ab5483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b9c0f3ed-3bfe-4f21-b281-2dfe44e80829" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_5871c8aa-23c1-46db-aee9-9e1d28ab5483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquitySharesConversionOfConvertibleSecurities_e48fbfdd-b1f7-4670-b17c-1ce140047875" xlink:href="amci-20230213.xsd#amci_TemporaryEquitySharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b9c0f3ed-3bfe-4f21-b281-2dfe44e80829" xlink:to="loc_amci_TemporaryEquitySharesConversionOfConvertibleSecurities_e48fbfdd-b1f7-4670-b17c-1ce140047875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityExerciseOfWarrants_942d21fe-d315-418e-90f2-a2c35543bd8f" xlink:href="amci-20230213.xsd#amci_TemporaryEquityExerciseOfWarrants"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b9c0f3ed-3bfe-4f21-b281-2dfe44e80829" xlink:to="loc_amci_TemporaryEquityExerciseOfWarrants_942d21fe-d315-418e-90f2-a2c35543bd8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_dd5b06ad-05af-473b-8401-dbd58c120b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b9c0f3ed-3bfe-4f21-b281-2dfe44e80829" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_dd5b06ad-05af-473b-8401-dbd58c120b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_1210cc34-02f3-49c8-a153-6525dd8576eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b9c0f3ed-3bfe-4f21-b281-2dfe44e80829" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_1210cc34-02f3-49c8-a153-6525dd8576eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityStockIssuanceCost_1e564e8d-90d9-46b2-8652-53afdee6fcaf" xlink:href="amci-20230213.xsd#amci_TemporaryEquityStockIssuanceCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_527e0c12-7806-4cf9-8107-40a7cb8612e3" xlink:to="loc_amci_TemporaryEquityStockIssuanceCost_1e564e8d-90d9-46b2-8652-53afdee6fcaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_bc2de6f7-6a7e-42d2-a802-a26dab3bd22f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_527e0c12-7806-4cf9-8107-40a7cb8612e3" xlink:to="loc_us-gaap_StatementTable_bc2de6f7-6a7e-42d2-a802-a26dab3bd22f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e95bd905-7b41-4828-9099-c7d61eab6770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_bc2de6f7-6a7e-42d2-a802-a26dab3bd22f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e95bd905-7b41-4828-9099-c7d61eab6770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a6e2f0c6-05ec-4af4-896b-4ea325c8f8cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e95bd905-7b41-4828-9099-c7d61eab6770" xlink:to="loc_us-gaap_EquityComponentDomain_a6e2f0c6-05ec-4af4-896b-4ea325c8f8cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6f971af9-99ab-4956-8d6a-ee64284d8578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a6e2f0c6-05ec-4af4-896b-4ea325c8f8cd" xlink:to="loc_us-gaap_CommonStockMember_6f971af9-99ab-4956-8d6a-ee64284d8578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_2add8e70-38a9-47c1-b5f0-845725128d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a6e2f0c6-05ec-4af4-896b-4ea325c8f8cd" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_2add8e70-38a9-47c1-b5f0-845725128d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_46774186-6194-4f7b-8058-bcd686735eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a6e2f0c6-05ec-4af4-896b-4ea325c8f8cd" xlink:to="loc_us-gaap_RetainedEarningsMember_46774186-6194-4f7b-8058-bcd686735eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7997418e-9530-4ec8-a7ab-44f129fa0b22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a6e2f0c6-05ec-4af4-896b-4ea325c8f8cd" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7997418e-9530-4ec8-a7ab-44f129fa0b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ff156a9a-37a8-4719-b914-38e6c6888b40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_bc2de6f7-6a7e-42d2-a802-a26dab3bd22f" xlink:to="loc_us-gaap_StatementLineItems_ff156a9a-37a8-4719-b914-38e6c6888b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_be557772-094e-412d-9f3b-27652677c28c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ff156a9a-37a8-4719-b914-38e6c6888b40" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_be557772-094e-412d-9f3b-27652677c28c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_849df79d-1425-44e5-964f-dbfde9346aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_be557772-094e-412d-9f3b-27652677c28c" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_849df79d-1425-44e5-964f-dbfde9346aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3088ecfc-6974-44e4-88b1-829e398287c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_be557772-094e-412d-9f3b-27652677c28c" xlink:to="loc_us-gaap_StockholdersEquity_3088ecfc-6974-44e4-88b1-829e398287c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_ade8c1e2-1c04-481d-96cf-1fd209aae11d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_be557772-094e-412d-9f3b-27652677c28c" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_ade8c1e2-1c04-481d-96cf-1fd209aae11d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments_fab2cc9c-dd73-41e4-97db-f74aee708a98" xlink:href="amci-20230213.xsd#amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_be557772-094e-412d-9f3b-27652677c28c" xlink:to="loc_amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments_fab2cc9c-dd73-41e4-97db-f74aee708a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_914046e5-bdff-4708-b381-d19186c958be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_be557772-094e-412d-9f3b-27652677c28c" xlink:to="loc_us-gaap_NetIncomeLoss_914046e5-bdff-4708-b381-d19186c958be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_96568cf0-b2ba-4b0b-9535-d8f35e4e5711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_be557772-094e-412d-9f3b-27652677c28c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_96568cf0-b2ba-4b0b-9535-d8f35e4e5711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_fd8506dc-5780-43a1-8885-9bc5a6776598" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_be557772-094e-412d-9f3b-27652677c28c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_fd8506dc-5780-43a1-8885-9bc5a6776598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_fd26f13b-9b70-4771-b2b2-00c2334eb258" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_be557772-094e-412d-9f3b-27652677c28c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_fd26f13b-9b70-4771-b2b2-00c2334eb258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_fe74db8d-ec7b-493e-bc67-be397d388d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_be557772-094e-412d-9f3b-27652677c28c" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_fe74db8d-ec7b-493e-bc67-be397d388d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_04a0304b-5822-43a2-9108-b22b728bec26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_be557772-094e-412d-9f3b-27652677c28c" xlink:to="loc_us-gaap_StockholdersEquity_04a0304b-5822-43a2-9108-b22b728bec26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="amci-20230213.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_4fcecaa4-bddc-4680-a1ab-6f55f8697bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d9070f5a-82b0-4e36-93f6-0071681ab55c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4fcecaa4-bddc-4680-a1ab-6f55f8697bc0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d9070f5a-82b0-4e36-93f6-0071681ab55c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_88c84006-66f6-48da-8bea-451aeca456d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d9070f5a-82b0-4e36-93f6-0071681ab55c" xlink:to="loc_us-gaap_NetIncomeLoss_88c84006-66f6-48da-8bea-451aeca456d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1a1e6ff0-7d51-46b0-ada5-f8e0a61b6534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d9070f5a-82b0-4e36-93f6-0071681ab55c" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1a1e6ff0-7d51-46b0-ada5-f8e0a61b6534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_6cb0c459-71d3-4f20-a5aa-d1f87901c173" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1a1e6ff0-7d51-46b0-ada5-f8e0a61b6534" xlink:to="loc_us-gaap_ShareBasedCompensation_6cb0c459-71d3-4f20-a5aa-d1f87901c173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_f48f7c01-1bd9-43ad-9d47-d4aa594a381e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1a1e6ff0-7d51-46b0-ada5-f8e0a61b6534" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_f48f7c01-1bd9-43ad-9d47-d4aa594a381e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_5e45bb73-8e54-479a-ac7a-03f2ed74d63d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1a1e6ff0-7d51-46b0-ada5-f8e0a61b6534" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_5e45bb73-8e54-479a-ac7a-03f2ed74d63d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_bc942319-647e-4988-ac02-715f207c3570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1a1e6ff0-7d51-46b0-ada5-f8e0a61b6534" xlink:to="loc_us-gaap_Depreciation_bc942319-647e-4988-ac02-715f207c3570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_9f55fef6-0e58-462a-955a-1db8df10e569" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1a1e6ff0-7d51-46b0-ada5-f8e0a61b6534" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_9f55fef6-0e58-462a-955a-1db8df10e569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NoncashRecognitionOfLicensingRevenue_81a8077a-a821-4140-bb06-23aa02248508" xlink:href="amci-20230213.xsd#amci_NoncashRecognitionOfLicensingRevenue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1a1e6ff0-7d51-46b0-ada5-f8e0a61b6534" xlink:to="loc_amci_NoncashRecognitionOfLicensingRevenue_81a8077a-a821-4140-bb06-23aa02248508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_5fc3deee-85ec-472a-a3bd-2890facf4be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1a1e6ff0-7d51-46b0-ada5-f8e0a61b6534" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_5fc3deee-85ec-472a-a3bd-2890facf4be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment_472eb03c-8bf2-42f4-a8ad-11a47f5c6e24" xlink:href="amci-20230213.xsd#amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1a1e6ff0-7d51-46b0-ada5-f8e0a61b6534" xlink:to="loc_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment_472eb03c-8bf2-42f4-a8ad-11a47f5c6e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_1cfffc23-0ab1-4ebc-9ded-4334f2924fe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1a1e6ff0-7d51-46b0-ada5-f8e0a61b6534" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_1cfffc23-0ab1-4ebc-9ded-4334f2924fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bea8d717-29c1-4982-a59c-f85e672d5401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1a1e6ff0-7d51-46b0-ada5-f8e0a61b6534" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bea8d717-29c1-4982-a59c-f85e672d5401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_7af9b71c-c7c6-4051-aaf8-7ba40a92ef5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bea8d717-29c1-4982-a59c-f85e672d5401" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_7af9b71c-c7c6-4051-aaf8-7ba40a92ef5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_442c76eb-7711-4002-bd2e-7dd37e2dd4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bea8d717-29c1-4982-a59c-f85e672d5401" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_442c76eb-7711-4002-bd2e-7dd37e2dd4a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_79bdd7aa-7603-456b-8d7d-66a5e8031f93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bea8d717-29c1-4982-a59c-f85e672d5401" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_79bdd7aa-7603-456b-8d7d-66a5e8031f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_f30fa009-d426-4cda-9c07-a690b1544fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bea8d717-29c1-4982-a59c-f85e672d5401" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_f30fa009-d426-4cda-9c07-a690b1544fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_b24095b1-a3eb-4df4-8af6-7d3df2f96b86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bea8d717-29c1-4982-a59c-f85e672d5401" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_b24095b1-a3eb-4df4-8af6-7d3df2f96b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_56131c12-ee8a-4975-ab52-cc8d45e8d04a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bea8d717-29c1-4982-a59c-f85e672d5401" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_56131c12-ee8a-4975-ab52-cc8d45e8d04a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_9d1e20ea-1041-41ac-bc25-2ce5e837dec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bea8d717-29c1-4982-a59c-f85e672d5401" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_9d1e20ea-1041-41ac-bc25-2ce5e837dec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3d8584f3-f7dd-4d1e-a7c5-228fd87bb912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d9070f5a-82b0-4e36-93f6-0071681ab55c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3d8584f3-f7dd-4d1e-a7c5-228fd87bb912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fdd46727-d2d1-4054-84be-f07613016143" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4fcecaa4-bddc-4680-a1ab-6f55f8697bc0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fdd46727-d2d1-4054-84be-f07613016143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4e4f675e-54e0-4433-b404-6a9c3d93b542" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fdd46727-d2d1-4054-84be-f07613016143" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4e4f675e-54e0-4433-b404-6a9c3d93b542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_fbd8a308-b227-40d5-b7a9-d9ed4a43ef77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fdd46727-d2d1-4054-84be-f07613016143" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_fbd8a308-b227-40d5-b7a9-d9ed4a43ef77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfOtherRealEstate_4a855164-1d7b-4cb7-9ed6-b028b4141d20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfOtherRealEstate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fdd46727-d2d1-4054-84be-f07613016143" xlink:to="loc_us-gaap_ProceedsFromSaleOfOtherRealEstate_4a855164-1d7b-4cb7-9ed6-b028b4141d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_64798b3c-d980-472b-a9c1-d917dc70ce55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fdd46727-d2d1-4054-84be-f07613016143" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_64798b3c-d980-472b-a9c1-d917dc70ce55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8608055b-a11a-4cd6-9b91-9d1ae0af8ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4fcecaa4-bddc-4680-a1ab-6f55f8697bc0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8608055b-a11a-4cd6-9b91-9d1ae0af8ee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises_176acfe6-c2c7-4e69-9368-90e133a53072" xlink:href="amci-20230213.xsd#amci_ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8608055b-a11a-4cd6-9b91-9d1ae0af8ee0" xlink:to="loc_amci_ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises_176acfe6-c2c7-4e69-9368-90e133a53072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_c364f9d3-4dcf-43fd-a977-ba08ebe327f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8608055b-a11a-4cd6-9b91-9d1ae0af8ee0" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_c364f9d3-4dcf-43fd-a977-ba08ebe327f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_358476ce-75aa-45a8-9af5-3d26c9e4836b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8608055b-a11a-4cd6-9b91-9d1ae0af8ee0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_358476ce-75aa-45a8-9af5-3d26c9e4836b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_a3674e71-b86f-4588-ade2-90d2319a29c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8608055b-a11a-4cd6-9b91-9d1ae0af8ee0" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_a3674e71-b86f-4588-ade2-90d2319a29c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_24ca5f9f-c40a-4144-b56b-537d0c67c5ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8608055b-a11a-4cd6-9b91-9d1ae0af8ee0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_24ca5f9f-c40a-4144-b56b-537d0c67c5ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfEquity_00bd92c1-eb6f-471e-b891-e3c4f1dee788" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8608055b-a11a-4cd6-9b91-9d1ae0af8ee0" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfEquity_00bd92c1-eb6f-471e-b891-e3c4f1dee788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_9b65bd02-29d8-4fff-8bd3-88b3434ed45c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8608055b-a11a-4cd6-9b91-9d1ae0af8ee0" xlink:to="loc_us-gaap_RepaymentsOfDebt_9b65bd02-29d8-4fff-8bd3-88b3434ed45c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_770684a3-02fa-4a67-aa93-9e54c78fcdd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8608055b-a11a-4cd6-9b91-9d1ae0af8ee0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_770684a3-02fa-4a67-aa93-9e54c78fcdd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_94894edb-881a-4727-bf9c-85cefb28415e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4fcecaa4-bddc-4680-a1ab-6f55f8697bc0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_94894edb-881a-4727-bf9c-85cefb28415e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7f688cf6-9ec0-4096-9834-c73142c3be9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4fcecaa4-bddc-4680-a1ab-6f55f8697bc0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7f688cf6-9ec0-4096-9834-c73142c3be9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8fbc2be0-d9ff-444c-9d93-c84fcb277178" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4fcecaa4-bddc-4680-a1ab-6f55f8697bc0" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8fbc2be0-d9ff-444c-9d93-c84fcb277178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_03634472-6191-4559-934f-d39c30a32eea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4fcecaa4-bddc-4680-a1ab-6f55f8697bc0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_03634472-6191-4559-934f-d39c30a32eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_b84a5d2a-d859-4b96-88db-81298f5efb81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4fcecaa4-bddc-4680-a1ab-6f55f8697bc0" xlink:to="loc_us-gaap_SupplementalCashFlowElementsAbstract_b84a5d2a-d859-4b96-88db-81298f5efb81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_97ed0e60-5179-4e92-8fca-af3327f65db3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_b84a5d2a-d859-4b96-88db-81298f5efb81" xlink:to="loc_us-gaap_InterestPaidNet_97ed0e60-5179-4e92-8fca-af3327f65db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_545f4207-6f32-4de4-8ec2-0fbeddbc9b32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_b84a5d2a-d859-4b96-88db-81298f5efb81" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_545f4207-6f32-4de4-8ec2-0fbeddbc9b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract_93f2a32c-8afe-4cd1-bd18-13d12a9d3048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4fcecaa4-bddc-4680-a1ab-6f55f8697bc0" xlink:to="loc_us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract_93f2a32c-8afe-4cd1-bd18-13d12a9d3048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1_98bb2217-0654-4963-a402-365ba47fa9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract_93f2a32c-8afe-4cd1-bd18-13d12a9d3048" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1_98bb2217-0654-4963-a402-365ba47fa9e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_3879b781-6240-4908-9699-f427920dc58d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract_93f2a32c-8afe-4cd1-bd18-13d12a9d3048" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_3879b781-6240-4908-9699-f427920dc58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_83021d86-9423-4545-9ac5-9071afd87c11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4fcecaa4-bddc-4680-a1ab-6f55f8697bc0" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_83021d86-9423-4545-9ac5-9071afd87c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NoncashLoanForgiveness_5a7794a4-b718-414f-8b56-6329e04add49" xlink:href="amci-20230213.xsd#amci_NoncashLoanForgiveness"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_83021d86-9423-4545-9ac5-9071afd87c11" xlink:to="loc_amci_NoncashLoanForgiveness_5a7794a4-b718-414f-8b56-6329e04add49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1_3dc07845-0e98-460c-a0ec-be14462cfc1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_83021d86-9423-4545-9ac5-9071afd87c11" xlink:to="loc_us-gaap_ConversionOfStockAmountConverted1_3dc07845-0e98-460c-a0ec-be14462cfc1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperations" xlink:type="simple" xlink:href="amci-20230213.xsd#DescriptionofOrganizationandBusinessOperations"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1b347366-b3c8-4002-b3f5-2791cc036be5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_f41616fa-a276-4306-8c5b-50c5f369482c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1b347366-b3c8-4002-b3f5-2791cc036be5" xlink:to="loc_us-gaap_NatureOfOperations_f41616fa-a276-4306-8c5b-50c5f369482c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="amci-20230213.xsd#BasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3343ac00-68c8-4200-bca2-64caf79aab0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_2d254171-b660-4e54-88cc-a52657f12592" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3343ac00-68c8-4200-bca2-64caf79aab0f" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_2d254171-b660-4e54-88cc-a52657f12592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/InitialPublicOffering" xlink:type="simple" xlink:href="amci-20230213.xsd#InitialPublicOffering"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/InitialPublicOffering" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_amci_InitialPublicOfferingAbstract_d0e6d609-ff52-4e82-b3c3-968c2bbf2e5e" xlink:href="amci-20230213.xsd#amci_InitialPublicOfferingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_InitialPublicOfferingTextBlock_d4e32610-274c-4820-8916-6413596bd384" xlink:href="amci-20230213.xsd#amci_InitialPublicOfferingTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_InitialPublicOfferingAbstract_d0e6d609-ff52-4e82-b3c3-968c2bbf2e5e" xlink:to="loc_amci_InitialPublicOfferingTextBlock_d4e32610-274c-4820-8916-6413596bd384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="amci-20230213.xsd#RelatedPartyTransactions"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RelatedPartyTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_aa2f00b1-fc11-445c-bdf0-c2cb87d2154f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_2ed06ea6-5545-4e4c-903f-d411a46a7d92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_aa2f00b1-fc11-445c-bdf0-c2cb87d2154f" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_2ed06ea6-5545-4e4c-903f-d411a46a7d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="amci-20230213.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6d160e4c-1660-4c8c-b2e0-a44335c34f1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1350e7f6-b16b-462a-b75f-53320c2e2756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6d160e4c-1660-4c8c-b2e0-a44335c34f1f" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1350e7f6-b16b-462a-b75f-53320c2e2756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemption" xlink:type="simple" xlink:href="amci-20230213.xsd#ClassACommonStockSubjecttoPossibleRedemption"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemption" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_3e89bbd6-76b8-4d23-a123-610dc20274e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityDisclosureTextBlock_a352de65-be32-467f-acf6-9517d5ba67ca" xlink:href="amci-20230213.xsd#amci_TemporaryEquityDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_3e89bbd6-76b8-4d23-a123-610dc20274e1" xlink:to="loc_amci_TemporaryEquityDisclosureTextBlock_a352de65-be32-467f-acf6-9517d5ba67ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/StockholdersEquityDeficit" xlink:type="simple" xlink:href="amci-20230213.xsd#StockholdersEquityDeficit"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/StockholdersEquityDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_dcf47597-b0a1-4660-9d68-89f2d5fe36b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_abd27759-1975-4ffc-a8eb-7c577e5d90ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_dcf47597-b0a1-4660-9d68-89f2d5fe36b2" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_abd27759-1975-4ffc-a8eb-7c577e5d90ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/Warrants" xlink:type="simple" xlink:href="amci-20230213.xsd#Warrants"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/Warrants" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_8ff81d74-2288-4ae2-82ba-122175a33bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WarrantsTextBlockTextBlock_07a71541-8c95-41fe-b583-ab5c9def65c2" xlink:href="amci-20230213.xsd#amci_WarrantsTextBlockTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_8ff81d74-2288-4ae2-82ba-122175a33bf6" xlink:to="loc_amci_WarrantsTextBlockTextBlock_07a71541-8c95-41fe-b583-ab5c9def65c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueMeasurements" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f04a3c24-343d-4190-8a37-fc22710c8844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_f22b7bf4-9f52-44db-8ba3-cc45c43423cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f04a3c24-343d-4190-8a37-fc22710c8844" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_f22b7bf4-9f52-44db-8ba3-cc45c43423cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SubsequentEvents" xlink:type="simple" xlink:href="amci-20230213.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_65bf34fb-f2fe-482e-a46a-c0d1953ab3dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_6c789cff-0787-40a2-87d7-30da3142c920" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_65bf34fb-f2fe-482e-a46a-c0d1953ab3dd" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_6c789cff-0787-40a2-87d7-30da3142c920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperations_1" xlink:type="simple" xlink:href="amci-20230213.xsd#DescriptionofOrganizationandBusinessOperations_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperations_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c17e8c70-b67f-4036-a934-5e5d11e1d7dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_0b00b15c-7990-4956-8479-a4ed82d74eae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c17e8c70-b67f-4036-a934-5e5d11e1d7dc" xlink:to="loc_us-gaap_NatureOfOperations_0b00b15c-7990-4956-8479-a4ed82d74eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPolicies_1" xlink:type="simple" xlink:href="amci-20230213.xsd#BasisofPresentationandSummaryofSignificantAccountingPolicies_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPolicies_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_074fa876-27ad-4d0e-8a7b-6ca009c90e96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_20e086a6-612e-4ad9-8f45-2295298fdc84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_074fa876-27ad-4d0e-8a7b-6ca009c90e96" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_20e086a6-612e-4ad9-8f45-2295298fdc84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/InitialPublicOffering_1" xlink:type="simple" xlink:href="amci-20230213.xsd#InitialPublicOffering_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/InitialPublicOffering_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_amci_InitialPublicOfferingAbstract_fe8db4c4-adc3-450a-a83d-308742a12f80" xlink:href="amci-20230213.xsd#amci_InitialPublicOfferingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_InitialPublicOfferingTextBlock_b4613653-8f6a-4ce4-b498-97457808d54d" xlink:href="amci-20230213.xsd#amci_InitialPublicOfferingTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_InitialPublicOfferingAbstract_fe8db4c4-adc3-450a-a83d-308742a12f80" xlink:to="loc_amci_InitialPublicOfferingTextBlock_b4613653-8f6a-4ce4-b498-97457808d54d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RelatedPartyTransactions_1" xlink:type="simple" xlink:href="amci-20230213.xsd#RelatedPartyTransactions_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RelatedPartyTransactions_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_26cc273e-8485-4ba9-924f-f5893aef4ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_ef0b7227-02e9-4ece-a113-4672dafd6091" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_26cc273e-8485-4ba9-924f-f5893aef4ee1" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_ef0b7227-02e9-4ece-a113-4672dafd6091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CommitmentsandContingencies_1" xlink:type="simple" xlink:href="amci-20230213.xsd#CommitmentsandContingencies_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/CommitmentsandContingencies_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ba309d62-b8c0-473c-b206-d199216756f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_dcbfbaef-0b45-44c4-8393-b442748b498c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ba309d62-b8c0-473c-b206-d199216756f4" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_dcbfbaef-0b45-44c4-8393-b442748b498c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemption_1" xlink:type="simple" xlink:href="amci-20230213.xsd#ClassACommonStockSubjecttoPossibleRedemption_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemption_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_260811a9-7207-48e1-8229-ff360ef37330" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityDisclosureTextBlock_22f000a5-d0f1-42ec-b250-fd6eaa4ef570" xlink:href="amci-20230213.xsd#amci_TemporaryEquityDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_260811a9-7207-48e1-8229-ff360ef37330" xlink:to="loc_amci_TemporaryEquityDisclosureTextBlock_22f000a5-d0f1-42ec-b250-fd6eaa4ef570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/StockholdersDeficit" xlink:type="simple" xlink:href="amci-20230213.xsd#StockholdersDeficit"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/StockholdersDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_9b54342b-91cc-4580-a9a6-05f9cd7bc29c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_51a24dbf-dc41-448b-a931-1a8a2e06f82e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_9b54342b-91cc-4580-a9a6-05f9cd7bc29c" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_51a24dbf-dc41-448b-a931-1a8a2e06f82e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/Warrants_1" xlink:type="simple" xlink:href="amci-20230213.xsd#Warrants_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/Warrants_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_bf8b3c22-ae93-4a6d-807d-231d2b815f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WarrantsTextBlockTextBlock_a9c11a4a-f3ad-4f7b-bd69-a641b101678e" xlink:href="amci-20230213.xsd#amci_WarrantsTextBlockTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_bf8b3c22-ae93-4a6d-807d-231d2b815f3d" xlink:to="loc_amci_WarrantsTextBlockTextBlock_a9c11a4a-f3ad-4f7b-bd69-a641b101678e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueMeasurements_1" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueMeasurements_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/FairValueMeasurements_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_99230344-75b0-4e92-8de7-3e5b5f2d8e06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_33c001f8-ef63-4b41-b5bf-4af9aa256b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_99230344-75b0-4e92-8de7-3e5b5f2d8e06" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_33c001f8-ef63-4b41-b5bf-4af9aa256b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/IncomeTaxes" xlink:type="simple" xlink:href="amci-20230213.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_97e52780-6d1d-4c48-98ea-ab31ce9e102a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_0b1e12e0-9799-4257-b60a-9057042a5555" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_97e52780-6d1d-4c48-98ea-ab31ce9e102a" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_0b1e12e0-9799-4257-b60a-9057042a5555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SubsequentEvents_1" xlink:type="simple" xlink:href="amci-20230213.xsd#SubsequentEvents_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/SubsequentEvents_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_2bb83318-6ce0-48d5-b963-dd732ac85fc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_dbe55936-2299-4b32-9668-09d7b6bddb31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_2bb83318-6ce0-48d5-b963-dd732ac85fc0" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_dbe55936-2299-4b32-9668-09d7b6bddb31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/DescriptionoftheBusiness" xlink:type="simple" xlink:href="amci-20230213.xsd#DescriptionoftheBusiness"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/DescriptionoftheBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b6d00d55-2e5e-41bb-85b0-3c586a9ea3c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_59754885-8b03-4739-95b3-f7093c3539ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b6d00d55-2e5e-41bb-85b0-3c586a9ea3c5" xlink:to="loc_us-gaap_NatureOfOperations_59754885-8b03-4739-95b3-f7093c3539ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="amci-20230213.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c57cc10b-c136-4d7a-88da-84cd78440696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_e2a8fb2f-b2b1-4402-a7c3-ef4bcd9cb66a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c57cc10b-c136-4d7a-88da-84cd78440696" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_e2a8fb2f-b2b1-4402-a7c3-ef4bcd9cb66a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/NetLossPerShare" xlink:type="simple" xlink:href="amci-20230213.xsd#NetLossPerShare"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/NetLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_bae7d8bd-ca38-46b2-9575-4169da40de55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_fe55efc8-81a7-4018-b6e5-4a3e1bebbed5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_bae7d8bd-ca38-46b2-9575-4169da40de55" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_fe55efc8-81a7-4018-b6e5-4a3e1bebbed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/Revenues" xlink:type="simple" xlink:href="amci-20230213.xsd#Revenues"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/Revenues" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5e1430e4-c0a6-4822-b9a1-5fd739384de1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_843ade35-3f05-446f-9e07-daa804384a59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5e1430e4-c0a6-4822-b9a1-5fd739384de1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_843ade35-3f05-446f-9e07-daa804384a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/Investments" xlink:type="simple" xlink:href="amci-20230213.xsd#Investments"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/Investments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_6a6878ea-bb46-4100-8226-9e30c4fb6c64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTextBlock_63798b62-4b3d-4a8c-8a91-eedd64a3ab80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_6a6878ea-bb46-4100-8226-9e30c4fb6c64" xlink:to="loc_us-gaap_InvestmentTextBlock_63798b62-4b3d-4a8c-8a91-eedd64a3ab80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValue" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValue"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/FairValue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_fed1a418-6c61-4c84-8cd7-a464b8fa267d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_34590032-71ad-46f1-9d8d-da2c0c80bcaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_fed1a418-6c61-4c84-8cd7-a464b8fa267d" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_34590032-71ad-46f1-9d8d-da2c0c80bcaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/IncomeTaxes_1" xlink:type="simple" xlink:href="amci-20230213.xsd#IncomeTaxes_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/IncomeTaxes_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e101e1ed-dba9-499b-bfac-5707358d19be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_f82d7cba-934c-4676-8c4a-259d9a4a6576" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e101e1ed-dba9-499b-bfac-5707358d19be" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_f82d7cba-934c-4676-8c4a-259d9a4a6576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/ShareBasedCompensation" xlink:type="simple" xlink:href="amci-20230213.xsd#ShareBasedCompensation"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/ShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_52f04f56-0ad8-4887-bcdf-f4947f59faec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_dc381577-8d9b-4cdc-9426-6b12db3f1b47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_52f04f56-0ad8-4887-bcdf-f4947f59faec" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_dc381577-8d9b-4cdc-9426-6b12db3f1b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RelatedPartyTransactions_2" xlink:type="simple" xlink:href="amci-20230213.xsd#RelatedPartyTransactions_2"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RelatedPartyTransactions_2" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_0d00e2a9-0b50-4b09-9b63-d56085db67a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_ce295168-491e-42c6-87e4-48ccebd5a572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_0d00e2a9-0b50-4b09-9b63-d56085db67a6" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_ce295168-491e-42c6-87e4-48ccebd5a572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStock" xlink:type="simple" xlink:href="amci-20230213.xsd#RedeemableConvertiblePreferredStock"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_1af837e8-be9d-4ec5-8b50-5074b3bf8395" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityDisclosureTextBlock_dbcd02f5-a169-48e8-b241-cb3ae4de274a" xlink:href="amci-20230213.xsd#amci_TemporaryEquityDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_1af837e8-be9d-4ec5-8b50-5074b3bf8395" xlink:to="loc_amci_TemporaryEquityDisclosureTextBlock_dbcd02f5-a169-48e8-b241-cb3ae4de274a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CommitmentsandContingencies_2" xlink:type="simple" xlink:href="amci-20230213.xsd#CommitmentsandContingencies_2"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/CommitmentsandContingencies_2" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0c773330-1f82-43b1-81fd-b7525a247da5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_fa75e6d2-3191-42f9-90d1-ac500099aa03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0c773330-1f82-43b1-81fd-b7525a247da5" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_fa75e6d2-3191-42f9-90d1-ac500099aa03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/Leases" xlink:type="simple" xlink:href="amci-20230213.xsd#Leases"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_103e36d9-3ed8-4fd3-9cd7-a18469e8eee4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_6c5de832-4959-4147-b815-9ed4a9168d72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesOfLessorDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_103e36d9-3ed8-4fd3-9cd7-a18469e8eee4" xlink:to="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_6c5de832-4959-4147-b815-9ed4a9168d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SubsequentEvents_2" xlink:type="simple" xlink:href="amci-20230213.xsd#SubsequentEvents_2"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/SubsequentEvents_2" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_dfc80f90-3eb0-4baa-b45f-cd4f1659e116" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_b3f8c319-0d3e-4a26-82d8-7f95e9304c90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_dfc80f90-3eb0-4baa-b45f-cd4f1659e116" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_b3f8c319-0d3e-4a26-82d8-7f95e9304c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/DescriptionoftheBusiness_1" xlink:type="simple" xlink:href="amci-20230213.xsd#DescriptionoftheBusiness_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/DescriptionoftheBusiness_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_32d2ae4e-2bb6-477c-8558-0c0b2ec43f05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_4436587f-e58d-4b70-aa19-0b239d82ab02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_32d2ae4e-2bb6-477c-8558-0c0b2ec43f05" xlink:to="loc_us-gaap_NatureOfOperations_4436587f-e58d-4b70-aa19-0b239d82ab02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPolicies_1" xlink:type="simple" xlink:href="amci-20230213.xsd#SummaryofSignificantAccountingPolicies_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPolicies_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2dbe59a1-3f26-40ef-81eb-de0bb68411b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_b7e10153-039c-496f-a872-5f6bc927ec6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2dbe59a1-3f26-40ef-81eb-de0bb68411b1" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_b7e10153-039c-496f-a872-5f6bc927ec6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/NetLossPerShare_1" xlink:type="simple" xlink:href="amci-20230213.xsd#NetLossPerShare_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/NetLossPerShare_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_594faeff-0de3-4207-b20c-e0596ef09575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_20695e57-7ef8-44b1-8c03-bbe8c410be3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_594faeff-0de3-4207-b20c-e0596ef09575" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_20695e57-7ef8-44b1-8c03-bbe8c410be3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/Revenues_1" xlink:type="simple" xlink:href="amci-20230213.xsd#Revenues_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/Revenues_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_28f6aae5-698f-4022-bcb1-2429b34ce999" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_585b6ba6-5535-4fa5-bafe-c331da47c51b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_28f6aae5-698f-4022-bcb1-2429b34ce999" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_585b6ba6-5535-4fa5-bafe-c331da47c51b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/Investments_1" xlink:type="simple" xlink:href="amci-20230213.xsd#Investments_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/Investments_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_801a8d98-73eb-4364-af41-53ca66001e49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_fa362df7-0a1d-48cb-aac9-ed501eccc6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_801a8d98-73eb-4364-af41-53ca66001e49" xlink:to="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_fa362df7-0a1d-48cb-aac9-ed501eccc6d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValue_1" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValue_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/FairValue_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c0b1c9af-93d0-47b0-9ef0-44f897130401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_8930dda4-342b-43a3-aac3-1bbc041ffac8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c0b1c9af-93d0-47b0-9ef0-44f897130401" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_8930dda4-342b-43a3-aac3-1bbc041ffac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/OtherCurrentAssets" xlink:type="simple" xlink:href="amci-20230213.xsd#OtherCurrentAssets"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/OtherCurrentAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_9bff44ed-f702-4b44-9d5d-e4d402673b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsTextBlock_084ed1cc-ad6a-4858-aed5-a3e42aa242b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_9bff44ed-f702-4b44-9d5d-e4d402673b6b" xlink:to="loc_us-gaap_OtherCurrentAssetsTextBlock_084ed1cc-ad6a-4858-aed5-a3e42aa242b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/PropertyPlantandEquipment" xlink:type="simple" xlink:href="amci-20230213.xsd#PropertyPlantandEquipment"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/PropertyPlantandEquipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c8101ac0-6a88-417e-8e6b-e793b4c52645" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_f81f201d-3cdb-4eb0-aa83-575496709431" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c8101ac0-6a88-417e-8e6b-e793b4c52645" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_f81f201d-3cdb-4eb0-aa83-575496709431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/Debt" xlink:type="simple" xlink:href="amci-20230213.xsd#Debt"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_34a6ba19-4b38-40c8-ad4a-d605449f63fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_b0c31d9d-6f9e-4cae-a5e7-a57867ee903a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_34a6ba19-4b38-40c8-ad4a-d605449f63fa" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_b0c31d9d-6f9e-4cae-a5e7-a57867ee903a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SAFE" xlink:type="simple" xlink:href="amci-20230213.xsd#SAFE"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/SAFE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4bbbe600-600b-41a8-8cc5-3df440cdbe9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SimpleAgreementForFutureEquityLiabilityDisclosureTextBlock_9e901cff-4162-4b12-9dab-0df5a2dbc4ef" xlink:href="amci-20230213.xsd#amci_SimpleAgreementForFutureEquityLiabilityDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4bbbe600-600b-41a8-8cc5-3df440cdbe9e" xlink:to="loc_amci_SimpleAgreementForFutureEquityLiabilityDisclosureTextBlock_9e901cff-4162-4b12-9dab-0df5a2dbc4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/WarrantLiabilities" xlink:type="simple" xlink:href="amci-20230213.xsd#WarrantLiabilities"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/WarrantLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d000455d-4fa6-4bd0-a550-8905d34e1e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesAndFairValueTextBlock_f697ea95-2ce1-4117-93bf-92a6fe603429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesAndFairValueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d000455d-4fa6-4bd0-a550-8905d34e1e0f" xlink:to="loc_us-gaap_DerivativesAndFairValueTextBlock_f697ea95-2ce1-4117-93bf-92a6fe603429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/IncomeTaxes_2" xlink:type="simple" xlink:href="amci-20230213.xsd#IncomeTaxes_2"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/IncomeTaxes_2" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_53ed0ef5-9165-4134-8be1-a2a62f4730be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_a58c374b-ee1e-4369-838b-606ceed9257e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_53ed0ef5-9165-4134-8be1-a2a62f4730be" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_a58c374b-ee1e-4369-838b-606ceed9257e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/StockBasedCompensation" xlink:type="simple" xlink:href="amci-20230213.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bce87067-ee1e-45c9-9dbf-cd450b666ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_19a4f729-baee-42fb-b6d4-563433a67cee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bce87067-ee1e-45c9-9dbf-cd450b666ba0" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_19a4f729-baee-42fb-b6d4-563433a67cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RelatedPartyTransactions_3" xlink:type="simple" xlink:href="amci-20230213.xsd#RelatedPartyTransactions_3"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RelatedPartyTransactions_3" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_a1b4b3ab-de3d-4774-b0b2-4bff025f838f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_17e6caea-ad0b-4694-9fcb-79fa5613972c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_a1b4b3ab-de3d-4774-b0b2-4bff025f838f" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_17e6caea-ad0b-4694-9fcb-79fa5613972c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/ShareholdersEquity" xlink:type="simple" xlink:href="amci-20230213.xsd#ShareholdersEquity"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/ShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_088e45ee-d267-4166-aa00-d237866531e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_15287aa9-9fac-41aa-aa4f-a20bd201a996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_088e45ee-d267-4166-aa00-d237866531e1" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_15287aa9-9fac-41aa-aa4f-a20bd201a996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStock_1" xlink:type="simple" xlink:href="amci-20230213.xsd#RedeemableConvertiblePreferredStock_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStock_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_acc107fd-6b05-474e-aa0d-ebbf5f9e3fea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityDisclosureTextBlock_e801cd46-7563-4b86-94d8-3d843b93702c" xlink:href="amci-20230213.xsd#amci_TemporaryEquityDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_acc107fd-6b05-474e-aa0d-ebbf5f9e3fea" xlink:to="loc_amci_TemporaryEquityDisclosureTextBlock_e801cd46-7563-4b86-94d8-3d843b93702c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/BenefitPlans" xlink:type="simple" xlink:href="amci-20230213.xsd#BenefitPlans"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/BenefitPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_da35b435-8154-4223-aa45-d2b784fa2d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanTextBlock_65bdfcc3-f654-4f86-844e-45343ce77621" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_da35b435-8154-4223-aa45-d2b784fa2d0c" xlink:to="loc_us-gaap_DefinedBenefitPlanTextBlock_65bdfcc3-f654-4f86-844e-45343ce77621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CommitmentsandContingencies_3" xlink:type="simple" xlink:href="amci-20230213.xsd#CommitmentsandContingencies_3"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/CommitmentsandContingencies_3" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f6848f03-ff4d-4c24-aa54-f8da69a2e599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5964785a-ccea-491b-a0a4-152c01a0068e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f6848f03-ff4d-4c24-aa54-f8da69a2e599" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5964785a-ccea-491b-a0a4-152c01a0068e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/Leases_1" xlink:type="simple" xlink:href="amci-20230213.xsd#Leases_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/Leases_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_abc75ada-1e3b-4e37-943a-b1a400e5fb55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_59b3137a-80ab-4380-aeb4-4b40d88d892d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesOfLessorDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_abc75ada-1e3b-4e37-943a-b1a400e5fb55" xlink:to="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_59b3137a-80ab-4380-aeb4-4b40d88d892d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_8003acd9-f47b-4b56-b42b-9c594e8eac15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_abc75ada-1e3b-4e37-943a-b1a400e5fb55" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_8003acd9-f47b-4b56-b42b-9c594e8eac15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SubsequentEvents_3" xlink:type="simple" xlink:href="amci-20230213.xsd#SubsequentEvents_3"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/SubsequentEvents_3" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_56901a61-082a-4655-bf41-d92a9d647179" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_0361f329-db09-46c6-abb6-2de28b6b230c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_56901a61-082a-4655-bf41-d92a9d647179" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_0361f329-db09-46c6-abb6-2de28b6b230c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="amci-20230213.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b0d4c48e-7ae4-43d2-9ead-0508cb39ba5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_506bc3ad-7d06-4baa-89bd-cf3f592688bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b0d4c48e-7ae4-43d2-9ead-0508cb39ba5e" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_506bc3ad-7d06-4baa-89bd-cf3f592688bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_b8d8e688-23cd-4b31-99ec-2a20fb708278" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b0d4c48e-7ae4-43d2-9ead-0508cb39ba5e" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_b8d8e688-23cd-4b31-99ec-2a20fb708278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_3bd2188b-bd33-46f8-8aa9-e2dd5a60adf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b0d4c48e-7ae4-43d2-9ead-0508cb39ba5e" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_3bd2188b-bd33-46f8-8aa9-e2dd5a60adf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_3a82d012-6a0c-4afb-bb72-991c8dbfa0c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b0d4c48e-7ae4-43d2-9ead-0508cb39ba5e" xlink:to="loc_us-gaap_UseOfEstimates_3a82d012-6a0c-4afb-bb72-991c8dbfa0c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_InvestmentsHeldInTrustAccountPolicyTextBlock_9c970709-4625-4697-a624-87c104181d21" xlink:href="amci-20230213.xsd#amci_InvestmentsHeldInTrustAccountPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b0d4c48e-7ae4-43d2-9ead-0508cb39ba5e" xlink:to="loc_amci_InvestmentsHeldInTrustAccountPolicyTextBlock_9c970709-4625-4697-a624-87c104181d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_7216b056-dd5e-4eb3-957f-6eb799d39fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b0d4c48e-7ae4-43d2-9ead-0508cb39ba5e" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_7216b056-dd5e-4eb3-957f-6eb799d39fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_200e3743-8d91-4132-9332-e2d912dab9f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b0d4c48e-7ae4-43d2-9ead-0508cb39ba5e" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_200e3743-8d91-4132-9332-e2d912dab9f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock_16de472d-03f7-4d4c-80f2-7882b345a6d9" xlink:href="amci-20230213.xsd#amci_OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b0d4c48e-7ae4-43d2-9ead-0508cb39ba5e" xlink:to="loc_amci_OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock_16de472d-03f7-4d4c-80f2-7882b345a6d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_72baab9d-ea8e-4522-969f-d6afce2544a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b0d4c48e-7ae4-43d2-9ead-0508cb39ba5e" xlink:to="loc_us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_72baab9d-ea8e-4522-969f-d6afce2544a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_93aa6ae4-1327-4ac7-b0e5-0b4899ce327e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b0d4c48e-7ae4-43d2-9ead-0508cb39ba5e" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_93aa6ae4-1327-4ac7-b0e5-0b4899ce327e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_cf16329f-a199-4f6d-95d2-fdbd9adc53d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b0d4c48e-7ae4-43d2-9ead-0508cb39ba5e" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_cf16329f-a199-4f6d-95d2-fdbd9adc53d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_1100f7e6-8c80-4f62-98fb-073e1abec621" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b0d4c48e-7ae4-43d2-9ead-0508cb39ba5e" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_1100f7e6-8c80-4f62-98fb-073e1abec621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_21506eac-430d-4cca-af6d-ab6443e79207" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b0d4c48e-7ae4-43d2-9ead-0508cb39ba5e" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_21506eac-430d-4cca-af6d-ab6443e79207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies_1" xlink:type="simple" xlink:href="amci-20230213.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_db7c978c-542f-4358-b82c-210c5078e54b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0bcad4ad-61b2-4121-bf8a-a4122491a56a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_db7c978c-542f-4358-b82c-210c5078e54b" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0bcad4ad-61b2-4121-bf8a-a4122491a56a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_0288c092-1f01-4197-b7a1-29f9a2c46ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_db7c978c-542f-4358-b82c-210c5078e54b" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_0288c092-1f01-4197-b7a1-29f9a2c46ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_9c043ee4-85d6-4de4-aa43-6fbdc9d79bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_db7c978c-542f-4358-b82c-210c5078e54b" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_9c043ee4-85d6-4de4-aa43-6fbdc9d79bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_61f73e5e-5cec-424b-ab4b-f1521649cfce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_db7c978c-542f-4358-b82c-210c5078e54b" xlink:to="loc_us-gaap_UseOfEstimates_61f73e5e-5cec-424b-ab4b-f1521649cfce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_InvestmentsHeldInTrustAccountPolicyTextBlock_574906c1-fbdd-42d3-8029-c7322ca0db83" xlink:href="amci-20230213.xsd#amci_InvestmentsHeldInTrustAccountPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_db7c978c-542f-4358-b82c-210c5078e54b" xlink:to="loc_amci_InvestmentsHeldInTrustAccountPolicyTextBlock_574906c1-fbdd-42d3-8029-c7322ca0db83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_0b16e2ce-f2fb-40ab-a807-c8e887f58d44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_db7c978c-542f-4358-b82c-210c5078e54b" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_0b16e2ce-f2fb-40ab-a807-c8e887f58d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_81efeca0-baba-4df3-86cb-c3f95077be5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_db7c978c-542f-4358-b82c-210c5078e54b" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_81efeca0-baba-4df3-86cb-c3f95077be5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock_e6808519-fa33-4eb0-a983-9b5e44db004e" xlink:href="amci-20230213.xsd#amci_OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_db7c978c-542f-4358-b82c-210c5078e54b" xlink:to="loc_amci_OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock_e6808519-fa33-4eb0-a983-9b5e44db004e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_91c49455-9b13-4807-a8f2-a8922c2da82b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_db7c978c-542f-4358-b82c-210c5078e54b" xlink:to="loc_us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_91c49455-9b13-4807-a8f2-a8922c2da82b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_b6491457-0935-42ad-9ccc-ba6b4e5836b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_db7c978c-542f-4358-b82c-210c5078e54b" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_b6491457-0935-42ad-9ccc-ba6b4e5836b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_8b212d49-b93b-4f55-b644-25d6e1c99274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_db7c978c-542f-4358-b82c-210c5078e54b" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_8b212d49-b93b-4f55-b644-25d6e1c99274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_b0e6d7ed-0dfc-4f87-8298-b091f6adcc6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_db7c978c-542f-4358-b82c-210c5078e54b" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_b0e6d7ed-0dfc-4f87-8298-b091f6adcc6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f6f524bc-20d7-41af-b466-ed6310988253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_db7c978c-542f-4358-b82c-210c5078e54b" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f6f524bc-20d7-41af-b466-ed6310988253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="amci-20230213.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9ac2fb8e-3346-4554-893f-4bfd159bf0a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_3345d2cb-9583-4963-a9af-b358ecd712c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9ac2fb8e-3346-4554-893f-4bfd159bf0a1" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_3345d2cb-9583-4963-a9af-b358ecd712c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_GoingConcernPolicyTextBlock_41ad2b4f-38be-4a70-b60b-c2bb42857c30" xlink:href="amci-20230213.xsd#amci_GoingConcernPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9ac2fb8e-3346-4554-893f-4bfd159bf0a1" xlink:to="loc_amci_GoingConcernPolicyTextBlock_41ad2b4f-38be-4a70-b60b-c2bb42857c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_2542fb80-8d86-434f-8a74-672a6695e327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9ac2fb8e-3346-4554-893f-4bfd159bf0a1" xlink:to="loc_us-gaap_UseOfEstimates_2542fb80-8d86-434f-8a74-672a6695e327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_da54125d-e372-4729-bde7-5e49f9d6cdad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9ac2fb8e-3346-4554-893f-4bfd159bf0a1" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_da54125d-e372-4729-bde7-5e49f9d6cdad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_601d9172-887a-4036-92f8-9de962672fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9ac2fb8e-3346-4554-893f-4bfd159bf0a1" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_601d9172-887a-4036-92f8-9de962672fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_d283b933-8b3a-4572-83a6-ea05e126323e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9ac2fb8e-3346-4554-893f-4bfd159bf0a1" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_d283b933-8b3a-4572-83a6-ea05e126323e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_58224f4f-8110-4626-b81b-0d11dc21d68e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9ac2fb8e-3346-4554-893f-4bfd159bf0a1" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_58224f4f-8110-4626-b81b-0d11dc21d68e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy_51bc9f2b-47ac-451f-ad0b-b7e81bcc1b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9ac2fb8e-3346-4554-893f-4bfd159bf0a1" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy_51bc9f2b-47ac-451f-ad0b-b7e81bcc1b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_5a8f2aa2-db63-4dd1-8254-301a207c3241" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9ac2fb8e-3346-4554-893f-4bfd159bf0a1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_5a8f2aa2-db63-4dd1-8254-301a207c3241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_fee1ce74-d59b-4fdc-8440-88900015d1f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9ac2fb8e-3346-4554-893f-4bfd159bf0a1" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_fee1ce74-d59b-4fdc-8440-88900015d1f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_0711fb47-cc09-4d75-8446-3809e9450da3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9ac2fb8e-3346-4554-893f-4bfd159bf0a1" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_0711fb47-cc09-4d75-8446-3809e9450da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_e77a3c4a-5808-4cf9-98d7-e9c4c6c45670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9ac2fb8e-3346-4554-893f-4bfd159bf0a1" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_e77a3c4a-5808-4cf9-98d7-e9c4c6c45670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies_1" xlink:type="simple" xlink:href="amci-20230213.xsd#SummaryofSignificantAccountingPoliciesPolicies_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_bf2fa9fd-cac9-41e1-a00c-4173e7097982" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ae65618b-7d96-485c-becc-e9963f566ca2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf2fa9fd-cac9-41e1-a00c-4173e7097982" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ae65618b-7d96-485c-becc-e9963f566ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_a4d8f5f1-8110-423d-8de7-cb63bdce6e12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf2fa9fd-cac9-41e1-a00c-4173e7097982" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_a4d8f5f1-8110-423d-8de7-cb63bdce6e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CoronavirusPolicyTextBlock_4b2886ae-bded-4c0a-8e7b-d7f655bf98c3" xlink:href="amci-20230213.xsd#amci_CoronavirusPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf2fa9fd-cac9-41e1-a00c-4173e7097982" xlink:to="loc_amci_CoronavirusPolicyTextBlock_4b2886ae-bded-4c0a-8e7b-d7f655bf98c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_GoingConcernPolicyTextBlock_a608f775-00de-44cb-a5f0-83839420292a" xlink:href="amci-20230213.xsd#amci_GoingConcernPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf2fa9fd-cac9-41e1-a00c-4173e7097982" xlink:to="loc_amci_GoingConcernPolicyTextBlock_a608f775-00de-44cb-a5f0-83839420292a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_755fde3c-2065-489b-8fd8-e3542799a373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf2fa9fd-cac9-41e1-a00c-4173e7097982" xlink:to="loc_us-gaap_UseOfEstimates_755fde3c-2065-489b-8fd8-e3542799a373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_6f0b157f-8fee-4c04-90c3-e438d797c333" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf2fa9fd-cac9-41e1-a00c-4173e7097982" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_6f0b157f-8fee-4c04-90c3-e438d797c333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_50c905fb-ae81-4136-8318-8d6a4fdb4965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf2fa9fd-cac9-41e1-a00c-4173e7097982" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_50c905fb-ae81-4136-8318-8d6a4fdb4965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy_ce84a4b3-f2a1-4a1d-ac1c-627c2a054d85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf2fa9fd-cac9-41e1-a00c-4173e7097982" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy_ce84a4b3-f2a1-4a1d-ac1c-627c2a054d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OtherCurrentAssetsPolicyTextBlock_8a22eb6a-3388-4a05-a630-4ff15d311437" xlink:href="amci-20230213.xsd#amci_OtherCurrentAssetsPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf2fa9fd-cac9-41e1-a00c-4173e7097982" xlink:to="loc_amci_OtherCurrentAssetsPolicyTextBlock_8a22eb6a-3388-4a05-a630-4ff15d311437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_84a2a992-ad8b-4081-9075-31136cc10d59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf2fa9fd-cac9-41e1-a00c-4173e7097982" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_84a2a992-ad8b-4081-9075-31136cc10d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeasesPolicyTextBlock_3e4af79e-fba8-47cf-bca5-18b5895b6116" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorLeasesPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf2fa9fd-cac9-41e1-a00c-4173e7097982" xlink:to="loc_us-gaap_LessorLeasesPolicyTextBlock_3e4af79e-fba8-47cf-bca5-18b5895b6116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_f7b71e4a-278e-4beb-886e-c1f086c1cd85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf2fa9fd-cac9-41e1-a00c-4173e7097982" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_f7b71e4a-278e-4beb-886e-c1f086c1cd85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_2b8ef67e-ba71-432a-84f8-5b2f93ef2b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf2fa9fd-cac9-41e1-a00c-4173e7097982" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_2b8ef67e-ba71-432a-84f8-5b2f93ef2b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_0f989466-3e62-4fa3-9df5-d84c2a3cd30c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf2fa9fd-cac9-41e1-a00c-4173e7097982" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_0f989466-3e62-4fa3-9df5-d84c2a3cd30c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WarrantsPolicyPolicyTextBlock_8f6b4068-b6ca-4158-b95b-ba2b585e4287" xlink:href="amci-20230213.xsd#amci_WarrantsPolicyPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf2fa9fd-cac9-41e1-a00c-4173e7097982" xlink:to="loc_amci_WarrantsPolicyPolicyTextBlock_8f6b4068-b6ca-4158-b95b-ba2b585e4287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtPolicyTextBlock_fa4e515d-77ec-4262-8f53-b56495774d86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf2fa9fd-cac9-41e1-a00c-4173e7097982" xlink:to="loc_us-gaap_DebtPolicyTextBlock_fa4e515d-77ec-4262-8f53-b56495774d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_cdbe82a9-fb72-4e23-b1b3-389737022b33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf2fa9fd-cac9-41e1-a00c-4173e7097982" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_cdbe82a9-fb72-4e23-b1b3-389737022b33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_8267e25f-1737-4495-9637-f1ecaaa6d38c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf2fa9fd-cac9-41e1-a00c-4173e7097982" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_8267e25f-1737-4495-9637-f1ecaaa6d38c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_fc5b52ab-32ff-40fd-8202-16897ad5377b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf2fa9fd-cac9-41e1-a00c-4173e7097982" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_fc5b52ab-32ff-40fd-8202-16897ad5377b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_88ad1447-359a-4f14-9134-bd668f80e17b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf2fa9fd-cac9-41e1-a00c-4173e7097982" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_88ad1447-359a-4f14-9134-bd668f80e17b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartyTransactionsPolicyPolicyTextBlock_0020ead3-9001-4276-a41b-4659f9e78371" xlink:href="amci-20230213.xsd#amci_RelatedPartyTransactionsPolicyPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf2fa9fd-cac9-41e1-a00c-4173e7097982" xlink:to="loc_amci_RelatedPartyTransactionsPolicyPolicyTextBlock_0020ead3-9001-4276-a41b-4659f9e78371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_b85bba94-4fed-4656-9e99-c45f1cbe3563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf2fa9fd-cac9-41e1-a00c-4173e7097982" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_b85bba94-4fed-4656-9e99-c45f1cbe3563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_cd9d8288-5df4-4d84-a4fd-1981cf74a9dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf2fa9fd-cac9-41e1-a00c-4173e7097982" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_cd9d8288-5df4-4d84-a4fd-1981cf74a9dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_e271a8df-7fcd-4385-820b-74a5a509bd0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf2fa9fd-cac9-41e1-a00c-4173e7097982" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_e271a8df-7fcd-4385-820b-74a5a509bd0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f213c95e-7462-4ab7-a098-886b2a6b7f07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf2fa9fd-cac9-41e1-a00c-4173e7097982" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f213c95e-7462-4ab7-a098-886b2a6b7f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="amci-20230213.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9e359da6-eee9-4c53-858e-88643133ff84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_1918ec98-c962-4b94-8459-983d3ad29264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9e359da6-eee9-4c53-858e-88643133ff84" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_1918ec98-c962-4b94-8459-983d3ad29264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionTables" xlink:type="simple" xlink:href="amci-20230213.xsd#ClassACommonStockSubjecttoPossibleRedemptionTables"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_bf183632-a712-40de-a5c6-3ac78ee99050" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityTableTextBlock_5427b2c9-301e-4c5e-b024-9e19c87953ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_bf183632-a712-40de-a5c6-3ac78ee99050" xlink:to="loc_us-gaap_TemporaryEquityTableTextBlock_5427b2c9-301e-4c5e-b024-9e19c87953ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_04206b08-b62f-4d9c-b11f-4bedbccfd210" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_4d9bef9e-9bfa-4a5b-88fa-e1b3b2ba324f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_04206b08-b62f-4d9c-b11f-4bedbccfd210" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_4d9bef9e-9bfa-4a5b-88fa-e1b3b2ba324f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_dd0c8d2e-f9dc-4005-b5ea-b10ec8ac4c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_04206b08-b62f-4d9c-b11f-4bedbccfd210" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_dd0c8d2e-f9dc-4005-b5ea-b10ec8ac4c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_3798c780-f6e6-4e9e-b6c9-8d24cf78e68a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_04206b08-b62f-4d9c-b11f-4bedbccfd210" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_3798c780-f6e6-4e9e-b6c9-8d24cf78e68a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables_1" xlink:type="simple" xlink:href="amci-20230213.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesTables_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e125c14d-559f-4750-ad03-999caad0fed0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ea6473f2-43f0-41a2-9c63-0eb4bd391015" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e125c14d-559f-4750-ad03-999caad0fed0" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ea6473f2-43f0-41a2-9c63-0eb4bd391015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionTables_1" xlink:type="simple" xlink:href="amci-20230213.xsd#ClassACommonStockSubjecttoPossibleRedemptionTables_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionTables_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_cbd7e393-db0e-4d1b-a05e-2a7622193790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityTableTextBlock_84de153b-01bf-49de-a713-3a85644abb7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_cbd7e393-db0e-4d1b-a05e-2a7622193790" xlink:to="loc_us-gaap_TemporaryEquityTableTextBlock_84de153b-01bf-49de-a713-3a85644abb7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueMeasurementsTables_1" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueMeasurementsTables_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/FairValueMeasurementsTables_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f268c769-43cc-4111-ba5d-ba42b55dea5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_53d1ed42-6853-4eb9-8251-2373b10f761a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f268c769-43cc-4111-ba5d-ba42b55dea5e" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_53d1ed42-6853-4eb9-8251-2373b10f761a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_9018b889-9383-4d8a-99e6-a70b9d6b086b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f268c769-43cc-4111-ba5d-ba42b55dea5e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_9018b889-9383-4d8a-99e6-a70b9d6b086b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_3ed36cf8-cc90-4bb7-88d6-4b6235cf0a94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f268c769-43cc-4111-ba5d-ba42b55dea5e" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_3ed36cf8-cc90-4bb7-88d6-4b6235cf0a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/IncomeTaxesTables" xlink:type="simple" xlink:href="amci-20230213.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b1b38890-8417-470a-beae-aa28643acee5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_0acde0d6-26ce-4806-89a0-6c4e5d15aa56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b1b38890-8417-470a-beae-aa28643acee5" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_0acde0d6-26ce-4806-89a0-6c4e5d15aa56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_9cc8a0f0-17d4-40de-90e8-0ebcddb0ade4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b1b38890-8417-470a-beae-aa28643acee5" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_9cc8a0f0-17d4-40de-90e8-0ebcddb0ade4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_5d493f0d-e790-495b-93a7-4f7204c0e560" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b1b38890-8417-470a-beae-aa28643acee5" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_5d493f0d-e790-495b-93a7-4f7204c0e560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="amci-20230213.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7acf59c9-73cb-4777-8bfa-bb86a2e22e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_30ce7ba4-55d9-4d19-8fb3-f0298774a206" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7acf59c9-73cb-4777-8bfa-bb86a2e22e1f" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_30ce7ba4-55d9-4d19-8fb3-f0298774a206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_e6393593-5c9e-4ef7-bb39-e8b3887167ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7acf59c9-73cb-4777-8bfa-bb86a2e22e1f" xlink:to="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_e6393593-5c9e-4ef7-bb39-e8b3887167ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/NetLossPerShareTables" xlink:type="simple" xlink:href="amci-20230213.xsd#NetLossPerShareTables"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/NetLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1b8b3d67-d284-4533-9921-ceee412b2792" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_5902876d-92fe-4ac7-9143-6e76cabbdeac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1b8b3d67-d284-4533-9921-ceee412b2792" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_5902876d-92fe-4ac7-9143-6e76cabbdeac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_4f56bbbe-f17b-4435-b559-43284920585d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1b8b3d67-d284-4533-9921-ceee412b2792" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_4f56bbbe-f17b-4435-b559-43284920585d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RevenuesTables" xlink:type="simple" xlink:href="amci-20230213.xsd#RevenuesTables"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RevenuesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_881eefec-ab74-4792-bf28-7510b180d50a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_5672522f-464d-4d90-b269-8c37a0951964" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_881eefec-ab74-4792-bf28-7510b180d50a" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_5672522f-464d-4d90-b269-8c37a0951964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_3e83848b-8537-40ed-8772-c49ec3224643" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_881eefec-ab74-4792-bf28-7510b180d50a" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_3e83848b-8537-40ed-8772-c49ec3224643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_da261842-1afa-4b64-a326-40ebd47aa9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_881eefec-ab74-4792-bf28-7510b180d50a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_da261842-1afa-4b64-a326-40ebd47aa9ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/InvestmentsTables" xlink:type="simple" xlink:href="amci-20230213.xsd#InvestmentsTables"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/InvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_c54cb49d-8d60-4d1a-8351-7ee01455506b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTableTextBlock_35f2f1d8-7ae1-476c-9899-4e3dbf39b3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_c54cb49d-8d60-4d1a-8351-7ee01455506b" xlink:to="loc_us-gaap_InvestmentTableTextBlock_35f2f1d8-7ae1-476c-9899-4e3dbf39b3cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueTables" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueTables"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/FairValueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_aa93d0ec-cbac-4c75-9355-80b5924a6f25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_e37ff9c7-e71e-4e59-857d-2dbec9140cab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_aa93d0ec-cbac-4c75-9355-80b5924a6f25" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_e37ff9c7-e71e-4e59-857d-2dbec9140cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_01883c3b-d65f-4404-b0d5-c1920fb93461" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_aa93d0ec-cbac-4c75-9355-80b5924a6f25" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_01883c3b-d65f-4404-b0d5-c1920fb93461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_05e2ec03-dd9b-4144-b6fd-4bba546946ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_aa93d0ec-cbac-4c75-9355-80b5924a6f25" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_05e2ec03-dd9b-4144-b6fd-4bba546946ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="amci-20230213.xsd#ShareBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/ShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9c086e8b-1321-4764-846e-e12ecf003bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_4ce50232-44c3-4a1f-b6fd-89e70b8ec585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9c086e8b-1321-4764-846e-e12ecf003bc2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_4ce50232-44c3-4a1f-b6fd-89e70b8ec585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RelatedPartyTransactionsTables" xlink:type="simple" xlink:href="amci-20230213.xsd#RelatedPartyTransactionsTables"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RelatedPartyTransactionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_aadc302f-725b-4b17-9a58-6384633da77b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_8fda267f-169d-4e8e-96a5-c26de63f49dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_aadc302f-725b-4b17-9a58-6384633da77b" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_8fda267f-169d-4e8e-96a5-c26de63f49dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockTables" xlink:type="simple" xlink:href="amci-20230213.xsd#RedeemableConvertiblePreferredStockTables"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_d8faee1f-bb88-4fb9-af95-e11aa3a2b32d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityTableTextBlock_47fddb9f-b15f-49c6-857e-32ac99f11768" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_d8faee1f-bb88-4fb9-af95-e11aa3a2b32d" xlink:to="loc_us-gaap_TemporaryEquityTableTextBlock_47fddb9f-b15f-49c6-857e-32ac99f11768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/LeasesTables" xlink:type="simple" xlink:href="amci-20230213.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_b8af53ca-2b34-4255-a77a-bdd7116d5dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_056ff6e3-2840-4253-aede-41d653674c49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLeaseIncomeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b8af53ca-2b34-4255-a77a-bdd7116d5dcf" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_056ff6e3-2840-4253-aede-41d653674c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesTables_1" xlink:type="simple" xlink:href="amci-20230213.xsd#SummaryofSignificantAccountingPoliciesTables_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesTables_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_332293fa-b080-4d05-a9ca-0ecae327e8a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_ad4b6397-6e82-47b4-bf21-b3cf6a75ad7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_332293fa-b080-4d05-a9ca-0ecae327e8a8" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_ad4b6397-6e82-47b4-bf21-b3cf6a75ad7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_5504f3e6-d5a6-4e06-8345-2e5e88c4907c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_332293fa-b080-4d05-a9ca-0ecae327e8a8" xlink:to="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_5504f3e6-d5a6-4e06-8345-2e5e88c4907c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_42816dcc-771a-4bb0-a84c-b5fe801645b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_332293fa-b080-4d05-a9ca-0ecae327e8a8" xlink:to="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_42816dcc-771a-4bb0-a84c-b5fe801645b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/NetLossPerShareTables_1" xlink:type="simple" xlink:href="amci-20230213.xsd#NetLossPerShareTables_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/NetLossPerShareTables_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_10ef9462-ac91-4214-9e8a-ad33d1e8bff8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_dac247cb-c1dd-4d59-a665-d7adadfe0f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_10ef9462-ac91-4214-9e8a-ad33d1e8bff8" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_dac247cb-c1dd-4d59-a665-d7adadfe0f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_2586b281-1ea8-47da-9d28-9594e535477d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_10ef9462-ac91-4214-9e8a-ad33d1e8bff8" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_2586b281-1ea8-47da-9d28-9594e535477d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RevenuesTables_1" xlink:type="simple" xlink:href="amci-20230213.xsd#RevenuesTables_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RevenuesTables_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5d334e77-cb83-4d70-99fa-ae3a5d69c403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_49efc242-d1f2-4b3e-a396-1980c6ebcb67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5d334e77-cb83-4d70-99fa-ae3a5d69c403" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_49efc242-d1f2-4b3e-a396-1980c6ebcb67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_22ee2c40-f853-4eed-b901-5354f9ebade3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5d334e77-cb83-4d70-99fa-ae3a5d69c403" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_22ee2c40-f853-4eed-b901-5354f9ebade3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_f5e4f61c-c11e-41e1-9c1e-88a68cc62211" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5d334e77-cb83-4d70-99fa-ae3a5d69c403" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_f5e4f61c-c11e-41e1-9c1e-88a68cc62211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/InvestmentsTables_1" xlink:type="simple" xlink:href="amci-20230213.xsd#InvestmentsTables_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/InvestmentsTables_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_00392465-b8e6-4c22-b95f-d5373a90ddcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_102eec91-5d25-4292-a347-f43b24719f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_00392465-b8e6-4c22-b95f-d5373a90ddcf" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_102eec91-5d25-4292-a347-f43b24719f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueTables_1" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueTables_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/FairValueTables_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_69b87e00-6b47-4dcc-bdf9-60f4ae23e093" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_f2372485-ede4-4ad7-ac8d-3ece55458ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_69b87e00-6b47-4dcc-bdf9-60f4ae23e093" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_f2372485-ede4-4ad7-ac8d-3ece55458ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_730f7cc9-6701-42d5-9934-63e50c9edff3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_69b87e00-6b47-4dcc-bdf9-60f4ae23e093" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_730f7cc9-6701-42d5-9934-63e50c9edff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_7a5e2fba-979a-4ad2-97bc-0d518d3a35c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_69b87e00-6b47-4dcc-bdf9-60f4ae23e093" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_7a5e2fba-979a-4ad2-97bc-0d518d3a35c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/OtherCurrentAssetsTables" xlink:type="simple" xlink:href="amci-20230213.xsd#OtherCurrentAssetsTables"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/OtherCurrentAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_038f2f2c-0350-426d-8fa5-12755416f31c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_a76db4d8-b8e3-493a-b3a1-fa964bce0c25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_038f2f2c-0350-426d-8fa5-12755416f31c" xlink:to="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_a76db4d8-b8e3-493a-b3a1-fa964bce0c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/PropertyPlantandEquipmentTables" xlink:type="simple" xlink:href="amci-20230213.xsd#PropertyPlantandEquipmentTables"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/PropertyPlantandEquipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8c1e5d02-04ca-4a9b-a66d-e8e0439e5e70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_128b5fc8-96f5-4829-bc3f-2753e0775876" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8c1e5d02-04ca-4a9b-a66d-e8e0439e5e70" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_128b5fc8-96f5-4829-bc3f-2753e0775876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/DebtTables" xlink:type="simple" xlink:href="amci-20230213.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2381c4cd-be8d-4f45-811d-56d388e9aad1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_475ba798-be2a-420f-9df5-9260b2bc07f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2381c4cd-be8d-4f45-811d-56d388e9aad1" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_475ba798-be2a-420f-9df5-9260b2bc07f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/IncomeTaxesTables_1" xlink:type="simple" xlink:href="amci-20230213.xsd#IncomeTaxesTables_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/IncomeTaxesTables_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_8b7fbf9f-01c8-440e-81a0-85c18d70c77d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_045fd689-3f74-40a5-b3c9-8e4c6b131db6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8b7fbf9f-01c8-440e-81a0-85c18d70c77d" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_045fd689-3f74-40a5-b3c9-8e4c6b131db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_84c176e6-85ff-468f-8c80-ebed12b6bc10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8b7fbf9f-01c8-440e-81a0-85c18d70c77d" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_84c176e6-85ff-468f-8c80-ebed12b6bc10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_fbf8420f-cad3-4386-a182-5b6fb9c6938b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8b7fbf9f-01c8-440e-81a0-85c18d70c77d" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_fbf8420f-cad3-4386-a182-5b6fb9c6938b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_71f2d968-17ac-4ea8-9bd4-3d56b984c1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8b7fbf9f-01c8-440e-81a0-85c18d70c77d" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_71f2d968-17ac-4ea8-9bd4-3d56b984c1fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="amci-20230213.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4917e75f-e93c-486d-9577-27541d949b27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_deb2aebd-f668-41df-8520-531175909403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4917e75f-e93c-486d-9577-27541d949b27" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_deb2aebd-f668-41df-8520-531175909403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_98440d39-6f74-477a-8a4f-d6948065688b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4917e75f-e93c-486d-9577-27541d949b27" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_98440d39-6f74-477a-8a4f-d6948065688b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_73f20209-06df-4749-9941-a09e42d8f968" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4917e75f-e93c-486d-9577-27541d949b27" xlink:to="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_73f20209-06df-4749-9941-a09e42d8f968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockTables_1" xlink:type="simple" xlink:href="amci-20230213.xsd#RedeemableConvertiblePreferredStockTables_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockTables_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_8a0224eb-166a-4226-90ee-8da0c35aaea3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityTableTextBlock_e0adc9a6-5fc7-4e15-92ae-11ce7d8476a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_8a0224eb-166a-4226-90ee-8da0c35aaea3" xlink:to="loc_us-gaap_TemporaryEquityTableTextBlock_e0adc9a6-5fc7-4e15-92ae-11ce7d8476a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/LeasesTables_1" xlink:type="simple" xlink:href="amci-20230213.xsd#LeasesTables_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/LeasesTables_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ab08d383-8846-417d-a855-cf02c79b52fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_87c05b0d-ad9f-4385-9ae2-faab6faf0149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ab08d383-8846-417d-a855-cf02c79b52fc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_87c05b0d-ad9f-4385-9ae2-faab6faf0149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AssetsAndLiabilitiesLesseeTableTextBlock_19c40f4f-a945-489f-878e-cfcc00cd42e5" xlink:href="amci-20230213.xsd#amci_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ab08d383-8846-417d-a855-cf02c79b52fc" xlink:to="loc_amci_AssetsAndLiabilitiesLesseeTableTextBlock_19c40f4f-a945-489f-878e-cfcc00cd42e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_79324f88-65ba-4473-a6fa-8cc155775e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ab08d383-8846-417d-a855-cf02c79b52fc" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_79324f88-65ba-4473-a6fa-8cc155775e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#DescriptionofOrganizationandBusinessOperationsDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e9f2477a-4b92-4e7d-9a89-9a7317878af3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_835a426e-aa7b-4391-a034-110c4158c650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e9f2477a-4b92-4e7d-9a89-9a7317878af3" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_835a426e-aa7b-4391-a034-110c4158c650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2530d8a9-de3c-4396-8847-1268ac3f95a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_835a426e-aa7b-4391-a034-110c4158c650" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2530d8a9-de3c-4396-8847-1268ac3f95a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_5bd94865-3579-4c78-a95c-d772bfad8dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2530d8a9-de3c-4396-8847-1268ac3f95a9" xlink:to="loc_us-gaap_RelatedPartyDomain_5bd94865-3579-4c78-a95c-d772bfad8dbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SponsorMember_1dabb120-dea3-4329-835a-ba59f584c285" xlink:href="amci-20230213.xsd#amci_SponsorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_5bd94865-3579-4c78-a95c-d772bfad8dbe" xlink:to="loc_amci_SponsorMember_1dabb120-dea3-4329-835a-ba59f584c285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_546ea855-bf03-424f-92d8-2dbe4fafdb3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_835a426e-aa7b-4391-a034-110c4158c650" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_546ea855-bf03-424f-92d8-2dbe4fafdb3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e5dc0220-6629-4cd3-86e9-2d55ef090568" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_546ea855-bf03-424f-92d8-2dbe4fafdb3e" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e5dc0220-6629-4cd3-86e9-2d55ef090568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_40c6cb18-e1e1-4c59-aa40-1dbf66f06ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e5dc0220-6629-4cd3-86e9-2d55ef090568" xlink:to="loc_us-gaap_IPOMember_40c6cb18-e1e1-4c59-aa40-1dbf66f06ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_b0d5386c-5764-4d47-aeb0-e3828818d213" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e5dc0220-6629-4cd3-86e9-2d55ef090568" xlink:to="loc_us-gaap_PrivatePlacementMember_b0d5386c-5764-4d47-aeb0-e3828818d213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_f41f6f05-f2e3-4355-ac5b-2ccd8aae22fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_835a426e-aa7b-4391-a034-110c4158c650" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_f41f6f05-f2e3-4355-ac5b-2ccd8aae22fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_fca87ae5-93bd-41fd-b248-56bf5a9b6fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_f41f6f05-f2e3-4355-ac5b-2ccd8aae22fd" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_fca87ae5-93bd-41fd-b248-56bf5a9b6fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_14e66f10-bc17-4136-ae0b-b22b9636804f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_fca87ae5-93bd-41fd-b248-56bf5a9b6fa4" xlink:to="loc_us-gaap_WarrantMember_14e66f10-bc17-4136-ae0b-b22b9636804f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PrivatePlacementWarrantsMember_b41e680c-ad5b-4653-89ec-0b4299f1238a" xlink:href="amci-20230213.xsd#amci_PrivatePlacementWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantMember_14e66f10-bc17-4136-ae0b-b22b9636804f" xlink:to="loc_amci_PrivatePlacementWarrantsMember_b41e680c-ad5b-4653-89ec-0b4299f1238a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_cee072c1-b291-4a49-876c-aaad333c81a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_835a426e-aa7b-4391-a034-110c4158c650" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_cee072c1-b291-4a49-876c-aaad333c81a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_52f59937-edd7-417c-aa9b-11f35a06cbfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_cee072c1-b291-4a49-876c-aaad333c81a1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_52f59937-edd7-417c-aa9b-11f35a06cbfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_74801853-0a6f-44eb-8ae2-b2124c9192f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_52f59937-edd7-417c-aa9b-11f35a06cbfc" xlink:to="loc_us-gaap_SubsequentEventMember_74801853-0a6f-44eb-8ae2-b2124c9192f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_702be989-4051-4b00-b19f-52090b63cb42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_835a426e-aa7b-4391-a034-110c4158c650" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_702be989-4051-4b00-b19f-52090b63cb42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_09eccf02-a80a-49f8-9c8a-81c6ae2289d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_702be989-4051-4b00-b19f-52090b63cb42" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_09eccf02-a80a-49f8-9c8a-81c6ae2289d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WorkingCapitalLoansMember_06065880-19f1-4bf7-89a8-dbd389cb6c1a" xlink:href="amci-20230213.xsd#amci_WorkingCapitalLoansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_09eccf02-a80a-49f8-9c8a-81c6ae2289d9" xlink:to="loc_amci_WorkingCapitalLoansMember_06065880-19f1-4bf7-89a8-dbd389cb6c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_0fa1f18b-e232-4166-a7b8-7bbf649ec9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_835a426e-aa7b-4391-a034-110c4158c650" xlink:to="loc_us-gaap_StatementClassOfStockAxis_0fa1f18b-e232-4166-a7b8-7bbf649ec9ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_31a628c9-10b6-47f5-928d-547a1da094df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0fa1f18b-e232-4166-a7b8-7bbf649ec9ed" xlink:to="loc_us-gaap_ClassOfStockDomain_31a628c9-10b6-47f5-928d-547a1da094df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_3ce506d2-2e96-4db4-a8bf-81509df937a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_31a628c9-10b6-47f5-928d-547a1da094df" xlink:to="loc_us-gaap_CommonClassAMember_3ce506d2-2e96-4db4-a8bf-81509df937a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_413a9339-4c81-4d5d-9bbe-9203cc5a1a7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_835a426e-aa7b-4391-a034-110c4158c650" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_413a9339-4c81-4d5d-9bbe-9203cc5a1a7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dc268c6c-41b0-445e-9d53-b9f9e6fe9d51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_413a9339-4c81-4d5d-9bbe-9203cc5a1a7e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dc268c6c-41b0-445e-9d53-b9f9e6fe9d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LanzatechGlobalMember_291d4eea-8b7b-4571-8b2a-1a0c1a459974" xlink:href="amci-20230213.xsd#amci_LanzatechGlobalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dc268c6c-41b0-445e-9d53-b9f9e6fe9d51" xlink:to="loc_amci_LanzatechGlobalMember_291d4eea-8b7b-4571-8b2a-1a0c1a459974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d17566be-e5b9-40f6-96ef-861780209ca0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_835a426e-aa7b-4391-a034-110c4158c650" xlink:to="loc_srt_RangeAxis_d17566be-e5b9-40f6-96ef-861780209ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4130e301-9a38-4da4-b6d4-2168538ce859" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d17566be-e5b9-40f6-96ef-861780209ca0" xlink:to="loc_srt_RangeMember_4130e301-9a38-4da4-b6d4-2168538ce859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e5619d78-14cd-42aa-adae-221a28997adf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4130e301-9a38-4da4-b6d4-2168538ce859" xlink:to="loc_srt_MinimumMember_e5619d78-14cd-42aa-adae-221a28997adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_88b1a476-f346-428f-9511-978cda3a082b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_835a426e-aa7b-4391-a034-110c4158c650" xlink:to="loc_dei_LegalEntityAxis_88b1a476-f346-428f-9511-978cda3a082b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_bd7c8032-576a-4291-9db3-0c494964c32d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_88b1a476-f346-428f-9511-978cda3a082b" xlink:to="loc_dei_EntityDomain_bd7c8032-576a-4291-9db3-0c494964c32d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_835a426e-aa7b-4391-a034-110c4158c650" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum_f0c8a8ed-f5bb-47ad-8c4b-b405fba46ad9" xlink:href="amci-20230213.xsd#amci_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum_f0c8a8ed-f5bb-47ad-8c4b-b405fba46ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_UnitsIssuedDuringPeriodSharesNewIssues_936aaf7a-72e7-4bf1-b5a9-ba11ec7199f6" xlink:href="amci-20230213.xsd#amci_UnitsIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_UnitsIssuedDuringPeriodSharesNewIssues_936aaf7a-72e7-4bf1-b5a9-ba11ec7199f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_3c079317-b6b2-4872-93a8-05dd088f9ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_3c079317-b6b2-4872-93a8-05dd088f9ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights_58b24ac9-a224-405a-836d-97da7e1a47bc" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights_58b24ac9-a224-405a-836d-97da7e1a47bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_a05d5756-92f7-4c37-8a6e-75d9e7ca611b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_a05d5756-92f7-4c37-8a6e-75d9e7ca611b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_44bd403f-17ee-4ed0-946c-6cc78596b890" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_44bd403f-17ee-4ed0-946c-6cc78596b890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_56d87219-79be-4368-8bb0-24971278adae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_56d87219-79be-4368-8bb0-24971278adae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_e16a0c31-d88d-4aa2-856a-b0bf1f1d56fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_e16a0c31-d88d-4aa2-856a-b0bf1f1d56fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TransactionCosts_cfc34899-738e-41df-998e-9e01150b12ab" xlink:href="amci-20230213.xsd#amci_TransactionCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_TransactionCosts_cfc34899-738e-41df-998e-9e01150b12ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering_ce1fb3e4-97a4-481c-95a0-84247a0acf27" xlink:href="amci-20230213.xsd#amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_TransactionCosts_cfc34899-738e-41df-998e-9e01150b12ab" xlink:to="loc_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering_ce1fb3e4-97a4-481c-95a0-84247a0acf27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SaleOfStockUnderwritingDiscounts_bf5d09f0-d5e1-4770-91e3-379a29d0a798" xlink:href="amci-20230213.xsd#amci_SaleOfStockUnderwritingDiscounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_TransactionCosts_cfc34899-738e-41df-998e-9e01150b12ab" xlink:to="loc_amci_SaleOfStockUnderwritingDiscounts_bf5d09f0-d5e1-4770-91e3-379a29d0a798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingDiscounts_bd1002a3-1242-49d1-a9ba-bf78114feadf" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingDiscounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_TransactionCosts_cfc34899-738e-41df-998e-9e01150b12ab" xlink:to="loc_amci_DeferredUnderwritingDiscounts_bd1002a3-1242-49d1-a9ba-bf78114feadf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SaleOfStockOtherOfferingCosts_5201c840-b679-4d18-847f-ca22fa7baf6c" xlink:href="amci-20230213.xsd#amci_SaleOfStockOtherOfferingCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_TransactionCosts_cfc34899-738e-41df-998e-9e01150b12ab" xlink:to="loc_amci_SaleOfStockOtherOfferingCosts_5201c840-b679-4d18-847f-ca22fa7baf6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PaymentsForInvestmentOfCashInTrustAccount_b5b8fde1-b1cb-400b-9ef0-8bd27deb3f44" xlink:href="amci-20230213.xsd#amci_PaymentsForInvestmentOfCashInTrustAccount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_PaymentsForInvestmentOfCashInTrustAccount_b5b8fde1-b1cb-400b-9ef0-8bd27deb3f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ConditionForFutureBusinessCombinationUseOfProceedsPercentage_fc82c614-89ef-4789-8e71-7e106658b321" xlink:href="amci-20230213.xsd#amci_ConditionForFutureBusinessCombinationUseOfProceedsPercentage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_ConditionForFutureBusinessCombinationUseOfProceedsPercentage_fc82c614-89ef-4789-8e71-7e106658b321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ConditionForFutureBusinessCombinationThresholdPercentageOwnership_25285574-43b0-454c-bbe9-821df810314a" xlink:href="amci-20230213.xsd#amci_ConditionForFutureBusinessCombinationThresholdPercentageOwnership"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_ConditionForFutureBusinessCombinationThresholdPercentageOwnership_25285574-43b0-454c-bbe9-821df810314a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_43efded9-5057-42d0-950c-466b1904711e" xlink:href="amci-20230213.xsd#amci_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_43efded9-5057-42d0-950c-466b1904711e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets_99bb052c-4817-4002-b9eb-4fc5a417a9e5" xlink:href="amci-20230213.xsd#amci_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets_99bb052c-4817-4002-b9eb-4fc5a417a9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MonthsToCompleteAcquisition_ee2a2326-b8f7-4263-a848-0bbf197e13dd" xlink:href="amci-20230213.xsd#amci_MonthsToCompleteAcquisition"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_MonthsToCompleteAcquisition_ee2a2326-b8f7-4263-a848-0bbf197e13dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RedemptionPeriodUponClosure_9f7fcd36-fbba-444b-869a-8a8f9f9db42a" xlink:href="amci-20230213.xsd#amci_RedemptionPeriodUponClosure"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_RedemptionPeriodUponClosure_9f7fcd36-fbba-444b-869a-8a8f9f9db42a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MaximumAllowedDissolutionExpenses_5dd12829-0817-4a13-aa40-3277ec34a4f8" xlink:href="amci-20230213.xsd#amci_MaximumAllowedDissolutionExpenses"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_MaximumAllowedDissolutionExpenses_5dd12829-0817-4a13-aa40-3277ec34a4f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount_2d35a79a-ebf1-45ac-b7c0-bac8f29f6cd7" xlink:href="amci-20230213.xsd#amci_TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount_2d35a79a-ebf1-45ac-b7c0-bac8f29f6cd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WorkingCapitalDeficit_2d756eea-a382-4c13-9c61-3c3be7a19d43" xlink:href="amci-20230213.xsd#amci_WorkingCapitalDeficit"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_WorkingCapitalDeficit_2d756eea-a382-4c13-9c61-3c3be7a19d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_cc0bbe28-451f-4c8a-bfba-ae9890e03bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_cc0bbe28-451f-4c8a-bfba-ae9890e03bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_aaa90dc1-f08b-4f5b-b438-bb735347f93f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_aaa90dc1-f08b-4f5b-b438-bb735347f93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNet_69410b18-1df0-4151-9686-e8fe7aa03dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNet"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_us-gaap_AssetsNet_69410b18-1df0-4151-9686-e8fe7aa03dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrustCurrent_9f4c9d91-e1ef-4286-9add-a023f6d538a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustCurrent"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_us-gaap_AssetsHeldInTrustCurrent_9f4c9d91-e1ef-4286-9add-a023f6d538a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_c869f921-18d4-4111-93f1-07994e955ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_c869f921-18d4-4111-93f1-07994e955ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_58e4b035-dd6d-4515-8488-2f1baa8f97dc" xlink:href="amci-20230213.xsd#amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_58e4b035-dd6d-4515-8488-2f1baa8f97dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1f5991fb-e8ff-4b83-98df-6ae4f93fc7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1f5991fb-e8ff-4b83-98df-6ae4f93fc7ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_d68f67cc-317a-44b9-a4c2-95db8dbb7e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_d68f67cc-317a-44b9-a4c2-95db8dbb7e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfSharesIssuedPerUnit_7e140c8e-7327-477d-92d0-9e3ed7e39225" xlink:href="amci-20230213.xsd#amci_NumberOfSharesIssuedPerUnit"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_NumberOfSharesIssuedPerUnit_7e140c8e-7327-477d-92d0-9e3ed7e39225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfWarrantsIssuedPerUnit_c0f9ef5a-25fd-4aac-8d97-f823f0c96790" xlink:href="amci-20230213.xsd#amci_NumberOfWarrantsIssuedPerUnit"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_NumberOfWarrantsIssuedPerUnit_c0f9ef5a-25fd-4aac-8d97-f823f0c96790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_FundHeldInTrustAccountPerPublicShare_10ec0a5e-155e-4b18-8a9e-83b0d12f7243" xlink:href="amci-20230213.xsd#amci_FundHeldInTrustAccountPerPublicShare"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_FundHeldInTrustAccountPerPublicShare_10ec0a5e-155e-4b18-8a9e-83b0d12f7243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose_d3b9c9e1-af19-4968-a88b-27c5846ed399" xlink:href="amci-20230213.xsd#amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose_d3b9c9e1-af19-4968-a88b-27c5846ed399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_9d475f8e-7126-4d44-b19a-e9af88d58774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_us-gaap_ShortTermBorrowings_9d475f8e-7126-4d44-b19a-e9af88d58774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WorkingCapitalLoan_56592bc4-65a7-4794-8f15-2a6e89d095d1" xlink:href="amci-20230213.xsd#amci_WorkingCapitalLoan"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_7751ef8a-cc3a-4c5c-84d4-f136d1a6e294" xlink:to="loc_amci_WorkingCapitalLoan_56592bc4-65a7-4794-8f15-2a6e89d095d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_614ebeec-7f01-45f7-9f5e-87bdaf20b427" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_eaccfc69-eeac-48d3-9a1f-b7f43909c0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_614ebeec-7f01-45f7-9f5e-87bdaf20b427" xlink:to="loc_us-gaap_StatementTable_eaccfc69-eeac-48d3-9a1f-b7f43909c0f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_fc208ac2-ba70-4046-a9f4-1f084f6507ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_eaccfc69-eeac-48d3-9a1f-b7f43909c0f7" xlink:to="loc_us-gaap_StatementClassOfStockAxis_fc208ac2-ba70-4046-a9f4-1f084f6507ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_60eec158-b8ef-4a81-80a8-93cdb3bf075b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fc208ac2-ba70-4046-a9f4-1f084f6507ff" xlink:to="loc_us-gaap_ClassOfStockDomain_60eec158-b8ef-4a81-80a8-93cdb3bf075b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_07437987-4a92-4439-89a0-97b5b1dcf5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_60eec158-b8ef-4a81-80a8-93cdb3bf075b" xlink:to="loc_us-gaap_CommonClassAMember_07437987-4a92-4439-89a0-97b5b1dcf5b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CommonClassaSubjectToRedemptionMember_d5e04a03-1da3-44c8-b4bb-baa97454532b" xlink:href="amci-20230213.xsd#amci_CommonClassaSubjectToRedemptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_60eec158-b8ef-4a81-80a8-93cdb3bf075b" xlink:to="loc_amci_CommonClassaSubjectToRedemptionMember_d5e04a03-1da3-44c8-b4bb-baa97454532b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_9c924c1e-6c05-4ab0-9166-939ea80522ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_eaccfc69-eeac-48d3-9a1f-b7f43909c0f7" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_9c924c1e-6c05-4ab0-9166-939ea80522ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5ae9c8a7-43e9-4d3a-8dd0-7d65c6615e24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_9c924c1e-6c05-4ab0-9166-939ea80522ff" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5ae9c8a7-43e9-4d3a-8dd0-7d65c6615e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_7ca95c40-e7e8-4e6e-b20c-dd0b47decb74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5ae9c8a7-43e9-4d3a-8dd0-7d65c6615e24" xlink:to="loc_us-gaap_IPOMember_7ca95c40-e7e8-4e6e-b20c-dd0b47decb74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_b7fff5db-7918-4b09-be46-db1cb4d7cbf6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_eaccfc69-eeac-48d3-9a1f-b7f43909c0f7" xlink:to="loc_dei_LegalEntityAxis_b7fff5db-7918-4b09-be46-db1cb4d7cbf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_7c8f1a70-3607-4770-82f7-6f1e8200d9dc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_b7fff5db-7918-4b09-be46-db1cb4d7cbf6" xlink:to="loc_dei_EntityDomain_7c8f1a70-3607-4770-82f7-6f1e8200d9dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AMCIACQUISITIONCORPIIMember_020233e8-cdad-4fc1-ad16-ee7876f41c57" xlink:href="amci-20230213.xsd#amci_AMCIACQUISITIONCORPIIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_7c8f1a70-3607-4770-82f7-6f1e8200d9dc" xlink:to="loc_amci_AMCIACQUISITIONCORPIIMember_020233e8-cdad-4fc1-ad16-ee7876f41c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5e6c802b-a9de-4d52-a44b-36f4022e33ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_eaccfc69-eeac-48d3-9a1f-b7f43909c0f7" xlink:to="loc_us-gaap_StatementLineItems_5e6c802b-a9de-4d52-a44b-36f4022e33ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_bf37ae0d-3114-43cb-9449-126a65ef68a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5e6c802b-a9de-4d52-a44b-36f4022e33ff" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_bf37ae0d-3114-43cb-9449-126a65ef68a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_891c03f5-d6cc-4000-bb6c-c7ddc945685b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5e6c802b-a9de-4d52-a44b-36f4022e33ff" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_891c03f5-d6cc-4000-bb6c-c7ddc945685b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2c0690c9-509e-4f75-82b1-8138bbd5b9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5e6c802b-a9de-4d52-a44b-36f4022e33ff" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2c0690c9-509e-4f75-82b1-8138bbd5b9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_070bd5fd-39c3-4a7d-bb0a-305ba1174f05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5e6c802b-a9de-4d52-a44b-36f4022e33ff" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_070bd5fd-39c3-4a7d-bb0a-305ba1174f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3d782982-a055-4975-a9c6-34bfd91adf6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5e6c802b-a9de-4d52-a44b-36f4022e33ff" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3d782982-a055-4975-a9c6-34bfd91adf6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_9e1805a5-f895-4658-b1d2-88aa05eeb4a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5e6c802b-a9de-4d52-a44b-36f4022e33ff" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_9e1805a5-f895-4658-b1d2-88aa05eeb4a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1ac25c04-5ea6-4faf-b435-8139c044d545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_301e24d2-a705-4c73-a278-5c3842593e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1ac25c04-5ea6-4faf-b435-8139c044d545" xlink:to="loc_us-gaap_StatementTable_301e24d2-a705-4c73-a278-5c3842593e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_a4fb1e03-ebb3-4b13-9a72-e9a70b9492fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_301e24d2-a705-4c73-a278-5c3842593e9d" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_a4fb1e03-ebb3-4b13-9a72-e9a70b9492fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_debdff50-ec87-4b4b-8361-d86c4bab70d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_a4fb1e03-ebb3-4b13-9a72-e9a70b9492fa" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_debdff50-ec87-4b4b-8361-d86c4bab70d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_ba6f2ffe-f564-497a-a9bd-450ed0d7926f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_debdff50-ec87-4b4b-8361-d86c4bab70d7" xlink:to="loc_us-gaap_CommonClassAMember_ba6f2ffe-f564-497a-a9bd-450ed0d7926f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_2364cfb9-2dd3-4be6-b318-44f7d50baf85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_debdff50-ec87-4b4b-8361-d86c4bab70d7" xlink:to="loc_us-gaap_CommonClassBMember_2364cfb9-2dd3-4be6-b318-44f7d50baf85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7db61d6f-99d1-4d29-a0ac-dea07600642e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_301e24d2-a705-4c73-a278-5c3842593e9d" xlink:to="loc_us-gaap_StatementLineItems_7db61d6f-99d1-4d29-a0ac-dea07600642e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EarningPerShareBasicAndDilutedAbstract_cd243423-eaff-4802-99e1-3c7e68d3867c" xlink:href="amci-20230213.xsd#amci_EarningPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7db61d6f-99d1-4d29-a0ac-dea07600642e" xlink:to="loc_amci_EarningPerShareBasicAndDilutedAbstract_cd243423-eaff-4802-99e1-3c7e68d3867c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumeratorAbstract_edfffc9e-71e3-4a68-b498-7445c31bc8dc" xlink:href="amci-20230213.xsd#amci_NumeratorAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_EarningPerShareBasicAndDilutedAbstract_cd243423-eaff-4802-99e1-3c7e68d3867c" xlink:to="loc_amci_NumeratorAbstract_edfffc9e-71e3-4a68-b498-7445c31bc8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_8579a650-4d6c-462c-a562-31a9df9cce97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_NumeratorAbstract_edfffc9e-71e3-4a68-b498-7445c31bc8dc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_8579a650-4d6c-462c-a562-31a9df9cce97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DenominatorForCalculationOfEarningsPerShareAbstract_b9304b5a-964e-40cf-aa85-792409812cba" xlink:href="amci-20230213.xsd#amci_DenominatorForCalculationOfEarningsPerShareAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_EarningPerShareBasicAndDilutedAbstract_cd243423-eaff-4802-99e1-3c7e68d3867c" xlink:to="loc_amci_DenominatorForCalculationOfEarningsPerShareAbstract_b9304b5a-964e-40cf-aa85-792409812cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0bba52a0-9f1d-4927-a836-187bf0641646" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_DenominatorForCalculationOfEarningsPerShareAbstract_b9304b5a-964e-40cf-aa85-792409812cba" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0bba52a0-9f1d-4927-a836-187bf0641646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1f95c99a-0b12-488f-96c1-81a30323f37f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_DenominatorForCalculationOfEarningsPerShareAbstract_b9304b5a-964e-40cf-aa85-792409812cba" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1f95c99a-0b12-488f-96c1-81a30323f37f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_49f64466-cd53-4581-b3a0-db45b3e5fd1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_DenominatorForCalculationOfEarningsPerShareAbstract_b9304b5a-964e-40cf-aa85-792409812cba" xlink:to="loc_us-gaap_EarningsPerShareBasic_49f64466-cd53-4581-b3a0-db45b3e5fd1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_729a08da-c3f4-4821-896b-76ea983d0c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_DenominatorForCalculationOfEarningsPerShareAbstract_b9304b5a-964e-40cf-aa85-792409812cba" xlink:to="loc_us-gaap_EarningsPerShareDiluted_729a08da-c3f4-4821-896b-76ea983d0c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/InitialPublicOfferingDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#InitialPublicOfferingDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/InitialPublicOfferingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_amci_InitialPublicOfferingAbstract_8f325af5-21a0-4f12-9299-2590d43e7767" xlink:href="amci-20230213.xsd#amci_InitialPublicOfferingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_04a48104-b824-495b-813d-cdff3f610879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_InitialPublicOfferingAbstract_8f325af5-21a0-4f12-9299-2590d43e7767" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_04a48104-b824-495b-813d-cdff3f610879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_7e9e493e-f7b3-497d-9335-b67a017d091f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_04a48104-b824-495b-813d-cdff3f610879" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_7e9e493e-f7b3-497d-9335-b67a017d091f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ea699391-8e0a-4212-a8d2-5806f605c7eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_7e9e493e-f7b3-497d-9335-b67a017d091f" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ea699391-8e0a-4212-a8d2-5806f605c7eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_7d4ac979-0bc2-4668-991c-121a9ab1f023" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ea699391-8e0a-4212-a8d2-5806f605c7eb" xlink:to="loc_us-gaap_CommonClassAMember_7d4ac979-0bc2-4668-991c-121a9ab1f023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_cfb85461-f83c-4a27-a1fa-cd747653fbab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ea699391-8e0a-4212-a8d2-5806f605c7eb" xlink:to="loc_us-gaap_IPOMember_cfb85461-f83c-4a27-a1fa-cd747653fbab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_41f71c98-d1ad-4bf9-8760-4d9195c43047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ea699391-8e0a-4212-a8d2-5806f605c7eb" xlink:to="loc_us-gaap_OverAllotmentOptionMember_41f71c98-d1ad-4bf9-8760-4d9195c43047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_0620c83c-3a92-4bc6-af7f-2750b3897afe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_04a48104-b824-495b-813d-cdff3f610879" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_0620c83c-3a92-4bc6-af7f-2750b3897afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_861197ea-4e75-4bcd-962d-b8bcf4f04441" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_0620c83c-3a92-4bc6-af7f-2750b3897afe" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_861197ea-4e75-4bcd-962d-b8bcf4f04441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_12545d31-b783-49d3-9e8c-081a3986faa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_861197ea-4e75-4bcd-962d-b8bcf4f04441" xlink:to="loc_us-gaap_WarrantMember_12545d31-b783-49d3-9e8c-081a3986faa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_ca91f874-2b4b-477f-b035-40246d1aec7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_04a48104-b824-495b-813d-cdff3f610879" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_ca91f874-2b4b-477f-b035-40246d1aec7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_835864d4-0f6b-49ba-b3b7-c99bbfb08aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ca91f874-2b4b-477f-b035-40246d1aec7d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_835864d4-0f6b-49ba-b3b7-c99bbfb08aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_62a63154-9a29-41ed-a5f2-85e03d6bffec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_835864d4-0f6b-49ba-b3b7-c99bbfb08aa6" xlink:to="loc_us-gaap_SubsequentEventMember_62a63154-9a29-41ed-a5f2-85e03d6bffec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_04a48104-b824-495b-813d-cdff3f610879" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_UnitsIssuedDuringPeriodSharesNewIssues_115c52b3-6426-4302-99bf-3d67d15b2b5b" xlink:href="amci-20230213.xsd#amci_UnitsIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:to="loc_amci_UnitsIssuedDuringPeriodSharesNewIssues_115c52b3-6426-4302-99bf-3d67d15b2b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_f8640123-acf3-4bf8-9fca-a5a208003f38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_f8640123-acf3-4bf8-9fca-a5a208003f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_65ed336d-9d19-4e7b-b47a-8c48b949b8de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_65ed336d-9d19-4e7b-b47a-8c48b949b8de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts_361ecaa5-1f33-4411-a6ca-5751394bd911" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:to="loc_us-gaap_DeferredOfferingCosts_361ecaa5-1f33-4411-a6ca-5751394bd911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SaleOfStockUnderwritingDiscounts_61fff495-1755-405f-9190-852fb5f74e5e" xlink:href="amci-20230213.xsd#amci_SaleOfStockUnderwritingDiscounts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:to="loc_amci_SaleOfStockUnderwritingDiscounts_61fff495-1755-405f-9190-852fb5f74e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering_e018b597-4608-4c1d-b840-7a73b05c6592" xlink:href="amci-20230213.xsd#amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:to="loc_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering_e018b597-4608-4c1d-b840-7a73b05c6592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SaleOfStockOtherOfferingCosts_0b5d2e0a-c46d-4c2f-a1dc-9683951d78f6" xlink:href="amci-20230213.xsd#amci_SaleOfStockOtherOfferingCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:to="loc_amci_SaleOfStockOtherOfferingCosts_0b5d2e0a-c46d-4c2f-a1dc-9683951d78f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_8f602268-f334-44d7-8176-c30dc39a5ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_8f602268-f334-44d7-8176-c30dc39a5ce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingCompensationNoncurrent_10923e0c-246c-47fd-83e1-a1a3276717eb" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingCompensationNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:to="loc_amci_DeferredUnderwritingCompensationNoncurrent_10923e0c-246c-47fd-83e1-a1a3276717eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OptionVestingPeriod_647a222f-1084-4895-b219-48ff76471b15" xlink:href="amci-20230213.xsd#amci_OptionVestingPeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:to="loc_amci_OptionVestingPeriod_647a222f-1084-4895-b219-48ff76471b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters_86db4fdd-b3e5-4c2a-b37f-ad9150caac1b" xlink:href="amci-20230213.xsd#amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:to="loc_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters_86db4fdd-b3e5-4c2a-b37f-ad9150caac1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_9b571df3-2e78-47a0-9c18-303413905cef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_9b571df3-2e78-47a0-9c18-303413905cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OptionToPurchaseAdditionalUnitsGivenToInvestors_404f7d04-d2ea-4fb4-af85-7b836bee010c" xlink:href="amci-20230213.xsd#amci_OptionToPurchaseAdditionalUnitsGivenToInvestors"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:to="loc_amci_OptionToPurchaseAdditionalUnitsGivenToInvestors_404f7d04-d2ea-4fb4-af85-7b836bee010c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_0e9179a9-f90c-432e-9ace-c306b96481cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_26c99254-db95-4983-81b6-29f0788009f4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_0e9179a9-f90c-432e-9ace-c306b96481cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#RelatedPartyTransactionsFounderSharesDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_5363db38-ca71-4d2d-a083-2e6d88f2cc48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_e9bb2635-8034-4c94-adec-5ce20c949c54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_5363db38-ca71-4d2d-a083-2e6d88f2cc48" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_e9bb2635-8034-4c94-adec-5ce20c949c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_4a500366-036d-4b2a-8ac8-9bc90bbd7aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_e9bb2635-8034-4c94-adec-5ce20c949c54" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_4a500366-036d-4b2a-8ac8-9bc90bbd7aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_b8b0fd13-2f6d-4955-82ba-c864a0542af6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_4a500366-036d-4b2a-8ac8-9bc90bbd7aa3" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_b8b0fd13-2f6d-4955-82ba-c864a0542af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_FounderSharesMember_01f6c120-290a-4bb5-adf2-7cdd5e33a5cd" xlink:href="amci-20230213.xsd#amci_FounderSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_b8b0fd13-2f6d-4955-82ba-c864a0542af6" xlink:to="loc_amci_FounderSharesMember_01f6c120-290a-4bb5-adf2-7cdd5e33a5cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7d91d1bf-5176-4b06-b388-c84237804bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_e9bb2635-8034-4c94-adec-5ce20c949c54" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7d91d1bf-5176-4b06-b388-c84237804bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_87066bc7-7ba4-43cf-8d81-564ec2979587" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7d91d1bf-5176-4b06-b388-c84237804bcc" xlink:to="loc_us-gaap_RelatedPartyDomain_87066bc7-7ba4-43cf-8d81-564ec2979587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SponsorMember_0bdf14c2-831c-485f-bbfe-9e5bf4fe9ca0" xlink:href="amci-20230213.xsd#amci_SponsorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_87066bc7-7ba4-43cf-8d81-564ec2979587" xlink:to="loc_amci_SponsorMember_0bdf14c2-831c-485f-bbfe-9e5bf4fe9ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AnchorInvestorsMember_7fcb756c-e73f-4058-9b73-d4b6974341a6" xlink:href="amci-20230213.xsd#amci_AnchorInvestorsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_87066bc7-7ba4-43cf-8d81-564ec2979587" xlink:to="loc_amci_AnchorInvestorsMember_7fcb756c-e73f-4058-9b73-d4b6974341a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_d7b719bd-5aa4-41af-a0d0-3abadf37e9f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_e9bb2635-8034-4c94-adec-5ce20c949c54" xlink:to="loc_us-gaap_StatementClassOfStockAxis_d7b719bd-5aa4-41af-a0d0-3abadf37e9f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_0893270d-8498-4879-aec7-ff5105f64b63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d7b719bd-5aa4-41af-a0d0-3abadf37e9f3" xlink:to="loc_us-gaap_ClassOfStockDomain_0893270d-8498-4879-aec7-ff5105f64b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_e93d15f2-a14b-436b-a216-f9b7c703b8e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0893270d-8498-4879-aec7-ff5105f64b63" xlink:to="loc_us-gaap_CommonClassBMember_e93d15f2-a14b-436b-a216-f9b7c703b8e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_52303ecb-8849-47c8-acf9-69bbd127fdc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_e9bb2635-8034-4c94-adec-5ce20c949c54" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_52303ecb-8849-47c8-acf9-69bbd127fdc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_bca14e86-2724-4514-9014-46cea3a55174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_52303ecb-8849-47c8-acf9-69bbd127fdc1" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_bca14e86-2724-4514-9014-46cea3a55174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_5e4d2546-6778-47d0-a5bf-703615102c43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_bca14e86-2724-4514-9014-46cea3a55174" xlink:to="loc_us-gaap_OverAllotmentOptionMember_5e4d2546-6778-47d0-a5bf-703615102c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_e8194cfa-e801-4342-b51a-1fff868d8ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_e9bb2635-8034-4c94-adec-5ce20c949c54" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_e8194cfa-e801-4342-b51a-1fff868d8ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6b5dd6f0-6f51-4263-8616-240cedd4eb1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e8194cfa-e801-4342-b51a-1fff868d8ad3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6b5dd6f0-6f51-4263-8616-240cedd4eb1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_b68cf1cc-1ed0-4032-b1d6-f3461ef09563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e8194cfa-e801-4342-b51a-1fff868d8ad3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_b68cf1cc-1ed0-4032-b1d6-f3461ef09563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_afc32434-e2f5-4102-8c96-60c75faf5185" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e8194cfa-e801-4342-b51a-1fff868d8ad3" xlink:to="loc_us-gaap_SharePrice_afc32434-e2f5-4102-8c96-60c75faf5185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfSharesSurrendered_b775dc38-2f37-4309-844e-df055c78d25d" xlink:href="amci-20230213.xsd#amci_NumberOfSharesSurrendered"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e8194cfa-e801-4342-b51a-1fff868d8ad3" xlink:to="loc_amci_NumberOfSharesSurrendered_b775dc38-2f37-4309-844e-df055c78d25d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SharesSurrenderedFairValueOfShares_d2d84bea-358a-4eeb-8ed9-88d830e298a6" xlink:href="amci-20230213.xsd#amci_SharesSurrenderedFairValueOfShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e8194cfa-e801-4342-b51a-1fff868d8ad3" xlink:to="loc_amci_SharesSurrenderedFairValueOfShares_d2d84bea-358a-4eeb-8ed9-88d830e298a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AggregateNumberOfSharesOwned_0f7263e2-c526-4f1f-b7e3-9511813d3bb3" xlink:href="amci-20230213.xsd#amci_AggregateNumberOfSharesOwned"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e8194cfa-e801-4342-b51a-1fff868d8ad3" xlink:to="loc_amci_AggregateNumberOfSharesOwned_0f7263e2-c526-4f1f-b7e3-9511813d3bb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfSharesSubjectToForfeiture_25ddf885-aa9e-4768-892f-190218f38986" xlink:href="amci-20230213.xsd#amci_NumberOfSharesSubjectToForfeiture"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e8194cfa-e801-4342-b51a-1fff868d8ad3" xlink:to="loc_amci_NumberOfSharesSubjectToForfeiture_25ddf885-aa9e-4768-892f-190218f38986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_fa8427ee-1d96-433a-88f1-24455f94e1be" xlink:href="amci-20230213.xsd#amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e8194cfa-e801-4342-b51a-1fff868d8ad3" xlink:to="loc_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_fa8427ee-1d96-433a-88f1-24455f94e1be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_ab7a7398-63cc-427c-bed4-308959bdd94a" xlink:href="amci-20230213.xsd#amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e8194cfa-e801-4342-b51a-1fff868d8ad3" xlink:to="loc_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_ab7a7398-63cc-427c-bed4-308959bdd94a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_2af93e2f-a87d-4fb6-90dd-d091279bcb41" xlink:href="amci-20230213.xsd#amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e8194cfa-e801-4342-b51a-1fff868d8ad3" xlink:to="loc_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_2af93e2f-a87d-4fb6-90dd-d091279bcb41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_87e20e92-da07-4f23-8202-364a00417674" xlink:href="amci-20230213.xsd#amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e8194cfa-e801-4342-b51a-1fff868d8ad3" xlink:to="loc_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_87e20e92-da07-4f23-8202-364a00417674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences_98fbca3b-4442-4e44-b33a-0f43543ded64" xlink:href="amci-20230213.xsd#amci_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e8194cfa-e801-4342-b51a-1fff868d8ad3" xlink:to="loc_amci_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences_98fbca3b-4442-4e44-b33a-0f43543ded64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#RelatedPartyTransactionsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_bb13cb93-91df-4f9c-a58a-c1b9046a3eea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ed821746-1d2e-403a-8fae-36687fd3d44e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_bb13cb93-91df-4f9c-a58a-c1b9046a3eea" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ed821746-1d2e-403a-8fae-36687fd3d44e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_6b111f83-e9b0-48a8-8474-159026a8c977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ed821746-1d2e-403a-8fae-36687fd3d44e" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_6b111f83-e9b0-48a8-8474-159026a8c977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_4ff1f188-e274-4f9e-a3a0-d72e703a47f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_6b111f83-e9b0-48a8-8474-159026a8c977" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_4ff1f188-e274-4f9e-a3a0-d72e703a47f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AdministrativeSupportAgreementMember_e6582682-8460-4479-a5b5-9dbe2751b01d" xlink:href="amci-20230213.xsd#amci_AdministrativeSupportAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_4ff1f188-e274-4f9e-a3a0-d72e703a47f9" xlink:to="loc_amci_AdministrativeSupportAgreementMember_e6582682-8460-4479-a5b5-9dbe2751b01d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartyLoansMember_a2bfa4b3-6a2b-47c8-9b10-751601373799" xlink:href="amci-20230213.xsd#amci_RelatedPartyLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_4ff1f188-e274-4f9e-a3a0-d72e703a47f9" xlink:to="loc_amci_RelatedPartyLoansMember_a2bfa4b3-6a2b-47c8-9b10-751601373799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_ae8e2a21-1930-432e-9563-ecaeed0c1736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ed821746-1d2e-403a-8fae-36687fd3d44e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_ae8e2a21-1930-432e-9563-ecaeed0c1736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_3d0f4bd7-17e5-4b68-a67e-37c58350d46f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_ae8e2a21-1930-432e-9563-ecaeed0c1736" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_3d0f4bd7-17e5-4b68-a67e-37c58350d46f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WorkingCapitalLoansWarrantMember_c8c76826-307f-46f6-a374-7f12212ab93c" xlink:href="amci-20230213.xsd#amci_WorkingCapitalLoansWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3d0f4bd7-17e5-4b68-a67e-37c58350d46f" xlink:to="loc_amci_WorkingCapitalLoansWarrantMember_c8c76826-307f-46f6-a374-7f12212ab93c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PrivatePlacementWarrantsMember_1ea3b51a-2b04-46a9-bbdc-1abdb04da060" xlink:href="amci-20230213.xsd#amci_PrivatePlacementWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3d0f4bd7-17e5-4b68-a67e-37c58350d46f" xlink:to="loc_amci_PrivatePlacementWarrantsMember_1ea3b51a-2b04-46a9-bbdc-1abdb04da060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_6e399ff1-911d-458c-9e0d-31f4ad5c8d21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ed821746-1d2e-403a-8fae-36687fd3d44e" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_6e399ff1-911d-458c-9e0d-31f4ad5c8d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ab5e4ee6-4ead-4b99-9c85-0567a4a1f78a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_6e399ff1-911d-458c-9e0d-31f4ad5c8d21" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ab5e4ee6-4ead-4b99-9c85-0567a4a1f78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_c2c55eca-292f-41e2-a57d-38741d532f75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ab5e4ee6-4ead-4b99-9c85-0567a4a1f78a" xlink:to="loc_us-gaap_PrivatePlacementMember_c2c55eca-292f-41e2-a57d-38741d532f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ea75088e-ce9a-4b77-a2f3-beaa97746489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ed821746-1d2e-403a-8fae-36687fd3d44e" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ea75088e-ce9a-4b77-a2f3-beaa97746489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_ab621efb-5242-457f-be60-2f3b89dabf04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ea75088e-ce9a-4b77-a2f3-beaa97746489" xlink:to="loc_us-gaap_RelatedPartyDomain_ab621efb-5242-457f-be60-2f3b89dabf04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SponsorMember_9cd2660c-4704-41c7-a65f-081e9a3723c5" xlink:href="amci-20230213.xsd#amci_SponsorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_ab621efb-5242-457f-be60-2f3b89dabf04" xlink:to="loc_amci_SponsorMember_9cd2660c-4704-41c7-a65f-081e9a3723c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_c7b9e6d9-583f-43a4-95cd-4a66a228a528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ed821746-1d2e-403a-8fae-36687fd3d44e" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_c7b9e6d9-583f-43a4-95cd-4a66a228a528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_dd06fb29-7af6-4923-8c32-bec83248275f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b9e6d9-583f-43a4-95cd-4a66a228a528" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_dd06fb29-7af6-4923-8c32-bec83248275f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_bba8aaac-05de-4aee-9f6c-eea4a7f987a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b9e6d9-583f-43a4-95cd-4a66a228a528" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_bba8aaac-05de-4aee-9f6c-eea4a7f987a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights_9cea3d45-0abe-4a5c-a5e1-64f69edc1f54" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b9e6d9-583f-43a4-95cd-4a66a228a528" xlink:to="loc_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights_9cea3d45-0abe-4a5c-a5e1-64f69edc1f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3d530c05-efee-4364-88c4-af88bdca4e70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b9e6d9-583f-43a4-95cd-4a66a228a528" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3d530c05-efee-4364-88c4-af88bdca4e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_8fc7c7c1-a953-440c-b3c2-2003b5c3c00f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b9e6d9-583f-43a4-95cd-4a66a228a528" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_8fc7c7c1-a953-440c-b3c2-2003b5c3c00f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_857c813a-d964-4994-8a87-2453a8169bdb" xlink:href="amci-20230213.xsd#amci_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b9e6d9-583f-43a4-95cd-4a66a228a528" xlink:to="loc_amci_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_857c813a-d964-4994-8a87-2453a8169bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MaximumLoansConvertibleIntoWarrants_c30ae5a0-708c-49c6-b273-c23e0bb936aa" xlink:href="amci-20230213.xsd#amci_MaximumLoansConvertibleIntoWarrants"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b9e6d9-583f-43a4-95cd-4a66a228a528" xlink:to="loc_amci_MaximumLoansConvertibleIntoWarrants_c30ae5a0-708c-49c6-b273-c23e0bb936aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OutstandingWorkingCapitalLoans_82ef05b4-afbc-4afe-b433-565567c41df1" xlink:href="amci-20230213.xsd#amci_OutstandingWorkingCapitalLoans"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b9e6d9-583f-43a4-95cd-4a66a228a528" xlink:to="loc_amci_OutstandingWorkingCapitalLoans_82ef05b4-afbc-4afe-b433-565567c41df1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_f0bbe974-1e16-4c2a-b227-677b0be8d6dc" xlink:href="amci-20230213.xsd#amci_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b9e6d9-583f-43a4-95cd-4a66a228a528" xlink:to="loc_amci_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_f0bbe974-1e16-4c2a-b227-677b0be8d6dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_a232eae2-5cae-4a08-802b-df1391d40243" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b9e6d9-583f-43a4-95cd-4a66a228a528" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_a232eae2-5cae-4a08-802b-df1391d40243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_cc8b3532-0991-4417-8a0e-2541c67da846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b9e6d9-583f-43a4-95cd-4a66a228a528" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_cc8b3532-0991-4417-8a0e-2541c67da846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_ab42eda1-7fd7-42c7-9ac4-f92b0442067d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b9e6d9-583f-43a4-95cd-4a66a228a528" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrent_ab42eda1-7fd7-42c7-9ac4-f92b0442067d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WorkingCapitalLoan_5a7e479b-4c24-4aab-91ea-42469c0d77b4" xlink:href="amci-20230213.xsd#amci_WorkingCapitalLoan"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b9e6d9-583f-43a4-95cd-4a66a228a528" xlink:to="loc_amci_WorkingCapitalLoan_5a7e479b-4c24-4aab-91ea-42469c0d77b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8c084aaf-7b86-49dd-8b8d-a37da33142e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_3acee5c0-2bc7-4dc4-9bff-256b9b2426fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8c084aaf-7b86-49dd-8b8d-a37da33142e6" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_3acee5c0-2bc7-4dc4-9bff-256b9b2426fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_6cfbdd5c-6d71-41ff-9eec-906e6f8a3cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_3acee5c0-2bc7-4dc4-9bff-256b9b2426fb" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_6cfbdd5c-6d71-41ff-9eec-906e6f8a3cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_eac3e71e-658e-4bc7-981f-832bcb343217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_6cfbdd5c-6d71-41ff-9eec-906e6f8a3cf2" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_eac3e71e-658e-4bc7-981f-832bcb343217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_aa1b93cf-6938-40b1-9032-cfd20c906cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_eac3e71e-658e-4bc7-981f-832bcb343217" xlink:to="loc_us-gaap_OverAllotmentOptionMember_aa1b93cf-6938-40b1-9032-cfd20c906cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingFeesMember_f5f0fd4d-bc99-4804-94c5-6e0f68ac7373" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingFeesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_eac3e71e-658e-4bc7-981f-832bcb343217" xlink:to="loc_amci_DeferredUnderwritingFeesMember_f5f0fd4d-bc99-4804-94c5-6e0f68ac7373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_840d3d53-b3c4-4363-8c23-560992bedf24" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_3acee5c0-2bc7-4dc4-9bff-256b9b2426fb" xlink:to="loc_dei_LegalEntityAxis_840d3d53-b3c4-4363-8c23-560992bedf24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_57b56199-be81-4d9f-821c-989e53b9f281" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_840d3d53-b3c4-4363-8c23-560992bedf24" xlink:to="loc_dei_EntityDomain_57b56199-be81-4d9f-821c-989e53b9f281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EvercoreGroupL.l.c.Member_d9e721c9-d626-47ce-801a-7ed90330dfff" xlink:href="amci-20230213.xsd#amci_EvercoreGroupL.l.c.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_57b56199-be81-4d9f-821c-989e53b9f281" xlink:to="loc_amci_EvercoreGroupL.l.c.Member_d9e721c9-d626-47ce-801a-7ed90330dfff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_7e2d1134-8bba-41b4-b03e-c0e92f0a940d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_3acee5c0-2bc7-4dc4-9bff-256b9b2426fb" xlink:to="loc_srt_TitleOfIndividualAxis_7e2d1134-8bba-41b4-b03e-c0e92f0a940d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_34fda081-5eff-4070-bfd4-1abc77413510" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_7e2d1134-8bba-41b4-b03e-c0e92f0a940d" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_34fda081-5eff-4070-bfd4-1abc77413510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CoplacementAgentMember_f976c122-952a-4982-9fbd-5c9f6fda451e" xlink:href="amci-20230213.xsd#amci_CoplacementAgentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_34fda081-5eff-4070-bfd4-1abc77413510" xlink:to="loc_amci_CoplacementAgentMember_f976c122-952a-4982-9fbd-5c9f6fda451e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_FinancialAdvisoryMember_0e879e3f-a386-4570-acf8-b05c087c66e5" xlink:href="amci-20230213.xsd#amci_FinancialAdvisoryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_34fda081-5eff-4070-bfd4-1abc77413510" xlink:to="loc_amci_FinancialAdvisoryMember_0e879e3f-a386-4570-acf8-b05c087c66e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_3aa1081c-cf5b-4310-8834-8747c4689289" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_3acee5c0-2bc7-4dc4-9bff-256b9b2426fb" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_3aa1081c-cf5b-4310-8834-8747c4689289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MaximumNumberOfDemandsForRegistrationOfSecurities_3fa30737-a857-43bf-b6cb-c9de1c274925" xlink:href="amci-20230213.xsd#amci_MaximumNumberOfDemandsForRegistrationOfSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_3aa1081c-cf5b-4310-8834-8747c4689289" xlink:to="loc_amci_MaximumNumberOfDemandsForRegistrationOfSecurities_3fa30737-a857-43bf-b6cb-c9de1c274925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OptionVestingPeriod_1396040f-047d-49c5-af32-1dbcdb29ec6f" xlink:href="amci-20230213.xsd#amci_OptionVestingPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_3aa1081c-cf5b-4310-8834-8747c4689289" xlink:to="loc_amci_OptionVestingPeriod_1396040f-047d-49c5-af32-1dbcdb29ec6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters_84ab91fb-5ee1-416c-b654-b0214b9a9887" xlink:href="amci-20230213.xsd#amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_3aa1081c-cf5b-4310-8834-8747c4689289" xlink:to="loc_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters_84ab91fb-5ee1-416c-b654-b0214b9a9887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_UnderwritingDiscountPercentage_04234913-1d6b-4417-8f9e-ab852d34c219" xlink:href="amci-20230213.xsd#amci_UnderwritingDiscountPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_3aa1081c-cf5b-4310-8834-8747c4689289" xlink:to="loc_amci_UnderwritingDiscountPercentage_04234913-1d6b-4417-8f9e-ab852d34c219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SaleOfStockUnderwritingDiscounts_d81a2149-f1aa-422e-bf32-4c39bf537aab" xlink:href="amci-20230213.xsd#amci_SaleOfStockUnderwritingDiscounts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_3aa1081c-cf5b-4310-8834-8747c4689289" xlink:to="loc_amci_SaleOfStockUnderwritingDiscounts_d81a2149-f1aa-422e-bf32-4c39bf537aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingDiscounts_78aa804f-0f59-4546-9a99-b9723b892e69" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingDiscounts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_3aa1081c-cf5b-4310-8834-8747c4689289" xlink:to="loc_amci_DeferredUnderwritingDiscounts_78aa804f-0f59-4546-9a99-b9723b892e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingDiscountPercentage_2ceefc0d-b159-40a1-809c-58dc01fed7c8" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingDiscountPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_3aa1081c-cf5b-4310-8834-8747c4689289" xlink:to="loc_amci_DeferredUnderwritingDiscountPercentage_2ceefc0d-b159-40a1-809c-58dc01fed7c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfSharesSubjectToForfeiture_cb273b7f-1d4a-4ccd-8a46-c8fd0aa537b8" xlink:href="amci-20230213.xsd#amci_NumberOfSharesSubjectToForfeiture"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_3aa1081c-cf5b-4310-8834-8747c4689289" xlink:to="loc_amci_NumberOfSharesSubjectToForfeiture_cb273b7f-1d4a-4ccd-8a46-c8fd0aa537b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromFeesReceived_4a4a4619-f94a-459d-b884-f7563a08ba0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromFeesReceived"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_3aa1081c-cf5b-4310-8834-8747c4689289" xlink:to="loc_us-gaap_ProceedsFromFeesReceived_4a4a4619-f94a-459d-b884-f7563a08ba0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares_dc7b771e-7289-470a-bbca-2dee80a0e665" xlink:href="amci-20230213.xsd#amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_3aa1081c-cf5b-4310-8834-8747c4689289" xlink:to="loc_amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares_dc7b771e-7289-470a-bbca-2dee80a0e665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants_8ca6d680-2028-4826-99c6-0f4997e1d1e7" xlink:href="amci-20230213.xsd#amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_3aa1081c-cf5b-4310-8834-8747c4689289" xlink:to="loc_amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants_8ca6d680-2028-4826-99c6-0f4997e1d1e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#ClassACommonStockSubjecttoPossibleRedemptionDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_bf1eb27a-e608-4b5a-8169-6c32aee8c685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_5ae3d0b2-151f-4292-b103-762033b73b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_bf1eb27a-e608-4b5a-8169-6c32aee8c685" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_5ae3d0b2-151f-4292-b103-762033b73b3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b638fdbc-a68a-47e6-92bd-81926bd1077b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_5ae3d0b2-151f-4292-b103-762033b73b3b" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b638fdbc-a68a-47e6-92bd-81926bd1077b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b673e447-4267-4e8f-ae23-2c6adc836d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b638fdbc-a68a-47e6-92bd-81926bd1077b" xlink:to="loc_us-gaap_ClassOfStockDomain_b673e447-4267-4e8f-ae23-2c6adc836d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_bfaea8c6-4b72-46cc-9688-70df33934fda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_b673e447-4267-4e8f-ae23-2c6adc836d3a" xlink:to="loc_us-gaap_CommonClassAMember_bfaea8c6-4b72-46cc-9688-70df33934fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CommonClassaSubjectToRedemptionMember_f369e75b-a3b9-44df-a32b-779cdfe88387" xlink:href="amci-20230213.xsd#amci_CommonClassaSubjectToRedemptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonClassAMember_bfaea8c6-4b72-46cc-9688-70df33934fda" xlink:to="loc_amci_CommonClassaSubjectToRedemptionMember_f369e75b-a3b9-44df-a32b-779cdfe88387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_b8a161d1-cc3f-4317-980e-515d61eb37c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_5ae3d0b2-151f-4292-b103-762033b73b3b" xlink:to="loc_us-gaap_TemporaryEquityLineItems_b8a161d1-cc3f-4317-980e-515d61eb37c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_1a24e4df-5904-494e-b711-86a84608494a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_b8a161d1-cc3f-4317-980e-515d61eb37c7" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_1a24e4df-5904-494e-b711-86a84608494a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_d7cfee3c-ac03-461f-93fb-0577ba8ed12c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_b8a161d1-cc3f-4317-980e-515d61eb37c7" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_d7cfee3c-ac03-461f-93fb-0577ba8ed12c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CommonStockNumberOfVotesPerShare_5a4ee8c9-c68c-4565-b817-8e72559bb2a8" xlink:href="amci-20230213.xsd#amci_CommonStockNumberOfVotesPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_b8a161d1-cc3f-4317-980e-515d61eb37c7" xlink:to="loc_amci_CommonStockNumberOfVotesPerShare_5a4ee8c9-c68c-4565-b817-8e72559bb2a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_bc1cae89-3d7b-4397-ba8b-f679ffa5d0b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_b8a161d1-cc3f-4317-980e-515d61eb37c7" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_bc1cae89-3d7b-4397-ba8b-f679ffa5d0b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_a9738f51-9ad3-4ae4-8bb6-cc81610ea656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_b8a161d1-cc3f-4317-980e-515d61eb37c7" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_a9738f51-9ad3-4ae4-8bb6-cc81610ea656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LessAbstract_dee913fd-7f80-4faf-951e-cb73db62f24d" xlink:href="amci-20230213.xsd#amci_LessAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_b8a161d1-cc3f-4317-980e-515d61eb37c7" xlink:to="loc_amci_LessAbstract_dee913fd-7f80-4faf-951e-cb73db62f24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityProceedsAllocatedToWarrants_dc744e8d-0ec6-4ce8-9433-388e17d093ab" xlink:href="amci-20230213.xsd#amci_TemporaryEquityProceedsAllocatedToWarrants"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_LessAbstract_dee913fd-7f80-4faf-951e-cb73db62f24d" xlink:to="loc_amci_TemporaryEquityProceedsAllocatedToWarrants_dc744e8d-0ec6-4ce8-9433-388e17d093ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityIssuanceCosts_b479770d-7fd6-4540-8cba-00e2e9d71159" xlink:href="amci-20230213.xsd#amci_TemporaryEquityIssuanceCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_LessAbstract_dee913fd-7f80-4faf-951e-cb73db62f24d" xlink:to="loc_amci_TemporaryEquityIssuanceCosts_b479770d-7fd6-4540-8cba-00e2e9d71159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PlusAbstract_2b6cc841-57d2-464c-b1af-b2ca5f7d29a0" xlink:href="amci-20230213.xsd#amci_PlusAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_b8a161d1-cc3f-4317-980e-515d61eb37c7" xlink:to="loc_amci_PlusAbstract_2b6cc841-57d2-464c-b1af-b2ca5f7d29a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_c4e19979-048e-4be5-86d4-37787e090b21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_PlusAbstract_2b6cc841-57d2-464c-b1af-b2ca5f7d29a0" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_c4e19979-048e-4be5-86d4-37787e090b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption_f1602b0c-ade8-4150-abd0-8a4be0815910" xlink:href="amci-20230213.xsd#amci_IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_PlusAbstract_2b6cc841-57d2-464c-b1af-b2ca5f7d29a0" xlink:to="loc_amci_IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption_f1602b0c-ade8-4150-abd0-8a4be0815910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_e9f4353f-55fb-46d5-97d2-4859be94e166" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_PlusAbstract_2b6cc841-57d2-464c-b1af-b2ca5f7d29a0" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_e9f4353f-55fb-46d5-97d2-4859be94e166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/StockholdersEquityDeficitPreferredStockSharesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#StockholdersEquityDeficitPreferredStockSharesDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/StockholdersEquityDeficitPreferredStockSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_3707d07d-feac-4973-92e6-4a47de7e3b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_b9afdd3e-fe1b-4fe0-873b-eccedeea64d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_3707d07d-feac-4973-92e6-4a47de7e3b9b" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_b9afdd3e-fe1b-4fe0-873b-eccedeea64d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_16f5a44f-5d4e-46c0-9179-7c2d8ab1154e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_3707d07d-feac-4973-92e6-4a47de7e3b9b" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_16f5a44f-5d4e-46c0-9179-7c2d8ab1154e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_cf6ce512-d672-4c57-8e34-18590671a0ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_3707d07d-feac-4973-92e6-4a47de7e3b9b" xlink:to="loc_us-gaap_PreferredStockSharesIssued_cf6ce512-d672-4c57-8e34-18590671a0ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_bc49164c-5a8a-4129-b9aa-fd5e14406ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_3707d07d-feac-4973-92e6-4a47de7e3b9b" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_bc49164c-5a8a-4129-b9aa-fd5e14406ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/StockholdersEquityDeficitCommonStockSharesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#StockholdersEquityDeficitCommonStockSharesDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/StockholdersEquityDeficitCommonStockSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_083b0baa-6351-4307-a096-8a5d46d615f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_5bab40fd-4728-4f47-8061-dcf6eec61b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_083b0baa-6351-4307-a096-8a5d46d615f5" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_5bab40fd-4728-4f47-8061-dcf6eec61b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_da6dcc9a-6ed1-4c2c-8f7e-02e753a2f319" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_5bab40fd-4728-4f47-8061-dcf6eec61b7e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_da6dcc9a-6ed1-4c2c-8f7e-02e753a2f319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_406957b4-abda-43fe-8fa7-571eec6adaf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_da6dcc9a-6ed1-4c2c-8f7e-02e753a2f319" xlink:to="loc_us-gaap_ClassOfStockDomain_406957b4-abda-43fe-8fa7-571eec6adaf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_dfcb59cb-8c72-4c26-a215-e7635bde48b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_406957b4-abda-43fe-8fa7-571eec6adaf4" xlink:to="loc_us-gaap_CommonClassAMember_dfcb59cb-8c72-4c26-a215-e7635bde48b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CommonClassaSubjectToRedemptionMember_b0a1452c-847d-439d-b8ae-4695148018c1" xlink:href="amci-20230213.xsd#amci_CommonClassaSubjectToRedemptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonClassAMember_dfcb59cb-8c72-4c26-a215-e7635bde48b0" xlink:to="loc_amci_CommonClassaSubjectToRedemptionMember_b0a1452c-847d-439d-b8ae-4695148018c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_e143f35c-4dbe-469f-a4d0-96684d4177d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_406957b4-abda-43fe-8fa7-571eec6adaf4" xlink:to="loc_us-gaap_CommonClassBMember_e143f35c-4dbe-469f-a4d0-96684d4177d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_ff36a3d0-a6f0-4e80-9efe-5f3de711e127" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_5bab40fd-4728-4f47-8061-dcf6eec61b7e" xlink:to="loc_us-gaap_ClassOfStockLineItems_ff36a3d0-a6f0-4e80-9efe-5f3de711e127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_ecdb5a8e-1b36-4688-a289-878c3fd75ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ff36a3d0-a6f0-4e80-9efe-5f3de711e127" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_ecdb5a8e-1b36-4688-a289-878c3fd75ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_4a63a917-1427-41f2-9a18-468ff9ea4c31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ff36a3d0-a6f0-4e80-9efe-5f3de711e127" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_4a63a917-1427-41f2-9a18-468ff9ea4c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_1d124d7b-3669-467f-b1e1-ab0be477852c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ff36a3d0-a6f0-4e80-9efe-5f3de711e127" xlink:to="loc_us-gaap_CommonStockSharesIssued_1d124d7b-3669-467f-b1e1-ab0be477852c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_9e986c4f-4668-4e2a-b538-c5847ee866b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ff36a3d0-a6f0-4e80-9efe-5f3de711e127" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_9e986c4f-4668-4e2a-b538-c5847ee866b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_9451c68d-df3b-4cf1-8f77-f09da9bdc28e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ff36a3d0-a6f0-4e80-9efe-5f3de711e127" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_9451c68d-df3b-4cf1-8f77-f09da9bdc28e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_5b2906d8-1d92-49a6-86f5-ec097b507923" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ff36a3d0-a6f0-4e80-9efe-5f3de711e127" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_5b2906d8-1d92-49a6-86f5-ec097b507923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1_21c77c9b-342e-4902-ab06-bdd2d4af8743" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ff36a3d0-a6f0-4e80-9efe-5f3de711e127" xlink:to="loc_us-gaap_ConversionOfStockSharesIssued1_21c77c9b-342e-4902-ab06-bdd2d4af8743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ConvertibleStockConversionRatio_462687d9-ef9c-4cd4-97bc-db6fb4253f52" xlink:href="amci-20230213.xsd#amci_ConvertibleStockConversionRatio"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ff36a3d0-a6f0-4e80-9efe-5f3de711e127" xlink:to="loc_amci_ConvertibleStockConversionRatio_462687d9-ef9c-4cd4-97bc-db6fb4253f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/WarrantsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#WarrantsDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/WarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_ae8a6df5-751a-44fe-babc-fa134a94e694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_42ff24c7-3197-4fdc-94ab-aecd8f2872be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_ae8a6df5-751a-44fe-babc-fa134a94e694" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_42ff24c7-3197-4fdc-94ab-aecd8f2872be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_06de9eb2-bc52-409e-a764-4d7909f1fd09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_42ff24c7-3197-4fdc-94ab-aecd8f2872be" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_06de9eb2-bc52-409e-a764-4d7909f1fd09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_6f925e87-c08a-4274-96d8-192dbec65ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_06de9eb2-bc52-409e-a764-4d7909f1fd09" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_6f925e87-c08a-4274-96d8-192dbec65ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PublicWarrantsMember_4e5803c8-8028-4ae8-92f5-f5c85fc24a4d" xlink:href="amci-20230213.xsd#amci_PublicWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_6f925e87-c08a-4274-96d8-192dbec65ac9" xlink:to="loc_amci_PublicWarrantsMember_4e5803c8-8028-4ae8-92f5-f5c85fc24a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PrivatePlacementWarrantsMember_96026862-cfc8-4dda-a9d5-3f897485a0fe" xlink:href="amci-20230213.xsd#amci_PrivatePlacementWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_6f925e87-c08a-4274-96d8-192dbec65ac9" xlink:to="loc_amci_PrivatePlacementWarrantsMember_96026862-cfc8-4dda-a9d5-3f897485a0fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_603fea72-69be-40c8-87ac-8bb4b2c0d84c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_42ff24c7-3197-4fdc-94ab-aecd8f2872be" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_603fea72-69be-40c8-87ac-8bb4b2c0d84c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_db499b86-8ebe-4dda-841b-dd2b08785cea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_603fea72-69be-40c8-87ac-8bb4b2c0d84c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_db499b86-8ebe-4dda-841b-dd2b08785cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_995eaedf-2931-4990-bd3c-bf664bc69d62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_603fea72-69be-40c8-87ac-8bb4b2c0d84c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_995eaedf-2931-4990-bd3c-bf664bc69d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights_09a292ef-d6fb-4454-a8ed-05d45500fbaa" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_603fea72-69be-40c8-87ac-8bb4b2c0d84c" xlink:to="loc_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights_09a292ef-d6fb-4454-a8ed-05d45500fbaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering_b9cf9f87-b70b-42be-8589-c70c2fabedc8" xlink:href="amci-20230213.xsd#amci_WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_603fea72-69be-40c8-87ac-8bb4b2c0d84c" xlink:to="loc_amci_WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering_b9cf9f87-b70b-42be-8589-c70c2fabedc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_29dce198-3634-417d-8353-944c4f504db4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_603fea72-69be-40c8-87ac-8bb4b2c0d84c" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_29dce198-3634-417d-8353-944c4f504db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PeriodForFillingRegistrationStatementAfterBusinessCombination_dda64794-93c7-4ee3-a984-d180aecec862" xlink:href="amci-20230213.xsd#amci_PeriodForFillingRegistrationStatementAfterBusinessCombination"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_603fea72-69be-40c8-87ac-8bb4b2c0d84c" xlink:to="loc_amci_PeriodForFillingRegistrationStatementAfterBusinessCombination_dda64794-93c7-4ee3-a984-d180aecec862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise_8a4321fb-090e-421c-8f1d-0923ef454cf7" xlink:href="amci-20230213.xsd#amci_PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_603fea72-69be-40c8-87ac-8bb4b2c0d84c" xlink:to="loc_amci_PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise_8a4321fb-090e-421c-8f1d-0923ef454cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#WarrantsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_12237962-f43c-4028-a26f-421ada2bc329" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_b35bd8c8-e010-42a1-bfc8-c2e060711280" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_12237962-f43c-4028-a26f-421ada2bc329" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_b35bd8c8-e010-42a1-bfc8-c2e060711280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_4b1bff85-4208-425d-bb12-4d15ec102ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_b35bd8c8-e010-42a1-bfc8-c2e060711280" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_4b1bff85-4208-425d-bb12-4d15ec102ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_9060aa84-9b54-49af-9b41-d0d8c7433575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_4b1bff85-4208-425d-bb12-4d15ec102ce0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_9060aa84-9b54-49af-9b41-d0d8c7433575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PublicWarrantsMember_b42c3f97-b87b-4fa4-a7ba-a68432fb3d9d" xlink:href="amci-20230213.xsd#amci_PublicWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_9060aa84-9b54-49af-9b41-d0d8c7433575" xlink:to="loc_amci_PublicWarrantsMember_b42c3f97-b87b-4fa4-a7ba-a68432fb3d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a6e7807c-9fb4-48f1-ae34-963d4fbb1ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_b35bd8c8-e010-42a1-bfc8-c2e060711280" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a6e7807c-9fb4-48f1-ae34-963d4fbb1ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6752f5c1-70b9-4963-b438-472d239e5c13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a6e7807c-9fb4-48f1-ae34-963d4fbb1ca8" xlink:to="loc_us-gaap_ClassOfStockDomain_6752f5c1-70b9-4963-b438-472d239e5c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_4473488f-264e-40e7-b462-8470d51b51b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6752f5c1-70b9-4963-b438-472d239e5c13" xlink:to="loc_us-gaap_CommonClassAMember_4473488f-264e-40e7-b462-8470d51b51b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WarrantConditionAxis_67557f60-0c4b-4576-b578-9c0523b7fc17" xlink:href="amci-20230213.xsd#amci_WarrantConditionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_b35bd8c8-e010-42a1-bfc8-c2e060711280" xlink:to="loc_amci_WarrantConditionAxis_67557f60-0c4b-4576-b578-9c0523b7fc17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WarrantConditionDomain_b9abe891-d675-41e0-9492-2f763b7b608c" xlink:href="amci-20230213.xsd#amci_WarrantConditionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_WarrantConditionAxis_67557f60-0c4b-4576-b578-9c0523b7fc17" xlink:to="loc_amci_WarrantConditionDomain_b9abe891-d675-41e0-9492-2f763b7b608c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_29668417-e47d-448b-8cdc-a51171743007" xlink:href="amci-20230213.xsd#amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_WarrantConditionDomain_b9abe891-d675-41e0-9492-2f763b7b608c" xlink:to="loc_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_29668417-e47d-448b-8cdc-a51171743007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_efbc2319-b59d-4bf7-9288-4a46e73e9f70" xlink:href="amci-20230213.xsd#amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_WarrantConditionDomain_b9abe891-d675-41e0-9492-2f763b7b608c" xlink:to="loc_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_efbc2319-b59d-4bf7-9288-4a46e73e9f70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_2b027379-0477-418b-a223-e76f42fb5051" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_b35bd8c8-e010-42a1-bfc8-c2e060711280" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_2b027379-0477-418b-a223-e76f42fb5051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_eb05eebe-b16b-4898-bfcf-6c5fcd482f49" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_2b027379-0477-418b-a223-e76f42fb5051" xlink:to="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_eb05eebe-b16b-4898-bfcf-6c5fcd482f49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_0138de82-1375-4fd0-8d9e-8786fa33933a" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_2b027379-0477-418b-a223-e76f42fb5051" xlink:to="loc_amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_0138de82-1375-4fd0-8d9e-8786fa33933a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RedemptionPeriod_0af54c37-3944-4abe-863a-9623b0e0e3a1" xlink:href="amci-20230213.xsd#amci_RedemptionPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_2b027379-0477-418b-a223-e76f42fb5051" xlink:to="loc_amci_RedemptionPeriod_0af54c37-3944-4abe-863a-9623b0e0e3a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_b787a683-8bf5-4503-87f5-b1a7a9d604e9" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_2b027379-0477-418b-a223-e76f42fb5051" xlink:to="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_b787a683-8bf5-4503-87f5-b1a7a9d604e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants_00fa3705-ec0a-44c4-b4ef-53ee1c364665" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_2b027379-0477-418b-a223-e76f42fb5051" xlink:to="loc_amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants_00fa3705-ec0a-44c4-b4ef-53ee1c364665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_efd5dff9-fd26-4a16-8213-5d28584c4440" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_2b027379-0477-418b-a223-e76f42fb5051" xlink:to="loc_us-gaap_SharePrice_efd5dff9-fd26-4a16-8213-5d28584c4440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PercentageOfGrossProceedsOnTotalEquityProceed_5beb6563-cae0-43a3-81ab-67bba3839913" xlink:href="amci-20230213.xsd#amci_PercentageOfGrossProceedsOnTotalEquityProceed"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_2b027379-0477-418b-a223-e76f42fb5051" xlink:to="loc_amci_PercentageOfGrossProceedsOnTotalEquityProceed_5beb6563-cae0-43a3-81ab-67bba3839913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_8f8112f0-3ad1-4950-a027-38fefbfbf84b" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_2b027379-0477-418b-a223-e76f42fb5051" xlink:to="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_8f8112f0-3ad1-4950-a027-38fefbfbf84b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices_a41c5e55-aaac-4110-a35a-1b996f1b846c" xlink:href="amci-20230213.xsd#amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_2b027379-0477-418b-a223-e76f42fb5051" xlink:to="loc_amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices_a41c5e55-aaac-4110-a35a-1b996f1b846c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_702d3479-f924-40ef-8544-03a0131eb132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_2b027379-0477-418b-a223-e76f42fb5051" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_702d3479-f924-40ef-8544-03a0131eb132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7cd331c6-6eca-408e-b935-50dab99d2265" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_412546e0-d74d-4992-bcf9-855acdba9713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7cd331c6-6eca-408e-b935-50dab99d2265" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_412546e0-d74d-4992-bcf9-855acdba9713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bad5c375-2435-4075-83d5-f0780c5bd803" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_412546e0-d74d-4992-bcf9-855acdba9713" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bad5c375-2435-4075-83d5-f0780c5bd803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_b12fc9ff-6785-4091-b683-bf2952cdbe0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bad5c375-2435-4075-83d5-f0780c5bd803" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_b12fc9ff-6785-4091-b683-bf2952cdbe0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_858641af-3df7-426e-9872-e66240dedda9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_b12fc9ff-6785-4091-b683-bf2952cdbe0d" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_858641af-3df7-426e-9872-e66240dedda9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_54af9af7-3ce7-4210-83d5-7a67115c5a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_412546e0-d74d-4992-bcf9-855acdba9713" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_54af9af7-3ce7-4210-83d5-7a67115c5a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eb154cf4-fe5e-4caf-97cb-810baf5f3a43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_54af9af7-3ce7-4210-83d5-7a67115c5a1c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eb154cf4-fe5e-4caf-97cb-810baf5f3a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_5808f3da-a427-4b01-ae66-9b8440b2a382" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eb154cf4-fe5e-4caf-97cb-810baf5f3a43" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_5808f3da-a427-4b01-ae66-9b8440b2a382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_189bbaef-c0b1-441a-b249-3cc3d1e333b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eb154cf4-fe5e-4caf-97cb-810baf5f3a43" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_189bbaef-c0b1-441a-b249-3cc3d1e333b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_22f4192a-f18f-44e9-8b8f-ccea4436740b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_412546e0-d74d-4992-bcf9-855acdba9713" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_22f4192a-f18f-44e9-8b8f-ccea4436740b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_a9f6d96a-e442-4999-9c80-d53448204f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_22f4192a-f18f-44e9-8b8f-ccea4436740b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_a9f6d96a-e442-4999-9c80-d53448204f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PublicWarrantsMember_2efa28af-3467-4166-8200-d162f0900d2a" xlink:href="amci-20230213.xsd#amci_PublicWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_a9f6d96a-e442-4999-9c80-d53448204f4c" xlink:to="loc_amci_PublicWarrantsMember_2efa28af-3467-4166-8200-d162f0900d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PrivatePlacementWarrantsMember_b57f6d9a-ff71-4e9a-adce-6a8e3d1860a8" xlink:href="amci-20230213.xsd#amci_PrivatePlacementWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_a9f6d96a-e442-4999-9c80-d53448204f4c" xlink:to="loc_amci_PrivatePlacementWarrantsMember_b57f6d9a-ff71-4e9a-adce-6a8e3d1860a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_80314774-5279-45b1-bb4e-cc8eed77cb7d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_412546e0-d74d-4992-bcf9-855acdba9713" xlink:to="loc_dei_LegalEntityAxis_80314774-5279-45b1-bb4e-cc8eed77cb7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_abd2ff6d-06cb-4f26-acfa-e8f373d80873" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_80314774-5279-45b1-bb4e-cc8eed77cb7d" xlink:to="loc_dei_EntityDomain_abd2ff6d-06cb-4f26-acfa-e8f373d80873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AMCIACQUISITIONCORPIIMember_8759678d-f806-4c1b-9cb1-3060d5d39932" xlink:href="amci-20230213.xsd#amci_AMCIACQUISITIONCORPIIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_abd2ff6d-06cb-4f26-acfa-e8f373d80873" xlink:to="loc_amci_AMCIACQUISITIONCORPIIMember_8759678d-f806-4c1b-9cb1-3060d5d39932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_06008f66-9008-4607-8958-f783cbe23a44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_412546e0-d74d-4992-bcf9-855acdba9713" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_06008f66-9008-4607-8958-f783cbe23a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_ec8ff52b-a43a-4b03-a222-49b4650bb8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_06008f66-9008-4607-8958-f783cbe23a44" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_ec8ff52b-a43a-4b03-a222-49b4650bb8cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_bc13bd31-357b-4f5b-a4fc-d01584df65ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_ec8ff52b-a43a-4b03-a222-49b4650bb8cf" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_bc13bd31-357b-4f5b-a4fc-d01584df65ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_9bb1f9cd-ceea-4c3a-a2e8-621fb1794b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_06008f66-9008-4607-8958-f783cbe23a44" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_9bb1f9cd-ceea-4c3a-a2e8-621fb1794b8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_822a92e9-ef97-41d6-88ff-2a3b0c405483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_9bb1f9cd-ceea-4c3a-a2e8-621fb1794b8a" xlink:to="loc_us-gaap_DerivativeLiabilities_822a92e9-ef97-41d6-88ff-2a3b0c405483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_01cec613-793a-468f-ae03-7c20e85e015f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_9bb1f9cd-ceea-4c3a-a2e8-621fb1794b8a" xlink:to="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_01cec613-793a-468f-ae03-7c20e85e015f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_c9fd1667-3562-4afa-a9a6-9e1a0112d284" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_06008f66-9008-4607-8958-f783cbe23a44" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_c9fd1667-3562-4afa-a9a6-9e1a0112d284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueMeasurementsLevel3fairvaluemeasurementsDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f0cf690e-f65f-4e53-92b1-61a0153adb6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_3b44f11d-4edb-49e8-b0a6-0db407cc6871" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f0cf690e-f65f-4e53-92b1-61a0153adb6b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_3b44f11d-4edb-49e8-b0a6-0db407cc6871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_0acd5f1f-bc3e-4315-82df-21388e1698ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_3b44f11d-4edb-49e8-b0a6-0db407cc6871" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_0acd5f1f-bc3e-4315-82df-21388e1698ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_9de0848b-32ce-4c3c-8b86-2daa203ab74b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_0acd5f1f-bc3e-4315-82df-21388e1698ae" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_9de0848b-32ce-4c3c-8b86-2daa203ab74b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExercisePriceMember_7544e836-f603-4a8d-a957-7999acc855a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExercisePriceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_9de0848b-32ce-4c3c-8b86-2daa203ab74b" xlink:to="loc_us-gaap_MeasurementInputExercisePriceMember_7544e836-f603-4a8d-a957-7999acc855a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_5385b988-6de1-4345-b661-232255fbf3a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_9de0848b-32ce-4c3c-8b86-2daa203ab74b" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_5385b988-6de1-4345-b661-232255fbf3a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_a6cff8cb-3fe1-493d-a72d-931ada24736c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_9de0848b-32ce-4c3c-8b86-2daa203ab74b" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_a6cff8cb-3fe1-493d-a72d-931ada24736c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_e0e209d7-b449-43f2-a654-0e71b47b0b65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_9de0848b-32ce-4c3c-8b86-2daa203ab74b" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_e0e209d7-b449-43f2-a654-0e71b47b0b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1e3bd8ff-091c-4cd5-81c4-e60b5ec9d77d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_9de0848b-32ce-4c3c-8b86-2daa203ab74b" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1e3bd8ff-091c-4cd5-81c4-e60b5ec9d77d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_26187533-6d61-40ab-8efe-2375d6cc7621" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_3b44f11d-4edb-49e8-b0a6-0db407cc6871" xlink:to="loc_dei_LegalEntityAxis_26187533-6d61-40ab-8efe-2375d6cc7621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_0b414506-d964-4096-b770-78df7373e843" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_26187533-6d61-40ab-8efe-2375d6cc7621" xlink:to="loc_dei_EntityDomain_0b414506-d964-4096-b770-78df7373e843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AMCIACQUISITIONCORPIIMember_fc402b49-5de7-437c-b911-031eec01af04" xlink:href="amci-20230213.xsd#amci_AMCIACQUISITIONCORPIIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_0b414506-d964-4096-b770-78df7373e843" xlink:to="loc_amci_AMCIACQUISITIONCORPIIMember_fc402b49-5de7-437c-b911-031eec01af04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_92e3753f-8fa3-4f18-ac35-99ac94520acf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_3b44f11d-4edb-49e8-b0a6-0db407cc6871" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_92e3753f-8fa3-4f18-ac35-99ac94520acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_d79e1ba7-2ce0-46d6-944a-450c3fa9bef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_92e3753f-8fa3-4f18-ac35-99ac94520acf" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_d79e1ba7-2ce0-46d6-944a-450c3fa9bef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5bff1cdb-2465-4ac4-9d09-d9dc33aaeef3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ddbb4878-c2ac-4648-be2f-bedc190bf77c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5bff1cdb-2465-4ac4-9d09-d9dc33aaeef3" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ddbb4878-c2ac-4648-be2f-bedc190bf77c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_50924c43-a0b4-46f5-9090-903ae56701ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ddbb4878-c2ac-4648-be2f-bedc190bf77c" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_50924c43-a0b4-46f5-9090-903ae56701ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_a1be14e1-b65d-46c5-a1f4-1e816ecd217c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_50924c43-a0b4-46f5-9090-903ae56701ed" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_a1be14e1-b65d-46c5-a1f4-1e816ecd217c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_6e08efe0-3d32-4557-b2ff-71afbce89279" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_a1be14e1-b65d-46c5-a1f4-1e816ecd217c" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_6e08efe0-3d32-4557-b2ff-71afbce89279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_26d6e6ba-d1f9-4300-9604-72d2aa48a2af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ddbb4878-c2ac-4648-be2f-bedc190bf77c" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_26d6e6ba-d1f9-4300-9604-72d2aa48a2af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_869f7b9b-bf17-4810-bc91-ef4d3db549d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_26d6e6ba-d1f9-4300-9604-72d2aa48a2af" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_869f7b9b-bf17-4810-bc91-ef4d3db549d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3a319a89-9f7d-417c-9d52-febd1dc1c660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_869f7b9b-bf17-4810-bc91-ef4d3db549d1" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3a319a89-9f7d-417c-9d52-febd1dc1c660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_333e0542-467f-4768-b531-c1a18155ea73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_869f7b9b-bf17-4810-bc91-ef4d3db549d1" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_333e0542-467f-4768-b531-c1a18155ea73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_bc5de0f2-bdd5-4a6b-84cc-4074131baaab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_333e0542-467f-4768-b531-c1a18155ea73" xlink:to="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_bc5de0f2-bdd5-4a6b-84cc-4074131baaab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b6a54be2-27ce-45bf-8a84-c56cfd179d86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_869f7b9b-bf17-4810-bc91-ef4d3db549d1" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b6a54be2-27ce-45bf-8a84-c56cfd179d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_ae240bb6-f986-4649-81f8-f739c9b3e812" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_cf1ef23f-30f1-4d6f-9979-0f60ce9e3ae0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_ae240bb6-f986-4649-81f8-f739c9b3e812" xlink:to="loc_us-gaap_SubsequentEventTable_cf1ef23f-30f1-4d6f-9979-0f60ce9e3ae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_ccc0ad2a-619e-4510-a549-610c348a26a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_cf1ef23f-30f1-4d6f-9979-0f60ce9e3ae0" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_ccc0ad2a-619e-4510-a549-610c348a26a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_52a02182-43ca-41dc-b418-fab45098e863" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ccc0ad2a-619e-4510-a549-610c348a26a1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_52a02182-43ca-41dc-b418-fab45098e863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_843c5bb3-f1e7-48ac-acee-50ba9f896433" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_52a02182-43ca-41dc-b418-fab45098e863" xlink:to="loc_us-gaap_SubsequentEventMember_843c5bb3-f1e7-48ac-acee-50ba9f896433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_f5a1bbd9-e847-4b2d-9038-9cb1f0e55439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_cf1ef23f-30f1-4d6f-9979-0f60ce9e3ae0" xlink:to="loc_us-gaap_StatementClassOfStockAxis_f5a1bbd9-e847-4b2d-9038-9cb1f0e55439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9e567789-e087-41bd-b061-b69750c0ec31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_f5a1bbd9-e847-4b2d-9038-9cb1f0e55439" xlink:to="loc_us-gaap_ClassOfStockDomain_9e567789-e087-41bd-b061-b69750c0ec31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_4075b45d-a593-4588-adb9-459722b32a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_9e567789-e087-41bd-b061-b69750c0ec31" xlink:to="loc_us-gaap_CommonClassAMember_4075b45d-a593-4588-adb9-459722b32a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_47f91f79-7cef-4f93-ae3e-91e481c0a5e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_cf1ef23f-30f1-4d6f-9979-0f60ce9e3ae0" xlink:to="loc_us-gaap_TypeOfArrangementAxis_47f91f79-7cef-4f93-ae3e-91e481c0a5e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a66d699b-50a2-47ca-badf-fdfd18746afb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_47f91f79-7cef-4f93-ae3e-91e481c0a5e5" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a66d699b-50a2-47ca-badf-fdfd18746afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_October2022SubscriptionAgreementsMember_ed8d850b-898d-463a-a454-5bd69211d385" xlink:href="amci-20230213.xsd#amci_October2022SubscriptionAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a66d699b-50a2-47ca-badf-fdfd18746afb" xlink:to="loc_amci_October2022SubscriptionAgreementsMember_ed8d850b-898d-463a-a454-5bd69211d385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_8d0edc14-8684-40fd-8c8a-10a4218e27f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_cf1ef23f-30f1-4d6f-9979-0f60ce9e3ae0" xlink:to="loc_us-gaap_SubsequentEventLineItems_8d0edc14-8684-40fd-8c8a-10a4218e27f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_be138c88-380c-46ea-915c-bb5d4ed7d20e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_8d0edc14-8684-40fd-8c8a-10a4218e27f0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_be138c88-380c-46ea-915c-bb5d4ed7d20e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_163936e3-2b19-4275-861c-187566216530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_8d0edc14-8684-40fd-8c8a-10a4218e27f0" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_163936e3-2b19-4275-861c-187566216530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#DescriptionofOrganizationandBusinessOperationsDetails_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c6cb1f07-237f-40e0-91f3-02890bee1964" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_7aa4c02c-fda4-499d-a116-307cc86fd54b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c6cb1f07-237f-40e0-91f3-02890bee1964" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_7aa4c02c-fda4-499d-a116-307cc86fd54b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_da7ee473-32de-44fa-9ac8-de0fe7b270cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_7aa4c02c-fda4-499d-a116-307cc86fd54b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_da7ee473-32de-44fa-9ac8-de0fe7b270cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_7f9ca51e-c02a-413f-8998-92fd719d613c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_da7ee473-32de-44fa-9ac8-de0fe7b270cd" xlink:to="loc_us-gaap_RelatedPartyDomain_7f9ca51e-c02a-413f-8998-92fd719d613c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SponsorMember_bc90bfda-4ded-43c2-b1ec-3747167eeb7e" xlink:href="amci-20230213.xsd#amci_SponsorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_7f9ca51e-c02a-413f-8998-92fd719d613c" xlink:to="loc_amci_SponsorMember_bc90bfda-4ded-43c2-b1ec-3747167eeb7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_feea4219-d05a-4c89-8203-f6232ea45430" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_7aa4c02c-fda4-499d-a116-307cc86fd54b" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_feea4219-d05a-4c89-8203-f6232ea45430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_15f37be4-ae8d-40be-a689-b2531208cb67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_feea4219-d05a-4c89-8203-f6232ea45430" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_15f37be4-ae8d-40be-a689-b2531208cb67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_a6d5d254-844a-4e73-a1a1-67aa543ed462" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_15f37be4-ae8d-40be-a689-b2531208cb67" xlink:to="loc_us-gaap_IPOMember_a6d5d254-844a-4e73-a1a1-67aa543ed462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_bc60b59a-b206-46dd-98bc-3fc46473f538" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_15f37be4-ae8d-40be-a689-b2531208cb67" xlink:to="loc_us-gaap_PrivatePlacementMember_bc60b59a-b206-46dd-98bc-3fc46473f538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_4fa455b3-d05e-4145-a205-22ec6ab0d9d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_7aa4c02c-fda4-499d-a116-307cc86fd54b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_4fa455b3-d05e-4145-a205-22ec6ab0d9d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_127791f0-8495-470a-8ed7-c0a94933fb0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_4fa455b3-d05e-4145-a205-22ec6ab0d9d8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_127791f0-8495-470a-8ed7-c0a94933fb0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_e85c91c1-2a63-460b-8ec2-dde0a88e491e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_127791f0-8495-470a-8ed7-c0a94933fb0d" xlink:to="loc_us-gaap_WarrantMember_e85c91c1-2a63-460b-8ec2-dde0a88e491e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PrivatePlacementWarrantsMember_e05642d0-d143-455b-8008-621e7e8bfac2" xlink:href="amci-20230213.xsd#amci_PrivatePlacementWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantMember_e85c91c1-2a63-460b-8ec2-dde0a88e491e" xlink:to="loc_amci_PrivatePlacementWarrantsMember_e05642d0-d143-455b-8008-621e7e8bfac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c9066e3b-d59a-4978-ba4b-bb128a1fbd38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_7aa4c02c-fda4-499d-a116-307cc86fd54b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c9066e3b-d59a-4978-ba4b-bb128a1fbd38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9756db90-e74f-4453-aa78-de7a0c3024ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c9066e3b-d59a-4978-ba4b-bb128a1fbd38" xlink:to="loc_us-gaap_EquityComponentDomain_9756db90-e74f-4453-aa78-de7a0c3024ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_e1ed1bd5-abf9-466c-a334-75317a2449c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9756db90-e74f-4453-aa78-de7a0c3024ef" xlink:to="loc_us-gaap_RetainedEarningsMember_e1ed1bd5-abf9-466c-a334-75317a2449c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_8ce35ddf-586f-4af4-9e1d-fb04a656b19e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9756db90-e74f-4453-aa78-de7a0c3024ef" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_8ce35ddf-586f-4af4-9e1d-fb04a656b19e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_34bc521c-2c8e-426f-93e0-181c8f716da9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_7aa4c02c-fda4-499d-a116-307cc86fd54b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_34bc521c-2c8e-426f-93e0-181c8f716da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_90d57eae-a15e-4f7f-8561-b98b61125345" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_34bc521c-2c8e-426f-93e0-181c8f716da9" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_90d57eae-a15e-4f7f-8561-b98b61125345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_65ea6fca-34da-4a29-988c-f3085e84eab1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_90d57eae-a15e-4f7f-8561-b98b61125345" xlink:to="loc_us-gaap_SubsequentEventMember_65ea6fca-34da-4a29-988c-f3085e84eab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_73a78aa9-49ce-47c9-a42b-c92eb4a272d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_7aa4c02c-fda4-499d-a116-307cc86fd54b" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_73a78aa9-49ce-47c9-a42b-c92eb4a272d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_c738ebca-a8f2-4cf0-8d39-d19b91fe784f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_73a78aa9-49ce-47c9-a42b-c92eb4a272d6" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_c738ebca-a8f2-4cf0-8d39-d19b91fe784f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WorkingCapitalLoansMember_bb9210fa-9e1f-4b92-a840-a2adfbb385d4" xlink:href="amci-20230213.xsd#amci_WorkingCapitalLoansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_c738ebca-a8f2-4cf0-8d39-d19b91fe784f" xlink:to="loc_amci_WorkingCapitalLoansMember_bb9210fa-9e1f-4b92-a840-a2adfbb385d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_4c755822-2724-4194-9d76-5f7bc4b8edbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_7aa4c02c-fda4-499d-a116-307cc86fd54b" xlink:to="loc_us-gaap_StatementClassOfStockAxis_4c755822-2724-4194-9d76-5f7bc4b8edbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f818b171-9c26-4fb1-80e1-8cacb5b4aba0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4c755822-2724-4194-9d76-5f7bc4b8edbb" xlink:to="loc_us-gaap_ClassOfStockDomain_f818b171-9c26-4fb1-80e1-8cacb5b4aba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_9aa98549-a064-476a-b132-d7a7dab7f0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_f818b171-9c26-4fb1-80e1-8cacb5b4aba0" xlink:to="loc_us-gaap_CommonClassAMember_9aa98549-a064-476a-b132-d7a7dab7f0cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_acb9b11b-c19f-4851-bf71-33458294f3e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_7aa4c02c-fda4-499d-a116-307cc86fd54b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_acb9b11b-c19f-4851-bf71-33458294f3e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_780d78ba-d19c-4761-9c23-d116cd02c61d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_acb9b11b-c19f-4851-bf71-33458294f3e4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_780d78ba-d19c-4761-9c23-d116cd02c61d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LanzatechGlobalMember_2aadbe74-6f15-4392-a702-dca0dd2774d2" xlink:href="amci-20230213.xsd#amci_LanzatechGlobalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_780d78ba-d19c-4761-9c23-d116cd02c61d" xlink:to="loc_amci_LanzatechGlobalMember_2aadbe74-6f15-4392-a702-dca0dd2774d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2143e65c-b89b-43a2-bcfd-2623818ae03d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_7aa4c02c-fda4-499d-a116-307cc86fd54b" xlink:to="loc_srt_RangeAxis_2143e65c-b89b-43a2-bcfd-2623818ae03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_048a9512-0959-4fb5-b35a-6c24dd3a1467" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_2143e65c-b89b-43a2-bcfd-2623818ae03d" xlink:to="loc_srt_RangeMember_048a9512-0959-4fb5-b35a-6c24dd3a1467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d0300676-1d6c-4de9-9317-be5638f17d68" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_048a9512-0959-4fb5-b35a-6c24dd3a1467" xlink:to="loc_srt_MinimumMember_d0300676-1d6c-4de9-9317-be5638f17d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_7aa4c02c-fda4-499d-a116-307cc86fd54b" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum_15c91bc1-0d32-4ca8-a60a-acb50e291104" xlink:href="amci-20230213.xsd#amci_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum_15c91bc1-0d32-4ca8-a60a-acb50e291104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_UnitsIssuedDuringPeriodSharesNewIssues_ca98ac2c-96bb-4921-9d3a-9e963ecb1b95" xlink:href="amci-20230213.xsd#amci_UnitsIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_UnitsIssuedDuringPeriodSharesNewIssues_ca98ac2c-96bb-4921-9d3a-9e963ecb1b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_fc38173f-00dd-48c7-b85e-7888abd33257" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_fc38173f-00dd-48c7-b85e-7888abd33257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights_598a943f-aed6-4df6-bf06-3c0af671f23c" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights_598a943f-aed6-4df6-bf06-3c0af671f23c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_a6249e89-f14e-48cb-a494-778d9db7bdcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_a6249e89-f14e-48cb-a494-778d9db7bdcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_bcf85891-9695-41a5-8850-632ebf014207" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_bcf85891-9695-41a5-8850-632ebf014207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_28e40c80-0f35-4d95-a570-1a4e63558eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_28e40c80-0f35-4d95-a570-1a4e63558eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_5f2988f5-cc2f-43f0-bac6-993cccfb8506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_5f2988f5-cc2f-43f0-bac6-993cccfb8506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_27d329b4-337c-4716-984a-6e302f727500" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_27d329b4-337c-4716-984a-6e302f727500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TransactionCosts_97981b7b-b14d-4d04-b172-a59be0bb7951" xlink:href="amci-20230213.xsd#amci_TransactionCosts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_TransactionCosts_97981b7b-b14d-4d04-b172-a59be0bb7951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering_fb3953ba-2234-4df3-93ee-08824703f2f4" xlink:href="amci-20230213.xsd#amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_TransactionCosts_97981b7b-b14d-4d04-b172-a59be0bb7951" xlink:to="loc_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering_fb3953ba-2234-4df3-93ee-08824703f2f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SaleOfStockUnderwritingDiscounts_576992aa-5003-479e-8413-a2130b6d8a9d" xlink:href="amci-20230213.xsd#amci_SaleOfStockUnderwritingDiscounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_TransactionCosts_97981b7b-b14d-4d04-b172-a59be0bb7951" xlink:to="loc_amci_SaleOfStockUnderwritingDiscounts_576992aa-5003-479e-8413-a2130b6d8a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingDiscounts_f55d8090-85e4-4d8e-8ebf-112d7a3c1736" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingDiscounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_TransactionCosts_97981b7b-b14d-4d04-b172-a59be0bb7951" xlink:to="loc_amci_DeferredUnderwritingDiscounts_f55d8090-85e4-4d8e-8ebf-112d7a3c1736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SaleOfStockOtherOfferingCosts_f6ed6c6e-6c07-4ab6-8ace-774dd3f8c5de" xlink:href="amci-20230213.xsd#amci_SaleOfStockOtherOfferingCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_TransactionCosts_97981b7b-b14d-4d04-b172-a59be0bb7951" xlink:to="loc_amci_SaleOfStockOtherOfferingCosts_f6ed6c6e-6c07-4ab6-8ace-774dd3f8c5de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PaymentsForInvestmentOfCashInTrustAccount_369b046d-4d7c-42f6-998e-c896493a93c2" xlink:href="amci-20230213.xsd#amci_PaymentsForInvestmentOfCashInTrustAccount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_PaymentsForInvestmentOfCashInTrustAccount_369b046d-4d7c-42f6-998e-c896493a93c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ConditionForFutureBusinessCombinationUseOfProceedsPercentage_4a37485d-8ad2-4ffb-8dd6-c7ff953dd8d8" xlink:href="amci-20230213.xsd#amci_ConditionForFutureBusinessCombinationUseOfProceedsPercentage"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_ConditionForFutureBusinessCombinationUseOfProceedsPercentage_4a37485d-8ad2-4ffb-8dd6-c7ff953dd8d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ConditionForFutureBusinessCombinationThresholdPercentageOwnership_af6defb6-39ce-4e54-a717-63e20325f79d" xlink:href="amci-20230213.xsd#amci_ConditionForFutureBusinessCombinationThresholdPercentageOwnership"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_ConditionForFutureBusinessCombinationThresholdPercentageOwnership_af6defb6-39ce-4e54-a717-63e20325f79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_9bc8a15c-0408-47a1-8afb-0a809143ec58" xlink:href="amci-20230213.xsd#amci_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_9bc8a15c-0408-47a1-8afb-0a809143ec58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets_caf1cc15-1198-472e-bd29-42dd9b549a28" xlink:href="amci-20230213.xsd#amci_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets_caf1cc15-1198-472e-bd29-42dd9b549a28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MonthsToCompleteAcquisition_e4956c31-ee3c-4f72-8b39-471dbc36f18a" xlink:href="amci-20230213.xsd#amci_MonthsToCompleteAcquisition"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_MonthsToCompleteAcquisition_e4956c31-ee3c-4f72-8b39-471dbc36f18a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RedemptionPeriodUponClosure_017bbf46-9259-4d53-b21f-0d269840ab40" xlink:href="amci-20230213.xsd#amci_RedemptionPeriodUponClosure"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_RedemptionPeriodUponClosure_017bbf46-9259-4d53-b21f-0d269840ab40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MaximumAllowedDissolutionExpenses_c4d0b8be-fdbc-44d5-9a7b-dcf1a403d59d" xlink:href="amci-20230213.xsd#amci_MaximumAllowedDissolutionExpenses"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_MaximumAllowedDissolutionExpenses_c4d0b8be-fdbc-44d5-9a7b-dcf1a403d59d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount_af7b8ddc-e5db-48a7-8c6b-76d31831148c" xlink:href="amci-20230213.xsd#amci_TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount_af7b8ddc-e5db-48a7-8c6b-76d31831148c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WorkingCapitalDeficit_06f2ab50-e178-4579-a2bb-d3a0f32443ab" xlink:href="amci-20230213.xsd#amci_WorkingCapitalDeficit"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_WorkingCapitalDeficit_06f2ab50-e178-4579-a2bb-d3a0f32443ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_435460a6-ccea-4d35-a259-4a29da4b5847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_435460a6-ccea-4d35-a259-4a29da4b5847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_1c127ea7-edbd-4e27-8407-4a3e8b815a95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_1c127ea7-edbd-4e27-8407-4a3e8b815a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_5b6b7d50-bae0-4f87-9e59-e6e938de9ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNet_ba4e00f7-28e3-4351-bd86-f63bd7cab182" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNet"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_us-gaap_AssetsNet_ba4e00f7-28e3-4351-bd86-f63bd7cab182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrustCurrent_169d285b-cd9a-4484-bbc7-22408aa1ec6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustCurrent"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_us-gaap_AssetsHeldInTrustCurrent_169d285b-cd9a-4484-bbc7-22408aa1ec6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_55104e0b-a730-406f-9949-5c7114473f61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_55104e0b-a730-406f-9949-5c7114473f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_d08df402-5e24-4fae-8a2e-26f0f1d448a0" xlink:href="amci-20230213.xsd#amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_d08df402-5e24-4fae-8a2e-26f0f1d448a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_f8eb0a95-4cfa-4eea-b387-867706629da0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_f8eb0a95-4cfa-4eea-b387-867706629da0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_4190d2fc-07aa-4c85-8b89-da2adebde2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_4190d2fc-07aa-4c85-8b89-da2adebde2d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfSharesIssuedPerUnit_22f175a5-6769-4911-91ae-9cd04baff910" xlink:href="amci-20230213.xsd#amci_NumberOfSharesIssuedPerUnit"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_NumberOfSharesIssuedPerUnit_22f175a5-6769-4911-91ae-9cd04baff910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfWarrantsIssuedPerUnit_c8355b4a-f26c-4c4b-ba20-8361993d1e2a" xlink:href="amci-20230213.xsd#amci_NumberOfWarrantsIssuedPerUnit"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_NumberOfWarrantsIssuedPerUnit_c8355b4a-f26c-4c4b-ba20-8361993d1e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_FundHeldInTrustAccountPerPublicShare_afb9a4c0-9f00-43f6-a353-1a6fb2c991e6" xlink:href="amci-20230213.xsd#amci_FundHeldInTrustAccountPerPublicShare"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_FundHeldInTrustAccountPerPublicShare_afb9a4c0-9f00-43f6-a353-1a6fb2c991e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose_2ea91e66-dc91-46f1-9630-73dfa4aa21e2" xlink:href="amci-20230213.xsd#amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose_2ea91e66-dc91-46f1-9630-73dfa4aa21e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_7e3bc4de-7c70-4860-95ec-52b7d092eee7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_us-gaap_ShortTermBorrowings_7e3bc4de-7c70-4860-95ec-52b7d092eee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WorkingCapitalLoan_8967e7dc-ccda-46f6-ada9-e6892cb5ca60" xlink:href="amci-20230213.xsd#amci_WorkingCapitalLoan"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_032dd345-8bf6-4dcc-a4ff-e3bc7a7d7d0b" xlink:to="loc_amci_WorkingCapitalLoan_8967e7dc-ccda-46f6-ada9-e6892cb5ca60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3c1c620f-5909-4f2f-a416-7c848dba697c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_139b2749-e680-4014-8079-e03a16adbd30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3c1c620f-5909-4f2f-a416-7c848dba697c" xlink:to="loc_us-gaap_StatementTable_139b2749-e680-4014-8079-e03a16adbd30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_9e565b72-63be-4e3d-8513-41a77fe50554" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_139b2749-e680-4014-8079-e03a16adbd30" xlink:to="loc_us-gaap_StatementClassOfStockAxis_9e565b72-63be-4e3d-8513-41a77fe50554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4b670743-7a56-4b7c-8ebb-daa52a9b11e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9e565b72-63be-4e3d-8513-41a77fe50554" xlink:to="loc_us-gaap_ClassOfStockDomain_4b670743-7a56-4b7c-8ebb-daa52a9b11e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_26f3a6d8-ff44-4915-a7fd-8a822ab51d28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_4b670743-7a56-4b7c-8ebb-daa52a9b11e4" xlink:to="loc_us-gaap_CommonClassAMember_26f3a6d8-ff44-4915-a7fd-8a822ab51d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CommonClassaSubjectToRedemptionMember_5f5327f5-a9b1-4d75-a7a9-08ae93c9eabf" xlink:href="amci-20230213.xsd#amci_CommonClassaSubjectToRedemptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_4b670743-7a56-4b7c-8ebb-daa52a9b11e4" xlink:to="loc_amci_CommonClassaSubjectToRedemptionMember_5f5327f5-a9b1-4d75-a7a9-08ae93c9eabf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_b2f417d5-5f79-401f-a2bf-d23fc156bdaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_139b2749-e680-4014-8079-e03a16adbd30" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_b2f417d5-5f79-401f-a2bf-d23fc156bdaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d7bb0813-c1b6-459a-802e-1184e6880dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_b2f417d5-5f79-401f-a2bf-d23fc156bdaf" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d7bb0813-c1b6-459a-802e-1184e6880dcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_88d531c5-5aaa-4931-a756-d8a71144970d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d7bb0813-c1b6-459a-802e-1184e6880dcb" xlink:to="loc_us-gaap_IPOMember_88d531c5-5aaa-4931-a756-d8a71144970d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_11a944ed-7338-4a45-bc87-8840a1b8676e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_139b2749-e680-4014-8079-e03a16adbd30" xlink:to="loc_us-gaap_StatementLineItems_11a944ed-7338-4a45-bc87-8840a1b8676e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFDICInsuredAmount_d39f4265-f30b-473f-8502-6bc852f69238" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFDICInsuredAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11a944ed-7338-4a45-bc87-8840a1b8676e" xlink:to="loc_us-gaap_CashFDICInsuredAmount_d39f4265-f30b-473f-8502-6bc852f69238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_06fdf701-8bcf-46df-8d05-8e15252f0f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11a944ed-7338-4a45-bc87-8840a1b8676e" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_06fdf701-8bcf-46df-8d05-8e15252f0f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_401a488a-ea28-4797-92fb-0fdf60ae0ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11a944ed-7338-4a45-bc87-8840a1b8676e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_401a488a-ea28-4797-92fb-0fdf60ae0ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_097a2c98-cca4-4766-98f9-b97feed0f588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11a944ed-7338-4a45-bc87-8840a1b8676e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_097a2c98-cca4-4766-98f9-b97feed0f588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_2c779c81-42d5-416f-a42d-ba88adcfee31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11a944ed-7338-4a45-bc87-8840a1b8676e" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_2c779c81-42d5-416f-a42d-ba88adcfee31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_728eff13-3bb1-4f8a-b08e-9e1aa55e2740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11a944ed-7338-4a45-bc87-8840a1b8676e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_728eff13-3bb1-4f8a-b08e-9e1aa55e2740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_9ab2b88a-a5b4-463d-8fd8-a28758009e54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11a944ed-7338-4a45-bc87-8840a1b8676e" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_9ab2b88a-a5b4-463d-8fd8-a28758009e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_cc39bc94-d873-4ce1-a3f2-b920b254c472" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1004a647-319e-410a-9baf-bf5b4536e07d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cc39bc94-d873-4ce1-a3f2-b920b254c472" xlink:to="loc_us-gaap_StatementTable_1004a647-319e-410a-9baf-bf5b4536e07d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_7fa5d1d6-af82-492b-b271-71489289e847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1004a647-319e-410a-9baf-bf5b4536e07d" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_7fa5d1d6-af82-492b-b271-71489289e847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_bd5bdc5d-af4f-4f9a-8c86-da5886609bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_7fa5d1d6-af82-492b-b271-71489289e847" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_bd5bdc5d-af4f-4f9a-8c86-da5886609bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_bbfe69c8-6de7-4d03-b9a7-cde6def7e601" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_bd5bdc5d-af4f-4f9a-8c86-da5886609bf0" xlink:to="loc_us-gaap_CommonClassAMember_bbfe69c8-6de7-4d03-b9a7-cde6def7e601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_afb77c5d-21b9-4b57-b943-2ffb78118d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_bd5bdc5d-af4f-4f9a-8c86-da5886609bf0" xlink:to="loc_us-gaap_CommonClassBMember_afb77c5d-21b9-4b57-b943-2ffb78118d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_02226b4f-dfd5-4a5a-9ea2-6b4f5074ecde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1004a647-319e-410a-9baf-bf5b4536e07d" xlink:to="loc_us-gaap_StatementLineItems_02226b4f-dfd5-4a5a-9ea2-6b4f5074ecde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EarningPerShareBasicAndDilutedAbstract_ee4261ac-0e46-4fb2-99db-31a7a966feca" xlink:href="amci-20230213.xsd#amci_EarningPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_02226b4f-dfd5-4a5a-9ea2-6b4f5074ecde" xlink:to="loc_amci_EarningPerShareBasicAndDilutedAbstract_ee4261ac-0e46-4fb2-99db-31a7a966feca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumeratorAbstract_fc939d97-6dc1-4fe0-957a-4a0e08d5eae4" xlink:href="amci-20230213.xsd#amci_NumeratorAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_EarningPerShareBasicAndDilutedAbstract_ee4261ac-0e46-4fb2-99db-31a7a966feca" xlink:to="loc_amci_NumeratorAbstract_fc939d97-6dc1-4fe0-957a-4a0e08d5eae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_1de91cb6-083b-49ec-a669-1a3d4fb8eb9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_NumeratorAbstract_fc939d97-6dc1-4fe0-957a-4a0e08d5eae4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_1de91cb6-083b-49ec-a669-1a3d4fb8eb9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DenominatorForCalculationOfEarningsPerShareAbstract_14d14aa1-cecf-4231-beca-f7505477ccbf" xlink:href="amci-20230213.xsd#amci_DenominatorForCalculationOfEarningsPerShareAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_EarningPerShareBasicAndDilutedAbstract_ee4261ac-0e46-4fb2-99db-31a7a966feca" xlink:to="loc_amci_DenominatorForCalculationOfEarningsPerShareAbstract_14d14aa1-cecf-4231-beca-f7505477ccbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_64caa038-02f0-4582-b872-46fa7c8e6da1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_DenominatorForCalculationOfEarningsPerShareAbstract_14d14aa1-cecf-4231-beca-f7505477ccbf" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_64caa038-02f0-4582-b872-46fa7c8e6da1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5a1e542c-2925-4f3c-9719-b66fea6eeb61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_DenominatorForCalculationOfEarningsPerShareAbstract_14d14aa1-cecf-4231-beca-f7505477ccbf" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5a1e542c-2925-4f3c-9719-b66fea6eeb61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_6167de40-dfaf-45f5-ba20-eec279e0c8bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_DenominatorForCalculationOfEarningsPerShareAbstract_14d14aa1-cecf-4231-beca-f7505477ccbf" xlink:to="loc_us-gaap_EarningsPerShareBasic_6167de40-dfaf-45f5-ba20-eec279e0c8bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_766a0040-ce50-40ae-a8bb-b9d8f62c70b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_DenominatorForCalculationOfEarningsPerShareAbstract_14d14aa1-cecf-4231-beca-f7505477ccbf" xlink:to="loc_us-gaap_EarningsPerShareDiluted_766a0040-ce50-40ae-a8bb-b9d8f62c70b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#InitialPublicOfferingDetails_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_amci_InitialPublicOfferingAbstract_6d41b5c2-4ed8-4787-882e-5c4726b66d6c" xlink:href="amci-20230213.xsd#amci_InitialPublicOfferingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_b097dbe5-d72d-4c31-8013-aae0fd24a11a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_InitialPublicOfferingAbstract_6d41b5c2-4ed8-4787-882e-5c4726b66d6c" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_b097dbe5-d72d-4c31-8013-aae0fd24a11a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_1abd08b1-d45e-434f-9169-9d9e132b87ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_b097dbe5-d72d-4c31-8013-aae0fd24a11a" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_1abd08b1-d45e-434f-9169-9d9e132b87ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5e47573f-4607-4e56-80bc-72fa1e557383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_1abd08b1-d45e-434f-9169-9d9e132b87ef" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5e47573f-4607-4e56-80bc-72fa1e557383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_791507c0-ee0f-4eaf-9f06-fc5604caede4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5e47573f-4607-4e56-80bc-72fa1e557383" xlink:to="loc_us-gaap_CommonClassAMember_791507c0-ee0f-4eaf-9f06-fc5604caede4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_b7b68806-ff44-4b6e-a64d-feb2a4533a90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5e47573f-4607-4e56-80bc-72fa1e557383" xlink:to="loc_us-gaap_IPOMember_b7b68806-ff44-4b6e-a64d-feb2a4533a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_066af362-b984-422d-b331-9e33cbed8bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5e47573f-4607-4e56-80bc-72fa1e557383" xlink:to="loc_us-gaap_OverAllotmentOptionMember_066af362-b984-422d-b331-9e33cbed8bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_70921261-0907-470a-a4ae-2f0b2ae655ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_b097dbe5-d72d-4c31-8013-aae0fd24a11a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_70921261-0907-470a-a4ae-2f0b2ae655ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_163bbe01-4cb3-48d0-bd8a-0ba924824db5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_70921261-0907-470a-a4ae-2f0b2ae655ac" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_163bbe01-4cb3-48d0-bd8a-0ba924824db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_cc3e5406-92dd-45b0-83bb-79a176b41b58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_163bbe01-4cb3-48d0-bd8a-0ba924824db5" xlink:to="loc_us-gaap_WarrantMember_cc3e5406-92dd-45b0-83bb-79a176b41b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_3c71802e-e355-4ca3-8cd9-443bea518b89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_b097dbe5-d72d-4c31-8013-aae0fd24a11a" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_3c71802e-e355-4ca3-8cd9-443bea518b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_829c4b56-c73d-4e5f-9841-9b36c4c08bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_3c71802e-e355-4ca3-8cd9-443bea518b89" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_829c4b56-c73d-4e5f-9841-9b36c4c08bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_e02b0f47-bac9-4d2e-9c9e-96c883c60a29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_829c4b56-c73d-4e5f-9841-9b36c4c08bf6" xlink:to="loc_us-gaap_SubsequentEventMember_e02b0f47-bac9-4d2e-9c9e-96c883c60a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_b097dbe5-d72d-4c31-8013-aae0fd24a11a" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_UnitsIssuedDuringPeriodSharesNewIssues_2f6b5999-2eb9-4512-8a4e-7df5817d3860" xlink:href="amci-20230213.xsd#amci_UnitsIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:to="loc_amci_UnitsIssuedDuringPeriodSharesNewIssues_2f6b5999-2eb9-4512-8a4e-7df5817d3860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_676ffd84-438f-4c65-a6a0-d9abde6b0f14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_676ffd84-438f-4c65-a6a0-d9abde6b0f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_0f9eea6e-3306-4736-b36c-02898ff33332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_0f9eea6e-3306-4736-b36c-02898ff33332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts_76aa0545-86cc-4acc-bff8-0af7616f83eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:to="loc_us-gaap_DeferredOfferingCosts_76aa0545-86cc-4acc-bff8-0af7616f83eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SaleOfStockUnderwritingDiscounts_22c3507f-da20-45a6-95eb-910e5890507c" xlink:href="amci-20230213.xsd#amci_SaleOfStockUnderwritingDiscounts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:to="loc_amci_SaleOfStockUnderwritingDiscounts_22c3507f-da20-45a6-95eb-910e5890507c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering_d871cbb4-1861-408d-9898-329f748c9515" xlink:href="amci-20230213.xsd#amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:to="loc_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering_d871cbb4-1861-408d-9898-329f748c9515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SaleOfStockOtherOfferingCosts_c36e427b-7c4d-4273-ba43-33bb9db661b5" xlink:href="amci-20230213.xsd#amci_SaleOfStockOtherOfferingCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:to="loc_amci_SaleOfStockOtherOfferingCosts_c36e427b-7c4d-4273-ba43-33bb9db661b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingCompensationNoncurrent_ac2a344d-d532-433c-80af-30f258a37f12" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingCompensationNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:to="loc_amci_DeferredUnderwritingCompensationNoncurrent_ac2a344d-d532-433c-80af-30f258a37f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OptionVestingPeriod_76f1eaf1-b07f-479d-aaee-1cd17f9fb4a7" xlink:href="amci-20230213.xsd#amci_OptionVestingPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:to="loc_amci_OptionVestingPeriod_76f1eaf1-b07f-479d-aaee-1cd17f9fb4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters_95c60086-76f3-484b-ad1b-f98030912150" xlink:href="amci-20230213.xsd#amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:to="loc_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters_95c60086-76f3-484b-ad1b-f98030912150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_1b885dee-6b31-40c5-94f8-700c8ec5fccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_1b885dee-6b31-40c5-94f8-700c8ec5fccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_99292f23-f581-498c-886e-9978334a9d51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_99292f23-f581-498c-886e-9978334a9d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OptionToPurchaseAdditionalUnitsGivenToInvestors_fc6848cf-4d7c-4538-bc65-94542fce8d9d" xlink:href="amci-20230213.xsd#amci_OptionToPurchaseAdditionalUnitsGivenToInvestors"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:to="loc_amci_OptionToPurchaseAdditionalUnitsGivenToInvestors_fc6848cf-4d7c-4538-bc65-94542fce8d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_122d7b45-4829-429c-b320-5d516735f55b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_fe3ba788-a31a-45fd-97d7-9ccd11acdfe7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_122d7b45-4829-429c-b320-5d516735f55b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#RelatedPartyTransactionsFounderSharesDetails_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_a4b4f566-4e98-4dc1-9201-f26012ab2ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_42144c07-bb95-4efa-a144-03f76fa212a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_a4b4f566-4e98-4dc1-9201-f26012ab2ad2" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_42144c07-bb95-4efa-a144-03f76fa212a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_8aac4915-1c8e-4740-9e29-7f797b930f57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_42144c07-bb95-4efa-a144-03f76fa212a0" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_8aac4915-1c8e-4740-9e29-7f797b930f57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_5a19b159-b1ac-4fc2-8537-2c7bee90f117" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_8aac4915-1c8e-4740-9e29-7f797b930f57" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_5a19b159-b1ac-4fc2-8537-2c7bee90f117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_FounderSharesMember_049f3a18-a345-4e6c-8ada-eb273945923f" xlink:href="amci-20230213.xsd#amci_FounderSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_5a19b159-b1ac-4fc2-8537-2c7bee90f117" xlink:to="loc_amci_FounderSharesMember_049f3a18-a345-4e6c-8ada-eb273945923f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_d1a5a645-90d1-40e8-9dbe-f2d7c4a76b44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_42144c07-bb95-4efa-a144-03f76fa212a0" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_d1a5a645-90d1-40e8-9dbe-f2d7c4a76b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_157c23d6-6436-4730-9e37-22e72e33ddf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_d1a5a645-90d1-40e8-9dbe-f2d7c4a76b44" xlink:to="loc_us-gaap_RelatedPartyDomain_157c23d6-6436-4730-9e37-22e72e33ddf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SponsorMember_b8909d4f-e9f4-42d5-b391-a621904a26f1" xlink:href="amci-20230213.xsd#amci_SponsorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_157c23d6-6436-4730-9e37-22e72e33ddf4" xlink:to="loc_amci_SponsorMember_b8909d4f-e9f4-42d5-b391-a621904a26f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AnchorInvestorsMember_17edc89c-cbf7-47e4-abaf-bf785ea43565" xlink:href="amci-20230213.xsd#amci_AnchorInvestorsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_157c23d6-6436-4730-9e37-22e72e33ddf4" xlink:to="loc_amci_AnchorInvestorsMember_17edc89c-cbf7-47e4-abaf-bf785ea43565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_cdba1205-7e8f-4061-ac3c-d2f2e8db06bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_42144c07-bb95-4efa-a144-03f76fa212a0" xlink:to="loc_us-gaap_StatementClassOfStockAxis_cdba1205-7e8f-4061-ac3c-d2f2e8db06bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a1196921-7fe0-4afe-b23e-d142434388d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_cdba1205-7e8f-4061-ac3c-d2f2e8db06bb" xlink:to="loc_us-gaap_ClassOfStockDomain_a1196921-7fe0-4afe-b23e-d142434388d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_c61cd6e7-076d-4f15-a4b6-89a56517e198" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a1196921-7fe0-4afe-b23e-d142434388d2" xlink:to="loc_us-gaap_CommonClassBMember_c61cd6e7-076d-4f15-a4b6-89a56517e198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_2b38a898-7d66-4f49-b2c1-51991045588c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_42144c07-bb95-4efa-a144-03f76fa212a0" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_2b38a898-7d66-4f49-b2c1-51991045588c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_7c5f33f8-9461-4cc2-9d20-7e7670158748" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2b38a898-7d66-4f49-b2c1-51991045588c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_7c5f33f8-9461-4cc2-9d20-7e7670158748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_b42f7c8b-d93c-454a-b9b2-1e29a266f030" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2b38a898-7d66-4f49-b2c1-51991045588c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_b42f7c8b-d93c-454a-b9b2-1e29a266f030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_b077ca0a-a89d-4e37-b302-f3da8efe1a04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2b38a898-7d66-4f49-b2c1-51991045588c" xlink:to="loc_us-gaap_SharePrice_b077ca0a-a89d-4e37-b302-f3da8efe1a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfSharesSurrendered_76e425fc-0265-4d1b-990d-c277c3f24ada" xlink:href="amci-20230213.xsd#amci_NumberOfSharesSurrendered"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2b38a898-7d66-4f49-b2c1-51991045588c" xlink:to="loc_amci_NumberOfSharesSurrendered_76e425fc-0265-4d1b-990d-c277c3f24ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AggregateNumberOfSharesOwned_424da5e5-3ee6-4d59-98c9-cac2afea8e61" xlink:href="amci-20230213.xsd#amci_AggregateNumberOfSharesOwned"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2b38a898-7d66-4f49-b2c1-51991045588c" xlink:to="loc_amci_AggregateNumberOfSharesOwned_424da5e5-3ee6-4d59-98c9-cac2afea8e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfSharesSubjectToForfeiture_5279524c-5a26-4ef3-bdd9-77f74f7f0481" xlink:href="amci-20230213.xsd#amci_NumberOfSharesSubjectToForfeiture"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2b38a898-7d66-4f49-b2c1-51991045588c" xlink:to="loc_amci_NumberOfSharesSubjectToForfeiture_5279524c-5a26-4ef3-bdd9-77f74f7f0481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_2ed8b038-8f3c-4668-afb9-b97b3573ef60" xlink:href="amci-20230213.xsd#amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2b38a898-7d66-4f49-b2c1-51991045588c" xlink:to="loc_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_2ed8b038-8f3c-4668-afb9-b97b3573ef60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_4a7f8b6f-274b-46fe-aa66-08447ae03e38" xlink:href="amci-20230213.xsd#amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2b38a898-7d66-4f49-b2c1-51991045588c" xlink:to="loc_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_4a7f8b6f-274b-46fe-aa66-08447ae03e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_3a85e767-213b-4d60-9b5c-1c46141c8174" xlink:href="amci-20230213.xsd#amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2b38a898-7d66-4f49-b2c1-51991045588c" xlink:to="loc_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_3a85e767-213b-4d60-9b5c-1c46141c8174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_57dfe31e-325d-40b6-b04f-86f16dc62faf" xlink:href="amci-20230213.xsd#amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2b38a898-7d66-4f49-b2c1-51991045588c" xlink:to="loc_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_57dfe31e-325d-40b6-b04f-86f16dc62faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences_ae7bacab-85c5-4f7b-8969-a8cc893215b7" xlink:href="amci-20230213.xsd#amci_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2b38a898-7d66-4f49-b2c1-51991045588c" xlink:to="loc_amci_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences_ae7bacab-85c5-4f7b-8969-a8cc893215b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#RelatedPartyTransactionsAdditionalInformationDetails_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_318e9227-9dae-4222-b895-1459555ebf67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c7a67ddf-e72c-45a7-a1c2-94d8604baaa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_318e9227-9dae-4222-b895-1459555ebf67" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c7a67ddf-e72c-45a7-a1c2-94d8604baaa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_85f3b641-c883-4255-a076-d974455a9d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c7a67ddf-e72c-45a7-a1c2-94d8604baaa6" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_85f3b641-c883-4255-a076-d974455a9d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_96ea2cdb-0949-49e3-bb43-93b3bf72a03c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_85f3b641-c883-4255-a076-d974455a9d6f" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_96ea2cdb-0949-49e3-bb43-93b3bf72a03c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AdministrativeSupportAgreementMember_4f5073a9-d5dc-4789-a6ee-80d8fec06de8" xlink:href="amci-20230213.xsd#amci_AdministrativeSupportAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_96ea2cdb-0949-49e3-bb43-93b3bf72a03c" xlink:to="loc_amci_AdministrativeSupportAgreementMember_4f5073a9-d5dc-4789-a6ee-80d8fec06de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartyLoansMember_9ad40c6d-9af4-489f-820f-244294532734" xlink:href="amci-20230213.xsd#amci_RelatedPartyLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_96ea2cdb-0949-49e3-bb43-93b3bf72a03c" xlink:to="loc_amci_RelatedPartyLoansMember_9ad40c6d-9af4-489f-820f-244294532734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_2a5ae534-578b-451e-9dfd-d88b7dccff46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c7a67ddf-e72c-45a7-a1c2-94d8604baaa6" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_2a5ae534-578b-451e-9dfd-d88b7dccff46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_3588b828-4261-4a64-a825-b2244acb76f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_2a5ae534-578b-451e-9dfd-d88b7dccff46" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_3588b828-4261-4a64-a825-b2244acb76f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WorkingCapitalLoansWarrantMember_c21421dc-8264-4cd7-8f4b-42320b1791b9" xlink:href="amci-20230213.xsd#amci_WorkingCapitalLoansWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3588b828-4261-4a64-a825-b2244acb76f2" xlink:to="loc_amci_WorkingCapitalLoansWarrantMember_c21421dc-8264-4cd7-8f4b-42320b1791b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PrivatePlacementWarrantsMember_a879c526-1c64-445e-a154-6b843f8167e9" xlink:href="amci-20230213.xsd#amci_PrivatePlacementWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3588b828-4261-4a64-a825-b2244acb76f2" xlink:to="loc_amci_PrivatePlacementWarrantsMember_a879c526-1c64-445e-a154-6b843f8167e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_3b49303d-e2f1-495e-845a-9501c6c53adf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c7a67ddf-e72c-45a7-a1c2-94d8604baaa6" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_3b49303d-e2f1-495e-845a-9501c6c53adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e4d1dbc9-6afe-402e-b9e3-36fdb054e0ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_3b49303d-e2f1-495e-845a-9501c6c53adf" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e4d1dbc9-6afe-402e-b9e3-36fdb054e0ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_ce9216cf-0bf6-4cff-87f1-b034ad273d12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e4d1dbc9-6afe-402e-b9e3-36fdb054e0ef" xlink:to="loc_us-gaap_PrivatePlacementMember_ce9216cf-0bf6-4cff-87f1-b034ad273d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_5027c353-a245-48f1-9e5b-7801890ad3cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c7a67ddf-e72c-45a7-a1c2-94d8604baaa6" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_5027c353-a245-48f1-9e5b-7801890ad3cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_6cb2ce6b-166a-4df3-a3ef-ef0181d4bc7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5027c353-a245-48f1-9e5b-7801890ad3cb" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_6cb2ce6b-166a-4df3-a3ef-ef0181d4bc7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_ad6fa048-dcfb-49fe-9cb0-f2ee464b9036" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_6cb2ce6b-166a-4df3-a3ef-ef0181d4bc7b" xlink:to="loc_us-gaap_SubsequentEventMember_ad6fa048-dcfb-49fe-9cb0-f2ee464b9036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c4753fc2-3569-4853-8e8b-f07114cab444" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c7a67ddf-e72c-45a7-a1c2-94d8604baaa6" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c4753fc2-3569-4853-8e8b-f07114cab444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_19627290-96db-4c56-8894-273eb5da3139" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c4753fc2-3569-4853-8e8b-f07114cab444" xlink:to="loc_us-gaap_RelatedPartyDomain_19627290-96db-4c56-8894-273eb5da3139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SponsorMember_0e5bd329-5e55-42f0-a7ca-04043f64c57b" xlink:href="amci-20230213.xsd#amci_SponsorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_19627290-96db-4c56-8894-273eb5da3139" xlink:to="loc_amci_SponsorMember_0e5bd329-5e55-42f0-a7ca-04043f64c57b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_e4beaa29-e215-43be-a465-125a0c472767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c7a67ddf-e72c-45a7-a1c2-94d8604baaa6" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_e4beaa29-e215-43be-a465-125a0c472767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_7c9ef227-faaf-4402-ae81-a38233af56bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e4beaa29-e215-43be-a465-125a0c472767" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_7c9ef227-faaf-4402-ae81-a38233af56bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_7bca2d53-a120-4397-adf9-aea94fff4c79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e4beaa29-e215-43be-a465-125a0c472767" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_7bca2d53-a120-4397-adf9-aea94fff4c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights_d1720d68-a0cc-45c6-bd7f-e9057c1a84a9" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e4beaa29-e215-43be-a465-125a0c472767" xlink:to="loc_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights_d1720d68-a0cc-45c6-bd7f-e9057c1a84a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_cb585564-ad80-467f-adbf-006de669dc58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e4beaa29-e215-43be-a465-125a0c472767" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_cb585564-ad80-467f-adbf-006de669dc58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_3f1529e5-ef33-47d1-b272-351ba900ff55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e4beaa29-e215-43be-a465-125a0c472767" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_3f1529e5-ef33-47d1-b272-351ba900ff55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_b0ca3a0b-18a6-40a0-9abb-6254fe8bb8e7" xlink:href="amci-20230213.xsd#amci_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e4beaa29-e215-43be-a465-125a0c472767" xlink:to="loc_amci_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_b0ca3a0b-18a6-40a0-9abb-6254fe8bb8e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MaximumLoansConvertibleIntoWarrants_d890335d-b3ec-4e1d-b165-4216f7c92aba" xlink:href="amci-20230213.xsd#amci_MaximumLoansConvertibleIntoWarrants"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e4beaa29-e215-43be-a465-125a0c472767" xlink:to="loc_amci_MaximumLoansConvertibleIntoWarrants_d890335d-b3ec-4e1d-b165-4216f7c92aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OutstandingWorkingCapitalLoans_4644991b-6030-4aa2-8458-edd07547915d" xlink:href="amci-20230213.xsd#amci_OutstandingWorkingCapitalLoans"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e4beaa29-e215-43be-a465-125a0c472767" xlink:to="loc_amci_OutstandingWorkingCapitalLoans_4644991b-6030-4aa2-8458-edd07547915d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_60199878-2629-43e4-9b8d-c820624b521d" xlink:href="amci-20230213.xsd#amci_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e4beaa29-e215-43be-a465-125a0c472767" xlink:to="loc_amci_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_60199878-2629-43e4-9b8d-c820624b521d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_b751fff8-4e07-4d17-8e22-e190319bbb00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e4beaa29-e215-43be-a465-125a0c472767" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_b751fff8-4e07-4d17-8e22-e190319bbb00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_13396fd6-e6ec-487b-8e1f-d289325f4837" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e4beaa29-e215-43be-a465-125a0c472767" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_13396fd6-e6ec-487b-8e1f-d289325f4837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_0f085e94-983e-475c-9b21-cfa95b5a150e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e4beaa29-e215-43be-a465-125a0c472767" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrent_0f085e94-983e-475c-9b21-cfa95b5a150e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WorkingCapitalLoan_13ef090d-1520-4b25-8c42-a7421d3fbaa3" xlink:href="amci-20230213.xsd#amci_WorkingCapitalLoan"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e4beaa29-e215-43be-a465-125a0c472767" xlink:to="loc_amci_WorkingCapitalLoan_13ef090d-1520-4b25-8c42-a7421d3fbaa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#CommitmentsandContingenciesDetails_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b73b9c34-5f6c-415e-9f9b-8488eb8a3420" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_aa69ceea-6983-444c-972f-bc362d4500a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b73b9c34-5f6c-415e-9f9b-8488eb8a3420" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_aa69ceea-6983-444c-972f-bc362d4500a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_c10a4aa5-6146-45ae-870b-28a1f5ad76fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_aa69ceea-6983-444c-972f-bc362d4500a3" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_c10a4aa5-6146-45ae-870b-28a1f5ad76fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0dbf0a95-459f-41f5-ab2b-6a8f8dc0ce85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_c10a4aa5-6146-45ae-870b-28a1f5ad76fb" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0dbf0a95-459f-41f5-ab2b-6a8f8dc0ce85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_da0aad13-2ada-432f-ad30-1764a3c05976" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0dbf0a95-459f-41f5-ab2b-6a8f8dc0ce85" xlink:to="loc_us-gaap_OverAllotmentOptionMember_da0aad13-2ada-432f-ad30-1764a3c05976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_4da68dde-dbed-4e9d-9af0-0115c5782c97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_aa69ceea-6983-444c-972f-bc362d4500a3" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_4da68dde-dbed-4e9d-9af0-0115c5782c97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MaximumNumberOfDemandsForRegistrationOfSecurities_eac94de3-45f1-48ea-87c7-02ef6bed9a0b" xlink:href="amci-20230213.xsd#amci_MaximumNumberOfDemandsForRegistrationOfSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_4da68dde-dbed-4e9d-9af0-0115c5782c97" xlink:to="loc_amci_MaximumNumberOfDemandsForRegistrationOfSecurities_eac94de3-45f1-48ea-87c7-02ef6bed9a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OptionVestingPeriod_77e8a116-018e-42bb-9991-b04831c6771e" xlink:href="amci-20230213.xsd#amci_OptionVestingPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_4da68dde-dbed-4e9d-9af0-0115c5782c97" xlink:to="loc_amci_OptionVestingPeriod_77e8a116-018e-42bb-9991-b04831c6771e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters_334cc09e-880f-4ebc-acd7-d75e1092fd6c" xlink:href="amci-20230213.xsd#amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_4da68dde-dbed-4e9d-9af0-0115c5782c97" xlink:to="loc_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters_334cc09e-880f-4ebc-acd7-d75e1092fd6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfSharesSubjectToForfeiture_835debaa-cca0-4597-ab74-1c73d89d1bfe" xlink:href="amci-20230213.xsd#amci_NumberOfSharesSubjectToForfeiture"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_4da68dde-dbed-4e9d-9af0-0115c5782c97" xlink:to="loc_amci_NumberOfSharesSubjectToForfeiture_835debaa-cca0-4597-ab74-1c73d89d1bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_UnderwritingDiscountPercentage_c6f5f777-bc06-4a92-bdba-ff8d8f7d4d90" xlink:href="amci-20230213.xsd#amci_UnderwritingDiscountPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_4da68dde-dbed-4e9d-9af0-0115c5782c97" xlink:to="loc_amci_UnderwritingDiscountPercentage_c6f5f777-bc06-4a92-bdba-ff8d8f7d4d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_UnderwriterCashDiscount_ea5565f1-6bb3-4f67-bd9c-1b7f72cd3019" xlink:href="amci-20230213.xsd#amci_UnderwriterCashDiscount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_4da68dde-dbed-4e9d-9af0-0115c5782c97" xlink:to="loc_amci_UnderwriterCashDiscount_ea5565f1-6bb3-4f67-bd9c-1b7f72cd3019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingDiscountPercentage_901c80a7-d85a-488c-b065-e554c0c77780" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingDiscountPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_4da68dde-dbed-4e9d-9af0-0115c5782c97" xlink:to="loc_amci_DeferredUnderwritingDiscountPercentage_901c80a7-d85a-488c-b065-e554c0c77780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredUnderwritingDiscounts_a2cd7c2d-b1cc-4dc0-9a58-f391b256ac0d" xlink:href="amci-20230213.xsd#amci_DeferredUnderwritingDiscounts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_4da68dde-dbed-4e9d-9af0-0115c5782c97" xlink:to="loc_amci_DeferredUnderwritingDiscounts_a2cd7c2d-b1cc-4dc0-9a58-f391b256ac0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#ClassACommonStockSubjecttoPossibleRedemptionDetails_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_e0926de9-cd0f-45d8-8d97-015e07a3dd3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_5327910c-ccdb-4a5e-8c10-38627e8e834d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_e0926de9-cd0f-45d8-8d97-015e07a3dd3d" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_5327910c-ccdb-4a5e-8c10-38627e8e834d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_7111d986-14da-4767-a5c6-dbfea618ba46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_5327910c-ccdb-4a5e-8c10-38627e8e834d" xlink:to="loc_us-gaap_StatementClassOfStockAxis_7111d986-14da-4767-a5c6-dbfea618ba46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a478a914-124b-4f4c-8197-371df81947e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7111d986-14da-4767-a5c6-dbfea618ba46" xlink:to="loc_us-gaap_ClassOfStockDomain_a478a914-124b-4f4c-8197-371df81947e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_a4778b6c-1de1-48e2-98b3-c58071263400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a478a914-124b-4f4c-8197-371df81947e1" xlink:to="loc_us-gaap_CommonClassAMember_a4778b6c-1de1-48e2-98b3-c58071263400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_25d50226-eb0e-42ac-bf55-79e8d29a9da0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_5327910c-ccdb-4a5e-8c10-38627e8e834d" xlink:to="loc_us-gaap_TemporaryEquityLineItems_25d50226-eb0e-42ac-bf55-79e8d29a9da0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_526d0cd4-ef1c-41ce-9e7c-e05847f4f91b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_25d50226-eb0e-42ac-bf55-79e8d29a9da0" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_526d0cd4-ef1c-41ce-9e7c-e05847f4f91b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_2e0b741f-c035-4915-bf9e-b163ba507384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_25d50226-eb0e-42ac-bf55-79e8d29a9da0" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_2e0b741f-c035-4915-bf9e-b163ba507384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityNumberOfVotesPerShare_53ddf5cc-c07b-406a-bdf7-fb94fe41a281" xlink:href="amci-20230213.xsd#amci_TemporaryEquityNumberOfVotesPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_25d50226-eb0e-42ac-bf55-79e8d29a9da0" xlink:to="loc_amci_TemporaryEquityNumberOfVotesPerShare_53ddf5cc-c07b-406a-bdf7-fb94fe41a281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_5644f054-f2d4-4fcc-906d-1c24005322f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_25d50226-eb0e-42ac-bf55-79e8d29a9da0" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_5644f054-f2d4-4fcc-906d-1c24005322f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_88265bad-3a44-4d0e-b268-7f02c147a01f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_25d50226-eb0e-42ac-bf55-79e8d29a9da0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_88265bad-3a44-4d0e-b268-7f02c147a01f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LessAbstract_046eaf39-7c97-44c1-bdf0-cfe757d7d0e8" xlink:href="amci-20230213.xsd#amci_LessAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_25d50226-eb0e-42ac-bf55-79e8d29a9da0" xlink:to="loc_amci_LessAbstract_046eaf39-7c97-44c1-bdf0-cfe757d7d0e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityProceedsAllocatedToWarrants_70edd542-76b5-48b1-bb8c-bc413b79e3e7" xlink:href="amci-20230213.xsd#amci_TemporaryEquityProceedsAllocatedToWarrants"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_LessAbstract_046eaf39-7c97-44c1-bdf0-cfe757d7d0e8" xlink:to="loc_amci_TemporaryEquityProceedsAllocatedToWarrants_70edd542-76b5-48b1-bb8c-bc413b79e3e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityIssuanceCosts_ac1c22eb-9d16-498f-8634-e0ad66c0ab02" xlink:href="amci-20230213.xsd#amci_TemporaryEquityIssuanceCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_LessAbstract_046eaf39-7c97-44c1-bdf0-cfe757d7d0e8" xlink:to="loc_amci_TemporaryEquityIssuanceCosts_ac1c22eb-9d16-498f-8634-e0ad66c0ab02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PlusAbstract_1c80b241-6060-4965-bbbc-9412a80ebe47" xlink:href="amci-20230213.xsd#amci_PlusAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_25d50226-eb0e-42ac-bf55-79e8d29a9da0" xlink:to="loc_amci_PlusAbstract_1c80b241-6060-4965-bbbc-9412a80ebe47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_bcd087b3-1103-4e05-9935-1b6836fd489d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_PlusAbstract_1c80b241-6060-4965-bbbc-9412a80ebe47" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_bcd087b3-1103-4e05-9935-1b6836fd489d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_5cf1d2fc-1e9b-4940-8ad1-d1a3142fc7d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_PlusAbstract_1c80b241-6060-4965-bbbc-9412a80ebe47" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_5cf1d2fc-1e9b-4940-8ad1-d1a3142fc7d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/StockholdersDeficitPreferredStockSharesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#StockholdersDeficitPreferredStockSharesDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/StockholdersDeficitPreferredStockSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_299ec93e-c96b-40c8-96df-cf261e8c1949" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_556a26cb-933f-4c9d-bfe7-7012ef774b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_299ec93e-c96b-40c8-96df-cf261e8c1949" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_556a26cb-933f-4c9d-bfe7-7012ef774b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5232c09a-cbbb-47cd-ad8a-2c9bab97f468" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_299ec93e-c96b-40c8-96df-cf261e8c1949" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5232c09a-cbbb-47cd-ad8a-2c9bab97f468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_6570d70b-3cda-4c39-adaa-d3d16d49f380" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_299ec93e-c96b-40c8-96df-cf261e8c1949" xlink:to="loc_us-gaap_PreferredStockSharesIssued_6570d70b-3cda-4c39-adaa-d3d16d49f380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_87c9f99b-763f-4f1e-aea7-c61667da0219" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_299ec93e-c96b-40c8-96df-cf261e8c1949" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_87c9f99b-763f-4f1e-aea7-c61667da0219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/StockholdersDeficitCommonStockSharesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#StockholdersDeficitCommonStockSharesDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/StockholdersDeficitCommonStockSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_25e89c78-76a9-46ab-97bb-efd6298d2eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_0a1e5536-7d69-4038-8b17-90604d94037a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_25e89c78-76a9-46ab-97bb-efd6298d2eeb" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_0a1e5536-7d69-4038-8b17-90604d94037a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_92b9a361-14a6-43c9-bf53-cc254c96885f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_0a1e5536-7d69-4038-8b17-90604d94037a" xlink:to="loc_us-gaap_StatementClassOfStockAxis_92b9a361-14a6-43c9-bf53-cc254c96885f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_ab0bb292-f2bb-4140-ada3-da8c6828ee48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_92b9a361-14a6-43c9-bf53-cc254c96885f" xlink:to="loc_us-gaap_ClassOfStockDomain_ab0bb292-f2bb-4140-ada3-da8c6828ee48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_b91fd885-53b2-49a7-a2ad-38273a521336" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_ab0bb292-f2bb-4140-ada3-da8c6828ee48" xlink:to="loc_us-gaap_CommonClassAMember_b91fd885-53b2-49a7-a2ad-38273a521336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CommonClassaSubjectToRedemptionMember_d29fb6e5-651c-4229-a76b-73112e69e79a" xlink:href="amci-20230213.xsd#amci_CommonClassaSubjectToRedemptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonClassAMember_b91fd885-53b2-49a7-a2ad-38273a521336" xlink:to="loc_amci_CommonClassaSubjectToRedemptionMember_d29fb6e5-651c-4229-a76b-73112e69e79a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_eed0810b-cd6c-407d-a969-48be86e9cad7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_ab0bb292-f2bb-4140-ada3-da8c6828ee48" xlink:to="loc_us-gaap_CommonClassBMember_eed0810b-cd6c-407d-a969-48be86e9cad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_ba1ccfa9-1671-4837-91f9-9541f4a7b460" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_0a1e5536-7d69-4038-8b17-90604d94037a" xlink:to="loc_us-gaap_ClassOfStockLineItems_ba1ccfa9-1671-4837-91f9-9541f4a7b460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_7cc145f6-a6a2-44a5-bcf3-eecefbe8a389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ba1ccfa9-1671-4837-91f9-9541f4a7b460" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_7cc145f6-a6a2-44a5-bcf3-eecefbe8a389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_b9b967aa-3a6b-4aab-9f96-c4517216040a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ba1ccfa9-1671-4837-91f9-9541f4a7b460" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_b9b967aa-3a6b-4aab-9f96-c4517216040a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_4cfb02f9-ca39-44a7-9df4-1701539fcba2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ba1ccfa9-1671-4837-91f9-9541f4a7b460" xlink:to="loc_us-gaap_CommonStockSharesIssued_4cfb02f9-ca39-44a7-9df4-1701539fcba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_7712d476-5788-4155-b47a-1c6b8b1ff155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ba1ccfa9-1671-4837-91f9-9541f4a7b460" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_7712d476-5788-4155-b47a-1c6b8b1ff155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_02a49cb7-9e73-49f0-9530-e9c097c7309e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ba1ccfa9-1671-4837-91f9-9541f4a7b460" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_02a49cb7-9e73-49f0-9530-e9c097c7309e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_b9464bad-2c35-4b71-bd61-2edb988543b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ba1ccfa9-1671-4837-91f9-9541f4a7b460" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_b9464bad-2c35-4b71-bd61-2edb988543b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1_bec6d527-295d-4ef8-8eac-8eeae630d5b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ba1ccfa9-1671-4837-91f9-9541f4a7b460" xlink:to="loc_us-gaap_ConversionOfStockSharesIssued1_bec6d527-295d-4ef8-8eac-8eeae630d5b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ConvertibleStockConversionRatio_031fe511-cbd0-4244-af51-50f27f8962d8" xlink:href="amci-20230213.xsd#amci_ConvertibleStockConversionRatio"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ba1ccfa9-1671-4837-91f9-9541f4a7b460" xlink:to="loc_amci_ConvertibleStockConversionRatio_031fe511-cbd0-4244-af51-50f27f8962d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/WarrantsDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#WarrantsDetails_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/WarrantsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_186f1741-ffbd-4801-b33c-fe75c6a76102" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_65842cf8-b341-4857-af1f-67c85f3d4167" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_186f1741-ffbd-4801-b33c-fe75c6a76102" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_65842cf8-b341-4857-af1f-67c85f3d4167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_10dfb356-e506-4b8b-aea3-9c76e22be7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_65842cf8-b341-4857-af1f-67c85f3d4167" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_10dfb356-e506-4b8b-aea3-9c76e22be7ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_4f9f749f-745e-4b33-915a-59de2ad082b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_10dfb356-e506-4b8b-aea3-9c76e22be7ef" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_4f9f749f-745e-4b33-915a-59de2ad082b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_a629f69b-70cc-413e-80d5-a10d4a7de0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_4f9f749f-745e-4b33-915a-59de2ad082b9" xlink:to="loc_us-gaap_WarrantMember_a629f69b-70cc-413e-80d5-a10d4a7de0cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PublicWarrantsMember_bf6c1339-542a-495e-92da-a655f360d2e3" xlink:href="amci-20230213.xsd#amci_PublicWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantMember_a629f69b-70cc-413e-80d5-a10d4a7de0cb" xlink:to="loc_amci_PublicWarrantsMember_bf6c1339-542a-495e-92da-a655f360d2e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WarrantConditionAxis_948273a4-8caa-4070-ad07-c8b712a6e95b" xlink:href="amci-20230213.xsd#amci_WarrantConditionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_65842cf8-b341-4857-af1f-67c85f3d4167" xlink:to="loc_amci_WarrantConditionAxis_948273a4-8caa-4070-ad07-c8b712a6e95b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WarrantConditionDomain_48ea59f1-b4d1-4cc0-9224-c1b83322c206" xlink:href="amci-20230213.xsd#amci_WarrantConditionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_WarrantConditionAxis_948273a4-8caa-4070-ad07-c8b712a6e95b" xlink:to="loc_amci_WarrantConditionDomain_48ea59f1-b4d1-4cc0-9224-c1b83322c206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_e912d944-44fc-49b9-a6a0-d7695a72df7d" xlink:href="amci-20230213.xsd#amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_WarrantConditionDomain_48ea59f1-b4d1-4cc0-9224-c1b83322c206" xlink:to="loc_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_e912d944-44fc-49b9-a6a0-d7695a72df7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_4c0bd206-7053-4e70-bd6d-de79f366d15c" xlink:href="amci-20230213.xsd#amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_WarrantConditionDomain_48ea59f1-b4d1-4cc0-9224-c1b83322c206" xlink:to="loc_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_4c0bd206-7053-4e70-bd6d-de79f366d15c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_06d023b9-1fa3-4156-b358-501eff38d214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_65842cf8-b341-4857-af1f-67c85f3d4167" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_06d023b9-1fa3-4156-b358-501eff38d214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_524d3dbb-cf99-43be-98cd-b7ae8ee760b8" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_06d023b9-1fa3-4156-b358-501eff38d214" xlink:to="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_524d3dbb-cf99-43be-98cd-b7ae8ee760b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants_9f2a1cea-9805-43d6-8be7-064dfe0f553d" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_06d023b9-1fa3-4156-b358-501eff38d214" xlink:to="loc_amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants_9f2a1cea-9805-43d6-8be7-064dfe0f553d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_fc49f683-ce16-48bb-a7c3-2f5b7b30983a" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_06d023b9-1fa3-4156-b358-501eff38d214" xlink:to="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_fc49f683-ce16-48bb-a7c3-2f5b7b30983a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices_0ecac309-a909-49cc-85ea-b4c184d12ab9" xlink:href="amci-20230213.xsd#amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_06d023b9-1fa3-4156-b358-501eff38d214" xlink:to="loc_amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices_0ecac309-a909-49cc-85ea-b4c184d12ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_dc6c7a95-5e99-4765-b611-ecfbcb7a9067" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_06d023b9-1fa3-4156-b358-501eff38d214" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_dc6c7a95-5e99-4765-b611-ecfbcb7a9067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_00edf6e7-b8a7-41de-b5e8-db678580d355" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_06d023b9-1fa3-4156-b358-501eff38d214" xlink:to="loc_amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_00edf6e7-b8a7-41de-b5e8-db678580d355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RedemptionPeriod_b79ca11f-5595-45ff-85e5-8ebb7500d5c9" xlink:href="amci-20230213.xsd#amci_RedemptionPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_06d023b9-1fa3-4156-b358-501eff38d214" xlink:to="loc_amci_RedemptionPeriod_b79ca11f-5595-45ff-85e5-8ebb7500d5c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#WarrantsAdditionalInformationDetails_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_462588cd-7eaa-4f79-8fe6-69422724e2bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_094fa258-0f93-426e-81c4-ec3f2c608017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_462588cd-7eaa-4f79-8fe6-69422724e2bd" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_094fa258-0f93-426e-81c4-ec3f2c608017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_4dcedc17-4867-4305-b65b-104798e3e24a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_094fa258-0f93-426e-81c4-ec3f2c608017" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_4dcedc17-4867-4305-b65b-104798e3e24a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_066c44e1-e50d-417e-9ba5-927fe99ec3c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_4dcedc17-4867-4305-b65b-104798e3e24a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_066c44e1-e50d-417e-9ba5-927fe99ec3c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PublicWarrantsMember_5cae2c82-0cbd-4748-9a66-c84dd333de52" xlink:href="amci-20230213.xsd#amci_PublicWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_066c44e1-e50d-417e-9ba5-927fe99ec3c9" xlink:to="loc_amci_PublicWarrantsMember_5cae2c82-0cbd-4748-9a66-c84dd333de52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PrivatePlacementWarrantsMember_f1caa473-ee76-4c59-a3c5-3b43df2fc0c0" xlink:href="amci-20230213.xsd#amci_PrivatePlacementWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_066c44e1-e50d-417e-9ba5-927fe99ec3c9" xlink:to="loc_amci_PrivatePlacementWarrantsMember_f1caa473-ee76-4c59-a3c5-3b43df2fc0c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_9f7229ba-1c01-4aee-be62-13c487e16cb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_094fa258-0f93-426e-81c4-ec3f2c608017" xlink:to="loc_us-gaap_StatementClassOfStockAxis_9f7229ba-1c01-4aee-be62-13c487e16cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_699853f2-4b4f-48b2-8237-6a386a261adc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9f7229ba-1c01-4aee-be62-13c487e16cb1" xlink:to="loc_us-gaap_ClassOfStockDomain_699853f2-4b4f-48b2-8237-6a386a261adc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_f7184929-052f-4577-9328-1cb3bac383bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_699853f2-4b4f-48b2-8237-6a386a261adc" xlink:to="loc_us-gaap_CommonClassAMember_f7184929-052f-4577-9328-1cb3bac383bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WarrantConditionAxis_bb24f23c-cab4-40a3-8078-a56a4fd92aef" xlink:href="amci-20230213.xsd#amci_WarrantConditionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_094fa258-0f93-426e-81c4-ec3f2c608017" xlink:to="loc_amci_WarrantConditionAxis_bb24f23c-cab4-40a3-8078-a56a4fd92aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WarrantConditionDomain_6364e875-f47f-4616-b088-2e6cc3cf8d94" xlink:href="amci-20230213.xsd#amci_WarrantConditionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_WarrantConditionAxis_bb24f23c-cab4-40a3-8078-a56a4fd92aef" xlink:to="loc_amci_WarrantConditionDomain_6364e875-f47f-4616-b088-2e6cc3cf8d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_53a2cf90-ef3e-4636-9436-4cf546e15807" xlink:href="amci-20230213.xsd#amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_WarrantConditionDomain_6364e875-f47f-4616-b088-2e6cc3cf8d94" xlink:to="loc_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_53a2cf90-ef3e-4636-9436-4cf546e15807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_c11738e6-dc89-428e-b844-17c77a7ca741" xlink:href="amci-20230213.xsd#amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_WarrantConditionDomain_6364e875-f47f-4616-b088-2e6cc3cf8d94" xlink:to="loc_amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_c11738e6-dc89-428e-b844-17c77a7ca741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_9741ed5c-fd97-4d07-a88f-6da49f7075fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_094fa258-0f93-426e-81c4-ec3f2c608017" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_9741ed5c-fd97-4d07-a88f-6da49f7075fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_421b1dc0-8261-40ad-a10b-edae00944bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_9741ed5c-fd97-4d07-a88f-6da49f7075fb" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_421b1dc0-8261-40ad-a10b-edae00944bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_7a046823-e04c-46a3-8a1d-ad234e0bfcec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_9741ed5c-fd97-4d07-a88f-6da49f7075fb" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_7a046823-e04c-46a3-8a1d-ad234e0bfcec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights_824dbc32-a719-4122-8af6-91708df71a21" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_9741ed5c-fd97-4d07-a88f-6da49f7075fb" xlink:to="loc_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights_824dbc32-a719-4122-8af6-91708df71a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering_efb4380a-961e-4f52-80b0-fe240531e10a" xlink:href="amci-20230213.xsd#amci_WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_9741ed5c-fd97-4d07-a88f-6da49f7075fb" xlink:to="loc_amci_WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering_efb4380a-961e-4f52-80b0-fe240531e10a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MaximumThresholdPeriodForFilingRegistrationStatementAfterBusinessCombination_ed1df239-a4de-45f1-b5bb-a894e6784848" xlink:href="amci-20230213.xsd#amci_MaximumThresholdPeriodForFilingRegistrationStatementAfterBusinessCombination"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_9741ed5c-fd97-4d07-a88f-6da49f7075fb" xlink:to="loc_amci_MaximumThresholdPeriodForFilingRegistrationStatementAfterBusinessCombination_ed1df239-a4de-45f1-b5bb-a894e6784848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_88064f0d-9018-4902-9882-70662d254c96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_9741ed5c-fd97-4d07-a88f-6da49f7075fb" xlink:to="loc_us-gaap_SharePrice_88064f0d-9018-4902-9882-70662d254c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PercentageOfGrossProceedsOnTotalEquityProceed_33444bde-04aa-4faf-839a-08c841ea238d" xlink:href="amci-20230213.xsd#amci_PercentageOfGrossProceedsOnTotalEquityProceed"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_9741ed5c-fd97-4d07-a88f-6da49f7075fb" xlink:to="loc_amci_PercentageOfGrossProceedsOnTotalEquityProceed_33444bde-04aa-4faf-839a-08c841ea238d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDaysSource2_aa2228d8-91a4-4f56-bea6-a3ab50969be2" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDaysSource2"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_9741ed5c-fd97-4d07-a88f-6da49f7075fb" xlink:to="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDaysSource2_aa2228d8-91a4-4f56-bea6-a3ab50969be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices_127d1b7d-7b96-49a9-be01-0a4fd16dda3b" xlink:href="amci-20230213.xsd#amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_9741ed5c-fd97-4d07-a88f-6da49f7075fb" xlink:to="loc_amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices_127d1b7d-7b96-49a9-be01-0a4fd16dda3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_d5796239-6492-458b-a5a5-9048aeeb8268" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_9741ed5c-fd97-4d07-a88f-6da49f7075fb" xlink:to="loc_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_d5796239-6492-458b-a5a5-9048aeeb8268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PeriodForFillingRegistrationStatementAfterBusinessCombination_4fd4224a-c0cd-44e9-8cf8-511b9f2a2a4e" xlink:href="amci-20230213.xsd#amci_PeriodForFillingRegistrationStatementAfterBusinessCombination"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_9741ed5c-fd97-4d07-a88f-6da49f7075fb" xlink:to="loc_amci_PeriodForFillingRegistrationStatementAfterBusinessCombination_4fd4224a-c0cd-44e9-8cf8-511b9f2a2a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise_06cda81e-c75d-4fda-a5b3-e7895af9f93c" xlink:href="amci-20230213.xsd#amci_PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_9741ed5c-fd97-4d07-a88f-6da49f7075fb" xlink:to="loc_amci_PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise_06cda81e-c75d-4fda-a5b3-e7895af9f93c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_64a27969-5631-4f1d-a13b-b8ea0889b772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7b52c479-5140-4edf-b32a-b88ed4ac1ac8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_64a27969-5631-4f1d-a13b-b8ea0889b772" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7b52c479-5140-4edf-b32a-b88ed4ac1ac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_61109597-defa-4ae9-81ac-8ce0e74d4764" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7b52c479-5140-4edf-b32a-b88ed4ac1ac8" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_61109597-defa-4ae9-81ac-8ce0e74d4764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_a0316df4-e6e6-413f-9bc9-e766b6cf1012" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_61109597-defa-4ae9-81ac-8ce0e74d4764" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_a0316df4-e6e6-413f-9bc9-e766b6cf1012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_85ea9d19-b76e-4d0d-8cc7-57db36219d93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_a0316df4-e6e6-413f-9bc9-e766b6cf1012" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_85ea9d19-b76e-4d0d-8cc7-57db36219d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_33ad746d-6e90-4208-af65-029f68957af7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7b52c479-5140-4edf-b32a-b88ed4ac1ac8" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_33ad746d-6e90-4208-af65-029f68957af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f2d20f2f-b8d7-4ce4-8437-1337b0c8ba0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_33ad746d-6e90-4208-af65-029f68957af7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f2d20f2f-b8d7-4ce4-8437-1337b0c8ba0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_0c498ffb-0607-484f-b3e7-371f62e03a91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f2d20f2f-b8d7-4ce4-8437-1337b0c8ba0c" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_0c498ffb-0607-484f-b3e7-371f62e03a91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_c9759be5-15f0-4705-8b2b-6237ac668af0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f2d20f2f-b8d7-4ce4-8437-1337b0c8ba0c" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_c9759be5-15f0-4705-8b2b-6237ac668af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_8a0d3a61-64dc-423d-a5a3-700d36097ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7b52c479-5140-4edf-b32a-b88ed4ac1ac8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_8a0d3a61-64dc-423d-a5a3-700d36097ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_8fc2b457-9874-458f-ae0b-db03cc7929dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_8a0d3a61-64dc-423d-a5a3-700d36097ef9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_8fc2b457-9874-458f-ae0b-db03cc7929dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PublicWarrantsMember_d9d28ec8-43d3-4d27-82e9-b2f3a888dfdc" xlink:href="amci-20230213.xsd#amci_PublicWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_8fc2b457-9874-458f-ae0b-db03cc7929dc" xlink:to="loc_amci_PublicWarrantsMember_d9d28ec8-43d3-4d27-82e9-b2f3a888dfdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PrivatePlacementWarrantsMember_1a353563-6fdc-415d-bca2-bf5969dd9835" xlink:href="amci-20230213.xsd#amci_PrivatePlacementWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_8fc2b457-9874-458f-ae0b-db03cc7929dc" xlink:to="loc_amci_PrivatePlacementWarrantsMember_1a353563-6fdc-415d-bca2-bf5969dd9835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eba0e873-ed6f-4acb-97bc-95f464c25713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7b52c479-5140-4edf-b32a-b88ed4ac1ac8" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eba0e873-ed6f-4acb-97bc-95f464c25713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_4721b638-0bd5-4f66-bd01-0bb5d601af8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eba0e873-ed6f-4acb-97bc-95f464c25713" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_4721b638-0bd5-4f66-bd01-0bb5d601af8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_5f7319a3-2d15-4598-9d86-9c31d00d5640" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_4721b638-0bd5-4f66-bd01-0bb5d601af8b" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_5f7319a3-2d15-4598-9d86-9c31d00d5640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_33de9596-7d01-48ec-9162-e68517bc1e25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eba0e873-ed6f-4acb-97bc-95f464c25713" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_33de9596-7d01-48ec-9162-e68517bc1e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_a653a3c9-b4b0-4c63-ae3c-cee1b3f9979a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_33de9596-7d01-48ec-9162-e68517bc1e25" xlink:to="loc_us-gaap_DerivativeLiabilities_a653a3c9-b4b0-4c63-ae3c-cee1b3f9979a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_47f4cdbc-9f4d-4a3e-8754-f55699f4c813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_33de9596-7d01-48ec-9162-e68517bc1e25" xlink:to="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_47f4cdbc-9f4d-4a3e-8754-f55699f4c813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueMeasurementsLevel3fairvaluemeasurementsDetails_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_03c4e4d1-eb7c-4e9f-99e8-7128cbf2ffcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_560fe087-7a21-4434-b82e-336df05c45ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_03c4e4d1-eb7c-4e9f-99e8-7128cbf2ffcb" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_560fe087-7a21-4434-b82e-336df05c45ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_571438ed-a02d-40c6-91b4-78ecadd1a932" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_560fe087-7a21-4434-b82e-336df05c45ad" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_571438ed-a02d-40c6-91b4-78ecadd1a932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_4081ba0e-a9a9-476f-9fb8-03cc15337611" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_571438ed-a02d-40c6-91b4-78ecadd1a932" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_4081ba0e-a9a9-476f-9fb8-03cc15337611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExercisePriceMember_4b481541-4c95-4d8e-8c00-01f8d8fb2c86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExercisePriceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_4081ba0e-a9a9-476f-9fb8-03cc15337611" xlink:to="loc_us-gaap_MeasurementInputExercisePriceMember_4b481541-4c95-4d8e-8c00-01f8d8fb2c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_33cfd1ef-e248-4b65-83af-afaff287a22a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_4081ba0e-a9a9-476f-9fb8-03cc15337611" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_33cfd1ef-e248-4b65-83af-afaff287a22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_0e747ab2-97f5-49a8-80d5-14a8f14ca268" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_4081ba0e-a9a9-476f-9fb8-03cc15337611" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_0e747ab2-97f5-49a8-80d5-14a8f14ca268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_00843266-f3fa-45f9-8d9b-71cf5029961a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_4081ba0e-a9a9-476f-9fb8-03cc15337611" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_00843266-f3fa-45f9-8d9b-71cf5029961a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_6a3c56de-8e52-4210-8850-4836b0278aac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_4081ba0e-a9a9-476f-9fb8-03cc15337611" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_6a3c56de-8e52-4210-8850-4836b0278aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_1cab0524-15a6-40cd-9e14-2d0615400196" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_560fe087-7a21-4434-b82e-336df05c45ad" xlink:to="loc_dei_LegalEntityAxis_1cab0524-15a6-40cd-9e14-2d0615400196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_7cd271a2-b608-43ff-9157-797fd6ee300d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1cab0524-15a6-40cd-9e14-2d0615400196" xlink:to="loc_dei_EntityDomain_7cd271a2-b608-43ff-9157-797fd6ee300d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AMCIACQUISITIONCORPIIMember_fbc4f033-072d-4f05-8d27-e183bbbc9bba" xlink:href="amci-20230213.xsd#amci_AMCIACQUISITIONCORPIIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_7cd271a2-b608-43ff-9157-797fd6ee300d" xlink:to="loc_amci_AMCIACQUISITIONCORPIIMember_fbc4f033-072d-4f05-8d27-e183bbbc9bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1d3db642-a943-4452-bead-f2402387674b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_560fe087-7a21-4434-b82e-336df05c45ad" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1d3db642-a943-4452-bead-f2402387674b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_afdb6a72-8bc6-4696-9388-225d17eeaa62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1d3db642-a943-4452-bead-f2402387674b" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_afdb6a72-8bc6-4696-9388-225d17eeaa62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a4d743c3-7cac-414b-8789-5d4df8a8f550" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_0af888c3-702a-4016-b920-1db750527b35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a4d743c3-7cac-414b-8789-5d4df8a8f550" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_0af888c3-702a-4016-b920-1db750527b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_a0cd681d-363e-4341-b7e1-bbb5746680ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_0af888c3-702a-4016-b920-1db750527b35" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_a0cd681d-363e-4341-b7e1-bbb5746680ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2e6f2df8-de30-4802-81c0-76b252f3d756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_a0cd681d-363e-4341-b7e1-bbb5746680ea" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2e6f2df8-de30-4802-81c0-76b252f3d756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_e6bfffa1-03bd-432a-98a1-92baede37e93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2e6f2df8-de30-4802-81c0-76b252f3d756" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_e6bfffa1-03bd-432a-98a1-92baede37e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_98169117-fe48-453d-99a2-eac38165dbab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_0af888c3-702a-4016-b920-1db750527b35" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_98169117-fe48-453d-99a2-eac38165dbab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1f39a9ad-6e3e-4631-9e6a-7539c70248d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_98169117-fe48-453d-99a2-eac38165dbab" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1f39a9ad-6e3e-4631-9e6a-7539c70248d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ebb36662-6ce4-4011-ae58-56a3b7ac5d23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1f39a9ad-6e3e-4631-9e6a-7539c70248d4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_ebb36662-6ce4-4011-ae58-56a3b7ac5d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_37ddc941-917e-42ac-adce-5f81761f9fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1f39a9ad-6e3e-4631-9e6a-7539c70248d4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_37ddc941-917e-42ac-adce-5f81761f9fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_eb48b37c-3fdf-46ff-afd1-23e0c9ca8f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1f39a9ad-6e3e-4631-9e6a-7539c70248d4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_eb48b37c-3fdf-46ff-afd1-23e0c9ca8f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_7712b432-6585-4ebc-a76d-4521ed894025" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1f39a9ad-6e3e-4631-9e6a-7539c70248d4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_7712b432-6585-4ebc-a76d-4521ed894025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_72a786c8-8a2d-4d3f-8e80-20b461b87632" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_7712b432-6585-4ebc-a76d-4521ed894025" xlink:to="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_72a786c8-8a2d-4d3f-8e80-20b461b87632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b20fc0c9-7b57-4c2d-bf86-d6321e3cdde6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1f39a9ad-6e3e-4631-9e6a-7539c70248d4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b20fc0c9-7b57-4c2d-bf86-d6321e3cdde6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/IncomeTaxesIncometaxprovisionDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#IncomeTaxesIncometaxprovisionDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/IncomeTaxesIncometaxprovisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9cf873bc-b794-4aeb-afae-678548586db6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_5b411453-98cc-4c41-9839-6a58e6a94f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9cf873bc-b794-4aeb-afae-678548586db6" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_5b411453-98cc-4c41-9839-6a58e6a94f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_ec8dc3e4-8982-41f0-8f35-fb547f03d051" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_5b411453-98cc-4c41-9839-6a58e6a94f2a" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_ec8dc3e4-8982-41f0-8f35-fb547f03d051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_ebf4dfef-fb38-49ba-a0f2-3f023642cde7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_5b411453-98cc-4c41-9839-6a58e6a94f2a" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_ebf4dfef-fb38-49ba-a0f2-3f023642cde7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_006fa66e-290a-44d1-aa8f-25633e799dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9cf873bc-b794-4aeb-afae-678548586db6" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_006fa66e-290a-44d1-aa8f-25633e799dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_a179a4c9-bbb4-48f5-83b9-b47961944d44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_006fa66e-290a-44d1-aa8f-25633e799dc3" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_a179a4c9-bbb4-48f5-83b9-b47961944d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_e573d7ea-0946-4ad5-8fc6-ff90efb315db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_006fa66e-290a-44d1-aa8f-25633e799dc3" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_e573d7ea-0946-4ad5-8fc6-ff90efb315db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_64250019-1978-4e5e-a911-1ebebfd8218c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9cf873bc-b794-4aeb-afae-678548586db6" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_64250019-1978-4e5e-a911-1ebebfd8218c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_88ce2280-24b6-456a-b89d-b23a84d6533e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9cf873bc-b794-4aeb-afae-678548586db6" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_88ce2280-24b6-456a-b89d-b23a84d6533e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/IncomeTaxesDeferredtaxassetsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#IncomeTaxesDeferredtaxassetsDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/IncomeTaxesDeferredtaxassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b948c397-9178-49ff-a374-8569071bd64f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_fc8b6634-63b1-4d47-a130-ceb3ec73316c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b948c397-9178-49ff-a374-8569071bd64f" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_fc8b6634-63b1-4d47-a130-ceb3ec73316c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_3db61465-c1eb-4797-b3d0-a70141e3bec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_fc8b6634-63b1-4d47-a130-ceb3ec73316c" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_3db61465-c1eb-4797-b3d0-a70141e3bec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_457644b8-1fa3-4237-b0cc-e0fb0fe964b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_3db61465-c1eb-4797-b3d0-a70141e3bec7" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_457644b8-1fa3-4237-b0cc-e0fb0fe964b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_405b6c5e-d376-473d-8445-3db0d50192e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_457644b8-1fa3-4237-b0cc-e0fb0fe964b0" xlink:to="loc_us-gaap_DomesticCountryMember_405b6c5e-d376-473d-8445-3db0d50192e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_ad6c963d-45d2-4bb7-a9ae-163773844127" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_fc8b6634-63b1-4d47-a130-ceb3ec73316c" xlink:to="loc_dei_LegalEntityAxis_ad6c963d-45d2-4bb7-a9ae-163773844127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8bd5d0de-7dfb-4a6a-9846-71ed73ed9464" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_ad6c963d-45d2-4bb7-a9ae-163773844127" xlink:to="loc_dei_EntityDomain_8bd5d0de-7dfb-4a6a-9846-71ed73ed9464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_AMCIACQUISITIONCORPIIMember_1914bd85-d8e0-40bd-900a-da4c609fa4fa" xlink:href="amci-20230213.xsd#amci_AMCIACQUISITIONCORPIIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_8bd5d0de-7dfb-4a6a-9846-71ed73ed9464" xlink:to="loc_amci_AMCIACQUISITIONCORPIIMember_1914bd85-d8e0-40bd-900a-da4c609fa4fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_9d30c61b-be0f-48da-b74a-d1ea9bd9eee9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_fc8b6634-63b1-4d47-a130-ceb3ec73316c" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_9d30c61b-be0f-48da-b74a-d1ea9bd9eee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_a6807c27-0695-4a82-b8f0-69bfbec99e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_9d30c61b-be0f-48da-b74a-d1ea9bd9eee9" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_a6807c27-0695-4a82-b8f0-69bfbec99e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts_a56a6ad9-14d4-4909-9365-5f30aebe8b41" xlink:href="amci-20230213.xsd#amci_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_a6807c27-0695-4a82-b8f0-69bfbec99e9b" xlink:to="loc_amci_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts_a56a6ad9-14d4-4909-9365-5f30aebe8b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_dd0b9c1a-0cf8-4084-9bab-0aba17f61910" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_a6807c27-0695-4a82-b8f0-69bfbec99e9b" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_dd0b9c1a-0cf8-4084-9bab-0aba17f61910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_cc1c9ef9-67d3-44ee-85a5-7b0f70e89d72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_a6807c27-0695-4a82-b8f0-69bfbec99e9b" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_cc1c9ef9-67d3-44ee-85a5-7b0f70e89d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_9c5ffc7a-81a6-46db-a433-b10117583e38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_a6807c27-0695-4a82-b8f0-69bfbec99e9b" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_9c5ffc7a-81a6-46db-a433-b10117583e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_13f411a9-053b-4c9d-b2c2-c56b9ad33cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_a6807c27-0695-4a82-b8f0-69bfbec99e9b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_13f411a9-053b-4c9d-b2c2-c56b9ad33cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_1d6f1f05-6163-4d27-9dff-31744f45e0ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_a6807c27-0695-4a82-b8f0-69bfbec99e9b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_1d6f1f05-6163-4d27-9dff-31744f45e0ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/IncomeTaxesReconciliationofthestatutoryfederalincometaxratebenefitDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#IncomeTaxesReconciliationofthestatutoryfederalincometaxratebenefitDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/IncomeTaxesReconciliationofthestatutoryfederalincometaxratebenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6b231daa-19ad-40df-a721-3e20a8a43c81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_0eb4fc97-a722-4aae-9ba1-2f491f1f661f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6b231daa-19ad-40df-a721-3e20a8a43c81" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_0eb4fc97-a722-4aae-9ba1-2f491f1f661f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b8260b3b-03f5-4485-abb3-e2e9b611b0ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6b231daa-19ad-40df-a721-3e20a8a43c81" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b8260b3b-03f5-4485-abb3-e2e9b611b0ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_c4e5d92f-b61a-4358-8c6d-ede4d09ccd95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6b231daa-19ad-40df-a721-3e20a8a43c81" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_c4e5d92f-b61a-4358-8c6d-ede4d09ccd95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_81ecb560-6f68-4757-904f-29166fd92920" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6b231daa-19ad-40df-a721-3e20a8a43c81" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_81ecb560-6f68-4757-904f-29166fd92920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_c2239955-09c6-45b4-9160-610417b9b6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6b231daa-19ad-40df-a721-3e20a8a43c81" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_c2239955-09c6-45b4-9160-610417b9b6c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_4749f82c-2a33-4d25-b553-74b8025b812b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6b231daa-19ad-40df-a721-3e20a8a43c81" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_4749f82c-2a33-4d25-b553-74b8025b812b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_778385e7-8cee-4474-92f3-8f7bce4dfbc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6b231daa-19ad-40df-a721-3e20a8a43c81" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_778385e7-8cee-4474-92f3-8f7bce4dfbc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_cb182168-157d-4708-a28f-842090676129" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6b231daa-19ad-40df-a721-3e20a8a43c81" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_cb182168-157d-4708-a28f-842090676129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SubsequentEventsDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#SubsequentEventsDetails_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/SubsequentEventsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_3f733ad7-31c4-4db8-a5f6-8186bb67634c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_a5080629-59ff-42e4-8951-0d999082fd21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_3f733ad7-31c4-4db8-a5f6-8186bb67634c" xlink:to="loc_us-gaap_SubsequentEventTable_a5080629-59ff-42e4-8951-0d999082fd21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e35f0ef1-7c26-421b-894b-a435a4e14e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_a5080629-59ff-42e4-8951-0d999082fd21" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e35f0ef1-7c26-421b-894b-a435a4e14e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9955463c-5935-404b-a7b4-375f33ad06a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e35f0ef1-7c26-421b-894b-a435a4e14e7c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9955463c-5935-404b-a7b4-375f33ad06a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LanzatechGlobalMember_2537c931-33ca-4bb9-a21c-d22902d7b85d" xlink:href="amci-20230213.xsd#amci_LanzatechGlobalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9955463c-5935-404b-a7b4-375f33ad06a8" xlink:to="loc_amci_LanzatechGlobalMember_2537c931-33ca-4bb9-a21c-d22902d7b85d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_936a8c3d-d768-4d53-8fef-01b133057b9c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_a5080629-59ff-42e4-8951-0d999082fd21" xlink:to="loc_srt_RangeAxis_936a8c3d-d768-4d53-8fef-01b133057b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2fc5e521-87ca-4a06-a52f-f00a5e59d9e1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_936a8c3d-d768-4d53-8fef-01b133057b9c" xlink:to="loc_srt_RangeMember_2fc5e521-87ca-4a06-a52f-f00a5e59d9e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_897720b6-f6bc-469e-900c-9922e5032f56" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2fc5e521-87ca-4a06-a52f-f00a5e59d9e1" xlink:to="loc_srt_MinimumMember_897720b6-f6bc-469e-900c-9922e5032f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_aaf4c946-adfe-4e8e-b211-d3a1fd70c180" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_a5080629-59ff-42e4-8951-0d999082fd21" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_aaf4c946-adfe-4e8e-b211-d3a1fd70c180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_100aff10-8d7e-4591-a785-33083425462a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_aaf4c946-adfe-4e8e-b211-d3a1fd70c180" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_100aff10-8d7e-4591-a785-33083425462a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_ec86211f-246c-44d9-8bbe-6b181a9a7c1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_100aff10-8d7e-4591-a785-33083425462a" xlink:to="loc_us-gaap_SubsequentEventMember_ec86211f-246c-44d9-8bbe-6b181a9a7c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_a79859ec-a34b-4491-95fd-9fc1bbf2d5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_a5080629-59ff-42e4-8951-0d999082fd21" xlink:to="loc_us-gaap_SubsequentEventLineItems_a79859ec-a34b-4491-95fd-9fc1bbf2d5f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationAssetCurrent_07f58aa7-51ee-47c7-b85a-3c9fff103ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationAssetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a79859ec-a34b-4491-95fd-9fc1bbf2d5f9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationAssetCurrent_07f58aa7-51ee-47c7-b85a-3c9fff103ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_1c1663a1-65d8-4ae0-8906-f9457f8a37dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a79859ec-a34b-4491-95fd-9fc1bbf2d5f9" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_1c1663a1-65d8-4ae0-8906-f9457f8a37dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_5c013b54-5c34-4a11-a5f1-5be5efdae0b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a79859ec-a34b-4491-95fd-9fc1bbf2d5f9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_5c013b54-5c34-4a11-a5f1-5be5efdae0b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNet_3a3c53d2-c934-4af6-9b0e-5257c6a353d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a79859ec-a34b-4491-95fd-9fc1bbf2d5f9" xlink:to="loc_us-gaap_AssetsNet_3a3c53d2-c934-4af6-9b0e-5257c6a353d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrustCurrent_cc7fb71f-c7cf-462c-87ed-8618960bb8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a79859ec-a34b-4491-95fd-9fc1bbf2d5f9" xlink:to="loc_us-gaap_AssetsHeldInTrustCurrent_cc7fb71f-c7cf-462c-87ed-8618960bb8cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/DescriptionoftheBusinessDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#DescriptionoftheBusinessDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/DescriptionoftheBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ffd2b5f0-6069-43d7-940e-628c1d1e86b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ScheduleOfReverseCapitalizationTable_c878226f-5929-43cc-b64c-c06c8c15f67c" xlink:href="amci-20230213.xsd#amci_ScheduleOfReverseCapitalizationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ffd2b5f0-6069-43d7-940e-628c1d1e86b5" xlink:to="loc_amci_ScheduleOfReverseCapitalizationTable_c878226f-5929-43cc-b64c-c06c8c15f67c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_518badbc-4395-4bea-a126-361b101c19f1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_ScheduleOfReverseCapitalizationTable_c878226f-5929-43cc-b64c-c06c8c15f67c" xlink:to="loc_srt_RangeAxis_518badbc-4395-4bea-a126-361b101c19f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_923567b9-097b-4840-89e6-2cc60a842e6a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_518badbc-4395-4bea-a126-361b101c19f1" xlink:to="loc_srt_RangeMember_923567b9-097b-4840-89e6-2cc60a842e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_32dd861e-95b5-4b08-b1a3-278399907be5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_923567b9-097b-4840-89e6-2cc60a842e6a" xlink:to="loc_srt_MinimumMember_32dd861e-95b5-4b08-b1a3-278399907be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6d77349a-b774-41f8-93fe-8893dabef303" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_923567b9-097b-4840-89e6-2cc60a842e6a" xlink:to="loc_srt_MaximumMember_6d77349a-b774-41f8-93fe-8893dabef303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_d85fe2b7-846f-43c0-b6f5-e45bd6d23131" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_ScheduleOfReverseCapitalizationTable_c878226f-5929-43cc-b64c-c06c8c15f67c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_d85fe2b7-846f-43c0-b6f5-e45bd6d23131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9c30d4f1-4318-4557-b320-06f62207180e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_d85fe2b7-846f-43c0-b6f5-e45bd6d23131" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9c30d4f1-4318-4557-b320-06f62207180e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_2f8a6b57-ac74-4c5c-836b-c125e01aea21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_9c30d4f1-4318-4557-b320-06f62207180e" xlink:to="loc_us-gaap_SubsequentEventMember_2f8a6b57-ac74-4c5c-836b-c125e01aea21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ScheduleOfReverseCapitalizationLineItems_c140a6d9-281c-4f43-aa64-f01f3e900687" xlink:href="amci-20230213.xsd#amci_ScheduleOfReverseCapitalizationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_ScheduleOfReverseCapitalizationTable_c878226f-5929-43cc-b64c-c06c8c15f67c" xlink:to="loc_amci_ScheduleOfReverseCapitalizationLineItems_c140a6d9-281c-4f43-aa64-f01f3e900687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_d4de3e9b-202d-4ac8-a7c1-b5b9868afcbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_ScheduleOfReverseCapitalizationLineItems_c140a6d9-281c-4f43-aa64-f01f3e900687" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_d4de3e9b-202d-4ac8-a7c1-b5b9868afcbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ReverseCapitalizationClosingCashCondition_a87600a6-1df3-4770-be5c-e23cfce553b1" xlink:href="amci-20230213.xsd#amci_ReverseCapitalizationClosingCashCondition"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_ScheduleOfReverseCapitalizationLineItems_c140a6d9-281c-4f43-aa64-f01f3e900687" xlink:to="loc_amci_ReverseCapitalizationClosingCashCondition_a87600a6-1df3-4770-be5c-e23cfce553b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_27054c58-a093-4270-9052-5b8ac2a3efc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_ScheduleOfReverseCapitalizationLineItems_c140a6d9-281c-4f43-aa64-f01f3e900687" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_27054c58-a093-4270-9052-5b8ac2a3efc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesGoingConcernandSegmentInformationDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#SummaryofSignificantAccountingPoliciesGoingConcernandSegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesGoingConcernandSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a8a0fc81-9e97-4822-ab27-14e82162d738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_dc0c2985-00f1-40ac-8b67-085ae02e632e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a8a0fc81-9e97-4822-ab27-14e82162d738" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_dc0c2985-00f1-40ac-8b67-085ae02e632e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_04a3b471-9861-40e5-be7d-1d97918db5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a8a0fc81-9e97-4822-ab27-14e82162d738" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_04a3b471-9861-40e5-be7d-1d97918db5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7c8f3e7a-8dbf-4f88-bf24-96823444a7b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a8a0fc81-9e97-4822-ab27-14e82162d738" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7c8f3e7a-8dbf-4f88-bf24-96823444a7b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6d42d407-3cc5-4384-8855-dbca43434eff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a8a0fc81-9e97-4822-ab27-14e82162d738" xlink:to="loc_us-gaap_NetIncomeLoss_6d42d407-3cc5-4384-8855-dbca43434eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_34a34a97-cfd8-40ea-b10f-0b117b672100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a8a0fc81-9e97-4822-ab27-14e82162d738" xlink:to="loc_us-gaap_NumberOfOperatingSegments_34a34a97-cfd8-40ea-b10f-0b117b672100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#SummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b866eefa-70d6-4a14-b7a2-2865ee1165fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_361781f8-e403-407a-941e-7e5291582bae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b866eefa-70d6-4a14-b7a2-2865ee1165fd" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_361781f8-e403-407a-941e-7e5291582bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashReconciliationDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashReconciliationDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_802c5b12-7bff-436d-887a-d6e47b5c4d54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ceea877e-feb5-41d3-8534-0793c4503125" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_802c5b12-7bff-436d-887a-d6e47b5c4d54" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ceea877e-feb5-41d3-8534-0793c4503125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_dd4a9c26-0d75-4d31-9dec-9da998521328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_802c5b12-7bff-436d-887a-d6e47b5c4d54" xlink:to="loc_us-gaap_RestrictedCash_dd4a9c26-0d75-4d31-9dec-9da998521328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_12b015f1-4f3b-4348-88b1-7e95ac88378d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_802c5b12-7bff-436d-887a-d6e47b5c4d54" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_12b015f1-4f3b-4348-88b1-7e95ac88378d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesTradeandOtherReceivablesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#SummaryofSignificantAccountingPoliciesTradeandOtherReceivablesDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesTradeandOtherReceivablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e4be60ee-c240-4b31-99e6-89e634e843fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_05e05d4d-ffb8-4e3d-ab9c-09ed127da663" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e4be60ee-c240-4b31-99e6-89e634e843fe" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_05e05d4d-ffb8-4e3d-ab9c-09ed127da663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9b1dbc38-47e3-4c6e-bf01-40e91bac596e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_7434e94f-6938-4cd3-86ba-e5a4098e82b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9b1dbc38-47e3-4c6e-bf01-40e91bac596e" xlink:to="loc_us-gaap_ConcentrationRiskTable_7434e94f-6938-4cd3-86ba-e5a4098e82b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c4ce5d67-5ae0-4228-893d-144a010ac007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_7434e94f-6938-4cd3-86ba-e5a4098e82b6" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c4ce5d67-5ae0-4228-893d-144a010ac007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2f0fd9a9-392e-4966-88fb-3e9f38916851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c4ce5d67-5ae0-4228-893d-144a010ac007" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2f0fd9a9-392e-4966-88fb-3e9f38916851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_55b932c7-07bf-4f82-8919-9b0e543dff64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2f0fd9a9-392e-4966-88fb-3e9f38916851" xlink:to="loc_us-gaap_SalesRevenueNetMember_55b932c7-07bf-4f82-8919-9b0e543dff64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_0a69ed67-4c1d-426b-a6fa-ba5f32cc03eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2f0fd9a9-392e-4966-88fb-3e9f38916851" xlink:to="loc_us-gaap_AccountsReceivableMember_0a69ed67-4c1d-426b-a6fa-ba5f32cc03eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_c7838422-4fe7-4fc7-9257-c5a7ab96dc2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_7434e94f-6938-4cd3-86ba-e5a4098e82b6" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_c7838422-4fe7-4fc7-9257-c5a7ab96dc2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_de46362b-80f1-41c9-b780-eb52ffce5829" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_c7838422-4fe7-4fc7-9257-c5a7ab96dc2e" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_de46362b-80f1-41c9-b780-eb52ffce5829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_dbcd99a5-2d44-4c43-8b8b-6fd9988f5a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_de46362b-80f1-41c9-b780-eb52ffce5829" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_dbcd99a5-2d44-4c43-8b8b-6fd9988f5a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_2f54c2aa-454e-4710-9201-f5cb05b582a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_de46362b-80f1-41c9-b780-eb52ffce5829" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_2f54c2aa-454e-4710-9201-f5cb05b582a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_64e2040e-820e-4577-baf6-6b727bb01358" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_7434e94f-6938-4cd3-86ba-e5a4098e82b6" xlink:to="loc_srt_StatementGeographicalAxis_64e2040e-820e-4577-baf6-6b727bb01358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_af41e5ce-10f2-4704-9766-90c92608acaf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_64e2040e-820e-4577-baf6-6b727bb01358" xlink:to="loc_srt_SegmentGeographicalDomain_af41e5ce-10f2-4704-9766-90c92608acaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_321ad319-6ec1-4fa4-9197-a2fbd0d5d949" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_af41e5ce-10f2-4704-9766-90c92608acaf" xlink:to="loc_us-gaap_NonUsMember_321ad319-6ec1-4fa4-9197-a2fbd0d5d949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_c19a6247-e4ef-4bc5-8c69-f95f29457b18" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_7434e94f-6938-4cd3-86ba-e5a4098e82b6" xlink:to="loc_srt_MajorCustomersAxis_c19a6247-e4ef-4bc5-8c69-f95f29457b18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_cf1bd91e-e446-46f2-8b7c-9afb50151434" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_c19a6247-e4ef-4bc5-8c69-f95f29457b18" xlink:to="loc_srt_NameOfMajorCustomerDomain_cf1bd91e-e446-46f2-8b7c-9afb50151434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CustomerAMember_9567f82f-7f2c-4c5a-8496-303aa72450e4" xlink:href="amci-20230213.xsd#amci_CustomerAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_cf1bd91e-e446-46f2-8b7c-9afb50151434" xlink:to="loc_amci_CustomerAMember_9567f82f-7f2c-4c5a-8496-303aa72450e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CustomerBMember_e7944bb1-604d-44ba-9700-83cc23eac6ae" xlink:href="amci-20230213.xsd#amci_CustomerBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_cf1bd91e-e446-46f2-8b7c-9afb50151434" xlink:to="loc_amci_CustomerBMember_e7944bb1-604d-44ba-9700-83cc23eac6ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CustomerCMember_6501a2df-e564-4275-992a-d8cee521db3d" xlink:href="amci-20230213.xsd#amci_CustomerCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_cf1bd91e-e446-46f2-8b7c-9afb50151434" xlink:to="loc_amci_CustomerCMember_6501a2df-e564-4275-992a-d8cee521db3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CustomerDMember_635276af-be4c-4fd5-acb6-2e155a270a86" xlink:href="amci-20230213.xsd#amci_CustomerDMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_cf1bd91e-e446-46f2-8b7c-9afb50151434" xlink:to="loc_amci_CustomerDMember_635276af-be4c-4fd5-acb6-2e155a270a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CustomerEMember_dbec7925-9ab5-457e-b49c-849a4c35151c" xlink:href="amci-20230213.xsd#amci_CustomerEMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_cf1bd91e-e446-46f2-8b7c-9afb50151434" xlink:to="loc_amci_CustomerEMember_dbec7925-9ab5-457e-b49c-849a4c35151c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_27773c39-9eac-4a84-94bb-e5f9e6b39b72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_7434e94f-6938-4cd3-86ba-e5a4098e82b6" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_27773c39-9eac-4a84-94bb-e5f9e6b39b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_ff03adfa-b640-4793-8a36-c49bd1cc844f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_27773c39-9eac-4a84-94bb-e5f9e6b39b72" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_ff03adfa-b640-4793-8a36-c49bd1cc844f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_16aea2d6-b06c-46b4-b9ab-a82751b8be07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_f03ff2e7-ef26-413f-8b74-e287b2f4fe08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_16aea2d6-b06c-46b4-b9ab-a82751b8be07" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_f03ff2e7-ef26-413f-8b74-e287b2f4fe08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a18e88d8-96ef-4c11-acae-efc54d9b08be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_f03ff2e7-ef26-413f-8b74-e287b2f4fe08" xlink:to="loc_us-gaap_NetIncomeLoss_a18e88d8-96ef-4c11-acae-efc54d9b08be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact_9656f3eb-e1fd-4fcf-9d70-7af6d6c16fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_f03ff2e7-ef26-413f-8b74-e287b2f4fe08" xlink:to="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact_9656f3eb-e1fd-4fcf-9d70-7af6d6c16fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_97c6c944-10e7-43b5-b191-5e42e85c2a98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_f03ff2e7-ef26-413f-8b74-e287b2f4fe08" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_97c6c944-10e7-43b5-b191-5e42e85c2a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_6538a588-465e-43de-b00c-a36af93a36a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_16aea2d6-b06c-46b4-b9ab-a82751b8be07" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_6538a588-465e-43de-b00c-a36af93a36a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c6064c12-ad42-4796-87bf-87bbc7661530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_6538a588-465e-43de-b00c-a36af93a36a7" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c6064c12-ad42-4796-87bf-87bbc7661530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e7ba5250-a0d2-4c55-9699-31d618516f09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_6538a588-465e-43de-b00c-a36af93a36a7" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e7ba5250-a0d2-4c55-9699-31d618516f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_6938d41d-689b-4725-8829-c92ee6c3dd52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_6538a588-465e-43de-b00c-a36af93a36a7" xlink:to="loc_us-gaap_EarningsPerShareBasic_6938d41d-689b-4725-8829-c92ee6c3dd52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_bec1f11c-187c-42cc-a476-0265c9fe2a65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_6538a588-465e-43de-b00c-a36af93a36a7" xlink:to="loc_us-gaap_EarningsPerShareDiluted_bec1f11c-187c-42cc-a476-0265c9fe2a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/LanzaTech10QNetLossPerShareAntidilutiveSharesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#LanzaTech10QNetLossPerShareAntidilutiveSharesDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/LanzaTech10QNetLossPerShareAntidilutiveSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7d5f626d-5d6b-4cd4-90c4-83efcfb9bc45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_27b2393a-0392-44c7-b9d0-420142014a54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7d5f626d-5d6b-4cd4-90c4-83efcfb9bc45" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_27b2393a-0392-44c7-b9d0-420142014a54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_da8a1684-aaed-4002-9033-be00e8997b54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_27b2393a-0392-44c7-b9d0-420142014a54" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_da8a1684-aaed-4002-9033-be00e8997b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bbc6adc9-65e6-4c6d-a1a6-9f3af3f57e53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_da8a1684-aaed-4002-9033-be00e8997b54" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bbc6adc9-65e6-4c6d-a1a6-9f3af3f57e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_0f72eafb-bf90-48ef-8123-8426b321afb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bbc6adc9-65e6-4c6d-a1a6-9f3af3f57e53" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_0f72eafb-bf90-48ef-8123-8426b321afb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_f600349d-b5a7-488a-b7fb-a3d86de15c04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bbc6adc9-65e6-4c6d-a1a6-9f3af3f57e53" xlink:to="loc_us-gaap_EmployeeStockOptionMember_f600349d-b5a7-488a-b7fb-a3d86de15c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_06e8c791-79f3-40c1-a16c-be9ef823c0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bbc6adc9-65e6-4c6d-a1a6-9f3af3f57e53" xlink:to="loc_us-gaap_RestrictedStockMember_06e8c791-79f3-40c1-a16c-be9ef823c0cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_b51fa1be-a34c-46fb-b525-8e979abce068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bbc6adc9-65e6-4c6d-a1a6-9f3af3f57e53" xlink:to="loc_us-gaap_WarrantMember_b51fa1be-a34c-46fb-b525-8e979abce068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_cb61deb2-333f-46c1-beed-4ba8d27c7576" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_27b2393a-0392-44c7-b9d0-420142014a54" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_cb61deb2-333f-46c1-beed-4ba8d27c7576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_28d2a8b9-e574-450b-85bf-415e7ccd98d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_cb61deb2-333f-46c1-beed-4ba8d27c7576" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_28d2a8b9-e574-450b-85bf-415e7ccd98d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleConversionRatio_8ab904e8-5321-46a4-aa7a-b543dfc4cafa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockConvertibleConversionRatio"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_cb61deb2-333f-46c1-beed-4ba8d27c7576" xlink:to="loc_us-gaap_PreferredStockConvertibleConversionRatio_8ab904e8-5321-46a4-aa7a-b543dfc4cafa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LiquidityPriceOfSAFEAndSAFEWarrants_b58906e7-081f-452c-82f5-f6a79aa31291" xlink:href="amci-20230213.xsd#amci_LiquidityPriceOfSAFEAndSAFEWarrants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_cb61deb2-333f-46c1-beed-4ba8d27c7576" xlink:to="loc_amci_LiquidityPriceOfSAFEAndSAFEWarrants_b58906e7-081f-452c-82f5-f6a79aa31291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne_b9deed10-7cf2-4d98-85d8-c60213e2d771" xlink:href="amci-20230213.xsd#amci_LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_cb61deb2-333f-46c1-beed-4ba8d27c7576" xlink:to="loc_amci_LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne_b9deed10-7cf2-4d98-85d8-c60213e2d771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#RevenuesDisaggregatedRevenueDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b1e621e7-30d6-454e-82f2-850228a2ae11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_7f37f525-2421-4c43-82c2-bb092a45408b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b1e621e7-30d6-454e-82f2-850228a2ae11" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_7f37f525-2421-4c43-82c2-bb092a45408b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_1601a8d6-7d4a-417f-9b0f-a9eef1ce9e44" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_7f37f525-2421-4c43-82c2-bb092a45408b" xlink:to="loc_srt_ProductOrServiceAxis_1601a8d6-7d4a-417f-9b0f-a9eef1ce9e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9a715959-7e1d-45f2-9f44-c62f9c329bd2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_1601a8d6-7d4a-417f-9b0f-a9eef1ce9e44" xlink:to="loc_srt_ProductsAndServicesDomain_9a715959-7e1d-45f2-9f44-c62f9c329bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ResearchAndDevelopmentMember_954cb40b-c223-4102-8122-a758d284692a" xlink:href="amci-20230213.xsd#amci_ResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9a715959-7e1d-45f2-9f44-c62f9c329bd2" xlink:to="loc_amci_ResearchAndDevelopmentMember_954cb40b-c223-4102-8122-a758d284692a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_JointDevelopmentAgreementsMember_d0a6a8e8-0e97-4ed5-8df8-60b2653abbbc" xlink:href="amci-20230213.xsd#amci_JointDevelopmentAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_ResearchAndDevelopmentMember_954cb40b-c223-4102-8122-a758d284692a" xlink:to="loc_amci_JointDevelopmentAgreementsMember_d0a6a8e8-0e97-4ed5-8df8-60b2653abbbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OtherContractResearchMember_8a7ffe74-59b0-4d14-a6f8-935aab4fae94" xlink:href="amci-20230213.xsd#amci_OtherContractResearchMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_ResearchAndDevelopmentMember_954cb40b-c223-4102-8122-a758d284692a" xlink:to="loc_amci_OtherContractResearchMember_8a7ffe74-59b0-4d14-a6f8-935aab4fae94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CarbonCaptureAndTransformationMember_951a61b5-857a-4b91-a9a0-428683d25510" xlink:href="amci-20230213.xsd#amci_CarbonCaptureAndTransformationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9a715959-7e1d-45f2-9f44-c62f9c329bd2" xlink:to="loc_amci_CarbonCaptureAndTransformationMember_951a61b5-857a-4b91-a9a0-428683d25510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAndServiceMember_0fd489cf-49ad-4401-a16f-aafcebc09aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicenseAndServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_CarbonCaptureAndTransformationMember_951a61b5-857a-4b91-a9a0-428683d25510" xlink:to="loc_us-gaap_LicenseAndServiceMember_0fd489cf-49ad-4401-a16f-aafcebc09aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CarbonSmartMember_9343bfef-5c0d-4008-ab2e-7e339440aa0a" xlink:href="amci-20230213.xsd#amci_CarbonSmartMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_CarbonCaptureAndTransformationMember_951a61b5-857a-4b91-a9a0-428683d25510" xlink:to="loc_amci_CarbonSmartMember_9343bfef-5c0d-4008-ab2e-7e339440aa0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EngineeringAndOtherServicesMember_44eb2712-3ec4-46e5-9989-138b4d11ac20" xlink:href="amci-20230213.xsd#amci_EngineeringAndOtherServicesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_CarbonCaptureAndTransformationMember_951a61b5-857a-4b91-a9a0-428683d25510" xlink:to="loc_amci_EngineeringAndOtherServicesMember_44eb2712-3ec4-46e5-9989-138b4d11ac20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_d154f728-83bf-4a9c-a784-cf210b87ba44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_7f37f525-2421-4c43-82c2-bb092a45408b" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_d154f728-83bf-4a9c-a784-cf210b87ba44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_50915808-a1bc-4c1a-995d-1d01a3130ffd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d154f728-83bf-4a9c-a784-cf210b87ba44" xlink:to="loc_us-gaap_Revenues_50915808-a1bc-4c1a-995d-1d01a3130ffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RevenuesAdditionalInformationDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#RevenuesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RevenuesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c2eeeda3-94b6-4f0e-8320-37f4bc577a57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_882b956d-61c2-450a-8ec3-bc0571d744ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c2eeeda3-94b6-4f0e-8320-37f4bc577a57" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_882b956d-61c2-450a-8ec3-bc0571d744ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_beb9f3dd-8e3f-4d52-8b5f-d388e608c04a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_882b956d-61c2-450a-8ec3-bc0571d744ce" xlink:to="loc_srt_ProductOrServiceAxis_beb9f3dd-8e3f-4d52-8b5f-d388e608c04a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_179fd5c9-ceaa-4175-9925-9b939e6dec98" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_beb9f3dd-8e3f-4d52-8b5f-d388e608c04a" xlink:to="loc_srt_ProductsAndServicesDomain_179fd5c9-ceaa-4175-9925-9b939e6dec98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAndServiceMember_cca5eeba-4850-4051-8fd9-ae229082a6cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicenseAndServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_179fd5c9-ceaa-4175-9925-9b939e6dec98" xlink:to="loc_us-gaap_LicenseAndServiceMember_cca5eeba-4850-4051-8fd9-ae229082a6cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EngineeringAndOtherServicesMember_14516721-38ca-4368-9051-613f8441bfaf" xlink:href="amci-20230213.xsd#amci_EngineeringAndOtherServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_179fd5c9-ceaa-4175-9925-9b939e6dec98" xlink:to="loc_amci_EngineeringAndOtherServicesMember_14516721-38ca-4368-9051-613f8441bfaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_1fcb3123-95b0-47a3-8d60-096cc26daa3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_882b956d-61c2-450a-8ec3-bc0571d744ce" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_1fcb3123-95b0-47a3-8d60-096cc26daa3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_cf3810d0-6d8d-4b48-b052-0103096532b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1fcb3123-95b0-47a3-8d60-096cc26daa3f" xlink:to="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_cf3810d0-6d8d-4b48-b052-0103096532b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_d24535e1-ff9a-4043-aa65-957ad8c9d7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1fcb3123-95b0-47a3-8d60-096cc26daa3f" xlink:to="loc_us-gaap_RevenueFromRelatedParties_d24535e1-ff9a-4043-aa65-957ad8c9d7cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BilledContractReceivables_c164a3e8-97e4-4782-96c0-da96582089da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BilledContractReceivables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1fcb3123-95b0-47a3-8d60-096cc26daa3f" xlink:to="loc_us-gaap_BilledContractReceivables_c164a3e8-97e4-4782-96c0-da96582089da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#RevenuesDisaggregationbyCustomerLocationDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6a9ff045-85d1-4319-9c1d-f8f73a313f16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_225e0623-021f-4b51-840f-2624efa06a54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6a9ff045-85d1-4319-9c1d-f8f73a313f16" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_225e0623-021f-4b51-840f-2624efa06a54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ebfc83ee-1c82-4b86-befe-f94590ba8de6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_225e0623-021f-4b51-840f-2624efa06a54" xlink:to="loc_srt_StatementGeographicalAxis_ebfc83ee-1c82-4b86-befe-f94590ba8de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b57353ec-6cb4-4190-adb6-4f2e8c988ca6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_ebfc83ee-1c82-4b86-befe-f94590ba8de6" xlink:to="loc_srt_SegmentGeographicalDomain_b57353ec-6cb4-4190-adb6-4f2e8c988ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NorthAmericaMember_0681ed4e-6e0f-477d-9aa5-f3a849bad165" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NorthAmericaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b57353ec-6cb4-4190-adb6-4f2e8c988ca6" xlink:to="loc_srt_NorthAmericaMember_0681ed4e-6e0f-477d-9aa5-f3a849bad165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_9ae0100d-2074-45ea-a3d9-cc2c1b5a199f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b57353ec-6cb4-4190-adb6-4f2e8c988ca6" xlink:to="loc_us-gaap_EMEAMember_9ae0100d-2074-45ea-a3d9-cc2c1b5a199f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaMember_55ac936e-6dee-4234-b2be-ae9c80b3408a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b57353ec-6cb4-4190-adb6-4f2e8c988ca6" xlink:to="loc_srt_AsiaMember_55ac936e-6dee-4234-b2be-ae9c80b3408a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_AU_0b5e8d04-589a-4122-8ea3-185729001cb3" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_AU"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b57353ec-6cb4-4190-adb6-4f2e8c988ca6" xlink:to="loc_country_AU_0b5e8d04-589a-4122-8ea3-185729001cb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_49660965-113f-499f-8287-4cdbec451b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_225e0623-021f-4b51-840f-2624efa06a54" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_49660965-113f-499f-8287-4cdbec451b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_5dc7a6ed-3c45-4898-9c04-11ac25dea679" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_49660965-113f-499f-8287-4cdbec451b7a" xlink:to="loc_us-gaap_Revenues_5dc7a6ed-3c45-4898-9c04-11ac25dea679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RevenuesContractBalancesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#RevenuesContractBalancesDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RevenuesContractBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a852b6b9-f3ff-4f2c-aeed-0ad59917b7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrentAbstract_90a49d80-adc2-4628-8144-7453ec263c26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a852b6b9-f3ff-4f2c-aeed-0ad59917b7f6" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrentAbstract_90a49d80-adc2-4628-8144-7453ec263c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_6392d1ed-e6eb-4ab6-a0bb-ac09b14ec80d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrentAbstract_90a49d80-adc2-4628-8144-7453ec263c26" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_6392d1ed-e6eb-4ab6-a0bb-ac09b14ec80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable_02b10b9c-fa9d-4d63-a687-af8f58deb690" xlink:href="amci-20230213.xsd#amci_ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrentAbstract_90a49d80-adc2-4628-8144-7453ec263c26" xlink:to="loc_amci_ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable_02b10b9c-fa9d-4d63-a687-af8f58deb690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContractWithCustomerAssetCurrentReclassifiedToReceivable_64f37451-98bb-41f8-a41d-c978393a109d" xlink:href="amci-20230213.xsd#amci_ContractWithCustomerAssetCurrentReclassifiedToReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrentAbstract_90a49d80-adc2-4628-8144-7453ec263c26" xlink:to="loc_amci_ContractWithCustomerAssetCurrentReclassifiedToReceivable_64f37451-98bb-41f8-a41d-c978393a109d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContractWithCustomerAssetCurrentForeignCurrencyTranslationAdjustment_a9d9c149-e261-4edc-8fcf-bbb4e2f8e3ac" xlink:href="amci-20230213.xsd#amci_ContractWithCustomerAssetCurrentForeignCurrencyTranslationAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrentAbstract_90a49d80-adc2-4628-8144-7453ec263c26" xlink:to="loc_amci_ContractWithCustomerAssetCurrentForeignCurrencyTranslationAdjustment_a9d9c149-e261-4edc-8fcf-bbb4e2f8e3ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_6c65e2d0-0e5f-4844-b704-84a0fce1d7f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrentAbstract_90a49d80-adc2-4628-8144-7453ec263c26" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_6c65e2d0-0e5f-4844-b704-84a0fce1d7f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContractWithCustomerLiabilityCurrentAbstract_5f6cee3e-31b1-4251-926e-6749d70728fd" xlink:href="amci-20230213.xsd#amci_ContractWithCustomerLiabilityCurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a852b6b9-f3ff-4f2c-aeed-0ad59917b7f6" xlink:to="loc_amci_ContractWithCustomerLiabilityCurrentAbstract_5f6cee3e-31b1-4251-926e-6749d70728fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_b70862ef-738c-47f6-b305-1b46a772a42c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_ContractWithCustomerLiabilityCurrentAbstract_5f6cee3e-31b1-4251-926e-6749d70728fd" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_b70862ef-738c-47f6-b305-1b46a772a42c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContractWithCustomerLiabilityCurrentAmountsCollected_d0cade47-8a4d-439a-92a1-34b472309905" xlink:href="amci-20230213.xsd#amci_ContractWithCustomerLiabilityCurrentAmountsCollected"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_ContractWithCustomerLiabilityCurrentAbstract_5f6cee3e-31b1-4251-926e-6749d70728fd" xlink:to="loc_amci_ContractWithCustomerLiabilityCurrentAmountsCollected_d0cade47-8a4d-439a-92a1-34b472309905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent_8d3357cf-619f-4c43-b1b2-1aa60d2b5054" xlink:href="amci-20230213.xsd#amci_ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_ContractWithCustomerLiabilityCurrentAbstract_5f6cee3e-31b1-4251-926e-6749d70728fd" xlink:to="loc_amci_ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent_8d3357cf-619f-4c43-b1b2-1aa60d2b5054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContractWithCustomerLiabilityCurrentRevenueRecognized_fc2a2048-0bf9-426d-b6ff-c448f76e8bc2" xlink:href="amci-20230213.xsd#amci_ContractWithCustomerLiabilityCurrentRevenueRecognized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_ContractWithCustomerLiabilityCurrentAbstract_5f6cee3e-31b1-4251-926e-6749d70728fd" xlink:to="loc_amci_ContractWithCustomerLiabilityCurrentRevenueRecognized_fc2a2048-0bf9-426d-b6ff-c448f76e8bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_ff202191-b7ed-46e4-8603-5ba1d58d6d64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_ContractWithCustomerLiabilityCurrentAbstract_5f6cee3e-31b1-4251-926e-6749d70728fd" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_ff202191-b7ed-46e4-8603-5ba1d58d6d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContractWithCustomerLiabilityNoncurrentAbstract_17513ed7-cb61-4456-894c-bd4afb97d95c" xlink:href="amci-20230213.xsd#amci_ContractWithCustomerLiabilityNoncurrentAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a852b6b9-f3ff-4f2c-aeed-0ad59917b7f6" xlink:to="loc_amci_ContractWithCustomerLiabilityNoncurrentAbstract_17513ed7-cb61-4456-894c-bd4afb97d95c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_6cfda781-19d9-475c-9858-84f772b4b7ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_ContractWithCustomerLiabilityNoncurrentAbstract_17513ed7-cb61-4456-894c-bd4afb97d95c" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_6cfda781-19d9-475c-9858-84f772b4b7ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContractWithCustomerLiabilityNoncurrentAmountsCollected_b12f8b16-5e18-4782-bb8d-ac8f50473024" xlink:href="amci-20230213.xsd#amci_ContractWithCustomerLiabilityNoncurrentAmountsCollected"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_ContractWithCustomerLiabilityNoncurrentAbstract_17513ed7-cb61-4456-894c-bd4afb97d95c" xlink:to="loc_amci_ContractWithCustomerLiabilityNoncurrentAmountsCollected_b12f8b16-5e18-4782-bb8d-ac8f50473024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContractWithCustomerLiabilityNoncurrentForeignCurrencyTranslationAdjustment_cf979b78-ace6-4c22-8101-415bb59f2155" xlink:href="amci-20230213.xsd#amci_ContractWithCustomerLiabilityNoncurrentForeignCurrencyTranslationAdjustment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_ContractWithCustomerLiabilityNoncurrentAbstract_17513ed7-cb61-4456-894c-bd4afb97d95c" xlink:to="loc_amci_ContractWithCustomerLiabilityNoncurrentForeignCurrencyTranslationAdjustment_cf979b78-ace6-4c22-8101-415bb59f2155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent_669772f8-e1b3-4231-844c-4d14d9a6c807" xlink:href="amci-20230213.xsd#amci_ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_ContractWithCustomerLiabilityNoncurrentAbstract_17513ed7-cb61-4456-894c-bd4afb97d95c" xlink:to="loc_amci_ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent_669772f8-e1b3-4231-844c-4d14d9a6c807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_c15bcaad-5270-455d-b53e-0a07933f0eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_ContractWithCustomerLiabilityNoncurrentAbstract_17513ed7-cb61-4456-894c-bd4afb97d95c" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_c15bcaad-5270-455d-b53e-0a07933f0eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RevenuesRemainingPerformanceObligationsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#RevenuesRemainingPerformanceObligationsDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RevenuesRemainingPerformanceObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_00941be4-03b8-4ec9-aca8-2fae1072a979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RevenueRemainingPerformanceObligationCurrentAmount_8d504328-ebb4-41e3-9e5f-e924b73521f9" xlink:href="amci-20230213.xsd#amci_RevenueRemainingPerformanceObligationCurrentAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_00941be4-03b8-4ec9-aca8-2fae1072a979" xlink:to="loc_amci_RevenueRemainingPerformanceObligationCurrentAmount_8d504328-ebb4-41e3-9e5f-e924b73521f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RevenueRemainingPerformanceObligationNoncurrentAmount_961d6461-e6bd-4677-915e-99b7d02049ab" xlink:href="amci-20230213.xsd#amci_RevenueRemainingPerformanceObligationNoncurrentAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_00941be4-03b8-4ec9-aca8-2fae1072a979" xlink:to="loc_amci_RevenueRemainingPerformanceObligationNoncurrentAmount_961d6461-e6bd-4677-915e-99b7d02049ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_d6f4fe03-16f5-44b5-a298-6a09e904dd2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_00941be4-03b8-4ec9-aca8-2fae1072a979" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_d6f4fe03-16f5-44b5-a298-6a09e904dd2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/InvestmentsScheduleofInvestmentsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#InvestmentsScheduleofInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/InvestmentsScheduleofInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_7ebeaca9-ab53-4891-b316-1f77d7bfafd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_InvestmentsTable_47cf546e-4244-4f61-a601-94836ea71f58" xlink:href="amci-20230213.xsd#amci_InvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_7ebeaca9-ab53-4891-b316-1f77d7bfafd0" xlink:to="loc_amci_InvestmentsTable_47cf546e-4244-4f61-a601-94836ea71f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_707444db-b084-44be-8506-73df38d63d18" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_InvestmentsTable_47cf546e-4244-4f61-a601-94836ea71f58" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_707444db-b084-44be-8506-73df38d63d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_302e059a-5b16-4cf8-80cf-230af1d86eb1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_707444db-b084-44be-8506-73df38d63d18" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_302e059a-5b16-4cf8-80cf-230af1d86eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember_25feef42-65e6-43f1-9c70-b5de46149b84" xlink:href="amci-20230213.xsd#amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_302e059a-5b16-4cf8-80cf-230af1d86eb1" xlink:to="loc_amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember_25feef42-65e6-43f1-9c70-b5de46149b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LanzaJetIncMember_7646f0d8-f2a8-47aa-9899-d0e9289025d0" xlink:href="amci-20230213.xsd#amci_LanzaJetIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_302e059a-5b16-4cf8-80cf-230af1d86eb1" xlink:to="loc_amci_LanzaJetIncMember_7646f0d8-f2a8-47aa-9899-d0e9289025d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_InvestmentsLineItems_354e51fa-786f-466a-bed7-8ebf126fdcc9" xlink:href="amci-20230213.xsd#amci_InvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_InvestmentsTable_47cf546e-4244-4f61-a601-94836ea71f58" xlink:to="loc_amci_InvestmentsLineItems_354e51fa-786f-466a-bed7-8ebf126fdcc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_87cc7c1b-d826-44b3-b96c-6c10ab7a472e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_InvestmentsLineItems_354e51fa-786f-466a-bed7-8ebf126fdcc9" xlink:to="loc_us-gaap_EquityMethodInvestments_87cc7c1b-d826-44b3-b96c-6c10ab7a472e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_1637db7c-d03f-44bc-94b7-1e9b7bd3ff7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_InvestmentsLineItems_354e51fa-786f-466a-bed7-8ebf126fdcc9" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_1637db7c-d03f-44bc-94b7-1e9b7bd3ff7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_2d25d91f-9efb-422e-8796-d3093cc39e99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_InvestmentsLineItems_354e51fa-786f-466a-bed7-8ebf126fdcc9" xlink:to="loc_us-gaap_Investments_2d25d91f-9efb-422e-8796-d3093cc39e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#InvestmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/InvestmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_df52660d-7464-4fc8-b5ee-343481644e40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_InvestmentsTable_f303dee1-5937-47f5-b761-b66aae7a2324" xlink:href="amci-20230213.xsd#amci_InvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_df52660d-7464-4fc8-b5ee-343481644e40" xlink:to="loc_amci_InvestmentsTable_f303dee1-5937-47f5-b761-b66aae7a2324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_fe3e5723-9fe3-4874-9b64-5d19e7786df3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_InvestmentsTable_f303dee1-5937-47f5-b761-b66aae7a2324" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_fe3e5723-9fe3-4874-9b64-5d19e7786df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_52d98fbc-8f1b-4cff-bda9-7790329c8b5b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_fe3e5723-9fe3-4874-9b64-5d19e7786df3" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_52d98fbc-8f1b-4cff-bda9-7790329c8b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LanzaJetIncMember_d7fbaec5-7a2d-47a9-a23a-ec8c1c59bc79" xlink:href="amci-20230213.xsd#amci_LanzaJetIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_52d98fbc-8f1b-4cff-bda9-7790329c8b5b" xlink:to="loc_amci_LanzaJetIncMember_d7fbaec5-7a2d-47a9-a23a-ec8c1c59bc79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember_d68604da-3c77-49c3-8505-700061924b4e" xlink:href="amci-20230213.xsd#amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_52d98fbc-8f1b-4cff-bda9-7790329c8b5b" xlink:to="loc_amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember_d68604da-3c77-49c3-8505-700061924b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_8100fbe3-63a1-4dd4-9295-51123d8e47a5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_InvestmentsTable_f303dee1-5937-47f5-b761-b66aae7a2324" xlink:to="loc_srt_ConsolidationItemsAxis_8100fbe3-63a1-4dd4-9295-51123d8e47a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_8b3b46d4-39b5-4b9a-9137-d4105fffb11d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_8100fbe3-63a1-4dd4-9295-51123d8e47a5" xlink:to="loc_srt_ConsolidationItemsDomain_8b3b46d4-39b5-4b9a-9137-d4105fffb11d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_35a35e91-0de9-4129-ab97-2e95312ef112" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_8b3b46d4-39b5-4b9a-9137-d4105fffb11d" xlink:to="loc_us-gaap_IntersegmentEliminationMember_35a35e91-0de9-4129-ab97-2e95312ef112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:href="amci-20230213.xsd#amci_InvestmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_InvestmentsTable_f303dee1-5937-47f5-b761-b66aae7a2324" xlink:to="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContributionOfProperty_54092028-8cdf-4468-947b-f53c97af350a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContributionOfProperty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:to="loc_us-gaap_ContributionOfProperty_54092028-8cdf-4468-947b-f53c97af350a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_683b157a-b66e-4eac-8f98-2e3c16be7e63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_683b157a-b66e-4eac-8f98-2e3c16be7e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2a971a85-b18c-400e-9137-e53c8115a754" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2a971a85-b18c-400e-9137-e53c8115a754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_1187ba30-2c86-4e4d-bd3e-43e46bf3f151" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:to="loc_us-gaap_ContractWithCustomerLiability_1187ba30-2c86-4e4d-bd3e-43e46bf3f151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RevenueFromContractWithCustomerAmortizationPeriod_1502524b-75cf-4dca-b4ec-8827586e2b2e" xlink:href="amci-20230213.xsd#amci_RevenueFromContractWithCustomerAmortizationPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:to="loc_amci_RevenueFromContractWithCustomerAmortizationPeriod_1502524b-75cf-4dca-b4ec-8827586e2b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfRoundsOfInvestments_c6834fd4-1232-49a4-b1c4-7dbdf7626875" xlink:href="amci-20230213.xsd#amci_NumberOfRoundsOfInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:to="loc_amci_NumberOfRoundsOfInvestments_c6834fd4-1232-49a4-b1c4-7dbdf7626875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EquityMethodInvestmentGainOnDilutionOfInvestment_31a3a02c-aa30-49b8-80ab-7e077c3724fb" xlink:href="amci-20230213.xsd#amci_EquityMethodInvestmentGainOnDilutionOfInvestment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:to="loc_amci_EquityMethodInvestmentGainOnDilutionOfInvestment_31a3a02c-aa30-49b8-80ab-7e077c3724fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EquityMethodInvestmentContingentRightToReceiveAdditionalInterest_6429c8ba-c4e4-4d01-a76f-a72fd6e727e2" xlink:href="amci-20230213.xsd#amci_EquityMethodInvestmentContingentRightToReceiveAdditionalInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:to="loc_amci_EquityMethodInvestmentContingentRightToReceiveAdditionalInterest_6429c8ba-c4e4-4d01-a76f-a72fd6e727e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_53a306af-105a-491f-9b8f-373772901e40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_53a306af-105a-491f-9b8f-373772901e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_ba9dac76-a6a1-4822-a969-d549c10fcb3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_ba9dac76-a6a1-4822-a969-d549c10fcb3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TransferFromForeignCurrencyTranslationToEquitySecurityInvestment_0de3f727-9f2d-4c94-90b7-dca94c45acc3" xlink:href="amci-20230213.xsd#amci_TransferFromForeignCurrencyTranslationToEquitySecurityInvestment"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:to="loc_amci_TransferFromForeignCurrencyTranslationToEquitySecurityInvestment_0de3f727-9f2d-4c94-90b7-dca94c45acc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_8b390cd6-2be8-4661-9c58-703b9a4065c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_8b390cd6-2be8-4661-9c58-703b9a4065c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_78358c72-ab84-428a-aa21-1db2a9f1efda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_78358c72-ab84-428a-aa21-1db2a9f1efda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_73173729-5057-4134-b331-7f34cc8c994d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_InvestmentsLineItems_1e9c7ba1-e06d-480b-88f0-be28feffc833" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_73173729-5057-4134-b331-7f34cc8c994d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueFinancialAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7727c966-9cb7-405b-9e83-58f6dff23759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3b7ba9e0-316e-4a82-bb1f-3ceebffe27b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7727c966-9cb7-405b-9e83-58f6dff23759" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3b7ba9e0-316e-4a82-bb1f-3ceebffe27b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_dd6e4089-f9f3-4d1f-a6cb-886d5e5c1c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3b7ba9e0-316e-4a82-bb1f-3ceebffe27b8" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_dd6e4089-f9f3-4d1f-a6cb-886d5e5c1c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_7e1ed6f3-429a-4671-af12-d19c85fb3595" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_dd6e4089-f9f3-4d1f-a6cb-886d5e5c1c5b" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_7e1ed6f3-429a-4671-af12-d19c85fb3595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_b5ecc242-83c0-4e62-9686-79853a74cfee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_7e1ed6f3-429a-4671-af12-d19c85fb3595" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_b5ecc242-83c0-4e62-9686-79853a74cfee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ce15d46a-0d49-43a8-b1f4-4c6e53cbf99d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3b7ba9e0-316e-4a82-bb1f-3ceebffe27b8" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ce15d46a-0d49-43a8-b1f4-4c6e53cbf99d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4b264ddd-4a25-4b50-92e1-a44fcbfc10fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ce15d46a-0d49-43a8-b1f4-4c6e53cbf99d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4b264ddd-4a25-4b50-92e1-a44fcbfc10fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_c267f7e3-6fa4-4420-8545-2b07c62009d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4b264ddd-4a25-4b50-92e1-a44fcbfc10fc" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_c267f7e3-6fa4-4420-8545-2b07c62009d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_fd49602b-f1d6-4472-8822-e413d69c4ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4b264ddd-4a25-4b50-92e1-a44fcbfc10fc" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_fd49602b-f1d6-4472-8822-e413d69c4ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_25f0dbf8-ada9-410e-8598-4209fee0d8d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4b264ddd-4a25-4b50-92e1-a44fcbfc10fc" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_25f0dbf8-ada9-410e-8598-4209fee0d8d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_c6f97b68-ebbd-4416-80e9-5a75a93ed784" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3b7ba9e0-316e-4a82-bb1f-3ceebffe27b8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_c6f97b68-ebbd-4416-80e9-5a75a93ed784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_2aa1bba7-6212-4ce8-9ff3-455a74d25a89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_c6f97b68-ebbd-4416-80e9-5a75a93ed784" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_2aa1bba7-6212-4ce8-9ff3-455a74d25a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_36ad3f63-d367-4426-9196-e5ceb56e8ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2aa1bba7-6212-4ce8-9ff3-455a74d25a89" xlink:to="loc_us-gaap_WarrantMember_36ad3f63-d367-4426-9196-e5ceb56e8ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SAFEWarrantMember_2a755666-8dab-4698-990f-15d37dd04d30" xlink:href="amci-20230213.xsd#amci_SAFEWarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2aa1bba7-6212-4ce8-9ff3-455a74d25a89" xlink:to="loc_amci_SAFEWarrantMember_2a755666-8dab-4698-990f-15d37dd04d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_cb457104-c200-4e31-8c9e-9f063355eef3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3b7ba9e0-316e-4a82-bb1f-3ceebffe27b8" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_cb457104-c200-4e31-8c9e-9f063355eef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_9b02b330-0458-4b0e-9e87-45063a5c474f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_cb457104-c200-4e31-8c9e-9f063355eef3" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_9b02b330-0458-4b0e-9e87-45063a5c474f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_158eae75-c77a-4388-845d-47c92ba23733" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_9b02b330-0458-4b0e-9e87-45063a5c474f" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_158eae75-c77a-4388-845d-47c92ba23733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e269bc7c-7f84-4fa0-8b59-fe6baf625a8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_cb457104-c200-4e31-8c9e-9f063355eef3" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e269bc7c-7f84-4fa0-8b59-fe6baf625a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_85a319a8-ad4f-4953-a57f-56a97e2d55f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e269bc7c-7f84-4fa0-8b59-fe6baf625a8b" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_85a319a8-ad4f-4953-a57f-56a97e2d55f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SimpleAgreementForFutureEquityLiability_23dbf7aa-b9d3-447e-b665-50605ecab058" xlink:href="amci-20230213.xsd#amci_SimpleAgreementForFutureEquityLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e269bc7c-7f84-4fa0-8b59-fe6baf625a8b" xlink:to="loc_amci_SimpleAgreementForFutureEquityLiability_23dbf7aa-b9d3-447e-b665-50605ecab058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_39708f67-91eb-47ec-85b8-65bedd8a0e50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e269bc7c-7f84-4fa0-8b59-fe6baf625a8b" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_39708f67-91eb-47ec-85b8-65bedd8a0e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueNarrativeDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/FairValueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b0d5cffc-db8f-4601-a76f-04d320105225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_de3d4536-9edf-4d73-9790-ade86e26f86e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b0d5cffc-db8f-4601-a76f-04d320105225" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_de3d4536-9edf-4d73-9790-ade86e26f86e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_946e24bb-a6ad-4960-9d37-8eeb71e3031e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_de3d4536-9edf-4d73-9790-ade86e26f86e" xlink:to="loc_srt_RangeAxis_946e24bb-a6ad-4960-9d37-8eeb71e3031e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_667bc230-1fe0-4a06-893b-4f58720b721e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_946e24bb-a6ad-4960-9d37-8eeb71e3031e" xlink:to="loc_srt_RangeMember_667bc230-1fe0-4a06-893b-4f58720b721e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_bf0fdd02-f754-4ed7-b4db-da950e7f68d8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_667bc230-1fe0-4a06-893b-4f58720b721e" xlink:to="loc_srt_MinimumMember_bf0fdd02-f754-4ed7-b4db-da950e7f68d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_489040dd-ff23-451b-8e20-0129a2d7de61" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_667bc230-1fe0-4a06-893b-4f58720b721e" xlink:to="loc_srt_MaximumMember_489040dd-ff23-451b-8e20-0129a2d7de61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b83e3a99-a663-414d-ada3-225779f4645c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_de3d4536-9edf-4d73-9790-ade86e26f86e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b83e3a99-a663-414d-ada3-225779f4645c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2a4f8233-f0e4-4dda-b3d4-ff24592d1b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b83e3a99-a663-414d-ada3-225779f4645c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2a4f8233-f0e4-4dda-b3d4-ff24592d1b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_6ef1bcfd-e205-4609-96b8-db301ece9ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b83e3a99-a663-414d-ada3-225779f4645c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_6ef1bcfd-e205-4609-96b8-db301ece9ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_0beeccd0-4957-4c51-bfb2-1fb5ee5806c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b83e3a99-a663-414d-ada3-225779f4645c" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_0beeccd0-4957-4c51-bfb2-1fb5ee5806c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SimpleAgreementForFutureEquityLiability_e0f8d684-cbad-4f69-9fac-7e87da36c065" xlink:href="amci-20230213.xsd#amci_SimpleAgreementForFutureEquityLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b83e3a99-a663-414d-ada3-225779f4645c" xlink:to="loc_amci_SimpleAgreementForFutureEquityLiability_e0f8d684-cbad-4f69-9fac-7e87da36c065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_d9583f90-bae9-476e-bfd2-05acf276319e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b83e3a99-a663-414d-ada3-225779f4645c" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_d9583f90-bae9-476e-bfd2-05acf276319e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueLevel3FairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_01c80356-3f99-4ecf-9b8a-d71b59b855ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_6a4bceb7-252b-4004-ac81-1b6b3b138ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_01c80356-3f99-4ecf-9b8a-d71b59b855ef" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_6a4bceb7-252b-4004-ac81-1b6b3b138ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_df5e3f44-d9dd-4d17-8c08-ddeaf7cd835a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_6a4bceb7-252b-4004-ac81-1b6b3b138ed1" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_df5e3f44-d9dd-4d17-8c08-ddeaf7cd835a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_6da678c7-9c86-41be-a8aa-09f55d827274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_df5e3f44-d9dd-4d17-8c08-ddeaf7cd835a" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_6da678c7-9c86-41be-a8aa-09f55d827274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_549ae470-d772-4118-828e-6ef55caa8c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6da678c7-9c86-41be-a8aa-09f55d827274" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_549ae470-d772-4118-828e-6ef55caa8c2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExercisePriceMember_668b2a04-8d11-40e9-b3a7-1a9f31676ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExercisePriceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6da678c7-9c86-41be-a8aa-09f55d827274" xlink:to="loc_us-gaap_MeasurementInputExercisePriceMember_668b2a04-8d11-40e9-b3a7-1a9f31676ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_e54c05a5-3b3c-411c-81af-f46eb89c5f04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6da678c7-9c86-41be-a8aa-09f55d827274" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_e54c05a5-3b3c-411c-81af-f46eb89c5f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_a5d074f9-9896-4880-b16e-53fe175c8a49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6da678c7-9c86-41be-a8aa-09f55d827274" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_a5d074f9-9896-4880-b16e-53fe175c8a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_23bb9595-5072-4efe-8b0c-3911944f7ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6da678c7-9c86-41be-a8aa-09f55d827274" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_23bb9595-5072-4efe-8b0c-3911944f7ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MeasurementInputProbabilityWeightingMember_3edba0fb-6428-45f4-8a8e-cb2aa993313c" xlink:href="amci-20230213.xsd#amci_MeasurementInputProbabilityWeightingMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6da678c7-9c86-41be-a8aa-09f55d827274" xlink:to="loc_amci_MeasurementInputProbabilityWeightingMember_3edba0fb-6428-45f4-8a8e-cb2aa993313c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MeasurementInputInterestRateMember_50a54f28-efd1-4a42-bedc-facc822435a5" xlink:href="amci-20230213.xsd#amci_MeasurementInputInterestRateMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6da678c7-9c86-41be-a8aa-09f55d827274" xlink:to="loc_amci_MeasurementInputInterestRateMember_50a54f28-efd1-4a42-bedc-facc822435a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MeasurementInputTimeToConversionMember_be165e8f-45f2-419b-8e51-d2c192e8011d" xlink:href="amci-20230213.xsd#amci_MeasurementInputTimeToConversionMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6da678c7-9c86-41be-a8aa-09f55d827274" xlink:to="loc_amci_MeasurementInputTimeToConversionMember_be165e8f-45f2-419b-8e51-d2c192e8011d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MeasurementInputLiquidityPriceMember_3408d71d-9af5-4e9a-b3d0-1fd7a29e3853" xlink:href="amci-20230213.xsd#amci_MeasurementInputLiquidityPriceMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6da678c7-9c86-41be-a8aa-09f55d827274" xlink:to="loc_amci_MeasurementInputLiquidityPriceMember_3408d71d-9af5-4e9a-b3d0-1fd7a29e3853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_cf355b15-f6b4-4f98-b93a-77b64aa97680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6da678c7-9c86-41be-a8aa-09f55d827274" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_cf355b15-f6b4-4f98-b93a-77b64aa97680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_001854f5-9106-4f76-8af0-954c2be65d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6da678c7-9c86-41be-a8aa-09f55d827274" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_001854f5-9106-4f76-8af0-954c2be65d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1098abe6-8dc0-4834-9ada-f22bd83dd4fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_6a4bceb7-252b-4004-ac81-1b6b3b138ed1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1098abe6-8dc0-4834-9ada-f22bd83dd4fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_d032f91d-41e1-4c03-ad27-7a8e133ef5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1098abe6-8dc0-4834-9ada-f22bd83dd4fe" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_d032f91d-41e1-4c03-ad27-7a8e133ef5f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SAFEWarrantNearTermMember_1b411fe4-2e09-4a33-91be-3e594a036b04" xlink:href="amci-20230213.xsd#amci_SAFEWarrantNearTermMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_d032f91d-41e1-4c03-ad27-7a8e133ef5f8" xlink:to="loc_amci_SAFEWarrantNearTermMember_1b411fe4-2e09-4a33-91be-3e594a036b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SAFEWarrantLongTermMember_7c469296-8af6-40e4-85ad-a20fcaa9a510" xlink:href="amci-20230213.xsd#amci_SAFEWarrantLongTermMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_d032f91d-41e1-4c03-ad27-7a8e133ef5f8" xlink:to="loc_amci_SAFEWarrantLongTermMember_7c469296-8af6-40e4-85ad-a20fcaa9a510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis_4053075e-3fd0-4d8c-a4c7-d7abe6ea033f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_6a4bceb7-252b-4004-ac81-1b6b3b138ed1" xlink:to="loc_us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis_4053075e-3fd0-4d8c-a4c7-d7abe6ea033f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain_c0eb8c04-d6e2-4d17-bd9d-25621c95505a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis_4053075e-3fd0-4d8c-a4c7-d7abe6ea033f" xlink:to="loc_us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain_c0eb8c04-d6e2-4d17-bd9d-25621c95505a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SecuritiesSubjectToMandatoryRedemptionNearTermMember_73ac9392-c846-4b4f-b878-864ed03f5599" xlink:href="amci-20230213.xsd#amci_SecuritiesSubjectToMandatoryRedemptionNearTermMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain_c0eb8c04-d6e2-4d17-bd9d-25621c95505a" xlink:to="loc_amci_SecuritiesSubjectToMandatoryRedemptionNearTermMember_73ac9392-c846-4b4f-b878-864ed03f5599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SecuritiesSubjectToMandatoryRedemptionLongTermMember_8b8bf5fa-5475-4f51-889d-d05b26d01add" xlink:href="amci-20230213.xsd#amci_SecuritiesSubjectToMandatoryRedemptionLongTermMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain_c0eb8c04-d6e2-4d17-bd9d-25621c95505a" xlink:to="loc_amci_SecuritiesSubjectToMandatoryRedemptionLongTermMember_8b8bf5fa-5475-4f51-889d-d05b26d01add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1d89fd94-4e59-4a0b-af8e-3fcc2d091992" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_6a4bceb7-252b-4004-ac81-1b6b3b138ed1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1d89fd94-4e59-4a0b-af8e-3fcc2d091992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SAFELiabilityMeasurementInput_9e36319b-a5f2-4131-a71a-fb36a2da24f6" xlink:href="amci-20230213.xsd#amci_SAFELiabilityMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1d89fd94-4e59-4a0b-af8e-3fcc2d091992" xlink:to="loc_amci_SAFELiabilityMeasurementInput_9e36319b-a5f2-4131-a71a-fb36a2da24f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_403c8504-3bcb-490f-a811-1e22aef7f6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1d89fd94-4e59-4a0b-af8e-3fcc2d091992" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_403c8504-3bcb-490f-a811-1e22aef7f6c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6a9cc753-dc3d-4156-8427-740f0f00d552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_d68cb897-7b10-409d-a388-f6796a203ece" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6a9cc753-dc3d-4156-8427-740f0f00d552" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_d68cb897-7b10-409d-a388-f6796a203ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_2cd53da9-8d89-4baa-921e-092e9b54fc20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_d68cb897-7b10-409d-a388-f6796a203ece" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_2cd53da9-8d89-4baa-921e-092e9b54fc20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_fa583aec-b2e9-4c31-bbc6-2391c839e6e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_2cd53da9-8d89-4baa-921e-092e9b54fc20" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_fa583aec-b2e9-4c31-bbc6-2391c839e6e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_61ab63d4-f6d4-46b7-be74-978c81dae7cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_fa583aec-b2e9-4c31-bbc6-2391c839e6e1" xlink:to="loc_us-gaap_WarrantMember_61ab63d4-f6d4-46b7-be74-978c81dae7cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SAFELiabilityMember_b96b9e88-bc44-49a5-ba7d-8351cfabb88a" xlink:href="amci-20230213.xsd#amci_SAFELiabilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_fa583aec-b2e9-4c31-bbc6-2391c839e6e1" xlink:to="loc_amci_SAFELiabilityMember_b96b9e88-bc44-49a5-ba7d-8351cfabb88a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SAFEWarrantMember_5edd37b4-f8cf-471c-a775-f13613c57d3f" xlink:href="amci-20230213.xsd#amci_SAFEWarrantMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_fa583aec-b2e9-4c31-bbc6-2391c839e6e1" xlink:to="loc_amci_SAFEWarrantMember_5edd37b4-f8cf-471c-a775-f13613c57d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_cd2d9a85-2a61-4ac3-a8dc-22916799a164" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_d68cb897-7b10-409d-a388-f6796a203ece" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_cd2d9a85-2a61-4ac3-a8dc-22916799a164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_52dcd283-d084-40f3-a906-e5d57b965e71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_cd2d9a85-2a61-4ac3-a8dc-22916799a164" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_52dcd283-d084-40f3-a906-e5d57b965e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_66acf4fe-ce0e-41ec-ae19-8b39bc5c41f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_52dcd283-d084-40f3-a906-e5d57b965e71" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_66acf4fe-ce0e-41ec-ae19-8b39bc5c41f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_7ed555b1-a673-4da8-a87e-61d9396709f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_52dcd283-d084-40f3-a906-e5d57b965e71" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_7ed555b1-a673-4da8-a87e-61d9396709f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_0db48777-3a37-4c74-a514-9addb9ecf074" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_52dcd283-d084-40f3-a906-e5d57b965e71" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_0db48777-3a37-4c74-a514-9addb9ecf074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3a6d1c3c-edbe-44c0-b8c8-048bcb26a947" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_52dcd283-d084-40f3-a906-e5d57b965e71" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3a6d1c3c-edbe-44c0-b8c8-048bcb26a947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_bf684d6e-d407-483a-a0d8-8d9774563a51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeTaxesTable_9f5a93a5-d871-4d05-8999-2a67f87ac80c" xlink:href="amci-20230213.xsd#amci_IncomeTaxesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_bf684d6e-d407-483a-a0d8-8d9774563a51" xlink:to="loc_amci_IncomeTaxesTable_9f5a93a5-d871-4d05-8999-2a67f87ac80c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_e45d3ab1-fb71-4ed2-82aa-e2edfc9f60ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_IncomeTaxesTable_9f5a93a5-d871-4d05-8999-2a67f87ac80c" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_e45d3ab1-fb71-4ed2-82aa-e2edfc9f60ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_262fe449-0c19-4113-a37a-f67cae018651" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_e45d3ab1-fb71-4ed2-82aa-e2edfc9f60ad" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_262fe449-0c19-4113-a37a-f67cae018651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_c73dcc38-0b27-4b30-a9d3-fcdeedf739eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_262fe449-0c19-4113-a37a-f67cae018651" xlink:to="loc_us-gaap_ForeignCountryMember_c73dcc38-0b27-4b30-a9d3-fcdeedf739eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_f96ca4e2-7bec-4e0c-b510-f777dc3bcb34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_IncomeTaxesTable_9f5a93a5-d871-4d05-8999-2a67f87ac80c" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_f96ca4e2-7bec-4e0c-b510-f777dc3bcb34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_e3bd2cec-8500-4b23-b3fc-71cecb65e96a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_f96ca4e2-7bec-4e0c-b510-f777dc3bcb34" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_e3bd2cec-8500-4b23-b3fc-71cecb65e96a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_InlandRevenueNewZealandMember_fc18a023-9756-4bee-a3fb-e9de9856efab" xlink:href="amci-20230213.xsd#amci_InlandRevenueNewZealandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_e3bd2cec-8500-4b23-b3fc-71cecb65e96a" xlink:to="loc_amci_InlandRevenueNewZealandMember_fc18a023-9756-4bee-a3fb-e9de9856efab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeTaxesLineItems_b2a03771-32cb-4a55-8c51-1fba60d0b734" xlink:href="amci-20230213.xsd#amci_IncomeTaxesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_IncomeTaxesTable_9f5a93a5-d871-4d05-8999-2a67f87ac80c" xlink:to="loc_amci_IncomeTaxesLineItems_b2a03771-32cb-4a55-8c51-1fba60d0b734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignEarningsRepatriated_913b52bd-b9f3-4199-b204-7b8a9b66306a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignEarningsRepatriated"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_IncomeTaxesLineItems_b2a03771-32cb-4a55-8c51-1fba60d0b734" xlink:to="loc_us-gaap_ForeignEarningsRepatriated_913b52bd-b9f3-4199-b204-7b8a9b66306a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_cecd9d51-eb69-4788-a6c2-922218d5892c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_IncomeTaxesLineItems_b2a03771-32cb-4a55-8c51-1fba60d0b734" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_cecd9d51-eb69-4788-a6c2-922218d5892c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2c17adbc-5da2-4f49-8531-cec3eae8ae2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_IncomeTaxesLineItems_b2a03771-32cb-4a55-8c51-1fba60d0b734" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_2c17adbc-5da2-4f49-8531-cec3eae8ae2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2094b39c-b93a-4fe4-85cc-a457fe993f23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_IncomeTaxesLineItems_b2a03771-32cb-4a55-8c51-1fba60d0b734" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2094b39c-b93a-4fe4-85cc-a457fe993f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_63c9430b-1b8a-4afc-8385-00670dd96fae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4b442d5e-5052-4233-a04e-1f4509eb4b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_63c9430b-1b8a-4afc-8385-00670dd96fae" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4b442d5e-5052-4233-a04e-1f4509eb4b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fa9cfd51-8a4b-4ca2-8519-9563ca6ca448" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4b442d5e-5052-4233-a04e-1f4509eb4b9d" xlink:to="loc_srt_RangeAxis_fa9cfd51-8a4b-4ca2-8519-9563ca6ca448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ae09eeed-4190-4bf5-be35-c2b510fb1469" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_fa9cfd51-8a4b-4ca2-8519-9563ca6ca448" xlink:to="loc_srt_RangeMember_ae09eeed-4190-4bf5-be35-c2b510fb1469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a5211925-ed4e-4f00-8200-e45363c60369" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ae09eeed-4190-4bf5-be35-c2b510fb1469" xlink:to="loc_srt_MinimumMember_a5211925-ed4e-4f00-8200-e45363c60369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4ef8cc14-adfb-4209-bbc2-81847893f55d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ae09eeed-4190-4bf5-be35-c2b510fb1469" xlink:to="loc_srt_MaximumMember_4ef8cc14-adfb-4209-bbc2-81847893f55d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2b2ffbff-82c7-4dde-817e-4b10632d0a85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4b442d5e-5052-4233-a04e-1f4509eb4b9d" xlink:to="loc_us-gaap_AwardTypeAxis_2b2ffbff-82c7-4dde-817e-4b10632d0a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d20e343f-b738-4954-9870-a2121f401017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2b2ffbff-82c7-4dde-817e-4b10632d0a85" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d20e343f-b738-4954-9870-a2121f401017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d9609a12-e7eb-4377-91ff-3020aa22b733" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d20e343f-b738-4954-9870-a2121f401017" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d9609a12-e7eb-4377-91ff-3020aa22b733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_3ffbdd4d-0062-4f84-9b19-a925c5700271" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d20e343f-b738-4954-9870-a2121f401017" xlink:to="loc_us-gaap_RestrictedStockMember_3ffbdd4d-0062-4f84-9b19-a925c5700271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16ae9acb-551a-40fd-8a3c-f654ae36e1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4b442d5e-5052-4233-a04e-1f4509eb4b9d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16ae9acb-551a-40fd-8a3c-f654ae36e1fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfShareBasedStockSchemes_7e3e6fb2-9262-409c-905c-4c21e8c9ed88" xlink:href="amci-20230213.xsd#amci_NumberOfShareBasedStockSchemes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16ae9acb-551a-40fd-8a3c-f654ae36e1fe" xlink:to="loc_amci_NumberOfShareBasedStockSchemes_7e3e6fb2-9262-409c-905c-4c21e8c9ed88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_891c9e22-2459-4b9a-86aa-5e76b1d5f264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16ae9acb-551a-40fd-8a3c-f654ae36e1fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_891c9e22-2459-4b9a-86aa-5e76b1d5f264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_829cc7f8-3d4d-494b-9e4e-7dc990a44040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16ae9acb-551a-40fd-8a3c-f654ae36e1fe" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_829cc7f8-3d4d-494b-9e4e-7dc990a44040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_e50efedf-5761-49ec-911f-bdf0a3dc6ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16ae9acb-551a-40fd-8a3c-f654ae36e1fe" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_e50efedf-5761-49ec-911f-bdf0a3dc6ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_12d494c5-309e-4ea5-8109-3228a868d65b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16ae9acb-551a-40fd-8a3c-f654ae36e1fe" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_12d494c5-309e-4ea5-8109-3228a868d65b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_539c5360-2e86-4290-ab24-ce1133ba3631" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16ae9acb-551a-40fd-8a3c-f654ae36e1fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_539c5360-2e86-4290-ab24-ce1133ba3631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_491facc2-1dbd-4d0a-9c80-309fbb49948a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16ae9acb-551a-40fd-8a3c-f654ae36e1fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_491facc2-1dbd-4d0a-9c80-309fbb49948a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/ShareBasedCompensationStockOptionAwardActivityDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#ShareBasedCompensationStockOptionAwardActivityDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/ShareBasedCompensationStockOptionAwardActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5561017b-2c5d-4c38-871e-6531aaf7f8c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6b4e5c92-01f9-4ee3-a678-32acab11102a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5561017b-2c5d-4c38-871e-6531aaf7f8c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6b4e5c92-01f9-4ee3-a678-32acab11102a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f97fb139-9bac-4882-b72d-680ab789b883" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6b4e5c92-01f9-4ee3-a678-32acab11102a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f97fb139-9bac-4882-b72d-680ab789b883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_274a49d5-684e-4a4a-a06f-78892d31ca61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6b4e5c92-01f9-4ee3-a678-32acab11102a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_274a49d5-684e-4a4a-a06f-78892d31ca61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1824f628-9661-4786-825b-5db466ffffb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6b4e5c92-01f9-4ee3-a678-32acab11102a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1824f628-9661-4786-825b-5db466ffffb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_5745cfcc-46d2-4bfd-a9eb-42dd80ac8042" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6b4e5c92-01f9-4ee3-a678-32acab11102a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_5745cfcc-46d2-4bfd-a9eb-42dd80ac8042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_09241cf5-413e-44d7-a3e4-5a585dea616c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6b4e5c92-01f9-4ee3-a678-32acab11102a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_09241cf5-413e-44d7-a3e4-5a585dea616c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_a61fc1d7-166c-442e-b67c-2cc1fba556dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5561017b-2c5d-4c38-871e-6531aaf7f8c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_a61fc1d7-166c-442e-b67c-2cc1fba556dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_ab2e056c-ce44-47b0-8a2a-392a229e1798" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5561017b-2c5d-4c38-871e-6531aaf7f8c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_ab2e056c-ce44-47b0-8a2a-392a229e1798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_181cbc9c-94cf-4706-858d-e08618208609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5561017b-2c5d-4c38-871e-6531aaf7f8c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_181cbc9c-94cf-4706-858d-e08618208609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ec7121ea-a049-4337-8fbc-1accb4636470" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_181cbc9c-94cf-4706-858d-e08618208609" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ec7121ea-a049-4337-8fbc-1accb4636470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_6993c2e1-b232-4d4b-a27b-a5c03595e083" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_181cbc9c-94cf-4706-858d-e08618208609" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_6993c2e1-b232-4d4b-a27b-a5c03595e083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_e65f92a7-57c1-4e16-984a-2791a5501819" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_181cbc9c-94cf-4706-858d-e08618208609" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_e65f92a7-57c1-4e16-984a-2791a5501819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_91b1b71e-b198-4af5-837f-f5bf89db1108" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_181cbc9c-94cf-4706-858d-e08618208609" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_91b1b71e-b198-4af5-837f-f5bf89db1108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ba68e5d3-bea2-4dcc-83cd-466c133d017c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_181cbc9c-94cf-4706-858d-e08618208609" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ba68e5d3-bea2-4dcc-83cd-466c133d017c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_67a8b09d-9830-44d7-b588-97650802bfe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5561017b-2c5d-4c38-871e-6531aaf7f8c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_67a8b09d-9830-44d7-b588-97650802bfe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_412d90ca-d8b8-4973-bb65-667f30080947" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5561017b-2c5d-4c38-871e-6531aaf7f8c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_412d90ca-d8b8-4973-bb65-667f30080947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ef8e8e58-07e7-4ea4-a56e-6d2f9b23b7d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5561017b-2c5d-4c38-871e-6531aaf7f8c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ef8e8e58-07e7-4ea4-a56e-6d2f9b23b7d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_6e791187-6d54-4659-9b29-1af2f6b38f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ef8e8e58-07e7-4ea4-a56e-6d2f9b23b7d6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_6e791187-6d54-4659-9b29-1af2f6b38f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_289c6bb8-5d4a-4523-93f7-3db6a24a49dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ef8e8e58-07e7-4ea4-a56e-6d2f9b23b7d6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_289c6bb8-5d4a-4523-93f7-3db6a24a49dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2bac4c10-0802-4458-9c76-a265b16ba472" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ef8e8e58-07e7-4ea4-a56e-6d2f9b23b7d6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2bac4c10-0802-4458-9c76-a265b16ba472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_d876ace2-e8e0-4834-b56c-68d875d6a538" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ef8e8e58-07e7-4ea4-a56e-6d2f9b23b7d6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_d876ace2-e8e0-4834-b56c-68d875d6a538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_03f88f7d-33e6-496f-a6c8-63e770c401cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ef8e8e58-07e7-4ea4-a56e-6d2f9b23b7d6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_03f88f7d-33e6-496f-a6c8-63e770c401cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_dafca8a1-19f3-4956-93eb-9856b83632c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ef8e8e58-07e7-4ea4-a56e-6d2f9b23b7d6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_dafca8a1-19f3-4956-93eb-9856b83632c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_4c56e525-0d5f-4675-8e5a-cad615a8c932" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ef8e8e58-07e7-4ea4-a56e-6d2f9b23b7d6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_4c56e525-0d5f-4675-8e5a-cad615a8c932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue_0c6c665c-ded0-4a0f-b23b-b743b564c6eb" xlink:href="amci-20230213.xsd#amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ef8e8e58-07e7-4ea4-a56e-6d2f9b23b7d6" xlink:to="loc_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue_0c6c665c-ded0-4a0f-b23b-b743b564c6eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue_cc21cf4d-5919-4c7e-8b03-f9f708ad31b0" xlink:href="amci-20230213.xsd#amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ef8e8e58-07e7-4ea4-a56e-6d2f9b23b7d6" xlink:to="loc_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue_cc21cf4d-5919-4c7e-8b03-f9f708ad31b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#RelatedPartyTransactionsDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_514ceca0-11e7-44e8-84ff-1d0bf1afcf9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_244aba86-e871-4e78-87a7-a7df1b56cbea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_514ceca0-11e7-44e8-84ff-1d0bf1afcf9f" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_244aba86-e871-4e78-87a7-a7df1b56cbea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_6067dc2f-60a6-47db-b58e-48051bb1f965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_244aba86-e871-4e78-87a7-a7df1b56cbea" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_6067dc2f-60a6-47db-b58e-48051bb1f965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_3d668435-28e7-4691-a729-9d7ec4623aab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_6067dc2f-60a6-47db-b58e-48051bb1f965" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_3d668435-28e7-4691-a729-9d7ec4623aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartyTransitionServicesAgreementMember_2a8fe926-bea9-43be-a663-854541d5a95d" xlink:href="amci-20230213.xsd#amci_RelatedPartyTransitionServicesAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_3d668435-28e7-4691-a729-9d7ec4623aab" xlink:to="loc_amci_RelatedPartyTransitionServicesAgreementMember_2a8fe926-bea9-43be-a663-854541d5a95d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartyInvestmentAgreementMember_99cdaae8-a67b-43c6-8fbd-ee99bc1e84de" xlink:href="amci-20230213.xsd#amci_RelatedPartyInvestmentAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_3d668435-28e7-4691-a729-9d7ec4623aab" xlink:to="loc_amci_RelatedPartyInvestmentAgreementMember_99cdaae8-a67b-43c6-8fbd-ee99bc1e84de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartyLeaseAgreementMember_259543b2-d108-4f91-95b4-4a9bac064d76" xlink:href="amci-20230213.xsd#amci_RelatedPartyLeaseAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_3d668435-28e7-4691-a729-9d7ec4623aab" xlink:to="loc_amci_RelatedPartyLeaseAgreementMember_259543b2-d108-4f91-95b4-4a9bac064d76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartySupplyAgreementMember_2949a828-eb9c-4f39-9e71-d65c55967e3f" xlink:href="amci-20230213.xsd#amci_RelatedPartySupplyAgreementMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_3d668435-28e7-4691-a729-9d7ec4623aab" xlink:to="loc_amci_RelatedPartySupplyAgreementMember_2949a828-eb9c-4f39-9e71-d65c55967e3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7e63a17d-236d-464b-8c0a-ccf8ce27e2df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_244aba86-e871-4e78-87a7-a7df1b56cbea" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7e63a17d-236d-464b-8c0a-ccf8ce27e2df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_0bc0e6f2-dcad-4e41-aebd-8ca569945589" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7e63a17d-236d-464b-8c0a-ccf8ce27e2df" xlink:to="loc_us-gaap_RelatedPartyDomain_0bc0e6f2-dcad-4e41-aebd-8ca569945589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_711f68e2-38e2-4732-a511-89caf650d224" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_0bc0e6f2-dcad-4e41-aebd-8ca569945589" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_711f68e2-38e2-4732-a511-89caf650d224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_4ff7e4ac-c549-42ff-9bd5-2221f047d9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_244aba86-e871-4e78-87a7-a7df1b56cbea" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_4ff7e4ac-c549-42ff-9bd5-2221f047d9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_6efb008a-9c08-4918-8e22-ad150bd68e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ff7e4ac-c549-42ff-9bd5-2221f047d9e5" xlink:to="loc_us-gaap_Investments_6efb008a-9c08-4918-8e22-ad150bd68e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_201888a1-173b-453b-a1fe-de7c295b2bde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ff7e4ac-c549-42ff-9bd5-2221f047d9e5" xlink:to="loc_us-gaap_RevenueFromRelatedParties_201888a1-173b-453b-a1fe-de7c295b2bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_ffb1b4fa-ab7c-417b-9b97-52fe58b54084" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ff7e4ac-c549-42ff-9bd5-2221f047d9e5" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_ffb1b4fa-ab7c-417b-9b97-52fe58b54084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LesseeOperatingLeaseNumberOfRenewalTerms_fe3c5454-3e1d-4f3c-896a-0976501cc744" xlink:href="amci-20230213.xsd#amci_LesseeOperatingLeaseNumberOfRenewalTerms"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ff7e4ac-c549-42ff-9bd5-2221f047d9e5" xlink:to="loc_amci_LesseeOperatingLeaseNumberOfRenewalTerms_fe3c5454-3e1d-4f3c-896a-0976501cc744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_f3870bec-47f9-4e0c-8108-2ef65b06fb71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ff7e4ac-c549-42ff-9bd5-2221f047d9e5" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_f3870bec-47f9-4e0c-8108-2ef65b06fb71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_b261947d-2ad9-41f8-9cad-aa6debbb6aac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ff7e4ac-c549-42ff-9bd5-2221f047d9e5" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_b261947d-2ad9-41f8-9cad-aa6debbb6aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_d8e7c984-58ce-402f-822a-e943d7f921ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ff7e4ac-c549-42ff-9bd5-2221f047d9e5" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_d8e7c984-58ce-402f-822a-e943d7f921ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_f105bed9-2f42-48cf-9c70-e017e5918af6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_bdded7d4-d8c9-434c-9bf8-8501311c80a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_f105bed9-2f42-48cf-9c70-e017e5918af6" xlink:to="loc_us-gaap_RevenueFromRelatedParties_bdded7d4-d8c9-434c-9bf8-8501311c80a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ccf69834-1be7-4255-bc8e-4fe22afedbf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_f105bed9-2f42-48cf-9c70-e017e5918af6" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ccf69834-1be7-4255-bc8e-4fe22afedbf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a786ae1e-0039-41f2-8a0f-be390f4e1e99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ccf69834-1be7-4255-bc8e-4fe22afedbf4" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a786ae1e-0039-41f2-8a0f-be390f4e1e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_046c714c-4127-4b8a-a0c8-dcedf05a3a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a786ae1e-0039-41f2-8a0f-be390f4e1e99" xlink:to="loc_us-gaap_RelatedPartyDomain_046c714c-4127-4b8a-a0c8-dcedf05a3a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_f7e86e3a-7bc9-47ad-a2df-4fcce256789f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_046c714c-4127-4b8a-a0c8-dcedf05a3a3e" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_f7e86e3a-7bc9-47ad-a2df-4fcce256789f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_00891f3c-bca8-4d8f-9e50-4830a4f6993b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ccf69834-1be7-4255-bc8e-4fe22afedbf4" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_00891f3c-bca8-4d8f-9e50-4830a4f6993b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_48e6bc74-efbc-4b27-abb3-d5b3b237e0d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_00891f3c-bca8-4d8f-9e50-4830a4f6993b" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_48e6bc74-efbc-4b27-abb3-d5b3b237e0d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TransactionsWithEquityMethodInvesteesMember_0d3a92a1-bf54-491a-a31a-9d43a43c5dff" xlink:href="amci-20230213.xsd#amci_TransactionsWithEquityMethodInvesteesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_48e6bc74-efbc-4b27-abb3-d5b3b237e0d9" xlink:to="loc_amci_TransactionsWithEquityMethodInvesteesMember_0d3a92a1-bf54-491a-a31a-9d43a43c5dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_d1f377ff-edfe-4e0a-b455-fc16a15eed43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ccf69834-1be7-4255-bc8e-4fe22afedbf4" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_d1f377ff-edfe-4e0a-b455-fc16a15eed43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_64c4b9e5-09d4-446d-8f38-52c3e8cbf0ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d1f377ff-edfe-4e0a-b455-fc16a15eed43" xlink:to="loc_us-gaap_AccountsReceivableNet_64c4b9e5-09d4-446d-8f38-52c3e8cbf0ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_115e5f78-5be9-4890-bd12-489d655b4ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d1f377ff-edfe-4e0a-b455-fc16a15eed43" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_115e5f78-5be9-4890-bd12-489d655b4ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PurchasesAndOpenAccountsPayableRelatedParties_43f85312-5796-46e7-b1e6-b573d5eb134d" xlink:href="amci-20230213.xsd#amci_PurchasesAndOpenAccountsPayableRelatedParties"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d1f377ff-edfe-4e0a-b455-fc16a15eed43" xlink:to="loc_amci_PurchasesAndOpenAccountsPayableRelatedParties_43f85312-5796-46e7-b1e6-b573d5eb134d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#RedeemableConvertiblePreferredStockDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_b761734f-60a9-4494-8800-93337d49a01f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_21d5f830-44b8-4d52-b085-36c6a9f73f12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_b761734f-60a9-4494-8800-93337d49a01f" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_21d5f830-44b8-4d52-b085-36c6a9f73f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_25335d25-35cf-4b3d-8f82-5eaabbe391ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_21d5f830-44b8-4d52-b085-36c6a9f73f12" xlink:to="loc_us-gaap_StatementClassOfStockAxis_25335d25-35cf-4b3d-8f82-5eaabbe391ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d415c96a-a4b6-4493-8a0f-176f2b307c6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_25335d25-35cf-4b3d-8f82-5eaabbe391ff" xlink:to="loc_us-gaap_ClassOfStockDomain_d415c96a-a4b6-4493-8a0f-176f2b307c6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_f3fe6368-2cf1-4d41-8c5a-bb4e709d1def" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d415c96a-a4b6-4493-8a0f-176f2b307c6f" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_f3fe6368-2cf1-4d41-8c5a-bb4e709d1def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_ef31616e-3089-4952-8344-d9c87e1b6686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d415c96a-a4b6-4493-8a0f-176f2b307c6f" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_ef31616e-3089-4952-8344-d9c87e1b6686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_0d855b0f-93a7-4dc9-bb95-d27abc21560c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d415c96a-a4b6-4493-8a0f-176f2b307c6f" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_0d855b0f-93a7-4dc9-bb95-d27abc21560c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_1a98258b-7d7f-465b-8846-8a7bf38fc523" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d415c96a-a4b6-4493-8a0f-176f2b307c6f" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_1a98258b-7d7f-465b-8846-8a7bf38fc523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_d0217291-76bb-4812-84cf-b10013d51717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d415c96a-a4b6-4493-8a0f-176f2b307c6f" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_d0217291-76bb-4812-84cf-b10013d51717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember_9e5efadb-1655-4f1a-9d2d-9cd854c9c336" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d415c96a-a4b6-4493-8a0f-176f2b307c6f" xlink:to="loc_us-gaap_SeriesFPreferredStockMember_9e5efadb-1655-4f1a-9d2d-9cd854c9c336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_74fc200a-f5fa-4673-8247-39f7d604e218" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_21d5f830-44b8-4d52-b085-36c6a9f73f12" xlink:to="loc_srt_RangeAxis_74fc200a-f5fa-4673-8247-39f7d604e218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ea56d26b-350c-4c12-a668-f65ce8e6a5d5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_74fc200a-f5fa-4673-8247-39f7d604e218" xlink:to="loc_srt_RangeMember_ea56d26b-350c-4c12-a668-f65ce8e6a5d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_bc910218-afde-4622-9473-87e7f6969851" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ea56d26b-350c-4c12-a668-f65ce8e6a5d5" xlink:to="loc_srt_MinimumMember_bc910218-afde-4622-9473-87e7f6969851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1041c5f1-22eb-4659-9d7b-d40a66fae2b1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ea56d26b-350c-4c12-a668-f65ce8e6a5d5" xlink:to="loc_srt_MaximumMember_1041c5f1-22eb-4659-9d7b-d40a66fae2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_68f48d78-6caf-4fea-8d04-4609ebfa0388" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_21d5f830-44b8-4d52-b085-36c6a9f73f12" xlink:to="loc_us-gaap_TemporaryEquityLineItems_68f48d78-6caf-4fea-8d04-4609ebfa0388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_e7335ae4-c2d8-40bf-a6d3-ee6f13edeb89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_68f48d78-6caf-4fea-8d04-4609ebfa0388" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_e7335ae4-c2d8-40bf-a6d3-ee6f13edeb89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_8deb2295-2c72-403f-b772-d7c455ac78f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_68f48d78-6caf-4fea-8d04-4609ebfa0388" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_8deb2295-2c72-403f-b772-d7c455ac78f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_2e686001-9126-4553-a048-fc7dead47a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_68f48d78-6caf-4fea-8d04-4609ebfa0388" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_2e686001-9126-4553-a048-fc7dead47a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityIssuePricePerShare_41308491-6aa6-4d84-ad9a-deda731c44f0" xlink:href="amci-20230213.xsd#amci_TemporaryEquityIssuePricePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_68f48d78-6caf-4fea-8d04-4609ebfa0388" xlink:to="loc_amci_TemporaryEquityIssuePricePerShare_41308491-6aa6-4d84-ad9a-deda731c44f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_d3eac69a-35e3-45b8-b6eb-7f8b2f5cb13b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_68f48d78-6caf-4fea-8d04-4609ebfa0388" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_d3eac69a-35e3-45b8-b6eb-7f8b2f5cb13b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_0c412200-96ae-4a22-b789-46899ccb1fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_68f48d78-6caf-4fea-8d04-4609ebfa0388" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_0c412200-96ae-4a22-b789-46899ccb1fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquitySharesConversionOfConvertibleSecurities_ca9535d4-cc22-4d7c-b474-f0bc2ae4c41a" xlink:href="amci-20230213.xsd#amci_TemporaryEquitySharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_68f48d78-6caf-4fea-8d04-4609ebfa0388" xlink:to="loc_amci_TemporaryEquitySharesConversionOfConvertibleSecurities_ca9535d4-cc22-4d7c-b474-f0bc2ae4c41a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityExerciseOfWarrants_0e316981-6a7b-4361-b6f9-3def1084b541" xlink:href="amci-20230213.xsd#amci_TemporaryEquityExerciseOfWarrants"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_68f48d78-6caf-4fea-8d04-4609ebfa0388" xlink:to="loc_amci_TemporaryEquityExerciseOfWarrants_0e316981-6a7b-4361-b6f9-3def1084b541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails_2" xlink:type="simple" xlink:href="amci-20230213.xsd#CommitmentsandContingenciesDetails_2"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails_2" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9f7156f5-c239-4bb3-ba4c-aa957c4dbe4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_3f8ccc9f-b441-4acb-8f84-347edadd8c11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9f7156f5-c239-4bb3-ba4c-aa957c4dbe4f" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_3f8ccc9f-b441-4acb-8f84-347edadd8c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/LeasesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#LeasesDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/LeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_dad82b9e-e762-49ec-80e2-0aa12c641d56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeaseTermOfContract_fb5a1c85-dd9b-4e6f-99b6-a9542a7ec60d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_dad82b9e-e762-49ec-80e2-0aa12c641d56" xlink:to="loc_us-gaap_LessorOperatingLeaseTermOfContract_fb5a1c85-dd9b-4e6f-99b6-a9542a7ec60d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LesssorOperatingLeaseNumberOfRenewalOptions_fda5be30-3c81-431d-95ff-c62786534865" xlink:href="amci-20230213.xsd#amci_LesssorOperatingLeaseNumberOfRenewalOptions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_dad82b9e-e762-49ec-80e2-0aa12c641d56" xlink:to="loc_amci_LesssorOperatingLeaseNumberOfRenewalOptions_fda5be30-3c81-431d-95ff-c62786534865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeaseRenewalTerm_2e795843-a9a3-499c-905a-a0dc60353e24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_dad82b9e-e762-49ec-80e2-0aa12c641d56" xlink:to="loc_us-gaap_LessorOperatingLeaseRenewalTerm_2e795843-a9a3-499c-905a-a0dc60353e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c207d64e-8872-47c7-8530-68c75cedd56d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_dad82b9e-e762-49ec-80e2-0aa12c641d56" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c207d64e-8872-47c7-8530-68c75cedd56d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_53180eb5-6291-4244-8981-9459786ee04a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c207d64e-8872-47c7-8530-68c75cedd56d" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_53180eb5-6291-4244-8981-9459786ee04a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_3379464e-44af-4543-8306-7e8abe05677d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_53180eb5-6291-4244-8981-9459786ee04a" xlink:to="loc_us-gaap_RelatedPartyDomain_3379464e-44af-4543-8306-7e8abe05677d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_ac52ef73-8e4d-47d2-8559-4b2ba5145862" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3379464e-44af-4543-8306-7e8abe05677d" xlink:to="loc_srt_AffiliatedEntityMember_ac52ef73-8e4d-47d2-8559-4b2ba5145862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_71818f4f-ad60-460f-9db5-a34f62b7c704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c207d64e-8872-47c7-8530-68c75cedd56d" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_71818f4f-ad60-460f-9db5-a34f62b7c704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_cbf4ae50-1100-496c-9204-1281fabceef8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_71818f4f-ad60-460f-9db5-a34f62b7c704" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_cbf4ae50-1100-496c-9204-1281fabceef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SubsequentEventsDetails_2" xlink:type="simple" xlink:href="amci-20230213.xsd#SubsequentEventsDetails_2"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/SubsequentEventsDetails_2" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_d344b53a-56f8-485a-b521-d5282a1bc6ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_7196ff1d-3991-4f29-aabf-1a291210bd40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_d344b53a-56f8-485a-b521-d5282a1bc6ed" xlink:to="loc_us-gaap_SubsequentEventTable_7196ff1d-3991-4f29-aabf-1a291210bd40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_83a1d8a2-7564-41dc-8206-78a30839eb93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_7196ff1d-3991-4f29-aabf-1a291210bd40" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_83a1d8a2-7564-41dc-8206-78a30839eb93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3da869a7-d601-42cb-ad30-90a491b8d0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_83a1d8a2-7564-41dc-8206-78a30839eb93" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3da869a7-d601-42cb-ad30-90a491b8d0b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_dd64c125-d969-4bf8-9d35-50557fb9bf78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3da869a7-d601-42cb-ad30-90a491b8d0b1" xlink:to="loc_us-gaap_SubsequentEventMember_dd64c125-d969-4bf8-9d35-50557fb9bf78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_2d1f9d5e-660e-4b21-8d78-15874d57b229" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_7196ff1d-3991-4f29-aabf-1a291210bd40" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_2d1f9d5e-660e-4b21-8d78-15874d57b229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_0c587682-970d-4356-98fe-025bc6997ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_2d1f9d5e-660e-4b21-8d78-15874d57b229" xlink:to="loc_us-gaap_ReceivableTypeDomain_0c587682-970d-4356-98fe-025bc6997ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SeniorSecuredNotesReceivableMember_406c1050-6cd6-45da-9181-5b86a70c4204" xlink:href="amci-20230213.xsd#amci_SeniorSecuredNotesReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_0c587682-970d-4356-98fe-025bc6997ea5" xlink:to="loc_amci_SeniorSecuredNotesReceivableMember_406c1050-6cd6-45da-9181-5b86a70c4204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SubordinatedSecuredNotesReceivableMember_0c617a32-58a9-4247-9d49-9173f994667b" xlink:href="amci-20230213.xsd#amci_SubordinatedSecuredNotesReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_0c587682-970d-4356-98fe-025bc6997ea5" xlink:to="loc_amci_SubordinatedSecuredNotesReceivableMember_0c617a32-58a9-4247-9d49-9173f994667b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OneTrancheOfNotesMember_e05d6449-2491-4092-b131-47d3d1581233" xlink:href="amci-20230213.xsd#amci_OneTrancheOfNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_0c587682-970d-4356-98fe-025bc6997ea5" xlink:to="loc_amci_OneTrancheOfNotesMember_e05d6449-2491-4092-b131-47d3d1581233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_ec1c7f9e-eca4-4e08-9cd5-b0b069879fcb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_7196ff1d-3991-4f29-aabf-1a291210bd40" xlink:to="loc_dei_LegalEntityAxis_ec1c7f9e-eca4-4e08-9cd5-b0b069879fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_9ce1024c-07f7-4838-aae4-68a94675c4ce" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_ec1c7f9e-eca4-4e08-9cd5-b0b069879fcb" xlink:to="loc_dei_EntityDomain_9ce1024c-07f7-4838-aae4-68a94675c4ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LanzaJetFreedomPinesFuelsLLCMember_3e868701-58c0-456a-837d-25d3fc57edad" xlink:href="amci-20230213.xsd#amci_LanzaJetFreedomPinesFuelsLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_9ce1024c-07f7-4838-aae4-68a94675c4ce" xlink:to="loc_amci_LanzaJetFreedomPinesFuelsLLCMember_3e868701-58c0-456a-837d-25d3fc57edad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_14dbd671-b818-48dc-b679-ddbe52fd3a50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_7196ff1d-3991-4f29-aabf-1a291210bd40" xlink:to="loc_us-gaap_SubsequentEventLineItems_14dbd671-b818-48dc-b679-ddbe52fd3a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_FrameworkAgreementRequiredEquityFunding_be474ba4-7389-42c2-a814-0be4e90fb137" xlink:href="amci-20230213.xsd#amci_FrameworkAgreementRequiredEquityFunding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_14dbd671-b818-48dc-b679-ddbe52fd3a50" xlink:to="loc_amci_FrameworkAgreementRequiredEquityFunding_be474ba4-7389-42c2-a814-0be4e90fb137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SimpleAgreementForFutureEquityInitialPurchaseAmount_447385e2-3c84-47b4-adf0-43eb9d69934b" xlink:href="amci-20230213.xsd#amci_SimpleAgreementForFutureEquityInitialPurchaseAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_14dbd671-b818-48dc-b679-ddbe52fd3a50" xlink:to="loc_amci_SimpleAgreementForFutureEquityInitialPurchaseAmount_447385e2-3c84-47b4-adf0-43eb9d69934b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjects_6b2f2a9f-434d-4820-81a5-06226e9f3d1d" xlink:href="amci-20230213.xsd#amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjects"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_14dbd671-b818-48dc-b679-ddbe52fd3a50" xlink:to="loc_amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjects_6b2f2a9f-434d-4820-81a5-06226e9f3d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjectsRemainingAmountReduction_5f42c802-ce44-45f6-8c13-76c3e95c61bc" xlink:href="amci-20230213.xsd#amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjectsRemainingAmountReduction"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_14dbd671-b818-48dc-b679-ddbe52fd3a50" xlink:to="loc_amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjectsRemainingAmountReduction_5f42c802-ce44-45f6-8c13-76c3e95c61bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_db53916a-db14-4cc1-a4c9-6c33eb13403c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_14dbd671-b818-48dc-b679-ddbe52fd3a50" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_db53916a-db14-4cc1-a4c9-6c33eb13403c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LineOfCreditFacilityInterestRate_82430e0c-c923-4fff-bcdc-a8a11d99fee5" xlink:href="amci-20230213.xsd#amci_LineOfCreditFacilityInterestRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_14dbd671-b818-48dc-b679-ddbe52fd3a50" xlink:to="loc_amci_LineOfCreditFacilityInterestRate_82430e0c-c923-4fff-bcdc-a8a11d99fee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NoteReceivableCommitmentToPurchase_c2fdd277-65ac-48bb-84ee-3845dcb749f5" xlink:href="amci-20230213.xsd#amci_NoteReceivableCommitmentToPurchase"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_14dbd671-b818-48dc-b679-ddbe52fd3a50" xlink:to="loc_amci_NoteReceivableCommitmentToPurchase_c2fdd277-65ac-48bb-84ee-3845dcb749f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_223d3d56-9086-4e11-ada3-f6692e7102cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_14dbd671-b818-48dc-b679-ddbe52fd3a50" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_223d3d56-9086-4e11-ada3-f6692e7102cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ClassOfWarrantOrRightAmountOfNotesPurchased_9be1b3a8-709f-4892-bf56-a959bbcc8cd5" xlink:href="amci-20230213.xsd#amci_ClassOfWarrantOrRightAmountOfNotesPurchased"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_14dbd671-b818-48dc-b679-ddbe52fd3a50" xlink:to="loc_amci_ClassOfWarrantOrRightAmountOfNotesPurchased_9be1b3a8-709f-4892-bf56-a959bbcc8cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ReverseCapitalizationClosingCashCondition_ec565aba-cc90-4cd1-9ff5-1b9781f6d26a" xlink:href="amci-20230213.xsd#amci_ReverseCapitalizationClosingCashCondition"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_14dbd671-b818-48dc-b679-ddbe52fd3a50" xlink:to="loc_amci_ReverseCapitalizationClosingCashCondition_ec565aba-cc90-4cd1-9ff5-1b9781f6d26a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_69da888f-4cc0-4b35-b1a3-77228fe19806" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_14dbd671-b818-48dc-b679-ddbe52fd3a50" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_69da888f-4cc0-4b35-b1a3-77228fe19806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#SummaryofSignificantAccountingPoliciesRestatementDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5ee309ee-1caf-42e4-b762-faaf8386f6db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_a5ce2833-5ed2-4ef7-afe0-4af6ea20ed6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5ee309ee-1caf-42e4-b762-faaf8386f6db" xlink:to="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_a5ce2833-5ed2-4ef7-afe0-4af6ea20ed6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_659a3593-fd87-420e-8f12-71d35817470c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_a5ce2833-5ed2-4ef7-afe0-4af6ea20ed6e" xlink:to="loc_srt_RestatementAxis_659a3593-fd87-420e-8f12-71d35817470c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_f5645697-470f-4c07-9a2c-d97755bfaebf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_659a3593-fd87-420e-8f12-71d35817470c" xlink:to="loc_srt_RestatementDomain_f5645697-470f-4c07-9a2c-d97755bfaebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_9081b480-1e61-49df-93aa-75e4a86f9939" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_f5645697-470f-4c07-9a2c-d97755bfaebf" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_9081b480-1e61-49df-93aa-75e4a86f9939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_88c985f1-65c6-4dd0-9c97-798ae70ef892" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_f5645697-470f-4c07-9a2c-d97755bfaebf" xlink:to="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_88c985f1-65c6-4dd0-9c97-798ae70ef892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_cfb7a99c-265a-419d-b2ee-835018beb0dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_a5ce2833-5ed2-4ef7-afe0-4af6ea20ed6e" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_cfb7a99c-265a-419d-b2ee-835018beb0dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_96c227f1-f1ea-438a-aa44-7b23cf77a8f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_cfb7a99c-265a-419d-b2ee-835018beb0dd" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_96c227f1-f1ea-438a-aa44-7b23cf77a8f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ErrorCorrectionEquityMethodInvestmentsIntangiblesAndFixedAssetsMember_6101c4d9-f0b2-4582-a633-5b10e3b2ccff" xlink:href="amci-20230213.xsd#amci_ErrorCorrectionEquityMethodInvestmentsIntangiblesAndFixedAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_96c227f1-f1ea-438a-aa44-7b23cf77a8f1" xlink:to="loc_amci_ErrorCorrectionEquityMethodInvestmentsIntangiblesAndFixedAssetsMember_6101c4d9-f0b2-4582-a633-5b10e3b2ccff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ErrorCorrectionEquityMethodInvestmentContributedIntellectualAssetMember_f165cd1b-0609-4f4b-83d5-e5e0848092e8" xlink:href="amci-20230213.xsd#amci_ErrorCorrectionEquityMethodInvestmentContributedIntellectualAssetMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_96c227f1-f1ea-438a-aa44-7b23cf77a8f1" xlink:to="loc_amci_ErrorCorrectionEquityMethodInvestmentContributedIntellectualAssetMember_f165cd1b-0609-4f4b-83d5-e5e0848092e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ErrorCorrectionEquityMethodInvestmentGainOnDilutionMember_ff4853ef-e36a-403c-be0d-0e7666a88042" xlink:href="amci-20230213.xsd#amci_ErrorCorrectionEquityMethodInvestmentGainOnDilutionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_96c227f1-f1ea-438a-aa44-7b23cf77a8f1" xlink:to="loc_amci_ErrorCorrectionEquityMethodInvestmentGainOnDilutionMember_ff4853ef-e36a-403c-be0d-0e7666a88042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_2d6d2482-84ff-4c80-b95d-fafaf2c6fbda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_a5ce2833-5ed2-4ef7-afe0-4af6ea20ed6e" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_2d6d2482-84ff-4c80-b95d-fafaf2c6fbda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_66ef4793-4558-4598-9707-841028437dda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_2d6d2482-84ff-4c80-b95d-fafaf2c6fbda" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_66ef4793-4558-4598-9707-841028437dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartySupplyAgreementMember_0ec85ba7-da3f-4ff5-8852-5db1fa1a4a2f" xlink:href="amci-20230213.xsd#amci_RelatedPartySupplyAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_66ef4793-4558-4598-9707-841028437dda" xlink:to="loc_amci_RelatedPartySupplyAgreementMember_0ec85ba7-da3f-4ff5-8852-5db1fa1a4a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d0466734-67c0-4c3b-b4a2-72bb07798279" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_a5ce2833-5ed2-4ef7-afe0-4af6ea20ed6e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d0466734-67c0-4c3b-b4a2-72bb07798279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_751d69e1-5472-4123-bb74-390404120633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d0466734-67c0-4c3b-b4a2-72bb07798279" xlink:to="loc_us-gaap_EquityComponentDomain_751d69e1-5472-4123-bb74-390404120633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_a9b360b5-1e04-4d5a-8165-d4a6a0169497" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_751d69e1-5472-4123-bb74-390404120633" xlink:to="loc_us-gaap_RetainedEarningsMember_a9b360b5-1e04-4d5a-8165-d4a6a0169497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_6710fbd7-3c7f-44a3-ae1c-f37681dfdcc9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_a5ce2833-5ed2-4ef7-afe0-4af6ea20ed6e" xlink:to="loc_srt_ConsolidationItemsAxis_6710fbd7-3c7f-44a3-ae1c-f37681dfdcc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a9e1b789-f22d-41be-8311-9701d4d9efd5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_6710fbd7-3c7f-44a3-ae1c-f37681dfdcc9" xlink:to="loc_srt_ConsolidationItemsDomain_a9e1b789-f22d-41be-8311-9701d4d9efd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_b827a09f-45e8-45f4-82c4-ee5902b40cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a9e1b789-f22d-41be-8311-9701d4d9efd5" xlink:to="loc_us-gaap_IntersegmentEliminationMember_b827a09f-45e8-45f4-82c4-ee5902b40cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ba23234c-afe9-4326-9331-115216504640" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_a5ce2833-5ed2-4ef7-afe0-4af6ea20ed6e" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ba23234c-afe9-4326-9331-115216504640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_7aab5ada-0852-4ec7-bbaf-298d17734a37" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ba23234c-afe9-4326-9331-115216504640" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_7aab5ada-0852-4ec7-bbaf-298d17734a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LanzaJetIncMember_890ec803-fd72-4262-aaaa-24c6c1826ee5" xlink:href="amci-20230213.xsd#amci_LanzaJetIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_7aab5ada-0852-4ec7-bbaf-298d17734a37" xlink:to="loc_amci_LanzaJetIncMember_890ec803-fd72-4262-aaaa-24c6c1826ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_a5ce2833-5ed2-4ef7-afe0-4af6ea20ed6e" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_e95a9f3b-50da-4e2e-b8f0-1b722c586dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:to="loc_us-gaap_EquityMethodInvestments_e95a9f3b-50da-4e2e-b8f0-1b722c586dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2a73b764-4bd2-4dc4-8f4b-052e8d21f2ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2a73b764-4bd2-4dc4-8f4b-052e8d21f2ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_16e5f4d2-d3c4-4d21-b9a2-578c76cc7a92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_16e5f4d2-d3c4-4d21-b9a2-578c76cc7a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_5a56d59c-f50d-49a9-8552-a6cec3a35933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:to="loc_us-gaap_RevenueFromRelatedParties_5a56d59c-f50d-49a9-8552-a6cec3a35933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_73b659c6-4cf7-4000-a108-49169d7b74e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_73b659c6-4cf7-4000-a108-49169d7b74e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_eac22738-9688-4276-8527-46d92dfe81ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_eac22738-9688-4276-8527-46d92dfe81ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9e0da47b-a39d-4658-a4e0-d025742bb953" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9e0da47b-a39d-4658-a4e0-d025742bb953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_9fee692c-63eb-4878-9213-d4c23fdcdd75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:to="loc_us-gaap_CostOfRevenue_9fee692c-63eb-4878-9213-d4c23fdcdd75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_a1032f36-0463-49ca-8cda-be76dbb9de62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_a1032f36-0463-49ca-8cda-be76dbb9de62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b86f0425-5abc-4d4f-8a05-2b4990d3eb6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:to="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b86f0425-5abc-4d4f-8a05-2b4990d3eb6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_cceae2fc-9d94-4658-8b49-64a662fd0d89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b86f0425-5abc-4d4f-8a05-2b4990d3eb6e" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_cceae2fc-9d94-4658-8b49-64a662fd0d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8e2b8442-966a-4599-a4f9-ca141f39d6de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b86f0425-5abc-4d4f-8a05-2b4990d3eb6e" xlink:to="loc_us-gaap_AssetsCurrent_8e2b8442-966a-4599-a4f9-ca141f39d6de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_48f5de03-877a-4819-960e-89fb14afe107" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b86f0425-5abc-4d4f-8a05-2b4990d3eb6e" xlink:to="loc_us-gaap_EquityMethodInvestments_48f5de03-877a-4819-960e-89fb14afe107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e8a6551e-bdc1-4d04-b9aa-5e9c1f4e42f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b86f0425-5abc-4d4f-8a05-2b4990d3eb6e" xlink:to="loc_us-gaap_Assets_e8a6551e-bdc1-4d04-b9aa-5e9c1f4e42f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_ce8bcf01-1d91-4586-9fc3-38ac8d93ce45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b86f0425-5abc-4d4f-8a05-2b4990d3eb6e" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_ce8bcf01-1d91-4586-9fc3-38ac8d93ce45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_0b4869b7-94bd-4b7d-ba23-651146ceb02e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b86f0425-5abc-4d4f-8a05-2b4990d3eb6e" xlink:to="loc_us-gaap_LiabilitiesCurrent_0b4869b7-94bd-4b7d-ba23-651146ceb02e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_53ea54e5-8635-4a52-8936-fdbc63eb8605" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b86f0425-5abc-4d4f-8a05-2b4990d3eb6e" xlink:to="loc_us-gaap_Liabilities_53ea54e5-8635-4a52-8936-fdbc63eb8605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c75a4841-26be-4cb0-a495-984bbd18fb4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b86f0425-5abc-4d4f-8a05-2b4990d3eb6e" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c75a4841-26be-4cb0-a495-984bbd18fb4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_debc201e-970e-43bc-b3c9-789de71d7d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b86f0425-5abc-4d4f-8a05-2b4990d3eb6e" xlink:to="loc_us-gaap_StockholdersEquity_debc201e-970e-43bc-b3c9-789de71d7d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_08ee9d47-4919-466e-8f18-c98eafb6759c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b86f0425-5abc-4d4f-8a05-2b4990d3eb6e" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_08ee9d47-4919-466e-8f18-c98eafb6759c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_c0d41b5d-639d-4fb1-82f3-359971bc7c20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:to="loc_us-gaap_IncomeStatementAbstract_c0d41b5d-639d-4fb1-82f3-359971bc7c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fc8541c8-f994-4ec9-9cfc-3c0676f6bb6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c0d41b5d-639d-4fb1-82f3-359971bc7c20" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fc8541c8-f994-4ec9-9cfc-3c0676f6bb6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_967be624-4747-4f2a-a0bb-cc25a049bc28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c0d41b5d-639d-4fb1-82f3-359971bc7c20" xlink:to="loc_us-gaap_RevenueFromRelatedParties_967be624-4747-4f2a-a0bb-cc25a049bc28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_558c2eb8-1438-458c-b2c0-3b7d7d80dd36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c0d41b5d-639d-4fb1-82f3-359971bc7c20" xlink:to="loc_us-gaap_Revenues_558c2eb8-1438-458c-b2c0-3b7d7d80dd36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CostOfRevenueFromContractsWithCustomersExcludingDepreciation_802add1b-b6ed-49a5-8e8d-5c4ae073825b" xlink:href="amci-20230213.xsd#amci_CostOfRevenueFromContractsWithCustomersExcludingDepreciation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c0d41b5d-639d-4fb1-82f3-359971bc7c20" xlink:to="loc_amci_CostOfRevenueFromContractsWithCustomersExcludingDepreciation_802add1b-b6ed-49a5-8e8d-5c4ae073825b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_ce76d455-6ac9-4234-9e64-c5de54134f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c0d41b5d-639d-4fb1-82f3-359971bc7c20" xlink:to="loc_us-gaap_OperatingExpenses_ce76d455-6ac9-4234-9e64-c5de54134f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_55870a47-bf09-4832-944f-a6d3d648d665" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c0d41b5d-639d-4fb1-82f3-359971bc7c20" xlink:to="loc_us-gaap_OperatingIncomeLoss_55870a47-bf09-4832-944f-a6d3d648d665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_73300547-b0d7-4bb8-b4c7-f2772a4871d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c0d41b5d-639d-4fb1-82f3-359971bc7c20" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_73300547-b0d7-4bb8-b4c7-f2772a4871d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment_8bf4d8d6-3610-436d-981e-aeed04557509" xlink:href="amci-20230213.xsd#amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c0d41b5d-639d-4fb1-82f3-359971bc7c20" xlink:to="loc_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment_8bf4d8d6-3610-436d-981e-aeed04557509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_83582993-241b-4680-b931-314eb7dbdfba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c0d41b5d-639d-4fb1-82f3-359971bc7c20" xlink:to="loc_us-gaap_NetIncomeLoss_83582993-241b-4680-b931-314eb7dbdfba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_73cb1646-c9bf-4adc-873d-04a952aa55ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c0d41b5d-639d-4fb1-82f3-359971bc7c20" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_73cb1646-c9bf-4adc-873d-04a952aa55ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_bbb853c8-79ef-4630-bb3a-4bf7cf2a46e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c0d41b5d-639d-4fb1-82f3-359971bc7c20" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_bbb853c8-79ef-4630-bb3a-4bf7cf2a46e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_3b1648cf-2abc-4058-9b04-ee1fb6583379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c0d41b5d-639d-4fb1-82f3-359971bc7c20" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_3b1648cf-2abc-4058-9b04-ee1fb6583379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_9d030b4b-f579-4ab2-853e-4b2bf63c7e70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c0d41b5d-639d-4fb1-82f3-359971bc7c20" xlink:to="loc_us-gaap_EarningsPerShareBasic_9d030b4b-f579-4ab2-853e-4b2bf63c7e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_b390b658-6905-4c21-86ec-af6c4ea627a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c0d41b5d-639d-4fb1-82f3-359971bc7c20" xlink:to="loc_us-gaap_EarningsPerShareDiluted_b390b658-6905-4c21-86ec-af6c4ea627a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_e4b1f51e-f902-47ec-b9e3-346ddbf8e706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:to="loc_us-gaap_StatementOfStockholdersEquityAbstract_e4b1f51e-f902-47ec-b9e3-346ddbf8e706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_202dd34b-d5b1-4d7a-98c3-2ed9286938b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_e4b1f51e-f902-47ec-b9e3-346ddbf8e706" xlink:to="loc_us-gaap_StockholdersEquity_202dd34b-d5b1-4d7a-98c3-2ed9286938b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_83368446-e73f-497c-9898-c4d22bc38da7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_e4b1f51e-f902-47ec-b9e3-346ddbf8e706" xlink:to="loc_us-gaap_NetIncomeLoss_83368446-e73f-497c-9898-c4d22bc38da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_51660052-5490-4484-ace5-4f22e8c82eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_e4b1f51e-f902-47ec-b9e3-346ddbf8e706" xlink:to="loc_us-gaap_StockholdersEquity_51660052-5490-4484-ace5-4f22e8c82eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_ff0498ca-21a3-46c2-a876-cdc5541903f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:to="loc_us-gaap_StatementOfCashFlowsAbstract_ff0498ca-21a3-46c2-a876-cdc5541903f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6b19d8ad-ec90-448e-a0b4-3fabadeb9803" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ff0498ca-21a3-46c2-a876-cdc5541903f6" xlink:to="loc_us-gaap_NetIncomeLoss_6b19d8ad-ec90-448e-a0b4-3fabadeb9803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NoncashRecognitionOfLicensingRevenue_7d8de20c-db1d-45f3-ac9e-414ee9f792bb" xlink:href="amci-20230213.xsd#amci_NoncashRecognitionOfLicensingRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ff0498ca-21a3-46c2-a876-cdc5541903f6" xlink:to="loc_amci_NoncashRecognitionOfLicensingRevenue_7d8de20c-db1d-45f3-ac9e-414ee9f792bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment_31561c4b-9fd9-423b-9be5-f2244cf4e369" xlink:href="amci-20230213.xsd#amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ff0498ca-21a3-46c2-a876-cdc5541903f6" xlink:to="loc_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment_31561c4b-9fd9-423b-9be5-f2244cf4e369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_01d97984-c8a2-4513-bdfd-e0f902c77f22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ff0498ca-21a3-46c2-a876-cdc5541903f6" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_01d97984-c8a2-4513-bdfd-e0f902c77f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9713c2f9-fb2d-40f7-8ee6-323ae993c170" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ff0498ca-21a3-46c2-a876-cdc5541903f6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9713c2f9-fb2d-40f7-8ee6-323ae993c170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a1b1cb04-11d8-43a3-bcff-0467f30ee8e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ff0498ca-21a3-46c2-a876-cdc5541903f6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a1b1cb04-11d8-43a3-bcff-0467f30ee8e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EquityMethodInvestmentGainOnDilutionOfInvestment_2b6566f8-29a3-4f4e-8c9a-dbe1b7dc2611" xlink:href="amci-20230213.xsd#amci_EquityMethodInvestmentGainOnDilutionOfInvestment"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_d1d02ac7-b63e-4796-9992-7088debc32be" xlink:to="loc_amci_EquityMethodInvestmentGainOnDilutionOfInvestment_2b6566f8-29a3-4f4e-8c9a-dbe1b7dc2611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#SummaryofSignificantAccountingPoliciesSegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4a86e77b-e643-4e25-bf55-2c6efefed85e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_45c5d364-93de-4eb0-a422-8828f4f29f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4a86e77b-e643-4e25-bf55-2c6efefed85e" xlink:to="loc_us-gaap_NumberOfOperatingSegments_45c5d364-93de-4eb0-a422-8828f4f29f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesGoingConcernDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#SummaryofSignificantAccountingPoliciesGoingConcernDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesGoingConcernDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_43ba7555-3a6e-4c06-a0f1-ff58a8db5798" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_78341412-fb1f-43b4-bbe4-0184a9841141" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_43ba7555-3a6e-4c06-a0f1-ff58a8db5798" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_78341412-fb1f-43b4-bbe4-0184a9841141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e11cefef-8825-4110-a6e5-66a169ee1b59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_43ba7555-3a6e-4c06-a0f1-ff58a8db5798" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e11cefef-8825-4110-a6e5-66a169ee1b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f8b0a637-3f6b-4d56-85f6-a299f105be2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_43ba7555-3a6e-4c06-a0f1-ff58a8db5798" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f8b0a637-3f6b-4d56-85f6-a299f105be2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7e7fbd1c-c6f4-44e6-b7ff-32c4e1c71126" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_43ba7555-3a6e-4c06-a0f1-ff58a8db5798" xlink:to="loc_us-gaap_NetIncomeLoss_7e7fbd1c-c6f4-44e6-b7ff-32c4e1c71126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#SummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_eb864c58-5556-43d1-a89f-038904f79be0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_81d37c67-9190-4969-94e0-2271cffe3a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eb864c58-5556-43d1-a89f-038904f79be0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_81d37c67-9190-4969-94e0-2271cffe3a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashReconciliationDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashReconciliationDetails_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashReconciliationDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9d1cd2ed-9258-4f71-bfa5-2dcabeac5722" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7569f006-5a3c-4328-8653-d788c4155c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9d1cd2ed-9258-4f71-bfa5-2dcabeac5722" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7569f006-5a3c-4328-8653-d788c4155c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_d4993ca0-8e1f-4712-a1c4-2429f5396a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9d1cd2ed-9258-4f71-bfa5-2dcabeac5722" xlink:to="loc_us-gaap_RestrictedCash_d4993ca0-8e1f-4712-a1c4-2429f5396a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c633a973-18a8-4062-b684-c90213bbf328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9d1cd2ed-9258-4f71-bfa5-2dcabeac5722" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c633a973-18a8-4062-b684-c90213bbf328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesTradeandOtherReceivablesDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#SummaryofSignificantAccountingPoliciesTradeandOtherReceivablesDetails_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesTradeandOtherReceivablesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_aaf1e062-e196-4085-b815-88434d7d1d79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ecf78572-a54f-4d25-8f8c-cc02c1ec1ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aaf1e062-e196-4085-b815-88434d7d1d79" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ecf78572-a54f-4d25-8f8c-cc02c1ec1ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentnetDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentnetDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentnetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c5371a60-66ca-448d-96b9-48b98d50d526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b2cde381-830e-4e9c-9a91-3da96cfe9829" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c5371a60-66ca-448d-96b9-48b98d50d526" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b2cde381-830e-4e9c-9a91-3da96cfe9829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fc88f4e3-3a51-45ad-95f8-3ef41ca65aff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b2cde381-830e-4e9c-9a91-3da96cfe9829" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fc88f4e3-3a51-45ad-95f8-3ef41ca65aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d4f1537c-e97a-47c1-bf1b-dd74dc0a7f13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fc88f4e3-3a51-45ad-95f8-3ef41ca65aff" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d4f1537c-e97a-47c1-bf1b-dd74dc0a7f13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_1d23c3f8-1616-489e-859b-f4007378c634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d4f1537c-e97a-47c1-bf1b-dd74dc0a7f13" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_1d23c3f8-1616-489e-859b-f4007378c634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_b2fc36b8-3676-44af-8168-2823192b8efd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d4f1537c-e97a-47c1-bf1b-dd74dc0a7f13" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_b2fc36b8-3676-44af-8168-2823192b8efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_bf7686a8-8056-42bd-a4d4-12210968f9da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VehiclesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d4f1537c-e97a-47c1-bf1b-dd74dc0a7f13" xlink:to="loc_us-gaap_VehiclesMember_bf7686a8-8056-42bd-a4d4-12210968f9da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_12abe3d7-176a-46c6-a8da-c621f5c08f85" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b2cde381-830e-4e9c-9a91-3da96cfe9829" xlink:to="loc_srt_RangeAxis_12abe3d7-176a-46c6-a8da-c621f5c08f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e069c5dd-ab1d-4121-a6bc-048b812d2bb5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_12abe3d7-176a-46c6-a8da-c621f5c08f85" xlink:to="loc_srt_RangeMember_e069c5dd-ab1d-4121-a6bc-048b812d2bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e47cdedb-7b95-4497-b8ca-a69de9c640d2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e069c5dd-ab1d-4121-a6bc-048b812d2bb5" xlink:to="loc_srt_MinimumMember_e47cdedb-7b95-4497-b8ca-a69de9c640d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2ae4bfd2-2d54-478e-9671-3ea36ea8503c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e069c5dd-ab1d-4121-a6bc-048b812d2bb5" xlink:to="loc_srt_MaximumMember_2ae4bfd2-2d54-478e-9671-3ea36ea8503c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_25ddaca1-8814-462b-a109-f81f56a5ecff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b2cde381-830e-4e9c-9a91-3da96cfe9829" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_25ddaca1-8814-462b-a109-f81f56a5ecff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_99d7200f-cb8f-4172-81f3-846675e47f63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_25ddaca1-8814-462b-a109-f81f56a5ecff" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_99d7200f-cb8f-4172-81f3-846675e47f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesWarrantsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#SummaryofSignificantAccountingPoliciesWarrantsDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesWarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2923df6a-999a-4c0a-ba5b-95d5f91af09a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_e6febd2e-b513-4b3b-8233-c12498814193" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2923df6a-999a-4c0a-ba5b-95d5f91af09a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_e6febd2e-b513-4b3b-8233-c12498814193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_ca5c43ab-3c81-4233-9373-5b5e299c8a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2923df6a-999a-4c0a-ba5b-95d5f91af09a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_ca5c43ab-3c81-4233-9373-5b5e299c8a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_d3b6d1ac-1b60-438b-975c-a2dc9bfa36e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2923df6a-999a-4c0a-ba5b-95d5f91af09a" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_d3b6d1ac-1b60-438b-975c-a2dc9bfa36e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_bc3488fc-deb3-4b90-b0f4-942cdddd88ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_28b27546-e380-4427-af30-eb3495db5804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bc3488fc-deb3-4b90-b0f4-942cdddd88ab" xlink:to="loc_us-gaap_ConcentrationRiskTable_28b27546-e380-4427-af30-eb3495db5804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_32918114-b31d-42fc-8139-1aac66048c66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_28b27546-e380-4427-af30-eb3495db5804" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_32918114-b31d-42fc-8139-1aac66048c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2abcc1c8-8232-4f73-abab-0651baac3df5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_32918114-b31d-42fc-8139-1aac66048c66" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2abcc1c8-8232-4f73-abab-0651baac3df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_1195b712-91e9-44f2-a48b-3836088859c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2abcc1c8-8232-4f73-abab-0651baac3df5" xlink:to="loc_us-gaap_SalesRevenueNetMember_1195b712-91e9-44f2-a48b-3836088859c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_53904858-3678-4eb9-aa4a-8d4e3ba0f65a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2abcc1c8-8232-4f73-abab-0651baac3df5" xlink:to="loc_us-gaap_AccountsReceivableMember_53904858-3678-4eb9-aa4a-8d4e3ba0f65a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_59e237e5-1e0c-400b-bf20-bc2991c358a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_28b27546-e380-4427-af30-eb3495db5804" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_59e237e5-1e0c-400b-bf20-bc2991c358a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_a6f08780-38ce-421b-b1af-f11379732796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_59e237e5-1e0c-400b-bf20-bc2991c358a0" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_a6f08780-38ce-421b-b1af-f11379732796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_119f84f8-b3e6-4c5a-92e0-07fd56b3e440" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_a6f08780-38ce-421b-b1af-f11379732796" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_119f84f8-b3e6-4c5a-92e0-07fd56b3e440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_6bde93d3-cc4c-4493-bd15-f42a9d8d13ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_a6f08780-38ce-421b-b1af-f11379732796" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_6bde93d3-cc4c-4493-bd15-f42a9d8d13ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_95441c91-f8e5-42e3-b0fc-e438c88de1be" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_28b27546-e380-4427-af30-eb3495db5804" xlink:to="loc_srt_StatementGeographicalAxis_95441c91-f8e5-42e3-b0fc-e438c88de1be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6d22a47c-ab11-4f03-bee4-14f987402fc8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_95441c91-f8e5-42e3-b0fc-e438c88de1be" xlink:to="loc_srt_SegmentGeographicalDomain_6d22a47c-ab11-4f03-bee4-14f987402fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_31c20e22-5a9a-4850-aec7-9658f8b3f715" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_6d22a47c-ab11-4f03-bee4-14f987402fc8" xlink:to="loc_us-gaap_NonUsMember_31c20e22-5a9a-4850-aec7-9658f8b3f715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_e03f5f9b-c47d-4df4-b39e-f4790026a497" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_28b27546-e380-4427-af30-eb3495db5804" xlink:to="loc_srt_MajorCustomersAxis_e03f5f9b-c47d-4df4-b39e-f4790026a497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_4da873b3-2c5b-4da1-93ca-dc252f6d8122" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_e03f5f9b-c47d-4df4-b39e-f4790026a497" xlink:to="loc_srt_NameOfMajorCustomerDomain_4da873b3-2c5b-4da1-93ca-dc252f6d8122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CustomerAMember_0d0fa4f4-3ce9-4133-8e4d-b7dcabe23866" xlink:href="amci-20230213.xsd#amci_CustomerAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_4da873b3-2c5b-4da1-93ca-dc252f6d8122" xlink:to="loc_amci_CustomerAMember_0d0fa4f4-3ce9-4133-8e4d-b7dcabe23866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CustomerBMember_f1e8fa5f-8f7c-4777-9812-df528215a9ae" xlink:href="amci-20230213.xsd#amci_CustomerBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_4da873b3-2c5b-4da1-93ca-dc252f6d8122" xlink:to="loc_amci_CustomerBMember_f1e8fa5f-8f7c-4777-9812-df528215a9ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CustomerCMember_4a235fa1-3443-4d76-878a-3825050d0dc1" xlink:href="amci-20230213.xsd#amci_CustomerCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_4da873b3-2c5b-4da1-93ca-dc252f6d8122" xlink:to="loc_amci_CustomerCMember_4a235fa1-3443-4d76-878a-3825050d0dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CustomerDMember_2cfc12bd-6502-46f0-8bd5-ffa365f286b9" xlink:href="amci-20230213.xsd#amci_CustomerDMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_4da873b3-2c5b-4da1-93ca-dc252f6d8122" xlink:to="loc_amci_CustomerDMember_2cfc12bd-6502-46f0-8bd5-ffa365f286b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_aae44aef-cff6-4371-ab25-f63f8c6c89c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_28b27546-e380-4427-af30-eb3495db5804" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_aae44aef-cff6-4371-ab25-f63f8c6c89c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_0674d98c-e43d-4e90-852f-fe6a52e032fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_aae44aef-cff6-4371-ab25-f63f8c6c89c9" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_0674d98c-e43d-4e90-852f-fe6a52e032fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_9de1c67e-8a5e-4d01-9ddd-749d572b46f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_e68be04c-fb6d-42e2-ac82-55fb89f9d92b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9de1c67e-8a5e-4d01-9ddd-749d572b46f6" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_e68be04c-fb6d-42e2-ac82-55fb89f9d92b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b4d5db0e-b207-4f54-9c2f-bff25d6746e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_e68be04c-fb6d-42e2-ac82-55fb89f9d92b" xlink:to="loc_us-gaap_NetIncomeLoss_b4d5db0e-b207-4f54-9c2f-bff25d6746e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact_88fd77a1-6d93-4e3d-b389-2a5fe276b92d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_e68be04c-fb6d-42e2-ac82-55fb89f9d92b" xlink:to="loc_us-gaap_PreferredStockDividendsIncomeStatementImpact_88fd77a1-6d93-4e3d-b389-2a5fe276b92d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_9fd5fe2e-f52f-4906-aeb3-0965ebabffaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_e68be04c-fb6d-42e2-ac82-55fb89f9d92b" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_9fd5fe2e-f52f-4906-aeb3-0965ebabffaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_80c4911a-9eea-47ad-8c7f-fc8e343a161d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9de1c67e-8a5e-4d01-9ddd-749d572b46f6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_80c4911a-9eea-47ad-8c7f-fc8e343a161d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ebdcd5ac-07d2-4cad-aed6-8ce7b2a53e27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_80c4911a-9eea-47ad-8c7f-fc8e343a161d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ebdcd5ac-07d2-4cad-aed6-8ce7b2a53e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7390dc27-832e-4600-837c-f4541eabbc67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_80c4911a-9eea-47ad-8c7f-fc8e343a161d" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7390dc27-832e-4600-837c-f4541eabbc67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_342bdbe3-347d-47bc-a3cb-ac60daa7bf45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_80c4911a-9eea-47ad-8c7f-fc8e343a161d" xlink:to="loc_us-gaap_EarningsPerShareBasic_342bdbe3-347d-47bc-a3cb-ac60daa7bf45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_dd176ff8-6060-4eca-8a29-ffec1b4a6153" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_80c4911a-9eea-47ad-8c7f-fc8e343a161d" xlink:to="loc_us-gaap_EarningsPerShareDiluted_dd176ff8-6060-4eca-8a29-ffec1b4a6153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/NetLossPerShareAntidilutiveSharesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#NetLossPerShareAntidilutiveSharesDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/NetLossPerShareAntidilutiveSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_33190c9b-7955-4458-8ed8-f3e3571c89a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5bd86ab9-6f02-4dfc-816f-b92d4e05605a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_33190c9b-7955-4458-8ed8-f3e3571c89a8" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5bd86ab9-6f02-4dfc-816f-b92d4e05605a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_8b405278-4868-4779-a8a2-ae29cc7468e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5bd86ab9-6f02-4dfc-816f-b92d4e05605a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_8b405278-4868-4779-a8a2-ae29cc7468e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_24978e2d-bb21-409a-bd67-d7f72b9ff7de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_8b405278-4868-4779-a8a2-ae29cc7468e1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_24978e2d-bb21-409a-bd67-d7f72b9ff7de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_a10e2338-5350-48a7-a905-77aa776bff5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_24978e2d-bb21-409a-bd67-d7f72b9ff7de" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_a10e2338-5350-48a7-a905-77aa776bff5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_fe4341b2-96b1-4eba-8862-5e0e41f7eb57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_24978e2d-bb21-409a-bd67-d7f72b9ff7de" xlink:to="loc_us-gaap_EmployeeStockOptionMember_fe4341b2-96b1-4eba-8862-5e0e41f7eb57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_44071837-ebad-41d8-a51b-c3f7e1f6aaf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_24978e2d-bb21-409a-bd67-d7f72b9ff7de" xlink:to="loc_us-gaap_RestrictedStockMember_44071837-ebad-41d8-a51b-c3f7e1f6aaf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_0630aadc-f7d6-41c3-95a5-020aa6fe1334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_24978e2d-bb21-409a-bd67-d7f72b9ff7de" xlink:to="loc_us-gaap_WarrantMember_0630aadc-f7d6-41c3-95a5-020aa6fe1334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_18cb625b-ecfc-4a08-a0a8-6c8e058188c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5bd86ab9-6f02-4dfc-816f-b92d4e05605a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_18cb625b-ecfc-4a08-a0a8-6c8e058188c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b8292252-e5f3-4750-807b-780f25e8d874" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_18cb625b-ecfc-4a08-a0a8-6c8e058188c0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b8292252-e5f3-4750-807b-780f25e8d874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleConversionRatio_49b999d1-865b-457b-ab5d-ae7589220814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockConvertibleConversionRatio"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_18cb625b-ecfc-4a08-a0a8-6c8e058188c0" xlink:to="loc_us-gaap_PreferredStockConvertibleConversionRatio_49b999d1-865b-457b-ab5d-ae7589220814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LiquidityPriceOfSAFEAndSAFEWarrants_5f139b9b-02a1-4386-b88e-383deb584378" xlink:href="amci-20230213.xsd#amci_LiquidityPriceOfSAFEAndSAFEWarrants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_18cb625b-ecfc-4a08-a0a8-6c8e058188c0" xlink:to="loc_amci_LiquidityPriceOfSAFEAndSAFEWarrants_5f139b9b-02a1-4386-b88e-383deb584378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne_4f693514-1c6d-4a24-8fbc-226eb90b6cc7" xlink:href="amci-20230213.xsd#amci_LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_18cb625b-ecfc-4a08-a0a8-6c8e058188c0" xlink:to="loc_amci_LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne_4f693514-1c6d-4a24-8fbc-226eb90b6cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#RevenuesDisaggregatedRevenueDetails_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8a493400-5b65-4da1-bde0-3e07aec6fa58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_b540b356-5700-4dbb-b06e-4bf69e77dd9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8a493400-5b65-4da1-bde0-3e07aec6fa58" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_b540b356-5700-4dbb-b06e-4bf69e77dd9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f72d1110-46e4-403e-bac4-1b8bb0c54280" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b540b356-5700-4dbb-b06e-4bf69e77dd9f" xlink:to="loc_srt_ProductOrServiceAxis_f72d1110-46e4-403e-bac4-1b8bb0c54280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_92b8bbfe-4750-4507-a6ca-d0bb8a3dd33d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_f72d1110-46e4-403e-bac4-1b8bb0c54280" xlink:to="loc_srt_ProductsAndServicesDomain_92b8bbfe-4750-4507-a6ca-d0bb8a3dd33d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ResearchAndDevelopmentMember_21d570d0-bbe9-4a3e-ac8e-36d50c10ed26" xlink:href="amci-20230213.xsd#amci_ResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_92b8bbfe-4750-4507-a6ca-d0bb8a3dd33d" xlink:to="loc_amci_ResearchAndDevelopmentMember_21d570d0-bbe9-4a3e-ac8e-36d50c10ed26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_JointDevelopmentAgreementsMember_8f0b8526-5ba6-4b7b-a2fc-d7b407ba9404" xlink:href="amci-20230213.xsd#amci_JointDevelopmentAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_ResearchAndDevelopmentMember_21d570d0-bbe9-4a3e-ac8e-36d50c10ed26" xlink:to="loc_amci_JointDevelopmentAgreementsMember_8f0b8526-5ba6-4b7b-a2fc-d7b407ba9404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OtherContractResearchMember_a9f9d374-50cb-458c-94c2-4c830c9d9ec1" xlink:href="amci-20230213.xsd#amci_OtherContractResearchMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_ResearchAndDevelopmentMember_21d570d0-bbe9-4a3e-ac8e-36d50c10ed26" xlink:to="loc_amci_OtherContractResearchMember_a9f9d374-50cb-458c-94c2-4c830c9d9ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CarbonCaptureAndTransformationMember_15a8b63b-03ba-4acf-90fd-da687543c377" xlink:href="amci-20230213.xsd#amci_CarbonCaptureAndTransformationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_92b8bbfe-4750-4507-a6ca-d0bb8a3dd33d" xlink:to="loc_amci_CarbonCaptureAndTransformationMember_15a8b63b-03ba-4acf-90fd-da687543c377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAndServiceMember_13a464f1-e5e6-489c-8828-b582b56061a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicenseAndServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_CarbonCaptureAndTransformationMember_15a8b63b-03ba-4acf-90fd-da687543c377" xlink:to="loc_us-gaap_LicenseAndServiceMember_13a464f1-e5e6-489c-8828-b582b56061a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_CarbonSmartMember_3a8f940b-ad01-44aa-a833-402e52c34b3f" xlink:href="amci-20230213.xsd#amci_CarbonSmartMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_CarbonCaptureAndTransformationMember_15a8b63b-03ba-4acf-90fd-da687543c377" xlink:to="loc_amci_CarbonSmartMember_3a8f940b-ad01-44aa-a833-402e52c34b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EngineeringAndOtherServicesMember_465ade6c-393d-42ad-814c-179c4bf7ad74" xlink:href="amci-20230213.xsd#amci_EngineeringAndOtherServicesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_CarbonCaptureAndTransformationMember_15a8b63b-03ba-4acf-90fd-da687543c377" xlink:to="loc_amci_EngineeringAndOtherServicesMember_465ade6c-393d-42ad-814c-179c4bf7ad74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_677fd964-80e7-4b25-b830-70471edbac40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b540b356-5700-4dbb-b06e-4bf69e77dd9f" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_677fd964-80e7-4b25-b830-70471edbac40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_216923c2-fd7b-49aa-9858-fafd2dc598ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_677fd964-80e7-4b25-b830-70471edbac40" xlink:to="loc_us-gaap_Revenues_216923c2-fd7b-49aa-9858-fafd2dc598ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#RevenuesDisaggregationbyCustomerLocationDetails_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_27cad7a5-2689-489f-b542-d4781d1a838a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_f35e77e1-0481-44cb-aa78-86af2f60d79a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_27cad7a5-2689-489f-b542-d4781d1a838a" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_f35e77e1-0481-44cb-aa78-86af2f60d79a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_1959904b-17a7-44e8-a8f3-081ec6ba8820" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f35e77e1-0481-44cb-aa78-86af2f60d79a" xlink:to="loc_srt_StatementGeographicalAxis_1959904b-17a7-44e8-a8f3-081ec6ba8820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7b647736-e17d-43c1-8f41-245f45616e4d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_1959904b-17a7-44e8-a8f3-081ec6ba8820" xlink:to="loc_srt_SegmentGeographicalDomain_7b647736-e17d-43c1-8f41-245f45616e4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NorthAmericaMember_7e97b8f6-333c-47e1-b8bd-47241edb0d16" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NorthAmericaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7b647736-e17d-43c1-8f41-245f45616e4d" xlink:to="loc_srt_NorthAmericaMember_7e97b8f6-333c-47e1-b8bd-47241edb0d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_f25b0f15-7bd6-4843-bffd-806bc11e5aed" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7b647736-e17d-43c1-8f41-245f45616e4d" xlink:to="loc_srt_EuropeMember_f25b0f15-7bd6-4843-bffd-806bc11e5aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaMember_232e414e-61c3-4ebd-b66d-87048f46d4e2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7b647736-e17d-43c1-8f41-245f45616e4d" xlink:to="loc_srt_AsiaMember_232e414e-61c3-4ebd-b66d-87048f46d4e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_AU_2948f984-254a-4f0e-8628-9eec39a88db0" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_AU"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7b647736-e17d-43c1-8f41-245f45616e4d" xlink:to="loc_country_AU_2948f984-254a-4f0e-8628-9eec39a88db0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_a5a5b89f-96d7-45e0-bee1-a9b447504278" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f35e77e1-0481-44cb-aa78-86af2f60d79a" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_a5a5b89f-96d7-45e0-bee1-a9b447504278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_99d1b550-2309-40b6-8ec1-68f631011c97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a5a5b89f-96d7-45e0-bee1-a9b447504278" xlink:to="loc_us-gaap_Revenues_99d1b550-2309-40b6-8ec1-68f631011c97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RevenuesContractBalancesDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#RevenuesContractBalancesDetails_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RevenuesContractBalancesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f59b7999-f4eb-4216-8c91-389634ceb9e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrentAbstract_da16120e-04e8-4d60-a0f5-3331b0cfd9e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f59b7999-f4eb-4216-8c91-389634ceb9e7" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrentAbstract_da16120e-04e8-4d60-a0f5-3331b0cfd9e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_a9822b29-b6f0-4f76-8571-dc4e3e35a32f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrentAbstract_da16120e-04e8-4d60-a0f5-3331b0cfd9e2" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_a9822b29-b6f0-4f76-8571-dc4e3e35a32f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable_6819be85-1094-4acb-8038-e37b72490885" xlink:href="amci-20230213.xsd#amci_ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrentAbstract_da16120e-04e8-4d60-a0f5-3331b0cfd9e2" xlink:to="loc_amci_ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable_6819be85-1094-4acb-8038-e37b72490885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContractWithCustomerAssetCurrentReclassifiedToReceivable_7f612105-09ce-4960-9be6-9d788778ed0b" xlink:href="amci-20230213.xsd#amci_ContractWithCustomerAssetCurrentReclassifiedToReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrentAbstract_da16120e-04e8-4d60-a0f5-3331b0cfd9e2" xlink:to="loc_amci_ContractWithCustomerAssetCurrentReclassifiedToReceivable_7f612105-09ce-4960-9be6-9d788778ed0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_cebe5b95-5389-470e-bad2-e40c6531f58d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrentAbstract_da16120e-04e8-4d60-a0f5-3331b0cfd9e2" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_cebe5b95-5389-470e-bad2-e40c6531f58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContractWithCustomerLiabilityCurrentAbstract_d31f85ec-131e-49e3-858d-4a6cf6d00de0" xlink:href="amci-20230213.xsd#amci_ContractWithCustomerLiabilityCurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f59b7999-f4eb-4216-8c91-389634ceb9e7" xlink:to="loc_amci_ContractWithCustomerLiabilityCurrentAbstract_d31f85ec-131e-49e3-858d-4a6cf6d00de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_b943e90d-66d8-4f5f-ab23-faa272309610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_ContractWithCustomerLiabilityCurrentAbstract_d31f85ec-131e-49e3-858d-4a6cf6d00de0" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_b943e90d-66d8-4f5f-ab23-faa272309610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContractWithCustomerLiabilityCurrentAmountsCollected_25d0fb59-b73b-485e-9294-074fba00275b" xlink:href="amci-20230213.xsd#amci_ContractWithCustomerLiabilityCurrentAmountsCollected"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_ContractWithCustomerLiabilityCurrentAbstract_d31f85ec-131e-49e3-858d-4a6cf6d00de0" xlink:to="loc_amci_ContractWithCustomerLiabilityCurrentAmountsCollected_25d0fb59-b73b-485e-9294-074fba00275b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent_d048e854-d22a-40b8-b64c-8734393f8604" xlink:href="amci-20230213.xsd#amci_ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_ContractWithCustomerLiabilityCurrentAbstract_d31f85ec-131e-49e3-858d-4a6cf6d00de0" xlink:to="loc_amci_ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent_d048e854-d22a-40b8-b64c-8734393f8604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_0bd7e946-ddde-4cae-9193-0f4f05afe4bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_ContractWithCustomerLiabilityCurrentAbstract_d31f85ec-131e-49e3-858d-4a6cf6d00de0" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_0bd7e946-ddde-4cae-9193-0f4f05afe4bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContractWithCustomerLiabilityNoncurrentAbstract_c5bfd00d-40f0-40de-af46-517277c4325a" xlink:href="amci-20230213.xsd#amci_ContractWithCustomerLiabilityNoncurrentAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f59b7999-f4eb-4216-8c91-389634ceb9e7" xlink:to="loc_amci_ContractWithCustomerLiabilityNoncurrentAbstract_c5bfd00d-40f0-40de-af46-517277c4325a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_7b2b858f-6e29-47da-9095-d68a88af518e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_ContractWithCustomerLiabilityNoncurrentAbstract_c5bfd00d-40f0-40de-af46-517277c4325a" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_7b2b858f-6e29-47da-9095-d68a88af518e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContractWithCustomerLiabilityNoncurrentAmountsCollected_00479c80-f4e7-4821-8a11-5bc3b2c0f531" xlink:href="amci-20230213.xsd#amci_ContractWithCustomerLiabilityNoncurrentAmountsCollected"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_ContractWithCustomerLiabilityNoncurrentAbstract_c5bfd00d-40f0-40de-af46-517277c4325a" xlink:to="loc_amci_ContractWithCustomerLiabilityNoncurrentAmountsCollected_00479c80-f4e7-4821-8a11-5bc3b2c0f531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent_52e96ffe-1f3e-457f-96d7-0bb0d5716a6d" xlink:href="amci-20230213.xsd#amci_ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_ContractWithCustomerLiabilityNoncurrentAbstract_c5bfd00d-40f0-40de-af46-517277c4325a" xlink:to="loc_amci_ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent_52e96ffe-1f3e-457f-96d7-0bb0d5716a6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ContractWithCustomerLiabilityCurrentRevenueRecognized_4c48ebc0-6ab1-41c4-b7e0-08dd1d70e3d3" xlink:href="amci-20230213.xsd#amci_ContractWithCustomerLiabilityCurrentRevenueRecognized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_ContractWithCustomerLiabilityNoncurrentAbstract_c5bfd00d-40f0-40de-af46-517277c4325a" xlink:to="loc_amci_ContractWithCustomerLiabilityCurrentRevenueRecognized_4c48ebc0-6ab1-41c4-b7e0-08dd1d70e3d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_50ad6558-89d7-4e08-a9c5-357a8a99af27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_ContractWithCustomerLiabilityNoncurrentAbstract_c5bfd00d-40f0-40de-af46-517277c4325a" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_50ad6558-89d7-4e08-a9c5-357a8a99af27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RevenuesAdditionalInformationDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#RevenuesAdditionalInformationDetails_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RevenuesAdditionalInformationDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_344e2767-ad6f-41c3-8463-24f01bbb4511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BilledContractReceivables_bd9d4876-2d3a-4eec-8750-b15e3f5a08c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BilledContractReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_344e2767-ad6f-41c3-8463-24f01bbb4511" xlink:to="loc_us-gaap_BilledContractReceivables_bd9d4876-2d3a-4eec-8750-b15e3f5a08c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RevenuesRemainingPerformanceObligationsDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#RevenuesRemainingPerformanceObligationsDetails_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RevenuesRemainingPerformanceObligationsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1b3206fe-11c2-4f7d-a342-0096a4465052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RevenueRemainingPerformanceObligationCurrentAmount_5b11cd5d-920e-424f-84fb-4f6e53673b19" xlink:href="amci-20230213.xsd#amci_RevenueRemainingPerformanceObligationCurrentAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1b3206fe-11c2-4f7d-a342-0096a4465052" xlink:to="loc_amci_RevenueRemainingPerformanceObligationCurrentAmount_5b11cd5d-920e-424f-84fb-4f6e53673b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RevenueRemainingPerformanceObligationNoncurrentAmount_7261f114-56b4-4758-9b72-3d22e98d8f62" xlink:href="amci-20230213.xsd#amci_RevenueRemainingPerformanceObligationNoncurrentAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1b3206fe-11c2-4f7d-a342-0096a4465052" xlink:to="loc_amci_RevenueRemainingPerformanceObligationNoncurrentAmount_7261f114-56b4-4758-9b72-3d22e98d8f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_7d03b5e9-d7ca-4b2b-bd1d-fef4302f592e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1b3206fe-11c2-4f7d-a342-0096a4465052" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_7d03b5e9-d7ca-4b2b-bd1d-fef4302f592e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/InvestmentsEquityMethodInvestmentsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#InvestmentsEquityMethodInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/InvestmentsEquityMethodInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_eda48075-c62e-46bf-8c07-98fe628d615c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f19f59cf-1793-4091-8b82-02f7fde0c0a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_eda48075-c62e-46bf-8c07-98fe628d615c" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f19f59cf-1793-4091-8b82-02f7fde0c0a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1bf2ffc8-12cc-468e-b13c-292898bec23a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f19f59cf-1793-4091-8b82-02f7fde0c0a1" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1bf2ffc8-12cc-468e-b13c-292898bec23a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_59d7e56d-fd81-424f-a7a6-df6e4f02c7e1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1bf2ffc8-12cc-468e-b13c-292898bec23a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_59d7e56d-fd81-424f-a7a6-df6e4f02c7e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LanzaJetIncMember_72601285-505a-468f-b731-f385ba3ce96f" xlink:href="amci-20230213.xsd#amci_LanzaJetIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_59d7e56d-fd81-424f-a7a6-df6e4f02c7e1" xlink:to="loc_amci_LanzaJetIncMember_72601285-505a-468f-b731-f385ba3ce96f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember_8d22cf81-646d-47ca-bdf7-c90ef1f619f4" xlink:href="amci-20230213.xsd#amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_59d7e56d-fd81-424f-a7a6-df6e4f02c7e1" xlink:to="loc_amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember_8d22cf81-646d-47ca-bdf7-c90ef1f619f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_654c2f7f-e21d-4448-aeb0-6878104651e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f19f59cf-1793-4091-8b82-02f7fde0c0a1" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_654c2f7f-e21d-4448-aeb0-6878104651e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_b39b7b93-5200-49ec-9b8e-ba914f9dc2ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_654c2f7f-e21d-4448-aeb0-6878104651e5" xlink:to="loc_us-gaap_EquityMethodInvestments_b39b7b93-5200-49ec-9b8e-ba914f9dc2ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/InvestmentsNarrativeDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#InvestmentsNarrativeDetails_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/InvestmentsNarrativeDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_ebe8bd03-6bb0-4073-8b9a-5c6d0dcf7f16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8d463a2a-8d91-4622-96bd-8e391bc6092a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_ebe8bd03-6bb0-4073-8b9a-5c6d0dcf7f16" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8d463a2a-8d91-4622-96bd-8e391bc6092a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c5285669-a31f-4af9-892d-60f256d462dc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8d463a2a-8d91-4622-96bd-8e391bc6092a" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c5285669-a31f-4af9-892d-60f256d462dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_af75611e-f3f8-41ad-883f-71ab668ba154" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c5285669-a31f-4af9-892d-60f256d462dc" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_af75611e-f3f8-41ad-883f-71ab668ba154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LanzaJetIncMember_c18bf726-8767-4a07-995a-177e62449fd2" xlink:href="amci-20230213.xsd#amci_LanzaJetIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_af75611e-f3f8-41ad-883f-71ab668ba154" xlink:to="loc_amci_LanzaJetIncMember_c18bf726-8767-4a07-995a-177e62449fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember_47f57589-066c-43e5-b8d5-6315a1b4eab7" xlink:href="amci-20230213.xsd#amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_af75611e-f3f8-41ad-883f-71ab668ba154" xlink:to="loc_amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember_47f57589-066c-43e5-b8d5-6315a1b4eab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_453117cc-a844-4a1c-b925-e436096f8e57" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8d463a2a-8d91-4622-96bd-8e391bc6092a" xlink:to="loc_srt_ConsolidationItemsAxis_453117cc-a844-4a1c-b925-e436096f8e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_76124291-b8be-40d3-8e60-3f101dd0ea4c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_453117cc-a844-4a1c-b925-e436096f8e57" xlink:to="loc_srt_ConsolidationItemsDomain_76124291-b8be-40d3-8e60-3f101dd0ea4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_8d56b6e1-f4a6-44b0-8e4b-94bcf52e75cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_76124291-b8be-40d3-8e60-3f101dd0ea4c" xlink:to="loc_us-gaap_IntersegmentEliminationMember_8d56b6e1-f4a6-44b0-8e4b-94bcf52e75cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_895bb86e-c401-4328-a4a0-3d5965e405c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8d463a2a-8d91-4622-96bd-8e391bc6092a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_895bb86e-c401-4328-a4a0-3d5965e405c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f5e934a5-456b-4d17-8b85-773635bce409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_895bb86e-c401-4328-a4a0-3d5965e405c8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f5e934a5-456b-4d17-8b85-773635bce409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntellectualPropertyMember_674abc35-956c-45ba-be60-07c827d839a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntellectualPropertyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f5e934a5-456b-4d17-8b85-773635bce409" xlink:to="loc_us-gaap_IntellectualPropertyMember_674abc35-956c-45ba-be60-07c827d839a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3e7309c6-3d23-441f-a7f3-24c0c2c35698" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8d463a2a-8d91-4622-96bd-8e391bc6092a" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3e7309c6-3d23-441f-a7f3-24c0c2c35698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContributionOfProperty_652300b5-f4aa-4745-9f42-0bbc9e5e17ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContributionOfProperty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3e7309c6-3d23-441f-a7f3-24c0c2c35698" xlink:to="loc_us-gaap_ContributionOfProperty_652300b5-f4aa-4745-9f42-0bbc9e5e17ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_0ed7ea75-b774-445d-8f43-340f9c47a080" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3e7309c6-3d23-441f-a7f3-24c0c2c35698" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_0ed7ea75-b774-445d-8f43-340f9c47a080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_efbd78d4-ed7b-4d99-876f-760fee0a027e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3e7309c6-3d23-441f-a7f3-24c0c2c35698" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_efbd78d4-ed7b-4d99-876f-760fee0a027e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_e39fb988-9f91-4d9d-a53d-0919592cec6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3e7309c6-3d23-441f-a7f3-24c0c2c35698" xlink:to="loc_us-gaap_ContractWithCustomerLiability_e39fb988-9f91-4d9d-a53d-0919592cec6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RevenueFromContractWithCustomerAmortizationPeriod_e52c2466-8730-4ed7-ad45-dec727eb3aac" xlink:href="amci-20230213.xsd#amci_RevenueFromContractWithCustomerAmortizationPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3e7309c6-3d23-441f-a7f3-24c0c2c35698" xlink:to="loc_amci_RevenueFromContractWithCustomerAmortizationPeriod_e52c2466-8730-4ed7-ad45-dec727eb3aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EquityMethodInvestmentContingentRightToReceiveAdditionalInterest_2518a859-cf32-4fd6-a473-283be42a633b" xlink:href="amci-20230213.xsd#amci_EquityMethodInvestmentContingentRightToReceiveAdditionalInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3e7309c6-3d23-441f-a7f3-24c0c2c35698" xlink:to="loc_amci_EquityMethodInvestmentContingentRightToReceiveAdditionalInterest_2518a859-cf32-4fd6-a473-283be42a633b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_ad1b38ac-c0a2-4896-99fd-1fa3ee85b801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3e7309c6-3d23-441f-a7f3-24c0c2c35698" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_ad1b38ac-c0a2-4896-99fd-1fa3ee85b801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EquityMethodInvestmentGainOnDilutionOfInvestment_e031030f-d76f-4620-bdff-7e130df9afae" xlink:href="amci-20230213.xsd#amci_EquityMethodInvestmentGainOnDilutionOfInvestment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3e7309c6-3d23-441f-a7f3-24c0c2c35698" xlink:to="loc_amci_EquityMethodInvestmentGainOnDilutionOfInvestment_e031030f-d76f-4620-bdff-7e130df9afae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_e87e20ad-e386-4e2e-9eac-0a30cdc01c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3e7309c6-3d23-441f-a7f3-24c0c2c35698" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_e87e20ad-e386-4e2e-9eac-0a30cdc01c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_c2ae9624-72fa-4eab-820f-c129e35b246f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3e7309c6-3d23-441f-a7f3-24c0c2c35698" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_c2ae9624-72fa-4eab-820f-c129e35b246f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_c5b03700-374e-494a-81d1-80429fe00fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3e7309c6-3d23-441f-a7f3-24c0c2c35698" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_c5b03700-374e-494a-81d1-80429fe00fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/InvestmentsSummarizedFinancialInformationDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#InvestmentsSummarizedFinancialInformationDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/InvestmentsSummarizedFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_26a14ea0-98b5-4af4-9cc2-6b3c7b02a275" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_86cef5b4-73fd-4771-aef5-eb7c1853cfb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_26a14ea0-98b5-4af4-9cc2-6b3c7b02a275" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_86cef5b4-73fd-4771-aef5-eb7c1853cfb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_f1100966-6d07-45b8-a382-e751b3cd691e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_86cef5b4-73fd-4771-aef5-eb7c1853cfb3" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_f1100966-6d07-45b8-a382-e751b3cd691e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_232364a7-2b62-48d8-b668-7220c2d9c1dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_f1100966-6d07-45b8-a382-e751b3cd691e" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_232364a7-2b62-48d8-b668-7220c2d9c1dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_708cb6e8-1721-437e-a8c5-021ddd1a1664" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_232364a7-2b62-48d8-b668-7220c2d9c1dd" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_708cb6e8-1721-437e-a8c5-021ddd1a1664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_db490cc5-d522-42b3-9b20-5398e6f0703a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_86cef5b4-73fd-4771-aef5-eb7c1853cfb3" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_db490cc5-d522-42b3-9b20-5398e6f0703a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_ab4726e7-9555-438a-96a4-0bbadfb499dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_db490cc5-d522-42b3-9b20-5398e6f0703a" xlink:to="loc_us-gaap_Revenues_ab4726e7-9555-438a-96a4-0bbadfb499dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_82eca11f-069f-45b5-8679-6203747ab89e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_db490cc5-d522-42b3-9b20-5398e6f0703a" xlink:to="loc_us-gaap_GrossProfit_82eca11f-069f-45b5-8679-6203747ab89e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7f215a94-039d-4496-ad33-0c8ab3f01fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_db490cc5-d522-42b3-9b20-5398e6f0703a" xlink:to="loc_us-gaap_NetIncomeLoss_7f215a94-039d-4496-ad33-0c8ab3f01fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5f017bfa-770e-407e-9661-50e82847384c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_db490cc5-d522-42b3-9b20-5398e6f0703a" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5f017bfa-770e-407e-9661-50e82847384c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_1667ce46-fb46-47e5-9a42-e033d75895a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_db490cc5-d522-42b3-9b20-5398e6f0703a" xlink:to="loc_us-gaap_AssetsCurrent_1667ce46-fb46-47e5-9a42-e033d75895a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_f0248569-6948-4bff-9450-d32d44517a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_db490cc5-d522-42b3-9b20-5398e6f0703a" xlink:to="loc_us-gaap_AssetsNoncurrent_f0248569-6948-4bff-9450-d32d44517a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_676e51eb-17f8-4206-b6db-57100f998635" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_db490cc5-d522-42b3-9b20-5398e6f0703a" xlink:to="loc_us-gaap_LiabilitiesCurrent_676e51eb-17f8-4206-b6db-57100f998635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_8ac21ba6-b115-4416-8e9b-df2ff9c92b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_db490cc5-d522-42b3-9b20-5398e6f0703a" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_8ac21ba6-b115-4416-8e9b-df2ff9c92b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/InvestmentsTransactionsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#InvestmentsTransactionsDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/InvestmentsTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_fec18f5c-cb3e-4b3d-a784-c3fb8124e849" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_0572abe6-30fa-4b01-b843-af149ef19530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_fec18f5c-cb3e-4b3d-a784-c3fb8124e849" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_0572abe6-30fa-4b01-b843-af149ef19530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_47bc1de6-cab9-4692-97f5-64c82fde0567" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_0572abe6-30fa-4b01-b843-af149ef19530" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_47bc1de6-cab9-4692-97f5-64c82fde0567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_9990a789-7acc-4ac0-9556-96fbac574ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_47bc1de6-cab9-4692-97f5-64c82fde0567" xlink:to="loc_us-gaap_RelatedPartyDomain_9990a789-7acc-4ac0-9556-96fbac574ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_49e27318-33c3-4c8f-b4b8-0d9f91447790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_9990a789-7acc-4ac0-9556-96fbac574ef9" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_49e27318-33c3-4c8f-b4b8-0d9f91447790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_81c80b30-c656-4ea9-ba58-44561bed088d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_0572abe6-30fa-4b01-b843-af149ef19530" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_81c80b30-c656-4ea9-ba58-44561bed088d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_c4ab963b-2361-4028-be4d-5e3b96722862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_81c80b30-c656-4ea9-ba58-44561bed088d" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_c4ab963b-2361-4028-be4d-5e3b96722862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TransactionsWithEquityMethodInvesteesMember_153604cc-0ee5-4367-81a3-25afd0254af4" xlink:href="amci-20230213.xsd#amci_TransactionsWithEquityMethodInvesteesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_c4ab963b-2361-4028-be4d-5e3b96722862" xlink:to="loc_amci_TransactionsWithEquityMethodInvesteesMember_153604cc-0ee5-4367-81a3-25afd0254af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_5e82ff31-907e-4a61-883d-395e10f699d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_0572abe6-30fa-4b01-b843-af149ef19530" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_5e82ff31-907e-4a61-883d-395e10f699d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_bc358419-5240-4865-b1fa-4f484e64377e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_5e82ff31-907e-4a61-883d-395e10f699d2" xlink:to="loc_us-gaap_RevenueFromRelatedParties_bc358419-5240-4865-b1fa-4f484e64377e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_fa9f5f75-9f4f-4627-a980-5c2dc14cfb57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_5e82ff31-907e-4a61-883d-395e10f699d2" xlink:to="loc_us-gaap_AccountsReceivableNet_fa9f5f75-9f4f-4627-a980-5c2dc14cfb57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PurchasesAndOpenAccountsPayableRelatedParties_75b3a94a-a09e-41d7-8978-a05cf22d0942" xlink:href="amci-20230213.xsd#amci_PurchasesAndOpenAccountsPayableRelatedParties"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_5e82ff31-907e-4a61-883d-395e10f699d2" xlink:to="loc_amci_PurchasesAndOpenAccountsPayableRelatedParties_75b3a94a-a09e-41d7-8978-a05cf22d0942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueFinancialAssetsandLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f51c503a-819f-44be-8925-fa6e32af71bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09f5f470-f825-4251-81be-3ed143236fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f51c503a-819f-44be-8925-fa6e32af71bd" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09f5f470-f825-4251-81be-3ed143236fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_85780d2f-b1e9-4ab2-b126-2051e289ae9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09f5f470-f825-4251-81be-3ed143236fc5" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_85780d2f-b1e9-4ab2-b126-2051e289ae9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_e932dfc9-3049-4aec-825a-5dad4c947647" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_85780d2f-b1e9-4ab2-b126-2051e289ae9a" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_e932dfc9-3049-4aec-825a-5dad4c947647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_7f44df46-0f59-4824-b95c-357df457e5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_e932dfc9-3049-4aec-825a-5dad4c947647" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_7f44df46-0f59-4824-b95c-357df457e5f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0022b06a-173e-498f-88eb-83d1867623ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09f5f470-f825-4251-81be-3ed143236fc5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0022b06a-173e-498f-88eb-83d1867623ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6cea754f-4c5b-44b4-9613-397b7e627862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0022b06a-173e-498f-88eb-83d1867623ff" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6cea754f-4c5b-44b4-9613-397b7e627862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_26122e94-d076-4698-b90a-b3900136a400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6cea754f-4c5b-44b4-9613-397b7e627862" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_26122e94-d076-4698-b90a-b3900136a400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_6b7be07d-3632-44ea-b38b-4283f6288873" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6cea754f-4c5b-44b4-9613-397b7e627862" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_6b7be07d-3632-44ea-b38b-4283f6288873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_7b00180c-a977-496f-b6f3-8850910b2df8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6cea754f-4c5b-44b4-9613-397b7e627862" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_7b00180c-a977-496f-b6f3-8850910b2df8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_30948ce3-ed24-4269-960e-b477392ec04c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09f5f470-f825-4251-81be-3ed143236fc5" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_30948ce3-ed24-4269-960e-b477392ec04c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_3381f6f0-c95e-474f-b5c3-524ccb0e2bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_30948ce3-ed24-4269-960e-b477392ec04c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_3381f6f0-c95e-474f-b5c3-524ccb0e2bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SAFEWarrantMember_0d5c81b4-ab79-483f-81dc-a73f50d13e06" xlink:href="amci-20230213.xsd#amci_SAFEWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3381f6f0-c95e-474f-b5c3-524ccb0e2bf3" xlink:to="loc_amci_SAFEWarrantMember_0d5c81b4-ab79-483f-81dc-a73f50d13e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_68148fc6-3d13-4c13-8869-febcdad03b68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09f5f470-f825-4251-81be-3ed143236fc5" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_68148fc6-3d13-4c13-8869-febcdad03b68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_415469f3-6651-46d3-a719-7aff87fbbec5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_68148fc6-3d13-4c13-8869-febcdad03b68" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_415469f3-6651-46d3-a719-7aff87fbbec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_7deef2d8-5bc4-4889-aead-89d19ddb1a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_415469f3-6651-46d3-a719-7aff87fbbec5" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_7deef2d8-5bc4-4889-aead-89d19ddb1a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e668c71f-ad94-439a-baec-d5683a7650e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_68148fc6-3d13-4c13-8869-febcdad03b68" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e668c71f-ad94-439a-baec-d5683a7650e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_c596ffab-c60c-4664-9a75-511ecd552ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e668c71f-ad94-439a-baec-d5683a7650e3" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_c596ffab-c60c-4664-9a75-511ecd552ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SimpleAgreementForFutureEquityLiability_d35d5588-7f65-426a-b788-09758418b89c" xlink:href="amci-20230213.xsd#amci_SimpleAgreementForFutureEquityLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e668c71f-ad94-439a-baec-d5683a7650e3" xlink:to="loc_amci_SimpleAgreementForFutureEquityLiability_d35d5588-7f65-426a-b788-09758418b89c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_ffe90ce4-0f4c-46b1-b3e9-e34767256ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e668c71f-ad94-439a-baec-d5683a7650e3" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_ffe90ce4-0f4c-46b1-b3e9-e34767256ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueNarrativeDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueNarrativeDetails_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/FairValueNarrativeDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_e3bc39e0-db6b-4faa-ace0-bde4b2753f25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4bf409d6-f953-4e21-87d2-272332dbfed4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e3bc39e0-db6b-4faa-ace0-bde4b2753f25" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4bf409d6-f953-4e21-87d2-272332dbfed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_385c3eae-8092-4c07-b293-22d16b621656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4bf409d6-f953-4e21-87d2-272332dbfed4" xlink:to="loc_us-gaap_StatementClassOfStockAxis_385c3eae-8092-4c07-b293-22d16b621656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6c5fd09a-9cca-467e-bf5c-74abe109b6dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_385c3eae-8092-4c07-b293-22d16b621656" xlink:to="loc_us-gaap_ClassOfStockDomain_6c5fd09a-9cca-467e-bf5c-74abe109b6dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_0df7c4ec-7a71-48a8-b36b-fec216f10583" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6c5fd09a-9cca-467e-bf5c-74abe109b6dc" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_0df7c4ec-7a71-48a8-b36b-fec216f10583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b314cd96-d72d-4e84-a69c-a3a0f9220a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4bf409d6-f953-4e21-87d2-272332dbfed4" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b314cd96-d72d-4e84-a69c-a3a0f9220a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_cb501457-e8e2-48f7-b0d0-5eaf7d804275" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b314cd96-d72d-4e84-a69c-a3a0f9220a0c" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_cb501457-e8e2-48f7-b0d0-5eaf7d804275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquitySharesConversionOfConvertibleSecurities_cf3f2e4d-cfb3-4c78-8d37-35bcabfef40b" xlink:href="amci-20230213.xsd#amci_TemporaryEquitySharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b314cd96-d72d-4e84-a69c-a3a0f9220a0c" xlink:to="loc_amci_TemporaryEquitySharesConversionOfConvertibleSecurities_cf3f2e4d-cfb3-4c78-8d37-35bcabfef40b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_5917740b-7b36-4f63-806f-8780b23ddf36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b314cd96-d72d-4e84-a69c-a3a0f9220a0c" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_5917740b-7b36-4f63-806f-8780b23ddf36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueLevel3FairValueMeasurementsDetails_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a3d0c1fe-12cc-447f-9dbb-221980f96222" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8e76b180-8721-4ba9-93bb-3056ab9539ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a3d0c1fe-12cc-447f-9dbb-221980f96222" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8e76b180-8721-4ba9-93bb-3056ab9539ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_527383fa-58e3-4765-987b-226b429e3067" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8e76b180-8721-4ba9-93bb-3056ab9539ac" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_527383fa-58e3-4765-987b-226b429e3067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_ff16be64-0f82-48f0-9229-f05aa99c5338" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_527383fa-58e3-4765-987b-226b429e3067" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_ff16be64-0f82-48f0-9229-f05aa99c5338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_db28ef60-003f-4c90-be07-c7b34087fe58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ff16be64-0f82-48f0-9229-f05aa99c5338" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_db28ef60-003f-4c90-be07-c7b34087fe58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExercisePriceMember_47f314d8-aceb-45ba-97f0-0bd2dc57f933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExercisePriceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ff16be64-0f82-48f0-9229-f05aa99c5338" xlink:to="loc_us-gaap_MeasurementInputExercisePriceMember_47f314d8-aceb-45ba-97f0-0bd2dc57f933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_ca3e9b5c-1895-4a98-84e1-fba6f4e2e14a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ff16be64-0f82-48f0-9229-f05aa99c5338" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_ca3e9b5c-1895-4a98-84e1-fba6f4e2e14a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_2745cbc2-0c06-4d37-aee5-b9701b9b71c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ff16be64-0f82-48f0-9229-f05aa99c5338" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_2745cbc2-0c06-4d37-aee5-b9701b9b71c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_2be7eee4-10da-4e29-a8e5-525c6aad0b40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ff16be64-0f82-48f0-9229-f05aa99c5338" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_2be7eee4-10da-4e29-a8e5-525c6aad0b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MeasurementInputProbabilityWeightingMember_e30e6fa2-106d-4c9e-b7d6-b217fe984c19" xlink:href="amci-20230213.xsd#amci_MeasurementInputProbabilityWeightingMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ff16be64-0f82-48f0-9229-f05aa99c5338" xlink:to="loc_amci_MeasurementInputProbabilityWeightingMember_e30e6fa2-106d-4c9e-b7d6-b217fe984c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MeasurementInputInterestRateMember_ed738a2a-78f1-4638-8c51-409efb3476f7" xlink:href="amci-20230213.xsd#amci_MeasurementInputInterestRateMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ff16be64-0f82-48f0-9229-f05aa99c5338" xlink:to="loc_amci_MeasurementInputInterestRateMember_ed738a2a-78f1-4638-8c51-409efb3476f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MeasurementInputTimeToConversionMember_afea1bb5-c08d-41f4-9575-161ed1dee711" xlink:href="amci-20230213.xsd#amci_MeasurementInputTimeToConversionMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ff16be64-0f82-48f0-9229-f05aa99c5338" xlink:to="loc_amci_MeasurementInputTimeToConversionMember_afea1bb5-c08d-41f4-9575-161ed1dee711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_MeasurementInputLiquidityPriceMember_2faaca17-8978-4656-8595-8c8c8e05517c" xlink:href="amci-20230213.xsd#amci_MeasurementInputLiquidityPriceMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ff16be64-0f82-48f0-9229-f05aa99c5338" xlink:to="loc_amci_MeasurementInputLiquidityPriceMember_2faaca17-8978-4656-8595-8c8c8e05517c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_d6cae5c0-9b4b-4dda-aaf4-aff00ff98b01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ff16be64-0f82-48f0-9229-f05aa99c5338" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_d6cae5c0-9b4b-4dda-aaf4-aff00ff98b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_aed2aa98-fe68-46ba-b976-297ec7beeffa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_ff16be64-0f82-48f0-9229-f05aa99c5338" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_aed2aa98-fe68-46ba-b976-297ec7beeffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_622ebd62-25cb-4967-b25f-410c71c5d245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8e76b180-8721-4ba9-93bb-3056ab9539ac" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_622ebd62-25cb-4967-b25f-410c71c5d245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8072605d-5a6f-4bac-9737-75e11efe5308" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_622ebd62-25cb-4967-b25f-410c71c5d245" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8072605d-5a6f-4bac-9737-75e11efe5308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DerivativeNearTermMember_c180c9eb-3ad0-4b64-b571-79c91cc75a9d" xlink:href="amci-20230213.xsd#amci_DerivativeNearTermMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8072605d-5a6f-4bac-9737-75e11efe5308" xlink:to="loc_amci_DerivativeNearTermMember_c180c9eb-3ad0-4b64-b571-79c91cc75a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DerivativeLongTermMember_1ad48db0-8a39-4d8e-a318-73d65b856004" xlink:href="amci-20230213.xsd#amci_DerivativeLongTermMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8072605d-5a6f-4bac-9737-75e11efe5308" xlink:to="loc_amci_DerivativeLongTermMember_1ad48db0-8a39-4d8e-a318-73d65b856004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_22580edc-9736-4e8d-a9d3-03848b0a1d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8e76b180-8721-4ba9-93bb-3056ab9539ac" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_22580edc-9736-4e8d-a9d3-03848b0a1d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_2fe7eca9-4b07-4ef0-9188-120e8e99b976" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_22580edc-9736-4e8d-a9d3-03848b0a1d3b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_2fe7eca9-4b07-4ef0-9188-120e8e99b976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SAFEWarrantNearTermMember_5b924cff-f062-47ea-a12a-4a78477a160c" xlink:href="amci-20230213.xsd#amci_SAFEWarrantNearTermMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2fe7eca9-4b07-4ef0-9188-120e8e99b976" xlink:to="loc_amci_SAFEWarrantNearTermMember_5b924cff-f062-47ea-a12a-4a78477a160c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SAFEWarrantLongTermMember_4308830c-733b-4755-9ef0-b18a47474ee3" xlink:href="amci-20230213.xsd#amci_SAFEWarrantLongTermMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2fe7eca9-4b07-4ef0-9188-120e8e99b976" xlink:to="loc_amci_SAFEWarrantLongTermMember_4308830c-733b-4755-9ef0-b18a47474ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_acf573eb-519c-4a14-983f-fdd2f047b21c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8e76b180-8721-4ba9-93bb-3056ab9539ac" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_acf573eb-519c-4a14-983f-fdd2f047b21c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_dcf84fcc-8f3c-47e0-a849-0205d4fa0e26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_acf573eb-519c-4a14-983f-fdd2f047b21c" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_dcf84fcc-8f3c-47e0-a849-0205d4fa0e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityMeasurementInput_a13ebe17-42d4-4ea1-96df-981994c10843" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityMeasurementInput"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_acf573eb-519c-4a14-983f-fdd2f047b21c" xlink:to="loc_us-gaap_DerivativeLiabilityMeasurementInput_a13ebe17-42d4-4ea1-96df-981994c10843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2994120b-0249-45c0-b66f-7ae3a96d1ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_58edcd02-4755-412b-a604-1719327fcd1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2994120b-0249-45c0-b66f-7ae3a96d1ec1" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_58edcd02-4755-412b-a604-1719327fcd1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_32cdbe9a-e2e4-441a-af7f-30d098e27986" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_58edcd02-4755-412b-a604-1719327fcd1b" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_32cdbe9a-e2e4-441a-af7f-30d098e27986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c8ba6a4f-b2cc-4973-93d5-cc88cd9d27e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_32cdbe9a-e2e4-441a-af7f-30d098e27986" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c8ba6a4f-b2cc-4973-93d5-cc88cd9d27e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_a8666fda-2457-4362-a034-50ae2c2a704e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c8ba6a4f-b2cc-4973-93d5-cc88cd9d27e1" xlink:to="loc_us-gaap_WarrantMember_a8666fda-2457-4362-a034-50ae2c2a704e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SAFELiabilityMember_2f6b7e5c-de2c-445f-88e0-a7b8311e27f9" xlink:href="amci-20230213.xsd#amci_SAFELiabilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c8ba6a4f-b2cc-4973-93d5-cc88cd9d27e1" xlink:to="loc_amci_SAFELiabilityMember_2f6b7e5c-de2c-445f-88e0-a7b8311e27f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SAFEWarrantMember_ec55f8d3-e475-4ec5-8478-6da1eea96bf1" xlink:href="amci-20230213.xsd#amci_SAFEWarrantMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c8ba6a4f-b2cc-4973-93d5-cc88cd9d27e1" xlink:to="loc_amci_SAFEWarrantMember_ec55f8d3-e475-4ec5-8478-6da1eea96bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_c7d8c0e2-203b-405f-9302-b6910f733e62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_58edcd02-4755-412b-a604-1719327fcd1b" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_c7d8c0e2-203b-405f-9302-b6910f733e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_887d655c-6e6b-4021-b2b6-bc8924bd84dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_c7d8c0e2-203b-405f-9302-b6910f733e62" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_887d655c-6e6b-4021-b2b6-bc8924bd84dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_f1c5396b-222c-4621-907d-1afc10024363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_887d655c-6e6b-4021-b2b6-bc8924bd84dd" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_f1c5396b-222c-4621-907d-1afc10024363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_443a89f2-2700-4646-a913-427b123602ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_887d655c-6e6b-4021-b2b6-bc8924bd84dd" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_443a89f2-2700-4646-a913-427b123602ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_feafd0ff-04fe-44af-a49e-1631bf4e259d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_887d655c-6e6b-4021-b2b6-bc8924bd84dd" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_feafd0ff-04fe-44af-a49e-1631bf4e259d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_a92f7d8b-8014-42f1-890b-1a3e011e148a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_887d655c-6e6b-4021-b2b6-bc8924bd84dd" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_a92f7d8b-8014-42f1-890b-1a3e011e148a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/OtherCurrentAssetsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#OtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/OtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_67fd2b60-9343-43dc-9812-b3b2b6fe6ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialsSuppliesAndOther_071b3817-7793-41ac-9a8b-cebead437f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialsSuppliesAndOther"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_67fd2b60-9343-43dc-9812-b3b2b6fe6ce7" xlink:to="loc_us-gaap_MaterialsSuppliesAndOther_071b3817-7793-41ac-9a8b-cebead437f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_ffe52e44-a8af-477e-87ce-96626a319864" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_67fd2b60-9343-43dc-9812-b3b2b6fe6ce7" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_ffe52e44-a8af-477e-87ce-96626a319864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_944d744f-f9d5-4d42-88ed-df7bd314149e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_67fd2b60-9343-43dc-9812-b3b2b6fe6ce7" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_944d744f-f9d5-4d42-88ed-df7bd314149e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_743dcc27-b57e-4411-a3bb-fed88294f764" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_67fd2b60-9343-43dc-9812-b3b2b6fe6ce7" xlink:to="loc_us-gaap_OtherAssetsCurrent_743dcc27-b57e-4411-a3bb-fed88294f764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/PropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#PropertyPlantandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/PropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_94bdd332-f720-4748-abd6-064e75ec92eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79357d81-b22e-4132-97a7-f4b269e83add" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_94bdd332-f720-4748-abd6-064e75ec92eb" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79357d81-b22e-4132-97a7-f4b269e83add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7282c13b-3f99-46d4-85db-99b5d5f945f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79357d81-b22e-4132-97a7-f4b269e83add" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7282c13b-3f99-46d4-85db-99b5d5f945f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0098ac62-85f9-4dd9-91f2-f72017445901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7282c13b-3f99-46d4-85db-99b5d5f945f2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0098ac62-85f9-4dd9-91f2-f72017445901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_00d26591-2283-4746-8276-b57ac73ba551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0098ac62-85f9-4dd9-91f2-f72017445901" xlink:to="loc_us-gaap_LandMember_00d26591-2283-4746-8276-b57ac73ba551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_6a315964-4df8-4e1c-ba65-a76ac060988f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0098ac62-85f9-4dd9-91f2-f72017445901" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_6a315964-4df8-4e1c-ba65-a76ac060988f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_4b2b7330-e297-4a71-a2d6-c60e8868fa64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0098ac62-85f9-4dd9-91f2-f72017445901" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_4b2b7330-e297-4a71-a2d6-c60e8868fa64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AutomobilesMember_ff78be49-35ec-40c8-91cb-a71d090e4df3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AutomobilesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0098ac62-85f9-4dd9-91f2-f72017445901" xlink:to="loc_us-gaap_AutomobilesMember_ff78be49-35ec-40c8-91cb-a71d090e4df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_89ee1bc0-d6cb-4ccf-ba73-625566e72fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0098ac62-85f9-4dd9-91f2-f72017445901" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_89ee1bc0-d6cb-4ccf-ba73-625566e72fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOtherTypesMember_0f6c6914-f7b9-43ec-8024-6fb5bb0a68d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentOtherTypesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0098ac62-85f9-4dd9-91f2-f72017445901" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentOtherTypesMember_0f6c6914-f7b9-43ec-8024-6fb5bb0a68d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_e69340e6-ff4e-464f-8f2c-1d2833289457" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0098ac62-85f9-4dd9-91f2-f72017445901" xlink:to="loc_us-gaap_ConstructionInProgressMember_e69340e6-ff4e-464f-8f2c-1d2833289457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b92be7d1-a870-42e1-95f7-901429f3e39f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79357d81-b22e-4132-97a7-f4b269e83add" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b92be7d1-a870-42e1-95f7-901429f3e39f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_da509181-0a00-45b3-bb24-71b712ab4449" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b92be7d1-a870-42e1-95f7-901429f3e39f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_da509181-0a00-45b3-bb24-71b712ab4449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3e305bc7-3977-4893-a125-4198769d3b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b92be7d1-a870-42e1-95f7-901429f3e39f" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3e305bc7-3977-4893-a125-4198769d3b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_825aa643-c269-4086-a0cf-2015bab92c50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b92be7d1-a870-42e1-95f7-901429f3e39f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_825aa643-c269-4086-a0cf-2015bab92c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/PropertyPlantandEquipmentNarrativeDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#PropertyPlantandEquipmentNarrativeDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/PropertyPlantandEquipmentNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_b3459308-ad39-4eb6-bfb7-14cb331fdb51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_22e733e4-db51-4a77-85ae-a05a2c45b1e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_b3459308-ad39-4eb6-bfb7-14cb331fdb51" xlink:to="loc_us-gaap_Depreciation_22e733e4-db51-4a77-85ae-a05a2c45b1e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/DebtDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#DebtDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/DebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_89b4755c-ba96-4707-a545-19ea74611827" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ab23c67b-d8b2-4540-a1aa-95e9cbb8d325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_89b4755c-ba96-4707-a545-19ea74611827" xlink:to="loc_us-gaap_DebtInstrumentTable_ab23c67b-d8b2-4540-a1aa-95e9cbb8d325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_427955f2-0f0d-43c6-b7c1-25f4e0e0bc92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ab23c67b-d8b2-4540-a1aa-95e9cbb8d325" xlink:to="loc_us-gaap_DebtInstrumentAxis_427955f2-0f0d-43c6-b7c1-25f4e0e0bc92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bf11bfd9-4906-4175-ac9f-1e6ddba612c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_427955f2-0f0d-43c6-b7c1-25f4e0e0bc92" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bf11bfd9-4906-4175-ac9f-1e6ddba612c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WTILoanMember_e6a2597b-f827-494b-9a12-59f318a8a024" xlink:href="amci-20230213.xsd#amci_WTILoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bf11bfd9-4906-4175-ac9f-1e6ddba612c1" xlink:to="loc_amci_WTILoanMember_e6a2597b-f827-494b-9a12-59f318a8a024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PPPLoanMember_ff4dd4a4-47a6-4c69-a99f-faf7dcf3d850" xlink:href="amci-20230213.xsd#amci_PPPLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bf11bfd9-4906-4175-ac9f-1e6ddba612c1" xlink:to="loc_amci_PPPLoanMember_ff4dd4a4-47a6-4c69-a99f-faf7dcf3d850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a9789556-dfe2-4955-8468-20edd3f6e9f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ab23c67b-d8b2-4540-a1aa-95e9cbb8d325" xlink:to="loc_us-gaap_DebtInstrumentLineItems_a9789556-dfe2-4955-8468-20edd3f6e9f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_debcdecf-d874-4607-8e5c-1941059eef03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9789556-dfe2-4955-8468-20edd3f6e9f8" xlink:to="loc_us-gaap_LongTermDebt_debcdecf-d874-4607-8e5c-1941059eef03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_40fc08e2-dd78-4a29-881c-fca74b354f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9789556-dfe2-4955-8468-20edd3f6e9f8" xlink:to="loc_us-gaap_LongTermDebtCurrent_40fc08e2-dd78-4a29-881c-fca74b354f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_efdc4677-b0f7-4091-9d1f-d391ce18815e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a9789556-dfe2-4955-8468-20edd3f6e9f8" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_efdc4677-b0f7-4091-9d1f-d391ce18815e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#DebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8fa1a923-6b34-4249-93ff-98c44b2bb695" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_bdc77ce2-20ae-4a01-bce3-d3994d8c2d00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8fa1a923-6b34-4249-93ff-98c44b2bb695" xlink:to="loc_us-gaap_DebtInstrumentTable_bdc77ce2-20ae-4a01-bce3-d3994d8c2d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_54e2b618-b963-4c8c-8115-b870641ae24d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_bdc77ce2-20ae-4a01-bce3-d3994d8c2d00" xlink:to="loc_us-gaap_DebtInstrumentAxis_54e2b618-b963-4c8c-8115-b870641ae24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5989e1ca-702f-4f09-8004-dc40d71fef57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_54e2b618-b963-4c8c-8115-b870641ae24d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5989e1ca-702f-4f09-8004-dc40d71fef57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_WTILoanMember_c13b8494-dfa9-4520-9865-4940db245845" xlink:href="amci-20230213.xsd#amci_WTILoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5989e1ca-702f-4f09-8004-dc40d71fef57" xlink:to="loc_amci_WTILoanMember_c13b8494-dfa9-4520-9865-4940db245845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_PPPLoanMember_8f6c588f-9275-4f11-938c-67830b6ba418" xlink:href="amci-20230213.xsd#amci_PPPLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5989e1ca-702f-4f09-8004-dc40d71fef57" xlink:to="loc_amci_PPPLoanMember_8f6c588f-9275-4f11-938c-67830b6ba418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_4cd6da2e-aabf-4021-ae8f-99b8183dace3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_bdc77ce2-20ae-4a01-bce3-d3994d8c2d00" xlink:to="loc_us-gaap_VariableRateAxis_4cd6da2e-aabf-4021-ae8f-99b8183dace3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_b237d3e7-a47c-42b6-89bd-dcaec46989fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_4cd6da2e-aabf-4021-ae8f-99b8183dace3" xlink:to="loc_us-gaap_VariableRateDomain_b237d3e7-a47c-42b6-89bd-dcaec46989fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_828914a3-4934-47be-9d50-541a76500c15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrimeRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_b237d3e7-a47c-42b6-89bd-dcaec46989fa" xlink:to="loc_us-gaap_PrimeRateMember_828914a3-4934-47be-9d50-541a76500c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_02e31ac2-e12b-4f79-80ad-7e5218f0bc44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_bdc77ce2-20ae-4a01-bce3-d3994d8c2d00" xlink:to="loc_us-gaap_DebtInstrumentLineItems_02e31ac2-e12b-4f79-80ad-7e5218f0bc44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_a79f4b41-a52a-40d1-bf97-a4886e4344e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02e31ac2-e12b-4f79-80ad-7e5218f0bc44" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_a79f4b41-a52a-40d1-bf97-a4886e4344e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_25990a60-d2b3-4d2f-83ba-7d50f817c6d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02e31ac2-e12b-4f79-80ad-7e5218f0bc44" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_25990a60-d2b3-4d2f-83ba-7d50f817c6d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a4b88278-0d0e-4bd5-a13a-e039417a1618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02e31ac2-e12b-4f79-80ad-7e5218f0bc44" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a4b88278-0d0e-4bd5-a13a-e039417a1618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_4b560b2f-5e57-45eb-9be8-7b3a25f54ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02e31ac2-e12b-4f79-80ad-7e5218f0bc44" xlink:to="loc_us-gaap_DebtInstrumentTerm_4b560b2f-5e57-45eb-9be8-7b3a25f54ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_cde48d2e-9337-42e3-a798-04a06e2258c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02e31ac2-e12b-4f79-80ad-7e5218f0bc44" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_cde48d2e-9337-42e3-a798-04a06e2258c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_b9a73aad-d03f-4746-85ee-72f210ac0367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02e31ac2-e12b-4f79-80ad-7e5218f0bc44" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_b9a73aad-d03f-4746-85ee-72f210ac0367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDecreaseForgiveness_6b5b58a1-c612-42a8-9312-42a2f72af9fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDecreaseForgiveness"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02e31ac2-e12b-4f79-80ad-7e5218f0bc44" xlink:to="loc_us-gaap_DebtInstrumentDecreaseForgiveness_6b5b58a1-c612-42a8-9312-42a2f72af9fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_4a31b029-58b1-41e0-a6a1-addea3ea7a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02e31ac2-e12b-4f79-80ad-7e5218f0bc44" xlink:to="loc_us-gaap_LongTermDebt_4a31b029-58b1-41e0-a6a1-addea3ea7a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SAFEDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#SAFEDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/SAFEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9ccfd2e7-ad17-435a-b315-1a5d255ad3e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_SimpleAgreementForFutureEquityLiability_e0d26a66-7354-4bfb-9920-b846215f6e32" xlink:href="amci-20230213.xsd#amci_SimpleAgreementForFutureEquityLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9ccfd2e7-ad17-435a-b315-1a5d255ad3e1" xlink:to="loc_amci_SimpleAgreementForFutureEquityLiability_e0d26a66-7354-4bfb-9920-b846215f6e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/IncomeTaxesComponentsofLossIncomeDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#IncomeTaxesComponentsofLossIncomeDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/IncomeTaxesComponentsofLossIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a6011711-02d5-4e50-a3ae-e71293dbbda5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeTaxesTable_4f660339-fdb9-4437-a64b-8e5e4d1ad128" xlink:href="amci-20230213.xsd#amci_IncomeTaxesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a6011711-02d5-4e50-a3ae-e71293dbbda5" xlink:to="loc_amci_IncomeTaxesTable_4f660339-fdb9-4437-a64b-8e5e4d1ad128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_f8336f54-b248-4cf0-90f4-69001b277b95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_IncomeTaxesTable_4f660339-fdb9-4437-a64b-8e5e4d1ad128" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_f8336f54-b248-4cf0-90f4-69001b277b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_984bb842-f6da-4b1f-82ab-74238ab2bbe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_f8336f54-b248-4cf0-90f4-69001b277b95" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_984bb842-f6da-4b1f-82ab-74238ab2bbe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_9af69f2b-d862-413c-b532-1642eab77f68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_984bb842-f6da-4b1f-82ab-74238ab2bbe5" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_9af69f2b-d862-413c-b532-1642eab77f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_InlandRevenueNewZealandMember_06300732-8d5f-42dc-ad6d-3b9661356f77" xlink:href="amci-20230213.xsd#amci_InlandRevenueNewZealandMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_984bb842-f6da-4b1f-82ab-74238ab2bbe5" xlink:to="loc_amci_InlandRevenueNewZealandMember_06300732-8d5f-42dc-ad6d-3b9661356f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeTaxesLineItems_fd44bc1e-4839-4b8e-92dd-ba662520b825" xlink:href="amci-20230213.xsd#amci_IncomeTaxesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_IncomeTaxesTable_4f660339-fdb9-4437-a64b-8e5e4d1ad128" xlink:to="loc_amci_IncomeTaxesLineItems_fd44bc1e-4839-4b8e-92dd-ba662520b825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_23fdf7a5-893d-47b8-baf1-bcbaf7c1a62a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_IncomeTaxesLineItems_fd44bc1e-4839-4b8e-92dd-ba662520b825" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_23fdf7a5-893d-47b8-baf1-bcbaf7c1a62a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_fb1e75d9-0f63-4e33-b432-9d2e290cff91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_IncomeTaxesLineItems_fd44bc1e-4839-4b8e-92dd-ba662520b825" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_fb1e75d9-0f63-4e33-b432-9d2e290cff91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_441fe825-8a69-4285-93ed-827b5eb73a66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_IncomeTaxesLineItems_fd44bc1e-4839-4b8e-92dd-ba662520b825" xlink:to="loc_us-gaap_NetIncomeLoss_441fe825-8a69-4285-93ed-827b5eb73a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/IncomeTaxesIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#IncomeTaxesIncomeTaxProvisionDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/IncomeTaxesIncomeTaxProvisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_36c5f934-9739-4418-b8a1-03e77d32b707" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeTaxesTable_c771eb70-b828-4d22-9db0-fb33e5b867c7" xlink:href="amci-20230213.xsd#amci_IncomeTaxesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_36c5f934-9739-4418-b8a1-03e77d32b707" xlink:to="loc_amci_IncomeTaxesTable_c771eb70-b828-4d22-9db0-fb33e5b867c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_b218de76-0484-496b-8fb9-e4c45ac6c773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_IncomeTaxesTable_c771eb70-b828-4d22-9db0-fb33e5b867c7" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_b218de76-0484-496b-8fb9-e4c45ac6c773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_fc9ed223-4d63-4550-809d-3384443d62a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_b218de76-0484-496b-8fb9-e4c45ac6c773" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_fc9ed223-4d63-4550-809d-3384443d62a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_2f1d3edc-a406-49f0-9cb4-e694f6da5c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_fc9ed223-4d63-4550-809d-3384443d62a6" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_2f1d3edc-a406-49f0-9cb4-e694f6da5c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_InlandRevenueNewZealandMember_b44bc324-2a7d-4c4f-be69-663e32c1162c" xlink:href="amci-20230213.xsd#amci_InlandRevenueNewZealandMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_fc9ed223-4d63-4550-809d-3384443d62a6" xlink:to="loc_amci_InlandRevenueNewZealandMember_b44bc324-2a7d-4c4f-be69-663e32c1162c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeTaxesLineItems_92e805ba-1346-4bec-a998-2cef7d9807cb" xlink:href="amci-20230213.xsd#amci_IncomeTaxesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_IncomeTaxesTable_c771eb70-b828-4d22-9db0-fb33e5b867c7" xlink:to="loc_amci_IncomeTaxesLineItems_92e805ba-1346-4bec-a998-2cef7d9807cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_81e9e8d6-edbe-414c-9d1a-bf75186c0f23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_IncomeTaxesLineItems_92e805ba-1346-4bec-a998-2cef7d9807cb" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_81e9e8d6-edbe-414c-9d1a-bf75186c0f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_784e1de0-21e6-4e28-9cbb-e543acd2b537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_81e9e8d6-edbe-414c-9d1a-bf75186c0f23" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_784e1de0-21e6-4e28-9cbb-e543acd2b537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_bc274077-3c96-400b-ab96-3cb3532d863a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_81e9e8d6-edbe-414c-9d1a-bf75186c0f23" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_bc274077-3c96-400b-ab96-3cb3532d863a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_b36aad99-c73a-4457-a794-4d28b882bc21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_81e9e8d6-edbe-414c-9d1a-bf75186c0f23" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_b36aad99-c73a-4457-a794-4d28b882bc21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_09c0a2d5-3294-4aba-a401-0d67d97696e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_IncomeTaxesLineItems_92e805ba-1346-4bec-a998-2cef7d9807cb" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_09c0a2d5-3294-4aba-a401-0d67d97696e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_0ba17cb0-9651-4cb4-a5c6-109944447d82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_09c0a2d5-3294-4aba-a401-0d67d97696e8" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_0ba17cb0-9651-4cb4-a5c6-109944447d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_4c297b9c-1b03-4b9a-aedf-cfc3c9471faf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_09c0a2d5-3294-4aba-a401-0d67d97696e8" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_4c297b9c-1b03-4b9a-aedf-cfc3c9471faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_54db3e58-05ae-4b7e-bce2-012c9e51ecbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_09c0a2d5-3294-4aba-a401-0d67d97696e8" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_54db3e58-05ae-4b7e-bce2-012c9e51ecbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#IncomeTaxesReconciliationDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6fdfafa8-6ae8-4712-a4d0-f274072b4ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_7f8f632b-dadc-447f-bee9-3393dc00881d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6fdfafa8-6ae8-4712-a4d0-f274072b4ebc" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_7f8f632b-dadc-447f-bee9-3393dc00881d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_54bdf45a-ef8e-43b5-a80d-763fadcbf74b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_7f8f632b-dadc-447f-bee9-3393dc00881d" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_54bdf45a-ef8e-43b5-a80d-763fadcbf74b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_70d271df-6238-46d6-8f88-42de2a5486bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_7f8f632b-dadc-447f-bee9-3393dc00881d" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_70d271df-6238-46d6-8f88-42de2a5486bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_b071398f-f4e9-4c91-9eb7-60f34cd14ff5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_7f8f632b-dadc-447f-bee9-3393dc00881d" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_b071398f-f4e9-4c91-9eb7-60f34cd14ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_fc5ff1ce-4d97-425f-b276-445b313a1b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_7f8f632b-dadc-447f-bee9-3393dc00881d" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_fc5ff1ce-4d97-425f-b276-445b313a1b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesAmount_97843bff-6e7e-4418-8bd3-d48779ff764c" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_7f8f632b-dadc-447f-bee9-3393dc00881d" xlink:to="loc_amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesAmount_97843bff-6e7e-4418-8bd3-d48779ff764c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_222cec12-85f5-4e52-8a2a-00fc884ba988" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_7f8f632b-dadc-447f-bee9-3393dc00881d" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_222cec12-85f5-4e52-8a2a-00fc884ba988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationInterestIncomeAmount_45e06706-0a77-49e7-be32-decb6a4a3a3e" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationInterestIncomeAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_7f8f632b-dadc-447f-bee9-3393dc00881d" xlink:to="loc_amci_EffectiveIncomeTaxRateReconciliationInterestIncomeAmount_45e06706-0a77-49e7-be32-decb6a4a3a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentAmount_5942c5c5-bdee-4e16-bedb-ebcc3d258d98" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_7f8f632b-dadc-447f-bee9-3393dc00881d" xlink:to="loc_amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentAmount_5942c5c5-bdee-4e16-bedb-ebcc3d258d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalAmount_0788a151-0d76-46f2-9df3-435b92e82c9d" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_7f8f632b-dadc-447f-bee9-3393dc00881d" xlink:to="loc_amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalAmount_0788a151-0d76-46f2-9df3-435b92e82c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyAmount_d6dfa0cd-0005-4d05-a59b-4d492ffe6e5a" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_7f8f632b-dadc-447f-bee9-3393dc00881d" xlink:to="loc_amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyAmount_d6dfa0cd-0005-4d05-a59b-4d492ffe6e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_358e2a62-90e0-4657-8608-42da766c95e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_7f8f632b-dadc-447f-bee9-3393dc00881d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_358e2a62-90e0-4657-8608-42da766c95e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_ce9c1865-14aa-4b9e-a42d-e65da6dc1ae3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_7f8f632b-dadc-447f-bee9-3393dc00881d" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_ce9c1865-14aa-4b9e-a42d-e65da6dc1ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessAmount_45312d25-0816-48af-a160-f319d3a3a406" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessAmount"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_7f8f632b-dadc-447f-bee9-3393dc00881d" xlink:to="loc_amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessAmount_45312d25-0816-48af-a160-f319d3a3a406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_8db5612b-18e8-4ce2-ae71-202f1f0d7cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_7f8f632b-dadc-447f-bee9-3393dc00881d" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_8db5612b-18e8-4ce2-ae71-202f1f0d7cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6c395d20-aae8-422a-b036-62f9b0067306" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_7f8f632b-dadc-447f-bee9-3393dc00881d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6c395d20-aae8-422a-b036-62f9b0067306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_e7d132fc-4c52-42be-84e7-3136753445a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6fdfafa8-6ae8-4712-a4d0-f274072b4ebc" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_e7d132fc-4c52-42be-84e7-3136753445a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_b27a887f-affb-462b-99ae-d8e36167541e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_e7d132fc-4c52-42be-84e7-3136753445a8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_b27a887f-affb-462b-99ae-d8e36167541e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_b29bd30f-9b8e-4aec-9555-d5a24654f48f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_e7d132fc-4c52-42be-84e7-3136753445a8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_b29bd30f-9b8e-4aec-9555-d5a24654f48f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_61fcb556-03ee-454b-a2e6-dd920aa8065f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_e7d132fc-4c52-42be-84e7-3136753445a8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_61fcb556-03ee-454b-a2e6-dd920aa8065f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_8573f397-8bf4-4eb9-b777-07e9d998e870" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_e7d132fc-4c52-42be-84e7-3136753445a8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_8573f397-8bf4-4eb9-b777-07e9d998e870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesPercent_830dc7f3-a9a4-471e-bc7a-7f1e3711bba9" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesPercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_e7d132fc-4c52-42be-84e7-3136753445a8" xlink:to="loc_amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesPercent_830dc7f3-a9a4-471e-bc7a-7f1e3711bba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_7d8d1618-d532-4567-b506-4099f08fc314" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_e7d132fc-4c52-42be-84e7-3136753445a8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_7d8d1618-d532-4567-b506-4099f08fc314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationInterestIncomePercent_e395125a-971a-4903-90a3-f382d9794821" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationInterestIncomePercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_e7d132fc-4c52-42be-84e7-3136753445a8" xlink:to="loc_amci_EffectiveIncomeTaxRateReconciliationInterestIncomePercent_e395125a-971a-4903-90a3-f382d9794821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentPercent_41b2025d-aa9b-4438-a389-b778036d6bcb" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentPercent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_e7d132fc-4c52-42be-84e7-3136753445a8" xlink:to="loc_amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentPercent_41b2025d-aa9b-4438-a389-b778036d6bcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalPercent_085e7fb6-6992-42f6-915b-1a784e03be62" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalPercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_e7d132fc-4c52-42be-84e7-3136753445a8" xlink:to="loc_amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalPercent_085e7fb6-6992-42f6-915b-1a784e03be62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyPercent_bab89a32-7780-4d4e-bbb5-bf84f23b03e1" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyPercent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_e7d132fc-4c52-42be-84e7-3136753445a8" xlink:to="loc_amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyPercent_bab89a32-7780-4d4e-bbb5-bf84f23b03e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessPercent_e9afce16-ed83-42a0-832a-ae182d665cdc" xlink:href="amci-20230213.xsd#amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessPercent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_e7d132fc-4c52-42be-84e7-3136753445a8" xlink:to="loc_amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessPercent_e9afce16-ed83-42a0-832a-ae182d665cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_2d9cb9a0-1783-4926-94a0-0bf921e82ece" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_e7d132fc-4c52-42be-84e7-3136753445a8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_2d9cb9a0-1783-4926-94a0-0bf921e82ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a88346fc-6edd-4943-9e1e-c528e7ca96c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_e7d132fc-4c52-42be-84e7-3136753445a8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a88346fc-6edd-4943-9e1e-c528e7ca96c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_23468f2a-d997-4c11-8236-2996c3d61382" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_8f986b7d-e13e-4d5e-a6c4-80544b539907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_23468f2a-d997-4c11-8236-2996c3d61382" xlink:to="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_8f986b7d-e13e-4d5e-a6c4-80544b539907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_b56434ae-469c-4e83-a7a0-68ab001af57f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_8f986b7d-e13e-4d5e-a6c4-80544b539907" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_b56434ae-469c-4e83-a7a0-68ab001af57f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_DeferredTaxAssetsLeasingArrangements_6dbf71dc-3516-44a3-a881-92feaf45c04e" xlink:href="amci-20230213.xsd#amci_DeferredTaxAssetsLeasingArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_8f986b7d-e13e-4d5e-a6c4-80544b539907" xlink:to="loc_amci_DeferredTaxAssetsLeasingArrangements_6dbf71dc-3516-44a3-a881-92feaf45c04e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses_5bf9112e-4ad4-4f90-a2fe-7bd32eb8f2d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_8f986b7d-e13e-4d5e-a6c4-80544b539907" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses_5bf9112e-4ad4-4f90-a2fe-7bd32eb8f2d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_7d1ecd17-ca38-4954-b8f4-0ea83a5d9168" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_8f986b7d-e13e-4d5e-a6c4-80544b539907" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_7d1ecd17-ca38-4954-b8f4-0ea83a5d9168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_bfbfb95f-c324-4d98-a821-4139b3b98d10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_8f986b7d-e13e-4d5e-a6c4-80544b539907" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_bfbfb95f-c324-4d98-a821-4139b3b98d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsEquityMethodInvestments_1959be8e-c33b-4787-a635-6093f72b0941" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_8f986b7d-e13e-4d5e-a6c4-80544b539907" xlink:to="loc_us-gaap_DeferredTaxAssetsEquityMethodInvestments_1959be8e-c33b-4787-a635-6093f72b0941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_3f01b3e5-8d11-4992-9b8e-07c449b26a89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_8f986b7d-e13e-4d5e-a6c4-80544b539907" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_3f01b3e5-8d11-4992-9b8e-07c449b26a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_511497ff-3b22-4a42-8097-75cfbbc1f78e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_8f986b7d-e13e-4d5e-a6c4-80544b539907" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_511497ff-3b22-4a42-8097-75cfbbc1f78e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_e86f50f9-10e2-4fb4-b656-7274b13a86bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_8f986b7d-e13e-4d5e-a6c4-80544b539907" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_e86f50f9-10e2-4fb4-b656-7274b13a86bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_e4f746c5-f863-4500-bde2-53b48c1f15ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_8f986b7d-e13e-4d5e-a6c4-80544b539907" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_e4f746c5-f863-4500-bde2-53b48c1f15ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_18949694-1237-4cdd-94d1-bac84f71bbb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_23468f2a-d997-4c11-8236-2996c3d61382" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_18949694-1237-4cdd-94d1-bac84f71bbb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_a10e12e9-e123-4bd8-ad80-946a849827c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_18949694-1237-4cdd-94d1-bac84f71bbb1" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_a10e12e9-e123-4bd8-ad80-946a849827c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_98e43397-1c88-4ac7-a6ab-a24eea8608f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_18949694-1237-4cdd-94d1-bac84f71bbb1" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_98e43397-1c88-4ac7-a6ab-a24eea8608f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_c627013a-b0b3-4069-bb46-1132c697dc01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_18949694-1237-4cdd-94d1-bac84f71bbb1" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_c627013a-b0b3-4069-bb46-1132c697dc01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_275a5335-c49a-44ca-ac80-a72c4e83f7d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_18949694-1237-4cdd-94d1-bac84f71bbb1" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_275a5335-c49a-44ca-ac80-a72c4e83f7d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2fd8d999-0ef3-46a5-bb0f-d06caf3ca973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeTaxesTable_7364abd1-3934-4e33-8754-213aeb5659e5" xlink:href="amci-20230213.xsd#amci_IncomeTaxesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2fd8d999-0ef3-46a5-bb0f-d06caf3ca973" xlink:to="loc_amci_IncomeTaxesTable_7364abd1-3934-4e33-8754-213aeb5659e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_ef3ff305-11ce-4151-b3b9-cbb72befa23f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_IncomeTaxesTable_7364abd1-3934-4e33-8754-213aeb5659e5" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_ef3ff305-11ce-4151-b3b9-cbb72befa23f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_70ff8a18-03be-4d1a-bfa3-ac2edd64ecec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_ef3ff305-11ce-4151-b3b9-cbb72befa23f" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_70ff8a18-03be-4d1a-bfa3-ac2edd64ecec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_3b6579f5-12c7-4fbc-9ea2-fdd21b718ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_70ff8a18-03be-4d1a-bfa3-ac2edd64ecec" xlink:to="loc_us-gaap_ResearchMember_3b6579f5-12c7-4fbc-9ea2-fdd21b718ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_5b1ee23e-d50a-4807-a1b9-4f56add5f210" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_IncomeTaxesTable_7364abd1-3934-4e33-8754-213aeb5659e5" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_5b1ee23e-d50a-4807-a1b9-4f56add5f210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_9622d0cc-4338-48e8-82ae-fb758e5fd56c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_5b1ee23e-d50a-4807-a1b9-4f56add5f210" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_9622d0cc-4338-48e8-82ae-fb758e5fd56c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_f82f69eb-3c60-4d47-bf5c-37e6b97f7f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_9622d0cc-4338-48e8-82ae-fb758e5fd56c" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_f82f69eb-3c60-4d47-bf5c-37e6b97f7f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_InlandRevenueNewZealandMember_442c35d8-f365-4cef-844d-7eb82b3e7bb2" xlink:href="amci-20230213.xsd#amci_InlandRevenueNewZealandMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_9622d0cc-4338-48e8-82ae-fb758e5fd56c" xlink:to="loc_amci_InlandRevenueNewZealandMember_442c35d8-f365-4cef-844d-7eb82b3e7bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_3eb8ce8a-da09-468f-b0e3-98ff72ec88f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_IncomeTaxesTable_7364abd1-3934-4e33-8754-213aeb5659e5" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_3eb8ce8a-da09-468f-b0e3-98ff72ec88f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_291ab73b-da3f-4f7f-a7f1-582580a9781d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_3eb8ce8a-da09-468f-b0e3-98ff72ec88f1" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_291ab73b-da3f-4f7f-a7f1-582580a9781d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_e3dee2d6-fd01-4c62-a40e-0e19450d7e15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_291ab73b-da3f-4f7f-a7f1-582580a9781d" xlink:to="loc_us-gaap_DomesticCountryMember_e3dee2d6-fd01-4c62-a40e-0e19450d7e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_ac24bb4e-e10f-41bb-9cad-918695fbf46a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_291ab73b-da3f-4f7f-a7f1-582580a9781d" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_ac24bb4e-e10f-41bb-9cad-918695fbf46a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_6fe1142d-7747-4cf5-a59a-ae36fc4c4ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_291ab73b-da3f-4f7f-a7f1-582580a9781d" xlink:to="loc_us-gaap_ForeignCountryMember_6fe1142d-7747-4cf5-a59a-ae36fc4c4ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_IncomeTaxesLineItems_8c0bb472-0dd9-4522-9286-6a7f943cdd68" xlink:href="amci-20230213.xsd#amci_IncomeTaxesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_IncomeTaxesTable_7364abd1-3934-4e33-8754-213aeb5659e5" xlink:to="loc_amci_IncomeTaxesLineItems_8c0bb472-0dd9-4522-9286-6a7f943cdd68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_95e7a445-604e-4c91-8fc4-b6f86d5a6a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_IncomeTaxesLineItems_8c0bb472-0dd9-4522-9286-6a7f943cdd68" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_95e7a445-604e-4c91-8fc4-b6f86d5a6a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OperatingLossAndTaxCreditCarryforwards_6c808b1e-323d-47e1-a8e6-9fb7633855a7" xlink:href="amci-20230213.xsd#amci_OperatingLossAndTaxCreditCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_IncomeTaxesLineItems_8c0bb472-0dd9-4522-9286-6a7f943cdd68" xlink:to="loc_amci_OperatingLossAndTaxCreditCarryforwards_6c808b1e-323d-47e1-a8e6-9fb7633855a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_6d07920a-6df4-41bd-8ff2-d3f951bedb4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_IncomeTaxesLineItems_8c0bb472-0dd9-4522-9286-6a7f943cdd68" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_6d07920a-6df4-41bd-8ff2-d3f951bedb4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OperatingLossCarryforwardsSubjectToExpiration_d421f1c9-d846-42d1-ad4e-5694aedb4281" xlink:href="amci-20230213.xsd#amci_OperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_IncomeTaxesLineItems_8c0bb472-0dd9-4522-9286-6a7f943cdd68" xlink:to="loc_amci_OperatingLossCarryforwardsSubjectToExpiration_d421f1c9-d846-42d1-ad4e-5694aedb4281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_OperatingLossCarryforwardsNotSubjectToExpiration_6a0b4b84-0883-4852-9130-6a21e09ca8c5" xlink:href="amci-20230213.xsd#amci_OperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_IncomeTaxesLineItems_8c0bb472-0dd9-4522-9286-6a7f943cdd68" xlink:to="loc_amci_OperatingLossCarryforwardsNotSubjectToExpiration_6a0b4b84-0883-4852-9130-6a21e09ca8c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ba9d9a82-72c3-4261-ab63-e9c6941e58cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_IncomeTaxesLineItems_8c0bb472-0dd9-4522-9286-6a7f943cdd68" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ba9d9a82-72c3-4261-ab63-e9c6941e58cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignEarningsRepatriated_8a839053-6c54-43d4-8675-c64e488707cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignEarningsRepatriated"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_IncomeTaxesLineItems_8c0bb472-0dd9-4522-9286-6a7f943cdd68" xlink:to="loc_us-gaap_ForeignEarningsRepatriated_8a839053-6c54-43d4-8675-c64e488707cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3c781734-e316-47b0-bb44-e1c7748d65cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_IncomeTaxesLineItems_8c0bb472-0dd9-4522-9286-6a7f943cdd68" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3c781734-e316-47b0-bb44-e1c7748d65cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_fdafbb01-113d-46d7-88c1-98c3c6b4d157" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_IncomeTaxesLineItems_8c0bb472-0dd9-4522-9286-6a7f943cdd68" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_fdafbb01-113d-46d7-88c1-98c3c6b4d157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_0af7cae8-8202-4ad5-8485-c0a521a44db2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_amci_IncomeTaxesLineItems_8c0bb472-0dd9-4522-9286-6a7f943cdd68" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_0af7cae8-8202-4ad5-8485-c0a521a44db2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ec6a9232-2cae-4a84-ab6f-4c84776c9e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7797a858-7ab3-4469-be75-e9499410eba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ec6a9232-2cae-4a84-ab6f-4c84776c9e5a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7797a858-7ab3-4469-be75-e9499410eba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3544d690-d641-452a-b8f2-4f35ccf471cd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7797a858-7ab3-4469-be75-e9499410eba8" xlink:to="loc_srt_RangeAxis_3544d690-d641-452a-b8f2-4f35ccf471cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d9792b32-5e99-4faf-bbd7-c4096cca1a31" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3544d690-d641-452a-b8f2-4f35ccf471cd" xlink:to="loc_srt_RangeMember_d9792b32-5e99-4faf-bbd7-c4096cca1a31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_aaf2135c-e170-4e65-9d0e-2a358699224e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d9792b32-5e99-4faf-bbd7-c4096cca1a31" xlink:to="loc_srt_MinimumMember_aaf2135c-e170-4e65-9d0e-2a358699224e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9e74cb6d-d035-4b52-80e2-5f4ad28969cb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d9792b32-5e99-4faf-bbd7-c4096cca1a31" xlink:to="loc_srt_MaximumMember_9e74cb6d-d035-4b52-80e2-5f4ad28969cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b6e18b91-5b68-4bcc-b9cc-523cfdfd073b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7797a858-7ab3-4469-be75-e9499410eba8" xlink:to="loc_us-gaap_AwardTypeAxis_b6e18b91-5b68-4bcc-b9cc-523cfdfd073b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e867f3f6-420e-419c-8aef-e97a90fb89ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_b6e18b91-5b68-4bcc-b9cc-523cfdfd073b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e867f3f6-420e-419c-8aef-e97a90fb89ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_b3604efc-d630-46ae-a6b8-0f1d21571bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e867f3f6-420e-419c-8aef-e97a90fb89ec" xlink:to="loc_us-gaap_EmployeeStockOptionMember_b3604efc-d630-46ae-a6b8-0f1d21571bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_85eb06d6-9369-463c-bd04-09f1c1e42fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e867f3f6-420e-419c-8aef-e97a90fb89ec" xlink:to="loc_us-gaap_RestrictedStockMember_85eb06d6-9369-463c-bd04-09f1c1e42fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e7c355f9-a2e3-4a4c-bb0e-6442a14eeb7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7797a858-7ab3-4469-be75-e9499410eba8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e7c355f9-a2e3-4a4c-bb0e-6442a14eeb7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_NumberOfShareBasedStockSchemes_4bc1442e-34d4-468d-902c-b437b5815652" xlink:href="amci-20230213.xsd#amci_NumberOfShareBasedStockSchemes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e7c355f9-a2e3-4a4c-bb0e-6442a14eeb7f" xlink:to="loc_amci_NumberOfShareBasedStockSchemes_4bc1442e-34d4-468d-902c-b437b5815652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_4bcc7f12-f524-4f3c-ac05-4866158cc5ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e7c355f9-a2e3-4a4c-bb0e-6442a14eeb7f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_4bcc7f12-f524-4f3c-ac05-4866158cc5ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4b1870bf-19bc-40c4-bc2a-60ec5c15ee18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e7c355f9-a2e3-4a4c-bb0e-6442a14eeb7f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4b1870bf-19bc-40c4-bc2a-60ec5c15ee18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_497cd31a-c879-4cb2-b61c-c4a653a02f89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e7c355f9-a2e3-4a4c-bb0e-6442a14eeb7f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_497cd31a-c879-4cb2-b61c-c4a653a02f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_6da0da0b-b1f0-49da-b465-e12e6d7352e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e7c355f9-a2e3-4a4c-bb0e-6442a14eeb7f" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_6da0da0b-b1f0-49da-b465-e12e6d7352e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_59613c3e-d483-4ee1-b333-f61dfd2a4aba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e7c355f9-a2e3-4a4c-bb0e-6442a14eeb7f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_59613c3e-d483-4ee1-b333-f61dfd2a4aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f07c951a-929f-4698-9421-e66a4a9279e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e7c355f9-a2e3-4a4c-bb0e-6442a14eeb7f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f07c951a-929f-4698-9421-e66a4a9279e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5f9c1877-2896-4bd0-83ed-447b2db5fd34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e7c355f9-a2e3-4a4c-bb0e-6442a14eeb7f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5f9c1877-2896-4bd0-83ed-447b2db5fd34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_673f1e21-0c4e-454c-b665-3d58990e0e58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e7c355f9-a2e3-4a4c-bb0e-6442a14eeb7f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_673f1e21-0c4e-454c-b665-3d58990e0e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_2f40502b-ba87-4210-8613-739ba900695c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e7c355f9-a2e3-4a4c-bb0e-6442a14eeb7f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_2f40502b-ba87-4210-8613-739ba900695c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/StockBasedCompensationStockOptionAwardActivityDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#StockBasedCompensationStockOptionAwardActivityDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/StockBasedCompensationStockOptionAwardActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_413b22bc-7e15-4b19-92da-40ad28bce931" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fb0b8c66-d853-4705-9b63-49f5b6bfafe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_413b22bc-7e15-4b19-92da-40ad28bce931" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fb0b8c66-d853-4705-9b63-49f5b6bfafe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6bd5b65b-b44e-4da3-ae30-e6670975a871" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fb0b8c66-d853-4705-9b63-49f5b6bfafe8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6bd5b65b-b44e-4da3-ae30-e6670975a871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f61cd9c5-1df0-4bfe-a7f1-fc48487dbde6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fb0b8c66-d853-4705-9b63-49f5b6bfafe8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f61cd9c5-1df0-4bfe-a7f1-fc48487dbde6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_fc8abd2d-585e-4bb0-a73d-16158f9d5751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fb0b8c66-d853-4705-9b63-49f5b6bfafe8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_fc8abd2d-585e-4bb0-a73d-16158f9d5751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_d423dfc0-5d50-41c4-b42c-ae44d3d9425b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fb0b8c66-d853-4705-9b63-49f5b6bfafe8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_d423dfc0-5d50-41c4-b42c-ae44d3d9425b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1009ad43-5e43-4977-84e9-7efa37463c95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fb0b8c66-d853-4705-9b63-49f5b6bfafe8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1009ad43-5e43-4977-84e9-7efa37463c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_83543413-078d-4295-9520-06e0d3e73b51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_413b22bc-7e15-4b19-92da-40ad28bce931" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_83543413-078d-4295-9520-06e0d3e73b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_3f150d7a-9458-4f61-bfda-da514d86d018" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_413b22bc-7e15-4b19-92da-40ad28bce931" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_3f150d7a-9458-4f61-bfda-da514d86d018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_28098f08-d4cd-4b86-ab73-64f71f131255" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_413b22bc-7e15-4b19-92da-40ad28bce931" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_28098f08-d4cd-4b86-ab73-64f71f131255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_66a276c0-4cdc-41e5-9115-7f0a32c8bc65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_28098f08-d4cd-4b86-ab73-64f71f131255" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_66a276c0-4cdc-41e5-9115-7f0a32c8bc65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_ecf519d9-f1d4-45c3-88cf-6d79f522be86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_28098f08-d4cd-4b86-ab73-64f71f131255" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_ecf519d9-f1d4-45c3-88cf-6d79f522be86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_a7e30b08-c755-4bee-b619-03991d1910a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_28098f08-d4cd-4b86-ab73-64f71f131255" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_a7e30b08-c755-4bee-b619-03991d1910a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_b72bfe43-2f23-41f0-9265-14534bc3d233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_28098f08-d4cd-4b86-ab73-64f71f131255" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_b72bfe43-2f23-41f0-9265-14534bc3d233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_44519568-2303-4ea7-87e6-151a5021718b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_28098f08-d4cd-4b86-ab73-64f71f131255" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_44519568-2303-4ea7-87e6-151a5021718b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_159ba469-76f2-4f4e-af39-51143892034c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_413b22bc-7e15-4b19-92da-40ad28bce931" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_159ba469-76f2-4f4e-af39-51143892034c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_5c460075-9847-453b-a000-63cbffc2940a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_413b22bc-7e15-4b19-92da-40ad28bce931" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_5c460075-9847-453b-a000-63cbffc2940a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_aec0e186-3195-439b-a2e7-a29894ca9aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_413b22bc-7e15-4b19-92da-40ad28bce931" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_aec0e186-3195-439b-a2e7-a29894ca9aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_c391ed57-d637-4109-a113-e54773f6ba85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_aec0e186-3195-439b-a2e7-a29894ca9aeb" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_c391ed57-d637-4109-a113-e54773f6ba85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_4fff3f98-5238-4394-8c4e-71888fc7e120" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_aec0e186-3195-439b-a2e7-a29894ca9aeb" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_4fff3f98-5238-4394-8c4e-71888fc7e120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2a2440a2-42c3-4739-bce1-0ead689241ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_aec0e186-3195-439b-a2e7-a29894ca9aeb" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2a2440a2-42c3-4739-bce1-0ead689241ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_870e7c3a-5ad2-4ed1-bdfc-2acdac675901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_aec0e186-3195-439b-a2e7-a29894ca9aeb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_870e7c3a-5ad2-4ed1-bdfc-2acdac675901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_2aea6601-b358-40f9-9a19-e5b74b4c9d97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_aec0e186-3195-439b-a2e7-a29894ca9aeb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_2aea6601-b358-40f9-9a19-e5b74b4c9d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_90df01b5-bc5c-449c-b5ac-cb5d677d46c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_aec0e186-3195-439b-a2e7-a29894ca9aeb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_90df01b5-bc5c-449c-b5ac-cb5d677d46c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_76cfb61c-82c0-4241-96e5-a4e8a4137a34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_aec0e186-3195-439b-a2e7-a29894ca9aeb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_76cfb61c-82c0-4241-96e5-a4e8a4137a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue_292ff97b-b0f5-4d55-ba7a-ed10aac694c0" xlink:href="amci-20230213.xsd#amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_aec0e186-3195-439b-a2e7-a29894ca9aeb" xlink:to="loc_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue_292ff97b-b0f5-4d55-ba7a-ed10aac694c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue_1aebdb3c-e71a-4c19-8f1b-40c426060d34" xlink:href="amci-20230213.xsd#amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_aec0e186-3195-439b-a2e7-a29894ca9aeb" xlink:to="loc_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue_1aebdb3c-e71a-4c19-8f1b-40c426060d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/StockBasedCompensationFairValueAssumptionsDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#StockBasedCompensationFairValueAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/StockBasedCompensationFairValueAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_179c1fd3-5961-4399-80b8-e337383101f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_98068630-4f10-40ab-b7b7-37cdabafa781" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_179c1fd3-5961-4399-80b8-e337383101f2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_98068630-4f10-40ab-b7b7-37cdabafa781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_952164c8-9e20-4f93-9d1e-aa3013339f08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_98068630-4f10-40ab-b7b7-37cdabafa781" xlink:to="loc_us-gaap_AwardTypeAxis_952164c8-9e20-4f93-9d1e-aa3013339f08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c0023a40-0841-4e2e-88c7-badc24b75d74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_952164c8-9e20-4f93-9d1e-aa3013339f08" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c0023a40-0841-4e2e-88c7-badc24b75d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4d5bfc3f-1512-485e-af3d-5be8ee38b88c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c0023a40-0841-4e2e-88c7-badc24b75d74" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4d5bfc3f-1512-485e-af3d-5be8ee38b88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a30e1f8-8a85-42bc-9275-3f4651e5fc04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_98068630-4f10-40ab-b7b7-37cdabafa781" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a30e1f8-8a85-42bc-9275-3f4651e5fc04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_8a7e9cbb-ee91-40ad-b82b-c01973b5dfc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a30e1f8-8a85-42bc-9275-3f4651e5fc04" xlink:to="loc_us-gaap_SharePrice_8a7e9cbb-ee91-40ad-b82b-c01973b5dfc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_e818dec0-ccf6-4aaf-a8e4-fe1a93532f99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a30e1f8-8a85-42bc-9275-3f4651e5fc04" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_e818dec0-ccf6-4aaf-a8e4-fe1a93532f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_d09bdef3-a3a5-498a-8016-40e31b78e7af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a30e1f8-8a85-42bc-9275-3f4651e5fc04" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_d09bdef3-a3a5-498a-8016-40e31b78e7af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_489512a1-f316-4a30-9c43-6e5e4affcef1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a30e1f8-8a85-42bc-9275-3f4651e5fc04" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_489512a1-f316-4a30-9c43-6e5e4affcef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7ed06be5-2551-40fe-833e-c58afac08c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a30e1f8-8a85-42bc-9275-3f4651e5fc04" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7ed06be5-2551-40fe-833e-c58afac08c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c9714e5a-9166-40cd-aed9-465f49d976f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6a30e1f8-8a85-42bc-9275-3f4651e5fc04" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c9714e5a-9166-40cd-aed9-465f49d976f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/StockBasedCompensationRestrictedStockAwardsActivityDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#StockBasedCompensationRestrictedStockAwardsActivityDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/StockBasedCompensationRestrictedStockAwardsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_71ac1572-37c7-460e-98dd-9ef8629ac708" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_25c928f5-a4f2-4fc3-b2cd-190f8c03f5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_71ac1572-37c7-460e-98dd-9ef8629ac708" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_25c928f5-a4f2-4fc3-b2cd-190f8c03f5c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6505ade0-ce5c-4280-884d-3839ea510256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_25c928f5-a4f2-4fc3-b2cd-190f8c03f5c0" xlink:to="loc_us-gaap_AwardTypeAxis_6505ade0-ce5c-4280-884d-3839ea510256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f276f50-b961-4519-8bea-e3e0df436964" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6505ade0-ce5c-4280-884d-3839ea510256" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f276f50-b961-4519-8bea-e3e0df436964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_db0fc0a1-23d6-4295-94b5-ab8264a7f60d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f276f50-b961-4519-8bea-e3e0df436964" xlink:to="loc_us-gaap_RestrictedStockMember_db0fc0a1-23d6-4295-94b5-ab8264a7f60d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aba192ce-95cb-4310-a787-80c7bc75ea35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_25c928f5-a4f2-4fc3-b2cd-190f8c03f5c0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aba192ce-95cb-4310-a787-80c7bc75ea35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e62ae742-a0da-467a-9e69-663655155a15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aba192ce-95cb-4310-a787-80c7bc75ea35" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e62ae742-a0da-467a-9e69-663655155a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7aae5001-64ac-4115-846d-cf6a570ded79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e62ae742-a0da-467a-9e69-663655155a15" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7aae5001-64ac-4115-846d-cf6a570ded79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_65a46d28-19b3-429b-b40c-a35100f4bbc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e62ae742-a0da-467a-9e69-663655155a15" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_65a46d28-19b3-429b-b40c-a35100f4bbc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_7f2136f5-fd8d-4e99-bf0a-d9f8daf6d8af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e62ae742-a0da-467a-9e69-663655155a15" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_7f2136f5-fd8d-4e99-bf0a-d9f8daf6d8af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c808225b-1b9e-4c24-aec0-5f5302549c63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e62ae742-a0da-467a-9e69-663655155a15" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c808225b-1b9e-4c24-aec0-5f5302549c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4c0477cd-861f-4344-9f49-282e42b6b937" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aba192ce-95cb-4310-a787-80c7bc75ea35" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4c0477cd-861f-4344-9f49-282e42b6b937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_eff902dc-fd44-44d4-99d1-58796518fda4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4c0477cd-861f-4344-9f49-282e42b6b937" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_eff902dc-fd44-44d4-99d1-58796518fda4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e587decf-2a96-47de-94d9-2a052db0ac7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4c0477cd-861f-4344-9f49-282e42b6b937" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e587decf-2a96-47de-94d9-2a052db0ac7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_45a126c5-dcd9-4a73-9a76-81fc75020c04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4c0477cd-861f-4344-9f49-282e42b6b937" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_45a126c5-dcd9-4a73-9a76-81fc75020c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3efb80c4-1e5e-4df7-bdfc-77b33272f0ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4c0477cd-861f-4344-9f49-282e42b6b937" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3efb80c4-1e5e-4df7-bdfc-77b33272f0ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#RelatedPartyTransactionsDetails_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_89482b2a-afd5-4ef2-8c79-a98a9b46334f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d33dd4d6-202f-4116-b889-6d874a02d1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_89482b2a-afd5-4ef2-8c79-a98a9b46334f" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d33dd4d6-202f-4116-b889-6d874a02d1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_dec29975-2310-403a-927d-24ffa7a73e53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d33dd4d6-202f-4116-b889-6d874a02d1fc" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_dec29975-2310-403a-927d-24ffa7a73e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_3b4bfc2d-4be0-4987-9d49-6698a9b11b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_dec29975-2310-403a-927d-24ffa7a73e53" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_3b4bfc2d-4be0-4987-9d49-6698a9b11b3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartyTransitionServicesAgreementMember_c2384b82-0959-462f-90f5-c3d2ff4359f4" xlink:href="amci-20230213.xsd#amci_RelatedPartyTransitionServicesAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_3b4bfc2d-4be0-4987-9d49-6698a9b11b3b" xlink:to="loc_amci_RelatedPartyTransitionServicesAgreementMember_c2384b82-0959-462f-90f5-c3d2ff4359f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartyInvestmentAgreementMember_e474fcef-4953-41bc-a2bb-e078f37e2f79" xlink:href="amci-20230213.xsd#amci_RelatedPartyInvestmentAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_3b4bfc2d-4be0-4987-9d49-6698a9b11b3b" xlink:to="loc_amci_RelatedPartyInvestmentAgreementMember_e474fcef-4953-41bc-a2bb-e078f37e2f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_RelatedPartySupplyAgreementMember_6ef0dbd3-3802-4ff2-95e6-6f22e31097ef" xlink:href="amci-20230213.xsd#amci_RelatedPartySupplyAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_3b4bfc2d-4be0-4987-9d49-6698a9b11b3b" xlink:to="loc_amci_RelatedPartySupplyAgreementMember_6ef0dbd3-3802-4ff2-95e6-6f22e31097ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_740bac47-ef37-4a7f-919a-53fc0e239518" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d33dd4d6-202f-4116-b889-6d874a02d1fc" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_740bac47-ef37-4a7f-919a-53fc0e239518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_64cf256d-bf6c-496e-aed2-1462493ca78c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_740bac47-ef37-4a7f-919a-53fc0e239518" xlink:to="loc_us-gaap_RelatedPartyDomain_64cf256d-bf6c-496e-aed2-1462493ca78c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_8a544c66-9903-4e43-a48b-36e0f02b7aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_64cf256d-bf6c-496e-aed2-1462493ca78c" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_8a544c66-9903-4e43-a48b-36e0f02b7aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_824a3409-b69e-404f-af52-f752060badff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d33dd4d6-202f-4116-b889-6d874a02d1fc" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_824a3409-b69e-404f-af52-f752060badff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_9049c9e0-ba89-4ff1-b3df-164e2427055a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_824a3409-b69e-404f-af52-f752060badff" xlink:to="loc_us-gaap_EquityMethodInvestments_9049c9e0-ba89-4ff1-b3df-164e2427055a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_e8e751e8-4d2d-4360-b4ad-22f561df04da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_824a3409-b69e-404f-af52-f752060badff" xlink:to="loc_us-gaap_AccountsReceivableNet_e8e751e8-4d2d-4360-b4ad-22f561df04da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_15dd20cc-e65a-4c42-9f0f-8d6bc2128d17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_824a3409-b69e-404f-af52-f752060badff" xlink:to="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_15dd20cc-e65a-4c42-9f0f-8d6bc2128d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_2f4650ea-1618-4f3f-92b5-ee22774fdf55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_824a3409-b69e-404f-af52-f752060badff" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_2f4650ea-1618-4f3f-92b5-ee22774fdf55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_2bc805be-554d-4cca-9e16-5b22ce76972f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_824a3409-b69e-404f-af52-f752060badff" xlink:to="loc_us-gaap_RevenueFromRelatedParties_2bc805be-554d-4cca-9e16-5b22ce76972f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_0d89e291-7584-481a-9524-89c4491a81e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_824a3409-b69e-404f-af52-f752060badff" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_0d89e291-7584-481a-9524-89c4491a81e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/ShareholdersEquityDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#ShareholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/ShareholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_03d4d5b3-a34e-43d3-b779-635d9e38691a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_c166dbc9-1f9a-4fec-a03c-5a41e72bec12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_03d4d5b3-a34e-43d3-b779-635d9e38691a" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_c166dbc9-1f9a-4fec-a03c-5a41e72bec12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityNumberOfVotesPerShare_eb90d5b6-d15f-426a-aa90-e5b41a4a45d9" xlink:href="amci-20230213.xsd#amci_TemporaryEquityNumberOfVotesPerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_03d4d5b3-a34e-43d3-b779-635d9e38691a" xlink:to="loc_amci_TemporaryEquityNumberOfVotesPerShare_eb90d5b6-d15f-426a-aa90-e5b41a4a45d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockAuthorizedIssuedandOutstandingSharesIssuePriceandCarryingValueDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#RedeemableConvertiblePreferredStockAuthorizedIssuedandOutstandingSharesIssuePriceandCarryingValueDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockAuthorizedIssuedandOutstandingSharesIssuePriceandCarryingValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_546d4809-8290-42b4-b142-331a3ea5ae3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_c5f1d3db-5337-458a-8a45-524a00b8e3d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_546d4809-8290-42b4-b142-331a3ea5ae3f" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_c5f1d3db-5337-458a-8a45-524a00b8e3d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1379bde6-dd4b-4509-bcd8-fe32533d0f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_c5f1d3db-5337-458a-8a45-524a00b8e3d0" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1379bde6-dd4b-4509-bcd8-fe32533d0f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6b15e8b4-4038-4526-83b3-cff14c53824e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1379bde6-dd4b-4509-bcd8-fe32533d0f6b" xlink:to="loc_us-gaap_ClassOfStockDomain_6b15e8b4-4038-4526-83b3-cff14c53824e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_415a3323-026e-451f-a2f6-eb175bb6a737" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6b15e8b4-4038-4526-83b3-cff14c53824e" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_415a3323-026e-451f-a2f6-eb175bb6a737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_453248fe-b8a7-4e74-81c5-aff4bab3260b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6b15e8b4-4038-4526-83b3-cff14c53824e" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_453248fe-b8a7-4e74-81c5-aff4bab3260b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_a48ca6f1-5302-4616-acde-509bb6c7d45d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6b15e8b4-4038-4526-83b3-cff14c53824e" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_a48ca6f1-5302-4616-acde-509bb6c7d45d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_c98162d1-f61e-4bd5-bb43-c9557e267660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6b15e8b4-4038-4526-83b3-cff14c53824e" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_c98162d1-f61e-4bd5-bb43-c9557e267660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_9bd4d6c9-9133-40df-880e-6b572b99103f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6b15e8b4-4038-4526-83b3-cff14c53824e" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_9bd4d6c9-9133-40df-880e-6b572b99103f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember_22cc61ad-59b7-4a63-974c-e79e9f918c51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6b15e8b4-4038-4526-83b3-cff14c53824e" xlink:to="loc_us-gaap_SeriesFPreferredStockMember_22cc61ad-59b7-4a63-974c-e79e9f918c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_37b93e9f-3eb7-4c10-b574-80547e535ec5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_c5f1d3db-5337-458a-8a45-524a00b8e3d0" xlink:to="loc_srt_RangeAxis_37b93e9f-3eb7-4c10-b574-80547e535ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_afea1b11-06fd-4067-b05a-461a5a5d520d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_37b93e9f-3eb7-4c10-b574-80547e535ec5" xlink:to="loc_srt_RangeMember_afea1b11-06fd-4067-b05a-461a5a5d520d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_28ab2932-0fb4-4c96-bb93-32203ed13797" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_afea1b11-06fd-4067-b05a-461a5a5d520d" xlink:to="loc_srt_MinimumMember_28ab2932-0fb4-4c96-bb93-32203ed13797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e1d05acc-4b7f-42b1-ac62-ca1c655124b3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_afea1b11-06fd-4067-b05a-461a5a5d520d" xlink:to="loc_srt_MaximumMember_e1d05acc-4b7f-42b1-ac62-ca1c655124b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_27c1645f-2bb5-44e8-96c1-b92e7469da72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_c5f1d3db-5337-458a-8a45-524a00b8e3d0" xlink:to="loc_us-gaap_TemporaryEquityLineItems_27c1645f-2bb5-44e8-96c1-b92e7469da72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_a7e0fb6b-8830-4018-b294-c4ad8fde8489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_27c1645f-2bb5-44e8-96c1-b92e7469da72" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_a7e0fb6b-8830-4018-b294-c4ad8fde8489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_3b2241f8-73c1-453a-824f-40aafee40fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_27c1645f-2bb5-44e8-96c1-b92e7469da72" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_3b2241f8-73c1-453a-824f-40aafee40fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_822de676-5dd5-4026-a081-ccc26090f972" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_27c1645f-2bb5-44e8-96c1-b92e7469da72" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_822de676-5dd5-4026-a081-ccc26090f972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityIssuePricePerShare_05f68bd6-6606-45ea-aa84-4620e802015d" xlink:href="amci-20230213.xsd#amci_TemporaryEquityIssuePricePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_27c1645f-2bb5-44e8-96c1-b92e7469da72" xlink:to="loc_amci_TemporaryEquityIssuePricePerShare_05f68bd6-6606-45ea-aa84-4620e802015d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_26d25ffd-5766-45e1-8147-cb47d9f96d90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_27c1645f-2bb5-44e8-96c1-b92e7469da72" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_26d25ffd-5766-45e1-8147-cb47d9f96d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockChangesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#RedeemableConvertiblePreferredStockChangesDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockChangesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_77177a7a-b90f-41bf-9e58-653a625382fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_cd7c3ded-35d2-4042-aea8-efbb7dc24f14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_77177a7a-b90f-41bf-9e58-653a625382fc" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_cd7c3ded-35d2-4042-aea8-efbb7dc24f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1fdf40f2-a0c3-4cea-b1cf-25c6f35a3d71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_cd7c3ded-35d2-4042-aea8-efbb7dc24f14" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1fdf40f2-a0c3-4cea-b1cf-25c6f35a3d71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_827a47ac-32b4-4539-b2ea-59e03bbea104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1fdf40f2-a0c3-4cea-b1cf-25c6f35a3d71" xlink:to="loc_us-gaap_ClassOfStockDomain_827a47ac-32b4-4539-b2ea-59e03bbea104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_0c9cb7e6-ea54-4036-a733-0cf73443db43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_827a47ac-32b4-4539-b2ea-59e03bbea104" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_0c9cb7e6-ea54-4036-a733-0cf73443db43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_a39aacb9-368f-4fb0-9348-9c43e324afc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_827a47ac-32b4-4539-b2ea-59e03bbea104" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_a39aacb9-368f-4fb0-9348-9c43e324afc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_e79ec7f9-1d20-41dd-a0a4-6cbb36de8ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_827a47ac-32b4-4539-b2ea-59e03bbea104" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_e79ec7f9-1d20-41dd-a0a4-6cbb36de8ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_65daf9a2-fe6b-4bb3-8368-ea95e4ee8578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_827a47ac-32b4-4539-b2ea-59e03bbea104" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_65daf9a2-fe6b-4bb3-8368-ea95e4ee8578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_dee5c003-2839-4603-9987-8ddb83c6d373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_827a47ac-32b4-4539-b2ea-59e03bbea104" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_dee5c003-2839-4603-9987-8ddb83c6d373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember_0b8d19a2-f46f-40d7-b02b-233514107916" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_827a47ac-32b4-4539-b2ea-59e03bbea104" xlink:to="loc_us-gaap_SeriesFPreferredStockMember_0b8d19a2-f46f-40d7-b02b-233514107916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_3b25a73c-97de-4b3f-9951-f4765d44a876" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_cd7c3ded-35d2-4042-aea8-efbb7dc24f14" xlink:to="loc_us-gaap_TemporaryEquityLineItems_3b25a73c-97de-4b3f-9951-f4765d44a876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d50fc952-97cc-4f52-8989-1580220b2593" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_3b25a73c-97de-4b3f-9951-f4765d44a876" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d50fc952-97cc-4f52-8989-1580220b2593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_880639c1-da8c-48bf-8a2d-752a96ecc9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d50fc952-97cc-4f52-8989-1580220b2593" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_880639c1-da8c-48bf-8a2d-752a96ecc9d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_d327aeae-37c1-43fe-b59e-064bef766455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d50fc952-97cc-4f52-8989-1580220b2593" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_d327aeae-37c1-43fe-b59e-064bef766455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_23ce97dd-829d-44d4-b344-818b65c89a0f" xlink:href="amci-20230213.xsd#amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d50fc952-97cc-4f52-8989-1580220b2593" xlink:to="loc_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_23ce97dd-829d-44d4-b344-818b65c89a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_b7dbe3d5-8720-495e-85da-e2f1e4577f45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d50fc952-97cc-4f52-8989-1580220b2593" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_b7dbe3d5-8720-495e-85da-e2f1e4577f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_7f241a1c-2c5e-4ec5-af98-49c4da420263" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d50fc952-97cc-4f52-8989-1580220b2593" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_7f241a1c-2c5e-4ec5-af98-49c4da420263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_a5452a53-e5dc-4a6d-ae91-67c3bc632ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d50fc952-97cc-4f52-8989-1580220b2593" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_a5452a53-e5dc-4a6d-ae91-67c3bc632ff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockNarrativeDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#RedeemableConvertiblePreferredStockNarrativeDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_54e64f88-8963-4ebf-bc74-b9bf7924ad09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_c4fc6ede-93e7-4783-8ad6-a07ca24c7291" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_54e64f88-8963-4ebf-bc74-b9bf7924ad09" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_c4fc6ede-93e7-4783-8ad6-a07ca24c7291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b02a24b6-f913-4e62-b006-82f6a85af061" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_c4fc6ede-93e7-4783-8ad6-a07ca24c7291" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b02a24b6-f913-4e62-b006-82f6a85af061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_792a58fa-9b99-485b-a1b3-96af0d7b9846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b02a24b6-f913-4e62-b006-82f6a85af061" xlink:to="loc_us-gaap_ClassOfStockDomain_792a58fa-9b99-485b-a1b3-96af0d7b9846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_45f23bc1-58db-47e7-bdc0-027721dec528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_792a58fa-9b99-485b-a1b3-96af0d7b9846" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_45f23bc1-58db-47e7-bdc0-027721dec528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_9f617756-60e3-4b2b-957e-ad6f4e82c270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_792a58fa-9b99-485b-a1b3-96af0d7b9846" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_9f617756-60e3-4b2b-957e-ad6f4e82c270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesFPreferredStockMember_c8013cc0-0384-4f95-9a33-0150dda4624a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesFPreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_792a58fa-9b99-485b-a1b3-96af0d7b9846" xlink:to="loc_us-gaap_SeriesFPreferredStockMember_c8013cc0-0384-4f95-9a33-0150dda4624a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_318d8ca0-5917-4479-97fc-89d701849593" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_c4fc6ede-93e7-4783-8ad6-a07ca24c7291" xlink:to="loc_us-gaap_TemporaryEquityLineItems_318d8ca0-5917-4479-97fc-89d701849593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_ce0eae0c-6de2-4cb2-93de-95c676a25e2f" xlink:href="amci-20230213.xsd#amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_318d8ca0-5917-4479-97fc-89d701849593" xlink:to="loc_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_ce0eae0c-6de2-4cb2-93de-95c676a25e2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_a22bb5d7-a8e2-42cb-b34e-2c98acc421c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_318d8ca0-5917-4479-97fc-89d701849593" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_a22bb5d7-a8e2-42cb-b34e-2c98acc421c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquityStockIssuedDuringPeriodPricePerShare_3904cb88-d038-4cf1-8d87-f362e067e6ad" xlink:href="amci-20230213.xsd#amci_TemporaryEquityStockIssuedDuringPeriodPricePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_318d8ca0-5917-4479-97fc-89d701849593" xlink:to="loc_amci_TemporaryEquityStockIssuedDuringPeriodPricePerShare_3904cb88-d038-4cf1-8d87-f362e067e6ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_TemporaryEquitySharesConversionOfConvertibleSecurities_344f2d9b-ce75-47e7-8007-a508af60d9aa" xlink:href="amci-20230213.xsd#amci_TemporaryEquitySharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_318d8ca0-5917-4479-97fc-89d701849593" xlink:to="loc_amci_TemporaryEquitySharesConversionOfConvertibleSecurities_344f2d9b-ce75-47e7-8007-a508af60d9aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_9fda3839-7db4-440e-bae9-1182f4aa7320" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_318d8ca0-5917-4479-97fc-89d701849593" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_9fda3839-7db4-440e-bae9-1182f4aa7320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/BenefitPlansDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#BenefitPlansDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/BenefitPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_f0fb7bcf-b5f3-46c4-ad9e-e5a37ea47970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_d346178c-ec15-4e47-86ac-c66426c59381" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_f0fb7bcf-b5f3-46c4-ad9e-e5a37ea47970" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_d346178c-ec15-4e47-86ac-c66426c59381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_9bd9f80a-1bbe-4859-a72c-5531aa025665" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_a3c1a12d-6179-4a79-b1ee-50409934ab1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9bd9f80a-1bbe-4859-a72c-5531aa025665" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_a3c1a12d-6179-4a79-b1ee-50409934ab1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_ba3ff0a2-4680-4ceb-9652-79eed055ce1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9bd9f80a-1bbe-4859-a72c-5531aa025665" xlink:to="loc_us-gaap_OperatingLeaseCost_ba3ff0a2-4680-4ceb-9652-79eed055ce1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_90f48dc5-feb6-4ae2-8862-f7550f930688" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9bd9f80a-1bbe-4859-a72c-5531aa025665" xlink:to="loc_us-gaap_VariableLeaseCost_90f48dc5-feb6-4ae2-8862-f7550f930688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_5b4c16de-9653-448b-97e4-6ea8d9ba9256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9bd9f80a-1bbe-4859-a72c-5531aa025665" xlink:to="loc_us-gaap_LeaseCost_5b4c16de-9653-448b-97e4-6ea8d9ba9256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeaseTermOfContract_074534e5-539a-46b2-b48c-ab1c95261c19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeaseTermOfContract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9bd9f80a-1bbe-4859-a72c-5531aa025665" xlink:to="loc_us-gaap_LessorOperatingLeaseTermOfContract_074534e5-539a-46b2-b48c-ab1c95261c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amci_LesssorOperatingLeaseNumberOfRenewalOptions_aee6770f-ccd2-4218-a5a2-80cbd17a1198" xlink:href="amci-20230213.xsd#amci_LesssorOperatingLeaseNumberOfRenewalOptions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9bd9f80a-1bbe-4859-a72c-5531aa025665" xlink:to="loc_amci_LesssorOperatingLeaseNumberOfRenewalOptions_aee6770f-ccd2-4218-a5a2-80cbd17a1198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeaseRenewalTerm_d1cdeb66-4b93-4ae3-ade8-4e206fa1bca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9bd9f80a-1bbe-4859-a72c-5531aa025665" xlink:to="loc_us-gaap_LessorOperatingLeaseRenewalTerm_d1cdeb66-4b93-4ae3-ade8-4e206fa1bca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_ef072933-9050-420a-ba81-d7663a52ef47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9bd9f80a-1bbe-4859-a72c-5531aa025665" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_ef072933-9050-420a-ba81-d7663a52ef47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/LeasesLeaseMaturitiesDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#LeasesLeaseMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/LeasesLeaseMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d56c62db-7356-4d82-82a6-41907dc3be8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_24477230-1554-4b78-b80b-0a4ecc2f9d46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d56c62db-7356-4d82-82a6-41907dc3be8e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_24477230-1554-4b78-b80b-0a4ecc2f9d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_621fd439-e77f-48d2-bc04-3502226da1d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d56c62db-7356-4d82-82a6-41907dc3be8e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_621fd439-e77f-48d2-bc04-3502226da1d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_054f553c-53c3-4087-819c-d924bb8072a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d56c62db-7356-4d82-82a6-41907dc3be8e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_054f553c-53c3-4087-819c-d924bb8072a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8cdcba73-2164-4594-a24a-8f9ad8dfbb59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d56c62db-7356-4d82-82a6-41907dc3be8e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8cdcba73-2164-4594-a24a-8f9ad8dfbb59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_e67d7d82-b437-4cef-bed0-6a344f5f0fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d56c62db-7356-4d82-82a6-41907dc3be8e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_e67d7d82-b437-4cef-bed0-6a344f5f0fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_b6e987a5-4da4-42f7-a32d-e5ed0bd52751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d56c62db-7356-4d82-82a6-41907dc3be8e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_b6e987a5-4da4-42f7-a32d-e5ed0bd52751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1275062b-07c3-49c4-8be5-e7dd3e1043d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d56c62db-7356-4d82-82a6-41907dc3be8e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1275062b-07c3-49c4-8be5-e7dd3e1043d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_6d880d1c-aef5-4a5f-aefa-fbc2135cb502" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d56c62db-7356-4d82-82a6-41907dc3be8e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_6d880d1c-aef5-4a5f-aefa-fbc2135cb502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_d97dcf80-139a-4b6b-97da-2f32b7580978" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d56c62db-7356-4d82-82a6-41907dc3be8e" xlink:to="loc_us-gaap_OperatingLeaseLiability_d97dcf80-139a-4b6b-97da-2f32b7580978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/LeasesLeaseMaturitiesDetails_1" xlink:type="simple" xlink:href="amci-20230213.xsd#LeasesLeaseMaturitiesDetails_1"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/LeasesLeaseMaturitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/LeasesLessorOperatingLeasePaymentstobeReceivedDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#LeasesLessorOperatingLeasePaymentstobeReceivedDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/LeasesLessorOperatingLeasePaymentstobeReceivedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_79540231-0e1c-4278-83f0-6164663fc639" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_8f0a06fc-37cc-45a4-9140-a344704a63b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_79540231-0e1c-4278-83f0-6164663fc639" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_8f0a06fc-37cc-45a4-9140-a344704a63b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_686c5e42-edb2-472b-a5e5-983cc3536a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_79540231-0e1c-4278-83f0-6164663fc639" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_686c5e42-edb2-472b-a5e5-983cc3536a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_c9f5822d-590a-44eb-b7c6-2eab83dfd1b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_79540231-0e1c-4278-83f0-6164663fc639" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_c9f5822d-590a-44eb-b7c6-2eab83dfd1b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_817c0744-e85e-4ee3-8771-373bedc6c9d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_79540231-0e1c-4278-83f0-6164663fc639" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_817c0744-e85e-4ee3-8771-373bedc6c9d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears_35fa557b-feaa-4c35-b43b-ceaee3ab725e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_79540231-0e1c-4278-83f0-6164663fc639" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears_35fa557b-feaa-4c35-b43b-ceaee3ab725e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter_cfa384ae-5c85-49e2-8c71-c7e1d08da3b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_79540231-0e1c-4278-83f0-6164663fc639" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter_cfa384ae-5c85-49e2-8c71-c7e1d08da3b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_05b8640e-922a-4c87-9f34-9b0680e6ec61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_79540231-0e1c-4278-83f0-6164663fc639" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_05b8640e-922a-4c87-9f34-9b0680e6ec61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/LeasesSupplementalInformationDetails" xlink:type="simple" xlink:href="amci-20230213.xsd#LeasesSupplementalInformationDetails"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/LeasesSupplementalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_df42be96-7a6b-4cff-9d8b-5e4f3e8fbda3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_227bc7b9-35f8-4c57-b162-cb2f67a9f973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_df42be96-7a6b-4cff-9d8b-5e4f3e8fbda3" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_227bc7b9-35f8-4c57-b162-cb2f67a9f973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_5489b7fc-698f-4bc3-8060-2f407da418a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_df42be96-7a6b-4cff-9d8b-5e4f3e8fbda3" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_5489b7fc-698f-4bc3-8060-2f407da418a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://amciacquisitioncorp/role/SubsequentEventsDetails_3" xlink:type="simple" xlink:href="amci-20230213.xsd#SubsequentEventsDetails_3"/>
  <link:presentationLink xlink:role="http://amciacquisitioncorp/role/SubsequentEventsDetails_3" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_e44ea92e-e5ca-4734-ba1d-ae5fee8da946" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationAssetCurrent_5f038fd0-b94b-458b-a357-452b964c6c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationAssetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_e44ea92e-e5ca-4734-ba1d-ae5fee8da946" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationAssetCurrent_5f038fd0-b94b-458b-a357-452b964c6c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>amci-20230213_g1.jpg
<TEXT>
begin 644 amci-20230213_g1.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" !I J@# 2(  A$! Q$!_\0
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MK02<]17XF6G_  ><?"26^6&Z_8+\4)"7PS1>.K)Y /\ <,(_]"K[N_X)X_\
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M'9ZEIFH_%+1+?4-.O[5)H+F%KM0T;QN"K*0<$$8Q7]:2_L$_L.8_Y,X^%O\
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M('_@\9_Y,<^%I_ZK!'_Z9[^OU^K\@?\ @\9_Y,<^%H/_ $6"/_TSW]>ID/\
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M]M!7](OQ ^-/P3^"NE+??%;XL^&?"MFD1"3^(->M[*,*O?=,Z@8^M>(>-/\
M@LY_P2I\!-(GB3]O+X:AK>?R)?L?B*.[V2>G[@/D>XXKV/\ 6;.JM3FH0T[<
MK9R?5,/%6<C^1WXG_"_XD_!KQUJ?PJ^,'@/5/#?B'2;KR=4T+Q!8F"[MI.9
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MYO?^#P#C_@HUX%7_ *H[:_IJ5_7QW"__ "-E_78[\=_ /B'_ ()2-_QLS^
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M]VOXX/\ @E)_RDR^ /\ V5O0?_2Q*_L?]?\ =KTN,?\ >J7^$PR[X9'\9_\
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M#.95_P"&&_BEA<?\7@DV^W_$GL/_ -5?SMQ<PK_USK^B;_@SF4?\,,_%)O\
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M6Q+34K_35:"QU6X@\QO,D6*Y:,2'&-W#8W$<$XR<^O-?V/?MA_\ !,/]A?\
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MC_82\)Q?#[X$_M"W#>&;6/;;^%O$NGQ:I8V*=EA68;[91_<B*K_LUZS\6_\
M@YR_X*W?%70;SPY8_&'P[X0M[R,I-<>$/"D,%PBE-N(YIVE>,]\J00>^.*_0
MGXJ?\&<?[,FNZVVH?!K]KSQSX:T\S;HM/U?1[/5!&/02KY+D?[V:P-#_ .#,
MWX76^I0R^)/V\O$MU9@?OK>Q\$6D,LGTD>9U7\5-?0/-.%ZDO:3@G+OR_P#
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M&\$'@?M_ZY_X;^W_ /DJOKY9WPYC??KPN_-'G_5<91C:+T/QE_:(_:^_:?\
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M'>BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
C "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>amci-20230213_g2.jpg
<TEXT>
begin 644 amci-20230213_g2.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" +#!6H# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^$9TYK_^W/[0\S[3AK8;/(\H;/\ CYZ[V^YTYX][KX"_9^_Y2N?''_L77_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4@Y5>Y\K? W]E7Q9\,_V+O%_PBU34-&G\2:Q8ZO:P75I/,UFK74+1QEV:)7
M!8;L(<#IFN[_ &-?@CKO[/'P$T;P1XCN]/O=5L[BZEDFTN222 B29G7!=$;.
M&&?EZU[=12E6G--/J[@HI'C'[57[+WA[]JCX>+X>UBXDTO4K.4W.F:M"F][2
M4C!RN1O1APRY&< @@@&OFMOV5?VP;K1?^$/N/C]I*^#]GV<W48D_M$Q8VX+_
M &<2'CMY_P"-??=%53Q$Z<>56:\U<'%/4^5])_8DB^'/['OC+X.>#]:%_JOB
M!99Y-4U@F&%[J18D+;8U<QIMA0!1N/'4YK$U#]@^Y\9?LA^!/ACKNOV^D>-?
M",CW=AKFDEYH(K@RR-CY@C,A5UR<*0R@C.,'[#HH^L5=[ZWO\PY4?%GB;]DS
MXT?M%:AX4TGXZ^,O"=QX(\.W*WC6/A.WN%N=7E52H:X:156-BK,"8^ '8!02
M&&E^T=^R+\1/B?\ M3>"?BEX(\3Z'X7MO#>C1VD3WBRR3BXCDNI%7R5CV-"W
MG1HV9 =I? . #]@T4UB:B=U;[NXN1'R3\/\ ]E7XC^*OVDM/^,?QJ\1^'=0U
M+0K4VNB:)X5BG%G#PX#L9@&!!DD;!W$LP^8!0M<?X;_8K^,7PM\9?$^T\ ^-
M_"EKX+^($S->WVKV4\VJV*.TA;R44"-F F=<N^#P=JGFON:BCZS4^7IV#D1\
M6_"?]C+Q[X%_8Q^(?P;U'4O#DVM:W<W$NG7]K<W!MMDBPC$VZ$,I!B;[JMP1
MZ5F_$OPS\8OV5/V(_ VC^#?&&B:+XJ\/70MKYH8UNAJ7GS2"*VM%GMVWR,\L
M?!5#\K<X'/W)5/4-%T_5I[*:^L+6\FL9OM%K)<0J[6\NTKOC)'RMAF&1@X)'
M>G]9DY7FKJ]PY5;0N5\P_"_]F#Q3X)_;:^(_QAOK_1Y?#/B32FL;2UMYI6O$
M<M9G,B&((%_T=^CD\KQUQ]/45A&HX)I=="FKGS'^Q?\ LP^*?V=-7^*%UXDO
M]'O8_%&K)?V0TJ:60QQAIB1)OB3#?O%^[N'!YKE_V:_V']5\ ?"7XM>!/B%?
M:7?V'C:Z=T?1)Y7:&,H0&)DB3#JQ5A@,,J,^E?8E%:O$5&Y/O;\-A<J/AO0_
MV6?VF?"OPSM_A+H?Q5\+Z5X$M9MMMXDLH[RWU^&W\WS/+39A%&<\"3.#MW[>
M*]OU[X<_&/1O&/POM?!/CRV'@'1(8;?Q-%X@?[3J6KA&7=)YKP2,790<GS$Y
M/:O=:*4J\I.[2^[N'*D%>*_#+_D!ZQ_V,FO?^G:[KVJO%?AE_P @/6/^QDU[
M_P!.UW77A/X<_5?J<.)^./H_T/1O"O\ R$)/^N1_F*ZJN5\*_P#(0D_ZY'^8
MKJJX\3_$.O#_  !1117*= 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*/;U?YW][#V-/^5?<<5_PI'X=?\ 0@^%_P#P36W_ ,11_P *1^'7_0@^%_\
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M_A2/PZ_Z$'PO_P"":V_^(H_X4C\.O^A!\+_^":V_^(KM:*/;U?YW][#V-/\
ME7W'%?\ "D?AU_T(/A?_ ,$UM_\ $5U&BZ'IWAS38=.TG3[72]/AW>5:64*P
MQ)EBQVHH &223@=235VBHE4G-6E)LJ-.$7>*2-GPK_R$)/\ KD?YBNJKE?"O
M_(0D_P"N1_F*ZJO%Q/\ $/6P_P  4445RG0%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% '.^+O^73_@?_ ++7/5T/B[_ET_X'
M_P"RUSU>QA_X:/+K?Q&%%%%=!@%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &SX5_Y"$G
M_7(_S%=57*^%?^0A)_UR/\Q755Y.)_B'IX?X HHHKE.@**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .=\7?\ +I_P/_V6N>KH
M?%W_ "Z?\#_]EKGJ]C#_ ,-'EUOXC"BBBN@P"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@#9\*_\ (0D_ZY'^8KJJY7PK_P A"3_KD?YBNJKR<3_$/3P_P!1117*= 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <[XN_Y
M=/\ @?\ [+7/5T/B[_ET_P"!_P#LM<]7L8?^&CRZW\1A111708!1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!L^%?^0A)_P!<C_,5U5<KX5_Y"$G_ %R/\Q755Y.)_B'I
MX?X HHHKE.@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** .=\7?\NG_ __ &6N>KH?%W_+I_P/_P!EKGJ]C#_PT>76_B,****Z
M# **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** -GPK_ ,A"3_KD?YBNJKE?"O\ R$)/^N1_
MF*ZJO)Q/\0]/#_ %%%%<IT!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!G:MI/]J>5^]\KR\_PYSG'O[5G?\ "(_]/?\ Y#_^
MO7145M&M.*LF92I0D[M'._\ "(_]/?\ Y#_^O1_PB/\ T]_^0_\ Z]=%15?6
M*G<GV-/L<[_PB/\ T]_^0_\ Z]'_  B/_3W_ .0__KUT5%'UBIW#V-/L<[_P
MB/\ T]_^0_\ Z]'_  B/_3W_ .0__KUT5%'UBIW#V-/L<[_PB/\ T]_^0_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK."PL;=!'#:VL2QQ1J.BJJ@ #V%6:\D_M#XG_P#0S>$O_"8NO_EC1_:'Q/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *\\KT.O/*]#"?:.+$] HHHKT#A"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "K&F_\A"U_ZZK_ #%5ZL:;_P A"U_ZZK_,5,OA94=T
M=W1117@GLA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>>5Z'7GE>AA/M'%
MB>@4445Z!PA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5
MC3?^0A:_]=5_F*KU8TW_ )"%K_UU7^8J9?"RH[H[NBBBO!/9"BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *\\KT.O/*]#"?:.+$] HHHKT#A"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "K&F_\ (0M?^NJ_S%5ZL:;_
M ,A"U_ZZK_,5,OA94=T=W1117@GLA1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %>>5Z'7GE>AA/M'%B>@4445Z!PA1110 4444 %%%% !1110 45SVE^)I;
M_P ;:_H;0HD6FVMG<)*"=SF8S @CV\H?F:Z&FTXZ,2:>P4444AA1110 4444
M %%%% !5C3?^0A:_]=5_F*KU8TW_ )"%K_UU7^8J9?"RH[H[NBBBO!/9"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ME?\ R91[&7=?>O\ ,/:Q[/[G_D>AT5YY_P +(\5?]$H\2_\ @?I7_P F4?\
M"R/%7_1*/$O_ ('Z5_\ )E'L9=U]Z_S#VL>S^Y_Y'H=%>>?\+(\5?]$H\2_^
M!^E?_)E'_"R/%7_1*/$O_@?I7_R91[&7=?>O\P]K'L_N?^1Z'17GG_"R/%7_
M $2CQ+_X'Z5_\F4?\+(\5?\ 1*/$O_@?I7_R91[&7=?>O\P]K'L_N?\ D>AT
M5YY_PLCQ5_T2CQ+_ .!^E?\ R91_PLCQ5_T2CQ+_ .!^E?\ R91[&7=?>O\
M,/:Q[/[G_D>AT5YY_P +(\5?]$H\2_\ @?I7_P F4?\ "R/%7_1*/$O_ ('Z
M5_\ )E'L9=U]Z_S#VL>S^Y_Y'H=%>>?\+(\5?]$H\2_^!^E?_)E'_"R/%7_1
M*/$O_@?I7_R91[&7=?>O\P]K'L_N?^1Z'17GG_"R/%7_ $2CQ+_X'Z5_\F5G
M>)/C1K?A'P[JFNZK\+_$UMI>F6LM[=S?;=+?RX8T+NVU;LDX52< $G'%-4)M
MV5OO7^8G6BE=W^Y_Y'JE%>>?\+(\5?\ 1*/$O_@?I7_R91_PLCQ5_P!$H\2_
M^!^E?_)E+V,NZ^]?YC]K'L_N?^1Z'17GG_"R/%7_ $2CQ+_X'Z5_\F4?\+(\
M5?\ 1*/$O_@?I7_R91[&7=?>O\P]K'L_N?\ D>AT5YY_PLCQ5_T2CQ+_ .!^
ME?\ R91_PLCQ5_T2CQ+_ .!^E?\ R91[&7=?>O\ ,/:Q[/[G_D>AT5YY_P +
M(\5?]$H\2_\ @?I7_P F4?\ "R/%7_1*/$O_ ('Z5_\ )E'L9=U]Z_S#VL>S
M^Y_Y'H=%>>?\+(\5?]$H\2_^!^E?_)E'_"R/%7_1*/$O_@?I7_R91[&7=?>O
M\P]K'L_N?^1Z'17GG_"R/%7_ $2CQ+_X'Z5_\F4?\+(\5?\ 1*/$O_@?I7_R
M91[&7=?>O\P]K'L_N?\ D>AT5YY_PLCQ5_T2CQ+_ .!^E?\ R91_PLCQ5_T2
MCQ+_ .!^E?\ R91[&7=?>O\ ,/:Q[/[G_D>AT5YY_P +(\5?]$H\2_\ @?I7
M_P F4?\ "R/%7_1*/$O_ ('Z5_\ )E'L9=U]Z_S#VL>S^Y_Y'H=%>>?\+(\5
M?]$H\2_^!^E?_)E'_"R/%7_1*/$O_@?I7_R91[&7=?>O\P]K'L_N?^1Z'17G
MG_"R/%7_ $2CQ+_X'Z5_\F4?\+(\5?\ 1*/$O_@?I7_R91[&7=?>O\P]K'L_
MN?\ D>AT5YY_PLCQ5_T2CQ+_ .!^E?\ R91_PLCQ5_T2CQ+_ .!^E?\ R91[
M&7=?>O\ ,/:Q[/[G_D>AT5YY_P +(\5?]$H\2_\ @?I7_P F4?\ "R/%7_1*
M/$O_ ('Z5_\ )E'L9=U]Z_S#VL>S^Y_Y'H=%>>?\+(\5?]$H\2_^!^E?_)E9
MOB;XU:[X1\-ZMKNI_"WQ+!INEVDU[=2_;=+;9%&A=VPMV2<*I. "?04U0G)V
M5OO7^8G6BE=W^Y_Y'JM%>7?\+4\<?]$8\2_^#;2/_DRC_A:GCC_HC'B7_P &
MVD?_ "93^KS[K_P*/^8>VCV?W/\ R/4:*\N_X6IXX_Z(QXE_\&VD?_)E'_"U
M/''_ $1CQ+_X-M(_^3*/J\^Z_P# H_YA[:/9_<_\CU&BO+O^%J>./^B,>)?_
M  ;:1_\ )E'_  M3QQ_T1CQ+_P"#;2/_ ),H^KS[K_P*/^8>VCV?W/\ R/4:
M*\N_X6IXX_Z(QXE_\&VD?_)E'_"U/''_ $1CQ+_X-M(_^3*/J\^Z_P# H_YA
M[:/9_<_\CU&BO+O^%J>./^B,>)?_  ;:1_\ )E'_  M3QQ_T1CQ+_P"#;2/_
M ),H^KS[K_P*/^8>VCV?W/\ R/4:*\N_X6IXX_Z(QXE_\&VD?_)E'_"U/''_
M $1CQ+_X-M(_^3*/J\^Z_P# H_YA[:/9_<_\CU&BO+O^%J>./^B,>)?_  ;:
M1_\ )E'_  M3QQ_T1CQ+_P"#;2/_ ),H^KS[K_P*/^8>VCV?W/\ R/4:*\N_
MX6IXX_Z(QXE_\&VD?_)E'_"U/''_ $1CQ+_X-M(_^3*/J\^Z_P# H_YA[:/9
M_<_\CU&BO+O^%J>./^B,>)?_  ;:1_\ )E'_  M3QQ_T1CQ+_P"#;2/_ ),H
M^KS[K_P*/^8>VCV?W/\ R/4:*\N_X6IXX_Z(QXE_\&VD?_)E'_"U/''_ $1C
MQ+_X-M(_^3*/J\^Z_P# H_YA[:/9_<_\CU&BO+O^%J>./^B,>)?_  ;:1_\
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MS_\  9?Y'K%%>3_\+7^(/_1$O$/_ (.M)_\ DJC_ (6O\0?^B)>(?_!UI/\
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M7_R91[&7=?>O\P]K'L_N?^1Z'17GG_"R/%7_ $2CQ+_X'Z5_\F4?\+(\5?\
M1*/$O_@?I7_R91[&7=?>O\P]K'L_N?\ D>AT5YY_PLCQ5_T2CQ+_ .!^E?\
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MM.,>C=KF%6JJ46^J1ZQ17 ?\*#^%W_1-_"7_ ((K7_XW1_PH/X7?]$W\)?\
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MO\J^]_\ R)W]%<!_PH/X7?\ 1-_"7_@BM?\ XW1_PH/X7?\ 1-_"7_@BM?\
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MMX65+:Z^R#-TMM<-;B*Y:(<ND+NRX.1P<5+#PB[-R_\  5_\D)5*CZ+[W_\
M(GT917S-X=\8?LN^*+'4+RR\/^$8[2QT8>()9[_PE]C1M/)V_:8S-;()4##:
M3'NPWRG#<5M_#>']GOXL:QJ^D^&O!/ANYU32(;>>_LKWP>;&:W2<,T+,EQ;1
MGYU4L..5*MT929=&"NVY:?W?_MA^TJ=E][_R/?J*\_\ ^%"?"_\ Z)MX1_\
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M_!%:_P#QNCEH_P S^Y?_ "0<U7^5?>__ )$]!KSS]HK_ )-]^)W_ &*^J?\
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MY5][_P#D3T&BO/O^%!_##_HF_A'_ ,$5K_\ &Z/^%!_##_HF_A'_ ,$5K_\
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M@YJO\J^]_P#R)Z!17G__  H3X7_]$V\(_P#@CM?_ (W1_P *$^%__1-O"/\
MX([7_P"-T<M'^9_<O_D@YJO\J^]__(GH%%>?_P#"A/A?_P!$V\(_^".U_P#C
M='_"A/A?_P!$V\(_^".U_P#C='+1_F?W+_Y(.:K_ "K[W_\ (GH%%>?_ /"A
M/A?_ -$V\(_^".U_^-USOPM72_ OB3XEZ/HNC6>F:;#XBB:*TL(TMX8]VE:>
M6VHJX&6))QU))K2-"%12]FVVE?5)=4N[[D2K2IM>T22?G?HWV\CV*BL[2=6_
MM3S?W7E>7C^+.<Y]O:M&N247%V9TQDI*Z"BL76M:GTVZ2*)(V4H&^8'/4CU]
MJ\R^)D=EXY\3?#31]>TK3]5TN;Q#*TMG>6ZS0R;=*U!EW(^5." 1D<$ ]JZJ
M6&E4U;LK-_<KG/4Q"AHM7=+[W8]GHKS[_A0?PP_Z)OX1_P#!%:__ !NC_A0?
MPP_Z)OX1_P#!%:__ !NIY:/\S^Y?_)%<U7^5?>__ )$]!HKS[_A0?PP_Z)OX
M1_\ !%:__&Z/^%!_##_HF_A'_P $5K_\;HY:/\S^Y?\ R0<U7^5?>_\ Y$]!
MHKS[_A0?PP_Z)OX1_P#!%:__ !NC_A0?PP_Z)OX1_P#!%:__ !NCEH_S/[E_
M\D'-5_E7WO\ ^1/0:*\^_P"%!_##_HF_A'_P16O_ ,;H_P"%!_##_HF_A'_P
M16O_ ,;HY:/\S^Y?_)!S5?Y5][_^1/0:*\^_X4'\,/\ HF_A'_P16O\ \;H_
MX4'\,/\ HF_A'_P16O\ \;HY:/\ ,_N7_P D'-5_E7WO_P"1&_M$?\D'^(7_
M & ;W_T2U>AUY\WP"^&#*0?AOX1P?30[4?\ LE'_  H/X8?]$W\(_P#@BM?_
M (W5OV#@H\ST;Z+K;^]Y$?O>9RY5][\_+S/0:*\^_P"%!_##_HF_A'_P16O_
M ,;H_P"%!_##_HF_A'_P16O_ ,;J.6C_ #/[E_\ )%\U7^5?>_\ Y$]!HKS[
M_A0?PP_Z)OX1_P#!%:__ !NC_A0?PP_Z)OX1_P#!%:__ !NCEH_S/[E_\D'-
M5_E7WO\ ^1/0:*\^_P"%!_##_HF_A'_P16O_ ,;H_P"%!_##_HF_A'_P16O_
M ,;HY:/\S^Y?_)!S5?Y5][_^1/0:*\^_X4'\,/\ HF_A'_P16O\ \;H_X4'\
M,/\ HF_A'_P16O\ \;HY:/\ ,_N7_P D'-5_E7WO_P"1/0:*\5\,Z+H_PY^-
M'BVR\,Z%I>AV4_A_1YI+;3[-+>-I/M.I@N5C"@L0%&>N%'I7K6BZA)J5J\LJ
MJK!ROR@XZ _UIUJ'L]4[K3\5?S%2K>TT:L]?P9H44R:800R2L"512QQUX&:R
M?^$JM/\ GG-_WR/\:YXPE+X4;2G&.[-FBO"_@C\$_ASJWP7\ WM]X \+WE[<
M^']/FGN;C1K:2261K:,L[,4RS$DDD\DFNU_X4'\+O^B;^$O_  16O_QNNJI2
MHTYN#D]';X5_\D<\*E6<5+E6OF__ )$[^BN _P"%!_"[_HF_A+_P16O_ ,;H
M_P"%!_"[_HF_A+_P16O_ ,;K/EH_S/\ \!7_ ,D7S5?Y5][_ /D3OZ*X#_A0
M?PN_Z)OX2_\ !%:__&Z/^%!_"[_HF_A+_P $5K_\;HY:/\S_ / 5_P#)!S5?
MY5][_P#D3OZ*X#_A0?PN_P"B;^$O_!%:_P#QNC_A0?PN_P"B;^$O_!%:_P#Q
MNCEH_P S_P# 5_\ )!S5?Y5][_\ D3OZ*X#_ (4'\+O^B;^$O_!%:_\ QNC_
M (4'\+O^B;^$O_!%:_\ QNCEH_S/_P !7_R0<U7^5?>__D3OZ\\^'O\ R4GX
MI?\ 84L__3=;5)_PH/X7?]$W\)?^"*U_^-TQ?@#\,%9R?ASX3(8Y _L*UXX_
MW*TC["*DN9ZKLNZ?\Q$O:R:?*M/-]O0]"HK@/^%!_"[_ *)OX2_\$5K_ /&Z
M/^%!_"[_ *)OX2_\$5K_ /&ZSY:/\S_\!7_R1?-5_E7WO_Y$[^BN _X4'\+O
M^B;^$O\ P16O_P ;H_X4'\+O^B;^$O\ P16O_P ;HY:/\S_\!7_R0<U7^5?>
M_P#Y$[^BN _X4'\+O^B;^$O_  16O_QNC_A0?PN_Z)OX2_\ !%:__&Z.6C_,
M_P#P%?\ R0<U7^5?>_\ Y$[^BN _X4'\+O\ HF_A+_P16O\ \;H_X4'\+O\
MHF_A+_P16O\ \;HY:/\ ,_\ P%?_ "0<U7^5?>__ )$[^BO#_BI\)_ /A#P[
MI>L:/X(\/:3J-KXCT)H[S3])MX9X\ZM:*VUU0$94L.#R"17K4/B2VGFCB6.8
M,[!1D#')QZU4J"Y%4IMM:K:VUO-]Q1K>^X3LGIUOO?R78UJ**@NKR&QC#S/L
M0G:#@GG\*Y4F]$=%[:LGHKRWXZ7&D^(/ EKIMRD-_:W?B#0H9K6XAWQS1MJU
MH&1E8892N00>"#6G_P *#^%W_1./"/\ X(K7_P"-UU*C&,%.HVKM].UO-=SG
M=63FXP2=DNO>_D^QW]%<!_PH/X7?]$X\(_\ @BM?_C='_"@_A=_T3CPC_P""
M*U_^-U/+0_F?_@*_^2'S5OY5][_R._HK@/\ A0?PN_Z)QX1_\$5K_P#&Z/\
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MM]0T4Y8B4HN+6_\ P/\ (.5)W"BBBN4L\N^!'_'GKG_8?U__ -.]U7J]>4?
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M_P!-.G5[%7COA_\ Y*!\4/\ L8(/_33IU>C@MZG^'_VZ)PXO:'K^C/1O"/\
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M:99:!$UO#$4\JU"W+C82Y5Y-I_>MN!5P%"A6?S3PG^QQ_P (OKWA/4O^$O\
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M>^AJ>=_'K_DG]O\ ]C!H7_IVM*OZ;_R$+7_KJO\ ,50^/7_)/[?_ +&#0O\
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MXX\,^(O^$B_M+^Q?A_I_@7[-]A\KSOLLID^U;O,;;NSCR\'']\UTWPW^$/\
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MWQIIO[/MS\';OX@Z#=>%GT.?18KJ'PK/%>IO5@LC.=09&P6R5"#(XR.M5O\
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MK-3^1??_ , ]RHKPW_A2/PZ_Z$'PO_X)K;_XBC_A2/PZ_P"A!\+_ /@FMO\
MXBCZG2_G?_@*_P#D@^LU/Y%]_P#P#W*BO#?^%(_#K_H0?"__ ()K;_XBC_A2
M/PZ_Z$'PO_X)K;_XBCZG2_G?_@*_^2#ZS4_D7W_\ ]RKS6;]G?P5)XOU?Q/!
M'KVF:SJ]Q'=ZA)I/B?5+&*ZE1%16DAAN4C;"J!@KC ]S7+_\*1^'7_0@^%__
M  36W_Q%'_"D?AU_T(/A?_P36W_Q%4L+3CM4?W?_ &POK-3^1??_ /:G2:7^
MS3\-]&U,:A9^'/)O,:D/,^W7+?\ '^P:\X,A'[P@=OE_AVU6NOV5_A=>:3%I
MDWAC?8Q>'?\ A$TB_M"Z&-+\U)?L^1+G[\:'?G?QC=C(K$_X4C\.O^A!\+_^
M":V_^(H_X4C\.O\ H0?"_P#X)K;_ .(JO81_Y^R^[_[87UBI_(OO_P#M3H=8
M_9C^&VN:EK%_=Z!,;K5OLKW;0ZI>0@RVP06\Z*DH$<\8C0+.@60#<-V&8%;C
M]F7X;W.BZ-IC>'I(X=(NKF\M;B#4KN*[\ZX#"Y:2Y6433><&(D$CL)!C<&P,
M<[_PI'X=?]"#X7_\$UM_\11_PI'X=?\ 0@^%_P#P36W_ ,11["/_ #]E]W_V
MP?6)_P B^_\ ^U/4_ 7@/0OACX/TSPMX9L?[-T+3(_)M+3SI)?+3<6QOD9F/
M)/4FM^O#?^%(_#K_ *$'PO\ ^":V_P#B*/\ A2/PZ_Z$'PO_ .":V_\ B*AX
M6DW=U'_X#_\ ;#^LU/Y%]_\ P#W*BO#?^%(_#K_H0?"__@FMO_B*/^%(_#K_
M *$'PO\ ^":V_P#B*7U.E_.__ 5_\D/ZS4_D7W_\ ]RHKPW_ (4C\.O^A!\+
M_P#@FMO_ (BC_A2/PZ_Z$'PO_P"":V_^(H^ITOYW_P" K_Y(/K-3^1??_P
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M"_\ X)K;_P"(H_X4C\.O^A!\+_\ @FMO_B*/J=+^=_\ @*_^2#ZS4_D7W_\
M /<J*\-_X4C\.O\ H0?"_P#X)K;_ .(H_P"%(_#K_H0?"_\ X)K;_P"(H^IT
MOYW_ . K_P"2#ZS4_D7W_P# /<J*\-_X4C\.O^A!\+_^":V_^(H_X4C\.O\
MH0?"_P#X)K;_ .(H^ITOYW_X"O\ Y(/K-3^1??\ \ ]RHKPW_A2/PZ_Z$'PO
M_P"":V_^(H_X4C\.O^A!\+_^":V_^(H^ITOYW_X"O_D@^LU/Y%]__ /<J*\-
M_P"%(_#K_H0?"_\ X)K;_P"(H_X4C\.O^A!\+_\ @FMO_B*/J=+^=_\ @*_^
M2#ZS4_D7W_\  /<J*\-_X4C\.O\ H0?"_P#X)K;_ .(H_P"%(_#K_H0?"_\
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MPO[X8?\ 11_"7_@\M?\ XY244?5Z'9_>O\@]O6[K[G_F+_PO[X8?]%'\)?\
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MPO\ ^":V_P#B*/J=+^=_^ K_ .2#ZS4_D7W_ / /<J*\-_X4C\.O^A!\+_\
M@FMO_B*/^%(_#K_H0?"__@FMO_B*/J=+^=_^ K_Y(/K-3^1??_P#W*BO#?\
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M^%__  36W_Q%'U.E_.__  %?_)!]9J?R+[_^ >Y45X;_ ,*1^'7_ $(/A?\
M\$UM_P#$4?\ "D?AU_T(/A?_ ,$UM_\ $4?4Z7\[_P# 5_\ )!]9J?R+[_\
M@'N5%>&_\*1^'7_0@^%__!-;?_$4?\*1^'7_ $(/A?\ \$UM_P#$4?4Z7\[_
M / 5_P#)!]9J?R+[_P#@'N5%>&_\*1^'7_0@^%__  36W_Q%'_"D?AU_T(/A
M?_P36W_Q%'U.E_.__ 5_\D'UFI_(OO\ ^ ==\>O^2?V__8P:%_Z=K2K^F_\
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M6:G\B^__ (![E17AO_"D?AU_T(/A?_P36W_Q%'_"D?AU_P!"#X7_ /!-;?\
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MH **** "BBB@ HHHH **** "BBB@ HHHH *T?#__ "%[?_@7_H)K.K1\/_\
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M**[#E"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "M'P_\
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MO^73_@?_ ++715SOB[_ET_X'_P"RUPX?^(CKK?PV<]1117L'EA1110 4444
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M_$1ZE7X&<K1117M'DA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M =K8)Z[3Z5/_ ,(_?_\ /#_Q]?\ &CVD.Z%R2[&=16C_ ,(_?_\ /#_Q]?\
M&C_A'[__ )X?^/K_ (T>TA_,A^SGV,ZBM'_A'[__ )X?^/K_ (T?\(_?_P#/
M#_Q]?\:/:0_F0>SGV,ZBM'_A'[__ )X?^/K_ (T?\(_?_P#/#_Q]?\:/:0_F
M0>SGV,ZBM'_A'[__ )X?^/K_ (T?\(_?_P#/#_Q]?\:/:0_F0>SGV+'A7_D(
M2?\ 7(_S%=57/^']+NK&\=YHMB&,J#N!YR/0UT%>9B&I3NCT**:A9G*^*O\
MD(1_]<A_,UC5T?B#2[J^O$>&+>@C"D[@.<GU-9O_  C]_P#\\/\ Q]?\:[J5
M2"@DV<=2$G-M(SJ*T?\ A'[_ /YX?^/K_C1_PC]__P \/_'U_P :U]I#^9&?
MLY]C.HK1_P"$?O\ _GA_X^O^-'_"/W__ #P_\?7_ !H]I#^9![.?8SJ*T?\
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M(3;5BO15C^S;O_GUF_[]G_"C^S;O_GUF_P"_9_PKMYH]SDY7V*]%6/[-N_\
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MG_Y$H^KUOY']S#V]+^=?>CT"BO/_ /A>'AW_ *!WC#_PBM9_^1*/^%X>'?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **;)(L,;.YPB@L3["O/?C5XLCT_X-^/+K
M3]0FM-0@T"_EM[BW+QR12+;R%&5A@JP(!!!X(K:E2E6FHQZNQE4J1IQ<GT/1
M**X#_A2WAW_H(^+O_"SUC_Y*H_X4MX=_Z"/B[_PL]8_^2JOEH?S/_P !7_R1
M'-6_E7WO_([^BN _X4MX=_Z"/B[_ ,+/6/\ Y*H_X4MX=_Z"/B[_ ,+/6/\
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M=-_[&CPY_P"GJRKT.NE2Y:2=EN_T.=QYJC5WLOU/.Q8_%C SK7@P'_L$7?\
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M10 4444 %%%% !1110 4444 5M2_Y!]U_P!<F_D:\0^-W_)&/'W_ &+^H?\
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M[RRLL4=P$3=(S,0J@98US_\ PK+3?^@QXM_\*_5O_DFN9TJ6(E*JI-7;Z?\
M!-U4J44J;BM$NO\ P#VJBO%?^%9:;_T&/%O_ (5^K?\ R31_PK+3?^@QXM_\
M*_5O_DFCZI3_ )W]W_!#ZS/^5??_ , ]JKQVV_99\)VGPK7P+%?ZREG!K3>(
M;/5%N(Q>V5\;DW*31,(]F4D8[0R,,<$-5?\ X5EIO_08\6_^%?JW_P DT?\
M"LM-_P"@QXM_\*_5O_DFKCAXQVF_N_X(OK$_Y%]__ +VH?LXV.HP>'KJ3QKX
MN/BK0K^[U"S\5R7L$U^K7*E)XO+D@:V6%EVJ(D@5%\M2H!R3C:I^Q]X3UJSU
MN&_U_P 57\VL^%(_"-Y>7VIK<W,ELDK2^>998V8SL[MDDE ,!44 "K?_  K+
M3?\ H,>+?_"OU;_Y)H_X5EIO_08\6_\ A7ZM_P#)-5[%+:H_N7^8?6)?R+[_
M /@$&L?L@^#M<7Q4)]2UQ/\ A([O1;V[\N>$;'TR...W$>8C@,(EWYSDD[2O
M:]#^RSX5A\8#5QJ>MG1U\0GQ7'X5-Q%_9D>JE1_I2CRO.SO!E\LRF,2$L$!J
M#_A66F_]!CQ;_P"%?JW_ ,DT?\*RTW_H,>+?_"OU;_Y)H]CT]H_N_P""'UB7
M\B^__@&7IO[&7A;P[X=T;3/#WBCQ5X;O--L=0TL:SIUS;?;+FSO+E[F:"4R6
M[1E1+(61E173 (;.2?,/C-^Q'XC\07VKZ%\/+W2?"_@#6O#^EZ!=V2ZA-!($
MM)7*O*AMYVN2B,-A6:W+'(E,BEMWL?\ PK+3?^@QXM_\*_5O_DFC_A66F_\
M08\6_P#A7ZM_\DUI&'*[^T?W?\$7MY?R+[_^ 5= _9]N!^U5JGQ9U.WTVQL[
M;0(M#TFSLKN6XDG<2.9+R<-$@BD$7EPJBF0%=Q+#@5V_C_X.Z=XX\2:+XFM=
M7U3PIXLTF*:UMM=T,P?:#;2X\RWD2>*6*6,LJ. \9*LH*E26SR7_  K+3?\
MH,>+?_"OU;_Y)H_X5EIO_08\6_\ A7ZM_P#)-9NA%M/G>FFW_!']8G_(OO\
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M%RFG(\L-S$L4]K*D=FD;1.BD9""0;FPXXQ1_X5EIO_08\6_^%?JW_P DT?\
M"LM-_P"@QXM_\*_5O_DFI5"*5E-_^ K_ #']8G_(OO\ ^ 97A[]C/PYX8N;2
M:Q\9>,XVT[0K[PYI&-0@1M)L[GM;ND </$1F.1V9Q@;BP50/<=!TK^PM#T[3
M?MEWJ/V.VCM_ME_+YMQ/L4+YDKX&YVQEFQR237D?_"LM-_Z#'BW_ ,*_5O\
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MDN'N%C2$1B%?GDHC3JRM:VO]V/EY>8N6'G_X$_\ ,^OKSXY6^GZK/IEU\?\
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MTNUT"WM_%$MM:6VE3QZE#,L]V5D%Z+K:,.-PQ "!@9R-U>>>*/$GBGPK\/\
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MNO$FMZW%9W;NOVE;C51:H]FLR;/,2-SY#<$PB7=5NG43WC_X"N]NQ/+#S_\
M G_F?<?]C?%#_H</"/\ X2EU_P#+*L^;5O'GA?Q=X.M-:UKP[J^FZWJ4NG2Q
MV&ASV<T>VQNKE761KR4?>M@I!3D,>17)?L5^-KSQQ\$Q=7O]K2/:ZM?6276J
M:RNLI<+',07M;X*#<VX8LB.Y=AL*EWVACW'Q/NHK;Q9\+)9&VHOB6;)P3_S"
M-2%8QE)U)4I);2Z+L^R%.,814TWNNK[KS/0J*I6^L6=U,L44VZ1N@VD=L^E7
M:\]Q<=&CM34M@KSK6M:\9:M\2M4\/>'M4T/2++3M(L;]Y-3TB:^DEDN)KQ"
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M4K[3HI+_ ,23P32?9KJ6V9VC6P<+N:$L '; (YK0_MKXH?\ 0G^$?_"KNO\
MY6TSX'S)+X*OW4Y5O$>OL#CL=8O*[[</6NVM*%.I*"IK1M?:_P SEI1G4IQF
MYO5+M_D<)_;7Q0_Z$_PC_P"%7=?_ "MH_MKXH?\ 0G^$?_"KNO\ Y6UW>X>M
M&X>M8^UA_P ^U_Y-_F:>SE_S\?X?Y'"?VU\4/^A/\(_^%7=?_*VC^VOBA_T)
M_A'_ ,*NZ_\ E;7=[AZU2UK7M,\-:3=:IJ^H6NE:9:1F6XO;V98884'5G=B%
M4#U)H]I'_GVO_)O\P]G+_GX_P_R.1_MKXH?]"?X1_P#"KNO_ )6T?VU\4/\
MH3_"/_A5W7_RMKN+>ZANK>.>"5)H9%#I)&P964C(((Z@CO3]P]:/:P_Y]K_R
M;_,/9R_Y^/\ #_(X3^VOBA_T)_A'_P *NZ_^5M']M?%#_H3_  C_ .%7=?\
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MY&N%KTL+\+.#$[H****[CC"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ(UKX.^%]0\?^(-0T6[\8>,-+FO=+UF]M9+ZS@M&GMMTOGM.R@L&0R2NZJ5
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MG_\ 0S>$O_"8NO\ Y8UO44:?RK[E_D&O\S^]_P"9@_VA\3_^AF\)?^$Q=?\
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MZ_\ EC6]11I_*ON7^0:_S/[W_F8/]H?$_P#Z&;PE_P"$Q=?_ "QH_M#XG_\
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M')1_Y]K[Y?YAS5?^?C_#_(R?^%@?$7_H3/"__A4W/_RNH_X6!\1?^A,\+_\
MA4W/_P KJUJ*.2C_ ,^U]\O\PYJO_/Q_A_D9/_"P/B+_ -"9X7_\*FY_^5U'
M_"P/B+_T)GA?_P *FY_^5U:U%')1_P"?:^^7^8<U7_GX_P /\C)_X6!\1?\
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M $(5HUG>(/\ D$7'_ ?_ $(5I3^./J14^!G&T445[AXX4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 :/A_P#Y"]O_ ,"_]!-=E7&^
M'_\ D+V__ O_ $$UV5>7BOC7H>CA_@9C>*O^0?'_ -=1_(URM=5XJ_Y!\?\
MUU'\C7*UU8;^&<^(^,****ZCF"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "NA\(_\O?\ P#_V:N>KH?"/_+W_ , _]FKGQ'\-F]'^(CHJ
M\\KT.O/*Y\)]HWQ/0****] X0HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH ]#HHHKY\]L**** "BBB@ HHHH **** "BBB@ HHHH
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M% !1110 4444 %%%% 'H=%%%?/GMA1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 <)XDU*[@^,7@BRCNIH[.XTW59
M)K=9"(Y60VFQF7."5W-@GIN..M=W7GGBC_DN'@#_ +!>L?\ H5E7H=;5/AAZ
M?JS*'Q2]?T04445B:A1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*P2^-E@DT/XN^-=0M+BRAU""_CTC3A9SPR@E#'<'31$[8'**Q9>-P&171_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MW%_X)T)/$=K9:1!HX@NOLVKK,)%>Y\YE,D?G?*XB4':/D'6DM_V$8E^%6O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %<)J7_(0NO\ KJW\S7=U
MPFI?\A"Z_P"NK?S-=V%^)G'B=D5Z***](X HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH [K3?^0?:_P#7)?Y"K-5M-_Y!]K_UR7^0
MJS7@R^)GLQV04445)04444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<)J7_(0NO^NK
M?S-=W7":E_R$+K_KJW\S7=A?B9QXG9%>BBBO2. **** "BBB@ HHHH ****
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M!1114E!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P \/_'U_P :/:0_F0>SGV,ZBM'_ (1^_P#^>'_CZ_XT?\(_?_\ /#_Q]?\
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M?^0?:_\ 7)?Y"K-064;0V<".,.L:J1[@5/7BRW9ZT=D%%%%2,**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
:HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>amci-20230213_g3.jpg
<TEXT>
begin 644 amci-20230213_g3.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ($ ZX# 2(  A$! Q$!_\0
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MV2LRZ=YA\@7&/,V9XW8)YQ[U5*3YG%N]OZ^\RQU*E[*E7IQ4>:]U=O6^ZO\
M9Z>J:U,_IVI3P>E+0<8_SQ70>*?28\+?#;X)^'] 'C+0Y_%&KZU$+IU\UD%G
M&3M&-N,@D-QR>/I6AX$^&/PT\5_%Y[72'37-$N;(W'V*0R(+638YV;OE)P0#
MU-5-1U_X9?&O0/#]QXI\47'A?5M+MA:2)]G,@F4$L"-H( RQ]#4W@#QK\+O
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ML4<AB 5 X'>O1_A_\4_#>C?"CPOIDGB=]%UBTU.>:1[>W\V2!6:7#892I!#
M'J<-ZTWXP^+? 7B7X?ZD]QJFDZ]XM%P#97>F6LEO*4R<M+^[12<=>O)%:*I6
M4TI;7[>9Q5,%ELL+*I2LIN*>L]O=3:6M[WOHT^UT?-'U[4?2CU%(*](^'#)H
MSF@"C&#38'W#^P=_R3KQ!_V%3_Z)CKPC]L/_ )+SK7_7&V_]$K7NW[!W_)._
M$/\ V%3_ .B8Z\)_;$_Y+QK7_7"V_P#1*UXE'_?9^G^1^FYG_P DOA?\2_\
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M\$G&WN.]$*U>:C;KN[;#Q.6Y5AI5?:))P3Y8\_Q:)ZZW3N[):77?<Y1_V/\
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M'W>^\?E6)XX^)6B_$B\L+S5[>XMSIT;0)!;O_P ?$8RR_.5^0[F89P>U&J_
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M?3U=_P!!QQU:"DD]6T[]=$U^3/2-1^,\NMG4H]4T6WO;2[U(:HEOY[H(9AN
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M4F<\5] ?\,9^,/\ GXM_S7_XNC_AC/QCG_7VWYK_ /%T<R[A_JYF_P#T#R/
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M _X8S\8_\][?\U_^+H_X8S\8?\][?\U_^+HYEW#_ %<S?_H'D?/_ .=+7O\
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M=?4_6Z'\Z/S#_5_-?^@>7W'SGC%+7T4/V(O&7_/W;?\ CO\ \72_\,1>,O\
MGZMOS7_XNCZW0_G0UP_FG_0/+[CYSS29]Z^C/^&(O&7_ #]VW_CO_P 71_PQ
M%XR_Y^K;_P =_P#BZ/K=#^9!_J_FO_0/+[CYTS[TF?>OHS_AB+QE_P _5M_X
M[_\ %T?\,1>,O^?JV_-/_BZ/K=#^9!_J_FO_ $#R^X^=.M&<U]%_\,0^,3UN
MK;_QW_XN@_L1>,<_\?5M_P"._P#Q='UNA_.@_L#-?^@>7W'SIMI,]LU]&_\
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MF:?U.A_(A?ZPYK_T$2/H_P#X;L\??] ?PY_X#7'_ ,?H_P"&[/'W_0(\.?\
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MX;RU'_H 6O\ WRW_ ,71_P -XZC_ -"_:_\ ?+?_ !=?*&<<4=*/J5#^4/\
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M_P"B7K\C^:>28*ABH3=:-[-'W7%6:8O+ZM*.&GRIIW_ ^OO^'@FI?]"[:_\
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MRE_X>":E_P!"[:_]\M_\<KY"HH_LC!?\^P_UDS3_ )_/\/\ (^O/^'@FI?\
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M]DD_\7;M?^N3_P J^K?VB_\ DB/C'_KQ;_T(5$?XT/5?F?MO#'_)/5_^W_\
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MOC77]*74;'09I[-EW"0RQID>P9@3^5)X<^"_C3Q9:276E:%-<V\;^6TAECC
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MFUS+>VFONVO97N>2:G\#O'&CZ8VHW>@316BJ&9_.B8J",@E0Q(X]JGL/V?\
MQ_J=G:W5MX=ED@ND62!C<0KYBGH0"X-?2&CZ/?\ @3XI>,/B#K>H1CP;J\$O
MV2;SF87(D=9(0%(P?D5OITK"^*&H-)XE^!YMW>&W.'CC4X"_ZC'':A8FHVDK
M>ORO8<\DPE.$JDW)6:7+=7UDHJ5^79WNM.F[/-= _9@\0ZMX%U36IX9(-1MY
M#'!8>9&#)@9)))P.W>N5U#X!^/=*L)+Z[\/206L<1F9VN(?N $D@;\GH>@S7
MU5XWT*Z\<Z1\2_#VD!;C53?^8(2<':4P#^AKS7]HR^&@_$/X8'4&(L["VM9Y
MXVY4!;AMYQ]%_2E2Q%2<K::_Y7-<;D^#P]%U$I6C97NK-N3B[Z/:VJ7IYGC$
M_P #O'%OHQU63P_.M@(Q*9!+&3L)P#MW;NOM6WXA^"3Z=\//"&MZ?-<7VK:[
M.\!L2BA8V5I!@'U^3OZU]&6D4VD_%&7XGW6JQ)X"-D!Y_FMM*F,Q+'MQC_6,
M..F:R?B7XIF;PO\ #S6/#-W::>UQJ]T]K+>92$AI;C[V ?O9].]+ZS4E**7]
M:/1@\EPE*G4E)O1:)V;MS17/&UM&FTKW]3YE\5?"#Q?X)TW[?K6BR65GYGE>
M:98W ;!."%8D<*>OI7'X&*^N_C%H$T?PIUK5?$-J/"^J3W"[8]+O6^R:G,5<
MM(8PJ@EL%LD'[QKY$[UV4*KJQNSYK-L## 5E"G>S5]=_GHK?=]XF,5V'P=&/
MBWX(_P"PY8_^E"5R KKO@\?^+N>"/^PY8_\ H]*VJ:0?H>?@_P#>:?\ B7YG
MZ2?$\?\ %M?%O_8(N_\ T2]?DA7ZX?$__DFGBW_L$7?_ *)>OR.'6JX<_AU/
M5'Z9QM_&H>C_ #08_.@#)  )/M2$UUGPJL(M3^(6B6TT8EBDN K(1D$8-?6S
MER1<NQ^<4X>TFH+J[%/Q!X$U[PM:VUQJFGO:0W&?+=G5@V,>A..HZU@;:]BU
M2\N-=T#XE>;.9H8KZ&9 Y+ $F7)&>F<#\J\='(K*C.4T^;=?Y7-\32C3DN39
M]_)M?H+2=.M!Y'%'Z5T'( Z5[5\+/@%IGB3P?/XO\9>(1X7\-AQ%%<*ADDD?
MK]T*>.*\5_G7U5X @MOV@_@-#X LKZ&Q\5:3*MQ;V\^0D\:+M&3VZC)P:\W'
M5)TZ:<7975WV7<]S*:%.O6E&<>:23<8O12?;I]W4\_\ BC\ =.\.:3I6L^#O
M$L/B?2]081Q(P*7#,=N,)M QAAU(KF[S]GKX@:=%%-=^'988))4A\SSXF 9B
M  <.<<L.OK7MFG_!7P/\*_$_@BRUCQ1/9^-3<Q/>0V$S!1EE&0^05 (?! Y]
ML5[1?Z/?:1\,OBA;W6EVFG*UK<RPM 0\US'Y!Q-*^T%R<$9.3\M>0\RG148P
M?,GU:M?6VG?U/HHY'3Q$JDZD>1I;1=TFHWUNG:^UF]/,^4OBC^RUXE\%:SI-
MEI%M)K27MM&YD$D:XF9V!C + X "G)&.3SQ7'ZK\$O%OA:\TH>(=(ETNROKN
M.U%P)8Y!EFV_PL>>OY5]@^(/A]+XB^-?ACQ<TTT.AC0DLX;JUN&A9I\S80LO
M(!WJ#]:H?$W3[NR^"]A97=A8Z==67B*W$]KIZ@)$&NE9"V%&6971B<<EZFEF
M=7]W!M-NU^^M_/IZ%U\BP_[VK%2BHW:UNFE;RZW=M>G4^<OC#^SEK7P[U+59
M]*M[K5/#FGK%YNI2&-2K.H."H.>IQTK1^#'[*WB'XD7]G-J\4VBZ#=VWVF&_
M5XV,JD*5VKDGD,#R!7T-=^+[>_\ V@/$OP\U8@Z9K]G"8]QS^^1(F"A3Q]U7
M/X4G@7Q;;#]J$^&;:<1:7H>CMIEG; ;55HV1&  X_@'Y5#Q^*]@XJW-R\U_*
MWYW_ .&-8Y/E_P!;4VWR.?)RW^U=_.W+;SUW/F;4/@/=:+X4\0W]_INN?;-,
MF:-);9;5[0*,X\QO-W@\'[JFN?N?@-X]M-$;5IO#LZV"Q^:THEB)"X/.T-N[
M'MVKZH\*>'[GX;_!_P <1^(8!"L>JFYD7&[,6#SCOT-9?Q*\):[K6O>+/B!H
M_C8Z%X:O],#6FHP7$BI<$"3;$6!!49[\_>/%=$,QJ<[BVK7WUL]M%;O?S.2K
MDM#V49J,KVU2:NM9:NZV5DNGJ?,OP8^'EO\ $_XBZ=X;N[N6PAN1(6FA4,R[
M4+< _2O;KG]D[P;K$>KV/A;QQ<ZCK^GQ-,]K>6C0Q@*1NR^S\L9YQ7G_ .R2
M2/CWHI9_,;;<$OG.X^6W.>]=!\7/VJ?B!<ZMKWAU-2AM-/69H0]K#Y4P4$<;
MU.>>A]1D5T8EXJ>*]GAY622?3N_)W^]''@5E]' >UQD.9N32T=]$NO,DM7O9
M^AYUJGP \>Z1IC:C<Z Z6 4.+C[1%AE) ! W9.<CM37^ 7C^/2#J9\-SBR$7
MG>9YT6=G'S;=^[N.U>U_''7$TVV^#ES?RL]I'ID,LH8[@3L^\<]^3S7JNI(\
MWQB7XIQZS$/ BZ3L:]65MK#*,4Q[@ _\!K&685XPC)I:WZ/H[);[O^D;QR;"
M5*LX1<O=<4]5HI*[D]-H_P!-'Q]X+^!OC#QM!!>V.C32:6\HC:Y\R-,>N S
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M8C_M_P#])/S. )8 =<\"O9O"?A>T^$FF1^*_%,,<^HR(6T[2),;A(.5D?J0
M<=O7FO+?#.NOX9UNUU*.W@NI+=@ZQW"[DSD'D?A3?$/B+4/%&J3:AJ5RUQ<R
MG+,3QGV%?63BY^[T/S##5:>'7M;7GT[+S??R7WEB_P#%NJZCXC;7);R4ZB)
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M?<<\<IQ.(4,%&JFE:25G9<ZOO;MW?H?(4OA_48='BU5[*=-,D<QI=F,B-F]
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M72NX,Y \8QS]:.0!^/-=G=?"_5?[3EM;-9+B.**&5IYX6@4-(@=4YSSC./4
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M#I2YXWY;ZC6%K.#J<ONK5MZ;_G\CAL8Z_K0/R[^U)0.:LY1>>_2DS@48YHH
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M:%M@RX!VC]YU^8?G6#C1;NVOP/5IULR4;*$G;K:5]V]UKU.LO?%OAJZ^*?\
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M-FWMP2^0_KQMY]$TSXU:'H$Z$>;=1RW<SR^7'RD<ENZ C)'(9AGVSUK!\1?
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M"TEZ>=K^E_P/;UTO3D^'\6L3V"75U%HEK)"DY+)$SW$ZG:IX P!QTXK7\5^
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M7U9@\?0Y+0ARRNG>R[)6^;U/I*70+/Q7>>(9M4B\V.#4V=;=3Y:2[+ .N5&
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MUM/%;C=,5DW2,%4*@4AN2.XKF=##<K][3;\?^"=JQ6-]HDX^\_>_!=%Y(W-
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M+O\ @Y_T%=)_\ '_ /C=? -)Q3]FNX_]>,;_ ,^:?W/_ .2/O_\ X7=\'/\
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MKX+_ /08TG_P7O\ _&Z_.L^U!&11_9U/^9A_KGB_^?-/[G_F?HI_POOX+?\
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MXFR?QHY]_P J/JD_^?LOO#_6##_] -+_ ,!/MC_A5'[.W:[C_P#!C<?XTO\
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M\+>_9V_YZ>&?_!-_]IK\Z.U'?VI_V'2_Y^R^]?Y!_K9B/^?%/[G_ )GZ,?\
M"WOV=O\ GKX9_P#!+_\ ::/^%N_L[_\ /3PS_P""4_\ QFOSHHI?V'2_Y^2^
M]?Y!_K9B/^?%/[G_ )GZ+_\ "W?V=_\ GIX9_P#!*?\ XS1_PMW]G?\ YZ>&
M?_!*?_C-?G111_8=+_G[+[U_D'^MF(_Y\4_N?^9^BQ^+O[.Y_P"6OAG_ ,$O
M_P!IKI_ 'C[X1Z[>7<?A-]&:XCC#3_8].\EMN>,GRQD9K\P>]?0?['?_ ",W
MB'_KTC_]#KDQ>3TZ-"515).WG_P#T,OXFKXG%0I2HP2?9.^WJ>:9]J =WM2]
M:",8KY(_' X')X'K2,0&P,G%=-X TB'5-;\V\A\_3[*-[BX1NA"HQ4'ZL *?
M?>,;9[J0VWA_2D@+'RU,+$@9[G=5)=3T:>%@Z2JU9\MWHK;VZG,<%0=V3Z4T
M'GTKU"RGLK3P;<ZQK?A[3TCN<0V"11,C.Y))?ECD *?S%>7X^;. /84FK;BQ
M6%CAE&TK\ROM:W;[Q3WHHXI",4CS]Q:,X'/'UK[C^"B^)'^ .ACPO)9QZE\^
M#?1EX\>:<\!AVSWK AN_%Q_:"\,6OBV33Y+A+.Z:(Z?&47'D/URS<\U"E=L^
M[?#%J-"K[5_O.3['NKG:Z\W3TU\CX[![8/-'^<5]01?L\:5,+_7-?M]9U235
M-5G2&#1(68VZEY"'DPK<?*/3[PKG[7]G#3_##^)]4\67T[Z'HS$+%9#;-,"Q
MVMN.0O"],=_:G='FSX;Q\+-Q5GUOLK7O+MIKU^\^?P.?44'[P[^PKZB^#OAG
MX=V'Q@M(]&O+G5I)+475GF566V(SE7('+#Y?3'<<UEZM\-?AM;^%+WQA?-JX
MM3?21+;QSKN?[F #LXY<YX/%%REP]6E1]JJL-Y7UT2C;6_S_ "[V/G$#/THK
MWRV^%O@#P_I6CS^)Y-6%UKL^;*&UE4""%FVIYA*'<<JQSQU%=]X4^'X^'G@?
MX@:)=3&YL_M$#K,OREX7\AO?D!L9]J+CP_#F(JNTY)*S;MJU[KDDUI:Z7^9\
MBT<BOH _L]Z7/\4[73X9+Q/"TFF+J;S2,-XC*)QOVXSN<=N@K9TSX%>!E\+6
MNO36WB/6;&]F8QMHQ\]H(CR@=5C;) .">.>U%T9T^',=-R6BY6UJ^UM?35:G
MS,!DXY_K28^E?0/P[\*V^O?"3Q396FKS0V<VJ0P1RR )&5;< [H>1],TSXN?
M!GPG\/-'>%EUVVOUA22+57@,UC.YSF/(4!3P.K'&>E%];&<LBQ"PRQ46N6UW
M=I=7HM7?;?1'@6/P]J",T'@\<@<"C/X51\V% Z44@.* 0M(M+29YH&&>U*/N
MBDQS2^U CVG]DC_DK5I_UR?^5?5O[1?_ "1'QC_UXM_Z$*^4OV21CXMVG_7)
M_P"5?5O[1?\ R1'QC_UXG^8J8_QH>J_,_;>&/^2>K_\ ;_\ Z2?F:U.I,4 >
M]?8'Y"+33UI<'MS4Z:?<R6S7*P2-;J<&4(=H^IZ4!9O8@QD?X4<$U8TVT>^O
M[:WCC:22614"+U8D]*]]\?\ _"-^%_!\NBZH;.:Z2RA2UT^V'^D6MUY8WM(=
MQ[[\C:.364Y\C2M>YW8?".O"=1RLH]^_;\#YZ'3_ !XHSGIU]*,9&.*,>O2M
MC@ X]:,8'/-?HAH:>/7^'?A$^#I]*BA^PCS_ .T8&D);)QC#KQBO']1^'!^)
M/COQE+\1[I8KW1+)91+I'[J/ 7<25;=G@^M>;#&*3=UMYZ[VVL?9XCAN=*%/
MV<VW.UKQM'X>;XN9]/(^4, G^M(<DXZ9[5[YXJ^%G@'3O"/ACQCIDNJSZ!=W
M+VUY \J^<^TR+NC.WC+(#C!ZUW-W\!/A18Z+X4O;UM=LF\12QK;V\EXA=5>,
MN&8>6"!@#/'5A6SQ4(I:/_ACSX9%B:DI14XZ)/?2TK6>W6]CY*)SSP/:@<YK
MZ.L_V>O#>C^*_'Z^(I;Z'P]H"(]LZ2B-Y=WF%1N*X)Q'V'>NDF_9Q^'3^)-*
M\-1SZQ%K.JZ>;J"1IU:.)@.K#8,@Y'&1TI/%4UW_ *U'#A_&35_=3O:S>M[N
M/XM-(^3<9QQCOS000>>E?2=W^S?X<\1>&Y&\*W]XVK66K1Z3>2W9!B=F:(%U
M4 8 $F<9/2KWB[]F3P_9^'/$,>F6OB&UU?1K07#ZA?PL+*Y( 9Q&=@!^7=T8
MT_K=/87^K^-LY)*R5]]]]%YJS/EXT?K7M7[(ZM_PM^T\O'F>5)MSTSM.*^F/
MB)'K:^#/%!^(T^CR>&]N;);:,QR^9Y@V9)<Y.W/ 'K45<5[*HJ=OQ-\!D?U[
M!RQ7M'&S?V;I65]7S*WW,_/TJ/;CKB@\#_"OIWX-_LV>&_B#X:AENHM?6[DB
M$QU&2!K6V^8 J$#J?-&"?F5L'@]ZZ1/#'@7P[\"$D-G>;Y+Z**:>)P'DN5 V
MD_*?D!8\>YYIRQ<$^5*[O8FEP_B)TE6J3C&+BY+7M;3\5Y'Q\!S0/UK[G^-'
M@?P?\1/B-X=T'5Y-0BUN]T@)8R6[@11X,A4N"IW?-GC(Z5P\/[*'AW4W\)G3
M[F]:&YN9X=2=IE("QA_N?+\N2HZYJ8XR#BG)6-ZW#.*C5E3H24TG;L^G36WQ
M+Y'RB /K2#KZX].]?4NO?LO^&_"VI^*KC4;C43HMDL(L?L[!YBTAB7D!?GYD
M;@8[5;O/V6O#6H?#^XUBP@UW2KJ *0VK_NVDPP5SY)167/)!)-5];I63[G/_
M *NXZ\HV5XINU];)M7_!V/D_':CWQ7T<_P"S9I.H_%#P]I]A+>)X5U#34U*2
M>5P7"%5)4/M !^<=JW]"_9V\ 7G@MO%#1:_K5C-<'RX](<2S11$ C*+&Q8@'
MGI5/%4TDR*>08RI*4=%:^[[6N_35'RG15[7X+*UUF\BTZ66XL4D(ADGCV.5_
MVAV-4>U=:U/G9+E;3/M[]@[_ ))WX@_["I_]$QUX3^V'Q\>-:_ZXVW_HE:]V
M_8-Y^'?B#_L*G_T3'7A7[8?_ "7C6O\ KC;?^B5KQ:/^^S]/\C]+S/\ Y)?"
M_P")?^W'BN<4$]O6C-!&5->V?F0<?3-:MGX3UC4+99[;3+F>%_NO'$2#]*W?
MA1\-[SXI^,[70[5UA#GS)Y6Z)$"-Q_+-=]\0?V@/$&AZ^=&\&ZI-H_A_38UM
MK>&$CYR"2S'W+,?R%82F^;DAJSU*&%I^Q>(Q+<87LK)-M]=VM$M_5'CFI:+?
MZ,56^LY;1G^Z)4*Y^F:I8R<8KZ$\*^)]5_:*\&:EX-UBZ:\\26S&_P!.O9C]
MX+@M&1_N^9C\*\"OK*;3KV>UG0I-!(T;H1]UE."/SS3IS<FXRW1&*PL:,85:
M+<J<MFU;5;I[ZK\FB#%')[49KZF_8D74FT_XA#2&A34O*L_L[7"[D#_Z1C(!
M&1G'>E6J^Q@YVV+RW!?VCBX8;FMS7UM?9-[77:VY\L@CM^%+P1_(U]Q?&[3_
M !%/\)GE\;V]E?ZI'>H+2;2[=E6 'JS?,V.@.?:N0^)/PEM?&WQ4M?[4U*[.
MDZ7X8BOKMW8&4H))_D0XP/N^AZUS0Q<9*[7?SV/:Q'#M6E-TZ<KOW=UROWK[
MZNUK7ZZ=CY+.0>^:.,GO]:^C_#_PO\+:FND>,_ TU]]AT_48[:]M+]Q)(K%\
M!@0!Q\Z'&.YKO/CM\+]'USQ_XC\7^*;JXA\.Z7!;H\%G@32L40#:2#CD^AJG
MBHJ7+;_A^UOF81R"O*C*JI+1KT<6F^;F[+E=]#XTP,48_P#K"OI"X_9CTKQ'
M<^&-6\,ZG,OAO60K/'>8,T"[<GD8!/7L*GC^"WPTU[2O'-SH=YJS3>'X3B">
M9<[P'PQ.WE3LZ<?6J^M4^G]=-3'^PL9=IV7;7XDES7CWT/F@\DXI<<U]E?%+
MX0IX[U[P^E[J]V-+T^R:]O6E(>0Q+\S)'@#!(4@'G''%>*^)/ WP[O;G0)_#
M>L:@T5Y,(KC20@N[P8<AB F",C&!M_G1#$QG8>+R2OAI23DK+:[2;VO97>U[
M;GCW>C'Z5]8>*/V:M T'P99>+-(AU;3;FWO+9S;:LXWNAGC3E-BE#R3@Y[5Y
MQ^U:,?$.V/\ TX6W_I/%3IXF-62C'S_"Q&,R:M@:,JM=ZKELEU4KZW^6UCQ4
M]:7%)U]Z,9KJ/  <TOYT8HQ0 8]J6DQ@XI:!C=M)3Z;MIIB8 "NO^#P_XNYX
M'_[#EC_Z4)7(8Q77_![_ )*YX(_[#MC_ .CTK.I\$O0Z\'_O%/\ Q+\S])/B
M@!_PK3Q;_P!@B[_]$O7Y(5^M_P 4/^2:>+?^P1=_^B7K\D*?#O\ #J>J/TSC
M?^-0]'^:$ SZ_@* 1W/2K&G7:6-[#/) ERD;;C%(,JWL:]>\8^"M$^(OA:Y\
M9^";0::MB -3T4-O:)C_ !ICG;D'MZ<U]5.JJ;2DM'U_KN?G]'#RKQDX/5:V
MZM=6O0\8S['WI>IS7L^@>'O#OQF\-0:7HUA'HGC73[?*HC?N]2 '.%ZA\J>A
M.=PXXKQVZMI;*YD@F1HIHV*LC#!!'6BG551N-K-= JX>5)1FG>,MFOQ7JB+.
M: :,8]OK1WK<Y -7=,T34-:D>.QM)KMD&6$*%L52'M7U9^S?\7]"TOX>W'A"
M'78/!6ORR^<FL7VTVSCG[Q+*!UZ9_E7'BJT\/3YX1YOZWZL]+ 8:GBZWLJL^
M56\M7V5VEKYL^6;VQN--N7M[J%[>=#AHY!@CZU#GIV^O>OL?Q5\(->^*/QH\
M)IXQN-,U32KNUE>/5M#C*"ZAB*'#'<XYW\'/\1J?XC?LE:3-I>FW6GZ8WAJ?
M^TX+*6+[8MR)H9)8T\S(5<'YFXYZ"N".:T$X1F]7VV_SZ=CUY</XIJI.DKQB
M[:JS>S\TM'WUZ7/C$#(ZT$^G-?2WQ1T;X0>$KO7O"/\ 9&I6NOV:*EK>+*'6
M:5E!&[Y/E&3SS6E<?#OX:_#O4/"/A37]$O=6U;6K1;B74HKE46$N6V@+L.<8
M4=?>MO[0CRJ7(]=EIM:]]SE_LB:G*'M8^[HW=Z.]K/3>_P O,^5OY4N>OZ#U
MK[$A_9]\$_#WPEXTU/Q'8W&M'1[I3"(91&S1.?D7)4\@,,G':M;0/V8/ 'C'
M5O"^NV\%[8:+J>D#4)-/\Y20Q6-E&[;T <@\<\=*Q>;4$G)IV[_*_P"1U1X=
MQ<VH)QYGTOJE?EOM;==SXP@T>^NK&6]AM)9+2'B2=4)5?J:J8YZ8([5]O^%+
MGPQXF_9U\=1>%-%N]*MW=X)+1Y1,[ML."N%'7/3!JQJO[,'@.?0-?L!IW]DZ
MQI]BUU&L>J1SS@;7*.Z! 0I*GZX.#4?VM"$G&K%JSMT\M_OZ7-?]7JM6$9X>
MHI7C?JEUT6GEUL?#!H^E?5OCGPI\+OA>GA>TU#PO=ZG=ZK&C23I=K&L:F1T+
M8*'/W3WHUGX ^%O!.L^,_$FK6\C^#[&R@:PA)VL9I4AQ\V,$;I#70LRIM)N+
M5]MM=4M-?,XY9)63:4XNUN;?W;IRN]-K+H?*1.*0U+<-')/*\<?E1LY*I_=!
M/ J/^&O5/GF)TXIU)C\Z6AB$_AH6@G!I,T .HHHI@--?0G['?_(S>(?^O2/_
M -#KY\)R<5]!_L=#/B;Q!_UYQ_\ H=>;F'^ZS_KJCVLF_P!_I>K_ "9YK2?Q
M"EHR1TY]J_-#XP].\'>'M3F^&^K/I<"W%WJ<HAP&&Y(U*L>/P;\ZY/PGH=O=
M>+[33M8E-G LVR8^A';\2*WOAB;BTL=8UD7$L:6$!2WC1CAYI!Y8&WN1O!J2
MSLX?!]C)X@UT"37YV,EI92]03_&X'YX..HXII7/IW2A5IX>?+916M]N5/\V[
MZ=37^//AZ?29=/D_M.WN-/8;+.RBX:&+:-I8=<X ZUY'QVJ]J^L7FO7DMY>S
M&661BQST!)S@#L/:J(]ABAZGCX[$0Q6(G5IQLGTO< ,TIZ4+T-%(\\][\$?'
MWPMI'PUL/"NO^&;S5X[4DLT5SY2DERP(P0?2J]O\;/!.B>-]'U[0?"5WIR6B
M3)/&UV9&EW1NHP68XY8'\*\,/2C-3RH^A6?8WEIQ]WW.6SY8W7+MK:Y]"6G[
M3EA?Z(=,US3+]HXKZ2[@?3IDC8J2^$D+ Y #]L=!S63IG[0ME/;>)-(UO1'E
M\/ZNQQ%8R;9H1N)7#.6'0\\&O$<8HIV0Y<09A+EYIWLK;+56M9]]#V;1?C1X
M;\+_ ! T?6]'\-26>GV%J]L\?FYN)]V,%FSMR,=@.IJAXT^+>C:WX D\,:7I
MM_ AO&N5FO)4<X.S@[0.?D/;O7E HZ']:+&#SC%NG*E=*,KWM%+=).UEILCV
M;3OC+X:U3P[X>M/%>A7U]J.B2!K>YT^=(E=%;<JN&!SR3G&.#5^Z_:0&LZ9X
MLM;S2Y6FUIXQ;"W8!($18E5<'))_=^O4UX5Q^-*&*L"I((_2E8T6>8Z*Y5);
M6>BN].75VUT=M3ZON?&%[X9_9EAFUB)+7Q#<I]BMDF4I*8=^0=I.<;4'->9_
M#_XP^&/">GZ5YVCZK;ZA9D&232[I5CN<#&9%E#\]3\NWK7DEYJEYJ*(MW>3W
M2H,*)I6?:/;)XJMCI^=%CIQ&?5YU:=2BK<D5%7LWIUVW?Y:'M)^/NG3:1XFM
M)_#D;G5K];L0HS+#M!8D, V[)W=B.E:>G_M!^&]!TZ^33- OQ+=6WD&QN[A9
M;*,X8953^\'7NYZ5X&.<=1F@G.>:=C".?8Z#34E=:?"O-]O-CII#+,[[0NYB
MV!T&::/TH)]*!QR/SIGSV[N)MI:,YH Z#M0%@I.]+D #)I"<<=2.U "]10.M
M%(,8H ]K_9)_Y*W:?]<G_E7U9^T7_P D1\8_]>)_F*^4OV2/^2MVO_7)_P"5
M?5O[1?\ R1'QC_UXM_Z$*F/\:'JOS/VWAG_DGL1_V_\ ^DGYG9KJ?!/PYU3Q
MV]P+ 0QQP@!I;B18T+-G:H+$ DXZ5SUAIUUJEW%:V<$EU<RL%2&)2S,3Z"O;
M]+LKKX,?#J.Z\0Z>L]SJ-\DMKI\SE=OE$,7W1D'^(<$]NE?5U)N*M'=GYC@L
M,JTG.JG[.*NWT\M;/=Z;'B6IZ?<Z1?S6=W$T%Q"</&XP17T3X3\;Z*/A5'JE
MV+B.PL(Y--N-*A5 L[2$C>&*DY E#?>ZKT[5Y]\9]'_M_4G\:Z,KW>AZ@J>;
M.O2WF VF-AU' 4\C^(<U--&++]G"U8[5>[U>0X[MMV__ !-8SM5C&_<]+#<^
M!KUE#5*+:?=75GZ/3R9Z!H_@[PKX:5M5TJQN9PNGF]MM6N9U:..1E'R'  RN
MXKCU6OG'5-0N-6U"YO;N4SW-Q(TCR-_$Q.2:%U6]%I]E%Y/]F/'DB0[/7ITJ
MKGK6M.FX-MNYYV+Q<<1&,:<.5+HN[_KKJ&>,4>]+2$8']:V/-/I*W_:,\!:C
MX8T73O$/@N_U2?3;<0+*EZ8AU[!6'KWK&C^//A'1V\41Z#X6O--MM9TTV8C:
MY\PHYR-[%B21R*\&ZB@'(_K7*L-37?[V>_+.\9*U^6ZTORQOM;>U]CVOPA\;
M?#FE> O"_AO6]!O-1CTB\DNY#%,JI*2TC*.>>"X_*G_%#XH>'_BWJ\5YI6E^
M)8]=3:EC:+/#);1X   C6/>?NC^*O$0,CT^M2VUS+9SK-!+)!*ARLD;%6'N"
M.15>PAS<ZW_S,?[6Q$J/U>=N31;*]HJRU\EL?4/[1WBJ\@^#?@W3=16.VU[4
MT6?4(ONR QH -RYR,^:W6N:/[2^F-\3?#OBC^Q;OR-+T\V;P&5=TC''S ] .
M*\'OM1N]2E$EY=S74@& \\C.?S)JMR,<'WJ(8:"CRR\_Q.G$9WB)UW5I:+W-
M[/X-GMWNWZGNGAS]H^'PQHFN6]IID_VV]UM-7AE9@40*8CL8=3GRCT]:T_&O
M[2>@^)M*UAHM$U$:OJ-L(?\ 2;E3:PL0 S*BX;.,]6(Z<5\\?C2'DBJ^KT[\
MUC+^VL:J?LN;W;6V7G^.K.Y^$'Q!M_AIXN75[FUEO(Q"\?EPL%;+*1G)^M8&
MN>))]7UV\O\ S9C!/=/<+#+(6 !<L!C/O6-W]J",>WM6W)'F<NIY;Q%3V2H7
M]U-OYNW^1]0:=^UEH":IH6JWF@ZI]OTZT^RF"UN(TM6X7+;2"V?EXRW0GBN0
MA^.V@W_@2Z\-ZOI&I&,7_P!NMI;*:-"I&-H?<&ST&< 5X=VYXHS_ )%8+#4X
M[(]:>>8VHO?DGNMEK=)._P!R/H/7OVF=+U;XN^&/&$6C7D=KI%F+5[9I4+R8
M+G(/3^,?E2^#/VJ#X5TOQ39R:=/=+J,LTM@=R_Z*77'/J,Y/%?/>,'\*/QX]
M:/JU*UFA+/,=&HZJGJVWLMVDG^"7YGT?X@_:[?5_#WAZQCT@K<V<L3WSRD%+
MA4'1<'(.0IY]*LW7[47AIGU]K;0=8>?6H]LC3W,;"-LK@( !A>.AR?>OF;OQ
M2@X.1P?6CZI26R-'G^8-MRG?;HNBM^3/L+2O&VH>#_V8?M6N1K9:WY9LM/$Z
M[)6AP-I"GDC"CGWKRCX:_&GPMX,T73X;G0M2M]3M)4D>ZTFZ"+<!<<2++O'.
M#G:%ZUX_>ZO?:C%''=WMQ<K&,(DTK.%'MDU3_AI1PT4FI=7<=;.JTITY4M.2
M*BKV?SVW]#J?B3XR3QWXQO\ 6XK&+3TN&R(8@>GJW)Y^G''2N8Z\TU:45U12
MBDD>#5J2K3=2>[=W\S[?_8-_Y)SX@_["Q_\ 1,=>$_MA_P#)>=:_ZXVW_HE:
M]V_8-_Y)SX@_["Q_]$QUX5^V%_R7K6O^N%K_ .B5KQJ/^^S]/\C](S/_ ))?
M"_XE_P"W'G7P]\"ZA\1?%5IHFFJ3-.?F?'"+W8^@Z5Z]XK^..C>#-9GT'0?"
M>CWVG:<3;+=7JRN\Q4XW965001CM7%?L_?$Z'X9>.([J]5&TNZ0P73$'<JG!
MRI'(Z=J9XX^!WBC1O$]_!INB7^IZ9YC/:W<$1E66(D[6RN>H'UKOFE*I:IM;
M3]3Y7#2J4<%[3!ZS<K2TNTK>[T>CUU\K'HDWBI=2\+:=\2_"UE;Z7XDT:Y\G
M4;"S#-&T'RL&*%F8*<."<]!VJOXU^!7_  L74H_$_A34M.BT_5(5F>VN;V*-
MH902K+AB#CY0?QZU!X<TC4?@W\+;V[EMY(_%?B=SIMOI=S'N818VEPF#R?,P
M,^E2:QH/PW^'$5CI/B*XU>[U\0":[2QNF5(F9FPN%XSMVG\:YDW%WI_+KI_P
M'U/8E%5::6*BDK)R3?+:6R:T>LHZM6\PG\/_ /#//PYO[[^T+27QGJLGV2$V
MMPDPM[<D%CA2>2$89/\ >KY]ED::1Y'8N[DLS-U)/4U[/X[\%>%=?^'#>+/!
MD]_,;*Y$-]:7DQD>)"<!\'G&YD&1QS7BY-=E#5-O>^I\]F=XSA2BDH)+EL[I
MWW=[*[;WTZ6Z!7K7P)^,.C?"ZR\366MZ-<ZS9ZS'#$T5O,(\!/,SD\'GS.Q[
M5Y)R/I7L7[/_ ,'_  ]\4+/Q/>>(M7N]'M-&2"3S;;;C#^9N+;E/3RQT]33K
M\GLW[38C*OK+QD%A+<^MKVML[WOIM?<Z37OVCO"=OX0U#1?"?A"?1S??+</=
M733 K@@XRQP<$TR\_:=L;OQP=4_L6X.DW.AKHUY;-(OFLH:5BR-T'^L[@]*9
M\0/V<-&3PK;:Y\.]:N/%$!N1:RQR;=Q<XVA?E7UKS'4?@]XTTGRA=^'+Z,S.
M(XTV!B[>@ .:YJ<,/-:?B]?Q/;Q6)SC#U+22MHURQ3C;6UN56ZN_<[ZW^.^@
M^$_#]IH'A31+VVTMKU;V^EU"9);B8AMP"LNU1C:@^[T'KS6_XE_:ETCQAJ7B
M"TU70+J7PUJ\<0>WCE5;B-T51E6^[C*YY!KQGQ!\+O%GA2R%YJV@7EE:DA?.
M>/*@DX )&<9/'/K78_"O]G[7/&>N6"ZQI>IZ9H=PK,U\L84J I(.&'0D#MWJ
MI4Z"7.W\[F%'&9M.:PM.-KV7+RV5M4KJVBU=^G4]!\,?'>ZU[7?"7AKP3H:0
M:9I2A1;:E<()K@!0O,FY5W')/ '7IQ7=6L%AX;\(?%>Y?PQ?>%_.B;S)=1E#
MF:0B4[8BN RCG&,]1R:^7O%OP]UKP9JUW-;VMW'I<>I2V%E?$X,K*[@<CN0A
M]*DOO#/C^]U9/#]U!K%S?RIYGV&29I"5_O$9(QSU]ZAT(.S@[+_@W[G52S7$
MT^:->FY35TM%97CRJWNW7R>J1ZUJ/[6=I<:]I]Q#H<WV 6C65[;S."\L;<-L
M((P<$XS6'HGQP\%^#;_1Y=!\(SL;*9I9+O4IA)<MN)W!2A5!QP,K7,^#OV?/
M%FN^,].T75-)O-)AG=3)<21_*L>X;B#TR 3_ (5#XG^!'BC3O&6H:-I.BZA?
MPVV&24H/F4@<D\#KGCK5*&'3Y4^G<QGBLXE%5Y0O[UE[JNGH]-+K9'HNJ_M-
M>')O#.L:1::'JO\ Q,+J*[:>ZN4=PRRH^. !C"8 Q7E?QA^(MO\ $OQ+%J=K
M9RV2);10%)F#$[(T0GCU*Y_&N6U_PYJGA;46L=6L)]/NE&?+G0J<>H]1]*S<
M>YK>G1IP?-'^OZL>1C,RQ>)BZ-=Z*VEDMK_YL3%+CFE_G2=O>N@\@#FC-!I:
M $ZBC\Z!THSZ4 'YT9HYI: $)'>NN^#W_)7/!'_8=L?_ $>E<B.U=?\ ![_D
MKG@?_L.6/_I0E9U/@?H=>$_WFG_B7YGZ1_%#_DFGBW_L$7?_ *)>OR0K];OB
MC_R37Q;_ -@B[_\ 1+U^2-5P[_#J>J/TOC?^-0]'^:&GI71>!?'>J_#S7X=6
MTF1%G3(,<R[HY%[AE].E<]CGMQZUU/@'X>ZGX^U3R+51;V<7S7.H3$+#;KZN
MQ( ^F:^LJ<G(_:;=3\[H*JZL?8WYNECT?Q7X5TO5?#W_  LCX?7$UE-9RA]2
MT[<&:RD;#*4&,[.'ZEON]:FEDL_VB] O[N6*#3O'6DVK.L5L"B:C$JES\I)S
M)P_0CJO'KF>(/$(UK/P]^&M@[:1++MFGCR9M18' D=G^XH&3CY1\QS3_ !1J
M&C?!C1GT/POJ,.K^(M1MF34]40%OLH8%##$<;<XW989/S<'(X\E1E9)7Y_LW
MW2_O>7];GT,IPO*3M[.WOVV<O[GGMMIO]D\<FA>WE>*12CHQ5E(Y!'!IM#NS
MN68[F8Y)/<T5[1\N)UX->R?#K]HRX\)>&E\/ZOH.G:_IT;!X#/"1(A QC<KK
MD?6O'*^GO@/\#? 7BWX4GQ/XK74S+]K>WSI\4\YP.G[N%6;MUQ7G8Z=&%*]>
M+:OTWN>UE-/%5<0XX62C*SO?:WG?0YC5/VM_$<_BW0-2T^PL-/T[1D:*WT](
MW*,C%<AB7)/"*.".]9'C#]H)]6^PMH6A6>AR07B7[2(\SL\R.KJ?FE88R@XQ
MZU>^)_PAT;5?&UCH7PMLM3U*1K<R745_!-:-$<_*6-RJ;1PW)XX/I7(W/P#\
M=VFO:5HSZ&K7^K*SV0AO;>2.<+][$BR%!C'<BL*4,%:,DE%VV;L[:[J_J]3M
MQ$\TO.FVYJ]KQ5U?16BTO1:>AW?B/]J.'6[+69HO".EP:[JUO]GNM1*R,6&-
MN0#(0"!T.*CTC]IY/LFBSZYX6T[6->T>%H;/4I!*&1?FVY E . Q'2N3@_9M
M^(=WJ5QIT&BVTU];Q^9-;1ZK9M)$O/WE$N5Z=Z?+^S1\1((H9I=$MHK>7B.X
M?5K)8F.[;M#F;;NW#&W.<]J7L\O2Y>9?^!>7KM;H'MLXE+G]G+_P#3>]]K7O
MUW->[_:6UG5? WB;0=1MHKJ;7;CSWN=I'EC?N"K\W0<#D'BMKPW^UYKGA>#P
MI;V6F6;PZ-IXTZ1)D8^<@5%W<./F_=CVY/%<##\ /'\^KWVF#P])'=60#7)G
MN(8XH\XQF5G"<Y'1JEM/V=_B%?Z^FB6_AXRZA);_ &J-%O+?9)%Q\ZR>9L8?
M,.C'K5RI8!IIN-M]UVM??L9PQ&;QDI14[_#L[Z.]MM[GH _:OCTCPOJ&B^'?
M"EAHT-R_G9C\QOWAXW'=(?:K\W[8J&ZUNZ@\*6-O>ZQ;M;WETID+N,,!C,A
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M;S4J-;FNWH;2KY8J*A"/O==-][>G3_@GLVK?L[:-XI\2F"*]DTFQ>:Z"V]M
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M8._Y)UX@_P"PL?\ T3'7A7[87_)>=;_ZX6W_ *)6O=?V#C_Q;OQ!_P!A8_\
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M)/'Q;M/^N3_R-?5O[1?_ "1'QC_UXG^8KY3_ &2?^2MVO_7)_P"5?5G[1?\
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MU_ Y<3AL)2IMQ^/MS;:)_/7IU*'A7X+ZUXMT*/4K>[TRU\]G6ULKRX,=Q=E
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MMW),H![_ "N*X?.37H4/:.'[QZW?YZ'CXKV7M+45:-EYZV5_Q!NU?0G['?\
MR,OB'_KT3_T.OGSUKZ"_8[_Y&;Q#_P!><?\ Z'7-F/\ NL_ZZG;DW^_TO7]&
M>:@XH)S1@TM?F9\8(O6@XH%!Z]* #G% [TM(,T .Q_DTG?C_ !I,4N<T#/9)
MO!W@_P *^&/#5QJ]Q/OU:VDGN)FB+[/OHGE%5XPRJ3G=WZ=IF\%>&Q?^']*A
MM7GAU/3KNY-ZQ ES&DCH5XP 0@!!!//45YK#X^UZ#3;;3Q?[K2VW"&.2%'V
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MK.J2!MRK#& =S;FZ+W/-9UAXSUC3;&.TM[L"WB),<<D22;<]<%@<4:G#/,,
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M?$?7FL)=.DU%X].N J7$5O%'&70'ID*#ZUL>(_B]JM[XEM=5TFYFL7L[/[%
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M^%W>/_\ H<-9_P# M_\ &D_X7?X__P"AQUC_ ,"W_P :+3[A_;'#G_0"_O\
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M-7_"[O'_ /T.&L_^!;_XT?\ "[O'_P#T.&L_^!;_ .-%I]P_MCAS_H!?W_\
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M[?$/_H=-:_\  Q_\:3_A>_Q$_P"AUUO_ ,#'_P :/88O_GX']J\/?] 3^_\
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M /C='_#$7Q$P?](T3_P+?_XW7-']JCXB#_F,G\W_ /BJ/^&J/B)_T&&_-_\
MXJBV,[H/:<.?\^ZGWHZ7_AB+XA_\]]$_\"W_ /C='_#$7Q#[3Z)_X%O_ /&Z
MYK_AJCXB?]!D_F__ ,52_P##4_Q$_P"@PWYO_P#%4[8SN@]IPY_S[J?>CI/^
M&(OB)C'GZ)Q_T^/_ /&Z3_AB'XB?\]]$_P# Q_\ XW7-_P##5'Q$_P"@P?\
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MCES_ -^#_P#'*3_A@+PQ_P!!RY_[\'_XY7R?_P - _$G_H>==_\  U_\:/\
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M'_KTC_\ 0Z^?.]?0?['?_(S>(?\ KTC_ /0Z\_,?]UG_ %U/9R;_ '^EZO\
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M% MECN5?[+?-&H'FR$95R!QEMKDX'>HHM/?3? .NQ7\9B*ZE#'&IZ&95E!_
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M7/B_1+R.]#06]Q?/(Q&,+(\)3\PC?E5_5&AU3Q!?:[.9].>/PI<H;">$J_\
MJY>1DCY3ZX[&EJ=$LHP,Y2]C4<K.VC75)WVZ:JV[MON?,V""0>HH]:5VR[$=
M"<T@]:H^*/:?V2/^2MVO_7)_Y5]6_M%_\D1\8_\ 7B?YBOE/]DG_ )*W:?\
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M]UC6(+R6)+.:W18XHX1L$04DJ% Z<D]*]&\':GXOUC4+_6+FX33O#5P0]_\
M:EWV3;45>8<[6<A5QD=<<U!9_M0>.;6U\F2ZM[V3&/M%TCO+_P!];JX'Q=X[
MUSQU?B\UK4)KV50%3S'+!%&> ">!R?SJ.64M'%+\3J]M0HOVD*LI-ZVMRZ^;
MYG^"^:.B^(?BKP_XCL+6/3;26SN;-VBC5 !;O&69BRH.$)+'@?7O7 9/U'UH
M7F@].<&MHQ459'EU:LJ\^>6XM==X \%V?C>[:Q^WS6MZL;2[?)#)M! Z[NO(
MXQ7(UV_P?\0V/ACQ5+>:A-Y$!M7C#^K$KQ^E3.ZB^7<UPJIRK157X6]2?2/A
M3/XM\/WVI^&Y+C4EM9(XC \(C=V<D< ,>.*R!\+O%9N;B :'=^=;OY<R #*-
M@'!Y]&'YUT?@KQ;IFE_#S4]-N;CRKJ74+698\=45B6->K?$_XI^%?'DFEPVV
ML+;#3-5BOF9UXEC6.+)7D?-E6&/85@ZE2,K6NO\ ACV:>$P5:A[1SY9I+2ZU
MNY=]K))]3YYB\%ZW<0VTL>FS,ES.UM"P P\BYRH]QM;\JT--^%GBO5PYM-"N
MYT1Y$<JH^4H2''7L0?RKUNU^)?A_Q++I$]Q?)I?V+5Y+B02?,3%Y3JK#IG)*
M\=LGKBNG\+W]IX@\>Z;KQE.GQ10:BZ0.N/.C+2;9%/&0002<<$XJ95IQ6J-:
M.686K)*-2]VMFEO:[^5]CQ[Q)\ ?$^B6.F7<%E+?P7=DE[(\0XA5E0X/T+@5
M-'\!=8AGU W8DCM;*R2[D>- S'<"=H&1R-I[UZ3J?Q;\,S>)]/N4OU:"'PY]
MA=@/^6W^C_+_ .0W_*N-U/QMHLEAX@D2]1O[0T:"VA3^+S$1P0P[?>%*,ZS6
MJ_ TJX7+J<VX2NO\2Z+TZL\^TSX=:YJ7B*72!831SVT\<%UN49MRYP"WZG\*
M2?P+=0>,KKP^BR7=S "3]F4,3A-V0"1VKV6P\<>&M/\ ''BS76UB&2TU:XMY
MK=5QOPK-NW#/&!BN,TKQII-O\;+[7);D+ILD<JK+CC)@VC]:M5*COIT_$XYX
M/"04%S[SL]5I&[5_NLSES\(/%^%<Z%=I <,)&4 ;2<9Z]*M:]\&?$FE:W-IU
MM82ZA)%!#,[0@8421HX'X;P/K7IR?%+PZOQ&@U,WH^QKI,UN6Q_&T<H _$L/
MSKH+SXR^&+S2=>L%;2;J:YCLY+7^U8!/!(4@BC=6&Y=I!#8Y_AJ'5K)KW3KA
M@,NE&7[VS3[K9)OMU=E_PY\_6WPP\57MW=6T&AW4EQ;,$FC51E&.< \^QITO
MPK\61+,SZ%=*L,Q@D)4?*XSE>OL:]SUW58OB+X#TZQ,T=C!:ZK:[+ZSL##9O
MLBE7R8QO(^7H/FY"DX'2L3XQ^*/#^IW5QHEU=R+Y/B"=[D*N'6(M@L/>JC6F
MVE8SJY;A:=-U.=M:6U2O>^FSV[]>AP/A_P"!7B[6=;M;"YTBXTZ.:X%NUQ.
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MEWNSQ?MP:6DZ_7^='YU]"?%BT4@%'?VH 6BBB@!%ZU]!_L=_\C)X@_Z]$_\
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M1_"?AK6-1\56NMOJM_J-LEM_8PMY4$/*,S,S(%('EX&#W%'A;Q?X,T'XM?\
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M+# UQ(L8DGD6-!D@9+,0 .?6J6,5/:3"VNX)F&1&ZO@=3@YH*5KJ^QW]_P#
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M;36N/M\<DCE67]TQC;!&=V/O&DZE;M^8XX/+)-_O'IYQN_Q25EYZ]-T>:?\
M"A=7.G:?<B_L'ENH))GM5N(S+%L* J5#YR-^#Q\I&#UKGM=^&&N>&])%_?\
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MT9I>T8?ZAX'_ )^R_#_(_.;_ (9]^(/_ $*]_P#]^C_A2?\ #/GQ _Z%>_\
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M\*_2S-&:/[3J?RH/]1\%_P _9?A_D?FE_P ,W_$?_H5K[_OT:/\ AF_XC_\
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MY4'^HN&_Y_R^Y'Y;?\*=\??]"3XC_P#!3<?_ !% ^#WCX?\ ,D>(S_W"9_\
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M2?\ @IN/_B*_4G-)O%']IS_E0?ZBX;_G]+[D?EQ_PIWQ[_T)'B/_ ,%-Q_\
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MU%S1FC_6'$?R+\1?ZEX/_GY+\/\ (_+K_AF/XF_]"E?_ /?HTO\ PS'\3?\
MH4[_ /[]&OU$S1FC_6'$?R+\0_U+P?\ S\E^'^1^7?\ PS'\3?\ H4[_ /[]
M&C_AF/XF?]"E?_\ ?HU^HF:,T?ZPXC^1?B'^I>#_ .?DOP_R/RZ_X9B^)O\
MT*>H?]^C1_PS'\3?^A3O_P#OT:_47.:6C_6'$?R+\1_ZEX/_ )^2_#_(_+K_
M (9C^)O_ $*=_P#]^C2?\,Q_$S_H4K__ +]&OU&I"<4?ZQ8C^1?B+_4O!_\
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M!3_XTO\ PEVN_P#0:U#_ ,"W_P :QP:7%%A^VJ_S/[S6_P"$OUW_ *#6H_\
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M&.O_ /0<U'_P+D_QH'C'7N^N:E_X%R?XUD"G4<L>P_:U/YG][-;_ (3'7?\
MH.:G_P"!<G^-+_PF.O\ _0<U+_P+D_QK&Z4N:7*NP>VJ_P S^\V/^$QU[_H.
M:E_X%R?XT@\8Z\3_ ,AS4O\ P+D_QK(XS2T<J[![6I_,_O-C_A,=?_Z#FI?^
M!<G^--_X3+7_ /H.:E_X%R?XUDTW!HY5V#VU7^9_>;'_  F/B _\QS4O_ N3
M_&C_ (3'Q /^8YJ7_@7)_C6.212\4<J["]K4_F?WFQ_PF6O_ /0;U+_P+D_Q
MH_X3'7_^@YJ7_@7)_C6-WZT#K1RKL/VU3^9_>;/_  F.O_\ 0<U+_P "Y/\
M&C_A,->_Z#FI?^!<G^-8W\5.HY8]@]M4_F?WFK_PF.O_ /0<U'_P+D_QI?\
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MR?XT?\)AK_\ T'-1_P# N3_&LCN*.HI<J[#]M4_F?WFQ_P )CK__ $'-1_\
M N3_ !H_X3'7_P#H.:E_X%R?XUC]..]'?K1RQ[![:K_,_O-;_A,=?_Z#FH_^
M!<G^-*/&.O\ _0<U+_P+D_QK'P!3J.6/8/:U/YG]YK_\)AK_ /T'-2_\"Y/\
M:/\ A,=?_P"@YJ7_ (%R?XUC]:6CECV#VM3^9_>:_P#PF&O?]!S4O_ N3_&D
M_P"$QU_MKFI?C=R?XUCC-"T<L>PO:U?YG]YL_P#"8Z__ -!S4O\ P+D_^*H_
MX3+Q!_T&]2_\"Y/\:QQTI#FCECV'[:I_,_O-@^,-?[ZYJ7_@7)_C1_PF&O\
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M_P#%5C]?_K4=^O%')'L/VM3^9_>;/_":>(?^@]J?_@9)_C1_PFGB'MKVI_\
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M\!65YK6KN\$FHP(([+H%4G=N8?WL ?3)K&HE:Y^I\$YCC56^I1CS4MV_Y?\
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MV;KW7UUZ^.M6-IH>D2M%+J$A(1L9R0,=  /S%>Y_LU0OJ'P\\<6MNIDG:_D
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M $$-9_[_ $7_ ,:HHI78+#4/^?:^Y"?\,M>%/^@AK/\ W^B_^-4?\,M>%/\
MH(:Q_P!_HO\ XU111=B^K4/Y%]R#_AEKPI_T$-8_[_1?_&J!^RWX4Q_R$-8_
M[_1?_&J**+L/JU#_ )]K[D=Q\)/V>?"?AKQ-_:2B\U"XA7,0O959$/J JKD_
M7-?0"H  !P/0445C/<_5^'*-.E@%[.*5V[V5CG?B#8RZAX5O;6*^N=.,J[#/
M:[/, )YQO5@/RKY?F_94\*W$LDLNJ:Y)([%V=KB$EB>I/[JBBO7P3:@[=SY[
MB6$:F)BIJ]EU]1G_  R9X0_Z".M_]_X?_C5(?V3O"(_YB.M?]_X?_C5%%>AS
MR[GR*PU#^1?<A/\ AD[PC_T$=:_[_P /_P :IQ_9.\(C_F(ZW_W_ (?_ (U1
M124Y=QO#4?Y%]R&G]D[PC_T$=;_[_P /_P :H_X9-\(_]!'6_P#O_#_\:HHI
M\\NXOJU#^1?<@_X9/\(_]!+6_P#O_#_\:H_X9/\ "/\ T$M;_P"_\/\ \:HH
MJ>>7<KZM0_D7W(/^&3_"/_01UK_O_#_\:H_X9/\ "/\ T$=;_P"_\/\ \:HH
MHYY=P^K4/Y%]R#_AD_PC_P!!+6_^_P##_P#&J</V3?"/_01UK_O_  __ !JB
MBFIR[A]6H?R+[D _9-\(_P#01UK_ +_P_P#QJF_\,G>$?^@CK7_?^'_XU111
MSR[B6&H_R+[D'_#)WA'_ *".M?\ ?^'_ .-4X?LG>$2/^0CK7_?^'_XU110I
MR[C^K4/Y%]R&G]D[PCG_ )".M_\ ?^'_ .-4?\,G>$?^@CK7_?\ A_\ C5%%
M"G+N+ZM0_D7W(4?LG>$>?^)CK7_?^'_XU2?\,G>$?^@CK7_?^'_XU112YY=Q
M_5J'\B^Y /V3?")_YB.M_P#?^'_XU3O^&3/"'_01UK_O_#_\:HHJN>7<EX:C
M_(ON0T_LF^$<_P#(1UO_ +_P_P#QJ@?LG>$1_P Q'6O^_P##_P#&J**.>7<%
MAJ'\B^Y!_P ,G>$?^@CK7_?^'_XU2_\ #)WA'&?[1UK_ +_P_P#QJBBIYY=R
MOJU'^1?<A1^R=X1Q_P A'6_^_P##_P#&J0_LG>$<_P#(1UO_ +_P_P#QJBBJ
MYY=Q?5J%_@7W(0_LG>$3_P Q'6O^_P##_P#&J</V3O"./^0CK7_?^'_XU112
M4Y=P^K4?Y%]R$7]D[PC_ -!'6O\ O_#_ /&J/^&3O")_YB.M?]_X?_C5%%+G
MEW#ZM1_D7W(3_AD[PC_T$=:_[_P__&J/^&3O"/\ T$=:_P"_\/\ \:HHHYY=
MQ_5J'\B^Y"_\,G^$?^@CK7_?^'_XU2?\,G>$?^@CK7_?^'_XU111SR[A]6H?
MR+[D'_#)WA'_ *".M?\ ?^'_ .-4X?LF^$<?\A'6_P#O_#_\:HHIJ<NXGAJ/
M\B^Y"-^R=X1_Z".M?]_X?_C5)_PR=X1_Z".M_P#?^'_XU112YY=P^K4?Y%]R
M#_AD[PC_ -!'6O\ O_#_ /&J7_AD_P (_P#01UK_ +_P_P#QJBBCGEW']6H?
MR+[D)_PR=X1_Z".M?]_X?_C5'_#)_A'_ *".M?\ ?^'_ .-444<\NX?5J'\B
M^Y"C]D[PCC_D(ZW_ -_X?_C5)_PR?X1_Z"6M_P#?^'_XU113YY=Q?5J/\B^Y
M#C^R=X1 _P"0CK?_ '_A_P#C5-_X9.\(_P#01UK_ +_P_P#QJBBASEW!8:C_
M "+[D!_9-\(Y_P"0CK?_ '_A_P#C5 _9-\(Y_P"0CK?_ '_A_P#C5%%/GEW%
M]6H?R+[D*W[)WA'_ *".M?\ ?^'_ .-4G_#)WA'_ *".M?\ ?^'_ .-445//
M+N4L-0_D7W(/^&3O"/\ T$=:_P"_\/\ \:H_X9.\(_\ 01UK_O\ P_\ QJBB
MCGEW#ZM0_D7W(7_AD_PC_P!!'6O^_P##_P#&JM:9^R=X.-_#YMYK$\>[YHWN
M(P&]CB,'\C112<Y6>I=/#4'.*<%OV1]9:3HUEH6GPV.GVZ6MI"H1(D'  X_&
MK6T#^5%%?,WN[L_<4E%*,59'F/QU\(#QOH$>DSZMJ.G6,_$\=@T2F49S@LR,
M0,@="*^>#^R!X-/_ #$M=_[_ ,/_ ,:HHK[3+92AAURNQ^99Y3A4QLN=)VMO
MKT$'[('@WI_:>N_^!$/_ ,:I?^&0/!O_ $$]=_\  B'_ .-445Z?M:G\S^\\
M#ZO1_D7W(/\ AD#P;_T$]=_\"(?_ (U1_P ,@>#?^@GKO_@1#_\ &J**/:U/
MYG]X?5Z/\B^Y!_PR!X-_Z">N_P#@1#_\:H_X9 \&_P#03UW_ ,"(?_C5%%+V
MM3^9_>'U>C_(ON0?\,@>#?\ H)Z[_P"!$/\ \:H_X9 \&_\ 03UW_P "(?\
MXU11356I_,_O#ZO1_D7W(/\ AD#P;_T$]=_\"(?_ (U1_P ,@>#?^@GKO_@1
M#_\ &J**/:U/YG]X?5Z/\B^Y!_PR!X-_Z">N_P#@1#_\:H_X9 \&_P#03UW_
M ,"(?_C5%%/VM3^9_>'U>C_(ON0?\,@>#?\ H)Z[_P"!$/\ \:H_X9 \&_\
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89%3A3P,>2*5V]E;J"C!/-.HHKS#Z __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>amci-20230213_g4.jpg
<TEXT>
begin 644 amci-20230213_g4.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %@ IP# 2(  A$! Q$!_\0
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MF?7HK[7_ !.^G@:M2BZT=D>M[%QC QZ8H\M<YVC\J%.Y0?6G5]0G<X!NP Y
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M@IYR?E%?/PUC]JNY/_(&\+VW_ D_^.FG!/VJY>?,\+1?[/[O_ T_[,[UZ?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MB%%O)AU,94MMZ\F@#ZHAO(+IITAFCE>!_+E6-P3&V =K8Z'!!P>Q'K7YG_\
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M6XOM+U6VB$ N[%ES)'DD*RL"#@DX/N:]OI,<YI-*2LS"M0IXB'LZL;H^/?\
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MYQD_Z5QR0!ZDX%>]/#TY:SB]/-?YGS-/$U8^[3DM>R?^1^EOPC^)NG_%_P
MZ;XITV)[>&[#!K>5@SQ.K%64D<'D?D179U^=_P &?V@_'WA/2=7T3X??">R2
MRL9VGOK2$WTYAE(P0?,F8ACL/RCD[3QUKI/A]^WKXZ\<>._#_AU/#.A*=3OX
M;1F03;E5W"LW+GH"3T[5Y<\'4O)QV7F>S3Q]/EBIO5^3W/NRBDI:\\]0****
M "BBB@ HHHH **** "BOFWXO_MO^&/AGXFN=!T[2KCQ+?V;F.[>*=8((G'5
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MG!.!U.:^I:YY)Q=F;IJ2N@HHHJ2@HHHH **** "BBB@ HHHH **** "BBB@
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M4K:[CV-87LB?9E;(/F!%4?/QC/H3^'LM<"DJ512IN]CTG!UZ3A55K[GY+_\
M#)WQ<_Z$;4!_P*/_ .*KL/A[\&/C-\/_ .T8D^&G]M6&H+%Y]EJ0!C+Q/OB<
M%)48%6YZX/((-?IQ17:\PJ25G%?C_F<$<LIQ=U)_A_D?G/X:\)?'WP_?ZG>3
M?#I-8GO-5&NQF_C7%KJ"[MMQ'LE7D;C\K;EX'%:_[*/[-OCO0OCGIOB/Q?X<
MN=,L+!)[KS[EDQ).RE%&%8\Y<M_P&OT Q1BLI8R;BXJ*5S6. A&49.3=M1:*
M**X#TPHHHH **** "BBB@ KS3]H_5/$&B?!;Q1J'AF]73M5MK;S1<E@K)&&!
MD*D\!MF['OTYQ7I=?+_[:/Q,\)_V#IW@/4/%EMHUY?:K9_VE"6(DBLB6+2'C
M[HPI_ 4<T8M.3LA\LIZ15V?GK<7,MY<2W$\CS3RL7DDD8LSL3DDD]234=?IO
MH?[._P '?'/PN2+PWI%A<Z3J$!^S:W;9:X)!QYBRL"V=R_3J,8-?G[XI^%]_
MH6O7%A:R1W\,4SP^?&PVC:Q&>V1QUKMA5C/8X9P<'9G%45W\/PP18I?-O2\A
M4[-J8 /8GGFLBV^'FJ27:QS+'%#GYI0X(Q[#K5\R,[F=X5M;BZ\06/V?<&CE
M60NO\*@Y)S7U!X0^*NM::\EG?Z[J4EE*<X>Y=@KYZG)SBO.;2PM["/9;PI"O
M?8H&?K5RVMI;R98H8VED8X"J,DUC)\PKOH?4GA#XIZKX;G!GFDU2R9>8)I22
M/0JQSC^5>W^#/%D'C+1Q?0Q/ 0YC>)SG:PP>#W'(KY4TJU>STRTMY&W211*C
M'W Q7IW@;XD3:/!IVC0:?&?,G5))E.&;<_7 ') ..?2L6KF\)M.S/>B0.IQ3
M&GC3JX%1_8T/WF9OJ:!8P?\ /,'Z\U.ATZC)-3MX^KU!)X@LX^K,?H*M_8K?
M'^IC_P"^12_8X!_RQC_[Y%4G#JB6I]&9;>++!.ID_P"^?_KU%_PFNECK(Z_5
M:UVL+9NMO$?J@J)]&L)1\]E;M]8UJTZ75/[R&JO1K[C/7QMHK'!O50_[2,/U
MQ5V#Q!IMU_JK^W<^@D&:K7'@[1;H$/IT'/=5VG]*QKWX4:!> [8I[<^L4Q_K
MFK2P[ZM?<S-O$+HG]Z.O2191E&#+ZJ<BG5YC=?!J>W;?I'B2]L#V5_F'_CI%
M9MQI/Q5\-C?8ZC::[$/^64I&XC_@0'_H5:+#TY_!57SNO^ 9/$U(?'2?RLSV
M&BO"Y/VAM8\*.$\7^#KVQ0'!N;=3L^OS<'\&KM_"7QQ\%^,F2.QUN"*Z;I;7
M9\F3Z -P?P)HJ8'$4X\[C==UJOO04\?AJDN13L^ST?W,[VBFALXYXZYI1S7"
M>@+2$9-+10!\D?M3^"M1^$_C;2OC9X0C$=Q:S)%K5JO"SH<*';'9@0C>^P]0
M37TWX(\76'CSPGI7B'2W+V.HP+<1Y^\N1RI]P<@CU!JSXC\/V/BK0=0T?4X%
MN;"^@>WGB;^)&&#_ #ZU\N_LG:Y??"OXE>+?@SKEPSBTF>\TB23CS$/+ ?[R
M%),#H?,KW[_7\$[_ ,2C^,/_ +5_@SYZW]GXY6_AUOPG_P#;+\4?6M%(.:6O
M /H0HHHH **** "BBB@ HHHH *IZOJUIH.E7FI7THM[*TB>>:4@G:B@DG YZ
M#M5RN*^-?_)(O&/_ &"KC_T6: .&U+]K'PU;1EK+0_$&I9&5:*S"(P^K,#^E
M<G<_M@7UY"_V+P=)IQP2LNJ/<-CZK% W\Z]ST.\?3?AUI-Q$H:1-.M]H;IDH
MH&?SKFKS1A>Q^9=W,US+*Q9W=N/H!T ]A3T)U-CP+K-YK.F6MQ?SM<W NGA$
MA15RIBW<A0!^GI79YQ7C]SX8L[&SD>UWV[1_.IB(7!]>,5T_A36/.L6CUF_1
MK>-4,;SN$#9+#:Q)^8_+_CGK2*.N-\UPY2T428X,S?ZM?I_>/L/S%.ALE1Q)
M*QGF_OOV^@Z#_.:K6_B/1YHR8-4L71)1;DQW"$+(0"$X/WB""!UYK0BE29 T
M;K(IZ,IR* 'T444 <D^K7UT[RI>/;H6(6.-$("YP,EE)S6WH5_)?6CF8AI8I
M#&S 8#< @X^A%<Q:?ZA?J?YFM_PM_P >]Y_U\?\ LB4V(VJ***0PHHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH \@_:E\>ZUX#^$M^_AS3[R^UO4G&GVQL
MX6D:!I <R$*"1@ X_P!HK7F'[*7[)%I\-;6U\:>,XTF\4%#-!:S$&/3E(SN;
M/67'4]%SQSS7U:0#UKC/C1X0OO'_ ,(_&/AG36B34-7TJYLK=IVP@>2,JNXX
M.!D^AK>-:4:;IQTON<TJ$9U54EK;8Z^WN(KJ)98)4FC;H\;!E/XBD2\@DN9;
M=)HWN(0K21*P+(&SM)'49P<>N#7S?XJ^"_Q2TT2:)X(\10Z=H@9KB&]%PMFR
M$V-Q$T(MX81&NZ>2.3>H&"-VTLO-3PU\$?BCHOBK1]8;67E_TNQ:_6YUB1S+
M;Q37!=)2B*TNV*8*@+$9&'#CYJP.D[?]I+XTZS\(++1#HUM9SSZA)+N>\1F5
M50+P K#DEASGM7A/_#:?CW_GRT/_ ,!I?_CM=[^VUI=YJ%OX1%I:3W6QKK=Y
M$3/MXBQG XKYCMO!&M7,3R"R:$)R5G(C;'KAL$#W.!7Z%E.%P$\%"KB(QN[Z
MOU9^69WC<RAF$Z6%E*R2T7HKGMFJ?MB^.;,61CM-%_?6RRMNMI#R2>G[SVKI
M/!/[1/Q2\?1PQZ%HNB:C?B64R0%3$/*18SD%IASE_4_2OGK7O#6K$::!I=XQ
M6S0';;N>=S>@K;\(7_BGP%%I.L:187D=_:WT[!6MG*LICB!5ACE3S7?5R_!N
ME>C"/-K:^W7S/,HYICU7M7J3Y-+VWZ;71]W>#?&__"1!K+4;*31/$,"!KK2K
MA@63_;1AQ(A[,/H<&NKKXNU+]H#QMXMBABN_"EM:ZC 2]IJ<0EMI8),=4+$A
MNARG(8 Y&*]6^"?QQ\3>+M>&B>)M,M89R0D=S:JXWD([$GJO&S!&006''6OB
M<3EE6BG/16U:33MZ=;'Z'@\XHUI1I^\[Z*3BU=^?2_IIZ;'O=%%%>(?1A111
M0 4444 %%%% !7R[^U?X6MO$&O6\LO@N+Q(\5AM%R]ZL!3+D[<'KZY]Z^HJ_
M/C]N[59Q\4[J"*>6-8=,A&U'(&3N/;ZUY>8S4*&JZGK99!SQ&G8^R? J_8O@
MEI*16@TPPZ*JK;(^_P @B+[NX=<8ZUR_[/7PVT6Q^'&F:G=Z9;76I:BAGEN)
MX@[;2QVJ,]!@"O(]&TK_ (2S]G[X7,==UW39/[*>.1=*U6:U650VWYPC -T/
M)]ZZ?]G;0U\)_$!M,37->OK-=,*6]IJ6JS7,,>&7[J.Q .!P<<<UK3Q*]V%M
M[?D85<(VY5+[7_,B^-W[..FZ79IJ_AC?;S37"Q-IS-N1V8G!1CROICI]*@T?
M]D"[;1$N=1U55U3:6-C"O[O/93)].X%4/B3X&76?&&L2_P#"4^+(H/MC3);P
MZ_<I%$X.?D4-A0#G '3M7KO[-+R'X=/'/J6HZK<1WLHDN-4O)+J7)"D#<Y)"
MX(XZ=?6MH8I3G[.QS5,$H0]JWV/F7Q1\&]6T'69+:15MEW959LY ]B 0P]P:
M]#\-?"G6]/TEHXM*GVVT;/)+)%L+]SC/)]@*^I+W2+'4GA>[M(;EX3NC:6,,
M4/MFIKFZALXC+<2I#&."\C!5'XFNQS.%45<^2H+>6YN$@BC:29VVJBC))]*]
MZ\%_".Q\.74.H7,SWEZ@#(K*%2-L=<=R/6NGBOO#\=R;A)]-2X;K(KQAS^/6
MMD'(]14\W-L:*ER;BT444C0**** "BBB@ HHHH 3&:,4M% #)(4GC:.1%D1A
M@JPR#^%>7>./V;/ OC=9'?3/[)O&'%UIA\D@^I7[I_$5ZI2=ZWI5ZM"7-2DT
M_(YZV'I8B/+5BI+S/E2_^&?QI^"1-WX)U\>,M&CY;2KW_6!1V5&/I_<8'VKH
M_AA^V5X=\2ZBNA>,;.7P1XD5O*>&_!6!G]-S %#[,!]37T1M&>E<!\4_@=X0
M^,&GFW\0:6CW*J1#J$'R7$/T?N/8Y'M7JK'4,5[N-IZ_S1T?S6S_  9Y#P%?
M"/FP-33^26L?D]U^1WD4BS('1U=&&593D$?6I*^+VD^)O[&EXC2R3>./AD7P
M<_ZRS4G'N8S^:'V)KZG^'?Q)T'XI>&X-;\/7R7EI)PZ=)(7[HZ]58?\ ZN*Y
M<5@98>*JPESTWM)?D^S\F=>%Q\<1)TIQ<*BWB_S3ZKS1U-?)G[96EW'P^\9^
M OBWI43?:-+O%L[X1]9(\EE!]BOFH3_MBOK(<BO-?VC_  >OCCX(^+M,*>9,
M+%[J =_-B_>H!]2@'XT\MK*ABH2E\+T?H]&&9T'B,).,?B6J]5JCT#2]1@UC
M3;6_M9!+:W,2S12#HR, 5/Y$5;KQ3]CKQ<WBWX ^'&E??<:<'TZ0DYP(FPG_
M )#*5[77+B:+P]:=%_9;7W'7A:RQ-"%9?:2?WA1117,=(4444 %%%% !1110
M 5Q7QJ_Y)%XQ_P"P5<?^BS7:UQ7QK_Y)%XQ_[!5Q_P"BS36XF361_P"+8:7C
MK_9]K_Z"E49=QMXN1W[5\3>(]2\3R_M7Z!H.DZOK/]F :3=3:>FHRBV\H6T$
MLW[LOMVXW$KC\*^V9-WV>+D=^U;5*?LTG?=7.>E6]JY)+9V*&I!O[/N.1]P]
MJ\3^/4$<_AO3/.BBF\JUOYD$J!PKKIUX58 @C(."#V(KVS4MWV"XY!^0]J^9
M/VFOA-X^^)U[X='@ZRO;ZVM;*5;I;2]$"@N67Y@77.5+COP2.]9PI^U?)>QI
M4J.C'G4;VZ(R-;^%OA_P;J&I3Z7'=V_V#XAZ3;P1-?RF)4DLH'8[&8J6+$_,
M03CCM7U+^S]&!HMS((BNX+\Y4G=\S_QYVGZ!1CWS7Y_?"B35AKU[#K5]JDU]
M:^*-)6=+F]DDQ,))(V8Y8@L!&J[N3A0 <5^@/P CSH]W+LD^8*/,D1<MAG_C
MW9;Z$#'OFLYT?857"Y5*M]8I*I:QZS1113+.&M/]0OU/\S6_X6_X][S_ *^/
M_9$K M/]0OU/\S6_X6_X][S_ *^/_9$JF+J;5%%%2,**** "BBB@ HHHH **
M** "BBB@ HHHH *0TM(1D4 9/BGQ7I/@K0[K5];U"#3--MD+RW%PX50/3W/H
M!R:P_A5\5="^,?A1?$/AZ:22P:>6WQ,NR161L<KVR,,/9A7@_P#P4-30(_A'
M9R:A ]SKLUXEOI2K/(H1B=TC[ =K84$<@\L*[']E+X"W_P #_"[)-K,EY%JU
MO!=W.G2P@?9;O8/,V.#R,8&"/X1S67,^?E6QY'UJM+'/#QBG!*[?5-[?E^I[
MU1116IZYP/Q8^"OAGXSZ?96OB*&Z(LI&D@FL[AH9$+ !AD=0<#@^@KQ7Q/\
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MFC7#,"P)_4"OT'@_U$?^Z/Y5ZN#DIRDX^1Y6.A*$8*7G^A)1117J'D!1110
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M!Q7K5% 'DVG?LT>$;/4H[ZY>_P!6G,RW%W_:+Q2I?28U .TR>6%;?_:ESN4
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M9&\<L$EN ) P]0W'.#^%>R5M04U%NINV95W!M*GLE8****Z3G"BBB@ HHHH
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MDZBVCJ>34S*FY>SPR=27EM\WLCL?C#^V?9:;J3>$_AE9'QMXON"8HWM%,MM
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MM444 %%%>=Q_'CPDNI^(+:[O'TVWT2Z%C<7]X%C@>X[Q)\VXL/0J,@$C(&:
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M.I7.X#G&.:Z457N].MK][9[B!)GMI1-"SC)C?!&X>APQ'XFF!9HHHH ****
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MSU&,52N/A]?6LXBFNK.-TLTU"Y+,^VUA=5*,YVX);>@"IN.3C&:UM$^-6O\
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MU'#Z\TGOIZ'&SPRVL\D,R/%+&Q1XY%*LK X((/0@]J_73]DKG]G+P'_UX?\
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M%!R,\5;3X ^"I+N#Q+;>'@VF"9;1;1=1D>X< F(=6P6W8(^?A5Z^GM]CI_\
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MQ%CELO-M[*0R&&211*P490D$>O8GM_/&MHWBF/6-4N[%;:6)[<'=(PRA((!
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MVT0(%M8%"#"@1@;?IZ41Z=:Q0/"EM"D+_>C6,!6^H[UQ]Q\<OAY:_P"M\;Z
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M8(P!&45<@@9P2N2,]_QKTK_AE.__ .AAM_\ P&;_ .*I?^&4[_\ Z&"W_P#
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MH_\ XY7+)XB?Q2;^?_!.J"PT/@BEZ1_X!NI&D:A54*HX  P*?7/_ /"63?\
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M/8S_ *:#V]/O^#.@HKG_ /A+)O\ H7M8_P"_4?\ \<H_X2R;_H7M8_[]1_\
MQRCV,_Z:#V]/O^#.@HKG_P#A+)O^A>UC_OU'_P#'*/\ A+)O^A>UC_OU'_\
M'*/8S_IH/;T^_P"#.@HKG_\ A+)O^A>UC_OU'_\ '*/^$LF_Z%[6/^_4?_QR
MCV,_Z:#V]/O^#.@HKG_^$LF_Z%[6/^_4?_QRM/2]0?4[=I6L[FQ(;;Y=TJAC
5P#D8)XY_0U,J<HJ[*C5C)V7ZG__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>amci-20230213_g5.jpg
<TEXT>
begin 644 amci-20230213_g5.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" '" C0# 2(  A$! Q$!_\0
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MQQHH5408"@= !3+JUAOK>2"YACN()%VO%*H96!Z@@\$5[4<YQ/UGVTIMPO\
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M@MIISNEDAB56D/JQ Y_&E7S"-5U6H64XQ6^W+;_(NC@94E33G?DE)[;\U_\
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M_"'2_@IJ^D> K/3[W5[[2)88H+"T)EAC,1\R61F7C:NXDDYR*OW?_*/<Y_Z
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M6,>562MZ)([,%AGA:7LW*[NW?U;?ZGR+JGQ-\.?"W]M#QEJ?B;4!IMG-HUM
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M2J'!7;&5QG)!//M7JU85J+HRY9-/T::_ WI556CS)->J:?W,****P-@HHHH
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M_:FG]H/K1]IK,\^C[3[T<P>U-/[3[T?:?>LS[0*/M%','M32^TX[THNJS/M
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M.RU%)P\%Q<8 \V%L,&".K)GMSQ0!]$T5A>+=>N_#NCM=V6ERZQ.&"B".9(@
M>K,[G"J.YKSBP_:*@UO3]%.D>'[K4]5U'4;O2FT^"YB(@N;>,R.&ESL*[1D.
M#C!% CV2BO(K#X_IKEOI=KH_AZ]U'Q+>/=)+HOG)&UJ+9D2=GD/RX5I(U!_B
M+#%:G[/>NW_B3X76.H:E)=O=RWVHAQ?.7E0+?7"JC$D_=554#.  !VH ])HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHI* %KE_%WCFT\,(8ABXOF&5A!X7W8]A6)\0/B9%H
M8DT_3766_(P\@Y$/^)_E7CD^H27,SS2N9)'.YF8\DUA.I;1'B8S,(TG[.EOW
M[&_JNOW.M7;7%W*9)#P!V ] *I_:1[UD?:CZ_K1]K-<]SYQU7)W;-?[2/2D^
MT#TK*-V:HZQXEL]"LGN[ZX2W@3^)CU]@.]7!2G)1@KMDNJEJSI/M(KFO%?Q*
MT3P=&3?W69R,K;0C=(WX=OJ2*\6\9_':_P!3+VNBJ;&UY4W#<RO]/[H_6O+9
M[B2YE>661I96.6=SDDU]QE_#-2I:IC'RKLM_F^AQ5,;;2!ZIXL_:!UC6 T.E
M1C2K<C!;AY#^../PKS&ZOI[Z=I[F9[B9^6DE8LQ_$U5S1NK[S#8+#X2/+0@E
M^?WGG2JRF[R9+OH#5%NHS7;8CF)=U&^HLX[4;J+!S$N^C?46:-U%@YB7?74:
M<^;"#_=KD@<FNIL,I8V^>Z9K\_XUTRZ/^)?DSS,P=Z2]2YNI=U0[_<4;J_#[
MGSER;?1NJ'?[TN[WHN',2[Z-]0[OQHW>]%PN3%LUV'@KXN>*/ +J-)U25+8$
M9M9?WD1'IM/3\,5Q._W%&^JC-P=XNQM2Q%2A+GI2<7W6A]B?#[]KG1-::.T\
M2V[:+<D ?:TS) Q]\<K^1'N*]YT[4;75K.*[LKB.ZMI5#)+$P96!Z<U^86^N
MO\!?%CQ)\-[KS-&OBD);<]K,-\+_ %7\.HP:]:CF4HZ55='W>7<6U:;4,:N9
M=UO\UL_P/T8HKQSX2_M):%\0Q#8ZALT;7&POD.V8YCCDHQ]_X3S]:]BR,5[U
M.K"K'F@[H_2\+BZ&,IJK0DI+^M^PM%%%:G6<+\0?#7B[Q Z)X<\26>CVDL#P
M75O>Z<+D/G^-3N7!P2,'(KC(_P!G8PI#IZ:R'T27PNOAF^MI+;]Y*JM(RRHP
M.$.96^7!' JQ\6_BM=^&_B7X(\'V-W-I8U=IKF[OH]/:Y(CCV!8UR-HW,QW,
M<[0O;(-=%8?'3P;?WFHV\.I2%K*VGNVD>VD5)8H1F5HF*XD"X_AS0,XN']FH
MZEX0U?0];NM$8W4$,4%WI6@PVD@>*5)4DEQD/\\:%DX4\C%7[7X#WS:!#9W5
MWHEK=)JUAJ+/H^C)9QNMM)OVLJG+%N1DG SP.M;D/[1/@FXAT^2*]O)!J!(L
ME6PF+7. I)C&W+##@Y'& 3VJ]_PO+P:?$PT+^U&^UFY^Q>=]GD^S_:,X\GS=
MNS?GC;GK0&I'\8OAG/\ $[1]+M8+VWM9;"_2^$5[;?:;:?:&&R6/(W+\V?J!
M7+?#C]GR;P'J>FW;:O;W(L]<U#6#%;V0MT(N;<1>6J*=J!3SP,8XKM8?B]X9
MN/&/_",B\G34VD>&,RVLB0RR+]Y$E*[688/ /8^E>8_"CXTZSK0\)7?B/48$
MT^Z\*7&LZC,8511)'/M+Y X 3/ XH U;3X!ZUX=UM->\/>)8+#7/MFHL\EQ9
M>;#+:W<L<IB9=P.Y&B0A@?7BN_\ A3X(N?AWX)M-"N]1_M:XAGNIWO/*\OS#
M-<R3?=R<8\S'X5CV7[0?@F_M;Z=-0N$6SA6YD2:SEC=H"P7SE5E!:/+#+#@9
MKKXO%FF3^)Y- CF9]3CLDU!XPAVK"SLBL6Z9+*W&<\9H V,XHR!7 ZU\</!V
MA^(7T:[U-H[F*9;>:86\C6\$K8VQR2A=B,2RC!/\0]:\/\4_M-ZQI\WC>[M;
MNXABLM5BT/3[,Z)(Z0[G56N7?&7<?O,)D+]W@Y% 6/JX'-+63H5YY?AJSN+N
M]>Y*VZR2W=Q"(&<8R79, )ZD<8KD/#GQ_P#!7BO7+/2=.U&>2[O8Y9[7S+.6
M-)XHUW-(C,H#)@Y!'7M0(]%HKS_2?CMX,UD:N8M3DA&EVOVV?[5:R0[K?)'F
MH&4;UR,97/)'K71>#O&FG>.M*?4-,%TL"2F%A=VTEN^X '[K@'&&'- &]111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M"9Q7E_Q0^*"Z0)=)TJ4&]/$LZ'/E>P_VOY4_XL_%%?#$3:5IT@;5)%_>./\
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MVKCO\]*3-5&4H24HNS1K1KU,/4C5INTEJF?J%X,\8:;X\\-V6MZ5+YMI<H&
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M;K5H08;N(/C^ZPX9?P((_"MRO?335T?NL)QJ14X.Z>J"BBBF6%%%% !1110
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MT&VCN-0NDM('E2!7DZ%W8*J_4D@5?!S0 M%%% !1110 4444 %%%% !1110
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M-.&R5@HHHK$U"BBB@ HHHH 0G )JFQW,35B=ML>/7BJU7$SDPHHHJC,****
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M& @[!;K]V,C.&4=@V<'D<UN:#X+T3PO-/+I.GPV,D\,$$C1 C='"FR)3[*O
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MK3B[,FTX$P(/F!<X#\#+  GN:[-2,^] #Z***!!1110 4444 %%%% !1110
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M0N"&;(.:J7/P['A"WUOQ);KJ?COQ2]GY%N-9GC<A0>(XU54C12?F; !;')H
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M6 Y&"0" >QYKGE_95\(VO@+PYX16ZU8Z5H6K#6+5S<1^:TXD:3#GR\%<L>
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M+>-I9IYW")&@&2S,>   22:X2']H+X?WNEZM?6?BBQN8=,MOM=QM8@K%G D
M(RR$D ,N1R.:M_&CP[?>)_AWJECIUH-1N28IOL+.%%VL<JNT.3P-ZJ5YXYYK
MC)+JY^)/C'P]J&F^&]6T6WT;3[H74VJ636IW2QJJVJ!@"^"I)*Y7Y1R<B@#>
M_9[^(,OQ.^'5EXAN-:M=8NKOYYDLH/*CM'(!, SRQ7(R36C#\>OA_/JUOIJ>
M*]/:]GG^S)%O/^MW%!&3C"L6! !()QQFK7P>TZZTCX4>#["^MY+2\MM)MHIH
M)5*O&ZQ*&4@]"#7S=X'FN_$?P,U[P-IWA?4I=6U?7;]8;]+4FS56O&)N6G^Z
MICVD%20_RC ((- 'TA=_%'PG:^+W\,2Z]9QZ^K;6T]G_ 'J_NQ)DCL-C!LGC
MFJOA3XP^"_'&K-IFA>)+'4[\1F8002<R1@X+H2,.H) RN17G_B#X9ZSK>A?&
MW2[*$VNHZ]%#;6-W+E%N<:9;Q</_ '=ZNA/;FJ>N)?\ Q7U#P-9Z-X6U3PS+
MH,LUU=W&HVAMH[(&RGMQ;Q,?]82\J<QY7:F<]*U1B]S;\>?M :#9WNEZ7X;\
M0:=>:Q+K=MIT]OG?\IDVS*IZ%E'7!)7N*]!?X@>'HM"U'66U6 :7IUS):7=T
M2=D,L<GENAXZA_E/O7S]&FLW?@'X>^#AX,UL:QH&LV/]I7$MEM@B6&3#W"2Y
MVR*_4%23@Y;%1>*=+\1:5\-OB5X%A\*ZUJFJZCX@N]2LY[&T+VTEK<7:W"R>
M:<#*ABI09;<.%(R:'H):GT/XF^*OA'P5JEMI>LZ]:6&HW"AX[1F+2E2=H<JH
M)5<\;C@>]<.O[2/A3Q--XTTK1?$>G6>IZ&A*75XKO#M"(SRLH )568J1GJIJ
M/2[V[^&_Q1\8RZMH.L:K#KT\-QI^J:;9-=($"!/LSE<F/:0S9;"X8G-8'Q'T
M_5KRR^-.AV^@ZK/=:W;07>G2Q6C/#<*+2&)D#KD;P\;#:3GH1FLC<]2\2?%_
MPAX#^R0^(O$=C87<UN+@1LQW&/O)M )5/]H\>]3Z[\7?!WAJ&UEU'Q#96\=U
M:B]MF#[_ #X25 >/;G>"6'W<GG/2O/;2_O?AEX_\0ZEJ?AS6]8L]8L+(V5SI
M5BUV8VAA$;VI5>4)8%P6POSGFJ?PK^'6J^'O'?@R?5=':!=/\*7D)?:'CLYY
M;R)UA#CY=PC++P>@;!Q0![5X=\1Z5XQT2VU71KZ#4]-N5W17-NX9&'U]?;M7
M.ZY\3_"OAWQ/;>'M0UNVM]9N6C6*T.2Y,C;8P<#"[FX&<9[51^!NB7GA_P )
M:G:WMG)8NVN:E-'%*FPF)[J1D8#T*D$>QKB/%,5]I7Q<-YX2L?$5MJU]J-G!
MJMO+IY;2[ZV!427'G8VHR1E@#N#93&TY&:3L3)7/4/\ A.=!_LB\U7^TH?[/
MLYWMKBXR=L<BMM93[@D"L?Q)\:/!'A#4+BQUCQ'9V-[;!6F@D)+QJR[@Q !(
M7:0=W09&37C.MP>(-+\'>-?!D/A36;S5;O7YKR&:*U)MI+6297\T2CY<@9&S
M[V1TQS6O8^+$\(_&CXI22^&=4ULW%MID<;:;9FXW.+4X@<#E-V?O, G!R1Q6
MAD>J:_\ %_P;X7CLWU/Q#96RWENMU:_.7-Q$WW7C"@[P>V,^M7)/BUX/L/"%
MKXEG\16":%=2"*WO1*"DSMG")CEF.#\H&>#Q7@GA=;GX5>._ L&KZ'?:A<V?
M@Z2*==+@^U26;-<!M@5?F*CA,J".!VYK2\*>']:\'SZ!XRU#PUJ,U@^M:I>R
MZ5:P>==Z?'>!/*F,*Y)*^6P=5RR^:< \U+V*CN>R)\9/!,WA<^)%\3:>-#6X
M^R/?-+B..;O&^?N,.,AL8[URD7[4G@:Y^)&A>$[75H+G^V+7S[6\1CL>0RB.
M.(#'5CG!Z<5POB3P=J_C2XU37H?#VH6FFZKXMT:XATZXMRDQAML"6[>+J@8X
M^\ V(P6 R*[?QII6HV'Q_P##6NII]Y/I-SHEQHOVRR@:86]Q),C(9 N2B8!.
M\C:,<FLS4[:T^+G@Z^\5MX;@\0V4NMK(T)M%DY,BC+1AONEP.2@.X#G%<C\3
MOC_X?\.6UWIVCZ_ITOB2WO8+1K1SOP[2HKQD]-X5C\N<CTKR_P"''PSN(I]$
M\/\ B23QR^J:1K7VT1B!3IKR)*SK="?;MV-G)&_?R1BI+^WUJ+X8CP*O@;5Y
M=<M==2>:5+/=:M$+L2&[6;[K9!S@'?G.1QF@#ZD@):-6/4J#4M16XQ$@/!VC
M(J6@ HHHH *\$_;+LEN_A=:DG#1ZA&5/_ 6%>]UX3^V'(%^%L )Y-_&!^35M
M1BIU(Q9XF=J,LMKJ6W*SX?.D\_ZP?E5E=*M<<R3?@!3C)^%()*^A^J4NQ_/L
M:5!?9(WTN /\KN5]&QFG#3;;'\?_ 'U3O,]Z-_O3^JTOY2O9T/Y41KIEN"<E
MR.PSBOTM^'3^9X#T!O6RB//^Z*_-;S/>OTG^&H(^'_A[/_/C#_Z"*\W'4H4X
MQ<4?H_!BA&K6Y%;1?FSI:***\D_5 HHHH **** "BBB@ HHHH **** "BBB@
M HHHH \#TWX1?$*WTSQ!X6&N:'I?AC5]1N[N2_LTFDU)8II"S1H&VQHQ!V[_
M )L9) )JQK/[/]W->>)AIMU9VVGZA)HAM(7W;HH[$G>&P.K#&,?CBO1(OBKX
M3G\12Z''KEM+J4(?S8T#,D912S!I -@8 $E2V1CI52S^-7@F^TG5-2B\16@L
MM,,8O)) R>0)#B-F# ':Q!PV,'!P>#0/4X#QW^SY<:_\1=;\16=GX7U6#7H[
M>.[3Q%8R326;1)Y>^$(P#AE RC;>5SNYQ76^'O!'BCP5XJOX]'O-(F\):E>M
M?30W<4BW=JS >8L94[7#$9!;;MST:F^(?VA?!>B^$?$&O6VJ)JL>BQ^9/:VJ
MMYQSG;A2,[6((#_=XZUTFB?$GPYXBMWDL=1$OEVHO9%>*2-DA)9=Y#*"!E6[
M=J ,OX0^#=8^'_AN;0]2N+&\MH+J9[*XM=ZN\3NS_O5;@,"Q'RDC S[5YSHO
M[/GB*S^(.D:W?ZCHU['IFMW.IC46BE;4+N*4RE8I&;Y4\L2*H"\$*/N]*]3C
M^*_A*?5++3H=;MY+V\BBN((%5BSQ2!BC].%(0\G@<9QD9L>&/B7X7\:7]S9Z
M)K=KJ-S;C<\<3'YESC>A.!(F?XEROO0!P_PB^"^I_#R]\,S7M]:72Z7H5WI4
MH@W9>26\6<,N0/E"J0<\YIW[5Z9^"&M8'26W/_D5:]?Q7E?[4%N;CX)>(0/X
M1$_Y2*::W/'SA<V78A?W)?DS\]3@THHI,^]=A_*]Q:Y7QBF)[<^JD?J*ZH=*
MYKQFOR6S>Y%>_D,N7,*?G?\ )GH8!VQ$?ZZ',;J!SZ4F?I1FOUD^M''BCK3<
MTN30,Z3X;7!M?B)X6FSCR]5M6SGTE6OV$C;?&K>H!K\6[2ZDLKJ&XB8K+$ZR
M(P[$'(K]DO"U^NK>&-(O5.Y;FSAF4CN&0'^M?G?%D-:,_5?D?H?"DURUH>C_
M #-2BBBOSX^^"BBB@!"H)HVC-+10!D^&?$NF^,-$M-8TB[2^TVZ4M#<1_=<
MD$C\0?RJOX,\&:;X$T8Z7I22):&>:YQ*^\[Y'+OSZ;F-?,7P3U/Q9X._9U\$
M>+8->B?3(YX;-]#-NI1X);WR"5D^]YH,FX=N,8KT33OB5XHN[>P\,M+&/%B>
M)Y-+NI%0#_0XOWQGVGD!H6C^;&,M0![?=)\H/I5>N"^/'Q U+X?>$;"72;>6
MYU#5-3M]+B,,!GDC\S<2Z1@C>P5#A<\DBO-;+XA>.K'PSXDOKN+5H+7P_+;Z
MA#=Z]I@LY-0M\D3VY7.-P&2I7'S;1ZUI'4SEH>[ZGK^G:+<V$%]>16LU_/\
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M0[4 /KDYZUZ%169H<%8_".P@\3V^LW>JZQJOV6X:[M;+4+LRV]M,P(WHN."
MS <\;C7>T44 %%%% !1110 5\'?MBZ^=6^,4UF"-FF6<-MP>[ RD_P#D0#\*
M^[9I4@A>5SM1%+,3V %?F'\2O$)\4>/_ !#JI)/VF]E=<G/R[B%'Y 5Z^6PO
M5<NR/SKC?$^SP,*"WG+\$O\ .QSN: Q'>F[A2;O:OI#\2N2;O?\ .C<:9NI-
MWM0%SK_A/I@UOXE^&+)AE9=0A#?3>#7Z:BO@;]D'1EUGXS6DKQB2.QM9KHY'
M (PJG\W%??)Z5\WF<KU5'LC]MX(H\F!J57]J7Y+_ (<,XI:\Z\?^.-=M?%^B
M^$O"T%C_ &M?027UQ>ZJCO;6ELC!2=J,K.[$X"[@.I)J;3?&6H^'?#VJ:EXF
MU'2]<2"<);GPQ:2EV!  1HC)(=Y;/1L8Q7D'Z*=_29 KSIOCSX7_ .$9M-8A
M&H79N;B2T33;>S=[Y9DSYB-#]Y2H&3GH,>M<A\6_CA<^!O"OB?4M*ENK^]C?
M3X+>V;3"PL3<,JAWP06.&) ;^(*O>@=CW3(]:6O)/"?Q5L-*T'6;W7/$%_JC
M65W!:B&[TM;:Z$SP(ZP+''_K';=G  ()(Z"MA_CEX8_X1B+68VOK@R736(TV
M&T=KT7"C<T1A^\&5?F(/;F@1Z%2UYK\$/B!=?$+3?%5]<S-)!:>(+JRM \/E
M/' @3:C+@'<"S YYSUZ57NOVD/!5G?M;SW%[$JW,UC]H:S?R3<QLP, ?H9&V
MG:HZT#/4J*X'0?C;X8\1/I$5M+=1W6I7L^G):W%NT<L-Q$GF/'*IY0[,-SV8
M>M1ZW\<_"^@S1P7#WDEQ+?76FQ0V]JTCRW%NF^1%4<DXZ>IH$>@Y'K1G%>9V
M/Q;T;Q%JO@Z[L-;DM-/U6._8V<UF,RF!5W^8[',)C.<C'.<'I534?C?HVM:>
MLNEWNIZ7:B^M(H]4DTIGM[Q9)@@6)GP&5LXW#H#D4 >KYS03BO-3^T%X1BUN
M;39);U!!J#Z7<WK6C_9;:X#^6$DE^ZNYR%4GJ2/6M6?XL:'#XUA\,RI?PW<T
MIMXKN2T=;228*6\I92-I? /'^R?2@#MJ*X#X$>+-2\<?"S2-:U>99]0N)+I9
M)%0("$N98UX''W4444 =_1110 4444 %%%% 'GGQHM_&K>%6N/ ]XD.HP$M)
M;M$&>9/1"> P]".:^#O$_P 1?&>N336^MZ_JTS*Q#VMQ<.JJ?3R\@ _A7Z9X
MQ7@_[07[.%O\1HY-;T%8[3Q%&OSH?E2Z _O8'WO0]^AJX22W/S[BG)<7CJ?M
M\'4E=+6%W9KR7?RZ^N_PUU.3U-&/<U8U'3KG2+Z>SO8)+:Z@<I)%*I5E8=B#
M5?K74?@;3BVFM1.G%)(@DC9&&58$$>QI?6C%--IW0CS26)H971NJL5IA%:OB
M>W^S:K(<?+( P_+FLHGBOV[#5EB*$*J^TDS[FC-5:<9]T)2]J3(H!Q74:BXY
MKW_]B;QVO@_XUV=E/($M=;B-@2S8'F$AH_Q)&![M7S_G-6M+U2YT;4K34+*9
M[>\M)4GAF0X9'4AE8?0@'\*Y,7AUBJ$Z,OM*QV8.N\+7A67V6?M'FEKEOAIX
MXM/B/X&T;Q%9D&.^@#LH/W)!PZ_@P-=37X/.$J<G"2LUH?N,)*<5*.S"BBBH
M+"BBB@ HHHH **** &N@=2#522,Q'GI5VFN@<8-4G8EJXD3[T!IQ.!FH8E,+
ME3RIZ&GR-VI,:V&,<G-(*7J*3I2&+0#BCMFDI@2HV>#4-T<E5_2G X.:<J[I
M-Y^@H6@GKH+#%Y:^YZU)112!:!1110,**** "BBB@ HHHH \W_:#\8CP3\)M
M=O0^RXFA-I!\V#YDGRC'T&3] :_-XOD\GDU]/_MQ>.C>ZUHWA6"3]S:(;VY4
M=#(WRI^2[O\ OJOEK=7U.74N2CS/J?@O&&-^M9C[&.U-6^>[_P OD3;O<T9]
M*AW4H:O3/A20GC&:7=[U$'QWHW4 ?7G["GAL>1XGU]U^=FBL8CCH!EW_ /9/
MRKZQ(R*\G_9?\)MX2^#VCI* )KX&]? P?GP0#^&*]8)P*^.Q4_:5I2/Z5R#"
M_4\LHTGO:[]7K^IYI\0_!/B&7QGHWB[PL]E<7]I;2:?=Z9J3LD-U;NP8X=0=
MKJ02"00<D&O/;7X+>,=.TO7)-*AT[PP-4\06NHRZ1H5\]HOV..'9)$LR(-CN
MP#$J!W&>:]S\0>,M#\*_9_[9U:RTO[0VR$7<ZQF0^@R>>WYU#>^.O#FG:Q!I
M-WKNGV^J3X\NSEND65\],*3GGM7(?0'@^D? KQ9IW@WQ!9S65J=9OM=N]6T^
M_M-<N([C3S)!$D;"X8&1CE&#!B=PK?U_X-^*M8\*^)+.ZO;.]U74VT-S=LY1
M9I+2:)[AR OR[MC$ 9Z@<5VV@_$6\UW7M<L5AT^VCTOQ$=%)N9V1YHQ9PW&Z
M, '=)NEQMX&U2<YIGC'XQZ1H.N:)I&GW^GZEJEYK5OI=S9I<*9;=9-^6*@Y!
M!4=?6@#B/&OP/U[Q!=:[>VTEN97\5VFOVD O9K<S11V@@>-I8L/&QRY!4]A5
MK3OA/K?AS5-(\1Z+H]E!J,&I7-S=Z9<:M/<?:(YH%B\QIY=S&8"-!G&-HQ7L
MTVJ6=KJ%M8RW44=Y=*[PP.X#R*F-Y4=P-RY],BJ</BK1KJQMKR+5+.2UN=_D
MSK,NR39G>0<X.W:V?3!]* .1^"O@[7O"6E^)6\1BR34=6UVZU79I[L\2I*$P
MN6 .1M-<W)\']7D\-:-88LC/:>-/^$@E)<[3;_:I)>/EY?:PX]<\UZ/8?$+P
MQJFE7FJ6FOZ;<Z;9G%S=172-'#_O-G _&L&_^.O@BPU_PYI#:]:33Z\LKV<L
M,Z-"1'@'<V[C+':N,Y(([&@#A]0^#WB6S\;ZAXIT];&YN8_%;:U:V<TYC6:V
MDT^WM7#,%.UPT3D<$=.>:F\,?";Q1!XR\-:[JXTY6M-?U?5;J.VF9@L=U R1
M*F5Y() /3IGVKUFW\8:'?:Y/HMOJ]C/JT S+8QW"M,GU3.15/Q5XS3PYJ6@Z
M9#:F^U/6+HP6]N) @6-%WS2L<'"H@[#EBB\;L@ \DU/X ZSK6L6)FN+:WL%G
MUYIGBE.]4O$41%1MY((.X=O>M?6?!7C?Q7X'T70=0T_1[&;3+ZPG,]K=,8YE
M@G5F*ILRGR+P#GGVK:^#7QTT[XMZ+KU\+&319-%NY+>Z@N)0^$7)24' ^5E4
MGIV([5S?AG]J:T\8Z!87FE>'+EM0U36KC1M.LKJY6%96B0.9))"/W8*G.,,>
M,#- :G,Z/X1\4_$#0/'7AJUMM-@T.^\:W4EQJ3S,)HH8[T22 1[<,YV84Y &
M<]JUI?A!XYU'QGI&H:E?"^BL?$?]J/<S:O<&,VPWA(XK3_5HP#<D@YQP1FN^
MT3QY)I?BZR\,ZMX:@T"]U*SN=5WV5RLT+-'(!)EMB$L0ZODC)R<CBN<\/?M,
M:;XG^&U[XJLM'N'E@U4:2FFM*!))(TPCC;=C@,K!^AX]: .Q^"7@S4/A_P##
M32M"U-H6OK:2Y9S;L63$ES+(N"0/X7';KFBM+P5XX@\56-]YT(TW4M.O)-/O
MK)Y YAF3#<-@;E9'C=3@95UX%% CJ**** "BBB@ HHHH **** /&OCO^SSIW
MQ2LI=1L%2R\2Q)^[F&%2X_V9.,_0]J^%-:T2^\.:I<:=J5K)9WL#;9(95((K
M]4*\K^.'P+TSXM:0718[+7X1FWOE4 M_L2<9*_RK2,[:,_.N).%X9BGBL(K5
M>JZ2_P"#Y]>I^>M%:_BKPGJO@O6I]*UBSELKV$\I(,;AV93W!]:QZZ=S\)G"
M=*3A-6:W3.>\8VGF6L5P!DQM@_0__7KD:]Q\!?#JY^*OB>V\-VV5^U!C)*%R
M(D52Q8^G0 >Y'K7B^L:5<Z'JEWI]W&T5U:RM#(C @A@<&OTKAO%*KAW0>\'^
M#_X-SZS+(5'A?:27NW:3^Y_J5LYHIB\4O<5]>>B.S13#2TT!]N?\$_/BPKQ:
MEX O90'7=?Z?N;[PX\R,#V^]C_>]*^U*_&WP'XRO_A]XOTKQ%IC[+S3YQ*F2
M<,.C*<=B"0?K7ZY>!/&-AX_\)Z7K^FRK+:7T*RC:P.PD<J?<'((]J_*N)<![
M#$?68+W9[^O_  =_O/U#AW'>WP_U>;]Z'Y=/NV^XZ"BBBOC3ZX**** "BBB@
M HHHH **** $/ J)LDTZ1NPIH&%SW/2@!/UHQUHQ1C -,!**7KUI*0 .M2QG
MM4=.4X:@"6BBB@ HHHH **** "BBB@ K*\3:_;>%O#^I:O>.$M;&W>XD)/95
M)Q]3T_&M6OE?]LGXI""WM_!EA/EY"MS?;'Z*"=D;8/J V#Z"NO"X>6*K*G'^
MD>?C\7'!8>59]-O7H?*'C?Q==^./%FIZY>$^=>SM+MS]Q2>%'T&!6'D^M:,U
MM%,.1L;^\M4+BUD@)/WE_O+TK[:5&5)6MH?S9BJ%;GE4J:W=V_4;D^M&3ZU$
M6QWHWGU/YUD>?8EW5T/P\\,S>-/'6A:)"CNU[>1Q/L&2L>[YV^@4,?PKF=Y]
M3^=?4/[#G@1M0\4:EXJGBS!81&VMW9>DK@;B#Z[<C_@5<^(J^RI2F>SD^!>8
M8ZEA^C>OHM7^!]GV-G%I]G;VL"B.""-8HU'0*!@#\A4S]*=17Q9_3*5M$>&_
M'O0+N;7=+UW1-&U'5_$MG:O#:PG3H[S39E9P3'<!B&C)P"'1@0,]>E<IX@\(
M:E+I_C70;GP+=7WB?6+]IK+Q%% CPH),>6YG)W1^2,+C'\'%?3F!Z48'I04>
M :-X'U^T\97-S-I\Y@/CTZCYY PUM_9$,/G?[OF*R_45QOAOP3JUOIOPUT2Y
M\!WR^)=!\10W&K^(GMT,<RJTGF3K-G=(KE@W(^M?6. >U&!Z4!<\E_:#\/:]
MJ&BZ'K/A2T-SXCTN_P!L9C'SBWGC:&8 \< ,CG_KF/2O,--^&7C7P1/XIM-,
MT>/5=*\.6-TOAZUNUWPWKWGE22#;D;MA-RN./O =S7U3@>@HQ2"Y\G6W@"[U
MF;QBVJ:%XHCT2\M-*,1M-+M;6=KJ"Y>3=';(NTHI$>1)N)7()-;MGX9UVYUC
MX6^(M:\("8Z=)JEE=)9Z9''+&DNT6T\D )"?<+-@_*6XZU]*8HQ3"Y\P_!GX
M87>D:_X<C\0V7BB/Q#HMU=RRWWV:S&GSL^_+FX6(32JX?(#.3G&>E>F>.$:S
M^-_P\OYE(LIK74M/64_=6=TB=%)[%EBD ]<8KU+%5K_2[+58XH[VT@O(XI4G
MC6>-7"2*<JX!'# @$'J#0!\JZ1\&_&5AX8T&#3+.33CX@:YT?Q)$QV/%;_:G
MFAN>/X@GFQYYXG7TKHK3P7;Z/X9\4:/XA\":QK6FWWBN^NK/^RX09K>+">5,
MA#!ES@@,ISQ7TCBC% 7/E[Q%X2^(%S\*=!UNWM-3U#Q9I%_?VUC#?N#?MIUT
MLD"&X8<-(@:&1O\ KGGK6K:_"+5/#_QET+3K*PE?P;(EGJUW=( L45U:6TMN
ML9'<N6ADZ?\ +,U]&8H*@]0* N?/%AX5U?QAXY^(>K:-.8M-EUU8HY58A9FB
ML;2&1E]<21NF?5".U%>_:;I5EH]FEII]I!8VB$E(+:,1HI)).%  &223[DT4
MK!<M4444Q!1110 4444 %%%% !1110!YY\8?@UI'Q;T3R+I5MM3A4_9;Y5&Z
M/OM/JOM7P-XZ\!ZQ\.O$%QI&LVQAN(S\LBY,<J]F0]P?_K&OT\KBOB?\*=$^
M*VA/I^J1^7,H)M[V(#S8&]03U'J.]7&7*?"\1<-4\VBZ]#W:R^Z7D_T9XU^Q
M=\/GTO0M0\5W,>V34/\ 1K;(Y$2MEC]"P'_?-> ?MW_#!O"/Q.A\26L(73-?
MBWDJ,!;A,"0'ZC:WOD^E?H+X;\/VGA70;#2+%/+M+.%88P!Z#J?<G)/UK@?V
MC?A/'\7?A=J>DJB_VG OVFQD(Y65><#@_>&5_&O:R?'?4L9&I)^Z]'Z/_(ZG
MDD:63QP,/BBK^LMW]^J/RA&,]*"<>WM3IX7MYI(I%*21L492,$$'!%1\U^T[
MGYE:P$Y^E+^= /K1G_.:86#'-?6'[#7QW'A/7W\#:Q<-_9>J2AK!W/RP7!ZK
MDGA7P./[WU-?)_YT^WGEM)XYX9'BFC8.DB'#*P.00>QKAQV#ACJ$J%3K^#Z,
M[L%BIX&O&O#IOYKJC]K%IU> ?LE?M!Q_&'PBNEZK(B^*-*C5+@#C[3&.%E S
MUZ;O?ZU[\#FOQ#$X:IA*TJ-56:/V?#XBGBJ4:U-W3%HHHKE.@**** "BBB@
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M,,VS#Z[5Y8?!';S\S]XX>R=97A^:HOWDM_+R_P _,****\$^L"BBB@ HHHH
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M\^SG-O;7PU!^[U??R]/S/V+AKA[ZJEC<6O?>R[>;\_R]=@4M%%?('Z,%%%%
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MB2&Z\(KX3DDV+N\L1E#,/]K!SCI1=?!S7)KZSU*#Q<UIJW]C?V'=SQV"E)H
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M6QF-:G67LX>>_P E_G8^7_@A^Q'?:U)::QX[+6&G_+(NE1,5GE'!VR''R#U
M.?<=:^T/#GAC2?"6E0Z;HVGP:;8Q !(;= H''4^I]SS6KBEKX+&8^OC97JO3
MMT1^MY=E6%RR'+0CKU;W?S_38S/$6L#P]H&IZH\9D2QM9;DQKU8(A; _*O"-
M G,_A7PIXV\:?$K7M)U77A:ZE#!8R^7IMN)BCI:"(1LC)\XCW29=LYW XKZ#
MN[:*\@EMYHUEAE0QR(XR&4C!!]L5XR_[/FHCPW;>$$\97;>"K:XMI8+">V62
MXBB@E26*!9L_<4QJ!D$@#&:\X]DUO$/QS7PK\0--T#4]*6WL]1OTTVWN?ML)
MG>5P2K>0&W^62,;L=2.*R9/C.GBWP1XFU:?1I5\/61,:RVNI*MRSK.J%'6-@
M\+=\$@X^M-?]G$-XA:]3Q"\=I_PD4?B0Q+:)YTLZMN"2S=70#(48&,]>*M7_
M .S^==UKQ%J^J:S$VI:O8)ISS65BD!:))DD5Y>29' 0*&/0<4 <!?>,=3/Q
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M3^-;+2O#O@K4(](7PIH5ZERNJQ3NUU=1QR&2-!'M 1MVT,<G@''6@#L-._:
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M^>*]6&;8">U:/WV_,\Z65XV.])_G^1X#6XYQ!:_]<5_K7H[_ +'_ ,7%./\
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M\9P?M$\9AB _WVP*_2GPE\%/ W@4[M#\,:?8R8QYHCWR'ZLV3^M=JJ!5
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; "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>amci-20230213_g6.jpg
<TEXT>
begin 644 amci-20230213_g6.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X1I>17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     @   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E    *8   !(     0
M $@    !    1TE-4" R+C$P+C(R   R,#(S.C Q.C(V(#$V.C(U.C0Y  $
M : #  $    !          @   $$  $      0   0$$  $   !T     @$#
M  ,    , 0   P$#  $    &    !@$#  $    &    %0$#  $    #
M 0($  $    2 0   @($  $   !$&0        @ "  ( /_8_^  $$I&248
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M*** "BBFR$K&Q'4 D4 .HKS<^)M<W$?;>_\ SR3_  IW_"2ZW_S^_P#D)/\
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M,A=/](7N.G6M6[^'OB26Y2ZBT^-9>Y,R94\C.<\Y&,_2MYM-II[F,4TFK;'
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MML5 -]I+_-TW../7[F,_0"O6:*5SNL,A0QP1H>JJ ?P%/HHI#"BBB@ HHHH
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M?\..G2KP&  .@HHH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<P
M    #61E<V,   $@    0&-P<G0   %@    -G=T<'0   &8    %&-H860
M  &L    +')865H   '8    %&)865H   'L    %&=865H   (     %')4
M4D,   (4    (&=44D,   (4    (&)44D,   (4    (&-H<FT   (T
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M87)A       #     F9F  #RIP  #5D  !/0   *6V-H<FT       ,
MH]<  %1\  !,S0  F9H  "9G   /7&UL=6,          0    QE;E53
M"    !P 1P!) $T 4&UL=6,          0    QE;E53    "    !P <P!2
M $< 0O_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! ?_" !$( E4%)0,!$0 "$0$#$0'_Q  >  $  @(# 0$!
M    !P@&"0,$!0(* ?_$ !T! 0 " P$! 0$            $!0(#!@$'" G_
MV@ , P$  A #$    =_@
M    (VOJND?UKA6&7SEDCN31LX]6WXG0_P";?/[AZ\Q_FSS^@_H]?7ID^FO[
MQ]^=^O[\\^=._FKI7JT=M%G-6_OT5EFGT3D_$ZVA_OC^>;/G!]$D<_:W;^5=
MR
M     !6[O.8TH?K/X4K)/IU%IYE9*S7EK7!N[YO@MX'S/C?+#IU\SN6,#Y!R
M'UFY,GUF^_=7V\^<MW\HYOW56'E?/NPC/Y/VM3^6Z"X=C7Y+W?+Y3^J?B71J
M+#FVZ/K:_N/MD> ZG=G^5?N0 Q\_A]GO'CGH$;$HF.GCF=     '5!PGH 'G
MGH                                                 %;^XYG3/^
MD/D6)_-.NB[A.IM/S=Q!?1U/M$G[]6(_H7Y+[OS7L,6NZC@^F<FV:_OW'^8.
M38]7C[KI=!7_ ';1?BAL>Y1VF$\1T46_*NYKQR=OXL>7'_FRTES ]J[J)P_3
MGQ[.:[/RI^CM7E5]8^6-X3J=UWY7^Z "@Y3TDHM$4]+&D4EGB&3QB5")R^IB
MYB9Y9G)&ID9X![IE1C9CQ,9C9ZA7,]TMN4],P,W)\
M                           !5CH:K\OTS1UN9O?I[L[UZZI5ECKVG1[L
M28=O?HG(7EA[*&=#5>#^B/E7\WZGOGWZ^_<<PH)F%[-G8I+3Q.-OH:^9=G7#
MANJC:-N[QF6W'G[&@LQ9U]J(^,=MN;_=?F''IW^-W7)_S'*QG#=1NH_*OW4
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M,],   \X^3TP
M4:Q]T<T5OY>[VOEE7[8\X5%=4OBT[-A5=)UYY>6@NJZN<G39/]E?G?AZ"MZL
M;;UOGW5]BFGP/\Q[>!>.Z2-:Z0Q],[(SX6Q^CF5%O*_'.@K/8\W\M1*\VME>
MK]C^>^Y\P[K[^H\)GOW[Y1]9>6(X;I]SOY4^Z@"I9@1(QB1FY!)/I&1]&8&-
MGO':);(X(I/7,F)+(H,U/?(R.,C0G,B0E$CX]$D(L>
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MY\X+JHL)PW4[E/RI]Y &&G.>>?1\F=%<STR1#) 5I,J/5/X8"6H
M                               !6JVJJ&]-SW*?9R'T?9R'\/H'\/Z?
M++^ME<.0^H=C+.>NG^6=<XGO39_TVQ\ATV::-P  K=AGHESPA.PB3A2V<B1]
MMM-66,XZ-1%AOBN7"BO1MMM!V81<18#UY]CQ^BG9#U31[&M=G7WIIYL/Q\J.
M64.S&?DF2XTQRM'@1-^O2'-L'YY:??'@G=GG\;;'^C*X>..4?K3X-Q]IS-@>
M&ZC<?^5/O( KV1T>D><8 72*M$C%;B7RVI3,SX]0BDC8V5
M                           K=:UM%.DH>7+'F]??CD\<F+[\?6>OY9GO
M]R?SS(<NCSRV7?\ <?/R\X/7%EGTL,V&6UKD>ES+3M  %8HDC4O0W$ YZI#F
MZ[)R(^#Z<;><_GU<YWYO.GKHVEP[O:]M8L_,YV89MIW;>I$&H6R5@/;\Q"_S
M7K8DE:(]V86XLZZ[\N)NKJ+')(<C\R-?.]K[/\ZOK\N[74A,CVKZNFIC"D7+
MXF\D#]*?)>_]9^<S[PW4[B?RI]Y      Q@R<
M                    %<K&NHU>T?9V8\[SE/[F^C[/MD>/#%]LL=U[(PYW
MH_3U>Y[TO.?3)K]ZLK3U-3ZPSVI<UT>8ZMH  H]CL_.#5V64[->-R8VZ/3MU
M5;F,:<-QG/6FO;59T)O*BQ>V,STP'CMF:#+VTVU34_1NJ#/T="-G@[R").K8
M!>55[M7FX.KLLRU9?EYPVTJWMA$'SM=;2=FPB\WV;YW'_P"<_L%B>^YCF_3W
MPJ>^'ZC<#^4_O(
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M/+/,,Y,-,E(H)=.L?)A!)9SD0DM&$'&>*5R+%DGD&'I$VD>'*>Z<)T#"BQH
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M#[)\_F?ZEP^VS\E??0!X9[@(M)2!&I)0  .$ZYWCPSW
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M=K?Y+^\ "K!X9+A5DET] ALE\KH6?/0(#)%.L0>2&9(9$3J9F
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M/]6X6_GQCZH ,5/,,[.D8<9J8H968<9B8><QDY&!Z)DIYYY))1]@
M               'D[==!/HO&:U/L7RSS]\7^^^_>'L0\?T\;5=Q:CZ'\_\
M[L\R"KL]T_YT^YY/$VZ4_P!$?$\!OJ/B]U];+1P;=7&<7N/5SU<##>I^<OT!
M9WD.K   K' L*2\UT7B;H4Q55EY78\M6ZQJ84GUF+[ZSUZ>^N)90)XB]'\8^
M<WJIVCW7OOURQ0V-HYVB%.+Z6?*&= 7Z+^%WQXKN^OM\V4Y895Z  %7ZZ9I-
M^?\ 66-RD8!U]%7V1HWB<-(A+R;IM^C<W5+I:+!J^58NMMK4>M8^V/E>R/:>
M;KR6;%IO"WRG-B^K36G3LX>94L^>>JHMG%7OV%5LWOZO?SB[-M9V5;\M6<YZ
MMA$R+2^NG^![L]&VH]S^O/<+76H Q0RLZ93\SDD4Z1Z)ZAXYR$9G =,ELXCQ
M#U3C/?/).0QTR0Q0S(X3RCUSH'"3                   8#9P-$WZ(^(XY
M80?Y[C],/[[F\RJ5\X[W.Y\"?>ZXS.*NYE[FKS9U\5^JZU?M/RNKO<<;Q98<
M66'7SA]7WW@]QX<XW PWD?G7] 69Y'JP  *T1M],**_Q.-E*M98=;KN8R*9#
MQ*)OK!?\C--7U/M77+RG4]+\8>_6SS'</8M>X?62X?MXL1<]*S"JO>K]G^+;
M"^%^@]3;YLKVZLK]  "KD61HGXOI?:V;+&=)581[KN?4YY%QEA1^]U2A^AOD
MNMR%:P+S=UF\/?$<3;+GF,T;L,YLZZ:L\-;TO# N9O<PD>>?$PN7TM)L[T[=
MBU185I\]T[4LFO=GIJ[E[Z^6J[EM"K-5S\*SU].ZA;#ZWW](L2P %3"V8(4/
M7(E/$/#)E,3,1.H2*1T>P9L=,CPF$^CQS#27##S-2L1*IEAU2'BP9.
M            !'=K7:'?TM\%Z^7GWC[]>:^SKW<NIBM?8ZQOB'V'93]B^76A
MSV0]>T%B/DOTJ.N\XN,^BHOC+'X8]-KZV[3U\M?#LT]?W7NZ_.OWRRO)=4
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MV?I=T[   *MGK'(>J1X3H>48J>B006$.B1*2<?)SD]
M      $>VE=HR_1_PCZ9<KWXT;/)Y[H\J:H$I[;/.BHL'YKH<9WQ;)]UQM)_
MEWTS])OS?N)OU>_/N'S[Y@\O1B\B/'UY"UN_9/D\>6U#N;_/OW"QG)],  !5
M"KLZ5\W?^+(BR[AG72JNL_C:(GD;O*ZGY_DW/]EV;SFO:Y7L/Y(CY7OPQR9&
MPWK^7H[6:O4MJOR^9Z*Q#1#UO02WR_;7 OX.U&V@Y5GB  *0,OR=8[O<]QVS
MQ9EK=6W0K,AX[EI\?)W/,OC'W+]7EH8TRM6>NPM'-F'7A8[[5\T@RY@^=\=^
MHX_ISOI]J^2PUW//5M^%?6+J[X^TJBL9AT[]?;W3A43J1[,N5IL]:UUZN]YG
M!>AJ:V?+N\ENDL?TMS88  %(213!2S)@1VSL$2F?'P9X5L,])1*R&3%P0
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M56OE>FO'S'1XWR?:7KZWB,3[SC8VNJ;!)\'SID/H9:^#+#;E\(^RSYS'1
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M#FO#4EKD8O53JE=G0>K>TTI1=DATUA@D7?O@C2;D[P
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MV55>:BLK^6V$7\]84\YFPJ=T4*N'<5/+8P,I]@2%6R8QYZZ_0U,C6EDY
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M]^G'D;SYFKH8N_CG-FK9X=-9^+E[]^8=>FMHYHMF0\IU_D]WROZ<+>!*6>(
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MZBN+^:<K_P V%JQNZVJ7.W7!CEX;'HY>2U'S[S/TM$W%\\/ D1;;?1>#I?\
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M5?E.BRC5GV-NF%=N$[1]O:D:H\A67;S?.&$[_0N)K;P?:9CJV_J4E5MPMVH
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MGG;<;8;D;B,*"1^ACI,[Z>X@  :X\XVA?+9!W8\A.,^O\KH^5D7CNINS\_\
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M?:NWD@  :]L6HRCN(7[?@9E[3Y9FVS*ON5Q]?-_J.P"/:QW5S:06]!/_ &W
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M\V]?Y7"WWR_T)8^1>                      5)F?$K.Q/KWL^3P
M                         ->N#27*\V#;\;O:?<?B[M"&/MBM.%29.-^.
M=^EUJC]7N HZO)O>3[G95-.J[=5V=#P6')K#>5EOJ:TW'=/SNMZ)[06?A\^/
MV(10   B&5'_ "K7$-XW0_/NQKUJD:I[NB@2;HL=4VO1Z6CP/=&R7E>FO--C
M=WIN4W6?#[VFLS'4G]VY+#;:#/\ S'00C"V9#Q?RJV7URJC#YTWWQ/M-FK.Z
M   PS.AK%*^0_P >     #V_+"VT/[:
M               -,5AAHND>7]B9?I*U90S$W?C3DZMGM=ES6>N<>>[/O;?+
M*_/OH]@K_CM$M']JR2QX_%+?DX6S89A[L(E4.]3H^+U':]]*Y<.L_GO[7HP
M  0GY[^3[H:V:Z:^V#\=UE>/(NGOJN4[=G%O9RG6X+:UD*]=Q..<3UF:]MSM
M@/T?\VV2_@GZA<SX[L_.S^Q>:P2GZ_T?=%DNPY'J?$/EV/\ VV=)&CO-[?#?
M0;;9X@  4OF_ ]4=O^+P     !^BSF_ZF         #QS'S-2"B-P
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MV /T6<W_ %,        &!$*F5$9EDR%2'P
M     #8 :R;C3^=3+*[,#/\ 0_6='JGY;Z]$O3?!LCNHTA:LJMU\GQ:[.N-A
MG[/S[[]L%A\C3_H(U_LN$U7V&V?N<FSY+KK.=O70?]"KJK66J";Z/^N_XA9@
M  "&-F/Y*8TJQ%%T=U>?OM0G9<3Y-W2]C?YL6^?=C6GIN7B6X@Y'N\KW?:93
MX[9^B/\ -$V5.*]K+W&S2_\ JFE\2BZ/R+2LF_M.<S#BND@CG.A_2[T_+W!K
MIP  %+IOP+5);_C #--=_P!'V-(VOJL>RK.]Y(P;9SOJXS,*V4  _19S?]3
M   *UROD\&[_ )WGFOI)NT?09<T]N / (%+,@       Z8.X >.\]AZ
M                  !3J=KTV<Q*Y++7^ASW;3FUQT^\]EMMFZHTTYT%QE[$
MN4VTEP[&KMCIGOE>[FR1Q5&?H'#>%S/>UWV2[87' VO^KU?C?1J?T-?F!V&C
M])GYLO0  !"OOOYE^9ZCHU]E@%U30[*@X;TG-VHNH&WKYQ]9MGTO :!)>$I<
M5U-6-G&;7?SQR]VOD/<^A9>XATN>B_\ 7&N)^@@R#2W^#W-/R7];*O!=3^AF
M[IKAQ)0  %+IOP+5);_C #+L+OR_8?;\WXUG4YUKZ+QLH'8\VXMG3@#]%G-_
MU,    AO=P?F>Q.+W#--=_)&OJP!5LM$?0 !1;;A*6/O7,+]\]LQTRKSWM&-
M^^9/Y[AOOG6]3KA[3[9C9W#+UO%5-F,XX^V5UY>X]
M    UL[=>MNKW7HY27>;KM>ERYCZ/XOF[RNV;":G?KUF;MHO.[*Q\;^@-1'U
M3X=;+E>L@_WI:V]7P&V3CK#4WOZJ:NB^9V]^V<U!OU2@\;=CZ^O#]1_Y;Z4
M                 4NF_ M4EO\ C       ?HLYO^I@       \ B GX  %
M*=F'E^N4\L'AF8F >^2CC[YOJ+,O,;+^ZLX(RQQ'WSME=\_)BQ]V#:<_8>@
M                     :[-F.C[#W]"=)+U<6\33;MV8#EC;")EL0@[>EEL
MW5<S(UR<Q]+AAT>JOZM\AS#7MRBDZ7**F=/>NGE.]H[^?1:C6K]GYZ*+B-\Y
MZ?U%?EZ_                  $?;.8J+,^(?P $,;^!IM-^#WSK_P!(Y[KZ
M4 #V\;"\,']#       "MI8LYP
M :YMV$DULCAL_(OS\@/=YTM?L\>>0O7[->,+?N5Y>56*_P <_P"&NM2O;0H#
MZ>AE3F>BCVNLMD=;62G8Q('ZR%<&;J@&_P!48W&C]*_S[8
M       .HTZ];+\P;%*W]2?UZ          *S%F0
M               "+M-CX$+JI F\G[4F!C&_VO$GVIVAKBI)&.XY[$>'GY%]
M)K,-^;V6EOZ'48]ISR.QU37SLK9K62I;[:H\"/OF>-OK#91/4N=6YSGLP  !
M7^1\SUO6?Y2      ]K&PW#TW[I                      %9RS
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M ?HLYO\ J8       !@I$ ,(+H&G<P<                  $X&U
M                      &#8YQ/*\@#WW5_[E.?'S[C8Y=*]C=G%W^5E8ET
ML:H-G&K['SM7KVS3FR[FY>#]%6>GM\P_7EFN_&O$G&/]V,<6&'Z9:+,   4N
MF_ M4EO^, )5T]GB^=/G^OIO,]A^SC/QC.H]'R5$>[B !^BSF_ZF    >5[#
MA7?\_P JPN95U=F (H,;)[.(_AS
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M-AVG99K#(
M ?#'%\ZC^/ !!V_YYJ*N/Q!NII/W]GNOI  .[Y(]_&R       K.68
M
M    (@W<-+^GN0         (^/))7
M                    !XF5?!^_YX     !E6%S,.GN@
M     !6LLF?T
M   %,IOP75!;_BT     "1]75;Y:#^D0         ^3Z           *X%CP
M                                                   "ETWX%JDM
M_P 8 >KC,X_<?3QEXYG59)A;>+E ]_&RQ7.F D75U.^>@_I&       !"1BI
MCQZA:0U?E/P                  #]
M                *73?@6J2W_& &487&7X7GVRRK"Y\;*!AN=#V6V/=G, 2
M+JZG?/0?TC       %=B220#^']
M                               !2Z;\"U26_P", )+U=;BN=-F.N]QC
M.GSS7TD:[>3R+&TP#9S0$BZNIWST'](P      (\,>)D  !5'/%[Y,.&7*9Q
MXKSGY.^'OOO8&RQGG'(
M                 4NF_ M4EO\ C      "1=74[YZ#^D8      %8"SX
M!KMW815[YZ+S$/6S_1LC;+RK&>,V8^THVXSIA[<O7G,6/H
M                                           B+=Q%&Y_YW_CP 0UN
MX.O4GY?<*%]TRC&X  D35U%_J_\ 3       \DA$L(   1M[YXOK&??/LD3'
MV/,O/H\\\0S;Q*V/N1/0
M                   !C>55K7L_R=M+JOV+_7H         KP3N>@
M
M               5J+*@
M                                         @,GP
M                                                       &M\A\
M                  &8&U
M                         A\Q\                  'H$X
M                                                      P[WS,?
M/8Z]\D7ST 8O[YE'GH'4(5RQG7'(1M[Y)/GH
M                                                 %/=F/=>5[R\
M]DE;'W'?7E/(^R3'C[XIWBP6'L=9>8Z>[XJ'MQF##W83JV<P
M
M!4C9CAGOG2.^9SX\0\?T/<\2!Y[73/&]&K.NN>/\,8]81[Y/F&5EL,@
M
M            !X[SV'H
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MA-SIEWL<@-EUVPGSTRQG(57UP^6GS"L$H1NF#9*)70AJS& U:P\U&.F)("W
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M1Z._&^RL#X\N5-'-8GS:]"%\Q'C9DSH+[22T9"M=.*SP4MOU#X?7''M._/\
M%)_;ZRAIHJLAE=L]$22#5KFSL//V4<X!E[(4^5Q2+@TT[;V/9LH26C62#8]?
M0C39BHU0*Q*?T[*P.>@*;'LJ(K-8F0X$U,T1/KLCPZ/+D9R,'NN-I%6$%)Q7
MR;G=J&<JJ?S;X$X.:H8H];<%URF:VJIXAM*CS'A5TKK/)^R2!=]W9AZ6^"L4
MTF8VU%:(*78(9>RWG,1RSY)U3.'I^MY/)!#U2"5@M1%['@5L7J^%(A8?[LCT
MNR,H:)]O;Q,)/I>EAS X,],\=UB9CM[_ !,5R?P;@B\[99+@KC!9E/,&Y7<K
M42@V&84%RZX7';8LPYK1&P:'+OGZ5MMAQR+7)$U-@ED5CXP2>DM-VE%A-B=:
MHSYPJ,6525GLCFX2"TIZKT4S6DE@Y54L?+?\P2C^,V,7#'6 UL.1KX6F/9MF
M6.DU\=KRM:NF1+58=_65G"]0RWTU.\6LE93P;4HIB/\ @;->>C:WBWDWB%%6
M*C1ZBQ%A0-=@$>4NDI@N\J"^V]JJ1(C2YY&<Y-(HEO!4CTCG@'9))2V89DHZ
ME.'JQB##'.>'F3CQ(4*(5,IRJ2)BK8RB?3F*K).QEQHT)7P],*BZ>^?XG\1%
M4&1._P!M@\_]?9"[N+[E\C6BI:'"N57JH8R)E.TSVH9KI1J=!(Q3>KK&,)QC
MS-WH*23D>MEY[GEY4;B%J4VR341E!:[(LK@.,I$ L,5"B#/I(B2PTDK"(87+
MHKZ9-)_:5RCM2HN*PY#)&,8RR&S_ +>NJL>P]<*PF6'0G#E@LN(DRU2K$,E?
M>$WJ':1\3=I\ 3\1US4G.]K3/'^XV1:"D^4>("[+/HD UNK9<J)I(#(K&M=K
MV.5/V4YM5ANE:9ISS#D?Z/?@;%D9B:^;N(J>J=" SGGXL",&MD4[0@!4,MY#
M<;$>1KG"I1B>E^,1\*'+I,-YMR1GP1L..%?;?-#YPX^ I:R8NQPQL&1*-Q"4
M<C' ^%8HDCT>EY\:ML0I+.!L\VEW0BE*U/\ /\2D4;,HI.#&!CA'>4_LA2D7
M4O+FOCZC(9&.;%%Y7QR(/V$)*3X !,=P7< LJ 3I!,29C'F2,>3!A-FVW8KQ
MP)'E"+0!97KK.%7;S/EK4>L:IV*I"2J4AR*@S#>2\WKC&,:\_!);VAQ9W7[G
M7[G7[G7[G7[G7[G7[G7[G7[G7[G7[G7[B=^X[01F)81'ZU;^WPW2/D>3,M%
MPB.I%4M<;+NMJ2O+)"0XZ.I[ U@M:[P(; R=<?$;<3AEQ1&R6M=QC5B=:ME
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MTWUYU3L<CBCZH@MS"/Q%U91DKIQR"8-V*99K_=8LT-5B13N638&Q];KJT^+
M\)Y$R*"E27/ :BV)UMV=96GD"YB7#OX&R<95KHQD<Q6AA[,^3=;@Y8"JZ/:7
M8XIJ:P89UR;+R]/ZGA@&MI!JS;ZF<IA+,H[616(E7I\<O+H--'C)L!"I+RG/
M,.%9#:414^WSR5RJ::)E<#IA&WS!#M8L4^;+*,XG,Z"7AS4GS[T_*7VPK >&
MLSB1$H['-&(<;C]HLTIF 6*BLSSAHHW^*FFM9(HU\)4G.OH"T!:L,K\CY#W;
M;K;C&,8^6EC8^RG2,2HZOARKZ9!\9VJ9E#D;.FMM1MLEI(1C9)!+C&P#1:#
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M!DFAONXU3'-O#;8P25&B%[(B=%B(3$L2&DY!Q,X.?IC[#,ED-J%46[_XZ?\
MN^T/V2:KZ21B40N,&0-_Z^%Y1K')D;RR"UBSCEE-.1HS3;)M1>'B+"V7!Q)J
MY5#5^I;I-N+J(Z;\]@,+>D+)CI 291A,2PE%V49%(&;17E0P-;;)O/ %-H)
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M^!9SQ&83KU;&5J'_ ,";T_*7V@#(T0W/<$N<:.C'XLPQ,EEO<XUJ0/?A1Y!
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M(&4IJ0V+@>;CZRHOU1?J@YCM,4F38=>0%D6LKS&*I+M2[YW1XPVA;G#(PW(
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MA1!)ZA<Q.;3M2:G&1C"T_P";Y_+%'VA>J3^% O8Y\O'!Q+;=#EKE%K#LC:A
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M.7$L75+)4$XO#:&48$I/OG6G%6ZO>W\$2Y0MM3(5<IX_;7('EM LI1&FH/\
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M04+VX#KB2J4LS)LV3BL!IG;*.[6YETJ;(SMT;YZ#AJ(7WQ\'F]PF5I0UT@%
MG#8B^=B>/9'<R)F1)RR[WJ[.42LINZHE%\\6O;GKX(VBJ=,ITT\F<6E#B0-V
M;@**L^PF#6&]HY1Z6E3B7+85WU447PG/7(V/9&Q[":@0I:AB0;9GE!!:*4G1
M PB'4)=!4$C(7O87AIHJ;)MH(K O(U$WL6I5:P0;&^%7+B-1&Q6UZ:BV[3II
M6%3+Y2AQ2NDK,VZ1S/C@3:=RTVCI VZ7'QQ.2Y'31R!RYVO$G.V3N',[\3GY
M3$Q+[P8DGQ0)EEOVE2B%)Z)4;Y>*.XVW)A3J7+J .MSEU==\N>O*)9K#EJ/Q
M1,.'0#3*)6^>(<,H<&(W%K\.<"66VO'<G/%K T]UIM<1+HHM)H.SU)J$TZ4"
MH^S%$D*M-U>IS,RM*95AV9#[TG3T,=RL2Z*>Y(3*G1,3#CN-T8)BE4F>V\51
M*8\44:<VH12Y5]M0=#4G,U),J%L.7=WS;2%GN=U6,O-I;<5<J(BEUFF;05UC
M9QR@422H%8F44:G=STN3:K%+5,K[FI4^:VE/LG-3;4PJ5=J)G9R:E9M'=*.Y
MTI=&"G*IZ)MI=4:FGY) <6[+R;C;#\PI+:BRQW0XEQ,NVZ]NT/OAIYQIDK6T
MRXX$I.W:93V1I+TG(25-;G-E]G9Y<I(,AB60]-TYMYTI3=2UJ*E=)UY;C[IZ
M;SKCA*CLI*//4*JOT&CRU=VI:GI5"I29I4M7796A+9=+D[3Z1.,S4O-/&>2T
MQ-/=Q3;DHTIG & ^MP[:L(EZE*-N4^5I-6-+EU[04R2:W$I)U93\U9#,NDEF
M7+U+]C9J8EY<[EB;?F&4I;4A3:)6EKF:55:J'4I12G:<TMDI)4[[(KF4)*57
MLG=&7)4"#BQ96M])ZBO_ '9[-?Y9_P#R"J_FYP@:W/>Z'XH6K%:_ >2%).($
M<!"IK?2[<NG)1("H&;@X "P[+6MXHEQNGWC\%'DO<'Y./*'&0ES>)[U=[_H5
M'/RP??P1?#G;$0!U99_+"K$FV@)-_%YXZ!%APOX>C>  %.6_J?Q1?ZG]JOSQ
M<)&/R<S;XHM;I=7EO"U6>;5Q_%!!65VX77'+W-HX7&U<EH/B4#'=:N1C:">4
MN77)_P#U("!Z=IAB02F38D5ZMG&?37C$C(AA PP^@Q)HZ0C%<8(VIEW!(R1M
M_P#,?&(HQ6WW3E_3@/\ 9AE]64..82D]5X8FDEI:>8$3SF#>?:K\5C%-92[+
M+Z\43*G*>\6TCVIUP+7KPROI;\8\%92T[+4YQLWL^PHV/&_5'L:@2ZIX=\D%
M0MXXIFT+3[*F)A/MZ75H'VHM:*M(+F6'7DJ&"V(B^=N5H<VA3(*$HD@N!9!!
MUMT</5SX]O"*#-EV:?=4+%>=N75X!#*]XV%\\7D41\7N%105LI R]M2?]E<,
MR[B*<2'+Y<H<4A-5EIL.XL\!:XDIRO?P<H]4I)<VD]LN48,0'VWXH]3Y&\J[
MK+5T)6VM!N;WN/EL?!% J"Z5M FE*!"5.D%Z]AFKX/X8JLLVAF56RZ'L314L
MI%K'AQB5NI#B2+$I4!VVRB68=0P4%O4:WC:F6F6*3.+:&)3K;B"GJ4DCQB^4
M.3:Z5,C<A;+[,QO% 9;TXN]ZHV9F'WZ!*SBVBI2T).9TR'&T2+\O-8&'7,#B
MLK'.W**K179?"9=0=Q=(* P^EX:F7!:7?1NK98RJ_DAR4EE$$6<.N/X4-,LI
M%D) /ECHIUR@H0HWL"->V%%.$ "UO+"7$DVC%G?W:F-T.1HR%4_:VAR5=J3"
MT5*9GI/:H3%*E704KIE-,CLU/,!U]LE-1J*)@K6A2I"4P2IF'Y^4F4T"O2,]
M*S$I512*E(S[+TN)MN4G%2;[,T$I$_)RDVE"E(W2M])MJN%$(4G"527S(42K
MIVFDJ[W:S(.BJ479TR%49JR*@D[ZG2E2FG&$TI$O39HL.34W+5*=5.M2KB6Y
M4%\)3*,-3,RTP].2U/:<)"YR;3-KEF $DXG4R$K.S9!("1N95Y6)0ND)Q*&V
MBJ1-"CS--VAIE45)T.A45^5E9:O,3 >IU.#$Q-)-3HM/EE2>]:"6R)GNI6];
M)E0G>ENES-,G-EWJ!,5Q.S\V*RNI*<FI>H/4NKRSLK)L,R\XNDRE0G4/4MV5
M?F)(*DG9=1GW[J;6$K3M94Y.<%$D)2HO5M5%IBI)^N/LOL&>4[.S4ZVQ+HFR
M9WN*G-S"9665-AIQ12[@EF& TDR'J@[1RE$JE.5M'M-W4^JDBENMUB>W<BQ)
M*F.ZF4+,ZER60ZVMA"6Y=!0L-!+F%*$1-34S.S#LW.S+\W-/K+C\S-/.3$P\
MX=5NO.J4XXL\5+42>?K^HK_W9[-?Y9__ ""J_F[@N0.<*]/&?D@)!4>SXX:2
M$NJ/P4W\)Z(\YC/(C47(A2@M"UH&93;K%KD@]E\NJ&'2HJ:5RZ-^&F7QW\$.
M(4T5 Z'0^>"NX '*UNWCXH2+)4HI!2-<RG/Q0G#GV'CU6@$$K_2[>0"+#H?X
MWGB]_M4Y > Y^$P5)L+)LJVM\N'"%C$I*K][I$J,3V$^^2L>&T/J4AIU21TD
MH41VIOE'SP*E)S3K4Y*.;M#I2"$7&$'(\XH6U#-95A0@@E/P<-O3C[BCOT?;
M)\\*#:6RX3GRX>*%;BHU5#;V-*94)<06K64H\%=0MP^6%,.OS[KR2 TD82!K
M8<0.>D,(W;>I/;!!<+@([W2T2.,K/1T!'@@,K"L7DX1M;-8*;3TX47#]CEV1
M25XTS1*4CVX:?:Q+=(VAU=^^R Y0R\ %;M5SE>\3ZE.AP6U20+<\XI"Q*,J3
M,'"K.T56884A]#@_I:G4+&O*WIQA<VVVW36\:E-N$+5B[Y)'$#ES/#*]LKTY
M]$Y)N(2OH!)XYGT_!#%-WB7GV4I]K<<'7<>6':J\TE]#MTEM)PI]XKA8^4]9
MBKO*-3,Q?/%WOO=8V8G=\$N$!*G!8A-[999=MHE!:7; -^_\KBC[A@2X"%6R
M%Q?GX>V)<,=QJ;4ZTD\BM(/B)O"*0Z)U#JC=(?4>H)Q&Q)Y6XZ1ZHM&JTYM!
MO)&EU"<8#8]NE9*9F&K_ *8TVM'ECU/*)5)2L%V=IE0E&['VR:DYB7;S_1.M
MH$;3TBH-U1J>D)&<F#BZ1EI9YVUCK[4A0&5M>N*'/S:I!"9QE]"\*>B\VM"A
MEQ"P".RT)<LL$6&?9#TXZA!P.(4?T*@3Y##DP_,)4W,-K6V3I@,5'U/*)59D
M3#DNXA>+%<)W?2O?/$+6BF-(IT@*:AES=MC"E103_M 83!E]VM+R6W2[BSPH
M5H#EPBK3E67*CN7$I8PV2 2JU['(9Z0S+3SJ,<T%8^5C?Q:Q+!T=$MN #0E"
MAY2(WCS;N33I3A.C:B/':'#,+T;='^(KY(;!#: 0;X1?MM"TE0_!"&5A1UUU
ML?\ Q7J*_P#=GLU_EG_\@JOYMF%N!'7")E-\\OQ0EU+F*V@^-1@=^OM^*$=Z
M5'^F.@#_ !1\IA>0/9"'-RW?@MPW'D'8<LN<!#:B7&SKKS!' CWJHR<2IM??
M)X]NGIQ,6[X\CA%^=_DBY3=/ \(T\,(OT\M&S\49]'GTO!<QTL@ ,NKP:Q@O
M>_5!U\,2I"9ADD^_S\L/(4%:62X5%/(I).8Y@Q,TBG38(?E&E7U. ><1)4.0
MIZL<LW@[+9?@]Q;%W&P.*TCQJ$59[N1@[P[HJ&6+*_9$A.!F5>?6S9:L>%VQ
MLH<+&*")R8=F9AS$EG%?/0B\-MG=7L80U8.*(R4,CI?A%.+:'%74F^>1@*2K
M2QC;%Y?\SM6/1G+D<DW&?9%'L&7@>^4X% =5M8EC96>4.%+A(Q 0S+*&(MC'
M<9VSPCKZH<2D'I1,2/=*=X.C;E#[+:E.-K3B5N2E/7TAD(%(EG44T8$BS10X
M3;H8A;I?'RAS?T1;B$))ELT[P=Z!V\N6L;.S+,P\ZI,TC<*6;C%<;SWPC:V8
M9EM^RE'3>NEM7,ZDB)M*GG%*0,13K;AVQLM,*#K:>%[#KSTB4OW.U?6Q^^5^
M9!!!((L1D0<B".!]V]17_NSV:_RQY:_5?S;5P\,3-\&4$GG$CF'>=T_'"[I7
M,#X)'WL$86)<\RI7E@K!!MRO#I(2V.JYY9Q+J*775#X-[6RL<L^K*'FUHET3
M"VRA+ERS<=\1\$_!SXZ0VT-W95L^EIPA20,B/#:%M6N?-Z?@A5TIN3>Z;"&Q
MEBYP!<P\;" G%$F&\9*CG8I0D:E2AKX(><=6AE*QT6TJ0C+47]SD$XIZ32??
M34NGQO($;6K$U.B31G@5:%2Y1*IE#J,\^N*1*[J66BW? >>\-_4\$-T-3K*9
ME3^%M5_:\0X'MT/XXDI6BIPIG%X$<7!K?Q7SBM(V=3+_ /9\VM3N6A(^+R?C
MBKTPS$D)D8E;H7Q'7+GUQ1 %)4H\.CY80E'.$L*?7A:&(DZ"U\CGX!Z<H9I%
M28:=<P*PD#G:%)47%)=U!@+LDIB?06YMI7P@3EV_CB4?96T<Q?#Y>$3<NF;E
MRVK.X^6 ]\S]3$NE%V%@.DVRNLYCMRC;&?<G'Y-R6;*DZJ"<S;0\LSU^"\3<
MR_3<2GV2-[S!XQL_,C%+/VPH4L_?>AB36')5E:=%(\Q(^+\R*IZB6P55GIB?
M7)3LF[-.K?>;D9Y;,N7758G%H9<0\EK$HE6[:P-)N0A"4V ^<#L!\&L_KD/W
MM'S@=@/@UG]<A^]H^<#L!\&L_KD/WM'S@=@/@UG]<A^]HG?R/VQ3DI,HDG*M
M+3BF'!*ONSJ7FFIC"=RMUKN<;QH+P[Q 4E2D7"5)590JM,G:+49RE5%E4O/2
M$PY+3#2O>K0=4G1;:TV<:<3=#K2D.()2H&/4D]2F7VR8G*U7^ZFJ,@JE9!$L
MYN'IR;2I)?>#A;7_ #-+)]JR'MKZU)"AW.XE7S@=@/@UG]<A^]H^<#L!\&L_
MKD/WM'S@=@/@UG]<A^]H^<#L!\&L_KD/WM'S@=@/@UG]<A^]H3Z@6P 4"6ZP
ML W*55+HJZCA82JQ_0J!Y$13J=)4F1E:;3I=$K(R3*)>68;OA;:0+ 742I2C
MWRUK*EN+*EK4I:B3^;:VPX+'\<&3;SL;90W+IEP<*B<>$GQVB>Z+S_(A/C*4
MQ.62S*(%KANZH2<_MLN<.*Q=@C9RF&K5%N01W\PMII(YXG-/%>/5<HTO04;+
MTR70E."1<4[;BXM8&>FECPC>%)0/T6&_5P\D/ )4+Z*O;QV/E@G"3GEAUZ^4
M)3C"UK^#T1P$-"Z0.LQA-Q#BB56A,MNV0Z2DXL)";W*0<L^5^$2;:3/-I5=-
ME96(%_"<AX8JP"#+LIT9;*=0>D22HDV'4./N;;XEG&YDZ2ZTOGL:4'/_ &Q*
MJF:A6YB>6H%BY(RRB74W.SRL6:4 )%LN]AOH)<2CWNEX*BAK'[[7JB1G,;Q[
MN6HR_O4I44 >+KBJO,V(E;[CKZ1OVQ3GFVWPIU((_1"_GBN3].32UI82 7D]
M,7OTB. X=@B@,-O-K2F^&Y5KQOS@R:@>C&SZI25J"&YH9*4.,;3U6GTZCJ,N
ME&\=1[5[ZQ S\=X?GIAYM4Q@]MQGWN5KG@.J)83\X][20&QJ,-_015YMYFH,
M2[Q'>$]Z!F%#QQ*K>WBBVH;M/2MU#,PA!?E$.L'/WW'**E*RLW49>7<1<K0D
M*-\[]1U$33B*75'I282G=(3=@*3<\N^.OX(VP?FIH[Q>[,J@]$(:2DV[1&SC
MB9MM.$=!%\ ' @ZGGG>-FU+519(N9K_F@'P33X3_ +('YG>J?ZDZ-MJE2*K3
MW&I*=$PQ)5ITV&_I-[]U)%K.STDF[;*5 ;]MQ#:W4HEFQ%,ILG1Z?)TNGLAB
M2D)=N6EVD^];;38%1]\M1NMQ9Z3CBE+42I1/YPSI .(V(ME>+'F/\W\,.+6^
M[B5;ID9#GD(?.)U9_16'@R^*$:WX)%XSUXZ_)&P#?L;MS2&IDA 1,RCBUKL
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M>;+_ +8ZP6S"MK$?-JG:=N4_F)N;:0B064E:J,S+(I:9-:B5(WZZ2@,+<Z2
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MOJ$*5Y$@P_5=D52H0W,KW]L[RDS;3@=U:)ER24M1:?N"<O:G!E_FB"IGX?\
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MV>^L-&_6N1_Y$?,YL]]8:-^M<C_R(^9S9[ZPT;]:Y'_D1\SFSWUAHWZUR/\
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M<Y*BLM(D-#908&2"A:.UX^7Q%S5#56-F<(2DI;.TU.(E0$1UPB9TQ49%5%:
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M1QC-!O%(S1FBL6XCU[HMQC,D7)H(VZ2K*FG?"5IVJP5;].$%7/ZJ140*&%
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MQC!L$DIILS,\I RK4"DJ L#;4[Q&+R^"HE$^![,A)(HE25&HUT)WP^IK:-E
M-N%X4Y66<%-<OYZ?W$X#_?S!O_=<._YMGV%KH8"ZFE_8F<0EI=2DKNI/2I>$
M<I)#;[,I5T2:Y%9>'2I2M=VO=$X])XEA[J$FE4FU;^*,!Y*B6E9X/#-X:5.,
M5U2E5:=D/IF<#>F9=95E-2D]58Y)S!F&"3OC.)9I2S>E3_9'*;'TS4RPE*2G
MP=:R>O-_9&'<K TU0[A'U\IZ_)\\)Y;M[)2N!B2Y;,NK <Z&:_9OA_&V7V29
M$WIV>OSP_P H,3864K-]1V;HP7%9N:4C:'FJ-X0N-8Y<_LIQ3_4OYNE/>,1-
M&!^$'YJXS\^_'UUC$^@C[P>80V'2$[(5O>)+;9;T%H;;7EU$3B#D6%'A3\<1
MC^1"V4*5TI*7'C-.Z,*0TRL#/7OC&E*SHRTILAYS""Z*Z6AMQ_J@FO3-#OI"
M<M=8F.AW?-&/*0K'I%%3IS@":'77C 0VMQQ"$U6%I.EZ>NZ,><6)1*!6V@%J
M=G",'E Y,S;A==!++14=HH=+OOZ(Y<,)E^3V"*3,/54M(^VK^>,/?;&*/!3B
MR/!DFF=1OEUI6),U;3OYH\PA'01]ZGS#WA<-PY]L[CYXJ>$)Z(AIE#Q4%_!%
M1#K>3HW&D;.)=J5*7/"!SK;/TQ,2DSM J6-$!0)'R0;PXE3JJ*'C]?1 DDHI
MUB&VT!20:=?5$JXTE\(2:FL3#9< ;WN"@B?DWL-4E"TD)>OIVPPN)MPN.$'H
MMFD81R;;Q/"O#$74"!;LB>P:=E'"%(4&P;&FZ,-;.97436)A-##WSPGT1-*R
M(!ZC##Z7"> K7LA3LJ@YTBT./HG,M!3)2WEKV&)5X3<L)=L\]L6[>$8)A<QB
M@F)?-4MBXX;O0?%&'<C&VL/=>=/N@6]Y#:)U"91U]"=RO3 ?SM*3QIY"#Z/W
M$X'_ 'ZP?_W3#_\ FVHJ>!BO4?7NC-2]/7Q1./;%K.8E7FW7'7+';V%;Z6/F
MAZ588;4'@,KBT[A77L[(GI%3#S;T@376D8;C#Q2&9@44@956T(UCEFJ7<E6U
M)*2LOWXTRGU[HY(!/@IO RNNA)TRTZM(Y9R;;2RL4U56%OG843QI;M]D%0/-
MUW0WB,\QH?%"\7?>3[KT_6D8)BZY>89-^EUQADX9IK,=\#2.7'[*,4_U+^;I
M3WC%J^#(RBI+R1^0Y"I=U//H>R)])<0V!KE3NZHEY*92FK5"*<XJYM.';!G\
M3,XJ5:2FU:K#@IXHDL6Q-]^:E[)\'!.8KK6D2DY/32DI<2%;1Y+>;/T>=Z:1
MR[FIB2=D:)2K:,,(LY3+E-:Q(XE-B8:YH54C_":>2.5,]/,/RR6P,JY-#AY^
M\E0]$,8G/J52J:G=M->J%8SB32J%E/;M:>B&,;FGG%-JEE<T Y@K,#XA$AC#
MSLZEE4LL)YU5$VL.R,FW1<Y8/)B3G)^7G79A*5,"A3DKF-[UK:/K<D4O+<3,
M)3GW9*]VL8QR:F9IT,2PS@Z+ IY(D.0DXVXX5(2DJ;0V=W0&I[8Y0<EI[%I"
M2D&V6R90@J5M ;#?2&^0+TO-N33JD(SM!O)PH-:[X;;1+I"<]<O-TX#MAOH(
M^\3YA[P4UAMM/$PZD!=0>KV$I.46@!0ZH[;QLAQ@I"=P57CN[*00K7,0!<@0
M[,,@9P#41*3/A@52V4E,8O.SDDOW)I*F]ZC73NC L1??G49P!4CC$E*IF)J5
M*U% .2Z:=7&L?5 P=DRK#[=:H;&@'E,2BLRU(7;+PB842ZMFG-=&;-\(>C='
MU,%*=PF89J%;%])&;>!QCE')R[^&J4M#*%!.J:5MVPS1E]T)O[HKS^M(FZ94
MJWG=#T)&D3#*7F\I44VW:WA$LW+*.4J(4*<X]0!X=?9!0T*I0,U:"]:^2!([
M(YQ45'1&D8*A,J_FVBCG-P:6[(Y&8@S)XA.*6ZJCB7+FEJ4MY33A>%\I91MM
M^5#]2I;AN?C&,9#:BZXA:CF-?+6&%<[+V^;]K:'A%#P/B@\W6W;:!?2_9>--
M8UTO!<0-5I':H#TP"#I?LO%#P,95?%/B,;-SXB_Q3\T;-SXB_P 4_-%#P/BB
MAX&*C2HKPK%#P,4/ P2!J0.V*CB/'&9/$>,>\X0X&L6PMU5DMXC).*/ (F6U
M'R")>=EYE-6W4$\*B"NEC2O5"C5)"156X>*,>F:--RR+K78_)K#*76)R2E"3
MLD\Y]W>BIKII F9><G'$IH[*RS:N?7I. <VN[40E:G7U.UV8:/-0+@TA4HIQ
M@S"*!3B<]N)C'79M+ZVWC[GFYM]]:1A$N]ATA*.,U>\* KFMEKPIKWQ*XBRX
MHE:MFXD9<NZHJ-\<M#,+9<=I8JHW0]*NM>&[2$RC["64O(YKR<U3N-*]_L^3
MKB_QZPGI"@S$^MHPK"W)AQHY2BXT$84P9=C(1NUWPBR0!>.7'[*,3_U+^;Y3
MWAQ < !%:*!\A^>%RR,G1\D'#ZT41:%,,.,K:6M3511)14U._2)+D!(-,>V+
MLZL%?QC?G=L8?R&P;PS$EIFG2"@W )&G&&.3."RK0I-.%7A((I4FU:GNWQRG
MY,X-B3DD3..6:3QUI$OR/P1A32O#E9@1:MXY0\G,$?5+5G%VE4#7@3#?(_!\
MV=$ZK,FX&:_GCZQ9"93F3.K)OH2?,8E^1$FPIS_Q@LFG1()IWT/KNAGDO+R9
M<G$8J9I39LUE(S9C3XHTUUBR&X;4O;$U(J>-/%#:BEU)<4:1.8A-R\PTJ6I1
M71)T-+]?#=WP,2VZN=-.(=5=Q(KS5'7N!TB:"Y-EM]$VOW8T-=XI7?K"YR47
M7PB=77M[(5-2!T*3UYAX]8;*2V@IZ)0DI^](%/)[RDG,K6'#SZ*MVQEMI ?(
M  &@A+N<T-N$4/L6WQD!ZQOAV7E<AYE^$2C3;6<I&3G:&U>OKB<81-5;*;+Y
MI-- 8P_"TRDVDH%0"+C36$S2F6I12!4I5SJ7H+1R@Q&7F\!/NS:W4M)YN8%6
MHK:))Q#D\Z@J JHC+6_BB>9#+J2;4;-3UT-C'U+TNO2<ZPAS9+4LK37X2173
MCW1B^!XF_)K3X4;UM77LO!:<EYEQASIMK*#7>0JE8?S9$U!!AX&NG&!#RN:#
MNO7JO:L.UUO3CN\<-#(L$Z&E*Q,.TR(I=2:CKAILA)6:IWB&6E-$*0NBG3QI
M6#R?Q!V;SAM]69*39*N%8F\*=81LYAM;:C2S@RGQ0938J*N'I_M_:L&E>N$B
MG:8^:./&'4A8%80,B12)A61LJ)H*1[;2J/A@TMK"IYN:> 1K6W=#$ZRPK*ZO
M*32A-K0%I<&=M0--+VA+CE0300E;AT(X5A;CR18]^[O@N+-:\?6L%;FGEM:%
MT*D:5!UC/ ND^2'JJ422D=\91\80,MN=OTI[RO-D5E.565656F55+&O4;Q*X
M_BF'+%'RH#@JL8/]4$Y$MS0*EYNEU'YHE.5V'/-UVC25TL"M(-:0T\)Z9<F"
MH*":E-#XJ1.']1/3&6C[YR-HT5;FU UW11[!I.7EZ+6Y/$..&A)32_.X:QB^
M**D @HOGZ5/3&&XE,S,HE25U26P==!'*-1+J2IQ))>%@176,(6TO"\*2,KBD
MI3G":*IIK32)O#6)NJF!LE GJOQ\<<I99Z7E@'59PE?,&NAO&)S34RU))3E3
MD:HH\#3UMQC)<C?PC**TM7A 84KX*K_),"06=$*/8(PG!5N.)6IM5,U*E)^:
M)&39EFDD!-4BPWPAP%&F4QF[8Y:?LFQ+_4_^0E?>,4GE8?+H>3JIY+7C0XK_
M .$?7,[UP.4;SRQ*I!S+W=<2LS.-/Y%H-J&X.\P^IR:PI (.@C# Y+8=B=!?
M9*\T2SC[JVB4FRG-WRXGWG4!NQU3YXD6?"7PX6U4!KIUQRF"@^R&DD)$LD'M
MS&&C,"Z0:[M=8Y*(6IB96H':956WUI#[DT7W0I)^V*W=<(0OP12E6TA^)1*G
M9P)<6$M@\VIW1--#P]#:'4Y=F=]HQ)EUJ7P184+N/:=BH07%3D[18KLD^:,7
MEW7,-P[:K &SM4[S6/:S,L^Z#QPWA+5Z&_;$NG(PPCXC+:?Q4 >\K=V2C"E[
M4UAYS(W'A42SVT73A!Z [!YO8RU,)3"_G]F7^V#N\\"TJ%=L/3.=IQH&ZA2G
MKU0Q).MXCMJ?"UIOC&G3X.5'?]$?4KFAM"D_<E>B)E:%L^;R1BZ<N+OG]\.?
MGP^JMNJ'M_L+%67!V0])ON2Z<H-#PA& S:PWSSJ-(<Y.EJ5:>?NX&QEKPAO#
M'W@K(DE(&[A"T.(>2-[)KXHY.<J90S33$R!5-$YS<6MU1RX::=?9G)=T%I(J
M4@_&MZ8F#F:4>S\X?M632G#?"36AUZO9<AQ]#+16LV":]\34\_B#A8920@VK
MU=T2& ,-C,\<ZMXUUAR48:=]S0$]GKXX?PMF;: 74'<16WBBLY@$RA+JE.R3
MII4ZIJ;5ZH\)8SLISI!>ID';>&Q>EH7H8-+]\(<:6O(E0*BK+3KKIY(FF%RS
M^Q?3LW$4JFUJ@'=:X(, <+P*@Z:B'P,_<(%(&[N\_O*QF2I/%)'C%(7+=4!M
M;>GK6!,.(Z/2&D8=RFF)8!%]-\?70J9\'J;M&I'?$]RB\(=:77H(*>^EH>F'
MIQTARNR)UB1FO )%P)/-R43V4UA_$6W)E*GTYDJ=HGJ4=\8*U,KE$+E3D32H
MAO&'6@4N-FJ;$TU(L3'*+%!., !--GFK_"AB4,U*N*%\B5*\0)C"E3DS/%*D
MG4CRTCVI=VV98MK&$X1*.LYETJ!7Q0UALDC_  ?DAN7830(%!P@-)3?U[O8"
MZ6CEF:\I,2/_ -G_ ,A*^\<H@V9)K:&@\*13[[9/^BL)89/&.3>%MOXRRX[F
M 32@W$;HQ/8-XDTR&D!"J!2M]!"9E&5$JA*2W0<_>/1"RQ+R,QE>:5MTT55#
MG-KPYL2S+0<:2C(L#,2H!0-2:[Q$PVE^82VM"0E*AWWB0EI-EJNR16D<IW*.
MA;;*"D- ;]:F)":*G I3+?--Q&"A# 6ZBY<OL_@_/&-3:V)PTE6MFJAS7!OK
M#LV%RVS"4^Z4[1$R,J<T8[BL^SB<I+2^5*';E5><.P:'O@3^*)>VBUUR+"*\
M:^:,7Q9UG#I)9>.:3S*1?I9@=?'NC ^4*YK$,04ZXL50V>;<;]Y\D<LL=4U@
MV"):6H5)2HZ'H1*\H9A<R&ML>T&,&.W'/68 H !NM]F-;PZO+IY8<"7>E7NA
M#;:-,W?#C3;HHK-"I% '-S=5_7UWQATFO;T /7OM6!)NK=#2144[X4V;@-K2
M14556![D#M""3T<OIAEQ"ZCNAU('&$WKVP$@FD(&1P4@+490 ]<.*+;V9.M]
M>R$K4HU(37LC$9=N9EDI-<RASJ&.2TPY@3F< ELI**$5-5=<.\IY]QD;!H&V
M]%8Q&8?5.!QT *<5F5S:7)O#NF87.7U\L+6LJ(M'NG5&5>Q</Q2(8FD)D^>$
MV'"$8K*LL-K4KG"F_P!$37*,3++:$\Y(12H'7$AC098<;;0G,M)%5IK>)BO/
M<H,RZUMQX" =C=-E!:E5WW,'$77V@EUQ2TIH*$^M84M*F%Y>K\\?M6;Q=!KN
MAM69-8<44I-*UA_'YQ&)>#[)10%?%.G;!69U:TN%2!P[/GA$Y(X>VE*T;J*6
M!4]<2V,8:Y9MX)J-%>IB4P)6)A+C+[)2JX(<1YM1XH')O$909\B7D(L<O.MW
M".4\NQ,X:XVN7V+J!8D7J-_5>);8K]J0ZNK[3R:4.H'&,0QQN4.RETE]]1HA
M(23SNI(NJ_=W09#E#B(VLS-^!H.C1)S4-Z%"*!-NO?!PS&I2BY:?#]+*;-4U
M_@J*DD>(Q(R10ZEZ8< =4YMW64'-2JJJX4'=;C&)*;GIMR9 6VE>0 9S7FH"
M!4]@C9J9YR#G3O&I[Z07VQDJH)4K0:5XTB8NY4<![">D.WWG2":P0.$!I.8&
M#+ME6:X[(E&6PI]2BJM.;>U:0A3[BMDGI;5)Z]F#SO)&Q9?2PQ+ZT&U5OKH>
MR,6FC*-&3;H0CF$JNJVL-MBC*P,R]L%<ZXCDSB;KI;E'LB&Z <P95>.L/;-8
M*2RG+I4"YZZQRDP]D2N>72M*N=M*FW52,%F Q+.I=RTRJ&G48Y.+E%X@<@%:
MFW?"</:F\]= /@:Z0E3TC-E#=VT*K0WJ!#&)!^Q0E':FD"BKA0(^3%134QG,
M5KVQRQ_9'B/^J?\ (RWO'*I*ER,J$U_O@U6G#83/DCD_R49G95+BB-+F)?!6
ML-Q!M2Z-HH %JLD\+G<1>.5$K,(5X4PTMQ/P5MI*@>PBL8).EQBKRLKJ?@JZ
M7BAR>S213X6FO#87T[8EYIM+B<SZ%V^)DR^4UB9GTHFBK,,NM:VM&&8JU-JV
M:74*XA*JQRD#+4H>>@K**TM6,.=7F75) J;D6C!UJM8T.AXQRK"$-(RTVMK;
M[]4,I/@H6YS2*6,3*5*;YH*NR,:P'%)G&9&9EY:8<:I<H;4I*==2-(.!8U59
M5A\VI 4F^Q5N^%IY8Y1LN>"[%84A=*95"A\48+*.LO3)3+/T<88 4E)RKR7X
M7H;BE*&.6;?A.#X*D)7MLRLP/2*R@UJ-2KRQA6$3QQ0),N^*JH*H5>E"?$%)
M)X5$85(*90-HDHL.D*;NN-+</LZTO#Q)K&T M6\9XSPF<;!H5CA&!+:<>6FH
M*E(&7K.L8 V'\07G2,K9YW5>)KDY(3:>8TE%1T@*=_FC$^18E[LG;9@;?%X>
M/T1.8:]AA!?;+:2JRC?S0YSA47A)I4'C"!50X5@)Y]8!!E[=</#W7JKY8"<M
M*VKI"PJI&X0U.*:<22UG2-1:,*Y1X4AE*'D-A5-"(Y0/2LW-!V26EP9B5!-L
MO5W0A:5#+F!5ET[X<4VETH*J*X0M:D5S"@XQX6%,/A!S4RA5-T-S3;S!;2X"
ML?!K#Z%+2A%38WINC"6Y9$JG/S[W.51H::1X,%92RR2DZ* IYZ1.(V;9"Q0P
MIA!9SDBY('72"T @CCIW0'"E8;KTJ^0$^C]K%=$]D,V3WQJ+ZQB"FVN=LT9R
M;&E]\2$J73M5BA78#UXQR?Y'X;B(_5<NA::5IEX\>LQ-?4DY.3:21+ED[E-*
M4@_-&(_4GQ["BJ9Y,8KMBCG&4=<RK('Q%=$TTO&#\O<4PN=.$\HI=<O,M*R*
MVR<EZTN-*'4*Z)CE")'&,%G)UG(@M,%1I05.7L]=8E)>8V@RH+\PX5>#-"I(
M2+EYRFC: =]C>MHPO#6)'W5U0?GG!5QY0S9<QLAJO1 ([[0M/,)WP;><]G?Z
M(*_!<82I-<DT.<=;+LL7W @'JW0'4:5O&-8BY(MMJ9'VQ5$JU 6+%)$(=:GY
M:6F)M18>:>1E<;J/=<V7(H?%6:4!XP]T^[V!J.WWK72%:P!U0.<:"YA+*2AL
M#[8/MR?B[Q7NA8;8F"ZQ1=&'0:;EE-A>F^.294F2G9F;YKJ<Q;2JY/9K$PLS
M4PM:S0K620>N$87,)9;<;9*DY@;4X=L2V(3&'S:5.)4V@'4@^B)'E?*E(2^4
MIL-=_7&/8U+OR^5I2#M*Y:;XF9Q;+92HY*UK6UHPN?9E)O:)>KV]MHP'&YR;
M6X&D%::Z@CAUPS-M'$,LR4A96.8K?>E.^)UN6*:E29<'0U_1K&W>DU!+2R_+
MV5MA6E3J+WM$F_MVLX-:"\9AQB;GY:20%OO);KI6.4DRW.8U.S#2@M#G@^50
MT.2580?*DCWC&T9Y9E/[Z;_X;T8$AUC",R >CN[(7)IQ-A"UN#,A"=XL0(;F
MD2BUR<][HRH!+-=Q!N8Q+ =N2_ARLN^V_?N@K>9&1=>$"YKQ,3FA[XY'I;\,
MC%Y-AYDK72N6E(\&ED2LQEIFRFGCC"D499[HY0RC"PAQ5,]$B)U*4RU$_(MW
MPC[6.R&YI3(M6W; QF9 *+T(X\8=P>2Q)PN3>6][^NL?6Q@K-VYQ0/Q0=.J%
MX5A^T:+CRYA+:RH!=P%4IFOOA$CAS4ZF;2W0)]?'I"YD+)IIF/GM T'8/LT4
MS"NE_-$[KS(2@ZG7?"$0M$+EJ$*[XY-HK.-]0/FCD\K+.8A]]Z3#*_<T_>CS
M",5=6B5=4VG,L#F^HC%79N8;/A#*LHK2HCX!A*D@G-Q@+10TUC:0U,)#&4ZW
MAY;9OUCSQ.33:%-:1B3SJVPMBNEZ1*3'A(\%*BE^F:^M$ZCZ8DL+<6O[:8<4
M6)EYO;=%Q2=>!,2V9)+@7FJ.-:0[,N.8CEO2L+5M&3U PS,!*)U.^J?3'A[K
M,S06!6!XS#4ZC:#.3Y/+&%8C,[-3,DVVXCIDJUS4^B)/'<8F%NRJFFPVBH50
M"H B8+CG3A:^8ZU]S&;QB)3$/"G5HK=M1'5ZZ^3O JZD\*_FG]K'%_!\<-#F
M"EZPH<T^NZ%$S6(!L]%)[H;(:*:6#>D<G>5;$DH-S'-K2BMWBAOE=@SC!'A2
M4D[ZQ/<JL/EI9UR5F XZ;"^@\L<K)M'*-)4ZVD3+6;8S"4\\#<E1U6.LZ;HD
M^4$ZWA+^'S!5D;5LUWNX4]%KB:ZU^+&!K>E=L[0J>GDI;>50$ML&AV2=Z4:9
MJ;]=(&7:;ZVT^36G=#OVK7KA=RGK3Z^2,48"G9,I%FRO\6J3YZPEI!N-X!I$
MTB30T4S13LR<PS5LH;^JD-NX=,KV$NZRZ!190E0)!3<*IU&D/=,?>CV!J.WW
ME1HDG@"?)"'4>NZGF[(4H*75/5#="4UTWP);X:!XHEFS[JLCG$?1$S(NJDW%
ML@YR\A%M:$FL2R'\.EPT]4;0:'KA]"<Q*.E6,/Q=V4YKX*FR,J1UPQ/X7-#W
M9M-^(B8P>7F*JEG!744.G 6B8PB>;*352DIK3A$_+.JYJQ"Y9"%<T4(\I]%H
MPS%7L*25@Y:GLB=Q6;?J^VHAQP'(H:YCI&!)Q-R0;=FU+>%*WJ8F9MDR@!2&
MU7&73OC!E9I=9&E/3['+3.W*-K^"86H+5F&\)_- ]XQ1)4PWEU2^A0_%6/3&
M&-I;P:0!3^N  OOX<(&#S,HVZ^5+2DJ)34D#*3;R4B<DA-MI4E7NJ":UN/-&
M#R>(!10IQ)1<:;HGL"\*FM@T14[AK7MC&>34_@DLN9>'-L46W;ZPK).2R%-?
M;":+II<T-HY.2JI>=-":=?;&*N*V)3F^#QAHU66U$\\TUC# $MH"M$Z>*,=?
M0\X0M712FF4TW0^H*9(%30BGCA1*&*C6D>%2[+*5/D!U76 *GMM'MO*IYJBF
MN:@((IXQK\T3$PTXG,TX4@@W)J.B=W'AP-(P_$$N+=:*6E%EA!!*;YB+YCOC
M%RPQ+R*UH2D/ E10,I)UUX4A.-X=M/!5 Y3;I7\<!D9JMKYIO?@?H@"@ X"G
MB^S5I:'@L?V04/:I-.Z$YTHJHWK!).L*4LZ[NR,"<<1,J4DT*4"GCI&!S3#,
M^YMKATU7>E>,?7+)-B@(M;7N]>R)KEC)LT3ESA=?):,4Y22\X@MI:&6AT MU
MPB<27E-E7-X17,ZKA6"@BF7OAJ9677$%50DT&G7#\ZMJ7FEE7.;%4GA$F\Q,
MX4PYL]K-.$?"(S7KH+:1C2YU$W+(3*T;4145/G@,O@(YX:2I(]RL<O54WAMK
M9X\*S>P!9550I>XMZB%8M*8:M \)+E=:)UB:FT/XZH!*BRZ"[2JKE5Z_1I&'
MOJ#!V4MM25%!JHV3NB;>F$8AF0A+-]YKYXEIAE4NL*F4YJ=6L2<MM9F:1M@L
M.*&72UCPB;PYV0G5.SC@5+5JD&UA?44B9:\&F)'$%G_PV9 ]R[?E:[^,89/H
METX@[+I4E(35BBC1(-+:WC"\;?9Q$I5G'A+"E7OSJ5S<+1A\XJ=<6AUP*II8
M#S0N7ROS%37,BA[*1*L,R\TXE#835:E$[ZGY6M+::>.*IS6'K3]JU5W0L$+J
M3$LL%)%>N)A5&5JX ^8Q@_NDU,.'X)W]T%=5=1'FA0![8HZ$6)I%9@J(YZNK
M=Z]D3V.-2SJ9-M&VFU$)V8Z**_=%?!H-1K$]-.>$MKV>>5EW N8*:"^:I-]=
MU#\6E36)#E%+NSK4NQ+S&5UP-ES)S!]\:4IU^6$H.?-W]E8F3EEP?7?UZ1.+
MH[AX20=I6M#P"=P/GXQ-- Y5@TYA/$U!2.[6L3N,M21##*3,S2@ &T;OOS<"
MNX:[S#[^+3:/U7*-,2]Z 'G5(I?G&Y[(Y)-A.(3:@E70*,VH11=P>LPB8$TM
MXIZ*%EL&NN77OK["!4BG'WERS:_O%>8PE:MH!?+O&X]7FWP5T6,G1H*C?7UT
M@+&77A'A90EM"/A:PB6S2K;B11:QSHPUA#:2'D@H%54^4FX/<8QV>VK^4*',
M/-I:E(9YRJG4W/;$TTG8I-/A1F*.B::Q*XC-2QJ'32O48:Y392$OIVP5;0<V
M G"L0&8A+:CQ5QZJQ-<FVT\YA0</ &L3F%3B4[-Q@E!OO&D2K3"=FU-'*A*Q
M1)--\85B;2)<2["TJ;&B;'SQ,2GA*%3+K-4@4RBJ>COM2,%=.S>0VBB4VRZ[
M^N\.S<NTCW5:6E=9^>.5F.2;LIX,IQ+NSK0@C?V0PXEUI+B>BK-3N44^CWB?
M"RRD(3F4746ZJ*C!Y=,Q@V'9O\%E*]V4T]>,<L,4:D\.V:%)S9!05'"VD(Y0
M/A03G*<RCQO&"8@SL\[TP$$I)^%\T2>)K]OD!#^9.TX[J]<<NIQF?P5N6EUI
M=>V1SI3J#XHD64R;.1=0[FZ!!UKXHE)MYF;)*%"IL8Q":G"L*6A0:(Z42TC,
M.97VVRH UK40V9UM% V:]T/LS+U5+00HZBHT\<>"EMLJ6*4IOK>%\ZPTCE6X
M^S,RK:*A"U"M##DF2XP,VJ JE8G9A<FS8Q@\U,*F)MQ-"E;*#0K"<Y^*-Y/9
MH+QRFQ=U.'X?5-2WS"*Z*RDVXCK[-YB7Q-^8Q.F16OIB09;<0FLQ?*+7UH+1
M3+S:URVKQI:OV:*9A72_FA\(XB$O(SJ;WIMI"PX5Z<SMWPI03K =;.\Q(3:-
MNI+2JJ">?7</GK#,T?#  ;]WH/&'EK!-5TN=^_TP'$K.51S*/1]=T-K2 X@@
M9LBO-"$3:9M3F7W-51QMV<?+6&W:.IS5ZK:7K&=O)<WON]?[8V3J)M;BJ;-1
M.^_BB>;VTK-ALISK0  2!I&'A]O#V0'DM*85[HO.*)ON[8QN<+CK#B<3!"*9
MKC<>V&,98<4A)?>=I8N):44J/$'0B,0]RFF\00VX\W4)*:93?JH?7C#F+ON*
M06,(VE-2XI-_R1!E\:?Q-J;1(M-L[*EE\ZJKY5#?ET33=$DUB:&BAQ/@U5DU
M2<U013=I2)[DG/S\WMSB#B$D[JPQR0=:H%/*R\:ZVB4Y.R\NE2FEK4Z2#H=W
M7'*;!_#I+9MYMOD( -KZ 5C&#B[#.'2$TR1+2N4.*1SC04W#6)/%F$RCK;-2
MEQ":9DE)!S4(4%4H;5IP-8F\5DE&3<EU46RSD=M0A=*6XZ4B1QAZ5?+I*@VM
M5CJ+]'OU[8P^?+Z2Z\>F* PGP</J*C<UH-?IA2$4S)KXOVK5TD]_HB;'-!'?
M$F]1RE>J,2>")1SCEC @$LNK5<K), W[(KSH*U"H!L8Q/%E2#89E@%STSS&$
MULC-JX>I-[FPI&R8E"N92[X1,.G9E]5]K,+/NF0[TYN:D[Z&/ UN)6WMWG'
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MUX1(-'P\DFP5:P&NO;U&,20E:\HI6EX\$R**QQ[(G&CX&5*-AO,2OZVE_P
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MZTM64I4* "V_2&_M:/O$^8>])D"4@J<RD[LM:=^8>:/:_P#RW\G_ -\>U_\
MEOY/_OCVO_RW\G_WQ[7_ .6_D_\ OCVO_P M_)_]\>U_^6_D_P#OCVO_ ,M_
M)_\ ?'M?_EOY/_OCVO\ \M_)_P#?'M?_ );^3_[X]K_\M_)_]\>U_P#EOY/_
M +X]K_\ *_D?]\.(+:U(5JG^T'O'[=S@0I("P#TJ>2L3D@VI6T9!2I)J GB.
M C#E*5AR NN9*4@UZHI^K*C>T=.-(?3GE4*!ND?1#/2ZJQBWNI99!IF< J-U
M_/$@^9<S<BNH6N833M23KY#'@ >2TAU2LQJE2Q>H"0K3CZ8"/!FFT)NA-$)%
MZT&G?#4P"XMO*:I*M_ 5H;6@3;:5<YE2N;6O7U]8AM29FX:RC>3_ &05HETV
M3NZ(-,W'Z89QA,BZZM4LEU0&S&;<5)L0"*#MIUP\[X2XI="WGSVU /4:]<2\
MOLY@.%2E90KC3J';6*AN34O@%&O%5.=XHPR;,\TM?^%0^ZTXD?)6<I[TT,'W
M%D?&78<8KKQCAW>?WE\T9>/!IP^))AK$76>A7QPC'IE-,R-KGYM*TH-.N,)2
MRVCPIQ%%*O2NE8G-D&770D7!-(9J^+IR\X^<]D3(0&"VDBM4GQ>O?%>;3RQR
M132<?-*\\WCE"HEP #X7HA2U)^#6%*S7[+0HIRIJJE":>2OHAD;6E,U .%8>
M3E<HE%>T4A(<2BFSU%:YHZ-136T H IEA*/U0HZ#*-V^_P \<G5>X/IUJDQB
M#:A/O$'11M&S6I((%KZ"F_R^6&$Y6DIX9OSB?>&P"55TRGSB.3<VRP_SAOCE
M!,(.#/6LI1\5XY+R>&*P-;LZ<I2*M=9WPTIEUAQJ6ND9@GL/K2)G#@TE1IO)
MA26P][H: 0N>PQH .$$]T-S$BMK,TA(X6AC$6\_@^\FL)=5+*0X?M8(*QNI#
MN.,OS>Q2-3$PA*1G38$",M3GX>Q-+2"R#ZW]?%&)*!;;IQ3$K]KAG?Z[XFTA
M5*_!,2R=I:-F?A::?^9F_P!<.?P/S$_MW-IS;,??_P#QAJ5%<RA#-4H4D6%#
MYHDEE;KE37*%#QYJ1,+\$PV9F+N$)4H).@I4T]$2'*.<FWF\C("7%! 3OJ3E
MIXXF'5JGB*>Y,/,)0KXQ ]T/9F/]L8RPN2Q-J9RT;F"%5W5-$+[QJ.HPRLMR
MTN[6O.-]:C)3COA;F=+8'QZ^*_IUZH:H'UK-!5:K]66&,SCR@ =F6TJKNJ5:
M>6O9 HTW7<-!Q.Z%+4XI"U:A2QOI3=$X.>]33.UW51"1<=B_+3YX15#9*A16
MX'C?+Y+GZ8?21A+E_@+OUTO&!2RFIV:M1J80R^. 5ERK[[5B9<S.4K9(H($;
M^_WF8^T/_@7/S#[&&,^$SC+5*U4+4K7Z8Q!A37@\JT#564*2!<::C4".4C?@
M<G+A*@5+ S)2:GKJ!<0PJC8 2=.'&)@+J5:4^#>I[/[8SGJCDDW[LZ=YN>SC
M&/*R/W%B;5'FXPX\ (;*5(4:CLK$H\RIUY+ZAE0>94TJ3K0'J C"G,.24Y@G
M<-1O,8O*R;Z\LHD(5NA6#3;;7/<2"JZ:D5R^/C$IR=F'@M:GDT151YPK0=]?
MIB9PW8)JFJ@.%QY(K68-/B@<;CUT[XY,',7&SO!MW1CCXEIJ9XYK) K]'KIP
MD,:VKNP*#5)X==>%^J <PK2E=WO#:-HM(K2AKV]7EA^=,E,H"!I32)S$ _@"
MMY*:QR5E%S6',DYBA"E&E\M^K2$R/@,TEXC*VNJ:?!^:.5;RI Y FH5>H^5"
M?=@I>O'JC%)99745%[:PEX-/8>V=5MHKNKS1&&-+>Y3ABG,5E56EA>,=P54L
MVTZA-4A-56MWVB;P[9.>%A(!%["GFB5GMJE.T O;B. KU\1K#LJ%C:I.G"%B
MJ<N^-B=]_7KB99#[00!OK7?:&*RPH16&E9LQXFOCB=!5EH2+U[=U+=M>Z)8A
MA-50'=MH>/ORD5SJ6M21NRK4D)2!J:4JK4FM1H-T!2@SG4.<&\Q'6$U_MA2%
M(07,ZRM SJJHY54NH9.B!2N6@!%KVA6:G-H#Q.@XFF^V@X[X9KE54E5''!51
MJ;*]=+<(<//2%J*&Z&X4457P4H4(M<7%>ND-&J3SBI.8Y%&Y*:#4[^=F )U
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M^[OB2=*6 C=6L<J7")$/)_\ 3/R[]N"7*'N()UA!"\AW+RGN(CVL9<0"VNY
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MQ2:FH[Q'A;K:&Y6;10)S%*M0H4RG+\9'5TAOC8/2$XU,R!S,S"@VM";I&<]
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MDK< *NT&D?5+PJ9G)-I3<LXM>0+HE-2$TK7LA2"A10:U2:'74;HP#^],I_\
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ML<@RFM#Q4FNZ H%(5\$C-7JUA#F=2QE("<I!.J@JMZ;M+5O3<(6K+0 9E*-
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M?3"^3[>FW(6-W")3"7Y104A\JZHPIF>F'DMI"E"G..Z/:'/+I62%*%"16)+
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MVK(9-Y&>GQ*YC&%SK,RB5Q)ITEC*E+G#:;ZTWU]$3\NF<EB^V+@&\<G<IG'
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M/T4@C,I":"Z4WO4#JOYQ R*5ERTW U-?F\D$)2$U34G6Y^>,@ST^#TOX/K:
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MZ[XC28A9>O\ #Q,"!G.DSM")(MH^I=H[Q$1WT^;]%2)[&P9(>WW3N7:)^)#
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M[:-[I7ER)E'0=2LD>WJAL9Z3@)?I(UA*UT:Y,9C@\2%FOT!DE*9+Y6+>HJZ
M[?/ 01>KES&DBU@D,?#0R&1T]>TQ(^GY.W 7LF_+UK;\VW%1>72ZF%HK2F"*
MS<9$=0Z\NDJ[B3/5KGYY$EP7!3.P^HM,I<LH8LD:F<-2V-=ZF00[9&=.^C(@
MNWZJG697?8&T5D-E>8@XE5"S9"9,NP235"$27E@IC=VX I$@DEK(@*8*09*Q
MZH:CVG8S<$3'EG;,C\>)*>PQIK,S$1W^>9F-.&](=!5$;G,[ 6XH&.D&L&R
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MS((#532*/@<#)P(EI'K^37PN>J5?MXTV,;S%D$='#&_(1-DL%E6ICJXYZ5E
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ML*I86M2NY.]-!].S5#J-'I.H$)U#W"<$?2(!G:R3$]/>"<:\6L2,5C\4VAU
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M] >GQ2MN5OL8XW,ILWL'HG80=9T[1* 9O0PPT:)P.NX8@X@H_N#I_P"&J_\
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M59JUP-T5T==WA^K,"3)5(=3R;N,M0*W+X>LW+;E(O)0/4*9!%1;4# ,0(#
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M*X>/M5C35ZI+,EKU,.[#TG;$3/R9^;CF%EBNQ$ES(URNIVZM*,9(JL!_XLX
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M'6\"^-?AY[]<^\:=00]>/#.B(=4-]-FGSUGL7N^C6(U^G7C!]_\ ])?ZHO\
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M-%D?:W7POZ5FRA/VO4YK@,10:P.GTKGLC.T\U;LA(,9[*K)\3!:]5G*&/FP
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M]B$Q6PZ,UCFJJV^K;4#+:$FR>L8M<1DTMRB*2Z6DZ]CUBK3QNY"[6(5>8LD
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MLFW6D#)GGF=SNK/;C(T<C==G^6;Z[2*F5MZ%E<58?4-*D94M!"_2L3LKKO1
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M->/=LU6V!B-=PS,:?3PW1SW0;R,>LPF]&-H *DD?FA/;='<OE^30=(X_[?\
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MT&?[Z9TTXU>WY_(OX3'P*?6?RCKP:U# QU,; C$=]PL9K,GWF==?HXY<8\I
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MU98TZZS%1N<QA#)L*9^QG-6]4LQ=YCY5MT^A84WQ-44,@[*=A3+$ 3%B;1U
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M52Y<3H )G;TQ^6,_&.TZ:Z</L,':Q[6-*.\1$F4EI&O?2-=(U[Z<?_#]7_\
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M+E=%NJ\)6^M94#Z[EE\I;4M$EL"?B)C,3\W%W#<D4^7.3O&]I*GRW7F@$-F
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MCX3I\8G7_-Q^7C#?X*Q_^B)_5\XK5\LOTO:>GPYJP<SZ]O2)X1<N-6Y]9Z+
M(B.N4DAHNT(1[0/D[]_DZ\678ZJC'+N,<\WM,*J%PYA-+1SS#:N-9B)ZA#,1
MMTUXY\<>7HY9OZ5+4]:C9FRE#/#6O*;! 0W:3K, 1:3\9XSL::B&$H!^V_\
M"$#I,?P?P3)>G&4U.N8'DKST/H7$6*Q#XII074I,^Z#KL,3*&">O47KK'%:J
MRY[<Q2NWL[+R;]@;=-M5T'XJK ?B1#) /787IPLKTSR9S.T.AXKK!6W[H^Y3
MDT#%2W7(O2OEE2K=I'3DR[*;6!6:H='RW<&"$VNAINB;.&WS2O 7_DYPR4S[
MNK'I-CILKD\ZEE?0*33:$EH$6K=3L JQ5,3]:K07OGS0,_+G Y.*SJR6\Q)$
M'!=-M2QNZ@D7@6>\HF$(VPU<]-JR$2G<$<<FXVU$]+E['W:E/HU^J<K-]4Y
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M+0N,NQTFV:M"9KF^%PQ,DQ,3*^B"H@MTS.Z CM,<+CYE*_\ 4CC#_P""\?\
MZ(K]7SK/F_\ R;CR3(EYN;L"/:8[_'O\\:QQ-D<>H5[/='=Z:5:_!LE8((;$
M>L:=M?7YN)9<S6/WS/?5YOTGZ(2J5^G;1?:/AQ]E!\7$W@#ENZ4N1#(@-*%B
M9'W@"6ND3IQS TM9ZM3"U]-?_P ZNH&9UGYN+35>'N:VK$R52_5<PIZIS\B&
M[M?GC37X:<4L1F.MC?'.\-XHE:>',XG8UBV[ 8D9CWFTHF!UD9X8@; OA+6
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M(S$/.SM(GN*.\@$<1T^>NK.W5E-]5]6NPATWB'AFM&1DH'IPU!1I$:S'$+6
M# :B;F:S.Z/+Y '36-?3TUX7U;5AFC=-%ET1[Q_XH==/RGP&X&EKMU@[%@X_
M>WOG3B27$Q'Q\["[3,:Z;CGCGFD)$,/I8ZX,3HV& RA82[RE.[[HDM.\>;;I
MOTV\<Z8:S&P,OC>952(EOV.A-XYC>U<=4X:K46QJ,S&I?*CC*8VU9MDA+JY]
M*XR70)5;-JK(0/3$%?+5NVD);=!^3VXU$#18%79\ >QX]A7N !G;.@]SCMV\
MZS[EQ9EU5C%$@H8""C:[I&,@<Q'DF-\[MT:S,+W0';M]E# >$A,4L9B>;*JO
MNQR>+R2IMZ"0Z[IJ+T_QR^?B$TJ-^V^CE[E25TZ-AVY3P6:"C1>@K@ZS(DHG
M;YQ^)<<D3F:EB@V;>.KW:]M?2?X;(2>+L=59:Q'4K.(=)CTF->,'RRU'0N8=
MW-%"YI.Y;Y1@LY*'JT@=L$G8)"6LQ(Z?/_:O&:?#QG\_A./-KI/$_-Z\;=?7
MMQ,:_*GCMZEZ\2(:R1=HB.!)T].-/C/?A:B;]TG2.^G'AMT:S&H_#MQ>PA/E
M!N#<HXF/NH=PB=?Q9GUXYFRV9O=.]063\2M!@8N6 :EXD8UTU/Y.V?3B8U&.
M\Q\GA!9"'-I0R/%!5V!8)7QA1L\D%Z=YXA6,"PFDQ@"(6R6QP[YTF)8N!B?R
MZ1QB&8:Z$<NFB@S)E;N_\(=2=#O0F(7H$2OM7TAGF[GIQB:E!I35Q==%-,L*
M#;T:XP =0HTU+:/>=(UGX<-KOVL2]1H<$]X-; D&#/T2,S'&3"H?3?B,LNYB
MSC7J=.N_KUR#]K'0E<ZSZS'%/(HQ]^\VS72QGA5;UBR5CN&3TVZ[]W;CW'*N
M1+Z6,!?^?BJ <L=-)N5#6-M#J"R.(86D1.NT=9_6>? 9$DL^3.:!8,>I 6#O
M041I!3K(ZQZ3^2>/$8'*OH2R=^S<3*I%VB1-9;AC0IV[C!DB#$C/O9VP*^8\
M-%A.NV;^,C0ITF(WDK643'?\24E/?08G7C[2R2.K ZG6L3X>P'KNGHM\QP/X
MTJ)DQ\/-IP&H@2U=+(/'0YT(X-.%JSNC:.U76R%GTGK,K1ILU*#628*&3X:O
M!KALRS4I\5 Q,QOC2; D4P0"*PF1,M.)!/VVEB@VC(Z.QYO&%KDRG6;(R6F@
M_=5R)&[RZ:U6I8MJ8!Z:L]1HLF7JJ)(G)UZ>UD!D !FW?&\REL1*QX$1K4W)
MN6216=4M0?13"IB'6HF=LD+&28Q7-X$H5GVF1XQ'3<LM;EZT4J()V,2L1%4Z
M=NI,*C4)\\$6FF[3C&N+7<VFAI:Z_*8N#GU[Z^;OKWUX$;]5;I#[F[S!91/[
M9%A<@Y11\X''&RQDFY#$C=K=-5L!+(UG>>$_;0[!LU]#GJ"V!9MTB&G)%/%2
M@>2BGE75J9(Q^1*$-;46L$?:(&?O8W@00*RZDC$3$3'?B/T/6.WKQMAHQ/Q]
M-.#9NAQ>D+$H[]OVWS1\>&L,B!3&;IC=_P!&-/C$<?[?GXGC!?Y3_P!<Y#]8
MQRI(QE6=KN EG"R@O9^33\K0OQ7%$_Y^!-C;R",-\]"SV$M?7L$SN+7O\.!?
MXW)DU8ME?7?+/AN^1"MFDEZ3/?YN.:')?8^U\)F2GJ3MD]F/(NE,2)S(R)07
MKII\.*SG+MDMG*F L!%4B7)E.+J1.XPJ6/)_BB/SSQB*]A;(IMP%*;>SKF3@
M*PW494,3)FL)U"5KWS##B>VSC*NPV-B$[:!P^:;)E3)91ELFQZ^HLY@>I D4
M=QF1CMQ8:"5D_>Y4;U0^9B+,%$[)U$ICRZ3LDH*-8GMQ]DNV=0VY$;W*'L^W
M*[!FH;-ML7>FI&T#WK3W+89 '?TB>$5R6W<.0J6RF3Z?F4 5EEK$B7E$B'1F
MGP+UB..954%Y3'*]K8I#!&_:EP,K.R/7;7>;9>"G*-4D'4CWHP6V1B.,((%9
M,EW+4$=FTYY3]II:,B3#/;M@]-1GMLCO\.$6*.;O9,IIL8P?'OM0JQ!IVB*U
MGJJ)U-<Z1.X.T[8[\?8T(JAINW<5:LV;#+3+1O,(M*\_5F348:;=N@CMTTU]
M.-DQNCI%N'Z"B-=8^;36.&S&Y(HRN_:N!TGK^#J]XD)&0 7E,Z_1/PXY2<D(
M9X3E;*0HN@3&*=7YGMI"PMH=T](9W'V@=/+\=)?8)(6K73Y6EI':"FUG0!I#
MU;![(*8F((ODZE,P6OK--S1#HW\GS+(!7L#>::KE/')DHFMOE,1*NGY(+8S0
MH[:3PV[378VIPET00+9EI*]IOF%,,EF93[L!,B'J;M9GOP,QROFB$DP<D'B2
M!9::F,:4Y^,]BGB%U.7\O4>FP74..J[JK0!&:H9%?;O,MHE.GQVSI/'*M[HG
M7\9RY@[?AV_=4>(QE9W19K$3O7OV'K$>:)[1^KYQ!A],2/EKS;9+S?INP,@.
MD?\ *'M#7TC=K/:.%[ML=BF-9TCU^GT_)QX/'KWG.V3;M.4I#XFTP&=/W(Q[
MP_Q(GC[)"&N\2(XZN)GX=E>-7U/D=-WGF(ZD1NF-2X!SBV ',N&-Q;=^B:JB
M>TML"4SHN3[0,S/S>NFES X:WU \0+/!I78@6:SNAJA6\"[[M-\2/KMCBU2P
M-E]S%U@ZZ*.4OPP\(R6K7+L?;L$,A4)1RFS3:72T+KQ,&N.,8C(7*%B_?ME=
MBECLI3R<(I36#:VSX!C_  [Y=Y24\A*8[]^^D3HM?_K?S<=R,_R1I'\,\!H/
M>4NCUF?AKW^'?3C['31<$S?R^:Q[$ZS#%G&);"Y(9G7:]5N-LQKYELCX1JX)
M+78U@_P'/SSQZ:?3.L_S1I'\.O%>Q!GU:]['[!TC:0M:P&3.GI ^68UF=9[<
M=;I[^BLV0$SV/IA);)^,1.FD_'CW-IV,LM @;3M,,Z+H9'G3H1]+I'$:>6%%
MKIQDV/QH^#3F*P+R-60L";$LJFM;M61;K>0QB"('I, 7HP=LQPI8SIU$V 9J
MY" (%SU_6TU:&=Q"85.V3^$[N%[HVDG,V-\1ITX\33KM6*XU[0 #LVQ\=?HX
M_P"WI_\ 'MQE*NW9-?(WE;8T\O3M-@1U_)&GT<3!Z![T9"(F2[3\>W 1K!3$
M1KZ?P=YB>)UC\2>T\-$H#;D.6($O74YJWYU\WQVK?Z:>A<-00S'B<H*VE!'L
M7%NS%6WH,^7S==BSC\7U+37CF7$K1EB@/:$M4R;!H:%6\'F$VK6GHZ)8JO$E
M$&PHB)UGAMJ_4J54)K^(8^P\.FD3ED4UL),-+K7B7,4E[)E@^^\J-#X"MCZ4
M=3P-VRS8*K"4X^:3M]ES8F1&1:(ATB%;(9,!'O"@9\%;*6*Y@Y=S6,:"MB#-
MGA)NBI1#WZA14,0[%YBUB-8[IR52Z&5Y?Z0X]646F$6\8PB08X_F6@/FQ=L)
M#:-J513?Y#F%&6I8C))D8.:QP!]M(;3L#8043ZSIU?FF- ^;CE/*K3*_TP8-
MV6@HUV,FYR/E7FSNI<2<EJ+(#R@P9B2DM?[5J(/5'4_^OL_]SC28F-)X@_FC
MC]_A?T\!$?-Z\#\3^'SS/"])V#(_#\G$24$PQG=$SKVTX$]Y+9$:#,3_ #<1
M!G/T%QFF,9[D*+NI)3I&FFGQX/7]N7^?@NT1PG2?[.O_ -<>*MQ$*:AE91@8
MV53O'IQ,2,07?7@7T*3+:#B9@TD!:Z3(EI&_=,P0R,Q$:ZQ,>O$J>AB6#\I;
M0(#C\HE$3Q1N_(7E*I57:!K),1Y8&)^$DM@_]#BRAG_@6:NUQU]=GE,8_>W=
MOT _+^L\_.F9CI<E<TMU'Y4;,'>+6/IC3MP!UF5WP?3ZP*+IF,]XVE6+S0Q<
M;!&4$8B*HZ<=6#,R$/-(26]#!V3&[378,_N("1TW=O6"Z,[A<5?PSHZC'60W
M+972M!E:?Y)UZNGD3)"6UQ!V\PGQE<RFV%ZJ8I75Q-V8CI7VK%2A\1,]3;1Q
M:9WLUB28"9@!DHB:-[,TYQOF35"AU39]LL*2-Y2-9K264>&#I@IG3 XZA;B+
MB5#6?9<FL^T.U>M6HT0Z:VVG/A4 E( QBI'0G,B>C\D9@[MEK+UZPV 0I;)K
MPLG[5JZ"!W?:P^26!,&PB(H8>^2GAHD7@Z. 1T>YBNH=_;X>#6/R2+Q+;(C)
M]^P3Z!'%$*"/$L=XJ6F&CS\7+:\V;BNB31DI9&_5<_*(QV!LUXHY#EG.L>OH
MPJQC,Y#&U9LK$?$*19C[:K0+-5A,=4/3MMXA',5&S@7S&@V&^_Q;)]-RKZHE
M0=]/*^%G'[3AB 77G"@=1ZK"W SQHMW+F!D7%VK.7,3&S4O*V##O''@N:,=C
MKR_96!?$%HPJ[YHLWOHW5S#Z[9G29<AH'O'Y7;AO+V%N%S-54YNSEG/-W9C%
M4U"+@\/S#W%RYKF&SVAU!ZLBDF]2>X5'R_"9<QC3$Y=<U;)^<EZU6'[B^.X9
MT948V)^:)B1ABUV(A<ZQHLYG^'OZZ<0LG3V_AGZ==>/>L,]/2)*?3@?*(P,:
M1M_V_/\ E_1P?^4O];W_ -8IW,D1B@LPE RN(DNL=#(F,1$S$=Q6?QXN$H+Z
MH4O:AI5';-[?*M7IN*0-9G,S&FTHXRH58O5'6<->FBV*;E##I$UP1',;T0!#
M.SRSV,9XB_3MY&+BHRR+^/G(G5IMKDNQ-6P.APQCJLZL,)6:+2P\.R!]WNQC
MJ7,YOZ>(I#8&6Y5^^RJM'62C8DPK+AD:15,E&F/=E 2.D8VX]K7"+QK[B58
MW)&S(PE.X-8F%RL8CY>NK!'9&O&;2_VU(@B^Q<UK1^S"K*IF I915L&M%5RF
M;]Q#+(#R1M+@[-*U<)BZ]N*[V&V'[US7"9U"3='2,]J2DCF!G4YTUGA]6;F0
MZ5%=6V]!/=UE$*PU9#!F$:RR?NJPTEDE^+,\>*+-YD=]H%^,7DKBTFCPRW-$
MEH$W0R"(S%LC !!Q'RM='KQ&<N!;?D<357;*]EF4ZPY.Q"YDJE\M[&;IUAR=
MW3_LTQQ9+)Y>UDFX[F/)8U;K-EC*K?"X]##%*SUZ1S[P^K\E@^7UB.*-T+=[
M'FZE>8Q@7+(J="C<I'2702QNR8B.J)[3;(3LU&8X 52Y7Z7J:;AMLG8<RWXU
MA+$%+? %67T[$-Z6R(W]4OE%Q8/:11-$ST'76=JI;H(_/I$_OZ<.KV ?"[ ,
M)M4-R6:DKK$).CWH0?03';O'?C!3*"3X(,Y2KK&];'9 9:J]NYH&$LUZK'%#
M9*-8TB._%G'%6%M-C,7!)F;)>ZI1;4V&.7&[RM'9.\O/&^8GR\<LEATTL,VG
M<RD=;Q%6YX<3KI)H+#Q5<S8V1\VARQ @)[8C7AUYIT; ^QK8]1&3Q=@C)V6W
M]7H*O,; 3U>Y3,P&[3=KVXR0I!$"K#06IPAPFR>D,C$KL$4#$S,;HB)U^/%S
M+5;K5KL9C*A25618DE;<@E;R-L6(F0+=^)(QVB9'MQR5>LGU;%WE+ERV]G>>
MHZQAZ;FGJ4R7G,Y+O,SW[S/ZOF]<M!,;N7#)C-VV!5S9@FE'E@IW' 2"XT[F
M0Q.D=^ &W?R=A\Q/6(*P55+F?7IR2KCS ?+H71"2\WIQ%?&XEIJ\N\I>8,<W
MX.-C:U>3DH^3$+F%Q.@R/?C[(N5K)BF#TUZT*EW5VE4IJB?>[1B=\]XC3R]N
MY<8^Y=#J4PYHJL>O3?U*XX\R<O9_9-0[$.G?XQQ!ZO04:0&]4K<N9CX*!H7H
M@8_&75.)TF DM)D<YBN7;];/NRE%]$*4WT5K^-E@0?6LU;Q5KLIT7MG[7*5C
MN,N&![S<!E#(B)G;MF=TSI$Z::%)3V&!&9UCCM$3^73CRZ1/Y/\ V_[.(\34
MEY,685+4/-<4CC>1LE(QM?#0$U;3VP$F+8UTTX^QHWL,CS8(=YG6197?&W3^
M?BWO><3XNS]S1)S]V+]L8?\ KQQ.K[104$,SX,)D=8[%M\9ZZ_.7[_#HKV2<
M3?!^0Z\I*!5?0TF?+8/ETT^5^-Q8"/\ DV1\>T&LX_Z7T<%[O80S,>]T$9TG
M2?-,AI_>ZSQD.759Q@83(;&6L.9]6BXU_P!F&&B4(> Q&UB) O36=(TFD_)6
M[=6JL[:FM33BXU?5H,Z116-%A=A+'2H9 @F.F7:1F-W"4XRS<+$>T(N7*385
M4\9H(SI#&*LE7W'K$BA:=$;5;?)KQ(T\/BZI3Z"QS\@P9_O \-OTGT@HC7Y^
MW%J]D=BK5JRRS9\O0'JOF3/8B9(AB9."B-3\OFUG7B14FP\)B/DATQG3YC80
M?S<(A.(+;,1$RZ\E6G;]Q#B[_#MQ'6J)7'QF+DMF.W_H '^&?_9Q@2(6Z'C<
MPB=NA;I $.B)^G:N=GTSZ:<6@GV:*0YB&PDS(EY.7WA:6Q8&2/$)!X=1G1EW
M0)BY:.W;/%O'5YN+9%RW::-,+1!9C.)+9UWJ4>BT]91BJOM.13,+E1/EB54T
MVKD#6D7GO7"VW,L01XC*7FNGSE!!"*]7H%"J@[ >F1:3"I*IXE49.S$YC*,4
M;KKJ[)D22A8&*:ZE+8PU+&(5!E)?'CEANNWP?,]9)SKI[IMKPK8[?BL4THGX
M:%&L<<VX'P%(5KSN3J-B*XAXZN+RVQ8@1CQ$%7,-XGK @0_ N%8C'ROECF"F
M,V<9MF&XYTRN8)$J(_*DXVZ^'VRLOQ"]./L('D@(+^'J\Z<I9 ?4(LX; <Q
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MWZ-.]*+5A_6L!9&!;7;7Z<PM/57O&(DH7,R,SN+<3?DS;Y50EWM2X5^*<,E
M&7BE4V;2.#)/FVV!"9CY&FL:Q'#[.8IWL6I017@733V;E(7TP!CS^VY8DDF<
M+(M3,ND$+'BHVA3M/6,P%H:MBOC**E0O5YBT=$;]IF0P>DA"E0,FMAAQAS-\
MM5:MX-P.?>K92F*&FF?,OI)E;GR9" GK &,DHBB->,M 1'EYKS2P^VX*"4JI
MN$/":=2""(VE<W;3GW>WR\5H&O<71OHB&O\ '!0KTM#6*ND3?=RKUET)B";!
M_)(PG?GZL.)INI+T K,6G+A-J-08\! 9C2!)6[SS$[2]X#-*IC(B>UG5*1]%
MPC9/^;OP.N8IQ9D984*L+ED;DV%A&R"F==%CM^F8X3B;-E#[9V.8#(9EW16%
MT:K:K#LQ ",>(K[IT.([?-KP_;;40#&Z7^4D,AC\I&[7ID7>3TDI&!@YD?/\
M,>+5XARU9?F$F3UQ5*1FJ"9* &ZO<W69Z\EU($9T-:X\W%S5.!2A/+S0WX_(
M*,QV96L6P^GDC]ST9%FO:!+2=_XO&1<=VG[S'55:^-46V'6- ^4UVHRVN\1]
M8F8TB9XJ5T /2]I9ARVI%%H&[[R2': MZ>PNQD7I ZGI.FD\A,8 K8?)?*QF
ML!@  RP=&2 0&9@!&>T#$S QVB?U?.2Q*1W_ *70F8[3L+FO!0R(GX:KW1^_
MP=N^D34K\4ADHG][75A:SIMCUTF9[<?]Z_+-/%U%@1C=N5ZRVL%8[I-"F+[3
MI'E\K==8]YIQSME+;S*_;R $YTK2)[5>&W!L4(+$20)!$"$=BF>,)CX,J_B^
M9) &B@+,J(<=Y3BLSW;X#6?=GY2C77AZZV6Y7R(-$P(+V.L<N6CAHR/KCUJ1
MNUD=.JYRO+K,1''+5'*8V$UMZ$VZ3GIL5;-1Y&E^078I@"Y7$^\(M .)3/6:
M?RN.:\K;JUY+]+7-%55J(7N8Y$5//I&FQZZUS9+-/,#])UTG1'B<.NC9*LC[
M;Q4^#=OZ(=R /<,F>\EO5/T,X"QR[E8RHN?" Q]M'0N[B6U@PMZ]Z'=EE'<4
MSKM^5KVQBLSB;E$""QT)).BWCT&^?J+DA80[@W01:KW#O$=8X^QHR2@=.=Z
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MUC[HL?AVXY6N_;+*[L'3%JCLS*>O5?9J,GPVNSJQL#OLXJ\L6 6-X66;&*9
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MO=<!/E6B3*!2:JGC'OV%LE38ZOE$.MV@!XR-;(\NY<F!>*X#8(;E8T.?-I+
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M>(LVA#[1O-T7<:+A$M4A(FEBS,XGW6ACKK$Z<<I6F6):QRLZ5J4XY%2JZP&
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MF;9, $NU50S8+U-ND*3JTHXR=&IF,KGTV,=C+RLG2!-0V+*W"WG<BXT7*HT
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M%JP@6:#KQG;SFY2AF;5E(,=7R.(=0_X.5-17A:\KAE9%D 63%^>1E8Q&G?C
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ML:U&/;;NK,$'6O+M ,M:QLE.P5S&D-TC49[QQWEMNP\XZKCDB"LC73<<^@Q
M_('@$4Z, 2E]6_<.1WV&Z:E.[U+6==H_"..<>9*P'-5=:EBEFT-NVSTSEX!\
M\1$^O[KC$<CBVPJ,D0B^:\A&T!'M!Z]]/R<6_:!L**EIU91NC;)UT1 *GOIV
MVQZ\3RC@S+:QGVVY?]B3KH4:Q^,7I'&+;T1\77L5K!'IY]RF S69]==8_6?L
M@V*Q2-E')'-;JY",&0N5@;YJ* F"@Y@X&8&1F"])B>-<LZH6]TJ0NPME-FE<
M9ZY$24MF"U8M0#*XCL4S.O#6(H44SEX9&LV4VNIT&2W5)RTQ!77#=I*E3+%[
M&?BQQE5]1*K]XQ(+G<H>IMSW6[J3TIE%;KD6@;16[S:SIQS!S>UQLDYG#X<;
MD$:_&YJWMJY A<10N:--5F\PY@ND3@*-"[SD[:M\4*[T4>HF1ZH8^F.W5*#+
MS]1RQ,O2(Z.ISYM297%)M8OY82KSJB=)F2$==NFZ(UF=L3Y9T+CEHJ$T%%2+
M*6K<S'5><G2Z2V'N/:4>528"/+M&2TB3GAM:TU9],VS,*5L#=TTG&G?72-GY
M/>#\W&+K4V])UBQG2_9'AF2$V_,(,UB(DQ(EZ%K!@9KT\W 5[M0"=!S:;#[6
MC@4)%TY0P%DH19(BV-()C-9$XTTU1*ZJBZ9V3L@=EM9#4:J8PG-$2):UA+&-
M<,3.T=-OW+A['6V\N<O@$5:URS3R=ZJ1H5N2MAU%N/K7-3>$%J*0G;MVCI#
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M$;Y@$EU]S7,@-VR;"*M9U;(Y8K].Z$RHF54;Z9112R=V[JH*?'3(+("A:PD
M!JB9R[19D8<_)\NOJBFR_I/*[2N&L68X9-36Q84A]5\C+TQ#%:;6>[R..RJY
M3D*F3?5OJ@5C(61=M=&U0@H?-ZPL0'YACTX3D3R+=D[W*J,7OK02V,@EL61[
M6 73TF)C3OQU_9((7TEFU*50@&QU-70N9UZ4-B-L%WZ>OE[<+4(5\="Z56A.
MB9DF^$(.C<;T]P$Z424/A8KZLK"9%DS)<)9CLO:RMO=+!-I CHRG4X!E-L)F
M8;Y>X&PM1(!C4QCC!,6,]&5Y+=H+)*2*UXCW@CK"Y*3_ !IB0^,<=+Y,@QZ2
M'21G1BYUW#,Z^DQZQ$S'IPJC+&+$<M*7:N@(E +ZTFY?XH=(2='5'3;N9'E$
MIXR XVP7B<C;!;_!,Z)G381>2+"97JM1 HI))]-O3G<9<<K;PV&)\PK.-\LU
M-/-&:41[BB)T802R(T\L%M^'ZQBDY1X5Z_Z;*,P; (QZOL?.B(Z#,3W$C[Z^
MD3PY^!>I\28JL1/6*(5(-^XBQA1'_1U[\8R1^ZSF<:'TQ)@Z)T_)K/[_ !8<
MKRE7J8B0F-=>HNC7T*?FG7X?/Q[0Q5IJ)SF*\+8-!;98.H6)1OCY,$U4A.NN
MN[3B,$=@IZ6.Q%Q?6T@H\=CZUEM81_&TEVHQZSWX5D65[-RL J%PUXDV*"M$
MDAW8A/128E)R/F#8N8F#+BMC*5F1RV(9!XF];\I&MOF;C+;7#+( @TLU)8!$
M#HE'?7CE+"U\JFUDEKE-\:["LF%]Y"(C89I&V&3M7TXCW1AH( );8L\L<PCN
M2;("?-HRI=JGY&A.O?88D.WM^-ZZ\2GO-=>AC*]>FVM^):1IVZ?;0XC[F6H_
M#7B&*8 9#;'>=L!;&(\H',]NI\%M^'R9XR#\ E2\EXNOE7TF(G2_:JFLC0>T
MXZ#W@O[H([B-8]O-,\-NVL7[WQY(L(W](AL-@WLUDTLD87\CY!&9_*V\$5C
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MTE]@Y=.OKW+7AW4>*RT,AUGUTX8LMC!@RB)&8GMKQA:L1,:Y?%_Z:C]9Y]9
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M'AU5_OL?9D(>.GEL5"UZ5B([:M4$S_!,:=^,<7VL[&9!1BJY:CK-690+($;
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M?3^AZ\87_"V._P!+5_:?'?\ .*I_JW+_ /'[V2L_<:-9UD_G+I!)0 _NF%H
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M)626E^MJQ59H(&F6P<=3<*X2H#(H'OQS#S#<L8Z<K1QD[L8%VO-@;/3]U0.
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M)P"5Z^FOS\%4;]TB(*?W^$5K; 4@"$WD4]Y")[C']]_FXHX*GTU8JF P1!I
ME(Z1IPM"V+,](TB./&]&(W=Q[?#B>W88[<;=DR(_1QC"Z8C,9"A/T_LE?ZS-
M_'POQMJZG'5V-'J#7-R;#R?TY\ID"ZQPL3U#>0R8F,2!??\ ^J\+^;N/O_\
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M(_A=QO8A?]Y%FOI__-XT\(&W_P"=5?\ ?<?L,=?_ )S5_P![QY:2_P"-U?\
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M*0"MX-.XK#&L %"4P,GM\P]^"H9_'VD5:VV<7:N3 6)27K4.NPO%0"M=U=C
MVPLI1$P*E#^A0_YOU?\ 6.5_\P&._P"<53_5N7_46L31@O\ A=U,'17%DV[/
M1ZX)HATYU-+VV=S*\ 4O<JM_R<1.#P[V!9O82B^M>LB[Q&QK[;; 8R'ZD+ Q
M:B%.JV&D'G82G5:A,\#1K$^G6Q^%PURK"FL6)W<A15D[61#;M^V9LVV(ZXS)
MP-8%[XA< '+)V5B[VY^E"WDD[0@7/R*J'CYD C;]O'++)QM[E9+R]].*3KKV
M6/;V15C,FDC/H6*.5=%-U25$>SPZE6)\*DO=UR6F5P/2&81;MM:A*T9$8>A$
M6FI>[&VT56@B75X:2[3$EMEZ8[:]0/7@<MB<FW(51N+H7$W*$8V[3L6%6'U-
MR5W<BAJ;2J=J5L7;F1E)"Q8S^HY6_P"<6$_UE6_XB')W+!B.6L*ZN4R7J&$H
M3IN/M_X6P"CI1\H-ZM-":!AX:@KWC-"N76^:W==WF6V&SYI\Q%(!KL7K.V.\
MS/\ YA,=_P XJG^K<O\ J+DV,;>L7K(=%&1HY5&/L4*YCM>-6'XC)B#K(S*V
M6AVO!$RI$IWNEJO9=+(4XC?UO'Y.MDNI\GI]*:^(Q71V^??NA^_4=)7MG?01
MG,,[)MQ@17J6:N5G&FRB)L:NC>&:-Z'I4;60ME>:=D52*>OM6&GMGW=:T+J[
M:T5@A:J<4A4NBJN$[MJJ:D(4F"W3L4.^2G69L9:C@?!YZPMNEN,F3<;4MV@(
M+5ZABIIBU+BAKBK+?DK5:FPP-2?<KB-^0H>T:Q+,"0-IE)HD7R7)L+%D"U<^
MG6183,3,&F9VR*\5BL:>.I>)&[:*S<C(7KMI2W)KD^R%2@H5556+ H0FHH8F
MPXSEA'K'Z/*W_.+"?ZRK?\0MY,AZKA@4TJ_?6S=?Y*Z8B/-,;O.>WS=(#F.\
M<$_(3UL[EV3?S-H_,P[#9(Q1N_:5A/9MCR=66F,1!Z1^JNYC$<FXRS4I9'(8
M[PQ<VN5E+!XYO382:[.5XH^\[2L&9,/VLE\_M_E[ELW88<'GKE_)Y#(5D,PF
M:P]6Z8XFYA1F+EV&V*Z0)]2RL838%FX=)TP&<N@A5O*8RM<L+JBP*X-<.XH2
M+6N8(1\(-K"^<IXR_,,U?'>RJOB/"=?PW7]X"X#K]&QTM9/Y719_>\5K.W9X
MA"7[-=VSJK$]N[0=VW=IKI&OKI'&?K\I\KIS%+ER^[$V\C?SX8<;F5J]/Q='
M%J'&9+KDCJ1JZVZA7+RZ-T,9XJ6[>.LXFR]4&_'6SKLL5&:S!+-E5KT'';<!
M S4ED,L!3-R@XJ9+')IN>_.8G&&-U;F*A%^QTG$,(L5CZHC]S*3D(GY0'Z?W
M;X[_ )Q5/]6Y?]>Y6_YQ83_65;_B%;'3[S$\GH#(VQ]5MS5G3PBC[:%T%[6C
M'P)=@)]9C]8RR.7*?+< ?-/,4+R67RN2AJ6%;\\^QZF#8MT+[2O7,JZGXX!'
MKC<-XP\A8_[FOV1+M^\80KQ5^[7NNLM!43,*7NF 6&LSL")*9.2GC X3F!7C
ML)RQ]CW WL=AK$[\7:O7Y7+LA=I3)*O&J"\.L; $H-D3T]="+[)/+5.LD\+3
MY7PO,F*IO ;0<O96SFL?C[7L8G]0\8-VL<RY5<EP0;0B.B(CQ6G$8C&8N;=.
MBRW..H5:/BF#7C:=CPRE=8QZAZ$S=,;RTGS3QF<KR1F@Q[,Q<;EKV R]2,A@
M;F5;'OK"R4=;(XMMS:,6&U[#U]@GPIBI0!15GZ,AA\1RHW)1RZ=B7XNUFPS9
M8NQ<LK\H9"LN!TJJL*VKG;N@O/U<5@FX?*Y [MNUDL?R9B'9:_4N-%8"ZVS"
MG>'$JI517Y1?X:@!&TH44RV8Y[PU7&W<#B*/._V,+^/Y>NG4DL2W,UK5B] *
MH7<A2KA;-2GBBO9*$JZ2C!+0-*^;<YE^6.6^9[!<SY?#!.?YFRE%V#K8TU@G
M&XZE6Y8S"J'1 A=-VK="TXV[RD-/-4Q7,EVO?O4VV5IL(M6;O_!_6(J*&V[=
M2D^PVLB8KRPJX[@6'K_=J6*.S-1H6%7*MCI]45V4BU<=1>X),#4YJYT.)'?!
MQNV[2[9O%:?^CMQ__;G_ #SQ]^\5_P!7;_W7'W[Q7_5V_P#=<??O%?\ 5V_]
MUQ]^\5_U=O\ W7%:[:?6O5+#903ZD.TKNTW+!T- =(<,'TRC6-5D);9D-W%/
M)'=I8_QBNN%6T%GQ **9Z1,@%S RU>UL#KN$3B"T+48^_>*_ZNW_ +KC[]XK
M_J[?^ZX^_>*_ZNW_ +KC[]XK_J[?^ZX^_>*_ZNW_ +KC'Y7*9:M85CK*KJJ]
M-3H)MBN4,K[V-V0  X0840)R<#L\N[='Z];OV)T13K.M-G_Q:%DPOWY@=(^G
MAF9MQ]O\RWK.9LEWW;',F*R]9_L<+B7+CTB'SI^L.QN.=<<A^1NY,RNL2QL/
MOLZKA&45ZP=(2^YC(2<1\HS]> S-RQD%VEX'+<NP%9M8$>"S"F*LMD6U',\4
M M+H'U>D,Z=1+8[3@#QN0S6*R?+F+'#4<W1?0]HNQHSN\)D%VL=:Q=U4GJ>U
MN-T$YDE[)XYBH769/*/YJ!89O,Y&V+LO:BOMFI /6A-:N%,Q%E=->HNN)",$
MHUB(0=?VSG,SNBN ,S=JO8*NJJF$)3674J4:R0V#$LD:_5>SWCV-/S<7ZV/Y
MHYPQ.-R1L.QBJ64J,J#UM9<-1V2QN0R>/!VXMX4<A7'OY('2-, 6&9D>7+?+
M59E+%9##O1XH:;S)UBM:C)5<E4O)>]C7M&Y5=JYS61,$9<5,O'-'.49ZGXL
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M,=O[OV7L-;\955;LT6-Z%FOMM5#Z=A6RTE#)Z9]M\#*R]0,H_0_2;TK?M/\
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M=DLX(YDR+D,SARVJ$2@&8:<: [F%)?.25JOSRR0LV2C-NNE 7\J)RF$GHZ2
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M@Z@]T 0$6@8E KL;5L9O;>*JA:\0:/8.A<OSWB:[^.:!QPD7+'$ *UF(P0-
MB,OEYZ*W&S@GC'@JX0SR%;A:'"]R32"Z42+"#Q'5VJ&C,V7(S1S3'3F^F!.C
M\JTU%QX.I&FKAY&3MZB'!L[AHWE7R4Y0CQ4YK,?OK95">B^KIGLNFDL'"X!H
M,$ @ 0:([$32)L3G'7@*;8$?;'75H(TQ)F.J?5,39/:Z/'UA&O=L0,B!C"*Z
MZ&+"@3W 8K/2R>8<!G<?S*V;#(:%5;)XJK6>0EM!$_!+Q L]8I7SS7RC-L<^
MU4U'HP*AD.<6/\3#@.<!@8' 9#DSY8?>Y&1G+(Q/X:#N^ OMRI$@5,(?R\(
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M7O3UN,3@V[EP^G\YG/B XE?4A3UXQY,WV*SU0Z%]L,*J[9T1FR\Z3UWC^V1
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M66)50S6@33?+4WS@\)E7Q;05KP(IF"/1:ISI4TI7 $*#Y@!<:-/!E"J/8\'
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MZ9:VB79Z];^>LY!#V.]*-ESITJQ%U3797Q%GS:@]$DT1 : @((&W,G%0XST
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M5S,@:G3:6@5HQT#U>T_.FP#VT#CKW @(W+4&"P-'%QK2NP@UNQC]' TP5^I
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M:&)MET4#<M1($K8./M,4?/$3-]QZ<PCM2VNK^0]\"YO^Q6=7P:NE-L$+'WM
MB^C-RL?<4L9%@8+$.Z>2^F>:@JUIF,5O=$6]JI6^]O'L5.N]@]E.EBY^J@""
MK1-;I><!?\ B#P&    3]2-IQ'$$FX%7-8,!5!"[PU;T'.&DQELBB':!@=;S
MV??TPKY??C/;]_3!*!1P18(7FIX ;B=XH7" =F\^&7X)_?O_ %/GBG7W_K.B
MIB$[\+6NA[4'.- $?:N7Q7P:J^02.H&Y/+2BX"92P7NM-<#8]&.G&(.3]O\
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MJ:&!NWIH7ZSG28B;,X;Q_OX)%FT5%\=W<$=A@;WTXB1<A3-S#0(VS>@^SP:
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M%TA-](%GP8)<-K"S538+!^(JKG$P3: .*L)H8^#5)103??$%4;KQ=<Q]Y<Z
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MC)!F.;.6B<^*2(J\7&LDV9A2Z "QRV\W&5H8-G9&087O"!0N"$O!$QB/RE:
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M1RN4E8OT.;4^.1 ?8VD0.>3 N):KAEI!W3L20@<7*)Z59(C#(18-/PE%I)/
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M]++"Q/'H!>[Y+1;F3Y2$>K"AMR:S%.+ANA4WP5, 0,\N;&&Q *P#V,5T<J&
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MHX"!A8E?M"*H2.+J3> )+FW.Q4B#O%Y0^& 2& !IFLU@_8II&L!IUMYSSB=
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MI@&;(+#"EDE[R:*2MY2A!>G0-X)1+ZI,7WB[YB9/HDCP)[/N9L\8W5K$0K0
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M/,: CGJG#:H:)5([D,2+N07W@78WOVS6N#KV!\L#N. QJ5E]HZ>I*D#>"_\
M,K?B<:D!=N;R4S >-4NQ<./#QD.$=C<GB% -6^??)S)L7@4V]-Y<+CHX1HO(
M(/J8N6COI>F!6%'5'_WG-8B]4[^#')"QM2P'JC 02":4A0B_&G$;Q=3AQ<A"
M)OG<Z2@P*U;&PSAH'59<?+)"2 ACUVV4H@(C&XZ8T0F;O5S&L;ZYT0E+:*B4
M]HX5)<5.09C4XXX#QUL_<-;*.R$P3>B"PZK%0F[#PNIK:0E"M#48=PIH(A1P
MZ\^$OF464-H4K-F!'@R 7A1*(].8-!,FB/!\V=-&Y+,!HA*QM4,>-AB')HG2
MP^:@BL*V8HY16A7(GT#EH#(%,.VR- E5%$RD&.E0QFR80"2+-@ A2063H &L
MAU6]%[A[C?(_$U>!96;ZAP]GS$(@2YX2E/04)>*E0W35IUHNJ_ G@IK(89H]
M:#A[+(AU61T/B7=[F;1%2)-F*3XPSE\**G>V5$A!3]9R@I@(%B2.(TK'NT6F
M,UUYXG2RKUZ6(G\E+]'B@"%J+&L3&@@    @!H T!H/S+P50F<<X@.%EG-"%
MQ1ZAI5\3;Q:KXXR*Y3>>:TON1XP5&\,49=DTRN( ;3Y=%Z CD^/C!A9NZQTG
M#T_R_ X4OKZ5."[G3L=S@854$&T-CK8T^6@B"YKP-V[[*=@125FL"MD K!RO
M(CXSADA,E3.]BA[O';]Z\F'O+M!&4Z_AYY+[,J;G3T$?]??JBC82'.1$.+6N
MQ<&(_H.QP<KU02RDI^3=!PQJP(Q^H(\QK'+4ZF";M971]FT"C/8IZ<+:D/L0
M 37/,TSM'O77@H(47>$Q:HM. ,8,7F@5J'T5%$=B;;ZV]IOU -4.E.9= JX;
M@BA[J7T#RK=Y0+MN*!4ZJ0IHXOC1=%0M4D(32GNVR @GF@*CH#>;G*<VOIZ
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M-:ISELR/^*KCD_E<*1P]*,%-\VR5]$BMDE-\;.K35EIR<90<B1;;N9Q'&?\
MX,$(::M&:BZM ;+TBXUZ+! =BN2C[ 4ZM_L7A%\'G(&EWW/ZE!25(,#!$%)W
M;& R.QQ1KK!,7\-Y)$2B\0-2-Z-MIG_%5[%JDC;9>]Y2&9[YM2+]-:08BO\
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M()Q'!C:^M%""DP$0X\:I2I(V, /08.9F='*",3)V6<S[0F1]3^+N4)B, 6!
M1R=13S-"4<^'L3-\Y:&RU+_A;5*I!\C-CIH'7KVXBY;,+AL/_CVFI$E>E/&H
M9IU_\2__V@ , P$  @ #    $
M          #%%VX'!(D"JN ;,5K@
M                                !/A,25KZ>]TCXY?R9,  (!)!(
M  )                                                    ,R<P+
M"J[^2"S\XQSI   ))!  !( () ) (((
M                  J-HV>Q KM<T#C>]UZ !( )))!!!(! !())(
M                                        $EX6M%3F;4SZY&E4)
M   !    )    (
M   '-34@OKWE">E('1E  ! !!)!!  (!( ))
M          !1;:23*:-Z1    %3Y7@)OUF4X3"2 /J0 ( (!!()) )   !!
M                                 /\ NGQ;>T&$K.    121&X 'L7?
M=L OQD@   002202                                         >P&
M9$2  -;Y4   >(@)228J"<_XV&6G0   0  """
M                   #5GD03OW]TJ-   =+-J(0*#GVR,_'JO.@     "
M                                          ,YDT]*LH"+ZX  !1L@
MB8/X-</Z#!B*S\
M     M 0'L0CB2L2@  !9X\.KP"F<623;1>\
M                           4POY[M'[1 4L   "%U35P9:RK0;N4T'H
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M#L65=01K<  !!'W0^]_#TAN00 XL   "0 ""2"02
M    !Z*3-"=UZT*X@  !P>ES1]LV#H!   );=BHE?.U]&MO)-:7@ 2   00"
M"                          $ AD?Z\E, "    (5;I.=G(J^ L   _4;
MA32KJ/BB]:@S,P  "2200"02"2"  ""                  "&388>PE6F_
M8   #B6AP*-D"J /@  3W<])D$4A!'[:^8B&   " 00"0 " 022 "0
M            "%5E8TS*O>LH   4[QGDJ /H."P  !TZ##!P/6GB$_!&C#
M                                  #[P: SO21E?>   ".1-T#$WL5]
M9   1B5'X\KB-BV^RV60,    " """200                        86;
MA2DWYS"#P   *9(F14DP:+/4  " VEI:,1ML'@"46$U$    "02"0 0
M    #;3K#J*$ 06<   ")"TL@[Y@^J5@  #Y3&,=-I4SNT    6&S!)^^EO_
M /\ :1'Y<                    !]GTF5627,B\    $$="HSN2#.0
MZZCT.ZM8)69    )P ;_ &E4L7BTP5?L\                     )#E*0O
M07TG4    N-:=N<U2AT!   ";D$\?TQ_&WU@  09>![;/];9,G(]V42@
M                8>H 'A;67]0@   5):35D,();C    "W9**8V4H#@P
M!S#,F;IX7#?=QP&'28                     $FGP_3;VL2L   !@$#I96
M"$3YX@  "^6P'TR%II:^@  5E34+)^XXT5[>GZI]
M #6IA'$(A ,>    9(7J&C;/;;VT   /,74N TTI%E   #5,1Q<V_ Y<BB;E
M2BL                    !(_)4RS9BWTD   "=K^M#>[EX^M   #GJ.9?T
M;C7D\@  -XA&RW@6O"K9@_W<L@                    1'L(/=/I=<%@
M =0.#*8-&S058   *KPI@3+<G@DH  "3'\?"78\,*S\*\7H$
M        !'!>;3:JYE2X    R_5JO@ 9YK3    A=YV8_P L;ZNP  #VS;<[
M;6I+#B 0I%OH                    "'R6^IB<9-X    %WH&J2$&$443
M  $U3S7/_1;@08   2CC&V3.CMYM2R9?M(                     *-+XB
M=K#("     ]>7KHW0_N'S(   Y2A_#OW#,4!P  %D[=Y;?F="S_,\4OKH
M                 &W[)XK DWFOX   #:U'L2O!5![J   "[XNBL0_'D0W
M                                        $ZT23F:<+8X    Y-BBC
M.CA)U8X   +L+*P/OY^10H    H     !@
M  !BF2MQN5S/O(   !:=#8C2(*?LB   !>=092B8\JL
M                         6+W933EPMEE    "WD-?!5@K!J@   OO\_[
M^Y=H)T(      )910                              !1%:(K]!@ "
M  !-8#1& 0U]0;    I?KF -N$9CR      :\[@H
M          71:=_L5:^+A    *7_ ""J0Z$BY8   -L+:=*#3*+E6
M                                 !3ZX%#KB<$"<    */!,!J<2?12
M                    0     !0                             6W[
M]_BS%SO0   'NYP^^KV J=*                   );;&+;:,
M                  !2;*.[8ADL+,    0)JDJ(>U4,'@
M        >                                &!%S),O3$BR    #M:5
MF1H:8>2@   ,O_\ _P#_ /R
M       !^E>NS'6=8$"    \ST+ZBE0''L@  !@                )(
M                              ,F3EY/E,$S;@   .[BVL<>IONO"
M. ""Y*          !)(                                  Y:@T1_
M Y#,    "UV)EK4:XT+@  !P!F;:P      :* !(       !L &
M               #R%*70KSJD&0   &IVX!+_!^8]<   . "^"6      &J@
M )   ,F?E\Z\&"P                       RB(N\+0;<ID
M       !P              (   . E@6+@WP>
M->YWT09@(K\P                  $TDJ&DDD       !(
M                      !PQU9753/?J"                     !A0
M        (                                    "&Z<8RV[\2M@
M-0     ,                      !
M        ;T5JN= ]-B:   !P
M                              'GA2Z*?_: 3P   . ,6!B
M !(                                                 !F;5)C8X
MBI44   !P!I#Z      !KP   (
M               !U^BZ;F#WJF0   .           /MP(   '-@)0@^J?[X
M                                      YC"1VZ\4,,N   !@
M0       (  /XR\&:=!"BR@
M               ++;9A;;8
M                                         "
M                                             !0     .
M              !
M       !@      P         (
M                              . &65D .        (!
M                                                    !P!E%.0!
MP       )!
M               . ).V" .           ,=NF&
M                                     !P     !P      !   !,TA
MN4
M)+;<%;;6      !    ,!,+-V
M                         !E0
M
M
M
M
M
M
M                   *,  0 .!@
M                                         !"XXY-&6SX
M
M    !,*P.:298
M                               !P
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MT5_.;O[<3U'X5?H<_M_3@@08!1S!0#/CXXB!PB/X51OIR=<CU]W@0#P!]O\
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M5%RR?;KZ\9/V(!H76Q^ZZQQ0AM,OJO[SYQR_)^?XXD4\< D>_P!C^,9\\!X
M)W/O9J?COB=]AZM9-&;O/YX155*9'$*MG4:,FN5."+",H+T%J3&GA'U'2U8]
M8OZ_6=H2= 8-,-<.+<UTZ%]L=$R;+<>>?$??^.8![?U_WJ?_ ._[CA/(1,+&
M3MJ.:8""&=KQ8P)#)\3#YO?6E&&UV!K=[1\,Z=G$:93WUWB=?MXSS%@%7"I$
M"%@1+53PXYX&,]6(P.,,.J/=>"%I -YNJ$J)^>+8&C9$5:7A^^&SCL3N;$"Z
M%7#TX+T<&L: "1$%(QP-Z=WADKW,FU\&M;U/OQ+1B2_*.+7]-\2K%KB8WJY(
M>2:SP[9:9AZ<_JXP8XZY:C+C3$W=ZAZXQ4LBC" RVYTM<\=BB($S&AC1^N>S
M "&R_$=(_3Z<+Q""QAF_$<^-:USI/CS<%[Z^OCWP).A'S#]?AWR[I#WX#7-7
MT_3_ *Y;NYNIIO[_ /O!>Y9AYM[T.S$_+QHJ)75(S.L>?EG$N8S4]/XN_!=\
MHC@I?,'0RGO[7A$A$BPQFJ'>7OD>.';Q/G$\<)$)$APV!<5>GKQ(C6+,0:CV
MY[K;,L7CVYS#)BWN:,#[_P"$J-X7[-Q#/.[Y]2?'B=<2*-K@P5T56#9EQS*S
M^/\ OE=)^G\\9\%R&7<//]QUS!&DDI#L#2L90QOKF0@+!AL8S=YI,3@& . 8
M+! :1R(H$XRT+01+@:*'9;$N>""$-(:-4[2Y#UXO(D72#6"TK//G/-O?Z[ #
M*9R,U0BR$!0(K?&IC:;U]CC_ #%WW^>,!C%P"_:?3\^,T$!1B$53 7OSXX.I
MLV;?P_W\\(68>SZ+]_7%0)@*.\XG>M?O.;<NYA+F7/GKBW3%D!NO^N9 LW^4
M_?\ P+50-S< P[R,=G @6D\I>V_MHWWPU#4-UVW/?W7*ZV\I;(+DB;,GQGI[
ML_?V?&OC=\\ +=R$N-Y<=E]< \""=#D?@F5WT^>4J?G00,D@F>L^N99O-G.5
M]^-C4/I7:>W&?YX2MDF?B;/CK'L?]-WT_0Y\3R^KZ<_4GSM^^O<]<<PDP^H^
MKU-5X4H3$3 B2>]^-^<,.1+L&:F1N/WQPUQ0,XGA8>'KT\K"-C0 I,@-?+Q!
M>3WQSAU[$?"Y_2'$11V;WNQWG?GG]QY?]^4Y;JSY+X^NN75?$PYP=7QY-:D>
M.Y<F'>O.=>IQ@$RHB@9&H,GIYQS4*]-OMQ^^/K'D@L^2":N_?YWPK*;"A29\
M(YZ2/>+9R8Q  V2RS,0B BE^SU%(<K %*)2"AV'"Y P(=*83%,WV\.UI-  5
M#(F7KWOF-$,6XQG0^MK[ZSR4@A(0M:*$-9S;.F\6$ADPT69N?RA?7$,48^Q]
M]?W5SQP;*8+W3[L[\G" $4C8RACOWO?!+K#6]8SOO^<9TEH(H*%\8WG[]YXQ
M6V4[GF;\<8X(MT?;7R?Q>H-50U*1,0,7\OOF#G%'?O\ NLO7-?H?O_?7,YQI
MG]_OGABN$>(_?QL3F.*HU<V==;T?]\9;8:"8 U=YW<W[JA@HNA<R=63QB?1X
M3*8% %\KH]OG',*0 &5) I*0RDER-6D9<;!0!H3W"*\01R)1Q>FCG]#KA;1G
M;KYY/C/?O_A=K7X?^_WYN^GZG/WQQ#LB&AABW N$A^NP8)3!<UB4"IX4-3E_
MH!(H2K$,KF_KDGCR10*0,:*538,9))&!02G52H,9 4D[,"0\&!QME]3*J&MD
M'>E6YQOY]G%'0Z$JPKT"$Q PTT&JB8V.'37=*.+$G/HZ9,R&7QOZ3'?B9'LR
MJ;:24E+>-PC;&L'+Y:;J'1GBRVFT2YT8UMWJ&A5)O -%Z$SGM^O$V9K!0;%<
M42^_'I,IWX?/KN=_&M<T!(^_#7.7S?\ #?\ LP^'OS9];Q0:)D!.MB8A\F=X
MPMR)A U96?\ N=\R.9PIXM^'O[\1K@&C=XTV8&=,<DX%2%@SR##UA]YQUQ&!
MFU;HL\F8[,3BAH'R%AZE3,*MQUQDD4I)IV$*WX.NN DJ$#"QF:[SMZO7%$2%
M5A6,:+G4ZX,_CGV]^,?<GKDBNMS*RXT\:6F!9SV,_O7X77XM]'_OQQT) :@3
M8T3\'6!.)B C#C<>UKESK.>1(6H"E>W8&ZHW.;R1)VJ)&L3.&Q7W)R[RRR5(
M"Z%,/OYY=E16#K&#'\;#@8 07 -]'/[WR_W@YH_47D\^>=EMR:\F\W6=[?MF
M>0O5_C.=S6IR4*7\S"2NC].!82"5F0" ]U&FIS^RW<_GEN56J%@1/6W]\YYA
M$R#67O>)_=4XA;D>FY/CW[X16CO5-&<9_/?&)*&%Q&C'G)B9]=\![P7*D@_L
M@7QCD51[3-JZSJ0WOQGA8V(C=S3JSXQ]H<3MP_R4[RB?!GC:@9%68SUG9V#'
M/%W@D&[:_6UK]N053T_H>_6<X=8X:2K:6:7$\?6X7Y>L'4 !#2='UONHZ(@0
M+VU'%9TZWKF") CQ%IO^W//3Q\]_K^>?C$^*_3[<8B>$OU'A]A'/?1.^K/F?
M'.X)?4"673_WBV*&"9CB:T]9_.9GC*8R;E>2=-V&]G#HHE%F#$-3?FRSTO"@
MQ1E'O'GL\^.0G) A4.@*N&CH@-EM4<YI>I\PSXQ@..Z>[(N,Z]^<[^?^%9M?
MK_'#0EI^F?QOEF*U@UUOUG0ZUR$,B<$HSD9GL<N!WS=E J+H@HW0].H\\)/
MH7,%DOEGC?"C+)JUL%F3Y7SE9PP#CZ'ZH,%DOYX(@JHJKB/2; A-"D6Y*KNG
MD-(8N)O&>.QB]7S':XQD_3:\/@<^:>>]\AXYN8Z_=Y*%I9G6<+RG+HF07Z?5
M][YXQ(=O6+J:>ODG>^$ADC=,W;0SWV9MT&Y@\!ASGZ_LS6.9*@8B3QC\S_"N
MGX!"]MIG6!XX4($67&)#-]M^QQ]'4%A14:NDC[Z>^-6&+.Z0!)!/)GXX(_$;
M-C5W]LSO)$R>X *HC.F9B9,8X!/ER5#&<.RUOF\(75)"NVX>7HOC@"4JHE07
MU,?79>84^0+$J8VQH-NN6/0'+D(K,N[)[P8#:UL&OU'AW,>^","0B [^7?SC
MKC0;'$7+(R6%ZQ])P$)&PVGC:F8>?%V0L_"!82MJ,D<15@!SAI @5D 91Q@$
MXND0G<7,P&F1I,\N:*(9HQZ4 _Z*[4 5L=:0*H!D4AP$#2%!*Z7Y^>O)R.2#
M;RO4\YQ]KPF_:@(/HB?[_P!9^C_I, _6)'?Q^G>. 4#GL&;U]_6NWG9KOY?C
M]^,K.4_&*_W'CCE##SY^_P#T\O$#3X3HO5YZOR_G@%+4(MI\>_?_ ':00A8N
MKKXBW&?GC<0*0AP_?7OMO$1A!ERLT=,\DO;:Z*HPC?DM?9O)G /-C6O9 ]%:
MW7>>@Y9 ;2H&P>7!=GZ\<YB1%Q#N7#^'WQU"$J-4''?>_G)P::Z06WX7SLLW
MXY*I%H@+%4@@85WK+PVIC( )H (&=DV;>)<:63L$&1SYOQS0+ 5$PIXQ\OUS
MF"&].G>^JYOO7WXX+YK]F-/O\=:X)@T49F&/O_ZYXA0#(#M72O4/?XY@V M)
M!CW#.S&<L>^/[]Y50+BC[N\8G)QG1,I:/<Q;BGLX60A &%ZFX8[WRCIJ)L N
M7:N>F2<V"T1$21KO3\:4SPX1"= SEB7&;[/&_P#Y471?]?/K?KYX#H7O!<><
M?[!=/WA./.N?S/KX^?\ 3_SG\\$TGPCST/N<H;=;^NOO_LC9,ZG=\<!="_ \
M_P# >1\/V_PGXI&%4X#M4 >>;EKM/UP^GQF<.HO;ZP3U#K@)L 4,/4W;GQCL
MV<#KZT3#DHF98/QKA)"),N*"AI6 OD9PDQT!%=1*/(8E[XER(.*-D!E/?XVM
M488)A%LQD0Q];R&5KHT7*[:I,.&\/RF#10T&TJ&DS)288$?/0*!+!1>[C'-J
MY+M*EEE=)X3/*YK,3  H%BA8(;Y?@_/\\#=^,?\ =\\B*+2I_?/O\<%L/L?S
MS-PF#'&/UM34.)(BN5!\8R3=WG>[PV-U*R;^9<?-\994"S'T^.& _P"#J@94
M-F+3[AX;)GC,BG1?HOP-^%-&'("N,05HH#JV3^>!B@: ,HUJT-><KQ\.0<S%
M0A2-9+S!ZO(8=8;,D/4Y3+;! &60&Z?IQ''#!I19YPSW1(P-@9,X 5LW!TQ9
MP,C0DT*HE ,NZ5G("P9H08L^^[MUP#0 )-E %'?AWKSS2*"815+%R_!.YRA4
MU Y6!= ,#+DXC9A$M/7LKE^F>CC*$$6';7D=QRX<[X>#)&%71@N_N=N.(%#)
M(2H*$C/?Y/ LT 0I!5109[*NN&%3PE$*'D:,=94R##.)X"N@5 (%?? %FUB
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MNIB]5&;"80F-\&6WO>$X]@B%!ZQ1Q1N2A0>)BC%H@J^C_J<$  "@T+*'H?\
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M:I PF(ND4=,8)F<<4.5I<L+?IK.K 4!Q=[SN74*EOKB DP32%A]U9ULXOYA
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MEL Q[-J^'EZR<"(G6GB?=^HB!HVA PWHCBVGGBB(FO[F<_\  ,*CS(@?:/\
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M&:83!BKLC V$G;S*!E3BP4=WO.IG+T)NT[*:-OD^&,[X4Q15+7VR6SZQO$T
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MR@#.3>XJXO#2E*A%R,XN85P>>N+ BA T%#*CC%SN<%'AO*&<](^-$,S@ =5
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M"KY;)XP<C,$>A)GY%_/.A4()->Z(Y;R,.4N=L]:D^#FS*J+4V?3NY_$Y-4[
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MI7P77U_G@!(OP&0R9:P7-F'V/EQ"#DA?&-F ^W"II$V.0.\NBJA*S@S? J\
MPJ3MUCQCGK_"?P[GTXPJ( S..?P/_ !&_P ZW_+R6 .4_F'_ (SZ_E^/7Y_H
MX>\?OV_MQ4Y6[-9=_P <_1>&?AM8G6;O<ATYO/Y_\>_VS7!Z5GX=_;.7DY+
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M2'3-#^+/@BP"MX'84; [)\IWQYX %$@+X$+3PW@$%G$=2N90%@A4(G '$6A
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M)_1_K\39 :-$$'4(+YL\8>#!S 6*T%-'M('G*A8P96  S;.),\Q$LPFI95N
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M<F[*TY"I!M88@G*&B;2'!/K? / I45P9WWRISU-K<KH0C6$SG/% A@R-&@7
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M\*)E4UJ=$&8_F>;0K7&*L<9P,G]#W4Q\R[QWWUP7 R :(N/.'8^,..4EB!L
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MO)7"!1F+DX 64  5$F;F9?K<8P;&V[5509A&&<8Q;AX<(%3A^DJ+)&+\-><
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MZ=W"(2G1#/@$5WHVG*3M,F-0UUC(J;Y''.-\<+$.6)X<-I("Y%71(9#T^Q/
MPE(R&)$#:$9##PY(,C*DP>;H==7.T9;HAZ*V)VO\S0+I%1+A&ZM?_EZ,O\OY
M<<&"YK]B1T,\ES\\'LA9]N($;[_6WCHX2R"Y!SHG\IY<F#OS(V+,SS]>$K=$
MB.NLS-]>NV<NAD\X-WM]YA[^.6 1"6U;2W%,?4UFL<-A(*=4$1F$Z."<TMH$
M>3+2V5LD(7YR_L]6HT43VXXG%-,!"%RA.>V2<I&X+UT(JS8(])3V\(22111B
M=)I(,/5X",4I!89HP8SG..B<1K0QBC1:P9<2?,YMG>EJFA90H$@-<-K>MM<A
M95E0V!OD@4U16!N5%0,*9Z>*T*DG:Q&85_)X.7:L)W_OXZFOGF>8I<!EG4RY
M3X]3^@#;!?!$?'7LXZ(%5!#>5%0J:?)"06, AL=@$UA2>'N0"S%50)BJ6^!F
M]=SA@[48BP^!!.HWOA@2N8-1.6JQCMTY9.P4LP2#%&;-:G:EA8VJRTTS?#_9
M>"-MF$,H"+#JC]<\(3$F*@>?O=GCYX1PBTC\C3/R*>^&[4''V_2W]\<8PG(F
M,="Z,_6%G*,?@6*9!A 2><[W3Z*P)J 0RI&>O?N/J$)=5P;N>L=;X)WVP&(5
ML"MR=D3B!EJ PZ8.]7?QP9 #9HB)*.(^\8YH8Q2EF=._6NG CJQ9K&SLIX<)
MC/ &4JM*57-B%F\3>)S&,#$(YS!SFT]?T!D$H+- -]UQ+82F0N!)N]V?>O#O
M!&B4$K#H%AB[ ,8- @E#:-\WSWP0W22,"2P8,RQZ,ZY1)+?89FYQ=Z,YY<.:
M:3*+F"-\><\4J/-('AO]>,4A&K-LWK<\$;VC5:*LE $<>_3YWHDZD8,)->\2
M'@V8YX--^=_G\_OQ?@2)!< 9OWH+-FUJT+X(W2S86GX.8IK#*+N]T._GC>%8
MU>"OH,UYLZY'E=3U)Y3779G/+?*$?H&\^!9Q49!42$Z0(8?&"UF2, NDW(+'
M5(,4.+*E,%0@3$55!6B,12(PCNNYZ#&C9C'/R,$$_E_[W+Z'=0?PM]:X**'A
M<]F;E/\ 7'6RI^51YW,?D$>;SE@2.)^C,>LR2<SHF\^WH+[ZZX)!Q0U@2#!"
MBN72?!RA4^B$?EE?0_2<9UT*9#U9?B!EXY@@TL\(K&%R_$K;P 4A62A0IJ]Y
M_$XG*T)6(*2.TUT=;U_L'.?K>W/]^1'&B 6-R78Z>K\$-$"B@TD,^GY]Y> )
MLT-YSD\U.NI<\44B;R YAJS('WWRO['82D,,&?0ZY*/N98SJ?/Z?3D9;*V.T
M35M=JYW,<<G *4IK]>S>ISZ)=1QW@\OQ.\9%@HAAHDQV'^>N"A!904^+-=YU
M7/ 0 6^B+Y3WH[M#? "= Q3HGLWUUO7)&S, <B>'B_)G'55 3B46E4Z)G)GZ
M\MM@M^+&#$\3OC=M4(#Z,O5=\9&]A$" 8=$[S*Z0@['U5!Y)94,G)C=PG;T,
M^,6W?GC@32BVX)<$IX^S>/7.(@$8RF2P=#<7_P"6&6$&3ST?G?TZX$A0@EI$
MG7N&'QW1P;@'S9=./CUOB@-4#NHV!BO7SK>>3( &X#J;=.;=!#WS*5!_)U7-
MN=3(T\D5%VGN7L?6>G,3BSZY&4!=8)G%J![(BVM'$8>,Z1;@EE*LHHF3G&RM
MN>/8_CLB:$+ WOBWI,P 8#+"BIA5\G&(\BO"D LBDR8=Q3@F8;*0D F33$)=
M99PB0ABRY(F4@R+)@N&D-(%E47:!@<-*9.$',6:@;6-!@&>L<*^D],#,@TR4
MM4*X8$.1$JE@=HNLSC"^Y90L ER,4^70+#%&N&G?OL,S5RER"+-)*[$<C=[I
M+_1_F/#PQ5/B;LP^<._) J840F/#OO-SG'?;J\\5L+\BD._&YOM4S+(M.VY6
M^/6"95TLI<BH.\R=NNIPTJ:>%#?T=X\P. "!S8OG+LOW^.N%N"0\ GC\;C.^
M*ZV.MFBY/)77OF0I6:X8MDF-KY-9O/ F#!\?](>XNO/TZX$"D*6>+<,,-NN5
M"#$;1>H?%YU%$YDPZJNRK&K3B<0,C$S[% \]$[QQP$Z1A17!9(X>W3'@:L"V
MDY7>KDP:G;>9=*IDD8ZH?J_H*<8Q[X#WYO!.XCM,("=TKKV\:G65H:8%DM<D
M%(2\O.@X!<WQUG.1>1!L!0!]I,'6/?*TP(A3+*K?7\R3= $A2@A&;#5W([X?
MZB  ,.C?/<-.N'$2&6@Q3(-S<C%ZXR0T814S #JE]V\84XBB(PF,_6ZJ)7F9
ME9GA\3?O$9O''(%(-MV*&K'H_(9(J <K(AMS=?/+)'F<T-]&X]>,=D<54"+M
MB 7<Q\7A\%-89A%0^?W*8U<MVBUC GF%QAG+_P EH;E)"2X ,'?!%L8P"ETQ
M6W7Z3B M<18J!@LKC71U<70I0A2FWV&]O!55.-( DQDK'_<599HHT3'I1^G#
M8BB3+ =$^^?KUS56$)(3SY+=XGKC0##XQ(0\?W#7&(I<^9KJ?NXGQQ#5N(J4
MZ^KH=E<0FI390+4S0H&#EP5PL );,V2ECMT7S.006BDW?6E?OXUBILPEANGJ
M]/?+L>"9PYJLJ9AGXO$=XL89-)J:\=7UP&Z25D%&&=%\[NKS"0!D&3LQZO77
M#K&+C'F_WS].1:2C.4=773OL>,F?H@6M-MR9JD\='(>,FK[\?H)[MX+2W48
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M_8O[\EV 4L#F^>D3WP<2*8K*]Z\]9\>PMAG2ZZ+KKN?MPU,:F?;Y]?;B#$:
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MQF]N&:>,U].H0/9G),=/$8WY]\&HCA[A"E@1$5<6:Y./Z!)-?B8KWCAD@<J
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MA+CWG/3P80PQ.PW!FE*F?*)0DE%,(K+LOOH0G 966L45JL@DK5L*%>$0: 5
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M%+71'PH-D@ "0+H QC0BG$Q(6(1J;Y$D!*JA>A3;YHEB$2JEI:\!"2  /
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MRH+H5(;[D=4SC7(E)FB+U<%^@7Z<H:1=YI:W!YG=V>E@)2SQ6S_R>>F7\/\
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M[Q"R56(YTWI-'1T8J,AH,7WA_>R\_DA2_)_4/8$P&#C148=%XJ5FDI *@!4
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M&UL-@?9U_P#-0!0 8@:(](E'@B<! .H2\2GJF*N_^A(J"+&A;(HSQ-^(:M#
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M'E_HF2!O_1#W1]/ZQI@*, !5?@__ )P!%I"NGHSQ#%]$0T)%;ZG&^.%F*1B
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MPHU9JA4VRI56X[V99T=S%%")>=ZWA"L((B5Y::#?D\'PT5!@9[)#0&.=]2T
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M3IA)S@W(A4V]2AZSK6(,R&%'.!",JAY[*H;+^DVH:J"X_"%#O$/:<4;'4N!
M5=CU9=9$"."X>01767P#4ZH G@+$/,T$B@AZ\\AJGV4U2:ZQV$6.0$1=2-Z&
M<L@,,*)UPBE= H;@.$U.Q%((2;",L='"4N;0G5TLA<J8;-':=;;>@FF<\;L[
MBT9TF",'J-JNQ#-8Q\XP[NB$KM<B@"ADB\\Q<.CY1<T4%3H"NX;&HXM^&!;Z
M>A14H.W)BI(N)DM^W,D26M3VI.CC78DM ZH"WOGA1;@\N80(<&3 HK?5B/-;
M/.JQ:WDQ*]88Q+-@,50THZ0RD0_(&ANZ/<1;IL'( (UJ9DZ 84S@!?H3; 5;
M8($UKB$+A=&^#4Y^^"* FU";+;3^S]OB^%QEFSRH>R"_A\'C:O,Q;T=UN$\3
MA[>2 W2BA-O;N(]$A"KR$LU)^7#VC=6"_>C(1>,6:*3HKL*.Y!);7=/+8IDT
M#(3L8-O*S:_S^S[!Q#'X1Q73V[%5IRQZLQ]HV3(=*(?3SV&?&MV=P/J82J\5
M3$$DW9_0D@P@V00+Y5049560;S/#<%I8BMV U&FPW)SEY8XZ6HE$V#4D@#UL
M8*1!DLHSL-"'"TV;CI82E0OMCKXXB$;P\@>ESY*:,3(=*(?3SV&7D9"$.C2W
M^E#D(H4/3OW-8%: 6E)9'D=%O4_845L$94Q\?J;MD#+Q8;TUPU>LA-_;W_J,
M$^;IR- "X0@)XTFSR07X']"<83,A3AZ4!=/L?'MSA@/5T_/^K_?$^3]J_N,$
M![>W(EAB_@&*:.7LQ'@#VK?TGTFY>//'*SB_QP/N?;?*0O7V8_A.-"]+UZ_S
MSV1]3_A8@Q_8QYG^/^?\N5NQ!>#GL7<GU3G_ $P ;W_&_P 7_,^/0.?0%CS]
MC'/F.0P=ART^S>)B$* @2CECD4$I1+F3:E6JS[*YF A >&LC);\+0,/,B&Z*
MUA7CT%S+=:9U!X3H1P_3 XS,E!+MING>!:%Y-+)CK%Z5K>X .$;3_"DJ^(C@
M]F,6 57Z+4 C.#-C@+!.&X)ZT:@61O3 7=K/!3"(RCXE)DJ*D>V"1K37^6H8
MN9 OO9?Y?2C<Q47Z*95,>D866*J@!3F:EK UJ#; -%100A>Q)"XQFY7P)]J.
MV#U4/0:.VW+#JVX21E"-:9DC^M:XTW8Z:%S.+U<!52\?#-RB9LL9Q^?^7)K6
M##"B[I)_[<;M-CC2$[8P9#7 S4Q "M,Z4?JY+U3..@QM8,G %B#H].?K34UD
ML@* U1$:PJ1D:V%DWB'+J^=&C?'1.\=)0V ::)7J=?%4QWT7B=@KT9QCZ]ZH
M;.EV/;SX4[=7DE7I7:\VHR@X:TQ?)X+.XJ=ZNMS])?=)IIYQ12@%L X4S9@W
MX8&F,@W3P6AHKEG ORKUV1[H-/P&$(8?D@V+M5I3YWK?UBMUL^I2TSAUL6'$
M^XCK-EQ7&6!928;T#M&P%U+ZI<"9X ?8D6OTE)M/4M@QI@5&K$#SCD^*C= ,
MJ:O19H4\::>/I(C4?=H;^334*6/C9J41YW?-QM>M6XD6??"8<*+HGC)E9XAH
M\T+*:KQ*5F0A&\5[ YI#_.?=]&)[(7N/%0T?-P4V0U^##M-J@;01E@DE'B</
MW93+B'^A5K>I6S+X(Q))'PG[/^<0 $/9N+HI$K[_ +TXO7^,$6(?7_ZX\:=]
M/EP92"?^.W'S#_/=,$E&/.NG[Y['[N/H?G_;%50DD+P?S_[B5FQ.WWOX^GC[
M[^.B\NYOAQEMU]')0)[F_P#[_/,Q6Z!W<$SP!A6020S;*(*@"A1)10$LZHTU
MSXKW-?;G\8851A>S@]G&%V-XOA]\C-3>EKZ\WO#: /F^'B_3^<#V _P?QE_]
M=O\ >6(WP[GA'K9K$OZW/$![%5&!,0JAG ,HL[U*:SM48$0E"Y=0A:Q0-5A-
MV-@67FC9!@#. [*0I$9L<IZD%.U HPW'7;;T53@G/2\=@EW>986,@]K)+[BO
MNFUBR81A-L#SHMPUC-3>J"WDGQR_YSW/C>TLID=6ODX69 U18%4RT"G"N$ZC
M/;./1:5:EHVK\8%E'Q1&FSC3_=3Y6  D:L"$W0N\I4#CF A1GB^GBRTA,^PR
MCR0PODA<4X.2BJ5$00G.$G 4="^6LDKN:%,GZZ#^RL3R &67C7T%;I9E0[(\
M#%8BKYOZ$=&ITBKXA$U F4A7EW/T.,,R2-U*Z!H,LF^-%^17 B36>]-'DVO1
M_P!K>:2PY;/?@4I "FX2(P5Y&2+8<?V'+F0^:7QAI][QU\/VA*3+;CG141K
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M*0URQ/J@6.+=FNX)^7\_S6:@PGAT5+SU_)YQ4 X(0Q88#G1R=C@BL:8/A_\
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M(N7>=LS+SAISBZ^"'H%L0(@;U%O^:,MB>G9 0JY( KY*,TFCU5@[)<Z\*JV
M89Q <*&32I^[EM<U)?XL=2/U($?,V0T(NAT-O3BBXU5!+:H2"/: "- *4_*#
MY'5HZR0$J$$F[_8_?7V(T&-/:KR?3I[XQM(FDV=AHX;)_CVQY$JV*SHP!C28
M9DL((-D,X C<#0!!9:T?<G)]<:4K4E!R?7?_ +@#P16$L$+!19@+:PT51G?%
MR($4YI0FJU !*#97^3WC<9X;@'4,0*:T2_F_[_SDTG!X3M\#FTHW:D?YY_G
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M]ORD2!9KJ\Z-*8A[T@8!XF<2J,951H@C29,Y V/]5=.- .QG7Y31$":,F2;
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MDB*8QT^($7DQC0"%N+@5@XE?:#X=QNJCCSA VAQ^G"4EYH6M"?ZP&9"%\SQ
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MR&#<-X)+PFY2(OH>5<>+U8T;B^T[+BZ@D6\D@')3$'N$  FJ)"8RKB8%^8L
MTG%>Q0)N7B0U&MQ#!7YA68_G#_\ *6I%/+%W5C!*Z\7G^;'1^P[=! - 41,L
MDV7<PB(4VJ^Z^ZU?=>U[>WX$0A1M(U>:)3V:/C XN1 #0/\ 6./!WC06K0TU
MX4$FB,$K6M$TT"8$'A$V]?;:(;AY%D'=3P*,?;88@U$T1C',\K;(99SB1)9%
MJ%?R/$+&P-@Z*/DP'(1!0]I8HL>Q(MP2)5=2WV\#@RJO*HQ/%0%7N&:N1P[*
M &WSB @ J80F06" G,)-4N;%:T#*2F$JFDT^W5/"\S4W]YI*[)W@^@!HX1*.
MC2T0@E3P&\O(#,%DX9[E-W\=!(L";R-=60/()H$AT_%>Q9[D(PQO6^$PJ;N!
MS+L'> =''^ZR& (CK31$P.2(A=$4 D@(!E-XL56GF1#?$80FL5''HTAI<F.M
MX@M8FJU5V%1"CA> "TC7.9TX,J%O$7 7OL1_<>UY^8(OQ#IAY0]?]LY.0))1
MQY;\2READSC+X$1@Q,FAPTVL[-&U(XO.=:3)NT&=GJQU.]I#G/V1\%0//ZO@
M>2;,WVRP)'=7'=F<%294>W<YBR8SCK->N$-LB$H5KSQ%\-UK""4YF T'=5C.
M_=*Q*5+NX0*$X:0A B3H; !1_P#0$=F@XF']9E +.0XWHA"+J^S,VP(6]2#5
MQ@QO?GB[32&P#4B'=?0!@L6.  ,BTT(XA:3%$A*LU3MBP\59[5C%Z@V 4A"*
M43AB7$:K"&>)4YS"#O XAJ'<!7GMVE*Y)%I()BS J$VE&'2JZ(!DQK]E$1Y5
MAG422S2O-,'/T/A5!$MBZT\%1=%$?YXKNZ=2)HS-6?S)\Q6WE>LRC*6^C3;#
M3Z) X.SG-JO'%Y!)714&"3!&NOZ6AR&0@E -WD"R'+C4O""A,(FB:V[A@@R%
MT("M,"DHF-Y0E.A5F&U4AM^@]6R2L.<$Y*L#98FTQAF04E-P-TX9SVNP*T84
M->PP:'YT!9+.$/J>!'W#$4;(P91"'9LZ#IIA<D@1Q"ZAFK0L$@8#+7L0JF8I
M:BFKD7(BU(W1".@@2T7[^L059'')H;APO9(_3,F0LT:'@-9-<881BM9<D^(Z
M-D);/0:Z%6C!K0N;A!OR$-C#@[G) D/&2@AA(P"MQ6/P9;J /(*!OC+BP&U&
M;FR #9?,^2C7L)4VHMM^<#TC#=)D#@U(T+,1CQ0*_P#).@9Z:@E,<IVAP82P
MSY]"#V >L 'T@\\@,!0P-EWW#-G87?!#8;=O5'76G4G:<2XS^%-HX<B*Q@1J
MWAF@+\O$@:GW49IQAPG2E:'D_1*N PD>)5!C*@**+8E:0@F,ZG1KR:3ZB(^&
MCO 6ZE O!NPU/SA]Q"]A4O,L8906[K0B/J$U=4W2S@8^@:,"1I0" @Z D%@;
MU >@'9<GF@ @D B.&DC0&4MZ U'J&*J"""VS;7%DN>4F%)ULI!$"?&44S-0K
MY42F@U BI8L@7( I+DWD_1T3>I*A$K%)Y:(VF(I2N"%RN,%2:%Z@(-'RD]V;
M><R'E;?B(&@$K+6JP%2'+_!8 :"F2"#PW >-%V;Y3^:.3F'6L(N2!W/K^2KU
MP8N1\Z60QNR1T5 N)3ZJ3F4TQ6%N&/J1R$';(2)-*-XEKP5Z:IU8>7P%58B&
M1OL6L ;-JQ,>=6N!$=!$+T=(&MEHNQK,E"%JB  QP),<\0W%&&R0,UD= T+(
M%L;P\J4\W@"+&4:8-!%BS!!%&Q?XWH9V ;LB0>Z$6(!<8&WOT\&6!ECWNU'P
MDZ^;6*8D )H$8Q(/W 4S04T+]EF#-2.8SI'NY!.\5J^742:-$,R!-NEMIE'-
MO.8;TZ=X ^Y\0,#)\').*D\IU&(-3 SC%ADCSAW7?MBM[YF,(/\ 4N_&0UZ_
MB(7W,R4A<6  Q!5V>JOC3/+/=@65X-$;'F.7 K92%EA!; .%\/20;9B=?5D-
M/$9,K >A=H(+H\OK&83(&$P6[HTO,"KI[F#-WZ-A)8^0[4ITW?$JDD:!42H]
MPI>4@1J EU\+(G0B*-96<&$9NFDK\0:]IL4 R[ >" R!)*P:04*Y/N$\&!W,
M4S)AQ 5.2'H;0*&(]^,=^>3IWAQ(ZZ.V:Z"E>4UCF03\L8F.&11P:<\% G+W
MX+$.@1_K>/)="!^EB8AF!TMC>DK\^V<PE"FEK.9+& KXN+ZK4\4$"V5ZWOAJ
M"T&1ER)(YJ7O@W0R511DK0"$>7!,*B'VK1@4==0[>DA4\C:DZ%+'129MH9#F
ML_:)[AJK5GO0%TBR3Q!!K_T ^3ES!&H_;+@6FBUL8M;,'PJ"1S NX/M$,\WX
M.N!S5S0HB+T BJ92R4@(/=EULCEAF?0*,$\TZ*H;9,B*P0X$0@B,AY0%ZL*8
M,Y#$47A<9%$9X"UQ9PKXPD-!#-+B',*8H58 .%:WZY3L(ZU0KUHJZ H_)6T/
M9=EK-WY'3A:;GO[SPKR/M<-(4^2#17D09:B\&G]<RX58, HC;LFU_@;SB^S#
MTW(2$'(H?)S\4%&X!X  &PO257AEI&='%6V@A&!SZ&PP&N2F#3XF@C[60S:V
M/0!"AAE'N'OW,>THZ%$.$4N*95#9;18J8+I,7:(TY!2-&Z;O>[DXOFV*S*$$
M $8H2Q\"10JWMR93[ X\=$2$#=!2Y9#%F?D4(B<@QASGI?9.V0 Y%69B:3)B
MDW2]2_D.HC#" Q(4750%61<_M #BY.7H938+H3>5\C<0(8B% 3 4# M.5O=S
MT#NHN F,\@."I*2@'E1"(P0B$1Q66SHIAAI-7#4$5$_"9JS1(I"8!/)P@3=:
M49=0.QW@\SR>PR$F! !(IPEC(19)=%%"LR;=O*!RZ,9S866#? HXZPN3=.4"
M.>R<J%A2N:/5,"P^(LY1P0R>A,9.#CU#<=B34-@8'>LW6([5,I)9^"1CY$M(
M#:Q*(5IU$Y;)6GA;J8;G1E>['1A4YNWO(QR+Q5- P1F"RNC[>F*._*%V(Q.0
M>=9%4)V+]@XM+X %^(O%NQ99M!J:B3U*64H2UD$.##[9->+HA.;0R;F08"*;
M0]88&6(\5#-PD,-"^,5$5:XSQVRFZE+S85$'"(F$DU;N)<R*'JU.'[D<FY;G
M%_B>J>TS,!CR;:@4 IRD?66QRO3<_P"/I<!,YC0"/(HS8$1!C;91#J9%B_!/
M"K8UCK+H85ID>D;)!3']N,3"UY-885714BL#GC.2,%:Z2S $8"0@B  !!$""
M&Q"DIY"M)$+3JJ%=&)E)M5&#18)4@B<04H)":84D-2F3YU7JPI(Z425646JH
M\@FWA7*!N'&0 B)1%'D60Y/"'9AH#1$#<LN%# @:SL<4A O;UTRX[;F(A\W'
M!!L5@@<XM5WKK0EI > $P-Y?24C9YCP!I5-<4J-2-?:!PA%2M$7*Z4TP5FPB
M!.*3=I/"?TO#X'#V2Y5HW+LI'VN&TJLRQBZ6&CMSSD+EKJ/-7N*NQ.,.'R)9
M36EQO2<.1;R/"M3:D:*G?-4Q:;5K>[5:EY>*)O6+F)6J]B.3H%M;FBAQP:L$
M=*'396#WMD&"@2.*&A31.U0$ZTX6"M D7=S(!1$84/E85 3=E0$D"N2GZ7U
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MM?TA[('ER& !$!$1!/G$(5((C2(]()PH32?K9JC62:5R!'=>AGA)$@+!"I/
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M@K5K0H8!*EG4T;-Z]P91+2 4U74+S"2?Y5&P%#9AM5BWJ=!P Z&AB4YV,%G
M2<#$F^LKY4[:P"FWGX>PU\EM[!J@8C 66"J;K! &U"/8 5.L@X1X9)H49& [
M-Z4;O4M/&SK>P#@W!($ESE:9*I(&.F6LQ"GDMA+BF)%:B;Z4/11VJNC]2P".
ME[9QY3@\,B9)8W;(AH)*IE=@04Q%(9,[,=H8W_$] >AIY41!Q:Y;'0^43T#
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M&>038I<VJ?)D/:4P;F$VT*B$9+2@7[S%6#!A3*X-36*T7HS@R^Q8E+8,8J%
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M9W@"]0@YK,S/S7WBAE<)MH &*"J/U":'!_AJRB(R6\C&*+KZPX\ "F:WY<0
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M9_6@1 _HB4":DR!%,(!95IA0B"4"*^ V;-FZ2/!,S"5LEQ],X]RAAW1$ O\
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7&NJ:CFH'_I\8%-VE#$46B,S_ *2?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>amci-20230213_g7.jpg
<TEXT>
begin 644 amci-20230213_g7.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #^ I@# 2(  A$! Q$!_\0
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MUKXG:3%X9TO0]$M;N&72D%_J5[(TDT=UMVMP#C*\/EB0Y) ((R>2\#ZW\;=
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MC)7D#FK7@[X^P_$7Q/H-GI%NUK:SW#)=+,\<C[6M'GC4[&/ER*5 9&P5.0:
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M HLEI'(^2.3EF)YJX\UI6[:_>B)VO&_?]&=S11169J%%%% !1110 5C>,_\
MD3]=_P"O"?\ ]%M6S6-XS_Y$_7?^O"?_ -%M0!\K?L]ZIK^J?%/Q3%=ZY>W6
MAZ=I]C!:Z;/<R21P,]O$Y9%)VKT(X]?2O=M6_P"/";#=OZUX3^S6,_$?QYQD
M^5IG_I''7NNK#_0)OE'3^M;UOB^2_(Y:'P_-_F?'_P ?OAKXH\#>,5\47/BB
M:ZTGQ->WBQ:?#<3)Y2K;RA589VD!69<#C!(Z&OKG]G617\"D*P.V9N%92!R3
MT'3\2:^8?VO=9\;/;^'(+G1+.+2;>]O?[,N!)\\_[E\[_GX^7)Z#I7=_!#QG
M\84\'E=,\*:3>VXF8;GN5.T^F%E&/QJ:OO<C\OU'1]US7G^A]:3?ZF3_ '37
M(Z3_ *^P^J_RKSMO&OQP*D/X(T8(?O$3=!_W^KT'12S2::7 5SLW =CMK,Z+
MFKJ_B?3M+\4Z!HUQ'(U_JOVC[*ZH"J^4@=\G.1D$=*WZY?7O!O\ ;7C;PMK_
M -J\K^Q/M7[C9GS?.C"=<\8QGH:Z<# ]:J7+96^?WDQO=W%K*U$;M;TE>H!E
M?\DQ_6M2N'UG1_%5Q\3M'O+34A%X8CMW^TVYBC+>9G[H)7=AOE[\;3TS54XJ
M3=W;1[DU).*5E?5;>IW-%)2UD:A1110 4444 %?'GC#PIXO\-_MDW7C^U\&Z
MQKV@111H)=.C4F0FS6([=S <-G/TK[#I, UWX/&2P<IM134HN+OV=NWH>;CL
M%'&Q@G)Q<)*2MW5^_J>"^/-9\0?'#P#XE\(0^!_$/AJYO;%S!>ZLD4<#2*59
M8R5<D%B,=/6N)^"GBSXE>$?AE:?#U?AGJ<.NV2RVL&JW)6.Q0.[,)7;OC<>%
MSNQ[U]88!I-HK>./C&DZ'LERW32N]':W?\#GEETI5E7]L^:SBW9:IN]MN_4^
M2?V3O#?C3X6>)_&/A;7_  KJ$B7]VT[:ZBA;0[4?Y@3][><8 ]><8KI?V,O
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MN06B8W#DH2.#C.,CTKZAUJQGU'2+RUM+MK"YFB9([I%W-$Q& P'J.M>+Z/\
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MI_RV4?Q =-XXY[@8],8GPF^*-G\6_"[:W8V5Q80B;R?*N7C9C\B2 _(Q XD
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MMU<S,7DGGOY7=V/4LQCR3[FH/^'>GQ._Y^] _P# N3_XW7Z245Q_7ZWD=_\
M9N'\_O/S^\ _L2?&'P-XFLM4TGQ)I6B3PR*S7%M>2D[0>0R; ''7Y3P<U]^Q
M!UB02,&< ;F P">YI]+7+5KSK-.9V4,/##IJ 4445@=(4444 %%%% !1110
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M3C#FCJSYM\5?M6?$#QC\3?%FB:/K:^%=+T6ZGMXDM;2*:241.R%F>0'DE2>
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M^.O@ =/%.G ?]=17/VGBG2/B)\8M!NO#VH0ZK;Z39SF[EMFWI#O&%#$="2.
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M0"L:U?VJMY_H4HV+E%%%<A04444 %%%% !1110 4444 %%%% !1110 4444
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M (-Y?_D6CZG7_E_%!]>P_P#-^#_R.AHKGOMOBK_H#:/_ .#>7_Y%H^V^*O\
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M.AHKGOMOBK_H#:/_ .#>7_Y%H^V^*O\ H#:/_P"#>7_Y%H^IU_Y?Q0?7L/\
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MKN.1+15NMEI+)]H(D4-/#T50RVZAPV>/6OMOBK_H#:/_ .#>7_Y%H^V^*O\
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M.AHKGOMOBK_H#:/_ .#>7_Y%H^V^*O\ H#:/_P"#>7_Y%H^IU_Y?Q0?7L/\
MS?@_\CH:*Y[[;XJ_Z VC_P#@WE_^1:/MOBK_ * VC_\ @WE_^1:/J=?^7\4'
MU[#_ ,WX/_(Z&BN>^V^*O^@-H_\ X-Y?_D6C[;XJ_P"@-H__ (-Y?_D6CZG7
M_E_%!]>P_P#-^#_R.AHKGOMOBK_H#:/_ .#>7_Y%H^V^*O\ H#:/_P"#>7_Y
M%H^IU_Y?Q0?7L/\ S?@_\CH:*Y[[;XJ_Z VC_P#@WE_^1:/MOBK_ * VC_\
M@WE_^1:/J=?^7\4'U[#_ ,WX/_(Z&BN>^V^*O^@-H_\ X-Y?_D6C[;XJ_P"@
M-H__ (-Y?_D6CZG7_E_%!]>P_P#-^#_R.AHKGOMOBK_H#:/_ .#>7_Y%H^V^
M*O\ H#:/_P"#>7_Y%H^IU_Y?Q0?7L/\ S?@_\CH:*Y[[;XJ_Z VC_P#@WE_^
M1:/MOBK_ * VC_\ @WE_^1:/J=?^7\4'U[#_ ,WX/_(Z&BN>^V^*O^@-H_\
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(-*IK!_F?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>amci-20230213_g8.jpg
<TEXT>
begin 644 amci-20230213_g8.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" "2 J@# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]_**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "B@DCH*0L0>E%P%HHSSC%-W^U%^@#J*** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **16W=J49[B@
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M ([7\3?]F6!P1I=KC@9^QIR?XE "YR!ST /K3O[*T[_H$6__ (!+_P#$T_\
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M]FSX^_M,^+S\/?V<O@QXB\::LJ^=<:=X;TQ[EHU/264+Q%[.^%/8FOI/6/\
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M)[+P7^T[^TKX3\%:MJ5G]LL-.US4A'-+;[RGF[0"57<& )Z[3Z&O; _R]/\
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M=&PXV,I^62-E^22-P4=>"H%=5;A+!5L/SX6I^I,<=4C*TT?VX.Y4X5"W(_\
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MYO.LDEE4U.+O!NR?F=F'Q"K*SW/2** <\T5X9U!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5^0/_!XS_P F.?"T?]5@C_\ 3/?U^OV><5^0?_!XRO\ Q@[\+>?^:PQ_
M^F?4?\*]7(?^1M2,,3_ D?SK3_+;R_\ 7-Z_LU_X)H_\H\?@;_V27P]_Z;X:
M_C*NO^/>;_KF]?V9_P#!-%O^->7P-'_5)?#W_IOAKZKC+_=Z2\S@R_W:DK]3
MW*BC\*.?2O@#UAI)(%>3_M:_L5?LT?MT_"O_ (4S^U1\,+7Q5H2WR7MO')--
M;S6MPH(6:&>!TDB?:S*2C+N#,"""17JS2D+R!UQU_*OR1_X+"?\ !S-X,_9
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MWTZQ"K#!$D<,:_="*,#]/SZU<^?UK\ZQF)K8O$.K.3;/7ITXTXV1\]_M$?\
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M?'W7YG\F'_!P3^S_ *Q^S[_P5E^*]E>V,D=EXOU6/Q9I$S1[4GAOT#L4]<7
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M=U!\V'D*^UD^5U%>?F'#^*R[#0JU'==?(Z*.*A6E9'X*?\%]?E_X+!_',_\
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M#&QQ+Q"G[[W8G2I\G);0_%7_ (@S?@O_ -'X^+__  C[3_X]2?\ $&3\%/\
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MJMOKW[87[5UYKD$+X?P_X!THV"2K_<:\N"\H3V1$;_:K]>/V9?V4O@%^Q_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
G"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>logo1aa.jpg
<TEXT>
begin 644 logo1aa.jpg
M_]C_X  02D9)1@ ! 0( +@ N  #_X0I"17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     P   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E    *8    O     0
M "\    !    1TE-4" R+C$P+C,R   R,#(S.C R.C$R(#(P.C,Q.C$W  $
M : #  $    !          D _@ $  $    !      $$  $      0   0$$
M  $    D     @$#  ,    8 0   P$#  $    &    !@$#  $    &
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MZ7#<0W S#*KCU4YJ6O.+;PCK.F:O$+:X_=GK*!C ]Q7H<DBV]NTDC?*@RQH
M<SJBEF( '<U674[%WV+=1%O0-7FMWJ&I>+M5-M;$I$.BYX ]35Z;X=W4<!>*
M]5I1SC9C/ZT >C@YIDDT<(!D=5!]37G'ACQ%=Z9J7]FWY)C)V_,?N&NQ\3Z;
M_:6BRQK_ *Q!N7ZT :Z2)*NY&#+ZBG$@#)Z5P'P^U0[Y]/E//#)D_7/]*Z'Q
M=J?]FZ)(0?WDH*+0!LI<PRMM256;T!ITDL<2YD<*/4FN)^'VFLL$U_)DE\*F
M?QS_ $JU\0B1HD6#C]Y0!UJ2)(NY&#+ZBDDFCA ,CJH/J:Y_P.2?#,)/]X_T
MK*^(Q(L[3!Q\S?TH [9'610R,"#W%))-'" 9'"@^IKS;P5XD-G-]@NF_<OC8
MQ/W36S\1&(TNW(/\9_I0!V*.LB[D8,OJ*=6!X-)/AN GU_PK.\:>))-,5+.U
M.)I 2S9^Z* .IEO+: XEF1#Z,<4^*>*89BD5Q[&O,=/\%ZGJT(NI[D1!^1N7
M)/\ *KEGX/UC3]3B\FZQ&3\TBC&/PH ]&Z5!]MMA_P MT_.I&0M$4)Y(QFN!
MN?A_*!)+]OZ<X\O_ .O0!W7VVU_Y[Q_G3H[F&5ML<JL?0&O&]$TJ36=3-F)_
M+.TMNQFN^T#PC)HVH?:6N_-&W&W9C^M '5U#-=06^/-E1,]-QQ6#XN\0G1;-
M4AP;B7.TYZ>_ZUQ^F>%]3\0I]LGN=B-R&89)H ]/AN(9QF*17 _NG-2UY1J.
MA:KX69;J*?<F?OJ,8^M=WX8UT:WI^]@!-'@. ?\ /I0!LR31P@&1U7/3)I4=
M74,A!![BN(^([$6ME@X^9OZ5G>"O$GV6;^S[IOW3XV,3T- 'H\DT<(!D=5!Z
M9-*CK(H9&#*>XKC/B*Q&G6A!_B;^E;7A(Y\-6F?[@_D* .&\;@KXG!?[FP8_
M,UZ;9LCV<31_<*C%8/BSPV=:MUE@(%Q&#C(^\/2N.LM=USP^OV1X2RKT5\\4
M >K5E^(@YT&["==A_E7%Z=J7B36=5BGC7;&AY'.VO1F021E' ((P10!YW\.'
MB%U>*>)"JX^G->C5Y?JOA[4O#^H_;-.W-%G(*CI[&B3QCKMQ%Y*0A7/&X YH
M @\6%)/%I$')X!QZY->J1@^4H;KCFN#\+>%+DWHU'4N"#E4(Y)]Z[^@#RK5X
MW\-^+%N(QB-CO4=./2I/%FHG7=8MK2U.Y%&!]3_^JNF\<Z0;_3%GB7,L)/ '
M4'_]58/@;1)6U-[NXC*K$!MW#J3_ /JH [_3K-+"PBMDZ(H%<U\0_P#D!Q?]
M=*Z^N4\?023Z-&L2%F\SH* +'@;_ )%F'_?/]*ROB/\ \>=I_O-_2M?P7$\/
MAR))%*MN/!_"LSX@V\MQ:6HBC+D,V<#Z4 8<_AO[7X8MM0M1B9%^=0/O# K.
MU#7VU+08;2?F:%N&SU'^17H_A:)H_#UNDBD''(/TKC/%_A=[2[%U9QEH9"<J
M!]TT =;X,_Y%N#ZG^E<1XQ&WQ43*/DX/X9KNO"$3Q>'H$D4JP/0_A53Q=X9.
MLQ)/;D"XC!&"/O"@#HHF#VJF(\%?EQ7GNKWOBG2D,\]R5B+8&,U3L]?UW04^
MR20%E7HKYXIES_;OBHEGC(BC&0.<4 =[X5O9[_0HKBY<O(2<DUJ77_'K+_NF
ML;P=$\'AV))%*L&.0?PK:N03:R ==IH \P\#?\C0?^N;?S%>J5YEX+L[B'Q(
M7DB95\L\D>XKTV@#S/XB!AJUN6^YL./TKOM':-])MC%C9L&,50\3Z -<L0J$
M+/'DH2/\^E<-::GKOADFV:$E,\*P./PH [_Q,T2^'[OS<;2A ^N*Y/X;J_GW
MK#[F%S^M9<]QKWBN183&1&#T .!]:]!\/Z*FB:>( =SGEVQC)H YOXD?\>ME
M_O-_[+63=>&_M/ABTU&U'[U$RZ@=1@5M_$*WFN+:S$4;.06SC\*W?#$3)X>M
M8Y%P0@!!^E 'FVI:^VIZ';6L_P#KH6/S9ZCC_"O1?"/_ "+5G_N#^0KC/%WA
M>2SNQ<V<9:&7.5 ^Z:[;PK&\7AVT1U*L%&0?I0!LTC*K?> -%%    , <4M%
M% !30B@Y"@&BB@!U%%% !1110 4444 %%%% !1110 4444 (RJWW@#0  ,"B
MB@!:*** "BBB@ I&4,,$9HHH   HP!@4M%% !1110 4444 ?_]G_X0V):'1T
M<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[
MOR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/B \>#IX;7!M971A
M('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)835 @0V]R92 T
M+C0N,"U%>&EV,B(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW
M,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^(#QR9&8Z1&5S8W)I
M<'1I;VX@<F1F.F%B;W5T/2(B('AM;&YS.GAM<$U-/2)H='1P.B\O;G,N861O
M8F4N8V]M+WAA<"\Q+C O;6TO(B!X;6QN<SIS=$5V=#TB:'1T<#HO+VYS+F%D
M;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E179E;G0C(B!X;6QN<SID
M8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B('AM;&YS.D=)
M35 ](FAT=' Z+R]W=W<N9VEM<"YO<F<O>&UP+R(@>&UL;G,Z>&UP/2)H='1P
M.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(B!X;7!-33I$;V-U;65N=$E$/2)G
M:6UP.F1O8VED.F=I;7 Z96-F8V$T-#4M.68U92TT,S1A+6(W9C4M.3DV,C9A
M835F-&1B(B!X;7!-33I);G-T86YC94E$/2)X;7 N:6ED.C R,C0T9#5A+3,P
M8S0M-#AB."TX-V0Q+60S-S0Y.&8T9#5F9B(@>&UP34TZ3W)I9VEN86Q$;V-U
M;65N=$E$/2)X;7 N9&ED.CEC-S@R8SDU+3DS.&8M-#9B8BUB,V4V+3$Q.#@V
M-3DY,C!A.2(@9&,Z1F]R;6%T/2)I;6%G92]J<&5G(B!'24U0.D%023TB,BXP
M(B!'24U0.E!L871F;W)M/2)7:6YD;W=S(B!'24U0.E1I;653=&%M<#TB,38W
M-C(U-30X-3DQ.#@W,R(@1TE-4#I697)S:6]N/2(R+C$P+C,R(B!X;7 Z0W)E
M871O<E1O;VP](D=)35 @,BXQ,"(@>&UP.DUE=&%D871A1&%T93TB,C R,SHP
M,CHQ,E0R,#HS,3HQ-RTP-CHP,"(@>&UP.DUO9&EF>41A=&4](C(P,C,Z,#(Z
M,3)4,C Z,S$Z,3<M,#8Z,# B/B \>&UP34TZ2&ES=&]R>3X@/')D9CI397$^
M(#QR9&8Z;&D@<W1%=G0Z86-T:6]N/2)S879E9"(@<W1%=G0Z8VAA;F=E9#TB
M+R(@<W1%=G0Z:6YS=&%N8V5)1#TB>&UP+FEI9#HX.34W-CAB-BTU-6$V+31D
M8V$M.34P."UD,&8W9#!B83(T-&4B('-T179T.G-O9G1W87)E06=E;G0](D=I
M;7 @,BXQ," H5VEN9&]W<RDB('-T179T.G=H96X](C(P,C,M,#(M,3)4,C Z
M,C Z,#@B+SX@/')D9CIL:2!S=$5V=#IA8W1I;VX](G-A=F5D(B!S=$5V=#IC
M:&%N9V5D/2(O(B!S=$5V=#II;G-T86YC94E$/2)X;7 N:6ED.C8P9C,S-#,W
M+35D.#8M-#=B,"UA9C$Q+3=B-V)D,F,P,C-B9B(@<W1%=G0Z<V]F='=A<F5!
M9V5N=#TB1VEM<" R+C$P("A7:6YD;W=S*2(@<W1%=G0Z=VAE;CTB,C R,RTP
M,BTQ,E0R,#HS,3HR-2(O/B \+W)D9CI397$^(#PO>&UP34TZ2&ES=&]R>3X@
M/"]R9&8Z1&5S8W)I<'1I;VX^(#PO<F1F.E)$1CX@/"]X.GAM<&UE=&$^(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/#]X<&%C:V5T(&5N9#TB=R(_/O_B K!)
M0T-?4%)/1DE,10 ! 0   J!L8VUS!#   &UN=')21T(@6%E:( ?G  ( #0 "
M !, )F%C<W!-4T94                                  #VU@ !
M -,M;&-M<P
M            #61E<V,   $@    0&-P<G0   %@    -G=T<'0   &8
M%&-H860   &L    +')865H   '8    %&)865H   'L    %&=865H   (
M    %')44D,   (4    (&=44D,   (4    (&)44D,   (4    (&-H<FT
M  (T    )&1M;F0   )8    )&1M9&0   )\    )&UL=6,          0
M  QE;E53    )    !P 1P!) $T 4  @ &( =0!I &P =  M &D ;@ @ ',
M4@!' $)M;'5C          $    ,96Y54P   !H    < %  =0!B &P :0!C
M "  1 !O &T 80!I &X  %A96B        #VU@ !     -,M<V8S,@
M 0Q"   %WO__\R4   >3  #]D/__^Z'___VB   #W   P&Y865H@
M;Z   #CU   #D%A96B         DGP  #X0  +;$6%E:(        &*7  "W
MAP  &-EP87)A       #     F9F  #RIP  #5D  !/0   *6V-H<FT
M  ,     H]<  %1\  !,S0  F9H  "9G   /7&UL=6,          0    QE
M;E53    "    !P 1P!) $T 4&UL=6,          0    QE;E53    "
M !P <P!2 $< 0O_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! ?_" !$( !L P ,!$0 "$0$#$0'_Q  =   " @,! 0$
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M,*3-=^E4K[Z'QD8@9-YC37&?,XQGS&,:_L_SYC777V_)K\?9_\0 %!$!
M                8/_:  @! P$!/P%!_\0 %!$!
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M\&H*H/J +_U_!8@$>AYQ90 /0"W^#SBRJ%^X ?\ 7XNK2NKYK"_]>OXO_\0
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MH"WZM[YO,]SH3+Q"+0"_O.GBVUPP:5)Z,=S\J<QD]>(A=GUE<]IC)DUXL6>
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M>D<L@NPF^X#^(,R71;X\?#7?X__:  P# 0 "  ,    0DDD  $@$@DD DD$
M@ $$ D @D  @$D @@$@D$ @ $$@@D   _\0 %!$!
M8/_:  @! P$!/Q!!_\0 %!$!                    8/_:  @! @$!/Q!!
M_\0 (! ! 0$! 0 " @,!         1$ (3$007'!(%'18?_:  @! 0 !/Q#Z
MQ];L')%53H!"]XJ^@0[XK (!CQD7P\<5O )4 :^0B]*G"L((B22.[RHE^^[)
M!P;R$/*!@0$A@J-+*,M;@O75%8,&^(Y*!2TP* 1=/PC#5*NK![?1G9/]C(H0
MOB"H./[5JN %(%D5$#1L^F<EK 2'KS++ ?HTPDT:@#@W7DQXWP!P3 V+D7T<
M5@@ P#$.R<X?A,"EOH\7XE*Q =9<I*P< .I@)Z(8)C2X<73X,E%,DY8$\5"^
MQ.@C.N%<9 )#'%$2N.Y)CYL.I(=.1K5M- %)E"8PZOAOE177J/H<,6P4A-%%
M]-HC@:&LN#\@L%@H&&B@ZR L5:E2P43$RCQI/=R5R)*MI>5)5>O07+)R^MU4
MEP0!XQ('NYS;='0JD %3'K"$#7H., -^/V57D?\ '2 8D54S,?\ EKAV$ZF5
M>$"DV Q#Q08_TV+XY)"AP96D,R&.D;/M->H$"R*-6^D6G/.$4AHH#N-=<.'2
M0%!'N->/^@_(4JE:Y3@SSET.),T1Q.P].?2#[!A;!>>2(O>Y06S><03(<WCX
M8H+S.8GG3'P)]^,C\<8B5<UR]<3$I;XJYR8&U1/J!;65'<S(!A Q0W7>+ZJ9
M,U\(P.O&#.1E5G66%O"SZ-[)718E0XOL!D-<ED1 G+[@%VSPZP#,:2O//8J0
M,PU %R*L</YOQQ,"B*O\$ZA]H<^T@L<B,3Y**:O\ AU%DX"M.5$CX],%!DW=
M9A&<+#DW(4*!17R+*,X]"2'+0FH$J!044WP6DU+-!*$U'(0 @@ 0>B(B/1)F
M>WN2T(#Y"&'!8N#8P^KYC9PQ43U\-9A1=DAO_P"YW%<OU!ZKEUBK+Z/;1O\
M.QU-0Y:@>">(!Z0 U-5]W5B+.M5>OP-182?]"0X<1\PDG5 =6J&"O5#K[_'[
M?P?O_/A^OS^G?9^']?[CB.AD.("(G$1'&)5$\*B@%@%2\^'Z_P"OZ<=#\'PE
-HJ#L512]+T<>?Q__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272204030784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LanzaTech Global, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001843724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272206871312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED BALANCE SHEETS<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 50,370,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">88,815,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">135,590,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,488,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">49,047,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">62,599,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Class A common stock subject to possible redemption</a></td>
<td class="nump">480,631,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">23,801,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(434,863,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; deficit</a></td>
<td class="num">(407,640,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, contingently redeemable preferred stock, and shareholders' deficit</a></td>
<td class="nump">135,590,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember', window );">AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">7,302<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid assets</a></td>
<td class="nump">277,812<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">285,114<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Investments held in trust account</a></td>
<td class="nump">150,969,468<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">151,254,582<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,687,915<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">1,356,763<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related party</a></td>
<td class="nump">736,123<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent', window );">Capital based tax payable</a></td>
<td class="nump">331,707<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_FranchiseTaxPayableCurrent', window );">Franchise tax payable</a></td>
<td class="nump">149,639<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income tax payable</a></td>
<td class="nump">54,366<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">4,316,513<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_DeferredUnderwritingCompensationNoncurrent', window );">Deferred underwriting commissions</a></td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares', window );">Derivative warrant liabilities</a></td>
<td class="nump">1,543,280<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">6,059,793<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value 1,000,000 shares authorized no shares issued or outstanding as of June 30, 2022 and December 31, 2021</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(5,099,235)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; deficit</a></td>
<td class="num">(5,098,860)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, contingently redeemable preferred stock, and shareholders' deficit</a></td>
<td class="nump">151,254,582<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember', window );">Class A Common Stock Subject to Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Class A common stock subject to possible redemption</a></td>
<td class="nump">150,293,649<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember', window );">Class A Common Stock Subject to Redemption | AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Class A common stock subject to possible redemption</a></td>
<td class="nump">150,293,649<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaNotSubjectToRedemptionMember', window );">Class A Common Stock Not Subject to Redemption | AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock | AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">$ 375<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_DeferredUnderwritingCompensationNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of balance sheet date of underwriting compensation deferred, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_DeferredUnderwritingCompensationNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_FranchiseTaxPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of franchise tax payable current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_FranchiseTaxPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6419918&amp;loc=d3e35281-107843<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of shares that would be issued, determined under the conditions specified in the contract if the settlement were to occur at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109262807&amp;loc=d3e22047-110879<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaNotSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amci_CommonClassaNotSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272205352832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Common stock subject to possible redemption, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued (in shares)</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding (in shares)</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value, (per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, shares issued (in shares)</a></td>
<td class="nump">2,110,346<span></span>
</td>
<td class="nump">2,106,934<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (usd per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, shares authorized (in shares)</a></td>
<td class="nump">36,326,815<span></span>
</td>
<td class="nump">36,326,815<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common shares, shares outstanding</a></td>
<td class="nump">2,110,346<span></span>
</td>
<td class="nump">2,106,934<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember', window );">AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value, (per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common shares, shares outstanding</a></td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Common stock subject to possible redemption, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Temporary Equity, Redemption Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (usd per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, shares authorized (in shares)</a></td>
<td class="nump">280,000,000<span></span>
</td>
<td class="nump">280,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common stock | AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Common stock subject to possible redemption, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Temporary Equity, Redemption Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (usd per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, shares authorized (in shares)</a></td>
<td class="nump">280,000,000<span></span>
</td>
<td class="nump">280,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember', window );">Class A Common Stock Subject to Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Common stock subject to possible redemption, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued (in shares)</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding (in shares)</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Temporary Equity, Redemption Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember', window );">Class A Common Stock Subject to Redemption | AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Common stock subject to possible redemption, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued (in shares)</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding (in shares)</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Temporary Equity, Redemption Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaNotSubjectToRedemptionMember', window );">Class A Common Stock Not Subject to Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common shares, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaNotSubjectToRedemptionMember', window );">Class A Common Stock Not Subject to Redemption | AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common shares, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, shares issued (in shares)</a></td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (usd per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, shares authorized (in shares)</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common shares, shares outstanding</a></td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock | AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, shares issued (in shares)</a></td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (usd per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, shares authorized (in shares)</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityRedemptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityRedemptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaNotSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amci_CommonClassaNotSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272202695888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>UNAUDITED CONDENSED STATEMENTS OF OPERATIONS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">8 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (56,223,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other (expense) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of derivative warrant liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(427,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (54,974,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding of common stock, basic (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,108,472,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding of common stock, diluted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,108,472,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per common share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (39,790)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per common share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (39,790)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember', window );">AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">$ 876,343<span></span>
</td>
<td class="nump">$ 284,686<span></span>
</td>
<td class="nump">$ 286,255<span></span>
</td>
<td class="nump">$ 3,677,205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty', window );">General and administrative expenses - related party</a></td>
<td class="nump">30,000<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_CapitalBaseTaxExpense', window );">Capital base tax expense</a></td>
<td class="nump">75,797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183,578<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductionTaxExpense', window );">Franchise tax expense</a></td>
<td class="nump">50,411<span></span>
</td>
<td class="nump">134,845<span></span>
</td>
<td class="nump">134,845<span></span>
</td>
<td class="nump">149,639<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(1,032,551)<span></span>
</td>
<td class="num">(439,531)<span></span>
</td>
<td class="num">(441,100)<span></span>
</td>
<td class="num">(4,100,422)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other (expense) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of derivative warrant liabilities</a></td>
<td class="nump">1,426,720<span></span>
</td>
<td class="nump">1,382,900<span></span>
</td>
<td class="nump">1,382,900<span></span>
</td>
<td class="nump">4,066,720<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants', window );">Gain from extinguishment of deferred underwriting commissions on public warrants</a></td>
<td class="nump">171,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities', window );">Offering costs allocated to derivative warrant liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(476,450)<span></span>
</td>
<td class="num">(476,450)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_IncomeFromInvestmentsHeldInTrustAccount', window );">Income from investments held in trust account</a></td>
<td class="nump">733,042<span></span>
</td>
<td class="nump">2,178<span></span>
</td>
<td class="nump">2,178<span></span>
</td>
<td class="nump">972,453<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="nump">1,298,911<span></span>
</td>
<td class="nump">469,097<span></span>
</td>
<td class="nump">467,528<span></span>
</td>
<td class="nump">1,110,451<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">54,366<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,366<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 1,244,545<span></span>
</td>
<td class="nump">$ 469,097<span></span>
</td>
<td class="nump">$ 467,528<span></span>
</td>
<td class="nump">$ 1,056,085<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common stock | AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other (expense) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding of common stock, basic (in shares)</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">9,130,435<span></span>
</td>
<td class="nump">3,428,571<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding of common stock, diluted (in shares)</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">9,130,435<span></span>
</td>
<td class="nump">3,428,571<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per common share</a></td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per common share</a></td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock | AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other (expense) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding of common stock, basic (in shares)</a></td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding of common stock, diluted (in shares)</a></td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per common share</a></td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per common share</a></td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_CapitalBaseTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of capital base tax expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_CapitalBaseTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from extinguishment of deferred underwriting commissions on public warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_IncomeFromInvestmentsHeldInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income from investments held in Trust Account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_IncomeFromInvestmentsHeldInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of offering costs allocated to derivative warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductionTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A tax assessed on oil and gas production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductionTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of selling, general and administrative expenses resulting from transactions, excluding transactions that are eliminated in consolidated or combined financial statements, with related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272198183424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>AMCI ACQUISITION CORP. II</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>AMCI ACQUISITION CORP. II</div>
</th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th">
<div>Accumulated Deficit </div>
<div>AMCI ACQUISITION CORP. II</div>
</th>
<th class="th"><div>Class A Common stock</div></th>
<th class="th">
<div>Class A Common stock </div>
<div>Common Stock [Member] </div>
<div>AMCI ACQUISITION CORP. II</div>
</th>
<th class="th">
<div>Class B Common Stock </div>
<div>Common Stock [Member] </div>
<div>AMCI ACQUISITION CORP. II</div>
</th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2019</a></td>
<td class="num">$ (276,592,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16,354,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (295,487,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(37,713,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37,713,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Dec. 31, 2020</a></td>
<td class="num">(311,216,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">18,818,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(333,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(30,591,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30,591,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Sep. 30, 2021</a></td>
<td class="num">(339,740,000)<span></span>
</td>
<td class="num">$ (10,318,806)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,914,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(363,791,000)<span></span>
</td>
<td class="num">$ (10,319,181)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 375<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2020</a></td>
<td class="num">(311,216,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">18,818,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(333,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(46,689,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(46,689,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Dec. 31, 2021</a></td>
<td class="num">(354,917,000)<span></span>
</td>
<td class="num">(10,739,596)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">21,711,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(379,889,000)<span></span>
</td>
<td class="num">(10,739,971)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 375<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Jan. 27, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the beginning (in shares) at Jan. 27, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Class B common stock to Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 431<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Class B common stock to Sponsor (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,312,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,126)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,126)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,126)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 431<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,312,500<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Jan. 27, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the beginning (in shares) at Jan. 27, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">467,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Sep. 30, 2021</a></td>
<td class="num">(339,740,000)<span></span>
</td>
<td class="num">(10,318,806)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,914,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(363,791,000)<span></span>
</td>
<td class="num">(10,319,181)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 375<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Jan. 27, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the beginning (in shares) at Jan. 27, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Class B common stock to Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 431<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Class B common stock to Sponsor (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,312,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Excess cash received over the fair value of the private warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,085,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,085,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited', window );">Forfeited shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (56)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Forfeited shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(562,500)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors', window );">Contribution from Sponsor upon sale of founder shares to Anchor Investors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,509,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,509,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Accretion of Class A common stock subject to possible redemption amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,406,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,619,383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,786,709<span></span>
</td>
<td class="num">$ (18,406,092)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Dec. 31, 2021</a></td>
<td class="num">(354,917,000)<span></span>
</td>
<td class="num">(10,739,596)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">21,711,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(379,889,000)<span></span>
</td>
<td class="num">(10,739,971)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 375<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,126)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 431<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the beginning (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,312,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(443)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(443)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,569)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 431<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,312,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Excess cash received over the fair value of the private warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,085,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,085,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited', window );">Forfeited shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (56)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Forfeited shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(562,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors', window );">Contribution from Sponsor upon sale of founder shares to Anchor Investors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,509,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,509,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Accretion of Class A common stock subject to possible redemption amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,406,092)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,619,383)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,786,709)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">469,097<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">469,097<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Sep. 30, 2021</a></td>
<td class="num">(339,740,000)<span></span>
</td>
<td class="num">(10,318,806)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,914,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(363,791,000)<span></span>
</td>
<td class="num">(10,319,181)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 375<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2021</a></td>
<td class="num">(354,917,000)<span></span>
</td>
<td class="num">(10,739,596)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">21,711,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(379,889,000)<span></span>
</td>
<td class="num">(10,739,971)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 375<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the beginning (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,542,722)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,542,722)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,282,318)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,282,693)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 375<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2021</a></td>
<td class="num">(354,917,000)<span></span>
</td>
<td class="num">(10,739,596)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">21,711,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(379,889,000)<span></span>
</td>
<td class="num">(10,739,971)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 375<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the beginning (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares', window );">Extinguishment of deferred underwriting commissions on public shares</a></td>
<td class="nump">4,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(54,974,000)<span></span>
</td>
<td class="nump">1,056,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54,974,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Sep. 30, 2022</a></td>
<td class="num">(407,640,000)<span></span>
</td>
<td class="num">(5,098,860)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">23,801,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(434,863,000)<span></span>
</td>
<td class="num">(5,099,235)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 375<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,282,318)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,282,693)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 375<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the beginning (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,354,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,354,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,928,056)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,928,431)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 375<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares', window );">Extinguishment of deferred underwriting commissions on public shares</a></td>
<td class="nump">4,900,000<span></span>
</td>
<td class="nump">4,878,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,878,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings', window );">Reclass from additional paid-in capital to retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,878,300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,878,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption', window );">Subsequent remeasurement of Class A common stock subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(293,649)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(293,649)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,244,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,244,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Sep. 30, 2022</a></td>
<td class="num">$ (407,640,000)<span></span>
</td>
<td class="num">$ (5,098,860)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 23,801,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (434,863,000)<span></span>
</td>
<td class="num">$ (5,099,235)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 375<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of adjustment to additional paid in capital extinguishment of deferred underwriting commissions on public shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents amount of Contribution from Sponsor upon sale of Founder Shares to Anchor Investors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase or decrease in equity due to re-measurement of common stock subject to possible redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from dividends legally declared (or paid) in excess of retained earnings balance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123466302&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph c(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272204378864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)<br></strong></div></th>
<th class="th">
<div>May 14, 2022 </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock | Sponsor | AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NumberOfSharesSurrendered', window );">Number of shares surrendered</a></td>
<td class="nump">718,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_AggregateNumberOfSharesOwned', window );">Aggregate number of shares owned</a></td>
<td class="nump">4,312,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_AggregateNumberOfSharesOwned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares owned by the founders after the impact of the stock dividend.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_AggregateNumberOfSharesOwned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_NumberOfSharesSurrendered">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the information pertaining to Number Of Shares Surrendered</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_NumberOfSharesSurrendered</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=amci_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=amci_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272204837680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="1">8 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">(Gain) loss on change in fair value of SAFE and warrant liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 427,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(71,336,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows From Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,530,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows From Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128,732,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">$ 115,700,000<span></span>
</td>
<td class="nump">51,034,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember', window );">AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Net Cash Provided by (Used in) Operating Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="nump">467,528<span></span>
</td>
<td class="nump">1,056,085<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares', window );">General and administrative expenses paid by Sponsor in exchange for issuance of Class B common stock</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">(Gain) loss on change in fair value of SAFE and warrant liabilities</a></td>
<td class="num">(1,382,900)<span></span>
</td>
<td class="num">(4,066,720)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants', window );">Gain from extinguishment of deferred underwriting commission on public warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(171,700)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities', window );">Offering costs allocated to derivative warrant liabilities</a></td>
<td class="nump">476,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_IncomeFromInvestmentsHeldInTrustAccount', window );">Income from investments held in the trust account</a></td>
<td class="num">(2,178)<span></span>
</td>
<td class="num">(972,453)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses</a></td>
<td class="nump">49,173<span></span>
</td>
<td class="nump">244,534<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">1,602,381<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_IncreaseDecreaseInDueToRelatedParties.', window );">Due to related party</a></td>
<td class="nump">19,723<span></span>
</td>
<td class="nump">686,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">138,034<span></span>
</td>
<td class="nump">1,127,030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_IncreaseDecreaseInCapitalBaseTaxPayable', window );">Capital base tax payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,578<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_IncreaseDecreaseFranchiseTaxPayable', window );">Franchise tax payable</a></td>
<td class="nump">134,845<span></span>
</td>
<td class="num">(38,598)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income tax payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,366<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(95,325)<span></span>
</td>
<td class="num">(345,097)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows From Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireTrustPreferredInvestments', window );">Cash deposited in trust account</a></td>
<td class="num">(150,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_PaymentsForInvestmentOfCashInTrustAccount', window );">Investment income released from Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(150,000,000)<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows From Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from note payable to related party</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds received from initial public offering, gross</a></td>
<td class="nump">150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds received from private placement</a></td>
<td class="nump">852,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">150,853,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash, cash equivalents and restricted cash</a></td>
<td class="nump">758,091<span></span>
</td>
<td class="num">(336,097)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">343,399<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">758,091<span></span>
</td>
<td class="nump">7,302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of noncash activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_DeferredOfferingCostsIncludedInNotesPayable', window );">Offering costs included in notes payable</a></td>
<td class="nump">1,968,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_OfferingCostsIncludedInAccountsPayableAccruedExpenses', window );">Offering costs included in accrued expenses</a></td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_DeferredUnderwritingFeePayable', window );">Offering costs paid by Sponsor in exchange for issuance of Class B common stock</a></td>
<td class="nump">24,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties', window );">Prepaid expenses paid by related party under note payable and advances</a></td>
<td class="nump">677,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NoncashRepaymentOfNotePayableAndAdvances', window );">Repayment of note payable and advances by Sponsor in exchange for issuance of private placement warrants</a></td>
<td class="nump">2,647,584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NoncashDeferredUnderwritingCommissions', window );">Deferred underwriting commissions in connection with the initial public offering</a></td>
<td class="nump">5,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering', window );">Value of Class B common stock transferred to Anchor Investors at initial public offering</a></td>
<td class="nump">$ 6,509,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NoncashExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares', window );">Extinguishment of deferred underwriting commissions on public shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,878,300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_DeferredOfferingCostsIncludedInNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred offering costs included in notes payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_DeferredOfferingCostsIncludedInNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_DeferredUnderwritingFeePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of underwriting fee payable deferred during the period, classified as non-cash investing and financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_DeferredUnderwritingFeePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from extinguishment of deferred underwriting commissions on public warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative expenses paid by Sponsor in exchange for shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_IncomeFromInvestmentsHeldInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income from investments held in Trust Account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_IncomeFromInvestmentsHeldInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_IncreaseDecreaseFranchiseTaxPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of franchise tax payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_IncreaseDecreaseFranchiseTaxPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_IncreaseDecreaseInCapitalBaseTaxPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The of increase (decrease) during the reporting period of capital base tax payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_IncreaseDecreaseInCapitalBaseTaxPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_IncreaseDecreaseInDueToRelatedParties.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in related party payables classified as other,</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_IncreaseDecreaseInDueToRelatedParties.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_NoncashDeferredUnderwritingCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash deferred underwriting commissions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_NoncashDeferredUnderwritingCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_NoncashExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of value of noncash extinguishment of deferred underwriting commissions on public shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_NoncashExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash prepaid expenses and other assets paid by related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_NoncashRepaymentOfNotePayableAndAdvances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash repayment of note payable and advances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_NoncashRepaymentOfNotePayableAndAdvances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of offering costs allocated to derivative warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_OfferingCostsIncludedInAccountsPayableAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of offering costs included in accounts payable or accrued expenses that were incurred during a noncash or partial noncash transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_OfferingCostsIncludedInAccountsPayableAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_PaymentsForInvestmentOfCashInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash outflow for investment of cash in trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_PaymentsForInvestmentOfCashInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of value of Class B common stock transferred to anchor investors at initial public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireTrustPreferredInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of trust preferred securities, which possess characteristics of both equity and debt securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireTrustPreferredInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272207047920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BALANCE SHEET - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 50,370,000<span></span>
</td>
<td class="nump">$ 128,318,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,503,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">88,815,000<span></span>
</td>
<td class="nump">148,675,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">135,590,000<span></span>
</td>
<td class="nump">193,011,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,488,000<span></span>
</td>
<td class="nump">2,444,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">49,047,000<span></span>
</td>
<td class="nump">49,290,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">62,599,000<span></span>
</td>
<td class="nump">67,297,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Class A common stock subject to possible redemption</a></td>
<td class="nump">480,631,000<span></span>
</td>
<td class="nump">480,631,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">23,801,000<span></span>
</td>
<td class="nump">21,711,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(434,863,000)<span></span>
</td>
<td class="num">(379,889,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; deficit</a></td>
<td class="num">(407,640,000)<span></span>
</td>
<td class="num">(354,917,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, contingently redeemable preferred stock, and shareholders' deficit</a></td>
<td class="nump">135,590,000<span></span>
</td>
<td class="nump">193,011,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember', window );">AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">7,302<span></span>
</td>
<td class="nump">343,399<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid assets</a></td>
<td class="nump">277,812<span></span>
</td>
<td class="nump">337,534<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">285,114<span></span>
</td>
<td class="nump">680,933<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_PrepaidExpensesLongTerm', window );">Prepaid expenses - long-term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">184,812<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Investments held in trust account</a></td>
<td class="nump">150,969,468<span></span>
</td>
<td class="nump">150,006,015<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">151,254,582<span></span>
</td>
<td class="nump">150,871,760<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,687,915<span></span>
</td>
<td class="nump">85,534<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">1,356,763<span></span>
</td>
<td class="nump">229,733<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related party</a></td>
<td class="nump">736,123<span></span>
</td>
<td class="nump">49,723<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent', window );">Capital based tax payable</a></td>
<td class="nump">331,707<span></span>
</td>
<td class="nump">198,129<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_FranchiseTaxPayableCurrent', window );">Franchise tax payable</a></td>
<td class="nump">149,639<span></span>
</td>
<td class="nump">188,237<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">4,316,513<span></span>
</td>
<td class="nump">751,356<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_DeferredUnderwritingCompensationNoncurrent', window );">Deferred underwriting commissions</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">5,250,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares', window );">Derivative warrant liabilities</a></td>
<td class="nump">1,543,280<span></span>
</td>
<td class="nump">5,610,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">6,059,793<span></span>
</td>
<td class="nump">11,611,356<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Class A common stock subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value 1,000,000 shares authorized no shares issued or outstanding as of June 30, 2022 and December 31, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(5,099,235)<span></span>
</td>
<td class="num">(10,739,971)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; deficit</a></td>
<td class="num">(5,098,860)<span></span>
</td>
<td class="num">(10,739,596)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, contingently redeemable preferred stock, and shareholders' deficit</a></td>
<td class="nump">151,254,582<span></span>
</td>
<td class="nump">150,871,760<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Class A common stock subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common stock | AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember', window );">Class A Common Stock Subject to Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Class A common stock subject to possible redemption</a></td>
<td class="nump">150,293,649<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember', window );">Class A Common Stock Subject to Redemption | AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Class A common stock subject to possible redemption</a></td>
<td class="nump">150,293,649<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaNotSubjectToRedemptionMember', window );">Class A Common Stock Not Subject to Redemption | AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock | AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">$ 375<span></span>
</td>
<td class="nump">$ 375<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_DeferredUnderwritingCompensationNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of balance sheet date of underwriting compensation deferred, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_DeferredUnderwritingCompensationNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_FranchiseTaxPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of franchise tax payable current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_FranchiseTaxPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_PrepaidExpensesLongTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Prepaid expenses - long-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_PrepaidExpensesLongTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6419918&amp;loc=d3e35281-107843<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of shares that would be issued, determined under the conditions specified in the contract if the settlement were to occur at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109262807&amp;loc=d3e22047-110879<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaNotSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amci_CommonClassaNotSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272204358912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BALANCE SHEET (Parenthetical)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value, (per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, shares authorized (in shares)</a></td>
<td class="nump">36,326,815<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, shares issued (in shares)</a></td>
<td class="nump">2,106,934<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common shares, shares outstanding</a></td>
<td class="nump">2,106,934<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (usd per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued (in shares)</a></td>
<td class="nump">29,521,810<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding (in shares)</a></td>
<td class="nump">29,521,810<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Common stock subject to possible redemption, par value | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, shares authorized (in shares)</a></td>
<td class="nump">280,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Temporary Equity, Redemption Price Per Share | $ / shares</a></td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (usd per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding (in shares)</a></td>
<td class="nump">15,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Common stock subject to possible redemption, par value | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember', window );">Class A Common Stock Subject to Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Temporary Equity, Redemption Price Per Share | $ / shares</a></td>
<td class="nump">10.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (usd per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued (in shares)</a></td>
<td class="nump">15,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding (in shares)</a></td>
<td class="nump">15,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Common stock subject to possible redemption, par value | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaNotSubjectToRedemptionMember', window );">Class A Common Stock Not Subject to Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common shares, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, shares authorized (in shares)</a></td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, shares issued (in shares)</a></td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common shares, shares outstanding</a></td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (usd per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityRedemptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityRedemptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaNotSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amci_CommonClassaNotSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272205322912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STATEMENT OF OPERATIONS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">8 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (56,223,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other (expense) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of derivative warrant liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(427,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (54,974,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average number of common shares outstanding - basic (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,108,472,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in calculating net loss per share, diluted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,108,472,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share - basic (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (39,790)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share - diluted (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (39,790)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember', window );">AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">$ 876,343<span></span>
</td>
<td class="nump">$ 284,686<span></span>
</td>
<td class="nump">$ 286,255<span></span>
</td>
<td class="nump">$ 3,677,205<span></span>
</td>
<td class="nump">$ 951,461<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty', window );">General and administrative expenses - related party</a></td>
<td class="nump">30,000<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_CapitalBaseTaxExpense', window );">Capital base tax expense</a></td>
<td class="nump">75,797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183,578<span></span>
</td>
<td class="nump">198,129<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductionTaxExpense', window );">Franchise tax expense</a></td>
<td class="nump">50,411<span></span>
</td>
<td class="nump">134,845<span></span>
</td>
<td class="nump">134,845<span></span>
</td>
<td class="nump">149,639<span></span>
</td>
<td class="nump">188,237<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(1,032,551)<span></span>
</td>
<td class="num">(439,531)<span></span>
</td>
<td class="num">(441,100)<span></span>
</td>
<td class="num">(4,100,422)<span></span>
</td>
<td class="num">(1,387,827)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other (expense) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of derivative warrant liabilities</a></td>
<td class="nump">1,426,720<span></span>
</td>
<td class="nump">1,382,900<span></span>
</td>
<td class="nump">1,382,900<span></span>
</td>
<td class="nump">4,066,720<span></span>
</td>
<td class="nump">1,905,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities', window );">Offering costs allocated to derivative warrant liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(476,450)<span></span>
</td>
<td class="num">(476,450)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(476,450)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_IncomeFromInvestmentsHeldInTrustAccount', window );">Income from investments held in trust account</a></td>
<td class="nump">733,042<span></span>
</td>
<td class="nump">2,178<span></span>
</td>
<td class="nump">2,178<span></span>
</td>
<td class="nump">972,453<span></span>
</td>
<td class="nump">6,015<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 1,244,545<span></span>
</td>
<td class="nump">$ 469,097<span></span>
</td>
<td class="nump">$ 467,528<span></span>
</td>
<td class="nump">$ 1,056,085<span></span>
</td>
<td class="nump">$ 46,738<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common stock | AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other (expense) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average number of common shares outstanding - basic (in shares)</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">9,130,435<span></span>
</td>
<td class="nump">3,428,571<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">4,690,909<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in calculating net loss per share, diluted (in shares)</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">9,130,435<span></span>
</td>
<td class="nump">3,428,571<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">4,690,909<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share - basic (usd per share)</a></td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share - diluted (usd per share)</a></td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock | AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other (expense) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average number of common shares outstanding - basic (in shares)</a></td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in calculating net loss per share, diluted (in shares)</a></td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share - basic (usd per share)</a></td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share - diluted (usd per share)</a></td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_CapitalBaseTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of capital base tax expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_CapitalBaseTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_IncomeFromInvestmentsHeldInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income from investments held in Trust Account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_IncomeFromInvestmentsHeldInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of offering costs allocated to derivative warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductionTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A tax assessed on oil and gas production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductionTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of selling, general and administrative expenses resulting from transactions, excluding transactions that are eliminated in consolidated or combined financial statements, with related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272205409136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>AMCI ACQUISITION CORP. II</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>AMCI ACQUISITION CORP. II</div>
</th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th">
<div>Accumulated Deficit </div>
<div>AMCI ACQUISITION CORP. II</div>
</th>
<th class="th"><div>Class A Common stock</div></th>
<th class="th">
<div>Class A Common stock </div>
<div>Common Stock [Member] </div>
<div>AMCI ACQUISITION CORP. II</div>
</th>
<th class="th">
<div>Class B Common Stock </div>
<div>Common Stock [Member] </div>
<div>AMCI ACQUISITION CORP. II</div>
</th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2019</a></td>
<td class="num">$ (276,592,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16,354,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (295,487,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(37,713,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37,713,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Dec. 31, 2020</a></td>
<td class="num">(311,216,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">18,818,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(333,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(30,591,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30,591,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Sep. 30, 2021</a></td>
<td class="num">(339,740,000)<span></span>
</td>
<td class="num">$ (10,318,806)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,914,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(363,791,000)<span></span>
</td>
<td class="num">$ (10,319,181)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 375<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2020</a></td>
<td class="num">(311,216,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">18,818,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(333,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(46,689,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(46,689,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Dec. 31, 2021</a></td>
<td class="num">(354,917,000)<span></span>
</td>
<td class="num">(10,739,596)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">21,711,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(379,889,000)<span></span>
</td>
<td class="num">(10,739,971)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 375<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Jan. 27, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the beginning (in shares) at Jan. 27, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Class B common stock to Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 431<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Class B common stock to Sponsor (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,312,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,126)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,126)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,126)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 431<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,312,500<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Jan. 27, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the beginning (in shares) at Jan. 27, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">467,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Sep. 30, 2021</a></td>
<td class="num">(339,740,000)<span></span>
</td>
<td class="num">(10,318,806)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,914,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(363,791,000)<span></span>
</td>
<td class="num">(10,319,181)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 375<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Jan. 27, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the beginning (in shares) at Jan. 27, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Class B common stock to Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 431<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Class B common stock to Sponsor (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,312,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Excess cash received over the fair value of the private warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,085,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,085,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited', window );">Forfeited shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (56)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Forfeited shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(562,500)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors', window );">Contribution from Sponsor upon sale of founder shares to Anchor Investors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,509,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,509,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Accretion of Class A common stock subject to possible redemption amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,406,092)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,619,383)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,786,709)<span></span>
</td>
<td class="nump">$ 18,406,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Dec. 31, 2021</a></td>
<td class="num">(354,917,000)<span></span>
</td>
<td class="num">(10,739,596)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">21,711,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(379,889,000)<span></span>
</td>
<td class="num">(10,739,971)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 375<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,126)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 431<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the beginning (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,312,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(443)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(443)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,569)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 431<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,312,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Excess cash received over the fair value of the private warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,085,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,085,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited', window );">Forfeited shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (56)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Forfeited shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(562,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors', window );">Contribution from Sponsor upon sale of founder shares to Anchor Investors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,509,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,509,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Accretion of Class A common stock subject to possible redemption amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,406,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,619,383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,786,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">469,097<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">469,097<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Sep. 30, 2021</a></td>
<td class="num">(339,740,000)<span></span>
</td>
<td class="num">(10,318,806)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,914,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(363,791,000)<span></span>
</td>
<td class="num">(10,319,181)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 375<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2021</a></td>
<td class="num">(354,917,000)<span></span>
</td>
<td class="num">(10,739,596)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">21,711,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(379,889,000)<span></span>
</td>
<td class="num">(10,739,971)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 375<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the beginning (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,542,722)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,542,722)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,282,318)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,282,693)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 375<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2021</a></td>
<td class="num">(354,917,000)<span></span>
</td>
<td class="num">(10,739,596)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">21,711,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(379,889,000)<span></span>
</td>
<td class="num">(10,739,971)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 375<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the beginning (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(54,974,000)<span></span>
</td>
<td class="nump">1,056,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54,974,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Sep. 30, 2022</a></td>
<td class="num">(407,640,000)<span></span>
</td>
<td class="num">(5,098,860)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">23,801,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(434,863,000)<span></span>
</td>
<td class="num">(5,099,235)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 375<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,282,318)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,282,693)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 375<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the beginning (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,354,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,354,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,928,056)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,928,431)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 375<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,244,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,244,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Sep. 30, 2022</a></td>
<td class="num">$ (407,640,000)<span></span>
</td>
<td class="num">$ (5,098,860)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 23,801,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (434,863,000)<span></span>
</td>
<td class="num">$ (5,099,235)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 375<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents amount of Contribution from Sponsor upon sale of Founder Shares to Anchor Investors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123466302&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph c(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272206429984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STATEMENT OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">8 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">(Gain) loss on change in fair value of SAFE and warrant liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 427,000<span></span>
</td>
<td class="nump">$ 699,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 563,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(71,336,000)<span></span>
</td>
<td class="num">(26,718,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(42,591,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows From Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,530,000)<span></span>
</td>
<td class="num">(4,201,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,747,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows From Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds received from private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,000<span></span>
</td>
<td class="nump">85,959,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">116,015,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128,732,000<span></span>
</td>
<td class="nump">60,909,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,909,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">$ 51,034,000<span></span>
</td>
<td class="nump">$ 115,700,000<span></span>
</td>
<td class="nump">$ 115,700,000<span></span>
</td>
<td class="nump">51,034,000<span></span>
</td>
<td class="nump">115,700,000<span></span>
</td>
<td class="nump">$ 128,732,000<span></span>
</td>
<td class="nump">128,732,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember', window );">AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Net Cash Provided by (Used in) Operating Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">467,528<span></span>
</td>
<td class="nump">1,056,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares', window );">General and administrative expenses paid by Sponsor in exchange for issuance of Class B common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">(Gain) loss on change in fair value of SAFE and warrant liabilities</a></td>
<td class="num">(1,426,720)<span></span>
</td>
<td class="num">(1,382,900)<span></span>
</td>
<td class="num">(1,382,900)<span></span>
</td>
<td class="num">(4,066,720)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,905,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities', window );">Offering costs allocated to derivative warrant liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">476,450<span></span>
</td>
<td class="nump">476,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">476,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_IncomeFromInvestmentsHeldInTrustAccount', window );">Income from investments held in the trust account</a></td>
<td class="num">(733,042)<span></span>
</td>
<td class="num">(2,178)<span></span>
</td>
<td class="num">(2,178)<span></span>
</td>
<td class="num">(972,453)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,015)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,173<span></span>
</td>
<td class="nump">244,534<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">155,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">1,602,381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,534<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_DueToRelatedParty', window );">Due to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireTrustPreferredInvestments', window );">Cash deposited in Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(150,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">138,034<span></span>
</td>
<td class="nump">1,127,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">199,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_IncreaseDecreaseInCapitalBaseTaxPayable', window );">Capital base tax payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_IncreaseDecreaseFranchiseTaxPayable', window );">Franchise tax payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,845<span></span>
</td>
<td class="num">(38,598)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">188,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(95,325)<span></span>
</td>
<td class="num">(345,097)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(510,017)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows From Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_PaymentsForInvestmentOfCashInTrustAccount', window );">Investment income released from Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(150,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(150,000,000)<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(150,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows From Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from note payable to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds received from initial public offering, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds received from private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">852,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">852,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,853,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,853,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash, cash equivalents and restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">758,091<span></span>
</td>
<td class="num">(336,097)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">343,399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">343,399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">$ 7,302<span></span>
</td>
<td class="nump">$ 758,091<span></span>
</td>
<td class="nump">758,091<span></span>
</td>
<td class="nump">$ 7,302<span></span>
</td>
<td class="nump">$ 758,091<span></span>
</td>
<td class="nump">343,399<span></span>
</td>
<td class="nump">$ 343,399<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of noncash activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_DeferredOfferingCostsIncludedInNotesPayable', window );">Offering costs included in notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,968,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_OfferingCostsIncludedInAccountsPayableAccruedExpenses', window );">Offering costs included in accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_DeferredUnderwritingFeePayable', window );">Offering costs paid by Sponsor in exchange for issuance of Class B common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_StockIssuanceCostsNoncash', window );">Offering costs included in notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,968,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties', window );">Prepaid expenses paid by related party under note payable and advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">677,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">677,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NoncashRepaymentOfNotePayableAndAdvances', window );">Repayment of note payable and advances by Sponsor in exchange for issuance of private placement warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,647,584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,647,584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NoncashDeferredUnderwritingCommissions', window );">Deferred underwriting commissions in connection with the initial public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering', window );">Value of Class B common stock transferred to Anchor Investors at initial public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,509,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,509,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_DeferredOfferingCostsIncludedInNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred offering costs included in notes payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_DeferredOfferingCostsIncludedInNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_DeferredUnderwritingFeePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of underwriting fee payable deferred during the period, classified as non-cash investing and financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_DeferredUnderwritingFeePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_DueToRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in related party payables classified as other, due within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_DueToRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative expenses paid by Sponsor in exchange for shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_IncomeFromInvestmentsHeldInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income from investments held in Trust Account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_IncomeFromInvestmentsHeldInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_IncreaseDecreaseFranchiseTaxPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of franchise tax payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_IncreaseDecreaseFranchiseTaxPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_IncreaseDecreaseInCapitalBaseTaxPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The of increase (decrease) during the reporting period of capital base tax payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_IncreaseDecreaseInCapitalBaseTaxPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_NoncashDeferredUnderwritingCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash deferred underwriting commissions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_NoncashDeferredUnderwritingCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash prepaid expenses and other assets paid by related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_NoncashRepaymentOfNotePayableAndAdvances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash repayment of note payable and advances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_NoncashRepaymentOfNotePayableAndAdvances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of offering costs allocated to derivative warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_OfferingCostsIncludedInAccountsPayableAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of offering costs included in accounts payable or accrued expenses that were incurred during a noncash or partial noncash transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_OfferingCostsIncludedInAccountsPayableAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_PaymentsForInvestmentOfCashInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash outflow for investment of cash in trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_PaymentsForInvestmentOfCashInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_StockIssuanceCostsNoncash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issuance costs noncash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_StockIssuanceCostsNoncash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of value of Class B common stock transferred to anchor investors at initial public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireTrustPreferredInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of trust preferred securities, which possess characteristics of both equity and debt securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireTrustPreferredInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272203990112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 50,370,000<span></span>
</td>
<td class="nump">$ 128,318,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsAndOtherReceivablesNetCurrent', window );">Trade and other receivables, net of allowance</a></td>
<td class="nump">11,588,000<span></span>
</td>
<td class="nump">2,878,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Contract assets</a></td>
<td class="nump">14,848,000<span></span>
</td>
<td class="nump">11,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">12,009,000<span></span>
</td>
<td class="nump">5,779,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">88,815,000<span></span>
</td>
<td class="nump">148,675,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">16,645,000<span></span>
</td>
<td class="nump">14,148,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use assets</a></td>
<td class="nump">3,343,000<span></span>
</td>
<td class="nump">4,686,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="nump">11,047,000<span></span>
</td>
<td class="nump">24,752,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue', window );">Equity Security Investment</a></td>
<td class="nump">14,990,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">750,000<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">135,590,000<span></span>
</td>
<td class="nump">193,011,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,488,000<span></span>
</td>
<td class="nump">2,444,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">8,064,000<span></span>
</td>
<td class="nump">7,059,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SimpleAgreementForFutureEquityLiability', window );">SAFE liability</a></td>
<td class="nump">27,221,000<span></span>
</td>
<td class="nump">28,271,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants</a></td>
<td class="nump">2,022,000<span></span>
</td>
<td class="nump">1,729,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities</a></td>
<td class="nump">2,968,000<span></span>
</td>
<td class="nump">3,476,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued salaries and wages</a></td>
<td class="nump">5,079,000<span></span>
</td>
<td class="nump">4,261,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current lease liabilities</a></td>
<td class="nump">2,205,000<span></span>
</td>
<td class="nump">2,050,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">49,047,000<span></span>
</td>
<td class="nump">49,290,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current lease liabilities</a></td>
<td class="nump">1,610,000<span></span>
</td>
<td class="nump">3,283,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Non-current contract liabilities</a></td>
<td class="nump">11,119,000<span></span>
</td>
<td class="nump">13,901,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">823,000<span></span>
</td>
<td class="nump">823,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">62,599,000<span></span>
</td>
<td class="nump">67,297,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable convertible preferred stock, $0.0001 par value</a></td>
<td class="nump">480,631,000<span></span>
</td>
<td class="nump">480,631,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">23,801,000<span></span>
</td>
<td class="nump">21,711,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">3,422,000<span></span>
</td>
<td class="nump">3,261,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(434,863,000)<span></span>
</td>
<td class="num">(379,889,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; deficit</a></td>
<td class="num">(407,640,000)<span></span>
</td>
<td class="num">(354,917,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, contingently redeemable preferred stock, and shareholders' deficit</a></td>
<td class="nump">$ 135,590,000<span></span>
</td>
<td class="nump">$ 193,011,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_SimpleAgreementForFutureEquityLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Simple Agreement for Future Equity Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_SimpleAgreementForFutureEquityLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndOtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsAndOtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI) and investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272207871456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Temporary equity par value (usd per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized (in shares)</a></td>
<td class="nump">29,747,033<span></span>
</td>
<td class="nump">29,747,033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,112,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued (in shares)</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,729,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding (in shares)</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">25,729,542<span></span>
</td>
<td class="nump">23,695,330<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (usd per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, shares authorized (in shares)</a></td>
<td class="nump">36,326,815<span></span>
</td>
<td class="nump">36,326,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,326,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, shares issued (in shares)</a></td>
<td class="nump">2,110,346<span></span>
</td>
<td class="nump">2,106,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,656,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common shares, shares outstanding</a></td>
<td class="nump">2,110,346<span></span>
</td>
<td class="nump">2,106,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,656,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272206751200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue from contracts with customers</a></td>
<td class="nump">$ 21,932,000<span></span>
</td>
<td class="nump">$ 13,317,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,871,000<span></span>
</td>
<td class="nump">$ 12,987,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer', window );">Revenue from collaborative arrangements</a></td>
<td class="nump">1,733,000<span></span>
</td>
<td class="nump">2,662,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,337,000<span></span>
</td>
<td class="nump">1,163,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue from related party transactions</a></td>
<td class="nump">2,116,000<span></span>
</td>
<td class="nump">2,348,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,253,000<span></span>
</td>
<td class="nump">4,203,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">25,781,000<span></span>
</td>
<td class="nump">18,327,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,461,000<span></span>
</td>
<td class="nump">18,353,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Cost and operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of revenues from contracts with customers (exclusive of depreciation shown below)</a></td>
<td class="num">(18,162,000)<span></span>
</td>
<td class="num">(8,480,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,167,000)<span></span>
</td>
<td class="num">(8,185,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="num">(39,858,000)<span></span>
</td>
<td class="num">(29,223,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(44,229,000)<span></span>
</td>
<td class="num">(34,454,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="num">(3,433,000)<span></span>
</td>
<td class="num">(2,763,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,806,000)<span></span>
</td>
<td class="num">(2,979,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expense</a></td>
<td class="num">(19,482,000)<span></span>
</td>
<td class="num">(11,595,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,216,000)<span></span>
</td>
<td class="num">(9,029,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total cost and operating expenses</a></td>
<td class="num">(82,004,000)<span></span>
</td>
<td class="num">(53,571,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(76,480,000)<span></span>
</td>
<td class="num">(58,054,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(56,223,000)<span></span>
</td>
<td class="num">(35,244,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(51,019,000)<span></span>
</td>
<td class="num">(39,701,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other (expense) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income (expense), net</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="num">(5,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,000)<span></span>
</td>
<td class="num">(351,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,065,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,065,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (expense) income, net</a></td>
<td class="num">(1,100,000)<span></span>
</td>
<td class="num">(778,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(673,000)<span></span>
</td>
<td class="nump">172,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other (expense) income, net</a></td>
<td class="num">(1,097,000)<span></span>
</td>
<td class="nump">2,282,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,385,000<span></span>
</td>
<td class="num">(179,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss before income taxes</a></td>
<td class="num">(57,320,000)<span></span>
</td>
<td class="num">(32,962,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(48,634,000)<span></span>
</td>
<td class="num">(39,880,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment', window );">Gain from equity method investees, net</a></td>
<td class="nump">2,346,000<span></span>
</td>
<td class="nump">2,371,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,945,000<span></span>
</td>
<td class="nump">2,167,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(54,974,000)<span></span>
</td>
<td class="num">(30,591,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(46,689,000)<span></span>
</td>
<td class="num">(37,713,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsIncomeStatementImpact', window );">Unpaid cumulative dividends on preferred stock</a></td>
<td class="num">(28,925,000)<span></span>
</td>
<td class="num">(27,068,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36,758,000)<span></span>
</td>
<td class="num">(31,291,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss allocated to common shareholders</a></td>
<td class="num">(83,899,000)<span></span>
</td>
<td class="num">(57,659,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(83,447,000)<span></span>
</td>
<td class="num">(69,004,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustments</a></td>
<td class="num">(767,000)<span></span>
</td>
<td class="num">(29,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,000<span></span>
</td>
<td class="nump">625,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (55,741,000)<span></span>
</td>
<td class="num">$ (30,620,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (46,594,000)<span></span>
</td>
<td class="num">$ (37,088,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share - basic (usd per share)</a></td>
<td class="num">$ (39,790)<span></span>
</td>
<td class="num">$ (30,190)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (42.59)<span></span>
</td>
<td class="num">$ (42.34)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share - diluted (usd per share)</a></td>
<td class="num">$ (39,790)<span></span>
</td>
<td class="num">$ (30,190)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (42.59)<span></span>
</td>
<td class="num">$ (42.34)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average number of common shares outstanding - basic (in shares)</a></td>
<td class="nump">2,108,472,000<span></span>
</td>
<td class="nump">1,909,635,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,959,165,000<span></span>
</td>
<td class="nump">1,629,821,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in calculating net loss per share, diluted (in shares)</a></td>
<td class="nump">2,108,472,000<span></span>
</td>
<td class="nump">1,909,635,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,959,165,000<span></span>
</td>
<td class="nump">1,629,821,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember', window );">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Cost and operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of revenues from contracts with customers (exclusive of depreciation shown below)</a></td>
<td class="num">$ (727,000)<span></span>
</td>
<td class="num">$ (935,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,254,000)<span></span>
</td>
<td class="num">$ (743,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_RelatedAndNonrelatedPartyStatusAxis=amci_RelatedPartyMember', window );">Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Cost and operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of revenues from contracts with customers (exclusive of depreciation shown below)</a></td>
<td class="num">$ (342,000)<span></span>
</td>
<td class="num">$ (575,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (808,000)<span></span>
</td>
<td class="num">$ (2,664,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Equity Method Investments and Gain On Dilution Of Investment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of product sold and service rendered, excluding depreciation, depletion, and amortization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsIncomeStatementImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsIncomeStatementImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue from collaborative arrangement. Excludes revenue from contract with customer under Topic 606.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126928961&amp;loc=SL5834089-161433<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.1(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_RelatedAndNonrelatedPartyStatusAxis=amci_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_RelatedAndNonrelatedPartyStatusAxis=amci_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272204008912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Net Cash Provided by (Used in) Operating Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (54,974)<span></span>
</td>
<td class="num">$ (30,591)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">2,067<span></span>
</td>
<td class="nump">1,790<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_FairValueAdjustmentOfWarrantsAndUnrealizedGainLossOnDerivatives', window );">(Gain) loss on change in fair value of SAFE and warrant liabilities</a></td>
<td class="num">(330)<span></span>
</td>
<td class="nump">699<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation of property, plant and equipment</a></td>
<td class="nump">3,433<span></span>
</td>
<td class="nump">2,763<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Non-cash lease expense</a></td>
<td class="nump">1,343<span></span>
</td>
<td class="nump">1,248<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NoncashRecognitionOfLicensingRevenue', window );">Non-cash recognition of licensing revenue</a></td>
<td class="num">(1,620)<span></span>
</td>
<td class="num">(1,516)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Gain from equity method investees, net</a></td>
<td class="num">(2,346)<span></span>
</td>
<td class="num">(2,371)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,065)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Net foreign exchange loss</a></td>
<td class="nump">1,311<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="num">(8,710)<span></span>
</td>
<td class="nump">3,581<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset', window );">Contract assets</a></td>
<td class="num">(3,270)<span></span>
</td>
<td class="num">(3,838)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(5,981)<span></span>
</td>
<td class="num">(558)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued salaries and wages</a></td>
<td class="nump">463<span></span>
</td>
<td class="nump">717<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="num">(471)<span></span>
</td>
<td class="nump">4,301<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(1,518)<span></span>
</td>
<td class="num">(1,389)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="num">(733)<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(71,336)<span></span>
</td>
<td class="num">(26,718)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows From Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property, plant and equipment</a></td>
<td class="num">(6,530)<span></span>
</td>
<td class="num">(4,201)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(6,530)<span></span>
</td>
<td class="num">(4,201)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows From Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises', window );">Proceeds from issue of equity instruments of the Company</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">83,775<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from exercise of a warrant</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfEquity', window );">Repurchase of equity instruments of the Company</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(396)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayment of borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(570)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">85,959<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="num">(77,843)<span></span>
</td>
<td class="nump">55,040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">128,732<span></span>
</td>
<td class="nump">60,909<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effects of currency translation on cash, cash equivalents and restricted cash</a></td>
<td class="nump">145<span></span>
</td>
<td class="num">(249)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">51,034<span></span>
</td>
<td class="nump">115,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Acquisition of property, plant and equipment under accounts payable</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">346<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Receipt of common shares as payment for option exercises</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">938<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NoncashLoanForgiveness', window );">PPP loan forgiveness</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3,065<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_FairValueAdjustmentOfWarrantsAndUnrealizedGainLossOnDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Adjustment Of Warrants And Unrealized Gain (Loss) On Derivatives</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_FairValueAdjustmentOfWarrantsAndUnrealizedGainLossOnDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_NoncashLoanForgiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash Loan Forgiveness</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_NoncashLoanForgiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_NoncashRecognitionOfLicensingRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash Recognition of Licensing Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_NoncashRecognitionOfLicensingRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Issuance Or Sale Of Equity, Excluding Warrant Exercises</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272197766272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND SHAREHOLDERS&#8217; DEFICIT (UNAUDITED) - USD ($)<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock Outstanding</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance, Redeemable Convertible Preferred Stock (in shares) at Dec. 31, 2019</a></td>
<td class="nump">23,695,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance, temporary equity at Dec. 31, 2019</a></td>
<td class="nump">$ 347,938,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of preferred stock (in shares)</a></td>
<td class="nump">2,034,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of preferred stock</a></td>
<td class="nump">$ 46,470,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, Redeemable Convertible Preferred Stock (in shares) at Dec. 31, 2020</a></td>
<td class="nump">25,729,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance, temporary equity at Dec. 31, 2020</a></td>
<td class="nump">$ 394,408,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityStockIssuanceCost', window );">Stock issuance cost</a></td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance, Common stock, shares outstanding (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,622,886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2019</a></td>
<td class="num">(276,592,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16,354,000<span></span>
</td>
<td class="num">$ (295,487,000)<span></span>
</td>
<td class="nump">$ 2,541,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">2,392,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,392,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(37,713,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37,713,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of options</a></td>
<td class="nump">72,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustments</a></td>
<td class="nump">$ 625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, Common stock, shares outstanding (in shares) at Dec. 31, 2020</a></td>
<td class="nump">1,656,415<span></span>
</td>
<td class="nump">1,656,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Dec. 31, 2020</a></td>
<td class="num">$ (311,216,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">18,818,000<span></span>
</td>
<td class="num">(333,200,000)<span></span>
</td>
<td class="nump">3,166,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of preferred stock (in shares)</a></td>
<td class="nump">3,634,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of preferred stock</a></td>
<td class="nump">$ 83,073,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquitySharesConversionOfConvertibleSecurities', window );">Exercise of warrants (in shares)</a></td>
<td class="nump">158,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityValueConversionOfConvertibleSecurities', window );">Exercise of warrants</a></td>
<td class="nump">$ 3,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, Redeemable Convertible Preferred Stock (in shares) at Sep. 30, 2021</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance, temporary equity at Sep. 30, 2021</a></td>
<td class="nump">$ 480,631,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityStockIssuanceCost', window );">Stock issuance cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">1,790,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,790,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments', window );">Repurchase of equity instruments</a></td>
<td class="num">(396,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(396,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(30,591,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30,591,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">448,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of options</a></td>
<td class="nump">702,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">702,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustments</a></td>
<td class="num">(29,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, Common stock, shares outstanding (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,104,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Sep. 30, 2021</a></td>
<td class="num">$ (339,740,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">20,914,000<span></span>
</td>
<td class="num">(363,791,000)<span></span>
</td>
<td class="nump">3,137,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance, Redeemable Convertible Preferred Stock (in shares) at Dec. 31, 2020</a></td>
<td class="nump">25,729,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance, temporary equity at Dec. 31, 2020</a></td>
<td class="nump">$ 394,408,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of preferred stock (in shares)</a></td>
<td class="nump">3,792,268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of preferred stock</a></td>
<td class="nump">$ 86,223,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, Redeemable Convertible Preferred Stock (in shares) at Dec. 31, 2021</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance, temporary equity at Dec. 31, 2021</a></td>
<td class="nump">$ 480,631,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityStockIssuanceCost', window );">Stock issuance cost</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance, Common stock, shares outstanding (in shares) at Dec. 31, 2020</a></td>
<td class="nump">1,656,415<span></span>
</td>
<td class="nump">1,656,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2020</a></td>
<td class="num">$ (311,216,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">18,818,000<span></span>
</td>
<td class="num">(333,200,000)<span></span>
</td>
<td class="nump">3,166,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">2,531,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,531,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments', window );">Repurchase of equity instruments</a></td>
<td class="num">(396,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(396,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (46,689,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(46,689,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of options (in shares)</a></td>
<td class="nump">620,000<span></span>
</td>
<td class="nump">450,519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of options</a></td>
<td class="nump">$ 758,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">758,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustments</a></td>
<td class="nump">$ 95,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, Common stock, shares outstanding (in shares) at Dec. 31, 2021</a></td>
<td class="nump">2,106,934<span></span>
</td>
<td class="nump">2,106,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Dec. 31, 2021</a></td>
<td class="num">$ (354,917,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">21,711,000<span></span>
</td>
<td class="num">(379,889,000)<span></span>
</td>
<td class="nump">3,261,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, Redeemable Convertible Preferred Stock (in shares) at Sep. 30, 2021</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance, temporary equity at Sep. 30, 2021</a></td>
<td class="nump">$ 480,631,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, Common stock, shares outstanding (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,104,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Sep. 30, 2021</a></td>
<td class="num">$ (339,740,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">20,914,000<span></span>
</td>
<td class="num">(363,791,000)<span></span>
</td>
<td class="nump">3,137,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, Redeemable Convertible Preferred Stock (in shares) at Dec. 31, 2021</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance, temporary equity at Dec. 31, 2021</a></td>
<td class="nump">$ 480,631,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, Common stock, shares outstanding (in shares) at Dec. 31, 2021</a></td>
<td class="nump">2,106,934<span></span>
</td>
<td class="nump">2,106,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Dec. 31, 2021</a></td>
<td class="num">$ (354,917,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">21,711,000<span></span>
</td>
<td class="num">(379,889,000)<span></span>
</td>
<td class="nump">3,261,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, Redeemable Convertible Preferred Stock (in shares) at Sep. 30, 2021</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance, temporary equity at Sep. 30, 2021</a></td>
<td class="nump">$ 480,631,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, Common stock, shares outstanding (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,104,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Sep. 30, 2021</a></td>
<td class="num">$ (339,740,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">20,914,000<span></span>
</td>
<td class="num">(363,791,000)<span></span>
</td>
<td class="nump">3,137,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance, Redeemable Convertible Preferred Stock (in shares) at Dec. 31, 2021</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance, temporary equity at Dec. 31, 2021</a></td>
<td class="nump">$ 480,631,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance, Common stock, shares outstanding (in shares) at Dec. 31, 2021</a></td>
<td class="nump">2,106,934<span></span>
</td>
<td class="nump">2,106,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2021</a></td>
<td class="num">$ (354,917,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">21,711,000<span></span>
</td>
<td class="num">(379,889,000)<span></span>
</td>
<td class="nump">3,261,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance, Redeemable Convertible Preferred Stock (in shares) at Dec. 31, 2021</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance, temporary equity at Dec. 31, 2021</a></td>
<td class="nump">$ 480,631,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, Redeemable Convertible Preferred Stock (in shares) at Sep. 30, 2022</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance, temporary equity at Sep. 30, 2022</a></td>
<td class="nump">$ 480,631,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance, Common stock, shares outstanding (in shares) at Dec. 31, 2021</a></td>
<td class="nump">2,106,934<span></span>
</td>
<td class="nump">2,106,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2021</a></td>
<td class="num">$ (354,917,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">21,711,000<span></span>
</td>
<td class="num">(379,889,000)<span></span>
</td>
<td class="nump">3,261,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">2,067,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,067,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (54,974,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54,974,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of options (in shares)</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">3,412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of options</a></td>
<td class="nump">$ 23,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax', window );">Transfer from foreign currency translation to equity security investment</a></td>
<td class="nump">928,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">928,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustments</a></td>
<td class="num">$ (767,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(767,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, Common stock, shares outstanding (in shares) at Sep. 30, 2022</a></td>
<td class="nump">2,110,346<span></span>
</td>
<td class="nump">2,110,346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Sep. 30, 2022</a></td>
<td class="num">$ (407,640,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">23,801,000<span></span>
</td>
<td class="num">(434,863,000)<span></span>
</td>
<td class="nump">3,422,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, Redeemable Convertible Preferred Stock (in shares) at Sep. 30, 2022</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance, temporary equity at Sep. 30, 2022</a></td>
<td class="nump">$ 480,631,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, Common stock, shares outstanding (in shares) at Sep. 30, 2022</a></td>
<td class="nump">2,110,346<span></span>
</td>
<td class="nump">2,110,346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Sep. 30, 2022</a></td>
<td class="num">$ (407,640,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 23,801,000<span></span>
</td>
<td class="num">$ (434,863,000)<span></span>
</td>
<td class="nump">$ 3,422,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Repurchase of Equity Instruments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TemporaryEquitySharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Shares, Conversion of Convertible Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TemporaryEquitySharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TemporaryEquityStockIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issuance Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TemporaryEquityStockIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issued During Period, Shares, New Issues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TemporaryEquityValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Value, Conversion of Convertible Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TemporaryEquityValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e709-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 40<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116633155&amp;loc=d3e31531-110899<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of new stock classified as temporary equity issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272205303008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 50,370,000<span></span>
</td>
<td class="nump">$ 128,318,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,495,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsAndOtherReceivablesNetCurrent', window );">Trade and other receivables, net of allowance</a></td>
<td class="nump">11,588,000<span></span>
</td>
<td class="nump">2,878,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,521,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Contract assets</a></td>
<td class="nump">14,848,000<span></span>
</td>
<td class="nump">11,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,186,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">12,009,000<span></span>
</td>
<td class="nump">5,779,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,387,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">88,815,000<span></span>
</td>
<td class="nump">148,675,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,589,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">16,645,000<span></span>
</td>
<td class="nump">14,148,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,609,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use assets</a></td>
<td class="nump">3,343,000<span></span>
</td>
<td class="nump">4,686,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,365,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="nump">11,047,000<span></span>
</td>
<td class="nump">24,752,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,217,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">750,000<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">135,590,000<span></span>
</td>
<td class="nump">193,011,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118,980,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,488,000<span></span>
</td>
<td class="nump">2,444,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,147,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">8,064,000<span></span>
</td>
<td class="nump">7,059,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,897,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SimpleAgreementForFutureEquityLiability', window );">SAFE liability</a></td>
<td class="nump">27,221,000<span></span>
</td>
<td class="nump">28,271,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants</a></td>
<td class="nump">2,022,000<span></span>
</td>
<td class="nump">1,729,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 107,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities</a></td>
<td class="nump">2,968,000<span></span>
</td>
<td class="nump">3,476,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,480,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued salaries and wages</a></td>
<td class="nump">5,079,000<span></span>
</td>
<td class="nump">4,261,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,492,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current lease liabilities</a></td>
<td class="nump">2,205,000<span></span>
</td>
<td class="nump">2,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,618,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">570,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">49,047,000<span></span>
</td>
<td class="nump">49,290,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,204,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current lease liabilities</a></td>
<td class="nump">1,610,000<span></span>
</td>
<td class="nump">3,283,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,334,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Non-current contract liabilities</a></td>
<td class="nump">11,119,000<span></span>
</td>
<td class="nump">13,901,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,291,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,065,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">823,000<span></span>
</td>
<td class="nump">823,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">894,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">62,599,000<span></span>
</td>
<td class="nump">67,297,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,788,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable convertible preferred stock, $0.0001 par value</a></td>
<td class="nump">480,631,000<span></span>
</td>
<td class="nump">480,631,000<span></span>
</td>
<td class="nump">$ 480,631,000<span></span>
</td>
<td class="nump">394,408,000<span></span>
</td>
<td class="nump">347,938,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">23,801,000<span></span>
</td>
<td class="nump">21,711,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,818,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">3,422,000<span></span>
</td>
<td class="nump">3,261,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,166,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(434,863,000)<span></span>
</td>
<td class="num">(379,889,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(333,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; deficit</a></td>
<td class="num">(407,640,000)<span></span>
</td>
<td class="num">(354,917,000)<span></span>
</td>
<td class="num">$ (339,740,000)<span></span>
</td>
<td class="num">(311,216,000)<span></span>
</td>
<td class="num">$ (276,592,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, contingently redeemable preferred stock, and shareholders' deficit</a></td>
<td class="nump">$ 135,590,000<span></span>
</td>
<td class="nump">$ 193,011,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118,980,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_SimpleAgreementForFutureEquityLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Simple Agreement for Future Equity Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_SimpleAgreementForFutureEquityLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndOtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsAndOtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272203957392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Temporary equity par value (usd per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized (in shares)</a></td>
<td class="nump">29,747,033<span></span>
</td>
<td class="nump">29,747,033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,112,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued (in shares)</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,729,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding (in shares)</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">25,729,542<span></span>
</td>
<td class="nump">23,695,330<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (usd per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, shares authorized (in shares)</a></td>
<td class="nump">36,326,815<span></span>
</td>
<td class="nump">36,326,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,326,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, shares issued (in shares)</a></td>
<td class="nump">2,110,346<span></span>
</td>
<td class="nump">2,106,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,656,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common shares, shares outstanding</a></td>
<td class="nump">2,110,346<span></span>
</td>
<td class="nump">2,106,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,656,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272198033520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue from contracts with customers</a></td>
<td class="nump">$ 21,932,000<span></span>
</td>
<td class="nump">$ 13,317,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,871,000<span></span>
</td>
<td class="nump">$ 12,987,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer', window );">Revenue from collaborative arrangements</a></td>
<td class="nump">1,733,000<span></span>
</td>
<td class="nump">2,662,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,337,000<span></span>
</td>
<td class="nump">1,163,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue from related party transactions</a></td>
<td class="nump">2,116,000<span></span>
</td>
<td class="nump">2,348,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,253,000<span></span>
</td>
<td class="nump">4,203,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">25,781,000<span></span>
</td>
<td class="nump">18,327,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,461,000<span></span>
</td>
<td class="nump">18,353,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Cost and operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of revenues from contracts with customers (exclusive of depreciation shown below)</a></td>
<td class="num">(18,162,000)<span></span>
</td>
<td class="num">(8,480,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,167,000)<span></span>
</td>
<td class="num">(8,185,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="num">(39,858,000)<span></span>
</td>
<td class="num">(29,223,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(44,229,000)<span></span>
</td>
<td class="num">(34,454,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">3,433,000<span></span>
</td>
<td class="nump">2,763,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,806,000<span></span>
</td>
<td class="nump">2,979,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expense</a></td>
<td class="num">(19,482,000)<span></span>
</td>
<td class="num">(11,595,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,216,000)<span></span>
</td>
<td class="num">(9,029,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total cost and operating expenses</a></td>
<td class="num">(82,004,000)<span></span>
</td>
<td class="num">(53,571,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(76,480,000)<span></span>
</td>
<td class="num">(58,054,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(56,223,000)<span></span>
</td>
<td class="num">(35,244,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(51,019,000)<span></span>
</td>
<td class="num">(39,701,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other (expense) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income (expense), net</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="num">(5,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,000)<span></span>
</td>
<td class="num">(351,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,065,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,065,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (expense) income, net</a></td>
<td class="num">(1,100,000)<span></span>
</td>
<td class="num">(778,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(673,000)<span></span>
</td>
<td class="nump">172,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other (expense) income, net</a></td>
<td class="num">(1,097,000)<span></span>
</td>
<td class="nump">2,282,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,385,000<span></span>
</td>
<td class="num">(179,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss before income taxes</a></td>
<td class="num">(57,320,000)<span></span>
</td>
<td class="num">(32,962,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(48,634,000)<span></span>
</td>
<td class="num">(39,880,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment', window );">Gain from equity method investees, net</a></td>
<td class="nump">2,346,000<span></span>
</td>
<td class="nump">2,371,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,945,000<span></span>
</td>
<td class="nump">2,167,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(54,974,000)<span></span>
</td>
<td class="num">(30,591,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(46,689,000)<span></span>
</td>
<td class="num">(37,713,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsIncomeStatementImpact', window );">Unpaid cumulative dividends on preferred stock</a></td>
<td class="num">(28,925,000)<span></span>
</td>
<td class="num">(27,068,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36,758,000)<span></span>
</td>
<td class="num">(31,291,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss allocated to common shareholders</a></td>
<td class="num">(83,899,000)<span></span>
</td>
<td class="num">(57,659,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(83,447,000)<span></span>
</td>
<td class="num">(69,004,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustments</a></td>
<td class="num">(767,000)<span></span>
</td>
<td class="num">(29,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,000<span></span>
</td>
<td class="nump">625,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (55,741,000)<span></span>
</td>
<td class="num">$ (30,620,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (46,594,000)<span></span>
</td>
<td class="num">$ (37,088,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share - basic (usd per share)</a></td>
<td class="num">$ (39,790)<span></span>
</td>
<td class="num">$ (30,190)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (42.59)<span></span>
</td>
<td class="num">$ (42.34)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share - diluted (usd per share)</a></td>
<td class="num">$ (39,790)<span></span>
</td>
<td class="num">$ (30,190)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (42.59)<span></span>
</td>
<td class="num">$ (42.34)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average number of common shares outstanding - basic (in shares)</a></td>
<td class="nump">2,108,472,000<span></span>
</td>
<td class="nump">1,909,635,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,959,165,000<span></span>
</td>
<td class="nump">1,629,821,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in calculating net loss per share, diluted (in shares)</a></td>
<td class="nump">2,108,472,000<span></span>
</td>
<td class="nump">1,909,635,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,959,165,000<span></span>
</td>
<td class="nump">1,629,821,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember', window );">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Cost and operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of revenues from contracts with customers (exclusive of depreciation shown below)</a></td>
<td class="num">$ (727,000)<span></span>
</td>
<td class="num">$ (935,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,254,000)<span></span>
</td>
<td class="num">$ (743,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_RelatedAndNonrelatedPartyStatusAxis=amci_RelatedPartyMember', window );">Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Cost and operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of revenues from contracts with customers (exclusive of depreciation shown below)</a></td>
<td class="num">$ (342,000)<span></span>
</td>
<td class="num">$ (575,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (808,000)<span></span>
</td>
<td class="num">$ (2,664,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Equity Method Investments and Gain On Dilution Of Investment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of product sold and service rendered, excluding depreciation, depletion, and amortization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsIncomeStatementImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsIncomeStatementImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue from collaborative arrangement. Excludes revenue from contract with customer under Topic 606.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126928961&amp;loc=SL5834089-161433<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.1(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_RelatedAndNonrelatedPartyStatusAxis=amci_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_RelatedAndNonrelatedPartyStatusAxis=amci_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272203664192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND SHAREHOLDERS&#8217; EQUITY (DEFICIT) - USD ($)<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock Outstanding</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance, Redeemable Convertible Preferred Stock (in shares) at Dec. 31, 2019</a></td>
<td class="nump">23,695,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance, temporary equity at Dec. 31, 2019</a></td>
<td class="nump">$ 347,938,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of preferred stock (in shares)</a></td>
<td class="nump">2,034,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of preferred stock</a></td>
<td class="nump">$ 46,470,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, Redeemable Convertible Preferred Stock (in shares) at Dec. 31, 2020</a></td>
<td class="nump">25,729,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance, temporary equity at Dec. 31, 2020</a></td>
<td class="nump">$ 394,408,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityStockIssuanceCost', window );">Stock issuance cost</a></td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance, Common stock, shares outstanding (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,622,886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2019</a></td>
<td class="num">(276,592,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16,354,000<span></span>
</td>
<td class="num">$ (295,487,000)<span></span>
</td>
<td class="nump">$ 2,541,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">2,392,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,392,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(37,713,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37,713,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of options</a></td>
<td class="nump">72,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">$ 625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">625,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, Common stock, shares outstanding (in shares) at Dec. 31, 2020</a></td>
<td class="nump">1,656,415<span></span>
</td>
<td class="nump">1,656,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Dec. 31, 2020</a></td>
<td class="num">$ (311,216,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">18,818,000<span></span>
</td>
<td class="num">(333,200,000)<span></span>
</td>
<td class="nump">3,166,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of preferred stock (in shares)</a></td>
<td class="nump">3,634,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of preferred stock</a></td>
<td class="nump">$ 83,073,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquitySharesConversionOfConvertibleSecurities', window );">Exercise of warrants (in shares)</a></td>
<td class="nump">158,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, Redeemable Convertible Preferred Stock (in shares) at Sep. 30, 2021</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance, temporary equity at Sep. 30, 2021</a></td>
<td class="nump">$ 480,631,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityStockIssuanceCost', window );">Stock issuance cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">1,790,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,790,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments', window );">Repurchase of equity instruments</a></td>
<td class="num">(396,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(396,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(30,591,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30,591,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">448,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of options</a></td>
<td class="nump">702,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">702,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, Common stock, shares outstanding (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,104,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Sep. 30, 2021</a></td>
<td class="num">$ (339,740,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">20,914,000<span></span>
</td>
<td class="num">(363,791,000)<span></span>
</td>
<td class="nump">3,137,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance, Redeemable Convertible Preferred Stock (in shares) at Dec. 31, 2020</a></td>
<td class="nump">25,729,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance, temporary equity at Dec. 31, 2020</a></td>
<td class="nump">$ 394,408,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of preferred stock (in shares)</a></td>
<td class="nump">3,792,268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of preferred stock</a></td>
<td class="nump">$ 86,223,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityExerciseOfWarrants', window );">Exercise of warrants</a></td>
<td class="nump">$ 3,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, Redeemable Convertible Preferred Stock (in shares) at Dec. 31, 2021</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance, temporary equity at Dec. 31, 2021</a></td>
<td class="nump">$ 480,631,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityStockIssuanceCost', window );">Stock issuance cost</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance, Common stock, shares outstanding (in shares) at Dec. 31, 2020</a></td>
<td class="nump">1,656,415<span></span>
</td>
<td class="nump">1,656,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2020</a></td>
<td class="num">$ (311,216,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">18,818,000<span></span>
</td>
<td class="num">(333,200,000)<span></span>
</td>
<td class="nump">3,166,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">2,531,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,531,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments', window );">Repurchase of equity instruments</a></td>
<td class="num">(396,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(396,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (46,689,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(46,689,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of options (in shares)</a></td>
<td class="nump">620,000<span></span>
</td>
<td class="nump">450,519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of options</a></td>
<td class="nump">$ 758,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">758,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">$ 95,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, Common stock, shares outstanding (in shares) at Dec. 31, 2021</a></td>
<td class="nump">2,106,934<span></span>
</td>
<td class="nump">2,106,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Dec. 31, 2021</a></td>
<td class="num">$ (354,917,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">21,711,000<span></span>
</td>
<td class="num">(379,889,000)<span></span>
</td>
<td class="nump">3,261,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, Redeemable Convertible Preferred Stock (in shares) at Sep. 30, 2021</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance, temporary equity at Sep. 30, 2021</a></td>
<td class="nump">$ 480,631,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, Common stock, shares outstanding (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,104,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Sep. 30, 2021</a></td>
<td class="num">$ (339,740,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">20,914,000<span></span>
</td>
<td class="num">(363,791,000)<span></span>
</td>
<td class="nump">3,137,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, Redeemable Convertible Preferred Stock (in shares) at Dec. 31, 2021</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance, temporary equity at Dec. 31, 2021</a></td>
<td class="nump">$ 480,631,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, Common stock, shares outstanding (in shares) at Dec. 31, 2021</a></td>
<td class="nump">2,106,934<span></span>
</td>
<td class="nump">2,106,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Dec. 31, 2021</a></td>
<td class="num">$ (354,917,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">21,711,000<span></span>
</td>
<td class="num">(379,889,000)<span></span>
</td>
<td class="nump">3,261,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, Redeemable Convertible Preferred Stock (in shares) at Sep. 30, 2021</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance, temporary equity at Sep. 30, 2021</a></td>
<td class="nump">$ 480,631,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, Common stock, shares outstanding (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,104,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Sep. 30, 2021</a></td>
<td class="num">$ (339,740,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">20,914,000<span></span>
</td>
<td class="num">(363,791,000)<span></span>
</td>
<td class="nump">3,137,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance, Redeemable Convertible Preferred Stock (in shares) at Dec. 31, 2021</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance, temporary equity at Dec. 31, 2021</a></td>
<td class="nump">$ 480,631,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance, Common stock, shares outstanding (in shares) at Dec. 31, 2021</a></td>
<td class="nump">2,106,934<span></span>
</td>
<td class="nump">2,106,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2021</a></td>
<td class="num">$ (354,917,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">21,711,000<span></span>
</td>
<td class="num">(379,889,000)<span></span>
</td>
<td class="nump">3,261,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance, Redeemable Convertible Preferred Stock (in shares) at Dec. 31, 2021</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance, temporary equity at Dec. 31, 2021</a></td>
<td class="nump">$ 480,631,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, Redeemable Convertible Preferred Stock (in shares) at Sep. 30, 2022</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance, temporary equity at Sep. 30, 2022</a></td>
<td class="nump">$ 480,631,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance, Common stock, shares outstanding (in shares) at Dec. 31, 2021</a></td>
<td class="nump">2,106,934<span></span>
</td>
<td class="nump">2,106,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2021</a></td>
<td class="num">$ (354,917,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">21,711,000<span></span>
</td>
<td class="num">(379,889,000)<span></span>
</td>
<td class="nump">3,261,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">2,067,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,067,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (54,974,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54,974,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of options (in shares)</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">3,412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of options</a></td>
<td class="nump">$ 23,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, Common stock, shares outstanding (in shares) at Sep. 30, 2022</a></td>
<td class="nump">2,110,346<span></span>
</td>
<td class="nump">2,110,346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Sep. 30, 2022</a></td>
<td class="num">$ (407,640,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">23,801,000<span></span>
</td>
<td class="num">(434,863,000)<span></span>
</td>
<td class="nump">3,422,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, Redeemable Convertible Preferred Stock (in shares) at Sep. 30, 2022</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance, temporary equity at Sep. 30, 2022</a></td>
<td class="nump">$ 480,631,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, Common stock, shares outstanding (in shares) at Sep. 30, 2022</a></td>
<td class="nump">2,110,346<span></span>
</td>
<td class="nump">2,110,346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Sep. 30, 2022</a></td>
<td class="num">$ (407,640,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 23,801,000<span></span>
</td>
<td class="num">$ (434,863,000)<span></span>
</td>
<td class="nump">$ 3,422,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Repurchase of Equity Instruments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TemporaryEquityExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Exercise of Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TemporaryEquityExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TemporaryEquitySharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Shares, Conversion of Convertible Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TemporaryEquitySharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TemporaryEquityStockIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issuance Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TemporaryEquityStockIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issued During Period, Shares, New Issues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of new stock classified as temporary equity issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272203891008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Net Cash Provided by (Used in) Operating Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (46,689)<span></span>
</td>
<td class="num">$ (37,713)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">2,531<span></span>
</td>
<td class="nump">2,392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">(Gain) loss on change in fair value of SAFE and warrant liabilities</a></td>
<td class="nump">563<span></span>
</td>
<td class="num">(105)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad debt expense and recoveries</a></td>
<td class="num">(27)<span></span>
</td>
<td class="nump">877<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation of property, plant and equipment</a></td>
<td class="nump">3,806<span></span>
</td>
<td class="nump">2,979<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Non-cash lease expense</a></td>
<td class="nump">1,679<span></span>
</td>
<td class="nump">1,565<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NoncashRecognitionOfLicensingRevenue', window );">Non-cash recognition of licensing revenue</a></td>
<td class="num">(2,022)<span></span>
</td>
<td class="num">(1,018)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of debt</a></td>
<td class="num">(3,065)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment', window );">Gain from equity method investees, net</a></td>
<td class="num">(1,945)<span></span>
</td>
<td class="num">(2,167)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Net foreign exchange loss</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="nump">2,670<span></span>
</td>
<td class="num">(4,470)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset', window );">Contract assets</a></td>
<td class="num">(5,514)<span></span>
</td>
<td class="num">(5,605)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(941)<span></span>
</td>
<td class="num">(364)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued salaries and wages</a></td>
<td class="nump">1,256<span></span>
</td>
<td class="nump">690<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="nump">5,762<span></span>
</td>
<td class="nump">3,167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(1,618)<span></span>
</td>
<td class="num">(1,204)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="nump">908<span></span>
</td>
<td class="nump">1,705<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(42,591)<span></span>
</td>
<td class="num">(39,271)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows From Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property, plant and equipment</a></td>
<td class="num">(5,752)<span></span>
</td>
<td class="num">(7,110)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from disposal of property, plant and equipment</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfOtherRealEstate', window );">Proceeds from disposal of investment property</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">513<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(5,747)<span></span>
</td>
<td class="num">(6,593)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows From Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises', window );">Proceeds from issue of equity instruments of the Company</a></td>
<td class="nump">83,831<span></span>
</td>
<td class="nump">46,572<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from exercise of a warrant</a></td>
<td class="nump">3,150<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issue of SAFE and warrant instruments</a></td>
<td class="nump">30,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of Stock Issuance Costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from Issuance of Debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,065<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfEquity', window );">Repurchase of equity instruments of the Company</a></td>
<td class="num">(396)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayment of borrowings</a></td>
<td class="num">(570)<span></span>
</td>
<td class="num">(4,880)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">116,015<span></span>
</td>
<td class="nump">44,727<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="nump">67,677<span></span>
</td>
<td class="num">(1,137)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">60,909<span></span>
</td>
<td class="nump">62,117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effects of currency translation on cash, cash equivalents and restricted cash</a></td>
<td class="nump">146<span></span>
</td>
<td class="num">(71)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">128,732<span></span>
</td>
<td class="nump">60,909<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">356<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract', window );"><strong>Additional Cash Flow Elements, Investing Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1', window );">Acquisition of equity method investment in LanzaJet through contribution of license</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Acquisition of property, plant and equipment under accounts payable</a></td>
<td class="nump">708<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NoncashLoanForgiveness', window );">PPP loan forgiveness</a></td>
<td class="nump">3,065<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Receipt of common shares as payment for option exercises</a></td>
<td class="nump">$ 938<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Equity Method Investments and Gain On Dilution Of Investment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_NoncashLoanForgiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash Loan Forgiveness</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_NoncashLoanForgiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_NoncashRecognitionOfLicensingRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash Recognition of Licensing Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_NoncashRecognitionOfLicensingRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Issuance Or Sale Of Equity, Excluding Warrant Exercises</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfOtherRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of other real estate not otherwise defined in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfOtherRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272316467136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Organization and Business Operations<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Description of Organization and Business Operations</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1 &#8212; Description of Organization and Business Operations</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AMCI Acquisition Corp. II (the &#8220;Company&#8221;) is a blank check company incorporated as a Delaware corporation on January 28, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the &#8220;business combination&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, the Company has neither engaged in any operations nor generated any revenues. All activity to date relates to the Company&#8217;s formation and the initial public offering (as defined below), described below and since the initial public offering, its search for a business combination target. The Company will not generate any operating revenues until after the completion of its initial business combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the initial public offering and from changes in the fair value of its derivative warrant liabilities, if applicable. The Company has selected December 31 as its fiscal year end.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s sponsor is AMCI Sponsor II LLC, a Delaware limited liability company (the &#8220;Sponsor&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registration statement for the Company&#8217;s initial public offering was declared effective on August 3, 2021 (the &#8220;effective date&#8221;). On August 6, 2021, the Company consummated its initial public offering (the &#8220;initial public offering&#8221;) of 15,000,000 units (the &#8220;units&#8221;). Each unit consists of one Class A common stock of the Company, par value $0.0001 per share (the &#8220;Class A common stock&#8221;), and one-half of one redeemable warrant of the Company (the &#8220;warrant&#8221;), each whole warrant entitling the holder thereof to purchase one Class A common stock for $11.50 per share. The units were sold at a price of $10.00 per unit, generating gross proceeds to the Company of $150,000,000 which is discussed in Note 3.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Simultaneously with the closing of the initial public offering, the Company completed the private sale of an aggregate of 3,500,000 warrants (the &#8220;private placement warrants&#8221;) to the Sponsor at a purchase price of $1.00 per private placement warrant, generating gross proceeds to the Company of $3,500,000. The private placement warrants are identical to the warrants sold in the initial public offering, except that the private placement warrants, so long as they are held by the Sponsor or its permitted transferees, (i) are not redeemable by the Company, (ii) may not (including the Class A common stock issuable upon exercise of such private placement warrants), subject to certain limited exceptions, be transferred, assigned or sold by such holders until 30 days after the completion of the Company&#8217;s initial business combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights. No underwriting discounts or commissions were paid with respect to such sales.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the initial public offering includes two instruments, Class A common stock and warrants, and as the warrants are classified as a financial liability, it is necessary to allocate the gross proceeds between Class A common stock and warrants. The Company adopted the residual method to allocate the gross proceeds between Class A common stock and warrants based on their relative fair values. The gross proceeds were first allocated to the fair value of the warrants and the residual amount was allocated to the Class A common stock. The percentage derived from this allocation was used to allocate the deferred offering costs between Class A common stock and warrants. Issuance costs allocated to the warrants were expensed to the Company&#8217;s unaudited condensed statements of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction costs of the initial public offering amounted to $13,782,542 and consisted of $1,500,000 of underwriting discount, $5,250,000 of deferred underwriting discount, $6,509,758 in fair value of Class B common stock issued to Anchor Investors, and $522,784 of other offering costs.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A total of $150,000,000 was placed in a U.S.-based trust account maintained by Continental Stock Transfer &amp; Trust Company, acting as trustee (the &#8220;trust account&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company must complete one or more initial business combination having an aggregate fair market value of at least 80% of the value of the assets held in the trust account (excluding the amount of deferred underwriting discounts held in trust and taxes payable on the income earned on the trust account) at the time of the signing a definitive agreement in connection with the initial business combination. However, the Company will only complete a business combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">register as an investment company under the Investment Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;). There is no assurance that the Company will be able to complete a business combination successfully.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the closing of the initial public offering, management has agreed that an amount equal to at least $10.00 per unit sold in the initial public offering, including the proceeds of the private placement warrants, will be held in a trust account, located in the United States with Continental Stock Transfer &amp; Trust Company acting as trustee, and will invest only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect to interest earned on the funds held in the trust account that may be released to the Company to pay taxes, if any, the proceeds from the initial public offering and the sale of the private placement warrants will not be released from the trust account until the earliest of (i) the completion of initial business combination, (ii) the redemption of the Company&#8217;s public shares if the Company is unable to complete an initial business combination by August 6, 2023, subject to applicable law, or (iii) the redemption of the Company&#8217;s public shares properly submitted in connection with a stockholder vote to amend its amended and restated certificate of incorporation to modify the substance or timing of the Company&#8217;s obligation to redeem 100% of its public shares if the Company has not consummated an initial business combination by August 6, 2023 or with respect to any other material provisions relating to stockholders&#8217; rights or pre-initial business combination activity. The proceeds deposited in the trust account could become subject to the claims of the Company&#8217;s creditors, if any, which could have priority over the claims of the Company&#8217;s public stockholders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will provide its public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial business combination either (i) in connection with a stockholder meeting called to approve the business combination or (ii) without a stockholder vote by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed business combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem all or a portion of their public shares upon the completion of the initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account calculated as of two business days prior to the consummation of the initial business combination, including interest earned on the funds held in the trust account (which interest shall be net of taxes payable), divided by the number of then outstanding public shares, subject to the limitations and on the conditions described herein. The amount in the trust account is initially anticipated to be $10.00 per public share. The per share amount the Company will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the representative of the underwriters.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares of common stock subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the initial public offering, in accordance with Financial Accounting Standards Board&#8217;s (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480, &#8220;Distinguishing Liabilities from Equity.&#8221; In such case, the Company will proceed with a business combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a business combination and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the business combination.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will have only 24 months from the closing of the initial public offering to complete the initial business combination (the &#8220;Combination Period&#8221;). However, if the Company is unable to complete the initial business combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfOTM5MA_6b8b7a9b-cdb9-4964-a6c2-9088a7366feb">ten</span> business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company&#8217;s remaining stockholders and the Company&#8217;s board of </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">directors, liquidate and dissolve, subject, in each case, to the Company&#8217;s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sponsor, officers and directors have agreed to (i) waive their redemption rights with respect to any founder shares and public shares they hold in connection with the completion of the initial business combination, (ii) waive their redemption rights with respect to any founder shares and public shares they hold in connection with a stockholder vote to approve an amendment to the Company&#8217;s amended and restated certificate of incorporation, (iii) waive their rights to liquidating distributions from the trust account with respect to any founder shares they hold if the Company fails to complete the initial business combination within the Combination Period, and (iv) vote their founder shares and any public shares purchased during or after the initial public offering in favor of the initial business combination.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party (other than the Company&#8217;s independent registered public accounting firm) or prospective target business who executed a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is enforceable), nor will it apply to any claims under the Company&#8217;s indemnity of the underwriters of the initial public offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor&#8217;s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would be able to satisfy those obligations. None of the Company&#8217;s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Emerging Growth Company Status</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities and Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s unaudited condensed financial statements with those of another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is continuing to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company&#8217;s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these unaudited condensed financial statements. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 16, 2022, President Biden signed into law the Inflation Reduction Act of 2022 (the &#8220;IR Act&#8221;), which, among other things, imposes a new 1% U.S. federal excise tax on certain repurchases of stock by &#8220;covered corporations&#8221; (which include publicly traded domestic (i.e., U.S.) corporations) beginning in 2023, with certain exceptions (the &#8220;Excise Tax&#8221;). The Excise Tax is imposed on the repurchasing corporation itself, not its stockholders from which the stock is repurchased. Because we are a Delaware corporation and our securities are trading on Nasdaq, we are a &#8220;covered corporation&#8221; for this purpose. The amount of the Excise Tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the Excise Tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the Excise Tax. The U.S. Department of the Treasury has authority to provide regulations and other guidance to carry out, and prevent the abuse or avoidance of the Excise Tax; however, no guidance has been issued to date. It is uncertain whether, and/or to what extent, the Excise Tax could apply to any repurchase by us of our common stock or in the event of our liquidation, in each instance after December 31, 2022, including any redemptions in connection with an initial business combination or in the event we do not consummate an initial business combination by August 6, 2023.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposed Business Combination</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2022, the Company entered into an agreement and plan of merger (the &#8220;Merger Agreement&#8221;) with AMCI Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (&#8220;Merger Sub&#8221;), and LanzaTech NZ, Inc., a Delaware corporation (&#8220;LanzaTech&#8221;). The transactions contemplated by the Merger Agreement are referred to herein as the &#8220;Proposed Business Combination.&#8221; The time of the closing of the Proposed Business Combination is referred to herein as the &#8220;Closing.&#8221;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Proposed Business Combination is approved by the Company&#8217;s stockholders and LanzaTech&#8217;s stockholders, and the closing conditions in the Merger Agreement are satisfied or waived, then, among other things, upon the terms and subject to the conditions of the Merger Agreement and in accordance with Delaware General Corporation Law, Merger Sub will merge with and into LanzaTech, with LanzaTech surviving the Merger as the Company&#8217;s wholly owned subsidiary (the &#8220;Merger&#8221;). In connection with the consummation of the Merger, the Company will be renamed &#8220;LanzaTech Global, Inc.&#8221; and is referred to herein as &#8220;New LanzaTech&#8221; as of the time following such change of name.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Merger Agreement, the Company has agreed to acquire all of the outstanding equity interests of LanzaTech for consideration consisting of equity interests of New LanzaTech valued at $1,817,000,000 in the aggregate. The consideration to be paid to holders of shares of LanzaTech capital stock will be shares of common stock of New LanzaTech (&#8220;New LanzaTech Common Stock&#8221;), valued at $10.00 per share, to be paid at the closing of the Merger. The number of shares of New LanzaTech Common Stock payable in the Merger in respect of each share of LanzaTech capital stock (each, a &#8220;LanzaTech Share&#8221;) will be determined based on the exchange ratio (the &#8220;Exchange Ratio&#8221;), and certain corresponding adjustments, in each case as set forth in the Merger Agreement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, at Closing: (i) each warrant to purchase LanzaTech Shares (each, a &#8220;LanzaTech Warrant&#8221;) that is outstanding and unexercised immediately prior to Closing and would automatically be exercised or exchanged in full in accordance with its terms by virtue of the occurrence of the Merger, will be so automatically exercised or exchanged in full for the applicable LanzaTech Shares, and each such LanzaTech Share will be treated as being issued and outstanding immediately prior to Closing and will be canceled and converted into the right to receive the applicable shares of New LanzaTech Common Stock; and (ii) each LanzaTech Warrant that is outstanding and unexercised immediately prior to the Closing and is not automatically exercised in full as </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">described in clause (i) will be converted into a warrant to purchase shares of New LanzaTech Common Stock, in which case (a) the number of shares underlying such New LanzaTech warrant (each, a &#8220;New LanzaTech Warrant&#8221;) will be determined by multiplying the number of LanzaTech Shares subject to such warrant immediately prior to Closing, by the Exchange Ratio and (b) the per share exercise price of such New LanzaTech Warrant will be determined by dividing the per share exercise price of such LanzaTech Warrant immediately prior to the Effective Time by the Exchange Ratio, except that in the case of certain warrants specified in the Merger Agreement, such exercise price will be $10.00.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, at Closing, each option to purchase LanzaTech Shares (each, a &#8220;LanzaTech Option&#8221;) will be converted into an option to purchase a number of shares of New LanzaTech Common Stock (rounded down to the nearest whole share) equal to the product of (i) the number of LanzaTech Shares subject to such LanzaTech Option multiplied by (ii) the Exchange Ratio. The exercise price of such New LanzaTech option will be equal to the quotient of (a) the exercise price per share of such LanzaTech Option in effect immediately prior to the Effective Time divided by (b) the Exchange Ratio (and as so determined, this exercise price will be rounded up to the nearest full cent).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, at Closing, each award of restricted shares of LanzaTech common stock (each, a &#8220;LanzaTech RSA&#8221;) that is outstanding immediately prior to the Effective Time will be converted into an award of restricted shares of New LanzaTech Common Stock (each, a &#8220;New LanzaTech RSA&#8221;) on the same terms and conditions as were applicable to such LanzaTech RSA immediately prior to the Effective Time, except that such New LanzaTech RSA will relate to a number of shares of New LanzaTech Common Stock equal to the number of LanzaTech Shares subject to such LanzaTech RSA, multiplied by the Exchange Ratio.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The closing of the Merger is subject to certain customary conditions, including, among others, (i) adoption by AMCI&#8217;s stockholders and LanzaTech&#8217;s stockholders of the Merger Agreement and their approval of certain other actions related to the Proposed Business Combination, (ii) the expiration or termination of the waiting period (or any extension thereof) applicable to the transactions contemplated by the Merger Agreement and any ancillary agreements, in each case under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, (iii) the effectiveness of a registration statement on Form S-4 (the &#8220;Registration Statement&#8221;) under the Securities Act with respect to the shares of New LanzaTech Common Stock to be paid as consideration in the Merger, (iv) there being no government order or law enjoining, prohibiting or making illegal the consummation of the Merger or the transactions contemplated by the Merger Agreement, (v) AMCI having at least $5,000,001 of net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) under the Exchange Act) after giving effect to any payments required to be made in connection with the redemption of AMCI&#8217;s public shares and the proceeds from the Subscription Agreements described below, (vi) AMCI having at least $230,000,000 of cash at the closing of the Merger, consisting of cash held in AMCI&#8217;s trust account after taking into account any redemption of AMCI&#8217;s public shares, and the proceeds from the Subscription Agreements described below, net of transaction expenses of AMCI and LanzaTech, and (vii) the listing on Nasdaq of the shares of New LanzaTech Common Stock issued in connection with the Proposed Business Combination.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Going Concern</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, the Company had approximately $7,000 in its operating bank account and a working capital deficit of approximately $3.5 million , not taking into account tax obligations of approximately $536,000 that may be paid from income from investments held in the trust account.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s liquidity needs up to September 30, 2022 have been satisfied through a contribution of $25,000 from the Sponsor to cover for certain offering costs in exchange for the issuance of Founder Shares, and a loan and advances from the Sponsor pursuant to the Note (as defined in Note 4). Subsequent to the initial public offering, net proceeds from the private placement of $0.9 million were placed in the operating account for working capital purposes. In addition, in order to finance transaction costs in connection with a business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#8217;s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 4). On March 28, 2022, the Company entered into a noninterest-bearing Working Capital Loan with its Sponsor for the principal amount of up to $1.5 million. As of September 30, 2022 and December 31, 2021, there were no amounts outstanding under any Working Capital Loan.</span></div>In connection with the Company&#8217;s assessment of going concern considerations in accordance with FASB Accounting Standards Update (&#8220;ASU&#8221;) 2014-15, &#8220;Disclosures of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern,&#8221; management has determined that the liquidity condition, and the mandatory liquidation and subsequent dissolution that will be required if the Company does not complete a business combination before August 6, 2023 raises substantial doubt about the Company&#8217;s ability to continue as a going concern. Although Management expects that it will be able to raise additional capital to support its planned activities and complete a business combination on or prior to August 6, 2023, it is uncertain whether it will be able to do so. No adjustments have been made to the carrying amounts of assets or liabilities should we be required to liquidate after August 6, 2023. The condensed financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern. The Company intends to complete a business combination before the mandatory liquidation date. Over this time period, the Company will be using the funds outside of the trust account for paying existing accounts payable, identifying and evaluating prospective initial business combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the business combination.<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1 &#8212; Description of Organization and Business Operations</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AMCI Acquisition Corp. II (the &#8220;Company&#8221;) is a blank check company incorporated as a Delaware corporation on January 28, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the &#8220;business combination&#8221;). </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the Company has neither engaged in any operations nor generated any revenues. All activity for the period from January 28, 2021 (inception) through December 31, 2021 relates to the Company&#8217;s formation and the initial public offering (&#8220;initial public offering&#8221;), described below. The Company will not generate any operating revenues until after the completion of its initial business combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the initial public offering and from changes in the fair value of its derivative warrant liabilities, if applicable. The Company has selected December 31 as its fiscal year end.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s sponsor is AMCI Sponsor II LLC, a Delaware limited liability company (the &#8220;Sponsor&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registration statement for the Company&#8217;s initial public offering was declared effective on August 3, 2021 (the &#8220;effective date&#8221;). On August 6, 2021, the Company consummated its initial public offering of 15,000,000 units (the &#8220;units&#8221;). Each unit consists of one Class A common stock of the Company, par value $0.0001 per share (the &#8220;Class A common stock&#8221;), and one-half of one redeemable warrant of the Company (the &#8220;warrant&#8221;), each whole warrant entitling the holder thereof to purchase one Class A common stock for $11.50 per share. The units were sold at a price of $10.00 per unit, generating gross proceeds to the Company of $150,000,000, which is discussed in Note 3.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Simultaneously with the closing of the initial public offering, the Company completed the private sale of an aggregate of 3,500,000 warrants (the &#8220;private placement warrants&#8221;) to the Sponsor at a purchase price of $1.00 per private placement warrant, generating gross proceeds to the Company of $3,500,000. The private placement warrants are identical to the warrants sold in the initial public offering, except that the private placement warrants, so long as they are held by the Sponsor or its permitted transferees, (i) are not redeemable by the Company, (ii) may not (including the Class A common stock issuable upon exercise of such private placement warrants), subject to certain limited exceptions, be transferred, assigned or sold by such holders until 30 days after the completion of the Company&#8217;s initial business combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights. No underwriting discounts or commissions were paid with respect to such sales.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the initial public offering includes two instruments, Class A common stock and warrants, and as the warrants are classified as a financial liability, it is necessary to allocate the gross proceeds between Class A common stock and warrants. The Company adopted the residual method to allocate the gross proceeds between Class A common stock and warrants based on their relative fair values. The gross proceeds were first allocated to the fair value of the warrants and the residual amount was allocated to the Class A common stock. The percentage derived from this allocation was used to allocate the deferred offering costs between Class A common stock and warrants. Issuance costs allocated to the warrants were expensed to the Company&#8217;s statement of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction costs of the initial public offering amounted to $13,782,542 and consisted of $1,500,000 of underwriting discount, $5,250,000 of deferred underwriting discount, $6,509,758 in fair value of Class B common stock issued to Anchor Investors, and $522,784 of other offering costs.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A total of $150,000,000 was placed in a U.S.-based trust account maintained by Continental Stock Transfer &amp; Trust Company, acting as trustee.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company must complete one or more initial business combination having an aggregate fair market value of at least 80% of the value of the assets held in the trust account (excluding the amount of deferred underwriting discounts held in trust and taxes payable on the income earned on the trust account) at the time of the signing a definitive agreement in connection with the initial business combination. However, the Company will only complete a business combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">register as an investment company under the Investment Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;). There is no assurance that the Company will be able to complete a business combination successfully.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the closing of the initial public offering, management has agreed that an amount equal to at least $10.00 per unit sold in the initial public offering, including the proceeds of the private placement warrants, will be held in a trust account (the &#8220;trust account&#8221;), located in the United States with Continental Stock Transfer &amp; Trust Company acting as trustee, and will invest only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect to interest earned on the funds held in the trust account that may be released to the Company to pay taxes, if any, the proceeds from the initial public offering and the sale of the private placement warrants will not be released from the trust account until the earliest of (i) the completion of initial business combination, (ii) the redemption of the Company&#8217;s public shares if the Company is unable to complete an initial business combination by August 6, 2023, subject to applicable law, or (iii) the redemption of the Company&#8217;s public shares properly submitted in connection with a stockholder vote to amend its amended and restated certificate of incorporation to modify the substance or timing of the Company&#8217;s obligation to redeem 100% of its public shares if the Company has not consummated an initial business combination by August 6, 2023 or with respect to any other material provisions relating to stockholders&#8217; rights or pre-initial business combination activity. The proceeds deposited in the trust account could become subject to the claims of the Company&#8217;s creditors, if any, which could have priority over the claims of the Company&#8217;s public stockholders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will provide its public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial business combination either (i) in connection with a stockholder meeting called to approve the business combination or (ii) without a stockholder vote by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed business combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem all or a portion of their public shares upon the completion of the initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account calculated as of two business days prior to the consummation of the initial business combination, including interest earned on the funds held in the trust account (which interest shall be net of taxes payable), divided by the number of then outstanding public shares, subject to the limitations and on the conditions described herein. The amount in the trust account is initially anticipated to be $10.00 per public share. The per share amount the Company will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the representative of the underwriters.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares of common stock subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the initial public offering, in accordance with Financial Accounting Standards Board&#8217;s (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480, &#8220;Distinguishing Liabilities from Equity.&#8221; In such case, the Company will proceed with a business combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a business combination and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the business combination.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will have only 24 months from the closing of the initial public offering to complete the initial business combination (the &#8220;Combination Period&#8221;). However, if the Company is unable to complete the initial business combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfOTMzMA_80eea167-68dd-4f47-a97c-0adf8eb467f8">ten</span> business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company&#8217;s remaining stockholders and the Company&#8217;s board of </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">directors, liquidate and dissolve, subject, in each case, to the Company&#8217;s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sponsor, officers and directors have agreed to (i) waive their redemption rights with respect to any founder shares and public shares they hold in connection with the completion of the initial business combination, (ii) waive their redemption rights with respect to any founder shares and public shares they hold in connection with a stockholder vote to approve an amendment to the Company&#8217;s amended and restated certificate of incorporation, (iii) waive their rights to liquidating distributions from the trust account with respect to any founder shares they hold if the Company fails to complete the initial business combination within the Combination Period, and (iv) vote their founder shares and any public shares purchased during or after the initial public offering in favor of the initial business combination.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party (other than the Company&#8217;s independent registered public accounting firm) or prospective target business who executed a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is enforceable), nor will it apply to any claims under the Company&#8217;s indemnity of the underwriters of the initial public offering against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor&#8217;s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would be able to satisfy those obligations. None of the Company&#8217;s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Emerging Growth Company Status</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is continuing to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company&#8217;s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposed Business Combination</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As more fully described in Note 11, on March 8, 2022, the Company entered into an agreement and plan of merger (the &#8220;Merger Agreement&#8221;) with AMCI Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (&#8220;Merger Sub&#8221;), and LanzaTech NZ, Inc., a Delaware corporation (&#8220;LanzaTech&#8221;). Upon consummation of the transactions, the Company will change its name to &#8220;LanzaTech Global, Inc.&#8221;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Going Concern</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the Company had approximately $0.3 million in its operating bank account and a working capital deficit of approximately $0.1 million.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s liquidity needs up to December 31, 2021 have been satisfied through a contribution of $25,000 from the Sponsor to cover for certain offering costs in exchange for the issuance of founder shares, and a loan and advances from the Sponsor pursuant to the Note (as defined in Note 4). Subsequent to the initial public offering, net proceeds from the private placement of $0.9 million were placed in the operating account for working capital purposes. In addition, in order to finance transaction costs in connection with a business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#8217;s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 4). As of December 31, 2021, there were no amounts outstanding under any Working Capital Loan.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company&#8217;s assessment of going concern considerations in accordance with Financial Accounting Standard Board&#8217;s Accounting Standards Update (&#8220;ASU&#8221;) 2014-15, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosures of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; management has determined that the Company would not be able to meet its obligations as they become due within one year after the date that the financial statements are available to be issued. As such, management has determined that the liquidity condition raises substantial doubt about the Company&#8217;s ability to continue as a going concern. As of December 31, 2021, no adjustments have been made to the carrying amounts of assets or liabilities.</span></div>Description of the Business<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reporting entity is LanzaTech NZ, Inc. (formerly known as LanzaTech New Zealand Limited) and its subsidiaries (collectively, &#8220;the Company&#8221; or "LanzaTech"). LanzaTech NZ, Inc. is a profit-oriented entity previously incorporated in New Zealand. Effective October 28, 2021, LanzaTech New Zealand Limited filed a Certificate of Incorporation to migrate its country of domicile from New Zealand to Delaware, in the United States, and change its corporate name to &#8220;LanzaTech NZ, Inc.&#8221; The amendment was approved by the Board of Directors of LanzaTech and was effected by the filing of a Certificate of Incorporation with the Delaware Secretary of State. The registered office location is c/o The Corporation Trust Company, Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware, 19801. The Company licenses its technology to customers, performs research and development in biotechnology, and provides engineering and other related services for commercial and government customers. Using the Company&#8217;s proprietary fermentation technology, the Company&#8217;s customers can convert certain carbon-rich waste gases into fuels and chemicals. The Company employs a licensing business model whereby its customers build, own and operate facilities that use the Company's technology, and in return, the Company is paid royalties based on the revenue generated from the use of its technology. In 2018, the Company, through its partners, launched the world&#8217;s first commercial waste gas to ethanol plant in China, followed by a second one in 2021, also in China, with others currently in development in various countries.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposed Merger</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2022, the Company entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with AMCI Acquisition Corp. II, a Delaware corporation (&#8220;AMCI&#8221;) and AMCI Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of AMCI (&#8220;Merger Sub&#8221;). Under the Merger Agreement, Merger Sub will merge with and into LanzaTech, with LanzaTech surviving the Merger as a wholly-owned subsidiary of AMCI (&#8220;the Business Combination&#8221;). In connection with the Business Combination, AMCI will be renamed LanzaTech Global, Inc. (&#8220;New LanzaTech&#8221;). AMCI has agreed to acquire all of the outstanding equity interests of LanzaTech for consideration consisting of an equity interest of New LanzaTech valued at approximately $1.8&#160;billion. Completion of the transaction is subject to certain customary regulatory consents and approval by stockholders of AMCI and the Company. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Merger Agreement was amended on December 7, 2022, to provide for, among other things, (i) the inclusion of the aggregate net proceeds from each of the AM SAFE Note and Brookfield SAFE in the Acquiror Closing Cash Amount, (ii) the reduction of the Minimum Closing Cash Condition from $250,000,000 to $230,000,000, (iii) the clarification that, to the extent that the Brookfield SAFE remains unexercised at Closing, it will be assumed by AMCI, remain in effect on the same terms and conditions as are in effect prior to the Closing and thereafter entitle the holder thereof to be issued shares of common stock in AMCI after the Closing, (iv) the clarification that, in the event that it becomes reasonably apparent to the parties that the Acquiror Closing Cash Amount will be less than the Minimum Closing Cash Condition, AMCI will use commercially reasonable efforts to enter into non-redemption agreements, or similar agreements, as may be necessary to satisfy the Minimum Closing Cash Condition, (v) the extension of the outside date applicable to the Closing from December 7, 2022 to February 28, 2023 and (vi) the elimination of LanzaTech's right to terminate the agreement in the event that we fail to, on or prior to July 7, 2022, enter into one or more additional subscription agreements or non-redemption agreements as a result of which the sum of the PIPE Investment Amount (including net proceeds under the AM SAFE Note to LanzaTech) and the aggregate number of shares of Class A common stock subject to non-redemption agreements multiplied by $10.00, minus certain transaction expenses and other liabilities at Closing, would be equal to at least the Minimum Closing Cash Condition.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger Agreement, AMCI entered into subscription agreements with certain investors pursuant to which AMCI agreed to issue and sell a private placement to close immediately prior to the Business Combination.</span></div>Description of the BusinessThe reporting entity is LanzaTech NZ, Inc. (formerly known as LanzaTech New Zealand Limited) and its subsidiaries (collectively, &#8220;the Company&#8221;). LanzaTech NZ, Inc. is a profit-oriented entity previously incorporated in New Zealand. Effective October 28, 2021, LanzaTech New Zealand Limited filed a Certificate of Incorporation to migrate its country of domicile from New Zealand to Delaware, in the United States, and change its corporate name to &#8220;LanzaTech NZ, Inc.&#8221; The amendment was approved by the Board of Directors of LanzaTech and was effected by the filing of a Certificate of Incorporation with the Delaware Secretary of State. All necessary adjustments have been recorded to present fairly the Company's financial position as of December&#160;31, 2021 and 2020 and the results of operations and cash flows for the years then ended. The registered office location is c/o The Corporation Trust Company, Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware, 19801. The Company licenses its technology to customers, performs research and development in biotechnology, and provides engineering and other related services for commercial and government customers. Using the Company&#8217;s proprietary fermentation technology, the Company&#8217;s customers can convert certain carbon-rich waste gases into fuels and chemicals. The Company employs a licensing business model whereby its customers build, own and operate facilities that use the Company's technology, and in return, the Company is paid royalties based on the revenue generated from the use of its technology. In 2018, the Company, through its equity method investee, launched the world&#8217;s first commercial waste gas to ethanol plant in China, followed by a second one in 2021, also in China, with others currently in development in various countries around the world.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272210941344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Summary of Significant Accounting Policies</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2 &#8212; Basis of Presentation and Summary of Significant Accounting Policies</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) for interim financial information and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022 or any future period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K filed by the Company with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on March 25, 2022.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of September 30, 2022 and December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of September 30, 2022 and December 31, 2021.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments Held in the Trust Account</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company&#8217;s investments held in the trust account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company&#8217;s investments held in the trust account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the trust account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the trust account are determined using available market information.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities which qualify as financial instruments under the FASB ASC 820, &#8220;Fair Value Measurement,&#8221; equal or approximate the carrying amounts represented in the condensed balance sheets.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Offering Costs Associated With Initial Public Offering</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the initial public offering that were directly related to the initial public offering. Offering costs were allocated to the separable financial instruments issued in the initial public offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and presented as non-operating expenses in the unaudited condensed statements of operations. Offering costs associated with the Class A common stock issued were charged against the carrying value of the shares of Class A common stock upon the completion of the initial public offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Class A Common Stock Shares Subject to Possible Redemption </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, &#8220;Distinguishing Liabilities from Equity.&#8221; Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders&#8217; equity. The Company&#8217;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of uncertain future events. Accordingly, as of the initial public offering, 15,000,000 shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders&#8217; equity (deficit) section of the Company&#8217;s condensed balance sheets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 480-10-S99, the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of the reporting period. This method would view the end of the reporting period as if it were also the redemption date of the security. Effective with the closing of the initial public offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The public warrants and the private placement warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The initial fair value of the public warrants issued in connection with the initial public offering was estimated using a Monte-Carlo simulation model. The fair value of the public warrants as of September 30, 2022 and as of December 31, 2021 is based on observable listed prices for such warrants. The fair value of the private placement warrants as of September 30, 2022 and as of December 31, 2021 is determined using a Black-Scholes option pricing model. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provides guidance on derecognition, classification, interest and penalties, accounting in period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company&#8217;s effective tax rate was 0.88% and 0.91% for the three and nine months ended September 30, 2022, respectively, and 0.00% for the three months ended September 30, 2021 and the period from January 28, 2021 (inception) through September 30, 2021. The effective tax rate differs from the statutory tax rate of 21% for the three and nine months ended September 30, 2022, the three months ended September 30, 2021 and the period from January 28, 2021 (inception) through September 30, 2021 due primarily to changes in fair value of derivative warrant liabilities, non-taxable gains on the settlement of deferred underwriting commissions, and the valuation allowance on the deferred tax assets.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Per Share Of Common Stock</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share.&#8221; The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the units sold in the initial public offering and the private placement warrants to purchase an aggregate of 11,000,000 shares of Class A common stock in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the three and nine months ended September 30, 2022 and for the three months ended September 30, 2021 and for the period from January 28, 2021 (inception) through September 30, 2021. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended <br/>September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248,909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332,524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,130,435</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.887%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Nine Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Period from January 28, 2021 <br/>(inception) through <br/>September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,428,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FASB issued ASU 2022-03, ASC Subtopic 820 &#8220;Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions&#8221;. The ASU amends ASC 820 to clarify that a contractual sales restriction is not considered in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. The ASU applies to both holders and issuers of equity and equity-linked securities measured at fair value. The amendments in this ASU are effective for the Company in fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is still evaluating the impact of this pronouncement on the condensed financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company&#8217;s unaudited condensed financial statements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2 &#8212; Basis of Presentation and Summary of Significant Accounting Policies</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;).</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2021.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments Held in the Trust Account</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company&#8217;s investments held in the trust account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company&#8217;s investments held in the trust account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the trust account in the accompanying statement of operations. The estimated fair values of investments held in the trust account are determined using available market information.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities which qualify as financial instruments under the FASB ASC 820, &#8220;Fair Value Measurement,&#8221; equal or approximate the carrying amounts represented in the balance sheet.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Offering Costs Associated with Initial Public Offering</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the initial public offering that were directly related to the initial public offering. Offering costs were allocated to the separable financial instruments issued in the initial public offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">presented as non-operating expenses in the statement of operations. Offering costs associated with the Class A common stock issued were charged against the carrying value of the shares of Class A common stock upon the completion of the initial public offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Class A Common Stock Subject to Possible Redemption </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, &#8220;Distinguishing Liabilities from Equity.&#8221; Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders&#8217; equity. The Company&#8217;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of uncertain future events. Accordingly, as of the initial public offering, 15,000,000 shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders&#8217; equity (deficit) section of the Company&#8217;s balance sheet.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 480-10-S99, the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of the reporting period. This method would view the end of the reporting period as if it were also the redemption date of the security. Effective with the closing of the initial public offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The public warrants and the private placement warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The initial fair value of the public warrants issued in connection with the initial public offering was estimated using a Monte-Carlo simulation model. The fair value of the public warrants as of December 31, 2021 is based on observable listed prices for such warrants. The fair value of the private placement warrants as of December 31, 2021 is determined using a Black-Scholes option pricing model. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Per Share of Common Stock</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share.&#8221; The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the units sold in the initial public offering and the private placement warrants to purchase an aggregate of 11,000,000 shares of Class A common stock in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the period from January 28, 2021 (inception) through December 31, 2021. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.451%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.805%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the period from January 28, 2021<br/>(inception) through December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income (loss) per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,690,909</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income (loss) per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2020-06, &#8220;Debt &#8212; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8212; Contracts in an Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity&#8221; (&#8220;ASU 2020-06&#8221;), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. ASU 2020-06 also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 on August 2, 2021 using the modified retrospective method for transition. Adoption of ASU 2020-06 did not impact the Company&#8217;s financial position, results of operations or cash flows.</span></div>The Company&#8217;s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company&#8217;s financial statements.Summary of Significant Accounting Policies <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements of LanzaTech NZ Inc. have been prepared in accordance with generally accepted accounting principles for interim financial information, and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America ("US GAAP"), the accounting principles, standards, and procedures adopted by the U.S. Securities and Exchange Commission, for complete financial statements. However, in the opinion of management, all adjustments (consisting of normal recurring accruals) have been made that are necessary for a fair presentation of the condensed consolidated financial statements for the interim periods. For further information refer to the Consolidated Financial Statements and Footnotes thereto included in the Company's Annual Report for the year ended December 31, 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a qualitative approach in assessing the consolidation requirement for variable interest entities ("VIEs"). This approach focuses on determining whether the Company has the power to direct the activities of the VIE that most significantly affect the VIE&#8217;s economic performance and whether the Company has the obligation to absorb losses, or the right to receive benefits, that could potentially be significant to the VIE.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds interests in certain VIEs for which it has been determined the Company is not the primary beneficiary. The Company's variable interests primarily relate to entities in which the Company has a non-controlling equity interest. Although these financial arrangements resulted in holding variable interests in these entities, they did not empower the Company to direct the activities of the VIEs that most significantly impact the VIEs' economic performance. The Company's interests in the VIEs are, therefore, accounted for under the equity method of accounting or alternative measurement. Refer to Note 5,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further information. The Company is exposed to the VIEs' losses and other impairment indicators up to the carrying value of each investment and any amounts receivable from the VIE, less amounts payable. Refer to Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further details on the transactions with VIEs.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Going Concern</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements of the Company have been prepared assuming the Company will continue as a going concern and in accordance with accounting principles generally accepted in the United States of America ("US GAAP"). The going concern basis of presentation assumes that the Company will continue in operation one year after the date these financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. The Company had cash and cash equivalents of $50,370 and an accumulated deficit of $(434,863) at September&#160;30, 2022 and cash outflows from operations of $(71,336) and a net loss of $(54,974) for the nine months ended September&#160;30, 2022. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has historically funded its operations through debt financing and issuance of equity securities. Based on the Company&#8217;s financial position as of the date these condensed consolidated financial statements were available to be issued, the Company projects that it will be able to cover its liquidity needs for the next twelve months with cash on hand. Accordingly, the Company&#8217;s condensed consolidated financial statements have been prepared on the basis that it will continue as a going concern.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates include fair value of equity awards granted to both employees and non-employees, the SAFE and the SAFE warrants.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in facts and circumstances or additional information may result in revised estimates, and actual results may differ from these estimates.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates as one operating segment which is the licensing of its technologies and related services such as research and development and engineering. The Chief Executive Officer who is the chief operating decision maker, reviews financial information on an aggregate basis for allocating resources and evaluating financial performance. Substantially all of the Company's long-lived assets are maintained in the United States. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currencies</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reporting currency is the U.S. Dollar. The Company has certain foreign subsidiaries where the functional currency is the local currency. All of the assets and liabilities of these subsidiaries are converted to U.S. dollars at the exchange rate in effect at the balance sheet date, income and expense accounts are translated at average rates for the period, and shareholder&#8217;s equity accounts are translated at historical rates. The effects of translating financial statements of foreign operations into our reporting currency are recognized as an adjustment in accumulated other comprehensive income (loss).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has foreign subsidiaries that have a functional currency of the U.S. dollar. Purchases and sales of assets and income and expense items denominated in foreign currencies are remeasured into U.S. dollar amounts on the respective dates of such transactions. Net realized foreign currency gains or losses relating to the differences between these recorded amounts and the U.S. dollar equivalent actually received or paid are included within Other (expense) income, net in the condensed consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. As of September&#160;30, 2022 and December&#160;31, 2021, the Company had $50,370 and $128,318 of cash and cash equivalents, respectively.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash and Other Cash Flows from Operating Activities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to maintain a cash deposit with a bank which consists of collateral on certain travel and expense programs maintained by the bank. The following represents a reconciliation of cash and cash equivalents in the condensed consolidated balance sheets to total cash, cash equivalents and restricted cash in the condensed consolidated statements of cash flows as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands).</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (presented within Other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,034&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,732&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade and Other Receivables </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables are reported net of allowances for doubtful accounts. The Company maintains allowances for doubtful accounts for estimated losses resulting from the inability of customers to make required payments. The Company estimates the allowance for doubtful accounts based on a variety of factors including the length of time receivables are past due, the financial health of customers, unusual macroeconomic conditions, and historical experience. As of September&#160;30, 2022 and December&#160;31, 2021, the Company recognized an allowance for doubtful accounts of $1,051 and $1,235, respectively.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with Accounting Standards Codification ("ASC") 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company primarily earns revenue from services related to feasibility studies and basic engineering design of commercial plants, licensing of technologies, joint development and contract </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">research activities to develop novel biocatalysts and related technologies, and sale of CarbonSmart ethanol produced using the Company's proprietary technologies.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is measured based on the consideration specified in a contract with a customer. The Company records taxes collected from customers and remitted to governmental authorities on a net basis. The Company&#8217;s payment terms are between 30-60 days and can vary by customer type and products offered. Management has evaluated the terms of our arrangements and determined that they do not contain significant financing components.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Carbon Capture and Transformation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides feasibility studies and basic design and engineering services used for detailed design, procurement, and construction of commercial plants that utilize the Company&#8217;s technologies, along with the sale of equipment and microbes. The services provided are recognized as a performance obligation satisfied over time. Revenue is recognized using the output method based on milestone completion, the cost-to-cost input method for certain engineering services, or the percentage of completion method as performance obligations are satisfied. Management has determined that the milestone completion and the associated contractual payment amounts are an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company licenses intellectual property to generate recurring revenue when its customers deploy carbon capture and transformation plants. When licenses are considered to be distinct performance obligations, the recognition of revenue is dependent on the terms of the contract, which may include fixed consideration or royalties based on sales or usage, in which case, the revenue is recognized when the subsequent sale or usage occurs or when the performance obligation to which some or all of the sales or usage-based royalty is allocated has been satisfied, whichever is later.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Services</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs research and development (&#8220;R&amp;D&#8221;) services related to novel technologies and development of biocatalysts for commercial applications, mainly to produce fuels and chemicals. The Company engages in two main types of R&amp;D services &#8211; joint development agreements, and other contract research, including projects with the U.S. Department of Energy. Such services are recognized as a performance obligation satisfied over time. Revenue is recognized based on milestone completion, when payments are contingent upon the achievement of such milestones, or based on percentage-completion method when enforceable rights to payment exist. When no milestones or phases are clearly defined, management has determined that the cost incurred, input method, is an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and estimates its variable consideration under the expected value method. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is not recognized in advance of customer acceptance of a milestone when such acceptance is contractually required. Payments for R&amp;D services with no contractual payments are not due from customers until a technical report is submitted; therefore, a contract asset is recognized at milestone completion but prior to the submission of a technical report. The contract asset represents the Company&#8217;s right to consideration for the services performed at milestone completion. Occasionally, customers provide payments in advance of the Company providing services which creates a contract liability for the Company. The contract liability represents the Company's obligation to provide services to a customer. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collaboration Arrangements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain partnership agreements that are within the scope of ASC 808, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides guidance on the presentation and disclosure of collaborative arrangements. Generally, the classification of the transactions under the collaborative arrangements is determined based on the nature of the contractual terms of the arrangement, along with the nature of the operations of the participants. The Company&#8217;s collaborative agreements generally include a provision of R&amp;D services related to novel technologies and biocatalysts. Amounts received for these services are classified as Revenue from collaborative arrangements in the condensed consolidated statements of operations and comprehensive loss. The Company's R&amp;D services are a major part of the Company's ongoing operations and therefore ASC 606 is applied to recognize revenue.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CarbonSmart</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's CarbonSmart business, initially CarbonSmart ethanol, is produced by LanzaTech licensed plants using the Company's proprietary technologies. Customers can buy CarbonSmart ethanol directly from LanzaTech, which the Company sources from these partnering plants. Revenue is recognized at a point in time when control transfers to the customer, which varies depending on the shipping terms. The Company acts as the principal in such transactions and accordingly, recognizes revenue and cost of revenues on a gross basis.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily due to their short-term nature, except for the warrant liability. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue generated from the Company&#8217;s customers outside of the United States for the nine months ended September&#160;30, 2022 and 2021 was approximately 61% and 65%, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021, approximately 35% and 35%, respectively, of trade accounts receivable and unbilled accounts receivable was due from customers located outside the United States. At September&#160;30, 2022 and December&#160;31, 2021, the value of property, plant, and equipment outside the United States was immaterial.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue by geographic region based on the customer&#8217;s location is presented in Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customers</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers representing 10% or greater of revenue were as follows for the nine months ended September&#160;30, 2022 and 2021:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Announced Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Financial Accounting Standard Board ("FASB") issued an Accounting Standard Update ("ASU") No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2020-10&#8221;). The standard contains improvements to the FASB Accounting Standards Codification (the &#8220;Codification&#8221;) by ensuring that all guidance that requires or provides an option for an entity to provide information in the notes to financial statements is codified in the disclosure section of the Codification. The standard also improves various topics in the Codification so that entities can apply guidance more consistently on codifications that are varied in nature where the original guidance may have been unclear. The amendments in ASU 2020-10 were effective for the Company for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption was permitted. There were no material impacts upon the adoption of ASU 2020-10, on its consolidated financial statements and related disclosures. </span></div>Summary of Significant Accounting Policies <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;US GAAP"). The consolidated financial statements include the accounts of LanzaTech NZ, Inc. and its wholly-owned consolidated subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of its evaluation, the Company makes judgments in determining whether an entity is a variable interest entity (&#8220;VIE&#8221;) and, if so, whether it is the primary beneficiary of the VIE and is thus required to consolidate the entity. A VIE is a legal entity that has a total equity investment that is insufficient to finance its activities without additional subordinated financial support or whose equity investors lack the characteristics of a controlling financial interest. Our variable interest arises from contractual, ownership or other monetary interests in the entity, which change with fluctuations in the fair value of the entity&#8217;s net assets. A VIE is consolidated by its primary beneficiary, the party that has both the power to direct the activities that most significantly impact the VIE&#8217;s economic performance, and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE. We consolidate a VIE when we are deemed to be the primary beneficiary. We assess whether or not we are the primary beneficiary of a VIE on an ongoing basis. If we are not deemed to be the primary beneficiary in a VIE, we account for the investment or other variable interests in a VIE in accordance with applicable US GAAP.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds interests in certain VIEs for which it has been determined the Company is not the primary beneficiary. The Company's variable interests primarily relate to entities in which the Company has a non-controlling equity interest. Although these financial arrangements resulted in holding variable interests in these entities, they did not empower the Company to direct the activities of the VIEs that most significantly impact the VIEs' economic performance. The Company's interests in the VIEs are, therefore, accounted for under the equity method of accounting. Refer to Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further information. The Company's maximum exposure to loss in connection with its interest in VIEs is its equity method investment and any amounts receivable from the VIE, less amounts payable. Refer to Note 14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further details on the transactions with VIEs.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restatement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 16, 2022, the Audit Committee of the Board of Directors of LanzaTech, after discussion with management of LanzaTech and LanzaTech&#8217;s independent registered public accounting firm, Deloitte &amp; Touche, </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LLP, concluded that LanzaTech&#8217;s previously issued audited consolidated financial statements as of and for the fiscal years ended December 31, 2021 and December 31, 2020 should no longer be relied upon. The errors leading to restatement were communicated to and discussed with AMCI upon their discovery. The AMCI Board considered the circumstances surrounding the restatement and concluded that it did not negatively impact its decision to proceed with the Business Combination primarily because of the individually immaterial adjustments. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined that its recorded share of equity method earnings amounts from an unconsolidated affiliate for the years ended December 31, 2021 and 2020 and its gain on dilution amount for the year ended December 31, 2021 were incorrect following the completion of LanzaJet, Inc's ("LanzaJet") financial statement audit. Additionally, the Company identified that it was not properly eliminating intra-entity profits related to revenue contracts with LanzaJet. As a result of the adjustments recorded by the unconsolidated affiliate and the identification of the error related to the elimination of intra-entity profits, the Company made the decision to restate its consolidated financial statements as of and for the years ended December 31, 2021 and 2020, on or around the completion of the audit of LanzaJet's financial statements for the years ended December 31, 2021 and 2020, on August 23, 2022. The Company also determined it was not properly accounting for its licensing arrangement with LanzaJet, and had not disclosed all significant related party transactions with its equity method investees. The Company has also revised these disclosures.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 250, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Changes and Error Corrections</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company evaluated the materiality of the adjustments, considering both quantitative and qualitative factors, and determined that the related aggregate impact was material to its consolidated financial statements as of and for the years ended December 31, 2021 and 2020. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Description of Errors Corrected</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Accounting for Equity Method Investments: </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The previously reported equity method investment in LanzaJet, Inc. (&#8220;LanzaJet&#8221;), as described in Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, contained errors in the Company's recorded share of LanzaJet losses for the years ended 2021 and 2020 as a result of adjustments made by LanzaJet to its financial statements in connection with the audit of LanzaJet's financial statements for the years ended December 31, 2021 and 2020. The adjustments primarily were comprised of (1) an adjustment to correct an error relating to the measurement of the intangible asset associated with the intellectual property contributed by the Company as described in Note 5 &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the related amortization; and (2), an adjustment to reclassify as a reduction to fixed assets certain government grants received by LanzaJet that it originally recorded as revenue. Other less significant adjustments were also identified and corrected in connection with the audit of LanzaJet's financial statements for the years ended December 31, 2021 and 2020. The net impact of these adjustments on the equity method investment's balance and accumulated deficit in the Company's Consolidated Balance Sheets was a decrease of $580 and $257 as of December 31, 2021 and 2020, respectively. The net impact of these adjustments on the gain from equity method investees in the Company&#8217;s Consolidated Statements of Operations and Comprehensive Loss was a decrease of $580 and $257 for the years ended December 31, 2021 and 2020, respectively. </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The previously reported revenue from related parties related to contributed intellectual property contained errors for intra-entity profit that was not previously eliminated, as described in Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The impact of these errors on the equity method investment's balance and accumulated deficit in the Consolidated Balance Sheets was $662 and $549 as of December 31, 2021 and 2020, respectively and $662 and $549 on revenue from related party transactions in the Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2021 and 2020, respectively.</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The previously reported gain on dilution, as described in Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, was not correctly calculated for the year ended December 31, 2021. The impact of these errors on the equity method investment's balance and accumulated deficit in the Consolidated Balance Sheets as of December 31, </span></div><div style="margin-bottom:9pt;padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021 was $322; and the impact on gain from equity method investees in the Consolidated Statements of Operations and Comprehensive Loss was $322 for the year ended December 31, 2021.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Additional Misstatements:</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The previously reported contract assets and other accrued liabilities included revenue and related cost of revenue amounts that was recorded in an inappropriate period. These amounts were recorded in 2021, however, the performance obligation was actually satisfied in 2020.. The impact of these errors on the contract assets and other accrued liabilities in the Consolidated Balance Sheet as of December 31, 2020 was $122; and the impact on revenue from contracts with customers and cost of revenue from contracts with customers in the Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2021 and 2020 was  $122.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Disclosure errors:</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company determined its licensing arrangement with LanzaJet, described in Note 5 &#8211; Investments, should have been accounted for as a transaction with a customer solely within the scope of Accounting Standards Codification 606 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from contracts with customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 606") rather than akin to an operating lease under Accounting Standards Codification 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 842"). The licensing arrangement is a contract with our customer, LanzaJet, that conveys to LanzaJet the right to use an intangible asset (IP). Contracts with customers are accounted for under ASC 606 unless they are within the scope of other accounting literature. Because the licensing arrangement conveys the right to use an intangible asset, it is not within the scope of ASC 842. Under limited circumstances, ASC 606 requires certain arrangements that do not, in substance, transfer control of an asset (i.e., when the arrangement contains certain repurchase rights or obligations) to be accounted for as leases. However, those limited circumstances are not present in our licensing arrangement with LanzaJet. Therefore, the Company concluded accounting for the arrangement under ASC 606 is required. Because the period over which the Company determined it was required to recognize revenue under ASC 606 was the same as the period of time over which it had been recognizing revenue, there was no effect on the amounts recorded in the consolidated financial statements. Additionally, the difference in timing of recognition of the variable consideration resulted in a difference between the carrying value of our equity method investment in LanzaJet and our proportionate share LanzaJet's book values, that was not previously disclosed. However, the disclosures in Note 5 &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, have been revised accordingly.</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company did not disclose in Note 5 &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, its obligation under a guarantee with sublicensing agreement between LanzaJet and a third party. The fair value of this guarantee was deemed immaterial as of December 31, 2021 and 2020.</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company did not include in its disclosure for related party transactions in Note 14 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that it also provided engineering services to one of its equity method investees, Beijing ShouGang LanzaTech Technology Co., LTD ("SGLT"), for which costs of $1,223 and $242 were incurred during the years ended December 31, 2021 and 2020. The Company also did not disclose that in 2019 it entered into a licensing agreement to receive licensing consideration from SGLT. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of the errors discussed above were individually material to the financial statements, however, their cumulative impact was material and resulted in a restatement of the 2021 and 2020 financial statements. The effects of the correction of these errors on the relevant financial statement line items is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Balance Sheet</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,738&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,011&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(378,162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(379,889)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(353,190)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(354,917)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, contingently redeemable preferred equity, and shareholders' deficit</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,738&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,011&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Balance Sheet</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,664&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(684)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,980&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,775&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,897&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,666&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,788&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(332,394)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(333,200)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310,410)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311,216)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, contingently redeemable preferred equity, and shareholders' deficit</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,664&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(684)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,980&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Operations and Comprehensive Loss</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from contracts with customers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from related party transactions</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,915&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(662)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,253&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,245&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(784)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,461&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue from contracts with customers (exclusive of depreciation shown below)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,289)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,167)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost and operating expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,602)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,480)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,357)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(662)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,019)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,972)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(662)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48,634)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(259)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,945&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,768)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(921)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,689)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss allocated to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82,526)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(921)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83,447)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,673)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(921)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,594)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share - basic and diluted</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.12)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.47)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.59)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Operations and Comprehensive Loss</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from contracts with customers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from related party transactions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,752&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(549)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,780&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(427)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,353&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue from contracts with customers (exclusive of depreciation shown below)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,063)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,185)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost and operating expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,932)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58,054)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,152)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(549)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,701)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,331)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(549)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,880)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,424&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(257)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,907)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,713)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss allocated to common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68,198)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69,004)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,282)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,088)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share - basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.84)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.50)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.34)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Changes in Redeemable Convertible Preferred Stock and Shareholders&#8217; Equity (Deficit)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit - Balance at December 31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(332,394)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(333,200)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit &#8211; balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310,410)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311,216)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,768)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(921)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,689)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit - balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(378,162)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(379,889)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit &#8211; balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(353,190)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(354,917)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Changes in Redeemable Convertible Preferred Stock and Shareholders&#8217; Equity (Deficit)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit - Balance at December 31, 2019</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(295,487)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(295,487)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit &#8211; balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276,592)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276,592)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,907)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,713)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit - balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(332,394)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(333,200)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit &#8211; balance at December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310,410)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311,216)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Cash Flows</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,768)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(921)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,689)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash recognition of licensing revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,684)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,022)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,945)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,636)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,514)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued salaries and wages</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,591)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,591)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Cash Flows</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,907)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,713)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash recognition of licensing revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,567)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,018)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,424)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,167)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,483)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,605)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued salaries and wages</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,271)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,271)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Other Disclosure Errors: </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 5 - Investments: The Company did not disclose intra-entity profits elimination amounts related to revenue contracts with LanzaJet of $662 and $549 as of December 31, 2021, and 2020, respectively as they were not eliminated. The previously disclosed gain on dilution was incorrect as of and for the year ended December 31, 2021.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on dilution</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates as one operating segment. Operating segments are defined as components of an enterprise for which separate financial information is evaluated regularly by the chief operating decision maker (&#8220;CODM&#8221;), in deciding how to allocate resources and assess performance.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company offers a variety of services and operates in multiple countries, the Company&#8217;s business operates in one operating segment because most of the Company&#8217;s service offerings are delivered and supported on a global basis, most of the Company&#8217;s service offerings are deployed in a nearly identical way, and the Company&#8217;s CODM evaluates the Company&#8217;s financial information and resources and assesses the performance of these resources on a consolidated basis. There are no segment managers who are held accountable by the CODM, or anyone else, for operations, operating results, and planning for components below the consolidated level. Accordingly, the Company has determined that it has a single reportable and operating segment. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for disaggregation of the Company&#8217;s revenues by customer location.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Coronavirus (COVID-19)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the World Health Organization declared the viral strain of coronavirus ("COVID-19") a global pandemic and recommended containment and mitigation measures worldwide. The spread of COVID-19 and the resulting economic contraction has resulted in increased business uncertainty. The consequences of a prolonged economic decline could include, but are not limited to, reduced revenues, increased instances of uncollectible customer receivables, and increased asset impairments in future periods. Accordingly, the Company cannot reasonably estimate the length or severity of this pandemic, or the extent to which the disruption may materially impact its consolidated balance sheets, consolidated statements of operations and comprehensive loss or statements of cash flows for future periods.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Going Concern</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements of the Company have been prepared assuming the Company will continue as a going concern and in accordance with US GAAP. The going concern basis of presentation assumes that the Company will continue in operation one year after the date these financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. The Company had cash and cash equivalents of $128,318 and an accumulated deficit of $379,889 at December&#160;31, 2021 and cash outflows from operations of $42,591 and a net loss of $46,689 for the year ended December&#160;31, 2021. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has historically funded its operations through debt financing and issuance of equity securities. Based on the Company&#8217;s financial position as of the date these consolidated financial statements were issued, the Company projects that it will be able to cover its liquidity needs for the next twelve months with cash on hand. Accordingly, the Company&#8217;s consolidated financial statements have been prepared on the basis that it will continue as a going concern.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates include fair value of equity awards granted to both employees and non-employees.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in facts and circumstances or additional information may result in revised estimates, and actual results may differ from these estimates.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currencies</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reporting currency is the U.S. Dollar. The Company has certain foreign subsidiaries where the functional currency is the local currency. All of the assets and liabilities of these subsidiaries are converted to U.S. dollars at the exchange rate in effect at the balance sheet date, income and expense accounts are translated at average rates for the period, and shareholder&#8217;s equity accounts are translated at historical rates. The effects of translating financial statements of foreign operations into our reporting currency are recognized as an adjustment in accumulated other comprehensive income (loss).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has foreign subsidiaries that have a functional currency of the U.S. dollar. Purchases and sales of assets and income and expense items denominated in foreign currencies are remeasured into U.S. dollar amounts on the respective dates of such transactions. Net realized foreign currency gains or losses relating to the differences between these recorded amounts and the U.S. dollar equivalent actually received or paid are included within Other income, net in the consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. As of December&#160;31, 2021 and 2020, the Company had $128,318 and $60,495 of cash and cash equivalents, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to maintain a cash deposit with a bank which consists of collateral on a travel and expense program maintained by the bank. The following represents a reconciliation of cash and cash equivalents in </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the consolidated balance sheets to total cash, cash equivalents and restricted cash in the consolidated statement of cash flows as of December 31, 2021 and December 31, 2020.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,495&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (presented within Other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,732&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,909&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade and Other Receivables </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables are reported net of allowances for doubtful accounts. The Company maintains allowances for doubtful accounts for estimated losses resulting from the inability of customers to make required payments. The Company estimates the allowance for doubtful accounts based on a variety of factors including the length of time receivables are past due, the financial health of customers, unusual macroeconomic conditions, and historical experience. As of December&#160;31, 2021 and 2020, the Company recognized an allowance for doubtful accounts of $1,235 and $1,325, respectively.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Current Assets</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current assets consist of prepaid expenses, materials and supplies, and other assets. Material and supplies consist of spare parts and consumables used for research and research equipment and is stated at the weighted average cost.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment, net</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost and include improvements that significantly increase capacities or extend the useful lives of existing plant and equipment.&#160;Depreciation is calculated using the straight-line method over the estimated useful life of the assets. Useful lives range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTA0_78de1c22-d3ad-43ae-a899-19a74e1b2357">three</span> to five years for instruments and equipment, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk3OTk5_761df305-309f-4903-a23c-ce62ac3f485c">three</span> to five years for office equipment and furniture and software, five years for vehicles and, for leasehold improvements, the shorter of the life of the improvement or the remaining term of the lease. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews the remaining useful life of its assets on a regular basis to determine whether changes have taken place that would suggest that a change to depreciation policies is warranted.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon retirement or disposal of property, plant and equipment, the cost and related accumulated depreciation are removed from the account, and the resulting gains or losses, if any, are recorded in the consolidated statements of operations and comprehensive loss. Net gains or losses related to asset dispositions are recognized in earnings in the period in which dispositions occur. Routine maintenance, repairs and replacements are expensed as incurred.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines&#160;if an arrangement is a lease at inception.&#160;Lease agreements are evaluated to classify the lease as a finance or operating&#160;lease.&#160;Operating lease assets and liabilities are recognized at the commencement date of the lease based on the present value of lease payments over the lease term. Lease assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. As most&#160;leases&#160;do not provide an implicit interest rate,&#160;the Company&#160;uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. Leases with an initial term of 12 months or less are not recorded on the Company&#8217;s consolidated balance sheets. The Company recognizes lease expense for these leases on a straight-line basis over the lease term.&#160;The Company accounts for lease components and non-lease components as a single lease component.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs a recoverability assessment of each of its long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indicators may include, but are not limited to, adverse changes in the regulatory environment in a jurisdiction where the Company operates, a decision to discontinue the development of a long-lived asset, early termination of a significant customer contract, or the introduction of newer technology.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When performing a recoverability assessment, the Company measures whether the estimated future undiscounted net cash flows expected to be generated by the asset exceeds its carrying value. In the event that an asset does not meet the recoverability test, the carrying value of the asset will be adjusted to fair value resulting in an impairment charge.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management develops the assumptions used in the recoverability assessment based on active contracts as well as information received from third-party industry sources. The Company did not record an impairment during the years ended December&#160;31, 2021 and 2020. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Method Investments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in entities over which the Company has significant influence, but not control, are accounted for using the&#160;equity method&#160;of accounting. Gain from&#160;equity method&#160;investees, net represents the Company&#8217;s proportionate share of net income or loss of its equity method investees and any gains or losses from the dilution of such investments.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity method&#160;investments are assessed for impairment whenever changes in the facts and circumstances indicate a loss in value may have occurred. When a loss is deemed to have occurred and is other than temporary, the carrying value of the&#160;equity method&#160;investment is written down to fair value. In evaluating whether a loss is other than temporary, the Company considers the length of time for which the conditions have existed and its intent and ability to hold the investment. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Simple Agreement for Future Equity (SAFE)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company issued a SAFE that allowed an investor to participate in future equity financings through a share-settled redemption of the amount invested (such notional being the &#8220;invested amount&#8221;). The Company determined that the SAFE was not legal form debt (i.e., no creditors&#8217; rights). The SAFE includes a provision allowing for cash redemption upon the occurrence of a change of control, the occurrence of which is outside the control of the Company. Therefore, the SAFE is classified as mark-to-market liability pursuant to Accounting Standards Codification (&#8220;ASC&#8221;) 480, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distinguishing Liability from Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has warrants to purchase preferred shares outstanding as of December&#160;31, 2021 and 2020 representing 225,223 and 383,281 preferred shares, respectively, which warrants expire at various dates through December 31, 2027. The exercise prices of the warrants range from $14.69 to $19.93 as of each of December&#160;31, 2021 and 2020. The Company accounts for its warrants as liabilities based upon the characteristics and provisions of each instrument. The liabilities are included in other accrued liabilities on the Company's consolidated balance sheets at their fair value on the date of issuance and are revalued in each subsequent reporting period until such instruments are exercised or expire. The change in fair value between reporting periods is included in other (expense) income, net in the consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further the warrant related to the SAFE of $1,729 is accounted for as a liability. This liability is recorded in current liabilities on the Company's consolidated balance sheets at fair value on the date of issuance and will be revalued each subsequent reporting period until such instrument is exercised or expire. The change in fair value between reporting periods is included in other (expense) income, net in the consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Term Debt and Debt Issuance Costs</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s debt consists of credit facilities with financial institutions. Costs directly related to the issuance of debt are reported on the consolidated balance sheets as a reduction from the carrying amount of the recognized debt liability and amortized over the term of the debt using the effective interest method.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal and Contingencies</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may be involved in legal actions in the ordinary course of business, inquiries and proceedings concerning employment, labor, environmental, and other claims. The Company will recognize a loss contingency in the consolidated financial statements when it is probable a liability has been incurred and the amount of the loss can be reasonably estimated. The Company will disclose any loss contingencies that do not meet both conditions if there is a reasonable possibility that a loss may have been incurred. Gain contingencies are not recorded until realized.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company primarily earns revenue from services related to feasibility studies and basic engineering design of commercial plants, licensing of technologies, joint development and contract research activities to develop novel biocatalysts and related technologies.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is measured based on the consideration specified in a contract with a customer. The Company records taxes collected from customers and remitted to governmental authorities on a net basis. The Company&#8217;s payment terms are between 30-60 days and can vary by customer type and products offered. We have evaluated the terms of our arrangements and determined that they do not contain significant financing components.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Carbon Capture and Transformation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides feasibility studies and basic design and engineering services used for detailed design, procurement, and construction of commercial plants that utilize the Company&#8217;s technologies, along with the sale of equipment and microbes. The services provided are recognized as a performance obligation satisfied over time. Revenue is recognized using the output method based on milestone completion, the cost-to-cost input method for certain engineering services, or the percentage of completion method when certain revenue recognition requirements are met. Management has determined that the milestone completion and the associated contractual payment amounts are an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company licenses intellectual property to generate recurring revenue when its customers deploy carbon capture and transformation plants. When licenses are considered to be distinct performance obligations, the recognition of revenue is dependent on the terms of the contract, which may include fixed consideration or royalties based on sales or usage, in which case, the revenue is recognized when the subsequent sale or usage occurs or when the performance obligation to which some or all of the sales or usage-based royalty is allocated has been satisfied, whichever is later.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Services</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs research and development (&#8220;R&amp;D&#8221;) services related to novel technologies and development of biocatalysts for commercial applications, mainly to produce fuels and chemicals. The Company engages in two main types of R&amp;D services &#8211; joint development agreements, and other contract research, including projects with the U.S. Department of Energy. Such services are recognized as a performance obligation satisfied over time. Revenue is recognized based on milestone completion, when such milestones are contractually defined, or based on stage of contract completion when not defined. For the latter, management has determined that the cost incurred, input method, is an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and estimates its variable consideration under the expected value method. Accordingly, the Company records a liability based on milestones achieved and the expected repayment of the development costs. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s joint development agreements may utilize the cost-to-cost method of revenue recognition or may include well defined payment milestones, dependent on the contract, both of which the Company evaluates against work completed prior to revenue recognition. For other contract research, the Company utilizes the cost-to-cost method of revenue recognition. These contracts have a fixed dollar amount which is based on the Company&#8217;s estimate of total costs to be incurred over the life of each contract. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is not recognized in advance of customer acceptance of a milestone, when such acceptance is contractually required. Payments for R&amp;D services with no contractual payments are not due from customers until a technical report is submitted; therefore, a contract asset is recognized at milestone completion but prior to the submission of a technical report. The contract asset represents the Company&#8217;s right to consideration for the services performed at milestone completion. Occasionally, customers provide payments in advance of the Company providing services which creates a contract liability for the Company. The contract liability represents the Company's obligation to provide services to a customer. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collaboration Arrangements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain partnership agreements that are within the scope of ASC 808, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides guidance on the presentation and disclosure of collaborative arrangements. Generally, the classification of the transactions under the collaborative arrangements is determined based on the nature of the contractual terms of the arrangement, along with the nature of the operations of the participants. The Company&#8217;s collaborative agreements generally include a provision of R&amp;D services related to novel technologies and biocatalysts. Amounts received for these services are classified as Revenue from collaborative arrangements in the consolidated statements of operations and comprehensive loss. The Company's R&amp;D services are a major part of the Company's ongoing operations and therefore ASC 606 is applied to recognize revenue.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenues</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s R&amp;D, engineering, and other direct costs of services related to revenue agreements with customers, related parties, and collaborative partners represent cost of revenue. Costs include both internal and third-party fixed and variable costs and include materials, supplies, labor, and fringe benefits.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incur research and development costs associated with various R&amp;D activities and expense these costs as incurred.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for equity-based compensation in accordance with ASC 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation &#8211; Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Accordingly, in exchange for employee and director services, compensation is given in the form of equity awards. The equity awards are recorded based on the grant date fair value and expensed over the requisite service period for the respective award.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s equity-based awards include stock option awards and restricted stock issued by the Company, which vest based on either time or the achievement of certain performance conditions. The Company records forfeitures as they occur. Compensation expense resulting from time-vesting-based awards is recognized in the Company&#8217;s consolidated statements of operations and comprehensive loss, primarily within research and development expenses, at the grant date fair value over the requisite service period. Compensation expense resulting from performance awards recognized over the requisite service period when it is probable that the performance condition will be met. The calculated compensation expense for performance awards is adjusted based on an estimate of awards ultimately expected to vest. The Company estimates grant date fair value using a Black-Scholes option pricing model that uses assumptions including expected volatility, expected term, and the expected risk-free rate of return. The Company has determined that the Black-Scholes option pricing model, as well as the underlying assumptions used in its application, is appropriate in estimating the fair value of its award grants.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows the asset and liability method of accounting for income taxes under ASC 740, Income Taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income tax assets are evaluated to determine if valuation allowances are required or should be adjusted. Valuation allowances are established based on a more likely than not standard. The ability to realize deferred tax assets depends on the Company&#8217;s ability to generate sufficient taxable income within the carryback or carryforward periods provided for in the tax law for each tax jurisdiction. The Company considers the various possible sources of taxable income when assessing the realization of its deferred tax assets. The valuation allowances recorded against deferred tax assets generated by taxable losses in certain jurisdictions will affect the provision for income taxes until the valuation allowances are released. The Company&#8217;s provision for income taxes will include no tax benefit for losses incurred and no tax expense with respect to income generated in these jurisdictions until the respective valuation allowance is eliminated.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records uncertain tax positions on the basis of a two-step process whereby it is determined whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position, and for those tax positions that meet the more likely than not criteria, the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority is recognized. The Company recognizes accrued interest and penalties related to unrecognized tax benefits in income tax expense.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Transactions</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows ASC 850-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for the identification of related parties and disclosure of related party transactions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. Refer to Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Note 14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further information.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss Per Share</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is computed by dividing net loss attributable to participating stock by the weighted average number of shares of participating stock outstanding during the period. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted net loss per share reflects potential dilution and is computed by dividing net loss attributable to participating stock by the weighted average number of shares of participating stock outstanding during the period. The dilutive effect of outstanding awards, if any, is reflected in diluted earnings per share by application of the treasury stock method or if-converted method, as applicable. Refer to Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Loss Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-term nature, except for the warrant liability. Refer to Note 11, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrant Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for more information.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties (Restated)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue generated from the Company&#8217;s customers outside of the United States for the years ended December&#160;31, 2021 and 2020 was approximately 38% and 14%, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, approximately 35% and 27%, respectively, of trade accounts receivable and unbilled accounts receivable was due from customers located outside the United States. At December&#160;31, 2021 and 2020, the value of property, plant, and equipment outside the United States was immaterial.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue by geographic region based on the customer&#8217;s location is presented in Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customers</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers representing 10% or greater of revenue were as follows for the years ended December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, two of the Company's customers separately represented 49% (Customer B) and 15% (Customer D) of total accounts receivable and contract assets on the consolidated balance sheet. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses (Topic 326): Disclosure Framework &#8211; Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2016-13&#8221;), which requires financial assets measured at amortized cost basis, including trade receivables, to be presented net of the amount expected to be collected. The measurement of all expected credit losses will be based on historical experience, current conditions, and reasonable and supportable forecasts. The Company adopted the new standard effective January 1, 2020, using a modified retrospective transition method, which requires a cumulative-effect adjustment, if any, to the opening balance of retained earnings to be recognized on the date of adoption with prior periods not restated. The adoption did not have a material impact on the Company&#8217;s financial position or results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles &#8211; Goodwill and Other &#8211; Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2018-15&#8221;), which requires a customer in a cloud computing arrangement that is a service contract to follow the internal-use software guidance in ASC 350-40 to determine which implementation costs to capitalize as assets. A customer&#8217;s accounting for the costs of the hosting component of the arrangement is not affected by the new guidance. The Company adopted ASU 2018-15 as of January 1, 2020 with no material impact on its consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2018, the FASB issued ASU 2018-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Stock Compensation Improvements to Non-employee Share-Based Payment Accounting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2018-07&#8221;), which simplifies the accounting for stock-based payments granted to non-employees for goods and services. Under ASU 2018-07, most of the guidance on such payments to non-employees will be aligned with the requirements for stock-based payments granted to employees. The Company early adopted ASU 2018-07 as of January 1, 2020 and its adoption did not have a material impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2019-12&#8221;), as part of its simplification initiative to reduce the cost and complexity in accounting for income taxes. ASU 2019-12 removes certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. ASU 2019-12 also amends other aspects of the guidance to help simplify and promote consistent application of US GAAP. The Company adopted ASU 2019-12 as of January 1, 2021 with no material impact on its consolidated financial statements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Announced Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2020-10&#8221;). The standard contains improvements to the FASB Accounting Standards Codification (the &#8220;Codification&#8221;) by ensuring that all guidance that requires or provides an option for an entity to provide information in the notes to financial statements is codified in the disclosure section of the Codification. The standard also improves various topics in the Codification so that entities can apply guidance more consistently on codifications that are varied in nature where the original guidance may have been unclear. The amendments in ASU 2020-10 are effective for the Company for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption is permitted. The Company does not expect the adoption of ASU 2020-10 to have a material impact on its consolidated financial statements and related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272210854480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Initial Public Offering<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_InitialPublicOfferingAbstract', window );"><strong>Initial Public Offering</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_InitialPublicOfferingTextBlock', window );">Initial Public Offering</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3 &#8212; Initial Public Offering</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 6, 2021, the Company consummated its initial public offering of 15,000,000 units, at an offering price of $10.00 per unit, generating gross proceeds of $150.0 million, and incurring offering costs of approximately $13.8 million, inclusive of $1.5 million of underwriting discount, approximately $5.3 million in deferred underwriting commissions, approximately $6.5 million in fair value of Class B common stock issued to Anchor Investors, and approximately $0.5 million in other offering costs. Each whole warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 8). Certain qualified institutional buyers or institutional accredited investors (the &#8220;Anchor Investors&#8221;) purchased 15,480,000 units in the initial public offering. None of the Anchor Investors are affiliated with any member of the Company&#8217;s management.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters had a 45-day option from the date of the underwriting agreement (August 3, 2021) to purchase up to an additional 2,250,000 units to cover over-allotments. On September 17, 2021, the over-allotment option expired unexercised, resulting in 562,500 shares of Class B common stock that were subject to forfeiture to be forfeited.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3 &#8212; Initial Public Offering</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 6, 2021, the Company consummated its initial public offering of 15,000,000 units, at an offering price of $10.00 per unit, generating gross proceeds of $150.0 million, and incurring offering costs of approximately $13.8 million, inclusive of $1.5 million of underwriting discount, approximately $5.3 million in deferred underwriting commissions, approximately $6.5 million in fair value of Class B common stock issued to Anchor Investors, and approximately $0.5 million in other offering costs. Each whole warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 8). Certain qualified institutional buyers or institutional accredited investors (the &#8220;Anchor Investors&#8221;) purchased 15,480,000 units in the initial public offering. None of the Anchor Investors are affiliated with any member of the Company&#8217;s management.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters had a 45-day option from the date of the underwriting agreement (August 3, 2021) to purchase up to an additional 2,250,000 units to cover over-allotments. On September 17, 2021, the over-allotment option expired unexercised, resulting in 562,500 shares of Class B common stock that were subject to forfeiture to be forfeited.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_InitialPublicOfferingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_InitialPublicOfferingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_InitialPublicOfferingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure on information about initial public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_InitialPublicOfferingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272210921744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4 &#8212; Related Party Transactions</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Founder Shares</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2021, the Sponsor paid $25,000, or approximately $0.005 per share, to cover certain offering costs in consideration for 5,031,250 shares of Class B common stock, par value $0.0001. In March 2021, the Sponsor transferred all of the founder shares it held to members of the Company&#8217;s board of directors, management </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">team, and persons or entities affiliated with AMCI Group (the &#8220;initial shareholders&#8221;). Such shares were fully paid. On May 14, 2021, the Sponsor surrendered 718,750 founder shares to the Company for no consideration, resulting in the Sponsor owning 4,312,500 founder shares. Up to 562,500 of the founder shares will be forfeited depending on the extent to which the underwriters&#8217; over-allotment is exercised. On September 17, 2021, the over-allotment option expired unexercised, resulting in 562,500 of the founder shares being forfeited.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In exchange for the Anchor Investors&#8217; participation in the initial public offering as described in Note 3, the Sponsor sold a total of 780,000 founder shares to the Anchor Investors. The Company determined that the fair value of these founder shares was approximately $6.5 million (or approximately $8.35 per share) using a Monte Carlo simulation. The Company recognized the excess fair value of these founder shares, over the price sold to the Anchor Investors, as an expense of the initial public offering resulting in a charge against the carrying value of Class A common stock subject to possible redemption.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial stockholders have agreed not to transfer, assign or sell any of their founder shares and any Class A common stocks issuable upon conversion thereof until the earlier to occur of: (A) one year after the completion of the initial business combination and (B) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction after the Company&#8217;s initial business combination that results in all of the Company&#8217;s stockholders having the right to exchange their Class A common stock for cash, securities or other property; except to certain permitted transferees and under certain circumstances (the &#8220;Lock-up&#8221;). Any permitted transferees will be subject to the same restrictions and other agreements of the company&#8217;s initial stockholders with respect to any founder shares. Notwithstanding the foregoing, the founder shares will be released from the Lock-up if the closing price of the Company&#8217;s Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the company&#8217;s initial business combination.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Private Placement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Simultaneously with the closing of the initial public offering, the Company&#8217;s Sponsor has purchased an aggregate of 3,500,000 private placement warrants, each exercisable to purchase one Class A common stock at $11.50 per share, at a price of $1.00 per warrant, or $3,500,000 in the aggregate.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The private placement warrants will not be redeemable by the Company so long as they are held by the initial purchasers or their permitted transferees. The initial purchasers, or their permitted transferees, have the option to exercise the private placement warrants on a cashless basis. If the private placement warrants are held by holders other than initial purchasers or their permitted transferees, the private placement warrants will be redeemable by the Company and exercisable by the holders on the same basis as the warrants included in the units being sold in the initial public offering. Otherwise, the private placement warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in the initial public offering.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the private placement warrants are held by holders other than the Sponsor or its permitted transferees, the private placement warrants will be redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the units being sold in the initial public offering.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Loans and Advances</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2021, the Sponsor agreed to loan the Company up to $300,000 to be used for a portion of the expenses of the initial public offering (&#8220;Note&#8221;). This loan was non-interest bearing, unsecured and payable upon the closing of the initial public offering. In addition to the Note, the Sponsor of the Company also paid certain administrative expenses and offering costs on behalf of the Company. These advances were due on demand and were non-interest bearing. The Company repaid the note payable and advances in exchange for the issuance of private placement warrants.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Working Capital Loans</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in order to finance transaction costs in connection with an intended business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#8217;s officers and directors may, but are not obligated </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to, loan the Company funds as may be required on a non-interest basis (&#8220;Working Capital Loans&#8221;). If the Company completes the initial business combination, it will repay the Working Capital Loans. In the event that the initial business combination does not close, the Company may use a portion of the working capital held outside the trust account to repay the Working Capital Loans but no proceeds from the trust account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-business combination entity at a price of $1.00 per warrant at the option of the lender. Such warrants would be identical to the private placement warrants. Except as set forth above, the terms of Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. On March 28, 2022, the Company entered into a noninterest-bearing Working Capital Loan with its Sponsor for the principal amount of up to $1.5 million. As of September 30, 2022 and December 31, 2021, the Company had no borrowings under the Working Capital Loans.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Administrative Service Fee</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the closing of the initial public offering, the Company will pay its Sponsor $10,000 per month for office space, secretarial and administrative services provided to members of the management team. Upon completion of the initial business combination or the Company&#8217;s liquidation, the Company will cease paying these monthly fees. For the three months ended September 30, 2022 and 2021, the Company incurred $30,000 and $20,000, respectively, of such fees, included as general and administrative fees &#8212; related party on the accompanying unaudited condensed statements of operations. For the nine months ended September 30, 2022 and for the period from January 28, 2021 (inception) through September 30, 2021, the Company incurred $90,000 and $20,000, respectively, of such fees, included as general and administrative fees &#8212; related party on the accompanying unaudited condensed statements of operations. As of September 30, 2022 and December 31, 2021, approximately $90,000 and $50,000, respectively, of such fees were included in due to related party on the accompanying condensed balance sheets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sponsor, officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on the Company&#8217;s behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. The Company&#8217;s audit committee will review on a quarterly basis all payments that were made by the Company to the Sponsor, directors, officers or directors of the Company, or any of their affiliates. As of September 30, 2022 and December 31, 2021, there were approximately $596,000 and $0, respectively, of such fees included as due to related party on the accompanying condensed balance sheets.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4 &#8212; Related Party Transactions</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Founder Shares</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2021, the Sponsor paid $25,000, or approximately $0.005 per share, to cover certain offering costs in consideration for 5,031,250 shares of Class B common stock, par value $0.0001. In March 2021, the Sponsor transferred all of the founder shares it held to members of the Company&#8217;s board of directors, management team, and persons or entities affiliated with AMCI Group (the &#8220;initial shareholders&#8221;). Such shares were fully paid. On May 14, 2021, the Sponsor surrendered 718,750 founder shares to the Company for no consideration, resulting in the Sponsor owning 4,312,500 founder shares. Up to 562,500 of the founder shares will be forfeited depending on the extent to which the underwriters&#8217; over-allotment is exercised. On September 17, 2021, the over-allotment option expired unexercised, resulting in 562,500 of the founder shares being forfeited.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In exchange for the Anchor Investors&#8217; participation in the initial public offering as described in Note 3, the Sponsor sold a total of 780,000 founder shares to the Anchor Investors. The Company determined that the fair value of these founder shares was approximately $6.5 million (or approximately $8.35 per share) using a Monte Carlo simulation. The Company recognized the excess fair value of these founder shares, over the price sold to the Anchor Investors, as an expense of the initial public offering resulting in a charge against the carrying value of Class A common stock subject to possible redemption.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial stockholders have agreed not to transfer, assign or sell any of their founder shares and any Class A common stocks issuable upon conversion thereof until the earlier to occur of: (A) one year after the completion of the initial business combination and (B) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction after the Company&#8217;s initial business combination that results in all of the Company&#8217;s stockholders having the right to exchange their Class A common stock for cash, securities or other property; except to certain permitted transferees and under certain circumstances (the &#8220;Lock-up&#8221;). Any permitted transferees will be subject to the same restrictions and other agreements of the company&#8217;s initial stockholders with respect to any founder shares. Notwithstanding the foregoing, the founder shares will be released from the Lock-up if the closing price of the Company&#8217;s Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the company&#8217;s initial business combination.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Private Placement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Simultaneously with the closing of the initial public offering, the Company&#8217;s Sponsor has purchased an aggregate of 3,500,000 private placement warrants, each exercisable to purchase one Class A common stock at $11.50 per share, at a price of $1.00 per warrant, or $3,500,000 in the aggregate.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The private placement warrants will not be redeemable by the Company so long as they are held by the initial purchasers or their permitted transferees. The initial purchasers, or their permitted transferees, have the option to exercise the private placement warrants on a cashless basis. If the private placement warrants are held by holders other than initial purchasers or their permitted transferees, the private placement warrants will be redeemable by the Company and exercisable by the holders on the same basis as the warrants included in the units being sold in the initial public offering. Otherwise, the private placement warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in the initial public offering.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the private placement warrants are held by holders other than the Sponsor or its permitted transferees, the private placement warrants will be redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the units being sold in the initial public offering.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Loans and Advances</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2021, the Sponsor agreed to loan the Company up to $300,000 to be used for a portion of the expenses of the initial public offering (&#8220;Note&#8221;). This loan was non-interest bearing, unsecured and payable upon the closing of the initial public offering. In addition to the Note, the Sponsor of the Company also paid certain administrative expenses and offering costs on behalf of the Company. These advances were due on demand and were non-interest bearing. The Company repaid the note payable and advances in exchange for the issuance of private placement warrants.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in order to finance transaction costs in connection with an intended business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#8217;s officers and directors may, but are not obligated to, loan the Company funds as may be required on a non-interest basis (&#8220;Working Capital Loans&#8221;). If the Company completes the initial business combination, it will repay the Working Capital Loans. In the event that the initial business combination does not close, the Company may use a portion of the working capital held outside the trust account to repay the Working Capital Loans but no proceeds from the trust account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-business combination entity at a price of $1.00 per warrant at the option of the lender. Such warrants would be identical to the private placement warrants. Except as set forth above, the terms of Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of December 31, 2021, the Company had no borrowings under the Working Capital Loans.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Administrative Service Fee</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the closing of the initial public offering, the Company will pay its Sponsor $10,000 per month for office space, secretarial and administrative services provided to members of the management team. Upon completion of the initial business combination or the Company&#8217;s liquidation, the Company will cease paying these monthly fees. For the period from January 28, 2021 (inception) through December 31, 2021, the Company incurred $50,000 of such fees, included as general and administrative fees &#8212; related party on the accompanying statement of operations. As of December 31, 2021, approximately $50,000 of such fees are included as due to related party on the accompanying balance sheet.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9 &#8212; Related Party Transactions</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021, the Company had an equity ownership in LanzaJet and SGLT with an aggregate carrying value of $26,037 and $24,752, respectively. The table below summarizes amounts related to transactions with these related parties (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,116&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,509&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases and open accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounts payable balance is for work that LanzaJet performed as a subcontractor to the Company. Refer to Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for more information. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the formation of LanzaJet, the Company entered into a transition services agreement with LanzaJet. The transition services agreement generally sets out the respective rights, responsibilities and obligations of the Company and LanzaJet with respect to R&amp;D services, access to office and laboratory space, business development and other administrative support services. The transition services agreement may be terminated by mutual consent of the Company and LanzaJet, by LanzaJet at any time, and by the Company upon breach or non-payment by LanzaJet. There are no substantive termination penalties in the event the Company terminates. For the nine months ended September&#160;30, 2022 and September&#160;30, 2021, the Company recognized revenue from related parties of approximately $148 and $355, respectively, under the transition services agreement. The Company also provides certain engineering and other services related to a gas-to-jet demonstration plant currently in development by LanzaJet pursuant to the Investment Agreement described in Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In connection with these services, the Company recognized revenue from LanzaJet of approximately $170 and $403, for the nine months ended September&#160;30, 2022 and September&#160;30, 2021, respectively. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, the Company executed an agreement to lease certain land to a subsidiary of LanzaJet for a period of 10 years with an option to renew this lease for five additional periods of one year with minimum annual rent due to the Company of $24. The lease commenced upon execution of the lease agreement and was subsequently amended in 2022 to extend the Pre-Development Term and annual rent amount. Refer to Note 12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for more information.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company supplies SGLT with certain water-soluble organic compounds required in the Company's proprietary gas fermentation process, and small-size equipment. As a result, for the nine months ended September&#160;30, 2022 and September&#160;30, 2021, the Company recognized revenue from related parties of approximately $151 and $69, respectively. The Company also provided engineering services and incurred costs of $$893 and $1,171 for the nine months ended September&#160;30, 2022 and September&#160;30, 2021, respectively. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, LanzaTech and SGLT entered into a license agreement in 2019, subsequently amended in 2021, to provide SGLT with the right to sublicense the intellectual property that LanzaTech previously licensed to SGLT. In exchange, the Company is entitled to receive licensing consideration, calculated as a percentage of the royalties received by SGLT from the sublicenses. Currently, SGLT sublicenses to certain of its subsidiaries that use LanzaTech's proprietary technology. The royalties received by SGLT are based on sales-and-usage of the sublicensed technology. For the nine months ended September&#160;30, 2022, and September&#160;30, 2021, the Company did not earn any sublicensing revenue as no royalties were received by SGLT.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div>Related Party Transactions<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, the Company had an equity ownership in LanzaJet and SGLT with an aggregate carrying value of $24,752 and $23,217, respectively. Trade receivables and contract assets of $1,071 and $3,257, from these equity method investees are included in accounts receivable, respectively. The Company made purchases and had open accounts payable of $2,575 as of and for the year ended December&#160;31, 2021. The accounts payable balance is for work that LanzaJet performed as a subcontractor to the Company. Refer to Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s, for more information.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the formation of LanzaJet, the Company entered into a transition services agreement with LanzaJet. The transition services agreement generally sets out the respective rights, responsibilities and obligations of the Company and LanzaJet with respect to R&amp;D services, business development and other administrative support services. The transition services agreement may be terminated by mutual consent of the Company and LanzaJet, by LanzaJet at any time, and by the Company upon breach or non-payment by LanzaJet. There are no substantive termination penalties in the event the Company terminates. During the years ended December&#160;31, 2021 and 2020, the Company recognized revenue from related parties of approximately $495 and $285, respectively, under the transition services agreement. The Company provides certain engineering and other services related to a gas-to-jet demonstration plant currently in development by LanzaJet pursuant to the Investment Agreement described in Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As a result, during the years ended December&#160;31, 2021 and 2020, the Company recognized revenue from related parties of approximately $428 and $2,740, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company supplies SGLT with its biocatalyst, certain water-soluble organic compounds required in the Company's proprietary gas fermentation process, and small-size equipment. As a result, during 2021 and 2020 the Company recognized revenue from related parties of approximately $282 and $156, respectively. The Company also provided engineering services and incurred costs of $1,223 and $242 during the years ended December&#160;31, 2021 and 2020, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, LanzaTech and SGLT entered into a license agreement in 2019, subsequently amended in 2021, to provide SGLT with the right to sublicense the intellectual property that LanzaTech previously licensed to SGLT. In </span></div>exchange, the Company is entitled to receive licensing consideration, calculated as a percentage of the royalties received by SGLT from the sublicenses. Currently, SGLT sublicenses to certain of its subsidiaries that use LanzaTech's proprietary technology. The royalties to be received by SGLT are based on sales-and-usage of the sublicensed technology. For the years ended December&#160;31, 2021 and 2020, the Company did not earn any sublicensing revenue as no royalties were received by SGLT.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272210260256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5 &#8212; Commitments and Contingencies</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Registration Rights</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of the (i) founder shares, which were issued in a private placement prior to the closing of the initial public offering, (ii) private placement warrants, which were issued in a private placement simultaneously with the closing of the initial public offering and the shares of Class A common stock underlying such private placement warrants and (iii) private placement warrants that may be issued upon conversion of Working Capital Loans will have registration rights to require the Company to register a sale of any of its securities held by them prior to the consummation of the initial business combination pursuant to a registration rights agreement to be signed prior to or on the effective date of the initial public offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent to the Company&#8217;s completion of its initial business combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. In addition, the Anchor Investors will, upon receipt of their founder shares, execute a registration rights agreement with respect to their founder shares.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Underwriting Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted the underwriters a 45-day option from the date of the underwriting agreement to purchase up to an additional 2,250,000 units to cover over-allotments, if any. On September 17, 2021, the over-allotment option expired unexercised, resulting in the forfeiture of 562,500 shares of founder shares. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters were paid an underwriting discount of one percent (1%) of the gross proceeds of the initial public offering, or $1,500,000. Additionally, in connection with the initial public offering, the Company agreed to pay the underwriters a deferred underwriting fee of 3.5% of the gross proceeds, or $5,250,000, of the initial public offering upon the completion of the Company&#8217;s initial business combination. On September 29, 2022, as discussed further below, Evercore Group L.L.C., (&#8220;Evercore&#8221;) the representative of the underwriters of the initial public offering, waived its deferred underwriting fee that accrued from its participation in the initial public offering. The Company recognized approximately $4.9 million of the commissions waiver as a reduction to additional paid-in capital in the condensed statements of changes in stockholders&#8217; deficit for the three and nine months ended September 30, 2022, as this portion represents an extinguishment of deferred underwriting commissions on public shares which was originally recognized in accumulated deficit. The remaining balance of approximately $172,000 is recognized as a gain from extinguishment of deferred underwriting commissions on public warrants in the condensed statements of operations, which represents the original amount expensed in the Company&#8217;s initial public offering.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 27, 2022 and September 29, 2022, the Company received notice and a formal letter, respectively, from Evercore Group, L.L.C., an underwriter in the Company&#8217;s initial public offering, advising that it had, among other things, (i) resigned from and ceased or refused to act in, its roles as co-placement agent, co-capital markets advisor and exclusive financial advisor to the Company in connection with the Merger and as underwriter in the Company&#8217;s initial public offering and (ii) waived its right to receive an aggregate of $13,050,000 in fees, all of which were contingent upon and payable upon the closing of the Merger, consisting of $500,000 for its role as co-placement agent, $7,500,000 for its role as exclusive financial advisor and $5,050,000 of deferred underwriting fees accrued from its participation in the Company&#8217;s initial public offering, as well as any expense reimbursements owed to it under those arrangements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5 &#8212; Commitments and Contingencies</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Registration Rights</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of the (i) founder shares, which were issued in a private placement prior to the closing of the initial public offering, (ii) private placement warrants, which were issued in a private placement simultaneously with the closing of the initial public offering and the shares of Class A common stock underlying such private placement </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">warrants and (iii) private placement warrants that may be issued upon conversion of Working Capital Loans will have registration rights to require the Company to register a sale of any of its securities held by them prior to the consummation of the initial business combination pursuant to a registration rights agreement to be signed prior to or on the effective date of the initial public offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent to the Company&#8217;s completion of its initial business combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. In addition, the Anchor Investors will, upon receipt of their founder shares, execute a registration rights agreement with respect to their founder shares.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Underwriting Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted the underwriters a 45-day option from the date of the underwriting agreement to purchase up to an additional 2,250,000 units to cover over-allotments, if any. On September 17, 2021, the over-allotment option expired unexercised, resulting in the forfeiture of 562,500 shares of founder shares.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters were paid an underwriting discount of one percent (1%) of the gross proceeds of the initial public offering, or $1,500,000. Additionally, the underwriters will be entitled to a deferred underwriting discount of 3.5% of the gross proceeds, or $5,250,000, of the initial public offering upon the completion of the Company&#8217;s initial business combination.</span></div>Commitments and Contingencies<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may be involved in legal proceedings and exposed to potential claims in the normal course of business. As of September&#160;30, 2022 and December&#160;31, 2021, the Company does not have any reasonable possible or probable losses from such claims. </span></div>Commitments and ContingenciesLitigationThe Company may be involved in legal proceedings and exposed to potential claims in the normal course of business. As of December 31, 2021 and December 31, 2020, it is not probable that the Company has incurred any losses from such claims.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272210264528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Class A Common Stock Subject to Possible Redemption<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityDisclosureTextBlock', window );">Class A Common Stock Subject to Possible Redemption</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6 &#8212; Class A Common Stock Subject to Possible Redemption</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of future events. The Company is authorized to issue 280,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of the Company&#8217;s Class A common stock are entitled to one vote for each share. As of September 30, 2022 and December 31, 2021, there were 15,000,000 shares of Class A common stock outstanding subject to possible redemption and are classified outside of permanent equity in the condensed balance sheets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Class A common stock subject to possible redemption reflected on the condensed balance sheets is reconciled in the following table:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross proceeds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount allocated to public warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,100,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,306,092)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of carrying value to redemption value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,406,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock subject to possible redemption, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subsequent remeasurement of Class A common stock subject to possible redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock subject to possible redemption, September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,293,649&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6 &#8212; Class A Common Stock Subject to Possible Redemption</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of future events. The Company is authorized to issue 280,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of the Company&#8217;s Class A common stock are entitled to one vote for each share. As of December 31, 2021, there were 15,000,000 shares of Class A common stock outstanding subject to possible redemption and are classified outside of permanent equity in the balance sheet.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Class A common stock subject to possible redemption reflected on the balance sheet is reconciled in the following table:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross proceeds from Initial Public Offering</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of Public Warrants at issuance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,100,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Offering costs allocated to Class A common stock subject to possible redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,306,092)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion on Class A common stock subject to possible redemption amount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,406,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock subject to possible redemption</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Redeemable, Convertible Preferred Stock<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has six outstanding series of contingently redeemable convertible preferred stock. The authorized, issued and outstanding shares, issue price, and carrying value as of September&#160;30, 2022, are as follows (in thousands, except share and per share amounts):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.287%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares Authorized</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.75 - 3.94</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,254,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.69</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,274,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,161,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.93</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series F</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,747,033&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,631&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in redeemable convertible preferred stock issued and outstanding during the nine months ended September&#160;30, 2022. The holders of preferred shares are entitled to receive dividends on an as converted to common shares basis as if all preferred shares had been converted into common shares on the date of such event. Dividends are cumulative and are payable in arrears at the rate of 8% of the original issue price.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, a warrant was exercised for a total issuance of 158,058 Series D preferred shares which led to an increase in redeemable convertible preferred stock of $3,150 during the nine months ended September&#160;30, 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redemption features of preferred shares are not fixed and do not have a determinable price on fixed or determinable dates. As of September&#160;30, 2022, the preferred shares are not currently redeemable, and it is not probable that the preferred shares will become redeemable, since it is uncertain whether or when circumstances exist that would constitute a deemed liquidation event. Accordingly, the Company has not adjusted the carrying value of the preferred shares to their redemption values.</span></div>Redeemable, Convertible Preferred Stock<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has six outstanding series of contingently redeemable convertible preferred stock. The authorized, issued and outstanding shares, issue price, and carrying value as of December&#160;31, 2021 and 2020 are as follows (in thousands, except share and per share amounts):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares Authorized</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.75 - 3.94</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,254,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.69</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,274,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,161,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.93</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series F</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,747,033&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,631&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares Authorized</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Issue Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.75 - 3.94</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,254,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,142,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,274,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,003,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">185,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,112,823&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,729,542&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">394,408&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable convertible preferred stock issued and outstanding as of December&#160;31, 2021 and 2020, and changes during the years ended December&#160;31, 2021 and 2020, were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.874%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.508%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.470%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.310%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="81" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Redeemable Convertible Preferred Stock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series B</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series C</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series D</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series E</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series F</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10,003,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">185,252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,149,745&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">71,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">23,695,330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">347,938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Preferred stock issuance, net of costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,034,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">46,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,034,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">46,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10,003,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">185,252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">25,729,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">394,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Preferred stock issuance, net of costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">158,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,792,268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">86,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10,161,362&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">188,402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">480,631&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records all preferred shares net of offering costs at their respective fair values on the dates of issuance. The preferred shares are classified outside of shareholders&#8217; (deficit) equity in the consolidated financial statements, as the preferred shares are redeemable under circumstances that qualify as a deemed liquidation event, which are outside the control of the Company. Upon the occurrence of a liquidation event, such as a voluntary or involuntary liquidation, dissolution or winding up of the Company, merger, consolidation, or change in control, the holders of Series E preferred stock are entitled, on a pari passu basis, to be paid out of the assets of the Company available for distribution before any payment is made to the holders of Series A, B, C, and D preferred shares and then to holders of common shares. In February 2020, the Company closed a Series E follow-on round with the issuance of 2,034,212 Series E preferred shares for net proceeds of $46,470 ($22.86 per share). In March 2021, a warrant was exercised for a total issuance of 158,058 Series D preferred shares and net proceeds of $3,150 ($19.93 per share). In April 2021, the Company closed a Series F round with the issuance of 3,634,210 Series F preferred shares for the net proceeds of $83,073 ($22.86 per share).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of preferred shares are entitled to cast the number of votes equal to the number of whole common shares into which the preferred shares are convertible. The holders of preferred shares also have consent rights, including in a number of cases subject to a separate class vote and a supermajority requirement, over certain actions including, among others (i) alterations or changes to the terms of the preferred shares, (ii) the election of a certain number of directors, including the designation of directors by holders of a specified series of preferred shares or by certain specified individual stockholders, and (iii) repurchases of shares, the authorization or designation of more senior class or series of shares, or certain issuances of new shares.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preferred shares are convertible at the holder&#8217;s option into common shares generally on a share-for-share basis. Each preferred share will be automatically converted into common stock upon either (i) the determination of the holders of certain requisite preferred shares or (ii) a firmly underwritten initial public offering of the Company&#8217;s shares that satisfies certain requirements (but not, for the avoidance of doubt, upon a business combination with a special purpose acquisition company, unless such conversion is otherwise effected pursuant to clause (i) above).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of preferred shares are entitled to receive dividends on an as converted to common shares basis as if all preferred shares had been converted into common shares on the date of such event. Dividends are cumulative and are payable in arrears at the rate of 8% of the original issue price. If dividends are payable on common shares, preferred shareholders also receive those dividends as if the preferred shares had been converted to common shares. Series D, E, and F preferred shareholders are entitled to be paid dividends prior to Series A, B, and C, on a pari passu basis. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redemption features of preferred shares are not fixed and do not have a determinable price on fixed or determinable dates. As of December&#160;31, 2021 and 2020, preferred shares are not currently redeemable, and it is not probable that preferred shares will become redeemable, since it is uncertain whether or when circumstances exist </span></div>that would constitute a deemed liquidation event. Accordingly, the Company has not adjusted the carrying value of the preferred shares to their redemption values.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TemporaryEquityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure on temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TemporaryEquityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272210250688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity (Deficit)</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7 &#8212; Stockholders&#8217; Equity (Deficit)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Preferred Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 and provides that shares of preferred stock may be issued from time to time in one or more series. The Company&#8217;s board of directors will be authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">applicable to the shares of each series. As of September 30, 2022 and December 31, 2021, there were no shares of preferred stock issued or outstanding.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Class A Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The Company is authorized to issue 280,000,000 shares of Class A common stock with a par value of $0.0001 per share. As of September 30, 2022 and December 31, 2021, there were 15,000,000 shares of Class A common stock issued and outstanding, all of which were subject to possible redemption and are classified as temporary equity (see Note 6).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Class B Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The Company is authorized to issue 20,000,000 Class B common stock with a par value of $0.0001 per share. As of September 30, 2022 and December 31, 2021, there were 3,750,000 shares of Class B common stock issued and outstanding (see Note 4).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of the Company&#8217;s stockholders except as required by law. Unless specified in the Company&#8217;s amended and restated certificate of incorporation, or as required by applicable provisions of the Delaware General Corporation Law (&#8220;DGCL&#8221;) or applicable stock exchange rules, the affirmative vote of a majority of the Company&#8217;s shares of common stock that are voted is required to approve any such matter voted on by its stockholders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Class B common stock will automatically convert into shares of Class A common stock concurrently with or immediately following the consummation of the initial business combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in connection with the initial business combination, the number of shares of Class A common stock issuable upon conversion of all founder shares will equal, in the aggregate, on an as-converted basis, 20% of the total number of shares of Class A common stock outstanding after such conversion (after giving effect to any redemptions of shares of Class A common stock by public stockholders), including the total number of shares of Class A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial business combination, excluding any shares of Class A common stock or equity-linked securities or rights exercisable for or convertible into shares of Class A common stock issued, or to be issued, to any seller in the initial business combination and any private placement warrants issued to the Sponsor, officers or directors upon conversion of working capital loans, provided that such conversion of founder shares will never occur on a less than one-for-one basis.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7 &#8212; Stockholders&#8217; Deficit</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Preferred Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 and provides that shares of preferred stock may be issued from time to time in one or more series. The Company&#8217;s board of directors will be authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. As of December 31, 2021, there were no shares of preferred stock issued or outstanding.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Class A Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The Company is authorized to issue 280,000,000 shares of Class A common stock with a par value of $0.0001 per share. As of December 31, 2021, there were 15,000,000 shares of Class A common stock issued and outstanding, all of which were subject to possible redemption and are classified as temporary equity (see Note 6).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Class B Common Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; The Company is authorized to issue 20,000,000 Class B common stock with a par value of $0.0001 per share. As of December 31, 2021, there were 3,750,000 shares of Class B common stock issued and outstanding (see Note 4).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of the Company&#8217;s stockholders except as required by law. Unless specified in the Company&#8217;s amended and restated certificate of incorporation, or as required by applicable provisions of the Delaware General Corporation Law (&#8220;DGCL&#8221;) or applicable stock exchange rules, the affirmative vote of a majority of the Company&#8217;s shares of common stock that are voted is required to approve any such matter voted on by its stockholders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Class B common stock will automatically convert into shares of Class A common stock concurrently with or immediately following the consummation of the initial business combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in connection with the initial business combination, the number of shares of Class A common stock issuable upon conversion of all founder shares will equal, in the aggregate, on an as-converted basis, 20% of the total number of shares of Class A common stock outstanding after such conversion (after giving effect to any redemptions of shares of Class A common stock by public stockholders), including the total number of shares of Class A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial business combination, excluding any shares of Class A common stock or equity-linked securities or rights exercisable for or convertible into shares of Class A common stock issued, or to be issued, to any seller in the initial business combination and any private placement warrants issued to the Sponsor, officers or directors upon conversion of working capital loans, provided that such conversion of founder shares will never occur on a less than one-for-one basis.</span></div>Shareholders&#8217; EquityThe securities of the Company are represented by common shares, par value $0.0001 per share. Each common share is entitled to one vote. With respect to payment of dividends and distribution of assets upon liquidation, dissolution or winding up of the Company, whether voluntary or involuntary, all common shares shall participate pro rata in such payment whenever funds are legally available and when declared by the Board of Directors of the Company, subject to the prior rights of holders of all classes of stock outstanding.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272210198864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrants and Rights Note Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_WarrantsTextBlockTextBlock', window );">Warrants</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8 &#8212; Warrants</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022 and December 31, 2021, in connection with the initial public offering, the Company has 7,500,000 public warrants and 3,500,000 private placement warrants outstanding.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each whole warrant entitles the registered holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment as discussed below, at any time commencing 30 days after the completion of the initial business combination, provided that the Company has an effective registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement) and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder. The warrants will expire five years after the completion of the Company&#8217;s initial business combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreed that as soon as practicable, but in no event later than fifteen (15) business days after the closing of the initial business combination, it will use its best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A common stock issuable upon exercise of the warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the shares of Class A </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">common stock issuable upon exercise of the warrants is not effective by the sixtieth (60th) business day after the closing of the initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Company&#8217;s Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a &#8220;covered security&#8221; under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of public warrants who exercise their warrants to do so on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, it will not be required to file or maintain in effect a registration statement, and in the event the Company do not so elect, it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once the warrants become exercisable, the Company may redeem the outstanding warrants:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in whole and not in part;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at a price of $0.01 per warrant;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">upon a minimum of 30 days&#8217; prior written notice of redemption to each warrant holder; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if, and only if, the closing price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading &#8220;&#8212; Warrants&#8201;&#8212;&#8201;Public Stockholders&#8217; Warrants&#8201;&#8212;&#8201;Anti-Dilution Adjustments&#8221;) for any 20 trading days within a 30-trading day period ending three trading days before we send the notice of redemption to the warrant holders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once the warrants become exercisable, the Company may redeem the outstanding warrants:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in whole and not in part;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at $0.10 per warrant upon a minimum of 30 days&#8217; prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table below, based on the redemption date and the &#8220;fair market value&#8221; (as defined below) of our Class A common stock except as otherwise described below; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if, and only if, the closing price of our Class A common stock equals or exceeds $10.00 per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading &#8220;&#8212; Warrants&#8201;&#8212;&#8201;Public Stockholders&#8217; Warrants&#8201;&#8212;&#8201;Anti-Dilution Adjustments&#8221;) for any 20 trading days within the 30-trading day period ending three trading days before we send the notice of redemption to the warrant holders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if (x) the Company issue additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of our initial business combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by the Company&#8217;s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any founder shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the &#8220;Newly Issued Price&#8221;), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of our initial business combination on the date of the consummation of the initial business combination (net of redemptions), and (z) the volume weighted average trading price of the Company&#8217;s Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummate the initial business combination (such price, the &#8220;Market Value&#8221;) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption </span></div>trigger price described above under &#8220;&#8212; Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00&#8221; will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described above under &#8220;&#8212; Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00&#8221; will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8 &#8212; Warrants</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, in connection with the initial public offering, the Company has 7,500,000 public warrants and 3,500,000 private placement warrants outstanding.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each whole warrant entitles the registered holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment as discussed below, at any time commencing 30 days after the completion of the initial business combination, provided that the Company has an effective registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement) and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder. The warrants will expire five years after the completion of the Company&#8217;s initial business combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreed that as soon as practicable, but in no event later than fifteen (15) business days after the closing of the initial business combination, it will use its best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A common stock issuable upon exercise of the warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the sixtieth (60th) business day after the closing of the initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Company&#8217;s Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a &#8220;covered security&#8221; under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of public warrants who </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">exercise their warrants to do so on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, it will not be required to file or maintain in effect a registration statement, and in the event the Company do not so elect, it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once the warrants become exercisable, the Company may redeem the outstanding warrants:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in whole and not in part;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at a price of $0.01 per warrant;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">upon a minimum of 30 days&#8217; prior written notice of redemption to each warrant holder; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if, and only if, the closing price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading &#8220;&#8212; Warrants &#8212; Public Stockholders&#8217; Warrants &#8212; Anti-Dilution Adjustments&#8221;) for any 20 trading days within a 30-trading day period ending three trading days before we send the notice of redemption to the warrant holders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once the warrants become exercisable, the Company may redeem the outstanding warrants:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in whole and not in part;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at $0.10 per warrant upon a minimum of 30 days&#8217; prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table below, based on the redemption date and the &#8220;fair market value&#8221; (as defined below) of our Class A common stock except as otherwise described below; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if, and only if, the closing price of our Class A common stock equals or exceeds $10.00 per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading &#8220;&#8212; Warrants &#8212; Public Stockholders&#8217; Warrants &#8212; Anti-Dilution Adjustments&#8221;) for any 20 trading days within the 30-trading day period ending three trading days before we send the notice of redemption to the warrant holders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if (x) the Company issue additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of our initial business combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by the Company&#8217;s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any founder shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the &#8220;Newly Issued Price&#8221;), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of our initial business combination on the date of the consummation of the initial business combination (net of redemptions), and (z) the volume weighted average trading price of the Company&#8217;s Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummate the initial business combination (such price, the &#8220;Market Value&#8221;) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price described above under &#8220;&#8212; Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00&#8221; will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described above under &#8220;&#8212; Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00&#8221; will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_WarrantsTextBlockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the entire disclosure of warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_WarrantsTextBlockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211091776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9 &#8212; Fair Value Measurements </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information about the Company&#8217;s financial assets and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy:</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September 30, 2022</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other <br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held in trust account</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,969,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201;public warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201;private placement warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493,280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2021</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held in trust account</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,006,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201; public warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,825,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201;private placement warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transfers to/from Levels 1, 2 and 3 are recognized at the beginning of the reporting period. The estimated fair value of public warrants was transferred from a Level 3 fair value measurement to a Level 1 measurement, when the public warrants were separately listed and traded in September 2021. There were no other transfers between levels in the nine months ended September 30, 2022 and in the period from January 28, 2021 (inception) through December 31, 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 assets include investments in mutual funds invested in U.S. government securities and derivative warrant liabilities (public warrants). The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For periods where no observable traded price is available, the fair value of the public warrants has been estimated using a Monte-Carlo simulation model and the private placement warrants has been estimated using a Black-Scholes option pricing model. For periods subsequent to the detachment of the public warrants from the units, the fair value of the public warrants is based on the observable listed price for such warrants. The estimated fair value of the public and private placement warrants, prior to the public warrants being traded in an active market, was determined using Level 3 inputs. Inherent in a Monte-Carlo simulation and Black-Scholes option pricing model are assumptions related to the unit price, expected volatility, risk-free interest rate, term to expiration, and dividend yield. The unit price is based on the publicly traded price of the units as of the measurement date. The Company estimated the volatility for the public and private placement warrants based on the implied volatility from the traded prices of warrants issued by other special purpose acquisition companies. The risk-free interest rate is based on </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">interpolated U.S. Treasury rates, commensurate with a similar term to the public and private placement warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. Finally, the Company does not anticipate paying a dividend. Any changes in these assumptions can change the valuation significantly.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2022 and 2021, the Company recognized a change to the statement of operations resulting from a decrease (increase) in the fair value of liabilities of approximately $1.4 million and $1.4 million, respectively, presented as change in fair value of derivative warrant liabilities on the accompanying statements of operations. For the nine months ended September 30, 2022 and for the period from January 28, 2021 (inception) through September 30, 2021, the Company recognized a change to the statement of operations resulting from a decrease (increase) in the fair value of liabilities of approximately $4.1 million and $1.4 million, respectively, presented as change in fair value of derivative warrant liabilities on the accompanying statements of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30, 2022 </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2021 </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.19</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.75</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the fair value of the derivative warrant liabilities, measured using Level 3 inputs, for the three and nine months ended September 30, 2022 is summarized as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,030,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,085,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(451,720)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493,280&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9 &#8212; Fair Value Measurement </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information as of December 31, 2021 about the Company&#8217;s financial assets and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held in Trust Account</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,006,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities &#8211; Public Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,825,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities &#8211; Private Placement Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transfers to/from Levels 1, 2 and 3 are recognized at the beginning of the reporting period. The estimated fair value of public warrants was transferred from a Level 3 fair value measurement to a Level 1 measurement, when the public warrants were separately listed and traded in September 2021. There were no other transfers between levels in the period from January 28, 2021 (inception) through December 31, 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 assets include investments in mutual funds invested in U.S. government securities and derivative warrant liabilities (public warrants). The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For periods where no observable traded price is available, the fair value of the public warrants has been estimated using a Monte-Carlo simulation model and the private placement warrants has been estimated using a Black-Scholes option pricing model. For periods subsequent to the detachment of the public warrants from the units, the fair value of the public warrants is based on the observable listed price for such warrants. The estimated fair value of the public and private placement warrants, prior to the public warrants being traded in an active market, was determined using Level 3 inputs. Inherent in a Monte-Carlo simulation and Black-Scholes option pricing model are assumptions related to the unit price, expected volatility, risk-free interest rate, term to expiration, and dividend yield. The unit price is based on the publicly traded price of the units as of the measurement date. The Company estimated the volatility for the public and private placement warrants based on the implied volatility from the traded prices of warrants issued by other special purpose acquisition companies. The risk-free interest rate is based on interpolated U.S. Treasury rates, commensurate with a similar term to the public and private placement warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. Finally, the Company does not anticipate paying a dividend. Any changes in these assumptions can change the valuation significantly.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of <br/>December 31, 2021 </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of <br/>August 6, 2021 </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining term (yrs)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.75</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.51</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the fair value of the derivative warrant liabilities, measured using Level 3 inputs, for the period from January 28, 2021 (inception) through December 31, 2021 is summarized as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at January 28, 2021 (inception)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of Public and Private Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,515,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer of Public Warrants to Level 1</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,100,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(630,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6 &#8212; Fair Value</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value hierarchy for its assets and liabilities measured at fair value as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,815&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,815&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has warrants to purchase preferred shares outstanding as of September&#160;30, 2022 and December&#160;31, 2021 representing 225,223 and 225,223 preferred shares, respectively, which warrants expire at various dates through December 31, 2027. The exercise prices of the warrants range from $14.69 to $19.93 as of each of September&#160;30, 2022 and December&#160;31, 2021. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The warrants are accounted for as liabilities in accordance with ASC 480, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distinguishing Liability from Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and are presented within other accrued liabilities on the condensed consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the condensed consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The fair value of the warrants was calculated using the Black-Scholes Option Pricing Model. For the nine months ended September&#160;30, 2022 and 2021, the Company recognized a change in the fair value of liabilities of approximately $(427) and $(699), respectively, on the condensed consolidated statements of operations and comprehensive loss within other (expense) income, net.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the warrants is determined using Level 3 inputs. Inherent in the Black-Scholes Option Pricing Model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its warrants based on implied volatility from the Company&#8217;s warrants and from historical volatility of select peer companies that match the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the weighted average inputs used in calculating the fair value of the preferred share warrants outstanding as of September&#160;30, 2022 and December&#160;31, 2021:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.03&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SAFE Liability and SAFE Warrant</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company issued a SAFE that allowed an investor to participate in future equity financings through a share-settled redemption of the amount invested (such notional being the &#8220;invested amount&#8221;). The SAFE had not yet converted as a qualifying financing had not yet occurred as of September&#160;30, 2022. At September&#160;30, 2022, the SAFE had a fair value of $27,221 and was recorded within current liabilities on the condensed consolidated balance sheet. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, the warrant related to the SAFE of $2,022 as of September&#160;30, 2022 is accounted for as a liability. This liability is recorded in current liabilities on the Company's condensed consolidated balance sheets at fair value on the date of issuance and will be revalued each subsequent reporting period until such instrument is exercised or expires. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in fair value between reporting periods for both the SAFE liability and SAFE warrant is included in other (expense) income, net in the condensed consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s SAFE liability and SAFE warrant are mark-to-market liabilities pursuant to ASC 480 and are classified within Level 3 of the fair value hierarchy as the Company is using a scenario-based approach which allowed the Company to estimate the implied value of the business based on the terms of the SAFE. Significant unobservable inputs included probability and expected term. Probability is based upon the likelihood of the Company closing a transaction with a special purpose acquisition company. The expected term was based on the anticipated time until the SAFE investments would have a conversion event. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE liability fair value measurement at September&#160;30, 2022 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liquidity price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE warrant fair value measurement at September&#160;30, 2022 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining life (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables represents a reconciliation of the contingent shares issuance liabilities fair value measurements using the significant unobservable inputs (Level 3) (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrants</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE warrant</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss / (gain) recognized in condensed statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,050)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,221&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrants</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE warrant</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of SAFE liability and warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss recognized in condensed statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,281&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div>Fair Value<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value hierarchy for its assets and liabilities measured at fair value as of December&#160;31, 2021 and 2020 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:13pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The warrants are accounted for as liabilities in accordance with ASC 480 and are presented within other accrued liabilities on the consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the warrants was calculated using the Black-Scholes Option Pricing Model. For the years ended December&#160;31, 2021 and 2020, the Company recognized a change in the fair value of liabilities of approximately $(563) and $105, respectively, on the statements of operations and comprehensive loss within other income (expense), net.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the warrants is determined using Level 3 inputs. Inherent in the Black-Scholes Option Pricing Model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its warrants based on implied volatility from the Company&#8217;s warrants and from historical volatility of select peer companies that match the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the weighted average inputs used in calculating the fair value of the preferred share warrants outstanding as of December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s SAFE liability and SAFE warrant are mark-to-market liabilities pursuant to ASC 480 and are classified within Level 3 of the fair value hierarchy as the Company is using a scenario-based approach which allowed the Company to estimate the implied value of the business based on the terms of the SAFE. Significant unobservable inputs included probability and expected term. Probability is based upon the likelihood of the Company closing a transaction with a special purpose acquisition company. The expected term was based on the anticipated time until the SAFE investments would have a conversion event. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE liability fair value measurement at December 31, 2021 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liquidity price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE warrant fair value measurement at December 31, 2021 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining life (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents a reconciliation of the contingent shares issuance liabilities fair value measurements using the significant unobservable inputs (Level 3) (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain recognized in statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of SAFE liability and warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss recognized in statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, a warrant was exercised for a total issuance of 158,058 Series D preferred shares. The fair value of this warrant was $107 as of January 1, 2020 and was remeasured to zero as of December 31, 2020. As a result, the exercise had no impact on the consolidated statement of operations and comprehensive loss as of and for the year ended December 31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272210232976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10 &#8212; Subsequent Events</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 18, 2022, the Company entered into additional subscription agreements (the &#8220;Subscription Agreements&#8221;) with certain accredited investors (collectively, the &#8220;Additional PIPE Investors&#8221;), pursuant to which, among other things, the Company agreed to issue and sell, in a private placement to close immediately prior to the closing of the Merger, an aggregate of 5,500,000 shares of Class A common stock at a purchase price of $10.00 per share to the Additional PIPE Investors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated subsequent events and transactions that occurred up to the date the unaudited condensed financial statements were issued. Based upon this review and except in the case of the foregoing, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11 &#8212; Subsequent Events</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated subsequent events and transactions that occurred up to the date financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2022, the Company entered into the Merger Agreement with Merger Sub and LanzaTech. The transactions contemplated by the Merger Agreement are referred to herein as the &#8220;Business Combination.&#8221; The time of the closing of the Business Combination is referred to herein as the &#8220;Closing.&#8221; The date of the Closing of the Business Combination is referred to herein as the &#8220;Closing Date.&#8221;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposed Business Combination</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Business Combination is approved by the Company&#8217;s stockholders and LanzaTech&#8217;s stockholders, and the closing conditions in the Merger Agreement are satisfied or waived, then, among other things, upon the terms and subject to the conditions of the Merger Agreement and in accordance with Delaware General Corporation Law, Merger Sub will merge with and into LanzaTech, with LanzaTech surviving the merger as the Company&#8217;s wholly owned subsidiary (the &#8220;Merger&#8221;). In connection with the consummation of the Merger, the Company will be renamed &#8220;LanzaTech Global, Inc.&#8221; and is referred to herein as &#8220;New LanzaTech&#8221; as of the time following such change of name.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Merger Agreement, the Company has agreed to acquire all of the outstanding equity interests of LanzaTech for consideration consisting of equity interests of New LanzaTech valued at $1,817,000,000 in the aggregate. The consideration to be paid to holders of shares of LanzaTech capital stock will be shares of common stock of New LanzaTech (&#8220;New LanzaTech Common Stock&#8221;), valued at $10.00 per share, to be paid at the closing of the Merger. The number of shares of New LanzaTech Common Stock payable in the Merger in respect of each share of LanzaTech capital stock (each, a &#8220;LanzaTech Share&#8221;) will be determined based on the exchange ratio (the &#8220;Exchange Ratio&#8221;), and certain corresponding adjustments, in each case as set forth in the Merger Agreement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, at Closing: (i) each warrant to purchase LanzaTech Shares (each, a &#8220;LanzaTech Warrant&#8221;) that is outstanding and unexercised immediately prior to Closing and would automatically be exercised or exchanged in full in accordance with its terms by virtue of the occurrence of the Merger, will be so automatically exercised or exchanged in full for the applicable LanzaTech Shares, and each such LanzaTech Share will be treated as being issued and outstanding immediately prior to Closing and will be canceled and converted into the right to receive the applicable shares of New LanzaTech Common Stock; and (ii) each LanzaTech Warrant that </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is outstanding and unexercised immediately prior to the Closing and is not automatically exercised in full as described in clause (i) will be converted into a warrant to purchase shares of New LanzaTech Common Stock, in which case (a) the number of shares underlying such New LanzaTech warrant (each, a &#8220;New LanzaTech Warrant&#8221;) will be determined by multiplying the number of LanzaTech Shares subject to such warrant immediately prior to Closing, by the Exchange Ratio and (b) the per share exercise price of such New LanzaTech Warrant will be determined by dividing the per share exercise price of such LanzaTech Warrant immediately prior to the Effective Time by the Exchange Ratio, except that in the case of certain warrants specified in the Merger Agreement, such exercise price will be $10.00.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, at Closing, each option to purchase LanzaTech Shares (each, a &#8220;LanzaTech Option&#8221;) will be converted into an option to purchase a number of shares of New LanzaTech Common Stock (rounded down to the nearest whole share) equal to the product of (i) the number of LanzaTech Shares subject to such LanzaTech Option multiplied by (ii) the Exchange Ratio. The exercise price of such New LanzaTech option will be equal to the quotient of (a) the exercise price per share of such LanzaTech Option in effect immediately prior to the Effective Time divided by (b) the Exchange Ratio (and as so determined, this exercise price will be rounded up to the nearest full cent).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, at Closing, each award of restricted shares of LanzaTech common stock (each, a &#8220;LanzaTech RSA&#8221;) that is outstanding immediately prior to the Effective Time will be converted into an award of restricted shares of New LanzaTech Common Stock (each, a &#8220;New LanzaTech RSA&#8221;) on the same terms and conditions as were applicable to such LanzaTech RSA immediately prior to the Effective Time, except that such New LanzaTech RSA will relate to a number of shares of New LanzaTech Common Stock equal to the number of LanzaTech Shares subject to such LanzaTech RSA, multiplied by the Exchange Ratio.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The closing of the Merger is subject to certain customary conditions, including, among others, (i) adoption by AMCI&#8217;s stockholders and LanzaTech&#8217;s stockholders of the Merger Agreement and their approval of certain other actions related to the Business Combination, (ii) the expiration or termination of the waiting period (or any extension thereof) applicable to the transactions contemplated by the Merger Agreement and any ancillary agreements, in each case under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, (iii) the effectiveness of a registration statement on Form S-4 (the &#8220;Registration Statement&#8221;) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) with respect to the shares of New LanzaTech Common Stock to be paid as consideration in the Merger, (iv) there being no government order or law enjoining, prohibiting or making illegal the consummation of the Merger or the transactions contemplated by the Merger Agreement, (v) AMCI having at least $5,000,001 of net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) under the Exchange Act) after giving effect to any payments required to be made in connection with the redemption of AMCI&#8217;s public shares and the proceeds from the Subscription Agreements described below, (vi) AMCI having at least $230,000,000 of cash at the closing of the Merger, consisting of cash held in AMCI&#8217;s trust account after taking into account any redemption of AMCI&#8217;s public shares, and the proceeds from the Subscription Agreements described below, net of transaction expenses of AMCI and LanzaTech, and (vii) the listing on Nasdaq of the shares of New LanzaTech Common Stock issued in connection with the Business Combination.</span></div> Subsequent Events<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated events occurring subsequent to September&#160;30, 2022 through December 12, 2022, the date the condensed consolidated financial statements were available to be issued. The Company has identified two transactions with BGTF LT Aggregator LP (&#8220;Brookfield&#8221;), an affiliate of Brookfield Asset Management Inc, and a transaction with LanzaJet, described as follows:</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Brookfield Framework Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 2, 2022, LanzaTech entered into a framework agreement with Brookfield (the &#8220;Brookfield Framework Agreement&#8221;). Under such agreement, LanzaTech agreed to exclusively offer Brookfield the opportunity to acquire or invest in certain projects to construct commercial production facilities employing carbon capture and transformation technology in the U.S., the European Union, the United Kingdom, Canada or Mexico for which LanzaTech is solely or jointly responsible for obtaining or providing equity financing, subject to certain exceptions. LanzaTech agreed to present Brookfield with projects that over the term of the agreement require equity funding of at least $500,000,000 in the aggregate. With respect to projects acquired by Brookfield, LanzaTech is entitled to a percentage of free cash flow generated by such projects determined in accordance with a hurdle-based return waterfall. Brookfield has no obligation under the Brookfield Framework Agreement to invest in any of the projects.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Brookfield SAFE</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 2, 2022, LanzaTech entered into a Simple Agreement for Future Equity (the &#8220;Brookfield SAFE&#8221;) with Brookfield. Under the Brookfield SAFE, LanzaTech agreed to issue to Brookfield the right to certain shares of its capital stock, the issuance of which is conditional upon LanzaTech obtaining certain necessary stockholder approvals and waivers, in exchange for the payment of $50,000,000 (the &#8220;Initial Purchase Amount&#8221;). On the fifth anniversary of the Brookfield SAFE, LanzaTech will repay in cash any remaining unconverted portion of the Initial Purchase Amount (the &#8220;Remaining Amount&#8221;) less any Non-Repayable Amount (as described below), plus interest in the high single digits, compounded annually. Brookfield has the option to extend the repayment date to the tenth anniversary of the date of the Brookfield SAFE if certain events do not occur.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the first of either (a) a transaction with the principal purpose of raising capital, pursuant to which LanzaTech issues and sells preferred stock at a fixed valuation (an &#8220;Equity Financing&#8221;), or (b) the completion of an initial public offering, a direct listing, or a merger of LanzaTech with a special purpose acquisition company, which includes the Business Combination (such a merger, a &#8220;de-SPAC Transaction&#8221; and such event described in (b), a &#8220;Liquidity Event&#8221;), Brookfield may, at any time at its option, convert all or a portion of the Initial Purchase Amount less any amount that has already been converted or repaid into shares of LanzaTech capital stock or, in the case of a de-SPAC Transaction, shares of common stock of the surviving public company in such de-SPAC Transaction (including, in the case of the Business Combination, New LanzaTech Common Stock). </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each $50,000,000 of aggregate equity funding required for qualifying projects acquired by Brookfield in accordance with the Brookfield Framework Agreement, the Remaining Amount will be reduced by $5,000,000 (such cumulative reductions the &#8220;Non-Repayable Amount&#8221;). Upon the first Equity Financing or Liquidity Event, the Non-Repayable Amount would convert automatically into shares of LanzaTech capital stock or, in the case of a de-SPAC Transaction, shares of common stock of the surviving public company in such de-SPAC Transaction (including, in the case of the Business Combination, New LanzaTech Common Stock), and thereafter, the Non-Repayable Amount will convert automatically on an as accrued basis.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LanzaJet Shareholder Loan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 9, 2022, the Company and the other LanzaJet shareholders entered into a Note Purchase Agreement (the &#8220;Note Purchase Agreement&#8221;), pursuant to which LanzaJet Freedom Pines Fuels LLC (&#8220;FPF&#8221;), a wholly owned subsidiary of LanzaJet, will issue, from time to time, notes in an aggregate principal amount of up to $147.0&#160;million (the &#8220;Notes&#8221;), comprised of approximately $113.5&#160;million aggregate principal amount of 6.00% Senior Secured Notes due December 31, 2043 and $33.5&#160;million aggregate principal amount of 6.00% Subordinated Secured Notes due December 31, 2043. The Company has committed to purchase $5.5&#160;million of Subordinated Secured Notes in a funding scheduled to occur on May 1, 2023. The Senior Secured Notes are secured by a security </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">interest over substantially all assets of FPF, and both the Senior Secured Notes and the Subordinated Secured Notes are secured by a security interest over all intellectual property owned or in-licensed by LanzaJet. LanzaJet also provides a guarantee of any costs and expenses required to complete the LanzaJet Freedom Pines Demonstration Facility and achieve commercial operation. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each purchaser of Notes under the Note Purchase Agreement is also entitled to receive a warrant for the right to purchase 575 shares of common stock of LanzaJet for each $10,000 of Notes purchased by such purchaser (which, in the case of the Company, will be equal to a right to purchase 316,250 shares of common stock of LanzaJet).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LanzaJet Note Purchase Agreement may be amended with the approval of holders of FPF and all holders of the LanzaJet Notes.  Upon an event of default under the Note Purchase Agreement, each purchaser may accelerate its own Notes. Enforcement against the collateral securing the Notes requires the approval of certain holders as specified in the Notes.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amended Merger Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Merger Agreement was amended on December 7, 2022, to provide for, among other things, (i) the inclusion of the aggregate net proceeds from each of the AM SAFE Note and Brookfield SAFE in the Acquiror Closing Cash Amount, (ii) the reduction of the Minimum Closing Cash Condition from $250,000,000 to $230,000,000, (iii) the clarification that, to the extent that the Brookfield SAFE remains unexercised at Closing, it will be assumed by AMCI, remain in effect on the same terms and conditions as are in effect prior to the Closing and thereafter entitle the holder thereof to be issued shares of common stock in AMCI after the Closing, (iv) the clarification that, in the event that it becomes reasonably apparent to the parties that the Acquiror Closing Cash Amount will be less than the Minimum Closing Cash Condition, AMCI will use commercially reasonable efforts to enter into non-redemption agreements, or similar agreements, as may be necessary to satisfy the Minimum Closing Cash Condition, (v) the extension of the outside date applicable to the Closing from December 7, 2022 to February 28, 2023 and (vi) the elimination of LanzaTech's right to terminate the agreement in the event that we fail to, on or prior to July 7, 2022, enter into one or more additional subscription agreements or non-redemption agreements as a result of which the sum of the PIPE Investment Amount (including net proceeds under the AM SAFE Note to LanzaTech) and the aggregate number of shares of Class A common stock subject to non-redemption agreements multiplied by $10.00, minus certain transaction expenses and other liabilities at Closing, would be equal to at least the Minimum Closing Cash Condition.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div>Subsequent Events<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated events occurring subsequent to December&#160;31, 2021 through May 9, 2022, the date the consolidated financial statements were available to be issued. The Company is not aware of any significant or material subsequent event that would require disclosure.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposed Merger</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2022, the Company entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with AMCI Acquisition Corp. II, a Delaware corporation (&#8220;AMCI&#8221;) and AMCI Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of AMCI (&#8220;Merger Sub&#8221;). Under the Merger Agreement, Merger Sub will merge with and into LanzaTech, with LanzaTech surviving the Merger as a wholly-owned subsidiary of AMCI (&#8220;the Merger&#8221;). In connection with the Merger, AMCI will be renamed LanzaTech Global, Inc (&#8220;New LanzaTech&#8221;). AMCI has agreed to acquire all of the outstanding equity interests of LanzaTech for consideration consisting of an equity interest of New LanzaTech valued at approximately $1.8&#160;billion. Completion of the transaction is subject to certain customary regulatory consents and approval by stockholders of AMCI and the Company.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger Agreement, on March 8, 2022, AMCI entered into subscription agreements with certain investors pursuant to which AMCI agreed to issue and sell a private placement to close immediately prior to the Merger.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272210233504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Organization and Business Operations<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Description of Organization and Business Operations</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1 &#8212; Description of Organization and Business Operations</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AMCI Acquisition Corp. II (the &#8220;Company&#8221;) is a blank check company incorporated as a Delaware corporation on January 28, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the &#8220;business combination&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, the Company has neither engaged in any operations nor generated any revenues. All activity to date relates to the Company&#8217;s formation and the initial public offering (as defined below), described below and since the initial public offering, its search for a business combination target. The Company will not generate any operating revenues until after the completion of its initial business combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the initial public offering and from changes in the fair value of its derivative warrant liabilities, if applicable. The Company has selected December 31 as its fiscal year end.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s sponsor is AMCI Sponsor II LLC, a Delaware limited liability company (the &#8220;Sponsor&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registration statement for the Company&#8217;s initial public offering was declared effective on August 3, 2021 (the &#8220;effective date&#8221;). On August 6, 2021, the Company consummated its initial public offering (the &#8220;initial public offering&#8221;) of 15,000,000 units (the &#8220;units&#8221;). Each unit consists of one Class A common stock of the Company, par value $0.0001 per share (the &#8220;Class A common stock&#8221;), and one-half of one redeemable warrant of the Company (the &#8220;warrant&#8221;), each whole warrant entitling the holder thereof to purchase one Class A common stock for $11.50 per share. The units were sold at a price of $10.00 per unit, generating gross proceeds to the Company of $150,000,000 which is discussed in Note 3.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Simultaneously with the closing of the initial public offering, the Company completed the private sale of an aggregate of 3,500,000 warrants (the &#8220;private placement warrants&#8221;) to the Sponsor at a purchase price of $1.00 per private placement warrant, generating gross proceeds to the Company of $3,500,000. The private placement warrants are identical to the warrants sold in the initial public offering, except that the private placement warrants, so long as they are held by the Sponsor or its permitted transferees, (i) are not redeemable by the Company, (ii) may not (including the Class A common stock issuable upon exercise of such private placement warrants), subject to certain limited exceptions, be transferred, assigned or sold by such holders until 30 days after the completion of the Company&#8217;s initial business combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights. No underwriting discounts or commissions were paid with respect to such sales.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the initial public offering includes two instruments, Class A common stock and warrants, and as the warrants are classified as a financial liability, it is necessary to allocate the gross proceeds between Class A common stock and warrants. The Company adopted the residual method to allocate the gross proceeds between Class A common stock and warrants based on their relative fair values. The gross proceeds were first allocated to the fair value of the warrants and the residual amount was allocated to the Class A common stock. The percentage derived from this allocation was used to allocate the deferred offering costs between Class A common stock and warrants. Issuance costs allocated to the warrants were expensed to the Company&#8217;s unaudited condensed statements of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction costs of the initial public offering amounted to $13,782,542 and consisted of $1,500,000 of underwriting discount, $5,250,000 of deferred underwriting discount, $6,509,758 in fair value of Class B common stock issued to Anchor Investors, and $522,784 of other offering costs.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A total of $150,000,000 was placed in a U.S.-based trust account maintained by Continental Stock Transfer &amp; Trust Company, acting as trustee (the &#8220;trust account&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company must complete one or more initial business combination having an aggregate fair market value of at least 80% of the value of the assets held in the trust account (excluding the amount of deferred underwriting discounts held in trust and taxes payable on the income earned on the trust account) at the time of the signing a definitive agreement in connection with the initial business combination. However, the Company will only complete a business combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">register as an investment company under the Investment Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;). There is no assurance that the Company will be able to complete a business combination successfully.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the closing of the initial public offering, management has agreed that an amount equal to at least $10.00 per unit sold in the initial public offering, including the proceeds of the private placement warrants, will be held in a trust account, located in the United States with Continental Stock Transfer &amp; Trust Company acting as trustee, and will invest only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect to interest earned on the funds held in the trust account that may be released to the Company to pay taxes, if any, the proceeds from the initial public offering and the sale of the private placement warrants will not be released from the trust account until the earliest of (i) the completion of initial business combination, (ii) the redemption of the Company&#8217;s public shares if the Company is unable to complete an initial business combination by August 6, 2023, subject to applicable law, or (iii) the redemption of the Company&#8217;s public shares properly submitted in connection with a stockholder vote to amend its amended and restated certificate of incorporation to modify the substance or timing of the Company&#8217;s obligation to redeem 100% of its public shares if the Company has not consummated an initial business combination by August 6, 2023 or with respect to any other material provisions relating to stockholders&#8217; rights or pre-initial business combination activity. The proceeds deposited in the trust account could become subject to the claims of the Company&#8217;s creditors, if any, which could have priority over the claims of the Company&#8217;s public stockholders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will provide its public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial business combination either (i) in connection with a stockholder meeting called to approve the business combination or (ii) without a stockholder vote by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed business combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem all or a portion of their public shares upon the completion of the initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account calculated as of two business days prior to the consummation of the initial business combination, including interest earned on the funds held in the trust account (which interest shall be net of taxes payable), divided by the number of then outstanding public shares, subject to the limitations and on the conditions described herein. The amount in the trust account is initially anticipated to be $10.00 per public share. The per share amount the Company will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the representative of the underwriters.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares of common stock subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the initial public offering, in accordance with Financial Accounting Standards Board&#8217;s (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480, &#8220;Distinguishing Liabilities from Equity.&#8221; In such case, the Company will proceed with a business combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a business combination and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the business combination.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will have only 24 months from the closing of the initial public offering to complete the initial business combination (the &#8220;Combination Period&#8221;). However, if the Company is unable to complete the initial business combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfOTM5MA_6b8b7a9b-cdb9-4964-a6c2-9088a7366feb">ten</span> business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company&#8217;s remaining stockholders and the Company&#8217;s board of </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">directors, liquidate and dissolve, subject, in each case, to the Company&#8217;s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sponsor, officers and directors have agreed to (i) waive their redemption rights with respect to any founder shares and public shares they hold in connection with the completion of the initial business combination, (ii) waive their redemption rights with respect to any founder shares and public shares they hold in connection with a stockholder vote to approve an amendment to the Company&#8217;s amended and restated certificate of incorporation, (iii) waive their rights to liquidating distributions from the trust account with respect to any founder shares they hold if the Company fails to complete the initial business combination within the Combination Period, and (iv) vote their founder shares and any public shares purchased during or after the initial public offering in favor of the initial business combination.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party (other than the Company&#8217;s independent registered public accounting firm) or prospective target business who executed a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is enforceable), nor will it apply to any claims under the Company&#8217;s indemnity of the underwriters of the initial public offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor&#8217;s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would be able to satisfy those obligations. None of the Company&#8217;s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Emerging Growth Company Status</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities and Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s unaudited condensed financial statements with those of another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is continuing to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company&#8217;s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these unaudited condensed financial statements. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 16, 2022, President Biden signed into law the Inflation Reduction Act of 2022 (the &#8220;IR Act&#8221;), which, among other things, imposes a new 1% U.S. federal excise tax on certain repurchases of stock by &#8220;covered corporations&#8221; (which include publicly traded domestic (i.e., U.S.) corporations) beginning in 2023, with certain exceptions (the &#8220;Excise Tax&#8221;). The Excise Tax is imposed on the repurchasing corporation itself, not its stockholders from which the stock is repurchased. Because we are a Delaware corporation and our securities are trading on Nasdaq, we are a &#8220;covered corporation&#8221; for this purpose. The amount of the Excise Tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the Excise Tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the Excise Tax. The U.S. Department of the Treasury has authority to provide regulations and other guidance to carry out, and prevent the abuse or avoidance of the Excise Tax; however, no guidance has been issued to date. It is uncertain whether, and/or to what extent, the Excise Tax could apply to any repurchase by us of our common stock or in the event of our liquidation, in each instance after December 31, 2022, including any redemptions in connection with an initial business combination or in the event we do not consummate an initial business combination by August 6, 2023.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposed Business Combination</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2022, the Company entered into an agreement and plan of merger (the &#8220;Merger Agreement&#8221;) with AMCI Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (&#8220;Merger Sub&#8221;), and LanzaTech NZ, Inc., a Delaware corporation (&#8220;LanzaTech&#8221;). The transactions contemplated by the Merger Agreement are referred to herein as the &#8220;Proposed Business Combination.&#8221; The time of the closing of the Proposed Business Combination is referred to herein as the &#8220;Closing.&#8221;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Proposed Business Combination is approved by the Company&#8217;s stockholders and LanzaTech&#8217;s stockholders, and the closing conditions in the Merger Agreement are satisfied or waived, then, among other things, upon the terms and subject to the conditions of the Merger Agreement and in accordance with Delaware General Corporation Law, Merger Sub will merge with and into LanzaTech, with LanzaTech surviving the Merger as the Company&#8217;s wholly owned subsidiary (the &#8220;Merger&#8221;). In connection with the consummation of the Merger, the Company will be renamed &#8220;LanzaTech Global, Inc.&#8221; and is referred to herein as &#8220;New LanzaTech&#8221; as of the time following such change of name.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Merger Agreement, the Company has agreed to acquire all of the outstanding equity interests of LanzaTech for consideration consisting of equity interests of New LanzaTech valued at $1,817,000,000 in the aggregate. The consideration to be paid to holders of shares of LanzaTech capital stock will be shares of common stock of New LanzaTech (&#8220;New LanzaTech Common Stock&#8221;), valued at $10.00 per share, to be paid at the closing of the Merger. The number of shares of New LanzaTech Common Stock payable in the Merger in respect of each share of LanzaTech capital stock (each, a &#8220;LanzaTech Share&#8221;) will be determined based on the exchange ratio (the &#8220;Exchange Ratio&#8221;), and certain corresponding adjustments, in each case as set forth in the Merger Agreement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, at Closing: (i) each warrant to purchase LanzaTech Shares (each, a &#8220;LanzaTech Warrant&#8221;) that is outstanding and unexercised immediately prior to Closing and would automatically be exercised or exchanged in full in accordance with its terms by virtue of the occurrence of the Merger, will be so automatically exercised or exchanged in full for the applicable LanzaTech Shares, and each such LanzaTech Share will be treated as being issued and outstanding immediately prior to Closing and will be canceled and converted into the right to receive the applicable shares of New LanzaTech Common Stock; and (ii) each LanzaTech Warrant that is outstanding and unexercised immediately prior to the Closing and is not automatically exercised in full as </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">described in clause (i) will be converted into a warrant to purchase shares of New LanzaTech Common Stock, in which case (a) the number of shares underlying such New LanzaTech warrant (each, a &#8220;New LanzaTech Warrant&#8221;) will be determined by multiplying the number of LanzaTech Shares subject to such warrant immediately prior to Closing, by the Exchange Ratio and (b) the per share exercise price of such New LanzaTech Warrant will be determined by dividing the per share exercise price of such LanzaTech Warrant immediately prior to the Effective Time by the Exchange Ratio, except that in the case of certain warrants specified in the Merger Agreement, such exercise price will be $10.00.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, at Closing, each option to purchase LanzaTech Shares (each, a &#8220;LanzaTech Option&#8221;) will be converted into an option to purchase a number of shares of New LanzaTech Common Stock (rounded down to the nearest whole share) equal to the product of (i) the number of LanzaTech Shares subject to such LanzaTech Option multiplied by (ii) the Exchange Ratio. The exercise price of such New LanzaTech option will be equal to the quotient of (a) the exercise price per share of such LanzaTech Option in effect immediately prior to the Effective Time divided by (b) the Exchange Ratio (and as so determined, this exercise price will be rounded up to the nearest full cent).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, at Closing, each award of restricted shares of LanzaTech common stock (each, a &#8220;LanzaTech RSA&#8221;) that is outstanding immediately prior to the Effective Time will be converted into an award of restricted shares of New LanzaTech Common Stock (each, a &#8220;New LanzaTech RSA&#8221;) on the same terms and conditions as were applicable to such LanzaTech RSA immediately prior to the Effective Time, except that such New LanzaTech RSA will relate to a number of shares of New LanzaTech Common Stock equal to the number of LanzaTech Shares subject to such LanzaTech RSA, multiplied by the Exchange Ratio.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The closing of the Merger is subject to certain customary conditions, including, among others, (i) adoption by AMCI&#8217;s stockholders and LanzaTech&#8217;s stockholders of the Merger Agreement and their approval of certain other actions related to the Proposed Business Combination, (ii) the expiration or termination of the waiting period (or any extension thereof) applicable to the transactions contemplated by the Merger Agreement and any ancillary agreements, in each case under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, (iii) the effectiveness of a registration statement on Form S-4 (the &#8220;Registration Statement&#8221;) under the Securities Act with respect to the shares of New LanzaTech Common Stock to be paid as consideration in the Merger, (iv) there being no government order or law enjoining, prohibiting or making illegal the consummation of the Merger or the transactions contemplated by the Merger Agreement, (v) AMCI having at least $5,000,001 of net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) under the Exchange Act) after giving effect to any payments required to be made in connection with the redemption of AMCI&#8217;s public shares and the proceeds from the Subscription Agreements described below, (vi) AMCI having at least $230,000,000 of cash at the closing of the Merger, consisting of cash held in AMCI&#8217;s trust account after taking into account any redemption of AMCI&#8217;s public shares, and the proceeds from the Subscription Agreements described below, net of transaction expenses of AMCI and LanzaTech, and (vii) the listing on Nasdaq of the shares of New LanzaTech Common Stock issued in connection with the Proposed Business Combination.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Going Concern</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, the Company had approximately $7,000 in its operating bank account and a working capital deficit of approximately $3.5 million , not taking into account tax obligations of approximately $536,000 that may be paid from income from investments held in the trust account.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s liquidity needs up to September 30, 2022 have been satisfied through a contribution of $25,000 from the Sponsor to cover for certain offering costs in exchange for the issuance of Founder Shares, and a loan and advances from the Sponsor pursuant to the Note (as defined in Note 4). Subsequent to the initial public offering, net proceeds from the private placement of $0.9 million were placed in the operating account for working capital purposes. In addition, in order to finance transaction costs in connection with a business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#8217;s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 4). On March 28, 2022, the Company entered into a noninterest-bearing Working Capital Loan with its Sponsor for the principal amount of up to $1.5 million. As of September 30, 2022 and December 31, 2021, there were no amounts outstanding under any Working Capital Loan.</span></div>In connection with the Company&#8217;s assessment of going concern considerations in accordance with FASB Accounting Standards Update (&#8220;ASU&#8221;) 2014-15, &#8220;Disclosures of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern,&#8221; management has determined that the liquidity condition, and the mandatory liquidation and subsequent dissolution that will be required if the Company does not complete a business combination before August 6, 2023 raises substantial doubt about the Company&#8217;s ability to continue as a going concern. Although Management expects that it will be able to raise additional capital to support its planned activities and complete a business combination on or prior to August 6, 2023, it is uncertain whether it will be able to do so. No adjustments have been made to the carrying amounts of assets or liabilities should we be required to liquidate after August 6, 2023. The condensed financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern. The Company intends to complete a business combination before the mandatory liquidation date. Over this time period, the Company will be using the funds outside of the trust account for paying existing accounts payable, identifying and evaluating prospective initial business combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the business combination.<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1 &#8212; Description of Organization and Business Operations</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AMCI Acquisition Corp. II (the &#8220;Company&#8221;) is a blank check company incorporated as a Delaware corporation on January 28, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the &#8220;business combination&#8221;). </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the Company has neither engaged in any operations nor generated any revenues. All activity for the period from January 28, 2021 (inception) through December 31, 2021 relates to the Company&#8217;s formation and the initial public offering (&#8220;initial public offering&#8221;), described below. The Company will not generate any operating revenues until after the completion of its initial business combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the initial public offering and from changes in the fair value of its derivative warrant liabilities, if applicable. The Company has selected December 31 as its fiscal year end.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s sponsor is AMCI Sponsor II LLC, a Delaware limited liability company (the &#8220;Sponsor&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registration statement for the Company&#8217;s initial public offering was declared effective on August 3, 2021 (the &#8220;effective date&#8221;). On August 6, 2021, the Company consummated its initial public offering of 15,000,000 units (the &#8220;units&#8221;). Each unit consists of one Class A common stock of the Company, par value $0.0001 per share (the &#8220;Class A common stock&#8221;), and one-half of one redeemable warrant of the Company (the &#8220;warrant&#8221;), each whole warrant entitling the holder thereof to purchase one Class A common stock for $11.50 per share. The units were sold at a price of $10.00 per unit, generating gross proceeds to the Company of $150,000,000, which is discussed in Note 3.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Simultaneously with the closing of the initial public offering, the Company completed the private sale of an aggregate of 3,500,000 warrants (the &#8220;private placement warrants&#8221;) to the Sponsor at a purchase price of $1.00 per private placement warrant, generating gross proceeds to the Company of $3,500,000. The private placement warrants are identical to the warrants sold in the initial public offering, except that the private placement warrants, so long as they are held by the Sponsor or its permitted transferees, (i) are not redeemable by the Company, (ii) may not (including the Class A common stock issuable upon exercise of such private placement warrants), subject to certain limited exceptions, be transferred, assigned or sold by such holders until 30 days after the completion of the Company&#8217;s initial business combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights. No underwriting discounts or commissions were paid with respect to such sales.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the initial public offering includes two instruments, Class A common stock and warrants, and as the warrants are classified as a financial liability, it is necessary to allocate the gross proceeds between Class A common stock and warrants. The Company adopted the residual method to allocate the gross proceeds between Class A common stock and warrants based on their relative fair values. The gross proceeds were first allocated to the fair value of the warrants and the residual amount was allocated to the Class A common stock. The percentage derived from this allocation was used to allocate the deferred offering costs between Class A common stock and warrants. Issuance costs allocated to the warrants were expensed to the Company&#8217;s statement of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction costs of the initial public offering amounted to $13,782,542 and consisted of $1,500,000 of underwriting discount, $5,250,000 of deferred underwriting discount, $6,509,758 in fair value of Class B common stock issued to Anchor Investors, and $522,784 of other offering costs.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A total of $150,000,000 was placed in a U.S.-based trust account maintained by Continental Stock Transfer &amp; Trust Company, acting as trustee.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company must complete one or more initial business combination having an aggregate fair market value of at least 80% of the value of the assets held in the trust account (excluding the amount of deferred underwriting discounts held in trust and taxes payable on the income earned on the trust account) at the time of the signing a definitive agreement in connection with the initial business combination. However, the Company will only complete a business combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">register as an investment company under the Investment Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;). There is no assurance that the Company will be able to complete a business combination successfully.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the closing of the initial public offering, management has agreed that an amount equal to at least $10.00 per unit sold in the initial public offering, including the proceeds of the private placement warrants, will be held in a trust account (the &#8220;trust account&#8221;), located in the United States with Continental Stock Transfer &amp; Trust Company acting as trustee, and will invest only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect to interest earned on the funds held in the trust account that may be released to the Company to pay taxes, if any, the proceeds from the initial public offering and the sale of the private placement warrants will not be released from the trust account until the earliest of (i) the completion of initial business combination, (ii) the redemption of the Company&#8217;s public shares if the Company is unable to complete an initial business combination by August 6, 2023, subject to applicable law, or (iii) the redemption of the Company&#8217;s public shares properly submitted in connection with a stockholder vote to amend its amended and restated certificate of incorporation to modify the substance or timing of the Company&#8217;s obligation to redeem 100% of its public shares if the Company has not consummated an initial business combination by August 6, 2023 or with respect to any other material provisions relating to stockholders&#8217; rights or pre-initial business combination activity. The proceeds deposited in the trust account could become subject to the claims of the Company&#8217;s creditors, if any, which could have priority over the claims of the Company&#8217;s public stockholders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will provide its public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial business combination either (i) in connection with a stockholder meeting called to approve the business combination or (ii) without a stockholder vote by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed business combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem all or a portion of their public shares upon the completion of the initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account calculated as of two business days prior to the consummation of the initial business combination, including interest earned on the funds held in the trust account (which interest shall be net of taxes payable), divided by the number of then outstanding public shares, subject to the limitations and on the conditions described herein. The amount in the trust account is initially anticipated to be $10.00 per public share. The per share amount the Company will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the representative of the underwriters.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares of common stock subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the initial public offering, in accordance with Financial Accounting Standards Board&#8217;s (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480, &#8220;Distinguishing Liabilities from Equity.&#8221; In such case, the Company will proceed with a business combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a business combination and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the business combination.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will have only 24 months from the closing of the initial public offering to complete the initial business combination (the &#8220;Combination Period&#8221;). However, if the Company is unable to complete the initial business combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfOTMzMA_80eea167-68dd-4f47-a97c-0adf8eb467f8">ten</span> business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company&#8217;s remaining stockholders and the Company&#8217;s board of </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">directors, liquidate and dissolve, subject, in each case, to the Company&#8217;s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sponsor, officers and directors have agreed to (i) waive their redemption rights with respect to any founder shares and public shares they hold in connection with the completion of the initial business combination, (ii) waive their redemption rights with respect to any founder shares and public shares they hold in connection with a stockholder vote to approve an amendment to the Company&#8217;s amended and restated certificate of incorporation, (iii) waive their rights to liquidating distributions from the trust account with respect to any founder shares they hold if the Company fails to complete the initial business combination within the Combination Period, and (iv) vote their founder shares and any public shares purchased during or after the initial public offering in favor of the initial business combination.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party (other than the Company&#8217;s independent registered public accounting firm) or prospective target business who executed a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is enforceable), nor will it apply to any claims under the Company&#8217;s indemnity of the underwriters of the initial public offering against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor&#8217;s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would be able to satisfy those obligations. None of the Company&#8217;s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Emerging Growth Company Status</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is continuing to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company&#8217;s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposed Business Combination</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As more fully described in Note 11, on March 8, 2022, the Company entered into an agreement and plan of merger (the &#8220;Merger Agreement&#8221;) with AMCI Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (&#8220;Merger Sub&#8221;), and LanzaTech NZ, Inc., a Delaware corporation (&#8220;LanzaTech&#8221;). Upon consummation of the transactions, the Company will change its name to &#8220;LanzaTech Global, Inc.&#8221;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Going Concern</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the Company had approximately $0.3 million in its operating bank account and a working capital deficit of approximately $0.1 million.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s liquidity needs up to December 31, 2021 have been satisfied through a contribution of $25,000 from the Sponsor to cover for certain offering costs in exchange for the issuance of founder shares, and a loan and advances from the Sponsor pursuant to the Note (as defined in Note 4). Subsequent to the initial public offering, net proceeds from the private placement of $0.9 million were placed in the operating account for working capital purposes. In addition, in order to finance transaction costs in connection with a business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#8217;s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 4). As of December 31, 2021, there were no amounts outstanding under any Working Capital Loan.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company&#8217;s assessment of going concern considerations in accordance with Financial Accounting Standard Board&#8217;s Accounting Standards Update (&#8220;ASU&#8221;) 2014-15, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosures of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; management has determined that the Company would not be able to meet its obligations as they become due within one year after the date that the financial statements are available to be issued. As such, management has determined that the liquidity condition raises substantial doubt about the Company&#8217;s ability to continue as a going concern. As of December 31, 2021, no adjustments have been made to the carrying amounts of assets or liabilities.</span></div>Description of the Business<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reporting entity is LanzaTech NZ, Inc. (formerly known as LanzaTech New Zealand Limited) and its subsidiaries (collectively, &#8220;the Company&#8221; or "LanzaTech"). LanzaTech NZ, Inc. is a profit-oriented entity previously incorporated in New Zealand. Effective October 28, 2021, LanzaTech New Zealand Limited filed a Certificate of Incorporation to migrate its country of domicile from New Zealand to Delaware, in the United States, and change its corporate name to &#8220;LanzaTech NZ, Inc.&#8221; The amendment was approved by the Board of Directors of LanzaTech and was effected by the filing of a Certificate of Incorporation with the Delaware Secretary of State. The registered office location is c/o The Corporation Trust Company, Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware, 19801. The Company licenses its technology to customers, performs research and development in biotechnology, and provides engineering and other related services for commercial and government customers. Using the Company&#8217;s proprietary fermentation technology, the Company&#8217;s customers can convert certain carbon-rich waste gases into fuels and chemicals. The Company employs a licensing business model whereby its customers build, own and operate facilities that use the Company's technology, and in return, the Company is paid royalties based on the revenue generated from the use of its technology. In 2018, the Company, through its partners, launched the world&#8217;s first commercial waste gas to ethanol plant in China, followed by a second one in 2021, also in China, with others currently in development in various countries.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposed Merger</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2022, the Company entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with AMCI Acquisition Corp. II, a Delaware corporation (&#8220;AMCI&#8221;) and AMCI Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of AMCI (&#8220;Merger Sub&#8221;). Under the Merger Agreement, Merger Sub will merge with and into LanzaTech, with LanzaTech surviving the Merger as a wholly-owned subsidiary of AMCI (&#8220;the Business Combination&#8221;). In connection with the Business Combination, AMCI will be renamed LanzaTech Global, Inc. (&#8220;New LanzaTech&#8221;). AMCI has agreed to acquire all of the outstanding equity interests of LanzaTech for consideration consisting of an equity interest of New LanzaTech valued at approximately $1.8&#160;billion. Completion of the transaction is subject to certain customary regulatory consents and approval by stockholders of AMCI and the Company. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Merger Agreement was amended on December 7, 2022, to provide for, among other things, (i) the inclusion of the aggregate net proceeds from each of the AM SAFE Note and Brookfield SAFE in the Acquiror Closing Cash Amount, (ii) the reduction of the Minimum Closing Cash Condition from $250,000,000 to $230,000,000, (iii) the clarification that, to the extent that the Brookfield SAFE remains unexercised at Closing, it will be assumed by AMCI, remain in effect on the same terms and conditions as are in effect prior to the Closing and thereafter entitle the holder thereof to be issued shares of common stock in AMCI after the Closing, (iv) the clarification that, in the event that it becomes reasonably apparent to the parties that the Acquiror Closing Cash Amount will be less than the Minimum Closing Cash Condition, AMCI will use commercially reasonable efforts to enter into non-redemption agreements, or similar agreements, as may be necessary to satisfy the Minimum Closing Cash Condition, (v) the extension of the outside date applicable to the Closing from December 7, 2022 to February 28, 2023 and (vi) the elimination of LanzaTech's right to terminate the agreement in the event that we fail to, on or prior to July 7, 2022, enter into one or more additional subscription agreements or non-redemption agreements as a result of which the sum of the PIPE Investment Amount (including net proceeds under the AM SAFE Note to LanzaTech) and the aggregate number of shares of Class A common stock subject to non-redemption agreements multiplied by $10.00, minus certain transaction expenses and other liabilities at Closing, would be equal to at least the Minimum Closing Cash Condition.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger Agreement, AMCI entered into subscription agreements with certain investors pursuant to which AMCI agreed to issue and sell a private placement to close immediately prior to the Business Combination.</span></div>Description of the BusinessThe reporting entity is LanzaTech NZ, Inc. (formerly known as LanzaTech New Zealand Limited) and its subsidiaries (collectively, &#8220;the Company&#8221;). LanzaTech NZ, Inc. is a profit-oriented entity previously incorporated in New Zealand. Effective October 28, 2021, LanzaTech New Zealand Limited filed a Certificate of Incorporation to migrate its country of domicile from New Zealand to Delaware, in the United States, and change its corporate name to &#8220;LanzaTech NZ, Inc.&#8221; The amendment was approved by the Board of Directors of LanzaTech and was effected by the filing of a Certificate of Incorporation with the Delaware Secretary of State. All necessary adjustments have been recorded to present fairly the Company's financial position as of December&#160;31, 2021 and 2020 and the results of operations and cash flows for the years then ended. The registered office location is c/o The Corporation Trust Company, Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware, 19801. The Company licenses its technology to customers, performs research and development in biotechnology, and provides engineering and other related services for commercial and government customers. Using the Company&#8217;s proprietary fermentation technology, the Company&#8217;s customers can convert certain carbon-rich waste gases into fuels and chemicals. The Company employs a licensing business model whereby its customers build, own and operate facilities that use the Company's technology, and in return, the Company is paid royalties based on the revenue generated from the use of its technology. In 2018, the Company, through its equity method investee, launched the world&#8217;s first commercial waste gas to ethanol plant in China, followed by a second one in 2021, also in China, with others currently in development in various countries around the world.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272210260256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Summary of Significant Accounting Policies</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2 &#8212; Basis of Presentation and Summary of Significant Accounting Policies</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) for interim financial information and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022 or any future period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K filed by the Company with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on March 25, 2022.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of September 30, 2022 and December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of September 30, 2022 and December 31, 2021.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments Held in the Trust Account</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company&#8217;s investments held in the trust account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company&#8217;s investments held in the trust account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the trust account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the trust account are determined using available market information.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities which qualify as financial instruments under the FASB ASC 820, &#8220;Fair Value Measurement,&#8221; equal or approximate the carrying amounts represented in the condensed balance sheets.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Offering Costs Associated With Initial Public Offering</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the initial public offering that were directly related to the initial public offering. Offering costs were allocated to the separable financial instruments issued in the initial public offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and presented as non-operating expenses in the unaudited condensed statements of operations. Offering costs associated with the Class A common stock issued were charged against the carrying value of the shares of Class A common stock upon the completion of the initial public offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Class A Common Stock Shares Subject to Possible Redemption </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, &#8220;Distinguishing Liabilities from Equity.&#8221; Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders&#8217; equity. The Company&#8217;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of uncertain future events. Accordingly, as of the initial public offering, 15,000,000 shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders&#8217; equity (deficit) section of the Company&#8217;s condensed balance sheets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 480-10-S99, the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of the reporting period. This method would view the end of the reporting period as if it were also the redemption date of the security. Effective with the closing of the initial public offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The public warrants and the private placement warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The initial fair value of the public warrants issued in connection with the initial public offering was estimated using a Monte-Carlo simulation model. The fair value of the public warrants as of September 30, 2022 and as of December 31, 2021 is based on observable listed prices for such warrants. The fair value of the private placement warrants as of September 30, 2022 and as of December 31, 2021 is determined using a Black-Scholes option pricing model. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provides guidance on derecognition, classification, interest and penalties, accounting in period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company&#8217;s effective tax rate was 0.88% and 0.91% for the three and nine months ended September 30, 2022, respectively, and 0.00% for the three months ended September 30, 2021 and the period from January 28, 2021 (inception) through September 30, 2021. The effective tax rate differs from the statutory tax rate of 21% for the three and nine months ended September 30, 2022, the three months ended September 30, 2021 and the period from January 28, 2021 (inception) through September 30, 2021 due primarily to changes in fair value of derivative warrant liabilities, non-taxable gains on the settlement of deferred underwriting commissions, and the valuation allowance on the deferred tax assets.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Per Share Of Common Stock</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share.&#8221; The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the units sold in the initial public offering and the private placement warrants to purchase an aggregate of 11,000,000 shares of Class A common stock in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the three and nine months ended September 30, 2022 and for the three months ended September 30, 2021 and for the period from January 28, 2021 (inception) through September 30, 2021. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended <br/>September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248,909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332,524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,130,435</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.887%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Nine Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Period from January 28, 2021 <br/>(inception) through <br/>September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,428,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FASB issued ASU 2022-03, ASC Subtopic 820 &#8220;Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions&#8221;. The ASU amends ASC 820 to clarify that a contractual sales restriction is not considered in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. The ASU applies to both holders and issuers of equity and equity-linked securities measured at fair value. The amendments in this ASU are effective for the Company in fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is still evaluating the impact of this pronouncement on the condensed financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company&#8217;s unaudited condensed financial statements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2 &#8212; Basis of Presentation and Summary of Significant Accounting Policies</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;).</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2021.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments Held in the Trust Account</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company&#8217;s investments held in the trust account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company&#8217;s investments held in the trust account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the trust account in the accompanying statement of operations. The estimated fair values of investments held in the trust account are determined using available market information.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities which qualify as financial instruments under the FASB ASC 820, &#8220;Fair Value Measurement,&#8221; equal or approximate the carrying amounts represented in the balance sheet.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Offering Costs Associated with Initial Public Offering</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the initial public offering that were directly related to the initial public offering. Offering costs were allocated to the separable financial instruments issued in the initial public offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">presented as non-operating expenses in the statement of operations. Offering costs associated with the Class A common stock issued were charged against the carrying value of the shares of Class A common stock upon the completion of the initial public offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Class A Common Stock Subject to Possible Redemption </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, &#8220;Distinguishing Liabilities from Equity.&#8221; Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders&#8217; equity. The Company&#8217;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of uncertain future events. Accordingly, as of the initial public offering, 15,000,000 shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders&#8217; equity (deficit) section of the Company&#8217;s balance sheet.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 480-10-S99, the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of the reporting period. This method would view the end of the reporting period as if it were also the redemption date of the security. Effective with the closing of the initial public offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The public warrants and the private placement warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The initial fair value of the public warrants issued in connection with the initial public offering was estimated using a Monte-Carlo simulation model. The fair value of the public warrants as of December 31, 2021 is based on observable listed prices for such warrants. The fair value of the private placement warrants as of December 31, 2021 is determined using a Black-Scholes option pricing model. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Per Share of Common Stock</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share.&#8221; The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the units sold in the initial public offering and the private placement warrants to purchase an aggregate of 11,000,000 shares of Class A common stock in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the period from January 28, 2021 (inception) through December 31, 2021. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.451%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.805%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the period from January 28, 2021<br/>(inception) through December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income (loss) per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,690,909</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income (loss) per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2020-06, &#8220;Debt &#8212; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8212; Contracts in an Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity&#8221; (&#8220;ASU 2020-06&#8221;), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. ASU 2020-06 also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 on August 2, 2021 using the modified retrospective method for transition. Adoption of ASU 2020-06 did not impact the Company&#8217;s financial position, results of operations or cash flows.</span></div>The Company&#8217;s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company&#8217;s financial statements.Summary of Significant Accounting Policies <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements of LanzaTech NZ Inc. have been prepared in accordance with generally accepted accounting principles for interim financial information, and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America ("US GAAP"), the accounting principles, standards, and procedures adopted by the U.S. Securities and Exchange Commission, for complete financial statements. However, in the opinion of management, all adjustments (consisting of normal recurring accruals) have been made that are necessary for a fair presentation of the condensed consolidated financial statements for the interim periods. For further information refer to the Consolidated Financial Statements and Footnotes thereto included in the Company's Annual Report for the year ended December 31, 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a qualitative approach in assessing the consolidation requirement for variable interest entities ("VIEs"). This approach focuses on determining whether the Company has the power to direct the activities of the VIE that most significantly affect the VIE&#8217;s economic performance and whether the Company has the obligation to absorb losses, or the right to receive benefits, that could potentially be significant to the VIE.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds interests in certain VIEs for which it has been determined the Company is not the primary beneficiary. The Company's variable interests primarily relate to entities in which the Company has a non-controlling equity interest. Although these financial arrangements resulted in holding variable interests in these entities, they did not empower the Company to direct the activities of the VIEs that most significantly impact the VIEs' economic performance. The Company's interests in the VIEs are, therefore, accounted for under the equity method of accounting or alternative measurement. Refer to Note 5,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further information. The Company is exposed to the VIEs' losses and other impairment indicators up to the carrying value of each investment and any amounts receivable from the VIE, less amounts payable. Refer to Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further details on the transactions with VIEs.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Going Concern</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements of the Company have been prepared assuming the Company will continue as a going concern and in accordance with accounting principles generally accepted in the United States of America ("US GAAP"). The going concern basis of presentation assumes that the Company will continue in operation one year after the date these financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. The Company had cash and cash equivalents of $50,370 and an accumulated deficit of $(434,863) at September&#160;30, 2022 and cash outflows from operations of $(71,336) and a net loss of $(54,974) for the nine months ended September&#160;30, 2022. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has historically funded its operations through debt financing and issuance of equity securities. Based on the Company&#8217;s financial position as of the date these condensed consolidated financial statements were available to be issued, the Company projects that it will be able to cover its liquidity needs for the next twelve months with cash on hand. Accordingly, the Company&#8217;s condensed consolidated financial statements have been prepared on the basis that it will continue as a going concern.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates include fair value of equity awards granted to both employees and non-employees, the SAFE and the SAFE warrants.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in facts and circumstances or additional information may result in revised estimates, and actual results may differ from these estimates.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates as one operating segment which is the licensing of its technologies and related services such as research and development and engineering. The Chief Executive Officer who is the chief operating decision maker, reviews financial information on an aggregate basis for allocating resources and evaluating financial performance. Substantially all of the Company's long-lived assets are maintained in the United States. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currencies</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reporting currency is the U.S. Dollar. The Company has certain foreign subsidiaries where the functional currency is the local currency. All of the assets and liabilities of these subsidiaries are converted to U.S. dollars at the exchange rate in effect at the balance sheet date, income and expense accounts are translated at average rates for the period, and shareholder&#8217;s equity accounts are translated at historical rates. The effects of translating financial statements of foreign operations into our reporting currency are recognized as an adjustment in accumulated other comprehensive income (loss).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has foreign subsidiaries that have a functional currency of the U.S. dollar. Purchases and sales of assets and income and expense items denominated in foreign currencies are remeasured into U.S. dollar amounts on the respective dates of such transactions. Net realized foreign currency gains or losses relating to the differences between these recorded amounts and the U.S. dollar equivalent actually received or paid are included within Other (expense) income, net in the condensed consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. As of September&#160;30, 2022 and December&#160;31, 2021, the Company had $50,370 and $128,318 of cash and cash equivalents, respectively.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash and Other Cash Flows from Operating Activities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to maintain a cash deposit with a bank which consists of collateral on certain travel and expense programs maintained by the bank. The following represents a reconciliation of cash and cash equivalents in the condensed consolidated balance sheets to total cash, cash equivalents and restricted cash in the condensed consolidated statements of cash flows as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands).</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (presented within Other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,034&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,732&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade and Other Receivables </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables are reported net of allowances for doubtful accounts. The Company maintains allowances for doubtful accounts for estimated losses resulting from the inability of customers to make required payments. The Company estimates the allowance for doubtful accounts based on a variety of factors including the length of time receivables are past due, the financial health of customers, unusual macroeconomic conditions, and historical experience. As of September&#160;30, 2022 and December&#160;31, 2021, the Company recognized an allowance for doubtful accounts of $1,051 and $1,235, respectively.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with Accounting Standards Codification ("ASC") 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company primarily earns revenue from services related to feasibility studies and basic engineering design of commercial plants, licensing of technologies, joint development and contract </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">research activities to develop novel biocatalysts and related technologies, and sale of CarbonSmart ethanol produced using the Company's proprietary technologies.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is measured based on the consideration specified in a contract with a customer. The Company records taxes collected from customers and remitted to governmental authorities on a net basis. The Company&#8217;s payment terms are between 30-60 days and can vary by customer type and products offered. Management has evaluated the terms of our arrangements and determined that they do not contain significant financing components.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Carbon Capture and Transformation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides feasibility studies and basic design and engineering services used for detailed design, procurement, and construction of commercial plants that utilize the Company&#8217;s technologies, along with the sale of equipment and microbes. The services provided are recognized as a performance obligation satisfied over time. Revenue is recognized using the output method based on milestone completion, the cost-to-cost input method for certain engineering services, or the percentage of completion method as performance obligations are satisfied. Management has determined that the milestone completion and the associated contractual payment amounts are an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company licenses intellectual property to generate recurring revenue when its customers deploy carbon capture and transformation plants. When licenses are considered to be distinct performance obligations, the recognition of revenue is dependent on the terms of the contract, which may include fixed consideration or royalties based on sales or usage, in which case, the revenue is recognized when the subsequent sale or usage occurs or when the performance obligation to which some or all of the sales or usage-based royalty is allocated has been satisfied, whichever is later.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Services</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs research and development (&#8220;R&amp;D&#8221;) services related to novel technologies and development of biocatalysts for commercial applications, mainly to produce fuels and chemicals. The Company engages in two main types of R&amp;D services &#8211; joint development agreements, and other contract research, including projects with the U.S. Department of Energy. Such services are recognized as a performance obligation satisfied over time. Revenue is recognized based on milestone completion, when payments are contingent upon the achievement of such milestones, or based on percentage-completion method when enforceable rights to payment exist. When no milestones or phases are clearly defined, management has determined that the cost incurred, input method, is an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and estimates its variable consideration under the expected value method. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is not recognized in advance of customer acceptance of a milestone when such acceptance is contractually required. Payments for R&amp;D services with no contractual payments are not due from customers until a technical report is submitted; therefore, a contract asset is recognized at milestone completion but prior to the submission of a technical report. The contract asset represents the Company&#8217;s right to consideration for the services performed at milestone completion. Occasionally, customers provide payments in advance of the Company providing services which creates a contract liability for the Company. The contract liability represents the Company's obligation to provide services to a customer. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collaboration Arrangements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain partnership agreements that are within the scope of ASC 808, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides guidance on the presentation and disclosure of collaborative arrangements. Generally, the classification of the transactions under the collaborative arrangements is determined based on the nature of the contractual terms of the arrangement, along with the nature of the operations of the participants. The Company&#8217;s collaborative agreements generally include a provision of R&amp;D services related to novel technologies and biocatalysts. Amounts received for these services are classified as Revenue from collaborative arrangements in the condensed consolidated statements of operations and comprehensive loss. The Company's R&amp;D services are a major part of the Company's ongoing operations and therefore ASC 606 is applied to recognize revenue.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CarbonSmart</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's CarbonSmart business, initially CarbonSmart ethanol, is produced by LanzaTech licensed plants using the Company's proprietary technologies. Customers can buy CarbonSmart ethanol directly from LanzaTech, which the Company sources from these partnering plants. Revenue is recognized at a point in time when control transfers to the customer, which varies depending on the shipping terms. The Company acts as the principal in such transactions and accordingly, recognizes revenue and cost of revenues on a gross basis.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily due to their short-term nature, except for the warrant liability. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue generated from the Company&#8217;s customers outside of the United States for the nine months ended September&#160;30, 2022 and 2021 was approximately 61% and 65%, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021, approximately 35% and 35%, respectively, of trade accounts receivable and unbilled accounts receivable was due from customers located outside the United States. At September&#160;30, 2022 and December&#160;31, 2021, the value of property, plant, and equipment outside the United States was immaterial.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue by geographic region based on the customer&#8217;s location is presented in Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customers</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers representing 10% or greater of revenue were as follows for the nine months ended September&#160;30, 2022 and 2021:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Announced Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Financial Accounting Standard Board ("FASB") issued an Accounting Standard Update ("ASU") No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2020-10&#8221;). The standard contains improvements to the FASB Accounting Standards Codification (the &#8220;Codification&#8221;) by ensuring that all guidance that requires or provides an option for an entity to provide information in the notes to financial statements is codified in the disclosure section of the Codification. The standard also improves various topics in the Codification so that entities can apply guidance more consistently on codifications that are varied in nature where the original guidance may have been unclear. The amendments in ASU 2020-10 were effective for the Company for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption was permitted. There were no material impacts upon the adoption of ASU 2020-10, on its consolidated financial statements and related disclosures. </span></div>Summary of Significant Accounting Policies <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;US GAAP"). The consolidated financial statements include the accounts of LanzaTech NZ, Inc. and its wholly-owned consolidated subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of its evaluation, the Company makes judgments in determining whether an entity is a variable interest entity (&#8220;VIE&#8221;) and, if so, whether it is the primary beneficiary of the VIE and is thus required to consolidate the entity. A VIE is a legal entity that has a total equity investment that is insufficient to finance its activities without additional subordinated financial support or whose equity investors lack the characteristics of a controlling financial interest. Our variable interest arises from contractual, ownership or other monetary interests in the entity, which change with fluctuations in the fair value of the entity&#8217;s net assets. A VIE is consolidated by its primary beneficiary, the party that has both the power to direct the activities that most significantly impact the VIE&#8217;s economic performance, and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE. We consolidate a VIE when we are deemed to be the primary beneficiary. We assess whether or not we are the primary beneficiary of a VIE on an ongoing basis. If we are not deemed to be the primary beneficiary in a VIE, we account for the investment or other variable interests in a VIE in accordance with applicable US GAAP.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds interests in certain VIEs for which it has been determined the Company is not the primary beneficiary. The Company's variable interests primarily relate to entities in which the Company has a non-controlling equity interest. Although these financial arrangements resulted in holding variable interests in these entities, they did not empower the Company to direct the activities of the VIEs that most significantly impact the VIEs' economic performance. The Company's interests in the VIEs are, therefore, accounted for under the equity method of accounting. Refer to Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further information. The Company's maximum exposure to loss in connection with its interest in VIEs is its equity method investment and any amounts receivable from the VIE, less amounts payable. Refer to Note 14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further details on the transactions with VIEs.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restatement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 16, 2022, the Audit Committee of the Board of Directors of LanzaTech, after discussion with management of LanzaTech and LanzaTech&#8217;s independent registered public accounting firm, Deloitte &amp; Touche, </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LLP, concluded that LanzaTech&#8217;s previously issued audited consolidated financial statements as of and for the fiscal years ended December 31, 2021 and December 31, 2020 should no longer be relied upon. The errors leading to restatement were communicated to and discussed with AMCI upon their discovery. The AMCI Board considered the circumstances surrounding the restatement and concluded that it did not negatively impact its decision to proceed with the Business Combination primarily because of the individually immaterial adjustments. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined that its recorded share of equity method earnings amounts from an unconsolidated affiliate for the years ended December 31, 2021 and 2020 and its gain on dilution amount for the year ended December 31, 2021 were incorrect following the completion of LanzaJet, Inc's ("LanzaJet") financial statement audit. Additionally, the Company identified that it was not properly eliminating intra-entity profits related to revenue contracts with LanzaJet. As a result of the adjustments recorded by the unconsolidated affiliate and the identification of the error related to the elimination of intra-entity profits, the Company made the decision to restate its consolidated financial statements as of and for the years ended December 31, 2021 and 2020, on or around the completion of the audit of LanzaJet's financial statements for the years ended December 31, 2021 and 2020, on August 23, 2022. The Company also determined it was not properly accounting for its licensing arrangement with LanzaJet, and had not disclosed all significant related party transactions with its equity method investees. The Company has also revised these disclosures.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 250, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Changes and Error Corrections</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company evaluated the materiality of the adjustments, considering both quantitative and qualitative factors, and determined that the related aggregate impact was material to its consolidated financial statements as of and for the years ended December 31, 2021 and 2020. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Description of Errors Corrected</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Accounting for Equity Method Investments: </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The previously reported equity method investment in LanzaJet, Inc. (&#8220;LanzaJet&#8221;), as described in Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, contained errors in the Company's recorded share of LanzaJet losses for the years ended 2021 and 2020 as a result of adjustments made by LanzaJet to its financial statements in connection with the audit of LanzaJet's financial statements for the years ended December 31, 2021 and 2020. The adjustments primarily were comprised of (1) an adjustment to correct an error relating to the measurement of the intangible asset associated with the intellectual property contributed by the Company as described in Note 5 &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the related amortization; and (2), an adjustment to reclassify as a reduction to fixed assets certain government grants received by LanzaJet that it originally recorded as revenue. Other less significant adjustments were also identified and corrected in connection with the audit of LanzaJet's financial statements for the years ended December 31, 2021 and 2020. The net impact of these adjustments on the equity method investment's balance and accumulated deficit in the Company's Consolidated Balance Sheets was a decrease of $580 and $257 as of December 31, 2021 and 2020, respectively. The net impact of these adjustments on the gain from equity method investees in the Company&#8217;s Consolidated Statements of Operations and Comprehensive Loss was a decrease of $580 and $257 for the years ended December 31, 2021 and 2020, respectively. </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The previously reported revenue from related parties related to contributed intellectual property contained errors for intra-entity profit that was not previously eliminated, as described in Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The impact of these errors on the equity method investment's balance and accumulated deficit in the Consolidated Balance Sheets was $662 and $549 as of December 31, 2021 and 2020, respectively and $662 and $549 on revenue from related party transactions in the Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2021 and 2020, respectively.</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The previously reported gain on dilution, as described in Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, was not correctly calculated for the year ended December 31, 2021. The impact of these errors on the equity method investment's balance and accumulated deficit in the Consolidated Balance Sheets as of December 31, </span></div><div style="margin-bottom:9pt;padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021 was $322; and the impact on gain from equity method investees in the Consolidated Statements of Operations and Comprehensive Loss was $322 for the year ended December 31, 2021.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Additional Misstatements:</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The previously reported contract assets and other accrued liabilities included revenue and related cost of revenue amounts that was recorded in an inappropriate period. These amounts were recorded in 2021, however, the performance obligation was actually satisfied in 2020.. The impact of these errors on the contract assets and other accrued liabilities in the Consolidated Balance Sheet as of December 31, 2020 was $122; and the impact on revenue from contracts with customers and cost of revenue from contracts with customers in the Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2021 and 2020 was  $122.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Disclosure errors:</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company determined its licensing arrangement with LanzaJet, described in Note 5 &#8211; Investments, should have been accounted for as a transaction with a customer solely within the scope of Accounting Standards Codification 606 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from contracts with customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 606") rather than akin to an operating lease under Accounting Standards Codification 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 842"). The licensing arrangement is a contract with our customer, LanzaJet, that conveys to LanzaJet the right to use an intangible asset (IP). Contracts with customers are accounted for under ASC 606 unless they are within the scope of other accounting literature. Because the licensing arrangement conveys the right to use an intangible asset, it is not within the scope of ASC 842. Under limited circumstances, ASC 606 requires certain arrangements that do not, in substance, transfer control of an asset (i.e., when the arrangement contains certain repurchase rights or obligations) to be accounted for as leases. However, those limited circumstances are not present in our licensing arrangement with LanzaJet. Therefore, the Company concluded accounting for the arrangement under ASC 606 is required. Because the period over which the Company determined it was required to recognize revenue under ASC 606 was the same as the period of time over which it had been recognizing revenue, there was no effect on the amounts recorded in the consolidated financial statements. Additionally, the difference in timing of recognition of the variable consideration resulted in a difference between the carrying value of our equity method investment in LanzaJet and our proportionate share LanzaJet's book values, that was not previously disclosed. However, the disclosures in Note 5 &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, have been revised accordingly.</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company did not disclose in Note 5 &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, its obligation under a guarantee with sublicensing agreement between LanzaJet and a third party. The fair value of this guarantee was deemed immaterial as of December 31, 2021 and 2020.</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company did not include in its disclosure for related party transactions in Note 14 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that it also provided engineering services to one of its equity method investees, Beijing ShouGang LanzaTech Technology Co., LTD ("SGLT"), for which costs of $1,223 and $242 were incurred during the years ended December 31, 2021 and 2020. The Company also did not disclose that in 2019 it entered into a licensing agreement to receive licensing consideration from SGLT. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of the errors discussed above were individually material to the financial statements, however, their cumulative impact was material and resulted in a restatement of the 2021 and 2020 financial statements. The effects of the correction of these errors on the relevant financial statement line items is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Balance Sheet</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,738&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,011&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(378,162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(379,889)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(353,190)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(354,917)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, contingently redeemable preferred equity, and shareholders' deficit</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,738&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,011&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Balance Sheet</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,664&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(684)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,980&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,775&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,897&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,666&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,788&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(332,394)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(333,200)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310,410)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311,216)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, contingently redeemable preferred equity, and shareholders' deficit</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,664&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(684)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,980&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Operations and Comprehensive Loss</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from contracts with customers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from related party transactions</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,915&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(662)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,253&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,245&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(784)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,461&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue from contracts with customers (exclusive of depreciation shown below)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,289)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,167)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost and operating expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,602)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,480)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,357)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(662)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,019)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,972)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(662)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48,634)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(259)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,945&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,768)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(921)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,689)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss allocated to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82,526)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(921)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83,447)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,673)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(921)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,594)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share - basic and diluted</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.12)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.47)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.59)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Operations and Comprehensive Loss</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from contracts with customers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from related party transactions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,752&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(549)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,780&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(427)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,353&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue from contracts with customers (exclusive of depreciation shown below)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,063)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,185)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost and operating expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,932)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58,054)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,152)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(549)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,701)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,331)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(549)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,880)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,424&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(257)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,907)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,713)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss allocated to common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68,198)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69,004)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,282)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,088)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share - basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.84)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.50)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.34)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Changes in Redeemable Convertible Preferred Stock and Shareholders&#8217; Equity (Deficit)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit - Balance at December 31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(332,394)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(333,200)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit &#8211; balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310,410)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311,216)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,768)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(921)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,689)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit - balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(378,162)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(379,889)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit &#8211; balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(353,190)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(354,917)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Changes in Redeemable Convertible Preferred Stock and Shareholders&#8217; Equity (Deficit)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit - Balance at December 31, 2019</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(295,487)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(295,487)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit &#8211; balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276,592)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276,592)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,907)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,713)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit - balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(332,394)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(333,200)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit &#8211; balance at December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310,410)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311,216)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Cash Flows</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,768)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(921)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,689)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash recognition of licensing revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,684)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,022)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,945)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,636)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,514)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued salaries and wages</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,591)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,591)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Cash Flows</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,907)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,713)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash recognition of licensing revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,567)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,018)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,424)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,167)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,483)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,605)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued salaries and wages</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,271)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,271)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Other Disclosure Errors: </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 5 - Investments: The Company did not disclose intra-entity profits elimination amounts related to revenue contracts with LanzaJet of $662 and $549 as of December 31, 2021, and 2020, respectively as they were not eliminated. The previously disclosed gain on dilution was incorrect as of and for the year ended December 31, 2021.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on dilution</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates as one operating segment. Operating segments are defined as components of an enterprise for which separate financial information is evaluated regularly by the chief operating decision maker (&#8220;CODM&#8221;), in deciding how to allocate resources and assess performance.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company offers a variety of services and operates in multiple countries, the Company&#8217;s business operates in one operating segment because most of the Company&#8217;s service offerings are delivered and supported on a global basis, most of the Company&#8217;s service offerings are deployed in a nearly identical way, and the Company&#8217;s CODM evaluates the Company&#8217;s financial information and resources and assesses the performance of these resources on a consolidated basis. There are no segment managers who are held accountable by the CODM, or anyone else, for operations, operating results, and planning for components below the consolidated level. Accordingly, the Company has determined that it has a single reportable and operating segment. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for disaggregation of the Company&#8217;s revenues by customer location.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Coronavirus (COVID-19)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the World Health Organization declared the viral strain of coronavirus ("COVID-19") a global pandemic and recommended containment and mitigation measures worldwide. The spread of COVID-19 and the resulting economic contraction has resulted in increased business uncertainty. The consequences of a prolonged economic decline could include, but are not limited to, reduced revenues, increased instances of uncollectible customer receivables, and increased asset impairments in future periods. Accordingly, the Company cannot reasonably estimate the length or severity of this pandemic, or the extent to which the disruption may materially impact its consolidated balance sheets, consolidated statements of operations and comprehensive loss or statements of cash flows for future periods.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Going Concern</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements of the Company have been prepared assuming the Company will continue as a going concern and in accordance with US GAAP. The going concern basis of presentation assumes that the Company will continue in operation one year after the date these financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. The Company had cash and cash equivalents of $128,318 and an accumulated deficit of $379,889 at December&#160;31, 2021 and cash outflows from operations of $42,591 and a net loss of $46,689 for the year ended December&#160;31, 2021. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has historically funded its operations through debt financing and issuance of equity securities. Based on the Company&#8217;s financial position as of the date these consolidated financial statements were issued, the Company projects that it will be able to cover its liquidity needs for the next twelve months with cash on hand. Accordingly, the Company&#8217;s consolidated financial statements have been prepared on the basis that it will continue as a going concern.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates include fair value of equity awards granted to both employees and non-employees.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in facts and circumstances or additional information may result in revised estimates, and actual results may differ from these estimates.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currencies</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reporting currency is the U.S. Dollar. The Company has certain foreign subsidiaries where the functional currency is the local currency. All of the assets and liabilities of these subsidiaries are converted to U.S. dollars at the exchange rate in effect at the balance sheet date, income and expense accounts are translated at average rates for the period, and shareholder&#8217;s equity accounts are translated at historical rates. The effects of translating financial statements of foreign operations into our reporting currency are recognized as an adjustment in accumulated other comprehensive income (loss).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has foreign subsidiaries that have a functional currency of the U.S. dollar. Purchases and sales of assets and income and expense items denominated in foreign currencies are remeasured into U.S. dollar amounts on the respective dates of such transactions. Net realized foreign currency gains or losses relating to the differences between these recorded amounts and the U.S. dollar equivalent actually received or paid are included within Other income, net in the consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. As of December&#160;31, 2021 and 2020, the Company had $128,318 and $60,495 of cash and cash equivalents, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to maintain a cash deposit with a bank which consists of collateral on a travel and expense program maintained by the bank. The following represents a reconciliation of cash and cash equivalents in </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the consolidated balance sheets to total cash, cash equivalents and restricted cash in the consolidated statement of cash flows as of December 31, 2021 and December 31, 2020.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,495&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (presented within Other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,732&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,909&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade and Other Receivables </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables are reported net of allowances for doubtful accounts. The Company maintains allowances for doubtful accounts for estimated losses resulting from the inability of customers to make required payments. The Company estimates the allowance for doubtful accounts based on a variety of factors including the length of time receivables are past due, the financial health of customers, unusual macroeconomic conditions, and historical experience. As of December&#160;31, 2021 and 2020, the Company recognized an allowance for doubtful accounts of $1,235 and $1,325, respectively.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Current Assets</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current assets consist of prepaid expenses, materials and supplies, and other assets. Material and supplies consist of spare parts and consumables used for research and research equipment and is stated at the weighted average cost.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment, net</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost and include improvements that significantly increase capacities or extend the useful lives of existing plant and equipment.&#160;Depreciation is calculated using the straight-line method over the estimated useful life of the assets. Useful lives range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTA0_78de1c22-d3ad-43ae-a899-19a74e1b2357">three</span> to five years for instruments and equipment, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk3OTk5_761df305-309f-4903-a23c-ce62ac3f485c">three</span> to five years for office equipment and furniture and software, five years for vehicles and, for leasehold improvements, the shorter of the life of the improvement or the remaining term of the lease. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews the remaining useful life of its assets on a regular basis to determine whether changes have taken place that would suggest that a change to depreciation policies is warranted.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon retirement or disposal of property, plant and equipment, the cost and related accumulated depreciation are removed from the account, and the resulting gains or losses, if any, are recorded in the consolidated statements of operations and comprehensive loss. Net gains or losses related to asset dispositions are recognized in earnings in the period in which dispositions occur. Routine maintenance, repairs and replacements are expensed as incurred.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines&#160;if an arrangement is a lease at inception.&#160;Lease agreements are evaluated to classify the lease as a finance or operating&#160;lease.&#160;Operating lease assets and liabilities are recognized at the commencement date of the lease based on the present value of lease payments over the lease term. Lease assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. As most&#160;leases&#160;do not provide an implicit interest rate,&#160;the Company&#160;uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. Leases with an initial term of 12 months or less are not recorded on the Company&#8217;s consolidated balance sheets. The Company recognizes lease expense for these leases on a straight-line basis over the lease term.&#160;The Company accounts for lease components and non-lease components as a single lease component.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs a recoverability assessment of each of its long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indicators may include, but are not limited to, adverse changes in the regulatory environment in a jurisdiction where the Company operates, a decision to discontinue the development of a long-lived asset, early termination of a significant customer contract, or the introduction of newer technology.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When performing a recoverability assessment, the Company measures whether the estimated future undiscounted net cash flows expected to be generated by the asset exceeds its carrying value. In the event that an asset does not meet the recoverability test, the carrying value of the asset will be adjusted to fair value resulting in an impairment charge.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management develops the assumptions used in the recoverability assessment based on active contracts as well as information received from third-party industry sources. The Company did not record an impairment during the years ended December&#160;31, 2021 and 2020. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Method Investments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in entities over which the Company has significant influence, but not control, are accounted for using the&#160;equity method&#160;of accounting. Gain from&#160;equity method&#160;investees, net represents the Company&#8217;s proportionate share of net income or loss of its equity method investees and any gains or losses from the dilution of such investments.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity method&#160;investments are assessed for impairment whenever changes in the facts and circumstances indicate a loss in value may have occurred. When a loss is deemed to have occurred and is other than temporary, the carrying value of the&#160;equity method&#160;investment is written down to fair value. In evaluating whether a loss is other than temporary, the Company considers the length of time for which the conditions have existed and its intent and ability to hold the investment. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Simple Agreement for Future Equity (SAFE)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company issued a SAFE that allowed an investor to participate in future equity financings through a share-settled redemption of the amount invested (such notional being the &#8220;invested amount&#8221;). The Company determined that the SAFE was not legal form debt (i.e., no creditors&#8217; rights). The SAFE includes a provision allowing for cash redemption upon the occurrence of a change of control, the occurrence of which is outside the control of the Company. Therefore, the SAFE is classified as mark-to-market liability pursuant to Accounting Standards Codification (&#8220;ASC&#8221;) 480, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distinguishing Liability from Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has warrants to purchase preferred shares outstanding as of December&#160;31, 2021 and 2020 representing 225,223 and 383,281 preferred shares, respectively, which warrants expire at various dates through December 31, 2027. The exercise prices of the warrants range from $14.69 to $19.93 as of each of December&#160;31, 2021 and 2020. The Company accounts for its warrants as liabilities based upon the characteristics and provisions of each instrument. The liabilities are included in other accrued liabilities on the Company's consolidated balance sheets at their fair value on the date of issuance and are revalued in each subsequent reporting period until such instruments are exercised or expire. The change in fair value between reporting periods is included in other (expense) income, net in the consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further the warrant related to the SAFE of $1,729 is accounted for as a liability. This liability is recorded in current liabilities on the Company's consolidated balance sheets at fair value on the date of issuance and will be revalued each subsequent reporting period until such instrument is exercised or expire. The change in fair value between reporting periods is included in other (expense) income, net in the consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Term Debt and Debt Issuance Costs</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s debt consists of credit facilities with financial institutions. Costs directly related to the issuance of debt are reported on the consolidated balance sheets as a reduction from the carrying amount of the recognized debt liability and amortized over the term of the debt using the effective interest method.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal and Contingencies</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may be involved in legal actions in the ordinary course of business, inquiries and proceedings concerning employment, labor, environmental, and other claims. The Company will recognize a loss contingency in the consolidated financial statements when it is probable a liability has been incurred and the amount of the loss can be reasonably estimated. The Company will disclose any loss contingencies that do not meet both conditions if there is a reasonable possibility that a loss may have been incurred. Gain contingencies are not recorded until realized.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company primarily earns revenue from services related to feasibility studies and basic engineering design of commercial plants, licensing of technologies, joint development and contract research activities to develop novel biocatalysts and related technologies.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is measured based on the consideration specified in a contract with a customer. The Company records taxes collected from customers and remitted to governmental authorities on a net basis. The Company&#8217;s payment terms are between 30-60 days and can vary by customer type and products offered. We have evaluated the terms of our arrangements and determined that they do not contain significant financing components.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Carbon Capture and Transformation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides feasibility studies and basic design and engineering services used for detailed design, procurement, and construction of commercial plants that utilize the Company&#8217;s technologies, along with the sale of equipment and microbes. The services provided are recognized as a performance obligation satisfied over time. Revenue is recognized using the output method based on milestone completion, the cost-to-cost input method for certain engineering services, or the percentage of completion method when certain revenue recognition requirements are met. Management has determined that the milestone completion and the associated contractual payment amounts are an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company licenses intellectual property to generate recurring revenue when its customers deploy carbon capture and transformation plants. When licenses are considered to be distinct performance obligations, the recognition of revenue is dependent on the terms of the contract, which may include fixed consideration or royalties based on sales or usage, in which case, the revenue is recognized when the subsequent sale or usage occurs or when the performance obligation to which some or all of the sales or usage-based royalty is allocated has been satisfied, whichever is later.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Services</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs research and development (&#8220;R&amp;D&#8221;) services related to novel technologies and development of biocatalysts for commercial applications, mainly to produce fuels and chemicals. The Company engages in two main types of R&amp;D services &#8211; joint development agreements, and other contract research, including projects with the U.S. Department of Energy. Such services are recognized as a performance obligation satisfied over time. Revenue is recognized based on milestone completion, when such milestones are contractually defined, or based on stage of contract completion when not defined. For the latter, management has determined that the cost incurred, input method, is an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and estimates its variable consideration under the expected value method. Accordingly, the Company records a liability based on milestones achieved and the expected repayment of the development costs. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s joint development agreements may utilize the cost-to-cost method of revenue recognition or may include well defined payment milestones, dependent on the contract, both of which the Company evaluates against work completed prior to revenue recognition. For other contract research, the Company utilizes the cost-to-cost method of revenue recognition. These contracts have a fixed dollar amount which is based on the Company&#8217;s estimate of total costs to be incurred over the life of each contract. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is not recognized in advance of customer acceptance of a milestone, when such acceptance is contractually required. Payments for R&amp;D services with no contractual payments are not due from customers until a technical report is submitted; therefore, a contract asset is recognized at milestone completion but prior to the submission of a technical report. The contract asset represents the Company&#8217;s right to consideration for the services performed at milestone completion. Occasionally, customers provide payments in advance of the Company providing services which creates a contract liability for the Company. The contract liability represents the Company's obligation to provide services to a customer. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collaboration Arrangements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain partnership agreements that are within the scope of ASC 808, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides guidance on the presentation and disclosure of collaborative arrangements. Generally, the classification of the transactions under the collaborative arrangements is determined based on the nature of the contractual terms of the arrangement, along with the nature of the operations of the participants. The Company&#8217;s collaborative agreements generally include a provision of R&amp;D services related to novel technologies and biocatalysts. Amounts received for these services are classified as Revenue from collaborative arrangements in the consolidated statements of operations and comprehensive loss. The Company's R&amp;D services are a major part of the Company's ongoing operations and therefore ASC 606 is applied to recognize revenue.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenues</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s R&amp;D, engineering, and other direct costs of services related to revenue agreements with customers, related parties, and collaborative partners represent cost of revenue. Costs include both internal and third-party fixed and variable costs and include materials, supplies, labor, and fringe benefits.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incur research and development costs associated with various R&amp;D activities and expense these costs as incurred.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for equity-based compensation in accordance with ASC 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation &#8211; Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Accordingly, in exchange for employee and director services, compensation is given in the form of equity awards. The equity awards are recorded based on the grant date fair value and expensed over the requisite service period for the respective award.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s equity-based awards include stock option awards and restricted stock issued by the Company, which vest based on either time or the achievement of certain performance conditions. The Company records forfeitures as they occur. Compensation expense resulting from time-vesting-based awards is recognized in the Company&#8217;s consolidated statements of operations and comprehensive loss, primarily within research and development expenses, at the grant date fair value over the requisite service period. Compensation expense resulting from performance awards recognized over the requisite service period when it is probable that the performance condition will be met. The calculated compensation expense for performance awards is adjusted based on an estimate of awards ultimately expected to vest. The Company estimates grant date fair value using a Black-Scholes option pricing model that uses assumptions including expected volatility, expected term, and the expected risk-free rate of return. The Company has determined that the Black-Scholes option pricing model, as well as the underlying assumptions used in its application, is appropriate in estimating the fair value of its award grants.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows the asset and liability method of accounting for income taxes under ASC 740, Income Taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income tax assets are evaluated to determine if valuation allowances are required or should be adjusted. Valuation allowances are established based on a more likely than not standard. The ability to realize deferred tax assets depends on the Company&#8217;s ability to generate sufficient taxable income within the carryback or carryforward periods provided for in the tax law for each tax jurisdiction. The Company considers the various possible sources of taxable income when assessing the realization of its deferred tax assets. The valuation allowances recorded against deferred tax assets generated by taxable losses in certain jurisdictions will affect the provision for income taxes until the valuation allowances are released. The Company&#8217;s provision for income taxes will include no tax benefit for losses incurred and no tax expense with respect to income generated in these jurisdictions until the respective valuation allowance is eliminated.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records uncertain tax positions on the basis of a two-step process whereby it is determined whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position, and for those tax positions that meet the more likely than not criteria, the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority is recognized. The Company recognizes accrued interest and penalties related to unrecognized tax benefits in income tax expense.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Transactions</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows ASC 850-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for the identification of related parties and disclosure of related party transactions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. Refer to Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Note 14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further information.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss Per Share</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is computed by dividing net loss attributable to participating stock by the weighted average number of shares of participating stock outstanding during the period. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted net loss per share reflects potential dilution and is computed by dividing net loss attributable to participating stock by the weighted average number of shares of participating stock outstanding during the period. The dilutive effect of outstanding awards, if any, is reflected in diluted earnings per share by application of the treasury stock method or if-converted method, as applicable. Refer to Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Loss Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-term nature, except for the warrant liability. Refer to Note 11, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrant Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for more information.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties (Restated)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue generated from the Company&#8217;s customers outside of the United States for the years ended December&#160;31, 2021 and 2020 was approximately 38% and 14%, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, approximately 35% and 27%, respectively, of trade accounts receivable and unbilled accounts receivable was due from customers located outside the United States. At December&#160;31, 2021 and 2020, the value of property, plant, and equipment outside the United States was immaterial.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue by geographic region based on the customer&#8217;s location is presented in Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customers</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers representing 10% or greater of revenue were as follows for the years ended December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, two of the Company's customers separately represented 49% (Customer B) and 15% (Customer D) of total accounts receivable and contract assets on the consolidated balance sheet. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses (Topic 326): Disclosure Framework &#8211; Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2016-13&#8221;), which requires financial assets measured at amortized cost basis, including trade receivables, to be presented net of the amount expected to be collected. The measurement of all expected credit losses will be based on historical experience, current conditions, and reasonable and supportable forecasts. The Company adopted the new standard effective January 1, 2020, using a modified retrospective transition method, which requires a cumulative-effect adjustment, if any, to the opening balance of retained earnings to be recognized on the date of adoption with prior periods not restated. The adoption did not have a material impact on the Company&#8217;s financial position or results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles &#8211; Goodwill and Other &#8211; Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2018-15&#8221;), which requires a customer in a cloud computing arrangement that is a service contract to follow the internal-use software guidance in ASC 350-40 to determine which implementation costs to capitalize as assets. A customer&#8217;s accounting for the costs of the hosting component of the arrangement is not affected by the new guidance. The Company adopted ASU 2018-15 as of January 1, 2020 with no material impact on its consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2018, the FASB issued ASU 2018-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Stock Compensation Improvements to Non-employee Share-Based Payment Accounting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2018-07&#8221;), which simplifies the accounting for stock-based payments granted to non-employees for goods and services. Under ASU 2018-07, most of the guidance on such payments to non-employees will be aligned with the requirements for stock-based payments granted to employees. The Company early adopted ASU 2018-07 as of January 1, 2020 and its adoption did not have a material impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2019-12&#8221;), as part of its simplification initiative to reduce the cost and complexity in accounting for income taxes. ASU 2019-12 removes certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. ASU 2019-12 also amends other aspects of the guidance to help simplify and promote consistent application of US GAAP. The Company adopted ASU 2019-12 as of January 1, 2021 with no material impact on its consolidated financial statements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Announced Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2020-10&#8221;). The standard contains improvements to the FASB Accounting Standards Codification (the &#8220;Codification&#8221;) by ensuring that all guidance that requires or provides an option for an entity to provide information in the notes to financial statements is codified in the disclosure section of the Codification. The standard also improves various topics in the Codification so that entities can apply guidance more consistently on codifications that are varied in nature where the original guidance may have been unclear. The amendments in ASU 2020-10 are effective for the Company for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption is permitted. The Company does not expect the adoption of ASU 2020-10 to have a material impact on its consolidated financial statements and related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211133328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Initial Public Offering<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_InitialPublicOfferingAbstract', window );"><strong>Initial Public Offering</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_InitialPublicOfferingTextBlock', window );">Initial Public Offering</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3 &#8212; Initial Public Offering</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 6, 2021, the Company consummated its initial public offering of 15,000,000 units, at an offering price of $10.00 per unit, generating gross proceeds of $150.0 million, and incurring offering costs of approximately $13.8 million, inclusive of $1.5 million of underwriting discount, approximately $5.3 million in deferred underwriting commissions, approximately $6.5 million in fair value of Class B common stock issued to Anchor Investors, and approximately $0.5 million in other offering costs. Each whole warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 8). Certain qualified institutional buyers or institutional accredited investors (the &#8220;Anchor Investors&#8221;) purchased 15,480,000 units in the initial public offering. None of the Anchor Investors are affiliated with any member of the Company&#8217;s management.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters had a 45-day option from the date of the underwriting agreement (August 3, 2021) to purchase up to an additional 2,250,000 units to cover over-allotments. On September 17, 2021, the over-allotment option expired unexercised, resulting in 562,500 shares of Class B common stock that were subject to forfeiture to be forfeited.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3 &#8212; Initial Public Offering</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 6, 2021, the Company consummated its initial public offering of 15,000,000 units, at an offering price of $10.00 per unit, generating gross proceeds of $150.0 million, and incurring offering costs of approximately $13.8 million, inclusive of $1.5 million of underwriting discount, approximately $5.3 million in deferred underwriting commissions, approximately $6.5 million in fair value of Class B common stock issued to Anchor Investors, and approximately $0.5 million in other offering costs. Each whole warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 8). Certain qualified institutional buyers or institutional accredited investors (the &#8220;Anchor Investors&#8221;) purchased 15,480,000 units in the initial public offering. None of the Anchor Investors are affiliated with any member of the Company&#8217;s management.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters had a 45-day option from the date of the underwriting agreement (August 3, 2021) to purchase up to an additional 2,250,000 units to cover over-allotments. On September 17, 2021, the over-allotment option expired unexercised, resulting in 562,500 shares of Class B common stock that were subject to forfeiture to be forfeited.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_InitialPublicOfferingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_InitialPublicOfferingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_InitialPublicOfferingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure on information about initial public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_InitialPublicOfferingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211122512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4 &#8212; Related Party Transactions</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Founder Shares</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2021, the Sponsor paid $25,000, or approximately $0.005 per share, to cover certain offering costs in consideration for 5,031,250 shares of Class B common stock, par value $0.0001. In March 2021, the Sponsor transferred all of the founder shares it held to members of the Company&#8217;s board of directors, management </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">team, and persons or entities affiliated with AMCI Group (the &#8220;initial shareholders&#8221;). Such shares were fully paid. On May 14, 2021, the Sponsor surrendered 718,750 founder shares to the Company for no consideration, resulting in the Sponsor owning 4,312,500 founder shares. Up to 562,500 of the founder shares will be forfeited depending on the extent to which the underwriters&#8217; over-allotment is exercised. On September 17, 2021, the over-allotment option expired unexercised, resulting in 562,500 of the founder shares being forfeited.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In exchange for the Anchor Investors&#8217; participation in the initial public offering as described in Note 3, the Sponsor sold a total of 780,000 founder shares to the Anchor Investors. The Company determined that the fair value of these founder shares was approximately $6.5 million (or approximately $8.35 per share) using a Monte Carlo simulation. The Company recognized the excess fair value of these founder shares, over the price sold to the Anchor Investors, as an expense of the initial public offering resulting in a charge against the carrying value of Class A common stock subject to possible redemption.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial stockholders have agreed not to transfer, assign or sell any of their founder shares and any Class A common stocks issuable upon conversion thereof until the earlier to occur of: (A) one year after the completion of the initial business combination and (B) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction after the Company&#8217;s initial business combination that results in all of the Company&#8217;s stockholders having the right to exchange their Class A common stock for cash, securities or other property; except to certain permitted transferees and under certain circumstances (the &#8220;Lock-up&#8221;). Any permitted transferees will be subject to the same restrictions and other agreements of the company&#8217;s initial stockholders with respect to any founder shares. Notwithstanding the foregoing, the founder shares will be released from the Lock-up if the closing price of the Company&#8217;s Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the company&#8217;s initial business combination.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Private Placement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Simultaneously with the closing of the initial public offering, the Company&#8217;s Sponsor has purchased an aggregate of 3,500,000 private placement warrants, each exercisable to purchase one Class A common stock at $11.50 per share, at a price of $1.00 per warrant, or $3,500,000 in the aggregate.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The private placement warrants will not be redeemable by the Company so long as they are held by the initial purchasers or their permitted transferees. The initial purchasers, or their permitted transferees, have the option to exercise the private placement warrants on a cashless basis. If the private placement warrants are held by holders other than initial purchasers or their permitted transferees, the private placement warrants will be redeemable by the Company and exercisable by the holders on the same basis as the warrants included in the units being sold in the initial public offering. Otherwise, the private placement warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in the initial public offering.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the private placement warrants are held by holders other than the Sponsor or its permitted transferees, the private placement warrants will be redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the units being sold in the initial public offering.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Loans and Advances</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2021, the Sponsor agreed to loan the Company up to $300,000 to be used for a portion of the expenses of the initial public offering (&#8220;Note&#8221;). This loan was non-interest bearing, unsecured and payable upon the closing of the initial public offering. In addition to the Note, the Sponsor of the Company also paid certain administrative expenses and offering costs on behalf of the Company. These advances were due on demand and were non-interest bearing. The Company repaid the note payable and advances in exchange for the issuance of private placement warrants.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Working Capital Loans</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in order to finance transaction costs in connection with an intended business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#8217;s officers and directors may, but are not obligated </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to, loan the Company funds as may be required on a non-interest basis (&#8220;Working Capital Loans&#8221;). If the Company completes the initial business combination, it will repay the Working Capital Loans. In the event that the initial business combination does not close, the Company may use a portion of the working capital held outside the trust account to repay the Working Capital Loans but no proceeds from the trust account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-business combination entity at a price of $1.00 per warrant at the option of the lender. Such warrants would be identical to the private placement warrants. Except as set forth above, the terms of Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. On March 28, 2022, the Company entered into a noninterest-bearing Working Capital Loan with its Sponsor for the principal amount of up to $1.5 million. As of September 30, 2022 and December 31, 2021, the Company had no borrowings under the Working Capital Loans.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Administrative Service Fee</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the closing of the initial public offering, the Company will pay its Sponsor $10,000 per month for office space, secretarial and administrative services provided to members of the management team. Upon completion of the initial business combination or the Company&#8217;s liquidation, the Company will cease paying these monthly fees. For the three months ended September 30, 2022 and 2021, the Company incurred $30,000 and $20,000, respectively, of such fees, included as general and administrative fees &#8212; related party on the accompanying unaudited condensed statements of operations. For the nine months ended September 30, 2022 and for the period from January 28, 2021 (inception) through September 30, 2021, the Company incurred $90,000 and $20,000, respectively, of such fees, included as general and administrative fees &#8212; related party on the accompanying unaudited condensed statements of operations. As of September 30, 2022 and December 31, 2021, approximately $90,000 and $50,000, respectively, of such fees were included in due to related party on the accompanying condensed balance sheets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sponsor, officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on the Company&#8217;s behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. The Company&#8217;s audit committee will review on a quarterly basis all payments that were made by the Company to the Sponsor, directors, officers or directors of the Company, or any of their affiliates. As of September 30, 2022 and December 31, 2021, there were approximately $596,000 and $0, respectively, of such fees included as due to related party on the accompanying condensed balance sheets.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4 &#8212; Related Party Transactions</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Founder Shares</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2021, the Sponsor paid $25,000, or approximately $0.005 per share, to cover certain offering costs in consideration for 5,031,250 shares of Class B common stock, par value $0.0001. In March 2021, the Sponsor transferred all of the founder shares it held to members of the Company&#8217;s board of directors, management team, and persons or entities affiliated with AMCI Group (the &#8220;initial shareholders&#8221;). Such shares were fully paid. On May 14, 2021, the Sponsor surrendered 718,750 founder shares to the Company for no consideration, resulting in the Sponsor owning 4,312,500 founder shares. Up to 562,500 of the founder shares will be forfeited depending on the extent to which the underwriters&#8217; over-allotment is exercised. On September 17, 2021, the over-allotment option expired unexercised, resulting in 562,500 of the founder shares being forfeited.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In exchange for the Anchor Investors&#8217; participation in the initial public offering as described in Note 3, the Sponsor sold a total of 780,000 founder shares to the Anchor Investors. The Company determined that the fair value of these founder shares was approximately $6.5 million (or approximately $8.35 per share) using a Monte Carlo simulation. The Company recognized the excess fair value of these founder shares, over the price sold to the Anchor Investors, as an expense of the initial public offering resulting in a charge against the carrying value of Class A common stock subject to possible redemption.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial stockholders have agreed not to transfer, assign or sell any of their founder shares and any Class A common stocks issuable upon conversion thereof until the earlier to occur of: (A) one year after the completion of the initial business combination and (B) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction after the Company&#8217;s initial business combination that results in all of the Company&#8217;s stockholders having the right to exchange their Class A common stock for cash, securities or other property; except to certain permitted transferees and under certain circumstances (the &#8220;Lock-up&#8221;). Any permitted transferees will be subject to the same restrictions and other agreements of the company&#8217;s initial stockholders with respect to any founder shares. Notwithstanding the foregoing, the founder shares will be released from the Lock-up if the closing price of the Company&#8217;s Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the company&#8217;s initial business combination.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Private Placement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Simultaneously with the closing of the initial public offering, the Company&#8217;s Sponsor has purchased an aggregate of 3,500,000 private placement warrants, each exercisable to purchase one Class A common stock at $11.50 per share, at a price of $1.00 per warrant, or $3,500,000 in the aggregate.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The private placement warrants will not be redeemable by the Company so long as they are held by the initial purchasers or their permitted transferees. The initial purchasers, or their permitted transferees, have the option to exercise the private placement warrants on a cashless basis. If the private placement warrants are held by holders other than initial purchasers or their permitted transferees, the private placement warrants will be redeemable by the Company and exercisable by the holders on the same basis as the warrants included in the units being sold in the initial public offering. Otherwise, the private placement warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in the initial public offering.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the private placement warrants are held by holders other than the Sponsor or its permitted transferees, the private placement warrants will be redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the units being sold in the initial public offering.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Loans and Advances</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2021, the Sponsor agreed to loan the Company up to $300,000 to be used for a portion of the expenses of the initial public offering (&#8220;Note&#8221;). This loan was non-interest bearing, unsecured and payable upon the closing of the initial public offering. In addition to the Note, the Sponsor of the Company also paid certain administrative expenses and offering costs on behalf of the Company. These advances were due on demand and were non-interest bearing. The Company repaid the note payable and advances in exchange for the issuance of private placement warrants.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in order to finance transaction costs in connection with an intended business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#8217;s officers and directors may, but are not obligated to, loan the Company funds as may be required on a non-interest basis (&#8220;Working Capital Loans&#8221;). If the Company completes the initial business combination, it will repay the Working Capital Loans. In the event that the initial business combination does not close, the Company may use a portion of the working capital held outside the trust account to repay the Working Capital Loans but no proceeds from the trust account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-business combination entity at a price of $1.00 per warrant at the option of the lender. Such warrants would be identical to the private placement warrants. Except as set forth above, the terms of Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of December 31, 2021, the Company had no borrowings under the Working Capital Loans.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Administrative Service Fee</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the closing of the initial public offering, the Company will pay its Sponsor $10,000 per month for office space, secretarial and administrative services provided to members of the management team. Upon completion of the initial business combination or the Company&#8217;s liquidation, the Company will cease paying these monthly fees. For the period from January 28, 2021 (inception) through December 31, 2021, the Company incurred $50,000 of such fees, included as general and administrative fees &#8212; related party on the accompanying statement of operations. As of December 31, 2021, approximately $50,000 of such fees are included as due to related party on the accompanying balance sheet.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9 &#8212; Related Party Transactions</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021, the Company had an equity ownership in LanzaJet and SGLT with an aggregate carrying value of $26,037 and $24,752, respectively. The table below summarizes amounts related to transactions with these related parties (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,116&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,509&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases and open accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounts payable balance is for work that LanzaJet performed as a subcontractor to the Company. Refer to Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for more information. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the formation of LanzaJet, the Company entered into a transition services agreement with LanzaJet. The transition services agreement generally sets out the respective rights, responsibilities and obligations of the Company and LanzaJet with respect to R&amp;D services, access to office and laboratory space, business development and other administrative support services. The transition services agreement may be terminated by mutual consent of the Company and LanzaJet, by LanzaJet at any time, and by the Company upon breach or non-payment by LanzaJet. There are no substantive termination penalties in the event the Company terminates. For the nine months ended September&#160;30, 2022 and September&#160;30, 2021, the Company recognized revenue from related parties of approximately $148 and $355, respectively, under the transition services agreement. The Company also provides certain engineering and other services related to a gas-to-jet demonstration plant currently in development by LanzaJet pursuant to the Investment Agreement described in Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In connection with these services, the Company recognized revenue from LanzaJet of approximately $170 and $403, for the nine months ended September&#160;30, 2022 and September&#160;30, 2021, respectively. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, the Company executed an agreement to lease certain land to a subsidiary of LanzaJet for a period of 10 years with an option to renew this lease for five additional periods of one year with minimum annual rent due to the Company of $24. The lease commenced upon execution of the lease agreement and was subsequently amended in 2022 to extend the Pre-Development Term and annual rent amount. Refer to Note 12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for more information.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company supplies SGLT with certain water-soluble organic compounds required in the Company's proprietary gas fermentation process, and small-size equipment. As a result, for the nine months ended September&#160;30, 2022 and September&#160;30, 2021, the Company recognized revenue from related parties of approximately $151 and $69, respectively. The Company also provided engineering services and incurred costs of $$893 and $1,171 for the nine months ended September&#160;30, 2022 and September&#160;30, 2021, respectively. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, LanzaTech and SGLT entered into a license agreement in 2019, subsequently amended in 2021, to provide SGLT with the right to sublicense the intellectual property that LanzaTech previously licensed to SGLT. In exchange, the Company is entitled to receive licensing consideration, calculated as a percentage of the royalties received by SGLT from the sublicenses. Currently, SGLT sublicenses to certain of its subsidiaries that use LanzaTech's proprietary technology. The royalties received by SGLT are based on sales-and-usage of the sublicensed technology. For the nine months ended September&#160;30, 2022, and September&#160;30, 2021, the Company did not earn any sublicensing revenue as no royalties were received by SGLT.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div>Related Party Transactions<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, the Company had an equity ownership in LanzaJet and SGLT with an aggregate carrying value of $24,752 and $23,217, respectively. Trade receivables and contract assets of $1,071 and $3,257, from these equity method investees are included in accounts receivable, respectively. The Company made purchases and had open accounts payable of $2,575 as of and for the year ended December&#160;31, 2021. The accounts payable balance is for work that LanzaJet performed as a subcontractor to the Company. Refer to Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s, for more information.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the formation of LanzaJet, the Company entered into a transition services agreement with LanzaJet. The transition services agreement generally sets out the respective rights, responsibilities and obligations of the Company and LanzaJet with respect to R&amp;D services, business development and other administrative support services. The transition services agreement may be terminated by mutual consent of the Company and LanzaJet, by LanzaJet at any time, and by the Company upon breach or non-payment by LanzaJet. There are no substantive termination penalties in the event the Company terminates. During the years ended December&#160;31, 2021 and 2020, the Company recognized revenue from related parties of approximately $495 and $285, respectively, under the transition services agreement. The Company provides certain engineering and other services related to a gas-to-jet demonstration plant currently in development by LanzaJet pursuant to the Investment Agreement described in Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As a result, during the years ended December&#160;31, 2021 and 2020, the Company recognized revenue from related parties of approximately $428 and $2,740, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company supplies SGLT with its biocatalyst, certain water-soluble organic compounds required in the Company's proprietary gas fermentation process, and small-size equipment. As a result, during 2021 and 2020 the Company recognized revenue from related parties of approximately $282 and $156, respectively. The Company also provided engineering services and incurred costs of $1,223 and $242 during the years ended December&#160;31, 2021 and 2020, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, LanzaTech and SGLT entered into a license agreement in 2019, subsequently amended in 2021, to provide SGLT with the right to sublicense the intellectual property that LanzaTech previously licensed to SGLT. In </span></div>exchange, the Company is entitled to receive licensing consideration, calculated as a percentage of the royalties received by SGLT from the sublicenses. Currently, SGLT sublicenses to certain of its subsidiaries that use LanzaTech's proprietary technology. The royalties to be received by SGLT are based on sales-and-usage of the sublicensed technology. For the years ended December&#160;31, 2021 and 2020, the Company did not earn any sublicensing revenue as no royalties were received by SGLT.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211020592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5 &#8212; Commitments and Contingencies</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Registration Rights</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of the (i) founder shares, which were issued in a private placement prior to the closing of the initial public offering, (ii) private placement warrants, which were issued in a private placement simultaneously with the closing of the initial public offering and the shares of Class A common stock underlying such private placement warrants and (iii) private placement warrants that may be issued upon conversion of Working Capital Loans will have registration rights to require the Company to register a sale of any of its securities held by them prior to the consummation of the initial business combination pursuant to a registration rights agreement to be signed prior to or on the effective date of the initial public offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent to the Company&#8217;s completion of its initial business combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. In addition, the Anchor Investors will, upon receipt of their founder shares, execute a registration rights agreement with respect to their founder shares.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Underwriting Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted the underwriters a 45-day option from the date of the underwriting agreement to purchase up to an additional 2,250,000 units to cover over-allotments, if any. On September 17, 2021, the over-allotment option expired unexercised, resulting in the forfeiture of 562,500 shares of founder shares. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters were paid an underwriting discount of one percent (1%) of the gross proceeds of the initial public offering, or $1,500,000. Additionally, in connection with the initial public offering, the Company agreed to pay the underwriters a deferred underwriting fee of 3.5% of the gross proceeds, or $5,250,000, of the initial public offering upon the completion of the Company&#8217;s initial business combination. On September 29, 2022, as discussed further below, Evercore Group L.L.C., (&#8220;Evercore&#8221;) the representative of the underwriters of the initial public offering, waived its deferred underwriting fee that accrued from its participation in the initial public offering. The Company recognized approximately $4.9 million of the commissions waiver as a reduction to additional paid-in capital in the condensed statements of changes in stockholders&#8217; deficit for the three and nine months ended September 30, 2022, as this portion represents an extinguishment of deferred underwriting commissions on public shares which was originally recognized in accumulated deficit. The remaining balance of approximately $172,000 is recognized as a gain from extinguishment of deferred underwriting commissions on public warrants in the condensed statements of operations, which represents the original amount expensed in the Company&#8217;s initial public offering.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 27, 2022 and September 29, 2022, the Company received notice and a formal letter, respectively, from Evercore Group, L.L.C., an underwriter in the Company&#8217;s initial public offering, advising that it had, among other things, (i) resigned from and ceased or refused to act in, its roles as co-placement agent, co-capital markets advisor and exclusive financial advisor to the Company in connection with the Merger and as underwriter in the Company&#8217;s initial public offering and (ii) waived its right to receive an aggregate of $13,050,000 in fees, all of which were contingent upon and payable upon the closing of the Merger, consisting of $500,000 for its role as co-placement agent, $7,500,000 for its role as exclusive financial advisor and $5,050,000 of deferred underwriting fees accrued from its participation in the Company&#8217;s initial public offering, as well as any expense reimbursements owed to it under those arrangements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5 &#8212; Commitments and Contingencies</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Registration Rights</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of the (i) founder shares, which were issued in a private placement prior to the closing of the initial public offering, (ii) private placement warrants, which were issued in a private placement simultaneously with the closing of the initial public offering and the shares of Class A common stock underlying such private placement </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">warrants and (iii) private placement warrants that may be issued upon conversion of Working Capital Loans will have registration rights to require the Company to register a sale of any of its securities held by them prior to the consummation of the initial business combination pursuant to a registration rights agreement to be signed prior to or on the effective date of the initial public offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent to the Company&#8217;s completion of its initial business combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. In addition, the Anchor Investors will, upon receipt of their founder shares, execute a registration rights agreement with respect to their founder shares.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Underwriting Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted the underwriters a 45-day option from the date of the underwriting agreement to purchase up to an additional 2,250,000 units to cover over-allotments, if any. On September 17, 2021, the over-allotment option expired unexercised, resulting in the forfeiture of 562,500 shares of founder shares.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters were paid an underwriting discount of one percent (1%) of the gross proceeds of the initial public offering, or $1,500,000. Additionally, the underwriters will be entitled to a deferred underwriting discount of 3.5% of the gross proceeds, or $5,250,000, of the initial public offering upon the completion of the Company&#8217;s initial business combination.</span></div>Commitments and Contingencies<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may be involved in legal proceedings and exposed to potential claims in the normal course of business. As of September&#160;30, 2022 and December&#160;31, 2021, the Company does not have any reasonable possible or probable losses from such claims. </span></div>Commitments and ContingenciesLitigationThe Company may be involved in legal proceedings and exposed to potential claims in the normal course of business. As of December 31, 2021 and December 31, 2020, it is not probable that the Company has incurred any losses from such claims.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272210233504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Class A Common Stock Subject to Possible Redemption<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityDisclosureTextBlock', window );">Class A Common Stock Subject to Possible Redemption</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6 &#8212; Class A Common Stock Subject to Possible Redemption</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of future events. The Company is authorized to issue 280,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of the Company&#8217;s Class A common stock are entitled to one vote for each share. As of September 30, 2022 and December 31, 2021, there were 15,000,000 shares of Class A common stock outstanding subject to possible redemption and are classified outside of permanent equity in the condensed balance sheets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Class A common stock subject to possible redemption reflected on the condensed balance sheets is reconciled in the following table:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross proceeds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount allocated to public warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,100,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,306,092)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of carrying value to redemption value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,406,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock subject to possible redemption, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subsequent remeasurement of Class A common stock subject to possible redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock subject to possible redemption, September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,293,649&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6 &#8212; Class A Common Stock Subject to Possible Redemption</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of future events. The Company is authorized to issue 280,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of the Company&#8217;s Class A common stock are entitled to one vote for each share. As of December 31, 2021, there were 15,000,000 shares of Class A common stock outstanding subject to possible redemption and are classified outside of permanent equity in the balance sheet.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Class A common stock subject to possible redemption reflected on the balance sheet is reconciled in the following table:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross proceeds from Initial Public Offering</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of Public Warrants at issuance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,100,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Offering costs allocated to Class A common stock subject to possible redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,306,092)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion on Class A common stock subject to possible redemption amount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,406,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock subject to possible redemption</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Redeemable, Convertible Preferred Stock<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has six outstanding series of contingently redeemable convertible preferred stock. The authorized, issued and outstanding shares, issue price, and carrying value as of September&#160;30, 2022, are as follows (in thousands, except share and per share amounts):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.287%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares Authorized</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.75 - 3.94</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,254,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.69</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,274,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,161,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.93</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series F</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,747,033&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,631&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in redeemable convertible preferred stock issued and outstanding during the nine months ended September&#160;30, 2022. The holders of preferred shares are entitled to receive dividends on an as converted to common shares basis as if all preferred shares had been converted into common shares on the date of such event. Dividends are cumulative and are payable in arrears at the rate of 8% of the original issue price.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, a warrant was exercised for a total issuance of 158,058 Series D preferred shares which led to an increase in redeemable convertible preferred stock of $3,150 during the nine months ended September&#160;30, 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redemption features of preferred shares are not fixed and do not have a determinable price on fixed or determinable dates. As of September&#160;30, 2022, the preferred shares are not currently redeemable, and it is not probable that the preferred shares will become redeemable, since it is uncertain whether or when circumstances exist that would constitute a deemed liquidation event. Accordingly, the Company has not adjusted the carrying value of the preferred shares to their redemption values.</span></div>Redeemable, Convertible Preferred Stock<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has six outstanding series of contingently redeemable convertible preferred stock. The authorized, issued and outstanding shares, issue price, and carrying value as of December&#160;31, 2021 and 2020 are as follows (in thousands, except share and per share amounts):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares Authorized</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.75 - 3.94</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,254,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.69</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,274,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,161,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.93</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series F</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,747,033&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,631&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares Authorized</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Issue Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.75 - 3.94</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,254,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,142,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,274,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,003,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">185,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,112,823&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,729,542&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">394,408&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable convertible preferred stock issued and outstanding as of December&#160;31, 2021 and 2020, and changes during the years ended December&#160;31, 2021 and 2020, were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.874%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.508%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.470%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.310%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="81" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Redeemable Convertible Preferred Stock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series B</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series C</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series D</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series E</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series F</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10,003,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">185,252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,149,745&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">71,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">23,695,330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">347,938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Preferred stock issuance, net of costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,034,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">46,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,034,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">46,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10,003,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">185,252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">25,729,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">394,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Preferred stock issuance, net of costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">158,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,792,268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">86,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10,161,362&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">188,402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">480,631&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records all preferred shares net of offering costs at their respective fair values on the dates of issuance. The preferred shares are classified outside of shareholders&#8217; (deficit) equity in the consolidated financial statements, as the preferred shares are redeemable under circumstances that qualify as a deemed liquidation event, which are outside the control of the Company. Upon the occurrence of a liquidation event, such as a voluntary or involuntary liquidation, dissolution or winding up of the Company, merger, consolidation, or change in control, the holders of Series E preferred stock are entitled, on a pari passu basis, to be paid out of the assets of the Company available for distribution before any payment is made to the holders of Series A, B, C, and D preferred shares and then to holders of common shares. In February 2020, the Company closed a Series E follow-on round with the issuance of 2,034,212 Series E preferred shares for net proceeds of $46,470 ($22.86 per share). In March 2021, a warrant was exercised for a total issuance of 158,058 Series D preferred shares and net proceeds of $3,150 ($19.93 per share). In April 2021, the Company closed a Series F round with the issuance of 3,634,210 Series F preferred shares for the net proceeds of $83,073 ($22.86 per share).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of preferred shares are entitled to cast the number of votes equal to the number of whole common shares into which the preferred shares are convertible. The holders of preferred shares also have consent rights, including in a number of cases subject to a separate class vote and a supermajority requirement, over certain actions including, among others (i) alterations or changes to the terms of the preferred shares, (ii) the election of a certain number of directors, including the designation of directors by holders of a specified series of preferred shares or by certain specified individual stockholders, and (iii) repurchases of shares, the authorization or designation of more senior class or series of shares, or certain issuances of new shares.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preferred shares are convertible at the holder&#8217;s option into common shares generally on a share-for-share basis. Each preferred share will be automatically converted into common stock upon either (i) the determination of the holders of certain requisite preferred shares or (ii) a firmly underwritten initial public offering of the Company&#8217;s shares that satisfies certain requirements (but not, for the avoidance of doubt, upon a business combination with a special purpose acquisition company, unless such conversion is otherwise effected pursuant to clause (i) above).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of preferred shares are entitled to receive dividends on an as converted to common shares basis as if all preferred shares had been converted into common shares on the date of such event. Dividends are cumulative and are payable in arrears at the rate of 8% of the original issue price. If dividends are payable on common shares, preferred shareholders also receive those dividends as if the preferred shares had been converted to common shares. Series D, E, and F preferred shareholders are entitled to be paid dividends prior to Series A, B, and C, on a pari passu basis. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redemption features of preferred shares are not fixed and do not have a determinable price on fixed or determinable dates. As of December&#160;31, 2021 and 2020, preferred shares are not currently redeemable, and it is not probable that preferred shares will become redeemable, since it is uncertain whether or when circumstances exist </span></div>that would constitute a deemed liquidation event. Accordingly, the Company has not adjusted the carrying value of the preferred shares to their redemption values.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TemporaryEquityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure on temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TemporaryEquityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211036144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Deficit<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity (Deficit)</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7 &#8212; Stockholders&#8217; Equity (Deficit)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Preferred Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 and provides that shares of preferred stock may be issued from time to time in one or more series. The Company&#8217;s board of directors will be authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">applicable to the shares of each series. As of September 30, 2022 and December 31, 2021, there were no shares of preferred stock issued or outstanding.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Class A Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The Company is authorized to issue 280,000,000 shares of Class A common stock with a par value of $0.0001 per share. As of September 30, 2022 and December 31, 2021, there were 15,000,000 shares of Class A common stock issued and outstanding, all of which were subject to possible redemption and are classified as temporary equity (see Note 6).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Class B Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The Company is authorized to issue 20,000,000 Class B common stock with a par value of $0.0001 per share. As of September 30, 2022 and December 31, 2021, there were 3,750,000 shares of Class B common stock issued and outstanding (see Note 4).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of the Company&#8217;s stockholders except as required by law. Unless specified in the Company&#8217;s amended and restated certificate of incorporation, or as required by applicable provisions of the Delaware General Corporation Law (&#8220;DGCL&#8221;) or applicable stock exchange rules, the affirmative vote of a majority of the Company&#8217;s shares of common stock that are voted is required to approve any such matter voted on by its stockholders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Class B common stock will automatically convert into shares of Class A common stock concurrently with or immediately following the consummation of the initial business combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in connection with the initial business combination, the number of shares of Class A common stock issuable upon conversion of all founder shares will equal, in the aggregate, on an as-converted basis, 20% of the total number of shares of Class A common stock outstanding after such conversion (after giving effect to any redemptions of shares of Class A common stock by public stockholders), including the total number of shares of Class A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial business combination, excluding any shares of Class A common stock or equity-linked securities or rights exercisable for or convertible into shares of Class A common stock issued, or to be issued, to any seller in the initial business combination and any private placement warrants issued to the Sponsor, officers or directors upon conversion of working capital loans, provided that such conversion of founder shares will never occur on a less than one-for-one basis.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7 &#8212; Stockholders&#8217; Deficit</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Preferred Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 and provides that shares of preferred stock may be issued from time to time in one or more series. The Company&#8217;s board of directors will be authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. As of December 31, 2021, there were no shares of preferred stock issued or outstanding.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Class A Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The Company is authorized to issue 280,000,000 shares of Class A common stock with a par value of $0.0001 per share. As of December 31, 2021, there were 15,000,000 shares of Class A common stock issued and outstanding, all of which were subject to possible redemption and are classified as temporary equity (see Note 6).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Class B Common Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; The Company is authorized to issue 20,000,000 Class B common stock with a par value of $0.0001 per share. As of December 31, 2021, there were 3,750,000 shares of Class B common stock issued and outstanding (see Note 4).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of the Company&#8217;s stockholders except as required by law. Unless specified in the Company&#8217;s amended and restated certificate of incorporation, or as required by applicable provisions of the Delaware General Corporation Law (&#8220;DGCL&#8221;) or applicable stock exchange rules, the affirmative vote of a majority of the Company&#8217;s shares of common stock that are voted is required to approve any such matter voted on by its stockholders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Class B common stock will automatically convert into shares of Class A common stock concurrently with or immediately following the consummation of the initial business combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in connection with the initial business combination, the number of shares of Class A common stock issuable upon conversion of all founder shares will equal, in the aggregate, on an as-converted basis, 20% of the total number of shares of Class A common stock outstanding after such conversion (after giving effect to any redemptions of shares of Class A common stock by public stockholders), including the total number of shares of Class A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial business combination, excluding any shares of Class A common stock or equity-linked securities or rights exercisable for or convertible into shares of Class A common stock issued, or to be issued, to any seller in the initial business combination and any private placement warrants issued to the Sponsor, officers or directors upon conversion of working capital loans, provided that such conversion of founder shares will never occur on a less than one-for-one basis.</span></div>Shareholders&#8217; EquityThe securities of the Company are represented by common shares, par value $0.0001 per share. Each common share is entitled to one vote. With respect to payment of dividends and distribution of assets upon liquidation, dissolution or winding up of the Company, whether voluntary or involuntary, all common shares shall participate pro rata in such payment whenever funds are legally available and when declared by the Board of Directors of the Company, subject to the prior rights of holders of all classes of stock outstanding.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211289056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrants and Rights Note Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_WarrantsTextBlockTextBlock', window );">Warrants</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8 &#8212; Warrants</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022 and December 31, 2021, in connection with the initial public offering, the Company has 7,500,000 public warrants and 3,500,000 private placement warrants outstanding.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each whole warrant entitles the registered holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment as discussed below, at any time commencing 30 days after the completion of the initial business combination, provided that the Company has an effective registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement) and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder. The warrants will expire five years after the completion of the Company&#8217;s initial business combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreed that as soon as practicable, but in no event later than fifteen (15) business days after the closing of the initial business combination, it will use its best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A common stock issuable upon exercise of the warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the shares of Class A </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">common stock issuable upon exercise of the warrants is not effective by the sixtieth (60th) business day after the closing of the initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Company&#8217;s Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a &#8220;covered security&#8221; under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of public warrants who exercise their warrants to do so on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, it will not be required to file or maintain in effect a registration statement, and in the event the Company do not so elect, it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once the warrants become exercisable, the Company may redeem the outstanding warrants:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in whole and not in part;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at a price of $0.01 per warrant;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">upon a minimum of 30 days&#8217; prior written notice of redemption to each warrant holder; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if, and only if, the closing price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading &#8220;&#8212; Warrants&#8201;&#8212;&#8201;Public Stockholders&#8217; Warrants&#8201;&#8212;&#8201;Anti-Dilution Adjustments&#8221;) for any 20 trading days within a 30-trading day period ending three trading days before we send the notice of redemption to the warrant holders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once the warrants become exercisable, the Company may redeem the outstanding warrants:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in whole and not in part;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at $0.10 per warrant upon a minimum of 30 days&#8217; prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table below, based on the redemption date and the &#8220;fair market value&#8221; (as defined below) of our Class A common stock except as otherwise described below; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if, and only if, the closing price of our Class A common stock equals or exceeds $10.00 per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading &#8220;&#8212; Warrants&#8201;&#8212;&#8201;Public Stockholders&#8217; Warrants&#8201;&#8212;&#8201;Anti-Dilution Adjustments&#8221;) for any 20 trading days within the 30-trading day period ending three trading days before we send the notice of redemption to the warrant holders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if (x) the Company issue additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of our initial business combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by the Company&#8217;s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any founder shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the &#8220;Newly Issued Price&#8221;), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of our initial business combination on the date of the consummation of the initial business combination (net of redemptions), and (z) the volume weighted average trading price of the Company&#8217;s Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummate the initial business combination (such price, the &#8220;Market Value&#8221;) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption </span></div>trigger price described above under &#8220;&#8212; Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00&#8221; will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described above under &#8220;&#8212; Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00&#8221; will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8 &#8212; Warrants</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, in connection with the initial public offering, the Company has 7,500,000 public warrants and 3,500,000 private placement warrants outstanding.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each whole warrant entitles the registered holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment as discussed below, at any time commencing 30 days after the completion of the initial business combination, provided that the Company has an effective registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement) and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder. The warrants will expire five years after the completion of the Company&#8217;s initial business combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreed that as soon as practicable, but in no event later than fifteen (15) business days after the closing of the initial business combination, it will use its best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A common stock issuable upon exercise of the warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the sixtieth (60th) business day after the closing of the initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Company&#8217;s Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a &#8220;covered security&#8221; under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of public warrants who </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">exercise their warrants to do so on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, it will not be required to file or maintain in effect a registration statement, and in the event the Company do not so elect, it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once the warrants become exercisable, the Company may redeem the outstanding warrants:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in whole and not in part;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at a price of $0.01 per warrant;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">upon a minimum of 30 days&#8217; prior written notice of redemption to each warrant holder; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if, and only if, the closing price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading &#8220;&#8212; Warrants &#8212; Public Stockholders&#8217; Warrants &#8212; Anti-Dilution Adjustments&#8221;) for any 20 trading days within a 30-trading day period ending three trading days before we send the notice of redemption to the warrant holders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once the warrants become exercisable, the Company may redeem the outstanding warrants:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in whole and not in part;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at $0.10 per warrant upon a minimum of 30 days&#8217; prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table below, based on the redemption date and the &#8220;fair market value&#8221; (as defined below) of our Class A common stock except as otherwise described below; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if, and only if, the closing price of our Class A common stock equals or exceeds $10.00 per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading &#8220;&#8212; Warrants &#8212; Public Stockholders&#8217; Warrants &#8212; Anti-Dilution Adjustments&#8221;) for any 20 trading days within the 30-trading day period ending three trading days before we send the notice of redemption to the warrant holders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if (x) the Company issue additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of our initial business combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by the Company&#8217;s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any founder shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the &#8220;Newly Issued Price&#8221;), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of our initial business combination on the date of the consummation of the initial business combination (net of redemptions), and (z) the volume weighted average trading price of the Company&#8217;s Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummate the initial business combination (such price, the &#8220;Market Value&#8221;) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price described above under &#8220;&#8212; Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00&#8221; will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described above under &#8220;&#8212; Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00&#8221; will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_WarrantsTextBlockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the entire disclosure of warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_WarrantsTextBlockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272212765664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9 &#8212; Fair Value Measurements </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information about the Company&#8217;s financial assets and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy:</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September 30, 2022</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other <br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held in trust account</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,969,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201;public warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201;private placement warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493,280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2021</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held in trust account</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,006,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201; public warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,825,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201;private placement warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transfers to/from Levels 1, 2 and 3 are recognized at the beginning of the reporting period. The estimated fair value of public warrants was transferred from a Level 3 fair value measurement to a Level 1 measurement, when the public warrants were separately listed and traded in September 2021. There were no other transfers between levels in the nine months ended September 30, 2022 and in the period from January 28, 2021 (inception) through December 31, 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 assets include investments in mutual funds invested in U.S. government securities and derivative warrant liabilities (public warrants). The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For periods where no observable traded price is available, the fair value of the public warrants has been estimated using a Monte-Carlo simulation model and the private placement warrants has been estimated using a Black-Scholes option pricing model. For periods subsequent to the detachment of the public warrants from the units, the fair value of the public warrants is based on the observable listed price for such warrants. The estimated fair value of the public and private placement warrants, prior to the public warrants being traded in an active market, was determined using Level 3 inputs. Inherent in a Monte-Carlo simulation and Black-Scholes option pricing model are assumptions related to the unit price, expected volatility, risk-free interest rate, term to expiration, and dividend yield. The unit price is based on the publicly traded price of the units as of the measurement date. The Company estimated the volatility for the public and private placement warrants based on the implied volatility from the traded prices of warrants issued by other special purpose acquisition companies. The risk-free interest rate is based on </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">interpolated U.S. Treasury rates, commensurate with a similar term to the public and private placement warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. Finally, the Company does not anticipate paying a dividend. Any changes in these assumptions can change the valuation significantly.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2022 and 2021, the Company recognized a change to the statement of operations resulting from a decrease (increase) in the fair value of liabilities of approximately $1.4 million and $1.4 million, respectively, presented as change in fair value of derivative warrant liabilities on the accompanying statements of operations. For the nine months ended September 30, 2022 and for the period from January 28, 2021 (inception) through September 30, 2021, the Company recognized a change to the statement of operations resulting from a decrease (increase) in the fair value of liabilities of approximately $4.1 million and $1.4 million, respectively, presented as change in fair value of derivative warrant liabilities on the accompanying statements of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30, 2022 </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2021 </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.19</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.75</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the fair value of the derivative warrant liabilities, measured using Level 3 inputs, for the three and nine months ended September 30, 2022 is summarized as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,030,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,085,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(451,720)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493,280&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9 &#8212; Fair Value Measurement </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information as of December 31, 2021 about the Company&#8217;s financial assets and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held in Trust Account</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,006,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities &#8211; Public Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,825,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities &#8211; Private Placement Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transfers to/from Levels 1, 2 and 3 are recognized at the beginning of the reporting period. The estimated fair value of public warrants was transferred from a Level 3 fair value measurement to a Level 1 measurement, when the public warrants were separately listed and traded in September 2021. There were no other transfers between levels in the period from January 28, 2021 (inception) through December 31, 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 assets include investments in mutual funds invested in U.S. government securities and derivative warrant liabilities (public warrants). The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For periods where no observable traded price is available, the fair value of the public warrants has been estimated using a Monte-Carlo simulation model and the private placement warrants has been estimated using a Black-Scholes option pricing model. For periods subsequent to the detachment of the public warrants from the units, the fair value of the public warrants is based on the observable listed price for such warrants. The estimated fair value of the public and private placement warrants, prior to the public warrants being traded in an active market, was determined using Level 3 inputs. Inherent in a Monte-Carlo simulation and Black-Scholes option pricing model are assumptions related to the unit price, expected volatility, risk-free interest rate, term to expiration, and dividend yield. The unit price is based on the publicly traded price of the units as of the measurement date. The Company estimated the volatility for the public and private placement warrants based on the implied volatility from the traded prices of warrants issued by other special purpose acquisition companies. The risk-free interest rate is based on interpolated U.S. Treasury rates, commensurate with a similar term to the public and private placement warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. Finally, the Company does not anticipate paying a dividend. Any changes in these assumptions can change the valuation significantly.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of <br/>December 31, 2021 </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of <br/>August 6, 2021 </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining term (yrs)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.75</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.51</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the fair value of the derivative warrant liabilities, measured using Level 3 inputs, for the period from January 28, 2021 (inception) through December 31, 2021 is summarized as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at January 28, 2021 (inception)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of Public and Private Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,515,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer of Public Warrants to Level 1</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,100,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(630,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6 &#8212; Fair Value</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value hierarchy for its assets and liabilities measured at fair value as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,815&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,815&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has warrants to purchase preferred shares outstanding as of September&#160;30, 2022 and December&#160;31, 2021 representing 225,223 and 225,223 preferred shares, respectively, which warrants expire at various dates through December 31, 2027. The exercise prices of the warrants range from $14.69 to $19.93 as of each of September&#160;30, 2022 and December&#160;31, 2021. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The warrants are accounted for as liabilities in accordance with ASC 480, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distinguishing Liability from Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and are presented within other accrued liabilities on the condensed consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the condensed consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The fair value of the warrants was calculated using the Black-Scholes Option Pricing Model. For the nine months ended September&#160;30, 2022 and 2021, the Company recognized a change in the fair value of liabilities of approximately $(427) and $(699), respectively, on the condensed consolidated statements of operations and comprehensive loss within other (expense) income, net.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the warrants is determined using Level 3 inputs. Inherent in the Black-Scholes Option Pricing Model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its warrants based on implied volatility from the Company&#8217;s warrants and from historical volatility of select peer companies that match the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the weighted average inputs used in calculating the fair value of the preferred share warrants outstanding as of September&#160;30, 2022 and December&#160;31, 2021:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.03&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SAFE Liability and SAFE Warrant</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company issued a SAFE that allowed an investor to participate in future equity financings through a share-settled redemption of the amount invested (such notional being the &#8220;invested amount&#8221;). The SAFE had not yet converted as a qualifying financing had not yet occurred as of September&#160;30, 2022. At September&#160;30, 2022, the SAFE had a fair value of $27,221 and was recorded within current liabilities on the condensed consolidated balance sheet. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, the warrant related to the SAFE of $2,022 as of September&#160;30, 2022 is accounted for as a liability. This liability is recorded in current liabilities on the Company's condensed consolidated balance sheets at fair value on the date of issuance and will be revalued each subsequent reporting period until such instrument is exercised or expires. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in fair value between reporting periods for both the SAFE liability and SAFE warrant is included in other (expense) income, net in the condensed consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s SAFE liability and SAFE warrant are mark-to-market liabilities pursuant to ASC 480 and are classified within Level 3 of the fair value hierarchy as the Company is using a scenario-based approach which allowed the Company to estimate the implied value of the business based on the terms of the SAFE. Significant unobservable inputs included probability and expected term. Probability is based upon the likelihood of the Company closing a transaction with a special purpose acquisition company. The expected term was based on the anticipated time until the SAFE investments would have a conversion event. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE liability fair value measurement at September&#160;30, 2022 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liquidity price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE warrant fair value measurement at September&#160;30, 2022 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining life (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables represents a reconciliation of the contingent shares issuance liabilities fair value measurements using the significant unobservable inputs (Level 3) (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrants</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE warrant</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss / (gain) recognized in condensed statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,050)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,221&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrants</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE warrant</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of SAFE liability and warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss recognized in condensed statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,281&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div>Fair Value<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value hierarchy for its assets and liabilities measured at fair value as of December&#160;31, 2021 and 2020 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:13pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The warrants are accounted for as liabilities in accordance with ASC 480 and are presented within other accrued liabilities on the consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the warrants was calculated using the Black-Scholes Option Pricing Model. For the years ended December&#160;31, 2021 and 2020, the Company recognized a change in the fair value of liabilities of approximately $(563) and $105, respectively, on the statements of operations and comprehensive loss within other income (expense), net.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the warrants is determined using Level 3 inputs. Inherent in the Black-Scholes Option Pricing Model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its warrants based on implied volatility from the Company&#8217;s warrants and from historical volatility of select peer companies that match the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the weighted average inputs used in calculating the fair value of the preferred share warrants outstanding as of December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s SAFE liability and SAFE warrant are mark-to-market liabilities pursuant to ASC 480 and are classified within Level 3 of the fair value hierarchy as the Company is using a scenario-based approach which allowed the Company to estimate the implied value of the business based on the terms of the SAFE. Significant unobservable inputs included probability and expected term. Probability is based upon the likelihood of the Company closing a transaction with a special purpose acquisition company. The expected term was based on the anticipated time until the SAFE investments would have a conversion event. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE liability fair value measurement at December 31, 2021 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liquidity price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE warrant fair value measurement at December 31, 2021 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining life (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents a reconciliation of the contingent shares issuance liabilities fair value measurements using the significant unobservable inputs (Level 3) (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain recognized in statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of SAFE liability and warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss recognized in statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, a warrant was exercised for a total issuance of 158,058 Series D preferred shares. The fair value of this warrant was $107 as of January 1, 2020 and was remeasured to zero as of December 31, 2020. As a result, the exercise had no impact on the consolidated statement of operations and comprehensive loss as of and for the year ended December 31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211064528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10 &#8212; Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal and Connecticut jurisdictions and are subject to examination. The income tax provision consists of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Period from January 28, 2021<br/>(inception) through December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290,181)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s net deferred tax assets are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Start-up/Organization costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">210,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">290,181&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(290,181)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax asset, net of allowance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax assets, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the period from January 28, 2021 (inception) through December 31, 2021, the valuation allowance was $290,181. As of December 31, 2021, the Company had $380,351 of U.S. federal net operating loss carryovers, which do not expire, available to offset future taxable income.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no unrecognized tax benefits as of December 31, 2021. No amounts were accrued for the payment of interest and penalties as of December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company&#8217;s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the statutory federal income tax rate (benefit) to the Company&#8217;s effective tax rate (benefit) is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Period from January 28, 2021 (inception) through December 31, 2021 </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory federal income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative warrant liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(855.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Offering costs allocated to derivative warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div>Income Taxes<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to federal state income taxes in the United States, as well as income taxes in foreign jurisdictions in which it conducts business. The Company does not provide for federal income taxes on the undistributed earnings of its foreign subsidiaries as such earnings are reinvested indefinitely. The Company and its foreign subsidiaries have historically been loss generating entities that have resulted in no excess earnings to consider for repatriation and accordingly there are no deferred income taxes recognized for the nine months ended September&#160;30, 2022 and 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded an income tax expense of $0 for the nine months ended September&#160;30, 2022 and 2021, representing an effective tax rate of 0%. The difference between the U.S. federal statutory rate of 21% and the Company's effective tax rate in the first nine months ended September&#160;30, 2022 is primarily due to a full valuation allowance related to the Company's U.S. deferred tax assets and tax benefits in the Company's foreign jurisdictions. For the first nine months ended September 30, 2021, the Company's effective tax rate was computed based on income tax rate in New Zealand of 28.0% as the Company was still domiciled in New Zealand. The Company reassesses the need for a valuation allowance on a quarterly basis. If it is determined that a portion or all of the valuation allowance is not required, it will generally be a benefit to the income tax provision in the period such determination is made.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts business in multiple jurisdictions within and outside the United States. Consequently, the Company is subject to periodic income tax examinations by domestic and foreign income tax authorities. The Company is subject to audits for tax years 2009 and onward for federal purposes. There are tax years which remain subject to examination in various other state and foreign jurisdictions that are not material to the Company's financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, the Company migrated its country of domicile from New Zealand to Delaware in the United States. On migration, the Company was deemed to have disposed of all its assets and liabilities to a third-party at market value which resulted in taxable income to the Company for New Zealand income tax purposes which was fully offset by net operating loss carryforwards and deferred R&amp;D credits in New Zealand. The migration to Delaware is classified as a tax-free reorganization for U.S. federal income tax purposes.</span></div>Income Taxes<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of (loss) income before income taxes and gain from equity method investees, net are as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,860)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Zealand</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,551)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,651)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,689)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,713)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of income tax expense were as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Zealand</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Zealand</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of income taxes computed at the statutory federal income tax rate (21.0% federal income tax rate in the United States for 2021 and 28.0% federal income tax rate in the New Zealand for </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020, respectively) to the income tax expense (benefit) reflected in the consolidated statement of operations and comprehensive loss (in thousands, except percentages):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit) at the statutory federal income tax rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,805)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,560)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax rate differential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(605)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,068)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,429)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,892)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income on receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(443)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(679)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible legal costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from redomiciliation of intellectual property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPP loan forgiveness</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(644)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(196)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax benefit</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of deferred tax assets and liabilities as of December&#160;31, 2021 and 2020, were as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss and credit carryforwards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,979&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,878&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued bonus</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,881&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,417&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113,276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108,300)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax asset</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,117&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease asset</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,429)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,941)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,605)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,117)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net deferred income tax assets and liabilities:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021 and 2020, the Company had $299,194 and $271,390, respectively, of tax losses and credits carried forward subject to shareholder continuity and acceptance in the countries where the Company has tax losses carried forward. R&amp;D tax credits included within these amounts are $35,147 and $40,556, respectively, which may be available to offset future income tax liabilities. At December&#160;31, 2021 and 2020, the net operating loss and credit carryforwards are comprised of $239,559 and $196,442 in the United States, $22,203 and $18,104 in state and local, $35,116 and $54,334 in New Zealand, and $4,589 and $2,510 in other foreign jurisdictions, respectively. At December&#160;31, 2021 and 2020, the Company had net operating loss carryforwards of approximately $136,454 and $132,373, respectively, that expire in various years from 2022 through 2037, plus $127,593 and $98,462, respectively, for which there is no expiration date. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 382 of the Internal Revenue Code imposes an annual limitation on the utilization of net operating loss carryforwards based on a statutory rate of return and the value of the corporation at the time of a &#8220;change of ownership&#8221; as defined by Section 382. The Company had a change in ownership</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in November 2014. T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">herefore, the Company&#8217;s ability to utilize its net operating loss carryforwards incurred prior to the 2014 ownership change, will be subject in future periods to annual limitations. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In assessing the realizability of deferred tax assets, the Company assesses whether it is more-likely-than-not that a portion or all of the deferred tax assets will not be realized. The Company considers the scheduled reversal of deferred tax liabilities, tax planning strategies and projected future taxable income in making this assessment. At December&#160;31, 2021 and 2020, a valuation allowance of $113,276 and $108,300, respectively, was recorded against certain deferred tax assets based on this assessment. The Company believes it is more-likely-than-not that the tax benefit of the remaining net deferred tax assets will be realized. The amount of net deferred tax assets considered realizable could be increased or reduced in the future if the Company&#8217;s assessment of future taxable income or tax planning strategies changes.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its foreign subsidiaries have historically been loss generating entities that have resulted in no excess earnings to consider for repatriation and accordingly there are no deferred income taxes recognized as of December&#160;31, 2021 and 2020.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021 and 2020, the Company had no tax liability or benefit related to uncertain tax positions. No interest or penalties related to uncertain taxes have been recognized on the accompanying consolidated statements of operations. Management does not expect a significant change in uncertain tax positions during the twelve months subsequent to December 31, 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts business in multiple jurisdictions within and outside the United States. Consequently, the Company is subject to periodic income tax examinations by domestic and foreign income tax authorities. During December 2021, the Internal Revenue Service completed an income tax examination of the Company&#8217;s U.S. federal income tax return for the year ended December 31, 2016, which resulted in no impact to the Company&#8217;s consolidated financial statements. The Company has no other ongoing tax examinations with domestic or foreign taxing authorities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, the Company migrated its country of domicile from New Zealand to Delaware in the United States. On migration, the Company was deemed to have disposed of all its assets and liabilities to a third-party at market value which resulted in taxable income to the Company for New Zealand income tax purposes. The migration to Delaware is classified as a tax-free reorganization for U.S. federal income tax purposes.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211101536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10 &#8212; Subsequent Events</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 18, 2022, the Company entered into additional subscription agreements (the &#8220;Subscription Agreements&#8221;) with certain accredited investors (collectively, the &#8220;Additional PIPE Investors&#8221;), pursuant to which, among other things, the Company agreed to issue and sell, in a private placement to close immediately prior to the closing of the Merger, an aggregate of 5,500,000 shares of Class A common stock at a purchase price of $10.00 per share to the Additional PIPE Investors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated subsequent events and transactions that occurred up to the date the unaudited condensed financial statements were issued. Based upon this review and except in the case of the foregoing, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11 &#8212; Subsequent Events</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated subsequent events and transactions that occurred up to the date financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2022, the Company entered into the Merger Agreement with Merger Sub and LanzaTech. The transactions contemplated by the Merger Agreement are referred to herein as the &#8220;Business Combination.&#8221; The time of the closing of the Business Combination is referred to herein as the &#8220;Closing.&#8221; The date of the Closing of the Business Combination is referred to herein as the &#8220;Closing Date.&#8221;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposed Business Combination</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Business Combination is approved by the Company&#8217;s stockholders and LanzaTech&#8217;s stockholders, and the closing conditions in the Merger Agreement are satisfied or waived, then, among other things, upon the terms and subject to the conditions of the Merger Agreement and in accordance with Delaware General Corporation Law, Merger Sub will merge with and into LanzaTech, with LanzaTech surviving the merger as the Company&#8217;s wholly owned subsidiary (the &#8220;Merger&#8221;). In connection with the consummation of the Merger, the Company will be renamed &#8220;LanzaTech Global, Inc.&#8221; and is referred to herein as &#8220;New LanzaTech&#8221; as of the time following such change of name.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Merger Agreement, the Company has agreed to acquire all of the outstanding equity interests of LanzaTech for consideration consisting of equity interests of New LanzaTech valued at $1,817,000,000 in the aggregate. The consideration to be paid to holders of shares of LanzaTech capital stock will be shares of common stock of New LanzaTech (&#8220;New LanzaTech Common Stock&#8221;), valued at $10.00 per share, to be paid at the closing of the Merger. The number of shares of New LanzaTech Common Stock payable in the Merger in respect of each share of LanzaTech capital stock (each, a &#8220;LanzaTech Share&#8221;) will be determined based on the exchange ratio (the &#8220;Exchange Ratio&#8221;), and certain corresponding adjustments, in each case as set forth in the Merger Agreement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, at Closing: (i) each warrant to purchase LanzaTech Shares (each, a &#8220;LanzaTech Warrant&#8221;) that is outstanding and unexercised immediately prior to Closing and would automatically be exercised or exchanged in full in accordance with its terms by virtue of the occurrence of the Merger, will be so automatically exercised or exchanged in full for the applicable LanzaTech Shares, and each such LanzaTech Share will be treated as being issued and outstanding immediately prior to Closing and will be canceled and converted into the right to receive the applicable shares of New LanzaTech Common Stock; and (ii) each LanzaTech Warrant that </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is outstanding and unexercised immediately prior to the Closing and is not automatically exercised in full as described in clause (i) will be converted into a warrant to purchase shares of New LanzaTech Common Stock, in which case (a) the number of shares underlying such New LanzaTech warrant (each, a &#8220;New LanzaTech Warrant&#8221;) will be determined by multiplying the number of LanzaTech Shares subject to such warrant immediately prior to Closing, by the Exchange Ratio and (b) the per share exercise price of such New LanzaTech Warrant will be determined by dividing the per share exercise price of such LanzaTech Warrant immediately prior to the Effective Time by the Exchange Ratio, except that in the case of certain warrants specified in the Merger Agreement, such exercise price will be $10.00.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, at Closing, each option to purchase LanzaTech Shares (each, a &#8220;LanzaTech Option&#8221;) will be converted into an option to purchase a number of shares of New LanzaTech Common Stock (rounded down to the nearest whole share) equal to the product of (i) the number of LanzaTech Shares subject to such LanzaTech Option multiplied by (ii) the Exchange Ratio. The exercise price of such New LanzaTech option will be equal to the quotient of (a) the exercise price per share of such LanzaTech Option in effect immediately prior to the Effective Time divided by (b) the Exchange Ratio (and as so determined, this exercise price will be rounded up to the nearest full cent).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, at Closing, each award of restricted shares of LanzaTech common stock (each, a &#8220;LanzaTech RSA&#8221;) that is outstanding immediately prior to the Effective Time will be converted into an award of restricted shares of New LanzaTech Common Stock (each, a &#8220;New LanzaTech RSA&#8221;) on the same terms and conditions as were applicable to such LanzaTech RSA immediately prior to the Effective Time, except that such New LanzaTech RSA will relate to a number of shares of New LanzaTech Common Stock equal to the number of LanzaTech Shares subject to such LanzaTech RSA, multiplied by the Exchange Ratio.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The closing of the Merger is subject to certain customary conditions, including, among others, (i) adoption by AMCI&#8217;s stockholders and LanzaTech&#8217;s stockholders of the Merger Agreement and their approval of certain other actions related to the Business Combination, (ii) the expiration or termination of the waiting period (or any extension thereof) applicable to the transactions contemplated by the Merger Agreement and any ancillary agreements, in each case under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, (iii) the effectiveness of a registration statement on Form S-4 (the &#8220;Registration Statement&#8221;) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) with respect to the shares of New LanzaTech Common Stock to be paid as consideration in the Merger, (iv) there being no government order or law enjoining, prohibiting or making illegal the consummation of the Merger or the transactions contemplated by the Merger Agreement, (v) AMCI having at least $5,000,001 of net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) under the Exchange Act) after giving effect to any payments required to be made in connection with the redemption of AMCI&#8217;s public shares and the proceeds from the Subscription Agreements described below, (vi) AMCI having at least $230,000,000 of cash at the closing of the Merger, consisting of cash held in AMCI&#8217;s trust account after taking into account any redemption of AMCI&#8217;s public shares, and the proceeds from the Subscription Agreements described below, net of transaction expenses of AMCI and LanzaTech, and (vii) the listing on Nasdaq of the shares of New LanzaTech Common Stock issued in connection with the Business Combination.</span></div> Subsequent Events<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated events occurring subsequent to September&#160;30, 2022 through December 12, 2022, the date the condensed consolidated financial statements were available to be issued. The Company has identified two transactions with BGTF LT Aggregator LP (&#8220;Brookfield&#8221;), an affiliate of Brookfield Asset Management Inc, and a transaction with LanzaJet, described as follows:</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Brookfield Framework Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 2, 2022, LanzaTech entered into a framework agreement with Brookfield (the &#8220;Brookfield Framework Agreement&#8221;). Under such agreement, LanzaTech agreed to exclusively offer Brookfield the opportunity to acquire or invest in certain projects to construct commercial production facilities employing carbon capture and transformation technology in the U.S., the European Union, the United Kingdom, Canada or Mexico for which LanzaTech is solely or jointly responsible for obtaining or providing equity financing, subject to certain exceptions. LanzaTech agreed to present Brookfield with projects that over the term of the agreement require equity funding of at least $500,000,000 in the aggregate. With respect to projects acquired by Brookfield, LanzaTech is entitled to a percentage of free cash flow generated by such projects determined in accordance with a hurdle-based return waterfall. Brookfield has no obligation under the Brookfield Framework Agreement to invest in any of the projects.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Brookfield SAFE</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 2, 2022, LanzaTech entered into a Simple Agreement for Future Equity (the &#8220;Brookfield SAFE&#8221;) with Brookfield. Under the Brookfield SAFE, LanzaTech agreed to issue to Brookfield the right to certain shares of its capital stock, the issuance of which is conditional upon LanzaTech obtaining certain necessary stockholder approvals and waivers, in exchange for the payment of $50,000,000 (the &#8220;Initial Purchase Amount&#8221;). On the fifth anniversary of the Brookfield SAFE, LanzaTech will repay in cash any remaining unconverted portion of the Initial Purchase Amount (the &#8220;Remaining Amount&#8221;) less any Non-Repayable Amount (as described below), plus interest in the high single digits, compounded annually. Brookfield has the option to extend the repayment date to the tenth anniversary of the date of the Brookfield SAFE if certain events do not occur.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the first of either (a) a transaction with the principal purpose of raising capital, pursuant to which LanzaTech issues and sells preferred stock at a fixed valuation (an &#8220;Equity Financing&#8221;), or (b) the completion of an initial public offering, a direct listing, or a merger of LanzaTech with a special purpose acquisition company, which includes the Business Combination (such a merger, a &#8220;de-SPAC Transaction&#8221; and such event described in (b), a &#8220;Liquidity Event&#8221;), Brookfield may, at any time at its option, convert all or a portion of the Initial Purchase Amount less any amount that has already been converted or repaid into shares of LanzaTech capital stock or, in the case of a de-SPAC Transaction, shares of common stock of the surviving public company in such de-SPAC Transaction (including, in the case of the Business Combination, New LanzaTech Common Stock). </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each $50,000,000 of aggregate equity funding required for qualifying projects acquired by Brookfield in accordance with the Brookfield Framework Agreement, the Remaining Amount will be reduced by $5,000,000 (such cumulative reductions the &#8220;Non-Repayable Amount&#8221;). Upon the first Equity Financing or Liquidity Event, the Non-Repayable Amount would convert automatically into shares of LanzaTech capital stock or, in the case of a de-SPAC Transaction, shares of common stock of the surviving public company in such de-SPAC Transaction (including, in the case of the Business Combination, New LanzaTech Common Stock), and thereafter, the Non-Repayable Amount will convert automatically on an as accrued basis.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LanzaJet Shareholder Loan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 9, 2022, the Company and the other LanzaJet shareholders entered into a Note Purchase Agreement (the &#8220;Note Purchase Agreement&#8221;), pursuant to which LanzaJet Freedom Pines Fuels LLC (&#8220;FPF&#8221;), a wholly owned subsidiary of LanzaJet, will issue, from time to time, notes in an aggregate principal amount of up to $147.0&#160;million (the &#8220;Notes&#8221;), comprised of approximately $113.5&#160;million aggregate principal amount of 6.00% Senior Secured Notes due December 31, 2043 and $33.5&#160;million aggregate principal amount of 6.00% Subordinated Secured Notes due December 31, 2043. The Company has committed to purchase $5.5&#160;million of Subordinated Secured Notes in a funding scheduled to occur on May 1, 2023. The Senior Secured Notes are secured by a security </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">interest over substantially all assets of FPF, and both the Senior Secured Notes and the Subordinated Secured Notes are secured by a security interest over all intellectual property owned or in-licensed by LanzaJet. LanzaJet also provides a guarantee of any costs and expenses required to complete the LanzaJet Freedom Pines Demonstration Facility and achieve commercial operation. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each purchaser of Notes under the Note Purchase Agreement is also entitled to receive a warrant for the right to purchase 575 shares of common stock of LanzaJet for each $10,000 of Notes purchased by such purchaser (which, in the case of the Company, will be equal to a right to purchase 316,250 shares of common stock of LanzaJet).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LanzaJet Note Purchase Agreement may be amended with the approval of holders of FPF and all holders of the LanzaJet Notes.  Upon an event of default under the Note Purchase Agreement, each purchaser may accelerate its own Notes. Enforcement against the collateral securing the Notes requires the approval of certain holders as specified in the Notes.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amended Merger Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Merger Agreement was amended on December 7, 2022, to provide for, among other things, (i) the inclusion of the aggregate net proceeds from each of the AM SAFE Note and Brookfield SAFE in the Acquiror Closing Cash Amount, (ii) the reduction of the Minimum Closing Cash Condition from $250,000,000 to $230,000,000, (iii) the clarification that, to the extent that the Brookfield SAFE remains unexercised at Closing, it will be assumed by AMCI, remain in effect on the same terms and conditions as are in effect prior to the Closing and thereafter entitle the holder thereof to be issued shares of common stock in AMCI after the Closing, (iv) the clarification that, in the event that it becomes reasonably apparent to the parties that the Acquiror Closing Cash Amount will be less than the Minimum Closing Cash Condition, AMCI will use commercially reasonable efforts to enter into non-redemption agreements, or similar agreements, as may be necessary to satisfy the Minimum Closing Cash Condition, (v) the extension of the outside date applicable to the Closing from December 7, 2022 to February 28, 2023 and (vi) the elimination of LanzaTech's right to terminate the agreement in the event that we fail to, on or prior to July 7, 2022, enter into one or more additional subscription agreements or non-redemption agreements as a result of which the sum of the PIPE Investment Amount (including net proceeds under the AM SAFE Note to LanzaTech) and the aggregate number of shares of Class A common stock subject to non-redemption agreements multiplied by $10.00, minus certain transaction expenses and other liabilities at Closing, would be equal to at least the Minimum Closing Cash Condition.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div>Subsequent Events<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated events occurring subsequent to December&#160;31, 2021 through May 9, 2022, the date the consolidated financial statements were available to be issued. The Company is not aware of any significant or material subsequent event that would require disclosure.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposed Merger</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2022, the Company entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with AMCI Acquisition Corp. II, a Delaware corporation (&#8220;AMCI&#8221;) and AMCI Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of AMCI (&#8220;Merger Sub&#8221;). Under the Merger Agreement, Merger Sub will merge with and into LanzaTech, with LanzaTech surviving the Merger as a wholly-owned subsidiary of AMCI (&#8220;the Merger&#8221;). In connection with the Merger, AMCI will be renamed LanzaTech Global, Inc (&#8220;New LanzaTech&#8221;). AMCI has agreed to acquire all of the outstanding equity interests of LanzaTech for consideration consisting of an equity interest of New LanzaTech valued at approximately $1.8&#160;billion. Completion of the transaction is subject to certain customary regulatory consents and approval by stockholders of AMCI and the Company.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger Agreement, on March 8, 2022, AMCI entered into subscription agreements with certain investors pursuant to which AMCI agreed to issue and sell a private placement to close immediately prior to the Merger.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272210262960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of the Business<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Description of the Business</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1 &#8212; Description of Organization and Business Operations</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AMCI Acquisition Corp. II (the &#8220;Company&#8221;) is a blank check company incorporated as a Delaware corporation on January 28, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the &#8220;business combination&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, the Company has neither engaged in any operations nor generated any revenues. All activity to date relates to the Company&#8217;s formation and the initial public offering (as defined below), described below and since the initial public offering, its search for a business combination target. The Company will not generate any operating revenues until after the completion of its initial business combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the initial public offering and from changes in the fair value of its derivative warrant liabilities, if applicable. The Company has selected December 31 as its fiscal year end.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s sponsor is AMCI Sponsor II LLC, a Delaware limited liability company (the &#8220;Sponsor&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registration statement for the Company&#8217;s initial public offering was declared effective on August 3, 2021 (the &#8220;effective date&#8221;). On August 6, 2021, the Company consummated its initial public offering (the &#8220;initial public offering&#8221;) of 15,000,000 units (the &#8220;units&#8221;). Each unit consists of one Class A common stock of the Company, par value $0.0001 per share (the &#8220;Class A common stock&#8221;), and one-half of one redeemable warrant of the Company (the &#8220;warrant&#8221;), each whole warrant entitling the holder thereof to purchase one Class A common stock for $11.50 per share. The units were sold at a price of $10.00 per unit, generating gross proceeds to the Company of $150,000,000 which is discussed in Note 3.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Simultaneously with the closing of the initial public offering, the Company completed the private sale of an aggregate of 3,500,000 warrants (the &#8220;private placement warrants&#8221;) to the Sponsor at a purchase price of $1.00 per private placement warrant, generating gross proceeds to the Company of $3,500,000. The private placement warrants are identical to the warrants sold in the initial public offering, except that the private placement warrants, so long as they are held by the Sponsor or its permitted transferees, (i) are not redeemable by the Company, (ii) may not (including the Class A common stock issuable upon exercise of such private placement warrants), subject to certain limited exceptions, be transferred, assigned or sold by such holders until 30 days after the completion of the Company&#8217;s initial business combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights. No underwriting discounts or commissions were paid with respect to such sales.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the initial public offering includes two instruments, Class A common stock and warrants, and as the warrants are classified as a financial liability, it is necessary to allocate the gross proceeds between Class A common stock and warrants. The Company adopted the residual method to allocate the gross proceeds between Class A common stock and warrants based on their relative fair values. The gross proceeds were first allocated to the fair value of the warrants and the residual amount was allocated to the Class A common stock. The percentage derived from this allocation was used to allocate the deferred offering costs between Class A common stock and warrants. Issuance costs allocated to the warrants were expensed to the Company&#8217;s unaudited condensed statements of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction costs of the initial public offering amounted to $13,782,542 and consisted of $1,500,000 of underwriting discount, $5,250,000 of deferred underwriting discount, $6,509,758 in fair value of Class B common stock issued to Anchor Investors, and $522,784 of other offering costs.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A total of $150,000,000 was placed in a U.S.-based trust account maintained by Continental Stock Transfer &amp; Trust Company, acting as trustee (the &#8220;trust account&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company must complete one or more initial business combination having an aggregate fair market value of at least 80% of the value of the assets held in the trust account (excluding the amount of deferred underwriting discounts held in trust and taxes payable on the income earned on the trust account) at the time of the signing a definitive agreement in connection with the initial business combination. However, the Company will only complete a business combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">register as an investment company under the Investment Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;). There is no assurance that the Company will be able to complete a business combination successfully.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the closing of the initial public offering, management has agreed that an amount equal to at least $10.00 per unit sold in the initial public offering, including the proceeds of the private placement warrants, will be held in a trust account, located in the United States with Continental Stock Transfer &amp; Trust Company acting as trustee, and will invest only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect to interest earned on the funds held in the trust account that may be released to the Company to pay taxes, if any, the proceeds from the initial public offering and the sale of the private placement warrants will not be released from the trust account until the earliest of (i) the completion of initial business combination, (ii) the redemption of the Company&#8217;s public shares if the Company is unable to complete an initial business combination by August 6, 2023, subject to applicable law, or (iii) the redemption of the Company&#8217;s public shares properly submitted in connection with a stockholder vote to amend its amended and restated certificate of incorporation to modify the substance or timing of the Company&#8217;s obligation to redeem 100% of its public shares if the Company has not consummated an initial business combination by August 6, 2023 or with respect to any other material provisions relating to stockholders&#8217; rights or pre-initial business combination activity. The proceeds deposited in the trust account could become subject to the claims of the Company&#8217;s creditors, if any, which could have priority over the claims of the Company&#8217;s public stockholders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will provide its public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial business combination either (i) in connection with a stockholder meeting called to approve the business combination or (ii) without a stockholder vote by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed business combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem all or a portion of their public shares upon the completion of the initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account calculated as of two business days prior to the consummation of the initial business combination, including interest earned on the funds held in the trust account (which interest shall be net of taxes payable), divided by the number of then outstanding public shares, subject to the limitations and on the conditions described herein. The amount in the trust account is initially anticipated to be $10.00 per public share. The per share amount the Company will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the representative of the underwriters.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares of common stock subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the initial public offering, in accordance with Financial Accounting Standards Board&#8217;s (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480, &#8220;Distinguishing Liabilities from Equity.&#8221; In such case, the Company will proceed with a business combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a business combination and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the business combination.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will have only 24 months from the closing of the initial public offering to complete the initial business combination (the &#8220;Combination Period&#8221;). However, if the Company is unable to complete the initial business combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfOTM5MA_6b8b7a9b-cdb9-4964-a6c2-9088a7366feb">ten</span> business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company&#8217;s remaining stockholders and the Company&#8217;s board of </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">directors, liquidate and dissolve, subject, in each case, to the Company&#8217;s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sponsor, officers and directors have agreed to (i) waive their redemption rights with respect to any founder shares and public shares they hold in connection with the completion of the initial business combination, (ii) waive their redemption rights with respect to any founder shares and public shares they hold in connection with a stockholder vote to approve an amendment to the Company&#8217;s amended and restated certificate of incorporation, (iii) waive their rights to liquidating distributions from the trust account with respect to any founder shares they hold if the Company fails to complete the initial business combination within the Combination Period, and (iv) vote their founder shares and any public shares purchased during or after the initial public offering in favor of the initial business combination.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party (other than the Company&#8217;s independent registered public accounting firm) or prospective target business who executed a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is enforceable), nor will it apply to any claims under the Company&#8217;s indemnity of the underwriters of the initial public offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor&#8217;s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would be able to satisfy those obligations. None of the Company&#8217;s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Emerging Growth Company Status</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities and Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s unaudited condensed financial statements with those of another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is continuing to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company&#8217;s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these unaudited condensed financial statements. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 16, 2022, President Biden signed into law the Inflation Reduction Act of 2022 (the &#8220;IR Act&#8221;), which, among other things, imposes a new 1% U.S. federal excise tax on certain repurchases of stock by &#8220;covered corporations&#8221; (which include publicly traded domestic (i.e., U.S.) corporations) beginning in 2023, with certain exceptions (the &#8220;Excise Tax&#8221;). The Excise Tax is imposed on the repurchasing corporation itself, not its stockholders from which the stock is repurchased. Because we are a Delaware corporation and our securities are trading on Nasdaq, we are a &#8220;covered corporation&#8221; for this purpose. The amount of the Excise Tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the Excise Tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the Excise Tax. The U.S. Department of the Treasury has authority to provide regulations and other guidance to carry out, and prevent the abuse or avoidance of the Excise Tax; however, no guidance has been issued to date. It is uncertain whether, and/or to what extent, the Excise Tax could apply to any repurchase by us of our common stock or in the event of our liquidation, in each instance after December 31, 2022, including any redemptions in connection with an initial business combination or in the event we do not consummate an initial business combination by August 6, 2023.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposed Business Combination</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2022, the Company entered into an agreement and plan of merger (the &#8220;Merger Agreement&#8221;) with AMCI Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (&#8220;Merger Sub&#8221;), and LanzaTech NZ, Inc., a Delaware corporation (&#8220;LanzaTech&#8221;). The transactions contemplated by the Merger Agreement are referred to herein as the &#8220;Proposed Business Combination.&#8221; The time of the closing of the Proposed Business Combination is referred to herein as the &#8220;Closing.&#8221;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Proposed Business Combination is approved by the Company&#8217;s stockholders and LanzaTech&#8217;s stockholders, and the closing conditions in the Merger Agreement are satisfied or waived, then, among other things, upon the terms and subject to the conditions of the Merger Agreement and in accordance with Delaware General Corporation Law, Merger Sub will merge with and into LanzaTech, with LanzaTech surviving the Merger as the Company&#8217;s wholly owned subsidiary (the &#8220;Merger&#8221;). In connection with the consummation of the Merger, the Company will be renamed &#8220;LanzaTech Global, Inc.&#8221; and is referred to herein as &#8220;New LanzaTech&#8221; as of the time following such change of name.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Merger Agreement, the Company has agreed to acquire all of the outstanding equity interests of LanzaTech for consideration consisting of equity interests of New LanzaTech valued at $1,817,000,000 in the aggregate. The consideration to be paid to holders of shares of LanzaTech capital stock will be shares of common stock of New LanzaTech (&#8220;New LanzaTech Common Stock&#8221;), valued at $10.00 per share, to be paid at the closing of the Merger. The number of shares of New LanzaTech Common Stock payable in the Merger in respect of each share of LanzaTech capital stock (each, a &#8220;LanzaTech Share&#8221;) will be determined based on the exchange ratio (the &#8220;Exchange Ratio&#8221;), and certain corresponding adjustments, in each case as set forth in the Merger Agreement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, at Closing: (i) each warrant to purchase LanzaTech Shares (each, a &#8220;LanzaTech Warrant&#8221;) that is outstanding and unexercised immediately prior to Closing and would automatically be exercised or exchanged in full in accordance with its terms by virtue of the occurrence of the Merger, will be so automatically exercised or exchanged in full for the applicable LanzaTech Shares, and each such LanzaTech Share will be treated as being issued and outstanding immediately prior to Closing and will be canceled and converted into the right to receive the applicable shares of New LanzaTech Common Stock; and (ii) each LanzaTech Warrant that is outstanding and unexercised immediately prior to the Closing and is not automatically exercised in full as </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">described in clause (i) will be converted into a warrant to purchase shares of New LanzaTech Common Stock, in which case (a) the number of shares underlying such New LanzaTech warrant (each, a &#8220;New LanzaTech Warrant&#8221;) will be determined by multiplying the number of LanzaTech Shares subject to such warrant immediately prior to Closing, by the Exchange Ratio and (b) the per share exercise price of such New LanzaTech Warrant will be determined by dividing the per share exercise price of such LanzaTech Warrant immediately prior to the Effective Time by the Exchange Ratio, except that in the case of certain warrants specified in the Merger Agreement, such exercise price will be $10.00.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, at Closing, each option to purchase LanzaTech Shares (each, a &#8220;LanzaTech Option&#8221;) will be converted into an option to purchase a number of shares of New LanzaTech Common Stock (rounded down to the nearest whole share) equal to the product of (i) the number of LanzaTech Shares subject to such LanzaTech Option multiplied by (ii) the Exchange Ratio. The exercise price of such New LanzaTech option will be equal to the quotient of (a) the exercise price per share of such LanzaTech Option in effect immediately prior to the Effective Time divided by (b) the Exchange Ratio (and as so determined, this exercise price will be rounded up to the nearest full cent).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, at Closing, each award of restricted shares of LanzaTech common stock (each, a &#8220;LanzaTech RSA&#8221;) that is outstanding immediately prior to the Effective Time will be converted into an award of restricted shares of New LanzaTech Common Stock (each, a &#8220;New LanzaTech RSA&#8221;) on the same terms and conditions as were applicable to such LanzaTech RSA immediately prior to the Effective Time, except that such New LanzaTech RSA will relate to a number of shares of New LanzaTech Common Stock equal to the number of LanzaTech Shares subject to such LanzaTech RSA, multiplied by the Exchange Ratio.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The closing of the Merger is subject to certain customary conditions, including, among others, (i) adoption by AMCI&#8217;s stockholders and LanzaTech&#8217;s stockholders of the Merger Agreement and their approval of certain other actions related to the Proposed Business Combination, (ii) the expiration or termination of the waiting period (or any extension thereof) applicable to the transactions contemplated by the Merger Agreement and any ancillary agreements, in each case under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, (iii) the effectiveness of a registration statement on Form S-4 (the &#8220;Registration Statement&#8221;) under the Securities Act with respect to the shares of New LanzaTech Common Stock to be paid as consideration in the Merger, (iv) there being no government order or law enjoining, prohibiting or making illegal the consummation of the Merger or the transactions contemplated by the Merger Agreement, (v) AMCI having at least $5,000,001 of net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) under the Exchange Act) after giving effect to any payments required to be made in connection with the redemption of AMCI&#8217;s public shares and the proceeds from the Subscription Agreements described below, (vi) AMCI having at least $230,000,000 of cash at the closing of the Merger, consisting of cash held in AMCI&#8217;s trust account after taking into account any redemption of AMCI&#8217;s public shares, and the proceeds from the Subscription Agreements described below, net of transaction expenses of AMCI and LanzaTech, and (vii) the listing on Nasdaq of the shares of New LanzaTech Common Stock issued in connection with the Proposed Business Combination.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Going Concern</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, the Company had approximately $7,000 in its operating bank account and a working capital deficit of approximately $3.5 million , not taking into account tax obligations of approximately $536,000 that may be paid from income from investments held in the trust account.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s liquidity needs up to September 30, 2022 have been satisfied through a contribution of $25,000 from the Sponsor to cover for certain offering costs in exchange for the issuance of Founder Shares, and a loan and advances from the Sponsor pursuant to the Note (as defined in Note 4). Subsequent to the initial public offering, net proceeds from the private placement of $0.9 million were placed in the operating account for working capital purposes. In addition, in order to finance transaction costs in connection with a business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#8217;s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 4). On March 28, 2022, the Company entered into a noninterest-bearing Working Capital Loan with its Sponsor for the principal amount of up to $1.5 million. As of September 30, 2022 and December 31, 2021, there were no amounts outstanding under any Working Capital Loan.</span></div>In connection with the Company&#8217;s assessment of going concern considerations in accordance with FASB Accounting Standards Update (&#8220;ASU&#8221;) 2014-15, &#8220;Disclosures of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern,&#8221; management has determined that the liquidity condition, and the mandatory liquidation and subsequent dissolution that will be required if the Company does not complete a business combination before August 6, 2023 raises substantial doubt about the Company&#8217;s ability to continue as a going concern. Although Management expects that it will be able to raise additional capital to support its planned activities and complete a business combination on or prior to August 6, 2023, it is uncertain whether it will be able to do so. No adjustments have been made to the carrying amounts of assets or liabilities should we be required to liquidate after August 6, 2023. The condensed financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern. The Company intends to complete a business combination before the mandatory liquidation date. Over this time period, the Company will be using the funds outside of the trust account for paying existing accounts payable, identifying and evaluating prospective initial business combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the business combination.<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1 &#8212; Description of Organization and Business Operations</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AMCI Acquisition Corp. II (the &#8220;Company&#8221;) is a blank check company incorporated as a Delaware corporation on January 28, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the &#8220;business combination&#8221;). </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the Company has neither engaged in any operations nor generated any revenues. All activity for the period from January 28, 2021 (inception) through December 31, 2021 relates to the Company&#8217;s formation and the initial public offering (&#8220;initial public offering&#8221;), described below. The Company will not generate any operating revenues until after the completion of its initial business combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the initial public offering and from changes in the fair value of its derivative warrant liabilities, if applicable. The Company has selected December 31 as its fiscal year end.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s sponsor is AMCI Sponsor II LLC, a Delaware limited liability company (the &#8220;Sponsor&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registration statement for the Company&#8217;s initial public offering was declared effective on August 3, 2021 (the &#8220;effective date&#8221;). On August 6, 2021, the Company consummated its initial public offering of 15,000,000 units (the &#8220;units&#8221;). Each unit consists of one Class A common stock of the Company, par value $0.0001 per share (the &#8220;Class A common stock&#8221;), and one-half of one redeemable warrant of the Company (the &#8220;warrant&#8221;), each whole warrant entitling the holder thereof to purchase one Class A common stock for $11.50 per share. The units were sold at a price of $10.00 per unit, generating gross proceeds to the Company of $150,000,000, which is discussed in Note 3.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Simultaneously with the closing of the initial public offering, the Company completed the private sale of an aggregate of 3,500,000 warrants (the &#8220;private placement warrants&#8221;) to the Sponsor at a purchase price of $1.00 per private placement warrant, generating gross proceeds to the Company of $3,500,000. The private placement warrants are identical to the warrants sold in the initial public offering, except that the private placement warrants, so long as they are held by the Sponsor or its permitted transferees, (i) are not redeemable by the Company, (ii) may not (including the Class A common stock issuable upon exercise of such private placement warrants), subject to certain limited exceptions, be transferred, assigned or sold by such holders until 30 days after the completion of the Company&#8217;s initial business combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights. No underwriting discounts or commissions were paid with respect to such sales.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the initial public offering includes two instruments, Class A common stock and warrants, and as the warrants are classified as a financial liability, it is necessary to allocate the gross proceeds between Class A common stock and warrants. The Company adopted the residual method to allocate the gross proceeds between Class A common stock and warrants based on their relative fair values. The gross proceeds were first allocated to the fair value of the warrants and the residual amount was allocated to the Class A common stock. The percentage derived from this allocation was used to allocate the deferred offering costs between Class A common stock and warrants. Issuance costs allocated to the warrants were expensed to the Company&#8217;s statement of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction costs of the initial public offering amounted to $13,782,542 and consisted of $1,500,000 of underwriting discount, $5,250,000 of deferred underwriting discount, $6,509,758 in fair value of Class B common stock issued to Anchor Investors, and $522,784 of other offering costs.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A total of $150,000,000 was placed in a U.S.-based trust account maintained by Continental Stock Transfer &amp; Trust Company, acting as trustee.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company must complete one or more initial business combination having an aggregate fair market value of at least 80% of the value of the assets held in the trust account (excluding the amount of deferred underwriting discounts held in trust and taxes payable on the income earned on the trust account) at the time of the signing a definitive agreement in connection with the initial business combination. However, the Company will only complete a business combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">register as an investment company under the Investment Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;). There is no assurance that the Company will be able to complete a business combination successfully.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the closing of the initial public offering, management has agreed that an amount equal to at least $10.00 per unit sold in the initial public offering, including the proceeds of the private placement warrants, will be held in a trust account (the &#8220;trust account&#8221;), located in the United States with Continental Stock Transfer &amp; Trust Company acting as trustee, and will invest only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect to interest earned on the funds held in the trust account that may be released to the Company to pay taxes, if any, the proceeds from the initial public offering and the sale of the private placement warrants will not be released from the trust account until the earliest of (i) the completion of initial business combination, (ii) the redemption of the Company&#8217;s public shares if the Company is unable to complete an initial business combination by August 6, 2023, subject to applicable law, or (iii) the redemption of the Company&#8217;s public shares properly submitted in connection with a stockholder vote to amend its amended and restated certificate of incorporation to modify the substance or timing of the Company&#8217;s obligation to redeem 100% of its public shares if the Company has not consummated an initial business combination by August 6, 2023 or with respect to any other material provisions relating to stockholders&#8217; rights or pre-initial business combination activity. The proceeds deposited in the trust account could become subject to the claims of the Company&#8217;s creditors, if any, which could have priority over the claims of the Company&#8217;s public stockholders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will provide its public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial business combination either (i) in connection with a stockholder meeting called to approve the business combination or (ii) without a stockholder vote by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed business combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem all or a portion of their public shares upon the completion of the initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account calculated as of two business days prior to the consummation of the initial business combination, including interest earned on the funds held in the trust account (which interest shall be net of taxes payable), divided by the number of then outstanding public shares, subject to the limitations and on the conditions described herein. The amount in the trust account is initially anticipated to be $10.00 per public share. The per share amount the Company will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the representative of the underwriters.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares of common stock subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the initial public offering, in accordance with Financial Accounting Standards Board&#8217;s (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480, &#8220;Distinguishing Liabilities from Equity.&#8221; In such case, the Company will proceed with a business combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a business combination and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the business combination.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will have only 24 months from the closing of the initial public offering to complete the initial business combination (the &#8220;Combination Period&#8221;). However, if the Company is unable to complete the initial business combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfOTMzMA_80eea167-68dd-4f47-a97c-0adf8eb467f8">ten</span> business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company&#8217;s remaining stockholders and the Company&#8217;s board of </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">directors, liquidate and dissolve, subject, in each case, to the Company&#8217;s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sponsor, officers and directors have agreed to (i) waive their redemption rights with respect to any founder shares and public shares they hold in connection with the completion of the initial business combination, (ii) waive their redemption rights with respect to any founder shares and public shares they hold in connection with a stockholder vote to approve an amendment to the Company&#8217;s amended and restated certificate of incorporation, (iii) waive their rights to liquidating distributions from the trust account with respect to any founder shares they hold if the Company fails to complete the initial business combination within the Combination Period, and (iv) vote their founder shares and any public shares purchased during or after the initial public offering in favor of the initial business combination.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party (other than the Company&#8217;s independent registered public accounting firm) or prospective target business who executed a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is enforceable), nor will it apply to any claims under the Company&#8217;s indemnity of the underwriters of the initial public offering against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor&#8217;s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would be able to satisfy those obligations. None of the Company&#8217;s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Emerging Growth Company Status</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is continuing to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company&#8217;s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposed Business Combination</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As more fully described in Note 11, on March 8, 2022, the Company entered into an agreement and plan of merger (the &#8220;Merger Agreement&#8221;) with AMCI Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (&#8220;Merger Sub&#8221;), and LanzaTech NZ, Inc., a Delaware corporation (&#8220;LanzaTech&#8221;). Upon consummation of the transactions, the Company will change its name to &#8220;LanzaTech Global, Inc.&#8221;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Going Concern</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the Company had approximately $0.3 million in its operating bank account and a working capital deficit of approximately $0.1 million.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s liquidity needs up to December 31, 2021 have been satisfied through a contribution of $25,000 from the Sponsor to cover for certain offering costs in exchange for the issuance of founder shares, and a loan and advances from the Sponsor pursuant to the Note (as defined in Note 4). Subsequent to the initial public offering, net proceeds from the private placement of $0.9 million were placed in the operating account for working capital purposes. In addition, in order to finance transaction costs in connection with a business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#8217;s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 4). As of December 31, 2021, there were no amounts outstanding under any Working Capital Loan.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company&#8217;s assessment of going concern considerations in accordance with Financial Accounting Standard Board&#8217;s Accounting Standards Update (&#8220;ASU&#8221;) 2014-15, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosures of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; management has determined that the Company would not be able to meet its obligations as they become due within one year after the date that the financial statements are available to be issued. As such, management has determined that the liquidity condition raises substantial doubt about the Company&#8217;s ability to continue as a going concern. As of December 31, 2021, no adjustments have been made to the carrying amounts of assets or liabilities.</span></div>Description of the Business<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reporting entity is LanzaTech NZ, Inc. (formerly known as LanzaTech New Zealand Limited) and its subsidiaries (collectively, &#8220;the Company&#8221; or "LanzaTech"). LanzaTech NZ, Inc. is a profit-oriented entity previously incorporated in New Zealand. Effective October 28, 2021, LanzaTech New Zealand Limited filed a Certificate of Incorporation to migrate its country of domicile from New Zealand to Delaware, in the United States, and change its corporate name to &#8220;LanzaTech NZ, Inc.&#8221; The amendment was approved by the Board of Directors of LanzaTech and was effected by the filing of a Certificate of Incorporation with the Delaware Secretary of State. The registered office location is c/o The Corporation Trust Company, Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware, 19801. The Company licenses its technology to customers, performs research and development in biotechnology, and provides engineering and other related services for commercial and government customers. Using the Company&#8217;s proprietary fermentation technology, the Company&#8217;s customers can convert certain carbon-rich waste gases into fuels and chemicals. The Company employs a licensing business model whereby its customers build, own and operate facilities that use the Company's technology, and in return, the Company is paid royalties based on the revenue generated from the use of its technology. In 2018, the Company, through its partners, launched the world&#8217;s first commercial waste gas to ethanol plant in China, followed by a second one in 2021, also in China, with others currently in development in various countries.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposed Merger</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2022, the Company entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with AMCI Acquisition Corp. II, a Delaware corporation (&#8220;AMCI&#8221;) and AMCI Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of AMCI (&#8220;Merger Sub&#8221;). Under the Merger Agreement, Merger Sub will merge with and into LanzaTech, with LanzaTech surviving the Merger as a wholly-owned subsidiary of AMCI (&#8220;the Business Combination&#8221;). In connection with the Business Combination, AMCI will be renamed LanzaTech Global, Inc. (&#8220;New LanzaTech&#8221;). AMCI has agreed to acquire all of the outstanding equity interests of LanzaTech for consideration consisting of an equity interest of New LanzaTech valued at approximately $1.8&#160;billion. Completion of the transaction is subject to certain customary regulatory consents and approval by stockholders of AMCI and the Company. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Merger Agreement was amended on December 7, 2022, to provide for, among other things, (i) the inclusion of the aggregate net proceeds from each of the AM SAFE Note and Brookfield SAFE in the Acquiror Closing Cash Amount, (ii) the reduction of the Minimum Closing Cash Condition from $250,000,000 to $230,000,000, (iii) the clarification that, to the extent that the Brookfield SAFE remains unexercised at Closing, it will be assumed by AMCI, remain in effect on the same terms and conditions as are in effect prior to the Closing and thereafter entitle the holder thereof to be issued shares of common stock in AMCI after the Closing, (iv) the clarification that, in the event that it becomes reasonably apparent to the parties that the Acquiror Closing Cash Amount will be less than the Minimum Closing Cash Condition, AMCI will use commercially reasonable efforts to enter into non-redemption agreements, or similar agreements, as may be necessary to satisfy the Minimum Closing Cash Condition, (v) the extension of the outside date applicable to the Closing from December 7, 2022 to February 28, 2023 and (vi) the elimination of LanzaTech's right to terminate the agreement in the event that we fail to, on or prior to July 7, 2022, enter into one or more additional subscription agreements or non-redemption agreements as a result of which the sum of the PIPE Investment Amount (including net proceeds under the AM SAFE Note to LanzaTech) and the aggregate number of shares of Class A common stock subject to non-redemption agreements multiplied by $10.00, minus certain transaction expenses and other liabilities at Closing, would be equal to at least the Minimum Closing Cash Condition.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger Agreement, AMCI entered into subscription agreements with certain investors pursuant to which AMCI agreed to issue and sell a private placement to close immediately prior to the Business Combination.</span></div>Description of the BusinessThe reporting entity is LanzaTech NZ, Inc. (formerly known as LanzaTech New Zealand Limited) and its subsidiaries (collectively, &#8220;the Company&#8221;). LanzaTech NZ, Inc. is a profit-oriented entity previously incorporated in New Zealand. Effective October 28, 2021, LanzaTech New Zealand Limited filed a Certificate of Incorporation to migrate its country of domicile from New Zealand to Delaware, in the United States, and change its corporate name to &#8220;LanzaTech NZ, Inc.&#8221; The amendment was approved by the Board of Directors of LanzaTech and was effected by the filing of a Certificate of Incorporation with the Delaware Secretary of State. All necessary adjustments have been recorded to present fairly the Company's financial position as of December&#160;31, 2021 and 2020 and the results of operations and cash flows for the years then ended. The registered office location is c/o The Corporation Trust Company, Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware, 19801. The Company licenses its technology to customers, performs research and development in biotechnology, and provides engineering and other related services for commercial and government customers. Using the Company&#8217;s proprietary fermentation technology, the Company&#8217;s customers can convert certain carbon-rich waste gases into fuels and chemicals. The Company employs a licensing business model whereby its customers build, own and operate facilities that use the Company's technology, and in return, the Company is paid royalties based on the revenue generated from the use of its technology. In 2018, the Company, through its equity method investee, launched the world&#8217;s first commercial waste gas to ethanol plant in China, followed by a second one in 2021, also in China, with others currently in development in various countries around the world.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211122512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2 &#8212; Basis of Presentation and Summary of Significant Accounting Policies</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) for interim financial information and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022 or any future period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K filed by the Company with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on March 25, 2022.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of September 30, 2022 and December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of September 30, 2022 and December 31, 2021.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments Held in the Trust Account</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company&#8217;s investments held in the trust account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company&#8217;s investments held in the trust account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the trust account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the trust account are determined using available market information.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities which qualify as financial instruments under the FASB ASC 820, &#8220;Fair Value Measurement,&#8221; equal or approximate the carrying amounts represented in the condensed balance sheets.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Offering Costs Associated With Initial Public Offering</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the initial public offering that were directly related to the initial public offering. Offering costs were allocated to the separable financial instruments issued in the initial public offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and presented as non-operating expenses in the unaudited condensed statements of operations. Offering costs associated with the Class A common stock issued were charged against the carrying value of the shares of Class A common stock upon the completion of the initial public offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Class A Common Stock Shares Subject to Possible Redemption </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, &#8220;Distinguishing Liabilities from Equity.&#8221; Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders&#8217; equity. The Company&#8217;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of uncertain future events. Accordingly, as of the initial public offering, 15,000,000 shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders&#8217; equity (deficit) section of the Company&#8217;s condensed balance sheets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 480-10-S99, the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of the reporting period. This method would view the end of the reporting period as if it were also the redemption date of the security. Effective with the closing of the initial public offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The public warrants and the private placement warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The initial fair value of the public warrants issued in connection with the initial public offering was estimated using a Monte-Carlo simulation model. The fair value of the public warrants as of September 30, 2022 and as of December 31, 2021 is based on observable listed prices for such warrants. The fair value of the private placement warrants as of September 30, 2022 and as of December 31, 2021 is determined using a Black-Scholes option pricing model. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provides guidance on derecognition, classification, interest and penalties, accounting in period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company&#8217;s effective tax rate was 0.88% and 0.91% for the three and nine months ended September 30, 2022, respectively, and 0.00% for the three months ended September 30, 2021 and the period from January 28, 2021 (inception) through September 30, 2021. The effective tax rate differs from the statutory tax rate of 21% for the three and nine months ended September 30, 2022, the three months ended September 30, 2021 and the period from January 28, 2021 (inception) through September 30, 2021 due primarily to changes in fair value of derivative warrant liabilities, non-taxable gains on the settlement of deferred underwriting commissions, and the valuation allowance on the deferred tax assets.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Per Share Of Common Stock</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share.&#8221; The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the units sold in the initial public offering and the private placement warrants to purchase an aggregate of 11,000,000 shares of Class A common stock in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the three and nine months ended September 30, 2022 and for the three months ended September 30, 2021 and for the period from January 28, 2021 (inception) through September 30, 2021. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended <br/>September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248,909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332,524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,130,435</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.887%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Nine Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Period from January 28, 2021 <br/>(inception) through <br/>September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,428,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FASB issued ASU 2022-03, ASC Subtopic 820 &#8220;Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions&#8221;. The ASU amends ASC 820 to clarify that a contractual sales restriction is not considered in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. The ASU applies to both holders and issuers of equity and equity-linked securities measured at fair value. The amendments in this ASU are effective for the Company in fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is still evaluating the impact of this pronouncement on the condensed financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company&#8217;s unaudited condensed financial statements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2 &#8212; Basis of Presentation and Summary of Significant Accounting Policies</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;).</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2021.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments Held in the Trust Account</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company&#8217;s investments held in the trust account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company&#8217;s investments held in the trust account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the trust account in the accompanying statement of operations. The estimated fair values of investments held in the trust account are determined using available market information.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities which qualify as financial instruments under the FASB ASC 820, &#8220;Fair Value Measurement,&#8221; equal or approximate the carrying amounts represented in the balance sheet.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Offering Costs Associated with Initial Public Offering</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the initial public offering that were directly related to the initial public offering. Offering costs were allocated to the separable financial instruments issued in the initial public offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">presented as non-operating expenses in the statement of operations. Offering costs associated with the Class A common stock issued were charged against the carrying value of the shares of Class A common stock upon the completion of the initial public offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Class A Common Stock Subject to Possible Redemption </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, &#8220;Distinguishing Liabilities from Equity.&#8221; Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders&#8217; equity. The Company&#8217;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of uncertain future events. Accordingly, as of the initial public offering, 15,000,000 shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders&#8217; equity (deficit) section of the Company&#8217;s balance sheet.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 480-10-S99, the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of the reporting period. This method would view the end of the reporting period as if it were also the redemption date of the security. Effective with the closing of the initial public offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The public warrants and the private placement warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The initial fair value of the public warrants issued in connection with the initial public offering was estimated using a Monte-Carlo simulation model. The fair value of the public warrants as of December 31, 2021 is based on observable listed prices for such warrants. The fair value of the private placement warrants as of December 31, 2021 is determined using a Black-Scholes option pricing model. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Per Share of Common Stock</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share.&#8221; The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the units sold in the initial public offering and the private placement warrants to purchase an aggregate of 11,000,000 shares of Class A common stock in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the period from January 28, 2021 (inception) through December 31, 2021. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.451%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.805%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the period from January 28, 2021<br/>(inception) through December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income (loss) per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,690,909</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income (loss) per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2020-06, &#8220;Debt &#8212; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8212; Contracts in an Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity&#8221; (&#8220;ASU 2020-06&#8221;), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. ASU 2020-06 also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 on August 2, 2021 using the modified retrospective method for transition. Adoption of ASU 2020-06 did not impact the Company&#8217;s financial position, results of operations or cash flows.</span></div>The Company&#8217;s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company&#8217;s financial statements.Summary of Significant Accounting Policies <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements of LanzaTech NZ Inc. have been prepared in accordance with generally accepted accounting principles for interim financial information, and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America ("US GAAP"), the accounting principles, standards, and procedures adopted by the U.S. Securities and Exchange Commission, for complete financial statements. However, in the opinion of management, all adjustments (consisting of normal recurring accruals) have been made that are necessary for a fair presentation of the condensed consolidated financial statements for the interim periods. For further information refer to the Consolidated Financial Statements and Footnotes thereto included in the Company's Annual Report for the year ended December 31, 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a qualitative approach in assessing the consolidation requirement for variable interest entities ("VIEs"). This approach focuses on determining whether the Company has the power to direct the activities of the VIE that most significantly affect the VIE&#8217;s economic performance and whether the Company has the obligation to absorb losses, or the right to receive benefits, that could potentially be significant to the VIE.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds interests in certain VIEs for which it has been determined the Company is not the primary beneficiary. The Company's variable interests primarily relate to entities in which the Company has a non-controlling equity interest. Although these financial arrangements resulted in holding variable interests in these entities, they did not empower the Company to direct the activities of the VIEs that most significantly impact the VIEs' economic performance. The Company's interests in the VIEs are, therefore, accounted for under the equity method of accounting or alternative measurement. Refer to Note 5,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further information. The Company is exposed to the VIEs' losses and other impairment indicators up to the carrying value of each investment and any amounts receivable from the VIE, less amounts payable. Refer to Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further details on the transactions with VIEs.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Going Concern</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements of the Company have been prepared assuming the Company will continue as a going concern and in accordance with accounting principles generally accepted in the United States of America ("US GAAP"). The going concern basis of presentation assumes that the Company will continue in operation one year after the date these financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. The Company had cash and cash equivalents of $50,370 and an accumulated deficit of $(434,863) at September&#160;30, 2022 and cash outflows from operations of $(71,336) and a net loss of $(54,974) for the nine months ended September&#160;30, 2022. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has historically funded its operations through debt financing and issuance of equity securities. Based on the Company&#8217;s financial position as of the date these condensed consolidated financial statements were available to be issued, the Company projects that it will be able to cover its liquidity needs for the next twelve months with cash on hand. Accordingly, the Company&#8217;s condensed consolidated financial statements have been prepared on the basis that it will continue as a going concern.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates include fair value of equity awards granted to both employees and non-employees, the SAFE and the SAFE warrants.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in facts and circumstances or additional information may result in revised estimates, and actual results may differ from these estimates.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates as one operating segment which is the licensing of its technologies and related services such as research and development and engineering. The Chief Executive Officer who is the chief operating decision maker, reviews financial information on an aggregate basis for allocating resources and evaluating financial performance. Substantially all of the Company's long-lived assets are maintained in the United States. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currencies</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reporting currency is the U.S. Dollar. The Company has certain foreign subsidiaries where the functional currency is the local currency. All of the assets and liabilities of these subsidiaries are converted to U.S. dollars at the exchange rate in effect at the balance sheet date, income and expense accounts are translated at average rates for the period, and shareholder&#8217;s equity accounts are translated at historical rates. The effects of translating financial statements of foreign operations into our reporting currency are recognized as an adjustment in accumulated other comprehensive income (loss).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has foreign subsidiaries that have a functional currency of the U.S. dollar. Purchases and sales of assets and income and expense items denominated in foreign currencies are remeasured into U.S. dollar amounts on the respective dates of such transactions. Net realized foreign currency gains or losses relating to the differences between these recorded amounts and the U.S. dollar equivalent actually received or paid are included within Other (expense) income, net in the condensed consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. As of September&#160;30, 2022 and December&#160;31, 2021, the Company had $50,370 and $128,318 of cash and cash equivalents, respectively.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash and Other Cash Flows from Operating Activities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to maintain a cash deposit with a bank which consists of collateral on certain travel and expense programs maintained by the bank. The following represents a reconciliation of cash and cash equivalents in the condensed consolidated balance sheets to total cash, cash equivalents and restricted cash in the condensed consolidated statements of cash flows as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands).</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (presented within Other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,034&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,732&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade and Other Receivables </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables are reported net of allowances for doubtful accounts. The Company maintains allowances for doubtful accounts for estimated losses resulting from the inability of customers to make required payments. The Company estimates the allowance for doubtful accounts based on a variety of factors including the length of time receivables are past due, the financial health of customers, unusual macroeconomic conditions, and historical experience. As of September&#160;30, 2022 and December&#160;31, 2021, the Company recognized an allowance for doubtful accounts of $1,051 and $1,235, respectively.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with Accounting Standards Codification ("ASC") 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company primarily earns revenue from services related to feasibility studies and basic engineering design of commercial plants, licensing of technologies, joint development and contract </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">research activities to develop novel biocatalysts and related technologies, and sale of CarbonSmart ethanol produced using the Company's proprietary technologies.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is measured based on the consideration specified in a contract with a customer. The Company records taxes collected from customers and remitted to governmental authorities on a net basis. The Company&#8217;s payment terms are between 30-60 days and can vary by customer type and products offered. Management has evaluated the terms of our arrangements and determined that they do not contain significant financing components.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Carbon Capture and Transformation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides feasibility studies and basic design and engineering services used for detailed design, procurement, and construction of commercial plants that utilize the Company&#8217;s technologies, along with the sale of equipment and microbes. The services provided are recognized as a performance obligation satisfied over time. Revenue is recognized using the output method based on milestone completion, the cost-to-cost input method for certain engineering services, or the percentage of completion method as performance obligations are satisfied. Management has determined that the milestone completion and the associated contractual payment amounts are an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company licenses intellectual property to generate recurring revenue when its customers deploy carbon capture and transformation plants. When licenses are considered to be distinct performance obligations, the recognition of revenue is dependent on the terms of the contract, which may include fixed consideration or royalties based on sales or usage, in which case, the revenue is recognized when the subsequent sale or usage occurs or when the performance obligation to which some or all of the sales or usage-based royalty is allocated has been satisfied, whichever is later.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Services</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs research and development (&#8220;R&amp;D&#8221;) services related to novel technologies and development of biocatalysts for commercial applications, mainly to produce fuels and chemicals. The Company engages in two main types of R&amp;D services &#8211; joint development agreements, and other contract research, including projects with the U.S. Department of Energy. Such services are recognized as a performance obligation satisfied over time. Revenue is recognized based on milestone completion, when payments are contingent upon the achievement of such milestones, or based on percentage-completion method when enforceable rights to payment exist. When no milestones or phases are clearly defined, management has determined that the cost incurred, input method, is an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and estimates its variable consideration under the expected value method. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is not recognized in advance of customer acceptance of a milestone when such acceptance is contractually required. Payments for R&amp;D services with no contractual payments are not due from customers until a technical report is submitted; therefore, a contract asset is recognized at milestone completion but prior to the submission of a technical report. The contract asset represents the Company&#8217;s right to consideration for the services performed at milestone completion. Occasionally, customers provide payments in advance of the Company providing services which creates a contract liability for the Company. The contract liability represents the Company's obligation to provide services to a customer. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collaboration Arrangements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain partnership agreements that are within the scope of ASC 808, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides guidance on the presentation and disclosure of collaborative arrangements. Generally, the classification of the transactions under the collaborative arrangements is determined based on the nature of the contractual terms of the arrangement, along with the nature of the operations of the participants. The Company&#8217;s collaborative agreements generally include a provision of R&amp;D services related to novel technologies and biocatalysts. Amounts received for these services are classified as Revenue from collaborative arrangements in the condensed consolidated statements of operations and comprehensive loss. The Company's R&amp;D services are a major part of the Company's ongoing operations and therefore ASC 606 is applied to recognize revenue.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CarbonSmart</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's CarbonSmart business, initially CarbonSmart ethanol, is produced by LanzaTech licensed plants using the Company's proprietary technologies. Customers can buy CarbonSmart ethanol directly from LanzaTech, which the Company sources from these partnering plants. Revenue is recognized at a point in time when control transfers to the customer, which varies depending on the shipping terms. The Company acts as the principal in such transactions and accordingly, recognizes revenue and cost of revenues on a gross basis.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily due to their short-term nature, except for the warrant liability. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue generated from the Company&#8217;s customers outside of the United States for the nine months ended September&#160;30, 2022 and 2021 was approximately 61% and 65%, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021, approximately 35% and 35%, respectively, of trade accounts receivable and unbilled accounts receivable was due from customers located outside the United States. At September&#160;30, 2022 and December&#160;31, 2021, the value of property, plant, and equipment outside the United States was immaterial.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue by geographic region based on the customer&#8217;s location is presented in Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customers</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers representing 10% or greater of revenue were as follows for the nine months ended September&#160;30, 2022 and 2021:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Announced Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Financial Accounting Standard Board ("FASB") issued an Accounting Standard Update ("ASU") No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2020-10&#8221;). The standard contains improvements to the FASB Accounting Standards Codification (the &#8220;Codification&#8221;) by ensuring that all guidance that requires or provides an option for an entity to provide information in the notes to financial statements is codified in the disclosure section of the Codification. The standard also improves various topics in the Codification so that entities can apply guidance more consistently on codifications that are varied in nature where the original guidance may have been unclear. The amendments in ASU 2020-10 were effective for the Company for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption was permitted. There were no material impacts upon the adoption of ASU 2020-10, on its consolidated financial statements and related disclosures. </span></div>Summary of Significant Accounting Policies <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;US GAAP"). The consolidated financial statements include the accounts of LanzaTech NZ, Inc. and its wholly-owned consolidated subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of its evaluation, the Company makes judgments in determining whether an entity is a variable interest entity (&#8220;VIE&#8221;) and, if so, whether it is the primary beneficiary of the VIE and is thus required to consolidate the entity. A VIE is a legal entity that has a total equity investment that is insufficient to finance its activities without additional subordinated financial support or whose equity investors lack the characteristics of a controlling financial interest. Our variable interest arises from contractual, ownership or other monetary interests in the entity, which change with fluctuations in the fair value of the entity&#8217;s net assets. A VIE is consolidated by its primary beneficiary, the party that has both the power to direct the activities that most significantly impact the VIE&#8217;s economic performance, and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE. We consolidate a VIE when we are deemed to be the primary beneficiary. We assess whether or not we are the primary beneficiary of a VIE on an ongoing basis. If we are not deemed to be the primary beneficiary in a VIE, we account for the investment or other variable interests in a VIE in accordance with applicable US GAAP.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds interests in certain VIEs for which it has been determined the Company is not the primary beneficiary. The Company's variable interests primarily relate to entities in which the Company has a non-controlling equity interest. Although these financial arrangements resulted in holding variable interests in these entities, they did not empower the Company to direct the activities of the VIEs that most significantly impact the VIEs' economic performance. The Company's interests in the VIEs are, therefore, accounted for under the equity method of accounting. Refer to Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further information. The Company's maximum exposure to loss in connection with its interest in VIEs is its equity method investment and any amounts receivable from the VIE, less amounts payable. Refer to Note 14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further details on the transactions with VIEs.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restatement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 16, 2022, the Audit Committee of the Board of Directors of LanzaTech, after discussion with management of LanzaTech and LanzaTech&#8217;s independent registered public accounting firm, Deloitte &amp; Touche, </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LLP, concluded that LanzaTech&#8217;s previously issued audited consolidated financial statements as of and for the fiscal years ended December 31, 2021 and December 31, 2020 should no longer be relied upon. The errors leading to restatement were communicated to and discussed with AMCI upon their discovery. The AMCI Board considered the circumstances surrounding the restatement and concluded that it did not negatively impact its decision to proceed with the Business Combination primarily because of the individually immaterial adjustments. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined that its recorded share of equity method earnings amounts from an unconsolidated affiliate for the years ended December 31, 2021 and 2020 and its gain on dilution amount for the year ended December 31, 2021 were incorrect following the completion of LanzaJet, Inc's ("LanzaJet") financial statement audit. Additionally, the Company identified that it was not properly eliminating intra-entity profits related to revenue contracts with LanzaJet. As a result of the adjustments recorded by the unconsolidated affiliate and the identification of the error related to the elimination of intra-entity profits, the Company made the decision to restate its consolidated financial statements as of and for the years ended December 31, 2021 and 2020, on or around the completion of the audit of LanzaJet's financial statements for the years ended December 31, 2021 and 2020, on August 23, 2022. The Company also determined it was not properly accounting for its licensing arrangement with LanzaJet, and had not disclosed all significant related party transactions with its equity method investees. The Company has also revised these disclosures.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 250, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Changes and Error Corrections</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company evaluated the materiality of the adjustments, considering both quantitative and qualitative factors, and determined that the related aggregate impact was material to its consolidated financial statements as of and for the years ended December 31, 2021 and 2020. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Description of Errors Corrected</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Accounting for Equity Method Investments: </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The previously reported equity method investment in LanzaJet, Inc. (&#8220;LanzaJet&#8221;), as described in Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, contained errors in the Company's recorded share of LanzaJet losses for the years ended 2021 and 2020 as a result of adjustments made by LanzaJet to its financial statements in connection with the audit of LanzaJet's financial statements for the years ended December 31, 2021 and 2020. The adjustments primarily were comprised of (1) an adjustment to correct an error relating to the measurement of the intangible asset associated with the intellectual property contributed by the Company as described in Note 5 &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the related amortization; and (2), an adjustment to reclassify as a reduction to fixed assets certain government grants received by LanzaJet that it originally recorded as revenue. Other less significant adjustments were also identified and corrected in connection with the audit of LanzaJet's financial statements for the years ended December 31, 2021 and 2020. The net impact of these adjustments on the equity method investment's balance and accumulated deficit in the Company's Consolidated Balance Sheets was a decrease of $580 and $257 as of December 31, 2021 and 2020, respectively. The net impact of these adjustments on the gain from equity method investees in the Company&#8217;s Consolidated Statements of Operations and Comprehensive Loss was a decrease of $580 and $257 for the years ended December 31, 2021 and 2020, respectively. </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The previously reported revenue from related parties related to contributed intellectual property contained errors for intra-entity profit that was not previously eliminated, as described in Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The impact of these errors on the equity method investment's balance and accumulated deficit in the Consolidated Balance Sheets was $662 and $549 as of December 31, 2021 and 2020, respectively and $662 and $549 on revenue from related party transactions in the Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2021 and 2020, respectively.</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The previously reported gain on dilution, as described in Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, was not correctly calculated for the year ended December 31, 2021. The impact of these errors on the equity method investment's balance and accumulated deficit in the Consolidated Balance Sheets as of December 31, </span></div><div style="margin-bottom:9pt;padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021 was $322; and the impact on gain from equity method investees in the Consolidated Statements of Operations and Comprehensive Loss was $322 for the year ended December 31, 2021.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Additional Misstatements:</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The previously reported contract assets and other accrued liabilities included revenue and related cost of revenue amounts that was recorded in an inappropriate period. These amounts were recorded in 2021, however, the performance obligation was actually satisfied in 2020.. The impact of these errors on the contract assets and other accrued liabilities in the Consolidated Balance Sheet as of December 31, 2020 was $122; and the impact on revenue from contracts with customers and cost of revenue from contracts with customers in the Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2021 and 2020 was  $122.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Disclosure errors:</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company determined its licensing arrangement with LanzaJet, described in Note 5 &#8211; Investments, should have been accounted for as a transaction with a customer solely within the scope of Accounting Standards Codification 606 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from contracts with customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 606") rather than akin to an operating lease under Accounting Standards Codification 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 842"). The licensing arrangement is a contract with our customer, LanzaJet, that conveys to LanzaJet the right to use an intangible asset (IP). Contracts with customers are accounted for under ASC 606 unless they are within the scope of other accounting literature. Because the licensing arrangement conveys the right to use an intangible asset, it is not within the scope of ASC 842. Under limited circumstances, ASC 606 requires certain arrangements that do not, in substance, transfer control of an asset (i.e., when the arrangement contains certain repurchase rights or obligations) to be accounted for as leases. However, those limited circumstances are not present in our licensing arrangement with LanzaJet. Therefore, the Company concluded accounting for the arrangement under ASC 606 is required. Because the period over which the Company determined it was required to recognize revenue under ASC 606 was the same as the period of time over which it had been recognizing revenue, there was no effect on the amounts recorded in the consolidated financial statements. Additionally, the difference in timing of recognition of the variable consideration resulted in a difference between the carrying value of our equity method investment in LanzaJet and our proportionate share LanzaJet's book values, that was not previously disclosed. However, the disclosures in Note 5 &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, have been revised accordingly.</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company did not disclose in Note 5 &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, its obligation under a guarantee with sublicensing agreement between LanzaJet and a third party. The fair value of this guarantee was deemed immaterial as of December 31, 2021 and 2020.</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company did not include in its disclosure for related party transactions in Note 14 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that it also provided engineering services to one of its equity method investees, Beijing ShouGang LanzaTech Technology Co., LTD ("SGLT"), for which costs of $1,223 and $242 were incurred during the years ended December 31, 2021 and 2020. The Company also did not disclose that in 2019 it entered into a licensing agreement to receive licensing consideration from SGLT. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of the errors discussed above were individually material to the financial statements, however, their cumulative impact was material and resulted in a restatement of the 2021 and 2020 financial statements. The effects of the correction of these errors on the relevant financial statement line items is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Balance Sheet</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,738&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,011&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(378,162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(379,889)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(353,190)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(354,917)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, contingently redeemable preferred equity, and shareholders' deficit</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,738&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,011&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Balance Sheet</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,664&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(684)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,980&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,775&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,897&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,666&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,788&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(332,394)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(333,200)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310,410)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311,216)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, contingently redeemable preferred equity, and shareholders' deficit</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,664&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(684)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,980&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Operations and Comprehensive Loss</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from contracts with customers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from related party transactions</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,915&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(662)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,253&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,245&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(784)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,461&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue from contracts with customers (exclusive of depreciation shown below)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,289)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,167)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost and operating expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,602)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,480)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,357)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(662)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,019)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,972)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(662)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48,634)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(259)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,945&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,768)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(921)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,689)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss allocated to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82,526)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(921)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83,447)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,673)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(921)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,594)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share - basic and diluted</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.12)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.47)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.59)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Operations and Comprehensive Loss</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from contracts with customers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from related party transactions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,752&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(549)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,780&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(427)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,353&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue from contracts with customers (exclusive of depreciation shown below)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,063)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,185)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost and operating expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,932)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58,054)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,152)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(549)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,701)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,331)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(549)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,880)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,424&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(257)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,907)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,713)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss allocated to common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68,198)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69,004)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,282)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,088)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share - basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.84)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.50)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.34)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Changes in Redeemable Convertible Preferred Stock and Shareholders&#8217; Equity (Deficit)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit - Balance at December 31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(332,394)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(333,200)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit &#8211; balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310,410)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311,216)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,768)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(921)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,689)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit - balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(378,162)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(379,889)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit &#8211; balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(353,190)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(354,917)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Changes in Redeemable Convertible Preferred Stock and Shareholders&#8217; Equity (Deficit)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit - Balance at December 31, 2019</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(295,487)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(295,487)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit &#8211; balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276,592)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276,592)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,907)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,713)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit - balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(332,394)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(333,200)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit &#8211; balance at December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310,410)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311,216)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Cash Flows</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,768)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(921)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,689)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash recognition of licensing revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,684)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,022)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,945)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,636)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,514)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued salaries and wages</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,591)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,591)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Cash Flows</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,907)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,713)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash recognition of licensing revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,567)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,018)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,424)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,167)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,483)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,605)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued salaries and wages</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,271)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,271)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Other Disclosure Errors: </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 5 - Investments: The Company did not disclose intra-entity profits elimination amounts related to revenue contracts with LanzaJet of $662 and $549 as of December 31, 2021, and 2020, respectively as they were not eliminated. The previously disclosed gain on dilution was incorrect as of and for the year ended December 31, 2021.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on dilution</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates as one operating segment. Operating segments are defined as components of an enterprise for which separate financial information is evaluated regularly by the chief operating decision maker (&#8220;CODM&#8221;), in deciding how to allocate resources and assess performance.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company offers a variety of services and operates in multiple countries, the Company&#8217;s business operates in one operating segment because most of the Company&#8217;s service offerings are delivered and supported on a global basis, most of the Company&#8217;s service offerings are deployed in a nearly identical way, and the Company&#8217;s CODM evaluates the Company&#8217;s financial information and resources and assesses the performance of these resources on a consolidated basis. There are no segment managers who are held accountable by the CODM, or anyone else, for operations, operating results, and planning for components below the consolidated level. Accordingly, the Company has determined that it has a single reportable and operating segment. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for disaggregation of the Company&#8217;s revenues by customer location.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Coronavirus (COVID-19)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the World Health Organization declared the viral strain of coronavirus ("COVID-19") a global pandemic and recommended containment and mitigation measures worldwide. The spread of COVID-19 and the resulting economic contraction has resulted in increased business uncertainty. The consequences of a prolonged economic decline could include, but are not limited to, reduced revenues, increased instances of uncollectible customer receivables, and increased asset impairments in future periods. Accordingly, the Company cannot reasonably estimate the length or severity of this pandemic, or the extent to which the disruption may materially impact its consolidated balance sheets, consolidated statements of operations and comprehensive loss or statements of cash flows for future periods.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Going Concern</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements of the Company have been prepared assuming the Company will continue as a going concern and in accordance with US GAAP. The going concern basis of presentation assumes that the Company will continue in operation one year after the date these financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. The Company had cash and cash equivalents of $128,318 and an accumulated deficit of $379,889 at December&#160;31, 2021 and cash outflows from operations of $42,591 and a net loss of $46,689 for the year ended December&#160;31, 2021. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has historically funded its operations through debt financing and issuance of equity securities. Based on the Company&#8217;s financial position as of the date these consolidated financial statements were issued, the Company projects that it will be able to cover its liquidity needs for the next twelve months with cash on hand. Accordingly, the Company&#8217;s consolidated financial statements have been prepared on the basis that it will continue as a going concern.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates include fair value of equity awards granted to both employees and non-employees.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in facts and circumstances or additional information may result in revised estimates, and actual results may differ from these estimates.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currencies</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reporting currency is the U.S. Dollar. The Company has certain foreign subsidiaries where the functional currency is the local currency. All of the assets and liabilities of these subsidiaries are converted to U.S. dollars at the exchange rate in effect at the balance sheet date, income and expense accounts are translated at average rates for the period, and shareholder&#8217;s equity accounts are translated at historical rates. The effects of translating financial statements of foreign operations into our reporting currency are recognized as an adjustment in accumulated other comprehensive income (loss).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has foreign subsidiaries that have a functional currency of the U.S. dollar. Purchases and sales of assets and income and expense items denominated in foreign currencies are remeasured into U.S. dollar amounts on the respective dates of such transactions. Net realized foreign currency gains or losses relating to the differences between these recorded amounts and the U.S. dollar equivalent actually received or paid are included within Other income, net in the consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. As of December&#160;31, 2021 and 2020, the Company had $128,318 and $60,495 of cash and cash equivalents, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to maintain a cash deposit with a bank which consists of collateral on a travel and expense program maintained by the bank. The following represents a reconciliation of cash and cash equivalents in </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the consolidated balance sheets to total cash, cash equivalents and restricted cash in the consolidated statement of cash flows as of December 31, 2021 and December 31, 2020.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,495&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (presented within Other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,732&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,909&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade and Other Receivables </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables are reported net of allowances for doubtful accounts. The Company maintains allowances for doubtful accounts for estimated losses resulting from the inability of customers to make required payments. The Company estimates the allowance for doubtful accounts based on a variety of factors including the length of time receivables are past due, the financial health of customers, unusual macroeconomic conditions, and historical experience. As of December&#160;31, 2021 and 2020, the Company recognized an allowance for doubtful accounts of $1,235 and $1,325, respectively.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Current Assets</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current assets consist of prepaid expenses, materials and supplies, and other assets. Material and supplies consist of spare parts and consumables used for research and research equipment and is stated at the weighted average cost.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment, net</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost and include improvements that significantly increase capacities or extend the useful lives of existing plant and equipment.&#160;Depreciation is calculated using the straight-line method over the estimated useful life of the assets. Useful lives range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTA0_78de1c22-d3ad-43ae-a899-19a74e1b2357">three</span> to five years for instruments and equipment, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk3OTk5_761df305-309f-4903-a23c-ce62ac3f485c">three</span> to five years for office equipment and furniture and software, five years for vehicles and, for leasehold improvements, the shorter of the life of the improvement or the remaining term of the lease. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews the remaining useful life of its assets on a regular basis to determine whether changes have taken place that would suggest that a change to depreciation policies is warranted.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon retirement or disposal of property, plant and equipment, the cost and related accumulated depreciation are removed from the account, and the resulting gains or losses, if any, are recorded in the consolidated statements of operations and comprehensive loss. Net gains or losses related to asset dispositions are recognized in earnings in the period in which dispositions occur. Routine maintenance, repairs and replacements are expensed as incurred.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines&#160;if an arrangement is a lease at inception.&#160;Lease agreements are evaluated to classify the lease as a finance or operating&#160;lease.&#160;Operating lease assets and liabilities are recognized at the commencement date of the lease based on the present value of lease payments over the lease term. Lease assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. As most&#160;leases&#160;do not provide an implicit interest rate,&#160;the Company&#160;uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. Leases with an initial term of 12 months or less are not recorded on the Company&#8217;s consolidated balance sheets. The Company recognizes lease expense for these leases on a straight-line basis over the lease term.&#160;The Company accounts for lease components and non-lease components as a single lease component.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs a recoverability assessment of each of its long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indicators may include, but are not limited to, adverse changes in the regulatory environment in a jurisdiction where the Company operates, a decision to discontinue the development of a long-lived asset, early termination of a significant customer contract, or the introduction of newer technology.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When performing a recoverability assessment, the Company measures whether the estimated future undiscounted net cash flows expected to be generated by the asset exceeds its carrying value. In the event that an asset does not meet the recoverability test, the carrying value of the asset will be adjusted to fair value resulting in an impairment charge.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management develops the assumptions used in the recoverability assessment based on active contracts as well as information received from third-party industry sources. The Company did not record an impairment during the years ended December&#160;31, 2021 and 2020. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Method Investments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in entities over which the Company has significant influence, but not control, are accounted for using the&#160;equity method&#160;of accounting. Gain from&#160;equity method&#160;investees, net represents the Company&#8217;s proportionate share of net income or loss of its equity method investees and any gains or losses from the dilution of such investments.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity method&#160;investments are assessed for impairment whenever changes in the facts and circumstances indicate a loss in value may have occurred. When a loss is deemed to have occurred and is other than temporary, the carrying value of the&#160;equity method&#160;investment is written down to fair value. In evaluating whether a loss is other than temporary, the Company considers the length of time for which the conditions have existed and its intent and ability to hold the investment. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Simple Agreement for Future Equity (SAFE)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company issued a SAFE that allowed an investor to participate in future equity financings through a share-settled redemption of the amount invested (such notional being the &#8220;invested amount&#8221;). The Company determined that the SAFE was not legal form debt (i.e., no creditors&#8217; rights). The SAFE includes a provision allowing for cash redemption upon the occurrence of a change of control, the occurrence of which is outside the control of the Company. Therefore, the SAFE is classified as mark-to-market liability pursuant to Accounting Standards Codification (&#8220;ASC&#8221;) 480, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distinguishing Liability from Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has warrants to purchase preferred shares outstanding as of December&#160;31, 2021 and 2020 representing 225,223 and 383,281 preferred shares, respectively, which warrants expire at various dates through December 31, 2027. The exercise prices of the warrants range from $14.69 to $19.93 as of each of December&#160;31, 2021 and 2020. The Company accounts for its warrants as liabilities based upon the characteristics and provisions of each instrument. The liabilities are included in other accrued liabilities on the Company's consolidated balance sheets at their fair value on the date of issuance and are revalued in each subsequent reporting period until such instruments are exercised or expire. The change in fair value between reporting periods is included in other (expense) income, net in the consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further the warrant related to the SAFE of $1,729 is accounted for as a liability. This liability is recorded in current liabilities on the Company's consolidated balance sheets at fair value on the date of issuance and will be revalued each subsequent reporting period until such instrument is exercised or expire. The change in fair value between reporting periods is included in other (expense) income, net in the consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Term Debt and Debt Issuance Costs</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s debt consists of credit facilities with financial institutions. Costs directly related to the issuance of debt are reported on the consolidated balance sheets as a reduction from the carrying amount of the recognized debt liability and amortized over the term of the debt using the effective interest method.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal and Contingencies</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may be involved in legal actions in the ordinary course of business, inquiries and proceedings concerning employment, labor, environmental, and other claims. The Company will recognize a loss contingency in the consolidated financial statements when it is probable a liability has been incurred and the amount of the loss can be reasonably estimated. The Company will disclose any loss contingencies that do not meet both conditions if there is a reasonable possibility that a loss may have been incurred. Gain contingencies are not recorded until realized.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company primarily earns revenue from services related to feasibility studies and basic engineering design of commercial plants, licensing of technologies, joint development and contract research activities to develop novel biocatalysts and related technologies.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is measured based on the consideration specified in a contract with a customer. The Company records taxes collected from customers and remitted to governmental authorities on a net basis. The Company&#8217;s payment terms are between 30-60 days and can vary by customer type and products offered. We have evaluated the terms of our arrangements and determined that they do not contain significant financing components.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Carbon Capture and Transformation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides feasibility studies and basic design and engineering services used for detailed design, procurement, and construction of commercial plants that utilize the Company&#8217;s technologies, along with the sale of equipment and microbes. The services provided are recognized as a performance obligation satisfied over time. Revenue is recognized using the output method based on milestone completion, the cost-to-cost input method for certain engineering services, or the percentage of completion method when certain revenue recognition requirements are met. Management has determined that the milestone completion and the associated contractual payment amounts are an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company licenses intellectual property to generate recurring revenue when its customers deploy carbon capture and transformation plants. When licenses are considered to be distinct performance obligations, the recognition of revenue is dependent on the terms of the contract, which may include fixed consideration or royalties based on sales or usage, in which case, the revenue is recognized when the subsequent sale or usage occurs or when the performance obligation to which some or all of the sales or usage-based royalty is allocated has been satisfied, whichever is later.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Services</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs research and development (&#8220;R&amp;D&#8221;) services related to novel technologies and development of biocatalysts for commercial applications, mainly to produce fuels and chemicals. The Company engages in two main types of R&amp;D services &#8211; joint development agreements, and other contract research, including projects with the U.S. Department of Energy. Such services are recognized as a performance obligation satisfied over time. Revenue is recognized based on milestone completion, when such milestones are contractually defined, or based on stage of contract completion when not defined. For the latter, management has determined that the cost incurred, input method, is an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and estimates its variable consideration under the expected value method. Accordingly, the Company records a liability based on milestones achieved and the expected repayment of the development costs. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s joint development agreements may utilize the cost-to-cost method of revenue recognition or may include well defined payment milestones, dependent on the contract, both of which the Company evaluates against work completed prior to revenue recognition. For other contract research, the Company utilizes the cost-to-cost method of revenue recognition. These contracts have a fixed dollar amount which is based on the Company&#8217;s estimate of total costs to be incurred over the life of each contract. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is not recognized in advance of customer acceptance of a milestone, when such acceptance is contractually required. Payments for R&amp;D services with no contractual payments are not due from customers until a technical report is submitted; therefore, a contract asset is recognized at milestone completion but prior to the submission of a technical report. The contract asset represents the Company&#8217;s right to consideration for the services performed at milestone completion. Occasionally, customers provide payments in advance of the Company providing services which creates a contract liability for the Company. The contract liability represents the Company's obligation to provide services to a customer. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collaboration Arrangements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain partnership agreements that are within the scope of ASC 808, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides guidance on the presentation and disclosure of collaborative arrangements. Generally, the classification of the transactions under the collaborative arrangements is determined based on the nature of the contractual terms of the arrangement, along with the nature of the operations of the participants. The Company&#8217;s collaborative agreements generally include a provision of R&amp;D services related to novel technologies and biocatalysts. Amounts received for these services are classified as Revenue from collaborative arrangements in the consolidated statements of operations and comprehensive loss. The Company's R&amp;D services are a major part of the Company's ongoing operations and therefore ASC 606 is applied to recognize revenue.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenues</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s R&amp;D, engineering, and other direct costs of services related to revenue agreements with customers, related parties, and collaborative partners represent cost of revenue. Costs include both internal and third-party fixed and variable costs and include materials, supplies, labor, and fringe benefits.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incur research and development costs associated with various R&amp;D activities and expense these costs as incurred.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for equity-based compensation in accordance with ASC 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation &#8211; Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Accordingly, in exchange for employee and director services, compensation is given in the form of equity awards. The equity awards are recorded based on the grant date fair value and expensed over the requisite service period for the respective award.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s equity-based awards include stock option awards and restricted stock issued by the Company, which vest based on either time or the achievement of certain performance conditions. The Company records forfeitures as they occur. Compensation expense resulting from time-vesting-based awards is recognized in the Company&#8217;s consolidated statements of operations and comprehensive loss, primarily within research and development expenses, at the grant date fair value over the requisite service period. Compensation expense resulting from performance awards recognized over the requisite service period when it is probable that the performance condition will be met. The calculated compensation expense for performance awards is adjusted based on an estimate of awards ultimately expected to vest. The Company estimates grant date fair value using a Black-Scholes option pricing model that uses assumptions including expected volatility, expected term, and the expected risk-free rate of return. The Company has determined that the Black-Scholes option pricing model, as well as the underlying assumptions used in its application, is appropriate in estimating the fair value of its award grants.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows the asset and liability method of accounting for income taxes under ASC 740, Income Taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income tax assets are evaluated to determine if valuation allowances are required or should be adjusted. Valuation allowances are established based on a more likely than not standard. The ability to realize deferred tax assets depends on the Company&#8217;s ability to generate sufficient taxable income within the carryback or carryforward periods provided for in the tax law for each tax jurisdiction. The Company considers the various possible sources of taxable income when assessing the realization of its deferred tax assets. The valuation allowances recorded against deferred tax assets generated by taxable losses in certain jurisdictions will affect the provision for income taxes until the valuation allowances are released. The Company&#8217;s provision for income taxes will include no tax benefit for losses incurred and no tax expense with respect to income generated in these jurisdictions until the respective valuation allowance is eliminated.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records uncertain tax positions on the basis of a two-step process whereby it is determined whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position, and for those tax positions that meet the more likely than not criteria, the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority is recognized. The Company recognizes accrued interest and penalties related to unrecognized tax benefits in income tax expense.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Transactions</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows ASC 850-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for the identification of related parties and disclosure of related party transactions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. Refer to Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Note 14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further information.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss Per Share</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is computed by dividing net loss attributable to participating stock by the weighted average number of shares of participating stock outstanding during the period. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted net loss per share reflects potential dilution and is computed by dividing net loss attributable to participating stock by the weighted average number of shares of participating stock outstanding during the period. The dilutive effect of outstanding awards, if any, is reflected in diluted earnings per share by application of the treasury stock method or if-converted method, as applicable. Refer to Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Loss Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-term nature, except for the warrant liability. Refer to Note 11, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrant Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for more information.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties (Restated)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue generated from the Company&#8217;s customers outside of the United States for the years ended December&#160;31, 2021 and 2020 was approximately 38% and 14%, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, approximately 35% and 27%, respectively, of trade accounts receivable and unbilled accounts receivable was due from customers located outside the United States. At December&#160;31, 2021 and 2020, the value of property, plant, and equipment outside the United States was immaterial.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue by geographic region based on the customer&#8217;s location is presented in Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customers</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers representing 10% or greater of revenue were as follows for the years ended December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, two of the Company's customers separately represented 49% (Customer B) and 15% (Customer D) of total accounts receivable and contract assets on the consolidated balance sheet. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses (Topic 326): Disclosure Framework &#8211; Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2016-13&#8221;), which requires financial assets measured at amortized cost basis, including trade receivables, to be presented net of the amount expected to be collected. The measurement of all expected credit losses will be based on historical experience, current conditions, and reasonable and supportable forecasts. The Company adopted the new standard effective January 1, 2020, using a modified retrospective transition method, which requires a cumulative-effect adjustment, if any, to the opening balance of retained earnings to be recognized on the date of adoption with prior periods not restated. The adoption did not have a material impact on the Company&#8217;s financial position or results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles &#8211; Goodwill and Other &#8211; Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2018-15&#8221;), which requires a customer in a cloud computing arrangement that is a service contract to follow the internal-use software guidance in ASC 350-40 to determine which implementation costs to capitalize as assets. A customer&#8217;s accounting for the costs of the hosting component of the arrangement is not affected by the new guidance. The Company adopted ASU 2018-15 as of January 1, 2020 with no material impact on its consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2018, the FASB issued ASU 2018-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Stock Compensation Improvements to Non-employee Share-Based Payment Accounting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2018-07&#8221;), which simplifies the accounting for stock-based payments granted to non-employees for goods and services. Under ASU 2018-07, most of the guidance on such payments to non-employees will be aligned with the requirements for stock-based payments granted to employees. The Company early adopted ASU 2018-07 as of January 1, 2020 and its adoption did not have a material impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2019-12&#8221;), as part of its simplification initiative to reduce the cost and complexity in accounting for income taxes. ASU 2019-12 removes certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. ASU 2019-12 also amends other aspects of the guidance to help simplify and promote consistent application of US GAAP. The Company adopted ASU 2019-12 as of January 1, 2021 with no material impact on its consolidated financial statements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Announced Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2020-10&#8221;). The standard contains improvements to the FASB Accounting Standards Codification (the &#8220;Codification&#8221;) by ensuring that all guidance that requires or provides an option for an entity to provide information in the notes to financial statements is codified in the disclosure section of the Codification. The standard also improves various topics in the Codification so that entities can apply guidance more consistently on codifications that are varied in nature where the original guidance may have been unclear. The amendments in ASU 2020-10 are effective for the Company for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption is permitted. The Company does not expect the adoption of ASU 2020-10 to have a material impact on its consolidated financial statements and related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211200544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text">Net Loss Per Share<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is computed by dividing net loss by the weighted-average number of shares of common stock of the Company outstanding during the period. Diluted net loss per share is computed by giving effect to all potential shares of common stock of the Company, including outstanding stock options, warrants, and contingently redeemable preferred stock, to the extent dilutive.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of basic and diluted net loss per share for the Company&#8217;s common stock (in thousands, except shares and per share amounts):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss for basic and diluted earnings per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,974)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,591)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid cumulative dividends on preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,925)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,068)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss allocated to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83,899)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,659)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares used in calculating net loss per share, basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,108,472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,909,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share, basic and diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.79)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.19)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In periods in which the Company reports a net loss, all share-based compensation awards are excluded from the calculation of diluted weighted average shares outstanding because of their anti-dilutive effect on earnings (loss) per share.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and 2021, potential shares of common stock not included in the computation of loss per share because their effect would be antidilutive include the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable convertible preferred stock (if converted)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,790,978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,540,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSAs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,117,671&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,867,263&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the organizational documents of the Company, the preferred shares are convertible by the holder at any time at their option. In addition, the preferred shares will automatically convert into common shares upon either (i) the determination of the holders of certain requisite preferred shares of the Company (which determination will be submitted for approval by such stockholders in connection with the Business Combination described in Note 1, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Description of the Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), or (ii) a firmly underwritten initial public offering of the Company&#8217;s shares that satisfies certain requirements (but not, for the avoidance of doubt, upon a business combination with a special purpose acquisition company, such as the Business Combination, unless such conversion is otherwise effected pursuant to clause (i) above). Such conversion would be at a 1:1 ratio, adjusted for certain corporate events. Upon conversion of the preferred shares, the cumulative accrued and declared dividends will become payable. The additional 29,521,810 of potential shares of common stock resulting from any such conversion are not included in the computation of diluted net loss per share in the nine months ended September&#160;30, 2022 and 2021, respectively, because doing so would be anti-dilutive. In connection with the SAFE, see Note 6 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company could issue additional potential shares of common stock upon closing of the Business Combination. Further, under the Simple Agreement for Future Equity ("SAFE") warrant, additional potential shares of common stock could be issued upon closing of the Business Combination and exercise of the warrant. These potential shares of common stock have not been issued as of September 30, 2022. The per share issuance price for the SAFE and SAFE warrant upon closing of the Business Combination is 100% of the liquidity price. If another qualified liquidity event occurs instead, the issuance price is 90% of the liquidity price.</span></div>Net Loss Per ShareBasic net loss per share is computed by dividing net loss by the weighted-average number of shares of common stock of the Company outstanding during the period. Diluted net loss per share is computed by giving effect to all potential shares of common stock of the Company, including outstanding stock options, warrants, and contingently redeemable preferred stock, to the extent dilutive.<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of basic and diluted net loss per share for the Company&#8217;s common stock (in thousands, except shares and per share amounts):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss for basic and diluted earnings per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,689)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,713)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid cumulative dividends on preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,758)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss allocated to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83,447)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69,004)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares used in calculating net loss per share, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,959,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,629,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share, basic and diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.59)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.34)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In periods in which the Company reports a net loss, all stock-based compensation awards are excluded from the calculation of diluted weighted average shares outstanding because of their anti-dilutive effect on earnings (loss) per share.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, potential shares of common stock not included in the computation of earnings per share because their effect would be antidilutive include the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable convertible preferred stock (if converted)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,729,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,848,420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,283,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSAs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,175,113&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,720,703&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the organizational documents of the Company, the preferred shares will automatically convert into common shares upon either (i) the determination of the holders of certain requisite preferred shares of the Company (which determination will be submitted for approval by such stockholders in connection with the Merger described below in Note 20) or (ii) a firmly underwritten initial public offering of the Company&#8217;s shares that satisfies certain requirements (but not, for the avoidance of doubt, upon a business combination with a special purpose acquisition company, such as the Merger, unless such conversion is otherwise effected pursuant to clause (i) above). Such conversion would be at a 1:1 ratio, adjusted for certain corporate events.Upon conversion of the preferred shares, the cumulative accrued and declared dividends will become payable.  The additional 29,521,810 and 25,729,542 of potential shares of common stock resulting from any such conversion are not included in the computation of diluted net loss per share in 2021 and 2020, respectively, because neither an initial public offering nor a stockholder determination of such conversion had occurred at the end of the period. In connection with the SAFE, see Note 10 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simple Agreement for Future Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company could issue additional potential shares of common stock upon closing of the Merger. Further, under the SAFE warrant, see Note 6 &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Note 11 &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrants Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, additional potential shares of common stock could be issued upon closing of the Merger and exercise of the warrant. These potential shares of common stock have not been issued as of December 31, 2021. The per share issuance price for the SAFE and SAFE warrant upon closing of the Merger is 100% of the liquidity price. If another qualified liquidity event occurs instead, the issuance price is 90% of the liquidity price.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272210215312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenues</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4 &#8212; Revenues</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregated Revenue</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents disaggregated revenue in the following categories (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Types:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joint development agreements</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other contract research</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,118&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,053&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CarbonSmart</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Engineering and other services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,756&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carbon capture and transformation revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,663&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,274&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,781&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,327&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from collaborative partners of $1,733 and $2,662 for the nine months ended September&#160;30, 2022 and 2021, is included in the table above within joint development agreements. Revenue from related parties is included in licensing for $1,620 and $1,518 with the remaining revenue of $496 and $830 in Engineering and other services, for the nine months ended September&#160;30, 2022 and 2021, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents disaggregation of the Company&#8217;s revenues by customer location for the nine months ended September&#160;30, 2022 and 2021 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.214%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,725&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Middle East, Africa (EMEA)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,781&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,327&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract balances</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides changes in contract assets and liabilities (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Contract Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Contract Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-current Contract Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022 as Restated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,901&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to unbilled accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases due to cash received</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled accounts receivable recognized in trade receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,085)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease on revaluation on currency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(804)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification from non-current to current contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,015)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification to revenue as a result of performance obligations satisfied</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,298)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,848&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,968&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,119&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in contract assets was mostly due to unbilled accounts receivables from contracts with customers where the Company performed engineering and other services, while the decrease in contract liabilities was primarily due to the recognition of revenue during the period related to advance payments previously received by the Company for engineering and other services contracts with customers. As of September&#160;30, 2022 and December&#160;31, 2021 the Company had $11,588 and $2,878, respectively, of billed accounts receivable, net of allowance.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contract liability balance is comprised of unconditional payments received from the Company&#8217;s customers prior to the satisfaction of the related performance obligations. Such amounts are anticipated to be recorded as revenues when services are performed in subsequent periods. The Company expects to recognize the amounts classified as current contract liabilities, in revenue within one year or less and those classified as non-current within two to three years. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Remaining performance obligations</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction price allocated to the remaining performance obligation represents contracted revenue that has not yet been recognized, which includes unearned revenue that will be recognized as revenue in future periods. Transaction price allocated to remaining performance obligations is influenced by several factors, including the length of the contract term compared to the research term and the existence of customer specific acceptance rights. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remaining performance obligations consisted of the following (in thousands): </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,087&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,377&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Revenues<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregated Revenue</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents disaggregated revenue in the following categories (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 5.5pt;text-align:center;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 5.5pt;text-align:center;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Types:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joint development agreements</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other contract research</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,897&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,910&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Engineering and other services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carbon capture and transformation revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,564&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:33pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,461&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,353&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from collaborative partners is included in the table above within joint development agreements. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents disaggregation of the Company&#8217;s revenues by customer location for the years ended December&#160;31, 2021 and 2020 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,732&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,461&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,353&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract balances</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides changes in contract assets and liabilities during the year ended December 31, 2021.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Contract Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Contract Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-current Contract Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020 as Restated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,291&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to unbilled accounts receivable as Restated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases due to cash received</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,690&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled accounts receivable recognized in trade receivables as Restated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,002)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification from long-term to short-term</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,080)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification to revenue as a result of performance obligations satisfied</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,104)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,700&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,476&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,901&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in contract assets was mostly due to unbilled accounts receivables from contracts with customers where the Company performed engineering and other services, while the increase in contract liabilities was primarily due to advance payments received under engineering and other services. As of December&#160;31, 2021 and 2020 the Company had $2,878 and $5,521, respectively, of billed accounts receivable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contract liability balance is comprised of unconditional payments received from the Company&#8217;s customers prior to the satisfaction of the related performance obligations. Such amounts are anticipated to be recorded as revenues when services are performed in subsequent periods. The Company expects to recognize the amounts classified as current contract liabilities, in revenue within one year or less and those classified as non-current within two and three years. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Remaining performance obligations</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction price allocated to the remaining performance obligation represents contracted revenue that has not yet been recognized, which includes unearned revenue that will be recognized as revenue in future periods. Transaction price allocated to remaining performance obligations is influenced by several factors, including the length of the contract term compared to the research term and the existence of customer specific acceptance rights. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remaining performance obligations consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,377&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,771&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211033952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTextBlock', window );">Investments</a></td>
<td class="text">Investments<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investments consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Category</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021 as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Method Investment in LanzaJet</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Security Investment in SGLT</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Investment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,037&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,752&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LanzaJet</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 13, 2020, the Company contributed $15,000 in intellectual property in exchange for a 37.5% interest (&#8220;Original Interest&#8221;) of LanzaJet, Inc. (&#8220;LanzaJet&#8221;) in connection with an investment agreement (&#8220;Investment Agreement&#8221;). The Company accounts for the transaction as a revenue transaction with a customer under ASC 606 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The licensing and technical support services provided are recognized as a single combined performance obligation satisfied over the expected period of those services, beginning May 2020 through December 2025. During the nine months ended September&#160;30, 2022 and 2021, the Company has recognized revenue from this arrangement of $1,620 and $1,516 respectively, net of intra-entity profit elimination. As of  September&#160;30, 2022 and December&#160;31, 2021, the Company has recorded deferred revenue of $8,734 and $10,746, respectively. Intra-entity profits related to revenue contracts with LanzaJet are $395 and $497 as of September&#160;30, 2022, and 2021, respectively. Intra-entity profit is amortized over the 15-year amortization period through 2034. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between February 1, 2021 and April 4, 2021, LanzaJet closed two additional rounds of investment which reduced the Original Interest to 25%. As a result, the Company recognized a gain on dilution of $503. The Company retained its contingent right to receive an additional interest in LanzaJet of up to 45&#160;million shares for no additional consideration. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of our equity method investment in LanzaJet as of September&#160;30, 2022 and December&#160;31, 2021 was approximately $3,600 and $3,100 less than our proportionate share of our equity method investees&#8217; book values, respectively. The basis differences are largely the result of a difference in the timing of recognition of variable consideration to which we may become entitled in exchange for our contribution of intellectual property to LanzaJet. The variable consideration we may receive will be in the form of additional ownership interests and the majority of the basis difference will reverse in connection with recognition of that variable consideration. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with a sublicense agreement to LanzaJet under our license agreement with Battelle Memorial Institute (&#8220;Battelle&#8221;), LanzaTech remains responsible for any failure by LanzaJet to pay royalties due to Battelle. The fair value of LanzaTech&#8217;s obligation under this guarantee was immaterial as of September&#160;30, 2022 and December 31, 2021.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SGLT</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2011, the Company contributed RMB 25,800 (approx. $4,000) in intellectual property in exchange for 30% of the registered capital of Beijing ShouGang LanzaTech Technology Co., LTD (&#8220;SGLT&#8221;). </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company&#8217;s interest in SGLT&#8217;s registered capital is approximately 10.01%. As the result of the admittance of new investors, the Company recognized a gain from dilution of $3,014 during the nine months ended September&#160;30, 2021. On April 29, 2022, SGLT closed a round of financing which reduced the Company's ownership to 9.31% and resulted in the recognition of gain from dilution of $3,368. On September 30, 2022, management of the Company determined that the Company no longer had significant influence over the operating and financial policies of SGLT due to the significant and sustained decrease in SGLT's technological dependence on LanzaTech. As such, as of September 30, 2022, the Company ceased applying the equity method and reclassified cumulative currency translation adjustments associated with its investment in SGLT of $928 to include those adjustments in the carrying value of its investment. Prospectively, the Company will account for its investment in the equity security of SGLT using the alternative measurement principals as permitted under ASC 321, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments - Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, because SGLT's fair value is not readily determinable. As the change is effective on September 30, 2022, the Company recorded SGLT's attributable net loss of $76, for the nine months ended September&#160;30, 2022, on the condensed consolidated statements of operations. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequently, under the alternative measurement method, LanzaTech will adjust the carrying value for observable changes in price and will reassess whether its investment in SGLT continues to qualify for such method. Additionally, LanzaTech will perform a qualitative assessment and recognize an impairment if their are sufficient indicators that the fair value of the SGLT investment is less than its carrying value. The changes in value and impairment charges (if any), are recorded in other (expense) income, net in the condensed consolidated statement of operations.</span></div>As of September&#160;30, 2022 and December&#160;31, 2021, there were no impairments of either equity investees. During the nine months ended September&#160;30, 2022 and the year ended December&#160;31, 2021, the Company received no dividends from equity investments.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -URI https://asc.fasb.org/topic&amp;trid=75115024<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 325<br> -URI https://asc.fasb.org/topic&amp;trid=2197064<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI https://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211107984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9 &#8212; Fair Value Measurements </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information about the Company&#8217;s financial assets and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy:</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September 30, 2022</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other <br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held in trust account</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,969,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201;public warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201;private placement warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493,280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2021</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held in trust account</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,006,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201; public warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,825,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201;private placement warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transfers to/from Levels 1, 2 and 3 are recognized at the beginning of the reporting period. The estimated fair value of public warrants was transferred from a Level 3 fair value measurement to a Level 1 measurement, when the public warrants were separately listed and traded in September 2021. There were no other transfers between levels in the nine months ended September 30, 2022 and in the period from January 28, 2021 (inception) through December 31, 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 assets include investments in mutual funds invested in U.S. government securities and derivative warrant liabilities (public warrants). The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For periods where no observable traded price is available, the fair value of the public warrants has been estimated using a Monte-Carlo simulation model and the private placement warrants has been estimated using a Black-Scholes option pricing model. For periods subsequent to the detachment of the public warrants from the units, the fair value of the public warrants is based on the observable listed price for such warrants. The estimated fair value of the public and private placement warrants, prior to the public warrants being traded in an active market, was determined using Level 3 inputs. Inherent in a Monte-Carlo simulation and Black-Scholes option pricing model are assumptions related to the unit price, expected volatility, risk-free interest rate, term to expiration, and dividend yield. The unit price is based on the publicly traded price of the units as of the measurement date. The Company estimated the volatility for the public and private placement warrants based on the implied volatility from the traded prices of warrants issued by other special purpose acquisition companies. The risk-free interest rate is based on </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">interpolated U.S. Treasury rates, commensurate with a similar term to the public and private placement warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. Finally, the Company does not anticipate paying a dividend. Any changes in these assumptions can change the valuation significantly.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2022 and 2021, the Company recognized a change to the statement of operations resulting from a decrease (increase) in the fair value of liabilities of approximately $1.4 million and $1.4 million, respectively, presented as change in fair value of derivative warrant liabilities on the accompanying statements of operations. For the nine months ended September 30, 2022 and for the period from January 28, 2021 (inception) through September 30, 2021, the Company recognized a change to the statement of operations resulting from a decrease (increase) in the fair value of liabilities of approximately $4.1 million and $1.4 million, respectively, presented as change in fair value of derivative warrant liabilities on the accompanying statements of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30, 2022 </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2021 </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.19</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.75</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the fair value of the derivative warrant liabilities, measured using Level 3 inputs, for the three and nine months ended September 30, 2022 is summarized as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,030,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,085,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(451,720)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493,280&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9 &#8212; Fair Value Measurement </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information as of December 31, 2021 about the Company&#8217;s financial assets and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held in Trust Account</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,006,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities &#8211; Public Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,825,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities &#8211; Private Placement Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transfers to/from Levels 1, 2 and 3 are recognized at the beginning of the reporting period. The estimated fair value of public warrants was transferred from a Level 3 fair value measurement to a Level 1 measurement, when the public warrants were separately listed and traded in September 2021. There were no other transfers between levels in the period from January 28, 2021 (inception) through December 31, 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 assets include investments in mutual funds invested in U.S. government securities and derivative warrant liabilities (public warrants). The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For periods where no observable traded price is available, the fair value of the public warrants has been estimated using a Monte-Carlo simulation model and the private placement warrants has been estimated using a Black-Scholes option pricing model. For periods subsequent to the detachment of the public warrants from the units, the fair value of the public warrants is based on the observable listed price for such warrants. The estimated fair value of the public and private placement warrants, prior to the public warrants being traded in an active market, was determined using Level 3 inputs. Inherent in a Monte-Carlo simulation and Black-Scholes option pricing model are assumptions related to the unit price, expected volatility, risk-free interest rate, term to expiration, and dividend yield. The unit price is based on the publicly traded price of the units as of the measurement date. The Company estimated the volatility for the public and private placement warrants based on the implied volatility from the traded prices of warrants issued by other special purpose acquisition companies. The risk-free interest rate is based on interpolated U.S. Treasury rates, commensurate with a similar term to the public and private placement warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. Finally, the Company does not anticipate paying a dividend. Any changes in these assumptions can change the valuation significantly.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of <br/>December 31, 2021 </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of <br/>August 6, 2021 </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining term (yrs)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.75</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.51</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the fair value of the derivative warrant liabilities, measured using Level 3 inputs, for the period from January 28, 2021 (inception) through December 31, 2021 is summarized as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at January 28, 2021 (inception)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of Public and Private Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,515,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer of Public Warrants to Level 1</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,100,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(630,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6 &#8212; Fair Value</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value hierarchy for its assets and liabilities measured at fair value as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,815&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,815&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has warrants to purchase preferred shares outstanding as of September&#160;30, 2022 and December&#160;31, 2021 representing 225,223 and 225,223 preferred shares, respectively, which warrants expire at various dates through December 31, 2027. The exercise prices of the warrants range from $14.69 to $19.93 as of each of September&#160;30, 2022 and December&#160;31, 2021. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The warrants are accounted for as liabilities in accordance with ASC 480, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distinguishing Liability from Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and are presented within other accrued liabilities on the condensed consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the condensed consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The fair value of the warrants was calculated using the Black-Scholes Option Pricing Model. For the nine months ended September&#160;30, 2022 and 2021, the Company recognized a change in the fair value of liabilities of approximately $(427) and $(699), respectively, on the condensed consolidated statements of operations and comprehensive loss within other (expense) income, net.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the warrants is determined using Level 3 inputs. Inherent in the Black-Scholes Option Pricing Model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its warrants based on implied volatility from the Company&#8217;s warrants and from historical volatility of select peer companies that match the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the weighted average inputs used in calculating the fair value of the preferred share warrants outstanding as of September&#160;30, 2022 and December&#160;31, 2021:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.03&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SAFE Liability and SAFE Warrant</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company issued a SAFE that allowed an investor to participate in future equity financings through a share-settled redemption of the amount invested (such notional being the &#8220;invested amount&#8221;). The SAFE had not yet converted as a qualifying financing had not yet occurred as of September&#160;30, 2022. At September&#160;30, 2022, the SAFE had a fair value of $27,221 and was recorded within current liabilities on the condensed consolidated balance sheet. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, the warrant related to the SAFE of $2,022 as of September&#160;30, 2022 is accounted for as a liability. This liability is recorded in current liabilities on the Company's condensed consolidated balance sheets at fair value on the date of issuance and will be revalued each subsequent reporting period until such instrument is exercised or expires. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in fair value between reporting periods for both the SAFE liability and SAFE warrant is included in other (expense) income, net in the condensed consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s SAFE liability and SAFE warrant are mark-to-market liabilities pursuant to ASC 480 and are classified within Level 3 of the fair value hierarchy as the Company is using a scenario-based approach which allowed the Company to estimate the implied value of the business based on the terms of the SAFE. Significant unobservable inputs included probability and expected term. Probability is based upon the likelihood of the Company closing a transaction with a special purpose acquisition company. The expected term was based on the anticipated time until the SAFE investments would have a conversion event. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE liability fair value measurement at September&#160;30, 2022 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liquidity price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE warrant fair value measurement at September&#160;30, 2022 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining life (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables represents a reconciliation of the contingent shares issuance liabilities fair value measurements using the significant unobservable inputs (Level 3) (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrants</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE warrant</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss / (gain) recognized in condensed statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,050)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,221&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrants</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE warrant</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of SAFE liability and warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss recognized in condensed statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,281&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div>Fair Value<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value hierarchy for its assets and liabilities measured at fair value as of December&#160;31, 2021 and 2020 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:13pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The warrants are accounted for as liabilities in accordance with ASC 480 and are presented within other accrued liabilities on the consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the warrants was calculated using the Black-Scholes Option Pricing Model. For the years ended December&#160;31, 2021 and 2020, the Company recognized a change in the fair value of liabilities of approximately $(563) and $105, respectively, on the statements of operations and comprehensive loss within other income (expense), net.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the warrants is determined using Level 3 inputs. Inherent in the Black-Scholes Option Pricing Model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its warrants based on implied volatility from the Company&#8217;s warrants and from historical volatility of select peer companies that match the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the weighted average inputs used in calculating the fair value of the preferred share warrants outstanding as of December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s SAFE liability and SAFE warrant are mark-to-market liabilities pursuant to ASC 480 and are classified within Level 3 of the fair value hierarchy as the Company is using a scenario-based approach which allowed the Company to estimate the implied value of the business based on the terms of the SAFE. Significant unobservable inputs included probability and expected term. Probability is based upon the likelihood of the Company closing a transaction with a special purpose acquisition company. The expected term was based on the anticipated time until the SAFE investments would have a conversion event. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE liability fair value measurement at December 31, 2021 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liquidity price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE warrant fair value measurement at December 31, 2021 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining life (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents a reconciliation of the contingent shares issuance liabilities fair value measurements using the significant unobservable inputs (Level 3) (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain recognized in statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of SAFE liability and warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss recognized in statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, a warrant was exercised for a total issuance of 158,058 Series D preferred shares. The fair value of this warrant was $107 as of January 1, 2020 and was remeasured to zero as of December 31, 2020. As a result, the exercise had no impact on the consolidated statement of operations and comprehensive loss as of and for the year ended December 31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211107984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10 &#8212; Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal and Connecticut jurisdictions and are subject to examination. The income tax provision consists of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Period from January 28, 2021<br/>(inception) through December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290,181)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s net deferred tax assets are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Start-up/Organization costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">210,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">290,181&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(290,181)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax asset, net of allowance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax assets, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the period from January 28, 2021 (inception) through December 31, 2021, the valuation allowance was $290,181. As of December 31, 2021, the Company had $380,351 of U.S. federal net operating loss carryovers, which do not expire, available to offset future taxable income.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no unrecognized tax benefits as of December 31, 2021. No amounts were accrued for the payment of interest and penalties as of December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company&#8217;s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the statutory federal income tax rate (benefit) to the Company&#8217;s effective tax rate (benefit) is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Period from January 28, 2021 (inception) through December 31, 2021 </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory federal income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative warrant liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(855.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Offering costs allocated to derivative warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div>Income Taxes<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to federal state income taxes in the United States, as well as income taxes in foreign jurisdictions in which it conducts business. The Company does not provide for federal income taxes on the undistributed earnings of its foreign subsidiaries as such earnings are reinvested indefinitely. The Company and its foreign subsidiaries have historically been loss generating entities that have resulted in no excess earnings to consider for repatriation and accordingly there are no deferred income taxes recognized for the nine months ended September&#160;30, 2022 and 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded an income tax expense of $0 for the nine months ended September&#160;30, 2022 and 2021, representing an effective tax rate of 0%. The difference between the U.S. federal statutory rate of 21% and the Company's effective tax rate in the first nine months ended September&#160;30, 2022 is primarily due to a full valuation allowance related to the Company's U.S. deferred tax assets and tax benefits in the Company's foreign jurisdictions. For the first nine months ended September 30, 2021, the Company's effective tax rate was computed based on income tax rate in New Zealand of 28.0% as the Company was still domiciled in New Zealand. The Company reassesses the need for a valuation allowance on a quarterly basis. If it is determined that a portion or all of the valuation allowance is not required, it will generally be a benefit to the income tax provision in the period such determination is made.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts business in multiple jurisdictions within and outside the United States. Consequently, the Company is subject to periodic income tax examinations by domestic and foreign income tax authorities. The Company is subject to audits for tax years 2009 and onward for federal purposes. There are tax years which remain subject to examination in various other state and foreign jurisdictions that are not material to the Company's financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, the Company migrated its country of domicile from New Zealand to Delaware in the United States. On migration, the Company was deemed to have disposed of all its assets and liabilities to a third-party at market value which resulted in taxable income to the Company for New Zealand income tax purposes which was fully offset by net operating loss carryforwards and deferred R&amp;D credits in New Zealand. The migration to Delaware is classified as a tax-free reorganization for U.S. federal income tax purposes.</span></div>Income Taxes<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of (loss) income before income taxes and gain from equity method investees, net are as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,860)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Zealand</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,551)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,651)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,689)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,713)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of income tax expense were as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Zealand</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Zealand</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of income taxes computed at the statutory federal income tax rate (21.0% federal income tax rate in the United States for 2021 and 28.0% federal income tax rate in the New Zealand for </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020, respectively) to the income tax expense (benefit) reflected in the consolidated statement of operations and comprehensive loss (in thousands, except percentages):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit) at the statutory federal income tax rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,805)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,560)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax rate differential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(605)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,068)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,429)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,892)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income on receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(443)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(679)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible legal costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from redomiciliation of intellectual property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPP loan forgiveness</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(644)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(196)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax benefit</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of deferred tax assets and liabilities as of December&#160;31, 2021 and 2020, were as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss and credit carryforwards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,979&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,878&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued bonus</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,881&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,417&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113,276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108,300)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax asset</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,117&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease asset</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,429)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,941)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,605)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,117)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net deferred income tax assets and liabilities:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021 and 2020, the Company had $299,194 and $271,390, respectively, of tax losses and credits carried forward subject to shareholder continuity and acceptance in the countries where the Company has tax losses carried forward. R&amp;D tax credits included within these amounts are $35,147 and $40,556, respectively, which may be available to offset future income tax liabilities. At December&#160;31, 2021 and 2020, the net operating loss and credit carryforwards are comprised of $239,559 and $196,442 in the United States, $22,203 and $18,104 in state and local, $35,116 and $54,334 in New Zealand, and $4,589 and $2,510 in other foreign jurisdictions, respectively. At December&#160;31, 2021 and 2020, the Company had net operating loss carryforwards of approximately $136,454 and $132,373, respectively, that expire in various years from 2022 through 2037, plus $127,593 and $98,462, respectively, for which there is no expiration date. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 382 of the Internal Revenue Code imposes an annual limitation on the utilization of net operating loss carryforwards based on a statutory rate of return and the value of the corporation at the time of a &#8220;change of ownership&#8221; as defined by Section 382. The Company had a change in ownership</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in November 2014. T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">herefore, the Company&#8217;s ability to utilize its net operating loss carryforwards incurred prior to the 2014 ownership change, will be subject in future periods to annual limitations. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In assessing the realizability of deferred tax assets, the Company assesses whether it is more-likely-than-not that a portion or all of the deferred tax assets will not be realized. The Company considers the scheduled reversal of deferred tax liabilities, tax planning strategies and projected future taxable income in making this assessment. At December&#160;31, 2021 and 2020, a valuation allowance of $113,276 and $108,300, respectively, was recorded against certain deferred tax assets based on this assessment. The Company believes it is more-likely-than-not that the tax benefit of the remaining net deferred tax assets will be realized. The amount of net deferred tax assets considered realizable could be increased or reduced in the future if the Company&#8217;s assessment of future taxable income or tax planning strategies changes.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its foreign subsidiaries have historically been loss generating entities that have resulted in no excess earnings to consider for repatriation and accordingly there are no deferred income taxes recognized as of December&#160;31, 2021 and 2020.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021 and 2020, the Company had no tax liability or benefit related to uncertain tax positions. No interest or penalties related to uncertain taxes have been recognized on the accompanying consolidated statements of operations. Management does not expect a significant change in uncertain tax positions during the twelve months subsequent to December 31, 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts business in multiple jurisdictions within and outside the United States. Consequently, the Company is subject to periodic income tax examinations by domestic and foreign income tax authorities. During December 2021, the Internal Revenue Service completed an income tax examination of the Company&#8217;s U.S. federal income tax return for the year ended December 31, 2016, which resulted in no impact to the Company&#8217;s consolidated financial statements. The Company has no other ongoing tax examinations with domestic or foreign taxing authorities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, the Company migrated its country of domicile from New Zealand to Delaware in the United States. On migration, the Company was deemed to have disposed of all its assets and liabilities to a third-party at market value which resulted in taxable income to the Company for New Zealand income tax purposes. The migration to Delaware is classified as a tax-free reorganization for U.S. federal income tax purposes.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211155824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation</a></td>
<td class="text">Share-Based Compensation<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers share option plans to employees, directors, and others providing similar employee-related services, which meet the definition of an equity-settled share-based payment.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has five ownership-based participation rights schemes for employees, directors, and certain third-party providers. In accordance with the provisions of the schemes, as approved by the directors and shareholders, grantees have been granted options to purchase common shares at an exercise price based on the fair value price of the Company&#8217;s common shares on the date of grant as approved by the directors. The stock options generally have a service condition of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzEyNjQ0MzgzNzI0Mzkx_1f5323c0-bbe0-45e6-bfd6-3ba4780f1116">two</span> to five years and vest over time as the service condition is being satisfied. Upon termination of employment, unvested stock options are evaluated for forfeiture or modifications, subject to the terms of the awards and Company's policies.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option awards outstanding as of September&#160;30, 2022 and changes during the period ended September&#160;30, 2022 were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares under option (thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average remaining contractual term (years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate intrinsic value (thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,848&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.16</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,796&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expecting to vest at January 1, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.16</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.85</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,806&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.39</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,032&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expecting to vest at September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.39</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.56</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded compensation expense of $2,067 and $1,790 for the nine months ended September&#160;30, 2022 and September&#160;30, 2021, respectively. Unrecognized compensation costs as of September&#160;30, 2022 was $3,835 and will be recognized over a weighted average of 2.27 years. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Awards (&#8220;RSAs&#8221;)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSAs become eligible to vest upon the satisfaction of a time-based service condition. However, in order to vest, a liquidity event, defined as acquisition, asset transfer, or initial listing, must occur within 10 years from the grant date. Upon a liquidity event, if the participant&#8217;s service has not terminated, the entire RSA award vests in full, whether or not previously eligible for vesting. If the participant&#8217;s service has terminated and they have satisfied the time-based service condition, the RSAs that are outstanding and eligible for vesting shall immediately vest in full. The time-based service requirements of the RSAs have a maximum term of three years from the date of grant.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, there were 579,660 outstanding unvested shares for a weighted average fair value of $4.72. There were no changes during the nine months ended September&#160;30, 2022.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, and September&#160;30, 2021 the Company concluded that the liquidity event performance condition described above for the RSAs was not probable of being satisfied at such time. As a result, the Company did not recognize any compensation cost during the nine months ended September&#160;30, 2022 and September&#160;30, 2021 for any RSAs granted.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div>Stock-Based Compensation<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers share option plans to employees, directors, and others providing consulting services, which meet the definition of an equity-settled stock-based payment.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has five ownership-based participation rights schemes for employees, directors, and certain third-party providers. In accordance with the provisions of the schemes, as approved by the directors and shareholders, grantees have been granted options to purchase common shares at an exercise price based on the fair value price of the Company&#8217;s common shares on the date of grant as approved by the directors. The stock options generally have a service condition of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEwOTk1MTE2Mjg0Mzgw_848b9b44-6118-41f1-9447-548b3ddf83fb">two</span> to five years and vest over time as the service condition is being satisfied. In November 2020, the Company granted 151,068 options which have a performance condition that accelerates vesting on liquidity event. All stock options have a term of 10 years from the date of grant. Upon termination of employment, unvested stock options are evaluated for forfeiture or modifications, subject to the terms of the awards and Company's policies.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option awards outstanding as of December&#160;31, 2021 and changes during the year ended December&#160;31, 2021 were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares under option (thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average remaining contractual term (years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate intrinsic value (thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at January 1, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,283&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.09</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expecting to vest at January 1, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.09</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable at January 1, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.47</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(721)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited/expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(334)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,848&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.16</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,796&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expecting to vest at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.16</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable at December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.85</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded compensation expense of $2,531 and $2,392 for the years ended December&#160;31, 2021 and 2020, respectively. Unrecognized compensation costs as of December&#160;31, 2021 was $6,120 and will be recognized over a weighted average of 2.7 years. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each stock option award was estimated on each grant date using the Black-Scholes option pricing model. The following assumptions were used and required significant judgment to determine:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Expected Term</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; the Company used the &#8220;simplified method&#8221; for estimating the expected term of plain-vanilla options, whereby the expected term equals the arithmetic average of the vesting term and LanzaTech&#8217;s contractual term of the option. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Risk-Free Interest Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The risk-free interest rate is based on the U.S. Treasury zero-coupon instruments with maturities similar to the expected term of LanzaTech&#8217;s stock options. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Expected Dividend</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; the expected dividend yield is based on the Company's expectation of future dividend payouts to common stockholders. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Expected Volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Due to the Company's limited historical data, a group of similar companies that are publicly traded was used to estimate the expected volatility. The historical volatility data was computed using the daily closing prices for the various companies' shares during the equivalent period of the calculated expected term of the stock-based awards.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the weighted-average assumptions applied in the Black-Scholes valuation of options for awards subject to expense recognition for the first time in the period, for the years ended December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant date fair value of options granted during 2021 and 2020 was $6.29 and $3.99 per option, respectively.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Awards (&#8220;RSAs&#8221;)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSAs become eligible to vest upon the satisfaction of a time-based service condition. However, in order to vest, a liquidity event, defined as acquisition, asset transfer, or initial listing, must occur within 10 years from the grant date. Upon a liquidity event, if the participant&#8217;s service has not terminated, the entire RSA award vests in full, whether or not previously eligible for vesting. If the participant&#8217;s service has terminated and they have satisfied the time-based service condition, the RSAs that are outstanding and eligible for vesting shall immediately vest in full. The time-based service requirements of the RSAs have a maximum term of three years from the date of grant.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSAs as of December&#160;31, 2021 and changes during the year ended December&#160;31, 2021 were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nonvested Shares (thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at January 1, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.76&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.72&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, the Company concluded that the liquidity event performance condition described above for the RSAs was not probable of being satisfied at such time. As a result, the Company did not recognize any compensation cost during the years ended December&#160;31, 2021 and 2020 for any RSAs granted.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211107984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4 &#8212; Related Party Transactions</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Founder Shares</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2021, the Sponsor paid $25,000, or approximately $0.005 per share, to cover certain offering costs in consideration for 5,031,250 shares of Class B common stock, par value $0.0001. In March 2021, the Sponsor transferred all of the founder shares it held to members of the Company&#8217;s board of directors, management </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">team, and persons or entities affiliated with AMCI Group (the &#8220;initial shareholders&#8221;). Such shares were fully paid. On May 14, 2021, the Sponsor surrendered 718,750 founder shares to the Company for no consideration, resulting in the Sponsor owning 4,312,500 founder shares. Up to 562,500 of the founder shares will be forfeited depending on the extent to which the underwriters&#8217; over-allotment is exercised. On September 17, 2021, the over-allotment option expired unexercised, resulting in 562,500 of the founder shares being forfeited.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In exchange for the Anchor Investors&#8217; participation in the initial public offering as described in Note 3, the Sponsor sold a total of 780,000 founder shares to the Anchor Investors. The Company determined that the fair value of these founder shares was approximately $6.5 million (or approximately $8.35 per share) using a Monte Carlo simulation. The Company recognized the excess fair value of these founder shares, over the price sold to the Anchor Investors, as an expense of the initial public offering resulting in a charge against the carrying value of Class A common stock subject to possible redemption.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial stockholders have agreed not to transfer, assign or sell any of their founder shares and any Class A common stocks issuable upon conversion thereof until the earlier to occur of: (A) one year after the completion of the initial business combination and (B) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction after the Company&#8217;s initial business combination that results in all of the Company&#8217;s stockholders having the right to exchange their Class A common stock for cash, securities or other property; except to certain permitted transferees and under certain circumstances (the &#8220;Lock-up&#8221;). Any permitted transferees will be subject to the same restrictions and other agreements of the company&#8217;s initial stockholders with respect to any founder shares. Notwithstanding the foregoing, the founder shares will be released from the Lock-up if the closing price of the Company&#8217;s Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the company&#8217;s initial business combination.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Private Placement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Simultaneously with the closing of the initial public offering, the Company&#8217;s Sponsor has purchased an aggregate of 3,500,000 private placement warrants, each exercisable to purchase one Class A common stock at $11.50 per share, at a price of $1.00 per warrant, or $3,500,000 in the aggregate.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The private placement warrants will not be redeemable by the Company so long as they are held by the initial purchasers or their permitted transferees. The initial purchasers, or their permitted transferees, have the option to exercise the private placement warrants on a cashless basis. If the private placement warrants are held by holders other than initial purchasers or their permitted transferees, the private placement warrants will be redeemable by the Company and exercisable by the holders on the same basis as the warrants included in the units being sold in the initial public offering. Otherwise, the private placement warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in the initial public offering.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the private placement warrants are held by holders other than the Sponsor or its permitted transferees, the private placement warrants will be redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the units being sold in the initial public offering.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Loans and Advances</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2021, the Sponsor agreed to loan the Company up to $300,000 to be used for a portion of the expenses of the initial public offering (&#8220;Note&#8221;). This loan was non-interest bearing, unsecured and payable upon the closing of the initial public offering. In addition to the Note, the Sponsor of the Company also paid certain administrative expenses and offering costs on behalf of the Company. These advances were due on demand and were non-interest bearing. The Company repaid the note payable and advances in exchange for the issuance of private placement warrants.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Working Capital Loans</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in order to finance transaction costs in connection with an intended business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#8217;s officers and directors may, but are not obligated </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to, loan the Company funds as may be required on a non-interest basis (&#8220;Working Capital Loans&#8221;). If the Company completes the initial business combination, it will repay the Working Capital Loans. In the event that the initial business combination does not close, the Company may use a portion of the working capital held outside the trust account to repay the Working Capital Loans but no proceeds from the trust account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-business combination entity at a price of $1.00 per warrant at the option of the lender. Such warrants would be identical to the private placement warrants. Except as set forth above, the terms of Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. On March 28, 2022, the Company entered into a noninterest-bearing Working Capital Loan with its Sponsor for the principal amount of up to $1.5 million. As of September 30, 2022 and December 31, 2021, the Company had no borrowings under the Working Capital Loans.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Administrative Service Fee</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the closing of the initial public offering, the Company will pay its Sponsor $10,000 per month for office space, secretarial and administrative services provided to members of the management team. Upon completion of the initial business combination or the Company&#8217;s liquidation, the Company will cease paying these monthly fees. For the three months ended September 30, 2022 and 2021, the Company incurred $30,000 and $20,000, respectively, of such fees, included as general and administrative fees &#8212; related party on the accompanying unaudited condensed statements of operations. For the nine months ended September 30, 2022 and for the period from January 28, 2021 (inception) through September 30, 2021, the Company incurred $90,000 and $20,000, respectively, of such fees, included as general and administrative fees &#8212; related party on the accompanying unaudited condensed statements of operations. As of September 30, 2022 and December 31, 2021, approximately $90,000 and $50,000, respectively, of such fees were included in due to related party on the accompanying condensed balance sheets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sponsor, officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on the Company&#8217;s behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. The Company&#8217;s audit committee will review on a quarterly basis all payments that were made by the Company to the Sponsor, directors, officers or directors of the Company, or any of their affiliates. As of September 30, 2022 and December 31, 2021, there were approximately $596,000 and $0, respectively, of such fees included as due to related party on the accompanying condensed balance sheets.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4 &#8212; Related Party Transactions</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Founder Shares</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2021, the Sponsor paid $25,000, or approximately $0.005 per share, to cover certain offering costs in consideration for 5,031,250 shares of Class B common stock, par value $0.0001. In March 2021, the Sponsor transferred all of the founder shares it held to members of the Company&#8217;s board of directors, management team, and persons or entities affiliated with AMCI Group (the &#8220;initial shareholders&#8221;). Such shares were fully paid. On May 14, 2021, the Sponsor surrendered 718,750 founder shares to the Company for no consideration, resulting in the Sponsor owning 4,312,500 founder shares. Up to 562,500 of the founder shares will be forfeited depending on the extent to which the underwriters&#8217; over-allotment is exercised. On September 17, 2021, the over-allotment option expired unexercised, resulting in 562,500 of the founder shares being forfeited.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In exchange for the Anchor Investors&#8217; participation in the initial public offering as described in Note 3, the Sponsor sold a total of 780,000 founder shares to the Anchor Investors. The Company determined that the fair value of these founder shares was approximately $6.5 million (or approximately $8.35 per share) using a Monte Carlo simulation. The Company recognized the excess fair value of these founder shares, over the price sold to the Anchor Investors, as an expense of the initial public offering resulting in a charge against the carrying value of Class A common stock subject to possible redemption.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial stockholders have agreed not to transfer, assign or sell any of their founder shares and any Class A common stocks issuable upon conversion thereof until the earlier to occur of: (A) one year after the completion of the initial business combination and (B) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction after the Company&#8217;s initial business combination that results in all of the Company&#8217;s stockholders having the right to exchange their Class A common stock for cash, securities or other property; except to certain permitted transferees and under certain circumstances (the &#8220;Lock-up&#8221;). Any permitted transferees will be subject to the same restrictions and other agreements of the company&#8217;s initial stockholders with respect to any founder shares. Notwithstanding the foregoing, the founder shares will be released from the Lock-up if the closing price of the Company&#8217;s Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the company&#8217;s initial business combination.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Private Placement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Simultaneously with the closing of the initial public offering, the Company&#8217;s Sponsor has purchased an aggregate of 3,500,000 private placement warrants, each exercisable to purchase one Class A common stock at $11.50 per share, at a price of $1.00 per warrant, or $3,500,000 in the aggregate.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The private placement warrants will not be redeemable by the Company so long as they are held by the initial purchasers or their permitted transferees. The initial purchasers, or their permitted transferees, have the option to exercise the private placement warrants on a cashless basis. If the private placement warrants are held by holders other than initial purchasers or their permitted transferees, the private placement warrants will be redeemable by the Company and exercisable by the holders on the same basis as the warrants included in the units being sold in the initial public offering. Otherwise, the private placement warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in the initial public offering.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the private placement warrants are held by holders other than the Sponsor or its permitted transferees, the private placement warrants will be redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the units being sold in the initial public offering.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Loans and Advances</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2021, the Sponsor agreed to loan the Company up to $300,000 to be used for a portion of the expenses of the initial public offering (&#8220;Note&#8221;). This loan was non-interest bearing, unsecured and payable upon the closing of the initial public offering. In addition to the Note, the Sponsor of the Company also paid certain administrative expenses and offering costs on behalf of the Company. These advances were due on demand and were non-interest bearing. The Company repaid the note payable and advances in exchange for the issuance of private placement warrants.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in order to finance transaction costs in connection with an intended business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#8217;s officers and directors may, but are not obligated to, loan the Company funds as may be required on a non-interest basis (&#8220;Working Capital Loans&#8221;). If the Company completes the initial business combination, it will repay the Working Capital Loans. In the event that the initial business combination does not close, the Company may use a portion of the working capital held outside the trust account to repay the Working Capital Loans but no proceeds from the trust account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-business combination entity at a price of $1.00 per warrant at the option of the lender. Such warrants would be identical to the private placement warrants. Except as set forth above, the terms of Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of December 31, 2021, the Company had no borrowings under the Working Capital Loans.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Administrative Service Fee</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the closing of the initial public offering, the Company will pay its Sponsor $10,000 per month for office space, secretarial and administrative services provided to members of the management team. Upon completion of the initial business combination or the Company&#8217;s liquidation, the Company will cease paying these monthly fees. For the period from January 28, 2021 (inception) through December 31, 2021, the Company incurred $50,000 of such fees, included as general and administrative fees &#8212; related party on the accompanying statement of operations. As of December 31, 2021, approximately $50,000 of such fees are included as due to related party on the accompanying balance sheet.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9 &#8212; Related Party Transactions</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021, the Company had an equity ownership in LanzaJet and SGLT with an aggregate carrying value of $26,037 and $24,752, respectively. The table below summarizes amounts related to transactions with these related parties (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,116&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,509&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases and open accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounts payable balance is for work that LanzaJet performed as a subcontractor to the Company. Refer to Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for more information. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the formation of LanzaJet, the Company entered into a transition services agreement with LanzaJet. The transition services agreement generally sets out the respective rights, responsibilities and obligations of the Company and LanzaJet with respect to R&amp;D services, access to office and laboratory space, business development and other administrative support services. The transition services agreement may be terminated by mutual consent of the Company and LanzaJet, by LanzaJet at any time, and by the Company upon breach or non-payment by LanzaJet. There are no substantive termination penalties in the event the Company terminates. For the nine months ended September&#160;30, 2022 and September&#160;30, 2021, the Company recognized revenue from related parties of approximately $148 and $355, respectively, under the transition services agreement. The Company also provides certain engineering and other services related to a gas-to-jet demonstration plant currently in development by LanzaJet pursuant to the Investment Agreement described in Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In connection with these services, the Company recognized revenue from LanzaJet of approximately $170 and $403, for the nine months ended September&#160;30, 2022 and September&#160;30, 2021, respectively. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, the Company executed an agreement to lease certain land to a subsidiary of LanzaJet for a period of 10 years with an option to renew this lease for five additional periods of one year with minimum annual rent due to the Company of $24. The lease commenced upon execution of the lease agreement and was subsequently amended in 2022 to extend the Pre-Development Term and annual rent amount. Refer to Note 12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for more information.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company supplies SGLT with certain water-soluble organic compounds required in the Company's proprietary gas fermentation process, and small-size equipment. As a result, for the nine months ended September&#160;30, 2022 and September&#160;30, 2021, the Company recognized revenue from related parties of approximately $151 and $69, respectively. The Company also provided engineering services and incurred costs of $$893 and $1,171 for the nine months ended September&#160;30, 2022 and September&#160;30, 2021, respectively. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, LanzaTech and SGLT entered into a license agreement in 2019, subsequently amended in 2021, to provide SGLT with the right to sublicense the intellectual property that LanzaTech previously licensed to SGLT. In exchange, the Company is entitled to receive licensing consideration, calculated as a percentage of the royalties received by SGLT from the sublicenses. Currently, SGLT sublicenses to certain of its subsidiaries that use LanzaTech's proprietary technology. The royalties received by SGLT are based on sales-and-usage of the sublicensed technology. For the nine months ended September&#160;30, 2022, and September&#160;30, 2021, the Company did not earn any sublicensing revenue as no royalties were received by SGLT.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div>Related Party Transactions<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, the Company had an equity ownership in LanzaJet and SGLT with an aggregate carrying value of $24,752 and $23,217, respectively. Trade receivables and contract assets of $1,071 and $3,257, from these equity method investees are included in accounts receivable, respectively. The Company made purchases and had open accounts payable of $2,575 as of and for the year ended December&#160;31, 2021. The accounts payable balance is for work that LanzaJet performed as a subcontractor to the Company. Refer to Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s, for more information.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the formation of LanzaJet, the Company entered into a transition services agreement with LanzaJet. The transition services agreement generally sets out the respective rights, responsibilities and obligations of the Company and LanzaJet with respect to R&amp;D services, business development and other administrative support services. The transition services agreement may be terminated by mutual consent of the Company and LanzaJet, by LanzaJet at any time, and by the Company upon breach or non-payment by LanzaJet. There are no substantive termination penalties in the event the Company terminates. During the years ended December&#160;31, 2021 and 2020, the Company recognized revenue from related parties of approximately $495 and $285, respectively, under the transition services agreement. The Company provides certain engineering and other services related to a gas-to-jet demonstration plant currently in development by LanzaJet pursuant to the Investment Agreement described in Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As a result, during the years ended December&#160;31, 2021 and 2020, the Company recognized revenue from related parties of approximately $428 and $2,740, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company supplies SGLT with its biocatalyst, certain water-soluble organic compounds required in the Company's proprietary gas fermentation process, and small-size equipment. As a result, during 2021 and 2020 the Company recognized revenue from related parties of approximately $282 and $156, respectively. The Company also provided engineering services and incurred costs of $1,223 and $242 during the years ended December&#160;31, 2021 and 2020, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, LanzaTech and SGLT entered into a license agreement in 2019, subsequently amended in 2021, to provide SGLT with the right to sublicense the intellectual property that LanzaTech previously licensed to SGLT. In </span></div>exchange, the Company is entitled to receive licensing consideration, calculated as a percentage of the royalties received by SGLT from the sublicenses. Currently, SGLT sublicenses to certain of its subsidiaries that use LanzaTech's proprietary technology. The royalties to be received by SGLT are based on sales-and-usage of the sublicensed technology. For the years ended December&#160;31, 2021 and 2020, the Company did not earn any sublicensing revenue as no royalties were received by SGLT.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211080816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable, Convertible Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityDisclosureTextBlock', window );">Redeemable, Convertible Preferred Stock</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6 &#8212; Class A Common Stock Subject to Possible Redemption</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of future events. The Company is authorized to issue 280,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of the Company&#8217;s Class A common stock are entitled to one vote for each share. As of September 30, 2022 and December 31, 2021, there were 15,000,000 shares of Class A common stock outstanding subject to possible redemption and are classified outside of permanent equity in the condensed balance sheets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Class A common stock subject to possible redemption reflected on the condensed balance sheets is reconciled in the following table:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross proceeds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount allocated to public warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,100,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,306,092)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of carrying value to redemption value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,406,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock subject to possible redemption, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subsequent remeasurement of Class A common stock subject to possible redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock subject to possible redemption, September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,293,649&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6 &#8212; Class A Common Stock Subject to Possible Redemption</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of future events. The Company is authorized to issue 280,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of the Company&#8217;s Class A common stock are entitled to one vote for each share. As of December 31, 2021, there were 15,000,000 shares of Class A common stock outstanding subject to possible redemption and are classified outside of permanent equity in the balance sheet.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Class A common stock subject to possible redemption reflected on the balance sheet is reconciled in the following table:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross proceeds from Initial Public Offering</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of Public Warrants at issuance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,100,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Offering costs allocated to Class A common stock subject to possible redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,306,092)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion on Class A common stock subject to possible redemption amount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,406,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock subject to possible redemption</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Redeemable, Convertible Preferred Stock<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has six outstanding series of contingently redeemable convertible preferred stock. The authorized, issued and outstanding shares, issue price, and carrying value as of September&#160;30, 2022, are as follows (in thousands, except share and per share amounts):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.287%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares Authorized</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.75 - 3.94</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,254,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.69</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,274,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,161,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.93</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series F</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,747,033&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,631&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in redeemable convertible preferred stock issued and outstanding during the nine months ended September&#160;30, 2022. The holders of preferred shares are entitled to receive dividends on an as converted to common shares basis as if all preferred shares had been converted into common shares on the date of such event. Dividends are cumulative and are payable in arrears at the rate of 8% of the original issue price.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, a warrant was exercised for a total issuance of 158,058 Series D preferred shares which led to an increase in redeemable convertible preferred stock of $3,150 during the nine months ended September&#160;30, 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redemption features of preferred shares are not fixed and do not have a determinable price on fixed or determinable dates. As of September&#160;30, 2022, the preferred shares are not currently redeemable, and it is not probable that the preferred shares will become redeemable, since it is uncertain whether or when circumstances exist that would constitute a deemed liquidation event. Accordingly, the Company has not adjusted the carrying value of the preferred shares to their redemption values.</span></div>Redeemable, Convertible Preferred Stock<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has six outstanding series of contingently redeemable convertible preferred stock. The authorized, issued and outstanding shares, issue price, and carrying value as of December&#160;31, 2021 and 2020 are as follows (in thousands, except share and per share amounts):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares Authorized</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.75 - 3.94</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,254,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.69</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,274,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,161,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.93</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series F</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,747,033&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,631&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares Authorized</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Issue Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.75 - 3.94</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,254,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,142,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,274,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,003,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">185,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,112,823&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,729,542&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">394,408&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable convertible preferred stock issued and outstanding as of December&#160;31, 2021 and 2020, and changes during the years ended December&#160;31, 2021 and 2020, were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.874%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.508%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.470%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.310%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="81" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Redeemable Convertible Preferred Stock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series B</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series C</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series D</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series E</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series F</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10,003,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">185,252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,149,745&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">71,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">23,695,330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">347,938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Preferred stock issuance, net of costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,034,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">46,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,034,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">46,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10,003,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">185,252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">25,729,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">394,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Preferred stock issuance, net of costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">158,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,792,268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">86,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10,161,362&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">188,402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">480,631&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records all preferred shares net of offering costs at their respective fair values on the dates of issuance. The preferred shares are classified outside of shareholders&#8217; (deficit) equity in the consolidated financial statements, as the preferred shares are redeemable under circumstances that qualify as a deemed liquidation event, which are outside the control of the Company. Upon the occurrence of a liquidation event, such as a voluntary or involuntary liquidation, dissolution or winding up of the Company, merger, consolidation, or change in control, the holders of Series E preferred stock are entitled, on a pari passu basis, to be paid out of the assets of the Company available for distribution before any payment is made to the holders of Series A, B, C, and D preferred shares and then to holders of common shares. In February 2020, the Company closed a Series E follow-on round with the issuance of 2,034,212 Series E preferred shares for net proceeds of $46,470 ($22.86 per share). In March 2021, a warrant was exercised for a total issuance of 158,058 Series D preferred shares and net proceeds of $3,150 ($19.93 per share). In April 2021, the Company closed a Series F round with the issuance of 3,634,210 Series F preferred shares for the net proceeds of $83,073 ($22.86 per share).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of preferred shares are entitled to cast the number of votes equal to the number of whole common shares into which the preferred shares are convertible. The holders of preferred shares also have consent rights, including in a number of cases subject to a separate class vote and a supermajority requirement, over certain actions including, among others (i) alterations or changes to the terms of the preferred shares, (ii) the election of a certain number of directors, including the designation of directors by holders of a specified series of preferred shares or by certain specified individual stockholders, and (iii) repurchases of shares, the authorization or designation of more senior class or series of shares, or certain issuances of new shares.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preferred shares are convertible at the holder&#8217;s option into common shares generally on a share-for-share basis. Each preferred share will be automatically converted into common stock upon either (i) the determination of the holders of certain requisite preferred shares or (ii) a firmly underwritten initial public offering of the Company&#8217;s shares that satisfies certain requirements (but not, for the avoidance of doubt, upon a business combination with a special purpose acquisition company, unless such conversion is otherwise effected pursuant to clause (i) above).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of preferred shares are entitled to receive dividends on an as converted to common shares basis as if all preferred shares had been converted into common shares on the date of such event. Dividends are cumulative and are payable in arrears at the rate of 8% of the original issue price. If dividends are payable on common shares, preferred shareholders also receive those dividends as if the preferred shares had been converted to common shares. Series D, E, and F preferred shareholders are entitled to be paid dividends prior to Series A, B, and C, on a pari passu basis. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redemption features of preferred shares are not fixed and do not have a determinable price on fixed or determinable dates. As of December&#160;31, 2021 and 2020, preferred shares are not currently redeemable, and it is not probable that preferred shares will become redeemable, since it is uncertain whether or when circumstances exist </span></div>that would constitute a deemed liquidation event. Accordingly, the Company has not adjusted the carrying value of the preferred shares to their redemption values.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TemporaryEquityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure on temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TemporaryEquityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211153312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5 &#8212; Commitments and Contingencies</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Registration Rights</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of the (i) founder shares, which were issued in a private placement prior to the closing of the initial public offering, (ii) private placement warrants, which were issued in a private placement simultaneously with the closing of the initial public offering and the shares of Class A common stock underlying such private placement warrants and (iii) private placement warrants that may be issued upon conversion of Working Capital Loans will have registration rights to require the Company to register a sale of any of its securities held by them prior to the consummation of the initial business combination pursuant to a registration rights agreement to be signed prior to or on the effective date of the initial public offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent to the Company&#8217;s completion of its initial business combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. In addition, the Anchor Investors will, upon receipt of their founder shares, execute a registration rights agreement with respect to their founder shares.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Underwriting Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted the underwriters a 45-day option from the date of the underwriting agreement to purchase up to an additional 2,250,000 units to cover over-allotments, if any. On September 17, 2021, the over-allotment option expired unexercised, resulting in the forfeiture of 562,500 shares of founder shares. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters were paid an underwriting discount of one percent (1%) of the gross proceeds of the initial public offering, or $1,500,000. Additionally, in connection with the initial public offering, the Company agreed to pay the underwriters a deferred underwriting fee of 3.5% of the gross proceeds, or $5,250,000, of the initial public offering upon the completion of the Company&#8217;s initial business combination. On September 29, 2022, as discussed further below, Evercore Group L.L.C., (&#8220;Evercore&#8221;) the representative of the underwriters of the initial public offering, waived its deferred underwriting fee that accrued from its participation in the initial public offering. The Company recognized approximately $4.9 million of the commissions waiver as a reduction to additional paid-in capital in the condensed statements of changes in stockholders&#8217; deficit for the three and nine months ended September 30, 2022, as this portion represents an extinguishment of deferred underwriting commissions on public shares which was originally recognized in accumulated deficit. The remaining balance of approximately $172,000 is recognized as a gain from extinguishment of deferred underwriting commissions on public warrants in the condensed statements of operations, which represents the original amount expensed in the Company&#8217;s initial public offering.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 27, 2022 and September 29, 2022, the Company received notice and a formal letter, respectively, from Evercore Group, L.L.C., an underwriter in the Company&#8217;s initial public offering, advising that it had, among other things, (i) resigned from and ceased or refused to act in, its roles as co-placement agent, co-capital markets advisor and exclusive financial advisor to the Company in connection with the Merger and as underwriter in the Company&#8217;s initial public offering and (ii) waived its right to receive an aggregate of $13,050,000 in fees, all of which were contingent upon and payable upon the closing of the Merger, consisting of $500,000 for its role as co-placement agent, $7,500,000 for its role as exclusive financial advisor and $5,050,000 of deferred underwriting fees accrued from its participation in the Company&#8217;s initial public offering, as well as any expense reimbursements owed to it under those arrangements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5 &#8212; Commitments and Contingencies</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Registration Rights</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of the (i) founder shares, which were issued in a private placement prior to the closing of the initial public offering, (ii) private placement warrants, which were issued in a private placement simultaneously with the closing of the initial public offering and the shares of Class A common stock underlying such private placement </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">warrants and (iii) private placement warrants that may be issued upon conversion of Working Capital Loans will have registration rights to require the Company to register a sale of any of its securities held by them prior to the consummation of the initial business combination pursuant to a registration rights agreement to be signed prior to or on the effective date of the initial public offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent to the Company&#8217;s completion of its initial business combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. In addition, the Anchor Investors will, upon receipt of their founder shares, execute a registration rights agreement with respect to their founder shares.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Underwriting Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted the underwriters a 45-day option from the date of the underwriting agreement to purchase up to an additional 2,250,000 units to cover over-allotments, if any. On September 17, 2021, the over-allotment option expired unexercised, resulting in the forfeiture of 562,500 shares of founder shares.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters were paid an underwriting discount of one percent (1%) of the gross proceeds of the initial public offering, or $1,500,000. Additionally, the underwriters will be entitled to a deferred underwriting discount of 3.5% of the gross proceeds, or $5,250,000, of the initial public offering upon the completion of the Company&#8217;s initial business combination.</span></div>Commitments and Contingencies<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may be involved in legal proceedings and exposed to potential claims in the normal course of business. As of September&#160;30, 2022 and December&#160;31, 2021, the Company does not have any reasonable possible or probable losses from such claims. </span></div>Commitments and ContingenciesLitigationThe Company may be involved in legal proceedings and exposed to potential claims in the normal course of business. As of December 31, 2021 and December 31, 2020, it is not probable that the Company has incurred any losses from such claims.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211289056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock', window );">Leases</a></td>
<td class="text">Leases <div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, the Company executed an agreement to lease certain land to a subsidiary of LanzaJet for a period of 10 years with an option to renew this lease for five additional periods of one year with minimum annual rent due. This agreement is accounted for as an operating lease. In February 2022, the lease agreement with LanzaJet was amended to extend the pre-development term of the lease until the earlier of commencement of construction of the alcohol-to-jet fuel facility on the leased land or December 31, 2023 and increased the annual base rent amount. The Company recognizes lease revenue on a straight-line basis over the life of the lease agreement. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents amounts included in Revenue from related party transactions in the Condensed Consolidated Statement of Operations related to lessor activity (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease income from operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Leases <div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases certain office space and laboratory facilities. The Company&#8217;s lease agreements typically do not contain any significant guarantees of asset values at the end of a lease, renewal options or restrictive covenants. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s adoption of ASC 842, Leases, all leases were classified as operating leases. During </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021 and 2020, t</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he discount rate used in the calculation of lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was 7.5%, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which is the estimate of the rate of interest that the Company would have to pay to borrow on a collateralized basis over a similar term.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating lease costs and variable lease costs for the years ended December&#160;31, 2021 and 2020 were $2,126 and $2,077 and $2,575 and $1,813, respectively. Cash paid for amounts included in the measurement of operating lease liabilities for the years ended December&#160;31, 2021 and 2020 was $2,059 and $1,765, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, lease payments for operating leases for the Company&#8217;s office facility and laboratories are shown below (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.279%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,818&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,333&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of weighted average remaining lease term and discount rate for all of the Company&#8217;s operating leases:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor Accounting</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, the Company executed an agreement to lease certain land to a subsidiary of LanzaJet for a period of 10 years with an option to renew this lease for five additional periods of one year with minimum annual rent due. This agreement is accounted for as an operating lease. We recognize lease revenue on a straight-line basis over the life of the lease agreement. The following future minimum lease payments due to us from the lease agreement at December 31, 2021, is as follows (in thousands)</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Lease revenue totaled $24 and $14 for the years ended December 31, 2021 and 2020.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for lessor's operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888252<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesOfLessorDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211163936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10 &#8212; Subsequent Events</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 18, 2022, the Company entered into additional subscription agreements (the &#8220;Subscription Agreements&#8221;) with certain accredited investors (collectively, the &#8220;Additional PIPE Investors&#8221;), pursuant to which, among other things, the Company agreed to issue and sell, in a private placement to close immediately prior to the closing of the Merger, an aggregate of 5,500,000 shares of Class A common stock at a purchase price of $10.00 per share to the Additional PIPE Investors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated subsequent events and transactions that occurred up to the date the unaudited condensed financial statements were issued. Based upon this review and except in the case of the foregoing, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11 &#8212; Subsequent Events</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated subsequent events and transactions that occurred up to the date financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2022, the Company entered into the Merger Agreement with Merger Sub and LanzaTech. The transactions contemplated by the Merger Agreement are referred to herein as the &#8220;Business Combination.&#8221; The time of the closing of the Business Combination is referred to herein as the &#8220;Closing.&#8221; The date of the Closing of the Business Combination is referred to herein as the &#8220;Closing Date.&#8221;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposed Business Combination</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Business Combination is approved by the Company&#8217;s stockholders and LanzaTech&#8217;s stockholders, and the closing conditions in the Merger Agreement are satisfied or waived, then, among other things, upon the terms and subject to the conditions of the Merger Agreement and in accordance with Delaware General Corporation Law, Merger Sub will merge with and into LanzaTech, with LanzaTech surviving the merger as the Company&#8217;s wholly owned subsidiary (the &#8220;Merger&#8221;). In connection with the consummation of the Merger, the Company will be renamed &#8220;LanzaTech Global, Inc.&#8221; and is referred to herein as &#8220;New LanzaTech&#8221; as of the time following such change of name.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Merger Agreement, the Company has agreed to acquire all of the outstanding equity interests of LanzaTech for consideration consisting of equity interests of New LanzaTech valued at $1,817,000,000 in the aggregate. The consideration to be paid to holders of shares of LanzaTech capital stock will be shares of common stock of New LanzaTech (&#8220;New LanzaTech Common Stock&#8221;), valued at $10.00 per share, to be paid at the closing of the Merger. The number of shares of New LanzaTech Common Stock payable in the Merger in respect of each share of LanzaTech capital stock (each, a &#8220;LanzaTech Share&#8221;) will be determined based on the exchange ratio (the &#8220;Exchange Ratio&#8221;), and certain corresponding adjustments, in each case as set forth in the Merger Agreement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, at Closing: (i) each warrant to purchase LanzaTech Shares (each, a &#8220;LanzaTech Warrant&#8221;) that is outstanding and unexercised immediately prior to Closing and would automatically be exercised or exchanged in full in accordance with its terms by virtue of the occurrence of the Merger, will be so automatically exercised or exchanged in full for the applicable LanzaTech Shares, and each such LanzaTech Share will be treated as being issued and outstanding immediately prior to Closing and will be canceled and converted into the right to receive the applicable shares of New LanzaTech Common Stock; and (ii) each LanzaTech Warrant that </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is outstanding and unexercised immediately prior to the Closing and is not automatically exercised in full as described in clause (i) will be converted into a warrant to purchase shares of New LanzaTech Common Stock, in which case (a) the number of shares underlying such New LanzaTech warrant (each, a &#8220;New LanzaTech Warrant&#8221;) will be determined by multiplying the number of LanzaTech Shares subject to such warrant immediately prior to Closing, by the Exchange Ratio and (b) the per share exercise price of such New LanzaTech Warrant will be determined by dividing the per share exercise price of such LanzaTech Warrant immediately prior to the Effective Time by the Exchange Ratio, except that in the case of certain warrants specified in the Merger Agreement, such exercise price will be $10.00.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, at Closing, each option to purchase LanzaTech Shares (each, a &#8220;LanzaTech Option&#8221;) will be converted into an option to purchase a number of shares of New LanzaTech Common Stock (rounded down to the nearest whole share) equal to the product of (i) the number of LanzaTech Shares subject to such LanzaTech Option multiplied by (ii) the Exchange Ratio. The exercise price of such New LanzaTech option will be equal to the quotient of (a) the exercise price per share of such LanzaTech Option in effect immediately prior to the Effective Time divided by (b) the Exchange Ratio (and as so determined, this exercise price will be rounded up to the nearest full cent).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, at Closing, each award of restricted shares of LanzaTech common stock (each, a &#8220;LanzaTech RSA&#8221;) that is outstanding immediately prior to the Effective Time will be converted into an award of restricted shares of New LanzaTech Common Stock (each, a &#8220;New LanzaTech RSA&#8221;) on the same terms and conditions as were applicable to such LanzaTech RSA immediately prior to the Effective Time, except that such New LanzaTech RSA will relate to a number of shares of New LanzaTech Common Stock equal to the number of LanzaTech Shares subject to such LanzaTech RSA, multiplied by the Exchange Ratio.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The closing of the Merger is subject to certain customary conditions, including, among others, (i) adoption by AMCI&#8217;s stockholders and LanzaTech&#8217;s stockholders of the Merger Agreement and their approval of certain other actions related to the Business Combination, (ii) the expiration or termination of the waiting period (or any extension thereof) applicable to the transactions contemplated by the Merger Agreement and any ancillary agreements, in each case under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, (iii) the effectiveness of a registration statement on Form S-4 (the &#8220;Registration Statement&#8221;) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) with respect to the shares of New LanzaTech Common Stock to be paid as consideration in the Merger, (iv) there being no government order or law enjoining, prohibiting or making illegal the consummation of the Merger or the transactions contemplated by the Merger Agreement, (v) AMCI having at least $5,000,001 of net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) under the Exchange Act) after giving effect to any payments required to be made in connection with the redemption of AMCI&#8217;s public shares and the proceeds from the Subscription Agreements described below, (vi) AMCI having at least $230,000,000 of cash at the closing of the Merger, consisting of cash held in AMCI&#8217;s trust account after taking into account any redemption of AMCI&#8217;s public shares, and the proceeds from the Subscription Agreements described below, net of transaction expenses of AMCI and LanzaTech, and (vii) the listing on Nasdaq of the shares of New LanzaTech Common Stock issued in connection with the Business Combination.</span></div> Subsequent Events<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated events occurring subsequent to September&#160;30, 2022 through December 12, 2022, the date the condensed consolidated financial statements were available to be issued. The Company has identified two transactions with BGTF LT Aggregator LP (&#8220;Brookfield&#8221;), an affiliate of Brookfield Asset Management Inc, and a transaction with LanzaJet, described as follows:</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Brookfield Framework Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 2, 2022, LanzaTech entered into a framework agreement with Brookfield (the &#8220;Brookfield Framework Agreement&#8221;). Under such agreement, LanzaTech agreed to exclusively offer Brookfield the opportunity to acquire or invest in certain projects to construct commercial production facilities employing carbon capture and transformation technology in the U.S., the European Union, the United Kingdom, Canada or Mexico for which LanzaTech is solely or jointly responsible for obtaining or providing equity financing, subject to certain exceptions. LanzaTech agreed to present Brookfield with projects that over the term of the agreement require equity funding of at least $500,000,000 in the aggregate. With respect to projects acquired by Brookfield, LanzaTech is entitled to a percentage of free cash flow generated by such projects determined in accordance with a hurdle-based return waterfall. Brookfield has no obligation under the Brookfield Framework Agreement to invest in any of the projects.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Brookfield SAFE</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 2, 2022, LanzaTech entered into a Simple Agreement for Future Equity (the &#8220;Brookfield SAFE&#8221;) with Brookfield. Under the Brookfield SAFE, LanzaTech agreed to issue to Brookfield the right to certain shares of its capital stock, the issuance of which is conditional upon LanzaTech obtaining certain necessary stockholder approvals and waivers, in exchange for the payment of $50,000,000 (the &#8220;Initial Purchase Amount&#8221;). On the fifth anniversary of the Brookfield SAFE, LanzaTech will repay in cash any remaining unconverted portion of the Initial Purchase Amount (the &#8220;Remaining Amount&#8221;) less any Non-Repayable Amount (as described below), plus interest in the high single digits, compounded annually. Brookfield has the option to extend the repayment date to the tenth anniversary of the date of the Brookfield SAFE if certain events do not occur.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the first of either (a) a transaction with the principal purpose of raising capital, pursuant to which LanzaTech issues and sells preferred stock at a fixed valuation (an &#8220;Equity Financing&#8221;), or (b) the completion of an initial public offering, a direct listing, or a merger of LanzaTech with a special purpose acquisition company, which includes the Business Combination (such a merger, a &#8220;de-SPAC Transaction&#8221; and such event described in (b), a &#8220;Liquidity Event&#8221;), Brookfield may, at any time at its option, convert all or a portion of the Initial Purchase Amount less any amount that has already been converted or repaid into shares of LanzaTech capital stock or, in the case of a de-SPAC Transaction, shares of common stock of the surviving public company in such de-SPAC Transaction (including, in the case of the Business Combination, New LanzaTech Common Stock). </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each $50,000,000 of aggregate equity funding required for qualifying projects acquired by Brookfield in accordance with the Brookfield Framework Agreement, the Remaining Amount will be reduced by $5,000,000 (such cumulative reductions the &#8220;Non-Repayable Amount&#8221;). Upon the first Equity Financing or Liquidity Event, the Non-Repayable Amount would convert automatically into shares of LanzaTech capital stock or, in the case of a de-SPAC Transaction, shares of common stock of the surviving public company in such de-SPAC Transaction (including, in the case of the Business Combination, New LanzaTech Common Stock), and thereafter, the Non-Repayable Amount will convert automatically on an as accrued basis.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LanzaJet Shareholder Loan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 9, 2022, the Company and the other LanzaJet shareholders entered into a Note Purchase Agreement (the &#8220;Note Purchase Agreement&#8221;), pursuant to which LanzaJet Freedom Pines Fuels LLC (&#8220;FPF&#8221;), a wholly owned subsidiary of LanzaJet, will issue, from time to time, notes in an aggregate principal amount of up to $147.0&#160;million (the &#8220;Notes&#8221;), comprised of approximately $113.5&#160;million aggregate principal amount of 6.00% Senior Secured Notes due December 31, 2043 and $33.5&#160;million aggregate principal amount of 6.00% Subordinated Secured Notes due December 31, 2043. The Company has committed to purchase $5.5&#160;million of Subordinated Secured Notes in a funding scheduled to occur on May 1, 2023. The Senior Secured Notes are secured by a security </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">interest over substantially all assets of FPF, and both the Senior Secured Notes and the Subordinated Secured Notes are secured by a security interest over all intellectual property owned or in-licensed by LanzaJet. LanzaJet also provides a guarantee of any costs and expenses required to complete the LanzaJet Freedom Pines Demonstration Facility and achieve commercial operation. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each purchaser of Notes under the Note Purchase Agreement is also entitled to receive a warrant for the right to purchase 575 shares of common stock of LanzaJet for each $10,000 of Notes purchased by such purchaser (which, in the case of the Company, will be equal to a right to purchase 316,250 shares of common stock of LanzaJet).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LanzaJet Note Purchase Agreement may be amended with the approval of holders of FPF and all holders of the LanzaJet Notes.  Upon an event of default under the Note Purchase Agreement, each purchaser may accelerate its own Notes. Enforcement against the collateral securing the Notes requires the approval of certain holders as specified in the Notes.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amended Merger Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Merger Agreement was amended on December 7, 2022, to provide for, among other things, (i) the inclusion of the aggregate net proceeds from each of the AM SAFE Note and Brookfield SAFE in the Acquiror Closing Cash Amount, (ii) the reduction of the Minimum Closing Cash Condition from $250,000,000 to $230,000,000, (iii) the clarification that, to the extent that the Brookfield SAFE remains unexercised at Closing, it will be assumed by AMCI, remain in effect on the same terms and conditions as are in effect prior to the Closing and thereafter entitle the holder thereof to be issued shares of common stock in AMCI after the Closing, (iv) the clarification that, in the event that it becomes reasonably apparent to the parties that the Acquiror Closing Cash Amount will be less than the Minimum Closing Cash Condition, AMCI will use commercially reasonable efforts to enter into non-redemption agreements, or similar agreements, as may be necessary to satisfy the Minimum Closing Cash Condition, (v) the extension of the outside date applicable to the Closing from December 7, 2022 to February 28, 2023 and (vi) the elimination of LanzaTech's right to terminate the agreement in the event that we fail to, on or prior to July 7, 2022, enter into one or more additional subscription agreements or non-redemption agreements as a result of which the sum of the PIPE Investment Amount (including net proceeds under the AM SAFE Note to LanzaTech) and the aggregate number of shares of Class A common stock subject to non-redemption agreements multiplied by $10.00, minus certain transaction expenses and other liabilities at Closing, would be equal to at least the Minimum Closing Cash Condition.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div>Subsequent Events<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated events occurring subsequent to December&#160;31, 2021 through May 9, 2022, the date the consolidated financial statements were available to be issued. The Company is not aware of any significant or material subsequent event that would require disclosure.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposed Merger</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2022, the Company entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with AMCI Acquisition Corp. II, a Delaware corporation (&#8220;AMCI&#8221;) and AMCI Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of AMCI (&#8220;Merger Sub&#8221;). Under the Merger Agreement, Merger Sub will merge with and into LanzaTech, with LanzaTech surviving the Merger as a wholly-owned subsidiary of AMCI (&#8220;the Merger&#8221;). In connection with the Merger, AMCI will be renamed LanzaTech Global, Inc (&#8220;New LanzaTech&#8221;). AMCI has agreed to acquire all of the outstanding equity interests of LanzaTech for consideration consisting of an equity interest of New LanzaTech valued at approximately $1.8&#160;billion. Completion of the transaction is subject to certain customary regulatory consents and approval by stockholders of AMCI and the Company.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger Agreement, on March 8, 2022, AMCI entered into subscription agreements with certain investors pursuant to which AMCI agreed to issue and sell a private placement to close immediately prior to the Merger.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272208184368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of the Business<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Description of the Business</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1 &#8212; Description of Organization and Business Operations</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AMCI Acquisition Corp. II (the &#8220;Company&#8221;) is a blank check company incorporated as a Delaware corporation on January 28, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the &#8220;business combination&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, the Company has neither engaged in any operations nor generated any revenues. All activity to date relates to the Company&#8217;s formation and the initial public offering (as defined below), described below and since the initial public offering, its search for a business combination target. The Company will not generate any operating revenues until after the completion of its initial business combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the initial public offering and from changes in the fair value of its derivative warrant liabilities, if applicable. The Company has selected December 31 as its fiscal year end.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s sponsor is AMCI Sponsor II LLC, a Delaware limited liability company (the &#8220;Sponsor&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registration statement for the Company&#8217;s initial public offering was declared effective on August 3, 2021 (the &#8220;effective date&#8221;). On August 6, 2021, the Company consummated its initial public offering (the &#8220;initial public offering&#8221;) of 15,000,000 units (the &#8220;units&#8221;). Each unit consists of one Class A common stock of the Company, par value $0.0001 per share (the &#8220;Class A common stock&#8221;), and one-half of one redeemable warrant of the Company (the &#8220;warrant&#8221;), each whole warrant entitling the holder thereof to purchase one Class A common stock for $11.50 per share. The units were sold at a price of $10.00 per unit, generating gross proceeds to the Company of $150,000,000 which is discussed in Note 3.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Simultaneously with the closing of the initial public offering, the Company completed the private sale of an aggregate of 3,500,000 warrants (the &#8220;private placement warrants&#8221;) to the Sponsor at a purchase price of $1.00 per private placement warrant, generating gross proceeds to the Company of $3,500,000. The private placement warrants are identical to the warrants sold in the initial public offering, except that the private placement warrants, so long as they are held by the Sponsor or its permitted transferees, (i) are not redeemable by the Company, (ii) may not (including the Class A common stock issuable upon exercise of such private placement warrants), subject to certain limited exceptions, be transferred, assigned or sold by such holders until 30 days after the completion of the Company&#8217;s initial business combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights. No underwriting discounts or commissions were paid with respect to such sales.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the initial public offering includes two instruments, Class A common stock and warrants, and as the warrants are classified as a financial liability, it is necessary to allocate the gross proceeds between Class A common stock and warrants. The Company adopted the residual method to allocate the gross proceeds between Class A common stock and warrants based on their relative fair values. The gross proceeds were first allocated to the fair value of the warrants and the residual amount was allocated to the Class A common stock. The percentage derived from this allocation was used to allocate the deferred offering costs between Class A common stock and warrants. Issuance costs allocated to the warrants were expensed to the Company&#8217;s unaudited condensed statements of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction costs of the initial public offering amounted to $13,782,542 and consisted of $1,500,000 of underwriting discount, $5,250,000 of deferred underwriting discount, $6,509,758 in fair value of Class B common stock issued to Anchor Investors, and $522,784 of other offering costs.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A total of $150,000,000 was placed in a U.S.-based trust account maintained by Continental Stock Transfer &amp; Trust Company, acting as trustee (the &#8220;trust account&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company must complete one or more initial business combination having an aggregate fair market value of at least 80% of the value of the assets held in the trust account (excluding the amount of deferred underwriting discounts held in trust and taxes payable on the income earned on the trust account) at the time of the signing a definitive agreement in connection with the initial business combination. However, the Company will only complete a business combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">register as an investment company under the Investment Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;). There is no assurance that the Company will be able to complete a business combination successfully.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the closing of the initial public offering, management has agreed that an amount equal to at least $10.00 per unit sold in the initial public offering, including the proceeds of the private placement warrants, will be held in a trust account, located in the United States with Continental Stock Transfer &amp; Trust Company acting as trustee, and will invest only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect to interest earned on the funds held in the trust account that may be released to the Company to pay taxes, if any, the proceeds from the initial public offering and the sale of the private placement warrants will not be released from the trust account until the earliest of (i) the completion of initial business combination, (ii) the redemption of the Company&#8217;s public shares if the Company is unable to complete an initial business combination by August 6, 2023, subject to applicable law, or (iii) the redemption of the Company&#8217;s public shares properly submitted in connection with a stockholder vote to amend its amended and restated certificate of incorporation to modify the substance or timing of the Company&#8217;s obligation to redeem 100% of its public shares if the Company has not consummated an initial business combination by August 6, 2023 or with respect to any other material provisions relating to stockholders&#8217; rights or pre-initial business combination activity. The proceeds deposited in the trust account could become subject to the claims of the Company&#8217;s creditors, if any, which could have priority over the claims of the Company&#8217;s public stockholders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will provide its public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial business combination either (i) in connection with a stockholder meeting called to approve the business combination or (ii) without a stockholder vote by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed business combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem all or a portion of their public shares upon the completion of the initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account calculated as of two business days prior to the consummation of the initial business combination, including interest earned on the funds held in the trust account (which interest shall be net of taxes payable), divided by the number of then outstanding public shares, subject to the limitations and on the conditions described herein. The amount in the trust account is initially anticipated to be $10.00 per public share. The per share amount the Company will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the representative of the underwriters.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares of common stock subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the initial public offering, in accordance with Financial Accounting Standards Board&#8217;s (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480, &#8220;Distinguishing Liabilities from Equity.&#8221; In such case, the Company will proceed with a business combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a business combination and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the business combination.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will have only 24 months from the closing of the initial public offering to complete the initial business combination (the &#8220;Combination Period&#8221;). However, if the Company is unable to complete the initial business combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfOTM5MA_6b8b7a9b-cdb9-4964-a6c2-9088a7366feb">ten</span> business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company&#8217;s remaining stockholders and the Company&#8217;s board of </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">directors, liquidate and dissolve, subject, in each case, to the Company&#8217;s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sponsor, officers and directors have agreed to (i) waive their redemption rights with respect to any founder shares and public shares they hold in connection with the completion of the initial business combination, (ii) waive their redemption rights with respect to any founder shares and public shares they hold in connection with a stockholder vote to approve an amendment to the Company&#8217;s amended and restated certificate of incorporation, (iii) waive their rights to liquidating distributions from the trust account with respect to any founder shares they hold if the Company fails to complete the initial business combination within the Combination Period, and (iv) vote their founder shares and any public shares purchased during or after the initial public offering in favor of the initial business combination.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party (other than the Company&#8217;s independent registered public accounting firm) or prospective target business who executed a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is enforceable), nor will it apply to any claims under the Company&#8217;s indemnity of the underwriters of the initial public offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor&#8217;s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would be able to satisfy those obligations. None of the Company&#8217;s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Emerging Growth Company Status</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities and Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s unaudited condensed financial statements with those of another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is continuing to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company&#8217;s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these unaudited condensed financial statements. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 16, 2022, President Biden signed into law the Inflation Reduction Act of 2022 (the &#8220;IR Act&#8221;), which, among other things, imposes a new 1% U.S. federal excise tax on certain repurchases of stock by &#8220;covered corporations&#8221; (which include publicly traded domestic (i.e., U.S.) corporations) beginning in 2023, with certain exceptions (the &#8220;Excise Tax&#8221;). The Excise Tax is imposed on the repurchasing corporation itself, not its stockholders from which the stock is repurchased. Because we are a Delaware corporation and our securities are trading on Nasdaq, we are a &#8220;covered corporation&#8221; for this purpose. The amount of the Excise Tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the Excise Tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the Excise Tax. The U.S. Department of the Treasury has authority to provide regulations and other guidance to carry out, and prevent the abuse or avoidance of the Excise Tax; however, no guidance has been issued to date. It is uncertain whether, and/or to what extent, the Excise Tax could apply to any repurchase by us of our common stock or in the event of our liquidation, in each instance after December 31, 2022, including any redemptions in connection with an initial business combination or in the event we do not consummate an initial business combination by August 6, 2023.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposed Business Combination</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2022, the Company entered into an agreement and plan of merger (the &#8220;Merger Agreement&#8221;) with AMCI Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (&#8220;Merger Sub&#8221;), and LanzaTech NZ, Inc., a Delaware corporation (&#8220;LanzaTech&#8221;). The transactions contemplated by the Merger Agreement are referred to herein as the &#8220;Proposed Business Combination.&#8221; The time of the closing of the Proposed Business Combination is referred to herein as the &#8220;Closing.&#8221;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Proposed Business Combination is approved by the Company&#8217;s stockholders and LanzaTech&#8217;s stockholders, and the closing conditions in the Merger Agreement are satisfied or waived, then, among other things, upon the terms and subject to the conditions of the Merger Agreement and in accordance with Delaware General Corporation Law, Merger Sub will merge with and into LanzaTech, with LanzaTech surviving the Merger as the Company&#8217;s wholly owned subsidiary (the &#8220;Merger&#8221;). In connection with the consummation of the Merger, the Company will be renamed &#8220;LanzaTech Global, Inc.&#8221; and is referred to herein as &#8220;New LanzaTech&#8221; as of the time following such change of name.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Merger Agreement, the Company has agreed to acquire all of the outstanding equity interests of LanzaTech for consideration consisting of equity interests of New LanzaTech valued at $1,817,000,000 in the aggregate. The consideration to be paid to holders of shares of LanzaTech capital stock will be shares of common stock of New LanzaTech (&#8220;New LanzaTech Common Stock&#8221;), valued at $10.00 per share, to be paid at the closing of the Merger. The number of shares of New LanzaTech Common Stock payable in the Merger in respect of each share of LanzaTech capital stock (each, a &#8220;LanzaTech Share&#8221;) will be determined based on the exchange ratio (the &#8220;Exchange Ratio&#8221;), and certain corresponding adjustments, in each case as set forth in the Merger Agreement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, at Closing: (i) each warrant to purchase LanzaTech Shares (each, a &#8220;LanzaTech Warrant&#8221;) that is outstanding and unexercised immediately prior to Closing and would automatically be exercised or exchanged in full in accordance with its terms by virtue of the occurrence of the Merger, will be so automatically exercised or exchanged in full for the applicable LanzaTech Shares, and each such LanzaTech Share will be treated as being issued and outstanding immediately prior to Closing and will be canceled and converted into the right to receive the applicable shares of New LanzaTech Common Stock; and (ii) each LanzaTech Warrant that is outstanding and unexercised immediately prior to the Closing and is not automatically exercised in full as </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">described in clause (i) will be converted into a warrant to purchase shares of New LanzaTech Common Stock, in which case (a) the number of shares underlying such New LanzaTech warrant (each, a &#8220;New LanzaTech Warrant&#8221;) will be determined by multiplying the number of LanzaTech Shares subject to such warrant immediately prior to Closing, by the Exchange Ratio and (b) the per share exercise price of such New LanzaTech Warrant will be determined by dividing the per share exercise price of such LanzaTech Warrant immediately prior to the Effective Time by the Exchange Ratio, except that in the case of certain warrants specified in the Merger Agreement, such exercise price will be $10.00.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, at Closing, each option to purchase LanzaTech Shares (each, a &#8220;LanzaTech Option&#8221;) will be converted into an option to purchase a number of shares of New LanzaTech Common Stock (rounded down to the nearest whole share) equal to the product of (i) the number of LanzaTech Shares subject to such LanzaTech Option multiplied by (ii) the Exchange Ratio. The exercise price of such New LanzaTech option will be equal to the quotient of (a) the exercise price per share of such LanzaTech Option in effect immediately prior to the Effective Time divided by (b) the Exchange Ratio (and as so determined, this exercise price will be rounded up to the nearest full cent).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, at Closing, each award of restricted shares of LanzaTech common stock (each, a &#8220;LanzaTech RSA&#8221;) that is outstanding immediately prior to the Effective Time will be converted into an award of restricted shares of New LanzaTech Common Stock (each, a &#8220;New LanzaTech RSA&#8221;) on the same terms and conditions as were applicable to such LanzaTech RSA immediately prior to the Effective Time, except that such New LanzaTech RSA will relate to a number of shares of New LanzaTech Common Stock equal to the number of LanzaTech Shares subject to such LanzaTech RSA, multiplied by the Exchange Ratio.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The closing of the Merger is subject to certain customary conditions, including, among others, (i) adoption by AMCI&#8217;s stockholders and LanzaTech&#8217;s stockholders of the Merger Agreement and their approval of certain other actions related to the Proposed Business Combination, (ii) the expiration or termination of the waiting period (or any extension thereof) applicable to the transactions contemplated by the Merger Agreement and any ancillary agreements, in each case under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, (iii) the effectiveness of a registration statement on Form S-4 (the &#8220;Registration Statement&#8221;) under the Securities Act with respect to the shares of New LanzaTech Common Stock to be paid as consideration in the Merger, (iv) there being no government order or law enjoining, prohibiting or making illegal the consummation of the Merger or the transactions contemplated by the Merger Agreement, (v) AMCI having at least $5,000,001 of net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) under the Exchange Act) after giving effect to any payments required to be made in connection with the redemption of AMCI&#8217;s public shares and the proceeds from the Subscription Agreements described below, (vi) AMCI having at least $230,000,000 of cash at the closing of the Merger, consisting of cash held in AMCI&#8217;s trust account after taking into account any redemption of AMCI&#8217;s public shares, and the proceeds from the Subscription Agreements described below, net of transaction expenses of AMCI and LanzaTech, and (vii) the listing on Nasdaq of the shares of New LanzaTech Common Stock issued in connection with the Proposed Business Combination.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Going Concern</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, the Company had approximately $7,000 in its operating bank account and a working capital deficit of approximately $3.5 million , not taking into account tax obligations of approximately $536,000 that may be paid from income from investments held in the trust account.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s liquidity needs up to September 30, 2022 have been satisfied through a contribution of $25,000 from the Sponsor to cover for certain offering costs in exchange for the issuance of Founder Shares, and a loan and advances from the Sponsor pursuant to the Note (as defined in Note 4). Subsequent to the initial public offering, net proceeds from the private placement of $0.9 million were placed in the operating account for working capital purposes. In addition, in order to finance transaction costs in connection with a business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#8217;s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 4). On March 28, 2022, the Company entered into a noninterest-bearing Working Capital Loan with its Sponsor for the principal amount of up to $1.5 million. As of September 30, 2022 and December 31, 2021, there were no amounts outstanding under any Working Capital Loan.</span></div>In connection with the Company&#8217;s assessment of going concern considerations in accordance with FASB Accounting Standards Update (&#8220;ASU&#8221;) 2014-15, &#8220;Disclosures of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern,&#8221; management has determined that the liquidity condition, and the mandatory liquidation and subsequent dissolution that will be required if the Company does not complete a business combination before August 6, 2023 raises substantial doubt about the Company&#8217;s ability to continue as a going concern. Although Management expects that it will be able to raise additional capital to support its planned activities and complete a business combination on or prior to August 6, 2023, it is uncertain whether it will be able to do so. No adjustments have been made to the carrying amounts of assets or liabilities should we be required to liquidate after August 6, 2023. The condensed financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern. The Company intends to complete a business combination before the mandatory liquidation date. Over this time period, the Company will be using the funds outside of the trust account for paying existing accounts payable, identifying and evaluating prospective initial business combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the business combination.<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1 &#8212; Description of Organization and Business Operations</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AMCI Acquisition Corp. II (the &#8220;Company&#8221;) is a blank check company incorporated as a Delaware corporation on January 28, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the &#8220;business combination&#8221;). </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the Company has neither engaged in any operations nor generated any revenues. All activity for the period from January 28, 2021 (inception) through December 31, 2021 relates to the Company&#8217;s formation and the initial public offering (&#8220;initial public offering&#8221;), described below. The Company will not generate any operating revenues until after the completion of its initial business combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the initial public offering and from changes in the fair value of its derivative warrant liabilities, if applicable. The Company has selected December 31 as its fiscal year end.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s sponsor is AMCI Sponsor II LLC, a Delaware limited liability company (the &#8220;Sponsor&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registration statement for the Company&#8217;s initial public offering was declared effective on August 3, 2021 (the &#8220;effective date&#8221;). On August 6, 2021, the Company consummated its initial public offering of 15,000,000 units (the &#8220;units&#8221;). Each unit consists of one Class A common stock of the Company, par value $0.0001 per share (the &#8220;Class A common stock&#8221;), and one-half of one redeemable warrant of the Company (the &#8220;warrant&#8221;), each whole warrant entitling the holder thereof to purchase one Class A common stock for $11.50 per share. The units were sold at a price of $10.00 per unit, generating gross proceeds to the Company of $150,000,000, which is discussed in Note 3.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Simultaneously with the closing of the initial public offering, the Company completed the private sale of an aggregate of 3,500,000 warrants (the &#8220;private placement warrants&#8221;) to the Sponsor at a purchase price of $1.00 per private placement warrant, generating gross proceeds to the Company of $3,500,000. The private placement warrants are identical to the warrants sold in the initial public offering, except that the private placement warrants, so long as they are held by the Sponsor or its permitted transferees, (i) are not redeemable by the Company, (ii) may not (including the Class A common stock issuable upon exercise of such private placement warrants), subject to certain limited exceptions, be transferred, assigned or sold by such holders until 30 days after the completion of the Company&#8217;s initial business combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights. No underwriting discounts or commissions were paid with respect to such sales.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the initial public offering includes two instruments, Class A common stock and warrants, and as the warrants are classified as a financial liability, it is necessary to allocate the gross proceeds between Class A common stock and warrants. The Company adopted the residual method to allocate the gross proceeds between Class A common stock and warrants based on their relative fair values. The gross proceeds were first allocated to the fair value of the warrants and the residual amount was allocated to the Class A common stock. The percentage derived from this allocation was used to allocate the deferred offering costs between Class A common stock and warrants. Issuance costs allocated to the warrants were expensed to the Company&#8217;s statement of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction costs of the initial public offering amounted to $13,782,542 and consisted of $1,500,000 of underwriting discount, $5,250,000 of deferred underwriting discount, $6,509,758 in fair value of Class B common stock issued to Anchor Investors, and $522,784 of other offering costs.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A total of $150,000,000 was placed in a U.S.-based trust account maintained by Continental Stock Transfer &amp; Trust Company, acting as trustee.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company must complete one or more initial business combination having an aggregate fair market value of at least 80% of the value of the assets held in the trust account (excluding the amount of deferred underwriting discounts held in trust and taxes payable on the income earned on the trust account) at the time of the signing a definitive agreement in connection with the initial business combination. However, the Company will only complete a business combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">register as an investment company under the Investment Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;). There is no assurance that the Company will be able to complete a business combination successfully.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the closing of the initial public offering, management has agreed that an amount equal to at least $10.00 per unit sold in the initial public offering, including the proceeds of the private placement warrants, will be held in a trust account (the &#8220;trust account&#8221;), located in the United States with Continental Stock Transfer &amp; Trust Company acting as trustee, and will invest only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect to interest earned on the funds held in the trust account that may be released to the Company to pay taxes, if any, the proceeds from the initial public offering and the sale of the private placement warrants will not be released from the trust account until the earliest of (i) the completion of initial business combination, (ii) the redemption of the Company&#8217;s public shares if the Company is unable to complete an initial business combination by August 6, 2023, subject to applicable law, or (iii) the redemption of the Company&#8217;s public shares properly submitted in connection with a stockholder vote to amend its amended and restated certificate of incorporation to modify the substance or timing of the Company&#8217;s obligation to redeem 100% of its public shares if the Company has not consummated an initial business combination by August 6, 2023 or with respect to any other material provisions relating to stockholders&#8217; rights or pre-initial business combination activity. The proceeds deposited in the trust account could become subject to the claims of the Company&#8217;s creditors, if any, which could have priority over the claims of the Company&#8217;s public stockholders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will provide its public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial business combination either (i) in connection with a stockholder meeting called to approve the business combination or (ii) without a stockholder vote by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed business combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem all or a portion of their public shares upon the completion of the initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account calculated as of two business days prior to the consummation of the initial business combination, including interest earned on the funds held in the trust account (which interest shall be net of taxes payable), divided by the number of then outstanding public shares, subject to the limitations and on the conditions described herein. The amount in the trust account is initially anticipated to be $10.00 per public share. The per share amount the Company will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the representative of the underwriters.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares of common stock subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the initial public offering, in accordance with Financial Accounting Standards Board&#8217;s (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480, &#8220;Distinguishing Liabilities from Equity.&#8221; In such case, the Company will proceed with a business combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a business combination and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the business combination.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will have only 24 months from the closing of the initial public offering to complete the initial business combination (the &#8220;Combination Period&#8221;). However, if the Company is unable to complete the initial business combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfOTMzMA_80eea167-68dd-4f47-a97c-0adf8eb467f8">ten</span> business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company&#8217;s remaining stockholders and the Company&#8217;s board of </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">directors, liquidate and dissolve, subject, in each case, to the Company&#8217;s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sponsor, officers and directors have agreed to (i) waive their redemption rights with respect to any founder shares and public shares they hold in connection with the completion of the initial business combination, (ii) waive their redemption rights with respect to any founder shares and public shares they hold in connection with a stockholder vote to approve an amendment to the Company&#8217;s amended and restated certificate of incorporation, (iii) waive their rights to liquidating distributions from the trust account with respect to any founder shares they hold if the Company fails to complete the initial business combination within the Combination Period, and (iv) vote their founder shares and any public shares purchased during or after the initial public offering in favor of the initial business combination.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party (other than the Company&#8217;s independent registered public accounting firm) or prospective target business who executed a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is enforceable), nor will it apply to any claims under the Company&#8217;s indemnity of the underwriters of the initial public offering against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor&#8217;s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would be able to satisfy those obligations. None of the Company&#8217;s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Emerging Growth Company Status</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is continuing to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company&#8217;s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposed Business Combination</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As more fully described in Note 11, on March 8, 2022, the Company entered into an agreement and plan of merger (the &#8220;Merger Agreement&#8221;) with AMCI Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (&#8220;Merger Sub&#8221;), and LanzaTech NZ, Inc., a Delaware corporation (&#8220;LanzaTech&#8221;). Upon consummation of the transactions, the Company will change its name to &#8220;LanzaTech Global, Inc.&#8221;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Going Concern</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the Company had approximately $0.3 million in its operating bank account and a working capital deficit of approximately $0.1 million.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s liquidity needs up to December 31, 2021 have been satisfied through a contribution of $25,000 from the Sponsor to cover for certain offering costs in exchange for the issuance of founder shares, and a loan and advances from the Sponsor pursuant to the Note (as defined in Note 4). Subsequent to the initial public offering, net proceeds from the private placement of $0.9 million were placed in the operating account for working capital purposes. In addition, in order to finance transaction costs in connection with a business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#8217;s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 4). As of December 31, 2021, there were no amounts outstanding under any Working Capital Loan.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company&#8217;s assessment of going concern considerations in accordance with Financial Accounting Standard Board&#8217;s Accounting Standards Update (&#8220;ASU&#8221;) 2014-15, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosures of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; management has determined that the Company would not be able to meet its obligations as they become due within one year after the date that the financial statements are available to be issued. As such, management has determined that the liquidity condition raises substantial doubt about the Company&#8217;s ability to continue as a going concern. As of December 31, 2021, no adjustments have been made to the carrying amounts of assets or liabilities.</span></div>Description of the Business<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reporting entity is LanzaTech NZ, Inc. (formerly known as LanzaTech New Zealand Limited) and its subsidiaries (collectively, &#8220;the Company&#8221; or "LanzaTech"). LanzaTech NZ, Inc. is a profit-oriented entity previously incorporated in New Zealand. Effective October 28, 2021, LanzaTech New Zealand Limited filed a Certificate of Incorporation to migrate its country of domicile from New Zealand to Delaware, in the United States, and change its corporate name to &#8220;LanzaTech NZ, Inc.&#8221; The amendment was approved by the Board of Directors of LanzaTech and was effected by the filing of a Certificate of Incorporation with the Delaware Secretary of State. The registered office location is c/o The Corporation Trust Company, Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware, 19801. The Company licenses its technology to customers, performs research and development in biotechnology, and provides engineering and other related services for commercial and government customers. Using the Company&#8217;s proprietary fermentation technology, the Company&#8217;s customers can convert certain carbon-rich waste gases into fuels and chemicals. The Company employs a licensing business model whereby its customers build, own and operate facilities that use the Company's technology, and in return, the Company is paid royalties based on the revenue generated from the use of its technology. In 2018, the Company, through its partners, launched the world&#8217;s first commercial waste gas to ethanol plant in China, followed by a second one in 2021, also in China, with others currently in development in various countries.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposed Merger</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2022, the Company entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with AMCI Acquisition Corp. II, a Delaware corporation (&#8220;AMCI&#8221;) and AMCI Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of AMCI (&#8220;Merger Sub&#8221;). Under the Merger Agreement, Merger Sub will merge with and into LanzaTech, with LanzaTech surviving the Merger as a wholly-owned subsidiary of AMCI (&#8220;the Business Combination&#8221;). In connection with the Business Combination, AMCI will be renamed LanzaTech Global, Inc. (&#8220;New LanzaTech&#8221;). AMCI has agreed to acquire all of the outstanding equity interests of LanzaTech for consideration consisting of an equity interest of New LanzaTech valued at approximately $1.8&#160;billion. Completion of the transaction is subject to certain customary regulatory consents and approval by stockholders of AMCI and the Company. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Merger Agreement was amended on December 7, 2022, to provide for, among other things, (i) the inclusion of the aggregate net proceeds from each of the AM SAFE Note and Brookfield SAFE in the Acquiror Closing Cash Amount, (ii) the reduction of the Minimum Closing Cash Condition from $250,000,000 to $230,000,000, (iii) the clarification that, to the extent that the Brookfield SAFE remains unexercised at Closing, it will be assumed by AMCI, remain in effect on the same terms and conditions as are in effect prior to the Closing and thereafter entitle the holder thereof to be issued shares of common stock in AMCI after the Closing, (iv) the clarification that, in the event that it becomes reasonably apparent to the parties that the Acquiror Closing Cash Amount will be less than the Minimum Closing Cash Condition, AMCI will use commercially reasonable efforts to enter into non-redemption agreements, or similar agreements, as may be necessary to satisfy the Minimum Closing Cash Condition, (v) the extension of the outside date applicable to the Closing from December 7, 2022 to February 28, 2023 and (vi) the elimination of LanzaTech's right to terminate the agreement in the event that we fail to, on or prior to July 7, 2022, enter into one or more additional subscription agreements or non-redemption agreements as a result of which the sum of the PIPE Investment Amount (including net proceeds under the AM SAFE Note to LanzaTech) and the aggregate number of shares of Class A common stock subject to non-redemption agreements multiplied by $10.00, minus certain transaction expenses and other liabilities at Closing, would be equal to at least the Minimum Closing Cash Condition.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger Agreement, AMCI entered into subscription agreements with certain investors pursuant to which AMCI agreed to issue and sell a private placement to close immediately prior to the Business Combination.</span></div>Description of the BusinessThe reporting entity is LanzaTech NZ, Inc. (formerly known as LanzaTech New Zealand Limited) and its subsidiaries (collectively, &#8220;the Company&#8221;). LanzaTech NZ, Inc. is a profit-oriented entity previously incorporated in New Zealand. Effective October 28, 2021, LanzaTech New Zealand Limited filed a Certificate of Incorporation to migrate its country of domicile from New Zealand to Delaware, in the United States, and change its corporate name to &#8220;LanzaTech NZ, Inc.&#8221; The amendment was approved by the Board of Directors of LanzaTech and was effected by the filing of a Certificate of Incorporation with the Delaware Secretary of State. All necessary adjustments have been recorded to present fairly the Company's financial position as of December&#160;31, 2021 and 2020 and the results of operations and cash flows for the years then ended. The registered office location is c/o The Corporation Trust Company, Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware, 19801. The Company licenses its technology to customers, performs research and development in biotechnology, and provides engineering and other related services for commercial and government customers. Using the Company&#8217;s proprietary fermentation technology, the Company&#8217;s customers can convert certain carbon-rich waste gases into fuels and chemicals. The Company employs a licensing business model whereby its customers build, own and operate facilities that use the Company's technology, and in return, the Company is paid royalties based on the revenue generated from the use of its technology. In 2018, the Company, through its equity method investee, launched the world&#8217;s first commercial waste gas to ethanol plant in China, followed by a second one in 2021, also in China, with others currently in development in various countries around the world.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211165680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2 &#8212; Basis of Presentation and Summary of Significant Accounting Policies</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) for interim financial information and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022 or any future period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K filed by the Company with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on March 25, 2022.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of September 30, 2022 and December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of September 30, 2022 and December 31, 2021.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments Held in the Trust Account</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company&#8217;s investments held in the trust account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company&#8217;s investments held in the trust account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the trust account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the trust account are determined using available market information.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities which qualify as financial instruments under the FASB ASC 820, &#8220;Fair Value Measurement,&#8221; equal or approximate the carrying amounts represented in the condensed balance sheets.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Offering Costs Associated With Initial Public Offering</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the initial public offering that were directly related to the initial public offering. Offering costs were allocated to the separable financial instruments issued in the initial public offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and presented as non-operating expenses in the unaudited condensed statements of operations. Offering costs associated with the Class A common stock issued were charged against the carrying value of the shares of Class A common stock upon the completion of the initial public offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Class A Common Stock Shares Subject to Possible Redemption </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, &#8220;Distinguishing Liabilities from Equity.&#8221; Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders&#8217; equity. The Company&#8217;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of uncertain future events. Accordingly, as of the initial public offering, 15,000,000 shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders&#8217; equity (deficit) section of the Company&#8217;s condensed balance sheets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 480-10-S99, the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of the reporting period. This method would view the end of the reporting period as if it were also the redemption date of the security. Effective with the closing of the initial public offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The public warrants and the private placement warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The initial fair value of the public warrants issued in connection with the initial public offering was estimated using a Monte-Carlo simulation model. The fair value of the public warrants as of September 30, 2022 and as of December 31, 2021 is based on observable listed prices for such warrants. The fair value of the private placement warrants as of September 30, 2022 and as of December 31, 2021 is determined using a Black-Scholes option pricing model. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provides guidance on derecognition, classification, interest and penalties, accounting in period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company&#8217;s effective tax rate was 0.88% and 0.91% for the three and nine months ended September 30, 2022, respectively, and 0.00% for the three months ended September 30, 2021 and the period from January 28, 2021 (inception) through September 30, 2021. The effective tax rate differs from the statutory tax rate of 21% for the three and nine months ended September 30, 2022, the three months ended September 30, 2021 and the period from January 28, 2021 (inception) through September 30, 2021 due primarily to changes in fair value of derivative warrant liabilities, non-taxable gains on the settlement of deferred underwriting commissions, and the valuation allowance on the deferred tax assets.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Per Share Of Common Stock</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share.&#8221; The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the units sold in the initial public offering and the private placement warrants to purchase an aggregate of 11,000,000 shares of Class A common stock in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the three and nine months ended September 30, 2022 and for the three months ended September 30, 2021 and for the period from January 28, 2021 (inception) through September 30, 2021. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended <br/>September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248,909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332,524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,130,435</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.887%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Nine Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Period from January 28, 2021 <br/>(inception) through <br/>September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,428,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FASB issued ASU 2022-03, ASC Subtopic 820 &#8220;Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions&#8221;. The ASU amends ASC 820 to clarify that a contractual sales restriction is not considered in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. The ASU applies to both holders and issuers of equity and equity-linked securities measured at fair value. The amendments in this ASU are effective for the Company in fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is still evaluating the impact of this pronouncement on the condensed financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company&#8217;s unaudited condensed financial statements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2 &#8212; Basis of Presentation and Summary of Significant Accounting Policies</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;).</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2021.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments Held in the Trust Account</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company&#8217;s investments held in the trust account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company&#8217;s investments held in the trust account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the trust account in the accompanying statement of operations. The estimated fair values of investments held in the trust account are determined using available market information.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities which qualify as financial instruments under the FASB ASC 820, &#8220;Fair Value Measurement,&#8221; equal or approximate the carrying amounts represented in the balance sheet.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Offering Costs Associated with Initial Public Offering</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the initial public offering that were directly related to the initial public offering. Offering costs were allocated to the separable financial instruments issued in the initial public offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">presented as non-operating expenses in the statement of operations. Offering costs associated with the Class A common stock issued were charged against the carrying value of the shares of Class A common stock upon the completion of the initial public offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Class A Common Stock Subject to Possible Redemption </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, &#8220;Distinguishing Liabilities from Equity.&#8221; Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders&#8217; equity. The Company&#8217;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of uncertain future events. Accordingly, as of the initial public offering, 15,000,000 shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders&#8217; equity (deficit) section of the Company&#8217;s balance sheet.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 480-10-S99, the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of the reporting period. This method would view the end of the reporting period as if it were also the redemption date of the security. Effective with the closing of the initial public offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The public warrants and the private placement warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The initial fair value of the public warrants issued in connection with the initial public offering was estimated using a Monte-Carlo simulation model. The fair value of the public warrants as of December 31, 2021 is based on observable listed prices for such warrants. The fair value of the private placement warrants as of December 31, 2021 is determined using a Black-Scholes option pricing model. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Per Share of Common Stock</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share.&#8221; The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the units sold in the initial public offering and the private placement warrants to purchase an aggregate of 11,000,000 shares of Class A common stock in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the period from January 28, 2021 (inception) through December 31, 2021. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.451%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.805%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the period from January 28, 2021<br/>(inception) through December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income (loss) per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,690,909</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income (loss) per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2020-06, &#8220;Debt &#8212; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8212; Contracts in an Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity&#8221; (&#8220;ASU 2020-06&#8221;), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. ASU 2020-06 also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 on August 2, 2021 using the modified retrospective method for transition. Adoption of ASU 2020-06 did not impact the Company&#8217;s financial position, results of operations or cash flows.</span></div>The Company&#8217;s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company&#8217;s financial statements.Summary of Significant Accounting Policies <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements of LanzaTech NZ Inc. have been prepared in accordance with generally accepted accounting principles for interim financial information, and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America ("US GAAP"), the accounting principles, standards, and procedures adopted by the U.S. Securities and Exchange Commission, for complete financial statements. However, in the opinion of management, all adjustments (consisting of normal recurring accruals) have been made that are necessary for a fair presentation of the condensed consolidated financial statements for the interim periods. For further information refer to the Consolidated Financial Statements and Footnotes thereto included in the Company's Annual Report for the year ended December 31, 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a qualitative approach in assessing the consolidation requirement for variable interest entities ("VIEs"). This approach focuses on determining whether the Company has the power to direct the activities of the VIE that most significantly affect the VIE&#8217;s economic performance and whether the Company has the obligation to absorb losses, or the right to receive benefits, that could potentially be significant to the VIE.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds interests in certain VIEs for which it has been determined the Company is not the primary beneficiary. The Company's variable interests primarily relate to entities in which the Company has a non-controlling equity interest. Although these financial arrangements resulted in holding variable interests in these entities, they did not empower the Company to direct the activities of the VIEs that most significantly impact the VIEs' economic performance. The Company's interests in the VIEs are, therefore, accounted for under the equity method of accounting or alternative measurement. Refer to Note 5,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further information. The Company is exposed to the VIEs' losses and other impairment indicators up to the carrying value of each investment and any amounts receivable from the VIE, less amounts payable. Refer to Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further details on the transactions with VIEs.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Going Concern</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements of the Company have been prepared assuming the Company will continue as a going concern and in accordance with accounting principles generally accepted in the United States of America ("US GAAP"). The going concern basis of presentation assumes that the Company will continue in operation one year after the date these financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. The Company had cash and cash equivalents of $50,370 and an accumulated deficit of $(434,863) at September&#160;30, 2022 and cash outflows from operations of $(71,336) and a net loss of $(54,974) for the nine months ended September&#160;30, 2022. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has historically funded its operations through debt financing and issuance of equity securities. Based on the Company&#8217;s financial position as of the date these condensed consolidated financial statements were available to be issued, the Company projects that it will be able to cover its liquidity needs for the next twelve months with cash on hand. Accordingly, the Company&#8217;s condensed consolidated financial statements have been prepared on the basis that it will continue as a going concern.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates include fair value of equity awards granted to both employees and non-employees, the SAFE and the SAFE warrants.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in facts and circumstances or additional information may result in revised estimates, and actual results may differ from these estimates.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates as one operating segment which is the licensing of its technologies and related services such as research and development and engineering. The Chief Executive Officer who is the chief operating decision maker, reviews financial information on an aggregate basis for allocating resources and evaluating financial performance. Substantially all of the Company's long-lived assets are maintained in the United States. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currencies</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reporting currency is the U.S. Dollar. The Company has certain foreign subsidiaries where the functional currency is the local currency. All of the assets and liabilities of these subsidiaries are converted to U.S. dollars at the exchange rate in effect at the balance sheet date, income and expense accounts are translated at average rates for the period, and shareholder&#8217;s equity accounts are translated at historical rates. The effects of translating financial statements of foreign operations into our reporting currency are recognized as an adjustment in accumulated other comprehensive income (loss).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has foreign subsidiaries that have a functional currency of the U.S. dollar. Purchases and sales of assets and income and expense items denominated in foreign currencies are remeasured into U.S. dollar amounts on the respective dates of such transactions. Net realized foreign currency gains or losses relating to the differences between these recorded amounts and the U.S. dollar equivalent actually received or paid are included within Other (expense) income, net in the condensed consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. As of September&#160;30, 2022 and December&#160;31, 2021, the Company had $50,370 and $128,318 of cash and cash equivalents, respectively.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash and Other Cash Flows from Operating Activities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to maintain a cash deposit with a bank which consists of collateral on certain travel and expense programs maintained by the bank. The following represents a reconciliation of cash and cash equivalents in the condensed consolidated balance sheets to total cash, cash equivalents and restricted cash in the condensed consolidated statements of cash flows as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands).</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (presented within Other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,034&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,732&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade and Other Receivables </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables are reported net of allowances for doubtful accounts. The Company maintains allowances for doubtful accounts for estimated losses resulting from the inability of customers to make required payments. The Company estimates the allowance for doubtful accounts based on a variety of factors including the length of time receivables are past due, the financial health of customers, unusual macroeconomic conditions, and historical experience. As of September&#160;30, 2022 and December&#160;31, 2021, the Company recognized an allowance for doubtful accounts of $1,051 and $1,235, respectively.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with Accounting Standards Codification ("ASC") 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company primarily earns revenue from services related to feasibility studies and basic engineering design of commercial plants, licensing of technologies, joint development and contract </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">research activities to develop novel biocatalysts and related technologies, and sale of CarbonSmart ethanol produced using the Company's proprietary technologies.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is measured based on the consideration specified in a contract with a customer. The Company records taxes collected from customers and remitted to governmental authorities on a net basis. The Company&#8217;s payment terms are between 30-60 days and can vary by customer type and products offered. Management has evaluated the terms of our arrangements and determined that they do not contain significant financing components.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Carbon Capture and Transformation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides feasibility studies and basic design and engineering services used for detailed design, procurement, and construction of commercial plants that utilize the Company&#8217;s technologies, along with the sale of equipment and microbes. The services provided are recognized as a performance obligation satisfied over time. Revenue is recognized using the output method based on milestone completion, the cost-to-cost input method for certain engineering services, or the percentage of completion method as performance obligations are satisfied. Management has determined that the milestone completion and the associated contractual payment amounts are an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company licenses intellectual property to generate recurring revenue when its customers deploy carbon capture and transformation plants. When licenses are considered to be distinct performance obligations, the recognition of revenue is dependent on the terms of the contract, which may include fixed consideration or royalties based on sales or usage, in which case, the revenue is recognized when the subsequent sale or usage occurs or when the performance obligation to which some or all of the sales or usage-based royalty is allocated has been satisfied, whichever is later.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Services</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs research and development (&#8220;R&amp;D&#8221;) services related to novel technologies and development of biocatalysts for commercial applications, mainly to produce fuels and chemicals. The Company engages in two main types of R&amp;D services &#8211; joint development agreements, and other contract research, including projects with the U.S. Department of Energy. Such services are recognized as a performance obligation satisfied over time. Revenue is recognized based on milestone completion, when payments are contingent upon the achievement of such milestones, or based on percentage-completion method when enforceable rights to payment exist. When no milestones or phases are clearly defined, management has determined that the cost incurred, input method, is an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and estimates its variable consideration under the expected value method. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is not recognized in advance of customer acceptance of a milestone when such acceptance is contractually required. Payments for R&amp;D services with no contractual payments are not due from customers until a technical report is submitted; therefore, a contract asset is recognized at milestone completion but prior to the submission of a technical report. The contract asset represents the Company&#8217;s right to consideration for the services performed at milestone completion. Occasionally, customers provide payments in advance of the Company providing services which creates a contract liability for the Company. The contract liability represents the Company's obligation to provide services to a customer. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collaboration Arrangements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain partnership agreements that are within the scope of ASC 808, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides guidance on the presentation and disclosure of collaborative arrangements. Generally, the classification of the transactions under the collaborative arrangements is determined based on the nature of the contractual terms of the arrangement, along with the nature of the operations of the participants. The Company&#8217;s collaborative agreements generally include a provision of R&amp;D services related to novel technologies and biocatalysts. Amounts received for these services are classified as Revenue from collaborative arrangements in the condensed consolidated statements of operations and comprehensive loss. The Company's R&amp;D services are a major part of the Company's ongoing operations and therefore ASC 606 is applied to recognize revenue.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CarbonSmart</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's CarbonSmart business, initially CarbonSmart ethanol, is produced by LanzaTech licensed plants using the Company's proprietary technologies. Customers can buy CarbonSmart ethanol directly from LanzaTech, which the Company sources from these partnering plants. Revenue is recognized at a point in time when control transfers to the customer, which varies depending on the shipping terms. The Company acts as the principal in such transactions and accordingly, recognizes revenue and cost of revenues on a gross basis.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily due to their short-term nature, except for the warrant liability. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue generated from the Company&#8217;s customers outside of the United States for the nine months ended September&#160;30, 2022 and 2021 was approximately 61% and 65%, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021, approximately 35% and 35%, respectively, of trade accounts receivable and unbilled accounts receivable was due from customers located outside the United States. At September&#160;30, 2022 and December&#160;31, 2021, the value of property, plant, and equipment outside the United States was immaterial.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue by geographic region based on the customer&#8217;s location is presented in Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customers</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers representing 10% or greater of revenue were as follows for the nine months ended September&#160;30, 2022 and 2021:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Announced Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Financial Accounting Standard Board ("FASB") issued an Accounting Standard Update ("ASU") No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2020-10&#8221;). The standard contains improvements to the FASB Accounting Standards Codification (the &#8220;Codification&#8221;) by ensuring that all guidance that requires or provides an option for an entity to provide information in the notes to financial statements is codified in the disclosure section of the Codification. The standard also improves various topics in the Codification so that entities can apply guidance more consistently on codifications that are varied in nature where the original guidance may have been unclear. The amendments in ASU 2020-10 were effective for the Company for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption was permitted. There were no material impacts upon the adoption of ASU 2020-10, on its consolidated financial statements and related disclosures. </span></div>Summary of Significant Accounting Policies <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;US GAAP"). The consolidated financial statements include the accounts of LanzaTech NZ, Inc. and its wholly-owned consolidated subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of its evaluation, the Company makes judgments in determining whether an entity is a variable interest entity (&#8220;VIE&#8221;) and, if so, whether it is the primary beneficiary of the VIE and is thus required to consolidate the entity. A VIE is a legal entity that has a total equity investment that is insufficient to finance its activities without additional subordinated financial support or whose equity investors lack the characteristics of a controlling financial interest. Our variable interest arises from contractual, ownership or other monetary interests in the entity, which change with fluctuations in the fair value of the entity&#8217;s net assets. A VIE is consolidated by its primary beneficiary, the party that has both the power to direct the activities that most significantly impact the VIE&#8217;s economic performance, and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE. We consolidate a VIE when we are deemed to be the primary beneficiary. We assess whether or not we are the primary beneficiary of a VIE on an ongoing basis. If we are not deemed to be the primary beneficiary in a VIE, we account for the investment or other variable interests in a VIE in accordance with applicable US GAAP.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds interests in certain VIEs for which it has been determined the Company is not the primary beneficiary. The Company's variable interests primarily relate to entities in which the Company has a non-controlling equity interest. Although these financial arrangements resulted in holding variable interests in these entities, they did not empower the Company to direct the activities of the VIEs that most significantly impact the VIEs' economic performance. The Company's interests in the VIEs are, therefore, accounted for under the equity method of accounting. Refer to Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further information. The Company's maximum exposure to loss in connection with its interest in VIEs is its equity method investment and any amounts receivable from the VIE, less amounts payable. Refer to Note 14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further details on the transactions with VIEs.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restatement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 16, 2022, the Audit Committee of the Board of Directors of LanzaTech, after discussion with management of LanzaTech and LanzaTech&#8217;s independent registered public accounting firm, Deloitte &amp; Touche, </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LLP, concluded that LanzaTech&#8217;s previously issued audited consolidated financial statements as of and for the fiscal years ended December 31, 2021 and December 31, 2020 should no longer be relied upon. The errors leading to restatement were communicated to and discussed with AMCI upon their discovery. The AMCI Board considered the circumstances surrounding the restatement and concluded that it did not negatively impact its decision to proceed with the Business Combination primarily because of the individually immaterial adjustments. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined that its recorded share of equity method earnings amounts from an unconsolidated affiliate for the years ended December 31, 2021 and 2020 and its gain on dilution amount for the year ended December 31, 2021 were incorrect following the completion of LanzaJet, Inc's ("LanzaJet") financial statement audit. Additionally, the Company identified that it was not properly eliminating intra-entity profits related to revenue contracts with LanzaJet. As a result of the adjustments recorded by the unconsolidated affiliate and the identification of the error related to the elimination of intra-entity profits, the Company made the decision to restate its consolidated financial statements as of and for the years ended December 31, 2021 and 2020, on or around the completion of the audit of LanzaJet's financial statements for the years ended December 31, 2021 and 2020, on August 23, 2022. The Company also determined it was not properly accounting for its licensing arrangement with LanzaJet, and had not disclosed all significant related party transactions with its equity method investees. The Company has also revised these disclosures.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 250, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Changes and Error Corrections</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company evaluated the materiality of the adjustments, considering both quantitative and qualitative factors, and determined that the related aggregate impact was material to its consolidated financial statements as of and for the years ended December 31, 2021 and 2020. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Description of Errors Corrected</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Accounting for Equity Method Investments: </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The previously reported equity method investment in LanzaJet, Inc. (&#8220;LanzaJet&#8221;), as described in Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, contained errors in the Company's recorded share of LanzaJet losses for the years ended 2021 and 2020 as a result of adjustments made by LanzaJet to its financial statements in connection with the audit of LanzaJet's financial statements for the years ended December 31, 2021 and 2020. The adjustments primarily were comprised of (1) an adjustment to correct an error relating to the measurement of the intangible asset associated with the intellectual property contributed by the Company as described in Note 5 &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the related amortization; and (2), an adjustment to reclassify as a reduction to fixed assets certain government grants received by LanzaJet that it originally recorded as revenue. Other less significant adjustments were also identified and corrected in connection with the audit of LanzaJet's financial statements for the years ended December 31, 2021 and 2020. The net impact of these adjustments on the equity method investment's balance and accumulated deficit in the Company's Consolidated Balance Sheets was a decrease of $580 and $257 as of December 31, 2021 and 2020, respectively. The net impact of these adjustments on the gain from equity method investees in the Company&#8217;s Consolidated Statements of Operations and Comprehensive Loss was a decrease of $580 and $257 for the years ended December 31, 2021 and 2020, respectively. </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The previously reported revenue from related parties related to contributed intellectual property contained errors for intra-entity profit that was not previously eliminated, as described in Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The impact of these errors on the equity method investment's balance and accumulated deficit in the Consolidated Balance Sheets was $662 and $549 as of December 31, 2021 and 2020, respectively and $662 and $549 on revenue from related party transactions in the Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2021 and 2020, respectively.</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The previously reported gain on dilution, as described in Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, was not correctly calculated for the year ended December 31, 2021. The impact of these errors on the equity method investment's balance and accumulated deficit in the Consolidated Balance Sheets as of December 31, </span></div><div style="margin-bottom:9pt;padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021 was $322; and the impact on gain from equity method investees in the Consolidated Statements of Operations and Comprehensive Loss was $322 for the year ended December 31, 2021.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Additional Misstatements:</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The previously reported contract assets and other accrued liabilities included revenue and related cost of revenue amounts that was recorded in an inappropriate period. These amounts were recorded in 2021, however, the performance obligation was actually satisfied in 2020.. The impact of these errors on the contract assets and other accrued liabilities in the Consolidated Balance Sheet as of December 31, 2020 was $122; and the impact on revenue from contracts with customers and cost of revenue from contracts with customers in the Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2021 and 2020 was  $122.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Disclosure errors:</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company determined its licensing arrangement with LanzaJet, described in Note 5 &#8211; Investments, should have been accounted for as a transaction with a customer solely within the scope of Accounting Standards Codification 606 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from contracts with customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 606") rather than akin to an operating lease under Accounting Standards Codification 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 842"). The licensing arrangement is a contract with our customer, LanzaJet, that conveys to LanzaJet the right to use an intangible asset (IP). Contracts with customers are accounted for under ASC 606 unless they are within the scope of other accounting literature. Because the licensing arrangement conveys the right to use an intangible asset, it is not within the scope of ASC 842. Under limited circumstances, ASC 606 requires certain arrangements that do not, in substance, transfer control of an asset (i.e., when the arrangement contains certain repurchase rights or obligations) to be accounted for as leases. However, those limited circumstances are not present in our licensing arrangement with LanzaJet. Therefore, the Company concluded accounting for the arrangement under ASC 606 is required. Because the period over which the Company determined it was required to recognize revenue under ASC 606 was the same as the period of time over which it had been recognizing revenue, there was no effect on the amounts recorded in the consolidated financial statements. Additionally, the difference in timing of recognition of the variable consideration resulted in a difference between the carrying value of our equity method investment in LanzaJet and our proportionate share LanzaJet's book values, that was not previously disclosed. However, the disclosures in Note 5 &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, have been revised accordingly.</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company did not disclose in Note 5 &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, its obligation under a guarantee with sublicensing agreement between LanzaJet and a third party. The fair value of this guarantee was deemed immaterial as of December 31, 2021 and 2020.</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company did not include in its disclosure for related party transactions in Note 14 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that it also provided engineering services to one of its equity method investees, Beijing ShouGang LanzaTech Technology Co., LTD ("SGLT"), for which costs of $1,223 and $242 were incurred during the years ended December 31, 2021 and 2020. The Company also did not disclose that in 2019 it entered into a licensing agreement to receive licensing consideration from SGLT. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of the errors discussed above were individually material to the financial statements, however, their cumulative impact was material and resulted in a restatement of the 2021 and 2020 financial statements. The effects of the correction of these errors on the relevant financial statement line items is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Balance Sheet</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,738&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,011&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(378,162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(379,889)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(353,190)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(354,917)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, contingently redeemable preferred equity, and shareholders' deficit</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,738&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,011&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Balance Sheet</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,664&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(684)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,980&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,775&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,897&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,666&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,788&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(332,394)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(333,200)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310,410)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311,216)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, contingently redeemable preferred equity, and shareholders' deficit</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,664&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(684)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,980&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Operations and Comprehensive Loss</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from contracts with customers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from related party transactions</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,915&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(662)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,253&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,245&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(784)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,461&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue from contracts with customers (exclusive of depreciation shown below)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,289)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,167)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost and operating expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,602)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,480)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,357)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(662)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,019)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,972)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(662)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48,634)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(259)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,945&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,768)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(921)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,689)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss allocated to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82,526)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(921)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83,447)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,673)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(921)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,594)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share - basic and diluted</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.12)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.47)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.59)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Operations and Comprehensive Loss</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from contracts with customers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from related party transactions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,752&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(549)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,780&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(427)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,353&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue from contracts with customers (exclusive of depreciation shown below)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,063)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,185)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost and operating expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,932)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58,054)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,152)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(549)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,701)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,331)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(549)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,880)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,424&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(257)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,907)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,713)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss allocated to common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68,198)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69,004)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,282)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,088)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share - basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.84)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.50)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.34)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Changes in Redeemable Convertible Preferred Stock and Shareholders&#8217; Equity (Deficit)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit - Balance at December 31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(332,394)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(333,200)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit &#8211; balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310,410)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311,216)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,768)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(921)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,689)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit - balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(378,162)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(379,889)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit &#8211; balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(353,190)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(354,917)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Changes in Redeemable Convertible Preferred Stock and Shareholders&#8217; Equity (Deficit)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit - Balance at December 31, 2019</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(295,487)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(295,487)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit &#8211; balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276,592)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276,592)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,907)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,713)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit - balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(332,394)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(333,200)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit &#8211; balance at December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310,410)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311,216)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Cash Flows</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,768)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(921)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,689)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash recognition of licensing revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,684)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,022)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,945)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,636)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,514)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued salaries and wages</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,591)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,591)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Cash Flows</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,907)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,713)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash recognition of licensing revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,567)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,018)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,424)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,167)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,483)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,605)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued salaries and wages</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,271)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,271)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Other Disclosure Errors: </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 5 - Investments: The Company did not disclose intra-entity profits elimination amounts related to revenue contracts with LanzaJet of $662 and $549 as of December 31, 2021, and 2020, respectively as they were not eliminated. The previously disclosed gain on dilution was incorrect as of and for the year ended December 31, 2021.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on dilution</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates as one operating segment. Operating segments are defined as components of an enterprise for which separate financial information is evaluated regularly by the chief operating decision maker (&#8220;CODM&#8221;), in deciding how to allocate resources and assess performance.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company offers a variety of services and operates in multiple countries, the Company&#8217;s business operates in one operating segment because most of the Company&#8217;s service offerings are delivered and supported on a global basis, most of the Company&#8217;s service offerings are deployed in a nearly identical way, and the Company&#8217;s CODM evaluates the Company&#8217;s financial information and resources and assesses the performance of these resources on a consolidated basis. There are no segment managers who are held accountable by the CODM, or anyone else, for operations, operating results, and planning for components below the consolidated level. Accordingly, the Company has determined that it has a single reportable and operating segment. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for disaggregation of the Company&#8217;s revenues by customer location.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Coronavirus (COVID-19)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the World Health Organization declared the viral strain of coronavirus ("COVID-19") a global pandemic and recommended containment and mitigation measures worldwide. The spread of COVID-19 and the resulting economic contraction has resulted in increased business uncertainty. The consequences of a prolonged economic decline could include, but are not limited to, reduced revenues, increased instances of uncollectible customer receivables, and increased asset impairments in future periods. Accordingly, the Company cannot reasonably estimate the length or severity of this pandemic, or the extent to which the disruption may materially impact its consolidated balance sheets, consolidated statements of operations and comprehensive loss or statements of cash flows for future periods.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Going Concern</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements of the Company have been prepared assuming the Company will continue as a going concern and in accordance with US GAAP. The going concern basis of presentation assumes that the Company will continue in operation one year after the date these financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. The Company had cash and cash equivalents of $128,318 and an accumulated deficit of $379,889 at December&#160;31, 2021 and cash outflows from operations of $42,591 and a net loss of $46,689 for the year ended December&#160;31, 2021. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has historically funded its operations through debt financing and issuance of equity securities. Based on the Company&#8217;s financial position as of the date these consolidated financial statements were issued, the Company projects that it will be able to cover its liquidity needs for the next twelve months with cash on hand. Accordingly, the Company&#8217;s consolidated financial statements have been prepared on the basis that it will continue as a going concern.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates include fair value of equity awards granted to both employees and non-employees.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in facts and circumstances or additional information may result in revised estimates, and actual results may differ from these estimates.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currencies</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reporting currency is the U.S. Dollar. The Company has certain foreign subsidiaries where the functional currency is the local currency. All of the assets and liabilities of these subsidiaries are converted to U.S. dollars at the exchange rate in effect at the balance sheet date, income and expense accounts are translated at average rates for the period, and shareholder&#8217;s equity accounts are translated at historical rates. The effects of translating financial statements of foreign operations into our reporting currency are recognized as an adjustment in accumulated other comprehensive income (loss).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has foreign subsidiaries that have a functional currency of the U.S. dollar. Purchases and sales of assets and income and expense items denominated in foreign currencies are remeasured into U.S. dollar amounts on the respective dates of such transactions. Net realized foreign currency gains or losses relating to the differences between these recorded amounts and the U.S. dollar equivalent actually received or paid are included within Other income, net in the consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. As of December&#160;31, 2021 and 2020, the Company had $128,318 and $60,495 of cash and cash equivalents, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to maintain a cash deposit with a bank which consists of collateral on a travel and expense program maintained by the bank. The following represents a reconciliation of cash and cash equivalents in </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the consolidated balance sheets to total cash, cash equivalents and restricted cash in the consolidated statement of cash flows as of December 31, 2021 and December 31, 2020.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,495&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (presented within Other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,732&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,909&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade and Other Receivables </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables are reported net of allowances for doubtful accounts. The Company maintains allowances for doubtful accounts for estimated losses resulting from the inability of customers to make required payments. The Company estimates the allowance for doubtful accounts based on a variety of factors including the length of time receivables are past due, the financial health of customers, unusual macroeconomic conditions, and historical experience. As of December&#160;31, 2021 and 2020, the Company recognized an allowance for doubtful accounts of $1,235 and $1,325, respectively.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Current Assets</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current assets consist of prepaid expenses, materials and supplies, and other assets. Material and supplies consist of spare parts and consumables used for research and research equipment and is stated at the weighted average cost.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment, net</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost and include improvements that significantly increase capacities or extend the useful lives of existing plant and equipment.&#160;Depreciation is calculated using the straight-line method over the estimated useful life of the assets. Useful lives range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTA0_78de1c22-d3ad-43ae-a899-19a74e1b2357">three</span> to five years for instruments and equipment, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk3OTk5_761df305-309f-4903-a23c-ce62ac3f485c">three</span> to five years for office equipment and furniture and software, five years for vehicles and, for leasehold improvements, the shorter of the life of the improvement or the remaining term of the lease. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews the remaining useful life of its assets on a regular basis to determine whether changes have taken place that would suggest that a change to depreciation policies is warranted.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon retirement or disposal of property, plant and equipment, the cost and related accumulated depreciation are removed from the account, and the resulting gains or losses, if any, are recorded in the consolidated statements of operations and comprehensive loss. Net gains or losses related to asset dispositions are recognized in earnings in the period in which dispositions occur. Routine maintenance, repairs and replacements are expensed as incurred.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines&#160;if an arrangement is a lease at inception.&#160;Lease agreements are evaluated to classify the lease as a finance or operating&#160;lease.&#160;Operating lease assets and liabilities are recognized at the commencement date of the lease based on the present value of lease payments over the lease term. Lease assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. As most&#160;leases&#160;do not provide an implicit interest rate,&#160;the Company&#160;uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. Leases with an initial term of 12 months or less are not recorded on the Company&#8217;s consolidated balance sheets. The Company recognizes lease expense for these leases on a straight-line basis over the lease term.&#160;The Company accounts for lease components and non-lease components as a single lease component.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs a recoverability assessment of each of its long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indicators may include, but are not limited to, adverse changes in the regulatory environment in a jurisdiction where the Company operates, a decision to discontinue the development of a long-lived asset, early termination of a significant customer contract, or the introduction of newer technology.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When performing a recoverability assessment, the Company measures whether the estimated future undiscounted net cash flows expected to be generated by the asset exceeds its carrying value. In the event that an asset does not meet the recoverability test, the carrying value of the asset will be adjusted to fair value resulting in an impairment charge.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management develops the assumptions used in the recoverability assessment based on active contracts as well as information received from third-party industry sources. The Company did not record an impairment during the years ended December&#160;31, 2021 and 2020. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Method Investments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in entities over which the Company has significant influence, but not control, are accounted for using the&#160;equity method&#160;of accounting. Gain from&#160;equity method&#160;investees, net represents the Company&#8217;s proportionate share of net income or loss of its equity method investees and any gains or losses from the dilution of such investments.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity method&#160;investments are assessed for impairment whenever changes in the facts and circumstances indicate a loss in value may have occurred. When a loss is deemed to have occurred and is other than temporary, the carrying value of the&#160;equity method&#160;investment is written down to fair value. In evaluating whether a loss is other than temporary, the Company considers the length of time for which the conditions have existed and its intent and ability to hold the investment. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Simple Agreement for Future Equity (SAFE)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company issued a SAFE that allowed an investor to participate in future equity financings through a share-settled redemption of the amount invested (such notional being the &#8220;invested amount&#8221;). The Company determined that the SAFE was not legal form debt (i.e., no creditors&#8217; rights). The SAFE includes a provision allowing for cash redemption upon the occurrence of a change of control, the occurrence of which is outside the control of the Company. Therefore, the SAFE is classified as mark-to-market liability pursuant to Accounting Standards Codification (&#8220;ASC&#8221;) 480, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distinguishing Liability from Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has warrants to purchase preferred shares outstanding as of December&#160;31, 2021 and 2020 representing 225,223 and 383,281 preferred shares, respectively, which warrants expire at various dates through December 31, 2027. The exercise prices of the warrants range from $14.69 to $19.93 as of each of December&#160;31, 2021 and 2020. The Company accounts for its warrants as liabilities based upon the characteristics and provisions of each instrument. The liabilities are included in other accrued liabilities on the Company's consolidated balance sheets at their fair value on the date of issuance and are revalued in each subsequent reporting period until such instruments are exercised or expire. The change in fair value between reporting periods is included in other (expense) income, net in the consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further the warrant related to the SAFE of $1,729 is accounted for as a liability. This liability is recorded in current liabilities on the Company's consolidated balance sheets at fair value on the date of issuance and will be revalued each subsequent reporting period until such instrument is exercised or expire. The change in fair value between reporting periods is included in other (expense) income, net in the consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Term Debt and Debt Issuance Costs</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s debt consists of credit facilities with financial institutions. Costs directly related to the issuance of debt are reported on the consolidated balance sheets as a reduction from the carrying amount of the recognized debt liability and amortized over the term of the debt using the effective interest method.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal and Contingencies</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may be involved in legal actions in the ordinary course of business, inquiries and proceedings concerning employment, labor, environmental, and other claims. The Company will recognize a loss contingency in the consolidated financial statements when it is probable a liability has been incurred and the amount of the loss can be reasonably estimated. The Company will disclose any loss contingencies that do not meet both conditions if there is a reasonable possibility that a loss may have been incurred. Gain contingencies are not recorded until realized.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company primarily earns revenue from services related to feasibility studies and basic engineering design of commercial plants, licensing of technologies, joint development and contract research activities to develop novel biocatalysts and related technologies.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is measured based on the consideration specified in a contract with a customer. The Company records taxes collected from customers and remitted to governmental authorities on a net basis. The Company&#8217;s payment terms are between 30-60 days and can vary by customer type and products offered. We have evaluated the terms of our arrangements and determined that they do not contain significant financing components.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Carbon Capture and Transformation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides feasibility studies and basic design and engineering services used for detailed design, procurement, and construction of commercial plants that utilize the Company&#8217;s technologies, along with the sale of equipment and microbes. The services provided are recognized as a performance obligation satisfied over time. Revenue is recognized using the output method based on milestone completion, the cost-to-cost input method for certain engineering services, or the percentage of completion method when certain revenue recognition requirements are met. Management has determined that the milestone completion and the associated contractual payment amounts are an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company licenses intellectual property to generate recurring revenue when its customers deploy carbon capture and transformation plants. When licenses are considered to be distinct performance obligations, the recognition of revenue is dependent on the terms of the contract, which may include fixed consideration or royalties based on sales or usage, in which case, the revenue is recognized when the subsequent sale or usage occurs or when the performance obligation to which some or all of the sales or usage-based royalty is allocated has been satisfied, whichever is later.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Services</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs research and development (&#8220;R&amp;D&#8221;) services related to novel technologies and development of biocatalysts for commercial applications, mainly to produce fuels and chemicals. The Company engages in two main types of R&amp;D services &#8211; joint development agreements, and other contract research, including projects with the U.S. Department of Energy. Such services are recognized as a performance obligation satisfied over time. Revenue is recognized based on milestone completion, when such milestones are contractually defined, or based on stage of contract completion when not defined. For the latter, management has determined that the cost incurred, input method, is an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and estimates its variable consideration under the expected value method. Accordingly, the Company records a liability based on milestones achieved and the expected repayment of the development costs. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s joint development agreements may utilize the cost-to-cost method of revenue recognition or may include well defined payment milestones, dependent on the contract, both of which the Company evaluates against work completed prior to revenue recognition. For other contract research, the Company utilizes the cost-to-cost method of revenue recognition. These contracts have a fixed dollar amount which is based on the Company&#8217;s estimate of total costs to be incurred over the life of each contract. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is not recognized in advance of customer acceptance of a milestone, when such acceptance is contractually required. Payments for R&amp;D services with no contractual payments are not due from customers until a technical report is submitted; therefore, a contract asset is recognized at milestone completion but prior to the submission of a technical report. The contract asset represents the Company&#8217;s right to consideration for the services performed at milestone completion. Occasionally, customers provide payments in advance of the Company providing services which creates a contract liability for the Company. The contract liability represents the Company's obligation to provide services to a customer. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collaboration Arrangements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain partnership agreements that are within the scope of ASC 808, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides guidance on the presentation and disclosure of collaborative arrangements. Generally, the classification of the transactions under the collaborative arrangements is determined based on the nature of the contractual terms of the arrangement, along with the nature of the operations of the participants. The Company&#8217;s collaborative agreements generally include a provision of R&amp;D services related to novel technologies and biocatalysts. Amounts received for these services are classified as Revenue from collaborative arrangements in the consolidated statements of operations and comprehensive loss. The Company's R&amp;D services are a major part of the Company's ongoing operations and therefore ASC 606 is applied to recognize revenue.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenues</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s R&amp;D, engineering, and other direct costs of services related to revenue agreements with customers, related parties, and collaborative partners represent cost of revenue. Costs include both internal and third-party fixed and variable costs and include materials, supplies, labor, and fringe benefits.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incur research and development costs associated with various R&amp;D activities and expense these costs as incurred.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for equity-based compensation in accordance with ASC 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation &#8211; Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Accordingly, in exchange for employee and director services, compensation is given in the form of equity awards. The equity awards are recorded based on the grant date fair value and expensed over the requisite service period for the respective award.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s equity-based awards include stock option awards and restricted stock issued by the Company, which vest based on either time or the achievement of certain performance conditions. The Company records forfeitures as they occur. Compensation expense resulting from time-vesting-based awards is recognized in the Company&#8217;s consolidated statements of operations and comprehensive loss, primarily within research and development expenses, at the grant date fair value over the requisite service period. Compensation expense resulting from performance awards recognized over the requisite service period when it is probable that the performance condition will be met. The calculated compensation expense for performance awards is adjusted based on an estimate of awards ultimately expected to vest. The Company estimates grant date fair value using a Black-Scholes option pricing model that uses assumptions including expected volatility, expected term, and the expected risk-free rate of return. The Company has determined that the Black-Scholes option pricing model, as well as the underlying assumptions used in its application, is appropriate in estimating the fair value of its award grants.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows the asset and liability method of accounting for income taxes under ASC 740, Income Taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income tax assets are evaluated to determine if valuation allowances are required or should be adjusted. Valuation allowances are established based on a more likely than not standard. The ability to realize deferred tax assets depends on the Company&#8217;s ability to generate sufficient taxable income within the carryback or carryforward periods provided for in the tax law for each tax jurisdiction. The Company considers the various possible sources of taxable income when assessing the realization of its deferred tax assets. The valuation allowances recorded against deferred tax assets generated by taxable losses in certain jurisdictions will affect the provision for income taxes until the valuation allowances are released. The Company&#8217;s provision for income taxes will include no tax benefit for losses incurred and no tax expense with respect to income generated in these jurisdictions until the respective valuation allowance is eliminated.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records uncertain tax positions on the basis of a two-step process whereby it is determined whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position, and for those tax positions that meet the more likely than not criteria, the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority is recognized. The Company recognizes accrued interest and penalties related to unrecognized tax benefits in income tax expense.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Transactions</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows ASC 850-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for the identification of related parties and disclosure of related party transactions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. Refer to Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Note 14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further information.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss Per Share</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is computed by dividing net loss attributable to participating stock by the weighted average number of shares of participating stock outstanding during the period. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted net loss per share reflects potential dilution and is computed by dividing net loss attributable to participating stock by the weighted average number of shares of participating stock outstanding during the period. The dilutive effect of outstanding awards, if any, is reflected in diluted earnings per share by application of the treasury stock method or if-converted method, as applicable. Refer to Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Loss Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-term nature, except for the warrant liability. Refer to Note 11, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrant Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for more information.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties (Restated)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue generated from the Company&#8217;s customers outside of the United States for the years ended December&#160;31, 2021 and 2020 was approximately 38% and 14%, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, approximately 35% and 27%, respectively, of trade accounts receivable and unbilled accounts receivable was due from customers located outside the United States. At December&#160;31, 2021 and 2020, the value of property, plant, and equipment outside the United States was immaterial.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue by geographic region based on the customer&#8217;s location is presented in Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customers</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers representing 10% or greater of revenue were as follows for the years ended December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, two of the Company's customers separately represented 49% (Customer B) and 15% (Customer D) of total accounts receivable and contract assets on the consolidated balance sheet. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses (Topic 326): Disclosure Framework &#8211; Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2016-13&#8221;), which requires financial assets measured at amortized cost basis, including trade receivables, to be presented net of the amount expected to be collected. The measurement of all expected credit losses will be based on historical experience, current conditions, and reasonable and supportable forecasts. The Company adopted the new standard effective January 1, 2020, using a modified retrospective transition method, which requires a cumulative-effect adjustment, if any, to the opening balance of retained earnings to be recognized on the date of adoption with prior periods not restated. The adoption did not have a material impact on the Company&#8217;s financial position or results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles &#8211; Goodwill and Other &#8211; Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2018-15&#8221;), which requires a customer in a cloud computing arrangement that is a service contract to follow the internal-use software guidance in ASC 350-40 to determine which implementation costs to capitalize as assets. A customer&#8217;s accounting for the costs of the hosting component of the arrangement is not affected by the new guidance. The Company adopted ASU 2018-15 as of January 1, 2020 with no material impact on its consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2018, the FASB issued ASU 2018-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Stock Compensation Improvements to Non-employee Share-Based Payment Accounting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2018-07&#8221;), which simplifies the accounting for stock-based payments granted to non-employees for goods and services. Under ASU 2018-07, most of the guidance on such payments to non-employees will be aligned with the requirements for stock-based payments granted to employees. The Company early adopted ASU 2018-07 as of January 1, 2020 and its adoption did not have a material impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2019-12&#8221;), as part of its simplification initiative to reduce the cost and complexity in accounting for income taxes. ASU 2019-12 removes certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. ASU 2019-12 also amends other aspects of the guidance to help simplify and promote consistent application of US GAAP. The Company adopted ASU 2019-12 as of January 1, 2021 with no material impact on its consolidated financial statements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Announced Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2020-10&#8221;). The standard contains improvements to the FASB Accounting Standards Codification (the &#8220;Codification&#8221;) by ensuring that all guidance that requires or provides an option for an entity to provide information in the notes to financial statements is codified in the disclosure section of the Codification. The standard also improves various topics in the Codification so that entities can apply guidance more consistently on codifications that are varied in nature where the original guidance may have been unclear. The amendments in ASU 2020-10 are effective for the Company for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption is permitted. The Company does not expect the adoption of ASU 2020-10 to have a material impact on its consolidated financial statements and related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211046672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text">Net Loss Per Share<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is computed by dividing net loss by the weighted-average number of shares of common stock of the Company outstanding during the period. Diluted net loss per share is computed by giving effect to all potential shares of common stock of the Company, including outstanding stock options, warrants, and contingently redeemable preferred stock, to the extent dilutive.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of basic and diluted net loss per share for the Company&#8217;s common stock (in thousands, except shares and per share amounts):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss for basic and diluted earnings per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,974)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,591)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid cumulative dividends on preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,925)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,068)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss allocated to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83,899)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,659)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares used in calculating net loss per share, basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,108,472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,909,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share, basic and diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.79)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.19)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In periods in which the Company reports a net loss, all share-based compensation awards are excluded from the calculation of diluted weighted average shares outstanding because of their anti-dilutive effect on earnings (loss) per share.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and 2021, potential shares of common stock not included in the computation of loss per share because their effect would be antidilutive include the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable convertible preferred stock (if converted)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,790,978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,540,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSAs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,117,671&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,867,263&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the organizational documents of the Company, the preferred shares are convertible by the holder at any time at their option. In addition, the preferred shares will automatically convert into common shares upon either (i) the determination of the holders of certain requisite preferred shares of the Company (which determination will be submitted for approval by such stockholders in connection with the Business Combination described in Note 1, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Description of the Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), or (ii) a firmly underwritten initial public offering of the Company&#8217;s shares that satisfies certain requirements (but not, for the avoidance of doubt, upon a business combination with a special purpose acquisition company, such as the Business Combination, unless such conversion is otherwise effected pursuant to clause (i) above). Such conversion would be at a 1:1 ratio, adjusted for certain corporate events. Upon conversion of the preferred shares, the cumulative accrued and declared dividends will become payable. The additional 29,521,810 of potential shares of common stock resulting from any such conversion are not included in the computation of diluted net loss per share in the nine months ended September&#160;30, 2022 and 2021, respectively, because doing so would be anti-dilutive. In connection with the SAFE, see Note 6 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company could issue additional potential shares of common stock upon closing of the Business Combination. Further, under the Simple Agreement for Future Equity ("SAFE") warrant, additional potential shares of common stock could be issued upon closing of the Business Combination and exercise of the warrant. These potential shares of common stock have not been issued as of September 30, 2022. The per share issuance price for the SAFE and SAFE warrant upon closing of the Business Combination is 100% of the liquidity price. If another qualified liquidity event occurs instead, the issuance price is 90% of the liquidity price.</span></div>Net Loss Per ShareBasic net loss per share is computed by dividing net loss by the weighted-average number of shares of common stock of the Company outstanding during the period. Diluted net loss per share is computed by giving effect to all potential shares of common stock of the Company, including outstanding stock options, warrants, and contingently redeemable preferred stock, to the extent dilutive.<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of basic and diluted net loss per share for the Company&#8217;s common stock (in thousands, except shares and per share amounts):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss for basic and diluted earnings per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,689)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,713)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid cumulative dividends on preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,758)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss allocated to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83,447)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69,004)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares used in calculating net loss per share, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,959,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,629,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share, basic and diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.59)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.34)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In periods in which the Company reports a net loss, all stock-based compensation awards are excluded from the calculation of diluted weighted average shares outstanding because of their anti-dilutive effect on earnings (loss) per share.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, potential shares of common stock not included in the computation of earnings per share because their effect would be antidilutive include the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable convertible preferred stock (if converted)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,729,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,848,420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,283,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSAs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,175,113&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,720,703&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the organizational documents of the Company, the preferred shares will automatically convert into common shares upon either (i) the determination of the holders of certain requisite preferred shares of the Company (which determination will be submitted for approval by such stockholders in connection with the Merger described below in Note 20) or (ii) a firmly underwritten initial public offering of the Company&#8217;s shares that satisfies certain requirements (but not, for the avoidance of doubt, upon a business combination with a special purpose acquisition company, such as the Merger, unless such conversion is otherwise effected pursuant to clause (i) above). Such conversion would be at a 1:1 ratio, adjusted for certain corporate events.Upon conversion of the preferred shares, the cumulative accrued and declared dividends will become payable.  The additional 29,521,810 and 25,729,542 of potential shares of common stock resulting from any such conversion are not included in the computation of diluted net loss per share in 2021 and 2020, respectively, because neither an initial public offering nor a stockholder determination of such conversion had occurred at the end of the period. In connection with the SAFE, see Note 10 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simple Agreement for Future Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company could issue additional potential shares of common stock upon closing of the Merger. Further, under the SAFE warrant, see Note 6 &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Note 11 &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrants Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, additional potential shares of common stock could be issued upon closing of the Merger and exercise of the warrant. These potential shares of common stock have not been issued as of December 31, 2021. The per share issuance price for the SAFE and SAFE warrant upon closing of the Merger is 100% of the liquidity price. If another qualified liquidity event occurs instead, the issuance price is 90% of the liquidity price.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211081344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenues</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4 &#8212; Revenues</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregated Revenue</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents disaggregated revenue in the following categories (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Types:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joint development agreements</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other contract research</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,118&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,053&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CarbonSmart</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Engineering and other services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,756&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carbon capture and transformation revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,663&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,274&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,781&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,327&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from collaborative partners of $1,733 and $2,662 for the nine months ended September&#160;30, 2022 and 2021, is included in the table above within joint development agreements. Revenue from related parties is included in licensing for $1,620 and $1,518 with the remaining revenue of $496 and $830 in Engineering and other services, for the nine months ended September&#160;30, 2022 and 2021, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents disaggregation of the Company&#8217;s revenues by customer location for the nine months ended September&#160;30, 2022 and 2021 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.214%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,725&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Middle East, Africa (EMEA)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,781&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,327&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract balances</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides changes in contract assets and liabilities (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Contract Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Contract Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-current Contract Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022 as Restated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,901&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to unbilled accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases due to cash received</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled accounts receivable recognized in trade receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,085)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease on revaluation on currency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(804)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification from non-current to current contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,015)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification to revenue as a result of performance obligations satisfied</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,298)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,848&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,968&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,119&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in contract assets was mostly due to unbilled accounts receivables from contracts with customers where the Company performed engineering and other services, while the decrease in contract liabilities was primarily due to the recognition of revenue during the period related to advance payments previously received by the Company for engineering and other services contracts with customers. As of September&#160;30, 2022 and December&#160;31, 2021 the Company had $11,588 and $2,878, respectively, of billed accounts receivable, net of allowance.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contract liability balance is comprised of unconditional payments received from the Company&#8217;s customers prior to the satisfaction of the related performance obligations. Such amounts are anticipated to be recorded as revenues when services are performed in subsequent periods. The Company expects to recognize the amounts classified as current contract liabilities, in revenue within one year or less and those classified as non-current within two to three years. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Remaining performance obligations</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction price allocated to the remaining performance obligation represents contracted revenue that has not yet been recognized, which includes unearned revenue that will be recognized as revenue in future periods. Transaction price allocated to remaining performance obligations is influenced by several factors, including the length of the contract term compared to the research term and the existence of customer specific acceptance rights. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remaining performance obligations consisted of the following (in thousands): </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,087&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,377&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Revenues<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregated Revenue</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents disaggregated revenue in the following categories (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 5.5pt;text-align:center;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 5.5pt;text-align:center;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Types:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joint development agreements</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other contract research</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,897&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,910&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Engineering and other services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carbon capture and transformation revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,564&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:33pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,461&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,353&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from collaborative partners is included in the table above within joint development agreements. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents disaggregation of the Company&#8217;s revenues by customer location for the years ended December&#160;31, 2021 and 2020 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,732&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,461&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,353&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract balances</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides changes in contract assets and liabilities during the year ended December 31, 2021.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Contract Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Contract Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-current Contract Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020 as Restated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,291&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to unbilled accounts receivable as Restated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases due to cash received</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,690&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled accounts receivable recognized in trade receivables as Restated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,002)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification from long-term to short-term</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,080)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification to revenue as a result of performance obligations satisfied</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,104)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,700&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,476&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,901&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in contract assets was mostly due to unbilled accounts receivables from contracts with customers where the Company performed engineering and other services, while the increase in contract liabilities was primarily due to advance payments received under engineering and other services. As of December&#160;31, 2021 and 2020 the Company had $2,878 and $5,521, respectively, of billed accounts receivable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contract liability balance is comprised of unconditional payments received from the Company&#8217;s customers prior to the satisfaction of the related performance obligations. Such amounts are anticipated to be recorded as revenues when services are performed in subsequent periods. The Company expects to recognize the amounts classified as current contract liabilities, in revenue within one year or less and those classified as non-current within two and three years. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Remaining performance obligations</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction price allocated to the remaining performance obligation represents contracted revenue that has not yet been recognized, which includes unearned revenue that will be recognized as revenue in future periods. Transaction price allocated to remaining performance obligations is influenced by several factors, including the length of the contract term compared to the research term and the existence of customer specific acceptance rights. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remaining performance obligations consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,377&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,771&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272210232976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock', window );">Investments</a></td>
<td class="text">Investments<div style="margin-bottom:9pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investments consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Category</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in LanzaJet</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,651&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in SGLT</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Investment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,752&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,217&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Method Investments</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LanzaJet</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 13, 2020, the Company contributed $15,000 in intellectual property in exchange for a 37.5% interest (&#8220;Original Interest&#8221;) of LanzaJet, Inc. (&#8220;LanzaJet&#8221;) and the right to future increase in ownership whereby LanzaTech could become a majority owner of LanzaJet if the intellectual property is used commercially in connection with an investment agreement (&#8220;Investment Agreement&#8221;). The Company also agreed to perform certain technical and administrative support services. LanzaJet is a sustainable fuels technology company dedicated to expanding sustainable aviation fuels (&#8220;SAF&#8221;) to reduce greenhouse gas emissions and the decarbonization of the aviation and transportation industries. LanzaJet&#8217;s access to the license is in perpetuity if certain key performance indicators (&#8220;KPI&#8217;s&#8221;) are met in accordance with the Investment Agreement. If these KPI&#8217;s are not met by December 31, 2025, the Company may terminate the license. The Company accounts for the transaction in accordance with ASC 606. The licensing and support services provided are recognized as a performance obligation satisfied over the expected period of those services, beginning May 2020 through December 2025. During the years ended December&#160;31, 2021 </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and 2020, the Company has recognized revenue from this arrangement of $2,025 and $1,018 and has recorded deferred revenue of $10,746 and $13,433 respectively. Further, the Company has eliminated intra-entity profits related to revenue contracts with LanzaJet of $662 and $549 as of December 31, 2021, and 2020, respectively. Intra-entity profit is amortized over the 15-year amortization period through 2034.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the Original Interest, the Investment Agreement allows at the option of the other investors party thereto to contribute additional funds towards building commercial plants and to receive a technology sublicense if certain KPI&#8217;s are met. At such point, the Company would receive an additional interest in LanzaJet of up to 45&#160;million shares for no additional consideration at that time. There would be no additional LanzaJet Board of Director representation with the potential increased interest. The additional tranches of interests in LanzaJet received upon the achievement of certain KPIs represent non-monetary variable consideration. The Company has applied the variable consideration constraint per ASC 606 and recognized no variable consideration as of December 31, 2021 as the Company has determined that it is not probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. The Company regularly reviews and updates its estimates. Any changes made are recorded as a cumulative adjustment in the period identified and revenue for future periods is recognized using the new adjusted estimate.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between February 1, and April 4, 2021, LanzaJet closed two additional rounds of investment which reduced the Company's Original Interest to 25%. As a result, the Company recognized a gain on dilution of $503. The Company retained its right to receive additional interest in LanzaJet of up to 45&#160;million shares for no additional consideration. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of our equity method investments as of December&#160;31, 2021 and 2020 was approximately $3,100 and $3,800 less than our proportionate share of our equity method investees&#8217; book values, respectively. The basis differences relate primarily to our equity method investment in LanzaJet and are largely the result of a difference in the timing of recognition of variable consideration to which we may become entitled in exchange for our contribution of IP to LanzaJet. The variable consideration we may receive will be in the form of additional ownership interests and the majority of the basis difference will reverse in connection with recognition of that variable consideration. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with a sublicense agreement to LanzaJet under our license agreement with Battelle Memorial Institute (&#8220;Battelle&#8221;), LanzaTech remains responsible for any failure by LanzaJet to pay royalties due to Battelle. The fair value of LanzaTech&#8217;s obligation under this guarantee was immaterial as of December&#160;31, 2021 and 2020.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SGLT</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2011, the Company contributed RMB 25,800 (approx. $4,000) in intellectual property in exchange for 30% of the registered capital of SGLT. SGLT utilizes and develops technologies and know-how in connection with the production of anhydrous ethanol from steel mill waste gases. The contribution was recognized as revenue in 2011.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, as the result of the admittance of new investors, the Company&#8217;s interest in SGLT&#8217;s registered capital is approximately 10.01% and 11.14%, respectively. The Company recognized a gain from the dilution of $3,048 and $3,811 during the years ended December 31, 2021 and December 31, 2020, respectively. The Company has continued to apply the equity method of accounting to the investment as the Company maintains significant influence via representation on SGLT&#8217;s Board of Directors and SGLT's significant dependency on the intellectual property the Company contributed.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents summarized aggregated financial information of the equity method investments:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selected Statement of Operations Information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,703)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,510)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,695)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,729)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to the Company</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,606)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,644)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selected Balance Sheet Information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, there were no impairments of equity method investees. During 2021 and 2020, the Company received no dividends from equity method investments. As of and for the years ended December 31, 2021 and December 31, 2020, sales, accounts receivable, and purchases and open accounts payable with equity method investees were as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,253&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases and open accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI https://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211177312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9 &#8212; Fair Value Measurements </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information about the Company&#8217;s financial assets and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy:</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September 30, 2022</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other <br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held in trust account</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,969,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201;public warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201;private placement warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493,280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2021</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held in trust account</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,006,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201; public warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,825,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201;private placement warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transfers to/from Levels 1, 2 and 3 are recognized at the beginning of the reporting period. The estimated fair value of public warrants was transferred from a Level 3 fair value measurement to a Level 1 measurement, when the public warrants were separately listed and traded in September 2021. There were no other transfers between levels in the nine months ended September 30, 2022 and in the period from January 28, 2021 (inception) through December 31, 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 assets include investments in mutual funds invested in U.S. government securities and derivative warrant liabilities (public warrants). The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For periods where no observable traded price is available, the fair value of the public warrants has been estimated using a Monte-Carlo simulation model and the private placement warrants has been estimated using a Black-Scholes option pricing model. For periods subsequent to the detachment of the public warrants from the units, the fair value of the public warrants is based on the observable listed price for such warrants. The estimated fair value of the public and private placement warrants, prior to the public warrants being traded in an active market, was determined using Level 3 inputs. Inherent in a Monte-Carlo simulation and Black-Scholes option pricing model are assumptions related to the unit price, expected volatility, risk-free interest rate, term to expiration, and dividend yield. The unit price is based on the publicly traded price of the units as of the measurement date. The Company estimated the volatility for the public and private placement warrants based on the implied volatility from the traded prices of warrants issued by other special purpose acquisition companies. The risk-free interest rate is based on </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">interpolated U.S. Treasury rates, commensurate with a similar term to the public and private placement warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. Finally, the Company does not anticipate paying a dividend. Any changes in these assumptions can change the valuation significantly.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2022 and 2021, the Company recognized a change to the statement of operations resulting from a decrease (increase) in the fair value of liabilities of approximately $1.4 million and $1.4 million, respectively, presented as change in fair value of derivative warrant liabilities on the accompanying statements of operations. For the nine months ended September 30, 2022 and for the period from January 28, 2021 (inception) through September 30, 2021, the Company recognized a change to the statement of operations resulting from a decrease (increase) in the fair value of liabilities of approximately $4.1 million and $1.4 million, respectively, presented as change in fair value of derivative warrant liabilities on the accompanying statements of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30, 2022 </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2021 </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.19</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.75</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the fair value of the derivative warrant liabilities, measured using Level 3 inputs, for the three and nine months ended September 30, 2022 is summarized as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,030,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,085,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(451,720)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493,280&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9 &#8212; Fair Value Measurement </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information as of December 31, 2021 about the Company&#8217;s financial assets and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held in Trust Account</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,006,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities &#8211; Public Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,825,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities &#8211; Private Placement Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transfers to/from Levels 1, 2 and 3 are recognized at the beginning of the reporting period. The estimated fair value of public warrants was transferred from a Level 3 fair value measurement to a Level 1 measurement, when the public warrants were separately listed and traded in September 2021. There were no other transfers between levels in the period from January 28, 2021 (inception) through December 31, 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 assets include investments in mutual funds invested in U.S. government securities and derivative warrant liabilities (public warrants). The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For periods where no observable traded price is available, the fair value of the public warrants has been estimated using a Monte-Carlo simulation model and the private placement warrants has been estimated using a Black-Scholes option pricing model. For periods subsequent to the detachment of the public warrants from the units, the fair value of the public warrants is based on the observable listed price for such warrants. The estimated fair value of the public and private placement warrants, prior to the public warrants being traded in an active market, was determined using Level 3 inputs. Inherent in a Monte-Carlo simulation and Black-Scholes option pricing model are assumptions related to the unit price, expected volatility, risk-free interest rate, term to expiration, and dividend yield. The unit price is based on the publicly traded price of the units as of the measurement date. The Company estimated the volatility for the public and private placement warrants based on the implied volatility from the traded prices of warrants issued by other special purpose acquisition companies. The risk-free interest rate is based on interpolated U.S. Treasury rates, commensurate with a similar term to the public and private placement warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. Finally, the Company does not anticipate paying a dividend. Any changes in these assumptions can change the valuation significantly.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of <br/>December 31, 2021 </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of <br/>August 6, 2021 </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining term (yrs)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.75</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.51</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the fair value of the derivative warrant liabilities, measured using Level 3 inputs, for the period from January 28, 2021 (inception) through December 31, 2021 is summarized as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at January 28, 2021 (inception)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of Public and Private Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,515,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer of Public Warrants to Level 1</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,100,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(630,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6 &#8212; Fair Value</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value hierarchy for its assets and liabilities measured at fair value as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,815&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,815&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has warrants to purchase preferred shares outstanding as of September&#160;30, 2022 and December&#160;31, 2021 representing 225,223 and 225,223 preferred shares, respectively, which warrants expire at various dates through December 31, 2027. The exercise prices of the warrants range from $14.69 to $19.93 as of each of September&#160;30, 2022 and December&#160;31, 2021. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The warrants are accounted for as liabilities in accordance with ASC 480, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distinguishing Liability from Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and are presented within other accrued liabilities on the condensed consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the condensed consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The fair value of the warrants was calculated using the Black-Scholes Option Pricing Model. For the nine months ended September&#160;30, 2022 and 2021, the Company recognized a change in the fair value of liabilities of approximately $(427) and $(699), respectively, on the condensed consolidated statements of operations and comprehensive loss within other (expense) income, net.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the warrants is determined using Level 3 inputs. Inherent in the Black-Scholes Option Pricing Model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its warrants based on implied volatility from the Company&#8217;s warrants and from historical volatility of select peer companies that match the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the weighted average inputs used in calculating the fair value of the preferred share warrants outstanding as of September&#160;30, 2022 and December&#160;31, 2021:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.03&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SAFE Liability and SAFE Warrant</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company issued a SAFE that allowed an investor to participate in future equity financings through a share-settled redemption of the amount invested (such notional being the &#8220;invested amount&#8221;). The SAFE had not yet converted as a qualifying financing had not yet occurred as of September&#160;30, 2022. At September&#160;30, 2022, the SAFE had a fair value of $27,221 and was recorded within current liabilities on the condensed consolidated balance sheet. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, the warrant related to the SAFE of $2,022 as of September&#160;30, 2022 is accounted for as a liability. This liability is recorded in current liabilities on the Company's condensed consolidated balance sheets at fair value on the date of issuance and will be revalued each subsequent reporting period until such instrument is exercised or expires. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in fair value between reporting periods for both the SAFE liability and SAFE warrant is included in other (expense) income, net in the condensed consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s SAFE liability and SAFE warrant are mark-to-market liabilities pursuant to ASC 480 and are classified within Level 3 of the fair value hierarchy as the Company is using a scenario-based approach which allowed the Company to estimate the implied value of the business based on the terms of the SAFE. Significant unobservable inputs included probability and expected term. Probability is based upon the likelihood of the Company closing a transaction with a special purpose acquisition company. The expected term was based on the anticipated time until the SAFE investments would have a conversion event. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE liability fair value measurement at September&#160;30, 2022 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liquidity price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE warrant fair value measurement at September&#160;30, 2022 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining life (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables represents a reconciliation of the contingent shares issuance liabilities fair value measurements using the significant unobservable inputs (Level 3) (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrants</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE warrant</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss / (gain) recognized in condensed statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,050)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,221&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrants</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE warrant</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of SAFE liability and warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss recognized in condensed statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,281&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div>Fair Value<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value hierarchy for its assets and liabilities measured at fair value as of December&#160;31, 2021 and 2020 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:13pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The warrants are accounted for as liabilities in accordance with ASC 480 and are presented within other accrued liabilities on the consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the warrants was calculated using the Black-Scholes Option Pricing Model. For the years ended December&#160;31, 2021 and 2020, the Company recognized a change in the fair value of liabilities of approximately $(563) and $105, respectively, on the statements of operations and comprehensive loss within other income (expense), net.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the warrants is determined using Level 3 inputs. Inherent in the Black-Scholes Option Pricing Model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its warrants based on implied volatility from the Company&#8217;s warrants and from historical volatility of select peer companies that match the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the weighted average inputs used in calculating the fair value of the preferred share warrants outstanding as of December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s SAFE liability and SAFE warrant are mark-to-market liabilities pursuant to ASC 480 and are classified within Level 3 of the fair value hierarchy as the Company is using a scenario-based approach which allowed the Company to estimate the implied value of the business based on the terms of the SAFE. Significant unobservable inputs included probability and expected term. Probability is based upon the likelihood of the Company closing a transaction with a special purpose acquisition company. The expected term was based on the anticipated time until the SAFE investments would have a conversion event. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE liability fair value measurement at December 31, 2021 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liquidity price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE warrant fair value measurement at December 31, 2021 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining life (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents a reconciliation of the contingent shares issuance liabilities fair value measurements using the significant unobservable inputs (Level 3) (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain recognized in statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of SAFE liability and warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss recognized in statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, a warrant was exercised for a total issuance of 158,058 Series D preferred shares. The fair value of this warrant was $107 as of January 1, 2020 and was remeasured to zero as of December 31, 2020. As a result, the exercise had no impact on the consolidated statement of operations and comprehensive loss as of and for the year ended December 31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211108784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Current Assets<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCurrentAssetsTextBlock', window );">Other Current Assets</a></td>
<td class="text">Other Current Assets <div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020 other current assets consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Materials and supplies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,900&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,952&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,779&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,387&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272207828112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant, and Equipment<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text">Property, Plant and Equipment<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, the Company&#8217;s property, plant and equipment, net consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vehicles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office Equipment and furniture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,521&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,298&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment, net</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,148&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,609&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;padding-right:33.2pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation for the years ended December&#160;31, 2021 and 2020 totaled $3,806 and $2,979, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211118224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">Debt<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, the Company&#8217;s debt consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 WTI Loan</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPP Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,635&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less amount due within one year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt due after one year, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,065&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2016, a loan facility was entered into with Venture Lending and Leasing VII, Inc. and Venture Lending and Leasing VIII, Inc. (the &#8220;2016 WTI Loan&#8221;) for a total of $17,500 available in three tranches, all of which have been drawn. Tranches one and two were fully repaid as of December&#160;31, 2020. The coupon interest rate for each tranche is the WSJ prime rate, at the time of each drawdown, plus 9.0%, but not less than 12.5%. The term of each drawdown is 39 months, including nine months of interest-only payments. The loan facility was secured by all of the Company&#8217;s assets. In March 2021, the Company repaid $570 on outstanding amounts owed on the 2016 WTI loan facility. As of December&#160;31, 2021, tranche three was fully repaid and the Company has no outstanding debt under this facility. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was required to meet certain non-financial covenants in its loan facility agreement. In 2021 and 2020, the Company was in compliance with all non-financial covenants. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Paycheck Protection Program Loan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, the Company was granted a loan in the amount of $3,065 pursuant to the Paycheck Protection Program (the &#8220;PPP Loan&#8221;) under the Coronavirus Aid, Relief and Economic Security Act. The PPP Loan has a two-year term and bears interest at a rate of 0.98% per annum. Monthly principal and interest payments are deferred for six months after the date of disbursement. The PPP Loan may be prepaid at any time prior to maturity with no prepayment penalties. The PPP Loan contains events of default and other provisions customary for a loan of this type. The PPP Loan may be forgiven if used under program parameters for payroll, mortgage interest, and rent expenses. During 2021 and 2020, the Company was in compliance with the terms of the PPP Loan.</span></div>On September 28, 2021, the Company received notice that the obligation of $3,065 had been forgiven, and the Company has no outstanding debt under this program. The Company recorded the gain on extinguishment in the 2021 consolidated statement of operations and comprehensive loss.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211147968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SAFE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SimpleAgreementForFutureEquityLiabilityDisclosureTextBlock', window );">SAFE</a></td>
<td class="text">SAFE<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company issued a SAFE that allows an investor to participate in future equity financings through a share-settled redemption of the amount invested (such notional being the &#8220;invested amount&#8221;). Upon the occurrence of a change of control, the investor has the right to receive the greater of (i) a cash payment equal to the invested amount under such SAFE, or (ii) the consideration payable in such change of control in respect of the number of common shares equal to the invested amount divided by the liquidity price set forth in the applicable SAFE. Upon an initial public offering or a business combination with a special purpose acquisition company, the investor has the right to receive a number of common shares equal to the invested amount divided by the liquidity price set forth in the applicable SAFE, except that if a business combination with a special purpose acquisition company involves a private placement of newly issued shares, the invested amount will be treated as participating in such private placement and exchanged for a number of common shares equal to the invested amount divided by the price per share applicable in such private placement (subject to a discount upon certain circumstances).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SAFE also contains change of control and initial public offering settlement alternatives described above, that settle differently upon a next round financing such that it allows the investor to participate in future equity </span></div>financings through a share-settled redemption at a discounted price to the price paid by other investors. That is, upon a future equity financing involving preferred shares, the SAFE would be settled into a number of preferred shares equal to the invested amount of the SAFE divided by a percentage of the discounted price investors paid to purchase preferred shares in the financing, with such discounted price calculated as a percentage of the price investors paid to purchase preferred shares in the financing.The SAFE had not yet converted to equity as a qualifying financing event had not occurred as of December 31, 2021. At December 31, 2021, the SAFE had a fair value of $28,271 and was recorded within current liabilities on the consolidated balance sheet.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_SimpleAgreementForFutureEquityLiabilityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Simple Agreement for Future Equity Liability Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_SimpleAgreementForFutureEquityLiabilityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272210253088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrant Liabilities<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesAndFairValueTextBlock', window );">Warrant Liabilities</a></td>
<td class="text">Warrant Liabilities<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with certain loan borrowing agreements and equity raises, the Company issues warrants to purchase preferred shares. The Company evaluated the accounting treatment for the preferred share warrants issued and concluded pursuant to its evaluation of ASC 480, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distinguishing Liabilities From Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and determined that there is an obligation to issue a variable number of shares and as such, were considered a liability in the consolidated balance sheets. The warrant liability requires the Company to remeasure the value of the underlying warrants and report the effect of the changes on the Company&#8217;s operations until the warrants are exercised or expired. The primary underlying risk exposure pertaining to the warrants is the change in fair value of the underlying preferred shares for each reporting period.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesAndFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivatives and fair value of assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI https://asc.fasb.org/topic&amp;trid=2155941<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesAndFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211086688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10 &#8212; Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal and Connecticut jurisdictions and are subject to examination. The income tax provision consists of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Period from January 28, 2021<br/>(inception) through December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290,181)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s net deferred tax assets are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Start-up/Organization costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">210,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">290,181&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(290,181)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax asset, net of allowance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax assets, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the period from January 28, 2021 (inception) through December 31, 2021, the valuation allowance was $290,181. As of December 31, 2021, the Company had $380,351 of U.S. federal net operating loss carryovers, which do not expire, available to offset future taxable income.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no unrecognized tax benefits as of December 31, 2021. No amounts were accrued for the payment of interest and penalties as of December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company&#8217;s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the statutory federal income tax rate (benefit) to the Company&#8217;s effective tax rate (benefit) is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Period from January 28, 2021 (inception) through December 31, 2021 </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory federal income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative warrant liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(855.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Offering costs allocated to derivative warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div>Income Taxes<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to federal state income taxes in the United States, as well as income taxes in foreign jurisdictions in which it conducts business. The Company does not provide for federal income taxes on the undistributed earnings of its foreign subsidiaries as such earnings are reinvested indefinitely. The Company and its foreign subsidiaries have historically been loss generating entities that have resulted in no excess earnings to consider for repatriation and accordingly there are no deferred income taxes recognized for the nine months ended September&#160;30, 2022 and 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded an income tax expense of $0 for the nine months ended September&#160;30, 2022 and 2021, representing an effective tax rate of 0%. The difference between the U.S. federal statutory rate of 21% and the Company's effective tax rate in the first nine months ended September&#160;30, 2022 is primarily due to a full valuation allowance related to the Company's U.S. deferred tax assets and tax benefits in the Company's foreign jurisdictions. For the first nine months ended September 30, 2021, the Company's effective tax rate was computed based on income tax rate in New Zealand of 28.0% as the Company was still domiciled in New Zealand. The Company reassesses the need for a valuation allowance on a quarterly basis. If it is determined that a portion or all of the valuation allowance is not required, it will generally be a benefit to the income tax provision in the period such determination is made.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts business in multiple jurisdictions within and outside the United States. Consequently, the Company is subject to periodic income tax examinations by domestic and foreign income tax authorities. The Company is subject to audits for tax years 2009 and onward for federal purposes. There are tax years which remain subject to examination in various other state and foreign jurisdictions that are not material to the Company's financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, the Company migrated its country of domicile from New Zealand to Delaware in the United States. On migration, the Company was deemed to have disposed of all its assets and liabilities to a third-party at market value which resulted in taxable income to the Company for New Zealand income tax purposes which was fully offset by net operating loss carryforwards and deferred R&amp;D credits in New Zealand. The migration to Delaware is classified as a tax-free reorganization for U.S. federal income tax purposes.</span></div>Income Taxes<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of (loss) income before income taxes and gain from equity method investees, net are as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,860)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Zealand</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,551)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,651)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,689)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,713)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of income tax expense were as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Zealand</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Zealand</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of income taxes computed at the statutory federal income tax rate (21.0% federal income tax rate in the United States for 2021 and 28.0% federal income tax rate in the New Zealand for </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020, respectively) to the income tax expense (benefit) reflected in the consolidated statement of operations and comprehensive loss (in thousands, except percentages):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit) at the statutory federal income tax rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,805)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,560)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax rate differential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(605)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,068)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,429)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,892)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income on receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(443)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(679)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible legal costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from redomiciliation of intellectual property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPP loan forgiveness</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(644)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(196)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax benefit</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of deferred tax assets and liabilities as of December&#160;31, 2021 and 2020, were as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss and credit carryforwards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,979&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,878&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued bonus</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,881&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,417&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113,276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108,300)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax asset</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,117&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease asset</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,429)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,941)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,605)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,117)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net deferred income tax assets and liabilities:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021 and 2020, the Company had $299,194 and $271,390, respectively, of tax losses and credits carried forward subject to shareholder continuity and acceptance in the countries where the Company has tax losses carried forward. R&amp;D tax credits included within these amounts are $35,147 and $40,556, respectively, which may be available to offset future income tax liabilities. At December&#160;31, 2021 and 2020, the net operating loss and credit carryforwards are comprised of $239,559 and $196,442 in the United States, $22,203 and $18,104 in state and local, $35,116 and $54,334 in New Zealand, and $4,589 and $2,510 in other foreign jurisdictions, respectively. At December&#160;31, 2021 and 2020, the Company had net operating loss carryforwards of approximately $136,454 and $132,373, respectively, that expire in various years from 2022 through 2037, plus $127,593 and $98,462, respectively, for which there is no expiration date. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 382 of the Internal Revenue Code imposes an annual limitation on the utilization of net operating loss carryforwards based on a statutory rate of return and the value of the corporation at the time of a &#8220;change of ownership&#8221; as defined by Section 382. The Company had a change in ownership</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in November 2014. T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">herefore, the Company&#8217;s ability to utilize its net operating loss carryforwards incurred prior to the 2014 ownership change, will be subject in future periods to annual limitations. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In assessing the realizability of deferred tax assets, the Company assesses whether it is more-likely-than-not that a portion or all of the deferred tax assets will not be realized. The Company considers the scheduled reversal of deferred tax liabilities, tax planning strategies and projected future taxable income in making this assessment. At December&#160;31, 2021 and 2020, a valuation allowance of $113,276 and $108,300, respectively, was recorded against certain deferred tax assets based on this assessment. The Company believes it is more-likely-than-not that the tax benefit of the remaining net deferred tax assets will be realized. The amount of net deferred tax assets considered realizable could be increased or reduced in the future if the Company&#8217;s assessment of future taxable income or tax planning strategies changes.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its foreign subsidiaries have historically been loss generating entities that have resulted in no excess earnings to consider for repatriation and accordingly there are no deferred income taxes recognized as of December&#160;31, 2021 and 2020.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021 and 2020, the Company had no tax liability or benefit related to uncertain tax positions. No interest or penalties related to uncertain taxes have been recognized on the accompanying consolidated statements of operations. Management does not expect a significant change in uncertain tax positions during the twelve months subsequent to December 31, 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts business in multiple jurisdictions within and outside the United States. Consequently, the Company is subject to periodic income tax examinations by domestic and foreign income tax authorities. During December 2021, the Internal Revenue Service completed an income tax examination of the Company&#8217;s U.S. federal income tax return for the year ended December 31, 2016, which resulted in no impact to the Company&#8217;s consolidated financial statements. The Company has no other ongoing tax examinations with domestic or foreign taxing authorities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, the Company migrated its country of domicile from New Zealand to Delaware in the United States. On migration, the Company was deemed to have disposed of all its assets and liabilities to a third-party at market value which resulted in taxable income to the Company for New Zealand income tax purposes. The migration to Delaware is classified as a tax-free reorganization for U.S. federal income tax purposes.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272210762144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Share-Based Compensation<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers share option plans to employees, directors, and others providing similar employee-related services, which meet the definition of an equity-settled share-based payment.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has five ownership-based participation rights schemes for employees, directors, and certain third-party providers. In accordance with the provisions of the schemes, as approved by the directors and shareholders, grantees have been granted options to purchase common shares at an exercise price based on the fair value price of the Company&#8217;s common shares on the date of grant as approved by the directors. The stock options generally have a service condition of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzEyNjQ0MzgzNzI0Mzkx_1f5323c0-bbe0-45e6-bfd6-3ba4780f1116">two</span> to five years and vest over time as the service condition is being satisfied. Upon termination of employment, unvested stock options are evaluated for forfeiture or modifications, subject to the terms of the awards and Company's policies.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option awards outstanding as of September&#160;30, 2022 and changes during the period ended September&#160;30, 2022 were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares under option (thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average remaining contractual term (years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate intrinsic value (thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,848&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.16</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,796&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expecting to vest at January 1, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.16</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.85</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,806&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.39</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,032&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expecting to vest at September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.39</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.56</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded compensation expense of $2,067 and $1,790 for the nine months ended September&#160;30, 2022 and September&#160;30, 2021, respectively. Unrecognized compensation costs as of September&#160;30, 2022 was $3,835 and will be recognized over a weighted average of 2.27 years. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Awards (&#8220;RSAs&#8221;)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSAs become eligible to vest upon the satisfaction of a time-based service condition. However, in order to vest, a liquidity event, defined as acquisition, asset transfer, or initial listing, must occur within 10 years from the grant date. Upon a liquidity event, if the participant&#8217;s service has not terminated, the entire RSA award vests in full, whether or not previously eligible for vesting. If the participant&#8217;s service has terminated and they have satisfied the time-based service condition, the RSAs that are outstanding and eligible for vesting shall immediately vest in full. The time-based service requirements of the RSAs have a maximum term of three years from the date of grant.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, there were 579,660 outstanding unvested shares for a weighted average fair value of $4.72. There were no changes during the nine months ended September&#160;30, 2022.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, and September&#160;30, 2021 the Company concluded that the liquidity event performance condition described above for the RSAs was not probable of being satisfied at such time. As a result, the Company did not recognize any compensation cost during the nine months ended September&#160;30, 2022 and September&#160;30, 2021 for any RSAs granted.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div>Stock-Based Compensation<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers share option plans to employees, directors, and others providing consulting services, which meet the definition of an equity-settled stock-based payment.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has five ownership-based participation rights schemes for employees, directors, and certain third-party providers. In accordance with the provisions of the schemes, as approved by the directors and shareholders, grantees have been granted options to purchase common shares at an exercise price based on the fair value price of the Company&#8217;s common shares on the date of grant as approved by the directors. The stock options generally have a service condition of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEwOTk1MTE2Mjg0Mzgw_848b9b44-6118-41f1-9447-548b3ddf83fb">two</span> to five years and vest over time as the service condition is being satisfied. In November 2020, the Company granted 151,068 options which have a performance condition that accelerates vesting on liquidity event. All stock options have a term of 10 years from the date of grant. Upon termination of employment, unvested stock options are evaluated for forfeiture or modifications, subject to the terms of the awards and Company's policies.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option awards outstanding as of December&#160;31, 2021 and changes during the year ended December&#160;31, 2021 were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares under option (thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average remaining contractual term (years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate intrinsic value (thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at January 1, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,283&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.09</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expecting to vest at January 1, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.09</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable at January 1, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.47</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(721)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited/expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(334)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,848&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.16</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,796&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expecting to vest at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.16</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable at December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.85</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded compensation expense of $2,531 and $2,392 for the years ended December&#160;31, 2021 and 2020, respectively. Unrecognized compensation costs as of December&#160;31, 2021 was $6,120 and will be recognized over a weighted average of 2.7 years. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each stock option award was estimated on each grant date using the Black-Scholes option pricing model. The following assumptions were used and required significant judgment to determine:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Expected Term</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; the Company used the &#8220;simplified method&#8221; for estimating the expected term of plain-vanilla options, whereby the expected term equals the arithmetic average of the vesting term and LanzaTech&#8217;s contractual term of the option. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Risk-Free Interest Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The risk-free interest rate is based on the U.S. Treasury zero-coupon instruments with maturities similar to the expected term of LanzaTech&#8217;s stock options. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Expected Dividend</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; the expected dividend yield is based on the Company's expectation of future dividend payouts to common stockholders. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Expected Volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Due to the Company's limited historical data, a group of similar companies that are publicly traded was used to estimate the expected volatility. The historical volatility data was computed using the daily closing prices for the various companies' shares during the equivalent period of the calculated expected term of the stock-based awards.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the weighted-average assumptions applied in the Black-Scholes valuation of options for awards subject to expense recognition for the first time in the period, for the years ended December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant date fair value of options granted during 2021 and 2020 was $6.29 and $3.99 per option, respectively.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Awards (&#8220;RSAs&#8221;)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSAs become eligible to vest upon the satisfaction of a time-based service condition. However, in order to vest, a liquidity event, defined as acquisition, asset transfer, or initial listing, must occur within 10 years from the grant date. Upon a liquidity event, if the participant&#8217;s service has not terminated, the entire RSA award vests in full, whether or not previously eligible for vesting. If the participant&#8217;s service has terminated and they have satisfied the time-based service condition, the RSAs that are outstanding and eligible for vesting shall immediately vest in full. The time-based service requirements of the RSAs have a maximum term of three years from the date of grant.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSAs as of December&#160;31, 2021 and changes during the year ended December&#160;31, 2021 were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nonvested Shares (thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at January 1, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.76&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.72&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, the Company concluded that the liquidity event performance condition described above for the RSAs was not probable of being satisfied at such time. As a result, the Company did not recognize any compensation cost during the years ended December&#160;31, 2021 and 2020 for any RSAs granted.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272210248352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4 &#8212; Related Party Transactions</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Founder Shares</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2021, the Sponsor paid $25,000, or approximately $0.005 per share, to cover certain offering costs in consideration for 5,031,250 shares of Class B common stock, par value $0.0001. In March 2021, the Sponsor transferred all of the founder shares it held to members of the Company&#8217;s board of directors, management </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">team, and persons or entities affiliated with AMCI Group (the &#8220;initial shareholders&#8221;). Such shares were fully paid. On May 14, 2021, the Sponsor surrendered 718,750 founder shares to the Company for no consideration, resulting in the Sponsor owning 4,312,500 founder shares. Up to 562,500 of the founder shares will be forfeited depending on the extent to which the underwriters&#8217; over-allotment is exercised. On September 17, 2021, the over-allotment option expired unexercised, resulting in 562,500 of the founder shares being forfeited.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In exchange for the Anchor Investors&#8217; participation in the initial public offering as described in Note 3, the Sponsor sold a total of 780,000 founder shares to the Anchor Investors. The Company determined that the fair value of these founder shares was approximately $6.5 million (or approximately $8.35 per share) using a Monte Carlo simulation. The Company recognized the excess fair value of these founder shares, over the price sold to the Anchor Investors, as an expense of the initial public offering resulting in a charge against the carrying value of Class A common stock subject to possible redemption.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial stockholders have agreed not to transfer, assign or sell any of their founder shares and any Class A common stocks issuable upon conversion thereof until the earlier to occur of: (A) one year after the completion of the initial business combination and (B) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction after the Company&#8217;s initial business combination that results in all of the Company&#8217;s stockholders having the right to exchange their Class A common stock for cash, securities or other property; except to certain permitted transferees and under certain circumstances (the &#8220;Lock-up&#8221;). Any permitted transferees will be subject to the same restrictions and other agreements of the company&#8217;s initial stockholders with respect to any founder shares. Notwithstanding the foregoing, the founder shares will be released from the Lock-up if the closing price of the Company&#8217;s Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the company&#8217;s initial business combination.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Private Placement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Simultaneously with the closing of the initial public offering, the Company&#8217;s Sponsor has purchased an aggregate of 3,500,000 private placement warrants, each exercisable to purchase one Class A common stock at $11.50 per share, at a price of $1.00 per warrant, or $3,500,000 in the aggregate.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The private placement warrants will not be redeemable by the Company so long as they are held by the initial purchasers or their permitted transferees. The initial purchasers, or their permitted transferees, have the option to exercise the private placement warrants on a cashless basis. If the private placement warrants are held by holders other than initial purchasers or their permitted transferees, the private placement warrants will be redeemable by the Company and exercisable by the holders on the same basis as the warrants included in the units being sold in the initial public offering. Otherwise, the private placement warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in the initial public offering.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the private placement warrants are held by holders other than the Sponsor or its permitted transferees, the private placement warrants will be redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the units being sold in the initial public offering.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Loans and Advances</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2021, the Sponsor agreed to loan the Company up to $300,000 to be used for a portion of the expenses of the initial public offering (&#8220;Note&#8221;). This loan was non-interest bearing, unsecured and payable upon the closing of the initial public offering. In addition to the Note, the Sponsor of the Company also paid certain administrative expenses and offering costs on behalf of the Company. These advances were due on demand and were non-interest bearing. The Company repaid the note payable and advances in exchange for the issuance of private placement warrants.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Working Capital Loans</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in order to finance transaction costs in connection with an intended business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#8217;s officers and directors may, but are not obligated </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to, loan the Company funds as may be required on a non-interest basis (&#8220;Working Capital Loans&#8221;). If the Company completes the initial business combination, it will repay the Working Capital Loans. In the event that the initial business combination does not close, the Company may use a portion of the working capital held outside the trust account to repay the Working Capital Loans but no proceeds from the trust account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-business combination entity at a price of $1.00 per warrant at the option of the lender. Such warrants would be identical to the private placement warrants. Except as set forth above, the terms of Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. On March 28, 2022, the Company entered into a noninterest-bearing Working Capital Loan with its Sponsor for the principal amount of up to $1.5 million. As of September 30, 2022 and December 31, 2021, the Company had no borrowings under the Working Capital Loans.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Administrative Service Fee</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the closing of the initial public offering, the Company will pay its Sponsor $10,000 per month for office space, secretarial and administrative services provided to members of the management team. Upon completion of the initial business combination or the Company&#8217;s liquidation, the Company will cease paying these monthly fees. For the three months ended September 30, 2022 and 2021, the Company incurred $30,000 and $20,000, respectively, of such fees, included as general and administrative fees &#8212; related party on the accompanying unaudited condensed statements of operations. For the nine months ended September 30, 2022 and for the period from January 28, 2021 (inception) through September 30, 2021, the Company incurred $90,000 and $20,000, respectively, of such fees, included as general and administrative fees &#8212; related party on the accompanying unaudited condensed statements of operations. As of September 30, 2022 and December 31, 2021, approximately $90,000 and $50,000, respectively, of such fees were included in due to related party on the accompanying condensed balance sheets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sponsor, officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on the Company&#8217;s behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. The Company&#8217;s audit committee will review on a quarterly basis all payments that were made by the Company to the Sponsor, directors, officers or directors of the Company, or any of their affiliates. As of September 30, 2022 and December 31, 2021, there were approximately $596,000 and $0, respectively, of such fees included as due to related party on the accompanying condensed balance sheets.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4 &#8212; Related Party Transactions</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Founder Shares</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2021, the Sponsor paid $25,000, or approximately $0.005 per share, to cover certain offering costs in consideration for 5,031,250 shares of Class B common stock, par value $0.0001. In March 2021, the Sponsor transferred all of the founder shares it held to members of the Company&#8217;s board of directors, management team, and persons or entities affiliated with AMCI Group (the &#8220;initial shareholders&#8221;). Such shares were fully paid. On May 14, 2021, the Sponsor surrendered 718,750 founder shares to the Company for no consideration, resulting in the Sponsor owning 4,312,500 founder shares. Up to 562,500 of the founder shares will be forfeited depending on the extent to which the underwriters&#8217; over-allotment is exercised. On September 17, 2021, the over-allotment option expired unexercised, resulting in 562,500 of the founder shares being forfeited.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In exchange for the Anchor Investors&#8217; participation in the initial public offering as described in Note 3, the Sponsor sold a total of 780,000 founder shares to the Anchor Investors. The Company determined that the fair value of these founder shares was approximately $6.5 million (or approximately $8.35 per share) using a Monte Carlo simulation. The Company recognized the excess fair value of these founder shares, over the price sold to the Anchor Investors, as an expense of the initial public offering resulting in a charge against the carrying value of Class A common stock subject to possible redemption.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial stockholders have agreed not to transfer, assign or sell any of their founder shares and any Class A common stocks issuable upon conversion thereof until the earlier to occur of: (A) one year after the completion of the initial business combination and (B) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction after the Company&#8217;s initial business combination that results in all of the Company&#8217;s stockholders having the right to exchange their Class A common stock for cash, securities or other property; except to certain permitted transferees and under certain circumstances (the &#8220;Lock-up&#8221;). Any permitted transferees will be subject to the same restrictions and other agreements of the company&#8217;s initial stockholders with respect to any founder shares. Notwithstanding the foregoing, the founder shares will be released from the Lock-up if the closing price of the Company&#8217;s Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the company&#8217;s initial business combination.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Private Placement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Simultaneously with the closing of the initial public offering, the Company&#8217;s Sponsor has purchased an aggregate of 3,500,000 private placement warrants, each exercisable to purchase one Class A common stock at $11.50 per share, at a price of $1.00 per warrant, or $3,500,000 in the aggregate.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The private placement warrants will not be redeemable by the Company so long as they are held by the initial purchasers or their permitted transferees. The initial purchasers, or their permitted transferees, have the option to exercise the private placement warrants on a cashless basis. If the private placement warrants are held by holders other than initial purchasers or their permitted transferees, the private placement warrants will be redeemable by the Company and exercisable by the holders on the same basis as the warrants included in the units being sold in the initial public offering. Otherwise, the private placement warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in the initial public offering.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the private placement warrants are held by holders other than the Sponsor or its permitted transferees, the private placement warrants will be redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the units being sold in the initial public offering.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Loans and Advances</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2021, the Sponsor agreed to loan the Company up to $300,000 to be used for a portion of the expenses of the initial public offering (&#8220;Note&#8221;). This loan was non-interest bearing, unsecured and payable upon the closing of the initial public offering. In addition to the Note, the Sponsor of the Company also paid certain administrative expenses and offering costs on behalf of the Company. These advances were due on demand and were non-interest bearing. The Company repaid the note payable and advances in exchange for the issuance of private placement warrants.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in order to finance transaction costs in connection with an intended business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#8217;s officers and directors may, but are not obligated to, loan the Company funds as may be required on a non-interest basis (&#8220;Working Capital Loans&#8221;). If the Company completes the initial business combination, it will repay the Working Capital Loans. In the event that the initial business combination does not close, the Company may use a portion of the working capital held outside the trust account to repay the Working Capital Loans but no proceeds from the trust account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-business combination entity at a price of $1.00 per warrant at the option of the lender. Such warrants would be identical to the private placement warrants. Except as set forth above, the terms of Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of December 31, 2021, the Company had no borrowings under the Working Capital Loans.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Administrative Service Fee</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the closing of the initial public offering, the Company will pay its Sponsor $10,000 per month for office space, secretarial and administrative services provided to members of the management team. Upon completion of the initial business combination or the Company&#8217;s liquidation, the Company will cease paying these monthly fees. For the period from January 28, 2021 (inception) through December 31, 2021, the Company incurred $50,000 of such fees, included as general and administrative fees &#8212; related party on the accompanying statement of operations. As of December 31, 2021, approximately $50,000 of such fees are included as due to related party on the accompanying balance sheet.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9 &#8212; Related Party Transactions</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021, the Company had an equity ownership in LanzaJet and SGLT with an aggregate carrying value of $26,037 and $24,752, respectively. The table below summarizes amounts related to transactions with these related parties (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,116&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,509&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases and open accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounts payable balance is for work that LanzaJet performed as a subcontractor to the Company. Refer to Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for more information. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the formation of LanzaJet, the Company entered into a transition services agreement with LanzaJet. The transition services agreement generally sets out the respective rights, responsibilities and obligations of the Company and LanzaJet with respect to R&amp;D services, access to office and laboratory space, business development and other administrative support services. The transition services agreement may be terminated by mutual consent of the Company and LanzaJet, by LanzaJet at any time, and by the Company upon breach or non-payment by LanzaJet. There are no substantive termination penalties in the event the Company terminates. For the nine months ended September&#160;30, 2022 and September&#160;30, 2021, the Company recognized revenue from related parties of approximately $148 and $355, respectively, under the transition services agreement. The Company also provides certain engineering and other services related to a gas-to-jet demonstration plant currently in development by LanzaJet pursuant to the Investment Agreement described in Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In connection with these services, the Company recognized revenue from LanzaJet of approximately $170 and $403, for the nine months ended September&#160;30, 2022 and September&#160;30, 2021, respectively. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, the Company executed an agreement to lease certain land to a subsidiary of LanzaJet for a period of 10 years with an option to renew this lease for five additional periods of one year with minimum annual rent due to the Company of $24. The lease commenced upon execution of the lease agreement and was subsequently amended in 2022 to extend the Pre-Development Term and annual rent amount. Refer to Note 12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for more information.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company supplies SGLT with certain water-soluble organic compounds required in the Company's proprietary gas fermentation process, and small-size equipment. As a result, for the nine months ended September&#160;30, 2022 and September&#160;30, 2021, the Company recognized revenue from related parties of approximately $151 and $69, respectively. The Company also provided engineering services and incurred costs of $$893 and $1,171 for the nine months ended September&#160;30, 2022 and September&#160;30, 2021, respectively. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, LanzaTech and SGLT entered into a license agreement in 2019, subsequently amended in 2021, to provide SGLT with the right to sublicense the intellectual property that LanzaTech previously licensed to SGLT. In exchange, the Company is entitled to receive licensing consideration, calculated as a percentage of the royalties received by SGLT from the sublicenses. Currently, SGLT sublicenses to certain of its subsidiaries that use LanzaTech's proprietary technology. The royalties received by SGLT are based on sales-and-usage of the sublicensed technology. For the nine months ended September&#160;30, 2022, and September&#160;30, 2021, the Company did not earn any sublicensing revenue as no royalties were received by SGLT.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div>Related Party Transactions<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, the Company had an equity ownership in LanzaJet and SGLT with an aggregate carrying value of $24,752 and $23,217, respectively. Trade receivables and contract assets of $1,071 and $3,257, from these equity method investees are included in accounts receivable, respectively. The Company made purchases and had open accounts payable of $2,575 as of and for the year ended December&#160;31, 2021. The accounts payable balance is for work that LanzaJet performed as a subcontractor to the Company. Refer to Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s, for more information.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the formation of LanzaJet, the Company entered into a transition services agreement with LanzaJet. The transition services agreement generally sets out the respective rights, responsibilities and obligations of the Company and LanzaJet with respect to R&amp;D services, business development and other administrative support services. The transition services agreement may be terminated by mutual consent of the Company and LanzaJet, by LanzaJet at any time, and by the Company upon breach or non-payment by LanzaJet. There are no substantive termination penalties in the event the Company terminates. During the years ended December&#160;31, 2021 and 2020, the Company recognized revenue from related parties of approximately $495 and $285, respectively, under the transition services agreement. The Company provides certain engineering and other services related to a gas-to-jet demonstration plant currently in development by LanzaJet pursuant to the Investment Agreement described in Note 5 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As a result, during the years ended December&#160;31, 2021 and 2020, the Company recognized revenue from related parties of approximately $428 and $2,740, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company supplies SGLT with its biocatalyst, certain water-soluble organic compounds required in the Company's proprietary gas fermentation process, and small-size equipment. As a result, during 2021 and 2020 the Company recognized revenue from related parties of approximately $282 and $156, respectively. The Company also provided engineering services and incurred costs of $1,223 and $242 during the years ended December&#160;31, 2021 and 2020, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, LanzaTech and SGLT entered into a license agreement in 2019, subsequently amended in 2021, to provide SGLT with the right to sublicense the intellectual property that LanzaTech previously licensed to SGLT. In </span></div>exchange, the Company is entitled to receive licensing consideration, calculated as a percentage of the royalties received by SGLT from the sublicenses. Currently, SGLT sublicenses to certain of its subsidiaries that use LanzaTech's proprietary technology. The royalties to be received by SGLT are based on sales-and-usage of the sublicensed technology. For the years ended December&#160;31, 2021 and 2020, the Company did not earn any sublicensing revenue as no royalties were received by SGLT.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272210226512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholders&#8217; Equity</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7 &#8212; Stockholders&#8217; Equity (Deficit)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Preferred Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 and provides that shares of preferred stock may be issued from time to time in one or more series. The Company&#8217;s board of directors will be authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">applicable to the shares of each series. As of September 30, 2022 and December 31, 2021, there were no shares of preferred stock issued or outstanding.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Class A Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The Company is authorized to issue 280,000,000 shares of Class A common stock with a par value of $0.0001 per share. As of September 30, 2022 and December 31, 2021, there were 15,000,000 shares of Class A common stock issued and outstanding, all of which were subject to possible redemption and are classified as temporary equity (see Note 6).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Class B Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The Company is authorized to issue 20,000,000 Class B common stock with a par value of $0.0001 per share. As of September 30, 2022 and December 31, 2021, there were 3,750,000 shares of Class B common stock issued and outstanding (see Note 4).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of the Company&#8217;s stockholders except as required by law. Unless specified in the Company&#8217;s amended and restated certificate of incorporation, or as required by applicable provisions of the Delaware General Corporation Law (&#8220;DGCL&#8221;) or applicable stock exchange rules, the affirmative vote of a majority of the Company&#8217;s shares of common stock that are voted is required to approve any such matter voted on by its stockholders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Class B common stock will automatically convert into shares of Class A common stock concurrently with or immediately following the consummation of the initial business combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in connection with the initial business combination, the number of shares of Class A common stock issuable upon conversion of all founder shares will equal, in the aggregate, on an as-converted basis, 20% of the total number of shares of Class A common stock outstanding after such conversion (after giving effect to any redemptions of shares of Class A common stock by public stockholders), including the total number of shares of Class A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial business combination, excluding any shares of Class A common stock or equity-linked securities or rights exercisable for or convertible into shares of Class A common stock issued, or to be issued, to any seller in the initial business combination and any private placement warrants issued to the Sponsor, officers or directors upon conversion of working capital loans, provided that such conversion of founder shares will never occur on a less than one-for-one basis.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7 &#8212; Stockholders&#8217; Deficit</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Preferred Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 and provides that shares of preferred stock may be issued from time to time in one or more series. The Company&#8217;s board of directors will be authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. As of December 31, 2021, there were no shares of preferred stock issued or outstanding.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Class A Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The Company is authorized to issue 280,000,000 shares of Class A common stock with a par value of $0.0001 per share. As of December 31, 2021, there were 15,000,000 shares of Class A common stock issued and outstanding, all of which were subject to possible redemption and are classified as temporary equity (see Note 6).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Class B Common Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; The Company is authorized to issue 20,000,000 Class B common stock with a par value of $0.0001 per share. As of December 31, 2021, there were 3,750,000 shares of Class B common stock issued and outstanding (see Note 4).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of the Company&#8217;s stockholders except as required by law. Unless specified in the Company&#8217;s amended and restated certificate of incorporation, or as required by applicable provisions of the Delaware General Corporation Law (&#8220;DGCL&#8221;) or applicable stock exchange rules, the affirmative vote of a majority of the Company&#8217;s shares of common stock that are voted is required to approve any such matter voted on by its stockholders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Class B common stock will automatically convert into shares of Class A common stock concurrently with or immediately following the consummation of the initial business combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in connection with the initial business combination, the number of shares of Class A common stock issuable upon conversion of all founder shares will equal, in the aggregate, on an as-converted basis, 20% of the total number of shares of Class A common stock outstanding after such conversion (after giving effect to any redemptions of shares of Class A common stock by public stockholders), including the total number of shares of Class A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial business combination, excluding any shares of Class A common stock or equity-linked securities or rights exercisable for or convertible into shares of Class A common stock issued, or to be issued, to any seller in the initial business combination and any private placement warrants issued to the Sponsor, officers or directors upon conversion of working capital loans, provided that such conversion of founder shares will never occur on a less than one-for-one basis.</span></div>Shareholders&#8217; EquityThe securities of the Company are represented by common shares, par value $0.0001 per share. Each common share is entitled to one vote. With respect to payment of dividends and distribution of assets upon liquidation, dissolution or winding up of the Company, whether voluntary or involuntary, all common shares shall participate pro rata in such payment whenever funds are legally available and when declared by the Board of Directors of the Company, subject to the prior rights of holders of all classes of stock outstanding.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272208300144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable, Convertible Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityDisclosureTextBlock', window );">Redeemable, Convertible Preferred Stock</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6 &#8212; Class A Common Stock Subject to Possible Redemption</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of future events. The Company is authorized to issue 280,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of the Company&#8217;s Class A common stock are entitled to one vote for each share. As of September 30, 2022 and December 31, 2021, there were 15,000,000 shares of Class A common stock outstanding subject to possible redemption and are classified outside of permanent equity in the condensed balance sheets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Class A common stock subject to possible redemption reflected on the condensed balance sheets is reconciled in the following table:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross proceeds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount allocated to public warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,100,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,306,092)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of carrying value to redemption value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,406,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock subject to possible redemption, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subsequent remeasurement of Class A common stock subject to possible redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock subject to possible redemption, September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,293,649&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6 &#8212; Class A Common Stock Subject to Possible Redemption</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of future events. The Company is authorized to issue 280,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of the Company&#8217;s Class A common stock are entitled to one vote for each share. As of December 31, 2021, there were 15,000,000 shares of Class A common stock outstanding subject to possible redemption and are classified outside of permanent equity in the balance sheet.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Class A common stock subject to possible redemption reflected on the balance sheet is reconciled in the following table:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross proceeds from Initial Public Offering</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of Public Warrants at issuance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,100,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Offering costs allocated to Class A common stock subject to possible redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,306,092)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion on Class A common stock subject to possible redemption amount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,406,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock subject to possible redemption</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Redeemable, Convertible Preferred Stock<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has six outstanding series of contingently redeemable convertible preferred stock. The authorized, issued and outstanding shares, issue price, and carrying value as of September&#160;30, 2022, are as follows (in thousands, except share and per share amounts):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.287%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares Authorized</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.75 - 3.94</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,254,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.69</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,274,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,161,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.93</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series F</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,747,033&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,631&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in redeemable convertible preferred stock issued and outstanding during the nine months ended September&#160;30, 2022. The holders of preferred shares are entitled to receive dividends on an as converted to common shares basis as if all preferred shares had been converted into common shares on the date of such event. Dividends are cumulative and are payable in arrears at the rate of 8% of the original issue price.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, a warrant was exercised for a total issuance of 158,058 Series D preferred shares which led to an increase in redeemable convertible preferred stock of $3,150 during the nine months ended September&#160;30, 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redemption features of preferred shares are not fixed and do not have a determinable price on fixed or determinable dates. As of September&#160;30, 2022, the preferred shares are not currently redeemable, and it is not probable that the preferred shares will become redeemable, since it is uncertain whether or when circumstances exist that would constitute a deemed liquidation event. Accordingly, the Company has not adjusted the carrying value of the preferred shares to their redemption values.</span></div>Redeemable, Convertible Preferred Stock<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has six outstanding series of contingently redeemable convertible preferred stock. The authorized, issued and outstanding shares, issue price, and carrying value as of December&#160;31, 2021 and 2020 are as follows (in thousands, except share and per share amounts):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares Authorized</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.75 - 3.94</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,254,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.69</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,274,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,161,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.93</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series F</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,747,033&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,631&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares Authorized</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Issue Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.75 - 3.94</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,254,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,142,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,274,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,003,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">185,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,112,823&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,729,542&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">394,408&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable convertible preferred stock issued and outstanding as of December&#160;31, 2021 and 2020, and changes during the years ended December&#160;31, 2021 and 2020, were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.874%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.508%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.470%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.310%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="81" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Redeemable Convertible Preferred Stock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series B</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series C</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series D</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series E</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series F</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10,003,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">185,252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,149,745&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">71,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">23,695,330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">347,938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Preferred stock issuance, net of costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,034,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">46,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,034,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">46,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10,003,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">185,252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">25,729,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">394,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Preferred stock issuance, net of costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">158,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,792,268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">86,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10,161,362&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">188,402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">480,631&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records all preferred shares net of offering costs at their respective fair values on the dates of issuance. The preferred shares are classified outside of shareholders&#8217; (deficit) equity in the consolidated financial statements, as the preferred shares are redeemable under circumstances that qualify as a deemed liquidation event, which are outside the control of the Company. Upon the occurrence of a liquidation event, such as a voluntary or involuntary liquidation, dissolution or winding up of the Company, merger, consolidation, or change in control, the holders of Series E preferred stock are entitled, on a pari passu basis, to be paid out of the assets of the Company available for distribution before any payment is made to the holders of Series A, B, C, and D preferred shares and then to holders of common shares. In February 2020, the Company closed a Series E follow-on round with the issuance of 2,034,212 Series E preferred shares for net proceeds of $46,470 ($22.86 per share). In March 2021, a warrant was exercised for a total issuance of 158,058 Series D preferred shares and net proceeds of $3,150 ($19.93 per share). In April 2021, the Company closed a Series F round with the issuance of 3,634,210 Series F preferred shares for the net proceeds of $83,073 ($22.86 per share).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of preferred shares are entitled to cast the number of votes equal to the number of whole common shares into which the preferred shares are convertible. The holders of preferred shares also have consent rights, including in a number of cases subject to a separate class vote and a supermajority requirement, over certain actions including, among others (i) alterations or changes to the terms of the preferred shares, (ii) the election of a certain number of directors, including the designation of directors by holders of a specified series of preferred shares or by certain specified individual stockholders, and (iii) repurchases of shares, the authorization or designation of more senior class or series of shares, or certain issuances of new shares.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preferred shares are convertible at the holder&#8217;s option into common shares generally on a share-for-share basis. Each preferred share will be automatically converted into common stock upon either (i) the determination of the holders of certain requisite preferred shares or (ii) a firmly underwritten initial public offering of the Company&#8217;s shares that satisfies certain requirements (but not, for the avoidance of doubt, upon a business combination with a special purpose acquisition company, unless such conversion is otherwise effected pursuant to clause (i) above).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of preferred shares are entitled to receive dividends on an as converted to common shares basis as if all preferred shares had been converted into common shares on the date of such event. Dividends are cumulative and are payable in arrears at the rate of 8% of the original issue price. If dividends are payable on common shares, preferred shareholders also receive those dividends as if the preferred shares had been converted to common shares. Series D, E, and F preferred shareholders are entitled to be paid dividends prior to Series A, B, and C, on a pari passu basis. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redemption features of preferred shares are not fixed and do not have a determinable price on fixed or determinable dates. As of December&#160;31, 2021 and 2020, preferred shares are not currently redeemable, and it is not probable that preferred shares will become redeemable, since it is uncertain whether or when circumstances exist </span></div>that would constitute a deemed liquidation event. Accordingly, the Company has not adjusted the carrying value of the preferred shares to their redemption values.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TemporaryEquityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure on temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TemporaryEquityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211158880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsAbstract', window );"><strong>Postemployment Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanTextBlock', window );">Benefit Plans</a></td>
<td class="text">Benefit PlansThe Company sponsors a 401(k) defined contribution retirement plan for the benefit of its employees, substantially all of whom are eligible to participate after meeting minimum qualifying requirements. Contributions to the plan are at the discretion of the Company. For the years ended December&#160;31, 2021 and 2020, the Company contributed $720 and $548, respectively, to the plan, which contributions are included within research and development expense in the consolidated statements of operations and comprehensive loss.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 715<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472162&amp;loc=d3e58407-109430<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2235042<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272293333824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5 &#8212; Commitments and Contingencies</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Registration Rights</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of the (i) founder shares, which were issued in a private placement prior to the closing of the initial public offering, (ii) private placement warrants, which were issued in a private placement simultaneously with the closing of the initial public offering and the shares of Class A common stock underlying such private placement warrants and (iii) private placement warrants that may be issued upon conversion of Working Capital Loans will have registration rights to require the Company to register a sale of any of its securities held by them prior to the consummation of the initial business combination pursuant to a registration rights agreement to be signed prior to or on the effective date of the initial public offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent to the Company&#8217;s completion of its initial business combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. In addition, the Anchor Investors will, upon receipt of their founder shares, execute a registration rights agreement with respect to their founder shares.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Underwriting Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted the underwriters a 45-day option from the date of the underwriting agreement to purchase up to an additional 2,250,000 units to cover over-allotments, if any. On September 17, 2021, the over-allotment option expired unexercised, resulting in the forfeiture of 562,500 shares of founder shares. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters were paid an underwriting discount of one percent (1%) of the gross proceeds of the initial public offering, or $1,500,000. Additionally, in connection with the initial public offering, the Company agreed to pay the underwriters a deferred underwriting fee of 3.5% of the gross proceeds, or $5,250,000, of the initial public offering upon the completion of the Company&#8217;s initial business combination. On September 29, 2022, as discussed further below, Evercore Group L.L.C., (&#8220;Evercore&#8221;) the representative of the underwriters of the initial public offering, waived its deferred underwriting fee that accrued from its participation in the initial public offering. The Company recognized approximately $4.9 million of the commissions waiver as a reduction to additional paid-in capital in the condensed statements of changes in stockholders&#8217; deficit for the three and nine months ended September 30, 2022, as this portion represents an extinguishment of deferred underwriting commissions on public shares which was originally recognized in accumulated deficit. The remaining balance of approximately $172,000 is recognized as a gain from extinguishment of deferred underwriting commissions on public warrants in the condensed statements of operations, which represents the original amount expensed in the Company&#8217;s initial public offering.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 27, 2022 and September 29, 2022, the Company received notice and a formal letter, respectively, from Evercore Group, L.L.C., an underwriter in the Company&#8217;s initial public offering, advising that it had, among other things, (i) resigned from and ceased or refused to act in, its roles as co-placement agent, co-capital markets advisor and exclusive financial advisor to the Company in connection with the Merger and as underwriter in the Company&#8217;s initial public offering and (ii) waived its right to receive an aggregate of $13,050,000 in fees, all of which were contingent upon and payable upon the closing of the Merger, consisting of $500,000 for its role as co-placement agent, $7,500,000 for its role as exclusive financial advisor and $5,050,000 of deferred underwriting fees accrued from its participation in the Company&#8217;s initial public offering, as well as any expense reimbursements owed to it under those arrangements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5 &#8212; Commitments and Contingencies</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Registration Rights</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of the (i) founder shares, which were issued in a private placement prior to the closing of the initial public offering, (ii) private placement warrants, which were issued in a private placement simultaneously with the closing of the initial public offering and the shares of Class A common stock underlying such private placement </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">warrants and (iii) private placement warrants that may be issued upon conversion of Working Capital Loans will have registration rights to require the Company to register a sale of any of its securities held by them prior to the consummation of the initial business combination pursuant to a registration rights agreement to be signed prior to or on the effective date of the initial public offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent to the Company&#8217;s completion of its initial business combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. In addition, the Anchor Investors will, upon receipt of their founder shares, execute a registration rights agreement with respect to their founder shares.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Underwriting Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted the underwriters a 45-day option from the date of the underwriting agreement to purchase up to an additional 2,250,000 units to cover over-allotments, if any. On September 17, 2021, the over-allotment option expired unexercised, resulting in the forfeiture of 562,500 shares of founder shares.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters were paid an underwriting discount of one percent (1%) of the gross proceeds of the initial public offering, or $1,500,000. Additionally, the underwriters will be entitled to a deferred underwriting discount of 3.5% of the gross proceeds, or $5,250,000, of the initial public offering upon the completion of the Company&#8217;s initial business combination.</span></div>Commitments and Contingencies<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may be involved in legal proceedings and exposed to potential claims in the normal course of business. As of September&#160;30, 2022 and December&#160;31, 2021, the Company does not have any reasonable possible or probable losses from such claims. </span></div>Commitments and ContingenciesLitigationThe Company may be involved in legal proceedings and exposed to potential claims in the normal course of business. As of December 31, 2021 and December 31, 2020, it is not probable that the Company has incurred any losses from such claims.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272210931152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock', window );">Leases</a></td>
<td class="text">Leases <div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, the Company executed an agreement to lease certain land to a subsidiary of LanzaJet for a period of 10 years with an option to renew this lease for five additional periods of one year with minimum annual rent due. This agreement is accounted for as an operating lease. In February 2022, the lease agreement with LanzaJet was amended to extend the pre-development term of the lease until the earlier of commencement of construction of the alcohol-to-jet fuel facility on the leased land or December 31, 2023 and increased the annual base rent amount. The Company recognizes lease revenue on a straight-line basis over the life of the lease agreement. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents amounts included in Revenue from related party transactions in the Condensed Consolidated Statement of Operations related to lessor activity (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease income from operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Leases <div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases certain office space and laboratory facilities. The Company&#8217;s lease agreements typically do not contain any significant guarantees of asset values at the end of a lease, renewal options or restrictive covenants. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s adoption of ASC 842, Leases, all leases were classified as operating leases. During </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021 and 2020, t</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he discount rate used in the calculation of lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was 7.5%, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which is the estimate of the rate of interest that the Company would have to pay to borrow on a collateralized basis over a similar term.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating lease costs and variable lease costs for the years ended December&#160;31, 2021 and 2020 were $2,126 and $2,077 and $2,575 and $1,813, respectively. Cash paid for amounts included in the measurement of operating lease liabilities for the years ended December&#160;31, 2021 and 2020 was $2,059 and $1,765, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, lease payments for operating leases for the Company&#8217;s office facility and laboratories are shown below (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.279%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,818&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,333&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of weighted average remaining lease term and discount rate for all of the Company&#8217;s operating leases:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor Accounting</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, the Company executed an agreement to lease certain land to a subsidiary of LanzaJet for a period of 10 years with an option to renew this lease for five additional periods of one year with minimum annual rent due. This agreement is accounted for as an operating lease. We recognize lease revenue on a straight-line basis over the life of the lease agreement. The following future minimum lease payments due to us from the lease agreement at December 31, 2021, is as follows (in thousands)</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Lease revenue totaled $24 and $14 for the years ended December 31, 2021 and 2020.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases <div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases certain office space and laboratory facilities. The Company&#8217;s lease agreements typically do not contain any significant guarantees of asset values at the end of a lease, renewal options or restrictive covenants. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s adoption of ASC 842, Leases, all leases were classified as operating leases. During </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021 and 2020, t</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he discount rate used in the calculation of lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was 7.5%, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which is the estimate of the rate of interest that the Company would have to pay to borrow on a collateralized basis over a similar term.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating lease costs and variable lease costs for the years ended December&#160;31, 2021 and 2020 were $2,126 and $2,077 and $2,575 and $1,813, respectively. Cash paid for amounts included in the measurement of operating lease liabilities for the years ended December&#160;31, 2021 and 2020 was $2,059 and $1,765, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, lease payments for operating leases for the Company&#8217;s office facility and laboratories are shown below (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.279%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,818&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,333&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of weighted average remaining lease term and discount rate for all of the Company&#8217;s operating leases:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor Accounting</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, the Company executed an agreement to lease certain land to a subsidiary of LanzaJet for a period of 10 years with an option to renew this lease for five additional periods of one year with minimum annual rent due. This agreement is accounted for as an operating lease. We recognize lease revenue on a straight-line basis over the life of the lease agreement. The following future minimum lease payments due to us from the lease agreement at December 31, 2021, is as follows (in thousands)</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Lease revenue totaled $24 and $14 for the years ended December 31, 2021 and 2020.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for lessor's operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888252<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesOfLessorDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211067248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10 &#8212; Subsequent Events</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 18, 2022, the Company entered into additional subscription agreements (the &#8220;Subscription Agreements&#8221;) with certain accredited investors (collectively, the &#8220;Additional PIPE Investors&#8221;), pursuant to which, among other things, the Company agreed to issue and sell, in a private placement to close immediately prior to the closing of the Merger, an aggregate of 5,500,000 shares of Class A common stock at a purchase price of $10.00 per share to the Additional PIPE Investors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated subsequent events and transactions that occurred up to the date the unaudited condensed financial statements were issued. Based upon this review and except in the case of the foregoing, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11 &#8212; Subsequent Events</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated subsequent events and transactions that occurred up to the date financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2022, the Company entered into the Merger Agreement with Merger Sub and LanzaTech. The transactions contemplated by the Merger Agreement are referred to herein as the &#8220;Business Combination.&#8221; The time of the closing of the Business Combination is referred to herein as the &#8220;Closing.&#8221; The date of the Closing of the Business Combination is referred to herein as the &#8220;Closing Date.&#8221;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposed Business Combination</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Business Combination is approved by the Company&#8217;s stockholders and LanzaTech&#8217;s stockholders, and the closing conditions in the Merger Agreement are satisfied or waived, then, among other things, upon the terms and subject to the conditions of the Merger Agreement and in accordance with Delaware General Corporation Law, Merger Sub will merge with and into LanzaTech, with LanzaTech surviving the merger as the Company&#8217;s wholly owned subsidiary (the &#8220;Merger&#8221;). In connection with the consummation of the Merger, the Company will be renamed &#8220;LanzaTech Global, Inc.&#8221; and is referred to herein as &#8220;New LanzaTech&#8221; as of the time following such change of name.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Merger Agreement, the Company has agreed to acquire all of the outstanding equity interests of LanzaTech for consideration consisting of equity interests of New LanzaTech valued at $1,817,000,000 in the aggregate. The consideration to be paid to holders of shares of LanzaTech capital stock will be shares of common stock of New LanzaTech (&#8220;New LanzaTech Common Stock&#8221;), valued at $10.00 per share, to be paid at the closing of the Merger. The number of shares of New LanzaTech Common Stock payable in the Merger in respect of each share of LanzaTech capital stock (each, a &#8220;LanzaTech Share&#8221;) will be determined based on the exchange ratio (the &#8220;Exchange Ratio&#8221;), and certain corresponding adjustments, in each case as set forth in the Merger Agreement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, at Closing: (i) each warrant to purchase LanzaTech Shares (each, a &#8220;LanzaTech Warrant&#8221;) that is outstanding and unexercised immediately prior to Closing and would automatically be exercised or exchanged in full in accordance with its terms by virtue of the occurrence of the Merger, will be so automatically exercised or exchanged in full for the applicable LanzaTech Shares, and each such LanzaTech Share will be treated as being issued and outstanding immediately prior to Closing and will be canceled and converted into the right to receive the applicable shares of New LanzaTech Common Stock; and (ii) each LanzaTech Warrant that </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is outstanding and unexercised immediately prior to the Closing and is not automatically exercised in full as described in clause (i) will be converted into a warrant to purchase shares of New LanzaTech Common Stock, in which case (a) the number of shares underlying such New LanzaTech warrant (each, a &#8220;New LanzaTech Warrant&#8221;) will be determined by multiplying the number of LanzaTech Shares subject to such warrant immediately prior to Closing, by the Exchange Ratio and (b) the per share exercise price of such New LanzaTech Warrant will be determined by dividing the per share exercise price of such LanzaTech Warrant immediately prior to the Effective Time by the Exchange Ratio, except that in the case of certain warrants specified in the Merger Agreement, such exercise price will be $10.00.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, at Closing, each option to purchase LanzaTech Shares (each, a &#8220;LanzaTech Option&#8221;) will be converted into an option to purchase a number of shares of New LanzaTech Common Stock (rounded down to the nearest whole share) equal to the product of (i) the number of LanzaTech Shares subject to such LanzaTech Option multiplied by (ii) the Exchange Ratio. The exercise price of such New LanzaTech option will be equal to the quotient of (a) the exercise price per share of such LanzaTech Option in effect immediately prior to the Effective Time divided by (b) the Exchange Ratio (and as so determined, this exercise price will be rounded up to the nearest full cent).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, at Closing, each award of restricted shares of LanzaTech common stock (each, a &#8220;LanzaTech RSA&#8221;) that is outstanding immediately prior to the Effective Time will be converted into an award of restricted shares of New LanzaTech Common Stock (each, a &#8220;New LanzaTech RSA&#8221;) on the same terms and conditions as were applicable to such LanzaTech RSA immediately prior to the Effective Time, except that such New LanzaTech RSA will relate to a number of shares of New LanzaTech Common Stock equal to the number of LanzaTech Shares subject to such LanzaTech RSA, multiplied by the Exchange Ratio.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The closing of the Merger is subject to certain customary conditions, including, among others, (i) adoption by AMCI&#8217;s stockholders and LanzaTech&#8217;s stockholders of the Merger Agreement and their approval of certain other actions related to the Business Combination, (ii) the expiration or termination of the waiting period (or any extension thereof) applicable to the transactions contemplated by the Merger Agreement and any ancillary agreements, in each case under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, (iii) the effectiveness of a registration statement on Form S-4 (the &#8220;Registration Statement&#8221;) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) with respect to the shares of New LanzaTech Common Stock to be paid as consideration in the Merger, (iv) there being no government order or law enjoining, prohibiting or making illegal the consummation of the Merger or the transactions contemplated by the Merger Agreement, (v) AMCI having at least $5,000,001 of net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) under the Exchange Act) after giving effect to any payments required to be made in connection with the redemption of AMCI&#8217;s public shares and the proceeds from the Subscription Agreements described below, (vi) AMCI having at least $230,000,000 of cash at the closing of the Merger, consisting of cash held in AMCI&#8217;s trust account after taking into account any redemption of AMCI&#8217;s public shares, and the proceeds from the Subscription Agreements described below, net of transaction expenses of AMCI and LanzaTech, and (vii) the listing on Nasdaq of the shares of New LanzaTech Common Stock issued in connection with the Business Combination.</span></div> Subsequent Events<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated events occurring subsequent to September&#160;30, 2022 through December 12, 2022, the date the condensed consolidated financial statements were available to be issued. The Company has identified two transactions with BGTF LT Aggregator LP (&#8220;Brookfield&#8221;), an affiliate of Brookfield Asset Management Inc, and a transaction with LanzaJet, described as follows:</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Brookfield Framework Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 2, 2022, LanzaTech entered into a framework agreement with Brookfield (the &#8220;Brookfield Framework Agreement&#8221;). Under such agreement, LanzaTech agreed to exclusively offer Brookfield the opportunity to acquire or invest in certain projects to construct commercial production facilities employing carbon capture and transformation technology in the U.S., the European Union, the United Kingdom, Canada or Mexico for which LanzaTech is solely or jointly responsible for obtaining or providing equity financing, subject to certain exceptions. LanzaTech agreed to present Brookfield with projects that over the term of the agreement require equity funding of at least $500,000,000 in the aggregate. With respect to projects acquired by Brookfield, LanzaTech is entitled to a percentage of free cash flow generated by such projects determined in accordance with a hurdle-based return waterfall. Brookfield has no obligation under the Brookfield Framework Agreement to invest in any of the projects.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Brookfield SAFE</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 2, 2022, LanzaTech entered into a Simple Agreement for Future Equity (the &#8220;Brookfield SAFE&#8221;) with Brookfield. Under the Brookfield SAFE, LanzaTech agreed to issue to Brookfield the right to certain shares of its capital stock, the issuance of which is conditional upon LanzaTech obtaining certain necessary stockholder approvals and waivers, in exchange for the payment of $50,000,000 (the &#8220;Initial Purchase Amount&#8221;). On the fifth anniversary of the Brookfield SAFE, LanzaTech will repay in cash any remaining unconverted portion of the Initial Purchase Amount (the &#8220;Remaining Amount&#8221;) less any Non-Repayable Amount (as described below), plus interest in the high single digits, compounded annually. Brookfield has the option to extend the repayment date to the tenth anniversary of the date of the Brookfield SAFE if certain events do not occur.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the first of either (a) a transaction with the principal purpose of raising capital, pursuant to which LanzaTech issues and sells preferred stock at a fixed valuation (an &#8220;Equity Financing&#8221;), or (b) the completion of an initial public offering, a direct listing, or a merger of LanzaTech with a special purpose acquisition company, which includes the Business Combination (such a merger, a &#8220;de-SPAC Transaction&#8221; and such event described in (b), a &#8220;Liquidity Event&#8221;), Brookfield may, at any time at its option, convert all or a portion of the Initial Purchase Amount less any amount that has already been converted or repaid into shares of LanzaTech capital stock or, in the case of a de-SPAC Transaction, shares of common stock of the surviving public company in such de-SPAC Transaction (including, in the case of the Business Combination, New LanzaTech Common Stock). </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each $50,000,000 of aggregate equity funding required for qualifying projects acquired by Brookfield in accordance with the Brookfield Framework Agreement, the Remaining Amount will be reduced by $5,000,000 (such cumulative reductions the &#8220;Non-Repayable Amount&#8221;). Upon the first Equity Financing or Liquidity Event, the Non-Repayable Amount would convert automatically into shares of LanzaTech capital stock or, in the case of a de-SPAC Transaction, shares of common stock of the surviving public company in such de-SPAC Transaction (including, in the case of the Business Combination, New LanzaTech Common Stock), and thereafter, the Non-Repayable Amount will convert automatically on an as accrued basis.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LanzaJet Shareholder Loan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 9, 2022, the Company and the other LanzaJet shareholders entered into a Note Purchase Agreement (the &#8220;Note Purchase Agreement&#8221;), pursuant to which LanzaJet Freedom Pines Fuels LLC (&#8220;FPF&#8221;), a wholly owned subsidiary of LanzaJet, will issue, from time to time, notes in an aggregate principal amount of up to $147.0&#160;million (the &#8220;Notes&#8221;), comprised of approximately $113.5&#160;million aggregate principal amount of 6.00% Senior Secured Notes due December 31, 2043 and $33.5&#160;million aggregate principal amount of 6.00% Subordinated Secured Notes due December 31, 2043. The Company has committed to purchase $5.5&#160;million of Subordinated Secured Notes in a funding scheduled to occur on May 1, 2023. The Senior Secured Notes are secured by a security </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">interest over substantially all assets of FPF, and both the Senior Secured Notes and the Subordinated Secured Notes are secured by a security interest over all intellectual property owned or in-licensed by LanzaJet. LanzaJet also provides a guarantee of any costs and expenses required to complete the LanzaJet Freedom Pines Demonstration Facility and achieve commercial operation. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each purchaser of Notes under the Note Purchase Agreement is also entitled to receive a warrant for the right to purchase 575 shares of common stock of LanzaJet for each $10,000 of Notes purchased by such purchaser (which, in the case of the Company, will be equal to a right to purchase 316,250 shares of common stock of LanzaJet).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LanzaJet Note Purchase Agreement may be amended with the approval of holders of FPF and all holders of the LanzaJet Notes.  Upon an event of default under the Note Purchase Agreement, each purchaser may accelerate its own Notes. Enforcement against the collateral securing the Notes requires the approval of certain holders as specified in the Notes.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amended Merger Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Merger Agreement was amended on December 7, 2022, to provide for, among other things, (i) the inclusion of the aggregate net proceeds from each of the AM SAFE Note and Brookfield SAFE in the Acquiror Closing Cash Amount, (ii) the reduction of the Minimum Closing Cash Condition from $250,000,000 to $230,000,000, (iii) the clarification that, to the extent that the Brookfield SAFE remains unexercised at Closing, it will be assumed by AMCI, remain in effect on the same terms and conditions as are in effect prior to the Closing and thereafter entitle the holder thereof to be issued shares of common stock in AMCI after the Closing, (iv) the clarification that, in the event that it becomes reasonably apparent to the parties that the Acquiror Closing Cash Amount will be less than the Minimum Closing Cash Condition, AMCI will use commercially reasonable efforts to enter into non-redemption agreements, or similar agreements, as may be necessary to satisfy the Minimum Closing Cash Condition, (v) the extension of the outside date applicable to the Closing from December 7, 2022 to February 28, 2023 and (vi) the elimination of LanzaTech's right to terminate the agreement in the event that we fail to, on or prior to July 7, 2022, enter into one or more additional subscription agreements or non-redemption agreements as a result of which the sum of the PIPE Investment Amount (including net proceeds under the AM SAFE Note to LanzaTech) and the aggregate number of shares of Class A common stock subject to non-redemption agreements multiplied by $10.00, minus certain transaction expenses and other liabilities at Closing, would be equal to at least the Minimum Closing Cash Condition.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div>Subsequent Events<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated events occurring subsequent to December&#160;31, 2021 through May 9, 2022, the date the consolidated financial statements were available to be issued. The Company is not aware of any significant or material subsequent event that would require disclosure.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposed Merger</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2022, the Company entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with AMCI Acquisition Corp. II, a Delaware corporation (&#8220;AMCI&#8221;) and AMCI Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of AMCI (&#8220;Merger Sub&#8221;). Under the Merger Agreement, Merger Sub will merge with and into LanzaTech, with LanzaTech surviving the Merger as a wholly-owned subsidiary of AMCI (&#8220;the Merger&#8221;). In connection with the Merger, AMCI will be renamed LanzaTech Global, Inc (&#8220;New LanzaTech&#8221;). AMCI has agreed to acquire all of the outstanding equity interests of LanzaTech for consideration consisting of an equity interest of New LanzaTech valued at approximately $1.8&#160;billion. Completion of the transaction is subject to certain customary regulatory consents and approval by stockholders of AMCI and the Company.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger Agreement, on March 8, 2022, AMCI entered into subscription agreements with certain investors pursuant to which AMCI agreed to issue and sell a private placement to close immediately prior to the Merger.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272207635552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) for interim financial information and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022 or any future period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K filed by the Company with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on March 25, 2022.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;).</span></div>The accompanying unaudited condensed consolidated financial statements of LanzaTech NZ Inc. have been prepared in accordance with generally accepted accounting principles for interim financial information, and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America ("US GAAP"), the accounting principles, standards, and procedures adopted by the U.S. Securities and Exchange Commission, for complete financial statements. However, in the opinion of management, all adjustments (consisting of normal recurring accruals) have been made that are necessary for a fair presentation of the condensed consolidated financial statements for the interim periods. For further information refer to the Consolidated Financial Statements and Footnotes thereto included in the Company's Annual Report for the year ended December 31, 2021.<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;US GAAP"). The consolidated financial statements include the accounts of LanzaTech NZ, Inc. and its wholly-owned consolidated subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of September 30, 2022 and December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue generated from the Company&#8217;s customers outside of the United States for the nine months ended September&#160;30, 2022 and 2021 was approximately 61% and 65%, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021, approximately 35% and 35%, respectively, of trade accounts receivable and unbilled accounts receivable was due from customers located outside the United States. At September&#160;30, 2022 and December&#160;31, 2021, the value of property, plant, and equipment outside the United States was immaterial.</span></div>The Company&#8217;s revenue by geographic region based on the customer&#8217;s location<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties (Restated)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue generated from the Company&#8217;s customers outside of the United States for the years ended December&#160;31, 2021 and 2020 was approximately 38% and 14%, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, approximately 35% and 27%, respectively, of trade accounts receivable and unbilled accounts receivable was due from customers located outside the United States. At December&#160;31, 2021 and 2020, the value of property, plant, and equipment outside the United States was immaterial.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue by geographic region based on the customer&#8217;s location is presented in Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customers</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers representing 10% or greater of revenue were as follows for the years ended December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div>As of December&#160;31, 2021, two of the Company's customers separately represented 49% (Customer B) and 15% (Customer D) of total accounts receivable and contract assets on the consolidated balance sheet.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of September 30, 2022 and December 31, 2021.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2021.</span></div>Cash and Cash EquivalentsThe Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates include fair value of equity awards granted to both employees and non-employees, the SAFE and the SAFE warrants.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in facts and circumstances or additional information may result in revised estimates, and actual results may differ from these estimates.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates include fair value of equity awards granted to both employees and non-employees.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in facts and circumstances or additional information may result in revised estimates, and actual results may differ from these estimates.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_InvestmentsHeldInTrustAccountPolicyTextBlock', window );">Investments Held in the Trust Account</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments Held in the Trust Account</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company&#8217;s investments held in the trust account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company&#8217;s investments held in the trust account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the trust account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the trust account are determined using available market information.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments Held in the Trust Account</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company&#8217;s investments held in the trust account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company&#8217;s investments held in the trust account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the trust account in the accompanying statement of operations. The estimated fair values of investments held in the trust account are determined using available market information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Financial Instruments</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities which qualify as financial instruments under the FASB ASC 820, &#8220;Fair Value Measurement,&#8221; equal or approximate the carrying amounts represented in the condensed balance sheets.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities which qualify as financial instruments under the FASB ASC 820, &#8220;Fair Value Measurement,&#8221; equal or approximate the carrying amounts represented in the balance sheet.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily due to their short-term nature, except for the warrant liability. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-term nature, except for the warrant liability. Refer to Note 11, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrant Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for more information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock', window );">Offering Costs Associated with Initial Public Offering</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Offering Costs Associated With Initial Public Offering</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the initial public offering that were directly related to the initial public offering. Offering costs were allocated to the separable financial instruments issued in the initial public offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and presented as non-operating expenses in the unaudited condensed statements of operations. Offering costs associated with the Class A common stock issued were charged against the carrying value of the shares of Class A common stock upon the completion of the initial public offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Offering Costs Associated with Initial Public Offering</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the initial public offering that were directly related to the initial public offering. Offering costs were allocated to the separable financial instruments issued in the initial public offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and </span></div>presented as non-operating expenses in the statement of operations. Offering costs associated with the Class A common stock issued were charged against the carrying value of the shares of Class A common stock upon the completion of the initial public offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock', window );">Class A Common Stock Shares Subject to Possible Redemption</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Class A Common Stock Shares Subject to Possible Redemption </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, &#8220;Distinguishing Liabilities from Equity.&#8221; Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders&#8217; equity. The Company&#8217;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of uncertain future events. Accordingly, as of the initial public offering, 15,000,000 shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders&#8217; equity (deficit) section of the Company&#8217;s condensed balance sheets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 480-10-S99, the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of the reporting period. This method would view the end of the reporting period as if it were also the redemption date of the security. Effective with the closing of the initial public offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Class A Common Stock Subject to Possible Redemption </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, &#8220;Distinguishing Liabilities from Equity.&#8221; Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders&#8217; equity. The Company&#8217;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of uncertain future events. Accordingly, as of the initial public offering, 15,000,000 shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders&#8217; equity (deficit) section of the Company&#8217;s balance sheet.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 480-10-S99, the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of the reporting period. This method would view the end of the reporting period as if it were also the redemption date of the security. Effective with the closing of the initial public offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The public warrants and the private placement warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The initial fair value of the public warrants issued in connection with the initial public offering was estimated using a Monte-Carlo simulation model. The fair value of the public warrants as of September 30, 2022 and as of December 31, 2021 is based on observable listed prices for such warrants. The fair value of the private placement warrants as of September 30, 2022 and as of December 31, 2021 is determined using a Black-Scholes option pricing model. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The public warrants and the private placement warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The initial fair value of the public warrants issued in connection with the initial public offering was estimated using a Monte-Carlo simulation model. The fair value of the public warrants as of December 31, 2021 is based on observable listed prices for such warrants. The fair value of the private placement warrants as of December 31, 2021 is determined using a Black-Scholes option pricing model. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</span></div>Simple Agreement for Future Equity (SAFE)<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company issued a SAFE that allowed an investor to participate in future equity financings through a share-settled redemption of the amount invested (such notional being the &#8220;invested amount&#8221;). The Company determined that the SAFE was not legal form debt (i.e., no creditors&#8217; rights). The SAFE includes a provision allowing for cash redemption upon the occurrence of a change of control, the occurrence of which is outside the control of the Company. Therefore, the SAFE is classified as mark-to-market liability pursuant to Accounting Standards Codification (&#8220;ASC&#8221;) 480, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distinguishing Liability from Equity</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also </span></div>provides guidance on derecognition, classification, interest and penalties, accounting in period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company&#8217;s effective tax rate was 0.88% and 0.91% for the three and nine months ended September 30, 2022, respectively, and 0.00% for the three months ended September 30, 2021 and the period from January 28, 2021 (inception) through September 30, 2021. The effective tax rate differs from the statutory tax rate of 21% for the three and nine months ended September 30, 2022, the three months ended September 30, 2021 and the period from January 28, 2021 (inception) through September 30, 2021 due primarily to changes in fair value of derivative warrant liabilities, non-taxable gains on the settlement of deferred underwriting commissions, and the valuation allowance on the deferred tax assets.<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows the asset and liability method of accounting for income taxes under ASC 740, Income Taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income tax assets are evaluated to determine if valuation allowances are required or should be adjusted. Valuation allowances are established based on a more likely than not standard. The ability to realize deferred tax assets depends on the Company&#8217;s ability to generate sufficient taxable income within the carryback or carryforward periods provided for in the tax law for each tax jurisdiction. The Company considers the various possible sources of taxable income when assessing the realization of its deferred tax assets. The valuation allowances recorded against deferred tax assets generated by taxable losses in certain jurisdictions will affect the provision for income taxes until the valuation allowances are released. The Company&#8217;s provision for income taxes will include no tax benefit for losses incurred and no tax expense with respect to income generated in these jurisdictions until the respective valuation allowance is eliminated.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records uncertain tax positions on the basis of a two-step process whereby it is determined whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position, and for those tax positions that meet the more likely than not criteria, the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority is recognized. The Company recognizes accrued interest and penalties related to unrecognized tax benefits in income tax expense.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income (Loss) Per Share of Common Stock</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Per Share Of Common Stock</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share.&#8221; The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the units sold in the initial public offering and the private placement warrants to purchase an aggregate of 11,000,000 shares of Class A common stock in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the three and nine months ended September 30, 2022 and for the three months ended September 30, 2021 and for the period from January 28, 2021 (inception) through September 30, 2021. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended <br/>September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248,909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332,524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,130,435</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.887%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Nine Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Period from January 28, 2021 <br/>(inception) through <br/>September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,428,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Per Share of Common Stock</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share.&#8221; The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the units sold in the initial public offering and the private placement warrants to purchase an aggregate of 11,000,000 shares of Class A common stock in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the period from January 28, 2021 (inception) through December 31, 2021. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.451%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.805%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the period from January 28, 2021<br/>(inception) through December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income (loss) per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,690,909</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income (loss) per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss Per Share</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is computed by dividing net loss attributable to participating stock by the weighted average number of shares of participating stock outstanding during the period. </span></div>Diluted net loss per share reflects potential dilution and is computed by dividing net loss attributable to participating stock by the weighted average number of shares of participating stock outstanding during the period. The dilutive effect of outstanding awards, if any, is reflected in diluted earnings per share by application of the treasury stock method or if-converted method, as applicable.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FASB issued ASU 2022-03, ASC Subtopic 820 &#8220;Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions&#8221;. The ASU amends ASC 820 to clarify that a contractual sales restriction is not considered in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. The ASU applies to both holders and issuers of equity and equity-linked securities measured at fair value. The amendments in this ASU are effective for the Company in fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is still evaluating the impact of this pronouncement on the condensed financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company&#8217;s unaudited condensed financial statements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2020-06, &#8220;Debt &#8212; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8212; Contracts in an Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity&#8221; (&#8220;ASU 2020-06&#8221;), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. ASU 2020-06 also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 on August 2, 2021 using the modified retrospective method for transition. Adoption of ASU 2020-06 did not impact the Company&#8217;s financial position, results of operations or cash flows.</span></div>The Company&#8217;s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company&#8217;s financial statements.<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Announced Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Financial Accounting Standard Board ("FASB") issued an Accounting Standard Update ("ASU") No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2020-10&#8221;). The standard contains improvements to the FASB Accounting Standards Codification (the &#8220;Codification&#8221;) by ensuring that all guidance that requires or provides an option for an entity to provide information in the notes to financial statements is codified in the disclosure section of the Codification. The standard also improves various topics in the Codification so that entities can apply guidance more consistently on codifications that are varied in nature where the original guidance may have been unclear. The amendments in ASU 2020-10 were effective for the Company for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption was permitted. There were no material impacts upon the adoption of ASU 2020-10, on its consolidated financial statements and related disclosures. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses (Topic 326): Disclosure Framework &#8211; Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2016-13&#8221;), which requires financial assets measured at amortized cost basis, including trade receivables, to be presented net of the amount expected to be collected. The measurement of all expected credit losses will be based on historical experience, current conditions, and reasonable and supportable forecasts. The Company adopted the new standard effective January 1, 2020, using a modified retrospective transition method, which requires a cumulative-effect adjustment, if any, to the opening balance of retained earnings to be recognized on the date of adoption with prior periods not restated. The adoption did not have a material impact on the Company&#8217;s financial position or results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles &#8211; Goodwill and Other &#8211; Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2018-15&#8221;), which requires a customer in a cloud computing arrangement that is a service contract to follow the internal-use software guidance in ASC 350-40 to determine which implementation costs to capitalize as assets. A customer&#8217;s accounting for the costs of the hosting component of the arrangement is not affected by the new guidance. The Company adopted ASU 2018-15 as of January 1, 2020 with no material impact on its consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2018, the FASB issued ASU 2018-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Stock Compensation Improvements to Non-employee Share-Based Payment Accounting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2018-07&#8221;), which simplifies the accounting for stock-based payments granted to non-employees for goods and services. Under ASU 2018-07, most of the guidance on such payments to non-employees will be aligned with the requirements for stock-based payments granted to employees. The Company early adopted ASU 2018-07 as of January 1, 2020 and its adoption did not have a material impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2019-12&#8221;), as part of its simplification initiative to reduce the cost and complexity in accounting for income taxes. ASU 2019-12 removes certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. ASU 2019-12 also amends other aspects of the guidance to help simplify and promote consistent application of US GAAP. The Company adopted ASU 2019-12 as of January 1, 2021 with no material impact on its consolidated financial statements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Announced Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2020-10&#8221;). The standard contains improvements to the FASB Accounting Standards Codification (the &#8220;Codification&#8221;) by ensuring that all guidance that requires or provides an option for an entity to provide information in the notes to financial statements is codified in the disclosure section of the Codification. The standard also improves various topics in the Codification so that entities can apply guidance more consistently on codifications that are varied in nature where the original guidance may have been unclear. The amendments in ASU 2020-10 are effective for the Company for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption is permitted. The Company does not expect the adoption of ASU 2020-10 to have a material impact on its consolidated financial statements and related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_InvestmentsHeldInTrustAccountPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investments held trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_InvestmentsHeldInTrustAccountPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of offering costs associated with the initial public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognition of changes in redemption value of mandatorily redeemable shares. Provides the period over which changes in redemption value are accreted, usually from the issuance date (or from the date that it becomes probable that the security will become redeemable, if later) to the earliest redemption date of the security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272206339344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) for interim financial information and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022 or any future period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K filed by the Company with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on March 25, 2022.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;).</span></div>The accompanying unaudited condensed consolidated financial statements of LanzaTech NZ Inc. have been prepared in accordance with generally accepted accounting principles for interim financial information, and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America ("US GAAP"), the accounting principles, standards, and procedures adopted by the U.S. Securities and Exchange Commission, for complete financial statements. However, in the opinion of management, all adjustments (consisting of normal recurring accruals) have been made that are necessary for a fair presentation of the condensed consolidated financial statements for the interim periods. For further information refer to the Consolidated Financial Statements and Footnotes thereto included in the Company's Annual Report for the year ended December 31, 2021.<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;US GAAP"). The consolidated financial statements include the accounts of LanzaTech NZ, Inc. and its wholly-owned consolidated subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of September 30, 2022 and December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue generated from the Company&#8217;s customers outside of the United States for the nine months ended September&#160;30, 2022 and 2021 was approximately 61% and 65%, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021, approximately 35% and 35%, respectively, of trade accounts receivable and unbilled accounts receivable was due from customers located outside the United States. At September&#160;30, 2022 and December&#160;31, 2021, the value of property, plant, and equipment outside the United States was immaterial.</span></div>The Company&#8217;s revenue by geographic region based on the customer&#8217;s location<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties (Restated)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue generated from the Company&#8217;s customers outside of the United States for the years ended December&#160;31, 2021 and 2020 was approximately 38% and 14%, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, approximately 35% and 27%, respectively, of trade accounts receivable and unbilled accounts receivable was due from customers located outside the United States. At December&#160;31, 2021 and 2020, the value of property, plant, and equipment outside the United States was immaterial.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue by geographic region based on the customer&#8217;s location is presented in Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customers</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers representing 10% or greater of revenue were as follows for the years ended December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div>As of December&#160;31, 2021, two of the Company's customers separately represented 49% (Customer B) and 15% (Customer D) of total accounts receivable and contract assets on the consolidated balance sheet.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of September 30, 2022 and December 31, 2021.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2021.</span></div>Cash and Cash EquivalentsThe Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates include fair value of equity awards granted to both employees and non-employees, the SAFE and the SAFE warrants.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in facts and circumstances or additional information may result in revised estimates, and actual results may differ from these estimates.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates include fair value of equity awards granted to both employees and non-employees.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in facts and circumstances or additional information may result in revised estimates, and actual results may differ from these estimates.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_InvestmentsHeldInTrustAccountPolicyTextBlock', window );">Investments Held in the Trust Account</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments Held in the Trust Account</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company&#8217;s investments held in the trust account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company&#8217;s investments held in the trust account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the trust account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the trust account are determined using available market information.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments Held in the Trust Account</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company&#8217;s investments held in the trust account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company&#8217;s investments held in the trust account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the trust account in the accompanying statement of operations. The estimated fair values of investments held in the trust account are determined using available market information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Financial Instruments</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities which qualify as financial instruments under the FASB ASC 820, &#8220;Fair Value Measurement,&#8221; equal or approximate the carrying amounts represented in the condensed balance sheets.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities which qualify as financial instruments under the FASB ASC 820, &#8220;Fair Value Measurement,&#8221; equal or approximate the carrying amounts represented in the balance sheet.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily due to their short-term nature, except for the warrant liability. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-term nature, except for the warrant liability. Refer to Note 11, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrant Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for more information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock', window );">Offering Costs Associated with Initial Public Offering</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Offering Costs Associated With Initial Public Offering</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the initial public offering that were directly related to the initial public offering. Offering costs were allocated to the separable financial instruments issued in the initial public offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and presented as non-operating expenses in the unaudited condensed statements of operations. Offering costs associated with the Class A common stock issued were charged against the carrying value of the shares of Class A common stock upon the completion of the initial public offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Offering Costs Associated with Initial Public Offering</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the initial public offering that were directly related to the initial public offering. Offering costs were allocated to the separable financial instruments issued in the initial public offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and </span></div>presented as non-operating expenses in the statement of operations. Offering costs associated with the Class A common stock issued were charged against the carrying value of the shares of Class A common stock upon the completion of the initial public offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock', window );">Class A Common Stock Subject to Possible Redemption</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Class A Common Stock Shares Subject to Possible Redemption </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, &#8220;Distinguishing Liabilities from Equity.&#8221; Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders&#8217; equity. The Company&#8217;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of uncertain future events. Accordingly, as of the initial public offering, 15,000,000 shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders&#8217; equity (deficit) section of the Company&#8217;s condensed balance sheets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 480-10-S99, the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of the reporting period. This method would view the end of the reporting period as if it were also the redemption date of the security. Effective with the closing of the initial public offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Class A Common Stock Subject to Possible Redemption </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, &#8220;Distinguishing Liabilities from Equity.&#8221; Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders&#8217; equity. The Company&#8217;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of uncertain future events. Accordingly, as of the initial public offering, 15,000,000 shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders&#8217; equity (deficit) section of the Company&#8217;s balance sheet.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 480-10-S99, the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of the reporting period. This method would view the end of the reporting period as if it were also the redemption date of the security. Effective with the closing of the initial public offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The public warrants and the private placement warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The initial fair value of the public warrants issued in connection with the initial public offering was estimated using a Monte-Carlo simulation model. The fair value of the public warrants as of September 30, 2022 and as of December 31, 2021 is based on observable listed prices for such warrants. The fair value of the private placement warrants as of September 30, 2022 and as of December 31, 2021 is determined using a Black-Scholes option pricing model. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The public warrants and the private placement warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The initial fair value of the public warrants issued in connection with the initial public offering was estimated using a Monte-Carlo simulation model. The fair value of the public warrants as of December 31, 2021 is based on observable listed prices for such warrants. The fair value of the private placement warrants as of December 31, 2021 is determined using a Black-Scholes option pricing model. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</span></div>Simple Agreement for Future Equity (SAFE)<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company issued a SAFE that allowed an investor to participate in future equity financings through a share-settled redemption of the amount invested (such notional being the &#8220;invested amount&#8221;). The Company determined that the SAFE was not legal form debt (i.e., no creditors&#8217; rights). The SAFE includes a provision allowing for cash redemption upon the occurrence of a change of control, the occurrence of which is outside the control of the Company. Therefore, the SAFE is classified as mark-to-market liability pursuant to Accounting Standards Codification (&#8220;ASC&#8221;) 480, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distinguishing Liability from Equity</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also </span></div>provides guidance on derecognition, classification, interest and penalties, accounting in period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company&#8217;s effective tax rate was 0.88% and 0.91% for the three and nine months ended September 30, 2022, respectively, and 0.00% for the three months ended September 30, 2021 and the period from January 28, 2021 (inception) through September 30, 2021. The effective tax rate differs from the statutory tax rate of 21% for the three and nine months ended September 30, 2022, the three months ended September 30, 2021 and the period from January 28, 2021 (inception) through September 30, 2021 due primarily to changes in fair value of derivative warrant liabilities, non-taxable gains on the settlement of deferred underwriting commissions, and the valuation allowance on the deferred tax assets.<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows the asset and liability method of accounting for income taxes under ASC 740, Income Taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income tax assets are evaluated to determine if valuation allowances are required or should be adjusted. Valuation allowances are established based on a more likely than not standard. The ability to realize deferred tax assets depends on the Company&#8217;s ability to generate sufficient taxable income within the carryback or carryforward periods provided for in the tax law for each tax jurisdiction. The Company considers the various possible sources of taxable income when assessing the realization of its deferred tax assets. The valuation allowances recorded against deferred tax assets generated by taxable losses in certain jurisdictions will affect the provision for income taxes until the valuation allowances are released. The Company&#8217;s provision for income taxes will include no tax benefit for losses incurred and no tax expense with respect to income generated in these jurisdictions until the respective valuation allowance is eliminated.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records uncertain tax positions on the basis of a two-step process whereby it is determined whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position, and for those tax positions that meet the more likely than not criteria, the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority is recognized. The Company recognizes accrued interest and penalties related to unrecognized tax benefits in income tax expense.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income (Loss) Per Share of Common Stock</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Per Share Of Common Stock</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share.&#8221; The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the units sold in the initial public offering and the private placement warrants to purchase an aggregate of 11,000,000 shares of Class A common stock in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the three and nine months ended September 30, 2022 and for the three months ended September 30, 2021 and for the period from January 28, 2021 (inception) through September 30, 2021. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended <br/>September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248,909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332,524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,130,435</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.887%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Nine Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Period from January 28, 2021 <br/>(inception) through <br/>September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,428,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Per Share of Common Stock</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share.&#8221; The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the units sold in the initial public offering and the private placement warrants to purchase an aggregate of 11,000,000 shares of Class A common stock in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the period from January 28, 2021 (inception) through December 31, 2021. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.451%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.805%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the period from January 28, 2021<br/>(inception) through December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income (loss) per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,690,909</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income (loss) per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss Per Share</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is computed by dividing net loss attributable to participating stock by the weighted average number of shares of participating stock outstanding during the period. </span></div>Diluted net loss per share reflects potential dilution and is computed by dividing net loss attributable to participating stock by the weighted average number of shares of participating stock outstanding during the period. The dilutive effect of outstanding awards, if any, is reflected in diluted earnings per share by application of the treasury stock method or if-converted method, as applicable.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FASB issued ASU 2022-03, ASC Subtopic 820 &#8220;Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions&#8221;. The ASU amends ASC 820 to clarify that a contractual sales restriction is not considered in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. The ASU applies to both holders and issuers of equity and equity-linked securities measured at fair value. The amendments in this ASU are effective for the Company in fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is still evaluating the impact of this pronouncement on the condensed financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company&#8217;s unaudited condensed financial statements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2020-06, &#8220;Debt &#8212; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8212; Contracts in an Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity&#8221; (&#8220;ASU 2020-06&#8221;), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. ASU 2020-06 also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 on August 2, 2021 using the modified retrospective method for transition. Adoption of ASU 2020-06 did not impact the Company&#8217;s financial position, results of operations or cash flows.</span></div>The Company&#8217;s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company&#8217;s financial statements.<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Announced Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Financial Accounting Standard Board ("FASB") issued an Accounting Standard Update ("ASU") No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2020-10&#8221;). The standard contains improvements to the FASB Accounting Standards Codification (the &#8220;Codification&#8221;) by ensuring that all guidance that requires or provides an option for an entity to provide information in the notes to financial statements is codified in the disclosure section of the Codification. The standard also improves various topics in the Codification so that entities can apply guidance more consistently on codifications that are varied in nature where the original guidance may have been unclear. The amendments in ASU 2020-10 were effective for the Company for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption was permitted. There were no material impacts upon the adoption of ASU 2020-10, on its consolidated financial statements and related disclosures. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses (Topic 326): Disclosure Framework &#8211; Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2016-13&#8221;), which requires financial assets measured at amortized cost basis, including trade receivables, to be presented net of the amount expected to be collected. The measurement of all expected credit losses will be based on historical experience, current conditions, and reasonable and supportable forecasts. The Company adopted the new standard effective January 1, 2020, using a modified retrospective transition method, which requires a cumulative-effect adjustment, if any, to the opening balance of retained earnings to be recognized on the date of adoption with prior periods not restated. The adoption did not have a material impact on the Company&#8217;s financial position or results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles &#8211; Goodwill and Other &#8211; Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2018-15&#8221;), which requires a customer in a cloud computing arrangement that is a service contract to follow the internal-use software guidance in ASC 350-40 to determine which implementation costs to capitalize as assets. A customer&#8217;s accounting for the costs of the hosting component of the arrangement is not affected by the new guidance. The Company adopted ASU 2018-15 as of January 1, 2020 with no material impact on its consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2018, the FASB issued ASU 2018-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Stock Compensation Improvements to Non-employee Share-Based Payment Accounting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2018-07&#8221;), which simplifies the accounting for stock-based payments granted to non-employees for goods and services. Under ASU 2018-07, most of the guidance on such payments to non-employees will be aligned with the requirements for stock-based payments granted to employees. The Company early adopted ASU 2018-07 as of January 1, 2020 and its adoption did not have a material impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2019-12&#8221;), as part of its simplification initiative to reduce the cost and complexity in accounting for income taxes. ASU 2019-12 removes certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. ASU 2019-12 also amends other aspects of the guidance to help simplify and promote consistent application of US GAAP. The Company adopted ASU 2019-12 as of January 1, 2021 with no material impact on its consolidated financial statements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Announced Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2020-10&#8221;). The standard contains improvements to the FASB Accounting Standards Codification (the &#8220;Codification&#8221;) by ensuring that all guidance that requires or provides an option for an entity to provide information in the notes to financial statements is codified in the disclosure section of the Codification. The standard also improves various topics in the Codification so that entities can apply guidance more consistently on codifications that are varied in nature where the original guidance may have been unclear. The amendments in ASU 2020-10 are effective for the Company for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption is permitted. The Company does not expect the adoption of ASU 2020-10 to have a material impact on its consolidated financial statements and related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_InvestmentsHeldInTrustAccountPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investments held trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_InvestmentsHeldInTrustAccountPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of offering costs associated with the initial public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognition of changes in redemption value of mandatorily redeemable shares. Provides the period over which changes in redemption value are accreted, usually from the issuance date (or from the date that it becomes probable that the security will become redeemable, if later) to the earliest redemption date of the security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272207805040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) for interim financial information and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022 or any future period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K filed by the Company with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on March 25, 2022.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;).</span></div>The accompanying unaudited condensed consolidated financial statements of LanzaTech NZ Inc. have been prepared in accordance with generally accepted accounting principles for interim financial information, and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America ("US GAAP"), the accounting principles, standards, and procedures adopted by the U.S. Securities and Exchange Commission, for complete financial statements. However, in the opinion of management, all adjustments (consisting of normal recurring accruals) have been made that are necessary for a fair presentation of the condensed consolidated financial statements for the interim periods. For further information refer to the Consolidated Financial Statements and Footnotes thereto included in the Company's Annual Report for the year ended December 31, 2021.<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;US GAAP"). The consolidated financial statements include the accounts of LanzaTech NZ, Inc. and its wholly-owned consolidated subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_GoingConcernPolicyTextBlock', window );">Going Concern</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Going Concern</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements of the Company have been prepared assuming the Company will continue as a going concern and in accordance with accounting principles generally accepted in the United States of America ("US GAAP"). The going concern basis of presentation assumes that the Company will continue in operation one year after the date these financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. The Company had cash and cash equivalents of $50,370 and an accumulated deficit of $(434,863) at September&#160;30, 2022 and cash outflows from operations of $(71,336) and a net loss of $(54,974) for the nine months ended September&#160;30, 2022. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has historically funded its operations through debt financing and issuance of equity securities. Based on the Company&#8217;s financial position as of the date these condensed consolidated financial statements were available to be issued, the Company projects that it will be able to cover its liquidity needs for the next twelve months with cash on hand. Accordingly, the Company&#8217;s condensed consolidated financial statements have been prepared on the basis that it will continue as a going concern.</span></div>Going ConcernThe accompanying consolidated financial statements of the Company have been prepared assuming the Company will continue as a going concern and in accordance with US GAAP. The going concern basis of presentation assumes that the Company will continue in operation one year after the date these financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates include fair value of equity awards granted to both employees and non-employees, the SAFE and the SAFE warrants.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in facts and circumstances or additional information may result in revised estimates, and actual results may differ from these estimates.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates include fair value of equity awards granted to both employees and non-employees.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in facts and circumstances or additional information may result in revised estimates, and actual results may differ from these estimates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates as one operating segment which is the licensing of its technologies and related services such as research and development and engineering. The Chief Executive Officer who is the chief operating decision maker, reviews financial information on an aggregate basis for allocating resources and evaluating financial performance. Substantially all of the Company's long-lived assets are maintained in the United States. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates as one operating segment. Operating segments are defined as components of an enterprise for which separate financial information is evaluated regularly by the chief operating decision maker (&#8220;CODM&#8221;), in deciding how to allocate resources and assess performance.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company offers a variety of services and operates in multiple countries, the Company&#8217;s business operates in one operating segment because most of the Company&#8217;s service offerings are delivered and supported on a global basis, most of the Company&#8217;s service offerings are deployed in a nearly identical way, and the Company&#8217;s CODM evaluates the Company&#8217;s financial information and resources and assesses the performance of these resources on a consolidated basis. There are no segment managers who are held accountable by the CODM, or anyone else, for operations, operating results, and planning for components below the consolidated level. Accordingly, the Company has determined that it has a single reportable and operating segment. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for disaggregation of the Company&#8217;s revenues by customer location.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currencies</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currencies</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reporting currency is the U.S. Dollar. The Company has certain foreign subsidiaries where the functional currency is the local currency. All of the assets and liabilities of these subsidiaries are converted to U.S. dollars at the exchange rate in effect at the balance sheet date, income and expense accounts are translated at average rates for the period, and shareholder&#8217;s equity accounts are translated at historical rates. The effects of translating financial statements of foreign operations into our reporting currency are recognized as an adjustment in accumulated other comprehensive income (loss).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has foreign subsidiaries that have a functional currency of the U.S. dollar. Purchases and sales of assets and income and expense items denominated in foreign currencies are remeasured into U.S. dollar amounts on the respective dates of such transactions. Net realized foreign currency gains or losses relating to the differences between these recorded amounts and the U.S. dollar equivalent actually received or paid are included within Other (expense) income, net in the condensed consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currencies</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reporting currency is the U.S. Dollar. The Company has certain foreign subsidiaries where the functional currency is the local currency. All of the assets and liabilities of these subsidiaries are converted to U.S. dollars at the exchange rate in effect at the balance sheet date, income and expense accounts are translated at average rates for the period, and shareholder&#8217;s equity accounts are translated at historical rates. The effects of translating financial statements of foreign operations into our reporting currency are recognized as an adjustment in accumulated other comprehensive income (loss).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has foreign subsidiaries that have a functional currency of the U.S. dollar. Purchases and sales of assets and income and expense items denominated in foreign currencies are remeasured into U.S. dollar amounts on the respective dates of such transactions. Net realized foreign currency gains or losses relating to the differences between these recorded amounts and the U.S. dollar equivalent actually received or paid are included within Other income, net in the consolidated statements of operations and comprehensive loss.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of September 30, 2022 and December 31, 2021.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2021.</span></div>Cash and Cash EquivalentsThe Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash and Other Cash Flows from Operating Activities</a></td>
<td class="text">Restricted Cash and Other Cash Flows from Operating ActivitiesThe Company is required to maintain a cash deposit with a bank which consists of collateral on certain travel and expense programs maintained by the bank. <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. As of December&#160;31, 2021 and 2020, the Company had $128,318 and $60,495 of cash and cash equivalents, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to maintain a cash deposit with a bank which consists of collateral on a travel and expense program maintained by the bank. The following represents a reconciliation of cash and cash equivalents in </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the consolidated balance sheets to total cash, cash equivalents and restricted cash in the consolidated statement of cash flows as of December 31, 2021 and December 31, 2020.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,495&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (presented within Other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,732&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,909&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy', window );">Trade and Other Receivables</a></td>
<td class="text">Trade and Other Receivables Receivables are reported net of allowances for doubtful accounts. The Company maintains allowances for doubtful accounts for estimated losses resulting from the inability of customers to make required payments. The Company estimates the allowance for doubtful accounts based on a variety of factors including the length of time receivables are past due, the financial health of customers, unusual macroeconomic conditions, and historical experience. Trade and Other Receivables Receivables are reported net of allowances for doubtful accounts. The Company maintains allowances for doubtful accounts for estimated losses resulting from the inability of customers to make required payments. The Company estimates the allowance for doubtful accounts based on a variety of factors including the length of time receivables are past due, the financial health of customers, unusual macroeconomic conditions, and historical experience.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with Accounting Standards Codification ("ASC") 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company primarily earns revenue from services related to feasibility studies and basic engineering design of commercial plants, licensing of technologies, joint development and contract </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">research activities to develop novel biocatalysts and related technologies, and sale of CarbonSmart ethanol produced using the Company's proprietary technologies.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is measured based on the consideration specified in a contract with a customer. The Company records taxes collected from customers and remitted to governmental authorities on a net basis. The Company&#8217;s payment terms are between 30-60 days and can vary by customer type and products offered. Management has evaluated the terms of our arrangements and determined that they do not contain significant financing components.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Carbon Capture and Transformation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides feasibility studies and basic design and engineering services used for detailed design, procurement, and construction of commercial plants that utilize the Company&#8217;s technologies, along with the sale of equipment and microbes. The services provided are recognized as a performance obligation satisfied over time. Revenue is recognized using the output method based on milestone completion, the cost-to-cost input method for certain engineering services, or the percentage of completion method as performance obligations are satisfied. Management has determined that the milestone completion and the associated contractual payment amounts are an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company licenses intellectual property to generate recurring revenue when its customers deploy carbon capture and transformation plants. When licenses are considered to be distinct performance obligations, the recognition of revenue is dependent on the terms of the contract, which may include fixed consideration or royalties based on sales or usage, in which case, the revenue is recognized when the subsequent sale or usage occurs or when the performance obligation to which some or all of the sales or usage-based royalty is allocated has been satisfied, whichever is later.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Services</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs research and development (&#8220;R&amp;D&#8221;) services related to novel technologies and development of biocatalysts for commercial applications, mainly to produce fuels and chemicals. The Company engages in two main types of R&amp;D services &#8211; joint development agreements, and other contract research, including projects with the U.S. Department of Energy. Such services are recognized as a performance obligation satisfied over time. Revenue is recognized based on milestone completion, when payments are contingent upon the achievement of such milestones, or based on percentage-completion method when enforceable rights to payment exist. When no milestones or phases are clearly defined, management has determined that the cost incurred, input method, is an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and estimates its variable consideration under the expected value method. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is not recognized in advance of customer acceptance of a milestone when such acceptance is contractually required. Payments for R&amp;D services with no contractual payments are not due from customers until a technical report is submitted; therefore, a contract asset is recognized at milestone completion but prior to the submission of a technical report. The contract asset represents the Company&#8217;s right to consideration for the services performed at milestone completion. Occasionally, customers provide payments in advance of the Company providing services which creates a contract liability for the Company. The contract liability represents the Company's obligation to provide services to a customer. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collaboration Arrangements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain partnership agreements that are within the scope of ASC 808, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides guidance on the presentation and disclosure of collaborative arrangements. Generally, the classification of the transactions under the collaborative arrangements is determined based on the nature of the contractual terms of the arrangement, along with the nature of the operations of the participants. The Company&#8217;s collaborative agreements generally include a provision of R&amp;D services related to novel technologies and biocatalysts. Amounts received for these services are classified as Revenue from collaborative arrangements in the condensed consolidated statements of operations and comprehensive loss. The Company's R&amp;D services are a major part of the Company's ongoing operations and therefore ASC 606 is applied to recognize revenue.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CarbonSmart</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's CarbonSmart business, initially CarbonSmart ethanol, is produced by LanzaTech licensed plants using the Company's proprietary technologies. Customers can buy CarbonSmart ethanol directly from LanzaTech, which the Company sources from these partnering plants. Revenue is recognized at a point in time when control transfers to the customer, which varies depending on the shipping terms. The Company acts as the principal in such transactions and accordingly, recognizes revenue and cost of revenues on a gross basis.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily due to their short-term nature, except for the warrant liability. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-term nature, except for the warrant liability. Refer to Note 11, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrant Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for more information.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of September 30, 2022 and December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue generated from the Company&#8217;s customers outside of the United States for the nine months ended September&#160;30, 2022 and 2021 was approximately 61% and 65%, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021, approximately 35% and 35%, respectively, of trade accounts receivable and unbilled accounts receivable was due from customers located outside the United States. At September&#160;30, 2022 and December&#160;31, 2021, the value of property, plant, and equipment outside the United States was immaterial.</span></div>The Company&#8217;s revenue by geographic region based on the customer&#8217;s location<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties (Restated)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue generated from the Company&#8217;s customers outside of the United States for the years ended December&#160;31, 2021 and 2020 was approximately 38% and 14%, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, approximately 35% and 27%, respectively, of trade accounts receivable and unbilled accounts receivable was due from customers located outside the United States. At December&#160;31, 2021 and 2020, the value of property, plant, and equipment outside the United States was immaterial.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue by geographic region based on the customer&#8217;s location is presented in Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customers</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers representing 10% or greater of revenue were as follows for the years ended December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div>As of December&#160;31, 2021, two of the Company's customers separately represented 49% (Customer B) and 15% (Customer D) of total accounts receivable and contract assets on the consolidated balance sheet.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FASB issued ASU 2022-03, ASC Subtopic 820 &#8220;Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions&#8221;. The ASU amends ASC 820 to clarify that a contractual sales restriction is not considered in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. The ASU applies to both holders and issuers of equity and equity-linked securities measured at fair value. The amendments in this ASU are effective for the Company in fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is still evaluating the impact of this pronouncement on the condensed financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company&#8217;s unaudited condensed financial statements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2020-06, &#8220;Debt &#8212; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8212; Contracts in an Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity&#8221; (&#8220;ASU 2020-06&#8221;), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. ASU 2020-06 also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 on August 2, 2021 using the modified retrospective method for transition. Adoption of ASU 2020-06 did not impact the Company&#8217;s financial position, results of operations or cash flows.</span></div>The Company&#8217;s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company&#8217;s financial statements.<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Announced Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Financial Accounting Standard Board ("FASB") issued an Accounting Standard Update ("ASU") No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2020-10&#8221;). The standard contains improvements to the FASB Accounting Standards Codification (the &#8220;Codification&#8221;) by ensuring that all guidance that requires or provides an option for an entity to provide information in the notes to financial statements is codified in the disclosure section of the Codification. The standard also improves various topics in the Codification so that entities can apply guidance more consistently on codifications that are varied in nature where the original guidance may have been unclear. The amendments in ASU 2020-10 were effective for the Company for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption was permitted. There were no material impacts upon the adoption of ASU 2020-10, on its consolidated financial statements and related disclosures. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses (Topic 326): Disclosure Framework &#8211; Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2016-13&#8221;), which requires financial assets measured at amortized cost basis, including trade receivables, to be presented net of the amount expected to be collected. The measurement of all expected credit losses will be based on historical experience, current conditions, and reasonable and supportable forecasts. The Company adopted the new standard effective January 1, 2020, using a modified retrospective transition method, which requires a cumulative-effect adjustment, if any, to the opening balance of retained earnings to be recognized on the date of adoption with prior periods not restated. The adoption did not have a material impact on the Company&#8217;s financial position or results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles &#8211; Goodwill and Other &#8211; Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2018-15&#8221;), which requires a customer in a cloud computing arrangement that is a service contract to follow the internal-use software guidance in ASC 350-40 to determine which implementation costs to capitalize as assets. A customer&#8217;s accounting for the costs of the hosting component of the arrangement is not affected by the new guidance. The Company adopted ASU 2018-15 as of January 1, 2020 with no material impact on its consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2018, the FASB issued ASU 2018-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Stock Compensation Improvements to Non-employee Share-Based Payment Accounting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2018-07&#8221;), which simplifies the accounting for stock-based payments granted to non-employees for goods and services. Under ASU 2018-07, most of the guidance on such payments to non-employees will be aligned with the requirements for stock-based payments granted to employees. The Company early adopted ASU 2018-07 as of January 1, 2020 and its adoption did not have a material impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2019-12&#8221;), as part of its simplification initiative to reduce the cost and complexity in accounting for income taxes. ASU 2019-12 removes certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. ASU 2019-12 also amends other aspects of the guidance to help simplify and promote consistent application of US GAAP. The Company adopted ASU 2019-12 as of January 1, 2021 with no material impact on its consolidated financial statements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Announced Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2020-10&#8221;). The standard contains improvements to the FASB Accounting Standards Codification (the &#8220;Codification&#8221;) by ensuring that all guidance that requires or provides an option for an entity to provide information in the notes to financial statements is codified in the disclosure section of the Codification. The standard also improves various topics in the Codification so that entities can apply guidance more consistently on codifications that are varied in nature where the original guidance may have been unclear. The amendments in ASU 2020-10 are effective for the Company for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption is permitted. The Company does not expect the adoption of ASU 2020-10 to have a material impact on its consolidated financial statements and related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_GoingConcernPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Going Concern</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_GoingConcernPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for treatment of receivables that are billable but have not been billed as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -URI https://asc.fasb.org/topic&amp;trid=2196771<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272199330528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) for interim financial information and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022 or any future period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K filed by the Company with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on March 25, 2022.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;).</span></div>The accompanying unaudited condensed consolidated financial statements of LanzaTech NZ Inc. have been prepared in accordance with generally accepted accounting principles for interim financial information, and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America ("US GAAP"), the accounting principles, standards, and procedures adopted by the U.S. Securities and Exchange Commission, for complete financial statements. However, in the opinion of management, all adjustments (consisting of normal recurring accruals) have been made that are necessary for a fair presentation of the condensed consolidated financial statements for the interim periods. For further information refer to the Consolidated Financial Statements and Footnotes thereto included in the Company's Annual Report for the year ended December 31, 2021.<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;US GAAP"). The consolidated financial statements include the accounts of LanzaTech NZ, Inc. and its wholly-owned consolidated subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates as one operating segment which is the licensing of its technologies and related services such as research and development and engineering. The Chief Executive Officer who is the chief operating decision maker, reviews financial information on an aggregate basis for allocating resources and evaluating financial performance. Substantially all of the Company's long-lived assets are maintained in the United States. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates as one operating segment. Operating segments are defined as components of an enterprise for which separate financial information is evaluated regularly by the chief operating decision maker (&#8220;CODM&#8221;), in deciding how to allocate resources and assess performance.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company offers a variety of services and operates in multiple countries, the Company&#8217;s business operates in one operating segment because most of the Company&#8217;s service offerings are delivered and supported on a global basis, most of the Company&#8217;s service offerings are deployed in a nearly identical way, and the Company&#8217;s CODM evaluates the Company&#8217;s financial information and resources and assesses the performance of these resources on a consolidated basis. There are no segment managers who are held accountable by the CODM, or anyone else, for operations, operating results, and planning for components below the consolidated level. Accordingly, the Company has determined that it has a single reportable and operating segment. See Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for disaggregation of the Company&#8217;s revenues by customer location.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_CoronavirusPolicyTextBlock', window );">Coronavirus</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Coronavirus (COVID-19)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the World Health Organization declared the viral strain of coronavirus ("COVID-19") a global pandemic and recommended containment and mitigation measures worldwide. The spread of COVID-19 and the resulting economic contraction has resulted in increased business uncertainty. The consequences of a prolonged economic decline could include, but are not limited to, reduced revenues, increased instances of uncollectible customer receivables, and increased asset impairments in future periods. Accordingly, the Company cannot reasonably estimate the length or severity of this pandemic, or the extent to which the disruption may materially impact its consolidated balance sheets, consolidated statements of operations and comprehensive loss or statements of cash flows for future periods.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_GoingConcernPolicyTextBlock', window );">Going Concern</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Going Concern</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements of the Company have been prepared assuming the Company will continue as a going concern and in accordance with accounting principles generally accepted in the United States of America ("US GAAP"). The going concern basis of presentation assumes that the Company will continue in operation one year after the date these financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. The Company had cash and cash equivalents of $50,370 and an accumulated deficit of $(434,863) at September&#160;30, 2022 and cash outflows from operations of $(71,336) and a net loss of $(54,974) for the nine months ended September&#160;30, 2022. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has historically funded its operations through debt financing and issuance of equity securities. Based on the Company&#8217;s financial position as of the date these condensed consolidated financial statements were available to be issued, the Company projects that it will be able to cover its liquidity needs for the next twelve months with cash on hand. Accordingly, the Company&#8217;s condensed consolidated financial statements have been prepared on the basis that it will continue as a going concern.</span></div>Going ConcernThe accompanying consolidated financial statements of the Company have been prepared assuming the Company will continue as a going concern and in accordance with US GAAP. The going concern basis of presentation assumes that the Company will continue in operation one year after the date these financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates include fair value of equity awards granted to both employees and non-employees, the SAFE and the SAFE warrants.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in facts and circumstances or additional information may result in revised estimates, and actual results may differ from these estimates.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates include fair value of equity awards granted to both employees and non-employees.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in facts and circumstances or additional information may result in revised estimates, and actual results may differ from these estimates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currencies</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currencies</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reporting currency is the U.S. Dollar. The Company has certain foreign subsidiaries where the functional currency is the local currency. All of the assets and liabilities of these subsidiaries are converted to U.S. dollars at the exchange rate in effect at the balance sheet date, income and expense accounts are translated at average rates for the period, and shareholder&#8217;s equity accounts are translated at historical rates. The effects of translating financial statements of foreign operations into our reporting currency are recognized as an adjustment in accumulated other comprehensive income (loss).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has foreign subsidiaries that have a functional currency of the U.S. dollar. Purchases and sales of assets and income and expense items denominated in foreign currencies are remeasured into U.S. dollar amounts on the respective dates of such transactions. Net realized foreign currency gains or losses relating to the differences between these recorded amounts and the U.S. dollar equivalent actually received or paid are included within Other (expense) income, net in the condensed consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currencies</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reporting currency is the U.S. Dollar. The Company has certain foreign subsidiaries where the functional currency is the local currency. All of the assets and liabilities of these subsidiaries are converted to U.S. dollars at the exchange rate in effect at the balance sheet date, income and expense accounts are translated at average rates for the period, and shareholder&#8217;s equity accounts are translated at historical rates. The effects of translating financial statements of foreign operations into our reporting currency are recognized as an adjustment in accumulated other comprehensive income (loss).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has foreign subsidiaries that have a functional currency of the U.S. dollar. Purchases and sales of assets and income and expense items denominated in foreign currencies are remeasured into U.S. dollar amounts on the respective dates of such transactions. Net realized foreign currency gains or losses relating to the differences between these recorded amounts and the U.S. dollar equivalent actually received or paid are included within Other income, net in the consolidated statements of operations and comprehensive loss.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash and Cash Equivalents, Cash Equivalents, and Restricted Cash</a></td>
<td class="text">Restricted Cash and Other Cash Flows from Operating ActivitiesThe Company is required to maintain a cash deposit with a bank which consists of collateral on certain travel and expense programs maintained by the bank. <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. As of December&#160;31, 2021 and 2020, the Company had $128,318 and $60,495 of cash and cash equivalents, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to maintain a cash deposit with a bank which consists of collateral on a travel and expense program maintained by the bank. The following represents a reconciliation of cash and cash equivalents in </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the consolidated balance sheets to total cash, cash equivalents and restricted cash in the consolidated statement of cash flows as of December 31, 2021 and December 31, 2020.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,495&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (presented within Other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,732&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,909&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy', window );">Trade and Other Receivables</a></td>
<td class="text">Trade and Other Receivables Receivables are reported net of allowances for doubtful accounts. The Company maintains allowances for doubtful accounts for estimated losses resulting from the inability of customers to make required payments. The Company estimates the allowance for doubtful accounts based on a variety of factors including the length of time receivables are past due, the financial health of customers, unusual macroeconomic conditions, and historical experience. Trade and Other Receivables Receivables are reported net of allowances for doubtful accounts. The Company maintains allowances for doubtful accounts for estimated losses resulting from the inability of customers to make required payments. The Company estimates the allowance for doubtful accounts based on a variety of factors including the length of time receivables are past due, the financial health of customers, unusual macroeconomic conditions, and historical experience.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_OtherCurrentAssetsPolicyTextBlock', window );">Other Current Assets</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Current Assets</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current assets consist of prepaid expenses, materials and supplies, and other assets. Material and supplies consist of spare parts and consumables used for research and research equipment and is stated at the weighted average cost.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment, Net</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment, net</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost and include improvements that significantly increase capacities or extend the useful lives of existing plant and equipment.&#160;Depreciation is calculated using the straight-line method over the estimated useful life of the assets. Useful lives range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTA0_78de1c22-d3ad-43ae-a899-19a74e1b2357">three</span> to five years for instruments and equipment, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk3OTk5_761df305-309f-4903-a23c-ce62ac3f485c">three</span> to five years for office equipment and furniture and software, five years for vehicles and, for leasehold improvements, the shorter of the life of the improvement or the remaining term of the lease. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews the remaining useful life of its assets on a regular basis to determine whether changes have taken place that would suggest that a change to depreciation policies is warranted.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon retirement or disposal of property, plant and equipment, the cost and related accumulated depreciation are removed from the account, and the resulting gains or losses, if any, are recorded in the consolidated statements of operations and comprehensive loss. Net gains or losses related to asset dispositions are recognized in earnings in the period in which dispositions occur. Routine maintenance, repairs and replacements are expensed as incurred.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines&#160;if an arrangement is a lease at inception.&#160;Lease agreements are evaluated to classify the lease as a finance or operating&#160;lease.&#160;Operating lease assets and liabilities are recognized at the commencement date of the lease based on the present value of lease payments over the lease term. Lease assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. As most&#160;leases&#160;do not provide an implicit interest rate,&#160;the Company&#160;uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. Leases with an initial term of 12 months or less are not recorded on the Company&#8217;s consolidated balance sheets. The Company recognizes lease expense for these leases on a straight-line basis over the lease term.&#160;The Company accounts for lease components and non-lease components as a single lease component.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs a recoverability assessment of each of its long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indicators may include, but are not limited to, adverse changes in the regulatory environment in a jurisdiction where the Company operates, a decision to discontinue the development of a long-lived asset, early termination of a significant customer contract, or the introduction of newer technology.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When performing a recoverability assessment, the Company measures whether the estimated future undiscounted net cash flows expected to be generated by the asset exceeds its carrying value. In the event that an asset does not meet the recoverability test, the carrying value of the asset will be adjusted to fair value resulting in an impairment charge.</span></div>Management develops the assumptions used in the recoverability assessment based on active contracts as well as information received from third-party industry sources.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Equity Method Investments</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Method Investments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in entities over which the Company has significant influence, but not control, are accounted for using the&#160;equity method&#160;of accounting. Gain from&#160;equity method&#160;investees, net represents the Company&#8217;s proportionate share of net income or loss of its equity method investees and any gains or losses from the dilution of such investments.</span></div>Equity method&#160;investments are assessed for impairment whenever changes in the facts and circumstances indicate a loss in value may have occurred. When a loss is deemed to have occurred and is other than temporary, the carrying value of the&#160;equity method&#160;investment is written down to fair value. In evaluating whether a loss is other than temporary, the Company considers the length of time for which the conditions have existed and its intent and ability to hold the investment.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Simple Agreement for Future Equity (SAFE)</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The public warrants and the private placement warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The initial fair value of the public warrants issued in connection with the initial public offering was estimated using a Monte-Carlo simulation model. The fair value of the public warrants as of September 30, 2022 and as of December 31, 2021 is based on observable listed prices for such warrants. The fair value of the private placement warrants as of September 30, 2022 and as of December 31, 2021 is determined using a Black-Scholes option pricing model. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The public warrants and the private placement warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The initial fair value of the public warrants issued in connection with the initial public offering was estimated using a Monte-Carlo simulation model. The fair value of the public warrants as of December 31, 2021 is based on observable listed prices for such warrants. The fair value of the private placement warrants as of December 31, 2021 is determined using a Black-Scholes option pricing model. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</span></div>Simple Agreement for Future Equity (SAFE)<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company issued a SAFE that allowed an investor to participate in future equity financings through a share-settled redemption of the amount invested (such notional being the &#8220;invested amount&#8221;). The Company determined that the SAFE was not legal form debt (i.e., no creditors&#8217; rights). The SAFE includes a provision allowing for cash redemption upon the occurrence of a change of control, the occurrence of which is outside the control of the Company. Therefore, the SAFE is classified as mark-to-market liability pursuant to Accounting Standards Codification (&#8220;ASC&#8221;) 480, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distinguishing Liability from Equity</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_WarrantsPolicyPolicyTextBlock', window );">Warrants</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has warrants to purchase preferred shares outstanding as of December&#160;31, 2021 and 2020 representing 225,223 and 383,281 preferred shares, respectively, which warrants expire at various dates through December 31, 2027. The exercise prices of the warrants range from $14.69 to $19.93 as of each of December&#160;31, 2021 and 2020. The Company accounts for its warrants as liabilities based upon the characteristics and provisions of each instrument. The liabilities are included in other accrued liabilities on the Company's consolidated balance sheets at their fair value on the date of issuance and are revalued in each subsequent reporting period until such instruments are exercised or expire. The change in fair value between reporting periods is included in other (expense) income, net in the consolidated statements of operations and comprehensive loss.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further the warrant related to the SAFE of $1,729 is accounted for as a liability. This liability is recorded in current liabilities on the Company's consolidated balance sheets at fair value on the date of issuance and will be revalued each subsequent reporting period until such instrument is exercised or expire. The change in fair value between reporting periods is included in other (expense) income, net in the consolidated statements of operations and comprehensive loss.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtPolicyTextBlock', window );">Long-Term Debt and Debt Issuance Costs</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Term Debt and Debt Issuance Costs</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s debt consists of credit facilities with financial institutions. Costs directly related to the issuance of debt are reported on the consolidated balance sheets as a reduction from the carrying amount of the recognized debt liability and amortized over the term of the debt using the effective interest method.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Legal and Contingencies</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal and Contingencies</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may be involved in legal actions in the ordinary course of business, inquiries and proceedings concerning employment, labor, environmental, and other claims. The Company will recognize a loss contingency in the consolidated financial statements when it is probable a liability has been incurred and the amount of the loss can be reasonably estimated. The Company will disclose any loss contingencies that do not meet both conditions if there is a reasonable possibility that a loss may have been incurred. Gain contingencies are not recorded until realized.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company primarily earns revenue from services related to feasibility studies and basic engineering design of commercial plants, licensing of technologies, joint development and contract research activities to develop novel biocatalysts and related technologies.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is measured based on the consideration specified in a contract with a customer. The Company records taxes collected from customers and remitted to governmental authorities on a net basis. The Company&#8217;s payment terms are between 30-60 days and can vary by customer type and products offered. We have evaluated the terms of our arrangements and determined that they do not contain significant financing components.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Carbon Capture and Transformation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides feasibility studies and basic design and engineering services used for detailed design, procurement, and construction of commercial plants that utilize the Company&#8217;s technologies, along with the sale of equipment and microbes. The services provided are recognized as a performance obligation satisfied over time. Revenue is recognized using the output method based on milestone completion, the cost-to-cost input method for certain engineering services, or the percentage of completion method when certain revenue recognition requirements are met. Management has determined that the milestone completion and the associated contractual payment amounts are an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company licenses intellectual property to generate recurring revenue when its customers deploy carbon capture and transformation plants. When licenses are considered to be distinct performance obligations, the recognition of revenue is dependent on the terms of the contract, which may include fixed consideration or royalties based on sales or usage, in which case, the revenue is recognized when the subsequent sale or usage occurs or when the performance obligation to which some or all of the sales or usage-based royalty is allocated has been satisfied, whichever is later.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Services</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs research and development (&#8220;R&amp;D&#8221;) services related to novel technologies and development of biocatalysts for commercial applications, mainly to produce fuels and chemicals. The Company engages in two main types of R&amp;D services &#8211; joint development agreements, and other contract research, including projects with the U.S. Department of Energy. Such services are recognized as a performance obligation satisfied over time. Revenue is recognized based on milestone completion, when such milestones are contractually defined, or based on stage of contract completion when not defined. For the latter, management has determined that the cost incurred, input method, is an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and estimates its variable consideration under the expected value method. Accordingly, the Company records a liability based on milestones achieved and the expected repayment of the development costs. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s joint development agreements may utilize the cost-to-cost method of revenue recognition or may include well defined payment milestones, dependent on the contract, both of which the Company evaluates against work completed prior to revenue recognition. For other contract research, the Company utilizes the cost-to-cost method of revenue recognition. These contracts have a fixed dollar amount which is based on the Company&#8217;s estimate of total costs to be incurred over the life of each contract. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is not recognized in advance of customer acceptance of a milestone, when such acceptance is contractually required. Payments for R&amp;D services with no contractual payments are not due from customers until a technical report is submitted; therefore, a contract asset is recognized at milestone completion but prior to the submission of a technical report. The contract asset represents the Company&#8217;s right to consideration for the services performed at milestone completion. Occasionally, customers provide payments in advance of the Company providing services which creates a contract liability for the Company. The contract liability represents the Company's obligation to provide services to a customer. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collaboration Arrangements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain partnership agreements that are within the scope of ASC 808, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides guidance on the presentation and disclosure of collaborative arrangements. Generally, the classification of the transactions under the collaborative arrangements is determined based on the nature of the contractual terms of the arrangement, along with the nature of the operations of the participants. The Company&#8217;s collaborative agreements generally include a provision of R&amp;D services related to novel technologies and biocatalysts. Amounts received for these services are classified as Revenue from collaborative arrangements in the consolidated statements of operations and comprehensive loss. The Company's R&amp;D services are a major part of the Company's ongoing operations and therefore ASC 606 is applied to recognize revenue.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenues</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s R&amp;D, engineering, and other direct costs of services related to revenue agreements with customers, related parties, and collaborative partners represent cost of revenue. Costs include both internal and third-party fixed and variable costs and include materials, supplies, labor, and fringe benefits.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incur research and development costs associated with various R&amp;D activities and expense these costs as incurred.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for equity-based compensation in accordance with ASC 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation &#8211; Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Accordingly, in exchange for employee and director services, compensation is given in the form of equity awards. The equity awards are recorded based on the grant date fair value and expensed over the requisite service period for the respective award.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s equity-based awards include stock option awards and restricted stock issued by the Company, which vest based on either time or the achievement of certain performance conditions. The Company records forfeitures as they occur. Compensation expense resulting from time-vesting-based awards is recognized in the Company&#8217;s consolidated statements of operations and comprehensive loss, primarily within research and development expenses, at the grant date fair value over the requisite service period. Compensation expense resulting from performance awards recognized over the requisite service period when it is probable that the performance condition will be met. The calculated compensation expense for performance awards is adjusted based on an estimate of awards ultimately expected to vest. The Company estimates grant date fair value using a Black-Scholes option pricing model that uses assumptions including expected volatility, expected term, and the expected risk-free rate of return. The Company has determined that the Black-Scholes option pricing model, as well as the underlying assumptions used in its application, is appropriate in estimating the fair value of its award grants.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also </span></div>provides guidance on derecognition, classification, interest and penalties, accounting in period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company&#8217;s effective tax rate was 0.88% and 0.91% for the three and nine months ended September 30, 2022, respectively, and 0.00% for the three months ended September 30, 2021 and the period from January 28, 2021 (inception) through September 30, 2021. The effective tax rate differs from the statutory tax rate of 21% for the three and nine months ended September 30, 2022, the three months ended September 30, 2021 and the period from January 28, 2021 (inception) through September 30, 2021 due primarily to changes in fair value of derivative warrant liabilities, non-taxable gains on the settlement of deferred underwriting commissions, and the valuation allowance on the deferred tax assets.<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows the asset and liability method of accounting for income taxes under ASC 740, Income Taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income tax assets are evaluated to determine if valuation allowances are required or should be adjusted. Valuation allowances are established based on a more likely than not standard. The ability to realize deferred tax assets depends on the Company&#8217;s ability to generate sufficient taxable income within the carryback or carryforward periods provided for in the tax law for each tax jurisdiction. The Company considers the various possible sources of taxable income when assessing the realization of its deferred tax assets. The valuation allowances recorded against deferred tax assets generated by taxable losses in certain jurisdictions will affect the provision for income taxes until the valuation allowances are released. The Company&#8217;s provision for income taxes will include no tax benefit for losses incurred and no tax expense with respect to income generated in these jurisdictions until the respective valuation allowance is eliminated.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records uncertain tax positions on the basis of a two-step process whereby it is determined whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position, and for those tax positions that meet the more likely than not criteria, the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority is recognized. The Company recognizes accrued interest and penalties related to unrecognized tax benefits in income tax expense.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_RelatedPartyTransactionsPolicyPolicyTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Transactions</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows ASC 850-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for the identification of related parties and disclosure of related party transactions.</span></div>Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Per Share Of Common Stock</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share.&#8221; The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the units sold in the initial public offering and the private placement warrants to purchase an aggregate of 11,000,000 shares of Class A common stock in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the three and nine months ended September 30, 2022 and for the three months ended September 30, 2021 and for the period from January 28, 2021 (inception) through September 30, 2021. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended <br/>September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248,909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332,524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,130,435</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.887%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Nine Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Period from January 28, 2021 <br/>(inception) through <br/>September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,428,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Per Share of Common Stock</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share.&#8221; The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the units sold in the initial public offering and the private placement warrants to purchase an aggregate of 11,000,000 shares of Class A common stock in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the period from January 28, 2021 (inception) through December 31, 2021. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.451%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.805%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the period from January 28, 2021<br/>(inception) through December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income (loss) per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,690,909</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income (loss) per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss Per Share</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is computed by dividing net loss attributable to participating stock by the weighted average number of shares of participating stock outstanding during the period. </span></div>Diluted net loss per share reflects potential dilution and is computed by dividing net loss attributable to participating stock by the weighted average number of shares of participating stock outstanding during the period. The dilutive effect of outstanding awards, if any, is reflected in diluted earnings per share by application of the treasury stock method or if-converted method, as applicable.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily due to their short-term nature, except for the warrant liability. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-term nature, except for the warrant liability. Refer to Note 11, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrant Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for more information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of September 30, 2022 and December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue generated from the Company&#8217;s customers outside of the United States for the nine months ended September&#160;30, 2022 and 2021 was approximately 61% and 65%, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021, approximately 35% and 35%, respectively, of trade accounts receivable and unbilled accounts receivable was due from customers located outside the United States. At September&#160;30, 2022 and December&#160;31, 2021, the value of property, plant, and equipment outside the United States was immaterial.</span></div>The Company&#8217;s revenue by geographic region based on the customer&#8217;s location<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties (Restated)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue generated from the Company&#8217;s customers outside of the United States for the years ended December&#160;31, 2021 and 2020 was approximately 38% and 14%, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, approximately 35% and 27%, respectively, of trade accounts receivable and unbilled accounts receivable was due from customers located outside the United States. At December&#160;31, 2021 and 2020, the value of property, plant, and equipment outside the United States was immaterial.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue by geographic region based on the customer&#8217;s location is presented in Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customers</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers representing 10% or greater of revenue were as follows for the years ended December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div>As of December&#160;31, 2021, two of the Company's customers separately represented 49% (Customer B) and 15% (Customer D) of total accounts receivable and contract assets on the consolidated balance sheet.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FASB issued ASU 2022-03, ASC Subtopic 820 &#8220;Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions&#8221;. The ASU amends ASC 820 to clarify that a contractual sales restriction is not considered in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. The ASU applies to both holders and issuers of equity and equity-linked securities measured at fair value. The amendments in this ASU are effective for the Company in fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is still evaluating the impact of this pronouncement on the condensed financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company&#8217;s unaudited condensed financial statements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2020-06, &#8220;Debt &#8212; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8212; Contracts in an Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity&#8221; (&#8220;ASU 2020-06&#8221;), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. ASU 2020-06 also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 on August 2, 2021 using the modified retrospective method for transition. Adoption of ASU 2020-06 did not impact the Company&#8217;s financial position, results of operations or cash flows.</span></div>The Company&#8217;s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company&#8217;s financial statements.<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Announced Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Financial Accounting Standard Board ("FASB") issued an Accounting Standard Update ("ASU") No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2020-10&#8221;). The standard contains improvements to the FASB Accounting Standards Codification (the &#8220;Codification&#8221;) by ensuring that all guidance that requires or provides an option for an entity to provide information in the notes to financial statements is codified in the disclosure section of the Codification. The standard also improves various topics in the Codification so that entities can apply guidance more consistently on codifications that are varied in nature where the original guidance may have been unclear. The amendments in ASU 2020-10 were effective for the Company for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption was permitted. There were no material impacts upon the adoption of ASU 2020-10, on its consolidated financial statements and related disclosures. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses (Topic 326): Disclosure Framework &#8211; Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2016-13&#8221;), which requires financial assets measured at amortized cost basis, including trade receivables, to be presented net of the amount expected to be collected. The measurement of all expected credit losses will be based on historical experience, current conditions, and reasonable and supportable forecasts. The Company adopted the new standard effective January 1, 2020, using a modified retrospective transition method, which requires a cumulative-effect adjustment, if any, to the opening balance of retained earnings to be recognized on the date of adoption with prior periods not restated. The adoption did not have a material impact on the Company&#8217;s financial position or results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles &#8211; Goodwill and Other &#8211; Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2018-15&#8221;), which requires a customer in a cloud computing arrangement that is a service contract to follow the internal-use software guidance in ASC 350-40 to determine which implementation costs to capitalize as assets. A customer&#8217;s accounting for the costs of the hosting component of the arrangement is not affected by the new guidance. The Company adopted ASU 2018-15 as of January 1, 2020 with no material impact on its consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2018, the FASB issued ASU 2018-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Stock Compensation Improvements to Non-employee Share-Based Payment Accounting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2018-07&#8221;), which simplifies the accounting for stock-based payments granted to non-employees for goods and services. Under ASU 2018-07, most of the guidance on such payments to non-employees will be aligned with the requirements for stock-based payments granted to employees. The Company early adopted ASU 2018-07 as of January 1, 2020 and its adoption did not have a material impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2019-12&#8221;), as part of its simplification initiative to reduce the cost and complexity in accounting for income taxes. ASU 2019-12 removes certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. ASU 2019-12 also amends other aspects of the guidance to help simplify and promote consistent application of US GAAP. The Company adopted ASU 2019-12 as of January 1, 2021 with no material impact on its consolidated financial statements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Announced Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2020-10&#8221;). The standard contains improvements to the FASB Accounting Standards Codification (the &#8220;Codification&#8221;) by ensuring that all guidance that requires or provides an option for an entity to provide information in the notes to financial statements is codified in the disclosure section of the Codification. The standard also improves various topics in the Codification so that entities can apply guidance more consistently on codifications that are varied in nature where the original guidance may have been unclear. The amendments in ASU 2020-10 are effective for the Company for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption is permitted. The Company does not expect the adoption of ASU 2020-10 to have a material impact on its consolidated financial statements and related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_CoronavirusPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Coronavirus</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_CoronavirusPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_GoingConcernPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Going Concern</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_GoingConcernPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_OtherCurrentAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Current Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_OtherCurrentAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_RelatedPartyTransactionsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party Transactions, Policy</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_RelatedPartyTransactionsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_WarrantsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants, Policy</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_WarrantsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangements entered into by lessor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL117410129-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919352-209981<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL117410129-209981<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL119206284-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for treatment of receivables that are billable but have not been billed as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -URI https://asc.fasb.org/topic&amp;trid=2196771<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272210250688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Calculation of Basic and Diluted Net Loss per Share</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended <br/>September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248,909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332,524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,130,435</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.887%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Nine Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Period from January 28, 2021 <br/>(inception) through <br/>September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,428,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.451%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.805%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the period from January 28, 2021<br/>(inception) through December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income (loss) per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,690,909</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income (loss) per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of basic and diluted net loss per share for the Company&#8217;s common stock (in thousands, except shares and per share amounts):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss for basic and diluted earnings per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,974)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,591)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid cumulative dividends on preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,925)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,068)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss allocated to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83,899)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,659)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares used in calculating net loss per share, basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,108,472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,909,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share, basic and diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.79)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.19)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In periods in which the Company reports a net loss, all share-based compensation awards are excluded from the calculation of diluted weighted average shares outstanding because of their anti-dilutive effect on earnings (loss) per share.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of basic and diluted net loss per share for the Company&#8217;s common stock (in thousands, except shares and per share amounts):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss for basic and diluted earnings per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,689)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,713)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid cumulative dividends on preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,758)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss allocated to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83,447)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69,004)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares used in calculating net loss per share, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,959,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,629,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share, basic and diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.59)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.34)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In periods in which the Company reports a net loss, all stock-based compensation awards are excluded from the calculation of diluted weighted average shares outstanding because of their anti-dilutive effect on earnings (loss) per share.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211067248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Class A Common Stock Subject to Possible Redemption (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityTableTextBlock', window );">Summary of reconciliation of common stock subject to possible redemption</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross proceeds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount allocated to public warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,100,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,306,092)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of carrying value to redemption value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,406,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock subject to possible redemption, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subsequent remeasurement of Class A common stock subject to possible redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock subject to possible redemption, September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,293,649&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross proceeds from Initial Public Offering</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of Public Warrants at issuance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,100,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Offering costs allocated to Class A common stock subject to possible redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,306,092)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion on Class A common stock subject to possible redemption amount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,406,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock subject to possible redemption</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>The authorized, issued and outstanding shares, issue price, and carrying value as of September&#160;30, 2022, are as follows (in thousands, except share and per share amounts):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.287%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares Authorized</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.75 - 3.94</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,254,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.69</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,274,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,161,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.93</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series F</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,747,033&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,631&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>The authorized, issued and outstanding shares, issue price, and carrying value as of December&#160;31, 2021 and 2020 are as follows (in thousands, except share and per share amounts):<div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares Authorized</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.75 - 3.94</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,254,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.69</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,274,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,161,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.93</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series F</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,747,033&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,631&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares Authorized</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Issue Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.75 - 3.94</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,254,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,142,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,274,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,003,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">185,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,112,823&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,729,542&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">394,408&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable convertible preferred stock issued and outstanding as of December&#160;31, 2021 and 2020, and changes during the years ended December&#160;31, 2021 and 2020, were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.874%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.508%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.470%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.310%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="81" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Redeemable Convertible Preferred Stock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series B</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series C</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series D</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series E</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series F</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10,003,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">185,252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,149,745&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">71,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">23,695,330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">347,938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Preferred stock issuance, net of costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,034,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">46,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,034,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">46,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10,003,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">185,252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">25,729,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">394,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Preferred stock issuance, net of costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">158,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,792,268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">86,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10,161,362&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">188,402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">480,631&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272206345040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Summary of assets and liabilities that are measured at fair value on a recurring basis</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September 30, 2022</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other <br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held in trust account</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,969,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201;public warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201;private placement warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493,280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2021</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held in trust account</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,006,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201; public warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,825,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201;private placement warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information as of December 31, 2021 about the Company&#8217;s financial assets and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held in Trust Account</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,006,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities &#8211; Public Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,825,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities &#8211; Private Placement Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value hierarchy for its assets and liabilities measured at fair value as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,815&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,815&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value hierarchy for its assets and liabilities measured at fair value as of December&#160;31, 2021 and 2020 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:13pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Summary of quantitative information regarding Level 3 fair value measurement inputs</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30, 2022 </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2021 </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.19</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.75</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of <br/>December 31, 2021 </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of <br/>August 6, 2021 </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining term (yrs)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.75</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.51</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the weighted average inputs used in calculating the fair value of the preferred share warrants outstanding as of September&#160;30, 2022 and December&#160;31, 2021:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.03&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE liability fair value measurement at September&#160;30, 2022 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liquidity price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE warrant fair value measurement at September&#160;30, 2022 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining life (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the weighted average inputs used in calculating the fair value of the preferred share warrants outstanding as of December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE liability fair value measurement at December 31, 2021 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liquidity price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE warrant fair value measurement at December 31, 2021 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining life (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Summary of change in the fair value of the derivative warrant liabilities, measured using Level 3 inputs</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,030,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,085,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(451,720)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493,280&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the fair value of the derivative warrant liabilities, measured using Level 3 inputs, for the period from January 28, 2021 (inception) through December 31, 2021 is summarized as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at January 28, 2021 (inception)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of Public and Private Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,515,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer of Public Warrants to Level 1</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,100,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(630,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables represents a reconciliation of the contingent shares issuance liabilities fair value measurements using the significant unobservable inputs (Level 3) (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrants</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE warrant</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss / (gain) recognized in condensed statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,050)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,221&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrants</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE warrant</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of SAFE liability and warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss recognized in condensed statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,281&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents a reconciliation of the contingent shares issuance liabilities fair value measurements using the significant unobservable inputs (Level 3) (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain recognized in statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of SAFE liability and warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss recognized in statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211086160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Calculation of Basic and Diluted Net Loss per Share</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended <br/>September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248,909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332,524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,130,435</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.887%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Nine Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Period from January 28, 2021 <br/>(inception) through <br/>September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,428,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.451%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.805%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the period from January 28, 2021<br/>(inception) through December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income (loss) per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,690,909</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income (loss) per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of basic and diluted net loss per share for the Company&#8217;s common stock (in thousands, except shares and per share amounts):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss for basic and diluted earnings per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,974)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,591)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid cumulative dividends on preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,925)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,068)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss allocated to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83,899)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,659)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares used in calculating net loss per share, basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,108,472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,909,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share, basic and diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.79)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.19)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In periods in which the Company reports a net loss, all share-based compensation awards are excluded from the calculation of diluted weighted average shares outstanding because of their anti-dilutive effect on earnings (loss) per share.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of basic and diluted net loss per share for the Company&#8217;s common stock (in thousands, except shares and per share amounts):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss for basic and diluted earnings per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,689)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,713)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid cumulative dividends on preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,758)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss allocated to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83,447)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69,004)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares used in calculating net loss per share, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,959,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,629,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share, basic and diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.59)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.34)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In periods in which the Company reports a net loss, all stock-based compensation awards are excluded from the calculation of diluted weighted average shares outstanding because of their anti-dilutive effect on earnings (loss) per share.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272210220976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Class A Common Stock Subject to Possible Redemption (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityTableTextBlock', window );">Summary of reconciliation of common stock subject to possible redemption</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross proceeds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount allocated to public warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,100,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,306,092)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of carrying value to redemption value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,406,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock subject to possible redemption, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subsequent remeasurement of Class A common stock subject to possible redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock subject to possible redemption, September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,293,649&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross proceeds from Initial Public Offering</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of Public Warrants at issuance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,100,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Offering costs allocated to Class A common stock subject to possible redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,306,092)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion on Class A common stock subject to possible redemption amount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,406,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock subject to possible redemption</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>The authorized, issued and outstanding shares, issue price, and carrying value as of September&#160;30, 2022, are as follows (in thousands, except share and per share amounts):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.287%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares Authorized</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.75 - 3.94</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,254,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.69</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,274,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,161,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.93</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series F</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,747,033&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,631&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>The authorized, issued and outstanding shares, issue price, and carrying value as of December&#160;31, 2021 and 2020 are as follows (in thousands, except share and per share amounts):<div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares Authorized</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.75 - 3.94</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,254,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.69</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,274,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,161,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.93</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series F</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,747,033&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,631&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares Authorized</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Issue Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.75 - 3.94</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,254,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,142,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,274,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,003,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">185,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,112,823&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,729,542&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">394,408&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable convertible preferred stock issued and outstanding as of December&#160;31, 2021 and 2020, and changes during the years ended December&#160;31, 2021 and 2020, were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.874%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.508%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.470%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.310%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="81" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Redeemable Convertible Preferred Stock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series B</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series C</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series D</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series E</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series F</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10,003,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">185,252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,149,745&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">71,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">23,695,330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">347,938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Preferred stock issuance, net of costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,034,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">46,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,034,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">46,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10,003,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">185,252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">25,729,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">394,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Preferred stock issuance, net of costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">158,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,792,268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">86,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10,161,362&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">188,402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">480,631&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272203574208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Summary of assets and liabilities that are measured at fair value on a recurring basis</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September 30, 2022</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other <br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held in trust account</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,969,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201;public warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201;private placement warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493,280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2021</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held in trust account</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,006,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201; public warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,825,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201;private placement warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information as of December 31, 2021 about the Company&#8217;s financial assets and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held in Trust Account</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,006,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities &#8211; Public Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,825,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities &#8211; Private Placement Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value hierarchy for its assets and liabilities measured at fair value as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,815&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,815&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value hierarchy for its assets and liabilities measured at fair value as of December&#160;31, 2021 and 2020 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:13pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Summary of quantitative information regarding Level 3 fair value measurement inputs</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30, 2022 </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2021 </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.19</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.75</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of <br/>December 31, 2021 </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of <br/>August 6, 2021 </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining term (yrs)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.75</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.51</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the weighted average inputs used in calculating the fair value of the preferred share warrants outstanding as of September&#160;30, 2022 and December&#160;31, 2021:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.03&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE liability fair value measurement at September&#160;30, 2022 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liquidity price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE warrant fair value measurement at September&#160;30, 2022 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining life (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the weighted average inputs used in calculating the fair value of the preferred share warrants outstanding as of December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE liability fair value measurement at December 31, 2021 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liquidity price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE warrant fair value measurement at December 31, 2021 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining life (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Summary of change in the fair value of the derivative warrant liabilities, measured using Level 3 inputs</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,030,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,085,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(451,720)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493,280&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the fair value of the derivative warrant liabilities, measured using Level 3 inputs, for the period from January 28, 2021 (inception) through December 31, 2021 is summarized as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at January 28, 2021 (inception)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of Public and Private Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,515,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer of Public Warrants to Level 1</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,100,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(630,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables represents a reconciliation of the contingent shares issuance liabilities fair value measurements using the significant unobservable inputs (Level 3) (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrants</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE warrant</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss / (gain) recognized in condensed statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,050)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,221&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrants</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE warrant</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of SAFE liability and warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss recognized in condensed statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,281&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents a reconciliation of the contingent shares issuance liabilities fair value measurements using the significant unobservable inputs (Level 3) (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain recognized in statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of SAFE liability and warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss recognized in statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272207491664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Income tax provision</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Period from January 28, 2021<br/>(inception) through December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290,181)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of income tax expense were as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Zealand</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Zealand</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Summary of significant components of the Company's deferred tax assets</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Start-up/Organization costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">210,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">290,181&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(290,181)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax asset, net of allowance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of deferred tax assets and liabilities as of December&#160;31, 2021 and 2020, were as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss and credit carryforwards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,979&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,878&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued bonus</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,881&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,417&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113,276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108,300)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax asset</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,117&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease asset</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,429)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,941)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,605)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,117)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net deferred income tax assets and liabilities:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of reconciliation of the total income tax provision tax rate to the statutory federal income tax rate</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Period from January 28, 2021 (inception) through December 31, 2021 </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory federal income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative warrant liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(855.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Offering costs allocated to derivative warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table>The following table is a reconciliation of income taxes computed at the statutory federal income tax rate (21.0% federal income tax rate in the United States for 2021 and 28.0% federal income tax rate in the New Zealand for <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020, respectively) to the income tax expense (benefit) reflected in the consolidated statement of operations and comprehensive loss (in thousands, except percentages):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit) at the statutory federal income tax rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,805)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,560)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax rate differential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(605)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,068)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,429)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,892)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income on receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(443)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(679)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible legal costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from redomiciliation of intellectual property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPP loan forgiveness</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(644)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(196)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax benefit</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211120976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule of cash and cash equivalents</a></td>
<td class="text">The following represents a reconciliation of cash and cash equivalents in the condensed consolidated balance sheets to total cash, cash equivalents and restricted cash in the condensed consolidated statements of cash flows as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands).<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (presented within Other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,034&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,732&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>The following represents a reconciliation of cash and cash equivalents in <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the consolidated balance sheets to total cash, cash equivalents and restricted cash in the consolidated statement of cash flows as of December 31, 2021 and December 31, 2020.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,495&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (presented within Other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,732&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,909&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Customer concentration risk</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers representing 10% or greater of revenue were as follows for the nine months ended September&#160;30, 2022 and 2021:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers representing 10% or greater of revenue were as follows for the years ended December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6442-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272210228992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Calculation of Basic and Diluted Net Loss per Share</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended <br/>September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248,909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332,524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,130,435</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.887%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Nine Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Period from January 28, 2021 <br/>(inception) through <br/>September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,428,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.451%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.805%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the period from January 28, 2021<br/>(inception) through December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income (loss) per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,690,909</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income (loss) per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of basic and diluted net loss per share for the Company&#8217;s common stock (in thousands, except shares and per share amounts):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss for basic and diluted earnings per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,974)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,591)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid cumulative dividends on preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,925)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,068)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss allocated to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83,899)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,659)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares used in calculating net loss per share, basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,108,472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,909,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share, basic and diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.79)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.19)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In periods in which the Company reports a net loss, all share-based compensation awards are excluded from the calculation of diluted weighted average shares outstanding because of their anti-dilutive effect on earnings (loss) per share.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of basic and diluted net loss per share for the Company&#8217;s common stock (in thousands, except shares and per share amounts):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss for basic and diluted earnings per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,689)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,713)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid cumulative dividends on preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,758)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss allocated to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83,447)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69,004)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares used in calculating net loss per share, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,959,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,629,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share, basic and diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.59)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.34)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In periods in which the Company reports a net loss, all stock-based compensation awards are excluded from the calculation of diluted weighted average shares outstanding because of their anti-dilutive effect on earnings (loss) per share.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and 2021, potential shares of common stock not included in the computation of loss per share because their effect would be antidilutive include the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable convertible preferred stock (if converted)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,790,978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,540,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSAs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,117,671&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,867,263&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, potential shares of common stock not included in the computation of earnings per share because their effect would be antidilutive include the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable convertible preferred stock (if converted)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,729,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,848,420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,283,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSAs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,175,113&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,720,703&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272207833408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregated revenue</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents disaggregated revenue in the following categories (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Types:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joint development agreements</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other contract research</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,118&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,053&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CarbonSmart</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Engineering and other services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,756&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carbon capture and transformation revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,663&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,274&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,781&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,327&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents disaggregation of the Company&#8217;s revenues by customer location for the nine months ended September&#160;30, 2022 and 2021 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.214%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,725&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Middle East, Africa (EMEA)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,781&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,327&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents disaggregated revenue in the following categories (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 5.5pt;text-align:center;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 5.5pt;text-align:center;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Types:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joint development agreements</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other contract research</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,897&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,910&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Engineering and other services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carbon capture and transformation revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,564&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:33pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,461&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,353&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents disaggregation of the Company&#8217;s revenues by customer location for the years ended December&#160;31, 2021 and 2020 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,732&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,461&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,353&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Changes in contract assets and liabilities</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides changes in contract assets and liabilities (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Contract Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Contract Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-current Contract Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022 as Restated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,901&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to unbilled accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases due to cash received</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled accounts receivable recognized in trade receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,085)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease on revaluation on currency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(804)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification from non-current to current contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,015)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification to revenue as a result of performance obligations satisfied</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,298)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,848&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,968&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,119&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides changes in contract assets and liabilities during the year ended December 31, 2021.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Contract Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Contract Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-current Contract Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020 as Restated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,291&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to unbilled accounts receivable as Restated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases due to cash received</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,690&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled accounts receivable recognized in trade receivables as Restated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,002)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification from long-term to short-term</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,080)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification to revenue as a result of performance obligations satisfied</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,104)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,700&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,476&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,901&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock', window );">Remaining performance obligations</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remaining performance obligations consisted of the following (in thousands): </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,087&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,377&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remaining performance obligations consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,377&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,771&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of expected timing for satisfying remaining performance obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272197863296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTableTextBlock', window );">Investments</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investments consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Category</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021 as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Method Investment in LanzaJet</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Security Investment in SGLT</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Investment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,037&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,752&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 325<br> -URI https://asc.fasb.org/topic&amp;trid=2197064<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -URI https://asc.fasb.org/topic&amp;trid=75115024<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI https://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211529792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Summary of assets and liabilities that are measured at fair value on a recurring basis</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September 30, 2022</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other <br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held in trust account</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,969,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201;public warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201;private placement warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493,280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2021</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held in trust account</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,006,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201; public warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,825,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201;private placement warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information as of December 31, 2021 about the Company&#8217;s financial assets and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held in Trust Account</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,006,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities &#8211; Public Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,825,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities &#8211; Private Placement Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value hierarchy for its assets and liabilities measured at fair value as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,815&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,815&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value hierarchy for its assets and liabilities measured at fair value as of December&#160;31, 2021 and 2020 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:13pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Summary of quantitative information regarding Level 3 fair value measurement inputs</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30, 2022 </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2021 </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.19</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.75</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of <br/>December 31, 2021 </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of <br/>August 6, 2021 </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining term (yrs)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.75</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.51</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the weighted average inputs used in calculating the fair value of the preferred share warrants outstanding as of September&#160;30, 2022 and December&#160;31, 2021:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.03&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE liability fair value measurement at September&#160;30, 2022 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liquidity price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE warrant fair value measurement at September&#160;30, 2022 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining life (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the weighted average inputs used in calculating the fair value of the preferred share warrants outstanding as of December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE liability fair value measurement at December 31, 2021 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liquidity price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE warrant fair value measurement at December 31, 2021 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining life (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Summary of change in the fair value of the derivative warrant liabilities, measured using Level 3 inputs</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,030,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,085,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(451,720)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493,280&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the fair value of the derivative warrant liabilities, measured using Level 3 inputs, for the period from January 28, 2021 (inception) through December 31, 2021 is summarized as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at January 28, 2021 (inception)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of Public and Private Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,515,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer of Public Warrants to Level 1</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,100,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(630,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables represents a reconciliation of the contingent shares issuance liabilities fair value measurements using the significant unobservable inputs (Level 3) (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrants</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE warrant</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss / (gain) recognized in condensed statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,050)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,221&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrants</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE warrant</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of SAFE liability and warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss recognized in condensed statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,281&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents a reconciliation of the contingent shares issuance liabilities fair value measurements using the significant unobservable inputs (Level 3) (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain recognized in statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of SAFE liability and warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss recognized in statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272210244512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Stock Options Activity</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option awards outstanding as of September&#160;30, 2022 and changes during the period ended September&#160;30, 2022 were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares under option (thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average remaining contractual term (years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate intrinsic value (thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,848&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.16</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,796&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expecting to vest at January 1, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.16</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.85</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,806&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.39</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,032&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expecting to vest at September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.39</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.56</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option awards outstanding as of December&#160;31, 2021 and changes during the year ended December&#160;31, 2021 were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares under option (thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average remaining contractual term (years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate intrinsic value (thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at January 1, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,283&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.09</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expecting to vest at January 1, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.09</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable at January 1, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.47</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(721)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited/expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(334)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,848&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.16</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,796&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expecting to vest at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.16</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable at December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.85</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211161408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">Amounts related to transactions with related parties</a></td>
<td class="text">The table below summarizes amounts related to transactions with these related parties (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,116&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,509&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases and open accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211140384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable, Convertible Preferred Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityTableTextBlock', window );">Authorized, issued and outstanding shares, issue price, and carrying value</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross proceeds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount allocated to public warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,100,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,306,092)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of carrying value to redemption value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,406,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock subject to possible redemption, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subsequent remeasurement of Class A common stock subject to possible redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock subject to possible redemption, September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,293,649&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross proceeds from Initial Public Offering</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of Public Warrants at issuance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,100,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Offering costs allocated to Class A common stock subject to possible redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,306,092)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion on Class A common stock subject to possible redemption amount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,406,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock subject to possible redemption</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>The authorized, issued and outstanding shares, issue price, and carrying value as of September&#160;30, 2022, are as follows (in thousands, except share and per share amounts):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.287%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares Authorized</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.75 - 3.94</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,254,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.69</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,274,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,161,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.93</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series F</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,747,033&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,631&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>The authorized, issued and outstanding shares, issue price, and carrying value as of December&#160;31, 2021 and 2020 are as follows (in thousands, except share and per share amounts):<div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares Authorized</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.75 - 3.94</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,254,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.69</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,274,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,161,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.93</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series F</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,747,033&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,631&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares Authorized</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Issue Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.75 - 3.94</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,254,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,142,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,274,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,003,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">185,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,112,823&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,729,542&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">394,408&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable convertible preferred stock issued and outstanding as of December&#160;31, 2021 and 2020, and changes during the years ended December&#160;31, 2021 and 2020, were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.874%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.508%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.470%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.310%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="81" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Redeemable Convertible Preferred Stock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series B</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series C</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series D</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series E</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series F</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10,003,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">185,252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,149,745&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">71,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">23,695,330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">347,938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Preferred stock issuance, net of costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,034,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">46,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,034,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">46,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10,003,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">185,252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">25,729,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">394,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Preferred stock issuance, net of costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">158,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,792,268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">86,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10,161,362&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">188,402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">480,631&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272204796560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock', window );">Operating Lease, Lease Income</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents amounts included in Revenue from related party transactions in the Condensed Consolidated Statement of Operations related to lessor activity (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease income from operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of income from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI https://asc.fasb.org/extlink&amp;oid=126900988&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272199206032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule of cash and cash equivalents</a></td>
<td class="text">The following represents a reconciliation of cash and cash equivalents in the condensed consolidated balance sheets to total cash, cash equivalents and restricted cash in the condensed consolidated statements of cash flows as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands).<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (presented within Other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,034&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,732&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>The following represents a reconciliation of cash and cash equivalents in <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the consolidated balance sheets to total cash, cash equivalents and restricted cash in the consolidated statement of cash flows as of December 31, 2021 and December 31, 2020.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,495&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (presented within Other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,732&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,909&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Customer concentration risk</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers representing 10% or greater of revenue were as follows for the nine months ended September&#160;30, 2022 and 2021:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers representing 10% or greater of revenue were as follows for the years ended December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock', window );">Schedule of error corrections</a></td>
<td class="text">The effects of the correction of these errors on the relevant financial statement line items is as follows:<div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Balance Sheet</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,738&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,011&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(378,162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(379,889)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(353,190)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(354,917)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, contingently redeemable preferred equity, and shareholders' deficit</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,738&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,011&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Balance Sheet</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,664&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(684)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,980&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,775&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,897&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,666&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,788&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(332,394)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(333,200)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310,410)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311,216)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, contingently redeemable preferred equity, and shareholders' deficit</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,664&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(684)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,980&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Operations and Comprehensive Loss</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from contracts with customers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from related party transactions</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,915&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(662)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,253&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,245&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(784)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,461&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue from contracts with customers (exclusive of depreciation shown below)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,289)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,167)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost and operating expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,602)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,480)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,357)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(662)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,019)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,972)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(662)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48,634)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(259)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,945&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,768)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(921)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,689)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss allocated to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82,526)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(921)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83,447)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,673)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(921)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,594)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share - basic and diluted</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.12)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.47)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.59)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Operations and Comprehensive Loss</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from contracts with customers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from related party transactions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,752&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(549)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,780&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(427)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,353&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue from contracts with customers (exclusive of depreciation shown below)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,063)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,185)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost and operating expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,932)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58,054)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,152)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(549)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,701)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,331)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(549)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,880)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,424&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(257)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,907)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,713)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss allocated to common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68,198)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69,004)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,282)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,088)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share - basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.84)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.50)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.34)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Changes in Redeemable Convertible Preferred Stock and Shareholders&#8217; Equity (Deficit)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit - Balance at December 31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(332,394)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(333,200)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit &#8211; balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310,410)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311,216)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,768)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(921)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,689)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit - balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(378,162)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(379,889)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit &#8211; balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(353,190)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,727)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(354,917)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Changes in Redeemable Convertible Preferred Stock and Shareholders&#8217; Equity (Deficit)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit - Balance at December 31, 2019</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(295,487)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(295,487)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit &#8211; balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276,592)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276,592)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,907)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,713)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit - balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(332,394)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(333,200)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; deficit &#8211; balance at December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310,410)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311,216)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Cash Flows</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,768)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(921)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,689)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash recognition of licensing revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,684)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,022)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,945)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,636)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,514)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued salaries and wages</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,591)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,591)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statement of Cash Flows</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,907)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,713)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash recognition of licensing revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,567)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,018)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from equity method investees, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,424)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,167)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,483)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,605)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued salaries and wages</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,271)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,271)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on dilution</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6442-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211045088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Calculation of Basic and Diluted Net Loss per Share</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended <br/>September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248,909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332,524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,130,435</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.887%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Nine Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Period from January 28, 2021 <br/>(inception) through <br/>September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,428,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.451%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.805%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the period from January 28, 2021<br/>(inception) through December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income (loss) per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocation of net income (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,690,909</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income (loss) per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of basic and diluted net loss per share for the Company&#8217;s common stock (in thousands, except shares and per share amounts):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss for basic and diluted earnings per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,974)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,591)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid cumulative dividends on preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,925)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,068)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss allocated to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83,899)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,659)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares used in calculating net loss per share, basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,108,472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,909,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share, basic and diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.79)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.19)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In periods in which the Company reports a net loss, all share-based compensation awards are excluded from the calculation of diluted weighted average shares outstanding because of their anti-dilutive effect on earnings (loss) per share.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of basic and diluted net loss per share for the Company&#8217;s common stock (in thousands, except shares and per share amounts):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss for basic and diluted earnings per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,689)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,713)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid cumulative dividends on preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,758)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss allocated to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83,447)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69,004)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares used in calculating net loss per share, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,959,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,629,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share, basic and diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.59)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.34)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In periods in which the Company reports a net loss, all stock-based compensation awards are excluded from the calculation of diluted weighted average shares outstanding because of their anti-dilutive effect on earnings (loss) per share.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and 2021, potential shares of common stock not included in the computation of loss per share because their effect would be antidilutive include the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable convertible preferred stock (if converted)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,790,978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,540,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSAs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,117,671&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,867,263&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, potential shares of common stock not included in the computation of earnings per share because their effect would be antidilutive include the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable convertible preferred stock (if converted)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,729,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,848,420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,283,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSAs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,175,113&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,720,703&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272209363840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregated revenue</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents disaggregated revenue in the following categories (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Types:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joint development agreements</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other contract research</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,118&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,053&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CarbonSmart</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Engineering and other services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,756&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carbon capture and transformation revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,663&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,274&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,781&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,327&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents disaggregation of the Company&#8217;s revenues by customer location for the nine months ended September&#160;30, 2022 and 2021 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.214%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,725&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Middle East, Africa (EMEA)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,781&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,327&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents disaggregated revenue in the following categories (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 5.5pt;text-align:center;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 5.5pt;text-align:center;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Types:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joint development agreements</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other contract research</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,897&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,910&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Engineering and other services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carbon capture and transformation revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,564&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:33pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,461&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,353&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents disaggregation of the Company&#8217;s revenues by customer location for the years ended December&#160;31, 2021 and 2020 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,732&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,461&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,353&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Changes in contract assets and liabilities</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides changes in contract assets and liabilities (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Contract Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Contract Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-current Contract Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022 as Restated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,901&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to unbilled accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases due to cash received</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled accounts receivable recognized in trade receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,085)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease on revaluation on currency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(804)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification from non-current to current contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,015)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification to revenue as a result of performance obligations satisfied</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,298)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,848&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,968&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,119&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides changes in contract assets and liabilities during the year ended December 31, 2021.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Contract Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Contract Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-current Contract Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020 as Restated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,291&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to unbilled accounts receivable as Restated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases due to cash received</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,690&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled accounts receivable recognized in trade receivables as Restated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,002)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification from long-term to short-term</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,080)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification to revenue as a result of performance obligations satisfied</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,104)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,700&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,476&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,901&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock', window );">Remaining performance obligations</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remaining performance obligations consisted of the following (in thousands): </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,087&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,377&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remaining performance obligations consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,377&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,771&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of expected timing for satisfying remaining performance obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211192624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Investments</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investments consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Category</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in LanzaJet</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,651&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in SGLT</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Investment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,752&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,217&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents summarized aggregated financial information of the equity method investments:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selected Statement of Operations Information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,703)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,510)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,695)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,729)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to the Company</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,606)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,644)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selected Balance Sheet Information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>As of and for the years ended December 31, 2021 and December 31, 2020, sales, accounts receivable, and purchases and open accounts payable with equity method investees were as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,253&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases and open accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272197741552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Summary of assets and liabilities that are measured at fair value on a recurring basis</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September 30, 2022</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other <br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held in trust account</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,969,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201;public warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201;private placement warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493,280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2021</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held in trust account</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,006,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201; public warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,825,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities&#8201;&#8211;&#8201;private placement warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information as of December 31, 2021 about the Company&#8217;s financial assets and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held in Trust Account</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,006,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities &#8211; Public Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,825,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities &#8211; Private Placement Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value hierarchy for its assets and liabilities measured at fair value as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,815&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,815&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value hierarchy for its assets and liabilities measured at fair value as of December&#160;31, 2021 and 2020 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:13pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement as of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Summary of quantitative information regarding Level 3 fair value measurement inputs</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30, 2022 </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2021 </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.19</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.75</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of <br/>December 31, 2021 </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of <br/>August 6, 2021 </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining term (yrs)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.75</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.51</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the weighted average inputs used in calculating the fair value of the preferred share warrants outstanding as of September&#160;30, 2022 and December&#160;31, 2021:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.03&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE liability fair value measurement at September&#160;30, 2022 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liquidity price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE warrant fair value measurement at September&#160;30, 2022 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining life (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the weighted average inputs used in calculating the fair value of the preferred share warrants outstanding as of December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE liability fair value measurement at December 31, 2021 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liquidity price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant inputs for Level 3 SAFE warrant fair value measurement at December 31, 2021 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Near Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining life (in years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time to conversion (in years)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Summary of change in the fair value of the derivative warrant liabilities, measured using Level 3 inputs</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,030,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,085,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(451,720)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493,280&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the fair value of the derivative warrant liabilities, measured using Level 3 inputs, for the period from January 28, 2021 (inception) through December 31, 2021 is summarized as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at January 28, 2021 (inception)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of Public and Private Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,515,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer of Public Warrants to Level 1</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,100,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(630,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative warrant liabilities at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables represents a reconciliation of the contingent shares issuance liabilities fair value measurements using the significant unobservable inputs (Level 3) (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrants</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE warrant</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss / (gain) recognized in condensed statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,050)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,221&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrants</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SAFE warrant</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of SAFE liability and warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss recognized in condensed statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,281&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents a reconciliation of the contingent shares issuance liabilities fair value measurements using the significant unobservable inputs (Level 3) (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SAFE warrant</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain recognized in statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of SAFE liability and warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss recognized in statement of operations and comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,271&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211067248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Current Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Schedule of Other Current Assets</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020 other current assets consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Materials and supplies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,900&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,952&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,779&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,387&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272202669936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant, and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, the Company&#8217;s property, plant and equipment, net consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vehicles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office Equipment and furniture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,521&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,298&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment, net</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,148&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,609&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211067248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of debt</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, the Company&#8217;s debt consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 WTI Loan</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPP Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,635&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less amount due within one year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt due after one year, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,065&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272206260608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Components of (loss) income before income taxes and gain from equity method investees, net</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of (loss) income before income taxes and gain from equity method investees, net are as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,860)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Zealand</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,551)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,651)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,689)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,713)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Income tax provision</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Period from January 28, 2021<br/>(inception) through December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290,181)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of income tax expense were as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Zealand</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Zealand</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Reconciliation of income taxes computed at statutory federal income tax rate</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Period from January 28, 2021 (inception) through December 31, 2021 </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory federal income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative warrant liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(855.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Offering costs allocated to derivative warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table>The following table is a reconciliation of income taxes computed at the statutory federal income tax rate (21.0% federal income tax rate in the United States for 2021 and 28.0% federal income tax rate in the New Zealand for <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020, respectively) to the income tax expense (benefit) reflected in the consolidated statement of operations and comprehensive loss (in thousands, except percentages):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit) at the statutory federal income tax rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,805)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,560)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax rate differential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(605)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,068)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,429)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,892)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income on receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(443)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(679)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible legal costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from redomiciliation of intellectual property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPP loan forgiveness</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(644)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(196)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax benefit</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Significant components of deferred tax assets and liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Start-up/Organization costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">210,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">290,181&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(290,181)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax asset, net of allowance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of deferred tax assets and liabilities as of December&#160;31, 2021 and 2020, were as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss and credit carryforwards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,979&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,878&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued bonus</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,881&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,417&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113,276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108,300)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax asset</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,117&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease asset</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,429)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,941)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,605)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,117)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net deferred income tax assets and liabilities:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272206749120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Stock Options Activity</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option awards outstanding as of September&#160;30, 2022 and changes during the period ended September&#160;30, 2022 were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares under option (thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average remaining contractual term (years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate intrinsic value (thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,848&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.16</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,796&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expecting to vest at January 1, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.16</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.85</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,806&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.39</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,032&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expecting to vest at September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.39</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.56</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option awards outstanding as of December&#160;31, 2021 and changes during the year ended December&#160;31, 2021 were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares under option (thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average remaining contractual term (years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate intrinsic value (thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at January 1, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,283&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.09</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expecting to vest at January 1, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.09</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable at January 1, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.47</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(721)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited/expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(334)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,848&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.16</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,796&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expecting to vest at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.16</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable at December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.85</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule Stock Options Valuation Assumptions</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the weighted-average assumptions applied in the Black-Scholes valuation of options for awards subject to expense recognition for the first time in the period, for the years ended December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock', window );">Restricted Stock Awards Activity</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSAs as of December&#160;31, 2021 and changes during the year ended December&#160;31, 2021 were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nonvested Shares (thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at January 1, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.76&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.72&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272205172944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable, Convertible Preferred Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityTableTextBlock', window );">Redeemable convertible preferred stock</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross proceeds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount allocated to public warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,100,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,306,092)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of carrying value to redemption value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,406,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock subject to possible redemption, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subsequent remeasurement of Class A common stock subject to possible redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock subject to possible redemption, September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,293,649&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross proceeds from Initial Public Offering</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of Public Warrants at issuance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,100,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Offering costs allocated to Class A common stock subject to possible redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,306,092)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion on Class A common stock subject to possible redemption amount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,406,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A common stock subject to possible redemption</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>The authorized, issued and outstanding shares, issue price, and carrying value as of September&#160;30, 2022, are as follows (in thousands, except share and per share amounts):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.287%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares Authorized</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.75 - 3.94</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,254,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.69</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,274,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,161,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.93</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series F</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,747,033&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,631&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>The authorized, issued and outstanding shares, issue price, and carrying value as of December&#160;31, 2021 and 2020 are as follows (in thousands, except share and per share amounts):<div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares Authorized</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.75 - 3.94</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,254,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.69</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,274,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,161,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.93</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series F</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.86</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,747,033&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,631&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares Authorized</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Issue Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.75 - 3.94</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,733,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,254,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,142,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,274,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,003,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">185,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,183,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,112,823&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,729,542&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">394,408&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable convertible preferred stock issued and outstanding as of December&#160;31, 2021 and 2020, and changes during the years ended December&#160;31, 2021 and 2020, were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.874%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.508%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.470%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.188%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.310%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="81" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Redeemable Convertible Preferred Stock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series B</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series C</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series D</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series E</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series F</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10,003,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">185,252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,149,745&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">71,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">23,695,330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">347,938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Preferred stock issuance, net of costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,034,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">46,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,034,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">46,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10,003,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">185,252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">25,729,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">394,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Preferred stock issuance, net of costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">158,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,792,268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">86,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,666,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,733,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,142,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">60,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10,161,362&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">188,402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5,183,957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">118,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,634,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">83,073&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">29,521,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">480,631&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272199282976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Lessee, Operating Lease, Liability, Maturity</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, lease payments for operating leases for the Company&#8217;s office facility and laboratories are shown below (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.279%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,818&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,333&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Assets And Liabilities, Lessee</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of weighted average remaining lease term and discount rate for all of the Company&#8217;s operating leases:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock', window );">Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity</a></td>
<td class="text">The following future minimum lease payments due to us from the lease agreement at December 31, 2021, is as follows (in thousands)<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Lessee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity of undiscounted cash flows to be received by lessor on annual basis for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272194554256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Organization and Business Operations (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 28, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 08, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Aug. 06, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>item </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>item </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 09, 2022 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum', window );">Condition for future business combination number of businesses minimum | item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights', window );">Price of warrant | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Sale of private placement warrants (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,223<span></span>
</td>
<td class="nump">225,223<span></span>
</td>
<td class="nump">225,223<span></span>
</td>
<td class="nump">383,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds received from private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SaleOfStockUnderwritingDiscounts', window );">Underwriting discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_DeferredUnderwritingDiscounts', window );">Deferred underwriting discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,250,000<span></span>
</td>
<td class="nump">$ 5,250,000<span></span>
</td>
<td class="nump">5,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_PaymentsForInvestmentOfCashInTrustAccount', window );">Payments for investment of cash in trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ConditionForFutureBusinessCombinationUseOfProceedsPercentage', window );">Condition for future business combination use of proceeds percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ConditionForFutureBusinessCombinationThresholdPercentageOwnership', window );">Condition For Future Business Combination Threshold Percentage Ownership</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination', window );">Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets', window );">Condition For Future Business Combination Threshold Net Tangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,001<span></span>
</td>
<td class="nump">$ 5,000,001<span></span>
</td>
<td class="nump">$ 5,000,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_MonthsToCompleteAcquisition', window );">Months to complete acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_RedemptionPeriodUponClosure', window );">Redemption period upon closure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 days<span></span>
</td>
<td class="text">10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_MaximumAllowedDissolutionExpenses', window );">Maximum allowed dissolution expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount', window );">Tax obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">536,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_WorkingCapitalDeficit', window );">Working capital deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrant | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="nump">$ 19.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of shares per warrant | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_FundHeldInTrustAccountPerPublicShare', window );">Funds in Trust Account per public share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose', window );">Proceeds held in operating account for working capital purpose</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrant | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=amci_LanzatechGlobalMember', window );">LanzaTech Global</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price, per unit | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Consideration consisting of equity interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,817,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustCurrent', window );">Cash held in AMCI's trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrant | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=amci_LanzatechGlobalMember', window );">LanzaTech Global | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Net tangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=amci_WorkingCapitalLoansMember', window );">Working Capital Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Outstanding balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Sale of private placement warrants (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">316,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | LanzaTech Global</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price, per unit | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrant | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | LanzaTech Global | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Net tangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustCurrent', window );">Cash held in AMCI's trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_UnitsIssuedDuringPeriodSharesNewIssues', window );">Number of units sold | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price, per unit | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds received from initial public offering, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TransactionCosts', window );">Transaction Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,782,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering', window );">Value of Class B common stock transferred to Anchor Investors at initial public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,509,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SaleOfStockUnderwritingDiscounts', window );">Underwriting discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_DeferredUnderwritingDiscounts', window );">Deferred underwriting discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SaleOfStockOtherOfferingCosts', window );">Other offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 522,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrant | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of shares per warrant | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NumberOfSharesIssuedPerUnit', window );">Number of shares in a unit | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NumberOfWarrantsIssuedPerUnit', window );">Number of warrants in a unit | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Class A Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose', window );">Proceeds held in operating account for working capital purpose</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement | private placement warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights', window );">Price of warrant | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Sale of private placement warrants (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds received from private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion', window );">Restrictions on transfer period of time after business combination completion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrant | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of shares per warrant | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=amci_SponsorMember', window );">Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_WorkingCapitalLoan', window );">Working Capital Loan</a></td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum number of businesses which the reporting entity must acquire with the net proceeds of the offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The threshold net tangible assets which the reporting entity must maintain in order to proceed with a business combination utilizing the proceeds of the offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ConditionForFutureBusinessCombinationThresholdPercentageOwnership">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The threshold percentage of voting interest to be acquired in a future business combination as specified for the use of proceeds from the offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ConditionForFutureBusinessCombinationThresholdPercentageOwnership</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ConditionForFutureBusinessCombinationUseOfProceedsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The threshold percentage of the assets held in the trust account funded by proceeds from the offering which must be used for purposes of consummating a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ConditionForFutureBusinessCombinationUseOfProceedsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_DeferredUnderwritingDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of balance sheet date of underwriting discounts deferred, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_DeferredUnderwritingDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_FundHeldInTrustAccountPerPublicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount of funds held in trust account per public share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_FundHeldInTrustAccountPerPublicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_MaximumAllowedDissolutionExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum amount permitted to be paid for dissolution expenses if a business combination is not completed within the specified period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_MaximumAllowedDissolutionExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_MonthsToCompleteAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the anticipated business timeline in months for completing a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_MonthsToCompleteAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_NumberOfSharesIssuedPerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of shares in a unit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_NumberOfSharesIssuedPerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_NumberOfWarrantsIssuedPerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of warrants in a unit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_NumberOfWarrantsIssuedPerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_PaymentsForInvestmentOfCashInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash outflow for investment of cash in trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_PaymentsForInvestmentOfCashInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of shares which the reporting entity is obligated to redeem if a business combination is not consummated using the offering proceeds within a specified period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of proceeds held in operating account for working capital purpose.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_RedemptionPeriodUponClosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period of time in which the reporting entity must redeem shares issued pursuant to the offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_RedemptionPeriodUponClosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period of time after completion of a business combination during which the shares or warrant may not be transferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_SaleOfStockOtherOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of other offering costs incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_SaleOfStockOtherOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_SaleOfStockUnderwritingDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of offering fees discounts for underwriters.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_SaleOfStockUnderwritingDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents tax obligations paid from income from investments held in the trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of transaction costs incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_UnitsIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new units issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_UnitsIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of value of Class B common stock transferred to anchor investors at initial public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_WorkingCapitalDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount represents the information about working capital deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_WorkingCapitalDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_WorkingCapitalLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the information pertaining to Working Capital Loans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_WorkingCapitalLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate within one year of the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net assets (liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=77885760&amp;loc=SL35686385-199418<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=118262037&amp;loc=d3e9915-115836<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874367-224272<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604008-122996<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874367-224272<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=amci_LanzatechGlobalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=amci_LanzatechGlobalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=amci_WorkingCapitalLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=amci_WorkingCapitalLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=amci_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=amci_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=amci_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=amci_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272196575216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory tax rate (as a percent)</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Common stock subject to possible redemption, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">25,729,542<span></span>
</td>
<td class="nump">23,695,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Aggregate purchase of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,117,671<span></span>
</td>
<td class="nump">33,867,263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,175,113<span></span>
</td>
<td class="nump">30,720,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember', window );">AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.88%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.91%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Common stock subject to possible redemption, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Aggregate purchase of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common stock | AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Common stock subject to possible redemption, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common stock | IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Common stock subject to possible redemption, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember', window );">Class A Common Stock Subject to Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Common stock subject to possible redemption, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember', window );">Class A Common Stock Subject to Redemption | AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Common stock subject to possible redemption, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember', window );">Class A Common Stock Subject to Redemption | IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Common stock subject to possible redemption, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272194379984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Net Income (Loss) Per Share of Common Stock (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">8 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_DenominatorForCalculationOfEarningsPerShareAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding of common stock, basic (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,108,472,000<span></span>
</td>
<td class="nump">1,909,635,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,959,165,000<span></span>
</td>
<td class="nump">1,629,821,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding of common stock, diluted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,108,472,000<span></span>
</td>
<td class="nump">1,909,635,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,959,165,000<span></span>
</td>
<td class="nump">1,629,821,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per common share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (39,790)<span></span>
</td>
<td class="num">$ (30,190)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (42.59)<span></span>
</td>
<td class="num">$ (42.34)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per common share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (39,790)<span></span>
</td>
<td class="num">$ (30,190)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (42.59)<span></span>
</td>
<td class="num">$ (42.34)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NumeratorAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Allocation of net income (loss)</a></td>
<td class="nump">$ 995,636<span></span>
</td>
<td class="nump">$ 332,524<span></span>
</td>
<td class="nump">$ 223,297<span></span>
</td>
<td class="nump">$ 844,868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_DenominatorForCalculationOfEarningsPerShareAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding of common stock, basic (in shares)</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">9,130,435<span></span>
</td>
<td class="nump">3,428,571<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,690,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding of common stock, diluted (in shares)</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">9,130,435<span></span>
</td>
<td class="nump">3,428,571<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,690,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per common share</a></td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per common share</a></td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NumeratorAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Allocation of net income (loss)</a></td>
<td class="nump">$ 248,909<span></span>
</td>
<td class="nump">$ 136,573<span></span>
</td>
<td class="nump">$ 244,231<span></span>
</td>
<td class="nump">$ 211,217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_DenominatorForCalculationOfEarningsPerShareAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding of common stock, basic (in shares)</a></td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding of common stock, diluted (in shares)</a></td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per common share</a></td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per common share</a></td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_DenominatorForCalculationOfEarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>No definition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_DenominatorForCalculationOfEarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_NumeratorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_NumeratorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272202760720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Initial Public Offering (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 17, 2021</div></th>
<th class="th"><div>Aug. 06, 2021</div></th>
<th class="th"><div>Aug. 03, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SaleOfStockUnderwritingDiscounts', window );">Underwriting discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of shares per warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="nump">$ 19.93<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common stock | Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_UnitsIssuedDuringPeriodSharesNewIssues', window );">Number of units sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price, per unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds received from initial public offering, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SaleOfStockUnderwritingDiscounts', window );">Underwriting discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering', window );">Value of Class B common stock transferred to Anchor Investors at initial public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,509,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SaleOfStockOtherOfferingCosts', window );">Other offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 522,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of shares per warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_DeferredUnderwritingCompensationNoncurrent', window );">Deferred underwriting commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_OptionToPurchaseAdditionalUnitsGivenToInvestors', window );">Option to purchase additional units given to investors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,480,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-allotment option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_OptionVestingPeriod', window );">Option vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">45 days<span></span>
</td>
<td class="text">45 days<span></span>
</td>
<td class="text">45 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters', window );">Option to purchase additional Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,250,000<span></span>
</td>
<td class="nump">2,250,000<span></span>
</td>
<td class="nump">2,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_OptionToPurchaseAdditionalUnitsGivenToInvestors', window );">Option to purchase additional units given to investors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Common stock forfeited</a></td>
<td class="nump">562,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_DeferredUnderwritingCompensationNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of balance sheet date of underwriting compensation deferred, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_DeferredUnderwritingCompensationNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_OptionToPurchaseAdditionalUnitsGivenToInvestors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Option to purchase additional units given to investors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_OptionToPurchaseAdditionalUnitsGivenToInvestors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the option to purchase additional Units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_OptionVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Option vesting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_OptionVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_SaleOfStockOtherOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of other offering costs incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_SaleOfStockOtherOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_SaleOfStockUnderwritingDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of offering fees discounts for underwriters.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_SaleOfStockUnderwritingDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_UnitsIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new units issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_UnitsIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of value of Class B common stock transferred to anchor investors at initial public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040515&amp;loc=d3e105025-122735<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272194536864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions - Founder Shares (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 14, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 29, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>D </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>D </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 17, 2021 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NumberOfSharesSubjectToForfeiture', window );">Number of shares subject to forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">562,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-allotment option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NumberOfSharesSubjectToForfeiture', window );">Number of shares subject to forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">562,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NumberOfSharesSubjectToForfeiture', window );">Number of shares subject to forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">562,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=amci_SponsorMember', window );">Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Aggregate purchase price | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=amci_FounderSharesMember', window );">Founder Shares | Over-allotment option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NumberOfSharesSubjectToForfeiture', window );">Number of shares subject to forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">562,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=amci_FounderSharesMember', window );">Founder Shares | Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Aggregate purchase price | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NumberOfSharesSurrendered', window );">Number of shares surrendered</a></td>
<td class="nump">718,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SharesSurrenderedFairValueOfShares', window );">Value of shares surrendered | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_AggregateNumberOfSharesOwned', window );">Aggregate number of shares owned</a></td>
<td class="nump">4,312,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NumberOfSharesSubjectToForfeiture', window );">Number of shares subject to forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">562,500<span></span>
</td>
<td class="nump">562,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion', window );">Restrictions on transfer period of time after business combination completion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger', window );">Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.00<span></span>
</td>
<td class="nump">$ 12.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays', window );">Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays', window );">Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences', window );">Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">150 days<span></span>
</td>
<td class="text">150 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=amci_FounderSharesMember', window );">Founder Shares | Sponsor | Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,031,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=amci_FounderSharesMember', window );">Founder Shares | Anchor Investors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">780,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Aggregate purchase price | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_AggregateNumberOfSharesOwned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares owned by the founders after the impact of the stock dividend.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_AggregateNumberOfSharesOwned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_NumberOfSharesSubjectToForfeiture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares owned by the founders subject to forfeiture if the underwriter overallotment option is not exercised in the proposed public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_NumberOfSharesSubjectToForfeiture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_NumberOfSharesSurrendered">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the information pertaining to Number Of Shares Surrendered</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_NumberOfSharesSurrendered</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period of time after completion of a business combination during which the shares or warrant may not be transferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_SharesSurrenderedFairValueOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of value of shares surrendered during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_SharesSurrenderedFairValueOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period of time after a business combination which must elapse before consideration of the share price condition for transfer of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The share price threshold that must be achieved in order to waive the restriction on transfer of shares during a restricted period after a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>When determining the condition for transfer of shares without restriction after a business combination, the number of consecutive trading days used to observe the share price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>When determining the condition for transfer of shares without restriction after a business combination, the number of days in which the share price must exceed the specified amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=amci_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=amci_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=amci_FounderSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=amci_FounderSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=amci_AnchorInvestorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=amci_AnchorInvestorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272206185600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">8 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 28, 2022</div></th>
<th class="th"><div>Aug. 06, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jan. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants to purchase shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,223<span></span>
</td>
<td class="nump">225,223<span></span>
</td>
<td class="nump">225,223<span></span>
</td>
<td class="nump">383,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of shares per warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights', window );">Price of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="nump">$ 19.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_OutstandingWorkingCapitalLoans', window );">Outstanding working capital loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=amci_SponsorMember', window );">Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_WorkingCapitalLoan', window );">Working Capital Loan</a></td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=amci_WorkingCapitalLoansWarrantMember', window );">Working capital loans warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights', window );">Price of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_MaximumLoansConvertibleIntoWarrants', window );">Loan conversion agreement warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=amci_WorkingCapitalLoansWarrantMember', window );">Working capital loans warrant | Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_WorkingCapitalLoan', window );">Working Capital Loan</a></td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=amci_PrivatePlacementWarrantsMember', window );">Private Placement Warrants | Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants to purchase shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of shares per warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights', window );">Price of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=amci_AdministrativeSupportAgreementMember', window );">Administrative Support Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth', window );">Expenses per month</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Related party fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">596,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Amount incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartyLoansMember', window );">Related Party Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote', window );">Maximum borrowing capacity of related party promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of maximum borrowing capacity of related party promissory note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_MaximumLoansConvertibleIntoWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum amount which a potential loan could have repaid through issuance of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_MaximumLoansConvertibleIntoWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_OutstandingWorkingCapitalLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the information pertaining to Outstanding Working Capital Loans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_OutstandingWorkingCapitalLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The contractual monthly amount to be paid for support services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_WorkingCapitalLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the information pertaining to Working Capital Loans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_WorkingCapitalLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=amci_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=amci_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=amci_WorkingCapitalLoansWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=amci_WorkingCapitalLoansWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=amci_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=amci_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=amci_AdministrativeSupportAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=amci_AdministrativeSupportAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartyLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartyLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272196532256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 29, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 03, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>item</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>item </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>item </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 17, 2021 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_MaximumNumberOfDemandsForRegistrationOfSecurities', window );">Maximum Number Of Demands For Registration Of Securities | item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_UnderwritingDiscountPercentage', window );">Underwriting Discount Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SaleOfStockUnderwritingDiscounts', window );">Underwriting discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_DeferredUnderwritingDiscounts', window );">Deferred underwriting discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,250,000<span></span>
</td>
<td class="nump">$ 5,250,000<span></span>
</td>
<td class="nump">$ 5,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_DeferredUnderwritingDiscountPercentage', window );">Deferred underwriting fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NumberOfSharesSubjectToForfeiture', window );">Number of shares subject to forfeiture | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">562,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares', window );">Commissions waiver as reduction to additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,900,000<span></span>
</td>
<td class="nump">$ 4,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=amci_EvercoreGroupL.l.c.Member', window );">Evercore Group, L.L.C.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromFeesReceived', window );">Aggregate fees received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=amci_EvercoreGroupL.l.c.Member', window );">Evercore Group, L.L.C. | Coplacement Agent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromFeesReceived', window );">Aggregate fees received</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=amci_EvercoreGroupL.l.c.Member', window );">Evercore Group, L.L.C. | Financial Advisory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromFeesReceived', window );">Aggregate fees received</a></td>
<td class="nump">7,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-allotment option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_OptionVestingPeriod', window );">Option vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">45 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">45 days<span></span>
</td>
<td class="text">45 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters', window );">Option to purchase additional Units | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,250,000<span></span>
</td>
<td class="nump">2,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NumberOfSharesSubjectToForfeiture', window );">Number of shares subject to forfeiture | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">562,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=amci_DeferredUnderwritingFeesMember', window );">Deferred Underwriting Fees | Evercore Group, L.L.C.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromFeesReceived', window );">Aggregate fees received</a></td>
<td class="nump">$ 5,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of adjustment to additional paid in capital extinguishment of deferred underwriting commissions on public shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_DeferredUnderwritingDiscountPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the information pertaining to Deferred Underwriting Discount Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_DeferredUnderwritingDiscountPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_DeferredUnderwritingDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of balance sheet date of underwriting discounts deferred, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_DeferredUnderwritingDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_MaximumNumberOfDemandsForRegistrationOfSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the maximum number of demands for registration of securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_MaximumNumberOfDemandsForRegistrationOfSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_NumberOfSharesSubjectToForfeiture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares owned by the founders subject to forfeiture if the underwriter overallotment option is not exercised in the proposed public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_NumberOfSharesSubjectToForfeiture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the option to purchase additional Units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_OptionVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Option vesting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_OptionVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_SaleOfStockUnderwritingDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of offering fees discounts for underwriters.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_SaleOfStockUnderwritingDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_UnderwritingDiscountPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the information pertaining to Underwriting Discount Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_UnderwritingDiscountPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromFeesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received for fees during the current period. This element excludes cash proceeds from license fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromFeesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=amci_EvercoreGroupL.l.c.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=amci_EvercoreGroupL.l.c.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=amci_CoplacementAgentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=amci_CoplacementAgentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=amci_FinancialAdvisoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=amci_FinancialAdvisoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=amci_DeferredUnderwritingFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=amci_DeferredUnderwritingFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272197042224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Class A Common Stock Subject to Possible Redemption (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, shares authorized (in shares) | shares</a></td>
<td class="nump">36,326,815<span></span>
</td>
<td class="nump">36,326,815<span></span>
</td>
<td class="nump">36,326,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,326,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (usd per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Common stock subject to possible redemption, outstanding | shares</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">25,729,542<span></span>
</td>
<td class="nump">23,695,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_PlusAbstract', window );"><strong>Plus:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Class A common stock subject to possible redemption</a></td>
<td class="nump">$ 480,631,000<span></span>
</td>
<td class="nump">$ 480,631,000<span></span>
</td>
<td class="nump">$ 480,631,000<span></span>
</td>
<td class="nump">$ 480,631,000<span></span>
</td>
<td class="nump">$ 394,408,000<span></span>
</td>
<td class="nump">$ 347,938,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, shares authorized (in shares) | shares</a></td>
<td class="nump">280,000,000<span></span>
</td>
<td class="nump">280,000,000<span></span>
</td>
<td class="nump">280,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (usd per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_CommonStockNumberOfVotesPerShare', window );">Number of votes per common stock | vote</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Common stock subject to possible redemption, outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock', window );">Gross proceeds from Initial Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_LessAbstract', window );"><strong>Less:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityProceedsAllocatedToWarrants', window );">Amount allocated to public warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityIssuanceCosts', window );">Class A common stock issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,306,092)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_PlusAbstract', window );"><strong>Plus:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Accretion of carrying value to redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,406,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Class A common stock subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember', window );">Class A Common Stock Subject to Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Common stock subject to possible redemption, outstanding | shares</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock', window );">Gross proceeds from Initial Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_LessAbstract', window );"><strong>Less:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityProceedsAllocatedToWarrants', window );">Amount allocated to public warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityIssuanceCosts', window );">Class A common stock issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,306,092)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_PlusAbstract', window );"><strong>Plus:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Accretion of carrying value to redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,406,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption', window );">Subsequent remeasurement of Class A common stock subject to possible redemption</a></td>
<td class="nump">$ 293,649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Class A common stock subject to possible redemption</a></td>
<td class="nump">$ 150,293,649<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_CommonStockNumberOfVotesPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of votes issued per common stock share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_CommonStockNumberOfVotesPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase or decrease in equity due to re-measurement of common stock subject to possible redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_LessAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>No definition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_LessAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_PlusAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_PlusAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TemporaryEquityIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuance costs related to temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TemporaryEquityIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TemporaryEquityProceedsAllocatedToWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gross proceeds allocated from temporary equity to warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TemporaryEquityProceedsAllocatedToWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R117.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272205271744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit) - Preferred Stock Shares (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred shares, shares authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred shares, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred shares, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R118.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272194421296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit) - Common Stock Shares (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Stockholders' Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, shares authorized (in shares)</a></td>
<td class="nump">36,326,815<span></span>
</td>
<td class="nump">36,326,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,326,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (usd per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, shares issued (in shares)</a></td>
<td class="nump">2,110,346<span></span>
</td>
<td class="nump">2,106,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,656,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common shares, shares outstanding (in shares)</a></td>
<td class="nump">2,110,346<span></span>
</td>
<td class="nump">2,106,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,656,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Common stock subject to possible redemption, issued</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,729,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Common stock subject to possible redemption, outstanding</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">25,729,542<span></span>
</td>
<td class="nump">23,695,330<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Stockholders' Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, shares authorized (in shares)</a></td>
<td class="nump">280,000,000<span></span>
</td>
<td class="nump">280,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (usd per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Common stock subject to possible redemption, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember', window );">Class A Common Stock Subject to Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Stockholders' Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Common stock subject to possible redemption, issued</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Common stock subject to possible redemption, outstanding</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Stockholders' Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, shares authorized (in shares)</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (usd per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, shares issued (in shares)</a></td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common shares, shares outstanding (in shares)</a></td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Number of Class A common stock issued upon conversion of each share (in shares)</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ConvertibleStockConversionRatio', window );">Ratio to be applied to the stock in the conversion</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ConvertibleStockConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The ratio to be applied to the stock in a conversion of convertible stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ConvertibleStockConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R119.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272207342384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of shares per warrant</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights', window );">Price of warrant</a></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering', window );">Threshold period days after the completion of the initial Business Combination for exercise of warrants</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">30 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Public Warrants expiration term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=amci_PublicWarrantsMember', window );">public warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">7,500,000<span></span>
</td>
<td class="nump">7,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_PeriodForFillingRegistrationStatementAfterBusinessCombination', window );">Period for filling registration statement after business combination</a></td>
<td class="text">15 days<span></span>
</td>
<td class="text">15 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise', window );">Period of time after which warrant holder may do cashless exercise</a></td>
<td class="text">60 days<span></span>
</td>
<td class="text">60 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=amci_PrivatePlacementWarrantsMember', window );">private placement warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">3,500,000<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_PeriodForFillingRegistrationStatementAfterBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents period for filling registration statement after business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_PeriodForFillingRegistrationStatementAfterBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>period of time after which warrant holder may do cashless exercise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The warrants exercisable term from the closing of the initial public offering, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=amci_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=amci_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=amci_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=amci_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R120.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272197185296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants Additional Information (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Public Warrants expiration term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=amci_PublicWarrantsMember', window );">public warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger', window );">Stock price trigger for redemption of public warrants (in dollars per share)</a></td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="nump">$ 18.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights', window );">Redemption price per public warrant (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_RedemptionPeriod', window );">Redemption period</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">30 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays', window );">Threshold trading days for redemption of public warrants</a></td>
<td class="text">20 days<span></span>
</td>
<td class="text">20 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants', window );">Minimum threshold written notice period for redemption of public warrants</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">30 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices', window );">Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)</a></td>
<td class="nump">115.00%<span></span>
</td>
<td class="nump">115.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=amci_PublicWarrantsMember', window );">public warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger', window );">Stock price trigger for redemption of public warrants (in dollars per share)</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights', window );">Redemption price per public warrant (in dollars per share)</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_RedemptionPeriod', window );">Redemption period</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">30 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays', window );">Threshold trading days for redemption of public warrants</a></td>
<td class="text">20 days<span></span>
</td>
<td class="text">20 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants', window );">Minimum threshold written notice period for redemption of public warrants</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">30 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices', window );">Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)</a></td>
<td class="nump">180.00%<span></span>
</td>
<td class="nump">180.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=amci_PublicWarrantsMember', window );">public warrants | Class A Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="nump">$ 9.20<span></span>
</td>
<td class="nump">$ 9.20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_PercentageOfGrossProceedsOnTotalEquityProceed', window );">Percentage of gross proceeds on total equity proceeds</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays', window );">Threshold consecutive trading days for redemption of public warrants</a></td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of adjustment of exercise price of warrants based on market value and newly issued price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum threshold period during which a written notice is required for redemption of warrants, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of the entity's common stock which would be required to be attained to trigger the redemption of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified consecutive trading days for stock price trigger considered for redemption of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days for stock price trigger considered for redemption of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Redemption price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_PercentageOfGrossProceedsOnTotalEquityProceed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of gross proceeds on total equity proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_PercentageOfGrossProceedsOnTotalEquityProceed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_RedemptionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Redemption period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_RedemptionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=amci_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=amci_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_WarrantConditionAxis=amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_WarrantConditionAxis=amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_WarrantConditionAxis=amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_WarrantConditionAxis=amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R121.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272202759648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Company's financial assets and liabilities that are measured at fair value (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">8 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of derivative warrant liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 427,000<span></span>
</td>
<td class="nump">$ 699,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 563,000<span></span>
</td>
<td class="num">$ (105,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember', window );">AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of derivative warrant liabilities</a></td>
<td class="num">$ (1,426,720)<span></span>
</td>
<td class="num">$ (1,382,900)<span></span>
</td>
<td class="num">$ (1,382,900)<span></span>
</td>
<td class="num">$ (4,066,720)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,905,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=amci_PublicWarrantsMember', window );">public warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration', window );">Derivative Liability, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Fair Value of Shares<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Fair Value of Shares<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Fair Value of Shares<span></span>
</td>
<td class="text">Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Fair Value of Shares<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments held in trust account</a></td>
<td class="nump">$ 150,969,468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,969,468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,006,015<span></span>
</td>
<td class="nump">$ 150,006,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1 | public warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">1,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,825,000<span></span>
</td>
<td class="nump">3,825,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 3 | private placement warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">$ 493,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 493,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,785,000<span></span>
</td>
<td class="nump">$ 1,785,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes derivative liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=amci_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=amci_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=amci_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=amci_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R122.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272197042816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Level 3 fair value measurements (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>Y </div>
<div>$ / shares </div>
<div>item</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>item</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Y</div>
</th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th">
<div>Aug. 06, 2021 </div>
<div>Y </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember', window );">Weighted average exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">17.31<span></span>
</td>
<td class="nump">17.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.39<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember', window );">Weighted average exercise price | AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">11.50<span></span>
</td>
<td class="nump">11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.889<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Expected volatility | AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.096<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.096<span></span>
</td>
<td class="nump">0.113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Stock price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">15.03<span></span>
</td>
<td class="nump">13.77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.68<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Stock price | AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">9.79<span></span>
</td>
<td class="nump">9.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Term | AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input | Y</a></td>
<td class="nump">5.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.004<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk-free interest rate | AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.0397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0132<span></span>
</td>
<td class="nump">0.0099<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R123.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272194366464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Change in the fair value of the derivative warrant liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList', window );">Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">(Gain) loss on change in fair value of SAFE and warrant liabilities<span></span>
</td>
<td class="text">(Gain) loss on change in fair value of SAFE and warrant liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">(Gain) loss on change in fair value of SAFE and warrant liabilities<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember', window );">Derivative Financial Instruments, Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Derivative warrant liabilities at the beginning</a></td>
<td class="nump">$ 945,000<span></span>
</td>
<td class="nump">$ 2,030,000<span></span>
</td>
<td class="nump">$ 1,785,000<span></span>
</td>
<td class="nump">$ 1,785,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of derivative liabilities</a></td>
<td class="num">(451,720)<span></span>
</td>
<td class="num">(1,085,000)<span></span>
</td>
<td class="nump">245,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (630,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Derivative warrant liabilities at the end</a></td>
<td class="nump">$ 493,280<span></span>
</td>
<td class="nump">$ 945,000<span></span>
</td>
<td class="nump">$ 2,030,000<span></span>
</td>
<td class="nump">$ 493,280<span></span>
</td>
<td class="nump">$ 1,785,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement in which net income is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R124.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272197741552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details) - Subsequent Event - Class A Common stock - Subscription Agreements<br></strong></div></th>
<th class="th">
<div>Oct. 18, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued | shares</a></td>
<td class="nump">5,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price, per unit | $ / shares</a></td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=amci_October2022SubscriptionAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=amci_October2022SubscriptionAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R125.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272195365584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Organization and Business Operations (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 28, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 08, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Aug. 06, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>item </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>item </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 09, 2022 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum', window );">Condition for future business combination number of businesses minimum | item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights', window );">Price of warrant | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">11.50<span></span>
</td>
<td class="nump">11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="nump">$ 19.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Sale of private placement warrants (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,223<span></span>
</td>
<td class="nump">225,223<span></span>
</td>
<td class="nump">225,223<span></span>
</td>
<td class="nump">383,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds received from private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SaleOfStockUnderwritingDiscounts', window );">Underwriting discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_DeferredUnderwritingDiscounts', window );">Deferred underwriting discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,250,000<span></span>
</td>
<td class="nump">$ 5,250,000<span></span>
</td>
<td class="nump">5,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_PaymentsForInvestmentOfCashInTrustAccount', window );">Payments for investment of cash in trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ConditionForFutureBusinessCombinationUseOfProceedsPercentage', window );">Condition for future business combination use of proceeds percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ConditionForFutureBusinessCombinationThresholdPercentageOwnership', window );">Condition For Future Business Combination Threshold Percentage Ownership</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination', window );">Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets', window );">Condition For Future Business Combination Threshold Net Tangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,001<span></span>
</td>
<td class="nump">$ 5,000,001<span></span>
</td>
<td class="nump">$ 5,000,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_MonthsToCompleteAcquisition', window );">Months to complete acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_RedemptionPeriodUponClosure', window );">Redemption period upon closure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 days<span></span>
</td>
<td class="text">10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_MaximumAllowedDissolutionExpenses', window );">Maximum allowed dissolution expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount', window );">Tax obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">536,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_WorkingCapitalDeficit', window );">Working capital deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrant | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="nump">$ 19.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of shares per warrant | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_FundHeldInTrustAccountPerPublicShare', window );">Funds in Trust Account per public share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose', window );">Proceeds held in operating account for working capital purpose</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrant | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.69<span></span>
</td>
<td class="nump">14.69<span></span>
</td>
<td class="nump">14.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=amci_LanzatechGlobalMember', window );">LanzaTech Global</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price, per unit | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Consideration consisting of equity interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,817,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustCurrent', window );">Cash held in AMCI's trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrant | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=amci_LanzatechGlobalMember', window );">LanzaTech Global | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Net tangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=amci_WorkingCapitalLoansMember', window );">Working Capital Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Outstanding balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Sale of private placement warrants (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">316,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | LanzaTech Global</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price, per unit | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrant | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | LanzaTech Global | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Net tangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustCurrent', window );">Cash held in AMCI's trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_UnitsIssuedDuringPeriodSharesNewIssues', window );">Number of units sold | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price, per unit | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds received from initial public offering, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TransactionCosts', window );">Transaction Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,782,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering', window );">Value of Class B common stock transferred to Anchor Investors at initial public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,509,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SaleOfStockUnderwritingDiscounts', window );">Underwriting discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_DeferredUnderwritingDiscounts', window );">Deferred underwriting discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SaleOfStockOtherOfferingCosts', window );">Other offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 522,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrant | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of shares per warrant | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NumberOfSharesIssuedPerUnit', window );">Number of shares in a unit | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NumberOfWarrantsIssuedPerUnit', window );">Number of warrants in a unit | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Class A Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose', window );">Proceeds held in operating account for working capital purpose</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement | Private Placement Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights', window );">Price of warrant | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Sale of private placement warrants (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds received from private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion', window );">Restrictions on transfer period of time after business combination completion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrant | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of shares per warrant | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=amci_SponsorMember', window );">Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_WorkingCapitalLoan', window );">Working Capital Loan</a></td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum number of businesses which the reporting entity must acquire with the net proceeds of the offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The threshold net tangible assets which the reporting entity must maintain in order to proceed with a business combination utilizing the proceeds of the offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ConditionForFutureBusinessCombinationThresholdPercentageOwnership">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The threshold percentage of voting interest to be acquired in a future business combination as specified for the use of proceeds from the offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ConditionForFutureBusinessCombinationThresholdPercentageOwnership</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ConditionForFutureBusinessCombinationUseOfProceedsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The threshold percentage of the assets held in the trust account funded by proceeds from the offering which must be used for purposes of consummating a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ConditionForFutureBusinessCombinationUseOfProceedsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_DeferredUnderwritingDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of balance sheet date of underwriting discounts deferred, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_DeferredUnderwritingDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_FundHeldInTrustAccountPerPublicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount of funds held in trust account per public share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_FundHeldInTrustAccountPerPublicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_MaximumAllowedDissolutionExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum amount permitted to be paid for dissolution expenses if a business combination is not completed within the specified period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_MaximumAllowedDissolutionExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_MonthsToCompleteAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the anticipated business timeline in months for completing a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_MonthsToCompleteAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_NumberOfSharesIssuedPerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of shares in a unit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_NumberOfSharesIssuedPerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_NumberOfWarrantsIssuedPerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of warrants in a unit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_NumberOfWarrantsIssuedPerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_PaymentsForInvestmentOfCashInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash outflow for investment of cash in trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_PaymentsForInvestmentOfCashInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of shares which the reporting entity is obligated to redeem if a business combination is not consummated using the offering proceeds within a specified period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of proceeds held in operating account for working capital purpose.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_RedemptionPeriodUponClosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period of time in which the reporting entity must redeem shares issued pursuant to the offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_RedemptionPeriodUponClosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period of time after completion of a business combination during which the shares or warrant may not be transferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_SaleOfStockOtherOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of other offering costs incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_SaleOfStockOtherOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_SaleOfStockUnderwritingDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of offering fees discounts for underwriters.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_SaleOfStockUnderwritingDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents tax obligations paid from income from investments held in the trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of transaction costs incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_UnitsIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new units issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_UnitsIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of value of Class B common stock transferred to anchor investors at initial public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_WorkingCapitalDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount represents the information about working capital deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_WorkingCapitalDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_WorkingCapitalLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the information pertaining to Working Capital Loans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_WorkingCapitalLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate within one year of the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net assets (liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=77885760&amp;loc=SL35686385-199418<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=118262037&amp;loc=d3e9915-115836<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874367-224272<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604008-122996<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874367-224272<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=amci_LanzatechGlobalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=amci_LanzatechGlobalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=amci_WorkingCapitalLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=amci_WorkingCapitalLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=amci_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=amci_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=amci_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=amci_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R126.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272197324656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFDICInsuredAmount', window );">Cash, FDIC Insured Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory tax rate (as a percent)</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Common stock subject to possible redemption, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">25,729,542<span></span>
</td>
<td class="nump">23,695,330<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Aggregate purchase of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,117,671<span></span>
</td>
<td class="nump">33,867,263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,175,113<span></span>
</td>
<td class="nump">30,720,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Common stock subject to possible redemption, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Aggregate purchase of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common stock | IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Common stock subject to possible redemption, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember', window );">Class A Common Stock Subject to Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Common stock subject to possible redemption, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember', window );">Class A Common Stock Subject to Redemption | IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Common stock subject to possible redemption, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFDICInsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFDICInsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R127.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272194472096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Net Income (Loss) Per Share of Common Stock (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">8 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_DenominatorForCalculationOfEarningsPerShareAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average number of common shares outstanding - basic (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,108,472,000<span></span>
</td>
<td class="nump">1,909,635,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,959,165,000<span></span>
</td>
<td class="nump">1,629,821,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in calculating net loss per share, diluted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,108,472,000<span></span>
</td>
<td class="nump">1,909,635,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,959,165,000<span></span>
</td>
<td class="nump">1,629,821,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share - basic (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (39,790)<span></span>
</td>
<td class="num">$ (30,190)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (42.59)<span></span>
</td>
<td class="num">$ (42.34)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share - diluted (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (39,790)<span></span>
</td>
<td class="num">$ (30,190)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (42.59)<span></span>
</td>
<td class="num">$ (42.34)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NumeratorAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Allocation of net loss</a></td>
<td class="nump">$ 995,636<span></span>
</td>
<td class="nump">$ 332,524<span></span>
</td>
<td class="nump">$ 223,297<span></span>
</td>
<td class="nump">$ 844,868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_DenominatorForCalculationOfEarningsPerShareAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average number of common shares outstanding - basic (in shares)</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">9,130,435<span></span>
</td>
<td class="nump">3,428,571<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,690,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in calculating net loss per share, diluted (in shares)</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">9,130,435<span></span>
</td>
<td class="nump">3,428,571<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,690,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share - basic (usd per share)</a></td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share - diluted (usd per share)</a></td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NumeratorAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Allocation of net loss</a></td>
<td class="nump">$ 248,909<span></span>
</td>
<td class="nump">$ 136,573<span></span>
</td>
<td class="nump">$ 244,231<span></span>
</td>
<td class="nump">$ 211,217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_DenominatorForCalculationOfEarningsPerShareAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average number of common shares outstanding - basic (in shares)</a></td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in calculating net loss per share, diluted (in shares)</a></td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share - basic (usd per share)</a></td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share - diluted (usd per share)</a></td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_DenominatorForCalculationOfEarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>No definition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_DenominatorForCalculationOfEarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_NumeratorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_NumeratorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>R128.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272202702816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Initial Public Offering (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 17, 2021</div></th>
<th class="th"><div>Aug. 06, 2021</div></th>
<th class="th"><div>Aug. 03, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SaleOfStockUnderwritingDiscounts', window );">Underwriting discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of shares per warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="nump">$ 19.93<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common stock | Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_UnitsIssuedDuringPeriodSharesNewIssues', window );">Number of units sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price, per unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds received from initial public offering, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SaleOfStockUnderwritingDiscounts', window );">Underwriting discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering', window );">Value of Class B common stock transferred to Anchor Investors at initial public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,509,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SaleOfStockOtherOfferingCosts', window );">Other offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">522,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_DeferredUnderwritingCompensationNoncurrent', window );">Deferred underwriting commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of shares per warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_OptionToPurchaseAdditionalUnitsGivenToInvestors', window );">Option to purchase additional units given to investors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,480,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-allotment option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_OptionVestingPeriod', window );">Option vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">45 days<span></span>
</td>
<td class="text">45 days<span></span>
</td>
<td class="text">45 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters', window );">Option to purchase additional Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,250,000<span></span>
</td>
<td class="nump">2,250,000<span></span>
</td>
<td class="nump">2,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_OptionToPurchaseAdditionalUnitsGivenToInvestors', window );">Option to purchase additional units given to investors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Common stock forfeited</a></td>
<td class="nump">562,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_DeferredUnderwritingCompensationNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of balance sheet date of underwriting compensation deferred, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_DeferredUnderwritingCompensationNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_OptionToPurchaseAdditionalUnitsGivenToInvestors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Option to purchase additional units given to investors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_OptionToPurchaseAdditionalUnitsGivenToInvestors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the option to purchase additional Units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_OptionVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Option vesting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_OptionVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_SaleOfStockOtherOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of other offering costs incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_SaleOfStockOtherOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_SaleOfStockUnderwritingDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of offering fees discounts for underwriters.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_SaleOfStockUnderwritingDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_UnitsIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new units issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_UnitsIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of value of Class B common stock transferred to anchor investors at initial public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040515&amp;loc=d3e105025-122735<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>R129.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272202707440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions - Founder Shares (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 29, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>D </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>D </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 17, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>May 14, 2021 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NumberOfSharesSubjectToForfeiture', window );">Number of shares subject to forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">562,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NumberOfSharesSubjectToForfeiture', window );">Number of shares subject to forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">562,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=amci_SponsorMember', window );">Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Aggregate purchase price | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=amci_FounderSharesMember', window );">Founder Shares | Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Aggregate purchase price | $</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Stock price (usd per share) | $ / shares</a></td>
<td class="nump">$ 0.005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NumberOfSharesSurrendered', window );">Number of shares surrendered</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">718,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_AggregateNumberOfSharesOwned', window );">Aggregate number of shares owned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,312,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NumberOfSharesSubjectToForfeiture', window );">Number of shares subject to forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">562,500<span></span>
</td>
<td class="nump">562,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion', window );">Restrictions on transfer period of time after business combination completion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger', window );">Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.00<span></span>
</td>
<td class="nump">$ 12.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays', window );">Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays', window );">Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences', window );">Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">150 days<span></span>
</td>
<td class="text">150 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=amci_FounderSharesMember', window );">Founder Shares | Sponsor | Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued</a></td>
<td class="nump">5,031,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Stock price (usd per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=amci_FounderSharesMember', window );">Founder Shares | Anchor Investors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued</a></td>
<td class="nump">780,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Aggregate purchase price | $</a></td>
<td class="nump">$ 6,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Stock price (usd per share) | $ / shares</a></td>
<td class="nump">$ 8.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_AggregateNumberOfSharesOwned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares owned by the founders after the impact of the stock dividend.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_AggregateNumberOfSharesOwned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_NumberOfSharesSubjectToForfeiture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares owned by the founders subject to forfeiture if the underwriter overallotment option is not exercised in the proposed public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_NumberOfSharesSubjectToForfeiture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_NumberOfSharesSurrendered">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the information pertaining to Number Of Shares Surrendered</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_NumberOfSharesSurrendered</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period of time after completion of a business combination during which the shares or warrant may not be transferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period of time after a business combination which must elapse before consideration of the share price condition for transfer of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The share price threshold that must be achieved in order to waive the restriction on transfer of shares during a restricted period after a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>When determining the condition for transfer of shares without restriction after a business combination, the number of consecutive trading days used to observe the share price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>When determining the condition for transfer of shares without restriction after a business combination, the number of days in which the share price must exceed the specified amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=amci_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=amci_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=amci_FounderSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=amci_FounderSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=amci_AnchorInvestorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=amci_AnchorInvestorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>R130.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272192750320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">8 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 28, 2022</div></th>
<th class="th"><div>Aug. 06, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Nov. 09, 2022</div></th>
<th class="th"><div>Jan. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants to purchase shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,223<span></span>
</td>
<td class="nump">225,223<span></span>
</td>
<td class="nump">225,223<span></span>
</td>
<td class="nump">383,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of shares per warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights', window );">Price of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="nump">$ 19.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_OutstandingWorkingCapitalLoans', window );">Outstanding working capital loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=amci_SponsorMember', window );">Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_WorkingCapitalLoan', window );">Working Capital Loan</a></td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants to purchase shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">316,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=amci_WorkingCapitalLoansWarrantMember', window );">Working capital loans warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights', window );">Price of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_MaximumLoansConvertibleIntoWarrants', window );">Loan conversion agreement warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=amci_WorkingCapitalLoansWarrantMember', window );">Working capital loans warrant | Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_WorkingCapitalLoan', window );">Working Capital Loan</a></td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=amci_PrivatePlacementWarrantsMember', window );">Private Placement Warrants | Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants to purchase shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of shares per warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights', window );">Price of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=amci_AdministrativeSupportAgreementMember', window );">Administrative Support Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth', window );">Expenses per month</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Related party fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">596,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Amount incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartyLoansMember', window );">Related Party Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote', window );">Maximum borrowing capacity of related party promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of maximum borrowing capacity of related party promissory note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_MaximumLoansConvertibleIntoWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum amount which a potential loan could have repaid through issuance of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_MaximumLoansConvertibleIntoWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_OutstandingWorkingCapitalLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the information pertaining to Outstanding Working Capital Loans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_OutstandingWorkingCapitalLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The contractual monthly amount to be paid for support services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_WorkingCapitalLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the information pertaining to Working Capital Loans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_WorkingCapitalLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=amci_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=amci_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=amci_WorkingCapitalLoansWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=amci_WorkingCapitalLoansWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=amci_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=amci_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=amci_AdministrativeSupportAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=amci_AdministrativeSupportAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartyLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartyLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>150
<FILENAME>R131.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272202751600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 03, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>item </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>item </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 17, 2021 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_MaximumNumberOfDemandsForRegistrationOfSecurities', window );">Maximum Number Of Demands For Registration Of Securities | item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NumberOfSharesSubjectToForfeiture', window );">Number of shares subject to forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">562,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_UnderwritingDiscountPercentage', window );">Underwriting Discount Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_UnderwriterCashDiscount', window );">Underwriter cash discount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_DeferredUnderwritingDiscountPercentage', window );">Deferred underwriting fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_DeferredUnderwritingDiscounts', window );">Deferred underwriting discount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,250,000<span></span>
</td>
<td class="nump">$ 5,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-allotment option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Description of Organization and Business Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_OptionVestingPeriod', window );">Option vesting period</a></td>
<td class="text">45 days<span></span>
</td>
<td class="text">45 days<span></span>
</td>
<td class="text">45 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters', window );">Option to purchase additional Units</a></td>
<td class="nump">2,250,000<span></span>
</td>
<td class="nump">2,250,000<span></span>
</td>
<td class="nump">2,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NumberOfSharesSubjectToForfeiture', window );">Number of shares subject to forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">562,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_DeferredUnderwritingDiscountPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the information pertaining to Deferred Underwriting Discount Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_DeferredUnderwritingDiscountPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_DeferredUnderwritingDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of balance sheet date of underwriting discounts deferred, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_DeferredUnderwritingDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_MaximumNumberOfDemandsForRegistrationOfSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the maximum number of demands for registration of securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_MaximumNumberOfDemandsForRegistrationOfSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_NumberOfSharesSubjectToForfeiture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares owned by the founders subject to forfeiture if the underwriter overallotment option is not exercised in the proposed public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_NumberOfSharesSubjectToForfeiture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the option to purchase additional Units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_OptionVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Option vesting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_OptionVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_UnderwriterCashDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the cash underwriting discount per unit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_UnderwriterCashDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_UnderwritingDiscountPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the information pertaining to Underwriting Discount Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_UnderwritingDiscountPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>R132.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272207246992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Class A Common Stock Subject to Possible Redemption (Details)<br></strong></div></th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Common stock subject to possible redemption, shares authorized | shares</a></td>
<td class="nump">29,747,033<span></span>
</td>
<td class="nump">29,747,033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,112,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Common stock subject to possible redemption, par value | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Common stock subject to possible redemption, outstanding | shares</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">25,729,542<span></span>
</td>
<td class="nump">23,695,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_PlusAbstract', window );"><strong>Plus:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Class A common stock subject to possible redemption</a></td>
<td class="nump">$ 480,631,000<span></span>
</td>
<td class="nump">$ 480,631,000<span></span>
</td>
<td class="nump">$ 480,631,000<span></span>
</td>
<td class="nump">$ 394,408,000<span></span>
</td>
<td class="nump">$ 347,938,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Common stock subject to possible redemption, shares authorized | shares</a></td>
<td class="nump">280,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Common stock subject to possible redemption, par value | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityNumberOfVotesPerShare', window );">Number of votes per common stock subject to possible redemption | vote</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Common stock subject to possible redemption, outstanding | shares</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock', window );">Gross proceeds from Initial Public Offering</a></td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_LessAbstract', window );"><strong>Less:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityProceedsAllocatedToWarrants', window );">Fair value of Public Warrants at issuance</a></td>
<td class="num">(5,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityIssuanceCosts', window );">Offering costs allocated to Class A common stock subject to possible redemption</a></td>
<td class="num">(13,306,092)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_PlusAbstract', window );"><strong>Plus:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Accretion of carrying value to redemption value</a></td>
<td class="nump">18,406,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Class A common stock subject to possible redemption</a></td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_LessAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>No definition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_LessAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_PlusAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_PlusAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TemporaryEquityIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuance costs related to temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TemporaryEquityIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TemporaryEquityNumberOfVotesPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of votes per common stock subject to possible redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TemporaryEquityNumberOfVotesPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TemporaryEquityProceedsAllocatedToWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gross proceeds allocated from temporary equity to warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TemporaryEquityProceedsAllocatedToWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>152
<FILENAME>R133.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272203746112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stockholders' Deficit - Preferred Stock Shares (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred shares, shares authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred shares, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred shares, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>153
<FILENAME>R134.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272207273056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Deficit - Common Stock Shares (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Stockholders' Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, shares authorized (in shares)</a></td>
<td class="nump">36,326,815<span></span>
</td>
<td class="nump">36,326,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,326,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (usd per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, shares issued (in shares)</a></td>
<td class="nump">2,110,346<span></span>
</td>
<td class="nump">2,106,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,656,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common shares, shares outstanding (in shares)</a></td>
<td class="nump">2,110,346<span></span>
</td>
<td class="nump">2,106,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,656,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding (in shares)</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">25,729,542<span></span>
</td>
<td class="nump">23,695,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued (in shares)</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,729,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Stockholders' Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, shares authorized (in shares)</a></td>
<td class="nump">280,000,000<span></span>
</td>
<td class="nump">280,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (usd per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember', window );">Class A Common Stock Subject to Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Stockholders' Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding (in shares)</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued (in shares)</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Stockholders' Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, shares authorized (in shares)</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (usd per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, shares issued (in shares)</a></td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common shares, shares outstanding (in shares)</a></td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Number of Class A common stock issued upon conversion of each share (in shares)</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ConvertibleStockConversionRatio', window );">Ratio to be applied to the stock in the conversion</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ConvertibleStockConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The ratio to be applied to the stock in a conversion of convertible stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ConvertibleStockConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amci_CommonClassaSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>154
<FILENAME>R135.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272192658080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Public Warrants expiration term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=amci_PublicWarrantsMember', window );">public warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger', window );">Stock price trigger for redemption of public warrants (in dollars per share)</a></td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="nump">$ 18.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants', window );">Minimum threshold written notice period for redemption of public warrants</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">30 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays', window );">Threshold trading days for redemption of public warrants</a></td>
<td class="text">20 days<span></span>
</td>
<td class="text">20 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices', window );">Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)</a></td>
<td class="nump">115.00%<span></span>
</td>
<td class="nump">115.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights', window );">Redemption price per public warrant (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_RedemptionPeriod', window );">Redemption period</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">30 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=amci_PublicWarrantsMember', window );">public warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger', window );">Stock price trigger for redemption of public warrants (in dollars per share)</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants', window );">Minimum threshold written notice period for redemption of public warrants</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">30 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays', window );">Threshold trading days for redemption of public warrants</a></td>
<td class="text">20 days<span></span>
</td>
<td class="text">20 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices', window );">Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)</a></td>
<td class="nump">180.00%<span></span>
</td>
<td class="nump">180.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights', window );">Redemption price per public warrant (in dollars per share)</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_RedemptionPeriod', window );">Redemption period</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">30 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of adjustment of exercise price of warrants based on market value and newly issued price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum threshold period during which a written notice is required for redemption of warrants, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of the entity's common stock which would be required to be attained to trigger the redemption of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days for stock price trigger considered for redemption of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Redemption price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_RedemptionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Redemption period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_RedemptionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=amci_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=amci_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_WarrantConditionAxis=amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_WarrantConditionAxis=amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_WarrantConditionAxis=amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_WarrantConditionAxis=amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>155
<FILENAME>R136.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272196200032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>D </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of shares per warrant | shares</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights', window );">Price of warrant</a></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering', window );">Threshold period days after the completion of the initial Business Combination for exercise of warrants</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">30 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_MaximumThresholdPeriodForFilingRegistrationStatementAfterBusinessCombination', window );">Threshold period for filling registration statement after business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=amci_PublicWarrantsMember', window );">public warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding | shares</a></td>
<td class="nump">7,500,000<span></span>
</td>
<td class="nump">7,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_PeriodForFillingRegistrationStatementAfterBusinessCombination', window );">Period for filling registration statement after business combination</a></td>
<td class="text">15 days<span></span>
</td>
<td class="text">15 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise', window );">Period of time after which warrant holder may do cashless exercise</a></td>
<td class="text">60 days<span></span>
</td>
<td class="text">60 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=amci_PublicWarrantsMember', window );">public warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices', window );">Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)</a></td>
<td class="nump">115.00%<span></span>
</td>
<td class="nump">115.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger', window );">Stock price trigger for redemption of public warrants (in dollars per share)</a></td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="nump">$ 18.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=amci_PublicWarrantsMember', window );">public warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices', window );">Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)</a></td>
<td class="nump">180.00%<span></span>
</td>
<td class="nump">180.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger', window );">Stock price trigger for redemption of public warrants (in dollars per share)</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=amci_PublicWarrantsMember', window );">public warrants | Class A Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Stock price (usd per share)</a></td>
<td class="nump">$ 9.20<span></span>
</td>
<td class="nump">$ 9.20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_PercentageOfGrossProceedsOnTotalEquityProceed', window );">Percentage of gross proceeds on total equity proceeds</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDaysSource2', window );">Threshold consecutive trading days for redemption of public warrants | D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=amci_PrivatePlacementWarrantsMember', window );">Private Placement Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding | shares</a></td>
<td class="nump">3,500,000<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of adjustment of exercise price of warrants based on market value and newly issued price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of the entity's common stock which would be required to be attained to trigger the redemption of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDaysSource2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified consecutive trading days for stock price trigger considered for redemption of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDaysSource2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_MaximumThresholdPeriodForFilingRegistrationStatementAfterBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum threshold period for filing registration statement after business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_MaximumThresholdPeriodForFilingRegistrationStatementAfterBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_PercentageOfGrossProceedsOnTotalEquityProceed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of gross proceeds on total equity proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_PercentageOfGrossProceedsOnTotalEquityProceed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_PeriodForFillingRegistrationStatementAfterBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents period for filling registration statement after business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_PeriodForFillingRegistrationStatementAfterBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>period of time after which warrant holder may do cashless exercise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The warrants exercisable term from the closing of the initial public offering, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=amci_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=amci_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_WarrantConditionAxis=amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_WarrantConditionAxis=amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_WarrantConditionAxis=amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_WarrantConditionAxis=amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=amci_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=amci_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>156
<FILENAME>R137.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272208497792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Company's financial assets and liabilities that are measured at fair value (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=amci_PublicWarrantsMember', window );">public warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration', window );">Derivative Liability, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Fair Value of Shares<span></span>
</td>
<td class="text">Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Fair Value of Shares<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments held in Trust Account</a></td>
<td class="nump">$ 150,969,468<span></span>
</td>
<td class="nump">$ 150,006,015<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1 | public warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">1,050,000<span></span>
</td>
<td class="nump">3,825,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 3 | Private Placement Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">$ 493,280<span></span>
</td>
<td class="nump">$ 1,785,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes derivative liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=amci_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=amci_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=amci_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=amci_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>157
<FILENAME>R138.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272196314720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Level 3 fair value measurements (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>Y </div>
<div>$ / shares </div>
<div>item</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>item</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Y</div>
</th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th">
<div>Aug. 06, 2021 </div>
<div>Y </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember', window );">Weighted average exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">17.31<span></span>
</td>
<td class="nump">17.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.39<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember', window );">Weighted average exercise price | AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">11.50<span></span>
</td>
<td class="nump">11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.889<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Expected volatility | AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.096<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.096<span></span>
</td>
<td class="nump">0.113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Stock price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">15.03<span></span>
</td>
<td class="nump">13.77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.68<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Stock price | AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">9.79<span></span>
</td>
<td class="nump">9.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Term | AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input | Y</a></td>
<td class="nump">5.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.004<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk-free interest rate | AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.0397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0132<span></span>
</td>
<td class="nump">0.0099<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>158
<FILENAME>R139.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272196057200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Change in the fair value of the derivative warrant liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList', window );">Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">(Gain) loss on change in fair value of SAFE and warrant liabilities<span></span>
</td>
<td class="text">(Gain) loss on change in fair value of SAFE and warrant liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">(Gain) loss on change in fair value of SAFE and warrant liabilities<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember', window );">Derivative Financial Instruments, Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Derivative warrant liabilities at the beginning</a></td>
<td class="nump">$ 945,000<span></span>
</td>
<td class="nump">$ 2,030,000<span></span>
</td>
<td class="nump">$ 1,785,000<span></span>
</td>
<td class="nump">$ 1,785,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Issuance of SAFE liability and warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,515,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3', window );">Transfer of Public Warrants to Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,100,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of derivative liabilities</a></td>
<td class="num">(451,720)<span></span>
</td>
<td class="num">(1,085,000)<span></span>
</td>
<td class="nump">245,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(630,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Derivative warrant liabilities at the end</a></td>
<td class="nump">$ 493,280<span></span>
</td>
<td class="nump">$ 945,000<span></span>
</td>
<td class="nump">$ 2,030,000<span></span>
</td>
<td class="nump">$ 493,280<span></span>
</td>
<td class="nump">$ 1,785,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as a liability out of level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement in which net income is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>159
<FILENAME>R140.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272206443456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Income tax provision (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(290,181)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">290,181<span></span>
</td>
<td class="nump">$ 7,958,000<span></span>
</td>
<td class="nump">$ 5,505,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>160
<FILENAME>R141.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272196268096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Deferred tax assets (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Components of Deferred Tax Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">$ 107,979,000<span></span>
</td>
<td class="nump">$ 107,979,000<span></span>
</td>
<td class="nump">$ 104,301,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred tax assets, gross</a></td>
<td class="nump">114,881,000<span></span>
</td>
<td class="nump">114,881,000<span></span>
</td>
<td class="nump">110,417,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(113,276,000)<span></span>
</td>
<td class="num">(113,276,000)<span></span>
</td>
<td class="num">(108,300,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax position</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Accrued interest and penalties</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember', window );">AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Components of Deferred Tax Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts', window );">Start-up/Organization costs</a></td>
<td class="nump">210,307<span></span>
</td>
<td class="nump">210,307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">79,874<span></span>
</td>
<td class="nump">79,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred tax assets, gross</a></td>
<td class="nump">290,181<span></span>
</td>
<td class="nump">290,181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(290,181)<span></span>
</td>
<td class="num">(290,181)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic | AMCI ACQUISITION CORP. II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Components of Deferred Tax Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">$ 380,351<span></span>
</td>
<td class="nump">$ 380,351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>" Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from capitalized start up and organization costs."</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=amci_AMCIACQUISITIONCORPIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>161
<FILENAME>R142.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272192447616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of the statutory federal income tax rate (benefit) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 290,181<span></span>
</td>
<td class="nump">$ 7,958,000<span></span>
</td>
<td class="nump">$ 5,505,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory federal income tax rate (in percent)</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent', window );">Change in fair value of derivative warrant liabilities (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(855.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Offering costs allocated to derivative warrant liabilities (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214.00%<span></span>
</td>
<td class="num">(0.30%)<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">620.90%<span></span>
</td>
<td class="num">(17.00%)<span></span>
</td>
<td class="num">(14.10%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113,276,000<span></span>
</td>
<td class="nump">$ 113,276,000<span></span>
</td>
<td class="nump">$ 108,300,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970579&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>162
<FILENAME>R143.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272206132688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Mar. 08, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationAssetCurrent', window );">Aggregate consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="nump">$ 19.93<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights (in dollars per share)</a></td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=amci_LanzatechGlobalMember', window );">LanzaTech Global</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price, per unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustCurrent', window );">Cash held in AMCI's trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=amci_LanzatechGlobalMember', window );">LanzaTech Global | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationAssetCurrent', window );">Aggregate consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,817,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price, per unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=amci_LanzatechGlobalMember', window );">LanzaTech Global | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Net tangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=amci_LanzatechGlobalMember', window );">LanzaTech Global | Minimum | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Net tangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustCurrent', window );">Cash held in AMCI's trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate within one year of the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net assets (liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=77885760&amp;loc=SL35686385-199418<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=118262037&amp;loc=d3e9915-115836<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874367-224272<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604008-122996<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874367-224272<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationAssetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized arising from contingent consideration in a business combination, expected to be realized within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6411-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationAssetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=amci_LanzatechGlobalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=amci_LanzatechGlobalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>163
<FILENAME>R144.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272204355840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Description of the Business (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 08, 2022</div></th>
<th class="th"><div>Dec. 07, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ScheduleOfReverseCapitalizationLineItems', window );"><strong>Schedule of Reverse Capitalization [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Purchase price</a></td>
<td class="nump">$ 1,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ReverseCapitalizationClosingCashCondition', window );">Minimum closing cash condition</a></td>
<td class="nump">$ 250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ScheduleOfReverseCapitalizationLineItems', window );"><strong>Schedule of Reverse Capitalization [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ReverseCapitalizationClosingCashCondition', window );">Minimum closing cash condition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ReverseCapitalizationClosingCashCondition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reverse Capitalization, Closing Cash Condition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ReverseCapitalizationClosingCashCondition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ScheduleOfReverseCapitalizationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Reverse Capitalization [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ScheduleOfReverseCapitalizationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>164
<FILENAME>R145.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272197912384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Going Concern and Segment Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 50,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 128,318<span></span>
</td>
<td class="nump">$ 60,495<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(434,863)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(379,889)<span></span>
</td>
<td class="num">(333,200)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(71,336)<span></span>
</td>
<td class="num">$ (26,718)<span></span>
</td>
<td class="num">(42,591)<span></span>
</td>
<td class="num">(39,271)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (54,974)<span></span>
</td>
<td class="num">$ (30,591)<span></span>
</td>
<td class="num">$ (46,689)<span></span>
</td>
<td class="num">$ (37,713)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>165
<FILENAME>R146.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211033952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 50,370<span></span>
</td>
<td class="nump">$ 128,318<span></span>
</td>
<td class="nump">$ 60,495<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>166
<FILENAME>R147.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272207555104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Cash, Cash Equivalents and Restricted Cash Reconciliation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 50,370<span></span>
</td>
<td class="nump">$ 128,318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash (presented within Other current assets)</a></td>
<td class="nump">664<span></span>
</td>
<td class="nump">414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash</a></td>
<td class="nump">$ 51,034<span></span>
</td>
<td class="nump">$ 128,732<span></span>
</td>
<td class="nump">$ 115,700<span></span>
</td>
<td class="nump">$ 60,909<span></span>
</td>
<td class="nump">$ 62,117<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>167
<FILENAME>R148.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272205359008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Trade and Other Receivables (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 1,051<span></span>
</td>
<td class="nump">$ 1,235<span></span>
</td>
<td class="nump">$ 1,325<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>168
<FILENAME>R149.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272204334048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Concentration of Credit Risk and Other Risks and Uncertainties (Details)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Geographic Concentration Risk | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">61.00%<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="nump">38.00%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Customer Concentration Risk | Customer A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Customer Concentration Risk | Customer B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Customer Concentration Risk | Customer C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Customer Concentration Risk | Customer D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Customer Concentration Risk | Customer E</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable | Geographic Concentration Risk | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable | Customer Concentration Risk | Customer B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable | Customer Concentration Risk | Customer D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=amci_CustomerAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=amci_CustomerAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=amci_CustomerBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=amci_CustomerBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=amci_CustomerCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=amci_CustomerCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=amci_CustomerDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=amci_CustomerDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=amci_CustomerEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=amci_CustomerEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>169
<FILENAME>R150.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272207173664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Schedule of Calculation of Basic and Diluted Net Loss per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for basic and diluted earnings per common share</a></td>
<td class="num">$ (54,974)<span></span>
</td>
<td class="num">$ (30,591)<span></span>
</td>
<td class="num">$ (46,689)<span></span>
</td>
<td class="num">$ (37,713)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsIncomeStatementImpact', window );">Unpaid cumulative dividends on preferred stock</a></td>
<td class="num">(28,925)<span></span>
</td>
<td class="num">(27,068)<span></span>
</td>
<td class="num">(36,758)<span></span>
</td>
<td class="num">(31,291)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss allocated to common shareholders</a></td>
<td class="num">$ (83,899)<span></span>
</td>
<td class="num">$ (57,659)<span></span>
</td>
<td class="num">$ (83,447)<span></span>
</td>
<td class="num">$ (69,004)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares used in calculating net loss per share, basic and diluted (in shares)</a></td>
<td class="nump">2,108,472,000<span></span>
</td>
<td class="nump">1,909,635,000<span></span>
</td>
<td class="nump">1,959,165,000<span></span>
</td>
<td class="nump">1,629,821,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in calculating net loss per share, diluted (in shares)</a></td>
<td class="nump">2,108,472,000<span></span>
</td>
<td class="nump">1,909,635,000<span></span>
</td>
<td class="nump">1,959,165,000<span></span>
</td>
<td class="nump">1,629,821,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share - basic (usd per share)</a></td>
<td class="num">$ (39,790)<span></span>
</td>
<td class="num">$ (30,190)<span></span>
</td>
<td class="num">$ (42.59)<span></span>
</td>
<td class="num">$ (42.34)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share - diluted (usd per share)</a></td>
<td class="num">$ (39,790)<span></span>
</td>
<td class="num">$ (30,190)<span></span>
</td>
<td class="num">$ (42.59)<span></span>
</td>
<td class="num">$ (42.34)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsIncomeStatementImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsIncomeStatementImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>170
<FILENAME>R151.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272206822976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LanzaTech 10Q Net Loss Per Share - Antidilutive Shares (Details)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares</a></td>
<td class="nump">34,117,671<span></span>
</td>
<td class="nump">33,867,263<span></span>
</td>
<td class="nump">34,175,113<span></span>
</td>
<td class="nump">30,720,703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionRatio', window );">Conversion ratio</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_LiquidityPriceOfSAFEAndSAFEWarrants', window );">Liquidity price of SAFE and SAFE warrants</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne', window );">Liquidity price of SAFE and SAFE warrants, condition one</a></td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember', window );">Redeemable convertible preferred stock (if converted)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">25,729,542<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares</a></td>
<td class="nump">3,790,978<span></span>
</td>
<td class="nump">3,540,570<span></span>
</td>
<td class="nump">3,848,420<span></span>
</td>
<td class="nump">4,283,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">RSAs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares</a></td>
<td class="nump">579,660<span></span>
</td>
<td class="nump">579,660<span></span>
</td>
<td class="nump">579,660<span></span>
</td>
<td class="nump">324,680<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares</a></td>
<td class="nump">225,223<span></span>
</td>
<td class="nump">225,223<span></span>
</td>
<td class="nump">225,223<span></span>
</td>
<td class="nump">383,281<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_LiquidityPriceOfSAFEAndSAFEWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liquidity Price of SAFE and SAFE Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_LiquidityPriceOfSAFEAndSAFEWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liquidity Price of SAFE and SAFE Warrants, Condition One</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common shares issuable upon conversion for each share of preferred stock to be converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>171
<FILENAME>R152.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272204887552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues - Disaggregated Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 25,781<span></span>
</td>
<td class="nump">$ 18,327<span></span>
</td>
<td class="nump">$ 25,461<span></span>
</td>
<td class="nump">$ 18,353<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=amci_ResearchAndDevelopmentMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">8,118<span></span>
</td>
<td class="nump">12,053<span></span>
</td>
<td class="nump">13,897<span></span>
</td>
<td class="nump">8,910<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=amci_JointDevelopmentAgreementsMember', window );">Joint development agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">4,018<span></span>
</td>
<td class="nump">10,660<span></span>
</td>
<td class="nump">11,700<span></span>
</td>
<td class="nump">6,928<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=amci_OtherContractResearchMember', window );">Other contract research</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">4,100<span></span>
</td>
<td class="nump">1,393<span></span>
</td>
<td class="nump">2,197<span></span>
</td>
<td class="nump">1,982<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=amci_CarbonCaptureAndTransformationMember', window );">Carbon capture and transformation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">17,663<span></span>
</td>
<td class="nump">6,274<span></span>
</td>
<td class="nump">11,564<span></span>
</td>
<td class="nump">9,443<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember', window );">Licensing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,620<span></span>
</td>
<td class="nump">1,518<span></span>
</td>
<td class="nump">2,025<span></span>
</td>
<td class="nump">1,018<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=amci_CarbonSmartMember', window );">CarbonSmart</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">3,413<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=amci_EngineeringAndOtherServicesMember', window );">Engineering and other services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 12,630<span></span>
</td>
<td class="nump">$ 4,756<span></span>
</td>
<td class="nump">$ 9,539<span></span>
</td>
<td class="nump">$ 8,425<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=amci_ResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=amci_ResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=amci_JointDevelopmentAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=amci_JointDevelopmentAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=amci_OtherContractResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=amci_OtherContractResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=amci_CarbonCaptureAndTransformationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=amci_CarbonCaptureAndTransformationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=amci_CarbonSmartMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=amci_CarbonSmartMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=amci_EngineeringAndOtherServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=amci_EngineeringAndOtherServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>172
<FILENAME>R153.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272205409952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer', window );">Revenue from collaborative arrangements</a></td>
<td class="nump">$ 1,733<span></span>
</td>
<td class="nump">$ 2,662<span></span>
</td>
<td class="nump">$ 3,337<span></span>
</td>
<td class="nump">$ 1,163<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue from related party transactions</a></td>
<td class="nump">2,116<span></span>
</td>
<td class="nump">2,348<span></span>
</td>
<td class="nump">3,253<span></span>
</td>
<td class="nump">4,203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BilledContractReceivables', window );">Billed accounts receivable, net of allowance</a></td>
<td class="nump">11,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,878<span></span>
</td>
<td class="nump">$ 5,521<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember', window );">Licensing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue from related party transactions</a></td>
<td class="nump">1,620<span></span>
</td>
<td class="nump">1,518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=amci_EngineeringAndOtherServicesMember', window );">Engineering and other services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue from related party transactions</a></td>
<td class="nump">$ 496<span></span>
</td>
<td class="nump">$ 830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BilledContractReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amounts due for billed services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the Company and, at a minimum, one other party. An example would be amounts billed to customers under contracts or programs but not paid as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55302-109406<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BilledContractReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue from collaborative arrangement. Excludes revenue from contract with customer under Topic 606.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126928961&amp;loc=SL5834089-161433<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.1(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=amci_EngineeringAndOtherServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=amci_EngineeringAndOtherServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>173
<FILENAME>R154.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272207220880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues - Disaggregation by Customer Location (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 25,781<span></span>
</td>
<td class="nump">$ 18,327<span></span>
</td>
<td class="nump">$ 25,461<span></span>
</td>
<td class="nump">$ 18,353<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_NorthAmericaMember', window );">North America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">12,361<span></span>
</td>
<td class="nump">12,725<span></span>
</td>
<td class="nump">15,825<span></span>
</td>
<td class="nump">15,732<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">Europe, Middle East, Africa (EMEA)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">7,894<span></span>
</td>
<td class="nump">5,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaMember', window );">Asia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">4,151<span></span>
</td>
<td class="nump">242<span></span>
</td>
<td class="nump">1,477<span></span>
</td>
<td class="nump">504<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_AU', window );">Australia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,375<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
<td class="nump">$ 637<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_NorthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_NorthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_AU">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_AU</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>174
<FILENAME>R155.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272196198544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues - Contract Balances (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrentAbstract', window );"><strong>Current Contract Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Beginning balance</a></td>
<td class="nump">$ 11,700<span></span>
</td>
<td class="nump">$ 6,186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable', window );">Additions to unbilled accounts receivable</a></td>
<td class="nump">19,355<span></span>
</td>
<td class="nump">8,516<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ContractWithCustomerAssetCurrentReclassifiedToReceivable', window );">Unbilled accounts receivable recognized in trade receivables</a></td>
<td class="num">(16,085)<span></span>
</td>
<td class="num">(3,002)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ContractWithCustomerAssetCurrentForeignCurrencyTranslationAdjustment', window );">Decrease on revaluation on currency</a></td>
<td class="num">(122)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Ending balance</a></td>
<td class="nump">14,848<span></span>
</td>
<td class="nump">11,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ContractWithCustomerLiabilityCurrentAbstract', window );"><strong>Current Contract Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Beginning balance</a></td>
<td class="nump">3,476<span></span>
</td>
<td class="nump">5,480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ContractWithCustomerLiabilityCurrentAmountsCollected', window );">Increases due to cash received</a></td>
<td class="nump">775<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent', window );">Reclassification from non-current to current contract liabilities</a></td>
<td class="nump">2,015<span></span>
</td>
<td class="nump">3,080<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ContractWithCustomerLiabilityCurrentRevenueRecognized', window );">Reclassification to revenue as a result of performance obligations satisfied</a></td>
<td class="num">(3,298)<span></span>
</td>
<td class="num">(5,104)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Ending balance</a></td>
<td class="nump">2,968<span></span>
</td>
<td class="nump">3,476<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ContractWithCustomerLiabilityNoncurrentAbstract', window );"><strong>Non-current Contract Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Beginning balance</a></td>
<td class="nump">13,901<span></span>
</td>
<td class="nump">11,291<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ContractWithCustomerLiabilityNoncurrentAmountsCollected', window );">Increases due to cash received</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">5,690<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ContractWithCustomerLiabilityNoncurrentForeignCurrencyTranslationAdjustment', window );">Decrease on revaluation on currency</a></td>
<td class="num">(804)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent', window );">Reclassification from non-current to current contract liabilities</a></td>
<td class="num">(2,015)<span></span>
</td>
<td class="num">(3,080)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Ending balance</a></td>
<td class="nump">$ 11,119<span></span>
</td>
<td class="nump">$ 13,901<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Asset, Current, Additions To Unbilled Accounts Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ContractWithCustomerAssetCurrentForeignCurrencyTranslationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Asset, Current, Foreign Currency Translation Adjustment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ContractWithCustomerAssetCurrentForeignCurrencyTranslationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ContractWithCustomerAssetCurrentReclassifiedToReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Asset, Current, Reclassified To Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ContractWithCustomerAssetCurrentReclassifiedToReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ContractWithCustomerLiabilityCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ContractWithCustomerLiabilityCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ContractWithCustomerLiabilityCurrentAmountsCollected">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Current, Amounts Collected</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ContractWithCustomerLiabilityCurrentAmountsCollected</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Current, Reclassification From Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ContractWithCustomerLiabilityCurrentRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Current, Revenue Recognized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ContractWithCustomerLiabilityCurrentRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ContractWithCustomerLiabilityNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ContractWithCustomerLiabilityNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ContractWithCustomerLiabilityNoncurrentAmountsCollected">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Noncurrent, Amounts Collected</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ContractWithCustomerLiabilityNoncurrentAmountsCollected</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ContractWithCustomerLiabilityNoncurrentForeignCurrencyTranslationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Noncurrent, Foreign Currency Translation Adjustment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ContractWithCustomerLiabilityNoncurrentForeignCurrencyTranslationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Noncurrent, Reclassification To Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>175
<FILENAME>R156.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211119664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenues - Remaining Performance Obligations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_RevenueRemainingPerformanceObligationCurrentAmount', window );">Current</a></td>
<td class="nump">$ 2,968<span></span>
</td>
<td class="nump">$ 3,476<span></span>
</td>
<td class="nump">$ 5,480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_RevenueRemainingPerformanceObligationNoncurrentAmount', window );">Non-current</a></td>
<td class="nump">11,119<span></span>
</td>
<td class="nump">13,901<span></span>
</td>
<td class="nump">11,291<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Total</a></td>
<td class="nump">$ 14,087<span></span>
</td>
<td class="nump">$ 17,377<span></span>
</td>
<td class="nump">$ 16,771<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_RevenueRemainingPerformanceObligationCurrentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Remaining Performance Obligation, Current, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_RevenueRemainingPerformanceObligationCurrentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_RevenueRemainingPerformanceObligationNoncurrentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Remaining Performance Obligation, Noncurrent, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_RevenueRemainingPerformanceObligationNoncurrentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>176
<FILENAME>R157.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272207370528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Schedule of Investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity Method Investments</a></td>
<td class="nump">$ 11,047<span></span>
</td>
<td class="nump">$ 24,752<span></span>
</td>
<td class="nump">$ 23,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity Security Investment in SGLT</a></td>
<td class="nump">14,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Total Investment</a></td>
<td class="nump">$ 26,037<span></span>
</td>
<td class="nump">24,752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember', window );">SGLT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity Method Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,319<span></span>
</td>
<td class="nump">9,566<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amci_LanzaJetIncMember', window );">LanzaJet</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity Method Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,433<span></span>
</td>
<td class="nump">$ 13,651<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_InvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_InvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amci_LanzaJetIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amci_LanzaJetIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>177
<FILENAME>R158.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272192623680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Narrative (Details)<br> &#165; in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Apr. 29, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 13, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 28, 2011 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 28, 2011 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Apr. 04, 2021 </div>
<div>USD ($) </div>
<div>invesstment_round </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (18,871,000)<span></span>
</td>
<td class="num">$ (12,987,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NumberOfRoundsOfInvestments', window );">Number of rounds of investments | invesstment_round</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_EquityMethodInvestmentGainOnDilutionOfInvestment', window );">Gain on dilution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">503,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TransferFromForeignCurrencyTranslationToEquitySecurityInvestment', window );">Transfer from foreign currency translation to equity security investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 928,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount', window );">Impairment on equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions', window );">Dividends from equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amci_LanzaJetIncMember', window );">LanzaJet</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContributionOfProperty', window );">Contribution of intellectual property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,620,000)<span></span>
</td>
<td class="num">$ (1,516,000)<span></span>
</td>
<td class="num">(2,025,000)<span></span>
</td>
<td class="num">(1,018,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,734,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,746,000<span></span>
</td>
<td class="nump">13,433,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_RevenueFromContractWithCustomerAmortizationPeriod', window );">Profit amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_EquityMethodInvestmentGainOnDilutionOfInvestment', window );">Gain on dilution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 503,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_EquityMethodInvestmentContingentRightToReceiveAdditionalInterest', window );">Contingent right to receive additional interest | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Equity method investments cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity', window );">Carrying value less than proportionate share of book value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,100,000<span></span>
</td>
<td class="nump">3,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amci_LanzaJetIncMember', window );">LanzaJet | Intra-entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">395,000<span></span>
</td>
<td class="nump">497,000<span></span>
</td>
<td class="num">$ (662,000)<span></span>
</td>
<td class="num">$ (549,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember', window );">SGLT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContributionOfProperty', window );">Contribution of intellectual property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="nump">&#165; 25,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="nump">9.31%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.01%<span></span>
</td>
<td class="nump">11.14%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_EquityMethodInvestmentGainOnDilutionOfInvestment', window );">Gain on dilution</a></td>
<td class="nump">$ 3,368,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,014,000<span></span>
</td>
<td class="nump">$ 3,048,000<span></span>
</td>
<td class="nump">$ 3,811,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Equity securities loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 76,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_EquityMethodInvestmentContingentRightToReceiveAdditionalInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Contingent Right To Receive Additional Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_EquityMethodInvestmentContingentRightToReceiveAdditionalInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_EquityMethodInvestmentGainOnDilutionOfInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Gain On Dilution Of Investment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_EquityMethodInvestmentGainOnDilutionOfInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_InvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_InvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_NumberOfRoundsOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Rounds of Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_NumberOfRoundsOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_RevenueFromContractWithCustomerAmortizationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue From Contract With Customer, Amortization Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_RevenueFromContractWithCustomerAmortizationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TransferFromForeignCurrencyTranslationToEquitySecurityInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transfer from Foreign Currency Translation to Equity Security Investment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TransferFromForeignCurrencyTranslationToEquitySecurityInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContributionOfProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of property contributed in noncash investing and financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContributionOfProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative impairment loss on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amci_LanzaJetIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amci_LanzaJetIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>178
<FILENAME>R159.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272196830896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Financial Assets and Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants</a></td>
<td class="nump">$ 2,022,000<span></span>
</td>
<td class="nump">$ 1,729,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 107,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SimpleAgreementForFutureEquityLiability', window );">SAFE liability</a></td>
<td class="nump">27,221,000<span></span>
</td>
<td class="nump">28,271,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">519,000<span></span>
</td>
<td class="nump">516,000<span></span>
</td>
<td class="nump">516,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,145,000<span></span>
</td>
<td class="nump">582,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SimpleAgreementForFutureEquityLiability', window );">SAFE liability</a></td>
<td class="nump">27,221,000<span></span>
</td>
<td class="nump">28,271,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Liabilities</a></td>
<td class="nump">30,815,000<span></span>
</td>
<td class="nump">31,145,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants</a></td>
<td class="nump">1,572,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | SAFE warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants</a></td>
<td class="nump">2,022,000<span></span>
</td>
<td class="nump">1,729,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">519,000<span></span>
</td>
<td class="nump">516,000<span></span>
</td>
<td class="nump">516,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SimpleAgreementForFutureEquityLiability', window );">SAFE liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1 | Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1 | SAFE warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SimpleAgreementForFutureEquityLiability', window );">SAFE liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 2 | Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 2 | SAFE warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,145,000<span></span>
</td>
<td class="nump">$ 582,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SimpleAgreementForFutureEquityLiability', window );">SAFE liability</a></td>
<td class="nump">27,221,000<span></span>
</td>
<td class="nump">28,271,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Liabilities</a></td>
<td class="nump">30,815,000<span></span>
</td>
<td class="nump">31,145,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 3 | Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants</a></td>
<td class="nump">1,572,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 3 | SAFE warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants</a></td>
<td class="nump">$ 2,022,000<span></span>
</td>
<td class="nump">$ 1,729,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_SimpleAgreementForFutureEquityLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Simple Agreement for Future Equity Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_SimpleAgreementForFutureEquityLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=amci_SAFEWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=amci_SAFEWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>179
<FILENAME>R160.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272194461808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants to purchase shares issued</a></td>
<td class="nump">225,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,223<span></span>
</td>
<td class="nump">383,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="nump">$ 19.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">(Gain) loss on change in fair value of SAFE and warrant liabilities</a></td>
<td class="nump">$ 427,000<span></span>
</td>
<td class="nump">$ 699,000<span></span>
</td>
<td class="nump">$ 563,000<span></span>
</td>
<td class="num">$ (105,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SimpleAgreementForFutureEquityLiability', window );">SAFE liability</a></td>
<td class="nump">27,221,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,271,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants</a></td>
<td class="nump">$ 2,022,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,729,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 107,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights (in dollars per share)</a></td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights (in dollars per share)</a></td>
<td class="nump">$ 19.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_SimpleAgreementForFutureEquityLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Simple Agreement for Future Equity Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_SimpleAgreementForFutureEquityLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>180
<FILENAME>R161.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272192897024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Level 3 Fair Value Measurements (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Stock price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">15.03<span></span>
</td>
<td class="nump">13.77<span></span>
</td>
<td class="nump">4.68<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember', window );">Weighted average exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">17.31<span></span>
</td>
<td class="nump">17.32<span></span>
</td>
<td class="nump">18.39<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Term | Near Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Term | Long-Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.769<span></span>
</td>
<td class="nump">0.706<span></span>
</td>
<td class="nump">0.889<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Expected volatility | Near Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.75<span></span>
</td>
<td class="nump">0.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Expected volatility | Long-Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.75<span></span>
</td>
<td class="nump">0.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.029<span></span>
</td>
<td class="nump">0.008<span></span>
</td>
<td class="nump">0.004<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk-free interest rate | Near Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.0333<span></span>
</td>
<td class="nump">0.0019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk-free interest rate | Long-Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.0405<span></span>
</td>
<td class="nump">0.0039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputProbabilityWeightingMember', window );">Probability weighting | Near Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SAFELiabilityMeasurementInput', window );">SAFE liability, measurement input</a></td>
<td class="nump">0.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputProbabilityWeightingMember', window );">Probability weighting | Long-Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SAFELiabilityMeasurementInput', window );">SAFE liability, measurement input</a></td>
<td class="nump">0.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputProbabilityWeightingMember', window );">Probability weighting | Near Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.41<span></span>
</td>
<td class="nump">0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputProbabilityWeightingMember', window );">Probability weighting | Long-Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.59<span></span>
</td>
<td class="nump">0.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputInterestRateMember', window );">Interest rate | Near Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.0406<span></span>
</td>
<td class="nump">0.0126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputInterestRateMember', window );">Interest rate | Long-Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.0406<span></span>
</td>
<td class="nump">0.0126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputTimeToConversionMember', window );">Time to conversion | Near Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SAFELiabilityMeasurementInput', window );">SAFE liability, measurement input</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputTimeToConversionMember', window );">Time to conversion | Long-Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SAFELiabilityMeasurementInput', window );">SAFE liability, measurement input</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputTimeToConversionMember', window );">Time to conversion | Near Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputTimeToConversionMember', window );">Time to conversion | Long-Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputLiquidityPriceMember', window );">Liquidity price | Near Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SAFELiabilityMeasurementInput', window );">SAFE liability, measurement input</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputLiquidityPriceMember', window );">Liquidity price | Long-Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SAFELiabilityMeasurementInput', window );">SAFE liability, measurement input</a></td>
<td class="nump">0.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Discount rate | Near Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SAFELiabilityMeasurementInput', window );">SAFE liability, measurement input</a></td>
<td class="nump">0.260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Discount rate | Long-Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SAFELiabilityMeasurementInput', window );">SAFE liability, measurement input</a></td>
<td class="nump">0.260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Expected dividend yield | Near Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Expected dividend yield | Long-Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_SAFELiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>SAFE Liability, Measurement Input</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_SAFELiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=amci_SAFEWarrantNearTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=amci_SAFEWarrantNearTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=amci_SAFEWarrantLongTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=amci_SAFEWarrantLongTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputProbabilityWeightingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputProbabilityWeightingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis=amci_SecuritiesSubjectToMandatoryRedemptionNearTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis=amci_SecuritiesSubjectToMandatoryRedemptionNearTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis=amci_SecuritiesSubjectToMandatoryRedemptionLongTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis=amci_SecuritiesSubjectToMandatoryRedemptionLongTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputTimeToConversionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputTimeToConversionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputLiquidityPriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputLiquidityPriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>181
<FILENAME>R162.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272203580160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value - Change in Fair Value of Derivative Warrant Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Derivative warrant liabilities at the beginning</a></td>
<td class="nump">$ 1,145<span></span>
</td>
<td class="nump">$ 582<span></span>
</td>
<td class="nump">$ 582<span></span>
</td>
<td class="nump">$ 687<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Issuance of SAFE liability and warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of derivative liabilities</a></td>
<td class="nump">427<span></span>
</td>
<td class="nump">699<span></span>
</td>
<td class="nump">563<span></span>
</td>
<td class="num">(105)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Derivative warrant liabilities at the end</a></td>
<td class="nump">1,572<span></span>
</td>
<td class="nump">1,281<span></span>
</td>
<td class="nump">1,145<span></span>
</td>
<td class="nump">582<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=amci_SAFELiabilityMember', window );">SAFE Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Derivative warrant liabilities at the beginning</a></td>
<td class="nump">28,271<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Issuance of SAFE liability and warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of derivative liabilities</a></td>
<td class="num">(1,050)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Derivative warrant liabilities at the end</a></td>
<td class="nump">27,221<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,271<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=amci_SAFEWarrantMember', window );">SAFE warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Derivative warrant liabilities at the beginning</a></td>
<td class="nump">1,729<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Issuance of SAFE liability and warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,729<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of derivative liabilities</a></td>
<td class="nump">293<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Derivative warrant liabilities at the end</a></td>
<td class="nump">$ 2,022<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,729<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=amci_SAFELiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=amci_SAFELiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=amci_SAFEWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=amci_SAFEWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>182
<FILENAME>R163.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272197696752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignEarningsRepatriated', window );">Foreign earnings repatriated</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign | New Zealand</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_IncomeTaxesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Taxes [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_IncomeTaxesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignEarningsRepatriated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign earnings repatriated from subsidiaries outside the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignEarningsRepatriated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=amci_InlandRevenueNewZealandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=amci_InlandRevenueNewZealandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>183
<FILENAME>R164.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272196494336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>scheme </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NumberOfShareBasedStockSchemes', window );">Number of share based stock schemes | scheme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expense</a></td>
<td class="nump">$ 2,067,000<span></span>
</td>
<td class="nump">$ 1,790,000<span></span>
</td>
<td class="nump">$ 2,531,000<span></span>
</td>
<td class="nump">$ 2,392,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation costs</a></td>
<td class="nump">$ 3,835,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized cost, recognition period</a></td>
<td class="text">2 years 3 months 7 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">RSAs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Award requisite service period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized cost, recognition period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested shares outstanding (in shares) | shares</a></td>
<td class="nump">579,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">580,000<span></span>
</td>
<td class="nump">325,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested shares weighted average fair value (usd per share) | $ / shares</a></td>
<td class="nump">$ 4.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.72<span></span>
</td>
<td class="nump">$ 4.68<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Award requisite service period</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Award requisite service period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_NumberOfShareBasedStockSchemes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Share Based Stock Schemes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_NumberOfShareBasedStockSchemes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>184
<FILENAME>R165.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272203585040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Stock Option Award Activity (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares under option (thousands)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">3,848<span></span>
</td>
<td class="nump">4,283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(620)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancelled/forfeited (in shares)</a></td>
<td class="num">(38)<span></span>
</td>
<td class="num">(721)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired (in shares)</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(334)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">3,806<span></span>
</td>
<td class="nump">3,848<span></span>
</td>
<td class="nump">4,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest (in shares)</a></td>
<td class="nump">3,806<span></span>
</td>
<td class="nump">3,848<span></span>
</td>
<td class="nump">4,283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Exercisable (in shares)</a></td>
<td class="nump">2,918<span></span>
</td>
<td class="nump">2,479<span></span>
</td>
<td class="nump">2,915<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted average exercise price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance (usd per share)</a></td>
<td class="nump">$ 6.55<span></span>
</td>
<td class="nump">$ 5.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (usd per share)</a></td>
<td class="nump">6.75<span></span>
</td>
<td class="nump">9.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Cancelled/forfeited (usd per share)</a></td>
<td class="nump">9.55<span></span>
</td>
<td class="nump">2.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Expired (usd per share)</a></td>
<td class="nump">6.61<span></span>
</td>
<td class="nump">2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance (usd per share)</a></td>
<td class="nump">6.52<span></span>
</td>
<td class="nump">6.55<span></span>
</td>
<td class="nump">$ 5.12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Vested and expecting to vest (usd per share)</a></td>
<td class="nump">6.52<span></span>
</td>
<td class="nump">6.55<span></span>
</td>
<td class="nump">5.12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable (usd per share)</a></td>
<td class="nump">$ 6.30<span></span>
</td>
<td class="nump">$ 6.31<span></span>
</td>
<td class="nump">$ 5.02<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding, Weighted average remaining contractual term</a></td>
<td class="text">5 years 4 months 20 days<span></span>
</td>
<td class="text">6 years 1 month 28 days<span></span>
</td>
<td class="text">5 years 1 month 2 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Vested and expecting, Weighted average remaining contractual term</a></td>
<td class="text">5 years 4 months 20 days<span></span>
</td>
<td class="text">6 years 1 month 28 days<span></span>
</td>
<td class="text">5 years 1 month 2 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable, Weighted average remaining contractual term</a></td>
<td class="text">4 years 6 months 21 days<span></span>
</td>
<td class="text">4 years 10 months 6 days<span></span>
</td>
<td class="text">3 years 5 months 19 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding, Aggregate intrinsic value</a></td>
<td class="nump">$ 42,032<span></span>
</td>
<td class="nump">$ 27,796<span></span>
</td>
<td class="nump">$ 2,582<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Vested and expecting to vest, Aggregate intrinsic value</a></td>
<td class="nump">42,032<span></span>
</td>
<td class="nump">27,796<span></span>
</td>
<td class="nump">2,582<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Exercisable, Aggregate intrinsic value</a></td>
<td class="nump">32,874<span></span>
</td>
<td class="nump">18,499<span></span>
</td>
<td class="nump">$ 2,582<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Exercised, Aggregate intrinsic value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue', window );">Cancelled/forfeited, Aggregate intrinsic value</a></td>
<td class="nump">188<span></span>
</td>
<td class="nump">1,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue', window );">Expired, Aggregate intrinsic value</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations, Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures, Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>185
<FILENAME>R166.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272202714400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2020 </div>
<div>USD ($) </div>
<div>renewal_option</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">$ 26,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenues</a></td>
<td class="nump">2,116<span></span>
</td>
<td class="nump">$ 2,348<span></span>
</td>
<td class="nump">3,253<span></span>
</td>
<td class="nump">$ 4,203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived', window );">Lease income receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartyTransitionServicesAgreementMember', window );">Related Party Transition Services Agreement | Equity Method Investee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenues</a></td>
<td class="nump">148<span></span>
</td>
<td class="nump">355<span></span>
</td>
<td class="nump">495<span></span>
</td>
<td class="nump">285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartyInvestmentAgreementMember', window );">Related Party Investment Agreement | Equity Method Investee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenues</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">403<span></span>
</td>
<td class="nump">428<span></span>
</td>
<td class="nump">2,740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartyLeaseAgreementMember', window );">Related Party Lease Agreement | Equity Method Investee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_LesseeOperatingLeaseNumberOfRenewalTerms', window );">Lease number of renewal terms | renewal_option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lease renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived', window );">Lease income receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartySupplyAgreementMember', window );">Related Party Supply Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Related party fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,223<span></span>
</td>
<td class="nump">242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartySupplyAgreementMember', window );">Related Party Supply Agreement | Equity Method Investee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenues</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">282<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Related party fees</a></td>
<td class="nump">$ 893<span></span>
</td>
<td class="nump">$ 1,171<span></span>
</td>
<td class="nump">$ 1,223<span></span>
</td>
<td class="nump">$ 242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_LesseeOperatingLeaseNumberOfRenewalTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Number Of Renewal Terms</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_LesseeOperatingLeaseNumberOfRenewalTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payments to be received by lessor for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.1(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartyTransitionServicesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartyTransitionServicesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartyInvestmentAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartyInvestmentAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartyLeaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartyLeaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartySupplyAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartySupplyAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>186
<FILENAME>R167.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272204981392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions - Schedule of Related Party Transactions (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenues</a></td>
<td class="nump">$ 2,116<span></span>
</td>
<td class="nump">$ 2,348<span></span>
</td>
<td class="nump">$ 3,253<span></span>
</td>
<td class="nump">$ 4,203<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,071<span></span>
</td>
<td class="nump">3,257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Contract assets</a></td>
<td class="nump">14,848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,700<span></span>
</td>
<td class="nump">6,186<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember', window );">Equity Method Investee | Transactions with Equity Method Investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,253<span></span>
</td>
<td class="nump">4,203<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable</a></td>
<td class="nump">1,509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,071<span></span>
</td>
<td class="nump">3,257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Contract assets</a></td>
<td class="nump">73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_PurchasesAndOpenAccountsPayableRelatedParties', window );">Purchases and open accounts payable</a></td>
<td class="nump">$ 1,863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,575<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_PurchasesAndOpenAccountsPayableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchases and Open Accounts Payable, Related Parties</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_PurchasesAndOpenAccountsPayableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 310<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126942793&amp;loc=d3e3073-115593<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.1(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=amci_TransactionsWithEquityMethodInvesteesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=amci_TransactionsWithEquityMethodInvesteesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>187
<FILENAME>R168.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272196726464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable, Convertible Preferred Stock (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,747,033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,747,033<span></span>
</td>
<td class="nump">26,112,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">25,729,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">25,729,542<span></span>
</td>
<td class="nump">23,695,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 480,631<span></span>
</td>
<td class="nump">$ 480,631<span></span>
</td>
<td class="nump">$ 480,631<span></span>
</td>
<td class="nump">$ 394,408<span></span>
</td>
<td class="nump">$ 347,938<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Dividend rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquitySharesConversionOfConvertibleSecurities', window );">Exercise of warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityExerciseOfWarrants', window );">Exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,666,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,666,503<span></span>
</td>
<td class="nump">4,666,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,666,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,666,503<span></span>
</td>
<td class="nump">4,666,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,666,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,666,503<span></span>
</td>
<td class="nump">4,666,503<span></span>
</td>
<td class="nump">4,666,503<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,230<span></span>
</td>
<td class="nump">$ 12,230<span></span>
</td>
<td class="nump">$ 12,230<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityIssuePricePerShare', window );">Issue price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityIssuePricePerShare', window );">Issue price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.94<span></span>
</td>
<td class="nump">$ 3.94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,733,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,733,370<span></span>
</td>
<td class="nump">1,733,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,733,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,733,370<span></span>
</td>
<td class="nump">1,733,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,733,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,733,370<span></span>
</td>
<td class="nump">1,733,370<span></span>
</td>
<td class="nump">1,733,370<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityIssuePricePerShare', window );">Issue price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.38<span></span>
</td>
<td class="nump">$ 10.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,000<span></span>
</td>
<td class="nump">$ 18,000<span></span>
</td>
<td class="nump">$ 18,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,254,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,254,733<span></span>
</td>
<td class="nump">4,254,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,142,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,142,408<span></span>
</td>
<td class="nump">4,142,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,142,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,142,408<span></span>
</td>
<td class="nump">4,142,408<span></span>
</td>
<td class="nump">4,142,408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityIssuePricePerShare', window );">Issue price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,850<span></span>
</td>
<td class="nump">$ 60,850<span></span>
</td>
<td class="nump">$ 60,850<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember', window );">Series D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,274,260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,274,260<span></span>
</td>
<td class="nump">10,274,260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,161,362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,161,362<span></span>
</td>
<td class="nump">10,003,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,161,362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,161,362<span></span>
</td>
<td class="nump">10,003,304<span></span>
</td>
<td class="nump">10,003,304<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityIssuePricePerShare', window );">Issue price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.93<span></span>
</td>
<td class="nump">$ 19.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 188,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 188,402<span></span>
</td>
<td class="nump">$ 185,252<span></span>
</td>
<td class="nump">$ 185,252<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquitySharesConversionOfConvertibleSecurities', window );">Exercise of warrants (in shares)</a></td>
<td class="nump">158,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityExerciseOfWarrants', window );">Exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember', window );">Series E</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,183,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,183,957<span></span>
</td>
<td class="nump">5,183,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,183,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,183,957<span></span>
</td>
<td class="nump">5,183,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,183,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,183,957<span></span>
</td>
<td class="nump">5,183,957<span></span>
</td>
<td class="nump">3,149,745<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityIssuePricePerShare', window );">Issue price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22.86<span></span>
</td>
<td class="nump">$ 22.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118,076<span></span>
</td>
<td class="nump">$ 118,076<span></span>
</td>
<td class="nump">$ 71,606<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesFPreferredStockMember', window );">Series F</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,634,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,634,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,634,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,634,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,634,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,634,210<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityIssuePricePerShare', window );">Issue price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83,073<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TemporaryEquityExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Exercise of Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TemporaryEquityExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TemporaryEquityIssuePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Issue Price Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TemporaryEquityIssuePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TemporaryEquitySharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Shares, Conversion of Convertible Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TemporaryEquitySharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage rate used to calculate dividend payments on preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesFPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesFPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>188
<FILENAME>R169.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211170752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Estimate of possible loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12021-110248<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>189
<FILENAME>R170.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272212095952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>May 31, 2020 </div>
<div>renewal_option</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeaseTermOfContract', window );">Term of contract</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_LesssorOperatingLeaseNumberOfRenewalOptions', window );">Number of renewal options | renewal_option</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeaseRenewalTerm', window );">Renewal term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncome', window );">Lease income from operating leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncome', window );">Lease income from operating leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_LesssorOperatingLeaseNumberOfRenewalOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lesssor, Operating Lease, Number Of Renewal Options</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_LesssorOperatingLeaseNumberOfRenewalOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessor's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919359-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919359-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123420820&amp;loc=SL77919311-209978<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI https://asc.fasb.org/extlink&amp;oid=126900988&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>190
<FILENAME>R171.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272206095696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Oct. 02, 2022</div></th>
<th class="th"><div>Dec. 07, 2022</div></th>
<th class="th"><div>Nov. 09, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Mar. 08, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants to purchase shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,223<span></span>
</td>
<td class="nump">383,281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ReverseCapitalizationClosingCashCondition', window );">Minimum closing cash condition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_FrameworkAgreementRequiredEquityFunding', window );">Required equity funding</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SimpleAgreementForFutureEquityInitialPurchaseAmount', window );">Initial purchase amount</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjects', window );">Required equity funding for qualifying projects</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjectsRemainingAmountReduction', window );">Required equity funding for qualifying projects, remaining amount reduction</a></td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NoteReceivableCommitmentToPurchase', window );">Notes receivable, commitment to purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants to purchase shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">316,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ReverseCapitalizationClosingCashCondition', window );">Minimum closing cash condition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | LanzaJet Freedom Pines Fuels LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Notes receivable, aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 147,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Senior Secured Notes Receivable | LanzaJet Freedom Pines Fuels LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Notes receivable, aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_LineOfCreditFacilityInterestRate', window );">Line of credit facility, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Subordinated Secured Notes Receivable | LanzaJet Freedom Pines Fuels LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Notes receivable, aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_LineOfCreditFacilityInterestRate', window );">Line of credit facility, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | One Tranche Of Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants to purchase shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ClassOfWarrantOrRightAmountOfNotesPurchased', window );">Amount of Notes purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ClassOfWarrantOrRightAmountOfNotesPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Amount Of Notes Purchased</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ClassOfWarrantOrRightAmountOfNotesPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_FrameworkAgreementRequiredEquityFunding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Framework Agreement, Required Equity Funding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_FrameworkAgreementRequiredEquityFunding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjects">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Framework Agreement, Required Equity Funding For Qualifying Projects</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjects</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjectsRemainingAmountReduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Framework Agreement, Required Equity Funding For Qualifying Projects, Remaining Amount Reduction</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjectsRemainingAmountReduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_LineOfCreditFacilityInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Interest Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_LineOfCreditFacilityInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_NoteReceivableCommitmentToPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Note Receivable, Commitment To Purchase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_NoteReceivableCommitmentToPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ReverseCapitalizationClosingCashCondition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reverse Capitalization, Closing Cash Condition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ReverseCapitalizationClosingCashCondition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_SimpleAgreementForFutureEquityInitialPurchaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Simple Agreement For Future Equity, Initial Purchase Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_SimpleAgreementForFutureEquityInitialPurchaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=amci_LanzaJetFreedomPinesFuelsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=amci_LanzaJetFreedomPinesFuelsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=amci_SeniorSecuredNotesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=amci_SeniorSecuredNotesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=amci_SubordinatedSecuredNotesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=amci_SubordinatedSecuredNotesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=amci_OneTrancheOfNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=amci_OneTrancheOfNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>191
<FILENAME>R172.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272189590640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Restatement (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Apr. 04, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,752<span></span>
</td>
<td class="nump">$ 23,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(434,863)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(379,889)<span></span>
</td>
<td class="num">(333,200)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Gain from equity method investees, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,346<span></span>
</td>
<td class="nump">$ 2,371<span></span>
</td>
<td class="num">(1,606)<span></span>
</td>
<td class="num">(1,644)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue from related party transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,116<span></span>
</td>
<td class="nump">2,348<span></span>
</td>
<td class="nump">3,253<span></span>
</td>
<td class="nump">4,203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Contract assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,700<span></span>
</td>
<td class="nump">6,186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,059<span></span>
</td>
<td class="nump">2,897<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,871<span></span>
</td>
<td class="nump">12,987<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Consolidated Balance Sheet</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Contract assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,700<span></span>
</td>
<td class="nump">6,186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">148,675<span></span>
</td>
<td class="nump">76,589<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,752<span></span>
</td>
<td class="nump">23,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">193,011<span></span>
</td>
<td class="nump">118,980<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,059<span></span>
</td>
<td class="nump">2,897<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,290<span></span>
</td>
<td class="nump">15,204<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,297<span></span>
</td>
<td class="nump">35,788<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(434,863)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(379,889)<span></span>
</td>
<td class="num">(333,200)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(407,640)<span></span>
</td>
<td class="num">(339,740)<span></span>
</td>
<td class="num">(354,917)<span></span>
</td>
<td class="num">(311,216)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, contingently redeemable preferred stock, and shareholders' deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">193,011<span></span>
</td>
<td class="nump">118,980<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Consolidated Statement of Operations and Comprehensive Loss</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,871<span></span>
</td>
<td class="nump">12,987<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,116<span></span>
</td>
<td class="nump">2,348<span></span>
</td>
<td class="nump">3,253<span></span>
</td>
<td class="nump">4,203<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,781<span></span>
</td>
<td class="nump">18,327<span></span>
</td>
<td class="nump">25,461<span></span>
</td>
<td class="nump">18,353<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_CostOfRevenueFromContractsWithCustomersExcludingDepreciation', window );">Cost of revenues from contracts with customers (exclusive of depreciation shown below)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,167)<span></span>
</td>
<td class="num">(8,185)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total cost and operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(76,480)<span></span>
</td>
<td class="num">(58,054)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(56,223)<span></span>
</td>
<td class="num">(35,244)<span></span>
</td>
<td class="num">(51,019)<span></span>
</td>
<td class="num">(39,701)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57,320)<span></span>
</td>
<td class="num">(32,962)<span></span>
</td>
<td class="num">(48,634)<span></span>
</td>
<td class="num">(39,880)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment', window );">Gain from equity method investees, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,346<span></span>
</td>
<td class="nump">2,371<span></span>
</td>
<td class="nump">1,945<span></span>
</td>
<td class="nump">2,167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54,974)<span></span>
</td>
<td class="num">(30,591)<span></span>
</td>
<td class="num">(46,689)<span></span>
</td>
<td class="num">(37,713)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss allocated to common shareholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(83,899)<span></span>
</td>
<td class="num">(57,659)<span></span>
</td>
<td class="num">(83,447)<span></span>
</td>
<td class="num">(69,004)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net loss allocated to common shareholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(83,447)<span></span>
</td>
<td class="num">(69,004)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (55,741)<span></span>
</td>
<td class="num">$ (30,620)<span></span>
</td>
<td class="num">$ (46,594)<span></span>
</td>
<td class="num">$ (37,088)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share - basic (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (39,790)<span></span>
</td>
<td class="num">$ (30,190)<span></span>
</td>
<td class="num">$ (42.59)<span></span>
</td>
<td class="num">$ (42.34)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share - diluted (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (39,790)<span></span>
</td>
<td class="num">$ (30,190)<span></span>
</td>
<td class="num">$ (42.59)<span></span>
</td>
<td class="num">$ (42.34)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Consolidated Statement of Changes in Redeemable Convertible Preferred Stock and Shareholders&#8217; Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (354,917)<span></span>
</td>
<td class="num">$ (311,216)<span></span>
</td>
<td class="num">$ (311,216)<span></span>
</td>
<td class="num">$ (276,592)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54,974)<span></span>
</td>
<td class="num">(30,591)<span></span>
</td>
<td class="num">(46,689)<span></span>
</td>
<td class="num">(37,713)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(407,640)<span></span>
</td>
<td class="num">(339,740)<span></span>
</td>
<td class="num">(354,917)<span></span>
</td>
<td class="num">(311,216)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfCashFlowsAbstract', window );"><strong>Consolidated Statement of Cash Flows</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54,974)<span></span>
</td>
<td class="num">(30,591)<span></span>
</td>
<td class="num">(46,689)<span></span>
</td>
<td class="num">(37,713)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NoncashRecognitionOfLicensingRevenue', window );">Non-cash recognition of licensing revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,620)<span></span>
</td>
<td class="num">(1,516)<span></span>
</td>
<td class="num">(2,022)<span></span>
</td>
<td class="num">(1,018)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment', window );">Gain from equity method investees, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,346<span></span>
</td>
<td class="nump">2,371<span></span>
</td>
<td class="nump">1,945<span></span>
</td>
<td class="nump">2,167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset', window );">Contract assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,270)<span></span>
</td>
<td class="num">(3,838)<span></span>
</td>
<td class="num">(5,514)<span></span>
</td>
<td class="num">(5,605)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued salaries and wages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">463<span></span>
</td>
<td class="nump">717<span></span>
</td>
<td class="nump">1,256<span></span>
</td>
<td class="nump">690<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(71,336)<span></span>
</td>
<td class="num">(26,718)<span></span>
</td>
<td class="num">(42,591)<span></span>
</td>
<td class="num">(39,271)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_EquityMethodInvestmentGainOnDilutionOfInvestment', window );">Gain on dilution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amci_LanzaJetIncMember', window );">LanzaJet</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,433<span></span>
</td>
<td class="nump">13,651<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,620<span></span>
</td>
<td class="nump">1,516<span></span>
</td>
<td class="nump">2,025<span></span>
</td>
<td class="nump">1,018<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Consolidated Balance Sheet</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,433<span></span>
</td>
<td class="nump">13,651<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Consolidated Statement of Operations and Comprehensive Loss</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,620<span></span>
</td>
<td class="nump">1,516<span></span>
</td>
<td class="nump">2,025<span></span>
</td>
<td class="nump">1,018<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfCashFlowsAbstract', window );"><strong>Consolidated Statement of Cash Flows</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_EquityMethodInvestmentGainOnDilutionOfInvestment', window );">Gain on dilution</a></td>
<td class="nump">$ 503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intra-entity | LanzaJet</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(395)<span></span>
</td>
<td class="num">(497)<span></span>
</td>
<td class="nump">662<span></span>
</td>
<td class="nump">549<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Consolidated Statement of Operations and Comprehensive Loss</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(395)<span></span>
</td>
<td class="num">(497)<span></span>
</td>
<td class="nump">662<span></span>
</td>
<td class="nump">549<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Accumulated Deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Consolidated Balance Sheet</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(434,863)<span></span>
</td>
<td class="num">(363,791)<span></span>
</td>
<td class="num">(379,889)<span></span>
</td>
<td class="num">(333,200)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Consolidated Statement of Operations and Comprehensive Loss</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54,974)<span></span>
</td>
<td class="num">(30,591)<span></span>
</td>
<td class="num">(46,689)<span></span>
</td>
<td class="num">(37,713)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Consolidated Statement of Changes in Redeemable Convertible Preferred Stock and Shareholders&#8217; Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(379,889)<span></span>
</td>
<td class="num">(333,200)<span></span>
</td>
<td class="num">(333,200)<span></span>
</td>
<td class="num">(295,487)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54,974)<span></span>
</td>
<td class="num">(30,591)<span></span>
</td>
<td class="num">(46,689)<span></span>
</td>
<td class="num">(37,713)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(434,863)<span></span>
</td>
<td class="num">(363,791)<span></span>
</td>
<td class="num">(379,889)<span></span>
</td>
<td class="num">(333,200)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfCashFlowsAbstract', window );"><strong>Consolidated Statement of Cash Flows</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54,974)<span></span>
</td>
<td class="num">(30,591)<span></span>
</td>
<td class="num">(46,689)<span></span>
</td>
<td class="num">(37,713)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartySupplyAgreementMember', window );">Related Party Supply Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Related party fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,223<span></span>
</td>
<td class="nump">242<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Previously Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,479<span></span>
</td>
<td class="nump">24,023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(378,162)<span></span>
</td>
<td class="num">(332,394)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue from related party transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,915<span></span>
</td>
<td class="nump">4,752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Contract assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,064<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,775<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,993<span></span>
</td>
<td class="nump">12,865<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Consolidated Balance Sheet</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Contract assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,064<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,467<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,479<span></span>
</td>
<td class="nump">24,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">194,738<span></span>
</td>
<td class="nump">119,664<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,775<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,666<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(378,162)<span></span>
</td>
<td class="num">(332,394)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(353,190)<span></span>
</td>
<td class="num">(310,410)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, contingently redeemable preferred stock, and shareholders' deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">194,738<span></span>
</td>
<td class="nump">119,664<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Consolidated Statement of Operations and Comprehensive Loss</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,993<span></span>
</td>
<td class="nump">12,865<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,915<span></span>
</td>
<td class="nump">4,752<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,245<span></span>
</td>
<td class="nump">18,780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_CostOfRevenueFromContractsWithCustomersExcludingDepreciation', window );">Cost of revenues from contracts with customers (exclusive of depreciation shown below)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,289)<span></span>
</td>
<td class="num">(8,063)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total cost and operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(76,602)<span></span>
</td>
<td class="num">(57,932)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50,357)<span></span>
</td>
<td class="num">(39,152)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(47,972)<span></span>
</td>
<td class="num">(39,331)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment', window );">Gain from equity method investees, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,204<span></span>
</td>
<td class="nump">2,424<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45,768)<span></span>
</td>
<td class="num">(36,907)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss allocated to common shareholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(82,526)<span></span>
</td>
<td class="num">(68,198)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net loss allocated to common shareholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(82,526)<span></span>
</td>
<td class="num">(68,198)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (45,673)<span></span>
</td>
<td class="num">$ (36,282)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share - basic (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (42.12)<span></span>
</td>
<td class="num">$ (41.84)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share - diluted (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (42.12)<span></span>
</td>
<td class="num">$ (41.84)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Consolidated Statement of Changes in Redeemable Convertible Preferred Stock and Shareholders&#8217; Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(353,190)<span></span>
</td>
<td class="num">(310,410)<span></span>
</td>
<td class="num">$ (310,410)<span></span>
</td>
<td class="num">$ (276,592)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45,768)<span></span>
</td>
<td class="num">(36,907)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(353,190)<span></span>
</td>
<td class="num">(310,410)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfCashFlowsAbstract', window );"><strong>Consolidated Statement of Cash Flows</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45,768)<span></span>
</td>
<td class="num">(36,907)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NoncashRecognitionOfLicensingRevenue', window );">Non-cash recognition of licensing revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,684)<span></span>
</td>
<td class="num">(1,567)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment', window );">Gain from equity method investees, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,204<span></span>
</td>
<td class="nump">2,424<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset', window );">Contract assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,636)<span></span>
</td>
<td class="num">(5,483)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued salaries and wages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,378<span></span>
</td>
<td class="nump">568<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(42,591)<span></span>
</td>
<td class="num">(39,271)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_EquityMethodInvestmentGainOnDilutionOfInvestment', window );">Gain on dilution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Previously Reported | Accumulated Deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Consolidated Balance Sheet</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(378,162)<span></span>
</td>
<td class="num">(332,394)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Consolidated Statement of Changes in Redeemable Convertible Preferred Stock and Shareholders&#8217; Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(378,162)<span></span>
</td>
<td class="num">(332,394)<span></span>
</td>
<td class="num">(332,394)<span></span>
</td>
<td class="num">(295,487)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(378,162)<span></span>
</td>
<td class="num">(332,394)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember', window );">Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,727)<span></span>
</td>
<td class="num">(806)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,727)<span></span>
</td>
<td class="num">(806)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue from related party transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(662)<span></span>
</td>
<td class="num">(549)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Contract assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(122)<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Consolidated Balance Sheet</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Contract assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,727)<span></span>
</td>
<td class="num">(806)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,727)<span></span>
</td>
<td class="num">(684)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,727)<span></span>
</td>
<td class="num">(806)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,727)<span></span>
</td>
<td class="num">(806)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, contingently redeemable preferred stock, and shareholders' deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,727)<span></span>
</td>
<td class="num">(684)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Consolidated Statement of Operations and Comprehensive Loss</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(122)<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(662)<span></span>
</td>
<td class="num">(549)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(784)<span></span>
</td>
<td class="num">(427)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_CostOfRevenueFromContractsWithCustomersExcludingDepreciation', window );">Cost of revenues from contracts with customers (exclusive of depreciation shown below)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122<span></span>
</td>
<td class="num">(122)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total cost and operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122<span></span>
</td>
<td class="num">(122)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(662)<span></span>
</td>
<td class="num">(549)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(662)<span></span>
</td>
<td class="num">(549)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment', window );">Gain from equity method investees, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(259)<span></span>
</td>
<td class="num">(257)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(921)<span></span>
</td>
<td class="num">(806)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss allocated to common shareholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(921)<span></span>
</td>
<td class="num">(806)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net loss allocated to common shareholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(921)<span></span>
</td>
<td class="num">(806)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (921)<span></span>
</td>
<td class="num">$ (806)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share - basic (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.47)<span></span>
</td>
<td class="num">$ (0.50)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share - diluted (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.47)<span></span>
</td>
<td class="num">$ (0.50)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Consolidated Statement of Changes in Redeemable Convertible Preferred Stock and Shareholders&#8217; Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,727)<span></span>
</td>
<td class="num">(806)<span></span>
</td>
<td class="num">$ (806)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(921)<span></span>
</td>
<td class="num">(806)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,727)<span></span>
</td>
<td class="num">(806)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfCashFlowsAbstract', window );"><strong>Consolidated Statement of Cash Flows</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(921)<span></span>
</td>
<td class="num">(806)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NoncashRecognitionOfLicensingRevenue', window );">Non-cash recognition of licensing revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">662<span></span>
</td>
<td class="nump">549<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment', window );">Gain from equity method investees, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(259)<span></span>
</td>
<td class="num">(257)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset', window );">Contract assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122<span></span>
</td>
<td class="num">(122)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued salaries and wages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(122)<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember', window );">Adjustments | Accumulated Deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Consolidated Balance Sheet</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,727)<span></span>
</td>
<td class="num">(806)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Consolidated Statement of Changes in Redeemable Convertible Preferred Stock and Shareholders&#8217; Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,727)<span></span>
</td>
<td class="num">$ (806)<span></span>
</td>
<td class="num">(806)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,727)<span></span>
</td>
<td class="num">(806)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember', window );">Adjustments | Error Correction, Equity Method Investments, Intangibles And Fixed Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">580<span></span>
</td>
<td class="nump">257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(580)<span></span>
</td>
<td class="num">(257)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Gain from equity method investees, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(580)<span></span>
</td>
<td class="num">(257)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Consolidated Balance Sheet</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">580<span></span>
</td>
<td class="nump">257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(580)<span></span>
</td>
<td class="num">(257)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember', window );">Adjustments | Error Correction, Equity Method Investment, Contributed Intellectual Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">662<span></span>
</td>
<td class="nump">549<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(662)<span></span>
</td>
<td class="num">(549)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue from related party transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(662)<span></span>
</td>
<td class="num">(549)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Consolidated Balance Sheet</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">662<span></span>
</td>
<td class="nump">549<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(662)<span></span>
</td>
<td class="num">(549)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Consolidated Statement of Operations and Comprehensive Loss</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(662)<span></span>
</td>
<td class="num">$ (549)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember', window );">Adjustments | Error Correction, Equity Method Investment, Gain On Dilution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Gain from equity method investees, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Consolidated Balance Sheet</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_CostOfRevenueFromContractsWithCustomersExcludingDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of Revenue From Contracts with Customers, Excluding Depreciation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_CostOfRevenueFromContractsWithCustomersExcludingDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_EquityMethodInvestmentGainOnDilutionOfInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Gain On Dilution Of Investment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_EquityMethodInvestmentGainOnDilutionOfInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Equity Method Investments and Gain On Dilution Of Investment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_NoncashRecognitionOfLicensingRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash Recognition of Licensing Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_NoncashRecognitionOfLicensingRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.1(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfCashFlowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfCashFlowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amci_LanzaJetIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amci_LanzaJetIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartySupplyAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartySupplyAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=amci_ErrorCorrectionEquityMethodInvestmentsIntangiblesAndFixedAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=amci_ErrorCorrectionEquityMethodInvestmentsIntangiblesAndFixedAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=amci_ErrorCorrectionEquityMethodInvestmentContributedIntellectualAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=amci_ErrorCorrectionEquityMethodInvestmentContributedIntellectualAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=amci_ErrorCorrectionEquityMethodInvestmentGainOnDilutionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=amci_ErrorCorrectionEquityMethodInvestmentGainOnDilutionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>192
<FILENAME>R173.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272210176016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Segment Information (Details) - segment<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>193
<FILENAME>R174.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272207726672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Going Concern (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 50,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 128,318<span></span>
</td>
<td class="nump">$ 60,495<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(434,863)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(379,889)<span></span>
</td>
<td class="num">(333,200)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(71,336)<span></span>
</td>
<td class="num">$ (26,718)<span></span>
</td>
<td class="num">(42,591)<span></span>
</td>
<td class="num">(39,271)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (54,974)<span></span>
</td>
<td class="num">$ (30,591)<span></span>
</td>
<td class="num">$ (46,689)<span></span>
</td>
<td class="num">$ (37,713)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>194
<FILENAME>R175.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211119008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 50,370<span></span>
</td>
<td class="nump">$ 128,318<span></span>
</td>
<td class="nump">$ 60,495<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>195
<FILENAME>R176.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272206418128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Cash, Cash Equivalents and Restricted Cash Reconciliation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 50,370<span></span>
</td>
<td class="nump">$ 128,318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash (presented within Other current assets)</a></td>
<td class="nump">664<span></span>
</td>
<td class="nump">414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash</a></td>
<td class="nump">$ 51,034<span></span>
</td>
<td class="nump">$ 128,732<span></span>
</td>
<td class="nump">$ 115,700<span></span>
</td>
<td class="nump">$ 60,909<span></span>
</td>
<td class="nump">$ 62,117<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>196
<FILENAME>R177.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272210253088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Trade and Other Receivables (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 1,051<span></span>
</td>
<td class="nump">$ 1,235<span></span>
</td>
<td class="nump">$ 1,325<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>197
<FILENAME>R178.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272207351648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Property, Plant and Equipment, net (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Instruments and equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Instruments and equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Office Equipment and furniture | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Office Equipment and furniture | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>198
<FILENAME>R179.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272196307152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Warrants (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Sale of private placement warrants (in shares)</a></td>
<td class="nump">225,223<span></span>
</td>
<td class="nump">225,223<span></span>
</td>
<td class="nump">383,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="nump">$ 19.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants</a></td>
<td class="nump">$ 2,022,000<span></span>
</td>
<td class="nump">$ 1,729,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 107,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>199
<FILENAME>R180.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272197471152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Concentration of Credit Risk and Other Risks and Uncertainties (Details)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Geographic Concentration Risk | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">61.00%<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="nump">38.00%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Customer Concentration Risk | Customer A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Customer Concentration Risk | Customer B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Customer Concentration Risk | Customer C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Customer Concentration Risk | Customer D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable | Geographic Concentration Risk | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable | Customer Concentration Risk | Customer B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable | Customer Concentration Risk | Customer D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=amci_CustomerAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=amci_CustomerAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=amci_CustomerBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=amci_CustomerBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=amci_CustomerCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=amci_CustomerCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=amci_CustomerDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=amci_CustomerDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>200
<FILENAME>R181.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272197940272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Schedule of Calculation of Basic and Diluted Net Loss per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for basic and diluted earnings per common share</a></td>
<td class="num">$ (54,974)<span></span>
</td>
<td class="num">$ (30,591)<span></span>
</td>
<td class="num">$ (46,689)<span></span>
</td>
<td class="num">$ (37,713)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsIncomeStatementImpact', window );">Unpaid cumulative dividends on preferred stock</a></td>
<td class="num">(28,925)<span></span>
</td>
<td class="num">(27,068)<span></span>
</td>
<td class="num">(36,758)<span></span>
</td>
<td class="num">(31,291)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss allocated to common shareholders</a></td>
<td class="num">$ (83,899)<span></span>
</td>
<td class="num">$ (57,659)<span></span>
</td>
<td class="num">$ (83,447)<span></span>
</td>
<td class="num">$ (69,004)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares used in calculating net loss per share, basic and diluted (in shares)</a></td>
<td class="nump">2,108,472,000<span></span>
</td>
<td class="nump">1,909,635,000<span></span>
</td>
<td class="nump">1,959,165,000<span></span>
</td>
<td class="nump">1,629,821,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in calculating net loss per share, diluted (in shares)</a></td>
<td class="nump">2,108,472,000<span></span>
</td>
<td class="nump">1,909,635,000<span></span>
</td>
<td class="nump">1,959,165,000<span></span>
</td>
<td class="nump">1,629,821,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share - basic (usd per share)</a></td>
<td class="num">$ (39,790)<span></span>
</td>
<td class="num">$ (30,190)<span></span>
</td>
<td class="num">$ (42.59)<span></span>
</td>
<td class="num">$ (42.34)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share - diluted (usd per share)</a></td>
<td class="num">$ (39,790)<span></span>
</td>
<td class="num">$ (30,190)<span></span>
</td>
<td class="num">$ (42.59)<span></span>
</td>
<td class="num">$ (42.34)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsIncomeStatementImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsIncomeStatementImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>201
<FILENAME>R182.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272207095520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Antidilutive Shares (Details)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares</a></td>
<td class="nump">34,117,671<span></span>
</td>
<td class="nump">33,867,263<span></span>
</td>
<td class="nump">34,175,113<span></span>
</td>
<td class="nump">30,720,703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionRatio', window );">Conversion ratio</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_LiquidityPriceOfSAFEAndSAFEWarrants', window );">Liquidity price of SAFE and SAFE warrants</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne', window );">Liquidity price of SAFE and SAFE warrants, condition one</a></td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember', window );">Redeemable convertible preferred stock (if converted)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">25,729,542<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares</a></td>
<td class="nump">3,790,978<span></span>
</td>
<td class="nump">3,540,570<span></span>
</td>
<td class="nump">3,848,420<span></span>
</td>
<td class="nump">4,283,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">RSAs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares</a></td>
<td class="nump">579,660<span></span>
</td>
<td class="nump">579,660<span></span>
</td>
<td class="nump">579,660<span></span>
</td>
<td class="nump">324,680<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares</a></td>
<td class="nump">225,223<span></span>
</td>
<td class="nump">225,223<span></span>
</td>
<td class="nump">225,223<span></span>
</td>
<td class="nump">383,281<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_LiquidityPriceOfSAFEAndSAFEWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liquidity Price of SAFE and SAFE Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_LiquidityPriceOfSAFEAndSAFEWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liquidity Price of SAFE and SAFE Warrants, Condition One</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common shares issuable upon conversion for each share of preferred stock to be converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>202
<FILENAME>R183.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272195594304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues - Disaggregated Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 25,781<span></span>
</td>
<td class="nump">$ 18,327<span></span>
</td>
<td class="nump">$ 25,461<span></span>
</td>
<td class="nump">$ 18,353<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=amci_ResearchAndDevelopmentMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">8,118<span></span>
</td>
<td class="nump">12,053<span></span>
</td>
<td class="nump">13,897<span></span>
</td>
<td class="nump">8,910<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=amci_JointDevelopmentAgreementsMember', window );">Joint development agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">4,018<span></span>
</td>
<td class="nump">10,660<span></span>
</td>
<td class="nump">11,700<span></span>
</td>
<td class="nump">6,928<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=amci_OtherContractResearchMember', window );">Other contract research</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">4,100<span></span>
</td>
<td class="nump">1,393<span></span>
</td>
<td class="nump">2,197<span></span>
</td>
<td class="nump">1,982<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=amci_CarbonCaptureAndTransformationMember', window );">Carbon capture and transformation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">17,663<span></span>
</td>
<td class="nump">6,274<span></span>
</td>
<td class="nump">11,564<span></span>
</td>
<td class="nump">9,443<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember', window );">Licensing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,620<span></span>
</td>
<td class="nump">1,518<span></span>
</td>
<td class="nump">2,025<span></span>
</td>
<td class="nump">1,018<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=amci_CarbonSmartMember', window );">CarbonSmart</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">3,413<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=amci_EngineeringAndOtherServicesMember', window );">Engineering and other services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 12,630<span></span>
</td>
<td class="nump">$ 4,756<span></span>
</td>
<td class="nump">$ 9,539<span></span>
</td>
<td class="nump">$ 8,425<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=amci_ResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=amci_ResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=amci_JointDevelopmentAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=amci_JointDevelopmentAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=amci_OtherContractResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=amci_OtherContractResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=amci_CarbonCaptureAndTransformationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=amci_CarbonCaptureAndTransformationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=amci_CarbonSmartMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=amci_CarbonSmartMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=amci_EngineeringAndOtherServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=amci_EngineeringAndOtherServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>203
<FILENAME>R184.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211933328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues - Disaggregation by Customer Location (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 25,781<span></span>
</td>
<td class="nump">$ 18,327<span></span>
</td>
<td class="nump">$ 25,461<span></span>
</td>
<td class="nump">$ 18,353<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_NorthAmericaMember', window );">North America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">12,361<span></span>
</td>
<td class="nump">12,725<span></span>
</td>
<td class="nump">15,825<span></span>
</td>
<td class="nump">15,732<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,522<span></span>
</td>
<td class="nump">2,117<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaMember', window );">Asia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">4,151<span></span>
</td>
<td class="nump">242<span></span>
</td>
<td class="nump">1,477<span></span>
</td>
<td class="nump">504<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_AU', window );">Australia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,375<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
<td class="nump">$ 637<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_NorthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_NorthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_AU">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_AU</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>204
<FILENAME>R185.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272197311296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues - Contract Balances (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrentAbstract', window );"><strong>Current Contract Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Beginning balance</a></td>
<td class="nump">$ 11,700<span></span>
</td>
<td class="nump">$ 6,186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable', window );">Additions to unbilled accounts receivable</a></td>
<td class="nump">19,355<span></span>
</td>
<td class="nump">8,516<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ContractWithCustomerAssetCurrentReclassifiedToReceivable', window );">Unbilled accounts receivable recognized in trade receivables</a></td>
<td class="num">(16,085)<span></span>
</td>
<td class="num">(3,002)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Ending balance</a></td>
<td class="nump">14,848<span></span>
</td>
<td class="nump">11,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ContractWithCustomerLiabilityCurrentAbstract', window );"><strong>Current Contract Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Beginning balance</a></td>
<td class="nump">3,476<span></span>
</td>
<td class="nump">5,480<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ContractWithCustomerLiabilityCurrentAmountsCollected', window );">Increases due to cash received</a></td>
<td class="nump">775<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent', window );">Reclassification from non-current to current contract liabilities</a></td>
<td class="nump">2,015<span></span>
</td>
<td class="nump">3,080<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Ending balance</a></td>
<td class="nump">2,968<span></span>
</td>
<td class="nump">3,476<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ContractWithCustomerLiabilityNoncurrentAbstract', window );"><strong>Non-current Contract Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Beginning balance</a></td>
<td class="nump">13,901<span></span>
</td>
<td class="nump">11,291<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ContractWithCustomerLiabilityNoncurrentAmountsCollected', window );">Increases due to cash received</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">5,690<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent', window );">Reclassification from non-current to current contract liabilities</a></td>
<td class="num">(2,015)<span></span>
</td>
<td class="num">(3,080)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ContractWithCustomerLiabilityCurrentRevenueRecognized', window );">Reclassification to revenue as a result of performance obligations satisfied</a></td>
<td class="num">(3,298)<span></span>
</td>
<td class="num">(5,104)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Ending balance</a></td>
<td class="nump">$ 11,119<span></span>
</td>
<td class="nump">$ 13,901<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Asset, Current, Additions To Unbilled Accounts Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ContractWithCustomerAssetCurrentReclassifiedToReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Asset, Current, Reclassified To Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ContractWithCustomerAssetCurrentReclassifiedToReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ContractWithCustomerLiabilityCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ContractWithCustomerLiabilityCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ContractWithCustomerLiabilityCurrentAmountsCollected">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Current, Amounts Collected</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ContractWithCustomerLiabilityCurrentAmountsCollected</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Current, Reclassification From Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ContractWithCustomerLiabilityCurrentRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Current, Revenue Recognized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ContractWithCustomerLiabilityCurrentRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ContractWithCustomerLiabilityNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ContractWithCustomerLiabilityNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ContractWithCustomerLiabilityNoncurrentAmountsCollected">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Noncurrent, Amounts Collected</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ContractWithCustomerLiabilityNoncurrentAmountsCollected</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Noncurrent, Reclassification To Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>205
<FILENAME>R186.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272307840928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenues - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BilledContractReceivables', window );">Billed accounts receivable, net of allowance</a></td>
<td class="nump">$ 11,588<span></span>
</td>
<td class="nump">$ 2,878<span></span>
</td>
<td class="nump">$ 5,521<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BilledContractReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amounts due for billed services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the Company and, at a minimum, one other party. An example would be amounts billed to customers under contracts or programs but not paid as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55302-109406<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BilledContractReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>206
<FILENAME>R187.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272199299488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenues - Remaining Performance Obligations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_RevenueRemainingPerformanceObligationCurrentAmount', window );">Current</a></td>
<td class="nump">$ 2,968<span></span>
</td>
<td class="nump">$ 3,476<span></span>
</td>
<td class="nump">$ 5,480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_RevenueRemainingPerformanceObligationNoncurrentAmount', window );">Non-current</a></td>
<td class="nump">11,119<span></span>
</td>
<td class="nump">13,901<span></span>
</td>
<td class="nump">11,291<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Total</a></td>
<td class="nump">$ 14,087<span></span>
</td>
<td class="nump">$ 17,377<span></span>
</td>
<td class="nump">$ 16,771<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_RevenueRemainingPerformanceObligationCurrentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Remaining Performance Obligation, Current, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_RevenueRemainingPerformanceObligationCurrentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_RevenueRemainingPerformanceObligationNoncurrentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Remaining Performance Obligation, Noncurrent, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_RevenueRemainingPerformanceObligationNoncurrentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>207
<FILENAME>R188.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272197298160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Equity Method Investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity Method Investments</a></td>
<td class="nump">$ 11,047<span></span>
</td>
<td class="nump">$ 24,752<span></span>
</td>
<td class="nump">$ 23,217<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amci_LanzaJetIncMember', window );">LanzaJet</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity Method Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,433<span></span>
</td>
<td class="nump">13,651<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember', window );">SGLT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity Method Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,319<span></span>
</td>
<td class="nump">$ 9,566<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amci_LanzaJetIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amci_LanzaJetIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>208
<FILENAME>R189.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272195352176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Narrative (Details)<br> &#165; in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Apr. 29, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 13, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 28, 2011 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 28, 2011 </div>
<div>CNY (&#165;)</div>
</th>
<th class="th">
<div>Apr. 04, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,871,000<span></span>
</td>
<td class="nump">$ 12,987,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_EquityMethodInvestmentGainOnDilutionOfInvestment', window );">Gain on dilution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">503,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Impairment on equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions', window );">Dividends from equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amci_LanzaJetIncMember', window );">LanzaJet</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContributionOfProperty', window );">Contribution of intellectual property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,620,000<span></span>
</td>
<td class="nump">$ 1,516,000<span></span>
</td>
<td class="nump">2,025,000<span></span>
</td>
<td class="nump">1,018,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,734,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,746,000<span></span>
</td>
<td class="nump">13,433,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_RevenueFromContractWithCustomerAmortizationPeriod', window );">Profit amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_EquityMethodInvestmentContingentRightToReceiveAdditionalInterest', window );">Contingent right to receive additional interest | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Equity method investments cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_EquityMethodInvestmentGainOnDilutionOfInvestment', window );">Gain on dilution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 503,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity', window );">Carrying value less than proportionate share of book value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,100,000<span></span>
</td>
<td class="nump">3,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amci_LanzaJetIncMember', window );">LanzaJet | Intra-entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (395,000)<span></span>
</td>
<td class="num">(497,000)<span></span>
</td>
<td class="nump">$ 662,000<span></span>
</td>
<td class="nump">$ 549,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember', window );">SGLT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContributionOfProperty', window );">Contribution of intellectual property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="nump">&#165; 25,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="nump">9.31%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.01%<span></span>
</td>
<td class="nump">11.14%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_EquityMethodInvestmentGainOnDilutionOfInvestment', window );">Gain on dilution</a></td>
<td class="nump">$ 3,368,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,014,000<span></span>
</td>
<td class="nump">$ 3,048,000<span></span>
</td>
<td class="nump">$ 3,811,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember', window );">SGLT | Intellectual Property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContributionOfProperty', window );">Contribution of intellectual property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="nump">&#165; 25,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_EquityMethodInvestmentContingentRightToReceiveAdditionalInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Contingent Right To Receive Additional Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_EquityMethodInvestmentContingentRightToReceiveAdditionalInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_EquityMethodInvestmentGainOnDilutionOfInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Gain On Dilution Of Investment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_EquityMethodInvestmentGainOnDilutionOfInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_RevenueFromContractWithCustomerAmortizationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue From Contract With Customer, Amortization Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_RevenueFromContractWithCustomerAmortizationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContributionOfProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of property contributed in noncash investing and financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContributionOfProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 35<br> -Paragraph 32<br> -URI https://asc.fasb.org/extlink&amp;oid=126903467&amp;loc=d3e32787-111569<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amci_LanzaJetIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amci_LanzaJetIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_IntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_IntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>209
<FILENAME>R190.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272196576784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Summarized Financial Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 25,781<span></span>
</td>
<td class="nump">$ 18,327<span></span>
</td>
<td class="nump">$ 25,461<span></span>
</td>
<td class="nump">$ 18,353<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(54,974)<span></span>
</td>
<td class="num">(30,591)<span></span>
</td>
<td class="num">(46,689)<span></span>
</td>
<td class="num">(37,713)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Net loss</a></td>
<td class="num">(2,346)<span></span>
</td>
<td class="num">$ (2,371)<span></span>
</td>
<td class="nump">1,606<span></span>
</td>
<td class="nump">1,644<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="nump">88,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">148,675<span></span>
</td>
<td class="nump">76,589<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="nump">$ 49,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,290<span></span>
</td>
<td class="nump">15,204<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember', window );">Equity Method Investment, Nonconsolidated Investee or Group of Investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,244<span></span>
</td>
<td class="nump">26,120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,703)<span></span>
</td>
<td class="num">(5,510)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,695)<span></span>
</td>
<td class="num">(9,729)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,204<span></span>
</td>
<td class="nump">55,188<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">270,454<span></span>
</td>
<td class="nump">133,794<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,499<span></span>
</td>
<td class="nump">33,540<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58,802<span></span>
</td>
<td class="nump">$ 21,674<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>210
<FILENAME>R191.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272203896960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Transactions (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Sales</a></td>
<td class="nump">$ 2,116<span></span>
</td>
<td class="nump">$ 2,348<span></span>
</td>
<td class="nump">$ 3,253<span></span>
</td>
<td class="nump">$ 4,203<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,071<span></span>
</td>
<td class="nump">3,257<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember', window );">Equity Method Investee | Transactions with Equity Method Investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,253<span></span>
</td>
<td class="nump">4,203<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable</a></td>
<td class="nump">1,509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,071<span></span>
</td>
<td class="nump">3,257<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_PurchasesAndOpenAccountsPayableRelatedParties', window );">Purchases and open accounts payable</a></td>
<td class="nump">$ 1,863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,575<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_PurchasesAndOpenAccountsPayableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchases and Open Accounts Payable, Related Parties</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_PurchasesAndOpenAccountsPayableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 310<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126942793&amp;loc=d3e3073-115593<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.1(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=amci_TransactionsWithEquityMethodInvesteesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=amci_TransactionsWithEquityMethodInvesteesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>211
<FILENAME>R192.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272189508096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Financial Assets and Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants</a></td>
<td class="nump">$ 2,022,000<span></span>
</td>
<td class="nump">$ 1,729,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 107,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SimpleAgreementForFutureEquityLiability', window );">SAFE liability</a></td>
<td class="nump">27,221,000<span></span>
</td>
<td class="nump">28,271,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">519,000<span></span>
</td>
<td class="nump">516,000<span></span>
</td>
<td class="nump">516,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,145,000<span></span>
</td>
<td class="nump">582,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SimpleAgreementForFutureEquityLiability', window );">SAFE liability</a></td>
<td class="nump">27,221,000<span></span>
</td>
<td class="nump">28,271,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Liabilities</a></td>
<td class="nump">30,815,000<span></span>
</td>
<td class="nump">31,145,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | SAFE warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants</a></td>
<td class="nump">2,022,000<span></span>
</td>
<td class="nump">1,729,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">519,000<span></span>
</td>
<td class="nump">516,000<span></span>
</td>
<td class="nump">516,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SimpleAgreementForFutureEquityLiability', window );">SAFE liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1 | SAFE warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SimpleAgreementForFutureEquityLiability', window );">SAFE liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 2 | SAFE warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,145,000<span></span>
</td>
<td class="nump">$ 582,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SimpleAgreementForFutureEquityLiability', window );">SAFE liability</a></td>
<td class="nump">27,221,000<span></span>
</td>
<td class="nump">28,271,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Liabilities</a></td>
<td class="nump">30,815,000<span></span>
</td>
<td class="nump">31,145,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 3 | SAFE warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants</a></td>
<td class="nump">$ 2,022,000<span></span>
</td>
<td class="nump">$ 1,729,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_SimpleAgreementForFutureEquityLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Simple Agreement for Future Equity Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_SimpleAgreementForFutureEquityLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=amci_SAFEWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=amci_SAFEWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>212
<FILENAME>R193.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272196602656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">(Gain) loss on change in fair value of SAFE and warrant liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 427,000<span></span>
</td>
<td class="nump">$ 699,000<span></span>
</td>
<td class="nump">$ 563,000<span></span>
</td>
<td class="num">$ (105,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquitySharesConversionOfConvertibleSecurities', window );">Exercise of warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,022,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,729,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 107,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember', window );">Series D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquitySharesConversionOfConvertibleSecurities', window );">Exercise of warrants (in shares)</a></td>
<td class="nump">158,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TemporaryEquitySharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Shares, Conversion of Convertible Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TemporaryEquitySharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>213
<FILENAME>R194.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272195902592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Level 3 Fair Value Measurements (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Stock price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">15.03<span></span>
</td>
<td class="nump">13.77<span></span>
</td>
<td class="nump">4.68<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember', window );">Weighted average exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">17.31<span></span>
</td>
<td class="nump">17.32<span></span>
</td>
<td class="nump">18.39<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Term | Near Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Term | Long-Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.769<span></span>
</td>
<td class="nump">0.706<span></span>
</td>
<td class="nump">0.889<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Expected volatility | Near Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.75<span></span>
</td>
<td class="nump">0.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Expected volatility | Long-Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.75<span></span>
</td>
<td class="nump">0.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.029<span></span>
</td>
<td class="nump">0.008<span></span>
</td>
<td class="nump">0.004<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk-free interest rate | Near Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.0333<span></span>
</td>
<td class="nump">0.0019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk-free interest rate | Long-Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.0405<span></span>
</td>
<td class="nump">0.0039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputProbabilityWeightingMember', window );">Probability weighting | Near Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.41<span></span>
</td>
<td class="nump">0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputProbabilityWeightingMember', window );">Probability weighting | Long-Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.59<span></span>
</td>
<td class="nump">0.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputProbabilityWeightingMember', window );">Probability weighting | Near Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivatives, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputProbabilityWeightingMember', window );">Probability weighting | Long-Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivatives, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputInterestRateMember', window );">Interest rate | Near Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.0406<span></span>
</td>
<td class="nump">0.0126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputInterestRateMember', window );">Interest rate | Long-Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.0406<span></span>
</td>
<td class="nump">0.0126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputTimeToConversionMember', window );">Time to conversion | Near Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputTimeToConversionMember', window );">Time to conversion | Long-Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputTimeToConversionMember', window );">Time to conversion | Near Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivatives, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputTimeToConversionMember', window );">Time to conversion | Long-Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivatives, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputLiquidityPriceMember', window );">Liquidity price | Near Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivatives, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputLiquidityPriceMember', window );">Liquidity price | Long-Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivatives, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Discount rate | Near Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivatives, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Discount rate | Long-Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivatives, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Expected dividend yield | Near Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Expected dividend yield | Long-Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure derivative liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=amci_SAFEWarrantNearTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=amci_SAFEWarrantNearTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=amci_SAFEWarrantLongTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=amci_SAFEWarrantLongTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputProbabilityWeightingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputProbabilityWeightingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=amci_DerivativeNearTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=amci_DerivativeNearTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=amci_DerivativeLongTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=amci_DerivativeLongTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputTimeToConversionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputTimeToConversionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputLiquidityPriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=amci_MeasurementInputLiquidityPriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>214
<FILENAME>R195.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211867648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value - Change in Fair Value of Derivative Warrant Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Derivative warrant liabilities at the beginning</a></td>
<td class="nump">$ 1,145<span></span>
</td>
<td class="nump">$ 582<span></span>
</td>
<td class="nump">$ 582<span></span>
</td>
<td class="nump">$ 687<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Issuance of SAFE liability and warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of derivative liabilities</a></td>
<td class="nump">427<span></span>
</td>
<td class="nump">699<span></span>
</td>
<td class="nump">563<span></span>
</td>
<td class="num">(105)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Derivative warrant liabilities at the end</a></td>
<td class="nump">1,572<span></span>
</td>
<td class="nump">1,281<span></span>
</td>
<td class="nump">1,145<span></span>
</td>
<td class="nump">582<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=amci_SAFELiabilityMember', window );">SAFE Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Derivative warrant liabilities at the beginning</a></td>
<td class="nump">28,271<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Issuance of SAFE liability and warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of derivative liabilities</a></td>
<td class="num">(1,050)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Derivative warrant liabilities at the end</a></td>
<td class="nump">27,221<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,271<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=amci_SAFEWarrantMember', window );">SAFE warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Derivative warrant liabilities at the beginning</a></td>
<td class="nump">1,729<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Issuance of SAFE liability and warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,729<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of derivative liabilities</a></td>
<td class="nump">293<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Derivative warrant liabilities at the end</a></td>
<td class="nump">$ 2,022<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,729<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=amci_SAFELiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=amci_SAFELiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=amci_SAFEWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=amci_SAFEWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>215
<FILENAME>R196.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272210007856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Current Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MaterialsSuppliesAndOther', window );">Materials and supplies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900<span></span>
</td>
<td class="nump">$ 1,952<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,503<span></span>
</td>
<td class="nump">1,419<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousCurrent', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,376<span></span>
</td>
<td class="nump">1,016<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">$ 12,009<span></span>
</td>
<td class="nump">$ 5,779<span></span>
</td>
<td class="nump">$ 4,387<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaterialsSuppliesAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of capitalized costs of materials, supplies, and other assets, which are not included in inventory but used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaterialsSuppliesAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>216
<FILENAME>R197.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272212047504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property, Plant, and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,521<span></span>
</td>
<td class="nump">$ 30,298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,373<span></span>
</td>
<td class="nump">18,689<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property, plant and equipment, net</a></td>
<td class="nump">$ 16,645<span></span>
</td>
<td class="nump">14,148<span></span>
</td>
<td class="nump">11,609<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,113<span></span>
</td>
<td class="nump">4,187<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Instruments and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,627<span></span>
</td>
<td class="nump">21,735<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember', window );">Vehicles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Office Equipment and furniture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,590<span></span>
</td>
<td class="nump">1,347<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentOtherTypesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">728<span></span>
</td>
<td class="nump">544<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,328<span></span>
</td>
<td class="nump">$ 2,363<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentOtherTypesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentOtherTypesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>217
<FILENAME>R198.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272210237648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant, and Equipment - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 3,433<span></span>
</td>
<td class="nump">$ 2,763<span></span>
</td>
<td class="nump">$ 3,806<span></span>
</td>
<td class="nump">$ 2,979<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>218
<FILENAME>R199.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272207062064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 28, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt, net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,635,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">570,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,065,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=amci_WTILoanMember', window );">2016 WTI Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">570,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=amci_PPPLoanMember', window );">PPP Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt, net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3,065,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=amci_WTILoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=amci_WTILoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=amci_PPPLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=amci_PPPLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>219
<FILENAME>R200.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272196378304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 28, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Outstanding debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3,635,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=amci_WTILoanMember', window );">2016 WTI Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">39 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 570,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Outstanding debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">570,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=amci_WTILoanMember', window );">2016 WTI Loan | Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=amci_PPPLoanMember', window );">PPP Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.98%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Issuance of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,065,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentDecreaseForgiveness', window );">Debt forgiveness</a></td>
<td class="nump">$ 3,065,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Outstanding debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3,065,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDecreaseForgiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease for amounts of indebtedness forgiven by the holder of the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDecreaseForgiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=amci_WTILoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=amci_WTILoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_PrimeRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=amci_PPPLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=amci_PPPLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>220
<FILENAME>R201.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272381071536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SAFE (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_SimpleAgreementForFutureEquityLiability', window );">SAFE liability</a></td>
<td class="nump">$ 27,221<span></span>
</td>
<td class="nump">$ 28,271<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_SimpleAgreementForFutureEquityLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Simple Agreement for Future Equity Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_SimpleAgreementForFutureEquityLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>221
<FILENAME>R202.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272204887264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components of (Loss) Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 722<span></span>
</td>
<td class="nump">$ 2,832<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (54,974)<span></span>
</td>
<td class="num">$ (30,591)<span></span>
</td>
<td class="num">(46,689)<span></span>
</td>
<td class="num">(37,713)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39,860)<span></span>
</td>
<td class="nump">106<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=amci_InlandRevenueNewZealandMember', window );">New Zealand</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7,551)<span></span>
</td>
<td class="num">$ (40,651)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_IncomeTaxesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Taxes [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_IncomeTaxesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=amci_InlandRevenueNewZealandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=amci_InlandRevenueNewZealandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>222
<FILENAME>R203.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211949744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Income Tax Provision (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (290,181)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=amci_InlandRevenueNewZealandMember', window );">New Zealand</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=amci_InlandRevenueNewZealandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=amci_InlandRevenueNewZealandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>223
<FILENAME>R204.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272195917056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract', window );"><strong>Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income tax (benefit) at the statutory federal income tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (9,805,000)<span></span>
</td>
<td class="num">$ (10,560,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign tax rate differential</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(605,000)<span></span>
</td>
<td class="nump">1,180,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State and local taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,068,000)<span></span>
</td>
<td class="num">(2,429,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses', window );">Effects of impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,281,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesAmount', window );">Foreign exchange differences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(143,000)<span></span>
</td>
<td class="num">(5,892,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">501,000<span></span>
</td>
<td class="nump">670,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_EffectiveIncomeTaxRateReconciliationInterestIncomeAmount', window );">Interest income on receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">882,000<span></span>
</td>
<td class="nump">2,120,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentAmount', window );">Equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(443,000)<span></span>
</td>
<td class="num">(679,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalAmount', window );">Non-deductible legal costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,291,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyAmount', window );">Gain from redomiciliation of intellectual property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,890,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">620.90%<span></span>
</td>
<td class="num">(17.00%)<span></span>
</td>
<td class="num">(14.10%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 290,181<span></span>
</td>
<td class="nump">$ 7,958,000<span></span>
</td>
<td class="nump">$ 5,505,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessAmount', window );">PPP loan forgiveness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(644,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186,000<span></span>
</td>
<td class="num">(196,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>Effective Income Tax Rate Reconciliation, Percent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Income tax (benefit) at the statutory federal income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign tax rate differential</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="num">(3.20%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State and local taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.70%<span></span>
</td>
<td class="nump">6.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses', window );">Effects of impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(27.90%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesPercent', window );">Foreign exchange differences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.10%)<span></span>
</td>
<td class="num">(1.80%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_EffectiveIncomeTaxRateReconciliationInterestIncomePercent', window );">Interest income on receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.90%)<span></span>
</td>
<td class="num">(5.70%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentPercent', window );">Equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalPercent', window );">Non-deductible legal costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.80%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyPercent', window );">Gain from redomiciliation of intellectual property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10.50%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessPercent', window );">PPP loan forgiveness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214.00%<span></span>
</td>
<td class="num">(0.30%)<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Total income tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Debt Forgiveness, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Debt Forgiveness, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Equity Method Investment, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Equity Method Investment, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Foreign Exchange Differences, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Foreign Exchange Differences, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Gain From Redomicilation Of Intellectual Property, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Gain From Redomicilation Of Intellectual Property, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_EffectiveIncomeTaxRateReconciliationInterestIncomeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Interest Income, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_EffectiveIncomeTaxRateReconciliationInterestIncomeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_EffectiveIncomeTaxRateReconciliationInterestIncomePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Interest Income, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_EffectiveIncomeTaxRateReconciliationInterestIncomePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Nondeductible Expense, Legal, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Nondeductible Expense, Legal, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to impairment loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible impairment loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>224
<FILENAME>R205.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272205279184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss and credit carryforwards</a></td>
<td class="nump">$ 107,979<span></span>
</td>
<td class="nump">$ 104,301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_DeferredTaxAssetsLeasingArrangements', window );">Operating lease liability</a></td>
<td class="nump">1,878<span></span>
</td>
<td class="nump">2,394<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses', window );">Accrued bonus</a></td>
<td class="nump">981<span></span>
</td>
<td class="nump">850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals', window );">Accrued expenses</a></td>
<td class="nump">1,566<span></span>
</td>
<td class="nump">429<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred revenue</a></td>
<td class="nump">309<span></span>
</td>
<td class="nump">1,018<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsEquityMethodInvestments', window );">Equity method investment</a></td>
<td class="nump">1,243<span></span>
</td>
<td class="nump">1,031<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">925<span></span>
</td>
<td class="nump">394<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Gross deferred tax asset</a></td>
<td class="nump">114,881<span></span>
</td>
<td class="nump">110,417<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(113,276)<span></span>
</td>
<td class="num">(108,300)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax asset</a></td>
<td class="nump">1,605<span></span>
</td>
<td class="nump">2,117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNetAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Operating lease asset</a></td>
<td class="num">(1,429)<span></span>
</td>
<td class="num">(1,941)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(176)<span></span>
</td>
<td class="num">(176)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(1,605)<span></span>
</td>
<td class="num">(2,117)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred income tax assets and liabilities:</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_DeferredTaxAssetsLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Leasing Arrangements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_DeferredTaxAssetsLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee bonuses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>225
<FILENAME>R206.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272206098624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory tax rate (as a percent)</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_OperatingLossAndTaxCreditCarryforwards', window );">Tax losses and credits carried forward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 299,194,000<span></span>
</td>
<td class="nump">$ 299,194,000<span></span>
</td>
<td class="nump">$ 271,390,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_OperatingLossCarryforwardsSubjectToExpiration', window );">Net operating loss carryforwards, subject to expiration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136,454,000<span></span>
</td>
<td class="nump">136,454,000<span></span>
</td>
<td class="nump">132,373,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_OperatingLossCarryforwardsNotSubjectToExpiration', window );">Net operating loss carryforwards, not subject to expiration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,593,000<span></span>
</td>
<td class="nump">127,593,000<span></span>
</td>
<td class="nump">98,462,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred tax assets valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,276,000<span></span>
</td>
<td class="nump">113,276,000<span></span>
</td>
<td class="nump">108,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignEarningsRepatriated', window );">Foreign earnings repatriated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Accrued interest and penalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and local</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_OperatingLossAndTaxCreditCarryforwards', window );">Tax losses and credits carried forward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,203,000<span></span>
</td>
<td class="nump">22,203,000<span></span>
</td>
<td class="nump">18,104,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_OperatingLossAndTaxCreditCarryforwards', window );">Tax losses and credits carried forward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,589,000<span></span>
</td>
<td class="nump">4,589,000<span></span>
</td>
<td class="nump">2,510,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember', window );">United States | Domestic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_OperatingLossAndTaxCreditCarryforwards', window );">Tax losses and credits carried forward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">239,559,000<span></span>
</td>
<td class="nump">239,559,000<span></span>
</td>
<td class="nump">196,442,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=amci_InlandRevenueNewZealandMember', window );">New Zealand | Domestic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_OperatingLossAndTaxCreditCarryforwards', window );">Tax losses and credits carried forward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,116,000<span></span>
</td>
<td class="nump">35,116,000<span></span>
</td>
<td class="nump">54,334,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember', window );">R&amp;D tax credits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,147,000<span></span>
</td>
<td class="nump">$ 35,147,000<span></span>
</td>
<td class="nump">$ 40,556,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_IncomeTaxesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Taxes [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_IncomeTaxesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_OperatingLossAndTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Loss And Tax Credit Carryforwards</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_OperatingLossAndTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_OperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards, Not Subject To Expiration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_OperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_OperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards, Subject To Expiration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_OperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignEarningsRepatriated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign earnings repatriated from subsidiaries outside the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignEarningsRepatriated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=amci_InlandRevenueNewZealandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=amci_InlandRevenueNewZealandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>226
<FILENAME>R207.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272206170928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Nov. 30, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>scheme </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_NumberOfShareBasedStockSchemes', window );">Number of share based stock schemes | scheme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Shares granted in period (in shares) | shares</a></td>
<td class="nump">151,068<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,067,000<span></span>
</td>
<td class="nump">$ 1,790,000<span></span>
</td>
<td class="nump">$ 2,531,000<span></span>
</td>
<td class="nump">$ 2,392,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,835,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value of options granted (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.29<span></span>
</td>
<td class="nump">$ 3.99<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized cost, recognition period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 3 months 7 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">RSAs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Award requisite service period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized cost, recognition period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested shares outstanding (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">579,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">580,000<span></span>
</td>
<td class="nump">325,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested shares weighted average fair value (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.72<span></span>
</td>
<td class="nump">$ 4.68<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Award requisite service period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Award requisite service period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_NumberOfShareBasedStockSchemes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Share Based Stock Schemes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_NumberOfShareBasedStockSchemes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>227
<FILENAME>R208.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211872304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Stock Option Award Activity (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares under option (thousands)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">3,848<span></span>
</td>
<td class="nump">4,283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancelled/forfeited (in shares)</a></td>
<td class="num">(38)<span></span>
</td>
<td class="num">(721)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired (in shares)</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(334)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">3,806<span></span>
</td>
<td class="nump">3,848<span></span>
</td>
<td class="nump">4,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest (in shares)</a></td>
<td class="nump">3,806<span></span>
</td>
<td class="nump">3,848<span></span>
</td>
<td class="nump">4,283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Exercisable (in shares)</a></td>
<td class="nump">2,918<span></span>
</td>
<td class="nump">2,479<span></span>
</td>
<td class="nump">2,915<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted average exercise price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance (usd per share)</a></td>
<td class="nump">$ 6.55<span></span>
</td>
<td class="nump">$ 5.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (usd per share)</a></td>
<td class="nump">6.75<span></span>
</td>
<td class="nump">9.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Cancelled/forfeited (usd per share)</a></td>
<td class="nump">9.55<span></span>
</td>
<td class="nump">2.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Expired (usd per share)</a></td>
<td class="nump">6.61<span></span>
</td>
<td class="nump">2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance (usd per share)</a></td>
<td class="nump">6.52<span></span>
</td>
<td class="nump">6.55<span></span>
</td>
<td class="nump">$ 5.12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Vested and expecting to vest (usd per share)</a></td>
<td class="nump">6.52<span></span>
</td>
<td class="nump">6.55<span></span>
</td>
<td class="nump">5.12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable (usd per share)</a></td>
<td class="nump">$ 6.30<span></span>
</td>
<td class="nump">$ 6.31<span></span>
</td>
<td class="nump">$ 5.02<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding, Weighted average remaining contractual term</a></td>
<td class="text">5 years 4 months 20 days<span></span>
</td>
<td class="text">6 years 1 month 28 days<span></span>
</td>
<td class="text">5 years 1 month 2 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Vested and expecting, Weighted average remaining contractual term</a></td>
<td class="text">5 years 4 months 20 days<span></span>
</td>
<td class="text">6 years 1 month 28 days<span></span>
</td>
<td class="text">5 years 1 month 2 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable, Weighted average remaining contractual term</a></td>
<td class="text">4 years 6 months 21 days<span></span>
</td>
<td class="text">4 years 10 months 6 days<span></span>
</td>
<td class="text">3 years 5 months 19 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding, Aggregate intrinsic value</a></td>
<td class="nump">$ 42,032<span></span>
</td>
<td class="nump">$ 27,796<span></span>
</td>
<td class="nump">$ 2,582<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Vested and expecting to vest, Aggregate intrinsic value</a></td>
<td class="nump">42,032<span></span>
</td>
<td class="nump">27,796<span></span>
</td>
<td class="nump">2,582<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Exercisable, Aggregate intrinsic value</a></td>
<td class="nump">32,874<span></span>
</td>
<td class="nump">18,499<span></span>
</td>
<td class="nump">$ 2,582<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Exercised, Aggregate intrinsic value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue', window );">Cancelled/forfeited, Aggregate intrinsic value</a></td>
<td class="nump">188<span></span>
</td>
<td class="nump">1,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue', window );">Expired, Aggregate intrinsic value</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations, Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures, Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>228
<FILENAME>R209.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272208398896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Fair Value Assumptions (Details) - Options - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Stock price (usd per share)</a></td>
<td class="nump">$ 9.33<span></span>
</td>
<td class="nump">$ 4.68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price (usd per share)</a></td>
<td class="nump">$ 9.33<span></span>
</td>
<td class="nump">$ 4.68<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="text">6 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">98.00%<span></span>
</td>
<td class="nump">100.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.09%<span></span>
</td>
<td class="nump">0.56%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>229
<FILENAME>R210.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272204341200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Restricted Stock Awards Activity (Details) - RSAs<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Nonvested Shares (thousands)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance (in shares) | shares</a></td>
<td class="nump">325<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">281<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(26)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance (in shares) | shares</a></td>
<td class="nump">580<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance, weighted average fair value (usd per share) | $ / shares</a></td>
<td class="nump">$ 4.68<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted, weighted average fair value (usd per share) | $ / shares</a></td>
<td class="nump">4.76<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited, weighted average fair value (usd per share) | $ / shares</a></td>
<td class="nump">4.68<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance, weighted average fair value (usd per share) | $ / shares</a></td>
<td class="nump">$ 4.72<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>230
<FILENAME>R211.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272195367984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="nump">$ 11,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,752<span></span>
</td>
<td class="nump">$ 23,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,071<span></span>
</td>
<td class="nump">3,257<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty', window );">Purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent', window );">Purchases and open accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue from related party transactions</a></td>
<td class="nump">2,116<span></span>
</td>
<td class="nump">$ 2,348<span></span>
</td>
<td class="nump">3,253<span></span>
</td>
<td class="nump">4,203<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartyTransitionServicesAgreementMember', window );">Related Party Transition Services Agreement | Equity Method Investee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue from related party transactions</a></td>
<td class="nump">148<span></span>
</td>
<td class="nump">355<span></span>
</td>
<td class="nump">495<span></span>
</td>
<td class="nump">285<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartyInvestmentAgreementMember', window );">Related Party Investment Agreement | Equity Method Investee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue from related party transactions</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">403<span></span>
</td>
<td class="nump">428<span></span>
</td>
<td class="nump">2,740<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartySupplyAgreementMember', window );">Related Party Supply Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Related party fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,223<span></span>
</td>
<td class="nump">242<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartySupplyAgreementMember', window );">Related Party Supply Agreement | Equity Method Investee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue from related party transactions</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">282<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Related party fees</a></td>
<td class="nump">$ 893<span></span>
</td>
<td class="nump">$ 1,171<span></span>
</td>
<td class="nump">$ 1,223<span></span>
</td>
<td class="nump">$ 242<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount for accounts payable to related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 310<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126942793&amp;loc=d3e3073-115593<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.1(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartyTransitionServicesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartyTransitionServicesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartyInvestmentAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartyInvestmentAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartySupplyAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=amci_RelatedPartySupplyAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>231
<FILENAME>R212.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211136336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Shareholders&#8217; Equity (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (usd per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>232
<FILENAME>R213.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272192808832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Redeemable, Convertible Preferred Stock - Authorized, Issued and Outstanding Shares, Issue Price, and Carrying Value (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares authorized (in shares)</a></td>
<td class="nump">29,747,033<span></span>
</td>
<td class="nump">29,747,033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,112,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares issued (in shares)</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,729,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares outstanding (in shares)</a></td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">25,729,542<span></span>
</td>
<td class="nump">23,695,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Carrying Amount</a></td>
<td class="nump">$ 480,631<span></span>
</td>
<td class="nump">$ 480,631<span></span>
</td>
<td class="nump">$ 480,631<span></span>
</td>
<td class="nump">$ 394,408<span></span>
</td>
<td class="nump">$ 347,938<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares authorized (in shares)</a></td>
<td class="nump">4,666,503<span></span>
</td>
<td class="nump">4,666,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,666,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares issued (in shares)</a></td>
<td class="nump">4,666,503<span></span>
</td>
<td class="nump">4,666,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,666,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares outstanding (in shares)</a></td>
<td class="nump">4,666,503<span></span>
</td>
<td class="nump">4,666,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,666,503<span></span>
</td>
<td class="nump">4,666,503<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Carrying Amount</a></td>
<td class="nump">$ 12,230<span></span>
</td>
<td class="nump">$ 12,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,230<span></span>
</td>
<td class="nump">$ 12,230<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityIssuePricePerShare', window );">Issue price (in dollars per share)</a></td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityIssuePricePerShare', window );">Issue price (in dollars per share)</a></td>
<td class="nump">$ 3.94<span></span>
</td>
<td class="nump">$ 3.94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares authorized (in shares)</a></td>
<td class="nump">1,733,370<span></span>
</td>
<td class="nump">1,733,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,733,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares issued (in shares)</a></td>
<td class="nump">1,733,370<span></span>
</td>
<td class="nump">1,733,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,733,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares outstanding (in shares)</a></td>
<td class="nump">1,733,370<span></span>
</td>
<td class="nump">1,733,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,733,370<span></span>
</td>
<td class="nump">1,733,370<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityIssuePricePerShare', window );">Issue price (in dollars per share)</a></td>
<td class="nump">$ 10.38<span></span>
</td>
<td class="nump">$ 10.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Carrying Amount</a></td>
<td class="nump">$ 18,000<span></span>
</td>
<td class="nump">$ 18,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,000<span></span>
</td>
<td class="nump">$ 18,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares authorized (in shares)</a></td>
<td class="nump">4,254,733<span></span>
</td>
<td class="nump">4,254,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,254,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares issued (in shares)</a></td>
<td class="nump">4,142,408<span></span>
</td>
<td class="nump">4,142,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,142,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares outstanding (in shares)</a></td>
<td class="nump">4,142,408<span></span>
</td>
<td class="nump">4,142,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,142,408<span></span>
</td>
<td class="nump">4,142,408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityIssuePricePerShare', window );">Issue price (in dollars per share)</a></td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Carrying Amount</a></td>
<td class="nump">$ 60,850<span></span>
</td>
<td class="nump">$ 60,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,850<span></span>
</td>
<td class="nump">$ 60,850<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember', window );">Series D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares authorized (in shares)</a></td>
<td class="nump">10,274,260<span></span>
</td>
<td class="nump">10,274,260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,274,260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares issued (in shares)</a></td>
<td class="nump">10,161,362<span></span>
</td>
<td class="nump">10,161,362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,003,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares outstanding (in shares)</a></td>
<td class="nump">10,161,362<span></span>
</td>
<td class="nump">10,161,362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,003,304<span></span>
</td>
<td class="nump">10,003,304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityIssuePricePerShare', window );">Issue price (in dollars per share)</a></td>
<td class="nump">$ 19.93<span></span>
</td>
<td class="nump">$ 19.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Carrying Amount</a></td>
<td class="nump">$ 188,402<span></span>
</td>
<td class="nump">$ 188,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 185,252<span></span>
</td>
<td class="nump">$ 185,252<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember', window );">Series E</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares authorized (in shares)</a></td>
<td class="nump">5,183,957<span></span>
</td>
<td class="nump">5,183,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,183,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares issued (in shares)</a></td>
<td class="nump">5,183,957<span></span>
</td>
<td class="nump">5,183,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,183,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares outstanding (in shares)</a></td>
<td class="nump">5,183,957<span></span>
</td>
<td class="nump">5,183,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,183,957<span></span>
</td>
<td class="nump">3,149,745<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityIssuePricePerShare', window );">Issue price (in dollars per share)</a></td>
<td class="nump">$ 22.86<span></span>
</td>
<td class="nump">$ 22.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Carrying Amount</a></td>
<td class="nump">$ 118,076<span></span>
</td>
<td class="nump">$ 118,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118,076<span></span>
</td>
<td class="nump">$ 71,606<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesFPreferredStockMember', window );">Series F</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares authorized (in shares)</a></td>
<td class="nump">3,634,210<span></span>
</td>
<td class="nump">3,634,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares issued (in shares)</a></td>
<td class="nump">3,634,210<span></span>
</td>
<td class="nump">3,634,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares outstanding (in shares)</a></td>
<td class="nump">3,634,210<span></span>
</td>
<td class="nump">3,634,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityIssuePricePerShare', window );">Issue price (in dollars per share)</a></td>
<td class="nump">$ 22.86<span></span>
</td>
<td class="nump">$ 22.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Carrying Amount</a></td>
<td class="nump">$ 83,073<span></span>
</td>
<td class="nump">$ 83,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TemporaryEquityIssuePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Issue Price Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TemporaryEquityIssuePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesFPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesFPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>233
<FILENAME>R214.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272196720240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable, Convertible Preferred Stock - Changes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Feb. 29, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance, Redeemable Convertible Preferred Stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,729,542<span></span>
</td>
<td class="nump">25,729,542<span></span>
</td>
<td class="nump">23,695,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance, temporary equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 394,408<span></span>
</td>
<td class="nump">$ 394,408<span></span>
</td>
<td class="nump">$ 347,938<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of preferred stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,634,210<span></span>
</td>
<td class="nump">3,792,268<span></span>
</td>
<td class="nump">2,034,212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83,073<span></span>
</td>
<td class="nump">$ 86,223<span></span>
</td>
<td class="nump">$ 46,470<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, Redeemable Convertible Preferred Stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">29,521,810<span></span>
</td>
<td class="nump">25,729,542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance, temporary equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 480,631<span></span>
</td>
<td class="nump">$ 480,631<span></span>
</td>
<td class="nump">$ 394,408<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance, Redeemable Convertible Preferred Stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,666,503<span></span>
</td>
<td class="nump">4,666,503<span></span>
</td>
<td class="nump">4,666,503<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance, temporary equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,230<span></span>
</td>
<td class="nump">$ 12,230<span></span>
</td>
<td class="nump">$ 12,230<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of preferred stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, Redeemable Convertible Preferred Stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,666,503<span></span>
</td>
<td class="nump">4,666,503<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance, temporary equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,230<span></span>
</td>
<td class="nump">$ 12,230<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance, Redeemable Convertible Preferred Stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,733,370<span></span>
</td>
<td class="nump">1,733,370<span></span>
</td>
<td class="nump">1,733,370<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance, temporary equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,000<span></span>
</td>
<td class="nump">$ 18,000<span></span>
</td>
<td class="nump">$ 18,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of preferred stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, Redeemable Convertible Preferred Stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,733,370<span></span>
</td>
<td class="nump">1,733,370<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance, temporary equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,000<span></span>
</td>
<td class="nump">$ 18,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance, Redeemable Convertible Preferred Stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,142,408<span></span>
</td>
<td class="nump">4,142,408<span></span>
</td>
<td class="nump">4,142,408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance, temporary equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,850<span></span>
</td>
<td class="nump">$ 60,850<span></span>
</td>
<td class="nump">$ 60,850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of preferred stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, Redeemable Convertible Preferred Stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,142,408<span></span>
</td>
<td class="nump">4,142,408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance, temporary equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,850<span></span>
</td>
<td class="nump">$ 60,850<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember', window );">Series D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance, Redeemable Convertible Preferred Stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,003,304<span></span>
</td>
<td class="nump">10,003,304<span></span>
</td>
<td class="nump">10,003,304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance, temporary equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 185,252<span></span>
</td>
<td class="nump">$ 185,252<span></span>
</td>
<td class="nump">$ 185,252<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of preferred stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158,058<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,150<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, Redeemable Convertible Preferred Stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,161,362<span></span>
</td>
<td class="nump">10,003,304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance, temporary equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 188,402<span></span>
</td>
<td class="nump">$ 185,252<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember', window );">Series E</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance, Redeemable Convertible Preferred Stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,183,957<span></span>
</td>
<td class="nump">5,183,957<span></span>
</td>
<td class="nump">3,149,745<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance, temporary equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118,076<span></span>
</td>
<td class="nump">$ 118,076<span></span>
</td>
<td class="nump">$ 71,606<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of preferred stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,034,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,034,212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 46,470<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, Redeemable Convertible Preferred Stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,183,957<span></span>
</td>
<td class="nump">5,183,957<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance, temporary equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118,076<span></span>
</td>
<td class="nump">$ 118,076<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesFPreferredStockMember', window );">Series F</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance, Redeemable Convertible Preferred Stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance, temporary equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of preferred stock (in shares)</a></td>
<td class="nump">3,634,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,634,210<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of preferred stock</a></td>
<td class="nump">$ 83,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83,073<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, Redeemable Convertible Preferred Stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,634,210<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance, temporary equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83,073<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issued During Period, Shares, New Issues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of new stock classified as temporary equity issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesFPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesFPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>234
<FILENAME>R215.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272196379504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable, Convertible Preferred Stock - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Feb. 29, 2020</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of preferred stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,634,210<span></span>
</td>
<td class="nump">3,792,268<span></span>
</td>
<td class="nump">2,034,212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83,073<span></span>
</td>
<td class="nump">$ 86,223<span></span>
</td>
<td class="nump">$ 46,470<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquitySharesConversionOfConvertibleSecurities', window );">Exercise of warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Dividend rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember', window );">Series E</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of preferred stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,034,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,034,212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 46,470<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityStockIssuedDuringPeriodPricePerShare', window );">Issuance of preferred stock (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember', window );">Series D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of preferred stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158,058<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,150<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityStockIssuedDuringPeriodPricePerShare', window );">Issuance of preferred stock (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquitySharesConversionOfConvertibleSecurities', window );">Exercise of warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesFPreferredStockMember', window );">Series F</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of preferred stock (in shares)</a></td>
<td class="nump">3,634,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,634,210<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of preferred stock</a></td>
<td class="nump">$ 83,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83,073<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_TemporaryEquityStockIssuedDuringPeriodPricePerShare', window );">Issuance of preferred stock (in dollars per share)</a></td>
<td class="nump">$ 22.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TemporaryEquitySharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Shares, Conversion of Convertible Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TemporaryEquitySharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TemporaryEquityStockIssuedDuringPeriodPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issued During Period, Price Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TemporaryEquityStockIssuedDuringPeriodPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issued During Period, Shares, New Issues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage rate used to calculate dividend payments on preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of new stock classified as temporary equity issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesFPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesFPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>235
<FILENAME>R216.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272211080288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsAbstract', window );"><strong>Postemployment Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Contributions to plan</a></td>
<td class="nump">$ 720<span></span>
</td>
<td class="nump">$ 548<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>236
<FILENAME>R217.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272207424112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>May 31, 2020 </div>
<div>renewal_option</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease, cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,126<span></span>
</td>
<td class="nump">$ 2,077<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease, cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,575<span></span>
</td>
<td class="nump">1,813<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Lease cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,059<span></span>
</td>
<td class="nump">1,765<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeaseTermOfContract', window );">Term of contract</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amci_LesssorOperatingLeaseNumberOfRenewalOptions', window );">Number of renewal options | renewal_option</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeaseRenewalTerm', window );">Renewal term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncome', window );">Lease income from operating leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amci_LesssorOperatingLeaseNumberOfRenewalOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lesssor, Operating Lease, Number Of Renewal Options</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amci_LesssorOperatingLeaseNumberOfRenewalOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amci_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessor's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919359-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919359-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123420820&amp;loc=SL77919311-209978<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI https://asc.fasb.org/extlink&amp;oid=126900988&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>237
<FILENAME>R218.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272208349456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Lease Maturities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 2,366<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">2,413<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">1,039<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">5,818<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Imputed interest</a></td>
<td class="nump">485<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 5,333<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>238
<FILENAME>R219.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272209966512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Lessor, Operating Lease, Payments to be Received (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears', window );">2023</a></td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears', window );">2024</a></td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears', window );">2025</a></td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears', window );">2026</a></td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter', window );">Thereafter</a></td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived', window );">Total lease payments</a></td>
<td class="nump">$ 288<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payments to be received by lessor for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>239
<FILENAME>R220.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272208527952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Supplemental Information (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (years)</a></td>
<td class="text">2 years 4 months 24 days<span></span>
</td>
<td class="text">3 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">7.50%<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>240
<FILENAME>R221.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140272210205024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details)<br> $ in Billions</strong></div></th>
<th class="th">
<div>Mar. 08, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationAssetCurrent', window );">Aggregate consideration</a></td>
<td class="nump">$ 1.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationAssetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized arising from contingent consideration in a business combination, expected to be realized within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6411-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationAssetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>241
<FILENAME>amci-20230213_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:amci="http://amciacquisitioncorp/20230213"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="amci-20230213.xsd" xlink:type="simple"/>
    <context id="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="idae72aba29fc40268c267b6f3b0eff28_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if090e35b3ace4abc92ca72a48339ebd7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amci:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i39b3f93aa3714933b05800e10c00a387_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amci:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2a9d6acf0a3443b8a9bfd210dcef6a0e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amci:CommonClassaNotSubjectToRedemptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib763267d74d64b8fbe45ac357a9f8f08_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amci:CommonClassaNotSubjectToRedemptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i28b4565471d542708454f455b422d119_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id57512e5cedd4b74bc2f1786d35220d2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i456af52614a84b9987f0558f3c9d3476_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1a8ff7f453974014b00746e89fa737d3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i80972ef154634fbfa900d162f556ef03_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7ec1172d9fda413997c83cfd78da69a8_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia6e8e0bf44ba47628681fa0a2b0c4d8e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i54e04e92a2f745c79145378982854e9d_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia80b8151be5a4bbda59a9bd0f4d2f0d4_D20210128-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5c83b432fed543cdbb0ae452750d8666_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib0792dc9052f4435aec8f1746381b495_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie106d118b90b4570a0b940a2a0611875_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i14e0883a4b7e4c05850198fa191fd751_D20210128-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i561b8e9c306343cbaa06d16947928777_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0df54c9e466f4cee877df6ba1a2a8b5c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8d10e6b77d0f437bb89153397dd47b71_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i331e64d7b36f44f3a66c631e0f8eeddb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iccfd9da1f9504cf29912dc80db305fc8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib7947124f41844b0939436b1a8f133ad_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0d0aee75172442178da88056a9989307_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ida7b05626e374502819328077c492d48_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie90832410d85447aa964ca438ac09c5f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6c3171eddba54a6b8c58c3219dea0549_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0c13bbdaf19b4cd897fbbb738aa40bdb_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iaf261b46a23c49b4a762205835c271ab_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i85ee8ec1448f491faaa8d5f1b8a40824_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i34104a0f3a774be48e18d60b95cb9e34_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie631ef4e3c7041e688921b3859fca7f5_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5d521767d60745fd9681006b5cd0f52f_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0bb75187403d4c7096a2ecce94a1cfe2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic24c8091c8be4348b39159f1dd9591dc_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i54638a76c0754184ad34989edb55bad0_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="idc67725111024800a8fe8de4f7e18d06_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic0513771cd0245b88eec6099822e8d74_I20210127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-27</instant>
        </period>
    </context>
    <context id="i763e0a3dbecb4e3795d7f408cf8a20d5_I20210127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-27</instant>
        </period>
    </context>
    <context id="iec832394a7514357811e3f793e5b673f_I20210127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-27</instant>
        </period>
    </context>
    <context id="ifc4dbb45fe26489b9bca7b77497e7ca7_I20210127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-27</instant>
        </period>
    </context>
    <context id="ib90981c31c9b45a98ded9929aeaa406e_I20210127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-27</instant>
        </period>
    </context>
    <context id="iacb1cd84cde241edbd72d0fcbd87e137_D20210128-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i68b075b25b0c44f6a65dc37835ddacab_D20210128-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i60a5cae9cdab4813bb1586b3eb4d1453_D20210128-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic78d5d5e9dab4e66927c72ef3a01cffb_D20210128-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia238c2a996b14c81929dd59e484951e5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5f0fcd477eed4404a2b0dc7ab62aec98_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i79b3bc37e87346618fe34e2a23526ca7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i44e48778017342f3ab0160bb5770cda2_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i97e926931d264729ab7aaa14e1843a88_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie687fdc1ee234a2686233327949a762b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8155dd44f1cf44b6963742cb3e993f91_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic3756d2ccfa146a8b4a56cd8bc84e1d6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib1634b21bc004766bd5719101e1d1b9a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3cd57aeb02fe49d7ab3297670b39a5ec_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if5e9fb5e65ac48fcaf2c511cdde6838a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5bd791fd96c546dbb9c9ea8bb1d75555_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i872f016ca939404ab1d0fbc4771bc03a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7bef5324e72a48db9ebecc0f92eacda1_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3ef0abc6bb5e4c13a1e3275c01c2d9be_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i54a9911fbd55474198f366931f8bbeda_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6c5914aab6b6409fa89292f8b33f2d63_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1cfc7a3d369645768bf19279957b83f3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if96f4a11922442b08faec4138ba298eb_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i89b183b3eb6542b0870815f5da77659b_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibc418deb7a554f8e82e462f5270ec4fe_D20210917-20210917">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-17</startDate>
            <endDate>2021-09-17</endDate>
        </period>
    </context>
    <context id="i6689ad9df05044c9b7cca157156ac7d3_I20220514">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-14</instant>
        </period>
    </context>
    <context id="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-06</startDate>
            <endDate>2021-08-06</endDate>
        </period>
    </context>
    <context id="ie730d94e9acc40f48d227ce51539c50b_I20210806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-06</instant>
        </period>
    </context>
    <context id="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-06</instant>
        </period>
    </context>
    <context id="iba67ebbc3e2147e2a5a1f7dbbeab0ccd_I20210806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-06</instant>
        </period>
    </context>
    <context id="i98ebad46078d44259754e031d9c5bd6d_D20210806-20210806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-06</startDate>
            <endDate>2021-08-06</endDate>
        </period>
    </context>
    <context id="i60c2802479f2421e81d073c740ec38f5_D20210806-20210806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
        </entity>
        <period>
            <startDate>2021-08-06</startDate>
            <endDate>2021-08-06</endDate>
        </period>
    </context>
    <context id="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i43e0774f1b034661961530c2cf95f99f_D20220308-20220308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amci:LanzatechGlobalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-08</startDate>
            <endDate>2022-03-08</endDate>
        </period>
    </context>
    <context id="i0f2a2868033e4660a17c0f7ba45d4aad_I20220308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amci:LanzatechGlobalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-08</instant>
        </period>
    </context>
    <context id="ib38307702eee44f3b72af83f31e3cf7d_I20220308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amci:LanzatechGlobalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-08</instant>
        </period>
    </context>
    <context id="i8883929afdf94d6986448173f1858e61_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibf1a938c139d435097214ed3b23c295f_I20210806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-06</instant>
        </period>
    </context>
    <context id="i6cdb37bb224f48e29779bad54f3033b8_D20220328-20220328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-28</startDate>
            <endDate>2022-03-28</endDate>
        </period>
    </context>
    <context id="i67af9d98434f4635b3c35ea4fd55d5c2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:WorkingCapitalLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5afd526069b8462e9de75a0d249417cf_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:WorkingCapitalLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i450b257d15c4448cabb4fa176b9c5882_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4b4c8d7ac58e4e2586992b9fe74034be_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amci:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i759728e90602443f941d8e14893c6860_D20210128-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i950a5ff168a044a0ba3702bafec5a66a_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4878d88c1b144a42922da4d1a6220176_D20210201-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id018cdbc6e7243f8a9576d62630018fd_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i70621bbf47964eb1927c544e539a3b0c_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id42184778b03400da7d8ae8bccfeca9b_D20210128-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="ia10b0438b73b4dd5bf7658eb1d2482c7_D20210201-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8294868a1493467a83fbece546a36f63_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i99c308a1e70a4da386ff5a6632f478d0_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i42d79bd723cf48078269f4e2acf3b597_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic7e0d5966ac7479ebfa164e10daa1272_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie7d75b9f8f1c40e39fde71392a72ee04_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i40a66b571894495b9172904623c3020a_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i17dcd8e30cd643c885ad894b1240e01c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie8be3aafc5054f04afe2e590fba42def_D20210128-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5fb60d41143f4f3d991562590f0fe6af_D20210128-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id44a938156574d23a69f5f980c896774_I20210806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-06</instant>
        </period>
    </context>
    <context id="i9caa935ece004b9ab6c6caa6377836b9_D20210803-20210803">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-03</startDate>
            <endDate>2021-08-03</endDate>
        </period>
    </context>
    <context id="i0d95a7ae67054cae98cfee5d7bdc74d0_D20210917-20210917">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-17</startDate>
            <endDate>2021-09-17</endDate>
        </period>
    </context>
    <context id="i1d5d9aae93c24a62a9caf5acab5abecc_D20210129-20210129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-29</startDate>
            <endDate>2021-01-29</endDate>
        </period>
    </context>
    <context id="if2ebc1a8b07f4d3391509c2584f8f003_I20210129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-29</instant>
        </period>
    </context>
    <context id="i08b6b03fda3a43f2bcbde1101ee39ff8_D20210129-20210129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-29</startDate>
            <endDate>2021-01-29</endDate>
        </period>
    </context>
    <context id="i74ee1ef3f5f34200a3a86559aefbe48d_I20210129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-29</instant>
        </period>
    </context>
    <context id="i8ba6d4f2129048179fa2e9c2275582f2_I20210514">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-14</instant>
        </period>
    </context>
    <context id="iea24dbc94fdc4dc58f170b69b6c3e2de_D20210514-20210514">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-14</startDate>
            <endDate>2021-05-14</endDate>
        </period>
    </context>
    <context id="ife30827df02148faa72d404a20bb4270_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0e2866880e0e48c8bbbc428a81262e75_I20210917">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-17</instant>
        </period>
    </context>
    <context id="ib652946365cc4c8c967e8a2df8bcdc17_D20210129-20210129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:AnchorInvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-29</startDate>
            <endDate>2021-01-29</endDate>
        </period>
    </context>
    <context id="i2674980052ce4cc69be120b4e40c0013_I20210129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:AnchorInvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-29</instant>
        </period>
    </context>
    <context id="i7f5a155717274afab3d521dfbf34a269_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i75f3392af70e4d85aac3d65a530d4294_I20210129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-29</instant>
        </period>
    </context>
    <context id="ic4acc15b7c694e09ba13c24b2db16e14_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:WorkingCapitalLoansWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i90361d85f46242c1b15c6d1084c691cc_D20220328-20220328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:WorkingCapitalLoansWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-28</startDate>
            <endDate>2022-03-28</endDate>
        </period>
    </context>
    <context id="i86b1870170ac4b14af116725cbaa1dfb_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic4fffab42a2f49dd80ac77b6fa45c8a1_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3924e9e376c84b7a875190639f24cc1f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ida667f998b1d43e1b6a919463e190674_D20210128-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i52caac5a377e45b8b201f83962c02a8e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ifcd72b5b1194408cba4cb6838372ac02_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8d2f9128cbf246cd945ae4ac218c0a51_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i383980889531482c9add5e621b85e027_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2d8e8fd5c9a54f1994bb8cd3e7be4dfb_I20210917">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-17</instant>
        </period>
    </context>
    <context id="iff3bcef644df441dabded615618c965f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:EvercoreGroupL.l.c.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i65896feef8e64216b26c18f33b966b64_D20220929-20220929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">amci:CoplacementAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:EvercoreGroupL.l.c.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-29</startDate>
            <endDate>2022-09-29</endDate>
        </period>
    </context>
    <context id="ib81de9f71a844a21bb8c1a0d4ae5b6ab_D20220929-20220929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">amci:FinancialAdvisoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:EvercoreGroupL.l.c.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-29</startDate>
            <endDate>2022-09-29</endDate>
        </period>
    </context>
    <context id="if178c64ffcb14c83b95a35515433f700_D20220929-20220929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">amci:DeferredUnderwritingFeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:EvercoreGroupL.l.c.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-29</startDate>
            <endDate>2022-09-29</endDate>
        </period>
    </context>
    <context id="ie50e9e7d91b842cf814d5cfc02ae90f3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i525804f64fa24dab94c10a95e9c90289_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amci:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0a43243fe73e4e0982e02d8804f9029b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amci:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5c002aa5301d41eea4dcb66a8e84489d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amci:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i55de68debcc94bafbd57bd3a38c3cfbd_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amci:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i246d06060759490897b705c5ed7fc8f0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i291fade0df2b465aa82cd6d5ea3294af_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie9b91be3831b484da13cf601329f6dbe_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i451ff43e2c50495caaa75e2af24f295d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i98b54305564e42f9abfa073cb3e4947b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i850b9630ce17489eb80c21a6da12ee2f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9c30db48f9bb482b9cb45b5c2227dd57_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1836ec53dd484e9b9bf84ece3ddced78_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie30c1da2c5304363b3b61cf5bb114865_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="amci:WarrantConditionAxis">amci:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia5a60bdcc4a4477db94a694066392510_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="amci:WarrantConditionAxis">amci:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if2e834c4b7e54fd3806cd19f77045daa_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ifa1f55ccc0e14b588cf21c809f2ea5b3_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if81ad5ca3f944114a295b408d90c868d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="icc3169776a3543fb889330eb5abfe41d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i417fef00be594681ab5912d70872db7e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i946a08fcd3a04e65862611981f20e270_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i818e11a86037425d8b4e148caf3f101c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if33c5b343220431f8fa1664c765aaf71_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9894e2c3dc734f0b880e510f21ccd046_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia5b0bb5d02764693b9a25febf0a6032b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2be463ef022149f1913c72172ac44e78_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9712786e3d6e4293bfa543a7f4306d3d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i179691d9e1bf479b916db187d97d10bc_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i10a81d94cb444487a1305e090e7ac9f0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibda8175b82524bcc9e6f7f7496388515_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0b029e7f84ba49809517714b945d453d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib01d619804214c1ba4cf7f01250d2ac3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0b3852e6684e45c08ebac5f6a1cb253d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaa37f22ae2644299a4ab468acaa968cd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1f13d0d3a95c4cdaa0dc91deeb0264b3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i402c8e15d0b54a389ec05f6fe78c92c5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3ff6463cfe5f4c1b946bb36d0cac2871_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if29e2998f81b49e2b4637ccd72f330be_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibfba6a12780447a3b8b33ecd046d9a4b_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if64ccb69704247c689ad8abffde913e9_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i974a103ab76f4dfebf71b623a294979d_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if1bafc618d6f473f9a793bbc10bcd6dc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i902dff4aa68147929f6d78320ff652e0_D20221018-20221018">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">amci:October2022SubscriptionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-18</startDate>
            <endDate>2022-10-18</endDate>
        </period>
    </context>
    <context id="i697f9a8b07d74a73b684f9ec2bc17566_I20221018">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">amci:October2022SubscriptionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-18</instant>
        </period>
    </context>
    <context id="i64c9dd51c7c74824810ac9d20592fd6b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amci:CommonClassaNotSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5052ad254932443fa86d172a353e56b2_D20210128-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib213ebc10b6a466a909031c9bd976e11_D20210128-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icfc521f27ebb491f8864b3a6e6a87d0b_D20210128-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i471e72d2c86b4efaaf8080c12ecaa577_D20210128-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifd535064e945451eb2cc6d863ed461a9_D20210128-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id0abd6277c4d4571a894945f36707ca5_D20210128-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia93b17d361a84b54b833904249951429_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib178386587034322a4ea05a95f29a04c_D20210128-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i717f3c096f124e38aff5fad8440a91a2_D20210128-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iaa0df75fa4824897be8997ed124b9bdc_D20210128-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibfb1e8d076954c04a1dbf3023d0849d7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia65ba84b6b954a5385d3241cfcb6736d_I20210917">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-17</instant>
        </period>
    </context>
    <context id="ie7e91bd1f75d4961a01179e9753dc8da_D20210128-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">amci:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic448f6ee37eb44f9ac584c6527e1d94e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:WorkingCapitalLoansWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie077d272226547f6a11f29862ca333d6_D20210128-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5c60188ae1f64a00af376413ca3e4b68_D20210128-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iefc421e312514841a1adc71514c3bb9a_D20210128-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i77e83a23de6644e3be03c1d9c1e36370_D20210128-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3cb1ba206598437fb974dd69c2b87e0f_D20210128-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="amci:WarrantConditionAxis">amci:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if77b5c86cfcc4c03a7007e9a9266feb2_D20210128-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="amci:WarrantConditionAxis">amci:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i182c81dada5746a896432e0206ca7183_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i87ed9aa6359e4e9da28c6fd65b021373_D20210128-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i11685a5fe8fb4e7580ffa0ca743f0062_I20210806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-06</instant>
        </period>
    </context>
    <context id="i64bb7db0f547412db51fb298ab7f1eb1_I20210806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-06</instant>
        </period>
    </context>
    <context id="ib14d34f779324c98acee7371373d9927_I20210806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-06</instant>
        </period>
    </context>
    <context id="ie04573b29e10454392fcd1c7a4d28cb2_I20210806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-06</instant>
        </period>
    </context>
    <context id="i531831f23f064c698db5bd956d8f7662_I20210806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-06</instant>
        </period>
    </context>
    <context id="i832a10c8d035443c86f96cddb14c1741_D20210128-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1031eb2976d644cfbbf5cce499b8af89_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:AMCIACQUISITIONCORPIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia6a395c8f57c4345b9c5c1927223b563_I20220308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amci:LanzatechGlobalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-08</instant>
        </period>
    </context>
    <context id="i1b9add4019654e2d87f0e463effed72f_I20220308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amci:LanzatechGlobalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-08</instant>
        </period>
    </context>
    <context id="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6fa285a120cf4338a950b439d1496dd7_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ieb733d9b6c67432ab5a278cc8f9ae7e7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic032ce31175f4c45b33f9642339eab9b_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="amci:RelatedAndNonrelatedPartyStatusAxis">amci:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6752cd0319b04183b8e6481ee3e75964_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="amci:RelatedAndNonrelatedPartyStatusAxis">amci:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia996051c39e14c1c956460fb2675ae34_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i34364739f4c64be69f7a57e53ecbd751_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i78e21c830827492786035892daf32e0d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i20c42717ddd94c808b501ab8475516e6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib0898c763893444f8318ba806e5872af_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib6fb523d0475453fbb376be661a6c994_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic1f4bcf8b20140f296bf2a34009e0064_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i98880ce312ba4017b552dd89dc664bb1_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic0a0ddb6c93245558effec1f57e566ba_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i13b3497fdd1e496ba1fa077592599faf_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i38e737447613466db8a474885460ec95_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i758897248ac340d7bb20c3abbe6a9817_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id15fe476907046a7b6b9b51738bf5917_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia4e845950e88489fa5590b0035aa2dea_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i4d49e0cbdb6445f7b88d97d435a55770_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7c18fa0bbec84bdcb7e52c35f80ede0a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i18eedd573381425c8c989e260801dafe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7e70eaff18414dc4b12fb6d52ddce0d0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i86b1d28db14d4ccea94e00a84975ab9a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6dfcd7c6d97d4ad18dc9629f6bf4066c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9a0614f9ac2b45cca8e106cb399680b8_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i55f893214d234b679544f44bd054f770_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib72b5d999a244a2ca01c9b4f197493e7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie7959fab1f2c4a659a441b16211f26c0_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4980eb4213814e27a8b8df2fb28468ac_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i63802ab78f814062927f14d9e2bb6b67_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i76d10658df3b4e6bad3f7a990812f829_D20220308-20220308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
        </entity>
        <period>
            <startDate>2022-03-08</startDate>
            <endDate>2022-03-08</endDate>
        </period>
    </context>
    <context id="i3e4ce82bb6ca465b8f60e74f553154c0_I20220308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
        </entity>
        <period>
            <instant>2022-03-08</instant>
        </period>
    </context>
    <context id="ia00417eab54343e78db23ff7c39f19cc_I20221207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-07</instant>
        </period>
    </context>
    <context id="i9e0585e1e90d4bfcaf7ee5c271d12b05_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1c9ab1e0b29947a7a657a947fe20cbe7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9d1fe9a7bf25419cb084a70d94fcaf1d_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie2e8db82a9c84e61945251a17b875f00_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia3449ace90ec469a8b933bce0d62a372_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i315f432e066e42e392096344bb252b66_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i67acca9fc71147e489123a8f993fe8b2_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i12519dc7dd4148c380c0b8e7e6b17007_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i47d9518ef3cd492aa38b19f292383c71_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i65b51113d1c84fe482ce3387414ff062_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5d26440e551243a091345a8db5c10bd8_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i89150b1561bc43ecbec2f1adb044c3f0_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia54c798db359416fb9d69e6545adde53_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9f5fbd11e5eb48dba2314084aadf7c9f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5424171a95fe47638686ad26cd8b4504_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i26fc510abd7a4c3b8c924af0c3ded993_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7ae7957cd9f6426986d2a7924166bbe8_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5741c6b90ae94985b512b131a7c7a8f1_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0abb7a85949a40588f25eea015f597df_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2ce64b99bdea417c846661dbfe732b7e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iafde522813d645e4811e7040d7545b79_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia9418ed0ad4f411e9f9d5e0c27663f80_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i762c119593394e9dab80370e5fe11b8f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:JointDevelopmentAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9c521e9c446743728abb9bb381113c58_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:JointDevelopmentAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7cfe038e19c5406ab72b862c3e2c4a7c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:OtherContractResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib55995d927ac49f2b032b95862ccebc3_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:OtherContractResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifffd25e8f7474755a9cbbfa56a92b938_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:ResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if1cd36f9560344a4a3455d63ec431e88_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:ResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i44a9fd092f5b4aaaa519e060a4d1a0bb_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic2ce93d60685463eacfcc8cdabd7567c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9a377b78b6e24777830917170e5b1313_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:CarbonSmartMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8409be642f8c496ca120218eb6fbf890_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:CarbonSmartMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icdff94687942421eaaf5757d75c7f1c2_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:EngineeringAndOtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2013e6baeeb243468ee04296b2f2e7b8_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:EngineeringAndOtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia1a1013d2add4d6090c80d57a0f917aa_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:CarbonCaptureAndTransformationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i266d893e21e44dd69a6f838fef0c5262_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:CarbonCaptureAndTransformationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia5573ff2e43a4c498f3126b9f6dfd70f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8145859fe60a449a937d2ca309df194f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7b913fb20765432a923bd689fe670302_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibdb81a8598ac482d9b8beedc98026777_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i782abe270873419eb029c509a796cfe0_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if05bbbf98c144ad8aa72922f1d64e7e2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i48ba258d15f74288bf5398c05269bbf6_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0e768c2b952146e1955ab2593a5abd0b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i285bf14114324cc3b2c392b9b984d16e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:LanzaJetIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie926aa19bc694f0586f296dab820baf8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3508735d501341a2badcc0f6a6be0770_D20200513-20200513">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:LanzaJetIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-13</startDate>
            <endDate>2020-05-13</endDate>
        </period>
    </context>
    <context id="iabbdb50d80c247b39bf74f30bb6e2aa1_I20200513">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:LanzaJetIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-13</instant>
        </period>
    </context>
    <context id="ibfcdf3126a1c413992b29dabc55a78ee_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:LanzaJetIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib6b123fcece94433b4a72c6716d59ddf_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:LanzaJetIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifaeb71870a2f4f65bef7abad49932d71_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:LanzaJetIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic197136819df4f3d91e14be688674014_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:LanzaJetIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id7c2c8dee6434965a0e89d9311bf370e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:LanzaJetIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i65fec460822f43acb02e40736b3b8a79_D20210201-20210404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-04-04</endDate>
        </period>
    </context>
    <context id="i0953d2d09b0e4116b4f9972716c60d69_I20210404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:LanzaJetIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-04</instant>
        </period>
    </context>
    <context id="i3f16003c0fce46c997e3bcde7fa19188_D20210201-20210404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:LanzaJetIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-04-04</endDate>
        </period>
    </context>
    <context id="i9f76a4903dee46c7a36a3359dafca0c1_D20110928-20110928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2011-09-28</startDate>
            <endDate>2011-09-28</endDate>
        </period>
    </context>
    <context id="ibea6cef92fd440f0849af4b7e43ac9d0_I20110928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2011-09-28</instant>
        </period>
    </context>
    <context id="ia16a7b02d1334a8c8712b104eafb3d0e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic62d084cb3144cc2a7041bace85abb24_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i7c67702cd8234f33a60771751ce65fbe_D20220429-20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-29</startDate>
            <endDate>2022-04-29</endDate>
        </period>
    </context>
    <context id="iaa61d655eb524064963927b0d13c1a26_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i16f9490902b14332975939591b56c0ce_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8b8a832fa95e40dd8e00caad65e8fc91_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i890286f3ce6f403f85f12ab3e67b6b6e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib7329eb228fb439b8a66213456cd7cd2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i102ea5a4d307404c84aab38c52f1411f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i379c9b036151404ba5af5925388baa54_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9ed25cf6aa114e57a8dac87f70ade94d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i84a93d4537e04f79aeb456018d0705ee_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia33dc2132bbc4f94ad2a656f9bd29ecb_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib9ef9ee81e0d436bae0f3213e39b62ea_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3f43e380d2624479993e527bb1c21058_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if25caf19e5b840e88f4735e4136a603a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i541e2e9fe4644a20b8b1b376f83dee9d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0624bd72b2cf4ede8ec463949522ea9a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idd5ccd73a28c47ebac5c69568150935f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia692081523eb4eeab727c1fc860a7079_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i18d637000e084883bc89386915d6aae9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8345fcb8c9f147978a79d376aea1f2aa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id9bb8758e465423fb3bbebe9bcea3ef7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0e8c018a77ea44b685797703d8a62a43_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1b34bf4c7df9425fa69de07cc96a2ac9_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ida50a4aa7f4047c9a5bf3fcef6f2d36d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2dae0c39f39546cdbbe879b2a2245fe6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i80812ae1293f45978d4c5ec6ccb77d63_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i350b1ab261cb4e4db6e8558ad63e36ba_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i255bc9e0c6fd4f8a8cfcde46d7515d42_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i07186a2d797e4458bf8d9a94dc91a2d0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i36aa3c86e8874dec967acf37511c6479_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia859bc758ac345ea9093ab9e82ff0731_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i04cf9359671d402dba7a452b2672fb05_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i43750276631c4e1ba6fc6ef8f398254e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2f2cde5be60544bbb0bd73ff5aef0cad_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5088a09b2ff24bc9bfba62c1ce63d419_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia52cfe0290ea4a978f3254d197b6c758_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i55050b0de34747fbba14961fb9a1e9be_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4e47b12b058d42d9b8a8500645afac39_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputProbabilityWeightingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis">amci:SecuritiesSubjectToMandatoryRedemptionNearTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ibd94d602b126443bb0f923d41ad8c7a1_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputProbabilityWeightingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis">amci:SecuritiesSubjectToMandatoryRedemptionLongTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iec52bedc36d740b58bbc9ba1b8a983fe_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputTimeToConversionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis">amci:SecuritiesSubjectToMandatoryRedemptionNearTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9ce1629b93bf43a19b229d4d55f31882_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputTimeToConversionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis">amci:SecuritiesSubjectToMandatoryRedemptionLongTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie070efbfc7bb4781b963dadb0a382d58_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputLiquidityPriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis">amci:SecuritiesSubjectToMandatoryRedemptionNearTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i49e4803247b0402587b5096b129d9f31_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputLiquidityPriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis">amci:SecuritiesSubjectToMandatoryRedemptionLongTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i09800e6ff5ef4478927f317abe6e7fb7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis">amci:SecuritiesSubjectToMandatoryRedemptionNearTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6c63b562f14d44b9952abb1eea623813_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis">amci:SecuritiesSubjectToMandatoryRedemptionLongTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib14e5758f2a840a3b657e5dd9d422ebe_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantNearTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputProbabilityWeightingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i192c0e38323342ae9304ab84b0debe13_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantLongTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputProbabilityWeightingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i37123c3b7a85495b95dd4d8511fc0442_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantNearTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0fa6834bd2214eff8b934f7fdaa67fbf_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantLongTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0172ec8bd8ce4a22879fb349fbbafc56_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantNearTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic9d5899a57c54d7990cac2605e65ebd3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantLongTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0aa6805e2b1149559fbad18c590187ff_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantNearTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="icda6841801c24b74be59d169bb943c1a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantLongTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5ca319150c654f32ae12b5fe4314342e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantNearTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputTimeToConversionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie7fb1eeb489e46439a3c7f8c3a135d2b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantLongTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputTimeToConversionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i50591f4e8c7a4c87a18ff51b7460e5d8_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantNearTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i32c536245c9a49b0a6be57c612f69c6d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantLongTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ieb39bfc330164ff6ba59e1d2825cd61d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantNearTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i114b807366e64e039876ae4814999f64_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantLongTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0945a26d694b428d8419686bb048d18d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7fb53208afd74e9483b23d0e4041d555_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFELiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i079f7d69cf684156b67ee6553c8b6aad_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFEWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i24da02763da74b0a98ebfa8693930419_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4e2cb48d3fed408fb6bf572cd6d907a7_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFELiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i339b33ace04542deabf468483e22dd7b_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFEWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ifcbb421dbd8a47549b523344e6362ae3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3c5b2e7ef7394f83aafc18d6214bf674_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFELiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9af2492b6f554a0eb3fc32f72a1bb287_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFEWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5618649df5e5458fa3e4d03670a6f48b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icce53a5d10814231a163555304304500_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFELiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iceff32fcb2af47c7981043c476b7ae54_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFEWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i68ebbca494b448ef875e3b5a750be5f7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i578deee2fa2d4d7bb7f94e488eeef63f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFELiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0e9a8a61ba8846269b1f093403d0655f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFEWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5dcdacedd7b3425b94c3894b1d80e349_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic04f0a1ede324c85b72039cfd7feb0b7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFELiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i78b91d141eb346fc856035c2b7e19205_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFEWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8a79cdf54f8341f5939209c59107cddb_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">amci:InlandRevenueNewZealandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6e7545b455184e6c8f1133a56f5e689c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibd4d0f3725b743bb9a13d0e7f76a6680_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id580de21b42b4e398c7373ee2244ec4a_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5b4e3fd1f02f47b5a39f57e583f20233_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i64009d0294a6447cbb23d3d0c5282ca7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9e411fa8a71f41a3b345b23c815aba64_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6c25a29e3caa42e99299fc9c41c7bac1_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:TransactionsWithEquityMethodInvesteesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id33f2498c7aa4d4ba897810160258324_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:TransactionsWithEquityMethodInvesteesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i578fdaf743b64320848f4efd3fbff206_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartyTransitionServicesAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i68abf404f20a4c66a39987d6172c4179_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartyTransitionServicesAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3e23e5276e6d4282a2e9f97732511ff8_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartyInvestmentAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8acbdb690ad34c79ba365f582f00b5da_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartyInvestmentAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i85c0c3423aa7412ca1b42997ac78fe99_I20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartyLeaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="i82d95c66ecd54340a53c89c11d9122a0_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartySupplyAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ica64ee13842e4d87b58d8e0776c87382_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartySupplyAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idce0b2fa8b1948daac1bdd0c26b6d051_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1dfc06d3caf74e879b017b7ba4bccc6c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9b90ee4e94cb439f99b65328a21b6c23_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib7233a4b0cd54bc9b9d31a1fda4e4f29_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1f16b3d33a074e1ba14330da0255fa2f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iab3c900d2c4e4b2a91220c825b2d6956_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie4c4d87c859840cc99ff35a606293d63_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1d3aaae919f443669873c0b2494eb950_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9f67793938594975ad7e63e3f8a4f312_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0e83a5ed9e3a42fbb38d656ae52b386c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ife262e1009764f0ebe3fdfe5ad4fb494_I20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="i8afc523d3a4c48d79839de0f31b51d9c_D20200501-20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="i274fc7fa467b4dfca60a8caf5ff1ce05_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i119eb57b7e1540229b6f3479667c5786_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4d01e01ebc9943c18b155b63bbd4d023_I20221002">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-02</instant>
        </period>
    </context>
    <context id="i82842e075dc846f3a2e003e61f072850_D20221002-20221002">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-02</startDate>
            <endDate>2022-10-02</endDate>
        </period>
    </context>
    <context id="i8e9aa0cf9cf540058d33cfcb743c1b90_I20221109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:LanzaJetFreedomPinesFuelsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-09</instant>
        </period>
    </context>
    <context id="i11190b90fcdd4adb805e60aa7b5e6559_I20221109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">amci:SeniorSecuredNotesReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:LanzaJetFreedomPinesFuelsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-09</instant>
        </period>
    </context>
    <context id="i841691236bcc4a358b07eb492c06d80c_I20221109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">amci:SubordinatedSecuredNotesReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amci:LanzaJetFreedomPinesFuelsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-09</instant>
        </period>
    </context>
    <context id="icfc212252c93424d9125b3ea9c058464_I20221109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-09</instant>
        </period>
    </context>
    <context id="i13deb916e76344f39ef3aa84463dff11_I20221109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">amci:OneTrancheOfNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-09</instant>
        </period>
    </context>
    <context id="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i45c8b69ce7724ca09fcd2a0e03378434_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i31c5c6ff291e4bfbaecc0f0138bbdc9b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1cd0c82523ad48cfbd1bd9a5c47959b6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="amci:RelatedAndNonrelatedPartyStatusAxis">amci:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i960c81aa420d4215ad749484380fb1d3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="amci:RelatedAndNonrelatedPartyStatusAxis">amci:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i946f64f7009a4a2082ea5e8ea9ae0377_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if07a33149ab34a4fbdf400d0fabf37f6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia22c1bdd47434793a0dc37fce48a996d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i94e27674b4054eeb8e5f88cdfd303c29_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i00591629b1be427aa8c0009cf1fb6f6e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifeb17f8540b2472cbe4d74587d5ad4aa_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5d56d77913a14f86a6d7945e10f160c2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5eb0c8c36cbc470dbddae10e948288a4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i05ec61c49dc34bc69ccd60b0af98c42e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i45b464fc79c145a2a521d5dd55876280_D20210401-20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="i68c741fd42694f06bc7e2689ea444d6a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ied8cd34c75144efca4224b616436546e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia9a4fe64e8384eb1ac82e12eceb516c9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie594942781b24073905212d61c4895df_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib670cc288d804b0da674a966573402b6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">amci:ErrorCorrectionEquityMethodInvestmentsIntangiblesAndFixedAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8f626d763fea4f03b5c54c8fd030b350_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">amci:ErrorCorrectionEquityMethodInvestmentsIntangiblesAndFixedAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic75b0e764db44a3ea1a1199da6c4795b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">amci:ErrorCorrectionEquityMethodInvestmentsIntangiblesAndFixedAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1ddd84d3244a4e469b4d90c6789d9b85_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">amci:ErrorCorrectionEquityMethodInvestmentsIntangiblesAndFixedAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icea6a4eaa3fa47bc9fd500d0e0e53a13_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">amci:ErrorCorrectionEquityMethodInvestmentContributedIntellectualAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5437a811e196420794bdd75c799bf19b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">amci:ErrorCorrectionEquityMethodInvestmentContributedIntellectualAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6272a6a1b0f14bc1a60665228d4ff94d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">amci:ErrorCorrectionEquityMethodInvestmentContributedIntellectualAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i89d112338dda40d0b977e99b3737e024_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">amci:ErrorCorrectionEquityMethodInvestmentContributedIntellectualAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie7dbd0916f2f407fbf3b88496fe98376_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">amci:ErrorCorrectionEquityMethodInvestmentGainOnDilutionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id9f5902630fa415a8d71cc63925f4a89_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">amci:ErrorCorrectionEquityMethodInvestmentGainOnDilutionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i142b45d688a94040896bab9c453fa022_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i475ef0e1c62c4e2194e47d2dab3b2b37_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartySupplyAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i84e5c0f8b51d4b4ea1203de397661f35_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartySupplyAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idccad26b9b674e58874df0b2f95fbd38_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8987593ef9dd4097a8751ede87870612_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ief2dc30089664149a39ac740dc44fcd1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i313f0012493b4bbbb3009a5a1bf811eb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6ba67557e60f4d1c9ab04d369b4a98b9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia0727c1578ba4d70a8b82b043575d5a6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i22ad32b2cf2844b38ba63af045e6e421_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaa2024ac8ce64a4cb2c146b06249fdb9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia5fbf727115a466bbef562191f56b933_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i979244b8b15f4cdba6249d9a452d49e9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iaeab5bba9ba24bbab921cc565da5880c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4715c3e771cb49659b7d7d1edf71bd81_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:LanzaJetIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia7a001a92c1048529f1d70f282ef5979_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:LanzaJetIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i51da7734998e408b9fefa2e716945170_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8253259ad4874f5a9b674506631abe14_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i05590867d0ee4d609cfc35f801b2bfb0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id306802fd9ee409aab98820719190d6a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idf64231b10064ce9b86e185225060418_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i831d5d72289e4ecebda264860e6ddb01_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib84e916b214e40bb9503c00b519d9b19_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2ad0ccd0af184ac4a13f4b4276bb623e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3806badc445d44dd82e2c5a6b9e25bfb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia7c702b96a6f4df9b250877d0384b508_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2179adde8d304d8280bfbc5ee18bc488_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3bcb50c289e34d1482c2e928125d7fde_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9f54a9cc2417463291611fdfdeedb0d2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i743ecbc9e30043a599d588f612598339_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i56b52dbeac4d4479bfb65e79f892fff0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idb494d52ad624b01abe6e93490255650_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amci:CustomerDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icaaa8522aec94f1aa360a0050053d993_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icfee3a338b794d7d95cda90ba4dd2425_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2678f5a65b234d35a12ce212238a1276_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifac9f30a87864eb3ac5fa0f54dde723a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i358ff5b6e3854374ba1d7d0c7d0343e5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i85c99d1acfdb4854a6eeb001415fd1fc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1bcdbff1e49a4f7893b55aef5e3383b0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6d734da8c6d54d6394aafbc36ef97fe0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia2e7fdecab214154afe7ef716788fbb0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:JointDevelopmentAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic848ff8d5c6f468b8ef166100477c3d3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:JointDevelopmentAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie5a5c7a4013b40f996deb5caeadbee89_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:OtherContractResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i25000550374347d98ff4260b0fe8fcc1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:OtherContractResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifcca0034fe6a4d0990224e5b8a5dd449_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:ResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i841b3eaf08c64e929bd5d8c3b5550936_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:ResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i84f5e809f9504f9aa1546f38557476d3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i941766ba89044c74b5ec672aca6c1610_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i339e323267704b6397de8db0f758c601_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:EngineeringAndOtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0d8cebd2641f4bcd972a34fb2e86777c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:EngineeringAndOtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i028a5508763345629acfb45969fb4396_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:CarbonCaptureAndTransformationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icb183fb29c764617802fbb8f9cc6ef0a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amci:CarbonCaptureAndTransformationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9d133fe090bf40acb6e27f45ba8c513d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i41997fda0c884eaeb59b9fa43fb3f3b5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i84559e50cc784ae4947d2762750bee39_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie1b898530c2c4589a32c8d8d907dc09f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i68d2069e34784ebfbc6b06f1d0168f28_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9f366cdc85054777b0fbbe8b243bd6b1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0f54cf1501b448c0a13761e8ce9c4f33_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i395f2b2b0888423698fc8b4613a0c7a8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5d2c4854af1c4ad183efa288b7c84140_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:LanzaJetIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4448ea0f5e794cccaf623e81ad622af0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7da793980258460bb178e447b22bf4df_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:LanzaJetIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iaa162be01a7e42838d798ac77c1e8764_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:LanzaJetIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie466fa6065e24c99b35c9b349c76a551_D20110928-20110928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2011-09-28</startDate>
            <endDate>2011-09-28</endDate>
        </period>
    </context>
    <context id="if87506a2fe1e44eea4a6cc3fad0ec2be_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9c210a255c684636bb39fa23a2370b08_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amci:BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8a7398a2daa84714af0a8aedf56e44db_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i429f6f8a96604c7ebb57f635a19670fb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idb56e9df9e8a4d3fb130ee2ff3f1a588_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic7779ec82a944d5989685ea5c473b325_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9677cfd1c23149c39d4d453a38d4b6f4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:TransactionsWithEquityMethodInvesteesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4dc568acac614adb953dfdedc71d98b5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:TransactionsWithEquityMethodInvesteesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i62a14169b57143bbada3e671e8a86ea6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:TransactionsWithEquityMethodInvesteesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic5cf4398c3d547eaa80b15bf808fd8c5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i80fc94b127ec4857ab5aacd4d3b22f07_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ice7ea95c9fb84d36a4857e2a761cf72f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if0c8f06ff99246cdb46b4b9b0600f524_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i22bd73e99737495a9bc32803b0a38fcb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if52a74eff3e34ea7bd679e63aa269811_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ida1349a04a004301b22372e88994a9b7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i43d8664385d6443a97bd2baa7945074d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i496bb986b9154962b5941a9ef4c15f9a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i84be5f6d8d7b4fb09cf5f8067275b5e2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2572a9b98e9a4c54ae3bd8e69a273beb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">amci:DerivativeNearTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputProbabilityWeightingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idf22b55e0fed4e0c81de5bef50d3013a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">amci:DerivativeLongTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputProbabilityWeightingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib114abec90f74932b5c8531cce6dc917_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">amci:DerivativeNearTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputTimeToConversionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i367f5f8cece445cfb46f812a669bcd7d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">amci:DerivativeLongTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputTimeToConversionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iccef67c1c54d4161a5720eded9695c69_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">amci:DerivativeNearTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputLiquidityPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib085f020f9a848ccb3533923ee8aafcf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">amci:DerivativeLongTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputLiquidityPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ica26df06c0a34ccf8742113f8a95570d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">amci:DerivativeNearTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie99d17fd90cb4d7987c8af1f52716253_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">amci:DerivativeLongTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic732fa66399e46eb8f8f50bfe6a6b35c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantNearTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputProbabilityWeightingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3318e30ec98146f5915d9bdc540724bb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantLongTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputProbabilityWeightingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9db1cfd579a04d91b7516eeb7322d953_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantNearTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibdd52c0f69244ffea4e30e908a904220_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantLongTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0f66a327ce0b49c890e6a99fa7f9fbaf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantNearTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1ca4d63251324696875efe201490b263_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantLongTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i82cb4f4ddcf64c0191fa7d4c0cb0521e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantNearTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7905b9a8c9624fa98a477251487eac0d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantLongTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i91c4e209e7064892a5423ab903a240cc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantNearTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputTimeToConversionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i57bff8b3d92f4c7cb9038273d4bf242f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantLongTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">amci:MeasurementInputTimeToConversionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i187fcf7aff144ee2ab2ff0d1b8136024_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantNearTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4c38034324df4a3dab4243d7adcb1f21_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantLongTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i64eaa8be4efb4867bb9b47e16fac72d7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantNearTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie146e5c775d746339943039ce5e4a6dd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">amci:SAFEWarrantLongTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9596a7ff3bea42e58dcd39b0f38a74fa_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i10f6a1f2d1324379935392c475073764_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFELiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7e89877de092491fa0ce31158a83134f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFEWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id8096c15e999498da5d65ca68368db35_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if06480e1451e4cb3931502d5a16df7c6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFELiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2859bc5f912d48f8a7b394269608ca11_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFEWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0741139789474a10a1ce163a9a98a470_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibbd46d99a3b44e778776bac9d32b613b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFELiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0b348afbe5de43b8843f3c23b5497e45_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amci:SAFEWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1e7e83e30c3d44fdb6bc2da913857f3f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i89df8c332f124e06ace60a1e9c5cab82_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if03679d2c8874922bb5588f668eb7d35_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic580d984d78b4b299abd56ff167e37d7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie4d0329f226943faa5580463c870698c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icb3aa04cd5e7479082b4f9014ca3e18c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if23e5af08c304d4997948a7aa3740d0c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5fa3bebd5c07454880ff014ca7706dc5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icf4b1adda3834411b36d3d632f21e01c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6165c558d2a64bd2ba478d320a293753_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i76b729f3daf846f681967ad7e92f649b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentOtherTypesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i39d2cbb02f9e4ba9b23e10f13e34d417_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentOtherTypesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id8a470f3b214430bbb7075de4c3b1041_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iacdef9e753d8416790fee52e2ac18e18_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4c4c3289f5c34d4b9daf93c4456e999f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amci:WTILoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifc118da157274cfdb66d08ffff284787_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amci:WTILoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i45b11649159e4d9ea0d390a541b073d1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amci:PPPLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i30198db7c24e48949cc55680e9933f73_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amci:PPPLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i404699cd00694919a171cbd57221125e_I20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amci:WTILoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="i593657e076c3432fa7ca2b295b005b97_D20160101-20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amci:WTILoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-01-01</startDate>
            <endDate>2016-12-31</endDate>
        </period>
    </context>
    <context id="idee985caefbc450c8367961aff024380_D20160101-20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amci:WTILoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-01-01</startDate>
            <endDate>2016-12-31</endDate>
        </period>
    </context>
    <context id="i9219179a97ab4a4b82c9454bafb8d9fe_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amci:WTILoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic037a70c12df457680d3fb392aa182f3_D20200401-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amci:PPPLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="i066afad72e9d4b139078a273831e92d4_I20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amci:PPPLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="i9e518f168d1f463d87802b9ada1450e7_D20210928-20210928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amci:PPPLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-28</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <context id="ia3c4ceff701e45aabe297c3d9da57706_I20210928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amci:PPPLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-28</instant>
        </period>
    </context>
    <context id="i8aafbe30b7bb4fd68e9bf6b7a590d428_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9bc03a6bd4624cafb93bad1d3f537cdc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie93366da59b6430ca421d5c1bbe96fbe_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">amci:InlandRevenueNewZealandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i674eabcf32014cbbbafe71136b7607fc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">amci:InlandRevenueNewZealandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7126fac96e634ad0af8988b83b1e7593_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i04acfe14cd6f4c0da7448253e2c86947_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i43158a95b30f4aaab73e7597bb3c2a77_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1bc2ae3cc9a8471192b73d09b8c4196c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i14808e8f9df64a649044715542143c00_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ied52ef89a5c14dea943af84ca5eee65e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i180c304002694f86a2cf308b957c10a8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">amci:InlandRevenueNewZealandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i46667c1000434c14a56ef64c99eb3a8c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">amci:InlandRevenueNewZealandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie04b19809090466ab84ebbe80fe42718_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib5a23afc7674452e9cdd8908a9228efd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7ec6ce83073a4b3dbe1336fd4cb6ec9a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3a3ce2d4285046a28faff5151642a219_D20201101-20201130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="i573b811889c3495891ffd2a6cb11821d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8edc4dc10f9f4f9bbe7fde8514cd754b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i213ef7ccde724ea7afd07d3e7e86daa8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i03b32e37b4f7484ea3c2ae0cc21ee87c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8891a21b42fd46edae0f2cb767f54ab4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i11fb672b3c844ef88abb79b5adf6a2f6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9d8b29d6eda64dde944469b96c9e6f69_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i803b263ea3554c628c2b2cd7af31afde_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4de62ab3a564461880c512002a30b250_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartyTransitionServicesAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i75c056609d254c53af9c29c67d99d60b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartyTransitionServicesAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id905c833627b4121b886db6e813419df_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartyInvestmentAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iae076a6656ae43ecb5bd532f5ce42d8c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartyInvestmentAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifcbed162e9304111b3a8a6214d89a1d1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartySupplyAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i28298076d77146a590f9bd3e1debbf12_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">amci:RelatedPartySupplyAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iac85d16334474caf87d510d9eb18ff97_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8a9c59f1273542b8ab3e8255d224f529_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1b658f2ff91349b3beaa5d4bd56ba109_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i579053a3cd4d442382bdb8ffa9a87db6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i51d874e0b5b94c329952825293416b35_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6147091081d14d69be73064143508062_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i75249f1eb69a41749449ae454de51fed_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9c54836fffa1449f85209e9cddadc72d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icae471cb37e8404291aadc66b866dff7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icbd1a0745c954062aab7bb0d81157304_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ice5b7039b91e4ef49110749cb0d4f41b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if0affa519b5d4e0aae8d04132534645a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i74eaaed6f417404bb146455ed9642f5a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iea72673f89f344d5a288193ba7de0128_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie65b1b4339964ae0830003a7a95f3358_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i90db5fda8f064408a48fcdc8d953f421_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i203a431eb37944ba9970e49c1a8973a0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ice29ee32562f4fbcacd93b5434eb9059_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i60f5e9b899c3402e921d693b6d34e7db_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3639631deb4141b89e868bff198a8abe_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i27b40d5ba4e24322ad9e1de0fd9901c5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i274b66feb9f24726acba535a568e1b1c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id2fd472d035b4442864a247790745af2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i004d3d6d81544e698359c68c43fc61d0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i306c9af6b46045cb8fca7a2fca95e245_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4d11321cc3a942239572275fcf381918_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5c8efec04d224fbaa59158d2f94edd4d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i909eedca48974777b86ab5582898a5a8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i70266a51f6fd4149be790adbf96c3a30_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i76b836230c434467ac363b81bab66632_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i695b4941729c41e48e97d09ddc96d4ac_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iabb8b1ba7cc04a52a91d508fcb565f43_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idad7341fd7894a348248ac1892d2d548_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i65a85eee2f814026a7777b50ae141b0b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia53cc2675c474ab094ee86871334ac6e_D20200201-20200229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843724</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-02-29</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="item">
        <measure>amci:item</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="d">
        <measure>amci:D</measure>
    </unit>
    <unit id="vote">
        <measure>amci:vote</measure>
    </unit>
    <unit id="y">
        <measure>amci:Y</measure>
    </unit>
    <unit id="segment">
        <measure>amci:segment</measure>
    </unit>
    <unit id="invesstment_round">
        <measure>amci:invesstment_round</measure>
    </unit>
    <unit id="cny">
        <measure>iso4217:CNY</measure>
    </unit>
    <unit id="scheme">
        <measure>amci:scheme</measure>
    </unit>
    <unit id="renewal_option">
        <measure>amci:renewal_option</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80L2ZyYWc6ZjQ2MWNjY2ZkMjI5NDkzNmE2M2FkODBlYWRlOGRiNjQvdGFibGU6MWFhYTQ3ZTY4ZDgzNDgxYzljNmFkZjI5ZDIzNDIyMzEvdGFibGVyYW5nZToxYWFhNDdlNjhkODM0ODFjOWM2YWRmMjlkMjM0MjIzMV85LTEtMS0xLTkwNjA5_5610a865-3378-4df1-aeaa-21c9597ce5af">0001843724</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80L2ZyYWc6ZjQ2MWNjY2ZkMjI5NDkzNmE2M2FkODBlYWRlOGRiNjQvdGFibGU6MWFhYTQ3ZTY4ZDgzNDgxYzljNmFkZjI5ZDIzNDIyMzEvdGFibGVyYW5nZToxYWFhNDdlNjhkODM0ODFjOWM2YWRmMjlkMjM0MjIzMV8xMC0xLTEtMS05MDYwOQ_1d12db85-2605-4e4b-892a-0ad6eeb93d1b">false</dei:AmendmentFlag>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMS0xLTEtMS05MDYwOQ_5bf746c1-aaa4-4b08-9297-6485b401608c"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMS0xLTEtMS05MDYwOQ_7ac9922d-8362-40a8-8ddd-1d7ff90fbda0"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMi0xLTEtMS05MDYwOQ_3f928196-5601-4957-9767-f0c9336b9944"
      unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMi0xLTEtMS05MDYwOQ_737bbe4c-6c1e-49c5-b812-933168a7413d"
      unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMy0xLTEtMS05MDYwOQ_46dfcb50-4974-4f20-9bba-b69b23025dfd"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMy0xLTEtMS05MDYwOQ_8b4a3e95-2c9d-4af3-b7b7-d4aba0738a9d"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfNC0xLTEtMS05MDYwOQ_af74ce2f-c8b9-4565-bf8b-916d65ce6cb3"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfNC0xLTEtMS05MDYwOQ_f59ad42b-74af-4068-a204-5d5a2120df66"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i456af52614a84b9987f0558f3c9d3476_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfNi0xLTEtMS05MDYwOQ_dd1b8f2d-52f4-462c-a97b-950d28c83e08"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i1a8ff7f453974014b00746e89fa737d3_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfNi0xLTEtMS05MDYwOQ_f0456f79-7b72-4e5e-9c45-7a75bf618afb"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i1a8ff7f453974014b00746e89fa737d3_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfNy0xLTEtMS05MDYwOQ_0b898de0-1946-474c-905d-01e8a44cd257"
      unitRef="shares">280000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i456af52614a84b9987f0558f3c9d3476_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfNy0xLTEtMS05MDYwOQ_760e0fd9-d3c6-493d-b0f3-b8ce777206be"
      unitRef="shares">280000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="i1a8ff7f453974014b00746e89fa737d3_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfOC0xLTEtMS05MDYwOQ_7b2afd9c-6474-4bbd-92ad-4100c98919b8"
      unitRef="usdPerShare">10.00</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i1a8ff7f453974014b00746e89fa737d3_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfOS0xLTEtMS05MDYwOQ_b50c8c18-3ada-4b6e-9da1-cc5117424d85"
      unitRef="shares">15000000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="i1a8ff7f453974014b00746e89fa737d3_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMTAtMS0xLTEtOTA2MDk_adcf5318-b2fe-45b8-afd2-45f4cc5fd2d8"
      unitRef="usdPerShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i39b3f93aa3714933b05800e10c00a387_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMTItMS0xLTEtOTA2MDk_7c48eaa0-d6d4-4f13-addf-ad61bc631733"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="i39b3f93aa3714933b05800e10c00a387_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMTMtMS0xLTEtOTA2MDk_12536a8b-418e-4f69-bd7d-4dd02564837a"
      unitRef="usdPerShare">10.00</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i39b3f93aa3714933b05800e10c00a387_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMTQtMS0xLTEtOTA2MDk_8a921baf-6308-48a3-bfa7-d26611e31826"
      unitRef="shares">15000000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="if090e35b3ace4abc92ca72a48339ebd7_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMTQtMS0xLTEtOTA2MDk_b4ce0a2f-97df-4677-b2bf-979e96866ec6"
      unitRef="shares">15000000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="if090e35b3ace4abc92ca72a48339ebd7_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMTUtMS0xLTEtOTA2MDk_042d3ea0-580d-488a-9395-1fa54054008c"
      unitRef="shares">15000000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i39b3f93aa3714933b05800e10c00a387_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMTUtMS0xLTEtOTA2MDk_52f02588-79ce-4776-91f7-ead26a6932e9"
      unitRef="shares">15000000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="i39b3f93aa3714933b05800e10c00a387_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMTYtMS0xLTEtOTA2MDk_6b3ed23f-400f-4349-b4e9-40341c4b3b00"
      unitRef="usdPerShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="if090e35b3ace4abc92ca72a48339ebd7_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMTYtMS0xLTEtOTA2MDk_e47585c6-90b1-41d6-8758-ddf9ec6b5f3d"
      unitRef="usdPerShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="i2a9d6acf0a3443b8a9bfd210dcef6a0e_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMTgtMS0xLTEtOTA2MDk_0e410db8-1fd1-4c96-ac20-1472fbfdc88b"
      unitRef="shares">0</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib763267d74d64b8fbe45ac357a9f8f08_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMTgtMS0xLTEtOTA2MDk_449e2287-e7e8-43d2-b635-562ea2c118c9"
      unitRef="shares">0</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib763267d74d64b8fbe45ac357a9f8f08_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMTktMS0xLTEtOTA2MDk_5b32247e-e3aa-4ea7-b157-ddb28854f583"
      unitRef="shares">0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i2a9d6acf0a3443b8a9bfd210dcef6a0e_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMTktMS0xLTEtOTA2MDk_651e98b9-ad62-4401-82cf-4f349e421e5b"
      unitRef="shares">0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i28b4565471d542708454f455b422d119_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMjEtMS0xLTEtOTA2MDk_03024671-7acb-48e7-8530-2747002b10d8"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="id57512e5cedd4b74bc2f1786d35220d2_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMjEtMS0xLTEtOTA2MDk_e7638b6d-3a02-40b5-b658-04f16b39ee59"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i28b4565471d542708454f455b422d119_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMjItMS0xLTEtOTA2MDk_5bc71d9c-3440-4b36-8a23-911112a056aa"
      unitRef="shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="id57512e5cedd4b74bc2f1786d35220d2_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMjItMS0xLTEtOTA2MDk_6055f394-b61b-4c69-abd5-6c6f35b0e91e"
      unitRef="shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i28b4565471d542708454f455b422d119_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMjMtMS0xLTEtOTA2MDk_26a52402-89ee-40fc-a60d-68a3b4b18664"
      unitRef="shares">3750000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="id57512e5cedd4b74bc2f1786d35220d2_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMjMtMS0xLTEtOTA2MDk_542305c0-4aaf-4d68-bbf2-0bf4e3eb6831"
      unitRef="shares">3750000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMjMtMS0xLTEtOTA2MDk_a06542a0-3585-4b1c-ad22-e5c002e16bdf"
      unitRef="shares">3750000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMy9mcmFnOjcxY2U2N2U0ZGZkZDQ1ZDJiNmM4MTJjMDRlMzJjMzUwL3RhYmxlOmI5ZTk5YTIwOTRjOTQ0Y2VhMzM2OGY3MTBkYzJmMDRjL3RhYmxlcmFuZ2U6YjllOTlhMjA5NGM5NDRjZWEzMzY4ZjcxMGRjMmYwNGNfMjMtMS0xLTEtOTA2MDk_a8709564-ceb1-45db-a993-e27f00b639c8"
      unitRef="shares">3750000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="i89b183b3eb6542b0870815f5da77659b_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yMi9mcmFnOmEzZjUxMTZkM2RlZDRiOTBhZDk2NDdkNjRiMmJhNTkwL3RhYmxlOjNmZmZmOTQxZmFmMTRlN2I5MTUzOGRmYmJjMzQyOGZmL3RhYmxlcmFuZ2U6M2ZmZmY5NDFmYWYxNGU3YjkxNTM4ZGZiYmMzNDI4ZmZfMS0xLTEtMS05MDYwOQ_0ad58a23-9f15-4df4-81dc-4b06c8fb9698"
      unitRef="shares">562500</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="ibc418deb7a554f8e82e462f5270ec4fe_D20210917-20210917"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yMi9mcmFnOmEzZjUxMTZkM2RlZDRiOTBhZDk2NDdkNjRiMmJhNTkwL3RhYmxlOjNmZmZmOTQxZmFmMTRlN2I5MTUzOGRmYmJjMzQyOGZmL3RhYmxlcmFuZ2U6M2ZmZmY5NDFmYWYxNGU3YjkxNTM4ZGZiYmMzNDI4ZmZfMS0yLTEtMS05MDYwOQ_61a8732f-6f6c-4819-b169-9f436709f86f"
      unitRef="shares">562500</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <amci:NumberOfSharesSurrendered
      contextRef="i6689ad9df05044c9b7cca157156ac7d3_I20220514"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yMi9mcmFnOmEzZjUxMTZkM2RlZDRiOTBhZDk2NDdkNjRiMmJhNTkwL3RhYmxlOjNmZmZmOTQxZmFmMTRlN2I5MTUzOGRmYmJjMzQyOGZmL3RhYmxlcmFuZ2U6M2ZmZmY5NDFmYWYxNGU3YjkxNTM4ZGZiYmMzNDI4ZmZfMi0yLTEtMS05MDYwOQ_cc6a84a6-64c2-4489-8397-5674f88dbd8b"
      unitRef="shares">718750</amci:NumberOfSharesSurrendered>
    <amci:AggregateNumberOfSharesOwned
      contextRef="i6689ad9df05044c9b7cca157156ac7d3_I20220514"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yMi9mcmFnOmEzZjUxMTZkM2RlZDRiOTBhZDk2NDdkNjRiMmJhNTkwL3RhYmxlOjNmZmZmOTQxZmFmMTRlN2I5MTUzOGRmYmJjMzQyOGZmL3RhYmxlcmFuZ2U6M2ZmZmY5NDFmYWYxNGU3YjkxNTM4ZGZiYmMzNDI4ZmZfMy0yLTEtMS05MDYwOQ_045dc3fb-a3f1-42b7-9361-33f01fd30f46"
      unitRef="shares">4312500</amci:AggregateNumberOfSharesOwned>
    <amci:RedemptionPeriodUponClosure
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfOTM5MA_6b8b7a9b-cdb9-4964-a6c2-9088a7366feb">P10D</amci:RedemptionPeriodUponClosure>
    <amci:NumberOfWarrantsIssuedPerUnit
      contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNC9mcmFnOjU4ZDAzNDU0NDIyNjQ5MThiNDc3ZDdjNGM0ZDEwNWI1L3RhYmxlOjA0MDEzZTI2ZjA3NjQxMjdiMDdkN2VmZGEzNGI2YjAzL3RhYmxlcmFuZ2U6MDQwMTNlMjZmMDc2NDEyN2IwN2Q3ZWZkYTM0YjZiMDNfMS0xLTEtMS05MDYwOQ_bc40759b-c589-446b-9b3d-17ac2fc3deb4"
      unitRef="shares">0.5</amci:NumberOfWarrantsIssuedPerUnit>
    <us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
      contextRef="i451ff43e2c50495caaa75e2af24f295d_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82MS9mcmFnOjUzYTM0YTYwYzQ0ZjQyMDM4ZDNhMTE1YjViYTZjNmMxL3RhYmxlOmJlZGVmM2NiNTA1NDQ5Y2FiMGRjMWQwY2FjY2YwMGIxL3RhYmxlcmFuZ2U6YmVkZWYzY2I1MDU0NDljYWIwZGMxZDBjYWNjZjAwYjFfMS0xLTEtMS05MDYwOQ_119936ac-bf98-4ded-a8d2-841dfb62f668">http://fasb.org/us-gaap/2022#SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares</us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
      contextRef="i98b54305564e42f9abfa073cb3e4947b_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82MS9mcmFnOjUzYTM0YTYwYzQ0ZjQyMDM4ZDNhMTE1YjViYTZjNmMxL3RhYmxlOmJlZGVmM2NiNTA1NDQ5Y2FiMGRjMWQwY2FjY2YwMGIxL3RhYmxlcmFuZ2U6YmVkZWYzY2I1MDU0NDljYWIwZGMxZDBjYWNjZjAwYjFfMS0yLTEtMS05MDYwOQ_d85e28b5-0b12-40cc-8eff-9b3082c71ab6">http://fasb.org/us-gaap/2022#SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares</us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
      contextRef="i974a103ab76f4dfebf71b623a294979d_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82MS9mcmFnOjUzYTM0YTYwYzQ0ZjQyMDM4ZDNhMTE1YjViYTZjNmMxL3RhYmxlOjMyYzAyNWQ0OWY0ODQ5NDc5ZWZlMmVkNzUzY2M5YjU1L3RhYmxlcmFuZ2U6MzJjMDI1ZDQ5ZjQ4NDk0NzllZmUyZWQ3NTNjYzliNTVfMS0xLTEtMS05MDYwOQ_82136c93-a7db-40b5-8c08-e3bba8f12ac8">http://fasb.org/us-gaap/2022#FairValueAdjustmentOfWarrants</us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList>
    <us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
      contextRef="if1bafc618d6f473f9a793bbc10bcd6dc_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82MS9mcmFnOjUzYTM0YTYwYzQ0ZjQyMDM4ZDNhMTE1YjViYTZjNmMxL3RhYmxlOjMyYzAyNWQ0OWY0ODQ5NDc5ZWZlMmVkNzUzY2M5YjU1L3RhYmxlcmFuZ2U6MzJjMDI1ZDQ5ZjQ4NDk0NzllZmUyZWQ3NTNjYzliNTVfMS0yLTEtMS05MDYwOQ_1d98c9ba-e0a7-4a86-bfca-9fdd5af572fa">http://fasb.org/us-gaap/2022#FairValueAdjustmentOfWarrants</us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMS0xLTEtMS05MDYwOQ_e84e1b26-c326-4c65-bccf-d7eb2db1ae4a"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMi0xLTEtMS05MDYwOQ_4f2d7613-29f3-495a-81f5-183d9aab08d0"
      unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMy0xLTEtMS05MDYwOQ_d121b401-bce9-4b62-971f-17557f794464"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfNC0xLTEtMS05MDYwOQ_2d74d0c9-88fd-463b-a2b8-cfc6c7f3498b"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfNi0xLTEtMS05MDYwOQ_9e404f70-d6fc-40f6-9741-4676c7ed32f3"
      unitRef="usdPerShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfNy0xLTEtMS05MDYwOQ_4d5bf236-0580-4aaa-bb3e-3f1ffb0afcd0"
      unitRef="shares">15000000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfOC0xLTEtMS05MDYwOQ_8951dea4-1f80-4194-9f52-be692cc83764"
      unitRef="usdPerShare">10.00</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfOS0xLTEtMS05MDYwOQ_b97fe59b-35a5-475b-a54a-5a5fa723d11a"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMTAtMS0xLTEtOTA2MDk_947997dd-68cd-482d-b123-40cc4817b070"
      unitRef="shares">280000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="i0a43243fe73e4e0982e02d8804f9029b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMTItMS0xLTEtOTA2MDk_7c7d4086-ff8a-4277-967e-4a8ecccb7c67"
      unitRef="usdPerShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i0a43243fe73e4e0982e02d8804f9029b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMTMtMS0xLTEtOTA2MDk_4b0816d9-ad15-41c1-a635-5ff534a3447b"
      unitRef="shares">15000000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i0a43243fe73e4e0982e02d8804f9029b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMTQtMS0xLTEtOTA2MDk_0d6f18de-c4ca-418d-9b10-0570fa6d3701"
      unitRef="shares">15000000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i525804f64fa24dab94c10a95e9c90289_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMTQtMS0xLTEtOTA2MDk_409870fa-6199-463f-beb4-a1b47313aa44"
      unitRef="shares">15000000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="i0a43243fe73e4e0982e02d8804f9029b_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMTUtMS0xLTEtOTA2MDk_088a194c-1b3d-4d8d-b1a6-85936ced9ea7"
      unitRef="usdPerShare">10.00</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i0a43243fe73e4e0982e02d8804f9029b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMTYtMS0xLTEtOTA2MDk_93519ddc-8ad2-4c4c-9835-38cfbc88bb13"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="i64c9dd51c7c74824810ac9d20592fd6b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMTgtMS0xLTEtOTA2MDk_70fe34cb-8035-4038-ad7f-3d9d2ec75aae"
      unitRef="shares">0</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i64c9dd51c7c74824810ac9d20592fd6b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMTktMS0xLTEtOTA2MDk_caea643c-5235-4385-857a-d2cbc66c090b"
      unitRef="shares">0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i246d06060759490897b705c5ed7fc8f0_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMjEtMS0xLTEtOTA2MDk_d4e4e546-6920-43ed-890a-7639061f1cd1"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i246d06060759490897b705c5ed7fc8f0_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMjItMS0xLTEtOTA2MDk_4973ba9a-271c-4ed0-85c7-582070e380f2"
      unitRef="shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i246d06060759490897b705c5ed7fc8f0_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMjMtMS0xLTEtOTA2MDk_335efc86-cb04-476a-b2f3-f4afe3bfe186"
      unitRef="shares">3750000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i291fade0df2b465aa82cd6d5ea3294af_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMjQtMS0xLTEtOTA2MDk_3539ca90-0c4e-431d-870d-a9ca278a607f"
      unitRef="shares">3750000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i246d06060759490897b705c5ed7fc8f0_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83Ni9mcmFnOjFlNjE0N2E3MmJjOTRjMGVhODRmMjM0MWU2ZDhkYThlL3RhYmxlOjZiZDZkZWEzMWYxODRkY2E5ZDkwZDYzY2U4OGRkMWE1L3RhYmxlcmFuZ2U6NmJkNmRlYTMxZjE4NGRjYTlkOTBkNjNjZTg4ZGQxYTVfMjQtMS0xLTEtOTA2MDk_4d3af28d-9737-4ec2-9c3d-79eb73ec2237"
      unitRef="shares">3750000</us-gaap:CommonStockSharesOutstanding>
    <amci:RedemptionPeriodUponClosure
      contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfOTMzMA_80eea167-68dd-4f47-a97c-0adf8eb467f8">P10D</amci:RedemptionPeriodUponClosure>
    <amci:NumberOfWarrantsIssuedPerUnit
      contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85NC9mcmFnOmJkYTI3OGY5MDQ0MDRhYjRiMGM3OGQzMDY3MGM0YTJiL3RhYmxlOjJmZGI4NWRjMjdjMTRiODRhNDc4Njc4MTI4OGU3ZmM4L3RhYmxlcmFuZ2U6MmZkYjg1ZGMyN2MxNGI4NGE0Nzg2NzgxMjg4ZTdmYzhfMS0xLTEtMS05MDYwOQ_937f0c40-aa52-43ea-9ad7-f705cc193d62"
      unitRef="shares">0.50</amci:NumberOfWarrantsIssuedPerUnit>
    <us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
      contextRef="i98b54305564e42f9abfa073cb3e4947b_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjEvZnJhZzo5YmUwNGU3MmU1NWE0MTU1ODRkNzBjYjQyZDBiOTk1MS90YWJsZToyMjZkNDY4ODk1NDg0Nzg3OWIwOWJkNWRlMjk2OWViNS90YWJsZXJhbmdlOjIyNmQ0Njg4OTU0ODQ3ODc5YjA5YmQ1ZGUyOTY5ZWI1XzEtMS0xLTEtOTA2MDk_28197a07-64ce-40a2-ba82-1434c5c3b4b8">http://fasb.org/us-gaap/2022#SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares</us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
      contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjEvZnJhZzo5YmUwNGU3MmU1NWE0MTU1ODRkNzBjYjQyZDBiOTk1MS90YWJsZTo4Y2M1ZDc0OGRmY2Q0NzlhOTUyYTEzODI3NWZiZjkwOC90YWJsZXJhbmdlOjhjYzVkNzQ4ZGZjZDQ3OWE5NTJhMTM4Mjc1ZmJmOTA4XzItMS0xLTEtOTA2MDk_c186d0df-d278-4109-bc8f-f2fe4c8c94ec">http://fasb.org/us-gaap/2022#FairValueAdjustmentOfWarrants</us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
      contextRef="i6e7545b455184e6c8f1133a56f5e689c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzEyNjQ0MzgzNzI0Mzkx_1f5323c0-bbe0-45e6-bfd6-3ba4780f1116">P2Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <amci:TemporaryEquityIssuePricePerShare
      contextRef="i1dfc06d3caf74e879b017b7ba4bccc6c_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMzU5L2ZyYWc6MmNkMjU2Mjk3N2NhNDVmNWE1YjBmZGRiODFlODhmZmMvdGV4dHJlZ2lvbjoyY2QyNTYyOTc3Y2E0NWY1YTViMGZkZGI4MWU4OGZmY181NDk3NTU4MTM5MjU_8c325cde-957c-43bc-a33f-3e7c1be91fc8"
      unitRef="usdPerShare">1.75</amci:TemporaryEquityIssuePricePerShare>
    <amci:TemporaryEquityIssuePricePerShare
      contextRef="i9b90ee4e94cb439f99b65328a21b6c23_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMzU5L2ZyYWc6MmNkMjU2Mjk3N2NhNDVmNWE1YjBmZGRiODFlODhmZmMvdGV4dHJlZ2lvbjoyY2QyNTYyOTc3Y2E0NWY1YTViMGZkZGI4MWU4OGZmY181NDk3NTU4MTM5MzI_18840379-ed0b-4a02-8cf7-ad4d4e4cb5ea"
      unitRef="usdPerShare">3.94</amci:TemporaryEquityIssuePricePerShare>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i51da7734998e408b9fefa2e716945170_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTA0_78de1c22-d3ad-43ae-a899-19a74e1b2357">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i05590867d0ee4d609cfc35f801b2bfb0_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk3OTk5_761df305-309f-4903-a23c-ce62ac3f485c">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
      contextRef="i7ec6ce83073a4b3dbe1336fd4cb6ec9a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEwOTk1MTE2Mjg0Mzgw_848b9b44-6118-41f1-9447-548b3ddf83fb">P2Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <amci:TemporaryEquityIssuePricePerShare
      contextRef="i8a9c59f1273542b8ab3e8255d224f529_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMzUwL2ZyYWc6ZTY1ZmEzZGFlMzVmNDQ5MThmZjE5YjJlYjZjNzBkZmMvdGV4dHJlZ2lvbjplNjVmYTNkYWUzNWY0NDkxOGZmMTliMmViNmM3MGRmY181NDk3NTU4MTQwODg_a18cc782-38b5-48b8-81e7-0ce4e087259e"
      unitRef="usdPerShare">1.75</amci:TemporaryEquityIssuePricePerShare>
    <amci:TemporaryEquityIssuePricePerShare
      contextRef="i1b658f2ff91349b3beaa5d4bd56ba109_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMzUwL2ZyYWc6ZTY1ZmEzZGFlMzVmNDQ5MThmZjE5YjJlYjZjNzBkZmMvdGV4dHJlZ2lvbjplNjVmYTNkYWUzNWY0NDkxOGZmMTliMmViNmM3MGRmY181NDk3NTU4MTQwOTk_e53f1854-8446-4f0f-9aaa-00a1d60c9cc4"
      unitRef="usdPerShare">3.94</amci:TemporaryEquityIssuePricePerShare>
    <amci:TemporaryEquityIssuePricePerShare
      contextRef="icbd1a0745c954062aab7bb0d81157304_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMzUwL2ZyYWc6ZTY1ZmEzZGFlMzVmNDQ5MThmZjE5YjJlYjZjNzBkZmMvdGV4dHJlZ2lvbjplNjVmYTNkYWUzNWY0NDkxOGZmMTliMmViNmM3MGRmY181NDk3NTU4MTQxMTE_ecd1a6fe-0a1d-4bc1-addc-b3100fc0276d"
      unitRef="usdPerShare">1.75</amci:TemporaryEquityIssuePricePerShare>
    <amci:TemporaryEquityIssuePricePerShare
      contextRef="ice5b7039b91e4ef49110749cb0d4f41b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMzUwL2ZyYWc6ZTY1ZmEzZGFlMzVmNDQ5MThmZjE5YjJlYjZjNzBkZmMvdGV4dHJlZ2lvbjplNjVmYTNkYWUzNWY0NDkxOGZmMTliMmViNmM3MGRmY181NDk3NTU4MTQxMDU_dfa80275-6209-4617-b37a-91174371c608"
      unitRef="usdPerShare">3.94</amci:TemporaryEquityIssuePricePerShare>
    <dei:DocumentType
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xL2ZyYWc6MjhlYTM5MzQ0OWY4NDFmYTg2MTUyMDgwYTFlNGI3NzIvdGV4dHJlZ2lvbjoyOGVhMzkzNDQ5Zjg0MWZhODYxNTIwODBhMWU0Yjc3Ml8xMDk5NTExNjMwMzczOQ_b9dc31a4-de0d-45ae-994d-1d4f118cfed7">S-1</dei:DocumentType>
    <dei:EntityRegistrantName
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xL2ZyYWc6MjhlYTM5MzQ0OWY4NDFmYTg2MTUyMDgwYTFlNGI3NzIvdGV4dHJlZ2lvbjoyOGVhMzkzNDQ5Zjg0MWZhODYxNTIwODBhMWU0Yjc3Ml8xMDk5NTExNjMwMzc3Ng_ad374cfd-9e8b-4867-8790-27870042e196">LanzaTech Global, Inc.</dei:EntityRegistrantName>
    <dei:EntityFilerCategory
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xL2ZyYWc6MjhlYTM5MzQ0OWY4NDFmYTg2MTUyMDgwYTFlNGI3NzIvdGFibGU6NmQ1MmFkYmQ5YjVkNDkxODkyYTY1Yjg5NWM1Mjg4M2QvdGFibGVyYW5nZTo2ZDUyYWRiZDliNWQ0OTE4OTJhNjViODk1YzUyODgzZF8xLTAtMS0xLTkwNjA5_04965d5b-b796-4c7c-8447-27736c1d7a57">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xL2ZyYWc6MjhlYTM5MzQ0OWY4NDFmYTg2MTUyMDgwYTFlNGI3NzIvdGFibGU6NmQ1MmFkYmQ5YjVkNDkxODkyYTY1Yjg5NWM1Mjg4M2QvdGFibGVyYW5nZTo2ZDUyYWRiZDliNWQ0OTE4OTJhNjViODk1YzUyODgzZF8xLTMtMS0xLTkwNjA5_5daa4453-1424-47af-b7cd-bb0de943d8e3">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xL2ZyYWc6MjhlYTM5MzQ0OWY4NDFmYTg2MTUyMDgwYTFlNGI3NzIvdGFibGU6NmQ1MmFkYmQ5YjVkNDkxODkyYTY1Yjg5NWM1Mjg4M2QvdGFibGVyYW5nZTo2ZDUyYWRiZDliNWQ0OTE4OTJhNjViODk1YzUyODgzZF8yLTMtMS0xLTkwNjA5_f162a3ed-91cf-4e39-9b7a-c36eed35ab1d">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xL2ZyYWc6MjhlYTM5MzQ0OWY4NDFmYTg2MTUyMDgwYTFlNGI3NzIvdGV4dHJlZ2lvbjoyOGVhMzkzNDQ5Zjg0MWZhODYxNTIwODBhMWU0Yjc3Ml8xMDk5NTExNjMwMzc0MA_dff1e791-751a-4ab2-ab21-46502e982353">false</dei:EntityExTransitionPeriod>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfNC0xLTEtMS05MDYwOQ_2ed69704-d6e8-4bda-ab41-643906196024"
      unitRef="usd">7302</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfNC0zLTEtMS05MDYwOQ_7b8d55a0-5b63-4bc8-8904-436fb1df02ca"
      unitRef="usd">343399</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfNS0xLTEtMS05MDYwOQ_e7b04999-c5c8-45c1-86af-4c1691bc0b9e"
      unitRef="usd">277812</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfNS0zLTEtMS05MDYwOQ_cbb8d26b-af61-44bb-871e-cf312a0864c3"
      unitRef="usd">337534</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent
      contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfNi0xLTEtMS05MDYwOQ_547407d4-4182-4195-af89-32029b1ef223"
      unitRef="usd">285114</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfNi0zLTEtMS05MDYwOQ_65d21260-35b1-4ea3-ad68-29a33c28404b"
      unitRef="usd">680933</us-gaap:AssetsCurrent>
    <amci:PrepaidExpensesLongTerm
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfNy0zLTEtMS05MDYwOQ_3b4156ca-c3db-41bb-9475-e2602c34a0d8"
      unitRef="usd">184812</amci:PrepaidExpensesLongTerm>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfOC0xLTEtMS05MDYwOQ_b34438ef-d062-420b-ad85-c9d6b13a3179"
      unitRef="usd">150969468</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfOC0zLTEtMS05MDYwOQ_0f4561df-2917-42ca-a6a4-f9f2a58aefa1"
      unitRef="usd">150006015</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:Assets
      contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfOS0xLTEtMS05MDYwOQ_75570294-d044-4564-a086-a86fbec96407"
      unitRef="usd">151254582</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfOS0zLTEtMS05MDYwOQ_5e16ded8-eb93-40a6-b653-f9d95d05fd4c"
      unitRef="usd">150871760</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMTMtMS0xLTEtOTA2MDk_cc3390cb-571b-40df-8386-744afe7e740f"
      unitRef="usd">1687915</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMTMtMy0xLTEtOTA2MDk_6111f828-e4a3-4d81-9aac-8345c1d2b3cd"
      unitRef="usd">85534</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMTQtMS0xLTEtOTA2MDk_dcbe55b9-050a-43e3-8ce5-66c58f35f99b"
      unitRef="usd">1356763</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMTQtMy0xLTEtOTA2MDk_bf9d0a4a-dc5c-4290-9993-d8d7a96a48b8"
      unitRef="usd">229733</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMTUtMS0xLTEtOTA2MDk_20768516-1b8b-4b1f-9904-55d266072350"
      unitRef="usd">736123</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMTUtMy0xLTEtOTA2MDk_f992dc01-e4a8-4772-a247-2dfcf5073b28"
      unitRef="usd">49723</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
      contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMTYtMS0xLTEtOTA2MDk_6aca43dc-6f05-4c2a-a05e-57a8feebf120"
      unitRef="usd">331707</us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMTYtMy0xLTEtOTA2MDk_185a106d-db63-4399-a0bc-93354edffe34"
      unitRef="usd">198129</us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent>
    <amci:FranchiseTaxPayableCurrent
      contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMTctMS0xLTEtOTA2MDk_4f667e8a-8386-4035-a2fa-5e77ea83a295"
      unitRef="usd">149639</amci:FranchiseTaxPayableCurrent>
    <amci:FranchiseTaxPayableCurrent
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMTctMy0xLTEtOTA2MDk_0c993451-1ce5-473e-88e9-ca98ffe0cd85"
      unitRef="usd">188237</amci:FranchiseTaxPayableCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMTgtMS0xLTEtOTA2MDk_5c1c216f-5ad2-4520-916a-0ac6ece63c68"
      unitRef="usd">54366</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMTktMS0xLTEtOTA2MDk_c38a505c-f0b8-4c6c-a2aa-ddbecedcdca6"
      unitRef="usd">4316513</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMTktMy0xLTEtOTA2MDk_5380f83d-3e5a-4547-b727-887d46a693f0"
      unitRef="usd">751356</us-gaap:LiabilitiesCurrent>
    <amci:DeferredUnderwritingCompensationNoncurrent
      contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMjAtMS0xLTEtOTA2MDk_f2d4ddd1-80c3-4d0b-9c74-6f695ccf3842"
      unitRef="usd">200000</amci:DeferredUnderwritingCompensationNoncurrent>
    <amci:DeferredUnderwritingCompensationNoncurrent
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMjAtMy0xLTEtOTA2MDk_cf1b9128-5d58-4831-b1e0-d2312641b356"
      unitRef="usd">5250000</amci:DeferredUnderwritingCompensationNoncurrent>
    <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
      contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMjEtMS0xLTEtOTA2MDk_5ce32fcf-37c3-4fb8-8c47-6fa6ca90d283"
      unitRef="usd">1543280</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares>
    <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMjEtMy0xLTEtOTA2MDk_4454e0d4-d702-4f7b-be31-236fb0b8de67"
      unitRef="usd">5610000</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares>
    <us-gaap:Liabilities
      contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMjItMS0xLTEtOTA2MDk_d06f3e70-4e3b-49fb-a183-ed695c9a373d"
      unitRef="usd">6059793</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMjItMy0xLTEtOTA2MDk_869d6d6a-7681-4792-817b-707d998189f4"
      unitRef="usd">11611356</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMjQtMS0xLTEtOTA2MDk_5004390f-588a-44a3-ba53-b44305f3643a"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMjQtMy0xLTEtOTA2MDk_5ccb5fce-4dc8-42a9-9ca0-653d920d7310"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="if090e35b3ace4abc92ca72a48339ebd7_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMjYtMS0xLTEtOTA2MDk_2cd82cc5-d9bb-4198-b065-2bf3cc7d4534"
      unitRef="usd">150293649</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i39b3f93aa3714933b05800e10c00a387_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMjYtMy0xLTEtOTA2MDk_08745514-cabb-488c-ab19-44b466822a61"
      unitRef="usd">150000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockValue
      contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMjktMS0xLTEtOTA2MDk_d373fc66-e885-4ba6-81fd-ae0c5634028b"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMjktMy0xLTEtOTA2MDk_e4be30b9-8767-4e67-9b7e-1722fece0b1f"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockValue
      contextRef="i2a9d6acf0a3443b8a9bfd210dcef6a0e_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMzAtMS0xLTEtOTA2MDk_a43f5e80-5c03-4b37-a38e-cbf3cb7d224c"
      unitRef="usd">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ib763267d74d64b8fbe45ac357a9f8f08_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMzAtMy0xLTEtOTA2MDk_d28487ac-8dfb-4633-982f-c085b65979dd"
      unitRef="usd">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i28b4565471d542708454f455b422d119_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMzEtMS0xLTEtOTA2MDk_3df73ba7-f733-4009-980b-d68354aec3e0"
      unitRef="usd">375</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="id57512e5cedd4b74bc2f1786d35220d2_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMzEtMy0xLTEtOTA2MDk_8a0ce581-d78e-49fc-afd3-a8c9164d40ed"
      unitRef="usd">375</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMzItMS0xLTEtOTA2MDk_e6c12ebd-440b-4798-8607-e77b04a16025"
      unitRef="usd">0</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMzItMy0xLTEtOTA2MDk_2461198c-44b8-4e1b-9758-84c86daff406"
      unitRef="usd">0</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMzMtMS0xLTEtOTA2MDk_4003378a-edb1-498f-86df-1e747b74c90c"
      unitRef="usd">-5099235</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMzMtMy0xLTEtOTA2MDk_06764561-dffb-4526-a866-e3f98e4bf315"
      unitRef="usd">-10739971</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMzQtMS0xLTEtOTA2MDk_137c6e43-506b-4a12-bb15-53bc388053e1"
      unitRef="usd">-5098860</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMzQtMy0xLTEtOTA2MDk_c145527f-2e45-4d38-bc2e-1aabbc68772d"
      unitRef="usd">-10739596</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMzUtMS0xLTEtOTA2MDk_b11b73c9-056e-4e6e-8302-84579ed8b573"
      unitRef="usd">151254582</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMC9mcmFnOmJjZDE1ZmFlMWM5ZjRkZWE4NzU5NTI3NjRjNTk3ZWU4L3RhYmxlOjBlYWFlZDQyMzNjNzQyMjA4NDRhNjg4OGVkMGYzY2UzL3RhYmxlcmFuZ2U6MGVhYWVkNDIzM2M3NDIyMDg0NGE2ODg4ZWQwZjNjZTNfMzUtMy0xLTEtOTA2MDk_2869497c-7883-4eba-9626-c4b3fac9f40d"
      unitRef="usd">150871760</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMS0xLTEtMS05MDYwOQ_ad48e93e-1adf-49d1-9989-602472d0f58c"
      unitRef="usd">876343</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMS0zLTEtMS05MDYwOQ_880846db-f6f2-4e2f-98c3-0627adba83de"
      unitRef="usd">284686</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMS01LTEtMS05MDYwOQ_74109254-c1ca-41d1-bc52-b117471c987d"
      unitRef="usd">3677205</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMS03LTEtMS05MDYwOQ_5b9ad450-4da6-49f2-89e4-cd86f5a3f14a"
      unitRef="usd">286255</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
      contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMi0xLTEtMS05MDYwOQ_7f1517f9-29db-4bb8-90d7-01fecd3d4cf4"
      unitRef="usd">30000</us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
      contextRef="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMi0zLTEtMS05MDYwOQ_461b088a-758f-4de8-8bb4-4f5b4b3e35a0"
      unitRef="usd">20000</us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
      contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMi01LTEtMS05MDYwOQ_d8512674-ac8c-422b-926b-dac3329f9ec0"
      unitRef="usd">90000</us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMi03LTEtMS05MDYwOQ_2ff127bf-1e26-42e5-be65-35a75ab845f2"
      unitRef="usd">20000</us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty>
    <amci:CapitalBaseTaxExpense
      contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMy0xLTEtMS05MDYwOQ_59dbe8ab-e560-495a-853a-0512ab9c4c06"
      unitRef="usd">75797</amci:CapitalBaseTaxExpense>
    <amci:CapitalBaseTaxExpense
      contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMy01LTEtMS05MDYwOQ_13e3834d-3b33-4151-8514-ea5d64612dce"
      unitRef="usd">183578</amci:CapitalBaseTaxExpense>
    <us-gaap:ProductionTaxExpense
      contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfNC0xLTEtMS05MDYwOQ_74041c60-f2b4-4914-8b75-69ffab5b22a4"
      unitRef="usd">50411</us-gaap:ProductionTaxExpense>
    <us-gaap:ProductionTaxExpense
      contextRef="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfNC0zLTEtMS05MDYwOQ_4481562f-fc27-47f8-a776-9ef7e3cfaef5"
      unitRef="usd">134845</us-gaap:ProductionTaxExpense>
    <us-gaap:ProductionTaxExpense
      contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfNC01LTEtMS05MDYwOQ_316ec4be-91f1-45db-b038-3e823e3b7993"
      unitRef="usd">149639</us-gaap:ProductionTaxExpense>
    <us-gaap:ProductionTaxExpense
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfNC03LTEtMS05MDYwOQ_59c7e584-d51c-4f81-965c-0d14b7dbb269"
      unitRef="usd">134845</us-gaap:ProductionTaxExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfNS0xLTEtMS05MDYwOQ_465b5760-d02d-4f7a-b0ee-08dea17dbba7"
      unitRef="usd">-1032551</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfNS0zLTEtMS05MDYwOQ_c40ff9cc-e0c1-44d4-aaa0-37b63102bbf1"
      unitRef="usd">-439531</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfNS01LTEtMS05MDYwOQ_d4a86e9f-f30d-4649-a43f-6908bed64293"
      unitRef="usd">-4100422</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfNS03LTEtMS05MDYwOQ_613fb58f-51c7-4e20-9c3c-898aada41a86"
      unitRef="usd">-441100</us-gaap:OperatingIncomeLoss>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfNy0xLTEtMS05MDYwOQ_2b028052-4f17-4b57-8289-5f774fa5467c"
      unitRef="usd">-1426720</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfNy0zLTEtMS05MDYwOQ_c299dcd7-4093-49f6-8440-617a996f7606"
      unitRef="usd">-1382900</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfNy01LTEtMS05MDYwOQ_fc84d293-a905-4f95-ab09-7c7267e15676"
      unitRef="usd">-4066720</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfNy03LTEtMS05MDYwOQ_2ffa446d-0610-406f-8ecb-3bdb2f7b80f1"
      unitRef="usd">-1382900</us-gaap:FairValueAdjustmentOfWarrants>
    <amci:GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants
      contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfOC0xLTEtMS05MDYwOQ_726c342f-f597-4825-9c7e-8e09a72cfbf8"
      unitRef="usd">171700</amci:GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants>
    <amci:GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants
      contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfOC01LTEtMS05MDYwOQ_c1837017-9cfd-45fe-9a5c-d8c6af86cf8c"
      unitRef="usd">171700</amci:GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants>
    <amci:OfferingCostsAllocatedToDerivativeWarrantLiabilities
      contextRef="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfOS0zLTEtMS05MDYwOQ_6b67d525-faee-430c-a4a2-028d75b754a4"
      unitRef="usd">476450</amci:OfferingCostsAllocatedToDerivativeWarrantLiabilities>
    <amci:OfferingCostsAllocatedToDerivativeWarrantLiabilities
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfOS03LTEtMS05MDYwOQ_2253877b-3686-4d44-8aac-82f95278ba64"
      unitRef="usd">476450</amci:OfferingCostsAllocatedToDerivativeWarrantLiabilities>
    <amci:IncomeFromInvestmentsHeldInTrustAccount
      contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTAtMS0xLTEtOTA2MDk_80c0ce7c-8224-4230-9bcd-1d6949de14e9"
      unitRef="usd">733042</amci:IncomeFromInvestmentsHeldInTrustAccount>
    <amci:IncomeFromInvestmentsHeldInTrustAccount
      contextRef="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTAtMy0xLTEtOTA2MDk_2d6a6ba4-8fd2-4aac-9df8-c6c2199a6b64"
      unitRef="usd">2178</amci:IncomeFromInvestmentsHeldInTrustAccount>
    <amci:IncomeFromInvestmentsHeldInTrustAccount
      contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTAtNS0xLTEtOTA2MDk_48d3c546-8e69-4727-bc47-39c2e95d7532"
      unitRef="usd">972453</amci:IncomeFromInvestmentsHeldInTrustAccount>
    <amci:IncomeFromInvestmentsHeldInTrustAccount
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTAtNy0xLTEtOTA2MDk_7130b32f-484c-44d7-906f-1315fe0f0d07"
      unitRef="usd">2178</amci:IncomeFromInvestmentsHeldInTrustAccount>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTEtMS0xLTEtOTA2MDk_4604b14f-75bc-47aa-a0ad-b81d11e14fe3"
      unitRef="usd">1298911</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTEtMy0xLTEtOTA2MDk_8da824e1-de6b-4a3f-ae04-79211afc53bc"
      unitRef="usd">469097</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTEtNS0xLTEtOTA2MDk_0a95ffab-2ca7-4644-8237-0037031a644e"
      unitRef="usd">1110451</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTEtNy0xLTEtOTA2MDk_78b095f5-2202-4050-aeab-b62cd9946dee"
      unitRef="usd">467528</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTItMS0xLTEtOTA2MDk_2df7ba50-c60c-42a5-9923-5d0b0f6fee0c"
      unitRef="usd">54366</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTItNS0xLTEtOTA2MDk_5410277d-8081-41d4-a2ed-7757a797cb2c"
      unitRef="usd">54366</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTMtMS0xLTEtOTA2MDk_58d8e922-0e56-4332-91a3-a64e27bedccf"
      unitRef="usd">1244545</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTMtMy0xLTEtOTA2MDk_292bcb37-f14a-4c16-9930-e8d8805ba1fa"
      unitRef="usd">469097</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTMtNS0xLTEtOTA2MDk_6666b3d8-e41e-4080-b1c8-d03f6ae15c10"
      unitRef="usd">1056085</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTMtNy0xLTEtOTA2MDk_84325c71-9904-4704-9770-7a710ea0da75"
      unitRef="usd">467528</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7ec1172d9fda413997c83cfd78da69a8_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTUtMS0xLTEtOTA2MDk_c0b9da0a-2858-4a80-96e1-bc36c7ea8ac8"
      unitRef="shares">15000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i7ec1172d9fda413997c83cfd78da69a8_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTUtMS0xLTEtOTA2MDk_c43d3ea0-baec-4af3-b87b-946e48b66bb9"
      unitRef="shares">15000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia6e8e0bf44ba47628681fa0a2b0c4d8e_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTUtMy0xLTEtOTA2MDk_338f46a2-a749-4bfb-a482-fab22e34803d"
      unitRef="shares">9130435</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia6e8e0bf44ba47628681fa0a2b0c4d8e_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTUtMy0xLTEtOTA2MDk_6bff9245-0e84-49c5-abe0-dbb9f3cecd6f"
      unitRef="shares">9130435</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i54e04e92a2f745c79145378982854e9d_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTUtNS0xLTEtOTA2MDk_1fc4fe8d-f7a5-495b-a931-83035ed3511d"
      unitRef="shares">15000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i54e04e92a2f745c79145378982854e9d_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTUtNS0xLTEtOTA2MDk_ab4413ff-356c-43a1-a259-dcb1b4c4b76c"
      unitRef="shares">15000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia80b8151be5a4bbda59a9bd0f4d2f0d4_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTUtNy0xLTEtOTA2MDk_3bd8277a-a0ed-4b64-b816-0c852ea47e65"
      unitRef="shares">3428571</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia80b8151be5a4bbda59a9bd0f4d2f0d4_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTUtNy0xLTEtOTA2MDk_978013b4-79f2-484c-9416-ca750773c4fd"
      unitRef="shares">3428571</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7ec1172d9fda413997c83cfd78da69a8_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTYtMS0xLTEtOTA2MDk_6bac8f29-f587-4948-9bdd-bab9345de1cf"
      unitRef="usdPerShare">0.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7ec1172d9fda413997c83cfd78da69a8_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTYtMS0xLTEtOTA2MDk_91c2bc70-adc1-4e02-8adc-856bf06f3f6b"
      unitRef="usdPerShare">0.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia6e8e0bf44ba47628681fa0a2b0c4d8e_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTYtMy0xLTEtOTA2MDk_016a37eb-1435-4fd1-9493-626969d90139"
      unitRef="usdPerShare">0.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia6e8e0bf44ba47628681fa0a2b0c4d8e_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTYtMy0xLTEtOTA2MDk_f8c929d6-7f0e-45d2-b32e-5803e03592db"
      unitRef="usdPerShare">0.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i54e04e92a2f745c79145378982854e9d_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTYtNS0xLTEtOTA2MDk_874cba48-848c-4822-a872-c2ae644843eb"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i54e04e92a2f745c79145378982854e9d_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTYtNS0xLTEtOTA2MDk_c1cdc175-bc63-48c8-8fcb-923a9f4d353e"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia80b8151be5a4bbda59a9bd0f4d2f0d4_D20210128-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTYtNy0xLTEtOTA2MDk_b37bbde1-f735-468d-b50f-1584ea42656d"
      unitRef="usdPerShare">0.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia80b8151be5a4bbda59a9bd0f4d2f0d4_D20210128-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTYtNy0xLTEtOTA2MDk_c2764a6a-f7ef-4383-86ae-2c8f8edd5b38"
      unitRef="usdPerShare">0.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5c83b432fed543cdbb0ae452750d8666_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTctMS0xLTEtOTA2MDk_10011bb1-915b-49c0-8858-302ff37c7a49"
      unitRef="shares">3750000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5c83b432fed543cdbb0ae452750d8666_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTctMS0xLTEtOTA2MDk_dba84638-a64a-413d-aefb-2da14d8be922"
      unitRef="shares">3750000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib0792dc9052f4435aec8f1746381b495_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTctMy0xLTEtOTA2MDk_4408f2d8-8315-4d88-8adc-aeaed6b7ecc5"
      unitRef="shares">3750000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib0792dc9052f4435aec8f1746381b495_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTctMy0xLTEtOTA2MDk_dbbebf20-0cda-4882-95c8-af6badd2d824"
      unitRef="shares">3750000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie106d118b90b4570a0b940a2a0611875_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTctNS0xLTEtOTA2MDk_0fc39d83-0e4e-471e-9064-89126f7fc961"
      unitRef="shares">3750000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie106d118b90b4570a0b940a2a0611875_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTctNS0xLTEtOTA2MDk_920ce994-7640-4ff6-b2be-241e461be604"
      unitRef="shares">3750000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i14e0883a4b7e4c05850198fa191fd751_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTctNy0xLTEtOTA2MDk_5e0d264a-c9e2-4db8-ac4f-7c63288b43a8"
      unitRef="shares">3750000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i14e0883a4b7e4c05850198fa191fd751_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTctNy0xLTEtOTA2MDk_a9096d44-010d-416c-bc6a-86ce0352a9e3"
      unitRef="shares">3750000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5c83b432fed543cdbb0ae452750d8666_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTgtMS0xLTEtOTA2MDk_144b7e08-1564-41c3-a876-e89513b56556"
      unitRef="usdPerShare">0.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5c83b432fed543cdbb0ae452750d8666_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTgtMS0xLTEtOTA2MDk_178d7683-ba47-456d-9295-906c5b22d5dd"
      unitRef="usdPerShare">0.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib0792dc9052f4435aec8f1746381b495_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTgtMy0xLTEtOTA2MDk_68c28f90-16ec-43d8-831a-f749cec949af"
      unitRef="usdPerShare">0.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib0792dc9052f4435aec8f1746381b495_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTgtMy0xLTEtOTA2MDk_75ae0364-c050-4f34-acfd-83effc2d9e1b"
      unitRef="usdPerShare">0.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie106d118b90b4570a0b940a2a0611875_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTgtNS0xLTEtOTA2MDk_1bcefe41-4e92-42b4-8281-fefa28036792"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie106d118b90b4570a0b940a2a0611875_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTgtNS0xLTEtOTA2MDk_b39ca7c5-216d-4d96-acba-7118d02df5a1"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i14e0883a4b7e4c05850198fa191fd751_D20210128-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTgtNy0xLTEtOTA2MDk_0e2c0e55-cbed-48c1-9a08-eac5328fbf4a"
      unitRef="usdPerShare">0.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i14e0883a4b7e4c05850198fa191fd751_D20210128-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xNi9mcmFnOjBlZTg1MWQ5OTFjZTQ4OTQ4OTE0MTRjOWQ1NDU4OTk3L3RhYmxlOjE3OTE4YjQ3OTA5NjRkZTliNjIwMjI5NThlNDRjZTFjL3RhYmxlcmFuZ2U6MTc5MThiNDc5MDk2NGRlOWI2MjAyMjk1OGU0NGNlMWNfMTgtNy0xLTEtOTA2MDk_c5531584-8d7b-4ff7-95bb-f6639b4136ea"
      unitRef="usdPerShare">0.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:SharesIssued
      contextRef="i561b8e9c306343cbaa06d16947928777_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMy0xLTEtMS05MDYwOQ_8e7c76e5-414b-4abb-9755-55b47b30bd93"
      unitRef="shares">0</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i561b8e9c306343cbaa06d16947928777_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMy0zLTEtMS05MDYwOQ_1ac29fbc-572e-42c7-a8dd-eba02ba56228"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i0df54c9e466f4cee877df6ba1a2a8b5c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMy01LTEtMS05MDYwOQ_a6d00d93-4369-4f08-87b1-8fc23686ec5e"
      unitRef="shares">3750000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i0df54c9e466f4cee877df6ba1a2a8b5c_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMy03LTEtMS05MDYwOQ_714683c2-863c-47ab-94c2-bdc02e6c2dbd"
      unitRef="usd">375</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8d10e6b77d0f437bb89153397dd47b71_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMy05LTEtMS05MDYwOQ_6a711e0b-99f5-472d-ac27-0b473b495ccc"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i331e64d7b36f44f3a66c631e0f8eeddb_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMy0xMS0xLTEtOTA2MDk_e93e44e3-2b39-4e63-9f19-e3a1de1af59a"
      unitRef="usd">-10739971</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMy0xMy0xLTEtOTA2MDk_ca3340c9-ff41-4caa-bf3a-4714dcbdb3ac"
      unitRef="usd">-10739596</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="iccfd9da1f9504cf29912dc80db305fc8_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfNC0xMS0xLTEtOTA2MDk_0ea731a3-257c-4832-b7e2-ccd66e008400"
      unitRef="usd">-3542722</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib7947124f41844b0939436b1a8f133ad_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfNC0xMy0xLTEtOTA2MDk_2317d8d6-1cc0-4f41-b25b-f6b6857642f0"
      unitRef="usd">-3542722</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="i0d0aee75172442178da88056a9989307_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfNS01LTEtMS05MDYwOQ_6f1bcee4-5163-449d-a859-1c15effb357a"
      unitRef="shares">3750000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i0d0aee75172442178da88056a9989307_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfNS03LTEtMS05MDYwOQ_5c045fce-4d7d-40d9-9e62-188c92005bed"
      unitRef="usd">375</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ida7b05626e374502819328077c492d48_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfNS0xMS0xLTEtOTA2MDk_bb4b1fc5-f502-45cb-b514-b6c324c1108f"
      unitRef="usd">-14282693</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie90832410d85447aa964ca438ac09c5f_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfNS0xMy0xLTEtOTA2MDk_11e7821a-a5fd-4e5b-a3b4-07d69c18fc64"
      unitRef="usd">-14282318</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i6c3171eddba54a6b8c58c3219dea0549_D20220401-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfNi0xMS0xLTEtOTA2MDk_e46aba94-029d-40b3-8c63-adcb836e35c6"
      unitRef="usd">3354262</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0c13bbdaf19b4cd897fbbb738aa40bdb_D20220401-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfNi0xMy0xLTEtOTA2MDk_f7e04d16-83a4-4931-9f87-94bab145e6fe"
      unitRef="usd">3354262</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="iaf261b46a23c49b4a762205835c271ab_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfNy01LTEtMS05MDYwOQ_c2c5ecbd-6bfa-4619-a730-10894f68ec88"
      unitRef="shares">3750000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="iaf261b46a23c49b4a762205835c271ab_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfNy03LTEtMS05MDYwOQ_40a6e66b-bc6e-48c2-8907-7774272cf11f"
      unitRef="usd">375</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i85ee8ec1448f491faaa8d5f1b8a40824_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfNy0xMS0xLTEtOTA2MDk_572a2c0f-5e53-4658-82dd-be9c0de8208c"
      unitRef="usd">-10928431</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i34104a0f3a774be48e18d60b95cb9e34_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfNy0xMy0xLTEtOTA2MDk_26328b7f-04b7-43e3-87d8-31298f19ce88"
      unitRef="usd">-10928056</us-gaap:StockholdersEquity>
    <amci:AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares
      contextRef="ie631ef4e3c7041e688921b3859fca7f5_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfOC05LTEtMS05MDYwOQ_d194c861-0864-44aa-b3c0-593c08e314c6"
      unitRef="usd">4878300</amci:AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares>
    <amci:AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares
      contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfOC0xMy0xLTEtOTA2MDk_d795fb90-302d-4323-a50a-0599e1b54eb7"
      unitRef="usd">4878300</amci:AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="ie631ef4e3c7041e688921b3859fca7f5_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfOS05LTEtMS05MDYwOQ_73e054e0-6b8f-44b6-9e76-923650fa1172"
      unitRef="usd">-4878300</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="i5d521767d60745fd9681006b5cd0f52f_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfOS0xMS0xLTEtOTA2MDk_5404fb44-84e5-4cf5-8e11-c7374ca05e9a"
      unitRef="usd">4878300</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <amci:IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption
      contextRef="i5d521767d60745fd9681006b5cd0f52f_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMTAtMTEtMS0xLTkwNjA5_941828e3-1f7b-4749-a15e-8b7e296e0f48"
      unitRef="usd">-293649</amci:IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption>
    <amci:IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption
      contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMTAtMTMtMS0xLTkwNjA5_02483270-035b-4b67-bea3-6e122a801d13"
      unitRef="usd">-293649</amci:IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption>
    <us-gaap:NetIncomeLoss
      contextRef="i5d521767d60745fd9681006b5cd0f52f_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMTEtMTEtMS0xLTkwNjA5_122ea289-a932-4c3d-a9a9-0f47c79f8fc1"
      unitRef="usd">1244545</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMTEtMTMtMS0xLTkwNjA5_0f063875-756f-43e8-b9cf-710253dbc021"
      unitRef="usd">1244545</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="i0bb75187403d4c7096a2ecce94a1cfe2_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMTItMS0xLTEtOTA2MDk_37435952-21e3-4439-9aec-412fd3c8b5f0"
      unitRef="shares">0</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i0bb75187403d4c7096a2ecce94a1cfe2_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMTItMy0xLTEtOTA2MDk_4ae20d00-e0e9-4b8b-938d-5a7e2984d06d"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="ic24c8091c8be4348b39159f1dd9591dc_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMTItNS0xLTEtOTA2MDk_31a82efc-713f-427b-92f9-88c320ae3df6"
      unitRef="shares">3750000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ic24c8091c8be4348b39159f1dd9591dc_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMTItNy0xLTEtOTA2MDk_4108af23-a212-4912-8d9a-d3de5a2b2c76"
      unitRef="usd">375</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i54638a76c0754184ad34989edb55bad0_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMTItOS0xLTEtOTA2MDk_1cfee17e-48e1-4e34-b6f7-59e227595be9"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idc67725111024800a8fe8de4f7e18d06_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMTItMTEtMS0xLTkwNjA5_1da54b12-4cc5-4dbd-9cd0-8c99a7769485"
      unitRef="usd">-5099235</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhlZGM5NjVlNmQzZTRjYzU5YTBhZjc3NDg5MDQwZjIxL3RhYmxlcmFuZ2U6OGVkYzk2NWU2ZDNlNGNjNTlhMGFmNzc0ODkwNDBmMjFfMTItMTMtMS0xLTkwNjA5_22963c06-10d7-4935-9793-9da243bef4db"
      unitRef="usd">-5098860</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="ic0513771cd0245b88eec6099822e8d74_I20210127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMy0xLTEtMS05MDYwOQ_be5905d5-ce0d-4733-9830-920ff496649d"
      unitRef="shares">0</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ic0513771cd0245b88eec6099822e8d74_I20210127"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMy0zLTEtMS05MDYwOQ_41a0c083-d260-4670-b6f3-7fa0d2b7eb76"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i763e0a3dbecb4e3795d7f408cf8a20d5_I20210127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMy01LTEtMS05MDYwOQ_046fc7f9-e92c-4215-8bc0-44581c93a078"
      unitRef="shares">0</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i763e0a3dbecb4e3795d7f408cf8a20d5_I20210127"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMy03LTEtMS05MDYwOQ_c5ec1aff-ac20-4298-8567-59992221aa62"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iec832394a7514357811e3f793e5b673f_I20210127"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMy05LTEtMS05MDYwOQ_823c7014-c71a-44d0-8a92-07abe2949ee4"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifc4dbb45fe26489b9bca7b77497e7ca7_I20210127"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMy0xMS0xLTEtOTA2MDk_6cc7afb8-2dcd-4bb7-b050-3b1aba658d46"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib90981c31c9b45a98ded9929aeaa406e_I20210127"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMy0xMy0xLTEtOTA2MDk_1104efbb-4951-4776-873d-f08ff0bcce1e"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="iacb1cd84cde241edbd72d0fcbd87e137_D20210128-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfNC01LTEtMS05MDYwOQ_50fe5d28-a220-4eb1-be83-31c5d31294db"
      unitRef="shares">4312500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="iacb1cd84cde241edbd72d0fcbd87e137_D20210128-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfNC03LTEtMS05MDYwOQ_1f7e8abf-a1ea-4c9a-9607-d4c5a5f3c535"
      unitRef="usd">431</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i68b075b25b0c44f6a65dc37835ddacab_D20210128-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfNC05LTEtMS05MDYwOQ_57632a2b-2dd0-4366-87ec-eb4652ce5a00"
      unitRef="usd">24569</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i60a5cae9cdab4813bb1586b3eb4d1453_D20210128-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfNC0xMy0xLTEtOTA2MDk_4a98a8ec-270a-4bb6-b5fe-1601c539ab91"
      unitRef="usd">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:NetIncomeLoss
      contextRef="ic78d5d5e9dab4e66927c72ef3a01cffb_D20210128-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfNS0xMS0xLTEtOTA2MDk_699a5701-eb9f-4a44-99b3-f3641fe53058"
      unitRef="usd">-1126</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i60a5cae9cdab4813bb1586b3eb4d1453_D20210128-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfNS0xMy0xLTEtOTA2MDk_dba78a6f-805a-48c6-b14e-cdc04482e15c"
      unitRef="usd">-1126</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="ia238c2a996b14c81929dd59e484951e5_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfNi0xLTEtMS05MDYwOQ_24e1bc97-de9d-4ba7-a086-1b8e33881b44"
      unitRef="shares">0</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ia238c2a996b14c81929dd59e484951e5_I20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfNi0zLTEtMS05MDYwOQ_beb44767-6b75-48d2-8fad-5f9bb7d6639d"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i5f0fcd477eed4404a2b0dc7ab62aec98_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfNi01LTEtMS05MDYwOQ_cc158baa-cc54-402c-8206-3ef434708707"
      unitRef="shares">4312500</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i5f0fcd477eed4404a2b0dc7ab62aec98_I20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfNi03LTEtMS05MDYwOQ_aa00a1ff-e175-467f-b0a3-d895dfde03a6"
      unitRef="usd">431</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i79b3bc37e87346618fe34e2a23526ca7_I20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfNi05LTEtMS05MDYwOQ_72a838f4-6e2f-4f1f-9dc9-71a5eebb77c5"
      unitRef="usd">24569</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i44e48778017342f3ab0160bb5770cda2_I20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfNi0xMS0xLTEtOTA2MDk_1482f512-0e01-49dc-827d-fa6d80ef67e2"
      unitRef="usd">-1126</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i97e926931d264729ab7aaa14e1843a88_I20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfNi0xMy0xLTEtOTA2MDk_2777d9d4-a62c-4de9-b75b-229ef5b1c251"
      unitRef="usd">23874</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ie687fdc1ee234a2686233327949a762b_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfNy0xMS0xLTEtOTA2MDk_6799ac80-9a74-4747-930a-4da9f5953122"
      unitRef="usd">-443</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8155dd44f1cf44b6963742cb3e993f91_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfNy0xMy0xLTEtOTA2MDk_8376991a-f744-4623-9121-3f4bd5a8c501"
      unitRef="usd">-443</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="ic3756d2ccfa146a8b4a56cd8bc84e1d6_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfOC0xLTEtMS05MDYwOQ_6f4a65b6-cd5f-4f90-96ed-00d496be8ad9"
      unitRef="shares">0</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ic3756d2ccfa146a8b4a56cd8bc84e1d6_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfOC0zLTEtMS05MDYwOQ_88e6420f-abe8-4f57-96e6-7f74f21ebae9"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="ib1634b21bc004766bd5719101e1d1b9a_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfOC01LTEtMS05MDYwOQ_39af1f34-9cae-4a7b-8c42-b6cc9f427096"
      unitRef="shares">4312500</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ib1634b21bc004766bd5719101e1d1b9a_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfOC03LTEtMS05MDYwOQ_3c189e79-8cfb-4908-b54a-85e33cf189e8"
      unitRef="usd">431</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3cd57aeb02fe49d7ab3297670b39a5ec_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfOC05LTEtMS05MDYwOQ_f8d209ab-7ee9-446f-8ea1-262c1496674e"
      unitRef="usd">24569</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if5e9fb5e65ac48fcaf2c511cdde6838a_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfOC0xMS0xLTEtOTA2MDk_c8f3c07c-109c-4f96-8b95-85fdd4685af1"
      unitRef="usd">-1569</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5bd791fd96c546dbb9c9ea8bb1d75555_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfOC0xMy0xLTEtOTA2MDk_d322be7c-ab14-40d6-aae8-5e561b27d0cf"
      unitRef="usd">23431</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="i872f016ca939404ab1d0fbc4771bc03a_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfOS05LTEtMS05MDYwOQ_03cbb36b-1c1a-4aed-9bdb-94ec653e2dd2"
      unitRef="usd">1085000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfOS0xMy0xLTEtOTA2MDk_5dda3c9f-483c-435e-9d2f-feeca1228770"
      unitRef="usd">1085000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="i7bef5324e72a48db9ebecc0f92eacda1_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTAtNS0xLTEtOTA2MDk_e7ad7e59-4cd9-4688-bdf3-29bc37ca4339"
      unitRef="shares">562500</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="i7bef5324e72a48db9ebecc0f92eacda1_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTAtNy0xLTEtOTA2MDk_b5f6c6d2-8ab5-4465-a5cb-cb53e01f7718"
      unitRef="usd">56</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="i872f016ca939404ab1d0fbc4771bc03a_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTAtOS0xLTEtOTA2MDk_a3720688-ef12-415f-8953-200d6afcd9c4"
      unitRef="usd">-56</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <amci:ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors
      contextRef="i872f016ca939404ab1d0fbc4771bc03a_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTEtOS0xLTEtOTA2MDk_530deeee-4df9-4e56-8d55-d4317d0e8d74"
      unitRef="usd">6509758</amci:ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors>
    <amci:ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors
      contextRef="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTEtMTMtMS0xLTkwNjA5_195fc3aa-bd4a-44cf-9883-b0aa74f66d80"
      unitRef="usd">6509758</amci:ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="i872f016ca939404ab1d0fbc4771bc03a_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTItOS0xLTEtOTA2MDk_fb272d73-549c-4376-a8ab-4b335996de38"
      unitRef="usd">7619383</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="i3ef0abc6bb5e4c13a1e3275c01c2d9be_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTItMTEtMS0xLTkwNjA5_16bcb312-f38d-4d3e-b5d4-9e7ad980329d"
      unitRef="usd">10786709</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTItMTMtMS0xLTkwNjA5_75f5690a-b147-4452-a10f-fb91ff255cfd"
      unitRef="usd">18406092</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:NetIncomeLoss
      contextRef="i3ef0abc6bb5e4c13a1e3275c01c2d9be_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTMtMTEtMS0xLTkwNjA5_e73573d1-44a4-4d13-a7d7-22968e1b5679"
      unitRef="usd">469097</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTMtMTMtMS0xLTkwNjA5_f5e360d2-2637-485d-8259-d57dc52ca4ef"
      unitRef="usd">469097</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="i54a9911fbd55474198f366931f8bbeda_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTQtMS0xLTEtOTA2MDk_39375110-dbed-43f6-a4aa-c74089ed1337"
      unitRef="shares">0</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i54a9911fbd55474198f366931f8bbeda_I20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTQtMy0xLTEtOTA2MDk_47b4c867-f03d-48eb-90ce-4a1de5c90369"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i6c5914aab6b6409fa89292f8b33f2d63_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTQtNS0xLTEtOTA2MDk_17bc6eaf-f282-47e4-8bb7-10250d7048c7"
      unitRef="shares">3750000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i6c5914aab6b6409fa89292f8b33f2d63_I20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTQtNy0xLTEtOTA2MDk_bf0e2fc0-187e-426b-b9c3-f9f8640da066"
      unitRef="usd">375</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1cfc7a3d369645768bf19279957b83f3_I20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTQtMTEtMS0xLTkwNjA5_682c613f-366f-48dd-9e5c-61cd91625a1a"
      unitRef="usd">-10319181</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if96f4a11922442b08faec4138ba298eb_I20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xOS9mcmFnOjc2Nzk2YjgwYjViZTQ2ZmI4NDJjMmU3Y2FhMWY0NjMwL3RhYmxlOjhjYjk0MGQ1YjZkNDRhY2E4MDMxNjBhZTRhNjVhZGJkL3RhYmxlcmFuZ2U6OGNiOTQwZDViNmQ0NGFjYTgwMzE2MGFlNGE2NWFkYmRfMTQtMTMtMS0xLTkwNjA5_07045090-6b80-4f7a-b43e-c99ed72e000a"
      unitRef="usd">-10318806</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMi0xLTEtMS05MDYwOQ_c32800d3-9c17-4437-a4d0-54945dec77d4"
      unitRef="usd">1056085</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMi0zLTEtMS05MDYwOQ_8ee7f3b4-4f8d-4e22-a8d1-f71ff1f06c7f"
      unitRef="usd">467528</us-gaap:ProfitLoss>
    <amci:GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfNC0zLTEtMS05MDYwOQ_47711072-5767-46fe-a2a7-d2483b5a7236"
      unitRef="usd">1000</amci:GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfNS0xLTEtMS05MDYwOQ_19d3f13a-a4bc-47b4-8991-e5bc26874f95"
      unitRef="usd">-4066720</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfNS0zLTEtMS05MDYwOQ_287f52df-211d-4801-bcd9-55624e5a33fc"
      unitRef="usd">-1382900</us-gaap:FairValueAdjustmentOfWarrants>
    <amci:GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants
      contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfNi0xLTEtMS05MDYwOQ_ca2ed25d-f419-4f1d-9574-57517a6ef5ef"
      unitRef="usd">171700</amci:GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants>
    <amci:OfferingCostsAllocatedToDerivativeWarrantLiabilities
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfNy0zLTEtMS05MDYwOQ_a211f24b-d927-47af-8470-fd8479fdb95c"
      unitRef="usd">476450</amci:OfferingCostsAllocatedToDerivativeWarrantLiabilities>
    <amci:IncomeFromInvestmentsHeldInTrustAccount
      contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfOC0xLTEtMS05MDYwOQ_ca03f775-7819-4a36-ac0c-eadfe8d1a16f"
      unitRef="usd">972453</amci:IncomeFromInvestmentsHeldInTrustAccount>
    <amci:IncomeFromInvestmentsHeldInTrustAccount
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfOC0zLTEtMS05MDYwOQ_0724d90a-3c7f-4d8c-a4b0-8f900c746172"
      unitRef="usd">2178</amci:IncomeFromInvestmentsHeldInTrustAccount>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMTAtMS0xLTEtOTA2MDk_ca7e12c9-1b9e-4554-a172-d1b093902829"
      unitRef="usd">-244534</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMTAtMy0xLTEtOTA2MDk_cb818a0c-161a-44d2-a741-fad244829515"
      unitRef="usd">-49173</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMTEtMS0xLTEtOTA2MDk_3d037858-e462-494f-be9a-0280b717bf31"
      unitRef="usd">1602381</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMTEtMy0xLTEtOTA2MDk_3195a0aa-41d9-41de-b285-78cbd588084c"
      unitRef="usd">3000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <amci:IncreaseDecreaseInDueToRelatedParties.
      contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMTItMS0xLTEtOTA2MDk_d42fa0e7-0608-400b-b12f-18fa8ab6d6fa"
      unitRef="usd">686400</amci:IncreaseDecreaseInDueToRelatedParties.>
    <amci:IncreaseDecreaseInDueToRelatedParties.
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMTItMy0xLTEtOTA2MDk_68423b72-8911-49a9-b578-377ff1fccad5"
      unitRef="usd">19723</amci:IncreaseDecreaseInDueToRelatedParties.>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMTMtMS0xLTEtOTA2MDk_7198266c-7058-4ede-b998-b6506a1d79df"
      unitRef="usd">1127030</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMTMtMy0xLTEtOTA2MDk_3adb603e-512e-47f5-90db-404dcd4ccff0"
      unitRef="usd">138034</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <amci:IncreaseDecreaseInCapitalBaseTaxPayable
      contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMTQtMS0xLTEtOTA2MDk_8bc83ddc-be83-412a-83d9-4218c4d34af5"
      unitRef="usd">133578</amci:IncreaseDecreaseInCapitalBaseTaxPayable>
    <amci:IncreaseDecreaseFranchiseTaxPayable
      contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMTUtMS0xLTEtOTA2MDk_aa326f6a-03a5-4d59-82b0-9bb2459e1d74"
      unitRef="usd">-38598</amci:IncreaseDecreaseFranchiseTaxPayable>
    <amci:IncreaseDecreaseFranchiseTaxPayable
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMTUtMy0xLTEtOTA2MDk_1b6e1ae6-8846-42bf-9d96-816655db1f7a"
      unitRef="usd">134845</amci:IncreaseDecreaseFranchiseTaxPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMTYtMS0xLTEtOTA2MDk_75dd9845-20c6-45b2-9a8a-fbb256881da7"
      unitRef="usd">54366</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMTctMS0xLTEtOTA2MDk_67be43c7-257e-4459-be7f-2ecc839d12dc"
      unitRef="usd">-345097</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMTctMy0xLTEtOTA2MDk_3be58d7e-c0e7-4769-b044-ab6be495689c"
      unitRef="usd">-95325</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireTrustPreferredInvestments
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMjAtMy0xLTEtOTA2MDk_75f06b58-2358-400a-97d9-a826a30812f9"
      unitRef="usd">150000000</us-gaap:PaymentsToAcquireTrustPreferredInvestments>
    <amci:PaymentsForInvestmentOfCashInTrustAccount
      contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMjEtMS0xLTEtOTA2MDk_c9c9f7ff-d2f7-4347-92c6-12ad79880a2f"
      unitRef="usd">-9000</amci:PaymentsForInvestmentOfCashInTrustAccount>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMjItMS0xLTEtOTA2MDk_ccfd6832-4ad2-4d4b-9ddf-8a34e4db70fa"
      unitRef="usd">9000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMjItMy0xLTEtOTA2MDk_4263a845-7ad8-43cc-bc6e-5bb332a5162c"
      unitRef="usd">-150000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMjUtMy0xLTEtOTA2MDk_b68aaf6a-d025-438f-a77b-8494c690265c"
      unitRef="usd">1000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMjYtMy0xLTEtOTA2MDk_8ffe1e0f-5548-4545-b82e-cd8b94aa5754"
      unitRef="usd">150000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMjctMy0xLTEtOTA2MDk_64654f1c-a025-4165-ac63-39ceb99dcd32"
      unitRef="usd">852416</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMjgtMy0xLTEtOTA2MDk_104a9357-2f38-4cbe-93d6-4c05a0e52cb6"
      unitRef="usd">150853416</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMzAtMS0xLTEtOTA2MDk_f16d8177-b772-4aa1-97d9-86a85b5fdf1c"
      unitRef="usd">-336097</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMzAtMy0xLTEtOTA2MDk_1a24bfeb-a9d2-4baa-b904-027413c14c7c"
      unitRef="usd">758091</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMzItMS0xLTEtOTA2MDk_016ddb9f-bf62-41c9-9a93-9f718ccc67a3"
      unitRef="usd">343399</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMzMtMS0xLTEtOTA2MDk_55ae8f0b-3342-443a-8851-61ad60814b1e"
      unitRef="usd">7302</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if96f4a11922442b08faec4138ba298eb_I20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMzMtMy0xLTEtOTA2MDk_485fe2a5-6a65-40a4-b958-a1220190c8a1"
      unitRef="usd">758091</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <amci:DeferredOfferingCostsIncludedInNotesPayable
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMzYtMy0xLTEtOTA2MDk_23b66971-0def-4c64-9bdc-5eaee79b6b39"
      unitRef="usd">1968784</amci:DeferredOfferingCostsIncludedInNotesPayable>
    <amci:OfferingCostsIncludedInAccountsPayableAccruedExpenses
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMzctMy0xLTEtOTA2MDk_f02d6446-bae3-4309-ab59-fc954db233b0"
      unitRef="usd">30000</amci:OfferingCostsIncludedInAccountsPayableAccruedExpenses>
    <amci:DeferredUnderwritingFeePayable
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMzgtMy0xLTEtOTA2MDk_2eede8fa-3d70-4389-8e9d-af7eb3127bd8"
      unitRef="usd">24000</amci:DeferredUnderwritingFeePayable>
    <amci:NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfMzktMy0xLTEtOTA2MDk_76a23594-c540-4faa-9e9b-01b2fc720cff"
      unitRef="usd">677800</amci:NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties>
    <amci:NoncashRepaymentOfNotePayableAndAdvances
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfNDAtMy0xLTEtOTA2MDk_18046cb8-2018-404c-aeb7-cfd9e087c071"
      unitRef="usd">2647584</amci:NoncashRepaymentOfNotePayableAndAdvances>
    <amci:NoncashDeferredUnderwritingCommissions
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfNDEtMy0xLTEtOTA2MDk_84b43cb8-fd07-49ae-8859-cb549622cd00"
      unitRef="usd">5250000</amci:NoncashDeferredUnderwritingCommissions>
    <amci:ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfNDItMy0xLTEtOTA2MDk_b544350b-4493-4309-b98e-b8a51391e7c5"
      unitRef="usd">6509758</amci:ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering>
    <amci:NoncashExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares
      contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8yNS9mcmFnOmU1NWE5NGJjZWQwODQzYjRiZWVlMmRhNWQzNDA1OTQ5L3RhYmxlOmU0NGI4ZGY4Mzg1YjRlMjFhOGEzZjQyZmRhZjBmZGY3L3RhYmxlcmFuZ2U6ZTQ0YjhkZjgzODViNGUyMWE4YTNmNDJmZGFmMGZkZjdfNDMtMS0xLTEtOTA2MDk_49ed7b9c-6e7c-411e-a7d1-5e17509f3991"
      unitRef="usd">4878300</amci:NoncashExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares>
    <us-gaap:NatureOfOperations
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjY1NzM_e7e70661-1026-4b4c-92b5-4e2c6cb6c688">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 1 &#x2014; Description of Organization and Business Operations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;AMCI Acquisition Corp. II (the &#x201c;Company&#x201d;) is a blank check company incorporated as a Delaware corporation on January 28, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the &#x201c;business combination&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September 30, 2022, the Company has neither engaged in any operations nor generated any revenues. All activity to date relates to the Company&#x2019;s formation and the initial public offering (as defined below), described below and since the initial public offering, its search for a business combination target. The Company will not generate any operating revenues until after the completion of its initial business combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the initial public offering and from changes in the fair value of its derivative warrant liabilities, if applicable. The Company has selected December 31 as its fiscal year end.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s sponsor is AMCI Sponsor II LLC, a Delaware limited liability company (the &#x201c;Sponsor&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The registration statement for the Company&#x2019;s initial public offering was declared effective on August 3, 2021 (the &#x201c;effective date&#x201d;). On August 6, 2021, the Company consummated its initial public offering (the &#x201c;initial public offering&#x201d;) of 15,000,000 units (the &#x201c;units&#x201d;). Each unit consists of one Class A common stock of the Company, par value $0.0001 per share (the &#x201c;Class A common stock&#x201d;), and one-half of one redeemable warrant of the Company (the &#x201c;warrant&#x201d;), each whole warrant entitling the holder thereof to purchase one Class A common stock for $11.50 per share. The units were sold at a price of $10.00 per unit, generating gross proceeds to the Company of $150,000,000 which is discussed in Note 3.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Simultaneously with the closing of the initial public offering, the Company completed the private sale of an aggregate of 3,500,000 warrants (the &#x201c;private placement warrants&#x201d;) to the Sponsor at a purchase price of $1.00 per private placement warrant, generating gross proceeds to the Company of $3,500,000. The private placement warrants are identical to the warrants sold in the initial public offering, except that the private placement warrants, so long as they are held by the Sponsor or its permitted transferees, (i) are not redeemable by the Company, (ii) may not (including the Class A common stock issuable upon exercise of such private placement warrants), subject to certain limited exceptions, be transferred, assigned or sold by such holders until 30 days after the completion of the Company&#x2019;s initial business combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights. No underwriting discounts or commissions were paid with respect to such sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As the initial public offering includes two instruments, Class A common stock and warrants, and as the warrants are classified as a financial liability, it is necessary to allocate the gross proceeds between Class A common stock and warrants. The Company adopted the residual method to allocate the gross proceeds between Class A common stock and warrants based on their relative fair values. The gross proceeds were first allocated to the fair value of the warrants and the residual amount was allocated to the Class A common stock. The percentage derived from this allocation was used to allocate the deferred offering costs between Class A common stock and warrants. Issuance costs allocated to the warrants were expensed to the Company&#x2019;s unaudited condensed statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transaction costs of the initial public offering amounted to $13,782,542 and consisted of $1,500,000 of underwriting discount, $5,250,000 of deferred underwriting discount, $6,509,758 in fair value of Class B common stock issued to Anchor Investors, and $522,784 of other offering costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A total of $150,000,000 was placed in a U.S.-based trust account maintained by Continental Stock Transfer &amp;amp; Trust Company, acting as trustee (the &#x201c;trust account&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company must complete one or more initial business combination having an aggregate fair market value of at least 80% of the value of the assets held in the trust account (excluding the amount of deferred underwriting discounts held in trust and taxes payable on the income earned on the trust account) at the time of the signing a definitive agreement in connection with the initial business combination. However, the Company will only complete a business combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;register as an investment company under the Investment Company Act of 1940, as amended (the &#x201c;Investment Company Act&#x201d;). There is no assurance that the Company will be able to complete a business combination successfully.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon the closing of the initial public offering, management has agreed that an amount equal to at least $10.00 per unit sold in the initial public offering, including the proceeds of the private placement warrants, will be held in a trust account, located in the United States with Continental Stock Transfer &amp;amp; Trust Company acting as trustee, and will invest only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect to interest earned on the funds held in the trust account that may be released to the Company to pay taxes, if any, the proceeds from the initial public offering and the sale of the private placement warrants will not be released from the trust account until the earliest of (i) the completion of initial business combination, (ii) the redemption of the Company&#x2019;s public shares if the Company is unable to complete an initial business combination by August 6, 2023, subject to applicable law, or (iii) the redemption of the Company&#x2019;s public shares properly submitted in connection with a stockholder vote to amend its amended and restated certificate of incorporation to modify the substance or timing of the Company&#x2019;s obligation to redeem 100% of its public shares if the Company has not consummated an initial business combination by August 6, 2023 or with respect to any other material provisions relating to stockholders&#x2019; rights or pre-initial business combination activity. The proceeds deposited in the trust account could become subject to the claims of the Company&#x2019;s creditors, if any, which could have priority over the claims of the Company&#x2019;s public stockholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company will provide its public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial business combination either (i) in connection with a stockholder meeting called to approve the business combination or (ii) without a stockholder vote by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed business combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem all or a portion of their public shares upon the completion of the initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account calculated as of two business days prior to the consummation of the initial business combination, including interest earned on the funds held in the trust account (which interest shall be net of taxes payable), divided by the number of then outstanding public shares, subject to the limitations and on the conditions described herein. The amount in the trust account is initially anticipated to be $10.00 per public share. The per share amount the Company will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the representative of the underwriters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The shares of common stock subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the initial public offering, in accordance with Financial Accounting Standards Board&#x2019;s (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 480, &#x201c;Distinguishing Liabilities from Equity.&#x201d; In such case, the Company will proceed with a business combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a business combination and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the business combination.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company will have only 24 months from the closing of the initial public offering to complete the initial business combination (the &#x201c;Combination Period&#x201d;). However, if the Company is unable to complete the initial business combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfOTM5MA_6b8b7a9b-cdb9-4964-a6c2-9088a7366feb"&gt;ten&lt;/span&gt; business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#x2019; rights as stockholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company&#x2019;s remaining stockholders and the Company&#x2019;s board of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;directors, liquidate and dissolve, subject, in each case, to the Company&#x2019;s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Sponsor, officers and directors have agreed to (i) waive their redemption rights with respect to any founder shares and public shares they hold in connection with the completion of the initial business combination, (ii) waive their redemption rights with respect to any founder shares and public shares they hold in connection with a stockholder vote to approve an amendment to the Company&#x2019;s amended and restated certificate of incorporation, (iii) waive their rights to liquidating distributions from the trust account with respect to any founder shares they hold if the Company fails to complete the initial business combination within the Combination Period, and (iv) vote their founder shares and any public shares purchased during or after the initial public offering in favor of the initial business combination.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party (other than the Company&#x2019;s independent registered public accounting firm) or prospective target business who executed a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is enforceable), nor will it apply to any claims under the Company&#x2019;s indemnity of the underwriters of the initial public offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor&#x2019;s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would be able to satisfy those obligations. None of the Company&#x2019;s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Emerging Growth Company Status&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is an &#x201c;emerging growth company,&#x201d; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities and Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s unaudited condensed financial statements with those of another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management is continuing to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company&#x2019;s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these unaudited condensed financial statements. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 16, 2022, President Biden signed into law the Inflation Reduction Act of 2022 (the &#x201c;IR Act&#x201d;), which, among other things, imposes a new 1% U.S. federal excise tax on certain repurchases of stock by &#x201c;covered corporations&#x201d; (which include publicly traded domestic (i.e., U.S.) corporations) beginning in 2023, with certain exceptions (the &#x201c;Excise Tax&#x201d;). The Excise Tax is imposed on the repurchasing corporation itself, not its stockholders from which the stock is repurchased. Because we are a Delaware corporation and our securities are trading on Nasdaq, we are a &#x201c;covered corporation&#x201d; for this purpose. The amount of the Excise Tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the Excise Tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the Excise Tax. The U.S. Department of the Treasury has authority to provide regulations and other guidance to carry out, and prevent the abuse or avoidance of the Excise Tax; however, no guidance has been issued to date. It is uncertain whether, and/or to what extent, the Excise Tax could apply to any repurchase by us of our common stock or in the event of our liquidation, in each instance after December 31, 2022, including any redemptions in connection with an initial business combination or in the event we do not consummate an initial business combination by August 6, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Proposed Business Combination&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 8, 2022, the Company entered into an agreement and plan of merger (the &#x201c;Merger Agreement&#x201d;) with AMCI Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (&#x201c;Merger Sub&#x201d;), and LanzaTech NZ, Inc., a Delaware corporation (&#x201c;LanzaTech&#x201d;). The transactions contemplated by the Merger Agreement are referred to herein as the &#x201c;Proposed Business Combination.&#x201d; The time of the closing of the Proposed Business Combination is referred to herein as the &#x201c;Closing.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the Proposed Business Combination is approved by the Company&#x2019;s stockholders and LanzaTech&#x2019;s stockholders, and the closing conditions in the Merger Agreement are satisfied or waived, then, among other things, upon the terms and subject to the conditions of the Merger Agreement and in accordance with Delaware General Corporation Law, Merger Sub will merge with and into LanzaTech, with LanzaTech surviving the Merger as the Company&#x2019;s wholly owned subsidiary (the &#x201c;Merger&#x201d;). In connection with the consummation of the Merger, the Company will be renamed &#x201c;LanzaTech Global, Inc.&#x201d; and is referred to herein as &#x201c;New LanzaTech&#x201d; as of the time following such change of name.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Merger Agreement, the Company has agreed to acquire all of the outstanding equity interests of LanzaTech for consideration consisting of equity interests of New LanzaTech valued at $1,817,000,000 in the aggregate. The consideration to be paid to holders of shares of LanzaTech capital stock will be shares of common stock of New LanzaTech (&#x201c;New LanzaTech Common Stock&#x201d;), valued at $10.00 per share, to be paid at the closing of the Merger. The number of shares of New LanzaTech Common Stock payable in the Merger in respect of each share of LanzaTech capital stock (each, a &#x201c;LanzaTech Share&#x201d;) will be determined based on the exchange ratio (the &#x201c;Exchange Ratio&#x201d;), and certain corresponding adjustments, in each case as set forth in the Merger Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Merger Agreement, at Closing: (i) each warrant to purchase LanzaTech Shares (each, a &#x201c;LanzaTech Warrant&#x201d;) that is outstanding and unexercised immediately prior to Closing and would automatically be exercised or exchanged in full in accordance with its terms by virtue of the occurrence of the Merger, will be so automatically exercised or exchanged in full for the applicable LanzaTech Shares, and each such LanzaTech Share will be treated as being issued and outstanding immediately prior to Closing and will be canceled and converted into the right to receive the applicable shares of New LanzaTech Common Stock; and (ii) each LanzaTech Warrant that is outstanding and unexercised immediately prior to the Closing and is not automatically exercised in full as &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;described in clause (i) will be converted into a warrant to purchase shares of New LanzaTech Common Stock, in which case (a) the number of shares underlying such New LanzaTech warrant (each, a &#x201c;New LanzaTech Warrant&#x201d;) will be determined by multiplying the number of LanzaTech Shares subject to such warrant immediately prior to Closing, by the Exchange Ratio and (b) the per share exercise price of such New LanzaTech Warrant will be determined by dividing the per share exercise price of such LanzaTech Warrant immediately prior to the Effective Time by the Exchange Ratio, except that in the case of certain warrants specified in the Merger Agreement, such exercise price will be $10.00.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Merger Agreement, at Closing, each option to purchase LanzaTech Shares (each, a &#x201c;LanzaTech Option&#x201d;) will be converted into an option to purchase a number of shares of New LanzaTech Common Stock (rounded down to the nearest whole share) equal to the product of (i) the number of LanzaTech Shares subject to such LanzaTech Option multiplied by (ii) the Exchange Ratio. The exercise price of such New LanzaTech option will be equal to the quotient of (a) the exercise price per share of such LanzaTech Option in effect immediately prior to the Effective Time divided by (b) the Exchange Ratio (and as so determined, this exercise price will be rounded up to the nearest full cent).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Merger Agreement, at Closing, each award of restricted shares of LanzaTech common stock (each, a &#x201c;LanzaTech RSA&#x201d;) that is outstanding immediately prior to the Effective Time will be converted into an award of restricted shares of New LanzaTech Common Stock (each, a &#x201c;New LanzaTech RSA&#x201d;) on the same terms and conditions as were applicable to such LanzaTech RSA immediately prior to the Effective Time, except that such New LanzaTech RSA will relate to a number of shares of New LanzaTech Common Stock equal to the number of LanzaTech Shares subject to such LanzaTech RSA, multiplied by the Exchange Ratio.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The closing of the Merger is subject to certain customary conditions, including, among others, (i) adoption by AMCI&#x2019;s stockholders and LanzaTech&#x2019;s stockholders of the Merger Agreement and their approval of certain other actions related to the Proposed Business Combination, (ii) the expiration or termination of the waiting period (or any extension thereof) applicable to the transactions contemplated by the Merger Agreement and any ancillary agreements, in each case under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, (iii) the effectiveness of a registration statement on Form S-4 (the &#x201c;Registration Statement&#x201d;) under the Securities Act with respect to the shares of New LanzaTech Common Stock to be paid as consideration in the Merger, (iv) there being no government order or law enjoining, prohibiting or making illegal the consummation of the Merger or the transactions contemplated by the Merger Agreement, (v) AMCI having at least $5,000,001 of net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) under the Exchange Act) after giving effect to any payments required to be made in connection with the redemption of AMCI&#x2019;s public shares and the proceeds from the Subscription Agreements described below, (vi) AMCI having at least $230,000,000 of cash at the closing of the Merger, consisting of cash held in AMCI&#x2019;s trust account after taking into account any redemption of AMCI&#x2019;s public shares, and the proceeds from the Subscription Agreements described below, net of transaction expenses of AMCI and LanzaTech, and (vii) the listing on Nasdaq of the shares of New LanzaTech Common Stock issued in connection with the Proposed Business Combination.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liquidity and Going Concern&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September 30, 2022, the Company had approximately $7,000 in its operating bank account and a working capital deficit of approximately $3.5 million , not taking into account tax obligations of approximately $536,000 that may be paid from income from investments held in the trust account.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s liquidity needs up to September 30, 2022 have been satisfied through a contribution of $25,000 from the Sponsor to cover for certain offering costs in exchange for the issuance of Founder Shares, and a loan and advances from the Sponsor pursuant to the Note (as defined in Note 4). Subsequent to the initial public offering, net proceeds from the private placement of $0.9 million were placed in the operating account for working capital purposes. In addition, in order to finance transaction costs in connection with a business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#x2019;s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 4). On March 28, 2022, the Company entered into a noninterest-bearing Working Capital Loan with its Sponsor for the principal amount of up to $1.5 million. As of September 30, 2022 and December 31, 2021, there were no amounts outstanding under any Working Capital Loan.&lt;/span&gt;&lt;/div&gt;In connection with the Company&#x2019;s assessment of going concern considerations in accordance with FASB Accounting Standards Update (&#x201c;ASU&#x201d;) 2014-15, &#x201c;Disclosures of Uncertainties about an Entity&#x2019;s Ability to Continue as a Going Concern,&#x201d; management has determined that the liquidity condition, and the mandatory liquidation and subsequent dissolution that will be required if the Company does not complete a business combination before August 6, 2023 raises substantial doubt about the Company&#x2019;s ability to continue as a going concern. Although Management expects that it will be able to raise additional capital to support its planned activities and complete a business combination on or prior to August 6, 2023, it is uncertain whether it will be able to do so. No adjustments have been made to the carrying amounts of assets or liabilities should we be required to liquidate after August 6, 2023. The condensed financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern. The Company intends to complete a business combination before the mandatory liquidation date. Over this time period, the Company will be using the funds outside of the trust account for paying existing accounts payable, identifying and evaluating prospective initial business combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the business combination.&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 1 &#x2014; Description of Organization and Business Operations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;AMCI Acquisition Corp. II (the &#x201c;Company&#x201d;) is a blank check company incorporated as a Delaware corporation on January 28, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the &#x201c;business combination&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, the Company has neither engaged in any operations nor generated any revenues. All activity for the period from January 28, 2021 (inception) through December 31, 2021 relates to the Company&#x2019;s formation and the initial public offering (&#x201c;initial public offering&#x201d;), described below. The Company will not generate any operating revenues until after the completion of its initial business combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the initial public offering and from changes in the fair value of its derivative warrant liabilities, if applicable. The Company has selected December 31 as its fiscal year end.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s sponsor is AMCI Sponsor II LLC, a Delaware limited liability company (the &#x201c;Sponsor&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The registration statement for the Company&#x2019;s initial public offering was declared effective on August 3, 2021 (the &#x201c;effective date&#x201d;). On August 6, 2021, the Company consummated its initial public offering of 15,000,000 units (the &#x201c;units&#x201d;). Each unit consists of one Class A common stock of the Company, par value $0.0001 per share (the &#x201c;Class A common stock&#x201d;), and one-half of one redeemable warrant of the Company (the &#x201c;warrant&#x201d;), each whole warrant entitling the holder thereof to purchase one Class A common stock for $11.50 per share. The units were sold at a price of $10.00 per unit, generating gross proceeds to the Company of $150,000,000, which is discussed in Note 3.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Simultaneously with the closing of the initial public offering, the Company completed the private sale of an aggregate of 3,500,000 warrants (the &#x201c;private placement warrants&#x201d;) to the Sponsor at a purchase price of $1.00 per private placement warrant, generating gross proceeds to the Company of $3,500,000. The private placement warrants are identical to the warrants sold in the initial public offering, except that the private placement warrants, so long as they are held by the Sponsor or its permitted transferees, (i) are not redeemable by the Company, (ii) may not (including the Class A common stock issuable upon exercise of such private placement warrants), subject to certain limited exceptions, be transferred, assigned or sold by such holders until 30 days after the completion of the Company&#x2019;s initial business combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights. No underwriting discounts or commissions were paid with respect to such sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As the initial public offering includes two instruments, Class A common stock and warrants, and as the warrants are classified as a financial liability, it is necessary to allocate the gross proceeds between Class A common stock and warrants. The Company adopted the residual method to allocate the gross proceeds between Class A common stock and warrants based on their relative fair values. The gross proceeds were first allocated to the fair value of the warrants and the residual amount was allocated to the Class A common stock. The percentage derived from this allocation was used to allocate the deferred offering costs between Class A common stock and warrants. Issuance costs allocated to the warrants were expensed to the Company&#x2019;s statement of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transaction costs of the initial public offering amounted to $13,782,542 and consisted of $1,500,000 of underwriting discount, $5,250,000 of deferred underwriting discount, $6,509,758 in fair value of Class B common stock issued to Anchor Investors, and $522,784 of other offering costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A total of $150,000,000 was placed in a U.S.-based trust account maintained by Continental Stock Transfer &amp;amp; Trust Company, acting as trustee.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company must complete one or more initial business combination having an aggregate fair market value of at least 80% of the value of the assets held in the trust account (excluding the amount of deferred underwriting discounts held in trust and taxes payable on the income earned on the trust account) at the time of the signing a definitive agreement in connection with the initial business combination. However, the Company will only complete a business combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;register as an investment company under the Investment Company Act of 1940, as amended (the &#x201c;Investment Company Act&#x201d;). There is no assurance that the Company will be able to complete a business combination successfully.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon the closing of the initial public offering, management has agreed that an amount equal to at least $10.00 per unit sold in the initial public offering, including the proceeds of the private placement warrants, will be held in a trust account (the &#x201c;trust account&#x201d;), located in the United States with Continental Stock Transfer &amp;amp; Trust Company acting as trustee, and will invest only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect to interest earned on the funds held in the trust account that may be released to the Company to pay taxes, if any, the proceeds from the initial public offering and the sale of the private placement warrants will not be released from the trust account until the earliest of (i) the completion of initial business combination, (ii) the redemption of the Company&#x2019;s public shares if the Company is unable to complete an initial business combination by August 6, 2023, subject to applicable law, or (iii) the redemption of the Company&#x2019;s public shares properly submitted in connection with a stockholder vote to amend its amended and restated certificate of incorporation to modify the substance or timing of the Company&#x2019;s obligation to redeem 100% of its public shares if the Company has not consummated an initial business combination by August 6, 2023 or with respect to any other material provisions relating to stockholders&#x2019; rights or pre-initial business combination activity. The proceeds deposited in the trust account could become subject to the claims of the Company&#x2019;s creditors, if any, which could have priority over the claims of the Company&#x2019;s public stockholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company will provide its public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial business combination either (i) in connection with a stockholder meeting called to approve the business combination or (ii) without a stockholder vote by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed business combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem all or a portion of their public shares upon the completion of the initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account calculated as of two business days prior to the consummation of the initial business combination, including interest earned on the funds held in the trust account (which interest shall be net of taxes payable), divided by the number of then outstanding public shares, subject to the limitations and on the conditions described herein. The amount in the trust account is initially anticipated to be $10.00 per public share. The per share amount the Company will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the representative of the underwriters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The shares of common stock subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the initial public offering, in accordance with Financial Accounting Standards Board&#x2019;s (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 480, &#x201c;Distinguishing Liabilities from Equity.&#x201d; In such case, the Company will proceed with a business combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a business combination and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the business combination.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company will have only 24 months from the closing of the initial public offering to complete the initial business combination (the &#x201c;Combination Period&#x201d;). However, if the Company is unable to complete the initial business combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfOTMzMA_80eea167-68dd-4f47-a97c-0adf8eb467f8"&gt;ten&lt;/span&gt; business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders&#x2019; rights as stockholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company&#x2019;s remaining stockholders and the Company&#x2019;s board of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;directors, liquidate and dissolve, subject, in each case, to the Company&#x2019;s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Sponsor, officers and directors have agreed to (i) waive their redemption rights with respect to any founder shares and public shares they hold in connection with the completion of the initial business combination, (ii) waive their redemption rights with respect to any founder shares and public shares they hold in connection with a stockholder vote to approve an amendment to the Company&#x2019;s amended and restated certificate of incorporation, (iii) waive their rights to liquidating distributions from the trust account with respect to any founder shares they hold if the Company fails to complete the initial business combination within the Combination Period, and (iv) vote their founder shares and any public shares purchased during or after the initial public offering in favor of the initial business combination.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party (other than the Company&#x2019;s independent registered public accounting firm) or prospective target business who executed a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is enforceable), nor will it apply to any claims under the Company&#x2019;s indemnity of the underwriters of the initial public offering against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor&#x2019;s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would be able to satisfy those obligations. None of the Company&#x2019;s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Emerging Growth Company Status&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is an &#x201c;emerging growth company,&#x201d; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management is continuing to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company&#x2019;s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Proposed Business Combination&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As more fully described in Note 11, on March 8, 2022, the Company entered into an agreement and plan of merger (the &#x201c;Merger Agreement&#x201d;) with AMCI Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (&#x201c;Merger Sub&#x201d;), and LanzaTech NZ, Inc., a Delaware corporation (&#x201c;LanzaTech&#x201d;). Upon consummation of the transactions, the Company will change its name to &#x201c;LanzaTech Global, Inc.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liquidity and Going Concern&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, the Company had approximately $0.3 million in its operating bank account and a working capital deficit of approximately $0.1 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s liquidity needs up to December 31, 2021 have been satisfied through a contribution of $25,000 from the Sponsor to cover for certain offering costs in exchange for the issuance of founder shares, and a loan and advances from the Sponsor pursuant to the Note (as defined in Note 4). Subsequent to the initial public offering, net proceeds from the private placement of $0.9 million were placed in the operating account for working capital purposes. In addition, in order to finance transaction costs in connection with a business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#x2019;s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 4). As of December 31, 2021, there were no amounts outstanding under any Working Capital Loan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Company&#x2019;s assessment of going concern considerations in accordance with Financial Accounting Standard Board&#x2019;s Accounting Standards Update (&#x201c;ASU&#x201d;) 2014-15, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disclosures of Uncertainties about an Entity&#x2019;s Ability to Continue as a Going Concern&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&#x201d; management has determined that the Company would not be able to meet its obligations as they become due within one year after the date that the financial statements are available to be issued. As such, management has determined that the liquidity condition raises substantial doubt about the Company&#x2019;s ability to continue as a going concern. As of December 31, 2021, no adjustments have been made to the carrying amounts of assets or liabilities.&lt;/span&gt;&lt;/div&gt;Description of the Business&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reporting entity is LanzaTech NZ, Inc. (formerly known as LanzaTech New Zealand Limited) and its subsidiaries (collectively, &#x201c;the Company&#x201d; or "LanzaTech"). LanzaTech NZ, Inc. is a profit-oriented entity previously incorporated in New Zealand. Effective October 28, 2021, LanzaTech New Zealand Limited filed a Certificate of Incorporation to migrate its country of domicile from New Zealand to Delaware, in the United States, and change its corporate name to &#x201c;LanzaTech NZ, Inc.&#x201d; The amendment was approved by the Board of Directors of LanzaTech and was effected by the filing of a Certificate of Incorporation with the Delaware Secretary of State. The registered office location is c/o The Corporation Trust Company, Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware, 19801. The Company licenses its technology to customers, performs research and development in biotechnology, and provides engineering and other related services for commercial and government customers. Using the Company&#x2019;s proprietary fermentation technology, the Company&#x2019;s customers can convert certain carbon-rich waste gases into fuels and chemicals. The Company employs a licensing business model whereby its customers build, own and operate facilities that use the Company's technology, and in return, the Company is paid royalties based on the revenue generated from the use of its technology. In 2018, the Company, through its partners, launched the world&#x2019;s first commercial waste gas to ethanol plant in China, followed by a second one in 2021, also in China, with others currently in development in various countries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Proposed Merger&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 8, 2022, the Company entered into an Agreement and Plan of Merger (the &#x201c;Merger Agreement&#x201d;) with AMCI Acquisition Corp. II, a Delaware corporation (&#x201c;AMCI&#x201d;) and AMCI Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of AMCI (&#x201c;Merger Sub&#x201d;). Under the Merger Agreement, Merger Sub will merge with and into LanzaTech, with LanzaTech surviving the Merger as a wholly-owned subsidiary of AMCI (&#x201c;the Business Combination&#x201d;). In connection with the Business Combination, AMCI will be renamed LanzaTech Global, Inc. (&#x201c;New LanzaTech&#x201d;). AMCI has agreed to acquire all of the outstanding equity interests of LanzaTech for consideration consisting of an equity interest of New LanzaTech valued at approximately $1.8&#160;billion. Completion of the transaction is subject to certain customary regulatory consents and approval by stockholders of AMCI and the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Merger Agreement was amended on December 7, 2022, to provide for, among other things, (i) the inclusion of the aggregate net proceeds from each of the AM SAFE Note and Brookfield SAFE in the Acquiror Closing Cash Amount, (ii) the reduction of the Minimum Closing Cash Condition from $250,000,000 to $230,000,000, (iii) the clarification that, to the extent that the Brookfield SAFE remains unexercised at Closing, it will be assumed by AMCI, remain in effect on the same terms and conditions as are in effect prior to the Closing and thereafter entitle the holder thereof to be issued shares of common stock in AMCI after the Closing, (iv) the clarification that, in the event that it becomes reasonably apparent to the parties that the Acquiror Closing Cash Amount will be less than the Minimum Closing Cash Condition, AMCI will use commercially reasonable efforts to enter into non-redemption agreements, or similar agreements, as may be necessary to satisfy the Minimum Closing Cash Condition, (v) the extension of the outside date applicable to the Closing from December 7, 2022 to February 28, 2023 and (vi) the elimination of LanzaTech's right to terminate the agreement in the event that we fail to, on or prior to July 7, 2022, enter into one or more additional subscription agreements or non-redemption agreements as a result of which the sum of the PIPE Investment Amount (including net proceeds under the AM SAFE Note to LanzaTech) and the aggregate number of shares of Class A common stock subject to non-redemption agreements multiplied by $10.00, minus certain transaction expenses and other liabilities at Closing, would be equal to at least the Minimum Closing Cash Condition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Merger Agreement, AMCI entered into subscription agreements with certain investors pursuant to which AMCI agreed to issue and sell a private placement to close immediately prior to the Business Combination.&lt;/span&gt;&lt;/div&gt;Description of the BusinessThe reporting entity is LanzaTech NZ, Inc. (formerly known as LanzaTech New Zealand Limited) and its subsidiaries (collectively, &#x201c;the Company&#x201d;). LanzaTech NZ, Inc. is a profit-oriented entity previously incorporated in New Zealand. Effective October 28, 2021, LanzaTech New Zealand Limited filed a Certificate of Incorporation to migrate its country of domicile from New Zealand to Delaware, in the United States, and change its corporate name to &#x201c;LanzaTech NZ, Inc.&#x201d; The amendment was approved by the Board of Directors of LanzaTech and was effected by the filing of a Certificate of Incorporation with the Delaware Secretary of State. All necessary adjustments have been recorded to present fairly the Company's financial position as of December&#160;31, 2021 and 2020 and the results of operations and cash flows for the years then ended. The registered office location is c/o The Corporation Trust Company, Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware, 19801. The Company licenses its technology to customers, performs research and development in biotechnology, and provides engineering and other related services for commercial and government customers. Using the Company&#x2019;s proprietary fermentation technology, the Company&#x2019;s customers can convert certain carbon-rich waste gases into fuels and chemicals. The Company employs a licensing business model whereby its customers build, own and operate facilities that use the Company's technology, and in return, the Company is paid royalties based on the revenue generated from the use of its technology. In 2018, the Company, through its equity method investee, launched the world&#x2019;s first commercial waste gas to ethanol plant in China, followed by a second one in 2021, also in China, with others currently in development in various countries around the world.</us-gaap:NatureOfOperations>
    <amci:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMzY2_c3e67605-b0fe-4fda-b933-5a510e719062"
      unitRef="item">1</amci:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum>
    <amci:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMTUyMQ_e825bf47-2cf7-4533-8ade-254db4d1f23d"
      unitRef="shares">15000000</amci:UnitsIssuedDuringPeriodSharesNewIssues>
    <amci:NumberOfSharesIssuedPerUnit
      contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMTU2Nw_cf5f6cd6-2d44-4085-b5b1-54d3bea4c781"
      unitRef="shares">1</amci:NumberOfSharesIssuedPerUnit>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ie730d94e9acc40f48d227ce51539c50b_I20210806"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMTYxNw_008057fd-0c35-42ac-8e0d-7a4fb0734c15"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMTc5MQ_ac75825c-ad7f-4fd8-9037-fcdfb30ec6d7"
      unitRef="shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMTgxOQ_8a38af25-eb9d-4c8d-8fb8-3e4f2b00a89f"
      unitRef="usdPerShare">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMTg2Nw_b88cb605-4929-4259-9c16-1e6b92ee7b7c"
      unitRef="usdPerShare">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMTkyNA_f7635828-6121-4c2f-9f22-0a14458db9f9"
      unitRef="usd">150000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="iba67ebbc3e2147e2a5a1f7dbbeab0ccd_I20210806"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjA3OQ_1872ee73-bdbb-4e76-b1f1-9f1d37eb98f9"
      unitRef="shares">3500000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <amci:ClassOfWarrantOrRightPriceOfWarrantsOrRights
      contextRef="iba67ebbc3e2147e2a5a1f7dbbeab0ccd_I20210806"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjE2NA_af37c0cb-3da5-4927-a0cf-65c36f5d1273"
      unitRef="usdPerShare">1.00</amci:ClassOfWarrantOrRightPriceOfWarrantsOrRights>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="i98ebad46078d44259754e031d9c5bd6d_D20210806-20210806"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjI0Mg_92185aca-eb79-4531-8884-cac29be444d5"
      unitRef="usd">3500000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <amci:RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion
      contextRef="i98ebad46078d44259754e031d9c5bd6d_D20210806-20210806"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjcwMA_e3d49d52-8564-48d8-b483-75f1bf86b536">P30D</amci:RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion>
    <amci:TransactionCosts
      contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMzgwNw_eae44901-16ec-43e6-aa4f-1b53f76cd126"
      unitRef="usd">13782542</amci:TransactionCosts>
    <amci:SaleOfStockUnderwritingDiscounts
      contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMzgyNw_947a5257-50e7-493c-828d-18a56d36cb16"
      unitRef="usd">1500000</amci:SaleOfStockUnderwritingDiscounts>
    <amci:DeferredUnderwritingDiscounts
      contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMzg1Ng_d9922010-57e4-4a2c-ab8f-bfa30f542d5e"
      unitRef="usd">5250000</amci:DeferredUnderwritingDiscounts>
    <amci:ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering
      contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMzg5NA_4694959e-20bb-4c39-98c3-b8fbfe89b507"
      unitRef="usd">6509758</amci:ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering>
    <amci:SaleOfStockOtherOfferingCosts
      contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMzk2Nw_4d9b43f6-9b3b-47cf-8d19-8ecc9edcfb30"
      unitRef="usd">522784</amci:SaleOfStockOtherOfferingCosts>
    <amci:PaymentsForInvestmentOfCashInTrustAccount
      contextRef="i60c2802479f2421e81d073c740ec38f5_D20210806-20210806"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfNDAwNg_c1b4cfc0-aa9b-4fd3-b13c-ade4955c3250"
      unitRef="usd">150000000</amci:PaymentsForInvestmentOfCashInTrustAccount>
    <amci:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfNDE3NQ_7412166a-fe7c-4098-a3bf-c0190506af33"
      unitRef="item">1</amci:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum>
    <amci:ConditionForFutureBusinessCombinationUseOfProceedsPercentage
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfNDI2NQ_714ee95d-ace5-4f8d-9169-0eae13048cd9"
      unitRef="number">80</amci:ConditionForFutureBusinessCombinationUseOfProceedsPercentage>
    <amci:ConditionForFutureBusinessCombinationThresholdPercentageOwnership
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfNDY2OQ_f2bf36ed-0d1a-4ffe-bbd8-d3bfabe7eef6"
      unitRef="number">50</amci:ConditionForFutureBusinessCombinationThresholdPercentageOwnership>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfNTE1NQ_05e48242-5b7d-4223-8bf9-99e75a15b2a0"
      unitRef="usdPerShare">10.00</us-gaap:SharesIssuedPricePerShare>
    <amci:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfNjUwMA_49bed0c6-6a68-4efb-9335-b6e145e55187"
      unitRef="number">1</amci:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination>
    <amci:FundHeldInTrustAccountPerPublicShare
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfODA5Ng_905b7f3c-0da5-4dd7-9920-a3da05af3595"
      unitRef="usdPerShare">10.00</amci:FundHeldInTrustAccountPerPublicShare>
    <amci:ConditionForFutureBusinessCombinationThresholdNetTangibleAssets
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfODc4OQ_a24095f4-033c-46fd-9b68-077f759432c6"
      unitRef="usd">5000001</amci:ConditionForFutureBusinessCombinationThresholdNetTangibleAssets>
    <amci:MonthsToCompleteAcquisition
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfOTAxOA_034dadea-563d-44be-8c4b-a4aa43206c65">P24M</amci:MonthsToCompleteAcquisition>
    <amci:MaximumAllowedDissolutionExpenses
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfOTY3Mw_c12b3efb-8a66-4cef-bd10-78521d99e36d"
      unitRef="usd">100000</amci:MaximumAllowedDissolutionExpenses>
    <amci:FundHeldInTrustAccountPerPublicShare
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMTE1MzE_2041902b-a92b-4883-85e8-843d52c434dd"
      unitRef="usdPerShare">10.00</amci:FundHeldInTrustAccountPerPublicShare>
    <amci:FundHeldInTrustAccountPerPublicShare
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMTE2OTA_4fcac67e-5011-48fb-830f-8231a626f1b9"
      unitRef="usdPerShare">10.00</amci:FundHeldInTrustAccountPerPublicShare>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="i43e0774f1b034661961530c2cf95f99f_D20220308-20220308"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMTg3MTQ_0241b268-c893-4ec9-8dd2-631bf565144b"
      unitRef="usd">1817000000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="i0f2a2868033e4660a17c0f7ba45d4aad_I20220308"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMTg5MDI_35254d1f-245f-4d8d-8d84-0cd3c27553d7"
      unitRef="usdPerShare">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i0f2a2868033e4660a17c0f7ba45d4aad_I20220308"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjA3MzE_93bd10c5-ddf1-43ce-bee1-7aa11b0a7021"
      unitRef="usdPerShare">10.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:AssetsNet
      contextRef="ib38307702eee44f3b72af83f31e3cf7d_I20220308"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjMwMDQ_4ca36b26-af10-405f-b78b-b435c3bdd76f"
      unitRef="usd">5000001</us-gaap:AssetsNet>
    <us-gaap:AssetsHeldInTrustCurrent
      contextRef="i0f2a2868033e4660a17c0f7ba45d4aad_I20220308"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjMzMTM_d320f3dd-7867-4754-9192-fa110613490e"
      unitRef="usd">230000000</us-gaap:AssetsHeldInTrustCurrent>
    <amci:ProceedsHeldInOperatingAccountForWorkingCapitalPurpose
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjM4MDc_31037c91-6ef6-4ba1-84a2-2173a105b992"
      unitRef="usd">7000</amci:ProceedsHeldInOperatingAccountForWorkingCapitalPurpose>
    <amci:WorkingCapitalDeficit
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjM4ODc_d963e54b-7b8b-4cc5-a53a-39c9179fcc4b"
      unitRef="usd">3500000</amci:WorkingCapitalDeficit>
    <amci:TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjM5NDk_86c3b82f-3285-445a-9116-9aaff006b183"
      unitRef="usd">536000</amci:TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i8883929afdf94d6986448173f1858e61_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjQxMjY_be831398-c046-4fe0-b442-9c745ac0fb50"
      unitRef="usd">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <amci:ProceedsHeldInOperatingAccountForWorkingCapitalPurpose
      contextRef="ibf1a938c139d435097214ed3b23c295f_I20210806"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjQ0MDI_c939b8a9-6f44-4960-8b96-a022b10b87b1"
      unitRef="usd">900000</amci:ProceedsHeldInOperatingAccountForWorkingCapitalPurpose>
    <amci:WorkingCapitalLoan
      contextRef="i6cdb37bb224f48e29779bad54f3033b8_D20220328-20220328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjQ4OTY_44cc37d8-ae01-4a7d-be07-a77a2fafe1af"
      unitRef="usd">1500000</amci:WorkingCapitalLoan>
    <us-gaap:ShortTermBorrowings
      contextRef="i67af9d98434f4635b3c35ea4fd55d5c2_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjQ5NTk_a9a3fffc-45c0-42b6-a08c-9c0d978cee06"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i5afd526069b8462e9de75a0d249417cf_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zMS9mcmFnOjJjODgzMzY5ZDg2NTRhODhiOGMxOGNjOWU5N2JiMzRmL3RleHRyZWdpb246MmM4ODMzNjlkODY1NGE4OGI4YzE4Y2M5ZTk3YmIzNGZfMjQ5NTk_ad010e4f-d9f7-42cc-a966-84c2d130560d"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTU0MDU_8c219329-b9ab-4242-9cc6-290d8a72d8c9">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 2 &#x2014; Basis of Presentation and Summary of Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;) for interim financial information and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022 or any future period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K filed by the Company with the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;) on March 25, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of September 30, 2022 and December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of September 30, 2022 and December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments Held in the Trust Account&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company&#x2019;s investments held in the trust account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company&#x2019;s investments held in the trust account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the trust account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the trust account are determined using available market information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the Company&#x2019;s assets and liabilities which qualify as financial instruments under the FASB ASC 820, &#x201c;Fair Value Measurement,&#x201d; equal or approximate the carrying amounts represented in the condensed balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Offering Costs Associated With Initial Public Offering&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the initial public offering that were directly related to the initial public offering. Offering costs were allocated to the separable financial instruments issued in the initial public offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and presented as non-operating expenses in the unaudited condensed statements of operations. Offering costs associated with the Class A common stock issued were charged against the carrying value of the shares of Class A common stock upon the completion of the initial public offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Class A Common Stock Shares Subject to Possible Redemption &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, &#x201c;Distinguishing Liabilities from Equity.&#x201d; Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#x2019;s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders&#x2019; equity. The Company&#x2019;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&#x2019;s control and subject to the occurrence of uncertain future events. Accordingly, as of the initial public offering, 15,000,000 shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders&#x2019; equity (deficit) section of the Company&#x2019;s condensed balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under ASC 480-10-S99, the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of the reporting period. This method would view the end of the reporting period as if it were also the redemption date of the security. Effective with the closing of the initial public offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, &#x201c;Derivatives and Hedging&#x201d; (&#x201c;ASC 815&#x201d;). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The public warrants and the private placement warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The initial fair value of the public warrants issued in connection with the initial public offering was estimated using a Monte-Carlo simulation model. The fair value of the public warrants as of September 30, 2022 and as of December 31, 2021 is based on observable listed prices for such warrants. The fair value of the private placement warrants as of September 30, 2022 and as of December 31, 2021 is determined using a Black-Scholes option pricing model. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, &#x201c;Income Taxes&#x201d; (&#x201c;ASC 740&#x201d;). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;provides guidance on derecognition, classification, interest and penalties, accounting in period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company&#x2019;s effective tax rate was 0.88% and 0.91% for the three and nine months ended September 30, 2022, respectively, and 0.00% for the three months ended September 30, 2021 and the period from January 28, 2021 (inception) through September 30, 2021. The effective tax rate differs from the statutory tax rate of 21% for the three and nine months ended September 30, 2022, the three months ended September 30, 2021 and the period from January 28, 2021 (inception) through September 30, 2021 due primarily to changes in fair value of derivative warrant liabilities, non-taxable gains on the settlement of deferred underwriting commissions, and the valuation allowance on the deferred tax assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Income (Loss) Per Share Of Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#x201c;Earnings Per Share.&#x201d; The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the units sold in the initial public offering and the private placement warrants to purchase an aggregate of 11,000,000 shares of Class A common stock in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the three and nine months ended September 30, 2022 and for the three months ended September 30, 2021 and for the period from January 28, 2021 (inception) through September 30, 2021. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended &lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended &lt;br/&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted net income per common share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allocation of net income &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;995,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,000,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,750,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,130,435&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,750,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.004%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended &lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Period from January 28, 2021 &lt;br/&gt;(inception) through &lt;br/&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted net income per common share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allocation of net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;844,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,428,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the FASB issued ASU 2022-03, ASC Subtopic 820 &#x201c;Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions&#x201d;. The ASU amends ASC 820 to clarify that a contractual sales restriction is not considered in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. The ASU applies to both holders and issuers of equity and equity-linked securities measured at fair value. The amendments in this ASU are effective for the Company in fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is still evaluating the impact of this pronouncement on the condensed financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company&#x2019;s unaudited condensed financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 2 &#x2014; Basis of Presentation and Summary of Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (&#x201c;US GAAP&#x201d;) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments Held in the Trust Account&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company&#x2019;s investments held in the trust account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company&#x2019;s investments held in the trust account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the trust account in the accompanying statement of operations. The estimated fair values of investments held in the trust account are determined using available market information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the Company&#x2019;s assets and liabilities which qualify as financial instruments under the FASB ASC 820, &#x201c;Fair Value Measurement,&#x201d; equal or approximate the carrying amounts represented in the balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Offering Costs Associated with Initial Public Offering&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the initial public offering that were directly related to the initial public offering. Offering costs were allocated to the separable financial instruments issued in the initial public offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;presented as non-operating expenses in the statement of operations. Offering costs associated with the Class A common stock issued were charged against the carrying value of the shares of Class A common stock upon the completion of the initial public offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Class A Common Stock Subject to Possible Redemption &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, &#x201c;Distinguishing Liabilities from Equity.&#x201d; Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#x2019;s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders&#x2019; equity. The Company&#x2019;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&#x2019;s control and subject to the occurrence of uncertain future events. Accordingly, as of the initial public offering, 15,000,000 shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders&#x2019; equity (deficit) section of the Company&#x2019;s balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under ASC 480-10-S99, the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of the reporting period. This method would view the end of the reporting period as if it were also the redemption date of the security. Effective with the closing of the initial public offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, &#x201c;Derivatives and Hedging&#x201d; (&#x201c;ASC 815&#x201d;). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The public warrants and the private placement warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The initial fair value of the public warrants issued in connection with the initial public offering was estimated using a Monte-Carlo simulation model. The fair value of the public warrants as of December 31, 2021 is based on observable listed prices for such warrants. The fair value of the private placement warrants as of December 31, 2021 is determined using a Black-Scholes option pricing model. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, &#x201c;Income Taxes&#x201d; (&#x201c;ASC 740&#x201d;). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Income (Loss) Per Share of Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#x201c;Earnings Per Share.&#x201d; The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the units sold in the initial public offering and the private placement warrants to purchase an aggregate of 11,000,000 shares of Class A common stock in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the period from January 28, 2021 (inception) through December 31, 2021. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the period from January 28, 2021&lt;br/&gt;(inception) through December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted net income (loss) per common share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allocation of net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,690,909&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,750,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted net income (loss) per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2020-06, &#x201c;Debt &#x2014; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#x2014; Contracts in an Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity&#x201d; (&#x201c;ASU 2020-06&#x201d;), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. ASU 2020-06 also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 on August 2, 2021 using the modified retrospective method for transition. Adoption of ASU 2020-06 did not impact the Company&#x2019;s financial position, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;The Company&#x2019;s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company&#x2019;s financial statements.Summary of Significant Accounting Policies &lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements of LanzaTech NZ Inc. have been prepared in accordance with generally accepted accounting principles for interim financial information, and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America ("US GAAP"), the accounting principles, standards, and procedures adopted by the U.S. Securities and Exchange Commission, for complete financial statements. However, in the opinion of management, all adjustments (consisting of normal recurring accruals) have been made that are necessary for a fair presentation of the condensed consolidated financial statements for the interim periods. For further information refer to the Consolidated Financial Statements and Footnotes thereto included in the Company's Annual Report for the year ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses a qualitative approach in assessing the consolidation requirement for variable interest entities ("VIEs"). This approach focuses on determining whether the Company has the power to direct the activities of the VIE that most significantly affect the VIE&#x2019;s economic performance and whether the Company has the obligation to absorb losses, or the right to receive benefits, that could potentially be significant to the VIE.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds interests in certain VIEs for which it has been determined the Company is not the primary beneficiary. The Company's variable interests primarily relate to entities in which the Company has a non-controlling equity interest. Although these financial arrangements resulted in holding variable interests in these entities, they did not empower the Company to direct the activities of the VIEs that most significantly impact the VIEs' economic performance. The Company's interests in the VIEs are, therefore, accounted for under the equity method of accounting or alternative measurement. Refer to Note 5,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for further information. The Company is exposed to the VIEs' losses and other impairment indicators up to the carrying value of each investment and any amounts receivable from the VIE, less amounts payable. Refer to Note 9, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Related Party Transactions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for further details on the transactions with VIEs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Going Concern&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements of the Company have been prepared assuming the Company will continue as a going concern and in accordance with accounting principles generally accepted in the United States of America ("US GAAP"). The going concern basis of presentation assumes that the Company will continue in operation one year after the date these financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. The Company had cash and cash equivalents of $50,370 and an accumulated deficit of $(434,863) at September&#160;30, 2022 and cash outflows from operations of $(71,336) and a net loss of $(54,974) for the nine months ended September&#160;30, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has historically funded its operations through debt financing and issuance of equity securities. Based on the Company&#x2019;s financial position as of the date these condensed consolidated financial statements were available to be issued, the Company projects that it will be able to cover its liquidity needs for the next twelve months with cash on hand. Accordingly, the Company&#x2019;s condensed consolidated financial statements have been prepared on the basis that it will continue as a going concern.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates include fair value of equity awards granted to both employees and non-employees, the SAFE and the SAFE warrants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in facts and circumstances or additional information may result in revised estimates, and actual results may differ from these estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Segment Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates as one operating segment which is the licensing of its technologies and related services such as research and development and engineering. The Chief Executive Officer who is the chief operating decision maker, reviews financial information on an aggregate basis for allocating resources and evaluating financial performance. Substantially all of the Company's long-lived assets are maintained in the United States. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s reporting currency is the U.S. Dollar. The Company has certain foreign subsidiaries where the functional currency is the local currency. All of the assets and liabilities of these subsidiaries are converted to U.S. dollars at the exchange rate in effect at the balance sheet date, income and expense accounts are translated at average rates for the period, and shareholder&#x2019;s equity accounts are translated at historical rates. The effects of translating financial statements of foreign operations into our reporting currency are recognized as an adjustment in accumulated other comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also has foreign subsidiaries that have a functional currency of the U.S. dollar. Purchases and sales of assets and income and expense items denominated in foreign currencies are remeasured into U.S. dollar amounts on the respective dates of such transactions. Net realized foreign currency gains or losses relating to the differences between these recorded amounts and the U.S. dollar equivalent actually received or paid are included within Other (expense) income, net in the condensed consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. As of September&#160;30, 2022 and December&#160;31, 2021, the Company had $50,370 and $128,318 of cash and cash equivalents, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Cash and Other Cash Flows from Operating Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is required to maintain a cash deposit with a bank which consists of collateral on certain travel and expense programs maintained by the bank. The following represents a reconciliation of cash and cash equivalents in the condensed consolidated balance sheets to total cash, cash equivalents and restricted cash in the condensed consolidated statements of cash flows as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash (presented within Other current assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Trade and Other Receivables &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Receivables are reported net of allowances for doubtful accounts. The Company maintains allowances for doubtful accounts for estimated losses resulting from the inability of customers to make required payments. The Company estimates the allowance for doubtful accounts based on a variety of factors including the length of time receivables are past due, the financial health of customers, unusual macroeconomic conditions, and historical experience. As of September&#160;30, 2022 and December&#160;31, 2021, the Company recognized an allowance for doubtful accounts of $1,051 and $1,235, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue in accordance with Accounting Standards Codification ("ASC") 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company primarily earns revenue from services related to feasibility studies and basic engineering design of commercial plants, licensing of technologies, joint development and contract &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;research activities to develop novel biocatalysts and related technologies, and sale of CarbonSmart ethanol produced using the Company's proprietary technologies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is measured based on the consideration specified in a contract with a customer. The Company records taxes collected from customers and remitted to governmental authorities on a net basis. The Company&#x2019;s payment terms are between 30-60 days and can vary by customer type and products offered. Management has evaluated the terms of our arrangements and determined that they do not contain significant financing components.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Carbon Capture and Transformation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company provides feasibility studies and basic design and engineering services used for detailed design, procurement, and construction of commercial plants that utilize the Company&#x2019;s technologies, along with the sale of equipment and microbes. The services provided are recognized as a performance obligation satisfied over time. Revenue is recognized using the output method based on milestone completion, the cost-to-cost input method for certain engineering services, or the percentage of completion method as performance obligations are satisfied. Management has determined that the milestone completion and the associated contractual payment amounts are an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company licenses intellectual property to generate recurring revenue when its customers deploy carbon capture and transformation plants. When licenses are considered to be distinct performance obligations, the recognition of revenue is dependent on the terms of the contract, which may include fixed consideration or royalties based on sales or usage, in which case, the revenue is recognized when the subsequent sale or usage occurs or when the performance obligation to which some or all of the sales or usage-based royalty is allocated has been satisfied, whichever is later.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Research and Development Services&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company performs research and development (&#x201c;R&amp;amp;D&#x201d;) services related to novel technologies and development of biocatalysts for commercial applications, mainly to produce fuels and chemicals. The Company engages in two main types of R&amp;amp;D services &#x2013; joint development agreements, and other contract research, including projects with the U.S. Department of Energy. Such services are recognized as a performance obligation satisfied over time. Revenue is recognized based on milestone completion, when payments are contingent upon the achievement of such milestones, or based on percentage-completion method when enforceable rights to payment exist. When no milestones or phases are clearly defined, management has determined that the cost incurred, input method, is an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and estimates its variable consideration under the expected value method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is not recognized in advance of customer acceptance of a milestone when such acceptance is contractually required. Payments for R&amp;amp;D services with no contractual payments are not due from customers until a technical report is submitted; therefore, a contract asset is recognized at milestone completion but prior to the submission of a technical report. The contract asset represents the Company&#x2019;s right to consideration for the services performed at milestone completion. Occasionally, customers provide payments in advance of the Company providing services which creates a contract liability for the Company. The contract liability represents the Company's obligation to provide services to a customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Collaboration Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has certain partnership agreements that are within the scope of ASC 808, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Collaborative Arrangements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which provides guidance on the presentation and disclosure of collaborative arrangements. Generally, the classification of the transactions under the collaborative arrangements is determined based on the nature of the contractual terms of the arrangement, along with the nature of the operations of the participants. The Company&#x2019;s collaborative agreements generally include a provision of R&amp;amp;D services related to novel technologies and biocatalysts. Amounts received for these services are classified as Revenue from collaborative arrangements in the condensed consolidated statements of operations and comprehensive loss. The Company's R&amp;amp;D services are a major part of the Company's ongoing operations and therefore ASC 606 is applied to recognize revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;CarbonSmart&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's CarbonSmart business, initially CarbonSmart ethanol, is produced by LanzaTech licensed plants using the Company's proprietary technologies. Customers can buy CarbonSmart ethanol directly from LanzaTech, which the Company sources from these partnering plants. Revenue is recognized at a point in time when control transfers to the customer, which varies depending on the shipping terms. The Company acts as the principal in such transactions and accordingly, recognizes revenue and cost of revenues on a gross basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level 1 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014; Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level 2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014; Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level 3 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014; Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily due to their short-term nature, except for the warrant liability. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk and Other Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue generated from the Company&#x2019;s customers outside of the United States for the nine months ended September&#160;30, 2022 and 2021 was approximately 61% and 65%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022 and December&#160;31, 2021, approximately 35% and 35%, respectively, of trade accounts receivable and unbilled accounts receivable was due from customers located outside the United States. At September&#160;30, 2022 and December&#160;31, 2021, the value of property, plant, and equipment outside the United States was immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s revenue by geographic region based on the customer&#x2019;s location is presented in Note 4, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenues&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customers representing 10% or greater of revenue were as follows for the nine months ended September&#160;30, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer E&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Announced Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, the Financial Accounting Standard Board ("FASB") issued an Accounting Standard Update ("ASU") No. 2020-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Codification Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU 2020-10&#x201d;). The standard contains improvements to the FASB Accounting Standards Codification (the &#x201c;Codification&#x201d;) by ensuring that all guidance that requires or provides an option for an entity to provide information in the notes to financial statements is codified in the disclosure section of the Codification. The standard also improves various topics in the Codification so that entities can apply guidance more consistently on codifications that are varied in nature where the original guidance may have been unclear. The amendments in ASU 2020-10 were effective for the Company for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption was permitted. There were no material impacts upon the adoption of ASU 2020-10, on its consolidated financial statements and related disclosures. &lt;/span&gt;&lt;/div&gt;Summary of Significant Accounting Policies &lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;US GAAP"). The consolidated financial statements include the accounts of LanzaTech NZ, Inc. and its wholly-owned consolidated subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of its evaluation, the Company makes judgments in determining whether an entity is a variable interest entity (&#x201c;VIE&#x201d;) and, if so, whether it is the primary beneficiary of the VIE and is thus required to consolidate the entity. A VIE is a legal entity that has a total equity investment that is insufficient to finance its activities without additional subordinated financial support or whose equity investors lack the characteristics of a controlling financial interest. Our variable interest arises from contractual, ownership or other monetary interests in the entity, which change with fluctuations in the fair value of the entity&#x2019;s net assets. A VIE is consolidated by its primary beneficiary, the party that has both the power to direct the activities that most significantly impact the VIE&#x2019;s economic performance, and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE. We consolidate a VIE when we are deemed to be the primary beneficiary. We assess whether or not we are the primary beneficiary of a VIE on an ongoing basis. If we are not deemed to be the primary beneficiary in a VIE, we account for the investment or other variable interests in a VIE in accordance with applicable US GAAP.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds interests in certain VIEs for which it has been determined the Company is not the primary beneficiary. The Company's variable interests primarily relate to entities in which the Company has a non-controlling equity interest. Although these financial arrangements resulted in holding variable interests in these entities, they did not empower the Company to direct the activities of the VIEs that most significantly impact the VIEs' economic performance. The Company's interests in the VIEs are, therefore, accounted for under the equity method of accounting. Refer to Note 5 - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for further information. The Company's maximum exposure to loss in connection with its interest in VIEs is its equity method investment and any amounts receivable from the VIE, less amounts payable. Refer to Note 14, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Related Party Transactions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for further details on the transactions with VIEs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restatement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 16, 2022, the Audit Committee of the Board of Directors of LanzaTech, after discussion with management of LanzaTech and LanzaTech&#x2019;s independent registered public accounting firm, Deloitte &amp;amp; Touche, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;LLP, concluded that LanzaTech&#x2019;s previously issued audited consolidated financial statements as of and for the fiscal years ended December 31, 2021 and December 31, 2020 should no longer be relied upon. The errors leading to restatement were communicated to and discussed with AMCI upon their discovery. The AMCI Board considered the circumstances surrounding the restatement and concluded that it did not negatively impact its decision to proceed with the Business Combination primarily because of the individually immaterial adjustments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined that its recorded share of equity method earnings amounts from an unconsolidated affiliate for the years ended December 31, 2021 and 2020 and its gain on dilution amount for the year ended December 31, 2021 were incorrect following the completion of LanzaJet, Inc's ("LanzaJet") financial statement audit. Additionally, the Company identified that it was not properly eliminating intra-entity profits related to revenue contracts with LanzaJet. As a result of the adjustments recorded by the unconsolidated affiliate and the identification of the error related to the elimination of intra-entity profits, the Company made the decision to restate its consolidated financial statements as of and for the years ended December 31, 2021 and 2020, on or around the completion of the audit of LanzaJet's financial statements for the years ended December 31, 2021 and 2020, on August 23, 2022. The Company also determined it was not properly accounting for its licensing arrangement with LanzaJet, and had not disclosed all significant related party transactions with its equity method investees. The Company has also revised these disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASC 250, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting Changes and Error Corrections&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company evaluated the materiality of the adjustments, considering both quantitative and qualitative factors, and determined that the related aggregate impact was material to its consolidated financial statements as of and for the years ended December 31, 2021 and 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Description of Errors Corrected&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Accounting for Equity Method Investments: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The previously reported equity method investment in LanzaJet, Inc. (&#x201c;LanzaJet&#x201d;), as described in Note 5 - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, contained errors in the Company's recorded share of LanzaJet losses for the years ended 2021 and 2020 as a result of adjustments made by LanzaJet to its financial statements in connection with the audit of LanzaJet's financial statements for the years ended December 31, 2021 and 2020. The adjustments primarily were comprised of (1) an adjustment to correct an error relating to the measurement of the intangible asset associated with the intellectual property contributed by the Company as described in Note 5 &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and the related amortization; and (2), an adjustment to reclassify as a reduction to fixed assets certain government grants received by LanzaJet that it originally recorded as revenue. Other less significant adjustments were also identified and corrected in connection with the audit of LanzaJet's financial statements for the years ended December 31, 2021 and 2020. The net impact of these adjustments on the equity method investment's balance and accumulated deficit in the Company's Consolidated Balance Sheets was a decrease of $580 and $257 as of December 31, 2021 and 2020, respectively. The net impact of these adjustments on the gain from equity method investees in the Company&#x2019;s Consolidated Statements of Operations and Comprehensive Loss was a decrease of $580 and $257 for the years ended December 31, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The previously reported revenue from related parties related to contributed intellectual property contained errors for intra-entity profit that was not previously eliminated, as described in Note 5 - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The impact of these errors on the equity method investment's balance and accumulated deficit in the Consolidated Balance Sheets was $662 and $549 as of December 31, 2021 and 2020, respectively and $662 and $549 on revenue from related party transactions in the Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The previously reported gain on dilution, as described in Note 5 - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, was not correctly calculated for the year ended December 31, 2021. The impact of these errors on the equity method investment's balance and accumulated deficit in the Consolidated Balance Sheets as of December 31, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021 was $322; and the impact on gain from equity method investees in the Consolidated Statements of Operations and Comprehensive Loss was $322 for the year ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Additional Misstatements:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The previously reported contract assets and other accrued liabilities included revenue and related cost of revenue amounts that was recorded in an inappropriate period. These amounts were recorded in 2021, however, the performance obligation was actually satisfied in 2020.. The impact of these errors on the contract assets and other accrued liabilities in the Consolidated Balance Sheet as of December 31, 2020 was $122; and the impact on revenue from contracts with customers and cost of revenue from contracts with customers in the Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2021 and 2020 was  $122.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Disclosure errors:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The Company determined its licensing arrangement with LanzaJet, described in Note 5 &#x2013; Investments, should have been accounted for as a transaction with a customer solely within the scope of Accounting Standards Codification 606 - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from contracts with customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; ("ASC 606") rather than akin to an operating lease under Accounting Standards Codification 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; ("ASC 842"). The licensing arrangement is a contract with our customer, LanzaJet, that conveys to LanzaJet the right to use an intangible asset (IP). Contracts with customers are accounted for under ASC 606 unless they are within the scope of other accounting literature. Because the licensing arrangement conveys the right to use an intangible asset, it is not within the scope of ASC 842. Under limited circumstances, ASC 606 requires certain arrangements that do not, in substance, transfer control of an asset (i.e., when the arrangement contains certain repurchase rights or obligations) to be accounted for as leases. However, those limited circumstances are not present in our licensing arrangement with LanzaJet. Therefore, the Company concluded accounting for the arrangement under ASC 606 is required. Because the period over which the Company determined it was required to recognize revenue under ASC 606 was the same as the period of time over which it had been recognizing revenue, there was no effect on the amounts recorded in the consolidated financial statements. Additionally, the difference in timing of recognition of the variable consideration resulted in a difference between the carrying value of our equity method investment in LanzaJet and our proportionate share LanzaJet's book values, that was not previously disclosed. However, the disclosures in Note 5 &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, have been revised accordingly.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The Company did not disclose in Note 5 &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, its obligation under a guarantee with sublicensing agreement between LanzaJet and a third party. The fair value of this guarantee was deemed immaterial as of December 31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The Company did not include in its disclosure for related party transactions in Note 14 - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Related Party Transactions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, that it also provided engineering services to one of its equity method investees, Beijing ShouGang LanzaTech Technology Co., LTD ("SGLT"), for which costs of $1,223 and $242 were incurred during the years ended December 31, 2021 and 2020. The Company also did not disclose that in 2019 it entered into a licensing agreement to receive licensing consideration from SGLT. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;None of the errors discussed above were individually material to the financial statements, however, their cumulative impact was material and resulted in a restatement of the 2021 and 2020 financial statements. The effects of the correction of these errors on the relevant financial statement line items is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(378,162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(379,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total shareholders&#x2019; deficit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(353,190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(354,917)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities, contingently redeemable preferred equity, and shareholders' deficit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(684)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(332,394)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(333,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total shareholders&#x2019; deficit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(310,410)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(311,216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities, contingently redeemable preferred equity, and shareholders' deficit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(684)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated Statement of Operations and Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue from contracts with customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue from related party transactions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(662)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(784)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue from contracts with customers (exclusive of depreciation shown below)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,289)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,167)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cost and operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76,602)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50,357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(662)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,972)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(662)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48,634)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain from equity method investees, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(921)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,689)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss allocated to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82,526)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(921)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83,447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,673)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(921)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,594)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated Statement of Operations and Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue from contracts with customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue from related party transactions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(427)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue from contracts with customers (exclusive of depreciation shown below)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,063)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,185)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cost and operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,932)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58,054)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,701)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss before income taxes &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,331)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,880)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain from equity method investees, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(257)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss allocated to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68,198)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69,004)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41.84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated Statement of Changes in Redeemable Convertible Preferred Stock and Shareholders&#x2019; Equity (Deficit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated deficit - Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(332,394)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(333,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total shareholders&#x2019; deficit &#x2013; balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(310,410)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(311,216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(921)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,689)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated deficit - balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(378,162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(379,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total shareholders&#x2019; deficit &#x2013; balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(353,190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(354,917)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated Statement of Changes in Redeemable Convertible Preferred Stock and Shareholders&#x2019; Equity (Deficit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated deficit - Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(295,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(295,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total shareholders&#x2019; deficit &#x2013; balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(276,592)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(276,592)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated deficit - balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(332,394)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(333,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total shareholders&#x2019; deficit &#x2013; balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(310,410)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(311,216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated Statement of Cash Flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(921)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,689)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to reconcile net loss to net cash used in operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash recognition of licensing revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,684)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,022)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain from equity method investees, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,945)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in operating assets and liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,636)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,514)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued salaries and wages&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net cash used in operating activities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42,591)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42,591)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated Statement of Cash Flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to reconcile net loss to net cash used in operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash recognition of licensing revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,567)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,018)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain from equity method investees, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,424)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,167)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in operating assets and liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,483)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,605)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued salaries and wages&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net cash used in operating activities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Other Disclosure Errors: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Note 5 - Investments: The Company did not disclose intra-entity profits elimination amounts related to revenue contracts with LanzaJet of $662 and $549 as of December 31, 2021, and 2020, respectively as they were not eliminated. The previously disclosed gain on dilution was incorrect as of and for the year ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on dilution&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Segment Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates as one operating segment. Operating segments are defined as components of an enterprise for which separate financial information is evaluated regularly by the chief operating decision maker (&#x201c;CODM&#x201d;), in deciding how to allocate resources and assess performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the Company offers a variety of services and operates in multiple countries, the Company&#x2019;s business operates in one operating segment because most of the Company&#x2019;s service offerings are delivered and supported on a global basis, most of the Company&#x2019;s service offerings are deployed in a nearly identical way, and the Company&#x2019;s CODM evaluates the Company&#x2019;s financial information and resources and assesses the performance of these resources on a consolidated basis. There are no segment managers who are held accountable by the CODM, or anyone else, for operations, operating results, and planning for components below the consolidated level. Accordingly, the Company has determined that it has a single reportable and operating segment. See Note 4, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenues&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for disaggregation of the Company&#x2019;s revenues by customer location.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Coronavirus (COVID-19)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the World Health Organization declared the viral strain of coronavirus ("COVID-19") a global pandemic and recommended containment and mitigation measures worldwide. The spread of COVID-19 and the resulting economic contraction has resulted in increased business uncertainty. The consequences of a prolonged economic decline could include, but are not limited to, reduced revenues, increased instances of uncollectible customer receivables, and increased asset impairments in future periods. Accordingly, the Company cannot reasonably estimate the length or severity of this pandemic, or the extent to which the disruption may materially impact its consolidated balance sheets, consolidated statements of operations and comprehensive loss or statements of cash flows for future periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Going Concern&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements of the Company have been prepared assuming the Company will continue as a going concern and in accordance with US GAAP. The going concern basis of presentation assumes that the Company will continue in operation one year after the date these financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. The Company had cash and cash equivalents of $128,318 and an accumulated deficit of $379,889 at December&#160;31, 2021 and cash outflows from operations of $42,591 and a net loss of $46,689 for the year ended December&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has historically funded its operations through debt financing and issuance of equity securities. Based on the Company&#x2019;s financial position as of the date these consolidated financial statements were issued, the Company projects that it will be able to cover its liquidity needs for the next twelve months with cash on hand. Accordingly, the Company&#x2019;s consolidated financial statements have been prepared on the basis that it will continue as a going concern.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates include fair value of equity awards granted to both employees and non-employees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in facts and circumstances or additional information may result in revised estimates, and actual results may differ from these estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s reporting currency is the U.S. Dollar. The Company has certain foreign subsidiaries where the functional currency is the local currency. All of the assets and liabilities of these subsidiaries are converted to U.S. dollars at the exchange rate in effect at the balance sheet date, income and expense accounts are translated at average rates for the period, and shareholder&#x2019;s equity accounts are translated at historical rates. The effects of translating financial statements of foreign operations into our reporting currency are recognized as an adjustment in accumulated other comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also has foreign subsidiaries that have a functional currency of the U.S. dollar. Purchases and sales of assets and income and expense items denominated in foreign currencies are remeasured into U.S. dollar amounts on the respective dates of such transactions. Net realized foreign currency gains or losses relating to the differences between these recorded amounts and the U.S. dollar equivalent actually received or paid are included within Other income, net in the consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents, and Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. As of December&#160;31, 2021 and 2020, the Company had $128,318 and $60,495 of cash and cash equivalents, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is required to maintain a cash deposit with a bank which consists of collateral on a travel and expense program maintained by the bank. The following represents a reconciliation of cash and cash equivalents in &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the consolidated balance sheets to total cash, cash equivalents and restricted cash in the consolidated statement of cash flows as of December 31, 2021 and December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash (presented within Other current assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Trade and Other Receivables &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Receivables are reported net of allowances for doubtful accounts. The Company maintains allowances for doubtful accounts for estimated losses resulting from the inability of customers to make required payments. The Company estimates the allowance for doubtful accounts based on a variety of factors including the length of time receivables are past due, the financial health of customers, unusual macroeconomic conditions, and historical experience. As of December&#160;31, 2021 and 2020, the Company recognized an allowance for doubtful accounts of $1,235 and $1,325, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Current Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current assets consist of prepaid expenses, materials and supplies, and other assets. Material and supplies consist of spare parts and consumables used for research and research equipment and is stated at the weighted average cost.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost and include improvements that significantly increase capacities or extend the useful lives of existing plant and equipment.&#160;Depreciation is calculated using the straight-line method over the estimated useful life of the assets. Useful lives range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTA0_78de1c22-d3ad-43ae-a899-19a74e1b2357"&gt;three&lt;/span&gt; to five years for instruments and equipment, &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk3OTk5_761df305-309f-4903-a23c-ce62ac3f485c"&gt;three&lt;/span&gt; to five years for office equipment and furniture and software, five years for vehicles and, for leasehold improvements, the shorter of the life of the improvement or the remaining term of the lease. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews the remaining useful life of its assets on a regular basis to determine whether changes have taken place that would suggest that a change to depreciation policies is warranted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon retirement or disposal of property, plant and equipment, the cost and related accumulated depreciation are removed from the account, and the resulting gains or losses, if any, are recorded in the consolidated statements of operations and comprehensive loss. Net gains or losses related to asset dispositions are recognized in earnings in the period in which dispositions occur. Routine maintenance, repairs and replacements are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines&#160;if an arrangement is a lease at inception.&#160;Lease agreements are evaluated to classify the lease as a finance or operating&#160;lease.&#160;Operating lease assets and liabilities are recognized at the commencement date of the lease based on the present value of lease payments over the lease term. Lease assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. As most&#160;leases&#160;do not provide an implicit interest rate,&#160;the Company&#160;uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. Leases with an initial term of 12 months or less are not recorded on the Company&#x2019;s consolidated balance sheets. The Company recognizes lease expense for these leases on a straight-line basis over the lease term.&#160;The Company accounts for lease components and non-lease components as a single lease component.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company performs a recoverability assessment of each of its long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indicators may include, but are not limited to, adverse changes in the regulatory environment in a jurisdiction where the Company operates, a decision to discontinue the development of a long-lived asset, early termination of a significant customer contract, or the introduction of newer technology.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When performing a recoverability assessment, the Company measures whether the estimated future undiscounted net cash flows expected to be generated by the asset exceeds its carrying value. In the event that an asset does not meet the recoverability test, the carrying value of the asset will be adjusted to fair value resulting in an impairment charge.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management develops the assumptions used in the recoverability assessment based on active contracts as well as information received from third-party industry sources. The Company did not record an impairment during the years ended December&#160;31, 2021 and 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Method Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments in entities over which the Company has significant influence, but not control, are accounted for using the&#160;equity method&#160;of accounting. Gain from&#160;equity method&#160;investees, net represents the Company&#x2019;s proportionate share of net income or loss of its equity method investees and any gains or losses from the dilution of such investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity method&#160;investments are assessed for impairment whenever changes in the facts and circumstances indicate a loss in value may have occurred. When a loss is deemed to have occurred and is other than temporary, the carrying value of the&#160;equity method&#160;investment is written down to fair value. In evaluating whether a loss is other than temporary, the Company considers the length of time for which the conditions have existed and its intent and ability to hold the investment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Simple Agreement for Future Equity (SAFE)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2021, the Company issued a SAFE that allowed an investor to participate in future equity financings through a share-settled redemption of the amount invested (such notional being the &#x201c;invested amount&#x201d;). The Company determined that the SAFE was not legal form debt (i.e., no creditors&#x2019; rights). The SAFE includes a provision allowing for cash redemption upon the occurrence of a change of control, the occurrence of which is outside the control of the Company. Therefore, the SAFE is classified as mark-to-market liability pursuant to Accounting Standards Codification (&#x201c;ASC&#x201d;) 480, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Distinguishing Liability from Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has warrants to purchase preferred shares outstanding as of December&#160;31, 2021 and 2020 representing 225,223 and 383,281 preferred shares, respectively, which warrants expire at various dates through December 31, 2027. The exercise prices of the warrants range from $14.69 to $19.93 as of each of December&#160;31, 2021 and 2020. The Company accounts for its warrants as liabilities based upon the characteristics and provisions of each instrument. The liabilities are included in other accrued liabilities on the Company's consolidated balance sheets at their fair value on the date of issuance and are revalued in each subsequent reporting period until such instruments are exercised or expire. The change in fair value between reporting periods is included in other (expense) income, net in the consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Further the warrant related to the SAFE of $1,729 is accounted for as a liability. This liability is recorded in current liabilities on the Company's consolidated balance sheets at fair value on the date of issuance and will be revalued each subsequent reporting period until such instrument is exercised or expire. The change in fair value between reporting periods is included in other (expense) income, net in the consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-Term Debt and Debt Issuance Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s debt consists of credit facilities with financial institutions. Costs directly related to the issuance of debt are reported on the consolidated balance sheets as a reduction from the carrying amount of the recognized debt liability and amortized over the term of the debt using the effective interest method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal and Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may be involved in legal actions in the ordinary course of business, inquiries and proceedings concerning employment, labor, environmental, and other claims. The Company will recognize a loss contingency in the consolidated financial statements when it is probable a liability has been incurred and the amount of the loss can be reasonably estimated. The Company will disclose any loss contingencies that do not meet both conditions if there is a reasonable possibility that a loss may have been incurred. Gain contingencies are not recorded until realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue in accordance with ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company primarily earns revenue from services related to feasibility studies and basic engineering design of commercial plants, licensing of technologies, joint development and contract research activities to develop novel biocatalysts and related technologies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is measured based on the consideration specified in a contract with a customer. The Company records taxes collected from customers and remitted to governmental authorities on a net basis. The Company&#x2019;s payment terms are between 30-60 days and can vary by customer type and products offered. We have evaluated the terms of our arrangements and determined that they do not contain significant financing components.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Carbon Capture and Transformation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company provides feasibility studies and basic design and engineering services used for detailed design, procurement, and construction of commercial plants that utilize the Company&#x2019;s technologies, along with the sale of equipment and microbes. The services provided are recognized as a performance obligation satisfied over time. Revenue is recognized using the output method based on milestone completion, the cost-to-cost input method for certain engineering services, or the percentage of completion method when certain revenue recognition requirements are met. Management has determined that the milestone completion and the associated contractual payment amounts are an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company licenses intellectual property to generate recurring revenue when its customers deploy carbon capture and transformation plants. When licenses are considered to be distinct performance obligations, the recognition of revenue is dependent on the terms of the contract, which may include fixed consideration or royalties based on sales or usage, in which case, the revenue is recognized when the subsequent sale or usage occurs or when the performance obligation to which some or all of the sales or usage-based royalty is allocated has been satisfied, whichever is later.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Research and Development Services&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company performs research and development (&#x201c;R&amp;amp;D&#x201d;) services related to novel technologies and development of biocatalysts for commercial applications, mainly to produce fuels and chemicals. The Company engages in two main types of R&amp;amp;D services &#x2013; joint development agreements, and other contract research, including projects with the U.S. Department of Energy. Such services are recognized as a performance obligation satisfied over time. Revenue is recognized based on milestone completion, when such milestones are contractually defined, or based on stage of contract completion when not defined. For the latter, management has determined that the cost incurred, input method, is an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and estimates its variable consideration under the expected value method. Accordingly, the Company records a liability based on milestones achieved and the expected repayment of the development costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s joint development agreements may utilize the cost-to-cost method of revenue recognition or may include well defined payment milestones, dependent on the contract, both of which the Company evaluates against work completed prior to revenue recognition. For other contract research, the Company utilizes the cost-to-cost method of revenue recognition. These contracts have a fixed dollar amount which is based on the Company&#x2019;s estimate of total costs to be incurred over the life of each contract. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is not recognized in advance of customer acceptance of a milestone, when such acceptance is contractually required. Payments for R&amp;amp;D services with no contractual payments are not due from customers until a technical report is submitted; therefore, a contract asset is recognized at milestone completion but prior to the submission of a technical report. The contract asset represents the Company&#x2019;s right to consideration for the services performed at milestone completion. Occasionally, customers provide payments in advance of the Company providing services which creates a contract liability for the Company. The contract liability represents the Company's obligation to provide services to a customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Collaboration Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has certain partnership agreements that are within the scope of ASC 808, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Collaborative Arrangements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which provides guidance on the presentation and disclosure of collaborative arrangements. Generally, the classification of the transactions under the collaborative arrangements is determined based on the nature of the contractual terms of the arrangement, along with the nature of the operations of the participants. The Company&#x2019;s collaborative agreements generally include a provision of R&amp;amp;D services related to novel technologies and biocatalysts. Amounts received for these services are classified as Revenue from collaborative arrangements in the consolidated statements of operations and comprehensive loss. The Company's R&amp;amp;D services are a major part of the Company's ongoing operations and therefore ASC 606 is applied to recognize revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost of Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s R&amp;amp;D, engineering, and other direct costs of services related to revenue agreements with customers, related parties, and collaborative partners represent cost of revenue. Costs include both internal and third-party fixed and variable costs and include materials, supplies, labor, and fringe benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We incur research and development costs associated with various R&amp;amp;D activities and expense these costs as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for equity-based compensation in accordance with ASC 718, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation &#x2013; Stock Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Accordingly, in exchange for employee and director services, compensation is given in the form of equity awards. The equity awards are recorded based on the grant date fair value and expensed over the requisite service period for the respective award.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s equity-based awards include stock option awards and restricted stock issued by the Company, which vest based on either time or the achievement of certain performance conditions. The Company records forfeitures as they occur. Compensation expense resulting from time-vesting-based awards is recognized in the Company&#x2019;s consolidated statements of operations and comprehensive loss, primarily within research and development expenses, at the grant date fair value over the requisite service period. Compensation expense resulting from performance awards recognized over the requisite service period when it is probable that the performance condition will be met. The calculated compensation expense for performance awards is adjusted based on an estimate of awards ultimately expected to vest. The Company estimates grant date fair value using a Black-Scholes option pricing model that uses assumptions including expected volatility, expected term, and the expected risk-free rate of return. The Company has determined that the Black-Scholes option pricing model, as well as the underlying assumptions used in its application, is appropriate in estimating the fair value of its award grants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company follows the asset and liability method of accounting for income taxes under ASC 740, Income Taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred income tax assets are evaluated to determine if valuation allowances are required or should be adjusted. Valuation allowances are established based on a more likely than not standard. The ability to realize deferred tax assets depends on the Company&#x2019;s ability to generate sufficient taxable income within the carryback or carryforward periods provided for in the tax law for each tax jurisdiction. The Company considers the various possible sources of taxable income when assessing the realization of its deferred tax assets. The valuation allowances recorded against deferred tax assets generated by taxable losses in certain jurisdictions will affect the provision for income taxes until the valuation allowances are released. The Company&#x2019;s provision for income taxes will include no tax benefit for losses incurred and no tax expense with respect to income generated in these jurisdictions until the respective valuation allowance is eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records uncertain tax positions on the basis of a two-step process whereby it is determined whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position, and for those tax positions that meet the more likely than not criteria, the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority is recognized. The Company recognizes accrued interest and penalties related to unrecognized tax benefits in income tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Related Party Transactions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company follows ASC 850-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Related Party Transactions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for the identification of related parties and disclosure of related party transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. Refer to Note 5 - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and Note 14, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Related Party Transactions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Loss Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net loss per share is computed by dividing net loss attributable to participating stock by the weighted average number of shares of participating stock outstanding during the period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted net loss per share reflects potential dilution and is computed by dividing net loss attributable to participating stock by the weighted average number of shares of participating stock outstanding during the period. The dilutive effect of outstanding awards, if any, is reflected in diluted earnings per share by application of the treasury stock method or if-converted method, as applicable. Refer to Note 3, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Loss Per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level 1 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014; Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-term nature, except for the warrant liability. Refer to Note 11, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Warrant Liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk and Other Risks and Uncertainties (Restated)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue generated from the Company&#x2019;s customers outside of the United States for the years ended December&#160;31, 2021 and 2020 was approximately 38% and 14%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021 and 2020, approximately 35% and 27%, respectively, of trade accounts receivable and unbilled accounts receivable was due from customers located outside the United States. At December&#160;31, 2021 and 2020, the value of property, plant, and equipment outside the United States was immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s revenue by geographic region based on the customer&#x2019;s location is presented in Note 4, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenues&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customers representing 10% or greater of revenue were as follows for the years ended December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, two of the Company's customers separately represented 49% (Customer B) and 15% (Customer D) of total accounts receivable and contract assets on the consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments &#x2013; Credit Losses (Topic 326): Disclosure Framework &#x2013; Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU 2016-13&#x201d;), which requires financial assets measured at amortized cost basis, including trade receivables, to be presented net of the amount expected to be collected. The measurement of all expected credit losses will be based on historical experience, current conditions, and reasonable and supportable forecasts. The Company adopted the new standard effective January 1, 2020, using a modified retrospective transition method, which requires a cumulative-effect adjustment, if any, to the opening balance of retained earnings to be recognized on the date of adoption with prior periods not restated. The adoption did not have a material impact on the Company&#x2019;s financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles &#x2013; Goodwill and Other &#x2013; Internal-Use Software (Subtopic 350-40): Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU 2018-15&#x201d;), which requires a customer in a cloud computing arrangement that is a service contract to follow the internal-use software guidance in ASC 350-40 to determine which implementation costs to capitalize as assets. A customer&#x2019;s accounting for the costs of the hosting component of the arrangement is not affected by the new guidance. The Company adopted ASU 2018-15 as of January 1, 2020 with no material impact on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2018, the FASB issued ASU 2018-07, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation - Stock Compensation Improvements to Non-employee Share-Based Payment Accounting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU 2018-07&#x201d;), which simplifies the accounting for stock-based payments granted to non-employees for goods and services. Under ASU 2018-07, most of the guidance on such payments to non-employees will be aligned with the requirements for stock-based payments granted to employees. The Company early adopted ASU 2018-07 as of January 1, 2020 and its adoption did not have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU 2019-12&#x201d;), as part of its simplification initiative to reduce the cost and complexity in accounting for income taxes. ASU 2019-12 removes certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. ASU 2019-12 also amends other aspects of the guidance to help simplify and promote consistent application of US GAAP. The Company adopted ASU 2019-12 as of January 1, 2021 with no material impact on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Announced Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, the FASB issued ASU No. 2020-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Codification Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU 2020-10&#x201d;). The standard contains improvements to the FASB Accounting Standards Codification (the &#x201c;Codification&#x201d;) by ensuring that all guidance that requires or provides an option for an entity to provide information in the notes to financial statements is codified in the disclosure section of the Codification. The standard also improves various topics in the Codification so that entities can apply guidance more consistently on codifications that are varied in nature where the original guidance may have been unclear. The amendments in ASU 2020-10 are effective for the Company for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption is permitted. The Company does not expect the adoption of ASU 2020-10 to have a material impact on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTU0MDY_80223e17-87ab-49e5-85fd-0edcfee32acb">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;) for interim financial information and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022 or any future period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K filed by the Company with the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;) on March 25, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (&#x201c;US GAAP&#x201d;) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;).&lt;/span&gt;&lt;/div&gt;The accompanying unaudited condensed consolidated financial statements of LanzaTech NZ Inc. have been prepared in accordance with generally accepted accounting principles for interim financial information, and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America ("US GAAP"), the accounting principles, standards, and procedures adopted by the U.S. Securities and Exchange Commission, for complete financial statements. However, in the opinion of management, all adjustments (consisting of normal recurring accruals) have been made that are necessary for a fair presentation of the condensed consolidated financial statements for the interim periods. For further information refer to the Consolidated Financial Statements and Footnotes thereto included in the Company's Annual Report for the year ended December 31, 2021.&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;US GAAP"). The consolidated financial statements include the accounts of LanzaTech NZ, Inc. and its wholly-owned consolidated subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTUzOTg_0068ae3b-4409-499b-995c-1ae01c906004">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of September 30, 2022 and December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk and Other Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue generated from the Company&#x2019;s customers outside of the United States for the nine months ended September&#160;30, 2022 and 2021 was approximately 61% and 65%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022 and December&#160;31, 2021, approximately 35% and 35%, respectively, of trade accounts receivable and unbilled accounts receivable was due from customers located outside the United States. At September&#160;30, 2022 and December&#160;31, 2021, the value of property, plant, and equipment outside the United States was immaterial.&lt;/span&gt;&lt;/div&gt;The Company&#x2019;s revenue by geographic region based on the customer&#x2019;s location&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk and Other Risks and Uncertainties (Restated)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue generated from the Company&#x2019;s customers outside of the United States for the years ended December&#160;31, 2021 and 2020 was approximately 38% and 14%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021 and 2020, approximately 35% and 27%, respectively, of trade accounts receivable and unbilled accounts receivable was due from customers located outside the United States. At December&#160;31, 2021 and 2020, the value of property, plant, and equipment outside the United States was immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s revenue by geographic region based on the customer&#x2019;s location is presented in Note 4, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenues&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customers representing 10% or greater of revenue were as follows for the years ended December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;As of December&#160;31, 2021, two of the Company's customers separately represented 49% (Customer B) and 15% (Customer D) of total accounts receivable and contract assets on the consolidated balance sheet.</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTU0MDM_4d195c44-3693-4d46-ab0b-e17eb368ad4a">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of September 30, 2022 and December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2021.&lt;/span&gt;&lt;/div&gt;Cash and Cash EquivalentsThe Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTcxMw_d0d990fd-86bc-4905-9c0b-54732926d110"
      unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTcxMw_d5d25ee2-e8c4-4953-84a3-d0b863c5192b"
      unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:UseOfEstimates
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTU0MDc_5da5e2b7-bc84-4b0e-840c-9ea9b5ee393a">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates include fair value of equity awards granted to both employees and non-employees, the SAFE and the SAFE warrants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in facts and circumstances or additional information may result in revised estimates, and actual results may differ from these estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates include fair value of equity awards granted to both employees and non-employees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in facts and circumstances or additional information may result in revised estimates, and actual results may differ from these estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <amci:InvestmentsHeldInTrustAccountPolicyTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTU0MDg_95f7201a-b7fa-445e-b5cb-4c56d891d75b">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments Held in the Trust Account&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company&#x2019;s investments held in the trust account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company&#x2019;s investments held in the trust account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the trust account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the trust account are determined using available market information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments Held in the Trust Account&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company&#x2019;s investments held in the trust account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company&#x2019;s investments held in the trust account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the trust account in the accompanying statement of operations. The estimated fair values of investments held in the trust account are determined using available market information.&lt;/span&gt;&lt;/div&gt;</amci:InvestmentsHeldInTrustAccountPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTUzOTk_2d2f34a4-1105-4ef7-8293-597078f5a443">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the Company&#x2019;s assets and liabilities which qualify as financial instruments under the FASB ASC 820, &#x201c;Fair Value Measurement,&#x201d; equal or approximate the carrying amounts represented in the condensed balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the Company&#x2019;s assets and liabilities which qualify as financial instruments under the FASB ASC 820, &#x201c;Fair Value Measurement,&#x201d; equal or approximate the carrying amounts represented in the balance sheet.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTU0MTE_b33f652b-57c0-421e-b3dd-772714c4d25f">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level 1 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014; Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level 2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014; Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level 3 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014; Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily due to their short-term nature, except for the warrant liability. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level 1 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014; Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-term nature, except for the warrant liability. Refer to Note 11, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Warrant Liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for more information.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <amci:OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTU0MDk_48a0f13c-a513-41c0-8868-77ffd14d1f0d">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Offering Costs Associated With Initial Public Offering&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the initial public offering that were directly related to the initial public offering. Offering costs were allocated to the separable financial instruments issued in the initial public offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and presented as non-operating expenses in the unaudited condensed statements of operations. Offering costs associated with the Class A common stock issued were charged against the carrying value of the shares of Class A common stock upon the completion of the initial public offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Offering Costs Associated with Initial Public Offering&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the initial public offering that were directly related to the initial public offering. Offering costs were allocated to the separable financial instruments issued in the initial public offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and &lt;/span&gt;&lt;/div&gt;presented as non-operating expenses in the statement of operations. Offering costs associated with the Class A common stock issued were charged against the carrying value of the shares of Class A common stock upon the completion of the initial public offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</amci:OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock>
    <us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTU0MTI_b0529009-8ffb-4cf8-808c-de8ae6645922">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Class A Common Stock Shares Subject to Possible Redemption &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, &#x201c;Distinguishing Liabilities from Equity.&#x201d; Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#x2019;s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders&#x2019; equity. The Company&#x2019;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&#x2019;s control and subject to the occurrence of uncertain future events. Accordingly, as of the initial public offering, 15,000,000 shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders&#x2019; equity (deficit) section of the Company&#x2019;s condensed balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under ASC 480-10-S99, the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of the reporting period. This method would view the end of the reporting period as if it were also the redemption date of the security. Effective with the closing of the initial public offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Class A Common Stock Subject to Possible Redemption &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, &#x201c;Distinguishing Liabilities from Equity.&#x201d; Class A common stock subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#x2019;s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders&#x2019; equity. The Company&#x2019;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&#x2019;s control and subject to the occurrence of uncertain future events. Accordingly, as of the initial public offering, 15,000,000 shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders&#x2019; equity (deficit) section of the Company&#x2019;s balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under ASC 480-10-S99, the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of the reporting period. This method would view the end of the reporting period as if it were also the redemption date of the security. Effective with the closing of the initial public offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.&lt;/span&gt;&lt;/div&gt;</us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i4b4c8d7ac58e4e2586992b9fe74034be_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfNzY1MQ_4c60d91f-b906-4aec-a065-7ab238577574"
      unitRef="shares">15000000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTU0MDA_05c45c16-7e4c-4d72-a411-da94f63f99bb">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, &#x201c;Derivatives and Hedging&#x201d; (&#x201c;ASC 815&#x201d;). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The public warrants and the private placement warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The initial fair value of the public warrants issued in connection with the initial public offering was estimated using a Monte-Carlo simulation model. The fair value of the public warrants as of September 30, 2022 and as of December 31, 2021 is based on observable listed prices for such warrants. The fair value of the private placement warrants as of September 30, 2022 and as of December 31, 2021 is determined using a Black-Scholes option pricing model. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, &#x201c;Derivatives and Hedging&#x201d; (&#x201c;ASC 815&#x201d;). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The public warrants and the private placement warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The initial fair value of the public warrants issued in connection with the initial public offering was estimated using a Monte-Carlo simulation model. The fair value of the public warrants as of December 31, 2021 is based on observable listed prices for such warrants. The fair value of the private placement warrants as of December 31, 2021 is determined using a Black-Scholes option pricing model. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.&lt;/span&gt;&lt;/div&gt;Simple Agreement for Future Equity (SAFE)&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2021, the Company issued a SAFE that allowed an investor to participate in future equity financings through a share-settled redemption of the amount invested (such notional being the &#x201c;invested amount&#x201d;). The Company determined that the SAFE was not legal form debt (i.e., no creditors&#x2019; rights). The SAFE includes a provision allowing for cash redemption upon the occurrence of a change of control, the occurrence of which is outside the control of the Company. Therefore, the SAFE is classified as mark-to-market liability pursuant to Accounting Standards Codification (&#x201c;ASC&#x201d;) 480, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Distinguishing Liability from Equity&lt;/span&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTU0MTA_906a4ab4-2048-48ce-9846-3be40f694c05">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, &#x201c;Income Taxes&#x201d; (&#x201c;ASC 740&#x201d;). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also &lt;/span&gt;&lt;/div&gt;provides guidance on derecognition, classification, interest and penalties, accounting in period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company&#x2019;s effective tax rate was 0.88% and 0.91% for the three and nine months ended September 30, 2022, respectively, and 0.00% for the three months ended September 30, 2021 and the period from January 28, 2021 (inception) through September 30, 2021. The effective tax rate differs from the statutory tax rate of 21% for the three and nine months ended September 30, 2022, the three months ended September 30, 2021 and the period from January 28, 2021 (inception) through September 30, 2021 due primarily to changes in fair value of derivative warrant liabilities, non-taxable gains on the settlement of deferred underwriting commissions, and the valuation allowance on the deferred tax assets.&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, &#x201c;Income Taxes&#x201d; (&#x201c;ASC 740&#x201d;). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company follows the asset and liability method of accounting for income taxes under ASC 740, Income Taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred income tax assets are evaluated to determine if valuation allowances are required or should be adjusted. Valuation allowances are established based on a more likely than not standard. The ability to realize deferred tax assets depends on the Company&#x2019;s ability to generate sufficient taxable income within the carryback or carryforward periods provided for in the tax law for each tax jurisdiction. The Company considers the various possible sources of taxable income when assessing the realization of its deferred tax assets. The valuation allowances recorded against deferred tax assets generated by taxable losses in certain jurisdictions will affect the provision for income taxes until the valuation allowances are released. The Company&#x2019;s provision for income taxes will include no tax benefit for losses incurred and no tax expense with respect to income generated in these jurisdictions until the respective valuation allowance is eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records uncertain tax positions on the basis of a two-step process whereby it is determined whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position, and for those tax positions that meet the more likely than not criteria, the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority is recognized. The Company recognizes accrued interest and penalties related to unrecognized tax benefits in income tax expense.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTE5OTM_9f3c4a93-d8fb-40af-a57a-ed6c83126df6"
      unitRef="number">0.0088</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTIwMDA_e881ca05-5c28-40fb-957c-92b2b199f7ab"
      unitRef="number">0.0091</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i759728e90602443f941d8e14893c6860_D20210128-20210131"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTIwNzc_34786fcf-b777-4eff-92a1-6ad38fffa85a"
      unitRef="number">0.0000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTIwNzc_7340d238-5d53-4188-84dc-ec4e8f099c5d"
      unitRef="number">0.0000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i950a5ff168a044a0ba3702bafec5a66a_D20210401-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTIwNzc_8d0be041-8f56-4846-904b-f3589bf59879"
      unitRef="number">0.0000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i4878d88c1b144a42922da4d1a6220176_D20210201-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTIwNzc_e483c2e8-45cc-47a7-94e4-ef111600a0de"
      unitRef="number">0.0000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="id018cdbc6e7243f8a9576d62630018fd_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTIyNjU_00dccf80-a00f-4dfa-a7bd-e0ae2a0d4f34"
      unitRef="number">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i70621bbf47964eb1927c544e539a3b0c_D20210401-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTIyNjU_3763ed26-2d05-4f21-8461-e04a78478673"
      unitRef="number">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="id42184778b03400da7d8ae8bccfeca9b_D20210128-20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTIyNjU_61f98752-21d2-493b-a046-588913f68cda"
      unitRef="number">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTIyNjU_6fc0e67a-8c9b-453b-bf3d-60259e0c938e"
      unitRef="number">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ia10b0438b73b4dd5bf7658eb1d2482c7_D20210201-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTIyNjU_74e195d3-9f04-45d3-87b4-4501c2d1f58d"
      unitRef="number">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTU0MDQ_72131a40-0fed-4536-95d0-4ba1ae757b68">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Income (Loss) Per Share Of Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#x201c;Earnings Per Share.&#x201d; The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the units sold in the initial public offering and the private placement warrants to purchase an aggregate of 11,000,000 shares of Class A common stock in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the three and nine months ended September 30, 2022 and for the three months ended September 30, 2021 and for the period from January 28, 2021 (inception) through September 30, 2021. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended &lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended &lt;br/&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted net income per common share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allocation of net income &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;995,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,000,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,750,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,130,435&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,750,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.004%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended &lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Period from January 28, 2021 &lt;br/&gt;(inception) through &lt;br/&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted net income per common share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allocation of net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;844,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,428,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Income (Loss) Per Share of Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#x201c;Earnings Per Share.&#x201d; The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the units sold in the initial public offering and the private placement warrants to purchase an aggregate of 11,000,000 shares of Class A common stock in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the period from January 28, 2021 (inception) through December 31, 2021. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the period from January 28, 2021&lt;br/&gt;(inception) through December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted net income (loss) per common share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allocation of net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,690,909&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,750,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted net income (loss) per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Loss Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net loss per share is computed by dividing net loss attributable to participating stock by the weighted average number of shares of participating stock outstanding during the period. &lt;/span&gt;&lt;/div&gt;Diluted net loss per share reflects potential dilution and is computed by dividing net loss attributable to participating stock by the weighted average number of shares of participating stock outstanding during the period. The dilutive effect of outstanding awards, if any, is reflected in diluted earnings per share by application of the treasury stock method or if-converted method, as applicable.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8294868a1493467a83fbece546a36f63_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTMzNjM_989ef914-8b9a-40fb-8623-e42dd05d926b"
      unitRef="shares">11000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTU0MTM_1ca8bff9-4375-44a2-bc5a-36fe2bc530f4">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended &lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended &lt;br/&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted net income per common share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allocation of net income &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;995,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,000,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,750,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,130,435&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,750,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.004%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Nine Months Ended &lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Period from January 28, 2021 &lt;br/&gt;(inception) through &lt;br/&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted net income per common share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allocation of net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;844,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,428,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the period from January 28, 2021&lt;br/&gt;(inception) through December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted net income (loss) per common share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allocation of net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,690,909&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,750,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted net income (loss) per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the calculation of basic and diluted net loss per share for the Company&#x2019;s common stock (in thousands, except shares and per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss for basic and diluted earnings per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,974)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,591)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unpaid cumulative dividends on preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,925)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,068)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss allocated to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83,899)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,659)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares used in calculating net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,108,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,909,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:21pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per common share, basic and diluted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30.19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;__________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;In periods in which the Company reports a net loss, all share-based compensation awards are excluded from the calculation of diluted weighted average shares outstanding because of their anti-dilutive effect on earnings (loss) per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the calculation of basic and diluted net loss per share for the Company&#x2019;s common stock (in thousands, except shares and per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss for basic and diluted earnings per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,689)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unpaid cumulative dividends on preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,758)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss allocated to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83,447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69,004)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares used in calculating net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,959,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,629,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:21pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per common share, basic and diluted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;__________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;In periods in which the Company reports a net loss, all stock-based compensation awards are excluded from the calculation of diluted weighted average shares outstanding because of their anti-dilutive effect on earnings (loss) per share.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i99c308a1e70a4da386ff5a6632f478d0_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfNC0xLTEtMS05MDYwOQ_799cced8-07e2-4bf6-9a78-ad89ec154542"
      unitRef="usd">995636</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i42d79bd723cf48078269f4e2acf3b597_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfNC0zLTEtMS05MDYwOQ_2c4f174a-975a-428a-92ba-0e46d28c4239"
      unitRef="usd">248909</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ic7e0d5966ac7479ebfa164e10daa1272_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfNC01LTEtMS05MDYwOQ_1ed83c00-6dcf-4897-8365-13556d7eafec"
      unitRef="usd">332524</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ie7d75b9f8f1c40e39fde71392a72ee04_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfNC03LTEtMS05MDYwOQ_7cf06308-fe0c-4732-bc26-8038572c0bb5"
      unitRef="usd">136573</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i99c308a1e70a4da386ff5a6632f478d0_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfNy0xLTEtMS05MDYwOQ_61ce089d-55e6-45a0-a039-22328dde8313"
      unitRef="shares">15000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i99c308a1e70a4da386ff5a6632f478d0_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfNy0xLTEtMS05MDYwOQ_cfd4b0b2-420f-429f-a32e-df83c15b34b4"
      unitRef="shares">15000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i42d79bd723cf48078269f4e2acf3b597_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfNy0zLTEtMS05MDYwOQ_91408058-3fce-456d-b3c4-130e91e45323"
      unitRef="shares">3750000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i42d79bd723cf48078269f4e2acf3b597_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfNy0zLTEtMS05MDYwOQ_ce1a504f-0d65-4723-803c-7ab9a42cd46f"
      unitRef="shares">3750000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic7e0d5966ac7479ebfa164e10daa1272_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfNy01LTEtMS05MDYwOQ_970d15b4-e5fc-4ccf-9c00-790fb18b8c95"
      unitRef="shares">9130435</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic7e0d5966ac7479ebfa164e10daa1272_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfNy01LTEtMS05MDYwOQ_c4fc7f0e-eccf-4031-be65-ada3a2e361d6"
      unitRef="shares">9130435</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie7d75b9f8f1c40e39fde71392a72ee04_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfNy03LTEtMS05MDYwOQ_93937af7-3cd8-428b-91f5-80ceb37ed1c8"
      unitRef="shares">3750000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie7d75b9f8f1c40e39fde71392a72ee04_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfNy03LTEtMS05MDYwOQ_f526f844-f6c1-4377-8f3e-23e3db5ebeac"
      unitRef="shares">3750000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i99c308a1e70a4da386ff5a6632f478d0_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfOC0xLTEtMS05MDYwOQ_5aa81add-8faa-45e7-9c3a-feb6ae061016"
      unitRef="usdPerShare">0.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i99c308a1e70a4da386ff5a6632f478d0_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfOC0xLTEtMS05MDYwOQ_df840ca5-8b40-4195-9c00-ef595f803e44"
      unitRef="usdPerShare">0.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i42d79bd723cf48078269f4e2acf3b597_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfOC0zLTEtMS05MDYwOQ_09f1a3f6-a626-42d1-8729-fb66f47cc6c3"
      unitRef="usdPerShare">0.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i42d79bd723cf48078269f4e2acf3b597_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfOC0zLTEtMS05MDYwOQ_0ee03c1f-a5af-4f8f-83ac-193e4488bb33"
      unitRef="usdPerShare">0.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic7e0d5966ac7479ebfa164e10daa1272_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfOC01LTEtMS05MDYwOQ_552ca31e-578a-46ba-a453-70ae5f7dde82"
      unitRef="usdPerShare">0.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic7e0d5966ac7479ebfa164e10daa1272_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfOC01LTEtMS05MDYwOQ_82d324b9-5f51-41da-9f1f-451187a9cd9a"
      unitRef="usdPerShare">0.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie7d75b9f8f1c40e39fde71392a72ee04_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfOC03LTEtMS05MDYwOQ_124b09be-c431-442a-bd68-615e9c6c9d9b"
      unitRef="usdPerShare">0.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie7d75b9f8f1c40e39fde71392a72ee04_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjEyMTU2Mjk3ZDlmMjRlMWFiNjU3YWJhM2ZjMTkzZjcyL3RhYmxlcmFuZ2U6MTIxNTYyOTdkOWYyNGUxYWI2NTdhYmEzZmMxOTNmNzJfOC03LTEtMS05MDYwOQ_f988bae6-a923-4514-b87e-7ff70ee5d280"
      unitRef="usdPerShare">0.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i40a66b571894495b9172904623c3020a_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfNC0xLTEtMS05MDYwOQ_8e4285ad-9d2d-4194-a72e-611ca2a47440"
      unitRef="usd">844868</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i17dcd8e30cd643c885ad894b1240e01c_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfNC0zLTEtMS05MDYwOQ_880fe067-c677-4a01-a228-fabd8e9f85f7"
      unitRef="usd">211217</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ie8be3aafc5054f04afe2e590fba42def_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfNC01LTEtMS05MDYwOQ_e544907e-840f-4909-b478-b2f840a6ce11"
      unitRef="usd">223297</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i5fb60d41143f4f3d991562590f0fe6af_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfNC03LTEtMS05MDYwOQ_be1abf9c-9068-4756-8ca5-14062774aedb"
      unitRef="usd">244231</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i40a66b571894495b9172904623c3020a_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfNy0xLTEtMS05MDYwOQ_bf99afef-b4ba-4ac2-86b5-b80e979c7732"
      unitRef="shares">15000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i40a66b571894495b9172904623c3020a_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfNy0xLTEtMS05MDYwOQ_fe8003dd-2615-41fe-a2d5-507f659d1822"
      unitRef="shares">15000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i17dcd8e30cd643c885ad894b1240e01c_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfNy0zLTEtMS05MDYwOQ_7fa9a89c-7b05-42a5-9d2c-f43dada02c5c"
      unitRef="shares">3750000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i17dcd8e30cd643c885ad894b1240e01c_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfNy0zLTEtMS05MDYwOQ_b6f9b7e9-ecb5-4051-a2c5-625802b6ad63"
      unitRef="shares">3750000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie8be3aafc5054f04afe2e590fba42def_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfNy01LTEtMS05MDYwOQ_5edefea0-2ff0-47c9-9f87-8aa18d0add47"
      unitRef="shares">3428571</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie8be3aafc5054f04afe2e590fba42def_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfNy01LTEtMS05MDYwOQ_7cf90125-013f-435b-b298-5925d7877326"
      unitRef="shares">3428571</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5fb60d41143f4f3d991562590f0fe6af_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfNy03LTEtMS05MDYwOQ_6bc482a3-154e-4f98-9a93-6876822e956b"
      unitRef="shares">3750000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5fb60d41143f4f3d991562590f0fe6af_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfNy03LTEtMS05MDYwOQ_b0778646-fe31-4ad3-9a5c-4cf5cb7022b2"
      unitRef="shares">3750000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i40a66b571894495b9172904623c3020a_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfOC0xLTEtMS05MDYwOQ_82f777f8-96ce-4291-af6c-ef5125afa324"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i40a66b571894495b9172904623c3020a_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfOC0xLTEtMS05MDYwOQ_f2b3fee6-a9e8-41d1-ac04-36d0e89f727d"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i17dcd8e30cd643c885ad894b1240e01c_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfOC0zLTEtMS05MDYwOQ_0fa7f5a2-e3c4-4960-99f3-998d37f4f52a"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i17dcd8e30cd643c885ad894b1240e01c_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfOC0zLTEtMS05MDYwOQ_e723aae7-f860-4a03-a741-7d568334206b"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie8be3aafc5054f04afe2e590fba42def_D20210128-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfOC01LTEtMS05MDYwOQ_924e98ad-7d6b-4551-9a5f-bbadd87fe49e"
      unitRef="usdPerShare">0.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie8be3aafc5054f04afe2e590fba42def_D20210128-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfOC01LTEtMS05MDYwOQ_9316f18e-1c12-48d7-86aa-1b7e08767682"
      unitRef="usdPerShare">0.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5fb60d41143f4f3d991562590f0fe6af_D20210128-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfOC03LTEtMS05MDYwOQ_2d25c3a7-3567-47db-beaf-cc5ca59eebc4"
      unitRef="usdPerShare">0.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5fb60d41143f4f3d991562590f0fe6af_D20210128-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RhYmxlOjI0YjdjYjBhNzg5ZDRiMDA4OGNmZmU0ZTQzYmI1ZTQzL3RhYmxlcmFuZ2U6MjRiN2NiMGE3ODlkNGIwMDg4Y2ZmZTRlNDNiYjVlNDNfOC03LTEtMS05MDYwOQ_dce29936-a876-46b1-99c8-67d7a3bc4aee"
      unitRef="usdPerShare">0.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNy9mcmFnOjJiYmY3NDlmMTdkOTQyNDM4YTc2ZGE5NTQyMzA4ZjQ5L3RleHRyZWdpb246MmJiZjc0OWYxN2Q5NDI0MzhhNzZkYTk1NDIzMDhmNDlfMTU0MDE_c06aa8a3-3330-4a3a-9f71-2579ad2b8d33">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the FASB issued ASU 2022-03, ASC Subtopic 820 &#x201c;Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions&#x201d;. The ASU amends ASC 820 to clarify that a contractual sales restriction is not considered in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. The ASU applies to both holders and issuers of equity and equity-linked securities measured at fair value. The amendments in this ASU are effective for the Company in fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is still evaluating the impact of this pronouncement on the condensed financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company&#x2019;s unaudited condensed financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2020-06, &#x201c;Debt &#x2014; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#x2014; Contracts in an Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity&#x201d; (&#x201c;ASU 2020-06&#x201d;), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. ASU 2020-06 also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 on August 2, 2021 using the modified retrospective method for transition. Adoption of ASU 2020-06 did not impact the Company&#x2019;s financial position, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;The Company&#x2019;s management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the Company&#x2019;s financial statements.&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Announced Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, the Financial Accounting Standard Board ("FASB") issued an Accounting Standard Update ("ASU") No. 2020-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Codification Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU 2020-10&#x201d;). The standard contains improvements to the FASB Accounting Standards Codification (the &#x201c;Codification&#x201d;) by ensuring that all guidance that requires or provides an option for an entity to provide information in the notes to financial statements is codified in the disclosure section of the Codification. The standard also improves various topics in the Codification so that entities can apply guidance more consistently on codifications that are varied in nature where the original guidance may have been unclear. The amendments in ASU 2020-10 were effective for the Company for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption was permitted. There were no material impacts upon the adoption of ASU 2020-10, on its consolidated financial statements and related disclosures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments &#x2013; Credit Losses (Topic 326): Disclosure Framework &#x2013; Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU 2016-13&#x201d;), which requires financial assets measured at amortized cost basis, including trade receivables, to be presented net of the amount expected to be collected. The measurement of all expected credit losses will be based on historical experience, current conditions, and reasonable and supportable forecasts. The Company adopted the new standard effective January 1, 2020, using a modified retrospective transition method, which requires a cumulative-effect adjustment, if any, to the opening balance of retained earnings to be recognized on the date of adoption with prior periods not restated. The adoption did not have a material impact on the Company&#x2019;s financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles &#x2013; Goodwill and Other &#x2013; Internal-Use Software (Subtopic 350-40): Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU 2018-15&#x201d;), which requires a customer in a cloud computing arrangement that is a service contract to follow the internal-use software guidance in ASC 350-40 to determine which implementation costs to capitalize as assets. A customer&#x2019;s accounting for the costs of the hosting component of the arrangement is not affected by the new guidance. The Company adopted ASU 2018-15 as of January 1, 2020 with no material impact on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2018, the FASB issued ASU 2018-07, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation - Stock Compensation Improvements to Non-employee Share-Based Payment Accounting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU 2018-07&#x201d;), which simplifies the accounting for stock-based payments granted to non-employees for goods and services. Under ASU 2018-07, most of the guidance on such payments to non-employees will be aligned with the requirements for stock-based payments granted to employees. The Company early adopted ASU 2018-07 as of January 1, 2020 and its adoption did not have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU 2019-12&#x201d;), as part of its simplification initiative to reduce the cost and complexity in accounting for income taxes. ASU 2019-12 removes certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. ASU 2019-12 also amends other aspects of the guidance to help simplify and promote consistent application of US GAAP. The Company adopted ASU 2019-12 as of January 1, 2021 with no material impact on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Announced Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, the FASB issued ASU No. 2020-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Codification Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU 2020-10&#x201d;). The standard contains improvements to the FASB Accounting Standards Codification (the &#x201c;Codification&#x201d;) by ensuring that all guidance that requires or provides an option for an entity to provide information in the notes to financial statements is codified in the disclosure section of the Codification. The standard also improves various topics in the Codification so that entities can apply guidance more consistently on codifications that are varied in nature where the original guidance may have been unclear. The amendments in ASU 2020-10 are effective for the Company for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption is permitted. The Company does not expect the adoption of ASU 2020-10 to have a material impact on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <amci:InitialPublicOfferingTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MC9mcmFnOjM5NzE2ZmRkNzc0YjRhYjM4MzVkY2UzODBmNWI0ZTU4L3RleHRyZWdpb246Mzk3MTZmZGQ3NzRiNGFiMzgzNWRjZTM4MGY1YjRlNThfMTE5NQ_7f07d1fd-e4cb-4aff-88d9-01b59c8eaf92">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 3 &#x2014; Initial Public Offering&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 6, 2021, the Company consummated its initial public offering of 15,000,000 units, at an offering price of $10.00 per unit, generating gross proceeds of $150.0 million, and incurring offering costs of approximately $13.8 million, inclusive of $1.5 million of underwriting discount, approximately $5.3 million in deferred underwriting commissions, approximately $6.5 million in fair value of Class B common stock issued to Anchor Investors, and approximately $0.5 million in other offering costs. Each whole warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 8). Certain qualified institutional buyers or institutional accredited investors (the &#x201c;Anchor Investors&#x201d;) purchased 15,480,000 units in the initial public offering. None of the Anchor Investors are affiliated with any member of the Company&#x2019;s management.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The underwriters had a 45-day option from the date of the underwriting agreement (August 3, 2021) to purchase up to an additional 2,250,000 units to cover over-allotments. On September 17, 2021, the over-allotment option expired unexercised, resulting in 562,500 shares of Class B common stock that were subject to forfeiture to be forfeited.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 3 &#x2014; Initial Public Offering&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 6, 2021, the Company consummated its initial public offering of 15,000,000 units, at an offering price of $10.00 per unit, generating gross proceeds of $150.0 million, and incurring offering costs of approximately $13.8 million, inclusive of $1.5 million of underwriting discount, approximately $5.3 million in deferred underwriting commissions, approximately $6.5 million in fair value of Class B common stock issued to Anchor Investors, and approximately $0.5 million in other offering costs. Each whole warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 8). Certain qualified institutional buyers or institutional accredited investors (the &#x201c;Anchor Investors&#x201d;) purchased 15,480,000 units in the initial public offering. None of the Anchor Investors are affiliated with any member of the Company&#x2019;s management.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The underwriters had a 45-day option from the date of the underwriting agreement (August 3, 2021) to purchase up to an additional 2,250,000 units to cover over-allotments. On September 17, 2021, the over-allotment option expired unexercised, resulting in 562,500 shares of Class B common stock that were subject to forfeiture to be forfeited.&lt;/span&gt;&lt;/div&gt;</amci:InitialPublicOfferingTextBlock>
    <amci:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MC9mcmFnOjM5NzE2ZmRkNzc0YjRhYjM4MzVkY2UzODBmNWI0ZTU4L3RleHRyZWdpb246Mzk3MTZmZGQ3NzRiNGFiMzgzNWRjZTM4MGY1YjRlNThfMTEy_aee6daff-51a7-49a9-aa66-bc9eec85f9b6"
      unitRef="shares">15000000</amci:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MC9mcmFnOjM5NzE2ZmRkNzc0YjRhYjM4MzVkY2UzODBmNWI0ZTU4L3RleHRyZWdpb246Mzk3MTZmZGQ3NzRiNGFiMzgzNWRjZTM4MGY1YjRlNThfMTQ2_4d82f9f6-0d75-4a8f-b77b-a663cbff2567"
      unitRef="usdPerShare">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MC9mcmFnOjM5NzE2ZmRkNzc0YjRhYjM4MzVkY2UzODBmNWI0ZTU4L3RleHRyZWdpb246Mzk3MTZmZGQ3NzRiNGFiMzgzNWRjZTM4MGY1YjRlNThfMTg4_a04295f0-c6cb-42ae-8870-1ae5589e270c"
      unitRef="usd">150000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:DeferredOfferingCosts
      contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MC9mcmFnOjM5NzE2ZmRkNzc0YjRhYjM4MzVkY2UzODBmNWI0ZTU4L3RleHRyZWdpb246Mzk3MTZmZGQ3NzRiNGFiMzgzNWRjZTM4MGY1YjRlNThfMjM4_8e016718-5081-4989-9042-ebc510b9546c"
      unitRef="usd">13800000</us-gaap:DeferredOfferingCosts>
    <amci:SaleOfStockUnderwritingDiscounts
      contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MC9mcmFnOjM5NzE2ZmRkNzc0YjRhYjM4MzVkY2UzODBmNWI0ZTU4L3RleHRyZWdpb246Mzk3MTZmZGQ3NzRiNGFiMzgzNWRjZTM4MGY1YjRlNThfMjU1_582718f3-855e-4989-9e70-07b13527bad1"
      unitRef="usd">1500000</amci:SaleOfStockUnderwritingDiscounts>
    <amci:DeferredUnderwritingCompensationNoncurrent
      contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MC9mcmFnOjM5NzE2ZmRkNzc0YjRhYjM4MzVkY2UzODBmNWI0ZTU4L3RleHRyZWdpb246Mzk3MTZmZGQ3NzRiNGFiMzgzNWRjZTM4MGY1YjRlNThfMjk4_e199f500-bce0-4781-814a-4758bd254c66"
      unitRef="usd">5300000</amci:DeferredUnderwritingCompensationNoncurrent>
    <amci:ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering
      contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MC9mcmFnOjM5NzE2ZmRkNzc0YjRhYjM4MzVkY2UzODBmNWI0ZTU4L3RleHRyZWdpb246Mzk3MTZmZGQ3NzRiNGFiMzgzNWRjZTM4MGY1YjRlNThfMzUz_33ef2661-453f-4d48-8fa3-d1d966a38f0e"
      unitRef="usd">6500000</amci:ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering>
    <amci:SaleOfStockOtherOfferingCosts
      contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MC9mcmFnOjM5NzE2ZmRkNzc0YjRhYjM4MzVkY2UzODBmNWI0ZTU4L3RleHRyZWdpb246Mzk3MTZmZGQ3NzRiNGFiMzgzNWRjZTM4MGY1YjRlNThfNDQw_014f3be6-ca28-4934-a44a-3cf2f0ec8d20"
      unitRef="usd">500000</amci:SaleOfStockOtherOfferingCosts>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MC9mcmFnOjM5NzE2ZmRkNzc0YjRhYjM4MzVkY2UzODBmNWI0ZTU4L3RleHRyZWdpb246Mzk3MTZmZGQ3NzRiNGFiMzgzNWRjZTM4MGY1YjRlNThfNTI3_da11c9c1-f55c-4f77-a95b-4346e6c187f7"
      unitRef="shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="id44a938156574d23a69f5f980c896774_I20210806"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MC9mcmFnOjM5NzE2ZmRkNzc0YjRhYjM4MzVkY2UzODBmNWI0ZTU4L3RleHRyZWdpb246Mzk3MTZmZGQ3NzRiNGFiMzgzNWRjZTM4MGY1YjRlNThfNTc0_e25cb108-6087-4c4f-b936-cd4e94b6244f"
      unitRef="usdPerShare">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <amci:OptionToPurchaseAdditionalUnitsGivenToInvestors
      contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MC9mcmFnOjM5NzE2ZmRkNzc0YjRhYjM4MzVkY2UzODBmNWI0ZTU4L3RleHRyZWdpb246Mzk3MTZmZGQ3NzRiNGFiMzgzNWRjZTM4MGY1YjRlNThfNzM2_493f5010-2639-4bb6-a4db-76664b75abb6"
      unitRef="shares">15480000</amci:OptionToPurchaseAdditionalUnitsGivenToInvestors>
    <amci:OptionVestingPeriod
      contextRef="i9caa935ece004b9ab6c6caa6377836b9_D20210803-20210803"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MC9mcmFnOjM5NzE2ZmRkNzc0YjRhYjM4MzVkY2UzODBmNWI0ZTU4L3RleHRyZWdpb246Mzk3MTZmZGQ3NzRiNGFiMzgzNWRjZTM4MGY1YjRlNThfMTE5Ng_452c3a7a-ab39-480b-a88e-bb8994fb1a33">P45D</amci:OptionVestingPeriod>
    <amci:OptionToPurchaseAdditionalUnitsGivenToInvestors
      contextRef="i9caa935ece004b9ab6c6caa6377836b9_D20210803-20210803"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MC9mcmFnOjM5NzE2ZmRkNzc0YjRhYjM4MzVkY2UzODBmNWI0ZTU4L3RleHRyZWdpb246Mzk3MTZmZGQ3NzRiNGFiMzgzNWRjZTM4MGY1YjRlNThfOTk2_42e77af3-29cf-4796-8cdb-3da13f11970f"
      unitRef="shares">2250000</amci:OptionToPurchaseAdditionalUnitsGivenToInvestors>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="i0d95a7ae67054cae98cfee5d7bdc74d0_D20210917-20210917"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MC9mcmFnOjM5NzE2ZmRkNzc0YjRhYjM4MzVkY2UzODBmNWI0ZTU4L3RleHRyZWdpb246Mzk3MTZmZGQ3NzRiNGFiMzgzNWRjZTM4MGY1YjRlNThfMTExNA_f2746955-9719-4786-b6a2-2f747d4c1be5"
      unitRef="shares">562500</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNzg2MQ_1bb3f816-df3d-49c6-b28a-8c793fc15bfb">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 4 &#x2014; Related Party Transactions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Founder Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 29, 2021, the Sponsor paid $25,000, or approximately $0.005 per share, to cover certain offering costs in consideration for 5,031,250 shares of Class B common stock, par value $0.0001. In March 2021, the Sponsor transferred all of the founder shares it held to members of the Company&#x2019;s board of directors, management &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;team, and persons or entities affiliated with AMCI Group (the &#x201c;initial shareholders&#x201d;). Such shares were fully paid. On May 14, 2021, the Sponsor surrendered 718,750 founder shares to the Company for no consideration, resulting in the Sponsor owning 4,312,500 founder shares. Up to 562,500 of the founder shares will be forfeited depending on the extent to which the underwriters&#x2019; over-allotment is exercised. On September 17, 2021, the over-allotment option expired unexercised, resulting in 562,500 of the founder shares being forfeited.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In exchange for the Anchor Investors&#x2019; participation in the initial public offering as described in Note 3, the Sponsor sold a total of 780,000 founder shares to the Anchor Investors. The Company determined that the fair value of these founder shares was approximately $6.5 million (or approximately $8.35 per share) using a Monte Carlo simulation. The Company recognized the excess fair value of these founder shares, over the price sold to the Anchor Investors, as an expense of the initial public offering resulting in a charge against the carrying value of Class A common stock subject to possible redemption.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The initial stockholders have agreed not to transfer, assign or sell any of their founder shares and any Class A common stocks issuable upon conversion thereof until the earlier to occur of: (A) one year after the completion of the initial business combination and (B) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction after the Company&#x2019;s initial business combination that results in all of the Company&#x2019;s stockholders having the right to exchange their Class A common stock for cash, securities or other property; except to certain permitted transferees and under certain circumstances (the &#x201c;Lock-up&#x201d;). Any permitted transferees will be subject to the same restrictions and other agreements of the company&#x2019;s initial stockholders with respect to any founder shares. Notwithstanding the foregoing, the founder shares will be released from the Lock-up if the closing price of the Company&#x2019;s Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the company&#x2019;s initial business combination.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Private Placement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Simultaneously with the closing of the initial public offering, the Company&#x2019;s Sponsor has purchased an aggregate of 3,500,000 private placement warrants, each exercisable to purchase one Class A common stock at $11.50 per share, at a price of $1.00 per warrant, or $3,500,000 in the aggregate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The private placement warrants will not be redeemable by the Company so long as they are held by the initial purchasers or their permitted transferees. The initial purchasers, or their permitted transferees, have the option to exercise the private placement warrants on a cashless basis. If the private placement warrants are held by holders other than initial purchasers or their permitted transferees, the private placement warrants will be redeemable by the Company and exercisable by the holders on the same basis as the warrants included in the units being sold in the initial public offering. Otherwise, the private placement warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in the initial public offering.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the private placement warrants are held by holders other than the Sponsor or its permitted transferees, the private placement warrants will be redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the units being sold in the initial public offering.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Related Party Loans and Advances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 29, 2021, the Sponsor agreed to loan the Company up to $300,000 to be used for a portion of the expenses of the initial public offering (&#x201c;Note&#x201d;). This loan was non-interest bearing, unsecured and payable upon the closing of the initial public offering. In addition to the Note, the Sponsor of the Company also paid certain administrative expenses and offering costs on behalf of the Company. These advances were due on demand and were non-interest bearing. The Company repaid the note payable and advances in exchange for the issuance of private placement warrants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Working Capital Loans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, in order to finance transaction costs in connection with an intended business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#x2019;s officers and directors may, but are not obligated &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to, loan the Company funds as may be required on a non-interest basis (&#x201c;Working Capital Loans&#x201d;). If the Company completes the initial business combination, it will repay the Working Capital Loans. In the event that the initial business combination does not close, the Company may use a portion of the working capital held outside the trust account to repay the Working Capital Loans but no proceeds from the trust account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-business combination entity at a price of $1.00 per warrant at the option of the lender. Such warrants would be identical to the private placement warrants. Except as set forth above, the terms of Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. On March 28, 2022, the Company entered into a noninterest-bearing Working Capital Loan with its Sponsor for the principal amount of up to $1.5 million. As of September 30, 2022 and December 31, 2021, the Company had no borrowings under the Working Capital Loans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Administrative Service Fee&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to the closing of the initial public offering, the Company will pay its Sponsor $10,000 per month for office space, secretarial and administrative services provided to members of the management team. Upon completion of the initial business combination or the Company&#x2019;s liquidation, the Company will cease paying these monthly fees. For the three months ended September 30, 2022 and 2021, the Company incurred $30,000 and $20,000, respectively, of such fees, included as general and administrative fees &#x2014; related party on the accompanying unaudited condensed statements of operations. For the nine months ended September 30, 2022 and for the period from January 28, 2021 (inception) through September 30, 2021, the Company incurred $90,000 and $20,000, respectively, of such fees, included as general and administrative fees &#x2014; related party on the accompanying unaudited condensed statements of operations. As of September 30, 2022 and December 31, 2021, approximately $90,000 and $50,000, respectively, of such fees were included in due to related party on the accompanying condensed balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Sponsor, officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on the Company&#x2019;s behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. The Company&#x2019;s audit committee will review on a quarterly basis all payments that were made by the Company to the Sponsor, directors, officers or directors of the Company, or any of their affiliates. As of September 30, 2022 and December 31, 2021, there were approximately $596,000 and $0, respectively, of such fees included as due to related party on the accompanying condensed balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 4 &#x2014; Related Party Transactions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Founder Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 29, 2021, the Sponsor paid $25,000, or approximately $0.005 per share, to cover certain offering costs in consideration for 5,031,250 shares of Class B common stock, par value $0.0001. In March 2021, the Sponsor transferred all of the founder shares it held to members of the Company&#x2019;s board of directors, management team, and persons or entities affiliated with AMCI Group (the &#x201c;initial shareholders&#x201d;). Such shares were fully paid. On May 14, 2021, the Sponsor surrendered 718,750 founder shares to the Company for no consideration, resulting in the Sponsor owning 4,312,500 founder shares. Up to 562,500 of the founder shares will be forfeited depending on the extent to which the underwriters&#x2019; over-allotment is exercised. On September 17, 2021, the over-allotment option expired unexercised, resulting in 562,500 of the founder shares being forfeited.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In exchange for the Anchor Investors&#x2019; participation in the initial public offering as described in Note 3, the Sponsor sold a total of 780,000 founder shares to the Anchor Investors. The Company determined that the fair value of these founder shares was approximately $6.5 million (or approximately $8.35 per share) using a Monte Carlo simulation. The Company recognized the excess fair value of these founder shares, over the price sold to the Anchor Investors, as an expense of the initial public offering resulting in a charge against the carrying value of Class A common stock subject to possible redemption.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The initial stockholders have agreed not to transfer, assign or sell any of their founder shares and any Class A common stocks issuable upon conversion thereof until the earlier to occur of: (A) one year after the completion of the initial business combination and (B) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction after the Company&#x2019;s initial business combination that results in all of the Company&#x2019;s stockholders having the right to exchange their Class A common stock for cash, securities or other property; except to certain permitted transferees and under certain circumstances (the &#x201c;Lock-up&#x201d;). Any permitted transferees will be subject to the same restrictions and other agreements of the company&#x2019;s initial stockholders with respect to any founder shares. Notwithstanding the foregoing, the founder shares will be released from the Lock-up if the closing price of the Company&#x2019;s Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the company&#x2019;s initial business combination.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Private Placement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Simultaneously with the closing of the initial public offering, the Company&#x2019;s Sponsor has purchased an aggregate of 3,500,000 private placement warrants, each exercisable to purchase one Class A common stock at $11.50 per share, at a price of $1.00 per warrant, or $3,500,000 in the aggregate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The private placement warrants will not be redeemable by the Company so long as they are held by the initial purchasers or their permitted transferees. The initial purchasers, or their permitted transferees, have the option to exercise the private placement warrants on a cashless basis. If the private placement warrants are held by holders other than initial purchasers or their permitted transferees, the private placement warrants will be redeemable by the Company and exercisable by the holders on the same basis as the warrants included in the units being sold in the initial public offering. Otherwise, the private placement warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in the initial public offering.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the private placement warrants are held by holders other than the Sponsor or its permitted transferees, the private placement warrants will be redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the units being sold in the initial public offering.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Related Party Loans and Advances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 29, 2021, the Sponsor agreed to loan the Company up to $300,000 to be used for a portion of the expenses of the initial public offering (&#x201c;Note&#x201d;). This loan was non-interest bearing, unsecured and payable upon the closing of the initial public offering. In addition to the Note, the Sponsor of the Company also paid certain administrative expenses and offering costs on behalf of the Company. These advances were due on demand and were non-interest bearing. The Company repaid the note payable and advances in exchange for the issuance of private placement warrants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, in order to finance transaction costs in connection with an intended business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#x2019;s officers and directors may, but are not obligated to, loan the Company funds as may be required on a non-interest basis (&#x201c;Working Capital Loans&#x201d;). If the Company completes the initial business combination, it will repay the Working Capital Loans. In the event that the initial business combination does not close, the Company may use a portion of the working capital held outside the trust account to repay the Working Capital Loans but no proceeds from the trust account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-business combination entity at a price of $1.00 per warrant at the option of the lender. Such warrants would be identical to the private placement warrants. Except as set forth above, the terms of Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of December 31, 2021, the Company had no borrowings under the Working Capital Loans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Administrative Service Fee&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to the closing of the initial public offering, the Company will pay its Sponsor $10,000 per month for office space, secretarial and administrative services provided to members of the management team. Upon completion of the initial business combination or the Company&#x2019;s liquidation, the Company will cease paying these monthly fees. For the period from January 28, 2021 (inception) through December 31, 2021, the Company incurred $50,000 of such fees, included as general and administrative fees &#x2014; related party on the accompanying statement of operations. As of December 31, 2021, approximately $50,000 of such fees are included as due to related party on the accompanying balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 9 &#x2014; Related Party Transactions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022 and December&#160;31, 2021, the Company had an equity ownership in LanzaJet and SGLT with an aggregate carrying value of $26,037 and $24,752, respectively. The table below summarizes amounts related to transactions with these related parties (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases and open accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accounts payable balance is for work that LanzaJet performed as a subcontractor to the Company. Refer to Note 5, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for more information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the formation of LanzaJet, the Company entered into a transition services agreement with LanzaJet. The transition services agreement generally sets out the respective rights, responsibilities and obligations of the Company and LanzaJet with respect to R&amp;amp;D services, access to office and laboratory space, business development and other administrative support services. The transition services agreement may be terminated by mutual consent of the Company and LanzaJet, by LanzaJet at any time, and by the Company upon breach or non-payment by LanzaJet. There are no substantive termination penalties in the event the Company terminates. For the nine months ended September&#160;30, 2022 and September&#160;30, 2021, the Company recognized revenue from related parties of approximately $148 and $355, respectively, under the transition services agreement. The Company also provides certain engineering and other services related to a gas-to-jet demonstration plant currently in development by LanzaJet pursuant to the Investment Agreement described in Note 5, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. In connection with these services, the Company recognized revenue from LanzaJet of approximately $170 and $403, for the nine months ended September&#160;30, 2022 and September&#160;30, 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020, the Company executed an agreement to lease certain land to a subsidiary of LanzaJet for a period of 10 years with an option to renew this lease for five additional periods of one year with minimum annual rent due to the Company of $24. The lease commenced upon execution of the lease agreement and was subsequently amended in 2022 to extend the Pre-Development Term and annual rent amount. Refer to Note 12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company supplies SGLT with certain water-soluble organic compounds required in the Company's proprietary gas fermentation process, and small-size equipment. As a result, for the nine months ended September&#160;30, 2022 and September&#160;30, 2021, the Company recognized revenue from related parties of approximately $151 and $69, respectively. The Company also provided engineering services and incurred costs of $$893 and $1,171 for the nine months ended September&#160;30, 2022 and September&#160;30, 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, LanzaTech and SGLT entered into a license agreement in 2019, subsequently amended in 2021, to provide SGLT with the right to sublicense the intellectual property that LanzaTech previously licensed to SGLT. In exchange, the Company is entitled to receive licensing consideration, calculated as a percentage of the royalties received by SGLT from the sublicenses. Currently, SGLT sublicenses to certain of its subsidiaries that use LanzaTech's proprietary technology. The royalties received by SGLT are based on sales-and-usage of the sublicensed technology. For the nine months ended September&#160;30, 2022, and September&#160;30, 2021, the Company did not earn any sublicensing revenue as no royalties were received by SGLT.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;Related Party Transactions&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021 and 2020, the Company had an equity ownership in LanzaJet and SGLT with an aggregate carrying value of $24,752 and $23,217, respectively. Trade receivables and contract assets of $1,071 and $3,257, from these equity method investees are included in accounts receivable, respectively. The Company made purchases and had open accounts payable of $2,575 as of and for the year ended December&#160;31, 2021. The accounts payable balance is for work that LanzaJet performed as a subcontractor to the Company. Refer to Note 5 - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s, for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the formation of LanzaJet, the Company entered into a transition services agreement with LanzaJet. The transition services agreement generally sets out the respective rights, responsibilities and obligations of the Company and LanzaJet with respect to R&amp;amp;D services, business development and other administrative support services. The transition services agreement may be terminated by mutual consent of the Company and LanzaJet, by LanzaJet at any time, and by the Company upon breach or non-payment by LanzaJet. There are no substantive termination penalties in the event the Company terminates. During the years ended December&#160;31, 2021 and 2020, the Company recognized revenue from related parties of approximately $495 and $285, respectively, under the transition services agreement. The Company provides certain engineering and other services related to a gas-to-jet demonstration plant currently in development by LanzaJet pursuant to the Investment Agreement described in Note 5 - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. As a result, during the years ended December&#160;31, 2021 and 2020, the Company recognized revenue from related parties of approximately $428 and $2,740, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company supplies SGLT with its biocatalyst, certain water-soluble organic compounds required in the Company's proprietary gas fermentation process, and small-size equipment. As a result, during 2021 and 2020 the Company recognized revenue from related parties of approximately $282 and $156, respectively. The Company also provided engineering services and incurred costs of $1,223 and $242 during the years ended December&#160;31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, LanzaTech and SGLT entered into a license agreement in 2019, subsequently amended in 2021, to provide SGLT with the right to sublicense the intellectual property that LanzaTech previously licensed to SGLT. In &lt;/span&gt;&lt;/div&gt;exchange, the Company is entitled to receive licensing consideration, calculated as a percentage of the royalties received by SGLT from the sublicenses. Currently, SGLT sublicenses to certain of its subsidiaries that use LanzaTech's proprietary technology. The royalties to be received by SGLT are based on sales-and-usage of the sublicensed technology. For the years ended December&#160;31, 2021 and 2020, the Company did not earn any sublicensing revenue as no royalties were received by SGLT.</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i1d5d9aae93c24a62a9caf5acab5abecc_D20210129-20210129"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfOTQ_2c8334ec-5e80-4a93-ab9c-945f239606b6"
      unitRef="usd">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharePrice
      contextRef="if2ebc1a8b07f4d3391509c2584f8f003_I20210129"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMTE1_d919dd19-1a0e-4d23-ae96-504b8f3fc155"
      unitRef="usdPerShare">0.005</us-gaap:SharePrice>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i08b6b03fda3a43f2bcbde1101ee39ff8_D20210129-20210129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMTgy_20bd27f0-d7ab-49c8-b607-68684e03db07"
      unitRef="shares">5031250</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharePrice
      contextRef="i74ee1ef3f5f34200a3a86559aefbe48d_I20210129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMjI3_9463bb68-d4d3-4796-bb65-075242680977"
      unitRef="usdPerShare">0.0001</us-gaap:SharePrice>
    <amci:NumberOfSharesSurrendered
      contextRef="i8ba6d4f2129048179fa2e9c2275582f2_I20210514"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNTIw_fffe6006-68c5-4d00-b6b7-030fcb9c7cf2"
      unitRef="shares">718750</amci:NumberOfSharesSurrendered>
    <amci:SharesSurrenderedFairValueOfShares
      contextRef="iea24dbc94fdc4dc58f170b69b6c3e2de_D20210514-20210514"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNTU3_148ef400-d84e-412a-93ef-271b0274ad14"
      unitRef="usd">0</amci:SharesSurrenderedFairValueOfShares>
    <amci:AggregateNumberOfSharesOwned
      contextRef="i8ba6d4f2129048179fa2e9c2275582f2_I20210514"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNjA3_fc1b30ba-679e-4fa6-88bf-1b64dc81f217"
      unitRef="shares">4312500</amci:AggregateNumberOfSharesOwned>
    <amci:NumberOfSharesSubjectToForfeiture
      contextRef="ife30827df02148faa72d404a20bb4270_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNjMy_ef489890-7a72-415e-812c-98ac147ba9a4"
      unitRef="shares">562500</amci:NumberOfSharesSubjectToForfeiture>
    <amci:NumberOfSharesSubjectToForfeiture
      contextRef="i0e2866880e0e48c8bbbc428a81262e75_I20210917"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfODM4_57d08c9b-6c4c-45a1-83ec-b63f63a7a329"
      unitRef="shares">562500</amci:NumberOfSharesSubjectToForfeiture>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ib652946365cc4c8c967e8a2df8bcdc17_D20210129-20210129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMTAxNQ_ebc25146-e423-4a9a-a98d-f6a1cde7a1d1"
      unitRef="shares">780000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ib652946365cc4c8c967e8a2df8bcdc17_D20210129-20210129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMTE0Mw_1506cb16-1274-4a0f-9182-b663b1472180"
      unitRef="usd">6500000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharePrice
      contextRef="i2674980052ce4cc69be120b4e40c0013_I20210129"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMTE2NA_ab89ed0f-edd5-422e-a304-bb2c4380b9d6"
      unitRef="usdPerShare">8.35</us-gaap:SharePrice>
    <amci:RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion
      contextRef="i7f5a155717274afab3d521dfbf34a269_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMTY3MA_c36223b5-aabe-4a8b-b3df-70c278771f36">P1Y</amci:RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion>
    <amci:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger
      contextRef="i7f5a155717274afab3d521dfbf34a269_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMjQ2MA_a1721919-5735-4de7-a51c-62e58b7da6c8"
      unitRef="usdPerShare">12.00</amci:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger>
    <amci:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays
      contextRef="i7f5a155717274afab3d521dfbf34a269_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMjU4NA_c0909f5f-42c8-4a2b-807f-df0e9c6df319"
      unitRef="d">20</amci:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays>
    <amci:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays
      contextRef="i7f5a155717274afab3d521dfbf34a269_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMjYxMQ_ff4dfde7-f340-4550-a19d-cde226cca019"
      unitRef="d">30</amci:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays>
    <amci:ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences
      contextRef="i7f5a155717274afab3d521dfbf34a269_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMjY1Mw_dccb2432-151d-4bb9-9af9-96b8379895af">P150D</amci:ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="iba67ebbc3e2147e2a5a1f7dbbeab0ccd_I20210806"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMjg0MA_274e41fb-dffe-4425-8f83-150cdd3f73f5"
      unitRef="shares">3500000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="iba67ebbc3e2147e2a5a1f7dbbeab0ccd_I20210806"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMjkwMA_e656b88c-f838-48ff-9f13-3e76ec89010a"
      unitRef="shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="iba67ebbc3e2147e2a5a1f7dbbeab0ccd_I20210806"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMjkyNw_11f3b296-11e5-40f0-8284-950609662739"
      unitRef="usdPerShare">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <amci:ClassOfWarrantOrRightPriceOfWarrantsOrRights
      contextRef="iba67ebbc3e2147e2a5a1f7dbbeab0ccd_I20210806"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMjk1NQ_c0d4b5a3-fcff-4b2e-8a4b-ad4865de3145"
      unitRef="usdPerShare">1.00</amci:ClassOfWarrantOrRightPriceOfWarrantsOrRights>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="i98ebad46078d44259754e031d9c5bd6d_D20210806-20210806"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfMjk3NA_cdb58e08-4544-4fef-a4a9-915f023a1858"
      unitRef="usd">3500000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <amci:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote
      contextRef="i75f3392af70e4d85aac3d65a530d4294_I20210129"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNDE5OQ_35af23b2-11ef-4d1f-a9a2-26c7ed2215fc"
      unitRef="usd">300000</amci:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote>
    <amci:MaximumLoansConvertibleIntoWarrants
      contextRef="ic4acc15b7c694e09ba13c24b2db16e14_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNTQzMA_e3bd5251-7ea6-4f91-88d7-199de8b537a8"
      unitRef="usd">1500000</amci:MaximumLoansConvertibleIntoWarrants>
    <amci:ClassOfWarrantOrRightPriceOfWarrantsOrRights
      contextRef="ic4acc15b7c694e09ba13c24b2db16e14_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNTU1MA_0fcb03b3-2187-4c33-a65c-2ccffd45359a"
      unitRef="usdPerShare">1.00</amci:ClassOfWarrantOrRightPriceOfWarrantsOrRights>
    <amci:WorkingCapitalLoan
      contextRef="i90361d85f46242c1b15c6d1084c691cc_D20220328-20220328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNTk1Ng_273fc780-ff40-46d7-acb0-41ae86cf29fa"
      unitRef="usd">1500000</amci:WorkingCapitalLoan>
    <amci:OutstandingWorkingCapitalLoans
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNjAyNA_3aba9188-dbd0-4991-b422-d790eef5750c"
      unitRef="usd">0</amci:OutstandingWorkingCapitalLoans>
    <amci:OutstandingWorkingCapitalLoans
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNjAyNA_6cdcece2-7677-405a-87d1-cd4b4b623e0c"
      unitRef="usd">0</amci:OutstandingWorkingCapitalLoans>
    <amci:RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth
      contextRef="i86b1870170ac4b14af116725cbaa1dfb_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNjE4OQ_12252aac-0be0-44d7-bb23-e395d5107698"
      unitRef="usd">10000</amci:RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="ic4fffab42a2f49dd80ac77b6fa45c8a1_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNjUxMw_334c398d-c9a0-4f33-9096-6d20f31e7258"
      unitRef="usd">30000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i3924e9e376c84b7a875190639f24cc1f_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNjUyMA_a0223daa-87de-4f37-b57d-f14f7d741797"
      unitRef="usd">20000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="i86b1870170ac4b14af116725cbaa1dfb_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNjgyNQ_b475c710-b233-48f1-bd1a-f391e107ee02"
      unitRef="usd">90000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="ida667f998b1d43e1b6a919463e190674_D20210128-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNjgzMg_c262ef83-0f65-43c3-895a-9ae21ea7f07b"
      unitRef="usd">20000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="i52caac5a377e45b8b201f83962c02a8e_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNzA1Mg_c748e9e6-bee8-4f02-8340-747579e83f48"
      unitRef="usd">90000</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="ifcd72b5b1194408cba4cb6838372ac02_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNzA1OQ_0880f6d8-91a8-4ff7-bf33-17b6711719a1"
      unitRef="usd">50000</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i86b1870170ac4b14af116725cbaa1dfb_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNzc0Ng_229d19a4-2fbd-4dcf-b929-a29c69e46e4c"
      unitRef="usd">596000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i8d2f9128cbf246cd945ae4ac218c0a51_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80My9mcmFnOmJhYjczOTY3ZjA2NjRhODU5YWVlMTVjYjNhNmZkMzc3L3RleHRyZWdpb246YmFiNzM5NjdmMDY2NGE4NTlhZWUxNWNiM2E2ZmQzNzdfNzc1Mw_ba48ee39-f1a5-456b-aa86-c608fced49e7"
      unitRef="usd">0</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80Ni9mcmFnOjFhNTk2MTYyYmNiOTQ2ZDU4YjNlNjc3MmJhNTgwZjE1L3RleHRyZWdpb246MWE1OTYxNjJiY2I5NDZkNThiM2U2NzcyYmE1ODBmMTVfMzk3OA_12a30fc1-25d8-46eb-8c21-17900b95b94a">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 5 &#x2014; Commitments and Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Registration Rights&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The holders of the (i) founder shares, which were issued in a private placement prior to the closing of the initial public offering, (ii) private placement warrants, which were issued in a private placement simultaneously with the closing of the initial public offering and the shares of Class A common stock underlying such private placement warrants and (iii) private placement warrants that may be issued upon conversion of Working Capital Loans will have registration rights to require the Company to register a sale of any of its securities held by them prior to the consummation of the initial business combination pursuant to a registration rights agreement to be signed prior to or on the effective date of the initial public offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain &#x201c;piggy-back&#x201d; registration rights with respect to registration statements filed subsequent to the Company&#x2019;s completion of its initial business combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. In addition, the Anchor Investors will, upon receipt of their founder shares, execute a registration rights agreement with respect to their founder shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Underwriting Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company granted the underwriters a 45-day option from the date of the underwriting agreement to purchase up to an additional 2,250,000 units to cover over-allotments, if any. On September 17, 2021, the over-allotment option expired unexercised, resulting in the forfeiture of 562,500 shares of founder shares. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The underwriters were paid an underwriting discount of one percent (1%) of the gross proceeds of the initial public offering, or $1,500,000. Additionally, in connection with the initial public offering, the Company agreed to pay the underwriters a deferred underwriting fee of 3.5% of the gross proceeds, or $5,250,000, of the initial public offering upon the completion of the Company&#x2019;s initial business combination. On September 29, 2022, as discussed further below, Evercore Group L.L.C., (&#x201c;Evercore&#x201d;) the representative of the underwriters of the initial public offering, waived its deferred underwriting fee that accrued from its participation in the initial public offering. The Company recognized approximately $4.9 million of the commissions waiver as a reduction to additional paid-in capital in the condensed statements of changes in stockholders&#x2019; deficit for the three and nine months ended September 30, 2022, as this portion represents an extinguishment of deferred underwriting commissions on public shares which was originally recognized in accumulated deficit. The remaining balance of approximately $172,000 is recognized as a gain from extinguishment of deferred underwriting commissions on public warrants in the condensed statements of operations, which represents the original amount expensed in the Company&#x2019;s initial public offering.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 27, 2022 and September 29, 2022, the Company received notice and a formal letter, respectively, from Evercore Group, L.L.C., an underwriter in the Company&#x2019;s initial public offering, advising that it had, among other things, (i) resigned from and ceased or refused to act in, its roles as co-placement agent, co-capital markets advisor and exclusive financial advisor to the Company in connection with the Merger and as underwriter in the Company&#x2019;s initial public offering and (ii) waived its right to receive an aggregate of $13,050,000 in fees, all of which were contingent upon and payable upon the closing of the Merger, consisting of $500,000 for its role as co-placement agent, $7,500,000 for its role as exclusive financial advisor and $5,050,000 of deferred underwriting fees accrued from its participation in the Company&#x2019;s initial public offering, as well as any expense reimbursements owed to it under those arrangements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 5 &#x2014; Commitments and Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Registration Rights&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The holders of the (i) founder shares, which were issued in a private placement prior to the closing of the initial public offering, (ii) private placement warrants, which were issued in a private placement simultaneously with the closing of the initial public offering and the shares of Class A common stock underlying such private placement &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;warrants and (iii) private placement warrants that may be issued upon conversion of Working Capital Loans will have registration rights to require the Company to register a sale of any of its securities held by them prior to the consummation of the initial business combination pursuant to a registration rights agreement to be signed prior to or on the effective date of the initial public offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain &#x201c;piggy-back&#x201d; registration rights with respect to registration statements filed subsequent to the Company&#x2019;s completion of its initial business combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. In addition, the Anchor Investors will, upon receipt of their founder shares, execute a registration rights agreement with respect to their founder shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Underwriting Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company granted the underwriters a 45-day option from the date of the underwriting agreement to purchase up to an additional 2,250,000 units to cover over-allotments, if any. On September 17, 2021, the over-allotment option expired unexercised, resulting in the forfeiture of 562,500 shares of founder shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The underwriters were paid an underwriting discount of one percent (1%) of the gross proceeds of the initial public offering, or $1,500,000. Additionally, the underwriters will be entitled to a deferred underwriting discount of 3.5% of the gross proceeds, or $5,250,000, of the initial public offering upon the completion of the Company&#x2019;s initial business combination.&lt;/span&gt;&lt;/div&gt;Commitments and Contingencies&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may be involved in legal proceedings and exposed to potential claims in the normal course of business. As of September&#160;30, 2022 and December&#160;31, 2021, the Company does not have any reasonable possible or probable losses from such claims. &lt;/span&gt;&lt;/div&gt;Commitments and ContingenciesLitigationThe Company may be involved in legal proceedings and exposed to potential claims in the normal course of business. As of December 31, 2021 and December 31, 2020, it is not probable that the Company has incurred any losses from such claims.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <amci:MaximumNumberOfDemandsForRegistrationOfSecurities
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80Ni9mcmFnOjFhNTk2MTYyYmNiOTQ2ZDU4YjNlNjc3MmJhNTgwZjE1L3RleHRyZWdpb246MWE1OTYxNjJiY2I5NDZkNThiM2U2NzcyYmE1ODBmMTVfODY3_4b52ebdd-244e-46d0-b1c1-58149733fffd"
      unitRef="item">3</amci:MaximumNumberOfDemandsForRegistrationOfSecurities>
    <amci:OptionVestingPeriod
      contextRef="i383980889531482c9add5e621b85e027_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80Ni9mcmFnOjFhNTk2MTYyYmNiOTQ2ZDU4YjNlNjc3MmJhNTgwZjE1L3RleHRyZWdpb246MWE1OTYxNjJiY2I5NDZkNThiM2U2NzcyYmE1ODBmMTVfMzk3OQ_839ccdbc-8e22-4333-b8eb-393b364ff187">P45D</amci:OptionVestingPeriod>
    <amci:OptionToPurchaseAdditionalUnitsGivenToUnderwriters
      contextRef="i383980889531482c9add5e621b85e027_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80Ni9mcmFnOjFhNTk2MTYyYmNiOTQ2ZDU4YjNlNjc3MmJhNTgwZjE1L3RleHRyZWdpb246MWE1OTYxNjJiY2I5NDZkNThiM2U2NzcyYmE1ODBmMTVfMTU2NQ_7b113c33-d026-42fe-8a33-e60b3f1cc36f"
      unitRef="shares">2250000</amci:OptionToPurchaseAdditionalUnitsGivenToUnderwriters>
    <amci:NumberOfSharesSubjectToForfeiture
      contextRef="i2d8e8fd5c9a54f1994bb8cd3e7be4dfb_I20210917"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80Ni9mcmFnOjFhNTk2MTYyYmNiOTQ2ZDU4YjNlNjc3MmJhNTgwZjE1L3RleHRyZWdpb246MWE1OTYxNjJiY2I5NDZkNThiM2U2NzcyYmE1ODBmMTVfMTcwOQ_c18c634d-041d-4dfb-b384-ae99f2cb106e"
      unitRef="shares">562500</amci:NumberOfSharesSubjectToForfeiture>
    <amci:UnderwritingDiscountPercentage
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80Ni9mcmFnOjFhNTk2MTYyYmNiOTQ2ZDU4YjNlNjc3MmJhNTgwZjE1L3RleHRyZWdpb246MWE1OTYxNjJiY2I5NDZkNThiM2U2NzcyYmE1ODBmMTVfMTgwNw_8efda7ec-68a0-4823-a722-38b72f02cc15"
      unitRef="number">0.01</amci:UnderwritingDiscountPercentage>
    <amci:SaleOfStockUnderwritingDiscounts
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80Ni9mcmFnOjFhNTk2MTYyYmNiOTQ2ZDU4YjNlNjc3MmJhNTgwZjE1L3RleHRyZWdpb246MWE1OTYxNjJiY2I5NDZkNThiM2U2NzcyYmE1ODBmMTVfMTg2OA_d972eb9a-1890-46f4-85f4-097a375ee45a"
      unitRef="usd">1500000</amci:SaleOfStockUnderwritingDiscounts>
    <amci:DeferredUnderwritingDiscountPercentage
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80Ni9mcmFnOjFhNTk2MTYyYmNiOTQ2ZDU4YjNlNjc3MmJhNTgwZjE1L3RleHRyZWdpb246MWE1OTYxNjJiY2I5NDZkNThiM2U2NzcyYmE1ODBmMTVfMjAwOA_09982a70-57b8-4f9c-b10d-1bb0ac1c9e08"
      unitRef="number">0.035</amci:DeferredUnderwritingDiscountPercentage>
    <amci:DeferredUnderwritingDiscounts
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80Ni9mcmFnOjFhNTk2MTYyYmNiOTQ2ZDU4YjNlNjc3MmJhNTgwZjE1L3RleHRyZWdpb246MWE1OTYxNjJiY2I5NDZkNThiM2U2NzcyYmE1ODBmMTVfMjAzNw_5fa2af6e-f444-471f-abb9-7b7a6b9008ad"
      unitRef="usd">5250000</amci:DeferredUnderwritingDiscounts>
    <amci:AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80Ni9mcmFnOjFhNTk2MTYyYmNiOTQ2ZDU4YjNlNjc3MmJhNTgwZjE1L3RleHRyZWdpb246MWE1OTYxNjJiY2I5NDZkNThiM2U2NzcyYmE1ODBmMTVfMjQzOQ_59dea2b5-b037-4434-9e30-ca00e55cf75b"
      unitRef="usd">4900000</amci:AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares>
    <amci:AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares
      contextRef="id018cdbc6e7243f8a9576d62630018fd_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80Ni9mcmFnOjFhNTk2MTYyYmNiOTQ2ZDU4YjNlNjc3MmJhNTgwZjE1L3RleHRyZWdpb246MWE1OTYxNjJiY2I5NDZkNThiM2U2NzcyYmE1ODBmMTVfMjQzOQ_c1afb6e7-cc69-4d9d-b4e4-1db78d10403e"
      unitRef="usd">4900000</amci:AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares>
    <us-gaap:ProceedsFromFeesReceived
      contextRef="iff3bcef644df441dabded615618c965f_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80Ni9mcmFnOjFhNTk2MTYyYmNiOTQ2ZDU4YjNlNjc3MmJhNTgwZjE1L3RleHRyZWdpb246MWE1OTYxNjJiY2I5NDZkNThiM2U2NzcyYmE1ODBmMTVfMzYwNQ_73a4b4e2-89cf-4599-b06f-ee4d3f7193d8"
      unitRef="usd">13050000</us-gaap:ProceedsFromFeesReceived>
    <us-gaap:ProceedsFromFeesReceived
      contextRef="i65896feef8e64216b26c18f33b966b64_D20220929-20220929"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80Ni9mcmFnOjFhNTk2MTYyYmNiOTQ2ZDU4YjNlNjc3MmJhNTgwZjE1L3RleHRyZWdpb246MWE1OTYxNjJiY2I5NDZkNThiM2U2NzcyYmE1ODBmMTVfMzcwOQ_25992c1b-e08d-4a7b-9487-58e411a1fb46"
      unitRef="usd">500000</us-gaap:ProceedsFromFeesReceived>
    <us-gaap:ProceedsFromFeesReceived
      contextRef="ib81de9f71a844a21bb8c1a0d4ae5b6ab_D20220929-20220929"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80Ni9mcmFnOjFhNTk2MTYyYmNiOTQ2ZDU4YjNlNjc3MmJhNTgwZjE1L3RleHRyZWdpb246MWE1OTYxNjJiY2I5NDZkNThiM2U2NzcyYmE1ODBmMTVfMzc0OA_7d4c63c0-0817-47f7-8c7b-c84a3fd5c25a"
      unitRef="usd">7500000</us-gaap:ProceedsFromFeesReceived>
    <us-gaap:ProceedsFromFeesReceived
      contextRef="if178c64ffcb14c83b95a35515433f700_D20220929-20220929"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80Ni9mcmFnOjFhNTk2MTYyYmNiOTQ2ZDU4YjNlNjc3MmJhNTgwZjE1L3RleHRyZWdpb246MWE1OTYxNjJiY2I5NDZkNThiM2U2NzcyYmE1ODBmMTVfMzc5OQ_25a9cf14-8cf4-4670-8a0d-491f787a1ef9"
      unitRef="usd">5050000</us-gaap:ProceedsFromFeesReceived>
    <amci:TemporaryEquityDisclosureTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OS9mcmFnOjg5MzRhOTk3NzlkZTQxNjRhZGZlMTg0MDhiMmI0OGIwL3RleHRyZWdpb246ODkzNGE5OTc3OWRlNDE2NGFkZmUxODQwOGIyYjQ4YjBfNzgz_0cb6b806-bca3-4f06-891c-f0dae291802e">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 6 &#x2014; Class A Common Stock Subject to Possible Redemption&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&#x2019;s control and subject to the occurrence of future events. The Company is authorized to issue 280,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of the Company&#x2019;s Class A common stock are entitled to one vote for each share. As of September 30, 2022 and December 31, 2021, there were 15,000,000 shares of Class A common stock outstanding subject to possible redemption and are classified outside of permanent equity in the condensed balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Class A common stock subject to possible redemption reflected on the condensed balance sheets is reconciled in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross proceeds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount allocated to public warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,100,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Class A common stock issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,306,092)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plus:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion of carrying value to redemption value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,406,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Class A common stock subject to possible redemption, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subsequent remeasurement of Class A common stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Class A common stock subject to possible redemption, September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,293,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 6 &#x2014; Class A Common Stock Subject to Possible Redemption&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Class A common stock feature certain redemption rights that are considered to be outside of the Company&#x2019;s control and subject to the occurrence of future events. The Company is authorized to issue 280,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of the Company&#x2019;s Class A common stock are entitled to one vote for each share. As of December 31, 2021, there were 15,000,000 shares of Class A common stock outstanding subject to possible redemption and are classified outside of permanent equity in the balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Class A common stock subject to possible redemption reflected on the balance sheet is reconciled in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross proceeds from Initial Public Offering&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of Public Warrants at issuance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,100,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Offering costs allocated to Class A common stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,306,092)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plus:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion on Class A common stock subject to possible redemption amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,406,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Class A common stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Redeemable, Convertible Preferred Stock&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has six outstanding series of contingently redeemable convertible preferred stock. The authorized, issued and outstanding shares, issue price, and carrying value as of September&#160;30, 2022, are as follows (in thousands, except share and per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.287%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares Authorized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;br/&gt;Issued and&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Issue Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,666,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,666,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.75 - 3.94&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,733,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,733,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.38&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,254,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,142,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.69&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,274,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,161,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.93&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series E&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,183,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,183,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.86&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series F&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,634,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,634,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.86&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,747,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,521,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no changes in redeemable convertible preferred stock issued and outstanding during the nine months ended September&#160;30, 2022. The holders of preferred shares are entitled to receive dividends on an as converted to common shares basis as if all preferred shares had been converted into common shares on the date of such event. Dividends are cumulative and are payable in arrears at the rate of 8% of the original issue price.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2021, a warrant was exercised for a total issuance of 158,058 Series D preferred shares which led to an increase in redeemable convertible preferred stock of $3,150 during the nine months ended September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Redemption features of preferred shares are not fixed and do not have a determinable price on fixed or determinable dates. As of September&#160;30, 2022, the preferred shares are not currently redeemable, and it is not probable that the preferred shares will become redeemable, since it is uncertain whether or when circumstances exist that would constitute a deemed liquidation event. Accordingly, the Company has not adjusted the carrying value of the preferred shares to their redemption values.&lt;/span&gt;&lt;/div&gt;Redeemable, Convertible Preferred Stock&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has six outstanding series of contingently redeemable convertible preferred stock. The authorized, issued and outstanding shares, issue price, and carrying value as of December&#160;31, 2021 and 2020 are as follows (in thousands, except share and per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares Authorized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;br/&gt;Issued and&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Issue Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,666,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,666,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.75 - 3.94&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,733,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,733,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.38&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,254,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,142,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.69&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,274,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,161,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.93&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series E&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,183,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,183,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.86&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series F&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,634,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,634,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.86&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,747,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,521,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Shares Authorized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Shares&lt;br/&gt;Issued and&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Issue Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Series A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,666,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,666,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:9pt;text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$1.75 - 3.94&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Series B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,733,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,733,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Series C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,254,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,142,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;60,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Series D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,274,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,003,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;185,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Series E&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,183,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,183,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;118,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26,112,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;25,729,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;394,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Redeemable convertible preferred stock issued and outstanding as of December&#160;31, 2021 and 2020, and changes during the years ended December&#160;31, 2021 and 2020, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.188%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.188%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.188%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.188%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="81" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Redeemable Convertible Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Series A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Series B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Series C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Series D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Series E&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Series F&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;4,666,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;12,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,733,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;18,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;4,142,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;60,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;10,003,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;185,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;3,149,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;71,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;23,695,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;347,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;Preferred stock issuance, net of costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;2,034,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;46,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;2,034,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;46,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;4,666,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;12,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,733,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;18,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;4,142,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;60,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;10,003,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;185,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;5,183,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;118,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;25,729,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;394,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;Preferred stock issuance, net of costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;158,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;3,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;3,634,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;83,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;3,792,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;86,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;4,666,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;12,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,733,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;18,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;4,142,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;60,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;10,161,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;188,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;5,183,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;118,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;3,634,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;83,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;29,521,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;480,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records all preferred shares net of offering costs at their respective fair values on the dates of issuance. The preferred shares are classified outside of shareholders&#x2019; (deficit) equity in the consolidated financial statements, as the preferred shares are redeemable under circumstances that qualify as a deemed liquidation event, which are outside the control of the Company. Upon the occurrence of a liquidation event, such as a voluntary or involuntary liquidation, dissolution or winding up of the Company, merger, consolidation, or change in control, the holders of Series E preferred stock are entitled, on a pari passu basis, to be paid out of the assets of the Company available for distribution before any payment is made to the holders of Series A, B, C, and D preferred shares and then to holders of common shares. In February 2020, the Company closed a Series E follow-on round with the issuance of 2,034,212 Series E preferred shares for net proceeds of $46,470 ($22.86 per share). In March 2021, a warrant was exercised for a total issuance of 158,058 Series D preferred shares and net proceeds of $3,150 ($19.93 per share). In April 2021, the Company closed a Series F round with the issuance of 3,634,210 Series F preferred shares for the net proceeds of $83,073 ($22.86 per share).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The holders of preferred shares are entitled to cast the number of votes equal to the number of whole common shares into which the preferred shares are convertible. The holders of preferred shares also have consent rights, including in a number of cases subject to a separate class vote and a supermajority requirement, over certain actions including, among others (i) alterations or changes to the terms of the preferred shares, (ii) the election of a certain number of directors, including the designation of directors by holders of a specified series of preferred shares or by certain specified individual stockholders, and (iii) repurchases of shares, the authorization or designation of more senior class or series of shares, or certain issuances of new shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Preferred shares are convertible at the holder&#x2019;s option into common shares generally on a share-for-share basis. Each preferred share will be automatically converted into common stock upon either (i) the determination of the holders of certain requisite preferred shares or (ii) a firmly underwritten initial public offering of the Company&#x2019;s shares that satisfies certain requirements (but not, for the avoidance of doubt, upon a business combination with a special purpose acquisition company, unless such conversion is otherwise effected pursuant to clause (i) above).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The holders of preferred shares are entitled to receive dividends on an as converted to common shares basis as if all preferred shares had been converted into common shares on the date of such event. Dividends are cumulative and are payable in arrears at the rate of 8% of the original issue price. If dividends are payable on common shares, preferred shareholders also receive those dividends as if the preferred shares had been converted to common shares. Series D, E, and F preferred shareholders are entitled to be paid dividends prior to Series A, B, and C, on a pari passu basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Redemption features of preferred shares are not fixed and do not have a determinable price on fixed or determinable dates. As of December&#160;31, 2021 and 2020, preferred shares are not currently redeemable, and it is not probable that preferred shares will become redeemable, since it is uncertain whether or when circumstances exist &lt;/span&gt;&lt;/div&gt;that would constitute a deemed liquidation event. Accordingly, the Company has not adjusted the carrying value of the preferred shares to their redemption values.</amci:TemporaryEquityDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ie50e9e7d91b842cf814d5cfc02ae90f3_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OS9mcmFnOjg5MzRhOTk3NzlkZTQxNjRhZGZlMTg0MDhiMmI0OGIwL3RleHRyZWdpb246ODkzNGE5OTc3OWRlNDE2NGFkZmUxODQwOGIyYjQ4YjBfMjc3_a5e7e350-eaab-472c-aa55-6efc12662de3"
      unitRef="shares">280000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ie50e9e7d91b842cf814d5cfc02ae90f3_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OS9mcmFnOjg5MzRhOTk3NzlkZTQxNjRhZGZlMTg0MDhiMmI0OGIwL3RleHRyZWdpb246ODkzNGE5OTc3OWRlNDE2NGFkZmUxODQwOGIyYjQ4YjBfMzMx_1bc4375f-5f74-466f-9ef0-e83fb363e9d8"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <amci:CommonStockNumberOfVotesPerShare
      contextRef="ie50e9e7d91b842cf814d5cfc02ae90f3_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OS9mcmFnOjg5MzRhOTk3NzlkZTQxNjRhZGZlMTg0MDhiMmI0OGIwL3RleHRyZWdpb246ODkzNGE5OTc3OWRlNDE2NGFkZmUxODQwOGIyYjQ4YjBfNDA3_349ec297-fa06-4283-862f-75f578e22895"
      unitRef="vote">1</amci:CommonStockNumberOfVotesPerShare>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i525804f64fa24dab94c10a95e9c90289_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OS9mcmFnOjg5MzRhOTk3NzlkZTQxNjRhZGZlMTg0MDhiMmI0OGIwL3RleHRyZWdpb246ODkzNGE5OTc3OWRlNDE2NGFkZmUxODQwOGIyYjQ4YjBfNDkw_00cf380e-6cd4-4973-9bf9-02c9a1bbf32a"
      unitRef="shares">15000000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i0a43243fe73e4e0982e02d8804f9029b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OS9mcmFnOjg5MzRhOTk3NzlkZTQxNjRhZGZlMTg0MDhiMmI0OGIwL3RleHRyZWdpb246ODkzNGE5OTc3OWRlNDE2NGFkZmUxODQwOGIyYjQ4YjBfNDkw_1c8fa93b-ab99-4963-98b9-87070421dac7"
      unitRef="shares">15000000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityTableTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OS9mcmFnOjg5MzRhOTk3NzlkZTQxNjRhZGZlMTg0MDhiMmI0OGIwL3RleHRyZWdpb246ODkzNGE5OTc3OWRlNDE2NGFkZmUxODQwOGIyYjQ4YjBfNzg0_c409f20b-71f7-4efa-9cad-77d5fa953837">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross proceeds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount allocated to public warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,100,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Class A common stock issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,306,092)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plus:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion of carrying value to redemption value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,406,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Class A common stock subject to possible redemption, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subsequent remeasurement of Class A common stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Class A common stock subject to possible redemption, September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,293,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross proceeds from Initial Public Offering&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of Public Warrants at issuance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,100,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Offering costs allocated to Class A common stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,306,092)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plus:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion on Class A common stock subject to possible redemption amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,406,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Class A common stock subject to possible redemption&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;The authorized, issued and outstanding shares, issue price, and carrying value as of September&#160;30, 2022, are as follows (in thousands, except share and per share amounts):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.287%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares Authorized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;br/&gt;Issued and&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Issue Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,666,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,666,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.75 - 3.94&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,733,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,733,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.38&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,254,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,142,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.69&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,274,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,161,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.93&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series E&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,183,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,183,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.86&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series F&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,634,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,634,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.86&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,747,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,521,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;The authorized, issued and outstanding shares, issue price, and carrying value as of December&#160;31, 2021 and 2020 are as follows (in thousands, except share and per share amounts):&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares Authorized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;br/&gt;Issued and&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Issue Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,666,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,666,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.75 - 3.94&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,733,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,733,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.38&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,254,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,142,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.69&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,274,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,161,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.93&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series E&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,183,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,183,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.86&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series F&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,634,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,634,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.86&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,747,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,521,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Shares Authorized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Shares&lt;br/&gt;Issued and&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Issue Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Series A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,666,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,666,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:9pt;text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$1.75 - 3.94&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Series B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,733,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,733,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Series C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,254,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,142,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;60,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Series D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,274,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,003,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;185,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Series E&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,183,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,183,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;118,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26,112,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;25,729,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;394,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Redeemable convertible preferred stock issued and outstanding as of December&#160;31, 2021 and 2020, and changes during the years ended December&#160;31, 2021 and 2020, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.874%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.188%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.188%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.188%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.188%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="81" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Redeemable Convertible Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Series A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Series B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Series C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Series D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Series E&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Series F&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;4,666,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;12,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,733,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;18,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;4,142,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;60,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;10,003,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;185,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;3,149,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;71,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;23,695,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;347,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;Preferred stock issuance, net of costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;2,034,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;46,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;2,034,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;46,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;4,666,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;12,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,733,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;18,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;4,142,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;60,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;10,003,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;185,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;5,183,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;118,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;25,729,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;394,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;Preferred stock issuance, net of costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;158,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;3,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;3,634,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;83,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;3,792,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;86,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;4,666,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;12,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,733,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;18,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;4,142,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;60,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;10,161,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;188,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;5,183,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;118,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;3,634,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;83,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;29,521,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;480,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:TemporaryEquityTableTextBlock>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="i5c002aa5301d41eea4dcb66a8e84489d_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OS9mcmFnOjg5MzRhOTk3NzlkZTQxNjRhZGZlMTg0MDhiMmI0OGIwL3RhYmxlOmJjOWNmMjQ3MzZmNTRmN2U5OTljMTU0ZDk5M2ViZWNjL3RhYmxlcmFuZ2U6YmM5Y2YyNDczNmY1NGY3ZTk5OWMxNTRkOTkzZWJlY2NfMC0xLTEtMS05MDYwOQ_8f7c3d34-e1b4-4a48-8ff7-8b7459124230"
      unitRef="usd">150000000</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <amci:TemporaryEquityProceedsAllocatedToWarrants
      contextRef="i5c002aa5301d41eea4dcb66a8e84489d_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OS9mcmFnOjg5MzRhOTk3NzlkZTQxNjRhZGZlMTg0MDhiMmI0OGIwL3RhYmxlOmJjOWNmMjQ3MzZmNTRmN2U5OTljMTU0ZDk5M2ViZWNjL3RhYmxlcmFuZ2U6YmM5Y2YyNDczNmY1NGY3ZTk5OWMxNTRkOTkzZWJlY2NfMi0xLTEtMS05MDYwOQ_6f16be67-2c4f-4ae7-a0e4-10c6eb743a16"
      unitRef="usd">-5100000</amci:TemporaryEquityProceedsAllocatedToWarrants>
    <amci:TemporaryEquityIssuanceCosts
      contextRef="i5c002aa5301d41eea4dcb66a8e84489d_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OS9mcmFnOjg5MzRhOTk3NzlkZTQxNjRhZGZlMTg0MDhiMmI0OGIwL3RhYmxlOmJjOWNmMjQ3MzZmNTRmN2U5OTljMTU0ZDk5M2ViZWNjL3RhYmxlcmFuZ2U6YmM5Y2YyNDczNmY1NGY3ZTk5OWMxNTRkOTkzZWJlY2NfMy0xLTEtMS05MDYwOQ_0bdab388-dbcc-44ac-8cbb-584004864069"
      unitRef="usd">-13306092</amci:TemporaryEquityIssuanceCosts>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="i5c002aa5301d41eea4dcb66a8e84489d_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OS9mcmFnOjg5MzRhOTk3NzlkZTQxNjRhZGZlMTg0MDhiMmI0OGIwL3RhYmxlOmJjOWNmMjQ3MzZmNTRmN2U5OTljMTU0ZDk5M2ViZWNjL3RhYmxlcmFuZ2U6YmM5Y2YyNDczNmY1NGY3ZTk5OWMxNTRkOTkzZWJlY2NfNS0xLTEtMS05MDYwOQ_d76a1475-f4fa-425e-b5bd-cca8cf3bc501"
      unitRef="usd">18406092</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i0a43243fe73e4e0982e02d8804f9029b_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OS9mcmFnOjg5MzRhOTk3NzlkZTQxNjRhZGZlMTg0MDhiMmI0OGIwL3RhYmxlOmJjOWNmMjQ3MzZmNTRmN2U5OTljMTU0ZDk5M2ViZWNjL3RhYmxlcmFuZ2U6YmM5Y2YyNDczNmY1NGY3ZTk5OWMxNTRkOTkzZWJlY2NfNi0xLTEtMS05MDYwOQ_d89afa10-f049-4c8d-928c-8cf16f320572"
      unitRef="usd">150000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <amci:IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption
      contextRef="i55de68debcc94bafbd57bd3a38c3cfbd_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OS9mcmFnOjg5MzRhOTk3NzlkZTQxNjRhZGZlMTg0MDhiMmI0OGIwL3RhYmxlOmJjOWNmMjQ3MzZmNTRmN2U5OTljMTU0ZDk5M2ViZWNjL3RhYmxlcmFuZ2U6YmM5Y2YyNDczNmY1NGY3ZTk5OWMxNTRkOTkzZWJlY2NfNy0xLTEtMS05MDYwOQ_0ce1e578-e563-4eeb-906b-45eb97867a7b"
      unitRef="usd">293649</amci:IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i525804f64fa24dab94c10a95e9c90289_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OS9mcmFnOjg5MzRhOTk3NzlkZTQxNjRhZGZlMTg0MDhiMmI0OGIwL3RhYmxlOmJjOWNmMjQ3MzZmNTRmN2U5OTljMTU0ZDk5M2ViZWNjL3RhYmxlcmFuZ2U6YmM5Y2YyNDczNmY1NGY3ZTk5OWMxNTRkOTkzZWJlY2NfOC0xLTEtMS05MDYwOQ_b4d9f236-9515-463d-a4fa-7f5c56c8f7cd"
      unitRef="usd">150293649</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfMzQxOQ_c2f6d55c-8691-4023-9cf6-f930be7b7425">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 7 &#x2014; Stockholders&#x2019; Equity (Deficit)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Preferred Stock&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 and provides that shares of preferred stock may be issued from time to time in one or more series. The Company&#x2019;s board of directors will be authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;applicable to the shares of each series. As of September 30, 2022 and December 31, 2021, there were no shares of preferred stock issued or outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Class A Common Stock&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; The Company is authorized to issue 280,000,000 shares of Class A common stock with a par value of $0.0001 per share. As of September 30, 2022 and December 31, 2021, there were 15,000,000 shares of Class A common stock issued and outstanding, all of which were subject to possible redemption and are classified as temporary equity (see Note 6).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Class B Common Stock&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; The Company is authorized to issue 20,000,000 Class B common stock with a par value of $0.0001 per share. As of September 30, 2022 and December 31, 2021, there were 3,750,000 shares of Class B common stock issued and outstanding (see Note 4).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of the Company&#x2019;s stockholders except as required by law. Unless specified in the Company&#x2019;s amended and restated certificate of incorporation, or as required by applicable provisions of the Delaware General Corporation Law (&#x201c;DGCL&#x201d;) or applicable stock exchange rules, the affirmative vote of a majority of the Company&#x2019;s shares of common stock that are voted is required to approve any such matter voted on by its stockholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Class B common stock will automatically convert into shares of Class A common stock concurrently with or immediately following the consummation of the initial business combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in connection with the initial business combination, the number of shares of Class A common stock issuable upon conversion of all founder shares will equal, in the aggregate, on an as-converted basis, 20% of the total number of shares of Class A common stock outstanding after such conversion (after giving effect to any redemptions of shares of Class A common stock by public stockholders), including the total number of shares of Class A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial business combination, excluding any shares of Class A common stock or equity-linked securities or rights exercisable for or convertible into shares of Class A common stock issued, or to be issued, to any seller in the initial business combination and any private placement warrants issued to the Sponsor, officers or directors upon conversion of working capital loans, provided that such conversion of founder shares will never occur on a less than one-for-one basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 7 &#x2014; Stockholders&#x2019; Deficit&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Preferred Stock &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014; The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 and provides that shares of preferred stock may be issued from time to time in one or more series. The Company&#x2019;s board of directors will be authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. As of December 31, 2021, there were no shares of preferred stock issued or outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Class A Common Stock&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; The Company is authorized to issue 280,000,000 shares of Class A common stock with a par value of $0.0001 per share. As of December 31, 2021, there were 15,000,000 shares of Class A common stock issued and outstanding, all of which were subject to possible redemption and are classified as temporary equity (see Note 6).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Class B Common Stock &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014; The Company is authorized to issue 20,000,000 Class B common stock with a par value of $0.0001 per share. As of December 31, 2021, there were 3,750,000 shares of Class B common stock issued and outstanding (see Note 4).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of the Company&#x2019;s stockholders except as required by law. Unless specified in the Company&#x2019;s amended and restated certificate of incorporation, or as required by applicable provisions of the Delaware General Corporation Law (&#x201c;DGCL&#x201d;) or applicable stock exchange rules, the affirmative vote of a majority of the Company&#x2019;s shares of common stock that are voted is required to approve any such matter voted on by its stockholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Class B common stock will automatically convert into shares of Class A common stock concurrently with or immediately following the consummation of the initial business combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in connection with the initial business combination, the number of shares of Class A common stock issuable upon conversion of all founder shares will equal, in the aggregate, on an as-converted basis, 20% of the total number of shares of Class A common stock outstanding after such conversion (after giving effect to any redemptions of shares of Class A common stock by public stockholders), including the total number of shares of Class A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial business combination, excluding any shares of Class A common stock or equity-linked securities or rights exercisable for or convertible into shares of Class A common stock issued, or to be issued, to any seller in the initial business combination and any private placement warrants issued to the Sponsor, officers or directors upon conversion of working capital loans, provided that such conversion of founder shares will never occur on a less than one-for-one basis.&lt;/span&gt;&lt;/div&gt;Shareholders&#x2019; EquityThe securities of the Company are represented by common shares, par value $0.0001 per share. Each common share is entitled to one vote. With respect to payment of dividends and distribution of assets upon liquidation, dissolution or winding up of the Company, whether voluntary or involuntary, all common shares shall participate pro rata in such payment whenever funds are legally available and when declared by the Board of Directors of the Company, subject to the prior rights of holders of all classes of stock outstanding.</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfOTg_3529f7cf-bebb-46fd-9b97-4ee89733be2b"
      unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfOTg_361ded67-2c4c-4266-a27b-5a86e3b85858"
      unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfMTQ3_5a6803fe-d329-45b4-8976-553733024ff0"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfMTQ3_f2702886-2a51-45f4-922a-70e7acc9516b"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfNTk0_05f24216-ceb4-40b5-a16d-6387d113a5f9"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfNTk0_09ef2793-29d4-4353-a2c7-6908d403ab89"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfNzA0_0ec255f1-787d-43b9-b310-3b7935f88a23"
      unitRef="shares">280000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ie50e9e7d91b842cf814d5cfc02ae90f3_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfNzA0_606711b3-a4f7-4c9d-9b5b-3ac77240e43f"
      unitRef="shares">280000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfNzU4_55185e3e-d93a-4b05-908a-4a549edf47ba"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ie50e9e7d91b842cf814d5cfc02ae90f3_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfNzU4_8ca3cb4a-3d76-4f4d-9041-c3ec7d4dc2d5"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i525804f64fa24dab94c10a95e9c90289_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfODMx_01aa148b-d110-4151-8fac-9e59b90e5f5c"
      unitRef="shares">15000000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i0a43243fe73e4e0982e02d8804f9029b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfODMx_e3712b99-a4b2-46f1-9bbc-8334ac1fb4bf"
      unitRef="shares">15000000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i246d06060759490897b705c5ed7fc8f0_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfMTA0OQ_44c86ba4-b61f-4a78-b6ca-d3077183700b"
      unitRef="shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i291fade0df2b465aa82cd6d5ea3294af_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfMTA0OQ_6d6c6439-20cd-4993-94de-e905a3b81fa7"
      unitRef="shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i246d06060759490897b705c5ed7fc8f0_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfMTA5Mw_882d08b1-47b8-45f7-973d-aae8ac83d07a"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i291fade0df2b465aa82cd6d5ea3294af_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfMTA5Mw_dae42586-73da-4e78-a60b-cd83a7b7896f"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="i291fade0df2b465aa82cd6d5ea3294af_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfMTE2Ng_11159f4c-7069-4f0f-9f43-512408c88a84"
      unitRef="shares">3750000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i246d06060759490897b705c5ed7fc8f0_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfMTE2Ng_469a6cee-b175-40a2-a49c-682962c5a127"
      unitRef="shares">3750000</us-gaap:CommonStockSharesIssued>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="ie9b91be3831b484da13cf601329f6dbe_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfMTk5Mg_9b960e85-873d-4699-92d3-888a74848941"
      unitRef="shares">1</us-gaap:ConversionOfStockSharesIssued1>
    <amci:ConvertibleStockConversionRatio
      contextRef="ie9b91be3831b484da13cf601329f6dbe_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfMjQ4Ng_5a2467f8-0c4a-4638-872b-40127a616885"
      unitRef="number">20</amci:ConvertibleStockConversionRatio>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="ie9b91be3831b484da13cf601329f6dbe_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81Mi9mcmFnOjEzMDdlZTU3ZTA5ZjQ4ZDhiZDA5YTVhNzNkMjUzZjFlL3RleHRyZWdpb246MTMwN2VlNTdlMDlmNDhkOGJkMDlhNWE3M2QyNTNmMWVfMzQwMw_892fea6e-3ef4-4a05-9445-49bdd3dac6e1"
      unitRef="shares">1</us-gaap:ConversionOfStockSharesIssued1>
    <amci:WarrantsTextBlockTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNjc5NA_2708d9de-7e04-4214-a69f-b0e57c67a59c">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 8 &#x2014; Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September 30, 2022 and December 31, 2021, in connection with the initial public offering, the Company has 7,500,000 public warrants and 3,500,000 private placement warrants outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each whole warrant entitles the registered holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment as discussed below, at any time commencing 30 days after the completion of the initial business combination, provided that the Company has an effective registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement) and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder. The warrants will expire five years after the completion of the Company&#x2019;s initial business combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has agreed that as soon as practicable, but in no event later than fifteen (15) business days after the closing of the initial business combination, it will use its best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A common stock issuable upon exercise of the warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the shares of Class A &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;common stock issuable upon exercise of the warrants is not effective by the sixtieth (60th) business day after the closing of the initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a &#x201c;cashless basis&#x201d; in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Company&#x2019;s Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a &#x201c;covered security&#x201d; under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of public warrants who exercise their warrants to do so on a &#x201c;cashless basis&#x201d; in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, it will not be required to file or maintain in effect a registration statement, and in the event the Company do not so elect, it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Once the warrants become exercisable, the Company may redeem the outstanding warrants:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;in whole and not in part;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;at a price of $0.01 per warrant;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;upon a minimum of 30 days&#x2019; prior written notice of redemption to each warrant holder; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;if, and only if, the closing price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading &#x201c;&#x2014; Warrants&#x2009;&#x2014;&#x2009;Public Stockholders&#x2019; Warrants&#x2009;&#x2014;&#x2009;Anti-Dilution Adjustments&#x201d;) for any 20 trading days within a 30-trading day period ending three trading days before we send the notice of redemption to the warrant holders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Once the warrants become exercisable, the Company may redeem the outstanding warrants:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;in whole and not in part;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;at $0.10 per warrant upon a minimum of 30 days&#x2019; prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table below, based on the redemption date and the &#x201c;fair market value&#x201d; (as defined below) of our Class A common stock except as otherwise described below; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;if, and only if, the closing price of our Class A common stock equals or exceeds $10.00 per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading &#x201c;&#x2014; Warrants&#x2009;&#x2014;&#x2009;Public Stockholders&#x2019; Warrants&#x2009;&#x2014;&#x2009;Anti-Dilution Adjustments&#x201d;) for any 20 trading days within the 30-trading day period ending three trading days before we send the notice of redemption to the warrant holders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, if (x) the Company issue additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of our initial business combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by the Company&#x2019;s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any founder shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the &#x201c;Newly Issued Price&#x201d;), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of our initial business combination on the date of the consummation of the initial business combination (net of redemptions), and (z) the volume weighted average trading price of the Company&#x2019;s Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummate the initial business combination (such price, the &#x201c;Market Value&#x201d;) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption &lt;/span&gt;&lt;/div&gt;trigger price described above under &#x201c;&#x2014; Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00&#x201d; will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described above under &#x201c;&#x2014; Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00&#x201d; will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 8 &#x2014; Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, in connection with the initial public offering, the Company has 7,500,000 public warrants and 3,500,000 private placement warrants outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each whole warrant entitles the registered holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment as discussed below, at any time commencing 30 days after the completion of the initial business combination, provided that the Company has an effective registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement) and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder. The warrants will expire five years after the completion of the Company&#x2019;s initial business combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has agreed that as soon as practicable, but in no event later than fifteen (15) business days after the closing of the initial business combination, it will use its best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A common stock issuable upon exercise of the warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the sixtieth (60th) business day after the closing of the initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a &#x201c;cashless basis&#x201d; in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Company&#x2019;s Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a &#x201c;covered security&#x201d; under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of public warrants who &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;exercise their warrants to do so on a &#x201c;cashless basis&#x201d; in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, it will not be required to file or maintain in effect a registration statement, and in the event the Company do not so elect, it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Once the warrants become exercisable, the Company may redeem the outstanding warrants:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;in whole and not in part;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;at a price of $0.01 per warrant;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;upon a minimum of 30 days&#x2019; prior written notice of redemption to each warrant holder; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;if, and only if, the closing price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading &#x201c;&#x2014; Warrants &#x2014; Public Stockholders&#x2019; Warrants &#x2014; Anti-Dilution Adjustments&#x201d;) for any 20 trading days within a 30-trading day period ending three trading days before we send the notice of redemption to the warrant holders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Once the warrants become exercisable, the Company may redeem the outstanding warrants:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;in whole and not in part;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;at $0.10 per warrant upon a minimum of 30 days&#x2019; prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table below, based on the redemption date and the &#x201c;fair market value&#x201d; (as defined below) of our Class A common stock except as otherwise described below; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;if, and only if, the closing price of our Class A common stock equals or exceeds $10.00 per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading &#x201c;&#x2014; Warrants &#x2014; Public Stockholders&#x2019; Warrants &#x2014; Anti-Dilution Adjustments&#x201d;) for any 20 trading days within the 30-trading day period ending three trading days before we send the notice of redemption to the warrant holders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, if (x) the Company issue additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of our initial business combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by the Company&#x2019;s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any founder shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the &#x201c;Newly Issued Price&#x201d;), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of our initial business combination on the date of the consummation of the initial business combination (net of redemptions), and (z) the volume weighted average trading price of the Company&#x2019;s Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummate the initial business combination (such price, the &#x201c;Market Value&#x201d;) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price described above under &#x201c;&#x2014; Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00&#x201d; will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described above under &#x201c;&#x2014; Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00&#x201d; will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.&lt;/span&gt;&lt;/div&gt;</amci:WarrantsTextBlockTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i451ff43e2c50495caaa75e2af24f295d_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMTM1_2d2501f8-f775-4085-8f2b-fc632e6e3f60"
      unitRef="shares">7500000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i98b54305564e42f9abfa073cb3e4947b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMTM1_a16c0d7a-d00e-4619-bcb0-47e0a30185c3"
      unitRef="shares">7500000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i850b9630ce17489eb80c21a6da12ee2f_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMTU4_41b9688a-010d-47d6-9e37-76a2eca9dc25"
      unitRef="shares">3500000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i9c30db48f9bb482b9cb45b5c2227dd57_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMTU4_9489fbd2-186b-4239-85ba-ca49f542cc5e"
      unitRef="shares">3500000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMjYz_87dfbf06-f921-4da7-91fd-9fc5457ab68f"
      unitRef="shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <amci:ClassOfWarrantOrRightPriceOfWarrantsOrRights
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMzEw_6eeb9f7f-a076-49b7-b026-c2a9186b889c"
      unitRef="usdPerShare">11.50</amci:ClassOfWarrantOrRightPriceOfWarrantsOrRights>
    <amci:WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMzg5_08cba45c-721c-4ef1-b4ea-c5ea232565c7">P30D</amci:WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfOTk0_eeb759cb-d0c2-4727-96f4-1a552b871870">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <amci:PeriodForFillingRegistrationStatementAfterBusinessCombination
      contextRef="i1836ec53dd484e9b9bf84ece3ddced78_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMTIzMA_ad6b7454-bb5f-4a21-8749-a14f4268b41d">P15D</amci:PeriodForFillingRegistrationStatementAfterBusinessCombination>
    <amci:PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise
      contextRef="i1836ec53dd484e9b9bf84ece3ddced78_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMTkyMQ_30ea98dc-f312-4cd5-8c0b-6494d6285b74">P60D</amci:PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise>
    <amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="ie30c1da2c5304363b3b61cf5bb114865_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMzE0NQ_0964dde3-7d60-4ff8-be4d-4fa663434478"
      unitRef="usdPerShare">18.00</amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <amci:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights
      contextRef="ie30c1da2c5304363b3b61cf5bb114865_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMzI3Ng_e8127131-ff32-4159-b694-24717b4a1c67"
      unitRef="usdPerShare">0.01</amci:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights>
    <amci:RedemptionPeriod
      contextRef="ie30c1da2c5304363b3b61cf5bb114865_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMzMxMA_0586c461-3dd9-4934-a548-8c5823c7d454">P30D</amci:RedemptionPeriod>
    <amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="ie30c1da2c5304363b3b61cf5bb114865_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMzQ1OA_ae4d39b3-237c-46bf-b29b-8f56e2267326"
      unitRef="usdPerShare">18.00</amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays
      contextRef="ie30c1da2c5304363b3b61cf5bb114865_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMzY5NQ_9616086f-34a3-4514-bb75-114e9894b8ea">P20D</amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays>
    <amci:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants
      contextRef="ie30c1da2c5304363b3b61cf5bb114865_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMzcyMA_864a4768-1a49-4b04-8884-ebbb38c71296">P30D</amci:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants>
    <amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="ia5a60bdcc4a4477db94a694066392510_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfMzkyMg_d35141ff-f1e9-42a4-85a0-8cb643d63625"
      unitRef="usdPerShare">10.00</amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <amci:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights
      contextRef="ia5a60bdcc4a4477db94a694066392510_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNDA0Mg_381330aa-d7b3-43d1-a21b-de660866d0e3"
      unitRef="usdPerShare">0.10</amci:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights>
    <amci:RedemptionPeriod
      contextRef="ia5a60bdcc4a4477db94a694066392510_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNDA3NQ_ce20302a-b810-4717-b6af-b2585f9c9e57">P30D</amci:RedemptionPeriod>
    <amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="ia5a60bdcc4a4477db94a694066392510_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNDUyMA_5ff2fa22-de9c-4abe-a387-103104723ae2"
      unitRef="usdPerShare">10.00</amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays
      contextRef="ia5a60bdcc4a4477db94a694066392510_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNDc2NA_78f24a5b-3eae-4793-b29f-413e093967fc">P20D</amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays>
    <amci:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants
      contextRef="ia5a60bdcc4a4477db94a694066392510_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNDc5MQ_2f66cebc-8583-47e5-8c01-afd92bbb1155">P30D</amci:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants>
    <us-gaap:SharePrice
      contextRef="if2e834c4b7e54fd3806cd19f77045daa_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNTE2Mw_2fbe88a9-7e47-418e-8faf-0bfe39f3c742"
      unitRef="usdPerShare">9.20</us-gaap:SharePrice>
    <amci:PercentageOfGrossProceedsOnTotalEquityProceed
      contextRef="ifa1f55ccc0e14b588cf21c809f2ea5b3_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNTU5MA_91b3f2ae-644a-43b5-a8a7-509507dfe7e5"
      unitRef="number">0.60</amci:PercentageOfGrossProceedsOnTotalEquityProceed>
    <amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays
      contextRef="ifa1f55ccc0e14b588cf21c809f2ea5b3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNTg5Ng_058e1812-a28a-4cfd-a867-b46757cdc1cd">P20D</amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays>
    <us-gaap:SharePrice
      contextRef="if2e834c4b7e54fd3806cd19f77045daa_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNjA3MA_7fac2243-fb86-46ea-ae4b-2bc7aa0fb78a"
      unitRef="usdPerShare">9.20</us-gaap:SharePrice>
    <amci:ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices
      contextRef="ie30c1da2c5304363b3b61cf5bb114865_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNjE3Mw_675d228a-ad74-4619-927f-3af1dfc17520"
      unitRef="number">1.15</amci:ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices>
    <amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="ie30c1da2c5304363b3b61cf5bb114865_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNjI0Mg_1a9d0544-d13d-4c76-ba08-e5752fc3876b"
      unitRef="usdPerShare">18.00</amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="ie30c1da2c5304363b3b61cf5bb114865_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNjM5NQ_e86c20a4-a113-4b96-bf2b-604c1b6d06a3"
      unitRef="usdPerShare">18.00</amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <amci:ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices
      contextRef="ia5a60bdcc4a4477db94a694066392510_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNjQ1Mw_765d1019-6313-4b0f-8bef-5bc1effd1ff2"
      unitRef="number">1.80</amci:ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices>
    <amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="ia5a60bdcc4a4477db94a694066392510_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNjUyNg_025edc5d-f30e-4abf-8c41-b7a107b37097"
      unitRef="usdPerShare">10.00</amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="ia5a60bdcc4a4477db94a694066392510_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81NS9mcmFnOjgzNjkzOTI2YWFiNTQ2Y2Q5OTgxOGM2MDkzM2MyOGIyL3RleHRyZWdpb246ODM2OTM5MjZhYWI1NDZjZDk5ODE4YzYwOTMzYzI4YjJfNjY3OQ_be99d9eb-4039-49cc-a718-87391c5e57b7"
      unitRef="usdPerShare">10.00</amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RleHRyZWdpb246Nzg4ODJlYWMzMGYyNDFhMDhmNDJkNWU0YjhmOTkxNmFfMzYxMQ_2fb6a4ab-8486-4567-b170-16e399504618">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 9 &#x2014; Fair Value Measurements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents information about the Company&#x2019;s financial assets and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;September 30, 2022&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active&lt;br/&gt;Markets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Other &lt;br/&gt;Observable Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Other&lt;br/&gt;Unobservable Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments held in trust account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,969,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&#x2009;&#x2013;&#x2009;public warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,050,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&#x2009;&#x2013;&#x2009;private placement warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active&lt;br/&gt;Markets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Other&lt;br/&gt;Observable Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Other&lt;br/&gt;Unobservable Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments held in trust account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,006,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&#x2009;&#x2013;&#x2009; public warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,825,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&#x2009;&#x2013;&#x2009;private placement warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transfers to/from Levels 1, 2 and 3 are recognized at the beginning of the reporting period. The estimated fair value of public warrants was transferred from a Level 3 fair value measurement to a Level 1 measurement, when the public warrants were separately listed and traded in September 2021. There were no other transfers between levels in the nine months ended September 30, 2022 and in the period from January 28, 2021 (inception) through December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 assets include investments in mutual funds invested in U.S. government securities and derivative warrant liabilities (public warrants). The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For periods where no observable traded price is available, the fair value of the public warrants has been estimated using a Monte-Carlo simulation model and the private placement warrants has been estimated using a Black-Scholes option pricing model. For periods subsequent to the detachment of the public warrants from the units, the fair value of the public warrants is based on the observable listed price for such warrants. The estimated fair value of the public and private placement warrants, prior to the public warrants being traded in an active market, was determined using Level 3 inputs. Inherent in a Monte-Carlo simulation and Black-Scholes option pricing model are assumptions related to the unit price, expected volatility, risk-free interest rate, term to expiration, and dividend yield. The unit price is based on the publicly traded price of the units as of the measurement date. The Company estimated the volatility for the public and private placement warrants based on the implied volatility from the traded prices of warrants issued by other special purpose acquisition companies. The risk-free interest rate is based on &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;interpolated U.S. Treasury rates, commensurate with a similar term to the public and private placement warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. Finally, the Company does not anticipate paying a dividend. Any changes in these assumptions can change the valuation significantly.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended September 30, 2022 and 2021, the Company recognized a change to the statement of operations resulting from a decrease (increase) in the fair value of liabilities of approximately $1.4 million and $1.4 million, respectively, presented as change in fair value of derivative warrant liabilities on the accompanying statements of operations. For the nine months ended September 30, 2022 and for the period from January 28, 2021 (inception) through September 30, 2021, the Company recognized a change to the statement of operations resulting from a decrease (increase) in the fair value of liabilities of approximately $4.1 million and $1.4 million, respectively, presented as change in fair value of derivative warrant liabilities on the accompanying statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 30, 2022 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.75&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the fair value of the derivative warrant liabilities, measured using Level 3 inputs, for the three and nine months ended September 30, 2022 is summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative warrant liabilities at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative warrant liabilities at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,030,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,085,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative warrant liabilities at June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(451,720)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative warrant liabilities at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 9 &#x2014; Fair Value Measurement &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents information as of December 31, 2021 about the Company&#x2019;s financial assets and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active&lt;br/&gt;Markets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Other&lt;br/&gt;Observable Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Other&lt;br/&gt;Unobservable Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments held in Trust Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,006,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities &#x2013; Public Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,825,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities &#x2013; Private Placement Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transfers to/from Levels 1, 2 and 3 are recognized at the beginning of the reporting period. The estimated fair value of public warrants was transferred from a Level 3 fair value measurement to a Level 1 measurement, when the public warrants were separately listed and traded in September 2021. There were no other transfers between levels in the period from January 28, 2021 (inception) through December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 assets include investments in mutual funds invested in U.S. government securities and derivative warrant liabilities (public warrants). The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For periods where no observable traded price is available, the fair value of the public warrants has been estimated using a Monte-Carlo simulation model and the private placement warrants has been estimated using a Black-Scholes option pricing model. For periods subsequent to the detachment of the public warrants from the units, the fair value of the public warrants is based on the observable listed price for such warrants. The estimated fair value of the public and private placement warrants, prior to the public warrants being traded in an active market, was determined using Level 3 inputs. Inherent in a Monte-Carlo simulation and Black-Scholes option pricing model are assumptions related to the unit price, expected volatility, risk-free interest rate, term to expiration, and dividend yield. The unit price is based on the publicly traded price of the units as of the measurement date. The Company estimated the volatility for the public and private placement warrants based on the implied volatility from the traded prices of warrants issued by other special purpose acquisition companies. The risk-free interest rate is based on interpolated U.S. Treasury rates, commensurate with a similar term to the public and private placement warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. Finally, the Company does not anticipate paying a dividend. Any changes in these assumptions can change the valuation significantly.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of &lt;br/&gt;December 31, 2021 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of &lt;br/&gt;August 6, 2021 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining term (yrs)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.51&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the fair value of the derivative warrant liabilities, measured using Level 3 inputs, for the period from January 28, 2021 (inception) through December 31, 2021 is summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative warrant liabilities at January 28, 2021 (inception)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of Public and Private Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,515,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfer of Public Warrants to Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,100,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(630,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative warrant liabilities at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 6 &#x2014; Fair Value&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company&#x2019;s fair value hierarchy for its assets and liabilities measured at fair value as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurement as of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SAFE warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SAFE liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurement as of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SAFE warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SAFE liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has warrants to purchase preferred shares outstanding as of September&#160;30, 2022 and December&#160;31, 2021 representing 225,223 and 225,223 preferred shares, respectively, which warrants expire at various dates through December 31, 2027. The exercise prices of the warrants range from $14.69 to $19.93 as of each of September&#160;30, 2022 and December&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The warrants are accounted for as liabilities in accordance with ASC 480, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Distinguishing Liability from Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and are presented within other accrued liabilities on the condensed consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the condensed consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The fair value of the warrants was calculated using the Black-Scholes Option Pricing Model. For the nine months ended September&#160;30, 2022 and 2021, the Company recognized a change in the fair value of liabilities of approximately $(427) and $(699), respectively, on the condensed consolidated statements of operations and comprehensive loss within other (expense) income, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the warrants is determined using Level 3 inputs. Inherent in the Black-Scholes Option Pricing Model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its warrants based on implied volatility from the Company&#x2019;s warrants and from historical volatility of select peer companies that match the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the weighted average inputs used in calculating the fair value of the preferred share warrants outstanding as of September&#160;30, 2022 and December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;SAFE Liability and SAFE Warrant&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2021, the Company issued a SAFE that allowed an investor to participate in future equity financings through a share-settled redemption of the amount invested (such notional being the &#x201c;invested amount&#x201d;). The SAFE had not yet converted as a qualifying financing had not yet occurred as of September&#160;30, 2022. At September&#160;30, 2022, the SAFE had a fair value of $27,221 and was recorded within current liabilities on the condensed consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Further, the warrant related to the SAFE of $2,022 as of September&#160;30, 2022 is accounted for as a liability. This liability is recorded in current liabilities on the Company's condensed consolidated balance sheets at fair value on the date of issuance and will be revalued each subsequent reporting period until such instrument is exercised or expires. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in fair value between reporting periods for both the SAFE liability and SAFE warrant is included in other (expense) income, net in the condensed consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s SAFE liability and SAFE warrant are mark-to-market liabilities pursuant to ASC 480 and are classified within Level 3 of the fair value hierarchy as the Company is using a scenario-based approach which allowed the Company to estimate the implied value of the business based on the terms of the SAFE. Significant unobservable inputs included probability and expected term. Probability is based upon the likelihood of the Company closing a transaction with a special purpose acquisition company. The expected term was based on the anticipated time until the SAFE investments would have a conversion event. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant inputs for Level 3 SAFE liability fair value measurement at September&#160;30, 2022 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Near Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-Term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Key assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability weighting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Time to conversion (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liquidity price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant inputs for Level 3 SAFE warrant fair value measurement at September&#160;30, 2022 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Near Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-Term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Key assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability weighting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Time to conversion (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables represents a reconciliation of the contingent shares issuance liabilities fair value measurements using the significant unobservable inputs (Level 3) (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;SAFE liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;SAFE warrant&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss / (gain) recognized in condensed statement of operations and comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,050)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;SAFE liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;SAFE warrant&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of SAFE liability and warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss recognized in condensed statement of operations and comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;Fair Value&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company&#x2019;s fair value hierarchy for its assets and liabilities measured at fair value as of December&#160;31, 2021 and 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurement as of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:13pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SAFE warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SAFE liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurement as of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The warrants are accounted for as liabilities in accordance with ASC 480 and are presented within other accrued liabilities on the consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the warrants was calculated using the Black-Scholes Option Pricing Model. For the years ended December&#160;31, 2021 and 2020, the Company recognized a change in the fair value of liabilities of approximately $(563) and $105, respectively, on the statements of operations and comprehensive loss within other income (expense), net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the warrants is determined using Level 3 inputs. Inherent in the Black-Scholes Option Pricing Model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its warrants based on implied volatility from the Company&#x2019;s warrants and from historical volatility of select peer companies that match the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the weighted average inputs used in calculating the fair value of the preferred share warrants outstanding as of December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s SAFE liability and SAFE warrant are mark-to-market liabilities pursuant to ASC 480 and are classified within Level 3 of the fair value hierarchy as the Company is using a scenario-based approach which allowed the Company to estimate the implied value of the business based on the terms of the SAFE. Significant unobservable inputs included probability and expected term. Probability is based upon the likelihood of the Company closing a transaction with a special purpose acquisition company. The expected term was based on the anticipated time until the SAFE investments would have a conversion event. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant inputs for Level 3 SAFE liability fair value measurement at December 31, 2021 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Near Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-Term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Key assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability weighting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Time to conversion (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liquidity price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant inputs for Level 3 SAFE warrant fair value measurement at December 31, 2021 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Near Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-Term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Key assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability weighting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Time to conversion (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents a reconciliation of the contingent shares issuance liabilities fair value measurements using the significant unobservable inputs (Level 3) (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SAFE liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SAFE warrant&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain recognized in statement of operations and comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of SAFE liability and warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss recognized in statement of operations and comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2021, a warrant was exercised for a total issuance of 158,058 Series D preferred shares. The fair value of this warrant was $107 as of January 1, 2020 and was remeasured to zero as of December 31, 2020. As a result, the exercise had no impact on the consolidated statement of operations and comprehensive loss as of and for the year ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RleHRyZWdpb246Nzg4ODJlYWMzMGYyNDFhMDhmNDJkNWU0YjhmOTkxNmFfMzYwOA_4024adb6-20e2-4c00-93ea-c03dacefc1f0">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;September 30, 2022&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active&lt;br/&gt;Markets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Other &lt;br/&gt;Observable Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Other&lt;br/&gt;Unobservable Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments held in trust account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,969,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&#x2009;&#x2013;&#x2009;public warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,050,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&#x2009;&#x2013;&#x2009;private placement warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active&lt;br/&gt;Markets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Other&lt;br/&gt;Observable Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Other&lt;br/&gt;Unobservable Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments held in trust account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,006,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&#x2009;&#x2013;&#x2009; public warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,825,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&#x2009;&#x2013;&#x2009;private placement warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents information as of December 31, 2021 about the Company&#x2019;s financial assets and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active&lt;br/&gt;Markets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Other&lt;br/&gt;Observable Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Other&lt;br/&gt;Unobservable Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments held in Trust Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,006,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities &#x2013; Public Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,825,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities &#x2013; Private Placement Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company&#x2019;s fair value hierarchy for its assets and liabilities measured at fair value as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurement as of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SAFE warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SAFE liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurement as of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SAFE warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SAFE liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company&#x2019;s fair value hierarchy for its assets and liabilities measured at fair value as of December&#160;31, 2021 and 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurement as of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:13pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SAFE warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SAFE liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurement as of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="if81ad5ca3f944114a295b408d90c868d_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOjk0ODgwNzc2OWFkMDQ3MDI4YmM4Y2Y2NjVjMTRkMzI1L3RhYmxlcmFuZ2U6OTQ4ODA3NzY5YWQwNDcwMjhiYzhjZjY2NWMxNGQzMjVfMi0yLTEtMS05MDYwOQ_392c19e0-d07a-4431-abec-f30cce9cd4f7"
      unitRef="usd">150969468</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:DerivativeLiabilities
      contextRef="icc3169776a3543fb889330eb5abfe41d_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOjk0ODgwNzc2OWFkMDQ3MDI4YmM4Y2Y2NjVjMTRkMzI1L3RhYmxlcmFuZ2U6OTQ4ODA3NzY5YWQwNDcwMjhiYzhjZjY2NWMxNGQzMjVfNC0yLTEtMS05MDYwOQ_a9942e42-f3f6-4713-bdf1-f0799f726850"
      unitRef="usd">1050000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i417fef00be594681ab5912d70872db7e_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOjk0ODgwNzc2OWFkMDQ3MDI4YmM4Y2Y2NjVjMTRkMzI1L3RhYmxlcmFuZ2U6OTQ4ODA3NzY5YWQwNDcwMjhiYzhjZjY2NWMxNGQzMjVfNS02LTEtMS05MDYwOQ_e4b8c6c3-e64f-46f9-ab5e-a6595f947b82"
      unitRef="usd">493280</us-gaap:DerivativeLiabilities>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i946a08fcd3a04e65862611981f20e270_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOmZhOTkwMTE3YWU1NzQ4ZGRhZDA3ZDU5NDc4NzM2MjJmL3RhYmxlcmFuZ2U6ZmE5OTAxMTdhZTU3NDhkZGFkMDdkNTk0Nzg3MzYyMmZfMi0yLTEtMS05MDYwOQ_b993c50f-43a9-4258-ba9d-67ffaa1ed279"
      unitRef="usd">150006015</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:DerivativeLiabilities
      contextRef="i818e11a86037425d8b4e148caf3f101c_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOmZhOTkwMTE3YWU1NzQ4ZGRhZDA3ZDU5NDc4NzM2MjJmL3RhYmxlcmFuZ2U6ZmE5OTAxMTdhZTU3NDhkZGFkMDdkNTk0Nzg3MzYyMmZfNC0yLTEtMS05MDYwOQ_9886944c-ebd3-405a-8f5a-c5b3d12db1f2"
      unitRef="usd">3825000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="if33c5b343220431f8fa1664c765aaf71_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOmZhOTkwMTE3YWU1NzQ4ZGRhZDA3ZDU5NDc4NzM2MjJmL3RhYmxlcmFuZ2U6ZmE5OTAxMTdhZTU3NDhkZGFkMDdkNTk0Nzg3MzYyMmZfNS02LTEtMS05MDYwOQ_ad56df1f-3f08-4674-9a64-1f8e0843d16a"
      unitRef="usd">1785000</us-gaap:DerivativeLiabilities>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="i63bac3907ca0434d93c3083cd119368f_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RleHRyZWdpb246Nzg4ODJlYWMzMGYyNDFhMDhmNDJkNWU0YjhmOTkxNmFfMjc0MQ_607d0ae2-2eff-4a5a-bb72-7f230a839aca"
      unitRef="usd">-1400000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="ib13f1167c4be499782f7b6954d95c04a_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RleHRyZWdpb246Nzg4ODJlYWMzMGYyNDFhMDhmNDJkNWU0YjhmOTkxNmFfMjc0OA_d6c28225-6f76-4a2e-babc-054097f4b9a1"
      unitRef="usd">-1400000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="i80972ef154634fbfa900d162f556ef03_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RleHRyZWdpb246Nzg4ODJlYWMzMGYyNDFhMDhmNDJkNWU0YjhmOTkxNmFfMzE1Ng_1f773683-964f-4b18-a18d-6f5ed6f332cd"
      unitRef="usd">-4100000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RleHRyZWdpb246Nzg4ODJlYWMzMGYyNDFhMDhmNDJkNWU0YjhmOTkxNmFfMzE2Mw_e30450bb-624a-4934-8406-4a620ef70476"
      unitRef="usd">-1400000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RleHRyZWdpb246Nzg4ODJlYWMzMGYyNDFhMDhmNDJkNWU0YjhmOTkxNmFfMzYwOQ_3c0e3823-82a1-49ff-934c-08c957bd2d10">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 30, 2022 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.75&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of &lt;br/&gt;December 31, 2021 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of &lt;br/&gt;August 6, 2021 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining term (yrs)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.51&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the weighted average inputs used in calculating the fair value of the preferred share warrants outstanding as of September&#160;30, 2022 and December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant inputs for Level 3 SAFE liability fair value measurement at September&#160;30, 2022 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Near Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-Term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Key assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability weighting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Time to conversion (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liquidity price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant inputs for Level 3 SAFE warrant fair value measurement at September&#160;30, 2022 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Near Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-Term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Key assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability weighting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Time to conversion (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the weighted average inputs used in calculating the fair value of the preferred share warrants outstanding as of December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant inputs for Level 3 SAFE liability fair value measurement at December 31, 2021 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Near Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-Term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Key assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability weighting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Time to conversion (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liquidity price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant inputs for Level 3 SAFE warrant fair value measurement at December 31, 2021 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Near Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-Term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Key assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability weighting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Time to conversion (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i9894e2c3dc734f0b880e510f21ccd046_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOjYwZjM2ZTFlMGY0MjRmY2VhYjQzMWVkODIwZDEzMGU3L3RhYmxlcmFuZ2U6NjBmMzZlMWUwZjQyNGZjZWFiNDMxZWQ4MjBkMTMwZTdfMS0xLTEtMS05MDYwOQ_a8692485-9b8a-46b4-825d-512e482145cb"
      unitRef="usdPerShare">11.50</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="ia5b0bb5d02764693b9a25febf0a6032b_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOjYwZjM2ZTFlMGY0MjRmY2VhYjQzMWVkODIwZDEzMGU3L3RhYmxlcmFuZ2U6NjBmMzZlMWUwZjQyNGZjZWFiNDMxZWQ4MjBkMTMwZTdfMS0zLTEtMS05MDYwOQ_0a839927-1eda-4920-af78-01408ed5217f"
      unitRef="usdPerShare">11.50</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i2be463ef022149f1913c72172ac44e78_I20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOjYwZjM2ZTFlMGY0MjRmY2VhYjQzMWVkODIwZDEzMGU3L3RhYmxlcmFuZ2U6NjBmMzZlMWUwZjQyNGZjZWFiNDMxZWQ4MjBkMTMwZTdfMi0xLTEtMS05MDYwOQ_00c3facd-df79-4c8b-9c30-fd2511eae647"
      unitRef="item">0.058</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i9712786e3d6e4293bfa543a7f4306d3d_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOjYwZjM2ZTFlMGY0MjRmY2VhYjQzMWVkODIwZDEzMGU3L3RhYmxlcmFuZ2U6NjBmMzZlMWUwZjQyNGZjZWFiNDMxZWQ4MjBkMTMwZTdfMi0zLTEtMS05MDYwOQ_a2a946c6-6882-4c67-acc6-8d97e8f62b9f"
      unitRef="item">0.096</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i179691d9e1bf479b916db187d97d10bc_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOjYwZjM2ZTFlMGY0MjRmY2VhYjQzMWVkODIwZDEzMGU3L3RhYmxlcmFuZ2U6NjBmMzZlMWUwZjQyNGZjZWFiNDMxZWQ4MjBkMTMwZTdfMy0xLTEtMS05MDYwOQ_3ca34311-7ce4-4a15-8552-c2f3b3a113b7"
      unitRef="usdPerShare">9.79</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i10a81d94cb444487a1305e090e7ac9f0_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOjYwZjM2ZTFlMGY0MjRmY2VhYjQzMWVkODIwZDEzMGU3L3RhYmxlcmFuZ2U6NjBmMzZlMWUwZjQyNGZjZWFiNDMxZWQ4MjBkMTMwZTdfMy0zLTEtMS05MDYwOQ_494eedfe-2f47-4f89-8e4c-8ee4c5f2d94b"
      unitRef="usdPerShare">9.66</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="ibda8175b82524bcc9e6f7f7496388515_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOjYwZjM2ZTFlMGY0MjRmY2VhYjQzMWVkODIwZDEzMGU3L3RhYmxlcmFuZ2U6NjBmMzZlMWUwZjQyNGZjZWFiNDMxZWQ4MjBkMTMwZTdfNC0xLTEtMS05MDYwOQ_58880635-de41-4f76-9b4c-e5f6efe8100e"
      unitRef="y">5.19</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i0b029e7f84ba49809517714b945d453d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOjYwZjM2ZTFlMGY0MjRmY2VhYjQzMWVkODIwZDEzMGU3L3RhYmxlcmFuZ2U6NjBmMzZlMWUwZjQyNGZjZWFiNDMxZWQ4MjBkMTMwZTdfNC0zLTEtMS05MDYwOQ_41b044f7-711f-4b2f-b835-18eeff0abeb0"
      unitRef="y">5.75</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="ib01d619804214c1ba4cf7f01250d2ac3_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOjYwZjM2ZTFlMGY0MjRmY2VhYjQzMWVkODIwZDEzMGU3L3RhYmxlcmFuZ2U6NjBmMzZlMWUwZjQyNGZjZWFiNDMxZWQ4MjBkMTMwZTdfNS0xLTEtMS05MDYwOQ_bb75b720-a815-4e63-9098-5b4a4ec741b7"
      unitRef="item">0.0397</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i0b3852e6684e45c08ebac5f6a1cb253d_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOjYwZjM2ZTFlMGY0MjRmY2VhYjQzMWVkODIwZDEzMGU3L3RhYmxlcmFuZ2U6NjBmMzZlMWUwZjQyNGZjZWFiNDMxZWQ4MjBkMTMwZTdfNS0zLTEtMS05MDYwOQ_338f7913-dd2a-41a9-9a2f-d1906259f2f6"
      unitRef="item">0.0132</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RleHRyZWdpb246Nzg4ODJlYWMzMGYyNDFhMDhmNDJkNWU0YjhmOTkxNmFfMzYxMA_06c087e7-5075-4d91-9ba8-5f4e5e343bb9">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative warrant liabilities at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative warrant liabilities at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,030,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,085,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative warrant liabilities at June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(451,720)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative warrant liabilities at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the fair value of the derivative warrant liabilities, measured using Level 3 inputs, for the period from January 28, 2021 (inception) through December 31, 2021 is summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative warrant liabilities at January 28, 2021 (inception)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of Public and Private Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,515,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfer of Public Warrants to Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,100,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(630,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative warrant liabilities at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables represents a reconciliation of the contingent shares issuance liabilities fair value measurements using the significant unobservable inputs (Level 3) (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;SAFE liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;SAFE warrant&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss / (gain) recognized in condensed statement of operations and comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,050)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;SAFE liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;SAFE warrant&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of SAFE liability and warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss recognized in condensed statement of operations and comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents a reconciliation of the contingent shares issuance liabilities fair value measurements using the significant unobservable inputs (Level 3) (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SAFE liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SAFE warrant&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain recognized in statement of operations and comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of SAFE liability and warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss recognized in statement of operations and comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="iaa37f22ae2644299a4ab468acaa968cd_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOmVjMGJlNWVkNzlmYTQ1MTQ5NWEzOTMyZGM5M2E3NDg0L3RhYmxlcmFuZ2U6ZWMwYmU1ZWQ3OWZhNDUxNDk1YTM5MzJkYzkzYTc0ODRfMC0xLTEtMS05MDYwOQ_09be21fd-35e7-4ca6-90a9-c5069abf0f0a"
      unitRef="usd">1785000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i1f13d0d3a95c4cdaa0dc91deeb0264b3_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOmVjMGJlNWVkNzlmYTQ1MTQ5NWEzOTMyZGM5M2E3NDg0L3RhYmxlcmFuZ2U6ZWMwYmU1ZWQ3OWZhNDUxNDk1YTM5MzJkYzkzYTc0ODRfMS0xLTEtMS05MDYwOQ_6409570c-a417-4d7f-b263-1a18f472a751"
      unitRef="usd">245000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i402c8e15d0b54a389ec05f6fe78c92c5_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOmVjMGJlNWVkNzlmYTQ1MTQ5NWEzOTMyZGM5M2E3NDg0L3RhYmxlcmFuZ2U6ZWMwYmU1ZWQ3OWZhNDUxNDk1YTM5MzJkYzkzYTc0ODRfMi0xLTEtMS05MDYwOQ_06787f78-d36c-49ab-b3cf-b8eaf479571f"
      unitRef="usd">2030000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i3ff6463cfe5f4c1b946bb36d0cac2871_D20220401-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOmVjMGJlNWVkNzlmYTQ1MTQ5NWEzOTMyZGM5M2E3NDg0L3RhYmxlcmFuZ2U6ZWMwYmU1ZWQ3OWZhNDUxNDk1YTM5MzJkYzkzYTc0ODRfMy0xLTEtMS05MDYwOQ_85c64131-d424-4b6a-880f-38889905966d"
      unitRef="usd">-1085000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="if29e2998f81b49e2b4637ccd72f330be_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOmVjMGJlNWVkNzlmYTQ1MTQ5NWEzOTMyZGM5M2E3NDg0L3RhYmxlcmFuZ2U6ZWMwYmU1ZWQ3OWZhNDUxNDk1YTM5MzJkYzkzYTc0ODRfNC0xLTEtMS05MDYwOQ_39e873a7-afaa-4697-95e4-c35c94a673e5"
      unitRef="usd">945000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ibfba6a12780447a3b8b33ecd046d9a4b_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOmVjMGJlNWVkNzlmYTQ1MTQ5NWEzOTMyZGM5M2E3NDg0L3RhYmxlcmFuZ2U6ZWMwYmU1ZWQ3OWZhNDUxNDk1YTM5MzJkYzkzYTc0ODRfNS0xLTEtMS05MDYwOQ_53d94fd1-8a68-44ae-b2a6-240206435286"
      unitRef="usd">-451720</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="if64ccb69704247c689ad8abffde913e9_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81OC9mcmFnOjc4ODgyZWFjMzBmMjQxYTA4ZjQyZDVlNGI4Zjk5MTZhL3RhYmxlOmVjMGJlNWVkNzlmYTQ1MTQ5NWEzOTMyZGM5M2E3NDg0L3RhYmxlcmFuZ2U6ZWMwYmU1ZWQ3OWZhNDUxNDk1YTM5MzJkYzkzYTc0ODRfNi0xLTEtMS05MDYwOQ_8a19a703-6c6f-4db7-a159-aa41072c53d7"
      unitRef="usd">493280</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NC9mcmFnOjNiMTk0YmIzNTJmZjRmNTFiMGEzNmM4YzE4ZDQ4OTdjL3RleHRyZWdpb246M2IxOTRiYjM1MmZmNGY1MWIwYTM2YzhjMThkNDg5N2NfODYx_ade7ea84-07d3-44d6-bb7b-6b65a3fc3b35">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 10 &#x2014; Subsequent Events&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 18, 2022, the Company entered into additional subscription agreements (the &#x201c;Subscription Agreements&#x201d;) with certain accredited investors (collectively, the &#x201c;Additional PIPE Investors&#x201d;), pursuant to which, among other things, the Company agreed to issue and sell, in a private placement to close immediately prior to the closing of the Merger, an aggregate of 5,500,000 shares of Class A common stock at a purchase price of $10.00 per share to the Additional PIPE Investors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluated subsequent events and transactions that occurred up to the date the unaudited condensed financial statements were issued. Based upon this review and except in the case of the foregoing, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 11 &#x2014; Subsequent Events&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluated subsequent events and transactions that occurred up to the date financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 8, 2022, the Company entered into the Merger Agreement with Merger Sub and LanzaTech. The transactions contemplated by the Merger Agreement are referred to herein as the &#x201c;Business Combination.&#x201d; The time of the closing of the Business Combination is referred to herein as the &#x201c;Closing.&#x201d; The date of the Closing of the Business Combination is referred to herein as the &#x201c;Closing Date.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Proposed Business Combination&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the Business Combination is approved by the Company&#x2019;s stockholders and LanzaTech&#x2019;s stockholders, and the closing conditions in the Merger Agreement are satisfied or waived, then, among other things, upon the terms and subject to the conditions of the Merger Agreement and in accordance with Delaware General Corporation Law, Merger Sub will merge with and into LanzaTech, with LanzaTech surviving the merger as the Company&#x2019;s wholly owned subsidiary (the &#x201c;Merger&#x201d;). In connection with the consummation of the Merger, the Company will be renamed &#x201c;LanzaTech Global, Inc.&#x201d; and is referred to herein as &#x201c;New LanzaTech&#x201d; as of the time following such change of name.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Merger Agreement, the Company has agreed to acquire all of the outstanding equity interests of LanzaTech for consideration consisting of equity interests of New LanzaTech valued at $1,817,000,000 in the aggregate. The consideration to be paid to holders of shares of LanzaTech capital stock will be shares of common stock of New LanzaTech (&#x201c;New LanzaTech Common Stock&#x201d;), valued at $10.00 per share, to be paid at the closing of the Merger. The number of shares of New LanzaTech Common Stock payable in the Merger in respect of each share of LanzaTech capital stock (each, a &#x201c;LanzaTech Share&#x201d;) will be determined based on the exchange ratio (the &#x201c;Exchange Ratio&#x201d;), and certain corresponding adjustments, in each case as set forth in the Merger Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Merger Agreement, at Closing: (i) each warrant to purchase LanzaTech Shares (each, a &#x201c;LanzaTech Warrant&#x201d;) that is outstanding and unexercised immediately prior to Closing and would automatically be exercised or exchanged in full in accordance with its terms by virtue of the occurrence of the Merger, will be so automatically exercised or exchanged in full for the applicable LanzaTech Shares, and each such LanzaTech Share will be treated as being issued and outstanding immediately prior to Closing and will be canceled and converted into the right to receive the applicable shares of New LanzaTech Common Stock; and (ii) each LanzaTech Warrant that &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;is outstanding and unexercised immediately prior to the Closing and is not automatically exercised in full as described in clause (i) will be converted into a warrant to purchase shares of New LanzaTech Common Stock, in which case (a) the number of shares underlying such New LanzaTech warrant (each, a &#x201c;New LanzaTech Warrant&#x201d;) will be determined by multiplying the number of LanzaTech Shares subject to such warrant immediately prior to Closing, by the Exchange Ratio and (b) the per share exercise price of such New LanzaTech Warrant will be determined by dividing the per share exercise price of such LanzaTech Warrant immediately prior to the Effective Time by the Exchange Ratio, except that in the case of certain warrants specified in the Merger Agreement, such exercise price will be $10.00.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Merger Agreement, at Closing, each option to purchase LanzaTech Shares (each, a &#x201c;LanzaTech Option&#x201d;) will be converted into an option to purchase a number of shares of New LanzaTech Common Stock (rounded down to the nearest whole share) equal to the product of (i) the number of LanzaTech Shares subject to such LanzaTech Option multiplied by (ii) the Exchange Ratio. The exercise price of such New LanzaTech option will be equal to the quotient of (a) the exercise price per share of such LanzaTech Option in effect immediately prior to the Effective Time divided by (b) the Exchange Ratio (and as so determined, this exercise price will be rounded up to the nearest full cent).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Merger Agreement, at Closing, each award of restricted shares of LanzaTech common stock (each, a &#x201c;LanzaTech RSA&#x201d;) that is outstanding immediately prior to the Effective Time will be converted into an award of restricted shares of New LanzaTech Common Stock (each, a &#x201c;New LanzaTech RSA&#x201d;) on the same terms and conditions as were applicable to such LanzaTech RSA immediately prior to the Effective Time, except that such New LanzaTech RSA will relate to a number of shares of New LanzaTech Common Stock equal to the number of LanzaTech Shares subject to such LanzaTech RSA, multiplied by the Exchange Ratio.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The closing of the Merger is subject to certain customary conditions, including, among others, (i) adoption by AMCI&#x2019;s stockholders and LanzaTech&#x2019;s stockholders of the Merger Agreement and their approval of certain other actions related to the Business Combination, (ii) the expiration or termination of the waiting period (or any extension thereof) applicable to the transactions contemplated by the Merger Agreement and any ancillary agreements, in each case under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, (iii) the effectiveness of a registration statement on Form S-4 (the &#x201c;Registration Statement&#x201d;) under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;) with respect to the shares of New LanzaTech Common Stock to be paid as consideration in the Merger, (iv) there being no government order or law enjoining, prohibiting or making illegal the consummation of the Merger or the transactions contemplated by the Merger Agreement, (v) AMCI having at least $5,000,001 of net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) under the Exchange Act) after giving effect to any payments required to be made in connection with the redemption of AMCI&#x2019;s public shares and the proceeds from the Subscription Agreements described below, (vi) AMCI having at least $230,000,000 of cash at the closing of the Merger, consisting of cash held in AMCI&#x2019;s trust account after taking into account any redemption of AMCI&#x2019;s public shares, and the proceeds from the Subscription Agreements described below, net of transaction expenses of AMCI and LanzaTech, and (vii) the listing on Nasdaq of the shares of New LanzaTech Common Stock issued in connection with the Business Combination.&lt;/span&gt;&lt;/div&gt; Subsequent Events&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has evaluated events occurring subsequent to September&#160;30, 2022 through December 12, 2022, the date the condensed consolidated financial statements were available to be issued. The Company has identified two transactions with BGTF LT Aggregator LP (&#x201c;Brookfield&#x201d;), an affiliate of Brookfield Asset Management Inc, and a transaction with LanzaJet, described as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Brookfield Framework Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 2, 2022, LanzaTech entered into a framework agreement with Brookfield (the &#x201c;Brookfield Framework Agreement&#x201d;). Under such agreement, LanzaTech agreed to exclusively offer Brookfield the opportunity to acquire or invest in certain projects to construct commercial production facilities employing carbon capture and transformation technology in the U.S., the European Union, the United Kingdom, Canada or Mexico for which LanzaTech is solely or jointly responsible for obtaining or providing equity financing, subject to certain exceptions. LanzaTech agreed to present Brookfield with projects that over the term of the agreement require equity funding of at least $500,000,000 in the aggregate. With respect to projects acquired by Brookfield, LanzaTech is entitled to a percentage of free cash flow generated by such projects determined in accordance with a hurdle-based return waterfall. Brookfield has no obligation under the Brookfield Framework Agreement to invest in any of the projects.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Brookfield SAFE&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 2, 2022, LanzaTech entered into a Simple Agreement for Future Equity (the &#x201c;Brookfield SAFE&#x201d;) with Brookfield. Under the Brookfield SAFE, LanzaTech agreed to issue to Brookfield the right to certain shares of its capital stock, the issuance of which is conditional upon LanzaTech obtaining certain necessary stockholder approvals and waivers, in exchange for the payment of $50,000,000 (the &#x201c;Initial Purchase Amount&#x201d;). On the fifth anniversary of the Brookfield SAFE, LanzaTech will repay in cash any remaining unconverted portion of the Initial Purchase Amount (the &#x201c;Remaining Amount&#x201d;) less any Non-Repayable Amount (as described below), plus interest in the high single digits, compounded annually. Brookfield has the option to extend the repayment date to the tenth anniversary of the date of the Brookfield SAFE if certain events do not occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following the first of either (a) a transaction with the principal purpose of raising capital, pursuant to which LanzaTech issues and sells preferred stock at a fixed valuation (an &#x201c;Equity Financing&#x201d;), or (b) the completion of an initial public offering, a direct listing, or a merger of LanzaTech with a special purpose acquisition company, which includes the Business Combination (such a merger, a &#x201c;de-SPAC Transaction&#x201d; and such event described in (b), a &#x201c;Liquidity Event&#x201d;), Brookfield may, at any time at its option, convert all or a portion of the Initial Purchase Amount less any amount that has already been converted or repaid into shares of LanzaTech capital stock or, in the case of a de-SPAC Transaction, shares of common stock of the surviving public company in such de-SPAC Transaction (including, in the case of the Business Combination, New LanzaTech Common Stock). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For each $50,000,000 of aggregate equity funding required for qualifying projects acquired by Brookfield in accordance with the Brookfield Framework Agreement, the Remaining Amount will be reduced by $5,000,000 (such cumulative reductions the &#x201c;Non-Repayable Amount&#x201d;). Upon the first Equity Financing or Liquidity Event, the Non-Repayable Amount would convert automatically into shares of LanzaTech capital stock or, in the case of a de-SPAC Transaction, shares of common stock of the surviving public company in such de-SPAC Transaction (including, in the case of the Business Combination, New LanzaTech Common Stock), and thereafter, the Non-Repayable Amount will convert automatically on an as accrued basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;LanzaJet Shareholder Loan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 9, 2022, the Company and the other LanzaJet shareholders entered into a Note Purchase Agreement (the &#x201c;Note Purchase Agreement&#x201d;), pursuant to which LanzaJet Freedom Pines Fuels LLC (&#x201c;FPF&#x201d;), a wholly owned subsidiary of LanzaJet, will issue, from time to time, notes in an aggregate principal amount of up to $147.0&#160;million (the &#x201c;Notes&#x201d;), comprised of approximately $113.5&#160;million aggregate principal amount of 6.00% Senior Secured Notes due December 31, 2043 and $33.5&#160;million aggregate principal amount of 6.00% Subordinated Secured Notes due December 31, 2043. The Company has committed to purchase $5.5&#160;million of Subordinated Secured Notes in a funding scheduled to occur on May 1, 2023. The Senior Secured Notes are secured by a security &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;interest over substantially all assets of FPF, and both the Senior Secured Notes and the Subordinated Secured Notes are secured by a security interest over all intellectual property owned or in-licensed by LanzaJet. LanzaJet also provides a guarantee of any costs and expenses required to complete the LanzaJet Freedom Pines Demonstration Facility and achieve commercial operation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each purchaser of Notes under the Note Purchase Agreement is also entitled to receive a warrant for the right to purchase 575 shares of common stock of LanzaJet for each $10,000 of Notes purchased by such purchaser (which, in the case of the Company, will be equal to a right to purchase 316,250 shares of common stock of LanzaJet).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The LanzaJet Note Purchase Agreement may be amended with the approval of holders of FPF and all holders of the LanzaJet Notes.  Upon an event of default under the Note Purchase Agreement, each purchaser may accelerate its own Notes. Enforcement against the collateral securing the Notes requires the approval of certain holders as specified in the Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Amended Merger Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Merger Agreement was amended on December 7, 2022, to provide for, among other things, (i) the inclusion of the aggregate net proceeds from each of the AM SAFE Note and Brookfield SAFE in the Acquiror Closing Cash Amount, (ii) the reduction of the Minimum Closing Cash Condition from $250,000,000 to $230,000,000, (iii) the clarification that, to the extent that the Brookfield SAFE remains unexercised at Closing, it will be assumed by AMCI, remain in effect on the same terms and conditions as are in effect prior to the Closing and thereafter entitle the holder thereof to be issued shares of common stock in AMCI after the Closing, (iv) the clarification that, in the event that it becomes reasonably apparent to the parties that the Acquiror Closing Cash Amount will be less than the Minimum Closing Cash Condition, AMCI will use commercially reasonable efforts to enter into non-redemption agreements, or similar agreements, as may be necessary to satisfy the Minimum Closing Cash Condition, (v) the extension of the outside date applicable to the Closing from December 7, 2022 to February 28, 2023 and (vi) the elimination of LanzaTech's right to terminate the agreement in the event that we fail to, on or prior to July 7, 2022, enter into one or more additional subscription agreements or non-redemption agreements as a result of which the sum of the PIPE Investment Amount (including net proceeds under the AM SAFE Note to LanzaTech) and the aggregate number of shares of Class A common stock subject to non-redemption agreements multiplied by $10.00, minus certain transaction expenses and other liabilities at Closing, would be equal to at least the Minimum Closing Cash Condition.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;Subsequent Events&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has evaluated events occurring subsequent to December&#160;31, 2021 through May 9, 2022, the date the consolidated financial statements were available to be issued. The Company is not aware of any significant or material subsequent event that would require disclosure.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Proposed Merger&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 8, 2022, the Company entered into an Agreement and Plan of Merger (the &#x201c;Merger Agreement&#x201d;) with AMCI Acquisition Corp. II, a Delaware corporation (&#x201c;AMCI&#x201d;) and AMCI Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of AMCI (&#x201c;Merger Sub&#x201d;). Under the Merger Agreement, Merger Sub will merge with and into LanzaTech, with LanzaTech surviving the Merger as a wholly-owned subsidiary of AMCI (&#x201c;the Merger&#x201d;). In connection with the Merger, AMCI will be renamed LanzaTech Global, Inc (&#x201c;New LanzaTech&#x201d;). AMCI has agreed to acquire all of the outstanding equity interests of LanzaTech for consideration consisting of an equity interest of New LanzaTech valued at approximately $1.8&#160;billion. Completion of the transaction is subject to certain customary regulatory consents and approval by stockholders of AMCI and the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Merger Agreement, on March 8, 2022, AMCI entered into subscription agreements with certain investors pursuant to which AMCI agreed to issue and sell a private placement to close immediately prior to the Merger.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i902dff4aa68147929f6d78320ff652e0_D20221018-20221018"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NC9mcmFnOjNiMTk0YmIzNTJmZjRmNTFiMGEzNmM4YzE4ZDQ4OTdjL3RleHRyZWdpb246M2IxOTRiYjM1MmZmNGY1MWIwYTM2YzhjMThkNDg5N2NfNDAy_62969dfa-ada7-4f10-b66b-4e07c125dcf8"
      unitRef="shares">5500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="i697f9a8b07d74a73b684f9ec2bc17566_I20221018"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NC9mcmFnOjNiMTk0YmIzNTJmZjRmNTFiMGEzNmM4YzE4ZDQ4OTdjL3RleHRyZWdpb246M2IxOTRiYjM1MmZmNGY1MWIwYTM2YzhjMThkNDg5N2NfNDU4_c0545a9a-b16c-40e0-9169-36339cfc4126"
      unitRef="usdPerShare">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMi0xLTEtMS05MDYwOQ_73041914-6ba4-47c6-83e2-51c61da2d0cd"
      unitRef="usd">343399</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMy0xLTEtMS05MDYwOQ_3b790c50-a125-49f6-963a-2e72168a55a0"
      unitRef="usd">337534</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfNC0xLTEtMS05MDYwOQ_48843f6c-2c6e-4fda-8c57-2e5f914a61a6"
      unitRef="usd">680933</us-gaap:AssetsCurrent>
    <amci:PrepaidExpensesLongTerm
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfNS0xLTEtMS05MDYwOQ_fed717b5-b17f-40cb-8187-7d96528e7840"
      unitRef="usd">184812</amci:PrepaidExpensesLongTerm>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfNi0xLTEtMS05MDYwOQ_885cf4bf-062f-4ccd-9a1a-a73e6ee51627"
      unitRef="usd">150006015</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:Assets
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfNy0xLTEtMS05MDYwOQ_85f29e46-2bc0-45d7-b4d4-3343bb557c62"
      unitRef="usd">150871760</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMTEtMS0xLTEtOTA2MDk_89cff7aa-e0f2-4788-81c3-3d0661837cf8"
      unitRef="usd">85534</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMTItMS0xLTEtOTA2MDk_5ee39c2e-29b6-48a2-b7b0-c6406c0abd48"
      unitRef="usd">229733</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMTMtMS0xLTEtOTA2MDk_2cc16b17-60bb-4ede-89ab-b1a289e0ca5c"
      unitRef="usd">49723</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMTQtMS0xLTEtOTA2MDk_5f54701c-44b7-471e-9402-2d436395191f"
      unitRef="usd">198129</us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent>
    <amci:FranchiseTaxPayableCurrent
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMTUtMS0xLTEtOTA2MDk_c7ce7bdf-3f93-40b4-bf11-fd86728ca3a9"
      unitRef="usd">188237</amci:FranchiseTaxPayableCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMTYtMS0xLTEtOTA2MDk_6aa0e1ee-93f9-4346-8179-ea8a8f7b5cfa"
      unitRef="usd">751356</us-gaap:LiabilitiesCurrent>
    <amci:DeferredUnderwritingCompensationNoncurrent
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMTctMS0xLTEtOTA2MDk_389bf53d-c41d-48ad-b5f1-d2d8f35b2043"
      unitRef="usd">5250000</amci:DeferredUnderwritingCompensationNoncurrent>
    <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMTgtMS0xLTEtOTA2MDk_75179c1b-5e4f-4a37-acaf-c823458ec2ce"
      unitRef="usd">5610000</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares>
    <us-gaap:Liabilities
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMTktMS0xLTEtOTA2MDk_f5fa079e-4a69-4842-b670-67af0542995e"
      unitRef="usd">11611356</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMjEtMS0xLTEtOTA2MDk_6fce97f4-ca15-4e4c-9d6e-0f6e682f14fd"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMjMtMS0xLTEtOTA2MDk_f16e8e82-9bb4-417f-ad73-212a30f3caea"
      unitRef="usd">150000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockValue
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMjYtMS0xLTEtOTA2MDk_08555ab8-2906-4037-bf08-4c64941c31d4"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="idae72aba29fc40268c267b6f3b0eff28_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMjYtMS0xLTEtOTA2MDk_75c284b6-f8c9-4edb-9777-b71271be399f"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockValue
      contextRef="i1a8ff7f453974014b00746e89fa737d3_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMjctMS0xLTEtOTA2MDk_461128f5-8409-461c-bf9c-e264dc26415b"
      unitRef="usd">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="id57512e5cedd4b74bc2f1786d35220d2_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMjgtMS0xLTEtOTA2MDk_54463d5e-f1fb-4b3e-bc3c-9d228a3a3562"
      unitRef="usd">375</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMjktMS0xLTEtOTA2MDk_0ab6624f-1201-4f58-96a7-12351d51cf1e"
      unitRef="usd">0</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMzAtMS0xLTEtOTA2MDk_ffba3de2-40a2-4232-a3c1-e1f2c99605fa"
      unitRef="usd">-10739971</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMzEtMS0xLTEtOTA2MDk_88047e9d-0b34-47c9-847b-018b235a9695"
      unitRef="usd">-10739596</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83My9mcmFnOjc4ZjY1MjAxNTZlOTQ3MTA4ZWVjOTQxMjViZGQxODY0L3RhYmxlOjVhZTQ2ZDU0NDMzZDRmNzY5Y2ZjYWZlMzYyYTliOTg4L3RhYmxlcmFuZ2U6NWFlNDZkNTQ0MzNkNGY3NjljZmNhZmUzNjJhOWI5ODhfMzItMS0xLTEtOTA2MDk_671f9ae9-803c-4842-8f4a-5a2310f8a711"
      unitRef="usd">150871760</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfMC0xLTEtMS05MDYwOQ_9882a6db-95ef-4b5f-bd9d-ea781d3b7220"
      unitRef="usd">951461</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfMS0xLTEtMS05MDYwOQ_b3883834-46ea-4c10-8d5a-cc859c70e37e"
      unitRef="usd">50000</us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty>
    <amci:CapitalBaseTaxExpense
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfMi0xLTEtMS05MDYwOQ_99702829-d4f9-446c-9c44-afdbe0cb01f0"
      unitRef="usd">198129</amci:CapitalBaseTaxExpense>
    <us-gaap:ProductionTaxExpense
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfMy0xLTEtMS05MDYwOQ_04ee8193-45a5-4fc6-8926-17b7c1f76d32"
      unitRef="usd">188237</us-gaap:ProductionTaxExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfNC0xLTEtMS05MDYwOQ_ff863cb4-e341-46f0-ad67-55f7da484290"
      unitRef="usd">-1387827</us-gaap:OperatingIncomeLoss>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfNi0xLTEtMS05MDYwOQ_f9d1d165-4f3c-464d-8320-8084c8d3b0d9"
      unitRef="usd">-1905000</us-gaap:FairValueAdjustmentOfWarrants>
    <amci:OfferingCostsAllocatedToDerivativeWarrantLiabilities
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfNy0xLTEtMS05MDYwOQ_51c19d17-ca89-4c89-828f-1d2f0f2d1a8d"
      unitRef="usd">476450</amci:OfferingCostsAllocatedToDerivativeWarrantLiabilities>
    <amci:IncomeFromInvestmentsHeldInTrustAccount
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfOC0xLTEtMS05MDYwOQ_f5c092db-22fe-414b-bb4a-f5a3651f56c0"
      unitRef="usd">6015</amci:IncomeFromInvestmentsHeldInTrustAccount>
    <us-gaap:NetIncomeLoss
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfOS0xLTEtMS05MDYwOQ_6ebbf9c2-16a3-45ef-8303-df4a622f9408"
      unitRef="usd">46738</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5052ad254932443fa86d172a353e56b2_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfMTEtMS0xLTEtOTA2MDk_8797735a-75e4-4f3c-b2f6-86f507207f6e"
      unitRef="shares">4690909</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5052ad254932443fa86d172a353e56b2_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfMTEtMS0xLTEtOTA2MDk_c4fe4f03-712d-4b1c-89d2-966b29febe5d"
      unitRef="shares">4690909</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5052ad254932443fa86d172a353e56b2_D20210128-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfMTItMS0xLTEtOTA2MDk_1403d029-2622-4707-9070-1f9cd31fbd5e"
      unitRef="usdPerShare">0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5052ad254932443fa86d172a353e56b2_D20210128-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfMTItMS0xLTEtOTA2MDk_8ea3b9a3-7e07-4361-955e-6adc0426b6f2"
      unitRef="usdPerShare">0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib213ebc10b6a466a909031c9bd976e11_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfMTMtMS0xLTEtOTA2MDk_263b0f7c-1b68-4ff0-af9d-06123e06731d"
      unitRef="shares">3750000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib213ebc10b6a466a909031c9bd976e11_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfMTMtMS0xLTEtOTA2MDk_52875b2d-c2ee-4ade-bbe3-e780a95b8bd3"
      unitRef="shares">3750000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib213ebc10b6a466a909031c9bd976e11_D20210128-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfMTQtMS0xLTEtOTA2MDk_1e031cad-7d56-4fd3-88e3-c581df3519e7"
      unitRef="usdPerShare">0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib213ebc10b6a466a909031c9bd976e11_D20210128-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OS9mcmFnOjJjNWVhMDNlMTc2NjRiZjU4N2FkNzRiYzNlNzUwNTE3L3RhYmxlOjNiMmJhMDNhNGNiYzQ1MGRiMGE4OWQyMDhkYmI1MzI1L3RhYmxlcmFuZ2U6M2IyYmEwM2E0Y2JjNDUwZGIwYTg5ZDIwOGRiYjUzMjVfMTQtMS0xLTEtOTA2MDk_66dad396-23b3-4985-9ca2-c3d1f19e83de"
      unitRef="usdPerShare">0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:SharesIssued
      contextRef="ic0513771cd0245b88eec6099822e8d74_I20210127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfMy0xLTEtMS05MDYwOQ_797fb4d1-1285-420b-909b-f4f20001d654"
      unitRef="shares">0</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ic0513771cd0245b88eec6099822e8d74_I20210127"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfMy0zLTEtMS05MDYwOQ_50a6b2be-ad1c-4e50-8776-9f1fb435e58b"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i763e0a3dbecb4e3795d7f408cf8a20d5_I20210127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfMy01LTEtMS05MDYwOQ_4febeb70-e1a4-4afe-b62a-f2f870e37f35"
      unitRef="shares">0</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i763e0a3dbecb4e3795d7f408cf8a20d5_I20210127"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfMy03LTEtMS05MDYwOQ_3cb2b53e-53aa-4eda-8582-24b69e866bf2"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iec832394a7514357811e3f793e5b673f_I20210127"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfMy05LTEtMS05MDYwOQ_e662f1d9-24cd-4595-9971-080e4f0c4faa"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifc4dbb45fe26489b9bca7b77497e7ca7_I20210127"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfMy0xMS0xLTEtOTA2MDk_b8f545ee-e8ae-4a97-b92a-f1ce7257e282"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib90981c31c9b45a98ded9929aeaa406e_I20210127"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfMy0xMy0xLTEtOTA2MDk_13253921-cc3a-4d93-be0a-77c7358ca099"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="icfc521f27ebb491f8864b3a6e6a87d0b_D20210128-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfNC01LTEtMS05MDYwOQ_04b96086-bc30-4ad5-84d2-b0fc3d3b7f17"
      unitRef="shares">4312500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="icfc521f27ebb491f8864b3a6e6a87d0b_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfNC03LTEtMS05MDYwOQ_1d55eef4-0ea4-4386-bc86-7ce4f9d56828"
      unitRef="usd">431</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i471e72d2c86b4efaaf8080c12ecaa577_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfNC05LTEtMS05MDYwOQ_8ceb63a2-519a-4d10-af4c-8c6a0211048f"
      unitRef="usd">24569</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfNC0xMy0xLTEtOTA2MDk_4096a9f8-9d9e-4924-8e15-92d80f327f30"
      unitRef="usd">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="i471e72d2c86b4efaaf8080c12ecaa577_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfNS05LTEtMS05MDYwOQ_9b569a39-956e-4d95-8142-a7aa07d84dec"
      unitRef="usd">1085000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfNS0xMy0xLTEtOTA2MDk_d58b4543-fc3c-4cbd-ab09-e07d5172ab44"
      unitRef="usd">1085000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="icfc521f27ebb491f8864b3a6e6a87d0b_D20210128-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfNi01LTEtMS05MDYwOQ_8464e29e-7f33-4b02-9925-c20db3969e17"
      unitRef="shares">562500</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="icfc521f27ebb491f8864b3a6e6a87d0b_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfNi03LTEtMS05MDYwOQ_306415f0-e7cb-4fa4-8ef5-b7c499b5ff22"
      unitRef="usd">56</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="i471e72d2c86b4efaaf8080c12ecaa577_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfNi05LTEtMS05MDYwOQ_c45d159e-4452-40d9-94d6-13e247e038a6"
      unitRef="usd">-56</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <amci:ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors
      contextRef="i471e72d2c86b4efaaf8080c12ecaa577_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfNy05LTEtMS05MDYwOQ_78dc728c-421a-4a86-8503-415ae7497f72"
      unitRef="usd">6509758</amci:ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors>
    <amci:ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfNy0xMy0xLTEtOTA2MDk_1739e79b-e9b0-4680-9d73-16e578da400f"
      unitRef="usd">6509758</amci:ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="i471e72d2c86b4efaaf8080c12ecaa577_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfOC05LTEtMS05MDYwOQ_62514f6d-6709-4161-83dc-d5ba683c0a55"
      unitRef="usd">-7619383</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="ifd535064e945451eb2cc6d863ed461a9_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfOC0xMS0xLTEtOTA2MDk_2867a873-02ad-4030-8c9e-99ff273a0ac1"
      unitRef="usd">-10786709</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfOC0xMy0xLTEtOTA2MDk_11df518d-7ae8-4210-ab1b-2a48fb5e6d08"
      unitRef="usd">-18406092</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:NetIncomeLoss
      contextRef="ifd535064e945451eb2cc6d863ed461a9_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfOS0xMS0xLTEtOTA2MDk_f807320c-f044-4ded-912d-7fc97796cbef"
      unitRef="usd">46738</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfOS0xMy0xLTEtOTA2MDk_d526e1ec-1279-411f-bdb5-b9120a35fda4"
      unitRef="usd">46738</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="i561b8e9c306343cbaa06d16947928777_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfMTAtMS0xLTEtOTA2MDk_ca261fde-eda2-4d7c-a22f-b1f28771a7a0"
      unitRef="shares">0</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i561b8e9c306343cbaa06d16947928777_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfMTAtMy0xLTEtOTA2MDk_fab67f5e-8b45-4486-9ae0-e994de09622c"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i0df54c9e466f4cee877df6ba1a2a8b5c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfMTAtNS0xLTEtOTA2MDk_53b3fe3b-f466-4091-a08a-83fae5afc55f"
      unitRef="shares">3750000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i0df54c9e466f4cee877df6ba1a2a8b5c_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfMTAtNy0xLTEtOTA2MDk_5bf78088-6708-45af-a445-5b63da694f5e"
      unitRef="usd">375</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8d10e6b77d0f437bb89153397dd47b71_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfMTAtOS0xLTEtOTA2MDk_fc3f41d1-56dd-4756-a580-1c6a84e6571f"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i331e64d7b36f44f3a66c631e0f8eeddb_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfMTAtMTEtMS0xLTkwNjA5_f0f3aea3-0a90-4e30-9286-9d705980d144"
      unitRef="usd">-10739971</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84Mi9mcmFnOmVlMGIzYjY0OTE5YjRhZDNhMDRkYTFiMDI0Nzk1MTAzL3RhYmxlOjUzMmJjYjFiMTk3NTRhZThiNmZmOGZjNjJlMjM4ZGM0L3RhYmxlcmFuZ2U6NTMyYmNiMWIxOTc1NGFlOGI2ZmY4ZmM2MmUyMzhkYzRfMTAtMTMtMS0xLTkwNjA5_bf177288-8bd9-4acd-9bb2-288d5cc28b19"
      unitRef="usd">-10739596</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMS0xLTEtMS05MDYwOQ_f6581450-c81b-4be5-b9a1-61cc5261b5e0"
      unitRef="usd">46738</us-gaap:ProfitLoss>
    <amci:GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMy0xLTEtMS05MDYwOQ_012ef73c-1943-438b-a60e-8305b2012925"
      unitRef="usd">1000</amci:GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfNC0xLTEtMS05MDYwOQ_0ba36467-6f6d-40c9-b4fe-19e914002546"
      unitRef="usd">-1905000</us-gaap:FairValueAdjustmentOfWarrants>
    <amci:OfferingCostsAllocatedToDerivativeWarrantLiabilities
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfNS0xLTEtMS05MDYwOQ_4cba809a-a6d2-439b-a71b-39c21489c2de"
      unitRef="usd">476450</amci:OfferingCostsAllocatedToDerivativeWarrantLiabilities>
    <amci:IncomeFromInvestmentsHeldInTrustAccount
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfNi0xLTEtMS05MDYwOQ_dfa83dbf-385a-43a8-adf4-6b041e4f84a5"
      unitRef="usd">6015</amci:IncomeFromInvestmentsHeldInTrustAccount>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfOC0xLTEtMS05MDYwOQ_38ffaadb-8f51-4b5d-9e70-77cb7aab8e6d"
      unitRef="usd">-155454</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfOS0xLTEtMS05MDYwOQ_512d6683-3e6c-47a1-b9d5-63df8d7d16f2"
      unitRef="usd">85534</us-gaap:IncreaseDecreaseInAccountsPayable>
    <amci:DueToRelatedParty
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMTAtMS0xLTEtOTA2MDk_b741b58a-09b0-4372-87f5-a0af35345f32"
      unitRef="usd">49723</amci:DueToRelatedParty>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMTEtMS0xLTEtOTA2MDk_b5616f9a-f67a-4e78-8aee-8b32d5129f13"
      unitRef="usd">199733</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <amci:IncreaseDecreaseInCapitalBaseTaxPayable
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMTItMS0xLTEtOTA2MDk_6efd4859-8353-4588-8eb3-3b321c45ce57"
      unitRef="usd">198129</amci:IncreaseDecreaseInCapitalBaseTaxPayable>
    <amci:IncreaseDecreaseFranchiseTaxPayable
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMTMtMS0xLTEtOTA2MDk_e4cab3fb-263a-4b3b-b5dc-10f34a2ed565"
      unitRef="usd">188237</amci:IncreaseDecreaseFranchiseTaxPayable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMTQtMS0xLTEtOTA2MDk_3dbf082d-9aeb-42d8-96c3-bc6c87ea428f"
      unitRef="usd">-510017</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <amci:PaymentsForInvestmentOfCashInTrustAccount
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMTctMS0xLTEtOTA2MDk_6143a93a-016c-48aa-93d2-4c02c84574c1"
      unitRef="usd">150000000</amci:PaymentsForInvestmentOfCashInTrustAccount>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMTgtMS0xLTEtOTA2MDk_869af83f-480a-43ad-97a6-27773d1036e8"
      unitRef="usd">-150000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMjEtMS0xLTEtOTA2MDk_346132c9-7fe9-47c6-8ada-01ce35cbadad"
      unitRef="usd">1000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMjItMS0xLTEtOTA2MDk_b1659c8d-7490-42ec-a00d-782406ef74be"
      unitRef="usd">150000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMjMtMS0xLTEtOTA2MDk_f4f183f0-418c-482a-92a1-374b38052fef"
      unitRef="usd">852416</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMjQtMS0xLTEtOTA2MDk_04b34572-a1e5-43a6-9146-4a433ea76225"
      unitRef="usd">150853416</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMjYtMS0xLTEtOTA2MDk_2421601f-7ff6-4ff5-a5af-62a6d125f125"
      unitRef="usd">343399</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib90981c31c9b45a98ded9929aeaa406e_I20210127"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMjgtMS0xLTEtOTA2MDk_3398dd5c-7999-43e6-afe9-1d20a2e62669"
      unitRef="usd">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMjktMS0xLTEtOTA2MDk_f41fcadc-5fa9-4ced-abf2-0bd97e3fcaf2"
      unitRef="usd">343399</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <amci:StockIssuanceCostsNoncash
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMzItMS0xLTEtOTA2MDk_84b6db88-c525-4903-8df2-c1938ab118b3"
      unitRef="usd">1968784</amci:StockIssuanceCostsNoncash>
    <amci:OfferingCostsIncludedInAccountsPayableAccruedExpenses
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMzMtMS0xLTEtOTA2MDk_466c841a-ebfd-4e0f-85f3-bf405cbc3e6a"
      unitRef="usd">30000</amci:OfferingCostsIncludedInAccountsPayableAccruedExpenses>
    <amci:DeferredUnderwritingFeePayable
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMzQtMS0xLTEtOTA2MDk_d9e2c3fd-8a33-4648-be21-40b1af13d679"
      unitRef="usd">24000</amci:DeferredUnderwritingFeePayable>
    <amci:NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMzUtMS0xLTEtOTA2MDk_0c6da33f-f7d4-4570-8a90-ec48be2331a4"
      unitRef="usd">677800</amci:NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties>
    <amci:NoncashRepaymentOfNotePayableAndAdvances
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMzYtMS0xLTEtOTA2MDk_3b5a34a3-974f-435b-b336-384baf429101"
      unitRef="usd">2647584</amci:NoncashRepaymentOfNotePayableAndAdvances>
    <amci:NoncashDeferredUnderwritingCommissions
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMzctMS0xLTEtOTA2MDk_23105c6b-59f9-49aa-9022-0670de7f4543"
      unitRef="usd">5250000</amci:NoncashDeferredUnderwritingCommissions>
    <amci:ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering
      contextRef="icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84NS9mcmFnOmJmNzdjNmVlNDExNzRmOTQ4NWViMjIzZjgzMDc5YTdmL3RhYmxlOmZiYjgxYmI4Mjk2ZTRlYjk4MTRhYmI3Y2U3MTIxM2M0L3RhYmxlcmFuZ2U6ZmJiODFiYjgyOTZlNGViOTgxNGFiYjdjZTcxMjEzYzRfMzgtMS0xLTEtOTA2MDk_1be21642-e06d-42a5-acbd-200319a00f03"
      unitRef="usd">6509758</amci:ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering>
    <amci:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum
      contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMzY2_2286dc58-62a2-4ab2-8c0b-9fef74713252"
      unitRef="item">1</amci:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum>
    <amci:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMTQ4MQ_e0534989-b78c-4663-9014-39fe73786945"
      unitRef="shares">15000000</amci:UnitsIssuedDuringPeriodSharesNewIssues>
    <amci:NumberOfSharesIssuedPerUnit
      contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMTUyNw_df87d620-f23b-4c13-89ab-2f5fb5a93c2a"
      unitRef="shares">1</amci:NumberOfSharesIssuedPerUnit>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ie730d94e9acc40f48d227ce51539c50b_I20210806"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMTU3Nw_d4b3da32-fd25-40b6-8ffb-48b7283cdf73"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMTc1MQ_df490069-a510-40a6-ac2f-f457b61d19d4"
      unitRef="shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMTc3OQ_d9b90c57-a956-4589-b770-b116791c0eb1"
      unitRef="usdPerShare">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMTgyNw_85850a0a-7fc9-4e2f-b88c-c351f49568be"
      unitRef="usdPerShare">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMTg4NA_b2fd2cf8-a157-40c1-b641-5c98124a0c8c"
      unitRef="usd">150000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="iba67ebbc3e2147e2a5a1f7dbbeab0ccd_I20210806"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMjA0MA_24c39fc9-c54c-47a7-b972-343f5ed8fd4d"
      unitRef="shares">3500000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <amci:ClassOfWarrantOrRightPriceOfWarrantsOrRights
      contextRef="iba67ebbc3e2147e2a5a1f7dbbeab0ccd_I20210806"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMjEyNQ_922a94d9-49f5-4484-83e2-45c6d5ece14a"
      unitRef="usdPerShare">1.00</amci:ClassOfWarrantOrRightPriceOfWarrantsOrRights>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="i98ebad46078d44259754e031d9c5bd6d_D20210806-20210806"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMjIwMw_4a25e55d-e5ed-4fae-a0de-3f99e7838b82"
      unitRef="usd">3500000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <amci:RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion
      contextRef="i98ebad46078d44259754e031d9c5bd6d_D20210806-20210806"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMjY2MQ_e0657ad2-fd13-404b-af6e-cd642cc9a93c">P30D</amci:RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion>
    <amci:TransactionCosts
      contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMzc0Nw_e9ea48f3-da8f-4c31-8c44-71d8f3e87a07"
      unitRef="usd">13782542</amci:TransactionCosts>
    <amci:SaleOfStockUnderwritingDiscounts
      contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMzc2Nw_6fad1d73-ca5e-4337-b89d-d8621d4d23a3"
      unitRef="usd">1500000</amci:SaleOfStockUnderwritingDiscounts>
    <amci:DeferredUnderwritingDiscounts
      contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMzc5Ng_ef28e91d-43c1-476c-a93e-90a29f25bfea"
      unitRef="usd">5250000</amci:DeferredUnderwritingDiscounts>
    <amci:ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering
      contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMzgzNA_a5cab3ab-de04-4d4e-8a12-5092b6628bac"
      unitRef="usd">6509758</amci:ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering>
    <amci:SaleOfStockOtherOfferingCosts
      contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMzkwNw_5c4d0548-b451-43dc-ad99-d6e396d2502e"
      unitRef="usd">522784</amci:SaleOfStockOtherOfferingCosts>
    <amci:PaymentsForInvestmentOfCashInTrustAccount
      contextRef="i60c2802479f2421e81d073c740ec38f5_D20210806-20210806"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMzk0Ng_f2ac49ad-1ee6-48c7-81b0-50acfb1cb4c1"
      unitRef="usd">150000000</amci:PaymentsForInvestmentOfCashInTrustAccount>
    <amci:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum
      contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfNDA5Mw_c92b8634-4d15-44d2-aa90-2a458831cf59"
      unitRef="item">1</amci:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum>
    <amci:ConditionForFutureBusinessCombinationUseOfProceedsPercentage
      contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfNDE4Mw_65fd8a4d-bdb0-470c-9ca5-cfafe5f5b49d"
      unitRef="number">80</amci:ConditionForFutureBusinessCombinationUseOfProceedsPercentage>
    <amci:ConditionForFutureBusinessCombinationThresholdPercentageOwnership
      contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfNDU4Nw_3a34b452-942f-4499-bd8d-83cc58c02fec"
      unitRef="number">50</amci:ConditionForFutureBusinessCombinationThresholdPercentageOwnership>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfNTA3Mw_02c7686a-f5c1-4c0a-a182-0e2b28d9b40c"
      unitRef="usdPerShare">10.00</us-gaap:SharesIssuedPricePerShare>
    <amci:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
      contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfNjQ0MA_ecb66a6a-6b95-47d4-a1e0-49e317d24426"
      unitRef="number">1</amci:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination>
    <amci:FundHeldInTrustAccountPerPublicShare
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfODAzNg_34f406bd-4ead-4f2c-8c51-8540e1fb1d44"
      unitRef="usdPerShare">10.00</amci:FundHeldInTrustAccountPerPublicShare>
    <amci:ConditionForFutureBusinessCombinationThresholdNetTangibleAssets
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfODcyOQ_37324c9b-59d0-455d-96b1-3baec80e6e27"
      unitRef="usd">5000001</amci:ConditionForFutureBusinessCombinationThresholdNetTangibleAssets>
    <amci:MonthsToCompleteAcquisition
      contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfODk1OA_4a402796-b87f-44f1-9856-5c1a1b702ea0">P24M</amci:MonthsToCompleteAcquisition>
    <amci:MaximumAllowedDissolutionExpenses
      contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfOTYxMw_c168c4fc-f8ef-41ff-9f62-9dbeead32ee9"
      unitRef="usd">100000</amci:MaximumAllowedDissolutionExpenses>
    <amci:FundHeldInTrustAccountPerPublicShare
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMTE0NzE_1ba1bb37-b562-4551-a28b-7358ecc27ae7"
      unitRef="usdPerShare">10.00</amci:FundHeldInTrustAccountPerPublicShare>
    <amci:FundHeldInTrustAccountPerPublicShare
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMTE2MzA_4036875b-14f8-4a92-beda-453ab45761da"
      unitRef="usdPerShare">10.00</amci:FundHeldInTrustAccountPerPublicShare>
    <amci:ProceedsHeldInOperatingAccountForWorkingCapitalPurpose
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMTYwMjQ_ca50ba98-c367-4041-924d-414be6654194"
      unitRef="usd">300000</amci:ProceedsHeldInOperatingAccountForWorkingCapitalPurpose>
    <amci:WorkingCapitalDeficit
      contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMTYxMDQ_8d8a76cd-57d7-4c09-8f07-0ee9708d7f90"
      unitRef="usd">100000</amci:WorkingCapitalDeficit>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="id0abd6277c4d4571a894945f36707ca5_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMTYyMDg_8b4ad65d-b74f-4930-b4b1-1fae3f242ed1"
      unitRef="usd">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <amci:ProceedsHeldInOperatingAccountForWorkingCapitalPurpose
      contextRef="ibf1a938c139d435097214ed3b23c295f_I20210806"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMTY0ODQ_d5ce28b0-d51b-444b-afa9-20f7bc4871af"
      unitRef="usd">900000</amci:ProceedsHeldInOperatingAccountForWorkingCapitalPurpose>
    <us-gaap:ShortTermBorrowings
      contextRef="i67af9d98434f4635b3c35ea4fd55d5c2_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85MS9mcmFnOjgxNjM5MmYwNDJjYTQ3Mjg4NWNkMDIyMGI4ZmNhNGU2L3RleHRyZWdpb246ODE2MzkyZjA0MmNhNDcyODg1Y2QwMjIwYjhmY2E0ZTZfMTY4NzY_24406358-7141-4973-8adb-0dc2816fb62c"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:CashFDICInsuredAmount
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85Ny9mcmFnOjIyZmU4NmQ4ZDBiMTQ4NTQ4ZjA1NjBhMTRiZTJlMDg1L3RleHRyZWdpb246MjJmZTg2ZDhkMGIxNDg1NDhmMDU2MGExNGJlMmUwODVfNjI1_c1152eb2-22b7-4040-a63c-5cd6e01649f5"
      unitRef="usd">250000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85Ny9mcmFnOjIyZmU4NmQ4ZDBiMTQ4NTQ4ZjA1NjBhMTRiZTJlMDg1L3RleHRyZWdpb246MjJmZTg2ZDhkMGIxNDg1NDhmMDU2MGExNGJlMmUwODVfOTgx_0247369e-7384-449e-8b0d-2a5e84dd78ad"
      unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ia93b17d361a84b54b833904249951429_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85Ny9mcmFnOjIyZmU4NmQ4ZDBiMTQ4NTQ4ZjA1NjBhMTRiZTJlMDg1L3RleHRyZWdpb246MjJmZTg2ZDhkMGIxNDg1NDhmMDU2MGExNGJlMmUwODVfNjc2NQ_18cb2d1e-9d5b-4dd7-8c39-59d2f91407b8"
      unitRef="shares">15000000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib178386587034322a4ea05a95f29a04c_D20210128-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85Ny9mcmFnOjIyZmU4NmQ4ZDBiMTQ4NTQ4ZjA1NjBhMTRiZTJlMDg1L3RleHRyZWdpb246MjJmZTg2ZDhkMGIxNDg1NDhmMDU2MGExNGJlMmUwODVfMTE3MTk_d1909f62-551c-483a-b19d-6f0ae42090b4"
      unitRef="shares">11000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i717f3c096f124e38aff5fad8440a91a2_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85Ny9mcmFnOjIyZmU4NmQ4ZDBiMTQ4NTQ4ZjA1NjBhMTRiZTJlMDg1L3RhYmxlOjM4NmZhYmFmYzI2MzQ0MDE5NzVkZjMxMGI4YTdkY2RhL3RhYmxlcmFuZ2U6Mzg2ZmFiYWZjMjYzNDQwMTk3NWRmMzEwYjhhN2RjZGFfNC0xLTEtMS05MDYwOQ_bfd155bd-839f-45cd-829d-56d29307ea53"
      unitRef="usd">25974</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="iaa0df75fa4824897be8997ed124b9bdc_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85Ny9mcmFnOjIyZmU4NmQ4ZDBiMTQ4NTQ4ZjA1NjBhMTRiZTJlMDg1L3RhYmxlOjM4NmZhYmFmYzI2MzQ0MDE5NzVkZjMxMGI4YTdkY2RhL3RhYmxlcmFuZ2U6Mzg2ZmFiYWZjMjYzNDQwMTk3NWRmMzEwYjhhN2RjZGFfNC0zLTEtMS05MDYwOQ_7ef945cd-5c06-47bf-953f-ae6f3cc51e66"
      unitRef="usd">20764</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i717f3c096f124e38aff5fad8440a91a2_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85Ny9mcmFnOjIyZmU4NmQ4ZDBiMTQ4NTQ4ZjA1NjBhMTRiZTJlMDg1L3RhYmxlOjM4NmZhYmFmYzI2MzQ0MDE5NzVkZjMxMGI4YTdkY2RhL3RhYmxlcmFuZ2U6Mzg2ZmFiYWZjMjYzNDQwMTk3NWRmMzEwYjhhN2RjZGFfNy0xLTEtMS05MDYwOQ_5b4b9350-4582-4bdb-929a-5f6b6d359e6b"
      unitRef="shares">4690909</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i717f3c096f124e38aff5fad8440a91a2_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85Ny9mcmFnOjIyZmU4NmQ4ZDBiMTQ4NTQ4ZjA1NjBhMTRiZTJlMDg1L3RhYmxlOjM4NmZhYmFmYzI2MzQ0MDE5NzVkZjMxMGI4YTdkY2RhL3RhYmxlcmFuZ2U6Mzg2ZmFiYWZjMjYzNDQwMTk3NWRmMzEwYjhhN2RjZGFfNy0xLTEtMS05MDYwOQ_efbeb947-a039-45f4-90b2-32503f6ee99e"
      unitRef="shares">4690909</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iaa0df75fa4824897be8997ed124b9bdc_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85Ny9mcmFnOjIyZmU4NmQ4ZDBiMTQ4NTQ4ZjA1NjBhMTRiZTJlMDg1L3RhYmxlOjM4NmZhYmFmYzI2MzQ0MDE5NzVkZjMxMGI4YTdkY2RhL3RhYmxlcmFuZ2U6Mzg2ZmFiYWZjMjYzNDQwMTk3NWRmMzEwYjhhN2RjZGFfNy0zLTEtMS05MDYwOQ_483513d9-8a2a-4f56-828c-1ab677f7fa3e"
      unitRef="shares">3750000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iaa0df75fa4824897be8997ed124b9bdc_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85Ny9mcmFnOjIyZmU4NmQ4ZDBiMTQ4NTQ4ZjA1NjBhMTRiZTJlMDg1L3RhYmxlOjM4NmZhYmFmYzI2MzQ0MDE5NzVkZjMxMGI4YTdkY2RhL3RhYmxlcmFuZ2U6Mzg2ZmFiYWZjMjYzNDQwMTk3NWRmMzEwYjhhN2RjZGFfNy0zLTEtMS05MDYwOQ_966f99f2-b0a5-4cb0-a311-19bb6232333a"
      unitRef="shares">3750000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i717f3c096f124e38aff5fad8440a91a2_D20210128-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85Ny9mcmFnOjIyZmU4NmQ4ZDBiMTQ4NTQ4ZjA1NjBhMTRiZTJlMDg1L3RhYmxlOjM4NmZhYmFmYzI2MzQ0MDE5NzVkZjMxMGI4YTdkY2RhL3RhYmxlcmFuZ2U6Mzg2ZmFiYWZjMjYzNDQwMTk3NWRmMzEwYjhhN2RjZGFfOC0xLTEtMS05MDYwOQ_4d081ec1-6748-4d82-8c61-f250b4f59bbe"
      unitRef="usdPerShare">0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i717f3c096f124e38aff5fad8440a91a2_D20210128-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85Ny9mcmFnOjIyZmU4NmQ4ZDBiMTQ4NTQ4ZjA1NjBhMTRiZTJlMDg1L3RhYmxlOjM4NmZhYmFmYzI2MzQ0MDE5NzVkZjMxMGI4YTdkY2RhL3RhYmxlcmFuZ2U6Mzg2ZmFiYWZjMjYzNDQwMTk3NWRmMzEwYjhhN2RjZGFfOC0xLTEtMS05MDYwOQ_9b583eea-3c47-4821-9870-2186f62d5c79"
      unitRef="usdPerShare">0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="iaa0df75fa4824897be8997ed124b9bdc_D20210128-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85Ny9mcmFnOjIyZmU4NmQ4ZDBiMTQ4NTQ4ZjA1NjBhMTRiZTJlMDg1L3RhYmxlOjM4NmZhYmFmYzI2MzQ0MDE5NzVkZjMxMGI4YTdkY2RhL3RhYmxlcmFuZ2U6Mzg2ZmFiYWZjMjYzNDQwMTk3NWRmMzEwYjhhN2RjZGFfOC0zLTEtMS05MDYwOQ_e4a84ca5-e275-4135-a4eb-0865a2358845"
      unitRef="usdPerShare">0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iaa0df75fa4824897be8997ed124b9bdc_D20210128-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF85Ny9mcmFnOjIyZmU4NmQ4ZDBiMTQ4NTQ4ZjA1NjBhMTRiZTJlMDg1L3RhYmxlOjM4NmZhYmFmYzI2MzQ0MDE5NzVkZjMxMGI4YTdkY2RhL3RhYmxlcmFuZ2U6Mzg2ZmFiYWZjMjYzNDQwMTk3NWRmMzEwYjhhN2RjZGFfOC0zLTEtMS05MDYwOQ_e866ea24-ebad-4f4a-ae4b-f5127aebc3c8"
      unitRef="usdPerShare">0.01</us-gaap:EarningsPerShareDiluted>
    <amci:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDAvZnJhZzowNTQwNTVmNWFlNTY0MTU0YTExMWE4ZDIwYTc1Y2M3Ny90ZXh0cmVnaW9uOjA1NDA1NWY1YWU1NjQxNTRhMTExYThkMjBhNzVjYzc3XzExMg_1621b5f9-a267-4a92-bdf5-6e63c0cb0c8b"
      unitRef="shares">15000000</amci:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDAvZnJhZzowNTQwNTVmNWFlNTY0MTU0YTExMWE4ZDIwYTc1Y2M3Ny90ZXh0cmVnaW9uOjA1NDA1NWY1YWU1NjQxNTRhMTExYThkMjBhNzVjYzc3XzE0Ng_7ac3fb2b-f7b6-4db3-89eb-4a3ea0bb2b39"
      unitRef="usdPerShare">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDAvZnJhZzowNTQwNTVmNWFlNTY0MTU0YTExMWE4ZDIwYTc1Y2M3Ny90ZXh0cmVnaW9uOjA1NDA1NWY1YWU1NjQxNTRhMTExYThkMjBhNzVjYzc3XzE4OA_d8449cc6-9e8f-4521-8bea-7f10f395854f"
      unitRef="usd">150000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:DeferredOfferingCosts
      contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDAvZnJhZzowNTQwNTVmNWFlNTY0MTU0YTExMWE4ZDIwYTc1Y2M3Ny90ZXh0cmVnaW9uOjA1NDA1NWY1YWU1NjQxNTRhMTExYThkMjBhNzVjYzc3XzIzOA_a4569ee5-c632-43a4-a118-33a0cac9d134"
      unitRef="usd">13800000</us-gaap:DeferredOfferingCosts>
    <amci:SaleOfStockUnderwritingDiscounts
      contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDAvZnJhZzowNTQwNTVmNWFlNTY0MTU0YTExMWE4ZDIwYTc1Y2M3Ny90ZXh0cmVnaW9uOjA1NDA1NWY1YWU1NjQxNTRhMTExYThkMjBhNzVjYzc3XzI1NQ_d03a30c5-a492-41c1-be1c-db1cc3df8c77"
      unitRef="usd">1500000</amci:SaleOfStockUnderwritingDiscounts>
    <amci:DeferredUnderwritingCompensationNoncurrent
      contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDAvZnJhZzowNTQwNTVmNWFlNTY0MTU0YTExMWE4ZDIwYTc1Y2M3Ny90ZXh0cmVnaW9uOjA1NDA1NWY1YWU1NjQxNTRhMTExYThkMjBhNzVjYzc3XzI5OA_e7855184-4fa8-44f2-a501-8cf7587202f0"
      unitRef="usd">5300000</amci:DeferredUnderwritingCompensationNoncurrent>
    <amci:ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering
      contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDAvZnJhZzowNTQwNTVmNWFlNTY0MTU0YTExMWE4ZDIwYTc1Y2M3Ny90ZXh0cmVnaW9uOjA1NDA1NWY1YWU1NjQxNTRhMTExYThkMjBhNzVjYzc3XzM1Mw_189418b0-bd39-4787-a430-04588f29456a"
      unitRef="usd">6500000</amci:ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering>
    <amci:SaleOfStockOtherOfferingCosts
      contextRef="i98db8f0e88ac4dc6be868cd9427cfa66_I20210806"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDAvZnJhZzowNTQwNTVmNWFlNTY0MTU0YTExMWE4ZDIwYTc1Y2M3Ny90ZXh0cmVnaW9uOjA1NDA1NWY1YWU1NjQxNTRhMTExYThkMjBhNzVjYzc3XzQ0MA_2aade448-41d6-4ed4-bc8c-88b8d9c17a4c"
      unitRef="usd">500000</amci:SaleOfStockOtherOfferingCosts>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDAvZnJhZzowNTQwNTVmNWFlNTY0MTU0YTExMWE4ZDIwYTc1Y2M3Ny90ZXh0cmVnaW9uOjA1NDA1NWY1YWU1NjQxNTRhMTExYThkMjBhNzVjYzc3XzUxOQ_92cdb5a5-50cb-4ad6-9a25-e1127897be92"
      unitRef="shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="id44a938156574d23a69f5f980c896774_I20210806"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDAvZnJhZzowNTQwNTVmNWFlNTY0MTU0YTExMWE4ZDIwYTc1Y2M3Ny90ZXh0cmVnaW9uOjA1NDA1NWY1YWU1NjQxNTRhMTExYThkMjBhNzVjYzc3XzU2Ng_259f5bc0-3929-464f-9714-c2004db717a8"
      unitRef="usdPerShare">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <amci:OptionToPurchaseAdditionalUnitsGivenToInvestors
      contextRef="ia8faaf2960ca423dabe283e32a395eea_D20210806-20210806"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDAvZnJhZzowNTQwNTVmNWFlNTY0MTU0YTExMWE4ZDIwYTc1Y2M3Ny90ZXh0cmVnaW9uOjA1NDA1NWY1YWU1NjQxNTRhMTExYThkMjBhNzVjYzc3XzcyOA_7967bc05-4117-46df-ac1d-30fe2faa47b4"
      unitRef="shares">15480000</amci:OptionToPurchaseAdditionalUnitsGivenToInvestors>
    <amci:OptionVestingPeriod
      contextRef="i9caa935ece004b9ab6c6caa6377836b9_D20210803-20210803"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDAvZnJhZzowNTQwNTVmNWFlNTY0MTU0YTExMWE4ZDIwYTc1Y2M3Ny90ZXh0cmVnaW9uOjA1NDA1NWY1YWU1NjQxNTRhMTExYThkMjBhNzVjYzc3XzExODg_9004b6a6-621b-487a-a96a-77f8214311ff">P45D</amci:OptionVestingPeriod>
    <amci:OptionToPurchaseAdditionalUnitsGivenToUnderwriters
      contextRef="i9caa935ece004b9ab6c6caa6377836b9_D20210803-20210803"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDAvZnJhZzowNTQwNTVmNWFlNTY0MTU0YTExMWE4ZDIwYTc1Y2M3Ny90ZXh0cmVnaW9uOjA1NDA1NWY1YWU1NjQxNTRhMTExYThkMjBhNzVjYzc3Xzk4OA_2a281dbc-94fd-45ea-b8bc-c8dbef01c41c"
      unitRef="shares">2250000</amci:OptionToPurchaseAdditionalUnitsGivenToUnderwriters>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="i0d95a7ae67054cae98cfee5d7bdc74d0_D20210917-20210917"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDAvZnJhZzowNTQwNTVmNWFlNTY0MTU0YTExMWE4ZDIwYTc1Y2M3Ny90ZXh0cmVnaW9uOjA1NDA1NWY1YWU1NjQxNTRhMTExYThkMjBhNzVjYzc3XzExMDY_bc7cd97d-ec67-44c8-b219-2094c266907a"
      unitRef="shares">562500</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i1d5d9aae93c24a62a9caf5acab5abecc_D20210129-20210129"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzk0_97f253e0-58e2-48b9-b8c0-57ed77a05e29"
      unitRef="usd">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharePrice
      contextRef="if2ebc1a8b07f4d3391509c2584f8f003_I20210129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzExNQ_f89f3d98-0cda-4f80-82a9-3e14d67cbcc9"
      unitRef="usdPerShare">0.005</us-gaap:SharePrice>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i08b6b03fda3a43f2bcbde1101ee39ff8_D20210129-20210129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzE4Mg_2820bd45-d179-42aa-9f0a-6379ddb4a3ce"
      unitRef="shares">5031250</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharePrice
      contextRef="i74ee1ef3f5f34200a3a86559aefbe48d_I20210129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzIyNw_eb9ade99-8dc5-4d3a-bd53-98f34f987430"
      unitRef="usdPerShare">0.0001</us-gaap:SharePrice>
    <amci:NumberOfSharesSurrendered
      contextRef="i8ba6d4f2129048179fa2e9c2275582f2_I20210514"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzUyMA_4df1a45c-003b-468a-956a-bee61505634d"
      unitRef="shares">718750</amci:NumberOfSharesSurrendered>
    <amci:AggregateNumberOfSharesOwned
      contextRef="i8ba6d4f2129048179fa2e9c2275582f2_I20210514"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzYwNw_33434c7d-db51-4d7f-a71a-37b8d1017b72"
      unitRef="shares">4312500</amci:AggregateNumberOfSharesOwned>
    <amci:NumberOfSharesSubjectToForfeiture
      contextRef="ibfb1e8d076954c04a1dbf3023d0849d7_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzYzMg_e9409684-db8d-4406-bf21-9998dc504ebc"
      unitRef="shares">562500</amci:NumberOfSharesSubjectToForfeiture>
    <amci:NumberOfSharesSubjectToForfeiture
      contextRef="ia65ba84b6b954a5385d3241cfcb6736d_I20210917"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzgzOA_0f41b7d7-7186-45dd-9268-5525247e191a"
      unitRef="shares">562500</amci:NumberOfSharesSubjectToForfeiture>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ib652946365cc4c8c967e8a2df8bcdc17_D20210129-20210129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzEwMTU_446b303f-cdd7-4de1-b364-3e2b97671821"
      unitRef="shares">780000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ib652946365cc4c8c967e8a2df8bcdc17_D20210129-20210129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzExNDM_b07a6b9f-f1ab-47c2-b8b4-5d428ed2cb25"
      unitRef="usd">6500000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharePrice
      contextRef="i2674980052ce4cc69be120b4e40c0013_I20210129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzExNjQ_e27c9ead-b45d-4327-b8bb-a078207f2ed6"
      unitRef="usdPerShare">8.35</us-gaap:SharePrice>
    <amci:RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion
      contextRef="ie7e91bd1f75d4961a01179e9753dc8da_D20210128-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzE2NzA_11fd7302-4bf0-4c6f-8078-ebd2c35aab4e">P1Y</amci:RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion>
    <amci:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger
      contextRef="ie7e91bd1f75d4961a01179e9753dc8da_D20210128-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzI0NjA_6b63d458-c502-4baf-a8d7-bae61127add9"
      unitRef="usdPerShare">12.00</amci:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger>
    <amci:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays
      contextRef="ie7e91bd1f75d4961a01179e9753dc8da_D20210128-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzI1ODQ_00cb2590-a67a-4591-821e-a4c074ba6bef"
      unitRef="d">20</amci:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays>
    <amci:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays
      contextRef="ie7e91bd1f75d4961a01179e9753dc8da_D20210128-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzI2MTE_23df0edf-ec7b-4f55-9ae6-09be9ebee70a"
      unitRef="d">30</amci:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays>
    <amci:ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences
      contextRef="ie7e91bd1f75d4961a01179e9753dc8da_D20210128-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzI2NTM_a4ff6dfa-4f07-4f36-84eb-4e0594ec817b">P150D</amci:ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="iba67ebbc3e2147e2a5a1f7dbbeab0ccd_I20210806"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzI4NDA_9e5c28ff-3e1d-4f43-ad73-3b480d2a32a7"
      unitRef="shares">3500000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="iba67ebbc3e2147e2a5a1f7dbbeab0ccd_I20210806"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzI5MDA_847e74bd-714b-4997-88b4-ecb5c1233340"
      unitRef="shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="iba67ebbc3e2147e2a5a1f7dbbeab0ccd_I20210806"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzI5Mjc_5bc093cf-6963-4565-8b91-3de1b1e9e7aa"
      unitRef="usdPerShare">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <amci:ClassOfWarrantOrRightPriceOfWarrantsOrRights
      contextRef="iba67ebbc3e2147e2a5a1f7dbbeab0ccd_I20210806"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzI5NTU_506884db-1135-49c1-9adc-3db8e7642c6a"
      unitRef="usdPerShare">1.00</amci:ClassOfWarrantOrRightPriceOfWarrantsOrRights>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="i98ebad46078d44259754e031d9c5bd6d_D20210806-20210806"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzI5NzQ_f50187ba-7a85-4101-869f-c1a68e67b05b"
      unitRef="usd">3500000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <amci:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote
      contextRef="i75f3392af70e4d85aac3d65a530d4294_I20210129"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzQxOTk_f303dd41-0924-48d8-abac-78bdd4d11c4d"
      unitRef="usd">300000</amci:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote>
    <amci:MaximumLoansConvertibleIntoWarrants
      contextRef="ic448f6ee37eb44f9ac584c6527e1d94e_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzU0MDg_1666bd50-21a7-48d5-b39f-7013d57b6a02"
      unitRef="usd">1500000</amci:MaximumLoansConvertibleIntoWarrants>
    <amci:ClassOfWarrantOrRightPriceOfWarrantsOrRights
      contextRef="ic448f6ee37eb44f9ac584c6527e1d94e_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzU1Mjg_19c58e08-4228-4433-b348-98e817e1a789"
      unitRef="usdPerShare">1.00</amci:ClassOfWarrantOrRightPriceOfWarrantsOrRights>
    <amci:OutstandingWorkingCapitalLoans
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzU4Mzc_0b9da650-0ee5-4148-8694-5ab2e95ee4e2"
      unitRef="usd">0</amci:OutstandingWorkingCapitalLoans>
    <amci:RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth
      contextRef="ie077d272226547f6a11f29862ca333d6_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzYwMDI_fc74b9d9-d5a6-43c1-abb8-8de5f1040869"
      unitRef="usd">10000</amci:RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="ie077d272226547f6a11f29862ca333d6_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzYzNDY_c1861287-670b-4334-8e10-33a553006753"
      unitRef="usd">50000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="ifcd72b5b1194408cba4cb6838372ac02_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDMvZnJhZzo3MGEwMGJmMzY0MTc0MjViYjY2MjI3NDIxYmY0MzU4Yy90ZXh0cmVnaW9uOjcwYTAwYmYzNjQxNzQyNWJiNjYyMjc0MjFiZjQzNThjXzY1MDc_52d7807b-d61f-4cb3-ade2-6d5373d66723"
      unitRef="usd">50000</us-gaap:DueToRelatedPartiesCurrent>
    <amci:MaximumNumberOfDemandsForRegistrationOfSecurities
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDYvZnJhZzoyYTQ2OTAwZGUyNzM0MDhiODZlN2RiYWE5YWQwZmVmOS90ZXh0cmVnaW9uOjJhNDY5MDBkZTI3MzQwOGI4NmU3ZGJhYTlhZDBmZWY5Xzg2Nw_61fd37fc-0508-45ec-9f05-e622685f1989"
      unitRef="item">3</amci:MaximumNumberOfDemandsForRegistrationOfSecurities>
    <amci:OptionVestingPeriod
      contextRef="i5c60188ae1f64a00af376413ca3e4b68_D20210128-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDYvZnJhZzoyYTQ2OTAwZGUyNzM0MDhiODZlN2RiYWE5YWQwZmVmOS90ZXh0cmVnaW9uOjJhNDY5MDBkZTI3MzQwOGI4NmU3ZGJhYTlhZDBmZWY5XzIwODg_cb6a484c-631c-47f3-83aa-6db32dc823c9">P45D</amci:OptionVestingPeriod>
    <amci:OptionToPurchaseAdditionalUnitsGivenToUnderwriters
      contextRef="i5c60188ae1f64a00af376413ca3e4b68_D20210128-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDYvZnJhZzoyYTQ2OTAwZGUyNzM0MDhiODZlN2RiYWE5YWQwZmVmOS90ZXh0cmVnaW9uOjJhNDY5MDBkZTI3MzQwOGI4NmU3ZGJhYTlhZDBmZWY5XzE1NjU_97ba6ac9-e271-4e86-be6a-a43d9358ec0a"
      unitRef="shares">2250000</amci:OptionToPurchaseAdditionalUnitsGivenToUnderwriters>
    <amci:NumberOfSharesSubjectToForfeiture
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDYvZnJhZzoyYTQ2OTAwZGUyNzM0MDhiODZlN2RiYWE5YWQwZmVmOS90ZXh0cmVnaW9uOjJhNDY5MDBkZTI3MzQwOGI4NmU3ZGJhYTlhZDBmZWY5XzE3MDk_2a71fc0e-fafc-4fa1-8e49-22a027c1b803"
      unitRef="shares">562500</amci:NumberOfSharesSubjectToForfeiture>
    <amci:UnderwritingDiscountPercentage
      contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDYvZnJhZzoyYTQ2OTAwZGUyNzM0MDhiODZlN2RiYWE5YWQwZmVmOS90ZXh0cmVnaW9uOjJhNDY5MDBkZTI3MzQwOGI4NmU3ZGJhYTlhZDBmZWY5XzE4MDY_812d3e75-50eb-48f8-9bc6-b82c7c5203c4"
      unitRef="number">0.01</amci:UnderwritingDiscountPercentage>
    <amci:UnderwriterCashDiscount
      contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDYvZnJhZzoyYTQ2OTAwZGUyNzM0MDhiODZlN2RiYWE5YWQwZmVmOS90ZXh0cmVnaW9uOjJhNDY5MDBkZTI3MzQwOGI4NmU3ZGJhYTlhZDBmZWY5XzE4Njc_485c661b-c150-4472-a1a4-e23b01869dc4"
      unitRef="usd">1500000</amci:UnderwriterCashDiscount>
    <amci:DeferredUnderwritingDiscountPercentage
      contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDYvZnJhZzoyYTQ2OTAwZGUyNzM0MDhiODZlN2RiYWE5YWQwZmVmOS90ZXh0cmVnaW9uOjJhNDY5MDBkZTI3MzQwOGI4NmU3ZGJhYTlhZDBmZWY5XzE5NTg_83e3330c-404b-4881-814e-6a758cafc556"
      unitRef="number">0.035</amci:DeferredUnderwritingDiscountPercentage>
    <amci:DeferredUnderwritingDiscounts
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDYvZnJhZzoyYTQ2OTAwZGUyNzM0MDhiODZlN2RiYWE5YWQwZmVmOS90ZXh0cmVnaW9uOjJhNDY5MDBkZTI3MzQwOGI4NmU3ZGJhYTlhZDBmZWY5XzE5ODc_fb7ff77c-d02f-4b9b-a010-a5db7fadfbfd"
      unitRef="usd">5250000</amci:DeferredUnderwritingDiscounts>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDkvZnJhZzo2MWVmOGFmNjBmNDg0NTM4YWI1OWZlMWRmZDU5NmFhZi90ZXh0cmVnaW9uOjYxZWY4YWY2MGY0ODQ1MzhhYjU5ZmUxZGZkNTk2YWFmXzI3Nw_cb32a20a-a0ce-4160-873b-cf047aa529d4"
      unitRef="shares">280000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDkvZnJhZzo2MWVmOGFmNjBmNDg0NTM4YWI1OWZlMWRmZDU5NmFhZi90ZXh0cmVnaW9uOjYxZWY4YWY2MGY0ODQ1MzhhYjU5ZmUxZGZkNTk2YWFmXzMzMQ_10591853-17e7-4573-95a5-802c12a91ebc"
      unitRef="usdPerShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <amci:TemporaryEquityNumberOfVotesPerShare
      contextRef="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDkvZnJhZzo2MWVmOGFmNjBmNDg0NTM4YWI1OWZlMWRmZDU5NmFhZi90ZXh0cmVnaW9uOjYxZWY4YWY2MGY0ODQ1MzhhYjU5ZmUxZGZkNTk2YWFmXzQwNw_739434d1-8362-420d-88cb-4ddc86819d1b"
      unitRef="vote">1</amci:TemporaryEquityNumberOfVotesPerShare>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDkvZnJhZzo2MWVmOGFmNjBmNDg0NTM4YWI1OWZlMWRmZDU5NmFhZi90ZXh0cmVnaW9uOjYxZWY4YWY2MGY0ODQ1MzhhYjU5ZmUxZGZkNTk2YWFmXzQ2Nw_da267036-7070-4b6e-9fc9-da49eaef76d9"
      unitRef="shares">15000000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="ib178386587034322a4ea05a95f29a04c_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDkvZnJhZzo2MWVmOGFmNjBmNDg0NTM4YWI1OWZlMWRmZDU5NmFhZi90YWJsZToxYzNkMGRjMDdkMzc0NTQyYjE4N2VlMzAxMDIyOWQ3MC90YWJsZXJhbmdlOjFjM2QwZGMwN2QzNzQ1NDJiMTg3ZWUzMDEwMjI5ZDcwXzAtMS0xLTEtOTA2MDk_399dd35f-19d7-40e4-9f92-2af87aef6946"
      unitRef="usd">150000000</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <amci:TemporaryEquityProceedsAllocatedToWarrants
      contextRef="ib178386587034322a4ea05a95f29a04c_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDkvZnJhZzo2MWVmOGFmNjBmNDg0NTM4YWI1OWZlMWRmZDU5NmFhZi90YWJsZToxYzNkMGRjMDdkMzc0NTQyYjE4N2VlMzAxMDIyOWQ3MC90YWJsZXJhbmdlOjFjM2QwZGMwN2QzNzQ1NDJiMTg3ZWUzMDEwMjI5ZDcwXzItMS0xLTEtOTA2MDk_288fd6b4-c4e9-47b9-9e15-c4a2fd345f5d"
      unitRef="usd">-5100000</amci:TemporaryEquityProceedsAllocatedToWarrants>
    <amci:TemporaryEquityIssuanceCosts
      contextRef="ib178386587034322a4ea05a95f29a04c_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDkvZnJhZzo2MWVmOGFmNjBmNDg0NTM4YWI1OWZlMWRmZDU5NmFhZi90YWJsZToxYzNkMGRjMDdkMzc0NTQyYjE4N2VlMzAxMDIyOWQ3MC90YWJsZXJhbmdlOjFjM2QwZGMwN2QzNzQ1NDJiMTg3ZWUzMDEwMjI5ZDcwXzMtMS0xLTEtOTA2MDk_61f89360-b017-4b67-9893-a023da1b16dc"
      unitRef="usd">-13306092</amci:TemporaryEquityIssuanceCosts>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="ib178386587034322a4ea05a95f29a04c_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDkvZnJhZzo2MWVmOGFmNjBmNDg0NTM4YWI1OWZlMWRmZDU5NmFhZi90YWJsZToxYzNkMGRjMDdkMzc0NTQyYjE4N2VlMzAxMDIyOWQ3MC90YWJsZXJhbmdlOjFjM2QwZGMwN2QzNzQ1NDJiMTg3ZWUzMDEwMjI5ZDcwXzUtMS0xLTEtOTA2MDk_b90b13e7-94c8-4165-8f9d-dfe9bdd19d28"
      unitRef="usd">18406092</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMDkvZnJhZzo2MWVmOGFmNjBmNDg0NTM4YWI1OWZlMWRmZDU5NmFhZi90YWJsZToxYzNkMGRjMDdkMzc0NTQyYjE4N2VlMzAxMDIyOWQ3MC90YWJsZXJhbmdlOjFjM2QwZGMwN2QzNzQ1NDJiMTg3ZWUzMDEwMjI5ZDcwXzYtMS0xLTEtOTA2MDk_e8e1ab87-e788-4f7b-aae8-8f5dce5ef68e"
      unitRef="usd">150000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTIvZnJhZzpkYTgxZjE4NWVjOTA0M2M4YmRiM2ZiOWE0Nzg3YzYxMy90ZXh0cmVnaW9uOmRhODFmMTg1ZWM5MDQzYzhiZGIzZmI5YTQ3ODdjNjEzXzg5_9dab5856-d98d-4d42-a24c-724e07a82917"
      unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTIvZnJhZzpkYTgxZjE4NWVjOTA0M2M4YmRiM2ZiOWE0Nzg3YzYxMy90ZXh0cmVnaW9uOmRhODFmMTg1ZWM5MDQzYzhiZGIzZmI5YTQ3ODdjNjEzXzEzOA_6bec9ee1-7732-4cf7-811b-0a024d512436"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTIvZnJhZzpkYTgxZjE4NWVjOTA0M2M4YmRiM2ZiOWE0Nzg3YzYxMy90ZXh0cmVnaW9uOmRhODFmMTg1ZWM5MDQzYzhiZGIzZmI5YTQ3ODdjNjEzXzU2Mg_2f083aa9-2469-4b1b-8b9d-673273724734"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTIvZnJhZzpkYTgxZjE4NWVjOTA0M2M4YmRiM2ZiOWE0Nzg3YzYxMy90ZXh0cmVnaW9uOmRhODFmMTg1ZWM5MDQzYzhiZGIzZmI5YTQ3ODdjNjEzXzY3Mg_1e2a3d24-ceeb-4ffb-a902-d2a76401f01b"
      unitRef="shares">280000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTIvZnJhZzpkYTgxZjE4NWVjOTA0M2M4YmRiM2ZiOWE0Nzg3YzYxMy90ZXh0cmVnaW9uOmRhODFmMTg1ZWM5MDQzYzhiZGIzZmI5YTQ3ODdjNjEzXzcyNg_2d6bef78-6c23-41bf-9eae-b34b11518902"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i0a43243fe73e4e0982e02d8804f9029b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTIvZnJhZzpkYTgxZjE4NWVjOTA0M2M4YmRiM2ZiOWE0Nzg3YzYxMy90ZXh0cmVnaW9uOmRhODFmMTg1ZWM5MDQzYzhiZGIzZmI5YTQ3ODdjNjEzXzc3Ng_ab08940d-ac4f-4068-ad2e-844ad77ef95b"
      unitRef="shares">15000000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i246d06060759490897b705c5ed7fc8f0_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTIvZnJhZzpkYTgxZjE4NWVjOTA0M2M4YmRiM2ZiOWE0Nzg3YzYxMy90ZXh0cmVnaW9uOmRhODFmMTg1ZWM5MDQzYzhiZGIzZmI5YTQ3ODdjNjEzXzk5NA_d615b093-b044-4fdd-ac14-1b7f6e282a3e"
      unitRef="shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i246d06060759490897b705c5ed7fc8f0_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTIvZnJhZzpkYTgxZjE4NWVjOTA0M2M4YmRiM2ZiOWE0Nzg3YzYxMy90ZXh0cmVnaW9uOmRhODFmMTg1ZWM5MDQzYzhiZGIzZmI5YTQ3ODdjNjEzXzEwMzg_3bd025c5-1073-4629-95cd-0df48ef00832"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="i246d06060759490897b705c5ed7fc8f0_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTIvZnJhZzpkYTgxZjE4NWVjOTA0M2M4YmRiM2ZiOWE0Nzg3YzYxMy90ZXh0cmVnaW9uOmRhODFmMTg1ZWM5MDQzYzhiZGIzZmI5YTQ3ODdjNjEzXzEwODg_dae399c9-1e14-4c55-9889-cf3bfbf0f16a"
      unitRef="shares">3750000</us-gaap:CommonStockSharesIssued>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="iefc421e312514841a1adc71514c3bb9a_D20210128-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTIvZnJhZzpkYTgxZjE4NWVjOTA0M2M4YmRiM2ZiOWE0Nzg3YzYxMy90ZXh0cmVnaW9uOmRhODFmMTg1ZWM5MDQzYzhiZGIzZmI5YTQ3ODdjNjEzXzE5MTQ_83d93f16-749e-4e9a-b8a0-22225b53dfde"
      unitRef="shares">1</us-gaap:ConversionOfStockSharesIssued1>
    <amci:ConvertibleStockConversionRatio
      contextRef="iefc421e312514841a1adc71514c3bb9a_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTIvZnJhZzpkYTgxZjE4NWVjOTA0M2M4YmRiM2ZiOWE0Nzg3YzYxMy90ZXh0cmVnaW9uOmRhODFmMTg1ZWM5MDQzYzhiZGIzZmI5YTQ3ODdjNjEzXzI0MDg_f75f0457-fc32-450f-9ff5-02ee0fcf906e"
      unitRef="number">20</amci:ConvertibleStockConversionRatio>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="iefc421e312514841a1adc71514c3bb9a_D20210128-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTIvZnJhZzpkYTgxZjE4NWVjOTA0M2M4YmRiM2ZiOWE0Nzg3YzYxMy90ZXh0cmVnaW9uOmRhODFmMTg1ZWM5MDQzYzhiZGIzZmI5YTQ3ODdjNjEzXzMzMjU_c2504a81-7ccd-4710-9f24-7cd4599eec2e"
      unitRef="shares">1</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i98b54305564e42f9abfa073cb3e4947b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzExMg_3698ec48-aa2b-4f0f-beca-6d02fa6accce"
      unitRef="shares">7500000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i9c30db48f9bb482b9cb45b5c2227dd57_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzEzNQ_10574a47-36e7-4c80-9822-162ebe33723b"
      unitRef="shares">3500000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzI0MA_1471caca-7776-44ee-9cf3-65fc5f9a2cf6"
      unitRef="shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <amci:ClassOfWarrantOrRightPriceOfWarrantsOrRights
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzI4Nw_5b638a48-b98d-4c3a-be97-0e3118d16bb0"
      unitRef="usdPerShare">11.50</amci:ClassOfWarrantOrRightPriceOfWarrantsOrRights>
    <amci:WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering
      contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzM2Ng_0622eb0e-f3c6-4053-b77b-779a68d2dfba">P30D</amci:WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering>
    <amci:MaximumThresholdPeriodForFilingRegistrationStatementAfterBusinessCombination
      contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2Xzk3MQ_32515392-b4d9-48af-9e20-1e04870aaca5">P5Y</amci:MaximumThresholdPeriodForFilingRegistrationStatementAfterBusinessCombination>
    <amci:PeriodForFillingRegistrationStatementAfterBusinessCombination
      contextRef="i77e83a23de6644e3be03c1d9c1e36370_D20210128-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzEyMDc_dfef4d29-51b7-4122-9116-11dd3dfb28a6">P15D</amci:PeriodForFillingRegistrationStatementAfterBusinessCombination>
    <amci:PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise
      contextRef="i77e83a23de6644e3be03c1d9c1e36370_D20210128-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzE4OTg_f7e3c3ce-e919-48c2-9ab4-cce99c5d2dae">P60D</amci:PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise>
    <amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="i3cb1ba206598437fb974dd69c2b87e0f_D20210128-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzMxMjI_44019d24-d32d-4cab-b9ac-28922a2fc7ce"
      unitRef="usdPerShare">18.00</amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <amci:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights
      contextRef="i3cb1ba206598437fb974dd69c2b87e0f_D20210128-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzMyNTM_530eb54b-f8c7-4da4-9c7e-85c0554a3515"
      unitRef="usdPerShare">0.01</amci:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights>
    <amci:RedemptionPeriod
      contextRef="i3cb1ba206598437fb974dd69c2b87e0f_D20210128-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzMyODc_60100c42-e0f1-4bd4-a21b-c1465cd2edf7">P30D</amci:RedemptionPeriod>
    <amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="i3cb1ba206598437fb974dd69c2b87e0f_D20210128-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzM0MzU_9cc9a2c9-18e3-4364-bb85-898d297e9676"
      unitRef="usdPerShare">18.00</amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays
      contextRef="i3cb1ba206598437fb974dd69c2b87e0f_D20210128-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzM2NzI_13365139-9389-42f7-8dcc-1e52f18b3f2e">P20D</amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays>
    <amci:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants
      contextRef="i3cb1ba206598437fb974dd69c2b87e0f_D20210128-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzM2OTc_5353c83a-7eb6-4da5-a581-1ac10f304a0e">P30D</amci:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants>
    <amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="if77b5c86cfcc4c03a7007e9a9266feb2_D20210128-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzM4OTk_0185f904-7ebf-4083-9575-42125ea51cf7"
      unitRef="usdPerShare">10.00</amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <amci:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights
      contextRef="if77b5c86cfcc4c03a7007e9a9266feb2_D20210128-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzQwMTk_d59b0d47-ea9e-4f73-9bfd-2aba13c90c1e"
      unitRef="usdPerShare">0.10</amci:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights>
    <amci:RedemptionPeriod
      contextRef="if77b5c86cfcc4c03a7007e9a9266feb2_D20210128-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzQwNTI_9f068794-5924-4f79-a92d-a0cce4b88b75">P30D</amci:RedemptionPeriod>
    <amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="if77b5c86cfcc4c03a7007e9a9266feb2_D20210128-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzQ0OTc_e0e68020-dd30-49e8-8425-a5a5883c9818"
      unitRef="usdPerShare">10.00</amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays
      contextRef="if77b5c86cfcc4c03a7007e9a9266feb2_D20210128-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzQ3NDE_a8689e54-7fdc-4961-8c1b-b110c01ae1f7">P20D</amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays>
    <amci:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants
      contextRef="if77b5c86cfcc4c03a7007e9a9266feb2_D20210128-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzQ3Njg_80fd0e8f-5477-4c95-a1c9-aa4ae9c5989a">P30D</amci:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants>
    <us-gaap:SharePrice
      contextRef="i182c81dada5746a896432e0206ca7183_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzUxNDA_d94f9ddd-8c84-47a8-8ea9-1a6ec848c081"
      unitRef="usdPerShare">9.20</us-gaap:SharePrice>
    <amci:PercentageOfGrossProceedsOnTotalEquityProceed
      contextRef="i87ed9aa6359e4e9da28c6fd65b021373_D20210128-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzU1Njc_4cf41e73-12ad-4e4c-befe-00cf9a2da874"
      unitRef="number">0.60</amci:PercentageOfGrossProceedsOnTotalEquityProceed>
    <amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDaysSource2
      contextRef="i87ed9aa6359e4e9da28c6fd65b021373_D20210128-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzU4NzM_9b13b6ff-f6da-470e-b325-864e497ea907"
      unitRef="d">20</amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDaysSource2>
    <us-gaap:SharePrice
      contextRef="i182c81dada5746a896432e0206ca7183_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzYwNDc_e865d953-90e2-4e27-bd19-1f890b4d8a95"
      unitRef="usdPerShare">9.20</us-gaap:SharePrice>
    <amci:ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices
      contextRef="i3cb1ba206598437fb974dd69c2b87e0f_D20210128-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzYxNTA_26a9dbda-cd58-400d-a463-31c8da138e2d"
      unitRef="number">1.15</amci:ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices>
    <amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="i3cb1ba206598437fb974dd69c2b87e0f_D20210128-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzYyMTk_474ed319-df46-4721-b3c4-d7fed8dadf38"
      unitRef="usdPerShare">18.00</amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="i3cb1ba206598437fb974dd69c2b87e0f_D20210128-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzYzNzI_580b4e05-e854-479b-8d53-a2113e0d1ec0"
      unitRef="usdPerShare">18.00</amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <amci:ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices
      contextRef="if77b5c86cfcc4c03a7007e9a9266feb2_D20210128-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzY0MzA_aa2191da-7eb2-427a-8521-6ba27ab474be"
      unitRef="number">1.80</amci:ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices>
    <amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="if77b5c86cfcc4c03a7007e9a9266feb2_D20210128-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzY1MDM_a306ab78-eecf-4e14-9084-3d92092902fe"
      unitRef="usdPerShare">10.00</amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="if77b5c86cfcc4c03a7007e9a9266feb2_D20210128-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTUvZnJhZzpmMTNlYzljN2IxM2Q0NDg4YjE3YWE2NDFhMDNjZDE4Ni90ZXh0cmVnaW9uOmYxM2VjOWM3YjEzZDQ0ODhiMTdhYTY0MWEwM2NkMTg2XzY2NTY_31068f17-1130-410b-9afd-c22ba3cb4dff"
      unitRef="usdPerShare">10.00</amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i946a08fcd3a04e65862611981f20e270_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZToxMzVmMjM0MDk3NzM0MjIzYjg4ODM3NzkzNDk2MGZhYi90YWJsZXJhbmdlOjEzNWYyMzQwOTc3MzQyMjNiODg4Mzc3OTM0OTYwZmFiXzMtMi0xLTEtOTA2MDk_0f22c5bf-225d-4b52-83b1-928d66f881fd"
      unitRef="usd">150006015</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:DerivativeLiabilities
      contextRef="i818e11a86037425d8b4e148caf3f101c_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZToxMzVmMjM0MDk3NzM0MjIzYjg4ODM3NzkzNDk2MGZhYi90YWJsZXJhbmdlOjEzNWYyMzQwOTc3MzQyMjNiODg4Mzc3OTM0OTYwZmFiXzUtMi0xLTEtOTA2MDk_9358140b-71bc-4b76-b62c-bc01c7f82fde"
      unitRef="usd">3825000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="if33c5b343220431f8fa1664c765aaf71_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZToxMzVmMjM0MDk3NzM0MjIzYjg4ODM3NzkzNDk2MGZhYi90YWJsZXJhbmdlOjEzNWYyMzQwOTc3MzQyMjNiODg4Mzc3OTM0OTYwZmFiXzYtNi0xLTEtOTA2MDk_b08822b7-0fd9-451f-968d-6ad9e73de630"
      unitRef="usd">1785000</us-gaap:DerivativeLiabilities>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="ia5b0bb5d02764693b9a25febf0a6032b_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZToxNDAxMGQ4NWY0ZTQ0ZjVjYWUxYjc0Yzg5ZjVjYTNmYS90YWJsZXJhbmdlOjE0MDEwZDg1ZjRlNDRmNWNhZTFiNzRjODlmNWNhM2ZhXzEtMS0xLTEtOTA2MDk_53208eea-da05-4e48-8a03-9dc64d04ceb7"
      unitRef="usdPerShare">11.50</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i11685a5fe8fb4e7580ffa0ca743f0062_I20210806"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZToxNDAxMGQ4NWY0ZTQ0ZjVjYWUxYjc0Yzg5ZjVjYTNmYS90YWJsZXJhbmdlOjE0MDEwZDg1ZjRlNDRmNWNhZTFiNzRjODlmNWNhM2ZhXzEtMy0xLTEtOTA2MDk_ae58f824-7d8f-426a-907c-1f3dd0497fd3"
      unitRef="usdPerShare">11.50</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i9712786e3d6e4293bfa543a7f4306d3d_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZToxNDAxMGQ4NWY0ZTQ0ZjVjYWUxYjc0Yzg5ZjVjYTNmYS90YWJsZXJhbmdlOjE0MDEwZDg1ZjRlNDRmNWNhZTFiNzRjODlmNWNhM2ZhXzItMS0xLTEtOTA2MDk_8b79369b-9371-426a-af92-82f97846f5a8"
      unitRef="number">0.096</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i64bb7db0f547412db51fb298ab7f1eb1_I20210806"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZToxNDAxMGQ4NWY0ZTQ0ZjVjYWUxYjc0Yzg5ZjVjYTNmYS90YWJsZXJhbmdlOjE0MDEwZDg1ZjRlNDRmNWNhZTFiNzRjODlmNWNhM2ZhXzItMy0xLTEtOTA2MDk_8ed93242-184c-43fe-b6e2-fb91bbf2553c"
      unitRef="number">0.113</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i10a81d94cb444487a1305e090e7ac9f0_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZToxNDAxMGQ4NWY0ZTQ0ZjVjYWUxYjc0Yzg5ZjVjYTNmYS90YWJsZXJhbmdlOjE0MDEwZDg1ZjRlNDRmNWNhZTFiNzRjODlmNWNhM2ZhXzMtMS0xLTEtOTA2MDk_0badb415-4adc-4b08-8359-4d5d54f51512"
      unitRef="usdPerShare">9.66</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="ib14d34f779324c98acee7371373d9927_I20210806"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZToxNDAxMGQ4NWY0ZTQ0ZjVjYWUxYjc0Yzg5ZjVjYTNmYS90YWJsZXJhbmdlOjE0MDEwZDg1ZjRlNDRmNWNhZTFiNzRjODlmNWNhM2ZhXzMtMy0xLTEtOTA2MDk_c8b750b7-53d0-478d-a2f2-39d77aed0e2e"
      unitRef="usdPerShare">9.66</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i0b029e7f84ba49809517714b945d453d_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZToxNDAxMGQ4NWY0ZTQ0ZjVjYWUxYjc0Yzg5ZjVjYTNmYS90YWJsZXJhbmdlOjE0MDEwZDg1ZjRlNDRmNWNhZTFiNzRjODlmNWNhM2ZhXzQtMS0xLTEtOTA2MDk_191c82a7-91fa-499e-812d-b46e4ed6a811"
      unitRef="y">5.75</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="ie04573b29e10454392fcd1c7a4d28cb2_I20210806"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZToxNDAxMGQ4NWY0ZTQ0ZjVjYWUxYjc0Yzg5ZjVjYTNmYS90YWJsZXJhbmdlOjE0MDEwZDg1ZjRlNDRmNWNhZTFiNzRjODlmNWNhM2ZhXzQtMy0xLTEtOTA2MDk_bab501fe-4c53-4169-9084-275114e0420a"
      unitRef="y">6.51</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i0b3852e6684e45c08ebac5f6a1cb253d_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZToxNDAxMGQ4NWY0ZTQ0ZjVjYWUxYjc0Yzg5ZjVjYTNmYS90YWJsZXJhbmdlOjE0MDEwZDg1ZjRlNDRmNWNhZTFiNzRjODlmNWNhM2ZhXzUtMS0xLTEtOTA2MDk_66916457-4899-45e7-91c5-76fcaa456495"
      unitRef="number">0.0132</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i531831f23f064c698db5bd956d8f7662_I20210806"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZToxNDAxMGQ4NWY0ZTQ0ZjVjYWUxYjc0Yzg5ZjVjYTNmYS90YWJsZXJhbmdlOjE0MDEwZDg1ZjRlNDRmNWNhZTFiNzRjODlmNWNhM2ZhXzUtMy0xLTEtOTA2MDk_f0bc8508-1acd-43cd-a2d9-a0e25dc74e8a"
      unitRef="number">0.0099</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="i832a10c8d035443c86f96cddb14c1741_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZTo1MzY0ZWVhYzc3ZTY0ODEyODVmZDU2NmJlMjI5MTY1MS90YWJsZXJhbmdlOjUzNjRlZWFjNzdlNjQ4MTI4NWZkNTY2YmUyMjkxNjUxXzEtMS0xLTEtOTA2MDk_7f32f6a0-d02b-4c41-b581-8c31ee93c747"
      unitRef="usd">7515000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
      contextRef="i832a10c8d035443c86f96cddb14c1741_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZTo1MzY0ZWVhYzc3ZTY0ODEyODVmZDU2NmJlMjI5MTY1MS90YWJsZXJhbmdlOjUzNjRlZWFjNzdlNjQ4MTI4NWZkNTY2YmUyMjkxNjUxXzItMS0xLTEtOTA2MDk_89468125-23c7-4ce6-b358-3d6d606ae1f1"
      unitRef="usd">-5100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i832a10c8d035443c86f96cddb14c1741_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZTo1MzY0ZWVhYzc3ZTY0ODEyODVmZDU2NmJlMjI5MTY1MS90YWJsZXJhbmdlOjUzNjRlZWFjNzdlNjQ4MTI4NWZkNTY2YmUyMjkxNjUxXzMtMS0xLTEtOTA2MDk_686c9b30-7e45-4010-bf49-5c30e532faca"
      unitRef="usd">-630000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="iaa37f22ae2644299a4ab468acaa968cd_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMTgvZnJhZzowNjBiNWU3YjAyYTc0MzYyYWMyMjNlZjM4MzA1ODAyMy90YWJsZTo1MzY0ZWVhYzc3ZTY0ODEyODVmZDU2NmJlMjI5MTY1MS90YWJsZXJhbmdlOjUzNjRlZWFjNzdlNjQ4MTI4NWZkNTY2YmUyMjkxNjUxXzQtMS0xLTEtOTA2MDk_90186d3a-8cf1-474a-b034-ee36ecbc963f"
      unitRef="usd">1785000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90ZXh0cmVnaW9uOjVmYjc0NjhhMWViNjRlNmNhYTk3MWQ2NzM3M2E1MmZmXzE5ODg_7bad12e9-3afc-4473-bb7f-3d748d71a00e">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 10 &#x2014; Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files income tax returns in the U.S. federal and Connecticut jurisdictions and are subject to examination. The income tax provision consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Period from January 28, 2021&lt;br/&gt;(inception) through December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(290,181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s net deferred tax assets are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Start-up/Organization costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;210,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;79,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;290,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(290,181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax asset, net of allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax assets, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the period from January 28, 2021 (inception) through December 31, 2021, the valuation allowance was $290,181. As of December 31, 2021, the Company had $380,351 of U.S. federal net operating loss carryovers, which do not expire, available to offset future taxable income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no unrecognized tax benefits as of December 31, 2021. No amounts were accrued for the payment of interest and penalties as of December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company&#x2019;s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the statutory federal income tax rate (benefit) to the Company&#x2019;s effective tax rate (benefit) is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Period from January 28, 2021 (inception) through December 31, 2021 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Statutory federal income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of derivative warrant liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(855.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Offering costs allocated to derivative warrant liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Income Taxes&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to federal state income taxes in the United States, as well as income taxes in foreign jurisdictions in which it conducts business. The Company does not provide for federal income taxes on the undistributed earnings of its foreign subsidiaries as such earnings are reinvested indefinitely. The Company and its foreign subsidiaries have historically been loss generating entities that have resulted in no excess earnings to consider for repatriation and accordingly there are no deferred income taxes recognized for the nine months ended September&#160;30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded an income tax expense of $0 for the nine months ended September&#160;30, 2022 and 2021, representing an effective tax rate of 0%. The difference between the U.S. federal statutory rate of 21% and the Company's effective tax rate in the first nine months ended September&#160;30, 2022 is primarily due to a full valuation allowance related to the Company's U.S. deferred tax assets and tax benefits in the Company's foreign jurisdictions. For the first nine months ended September 30, 2021, the Company's effective tax rate was computed based on income tax rate in New Zealand of 28.0% as the Company was still domiciled in New Zealand. The Company reassesses the need for a valuation allowance on a quarterly basis. If it is determined that a portion or all of the valuation allowance is not required, it will generally be a benefit to the income tax provision in the period such determination is made.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company conducts business in multiple jurisdictions within and outside the United States. Consequently, the Company is subject to periodic income tax examinations by domestic and foreign income tax authorities. The Company is subject to audits for tax years 2009 and onward for federal purposes. There are tax years which remain subject to examination in various other state and foreign jurisdictions that are not material to the Company's financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2021, the Company migrated its country of domicile from New Zealand to Delaware in the United States. On migration, the Company was deemed to have disposed of all its assets and liabilities to a third-party at market value which resulted in taxable income to the Company for New Zealand income tax purposes which was fully offset by net operating loss carryforwards and deferred R&amp;amp;D credits in New Zealand. The migration to Delaware is classified as a tax-free reorganization for U.S. federal income tax purposes.&lt;/span&gt;&lt;/div&gt;Income Taxes&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of (loss) income before income taxes and gain from equity method investees, net are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,860)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New Zealand&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,551)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,651)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,689)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of income tax expense were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New Zealand&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New Zealand&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a reconciliation of income taxes computed at the statutory federal income tax rate (21.0% federal income tax rate in the United States for 2021 and 28.0% federal income tax rate in the New Zealand for &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2020, respectively) to the income tax expense (benefit) reflected in the consolidated statement of operations and comprehensive loss (in thousands, except percentages):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax (benefit) at the statutory federal income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,805)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,560)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign tax rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(605)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,068)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,892)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income on receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(679)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible legal costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain from redomiciliation of intellectual property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PPP loan forgiveness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(644)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant components of deferred tax assets and liabilities as of December&#160;31, 2021 and 2020, were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss and credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued bonus&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113,276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108,300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,941)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,605)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net deferred income tax assets and liabilities:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2021 and 2020, the Company had $299,194 and $271,390, respectively, of tax losses and credits carried forward subject to shareholder continuity and acceptance in the countries where the Company has tax losses carried forward. R&amp;amp;D tax credits included within these amounts are $35,147 and $40,556, respectively, which may be available to offset future income tax liabilities. At December&#160;31, 2021 and 2020, the net operating loss and credit carryforwards are comprised of $239,559 and $196,442 in the United States, $22,203 and $18,104 in state and local, $35,116 and $54,334 in New Zealand, and $4,589 and $2,510 in other foreign jurisdictions, respectively. At December&#160;31, 2021 and 2020, the Company had net operating loss carryforwards of approximately $136,454 and $132,373, respectively, that expire in various years from 2022 through 2037, plus $127,593 and $98,462, respectively, for which there is no expiration date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Section 382 of the Internal Revenue Code imposes an annual limitation on the utilization of net operating loss carryforwards based on a statutory rate of return and the value of the corporation at the time of a &#x201c;change of ownership&#x201d; as defined by Section 382. The Company had a change in ownership&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in November 2014. T&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;herefore, the Company&#x2019;s ability to utilize its net operating loss carryforwards incurred prior to the 2014 ownership change, will be subject in future periods to annual limitations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In assessing the realizability of deferred tax assets, the Company assesses whether it is more-likely-than-not that a portion or all of the deferred tax assets will not be realized. The Company considers the scheduled reversal of deferred tax liabilities, tax planning strategies and projected future taxable income in making this assessment. At December&#160;31, 2021 and 2020, a valuation allowance of $113,276 and $108,300, respectively, was recorded against certain deferred tax assets based on this assessment. The Company believes it is more-likely-than-not that the tax benefit of the remaining net deferred tax assets will be realized. The amount of net deferred tax assets considered realizable could be increased or reduced in the future if the Company&#x2019;s assessment of future taxable income or tax planning strategies changes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and its foreign subsidiaries have historically been loss generating entities that have resulted in no excess earnings to consider for repatriation and accordingly there are no deferred income taxes recognized as of December&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2021 and 2020, the Company had no tax liability or benefit related to uncertain tax positions. No interest or penalties related to uncertain taxes have been recognized on the accompanying consolidated statements of operations. Management does not expect a significant change in uncertain tax positions during the twelve months subsequent to December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company conducts business in multiple jurisdictions within and outside the United States. Consequently, the Company is subject to periodic income tax examinations by domestic and foreign income tax authorities. During December 2021, the Internal Revenue Service completed an income tax examination of the Company&#x2019;s U.S. federal income tax return for the year ended December 31, 2016, which resulted in no impact to the Company&#x2019;s consolidated financial statements. The Company has no other ongoing tax examinations with domestic or foreign taxing authorities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2021, the Company migrated its country of domicile from New Zealand to Delaware in the United States. On migration, the Company was deemed to have disposed of all its assets and liabilities to a third-party at market value which resulted in taxable income to the Company for New Zealand income tax purposes. The migration to Delaware is classified as a tax-free reorganization for U.S. federal income tax purposes.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90ZXh0cmVnaW9uOjVmYjc0NjhhMWViNjRlNmNhYTk3MWQ2NzM3M2E1MmZmXzE5ODk_ce3cac7e-f92b-4ee2-a7cf-38aa1fada581">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Period from January 28, 2021&lt;br/&gt;(inception) through December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(290,181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of income tax expense were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New Zealand&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New Zealand&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90YWJsZTo4NWRjZDZjY2VhMDE0ZGY1ODMyMzA5ODYwMmUzYmRlMS90YWJsZXJhbmdlOjg1ZGNkNmNjZWEwMTRkZjU4MzIzMDk4NjAyZTNiZGUxXzItMS0xLTEtOTA2MDk_a7a207a9-dbba-4987-bcff-943c91ccb3e1"
      unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90YWJsZTo4NWRjZDZjY2VhMDE0ZGY1ODMyMzA5ODYwMmUzYmRlMS90YWJsZXJhbmdlOjg1ZGNkNmNjZWEwMTRkZjU4MzIzMDk4NjAyZTNiZGUxXzMtMS0xLTEtOTA2MDk_2d56e2cb-7966-49d8-8971-af09ce8e880f"
      unitRef="usd">0</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90YWJsZTo4NWRjZDZjY2VhMDE0ZGY1ODMyMzA5ODYwMmUzYmRlMS90YWJsZXJhbmdlOjg1ZGNkNmNjZWEwMTRkZjU4MzIzMDk4NjAyZTNiZGUxXzUtMS0xLTEtOTA2MDk_30f499da-3a3a-4a29-8fef-f4c4d7fa75c4"
      unitRef="usd">-290181</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90YWJsZTo4NWRjZDZjY2VhMDE0ZGY1ODMyMzA5ODYwMmUzYmRlMS90YWJsZXJhbmdlOjg1ZGNkNmNjZWEwMTRkZjU4MzIzMDk4NjAyZTNiZGUxXzYtMS0xLTEtOTA2MDk_454fa62f-c8b7-49d8-ba30-63a3e518dc64"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90YWJsZTo4NWRjZDZjY2VhMDE0ZGY1ODMyMzA5ODYwMmUzYmRlMS90YWJsZXJhbmdlOjg1ZGNkNmNjZWEwMTRkZjU4MzIzMDk4NjAyZTNiZGUxXzctMS0xLTEtOTA2MDk_de068258-33f5-4846-ba36-b71fada20cd2"
      unitRef="usd">290181</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90YWJsZTo4NWRjZDZjY2VhMDE0ZGY1ODMyMzA5ODYwMmUzYmRlMS90YWJsZXJhbmdlOjg1ZGNkNmNjZWEwMTRkZjU4MzIzMDk4NjAyZTNiZGUxXzgtMS0xLTEtOTA2MDk_51db61c4-11b2-4b03-83c4-aab2d4cbbc73"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90ZXh0cmVnaW9uOjVmYjc0NjhhMWViNjRlNmNhYTk3MWQ2NzM3M2E1MmZmXzE5OTA_d9c342b9-f63e-49a1-97c8-0370495dd798">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Start-up/Organization costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;210,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;79,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;290,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(290,181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax asset, net of allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant components of deferred tax assets and liabilities as of December&#160;31, 2021 and 2020, were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss and credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued bonus&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113,276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108,300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,941)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,605)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net deferred income tax assets and liabilities:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <amci:DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90YWJsZTo1ZWVmOTI3Yzk2NmY0MGJhYWFkMjgzMmNiYmQ2NGE2OS90YWJsZXJhbmdlOjVlZWY5MjdjOTY2ZjQwYmFhYWQyODMyY2JiZDY0YTY5XzItMS0xLTEtOTA2MDk_f4ae6ee8-9f8d-4027-9477-5c62c68f7ce6"
      unitRef="usd">210307</amci:DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90YWJsZTo1ZWVmOTI3Yzk2NmY0MGJhYWFkMjgzMmNiYmQ2NGE2OS90YWJsZXJhbmdlOjVlZWY5MjdjOTY2ZjQwYmFhYWQyODMyY2JiZDY0YTY5XzMtMS0xLTEtOTA2MDk_2001f559-1c2d-419b-9d5a-92600f22358f"
      unitRef="usd">79874</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90YWJsZTo1ZWVmOTI3Yzk2NmY0MGJhYWFkMjgzMmNiYmQ2NGE2OS90YWJsZXJhbmdlOjVlZWY5MjdjOTY2ZjQwYmFhYWQyODMyY2JiZDY0YTY5XzQtMS0xLTEtOTA2MDk_0a453e4f-2bcf-4add-a600-74e6dcf9965f"
      unitRef="usd">290181</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90YWJsZTo1ZWVmOTI3Yzk2NmY0MGJhYWFkMjgzMmNiYmQ2NGE2OS90YWJsZXJhbmdlOjVlZWY5MjdjOTY2ZjQwYmFhYWQyODMyY2JiZDY0YTY5XzUtMS0xLTEtOTA2MDk_6df78da7-cd53-4f2a-89e0-bec1ccccd3e9"
      unitRef="usd">290181</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90ZXh0cmVnaW9uOjVmYjc0NjhhMWViNjRlNmNhYTk3MWQ2NzM3M2E1MmZmXzExNTA_548394a9-7cc0-4952-8f2e-f4e100a3b88b"
      unitRef="usd">290181</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i1031eb2976d644cfbbf5cce499b8af89_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90ZXh0cmVnaW9uOjVmYjc0NjhhMWViNjRlNmNhYTk3MWQ2NzM3M2E1MmZmXzExOTU_881b967b-d7b5-49f2-9c77-5d75f2fa80b4"
      unitRef="usd">380351</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90ZXh0cmVnaW9uOjVmYjc0NjhhMWViNjRlNmNhYTk3MWQ2NzM3M2E1MmZmXzEzMjA_3b238f48-613e-4d0d-a57e-3429e99eb3f1"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90ZXh0cmVnaW9uOjVmYjc0NjhhMWViNjRlNmNhYTk3MWQ2NzM3M2E1MmZmXzEzNzQ_e39fa352-d56c-4b7e-ba7b-1572a7b39ad9"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90ZXh0cmVnaW9uOjVmYjc0NjhhMWViNjRlNmNhYTk3MWQ2NzM3M2E1MmZmXzE5OTE_2e637002-10d3-4919-9d0d-197e3f8ceaf7">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Period from January 28, 2021 (inception) through December 31, 2021 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Statutory federal income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of derivative warrant liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(855.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Offering costs allocated to derivative warrant liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;The following table is a reconciliation of income taxes computed at the statutory federal income tax rate (21.0% federal income tax rate in the United States for 2021 and 28.0% federal income tax rate in the New Zealand for &lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2020, respectively) to the income tax expense (benefit) reflected in the consolidated statement of operations and comprehensive loss (in thousands, except percentages):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax (benefit) at the statutory federal income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,805)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,560)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign tax rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(605)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,068)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,892)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income on receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(679)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible legal costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain from redomiciliation of intellectual property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PPP loan forgiveness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(644)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90YWJsZTplMzk2OWJkOWM3NTE0MTc3ODhmMDc1ZmNmYmIzOGJhNy90YWJsZXJhbmdlOmUzOTY5YmQ5Yzc1MTQxNzc4OGYwNzVmY2ZiYjM4YmE3XzEtMS0xLTEtOTA2MDk_ed8f8bd5-cfbb-4a5a-ab8d-92c0d8746c5a"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90YWJsZTplMzk2OWJkOWM3NTE0MTc3ODhmMDc1ZmNmYmIzOGJhNy90YWJsZXJhbmdlOmUzOTY5YmQ5Yzc1MTQxNzc4OGYwNzVmY2ZiYjM4YmE3XzItMS0xLTEtOTA2MDk_a8bda234-1dd0-406d-addd-853d504750e2"
      unitRef="number">8.559</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90YWJsZTplMzk2OWJkOWM3NTE0MTc3ODhmMDc1ZmNmYmIzOGJhNy90YWJsZXJhbmdlOmUzOTY5YmQ5Yzc1MTQxNzc4OGYwNzVmY2ZiYjM4YmE3XzMtMS0xLTEtOTA2MDk_0c3c48eb-aa89-4c2c-b62a-cecde9bbbad0"
      unitRef="number">2.140</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90YWJsZTplMzk2OWJkOWM3NTE0MTc3ODhmMDc1ZmNmYmIzOGJhNy90YWJsZXJhbmdlOmUzOTY5YmQ5Yzc1MTQxNzc4OGYwNzVmY2ZiYjM4YmE3XzQtMS0xLTEtOTA2MDk_4684cb06-0d0a-47d5-9333-6ce1a45f0d94"
      unitRef="number">6.209</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjQvZnJhZzo1ZmI3NDY4YTFlYjY0ZTZjYWE5NzFkNjczNzNhNTJmZi90YWJsZTplMzk2OWJkOWM3NTE0MTc3ODhmMDc1ZmNmYmIzOGJhNy90YWJsZXJhbmdlOmUzOTY5YmQ5Yzc1MTQxNzc4OGYwNzVmY2ZiYjM4YmE3XzUtMS0xLTEtOTA2MDk_c5b4d4c2-22e9-4036-a867-be6ac58f4401"
      unitRef="number">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:BusinessCombinationContingentConsiderationAssetCurrent
      contextRef="ia6a395c8f57c4345b9c5c1927223b563_I20220308"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjcvZnJhZzpkODdkZjEzZGM1MWE0NmFjOTAyYjA5NTJhZmM4M2NjZS90ZXh0cmVnaW9uOmQ4N2RmMTNkYzUxYTQ2YWM5MDJiMDk1MmFmYzgzY2NlXzE1ODM_a45a7d0b-1740-4763-b404-234989ecf73e"
      unitRef="usd">1817000000</us-gaap:BusinessCombinationContingentConsiderationAssetCurrent>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="ia6a395c8f57c4345b9c5c1927223b563_I20220308"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjcvZnJhZzpkODdkZjEzZGM1MWE0NmFjOTAyYjA5NTJhZmM4M2NjZS90ZXh0cmVnaW9uOmQ4N2RmMTNkYzUxYTQ2YWM5MDJiMDk1MmFmYzgzY2NlXzE3NzE_4007679a-9d77-4c63-8f6f-2de767839b0a"
      unitRef="usdPerShare">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="ia6a395c8f57c4345b9c5c1927223b563_I20220308"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjcvZnJhZzpkODdkZjEzZGM1MWE0NmFjOTAyYjA5NTJhZmM4M2NjZS90ZXh0cmVnaW9uOmQ4N2RmMTNkYzUxYTQ2YWM5MDJiMDk1MmFmYzgzY2NlXzM2MDA_4328ef0c-9307-4c9f-8745-000b5aadc550"
      unitRef="usdPerShare">10.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:AssetsNet
      contextRef="i1b9add4019654e2d87f0e463effed72f_I20220308"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjcvZnJhZzpkODdkZjEzZGM1MWE0NmFjOTAyYjA5NTJhZmM4M2NjZS90ZXh0cmVnaW9uOmQ4N2RmMTNkYzUxYTQ2YWM5MDJiMDk1MmFmYzgzY2NlXzU5MDc_4f4e4f3a-9516-4c26-8660-7bf3c6b47b21"
      unitRef="usd">5000001</us-gaap:AssetsNet>
    <us-gaap:AssetsHeldInTrustCurrent
      contextRef="i1b9add4019654e2d87f0e463effed72f_I20220308"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8xMjcvZnJhZzpkODdkZjEzZGM1MWE0NmFjOTAyYjA5NTJhZmM4M2NjZS90ZXh0cmVnaW9uOmQ4N2RmMTNkYzUxYTQ2YWM5MDJiMDk1MmFmYzgzY2NlXzYyMTY_db578b5a-2e25-4b40-b5e8-d7800ef2be3c"
      unitRef="usd">230000000</us-gaap:AssetsHeldInTrustCurrent>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzQtMS0xLTEtOTA3MDc_4be7a95c-ef8f-4aca-bda6-684d62c2c62f"
      unitRef="usd">50370000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzQtMy0xLTEtOTA3MDc_e9d1675a-a926-4452-b5fa-4588c28c201e"
      unitRef="usd">128318000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzUtMS0xLTEtOTA3MDc_e008ddfc-f5be-4c70-86d3-d5af181a6391"
      unitRef="usd">11588000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzUtMy0xLTEtOTA3MDc_8d4c4640-c5af-4a80-a12d-93b7de86b197"
      unitRef="usd">2878000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzYtMS0xLTEtOTA3MDc_2afd77ce-bb33-4117-ab43-ff9188f3598f"
      unitRef="usd">14848000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzYtMy0xLTEtOTA3MDc_bfaa2a3d-6f8d-4a50-afe5-77a5a8c87ce7"
      unitRef="usd">11700000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzctMS0xLTEtOTA3MDc_00cba1f5-e791-4cf6-8726-c7109625dd46"
      unitRef="usd">12009000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzctMy0xLTEtOTA3MDc_58b305ca-9447-41bd-b713-67f8997d5ebf"
      unitRef="usd">5779000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzgtMS0xLTEtOTkxODE_d5d6e0dd-5da8-42b2-82d5-2909f58a403c"
      unitRef="usd">88815000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzgtMy0xLTEtOTkyNjM_1d0c92ae-9b17-485f-8c01-cc70ae5f4ca4"
      unitRef="usd">148675000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzktMS0xLTEtOTA3MDc_b89328c3-6cca-411e-9688-9ca742196626"
      unitRef="usd">16645000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzktMy0xLTEtOTA3MDc_66c942ba-bda8-4ef2-963c-6d8ac426ff72"
      unitRef="usd">14148000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzEwLTEtMS0xLTkwNzA3_c1b3c833-00d6-457f-8448-22f4292d4567"
      unitRef="usd">3343000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzEwLTMtMS0xLTkwNzA3_765fe67a-5ca7-49c6-9650-7f63dd1b3ab0"
      unitRef="usd">4686000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:EquityMethodInvestments
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzExLTEtMS0xLTkwNzA3_9f180717-bcff-4503-a17d-cb684a849ca2"
      unitRef="usd">11047000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzExLTMtMS0xLTkwNzA3_f279425a-3533-4046-ab59-56df85eaa96f"
      unitRef="usd">24752000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzEyLTEtMS0xLTkwNzA3_13ce506f-dd15-446a-bb05-1f84c34a4b15"
      unitRef="usd">14990000</us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue>
    <us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzEyLTMtMS0xLTkwNzA3_c94e3780-2505-45c2-a167-89bab141ba79"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzEzLTEtMS0xLTkwNzA3_c5ef134a-a779-41a8-a475-32b0eeb48481"
      unitRef="usd">750000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzEzLTMtMS0xLTkwNzA3_720a91fb-4279-4220-9b50-d16b67fd526a"
      unitRef="usd">750000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzE0LTEtMS0xLTk5MjY2_1b7bfad9-c942-4ca1-b722-bfcdc74c155d"
      unitRef="usd">135590000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzE0LTMtMS0xLTkwNzA3_c4ddde92-449f-4948-bd66-606d1a49ea1b"
      unitRef="usd">193011000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzE3LTEtMS0xLTkwNzA3_e72203d0-6959-44a9-ae6b-f726457a7aef"
      unitRef="usd">1488000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzE3LTMtMS0xLTkwNzA3_e50688f6-1b1b-4a17-a66a-d6f5c0ec3cdc"
      unitRef="usd">2444000</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzE4LTEtMS0xLTkwNzA3_0c21dc31-9fe0-4ad3-8957-78de4532d824"
      unitRef="usd">8064000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzE4LTMtMS0xLTkwNzA3_b4314c31-c6b7-4bbb-9889-74887b36fb22"
      unitRef="usd">7059000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <amci:SimpleAgreementForFutureEquityLiability
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzE5LTEtMS0xLTkwNzA3_35d9ac4e-0b55-4c2a-a0ef-5075294a75c7"
      unitRef="usd">27221000</amci:SimpleAgreementForFutureEquityLiability>
    <amci:SimpleAgreementForFutureEquityLiability
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzE5LTMtMS0xLTkwNzA3_e83f7da0-5093-4b82-af9a-11e90236fa69"
      unitRef="usd">28271000</amci:SimpleAgreementForFutureEquityLiability>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzIwLTEtMS0xLTkwNzA3_c3877934-087d-4e53-9a07-78a3e38dbe99"
      unitRef="usd">2022000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzIwLTMtMS0xLTkwNzA3_0c71e64b-112f-4d72-8934-9dc71d71c198"
      unitRef="usd">1729000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzIxLTEtMS0xLTkwNzA3_1f00fe2c-faa3-4247-af1b-0a8336188fff"
      unitRef="usd">2968000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzIxLTMtMS0xLTkwNzA3_74655878-1a34-42fc-ad06-f982a5a688d0"
      unitRef="usd">3476000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzIyLTEtMS0xLTkwNzA3_f14ee44d-331b-4787-ab1e-a23638cb38a8"
      unitRef="usd">5079000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzIyLTMtMS0xLTkwNzA3_93f283d4-0aa2-42d7-bb89-bbf81d927175"
      unitRef="usd">4261000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzIzLTEtMS0xLTkwNzA3_1205ff09-5c22-4ebf-8506-ffb183fbd807"
      unitRef="usd">2205000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzIzLTMtMS0xLTkwNzA3_70fd09cf-3821-4adf-9260-e07fae07b935"
      unitRef="usd">2050000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzI0LTEtMS0xLTk5Mjk5_2cd7829b-3983-4ac0-967a-f71c9f9475ac"
      unitRef="usd">49047000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzI0LTMtMS0xLTk5MzAy_e250afff-8303-4071-a73a-aa61739540c1"
      unitRef="usd">49290000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzI1LTEtMS0xLTkwNzA3_b0c87482-79fc-4084-8919-a8b2c53b37cf"
      unitRef="usd">1610000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzI1LTMtMS0xLTkwNzA3_f720371a-92ea-4c92-810e-2e092585a063"
      unitRef="usd">3283000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzI2LTEtMS0xLTkwNzA3_eef7e1f1-a039-4f80-92fa-ce826f439c58"
      unitRef="usd">11119000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzI2LTMtMS0xLTkwNzA3_59d993e5-e480-405d-9bdd-842577db5c6e"
      unitRef="usd">13901000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzI3LTEtMS0xLTkwNzA3_a75b6a5d-71ff-4b1b-8ffc-5684a2b3373f"
      unitRef="usd">823000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzI3LTMtMS0xLTkwNzA3_d996ab44-1501-43dc-a192-809852b94fb4"
      unitRef="usd">823000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzI4LTEtMS0xLTk5Mjk5_0a587c5d-978c-44ac-b958-024e9567ce64"
      unitRef="usd">62599000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzI4LTMtMS0xLTk5MzAy_7b498885-cabe-4683-90ac-08ae79bb549b"
      unitRef="usd">67297000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzI5LTEtMS0xLTk5MzYw_93b84215-85bd-42b2-ba5b-936d475af0fe"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzI5LTMtMS0xLTk5MzYw_c0b6d7cf-af10-46f7-9850-64707c360f1f"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzMyLTAtMS0xLTkwNzA3L3RleHRyZWdpb246ZDNmYTQ4NmNjYmQ2NDY0NTk3OTZlMDVlM2RlN2M1ODZfNDU_b14c31d6-0582-4dd1-9527-4560d8788747"
      unitRef="usdPerShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzMyLTAtMS0xLTkwNzA3L3RleHRyZWdpb246ZDNmYTQ4NmNjYmQ2NDY0NTk3OTZlMDVlM2RlN2M1ODZfNDU_c2db7f73-9b00-4c5c-9a47-e807e2341f68"
      unitRef="usdPerShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzMyLTAtMS0xLTkwNzA3L3RleHRyZWdpb246ZDNmYTQ4NmNjYmQ2NDY0NTk3OTZlMDVlM2RlN2M1ODZfNTk_77f63a85-7448-4b8a-86b9-17e4adc27e17"
      unitRef="shares">29747033</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzMyLTAtMS0xLTkwNzA3L3RleHRyZWdpb246ZDNmYTQ4NmNjYmQ2NDY0NTk3OTZlMDVlM2RlN2M1ODZfNTk_b5c0536b-a201-4898-b32e-8df3171156ca"
      unitRef="shares">29747033</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzMyLTAtMS0xLTkwNzA3L3RleHRyZWdpb246ZDNmYTQ4NmNjYmQ2NDY0NTk3OTZlMDVlM2RlN2M1ODZfODE_9e872197-94e0-4129-ac82-6a14cbf36648"
      unitRef="shares">29521810</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzMyLTAtMS0xLTkwNzA3L3RleHRyZWdpb246ZDNmYTQ4NmNjYmQ2NDY0NTk3OTZlMDVlM2RlN2M1ODZfODE_b0aeceda-ef75-4d48-97a0-fff5a1b4662f"
      unitRef="shares">29521810</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzMyLTAtMS0xLTkwNzA3L3RleHRyZWdpb246ZDNmYTQ4NmNjYmQ2NDY0NTk3OTZlMDVlM2RlN2M1ODZfODE_c8050675-d814-4276-a944-d08393b23d4d"
      unitRef="shares">29521810</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzMyLTAtMS0xLTkwNzA3L3RleHRyZWdpb246ZDNmYTQ4NmNjYmQ2NDY0NTk3OTZlMDVlM2RlN2M1ODZfODE_d3aab95a-a376-4ddb-884c-ad50a4e51a58"
      unitRef="shares">29521810</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzMyLTEtMS0xLTkwNzA3_0a2514d9-6750-4ec3-8e77-0b7ec08f74fb"
      unitRef="usd">480631000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzMyLTMtMS0xLTkwNzA3_1faf0950-d3ee-40f8-8c55-1ddf8d52958c"
      unitRef="usd">480631000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM0LTAtMS0xLTkwNzA3L3RleHRyZWdpb246NWQ2MjcxZmQ4NjEyNDhkNmExNzJlNzhlYzU1YWVkMjVfMTk_a2e817c6-e701-44e8-bdb6-0eecdd6b12dc"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM0LTAtMS0xLTkwNzA3L3RleHRyZWdpb246NWQ2MjcxZmQ4NjEyNDhkNmExNzJlNzhlYzU1YWVkMjVfMTk_b4e43c07-2ac5-4ab4-a446-13de29026d99"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM0LTAtMS0xLTkwNzA3L3RleHRyZWdpb246NWQ2MjcxZmQ4NjEyNDhkNmExNzJlNzhlYzU1YWVkMjVfMzM_01109a43-b8ed-4d00-a577-88865c822825"
      unitRef="shares">36326815</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM0LTAtMS0xLTkwNzA3L3RleHRyZWdpb246NWQ2MjcxZmQ4NjEyNDhkNmExNzJlNzhlYzU1YWVkMjVfMzM_750abc69-0804-4296-8fe3-7201d8392445"
      unitRef="shares">36326815</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM0LTAtMS0xLTkwNzA3L3RleHRyZWdpb246NWQ2MjcxZmQ4NjEyNDhkNmExNzJlNzhlYzU1YWVkMjVfNTU_2405acb9-a192-4c66-a2d8-18796a7edb66"
      unitRef="shares">2110346</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM0LTAtMS0xLTkwNzA3L3RleHRyZWdpb246NWQ2MjcxZmQ4NjEyNDhkNmExNzJlNzhlYzU1YWVkMjVfNTU_425d3f5a-e640-48eb-9302-073dcc6e53bd"
      unitRef="shares">2110346</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM0LTAtMS0xLTkwNzA3L3RleHRyZWdpb246NWQ2MjcxZmQ4NjEyNDhkNmExNzJlNzhlYzU1YWVkMjVfNjI_69820550-c349-4199-ae64-af0c0189c632"
      unitRef="shares">2106934</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM0LTAtMS0xLTkwNzA3L3RleHRyZWdpb246NWQ2MjcxZmQ4NjEyNDhkNmExNzJlNzhlYzU1YWVkMjVfNjI_83c30b22-dbde-4192-b470-8f638d59bd31"
      unitRef="shares">2106934</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM0LTEtMS0xLTkwNzA3_08837169-2961-4af3-b3a0-f4c7da877a10"
      unitRef="usd">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM0LTMtMS0xLTkwNzA3_79651307-3f7e-4ce1-8dab-304837e40994"
      unitRef="usd">0</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM1LTEtMS0xLTkwNzA3_9ecb0774-252b-4f00-b372-bfdc4cc5c8f1"
      unitRef="usd">23801000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM1LTMtMS0xLTkwNzA3_38b1b185-6b6b-4bfa-8157-029915f228c3"
      unitRef="usd">21711000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM2LTEtMS0xLTkwNzA3_c36d0e89-41f5-4098-9042-9a5e7c22f602"
      unitRef="usd">3422000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM2LTMtMS0xLTkwNzA3_5e833418-512f-483c-ad0b-4c2e5fc476b9"
      unitRef="usd">3261000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM3LTEtMS0xLTkwNzA3_b941e408-2a16-403f-97b4-363fadc266b1"
      unitRef="usd">-434863000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM3LTMtMS0xLTkwNzA3_96f7aa7c-09d0-4318-99c6-404941c5656a"
      unitRef="usd">-379889000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM4LTEtMS0xLTk5MzA1_d00502ac-2eec-4bea-80b5-3f84da83fa9b"
      unitRef="usd">-407640000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM4LTMtMS0xLTk5MzEw_49d60a0d-5a2c-490e-af08-4389885517dc"
      unitRef="usd">-354917000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM5LTEtMS0xLTk5MzA1_ea269387-8aa2-4c66-af24-75192f2ef688"
      unitRef="usd">135590000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NDMvZnJhZzplMjM3NzQ4OGVlNGY0ZGIyYWZhNzZmMDk2MjdhMmU0NS90YWJsZTpiMWRmMjlmZTBhMjQ0ZTZiYTU1OTQ0MDk2Y2EwYTg1MC90YWJsZXJhbmdlOmIxZGYyOWZlMGEyNDRlNmJhNTU5NDQwOTZjYTBhODUwXzM5LTMtMS0xLTk5MzEw_8cd4fabb-4a7b-4777-add7-b9f0061e3f10"
      unitRef="usd">193011000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzQtMS0xLTEtOTA3MTA_576d605f-d478-477b-a7de-927782680876"
      unitRef="usd">21932000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzQtMy0xLTEtOTA3MTA_b7f3a625-21ba-4890-b367-997f3dc49b4f"
      unitRef="usd">13317000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzUtMS0xLTEtOTA3MTA_9a8b17fe-3a8a-4d4a-b77f-ebdd448db6d6"
      unitRef="usd">1733000</us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer>
    <us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzUtMy0xLTEtOTA3MTA_663c52eb-b4fc-4af6-ad31-709bee93131d"
      unitRef="usd">2662000</us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzYtMS0xLTEtOTA3MTA_ebb93582-da5a-46e6-891a-b714dfc92b18"
      unitRef="usd">2116000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzYtMy0xLTEtOTA3MTA_20470455-fabb-40f5-9e02-d2d818565972"
      unitRef="usd">2348000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:Revenues
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzctMS0xLTEtOTk1NzQ_a95deb6c-3856-4ad0-9238-0fa1af661a84"
      unitRef="usd">25781000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzctMy0xLTEtOTA3MTA_71f95f28-c40c-415a-93cc-9beb125a5557"
      unitRef="usd">18327000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzEwLTEtMS0xLTkwNzEw_7acf49d0-f1ba-4fce-8825-d3a439a925bb"
      unitRef="usd">18162000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzEwLTMtMS0xLTkwNzEw_371009d2-8fdd-4051-bc0a-0bd0eed521ce"
      unitRef="usd">8480000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="i6fa285a120cf4338a950b439d1496dd7_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzExLTEtMS0xLTkwNzEw_369f9824-7d72-4bfc-8893-0076d5d609af"
      unitRef="usd">727000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="ieb733d9b6c67432ab5a278cc8f9ae7e7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzExLTMtMS0xLTkwNzEw_0d2ce464-f26f-44d2-9bca-d509f8fbc388"
      unitRef="usd">935000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="ic032ce31175f4c45b33f9642339eab9b_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzEyLTEtMS0xLTkwNzEw_adba5501-a16d-4557-8463-146f7f396033"
      unitRef="usd">342000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="i6752cd0319b04183b8e6481ee3e75964_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzEyLTMtMS0xLTkwNzEw_647e2352-6481-46d2-a1d9-ae30440ae338"
      unitRef="usd">575000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzEzLTEtMS0xLTkwNzEw_e809d846-8f83-40d2-96b5-057e66fbc4d2"
      unitRef="usd">39858000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzEzLTMtMS0xLTkwNzEw_46dca58a-c506-4e0c-90f4-1e846c90eccb"
      unitRef="usd">29223000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:Depreciation
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzE0LTEtMS0xLTkwNzEw_75112d74-99ce-45fc-849d-0f9e570fbbdc"
      unitRef="usd">3433000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzE0LTMtMS0xLTkwNzEw_796a23ce-2ee1-4e7b-91e0-972ec4a380e8"
      unitRef="usd">2763000</us-gaap:Depreciation>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzE1LTEtMS0xLTkwNzEw_47e6e106-9d9c-4379-b72f-a17852efd48e"
      unitRef="usd">19482000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzE1LTMtMS0xLTkwNzEw_a7d0da62-bfe8-4c6d-8389-44f977b27ff7"
      unitRef="usd">11595000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzE2LTEtMS0xLTk5NTc4_1ad5482b-d1b8-4908-922d-fb4036bf55af"
      unitRef="usd">82004000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzE2LTMtMS0xLTkwNzEw_d23b1bbe-f11e-48de-8573-337ed3df37d8"
      unitRef="usd">53571000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzE3LTEtMS0xLTk5NTc4_ead8d0d2-fae3-4256-9ec4-0096e3774c88"
      unitRef="usd">-56223000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzE3LTMtMS0xLTkwNzEw_830987e9-5860-42b5-8a8f-cd54e1794672"
      unitRef="usd">-35244000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzE5LTEtMS0xLTkwNzEw_78eb1e19-b8a1-4ef5-a10a-7f483f8b4969"
      unitRef="usd">3000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzE5LTMtMS0xLTkwNzEw_0599cca7-0887-4dc7-879f-4697ddeecad2"
      unitRef="usd">-5000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzIwLTEtMS0xLTkwNzEw_e0ac5871-86a3-481d-9475-ebd02a653882"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzIwLTMtMS0xLTkwNzEw_d444afc7-c8d1-49f9-a230-cfa68e7e7854"
      unitRef="usd">3065000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzIxLTEtMS0xLTkwNzEw_36ef1e91-d446-4fa5-b8bc-a5b0abdbc51b"
      unitRef="usd">-1100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzIxLTMtMS0xLTkwNzEw_12bdb33b-b412-4820-af65-4f825bf3fbf9"
      unitRef="usd">-778000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzIyLTEtMS0xLTk5NTgx_20893fed-efa6-42ce-adde-971fed439a88"
      unitRef="usd">-1097000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzIyLTMtMS0xLTk5NTg1_9d97701d-0b43-4f6b-9560-17295e8a98d0"
      unitRef="usd">2282000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzIzLTEtMS0xLTk5NTgx_82c09984-2344-47c4-932b-870f86c01320"
      unitRef="usd">-57320000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzIzLTMtMS0xLTk5NTg1_5b9c069a-53e7-4903-8900-092c4b87fee5"
      unitRef="usd">-32962000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzI0LTEtMS0xLTkwNzEw_d1cbf149-6d92-4f89-a4c3-ebc0d757d28f"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzI0LTMtMS0xLTkwNzEw_1a1ba826-7c70-4321-9286-8eaaecc2cc0f"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzI1LTEtMS0xLTkwNzEw_a37ab943-c334-4fd5-a853-60ddc855e6cf"
      unitRef="usd">2346000</amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment>
    <amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzI1LTMtMS0xLTkwNzEw_13820b58-a4d2-43fe-93b7-e0f9486ec73a"
      unitRef="usd">2371000</amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment>
    <us-gaap:NetIncomeLoss
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzI2LTEtMS0xLTk5NTgx_0269c412-fc29-4432-83d2-d0ff6d29860d"
      unitRef="usd">-54974000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzI2LTMtMS0xLTkwNzEw_8eb19940-a52c-4c49-aa67-2548899e0537"
      unitRef="usd">-30591000</us-gaap:NetIncomeLoss>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzI4LTEtMS0xLTkwNzEw_2d089ff3-c271-487a-804a-b05c5c804a9e"
      unitRef="usd">28925000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzI4LTMtMS0xLTkwNzEw_c1b2000d-f8c6-42e6-b7e6-0bbe9fcec20e"
      unitRef="usd">27068000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzI5LTEtMS0xLTkwNzEw_f67e847b-18ca-47de-beb8-54bc1b9212c7"
      unitRef="usd">-83899000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzI5LTMtMS0xLTk5NTg4_958097a3-d10e-4a49-960d-8c78b812e04c"
      unitRef="usd">-57659000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzMyLTEtMS0xLTkwNzEw_274efbd5-1640-46ec-8d17-a4afcfb5ddf7"
      unitRef="usd">-767000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzMyLTMtMS0xLTkwNzEw_3a1fa224-8b3b-4fa4-bc74-4ab974713068"
      unitRef="usd">-29000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzMzLTEtMS0xLTk5NTk2_94090f2e-40f2-4254-b0d7-286c0eafa1c1"
      unitRef="usd">-55741000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzMzLTMtMS0xLTkwNzEw_783af38e-add1-436b-9fa3-096b29fcf776"
      unitRef="usd">-30620000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasic
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzM1LTEtMS0xLTkwNzEw_4cc13ab2-86f1-4ada-9dd2-3b4f26110ea5"
      unitRef="usdPerShare">-39790</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzM1LTEtMS0xLTkwNzEw_8c2cb863-b14d-480b-ba1d-451e1d089909"
      unitRef="usdPerShare">-39790</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzM1LTMtMS0xLTkwNzEw_946673d5-f332-4531-82f1-f5338e53b6e5"
      unitRef="usdPerShare">-30190</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzM1LTMtMS0xLTkwNzEw_c7a8539f-a0f1-4c59-b03e-6394bc735e97"
      unitRef="usdPerShare">-30190</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzM2LTEtMS0xLTkwNzEw_30ef1d57-910b-4b89-9f0c-359113d3d40e"
      unitRef="shares">2108472000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzM2LTEtMS0xLTkwNzEw_4e26ab3a-7ce9-48fc-817a-f4a09b55c5ab"
      unitRef="shares">2108472000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzM2LTMtMS0xLTkwNzEw_75f71a28-7c68-4e34-921a-c3014d787de1"
      unitRef="shares">1909635000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NTQvZnJhZzozNjJkZTZlNjhkZjU0ZGFlOWFjMjg3YzliNmIzODg4OC90YWJsZTo2MDcxOGVkZDU4NDA0OTExYTQ4NmIxNWVjNTI3OTRmMi90YWJsZXJhbmdlOjYwNzE4ZWRkNTg0MDQ5MTFhNDg2YjE1ZWM1Mjc5NGYyXzM2LTMtMS0xLTkwNzEw_fc6976f2-61da-48e1-814d-3eeaa95e8ac8"
      unitRef="shares">1909635000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzMtMS0xLTEtOTA3MTI_75e75683-052d-49b1-a313-fb4cde2afdd3"
      unitRef="usd">-54974000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzMtMy0xLTEtOTA3MTI_f1e4ad83-e20e-48b1-a5eb-24fd8734a18a"
      unitRef="usd">-30591000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzUtMS0xLTEtOTA3MTI_d6c240ea-bebe-4218-b2a2-643d3f4cbf17"
      unitRef="usd">2067000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzUtMy0xLTEtOTA3MTI_3e52b56d-db4d-46a8-90fa-552369d3779c"
      unitRef="usd">1790000</us-gaap:ShareBasedCompensation>
    <amci:FairValueAdjustmentOfWarrantsAndUnrealizedGainLossOnDerivatives
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzYtMS0xLTEtOTA3MTI_52acac58-6597-4ad6-a7fd-d997b6df43c0"
      unitRef="usd">-330000</amci:FairValueAdjustmentOfWarrantsAndUnrealizedGainLossOnDerivatives>
    <amci:FairValueAdjustmentOfWarrantsAndUnrealizedGainLossOnDerivatives
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzYtMy0xLTEtOTA3MTI_30bafa3f-4b90-4acb-b7cc-afd0f555354b"
      unitRef="usd">699000</amci:FairValueAdjustmentOfWarrantsAndUnrealizedGainLossOnDerivatives>
    <us-gaap:Depreciation
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzctMS0xLTEtOTA3MTI_d1f6b60d-79c9-48f1-b099-1fc96e6db645"
      unitRef="usd">3433000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzctMy0xLTEtOTA3MTI_8733272e-246b-4ad6-9dc2-20c6d174b807"
      unitRef="usd">2763000</us-gaap:Depreciation>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzgtMS0xLTEtOTA3MTI_a9f8ade7-8040-46cf-b09f-4b89b12ad888"
      unitRef="usd">1343000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzgtMy0xLTEtOTA3MTI_49211779-1715-4789-9526-59df833616c0"
      unitRef="usd">1248000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <amci:NoncashRecognitionOfLicensingRevenue
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzktMS0xLTEtOTA3MTI_3dda1ab1-56cf-4576-b935-feb13d5e4c93"
      unitRef="usd">1620000</amci:NoncashRecognitionOfLicensingRevenue>
    <amci:NoncashRecognitionOfLicensingRevenue
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzktMy0xLTEtOTA3MTI_2c51b5d3-c6ff-4177-8dc1-cbf84e454129"
      unitRef="usd">1516000</amci:NoncashRecognitionOfLicensingRevenue>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzEwLTEtMS0xLTkwNzEy_adb2ff02-fabb-4488-8ad9-4e99f8e694e5"
      unitRef="usd">2346000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzEwLTMtMS0xLTkwNzEy_9b9ae180-4083-49b6-8996-aa7de7bfd94d"
      unitRef="usd">2371000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzExLTEtMS0xLTkwNzEy_30133795-9faf-4840-a6a6-186d0f4668eb"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzExLTMtMS0xLTkwNzEy_95d52f3e-1b73-4e23-984b-14a15b070c91"
      unitRef="usd">3065000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzEyLTEtMS0xLTkwNzEy_4cf29eef-66e7-493c-8558-4763c2fa7758"
      unitRef="usd">-1311000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzEyLTMtMS0xLTkwNzEy_1b850324-6d93-4e22-9c29-3a7290491e22"
      unitRef="usd">-11000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzE0LTEtMS0xLTkwNzEy_97734b86-f51e-43c9-9941-7540861aad3e"
      unitRef="usd">8710000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzE0LTMtMS0xLTkwNzEy_a4c3a945-cc9d-4fe5-b8ce-0d26496c7e04"
      unitRef="usd">-3581000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzE1LTEtMS0xLTkwNzEy_df4b8b79-ec8d-4f2b-af5a-ed1394b80c75"
      unitRef="usd">3270000</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzE1LTMtMS0xLTkwNzEy_02907d7f-083d-4f94-aa52-360d54f4923a"
      unitRef="usd">3838000</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzE2LTEtMS0xLTkwNzEy_0e4751e8-fbb5-406e-bf30-84cd6583b41c"
      unitRef="usd">5981000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzE2LTMtMS0xLTkwNzEy_6525cfe6-d7d9-48b6-9eea-9d3ab9c4a49c"
      unitRef="usd">558000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzE3LTEtMS0xLTkwNzEy_3a345f4b-0541-4d1e-a7e3-a7f3219740f3"
      unitRef="usd">463000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzE3LTMtMS0xLTkwNzEy_44a8095e-714f-4025-b4eb-830b1f614f31"
      unitRef="usd">717000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzE4LTEtMS0xLTkwNzEy_7e3dfb69-f415-44bd-b8e9-2808e5637277"
      unitRef="usd">-471000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzE4LTMtMS0xLTkwNzEy_7fcefeec-7cd1-41bf-99d4-b4d39fec5695"
      unitRef="usd">4301000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzE5LTEtMS0xLTkwNzEy_05569863-0ed4-4887-8e11-c406476a90d6"
      unitRef="usd">-1518000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzE5LTMtMS0xLTkwNzEy_a29e311c-78b6-4eec-9652-ebce068739d6"
      unitRef="usd">-1389000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzIwLTEtMS0xLTkwNzEy_0d9ec78f-378e-4d62-ab3d-612f3976c4ec"
      unitRef="usd">-733000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzIwLTMtMS0xLTkwNzEy_393a54f2-0015-42cd-ab82-358bc095b89f"
      unitRef="usd">1500000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzIxLTEtMS0xLTk5ODE3_4212ed9d-574d-40d1-bcbf-019ba3eecd63"
      unitRef="usd">-71336000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzIxLTMtMS0xLTk5ODEy_14bce2e3-5200-47ab-9555-52f15fa4c3a4"
      unitRef="usd">-26718000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzIzLTEtMS0xLTkwNzEy_39ba6381-6121-4176-bfda-5784e7e634a2"
      unitRef="usd">6530000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzIzLTMtMS0xLTkwNzEy_0df81d56-b341-4646-afd7-74d928e7c14d"
      unitRef="usd">4201000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzI0LTEtMS0xLTk5ODI4_4daaa322-6499-4957-ae25-7b89775f015b"
      unitRef="usd">-6530000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzI0LTMtMS0xLTk5ODI4_5429ee0e-5e02-4100-ac38-abf59fd86a82"
      unitRef="usd">-4201000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <amci:ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzI2LTEtMS0xLTkwNzEy_d746b00c-51f8-4c2b-a027-2a917ac457a6"
      unitRef="usd">23000</amci:ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises>
    <amci:ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzI2LTMtMS0xLTkwNzEy_50a70339-0349-4a45-b477-d773bf577ce1"
      unitRef="usd">83775000</amci:ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzI3LTEtMS0xLTkwNzEy_26f4c66f-44fa-402c-b774-0b51d7dc78bf"
      unitRef="usd">0</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzI3LTMtMS0xLTkwNzEy_8c3bda6a-e007-466c-b49d-eee3efd099d0"
      unitRef="usd">3150000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:PaymentsForRepurchaseOfEquity
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzI4LTEtMS0xLTkwNzEy_c14b1592-0ae3-44d5-91ae-eeb7316df97f"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfEquity>
    <us-gaap:PaymentsForRepurchaseOfEquity
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzI4LTMtMS0xLTkwNzEy_39919e06-60e3-440c-9b5f-496ae1a6046f"
      unitRef="usd">396000</us-gaap:PaymentsForRepurchaseOfEquity>
    <us-gaap:RepaymentsOfDebt
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzI5LTEtMS0xLTkwNzEy_5ec19ed3-9d14-4aa5-9e68-56fbed3a8107"
      unitRef="usd">0</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzI5LTMtMS0xLTkwNzEy_dae40cd3-c009-4da7-a021-f98c3bdaf223"
      unitRef="usd">570000</us-gaap:RepaymentsOfDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzMwLTEtMS0xLTk5ODMy_7715d86b-0474-4b91-af0a-f9876539e67c"
      unitRef="usd">23000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzMwLTMtMS0xLTk5ODMx_7ed39236-291d-4b2b-ad92-94b6dd5ab952"
      unitRef="usd">85959000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzMxLTEtMS0xLTk5ODMy_6cd35d47-6a77-49e4-bf99-f379e0bca948"
      unitRef="usd">-77843000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzMxLTMtMS0xLTkwNzEy_fa30dd25-64ed-4541-b1a2-d05287575f39"
      unitRef="usd">55040000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzMyLTEtMS0xLTkwNzEy_0fff2acc-9835-49b1-9c81-2f3fea210f50"
      unitRef="usd">128732000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzMyLTMtMS0xLTkwNzEy_4c061cf2-81d4-4bcb-9356-77d261079a75"
      unitRef="usd">60909000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzMzLTEtMS0xLTkwNzEy_4aef9530-ffd1-4128-bd79-672bbb12b52f"
      unitRef="usd">145000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzMzLTMtMS0xLTkwNzEy_1507b220-b4ee-48cb-8b3c-e7d4904836f7"
      unitRef="usd">-249000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzM0LTEtMS0xLTk5ODMy_3e4a0a76-aa93-4dfa-8762-a28c8f5424ec"
      unitRef="usd">51034000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i34364739f4c64be69f7a57e53ecbd751_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzM0LTMtMS0xLTk5ODMx_d983cf5c-1ef9-4c67-80b1-a79929eac2d1"
      unitRef="usd">115700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzM2LTEtMS0xLTkwNzEy_9c313323-212b-4ac7-bebb-11227f3b0a04"
      unitRef="usd">107000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzM2LTMtMS0xLTkwNzEy_ebfaf472-ecfb-4b95-995f-8cbac7cd4937"
      unitRef="usd">346000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzM3LTEtMS0xLTkwNzEy_79cfebc4-aa64-4b4d-9637-e5e7499eff9f"
      unitRef="usd">0</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzM3LTMtMS0xLTkwNzEy_18e5be34-8ae7-4a1a-8467-68f67a7fa103"
      unitRef="usd">938000</us-gaap:ConversionOfStockAmountConverted1>
    <amci:NoncashLoanForgiveness
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzM4LTEtMS0xLTkwNzEy_27ca5cb7-7a9c-4aed-9af4-aa8d2ca69591"
      unitRef="usd">0</amci:NoncashLoanForgiveness>
    <amci:NoncashLoanForgiveness
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NjQvZnJhZzo0ZGI2OWIxMGRiM2Q0MjIyODlhZjRjMzU1NzZjZWNjYy90YWJsZTpiNjJlNmM1N2M4MGQ0NmZjODFkMDU0NTI2ZjE3M2I2OS90YWJsZXJhbmdlOmI2MmU2YzU3YzgwZDQ2ZmM4MWQwNTQ1MjZmMTczYjY5XzM4LTMtMS0xLTkwNzEy_69f4aff9-ee87-462b-88b8-f071849fdae1"
      unitRef="usd">3065000</amci:NoncashLoanForgiveness>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzgtMS0xLTEtOTA3MTQ_aae21c98-321c-4524-b1c1-e93c64bf9468"
      unitRef="shares">29521810</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzgtMy0xLTEtOTA3MTQ_48cd4831-bb5d-4c0f-84a8-e362912d0a2d"
      unitRef="usd">480631000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i78e21c830827492786035892daf32e0d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzgtNi0xLTEtOTA3MTQ_60b2fa77-7af7-4864-a250-24d08f4c6612"
      unitRef="shares">2106934</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i78e21c830827492786035892daf32e0d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzgtOC0xLTEtOTA3MTQ_164f2e08-efb5-4a20-b36c-2ff58ee00dd5"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i20c42717ddd94c808b501ab8475516e6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzgtMTAtMS0xLTkwNzE0_9abc4b1c-7055-4aaf-8ecd-823989661b5f"
      unitRef="usd">21711000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib0898c763893444f8318ba806e5872af_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzgtMTItMS0xLTkwNzE0_e3a677af-df70-4c95-b3af-7fbdb51f3595"
      unitRef="usd">-379889000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib6fb523d0475453fbb376be661a6c994_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzgtMTQtMS0xLTkwNzE0_ac122f4e-8ebe-4d28-bedb-be78288dd63b"
      unitRef="usd">3261000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzgtMTYtMS0xLTkwNzE0_776255ab-6cf7-44d2-b024-ddd882e180d7"
      unitRef="usd">-354917000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic1f4bcf8b20140f296bf2a34009e0064_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzEwLTEwLTEtMS05MDcxNA_5daf6295-442c-4995-8944-920ff0e2869f"
      unitRef="usd">2067000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzEwLTE2LTEtMS05MDcxNA_31e66e40-8734-4928-8372-29031fe6d6b0"
      unitRef="usd">2067000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i98880ce312ba4017b552dd89dc664bb1_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzExLTEyLTEtMS05MDcxNA_a2c2d905-9029-4ae7-9b35-b9575077d315"
      unitRef="usd">-54974000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzExLTE2LTEtMS05MDcxNA_f7fbd35d-f75c-481c-a9b9-d6e9528437aa"
      unitRef="usd">-54974000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ic0a0ddb6c93245558effec1f57e566ba_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzEyLTYtMS0xLTkwNzE0_b893b993-8178-4006-822b-a32f161168a5"
      unitRef="shares">3412</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic1f4bcf8b20140f296bf2a34009e0064_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzEyLTEwLTEtMS05MDcxNA_6cf43a8f-ed6e-4f0f-8ab8-29b0314d344b"
      unitRef="usd">23000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzEyLTE2LTEtMS05MDcxNA_41cb08dd-f8a8-4418-bc9b-00081503fc12"
      unitRef="usd">23000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="i13b3497fdd1e496ba1fa077592599faf_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzEzLTE0LTEtMS05MDcxNA_4ab67200-44fb-4226-a3e0-d41b7982bd5e"
      unitRef="usd">-928000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzEzLTE2LTEtMS05MDcxNA_7a90a4a7-8cc7-48a5-a93d-848f006d0583"
      unitRef="usd">-928000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i13b3497fdd1e496ba1fa077592599faf_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzE0LTE0LTEtMS05MDcxNA_85afc25f-b58f-4191-a0c8-1415fd1e584c"
      unitRef="usd">-767000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzE0LTE2LTEtMS05MDcxNA_deb93d03-dee4-4a4d-ac6a-1e345ba57864"
      unitRef="usd">-767000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzE1LTEtMS0xLTEwMDIyOQ_ba14e279-4a34-436e-bee4-62bfd8528c09"
      unitRef="shares">29521810</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzE1LTMtMS0xLTEwMDIyOQ_4d6ed53f-ec00-49d8-bb1c-61a51becdde6"
      unitRef="usd">480631000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i38e737447613466db8a474885460ec95_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzE1LTYtMS0xLTEwMDIyOQ_ac273511-3dd3-41ca-9826-3d7388999357"
      unitRef="shares">2110346</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i38e737447613466db8a474885460ec95_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzE1LTgtMS0xLTEwMDIyOQ_d4489092-3aa2-48dd-9bca-706d4cb5d285"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i758897248ac340d7bb20c3abbe6a9817_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzE1LTEwLTEtMS0xMDAyMjY_cca52f3f-1518-4777-884f-a6e2fd0ffde7"
      unitRef="usd">23801000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id15fe476907046a7b6b9b51738bf5917_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzE1LTEyLTEtMS0xMDAyMjY_5a424570-3dfe-4d0e-a838-ed3fafe5b10a"
      unitRef="usd">-434863000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia4e845950e88489fa5590b0035aa2dea_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzE1LTE0LTEtMS0xMDAyMjM_87ab1c66-dec2-4d30-89c0-1cf6a4fa7f1b"
      unitRef="usd">3422000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTpiMzM3MDQ5M2ZkNzM0OTg4YTU4ZjczMGMwNTJkY2Q4Yi90YWJsZXJhbmdlOmIzMzcwNDkzZmQ3MzQ5ODhhNThmNzMwYzA1MmRjZDhiXzE1LTE2LTEtMS0xMDAyMTM_2d0a1e96-4e31-49e8-ba69-dab6fc5ce4ea"
      unitRef="usd">-407640000</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzgtMS0xLTEtOTA3MTQ_3ac72db6-0b23-4fa7-8aea-c49240282193"
      unitRef="shares">25729542</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzgtMy0xLTEtOTA3MTQ_04c1bd2c-70f2-4e4f-8b2a-1b14de951fcc"
      unitRef="usd">394408000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i4d49e0cbdb6445f7b88d97d435a55770_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzgtNi0xLTEtOTA3MTQ_ae95a750-4887-46dd-9532-c612ca4213b4"
      unitRef="shares">1656415</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i4d49e0cbdb6445f7b88d97d435a55770_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzgtOC0xLTEtOTA3MTQ_edf73803-053d-45c8-8f31-2822810a5b51"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7c18fa0bbec84bdcb7e52c35f80ede0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzgtMTAtMS0xLTkwNzE0_333d7efd-e111-4915-8f53-274cd2bf8852"
      unitRef="usd">18818000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i18eedd573381425c8c989e260801dafe_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzgtMTItMS0xLTkwNzE0_c98585f8-a48d-4ce4-b6ab-0317f55a32d6"
      unitRef="usd">-333200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7e70eaff18414dc4b12fb6d52ddce0d0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzgtMTQtMS0xLTkwNzE0_1cabb4fd-e2d6-4bed-acc2-b7d209f3f232"
      unitRef="usd">3166000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzgtMTYtMS0xLTkwNzE0_267cd072-534b-47f0-890b-35fe098c5d24"
      unitRef="usd">-311216000</us-gaap:StockholdersEquity>
    <amci:TemporaryEquityStockIssuanceCost
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzktMC0xLTEtOTA3MTQvdGV4dHJlZ2lvbjo0N2M0ZTdlYTJmM2Y0OWRmOGZlNmFhZjliZjY3MTNjOF8xNDI5MzY1MTE2MTE1Ng_7eb8da91-e01f-45a7-94df-14a230d404c9"
      unitRef="usd">0</amci:TemporaryEquityStockIssuanceCost>
    <amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzktMS0xLTEtOTA3MTQ_982ba8f4-72a6-4206-9f17-9f18f1dd3e1a"
      unitRef="shares">3634210</amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzktMy0xLTEtOTA3MTQ_c88d97fe-7738-40bb-940b-d77c5bb041ae"
      unitRef="usd">83073000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <amci:TemporaryEquitySharesConversionOfConvertibleSecurities
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzEwLTEtMS0xLTkwNzE0_119d3e1a-8c75-4097-b1a4-dba6db262018"
      unitRef="shares">158058</amci:TemporaryEquitySharesConversionOfConvertibleSecurities>
    <amci:TemporaryEquityValueConversionOfConvertibleSecurities
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzEwLTMtMS0xLTkwNzE0_8426c3cf-80c4-4c3b-a143-59a3f1bbbefe"
      unitRef="usd">3150000</amci:TemporaryEquityValueConversionOfConvertibleSecurities>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i86b1d28db14d4ccea94e00a84975ab9a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzExLTEwLTEtMS05MDcxNA_c9c47b1e-0211-4f7b-9160-17e5d1946be1"
      unitRef="usd">1790000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzExLTE2LTEtMS05MDcxNA_2ccdcbc1-492e-4cd6-b490-61266e179e5e"
      unitRef="usd">1790000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <amci:AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments
      contextRef="i86b1d28db14d4ccea94e00a84975ab9a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzEyLTEwLTEtMS05MDcxNA_bb259cb9-7f69-4085-91ec-14c82b314bd5"
      unitRef="usd">396000</amci:AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments>
    <amci:AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzEyLTE2LTEtMS05MDcxNA_5b203e66-1029-4f52-ab1a-4605f9165a71"
      unitRef="usd">396000</amci:AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments>
    <us-gaap:NetIncomeLoss
      contextRef="i6dfcd7c6d97d4ad18dc9629f6bf4066c_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzEzLTEyLTEtMS05MDcxNA_d5505aec-966b-47ba-a7ec-8cce26b24c57"
      unitRef="usd">-30591000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzEzLTE2LTEtMS05MDcxNA_84558695-f1d4-48f1-8ee7-efa9036a34cd"
      unitRef="usd">-30591000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i9a0614f9ac2b45cca8e106cb399680b8_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzE0LTYtMS0xLTkwNzE0_fa4ddf73-d05e-4994-8a3c-492253fa96df"
      unitRef="shares">448019</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i86b1d28db14d4ccea94e00a84975ab9a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzE0LTEwLTEtMS05MDcxNA_6725daaa-976f-4968-b42c-016e0852fedb"
      unitRef="usd">702000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzE0LTE2LTEtMS05MDcxNA_13e1664e-1e53-4959-aa91-d0acb2b01430"
      unitRef="usd">702000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i55f893214d234b679544f44bd054f770_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzE1LTE0LTEtMS05MDcxNA_b19a8096-a319-4d76-8782-f9a9389dc1eb"
      unitRef="usd">-29000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzE1LTE2LTEtMS05MDcxNA_aedee15a-5e29-4907-9bf8-8799098233dd"
      unitRef="usd">-29000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i34364739f4c64be69f7a57e53ecbd751_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzE2LTEtMS0xLTkwNzE0_a7d41d39-7a19-40dc-a9bd-53b3e2413652"
      unitRef="shares">29521810</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i34364739f4c64be69f7a57e53ecbd751_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzE2LTMtMS0xLTEwMDIzMg_3b53c4b3-fefe-416b-86ac-70065f2918c8"
      unitRef="usd">480631000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib72b5d999a244a2ca01c9b4f197493e7_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzE2LTYtMS0xLTEwMDI0OQ_77093263-0cd4-4f33-aac7-6768097b2dd9"
      unitRef="shares">2104434</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ib72b5d999a244a2ca01c9b4f197493e7_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzE2LTgtMS0xLTEwMDI0OQ_8478040f-d09c-4da8-bebb-6a442da95cbd"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie7959fab1f2c4a659a441b16211f26c0_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzE2LTEwLTEtMS0xMDAyNDY_3eea6cf0-ebfa-4602-8029-db9cdedd8a6c"
      unitRef="usd">20914000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4980eb4213814e27a8b8df2fb28468ac_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzE2LTEyLTEtMS0xMDAyNDM_de51993c-e7f7-4b68-92b5-6f7ba9042f8c"
      unitRef="usd">-363791000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i63802ab78f814062927f14d9e2bb6b67_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzE2LTE0LTEtMS0xMDAyNDA_476325be-6cdb-458b-b4f1-bd78cfb6fcf0"
      unitRef="usd">3137000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i34364739f4c64be69f7a57e53ecbd751_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82NzEvZnJhZzo2YjkwN2MyYTA2MmI0MDA4OGZiMTRmMjJlYTY0ZjdlYy90YWJsZTphYTczNDk5NGIxN2Y0ODAzYjYxNzg1MmI4OTI3OGNjNi90YWJsZXJhbmdlOmFhNzM0OTk0YjE3ZjQ4MDNiNjE3ODUyYjg5Mjc4Y2M2XzE2LTE2LTEtMS0xMDAyMzc_de91f235-083c-4db9-b878-627ee30d8ee0"
      unitRef="usd">-339740000</us-gaap:StockholdersEquity>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i76d10658df3b4e6bad3f7a990812f829_D20220308-20220308"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82ODkvZnJhZzo0M2YwMTI1ZGY5YjU0YmVhOTBjNWVmYjEwODg5ZDQyMi90ZXh0cmVnaW9uOjQzZjAxMjVkZjliNTRiZWE5MGM1ZWZiMTA4ODlkNDIyXzEyNjQ0MzgzNzI4NTg4_143aa043-927c-4c82-8a32-381a9683455b"
      unitRef="usd">1800000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <amci:ReverseCapitalizationClosingCashCondition
      contextRef="i3e4ce82bb6ca465b8f60e74f553154c0_I20220308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82ODkvZnJhZzo0M2YwMTI1ZGY5YjU0YmVhOTBjNWVmYjEwODg5ZDQyMi90ZXh0cmVnaW9uOjQzZjAxMjVkZjliNTRiZWE5MGM1ZWZiMTA4ODlkNDIyXzEwOTk1MTE2Mjg2ODg4_0c0282a5-8578-41ce-b8e1-b37852b76e39"
      unitRef="usd">250000000</amci:ReverseCapitalizationClosingCashCondition>
    <amci:ReverseCapitalizationClosingCashCondition
      contextRef="ia00417eab54343e78db23ff7c39f19cc_I20221207"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82ODkvZnJhZzo0M2YwMTI1ZGY5YjU0YmVhOTBjNWVmYjEwODg5ZDQyMi90ZXh0cmVnaW9uOjQzZjAxMjVkZjliNTRiZWE5MGM1ZWZiMTA4ODlkNDIyXzEwOTk1MTE2Mjg2OTAy_fca78457-1fc6-427d-b072-30e6289484a7"
      unitRef="usd">230000000</amci:ReverseCapitalizationClosingCashCondition>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="ia00417eab54343e78db23ff7c39f19cc_I20221207"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82ODkvZnJhZzo0M2YwMTI1ZGY5YjU0YmVhOTBjNWVmYjEwODg5ZDQyMi90ZXh0cmVnaW9uOjQzZjAxMjVkZjliNTRiZWE5MGM1ZWZiMTA4ODlkNDIyXzEyNjQ0MzgzNzI4NTgw_be62af44-8bb4-4d3f-a131-1254568a1b4a"
      unitRef="usdPerShare">10.00</us-gaap:SaleOfStockPricePerShare>
    <amci:GoingConcernPolicyTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzEyNjQ0MzgzNzYwNTAy_49c1a415-2d28-48a6-960c-c97e0f51e636">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Going Concern&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements of the Company have been prepared assuming the Company will continue as a going concern and in accordance with accounting principles generally accepted in the United States of America ("US GAAP"). The going concern basis of presentation assumes that the Company will continue in operation one year after the date these financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. The Company had cash and cash equivalents of $50,370 and an accumulated deficit of $(434,863) at September&#160;30, 2022 and cash outflows from operations of $(71,336) and a net loss of $(54,974) for the nine months ended September&#160;30, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has historically funded its operations through debt financing and issuance of equity securities. Based on the Company&#x2019;s financial position as of the date these condensed consolidated financial statements were available to be issued, the Company projects that it will be able to cover its liquidity needs for the next twelve months with cash on hand. Accordingly, the Company&#x2019;s condensed consolidated financial statements have been prepared on the basis that it will continue as a going concern.&lt;/span&gt;&lt;/div&gt;Going ConcernThe accompanying consolidated financial statements of the Company have been prepared assuming the Company will continue as a going concern and in accordance with US GAAP. The going concern basis of presentation assumes that the Company will continue in operation one year after the date these financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business.</amci:GoingConcernPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzMwMzI_4be7a95c-ef8f-4aca-bda6-684d62c2c62f"
      unitRef="usd">50370000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzMwNjc_b941e408-2a16-403f-97b4-363fadc266b1"
      unitRef="usd">-434863000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzEwOTk1MTE2MzE4ODYz_c5d36cc5-741e-43a2-b0fa-d2164e66e3d6"
      unitRef="usd">-71336000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetIncomeLoss
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzMxMzU_4c8900a3-ad17-45ef-864a-9bf0cff99e89"
      unitRef="usd">-54974000</us-gaap:NetIncomeLoss>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzEyNjQ0MzgzNzYwNTAz_5dba1736-faf0-4a37-b969-d2c1df1594bd">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Segment Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates as one operating segment which is the licensing of its technologies and related services such as research and development and engineering. The Chief Executive Officer who is the chief operating decision maker, reviews financial information on an aggregate basis for allocating resources and evaluating financial performance. Substantially all of the Company's long-lived assets are maintained in the United States. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Segment Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates as one operating segment. Operating segments are defined as components of an enterprise for which separate financial information is evaluated regularly by the chief operating decision maker (&#x201c;CODM&#x201d;), in deciding how to allocate resources and assess performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the Company offers a variety of services and operates in multiple countries, the Company&#x2019;s business operates in one operating segment because most of the Company&#x2019;s service offerings are delivered and supported on a global basis, most of the Company&#x2019;s service offerings are deployed in a nearly identical way, and the Company&#x2019;s CODM evaluates the Company&#x2019;s financial information and resources and assesses the performance of these resources on a consolidated basis. There are no segment managers who are held accountable by the CODM, or anyone else, for operations, operating results, and planning for components below the consolidated level. Accordingly, the Company has determined that it has a single reportable and operating segment. See Note 4, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenues&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for disaggregation of the Company&#x2019;s revenues by customer location.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzEwOTk1MTE2MzE4ODgy_6efbdcf3-c216-4d2a-b246-0e238996b17b"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzEyNjQ0MzgzNzYwNTA0_445633bb-1116-4d7b-aa32-cab16fb0270e">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s reporting currency is the U.S. Dollar. The Company has certain foreign subsidiaries where the functional currency is the local currency. All of the assets and liabilities of these subsidiaries are converted to U.S. dollars at the exchange rate in effect at the balance sheet date, income and expense accounts are translated at average rates for the period, and shareholder&#x2019;s equity accounts are translated at historical rates. The effects of translating financial statements of foreign operations into our reporting currency are recognized as an adjustment in accumulated other comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also has foreign subsidiaries that have a functional currency of the U.S. dollar. Purchases and sales of assets and income and expense items denominated in foreign currencies are remeasured into U.S. dollar amounts on the respective dates of such transactions. Net realized foreign currency gains or losses relating to the differences between these recorded amounts and the U.S. dollar equivalent actually received or paid are included within Other (expense) income, net in the condensed consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s reporting currency is the U.S. Dollar. The Company has certain foreign subsidiaries where the functional currency is the local currency. All of the assets and liabilities of these subsidiaries are converted to U.S. dollars at the exchange rate in effect at the balance sheet date, income and expense accounts are translated at average rates for the period, and shareholder&#x2019;s equity accounts are translated at historical rates. The effects of translating financial statements of foreign operations into our reporting currency are recognized as an adjustment in accumulated other comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also has foreign subsidiaries that have a functional currency of the U.S. dollar. Purchases and sales of assets and income and expense items denominated in foreign currencies are remeasured into U.S. dollar amounts on the respective dates of such transactions. Net realized foreign currency gains or losses relating to the differences between these recorded amounts and the U.S. dollar equivalent actually received or paid are included within Other income, net in the consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzYyMTU_4be7a95c-ef8f-4aca-bda6-684d62c2c62f"
      unitRef="usd">50370000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzYyMjI_e9d1675a-a926-4452-b5fa-4588c28c201e"
      unitRef="usd">128318000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzEyNjQ0MzgzNzYwNTA1_37c5a75a-91cb-4037-8a86-e00c0cefa119">Restricted Cash and Other Cash Flows from Operating ActivitiesThe Company is required to maintain a cash deposit with a bank which consists of collateral on certain travel and expense programs maintained by the bank. &lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents, and Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. As of December&#160;31, 2021 and 2020, the Company had $128,318 and $60,495 of cash and cash equivalents, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is required to maintain a cash deposit with a bank which consists of collateral on a travel and expense program maintained by the bank. The following represents a reconciliation of cash and cash equivalents in &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the consolidated balance sheets to total cash, cash equivalents and restricted cash in the consolidated statement of cash flows as of December 31, 2021 and December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash (presented within Other current assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzEyNjQ0MzgzNzYwNTA2_14be1a80-0763-4159-a69a-18646913aa12">The following represents a reconciliation of cash and cash equivalents in the condensed consolidated balance sheets to total cash, cash equivalents and restricted cash in the condensed consolidated statements of cash flows as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands).&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash (presented within Other current assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;The following represents a reconciliation of cash and cash equivalents in &lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the consolidated balance sheets to total cash, cash equivalents and restricted cash in the consolidated statement of cash flows as of December 31, 2021 and December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash (presented within Other current assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTpkOTkyMWE0ZDU1MGY0NjJkODliYWNhODliNmQ0OTkwMi90YWJsZXJhbmdlOmQ5OTIxYTRkNTUwZjQ2MmQ4OWJhY2E4OWI2ZDQ5OTAyXzItMS0xLTEtOTA3MTc_54ad6417-3e90-44b3-bad9-fa826203f99b"
      unitRef="usd">50370000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTpkOTkyMWE0ZDU1MGY0NjJkODliYWNhODliNmQ0OTkwMi90YWJsZXJhbmdlOmQ5OTIxYTRkNTUwZjQ2MmQ4OWJhY2E4OWI2ZDQ5OTAyXzItMy0xLTEtOTA3MTc_f62aa66b-42fc-4129-a73f-10db6c3c9005"
      unitRef="usd">128318000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTpkOTkyMWE0ZDU1MGY0NjJkODliYWNhODliNmQ0OTkwMi90YWJsZXJhbmdlOmQ5OTIxYTRkNTUwZjQ2MmQ4OWJhY2E4OWI2ZDQ5OTAyXzMtMS0xLTEtOTA3MTc_101f4207-dee3-4d5f-80c9-b1463bb5eae2"
      unitRef="usd">664000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTpkOTkyMWE0ZDU1MGY0NjJkODliYWNhODliNmQ0OTkwMi90YWJsZXJhbmdlOmQ5OTIxYTRkNTUwZjQ2MmQ4OWJhY2E4OWI2ZDQ5OTAyXzMtMy0xLTEtOTA3MTc_51244441-1acd-466a-9a23-9bfa40691a5a"
      unitRef="usd">414000</us-gaap:RestrictedCash>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTpkOTkyMWE0ZDU1MGY0NjJkODliYWNhODliNmQ0OTkwMi90YWJsZXJhbmdlOmQ5OTIxYTRkNTUwZjQ2MmQ4OWJhY2E4OWI2ZDQ5OTAyXzQtMS0xLTEtMTAzOTkw_d5012947-df1e-4920-b403-93fd312d2f76"
      unitRef="usd">51034000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTpkOTkyMWE0ZDU1MGY0NjJkODliYWNhODliNmQ0OTkwMi90YWJsZXJhbmdlOmQ5OTIxYTRkNTUwZjQ2MmQ4OWJhY2E4OWI2ZDQ5OTAyXzQtMy0xLTEtMTAzOTkw_b13f6818-6532-4612-b248-a3e6d41c7384"
      unitRef="usd">128732000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzEyNjQ0MzgzNzYwNTA3_2ae97da4-14ef-4461-b43c-3905da4a9344">Trade and Other Receivables Receivables are reported net of allowances for doubtful accounts. The Company maintains allowances for doubtful accounts for estimated losses resulting from the inability of customers to make required payments. The Company estimates the allowance for doubtful accounts based on a variety of factors including the length of time receivables are past due, the financial health of customers, unusual macroeconomic conditions, and historical experience. Trade and Other Receivables Receivables are reported net of allowances for doubtful accounts. The Company maintains allowances for doubtful accounts for estimated losses resulting from the inability of customers to make required payments. The Company estimates the allowance for doubtful accounts based on a variety of factors including the length of time receivables are past due, the financial health of customers, unusual macroeconomic conditions, and historical experience.</us-gaap:TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzczMDM_40a0eeb9-9238-4194-ae37-de91afbc7d93"
      unitRef="usd">1051000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzczMTA_9958e039-0384-4885-b0d3-707db7252a34"
      unitRef="usd">1235000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzEyNjQ0MzgzNzYwNTA4_79c0d118-cf48-4d73-a848-bc3e061a9c39">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue in accordance with Accounting Standards Codification ("ASC") 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company primarily earns revenue from services related to feasibility studies and basic engineering design of commercial plants, licensing of technologies, joint development and contract &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;research activities to develop novel biocatalysts and related technologies, and sale of CarbonSmart ethanol produced using the Company's proprietary technologies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is measured based on the consideration specified in a contract with a customer. The Company records taxes collected from customers and remitted to governmental authorities on a net basis. The Company&#x2019;s payment terms are between 30-60 days and can vary by customer type and products offered. Management has evaluated the terms of our arrangements and determined that they do not contain significant financing components.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Carbon Capture and Transformation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company provides feasibility studies and basic design and engineering services used for detailed design, procurement, and construction of commercial plants that utilize the Company&#x2019;s technologies, along with the sale of equipment and microbes. The services provided are recognized as a performance obligation satisfied over time. Revenue is recognized using the output method based on milestone completion, the cost-to-cost input method for certain engineering services, or the percentage of completion method as performance obligations are satisfied. Management has determined that the milestone completion and the associated contractual payment amounts are an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company licenses intellectual property to generate recurring revenue when its customers deploy carbon capture and transformation plants. When licenses are considered to be distinct performance obligations, the recognition of revenue is dependent on the terms of the contract, which may include fixed consideration or royalties based on sales or usage, in which case, the revenue is recognized when the subsequent sale or usage occurs or when the performance obligation to which some or all of the sales or usage-based royalty is allocated has been satisfied, whichever is later.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Research and Development Services&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company performs research and development (&#x201c;R&amp;amp;D&#x201d;) services related to novel technologies and development of biocatalysts for commercial applications, mainly to produce fuels and chemicals. The Company engages in two main types of R&amp;amp;D services &#x2013; joint development agreements, and other contract research, including projects with the U.S. Department of Energy. Such services are recognized as a performance obligation satisfied over time. Revenue is recognized based on milestone completion, when payments are contingent upon the achievement of such milestones, or based on percentage-completion method when enforceable rights to payment exist. When no milestones or phases are clearly defined, management has determined that the cost incurred, input method, is an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and estimates its variable consideration under the expected value method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is not recognized in advance of customer acceptance of a milestone when such acceptance is contractually required. Payments for R&amp;amp;D services with no contractual payments are not due from customers until a technical report is submitted; therefore, a contract asset is recognized at milestone completion but prior to the submission of a technical report. The contract asset represents the Company&#x2019;s right to consideration for the services performed at milestone completion. Occasionally, customers provide payments in advance of the Company providing services which creates a contract liability for the Company. The contract liability represents the Company's obligation to provide services to a customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Collaboration Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has certain partnership agreements that are within the scope of ASC 808, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Collaborative Arrangements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which provides guidance on the presentation and disclosure of collaborative arrangements. Generally, the classification of the transactions under the collaborative arrangements is determined based on the nature of the contractual terms of the arrangement, along with the nature of the operations of the participants. The Company&#x2019;s collaborative agreements generally include a provision of R&amp;amp;D services related to novel technologies and biocatalysts. Amounts received for these services are classified as Revenue from collaborative arrangements in the condensed consolidated statements of operations and comprehensive loss. The Company's R&amp;amp;D services are a major part of the Company's ongoing operations and therefore ASC 606 is applied to recognize revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;CarbonSmart&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's CarbonSmart business, initially CarbonSmart ethanol, is produced by LanzaTech licensed plants using the Company's proprietary technologies. Customers can buy CarbonSmart ethanol directly from LanzaTech, which the Company sources from these partnering plants. Revenue is recognized at a point in time when control transfers to the customer, which varies depending on the shipping terms. The Company acts as the principal in such transactions and accordingly, recognizes revenue and cost of revenues on a gross basis.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9e0585e1e90d4bfcaf7ee5c271d12b05_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzE0Njkx_5ecba68c-a103-4835-b271-c8adaf82ab62"
      unitRef="number">0.61</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i1c9ab1e0b29947a7a657a947fe20cbe7_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzE0Njk4_4ad09a72-545e-4cd0-8719-0c2c57b127d3"
      unitRef="number">0.65</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9d1fe9a7bf25419cb084a70d94fcaf1d_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzE0NzQ3_d48841c2-13c7-4c98-99e0-a9526ffa6288"
      unitRef="number">0.35</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie2e8db82a9c84e61945251a17b875f00_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzE0NzU0_0c9825e1-4f47-4b8f-988e-3bbbf198e42e"
      unitRef="number">0.35</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90ZXh0cmVnaW9uOjBiZmJlMDI3MWRjZjQzZDBiNzgxMjc3NTM5Mjc0NzdiXzE1OTQyOTE4NjQzODM4_7ec3719b-c8d3-491b-9082-d205fe9fe218">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customers representing 10% or greater of revenue were as follows for the nine months ended September&#160;30, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer E&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customers representing 10% or greater of revenue were as follows for the years ended December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia3449ace90ec469a8b933bce0d62a372_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTo5ZGIwYTQxZmI4MDI0YTY2OWUwOTc0ZGMyMDE5Mzk5Yy90YWJsZXJhbmdlOjlkYjBhNDFmYjgwMjRhNjY5ZTA5NzRkYzIwMTkzOTljXzItMS0xLTEtOTA3MTc_a2df08be-d2cb-44a3-a4a1-d28b2c7fe87d"
      unitRef="number">0.24</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i315f432e066e42e392096344bb252b66_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTo5ZGIwYTQxZmI4MDI0YTY2OWUwOTc0ZGMyMDE5Mzk5Yy90YWJsZXJhbmdlOjlkYjBhNDFmYjgwMjRhNjY5ZTA5NzRkYzIwMTkzOTljXzItMy0xLTEtOTA3MTc_083478f8-39cf-4b8a-8656-bfdb6a1fa074"
      unitRef="number">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i67acca9fc71147e489123a8f993fe8b2_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTo5ZGIwYTQxZmI4MDI0YTY2OWUwOTc0ZGMyMDE5Mzk5Yy90YWJsZXJhbmdlOjlkYjBhNDFmYjgwMjRhNjY5ZTA5NzRkYzIwMTkzOTljXzMtMS0xLTEtOTA3MTc_e319c743-150b-48fc-a05b-93fbfe1b65fa"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i12519dc7dd4148c380c0b8e7e6b17007_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTo5ZGIwYTQxZmI4MDI0YTY2OWUwOTc0ZGMyMDE5Mzk5Yy90YWJsZXJhbmdlOjlkYjBhNDFmYjgwMjRhNjY5ZTA5NzRkYzIwMTkzOTljXzMtMy0xLTEtOTA3MTc_6e865643-83b3-430f-bdd4-f98766d7a6b5"
      unitRef="number">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i47d9518ef3cd492aa38b19f292383c71_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTo5ZGIwYTQxZmI4MDI0YTY2OWUwOTc0ZGMyMDE5Mzk5Yy90YWJsZXJhbmdlOjlkYjBhNDFmYjgwMjRhNjY5ZTA5NzRkYzIwMTkzOTljXzQtMS0xLTEtOTA3MTc_09332514-2ec9-4697-ab45-4be5ae4cc5fd"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i65b51113d1c84fe482ce3387414ff062_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTo5ZGIwYTQxZmI4MDI0YTY2OWUwOTc0ZGMyMDE5Mzk5Yy90YWJsZXJhbmdlOjlkYjBhNDFmYjgwMjRhNjY5ZTA5NzRkYzIwMTkzOTljXzQtMy0xLTEtOTA3MTc_7c9555b5-58fd-4c11-b279-bcfc200c3cb5"
      unitRef="number">0.03</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i5d26440e551243a091345a8db5c10bd8_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTo5ZGIwYTQxZmI4MDI0YTY2OWUwOTc0ZGMyMDE5Mzk5Yy90YWJsZXJhbmdlOjlkYjBhNDFmYjgwMjRhNjY5ZTA5NzRkYzIwMTkzOTljXzUtMS0xLTEtOTA3MTc_69a97167-e733-40d9-ac92-40b1890f3899"
      unitRef="number">0.08</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i89150b1561bc43ecbec2f1adb044c3f0_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTo5ZGIwYTQxZmI4MDI0YTY2OWUwOTc0ZGMyMDE5Mzk5Yy90YWJsZXJhbmdlOjlkYjBhNDFmYjgwMjRhNjY5ZTA5NzRkYzIwMTkzOTljXzUtMy0xLTEtOTA3MTc_b0806a22-86f6-4c28-905e-b667e63bc963"
      unitRef="number">0.34</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia54c798db359416fb9d69e6545adde53_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTo5ZGIwYTQxZmI4MDI0YTY2OWUwOTc0ZGMyMDE5Mzk5Yy90YWJsZXJhbmdlOjlkYjBhNDFmYjgwMjRhNjY5ZTA5NzRkYzIwMTkzOTljXzYtMS0xLTEtOTA3MTc_47d8b801-d0bd-4415-9395-ad7d7d806597"
      unitRef="number">0.08</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9f5fbd11e5eb48dba2314084aadf7c9f_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF82OTUvZnJhZzowYmZiZTAyNzFkY2Y0M2QwYjc4MTI3NzUzOTI3NDc3Yi90YWJsZTo5ZGIwYTQxZmI4MDI0YTY2OWUwOTc0ZGMyMDE5Mzk5Yy90YWJsZXJhbmdlOjlkYjBhNDFmYjgwMjRhNjY5ZTA5NzRkYzIwMTkzOTljXzYtMy0xLTEtOTA3MTc_862147dc-40ed-4236-8fae-df4b6c339224"
      unitRef="number">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90ZXh0cmVnaW9uOmFmZjIwZTcyOGQyZjQ1YmFiZTdkMjU1NWJhOWVkNGIxXzEzNzQzODk1MzUzNTY1_7ec9160f-e2c6-4a81-9f9a-fdcf51049c8f">Net Loss Per Share&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net loss per share is computed by dividing net loss by the weighted-average number of shares of common stock of the Company outstanding during the period. Diluted net loss per share is computed by giving effect to all potential shares of common stock of the Company, including outstanding stock options, warrants, and contingently redeemable preferred stock, to the extent dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the calculation of basic and diluted net loss per share for the Company&#x2019;s common stock (in thousands, except shares and per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss for basic and diluted earnings per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,974)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,591)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unpaid cumulative dividends on preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,925)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,068)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss allocated to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83,899)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,659)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares used in calculating net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,108,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,909,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:21pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per common share, basic and diluted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30.19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;__________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;In periods in which the Company reports a net loss, all share-based compensation awards are excluded from the calculation of diluted weighted average shares outstanding because of their anti-dilutive effect on earnings (loss) per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022 and 2021, potential shares of common stock not included in the computation of loss per share because their effect would be antidilutive include the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable convertible preferred stock (if converted)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,521,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,521,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,790,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,540,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSAs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;579,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;579,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,117,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,867,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the organizational documents of the Company, the preferred shares are convertible by the holder at any time at their option. In addition, the preferred shares will automatically convert into common shares upon either (i) the determination of the holders of certain requisite preferred shares of the Company (which determination will be submitted for approval by such stockholders in connection with the Business Combination described in Note 1, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Description of the Business&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), or (ii) a firmly underwritten initial public offering of the Company&#x2019;s shares that satisfies certain requirements (but not, for the avoidance of doubt, upon a business combination with a special purpose acquisition company, such as the Business Combination, unless such conversion is otherwise effected pursuant to clause (i) above). Such conversion would be at a 1:1 ratio, adjusted for certain corporate events. Upon conversion of the preferred shares, the cumulative accrued and declared dividends will become payable. The additional 29,521,810 of potential shares of common stock resulting from any such conversion are not included in the computation of diluted net loss per share in the nine months ended September&#160;30, 2022 and 2021, respectively, because doing so would be anti-dilutive. In connection with the SAFE, see Note 6 - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company could issue additional potential shares of common stock upon closing of the Business Combination. Further, under the Simple Agreement for Future Equity ("SAFE") warrant, additional potential shares of common stock could be issued upon closing of the Business Combination and exercise of the warrant. These potential shares of common stock have not been issued as of September 30, 2022. The per share issuance price for the SAFE and SAFE warrant upon closing of the Business Combination is 100% of the liquidity price. If another qualified liquidity event occurs instead, the issuance price is 90% of the liquidity price.&lt;/span&gt;&lt;/div&gt;Net Loss Per ShareBasic net loss per share is computed by dividing net loss by the weighted-average number of shares of common stock of the Company outstanding during the period. Diluted net loss per share is computed by giving effect to all potential shares of common stock of the Company, including outstanding stock options, warrants, and contingently redeemable preferred stock, to the extent dilutive.&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the calculation of basic and diluted net loss per share for the Company&#x2019;s common stock (in thousands, except shares and per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss for basic and diluted earnings per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,689)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unpaid cumulative dividends on preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,758)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss allocated to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83,447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69,004)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares used in calculating net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,959,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,629,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:21pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per common share, basic and diluted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;__________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;In periods in which the Company reports a net loss, all stock-based compensation awards are excluded from the calculation of diluted weighted average shares outstanding because of their anti-dilutive effect on earnings (loss) per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021 and 2020, potential shares of common stock not included in the computation of earnings per share because their effect would be antidilutive include the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable convertible preferred stock (if converted)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,521,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,729,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,848,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,283,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSAs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;579,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,175,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,720,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the organizational documents of the Company, the preferred shares will automatically convert into common shares upon either (i) the determination of the holders of certain requisite preferred shares of the Company (which determination will be submitted for approval by such stockholders in connection with the Merger described below in Note 20) or (ii) a firmly underwritten initial public offering of the Company&#x2019;s shares that satisfies certain requirements (but not, for the avoidance of doubt, upon a business combination with a special purpose acquisition company, such as the Merger, unless such conversion is otherwise effected pursuant to clause (i) above). Such conversion would be at a 1:1 ratio, adjusted for certain corporate events.Upon conversion of the preferred shares, the cumulative accrued and declared dividends will become payable.  The additional 29,521,810 and 25,729,542 of potential shares of common stock resulting from any such conversion are not included in the computation of diluted net loss per share in 2021 and 2020, respectively, because neither an initial public offering nor a stockholder determination of such conversion had occurred at the end of the period. In connection with the SAFE, see Note 10 - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simple Agreement for Future Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company could issue additional potential shares of common stock upon closing of the Merger. Further, under the SAFE warrant, see Note 6 &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and Note 11 &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Warrants Liability&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, additional potential shares of common stock could be issued upon closing of the Merger and exercise of the warrant. These potential shares of common stock have not been issued as of December 31, 2021. The per share issuance price for the SAFE and SAFE warrant upon closing of the Merger is 100% of the liquidity price. If another qualified liquidity event occurs instead, the issuance price is 90% of the liquidity price.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTphMDljODYyZGZkMDU0MzdlOWE2MzExNmJmODc0NjgxZC90YWJsZXJhbmdlOmEwOWM4NjJkZmQwNTQzN2U5YTYzMTE2YmY4NzQ2ODFkXzMtMS0xLTEtOTA3MTc_bd4888b6-d1ff-4400-a81a-b047a2b1499f"
      unitRef="usd">-54974000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTphMDljODYyZGZkMDU0MzdlOWE2MzExNmJmODc0NjgxZC90YWJsZXJhbmdlOmEwOWM4NjJkZmQwNTQzN2U5YTYzMTE2YmY4NzQ2ODFkXzMtMy0xLTEtOTA3MTc_ded3efb6-b883-4f89-9010-587c27522a65"
      unitRef="usd">-30591000</us-gaap:NetIncomeLoss>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTphMDljODYyZGZkMDU0MzdlOWE2MzExNmJmODc0NjgxZC90YWJsZXJhbmdlOmEwOWM4NjJkZmQwNTQzN2U5YTYzMTE2YmY4NzQ2ODFkXzQtMS0xLTEtOTA3MTc_6709117e-10e5-43ed-9310-c17adedc0989"
      unitRef="usd">28925000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTphMDljODYyZGZkMDU0MzdlOWE2MzExNmJmODc0NjgxZC90YWJsZXJhbmdlOmEwOWM4NjJkZmQwNTQzN2U5YTYzMTE2YmY4NzQ2ODFkXzQtMy0xLTEtOTA3MTc_44615719-d6b0-4ab0-9c3e-f0f971b95c15"
      unitRef="usd">27068000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTphMDljODYyZGZkMDU0MzdlOWE2MzExNmJmODc0NjgxZC90YWJsZXJhbmdlOmEwOWM4NjJkZmQwNTQzN2U5YTYzMTE2YmY4NzQ2ODFkXzUtMS0xLTEtMTA1Mjc4_8b9d9aab-e297-4bec-b875-d8bc1c815488"
      unitRef="usd">-83899000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTphMDljODYyZGZkMDU0MzdlOWE2MzExNmJmODc0NjgxZC90YWJsZXJhbmdlOmEwOWM4NjJkZmQwNTQzN2U5YTYzMTE2YmY4NzQ2ODFkXzUtMy0xLTEtMTA1Mjgx_086539ae-59b0-4a8b-a061-b82e85656f6d"
      unitRef="usd">-57659000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTphMDljODYyZGZkMDU0MzdlOWE2MzExNmJmODc0NjgxZC90YWJsZXJhbmdlOmEwOWM4NjJkZmQwNTQzN2U5YTYzMTE2YmY4NzQ2ODFkXzgtMS0xLTEtOTA3MTc_55818624-cc38-4ddf-a20d-2e4bae0eb20a"
      unitRef="shares">2108472000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTphMDljODYyZGZkMDU0MzdlOWE2MzExNmJmODc0NjgxZC90YWJsZXJhbmdlOmEwOWM4NjJkZmQwNTQzN2U5YTYzMTE2YmY4NzQ2ODFkXzgtMS0xLTEtOTA3MTc_5bb9e8ad-92aa-4633-bbc3-d4c948120f9c"
      unitRef="shares">2108472000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTphMDljODYyZGZkMDU0MzdlOWE2MzExNmJmODc0NjgxZC90YWJsZXJhbmdlOmEwOWM4NjJkZmQwNTQzN2U5YTYzMTE2YmY4NzQ2ODFkXzgtMy0xLTEtOTA3MTc_4ad0362e-8dba-476a-b3cc-3f44e46057d4"
      unitRef="shares">1909635000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTphMDljODYyZGZkMDU0MzdlOWE2MzExNmJmODc0NjgxZC90YWJsZXJhbmdlOmEwOWM4NjJkZmQwNTQzN2U5YTYzMTE2YmY4NzQ2ODFkXzgtMy0xLTEtOTA3MTc_77845e31-3cc3-4d2a-978c-3d0808ae8f75"
      unitRef="shares">1909635000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTphMDljODYyZGZkMDU0MzdlOWE2MzExNmJmODc0NjgxZC90YWJsZXJhbmdlOmEwOWM4NjJkZmQwNTQzN2U5YTYzMTE2YmY4NzQ2ODFkXzEwLTEtMS0xLTkwNzE3_17122848-ee6a-4635-b91b-19f1d00dd5ea"
      unitRef="usdPerShare">-39790</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTphMDljODYyZGZkMDU0MzdlOWE2MzExNmJmODc0NjgxZC90YWJsZXJhbmdlOmEwOWM4NjJkZmQwNTQzN2U5YTYzMTE2YmY4NzQ2ODFkXzEwLTEtMS0xLTkwNzE3_fe4ba0aa-28cf-4dac-85df-a920e3ce4f28"
      unitRef="usdPerShare">-39790</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTphMDljODYyZGZkMDU0MzdlOWE2MzExNmJmODc0NjgxZC90YWJsZXJhbmdlOmEwOWM4NjJkZmQwNTQzN2U5YTYzMTE2YmY4NzQ2ODFkXzEwLTMtMS0xLTkwNzE3_1d9de965-fa02-4f4f-bb83-a411b6d20965"
      unitRef="usdPerShare">-30190</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTphMDljODYyZGZkMDU0MzdlOWE2MzExNmJmODc0NjgxZC90YWJsZXJhbmdlOmEwOWM4NjJkZmQwNTQzN2U5YTYzMTE2YmY4NzQ2ODFkXzEwLTMtMS0xLTkwNzE3_4d67c3c9-6b9e-42df-a9cb-e524c2259927"
      unitRef="usdPerShare">-30190</us-gaap:EarningsPerShareBasic>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90ZXh0cmVnaW9uOmFmZjIwZTcyOGQyZjQ1YmFiZTdkMjU1NWJhOWVkNGIxXzEzNzQzODk1MzUzNTY5_4e898582-80d9-40ca-8e9f-66b9898220ec">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022 and 2021, potential shares of common stock not included in the computation of loss per share because their effect would be antidilutive include the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable convertible preferred stock (if converted)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,521,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,521,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,790,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,540,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSAs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;579,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;579,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,117,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,867,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021 and 2020, potential shares of common stock not included in the computation of earnings per share because their effect would be antidilutive include the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable convertible preferred stock (if converted)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,521,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,729,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,848,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,283,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSAs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;579,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,175,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,720,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5424171a95fe47638686ad26cd8b4504_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTo1ZTQxYjA0Mjc1ODE0MTU3YTNjNDMzNDhkNWQzNmE5Zi90YWJsZXJhbmdlOjVlNDFiMDQyNzU4MTQxNTdhM2M0MzM0OGQ1ZDM2YTlmXzItMS0xLTEtOTA3MTc_cde20063-2087-467d-8d80-19a8ed20e5e3"
      unitRef="shares">29521810</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i26fc510abd7a4c3b8c924af0c3ded993_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTo1ZTQxYjA0Mjc1ODE0MTU3YTNjNDMzNDhkNWQzNmE5Zi90YWJsZXJhbmdlOjVlNDFiMDQyNzU4MTQxNTdhM2M0MzM0OGQ1ZDM2YTlmXzItMy0xLTEtOTA3MTc_b66e2085-beb7-429f-b46c-619dc9b0e570"
      unitRef="shares">29521810</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7ae7957cd9f6426986d2a7924166bbe8_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTo1ZTQxYjA0Mjc1ODE0MTU3YTNjNDMzNDhkNWQzNmE5Zi90YWJsZXJhbmdlOjVlNDFiMDQyNzU4MTQxNTdhM2M0MzM0OGQ1ZDM2YTlmXzMtMS0xLTEtOTA3MTc_0280a094-3264-4ae1-b3ec-9672639538ec"
      unitRef="shares">3790978</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5741c6b90ae94985b512b131a7c7a8f1_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTo1ZTQxYjA0Mjc1ODE0MTU3YTNjNDMzNDhkNWQzNmE5Zi90YWJsZXJhbmdlOjVlNDFiMDQyNzU4MTQxNTdhM2M0MzM0OGQ1ZDM2YTlmXzMtMy0xLTEtOTA3MTc_fb7c5020-3d67-48b9-9cf0-19b592a03c4c"
      unitRef="shares">3540570</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0abb7a85949a40588f25eea015f597df_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTo1ZTQxYjA0Mjc1ODE0MTU3YTNjNDMzNDhkNWQzNmE5Zi90YWJsZXJhbmdlOjVlNDFiMDQyNzU4MTQxNTdhM2M0MzM0OGQ1ZDM2YTlmXzQtMS0xLTEtOTA3MTc_05b5a04b-2dc2-43f3-8628-8f5aa55ef222"
      unitRef="shares">579660</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2ce64b99bdea417c846661dbfe732b7e_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTo1ZTQxYjA0Mjc1ODE0MTU3YTNjNDMzNDhkNWQzNmE5Zi90YWJsZXJhbmdlOjVlNDFiMDQyNzU4MTQxNTdhM2M0MzM0OGQ1ZDM2YTlmXzQtMy0xLTEtOTA3MTc_957e2144-2fc1-4b65-b3ca-87b46abfcb7a"
      unitRef="shares">579660</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iafde522813d645e4811e7040d7545b79_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTo1ZTQxYjA0Mjc1ODE0MTU3YTNjNDMzNDhkNWQzNmE5Zi90YWJsZXJhbmdlOjVlNDFiMDQyNzU4MTQxNTdhM2M0MzM0OGQ1ZDM2YTlmXzUtMS0xLTEtOTA3MTc_8e33b9c8-1be2-48be-9c78-c452648894d6"
      unitRef="shares">225223</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia9418ed0ad4f411e9f9d5e0c27663f80_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTo1ZTQxYjA0Mjc1ODE0MTU3YTNjNDMzNDhkNWQzNmE5Zi90YWJsZXJhbmdlOjVlNDFiMDQyNzU4MTQxNTdhM2M0MzM0OGQ1ZDM2YTlmXzUtMy0xLTEtOTA3MTc_edd58592-ff85-4a28-b703-485c9a3b163b"
      unitRef="shares">225223</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTo1ZTQxYjA0Mjc1ODE0MTU3YTNjNDMzNDhkNWQzNmE5Zi90YWJsZXJhbmdlOjVlNDFiMDQyNzU4MTQxNTdhM2M0MzM0OGQ1ZDM2YTlmXzctMS0xLTEtMTA1MzI2_4f9a6d61-c530-4707-9784-505299a75aa0"
      unitRef="shares">34117671</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90YWJsZTo1ZTQxYjA0Mjc1ODE0MTU3YTNjNDMzNDhkNWQzNmE5Zi90YWJsZXJhbmdlOjVlNDFiMDQyNzU4MTQxNTdhM2M0MzM0OGQ1ZDM2YTlmXzctMy0xLTEtMTA1MzI5_a4151249-6bc3-4685-a7dc-7936808b0a1e"
      unitRef="shares">33867263</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:PreferredStockConvertibleConversionRatio
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90ZXh0cmVnaW9uOmFmZjIwZTcyOGQyZjQ1YmFiZTdkMjU1NWJhOWVkNGIxXzEwOTk1MTE2Mjg0MTMx_03bcc109-bbaa-4200-9381-045bac4ef156"
      unitRef="number">1</us-gaap:PreferredStockConvertibleConversionRatio>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5424171a95fe47638686ad26cd8b4504_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90ZXh0cmVnaW9uOmFmZjIwZTcyOGQyZjQ1YmFiZTdkMjU1NWJhOWVkNGIxXzIwMjM_cde20063-2087-467d-8d80-19a8ed20e5e3"
      unitRef="shares">29521810</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <amci:LiquidityPriceOfSAFEAndSAFEWarrants
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90ZXh0cmVnaW9uOmFmZjIwZTcyOGQyZjQ1YmFiZTdkMjU1NWJhOWVkNGIxXzEyNjQ0MzgzNzI1Nzc5_8c5b3f4b-6e1b-4387-8c2a-33faae080a5c"
      unitRef="number">1</amci:LiquidityPriceOfSAFEAndSAFEWarrants>
    <amci:LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDEvZnJhZzphZmYyMGU3MjhkMmY0NWJhYmU3ZDI1NTViYTllZDRiMS90ZXh0cmVnaW9uOmFmZjIwZTcyOGQyZjQ1YmFiZTdkMjU1NWJhOWVkNGIxXzEyNjQ0MzgzNzI1Nzg1_788a3e95-13a2-4767-883f-0997754aff29"
      unitRef="number">0.90</amci:LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90ZXh0cmVnaW9uOjJlOWYyNWYwNmY2ZDQzOWVhY2NhMGQxYmMyMjVjMDFiXzEzNzQzODk1MzUxOTU3_c0315e9c-96a9-4663-b372-4fbcc4c7b559">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Note 4 &#x2014; Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregated Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents disaggregated revenue in the following categories (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contract Types:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Joint development agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other contract research&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CarbonSmart&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Engineering and other services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carbon capture and transformation revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:21pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from collaborative partners of $1,733 and $2,662 for the nine months ended September&#160;30, 2022 and 2021, is included in the table above within joint development agreements. Revenue from related parties is included in licensing for $1,620 and $1,518 with the remaining revenue of $496 and $830 in Engineering and other services, for the nine months ended September&#160;30, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents disaggregation of the Company&#x2019;s revenues by customer location for the nine months ended September&#160;30, 2022 and 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.214%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe, Middle East, Africa (EMEA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Australia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract balances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides changes in contract assets and liabilities (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Current Contract Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Current Contract Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-current Contract Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2022 as Restated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions to unbilled accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases due to cash received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unbilled accounts receivable recognized in trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,085)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease on revaluation on currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(804)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification from non-current to current contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification to revenue as a result of performance obligations satisfied&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The increase in contract assets was mostly due to unbilled accounts receivables from contracts with customers where the Company performed engineering and other services, while the decrease in contract liabilities was primarily due to the recognition of revenue during the period related to advance payments previously received by the Company for engineering and other services contracts with customers. As of September&#160;30, 2022 and December&#160;31, 2021 the Company had $11,588 and $2,878, respectively, of billed accounts receivable, net of allowance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The contract liability balance is comprised of unconditional payments received from the Company&#x2019;s customers prior to the satisfaction of the related performance obligations. Such amounts are anticipated to be recorded as revenues when services are performed in subsequent periods. The Company expects to recognize the amounts classified as current contract liabilities, in revenue within one year or less and those classified as non-current within two to three years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Remaining performance obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transaction price allocated to the remaining performance obligation represents contracted revenue that has not yet been recognized, which includes unearned revenue that will be recognized as revenue in future periods. Transaction price allocated to remaining performance obligations is influenced by several factors, including the length of the contract term compared to the research term and the existence of customer specific acceptance rights. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Remaining performance obligations consisted of the following (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Revenues&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregated Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents disaggregated revenue in the following categories (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 5.5pt;text-align:center;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 5.5pt;text-align:center;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contract Types:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Joint development agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other contract research&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Engineering and other services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carbon capture and transformation revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:33pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from collaborative partners is included in the table above within joint development agreements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents disaggregation of the Company&#x2019;s revenues by customer location for the years ended December&#160;31, 2021 and 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Australia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract balances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides changes in contract assets and liabilities during the year ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Current Contract Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Current Contract Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-current Contract Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020 as Restated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions to unbilled accounts receivable as Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases due to cash received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unbilled accounts receivable recognized in trade receivables as Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,002)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification from long-term to short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,080)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification to revenue as a result of performance obligations satisfied&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The increase in contract assets was mostly due to unbilled accounts receivables from contracts with customers where the Company performed engineering and other services, while the increase in contract liabilities was primarily due to advance payments received under engineering and other services. As of December&#160;31, 2021 and 2020 the Company had $2,878 and $5,521, respectively, of billed accounts receivable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The contract liability balance is comprised of unconditional payments received from the Company&#x2019;s customers prior to the satisfaction of the related performance obligations. Such amounts are anticipated to be recorded as revenues when services are performed in subsequent periods. The Company expects to recognize the amounts classified as current contract liabilities, in revenue within one year or less and those classified as non-current within two and three years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Remaining performance obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transaction price allocated to the remaining performance obligation represents contracted revenue that has not yet been recognized, which includes unearned revenue that will be recognized as revenue in future periods. Transaction price allocated to remaining performance obligations is influenced by several factors, including the length of the contract term compared to the research term and the existence of customer specific acceptance rights. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Remaining performance obligations consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90ZXh0cmVnaW9uOjJlOWYyNWYwNmY2ZDQzOWVhY2NhMGQxYmMyMjVjMDFiXzEzNzQzODk1MzUxOTU4_63c9a93f-2474-4ac5-8a25-99f82b2c70f8">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents disaggregated revenue in the following categories (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contract Types:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Joint development agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other contract research&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CarbonSmart&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Engineering and other services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carbon capture and transformation revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:21pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents disaggregation of the Company&#x2019;s revenues by customer location for the nine months ended September&#160;30, 2022 and 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.214%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe, Middle East, Africa (EMEA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Australia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents disaggregated revenue in the following categories (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 5.5pt;text-align:center;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 5.5pt;text-align:center;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contract Types:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Joint development agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other contract research&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Engineering and other services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carbon capture and transformation revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:33pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents disaggregation of the Company&#x2019;s revenues by customer location for the years ended December&#160;31, 2021 and 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Australia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="i762c119593394e9dab80370e5fe11b8f_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzMtMS0xLTEtOTA3MTc_6f0af3b6-591a-4234-ae43-ab874fb4d1ec"
      unitRef="usd">4018000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9c521e9c446743728abb9bb381113c58_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzMtMy0xLTEtOTA3MTc_38c6a9ea-873d-421d-86a6-709f3bdde10c"
      unitRef="usd">10660000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7cfe038e19c5406ab72b862c3e2c4a7c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzQtMS0xLTEtOTA3MTc_d64e73b2-deeb-4d3b-b423-8024200df38a"
      unitRef="usd">4100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib55995d927ac49f2b032b95862ccebc3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzQtMy0xLTEtOTA3MTc_9af36ac2-a0f3-466d-ae8c-6ff322f15e4a"
      unitRef="usd">1393000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifffd25e8f7474755a9cbbfa56a92b938_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzUtMS0xLTEtOTA3MTc_99d8a78e-9d06-45b9-9b36-229f178add68"
      unitRef="usd">8118000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if1cd36f9560344a4a3455d63ec431e88_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzUtMy0xLTEtOTA3MTc_7e136c2e-a5c1-4b83-ba31-2c756e4e8d66"
      unitRef="usd">12053000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i44a9fd092f5b4aaaa519e060a4d1a0bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzctMS0xLTEtOTA3MTc_f6a750b7-77a9-49c8-9173-9d14568ed5a5"
      unitRef="usd">1620000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic2ce93d60685463eacfcc8cdabd7567c_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzctMy0xLTEtOTA3MTc_192df2dc-a3ce-48af-bbcb-3aaa1e53c982"
      unitRef="usd">1518000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9a377b78b6e24777830917170e5b1313_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzgtMS0xLTEtOTA3MTc_ff57cf55-b13f-45a0-a305-e790e0b6714d"
      unitRef="usd">3413000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8409be642f8c496ca120218eb6fbf890_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzgtMy0xLTEtOTA3MTc_b9e348a8-bf3e-4e62-8726-8aaba1bc4240"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icdff94687942421eaaf5757d75c7f1c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzktMS0xLTEtOTA3MTc_45932519-653c-40b2-b319-7070ada8e6c4"
      unitRef="usd">12630000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2013e6baeeb243468ee04296b2f2e7b8_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzktMy0xLTEtOTA3MTc_85a60493-9493-4a91-8b81-70c531a8d477"
      unitRef="usd">4756000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia1a1013d2add4d6090c80d57a0f917aa_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzEwLTEtMS0xLTkwNzE3_f8edd3e1-5825-4325-9b4b-d6d11084fd25"
      unitRef="usd">17663000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i266d893e21e44dd69a6f838fef0c5262_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzEwLTMtMS0xLTkwNzE3_5fd1c11b-495e-481b-89cc-8f04fc8e47cd"
      unitRef="usd">6274000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzEyLTEtMS0xLTkwNzE3_93dc3635-b6c3-4a1e-a1d0-77a67110acb9"
      unitRef="usd">25781000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTo3N2ZhNzJkYzk4NjE0NzI3OGUxOGEyMzIxN2U0NDdmNi90YWJsZXJhbmdlOjc3ZmE3MmRjOTg2MTQ3Mjc4ZTE4YTIzMjE3ZTQ0N2Y2XzEyLTMtMS0xLTkwNzE3_fb980201-15b8-44bf-8414-7a38c5cc2d15"
      unitRef="usd">18327000</us-gaap:Revenues>
    <us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90ZXh0cmVnaW9uOjJlOWYyNWYwNmY2ZDQzOWVhY2NhMGQxYmMyMjVjMDFiXzE4MQ_9a8b17fe-3a8a-4d4a-b77f-ebdd448db6d6"
      unitRef="usd">1733000</us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer>
    <us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90ZXh0cmVnaW9uOjJlOWYyNWYwNmY2ZDQzOWVhY2NhMGQxYmMyMjVjMDFiXzE4OA_663c52eb-b4fc-4af6-ad31-709bee93131d"
      unitRef="usd">2662000</us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i44a9fd092f5b4aaaa519e060a4d1a0bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90ZXh0cmVnaW9uOjJlOWYyNWYwNmY2ZDQzOWVhY2NhMGQxYmMyMjVjMDFiXzEwOTk1MTE2MjgyNTQ1_fdd73c5e-f987-4226-9f1b-fd9ad6498eee"
      unitRef="usd">1620000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="ic2ce93d60685463eacfcc8cdabd7567c_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90ZXh0cmVnaW9uOjJlOWYyNWYwNmY2ZDQzOWVhY2NhMGQxYmMyMjVjMDFiXzEwOTk1MTE2MjgyNTU3_6e70d105-9d65-4720-a28e-73868419273a"
      unitRef="usd">1518000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="icdff94687942421eaaf5757d75c7f1c2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90ZXh0cmVnaW9uOjJlOWYyNWYwNmY2ZDQzOWVhY2NhMGQxYmMyMjVjMDFiXzEyNjQ0MzgzNzI0MTcw_2a81f027-008b-43a8-8ce4-4cf7ec8a967f"
      unitRef="usd">496000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i2013e6baeeb243468ee04296b2f2e7b8_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90ZXh0cmVnaW9uOjJlOWYyNWYwNmY2ZDQzOWVhY2NhMGQxYmMyMjVjMDFiXzEyNjQ0MzgzNzI0MTc2_3fae5227-c062-495a-8e8e-2fce4caac370"
      unitRef="usd">830000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:Revenues
      contextRef="ia5573ff2e43a4c498f3126b9f6dfd70f_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTowZDdjY2ZmMzQ1ODE0NTg3YjM2ZDZiMWYyZjFlODFlOC90YWJsZXJhbmdlOjBkN2NjZmYzNDU4MTQ1ODdiMzZkNmIxZjJmMWU4MWU4XzItMS0xLTEtOTA3MTc_75f2c455-e9c8-406b-bd59-fcc741e6a224"
      unitRef="usd">12361000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8145859fe60a449a937d2ca309df194f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTowZDdjY2ZmMzQ1ODE0NTg3YjM2ZDZiMWYyZjFlODFlOC90YWJsZXJhbmdlOjBkN2NjZmYzNDU4MTQ1ODdiMzZkNmIxZjJmMWU4MWU4XzItMy0xLTEtOTA3MTc_35ce2b3e-de2e-4b68-9eaa-78c19f0a2084"
      unitRef="usd">12725000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7b913fb20765432a923bd689fe670302_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTowZDdjY2ZmMzQ1ODE0NTg3YjM2ZDZiMWYyZjFlODFlOC90YWJsZXJhbmdlOjBkN2NjZmYzNDU4MTQ1ODdiMzZkNmIxZjJmMWU4MWU4XzMtMS0xLTEtOTA3MTc_19b9bc8b-7619-4d69-af36-dbb9f197d784"
      unitRef="usd">7894000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibdb81a8598ac482d9b8beedc98026777_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTowZDdjY2ZmMzQ1ODE0NTg3YjM2ZDZiMWYyZjFlODFlOC90YWJsZXJhbmdlOjBkN2NjZmYzNDU4MTQ1ODdiMzZkNmIxZjJmMWU4MWU4XzMtMy0xLTEtOTA3MTc_e2589a09-6f72-421b-9d9c-2134214f7248"
      unitRef="usd">5210000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i782abe270873419eb029c509a796cfe0_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTowZDdjY2ZmMzQ1ODE0NTg3YjM2ZDZiMWYyZjFlODFlOC90YWJsZXJhbmdlOjBkN2NjZmYzNDU4MTQ1ODdiMzZkNmIxZjJmMWU4MWU4XzQtMS0xLTEtOTA3MTc_5f77cbe5-5488-4e05-a47c-6329acfde7d6"
      unitRef="usd">4151000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if05bbbf98c144ad8aa72922f1d64e7e2_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTowZDdjY2ZmMzQ1ODE0NTg3YjM2ZDZiMWYyZjFlODFlOC90YWJsZXJhbmdlOjBkN2NjZmYzNDU4MTQ1ODdiMzZkNmIxZjJmMWU4MWU4XzQtMy0xLTEtOTA3MTc_2b52d7fa-cd38-4c30-a51e-b08164a718b9"
      unitRef="usd">242000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i48ba258d15f74288bf5398c05269bbf6_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTowZDdjY2ZmMzQ1ODE0NTg3YjM2ZDZiMWYyZjFlODFlOC90YWJsZXJhbmdlOjBkN2NjZmYzNDU4MTQ1ODdiMzZkNmIxZjJmMWU4MWU4XzUtMS0xLTEtOTA3MTc_16bf8807-b5f0-4738-b34b-38328fbccb5a"
      unitRef="usd">1375000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0e768c2b952146e1955ab2593a5abd0b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTowZDdjY2ZmMzQ1ODE0NTg3YjM2ZDZiMWYyZjFlODFlOC90YWJsZXJhbmdlOjBkN2NjZmYzNDU4MTQ1ODdiMzZkNmIxZjJmMWU4MWU4XzUtMy0xLTEtOTA3MTc_e6cd24dd-52f0-4037-9d3d-6e7d137ee814"
      unitRef="usd">150000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTowZDdjY2ZmMzQ1ODE0NTg3YjM2ZDZiMWYyZjFlODFlOC90YWJsZXJhbmdlOjBkN2NjZmYzNDU4MTQ1ODdiMzZkNmIxZjJmMWU4MWU4XzYtMS0xLTEtMTAyODQ4_647a64ae-aa15-4e3c-958f-679926724718"
      unitRef="usd">25781000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTowZDdjY2ZmMzQ1ODE0NTg3YjM2ZDZiMWYyZjFlODFlOC90YWJsZXJhbmdlOjBkN2NjZmYzNDU4MTQ1ODdiMzZkNmIxZjJmMWU4MWU4XzYtMy0xLTEtMTAyODQ4_e0b35b07-93af-4f17-ad0c-dbdb41226825"
      unitRef="usd">18327000</us-gaap:Revenues>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90ZXh0cmVnaW9uOjJlOWYyNWYwNmY2ZDQzOWVhY2NhMGQxYmMyMjVjMDFiXzEzNzQzODk1MzUxOTYw_caaa6e1a-25be-44f0-9cf3-7f8c07bbcf93">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides changes in contract assets and liabilities (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Current Contract Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Current Contract Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-current Contract Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2022 as Restated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions to unbilled accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases due to cash received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unbilled accounts receivable recognized in trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,085)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease on revaluation on currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(804)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification from non-current to current contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification to revenue as a result of performance obligations satisfied&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides changes in contract assets and liabilities during the year ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Current Contract Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Current Contract Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-current Contract Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020 as Restated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions to unbilled accounts receivable as Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases due to cash received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unbilled accounts receivable recognized in trade receivables as Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,002)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification from long-term to short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,080)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification to revenue as a result of performance obligations satisfied&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTozZDMwYjFhM2FiYWU0ZTQ2YTgxNjdmNzg2MjE0MGYyZC90YWJsZXJhbmdlOjNkMzBiMWEzYWJhZTRlNDZhODE2N2Y3ODYyMTQwZjJkXzEtMS0xLTEtOTA3MTc_cfd43cc6-7f45-48dd-879f-46aed905f893"
      unitRef="usd">11700000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTozZDMwYjFhM2FiYWU0ZTQ2YTgxNjdmNzg2MjE0MGYyZC90YWJsZXJhbmdlOjNkMzBiMWEzYWJhZTRlNDZhODE2N2Y3ODYyMTQwZjJkXzEtMy0xLTEtOTA3MTc_f7bc87b0-d075-44fc-80f6-d3c2fa2d4fe7"
      unitRef="usd">3476000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTozZDMwYjFhM2FiYWU0ZTQ2YTgxNjdmNzg2MjE0MGYyZC90YWJsZXJhbmdlOjNkMzBiMWEzYWJhZTRlNDZhODE2N2Y3ODYyMTQwZjJkXzEtNS0xLTEtOTA3MTc_33535710-976d-4be4-af07-a44b3d4d523e"
      unitRef="usd">13901000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <amci:ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTozZDMwYjFhM2FiYWU0ZTQ2YTgxNjdmNzg2MjE0MGYyZC90YWJsZXJhbmdlOjNkMzBiMWEzYWJhZTRlNDZhODE2N2Y3ODYyMTQwZjJkXzItMS0xLTEtOTA3MTc_e3f9b858-42c7-46cf-b15d-ce07e2377593"
      unitRef="usd">19355000</amci:ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable>
    <amci:ContractWithCustomerLiabilityCurrentAmountsCollected
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTozZDMwYjFhM2FiYWU0ZTQ2YTgxNjdmNzg2MjE0MGYyZC90YWJsZXJhbmdlOjNkMzBiMWEzYWJhZTRlNDZhODE2N2Y3ODYyMTQwZjJkXzMtMy0xLTEtOTA3MTc_2bfc5379-8387-408f-89d4-842489e125cd"
      unitRef="usd">775000</amci:ContractWithCustomerLiabilityCurrentAmountsCollected>
    <amci:ContractWithCustomerLiabilityNoncurrentAmountsCollected
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTozZDMwYjFhM2FiYWU0ZTQ2YTgxNjdmNzg2MjE0MGYyZC90YWJsZXJhbmdlOjNkMzBiMWEzYWJhZTRlNDZhODE2N2Y3ODYyMTQwZjJkXzMtNS0xLTEtOTA3MTc_6b9f20dc-47d5-4588-9746-93741c4d0f4b"
      unitRef="usd">37000</amci:ContractWithCustomerLiabilityNoncurrentAmountsCollected>
    <amci:ContractWithCustomerAssetCurrentReclassifiedToReceivable
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTozZDMwYjFhM2FiYWU0ZTQ2YTgxNjdmNzg2MjE0MGYyZC90YWJsZXJhbmdlOjNkMzBiMWEzYWJhZTRlNDZhODE2N2Y3ODYyMTQwZjJkXzQtMS0xLTEtOTA3MTc_c7834261-3504-48fc-bbab-a71855b2b4bd"
      unitRef="usd">16085000</amci:ContractWithCustomerAssetCurrentReclassifiedToReceivable>
    <amci:ContractWithCustomerAssetCurrentForeignCurrencyTranslationAdjustment
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTozZDMwYjFhM2FiYWU0ZTQ2YTgxNjdmNzg2MjE0MGYyZC90YWJsZXJhbmdlOjNkMzBiMWEzYWJhZTRlNDZhODE2N2Y3ODYyMTQwZjJkXzUtMS0xLTEtOTA3MTc_96f95811-4327-4363-a1d1-8e29d67cd1cb"
      unitRef="usd">-122000</amci:ContractWithCustomerAssetCurrentForeignCurrencyTranslationAdjustment>
    <amci:ContractWithCustomerLiabilityNoncurrentForeignCurrencyTranslationAdjustment
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTozZDMwYjFhM2FiYWU0ZTQ2YTgxNjdmNzg2MjE0MGYyZC90YWJsZXJhbmdlOjNkMzBiMWEzYWJhZTRlNDZhODE2N2Y3ODYyMTQwZjJkXzUtNS0xLTEtOTA3MTc_adbdd106-a29a-4201-8f13-0b9dbe64bd5a"
      unitRef="usd">-804000</amci:ContractWithCustomerLiabilityNoncurrentForeignCurrencyTranslationAdjustment>
    <amci:ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTozZDMwYjFhM2FiYWU0ZTQ2YTgxNjdmNzg2MjE0MGYyZC90YWJsZXJhbmdlOjNkMzBiMWEzYWJhZTRlNDZhODE2N2Y3ODYyMTQwZjJkXzYtMy0xLTEtOTA3MTc_77ad9fc0-5655-4369-803c-65f1d978cd83"
      unitRef="usd">2015000</amci:ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent>
    <amci:ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTozZDMwYjFhM2FiYWU0ZTQ2YTgxNjdmNzg2MjE0MGYyZC90YWJsZXJhbmdlOjNkMzBiMWEzYWJhZTRlNDZhODE2N2Y3ODYyMTQwZjJkXzYtNS0xLTEtOTA3MTc_d33b3c1f-6cfd-4d83-bd54-cc3e74e136d7"
      unitRef="usd">2015000</amci:ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent>
    <amci:ContractWithCustomerLiabilityCurrentRevenueRecognized
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTozZDMwYjFhM2FiYWU0ZTQ2YTgxNjdmNzg2MjE0MGYyZC90YWJsZXJhbmdlOjNkMzBiMWEzYWJhZTRlNDZhODE2N2Y3ODYyMTQwZjJkXzctMy0xLTEtOTA3MTc_091fd8f7-2613-4172-90c5-2ef95708a4bd"
      unitRef="usd">3298000</amci:ContractWithCustomerLiabilityCurrentRevenueRecognized>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTozZDMwYjFhM2FiYWU0ZTQ2YTgxNjdmNzg2MjE0MGYyZC90YWJsZXJhbmdlOjNkMzBiMWEzYWJhZTRlNDZhODE2N2Y3ODYyMTQwZjJkXzgtMS0xLTEtMTAyODYw_f25f9782-8315-4a8f-9d72-1ae154002ca2"
      unitRef="usd">14848000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTozZDMwYjFhM2FiYWU0ZTQ2YTgxNjdmNzg2MjE0MGYyZC90YWJsZXJhbmdlOjNkMzBiMWEzYWJhZTRlNDZhODE2N2Y3ODYyMTQwZjJkXzgtMy0xLTEtMTAyODYw_72d3a6b7-656c-4f88-b904-566ae5e8023e"
      unitRef="usd">2968000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTozZDMwYjFhM2FiYWU0ZTQ2YTgxNjdmNzg2MjE0MGYyZC90YWJsZXJhbmdlOjNkMzBiMWEzYWJhZTRlNDZhODE2N2Y3ODYyMTQwZjJkXzgtNS0xLTEtMTAyODYw_7986b276-d626-4bdf-bf8d-bce253dd3205"
      unitRef="usd">11119000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:BilledContractReceivables
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90ZXh0cmVnaW9uOjJlOWYyNWYwNmY2ZDQzOWVhY2NhMGQxYmMyMjVjMDFiXzExODQ_756327a0-d0ed-41e9-93bf-982a4599442a"
      unitRef="usd">11588000</us-gaap:BilledContractReceivables>
    <us-gaap:BilledContractReceivables
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90ZXh0cmVnaW9uOjJlOWYyNWYwNmY2ZDQzOWVhY2NhMGQxYmMyMjVjMDFiXzExOTE_e563cbab-3a1a-4563-abed-7890ce9d1dbb"
      unitRef="usd">2878000</us-gaap:BilledContractReceivables>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90ZXh0cmVnaW9uOjJlOWYyNWYwNmY2ZDQzOWVhY2NhMGQxYmMyMjVjMDFiXzEzNzQzODk1MzUxOTYx_6bd0a197-5593-4c42-a13e-6e6384f29bdc">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Remaining performance obligations consisted of the following (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Remaining performance obligations consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock>
    <amci:RevenueRemainingPerformanceObligationCurrentAmount
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTphNjk4ZmY2NGQxM2I0NjBmODA4ZWYwMDllODMzNzEzYS90YWJsZXJhbmdlOmE2OThmZjY0ZDEzYjQ2MGY4MDhlZjAwOWU4MzM3MTNhXzItMS0xLTEtOTA3MTc_7378990f-e35d-422a-b703-9426f2b2b096"
      unitRef="usd">2968000</amci:RevenueRemainingPerformanceObligationCurrentAmount>
    <amci:RevenueRemainingPerformanceObligationCurrentAmount
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTphNjk4ZmY2NGQxM2I0NjBmODA4ZWYwMDllODMzNzEzYS90YWJsZXJhbmdlOmE2OThmZjY0ZDEzYjQ2MGY4MDhlZjAwOWU4MzM3MTNhXzItMy0xLTEtOTA3MTc_5a3628a9-517a-42f6-9da6-ebf4bfdd9353"
      unitRef="usd">3476000</amci:RevenueRemainingPerformanceObligationCurrentAmount>
    <amci:RevenueRemainingPerformanceObligationNoncurrentAmount
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTphNjk4ZmY2NGQxM2I0NjBmODA4ZWYwMDllODMzNzEzYS90YWJsZXJhbmdlOmE2OThmZjY0ZDEzYjQ2MGY4MDhlZjAwOWU4MzM3MTNhXzMtMS0xLTEtOTA3MTc_626b9cfd-2a8a-488f-b521-e7be877e0708"
      unitRef="usd">11119000</amci:RevenueRemainingPerformanceObligationNoncurrentAmount>
    <amci:RevenueRemainingPerformanceObligationNoncurrentAmount
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTphNjk4ZmY2NGQxM2I0NjBmODA4ZWYwMDllODMzNzEzYS90YWJsZXJhbmdlOmE2OThmZjY0ZDEzYjQ2MGY4MDhlZjAwOWU4MzM3MTNhXzMtMy0xLTEtOTA3MTc_047996da-60e8-4a7d-9308-534965559538"
      unitRef="usd">13901000</amci:RevenueRemainingPerformanceObligationNoncurrentAmount>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTphNjk4ZmY2NGQxM2I0NjBmODA4ZWYwMDllODMzNzEzYS90YWJsZXJhbmdlOmE2OThmZjY0ZDEzYjQ2MGY4MDhlZjAwOWU4MzM3MTNhXzQtMS0xLTEtMTAyOTIw_6b574e9c-1c27-49f0-a50e-ab1d9928a840"
      unitRef="usd">14087000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MDcvZnJhZzoyZTlmMjVmMDZmNmQ0MzllYWNjYTBkMWJjMjI1YzAxYi90YWJsZTphNjk4ZmY2NGQxM2I0NjBmODA4ZWYwMDllODMzNzEzYS90YWJsZXJhbmdlOmE2OThmZjY0ZDEzYjQ2MGY4MDhlZjAwOWU4MzM3MTNhXzQtMy0xLTEtMTAyOTIw_9e4f2f1c-471e-4f02-be19-1b8430bb8084"
      unitRef="usd">17377000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:InvestmentTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzE1OTQyOTE4NjEyMzM0_e7fb4e97-d03c-474c-b6fe-0c53ec4f2cf3">Investments&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s investments consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021 as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity Method Investment in LanzaJet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity Security Investment in SGLT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Investment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;LanzaJet&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 13, 2020, the Company contributed $15,000 in intellectual property in exchange for a 37.5% interest (&#x201c;Original Interest&#x201d;) of LanzaJet, Inc. (&#x201c;LanzaJet&#x201d;) in connection with an investment agreement (&#x201c;Investment Agreement&#x201d;). The Company accounts for the transaction as a revenue transaction with a customer under ASC 606 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The licensing and technical support services provided are recognized as a single combined performance obligation satisfied over the expected period of those services, beginning May 2020 through December 2025. During the nine months ended September&#160;30, 2022 and 2021, the Company has recognized revenue from this arrangement of $1,620 and $1,516 respectively, net of intra-entity profit elimination. As of  September&#160;30, 2022 and December&#160;31, 2021, the Company has recorded deferred revenue of $8,734 and $10,746, respectively. Intra-entity profits related to revenue contracts with LanzaJet are $395 and $497 as of September&#160;30, 2022, and 2021, respectively. Intra-entity profit is amortized over the 15-year amortization period through 2034. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Between February 1, 2021 and April 4, 2021, LanzaJet closed two additional rounds of investment which reduced the Original Interest to 25%. As a result, the Company recognized a gain on dilution of $503. The Company retained its contingent right to receive an additional interest in LanzaJet of up to 45&#160;million shares for no additional consideration. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of our equity method investment in LanzaJet as of September&#160;30, 2022 and December&#160;31, 2021 was approximately $3,600 and $3,100 less than our proportionate share of our equity method investees&#x2019; book values, respectively. The basis differences are largely the result of a difference in the timing of recognition of variable consideration to which we may become entitled in exchange for our contribution of intellectual property to LanzaJet. The variable consideration we may receive will be in the form of additional ownership interests and the majority of the basis difference will reverse in connection with recognition of that variable consideration. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with a sublicense agreement to LanzaJet under our license agreement with Battelle Memorial Institute (&#x201c;Battelle&#x201d;), LanzaTech remains responsible for any failure by LanzaJet to pay royalties due to Battelle. The fair value of LanzaTech&#x2019;s obligation under this guarantee was immaterial as of September&#160;30, 2022 and December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;SGLT&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 28, 2011, the Company contributed RMB 25,800 (approx. $4,000) in intellectual property in exchange for 30% of the registered capital of Beijing ShouGang LanzaTech Technology Co., LTD (&#x201c;SGLT&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the Company&#x2019;s interest in SGLT&#x2019;s registered capital is approximately 10.01%. As the result of the admittance of new investors, the Company recognized a gain from dilution of $3,014 during the nine months ended September&#160;30, 2021. On April 29, 2022, SGLT closed a round of financing which reduced the Company's ownership to 9.31% and resulted in the recognition of gain from dilution of $3,368. On September 30, 2022, management of the Company determined that the Company no longer had significant influence over the operating and financial policies of SGLT due to the significant and sustained decrease in SGLT's technological dependence on LanzaTech. As such, as of September 30, 2022, the Company ceased applying the equity method and reclassified cumulative currency translation adjustments associated with its investment in SGLT of $928 to include those adjustments in the carrying value of its investment. Prospectively, the Company will account for its investment in the equity security of SGLT using the alternative measurement principals as permitted under ASC 321, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments - Equity Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, because SGLT's fair value is not readily determinable. As the change is effective on September 30, 2022, the Company recorded SGLT's attributable net loss of $76, for the nine months ended September&#160;30, 2022, on the condensed consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequently, under the alternative measurement method, LanzaTech will adjust the carrying value for observable changes in price and will reassess whether its investment in SGLT continues to qualify for such method. Additionally, LanzaTech will perform a qualitative assessment and recognize an impairment if their are sufficient indicators that the fair value of the SGLT investment is less than its carrying value. The changes in value and impairment charges (if any), are recorded in other (expense) income, net in the condensed consolidated statement of operations.&lt;/span&gt;&lt;/div&gt;As of September&#160;30, 2022 and December&#160;31, 2021, there were no impairments of either equity investees. During the nine months ended September&#160;30, 2022 and the year ended December&#160;31, 2021, the Company received no dividends from equity investments.</us-gaap:InvestmentTextBlock>
    <us-gaap:InvestmentTableTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzE1OTQyOTE4NjEyMzM1_2236459d-3621-4afe-abdc-a6e396546679">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s investments consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021 as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity Method Investment in LanzaJet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity Security Investment in SGLT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Investment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentTableTextBlock>
    <us-gaap:EquityMethodInvestments
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90YWJsZTo2YmZhNjJlNjYyMTM0NGM1YTMyZmZhMjdmMmRmMmY4ZC90YWJsZXJhbmdlOjZiZmE2MmU2NjIxMzQ0YzVhMzJmZmEyN2YyZGYyZjhkXzMtMS0xLTEtOTA3MTc_e90744ed-a634-4247-bf36-76543108a1b4"
      unitRef="usd">11047000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i285bf14114324cc3b2c392b9b984d16e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90YWJsZTo2YmZhNjJlNjYyMTM0NGM1YTMyZmZhMjdmMmRmMmY4ZC90YWJsZXJhbmdlOjZiZmE2MmU2NjIxMzQ0YzVhMzJmZmEyN2YyZGYyZjhkXzMtMy0xLTEtOTA3MTc_2c83c773-53f4-44cf-bcbb-0a5f6994dcc0"
      unitRef="usd">12433000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90YWJsZTo2YmZhNjJlNjYyMTM0NGM1YTMyZmZhMjdmMmRmMmY4ZC90YWJsZXJhbmdlOjZiZmE2MmU2NjIxMzQ0YzVhMzJmZmEyN2YyZGYyZjhkXzQtMS0xLTEtOTA3MTc_ecd9e435-7754-436c-ad0b-477905f32976"
      unitRef="usd">14990000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquityMethodInvestments
      contextRef="ie926aa19bc694f0586f296dab820baf8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90YWJsZTo2YmZhNjJlNjYyMTM0NGM1YTMyZmZhMjdmMmRmMmY4ZC90YWJsZXJhbmdlOjZiZmE2MmU2NjIxMzQ0YzVhMzJmZmEyN2YyZGYyZjhkXzQtMy0xLTEtOTA3MTc_27263d9b-1562-40a2-977a-8f754225f2ba"
      unitRef="usd">12319000</us-gaap:EquityMethodInvestments>
    <us-gaap:Investments
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90YWJsZTo2YmZhNjJlNjYyMTM0NGM1YTMyZmZhMjdmMmRmMmY4ZC90YWJsZXJhbmdlOjZiZmE2MmU2NjIxMzQ0YzVhMzJmZmEyN2YyZGYyZjhkXzUtMS0xLTEtOTA3MTc_e0284e2c-3b46-432a-8f0e-5f914d69a273"
      unitRef="usd">26037000</us-gaap:Investments>
    <us-gaap:Investments
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90YWJsZTo2YmZhNjJlNjYyMTM0NGM1YTMyZmZhMjdmMmRmMmY4ZC90YWJsZXJhbmdlOjZiZmE2MmU2NjIxMzQ0YzVhMzJmZmEyN2YyZGYyZjhkXzUtMy0xLTEtOTA3MTc_d9f7b924-0b4d-4aae-9135-964d3edfa8c9"
      unitRef="usd">24752000</us-gaap:Investments>
    <us-gaap:ContributionOfProperty
      contextRef="i3508735d501341a2badcc0f6a6be0770_D20200513-20200513"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzE0OQ_59e0a865-5dea-4a27-a7a7-ee4c03fc278b"
      unitRef="usd">15000000</us-gaap:ContributionOfProperty>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="iabbdb50d80c247b39bf74f30bb6e2aa1_I20200513"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzE5NQ_1d8eaf7a-9530-47bf-8f2c-391ca616ed52"
      unitRef="number">0.375</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibfcdf3126a1c413992b29dabc55a78ee_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzc3Mw_537f6fe9-bf94-4f38-871c-687bd960abe1"
      unitRef="usd">1620000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib6b123fcece94433b4a72c6716d59ddf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzc4MA_d620fe4b-3cc7-45cd-8f24-e64131e62636"
      unitRef="usd">1516000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ifaeb71870a2f4f65bef7abad49932d71_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzg3NA_4914cc61-5cb5-4c73-b631-891fa8d258bc"
      unitRef="usd">8734000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i285bf14114324cc3b2c392b9b984d16e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzg4MQ_f6be441e-f48c-4d14-b428-563ee3064148"
      unitRef="usd">10746000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic197136819df4f3d91e14be688674014_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzk4Mw_2495db85-8d70-42c9-ada4-8da080b0ca15"
      unitRef="usd">-395000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id7c2c8dee6434965a0e89d9311bf370e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzk5MA_7e2fc3cb-6711-42b5-9b0b-96ef934baee6"
      unitRef="usd">-497000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <amci:RevenueFromContractWithCustomerAmortizationPeriod
      contextRef="ibfcdf3126a1c413992b29dabc55a78ee_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzE1OTQyOTE4NjEyMzQ4_b598eca3-6fd1-4be8-bd60-d1fdea57fadc">P15Y</amci:RevenueFromContractWithCustomerAmortizationPeriod>
    <amci:NumberOfRoundsOfInvestments
      contextRef="i65fec460822f43acb02e40736b3b8a79_D20210201-20210404"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzEwOTk1MTE2Mjg3Mzkw_a3d39608-123b-48f7-9a23-48e1b39a9671"
      unitRef="invesstment_round">2</amci:NumberOfRoundsOfInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i0953d2d09b0e4116b4f9972716c60d69_I20210404"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzEyNjQ0MzgzNzI4OTc5_0215ec19-acd3-407d-abf3-7a9c7e9c89bf"
      unitRef="number">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <amci:EquityMethodInvestmentGainOnDilutionOfInvestment
      contextRef="i3f16003c0fce46c997e3bcde7fa19188_D20210201-20210404"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzEzMTE_73b074ed-a92e-4d64-8026-68e817a81977"
      unitRef="usd">503000</amci:EquityMethodInvestmentGainOnDilutionOfInvestment>
    <amci:EquityMethodInvestmentContingentRightToReceiveAdditionalInterest
      contextRef="i0953d2d09b0e4116b4f9972716c60d69_I20210404"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzEyNjQ0MzgzNzI4OTg0_cf76e815-6ca9-4108-994b-fcf71433babf"
      unitRef="shares">45000000</amci:EquityMethodInvestmentContingentRightToReceiveAdditionalInterest>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i3f16003c0fce46c997e3bcde7fa19188_D20210201-20210404"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzEwOTk1MTE2Mjg3Mzkx_5ff08a23-5aed-4c4d-b183-ea39bb5ba50b"
      unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
      contextRef="ifaeb71870a2f4f65bef7abad49932d71_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzE1NjA_bc4c9a36-f9b9-4c43-985f-06fd0d2b7c7b"
      unitRef="usd">3600000</us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity>
    <us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
      contextRef="i285bf14114324cc3b2c392b9b984d16e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzE1Njg_a165c7e1-5464-411f-8465-db2c33e54311"
      unitRef="usd">3100000</us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity>
    <us-gaap:ContributionOfProperty
      contextRef="i9f76a4903dee46c7a36a3359dafca0c1_D20110928-20110928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzI0ODc_950f0822-5896-4b4a-b1fc-f44eb2e6dad1"
      unitRef="cny">25800000</us-gaap:ContributionOfProperty>
    <us-gaap:ContributionOfProperty
      contextRef="i9f76a4903dee46c7a36a3359dafca0c1_D20110928-20110928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzI0OTk_c5e0f6d5-0c32-48fb-ac82-5a96a81f8899"
      unitRef="usd">4000000</us-gaap:ContributionOfProperty>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ibea6cef92fd440f0849af4b7e43ac9d0_I20110928"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzI1NDQ_93604c93-578e-439a-9b17-d4b7c41b01a3"
      unitRef="number">0.30</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ie926aa19bc694f0586f296dab820baf8_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzI3MTM_16e8f094-1592-4fbc-8d5c-51495cee8304"
      unitRef="number">0.1001</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <amci:EquityMethodInvestmentGainOnDilutionOfInvestment
      contextRef="ia16a7b02d1334a8c8712b104eafb3d0e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzI4MTQ_d446038b-64a1-4b0c-8480-a4dc9643b90f"
      unitRef="usd">3014000</amci:EquityMethodInvestmentGainOnDilutionOfInvestment>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ic62d084cb3144cc2a7041bace85abb24_I20220429"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzI5NDM_cac3c96e-5d23-435e-92f8-56d53f19335a"
      unitRef="number">0.0931</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <amci:EquityMethodInvestmentGainOnDilutionOfInvestment
      contextRef="i7c67702cd8234f33a60771751ce65fbe_D20220429-20220429"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzMwMDM_8e2cbe75-3bb6-4928-afa7-46d4c1c2fe65"
      unitRef="usd">3368000</amci:EquityMethodInvestmentGainOnDilutionOfInvestment>
    <amci:TransferFromForeignCurrencyTranslationToEquitySecurityInvestment
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzEyNjQ0MzgzNzI5MDAx_115b1849-43a8-43ab-8e28-fd718c24a15b"
      unitRef="usd">928000</amci:TransferFromForeignCurrencyTranslationToEquitySecurityInvestment>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="iaa61d655eb524064963927b0d13c1a26_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzEyNjQ0MzgzNzI4OTk2_0543a7de-c7cb-474f-a9db-7b1892c83a1c"
      unitRef="usd">-76000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzEwOTk1MTE2Mjg3Mzcy_0e9773a8-c667-4446-be45-d247eb240caa"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzEwOTk1MTE2Mjg3Mzcy_c317dda4-9505-4d02-8907-63a78350aadd"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzEwOTk1MTE2Mjg3Mzgw_711cec94-9397-4217-9b0a-ae1b8341bced"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTMvZnJhZzo4NThkOTVjNGNhMzk0OWJiODgxMGZlNTU4NTA0NmVkZS90ZXh0cmVnaW9uOjg1OGQ5NWM0Y2EzOTQ5YmI4ODEwZmU1NTg1MDQ2ZWRlXzEwOTk1MTE2Mjg3Mzgw_9b8c4a4e-f2bb-4e9c-82be-3e303b48d977"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if81ad5ca3f944114a295b408d90c868d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzQtMS0xLTEtOTA3MTc_267c43fb-7099-48e5-9008-6a30c1f23ef8"
      unitRef="usd">519000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i8b8a832fa95e40dd8e00caad65e8fc91_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzQtMy0xLTEtOTA3MTc_081ceca8-18ba-4d2a-ab60-dad425ec3fa9"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i890286f3ce6f403f85f12ab3e67b6b6e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzQtNS0xLTEtOTA3MTc_7203df67-7869-4b3a-a02b-4b8a5ec428ec"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ib7329eb228fb439b8a66213456cd7cd2_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzQtNy0xLTEtMTAzNDI2_957312d4-8323-40ba-8479-6bdaf11e9bf5"
      unitRef="usd">519000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="i102ea5a4d307404c84aab38c52f1411f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzctMS0xLTEtOTA3MTc_a2465503-cba0-4883-8d9f-b75958814025"
      unitRef="usd">0</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="i379c9b036151404ba5af5925388baa54_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzctMy0xLTEtOTA3MTc_fc333e17-f9d1-40df-a596-f067fca887b3"
      unitRef="usd">0</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="i9ed25cf6aa114e57a8dac87f70ade94d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzctNS0xLTEtOTA3MTc_93741a35-1ed1-4d0c-9bd8-b8d393c3cbc1"
      unitRef="usd">1572000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="i84a93d4537e04f79aeb456018d0705ee_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzctNy0xLTEtMTAzNDI2_2a639001-2040-4c83-a7d4-cb64bf4e6035"
      unitRef="usd">1572000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="ia33dc2132bbc4f94ad2a656f9bd29ecb_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzgtMS0xLTEtOTA3MTc_d707f99c-8d91-4f6c-ae9c-f51ba8b36a68"
      unitRef="usd">0</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="ib9ef9ee81e0d436bae0f3213e39b62ea_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzgtMy0xLTEtOTA3MTc_6404bb18-f4b1-405a-aab1-dc0bfb1fb5ca"
      unitRef="usd">0</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="i3f43e380d2624479993e527bb1c21058_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzgtNS0xLTEtOTA3MTc_b1a4ed67-bd13-4510-9aa6-512bac660474"
      unitRef="usd">2022000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="if25caf19e5b840e88f4735e4136a603a_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzgtNy0xLTEtMTAzNDI2_e37b20cb-c61a-4338-8fd9-dd22c4191945"
      unitRef="usd">2022000</us-gaap:WarrantsAndRightsOutstanding>
    <amci:SimpleAgreementForFutureEquityLiability
      contextRef="if81ad5ca3f944114a295b408d90c868d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzktMS0xLTEtOTA3MTc_b5196d03-a4a7-4f71-9bfa-00315087435d"
      unitRef="usd">0</amci:SimpleAgreementForFutureEquityLiability>
    <amci:SimpleAgreementForFutureEquityLiability
      contextRef="i8b8a832fa95e40dd8e00caad65e8fc91_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzktMy0xLTEtOTA3MTc_f0ddca9e-3501-4c21-9d0f-1579577833cd"
      unitRef="usd">0</amci:SimpleAgreementForFutureEquityLiability>
    <amci:SimpleAgreementForFutureEquityLiability
      contextRef="i890286f3ce6f403f85f12ab3e67b6b6e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzktNS0xLTEtOTA3MTc_36d7c02b-c894-461d-b0ba-b2043d66d7eb"
      unitRef="usd">27221000</amci:SimpleAgreementForFutureEquityLiability>
    <amci:SimpleAgreementForFutureEquityLiability
      contextRef="ib7329eb228fb439b8a66213456cd7cd2_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzktNy0xLTEtMTAzNDI2_726d08a8-cdc3-4f34-a317-8021e3f66b16"
      unitRef="usd">27221000</amci:SimpleAgreementForFutureEquityLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if81ad5ca3f944114a295b408d90c868d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzEwLTEtMS0xLTEwMzQyNg_a95241ec-5dd0-4771-9872-a2d5ecb9f017"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i8b8a832fa95e40dd8e00caad65e8fc91_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzEwLTMtMS0xLTEwMzQyNg_d5e0e91c-8c9f-4e77-8511-493f5d15793c"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i890286f3ce6f403f85f12ab3e67b6b6e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzEwLTUtMS0xLTEwMzQyNg_3190f0c3-c370-4470-a008-4a2c9e2107ba"
      unitRef="usd">30815000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ib7329eb228fb439b8a66213456cd7cd2_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTowMGQ0OWNmZWMzMDM0MjQwOWZmMTEyNWMzNTNlNWM3ZC90YWJsZXJhbmdlOjAwZDQ5Y2ZlYzMwMzQyNDA5ZmYxMTI1YzM1M2U1YzdkXzEwLTctMS0xLTEwMzQyNg_a0956a9f-d94a-43ab-a5ba-8723b4483a8a"
      unitRef="usd">30815000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i946a08fcd3a04e65862611981f20e270_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzQtMS0xLTEtMTAzNDE0_908f6e92-159b-458f-874f-00224d8e41b4"
      unitRef="usd">516000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i541e2e9fe4644a20b8b1b376f83dee9d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzQtMy0xLTEtMTAzNDE0_c9a3c721-784d-415f-aa45-7b092ac9e29c"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i0624bd72b2cf4ede8ec463949522ea9a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzQtNS0xLTEtMTAzNDE0_4d063c17-d79b-42bb-aa0e-f4a6db199e45"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="idd5ccd73a28c47ebac5c69568150935f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzQtNy0xLTEtMTAzNDE0_ac6e0774-f59f-4149-b832-5013d3c78007"
      unitRef="usd">516000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="i946a08fcd3a04e65862611981f20e270_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzctMS0xLTEtOTA3MTc_fa91582c-9dfd-4557-9b07-e0249d6b7591"
      unitRef="usd">0</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="i541e2e9fe4644a20b8b1b376f83dee9d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzctMy0xLTEtOTA3MTc_5e5d7714-4eb8-4278-876a-ba36f9898985"
      unitRef="usd">0</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="i0624bd72b2cf4ede8ec463949522ea9a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzctNS0xLTEtOTA3MTc_220c52d4-4b02-49d9-8882-63704e062677"
      unitRef="usd">1145000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="idd5ccd73a28c47ebac5c69568150935f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzctNy0xLTEtMTAzNDE0_7caebe61-fd36-4f4f-879a-b35624104295"
      unitRef="usd">1145000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="ia692081523eb4eeab727c1fc860a7079_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzgtMS0xLTEtOTA3MTc_d3b810f3-40a1-4a9e-bae1-c7f82213be7c"
      unitRef="usd">0</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="i18d637000e084883bc89386915d6aae9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzgtMy0xLTEtOTA3MTc_03c8d225-9256-4cbd-b82f-f03c326f2114"
      unitRef="usd">0</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="i8345fcb8c9f147978a79d376aea1f2aa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzgtNS0xLTEtOTA3MTc_80da59ea-7d02-43f2-bb9d-ec77b7a5d9be"
      unitRef="usd">1729000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="id9bb8758e465423fb3bbebe9bcea3ef7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzgtNy0xLTEtMTAzNDE0_1e04762a-098b-49a5-bf53-c6ffe7bed45b"
      unitRef="usd">1729000</us-gaap:WarrantsAndRightsOutstanding>
    <amci:SimpleAgreementForFutureEquityLiability
      contextRef="i946a08fcd3a04e65862611981f20e270_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzktMS0xLTEtOTA3MTc_2d106706-abe2-4bf4-9a2f-109421c263ad"
      unitRef="usd">0</amci:SimpleAgreementForFutureEquityLiability>
    <amci:SimpleAgreementForFutureEquityLiability
      contextRef="i541e2e9fe4644a20b8b1b376f83dee9d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzktMy0xLTEtOTA3MTc_56bb4e94-dcac-4696-b4ca-91b79c68f2ce"
      unitRef="usd">0</amci:SimpleAgreementForFutureEquityLiability>
    <amci:SimpleAgreementForFutureEquityLiability
      contextRef="i0624bd72b2cf4ede8ec463949522ea9a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzktNS0xLTEtOTA3MTc_79d74fb3-13c1-42f6-95d8-3974015bc6aa"
      unitRef="usd">28271000</amci:SimpleAgreementForFutureEquityLiability>
    <amci:SimpleAgreementForFutureEquityLiability
      contextRef="idd5ccd73a28c47ebac5c69568150935f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzktNy0xLTEtMTAzNDE0_9a3851b1-c7c6-4cbe-a209-5afcb2501b0b"
      unitRef="usd">28271000</amci:SimpleAgreementForFutureEquityLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i946a08fcd3a04e65862611981f20e270_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzEwLTEtMS0xLTEwMzQxNA_25ae9d72-cc0a-442c-a2c0-9284921ebf61"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i541e2e9fe4644a20b8b1b376f83dee9d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzEwLTMtMS0xLTEwMzQxNA_b1adf403-408f-4b5a-8cf4-ee144bd190f6"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i0624bd72b2cf4ede8ec463949522ea9a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzEwLTUtMS0xLTEwMzQxNA_7e28c1e8-fb66-45ff-9264-9b6bbe36b868"
      unitRef="usd">31145000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="idd5ccd73a28c47ebac5c69568150935f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTplNmQ4OGI2OGVmNDI0ZDAxYWYzMmQ0MDNjOTZlZjUxYi90YWJsZXJhbmdlOmU2ZDg4YjY4ZWY0MjRkMDFhZjMyZDQwM2M5NmVmNTFiXzEwLTctMS0xLTEwMzQxNA_08239dbd-88b8-4951-add6-60a2c042c192"
      unitRef="usd">31145000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90ZXh0cmVnaW9uOjk0ODAwMjlkMTliZjRlMWQ4ZGQ4OTU0ZTgzODk0ODQ5XzI4Mw_903ce5f7-1718-47f9-a5c3-96d104128a60"
      unitRef="shares">225223</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90ZXh0cmVnaW9uOjk0ODAwMjlkMTliZjRlMWQ4ZGQ4OTU0ZTgzODk0ODQ5XzEwOTk1MTE2Mjg2NDEz_d400d76b-a03a-40f6-8fb7-b85f54c921c8"
      unitRef="shares">225223</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i0e8c018a77ea44b685797703d8a62a43_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90ZXh0cmVnaW9uOjk0ODAwMjlkMTliZjRlMWQ4ZGQ4OTU0ZTgzODk0ODQ5XzQzOA_d383ec08-7fc6-4486-aa3a-e92640b8a088"
      unitRef="usdPerShare">14.69</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i1b34bf4c7df9425fa69de07cc96a2ac9_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90ZXh0cmVnaW9uOjk0ODAwMjlkMTliZjRlMWQ4ZGQ4OTU0ZTgzODk0ODQ5XzQzOA_d862fc0f-e1fa-44af-b792-2bfc3768013b"
      unitRef="usdPerShare">14.69</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="ida50a4aa7f4047c9a5bf3fcef6f2d36d_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90ZXh0cmVnaW9uOjk0ODAwMjlkMTliZjRlMWQ4ZGQ4OTU0ZTgzODk0ODQ5XzQ0NA_0d9f6cdf-a912-4cab-90a7-518ff0e6bfef"
      unitRef="usdPerShare">19.93</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i2dae0c39f39546cdbbe879b2a2245fe6_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90ZXh0cmVnaW9uOjk0ODAwMjlkMTliZjRlMWQ4ZGQ4OTU0ZTgzODk0ODQ5XzQ0NA_51f4dcff-4d7c-4086-a805-e3d0b7de959d"
      unitRef="usdPerShare">19.93</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90ZXh0cmVnaW9uOjk0ODAwMjlkMTliZjRlMWQ4ZGQ4OTU0ZTgzODk0ODQ5XzExMDY_6a5fe816-8b8f-4556-baf6-b068e4ba366c"
      unitRef="usd">427000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90ZXh0cmVnaW9uOjk0ODAwMjlkMTliZjRlMWQ4ZGQ4OTU0ZTgzODk0ODQ5XzExMTM_3ed9f528-a8ff-43af-ba23-78127723683d"
      unitRef="usd">699000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i80812ae1293f45978d4c5ec6ccb77d63_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpjMmVmZTU2ZWUwYmQ0ZWU2OTY4ZjIzZjgwZDNlOTE0Ny90YWJsZXJhbmdlOmMyZWZlNTZlZTBiZDRlZTY5NjhmMjNmODBkM2U5MTQ3XzEtMS0xLTEtOTA3MTc_0885110c-f268-42d7-826d-e522694de168"
      unitRef="usdPerShare">15.03</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i350b1ab261cb4e4db6e8558ad63e36ba_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpjMmVmZTU2ZWUwYmQ0ZWU2OTY4ZjIzZjgwZDNlOTE0Ny90YWJsZXJhbmdlOmMyZWZlNTZlZTBiZDRlZTY5NjhmMjNmODBkM2U5MTQ3XzEtMy0xLTEtOTA3MTc_14f72355-82cb-4b9a-a224-0e4ced58e02f"
      unitRef="usdPerShare">13.77</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i255bc9e0c6fd4f8a8cfcde46d7515d42_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpjMmVmZTU2ZWUwYmQ0ZWU2OTY4ZjIzZjgwZDNlOTE0Ny90YWJsZXJhbmdlOmMyZWZlNTZlZTBiZDRlZTY5NjhmMjNmODBkM2U5MTQ3XzItMS0xLTEtOTA3MTc_21972f8d-ea1c-4c31-8858-b368b96e7d68"
      unitRef="usdPerShare">17.31</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i07186a2d797e4458bf8d9a94dc91a2d0_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpjMmVmZTU2ZWUwYmQ0ZWU2OTY4ZjIzZjgwZDNlOTE0Ny90YWJsZXJhbmdlOmMyZWZlNTZlZTBiZDRlZTY5NjhmMjNmODBkM2U5MTQ3XzItMy0xLTEtOTA3MTc_c347a686-6b96-4d7e-9d4b-7dac8232af78"
      unitRef="usdPerShare">17.32</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i36aa3c86e8874dec967acf37511c6479_I20220930"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpjMmVmZTU2ZWUwYmQ0ZWU2OTY4ZjIzZjgwZDNlOTE0Ny90YWJsZXJhbmdlOmMyZWZlNTZlZTBiZDRlZTY5NjhmMjNmODBkM2U5MTQ3XzMtMS0xLTEtOTA3MTc_9353e15b-dbaf-49a6-908d-80e24c1ebeba"
      unitRef="number">2.3</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="ia859bc758ac345ea9093ab9e82ff0731_I20211231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpjMmVmZTU2ZWUwYmQ0ZWU2OTY4ZjIzZjgwZDNlOTE0Ny90YWJsZXJhbmdlOmMyZWZlNTZlZTBiZDRlZTY5NjhmMjNmODBkM2U5MTQ3XzMtMy0xLTEtOTA3MTc_fd992d18-072c-49e2-a71f-5c63c7d8efcf"
      unitRef="number">2.8</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i04cf9359671d402dba7a452b2672fb05_I20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpjMmVmZTU2ZWUwYmQ0ZWU2OTY4ZjIzZjgwZDNlOTE0Ny90YWJsZXJhbmdlOmMyZWZlNTZlZTBiZDRlZTY5NjhmMjNmODBkM2U5MTQ3XzQtMS0xLTEtOTA3MTc_f5cf5d9f-63cd-4ea4-a213-e045a76a30fc"
      unitRef="number">0.769</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i43750276631c4e1ba6fc6ef8f398254e_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpjMmVmZTU2ZWUwYmQ0ZWU2OTY4ZjIzZjgwZDNlOTE0Ny90YWJsZXJhbmdlOmMyZWZlNTZlZTBiZDRlZTY5NjhmMjNmODBkM2U5MTQ3XzQtMy0xLTEtOTA3MTc_55a35914-10c3-41f2-84ba-d2385293e03d"
      unitRef="number">0.706</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i2f2cde5be60544bbb0bd73ff5aef0cad_I20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpjMmVmZTU2ZWUwYmQ0ZWU2OTY4ZjIzZjgwZDNlOTE0Ny90YWJsZXJhbmdlOmMyZWZlNTZlZTBiZDRlZTY5NjhmMjNmODBkM2U5MTQ3XzUtMS0xLTEtOTA3MTc_4a9e0d71-601a-4d17-8457-9abaf608a293"
      unitRef="number">0.029</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i5088a09b2ff24bc9bfba62c1ce63d419_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpjMmVmZTU2ZWUwYmQ0ZWU2OTY4ZjIzZjgwZDNlOTE0Ny90YWJsZXJhbmdlOmMyZWZlNTZlZTBiZDRlZTY5NjhmMjNmODBkM2U5MTQ3XzUtMy0xLTEtOTA3MTc_85f1d499-694d-4cc4-9cc9-5ba1bb22e87c"
      unitRef="number">0.008</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="ia52cfe0290ea4a978f3254d197b6c758_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpjMmVmZTU2ZWUwYmQ0ZWU2OTY4ZjIzZjgwZDNlOTE0Ny90YWJsZXJhbmdlOmMyZWZlNTZlZTBiZDRlZTY5NjhmMjNmODBkM2U5MTQ3XzYtMS0xLTEtOTA3MTc_0cab51d9-3dd9-45a6-886f-9185d0452609"
      unitRef="number">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i55050b0de34747fbba14961fb9a1e9be_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpjMmVmZTU2ZWUwYmQ0ZWU2OTY4ZjIzZjgwZDNlOTE0Ny90YWJsZXJhbmdlOmMyZWZlNTZlZTBiZDRlZTY5NjhmMjNmODBkM2U5MTQ3XzYtMy0xLTEtOTA3MTc_7f1e35d7-7534-4743-94e9-a6907267b574"
      unitRef="number">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <amci:SimpleAgreementForFutureEquityLiability
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90ZXh0cmVnaW9uOjk0ODAwMjlkMTliZjRlMWQ4ZGQ4OTU0ZTgzODk0ODQ5XzI2MTE_35d9ac4e-0b55-4c2a-a0ef-5075294a75c7"
      unitRef="usd">27221000</amci:SimpleAgreementForFutureEquityLiability>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90ZXh0cmVnaW9uOjk0ODAwMjlkMTliZjRlMWQ4ZGQ4OTU0ZTgzODk0ODQ5XzI3NDg_c3877934-087d-4e53-9a07-78a3e38dbe99"
      unitRef="usd">2022000</us-gaap:WarrantsAndRightsOutstanding>
    <amci:SAFELiabilityMeasurementInput
      contextRef="i4e47b12b058d42d9b8a8500645afac39_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpmNjkwMWI4OTAxODY0Y2ZmOTNiZjg0MzIxZGYwZmVmMy90YWJsZXJhbmdlOmY2OTAxYjg5MDE4NjRjZmY5M2JmODQzMjFkZjBmZWYzXzItMS0xLTEtOTA3MTc_52cbc599-38c8-43a6-bdac-38e2d7d51026"
      unitRef="number">0.41</amci:SAFELiabilityMeasurementInput>
    <amci:SAFELiabilityMeasurementInput
      contextRef="ibd94d602b126443bb0f923d41ad8c7a1_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpmNjkwMWI4OTAxODY0Y2ZmOTNiZjg0MzIxZGYwZmVmMy90YWJsZXJhbmdlOmY2OTAxYjg5MDE4NjRjZmY5M2JmODQzMjFkZjBmZWYzXzItMy0xLTEtOTA3MTc_3b67345c-493f-4abd-a946-288926a92f9b"
      unitRef="number">0.59</amci:SAFELiabilityMeasurementInput>
    <amci:SAFELiabilityMeasurementInput
      contextRef="iec52bedc36d740b58bbc9ba1b8a983fe_I20220930"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpmNjkwMWI4OTAxODY0Y2ZmOTNiZjg0MzIxZGYwZmVmMy90YWJsZXJhbmdlOmY2OTAxYjg5MDE4NjRjZmY5M2JmODQzMjFkZjBmZWYzXzMtMS0xLTEtOTA3MTc_0e86975a-bfbd-46cf-9ad1-50d1060d3ae3"
      unitRef="number">0.3</amci:SAFELiabilityMeasurementInput>
    <amci:SAFELiabilityMeasurementInput
      contextRef="i9ce1629b93bf43a19b229d4d55f31882_I20220930"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpmNjkwMWI4OTAxODY0Y2ZmOTNiZjg0MzIxZGYwZmVmMy90YWJsZXJhbmdlOmY2OTAxYjg5MDE4NjRjZmY5M2JmODQzMjFkZjBmZWYzXzMtMy0xLTEtOTA3MTc_5b039636-4495-4ca5-a313-605d08e58484"
      unitRef="number">1.0</amci:SAFELiabilityMeasurementInput>
    <amci:SAFELiabilityMeasurementInput
      contextRef="ie070efbfc7bb4781b963dadb0a382d58_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpmNjkwMWI4OTAxODY0Y2ZmOTNiZjg0MzIxZGYwZmVmMy90YWJsZXJhbmdlOmY2OTAxYjg5MDE4NjRjZmY5M2JmODQzMjFkZjBmZWYzXzQtMS0xLTEtOTA3MTc_2b854dcf-b4a2-45ce-9ffd-5750bf48352c"
      unitRef="number">1</amci:SAFELiabilityMeasurementInput>
    <amci:SAFELiabilityMeasurementInput
      contextRef="i49e4803247b0402587b5096b129d9f31_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpmNjkwMWI4OTAxODY0Y2ZmOTNiZjg0MzIxZGYwZmVmMy90YWJsZXJhbmdlOmY2OTAxYjg5MDE4NjRjZmY5M2JmODQzMjFkZjBmZWYzXzQtMy0xLTEtOTA3MTc_0b4968ac-00b1-481e-a334-c490b7cc727e"
      unitRef="number">0.90</amci:SAFELiabilityMeasurementInput>
    <amci:SAFELiabilityMeasurementInput
      contextRef="i09800e6ff5ef4478927f317abe6e7fb7_I20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpmNjkwMWI4OTAxODY0Y2ZmOTNiZjg0MzIxZGYwZmVmMy90YWJsZXJhbmdlOmY2OTAxYjg5MDE4NjRjZmY5M2JmODQzMjFkZjBmZWYzXzUtMS0xLTEtOTA3MTc_7916d42e-4c32-4562-a7e0-e3eb887c1147"
      unitRef="number">0.260</amci:SAFELiabilityMeasurementInput>
    <amci:SAFELiabilityMeasurementInput
      contextRef="i6c63b562f14d44b9952abb1eea623813_I20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTpmNjkwMWI4OTAxODY0Y2ZmOTNiZjg0MzIxZGYwZmVmMy90YWJsZXJhbmdlOmY2OTAxYjg5MDE4NjRjZmY5M2JmODQzMjFkZjBmZWYzXzUtMy0xLTEtOTA3MTc_9420224a-fba6-4ce8-ae4e-269d12958e50"
      unitRef="number">0.260</amci:SAFELiabilityMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="ib14e5758f2a840a3b657e5dd9d422ebe_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTphMmU3MGY5YTI4NjA0ZmZlYjIzZGU5NWRkNzg2MjBlNS90YWJsZXJhbmdlOmEyZTcwZjlhMjg2MDRmZmViMjNkZTk1ZGQ3ODYyMGU1XzItMS0xLTEtOTA3MTc_343b1f55-061d-4cfb-9c28-fb9e371361c4"
      unitRef="number">0.41</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i192c0e38323342ae9304ab84b0debe13_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTphMmU3MGY5YTI4NjA0ZmZlYjIzZGU5NWRkNzg2MjBlNS90YWJsZXJhbmdlOmEyZTcwZjlhMjg2MDRmZmViMjNkZTk1ZGQ3ODYyMGU1XzItMy0xLTEtOTA3MTc_012306f7-8e2e-4926-9ac3-aa282fd68b40"
      unitRef="number">0.59</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i37123c3b7a85495b95dd4d8511fc0442_I20220930"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTphMmU3MGY5YTI4NjA0ZmZlYjIzZGU5NWRkNzg2MjBlNS90YWJsZXJhbmdlOmEyZTcwZjlhMjg2MDRmZmViMjNkZTk1ZGQ3ODYyMGU1XzMtMS0xLTEtOTA3MTc_0d083398-cdcf-4c31-9510-f31819ff2c99"
      unitRef="number">5.0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i0fa6834bd2214eff8b934f7fdaa67fbf_I20220930"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTphMmU3MGY5YTI4NjA0ZmZlYjIzZGU5NWRkNzg2MjBlNS90YWJsZXJhbmdlOmEyZTcwZjlhMjg2MDRmZmViMjNkZTk1ZGQ3ODYyMGU1XzMtMy0xLTEtOTA3MTc_8f620e6d-db97-4c32-8948-f6b8d78c6968"
      unitRef="number">5.0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i0172ec8bd8ce4a22879fb349fbbafc56_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTphMmU3MGY5YTI4NjA0ZmZlYjIzZGU5NWRkNzg2MjBlNS90YWJsZXJhbmdlOmEyZTcwZjlhMjg2MDRmZmViMjNkZTk1ZGQ3ODYyMGU1XzQtMS0xLTEtOTA3MTc_259d5594-3622-4f27-aed4-5d7a22bd03b3"
      unitRef="number">0.75</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="ic9d5899a57c54d7990cac2605e65ebd3_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTphMmU3MGY5YTI4NjA0ZmZlYjIzZGU5NWRkNzg2MjBlNS90YWJsZXJhbmdlOmEyZTcwZjlhMjg2MDRmZmViMjNkZTk1ZGQ3ODYyMGU1XzQtMy0xLTEtOTA3MTc_1aaf75b9-fd80-4b5f-b6b3-0288b04b24f8"
      unitRef="number">0.75</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i0aa6805e2b1149559fbad18c590187ff_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTphMmU3MGY5YTI4NjA0ZmZlYjIzZGU5NWRkNzg2MjBlNS90YWJsZXJhbmdlOmEyZTcwZjlhMjg2MDRmZmViMjNkZTk1ZGQ3ODYyMGU1XzUtMS0xLTEtOTA3MTc_38a98a93-c76b-493c-9afa-ce744cf73ad0"
      unitRef="number">0.0406</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="icda6841801c24b74be59d169bb943c1a_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTphMmU3MGY5YTI4NjA0ZmZlYjIzZGU5NWRkNzg2MjBlNS90YWJsZXJhbmdlOmEyZTcwZjlhMjg2MDRmZmViMjNkZTk1ZGQ3ODYyMGU1XzUtMy0xLTEtOTA3MTc_e974c56d-94ea-41af-b992-5f432a533ab8"
      unitRef="number">0.0406</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i5ca319150c654f32ae12b5fe4314342e_I20220930"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTphMmU3MGY5YTI4NjA0ZmZlYjIzZGU5NWRkNzg2MjBlNS90YWJsZXJhbmdlOmEyZTcwZjlhMjg2MDRmZmViMjNkZTk1ZGQ3ODYyMGU1XzYtMS0xLTEtOTA3MTc_4f4e2a59-9770-4e2b-aee2-a5d8f864fdb2"
      unitRef="number">0.3</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="ie7fb1eeb489e46439a3c7f8c3a135d2b_I20220930"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTphMmU3MGY5YTI4NjA0ZmZlYjIzZGU5NWRkNzg2MjBlNS90YWJsZXJhbmdlOmEyZTcwZjlhMjg2MDRmZmViMjNkZTk1ZGQ3ODYyMGU1XzYtMy0xLTEtOTA3MTc_d5fe7fb3-e3c7-427b-b8e1-3c923a6e3a7b"
      unitRef="number">1.0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i50591f4e8c7a4c87a18ff51b7460e5d8_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTphMmU3MGY5YTI4NjA0ZmZlYjIzZGU5NWRkNzg2MjBlNS90YWJsZXJhbmdlOmEyZTcwZjlhMjg2MDRmZmViMjNkZTk1ZGQ3ODYyMGU1XzctMS0xLTEtOTA3MTc_770d2d0d-a1c6-4009-bffa-f5d0ee232f0a"
      unitRef="number">0.0333</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i32c536245c9a49b0a6be57c612f69c6d_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTphMmU3MGY5YTI4NjA0ZmZlYjIzZGU5NWRkNzg2MjBlNS90YWJsZXJhbmdlOmEyZTcwZjlhMjg2MDRmZmViMjNkZTk1ZGQ3ODYyMGU1XzctMy0xLTEtOTA3MTc_3c5c8b70-9236-45fe-aacd-dbdd64f76650"
      unitRef="number">0.0405</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="ieb39bfc330164ff6ba59e1d2825cd61d_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTphMmU3MGY5YTI4NjA0ZmZlYjIzZGU5NWRkNzg2MjBlNS90YWJsZXJhbmdlOmEyZTcwZjlhMjg2MDRmZmViMjNkZTk1ZGQ3ODYyMGU1XzgtMS0xLTEtOTA3MTc_cc4731da-b2eb-46e7-835e-d886a542a3d9"
      unitRef="number">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i114b807366e64e039876ae4814999f64_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTphMmU3MGY5YTI4NjA0ZmZlYjIzZGU5NWRkNzg2MjBlNS90YWJsZXJhbmdlOmEyZTcwZjlhMjg2MDRmZmViMjNkZTk1ZGQ3ODYyMGU1XzgtMy0xLTEtOTA3MTc_1bf76296-170e-4a2c-86e0-dfd58b7cf10e"
      unitRef="number">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i0945a26d694b428d8419686bb048d18d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTo4N2E5ODg1MzlhMTg0OWNjYWFhYWRkNzk4NWViOGYwYS90YWJsZXJhbmdlOjg3YTk4ODUzOWExODQ5Y2NhYWFhZGQ3OTg1ZWI4ZjBhXzEtMS0xLTEtOTA3MTc_79504280-67f7-4a1b-b120-bb4df56e4ecc"
      unitRef="usd">1145000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i7fb53208afd74e9483b23d0e4041d555_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTo4N2E5ODg1MzlhMTg0OWNjYWFhYWRkNzk4NWViOGYwYS90YWJsZXJhbmdlOjg3YTk4ODUzOWExODQ5Y2NhYWFhZGQ3OTg1ZWI4ZjBhXzEtMi0xLTEtOTA3MTc_aa50dcc0-e9ef-4cc3-88dc-171952e9a2e0"
      unitRef="usd">28271000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i079f7d69cf684156b67ee6553c8b6aad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTo4N2E5ODg1MzlhMTg0OWNjYWFhYWRkNzk4NWViOGYwYS90YWJsZXJhbmdlOjg3YTk4ODUzOWExODQ5Y2NhYWFhZGQ3OTg1ZWI4ZjBhXzEtMy0xLTEtOTA3MTc_63955c1e-0865-48af-8919-e7fc5ecd9408"
      unitRef="usd">1729000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i24da02763da74b0a98ebfa8693930419_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTo4N2E5ODg1MzlhMTg0OWNjYWFhYWRkNzk4NWViOGYwYS90YWJsZXJhbmdlOjg3YTk4ODUzOWExODQ5Y2NhYWFhZGQ3OTg1ZWI4ZjBhXzItMS0xLTEtOTA3MTc_ec7e42d7-2354-4b80-ad4e-750ecf6eed95"
      unitRef="usd">-427000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i4e2cb48d3fed408fb6bf572cd6d907a7_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTo4N2E5ODg1MzlhMTg0OWNjYWFhYWRkNzk4NWViOGYwYS90YWJsZXJhbmdlOjg3YTk4ODUzOWExODQ5Y2NhYWFhZGQ3OTg1ZWI4ZjBhXzItMi0xLTEtOTA3MTc_b45c640b-0199-4b27-82cb-abda4f5c9ffb"
      unitRef="usd">1050000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i339b33ace04542deabf468483e22dd7b_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTo4N2E5ODg1MzlhMTg0OWNjYWFhYWRkNzk4NWViOGYwYS90YWJsZXJhbmdlOjg3YTk4ODUzOWExODQ5Y2NhYWFhZGQ3OTg1ZWI4ZjBhXzItMy0xLTEtOTA3MTc_22401323-0955-4b4b-99b3-4323d111e6f8"
      unitRef="usd">-293000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ifcbb421dbd8a47549b523344e6362ae3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTo4N2E5ODg1MzlhMTg0OWNjYWFhYWRkNzk4NWViOGYwYS90YWJsZXJhbmdlOjg3YTk4ODUzOWExODQ5Y2NhYWFhZGQ3OTg1ZWI4ZjBhXzMtMS0xLTEtOTA3MTc_3166743e-ab40-4a2d-a55d-a8a8ffba7a3d"
      unitRef="usd">1572000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i3c5b2e7ef7394f83aafc18d6214bf674_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTo4N2E5ODg1MzlhMTg0OWNjYWFhYWRkNzk4NWViOGYwYS90YWJsZXJhbmdlOjg3YTk4ODUzOWExODQ5Y2NhYWFhZGQ3OTg1ZWI4ZjBhXzMtMi0xLTEtOTA3MTc_2b687400-06c0-4dc8-9cda-67160facdf10"
      unitRef="usd">27221000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i9af2492b6f554a0eb3fc32f72a1bb287_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTo4N2E5ODg1MzlhMTg0OWNjYWFhYWRkNzk4NWViOGYwYS90YWJsZXJhbmdlOjg3YTk4ODUzOWExODQ5Y2NhYWFhZGQ3OTg1ZWI4ZjBhXzMtMy0xLTEtOTA3MTc_592565c3-c6e5-4a28-bed1-aa482c981950"
      unitRef="usd">2022000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i5618649df5e5458fa3e4d03670a6f48b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTozNGU4YzdkNzk2MmQ0YWMwYTkzMDI1YTUxNmI4OTliYS90YWJsZXJhbmdlOjM0ZThjN2Q3OTYyZDRhYzBhOTMwMjVhNTE2Yjg5OWJhXzEtMS0xLTEtOTA3MTc_d6930405-3d43-44ee-b817-c0011b9a6db2"
      unitRef="usd">582000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="icce53a5d10814231a163555304304500_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTozNGU4YzdkNzk2MmQ0YWMwYTkzMDI1YTUxNmI4OTliYS90YWJsZXJhbmdlOjM0ZThjN2Q3OTYyZDRhYzBhOTMwMjVhNTE2Yjg5OWJhXzEtMi0xLTEtOTA3MTc_5ecae1dd-1d73-42ed-ae1b-b90dee1811d6"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="iceff32fcb2af47c7981043c476b7ae54_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTozNGU4YzdkNzk2MmQ0YWMwYTkzMDI1YTUxNmI4OTliYS90YWJsZXJhbmdlOjM0ZThjN2Q3OTYyZDRhYzBhOTMwMjVhNTE2Yjg5OWJhXzEtMy0xLTEtOTA3MTc_080926f3-bc41-41bc-ad61-c0534c5fee58"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="i68ebbca494b448ef875e3b5a750be5f7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTozNGU4YzdkNzk2MmQ0YWMwYTkzMDI1YTUxNmI4OTliYS90YWJsZXJhbmdlOjM0ZThjN2Q3OTYyZDRhYzBhOTMwMjVhNTE2Yjg5OWJhXzItMS0xLTEtOTA3MTc_7d576e77-60da-4913-9219-561f3b20ebac"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="i578deee2fa2d4d7bb7f94e488eeef63f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTozNGU4YzdkNzk2MmQ0YWMwYTkzMDI1YTUxNmI4OTliYS90YWJsZXJhbmdlOjM0ZThjN2Q3OTYyZDRhYzBhOTMwMjVhNTE2Yjg5OWJhXzItMi0xLTEtOTA3MTc_af5dbdc5-100f-4c7a-8089-207f96404f25"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="i0e9a8a61ba8846269b1f093403d0655f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTozNGU4YzdkNzk2MmQ0YWMwYTkzMDI1YTUxNmI4OTliYS90YWJsZXJhbmdlOjM0ZThjN2Q3OTYyZDRhYzBhOTMwMjVhNTE2Yjg5OWJhXzItMy0xLTEtOTA3MTc_7d43e709-c155-4963-95d2-53d959fa292a"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i68ebbca494b448ef875e3b5a750be5f7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTozNGU4YzdkNzk2MmQ0YWMwYTkzMDI1YTUxNmI4OTliYS90YWJsZXJhbmdlOjM0ZThjN2Q3OTYyZDRhYzBhOTMwMjVhNTE2Yjg5OWJhXzMtMS0xLTEtOTA3MTc_0d6fe7fb-1798-42e6-adf9-22869d230ce1"
      unitRef="usd">-699000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i578deee2fa2d4d7bb7f94e488eeef63f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTozNGU4YzdkNzk2MmQ0YWMwYTkzMDI1YTUxNmI4OTliYS90YWJsZXJhbmdlOjM0ZThjN2Q3OTYyZDRhYzBhOTMwMjVhNTE2Yjg5OWJhXzMtMi0xLTEtOTA3MTc_262481ec-f3ad-4f1f-9f7c-f438d26c9c28"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i0e9a8a61ba8846269b1f093403d0655f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTozNGU4YzdkNzk2MmQ0YWMwYTkzMDI1YTUxNmI4OTliYS90YWJsZXJhbmdlOjM0ZThjN2Q3OTYyZDRhYzBhOTMwMjVhNTE2Yjg5OWJhXzMtMy0xLTEtOTA3MTc_90a1dfcd-f25b-4ad7-99c7-f729f09d5449"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i5dcdacedd7b3425b94c3894b1d80e349_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTozNGU4YzdkNzk2MmQ0YWMwYTkzMDI1YTUxNmI4OTliYS90YWJsZXJhbmdlOjM0ZThjN2Q3OTYyZDRhYzBhOTMwMjVhNTE2Yjg5OWJhXzQtMS0xLTEtOTA3MTc_e2255602-3bf5-44ee-bd1d-7db58bd1d70b"
      unitRef="usd">1281000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ic04f0a1ede324c85b72039cfd7feb0b7_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTozNGU4YzdkNzk2MmQ0YWMwYTkzMDI1YTUxNmI4OTliYS90YWJsZXJhbmdlOjM0ZThjN2Q3OTYyZDRhYzBhOTMwMjVhNTE2Yjg5OWJhXzQtMi0xLTEtOTA3MTc_94999727-27ac-4dc1-a9b6-70bf3be736f2"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i78b91d141eb346fc856035c2b7e19205_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83MTkvZnJhZzo5NDgwMDI5ZDE5YmY0ZTFkOGRkODk1NGU4Mzg5NDg0OS90YWJsZTozNGU4YzdkNzk2MmQ0YWMwYTkzMDI1YTUxNmI4OTliYS90YWJsZXJhbmdlOjM0ZThjN2Q3OTYyZDRhYzBhOTMwMjVhNTE2Yjg5OWJhXzQtMy0xLTEtOTA3MTc_ded479d0-6187-4286-880f-2026c41de29a"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:ForeignEarningsRepatriated
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NTgvZnJhZzo0NWFhNzEzMGQ4ODM0YWI2YThkZjJkNmVjYTkyODdkMy90ZXh0cmVnaW9uOjQ1YWE3MTMwZDg4MzRhYjZhOGRmMmQ2ZWNhOTI4N2QzXzEwOTk1MTE2MjgyNzY4_5ef7f81c-4b44-4cfc-b46e-33027aea4800"
      unitRef="usd">0</us-gaap:ForeignEarningsRepatriated>
    <us-gaap:ForeignEarningsRepatriated
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NTgvZnJhZzo0NWFhNzEzMGQ4ODM0YWI2YThkZjJkNmVjYTkyODdkMy90ZXh0cmVnaW9uOjQ1YWE3MTMwZDg4MzRhYjZhOGRmMmQ2ZWNhOTI4N2QzXzEwOTk1MTE2MjgyNzY4_623b2974-7fb6-4827-aacc-c50a8576abd4"
      unitRef="usd">0</us-gaap:ForeignEarningsRepatriated>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NTgvZnJhZzo0NWFhNzEzMGQ4ODM0YWI2YThkZjJkNmVjYTkyODdkMy90ZXh0cmVnaW9uOjQ1YWE3MTMwZDg4MzRhYjZhOGRmMmQ2ZWNhOTI4N2QzXzEwOTk1MTE2MjgyNzc2_0c102a5e-5578-44f4-8330-863792a60a95"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NTgvZnJhZzo0NWFhNzEzMGQ4ODM0YWI2YThkZjJkNmVjYTkyODdkMy90ZXh0cmVnaW9uOjQ1YWE3MTMwZDg4MzRhYjZhOGRmMmQ2ZWNhOTI4N2QzXzEwOTk1MTE2MjgyNzc2_790540e5-9b34-45b6-836a-cdb509edfae4"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NTgvZnJhZzo0NWFhNzEzMGQ4ODM0YWI2YThkZjJkNmVjYTkyODdkMy90ZXh0cmVnaW9uOjQ1YWE3MTMwZDg4MzRhYjZhOGRmMmQ2ZWNhOTI4N2QzXzEwOTk1MTE2MjgyNzY1_4026b52d-7dd0-47cf-9617-8525486b1c07"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NTgvZnJhZzo0NWFhNzEzMGQ4ODM0YWI2YThkZjJkNmVjYTkyODdkMy90ZXh0cmVnaW9uOjQ1YWE3MTMwZDg4MzRhYjZhOGRmMmQ2ZWNhOTI4N2QzXzEwOTk1MTE2MjgyNzY1_ee060e2e-7a31-4e65-96dd-90ef339f43b0"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NTgvZnJhZzo0NWFhNzEzMGQ4ODM0YWI2YThkZjJkNmVjYTkyODdkMy90ZXh0cmVnaW9uOjQ1YWE3MTMwZDg4MzRhYjZhOGRmMmQ2ZWNhOTI4N2QzXzEyNjQ0MzgzNzI0NDIw_5d3edb14-7dd3-467e-afe0-8cc6ce51f5d4"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NTgvZnJhZzo0NWFhNzEzMGQ4ODM0YWI2YThkZjJkNmVjYTkyODdkMy90ZXh0cmVnaW9uOjQ1YWE3MTMwZDg4MzRhYjZhOGRmMmQ2ZWNhOTI4N2QzXzEyNjQ0MzgzNzI0NDIw_88f65c56-d69a-4f97-957f-2df19f1428e6"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i8a79cdf54f8341f5939209c59107cddb_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NTgvZnJhZzo0NWFhNzEzMGQ4ODM0YWI2YThkZjJkNmVjYTkyODdkMy90ZXh0cmVnaW9uOjQ1YWE3MTMwZDg4MzRhYjZhOGRmMmQ2ZWNhOTI4N2QzXzExNTU_2faead93-4fe9-45b5-a4b0-f69759985e3e"
      unitRef="number">0.280</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzEzNzQzODk1MzUyMjEx_8f0f3727-34f2-453c-9381-01643e30a207">Share-Based Compensation&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company offers share option plans to employees, directors, and others providing similar employee-related services, which meet the definition of an equity-settled share-based payment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Options &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has five ownership-based participation rights schemes for employees, directors, and certain third-party providers. In accordance with the provisions of the schemes, as approved by the directors and shareholders, grantees have been granted options to purchase common shares at an exercise price based on the fair value price of the Company&#x2019;s common shares on the date of grant as approved by the directors. The stock options generally have a service condition of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzEyNjQ0MzgzNzI0Mzkx_1f5323c0-bbe0-45e6-bfd6-3ba4780f1116"&gt;two&lt;/span&gt; to five years and vest over time as the service condition is being satisfied. Upon termination of employment, unvested stock options are evaluated for forfeiture or modifications, subject to the terms of the awards and Company's policies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock option awards outstanding as of September&#160;30, 2022 and changes during the period ended September&#160;30, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares under option (thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average remaining contractual term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate intrinsic value (thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expecting to vest at January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.85&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled/forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.39&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expecting to vest at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.39&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.56&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded compensation expense of $2,067 and $1,790 for the nine months ended September&#160;30, 2022 and September&#160;30, 2021, respectively. Unrecognized compensation costs as of September&#160;30, 2022 was $3,835 and will be recognized over a weighted average of 2.27 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Stock Awards (&#x201c;RSAs&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSAs become eligible to vest upon the satisfaction of a time-based service condition. However, in order to vest, a liquidity event, defined as acquisition, asset transfer, or initial listing, must occur within 10 years from the grant date. Upon a liquidity event, if the participant&#x2019;s service has not terminated, the entire RSA award vests in full, whether or not previously eligible for vesting. If the participant&#x2019;s service has terminated and they have satisfied the time-based service condition, the RSAs that are outstanding and eligible for vesting shall immediately vest in full. The time-based service requirements of the RSAs have a maximum term of three years from the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022, there were 579,660 outstanding unvested shares for a weighted average fair value of $4.72. There were no changes during the nine months ended September&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022, and September&#160;30, 2021 the Company concluded that the liquidity event performance condition described above for the RSAs was not probable of being satisfied at such time. As a result, the Company did not recognize any compensation cost during the nine months ended September&#160;30, 2022 and September&#160;30, 2021 for any RSAs granted.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;Stock-Based Compensation&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company offers share option plans to employees, directors, and others providing consulting services, which meet the definition of an equity-settled stock-based payment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Options &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has five ownership-based participation rights schemes for employees, directors, and certain third-party providers. In accordance with the provisions of the schemes, as approved by the directors and shareholders, grantees have been granted options to purchase common shares at an exercise price based on the fair value price of the Company&#x2019;s common shares on the date of grant as approved by the directors. The stock options generally have a service condition of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEwOTk1MTE2Mjg0Mzgw_848b9b44-6118-41f1-9447-548b3ddf83fb"&gt;two&lt;/span&gt; to five years and vest over time as the service condition is being satisfied. In November 2020, the Company granted 151,068 options which have a performance condition that accelerates vesting on liquidity event. All stock options have a term of 10 years from the date of grant. Upon termination of employment, unvested stock options are evaluated for forfeiture or modifications, subject to the terms of the awards and Company's policies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock option awards outstanding as of December&#160;31, 2021 and changes during the year ended December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares under option (thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average remaining contractual term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate intrinsic value (thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding at January 1, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.09&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expecting to vest at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.09&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercisable at January 1, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.47&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(721)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled/forfeited/expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expecting to vest at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercisable at December 31, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.85&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded compensation expense of $2,531 and $2,392 for the years ended December&#160;31, 2021 and 2020, respectively. Unrecognized compensation costs as of December&#160;31, 2021 was $6,120 and will be recognized over a weighted average of 2.7 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each stock option award was estimated on each grant date using the Black-Scholes option pricing model. The following assumptions were used and required significant judgment to determine:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Expected Term&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; the Company used the &#x201c;simplified method&#x201d; for estimating the expected term of plain-vanilla options, whereby the expected term equals the arithmetic average of the vesting term and LanzaTech&#x2019;s contractual term of the option. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Risk-Free Interest Rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; The risk-free interest rate is based on the U.S. Treasury zero-coupon instruments with maturities similar to the expected term of LanzaTech&#x2019;s stock options. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Expected Dividend&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; the expected dividend yield is based on the Company's expectation of future dividend payouts to common stockholders. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Expected Volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; Due to the Company's limited historical data, a group of similar companies that are publicly traded was used to estimate the expected volatility. The historical volatility data was computed using the daily closing prices for the various companies' shares during the equivalent period of the calculated expected term of the stock-based awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the weighted-average assumptions applied in the Black-Scholes valuation of options for awards subject to expense recognition for the first time in the period, for the years ended December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average grant date fair value of options granted during 2021 and 2020 was $6.29 and $3.99 per option, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Stock Awards (&#x201c;RSAs&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSAs become eligible to vest upon the satisfaction of a time-based service condition. However, in order to vest, a liquidity event, defined as acquisition, asset transfer, or initial listing, must occur within 10 years from the grant date. Upon a liquidity event, if the participant&#x2019;s service has not terminated, the entire RSA award vests in full, whether or not previously eligible for vesting. If the participant&#x2019;s service has terminated and they have satisfied the time-based service condition, the RSAs that are outstanding and eligible for vesting shall immediately vest in full. The time-based service requirements of the RSAs have a maximum term of three years from the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSAs as of December&#160;31, 2021 and changes during the year ended December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nonvested Shares (thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding at January 1, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021 and 2020, the Company concluded that the liquidity event performance condition described above for the RSAs was not probable of being satisfied at such time. As a result, the Company did not recognize any compensation cost during the years ended December&#160;31, 2021 and 2020 for any RSAs granted.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <amci:NumberOfShareBasedStockSchemes
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzEwOTk1MTE2MjgyNzg1_058a1350-8b17-4355-9766-2df0c815688a"
      unitRef="scheme">5</amci:NumberOfShareBasedStockSchemes>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
      contextRef="ibd4d0f3725b743bb9a13d0e7f76a6680_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzEyNjQ0MzgzNzI0NDAx_775b83b1-d5c4-4a00-adf7-622503806752">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzEzNzQzODk1MzUyMjEz_245539e9-9434-4f0f-85af-c855bc39d18e">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock option awards outstanding as of September&#160;30, 2022 and changes during the period ended September&#160;30, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares under option (thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average remaining contractual term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate intrinsic value (thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expecting to vest at January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.85&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled/forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.39&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expecting to vest at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.39&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.56&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock option awards outstanding as of December&#160;31, 2021 and changes during the year ended December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares under option (thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average remaining contractual term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate intrinsic value (thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding at January 1, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.09&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expecting to vest at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.09&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercisable at January 1, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.47&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(721)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled/forfeited/expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expecting to vest at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercisable at December 31, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.85&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzEtMS0xLTEtOTA3MTc_ca49e918-ae00-489b-af55-b54d591b40e0"
      unitRef="shares">3848000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzEtMy0xLTEtOTA3MTc_40107fe1-3161-41bf-8256-163471a0dab5"
      unitRef="usdPerShare">6.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzEtNS0xLTEtOTA3MTc_b6d020b8-97c8-4d43-99b1-7a876e067cb0">P6Y1M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzEtNy0xLTEtOTA3MTc_fee98050-af1e-413d-b2e8-770a25acdd8a"
      unitRef="usd">27796000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzItMS0xLTEtOTA3MTc_6cf76058-8183-4c58-a646-d46085f9952a"
      unitRef="shares">3848000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzItMy0xLTEtOTA3MTc_56cd5b9b-3bd9-4263-be51-991e46fd83f5"
      unitRef="usdPerShare">6.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzItNS0xLTEtOTA3MTc_979be31b-92a1-43aa-9222-701e0706a563">P6Y1M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzItNy0xLTEtOTA3MTc_f854138a-6619-4785-b847-b6a2cc3961c1"
      unitRef="usd">27796000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzMtMS0xLTEtOTA3MTc_4b124198-0039-4cee-b350-a8bfce975028"
      unitRef="shares">2479000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzMtMy0xLTEtOTA3MTc_24ae6db1-e3a3-49e9-ad58-431e4f727586"
      unitRef="usdPerShare">6.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzMtNS0xLTEtOTA3MTc_a2fab849-153d-4d4f-a704-7c83a5510251">P4Y10M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzMtNy0xLTEtOTA3MTc_2d8705f8-b6b6-4852-8287-92b7153c4e88"
      unitRef="usd">18499000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzQtMS0xLTEtOTA3MTc_abc1315c-d5cb-470f-b6c6-b9f0339b39e4"
      unitRef="shares">3000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzQtMy0xLTEtOTA3MTc_a8e6d36b-61e8-47e5-a487-a25d8e3b4dfb"
      unitRef="usdPerShare">6.75</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzQtNy0xLTEtOTA3MTc_594ad8fa-a982-4681-9170-856adaa03d4f"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzUtMS0xLTEtOTA3MTc_307d66c5-92ca-4923-bd41-03b78ba3c550"
      unitRef="shares">38000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzUtMy0xLTEtOTA3MTc_b0476843-94fb-4570-b20d-77a2d00be2a8"
      unitRef="usdPerShare">9.55</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <amci:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzUtNy0xLTEtOTA3MTc_d5a1c51f-3c49-4e3d-8026-94ae0692877f"
      unitRef="usd">188000</amci:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzYtMS0xLTEtOTA3MTc_1d63206c-27c2-426c-af75-a466adb607e2"
      unitRef="shares">1000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzYtMy0xLTEtOTA3MTc_854d721e-c1e7-45fe-86a8-a16ba0f840bb"
      unitRef="usdPerShare">6.61</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <amci:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzYtNy0xLTEtOTA3MTc_e71d31f2-ce29-47c5-9655-f054a0a3a3f7"
      unitRef="usd">4000</amci:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzctMS0xLTEtOTA3MTc_8840b6e3-4a2e-45c0-8f43-4089897a8d23"
      unitRef="shares">3806000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzctMy0xLTEtOTA3MTc_d4585a78-83cf-40a3-863b-d5b5c2d76feb"
      unitRef="usdPerShare">6.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzctNS0xLTEtOTA3MTc_97c08d4d-7d8b-4aa1-91d0-33366bff08b9">P5Y4M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzctNy0xLTEtOTA3MTc_56935bc3-9bde-4aed-bb82-56c8de73cb0d"
      unitRef="usd">42032000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzgtMS0xLTEtOTA3MTc_f79c4a24-4bf9-4c3c-9cfd-37ca5e255d1d"
      unitRef="shares">3806000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzgtMy0xLTEtOTA3MTc_eb344375-e6c9-4f66-9240-e43c0222380a"
      unitRef="usdPerShare">6.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzgtNS0xLTEtOTA3MTc_c7090c6d-6076-40d4-9750-60d25de57cc4">P5Y4M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzgtNy0xLTEtOTA3MTc_2b9178a8-bcb3-43b2-bf7d-e87b5b310276"
      unitRef="usd">42032000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzktMS0xLTEtOTA3MTc_d3ccd9a2-94e5-46b9-bfc8-67c7d23e13f6"
      unitRef="shares">2918000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzktMy0xLTEtOTA3MTc_9eb92e7f-7a86-4c06-8208-d906e435f0c7"
      unitRef="usdPerShare">6.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzktNS0xLTEtOTA3MTc_0a081f18-2061-49d3-b5d1-070d2ac14640">P4Y6M21D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90YWJsZTpiMjU4OWU1MmIzNTQ0MTI5YjVhZDA0YjA4NGU5ZWY3OS90YWJsZXJhbmdlOmIyNTg5ZTUyYjM1NDQxMjliNWFkMDRiMDg0ZTllZjc5XzktNy0xLTEtOTA3MTc_698de498-11ba-48e9-80e9-94b9bdc9d868"
      unitRef="usd">32874000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzExMDQ_888ba1d1-fbc5-41d0-9a3d-104c7d8b0de6"
      unitRef="usd">2067000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzExMTE_3614c777-7902-4bd5-bb0a-c2bc56ba1eb0"
      unitRef="usd">1790000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzEyMTA_5e8eb45e-7d32-4cac-8369-ae0b69afc8c8"
      unitRef="usd">3835000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="id580de21b42b4e398c7373ee2244ec4a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzEwOTk1MTE2MjgyNzc0_075c25e1-bde5-455a-b7ce-9113b2c7cef9">P2Y3M7D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i5b4e3fd1f02f47b5a39f57e583f20233_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzEyNjQ0MzgzNzI0NDE5_cccdd4f8-4833-43c2-8338-6f36cb1ae731">P10Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
      contextRef="i5b4e3fd1f02f47b5a39f57e583f20233_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzEwOTk1MTE2MjgyNzk0_483ea750-2f04-4179-b2e4-d1d1f3c0abf0">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i64009d0294a6447cbb23d3d0c5282ca7_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzIwMjI_212e5337-c586-4d24-bb64-7b66abfd0956"
      unitRef="shares">579660</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i64009d0294a6447cbb23d3d0c5282ca7_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzIwOTE_4dec10ac-3039-439f-bcc6-1bb881c7d36a"
      unitRef="usdPerShare">4.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9e411fa8a71f41a3b345b23c815aba64_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzEwOTk1MTE2MjgyNzc2_82d4152a-9b37-433a-8f10-d806522e973a"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5b4e3fd1f02f47b5a39f57e583f20233_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NjUvZnJhZzo4MzVlNjc2ZjhjOGE0NGQyYWE1ZGZiNzRjNzZhN2VlYi90ZXh0cmVnaW9uOjgzNWU2NzZmOGM4YTQ0ZDJhYTVkZmI3NGM3NmE3ZWViXzEwOTk1MTE2MjgyNzc2_a63a8e48-d9ad-4af1-896e-9f4e05b3e244"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:Investments
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90ZXh0cmVnaW9uOmNmNDZjNGQ4MWIwZjRkNWQ5ZTMwMzRiZjBjOGRjOGNlXzE1MA_e0284e2c-3b46-432a-8f0e-5f914d69a273"
      unitRef="usd">26037000</us-gaap:Investments>
    <us-gaap:Investments
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90ZXh0cmVnaW9uOmNmNDZjNGQ4MWIwZjRkNWQ5ZTMwMzRiZjBjOGRjOGNlXzE1Nw_d9f7b924-0b4d-4aae-9135-964d3edfa8c9"
      unitRef="usd">24752000</us-gaap:Investments>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90ZXh0cmVnaW9uOmNmNDZjNGQ4MWIwZjRkNWQ5ZTMwMzRiZjBjOGRjOGNlXzEzNzQzODk1MzUzNzMz_582e6c4d-7037-4798-820b-0e5520fe0f68">The table below summarizes amounts related to transactions with these related parties (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases and open accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90YWJsZToxYWNiYjg1NzgzZDc0Y2I5YTYyZjI0NzYyNzUyNGRiYS90YWJsZXJhbmdlOjFhY2JiODU3ODNkNzRjYjlhNjJmMjQ3NjI3NTI0ZGJhXzItMS0xLTEtOTA3MTc_51141796-7690-4de4-94b4-c251b37b43a8"
      unitRef="usd">2116000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90YWJsZToxYWNiYjg1NzgzZDc0Y2I5YTYyZjI0NzYyNzUyNGRiYS90YWJsZXJhbmdlOjFhY2JiODU3ODNkNzRjYjlhNjJmMjQ3NjI3NTI0ZGJhXzItMy0xLTEtOTA3MTc_7fc9fdae-edd5-4ee0-99b7-4791485469e3"
      unitRef="usd">2348000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:AccountsReceivableNet
      contextRef="i6c25a29e3caa42e99299fc9c41c7bac1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90YWJsZToxYWNiYjg1NzgzZDc0Y2I5YTYyZjI0NzYyNzUyNGRiYS90YWJsZXJhbmdlOjFhY2JiODU3ODNkNzRjYjlhNjJmMjQ3NjI3NTI0ZGJhXzYtMS0xLTEtOTA3MTc_6c2724f9-d426-4846-aaac-70120887ea95"
      unitRef="usd">1509000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="id33f2498c7aa4d4ba897810160258324_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90YWJsZToxYWNiYjg1NzgzZDc0Y2I5YTYyZjI0NzYyNzUyNGRiYS90YWJsZXJhbmdlOjFhY2JiODU3ODNkNzRjYjlhNjJmMjQ3NjI3NTI0ZGJhXzYtMy0xLTEtOTA3MTc_c8bd1f41-7a6b-4fc1-abb4-ae4e65e89156"
      unitRef="usd">1071000</us-gaap:AccountsReceivableNet>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i6c25a29e3caa42e99299fc9c41c7bac1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90YWJsZToxYWNiYjg1NzgzZDc0Y2I5YTYyZjI0NzYyNzUyNGRiYS90YWJsZXJhbmdlOjFhY2JiODU3ODNkNzRjYjlhNjJmMjQ3NjI3NTI0ZGJhXzctMS0xLTEtOTA3MTc_ea88b0f7-cad3-4a82-8978-cf8adea80083"
      unitRef="usd">73000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="id33f2498c7aa4d4ba897810160258324_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90YWJsZToxYWNiYjg1NzgzZDc0Y2I5YTYyZjI0NzYyNzUyNGRiYS90YWJsZXJhbmdlOjFhY2JiODU3ODNkNzRjYjlhNjJmMjQ3NjI3NTI0ZGJhXzctMy0xLTEtOTA3MTc_a3fa96fd-69cb-42b9-a071-25667561a634"
      unitRef="usd">60000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <amci:PurchasesAndOpenAccountsPayableRelatedParties
      contextRef="i6c25a29e3caa42e99299fc9c41c7bac1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90YWJsZToxYWNiYjg1NzgzZDc0Y2I5YTYyZjI0NzYyNzUyNGRiYS90YWJsZXJhbmdlOjFhY2JiODU3ODNkNzRjYjlhNjJmMjQ3NjI3NTI0ZGJhXzgtMS0xLTEtOTA3MTc_78c8679c-1e57-49ec-aabf-7f793f9851f3"
      unitRef="usd">1863000</amci:PurchasesAndOpenAccountsPayableRelatedParties>
    <amci:PurchasesAndOpenAccountsPayableRelatedParties
      contextRef="id33f2498c7aa4d4ba897810160258324_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90YWJsZToxYWNiYjg1NzgzZDc0Y2I5YTYyZjI0NzYyNzUyNGRiYS90YWJsZXJhbmdlOjFhY2JiODU3ODNkNzRjYjlhNjJmMjQ3NjI3NTI0ZGJhXzgtMy0xLTEtOTA3MTc_63a10f3b-5f06-42a4-bc3e-77cceb36f635"
      unitRef="usd">2575000</amci:PurchasesAndOpenAccountsPayableRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i578fdaf743b64320848f4efd3fbff206_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90ZXh0cmVnaW9uOmNmNDZjNGQ4MWIwZjRkNWQ5ZTMwMzRiZjBjOGRjOGNlXzExOTY_23f94841-a53f-4399-8d41-e5260d78c354"
      unitRef="usd">148000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i68abf404f20a4c66a39987d6172c4179_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90ZXh0cmVnaW9uOmNmNDZjNGQ4MWIwZjRkNWQ5ZTMwMzRiZjBjOGRjOGNlXzEyMDM_64cb5f78-4e5b-4b8b-beb8-523ce526b902"
      unitRef="usd">355000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i3e23e5276e6d4282a2e9f97732511ff8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90ZXh0cmVnaW9uOmNmNDZjNGQ4MWIwZjRkNWQ5ZTMwMzRiZjBjOGRjOGNlXzE1NzY_986a5c2a-f22a-45c4-90cf-87c84ec3f45c"
      unitRef="usd">170000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i8acbdb690ad34c79ba365f582f00b5da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90ZXh0cmVnaW9uOmNmNDZjNGQ4MWIwZjRkNWQ5ZTMwMzRiZjBjOGRjOGNlXzE1ODM_7d603ec1-d1df-47c6-8a83-198af78361bd"
      unitRef="usd">403000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i85c0c3423aa7412ca1b42997ac78fe99_I20200531"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90ZXh0cmVnaW9uOmNmNDZjNGQ4MWIwZjRkNWQ5ZTMwMzRiZjBjOGRjOGNlXzEyNjQ0MzgzNzI1OTQw_26139f3c-aaec-4d1a-b6b8-c846bdd6c984">P10Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <amci:LesseeOperatingLeaseNumberOfRenewalTerms
      contextRef="i85c0c3423aa7412ca1b42997ac78fe99_I20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90ZXh0cmVnaW9uOmNmNDZjNGQ4MWIwZjRkNWQ5ZTMwMzRiZjBjOGRjOGNlXzE1OTQyOTE4NjA5Mjky_5ad92fc8-4739-4eff-a082-e0e70cf79fa9"
      unitRef="renewal_option">5</amci:LesseeOperatingLeaseNumberOfRenewalTerms>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i85c0c3423aa7412ca1b42997ac78fe99_I20200531"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90ZXh0cmVnaW9uOmNmNDZjNGQ4MWIwZjRkNWQ5ZTMwMzRiZjBjOGRjOGNlXzE1OTQyOTE4NjA5MzA3_c384846c-f7ad-43ca-a277-f68ab207dc4f">P1Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceived
      contextRef="i85c0c3423aa7412ca1b42997ac78fe99_I20200531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90ZXh0cmVnaW9uOmNmNDZjNGQ4MWIwZjRkNWQ5ZTMwMzRiZjBjOGRjOGNlXzEyNjQ0MzgzNzI1OTM2_ca3e8d68-71c1-4c56-8196-fbd5f6714614"
      unitRef="usd">24000</us-gaap:LessorOperatingLeasePaymentsToBeReceived>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i82d95c66ecd54340a53c89c11d9122a0_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90ZXh0cmVnaW9uOmNmNDZjNGQ4MWIwZjRkNWQ5ZTMwMzRiZjBjOGRjOGNlXzIzNzE_ee896a0a-532a-4272-a0af-1e34befd0f3b"
      unitRef="usd">151000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="ica64ee13842e4d87b58d8e0776c87382_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90ZXh0cmVnaW9uOmNmNDZjNGQ4MWIwZjRkNWQ5ZTMwMzRiZjBjOGRjOGNlXzIzNzg_6a4eb452-06b9-438e-b3d9-46e8c14255f9"
      unitRef="usd">69000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i82d95c66ecd54340a53c89c11d9122a0_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90ZXh0cmVnaW9uOmNmNDZjNGQ4MWIwZjRkNWQ5ZTMwMzRiZjBjOGRjOGNlXzI0NjY_6f13e134-b2c7-44bb-b546-4d5eef37c3f4"
      unitRef="usd">893000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="ica64ee13842e4d87b58d8e0776c87382_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83NzMvZnJhZzpjZjQ2YzRkODFiMGY0ZDVkOWUzMDM0YmYwYzhkYzhjZS90ZXh0cmVnaW9uOmNmNDZjNGQ4MWIwZjRkNWQ5ZTMwMzRiZjBjOGRjOGNlXzI0NzM_b2383ea6-950c-4cff-ab87-a86b51b3e406"
      unitRef="usd">1171000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="idce0b2fa8b1948daac1bdd0c26b6d051_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzEtMS0xLTEtOTA3MTc_d6bfd1e6-b72f-4baa-9114-dc9f3522c5ed"
      unitRef="shares">4666503</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="idce0b2fa8b1948daac1bdd0c26b6d051_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzEtMy0xLTEtOTA3MTc_bfc21d00-d498-47b9-ac62-e5d7ad89a098"
      unitRef="shares">4666503</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="idce0b2fa8b1948daac1bdd0c26b6d051_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzEtMy0xLTEtOTA3MTc_d1f43b1f-4f1b-48e3-aba3-45c9a26f478f"
      unitRef="shares">4666503</us-gaap:TemporaryEquitySharesOutstanding>
    <amci:TemporaryEquityIssuePricePerShare
      contextRef="i1dfc06d3caf74e879b017b7ba4bccc6c_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzEtNS0xLTEtOTA3MTcvdGV4dHJlZ2lvbjo2MDI0NzlkMDhiNDc0MmRkODAzOTk5NmRmZTQ4MTEzNV81NDk3NTU4MTM5MDk_8c325cde-957c-43bc-a33f-3e7c1be91fc8"
      unitRef="usdPerShare">1.75</amci:TemporaryEquityIssuePricePerShare>
    <amci:TemporaryEquityIssuePricePerShare
      contextRef="i9b90ee4e94cb439f99b65328a21b6c23_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzEtNS0xLTEtOTA3MTcvdGV4dHJlZ2lvbjo2MDI0NzlkMDhiNDc0MmRkODAzOTk5NmRmZTQ4MTEzNV81NDk3NTU4MTM5MTY_18840379-ed0b-4a02-8cf7-ad4d4e4cb5ea"
      unitRef="usdPerShare">3.94</amci:TemporaryEquityIssuePricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="idce0b2fa8b1948daac1bdd0c26b6d051_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzEtNy0xLTEtOTA3MTc_35397cc3-d4a7-42c2-9a6a-a998421152e2"
      unitRef="usd">12230000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="ib7233a4b0cd54bc9b9d31a1fda4e4f29_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzItMS0xLTEtOTA3MTc_e820fad7-9b77-4a8d-a57e-589863ee5cb4"
      unitRef="shares">1733370</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ib7233a4b0cd54bc9b9d31a1fda4e4f29_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzItMy0xLTEtOTA3MTc_8ea52767-5690-4746-8d2d-f7230edbed10"
      unitRef="shares">1733370</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="ib7233a4b0cd54bc9b9d31a1fda4e4f29_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzItMy0xLTEtOTA3MTc_c7baf515-a9b1-417b-933e-82068209a9fa"
      unitRef="shares">1733370</us-gaap:TemporaryEquitySharesIssued>
    <amci:TemporaryEquityIssuePricePerShare
      contextRef="ib7233a4b0cd54bc9b9d31a1fda4e4f29_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzItNS0xLTEtOTA3MTc_1e19e36a-f1f6-4254-95da-fbe19e8bbfca"
      unitRef="usdPerShare">10.38</amci:TemporaryEquityIssuePricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ib7233a4b0cd54bc9b9d31a1fda4e4f29_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzItNy0xLTEtOTA3MTc_f6788442-1ea2-4c8a-b2c8-548075b4a20c"
      unitRef="usd">18000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i1f16b3d33a074e1ba14330da0255fa2f_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzMtMS0xLTEtOTA3MTc_803fdf6e-d6c5-494a-8952-23a2f9625545"
      unitRef="shares">4254733</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i1f16b3d33a074e1ba14330da0255fa2f_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzMtMy0xLTEtOTA3MTc_31ded89c-36cb-419e-a5af-16a2f885c82c"
      unitRef="shares">4142408</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i1f16b3d33a074e1ba14330da0255fa2f_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzMtMy0xLTEtOTA3MTc_efc3c2f1-eb5d-439b-9980-91e4a7a8aaa9"
      unitRef="shares">4142408</us-gaap:TemporaryEquitySharesOutstanding>
    <amci:TemporaryEquityIssuePricePerShare
      contextRef="i1f16b3d33a074e1ba14330da0255fa2f_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzMtNS0xLTEtOTA3MTc_912fe16e-9e83-4660-8635-156020b2b88c"
      unitRef="usdPerShare">14.69</amci:TemporaryEquityIssuePricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i1f16b3d33a074e1ba14330da0255fa2f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzMtNy0xLTEtOTA3MTc_a55d53fb-6537-4482-b66a-5c8814e27d6c"
      unitRef="usd">60850000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="iab3c900d2c4e4b2a91220c825b2d6956_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzQtMS0xLTEtOTA3MTc_5dc6cfb9-e8fc-4ae9-80c8-3238434e08f7"
      unitRef="shares">10274260</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="iab3c900d2c4e4b2a91220c825b2d6956_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzQtMy0xLTEtOTA3MTc_96eb25e5-bdb4-4684-b388-a5050ba27615"
      unitRef="shares">10161362</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="iab3c900d2c4e4b2a91220c825b2d6956_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzQtMy0xLTEtOTA3MTc_b53a1568-1227-44f0-90ef-ab8fa0815669"
      unitRef="shares">10161362</us-gaap:TemporaryEquitySharesIssued>
    <amci:TemporaryEquityIssuePricePerShare
      contextRef="iab3c900d2c4e4b2a91220c825b2d6956_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzQtNS0xLTEtOTA3MTc_10e12ed8-f7c6-4e58-b450-f4d91fda6827"
      unitRef="usdPerShare">19.93</amci:TemporaryEquityIssuePricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="iab3c900d2c4e4b2a91220c825b2d6956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzQtNy0xLTEtOTA3MTc_32a41864-ab01-4427-b42c-bf777b1971f2"
      unitRef="usd">188402000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="ie4c4d87c859840cc99ff35a606293d63_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzUtMS0xLTEtOTA3MTc_ed0bf039-d01e-4f24-ac15-ec9a3582de0d"
      unitRef="shares">5183957</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ie4c4d87c859840cc99ff35a606293d63_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzUtMy0xLTEtOTA3MTc_bb90b170-30b7-46d4-a8ce-71e3230efed1"
      unitRef="shares">5183957</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="ie4c4d87c859840cc99ff35a606293d63_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzUtMy0xLTEtOTA3MTc_e57fcd0c-211b-47ba-b93d-e9ee7b84db8b"
      unitRef="shares">5183957</us-gaap:TemporaryEquitySharesIssued>
    <amci:TemporaryEquityIssuePricePerShare
      contextRef="ie4c4d87c859840cc99ff35a606293d63_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzUtNS0xLTEtOTA3MTc_9876f389-f177-4cd4-a81a-14f26138514a"
      unitRef="usdPerShare">22.86</amci:TemporaryEquityIssuePricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ie4c4d87c859840cc99ff35a606293d63_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzUtNy0xLTEtOTA3MTc_60d635fe-aba2-4aa4-b26f-78f37ac4973d"
      unitRef="usd">118076000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i1d3aaae919f443669873c0b2494eb950_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzYtMS0xLTEtOTA3MTc_89fe3b53-4a51-41ed-8de5-3035253ff7ec"
      unitRef="shares">3634210</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i1d3aaae919f443669873c0b2494eb950_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzYtMy0xLTEtOTA3MTc_58e6d317-990c-487f-865a-97e278f66da1"
      unitRef="shares">3634210</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i1d3aaae919f443669873c0b2494eb950_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzYtMy0xLTEtOTA3MTc_b8ffac56-3d6e-449d-aa2e-a39c3ad4aab4"
      unitRef="shares">3634210</us-gaap:TemporaryEquitySharesIssued>
    <amci:TemporaryEquityIssuePricePerShare
      contextRef="i1d3aaae919f443669873c0b2494eb950_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzYtNS0xLTEtOTA3MTc_725f45a4-e3dc-4402-9758-26dadb26eb37"
      unitRef="usdPerShare">22.86</amci:TemporaryEquityIssuePricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i1d3aaae919f443669873c0b2494eb950_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzYtNy0xLTEtOTA3MTc_c7637558-f52a-4b69-a895-ece8d2969dd5"
      unitRef="usd">83073000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzctMS0xLTEtMTAzNTIz_fba0096b-225a-4e61-9f77-6e9ca8e93fa5"
      unitRef="shares">29747033</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzctMy0xLTEtMTAzNTIz_7c1c1aba-4479-4c1e-b4c9-9463a49b7871"
      unitRef="shares">29521810</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzctMy0xLTEtMTAzNTIz_e22cbe58-d101-464a-9208-939135bf053b"
      unitRef="shares">29521810</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90YWJsZTo3YjA0NzNiMGQ1OTM0MDg3ODk1MGJmMTg1MWI4NDE1Mi90YWJsZXJhbmdlOjdiMDQ3M2IwZDU5MzQwODc4OTUwYmYxODUxYjg0MTUyXzctNy0xLTEtMTAzNTIz_df66dc74-4a56-4c0d-9afe-a7be43829238"
      unitRef="usd">480631000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90ZXh0cmVnaW9uOmNmODQzZTk3ZjA2MDQ4MTY5ZTE0NDFlOWQ0M2QzYjFhXzEyNjQ0MzgzNzIyMjg5_56f147d4-0648-4c97-9d91-58a60458b1fa"
      unitRef="number">0.08</us-gaap:PreferredStockDividendRatePercentage>
    <amci:TemporaryEquitySharesConversionOfConvertibleSecurities
      contextRef="i9f67793938594975ad7e63e3f8a4f312_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90ZXh0cmVnaW9uOmNmODQzZTk3ZjA2MDQ4MTY5ZTE0NDFlOWQ0M2QzYjFhXzc5MA_7a61295e-3800-40ca-9b0e-7f99dc33386a"
      unitRef="shares">158058</amci:TemporaryEquitySharesConversionOfConvertibleSecurities>
    <amci:TemporaryEquityExerciseOfWarrants
      contextRef="i0e83a5ed9e3a42fbb38d656ae52b386c_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODUvZnJhZzpjZjg0M2U5N2YwNjA0ODE2OWUxNDQxZTlkNDNkM2IxYS90ZXh0cmVnaW9uOmNmODQzZTk3ZjA2MDQ4MTY5ZTE0NDFlOWQ0M2QzYjFhXzg4OQ_1399e738-a5e6-478c-8cbb-629ff8ae0015"
      unitRef="usd">3150000</amci:TemporaryEquityExerciseOfWarrants>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODkvZnJhZzo5YjA1YTA5OWZmMTc0Mjk4ODFlYzA2YzUxNDE4Y2Q1Zi90ZXh0cmVnaW9uOjliMDVhMDk5ZmYxNzQyOTg4MWVjMDZjNTE0MThjZDVmXzEyNjQ0MzgzNzIwMDI3_e8ad006d-1c80-462c-add7-c446719a194b"
      unitRef="usd">0</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="i8fe007d2f6c3443b96f79645ce3c9a76_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83ODkvZnJhZzo5YjA1YTA5OWZmMTc0Mjk4ODFlYzA2YzUxNDE4Y2Q1Zi90ZXh0cmVnaW9uOjliMDVhMDk5ZmYxNzQyOTg4MWVjMDZjNTE0MThjZDVmXzEyNjQ0MzgzNzIwMDI3_ec89333c-0a38-4707-b2c0-df830bcc25f9"
      unitRef="usd">0</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:OperatingLeasesOfLessorDisclosureTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OTYvZnJhZzpkNTZhODA0MDAzYTQ0ZDZjOWQ1NDNkZTFkYTdjMTk1ZC90ZXh0cmVnaW9uOmQ1NmE4MDQwMDNhNDRkNmM5ZDU0M2RlMWRhN2MxOTVkXzEwOTk1MTE2Mjc5NTk0_ae96a430-9041-4765-acd0-0f41a474d624">Leases &lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020, the Company executed an agreement to lease certain land to a subsidiary of LanzaJet for a period of 10 years with an option to renew this lease for five additional periods of one year with minimum annual rent due. This agreement is accounted for as an operating lease. In February 2022, the lease agreement with LanzaJet was amended to extend the pre-development term of the lease until the earlier of commencement of construction of the alcohol-to-jet fuel facility on the leased land or December 31, 2023 and increased the annual base rent amount. The Company recognizes lease revenue on a straight-line basis over the life of the lease agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents amounts included in Revenue from related party transactions in the Condensed Consolidated Statement of Operations related to lessor activity (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease income from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Leases &lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases certain office space and laboratory facilities. The Company&#x2019;s lease agreements typically do not contain any significant guarantees of asset values at the end of a lease, renewal options or restrictive covenants. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2019;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s adoption of ASC 842, Leases, all leases were classified as operating leases. During &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021 and 2020, t&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;he discount rate used in the calculation of lease liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;was 7.5%, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;which is the estimate of the rate of interest that the Company would have to pay to borrow on a collateralized basis over a similar term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total operating lease costs and variable lease costs for the years ended December&#160;31, 2021 and 2020 were $2,126 and $2,077 and $2,575 and $1,813, respectively. Cash paid for amounts included in the measurement of operating lease liabilities for the years ended December&#160;31, 2021 and 2020 was $2,059 and $1,765, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, lease payments for operating leases for the Company&#x2019;s office facility and laboratories are shown below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.279%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of weighted average remaining lease term and discount rate for all of the Company&#x2019;s operating leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessor Accounting&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020, the Company executed an agreement to lease certain land to a subsidiary of LanzaJet for a period of 10 years with an option to renew this lease for five additional periods of one year with minimum annual rent due. This agreement is accounted for as an operating lease. We recognize lease revenue on a straight-line basis over the life of the lease agreement. The following future minimum lease payments due to us from the lease agreement at December 31, 2021, is as follows (in thousands)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Lease revenue totaled $24 and $14 for the years ended December 31, 2021 and 2020.</us-gaap:OperatingLeasesOfLessorDisclosureTextBlock>
    <us-gaap:LessorOperatingLeaseTermOfContract
      contextRef="ife262e1009764f0ebe3fdfe5ad4fb494_I20200531"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OTYvZnJhZzpkNTZhODA0MDAzYTQ0ZDZjOWQ1NDNkZTFkYTdjMTk1ZC90ZXh0cmVnaW9uOmQ1NmE4MDQwMDNhNDRkNmM5ZDU0M2RlMWRhN2MxOTVkXzEyNjQ0MzgzNzIxMjE1_d7909957-7f56-4cc2-a08f-ea21a5fcda30">P10Y</us-gaap:LessorOperatingLeaseTermOfContract>
    <amci:LesssorOperatingLeaseNumberOfRenewalOptions
      contextRef="i8afc523d3a4c48d79839de0f31b51d9c_D20200501-20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OTYvZnJhZzpkNTZhODA0MDAzYTQ0ZDZjOWQ1NDNkZTFkYTdjMTk1ZC90ZXh0cmVnaW9uOmQ1NmE4MDQwMDNhNDRkNmM5ZDU0M2RlMWRhN2MxOTVkXzEyNjQ0MzgzNzIxMjMw_0f62e767-c37f-49cc-be6a-94d320e30d94"
      unitRef="renewal_option">5</amci:LesssorOperatingLeaseNumberOfRenewalOptions>
    <us-gaap:LessorOperatingLeaseRenewalTerm
      contextRef="ife262e1009764f0ebe3fdfe5ad4fb494_I20200531"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OTYvZnJhZzpkNTZhODA0MDAzYTQ0ZDZjOWQ1NDNkZTFkYTdjMTk1ZC90ZXh0cmVnaW9uOmQ1NmE4MDQwMDNhNDRkNmM5ZDU0M2RlMWRhN2MxOTVkXzEyNjQ0MzgzNzIxMjQz_79265e4c-6fa6-464d-95d4-c0c68f2016d0">P1Y</us-gaap:LessorOperatingLeaseRenewalTerm>
    <us-gaap:OperatingLeaseLeaseIncomeTableTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OTYvZnJhZzpkNTZhODA0MDAzYTQ0ZDZjOWQ1NDNkZTFkYTdjMTk1ZC90ZXh0cmVnaW9uOmQ1NmE4MDQwMDNhNDRkNmM5ZDU0M2RlMWRhN2MxOTVkXzEwOTk1MTE2Mjc5NTk1_04cf309e-d576-4ff2-9753-2b360ad4e13b">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents amounts included in Revenue from related party transactions in the Condensed Consolidated Statement of Operations related to lessor activity (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease income from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OperatingLeaseLeaseIncomeTableTextBlock>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="i274fc7fa467b4dfca60a8caf5ff1ce05_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OTYvZnJhZzpkNTZhODA0MDAzYTQ0ZDZjOWQ1NDNkZTFkYTdjMTk1ZC90YWJsZToxOWUyNjM5ODNiZDQ0MWQ4OTdiMzM0YjhiOThlOWU2YS90YWJsZXJhbmdlOjE5ZTI2Mzk4M2JkNDQxZDg5N2IzMzRiOGI5OGU5ZTZhXzItMS0xLTEtOTA3MTc_366f7789-15eb-47b1-a919-27882dfffeeb"
      unitRef="usd">25000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="i119eb57b7e1540229b6f3479667c5786_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF83OTYvZnJhZzpkNTZhODA0MDAzYTQ0ZDZjOWQ1NDNkZTFkYTdjMTk1ZC90YWJsZToxOWUyNjM5ODNiZDQ0MWQ4OTdiMzM0YjhiOThlOWU2YS90YWJsZXJhbmdlOjE5ZTI2Mzk4M2JkNDQxZDg5N2IzMzRiOGI5OGU5ZTZhXzItMy0xLTEtOTA3MTc_31de8e57-d15c-4bdb-9bfb-6ac6bc7a66ef"
      unitRef="usd">18000</us-gaap:OperatingLeaseLeaseIncome>
    <amci:FrameworkAgreementRequiredEquityFunding
      contextRef="i4d01e01ebc9943c18b155b63bbd4d023_I20221002"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzE1OTQyOTE4NjE4MTA2_65694e7f-fa8a-4483-a0d7-1aceb95b73bb"
      unitRef="usd">500000000</amci:FrameworkAgreementRequiredEquityFunding>
    <amci:SimpleAgreementForFutureEquityInitialPurchaseAmount
      contextRef="i82842e075dc846f3a2e003e61f072850_D20221002-20221002"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzEyNjQ0MzgzNzM0NzM5_f5f33273-c868-44b7-863f-cf48d363bc44"
      unitRef="usd">50000000</amci:SimpleAgreementForFutureEquityInitialPurchaseAmount>
    <amci:FrameworkAgreementRequiredEquityFundingForQualifyingProjects
      contextRef="i4d01e01ebc9943c18b155b63bbd4d023_I20221002"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzEyNjQ0MzgzNzM0NzUy_6d7e9c75-7fa3-485a-b470-77165fe598a9"
      unitRef="usd">50000000</amci:FrameworkAgreementRequiredEquityFundingForQualifyingProjects>
    <amci:FrameworkAgreementRequiredEquityFundingForQualifyingProjectsRemainingAmountReduction
      contextRef="i4d01e01ebc9943c18b155b63bbd4d023_I20221002"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzEyNjQ0MzgzNzM0NzY1_05bc8d7c-9e41-4c17-b528-dd1c01447a29"
      unitRef="usd">5000000</amci:FrameworkAgreementRequiredEquityFundingForQualifyingProjectsRemainingAmountReduction>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i8e9aa0cf9cf540058d33cfcb743c1b90_I20221109"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzEyNjQ0MzgzNzM0NzIz_d69d0a42-f0e4-4513-97d4-66686261d2b3"
      unitRef="usd">147000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i11190b90fcdd4adb805e60aa7b5e6559_I20221109"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzEyNjQ0MzgzNzM0NzAw_faac5577-97fa-4be7-9fed-c91004d54b75"
      unitRef="usd">113500000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <amci:LineOfCreditFacilityInterestRate
      contextRef="i11190b90fcdd4adb805e60aa7b5e6559_I20221109"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzEyNjQ0MzgzNzM0NzE2_98c0a522-7b45-46df-9f39-1e81ccfa9aa4"
      unitRef="number">0.0600</amci:LineOfCreditFacilityInterestRate>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i841691236bcc4a358b07eb492c06d80c_I20221109"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzEyNjQ0MzgzNzM0Njg1_e6f1bac0-7b4c-4dc3-92e9-f9bc88849ecb"
      unitRef="usd">33500000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <amci:LineOfCreditFacilityInterestRate
      contextRef="i841691236bcc4a358b07eb492c06d80c_I20221109"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzEyNjQ0MzgzNzM0Njc4_02e537c7-0cbb-47f4-8f0b-8a2685bbde25"
      unitRef="number">0.0600</amci:LineOfCreditFacilityInterestRate>
    <amci:NoteReceivableCommitmentToPurchase
      contextRef="icfc212252c93424d9125b3ea9c058464_I20221109"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzEyNjQ0MzgzNzM0NjY0_244ec4ef-760a-4779-b99a-43372894687d"
      unitRef="usd">5500000</amci:NoteReceivableCommitmentToPurchase>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i13deb916e76344f39ef3aa84463dff11_I20221109"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzEyNjQ0MzgzNzM0NjUw_6b10ff68-8358-491f-a350-3a3d0693be05"
      unitRef="shares">575</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <amci:ClassOfWarrantOrRightAmountOfNotesPurchased
      contextRef="i13deb916e76344f39ef3aa84463dff11_I20221109"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzEyNjQ0MzgzNzM0NjQx_2df417aa-8d04-416c-b6fc-23f6c9f07f49"
      unitRef="usd">10000</amci:ClassOfWarrantOrRightAmountOfNotesPurchased>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="icfc212252c93424d9125b3ea9c058464_I20221109"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzEyNjQ0MzgzNzM0NjU1_6f3b668a-9428-4660-a73b-821c69ec4afd"
      unitRef="shares">316250</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <amci:ReverseCapitalizationClosingCashCondition
      contextRef="i3e4ce82bb6ca465b8f60e74f553154c0_I20220308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzEyNjQ0MzgzNzM0NjA1_7a0957ab-e997-467c-a67e-abe53f87c375"
      unitRef="usd">250000000</amci:ReverseCapitalizationClosingCashCondition>
    <amci:ReverseCapitalizationClosingCashCondition
      contextRef="ia00417eab54343e78db23ff7c39f19cc_I20221207"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzEyNjQ0MzgzNzM0NjE5_093d1057-72fd-4818-8108-6fe5f26a0a11"
      unitRef="usd">230000000</amci:ReverseCapitalizationClosingCashCondition>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="ia00417eab54343e78db23ff7c39f19cc_I20221207"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF84MDEvZnJhZzo5YWU1MDk1YjU5OWU0YzYyYTEzMGYwZTM2NDY4ZWZiMC90ZXh0cmVnaW9uOjlhZTUwOTViNTk5ZTRjNjJhMTMwZjBlMzY0NjhlZmIwXzEyNjQ0MzgzNzM0NjMz_031c790b-d692-4570-8efd-e9b50f8bd402"
      unitRef="usdPerShare">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzUtMS0xLTEtOTA2MTg_eeef63a0-d6f1-4f00-a84e-80ba462c1ca7"
      unitRef="usd">128318000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzUtMy0xLTEtOTA2MTg_5e0796c0-5938-41d5-8adf-dfde7a897c23"
      unitRef="usd">60495000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzYtMS0xLTEtOTA2MTg_ebeaea22-4903-4268-a18c-7542bc7eef04"
      unitRef="usd">2878000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzYtMy0xLTEtOTA2MTg_5208a64c-070f-47f2-a346-07bcc808406b"
      unitRef="usd">5521000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzctMS0xLTEtOTA2MTg_1f366894-d382-4d98-bd78-895c0dab1ac5"
      unitRef="usd">11700000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzctMy0xLTEtOTA2MTg_36065a00-d6dd-45fe-8834-cd4557deedf7"
      unitRef="usd">6186000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzgtMS0xLTEtOTA2MTg_ae544e8b-7634-49eb-a531-73dbecd2b2f1"
      unitRef="usd">5779000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzgtMy0xLTEtOTA2MTg_f3191170-6d76-4d08-98c9-66d4e034a7fc"
      unitRef="usd">4387000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzktMS0xLTEtMTAwMDM0_f45ae89e-374f-4dde-9dac-19820bf9cf72"
      unitRef="usd">148675000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzktMy0xLTEtMTAwMDM0_cf36f115-4254-45f3-a70f-3290a69b9f33"
      unitRef="usd">76589000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzEwLTEtMS0xLTkwNjE4_d3556e6f-c694-4e3b-966c-f45eb25c4161"
      unitRef="usd">14148000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzEwLTMtMS0xLTkwNjE4_1eca5388-3fea-48a5-9af2-c8717b5b5daa"
      unitRef="usd">11609000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzExLTEtMS0xLTkwNjE4_1ea64747-d5ba-4547-9a83-046e06564b2d"
      unitRef="usd">4686000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzExLTMtMS0xLTkwNjE4_1ab7a265-861f-4bbf-84d9-b1141075fecd"
      unitRef="usd">6365000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:EquityMethodInvestments
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzEyLTEtMS0xLTkwNjE4_06dd6c9c-9a8d-46eb-8519-859fe3b9321e"
      unitRef="usd">24752000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzEyLTMtMS0xLTkwNjE4_3f21b6a2-b02e-45b1-9ba9-b0b464c13ecd"
      unitRef="usd">23217000</us-gaap:EquityMethodInvestments>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzEzLTEtMS0xLTkwNjE4_4d1b5a99-cf92-4dda-8710-57c27f386e7e"
      unitRef="usd">750000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzEzLTMtMS0xLTkwNjE4_d3ca67c4-1c72-4e5a-a3a7-7eedb6c8e506"
      unitRef="usd">1200000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzE0LTEtMS0xLTEwMDAzNA_6bd80eaa-da5c-4c45-975f-eda1f9d40154"
      unitRef="usd">193011000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzE0LTMtMS0xLTkwNjE4_1ec0e5ab-d374-4a97-a411-eba8e3a2e5e8"
      unitRef="usd">118980000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzE3LTEtMS0xLTkwNjE4_4dd88c53-d5f5-4ecb-a54c-9427d9e377dd"
      unitRef="usd">2444000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzE3LTMtMS0xLTkwNjE4_3b7ce1bb-7339-41f2-8924-03428c5fa70f"
      unitRef="usd">1147000</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzE4LTEtMS0xLTkwNjE4_f6796160-c7c9-4da0-a95e-82f9781146b3"
      unitRef="usd">7059000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzE4LTMtMS0xLTkwNjE4_bea734e6-b894-44aa-9b29-b8925bd38194"
      unitRef="usd">2897000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <amci:SimpleAgreementForFutureEquityLiability
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzE5LTEtMS0xLTkwNjE4_100a6ead-a1e9-425a-8ab5-05f7cc4ff5f2"
      unitRef="usd">28271000</amci:SimpleAgreementForFutureEquityLiability>
    <amci:SimpleAgreementForFutureEquityLiability
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzE5LTMtMS0xLTkwNjE4_3f7cbbb0-e973-4ca1-b235-05a90ede7538"
      unitRef="usd">0</amci:SimpleAgreementForFutureEquityLiability>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzIwLTEtMS0xLTkwNjE4_32370669-7205-47f9-8b4e-4b01571f5d24"
      unitRef="usd">1729000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzIwLTMtMS0xLTkwNjE4_3262c62a-7634-4dbb-8313-2e0322d885d5"
      unitRef="usd">0</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzIxLTEtMS0xLTkwNjE4_8a4d6d18-711d-4056-816f-3f29b6e11fc8"
      unitRef="usd">3476000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzIxLTMtMS0xLTkwNjE4_68260e99-ccff-4b6d-8257-45f9c8d2f2e4"
      unitRef="usd">5480000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzIyLTEtMS0xLTkwNjE4_84f68a43-c903-47ba-8c44-43f6e01c269c"
      unitRef="usd">4261000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzIyLTMtMS0xLTkwNjE4_8cd24b54-0e63-4102-a51f-b39d70a1d04f"
      unitRef="usd">3492000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzIzLTEtMS0xLTkwNjE4_5c1d8bb3-1b20-45ab-ab8d-e60e7d080768"
      unitRef="usd">2050000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzIzLTMtMS0xLTkwNjE4_f4130a79-8bf6-4b99-aeab-9b5be4df08b3"
      unitRef="usd">1618000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzI0LTEtMS0xLTkwNjE4_ca71cf4d-95c7-41ab-909a-c00664f57393"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzI0LTMtMS0xLTkwNjE4_00900c16-9c8f-4aae-998d-9eda5dd54391"
      unitRef="usd">570000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzI1LTEtMS0xLTEwMDAzNA_33c96333-92b3-47a7-89d4-dd83f0e0ff56"
      unitRef="usd">49290000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzI1LTMtMS0xLTEwMDAzNA_b40925ef-9507-425f-87b5-a206ef12b831"
      unitRef="usd">15204000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzI2LTEtMS0xLTkwNjE4_6e0502d7-32c6-4340-8d70-4c1e4100be85"
      unitRef="usd">3283000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzI2LTMtMS0xLTkwNjE4_78754351-0d53-43e7-a1cb-dc9e92e2d17f"
      unitRef="usd">5334000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzI3LTEtMS0xLTkwNjE4_8eae18a2-2e48-4582-bc67-bc892cda6f10"
      unitRef="usd">13901000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzI3LTMtMS0xLTkwNjE4_020f023c-7757-402f-9f11-0559ed68fb92"
      unitRef="usd">11291000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzI4LTEtMS0xLTkwNjE4_10e53d8b-9d19-4904-909c-d9ebb54a97bd"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzI4LTMtMS0xLTkwNjE4_52d0d1d8-c1b8-49c4-ae5e-fa21c7808f39"
      unitRef="usd">3065000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzI5LTEtMS0xLTkwNjE4_147a253b-d810-47e4-8a30-9d68e1c1ffc9"
      unitRef="usd">823000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzI5LTMtMS0xLTkwNjE4_56c0bd08-eadd-42ac-bf6c-d028a4cac82a"
      unitRef="usd">894000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzMwLTEtMS0xLTEwMDAzNA_747cf831-e930-442c-8d5d-b77fd93cffd7"
      unitRef="usd">67297000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzMwLTMtMS0xLTEwMDAzNA_83c19ec9-0cbd-476b-b89a-ba967d8a4de9"
      unitRef="usd">35788000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzMxLTEtMS0xLTEwMDA3Mw_30c73755-6798-476b-8804-a1e54e27d14d"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzMxLTMtMS0xLTEwMDA3MA_691e241e-6005-47eb-a977-654476c1b334"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM0LTAtMS0xLTkwNjE4L3RleHRyZWdpb246ZTAyYzNiZmI5Y2M1NDk5M2FiYjQyNTk3YTdiOTlmNjZfNDU_28c0f2ac-8575-4c75-b09e-60be838ff3e2"
      unitRef="usdPerShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM0LTAtMS0xLTkwNjE4L3RleHRyZWdpb246ZTAyYzNiZmI5Y2M1NDk5M2FiYjQyNTk3YTdiOTlmNjZfNDU_51423a24-69ec-4984-a548-076f60c64239"
      unitRef="usdPerShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM0LTAtMS0xLTkwNjE4L3RleHRyZWdpb246ZTAyYzNiZmI5Y2M1NDk5M2FiYjQyNTk3YTdiOTlmNjZfNTk_08b17727-6323-4015-9db3-4c87264488b8"
      unitRef="shares">29747033</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM0LTAtMS0xLTkwNjE4L3RleHRyZWdpb246ZTAyYzNiZmI5Y2M1NDk5M2FiYjQyNTk3YTdiOTlmNjZfNjY_c3e57ba9-87f0-4c58-9042-5f220fd69184"
      unitRef="shares">26112823</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM0LTAtMS0xLTkwNjE4L3RleHRyZWdpb246ZTAyYzNiZmI5Y2M1NDk5M2FiYjQyNTk3YTdiOTlmNjZfODg_d1280e21-ab82-41c6-968e-0ad8675b6aee"
      unitRef="shares">29521810</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM0LTAtMS0xLTkwNjE4L3RleHRyZWdpb246ZTAyYzNiZmI5Y2M1NDk5M2FiYjQyNTk3YTdiOTlmNjZfODg_ffa85e89-1c63-4120-8051-38d6969036dd"
      unitRef="shares">29521810</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM0LTAtMS0xLTkwNjE4L3RleHRyZWdpb246ZTAyYzNiZmI5Y2M1NDk5M2FiYjQyNTk3YTdiOTlmNjZfOTU_00c18d1b-e8eb-4944-9669-85e17463f623"
      unitRef="shares">25729542</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM0LTAtMS0xLTkwNjE4L3RleHRyZWdpb246ZTAyYzNiZmI5Y2M1NDk5M2FiYjQyNTk3YTdiOTlmNjZfOTU_c07c9700-55a9-4983-80d2-d682d4a43499"
      unitRef="shares">25729542</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM0LTEtMS0xLTkwNjE4_79172363-c892-48ce-aa25-cec9227a60f8"
      unitRef="usd">480631000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM0LTMtMS0xLTkwNjE4_4e60710b-982f-4f50-b189-aa411fc99cc0"
      unitRef="usd">394408000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM2LTAtMS0xLTkwNjE4L3RleHRyZWdpb246NzRmYWQzNDAzMjcwNDcwNzljYzllYjFkZmEzZTYzZjJfMTk_221c5847-09c8-4ac5-b97f-3a057c216f0f"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM2LTAtMS0xLTkwNjE4L3RleHRyZWdpb246NzRmYWQzNDAzMjcwNDcwNzljYzllYjFkZmEzZTYzZjJfMTk_8f598eb1-3018-4f3c-b71f-196dce453160"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM2LTAtMS0xLTkwNjE4L3RleHRyZWdpb246NzRmYWQzNDAzMjcwNDcwNzljYzllYjFkZmEzZTYzZjJfMzM_c1edda4e-f7df-40e9-a5ba-3efc96b3806e"
      unitRef="shares">36326815</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM2LTAtMS0xLTkwNjE4L3RleHRyZWdpb246NzRmYWQzNDAzMjcwNDcwNzljYzllYjFkZmEzZTYzZjJfMzM_c987e00c-f8e5-433a-9a03-12b684e2a765"
      unitRef="shares">36326815</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM2LTAtMS0xLTkwNjE4L3RleHRyZWdpb246NzRmYWQzNDAzMjcwNDcwNzljYzllYjFkZmEzZTYzZjJfNTU_1f4ebde1-abb7-4570-9c81-c3c9fc9db0a8"
      unitRef="shares">2106934</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM2LTAtMS0xLTkwNjE4L3RleHRyZWdpb246NzRmYWQzNDAzMjcwNDcwNzljYzllYjFkZmEzZTYzZjJfNTU_e8aa24d9-9082-4e7c-9a84-d326585471cb"
      unitRef="shares">2106934</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM2LTAtMS0xLTkwNjE4L3RleHRyZWdpb246NzRmYWQzNDAzMjcwNDcwNzljYzllYjFkZmEzZTYzZjJfNjI_5ca1e5cb-08fc-4a85-b403-7ba0b5249733"
      unitRef="shares">1656415</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM2LTAtMS0xLTkwNjE4L3RleHRyZWdpb246NzRmYWQzNDAzMjcwNDcwNzljYzllYjFkZmEzZTYzZjJfNjI_7707e025-3af8-4018-84f0-fa71918093c0"
      unitRef="shares">1656415</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM2LTEtMS0xLTkwNjE4_9abe4844-f808-4472-8233-9c69ca33746e"
      unitRef="usd">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM2LTMtMS0xLTkwNjE4_cce7ee32-3177-46bb-816e-be0e46c4be05"
      unitRef="usd">0</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM3LTEtMS0xLTkwNjE4_8dd83afd-21bc-4937-9366-0df26b35128d"
      unitRef="usd">21711000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM3LTMtMS0xLTkwNjE4_e002affb-c8ab-4172-9b0b-bb938a0b6c8f"
      unitRef="usd">18818000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM4LTEtMS0xLTkwNjE4_9fa9c1fc-f31d-4302-b7fc-9480d76551c5"
      unitRef="usd">3261000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM4LTMtMS0xLTkwNjE4_00ec0ca8-45ff-4194-b222-47fa62fdcacb"
      unitRef="usd">3166000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM5LTEtMS0xLTkwNjE4_1c4e878d-dcbe-4a40-9f8d-dfe130f8b8bf"
      unitRef="usd">-379889000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzM5LTMtMS0xLTkwNjE4_367f8596-685e-4265-9721-27722fa7f5cd"
      unitRef="usd">-333200000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzQwLTEtMS0xLTEwMDAzNA_57c4598b-f8f0-48c0-b09f-b4df4440ecbf"
      unitRef="usd">-354917000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzQwLTMtMS0xLTEwMDAzNA_e0c1b79e-ae71-4a48-8507-7cfe752dd4f1"
      unitRef="usd">-311216000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzQxLTEtMS0xLTEwMDAzNA_8abba99e-59b5-4e5c-8a7f-8e12a44b6d9d"
      unitRef="usd">193011000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzAvZnJhZzpmYWM4MWI1ODU1ZTU0OThlOWMwMTJhYzIyNTY3NTU0My90YWJsZTpiY2IwOTQ4YjFlMTQ0ODVjOWFlZTY3NjM3NjdiODBiZi90YWJsZXJhbmdlOmJjYjA5NDhiMWUxNDQ4NWM5YWVlNjc2Mzc2N2I4MGJmXzQxLTMtMS0xLTEwMDAzNA_0dd91a99-1364-415d-8b76-1e0ed791bd19"
      unitRef="usd">118980000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzQtMS0xLTEtOTA2MTg_b4cce1df-ceca-4db5-a3a3-c87c930070aa"
      unitRef="usd">18871000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzQtMy0xLTEtOTA2MTg_660cda08-f37f-47ec-869b-43c5acc12438"
      unitRef="usd">12987000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzUtMS0xLTEtOTA2MTg_13d326e6-3aff-446d-acc4-c059ef461bf0"
      unitRef="usd">3337000</us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer>
    <us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzUtMy0xLTEtOTA2MTg_4fdd4784-bb52-4c25-8eef-3a77274d00f8"
      unitRef="usd">1163000</us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzYtMS0xLTEtOTA2MTg_5f91fba1-8c8e-468d-ae93-2e1718ca2deb"
      unitRef="usd">3253000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzYtMy0xLTEtOTA2MTg_dff092ac-66bd-48cd-af42-365d4f62c659"
      unitRef="usd">4203000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:Revenues
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzctMS0xLTEtMTAwMDA2_afc8d549-ec3f-4ba1-9b20-7563d3c128d6"
      unitRef="usd">25461000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzctMy0xLTEtOTA2MTg_4e35fc25-388e-4ebf-b06d-57b5af23e4a3"
      unitRef="usd">18353000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzEwLTEtMS0xLTkwNjE4_0eaf0586-cd78-40ec-9182-c839a1447dfd"
      unitRef="usd">13167000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzEwLTMtMS0xLTkwNjE4_1f8ad7f4-6065-4e92-9ba3-1904104d0b11"
      unitRef="usd">8185000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="i45c8b69ce7724ca09fcd2a0e03378434_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzExLTEtMS0xLTkwNjE4_1d26a4ef-7c37-4c62-8bc6-d28aceb5c94a"
      unitRef="usd">1254000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="i31c5c6ff291e4bfbaecc0f0138bbdc9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzExLTMtMS0xLTkwNjE4_fbe40e9b-8919-43af-9190-42e833a84d93"
      unitRef="usd">743000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="i1cd0c82523ad48cfbd1bd9a5c47959b6_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzEyLTEtMS0xLTkwNjE4_f9a1e9a8-270c-468d-9e31-986d4e41b8f4"
      unitRef="usd">808000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="i960c81aa420d4215ad749484380fb1d3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzEyLTMtMS0xLTkwNjE4_233a9240-2df3-4b9f-a082-d237710bc4bb"
      unitRef="usd">2664000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzEzLTEtMS0xLTkwNjE4_1e3c9a71-7f4d-454c-a4e6-154620b0f4f8"
      unitRef="usd">44229000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzEzLTMtMS0xLTkwNjE4_14490cda-8b80-4889-972c-286da3319bc0"
      unitRef="usd">34454000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:Depreciation
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzE0LTEtMS0xLTkwNjE4_5414e862-0cfd-4bff-a8da-1fd7769514b6"
      unitRef="usd">3806000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzE0LTMtMS0xLTkwNjE4_721e852e-1059-49a5-b3d6-ff5e7180a979"
      unitRef="usd">2979000</us-gaap:Depreciation>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzE1LTEtMS0xLTkwNjE4_032d6280-bb4c-4284-a92f-6cd84195aec8"
      unitRef="usd">13216000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzE1LTMtMS0xLTkwNjE4_84d1b0a6-8928-48b6-919f-3b944b535382"
      unitRef="usd">9029000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzE2LTEtMS0xLTEwMDAwOA_c50f6a3c-e8d1-4c9f-a2c4-cfab0bc79bd6"
      unitRef="usd">76480000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzE2LTMtMS0xLTkwNjE4_51ecd52c-be6d-4762-97a2-1d9c417d3176"
      unitRef="usd">58054000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzE3LTEtMS0xLTEwMDAwOA_9a201a98-edb6-4d7f-80df-7a5d3854f4b4"
      unitRef="usd">-51019000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzE3LTMtMS0xLTkwNjE4_d9bbb0f9-cb82-40a0-ae39-e67e98dad6dc"
      unitRef="usd">-39701000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzE5LTEtMS0xLTkwNjE4_7321e4f9-5799-49de-8a03-7e296d21baa1"
      unitRef="usd">-7000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzE5LTMtMS0xLTkwNjE4_41ef98af-65f2-4560-9070-1640a92a64e6"
      unitRef="usd">-351000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzIwLTEtMS0xLTEwMDAxMQ_47425913-a158-45bb-a060-1889d4e09135"
      unitRef="usd">3065000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzIwLTMtMS0xLTEwMDAxMQ_383dcbc3-883e-461a-a099-78e464b85839"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzIxLTEtMS0xLTkwNjE4_0a267b3b-20ac-434b-901f-86d2d669c23b"
      unitRef="usd">-673000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzIxLTMtMS0xLTkwNjE4_cb52ea9b-ce1d-4185-9670-d31fbb190b3f"
      unitRef="usd">172000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzIyLTEtMS0xLTEwMDAxMQ_2790ea14-fdcb-404b-af7c-e21d62aa1c31"
      unitRef="usd">2385000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzIyLTMtMS0xLTEwMDAxMQ_43f53694-6fe4-42a5-ab5d-5740f458bb8e"
      unitRef="usd">-179000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzIzLTEtMS0xLTEwMDAxMQ_de03b610-38a9-4a93-b4ce-4c0316b9e581"
      unitRef="usd">-48634000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzIzLTMtMS0xLTEwMDAxMQ_3857ff1d-ae08-471f-8df6-1a8cba47d226"
      unitRef="usd">-39880000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzI0LTEtMS0xLTEwMDAxMQ_e1416e1f-313d-4181-869d-e6012b9ead76"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzI0LTMtMS0xLTkwNjE4_a9c78d71-2ee8-418e-bd60-90c485a547dd"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzI1LTEtMS0xLTkwNjE4_ca3a4b6a-a37a-418b-a095-1bf3e9cf0de9"
      unitRef="usd">1945000</amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment>
    <amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzI1LTMtMS0xLTkwNjE4_64ecc3a5-73b4-4ade-ac4d-4596102ac7f6"
      unitRef="usd">2167000</amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment>
    <us-gaap:NetIncomeLoss
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzI2LTEtMS0xLTEwMDAxMQ_73fd9b7b-9bb4-4633-9611-b64e0727f741"
      unitRef="usd">-46689000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzI2LTMtMS0xLTkwNjE4_7dae49c5-6e96-4959-adc5-6888d80e563e"
      unitRef="usd">-37713000</us-gaap:NetIncomeLoss>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzI4LTEtMS0xLTkwNjE4_67331bb7-302b-4546-a16f-6b9cfd22665c"
      unitRef="usd">36758000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzI4LTMtMS0xLTEwMDAxNQ_64d699fd-ec5a-47ef-87ad-3715fe86799c"
      unitRef="usd">31291000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzI5LTEtMS0xLTkwNjE4_6e418212-f618-47b3-9340-3f460881fb02"
      unitRef="usd">-83447000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzI5LTMtMS0xLTEwMDAxNQ_3abf0611-6fd7-4213-b851-36601ae85acb"
      unitRef="usd">-69004000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzMyLTEtMS0xLTkwNjE4_de8b3341-5adc-429d-a4ab-f270800de1e5"
      unitRef="usd">95000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzMyLTMtMS0xLTkwNjE4_a8423fdf-4794-4b05-86cf-9208c88780b6"
      unitRef="usd">625000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzMzLTEtMS0xLTEwMDAxNQ_2eb1757c-da0e-4f23-88a5-2d1bef9b9b3d"
      unitRef="usd">-46594000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzMzLTMtMS0xLTkwNjE4_c5f2791d-95fa-410c-a794-c4a64f727233"
      unitRef="usd">-37088000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzM1LTEtMS0xLTkwNjE4_7a6d9e8f-6154-4f5f-9e0c-75831b2912d5"
      unitRef="usdPerShare">-42.59</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzM1LTEtMS0xLTkwNjE4_8a8d08a3-5164-46f2-b6c3-2e4fa2d36871"
      unitRef="usdPerShare">-42.59</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzM1LTMtMS0xLTkwNjE4_5c9c0b5e-f842-4990-8921-b5591d5cdc78"
      unitRef="usdPerShare">-42.34</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzM1LTMtMS0xLTkwNjE4_893cf890-89e4-4775-8333-b07ac4e21b3d"
      unitRef="usdPerShare">-42.34</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzM2LTEtMS0xLTkwNjE4_0a2734a5-9881-4cf6-bdf1-239005a4a1a3"
      unitRef="shares">1959165000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzM2LTEtMS0xLTkwNjE4_237b9631-b3b4-4d9e-918f-267e61e0ff6b"
      unitRef="shares">1959165000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzM2LTMtMS0xLTkwNjE4_d2141d30-19d0-40af-beab-a6bc57fe7b8d"
      unitRef="shares">1629821000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zNzkvZnJhZzpmZDI1NzI4YTM2OWM0NTA4OWRkZWY1NGJlMDQ2ODM0MS90YWJsZToxNzVkMTk5M2VlZTI0MGJiYjM4ZWE0NDRlOWE1ZTFhOC90YWJsZXJhbmdlOjE3NWQxOTkzZWVlMjQwYmJiMzhlYTQ0NGU5YTVlMWE4XzM2LTMtMS0xLTkwNjE4_d9a75a13-35c0-4a8b-a2b7-9c808a698d92"
      unitRef="shares">1629821000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i946f64f7009a4a2082ea5e8ea9ae0377_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzItMS0xLTEtOTA2MTg_8f726e2c-a614-4d5c-b591-b676a623f7d9"
      unitRef="shares">23695330</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i946f64f7009a4a2082ea5e8ea9ae0377_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzItMy0xLTEtOTA2MTg_eca8dac2-503d-40d2-a423-eff6747cc990"
      unitRef="usd">347938000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="if07a33149ab34a4fbdf400d0fabf37f6_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzItNi0xLTEtOTA2MTg_ef6af4f6-17b6-4cee-801e-eed2a0d967a9"
      unitRef="shares">1622886</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="if07a33149ab34a4fbdf400d0fabf37f6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzItOC0xLTEtOTA2MTg_8c013d6c-7947-44a5-ac07-2918a9125649"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia22c1bdd47434793a0dc37fce48a996d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzItMTAtMS0xLTkwNjE4_30042851-5004-4f20-9f80-bda97bda5aad"
      unitRef="usd">16354000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i94e27674b4054eeb8e5f88cdfd303c29_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzItMTItMS0xLTkwNjE4_0d8be6e1-64c1-4d61-9141-ec8fd4850fc8"
      unitRef="usd">-295487000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i00591629b1be427aa8c0009cf1fb6f6e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzItMTQtMS0xLTkwNjE4_63ac087a-2b28-4c64-870f-6c05303a1021"
      unitRef="usd">2541000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i946f64f7009a4a2082ea5e8ea9ae0377_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzItMTYtMS0xLTEwMDM0Mw_46ce2c06-e376-4932-ad80-71e088993269"
      unitRef="usd">-276592000</us-gaap:StockholdersEquity>
    <amci:TemporaryEquityStockIssuanceCost
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzMtMC0xLTEtOTA2MTgvdGV4dHJlZ2lvbjoyYWEwZTEwYzUwZGY0MTA2YTdlNzFlZGM3YTQ1ZGU1OF8xMDk5NTExNjI3NzgzMQ_743a4dcc-2bc6-4478-b8c5-266a1143fe94"
      unitRef="usd">30000</amci:TemporaryEquityStockIssuanceCost>
    <amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzMtMS0xLTEtOTA2MTg_02b61ac7-05ec-4e40-9962-4f31e8f3dd0e"
      unitRef="shares">2034212</amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzMtMy0xLTEtOTA2MTg_d3116525-f1f9-44e5-8523-350cb656d7db"
      unitRef="usd">46470000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ifeb17f8540b2472cbe4d74587d5ad4aa_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzQtMTAtMS0xLTkwNjE4_77347821-4f0f-497c-85d4-8d2d4870d9f3"
      unitRef="usd">2392000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzQtMTYtMS0xLTEwMDM0Mw_066d1b73-8547-490a-992e-feafd42e194f"
      unitRef="usd">2392000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i5d56d77913a14f86a6d7945e10f160c2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzUtMTItMS0xLTkwNjE4_85c6b985-a070-42a4-a724-543694cb0c9e"
      unitRef="usd">-37713000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzUtMTYtMS0xLTEwMDM0Mw_e15f5f3a-8c51-4cf8-b83d-9e30cd62cc48"
      unitRef="usd">-37713000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i5eb0c8c36cbc470dbddae10e948288a4_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzYtNi0xLTEtOTA2MTg_0ef44b5b-0048-4148-8d19-5428d5c6ff1b"
      unitRef="shares">33529</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ifeb17f8540b2472cbe4d74587d5ad4aa_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzYtMTAtMS0xLTkwNjE4_a5a47c99-7be2-4e4d-82a8-124a6bcf19af"
      unitRef="usd">72000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzYtMTYtMS0xLTEwMDM0Mw_c6dd3f48-1c25-4593-b709-865d8a648f31"
      unitRef="usd">72000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i05ec61c49dc34bc69ccd60b0af98c42e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzctMTQtMS0xLTkwNjE4_067a82d8-07bf-4e57-88ec-af96d4291b0e"
      unitRef="usd">625000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzctMTYtMS0xLTEwMDM0Mw_357cdc41-03e1-4ef7-9f83-9afae2ba021f"
      unitRef="usd">625000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzgtMS0xLTEtMTAwMzIz_f24b64dd-8069-4d12-8022-daede5aea988"
      unitRef="shares">25729542</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzgtMy0xLTEtMTAwMzIz_4208c034-3e66-4971-8ad0-81ef8868a74c"
      unitRef="usd">394408000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i4d49e0cbdb6445f7b88d97d435a55770_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzgtNi0xLTEtMTAwMzMx_8c1f81f6-d933-436f-b9a6-a1bb4f63b651"
      unitRef="shares">1656415</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i4d49e0cbdb6445f7b88d97d435a55770_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzgtOC0xLTEtMTAwMzMx_9e50ab09-2c29-4eb7-9f85-ca3476e932b2"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7c18fa0bbec84bdcb7e52c35f80ede0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzgtMTAtMS0xLTEwMDMzNA_cf450e11-7afc-4be0-9d9b-0cd26fb674c4"
      unitRef="usd">18818000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i18eedd573381425c8c989e260801dafe_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzgtMTItMS0xLTEwMDMzNw_2a1bf98f-bc42-4e44-9969-10e8dce408b0"
      unitRef="usd">-333200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7e70eaff18414dc4b12fb6d52ddce0d0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzgtMTQtMS0xLTEwMDM0MA_9e167ca3-3082-44f8-a550-564197531917"
      unitRef="usd">3166000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzgtMTYtMS0xLTEwMDM0Mw_810449ee-9198-4d7e-9b85-ed6c99ec8034"
      unitRef="usd">-311216000</us-gaap:StockholdersEquity>
    <amci:TemporaryEquityStockIssuanceCost
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzktMC0xLTEtOTA2MTgvdGV4dHJlZ2lvbjpmZjIwY2E2ZTBiNTQ0M2Y0OThhNTNlZGNiNjhjZWMxZF82Ng_22029cf0-d1a5-4bea-bdff-3529eee0ed2f"
      unitRef="usd">0</amci:TemporaryEquityStockIssuanceCost>
    <amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="i45b464fc79c145a2a521d5dd55876280_D20210401-20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzktMS0xLTEtOTA2MTg_4649de70-6da7-4a9b-960b-f4f5d6c67ec6"
      unitRef="shares">3634210</amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="i45b464fc79c145a2a521d5dd55876280_D20210401-20210430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzktMy0xLTEtOTA2MTg_967c829c-e99b-4cbb-aa8a-c4def402c379"
      unitRef="usd">83073000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <amci:TemporaryEquitySharesConversionOfConvertibleSecurities
      contextRef="i9f67793938594975ad7e63e3f8a4f312_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzEwLTEtMS0xLTkwNjE4_8525332d-3170-4341-83b7-390b93b4670d"
      unitRef="shares">158058</amci:TemporaryEquitySharesConversionOfConvertibleSecurities>
    <amci:TemporaryEquityExerciseOfWarrants
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzEwLTMtMS0xLTkwNjE4_6403d042-2785-4eec-8cad-33f5f24af997"
      unitRef="usd">3150000</amci:TemporaryEquityExerciseOfWarrants>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i68c741fd42694f06bc7e2689ea444d6a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzExLTEwLTEtMS05MDYxOA_913edd57-53c9-41db-89b5-129dcf296c80"
      unitRef="usd">2531000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzExLTE2LTEtMS05MDYxOA_965e58a9-8c6a-4e03-8a4f-95f7119a3754"
      unitRef="usd">2531000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <amci:AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments
      contextRef="i68c741fd42694f06bc7e2689ea444d6a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzEyLTEwLTEtMS05MDYxOA_721d5bcc-ca99-4328-a924-e7f123f9c9bb"
      unitRef="usd">396000</amci:AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments>
    <amci:AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzEyLTE2LTEtMS05MDYxOA_37234046-44ac-4165-aac6-653004379d47"
      unitRef="usd">396000</amci:AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments>
    <us-gaap:NetIncomeLoss
      contextRef="ied8cd34c75144efca4224b616436546e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzEzLTEyLTEtMS05MDYxOA_b18e300b-88cd-4ad9-b4a4-04b1eb3e30c8"
      unitRef="usd">-46689000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzEzLTE2LTEtMS0xMDAzNDM_d5a5e1ef-5a13-4e60-9e5b-ba548fadb288"
      unitRef="usd">-46689000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ia9a4fe64e8384eb1ac82e12eceb516c9_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzE0LTYtMS0xLTkwNjE4_f132d57f-f7fc-4087-a400-4370d328570c"
      unitRef="shares">450519</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i68c741fd42694f06bc7e2689ea444d6a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzE0LTEwLTEtMS05MDYxOA_5e0f2fdd-b5bf-478e-98f0-fb2250c13441"
      unitRef="usd">758000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzE0LTE2LTEtMS05MDYxOA_26bbc367-d4f0-482d-b214-0e6371f8c938"
      unitRef="usd">758000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ie594942781b24073905212d61c4895df_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzE1LTE0LTEtMS05MDYxOA_88e9183a-8030-4325-84f7-e8a6f005f405"
      unitRef="usd">95000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzE1LTE2LTEtMS05MDYxOA_1d980cc5-6284-406f-ae83-c76c44f9c0b5"
      unitRef="usd">95000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzE2LTEtMS0xLTEwMDMyNw_ffa9f4e5-c4d1-4df9-8295-76ab17d13a51"
      unitRef="shares">29521810</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzE2LTMtMS0xLTEwMDMyNw_9fd9ea47-9e3b-4a34-a5d2-0b84587d5660"
      unitRef="usd">480631000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i78e21c830827492786035892daf32e0d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzE2LTYtMS0xLTEwMDMzMQ_61a9903a-d40c-4938-9691-b01819859c12"
      unitRef="shares">2106934</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i78e21c830827492786035892daf32e0d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzE2LTgtMS0xLTEwMDMzMQ_6e91a306-8f0d-4559-86c5-181ad9073560"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i20c42717ddd94c808b501ab8475516e6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzE2LTEwLTEtMS0xMDAzMzQ_5de0bc70-102d-4e63-b037-e6c879f4c71c"
      unitRef="usd">21711000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib0898c763893444f8318ba806e5872af_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzE2LTEyLTEtMS0xMDAzMzc_26489eb7-41da-4087-8869-7e8017baf263"
      unitRef="usd">-379889000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib6fb523d0475453fbb376be661a6c994_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzE2LTE0LTEtMS0xMDAzNDA_5c9d9723-2c20-445d-81fc-32b4381535cd"
      unitRef="usd">3261000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zODgvZnJhZzowY2NlZTJhNTg2OTA0ZjI4YjQ1NDI0NDE2ZDFhOTU3OS90YWJsZTplNjNmNzcyYTA2YWI0YjFhYjI4ZjAyMTQ3Yjc3NTE1NC90YWJsZXJhbmdlOmU2M2Y3NzJhMDZhYjRiMWFiMjhmMDIxNDdiNzc1MTU0XzE2LTE2LTEtMS0xMDAzNDM_80568e35-6b81-4deb-a547-1cac4d4623d5"
      unitRef="usd">-354917000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQtMS0xLTEtOTA2MTg_2deeca7e-70e2-4fa8-b509-9b4a2ad950ea"
      unitRef="usd">-46689000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQtMy0xLTEtOTA2MTg_7880da65-e801-45b2-b981-896eefaae81e"
      unitRef="usd">-37713000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzYtMS0xLTEtOTA2MTg_f3cc3f80-6f6e-4a76-92ff-2f571853de0d"
      unitRef="usd">2531000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzYtMy0xLTEtOTA2MTg_809340e8-7d52-4484-95b9-8bc39c42d4c3"
      unitRef="usd">2392000</us-gaap:ShareBasedCompensation>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzctMS0xLTEtOTA2MTg_8314ad76-3a3c-4077-90bd-3f5ab3bf5266"
      unitRef="usd">563000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzctMy0xLTEtOTA2MTg_83ac635d-4fa4-4c68-bd87-e5959ceb0fde"
      unitRef="usd">-105000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzgtMS0xLTEtOTA2MTg_ff88c173-5058-4fc6-8bde-7cd7a1f82039"
      unitRef="usd">-27000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzgtMy0xLTEtOTA2MTg_7bf8e3d7-e3d0-4736-962c-0c422f217c5e"
      unitRef="usd">877000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:Depreciation
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzktMS0xLTEtOTA2MTg_75f24d91-4fb0-4387-a963-a785951724d6"
      unitRef="usd">3806000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzktMy0xLTEtOTA2MTg_99b05299-338e-4064-b070-66460abf3fee"
      unitRef="usd">2979000</us-gaap:Depreciation>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzEwLTEtMS0xLTkwNjE4_51d21668-7715-423b-80a0-a15394099db6"
      unitRef="usd">1679000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzEwLTMtMS0xLTkwNjE4_93c75923-1a5f-4175-a92a-9f9228729316"
      unitRef="usd">1565000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <amci:NoncashRecognitionOfLicensingRevenue
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzExLTEtMS0xLTkwNjE4_2d46e931-c7e1-4dfb-a629-47db87654797"
      unitRef="usd">2022000</amci:NoncashRecognitionOfLicensingRevenue>
    <amci:NoncashRecognitionOfLicensingRevenue
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzExLTMtMS0xLTkwNjE4_8b61f4a3-f175-4168-97ec-be0b79c9b08b"
      unitRef="usd">1018000</amci:NoncashRecognitionOfLicensingRevenue>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzEyLTEtMS0xLTkwNjE4_d5c78837-22d7-445e-9013-1f725df3f4ba"
      unitRef="usd">3065000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzEyLTMtMS0xLTkwNjE4_15eb0bb3-2939-439a-b6e2-38cd60ea9f51"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzEzLTEtMS0xLTkwNjE4_56f6d0f3-b521-4c2c-9623-7e5e1a066498"
      unitRef="usd">1945000</amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment>
    <amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzEzLTMtMS0xLTkwNjE4_d76ebb77-7fd9-49f1-839f-646f7d346fa1"
      unitRef="usd">2167000</amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzE0LTEtMS0xLTkwNjE4_b4f1a810-ac58-47f3-b5aa-180c8577f889"
      unitRef="usd">-55000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzE0LTMtMS0xLTkwNjE4_e0da67aa-e3cb-4d4d-93de-89de3d36bef1"
      unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzE2LTEtMS0xLTkwNjE4_b552ad6f-ce07-45e5-898c-fcdb7c5bacdb"
      unitRef="usd">-2670000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzE2LTMtMS0xLTkwNjE4_d8a75871-c7bd-4a81-8489-b7670ab20706"
      unitRef="usd">4470000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzE3LTEtMS0xLTkwNjE4_3c3388c1-51dd-43f2-b51b-05b357c77e7b"
      unitRef="usd">5514000</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzE3LTMtMS0xLTkwNjE4_7a497488-8c7a-4d4c-a86b-6266cd6ed737"
      unitRef="usd">5605000</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzE4LTEtMS0xLTkwNjE4_afd6aee8-2f4f-4715-bc44-1f38594b6134"
      unitRef="usd">941000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzE4LTMtMS0xLTkwNjE4_626915e1-13b1-4b09-8909-30da7430bbb5"
      unitRef="usd">364000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzE5LTEtMS0xLTkwNjE4_45cb5612-c9c6-4288-b093-e2c25df17061"
      unitRef="usd">1256000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzE5LTMtMS0xLTkwNjE4_ddbc996c-d36c-4186-b640-7d356c4c5c95"
      unitRef="usd">690000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzIwLTEtMS0xLTkwNjE4_2c0c9cc8-9f7a-4585-a3cd-1b5e0c5c5e5f"
      unitRef="usd">5762000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzIwLTMtMS0xLTkwNjE4_d3a47522-9353-4596-8639-e621c3dec4e9"
      unitRef="usd">3167000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzIxLTEtMS0xLTkwNjE4_eb2a2b77-66c5-4614-bd88-6bd901d007f8"
      unitRef="usd">-1618000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzIxLTMtMS0xLTkwNjE4_07331ac3-1087-479c-8208-03e418f657d4"
      unitRef="usd">-1204000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzIyLTEtMS0xLTkwNjE4_3d6ccbf7-16bb-4157-80f7-754cc5503532"
      unitRef="usd">908000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzIyLTMtMS0xLTkwNjE4_ec22d5e7-f216-4d90-ba30-8f1434ebb99d"
      unitRef="usd">1705000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzIzLTEtMS0xLTEwMDE4MQ_0f195c09-c083-45bb-a9e5-af52fd3c1d08"
      unitRef="usd">-42591000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzIzLTMtMS0xLTEwMDE4MQ_6994ae70-dfb8-4505-be5f-d627f1e42897"
      unitRef="usd">-39271000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzI1LTEtMS0xLTkwNjE4_950c8111-3280-4bfb-ad7c-cef4caab9456"
      unitRef="usd">5752000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzI1LTMtMS0xLTkwNjE4_d7e546b2-5a3c-492e-a78c-d2ff8fac78f6"
      unitRef="usd">7110000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzI2LTEtMS0xLTkwNjE4_0bd5e4c6-ca1e-4fa2-9fcb-547a6d48de37"
      unitRef="usd">5000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzI2LTMtMS0xLTkwNjE4_f878f65a-e29c-4ecb-8c4c-168e591c9d2d"
      unitRef="usd">4000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfOtherRealEstate
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzI3LTEtMS0xLTkwNjE4_dab5a426-c8c4-46e2-8f04-fb2252ed61b7"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfOtherRealEstate>
    <us-gaap:ProceedsFromSaleOfOtherRealEstate
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzI3LTMtMS0xLTkwNjE4_8dd483be-4b40-414e-aad6-86c8b80b763e"
      unitRef="usd">513000</us-gaap:ProceedsFromSaleOfOtherRealEstate>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzI4LTEtMS0xLTEwMDE4NQ_550c6df7-e5c4-47ad-a06c-a4ef0fd96deb"
      unitRef="usd">-5747000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzI4LTMtMS0xLTEwMDE4NQ_8987a114-45cb-45c6-ac56-13e78dfaa381"
      unitRef="usd">-6593000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <amci:ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzMwLTEtMS0xLTkwNjE4_c98cf063-58fc-4718-af99-6220e54eee91"
      unitRef="usd">83831000</amci:ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises>
    <amci:ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzMwLTMtMS0xLTkwNjE4_ba074f6c-0ed8-47b8-be06-917c6b50d916"
      unitRef="usd">46572000</amci:ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzMxLTEtMS0xLTkwNjE4_6b085ff2-5684-4e42-a38c-0422fb9b2777"
      unitRef="usd">3150000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzMxLTMtMS0xLTkwNjE4_6375e478-d673-4fad-8973-ee08ae0bb778"
      unitRef="usd">0</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzMyLTEtMS0xLTkwNjE4_cc483307-e56b-4250-ab01-c91ad33a2007"
      unitRef="usd">30000000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzMyLTMtMS0xLTkwNjE4_b2ff1602-09c9-470f-b884-10ba372e3925"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzMzLTEtMS0xLTkwNjE4_0c551e99-fe06-4502-92d3-943d88c4a67b"
      unitRef="usd">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzMzLTMtMS0xLTkwNjE4_d89c2748-aef4-434e-b417-5828fd97cc3d"
      unitRef="usd">30000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzM0LTEtMS0xLTkwNjE4_8e5dc630-f70b-4d45-9700-521ae6d632ea"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzM0LTMtMS0xLTkwNjE4_19a0eb8a-cffe-47a8-80bc-abcae7ffdbf1"
      unitRef="usd">3065000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:PaymentsForRepurchaseOfEquity
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzM1LTEtMS0xLTkwNjE4_dae8b7d4-9dc5-443e-9d40-caf1d1755790"
      unitRef="usd">396000</us-gaap:PaymentsForRepurchaseOfEquity>
    <us-gaap:PaymentsForRepurchaseOfEquity
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzM1LTMtMS0xLTkwNjE4_707bd8b0-ec4e-436b-b82f-30aba8e279ce"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfEquity>
    <us-gaap:RepaymentsOfDebt
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzM2LTEtMS0xLTkwNjE4_145b4158-6356-44bd-8af4-53883b687fc6"
      unitRef="usd">570000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzM2LTMtMS0xLTkwNjE4_a17c85af-a908-45a8-96bd-314a51a52408"
      unitRef="usd">4880000</us-gaap:RepaymentsOfDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzM3LTEtMS0xLTEwMDE5Mg_98785849-8815-4a1e-9b44-0f0825848dac"
      unitRef="usd">116015000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzM3LTMtMS0xLTEwMDE5Mg_d1db09e1-3881-476d-9875-b32c37964b9c"
      unitRef="usd">44727000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzM4LTEtMS0xLTEwMDIwMA_03055c1b-97e6-4070-9cce-b231a92baf77"
      unitRef="usd">67677000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzM4LTMtMS0xLTkwNjE4_a6c716a3-fab5-470f-8e5b-bf5f891b3ffd"
      unitRef="usd">-1137000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzM5LTEtMS0xLTkwNjE4_1d51bd0c-e75e-4b99-b561-96b492ebc647"
      unitRef="usd">60909000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i946f64f7009a4a2082ea5e8ea9ae0377_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzM5LTMtMS0xLTkwNjE4_b63cb6f3-a6b8-4bed-8049-b4f37935bc1e"
      unitRef="usd">62117000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQwLTEtMS0xLTkwNjE4_caa6fdf4-c470-4f2d-92f0-e0f7d1a933b8"
      unitRef="usd">146000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQwLTMtMS0xLTkwNjE4_6dac7797-ee80-4181-afbe-af19c44b135f"
      unitRef="usd">-71000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQxLTEtMS0xLTkwNjE4_e58ff2a4-4c76-4517-a3d2-1e35cbceb59e"
      unitRef="usd">128732000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQxLTMtMS0xLTkwNjE4_41d6a5be-b2c3-40bc-a6a2-122630dd4ba9"
      unitRef="usd">60909000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQzLTEtMS0xLTkwNjE4_df6d95e7-1b40-4bf3-95e3-8994686f2034"
      unitRef="usd">13000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQzLTMtMS0xLTkwNjE4_aaf2c4a4-7be2-466a-92cb-578b443af80a"
      unitRef="usd">356000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQ0LTEtMS0xLTkwNjE4_46d5ff8d-4266-4adb-8b80-6bc82ab0af9e"
      unitRef="usd">0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQ0LTMtMS0xLTkwNjE4_94872c8c-c2bd-4fae-82c8-84ac8a7a6e01"
      unitRef="usd">0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:NoncashOrPartNoncashAcquisitionInvestmentsAcquired1
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQ2LTEtMS0xLTkwNjE4_84b3ec7b-2bd8-46bb-bf57-326b4a27f97f"
      unitRef="usd">0</us-gaap:NoncashOrPartNoncashAcquisitionInvestmentsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionInvestmentsAcquired1
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQ2LTMtMS0xLTkwNjE4_122b787e-0639-42ae-8353-c13c8bfe293d"
      unitRef="usd">15000000</us-gaap:NoncashOrPartNoncashAcquisitionInvestmentsAcquired1>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQ3LTEtMS0xLTkwNjE4_e3da3f11-a503-49c6-8d68-2d8494a8e47c"
      unitRef="usd">708000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQ3LTMtMS0xLTkwNjE4_08c30ab6-1cd3-4a2f-8c6b-1584d40fcd4b"
      unitRef="usd">20000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <amci:NoncashLoanForgiveness
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQ5LTEtMS0xLTkwNjE4_ef168628-b73c-4c53-8cbb-9454bbd48f66"
      unitRef="usd">3065000</amci:NoncashLoanForgiveness>
    <amci:NoncashLoanForgiveness
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzQ5LTMtMS0xLTEwMDIwNQ_8633d529-1a78-473d-a47a-c15a2c7cf959"
      unitRef="usd">0</amci:NoncashLoanForgiveness>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzUwLTEtMS0xLTkwNjE4_415fa49f-0d3f-4851-b807-2c1c24a66e0d"
      unitRef="usd">938000</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF8zOTcvZnJhZzpjZmIwZGZmYjAzMTg0MjY3OTNiNmQ3ZjRjYTEwZjVhYi90YWJsZTo3MTQ0YjVhNDc2ZmY0Mjk3OTZmMDNhMjllN2U0NTFiOS90YWJsZXJhbmdlOjcxNDRiNWE0NzZmZjQyOTc5NmYwM2EyOWU3ZTQ1MWI5XzUwLTMtMS0xLTkwNjE4_f3faf4a3-2889-44fd-bb45-1f957bb4e597"
      unitRef="usd">0</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ib670cc288d804b0da674a966573402b6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NjE2_568b7b56-0cef-4fb2-9cc1-f4082a4137dd"
      unitRef="usd">-580000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:EquityMethodInvestments
      contextRef="ib670cc288d804b0da674a966573402b6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NjE2_c3872c20-a737-46d5-9f7e-b0a51cba21f8"
      unitRef="usd">580000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i8f626d763fea4f03b5c54c8fd030b350_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NjIy_3d5a88a3-7ec5-439e-b666-9541ed3a3c05"
      unitRef="usd">257000</us-gaap:EquityMethodInvestments>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i8f626d763fea4f03b5c54c8fd030b350_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NjIy_6b5e0c98-e312-4313-be39-6d46d549d023"
      unitRef="usd">-257000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ic75b0e764db44a3ea1a1199da6c4795b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NjA0_7553a497-34df-452b-aec2-9b6f6839fb9d"
      unitRef="usd">-580000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i1ddd84d3244a4e469b4d90c6789d9b85_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NjEw_ccd5e483-a9f1-4edb-922d-25da02a66594"
      unitRef="usd">-257000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="icea6a4eaa3fa47bc9fd500d0e0e53a13_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTky_455b0540-74c4-4062-8b44-c16b8020f49a"
      unitRef="usd">-662000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:EquityMethodInvestments
      contextRef="icea6a4eaa3fa47bc9fd500d0e0e53a13_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTky_71c00ec1-797f-4bdd-94ba-f28001002047"
      unitRef="usd">662000</us-gaap:EquityMethodInvestments>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i5437a811e196420794bdd75c799bf19b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTk4_a162734b-f7ed-445b-b4b5-77fcc04d69c8"
      unitRef="usd">-549000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:EquityMethodInvestments
      contextRef="i5437a811e196420794bdd75c799bf19b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTk4_bf80199d-4311-4bb0-af62-bd65e634477a"
      unitRef="usd">549000</us-gaap:EquityMethodInvestments>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i6272a6a1b0f14bc1a60665228d4ff94d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTgw_8dcfceb6-30e6-4c71-98ef-49fdbdf81475"
      unitRef="usd">-662000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i89d112338dda40d0b977e99b3737e024_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTg2_96947d5a-51c4-40e9-bd1c-2b5c6f7970d4"
      unitRef="usd">-549000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:EquityMethodInvestments
      contextRef="ie7dbd0916f2f407fbf3b88496fe98376_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTc0_c5c4ec26-e7d1-47f0-adc6-b235c2d121eb"
      unitRef="usd">322000</us-gaap:EquityMethodInvestments>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ie7dbd0916f2f407fbf3b88496fe98376_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTc0_fd9ba952-a01c-4ede-8593-6709b2c6c7bc"
      unitRef="usd">322000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="id9f5902630fa415a8d71cc63925f4a89_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTY4_e9df5444-3850-4045-9df4-dfdfbe1edc07"
      unitRef="usd">322000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i142b45d688a94040896bab9c453fa022_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTYy_05e1a422-f32d-4d83-9fa3-8d541cfb0659"
      unitRef="usd">122000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i142b45d688a94040896bab9c453fa022_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTYy_1804b876-f72d-4a20-8ae5-2f852db202aa"
      unitRef="usd">122000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:CostOfRevenue
      contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEwOTk1MTE2MzcyNzkz_6828adcd-ac57-407e-b152-e09116ec4b82"
      unitRef="usd">122000</us-gaap:CostOfRevenue>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEwOTk1MTE2MzcyNzkz_c9ef5cc5-92f3-4c34-b395-0240e72b95ba"
      unitRef="usd">122000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i475ef0e1c62c4e2194e47d2dab3b2b37_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTQw_27eb92a7-eaa2-4a15-bf57-3bc4ac19be82"
      unitRef="usd">1223000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i84e5c0f8b51d4b4ea1203de397661f35_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTQ4_8df34b04-6196-4be1-9470-f1f444e74d59"
      unitRef="usd">242000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk4MDQy_87d2ecea-ecba-4823-a532-e39d309f5065">The effects of the correction of these errors on the relevant financial statement line items is as follows:&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(378,162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(379,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total shareholders&#x2019; deficit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(353,190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(354,917)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities, contingently redeemable preferred equity, and shareholders' deficit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(684)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(332,394)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(333,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total shareholders&#x2019; deficit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(310,410)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(311,216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities, contingently redeemable preferred equity, and shareholders' deficit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(684)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated Statement of Operations and Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue from contracts with customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue from related party transactions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(662)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(784)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue from contracts with customers (exclusive of depreciation shown below)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,289)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,167)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cost and operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76,602)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50,357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(662)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,972)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(662)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48,634)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain from equity method investees, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(921)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,689)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss allocated to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82,526)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(921)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83,447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,673)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(921)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,594)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated Statement of Operations and Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue from contracts with customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue from related party transactions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(427)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue from contracts with customers (exclusive of depreciation shown below)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,063)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,185)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cost and operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,932)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58,054)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,701)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss before income taxes &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,331)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,880)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain from equity method investees, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(257)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss allocated to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68,198)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69,004)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41.84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated Statement of Changes in Redeemable Convertible Preferred Stock and Shareholders&#x2019; Equity (Deficit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated deficit - Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(332,394)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(333,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total shareholders&#x2019; deficit &#x2013; balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(310,410)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(311,216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(921)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,689)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated deficit - balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(378,162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(379,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total shareholders&#x2019; deficit &#x2013; balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(353,190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(354,917)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated Statement of Changes in Redeemable Convertible Preferred Stock and Shareholders&#x2019; Equity (Deficit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated deficit - Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(295,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(295,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total shareholders&#x2019; deficit &#x2013; balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(276,592)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(276,592)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated deficit - balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(332,394)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(333,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total shareholders&#x2019; deficit &#x2013; balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(310,410)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(311,216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated Statement of Cash Flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(921)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,689)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to reconcile net loss to net cash used in operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash recognition of licensing revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,684)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,022)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain from equity method investees, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,945)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in operating assets and liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,636)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,514)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued salaries and wages&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net cash used in operating activities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42,591)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42,591)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated Statement of Cash Flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to reconcile net loss to net cash used in operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash recognition of licensing revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,567)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,018)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain from equity method investees, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,424)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,167)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in operating assets and liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,483)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,605)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued salaries and wages&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net cash used in operating activities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on dilution&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock>
    <us-gaap:EquityMethodInvestments
      contextRef="idccad26b9b674e58874df0b2f95fbd38_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpmMzc5ZmY4ZDMyNGE0YjJiOGQ1NTAxZWE4OGM4NDQxYS90YWJsZXJhbmdlOmYzNzlmZjhkMzI0YTRiMmI4ZDU1MDFlYTg4Yzg0NDFhXzMtMS0xLTEtOTA2MTg_af807c2d-398f-44fb-9ce8-31fb28d75fd5"
      unitRef="usd">26479000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i8987593ef9dd4097a8751ede87870612_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpmMzc5ZmY4ZDMyNGE0YjJiOGQ1NTAxZWE4OGM4NDQxYS90YWJsZXJhbmdlOmYzNzlmZjhkMzI0YTRiMmI4ZDU1MDFlYTg4Yzg0NDFhXzMtMi0xLTEtOTA2MTg_6b45b833-747d-4d47-b9a7-9d2126fa7b72"
      unitRef="usd">-1727000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpmMzc5ZmY4ZDMyNGE0YjJiOGQ1NTAxZWE4OGM4NDQxYS90YWJsZXJhbmdlOmYzNzlmZjhkMzI0YTRiMmI4ZDU1MDFlYTg4Yzg0NDFhXzMtMy0xLTEtOTA2MTg_286b4618-814a-4978-a3bf-2cf4fa19beca"
      unitRef="usd">24752000</us-gaap:EquityMethodInvestments>
    <us-gaap:Assets
      contextRef="idccad26b9b674e58874df0b2f95fbd38_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpmMzc5ZmY4ZDMyNGE0YjJiOGQ1NTAxZWE4OGM4NDQxYS90YWJsZXJhbmdlOmYzNzlmZjhkMzI0YTRiMmI4ZDU1MDFlYTg4Yzg0NDFhXzQtMS0xLTEtOTA2MTg_2eaf51b1-6b17-42a4-984e-1d5452c82634"
      unitRef="usd">194738000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i8987593ef9dd4097a8751ede87870612_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpmMzc5ZmY4ZDMyNGE0YjJiOGQ1NTAxZWE4OGM4NDQxYS90YWJsZXJhbmdlOmYzNzlmZjhkMzI0YTRiMmI4ZDU1MDFlYTg4Yzg0NDFhXzQtMi0xLTEtOTA2MTg_b1832a1b-4227-4057-8e1b-8b24001b424b"
      unitRef="usd">-1727000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpmMzc5ZmY4ZDMyNGE0YjJiOGQ1NTAxZWE4OGM4NDQxYS90YWJsZXJhbmdlOmYzNzlmZjhkMzI0YTRiMmI4ZDU1MDFlYTg4Yzg0NDFhXzQtMy0xLTEtOTA2MTg_f32d79b4-c6a1-4601-9783-2e3273d417a2"
      unitRef="usd">193011000</us-gaap:Assets>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="idccad26b9b674e58874df0b2f95fbd38_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpmMzc5ZmY4ZDMyNGE0YjJiOGQ1NTAxZWE4OGM4NDQxYS90YWJsZXJhbmdlOmYzNzlmZjhkMzI0YTRiMmI4ZDU1MDFlYTg4Yzg0NDFhXzUtMS0xLTEtOTA2MTg_b2bfab66-dbb5-4758-a5c0-4bac32405236"
      unitRef="usd">-378162000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i8987593ef9dd4097a8751ede87870612_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpmMzc5ZmY4ZDMyNGE0YjJiOGQ1NTAxZWE4OGM4NDQxYS90YWJsZXJhbmdlOmYzNzlmZjhkMzI0YTRiMmI4ZDU1MDFlYTg4Yzg0NDFhXzUtMi0xLTEtOTA2MTg_b792793a-7d61-4e63-b807-81142b184ebe"
      unitRef="usd">-1727000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpmMzc5ZmY4ZDMyNGE0YjJiOGQ1NTAxZWE4OGM4NDQxYS90YWJsZXJhbmdlOmYzNzlmZjhkMzI0YTRiMmI4ZDU1MDFlYTg4Yzg0NDFhXzUtMy0xLTEtOTA2MTg_970cb0d9-d366-4cbf-82b9-9c5139df1f3c"
      unitRef="usd">-379889000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="idccad26b9b674e58874df0b2f95fbd38_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpmMzc5ZmY4ZDMyNGE0YjJiOGQ1NTAxZWE4OGM4NDQxYS90YWJsZXJhbmdlOmYzNzlmZjhkMzI0YTRiMmI4ZDU1MDFlYTg4Yzg0NDFhXzYtMS0xLTEtOTA2MTg_71f7a841-3bc0-4d54-8645-286f2528a65b"
      unitRef="usd">-353190000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8987593ef9dd4097a8751ede87870612_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpmMzc5ZmY4ZDMyNGE0YjJiOGQ1NTAxZWE4OGM4NDQxYS90YWJsZXJhbmdlOmYzNzlmZjhkMzI0YTRiMmI4ZDU1MDFlYTg4Yzg0NDFhXzYtMi0xLTEtOTA2MTg_0eab9560-896f-4d91-80f3-31bdac6b890e"
      unitRef="usd">-1727000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpmMzc5ZmY4ZDMyNGE0YjJiOGQ1NTAxZWE4OGM4NDQxYS90YWJsZXJhbmdlOmYzNzlmZjhkMzI0YTRiMmI4ZDU1MDFlYTg4Yzg0NDFhXzYtMy0xLTEtOTA2MTg_2226f8b4-3b38-4fd8-a0cd-4ccaa92d105c"
      unitRef="usd">-354917000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="idccad26b9b674e58874df0b2f95fbd38_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpmMzc5ZmY4ZDMyNGE0YjJiOGQ1NTAxZWE4OGM4NDQxYS90YWJsZXJhbmdlOmYzNzlmZjhkMzI0YTRiMmI4ZDU1MDFlYTg4Yzg0NDFhXzctMS0xLTEtOTA2MTg_7f10212d-da47-4782-9813-26e8cf4c19d6"
      unitRef="usd">194738000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i8987593ef9dd4097a8751ede87870612_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpmMzc5ZmY4ZDMyNGE0YjJiOGQ1NTAxZWE4OGM4NDQxYS90YWJsZXJhbmdlOmYzNzlmZjhkMzI0YTRiMmI4ZDU1MDFlYTg4Yzg0NDFhXzctMi0xLTEtOTA2MTg_fac99856-00bf-4ab7-9766-2628e4b43b65"
      unitRef="usd">-1727000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpmMzc5ZmY4ZDMyNGE0YjJiOGQ1NTAxZWE4OGM4NDQxYS90YWJsZXJhbmdlOmYzNzlmZjhkMzI0YTRiMmI4ZDU1MDFlYTg4Yzg0NDFhXzctMy0xLTEtOTA2MTg_2a8614df-ac72-4b53-a9c0-f34c090b1c8b"
      unitRef="usd">193011000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="ief2dc30089664149a39ac740dc44fcd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzMtMS0xLTEtOTA2MTg_604135fb-34f3-42d5-92ae-dff6cb3362f8"
      unitRef="usd">6064000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i142b45d688a94040896bab9c453fa022_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzMtMi0xLTEtOTA2MTg_f5ccde99-4cb8-4890-bf12-30a52813130c"
      unitRef="usd">122000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzMtMy0xLTEtOTA2MTg_04d4cd26-b387-42ca-8f7d-fbe04706b37a"
      unitRef="usd">6186000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ief2dc30089664149a39ac740dc44fcd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzQtMS0xLTEtOTA2MTg_b33e5469-9c8b-4f67-9b0a-ee7ee4abbc98"
      unitRef="usd">76467000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i142b45d688a94040896bab9c453fa022_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzQtMi0xLTEtOTA2MTg_5cbb464b-0dd1-4647-8d0d-3c82d0220519"
      unitRef="usd">122000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzQtMy0xLTEtOTA2MTg_1a3a6baa-2c50-4537-9b15-6bebf089adec"
      unitRef="usd">76589000</us-gaap:AssetsCurrent>
    <us-gaap:EquityMethodInvestments
      contextRef="ief2dc30089664149a39ac740dc44fcd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzUtMS0xLTEtOTA2MTg_761d9967-d2ba-4f15-bfcd-91e6696509e0"
      unitRef="usd">24023000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i142b45d688a94040896bab9c453fa022_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzUtMi0xLTEtOTA2MTg_dd77cdad-9bc5-4958-8f4e-79f6a610478d"
      unitRef="usd">-806000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzUtMy0xLTEtOTA2MTg_ee8ffd38-3a7a-4936-988c-3d5940733eca"
      unitRef="usd">23217000</us-gaap:EquityMethodInvestments>
    <us-gaap:Assets
      contextRef="ief2dc30089664149a39ac740dc44fcd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzYtMS0xLTEtOTA2MTg_5dc7fad2-978e-46dd-972b-a2dd113a6b9b"
      unitRef="usd">119664000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i142b45d688a94040896bab9c453fa022_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzYtMi0xLTEtOTA2MTg_d68b5119-6fed-4714-9614-df64672f96df"
      unitRef="usd">-684000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzYtMy0xLTEtOTA2MTg_000d896b-3b17-4591-b612-8332dd148d60"
      unitRef="usd">118980000</us-gaap:Assets>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ief2dc30089664149a39ac740dc44fcd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzctMS0xLTEtOTA2MTg_e866eeab-cbcd-4179-9d38-bc42e3c7f0ec"
      unitRef="usd">2775000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i142b45d688a94040896bab9c453fa022_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzctMi0xLTEtOTA2MTg_c1911a96-112f-4d41-b944-46f018d5acf9"
      unitRef="usd">122000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzctMy0xLTEtOTA2MTg_4d60dc2d-1754-4524-8568-3780882662c8"
      unitRef="usd">2897000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ief2dc30089664149a39ac740dc44fcd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzgtMS0xLTEtOTA2MTg_1d86b3e1-58f8-4c7c-b4cb-e03e691d3346"
      unitRef="usd">15082000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i142b45d688a94040896bab9c453fa022_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzgtMi0xLTEtOTA2MTg_9097bfa9-0004-4275-9268-e4d4c19fd837"
      unitRef="usd">122000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzgtMy0xLTEtOTA2MTg_4dcd0bb1-8bdd-4594-8124-7755106b7f63"
      unitRef="usd">15204000</us-gaap:LiabilitiesCurrent>
    <us-gaap:Liabilities
      contextRef="ief2dc30089664149a39ac740dc44fcd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzktMS0xLTEtOTA2MTg_3f264050-df9e-4ed2-a617-f99171bf5560"
      unitRef="usd">35666000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i142b45d688a94040896bab9c453fa022_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzktMi0xLTEtOTA2MTg_6ccf222c-6673-4430-9650-796d982acee6"
      unitRef="usd">122000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzktMy0xLTEtOTA2MTg_7b6c1119-9860-4fc2-a155-46245acab801"
      unitRef="usd">35788000</us-gaap:Liabilities>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ief2dc30089664149a39ac740dc44fcd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzEwLTEtMS0xLTkwNjE4_5bd3c9f9-401e-4ab1-aa9f-3f62967c2593"
      unitRef="usd">-332394000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i142b45d688a94040896bab9c453fa022_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzEwLTItMS0xLTkwNjE4_11273836-a35f-4e99-a574-f5da0bed6522"
      unitRef="usd">-806000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzEwLTMtMS0xLTkwNjE4_b498ae3c-bacd-4226-b7e7-0f1eae4b5391"
      unitRef="usd">-333200000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="ief2dc30089664149a39ac740dc44fcd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzExLTEtMS0xLTkwNjE4_8c1f8015-fe28-4f7f-87eb-ab69f2fe198d"
      unitRef="usd">-310410000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i142b45d688a94040896bab9c453fa022_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzExLTItMS0xLTkwNjE4_80f2e8d0-73ec-466f-95e7-e90693468637"
      unitRef="usd">-806000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzExLTMtMS0xLTkwNjE4_d6b13137-0fba-4734-a55b-57e6d978c6f1"
      unitRef="usd">-311216000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ief2dc30089664149a39ac740dc44fcd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzEyLTEtMS0xLTkwNjE4_2f7e976e-1fc9-40b4-abd9-75624faf877b"
      unitRef="usd">119664000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i142b45d688a94040896bab9c453fa022_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzEyLTItMS0xLTkwNjE4_b7954321-1daf-4480-aa64-ab16a1fa3a4d"
      unitRef="usd">-684000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxYmZkNzUwNDIzNWU0Y2YwYThjYWUyNTJiYjU3Y2JlNC90YWJsZXJhbmdlOjFiZmQ3NTA0MjM1ZTRjZjBhOGNhZTI1MmJiNTdjYmU0XzEyLTMtMS0xLTkwNjE4_5edafbf0-b725-4059-9149-154a25427eff"
      unitRef="usd">118980000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzMtMS0xLTEtOTA2MTg_a5b1e917-4f01-4151-8b96-c7a343969759"
      unitRef="usd">18993000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzMtMi0xLTEtOTA2MTg_536b9281-52d3-44e0-bcfd-9667c2565c02"
      unitRef="usd">-122000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzMtMy0xLTEtOTA2MTg_4fcec587-2a40-42ac-800e-6771d872ad4f"
      unitRef="usd">18871000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzQtMS0xLTEtOTA2MTg_debba524-8380-40f1-8a87-de55a89b10f9"
      unitRef="usd">3915000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzQtMi0xLTEtOTA2MTg_2503d78e-aac5-441c-9867-d12df477d295"
      unitRef="usd">-662000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzQtMy0xLTEtOTA2MTg_075dea97-40a3-4874-b0c7-bcfb09f9043a"
      unitRef="usd">3253000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:Revenues
      contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzUtMS0xLTEtOTA2MTg_d08934e0-4c6d-4b90-9dff-8f8baf18d345"
      unitRef="usd">26245000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzUtMi0xLTEtOTA2MTg_aa05db9b-af0c-4a94-bded-22ba66a4bab3"
      unitRef="usd">-784000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzUtMy0xLTEtOTA2MTg_1ef6cef5-30fd-4990-aa67-b085d791744a"
      unitRef="usd">25461000</us-gaap:Revenues>
    <amci:CostOfRevenueFromContractsWithCustomersExcludingDepreciation
      contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzYtMS0xLTEtOTA2MTg_9bbf3da1-da5f-45df-8329-e99af942e070"
      unitRef="usd">13289000</amci:CostOfRevenueFromContractsWithCustomersExcludingDepreciation>
    <amci:CostOfRevenueFromContractsWithCustomersExcludingDepreciation
      contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzYtMi0xLTEtOTA2MTg_2b067f2f-c7fe-4a49-9ef0-58914430fc87"
      unitRef="usd">-122000</amci:CostOfRevenueFromContractsWithCustomersExcludingDepreciation>
    <amci:CostOfRevenueFromContractsWithCustomersExcludingDepreciation
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzYtMy0xLTEtOTA2MTg_f4948059-5bab-42e3-b620-66f01c066096"
      unitRef="usd">13167000</amci:CostOfRevenueFromContractsWithCustomersExcludingDepreciation>
    <us-gaap:OperatingExpenses
      contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzctMS0xLTEtOTA2MTg_a40612a8-f0cb-4d54-b5a5-19918fbfec19"
      unitRef="usd">76602000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzctMi0xLTEtOTA2MTg_e4c7e737-e3fa-47ff-8a79-af3ba2335311"
      unitRef="usd">-122000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzctMy0xLTEtOTA2MTg_97cc8d47-e14a-441f-955a-3b6470c8eefa"
      unitRef="usd">76480000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzgtMS0xLTEtOTA2MTg_b6261a5a-3c09-4d4e-828c-99f5129b92fa"
      unitRef="usd">-50357000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzgtMi0xLTEtOTA2MTg_0b697aae-6347-4e53-bb90-5fec2e617d67"
      unitRef="usd">-662000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzgtMy0xLTEtOTA2MTg_4dc23c4a-34fa-4cb3-9a29-1a63ec3ab1d6"
      unitRef="usd">-51019000</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzktMS0xLTEtOTA2MTg_7f6dcd90-f1fb-42ce-a6bd-2a5d1c6ac258"
      unitRef="usd">-47972000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzktMi0xLTEtOTA2MTg_68a9407a-d1eb-4020-b1e9-6e72c987a5f2"
      unitRef="usd">-662000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzktMy0xLTEtOTA2MTg_3b3e6a07-8fe4-49ad-9971-748150cf0430"
      unitRef="usd">-48634000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment
      contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzEwLTEtMS0xLTkwNjE4_0318061d-f94a-4096-81a5-05f3d4ae8624"
      unitRef="usd">2204000</amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment>
    <amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment
      contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzEwLTItMS0xLTkwNjE4_ef2a149c-bc58-4278-8ab8-fe85cf206210"
      unitRef="usd">-259000</amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment>
    <amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzEwLTMtMS0xLTkwNjE4_df615396-f3c0-486a-b61b-b1382dcd48a2"
      unitRef="usd">1945000</amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment>
    <us-gaap:NetIncomeLoss
      contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzExLTEtMS0xLTkwNjE4_3a207f14-5718-4afc-a38b-5ac272f409f9"
      unitRef="usd">-45768000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzExLTItMS0xLTkwNjE4_f2e53261-0aec-4561-97c0-64077fc8e220"
      unitRef="usd">-921000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzExLTMtMS0xLTkwNjE4_8d4c46fc-126d-44dd-9983-c161cc29d5f7"
      unitRef="usd">-46689000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzEyLTEtMS0xLTkwNjE4_45b7a812-1bfb-426c-9b05-2f484255e21c"
      unitRef="usd">-82526000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzEyLTEtMS0xLTkwNjE4_7c21b2b8-299c-4c90-aa11-9774c483319f"
      unitRef="usd">-82526000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzEyLTItMS0xLTkwNjE4_ea3ea404-f82c-4dbd-b72c-8d9bac09d7a2"
      unitRef="usd">-921000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzEyLTItMS0xLTkwNjE4_f2b15ea9-0e42-4dfc-b31d-9021db79d1b1"
      unitRef="usd">-921000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzEyLTMtMS0xLTkwNjE4_40c41d80-a98c-4884-9428-3348f6f19da5"
      unitRef="usd">-83447000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzEyLTMtMS0xLTkwNjE4_c36c853c-308a-4073-be59-9cebbe27f3f2"
      unitRef="usd">-83447000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzEzLTEtMS0xLTkwNjE4_610223e4-df34-4ed3-9a3d-d2cafd0b1b5a"
      unitRef="usd">-45673000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzEzLTItMS0xLTkwNjE4_b3deb2c5-b51c-4853-8089-8caab5dfcdfb"
      unitRef="usd">-921000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzEzLTMtMS0xLTkwNjE4_6357882f-dcc5-42a6-9ea9-2463b1251766"
      unitRef="usd">-46594000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzE1LTEtMS0xLTkwNjE4_8b51293d-7318-474a-a6b6-bc485e6fa2a2"
      unitRef="usdPerShare">-42.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzE1LTEtMS0xLTkwNjE4_fa6b7b66-0d80-4f7a-8aa5-b5e1340461fd"
      unitRef="usdPerShare">-42.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzE1LTItMS0xLTkwNjE4_8e4c825b-3f09-431f-84b5-b48fd343b175"
      unitRef="usdPerShare">-0.47</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzE1LTItMS0xLTkwNjE4_a8dbf8b1-f7ae-4b01-a320-6184a8e4c1f6"
      unitRef="usdPerShare">-0.47</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzE1LTMtMS0xLTkwNjE4_614d7c92-6c06-413d-9219-f7854cd98ba7"
      unitRef="usdPerShare">-42.59</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNTA3Mzc4MTBhNTU0Nzg2YmM2MGRjMGJiYTRjM2Q0NS90YWJsZXJhbmdlOmU1MDczNzgxMGE1NTQ3ODZiYzYwZGMwYmJhNGMzZDQ1XzE1LTMtMS0xLTkwNjE4_c6be22d3-564c-4f24-99d0-ce6f9ac0bd87"
      unitRef="usdPerShare">-42.59</us-gaap:EarningsPerShareDiluted>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzMtMS0xLTEtOTA2MTg_1c7cdd16-472f-42da-9891-30db0578b47c"
      unitRef="usd">12865000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzMtMi0xLTEtOTA2MTg_4bf03ec1-248a-4302-a424-deaee3eff4ac"
      unitRef="usd">122000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzMtMy0xLTEtOTA2MTg_dc441720-3209-4455-8446-f33edc0e4b28"
      unitRef="usd">12987000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzQtMS0xLTEtOTA2MTg_dafb549d-6952-4420-9823-c79665eba221"
      unitRef="usd">4752000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzQtMi0xLTEtOTA2MTg_e61b7a86-f8ba-4c75-8af1-c70e7ae54d9f"
      unitRef="usd">-549000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzQtMy0xLTEtOTA2MTg_0ede6b80-1f56-4295-99b2-aadcb77cd337"
      unitRef="usd">4203000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:Revenues
      contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzUtMS0xLTEtOTA2MTg_f117a3da-c5a6-4abd-bf6f-fa44e1527174"
      unitRef="usd">18780000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzUtMi0xLTEtOTA2MTg_349d46b5-58df-4579-8ab6-d54a113a2cf8"
      unitRef="usd">-427000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzUtMy0xLTEtOTA2MTg_fac029eb-8f8f-4a9d-83ed-1f9d33d71636"
      unitRef="usd">18353000</us-gaap:Revenues>
    <amci:CostOfRevenueFromContractsWithCustomersExcludingDepreciation
      contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzYtMS0xLTEtOTA2MTg_3d9e0a04-5bf7-439b-af6d-f277be9f20c4"
      unitRef="usd">8063000</amci:CostOfRevenueFromContractsWithCustomersExcludingDepreciation>
    <amci:CostOfRevenueFromContractsWithCustomersExcludingDepreciation
      contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzYtMi0xLTEtOTA2MTg_01c3d8e1-5c10-458e-b272-9455cf42e112"
      unitRef="usd">122000</amci:CostOfRevenueFromContractsWithCustomersExcludingDepreciation>
    <amci:CostOfRevenueFromContractsWithCustomersExcludingDepreciation
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzYtMy0xLTEtOTA2MTg_6aa17882-7ca0-4c95-81e8-6b7f14eed8a3"
      unitRef="usd">8185000</amci:CostOfRevenueFromContractsWithCustomersExcludingDepreciation>
    <us-gaap:OperatingExpenses
      contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzctMS0xLTEtOTA2MTg_ff470f85-9aac-4ec0-80d6-773b41b1c7d6"
      unitRef="usd">57932000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzctMi0xLTEtOTA2MTg_6c215048-22f9-427d-9faf-4f9afbd643db"
      unitRef="usd">122000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzctMy0xLTEtOTA2MTg_7c6db7af-85cc-4c6a-b47f-fe002598afd8"
      unitRef="usd">58054000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzgtMS0xLTEtOTA2MTg_1fdad722-4dfc-4f40-90af-31a59db3af94"
      unitRef="usd">-39152000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzgtMi0xLTEtOTA2MTg_977990b1-865f-4be6-9d0f-b4a1ac4228d7"
      unitRef="usd">-549000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzgtMy0xLTEtOTA2MTg_a7cc5a97-7969-4043-afcb-a331e03398d7"
      unitRef="usd">-39701000</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzktMS0xLTEtOTA2MTg_96651436-fde4-4713-b18a-bf00bfe595ba"
      unitRef="usd">-39331000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzktMi0xLTEtOTA2MTg_b96530e2-435b-4b93-8206-8f99af070576"
      unitRef="usd">-549000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzktMy0xLTEtOTA2MTg_69a30fd9-3c87-4a7c-ba0f-a87c11c5bcbd"
      unitRef="usd">-39880000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment
      contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzEwLTEtMS0xLTkwNjE4_10ec46d0-9a1c-42e1-928b-73f6b75a5753"
      unitRef="usd">2424000</amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment>
    <amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment
      contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzEwLTItMS0xLTkwNjE4_fc888f6f-e6a2-4896-b6c3-dadb913a4391"
      unitRef="usd">-257000</amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment>
    <amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzEwLTMtMS0xLTkwNjE4_476fc1dc-2970-4554-914c-efce47256afc"
      unitRef="usd">2167000</amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment>
    <us-gaap:NetIncomeLoss
      contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzExLTEtMS0xLTkwNjE4_2ad30d6d-7b49-420e-b31a-d4fc4bba003d"
      unitRef="usd">-36907000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzExLTItMS0xLTkwNjE4_0c06ed8d-be39-4dc8-8868-5ec914eb613e"
      unitRef="usd">-806000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzExLTMtMS0xLTkwNjE4_144213bd-74b7-4c18-8d1e-7ab44c81fd4f"
      unitRef="usd">-37713000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzEyLTEtMS0xLTkwNjE4_262312ff-01d2-448d-88a0-cdfa067b654e"
      unitRef="usd">-68198000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzEyLTEtMS0xLTkwNjE4_2ad93a58-f365-4a92-b9c9-76ffc2c578e2"
      unitRef="usd">-68198000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzEyLTItMS0xLTkwNjE4_837f6362-490b-44d5-b331-618266821824"
      unitRef="usd">-806000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzEyLTItMS0xLTkwNjE4_a23fca93-047e-4a1e-92ac-612db8c6aaf6"
      unitRef="usd">-806000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzEyLTMtMS0xLTkwNjE4_4bbead41-6b93-49ef-9aad-d14d0f3a6539"
      unitRef="usd">-69004000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzEyLTMtMS0xLTkwNjE4_7247a72c-cf6b-49e8-9f5c-92ba8b83b573"
      unitRef="usd">-69004000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzEzLTEtMS0xLTkwNjE4_9cec75f9-ae7c-47d3-af49-bc21f893b7b0"
      unitRef="usd">-36282000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzEzLTItMS0xLTkwNjE4_344a8e6d-25dd-4339-88e8-f3c58d97fad3"
      unitRef="usd">-806000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzEzLTMtMS0xLTkwNjE4_694b05e4-82ab-47df-a52e-e97b9a92a799"
      unitRef="usd">-37088000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasic
      contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzE1LTEtMS0xLTkwNjE4_7f2d6fe3-3aa4-4a3d-9714-304522e5ea1c"
      unitRef="usdPerShare">-41.84</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzE1LTEtMS0xLTkwNjE4_cb28fd04-1039-497d-9a20-ff36267c01b9"
      unitRef="usdPerShare">-41.84</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzE1LTItMS0xLTkwNjE4_9ae533d1-0c11-4ed0-a2c0-a5ad3b344c64"
      unitRef="usdPerShare">-0.50</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzE1LTItMS0xLTkwNjE4_d319d7ae-8ecc-4024-b603-3de0b24a895d"
      unitRef="usdPerShare">-0.50</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzE1LTMtMS0xLTkwNjE4_6fea7826-1fe3-4a6e-951d-8674bd093bb2"
      unitRef="usdPerShare">-42.34</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpjNzZhYTRkZDM5MTc0Y2FiYmU1NGM0ZWY4MmQ3ODUxOS90YWJsZXJhbmdlOmM3NmFhNGRkMzkxNzRjYWJiZTU0YzRlZjgyZDc4NTE5XzE1LTMtMS0xLTkwNjE4_c077357b-02ec-4aac-a2d4-ed8538ed3c0c"
      unitRef="usdPerShare">-42.34</us-gaap:EarningsPerShareDiluted>
    <us-gaap:StockholdersEquity
      contextRef="i313f0012493b4bbbb3009a5a1bf811eb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTphZjNmMTA2MjRhZTA0ZGQxYjJhNTZkZDFjNDk3YjI5Yi90YWJsZXJhbmdlOmFmM2YxMDYyNGFlMDRkZDFiMmE1NmRkMWM0OTdiMjliXzMtMS0xLTEtOTA2MTg_a19676c8-7957-4bc1-8f8b-79722e6f9efd"
      unitRef="usd">-332394000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6ba67557e60f4d1c9ab04d369b4a98b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTphZjNmMTA2MjRhZTA0ZGQxYjJhNTZkZDFjNDk3YjI5Yi90YWJsZXJhbmdlOmFmM2YxMDYyNGFlMDRkZDFiMmE1NmRkMWM0OTdiMjliXzMtMi0xLTEtOTA2MTg_85d6c961-a7bc-4d9e-bb8f-bf8202dd8869"
      unitRef="usd">-806000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i18eedd573381425c8c989e260801dafe_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTphZjNmMTA2MjRhZTA0ZGQxYjJhNTZkZDFjNDk3YjI5Yi90YWJsZXJhbmdlOmFmM2YxMDYyNGFlMDRkZDFiMmE1NmRkMWM0OTdiMjliXzMtMy0xLTEtOTA2MTg_17ed0d90-61b4-419b-b210-f799af00cfb9"
      unitRef="usd">-333200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ief2dc30089664149a39ac740dc44fcd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTphZjNmMTA2MjRhZTA0ZGQxYjJhNTZkZDFjNDk3YjI5Yi90YWJsZXJhbmdlOmFmM2YxMDYyNGFlMDRkZDFiMmE1NmRkMWM0OTdiMjliXzQtMS0xLTEtOTA2MTg_fa56c6da-e16b-4c00-b898-7afe58ca73e5"
      unitRef="usd">-310410000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i142b45d688a94040896bab9c453fa022_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTphZjNmMTA2MjRhZTA0ZGQxYjJhNTZkZDFjNDk3YjI5Yi90YWJsZXJhbmdlOmFmM2YxMDYyNGFlMDRkZDFiMmE1NmRkMWM0OTdiMjliXzQtMi0xLTEtOTA2MTg_5dcc0389-5bc9-41ca-b43a-b4a4109621f9"
      unitRef="usd">-806000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTphZjNmMTA2MjRhZTA0ZGQxYjJhNTZkZDFjNDk3YjI5Yi90YWJsZXJhbmdlOmFmM2YxMDYyNGFlMDRkZDFiMmE1NmRkMWM0OTdiMjliXzQtMy0xLTEtOTA2MTg_ec089af0-e352-4d34-b327-f26d714f9506"
      unitRef="usd">-311216000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTphZjNmMTA2MjRhZTA0ZGQxYjJhNTZkZDFjNDk3YjI5Yi90YWJsZXJhbmdlOmFmM2YxMDYyNGFlMDRkZDFiMmE1NmRkMWM0OTdiMjliXzUtMS0xLTEtOTA2MTg_1c66b56b-3d08-47a6-9c90-3696a9788b85"
      unitRef="usd">-45768000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTphZjNmMTA2MjRhZTA0ZGQxYjJhNTZkZDFjNDk3YjI5Yi90YWJsZXJhbmdlOmFmM2YxMDYyNGFlMDRkZDFiMmE1NmRkMWM0OTdiMjliXzUtMi0xLTEtOTA2MTg_ae03e10d-befc-43d0-abaa-aa4fb7f8c912"
      unitRef="usd">-921000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTphZjNmMTA2MjRhZTA0ZGQxYjJhNTZkZDFjNDk3YjI5Yi90YWJsZXJhbmdlOmFmM2YxMDYyNGFlMDRkZDFiMmE1NmRkMWM0OTdiMjliXzUtMy0xLTEtOTA2MTg_aab2cee3-ccbc-41b9-aef9-e789c686c47a"
      unitRef="usd">-46689000</us-gaap:NetIncomeLoss>
    <us-gaap:StockholdersEquity
      contextRef="ia0727c1578ba4d70a8b82b043575d5a6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTphZjNmMTA2MjRhZTA0ZGQxYjJhNTZkZDFjNDk3YjI5Yi90YWJsZXJhbmdlOmFmM2YxMDYyNGFlMDRkZDFiMmE1NmRkMWM0OTdiMjliXzYtMS0xLTEtOTA2MTg_56d12ce1-bafa-47ba-a3b3-68cdb90174a2"
      unitRef="usd">-378162000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i22ad32b2cf2844b38ba63af045e6e421_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTphZjNmMTA2MjRhZTA0ZGQxYjJhNTZkZDFjNDk3YjI5Yi90YWJsZXJhbmdlOmFmM2YxMDYyNGFlMDRkZDFiMmE1NmRkMWM0OTdiMjliXzYtMi0xLTEtOTA2MTg_6a32bb72-b6a1-49e4-bdb8-5a55f1a9592c"
      unitRef="usd">-1727000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib0898c763893444f8318ba806e5872af_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTphZjNmMTA2MjRhZTA0ZGQxYjJhNTZkZDFjNDk3YjI5Yi90YWJsZXJhbmdlOmFmM2YxMDYyNGFlMDRkZDFiMmE1NmRkMWM0OTdiMjliXzYtMy0xLTEtOTA2MTg_b63517e5-aff4-46b8-8dca-922b3490b1aa"
      unitRef="usd">-379889000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idccad26b9b674e58874df0b2f95fbd38_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTphZjNmMTA2MjRhZTA0ZGQxYjJhNTZkZDFjNDk3YjI5Yi90YWJsZXJhbmdlOmFmM2YxMDYyNGFlMDRkZDFiMmE1NmRkMWM0OTdiMjliXzctMS0xLTEtOTA2MTg_ae8abbe0-3739-44f1-8bef-372decb57639"
      unitRef="usd">-353190000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8987593ef9dd4097a8751ede87870612_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTphZjNmMTA2MjRhZTA0ZGQxYjJhNTZkZDFjNDk3YjI5Yi90YWJsZXJhbmdlOmFmM2YxMDYyNGFlMDRkZDFiMmE1NmRkMWM0OTdiMjliXzctMi0xLTEtOTA2MTg_2f74c73a-df25-4482-af91-c6cc5a5a4df0"
      unitRef="usd">-1727000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTphZjNmMTA2MjRhZTA0ZGQxYjJhNTZkZDFjNDk3YjI5Yi90YWJsZXJhbmdlOmFmM2YxMDYyNGFlMDRkZDFiMmE1NmRkMWM0OTdiMjliXzctMy0xLTEtOTA2MTg_a38b7a4e-29ca-44f3-98ce-0c75b5db1219"
      unitRef="usd">-354917000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iaa2024ac8ce64a4cb2c146b06249fdb9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNGJjNjJjMzE5MGY0YTcxODU4YWVlOGE5M2JkMzQwYi90YWJsZXJhbmdlOmU0YmM2MmMzMTkwZjRhNzE4NThhZWU4YTkzYmQzNDBiXzMtMS0xLTEtOTA2MTg_a4169aab-dd8f-4328-9e7b-ab54744c7841"
      unitRef="usd">-295487000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia5fbf727115a466bbef562191f56b933_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNGJjNjJjMzE5MGY0YTcxODU4YWVlOGE5M2JkMzQwYi90YWJsZXJhbmdlOmU0YmM2MmMzMTkwZjRhNzE4NThhZWU4YTkzYmQzNDBiXzMtMi0xLTEtOTA2MTg_fde8caaf-aae7-412a-9c2e-1016e62234fa"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i94e27674b4054eeb8e5f88cdfd303c29_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNGJjNjJjMzE5MGY0YTcxODU4YWVlOGE5M2JkMzQwYi90YWJsZXJhbmdlOmU0YmM2MmMzMTkwZjRhNzE4NThhZWU4YTkzYmQzNDBiXzMtMy0xLTEtOTA2MTg_0d3fb525-7833-4a07-bc41-1057d00607bb"
      unitRef="usd">-295487000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i979244b8b15f4cdba6249d9a452d49e9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNGJjNjJjMzE5MGY0YTcxODU4YWVlOGE5M2JkMzQwYi90YWJsZXJhbmdlOmU0YmM2MmMzMTkwZjRhNzE4NThhZWU4YTkzYmQzNDBiXzQtMS0xLTEtOTA2MTg_6fa6db95-4e61-4419-9297-e969211b37d8"
      unitRef="usd">-276592000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iaeab5bba9ba24bbab921cc565da5880c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNGJjNjJjMzE5MGY0YTcxODU4YWVlOGE5M2JkMzQwYi90YWJsZXJhbmdlOmU0YmM2MmMzMTkwZjRhNzE4NThhZWU4YTkzYmQzNDBiXzQtMi0xLTEtOTA2MTg_3e15baef-c59c-4591-924f-6c1e8b88ceae"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i946f64f7009a4a2082ea5e8ea9ae0377_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNGJjNjJjMzE5MGY0YTcxODU4YWVlOGE5M2JkMzQwYi90YWJsZXJhbmdlOmU0YmM2MmMzMTkwZjRhNzE4NThhZWU4YTkzYmQzNDBiXzQtMy0xLTEtOTA2MTg_1d467545-0362-4b05-aace-b993ab4647df"
      unitRef="usd">-276592000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNGJjNjJjMzE5MGY0YTcxODU4YWVlOGE5M2JkMzQwYi90YWJsZXJhbmdlOmU0YmM2MmMzMTkwZjRhNzE4NThhZWU4YTkzYmQzNDBiXzUtMS0xLTEtOTA2MTg_f3673dfe-71a7-43a1-a11f-7dbf8770a8b8"
      unitRef="usd">-36907000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNGJjNjJjMzE5MGY0YTcxODU4YWVlOGE5M2JkMzQwYi90YWJsZXJhbmdlOmU0YmM2MmMzMTkwZjRhNzE4NThhZWU4YTkzYmQzNDBiXzUtMi0xLTEtOTA2MTg_c690d1ef-faa2-4f8d-b461-27d1992c6444"
      unitRef="usd">-806000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNGJjNjJjMzE5MGY0YTcxODU4YWVlOGE5M2JkMzQwYi90YWJsZXJhbmdlOmU0YmM2MmMzMTkwZjRhNzE4NThhZWU4YTkzYmQzNDBiXzUtMy0xLTEtOTA2MTg_e9b039a3-202b-4743-92ef-9ac1e3b66e4a"
      unitRef="usd">-37713000</us-gaap:NetIncomeLoss>
    <us-gaap:StockholdersEquity
      contextRef="i313f0012493b4bbbb3009a5a1bf811eb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNGJjNjJjMzE5MGY0YTcxODU4YWVlOGE5M2JkMzQwYi90YWJsZXJhbmdlOmU0YmM2MmMzMTkwZjRhNzE4NThhZWU4YTkzYmQzNDBiXzYtMS0xLTEtOTA2MTg_833dda64-c47d-4ff5-9feb-f3fb80a6fc38"
      unitRef="usd">-332394000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6ba67557e60f4d1c9ab04d369b4a98b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNGJjNjJjMzE5MGY0YTcxODU4YWVlOGE5M2JkMzQwYi90YWJsZXJhbmdlOmU0YmM2MmMzMTkwZjRhNzE4NThhZWU4YTkzYmQzNDBiXzYtMi0xLTEtOTA2MTg_ceabccf8-6a61-4ccd-96bb-0d09e60cd883"
      unitRef="usd">-806000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i18eedd573381425c8c989e260801dafe_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNGJjNjJjMzE5MGY0YTcxODU4YWVlOGE5M2JkMzQwYi90YWJsZXJhbmdlOmU0YmM2MmMzMTkwZjRhNzE4NThhZWU4YTkzYmQzNDBiXzYtMy0xLTEtOTA2MTg_3e2ebe59-28e5-4881-a24d-798c2f923a5b"
      unitRef="usd">-333200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ief2dc30089664149a39ac740dc44fcd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNGJjNjJjMzE5MGY0YTcxODU4YWVlOGE5M2JkMzQwYi90YWJsZXJhbmdlOmU0YmM2MmMzMTkwZjRhNzE4NThhZWU4YTkzYmQzNDBiXzctMS0xLTEtOTA2MTg_76e5671f-a841-4e05-8693-917fb39924c5"
      unitRef="usd">-310410000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i142b45d688a94040896bab9c453fa022_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNGJjNjJjMzE5MGY0YTcxODU4YWVlOGE5M2JkMzQwYi90YWJsZXJhbmdlOmU0YmM2MmMzMTkwZjRhNzE4NThhZWU4YTkzYmQzNDBiXzctMi0xLTEtOTA2MTg_37a10ac0-b1ca-4fa6-b005-bb357f4a6a2f"
      unitRef="usd">-806000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNGJjNjJjMzE5MGY0YTcxODU4YWVlOGE5M2JkMzQwYi90YWJsZXJhbmdlOmU0YmM2MmMzMTkwZjRhNzE4NThhZWU4YTkzYmQzNDBiXzctMy0xLTEtOTA2MTg_be5fd46a-b3ed-416c-967a-26d11063e3e8"
      unitRef="usd">-311216000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzMtMS0xLTEtOTA2MTg_37695cb8-47c4-4504-b3bf-cb83c9c4cb5a"
      unitRef="usd">-45768000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzMtMi0xLTEtOTA2MTg_6aa68811-a174-453a-b508-387ce24565ce"
      unitRef="usd">-921000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzMtMy0xLTEtOTA2MTg_8899e8ca-3a3b-4656-8a59-27ae2c47178f"
      unitRef="usd">-46689000</us-gaap:NetIncomeLoss>
    <amci:NoncashRecognitionOfLicensingRevenue
      contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzUtMS0xLTEtOTA2MTg_1b4dd543-6bcb-4bfe-b553-22a28bdbd585"
      unitRef="usd">2684000</amci:NoncashRecognitionOfLicensingRevenue>
    <amci:NoncashRecognitionOfLicensingRevenue
      contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzUtMi0xLTEtOTA2MTg_d0dbb9d9-9e9a-49fb-b57a-e7a3307d238b"
      unitRef="usd">-662000</amci:NoncashRecognitionOfLicensingRevenue>
    <amci:NoncashRecognitionOfLicensingRevenue
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzUtMy0xLTEtOTA2MTg_99e1d8cf-5665-404a-a5ca-c02648b6bea1"
      unitRef="usd">2022000</amci:NoncashRecognitionOfLicensingRevenue>
    <amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment
      contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzYtMS0xLTEtOTA2MTg_1516b691-90f3-4ac9-8a08-7f35b03ae22f"
      unitRef="usd">2204000</amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment>
    <amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment
      contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzYtMi0xLTEtOTA2MTg_644c30c5-6ee6-4834-9fee-ff14c340a2b3"
      unitRef="usd">-259000</amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment>
    <amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzYtMy0xLTEtOTA2MTg_a6cf7b0c-1e08-498c-b860-8849d3776ebd"
      unitRef="usd">1945000</amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset
      contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzgtMS0xLTEtOTA2MTg_9b830c5e-a009-465b-ae2d-5608f6a7d8c6"
      unitRef="usd">5636000</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset
      contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzgtMi0xLTEtOTA2MTg_b6dd629f-662f-4988-b9e0-da8c14365beb"
      unitRef="usd">-122000</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzgtMy0xLTEtOTA2MTg_a0bf7414-5114-4f56-aa8f-2850e34aa991"
      unitRef="usd">5514000</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzktMS0xLTEtOTA2MTg_5c3bbe09-6181-4fb1-bc2a-39d2731e6b87"
      unitRef="usd">1378000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzktMi0xLTEtOTA2MTg_197e17c8-a38b-44b0-9aa3-004edc1e4fbc"
      unitRef="usd">-122000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzktMy0xLTEtOTA2MTg_62bc47b6-5831-4643-badb-922c12a968b9"
      unitRef="usd">1256000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzEwLTEtMS0xLTkwNjE4_c6937d46-6090-4d05-8bd4-16b94ac7d948"
      unitRef="usd">-42591000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="iac1f8c02ffba4583b2633d6f9ce3cb08_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzEwLTItMS0xLTkwNjE4_cc5d42a5-da0e-4a36-a0cf-93ae9ed2549b"
      unitRef="usd">0</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTplNWIwNWMyMzQwNTk0NWZlOWZiMDEwNTA0ZWFiZjcyMy90YWJsZXJhbmdlOmU1YjA1YzIzNDA1OTQ1ZmU5ZmIwMTA1MDRlYWJmNzIzXzEwLTMtMS0xLTkwNjE4_95af01e0-def0-48e2-91c0-3d0243ed0280"
      unitRef="usd">-42591000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetIncomeLoss
      contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzMtMS0xLTEtOTA2MTg_9765639d-b8f0-42e8-9ea3-19e0ad84bfbc"
      unitRef="usd">-36907000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzMtMi0xLTEtOTA2MTg_ccbf9ae0-9e03-4975-b7d0-d039a0bf8e0f"
      unitRef="usd">-806000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzMtMy0xLTEtOTA2MTg_ae924edb-60ef-4a23-95f6-30137e38d177"
      unitRef="usd">-37713000</us-gaap:NetIncomeLoss>
    <amci:NoncashRecognitionOfLicensingRevenue
      contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzUtMS0xLTEtOTA2MTg_625cacb9-cd1f-4d9d-b49a-266e3bfa39ac"
      unitRef="usd">1567000</amci:NoncashRecognitionOfLicensingRevenue>
    <amci:NoncashRecognitionOfLicensingRevenue
      contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzUtMi0xLTEtOTA2MTg_76e126a4-3410-4a1c-8a63-4608e48d1c8e"
      unitRef="usd">-549000</amci:NoncashRecognitionOfLicensingRevenue>
    <amci:NoncashRecognitionOfLicensingRevenue
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzUtMy0xLTEtOTA2MTg_2013263d-facf-402f-9980-4a73439888e0"
      unitRef="usd">1018000</amci:NoncashRecognitionOfLicensingRevenue>
    <amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment
      contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzYtMS0xLTEtOTA2MTg_8f5fc5e3-968f-4757-ac44-134cfa41bc66"
      unitRef="usd">2424000</amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment>
    <amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment
      contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzYtMi0xLTEtOTA2MTg_b2894806-63be-4d7d-a0f6-4488ac2e8eb7"
      unitRef="usd">-257000</amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment>
    <amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzYtMy0xLTEtOTA2MTg_2f57ba85-52e4-415e-aaf9-93e970ef4087"
      unitRef="usd">2167000</amci:IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset
      contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzgtMS0xLTEtOTA2MTg_d766fcb4-8d02-4722-97d4-f166a25bf505"
      unitRef="usd">5483000</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset
      contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzgtMi0xLTEtOTA2MTg_9bbcfc0a-1099-4237-b1cd-f047d45378ce"
      unitRef="usd">122000</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzgtMy0xLTEtOTA2MTg_a79c242d-b87f-4db7-99cd-48d4734dbf15"
      unitRef="usd">5605000</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzktMS0xLTEtOTA2MTg_b33da788-860d-472f-bba4-23eed6390e9c"
      unitRef="usd">568000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzktMi0xLTEtOTA2MTg_a5a6dd69-1564-41e8-9fd9-1a2d63a27006"
      unitRef="usd">122000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzktMy0xLTEtOTA2MTg_559f3851-08c3-49bb-becf-bfd44466ec22"
      unitRef="usd">690000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i036ed5483d654dfaa5ef4ae4f1c70d7a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzEwLTEtMS0xLTkwNjE4_2d143e25-56e4-4e0c-8621-3e3b79d790ce"
      unitRef="usd">-39271000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ide5520a1a13c4c64a2e93cf17d0c4c49_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzEwLTItMS0xLTkwNjE4_925dab67-eadf-4626-9ebc-5eedbed3c36d"
      unitRef="usd">0</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZToxZTA2YWEzNGUxZmM0MzNiOTUxMzMzM2NlZDhjYmU3Ni90YWJsZXJhbmdlOjFlMDZhYTM0ZTFmYzQzM2I5NTEzMzMzY2VkOGNiZTc2XzEwLTMtMS0xLTkwNjE4_ea6bfb5e-bae4-43ca-a961-874ad56d3129"
      unitRef="usd">-39271000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4715c3e771cb49659b7d7d1edf71bd81_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzExMTk4_2c0ac6d9-312b-4bd7-97a8-a310024c235b"
      unitRef="usd">662000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7a001a92c1048529f1d70f282ef5979_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzExMjA1_b6c2e032-cb3a-4b55-9f63-101e95489eef"
      unitRef="usd">549000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <amci:EquityMethodInvestmentGainOnDilutionOfInvestment
      contextRef="i1b3072bbd46d4c38bfa4732be01dff68_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTowMzkwZjI1OGE3ZDk0Y2MwOGYwYjFlNGE1ZDY3ZTljOC90YWJsZXJhbmdlOjAzOTBmMjU4YTdkOTRjYzA4ZjBiMWU0YTVkNjdlOWM4XzItMS0xLTEtOTA2MTg_dc7aa9fb-912b-41f4-8d75-e27c11566e2a"
      unitRef="usd">181000</amci:EquityMethodInvestmentGainOnDilutionOfInvestment>
    <amci:EquityMethodInvestmentGainOnDilutionOfInvestment
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTowMzkwZjI1OGE3ZDk0Y2MwOGYwYjFlNGE1ZDY3ZTljOC90YWJsZXJhbmdlOjAzOTBmMjU4YTdkOTRjYzA4ZjBiMWU0YTVkNjdlOWM4XzItMi0xLTEtOTA2MTg_7390010a-5e60-4b6f-ac9a-e208c49b6e08"
      unitRef="usd">503000</amci:EquityMethodInvestmentGainOnDilutionOfInvestment>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTMz_c938a68d-ef71-446d-a957-4f900cf1ad20"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEwOTk1MTE2MzczMTE5_13032edc-e6d3-4fcf-a4a1-12248b4ed8eb"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <amci:CoronavirusPolicyTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NjMx_dc28a29a-3598-4ca0-a086-3779910c67d4">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Coronavirus (COVID-19)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the World Health Organization declared the viral strain of coronavirus ("COVID-19") a global pandemic and recommended containment and mitigation measures worldwide. The spread of COVID-19 and the resulting economic contraction has resulted in increased business uncertainty. The consequences of a prolonged economic decline could include, but are not limited to, reduced revenues, increased instances of uncollectible customer receivables, and increased asset impairments in future periods. Accordingly, the Company cannot reasonably estimate the length or severity of this pandemic, or the extent to which the disruption may materially impact its consolidated balance sheets, consolidated statements of operations and comprehensive loss or statements of cash flows for future periods.&lt;/span&gt;&lt;/div&gt;</amci:CoronavirusPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEzODU0_eeef63a0-d6f1-4f00-a84e-80ba462c1ca7"
      unitRef="usd">128318000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEzODg4_1c4e878d-dcbe-4a40-9f8d-dfe130f8b8bf"
      unitRef="usd">-379889000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEzOTM0_4d2c388e-3d4d-41a4-aceb-587dcdff03a2"
      unitRef="usd">-42591000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetIncomeLoss
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEzOTU1_f6496454-eb77-4fa9-b2c1-9006c9ee67f6"
      unitRef="usd">-46689000</us-gaap:NetIncomeLoss>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE2NDk1_eeef63a0-d6f1-4f00-a84e-80ba462c1ca7"
      unitRef="usd">128318000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE2NTAy_5e0796c0-5938-41d5-8adf-dfde7a897c23"
      unitRef="usd">60495000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTozNjc1MDRkZDlkNjY0ZDUwYTRiMzgyNzYxM2E5OGFmYS90YWJsZXJhbmdlOjM2NzUwNGRkOWQ2NjRkNTBhNGIzODI3NjEzYTk4YWZhXzItMS0xLTEtOTA2MTg_8cdb2635-fa3d-44ff-96e5-a509d0349ebf"
      unitRef="usd">128318000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTozNjc1MDRkZDlkNjY0ZDUwYTRiMzgyNzYxM2E5OGFmYS90YWJsZXJhbmdlOjM2NzUwNGRkOWQ2NjRkNTBhNGIzODI3NjEzYTk4YWZhXzItMy0xLTEtOTA2MTg_2360910d-a822-446d-b91f-e85001a3a322"
      unitRef="usd">60495000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTozNjc1MDRkZDlkNjY0ZDUwYTRiMzgyNzYxM2E5OGFmYS90YWJsZXJhbmdlOjM2NzUwNGRkOWQ2NjRkNTBhNGIzODI3NjEzYTk4YWZhXzMtMS0xLTEtOTA2MTg_2f4026da-dd91-431d-837a-60466b2286e0"
      unitRef="usd">414000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTozNjc1MDRkZDlkNjY0ZDUwYTRiMzgyNzYxM2E5OGFmYS90YWJsZXJhbmdlOjM2NzUwNGRkOWQ2NjRkNTBhNGIzODI3NjEzYTk4YWZhXzMtMy0xLTEtOTA2MTg_a795be53-afcc-4728-b9d7-0fa5d5053830"
      unitRef="usd">414000</us-gaap:RestrictedCash>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTozNjc1MDRkZDlkNjY0ZDUwYTRiMzgyNzYxM2E5OGFmYS90YWJsZXJhbmdlOjM2NzUwNGRkOWQ2NjRkNTBhNGIzODI3NjEzYTk4YWZhXzQtMS0xLTEtOTA2MTg_42c54b7f-fb05-4b7f-896e-67b938eb7212"
      unitRef="usd">128732000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTozNjc1MDRkZDlkNjY0ZDUwYTRiMzgyNzYxM2E5OGFmYS90YWJsZXJhbmdlOjM2NzUwNGRkOWQ2NjRkNTBhNGIzODI3NjEzYTk4YWZhXzQtMy0xLTEtOTA2MTg_2db59a05-985d-43c9-9d4a-2825e92c590a"
      unitRef="usd">60909000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE3NTA4_6bbfec4d-1f4c-4c09-8055-06c1e77bb0f9"
      unitRef="usd">1235000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE3NTE1_2d7d0958-4ad3-4e55-b72d-7177f67c5b08"
      unitRef="usd">1325000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <amci:OtherCurrentAssetsPolicyTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NjM4_4ab97cc7-cd0c-4397-a5e2-ee73a78e13c0">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Current Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current assets consist of prepaid expenses, materials and supplies, and other assets. Material and supplies consist of spare parts and consumables used for research and research equipment and is stated at the weighted average cost.&lt;/span&gt;&lt;/div&gt;</amci:OtherCurrentAssetsPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NjM5_6f2079d6-9a8d-44d8-aad9-694ccfa5aa1a">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost and include improvements that significantly increase capacities or extend the useful lives of existing plant and equipment.&#160;Depreciation is calculated using the straight-line method over the estimated useful life of the assets. Useful lives range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTA0_78de1c22-d3ad-43ae-a899-19a74e1b2357"&gt;three&lt;/span&gt; to five years for instruments and equipment, &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk3OTk5_761df305-309f-4903-a23c-ce62ac3f485c"&gt;three&lt;/span&gt; to five years for office equipment and furniture and software, five years for vehicles and, for leasehold improvements, the shorter of the life of the improvement or the remaining term of the lease. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews the remaining useful life of its assets on a regular basis to determine whether changes have taken place that would suggest that a change to depreciation policies is warranted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon retirement or disposal of property, plant and equipment, the cost and related accumulated depreciation are removed from the account, and the resulting gains or losses, if any, are recorded in the consolidated statements of operations and comprehensive loss. Net gains or losses related to asset dispositions are recognized in earnings in the period in which dispositions occur. Routine maintenance, repairs and replacements are expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i8253259ad4874f5a9b674506631abe14_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NTE2_fa398fb4-70f5-4423-861b-236c205b81bc">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="id306802fd9ee409aab98820719190d6a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk4MDE4_9ba8b725-f7c6-4087-a62d-6aeb6efa7c6b">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="idf64231b10064ce9b86e185225060418_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk4MDM3_6d54f517-5c70-46b6-8b15-00ef745a181b">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:LessorLeasesPolicyTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NjQw_dc731ab2-5d38-4e34-b245-c448d5582746">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines&#160;if an arrangement is a lease at inception.&#160;Lease agreements are evaluated to classify the lease as a finance or operating&#160;lease.&#160;Operating lease assets and liabilities are recognized at the commencement date of the lease based on the present value of lease payments over the lease term. Lease assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. As most&#160;leases&#160;do not provide an implicit interest rate,&#160;the Company&#160;uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. Leases with an initial term of 12 months or less are not recorded on the Company&#x2019;s consolidated balance sheets. The Company recognizes lease expense for these leases on a straight-line basis over the lease term.&#160;The Company accounts for lease components and non-lease components as a single lease component.&lt;/span&gt;&lt;/div&gt;</us-gaap:LessorLeasesPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk3OTY5_2091368a-00e5-4aaf-bde8-8496595d061c">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company performs a recoverability assessment of each of its long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indicators may include, but are not limited to, adverse changes in the regulatory environment in a jurisdiction where the Company operates, a decision to discontinue the development of a long-lived asset, early termination of a significant customer contract, or the introduction of newer technology.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When performing a recoverability assessment, the Company measures whether the estimated future undiscounted net cash flows expected to be generated by the asset exceeds its carrying value. In the event that an asset does not meet the recoverability test, the carrying value of the asset will be adjusted to fair value resulting in an impairment charge.&lt;/span&gt;&lt;/div&gt;Management develops the assumptions used in the recoverability assessment based on active contracts as well as information received from third-party industry sources.</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk3OTcw_356b952a-07de-4e4c-8bc5-370e74b4a398">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Method Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments in entities over which the Company has significant influence, but not control, are accounted for using the&#160;equity method&#160;of accounting. Gain from&#160;equity method&#160;investees, net represents the Company&#x2019;s proportionate share of net income or loss of its equity method investees and any gains or losses from the dilution of such investments.&lt;/span&gt;&lt;/div&gt;Equity method&#160;investments are assessed for impairment whenever changes in the facts and circumstances indicate a loss in value may have occurred. When a loss is deemed to have occurred and is other than temporary, the carrying value of the&#160;equity method&#160;investment is written down to fair value. In evaluating whether a loss is other than temporary, the Company considers the length of time for which the conditions have existed and its intent and ability to hold the investment.</us-gaap:EquityMethodInvestmentsPolicy>
    <amci:WarrantsPolicyPolicyTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk3OTcy_c44c5ba1-063e-4eab-8244-219a00a6e305">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has warrants to purchase preferred shares outstanding as of December&#160;31, 2021 and 2020 representing 225,223 and 383,281 preferred shares, respectively, which warrants expire at various dates through December 31, 2027. The exercise prices of the warrants range from $14.69 to $19.93 as of each of December&#160;31, 2021 and 2020. The Company accounts for its warrants as liabilities based upon the characteristics and provisions of each instrument. The liabilities are included in other accrued liabilities on the Company's consolidated balance sheets at their fair value on the date of issuance and are revalued in each subsequent reporting period until such instruments are exercised or expire. The change in fair value between reporting periods is included in other (expense) income, net in the consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Further the warrant related to the SAFE of $1,729 is accounted for as a liability. This liability is recorded in current liabilities on the Company's consolidated balance sheets at fair value on the date of issuance and will be revalued each subsequent reporting period until such instrument is exercised or expire. The change in fair value between reporting periods is included in other (expense) income, net in the consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;/div&gt;</amci:WarrantsPolicyPolicyTextBlock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzIyODI4_e892d144-1090-4936-90cb-2e609259e814"
      unitRef="shares">225223</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzIyODM1_996db12c-946a-470c-9339-9674b9498ed0"
      unitRef="shares">383281</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzIyOTgz_22b99194-1a30-4761-9c73-95c7dd880ed7"
      unitRef="usdPerShare">14.69</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzIyOTg5_d3590132-9eef-4a60-8120-93e449de3a52"
      unitRef="usdPerShare">19.93</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzIzNTkw_32370669-7205-47f9-8b4e-4b01571f5d24"
      unitRef="usd">1729000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:DebtPolicyTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk3OTcz_bfa7408a-94ce-431f-a6f3-1c9ab25e51e8">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-Term Debt and Debt Issuance Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s debt consists of credit facilities with financial institutions. Costs directly related to the issuance of debt are reported on the consolidated balance sheets as a reduction from the carrying amount of the recognized debt liability and amortized over the term of the debt using the effective interest method.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtPolicyTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk3OTc0_941ef884-56e5-4738-9427-77b0998f94ec">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal and Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may be involved in legal actions in the ordinary course of business, inquiries and proceedings concerning employment, labor, environmental, and other claims. The Company will recognize a loss contingency in the consolidated financial statements when it is probable a liability has been incurred and the amount of the loss can be reasonably estimated. The Company will disclose any loss contingencies that do not meet both conditions if there is a reasonable possibility that a loss may have been incurred. Gain contingencies are not recorded until realized.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk3OTc1_99425717-4d08-44fa-9d84-d44bfa319e93">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue in accordance with ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company primarily earns revenue from services related to feasibility studies and basic engineering design of commercial plants, licensing of technologies, joint development and contract research activities to develop novel biocatalysts and related technologies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is measured based on the consideration specified in a contract with a customer. The Company records taxes collected from customers and remitted to governmental authorities on a net basis. The Company&#x2019;s payment terms are between 30-60 days and can vary by customer type and products offered. We have evaluated the terms of our arrangements and determined that they do not contain significant financing components.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Carbon Capture and Transformation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company provides feasibility studies and basic design and engineering services used for detailed design, procurement, and construction of commercial plants that utilize the Company&#x2019;s technologies, along with the sale of equipment and microbes. The services provided are recognized as a performance obligation satisfied over time. Revenue is recognized using the output method based on milestone completion, the cost-to-cost input method for certain engineering services, or the percentage of completion method when certain revenue recognition requirements are met. Management has determined that the milestone completion and the associated contractual payment amounts are an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company licenses intellectual property to generate recurring revenue when its customers deploy carbon capture and transformation plants. When licenses are considered to be distinct performance obligations, the recognition of revenue is dependent on the terms of the contract, which may include fixed consideration or royalties based on sales or usage, in which case, the revenue is recognized when the subsequent sale or usage occurs or when the performance obligation to which some or all of the sales or usage-based royalty is allocated has been satisfied, whichever is later.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Research and Development Services&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company performs research and development (&#x201c;R&amp;amp;D&#x201d;) services related to novel technologies and development of biocatalysts for commercial applications, mainly to produce fuels and chemicals. The Company engages in two main types of R&amp;amp;D services &#x2013; joint development agreements, and other contract research, including projects with the U.S. Department of Energy. Such services are recognized as a performance obligation satisfied over time. Revenue is recognized based on milestone completion, when such milestones are contractually defined, or based on stage of contract completion when not defined. For the latter, management has determined that the cost incurred, input method, is an appropriate measure of progress towards complete satisfaction of the performance obligations under ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and estimates its variable consideration under the expected value method. Accordingly, the Company records a liability based on milestones achieved and the expected repayment of the development costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s joint development agreements may utilize the cost-to-cost method of revenue recognition or may include well defined payment milestones, dependent on the contract, both of which the Company evaluates against work completed prior to revenue recognition. For other contract research, the Company utilizes the cost-to-cost method of revenue recognition. These contracts have a fixed dollar amount which is based on the Company&#x2019;s estimate of total costs to be incurred over the life of each contract. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is not recognized in advance of customer acceptance of a milestone, when such acceptance is contractually required. Payments for R&amp;amp;D services with no contractual payments are not due from customers until a technical report is submitted; therefore, a contract asset is recognized at milestone completion but prior to the submission of a technical report. The contract asset represents the Company&#x2019;s right to consideration for the services performed at milestone completion. Occasionally, customers provide payments in advance of the Company providing services which creates a contract liability for the Company. The contract liability represents the Company's obligation to provide services to a customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Collaboration Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has certain partnership agreements that are within the scope of ASC 808, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Collaborative Arrangements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which provides guidance on the presentation and disclosure of collaborative arrangements. Generally, the classification of the transactions under the collaborative arrangements is determined based on the nature of the contractual terms of the arrangement, along with the nature of the operations of the participants. The Company&#x2019;s collaborative agreements generally include a provision of R&amp;amp;D services related to novel technologies and biocatalysts. Amounts received for these services are classified as Revenue from collaborative arrangements in the consolidated statements of operations and comprehensive loss. The Company's R&amp;amp;D services are a major part of the Company's ongoing operations and therefore ASC 606 is applied to recognize revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost of Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s R&amp;amp;D, engineering, and other direct costs of services related to revenue agreements with customers, related parties, and collaborative partners represent cost of revenue. Costs include both internal and third-party fixed and variable costs and include materials, supplies, labor, and fringe benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We incur research and development costs associated with various R&amp;amp;D activities and expense these costs as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk3OTc2_65ca9fe6-40e5-4a01-a950-c437ccd46b73">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for equity-based compensation in accordance with ASC 718, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation &#x2013; Stock Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Accordingly, in exchange for employee and director services, compensation is given in the form of equity awards. The equity awards are recorded based on the grant date fair value and expensed over the requisite service period for the respective award.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s equity-based awards include stock option awards and restricted stock issued by the Company, which vest based on either time or the achievement of certain performance conditions. The Company records forfeitures as they occur. Compensation expense resulting from time-vesting-based awards is recognized in the Company&#x2019;s consolidated statements of operations and comprehensive loss, primarily within research and development expenses, at the grant date fair value over the requisite service period. Compensation expense resulting from performance awards recognized over the requisite service period when it is probable that the performance condition will be met. The calculated compensation expense for performance awards is adjusted based on an estimate of awards ultimately expected to vest. The Company estimates grant date fair value using a Black-Scholes option pricing model that uses assumptions including expected volatility, expected term, and the expected risk-free rate of return. The Company has determined that the Black-Scholes option pricing model, as well as the underlying assumptions used in its application, is appropriate in estimating the fair value of its award grants.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <amci:RelatedPartyTransactionsPolicyPolicyTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzE1OTQyOTE4Njk3OTc4_9e149c09-f857-45f9-9d94-8c9f4e079327">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Related Party Transactions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company follows ASC 850-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Related Party Transactions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for the identification of related parties and disclosure of related party transactions.&lt;/span&gt;&lt;/div&gt;Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.</amci:RelatedPartyTransactionsPolicyPolicyTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i831d5d72289e4ecebda264860e6ddb01_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzM4ODI2_6367ec26-769b-49c9-9ae6-d02ec5367a3e"
      unitRef="number">0.38</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib84e916b214e40bb9503c00b519d9b19_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzM4ODMz_5ca75fc2-edca-4d59-abb6-2bfb537a7921"
      unitRef="number">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie2e8db82a9c84e61945251a17b875f00_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzM4ODgy_3626e304-1c04-4321-a4d5-721feb0789a9"
      unitRef="number">0.35</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i2ad0ccd0af184ac4a13f4b4276bb623e_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzM4ODg5_a441b973-e9d2-4a36-bf54-d363623bb4c3"
      unitRef="number">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i3806badc445d44dd82e2c5a6b9e25bfb_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpiODAwN2ZjMTBkYjM0ZTU3OTRmOTU0NWFjNzQ0ZmVkZS90YWJsZXJhbmdlOmI4MDA3ZmMxMGRiMzRlNTc5NGY5NTQ1YWM3NDRmZWRlXzMtMS0xLTEtOTA2MTg_4e6808ab-7c3a-45c3-a94e-59186c7d5399"
      unitRef="number">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia7c702b96a6f4df9b250877d0384b508_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpiODAwN2ZjMTBkYjM0ZTU3OTRmOTU0NWFjNzQ0ZmVkZS90YWJsZXJhbmdlOmI4MDA3ZmMxMGRiMzRlNTc5NGY5NTQ1YWM3NDRmZWRlXzMtMy0xLTEtOTA2MTg_eb0390f1-19ca-41fe-9489-1ec642e35c52"
      unitRef="number">0.28</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i2179adde8d304d8280bfbc5ee18bc488_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpiODAwN2ZjMTBkYjM0ZTU3OTRmOTU0NWFjNzQ0ZmVkZS90YWJsZXJhbmdlOmI4MDA3ZmMxMGRiMzRlNTc5NGY5NTQ1YWM3NDRmZWRlXzQtMS0xLTEtOTA2MTg_a5d8e431-8ecc-4346-90a8-6a551120e316"
      unitRef="number">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i3bcb50c289e34d1482c2e928125d7fde_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpiODAwN2ZjMTBkYjM0ZTU3OTRmOTU0NWFjNzQ0ZmVkZS90YWJsZXJhbmdlOmI4MDA3ZmMxMGRiMzRlNTc5NGY5NTQ1YWM3NDRmZWRlXzQtMy0xLTEtOTA2MTg_64254793-df10-4d24-9023-12722cb445f8"
      unitRef="number">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9f54a9cc2417463291611fdfdeedb0d2_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpiODAwN2ZjMTBkYjM0ZTU3OTRmOTU0NWFjNzQ0ZmVkZS90YWJsZXJhbmdlOmI4MDA3ZmMxMGRiMzRlNTc5NGY5NTQ1YWM3NDRmZWRlXzUtMS0xLTEtOTA2MTg_78a3e8f6-d157-4ba8-b80a-9087bb2a61fa"
      unitRef="number">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i743ecbc9e30043a599d588f612598339_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90YWJsZTpiODAwN2ZjMTBkYjM0ZTU3OTRmOTU0NWFjNzQ0ZmVkZS90YWJsZXJhbmdlOmI4MDA3ZmMxMGRiMzRlNTc5NGY5NTQ1YWM3NDRmZWRlXzUtMy0xLTEtOTA2MTg_8c008db4-d0d7-4276-a03c-307e1215fefb"
      unitRef="number">0.22</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i56b52dbeac4d4479bfb65e79f892fff0_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NDY2_9c737571-adcc-49a2-a357-9c60a9ff4887"
      unitRef="number">0.49</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="idb494d52ad624b01abe6e93490255650_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MTYvZnJhZzphMTc0MjY1M2M3MGU0ODM0YjZmZmZjYmU2YjQ5MThmNC90ZXh0cmVnaW9uOmExNzQyNjUzYzcwZTQ4MzRiNmZmZmNiZTZiNDkxOGY0XzEyNjQ0MzgzODE0NDcx_905dde0a-a6c8-4e84-8a18-23bc381968a9"
      unitRef="number">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:NetIncomeLoss
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZToyMmQzM2Q4MWExYjY0MjFhOGUwMjdlNDQyYjE0NGRjZS90YWJsZXJhbmdlOjIyZDMzZDgxYTFiNjQyMWE4ZTAyN2U0NDJiMTQ0ZGNlXzQtMS0xLTEtOTA2MTg_fed67763-e872-4be3-8299-0ebe0a8c4b77"
      unitRef="usd">-46689000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZToyMmQzM2Q4MWExYjY0MjFhOGUwMjdlNDQyYjE0NGRjZS90YWJsZXJhbmdlOjIyZDMzZDgxYTFiNjQyMWE4ZTAyN2U0NDJiMTQ0ZGNlXzQtMy0xLTEtOTA2MTg_1be9c2f4-1833-49eb-b570-82e4fc6a9e2a"
      unitRef="usd">-37713000</us-gaap:NetIncomeLoss>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZToyMmQzM2Q4MWExYjY0MjFhOGUwMjdlNDQyYjE0NGRjZS90YWJsZXJhbmdlOjIyZDMzZDgxYTFiNjQyMWE4ZTAyN2U0NDJiMTQ0ZGNlXzUtMS0xLTEtOTA2MTg_5ac9ceb4-c10c-4f8d-af99-e8d6fa3cb010"
      unitRef="usd">36758000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZToyMmQzM2Q4MWExYjY0MjFhOGUwMjdlNDQyYjE0NGRjZS90YWJsZXJhbmdlOjIyZDMzZDgxYTFiNjQyMWE4ZTAyN2U0NDJiMTQ0ZGNlXzUtMy0xLTEtOTA2MTg_1e9c22c4-4a9f-4324-8dba-acfbd0601235"
      unitRef="usd">31291000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZToyMmQzM2Q4MWExYjY0MjFhOGUwMjdlNDQyYjE0NGRjZS90YWJsZXJhbmdlOjIyZDMzZDgxYTFiNjQyMWE4ZTAyN2U0NDJiMTQ0ZGNlXzYtMS0xLTEtMTA1MzY5_a0b9b7f1-8a28-424b-974f-65e635a4f2f0"
      unitRef="usd">-83447000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZToyMmQzM2Q4MWExYjY0MjFhOGUwMjdlNDQyYjE0NGRjZS90YWJsZXJhbmdlOjIyZDMzZDgxYTFiNjQyMWE4ZTAyN2U0NDJiMTQ0ZGNlXzYtMy0xLTEtMTA1MzU4_4cc1215b-683e-4c1a-a1f3-77ba959054e8"
      unitRef="usd">-69004000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZToyMmQzM2Q4MWExYjY0MjFhOGUwMjdlNDQyYjE0NGRjZS90YWJsZXJhbmdlOjIyZDMzZDgxYTFiNjQyMWE4ZTAyN2U0NDJiMTQ0ZGNlXzktMS0xLTEtOTA2MTg_85dda7ab-7ed4-48dc-b99e-049e6bde6fdd"
      unitRef="shares">1959165000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZToyMmQzM2Q4MWExYjY0MjFhOGUwMjdlNDQyYjE0NGRjZS90YWJsZXJhbmdlOjIyZDMzZDgxYTFiNjQyMWE4ZTAyN2U0NDJiMTQ0ZGNlXzktMS0xLTEtOTA2MTg_ae625271-4af5-4ec3-a1ed-de34de7e8306"
      unitRef="shares">1959165000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZToyMmQzM2Q4MWExYjY0MjFhOGUwMjdlNDQyYjE0NGRjZS90YWJsZXJhbmdlOjIyZDMzZDgxYTFiNjQyMWE4ZTAyN2U0NDJiMTQ0ZGNlXzktMy0xLTEtOTA2MTg_02894df7-c492-433d-a7fe-e5e2c6d65bd2"
      unitRef="shares">1629821000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZToyMmQzM2Q4MWExYjY0MjFhOGUwMjdlNDQyYjE0NGRjZS90YWJsZXJhbmdlOjIyZDMzZDgxYTFiNjQyMWE4ZTAyN2U0NDJiMTQ0ZGNlXzktMy0xLTEtOTA2MTg_20851da3-be2d-43f8-a486-89bf69965dcb"
      unitRef="shares">1629821000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZToyMmQzM2Q4MWExYjY0MjFhOGUwMjdlNDQyYjE0NGRjZS90YWJsZXJhbmdlOjIyZDMzZDgxYTFiNjQyMWE4ZTAyN2U0NDJiMTQ0ZGNlXzExLTEtMS0xLTkwNjE4_76523769-8874-4261-abff-190b9e9ef324"
      unitRef="usdPerShare">-42.59</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZToyMmQzM2Q4MWExYjY0MjFhOGUwMjdlNDQyYjE0NGRjZS90YWJsZXJhbmdlOjIyZDMzZDgxYTFiNjQyMWE4ZTAyN2U0NDJiMTQ0ZGNlXzExLTEtMS0xLTkwNjE4_dc729dff-3327-469f-9afa-84e911774d77"
      unitRef="usdPerShare">-42.59</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZToyMmQzM2Q4MWExYjY0MjFhOGUwMjdlNDQyYjE0NGRjZS90YWJsZXJhbmdlOjIyZDMzZDgxYTFiNjQyMWE4ZTAyN2U0NDJiMTQ0ZGNlXzExLTMtMS0xLTkwNjE4_11cb4b0e-f074-411e-b978-42a16dcd956b"
      unitRef="usdPerShare">-42.34</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZToyMmQzM2Q4MWExYjY0MjFhOGUwMjdlNDQyYjE0NGRjZS90YWJsZXJhbmdlOjIyZDMzZDgxYTFiNjQyMWE4ZTAyN2U0NDJiMTQ0ZGNlXzExLTMtMS0xLTkwNjE4_fe59b5c6-6008-4ac8-bacd-40bb74acb889"
      unitRef="usdPerShare">-42.34</us-gaap:EarningsPerShareBasic>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="icaaa8522aec94f1aa360a0050053d993_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZTo4ODAxOTMyNjkzZjg0NWMyYjAyMGRiNjMxZWQ1N2JiMC90YWJsZXJhbmdlOjg4MDE5MzI2OTNmODQ1YzJiMDIwZGI2MzFlZDU3YmIwXzItMS0xLTEtOTA2MTg_fb92a09b-a9a9-4b0b-b4a0-ee608d155393"
      unitRef="shares">29521810</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="icfee3a338b794d7d95cda90ba4dd2425_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZTo4ODAxOTMyNjkzZjg0NWMyYjAyMGRiNjMxZWQ1N2JiMC90YWJsZXJhbmdlOjg4MDE5MzI2OTNmODQ1YzJiMDIwZGI2MzFlZDU3YmIwXzItMy0xLTEtOTA2MTg_51fc46bd-3c2a-4e06-9e9c-db125e2c700e"
      unitRef="shares">25729542</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2678f5a65b234d35a12ce212238a1276_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZTo4ODAxOTMyNjkzZjg0NWMyYjAyMGRiNjMxZWQ1N2JiMC90YWJsZXJhbmdlOjg4MDE5MzI2OTNmODQ1YzJiMDIwZGI2MzFlZDU3YmIwXzMtMS0xLTEtOTA2MTg_974949bd-a1ef-42e4-9277-c9c07a1dc2ff"
      unitRef="shares">3848420</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ifac9f30a87864eb3ac5fa0f54dde723a_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZTo4ODAxOTMyNjkzZjg0NWMyYjAyMGRiNjMxZWQ1N2JiMC90YWJsZXJhbmdlOjg4MDE5MzI2OTNmODQ1YzJiMDIwZGI2MzFlZDU3YmIwXzMtMy0xLTEtOTA2MTg_6f3a08be-5735-43de-b81c-c77894dc6739"
      unitRef="shares">4283200</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i358ff5b6e3854374ba1d7d0c7d0343e5_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZTo4ODAxOTMyNjkzZjg0NWMyYjAyMGRiNjMxZWQ1N2JiMC90YWJsZXJhbmdlOjg4MDE5MzI2OTNmODQ1YzJiMDIwZGI2MzFlZDU3YmIwXzQtMS0xLTEtOTA2MTg_86f26717-169b-4312-9125-0dc0d53df63b"
      unitRef="shares">579660</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i85c99d1acfdb4854a6eeb001415fd1fc_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZTo4ODAxOTMyNjkzZjg0NWMyYjAyMGRiNjMxZWQ1N2JiMC90YWJsZXJhbmdlOjg4MDE5MzI2OTNmODQ1YzJiMDIwZGI2MzFlZDU3YmIwXzQtMy0xLTEtOTA2MTg_caee94d2-c715-497e-ab07-1e622f1126b0"
      unitRef="shares">324680</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1bcdbff1e49a4f7893b55aef5e3383b0_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZTo4ODAxOTMyNjkzZjg0NWMyYjAyMGRiNjMxZWQ1N2JiMC90YWJsZXJhbmdlOjg4MDE5MzI2OTNmODQ1YzJiMDIwZGI2MzFlZDU3YmIwXzUtMS0xLTEtOTA2MTg_28714bf2-a3ab-4f36-9a3d-848457b3eeb7"
      unitRef="shares">225223</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i6d734da8c6d54d6394aafbc36ef97fe0_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZTo4ODAxOTMyNjkzZjg0NWMyYjAyMGRiNjMxZWQ1N2JiMC90YWJsZXJhbmdlOjg4MDE5MzI2OTNmODQ1YzJiMDIwZGI2MzFlZDU3YmIwXzUtMy0xLTEtOTA2MTg_274972cc-736b-4aa7-9a88-c704caf8219d"
      unitRef="shares">383281</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZTo4ODAxOTMyNjkzZjg0NWMyYjAyMGRiNjMxZWQ1N2JiMC90YWJsZXJhbmdlOjg4MDE5MzI2OTNmODQ1YzJiMDIwZGI2MzFlZDU3YmIwXzYtMS0xLTEtMTA1MzYx_f7bac6d4-2308-49e9-90a9-84317f651ad3"
      unitRef="shares">34175113</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90YWJsZTo4ODAxOTMyNjkzZjg0NWMyYjAyMGRiNjMxZWQ1N2JiMC90YWJsZXJhbmdlOjg4MDE5MzI2OTNmODQ1YzJiMDIwZGI2MzFlZDU3YmIwXzYtMy0xLTEtMTA1MzY2_4705f548-f086-4a88-89f8-6b2f19c4cd42"
      unitRef="shares">30720703</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:PreferredStockConvertibleConversionRatio
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90ZXh0cmVnaW9uOjFiYzk2Mjk3ZjBiMTQwNzU5MTJlYWRkYTIyMGI5N2ZjXzEwOTk1MTE2MjgzOTE3_132ec162-8f6e-4799-9b87-b40a677cfefc"
      unitRef="number">1</us-gaap:PreferredStockConvertibleConversionRatio>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="icaaa8522aec94f1aa360a0050053d993_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90ZXh0cmVnaW9uOjFiYzk2Mjk3ZjBiMTQwNzU5MTJlYWRkYTIyMGI5N2ZjXzE3NzI_a5b1c017-4d39-46d2-a294-66f93e8d20cd"
      unitRef="shares">29521810</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="icfee3a338b794d7d95cda90ba4dd2425_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90ZXh0cmVnaW9uOjFiYzk2Mjk3ZjBiMTQwNzU5MTJlYWRkYTIyMGI5N2ZjXzE3Nzk_981c30fc-8e9c-4fab-9064-78b881bfca4f"
      unitRef="shares">25729542</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <amci:LiquidityPriceOfSAFEAndSAFEWarrants
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90ZXh0cmVnaW9uOjFiYzk2Mjk3ZjBiMTQwNzU5MTJlYWRkYTIyMGI5N2ZjXzEyNjQ0MzgzNzI1NTYy_9fa7cada-b161-488c-919e-efbc7b0964fb"
      unitRef="number">1</amci:LiquidityPriceOfSAFEAndSAFEWarrants>
    <amci:LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjIvZnJhZzoxYmM5NjI5N2YwYjE0MDc1OTEyZWFkZGEyMjBiOTdmYy90ZXh0cmVnaW9uOjFiYzk2Mjk3ZjBiMTQwNzU5MTJlYWRkYTIyMGI5N2ZjXzEyNjQ0MzgzNzI1NTU3_5c806afe-ca49-4de0-a922-c82e6cdd846f"
      unitRef="number">0.90</amci:LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne>
    <us-gaap:Revenues
      contextRef="ia2e7fdecab214154afe7ef716788fbb0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTo3ZjQ1MzFlYWI3MGQ0MmExODQxMDYzOTBlZmMxNDM1My90YWJsZXJhbmdlOjdmNDUzMWVhYjcwZDQyYTE4NDEwNjM5MGVmYzE0MzUzXzQtMS0xLTEtOTA2MTg_3e51e3ac-3f8a-4201-8fe0-15b2dee54f9c"
      unitRef="usd">11700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic848ff8d5c6f468b8ef166100477c3d3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTo3ZjQ1MzFlYWI3MGQ0MmExODQxMDYzOTBlZmMxNDM1My90YWJsZXJhbmdlOjdmNDUzMWVhYjcwZDQyYTE4NDEwNjM5MGVmYzE0MzUzXzQtMy0xLTEtOTA2MTg_36198028-3fe6-4c2c-99b5-99b5caf5286a"
      unitRef="usd">6928000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie5a5c7a4013b40f996deb5caeadbee89_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTo3ZjQ1MzFlYWI3MGQ0MmExODQxMDYzOTBlZmMxNDM1My90YWJsZXJhbmdlOjdmNDUzMWVhYjcwZDQyYTE4NDEwNjM5MGVmYzE0MzUzXzUtMS0xLTEtOTA2MTg_345174e2-85df-4450-b681-4804e41a2664"
      unitRef="usd">2197000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i25000550374347d98ff4260b0fe8fcc1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTo3ZjQ1MzFlYWI3MGQ0MmExODQxMDYzOTBlZmMxNDM1My90YWJsZXJhbmdlOjdmNDUzMWVhYjcwZDQyYTE4NDEwNjM5MGVmYzE0MzUzXzUtMy0xLTEtOTA2MTg_471b9ab0-7c33-4625-b54e-ff4c78de1102"
      unitRef="usd">1982000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifcca0034fe6a4d0990224e5b8a5dd449_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTo3ZjQ1MzFlYWI3MGQ0MmExODQxMDYzOTBlZmMxNDM1My90YWJsZXJhbmdlOjdmNDUzMWVhYjcwZDQyYTE4NDEwNjM5MGVmYzE0MzUzXzYtMS0xLTEtOTA2MTg_aaf49218-95d2-47ea-bdb3-a26fb6517554"
      unitRef="usd">13897000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i841b3eaf08c64e929bd5d8c3b5550936_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTo3ZjQ1MzFlYWI3MGQ0MmExODQxMDYzOTBlZmMxNDM1My90YWJsZXJhbmdlOjdmNDUzMWVhYjcwZDQyYTE4NDEwNjM5MGVmYzE0MzUzXzYtMy0xLTEtOTA2MTg_1e7ee98f-a9c1-43f8-b43e-cca4d9999ec4"
      unitRef="usd">8910000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i84f5e809f9504f9aa1546f38557476d3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTo3ZjQ1MzFlYWI3MGQ0MmExODQxMDYzOTBlZmMxNDM1My90YWJsZXJhbmdlOjdmNDUzMWVhYjcwZDQyYTE4NDEwNjM5MGVmYzE0MzUzXzgtMS0xLTEtOTA2MTg_b9d765f6-d9c4-4ac5-ac07-08c43ba8bae8"
      unitRef="usd">2025000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i941766ba89044c74b5ec672aca6c1610_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTo3ZjQ1MzFlYWI3MGQ0MmExODQxMDYzOTBlZmMxNDM1My90YWJsZXJhbmdlOjdmNDUzMWVhYjcwZDQyYTE4NDEwNjM5MGVmYzE0MzUzXzgtMy0xLTEtOTA2MTg_6a1b9b05-1e04-4af5-a271-90c6e888382a"
      unitRef="usd">1018000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i339e323267704b6397de8db0f758c601_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTo3ZjQ1MzFlYWI3MGQ0MmExODQxMDYzOTBlZmMxNDM1My90YWJsZXJhbmdlOjdmNDUzMWVhYjcwZDQyYTE4NDEwNjM5MGVmYzE0MzUzXzktMS0xLTEtOTA2MTg_04509d9a-05bd-4642-99f6-180ace1f8822"
      unitRef="usd">9539000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0d8cebd2641f4bcd972a34fb2e86777c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTo3ZjQ1MzFlYWI3MGQ0MmExODQxMDYzOTBlZmMxNDM1My90YWJsZXJhbmdlOjdmNDUzMWVhYjcwZDQyYTE4NDEwNjM5MGVmYzE0MzUzXzktMy0xLTEtOTA2MTg_5e3aa1cf-22c7-427f-99da-7c8a6cb401f5"
      unitRef="usd">8425000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i028a5508763345629acfb45969fb4396_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTo3ZjQ1MzFlYWI3MGQ0MmExODQxMDYzOTBlZmMxNDM1My90YWJsZXJhbmdlOjdmNDUzMWVhYjcwZDQyYTE4NDEwNjM5MGVmYzE0MzUzXzEwLTEtMS0xLTkwNjE4_45e1bbac-3471-4e43-b645-d3165bb3607e"
      unitRef="usd">11564000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icb183fb29c764617802fbb8f9cc6ef0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTo3ZjQ1MzFlYWI3MGQ0MmExODQxMDYzOTBlZmMxNDM1My90YWJsZXJhbmdlOjdmNDUzMWVhYjcwZDQyYTE4NDEwNjM5MGVmYzE0MzUzXzEwLTMtMS0xLTkwNjE4_814c14b7-0577-4809-816c-cc61a40a04b8"
      unitRef="usd">9443000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTo3ZjQ1MzFlYWI3MGQ0MmExODQxMDYzOTBlZmMxNDM1My90YWJsZXJhbmdlOjdmNDUzMWVhYjcwZDQyYTE4NDEwNjM5MGVmYzE0MzUzXzEyLTEtMS0xLTkwNjE4_83fea5f9-f960-4cbe-ad4a-b832297633f5"
      unitRef="usd">25461000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTo3ZjQ1MzFlYWI3MGQ0MmExODQxMDYzOTBlZmMxNDM1My90YWJsZXJhbmdlOjdmNDUzMWVhYjcwZDQyYTE4NDEwNjM5MGVmYzE0MzUzXzEyLTMtMS0xLTkwNjE4_248958b9-5ebc-41f1-9081-395e002af04a"
      unitRef="usd">18353000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9d133fe090bf40acb6e27f45ba8c513d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTozZjMyMjQ1Njg1Nzc0YzFjODIzZWVhNzgxZTgxMDA0Mi90YWJsZXJhbmdlOjNmMzIyNDU2ODU3NzRjMWM4MjNlZWE3ODFlODEwMDQyXzMtMS0xLTEtOTA2MTg_32d89fb3-38ac-4a5a-ba4d-5cd229b4fa7d"
      unitRef="usd">15825000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i41997fda0c884eaeb59b9fa43fb3f3b5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTozZjMyMjQ1Njg1Nzc0YzFjODIzZWVhNzgxZTgxMDA0Mi90YWJsZXJhbmdlOjNmMzIyNDU2ODU3NzRjMWM4MjNlZWE3ODFlODEwMDQyXzMtMy0xLTEtOTA2MTg_62ab5839-1c7d-49e6-814c-f4cda1f0a5aa"
      unitRef="usd">15732000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i84559e50cc784ae4947d2762750bee39_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTozZjMyMjQ1Njg1Nzc0YzFjODIzZWVhNzgxZTgxMDA0Mi90YWJsZXJhbmdlOjNmMzIyNDU2ODU3NzRjMWM4MjNlZWE3ODFlODEwMDQyXzQtMS0xLTEtOTA2MTg_b3333326-ba4a-4283-b809-c737f7938591"
      unitRef="usd">7522000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie1b898530c2c4589a32c8d8d907dc09f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTozZjMyMjQ1Njg1Nzc0YzFjODIzZWVhNzgxZTgxMDA0Mi90YWJsZXJhbmdlOjNmMzIyNDU2ODU3NzRjMWM4MjNlZWE3ODFlODEwMDQyXzQtMy0xLTEtOTA2MTg_18eeed54-31c5-479c-a411-3a0624051553"
      unitRef="usd">2117000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i68d2069e34784ebfbc6b06f1d0168f28_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTozZjMyMjQ1Njg1Nzc0YzFjODIzZWVhNzgxZTgxMDA0Mi90YWJsZXJhbmdlOjNmMzIyNDU2ODU3NzRjMWM4MjNlZWE3ODFlODEwMDQyXzUtMS0xLTEtOTA2MTg_a8958f1a-775f-42c8-9095-bd6e43355561"
      unitRef="usd">1477000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9f366cdc85054777b0fbbe8b243bd6b1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTozZjMyMjQ1Njg1Nzc0YzFjODIzZWVhNzgxZTgxMDA0Mi90YWJsZXJhbmdlOjNmMzIyNDU2ODU3NzRjMWM4MjNlZWE3ODFlODEwMDQyXzUtMy0xLTEtOTA2MTg_74ca16e2-d68d-44c3-a63a-ce578e7def84"
      unitRef="usd">504000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0f54cf1501b448c0a13761e8ce9c4f33_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTozZjMyMjQ1Njg1Nzc0YzFjODIzZWVhNzgxZTgxMDA0Mi90YWJsZXJhbmdlOjNmMzIyNDU2ODU3NzRjMWM4MjNlZWE3ODFlODEwMDQyXzYtMS0xLTEtOTA2MTg_521178f6-adeb-49d9-bb7f-e9363a8d6933"
      unitRef="usd">637000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i395f2b2b0888423698fc8b4613a0c7a8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTozZjMyMjQ1Njg1Nzc0YzFjODIzZWVhNzgxZTgxMDA0Mi90YWJsZXJhbmdlOjNmMzIyNDU2ODU3NzRjMWM4MjNlZWE3ODFlODEwMDQyXzYtMy0xLTEtOTA2MTg_323df867-6c8b-4470-8066-b33a6c7d01ee"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTozZjMyMjQ1Njg1Nzc0YzFjODIzZWVhNzgxZTgxMDA0Mi90YWJsZXJhbmdlOjNmMzIyNDU2ODU3NzRjMWM4MjNlZWE3ODFlODEwMDQyXzctMS0xLTEtOTA2MTg_03dc7b0b-b0ff-4750-a463-4242f795c94f"
      unitRef="usd">25461000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTozZjMyMjQ1Njg1Nzc0YzFjODIzZWVhNzgxZTgxMDA0Mi90YWJsZXJhbmdlOjNmMzIyNDU2ODU3NzRjMWM4MjNlZWE3ODFlODEwMDQyXzctMy0xLTEtMTAzNTgz_fb9851cd-62be-4bd2-a3d0-167a75d0213d"
      unitRef="usd">18353000</us-gaap:Revenues>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTpmZTYzZTMyMmVkMzI0YjNkOGM1NjhkYWNmMmRjYjRjYi90YWJsZXJhbmdlOmZlNjNlMzIyZWQzMjRiM2Q4YzU2OGRhY2YyZGNiNGNiXzEtMS0xLTEtOTA2MTg_7f1d2bd8-4f2a-4327-98ef-128abe281cab"
      unitRef="usd">6186000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTpmZTYzZTMyMmVkMzI0YjNkOGM1NjhkYWNmMmRjYjRjYi90YWJsZXJhbmdlOmZlNjNlMzIyZWQzMjRiM2Q4YzU2OGRhY2YyZGNiNGNiXzEtMy0xLTEtOTA2MTg_a7339fad-3fa2-4d81-9aa3-aa7e2eb164be"
      unitRef="usd">5480000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTpmZTYzZTMyMmVkMzI0YjNkOGM1NjhkYWNmMmRjYjRjYi90YWJsZXJhbmdlOmZlNjNlMzIyZWQzMjRiM2Q4YzU2OGRhY2YyZGNiNGNiXzEtNS0xLTEtOTA2MTg_318dd8fe-1591-46e1-9499-e2cc1546b3dd"
      unitRef="usd">11291000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <amci:ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTpmZTYzZTMyMmVkMzI0YjNkOGM1NjhkYWNmMmRjYjRjYi90YWJsZXJhbmdlOmZlNjNlMzIyZWQzMjRiM2Q4YzU2OGRhY2YyZGNiNGNiXzItMS0xLTEtOTA2MTg_1cf24101-9e19-4d76-861b-d4ed7084c006"
      unitRef="usd">8516000</amci:ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable>
    <amci:ContractWithCustomerLiabilityCurrentAmountsCollected
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTpmZTYzZTMyMmVkMzI0YjNkOGM1NjhkYWNmMmRjYjRjYi90YWJsZXJhbmdlOmZlNjNlMzIyZWQzMjRiM2Q4YzU2OGRhY2YyZGNiNGNiXzMtMy0xLTEtOTA2MTg_fd4ea8d7-f565-465a-b0a4-0bb27e8311de"
      unitRef="usd">20000</amci:ContractWithCustomerLiabilityCurrentAmountsCollected>
    <amci:ContractWithCustomerLiabilityNoncurrentAmountsCollected
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTpmZTYzZTMyMmVkMzI0YjNkOGM1NjhkYWNmMmRjYjRjYi90YWJsZXJhbmdlOmZlNjNlMzIyZWQzMjRiM2Q4YzU2OGRhY2YyZGNiNGNiXzMtNS0xLTEtOTA2MTg_49b001aa-32b9-4f49-9237-26f715268043"
      unitRef="usd">5690000</amci:ContractWithCustomerLiabilityNoncurrentAmountsCollected>
    <amci:ContractWithCustomerAssetCurrentReclassifiedToReceivable
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTpmZTYzZTMyMmVkMzI0YjNkOGM1NjhkYWNmMmRjYjRjYi90YWJsZXJhbmdlOmZlNjNlMzIyZWQzMjRiM2Q4YzU2OGRhY2YyZGNiNGNiXzQtMS0xLTEtOTA2MTg_ff2db7f5-b03b-4b93-8cf1-4f1c7fd28d50"
      unitRef="usd">3002000</amci:ContractWithCustomerAssetCurrentReclassifiedToReceivable>
    <amci:ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTpmZTYzZTMyMmVkMzI0YjNkOGM1NjhkYWNmMmRjYjRjYi90YWJsZXJhbmdlOmZlNjNlMzIyZWQzMjRiM2Q4YzU2OGRhY2YyZGNiNGNiXzUtMy0xLTEtOTA2MTg_0065a5d3-f814-4268-8e2b-fd868c2b2df6"
      unitRef="usd">3080000</amci:ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent>
    <amci:ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTpmZTYzZTMyMmVkMzI0YjNkOGM1NjhkYWNmMmRjYjRjYi90YWJsZXJhbmdlOmZlNjNlMzIyZWQzMjRiM2Q4YzU2OGRhY2YyZGNiNGNiXzUtNS0xLTEtOTA2MTg_ddc8aa96-5c5e-4956-96b9-f27a2486ba89"
      unitRef="usd">3080000</amci:ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent>
    <amci:ContractWithCustomerLiabilityCurrentRevenueRecognized
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTpmZTYzZTMyMmVkMzI0YjNkOGM1NjhkYWNmMmRjYjRjYi90YWJsZXJhbmdlOmZlNjNlMzIyZWQzMjRiM2Q4YzU2OGRhY2YyZGNiNGNiXzYtMy0xLTEtOTA2MTg_2638c183-55df-4a68-8c56-5503cd1de72e"
      unitRef="usd">5104000</amci:ContractWithCustomerLiabilityCurrentRevenueRecognized>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTpmZTYzZTMyMmVkMzI0YjNkOGM1NjhkYWNmMmRjYjRjYi90YWJsZXJhbmdlOmZlNjNlMzIyZWQzMjRiM2Q4YzU2OGRhY2YyZGNiNGNiXzctMS0xLTEtMTAzNTkz_c55fd091-3081-4044-9ade-6023f4175b02"
      unitRef="usd">11700000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTpmZTYzZTMyMmVkMzI0YjNkOGM1NjhkYWNmMmRjYjRjYi90YWJsZXJhbmdlOmZlNjNlMzIyZWQzMjRiM2Q4YzU2OGRhY2YyZGNiNGNiXzctMy0xLTEtMTAzNTkz_8d6f08e6-1673-4da8-a475-cfa7ee300432"
      unitRef="usd">3476000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTpmZTYzZTMyMmVkMzI0YjNkOGM1NjhkYWNmMmRjYjRjYi90YWJsZXJhbmdlOmZlNjNlMzIyZWQzMjRiM2Q4YzU2OGRhY2YyZGNiNGNiXzctNS0xLTEtMTAzNTkz_1796bff5-d977-48ee-a7cb-20a3d55e7b96"
      unitRef="usd">13901000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:BilledContractReceivables
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90ZXh0cmVnaW9uOjFmMjdlMTc1NzliYjQxNmJhMjdkNjI3MDZhNDQ4ZjJmXzg1Mg_53e4fb71-0d66-4553-821d-1fdde11f7be1"
      unitRef="usd">2878000</us-gaap:BilledContractReceivables>
    <us-gaap:BilledContractReceivables
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90ZXh0cmVnaW9uOjFmMjdlMTc1NzliYjQxNmJhMjdkNjI3MDZhNDQ4ZjJmXzg1OQ_abf5daeb-73a0-4b31-9456-2347e6f3210c"
      unitRef="usd">5521000</us-gaap:BilledContractReceivables>
    <amci:RevenueRemainingPerformanceObligationCurrentAmount
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTphMzQ0ODMxMzg2NGM0ZjM4YjI0YTcxY2FmMTRlNTZjZC90YWJsZXJhbmdlOmEzNDQ4MzEzODY0YzRmMzhiMjRhNzFjYWYxNGU1NmNkXzItMS0xLTEtOTA2MTg_fc549038-2b27-424f-b8bf-02e1c61ac989"
      unitRef="usd">3476000</amci:RevenueRemainingPerformanceObligationCurrentAmount>
    <amci:RevenueRemainingPerformanceObligationCurrentAmount
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTphMzQ0ODMxMzg2NGM0ZjM4YjI0YTcxY2FmMTRlNTZjZC90YWJsZXJhbmdlOmEzNDQ4MzEzODY0YzRmMzhiMjRhNzFjYWYxNGU1NmNkXzItMy0xLTEtOTA2MTg_1802684a-be6f-453c-883a-68018cc82e21"
      unitRef="usd">5480000</amci:RevenueRemainingPerformanceObligationCurrentAmount>
    <amci:RevenueRemainingPerformanceObligationNoncurrentAmount
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTphMzQ0ODMxMzg2NGM0ZjM4YjI0YTcxY2FmMTRlNTZjZC90YWJsZXJhbmdlOmEzNDQ4MzEzODY0YzRmMzhiMjRhNzFjYWYxNGU1NmNkXzMtMS0xLTEtOTA2MTg_f4b63380-5e0c-47b9-9339-53f3bffa20df"
      unitRef="usd">13901000</amci:RevenueRemainingPerformanceObligationNoncurrentAmount>
    <amci:RevenueRemainingPerformanceObligationNoncurrentAmount
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTphMzQ0ODMxMzg2NGM0ZjM4YjI0YTcxY2FmMTRlNTZjZC90YWJsZXJhbmdlOmEzNDQ4MzEzODY0YzRmMzhiMjRhNzFjYWYxNGU1NmNkXzMtMy0xLTEtOTA2MTg_2b936e17-2fa7-460b-99df-2551cae19d1d"
      unitRef="usd">11291000</amci:RevenueRemainingPerformanceObligationNoncurrentAmount>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTphMzQ0ODMxMzg2NGM0ZjM4YjI0YTcxY2FmMTRlNTZjZC90YWJsZXJhbmdlOmEzNDQ4MzEzODY0YzRmMzhiMjRhNzFjYWYxNGU1NmNkXzQtMS0xLTEtMTAzNjAz_3048df72-917d-4e15-9cb7-e68dd7eb2d7d"
      unitRef="usd">17377000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MjgvZnJhZzoxZjI3ZTE3NTc5YmI0MTZiYTI3ZDYyNzA2YTQ0OGYyZi90YWJsZTphMzQ0ODMxMzg2NGM0ZjM4YjI0YTcxY2FmMTRlNTZjZC90YWJsZXJhbmdlOmEzNDQ4MzEzODY0YzRmMzhiMjRhNzFjYWYxNGU1NmNkXzQtMy0xLTEtMTAzNjAz_9e5a3036-a270-4ef9-bf14-2273e68096c6"
      unitRef="usd">16771000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzE1OTQyOTE4NjEwNTU1_7e801bf9-1c5d-4084-a08e-63e4f7b03e94">Investments&lt;div style="margin-bottom:9pt;margin-top:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s investments consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in LanzaJet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in SGLT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Investment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Equity Method Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;LanzaJet&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 13, 2020, the Company contributed $15,000 in intellectual property in exchange for a 37.5% interest (&#x201c;Original Interest&#x201d;) of LanzaJet, Inc. (&#x201c;LanzaJet&#x201d;) and the right to future increase in ownership whereby LanzaTech could become a majority owner of LanzaJet if the intellectual property is used commercially in connection with an investment agreement (&#x201c;Investment Agreement&#x201d;). The Company also agreed to perform certain technical and administrative support services. LanzaJet is a sustainable fuels technology company dedicated to expanding sustainable aviation fuels (&#x201c;SAF&#x201d;) to reduce greenhouse gas emissions and the decarbonization of the aviation and transportation industries. LanzaJet&#x2019;s access to the license is in perpetuity if certain key performance indicators (&#x201c;KPI&#x2019;s&#x201d;) are met in accordance with the Investment Agreement. If these KPI&#x2019;s are not met by December 31, 2025, the Company may terminate the license. The Company accounts for the transaction in accordance with ASC 606. The licensing and support services provided are recognized as a performance obligation satisfied over the expected period of those services, beginning May 2020 through December 2025. During the years ended December&#160;31, 2021 &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and 2020, the Company has recognized revenue from this arrangement of $2,025 and $1,018 and has recorded deferred revenue of $10,746 and $13,433 respectively. Further, the Company has eliminated intra-entity profits related to revenue contracts with LanzaJet of $662 and $549 as of December 31, 2021, and 2020, respectively. Intra-entity profit is amortized over the 15-year amortization period through 2034.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the Original Interest, the Investment Agreement allows at the option of the other investors party thereto to contribute additional funds towards building commercial plants and to receive a technology sublicense if certain KPI&#x2019;s are met. At such point, the Company would receive an additional interest in LanzaJet of up to 45&#160;million shares for no additional consideration at that time. There would be no additional LanzaJet Board of Director representation with the potential increased interest. The additional tranches of interests in LanzaJet received upon the achievement of certain KPIs represent non-monetary variable consideration. The Company has applied the variable consideration constraint per ASC 606 and recognized no variable consideration as of December 31, 2021 as the Company has determined that it is not probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. The Company regularly reviews and updates its estimates. Any changes made are recorded as a cumulative adjustment in the period identified and revenue for future periods is recognized using the new adjusted estimate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Between February 1, and April 4, 2021, LanzaJet closed two additional rounds of investment which reduced the Company's Original Interest to 25%. As a result, the Company recognized a gain on dilution of $503. The Company retained its right to receive additional interest in LanzaJet of up to 45&#160;million shares for no additional consideration. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of our equity method investments as of December&#160;31, 2021 and 2020 was approximately $3,100 and $3,800 less than our proportionate share of our equity method investees&#x2019; book values, respectively. The basis differences relate primarily to our equity method investment in LanzaJet and are largely the result of a difference in the timing of recognition of variable consideration to which we may become entitled in exchange for our contribution of IP to LanzaJet. The variable consideration we may receive will be in the form of additional ownership interests and the majority of the basis difference will reverse in connection with recognition of that variable consideration. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with a sublicense agreement to LanzaJet under our license agreement with Battelle Memorial Institute (&#x201c;Battelle&#x201d;), LanzaTech remains responsible for any failure by LanzaJet to pay royalties due to Battelle. The fair value of LanzaTech&#x2019;s obligation under this guarantee was immaterial as of December&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;SGLT&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 28, 2011, the Company contributed RMB 25,800 (approx. $4,000) in intellectual property in exchange for 30% of the registered capital of SGLT. SGLT utilizes and develops technologies and know-how in connection with the production of anhydrous ethanol from steel mill waste gases. The contribution was recognized as revenue in 2011.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021 and 2020, as the result of the admittance of new investors, the Company&#x2019;s interest in SGLT&#x2019;s registered capital is approximately 10.01% and 11.14%, respectively. The Company recognized a gain from the dilution of $3,048 and $3,811 during the years ended December 31, 2021 and December 31, 2020, respectively. The Company has continued to apply the equity method of accounting to the investment as the Company maintains significant influence via representation on SGLT&#x2019;s Board of Directors and SGLT's significant dependency on the intellectual property the Company contributed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents summarized aggregated financial information of the equity method investments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selected Statement of Operations Information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,729)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to the Company&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,606)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,644)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selected Balance Sheet Information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021 and 2020, there were no impairments of equity method investees. During 2021 and 2020, the Company received no dividends from equity method investments. As of and for the years ended December 31, 2021 and December 31, 2020, sales, accounts receivable, and purchases and open accounts payable with equity method investees were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases and open accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzE1OTQyOTE4NjEwNTU2_43fceb24-6b53-4cc4-b79e-c22073c5cb97">&lt;div style="margin-bottom:9pt;margin-top:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s investments consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in LanzaJet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in SGLT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Investment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents summarized aggregated financial information of the equity method investments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selected Statement of Operations Information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,729)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to the Company&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,606)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,644)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selected Balance Sheet Information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;As of and for the years ended December 31, 2021 and December 31, 2020, sales, accounts receivable, and purchases and open accounts payable with equity method investees were as follows (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases and open accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:EquityMethodInvestments
      contextRef="i285bf14114324cc3b2c392b9b984d16e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo4ZGVmMzhhOWZkYTY0YmUxYmYxMGI4ZGFiYzhlYTM4OC90YWJsZXJhbmdlOjhkZWYzOGE5ZmRhNjRiZTFiZjEwYjhkYWJjOGVhMzg4XzQtMi0xLTEtOTA2MTg_66ec5e7a-50e8-4a98-866f-b132877b443f"
      unitRef="usd">12433000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i5d2c4854af1c4ad183efa288b7c84140_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo4ZGVmMzhhOWZkYTY0YmUxYmYxMGI4ZGFiYzhlYTM4OC90YWJsZXJhbmdlOjhkZWYzOGE5ZmRhNjRiZTFiZjEwYjhkYWJjOGVhMzg4XzQtNC0xLTEtOTA2MTg_f3553f9b-11cc-41f7-a1bf-a1a9c5edde3e"
      unitRef="usd">13651000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ie926aa19bc694f0586f296dab820baf8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo4ZGVmMzhhOWZkYTY0YmUxYmYxMGI4ZGFiYzhlYTM4OC90YWJsZXJhbmdlOjhkZWYzOGE5ZmRhNjRiZTFiZjEwYjhkYWJjOGVhMzg4XzUtMi0xLTEtOTA2MTg_aa9c64ef-1367-460f-8267-735dbbef97a0"
      unitRef="usd">12319000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i4448ea0f5e794cccaf623e81ad622af0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo4ZGVmMzhhOWZkYTY0YmUxYmYxMGI4ZGFiYzhlYTM4OC90YWJsZXJhbmdlOjhkZWYzOGE5ZmRhNjRiZTFiZjEwYjhkYWJjOGVhMzg4XzUtNC0xLTEtOTA2MTg_5f1f7ae0-f3eb-4daa-b3e5-abbfd4f69d99"
      unitRef="usd">9566000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo4ZGVmMzhhOWZkYTY0YmUxYmYxMGI4ZGFiYzhlYTM4OC90YWJsZXJhbmdlOjhkZWYzOGE5ZmRhNjRiZTFiZjEwYjhkYWJjOGVhMzg4XzYtNC0xLTEtMTAzNjE5_5b9604b7-5b22-43d7-a768-0d4d68b09b4b"
      unitRef="usd">24752000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo4ZGVmMzhhOWZkYTY0YmUxYmYxMGI4ZGFiYzhlYTM4OC90YWJsZXJhbmdlOjhkZWYzOGE5ZmRhNjRiZTFiZjEwYjhkYWJjOGVhMzg4XzYtNi0xLTEtMTAzNjE5_06c13aaa-87b7-42f5-b681-64f9ac7158f7"
      unitRef="usd">23217000</us-gaap:EquityMethodInvestments>
    <us-gaap:ContributionOfProperty
      contextRef="i3508735d501341a2badcc0f6a6be0770_D20200513-20200513"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzE3Ng_db2fbade-1bbb-4cc4-946a-1b76689e1026"
      unitRef="usd">15000000</us-gaap:ContributionOfProperty>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="iabbdb50d80c247b39bf74f30bb6e2aa1_I20200513"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzIyMg_2a8a185b-1db7-44ee-9b82-89df186c9b26"
      unitRef="number">0.375</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7da793980258460bb178e447b22bf4df_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzE0MDI_da879107-fb8a-4577-b570-9b328b3872be"
      unitRef="usd">2025000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaa162be01a7e42838d798ac77c1e8764_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzE0MDk_23375173-4b8f-49fb-b932-3e82baf35e6e"
      unitRef="usd">1018000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i285bf14114324cc3b2c392b9b984d16e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzE0NDk_db609870-92ae-4c09-85c9-36dd5a1cfbca"
      unitRef="usd">10746000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i5d2c4854af1c4ad183efa288b7c84140_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzE0NTY_44b16308-1bc8-453f-991a-cf20b8cbe92f"
      unitRef="usd">13433000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4715c3e771cb49659b7d7d1edf71bd81_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzE1Nzc_2c0ac6d9-312b-4bd7-97a8-a310024c235b"
      unitRef="usd">662000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7a001a92c1048529f1d70f282ef5979_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzE1ODQ_b6c2e032-cb3a-4b55-9f63-101e95489eef"
      unitRef="usd">549000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <amci:RevenueFromContractWithCustomerAmortizationPeriod
      contextRef="i7da793980258460bb178e447b22bf4df_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzEwOTk1MTE2Mjg1Njkz_8d21437e-5087-4b39-9829-aa4895be3a9b">P15Y</amci:RevenueFromContractWithCustomerAmortizationPeriod>
    <amci:EquityMethodInvestmentContingentRightToReceiveAdditionalInterest
      contextRef="i0953d2d09b0e4116b4f9972716c60d69_I20210404"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzIwNTc_fb88a7c3-b532-4284-8d2d-c3b61e09e2ef"
      unitRef="shares">45000000</amci:EquityMethodInvestmentContingentRightToReceiveAdditionalInterest>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i3f16003c0fce46c997e3bcde7fa19188_D20210201-20210404"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzEwOTk1MTE2Mjg1NjI4_843c8ec0-3514-4fda-b57e-d8a855ace5dc"
      unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <amci:NumberOfRoundsOfInvestments
      contextRef="i65fec460822f43acb02e40736b3b8a79_D20210201-20210404"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzEwOTk1MTE2Mjg1NjMw_b495b88d-aae0-4c6b-add5-464bc4c6eaae"
      unitRef="invesstment_round">2</amci:NumberOfRoundsOfInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i0953d2d09b0e4116b4f9972716c60d69_I20210404"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzEyNjQ0MzgzNzI3MTk2_68f4ba4d-4402-41ef-ab39-c858a048be87"
      unitRef="number">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <amci:EquityMethodInvestmentGainOnDilutionOfInvestment
      contextRef="i3f16003c0fce46c997e3bcde7fa19188_D20210201-20210404"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzEwOTk1MTE2Mjg1NTg3_82385278-742f-4ef4-9747-479f73a6bfed"
      unitRef="usd">503000</amci:EquityMethodInvestmentGainOnDilutionOfInvestment>
    <amci:EquityMethodInvestmentContingentRightToReceiveAdditionalInterest
      contextRef="i0953d2d09b0e4116b4f9972716c60d69_I20210404"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzEyNjQ0MzgzNzI3MjAx_07cc009e-3838-40c6-b11e-377a039c155a"
      unitRef="shares">45000000</amci:EquityMethodInvestmentContingentRightToReceiveAdditionalInterest>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i3f16003c0fce46c997e3bcde7fa19188_D20210201-20210404"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzEwOTk1MTE2Mjg1NjI5_cb4756f8-f6ea-43a9-a54c-7613f5e13a4d"
      unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
      contextRef="i285bf14114324cc3b2c392b9b984d16e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzEyNjQ0MzgzNzI3MTgw_3258513a-0d39-4f66-8394-d919fdd8e157"
      unitRef="usd">3100000</us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity>
    <us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
      contextRef="i5d2c4854af1c4ad183efa288b7c84140_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzEyNjQ0MzgzNzI3MTg4_9d6ac856-d92b-4171-846b-097dc3a08e75"
      unitRef="usd">3800000</us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity>
    <us-gaap:ContributionOfProperty
      contextRef="ie466fa6065e24c99b35c9b349c76a551_D20110928-20110928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzQzNDg_8b356f20-bc7e-41e5-ad86-a455cdb79a3d"
      unitRef="cny">25800000</us-gaap:ContributionOfProperty>
    <us-gaap:ContributionOfProperty
      contextRef="ie466fa6065e24c99b35c9b349c76a551_D20110928-20110928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzQzNjA_f9de3106-eaef-4685-bd9d-9a2b909783aa"
      unitRef="usd">4000000</us-gaap:ContributionOfProperty>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ibea6cef92fd440f0849af4b7e43ac9d0_I20110928"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzQ0MDU_5743c8d2-9612-4bf6-be06-dc2ecf9dec0d"
      unitRef="number">0.30</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ie926aa19bc694f0586f296dab820baf8_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzQ3Njg_39c0e0a6-37d2-4707-ac2a-56e5974dc07e"
      unitRef="number">0.1001</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i4448ea0f5e794cccaf623e81ad622af0_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzQ3NzU_625bbb8a-0839-417d-a3d1-bbfc55dd5eaf"
      unitRef="number">0.1114</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <amci:EquityMethodInvestmentGainOnDilutionOfInvestment
      contextRef="if87506a2fe1e44eea4a6cc3fad0ec2be_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzQ4NDQ_bb015e91-1774-4628-b312-dfe662d6d7e5"
      unitRef="usd">3048000</amci:EquityMethodInvestmentGainOnDilutionOfInvestment>
    <amci:EquityMethodInvestmentGainOnDilutionOfInvestment
      contextRef="i9c210a255c684636bb39fa23a2370b08_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzQ4NTE_3f65ac35-6015-42b3-a8e2-26404abb4355"
      unitRef="usd">3811000</amci:EquityMethodInvestmentGainOnDilutionOfInvestment>
    <us-gaap:Revenues
      contextRef="i8a7398a2daa84714af0a8aedf56e44db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzQtMS0xLTEtOTA2MTg_55e04238-c2c5-4fe4-8477-dfaec5ba09d9"
      unitRef="usd">40244000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i429f6f8a96604c7ebb57f635a19670fb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzQtMy0xLTEtOTA2MTg_c929a864-0cb5-4e80-b5ad-b138b48efc41"
      unitRef="usd">26120000</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="i8a7398a2daa84714af0a8aedf56e44db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzUtMS0xLTEtOTA2MTg_214ed423-f316-4812-83ab-0876d8d11c80"
      unitRef="usd">-5703000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i429f6f8a96604c7ebb57f635a19670fb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzUtMy0xLTEtOTA2MTg_3ccb2b1a-c6a2-436d-908f-f3b52817f9f0"
      unitRef="usd">-5510000</us-gaap:GrossProfit>
    <us-gaap:NetIncomeLoss
      contextRef="i8a7398a2daa84714af0a8aedf56e44db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzYtMS0xLTEtOTA2MTg_a841048a-cad9-4dd3-9f34-563a2bcb12e8"
      unitRef="usd">-9695000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i429f6f8a96604c7ebb57f635a19670fb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzYtMy0xLTEtOTA2MTg_1f73109c-85b0-43ed-8169-5ecdff6f916e"
      unitRef="usd">-9729000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzctMS0xLTEtOTA2MTg_c3430abb-e89d-45a5-ad66-06dcf37693e8"
      unitRef="usd">-1606000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzctMy0xLTEtOTA2MTg_3cf6d7c2-7a25-47e5-a0a8-ef5e048e1d98"
      unitRef="usd">-1644000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:AssetsCurrent
      contextRef="idb56e9df9e8a4d3fb130ee2ff3f1a588_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzEzLTEtMS0xLTkwNjE4_202c9088-5eef-40c4-8811-1069e31e2c12"
      unitRef="usd">56204000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ic7779ec82a944d5989685ea5c473b325_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzEzLTMtMS0xLTkwNjE4_0682570b-0f28-4622-9524-d4d533ad4eb1"
      unitRef="usd">55188000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="idb56e9df9e8a4d3fb130ee2ff3f1a588_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzE0LTEtMS0xLTkwNjE4_130dbb26-4772-4e9e-b744-ac4a48c6f1e3"
      unitRef="usd">270454000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="ic7779ec82a944d5989685ea5c473b325_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzE0LTMtMS0xLTkwNjE4_84df0683-ad7c-4b14-a953-91a4456500ba"
      unitRef="usd">133794000</us-gaap:AssetsNoncurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="idb56e9df9e8a4d3fb130ee2ff3f1a588_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzE1LTEtMS0xLTkwNjE4_3e1b6968-53e6-47a2-ba3d-22d4a75741d6"
      unitRef="usd">64499000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ic7779ec82a944d5989685ea5c473b325_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzE1LTMtMS0xLTkwNjE4_0c1f591d-c4fb-4441-8628-59c41e0f73d1"
      unitRef="usd">33540000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="idb56e9df9e8a4d3fb130ee2ff3f1a588_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzE2LTEtMS0xLTkwNjE4_c4b55ce6-7822-4183-9a54-7c23abc398b3"
      unitRef="usd">58802000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="ic7779ec82a944d5989685ea5c473b325_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZTo5YjBjZDJlZDBiYzU0Nzk5OGNmMzg2ZmU5OTc2NDljNC90YWJsZXJhbmdlOjliMGNkMmVkMGJjNTQ3OTk4Y2YzODZmZTk5NzY0OWM0XzE2LTMtMS0xLTkwNjE4_5b7bd7d8-eaa5-4795-a4d3-d225599eae4d"
      unitRef="usd">21674000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzEwOTk1MTE2Mjg1NjE3_b0b07a60-18d0-4051-8b54-4e38c4b5894b"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzEwOTk1MTE2Mjg1NjE3_b3ee6690-f98d-439d-a6d2-de92f91087d2"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzEwOTk1MTE2Mjg1NjUz_5f09c4d1-f33d-4aa1-9faa-000d6020d74c"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90ZXh0cmVnaW9uOjFhMWVhNjExZTEzODRkYzFhYzY0ZmQyNjIzYzE0NTEzXzEwOTk1MTE2Mjg1NjUz_7b44d892-534b-494e-a846-7d05048a790c"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i9677cfd1c23149c39d4d453a38d4b6f4_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZToyOThhZmE1MDdlOTg0NTNiODBlYjk0NzVkMWNkMGU0YS90YWJsZXJhbmdlOjI5OGFmYTUwN2U5ODQ1M2I4MGViOTQ3NWQxY2QwZTRhXzMtMS0xLTEtOTA2MTg_6912a520-8dfa-4079-9596-ed4f21cf6d7f"
      unitRef="usd">3253000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i4dc568acac614adb953dfdedc71d98b5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZToyOThhZmE1MDdlOTg0NTNiODBlYjk0NzVkMWNkMGU0YS90YWJsZXJhbmdlOjI5OGFmYTUwN2U5ODQ1M2I4MGViOTQ3NWQxY2QwZTRhXzMtMy0xLTEtOTA2MTg_341af267-e98a-497d-997d-96a321b7b9f3"
      unitRef="usd">4203000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:AccountsReceivableNet
      contextRef="id33f2498c7aa4d4ba897810160258324_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZToyOThhZmE1MDdlOTg0NTNiODBlYjk0NzVkMWNkMGU0YS90YWJsZXJhbmdlOjI5OGFmYTUwN2U5ODQ1M2I4MGViOTQ3NWQxY2QwZTRhXzQtMS0xLTEtOTA2MTg_699f6b91-eeda-4836-bcbf-6ce47e02152b"
      unitRef="usd">1071000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="i62a14169b57143bbada3e671e8a86ea6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZToyOThhZmE1MDdlOTg0NTNiODBlYjk0NzVkMWNkMGU0YS90YWJsZXJhbmdlOjI5OGFmYTUwN2U5ODQ1M2I4MGViOTQ3NWQxY2QwZTRhXzQtMy0xLTEtOTA2MTg_96dbde6e-af31-4c48-b8c7-f49144ea9410"
      unitRef="usd">3257000</us-gaap:AccountsReceivableNet>
    <amci:PurchasesAndOpenAccountsPayableRelatedParties
      contextRef="id33f2498c7aa4d4ba897810160258324_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZToyOThhZmE1MDdlOTg0NTNiODBlYjk0NzVkMWNkMGU0YS90YWJsZXJhbmdlOjI5OGFmYTUwN2U5ODQ1M2I4MGViOTQ3NWQxY2QwZTRhXzUtMS0xLTEtOTA2MTg_f0d7a542-d1c1-4071-8fa3-494eadae48ec"
      unitRef="usd">2575000</amci:PurchasesAndOpenAccountsPayableRelatedParties>
    <amci:PurchasesAndOpenAccountsPayableRelatedParties
      contextRef="i62a14169b57143bbada3e671e8a86ea6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80MzQvZnJhZzoxYTFlYTYxMWUxMzg0ZGMxYWM2NGZkMjYyM2MxNDUxMy90YWJsZToyOThhZmE1MDdlOTg0NTNiODBlYjk0NzVkMWNkMGU0YS90YWJsZXJhbmdlOjI5OGFmYTUwN2U5ODQ1M2I4MGViOTQ3NWQxY2QwZTRhXzUtMy0xLTEtOTA2MTg_821d20ae-992b-4e06-b748-716ba8baa0c5"
      unitRef="usd">0</amci:PurchasesAndOpenAccountsPayableRelatedParties>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i946a08fcd3a04e65862611981f20e270_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzQtMS0xLTEtMTAzNjg1_65333c6d-6849-4a32-8296-03b6b5de746a"
      unitRef="usd">516000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i541e2e9fe4644a20b8b1b376f83dee9d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzQtMy0xLTEtMTAzNjg1_c06fc672-0c16-48e0-910d-7434bb328a90"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i0624bd72b2cf4ede8ec463949522ea9a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzQtNS0xLTEtMTAzNjg1_b403d1dc-9661-43c5-a3ee-768f4ac4f6cb"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="idd5ccd73a28c47ebac5c69568150935f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzQtNy0xLTEtMTAzNjg1_fa709c45-73e7-497a-b66e-77664ff79134"
      unitRef="usd">516000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="i946a08fcd3a04e65862611981f20e270_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzctMS0xLTEtOTA2MTg_11b9cbf1-0c9c-4fb6-b665-e80624e8423c"
      unitRef="usd">0</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="i541e2e9fe4644a20b8b1b376f83dee9d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzctMy0xLTEtOTA2MTg_f08e59de-b904-4b50-abb1-08472ab1fcda"
      unitRef="usd">0</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="i0624bd72b2cf4ede8ec463949522ea9a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzctNS0xLTEtOTA2MTg_db19570e-29c2-4b23-b446-c165f75c27b9"
      unitRef="usd">1145000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="idd5ccd73a28c47ebac5c69568150935f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzctNy0xLTEtMTAzNjg1_f4defbda-2133-419a-a79b-6ddbc5e9892b"
      unitRef="usd">1145000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="ia692081523eb4eeab727c1fc860a7079_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzgtMS0xLTEtMTAzNjg1_302c7a74-3f45-49f9-925f-3e8e3ed56019"
      unitRef="usd">0</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="i18d637000e084883bc89386915d6aae9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzgtMy0xLTEtMTAzNjg1_1b8d304f-9107-4470-ac39-4403f0467e67"
      unitRef="usd">0</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="i8345fcb8c9f147978a79d376aea1f2aa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzgtNS0xLTEtMTAzNjg1_30aec2c1-cf60-4cc6-968a-5bde3c552b38"
      unitRef="usd">1729000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="id9bb8758e465423fb3bbebe9bcea3ef7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzgtNy0xLTEtMTAzNjg1_0445a1a7-162a-4bdc-95de-583e89951b98"
      unitRef="usd">1729000</us-gaap:WarrantsAndRightsOutstanding>
    <amci:SimpleAgreementForFutureEquityLiability
      contextRef="i946a08fcd3a04e65862611981f20e270_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzktMS0xLTEtMTAzNjg1_cd58af5c-ff99-4125-98ac-a0cc876612c2"
      unitRef="usd">0</amci:SimpleAgreementForFutureEquityLiability>
    <amci:SimpleAgreementForFutureEquityLiability
      contextRef="i541e2e9fe4644a20b8b1b376f83dee9d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzktMy0xLTEtMTAzNjg1_0c54095a-45e8-47e6-8c78-c8da72bc15d1"
      unitRef="usd">0</amci:SimpleAgreementForFutureEquityLiability>
    <amci:SimpleAgreementForFutureEquityLiability
      contextRef="i0624bd72b2cf4ede8ec463949522ea9a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzktNS0xLTEtMTAzNjg1_928d9e82-3102-47a0-80ed-72f37de107c8"
      unitRef="usd">28271000</amci:SimpleAgreementForFutureEquityLiability>
    <amci:SimpleAgreementForFutureEquityLiability
      contextRef="idd5ccd73a28c47ebac5c69568150935f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzktNy0xLTEtMTAzNjg1_5d2d4da2-494c-411d-bbdd-cc08dd89923f"
      unitRef="usd">28271000</amci:SimpleAgreementForFutureEquityLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i946a08fcd3a04e65862611981f20e270_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzEwLTEtMS0xLTEwMzY4NQ_a80993c7-9ff8-48f8-b967-904d5f56cb87"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i541e2e9fe4644a20b8b1b376f83dee9d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzEwLTMtMS0xLTEwMzY4NQ_1e8453b4-9578-4444-a19c-feb610333334"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i0624bd72b2cf4ede8ec463949522ea9a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzEwLTUtMS0xLTEwMzY4NQ_56ef9c20-0a3b-44e5-95c8-67efb630807a"
      unitRef="usd">31145000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="idd5ccd73a28c47ebac5c69568150935f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo0ODQwOTlhMTQzZjA0ZWY5OWNlZWM0OWEzMDg3MmU5MS90YWJsZXJhbmdlOjQ4NDA5OWExNDNmMDRlZjk5Y2VlYzQ5YTMwODcyZTkxXzEwLTctMS0xLTEwMzY4NQ_3d25e6c3-3693-4d67-9e00-a10db7e2c700"
      unitRef="usd">31145000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ic5cf4398c3d547eaa80b15bf808fd8c5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3MjFjMDZhOGNiODc0NDA4YTUxY2FjMmFhNTcwMTY1OC90YWJsZXJhbmdlOjcyMWMwNmE4Y2I4NzQ0MDhhNTFjYWMyYWE1NzAxNjU4XzQtMS0xLTEtMTAzNjg5_09cd4b14-03f2-467d-8847-b19090e91ee7"
      unitRef="usd">516000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i80fc94b127ec4857ab5aacd4d3b22f07_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3MjFjMDZhOGNiODc0NDA4YTUxY2FjMmFhNTcwMTY1OC90YWJsZXJhbmdlOjcyMWMwNmE4Y2I4NzQ0MDhhNTFjYWMyYWE1NzAxNjU4XzQtMy0xLTEtMTAzNjg5_54beb3b9-e5bb-4fb0-b973-6cfc3b74c88c"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ice7ea95c9fb84d36a4857e2a761cf72f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3MjFjMDZhOGNiODc0NDA4YTUxY2FjMmFhNTcwMTY1OC90YWJsZXJhbmdlOjcyMWMwNmE4Y2I4NzQ0MDhhNTFjYWMyYWE1NzAxNjU4XzQtNS0xLTEtMTAzNjg5_8bb4d04a-d2a8-4940-bf38-a59b19dd79f1"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if0c8f06ff99246cdb46b4b9b0600f524_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3MjFjMDZhOGNiODc0NDA4YTUxY2FjMmFhNTcwMTY1OC90YWJsZXJhbmdlOjcyMWMwNmE4Y2I4NzQ0MDhhNTFjYWMyYWE1NzAxNjU4XzQtNy0xLTEtMTAzNjg5_c0f3b7f4-2ec5-4cb1-b0fc-154c2e00d63c"
      unitRef="usd">516000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="ic5cf4398c3d547eaa80b15bf808fd8c5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3MjFjMDZhOGNiODc0NDA4YTUxY2FjMmFhNTcwMTY1OC90YWJsZXJhbmdlOjcyMWMwNmE4Y2I4NzQ0MDhhNTFjYWMyYWE1NzAxNjU4XzctMS0xLTEtOTA2MTg_2ab12c3f-08fb-40bd-9248-cc0df5cb74a5"
      unitRef="usd">0</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="i80fc94b127ec4857ab5aacd4d3b22f07_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3MjFjMDZhOGNiODc0NDA4YTUxY2FjMmFhNTcwMTY1OC90YWJsZXJhbmdlOjcyMWMwNmE4Y2I4NzQ0MDhhNTFjYWMyYWE1NzAxNjU4XzctMy0xLTEtOTA2MTg_e28a806d-af1a-442d-8cc0-bcf9ad78a79e"
      unitRef="usd">0</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="ice7ea95c9fb84d36a4857e2a761cf72f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3MjFjMDZhOGNiODc0NDA4YTUxY2FjMmFhNTcwMTY1OC90YWJsZXJhbmdlOjcyMWMwNmE4Y2I4NzQ0MDhhNTFjYWMyYWE1NzAxNjU4XzctNS0xLTEtOTA2MTg_2381a6b4-6fb5-48cf-9212-5733364b4d70"
      unitRef="usd">582000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="if0c8f06ff99246cdb46b4b9b0600f524_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3MjFjMDZhOGNiODc0NDA4YTUxY2FjMmFhNTcwMTY1OC90YWJsZXJhbmdlOjcyMWMwNmE4Y2I4NzQ0MDhhNTFjYWMyYWE1NzAxNjU4XzctNy0xLTEtMTAzNjky_c5d12be3-d7f9-49b6-ab54-57ba31a2ee18"
      unitRef="usd">582000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90ZXh0cmVnaW9uOmE0NWFkYmNmYzUwZTQwYjlhYmQ3MmNmMzJlOWU5YmJlXzc0NQ_4713a589-f622-4786-b727-08d236012cc9"
      unitRef="usd">563000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90ZXh0cmVnaW9uOmE0NWFkYmNmYzUwZTQwYjlhYmQ3MmNmMzJlOWU5YmJlXzc1Mg_757a46c2-5193-48ad-b159-15722b180b32"
      unitRef="usd">-105000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i350b1ab261cb4e4db6e8558ad63e36ba_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTpmODhlMmY4NzEyMGI0ZjZmYjM2ZGZiYjMxMTUzNmJhMy90YWJsZXJhbmdlOmY4OGUyZjg3MTIwYjRmNmZiMzZkZmJiMzExNTM2YmEzXzEtMS0xLTEtOTA2MTg_a316a007-786e-4f89-9083-9c4be608e404"
      unitRef="usdPerShare">13.77</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i22bd73e99737495a9bc32803b0a38fcb_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTpmODhlMmY4NzEyMGI0ZjZmYjM2ZGZiYjMxMTUzNmJhMy90YWJsZXJhbmdlOmY4OGUyZjg3MTIwYjRmNmZiMzZkZmJiMzExNTM2YmEzXzEtMy0xLTEtOTA2MTg_caf68faa-da66-42ae-b81c-e23975acd701"
      unitRef="usdPerShare">4.68</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i07186a2d797e4458bf8d9a94dc91a2d0_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTpmODhlMmY4NzEyMGI0ZjZmYjM2ZGZiYjMxMTUzNmJhMy90YWJsZXJhbmdlOmY4OGUyZjg3MTIwYjRmNmZiMzZkZmJiMzExNTM2YmEzXzItMS0xLTEtOTA2MTg_ad8f51b8-6e8a-4e2c-84ab-7cb9174da8ba"
      unitRef="usdPerShare">17.32</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="if52a74eff3e34ea7bd679e63aa269811_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTpmODhlMmY4NzEyMGI0ZjZmYjM2ZGZiYjMxMTUzNmJhMy90YWJsZXJhbmdlOmY4OGUyZjg3MTIwYjRmNmZiMzZkZmJiMzExNTM2YmEzXzItMy0xLTEtOTA2MTg_6961e632-db8e-4f0c-9fac-d3c9a1fb2cd5"
      unitRef="usdPerShare">18.39</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="ia859bc758ac345ea9093ab9e82ff0731_I20211231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTpmODhlMmY4NzEyMGI0ZjZmYjM2ZGZiYjMxMTUzNmJhMy90YWJsZXJhbmdlOmY4OGUyZjg3MTIwYjRmNmZiMzZkZmJiMzExNTM2YmEzXzMtMS0xLTEtOTA2MTg_a5d9b960-2f55-4031-83e3-67363ca7f30e"
      unitRef="number">2.8</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="ida1349a04a004301b22372e88994a9b7_I20201231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTpmODhlMmY4NzEyMGI0ZjZmYjM2ZGZiYjMxMTUzNmJhMy90YWJsZXJhbmdlOmY4OGUyZjg3MTIwYjRmNmZiMzZkZmJiMzExNTM2YmEzXzMtMy0xLTEtOTA2MTg_e0eb10b5-59ce-4970-b123-a89019688d58"
      unitRef="number">2.8</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i43750276631c4e1ba6fc6ef8f398254e_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTpmODhlMmY4NzEyMGI0ZjZmYjM2ZGZiYjMxMTUzNmJhMy90YWJsZXJhbmdlOmY4OGUyZjg3MTIwYjRmNmZiMzZkZmJiMzExNTM2YmEzXzQtMS0xLTEtOTA2MTg_c7e0563b-ff50-43fa-94df-dabdbef45296"
      unitRef="number">0.706</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i43d8664385d6443a97bd2baa7945074d_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTpmODhlMmY4NzEyMGI0ZjZmYjM2ZGZiYjMxMTUzNmJhMy90YWJsZXJhbmdlOmY4OGUyZjg3MTIwYjRmNmZiMzZkZmJiMzExNTM2YmEzXzQtMy0xLTEtOTA2MTg_05f6819d-ed8e-49df-93da-9b348e4a2e14"
      unitRef="number">0.889</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i5088a09b2ff24bc9bfba62c1ce63d419_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTpmODhlMmY4NzEyMGI0ZjZmYjM2ZGZiYjMxMTUzNmJhMy90YWJsZXJhbmdlOmY4OGUyZjg3MTIwYjRmNmZiMzZkZmJiMzExNTM2YmEzXzUtMS0xLTEtOTA2MTg_c16e934a-f6df-4d3f-a7ca-d66635d9e02c"
      unitRef="number">0.008</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i496bb986b9154962b5941a9ef4c15f9a_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTpmODhlMmY4NzEyMGI0ZjZmYjM2ZGZiYjMxMTUzNmJhMy90YWJsZXJhbmdlOmY4OGUyZjg3MTIwYjRmNmZiMzZkZmJiMzExNTM2YmEzXzUtMy0xLTEtOTA2MTg_70a69156-995f-4205-97b1-6cadbe679ce9"
      unitRef="number">0.004</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i55050b0de34747fbba14961fb9a1e9be_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTpmODhlMmY4NzEyMGI0ZjZmYjM2ZGZiYjMxMTUzNmJhMy90YWJsZXJhbmdlOmY4OGUyZjg3MTIwYjRmNmZiMzZkZmJiMzExNTM2YmEzXzYtMS0xLTEtOTA2MTg_289c0462-aa8e-4049-b779-b8c0084a26c0"
      unitRef="number">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i84be5f6d8d7b4fb09cf5f8067275b5e2_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTpmODhlMmY4NzEyMGI0ZjZmYjM2ZGZiYjMxMTUzNmJhMy90YWJsZXJhbmdlOmY4OGUyZjg3MTIwYjRmNmZiMzZkZmJiMzExNTM2YmEzXzYtMy0xLTEtOTA2MTg_1eef60e1-c57f-41aa-a2d7-bdaf80b0bb59"
      unitRef="number">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i2572a9b98e9a4c54ae3bd8e69a273beb_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTplYzQ1NTU4ZTQyNTQ0YWU0YTI3MjkyOWI0OGNmMWI5MS90YWJsZXJhbmdlOmVjNDU1NThlNDI1NDRhZTRhMjcyOTI5YjQ4Y2YxYjkxXzItMS0xLTEtOTA2MTg_a31cc5be-fb48-46c1-80df-96605b28457f"
      unitRef="number">0.25</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="idf22b55e0fed4e0c81de5bef50d3013a_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTplYzQ1NTU4ZTQyNTQ0YWU0YTI3MjkyOWI0OGNmMWI5MS90YWJsZXJhbmdlOmVjNDU1NThlNDI1NDRhZTRhMjcyOTI5YjQ4Y2YxYjkxXzItMy0xLTEtOTA2MTg_bce32899-e0cd-46d3-920f-34ca13183097"
      unitRef="number">0.75</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ib114abec90f74932b5c8531cce6dc917_I20211231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTplYzQ1NTU4ZTQyNTQ0YWU0YTI3MjkyOWI0OGNmMWI5MS90YWJsZXJhbmdlOmVjNDU1NThlNDI1NDRhZTRhMjcyOTI5YjQ4Y2YxYjkxXzMtMS0xLTEtOTA2MTg_1e8295ca-ea81-48f3-ae08-1fc21b17df58"
      unitRef="number">0.5</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i367f5f8cece445cfb46f812a669bcd7d_I20211231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTplYzQ1NTU4ZTQyNTQ0YWU0YTI3MjkyOWI0OGNmMWI5MS90YWJsZXJhbmdlOmVjNDU1NThlNDI1NDRhZTRhMjcyOTI5YjQ4Y2YxYjkxXzMtMy0xLTEtOTA2MTg_c755823c-0579-4775-a78a-e4e8c5c8bd14"
      unitRef="number">1.0</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="iccef67c1c54d4161a5720eded9695c69_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTplYzQ1NTU4ZTQyNTQ0YWU0YTI3MjkyOWI0OGNmMWI5MS90YWJsZXJhbmdlOmVjNDU1NThlNDI1NDRhZTRhMjcyOTI5YjQ4Y2YxYjkxXzQtMS0xLTEtOTA2MTg_84cbbdbe-72a8-4ce3-9f8b-b7b5666909ff"
      unitRef="number">1</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ib085f020f9a848ccb3533923ee8aafcf_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTplYzQ1NTU4ZTQyNTQ0YWU0YTI3MjkyOWI0OGNmMWI5MS90YWJsZXJhbmdlOmVjNDU1NThlNDI1NDRhZTRhMjcyOTI5YjQ4Y2YxYjkxXzQtMy0xLTEtOTA2MTg_567a5330-4603-4b13-9b12-2a5dd7b086a9"
      unitRef="number">0.90</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ica26df06c0a34ccf8742113f8a95570d_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTplYzQ1NTU4ZTQyNTQ0YWU0YTI3MjkyOWI0OGNmMWI5MS90YWJsZXJhbmdlOmVjNDU1NThlNDI1NDRhZTRhMjcyOTI5YjQ4Y2YxYjkxXzUtMS0xLTEtOTA2MTg_db0dd0ac-2ddc-4c8b-a544-eb41e6c3ca21"
      unitRef="number">0.171</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ie99d17fd90cb4d7987c8af1f52716253_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTplYzQ1NTU4ZTQyNTQ0YWU0YTI3MjkyOWI0OGNmMWI5MS90YWJsZXJhbmdlOmVjNDU1NThlNDI1NDRhZTRhMjcyOTI5YjQ4Y2YxYjkxXzUtMy0xLTEtOTA2MTg_75b0952b-1833-4077-8d08-bb556eb6bc94"
      unitRef="number">0.171</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="ic732fa66399e46eb8f8f50bfe6a6b35c_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo1OGM5OGVjNjhlYWQ0Zjg3OWY1MDUyOTgzYWI3MzNjOC90YWJsZXJhbmdlOjU4Yzk4ZWM2OGVhZDRmODc5ZjUwNTI5ODNhYjczM2M4XzItMS0xLTEtOTA2MTg_0d1bde8d-560c-4ab4-bfc5-cb1d28546eb2"
      unitRef="number">0.25</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i3318e30ec98146f5915d9bdc540724bb_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo1OGM5OGVjNjhlYWQ0Zjg3OWY1MDUyOTgzYWI3MzNjOC90YWJsZXJhbmdlOjU4Yzk4ZWM2OGVhZDRmODc5ZjUwNTI5ODNhYjczM2M4XzItMy0xLTEtOTA2MTg_3dde7723-5551-46d2-a7ff-eb1fcc42bed2"
      unitRef="number">0.75</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i9db1cfd579a04d91b7516eeb7322d953_I20211231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo1OGM5OGVjNjhlYWQ0Zjg3OWY1MDUyOTgzYWI3MzNjOC90YWJsZXJhbmdlOjU4Yzk4ZWM2OGVhZDRmODc5ZjUwNTI5ODNhYjczM2M4XzMtMS0xLTEtOTA2MTg_8b153db3-00c8-4297-8fd2-07e19e26d86e"
      unitRef="number">5.0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="ibdd52c0f69244ffea4e30e908a904220_I20211231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo1OGM5OGVjNjhlYWQ0Zjg3OWY1MDUyOTgzYWI3MzNjOC90YWJsZXJhbmdlOjU4Yzk4ZWM2OGVhZDRmODc5ZjUwNTI5ODNhYjczM2M4XzMtMy0xLTEtOTA2MTg_a93d611c-c704-4487-9a5c-1375bc4499e1"
      unitRef="number">5.0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i0f66a327ce0b49c890e6a99fa7f9fbaf_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo1OGM5OGVjNjhlYWQ0Zjg3OWY1MDUyOTgzYWI3MzNjOC90YWJsZXJhbmdlOjU4Yzk4ZWM2OGVhZDRmODc5ZjUwNTI5ODNhYjczM2M4XzQtMS0xLTEtOTA2MTg_5bda4efd-6097-4915-b99a-e479118d6fff"
      unitRef="number">0.60</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i1ca4d63251324696875efe201490b263_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo1OGM5OGVjNjhlYWQ0Zjg3OWY1MDUyOTgzYWI3MzNjOC90YWJsZXJhbmdlOjU4Yzk4ZWM2OGVhZDRmODc5ZjUwNTI5ODNhYjczM2M4XzQtMy0xLTEtOTA2MTg_82326126-55c2-4edb-b716-bdb6631209fc"
      unitRef="number">0.60</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i82cb4f4ddcf64c0191fa7d4c0cb0521e_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo1OGM5OGVjNjhlYWQ0Zjg3OWY1MDUyOTgzYWI3MzNjOC90YWJsZXJhbmdlOjU4Yzk4ZWM2OGVhZDRmODc5ZjUwNTI5ODNhYjczM2M4XzUtMS0xLTEtOTA2MTg_5c3fa68c-9ec0-4cca-b652-e8fffb611e56"
      unitRef="number">0.0126</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i7905b9a8c9624fa98a477251487eac0d_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo1OGM5OGVjNjhlYWQ0Zjg3OWY1MDUyOTgzYWI3MzNjOC90YWJsZXJhbmdlOjU4Yzk4ZWM2OGVhZDRmODc5ZjUwNTI5ODNhYjczM2M4XzUtMy0xLTEtOTA2MTg_615b6fa5-b22f-488b-be50-6a66c4b278ef"
      unitRef="number">0.0126</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i91c4e209e7064892a5423ab903a240cc_I20211231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo1OGM5OGVjNjhlYWQ0Zjg3OWY1MDUyOTgzYWI3MzNjOC90YWJsZXJhbmdlOjU4Yzk4ZWM2OGVhZDRmODc5ZjUwNTI5ODNhYjczM2M4XzYtMS0xLTEtOTA2MTg_f7527333-c7d5-49b9-98ec-a18a84b3f247"
      unitRef="number">0.5</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i57bff8b3d92f4c7cb9038273d4bf242f_I20211231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo1OGM5OGVjNjhlYWQ0Zjg3OWY1MDUyOTgzYWI3MzNjOC90YWJsZXJhbmdlOjU4Yzk4ZWM2OGVhZDRmODc5ZjUwNTI5ODNhYjczM2M4XzYtMy0xLTEtOTA2MTg_756f6e69-ec62-41c7-bef1-458f51aa9780"
      unitRef="number">1.0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i187fcf7aff144ee2ab2ff0d1b8136024_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo1OGM5OGVjNjhlYWQ0Zjg3OWY1MDUyOTgzYWI3MzNjOC90YWJsZXJhbmdlOjU4Yzk4ZWM2OGVhZDRmODc5ZjUwNTI5ODNhYjczM2M4XzctMS0xLTEtOTA2MTg_88cd8914-6c48-439a-8f35-3ad9ffe96aca"
      unitRef="number">0.0019</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i4c38034324df4a3dab4243d7adcb1f21_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo1OGM5OGVjNjhlYWQ0Zjg3OWY1MDUyOTgzYWI3MzNjOC90YWJsZXJhbmdlOjU4Yzk4ZWM2OGVhZDRmODc5ZjUwNTI5ODNhYjczM2M4XzctMy0xLTEtOTA2MTg_f22e19de-1870-4225-8e8d-8e79fca56458"
      unitRef="number">0.0039</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i64eaa8be4efb4867bb9b47e16fac72d7_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo1OGM5OGVjNjhlYWQ0Zjg3OWY1MDUyOTgzYWI3MzNjOC90YWJsZXJhbmdlOjU4Yzk4ZWM2OGVhZDRmODc5ZjUwNTI5ODNhYjczM2M4XzgtMS0xLTEtOTA2MTg_147202cd-dcba-4739-8e78-76c84a74bc6f"
      unitRef="number">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="ie146e5c775d746339943039ce5e4a6dd_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo1OGM5OGVjNjhlYWQ0Zjg3OWY1MDUyOTgzYWI3MzNjOC90YWJsZXJhbmdlOjU4Yzk4ZWM2OGVhZDRmODc5ZjUwNTI5ODNhYjczM2M4XzgtMy0xLTEtOTA2MTg_0e9e1e8c-9a42-485b-af1d-e0d8bb5e8fd8"
      unitRef="number">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i9596a7ff3bea42e58dcd39b0f38a74fa_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzEtMS0xLTEtOTA2MTg_eeaee7e6-fb46-499e-922d-eceb83427372"
      unitRef="usd">687000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i10f6a1f2d1324379935392c475073764_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzEtMy0xLTEtMTAzNzIz_b6b0c41c-6489-4d10-9675-c2d56e5061af"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i7e89877de092491fa0ce31158a83134f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzEtNS0xLTEtMTAzNzIz_15c3c423-a073-4de0-97a3-84f7ad38fecf"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="id8096c15e999498da5d65ca68368db35_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzItMS0xLTEtOTA2MTg_54de8044-e95c-4e04-9d46-384c571def87"
      unitRef="usd">105000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="if06480e1451e4cb3931502d5a16df7c6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzItMy0xLTEtMTAzNzIz_af0a0310-4f9f-4679-953c-dfbe6cf68abc"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i2859bc5f912d48f8a7b394269608ca11_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzItNS0xLTEtMTAzNzIz_0c4cdf89-4363-4816-8c4a-fb3613b0b703"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i5618649df5e5458fa3e4d03670a6f48b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzMtMS0xLTEtMTAzNzIz_db27a6d9-19cc-4a60-83de-a6fb36039bd1"
      unitRef="usd">582000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="icce53a5d10814231a163555304304500_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzMtMy0xLTEtMTAzNzIz_819fb6b9-1e1e-44f0-9e4c-b5c24ddc1545"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="iceff32fcb2af47c7981043c476b7ae54_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzMtNS0xLTEtMTAzNzIz_b94bcf18-e52d-4cf9-b006-5ca431331ba1"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="i0741139789474a10a1ce163a9a98a470_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzQtMS0xLTEtMTAzNzI3_0ad55d97-411c-4049-a9c5-aae547e6350f"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="ibbd46d99a3b44e778776bac9d32b613b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzQtMy0xLTEtMTAzNzI3_ff5cd3df-c5b8-4b82-aecd-44abf8bfca49"
      unitRef="usd">28271000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="i0b348afbe5de43b8843f3c23b5497e45_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzQtNS0xLTEtMTAzNzI3_fda5d9ed-e253-49cc-ba60-de7b418c12a4"
      unitRef="usd">1729000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i0741139789474a10a1ce163a9a98a470_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzUtMS0xLTEtOTA2MTg_25108e3e-67ae-473e-b123-f9d58e55a3db"
      unitRef="usd">-563000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ibbd46d99a3b44e778776bac9d32b613b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzUtMy0xLTEtMTAzNzI3_763cd95a-d586-411a-a81e-8383db08ca8a"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i0b348afbe5de43b8843f3c23b5497e45_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzUtNS0xLTEtMTAzNzI3_1ff52c01-9bbd-49ac-97e7-123d5d55fb44"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i0945a26d694b428d8419686bb048d18d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzYtMS0xLTEtMTAzNzI3_56b8fe9a-1dba-447d-b149-0481a1161857"
      unitRef="usd">1145000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i7fb53208afd74e9483b23d0e4041d555_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzYtMy0xLTEtMTAzNzI3_64e1b1f2-f896-4a09-9234-f091036d387f"
      unitRef="usd">28271000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i079f7d69cf684156b67ee6553c8b6aad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90YWJsZTo3NWRiYTU0NDkzNjI0ODJiYWE0MzFjZjA4M2FiZGY4ZS90YWJsZXJhbmdlOjc1ZGJhNTQ0OTM2MjQ4MmJhYTQzMWNmMDgzYWJkZjhlXzYtNS0xLTEtMTAzNzI3_a5912993-bc77-4903-a38d-c06738cd3329"
      unitRef="usd">1729000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <amci:TemporaryEquitySharesConversionOfConvertibleSecurities
      contextRef="i9f67793938594975ad7e63e3f8a4f312_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90ZXh0cmVnaW9uOmE0NWFkYmNmYzUwZTQwYjlhYmQ3MmNmMzJlOWU5YmJlXzEyNjQ0MzgzNzMwNjk5_7b774582-92de-4764-a6c0-4a0405180f05"
      unitRef="shares">158058</amci:TemporaryEquitySharesConversionOfConvertibleSecurities>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="i946f64f7009a4a2082ea5e8ea9ae0377_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90ZXh0cmVnaW9uOmE0NWFkYmNmYzUwZTQwYjlhYmQ3MmNmMzJlOWU5YmJlXzEyNjQ0MzgzNzMwNzA4_eda6a868-79b5-468a-ad22-19410007f1e1"
      unitRef="usd">107000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDAvZnJhZzphNDVhZGJjZmM1MGU0MGI5YWJkNzJjZjMyZTllOWJiZS90ZXh0cmVnaW9uOmE0NWFkYmNmYzUwZTQwYjlhYmQ3MmNmMzJlOWU5YmJlXzE1OTQyOTE4NjE0MDUy_93853490-dd70-4728-a61d-8f3eb150d2e3"
      unitRef="usd">0</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:OtherCurrentAssetsTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDYvZnJhZzoyNjNmY2MyY2NhMzg0MjEzYjFkYTI4Y2FjNDk4YzVlNS90ZXh0cmVnaW9uOjI2M2ZjYzJjY2EzODQyMTNiMWRhMjhjYWM0OThjNWU1XzEwOTk1MTE2Mjc4MDE4_4d2f8870-25ec-4fa8-bd22-d17fdcb74f4b">Other Current Assets &lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021 and 2020 other current assets consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Materials and supplies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherCurrentAssetsTextBlock>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDYvZnJhZzoyNjNmY2MyY2NhMzg0MjEzYjFkYTI4Y2FjNDk4YzVlNS90ZXh0cmVnaW9uOjI2M2ZjYzJjY2EzODQyMTNiMWRhMjhjYWM0OThjNWU1XzEwOTk1MTE2Mjc4MDE5_2bd0eee3-5936-4cd5-88b3-d58ca7adc471">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021 and 2020 other current assets consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Materials and supplies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <us-gaap:MaterialsSuppliesAndOther
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDYvZnJhZzoyNjNmY2MyY2NhMzg0MjEzYjFkYTI4Y2FjNDk4YzVlNS90YWJsZTowYmE1YTI1MDcwY2I0NTM5YWM5YjdmZjA5OTcwNGRkMC90YWJsZXJhbmdlOjBiYTVhMjUwNzBjYjQ1MzlhYzliN2ZmMDk5NzA0ZGQwXzItMS0xLTEtOTA2MTg_a27ba717-5ae2-4af5-87a2-dae08e590c14"
      unitRef="usd">2900000</us-gaap:MaterialsSuppliesAndOther>
    <us-gaap:MaterialsSuppliesAndOther
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDYvZnJhZzoyNjNmY2MyY2NhMzg0MjEzYjFkYTI4Y2FjNDk4YzVlNS90YWJsZTowYmE1YTI1MDcwY2I0NTM5YWM5YjdmZjA5OTcwNGRkMC90YWJsZXJhbmdlOjBiYTVhMjUwNzBjYjQ1MzlhYzliN2ZmMDk5NzA0ZGQwXzItMy0xLTEtOTA2MTg_54f8aa60-004a-45bb-bf94-9f80e71f0d19"
      unitRef="usd">1952000</us-gaap:MaterialsSuppliesAndOther>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDYvZnJhZzoyNjNmY2MyY2NhMzg0MjEzYjFkYTI4Y2FjNDk4YzVlNS90YWJsZTowYmE1YTI1MDcwY2I0NTM5YWM5YjdmZjA5OTcwNGRkMC90YWJsZXJhbmdlOjBiYTVhMjUwNzBjYjQ1MzlhYzliN2ZmMDk5NzA0ZGQwXzMtMS0xLTEtOTA2MTg_57e465de-3615-43b1-a710-51b943178333"
      unitRef="usd">1503000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDYvZnJhZzoyNjNmY2MyY2NhMzg0MjEzYjFkYTI4Y2FjNDk4YzVlNS90YWJsZTowYmE1YTI1MDcwY2I0NTM5YWM5YjdmZjA5OTcwNGRkMC90YWJsZXJhbmdlOjBiYTVhMjUwNzBjYjQ1MzlhYzliN2ZmMDk5NzA0ZGQwXzMtMy0xLTEtOTA2MTg_0b61f80d-4e09-4a27-8991-54e53251f312"
      unitRef="usd">1419000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:OtherAssetsMiscellaneousCurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDYvZnJhZzoyNjNmY2MyY2NhMzg0MjEzYjFkYTI4Y2FjNDk4YzVlNS90YWJsZTowYmE1YTI1MDcwY2I0NTM5YWM5YjdmZjA5OTcwNGRkMC90YWJsZXJhbmdlOjBiYTVhMjUwNzBjYjQ1MzlhYzliN2ZmMDk5NzA0ZGQwXzQtMS0xLTEtOTA2MTg_e6741f08-71af-4e0c-b484-6b847118c968"
      unitRef="usd">1376000</us-gaap:OtherAssetsMiscellaneousCurrent>
    <us-gaap:OtherAssetsMiscellaneousCurrent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDYvZnJhZzoyNjNmY2MyY2NhMzg0MjEzYjFkYTI4Y2FjNDk4YzVlNS90YWJsZTowYmE1YTI1MDcwY2I0NTM5YWM5YjdmZjA5OTcwNGRkMC90YWJsZXJhbmdlOjBiYTVhMjUwNzBjYjQ1MzlhYzliN2ZmMDk5NzA0ZGQwXzQtMy0xLTEtOTA2MTg_65360af9-d206-4912-9ce4-1bbf490f2b4b"
      unitRef="usd">1016000</us-gaap:OtherAssetsMiscellaneousCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDYvZnJhZzoyNjNmY2MyY2NhMzg0MjEzYjFkYTI4Y2FjNDk4YzVlNS90YWJsZTowYmE1YTI1MDcwY2I0NTM5YWM5YjdmZjA5OTcwNGRkMC90YWJsZXJhbmdlOjBiYTVhMjUwNzBjYjQ1MzlhYzliN2ZmMDk5NzA0ZGQwXzQtMS0xLTEtMTAwNTM0_1a6f9d7e-d7a2-4488-aec9-4e4abbe6a4a1"
      unitRef="usd">5779000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NDYvZnJhZzoyNjNmY2MyY2NhMzg0MjEzYjFkYTI4Y2FjNDk4YzVlNS90YWJsZTowYmE1YTI1MDcwY2I0NTM5YWM5YjdmZjA5OTcwNGRkMC90YWJsZXJhbmdlOjBiYTVhMjUwNzBjYjQ1MzlhYzliN2ZmMDk5NzA0ZGQwXzQtMy0xLTEtMTAwNTM3_68b167a6-a399-47b6-918c-5b342059a941"
      unitRef="usd">4387000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90ZXh0cmVnaW9uOmU1ZDE0ZmNiZWU1YTQ0OWQ5OWUxZjllYjllMzJmNmQ3XzEwOTk1MTE2Mjc4MTAw_cbe102c9-a435-4526-bfa4-7f193b9e960e">Property, Plant and Equipment&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021 and 2020, the Company&#x2019;s property, plant and equipment, net consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office Equipment and furniture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property, plant and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;padding-right:33.2pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation for the years ended December&#160;31, 2021 and 2020 totaled $3,806 and $2,979, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90ZXh0cmVnaW9uOmU1ZDE0ZmNiZWU1YTQ0OWQ5OWUxZjllYjllMzJmNmQ3XzEwOTk1MTE2Mjc4MTAx_04180521-20a3-4a46-88e6-51ab83974bfa">&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021 and 2020, the Company&#x2019;s property, plant and equipment, net consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office Equipment and furniture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property, plant and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1e7e83e30c3d44fdb6bc2da913857f3f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzItMS0xLTEtOTA2MTg_553cf9c5-ed64-459f-a1c9-44ced906dbb4"
      unitRef="usd">64000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i89df8c332f124e06ace60a1e9c5cab82_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzItMy0xLTEtOTA2MTg_7d58267f-b54f-4fd8-ba13-58d41034d1e4"
      unitRef="usd">64000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="if03679d2c8874922bb5588f668eb7d35_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzMtMS0xLTEtOTA2MTg_0b7d78a2-3c8a-4c0c-8fe3-f1ffebe56419"
      unitRef="usd">4113000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic580d984d78b4b299abd56ff167e37d7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzMtMy0xLTEtOTA2MTg_54f26a0a-f0e4-461d-9dde-d71796f203c3"
      unitRef="usd">4187000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie4d0329f226943faa5580463c870698c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzQtMS0xLTEtOTA2MTg_9b0399c8-b7d2-4cdd-af6d-c1bb9a4fa698"
      unitRef="usd">26627000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="icb3aa04cd5e7479082b4f9014ca3e18c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzQtMy0xLTEtOTA2MTg_0029ccd3-a1a2-4880-b994-6039c00cd5cb"
      unitRef="usd">21735000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="if23e5af08c304d4997948a7aa3740d0c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzUtMS0xLTEtOTA2MTg_2e56ff1a-8980-41e1-a336-8b08e5125b23"
      unitRef="usd">71000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i5fa3bebd5c07454880ff014ca7706dc5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzUtMy0xLTEtOTA2MTg_71ea4923-61f2-4e4b-9764-39568b44c413"
      unitRef="usd">58000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="icf4b1adda3834411b36d3d632f21e01c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzYtMS0xLTEtOTA2MTg_e6e0560b-12cd-4992-a01b-a18c1904b76a"
      unitRef="usd">1590000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6165c558d2a64bd2ba478d320a293753_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzYtMy0xLTEtOTA2MTg_27a31d4e-703c-43d4-ab37-abfed8d2968f"
      unitRef="usd">1347000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i76b729f3daf846f681967ad7e92f649b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzctMS0xLTEtOTA2MTg_dd1c993a-ed4f-4b88-bc36-5203f037f255"
      unitRef="usd">728000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i39d2cbb02f9e4ba9b23e10f13e34d417_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzctMy0xLTEtOTA2MTg_48203ab4-81d2-4aeb-ae31-32b8fd32d3cb"
      unitRef="usd">544000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="id8a470f3b214430bbb7075de4c3b1041_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzgtMS0xLTEtOTA2MTg_30aaf7f9-3ec9-413f-9dd7-2a28d48c4007"
      unitRef="usd">3328000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iacdef9e753d8416790fee52e2ac18e18_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzgtMy0xLTEtOTA2MTg_92d9cd92-4647-4c75-9522-bc3eb3ea57d2"
      unitRef="usd">2363000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzgtMS0xLTEtMTAwNTU3_f172b777-6ae7-4dcb-bcf2-f445a4084615"
      unitRef="usd">36521000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzgtMy0xLTEtMTAwNTYw_5e3c4f2b-9894-4e89-9f3f-83dbe7509e27"
      unitRef="usd">30298000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzExLTEtMS0xLTkwNjE4_ea14775b-94cb-4f1f-bd02-08b30f9c79fd"
      unitRef="usd">22373000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzExLTMtMS0xLTkwNjE4_f1dec1d9-39ab-4f14-a902-0be51b653587"
      unitRef="usd">18689000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzEyLTEtMS0xLTEwMDU2Mw_1446ba35-e6f3-4b97-bcf2-193894031e05"
      unitRef="usd">14148000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90YWJsZTpiYTE3NGFkYTAwYmY0MTVjYjBiZTQ0ZWZkYTkyNTUyNC90YWJsZXJhbmdlOmJhMTc0YWRhMDBiZjQxNWNiMGJlNDRlZmRhOTI1NTI0XzEyLTMtMS0xLTEwMDU2Mw_84299ad5-e9d9-41c2-b902-770c9a81bf7d"
      unitRef="usd">11609000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90ZXh0cmVnaW9uOmU1ZDE0ZmNiZWU1YTQ0OWQ5OWUxZjllYjllMzJmNmQ3XzIwNg_5ef667f9-ecf5-4ffc-b23e-d0b0d747754c"
      unitRef="usd">3806000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTIvZnJhZzplNWQxNGZjYmVlNWE0NDlkOTllMWY5ZWI5ZTMyZjZkNy90ZXh0cmVnaW9uOmU1ZDE0ZmNiZWU1YTQ0OWQ5OWUxZjllYjllMzJmNmQ3XzIxMw_fcdf9442-2417-42cd-8674-e6dd7d976091"
      unitRef="usd">2979000</us-gaap:Depreciation>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90ZXh0cmVnaW9uOjQ3MDdlMzY3NDU1ODQ4NmE4NjM5NzJmNzYyNzY2MjI1XzE1OTQyOTE4NjA1Mjg2_183f109b-23fb-48fb-b96b-c685f14a18af">Debt&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021 and 2020, the Company&#x2019;s debt consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2016 WTI Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PPP Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less amount due within one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt due after one year, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2016, a loan facility was entered into with Venture Lending and Leasing VII, Inc. and Venture Lending and Leasing VIII, Inc. (the &#x201c;2016 WTI Loan&#x201d;) for a total of $17,500 available in three tranches, all of which have been drawn. Tranches one and two were fully repaid as of December&#160;31, 2020. The coupon interest rate for each tranche is the WSJ prime rate, at the time of each drawdown, plus 9.0%, but not less than 12.5%. The term of each drawdown is 39 months, including nine months of interest-only payments. The loan facility was secured by all of the Company&#x2019;s assets. In March 2021, the Company repaid $570 on outstanding amounts owed on the 2016 WTI loan facility. As of December&#160;31, 2021, tranche three was fully repaid and the Company has no outstanding debt under this facility. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company was required to meet certain non-financial covenants in its loan facility agreement. In 2021 and 2020, the Company was in compliance with all non-financial covenants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Paycheck Protection Program Loan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2020, the Company was granted a loan in the amount of $3,065 pursuant to the Paycheck Protection Program (the &#x201c;PPP Loan&#x201d;) under the Coronavirus Aid, Relief and Economic Security Act. The PPP Loan has a two-year term and bears interest at a rate of 0.98% per annum. Monthly principal and interest payments are deferred for six months after the date of disbursement. The PPP Loan may be prepaid at any time prior to maturity with no prepayment penalties. The PPP Loan contains events of default and other provisions customary for a loan of this type. The PPP Loan may be forgiven if used under program parameters for payroll, mortgage interest, and rent expenses. During 2021 and 2020, the Company was in compliance with the terms of the PPP Loan.&lt;/span&gt;&lt;/div&gt;On September 28, 2021, the Company received notice that the obligation of $3,065 had been forgiven, and the Company has no outstanding debt under this program. The Company recorded the gain on extinguishment in the 2021 consolidated statement of operations and comprehensive loss.</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90ZXh0cmVnaW9uOjQ3MDdlMzY3NDU1ODQ4NmE4NjM5NzJmNzYyNzY2MjI1XzE1OTQyOTE4NjA1Mjg3_726347a9-caa2-40c8-9805-88fed152480f">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021 and 2020, the Company&#x2019;s debt consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2016 WTI Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PPP Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less amount due within one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt due after one year, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i4c4c3289f5c34d4b9daf93c4456e999f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90YWJsZTphZDUzYmI0M2VkNmY0NDMzOWNhYmQ1ZDFhODRlMzQ5NC90YWJsZXJhbmdlOmFkNTNiYjQzZWQ2ZjQ0MzM5Y2FiZDVkMWE4NGUzNDk0XzItMS0xLTEtOTA2MTg_724a444c-cae7-420c-addc-3abaf8ab3fab"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ifc118da157274cfdb66d08ffff284787_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90YWJsZTphZDUzYmI0M2VkNmY0NDMzOWNhYmQ1ZDFhODRlMzQ5NC90YWJsZXJhbmdlOmFkNTNiYjQzZWQ2ZjQ0MzM5Y2FiZDVkMWE4NGUzNDk0XzItMy0xLTEtOTA2MTg_c057e9c4-f39b-4458-ab5a-e26034888d63"
      unitRef="usd">570000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i45b11649159e4d9ea0d390a541b073d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90YWJsZTphZDUzYmI0M2VkNmY0NDMzOWNhYmQ1ZDFhODRlMzQ5NC90YWJsZXJhbmdlOmFkNTNiYjQzZWQ2ZjQ0MzM5Y2FiZDVkMWE4NGUzNDk0XzMtMS0xLTEtOTA2MTg_1c907713-d969-416b-b357-b1c0039e6ce4"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i30198db7c24e48949cc55680e9933f73_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90YWJsZTphZDUzYmI0M2VkNmY0NDMzOWNhYmQ1ZDFhODRlMzQ5NC90YWJsZXJhbmdlOmFkNTNiYjQzZWQ2ZjQ0MzM5Y2FiZDVkMWE4NGUzNDk0XzMtMy0xLTEtOTA2MTg_eabc40df-963c-4445-a3dd-a76aecbcb9f1"
      unitRef="usd">3065000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90YWJsZTphZDUzYmI0M2VkNmY0NDMzOWNhYmQ1ZDFhODRlMzQ5NC90YWJsZXJhbmdlOmFkNTNiYjQzZWQ2ZjQ0MzM5Y2FiZDVkMWE4NGUzNDk0XzMtMS0xLTEtMTAzNzQy_79dae61d-9c0a-4b10-b01d-c062d3c3986e"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90YWJsZTphZDUzYmI0M2VkNmY0NDMzOWNhYmQ1ZDFhODRlMzQ5NC90YWJsZXJhbmdlOmFkNTNiYjQzZWQ2ZjQ0MzM5Y2FiZDVkMWE4NGUzNDk0XzMtMy0xLTEtMTAzNzQy_bd375d30-1066-44a4-815b-3495c22215ac"
      unitRef="usd">3635000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90YWJsZTphZDUzYmI0M2VkNmY0NDMzOWNhYmQ1ZDFhODRlMzQ5NC90YWJsZXJhbmdlOmFkNTNiYjQzZWQ2ZjQ0MzM5Y2FiZDVkMWE4NGUzNDk0XzUtMS0xLTEtOTA2MTg_a7fc4e72-5ca5-45f2-a12b-ce42367ba904"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90YWJsZTphZDUzYmI0M2VkNmY0NDMzOWNhYmQ1ZDFhODRlMzQ5NC90YWJsZXJhbmdlOmFkNTNiYjQzZWQ2ZjQ0MzM5Y2FiZDVkMWE4NGUzNDk0XzUtMy0xLTEtOTA2MTg_d4737846-60f2-43ad-bd1a-436557bf0a36"
      unitRef="usd">570000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90YWJsZTphZDUzYmI0M2VkNmY0NDMzOWNhYmQ1ZDFhODRlMzQ5NC90YWJsZXJhbmdlOmFkNTNiYjQzZWQ2ZjQ0MzM5Y2FiZDVkMWE4NGUzNDk0XzUtMS0xLTEtMTAzNzQy_7bc5b827-7010-4b57-bcaa-96382d09e199"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90YWJsZTphZDUzYmI0M2VkNmY0NDMzOWNhYmQ1ZDFhODRlMzQ5NC90YWJsZXJhbmdlOmFkNTNiYjQzZWQ2ZjQ0MzM5Y2FiZDVkMWE4NGUzNDk0XzUtMy0xLTEtMTAzNzQy_0bd9ebe2-e098-48e9-a8d9-58dfe403ab53"
      unitRef="usd">3065000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i404699cd00694919a171cbd57221125e_I20161231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90ZXh0cmVnaW9uOjQ3MDdlMzY3NDU1ODQ4NmE4NjM5NzJmNzYyNzY2MjI1XzI2NQ_e6ff3d00-43dc-463c-b48b-01426134717e"
      unitRef="usd">17500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i593657e076c3432fa7ca2b295b005b97_D20160101-20161231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90ZXh0cmVnaW9uOjQ3MDdlMzY3NDU1ODQ4NmE4NjM5NzJmNzYyNzY2MjI1XzQ3Ng_de3525f1-0780-41ff-b1a4-6f1042c242a5"
      unitRef="number">0.090</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i404699cd00694919a171cbd57221125e_I20161231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90ZXh0cmVnaW9uOjQ3MDdlMzY3NDU1ODQ4NmE4NjM5NzJmNzYyNzY2MjI1XzQ5OA_589820dd-fa69-40ac-a584-2787caac1585"
      unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="idee985caefbc450c8367961aff024380_D20160101-20161231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90ZXh0cmVnaW9uOjQ3MDdlMzY3NDU1ODQ4NmE4NjM5NzJmNzYyNzY2MjI1XzE1OTQyOTE4NjA1MzAy_64d1ce5f-6ff1-4fb7-99bd-fea2cc29d13c">P39M</us-gaap:DebtInstrumentTerm>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i9219179a97ab4a4b82c9454bafb8d9fe_D20210301-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90ZXh0cmVnaW9uOjQ3MDdlMzY3NDU1ODQ4NmE4NjM5NzJmNzYyNzY2MjI1XzEyNjQ0MzgzNzIxOTUz_479cda92-8c2e-4a83-9e49-9663842e1cb2"
      unitRef="usd">570000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="ic037a70c12df457680d3fb392aa182f3_D20200401-20200430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90ZXh0cmVnaW9uOjQ3MDdlMzY3NDU1ODQ4NmE4NjM5NzJmNzYyNzY2MjI1XzExMjY_0b47eb60-5656-418e-a43a-8b27c9f52cde"
      unitRef="usd">3065000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i066afad72e9d4b139078a273831e92d4_I20200430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90ZXh0cmVnaW9uOjQ3MDdlMzY3NDU1ODQ4NmE4NjM5NzJmNzYyNzY2MjI1XzEzMTY_f87adf00-be28-4f84-87e9-db7522ea5a4f"
      unitRef="number">0.0098</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentDecreaseForgiveness
      contextRef="i9e518f168d1f463d87802b9ada1450e7_D20210928-20210928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90ZXh0cmVnaW9uOjQ3MDdlMzY3NDU1ODQ4NmE4NjM5NzJmNzYyNzY2MjI1XzEwOTk1MTE2MjgwMzI0_0bae7892-c568-4acd-85a8-4147581f1ec5"
      unitRef="usd">3065000</us-gaap:DebtInstrumentDecreaseForgiveness>
    <us-gaap:LongTermDebt
      contextRef="ia3c4ceff701e45aabe297c3d9da57706_I20210928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NTgvZnJhZzo0NzA3ZTM2NzQ1NTg0ODZhODYzOTcyZjc2Mjc2NjIyNS90ZXh0cmVnaW9uOjQ3MDdlMzY3NDU1ODQ4NmE4NjM5NzJmNzYyNzY2MjI1XzEyNjQ0MzgzNzIxOTQ0_712f8707-9046-4b71-8ba5-6728dfb235ff"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <amci:SimpleAgreementForFutureEquityLiabilityDisclosureTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NjQvZnJhZzpkNDE3NzAwNmY2OTQ0NWYyYjdmMjllNzg0ZGMwZDkxNS90ZXh0cmVnaW9uOmQ0MTc3MDA2ZjY5NDQ1ZjJiN2YyOWU3ODRkYzBkOTE1XzE1OTQyOTE4NjA1MDQ5_a9da5f51-bf6a-47fb-99d3-ac7872e21042">SAFE&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2021, the Company issued a SAFE that allows an investor to participate in future equity financings through a share-settled redemption of the amount invested (such notional being the &#x201c;invested amount&#x201d;). Upon the occurrence of a change of control, the investor has the right to receive the greater of (i) a cash payment equal to the invested amount under such SAFE, or (ii) the consideration payable in such change of control in respect of the number of common shares equal to the invested amount divided by the liquidity price set forth in the applicable SAFE. Upon an initial public offering or a business combination with a special purpose acquisition company, the investor has the right to receive a number of common shares equal to the invested amount divided by the liquidity price set forth in the applicable SAFE, except that if a business combination with a special purpose acquisition company involves a private placement of newly issued shares, the invested amount will be treated as participating in such private placement and exchanged for a number of common shares equal to the invested amount divided by the price per share applicable in such private placement (subject to a discount upon certain circumstances).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The SAFE also contains change of control and initial public offering settlement alternatives described above, that settle differently upon a next round financing such that it allows the investor to participate in future equity &lt;/span&gt;&lt;/div&gt;financings through a share-settled redemption at a discounted price to the price paid by other investors. That is, upon a future equity financing involving preferred shares, the SAFE would be settled into a number of preferred shares equal to the invested amount of the SAFE divided by a percentage of the discounted price investors paid to purchase preferred shares in the financing, with such discounted price calculated as a percentage of the price investors paid to purchase preferred shares in the financing.The SAFE had not yet converted to equity as a qualifying financing event had not occurred as of December 31, 2021. At December 31, 2021, the SAFE had a fair value of $28,271 and was recorded within current liabilities on the consolidated balance sheet.</amci:SimpleAgreementForFutureEquityLiabilityDisclosureTextBlock>
    <amci:SimpleAgreementForFutureEquityLiability
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NjQvZnJhZzpkNDE3NzAwNmY2OTQ0NWYyYjdmMjllNzg0ZGMwZDkxNS90ZXh0cmVnaW9uOmQ0MTc3MDA2ZjY5NDQ1ZjJiN2YyOWU3ODRkYzBkOTE1XzIxNjY_100a6ead-a1e9-425a-8ab5-05f7cc4ff5f2"
      unitRef="usd">28271000</amci:SimpleAgreementForFutureEquityLiability>
    <us-gaap:DerivativesAndFairValueTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NjgvZnJhZzoxMjcyNGM3MjNlZTc0NWNjYmQzMjc3MTFlM2UzMDE3OS90ZXh0cmVnaW9uOjEyNzI0YzcyM2VlNzQ1Y2NiZDMyNzcxMWUzZTMwMTc5XzEwOTk1MTE2Mjc4Njkw_99614d62-6132-4200-a8c6-17b86ff5b2be">Warrant Liabilities&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with certain loan borrowing agreements and equity raises, the Company issues warrants to purchase preferred shares. The Company evaluated the accounting treatment for the preferred share warrants issued and concluded pursuant to its evaluation of ASC 480, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Distinguishing Liabilities From Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and determined that there is an obligation to issue a variable number of shares and as such, were considered a liability in the consolidated balance sheets. The warrant liability requires the Company to remeasure the value of the underlying warrants and report the effect of the changes on the Company&#x2019;s operations until the warrants are exercised or expired. The primary underlying risk exposure pertaining to the warrants is the change in fair value of the underlying preferred shares for each reporting period.&lt;/span&gt;</us-gaap:DerivativesAndFairValueTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzE1OTQyOTE4NjA3MzQy_a4950562-2991-4731-a1da-216f5f74e0de">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of (loss) income before income taxes and gain from equity method investees, net are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,860)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New Zealand&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,551)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,651)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,689)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i8aafbe30b7bb4fd68e9bf6b7a590d428_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo1ZjNkNDdhZmEwOTk0YTFlODdiOTA3NTEzZTdjYjg5My90YWJsZXJhbmdlOjVmM2Q0N2FmYTA5OTRhMWU4N2I5MDc1MTNlN2NiODkzXzMtMS0xLTEtOTA2MTg_2fabe8bf-1acc-4d6b-804c-8c97c606d832"
      unitRef="usd">-39860000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i9bc03a6bd4624cafb93bad1d3f537cdc_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo1ZjNkNDdhZmEwOTk0YTFlODdiOTA3NTEzZTdjYjg5My90YWJsZXJhbmdlOjVmM2Q0N2FmYTA5OTRhMWU4N2I5MDc1MTNlN2NiODkzXzMtMy0xLTEtOTA2MTg_b1f6af01-36fc-4094-a1ec-343b50ca7195"
      unitRef="usd">106000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ie93366da59b6430ca421d5c1bbe96fbe_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo1ZjNkNDdhZmEwOTk0YTFlODdiOTA3NTEzZTdjYjg5My90YWJsZXJhbmdlOjVmM2Q0N2FmYTA5OTRhMWU4N2I5MDc1MTNlN2NiODkzXzQtMS0xLTEtOTA2MTg_18fcb163-8d14-40b2-b872-827779d932f7"
      unitRef="usd">-7551000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i674eabcf32014cbbbafe71136b7607fc_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo1ZjNkNDdhZmEwOTk0YTFlODdiOTA3NTEzZTdjYjg5My90YWJsZXJhbmdlOjVmM2Q0N2FmYTA5OTRhMWU4N2I5MDc1MTNlN2NiODkzXzQtMy0xLTEtOTA2MTg_825f1b93-172d-421a-aee6-81a113a8646f"
      unitRef="usd">-40651000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo1ZjNkNDdhZmEwOTk0YTFlODdiOTA3NTEzZTdjYjg5My90YWJsZXJhbmdlOjVmM2Q0N2FmYTA5OTRhMWU4N2I5MDc1MTNlN2NiODkzXzUtMS0xLTEtOTA2MTg_be77ec53-d871-4305-97d3-9e8b3511cecf"
      unitRef="usd">722000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo1ZjNkNDdhZmEwOTk0YTFlODdiOTA3NTEzZTdjYjg5My90YWJsZXJhbmdlOjVmM2Q0N2FmYTA5OTRhMWU4N2I5MDc1MTNlN2NiODkzXzUtMy0xLTEtOTA2MTg_fa880a6b-1e70-4f30-a250-7a75971d019d"
      unitRef="usd">2832000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:NetIncomeLoss
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo1ZjNkNDdhZmEwOTk0YTFlODdiOTA3NTEzZTdjYjg5My90YWJsZXJhbmdlOjVmM2Q0N2FmYTA5OTRhMWU4N2I5MDc1MTNlN2NiODkzXzYtMS0xLTEtOTA2MTg_9cc31a22-bf6e-44c6-ab69-bda7a1014c3d"
      unitRef="usd">-46689000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo1ZjNkNDdhZmEwOTk0YTFlODdiOTA3NTEzZTdjYjg5My90YWJsZXJhbmdlOjVmM2Q0N2FmYTA5OTRhMWU4N2I5MDc1MTNlN2NiODkzXzYtMy0xLTEtOTA2MTg_f0b225dc-a0e4-4114-a02d-61e241c2a9c0"
      unitRef="usd">-37713000</us-gaap:NetIncomeLoss>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i8aafbe30b7bb4fd68e9bf6b7a590d428_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzMtMS0xLTEtOTA2MTg_8f0eb65a-b8d3-4740-b15b-118fa8677d0a"
      unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i9bc03a6bd4624cafb93bad1d3f537cdc_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzMtMy0xLTEtOTA2MTg_440987b4-38ea-4a58-91ed-01763a9e883c"
      unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ie93366da59b6430ca421d5c1bbe96fbe_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzQtMS0xLTEtMTA2NTY2_d5270eb1-9cf2-4abb-8fee-0bc44b83f08c"
      unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i674eabcf32014cbbbafe71136b7607fc_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzQtMy0xLTEtMTA2NTY2_4d30cd8d-949d-4d6c-85a9-0c377c855d8c"
      unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzUtMS0xLTEtOTA2MTg_d289a7a5-b221-4e2a-83b4-3daf5b1daf6f"
      unitRef="usd">0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzUtMy0xLTEtOTA2MTg_5e0d1802-91f5-432c-9c20-d667a48802e7"
      unitRef="usd">0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzYtMS0xLTEtMTAzODA5_c54b9acc-4fe3-476d-af27-d9554d060b2d"
      unitRef="usd">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzYtMy0xLTEtMTAzODA5_10034237-96f8-4a9e-88f1-8275f4ca2d06"
      unitRef="usd">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i8aafbe30b7bb4fd68e9bf6b7a590d428_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzgtMS0xLTEtOTA2MTg_e8f5fd06-a519-4aa4-a5e8-70ff75143d71"
      unitRef="usd">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i9bc03a6bd4624cafb93bad1d3f537cdc_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzgtMy0xLTEtOTA2MTg_f9ad4456-b4fa-4624-bfb0-fc0d7cc06ffd"
      unitRef="usd">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ie93366da59b6430ca421d5c1bbe96fbe_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzktMS0xLTEtMTAzODA5_31cb6a41-8297-457a-ab61-c952b641bdae"
      unitRef="usd">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i674eabcf32014cbbbafe71136b7607fc_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzktMy0xLTEtMTAzODA5_46ee91ef-81a0-4e92-a027-6be3d339738d"
      unitRef="usd">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzEwLTEtMS0xLTkwNjE4_cb2b31e7-3804-4949-9c48-c479342a8a3a"
      unitRef="usd">0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzEwLTMtMS0xLTkwNjE4_8fe0ec4a-13da-4f1b-9da6-18c3b2858bdb"
      unitRef="usd">0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzExLTEtMS0xLTEwMzgwOQ_eb56fd2e-f390-435d-b4b2-b086051916e7"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTo5MTczYTI2NzU4YmE0MzhhYjkyNjBkZjY4OGMwYTE5YS90YWJsZXJhbmdlOjkxNzNhMjY3NThiYTQzOGFiOTI2MGRmNjg4YzBhMTlhXzExLTMtMS0xLTEwMzgwOQ_4d6b76a5-819f-4015-8481-794aaeff87fc"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzMzNg_bd30c525-b933-44d8-a79a-b23af15cad91"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzM5NQ_987aa55c-61b5-4c36-ba87-9faf2ee05be8"
      unitRef="number">0.280</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzMtMS0xLTEtOTA2MTg_ad2f8d6d-11c6-4d56-b208-83ca591942d7"
      unitRef="usd">-9805000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzMtMi0xLTEtOTA2MTg_bd30c525-b933-44d8-a79a-b23af15cad91"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzMtNC0xLTEtOTA2MTg_b0269dc3-2782-4d4d-94d6-3eab7539569a"
      unitRef="usd">-10560000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzMtNS0xLTEtOTA2MTg_987aa55c-61b5-4c36-ba87-9faf2ee05be8"
      unitRef="number">0.280</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzQtMS0xLTEtOTA2MTg_a7f05575-097d-4f14-90fb-6970660bd2c6"
      unitRef="usd">-605000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzQtMi0xLTEtOTA2MTg_b7bdef8e-3cfa-4688-a8cb-189fffb8573b"
      unitRef="number">0.013</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzQtNC0xLTEtOTA2MTg_3c4a67ca-2bbc-4f70-9cbd-172337d96039"
      unitRef="usd">1180000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzQtNS0xLTEtOTA2MTg_9b676220-acde-4c3e-9f7d-462bd3e437c7"
      unitRef="number">-0.032</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzUtMS0xLTEtOTA2MTg_a0b250e6-4028-47c7-8ad3-c1333ceefaa9"
      unitRef="usd">-4068000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzUtMi0xLTEtOTA2MTg_c5ccf8f1-cf81-43a3-ba52-6dea192f4aa0"
      unitRef="number">0.087</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzUtNC0xLTEtOTA2MTg_9d3eb903-5bf1-4c7e-be03-27e8683036e4"
      unitRef="usd">-2429000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzUtNS0xLTEtOTA2MTg_831e066e-62c6-487d-8fad-fe1aad95fbb5"
      unitRef="number">0.064</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzYtMS0xLTEtOTA2MTg_783c1684-caec-432b-86c5-96bd1691d09e"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzYtMi0xLTEtOTA2MTg_c2ba4497-32fe-4063-9530-901e4fe766d0"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzYtNC0xLTEtOTA2MTg_3675a987-9ad9-4ca5-9268-64db5e8de950"
      unitRef="usd">10281000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzYtNS0xLTEtOTA2MTg_6ee7761a-0ebe-4436-9056-2d27701c9ae0"
      unitRef="number">-0.279</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <amci:EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesAmount
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzctMS0xLTEtOTA2MTg_4c50a2c9-c9df-4a45-bb80-5c58670d2c3d"
      unitRef="usd">-143000</amci:EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesAmount>
    <amci:EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesPercent
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzctMi0xLTEtOTA2MTg_3d14d962-36c7-429a-845e-10a71b371f60"
      unitRef="number">0.003</amci:EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesPercent>
    <amci:EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesAmount
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzctNC0xLTEtOTA2MTg_f553fe5d-578e-4ee7-afdb-5f824abc533f"
      unitRef="usd">-5892000</amci:EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesAmount>
    <amci:EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesPercent
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzctNS0xLTEtOTA2MTg_5eb690b8-1e8d-4d2f-8902-ef0049f12ed7"
      unitRef="number">0.160</amci:EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesPercent>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzgtMS0xLTEtOTA2MTg_ba7ad18e-540e-4a25-aa1a-6fb4c57f3061"
      unitRef="usd">501000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzgtMi0xLTEtOTA2MTg_ba72f760-46df-4024-b68b-8b860e6df5cc"
      unitRef="number">-0.011</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzgtNC0xLTEtOTA2MTg_90b0b97b-8827-48c8-8227-3f79af923531"
      unitRef="usd">670000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzgtNS0xLTEtOTA2MTg_d3bee6f7-1b83-4af4-89c9-bd180c1ca395"
      unitRef="number">-0.018</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <amci:EffectiveIncomeTaxRateReconciliationInterestIncomeAmount
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzktMS0xLTEtOTA2MTg_b6d22f89-4613-4755-b7a6-4cf57174b1b1"
      unitRef="usd">882000</amci:EffectiveIncomeTaxRateReconciliationInterestIncomeAmount>
    <amci:EffectiveIncomeTaxRateReconciliationInterestIncomePercent
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzktMi0xLTEtOTA2MTg_f55017f4-4050-489e-9c1c-0f45cf79d94a"
      unitRef="number">-0.019</amci:EffectiveIncomeTaxRateReconciliationInterestIncomePercent>
    <amci:EffectiveIncomeTaxRateReconciliationInterestIncomeAmount
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzktNC0xLTEtOTA2MTg_44b81ef4-4e6f-41fa-a10c-45e2fc891f03"
      unitRef="usd">2120000</amci:EffectiveIncomeTaxRateReconciliationInterestIncomeAmount>
    <amci:EffectiveIncomeTaxRateReconciliationInterestIncomePercent
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzktNS0xLTEtOTA2MTg_73fbd9c4-d9b0-4a96-a498-cc3c3969213a"
      unitRef="number">-0.057</amci:EffectiveIncomeTaxRateReconciliationInterestIncomePercent>
    <amci:EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentAmount
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzEwLTEtMS0xLTkwNjE4_2259cf90-6a8e-4606-adcf-d136f06db8bc"
      unitRef="usd">-443000</amci:EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentAmount>
    <amci:EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentPercent
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzEwLTItMS0xLTkwNjE4_0e5ab231-8975-42af-b5bc-397fcdc71ece"
      unitRef="number">0.009</amci:EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentPercent>
    <amci:EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentAmount
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzEwLTQtMS0xLTkwNjE4_1c17bd6f-8e03-4134-99f3-2cf77d95221c"
      unitRef="usd">-679000</amci:EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentAmount>
    <amci:EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentPercent
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzEwLTUtMS0xLTkwNjE4_bdab59e1-6b34-43bc-b001-373706afa834"
      unitRef="number">0.018</amci:EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentPercent>
    <amci:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalAmount
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzExLTEtMS0xLTkwNjE4_42e78396-6792-47fc-8fa5-53864ec75432"
      unitRef="usd">1291000</amci:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalAmount>
    <amci:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalPercent
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzExLTItMS0xLTkwNjE4_91edd467-cba8-45fa-a14b-8c230565ec8e"
      unitRef="number">-0.028</amci:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalPercent>
    <amci:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalAmount
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzExLTQtMS0xLTkwNjE4_4e2ac24a-e4f6-4133-97da-8a78d253e4e0"
      unitRef="usd">0</amci:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalAmount>
    <amci:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalPercent
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzExLTUtMS0xLTkwNjE4_d40dd0c6-17bb-455b-bcf3-2b8b46e7c2aa"
      unitRef="number">0</amci:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalPercent>
    <amci:EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyAmount
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzEyLTEtMS0xLTkwNjE4_e13624f5-c7e5-47cf-b2ac-573c0b2729b1"
      unitRef="usd">4890000</amci:EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyAmount>
    <amci:EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyPercent
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzEyLTItMS0xLTkwNjE4_d1b5431c-0770-4859-b003-d2230b7046c2"
      unitRef="number">-0.105</amci:EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyPercent>
    <amci:EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyAmount
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzEyLTUtMS0xLTEwMzgyNg_6944b8b7-d4b5-4774-abfe-d6da70eb0f86"
      unitRef="usd">0</amci:EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyAmount>
    <amci:EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyPercent
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzEyLTctMS0xLTEwMzgyNg_70c762bb-9db5-44f2-9706-1233c08ae21c"
      unitRef="number">0</amci:EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyPercent>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzEzLTEtMS0xLTkwNjE4_cf91be70-9036-4d0a-a805-bf14085984df"
      unitRef="usd">7958000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzEzLTItMS0xLTkwNjE4_07010753-f59e-4805-bd2b-8f25546df7a6"
      unitRef="number">-0.170</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzEzLTQtMS0xLTkwNjE4_11e9b286-956c-4f48-9047-f5d478218b61"
      unitRef="usd">5505000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzEzLTUtMS0xLTkwNjE4_29279f90-58a0-4e50-b600-987f6dc6638f"
      unitRef="number">-0.141</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <amci:EffectiveIncomeTaxRateReconciliationDebtForgivenessAmount
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzE0LTEtMS0xLTkwNjE4_4219f644-2722-4cf0-92e5-16a0ab5ffca2"
      unitRef="usd">644000</amci:EffectiveIncomeTaxRateReconciliationDebtForgivenessAmount>
    <amci:EffectiveIncomeTaxRateReconciliationDebtForgivenessPercent
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzE0LTItMS0xLTkwNjE4_eb76abaa-3f3e-43c8-b406-34af5bf4a7b9"
      unitRef="number">-0.014</amci:EffectiveIncomeTaxRateReconciliationDebtForgivenessPercent>
    <amci:EffectiveIncomeTaxRateReconciliationDebtForgivenessAmount
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzE0LTQtMS0xLTkwNjE4_3fb376b7-5928-4edd-9f71-b480eb0e7f80"
      unitRef="usd">0</amci:EffectiveIncomeTaxRateReconciliationDebtForgivenessAmount>
    <amci:EffectiveIncomeTaxRateReconciliationDebtForgivenessPercent
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzE0LTUtMS0xLTkwNjE4_8d28bf71-3a34-4d94-9744-4665346fb0eb"
      unitRef="number">0</amci:EffectiveIncomeTaxRateReconciliationDebtForgivenessPercent>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzE1LTEtMS0xLTkwNjE4_a8bdc6b0-f0b6-40ae-95af-402620bfa1d8"
      unitRef="usd">186000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzE1LTItMS0xLTkwNjE4_984deeb4-4e0a-42e9-9d65-08d004c04b09"
      unitRef="number">-0.003</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzE1LTQtMS0xLTkwNjE4_f8fab86f-8778-4ab8-a813-c3b9d8bb4663"
      unitRef="usd">-196000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzE1LTUtMS0xLTkwNjE4_34f48e35-d7d1-4791-8c44-ba469b0fe2be"
      unitRef="number">0.005</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzE2LTEtMS0xLTEwMzgyNg_458feac6-207a-4f3f-a39a-dea74a97df0b"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzE2LTMtMS0xLTEwMzgyNg_48be2175-746c-4718-86dc-194123e43caf"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzE2LTUtMS0xLTEwMzgyNg_5841875a-1548-4e24-b244-024c69840556"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZToyMTU3NzA4ZjM2ZmE0ZWU1ODgxMzEwNDYwN2MzOWM2Yi90YWJsZXJhbmdlOjIxNTc3MDhmMzZmYTRlZTU4ODEzMTA0NjA3YzM5YzZiXzE2LTctMS0xLTEwMzgyNg_1c4beeb3-19d2-44e8-b6c2-6689bc419312"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzMtMS0xLTEtOTA2MTg_0ddfd107-cb16-45b4-8e51-db58b57012e8"
      unitRef="usd">107979000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzMtMy0xLTEtOTA2MTg_4f823864-5d5b-4c50-9c55-4779231602ba"
      unitRef="usd">104301000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <amci:DeferredTaxAssetsLeasingArrangements
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzQtMS0xLTEtOTA2MTg_42cb086c-621c-4f33-aef2-0b73d8366cd5"
      unitRef="usd">1878000</amci:DeferredTaxAssetsLeasingArrangements>
    <amci:DeferredTaxAssetsLeasingArrangements
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzQtMy0xLTEtOTA2MTg_6295ded2-f0f1-4eb5-afdc-207726e5eb11"
      unitRef="usd">2394000</amci:DeferredTaxAssetsLeasingArrangements>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzUtMS0xLTEtOTA2MTg_5e334046-2367-4fc8-94d4-9493ec7d23c0"
      unitRef="usd">981000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzUtMy0xLTEtOTA2MTg_0807419d-f9f9-418b-94da-6d1d191a99c5"
      unitRef="usd">850000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzYtMS0xLTEtOTA2MTg_386ef617-6e14-483e-92e7-f34e7a44b000"
      unitRef="usd">1566000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzYtMy0xLTEtOTA2MTg_5345820e-3b4e-4df8-9476-3107a65e08d4"
      unitRef="usd">429000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzctMS0xLTEtOTA2MTg_4ad87bb8-9140-4845-a51d-5eb43b7939a8"
      unitRef="usd">309000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzctMy0xLTEtOTA2MTg_0ce8daf2-f806-460f-8d07-9ba34687afe2"
      unitRef="usd">1018000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsEquityMethodInvestments
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzgtMS0xLTEtOTA2MTg_5d41037c-c199-4bc2-8992-1654e7fae65f"
      unitRef="usd">1243000</us-gaap:DeferredTaxAssetsEquityMethodInvestments>
    <us-gaap:DeferredTaxAssetsEquityMethodInvestments
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzgtMy0xLTEtOTA2MTg_c2703a6f-a557-4b51-8139-00cfcf9033e6"
      unitRef="usd">1031000</us-gaap:DeferredTaxAssetsEquityMethodInvestments>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzktMS0xLTEtOTA2MTg_f8d671ae-f2fc-41c7-a6c0-af81a58a1811"
      unitRef="usd">925000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzktMy0xLTEtOTA2MTg_414cadd0-8638-4237-b79c-6b6d71f719b3"
      unitRef="usd">394000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzEwLTItMS0xLTEwMzg1OA_27417e59-c0bf-4ade-9e45-019c35fb3cc3"
      unitRef="usd">114881000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzEwLTQtMS0xLTEwMzg1OA_98964e74-e8b1-469c-b6e1-a099b1208f0f"
      unitRef="usd">110417000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzExLTEtMS0xLTkwNjE4_91e95bfd-852f-49e1-ad83-80cd0125b832"
      unitRef="usd">113276000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzExLTMtMS0xLTkwNjE4_fc9756b2-f758-4262-99fb-daa23ba118c5"
      unitRef="usd">108300000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzEyLTItMS0xLTEwMzg1OA_ba61881f-6fb3-4d99-b3cd-ffc8868ef44b"
      unitRef="usd">1605000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzEyLTQtMS0xLTEwMzg1OA_15dbba94-9a6d-4163-95db-3de2f4cc2170"
      unitRef="usd">2117000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzE0LTEtMS0xLTkwNjE4_e6eec02e-4814-4229-9486-e2f1b5fa3537"
      unitRef="usd">1429000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzE0LTMtMS0xLTkwNjE4_f3ae3032-b5f6-47f3-acac-5ec041b64d28"
      unitRef="usd">1941000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzE1LTEtMS0xLTkwNjE4_e848d44b-60b1-4413-a257-b12d52cce60d"
      unitRef="usd">176000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzE1LTMtMS0xLTkwNjE4_28bd6842-0f78-4a98-b1c7-4397231df7bf"
      unitRef="usd">176000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzE2LTItMS0xLTEwMzg1OA_0df82fcf-c9e8-4ad7-849d-426b90f5ce9b"
      unitRef="usd">1605000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzE2LTQtMS0xLTEwMzg1OA_75364d7e-1ebc-4c7e-a8bd-b0e8941fe47a"
      unitRef="usd">2117000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzE4LTItMS0xLTEwMzg1OA_2577df8f-664b-42d8-b762-6f1c3171db7f"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90YWJsZTozMDRjZGNkZDM3Njg0YjAzYjg5NzU0NTFlYzk2ZmNmMS90YWJsZXJhbmdlOjMwNGNkY2RkMzc2ODRiMDNiODk3NTQ1MWVjOTZmY2YxXzE4LTQtMS0xLTEwMzg1OA_95e17fc8-dc94-4031-988a-1bc5ba6e1e60"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <amci:OperatingLossAndTaxCreditCarryforwards
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2Xzc3Mw_bd4344ff-dd30-4ce9-8d74-ff4ed271c0a7"
      unitRef="usd">299194000</amci:OperatingLossAndTaxCreditCarryforwards>
    <amci:OperatingLossAndTaxCreditCarryforwards
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2Xzc4MA_fcea64ed-d279-4cf8-a66c-2bfd11f8460b"
      unitRef="usd">271390000</amci:OperatingLossAndTaxCreditCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i7126fac96e634ad0af8988b83b1e7593_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEwMDY_11fb7005-1afc-45ea-9adb-377daf953d94"
      unitRef="usd">35147000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i04acfe14cd6f4c0da7448253e2c86947_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEwMTM_8369a140-a854-47b5-a577-cecc24d89be9"
      unitRef="usd">40556000</us-gaap:TaxCreditCarryforwardAmount>
    <amci:OperatingLossAndTaxCreditCarryforwards
      contextRef="i43158a95b30f4aaab73e7597bb3c2a77_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzExNzQ_5a601b14-1056-428c-9c25-550934683357"
      unitRef="usd">239559000</amci:OperatingLossAndTaxCreditCarryforwards>
    <amci:OperatingLossAndTaxCreditCarryforwards
      contextRef="i1bc2ae3cc9a8471192b73d09b8c4196c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzExODE_691c4090-1ff2-4c77-82f5-6366c7abe237"
      unitRef="usd">196442000</amci:OperatingLossAndTaxCreditCarryforwards>
    <amci:OperatingLossAndTaxCreditCarryforwards
      contextRef="i14808e8f9df64a649044715542143c00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEyMDY_95b5b1d3-a114-41b6-8fe4-177c7d98e54b"
      unitRef="usd">22203000</amci:OperatingLossAndTaxCreditCarryforwards>
    <amci:OperatingLossAndTaxCreditCarryforwards
      contextRef="ied52ef89a5c14dea943af84ca5eee65e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEyMTM_a70ac59e-c813-4a53-980d-e220ce62e353"
      unitRef="usd">18104000</amci:OperatingLossAndTaxCreditCarryforwards>
    <amci:OperatingLossAndTaxCreditCarryforwards
      contextRef="i180c304002694f86a2cf308b957c10a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEyMzY_da9be9a8-183c-493d-a8c9-f677f36dc96b"
      unitRef="usd">35116000</amci:OperatingLossAndTaxCreditCarryforwards>
    <amci:OperatingLossAndTaxCreditCarryforwards
      contextRef="i46667c1000434c14a56ef64c99eb3a8c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEyNDM_9a879170-9cff-433d-8db4-4d92c31e7dfe"
      unitRef="usd">54334000</amci:OperatingLossAndTaxCreditCarryforwards>
    <amci:OperatingLossAndTaxCreditCarryforwards
      contextRef="ie04b19809090466ab84ebbe80fe42718_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEyNjY_36b6597d-7f18-486a-abf7-fe7522567d76"
      unitRef="usd">4589000</amci:OperatingLossAndTaxCreditCarryforwards>
    <amci:OperatingLossAndTaxCreditCarryforwards
      contextRef="ib5a23afc7674452e9cdd8908a9228efd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEyNzM_00ac3426-6131-440c-a12d-16b80a399dc7"
      unitRef="usd">2510000</amci:OperatingLossAndTaxCreditCarryforwards>
    <amci:OperatingLossCarryforwardsSubjectToExpiration
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzE0MDI_0693b6bc-05b8-431a-a04e-ec3387c64fa5"
      unitRef="usd">136454000</amci:OperatingLossCarryforwardsSubjectToExpiration>
    <amci:OperatingLossCarryforwardsSubjectToExpiration
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzE0MDk_16749047-8898-4910-b33d-c91417f0a110"
      unitRef="usd">132373000</amci:OperatingLossCarryforwardsSubjectToExpiration>
    <amci:OperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzE0ODU_1c8ac200-51d2-4262-a7ba-b66c7e50c6d4"
      unitRef="usd">127593000</amci:OperatingLossCarryforwardsNotSubjectToExpiration>
    <amci:OperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzE0OTI_85a9c25b-540f-4a84-8c46-b88398bc9b23"
      unitRef="usd">98462000</amci:OperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzI0MzI_0137224b-3e90-4e73-a380-c7e7b6263c98"
      unitRef="usd">113276000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzI0Mzk_e628183c-20bb-4ef6-9ce2-c4064f6dd621"
      unitRef="usd">108300000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ForeignEarningsRepatriated
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEwOTk1MTE2MjgyMzcy_4a6d7663-3094-4bcb-a265-f972922b035e"
      unitRef="usd">0</us-gaap:ForeignEarningsRepatriated>
    <us-gaap:ForeignEarningsRepatriated
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEwOTk1MTE2MjgyMzcy_624a85cf-7de9-454a-a803-41d9a4e38f4d"
      unitRef="usd">0</us-gaap:ForeignEarningsRepatriated>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEwOTk1MTE2MjgyMzgx_3eaad12f-6cd7-4f76-ac1d-89a6ae00f867"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEwOTk1MTE2MjgyMzgx_de4ab60d-5ec5-4858-b19d-01c95a468c5f"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEwOTk1MTE2MjgyMzg5_8be8ec18-65af-457b-8c01-8a5ebe77470a"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEwOTk1MTE2MjgyMzg5_d7f28bca-5665-409f-bde6-de815528c0f3"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEwOTk1MTE2MjgyMzk3_3b6e8709-90cf-472f-98dd-e89368f745fa"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80NzQvZnJhZzoyOTdlYzg1M2YyNjA0MzVmYmEwMDk1NmI4YjU0NjA4Ni90ZXh0cmVnaW9uOjI5N2VjODUzZjI2MDQzNWZiYTAwOTU2YjhiNTQ2MDg2XzEwOTk1MTE2MjgyMzk3_89c376be-0cd1-484a-8513-e688dbe61fa1"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <amci:NumberOfShareBasedStockSchemes
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEwOTk1MTE2Mjg0NDA0_2744e875-2af2-4c3b-83a1-4159ad843f5f"
      unitRef="scheme">5</amci:NumberOfShareBasedStockSchemes>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
      contextRef="ibd4d0f3725b743bb9a13d0e7f76a6680_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEwOTk1MTE2Mjg0Mzg4_3508be3a-ff3d-4b84-a7e6-bf8940faef01">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i3a3ce2d4285046a28faff5151642a219_D20201101-20201130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEyNjQ0MzgzNzI2MDE1_ca72cf36-2108-4206-941c-b249b9797095"
      unitRef="shares">151068</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEyNjQ0MzgzNzI2MDIz_3df6a6af-69d6-4adf-8ff8-bb1595b5028b">P10Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzEtMS0xLTEtOTA2MTg_e6ebcba5-bafd-4f0b-b18f-5397988e40f5"
      unitRef="shares">4283000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzEtMy0xLTEtOTA2MTg_b1f9bc3b-4001-4619-a090-948d8813b1da"
      unitRef="usdPerShare">5.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzEtNS0xLTEtOTA2MTg_c9f9894e-883a-443a-9d20-c94a76a45ba0">P5Y1M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzEtNy0xLTEtOTA2MTg_fde8cb66-5920-4cf5-8370-68f0f7c25adf"
      unitRef="usd">2582000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzItMS0xLTEtOTA2MTg_3cc1e9a9-2bfd-4875-957e-e94f41285f24"
      unitRef="shares">4283000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzItMy0xLTEtOTA2MTg_bf29fd65-c8ac-4e50-a52c-725050fe07cb"
      unitRef="usdPerShare">5.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzItNS0xLTEtOTA2MTg_1aa77258-13b9-4c39-8d96-5265c5c71e13">P5Y1M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzItNy0xLTEtOTA2MTg_c29cfdcb-9d98-4459-b6f8-e5a08ec84e5c"
      unitRef="usd">2582000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzMtMS0xLTEtOTA2MTg_54e94a70-7ad6-4ae3-aab1-c65c5b94c12e"
      unitRef="shares">2915000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzMtMy0xLTEtOTA2MTg_90340d9e-ae3e-4aeb-97e0-6034d2110b24"
      unitRef="usdPerShare">5.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzMtNS0xLTEtOTA2MTg_9543d9fc-c60a-421d-96ab-fd189a17185a">P3Y5M19D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzMtNy0xLTEtOTA2MTg_95e56246-d78e-4447-ab4b-6b9deda65efb"
      unitRef="usd">2582000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzQtMS0xLTEtOTA2MTg_42df3c2d-c86b-43a4-9a23-bc4af0bdae4f"
      unitRef="shares">620000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzQtMy0xLTEtOTA2MTg_efab4132-24cf-4eac-822e-d71e51475427"
      unitRef="usdPerShare">9.33</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzQtNy0xLTEtOTA2MTg_99cfb7e8-9e55-44cd-ae7a-91f58cb747b6"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzUtMS0xLTEtOTA2MTg_096738cc-de54-4e71-9ac9-acdf21d0c0c5"
      unitRef="shares">721000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzUtMy0xLTEtOTA2MTg_5df55e8a-67fc-4f9b-9d60-f1cfff4969c8"
      unitRef="usdPerShare">2.36</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <amci:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzUtNy0xLTEtOTA2MTg_e4e31f28-ca48-40b3-868d-0562088b9b1f"
      unitRef="usd">1741000</amci:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzYtMS0xLTEtOTA2MTg_ce6cdaf9-75a8-44bb-bc7c-33c35b939dbb"
      unitRef="shares">334000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzYtMy0xLTEtOTA2MTg_6f7cdb50-58e0-4676-af03-719528e8b767"
      unitRef="usdPerShare">2.50</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <amci:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzYtNy0xLTEtOTA2MTg_00a23a63-bf1d-4563-8dc5-48437665a384"
      unitRef="usd">755000</amci:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzctMS0xLTEtOTA2MTg_8a7ec6f9-5428-4d6d-b93e-dac70a41bde5"
      unitRef="shares">3848000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzctMy0xLTEtOTA2MTg_3e55e338-4ae6-4c06-ac5c-e889902df5f8"
      unitRef="usdPerShare">6.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzctNS0xLTEtOTA2MTg_5827ef19-80e9-4e3b-94d7-99fbb1388494">P6Y1M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzctNy0xLTEtOTA2MTg_cfb0187d-3be3-44e8-93ee-d2bc24ba87dc"
      unitRef="usd">27796000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzgtMS0xLTEtOTA2MTg_348ac829-f154-46a0-a920-2a0bef743386"
      unitRef="shares">3848000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzgtMy0xLTEtOTA2MTg_118e2664-53a3-40c8-ad8c-912847a7a52b"
      unitRef="usdPerShare">6.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzgtNS0xLTEtOTA2MTg_01850e65-0919-45e5-96c6-ee827033fa12">P6Y1M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzgtNy0xLTEtOTA2MTg_4d83f52a-36b0-4e10-b2f6-9dcf35b0851c"
      unitRef="usd">27796000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzktMS0xLTEtOTA2MTg_4d3a8a0f-884e-49cf-9910-d5d1cb997775"
      unitRef="shares">2479000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzktMy0xLTEtOTA2MTg_8cd0f31e-456a-4097-a333-be79fe9e77bc"
      unitRef="usdPerShare">6.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzktNS0xLTEtOTA2MTg_35c724d6-ebad-4188-88ec-9174147148e1">P4Y10M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpmYTAyM2UyOTMzZWM0N2I1YTVjYzliNDg4ZWVlODNlZC90YWJsZXJhbmdlOmZhMDIzZTI5MzNlYzQ3YjVhNWNjOWI0ODhlZWU4M2VkXzktNy0xLTEtOTA2MTg_abe71e51-9ecb-4d56-ba0e-0c79a3dbe734"
      unitRef="usd">18499000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEyODg_3fd66100-f91b-483a-9fd3-190aff3b4352"
      unitRef="usd">2531000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEyOTU_117d56aa-b330-4286-85ba-a4352b346a06"
      unitRef="usd">2392000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEzODg_e340967e-646f-420b-8373-7f056cff81b3"
      unitRef="usd">6120000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i573b811889c3495891ffd2a6cb11821d_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEwOTk1MTE2Mjg0NDEz_5e84cddf-0da2-4c7d-9ad7-381de3ccbb62">P2Y8M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEwOTk1MTE2Mjg0Mzc5_92627356-2b9b-4e36-ab45-3d6849cc7264">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the weighted-average assumptions applied in the Black-Scholes valuation of options for awards subject to expense recognition for the first time in the period, for the years ended December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharePrice
      contextRef="i8edc4dc10f9f4f9bbe7fde8514cd754b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZToxNTE5YjNlMjA4MmY0ODkwODdiODQwOWVjNmQxMzY3ZS90YWJsZXJhbmdlOjE1MTliM2UyMDgyZjQ4OTA4N2I4NDA5ZWM2ZDEzNjdlXzItMS0xLTEtOTA2MTg_1840e45b-424e-47d3-943f-bd016f770330"
      unitRef="usdPerShare">9.33</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="i213ef7ccde724ea7afd07d3e7e86daa8_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZToxNTE5YjNlMjA4MmY0ODkwODdiODQwOWVjNmQxMzY3ZS90YWJsZXJhbmdlOjE1MTliM2UyMDgyZjQ4OTA4N2I4NDA5ZWM2ZDEzNjdlXzItMy0xLTEtOTA2MTg_4de46539-edf9-4d7e-938c-e03b021f9c8c"
      unitRef="usdPerShare">4.68</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="i8edc4dc10f9f4f9bbe7fde8514cd754b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZToxNTE5YjNlMjA4MmY0ODkwODdiODQwOWVjNmQxMzY3ZS90YWJsZXJhbmdlOjE1MTliM2UyMDgyZjQ4OTA4N2I4NDA5ZWM2ZDEzNjdlXzMtMS0xLTEtOTA2MTg_ca26b58d-c112-4545-8828-ffc6a5ef138c"
      unitRef="usdPerShare">9.33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="i213ef7ccde724ea7afd07d3e7e86daa8_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZToxNTE5YjNlMjA4MmY0ODkwODdiODQwOWVjNmQxMzY3ZS90YWJsZXJhbmdlOjE1MTliM2UyMDgyZjQ4OTA4N2I4NDA5ZWM2ZDEzNjdlXzMtMy0xLTEtOTA2MTg_77606d16-d3ac-485f-923d-5531dc0d6d7c"
      unitRef="usdPerShare">4.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i573b811889c3495891ffd2a6cb11821d_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZToxNTE5YjNlMjA4MmY0ODkwODdiODQwOWVjNmQxMzY3ZS90YWJsZXJhbmdlOjE1MTliM2UyMDgyZjQ4OTA4N2I4NDA5ZWM2ZDEzNjdlXzQtMS0xLTEtOTA2MTg_2706778a-fa25-4474-8a53-7f630af6df23">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i03b32e37b4f7484ea3c2ae0cc21ee87c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZToxNTE5YjNlMjA4MmY0ODkwODdiODQwOWVjNmQxMzY3ZS90YWJsZXJhbmdlOjE1MTliM2UyMDgyZjQ4OTA4N2I4NDA5ZWM2ZDEzNjdlXzQtMy0xLTEtOTA2MTg_fedee1a0-16ca-4373-a143-991d27a6657e">P6Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i573b811889c3495891ffd2a6cb11821d_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZToxNTE5YjNlMjA4MmY0ODkwODdiODQwOWVjNmQxMzY3ZS90YWJsZXJhbmdlOjE1MTliM2UyMDgyZjQ4OTA4N2I4NDA5ZWM2ZDEzNjdlXzUtMS0xLTEtOTA2MTg_a6acfbd2-02a6-455d-aa58-7de831ce0298"
      unitRef="number">0.980</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i03b32e37b4f7484ea3c2ae0cc21ee87c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZToxNTE5YjNlMjA4MmY0ODkwODdiODQwOWVjNmQxMzY3ZS90YWJsZXJhbmdlOjE1MTliM2UyMDgyZjQ4OTA4N2I4NDA5ZWM2ZDEzNjdlXzUtMy0xLTEtOTA2MTg_8658c6a2-3a79-4ef4-a0f5-886c0c36370d"
      unitRef="number">1.006</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i573b811889c3495891ffd2a6cb11821d_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZToxNTE5YjNlMjA4MmY0ODkwODdiODQwOWVjNmQxMzY3ZS90YWJsZXJhbmdlOjE1MTliM2UyMDgyZjQ4OTA4N2I4NDA5ZWM2ZDEzNjdlXzYtMS0xLTEtOTA2MTg_8055367b-d168-4fe5-a80c-6895cc000b26"
      unitRef="number">0.0109</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i03b32e37b4f7484ea3c2ae0cc21ee87c_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZToxNTE5YjNlMjA4MmY0ODkwODdiODQwOWVjNmQxMzY3ZS90YWJsZXJhbmdlOjE1MTliM2UyMDgyZjQ4OTA4N2I4NDA5ZWM2ZDEzNjdlXzYtMy0xLTEtOTA2MTg_8b1294ce-2e11-4df6-9700-d41489fefa26"
      unitRef="number">0.0056</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i573b811889c3495891ffd2a6cb11821d_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZToxNTE5YjNlMjA4MmY0ODkwODdiODQwOWVjNmQxMzY3ZS90YWJsZXJhbmdlOjE1MTliM2UyMDgyZjQ4OTA4N2I4NDA5ZWM2ZDEzNjdlXzctMS0xLTEtOTA2MTg_f056a3cd-2148-4b1d-ad32-43fdc19a4d15"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i03b32e37b4f7484ea3c2ae0cc21ee87c_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZToxNTE5YjNlMjA4MmY0ODkwODdiODQwOWVjNmQxMzY3ZS90YWJsZXJhbmdlOjE1MTliM2UyMDgyZjQ4OTA4N2I4NDA5ZWM2ZDEzNjdlXzctMy0xLTEtOTA2MTg_be30f48f-b321-4491-bfad-5d551a98bcca"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzI4OTQ_3499dcec-2f31-4a1c-858f-a12994c81b09"
      unitRef="usdPerShare">6.29</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzI5MDE_437754a1-7965-48fc-ad21-1b0743bc0d26"
      unitRef="usdPerShare">3.99</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i8891a21b42fd46edae0f2cb767f54ab4_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEwOTk1MTE2Mjg0NDE2_2952282e-d94d-4c92-a2c7-4255049ffd5a">P10Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
      contextRef="i8891a21b42fd46edae0f2cb767f54ab4_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEwOTk1MTE2Mjg0NDI5_15ea1398-383b-4e7e-9db7-2c83055582d2">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEwOTk1MTE2Mjg0Mzc4_84561739-c71b-4128-969f-6680d2a692b3">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSAs as of December&#160;31, 2021 and changes during the year ended December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nonvested Shares (thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding at January 1, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i11fb672b3c844ef88abb79b5adf6a2f6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpjMzhhN2RlZmE0Nzg0NmU1YWFhMjY0ZTkyMDI1NWRiOC90YWJsZXJhbmdlOmMzOGE3ZGVmYTQ3ODQ2ZTVhYWEyNjRlOTIwMjU1ZGI4XzEtMS0xLTEtOTA2MTg_62979af0-9fed-401d-b8e4-3f04e6e10095"
      unitRef="shares">325000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i11fb672b3c844ef88abb79b5adf6a2f6_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpjMzhhN2RlZmE0Nzg0NmU1YWFhMjY0ZTkyMDI1NWRiOC90YWJsZXJhbmdlOmMzOGE3ZGVmYTQ3ODQ2ZTVhYWEyNjRlOTIwMjU1ZGI4XzEtMy0xLTEtOTA2MTg_aae6e742-8fd2-4ef6-8ef4-28e9d966ec06"
      unitRef="usdPerShare">4.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i8891a21b42fd46edae0f2cb767f54ab4_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpjMzhhN2RlZmE0Nzg0NmU1YWFhMjY0ZTkyMDI1NWRiOC90YWJsZXJhbmdlOmMzOGE3ZGVmYTQ3ODQ2ZTVhYWEyNjRlOTIwMjU1ZGI4XzItMS0xLTEtOTA2MTg_9a0f6eb5-cae1-427d-b094-3140c172f7b6"
      unitRef="shares">281000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i8891a21b42fd46edae0f2cb767f54ab4_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpjMzhhN2RlZmE0Nzg0NmU1YWFhMjY0ZTkyMDI1NWRiOC90YWJsZXJhbmdlOmMzOGE3ZGVmYTQ3ODQ2ZTVhYWEyNjRlOTIwMjU1ZGI4XzItMy0xLTEtOTA2MTg_8f48d20e-a8d6-4564-bd00-3fa4ffe505e4"
      unitRef="usdPerShare">4.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i8891a21b42fd46edae0f2cb767f54ab4_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpjMzhhN2RlZmE0Nzg0NmU1YWFhMjY0ZTkyMDI1NWRiOC90YWJsZXJhbmdlOmMzOGE3ZGVmYTQ3ODQ2ZTVhYWEyNjRlOTIwMjU1ZGI4XzMtMS0xLTEtOTA2MTg_9c4ff371-a1ba-4985-875b-c4501093a63a"
      unitRef="shares">26000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i8891a21b42fd46edae0f2cb767f54ab4_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpjMzhhN2RlZmE0Nzg0NmU1YWFhMjY0ZTkyMDI1NWRiOC90YWJsZXJhbmdlOmMzOGE3ZGVmYTQ3ODQ2ZTVhYWEyNjRlOTIwMjU1ZGI4XzMtMy0xLTEtOTA2MTg_aa35a09a-7689-4449-8a9f-7fcd3fac2d43"
      unitRef="usdPerShare">4.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i9d8b29d6eda64dde944469b96c9e6f69_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpjMzhhN2RlZmE0Nzg0NmU1YWFhMjY0ZTkyMDI1NWRiOC90YWJsZXJhbmdlOmMzOGE3ZGVmYTQ3ODQ2ZTVhYWEyNjRlOTIwMjU1ZGI4XzQtMS0xLTEtOTA2MTg_1663d632-06ab-4e85-908a-bbe59abac6da"
      unitRef="shares">580000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i9d8b29d6eda64dde944469b96c9e6f69_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90YWJsZTpjMzhhN2RlZmE0Nzg0NmU1YWFhMjY0ZTkyMDI1NWRiOC90YWJsZXJhbmdlOmMzOGE3ZGVmYTQ3ODQ2ZTVhYWEyNjRlOTIwMjU1ZGI4XzQtMy0xLTEtOTA2MTg_c193b501-6da0-46fe-bf82-6f072515ad0b"
      unitRef="usdPerShare">4.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i803b263ea3554c628c2b2cd7af31afde_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEwOTk1MTE2Mjg0NDcz_14a14f19-b859-47f7-848d-487050247b90"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8891a21b42fd46edae0f2cb767f54ab4_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODEvZnJhZzo5MGU0ZjMyZmIwNmE0OTM0OTBiZjU2ODg3OTQ0ZDBiNi90ZXh0cmVnaW9uOjkwZTRmMzJmYjA2YTQ5MzQ5MGJmNTY4ODc5NDRkMGI2XzEwOTk1MTE2Mjg0NDcz_73bd7ec2-62eb-4364-963a-5bad5eaf0f12"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EquityMethodInvestments
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODgvZnJhZzo2ZmQ2MWFmNTE5ODA0OTcwOWE2NWMxNjM0ZGZkMjNiOS90ZXh0cmVnaW9uOjZmZDYxYWY1MTk4MDQ5NzA5YTY1YzE2MzRkZmQyM2I5XzE1Mg_01521cfc-301d-4e22-97a0-180f07e0d52a"
      unitRef="usd">24752000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODgvZnJhZzo2ZmQ2MWFmNTE5ODA0OTcwOWE2NWMxNjM0ZGZkMjNiOS90ZXh0cmVnaW9uOjZmZDYxYWY1MTk4MDQ5NzA5YTY1YzE2MzRkZmQyM2I5XzE1OQ_0755ea81-bdeb-4546-a332-3e1ebbf772fe"
      unitRef="usd">23217000</us-gaap:EquityMethodInvestments>
    <us-gaap:AccountsReceivableNet
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODgvZnJhZzo2ZmQ2MWFmNTE5ODA0OTcwOWE2NWMxNjM0ZGZkMjNiOS90ZXh0cmVnaW9uOjZmZDYxYWY1MTk4MDQ5NzA5YTY1YzE2MzRkZmQyM2I5XzIxOA_e1e0e8d5-5118-4933-bef3-26cda7900629"
      unitRef="usd">1071000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODgvZnJhZzo2ZmQ2MWFmNTE5ODA0OTcwOWE2NWMxNjM0ZGZkMjNiOS90ZXh0cmVnaW9uOjZmZDYxYWY1MTk4MDQ5NzA5YTY1YzE2MzRkZmQyM2I5XzIyNQ_9406913e-5ae2-4db7-b13a-8ebe8d32b966"
      unitRef="usd">3257000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODgvZnJhZzo2ZmQ2MWFmNTE5ODA0OTcwOWE2NWMxNjM0ZGZkMjNiOS90ZXh0cmVnaW9uOjZmZDYxYWY1MTk4MDQ5NzA5YTY1YzE2MzRkZmQyM2I5XzM3NQ_4a903ee4-b0b6-4678-b57f-1250afd4dad6"
      unitRef="usd">2575000</us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODgvZnJhZzo2ZmQ2MWFmNTE5ODA0OTcwOWE2NWMxNjM0ZGZkMjNiOS90ZXh0cmVnaW9uOjZmZDYxYWY1MTk4MDQ5NzA5YTY1YzE2MzRkZmQyM2I5XzM3NQ_5f4bba26-e211-4a5d-8f3d-35c3e9a54bb3"
      unitRef="usd">2575000</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i4de62ab3a564461880c512002a30b250_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODgvZnJhZzo2ZmQ2MWFmNTE5ODA0OTcwOWE2NWMxNjM0ZGZkMjNiOS90ZXh0cmVnaW9uOjZmZDYxYWY1MTk4MDQ5NzA5YTY1YzE2MzRkZmQyM2I5XzEyODQ_1197bd07-9dfd-4c29-a9fc-bdd5500767a8"
      unitRef="usd">495000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i75c056609d254c53af9c29c67d99d60b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODgvZnJhZzo2ZmQ2MWFmNTE5ODA0OTcwOWE2NWMxNjM0ZGZkMjNiOS90ZXh0cmVnaW9uOjZmZDYxYWY1MTk4MDQ5NzA5YTY1YzE2MzRkZmQyM2I5XzEyOTE_7eb9893c-c78b-411d-b644-f03ace062610"
      unitRef="usd">285000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="id905c833627b4121b886db6e813419df_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODgvZnJhZzo2ZmQ2MWFmNTE5ODA0OTcwOWE2NWMxNjM0ZGZkMjNiOS90ZXh0cmVnaW9uOjZmZDYxYWY1MTk4MDQ5NzA5YTY1YzE2MzRkZmQyM2I5XzE2Nzk_6eed7976-f772-452a-9b01-7eea8d65adf7"
      unitRef="usd">428000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="iae076a6656ae43ecb5bd532f5ce42d8c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODgvZnJhZzo2ZmQ2MWFmNTE5ODA0OTcwOWE2NWMxNjM0ZGZkMjNiOS90ZXh0cmVnaW9uOjZmZDYxYWY1MTk4MDQ5NzA5YTY1YzE2MzRkZmQyM2I5XzE2ODY_e84f4214-8749-4148-ac7d-0c3907f4f063"
      unitRef="usd">2740000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="ifcbed162e9304111b3a8a6214d89a1d1_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODgvZnJhZzo2ZmQ2MWFmNTE5ODA0OTcwOWE2NWMxNjM0ZGZkMjNiOS90ZXh0cmVnaW9uOjZmZDYxYWY1MTk4MDQ5NzA5YTY1YzE2MzRkZmQyM2I5XzEyNjQ0MzgzNzIyMzcy_24f7acf4-08ed-434d-bf95-4da094be4d97"
      unitRef="usd">282000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i28298076d77146a590f9bd3e1debbf12_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODgvZnJhZzo2ZmQ2MWFmNTE5ODA0OTcwOWE2NWMxNjM0ZGZkMjNiOS90ZXh0cmVnaW9uOjZmZDYxYWY1MTk4MDQ5NzA5YTY1YzE2MzRkZmQyM2I5XzEyNjQ0MzgzNzIyMzc4_7cdedf47-a972-435d-a218-38be9bae9c42"
      unitRef="usd">156000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="ifcbed162e9304111b3a8a6214d89a1d1_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODgvZnJhZzo2ZmQ2MWFmNTE5ODA0OTcwOWE2NWMxNjM0ZGZkMjNiOS90ZXh0cmVnaW9uOjZmZDYxYWY1MTk4MDQ5NzA5YTY1YzE2MzRkZmQyM2I5XzEyNjQ0MzgzNzIyMzU4_acc1be3c-87b5-4a02-9ff8-9047fe0bb483"
      unitRef="usd">1223000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i28298076d77146a590f9bd3e1debbf12_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80ODgvZnJhZzo2ZmQ2MWFmNTE5ODA0OTcwOWE2NWMxNjM0ZGZkMjNiOS90ZXh0cmVnaW9uOjZmZDYxYWY1MTk4MDQ5NzA5YTY1YzE2MzRkZmQyM2I5XzEyNjQ0MzgzNzIyMzY2_078481bb-b04a-4a6b-a082-8bb70ec9735e"
      unitRef="usd">242000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTIvZnJhZzpkMzY5MTUzZDU1ODM0MzY2OWRmYzI3YjRmNzUyMTFhZC90ZXh0cmVnaW9uOmQzNjkxNTNkNTU4MzQzNjY5ZGZjMjdiNGY3NTIxMWFkXzExMA_221c5847-09c8-4ac5-b97f-3a057c216f0f"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTIvZnJhZzpkMzY5MTUzZDU1ODM0MzY2OWRmYzI3YjRmNzUyMTFhZC90ZXh0cmVnaW9uOmQzNjkxNTNkNTU4MzQzNjY5ZGZjMjdiNGY3NTIxMWFkXzExMA_8f598eb1-3018-4f3c-b71f-196dce453160"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <amci:TemporaryEquityNumberOfVotesPerShare
      contextRef="i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTIvZnJhZzpkMzY5MTUzZDU1ODM0MzY2OWRmYzI3YjRmNzUyMTFhZC90ZXh0cmVnaW9uOmQzNjkxNTNkNTU4MzQzNjY5ZGZjMjdiNGY3NTIxMWFkXzEwOTk1MTE2Mjc4Mzg4_d824e453-a833-4b18-a323-b832be745ae3"
      unitRef="vote">1</amci:TemporaryEquityNumberOfVotesPerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="iac85d16334474caf87d510d9eb18ff97_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzItMS0xLTEtOTA2MTg_e7d6899c-3f0e-47ce-93d5-6574ff5f2450"
      unitRef="shares">4666503</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="iac85d16334474caf87d510d9eb18ff97_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzItMy0xLTEtOTA2MTg_0dcb58b4-463e-47b0-91e0-7f270a23ed07"
      unitRef="shares">4666503</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="iac85d16334474caf87d510d9eb18ff97_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzItMy0xLTEtOTA2MTg_7f21e596-96c3-4951-9152-41bfc2d4f553"
      unitRef="shares">4666503</us-gaap:TemporaryEquitySharesOutstanding>
    <amci:TemporaryEquityIssuePricePerShare
      contextRef="i8a9c59f1273542b8ab3e8255d224f529_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzItNS0xLTEtOTA2MTgvdGV4dHJlZ2lvbjpiZmFjNzM4MWYzZDU0YWJhYjJhNzMyYWI3NzM5MWFmMl81NDk3NTU4MTM5MDk_a18cc782-38b5-48b8-81e7-0ce4e087259e"
      unitRef="usdPerShare">1.75</amci:TemporaryEquityIssuePricePerShare>
    <amci:TemporaryEquityIssuePricePerShare
      contextRef="i1b658f2ff91349b3beaa5d4bd56ba109_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzItNS0xLTEtOTA2MTgvdGV4dHJlZ2lvbjpiZmFjNzM4MWYzZDU0YWJhYjJhNzMyYWI3NzM5MWFmMl81NDk3NTU4MTM5MTY_e53f1854-8446-4f0f-9aaa-00a1d60c9cc4"
      unitRef="usdPerShare">3.94</amci:TemporaryEquityIssuePricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="iac85d16334474caf87d510d9eb18ff97_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzItNy0xLTEtOTA2MTg_99fb48f7-4c3f-4f96-b96f-f2c169fc3f58"
      unitRef="usd">12230000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i579053a3cd4d442382bdb8ffa9a87db6_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzMtMS0xLTEtOTA2MTg_2a562577-4099-4dfe-af41-3357100b55aa"
      unitRef="shares">1733370</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i579053a3cd4d442382bdb8ffa9a87db6_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzMtMy0xLTEtOTA2MTg_8105e51b-1daa-488d-9d33-646f92bc149c"
      unitRef="shares">1733370</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i579053a3cd4d442382bdb8ffa9a87db6_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzMtMy0xLTEtOTA2MTg_9ce462da-6894-43d6-ad43-a4d5577a2860"
      unitRef="shares">1733370</us-gaap:TemporaryEquitySharesIssued>
    <amci:TemporaryEquityIssuePricePerShare
      contextRef="i579053a3cd4d442382bdb8ffa9a87db6_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzMtNS0xLTEtOTA2MTg_6c810dda-5c8d-4c01-99fa-e1b4b7fb9990"
      unitRef="usdPerShare">10.38</amci:TemporaryEquityIssuePricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i579053a3cd4d442382bdb8ffa9a87db6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzMtNy0xLTEtOTA2MTg_5767f11b-0119-495c-a5fa-0b4881bc4945"
      unitRef="usd">18000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i51d874e0b5b94c329952825293416b35_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzQtMS0xLTEtOTA2MTg_7f3f0fd5-b475-44f4-b6f0-147f7d56a8c4"
      unitRef="shares">4254733</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i51d874e0b5b94c329952825293416b35_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzQtMy0xLTEtOTA2MTg_005d8e48-8e93-444a-aa9b-cd31e589c4fa"
      unitRef="shares">4142408</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i51d874e0b5b94c329952825293416b35_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzQtMy0xLTEtOTA2MTg_31419515-79d2-4561-99fb-93ee0ac06ee8"
      unitRef="shares">4142408</us-gaap:TemporaryEquitySharesIssued>
    <amci:TemporaryEquityIssuePricePerShare
      contextRef="i51d874e0b5b94c329952825293416b35_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzQtNS0xLTEtOTA2MTg_a2cf795f-2f59-449b-86bf-3dd5adbf31c1"
      unitRef="usdPerShare">14.69</amci:TemporaryEquityIssuePricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i51d874e0b5b94c329952825293416b35_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzQtNy0xLTEtOTA2MTg_e6db881f-d94b-4dfa-afec-1c4eb9f42aad"
      unitRef="usd">60850000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i6147091081d14d69be73064143508062_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzUtMS0xLTEtOTA2MTg_b52daf12-dcc8-419e-a5b3-f780568c426c"
      unitRef="shares">10274260</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i6147091081d14d69be73064143508062_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzUtMy0xLTEtOTA2MTg_0458a0ed-7b35-4ab5-98a3-4bad49deb5f4"
      unitRef="shares">10161362</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i6147091081d14d69be73064143508062_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzUtMy0xLTEtOTA2MTg_83f5241d-e3e7-4d90-aa35-2006f2192479"
      unitRef="shares">10161362</us-gaap:TemporaryEquitySharesOutstanding>
    <amci:TemporaryEquityIssuePricePerShare
      contextRef="i6147091081d14d69be73064143508062_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzUtNS0xLTEtOTA2MTg_76b2ce9f-923f-49c4-be2d-55cd1a2c6e17"
      unitRef="usdPerShare">19.93</amci:TemporaryEquityIssuePricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i6147091081d14d69be73064143508062_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzUtNy0xLTEtOTA2MTg_8d367a9f-9d2b-4da5-858e-ffa53b9b95c5"
      unitRef="usd">188402000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i75249f1eb69a41749449ae454de51fed_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzYtMS0xLTEtOTA2MTg_8e171d4f-7892-4703-853e-bfe40056183a"
      unitRef="shares">5183957</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i75249f1eb69a41749449ae454de51fed_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzYtMy0xLTEtOTA2MTg_0f6817c9-9656-4a55-a4c9-fe1274e85749"
      unitRef="shares">5183957</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i75249f1eb69a41749449ae454de51fed_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzYtMy0xLTEtOTA2MTg_b7f88a60-f154-47a1-abe2-c3eee374bcce"
      unitRef="shares">5183957</us-gaap:TemporaryEquitySharesIssued>
    <amci:TemporaryEquityIssuePricePerShare
      contextRef="i75249f1eb69a41749449ae454de51fed_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzYtNS0xLTEtOTA2MTg_fbe4f73d-81fd-4ccd-a2eb-61d41cd6e226"
      unitRef="usdPerShare">22.86</amci:TemporaryEquityIssuePricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i75249f1eb69a41749449ae454de51fed_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzYtNy0xLTEtOTA2MTg_7fc2595e-742e-444e-9e01-2d2d05b25227"
      unitRef="usd">118076000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i9c54836fffa1449f85209e9cddadc72d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzctMS0xLTEtOTA2MTg_d712eed9-189a-4322-958f-a11556360e22"
      unitRef="shares">3634210</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i9c54836fffa1449f85209e9cddadc72d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzctMy0xLTEtOTA2MTg_dba7ac8b-7417-4a03-a358-8058b3ab8865"
      unitRef="shares">3634210</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i9c54836fffa1449f85209e9cddadc72d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzctMy0xLTEtOTA2MTg_f32731f4-4078-4063-8d69-2109b3129af7"
      unitRef="shares">3634210</us-gaap:TemporaryEquitySharesOutstanding>
    <amci:TemporaryEquityIssuePricePerShare
      contextRef="i9c54836fffa1449f85209e9cddadc72d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzctNS0xLTEtOTA2MTg_675198ab-14c4-4786-8f32-b65adf8bc96d"
      unitRef="usdPerShare">22.86</amci:TemporaryEquityIssuePricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i9c54836fffa1449f85209e9cddadc72d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzctNy0xLTEtOTA2MTg_69095c12-7771-44d1-ad4d-a0c8318ff6d1"
      unitRef="usd">83073000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzgtMS0xLTEtMTAzOTMx_6433ca6e-ed26-4420-b32d-7ae16245a737"
      unitRef="shares">29747033</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzgtMy0xLTEtMTAzOTM1_36a6fe36-c042-4eff-974c-84f767bd7b27"
      unitRef="shares">29521810</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzgtMy0xLTEtMTAzOTM1_ab7b9c99-b388-402c-a45c-93c6d8f8b849"
      unitRef="shares">29521810</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo3Yzg3MWM1MjM5YWU0NDY2OGMxZDg0MTRhM2FkZmUxZS90YWJsZXJhbmdlOjdjODcxYzUyMzlhZTQ0NjY4YzFkODQxNGEzYWRmZTFlXzgtNy0xLTEtMTAzOTM4_6132638c-ccdf-42f5-a95b-1079331e78da"
      unitRef="usd">480631000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="icae471cb37e8404291aadc66b866dff7_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzItMS0xLTEtOTA2MTg_a123593c-ae60-40f8-a08b-c580b07ed266"
      unitRef="shares">4666503</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="icae471cb37e8404291aadc66b866dff7_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzItMy0xLTEtOTA2MTg_5494fc29-f8dc-49c9-8033-26ba2b198427"
      unitRef="shares">4666503</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="icae471cb37e8404291aadc66b866dff7_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzItMy0xLTEtOTA2MTg_d707c45b-0510-4a98-b6c1-d708442fece0"
      unitRef="shares">4666503</us-gaap:TemporaryEquitySharesOutstanding>
    <amci:TemporaryEquityIssuePricePerShare
      contextRef="icbd1a0745c954062aab7bb0d81157304_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzItNS0xLTEtOTA2MTgvdGV4dHJlZ2lvbjphZjczYTdjYTVjZTg0ZTA4YjVjODA1Yzg1ODg2YjUwM181NDk3NTU4MTM5MDk_ecd1a6fe-0a1d-4bc1-addc-b3100fc0276d"
      unitRef="usdPerShare">1.75</amci:TemporaryEquityIssuePricePerShare>
    <amci:TemporaryEquityIssuePricePerShare
      contextRef="ice5b7039b91e4ef49110749cb0d4f41b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzItNS0xLTEtOTA2MTgvdGV4dHJlZ2lvbjphZjczYTdjYTVjZTg0ZTA4YjVjODA1Yzg1ODg2YjUwM181NDk3NTU4MTM5MTY_dfa80275-6209-4617-b37a-91174371c608"
      unitRef="usdPerShare">3.94</amci:TemporaryEquityIssuePricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="icae471cb37e8404291aadc66b866dff7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzItNy0xLTEtOTA2MTg_d300e775-93a4-4509-a551-e4d778dd9a5e"
      unitRef="usd">12230000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="if0affa519b5d4e0aae8d04132534645a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzMtMS0xLTEtOTA2MTg_5d942941-fca0-438f-bb6a-e58d7c434953"
      unitRef="shares">1733370</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="if0affa519b5d4e0aae8d04132534645a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzMtMy0xLTEtOTA2MTg_782408eb-16da-435f-88c1-e0dd8a368be3"
      unitRef="shares">1733370</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="if0affa519b5d4e0aae8d04132534645a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzMtMy0xLTEtOTA2MTg_fe16c32f-484b-4723-990b-f29fab7f4852"
      unitRef="shares">1733370</us-gaap:TemporaryEquitySharesIssued>
    <amci:TemporaryEquityIssuePricePerShare
      contextRef="if0affa519b5d4e0aae8d04132534645a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzMtNS0xLTEtOTA2MTg_d96bae44-4ce1-4e08-82ca-6722cba1fb03"
      unitRef="usdPerShare">10.38</amci:TemporaryEquityIssuePricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="if0affa519b5d4e0aae8d04132534645a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzMtNy0xLTEtOTA2MTg_1b4438cd-f542-48c6-a103-6fbbede451fc"
      unitRef="usd">18000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i74eaaed6f417404bb146455ed9642f5a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzQtMS0xLTEtOTA2MTg_88ec5197-aa4d-48b8-8d14-ef73aaabe892"
      unitRef="shares">4254733</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i74eaaed6f417404bb146455ed9642f5a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzQtMy0xLTEtOTA2MTg_5e4783dc-f20c-4606-bd41-0807f1a2ef6c"
      unitRef="shares">4142408</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i74eaaed6f417404bb146455ed9642f5a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzQtMy0xLTEtOTA2MTg_8797e2c7-94f0-48c2-ae78-c17faaa9fb03"
      unitRef="shares">4142408</us-gaap:TemporaryEquitySharesOutstanding>
    <amci:TemporaryEquityIssuePricePerShare
      contextRef="i74eaaed6f417404bb146455ed9642f5a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzQtNS0xLTEtOTA2MTg_960ae2a2-3ca3-4b53-be49-4a399db46328"
      unitRef="usdPerShare">14.69</amci:TemporaryEquityIssuePricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i74eaaed6f417404bb146455ed9642f5a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzQtNy0xLTEtOTA2MTg_a9a5f7c3-f0d5-4022-87be-2857a1f531c4"
      unitRef="usd">60850000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="iea72673f89f344d5a288193ba7de0128_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzUtMS0xLTEtOTA2MTg_366cf9e6-c409-4fef-96ac-0cc347d0d14d"
      unitRef="shares">10274260</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="iea72673f89f344d5a288193ba7de0128_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzUtMy0xLTEtOTA2MTg_6cda9385-fec9-4b59-b0c5-7116c596a778"
      unitRef="shares">10003304</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="iea72673f89f344d5a288193ba7de0128_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzUtMy0xLTEtOTA2MTg_cd10460c-07ec-4acc-b331-068bf536b475"
      unitRef="shares">10003304</us-gaap:TemporaryEquitySharesOutstanding>
    <amci:TemporaryEquityIssuePricePerShare
      contextRef="iea72673f89f344d5a288193ba7de0128_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzUtNS0xLTEtOTA2MTg_d0243d75-deea-40cf-b6d0-0f9c525c639d"
      unitRef="usdPerShare">19.93</amci:TemporaryEquityIssuePricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="iea72673f89f344d5a288193ba7de0128_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzUtNy0xLTEtOTA2MTg_adf0e7ac-befd-4b69-bd74-7f0a4eb2a73f"
      unitRef="usd">185252000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="ie65b1b4339964ae0830003a7a95f3358_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzYtMS0xLTEtOTA2MTg_e209d18c-2613-4f58-9e1f-5192fa1967d3"
      unitRef="shares">5183957</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="ie65b1b4339964ae0830003a7a95f3358_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzYtMy0xLTEtOTA2MTg_76bf0950-4f64-4a00-877a-a90e2311f970"
      unitRef="shares">5183957</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ie65b1b4339964ae0830003a7a95f3358_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzYtMy0xLTEtOTA2MTg_7b1fb6af-6d4a-4b5e-8345-dcf7f17402ff"
      unitRef="shares">5183957</us-gaap:TemporaryEquitySharesOutstanding>
    <amci:TemporaryEquityIssuePricePerShare
      contextRef="ie65b1b4339964ae0830003a7a95f3358_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzYtNS0xLTEtOTA2MTg_e978b490-b95c-4e8e-ba1a-c42a5d7fb1dd"
      unitRef="usdPerShare">22.86</amci:TemporaryEquityIssuePricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ie65b1b4339964ae0830003a7a95f3358_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzYtNy0xLTEtOTA2MTg_1cee6207-785f-4b14-a1a8-e56d2b89b50c"
      unitRef="usd">118076000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzctMS0xLTEtMTAzOTQ2_06c80540-0906-4949-aa32-2e714864966a"
      unitRef="shares">26112823</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzctMy0xLTEtMTAzOTQ4_235f836e-901d-4560-b770-050e54ad0c92"
      unitRef="shares">25729542</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzctMy0xLTEtMTAzOTQ4_58786c75-857f-41fc-95cd-b3adfc82c3f4"
      unitRef="shares">25729542</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo0NmQzYjYxYjY1NTY0MDQ1OWY2M2JjMDMwNmJkYTg3ZC90YWJsZXJhbmdlOjQ2ZDNiNjFiNjU1NjQwNDU5ZjYzYmMwMzA2YmRhODdkXzctNy0xLTEtMTAzOTUx_1b87007f-fed5-4849-9e29-cbb8131b1406"
      unitRef="usd">394408000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i90db5fda8f064408a48fcdc8d953f421_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzMtMS0xLTEtMTAzOTU3_96196587-39aa-400b-983b-b785d54926c2"
      unitRef="shares">4666503</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i90db5fda8f064408a48fcdc8d953f421_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzMtMy0xLTEtMTAzOTU3_dc80ce45-bde6-40fe-a76a-429d358ad0fb"
      unitRef="usd">12230000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i203a431eb37944ba9970e49c1a8973a0_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzMtNS0xLTEtMTAzOTYx_0e1a4494-344d-405d-b618-97aab898e55b"
      unitRef="shares">1733370</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i203a431eb37944ba9970e49c1a8973a0_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzMtNy0xLTEtMTAzOTYx_9edeba73-ead8-4435-9753-e813ed6ffa9a"
      unitRef="usd">18000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ice29ee32562f4fbcacd93b5434eb9059_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzMtOS0xLTEtMTAzOTYz_4c9bcfe3-c7da-4c95-88be-24fbf1d20d1e"
      unitRef="shares">4142408</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ice29ee32562f4fbcacd93b5434eb9059_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzMtMTEtMS0xLTEwMzk2Mw_fd329b72-f318-4183-9796-ef0d839b5222"
      unitRef="usd">60850000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i60f5e9b899c3402e921d693b6d34e7db_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzMtMTMtMS0xLTEwMzk2Nw_b806fb35-a654-439a-a57b-f55ce41e5f17"
      unitRef="shares">10003304</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i60f5e9b899c3402e921d693b6d34e7db_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzMtMTUtMS0xLTEwMzk2Nw_17c27544-d5b3-4ffa-9708-472072196510"
      unitRef="usd">185252000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i3639631deb4141b89e868bff198a8abe_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzMtMTctMS0xLTEwMzk3MA_85153eaf-2922-451d-be3c-e0e4e289bc3a"
      unitRef="shares">3149745</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i3639631deb4141b89e868bff198a8abe_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzMtMTktMS0xLTEwMzk3MA_a728b6ba-e6c5-49ca-9803-47cae70a8ceb"
      unitRef="usd">71606000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i27b40d5ba4e24322ad9e1de0fd9901c5_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzMtMjEtMS0xLTEwMzk3Mg_38b3ebf3-4d82-4671-a40a-0512916989f9"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i27b40d5ba4e24322ad9e1de0fd9901c5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzMtMjMtMS0xLTEwMzk3Mg_7455d014-dd24-4efe-bce0-9a864f9dbf32"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i946f64f7009a4a2082ea5e8ea9ae0377_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzMtMjUtMS0xLTEwMzk3Ng_fc356742-e503-4d33-83ca-e5f5af23d088"
      unitRef="shares">23695330</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i946f64f7009a4a2082ea5e8ea9ae0377_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzMtMjctMS0xLTEwMzk3Ng_c35a2ffd-3fce-435f-934c-91c54e80909a"
      unitRef="usd">347938000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="i274b66feb9f24726acba535a568e1b1c_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzQtMS0xLTEtMTAzOTU3_5cfb9f39-c0fa-4d8a-97f6-c0667699d371"
      unitRef="shares">0</amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="i274b66feb9f24726acba535a568e1b1c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzQtMy0xLTEtMTAzOTU3_20aaa251-926a-4e64-8cbf-bc33ac9d3805"
      unitRef="usd">0</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="id2fd472d035b4442864a247790745af2_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzQtNS0xLTEtMTAzOTYx_8488f30b-4192-4031-bd89-0edfa9f89244"
      unitRef="shares">0</amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="id2fd472d035b4442864a247790745af2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzQtNy0xLTEtMTAzOTYx_e8753823-2e7d-4ee7-8222-18be0ee600a4"
      unitRef="usd">0</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="i004d3d6d81544e698359c68c43fc61d0_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzQtOS0xLTEtMTAzOTYz_7913eaa4-2365-40a4-91b2-4e21a8235de5"
      unitRef="shares">0</amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="i004d3d6d81544e698359c68c43fc61d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzQtMTEtMS0xLTEwMzk2Mw_e9de6a59-23e4-4e8f-8b45-3ddf687a3c34"
      unitRef="usd">0</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="i306c9af6b46045cb8fca7a2fca95e245_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzQtMTMtMS0xLTEwMzk2Nw_13b65a1b-dc45-4466-9a07-489e4e2669c7"
      unitRef="shares">0</amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="i306c9af6b46045cb8fca7a2fca95e245_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzQtMTUtMS0xLTEwMzk2Nw_1b088ee8-67c4-48c7-9997-ea8b4472fe53"
      unitRef="usd">0</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="i4d11321cc3a942239572275fcf381918_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzQtMTctMS0xLTEwMzk3MA_9ddfdda5-54e8-4df9-b1a1-505e89cd87bc"
      unitRef="shares">2034212</amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="i4d11321cc3a942239572275fcf381918_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzQtMTktMS0xLTEwMzk3MA_6e0a4b0a-802a-4557-846c-1e4384d41bf5"
      unitRef="usd">46470000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="i5c8efec04d224fbaa59158d2f94edd4d_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzQtMjEtMS0xLTEwMzk3Mg_29cefd93-ba2e-448e-aedc-cfc69dd916ca"
      unitRef="shares">0</amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="i5c8efec04d224fbaa59158d2f94edd4d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzQtMjMtMS0xLTEwMzk3Mg_86fab3c9-30a5-4a89-a89d-a188b0ff91df"
      unitRef="usd">0</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzQtMjUtMS0xLTEwMzk3Ng_5f99b6d6-cb13-4ba7-a8b7-da69b301016a"
      unitRef="shares">2034212</amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzQtMjctMS0xLTEwMzk3Ng_52db0a17-153c-4d95-9ffc-a8c1965cfc92"
      unitRef="usd">46470000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="icae471cb37e8404291aadc66b866dff7_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzUtMS0xLTEtMTAzOTU3_22842f6f-0a7f-4564-a733-bd05951d608b"
      unitRef="shares">4666503</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="icae471cb37e8404291aadc66b866dff7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzUtMy0xLTEtMTAzOTU3_76494529-c09f-4ae7-aad6-696b44d777fa"
      unitRef="usd">12230000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="if0affa519b5d4e0aae8d04132534645a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzUtNS0xLTEtMTAzOTYx_6b6d9236-a9a0-4762-9950-fdd12930e94a"
      unitRef="shares">1733370</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="if0affa519b5d4e0aae8d04132534645a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzUtNy0xLTEtMTAzOTYx_e321e629-a3c3-4ab7-8956-0ff7b8a2434b"
      unitRef="usd">18000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i74eaaed6f417404bb146455ed9642f5a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzUtOS0xLTEtMTAzOTYz_0e1c9f2f-bd7f-4e36-b48a-b54a59463978"
      unitRef="shares">4142408</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i74eaaed6f417404bb146455ed9642f5a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzUtMTEtMS0xLTEwMzk2Mw_e5990720-e68b-474d-9696-18b0f53f2efb"
      unitRef="usd">60850000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="iea72673f89f344d5a288193ba7de0128_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzUtMTMtMS0xLTEwMzk2Nw_a1898ee0-45e7-4535-ac71-1b47ab9bd02d"
      unitRef="shares">10003304</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="iea72673f89f344d5a288193ba7de0128_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzUtMTUtMS0xLTEwMzk2Nw_7dd3f318-146a-49f3-8946-8e409a4abc3e"
      unitRef="usd">185252000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ie65b1b4339964ae0830003a7a95f3358_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzUtMTctMS0xLTEwMzk3MA_b8fea4c3-7d45-41ee-b1cd-db7eaa42b76e"
      unitRef="shares">5183957</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ie65b1b4339964ae0830003a7a95f3358_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzUtMTktMS0xLTEwMzk3MA_4c4baf0d-2ac8-4b4f-9aa3-aab53cfcca06"
      unitRef="usd">118076000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i909eedca48974777b86ab5582898a5a8_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzUtMjEtMS0xLTEwMzk3Mg_3ac7e9b5-7bb0-442c-8981-34bf4e51456f"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i909eedca48974777b86ab5582898a5a8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzUtMjMtMS0xLTEwMzk3Mg_9ccaac41-edd3-4de5-a230-22455ae9191e"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzUtMjUtMS0xLTEwMzk3Ng_33b941a6-8ccc-4ae1-a1f8-86e77dbde46e"
      unitRef="shares">25729542</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzUtMjctMS0xLTEwMzk3Ng_4d62e153-5c87-478e-9f5a-42d2e6facae1"
      unitRef="usd">394408000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="i70266a51f6fd4149be790adbf96c3a30_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzYtMS0xLTEtOTA2MTg_419aa2d3-ef27-4258-a296-b82d3c5ef8bc"
      unitRef="shares">0</amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="i70266a51f6fd4149be790adbf96c3a30_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzYtMy0xLTEtOTA2MTg_5fcd54cc-8ff1-4051-ac3b-1b9e600b18b1"
      unitRef="usd">0</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="i76b836230c434467ac363b81bab66632_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzYtNS0xLTEtOTA2MTg_ee0dea95-d7b9-4ea2-ae0d-47269ea0be7f"
      unitRef="shares">0</amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="i76b836230c434467ac363b81bab66632_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzYtNy0xLTEtOTA2MTg_91e5d214-fe7b-4b29-b394-5c94927e9c8d"
      unitRef="usd">0</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="i695b4941729c41e48e97d09ddc96d4ac_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzYtOS0xLTEtOTA2MTg_4fc34525-f9e9-452b-8e3d-2836387ef3e4"
      unitRef="shares">0</amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="i695b4941729c41e48e97d09ddc96d4ac_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzYtMTEtMS0xLTkwNjE4_7f8a2e7d-4110-4e51-a834-6236cdcf950c"
      unitRef="usd">0</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="iabb8b1ba7cc04a52a91d508fcb565f43_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzYtMTMtMS0xLTkwNjE4_e6aa8cfe-bebc-4b7e-aae7-6a6c053af00c"
      unitRef="shares">158058</amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="iabb8b1ba7cc04a52a91d508fcb565f43_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzYtMTUtMS0xLTkwNjE4_4a797d38-494a-473d-a4b6-04f9645a6004"
      unitRef="usd">3150000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="idad7341fd7894a348248ac1892d2d548_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzYtMTctMS0xLTkwNjE4_61451b5b-1de2-4feb-9055-e1d65b39693e"
      unitRef="shares">0</amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="idad7341fd7894a348248ac1892d2d548_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzYtMTktMS0xLTkwNjE4_d9f1b336-3a98-4f5e-9c06-3387d7183b8c"
      unitRef="usd">0</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="i65a85eee2f814026a7777b50ae141b0b_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzYtMjEtMS0xLTkwNjE4_e50edadb-90c3-4b24-b054-d91979c823e7"
      unitRef="shares">3634210</amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="i65a85eee2f814026a7777b50ae141b0b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzYtMjMtMS0xLTkwNjE4_82a85272-5a78-4072-9571-d8ec26e94613"
      unitRef="usd">83073000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzYtMjUtMS0xLTEwMzk3Ng_2998f694-f1f2-46ae-a55a-c760298a069a"
      unitRef="shares">3792268</amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzYtMjctMS0xLTEwMzk3Ng_cee73ad1-3ab0-430c-86c1-a46df64a8f1c"
      unitRef="usd">86223000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="iac85d16334474caf87d510d9eb18ff97_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzctMS0xLTEtMTAzOTU3_4f1a162b-cc4d-4532-9d1a-a9060df3e07b"
      unitRef="shares">4666503</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="iac85d16334474caf87d510d9eb18ff97_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzctMy0xLTEtMTAzOTU3_d3d29862-b3ad-482d-85cd-c65bddb0d241"
      unitRef="usd">12230000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i579053a3cd4d442382bdb8ffa9a87db6_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzctNS0xLTEtMTAzOTYx_9efc3afb-45a7-40e5-a083-c93d7b81ec48"
      unitRef="shares">1733370</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i579053a3cd4d442382bdb8ffa9a87db6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzctNy0xLTEtMTAzOTYx_c3b07b02-b0a4-4c1d-9abb-dfebf74a98f8"
      unitRef="usd">18000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i51d874e0b5b94c329952825293416b35_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzctOS0xLTEtMTAzOTYz_34cfaaad-7711-4238-b605-357e29db66da"
      unitRef="shares">4142408</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i51d874e0b5b94c329952825293416b35_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzctMTEtMS0xLTEwMzk2Mw_f0b0a936-074e-49a5-9d2e-860e83e3169b"
      unitRef="usd">60850000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i6147091081d14d69be73064143508062_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzctMTMtMS0xLTEwMzk2Nw_96e7ce60-1822-4e4f-bac8-d15742b89c50"
      unitRef="shares">10161362</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i6147091081d14d69be73064143508062_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzctMTUtMS0xLTEwMzk2Nw_dfe0d866-0623-4082-ada2-957a8936698d"
      unitRef="usd">188402000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i75249f1eb69a41749449ae454de51fed_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzctMTctMS0xLTEwMzk3MA_b33b3a3a-53aa-406f-a7b0-f3e7eb131e05"
      unitRef="shares">5183957</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i75249f1eb69a41749449ae454de51fed_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzctMTktMS0xLTEwMzk3MA_9eb25c21-c994-4267-a3d1-07311ff35009"
      unitRef="usd">118076000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i9c54836fffa1449f85209e9cddadc72d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzctMjEtMS0xLTkwNjE4_56d73ba1-e7f2-4227-b291-9267025f3a02"
      unitRef="shares">3634210</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i9c54836fffa1449f85209e9cddadc72d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzctMjMtMS0xLTkwNjE4_ed552657-87ca-4016-b6ad-27ac8dd0a7fa"
      unitRef="usd">83073000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzctMjUtMS0xLTEwMzk3Ng_6aca8400-5cee-45dd-bf49-0dabc470e6c6"
      unitRef="shares">29521810</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90YWJsZTo1NjUyNDJiYTk4YmU0ZTEwYTVlNDZkZTA3NTRkOTFjYi90YWJsZXJhbmdlOjU2NTI0MmJhOThiZTRlMTBhNWU0NmRlMDc1NGQ5MWNiXzctMjctMS0xLTEwMzk3Ng_d0a80d7a-b30a-4cf6-adb2-54f15ef74a60"
      unitRef="usd">480631000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="ia53cc2675c474ab094ee86871334ac6e_D20200201-20200229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90ZXh0cmVnaW9uOjRjN2Y5MDQwMTVkODRiZDdiNGFiOTU4MGQwYjdhOTYwXzEzODc_fc6de623-aa44-4a67-ad9d-d7ff572a8b6a"
      unitRef="shares">2034212</amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="ia53cc2675c474ab094ee86871334ac6e_D20200201-20200229"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90ZXh0cmVnaW9uOjRjN2Y5MDQwMTVkODRiZDdiNGFiOTU4MGQwYjdhOTYwXzE0MzY_e9d6c13f-02f9-4ee8-a2b8-e8c8ec79da83"
      unitRef="usd">46470000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <amci:TemporaryEquityStockIssuedDuringPeriodPricePerShare
      contextRef="ia53cc2675c474ab094ee86871334ac6e_D20200201-20200229"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90ZXh0cmVnaW9uOjRjN2Y5MDQwMTVkODRiZDdiNGFiOTU4MGQwYjdhOTYwXzE0NDA_ee1b8f07-59ef-4267-ba1d-66b263bdc650"
      unitRef="usdPerShare">22.86</amci:TemporaryEquityStockIssuedDuringPeriodPricePerShare>
    <amci:TemporaryEquitySharesConversionOfConvertibleSecurities
      contextRef="i9f67793938594975ad7e63e3f8a4f312_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90ZXh0cmVnaW9uOjRjN2Y5MDQwMTVkODRiZDdiNGFiOTU4MGQwYjdhOTYwXzE1MTg_8525332d-3170-4341-83b7-390b93b4670d"
      unitRef="shares">158058</amci:TemporaryEquitySharesConversionOfConvertibleSecurities>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="i9f67793938594975ad7e63e3f8a4f312_D20210301-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90ZXh0cmVnaW9uOjRjN2Y5MDQwMTVkODRiZDdiNGFiOTU4MGQwYjdhOTYwXzE3MDQyNDMwMjM0ODYx_e6ba6be5-da57-4702-836a-309edafcfa57"
      unitRef="usd">3150000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <amci:TemporaryEquityStockIssuedDuringPeriodPricePerShare
      contextRef="i9f67793938594975ad7e63e3f8a4f312_D20210301-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90ZXh0cmVnaW9uOjRjN2Y5MDQwMTVkODRiZDdiNGFiOTU4MGQwYjdhOTYwXzEwOTk1MTE2MjgyMDc4_69cc02a9-2322-44ca-85e0-8e94cb6e0e8a"
      unitRef="usdPerShare">19.93</amci:TemporaryEquityStockIssuedDuringPeriodPricePerShare>
    <amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="i45b464fc79c145a2a521d5dd55876280_D20210401-20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90ZXh0cmVnaW9uOjRjN2Y5MDQwMTVkODRiZDdiNGFiOTU4MGQwYjdhOTYwXzE2NjI_4649de70-6da7-4a9b-960b-f4f5d6c67ec6"
      unitRef="shares">3634210</amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="i45b464fc79c145a2a521d5dd55876280_D20210401-20210430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90ZXh0cmVnaW9uOjRjN2Y5MDQwMTVkODRiZDdiNGFiOTU4MGQwYjdhOTYwXzE3MTU_967c829c-e99b-4cbb-aa8a-c4def402c379"
      unitRef="usd">83073000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <amci:TemporaryEquityStockIssuedDuringPeriodPricePerShare
      contextRef="i45b464fc79c145a2a521d5dd55876280_D20210401-20210430"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90ZXh0cmVnaW9uOjRjN2Y5MDQwMTVkODRiZDdiNGFiOTU4MGQwYjdhOTYwXzE3MTk_605c39de-53b1-4a6e-9fef-f7e9c9c74690"
      unitRef="usdPerShare">22.86</amci:TemporaryEquityStockIssuedDuringPeriodPricePerShare>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF80OTkvZnJhZzo0YzdmOTA0MDE1ZDg0YmQ3YjRhYjk1ODBkMGI3YTk2MC90ZXh0cmVnaW9uOjRjN2Y5MDQwMTVkODRiZDdiNGFiOTU4MGQwYjdhOTYwXzEyNjQ0MzgzNzIzNzIx_3f5afd6c-1fb9-424b-b5ef-71db1b1d4cd3"
      unitRef="number">0.08</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:DefinedBenefitPlanTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MDMvZnJhZzpiMGE2NjgxODAyNmY0NWUyOGY3MTk4ZTRmM2M5MzY2OS90ZXh0cmVnaW9uOmIwYTY2ODE4MDI2ZjQ1ZTI4ZjcxOThlNGYzYzkzNjY5XzE1OTQyOTE4NjAzMzg5_d62c9e4d-1b35-4f9d-94cf-c5b7e612ff24">Benefit PlansThe Company sponsors a 401(k) defined contribution retirement plan for the benefit of its employees, substantially all of whom are eligible to participate after meeting minimum qualifying requirements. Contributions to the plan are at the discretion of the Company. For the years ended December&#160;31, 2021 and 2020, the Company contributed $720 and $548, respectively, to the plan, which contributions are included within research and development expense in the consolidated statements of operations and comprehensive loss.</us-gaap:DefinedBenefitPlanTextBlock>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MDMvZnJhZzpiMGE2NjgxODAyNmY0NWUyOGY3MTk4ZTRmM2M5MzY2OS90ZXh0cmVnaW9uOmIwYTY2ODE4MDI2ZjQ1ZTI4ZjcxOThlNGYzYzkzNjY5XzM1MA_a4547216-c10e-46fc-8e03-955c98a94c90"
      unitRef="usd">720000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MDMvZnJhZzpiMGE2NjgxODAyNmY0NWUyOGY3MTk4ZTRmM2M5MzY2OS90ZXh0cmVnaW9uOmIwYTY2ODE4MDI2ZjQ1ZTI4ZjcxOThlNGYzYzkzNjY5XzM1Nw_29536b44-6e7a-462c-b8a9-e5ad9defee2b"
      unitRef="usd">548000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzEwOTk1MTE2Mjc5Njc0_ba1b5d92-7ca1-4584-a6ad-e2737757af8f">Leases &lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases certain office space and laboratory facilities. The Company&#x2019;s lease agreements typically do not contain any significant guarantees of asset values at the end of a lease, renewal options or restrictive covenants. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2019;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s adoption of ASC 842, Leases, all leases were classified as operating leases. During &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021 and 2020, t&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;he discount rate used in the calculation of lease liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;was 7.5%, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;which is the estimate of the rate of interest that the Company would have to pay to borrow on a collateralized basis over a similar term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total operating lease costs and variable lease costs for the years ended December&#160;31, 2021 and 2020 were $2,126 and $2,077 and $2,575 and $1,813, respectively. Cash paid for amounts included in the measurement of operating lease liabilities for the years ended December&#160;31, 2021 and 2020 was $2,059 and $1,765, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, lease payments for operating leases for the Company&#x2019;s office facility and laboratories are shown below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.279%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of weighted average remaining lease term and discount rate for all of the Company&#x2019;s operating leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessor Accounting&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020, the Company executed an agreement to lease certain land to a subsidiary of LanzaJet for a period of 10 years with an option to renew this lease for five additional periods of one year with minimum annual rent due. This agreement is accounted for as an operating lease. We recognize lease revenue on a straight-line basis over the life of the lease agreement. The following future minimum lease payments due to us from the lease agreement at December 31, 2021, is as follows (in thousands)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Lease revenue totaled $24 and $14 for the years ended December 31, 2021 and 2020.</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzEwOTk1MTE2Mjc5NzEx_1f93508d-288b-493c-b9ec-d7aff22276cd"
      unitRef="number">0.075</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzEwOTk1MTE2Mjc5NzEx_cd90eb9d-32d9-4f9e-a70f-26c30e2901a7"
      unitRef="number">0.075</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseCost
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzY3Mw_3deb38e4-8d3d-4418-b2a0-d62fcc741582"
      unitRef="usd">2126000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzY4MA_ee51c574-5dcb-453c-a6f2-c4b365338eb2"
      unitRef="usd">2077000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzY4Nw_db161f28-993f-4f74-8353-b3e81b8bf94e"
      unitRef="usd">2575000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzY5NA_9e3647a7-0797-4a5a-b8c0-ee61209da4b9"
      unitRef="usd">1813000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzgyNw_669ada02-7507-4724-94e0-b2ceabecce18"
      unitRef="usd">2059000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzgzNA_a73c5c93-f2bc-4375-ba2e-aec126bce4fa"
      unitRef="usd">1765000</us-gaap:LeaseCost>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzEwOTk1MTE2Mjc5NjY5_3f5133d0-f011-4435-9553-cb7b847c02d8">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, lease payments for operating leases for the Company&#x2019;s office facility and laboratories are shown below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.279%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTpiMDFkZjYzNWIyM2Y0YWY0OTYxMDhlODM4ODNmMTA2Ni90YWJsZXJhbmdlOmIwMWRmNjM1YjIzZjRhZjQ5NjEwOGU4Mzg4M2YxMDY2XzEtMS0xLTEtOTA2MTg_730122be-3137-4a92-a1ab-5bfcc62a8119"
      unitRef="usd">2366000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTpiMDFkZjYzNWIyM2Y0YWY0OTYxMDhlODM4ODNmMTA2Ni90YWJsZXJhbmdlOmIwMWRmNjM1YjIzZjRhZjQ5NjEwOGU4Mzg4M2YxMDY2XzItMS0xLTEtOTA2MTg_573ef46c-f3e3-420e-8c1f-346812359759"
      unitRef="usd">2413000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTpiMDFkZjYzNWIyM2Y0YWY0OTYxMDhlODM4ODNmMTA2Ni90YWJsZXJhbmdlOmIwMWRmNjM1YjIzZjRhZjQ5NjEwOGU4Mzg4M2YxMDY2XzMtMS0xLTEtOTA2MTg_8a219a6b-1feb-4d17-81b9-b0d67ad438ec"
      unitRef="usd">1039000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTpiMDFkZjYzNWIyM2Y0YWY0OTYxMDhlODM4ODNmMTA2Ni90YWJsZXJhbmdlOmIwMWRmNjM1YjIzZjRhZjQ5NjEwOGU4Mzg4M2YxMDY2XzQtMS0xLTEtOTA2MTg_737b9553-4156-463c-a7f9-b3d5c84ff5bb"
      unitRef="usd">0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTpiMDFkZjYzNWIyM2Y0YWY0OTYxMDhlODM4ODNmMTA2Ni90YWJsZXJhbmdlOmIwMWRmNjM1YjIzZjRhZjQ5NjEwOGU4Mzg4M2YxMDY2XzUtMS0xLTEtOTA2MTg_7a3a7204-bb69-420c-8b50-8c3c2687463a"
      unitRef="usd">0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTpiMDFkZjYzNWIyM2Y0YWY0OTYxMDhlODM4ODNmMTA2Ni90YWJsZXJhbmdlOmIwMWRmNjM1YjIzZjRhZjQ5NjEwOGU4Mzg4M2YxMDY2XzYtMS0xLTEtOTA2MTg_4dee4893-c22c-4bd4-b8a7-65b83b737bd1"
      unitRef="usd">0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTpiMDFkZjYzNWIyM2Y0YWY0OTYxMDhlODM4ODNmMTA2Ni90YWJsZXJhbmdlOmIwMWRmNjM1YjIzZjRhZjQ5NjEwOGU4Mzg4M2YxMDY2XzctMi0xLTEtMTA1NTQ1_12168446-512b-4f54-8fa6-55d20f6eac3d"
      unitRef="usd">5818000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTpiMDFkZjYzNWIyM2Y0YWY0OTYxMDhlODM4ODNmMTA2Ni90YWJsZXJhbmdlOmIwMWRmNjM1YjIzZjRhZjQ5NjEwOGU4Mzg4M2YxMDY2XzgtMS0xLTEtOTA2MTg_17af482e-1ea1-47e9-a2f4-548eb672aa77"
      unitRef="usd">485000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTpiMDFkZjYzNWIyM2Y0YWY0OTYxMDhlODM4ODNmMTA2Ni90YWJsZXJhbmdlOmIwMWRmNjM1YjIzZjRhZjQ5NjEwOGU4Mzg4M2YxMDY2XzktMi0xLTEtMTA1NTQ1_651266c3-ca15-479f-b4b3-a5a84fc0502a"
      unitRef="usd">5333000</us-gaap:OperatingLeaseLiability>
    <amci:AssetsAndLiabilitiesLesseeTableTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzEwOTk1MTE2Mjc5Njcw_4536995a-e033-4876-b6d6-782205cba4ef">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of weighted average remaining lease term and discount rate for all of the Company&#x2019;s operating leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</amci:AssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTowMjY2YTVjYjA3ODA0OWVkOTgwMjU1OTYxZGJjZTRlYi90YWJsZXJhbmdlOjAyNjZhNWNiMDc4MDQ5ZWQ5ODAyNTU5NjFkYmNlNGViXzItMS0xLTEtOTA2MTg_672c7a4a-cc0d-4413-96fe-58d00bf91e36">P2Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTowMjY2YTVjYjA3ODA0OWVkOTgwMjU1OTYxZGJjZTRlYi90YWJsZXJhbmdlOjAyNjZhNWNiMDc4MDQ5ZWQ5ODAyNTU5NjFkYmNlNGViXzItMy0xLTEtOTA2MTg_9c8ec383-d115-401b-8d8b-ae0402f80b5c">P3Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTowMjY2YTVjYjA3ODA0OWVkOTgwMjU1OTYxZGJjZTRlYi90YWJsZXJhbmdlOjAyNjZhNWNiMDc4MDQ5ZWQ5ODAyNTU5NjFkYmNlNGViXzMtMS0xLTEtOTA2MTg_d3715867-1953-4e16-a737-3c4512de75e0"
      unitRef="number">0.075</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ia996051c39e14c1c956460fb2675ae34_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTowMjY2YTVjYjA3ODA0OWVkOTgwMjU1OTYxZGJjZTRlYi90YWJsZXJhbmdlOjAyNjZhNWNiMDc4MDQ5ZWQ5ODAyNTU5NjFkYmNlNGViXzMtMy0xLTEtOTA2MTg_e609f3ea-4dc4-4cd4-a349-9d5a3109b665"
      unitRef="number">0.075</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LessorOperatingLeaseTermOfContract
      contextRef="ife262e1009764f0ebe3fdfe5ad4fb494_I20200531"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzEyNjQ0MzgzNzIxMzE3_a52f441a-d449-449e-86db-75b05e0bcda0">P10Y</us-gaap:LessorOperatingLeaseTermOfContract>
    <amci:LesssorOperatingLeaseNumberOfRenewalOptions
      contextRef="i8afc523d3a4c48d79839de0f31b51d9c_D20200501-20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzEwOTk1MTE2Mjc5Njkw_07fa8d93-85cd-4a7b-a540-283eca314d19"
      unitRef="renewal_option">5</amci:LesssorOperatingLeaseNumberOfRenewalOptions>
    <us-gaap:LessorOperatingLeaseRenewalTerm
      contextRef="ife262e1009764f0ebe3fdfe5ad4fb494_I20200531"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzEwOTk1MTE2Mjc5Njc2_d54ea6b7-da00-47ed-bf1c-50e99897506f">P1Y</us-gaap:LessorOperatingLeaseRenewalTerm>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock
      contextRef="i64d0962e6096455d8d081d939276b2bb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzEwOTk1MTE2Mjc5Njcx_0d3a91f3-bde1-41a1-90aa-2962212e8082">The following future minimum lease payments due to us from the lease agreement at December 31, 2021, is as follows (in thousands)&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTo0ZWEzNWY4NGZiNTk0NTIzYmU3ZjIwMzI4ZGYwYTYzZC90YWJsZXJhbmdlOjRlYTM1Zjg0ZmI1OTQ1MjNiZTdmMjAzMjhkZjBhNjNkXzEtMS0xLTEtOTA2MTg_a58adc9c-afdb-4b15-8683-6827b0513360"
      unitRef="usd">24000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTo0ZWEzNWY4NGZiNTk0NTIzYmU3ZjIwMzI4ZGYwYTYzZC90YWJsZXJhbmdlOjRlYTM1Zjg0ZmI1OTQ1MjNiZTdmMjAzMjhkZjBhNjNkXzItMS0xLTEtOTA2MTg_a887936f-e47f-419a-ad4e-f94c67dfe43a"
      unitRef="usd">24000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedThreeYears
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTo0ZWEzNWY4NGZiNTk0NTIzYmU3ZjIwMzI4ZGYwYTYzZC90YWJsZXJhbmdlOjRlYTM1Zjg0ZmI1OTQ1MjNiZTdmMjAzMjhkZjBhNjNkXzMtMS0xLTEtOTA2MTg_4d3c4969-256b-49b5-8227-230e13467490"
      unitRef="usd">24000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedThreeYears>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedFourYears
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTo0ZWEzNWY4NGZiNTk0NTIzYmU3ZjIwMzI4ZGYwYTYzZC90YWJsZXJhbmdlOjRlYTM1Zjg0ZmI1OTQ1MjNiZTdmMjAzMjhkZjBhNjNkXzQtMS0xLTEtOTA2MTg_087ad943-2464-4c41-9ea8-f795df3f7306"
      unitRef="usd">24000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedFourYears>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedFiveYears
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTo0ZWEzNWY4NGZiNTk0NTIzYmU3ZjIwMzI4ZGYwYTYzZC90YWJsZXJhbmdlOjRlYTM1Zjg0ZmI1OTQ1MjNiZTdmMjAzMjhkZjBhNjNkXzUtMS0xLTEtOTA2MTg_24ba9eaf-d05b-432b-a007-05e2a00c2717"
      unitRef="usd">24000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedFiveYears>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedThereafter
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTo0ZWEzNWY4NGZiNTk0NTIzYmU3ZjIwMzI4ZGYwYTYzZC90YWJsZXJhbmdlOjRlYTM1Zjg0ZmI1OTQ1MjNiZTdmMjAzMjhkZjBhNjNkXzYtMS0xLTEtOTA2MTg_e92cb201-82d6-4088-9bd6-0b8900976cf1"
      unitRef="usd">168000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedThereafter>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceived
      contextRef="i450b257d15c4448cabb4fa176b9c5882_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90YWJsZTo0ZWEzNWY4NGZiNTk0NTIzYmU3ZjIwMzI4ZGYwYTYzZC90YWJsZXJhbmdlOjRlYTM1Zjg0ZmI1OTQ1MjNiZTdmMjAzMjhkZjBhNjNkXzctMS0xLTEtOTA2MTg_a2d1b23d-f7c7-496f-a658-343601a8e48b"
      unitRef="usd">288000</us-gaap:LessorOperatingLeasePaymentsToBeReceived>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="i16f9490902b14332975939591b56c0ce_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzEyNjQ0MzgzNzIxMzA4_6fd04359-15da-483e-bfa1-d0eed8760424"
      unitRef="usd">24000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTQvZnJhZzo2MTFjZTA5OWYyNGQ0MDM2YWU4NDZmZmU5ZWM5ZGUzOS90ZXh0cmVnaW9uOjYxMWNlMDk5ZjI0ZDQwMzZhZTg0NmZmZTllYzlkZTM5XzEyNjQ0MzgzNzIxMzEz_84e8144c-fb83-446f-9caa-19c327012dc6"
      unitRef="usd">14000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:BusinessCombinationContingentConsiderationAssetCurrent
      contextRef="i3e4ce82bb6ca465b8f60e74f553154c0_I20220308"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmI4MmUxMTRjZDE5ZjQ1YWZhZTczZTdhNjRlNDJmMjA4L3NlYzpiODJlMTE0Y2QxOWY0NWFmYWU3M2U3YTY0ZTQyZjIwOF81MTgvZnJhZzo2ZDhmODMyMGU2NDU0MDgxYWE1NDZlODI0NjFjOGZmOS90ZXh0cmVnaW9uOjZkOGY4MzIwZTY0NTQwODFhYTU0NmU4MjQ2MWM4ZmY5XzEyNjQ0MzgzNzIwOTEw_2d3fc55d-f471-4a63-9d42-7ed89de08916"
      unitRef="usd">1800000000</us-gaap:BusinessCombinationContingentConsiderationAssetCurrent>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>242
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MC99=;]HP%(;_BI5)NVK)!Q1H!Y& MENUM4*EVRZF79CD0*PZ=F8[!?;K=YQ
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M-"X.5Y0L:"8,^._+-&6O)Z*!W5<XH_\!4$L#!!0    ( .>$35:8D!M@9A,
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M[2BBPR=:6!$A=A/A+:N%DI.WN<!+6HOD&)]J&[41C&(#M&E(0^@ K1@0G\.
M8SA-;@L#FD2)D1(6$H0A="2%XD#L[F8GG\*Y_4TXA?/@2(]942!V4Z"G4SCW
M5:;* FSAW';_#&>CHE.<^#RHPU[;8%_>]+MLBJ2)FZ3O3T\Q?@PNQ91"2==
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M-0O)>Z:66]<-=S@P4&GQ<#N)1[L)YM9W+&8<K11NNPW+N[7,;;E%L2N'>NJ
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MEG8'/-V4#]G<IYRG<?ERS>B2905 ?+Y*4_YR4"38/SHV^1]02P,$%     @
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ME(U)VA_!VLO<N;X-YJ,D3(R#6%])K+Y=8QT>Q@[7$Z32-H72,B@MA](8E%9
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M1>L&A)*.DS]ZSW1 Q@I404ZH^Y*C8!R$?E_.@CK.H30&I150&C<6<3+I[Y&
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M7S7-]MN'TY;_M5G_MO=Q]G]02P,$%     @ YX1-5OVE=%' #   R'0  !D
M  !X;"]W;W)K<VAE971S+W-H965T,3(N>&ULM9UM<YLZ&H;_BB:[L]/.M U(
M8' WS4P:WC*S;;)->\Z'G?U ;#EFB\$'<-+^^Q4O,09D!=H[7UK;D:Y'6+<?
M23<"SA[3['N^YKP@/S9QDG\X61?%]OWI:;Y8\TV8OTNW/!%_6:79)BS$V^S^
M--]F/%Q6E3;Q*=6TV>DFC)*3\[/JLYOL_"S=%7&4\)N,Y+O-)LQ^?N1Q^OCA
M1#]Y^N!+=+\NR@].S\^VX3V_Y<6W[4TFWIWN*<MHPY,\2A.2\=6'DPO]?6!J
M986JQ!\1?\P/7I/R4.[2]'OYYFKYX40K6\1COBA*1"C^>^"7/(Y+DFC'7PWT
M9!^SK'CX^HGN50<O#N8NS/EE&O\9+8OUAQ/[A"SY*MS%Q9?T,>#- 9DE;Y'&
M>?4O>6S*:B=DL<N+=--4%BW81$G]?_BC^2(.*@B.O )M*M!^!>-(!=948&,C
M&$T%8VP%LZE@CFW2K*DPZU>8':E@-16LL17LIH)=]6[='55?.F$1GI]EZ2/)
MRM*"5KZH!%'5%ET8):5V;XM,_#42]8KSVZ\77]U/[N>OY-HCEQ>W ?'^=?WG
M+7E+OMTZY-7?7Y^=%B),6?ATT2 _UDAZ!,G(IS0IUCEQDR5?2NH[ZOKV<_5=
M=?WY<_5]=7U=?PX0/ .@"L"IZ*!]+]&G7OI(E<1;OGU'F/:&4(U228,NQU?7
M91WR>]7=WVN\]WO1?75UAR]$=?UH]>"7JW=ZDNU_;ZSBL2.\B^7_Q(]:)/\B
M)T4JLO\B3191S$DBQJDXS:M/R]>+,%^37<Z7)$J(&*JRL(B2^SK71T7$\_>R
M7V8=W) '+\?!]_DV7/ /)V*@RWGVP$_.__$W?:;]4R8J),Q!PEPDS$/"?"0L
M ,$Z0C7V0C54]/-7OICXO*XE*>88BW68W/-2BZLPRLA#&.\X25?D]L)S29@L
MR6.896$B-!R%=U%<*50F4&70J0)%PAPDS*UA9@4KIX\/YP:U-$T[.WTXE-ZP
MV&P^'Q3SD4T+AC'-&3N,V9&+N9>+J<QKEY4^\EZRRG,N\EPICP-92!.7B=0%
M$N8@82X2YB%A/A(6@& =)<[V2IPI$]?G,8.G3()*[%0)(F$.$N;6L-G![_^M
MI3,V&V8G24DZLW1[F*"0#0PD80UJSO6C.<K:*\-2YZA2%9Y8K>?$R](-N4H>
M>%X)XT(]J[*0RD#"'"3,1<(\),Q'P@(0K"-!>R]!>UIRBO8:5"<G)7:J!)$P
M!PES[>%O?V:6LY-^;I(4-*BF#U,3LGF!)*II&=;1S#3?RV(^*3-Y41**9>'S
MF6F.E 42YB!A+A+F(6$^$A: 8!T)ZEKK!&K*W'23I0O.EWEI2O#H0>2G5:G%
M;18]A 4GVUB$+HT+J2.H1$\5(I3F0&DNE.9!:3Z4%C2TPVQ79>*CV4X_,)WU
M<</@-DL?HJ60VMU/LMHG/?50J&9/UAJ2YD!I;D,[[ '*AF.AI)AMSDV)D0!M
M7B")JXNRNGE<(;15"%4JI!P1W]0:X7_M1 :**\NTM!)$RXHL6A1"-=7?PX+<
M\?LH24KII"LBEGM1*K/M/ZIC3E8.DN9 :6Y#ZW0-M2U&)>H9%IUI<TVF'F03
M@S%QN^)I/79=Z8Q.% \7'ZMEPX:6F:XQ8_ -74I*ZKII:<,)K#.^J-L4G3T;
MWY.4/ +U9?'E"@EDU$'1;E>U+K.NMIDO/EU>D8O+?W^[NKWZ>G7]F5Q>?[EY
M1ZZNI!T!=8^A- =*<Z$T#TKSH;0 1>OJK[6M=;5O7<Y$JM77S<%,Y-6W>G7^
MFESOO<-V(4;^<W$GDHB8I/Q7*E*HE0VE.5":"Z5Y4)H/I04H6E>DK:.M/V]I
MER?BI'*#VM90FJ,/K5QC9IG4[@]PPW*Z9LXTV^R/;\CF^?+F,;L__(&"=CN_
M-:UUM6O]PCL&=*BY#:4Y4)H+I7E0F@^E!2A:5[&MQZVK36Z?)T)\<37?#I>;
M*(G*X;+<HTCXCRU/<C&&;L.H&FIOMVF2IUDI6?ZCV62P*M_G^2Y,%M4>@\LX
M%"K_2!;I9I,F)"_2Q7>IE*$F.93FZ$/K>&A6N]"8'I3FCSJ" !6S*[W61]>5
M'NE+[5IIHG:,?]V@,XL.5H"RDLRF\^$"<&Q)5U;2T&;#Z)[ZVYG<X[(6SC53
MTNLOX5S3UKFF:N?Z>K42BW<QUBW2O%SGQW&Z",LEOA@9E[SRK\OD,[*SU<&F
MIA$Z=%$-:V:8?3F,+.="6^=!:?[(8PA04;MR:=UGJG:?KQ(QDO#Z[$9]_K6>
M7:UY7,V=BC4G128F76+NM$AW\C,>=&A^OK48TPS:RPBR@E2W['[_CRKFRHK-
M+6J8K)<*U-_!Y)Z5A"V=WG['@H)V.[8UC2E5GT;]S4UH%.H/0VD.E.9":1Z4
MYD-I 8K6E61K15.U%7V3\6JJ^S3QE<H.NFL;2G/HT/LUYKK%^FEI6(P:(BD9
M_:P$W6PMB:J;IF$:_;3T$ANI:>MQTV<\[GH4*1<]/\.[F$LU +6VH32GH?5/
M!/<E,"PE@)39>E\#4#=:$M8V!\(+4$&[$FAM9JIT",\=L>ZHS)NXFI=NPZSX
M*94!U#R&TAPHS872/"C-;VC=I&=1UM?42[C"M'6%J=H5KDY;+/DVS:.B-OV^
M5I/6"\6D%6H60VD.E>S[K;822,Z(0B-[4)H/I04H6E=CK?E,E59A.71E._[,
M] 7J($-I3D/K#$K,UOK#@RLKIU-+8WV'!=H\7Q9V/A?+R'ZF>0E#E[:&+E4;
MNI?A-BK"N+I(G!3A#^5$!FK"0FD.E.92B2'*F-E?LGO0J+XLZMS6Z;POF9<P
M8FEKQ%*U$>ME8;)81R/T MW"#*4Y=&B ZLRP#;.?/21&*;/-^4 )4'M6UCK;
MILSJ*^$ES%G6FK-,;<[^\O58:NY494!I#ALZG6_G)J-]9<C*,</4YKU.\J#-
M\V5A35W3]+XV4&&[VFB=6*:K#;M?O2*+0?< 0VD.E.9":1Z4YD-I 8K6U6)K
M'C/UCN.K_9D D:2J$P1BM<[#_.DZB&<75VK^9$U"W6,HS67#K;O#[<(>-*8O
MB7EL>1B@(G>5='"+#[7G^\L7^:FYDQ6$O7_'T&L]NCR7E)7I WOCC?'M"U"1
MN_IH_6!F3!KU1E_MQZ F,93F0&DNE.9!:3Z4%J!H72VVQC13&]/[B_ZJ,2Y)
MRPO]ZL7:*+]:39^L2*A?S88NKF3+%32F!Z7YHXX@0,7L*JBUH9G:ACYRV6B4
MB#P6QF2[NXNC!4F;+3IOR'UV9">S.LYD+4'-:2;9H7QL\(-ZTU":/_XP E3@
MKJI:XYFIC>??N1A9C9XL)*@AS8:.KVU20Y_U503=K RE^2./(4!%[4JH=:W9
MR'MM_,I%QFKV9 U!;6PFL8!-S3:91$;0#<50FC_^, )4X*Z26C.;J<WL4DFO
MEGR1E7; Z](>J%Z52[O%Z$M-I2J#FM]0FL.&]K)EVMI<[TM,9GZSF<3BA+K?
MDK#,8&S>/P^"BMJ]B6+K?AMJ]_M%KF-7QYPJ&RC-,8;6<W^&)"DBZSH/VC#_
M^88%J(!=K;1NN*'>EPR^;+V)=GB%M\6T_O9D62G)S]PQACN I>E@5%1O9%1?
M$E7Z*Y?P>N6Z?=*ZPH9Z2_'M;KN-JYFF6,LLHWP1I_DNJRXB2=*D[@NU:6-
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MA=FQ ;<I1I(0FJ  %OUH&'>DPQUQXVZZGYHU*YC4,IMRXDEOKD'!Q*98X$5
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MPU.?VG@]]ZD?AP @(%L:)7$\7/_2CL;TR,EJ XD:6+@N]39DSWTO:O8_EGK
ME@9^@H?!03LD4S>2+<2=-25%PPY5/"/9)5DKL1K0]./^RQEQ8!]M#YP?0*8#
MYP?CWHL:\Y;L'R8?\ZK6I=Q2M_7>1=J)W+UXVMTHL6[>W3P(I4397*XXT^J-
M@?Y]*81ZN3&O@]K7?Y/_ %!+ P04    " #GA$U65[B&P,L#  !X$@  &0
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M,B@(D0:UJZ.GF3RLH(W RH7\.VCH],'M"!E1$[([UI4]F5C%8,.+0(S%]!R
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MR$.DM9*ZUIK70YI\L;Q#F&$Y:L(8TX[2436E4V&<I-FFWFQ/0+D=Y2C*H!R
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MSIC--_]3RT]5K$*"@JN2%?,L9@D%68-8O]7C6 >VK&,)>!M*TH;RTF9;<,X
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MI/?"E.B%Z0OINZ)LC^&+#4J+_/&VYF6&UOP!W//2QQQ]&*@J2J4V1B4L .@
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M8QZ-,N28$J"K"B%1SR *H#LZBI4,Z?JIX +=>'@9!N&E0(D2V)H O("H12V
M303J2$?#"SAV;*C.AV",KJ&J"1U%Q&J.^+6HVD6OA7:@P6[-]&.PH=KI0Z+4
M(J:,?J .;C2D4(S8P%"9A6+T' ,/0]J10VPI>\9[OF1EW2HT _07E.:QZ![
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MR))1S)A_?O9YUW1KA;M6^<=Z54SDRY/V>M2R^BQ/+K[])DC\GRC?D6(<*29
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MAE(6J!J'J@F4FNZ\ C&A'<0,67(_["N1-Y/Y"0N(=AF:.0-5XU U@5+3C54
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MH/!DU?&^ZDLNTO*$W%+DN=B5EUO.5&9J ?7[6HC\Y8M^07/(\NI_4$L#!!0
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M_KL!'8DMQ3^FA!IXE9P&&>: KXX^;;TTVBKO#Y:P;"D9;;;DQ%XC:8='X"3
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M@EQD9OUCDTJVRHV3_R!'L,*<DDJ*2DG]#1N?,]UL+[[N^>)TD^YAW,=-WUV
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MUO@ _#ZO0,G(!UP ^W\(O-?_"U!+ P04    " #GA$U6Q1J#@5X;  #9A@
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M(=7R$N2E(+N!D["5\=)];TW 1Q^U.*Z6^(":VNEO$^X=++(0GT!Y^9F10F$
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M:!AX#ETSAR;$H0DS<.("ORIZYP(Q[V4JV0*T>.+CGF3UX&\OYTTSH(_LZ&;
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MX<GF]F=/EH!U?A)ZCKUUN9S!H\/!P[,#M@_N#7B3."1^[T>E"GJYD !K--X
MUQ%)NC<XP4KI3T3>L_\%4$L#!!0    ( .>$35:Q[YE+3@0  ,H.   9
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M3Y&I@3L:^.D32(/F,?PRU04?HM.W'>23JB#*UFSS)1KQU,<E> XBU+E9559
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MH'(L?D(,Y[DF_Q/>TQO(=&;*!31KSNUT>M[HHK@_7LCLEF_,SG?BQP&/T&V
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MHX,Q ^1I[,!$@#L^6NL(1RI0>1N#C?+[(;DI&XXI&KL90?>4PJN:@!_T *A
ME<!T2(3&R:9K0!W1! I\Y!;'8F(GI)&F!N^BBD<(14>( >7]*8 I#Z4&6.B3
M\7#8449S$:H$8=QJ7\;:L=Q#PA #'B(8W*Y.=),A-%G4:<WY.(28YL0L:S$5
M2JJTG4>1$:?H-$PJ%M+(.HM#T#8GL[.4:R6\&!)''!34G3D@_CM/-F/@%\C"
M 3]VI,U /,"3BW&'@) 5%[^NY>:]X'UI_"1<MS,X%OR4>=^5V-O3#GHLY51M
MD1XQ5B2/2-"#HH*T3/K6B754.QG![0*0;"K L+!#Z=<Y@NWY2O/<STF,2"XE
M.A'@H0&#"Q#BLRY\PH<>V!7'33:)3,^4)/P0_DXM6Q_+-,Z:T)AP&7#6T/!(
M%?#X8;"7.'&%A.[U>5A)=ZLH[,D@B"/A/$AZJEU+L(8C&C'7/=\>Q_;UEP_*
M%2H*@PE_':C^E/)B6!%Y[(DS)'/*8T2!9E5T,\C1["29=J,$98*B&0KY1\\&
M![:L/X.&V&)(%SJ=7!@UZ#G;Y[/H6,(G# QBW9.CKOMR/>K1WP?^T5FR;_DA
MX,DZ-,W>K[VI3-[^R:[PYZ.51AK@1]4%I'?I"_QUM<#)J:\$ZQB&B.8X'X72
M8A47D:(?C)_?"SR_%WA^+_#\7N#YO<#S>X'G]P+_L_<"3PCL8G^KI.P[X0^-
M_3\\YK_'PR)FPC!V^W95KZQ9Q6PV&!E-;S"-V]WXV]ANHFXPK=2L*C-25YN3
M4!W/#4 !TP]9V5L"G)F9IX=.%OT.&1WOSH9!V9N86P02#BBQGL9B+#TXHY$4
M1GE-/P K3%[P34P)5*(XW;CR1#O'8M=GHLG@*U]%@RQ]RR3PP&7\X+>YN_E<
M>AV_$CXLC]]:/TB'$YT'@DMLG8[/YJ-8=OJ+8!O^9KBP(=B*?Y9*(HAH 9XO
M+:#M+DC!YB/RU1]02P,$%     @ YX1-5C;C^Z3M"P  K2L  !D   !X;"]W
M;W)K<VAE971S+W-H965T,C@N>&UL[5IM<]RV$?XKF(N:L6?H$X_W*L76C"3;
M33I-J[&29CJ=?L"1.!T2DK@ H,[JK^^S $'R[GARK#B9)LT'RSQRL=A=[#[[
M0K[<*OV#60MAV?LB+\VKP=K:S?GIJ4G7HN!FJ#:BQ).5T@6W^*GO3LU&"YZY
M145^FL3Q[+3@LAQ<O'3W;O3%2U797);B1C-3%077#U<B5]M7@]$@W'@G[]:6
M;IQ>O-SP.W$K[+>;&XU?IPV73!:B-%*53(O5J\'EZ/QJ0O2.X!]2;$WGFI$F
M2Z5^H!]?9:\&,0DD<I%:XL#QW[VX%GE.C"#&CS7/0;,E+>Q>!^YOG>[09<F-
MN%;Y=S*SZU>#Q8!E8L6KW+Y3VR]%K<^4^*4J-^XOVWK::3)@:66L*NK%D*"0
MI?^?OZ_MT%FPB(\L2.H%B9/;;^2D?,TMOWBIU99IH@8WNG"JNM403I9T*+=6
MXZG$.GMQG7-CV"6[5D4!(]U:E?[ ;JOE][ :LXK=*&/D,A?LG<A$L2%+OCRU
MV)B6GZ;U)E=^D^3()F?L:U7:M6%ORDQDN^M/(7 C=1*DODH>97@K-D,VCB.6
MQ$GR"+]Q8X6QXS<^PN\;J*8TG)*]^;&2]H&]EB;-E:FT8/^Z7!JKX3W_[E/<
M\YWT\Z6(.C<;GHI7 X2,$?I>#"X^_VPTB[]X1.I)(_7D,>Z?ZNP>W:1?A;\I
M*]B,??[9(ADE7[ G",*^60NBW_#RP;&9?V$:/JGG8QR?E>"6SB$5V@)D@ 0-
M#TTA9YA=<\LXD2B 129 0;LN!0,*T0VF5B ZW _T5B/D>)D!E1IQB52E::6U
M*%.W>%4Y$<2]* &!7=F9-(Q7=JVT_(_?5AI3"98LXBB.W3]FUA#.$)]>!;?2
MKAEG&Z[9/<\KM^%)/,3*$=L([9</V9<JAVKFF"Z]K,DH$%G:W,NF2L'NZ>R
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M>'Z7H4<XM=22FQ!66[,&S%ERG'1.>&!M2[7D#I4Q"!Z@MY+-9<*TK"IK=MI
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M'1^]'L4<]P_>M.$U[\)X3*_PL2*)D%@ WY<&$S$]\ :;]_YG_P902P,$%
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MD*IZ@-6^6F<K.%7/C8(MN]&V2+G8Z@66:UN>E9(<M"K5=_>H]!S-ZM?5TX=
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M+(*RH\,^&D>'PNX&*LFE\7<22B1XC.)64#ZEZ@;>=H@LHPXM%S+F<%5YBE/
M-"*1B72!:E@+]&!_,M.N6#P&I9E5@4;CL9J>8"ZF!&:-@PABD$OX+8?]X$ZG
M8?4FPYMSM!0PD\HE<HWNPJG@$:<O>!HKY"./37I<J BT29:)Z[5[^9:EG\/H
MF].KZ5S%(!1E@BDR@;=I@SKK.@>6/^;6N7!?D"*?SFG#%LY(.W@C3T"L^\H#
M\S%4P1&F:KSOR-KZI)$UE O&7HJ9VP.+LQ5*KEUJ';P':ULVU\F;""I>RI#
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M7F_<B")=2=3+BHP<7S3$%*K63A33JXHBN:GH&T_Q5N(XWF9SGOL[;B+*JC=
M=%U(4DP':OO2U';BR[$76<"SI)R)5\#&XNH*\]EP/RQ+[H7YW->/(Q LQ(%
MQ0MC?&UJ)QAN->_)F G<8?<0 +;?T1T>CODC[ZU]"/?6/+Z/[\4WKKOWMIH?
M((F^*+F2-G@7;?C^4MS(C;3\URZ&8=#=!;#O:EB_\C!^+N:<C8])V&,-O^D.
M1MT[O @V%:N.AN<8;;C('*+M^=W6[&$8:TET[1Y6I7)FMG26 ':4=9>+ZOPD
M0?P=@NUR%..XX^<"?O"G MS-M*'?CCA.?M>#].:<FC8TEL0_\1&^#3^0<L:_
M"Q)?YU]7 =HL,2HNU *63L;/3@\X7O ?&K.F7PF9FP:82'^NE 3FX OP?&'
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M6@YX'1=D?"AL6.$UJ)0_F>8+JY!?2W$(2*E\\$U8IJ&V-U-VDK'5&/;9)F
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M5@4\ BJHV4A$+(V:^$'FWKA]T !3'+(,SSFAU(>/381",@.XJ5BDFF$R)*,
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MNNWW*?8G0-FQP7?:(PVH-9M*8/?NNU,!8]0&J1 W(LOIC-C="5RO00!@7P<
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MJ-M(83GC1%HR"+!AGB]-B;O^P1AG-[5U6NS)I>WPX39& 1>@R#P*"";&6W\
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MD!GV6]ND42WUUI38_+]-MK*A!IX$N:J??=P;HXDKT2S(YZ_2F"NI7 7E.K;
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ML!1(U4&[M-KB?@/S&%YGX^ML?)V-K[/Q=3;^,!M_]A<V&=TO*C2[<(NR$$9
M=]48=H>+VF5W/WD2[VYYGYG946F"Q()4T_AL$8'I;D[=PNDZW%:VVM'=)SR6
M=-E$XP7HO-#4"_W"&QBNKYM_ 5!+ P04    " #GA$U68#9B4]D1  !"5P
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M]2I/?F,AR8<B!71Y6,R W8&?*4P2*:>Y'7H)2/>2?06<IUYSIZ%ZWB,%?,'
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M+W=O<FMS:&5E=',O<VAE970T,"YX;6SM6VUO&[D1_BN$[GJ0 45>R7'BBU\
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M!'Q#KN 5K<CTIU(G+"RHWL,L.;O",QZ=H1 Z@(7*=4QXF$ M3S$J$/=[0A+
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M+?(LA\@ZRY-(VWN&[5^\*X]=JUN1)B1>C?'3Q%LD-*I,THJS%I*/UT1]8BS
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M@,_%EP1\F(5CV*4IP3[<#^.IEK-EW&59QGUXP'6^.J[S@-,\X#0/.,T#3O.
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MQ@\\'U(O"#;"-6R5X/OX$!6^X#^Z48HS"7[@X9?VLH\P"I_[^J)X5R]^'3%
M!45_#L8_[&.U@R^O:Q5.S_.Q +*7_:3;5BUUO6[7K-4G0>\LDQKJ6NT6M@0C
M*"@+P +=(@6K<)A!#PP8_*K,/F[<:SM(J9I\O2-:'%O5GVR P27>MN8A-1MY
M;O.GR>W%R4!0/BY58'@E"&@@PS?88Y^QXVM0[XF+$& Z+]-,VT.@+3U[+QS2
M(V5]'PKC<7>-ML:GN0H$V59+CRQ"?&_6<:G^*&Q$-MUSD8:TUX:YEL\X(:M?
M2&*#\28,OT-J1H?A*&CD[>N??30\0F=0*?^PTXZ_!D1_"$!?@^?W./!8@^</
MDJ;_+4C3."B^?BF4^W[H]9\$L_[&D6K*Y!:C;@\&OP]$W1]T+40=^/T6@/I>
M2+3IRJHV[0&)?D"B'Y#HOS02W1[#SLU'2J=K #,!RX^@3QF,]L*70Q:,O.ZX
M 5\>M>/+!E@>C0A!;NN8#++L>[T#\>4'D.@!)/H3@D0-WOKE@)&P1#AVH1C]
MPS B" &(N=C+E\&(_B!)' 01#9!U>JE#1($7TO.AYK*?<-L#7F!.U+KCSX:(
M_E\0(GQ6=S :-O9G_P"UKN$<!Z(;QU"$G^S -S8;TR\&W-A^V@&\[L4-]!8'
M\A*TXV^O$_M/G.9HEI?$8XRMSJ-,99A12RX=[H/^J./W1^Q*I&AC+S<>@&MN
M]:2N[0--TK#%+*ICR[*]!8?$ JU-;QX^$\[M_X=W;.5JZQQSWHH9%?)08\-]
MH"X,#>[_QF-P:&LZO::?A3MS?KUO(=)K^HU"/*:$H&Q^R*_\MOP9Q OSZW_5
M</,;BJ#):PG$QF(&4WUOV#^"GH%^E]!\R-22?@MPHK),+>CM7/!(I#@ [L^4
MRHH/N$'YXY#/_@=02P,$%     @ YX1-5I5ZM2G_#P  H#(  !D   !X;"]W
M;W)K<VAE971S+W-H965T-#(N>&UL[5MIC]O&&?XK@\TZU0*TEJ3N]0$X=M*Z
M0&S#FZ1HBWX8D2-I8HI4AN0>^?5]WG>&ET3N;A*@'X("QEHBYWC/YSUF]/(V
M,U_RG5*%N-LG:?[J;%<4AZO+RSS:J;W,Q]E!I7BSR<Q>%OAJMI?YP2@9\Z1]
M<AGZ_OQR+W5Z]OHE/_MD7K_,RB+1J?ID1%[N]]+<?Z.2[/;567!6/?BLM[N"
M'ER^?GF06W6MBA\/GPR^7=:KQ'JOTEQGJ3!J\^KL37#US93&\X"?M+K-6Y\%
M<;+.LB_TY7W\ZLPG@E2BHH)6D/CO1KU524(+@8Q?W)IG]98TL?VY6OT[YAV\
MK&6NWF;)/W1<[%Z=+<]$K#:R3(K/V>W?E.-G1NM%69+S7W%KQTXF9R(J\R+;
MN\F@8*]3^[^\<W)H35CZ Q-"-R%DNNU&3.4[6<C7+TUV*PR-QFKT@5GEV2!.
MIZ24Z\+@K<:\XO7[-,KV2OP@[U3^\K+ BO3\,G*SO[&SPX'9*_%]EA:[7'R;
MQBKNSK\$)34Y847.-^&#"UZKPUA,?$^$?A@^L-ZD9F_"ZTT>94^\TWF49'EI
ME/CWFW5>&!C$?_I8MBM.^U<D)[G*#S)2K\[@!;DR-^KL]==?!7/_Q0/T3FMZ
MIP^M_J@Z'I[](2N4"'SQ]5?+, A?B/9JXH>=$F^S_4&F]V*C$SS1]G4!X1A5
ME":E1Z+ N!_'UV.Q4;$R,A$RC3$Q3<F/HK(0/Y=&Y[%FK\KYK81,\W+],T:(
M(A/J3L)2);T?\[:MC0XFN]'LT1%FZ[S(1;;A/3=9 H30Z?9*P-_XT2=E=!:+
MC<GVXN\R+8$:(ERR<03B;6F,2@OQG2/SO&;[NI"00_7MG=HHC(SK@:-PY7O!
M,KAP W^222DM1! %,HV4<$,J"78I;W9JR90?+5[D(@62QM6>-%'FN0*;)"29
M.S;S*] 5J?U:&3$)'$?O3F==$8VF>%X>+C^:K4SUKY;2*"/)G8LP\+V)OQ ?
ML"F VN!MNA4P\UQ$TIA[H/:M-'$N%BMON9B*'[("$N@CK^*X3QJ-Q$Y)])AA
MZ+ 9?MXR0!Z4YT05:11Q(ZEXP)P>0CR@6XIPL"?=LHU :[FXW2G,-T(70N=B
MGT&8B?ZBDGLL*U.19@5]*$1.ZCIDQNY@B*K*P/JXOM5X3Y/7%6TJMC8+5-=[
M,H_'22:*8H4P&1/-Y2&S3K15*2O$SMN4!4$/9LEU4KM$#%]RHCFPL;,+WNYT
MM!.%VH,1LOE8;["I@FQSD,.PD[*B2?1N8>!O"9>DM>4^*U.0M59VC_K-6'S?
M)UO:G:)]7";@RZ@;/)3)H'[@".3I>-K/$R$".TPBTY2H)*PMU%8SY$"]7RS+
MD)HU#B)G+-YL"NBWHJJ66TN!.K5)"!OGC=0)[=JQE[5*-,C/G2WH;:HW.I*D
M%0C/%$A2BGO@$^/.K2YVX#8_.-ARW!SI>\ARB,N=9.$ACR![5'D!@C1B,1 1
MJX'PFU-G&M?H=G@(W480ICK0U L,-EFYW9TBAL?K]&PB;D'9N?-:B)9!=F!Z
M%1-V,A;GDR7P9!;0\$X,2 ?P)2-;\9S!QAF[DKH[: .]U"HBX6:;3=X8:]=B
MV.'P]);^I!ET96"YT-VO3N1K>-)&D]#[&1F+#UEM];R*C")3DH56LI;W;""8
M#1/ B+Q@#<)I)1Q=/;!T.V["9",;=@ \Q*N\)5@G,^6W>8F52N" (3>BG)0-
M,<K*A!PK!ZB0"[0-TU$&(3+-,LD)M@AYC&:HOM%6N6PG)(1#ENLFMK9(:X7@
M5L1M16- PCV6_IF$(N](D[(L=IG1+(&<3$[4=C?NC6XM9XLS3'(*YVV)51)V
MP4'&ZH-D,ZQ/AM^*5X@T I9O(4]8%:^4JCLL>:N2&P7,ITP3QBQHM332B>XX
M*;RO*(L,3E09;3N_(20?N7TO2$)%#W,*,,M50M\<AJLF?#\I1WF2%W,:\C#E
ML$-?/!-OK7A@01NI#3N^LC!M](UDPF&/ALP*PEE#0JS8T7(V&Z\NL,!'BB.D
M=YL_$%Y$DI < GEDD3"8'M'0ASOST!^O,.I]V_[@9+D2/D\?-MF*]YR3LD8"
MJLE*4TVT<M9&_D*^#ON1^<EHPF/XV%&J6D=6S=&/HB(\HH3=(PAUO:FV;<[Z
M8L5 <JH=#'+!'DZ/H&+TNB02E304^1A2R,XK>L NHIN6QB%.7H*:>K#DZ*-3
M!#!:1 -'-IIX3NZ[U!%R#2Z[D] @@BL,"@A#7K56*K687:4DL #*(%BQ[+8\
MR0(4[TPPK.Z0;^0->=!1%9U9',A$)#AV)D!E0!1E)L98SLH8ABV@U_&S([D6
M*%0PC8TJ1Q>43D'9<!_G+JXJY*U.H9E6,S0#V: ^M3XHXMS_??MXW9P+Z_?@
M!-;WGUF*FFP-D@=XJ9Z:J@&K:G88/+.94\/37WH1R3G#1AO$L"<Q C\[&"2S
M1D,Q<<GQ>#A! ;=)A0E=8IB#H5RH@^N.QF9JKT,VJ="3F>GF+/T"HMP'^C^P
M)U+')B8G/894D/@!\?E?R/:(?-+ <NP_$S:EJ\V*%LL+"E-QMM<(.M8]6E./
MS=#FM"IW <Q9M^P5-7T1OR!F( *2HTI4Q&/Q?N/*G%CA.8(W29N\5 Y4-GU+
M:XM?1OU2(AN+/5J2PZW% (L+6-'IK-)V;ZGNU.D25@:MBC2[+95D,E9=49Q
M+&?_5%<=D/IUH9ER<6U1)"L+PIA3Q!]3%R('/YQ^=9/7;BBQA.KHH30(Z@3,
M8@SM69EG:WPK,WHHT9)E[)"89]T#+1$K?7]E>4FI^NX$CT-ID,"Y11U$-C-M
M?#**VJD#+14;>L%@B?#"-;&-F&T^NL*UML-07#29Y8E[(]; <G05@CDK'8MW
MMD(]K1?V>FL8)XC_B'(]H!DE(\Y/;$K4]C'L^ [8PBES7T@?BX^I6Q9T>R=^
M&"L0Q<MPN$+ )4G&595H"X0:D-K)"P,>+,S$SP]P-D10$H3Y@HK$)E&5W)L
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MQZM3*NK.H=FHN9]DM[/(17GE6%R[VU43)!*N&\491PKX^.S@\VT6*\J.,NN
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M%R;8<NRAB>T-/WC!Y4]T9N,.+FJ&FQ.,DP3E6ID;'=D$-5%%SR%R<_J2]6/
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MB0 J4EE)YM,"7$#"9%E;HV2T:[]7CF?!/]I*MLS*S( EJ"S\M="5K#*-HM/
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M-@=Z"Z=18$06"Q Y_!(^GZ47%D+&=LQT=OBZ  ^,Q-(^YOA6-FYU R/04B3
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M@!< SBS&FJ"R'R"< V$1D;+.R6D@C>O[<2Z9R(B?:V0Q50-?OZW@'V>!#B4
M_>'R^JVK[PR.NT(OQ4BFT0Z[O+YRH[Y4:P#M_ 5$N?+K.R _3-*99HES_>0+
MV>RXOJ=]G\@,$!]P/CRCGI!M*K*)MV9E5_8A;MX <JER85!32:(GS D]L178
M"1. 0>AIE9'E #=I?TTT(LV@%4DI]/JMLJ$7$9:3?R3.@2(0]D/KEE.BGO]'
M"<6;RBJ/D0S.E@-!O@E%5M-SC.RP^\Q%#@\+]B.W_5YST>M<<M__ G-5N4]K
MN%S3@Z*%>Y<- N;M50<X"EV6# ,IMI^^G4=J?P.-3QO#!.K6$ALI"AU U%%_
MHH.KF@I!O\,46$-,!_J/=!FEN""Z+-$]D B7_,G"@"#DW#:3H]($I^!&._U/
M4DY%<I&,X9QZ$!)+T.U;-=2&0E9Q)'%?WC%UCFU0KJ#DE\_%D[L4AUO,9E+8
M3)%/P"60.=S6F/-L7J@BA&^487>/ZB].2XKG/Q1.S"O>C@@%KA![-2W67)>2
M11K*>#[.VQ'*_KL!'8DMQ3^FA!IXE9P&&>: 1T>?MEX:;97W!TM8MI2,-EMR
M8J^1M,,#<!)@(!;YN3)%\X>*NROH,BII<P,4PL5[J0!I90!&[DCWH6?M*M3C
M]=E8-^_.L@?"LY4[-:US];$*RUHP4H]S%E7^5M^VR!/4",)"#9Z2PN)@G6/3
M3WM' H]]M""BJ*(0!5R;!]["B$5:(N)E4HDHZHH(2AS"B7.W)2(X>\-]LZO)
M.T9&1T9(T+E"K0>4;=GY1?<9LZ\@!G-NU5#41&83^JX%U-<SJI%^4/=$*LYB
MKTC##OUPLJ^2'DERL+&%M+:ILA'?5_A*TDPJ:X.Z[M:SXT&$<DF!7"2377P1
M.:^I>LEJH#VE:<F.!"#R>GFGQ3?M,A9563PJ=\F4Y NE,ET8LZ364@A#DDOD
MV_R<<XX6X<X*^ACO'582;*MR4&F!0=5K9,FR=946[12G\J[HW-2K(V':<8Z$
MR$+?ZJPCQXD56\U=4'<L[@"[5W&46Z]*]$AWQGN<,("U<=N$#IG9(*>#>($;
MP<%>64G ;X;QX]/A0XA8E8%O&$8E]U:\%PI[0H(FG;!IU$6\P=<!)->^N.:*
M56=GH\6J^/$!;VXHT:B:K]+<8=4>\2EU][-^ZBBF)ARX."/P:1BU2Q7'=P'W
M *IA=0ZOPA1/J&;#DA\I!<Q#POS-_$ZZ.AT- F_*^D5V4= 8!G;:)*X %W2Y
MLB]6DCM(P0;*Y7;Y4N:2TAX@H!?R9*IDM#5=K;<62C:2QW2E/KN+=DF>:E@>
M^9DJZB-99.NWP9S>;9-*%=,B2EB%OB,%Y%;0#74U"Y^E+EOG<Q9I,.P&*&8=
MSAW2C,TX[_%X ;+NCW6UH5(<PX'EN:Z)8AUJXG)MOG;<@L=)J3:UP6;0-M\K
MI5E4Q6Q.TD"9>N-S$7_K5FMPL^HV^=35_G3'-7[5K9TT34\GTTB"_O;I[74H
M.^RL&"X[M>HKD#6_4=SQ@QZZ"#4H-G9"Q0.[4>#I=&C1*>U'C?:!Y\Z%6+18
MWG,'3F%]+ J$T6)T\#2RW3#V>C2V<8UM"&RK5'(V 2BY\^F")M='Z7P(U5MR
M9OF(6QR:6,*=GYX[NJEZIH .QY]N"WWG:7 Z35TN"?.L$/>B:(6"COG*FA0E
MVQ#D281=EXWD%TK;P DN)H#*F'>,?'L7=#$Q4?LT&XJOT!_FRFQ9E3.),($#
M#$CZ';NOW+@Y!!(=[D#C/Y2S!JE8X-<ERBA$D)B) R//*R.MUK6^,=R"+)%&
M?I+\T-7((ZG#[N1T>C@[.IPXV; ,+-MK=C ,[7HW2Y1Z@_H'0:&BIDM@!9S0
MN$04%S=MI=0O=,C.<Y.*#J2/%(#B1I<*_8&>I1LYAS!TI@#48R43833&N3SJ
MH?53!JP\:%R15._E7%1@:<]'+6WXL-45W".\2[H>A4X.11P]Q?&SZJ <(2S9
MIX0.FY!*6;>8OK+<01%);MN;^50;BXQTX,7P#B@MZSCA(9YQUD(%1"DW=!W<
M&=8 'LQNUX"':N2XC#TM(WT_P39XRM%]V-H?EYT(Y@TF\Y5#+*W-R;V %J+F
M<6VP)-CX7;96/=/T.36=H)&U'EZ]S>J1IY!*6]*8P2-*47/M$',X<,/NLFW9
MNG<\XA9VC/9KA?:+AM:@P$;+[T,MH)Y5@V90X1-)P*ERP'[=^<,6]JS>#M9%
M/W+'SSP5DH@;DH4CNL8V'^U@;R2JR;J"8E6S\BE G:FN\6T>5<L!K^."C ^%
M#2N\!I7R9]-\917R:RD. 2F5C[X)RS34]F;*3C*V&L,^VP0,X*C,G\SY]/</
M[XXGWX$Y0#\/.<UV8.40_-0<+2$68$KJ/,\MGQLL^=%J0]E.YZK>&(BBPNHX
MF#>L!Z(Z9<5JE^RSAF<#*A22\PBA J"UL<T-0;(6X'Q*^8W@Y*(XDDX&<!7T
M,C&RL(@PC9RT4+F!#>2ZQ6,9G'8>C,X;_6"FM2>-'LCB8EJDQ9]CU?RWCINE
M1+^L,&@5-'A7 IB36AD(0DJ;6]ZX"X^T39[9LZV_4"\Z<LM;_">1<QJ4IJ$T
M\1(;M>8%JZ//-I'@W:AI[,I^^!P[LB0]*29$,'$F01BP(X:A* _4G(E*9/)G
M[NZ::["4@ Y]2Z=26G5+QS#%Y04'2[)Q;&RI"@?>MZR>8:,%X=?E-.TQ)5^F
M9:2RPD"S4BMDYAS0UK3 #H?F1)^D!,Q1--$1B"THB%*R>]Q_1-K(.^3V"$S?
M;.-6OJC;N-_9?T_68<7=!"($;J=<SO0=0L#NNIBS:TU'=,.> &($GX&S'>4!
MWD!UO!7ML]$<#@P?"><:5!TZ-/@(HHN2H&7RLVIR]7OJYQFG@B4"EU!,8VLH
M445:1"Q&"Y\(PW+TQ#5K#W9UM[Y,&^QVJ$W:_QPD*=C&ULR2&&1)XX'5\AZJ
M=)0VC*'@.%?%Y<8QD"W?(/\'9[-(^]L,SNA@'A *A*2G"1'@/J+LD/;"([XG
M6$Y5>2[J<X!CG9,5[Y8I1*+Y3F-DSZE7QN07VW]).>L.K'(MS4:VM@0^<%>$
M30JD A:8U:2697!758T-G%V;2MB$A\-YWVI&1A(T^$TE [9XY"6$2T+"LO(3
M(T S/,OBCU.@Z@8TM$FH%VUJ*+5V@QJ"5"MI]+3/D6R_HDR>)P%JHHY+9%W=
M.WU;VV0B;T^>"1*\OJR'=*=-<)4A.+MMM;;/X#$ N0LJAPI)]_3Q]4$#<18#
MY+L!']\,> *F1?JC7"(D+,N ,?I(%OK%T#4+<;D@2.DSCQ2*_$B^:B+2M1_Y
MJTO[O&M'(%30&79YY+J;I2 4V4FZ2P,J.HE<T$$%]&^[&9A+@UT:_2/-,0 P
M>YS-^4F5_U1?-&SXY_^Z9UT[E1L2FXW@& 4[>$!\[I"2-%0?!Q(A2I\,()2[
M@>P)0%EM)[E<4\:7GB[MM0OLICD9HGO N.()?1?( R>VZ8I>1YV_R2 TDQ%!
M!A])79;7[C#HJQ)Q&<0S)UX-QWE4%>!6@W+8"7)-/NAM,F#]-E2_KB!Y>]TR
M'^K\<<SU(]M0NDK&,ME/V"+MF95SO"105FN(]#D\B;/C&1DT_XVYL29'YHH3
M\@ZW8U*T+;N>V3^,5>^W6_P^RJ4SH43:HBF$4PKOK>E+5?)C4<VP#0>%T>6!
MRWR<366&G\%<]V4S"!%(/.:PW6I#@1LU$''>!IY 6$X@9K/YH#XQM\LEOE]"
MSC-Q>\KVV2CI&[.-B 20W^V<.U+1VQ<6D*./(KY#HZ.=LNM!'M632?IB\MP=
M+!1Y<!V>K*?BQ;B!D$X](T[MR>MYT%KG5XKO#K*$'&G"VX+S<(A.B%(<<QW?
M7Q'N*2Z>IB'(XD7VM!W3CG?KVS@]F., A+VR 1=0A,/]$D@1= :XD+L#.X?X
M6.J];__<-0X-#"!CT0:VJ"J#X\_NAJ:$"#:<=_R,/\5VS1__J1'TRF:K7;@:
MMRLE="M-<&II2 ; =^AJ=(2=$MR6$J"(F(KOJ3S/MX;(?2'AE2 ]?#0[$/:/
M^"J21#+(D9#AGKO27R5@5J!;## ])CUL)[) QL>\V&/LV@I55D:A3'09 0RQ
MN.>6OHZJ;5OJ'(,]MA)8,C-UZ^.>*H,8C=)&?87H9*?J@7#/^K;7+:@5]1$I
M!0UB4M1QO=_=TGA(2_JW.>\_TN1X/R9EP@QQ4FB;/2[!^6^MKTCQ':5&J)Z<
M:>ED"C?R$ %]Z?LZ:(=;3/+MS$'Z/=B6))[&R&,IHL)^;A2X@H)XZJ&SB(EQ
MH0;EX2&[)YF5XRPX!LN@[9"2H[I&<>?L7#RE7;XO<?%3?:D;4E1X*+QHS9J7
MBD'9$O# @9+># 9C%X.EUF^,=1USP8QW[_MJW*4I[G:;@=U;1AG>#YT"<.=7
M[YMY>]91UGKOBE1?T!$9W%9\G8UH8:)TD)7P]^-PIM2?H=K6QE(?B6"W^V;#
M^CB=+K= 56OK.WR+.O^T#E)/XU)2#BVC'FO0#VOJ)<1$XJ:T6RRUHB,A?)L5
MS7,4GXJ1CKOP/.8C.+N_5RLETI/@VM)BZK/#\B >%LRXHT8AZ+]W56LDEV$5
M1&]2S]?;C"P0HW/ V?^'<G1P?L9*9D]H#^5^&S!Z7NA23CR.,*FE7K?NTXZ4
M+]ZW<O1-+(P1&-TM@I/!DLAW@RYOZ-*.\_3GZ\N=[LE#D3@N#+L!WB4!.[5\
M"+AXG)RD='%O$.@JN3<F[E3I,1#,^-#MQOIN@,]Q+D()7\1)P=9C-4 D'-\D
MQ !%VA/A,>D=C$20&09NZ.(KD3':]B@.<HA18L+>.Y:+Y&->[^/5AV]-H^Q,
M6;34@QTVJ%B(Y81!9MMPBO!JH9VIH."(NKY=F]JE.*6:%R8--HH/BTFQ]I#J
MP'><^:7SH2W?,'C4X\/VVY)PTER.Y;ZB0&JXI&8_1O+=(G]5=7M\G55M>_RY
M F+AI4"MX7[4#RO*>'%-T+6//'^6!L?>7<<*X8E.+HTTN< 'O+([N3X^CV*_
MS^'C[D9G)\JC7:/]YO^@/+-;C,*HN^DE$2+_(^5V?B*21!98 ?"W0^#Y.^K2
MQ4*F+G^K3$GL#FA;FAG3'J^:45])<Q:%7JCBGA13(G'1H^D/T *PE("V%V\,
M'#G#!-'  36^U=>YCP/!(5VV<:8N)L>3PP6U9GG*A&U#1U)46'#B3DRO5#)<
M*UC83F1/*H^<I8DO5HAT17R,PN93MV_$N.YF_IYLA["F?V\Q8M",H7!ZYN^Y
MHNH=7MN[(VF3]K)?-,#V?$>[Z/7I\\$/81DRF?:7J!*S&QGI'X$->[PXN%5)
M[EEK[.JQAI8S,#=6.11V^[:4VRNC[I93B>)'V&)W-2'YB>I>F&]$D'ZL$(RK
M"HMRY8,OXL[9=-R:%=O_)\]M,C+H"(%Y9W@KNJ<2U72J^BO?.\"9-&S]S0RA
MLS?GV<E%L@+5@)OCFOL0[:E+(6@<W9[GXNP901?>)D,ZCN@N]WW)_^VU.#L.
M(0S?UEPXK);$4^S,;F.2^V^H/.K+%>T2?.#%TMZ5)8>[<"M/IJ2@ A;U+?M4
MZ^?<LK7=\9V"7&1F_6.32K;*C9/_($>PPIR22HI*2?T-&Y\SW6POON[YXG23
M[F'<QTW?G8/CCD(%.BTX+#=ZA!K%:ELJMV_B0<2<GGSGN(-O]737ZU%:SO&@
M990Y]>K'S&>[#GHE>D0E&3  F+N$(JOCT;M]<'#X%&.(/&YY4_.Y*4QPWLB?
MWPSI.5C0&3GA":S-G>"V=5S$0OK!;5M *,G_$'Q<"3Y^JK")<HR2KFX\?4#A
M&!M&;4'C> 8!':XSM)[/L%H,N<.^, 8O02B"+A66JR<3KQO&7Q] ^.F7\/DR
M<<R1:D*3S!V'<BP78Q@Z2?8OF_A/?]G$,%O\J]XUX5#)X0ZIMCX=Z )I[@@Z
M<A9A"\P_\'45#[L:?^L=%OOW3>S?-[%_W\0 3-7^'1+_?]\AD>Y?(K%_B<3^
M)1+[ETCL7R*Q?XG$_B426QV^KI:Q?U_$?_+[(O9O@]B_#6+_-HCE_FT0__=O
M@[C_U37[]T7LWQ>Q?U_$_GT1^_=%[-\7L7]?Q'"Z9?^^B/W[(O;OB]B_+^)?
M\[Z(5T_;-Z^>F@;^RN!/76W@[V8)JN*=:M6;5]0C<*6+@FX?*MO7!Y.#X%L\
MZ_OZX'+R_>7TX"F,](^_>;6&".:CPFNA&O!NYS#T].3YQ0';&?NAK=8X93*K
MVK9:T7^7&F2UQ@?@]WD%2D8^X +8_T/@O?E?4$L#!!0    ( .>$359TT&"B
M71L  *6&   9    >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;.U=ZW/;1I+_
M5U#:[*Y<!5$D];#D5Y4LVXGW$MMEVLG57=V'(3 D$0,89@80Q?SUUX^9P8
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M*FE@)83J0]0GUQBIC?94"_Y\C6<#>HW/&^CU4FALVS,-!S[_'JZ,F;=JI=B
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M9"<^I+-.C6QL/UPW^=[TZ)E.DQC'L70=!%=&9EA&,*XFXO WH.@\:R4ERKK
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MGQO,C9:PO3!VF;@4"4=8:]Y*#:>M/&ZXU+ ?=MN,.B*T_6VX!^S<R<"!I*4
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M6](E?^MI^(:H=A0'JSZHOWB'"HLRQ)TJQ(3]B)(4/$*F[[E#U1.*Q^CN]NP
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M>B,VWS[VPM=<"79!"\K(OIY)6+>T?@K; #2,1>V'!88;W8 XHJ?TA0#HH#F
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M1[#E*G67+VNR[YQW5/1521R%0U_9*@WB626&S9Q@ 2!NYIB3*E0^'0)8#-G
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MJUP8OR*QM34W.M?54CA=ZD+:5N3,JD)ZG$SQT1FIV*QTMA(EH0^DJ9UTI?E
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M5_P]+?UH'@D*5"+;]QB]=FB?B)'$7=_>X3%%PH&J+?6J9@LZ%]_K.[_21H@
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M#0ZG/6;"_3=,G&[\G7.A'6ZP?E@*G@M#"_"]T-JM)V2@^R?$Z5]02P,$%
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MQ&DA%4KRWB31E:Z^E#CM;9$'B \];M?>#<@YPB*2U*J@TJ/Y?@O048X?4F+
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MP;4$@:/*.N9-TJ(Z%_6$&@0V!WH+IU%@1!8+$#G\$CZ?I1<60L9VS'1V^+H
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M*[K3H-@.S<T1NQ$XFG00$JF*#5:-02PX=C]7L V8;U,;8F"4\ZI#!H-=(P4
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MRYWNR4.1."X,NP'>)0$[M7P(N'B<G*1T<6\0Z"JY-R;N5.DQ$,SXT.W&^FZ
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M -C7 8!%7CKRZJCD%M_*QOPWL)W9;(UZ/NL%R: CDB.85U>3Y]'5Y#JZ& .
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MX=D!^P?W#4232!)_[T>E"OIR(0'6:'P /D<DZ;[!!59*?R+VGOTO4$L#!!0
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M%Z D0N.%GQX0)EI+?"%,""D\@_8,V&]XN5(9E-!YWTPV&&7<C(1G295Q)U@
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M*OE29MZ/IRY0:HG[SB7)5Z?IDU<DM1\_1@URZ+O:L//5,R>P]&V7%!EU@/\
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MO"NYWO#FW@96]E+W.F@VO^_J! ZN9>&(ODC*7Y&G;Z6"E2\A0U5PBKW0B]+
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M]BNP.S"DD$NK%#]U\@W,>-5-=K*.AG$B9.%,()"3V&"#\J/(P(ZDF(!PE<[
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M!#T#_?J@^9"I)?WBWT1EF5K0V[G@D4AQ -R?*945'W"#\B<@G_T/4$L#!!0
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MEC72-RL5UL]F^L;LQZZ7B;8I^6G<$%Y@>T2AS*GRX*+.9]FDOE3XRZ##1[,
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M& +,L*B>TV>C4;F::]=Y#;U0)H'5'QO.EZK3=4:KA(TYK%5.38%A0IZNKV
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M_+K(0[=YB:Y+=XO*1=Q4TF.#JR%Y-L#WA7-Q\\()ALOF_"M02P,$%     @
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MU4ABP.>5<^&XD #3Z[_]%U!+ P04    " #GA$U6E7JU*?\/  "@,@  &0
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M;-+S[YV:+Y79\.\L%J:J3,&7:P5R9&D!GB^-J9HOM$'[PYN+_P)02P,$%
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M=:G$N?CI#U?3</I4[%'2S[J"98VX74L\+?Z6B[_(O$(LB^DU&RD,1+E6XK;
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M7M .\PMW==P6FP1F6M#79JD2TE6LD+UB6EF[_=3GDI6MQ6:=0!OT':^Q,7C
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M2(/F,?PRU04?HM.W'>23JB#*UFSS)1KQU,<E> XBU+E9559 59IL>D3<==2
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M+:8?V/+"8(K#A'R7C&CGB6TM#5O^CV"0 /[>>$]/$]G@]&=:_PM02P,$%
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M?HVC@S$#Y&GLP$2 .SY:ZPA'*E!Y&X.-\OLAN2D;CBD:NQE!]Y3"JYJ '_0
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MW^:"9\+0!KQ?:.V:!1EH?WPY_Q-02P,$%     @ YX1-5D7RV#6;%   0D8
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M@".67.9SCIK\Q!V6,%@(0XF>F5'*G.H:0[4[> N.[@G5L2SK=@[*YKGNJZ]
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M#2@&&D,2Y_O-S+_:<@M14R:-Y;D!Q\\*K<%JK]%5M36.7U#I1VJ>>6!!'QB
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M61<T2)?]X$ONEMS]S'2-^$@_1!+\FBJH L.A\:;R&UU4P!5W)T<N(3BRKC$
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MK1D@[:<6'22\/K%:@R35=/:M1XCV=/HU=".+2">@EH;N[+8"MK'F2VNG11X
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M4CZ-6(P$ SJ)KQ(6@HDYTYJN%*8 C"0OV)K8NB&8K-.(@B?OP2IH/^P9 YO
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M[I4#AB<$MZ!COQ5F3U+4-^*F$(K2G5S.:<5]+8S;B7TS1CD5"^TB\X+]22,
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MJ3-<]7P3.3#'T65![ZEU5N [,,Q*%" ;$8<QC2S2GT$F,$[W >>P2[1\>+3
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MPB!?6/*#\5J@R9H"\8'D]*_04=VXI7X4'_%/CY@MZ).?X-R;P?Z%ANO/=;K
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MVOY?4-8=%7T-%=U1S!=1C.C??SC1,"1^ ZJYA9HRVDE--9Y7*YN\&3W%OO
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M8<WG$"B9&[+K+"\4?Z:*72&/!O'S"TB$QBH[?;R;5<";!;E@8W/<&EP?Y\Z
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M7<NM@>Z H0--0R=!'H+&+>: FL,7^8(#!X%DB+'EI!:0BY&,Z7:E=C4C4
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M)*47GGB^5+83<& -5=W9]T3MC>_^FJW6W[RP-L>8UL%2?:O92B]:,Y#ZTGU
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M0\ SMZ$&CS]OENP>03LT7,6:!C:?\DV W BQ38B)1DQL6Y"16)1$<)KNY3/
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MY:V\1)(%%ZJ"Q:^SHZ%U@*@H,0I&( R)P&H86!,)PZ($T]4J8R<*QOD"X23
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MV"LZCD]> 7A@@TRZ4V R)?40S*Z0YBUUCH^).@]3J=2+_&MEL^WMK1K=</Z
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MD)$S&)DFBL@GAN<+)O:93,G1 Z-2'<-@6#5"9Q"23UQ]_6DJ&2,2E^[ &0U
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M>W&,I6LQ-$#"DT3>???=?1*9LZV0']0&0)-/=<75^62C=7,ZGZM\ S55,]$
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M#%D-[[PN1-E7YTK4#>6?GS]+L0E?JA&'%OD',F4<)XE6H3/E$/B40Z.'S$V
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MH["R8 ?X?2J$+A]P@NKKI?/? 5!+ P04    " #GA$U6MT%/D*,&  !I$0
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MN,#UY?LD\FMJ>!#[,WYNOX^(U(C8DJ@E^Z)3CX;0-,A(G+LWN_/!?DXEJ:[
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M77O+%3C4<;%MPPJM=[RP9OL!)KZ#:DX.:V=#B?4TE.R5T*>BY;]K_[?3X>%
M/[JD1T<(9TD7M,,Q!8HOL3ZCPR&P%0X'Z'!T[]#NT1%X0(FC8RC0^W'+04/Y
M/^O=V\":M3&W4WKQA#6POL+IWG878(OZWN>^>WU[]I:*30I&9&P-0ZUI %DL
MZANI^D'QTMP"K;A2/#?BEE%8:W0'^+[F$ W-@YZ@NQ:<_PM02P,$%     @
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MA@N&BA9Z KZ?<:[:&[U ]Q%N]"]02P,$%     @ YX1-5O0U/T*K @  X 4
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M>I>]C@.JNB>50C(O=W@AR5R$4DS,"49E'<S[4DK:*39 ?=3'_P!02P,$%
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M37/V$$L^ 18^&555P(II U(1=*E#/@%U@#(6*'O='QP+"[P.&M")HE9T+#8
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M3S5:-;+3I+%P55N@#UB8P5M1ZJV"EV7*T_OR4_2V<YFV+E_1DPJ7?#<!SR%
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MZDS,6UG6K^EZH<7.OF!70N-[V));SE(N#0-^7PNAVX4QT/U)8_X74$L#!!0
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MH+IJVPV,;%R%6TA#]=)U-_2#@LH:T/I*2O,\L 'VOSRSOP!02P,$%     @
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MG?X+Y8 &^)Z/]WY%X%TD#0]+ > 3#*FB>9X4\"<A<5 &B-!T<UG/ )[CF[+
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MF#;T#T'M'&B_5LH>#!=@^BNM?@%02P,$%     @ YX1-5C5@I1N> @  N 4
M !H   !X;"]W;W)K<VAE971S+W-H965T,3 T+GAM;'U4VV[;, S]%<(=BA8H
MZDMN79H82)H-*] "0=.M#\,>9)N.C<J2)\E-\_>CY,3-@#0O-D7R'![*)B<;
MJ5YU@6C@O>)"3[W"F'KL^SHML&+Z6M8H*))+53%#1[7V=:V090Y4<3\*@J%?
ML5)X\<3YEBJ>R,;P4N!2@6ZJBJGM'+G<3+W0VSN>RG5AK,./)S5;XPK-SWJI
MZ.1W+%E9H="E%* PGWJS<#SOVWR7\*O$C3ZPP7:22/EJ#_?9U NL(.28&LO
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M_P A>_U5(#*'XVSPXTE7=-P(?"_FTR+,W)VNTWJ=5<%UA>\%TU_"RL%T#LD
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M0R^@+WKI(-H.JT9ZXJ@.1CJ<^BY8@8>^BHQ* 1TFDY#\LPIX#VD-Z=SO'RH
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M<(5/5)"& /<70NAF8@2TC]Z+OP%02P,$%     @ YX1-5N]D$O$V!0  NA
M !H   !X;"]W;W)K<VAE971S+W-H965T,3 W+GAM;.U8VX[;-A#]E8%C! G
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MK "]7TIIFHTUT/ZY8O(G4$L#!!0    ( .>$35;2]!8WL0,  & )   :
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M]I>?M  W#4#X"L![N)>ER37\6J:8OI3WB4S'*#PRN@D' 9^P&D,4C" ,PG
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MFR)=O[WH7Y#'M"C25?7E0D8SF943J)\_I6FQ^Z8<H#Q@J%KLV_\!4$L#!!0
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M,I+I+A+Y3"0RN8_"=)T0-5RP18U>X>M[37J-KQ\VZ76^?M*D-_EZ2IL 5@.
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M2;E'LCS(Z+[80/>=9AF-BI<[XJU)D@>P]S>49F\'>8+C3M79?U!+ P04
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MX-//E(7[<&0_.*#UNJ T#Y3F0]%T(=06JV5TWV8/6Q&LR4M^<I6G'YDD&L4
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M<?YR34E(159 O;_D/'VYR"JHCC+/_@-02P,$%     @ YX1-5E&%@,'1!P
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MBOV1/SR[!X"2*IT_;CM__(K.EZ_?7$39)LX>+Q$86Q+0Q>D(&,OM2^ \J9X
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M B0&K@>H]PO&Y/I&.VA^<9G]"U!+ P04    " #GA$U6%_^"_3T&  #@-0
M&@   'AL+W=O<FMS:&5E=',O<VAE970Q,C$N>&ULS9MK;^)&%(;_RHA6[:Z4
M#;8!@],$*<&WD3;=-.QN/U3],,  [OK"S@R02/WQ'5]B,#@3(XZJ_9+89M[G
MG+%??)PY\?4V8=_XDE*!GJ(PYC>MI1"KJW:;3Y<T(OPR6=%8?C)/6$2$W&6+
M-E\Q2F:9* K;AJ:9[8@$<6MXG1U[8,/K9"W"(*8/#/%U%!'V?$?#9'O3TELO
M!QZ#Q5*D!]K#ZQ59T#$57U8/3.ZU2\HLB&C,@R1&C,YO6K?Z%=:M5)"-^!K0
M+=_;1NE4)DGR+=W!LYN6EF9$0SH5*8+(7QLZHF&8DF0>WPMHJXR9"O>W7^AN
M-GDYF0GA=)2$?P8SL;QI#5IH1N=D'8K'9.O38D*]E#=-0I[]1-MBK-9"TS47
M252(9091$.>_R5-Q(IH(C$)@' CT[BN"3B'H' IZKPBZA:#;-*5>(>@U3<DL
M!&;3"/U"T&\J&!2"0=.4K$*0^:N=7[_LXMM$D.$U2[:(I:,E+=W(')2IY34/
MXM3L8\'DIX'4B:%+ H:^DG!-T3TE?,VH=++@Z ,:)=&*Q,^_<C0/8A)/ Q(B
MPCF5'Y)XAL* 3((P$ 'E2"R)0(11%.6(&9+[\Y2\R<CO;"I($/+W$OME;*-W
M/[^_;@N9?9I#>UID>I=G:KR2:0?=)[%8<N3$,SJKT=MJ_> MO:/66V_I/;5>
MU]\"^&\ # 6@+:][>?&-EXM_9RB)8[JZ1!WM AF:8=0D-&HNU^LNR'ERY[SD
MW?.B>VJY3:=2KK\J]\^3X^9R36&$3GD7Z&2\SBN\C[LO\U7=-S-7=^O5:3V^
MXBLRI3<M67 Y91O:&O[RDVYJO]69"A)F0\(<2)@+"?,@83XD# /!*K;MEK;M
MJNC#T9+$"XJ">+_8)'/YL,."#4F?HM"6,$9BL5^NZ@RNC'.JP2%A-B3,R6&]
M#)8^!F^&7:.O:?(6LMFW[O$PT[*.AGF0J?G',7MFYR@F/A[V0==Z^^,J3NJ5
M3NHIG71[/\+H=O3'%SS&G_&GW]'HT^/#)<*XSBQ*U*EF@839D# '$N9"PCQ(
MF \)PT"PBH?-TL/F647<A+0M),R&A#F0,!<2YD'"?$@8!H)5;-LO;=O_GXIX
MOZ8V= VS;QP4D5'=P,[ L ZKC=UTH%,SL*N9QZ%=Y;DXU5!UZ5G5:IB;!3(J
M!H)5S#(HS3)0FF6UGH3!],40M2Y0 DZ]S4'";$B8 PES(6$>),R'A&$@6,6Y
M5NE<ZZSJ;$':%A)F0\(<2)@+"?,@83XD# /!*K;5M=T"L::\Y=J[.OSBX><+
M-!9$9$O%::EVRP7BAX0'61/C+^=)I"V124B1$Z\CRDAZ_._:=5]U CLZCKE@
MZWR!>KR>_$.G HD$W9-X1D3"GM$CG=%HE0:2&5(APCS%SY1%_ +MK77+I,=+
MPFJ?(T;J?$[]^H#2G!_L7+F@L_-^L-GY/U@^&.IL5V\%>[TB73W?,LT+.:'I
MFK$@7J!_T4>ZH2&J6\>^4Q-/K6N@-!N4YH#27%":!TKS06D8BE;UM+'SM*%\
M+KO-6IJUCV2%$LJ[D#0;E.: TEQ0F@=*\T%I&(I6]>ZN:Z<KNRM#'&\H%WG5
M6=)PEBZBR#+$!2+3:;*.1:VK.T>K!GI/LTRK:PX.UDG4X4^V+&BOKODT7-#
M7GU@33,UO7>P[-)\*(;*L>JD72--5W?2WJCL<JO!RHLZQLGW2] V&BC- :6Y
MH#0/E.:#TC 4K>KR79-/[YVU!J.#=O9 :38HS0&EN: T#Y3F@](P%*UJX%V'
M3U=V8O;78M[HA10@<[_T9)V!PUZ(.N+)+@5MY36=A L:UJL)VQD8-6V5I@,Q
M5'Y5V^PZ;+JZQ::N[IVTNF>^HF@5RBRRE0EEH8?L)XU :38HS0&EN: T#Y3F
M@](P%*UJ^%V74!^<5^A!FX2@-!N4YH#27%":!TKS06D8BE8U\*Y9J"N;.J<4
M>NOH;\RNU3$&1W4>M"<(2G,:SL$%C>K51-7[@[HRWW @ALHO-TU[[ZV.B+)%
M]DH01]G"3OX_LN71\K6CV^QEFX/C=_K52*\Y[NA7;MUQ/WU]*7N[9!<V?_?I
MGK!%$',4TKE,0;OLRW/"\M>)\AV1K+)W32:)$$F4;2XIF5&6#I"?SY-$O.RD
M <J7NH;_ 5!+ P04    " #GA$U6AWI]8@,'  #>30  &@   'AL+W=O<FMS
M:&5E=',O<VAE970Q,C(N>&ULQ9QK;^)&%(;_RHA652OM@B]@8)L@)=@S@[3;
M39.]J*KZP0N38,5@UC8D*_7'=VP<S'CM6:R^$OF0<)GSG/'XU3F9<VQ?/$7Q
M8[(4(B7/JW"=7':6:;IYT^LE\Z58^4DWVHBU_.8^BE=^*M_&#[UD$PM_D1NM
MPIYE&$YOY0?KSN0B_^PFGEQ$VS0,UN(F)LEVM?+C;]<BC)XN.V;GY8/;X&&9
M9A_T)A<;_T'<B?3CYB:6[WH'RB)8B7421&L2B_O+SI7YAMNY03[B4R">DJ/7
M)#N4+U'TF+V9+2X[1C8C$8IYFB%\^6<GIB(,,Y*<Q]<"VCGXS R/7[_0:7[P
M\F"^^(F81N'G8)$N+SNC#EF(>W\;IK?1$Q?% 0TRWCP*D_PW>=J/=>3@^39)
MHU5A+&>P"M;[O_YSL1!'!K;58& 5!E;%P!HT&-B%@5TQ,,<-!OW"H%\U<!H,
M!H7!H&K0;S!P"@.G>@S#!H-A83 \]:!'A<$H/[O[TY&?2]=/_<E%'#V1.!LM
M:=F+7!"YM3R%P3K3[ET:RV\#:9=.J!_$Y),?;@5Y)_QD&PLIS#0AK\E;L1,A
ML<E]-F*7CU@=C_C5%:D?A,EO%[U43B3#]>:%T^N]4ZO!Z9W8=(EMO"*685GD
M+_(SZ9%DZ<<B(4$J5C7 J1[HBKD$FCG0/,+5D-PVI(;9>&T8?]4 : M C3G3
MFU]M'[K$<%[\Z]>#GSX5HY'4DZH[2,\Z2,_*T?T&].<\KH@%\7<BEG&2B&<1
MSX-$D$T<S$6=K+3 +,R_23;^7%QV9!Q/1+P3G<DO/YF.\7N=I) P%PGSD#"*
MA#$DC(-@BOCL@_CLG&ZWBGMDMMYL96SSUXO\2S_/KQ_$?+D.OFYE>/K[K>20
MF0P+R3]U K61 D7"7"3,0\(H$L:0, Z"*0+M'P3:UT='/XY]F6=?'6==$F3Z
MK!/>'F;N:=D_K+N).>S:,GOLCB75,,Q2A[G:J;45"Q)&D3"&A/&ZI1UU[?%A
M:149# XR&/R?)$G^)5?OIC-R-?WSX^QN]F'V_@\R?7][TR6S69U,M,[:QB<D
MS$7"/"2,(F$,">,@F"),YR!,YQP)U$$*% ESD3 /":-(&$/". BF"'1X$.@0
MF4"'->';[ XJ^?.D4:YV8FVE@H11)(R=M!@<Y%+1P.B@@9%6 ][S1LRS[+F+
M0AF*PB#]5G?NM9"V00<)<Y$P#PFC2!A#PC@(I@AN?!#<^!Q9<8P4*!+F(F$>
M$D:1,(:$<1!,$:AIE 5? YD7"YHY.(KR1G?HC"N94>^UK:R@- ]*HPTK8CCJ
MBC"H5U[O=31JV%^:1PT LVV.;+NKU'MH&Y^@-!=*\Z T"J4Q*(VC:*HJR]Z
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M;BU,8:Z5HJH28+YM/7,CJE#JZ<8@*J^6,D>0_BB6MT"S!BAY NA+[GK0O[J
M)$X2> X,;,$-VG;X5Y!1MEW*29=R$DX8_&?*\.,C><"-0V5_G@)NY(:GY7S7
MC&W%<YQ$U!86S0ZC[,6S_F7\]@SLH(,=G%///M=JB0;T^E &86V-*_A]LAX-
M;Z-X&11]4^ZRT2CV3\IV)U"&'<KP+,JB-GE!#0"5$3E>0$5<=2D<L?S]3*=X
M&MG1$4__,0H[^H/]9?")FXTH+4A<4U#<>T/1IFFPQG"Z"C_U4CMJD3 MZ$Y"
MXQUH?ZVU.QB^3[I;+OL#4$L#!!0    ( .>$3592*=BV2A,  *$  0 :
M>&PO=V]R:W-H965T<R]S:&5E=#$R-2YX;6S-G>]OVS8>A_\5(3?<;4"16++E
M'[TT0!I1)(%U#=9N>W&X%XK-V,)LR97DI!WNCS]*EDW3IBDI]UEV>[$Z#O60
MMI_0E#[Z2M?/:?9[OA"B<+ZNEDG^[F)1%.NW5U?Y="%647Z9KD4B?_.89JNH
MD#]F\ZM\G8EH5FVT6EYYO=[P:A7%R<7-=?7<?79SG6Z*99R(^\S)-ZM5E'U[
M+Y;I\[L+]V+WQ,_Q?%&43US=7*^CN?@DBE_6]YG\Z6I/F<4KD>1QFCB9>'QW
M<>N^Y9-!N4'5XM=8/.<'CYWRI3RDZ>_E#WSV[J)7CD@LQ;0H$9'\YTG<B>6R
M),EQ?*FA%_L^RPT/'^_H8?7BY8MYB')QERY_BV?%XMW%^,*9B<=HLRQ^3I^9
MJ%^07_*FZ3*O_N\\UVU[%\YTDQ?IJMY8CF 5)]M_HZ_U&W&P@>>=V<"K-_".
M-NCWSVS0KS?H'VTP.#>D0;W!X'@#_\P&?KV!WW:#8;W!L.V01O4&H[8;C.L-
MQL=OJWMF@TF]P:328?OY51]^$!71S766/CM9V5K2R@>50=76\C./DU+V3T4F
M?QO+[8J;0.33+%Y7XJ6/SL=L'B7Q']%6Q&3FO-_D<HL\=SZN158]G3O?!Z*(
MXF7^P_55(8=0@JZF=7=DVYUWIKN)\R%-BD7ND&0F9H;M0_OVKML$H T SP*X
MDF_>_AWT=N_@>\]*_!!EEXXW?N-X/<]S?OD4.-]_9WIG[EI@>D<8YSOGRLD7
M429R S&P$V\W<TD<5D370#P/)G;P)[&^=/J]HZ'&A5BUHH=V>B"FDNX>#;LU
MG;Z$W@;,VH-[G<#<#OXI?9(?XZ1^MTT43=O^_@^_7V'[N#]\P]C?;SL9F#LI
MOZG?YNMH*MY=R*_B7&1/XN+F[W]SA[U_FOY"D+  "2-(6(B$422,(6$<!-/L
M'NSM'MCH-W=I,HLKE^5ZT'G<%)M,. \[I:?IZB%.MJXGF]6#R,H_@=VOY=^J
M_**-5YN5\Y]JWC%Y;^V^J_=(6("$D2UL6,'*=?/3C7M]]70H<V,+BAP00\(X
M"*89ZN\-]1L,7:VD?MOY_(VSCC+G*5INA//])I\Y<L[=_NH'Z:!U$?#>VDU7
M$Y&P  DC6]CHP+/>9:_7.]:Q73/:KAEKUXR#7JCFT7#OT=#JT7T63T4Y?3U'
M618E1:,O5EQ77Y"P  DC6]CD<%YR+_TC6[:-W(&U%6W5BB%'ST$PS:C1WJB1
M?69:1O([\L H^0V:E<<,WCCBJ\BF<2Z<]9%U^;Z1W#V,$V>6+I=1EG>9QZR#
MZNHE$A8@800)"T>GD@\NAY,C?UNU8H96D\M)_VBJ PU?$W.\%W-L%?-3M*R<
MD_(]1864<"E[6@EIZ-["TKVM8J5PYV6S=M15-B0L0,+(^&1QYGF^YQU]J&&[
M9K1=,W;:K#_N>^/C+TW0"]5,FNQ-FC1\::93(6:YDXFIB)_$S'G,TM6I6"9U
MK.2NZB!A 1)&D+ 0":-;F'_H5V_[WY&(IPV/6G#0N#0'W9XZ]-JS6OA+,A/9
M<R;W4Y.Y,XOS:;HQ*V?G='4.2@N@-%+3#C\SUS=\MB&T6PJE,2B-HVBZI ?Y
M@&N5-!"/(LOD#+EI;:L5V-E6)"V TDA-.[35]WR3K2T;TKKAL*DA@[X0CJ+I
MCGG*,<_^=1Q]*[]M\^I@79P\B;RHEG5RK3>-\H5\RBFR35XXT?2\==8N.EN'
MI 4US3"K'7^N!-IQ"*51*(U!:1Q%TPU688IK/9K=X7CS)J_W8>H5J-Q#GDK7
MH[DP6@W-5Z"T $HC->UPYAN?3*/-;2AT5 Q*XRB:+JG*1-RVH4@H)0VWDNYS
MOKL#23\O9/^+=#ES[O=Z.A^?$Y'EBWAM%!4:B$!I 91&W-/$PS\1M;D-A8Z*
M06D<1=-%5=&(:\]&/CXLX_G6Q"*5^^@S(5;._48^.W4^;=/T^-&16L;%-V>6
MRA^3M"AGV?52R-WWR"SU]U$N?U7/MZ8S--[;A]598FB8 J61FE;N6YQ-]EJT
MH=!1,2B-HVBZQ"J7<>W!S$MFVY]$X7R.DGG\L!3.;9Z+PGCTTMYS9T^A(0Z4
M1FJ:MN-4+9M/9&W9D+9MR* OA*-HNHPJTG'MF4Y]SIN<3=4L.?VRB?/*4*-C
MT#P&2@N@--+PUGD#9U6]>\8=K)=O2Z&O@D%I'$73=55!CVM/>GZ67_FK[;EI
M\OLZ3F?.9BT?3Y=I+F=1HZ[01 =*"Z TTO#6N3UG%GTSR_K2+2GT%3 HC:-H
MNJHJ27+M4=*'Z&MUJEBT7*;/8E8>&<W3Y:9R5WQ=BR0W)Y!V;&=AH4$2E$;<
MTQS&-1[2;]>.0D?'H#2.HNEGHJM$R;,G2I^CKTZZWWDR>F<G=/4.2@N@-%+3
MM)WP_O#4.VBO%$IC4!I'T70[593DV:.DW]+L]S(\FD;KN(B694U2/(V-1_/M
MI,Z60C,D*(UXI]%0WYAX&AH:IT?H\!B4QE$T74"5,WGVG(F<.WVM\>0T.[BS
MC]!T"4HC4%I8TYK.4&O7C)F:&<Y10[T$W3*5!7GV+.BG?45!7?E3G@2I1+-(
M!@U[H+0 2B/>:9!S?$"GN0EM;L*@P^8HFBZ6RF\\>WX3;I)97H;AGZLP_'8;
MAE=ZK;<'QRNWFB<S:%8#I050&JEI^G?FL6C-;6B+-@PZ<HZBZ:JI!,:S)S#[
M$R078CDKE4NW58!R]5:?@U$%W<]'*[KU)ENGN?$ C;W#SM)!LQ4HC=2T0UE&
MAN7<::N^<3G7KAV#O@:.HNGZJ>S$LV<G'[;U=T:/H-D'E!9 :01*"Z$T"J4Q
M*(VC:+J[*FKQML?&_^3":@^:OT!I 91&H+002J-0&H/2.(JF>ZXR&L\>%_Q%
M96+V477^NX &/5 :J6D-.\5ANV:T73,&?0D<1=,55=F,9\]F_H?C/=!T!DH+
MH#12T_3J5I-F[=K1ENT8]%5P%$V_E(K*7?KVW.7'*/DC^BRF"X<NTX=H:5+*
MCNBJ%)060&D$2@NA- JE,2B-HVBZQ"J>Z;NOL7#M0Z,;*"V T@B4%D)I%$IC
M4!I'T73/50K4;Z@VVF331;1;%;RI%I^;)&Y>%-BYG<TV% 4='=0)H#T2*"V$
MTBB4QJ TCJ+IOAY<J*VAMNBOV=&RCZJS[?T6MF,OV8:]9AOVHFW8J[9A+]OV
M9X1<?15R]>TAUYU<5L2S>H'A3,N?\BIWD'*++YNRXB-."B&[-I\;;\=WUM80
M_(S=D:ET,X#V3*"T$$JC4!J#TCB*INNK@K-^4W!63L3[:;9YEH7&8OW3L.AT
MEH6&75!:"*51*(U!:1Q%TS55 5N_H3BI+*O?9;NW'^[X/_+F$GL[L[.KIX4X
MGOE"+@&T8P*EA5 :A=(8E,91-%U9E:OU[;4T+S^8:P=W]G;48HZ%!F106@BE
M42B-06D<1=.%50%9WQZ0'1\4EIY:SFNPPSI+"LVUH#0"I850&H72&)3&431=
M9Q6F]2>O<G@8FJQ!:0&41J"T$$JC4!J#TCB*IE\X7F5Y WN65];@%[L:_.AL
M#;Z=TM7CP>EU[XQ5Z0&T6P*EA5 :A=(8E,91-%U1E=0-[(54VR/"M\[N&O)%
M.OW=Z"@TBH/2 BB-0&DAE$:A- :E<11-%UE%<0/O-=84 V@P!Z4%4!J!TD(H
MC4)I#$KC*)KNN8KP!DV7!P3=[,/>3V?3H25B4!JI:8TW_&C9CK9LQZ"O@J-H
MNG<'=T&RAVF[BNN[NC[GQS0Z,X-"4S,H+8#2")060FD42F-0&D?1=)-5KC;P
M7V6E (W;H+0 2B-06@BE42B-06D<1=,]5\'<P![,?=P4>2&%+F?MAV@9)5-C
M-:6=TMEC:!4<E$8&IS'A<2EE<Q/:W(1!A\U1-%TC%98-[&'9I\U#+KYLRHNH
MDZ<S-S*Q(SH[!*TP@]((E!9":11*8U :1]%TB56 -AB_RG<^-%F#T@(HC4!I
M(91&H30&I7$43?=<)6L#>YD:\+YF]IXZNPY-UZ T J6%4!J%TAB4QFN:=GLV
M=^@=7)Y>OYVMRLU\>VYVO.20GK8IB[-3NQH+I050&H'20BB-0FD,2N,HFNZU
M"MO\5RF+\Z%9')060&D$2@NA- JE,2B-HVBZYRJ+\_^DLC@[M[/9+<KBH#T2
M*"V$TBB4QJ TCJ+IOJI,S?^_+(NSCZJS[89+&)[8#LW5H+002J-0&H/2.(JF
MVZZ2/-^>Y'6M*[+C.FLZ:*$I-*:#TD(HC4)I#$KC*)JNJ8KI?'OYV\N+-.S@
MSL*V*(2#]DB@M!!*HU :@](XBJ8+J_(VWYZWM3AJ8:_;L/,[>PM-XJ T J6%
M4!J%TAB4QE$TW7 5!?JO<CU*'YH60FD!E$:@M!!*HU :@](XBJ9[KM)"WUYN
MU[)NPT[I[/'X9)UAKMN =DN@M!!*HU :@](XBJ8KJH(^WQ[TO:CJWL[L+.SI
M3;;.5=U#.R906@BE42B-06D<1=.4':I4;VA/]?C]1^=?'T1Y1Y-_F^RT;][5
M3B@M@-((E!9":11*8U :1]%T@55\-WR5^&X(C>^@M !*(U!:"*51*(U!:1Q%
MTSU7\=W0'M^INTZ5H5WNY.7]Q&VG"MEYG8V&%LW5-.UXLV]:I!!HOR&41J$T
M!J5Q%$VW585W0WMX]^*PV<[M;"VT &[8?(U+ NTQA-(HE,:@-(ZBZ;ZJ^&UH
MC]_^HK#9/JK.MB-I04W3;BCA7OK'OD-S/"B-0FD,2N,HFNZ[RO&&+>__EHFI
MB)_$S'G,TI43RRDZKN[S5MUN,'U\%%F<S-\X\RS-S09#8STH+1@:0D+?>"R$
M0#L.H30*I3$HC:-HNL8JW1O:T[W/<A[.HVFULW>7GKEBL)W165%H@E?3M(5P
M?S3V_(%W;"@TG8/2*)3&H#2.HNF&JG1N:"_4^[6Z#(1<-&Q7&.^=Z<$U?9RB
M]%?.L9F<@(O4N4VF"[FFX,F3D+^72XFH.#<E&T6'1GA06E#3#D4?^KW)R!\?
M>PY-YZ T"J4Q*(VC:+KG*IT;VM.Y7Y*9R)ZSN+J4^RS.S\8==DYG2:'5>C7-
M<%CB6%)H/@>E42B-06D<1=,E5?G<T)[/!:*>:S>M;86&<U!:,#RM]/(]WV0K
M-)J#TBB4QJ TCJ)IMHY4-#>R1W,?BT5UP'?[A2\7#F?6MW9,5T>AM&!DN.ZE
MYXW&@R-%H;V&4!J%TAB4QE$T75$5OHWL%ZKL>M:Z'==956C*5M.L1W>A/890
M&H72&)3&431=4Y6=C>S9V<O/6K>#.PL+#=%J6L,!6FB?(91&H30&I7$435=6
M!6@C>X"FXMZMG-4DJZRU& L-T*"T8&2HACO6%9J?06D42F-0&D?1=%U5?C:R
MYV<GNL:)$^T27XNLT/P+2@MJFE56:/@%I5$HC4%I'$73957AU\@>?BE9]TEN
M2UVA81>4%M0TUSWPM7>Z&H#F7% :A=(8E,91--U8E7.-[#G7X5FZTM"V]P>P
M4SO["DV^H#0"I850&H72&)3&433=:Y6.C5ZE=FT$#;Z@M !*(U!:"*51*(U!
M:1Q%TSU7Z=C(GH[![@]@[Z>SZ=#TK*8U78&?0'L-H30*I3$HC:-HNL,J/!O9
MP[/[^NJ5][NK5QK]A.9E4%H I1$H+832*)3&H#2.HFD6CU6H-NZ]QHIC#,W<
MH+0 2B-06@BE42B-06D<1=,]5\G<N"F9JT_PW94CIUN?D_FN%MEY3#/GN;Z!
MS+2^@<QZDZW3W'A+ GN'G96'9G?CT^QN8CIO!]IK"*51*(U!:1Q%TV56^=VX
MX=*5QTL/N4X^?>ZW^F">45YHC@>E!5 :@=)"*(U":0Q*XRB:KKC*^\;]5UF7
M0-,_*"V T@B4%D)I%$IC4!I'T73/55 XM@>%]UW/P+#S.AL-C0AKFG;*T/&*
M QH10FD42F-0&D?1=$U51#BV1X1_43VH?52=98<&C#6MX70C:)\AE$:A- :E
M<11-]UT%C..&RV3B;E%C[ZFSP]#0<7Q:;M<W%GA NPVA- JE,2B-HVBZQBI/
M'-NK[<Z4-9]8;?06&B)":4%-\YN]A>:#4!J%TAB4QE$TW5N5#X[M^>#/(B_D
M:J+:K7/D'M^N+K1<.\3IK)R9BW@EG.BQD$\^[/8%I^GJ(4ZV.XGR\7HIRH=&
MN:&Y(906-+PW_9XSB[Z9OFH(=!PAE$:A- :E<11-MUTEB6-[DOCRT_'MX,X:
M0^/%FM:T/H;&AE :A=(8E,91-$W9B8H-)_9:O!>?CF_G=C462@MJFNT,9VB'
M(91&H30&I7$43==5I7\3>_KW:2T7$FEF%!(:XT%I 91&H+002J-0&H/2.(JF
MNZO"OHGW&DG(!)KX06D!E$:@M!!*HU :@](XBJ9[KA*_B;W"[W8^S\2\.BRA
M72S3*#,TUH/2 BB-3$ZOL5E=TT)?EX3MFE'HV!B4QE$T73\5Q$WL0=QO]9D_
M=_69/S^FD?'(P<20<9D./=W9^^ML%9)&H+002J-0&H/2.(JV=?0J7PA1!%$1
MW5RO1#87=V*Y+(]B;1*)+Q<(^V>=3#Q*A]VWM][%U<GSU'W+W/+Y*X6YN5Y'
M<_$ARN9QDCM+\2B1O<NR;JN*Y'8_%.GZW85<X#RD19&NJH<+$<U$5C:0OW],
MTV+W0]E!>8)<->R;_P)02P,$%     @ YX1-5B<&-KHA!@  538  !H   !X
M;"]W;W)K<VAE971S+W-H965T,3(V+GAM;+V;:V_B.!2&_XK%KE8S4K?$ 0)T
M*5+;W*-JJT&S^V&U'UPPD)U<F-BTL]+^^'4N#80&QVB.IA]:$L[['(>\Q[%Q
M/7M-LR]L2RE'W^(H8;>]+>>[FWZ?+;<T)NPZW=%$O+-.LYAP<9AM^FR74;(J
M1''4US7-Z,<D3'KS67'N*9O/TCV/PH0^98CMXYAD_][3*'V][>'>VXE/X6;+
M\Q/]^6Q'-G1!^>?=4R:.^C5E%<8T86&:H(RN;WMW^"; XUQ01/P1TE=V]!KE
ME_*<IE_R V]UV]/R%M&(+GF.(.+/"WV@49231#N^5M!>G3,7'K]^H]O%Q8N+
M>2:,/J31G^&*;V][DQY:T3791_Q3^NK2ZH)&.6^91JSXC5ZK6*V'EGO&T[@2
MBQ;$85+^)=^J#^)(@(=G!'HET$\%HS."0248J J&E6"H*AA5@I&JP*@$ANI%
MCRO!^%1@G!%,*L%$53"M!%/5)F'M[<YIRI+Z9I>F*UU26,PDG,QG6?J*LCQ>
M\/(7A4\+O7!6F.0EM>"9>#<4.CZ_)RQD*%VCIXPRFG!2&CU9H4599/E[BW"3
MA.MP21*.[I;+=)_P,-F@IS0*ER%EZ(-).0DC]A']BCXO3/3AYX^S/A>MRW/T
MEU5+'LJ6Z&=:HJ/'-.%;AJQD15<M>E.N'W3I+;G>Z-+;<OVT2^_*]1AW ;P.
M@.P3[ M?U.;0W\QQKTN)/DFNT0!?(5W3<=L=E<L?22:5FW+Y@NZ$7"OD>MO]
M5)>W9;>_+[OS?=E=N=RD2^E'YWV?W%>7:RWR0%F.IQ(;#NH^:E#PAF=X#X1M
MKY!M>@_(2]@^HRMT%^>=4$O3[J6H?(!RPW9D26][N[S#RUYH;_[+3]C0?FOS
M-R3,A(19D# ;$N9 PMP2-BI@^>CP9:Z/-/$SZ[\<5X-:F _9M  (UJB(85T1
MP\Z*0/3K/GPAD7AHL[9"D!(N+01(F#E\=[=.;I0%F<[N3.= IG,[TWF=$3YD
M@P(@6,.HH]JH(ZE1K?6:%I,FQ,DWE!%.VZPJ95QJ54B8"0FS(&%V"<MG$&=M
MW1WB=H=XW2%^=T@ =.T-$QJU"0VI"1=B5K/GJ9C+O)D0?2 ,$;2CV5)TGVV3
ME7NCY9JN\\'4\64]*$692E&64I2M%.5(/Y!+>S2EE)Y2E-\>-3EQ"U#S&VX9
MUVX9RY^M:1R+*;"8>R^_(+9__D=T8(BG:)<R%CY'%(GQ)XUW^3SY"J5[SKB8
M+8OI<)N)I)DN[=@@868),XY'3-.1CB?X]%&L&FBK!CJJ@:YJH*<:Z+<$CL8B
M=JB?&+ E<&!,1X/!@=@PUZ0VUT1JKKO-)J.;O ?:[;/EEC":?[]2>*W-/U+8
MI?Z!A)F0, L29D_>W;K!$..Q,3[M(UL"!Q-CK!N#$Q]"-L]K;=YXA/%)5K\E
M4!OKVE@["0R FM?P\[3V\U3>64:$,72'CCO--B-+*9<:&1)F0L(L2)@-"7,@
M82XDS(.$^9"P  C6*"RL';Z8UW[8.$2>ZM+Z Z69H#0+E&:#TAQ0FEO1CA\0
MN/C2Z]VW8\J1/F@+ RA:LX".5K8PY%A+3KNX1B!I)BC- J79%:WA+MSF+@<T
MKZN<UP/-ZX/2 BA:LT;T0XWH%X_?T'_(>_H=_?5(XV>:_=U:*U+JQ;4"23-!
M:18HS0:E.: T%Y3F@=)\4%H 16O6W&$U$W<L9T(.[$"7.T%I)BC- J79H#0'
ME.96-)6!G6JD#]K" (K6+*##XB?N6/UL/K0612$M#H7TJ:Z?UI(!71@%I9F@
M- N49H/2'%":"TKS0&D^*"V HC5+[["<B^7KN:#/+M!E7U":6=&Z>U8+-*^M
MG-<!S>LJY_64(WW0%@90M*;Q#TO(6+Z&K/[,49D^02[//H#23%":!4JS06D.
M*,T%I7F@-!^4%D#1FI5X6)['/VY]7I[JXD($7:''[]>@SSV"(//:RGD=T+PN
M*,T#I?F@M "*5A90_VCS1TRS3;$_B:%BET;Y/];UV7H/U%VQ\^?DO(UO'-QR
MWL,W?KG9Y( O-UP]DFP3)@Q%="U2:==C\8S.RCU,Y0%/=\76D^>4\S0N7FXI
M6=$L#Q#OK].4OQWD">J=9//_ 5!+ P04    " #GA$U6WG**:? &    .P
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M#M$6%XJO\S.<3UPIGN8O5Y3$5)@"^OT%Y^KYPE10'66>_@=02P,$%     @
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M-'-L-*87MIM>QXQL?77JS@U[#;TU!;7+0&D!*(U T4SE&[L,CU[(W\:@NZM
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M6^I0YWRJ/X"B/#-:WBB^+LXX/G*E>%I<1HSJ)5=>0+^^Y%SM;O(*ZI.[\_\
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M\F#.TW) \?OGI/A#4-\I)RB_5*M:G>G?4$L#!!0    ( .>$35:M>CPQ5@0
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M*\!R<Z,JR.\+2L7V1370W"3/_@-02P,$%     @ YX1-5E'Y#X"5!0  @"<
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M=4O)FO+<0/V^84SN+_( ]:&[Q7]02P,$%     @ YX1-5HZ/-+^) @  7 <
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M(@/$_24A_*D@&VB/I<(_4$L#!!0    ( .>$35:\O 3^-00  )<4   :
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MPNB9,>[&$S :?WJ:3">?)_<?P?C^\>$:3"9U!$:I<S?B-L5P2V([*41P4ZC
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M>))?+BF949$9Z/=SSM7;339 U8L<?@=02P,$%     @ YX1-5AL7L"#S!
M5R   !H   !X;"]W;W)K<VAE971S+W-H965T,30R+GAM;*V::V^K-AS&OXK%
M+DJE+3$DY-(ED=H""4C5JG;G[,6T%PYQ$G0 Y]A.TO/M9PREN5!#5K]IP/R?
MGPU^?._X0.@WML&8@]<D3MG$V'"^O>UT6+C!"6)MLL6I>+(B-$%<W-)UAVTI
M1DLI2N*.!6&_DZ H-:9CF?9$IV.RXW&4XB<*V"Y)$/UQCV-RF!BF\9;P'*TW
M/$OH3,=;M,8OF'_9/E%QURDIRRC!*8M("BA>38P[\S8PI4!&?(WP@1U=@^Q5
M%H1\RV[\Y<2 68EPC$.>(9#XV>,'',<9293C>P$URCPSX?'U&]V3+R]>9H$8
M?B#QW]&2;R;&T !+O$*[F#^3PQP7+V1GO)#$3/X%AR(6&B#<,4Z20BQ*D$1I
M_HM>BP]Q)#!['PBL0F"="^P/!-U"T&TJZ!6"7E.!70CLIH)^(>@W?>E!(1B<
M"_H?"(:%8-A4,"H$HZ9%,N%;S4'IH+S*I5\<Q-%T3,D!T"Q>\+(+:3JI%S:)
MTJQ]O' JGD9"QZ=^&I($@[_0*V;@=_",0Y*&41PAZ5ZR GR# >.([SBA/\ *
M+S%%,8AR&4>O@"*.06N!4[R*^ UH.9BC*&8W@O;EQ0&MGV_&'2Y*FN77"8M2
M/>2ELCXHE04>2<HW#+CI$B\K](Y:WZW3NVI]OT[OJ?6C.OU<K3?-.H!? U!]
MP8[P2&D4Z\TH]Y:2&*"T#;KF;\""EEE5HVKY(Z)*N:.6O^"MD$,IMZKJL[F\
M*G?O<[G//I?[7"UW<*C\=/[GY$%S.53XJ%MV.%W)Z]9V.,")6!@3MJ,8_'.W
M8)R*P?+?BA+>Y\1>-3&;0=RR+0KQQ!!3!(;I'AO37W\R^_"/*I_JA#DZ8:Y.
MF*<3-M,)F^N$^3IA@2;82;OHE>VBIZ)/'S8H76,QL((]BG?Y\(MB,7U%:8BK
M&H42=VVCT ES=,)<G3!/)VRF$S;/8;:$96N:_=0:07,H.NS]L=TOPP8C>P@A
M/(T++N-L&]K'<2<FM4N3VDJ3'G7>[JM8HC$Q\[LO9GY5'E72KO6H3IBC$^;J
MA'GV1=6=5>ZL-F)>&^'71@2JB!/S]$OS])7F>:E?18C>;XMIB--J.^7\; GT
M7J:V==9&'AI%.8VBW$917J.HF?+K7-M?-,K2;Q055$<-JVM[4-;VH.%XMD(1
ME8,:SM:3HN:C/<HV1< !48I2#L1J<R&6G#P22] Z"R@SO;9'T0ES=,)<G3!/
M)VRF$S976Z@UM.WV"/Y2901?9SD"3;"3AC(L&\I0^99_KE:B2:1K$!+&F9SS
MA:(S7 )./MM8E!E?VUATPAR=,%<GS-,)F^F$S8>7W;35-GMG7;[:;"W8[E8W
MJ*# 6R>C (1V]3 P*MT]^O_+FEH#*]G7&E@GS-$)<W7"/)VPF4[8?'3IL'[;
M@J,S!ZL-U3('PI75%JY3]MKFA?+$U29\WS:'2I@K>FUYM%/.7JO\JX9<:V"M
M-$<KS=5*\PK:Z93T;#K=(&;>(,9O$!.H8TXM='3R8BHM]+79/H^:<K6'=-(<
MK317*\W32IMII<T+VO'BVC2[UJ!_L9/C-P\-JD+AL OAY;Y/Y^C$,,%T+4^H
MF9B"[E*>[^67J>4I^)T\^SU+]\S;F5F1[F>GYO*$\AV?'[D_(KJ.4@9BO!)9
MP?9 E)?FI]CY#2=;>5ZY()R31%YN,!)3X2Q /%\1PM]NL@S*_R68_@=02P,$
M%     @ YX1-5E^%4H#5!   <R<  !H   !X;"]W;W)K<VAE971S+W-H965T
M,30S+GAM;,V:VV[C-A"&7X50BW872*V#3W%J&\A:;!M@4P2;;GM1](*6Q[:P
MDN@EJ3@M^O"E9$4R4X4K%5,@N7 DF_.1_,<:^A<U/W+Q2>X!%'E,DTPNG+U2
MARO7E=$>4B8'_ "9_F3+1<J4/A4[5QX$L$T9E"9NX'D3-V5QYBSGY7MW8CGG
MN4KB#.X$D7F:,O'G.TCX<>'XSM,;'^+=7A5ON,OY@>W@'M3'PYW09VY-V<0I
M9#+F&1&P73C7_A4-1D5 V>+7&([R[)@44UES_JDXN=DL'*\8$200J0+!]+\'
M6$&2%"0]CL\5U*G[+ +/CY_H/Y23UY-9,PDKGOP6;]1^X5PZ9 -;EB?J S_^
M!-6$Q@4OXHDL7\FQ:NLY),JEXFD5K$>0QMGI/WNLA#@+\$<O! 150/ \8/Q"
MP+ *&';M850%C+H&C*N <NKN:>ZE<"%3;#D7_$A$T5K3BH-2_3):ZQ5GQ1?E
M7@G]::SCU/(^7TOXG$.F"'W0KY*\"4&Q.)%OR7?DXWU(WGS]=NXJW541X$85
M]MT)&[R$A<. #+T+$GA!T!*^LH??,C$@WN6+X:$]/(1(]^Z7X7Y+..T>[IGA
MKI:WUCBH-0Y*WK"CQN3W][H%N5&0RC_:M#WA1NVXHG1<R0.+8.'HVB!!/("S
M_.8K?^)]WZ8T)BS$A%$DF)&389V3H8V^O-[M!.R8 A)Q7?4V(%A1N-JR807U
MS<8)-BYA11%_6/J77O4W=Q_.M<;LER+!#*U'M=8CJ]:KA$E)^)8<F1!,?_^Y
M(*(HX!<$'D%$L01R$'$$9VUDW4A7I#@C&YXD3$AR +W*[9F UJ)D'4??5&'"
MPA-L=I[WT6 R,U-.6UK-!K-AW<J0?US+/[;*?QMG<9JG;7I9 _OJA0D+,6$4
M"6:H/ZG5G^ 6_PEF3C!A(2:,(L&,G$SKG$Q?24&:=KGL5];1]LU2IRXI4I>&
M_)>U_)=6^=^S["_V"T1[\F/"URQI$\Y*Z'L58,)"3!A%@AEIF-5IF.%6IAEF
M3C!A(2:,(L&,G/A>X\<\Z\5QEXMHSYX*T$597_(L5JT>S(KJFY&*9OPV??Z;
M%+5'BD4SI3ZSOOXK60;L ^F=*+]#HC![I%@T,U&-?_:M5G"Y8G)/]I!LB%;\
M^G9U\ZTD2N12$19%/,_:+PY4%UW1SC4/ANV^#;5CBD4SI6]LLF_WR<_7:O(W
M>;YNM(J/:II1:2$JC6+1S/PTUMH?X2[B/JI'1J6%J#2*13,ST[ANWVZ[>]QA
MLI-ZYV3<<H_)G[;7*E2?C44S%6^<MF\UC?U^.J':[(IF7Y%1[3,6S92Z,=#^
M:W'0]H'T3M2T0Z(P>Z18-#-1C=7V^WEMO7Y;[@?:8;W%1O7=J#2*13/3TEAO
M']E[^ZCF&Y46HM(H%LW<JFO\=V#WWS^#(HIENWB= -%%#I1LW:)#M=[!OZWW
MN%RN_6>U";5;BD4SI6[\=V#WWR_7IHXNP\[OG01,6HA*HU@T,U-G&]C8.]BX
M6]BX>]BXF]C_AS\/&G\>V/UYUW*%ZL<KVN3+Y0K5:F/13*D;JQU\81O[O]R%
MLC-["S_J?!<*M6.*13M)[YX]KU0\CG;+Q"[.)$E@J_'>8*HG*$Y/>)U.%#^4
MCS"MN5(\+0_WP+2E+AKHS[><JZ>3XJFH^CF[Y3]02P,$%     @ YX1-5E4C
M;)K! @  L D  !H   !X;"]W;W)K<VAE971S+W-H965T,30T+GAM;+6676^;
M,!2&_XK%IJF5MD+(%^H2I#79U$JK%#7J=C'MPC$GP:K!U#9)MU^_8T-1TE*D
M5EDNB U^W^/GX(,]V4EUIU, 0QXRD>NIEQI3G/N^9BED5)_) G)\LI8JHP:[
M:N/K0@%-G"@3?A@$(S^C//?BB;NW4/%$ED;P'!:*Z#++J/IS 4+NIE[/>[QQ
MPS>IL3?\>%+0#2S!W!8+A3V_<4EX!KGF,B<*UE/O2^]\%MGQ;L /#CN]UR:6
M9"7EG>U<)5,OL!," <Q8!XI_6YB!$-8(IW%?>WI-2"O<;S^Z?W/LR+*B&F92
M_.2)2:=>Y)$$UK04YD;N+J'F&5H_)H5V5[*KQ@YP,"NUD5DMQAED/*_^Z4.=
MAST!^K0+PEH0/A4,7A#T:T'?@58S<UAS:F@\47)'E!V-;K;A<N/42,-S^Q:7
M1N%3CCH3ST$SQ0N74KDF)@5R46H<I#4YF8.A7.A3\HG<+N?DY/WIQ#<8U$I]
M5@>XJ *$+P2XINJ,!-%'$@9AV"*?=<OGP% ^;I/[B-KPA@UOZ/SZ+_@ML0R2
M4H"%O8$M* UD1@MNJ.!_J4O#K^^H(5<&,OV[C;<*,&@/8*ON7!>4P=3#LM*@
MMN#%'][U1L'G-OHCF1WDHM_DHM_E'B]*Q5(L 5(HSJ -M=(/G=Y^#[9Q+PKJ
MW\3?[H-TAGHCR* !&72"7/.<9V5&F)"X=#>$49T2)O.$VQ?:!C9X!A8.V[DZ
M([^1:]AP#3NYEN5*PWT)N2%?MWAM(^ET>.UJ/)+9 >RH@1W][\H<'3,71S([
MR,6XR<7XR NZT^^UZ./GU=%_6AT'7%'#%74O:%J]7]S6V%WUV2$GI4Y( 7BR
M2*F"UAVFT_2U<-'S;]I3*G]O/[5G&=S#-CS71, :1<'9&-6J.A]4'2,+M\6N
MI,$-VS53/%*!L@/P^5I*\]BQNW9S2(O_ 5!+ P04    " #GA$U6_#1.NZ<#
M  "L#   &@   'AL+W=O<FMS:&5E=',O<VAE970Q-#4N>&ULK5?;CMLV$/T5
M0@V*#9!=7:B;M[: ]:5M'E(LXJ9]*/I 2[1%1"(=DK)3(!]?DI(56^8JN\"^
M2"0U<V;FS) <38^,?Q8EQA)\K2LJ9DXIY?[>=45>XAJ).[;'5'W9,EXCJ:9\
MYXH]QZ@P2G7E!IX7NS4BU,FF9NV19U/6R(I0_,B!:.H:\?_FN&+'F>,[IX6/
M9%=*O>!FTSW:X366G_:/7,W<'J4@-::", HXWLZ<!_]^E6IY(_ 7P4=Q-@8Z
MD@UCG_7D?3%S/.T0KG N-0)2KP->X*K20,J-+QVFTYO4BN?C$_JO)G85RP8)
MO&#5WZ20Y<Q)'5#@+6HJ^9$=?\==/)'&RUDES!,<.UG/ 7DC)*L[9>5!36C[
M1E\['LX4X%,*0:<0#!2"X D%V"G YUH(.X7PN1:B3L&$[K:Q&^*62*)LRMD1
M<"VMT/3 L&^T%5^$ZCI92ZZ^$J4GLW5;'X!MP9KL*-F2'%$)'O*<-502N@./
MK"(YP0+<@M^87E@PFF.N<DP+L,8[5302O*=MR>K<WRRQ1*02;\$;0"CXLV2-
M4+)BZDKEL#;KYIUS\]:YX GG)N #H[(48$4+7%CTE^/Z?C "X"JF>KJ"$UWS
M8!1QC?=W 'KO0. % ?BT7H*;-V^!:%FP.+AX/IQ_@K/%.0ZSQ+F"\2]A1KQ:
M/1_.LWMU01[L:PT:7/@$KJVH_GG8",G5<?&OK3Q:O-".IX_0>[%'.9XYZHP4
MF!^PD_W\DQ][O]A2\9I@R]<$6[T2V$52PCXIX1AZMD"B-%LYUP/\I2$'5*FR
ML6[7%BHR4/H&.F21!Q-OZA[.B1XU^%*BKTWZ00K]]-+FZEHL]L))U$M=<!/U
MW$2CW*B";>JF0A(7^O)1%6O;3?,6)#ZS?1O",(WA@)=18R_EQ6(4)I,TG0R(
ML<E!J-H(.S5Q3TT\2LT?JH4Q%=,(18XZYE7GPI'9V^;N)U+M;AM9\;4_B0]A
M/. JOLKG;1 GP[0O+6AA$$W\ 0D6,3@)$M_.0=)SD/R0 T)S5F-P4S$A;"?W
M/+D.) HG23B(UR(&O:M EA:Q,(ZODFY#2Q3-]GC3/MYT/-ZFWF"N6X7OR>XN
M&0&^C=PW\_2*_T%@BU'++]T;/S2W>B5S+8WN6?M58[XS?:\ YK)K;\=^M6^M
M'TQ'.5B?^_<+W[*^5*UXVSE_AV_[^ ^([P@5H,);9<J[2U3.>=L;MQ/)]J;Y
MVS"I6DDS+-7O!.9:0'W?,B9/$VV@_T')_@=02P,$%     @ YX1-5N2D 5-;
M @  '08  !H   !X;"]W;W)K<VAE971S+W-H965T,30V+GAM;*V576_:,!2&
M_XJ555,K;>0+*&,A$B6KMHM)J*S;Q;0+DYP0JXZ=V@[I_OUL)\U #147O2''
M]GG>G/,Z-E'#Q8,L !1Z*BF3"Z=0JIJ[KDP+*+$<\0J87LFY*+'20[%S924
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M?AG*FDY8I!,6:X+U4NETJ714]'XJSY;9;0/Q:HC\YCS/; ="W_/AQ'P^C/*
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M+-L=L4(ER[%:JT&(3ANB\Y40.8U8O$-27:3H'^6OV5[^-@E5R%K2I2,.$A9
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MP1)Y.\0^2LB.9SO&BV=EG6BYO>O$[%Q-T;%1_FN/E#8TKP.EN5":!Z7Y4%H
MI84H6KL&&KN5:MVKQ<]/*>/Y)MX1H?:E&"6B!Z:4/-1LK6G4/)[TO;.FXU/!
M0XU4*,U]V0>CM0_FR2YXT*0^E!9 :2&*UE9R8Y32_Y-3JN?VEC;4*X72'"C-
MA=*\FG9\&?B63LSN*.A3E2LY%MS3EH&*:1KFN+M2KLQNT-E9HY,V3B?56YTV
M6S/.V8KP2J!*"4*-3"C-AM(<*,V%TKR:=BRLV=0:*10(-345::DQ'77U'-*N
M=TNMD66=5VGC1U*](?F%9^NX(-$VXT7\9^7+B!E!G"E]=SVLMUZAYB24YD!I
M+I3FO7)*Z9@\LT@YYOG0C@3?WY$0U9&V[!N3DNI=RDM\>#VBM]BA?B.4YD!I
M+NVZA"J7VH-F]:&T $H+4;2VV!O?D>J-1[G>$:</TGCD\L<8TGCG;,GD7?31
M:A7+ HB2<AE$I"_(7^=O>?Z@3]6[**!>))3F0&DN[5IZ(^5BCP?-ZT-I 906
MHFCMLFA<3*JW,9US#KRXBLS5%A+4Q(32;"C-@=+<FG8\(G14CTSH0VD!E!:B
M:.W?!#46J:FW2&\CSI_%:$ >HV3/2,+RG!2;*"T7ON5%@!@+"E:- ')Q7/YP
ML&JKJ@A]LKX5 :794)H#I;E0FE?3CNO+FBC&%A^:-E"EI8JT8=WP>/"S9NV&
M;34W+J>IM8H.AK^8LP1RY>^M^/Z.U>:-GM1;JE"3$TISH#072O.@-!]*"Z"T
M$$5K5T9C<IHFS/\WH;XFE&9#:0Z4YD)I'I3F0VD!E!:B:.W2:+Q/4^]]?K=C
MI.?VKA/H3T^A- =*<Z$TKZ:U9A/SKK?C*]J-YM.N6U2W:_E*D]*!.IW&*!J.
M1_/STYC&PS3U'N:=]_&;4G!0BQ)*LZ$T!TISH30/2O.AM !*"U&T=ADTEJDY
MQLU9H-8IE&9#:0Z4YD)I'I3F0VD!E!:B:.W2:'Q:4^^E??<]BWIN[SJ!6K8U
M[7A ':G6Q)VZ(6W]>GD\.VWG0KOG06D^E!9 :2&*UA9WX\::>C?VTIL1:\S)
M[8/&W*)M'=SJ\_66:9VV?<>?=:K12UJYT)YY4)H/I07JDT4-@YY.J]4-*1V=
MF58WQJ>I-SXO<?EK1&L1TYIT?]1ZJ\_56U-0KQ)*<Z$T#TKS5:?+H-U[M0)E
MPU'WO(:JAC-*SU_5-0:C>9'!6/^X/68Y2;)<O;  -1:A-!M*<Z T%TKSS*Y-
M.>W>C>=#DP906HBB58H?'CVU<<OX0_F44&F/[]-")CG:>G@2Z?OR^9LGVVUZ
MY5#%=H]>^:KM ;T*J^>/-FFKQZ%^BOA#G(I*8FO1!>/=5)PM7CUAM'I39+OR
M69+W65%DV_+EAD4KQF4#\?DZRXJ7-S+!X3FOB_\!4$L#!!0    ( .>$35;L
MIVB"B@<  !11   :    >&PO=V]R:W-H965T<R]S:&5E=#$U.2YX;6RUG.%O
MFS@8A_\5E#N==M)NB0TD;:^-M,:N[J2=-*VW[3--W!:-A QHNTGWQQ\0%N/A
MO$#XY<O6M._[8%X;D\>)N7R)DR_IHU*9\VT=;=*KT6.6;2_&XW3YJ-9!^B;>
MJDW^E_LX60=9_C)Y&*?;1 6K,FD=C?ED,AVO@W SFE^6OWN?S"_CIRP*-^I]
MXJ1/ZW60?+]64?QR-6*C'[_X$#X\9L4OQO/+;?"@;E7V<?L^R5^-]Y15N%:;
M-(PW3J+NKT9OV87TIT5"&?$I5"]I[6>G.)6[./Y2O/A[=36:%"U2D5IF!2+(
M_WM6"Q5%!2EOQ]<*.MH?LTBL__R#?E.>?'XR=T&J%G'T.5QECU>CLY&S4O?!
M4Y1]B%_^4M4)^05O&4=I^:_SLHN=3D?.\BG-XG65G+=@'6YV_P??JD+4$IAW
M((%7";QK@ELEN%T3O"K!ZYK@5PGEJ8]WYUX63@19,+],XA<G*:)S6O%#6?TR
M.Z]7N"D&RFV6Y'\-\[QL?A.$B?,IB)Z4\X=S$VZ"S3(,(N=MFJHL=8+-RGD7
M!G=A%&:A2IU70F5!&*6_Y\$?;X7SZM??+\=9WHP"-EY6A[S>'9(?..2MVKYQ
MW,EKAT\XMZ0OZ'2AEGDZ*].9)5UT3Y]8TF7G='9NIH_STN_KS_?UYR7//<"K
M5??"5LI=MF?/+F:1BW0;+-75*)\F4I4\J]'\MU_8=/*GK;!(F$#") AF=(&[
M[P*7HL\_!TD2;++45OY=IE]F%G/N\[P8M)-)/G*>ZY5MQK$9/V_$B6;<3Q'2
M0IK,ZB#C'+W].7KD.=Z^O9%.5(VU[[8SW>5/ZV<ZXYPU3]42>,9GS4#1#/SY
M7,DV']GK_KXB/ED1/?&]=CZHY5.2A)L'6V%(3-\K$ D32)@$P8R^F.[[8DI.
M@KN[C77^FR*KCX0))$R"8$;U9_OJS\@K81&DCX[Z^A0^!Y$Z, _.&M>RSYK3
MV\(6-FW.#-W")-GL(XMRMB_*V:#[\AER7")A @F3()C1!>?[+C@_^KY,9O8M
M_WEC.#+F^<UAVXSSSYKO!22H;4;-V$2_GY\,O--7@ ZW>END_5Y/-ZKOJ$/1
MS!+6E(B1)?PWSG(%JLT UBJR1FW<R1EK#IN%+=(^P.AV]:XBB&9648L-(]^T
MV]]@.?\YU&5-(_M>UU":@-(DBF9VCE8>Y@ZZO3%2F7IW!)(FH#2)HID=H;V,
MT6)&7@U-@V+^S&*?]#%ZUQ=)DRB:65]M>>P(S<MGH?(V^;(KOK7V4.V#T@24
M)E$TLX.T^C':_5IG(J@!0FD"2I,HFMD1V@(9K8'D3-0T-OLZF"70OA!&-Z9W
MZ4ZABDR[(B,]Z. D\TX]J\BQ+5)?T\3>PQIJD%":1-',OM$2R<Z/75MB4(N$
MT@24)E$T\R,.[:2<=M(N*TR\Z9K6)29KG&6-J6.<I)M^;&FT:W(V[/,?I!(N
MH#0!I4D4S>R(VN=PM*Y2MS\ZM7<G\+8/1D1[B$2UR2R7%DA.?VC6OLQ4 8AS
M6+2'"+H9O<?8*62/:]GCM.QU6ECBK9^;+=I#!-V2WG4[A<1Q+7'\.(FKWE^U
M+"K1\-Y7+U3EH#2)HIG=I%6.#U,Y#E4Y*$U :1)%,SM"JQP_7N5XT] :TPO2
MS024)E$TL[+:]/@@T^NPL$0?H/=% !4_*$VB:&97:?'CM/BUSD90^X/2!)0F
M433SVU7:_ES:_LCO5S4MK?'5JM8003>@;[E0-+-<V@A=^M-'>HJQ?6'RFB;V
M'<I0FH#2)(IF]HV61)?^MB:QF.1"'1%*$U":1-',/JA]6Y,VSRZ+26Z[>[:'
MB/802;?UV%IHH72]0?<X%VF!"RA-0&D213,[0ANJ2QLJ>8^#^F=%(\=M:XA$
MM<DLES9%EQ2@#JM'%8"\@EM#!-V,WF/L%%;G:JMS::OKM'KDMNM=>XB@6]*[
M;J=P-E<[FSO$V7C+ZA$-[WWU0GT-2I,HFME-VM?<8;[F0GT-2A-0FD31S)TB
MVM>\XWW-:_<UFMZWLE":1-',RFJU\P:I78?5(_H ?2\"*$U :1)%,[M*FYXW
M;%^>!]4]*$U :1)%,SM"ZYYW_.X\KUWSVD,$W8#>Y3J%$7JU?7[T1XST%.-:
MJPB51"A-0&D213/[1DNBYQ^[>N1!'1%*$U":1-',/M#FZ='FV67UR&MWS_80
MT1XBZ;8>6PLME-YLV#T.:8$+*$U :1)%,SM"&ZI'&RIYCX/Z9T5KW^M6!=;W
MH5LWNZ&:9U9.2Z-'[Q'LL*^]N6OOT,9V2^2!G>U0W4/1S&WP6O=\6O<Z+2OY
M3>\[L-O-%FD?8G2[^E8113.KJ-7.'Z)V;LLB$PWO>Y%#:0)*DRB:V4U:Z_QA
M6N=#M0Y*$U":1-',CM!:YQ^O=7[3V>S[WNAC]*XOU -1-+.^V@/]01[88:F)
M/D#O2P&JA5":1-',KJH]B(;6PM8Y"?L$&NPC:+#/H#F%&_K:#7W:#<DY:=IX
M/VS? 6<)M.^ HQO3NW10E1S7'BA7/"_PGR!Y"#>I$ZG['#]Y,\M/+]D]@F_W
M(HNWY3/F[N(LB]?ECX\J6*FD",C_?A_'V8\7Q6/K]@]"G/\/4$L#!!0    (
M .>$358L>64EEP0  * :   :    >&PO=V]R:W-H965T<R]S:&5E=#$V,"YX
M;6S-6=%NHS@4_16+7:U:J5/ 24C232(U 79'FE95JYEY&.V#"TYB#>"L;9K.
MWZ\-A(1 /<G(6O6E!>>><Z_/,1<PDRUEW_D:8P%>TR3C4VLMQ.;&MGFTQBGB
MUW2#,_G+DK(4"7G*5C;?,(SB I0F-G0<STX1R:S9I!A[8+,)S45",OS  ,_3
M%+$?<YS0[=1RK=W (UFMA1JP9Y,-6N$G+#YO'I@\LVN6F*0XXX1F@.'EU+IU
M;T*WKP!%Q!>"M_S@&*BI/%/Z79U\C*>6HRK""8Z$HD#RWPM>X"113+*.?RM2
MJ\ZI@(?'._:PF+R<S#/B>$&3KR06ZZDULD",ERA/Q"/=_HVK"0T47T037OP%
MVRK6L4"4<T'3"BPK2$E6_D>OE1 ' ,G3#8 5 !X#^F\ >A6@=PSPW@#T*T#_
MU R#"C X%>!5 *_0OA2K4-I' LTFC&X!4]&231T4=A5H*3#)U,IZ$DS^2B1.
MS$)$&/B"DAR##^ >,8:4T^#"QP*1A%_*T<]//KCX_7)B"YE/H>RHXIZ7W/ -
M[C&XHYE8<Q!D,8X[\+X>[T(-@2TG6L\6[F8[AUK&)[RY!CWG"D 'PHZ"%J?#
MW:[YZ.$^CB3<?1,>G YW.N#AR7!WK-&R5Z^<7L'7^^G*N0*WG&/! <IB\(F@
M9Y(003 '=QCQG.$8R!;RB*.<,9*MBJA[FK%Z8(XXX>#;)YD ?!0XY?]TK;6R
MFGYW-:H!W_ -BO#4DAV68_:"K=D?O[F>\V>7SR;)?)-D@4FRT!!98WWTZ_71
MU['/[O/T&3- EV"KVDHFUX>@8).S:"WO!("OD<P)".=Y9V^8E^Q>P:[NCR\S
M" <0]B;VRZ&3VB+.=?*TG$$[K#?JP9';# L-E=90?U"K/]"JOT@0YP?B \H
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MZ0%;\S__@$/G+Y6H)LD\DV2^(;*6_/U*_G[.WCN[:B]:*_$.(Y92O 9B"W[
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M.97O1=:<^IN"H+4^I=Y2(<^\^G(%. >F N3]!:7BOJ :Z+Z]1'\!4$L#!!0
M   ( .>$35;:"#R10P4  "XC   :    >&PO=V]R:W-H965T<R]S:&5E=#$V
M-"YX;6S%6FUOZC84_BM6=C7U2O<V<<)K!TB%9-J5UKNJJ-N':1_<Q$#4).;:
M!MII/WYV$O)2C('*4K] 8LYYSCG/<8P?\&A'Z#-;8<S!2YID;&RM.%_?V#8+
M5SA%[)JL<28^61":(BYNZ=)F:XI1E#NEB>TZ3L].49Q9DU$^=D\G([+A29SA
M>PK8)DT1?9WBA.S&%K3V P_Q<L7E@#T9K=$2SS%_7-]3<6=7*%&<XHS%) ,4
M+\;6+;P)7%<ZY!9_QGC'&M= EO)$R+.\^1:-+4=FA!,<<@F!Q-L6SW"22"21
MQX\2U*IB2L?F]1[]U[QX4<P38GA&DK_BB*_&UL "$5Z@3<(?R.XW7!;4E7@A
M25C^"G:%;7]H@7##.$E+9Y%!&F?%.WHIB6@X=)PC#F[IX+YQ$,RH';S2P7L;
MH7_$H5,Z=,Y-J5LZY*7;1>TY<3[B:#*B9 >HM!9H\B)G/_<6?,69G"AS3L6G
ML?#CD_D*4?QU*JB.P(RD8OXQE'?P*_B.*$6RC>#*QQS%"?L\LKF(*3WML,2?
M%OCN$?PAN",97S$09!&.%/Z^WA^Z&@!;%%M5[.XKGKI:Q#E>7P//^0)<QW7!
MX]P'5Y\^@T_ !DQRP<HW1:JS\X'A'EA5L1[&QZ& @6T8D*\0^*PT@_/QG7/K
M;S'M57/+RR-YE\ZM6S&QLJ6H)^/@Z14T[>[1:SY\NT,T G__+B#!-XY3]H]J
M[A7Q.^KX<HV]86L4XK$E%E&&Z19;DY]_@CWG%U5W38+Y)L$"0V"M)G:J)G9T
MZ)/OF_0)4T 6Q;S(5^4(B'4I?"XG)0/_E5>J%FG1+VV123"_ .OE8/+[=#OI
MCNQMDW=#X5J\=RO>NUK>6P\,?I'72GX+E&ZC"M?I]1W':=<R.[2#_:%S8.<K
M\+H>/+ +%';>T&W:M<KN567WM&4_9A2'9)G%_XI9%C8Y" GCJN5NVCO(Q!MX
MW4,&M($OG3R'07O0/:0S,!2TQ66_XK*OY?*/M21.R9G6\=*GTB28;Q(L, 36
M8G]0L3_XX&^_@<DFF@3S38(%AL!:31Q631Q>LAPQ_@64 WDKUYC&1+6KG>IA
M7?"*$67  VFQN>V#"+TJ]YQ:H$O[<EY6@WU68O-])*W 4%JMID"G%BV.-M.'
M^:UR6=.[7?I(&$7SC:(%IM#:#6BH1OC!BUN9@*E6FD3SC:(%IM#:K73K5KK:
M9ZEH!\4_-C&+.08R0AQBS=IV M KEA%E&[2>%[?AO7D$IO)H4U[K8JA5;&?O
M[4N8YB[S[:;VM(E_VB30FK2+K'4CU O'=W]UGL"%CF9^&16([T\D,)5(F_M:
M.T*]>'S,MIAQJ=.+GW3(AC..LBC.EN JSLKASU*X'_L5:5J&:.GC_K#7.YB!
MVE0NYEP1=:#050H[S^T>E9^PUI_PE !M4[?+?VH6]VB+*5IBL$ Q!5N4;#"X
MVK!(3N3"5M)9_XRFI+0(/6PDW;GNNV\)-2I4SXH9**UZ@R-DU@(4ZA7H79S%
MZ295<F%4@AI%\XVB!:;0VCVH92C\:!T*C0I1HVB^4;3 %%J[E;48A7J!]HZM
MVEF*3]D&H\+SW7D$IO)H_U=4*TU7KS3OT,NQ%4SO>>FT-XKF&T4+3*&U>U"+
M3?>CQ:9K5&P:1?.-H@6FT-JMK,6F:UILG@#L'E_!])X7M\$D6F *K6B#W?C_
M/\5TF1^\8$)T;3)>_%U;C5:'.V[S(PUOQJ?P9@85XSZ\"8JC&S5\<9+D#M%E
MG#&0X(4(Y5SWQ;Z<%H<SBAM.UOGI@R?".4GSRQ5&$:;20'R^((3O;V2 ZHC,
MY']02P,$%     @ YX1-5L,-ZWP+!@  U!\  !H   !X;"]W;W)K<VAE971S
M+W-H965T,38U+GAM;+596V_;-AC]*X17#"F0VB)UL9PY!AQKP_90-&C6]F'8
M R,QME!=/)*VDW\_4I)UI2G9=?O02/+W'7WGD"(/R?DAI=_9AA .7N,H8?>C
M#>?;N\F$^1L28S9.MR01O[RD-,9<W-+UA&TIP4&6%$<39!C.),9A,EK,LV>/
M=#%/=SP*$_)( =O%,:9O#R1*#_<C.#H^^!RN-UP^F"SF6[PF3X1_V3Y2<3<I
M48(P)@D+TP10\G(_6L([#[DR(8OX&I(#JUT#2>4Y3;_+F[^"^Y$A*R(1\;F$
MP.+/GJQ(%$DD4<=_!>BH?*=,K%\?T?_(R LRSYB151I]"P.^N1^Y(Q"0%[R+
M^.?T\"<I"-D2ST\CEOT/#D6L,0+^CO$T+I)%!7&8Y'_Q:R%$+0'9)Q)0D8"&
M)IA%@CDTP2H2K$R9G$JF@X<Y7LQI>@!41@LT>9&)F64+^F$BV_V)4_%K*/+X
MXFF#*?GP()0+P"J-17=B.&N0#^")I_YW\&F;W2X/F 9@*5LIY&_@QB,<AQ%[
M+^*^/'G@YMU[\ Y, )-P#(0)^)*$G-W6'OR]27<,)X%X^*YQ/Y]P0426,_&+
MHA_RHM&)HF?@8YKP#0._)P$)%/DK?3Y$&H")4+"4$1UE?$!:Q">R'0/3N 7(
M0$A5D#[=([Y(AUDZ5*1[P],-#1NS[!1FAF?J.@4#.R$.!6G> 6[XL;W>JQHL
M![34@'+PNF-;[)/[D1B=&*%[,EK\^@MTC-]48ET3S+L26$-(JQ32TJ$O'L@Z
M3)(P68NQ*<*)3\"-Z/GY-Z&4,8=S,C@Y9.\7IFNY\\F^+D\WR$*NV0SRM(5=
M2-LN:=M:VK^_$NJ'<DCIH6MWF'QH\5@I0AS9R1MDM>5<2-8IR3I:LBO9KE%$
M@HF8A5](R/MI.PK:[496Q$SEV-#@K:WL0M[3DO>TIY&W(>WG.NWR:+%8*4),
MTVI1U19S(56WI.KJJ2;!&=^PJ_B&#:?%6174_M"];E#C0V]PF95<9EHN7PF3
M/50,Y("\;H7[$C<\!7OQN(_8; @Q55"'6#?H-#%H5%;&&#+LX.>HMXT*I'H%
M: ;;WZ JRIK.6F346/8)-C5C!K63\+?,LLJFVA,J++AHKGQ4!5L:^D3)"EYS
M%KXJFG<MM*::J%(3G3L3[U@ ML+@9-U$W4MRS%FM99VQ;;=[23?*'D/4[B7:
M^B[E7SDZJ/4Y]2EY .\<"UH-XM,.<478;&RVG8B^LDN95Q8,ZCV8<GX>H(&E
M(F?;1NU?>R)3Y:"QZ;0%^1G>#%;F#/:YLV+B'B""K>H(3H>W(@R-[3;MG^'2
M8&73H-ZGM2?Q >P=%7L;M=FKPSKT'?TPT:15N3"HMV&=^5R2+"?T 22GPTBJ
MPSHD%6$:EI4!@ST.K#ZU#R#E*@;N]LI"'=2VV(HH>VR<(E2Y,#CK7V*K]EV6
ME.)D36*2</#\!NIQC_@M>YSMQ=P6.S/L%BR#()27. )>R/PH93NY?/]G^<PX
MQ3[_5RF1UB:>[16NB>9="ZVYE5/Y2*3WD9]VG'&<#1>WH&/#*)';J?(K\],D
MTW<GA.>$QBJ9>UYE@S>"*0,6B/,-*62  +^I]L16/5!. 05S*(#<4TC>P*)*
M) 504]K*U"*MS5..5C^NL?Z=9VFLASI'XV%%#=>XLKI(;W5K8^6/2ZM_E56P
M<$IIX6EIAT%!XXCEG-96#V464/81"<YZU:V,--(;Z<;@L%RO*5EC3D HM P3
M%OI@CZ.=<G56 -N-5:]AMF=:11B:3F=M$ZD*L]T3\Q*JW#+2NV6=G3B7KVJ?
M4L&W&Z;DJP@[S;<RPVC05F7^L9Q'K[LS:2)W:K7I=<.@:\W:FPA%V,#FK$PO
MZC&]QV7?N>2ZVX]&FUAOB*<O[M)YO++&2&^-%2N_<V7H;DU"M[U+I J:6FT?
MJ:_U4BTJ XWZ#'2VZ#N7O]L=LMKLNR'3SK) 7]RYY">UX\Z8T'5V;,S$?+9+
M>'YD5SXMCZ:7V8%LZ_D*WGGY 7,%DY]W?\1T+;0!$7D1D,9X*OC1_ @YO^'I
M-CM4?4XY3^/L<D-P0*@,$+^_I"D_WL@7E ?YB_\!4$L#!!0    ( .>$3584
MQ+=BKP4  #(M   :    >&PO=V]R:W-H965T<R]S:&5E=#$V-BYX;6RUFFMO
MXC@4AO^*Q8Y6,]*JQ$X(T 6D:9-H*TVEJIW9_;!:K5(X0#2Y,+&!J;0_?IU+
M$Y*XYJ+3+RT)YSR._3K'R8LG^R3]SM< @OR,PIA/>VLA-M?]/I^O(?+Y5;*!
M6'ZS3-+(%_(P7?7Y)@5_D2=%89\9AMV/_"#NS2;YN8=T-DFV(@QB>$@)WT:1
MG[[<0)CLISW:>SWQ&*S6(CO1GTTV_@J>0'S;/*3RJ%]1%D$$,0^2F*2PG/8^
MTVN/#;*$/.+/ /;\X#/)NO*<)-^S@[O%M&=D5P0AS$6&\.6_'=Q"&&8D>1T_
M2FBO:C-+//S\2O?RSLO.//L<;I/PKV AUM/>J$<6L/2WH7A,]G] V:'\ N=)
MR/._9%_$VN,>F6^Y2*(R65Y!%,3%?_]G.1 '"8R]D<#*!'9J@EDFF*<F6&6"
M=6K"H$P8M!),^XT$NTRP\[$O!BL?:<<7_FR2)GN29M&2EGW(Y<JSY0 '<3:S
MGD0JOPUDGI@]0N@+6) '/Q4OY&OJQ]S/->?DHP/"#T+^B7P@04R^KI,M]^,%
MG_2%;#A+[\_+1FZ*1M@;C8S)?1*+-2=NO("%(M_1YU.F ?1ECZMNL]=NWS M
M\0DV5\0T?B/,8(Q\>W+(QP^?%!=V>SJ&:C".'N/ 7&+H48Q[.L;08#P]YMY_
MZ5!D$8EA[X?_)IML<F@4,*N)9^:MF.=.//+W%QE*[@1$_!_57"NXEIJ;5>)K
MOO'G,.W)4LLAW4%O]NLOU#9^5^F+"7,P82XFS$."-92V*J4M'7UV%^^ "[D:
M"67I*)('>7*V#NYFS#;,X:2_.]1)V\2Y.BF:M(8#UFS2Q6S20X(U!!A4 @RT
M CS"#N(M*$>_R+0/AX)2NS7X@^YXF=:H&>1T228;F*TQ[9(L9K2"/&UO+APK
MNQHK6SM67T ^ILCE;IY$((O>'(*=_QR":NBTH'/K$";,L;NBCEIRN9@->DBP
MAF+#2K'AD=G=64B"?!UYD@T%<^#D\RH%R.H/^8^X/[:!#+L'L4X6I"A-H)17
MV^JY\F+"'$R8BPGSD&"->3"JYL'HG1XH1IA*8\(<3)B+"?.08 VEQY72XXO7
MLW&G]-'V2G7;C3$'@]9JUHVQQJT8MQO#1JT83]N3"\>)&O7+G7%&;:P?Q"XL
MB?K6SKU34&D.*LU%I7E8M.8L.'C%I^]4&4LPEN"8- >5YJ+2/"Q:4W!6"\XN
M+I!E:J-"#HU6A50$6>W'=$<5Q-J/F8H@-K1:[7GZ_EPZ7K450;7OOZT;I'@%
MN+!"HIH3J#0'E>:BTCPL6G,"U X%M=ZK0F*Z!+>H- >5YJ+2/"Q:4_#:$:%Z
M2Z2XQP6DD5)4) >B%!63YJ#27%2:=V30J4%>P$^Y3L':IZ&G&#7Q-GJ&E"3+
M5X,ZUY3+FJTSK$N540T<5)J#2G-1:1[MVDOU6T]3S=K#H7H3IU#S4$.E8JB>
M#"K-0:6YJ#3OR.#3_+;4W96U!T.U+_[GV*=ZTMEBHOHNJ#07E>:5M.:O%V_<
M?[6C0H]9*H</0$_;S29\J1^!E?(A.1NE?)@T!Y7FHM(\+%KS9^_:$6+&.SWI
M,E3S!Y7FH-)<5)J'16L*7IL_3.LU5()O<L&7H'8%])"SQ44U>DI:P[%@K/W+
MHB**6:V?=#VL"VMJ4?LR[)@OHZNR9QD-^I;.%@R3YJ#27%2:AT5KSH#::6+O
MM>N%H3I+J#0'E>:BTCPL6E/PVEEB^LTO.BNV3&T4M@%M6;&*('O<<F(5,6S4
MWLZB;,UN%\CWL&58;<NP8SM53EJLNKM(1F.S/6[=($J'M#URBBC%VJ+8 --=
M6U"WK?0/MG1&D*[RS;><S)-M+(I-=M79:H/OYWQ;:^O\#;V^I8KS#KUVB^V[
M-;[837SOIZL@YB2$I6S*N!K*CJ7%!MWB0"2;?$/I<R)$$N4?U^ O(,T"Y/?+
M)!&O!UD#U3;IV?]02P,$%     @ YX1-5F$"[Z\1!   =14  !H   !X;"]W
M;W)K<VAE971S+W-H965T,38W+GAM;+5848_:.!#^*U:N.K72W28.), >(.T2
MJEOI5D)+>_=0W8-)!A(UB:EMH"O=CS\["8$$$RV5^P*Q,]\W]C>39#SC V5?
M>0P@T/<LS?G$BH78WMLV#V/("+^C6\CEG35E&1%RR#8VWS(@40'*4MMU'-_.
M2));TW$QMV#3,=V)-,EAP1#?91EAKX^0TL/$PM9QXB79Q$)-V-/QEFQ@">+S
M=L'DR*Y9HB2#G"<T1PS6$^L!W\]Q7P$*B[\3./"S:Z2VLJ+TJQH\11/+42N"
M%$*A*(C\V\,,TE0QR75\JTBMVJ<"GE\?V3\6FY>;61$.,YK^DT0BGEA#"T6P
M)KM4O-##GU!MR%-\(4UY\8L.E:UCH7#'!<TJL%Q!EN3E/_E>"7$&D#QZ@%L!
MW#:@?P70JP"]-L"_ NA7@/Y;/7@5H-BZ7>Z]$"X@@DS'C!X04]:235T4ZA=H
MJ5>2JT19"B;O)A(GIB^0$@$16A F7M$G1G).BA!R]#M:RK2,=BD@ND8=AN\#
M$"1)^0<)^;P,T/MW'] [E.3H4TQWG.01']M"KE5YM,-J78_ENMPKZQJA9YJ+
MF*-Y'D&DP0?=>.QV$-A2I%HI]ZC4H]O)N(3M'>HYOR'7<5W-@F9OAV/=?KKA
M 802CJ_"YV^'.QUB].JTZ15\O=O3YLO#B@LF1__JHE[2]O6TZJUXS[<DA(DE
M7WL<V!ZLZ:^_8-_Y0Z>X2;+ )-G<$%DC-OTZ-OTN=AF;/>0[T#YT)=(KD.H;
MLI^Z&/MC>W\NJ\:HUQ\VC8)+HY[K]9I&\TNCONN<C!K;\^KM>3^6>NC+7](4
M/0G(N#;W/).Y9Y(L,$DV-T36"(Y?!\?OS+V',*2[7'!90X20[,DJ!5TD.DEN
MC81)LJ D\\\R%CL#W$KK2R.9^P-]6@]JY0:=RLWDUTJ]-1'A'(3VX1U<KJT_
M;#^8LTXWM\JA<8D'CM/2X]+*QT-?K\>PUF/8J<?\VRZ1S_<SB)A&Z"G? Q<
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MY>2D*('JF3ZA0AEGH=TX.SY&%-]/'2/L$%?)H+0<2F-0&H?2!(JFEXJRU\(
M>XP(H9X;E)9#:0Q*XU":0-'TJE&>6VAU9W[R&&&'.I=..-@31Q?3N'>,@.9D
MI)R<%"50/=,E5 98>,8 VQTCWAN%@GI=4%H.I3$HC4-I D73"T19:V$,/C)
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M>_S>[DU;K;=/?_M:M6VUW+Y\D,5<UIN [N]W5=6^O-DD.#P$\?K_4$L#!!0
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M=E5OVH#FWZ_7ZYW^I;W!U_7FU_W7N?Q_4$L#!!0    ( .>$35;KC;3#6@(
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M;"]W;W)K<VAE971S+W-H965T,3<V+GAM;*U6R6[;,!#]%4(-B@1(HUV.4UM
MX@7MH:AA-^VAZ(&6QQ81B51)VD[_OB2EJ%X45P%\L;C,>S-\,Z2GMV7\2:0
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M4Y^[9FYN1"#M!/,]$T*O.W:!YHXU^0M02P,$%     @ YX1-5C1D%^+B @
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MHR-G2)T?+-0>=J(WYM!Q.W3\7EHRMTZ,L[F+URPDC8#2*!3-+%SK0L,>N)Z
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MZXF56*@@2]Q4\BO;_4*Z"85*+V>5T'_1KL,Z%LH;(5G=D6$$=4G;7_R],^*
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M)"\'RI-@\FXB_<3JD1YI?J <_8R"A$?;+:/;2- U:FZ@UP$549+R-]+BTU.
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MQ0FW;$;BT@)4!HCY%2'\J2./N<TUR/L'4$L#!!0    ( .>$35:@!Y.9A @
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M.AN)?=*J=:P&G!2J-[HG7'1:ZC$6[390:2#65X3PIX%TT#3P_E]02P,$%
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M*\_!RAM!-_H8YID*07-]N0:< E,!\OF24O%ZHQ+4AY'3_P!02P,$%     @
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M3-?L9L3][4SG400_A1UPR XXO!UXFZ4WT<W!QC[4-4;QYFYH!>:9VK,)NK.
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M?GZ;IL6W%]4W/AV_$NSZ?U!+ P04    " #GA$U6\";$J>H$  "^'   &@
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MYI0,DQ0["_&UD+8$=0,$M:_=[ROF)7=KED>N*ZTH&29%KV!2Y8N.J:U W1E
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MH_U[A'?-[OE@_,(^7]B*\5B^=VBVM@_X]J7%1URO<\)0 2LQE746BL76[7N
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M#$"_WW*N7F_, :0Y<"[_!U!+ P04    " #GA$U6(!&ZI) '  ".3@  &@
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M/7PH#Z@W<U&?06VKO=]-JK^JE^X,-KLS#U$2Q>NXKK+FR*:5!:5YH#0?E!9
MT:J*ENX,?FMW!H.Z,Z T#Y3F@]("*%IU8I3N##;["\UOYLW QD)?9'_4B@IJ
MP[PZCP JCZJ I>N"S:[+ WD^N5:#&B^@- ^4YH/2 BA:5='2>,%O;;Q@4.,%
ME.:!TGQ06@!%JTZ,TGC!T,:+&=A8:'-ZKF&M!C5>0&D!%"T3M;WW_F],^3Q]
M4UN@*5LG,GM1LCA;O U^E[X#?7!^;-]X=LUYW[X)LG>]2WSVZOD#X?,H$6A)
M9ZHKZ[JG!L:SM[FS#Y*MTK>/GYB4+$X/%Y2$E.L&ZOL98W+W07=0O%,_^A]0
M2P,$%     @ YX1-5I1&U-()!@  TA\  !H   !X;"]W;W)K<VAE971S+W-H
M965T,C X+GAM;+596V_;-AC]*X17#"F0VB)UL9PY!AQKP_90-&C6]F'8 R,Q
MME!=/)*VDW\_4I)UI2G9=?O02/+W'7WGD"(/R?DAI=_9AA .7N,H8?>C#>?;
MN\F$^1L28S9.MR01O[RD-,9<W-+UA&TIP4&6%$<39!C.),9A,EK,LV>/=#%/
M=SP*$_)( =O%,:9O#R1*#_<C.#H^^!RN-UP^F"SF6[PF3X1_V3Y2<3<I48(P
M)@D+TP10\G(_6L([#[DR(8OX&I(#JUT#2>4Y3;_+F[^"^Y$A*R(1\;F$P.+/
MGJQ(%$DD4<=_!>BH?*=,K%\?T?_(R LRSYB151I]"P.^N1^Y(Q"0%[R+^.?T
M\"<I"-D2ST\CEOT/#D6L,0+^CO$T+I)%!7&8Y'_Q:R%$+0'9)Q)0D8"&)IA%
M@CDTP2H2K$R9G$JF@X<Y7LQI>@!41@LT>9&)F64+^F$BV_V)4_%K*/+XXHFG
M_O</#T*Y *S26'0GAK,&^0"RG\"G;7:[/& :@*5LI9"_@1N/<!Q&[+V(^_+D
M@9MW[\$[, %L@REA($S ER3D[+;VX.]-NF,X"<3#=XW[^80+(K*<B5\4_9 7
MC4X4/0,?TX1O&/@]"4B@R%_I\R'2 $R$@J6,Z"CC ](B/I'M&)C&+4 &0JJ"
M].D>\44ZS-*A(MT;GFYHV)AEIS S//,4F[S1=D(<"M*\ ]SP8WN]5S58#FBI
M >7@=<>VV"?W(S$Z,4+W9+3X]1?H&+^IQ+HFF'<EL(:05BFDI4-?/)!UF"1A
MLA9C4X03GX ;T?/S;T(I8P[G9'!RR-XO3-=RYY-]79YND(5<LQGD:0N[D+9=
MTK:UM']_)=0/Y9#20]?NTFUQ[48XLHLWJ&J+N9"J4U)UM%17LE6CB 03,0>_
MD)#WDW8ZE#Z8[296Q$SER-#@K:WL0M[3DO>TIXFW(>WG.NWR:+%8*4),TVI1
MU19S(56WI.KJJ2;!&5^PJ_B"#:?%6174_LR];E#C,V]PF95<9EHN7PF3/50,
MXX"\;H7W$C<\!7OQN(_8; @Q55"'6#?H-#%H5$;&&#+HX.>HMXT*I'H%: ;;
MWZ JRIK.6F346/8)-C5;!K53\+?,L,JFVA,J#+AHKGQ,!5L:^D3)"EYS#KXJ
MFG<MM*::J%(3G3L/[U@ ML+>9-U$W4MRS%E][AG;=KN7=*/L,43M7J*M[U+^
ME9^#6I=3GY '\,ZQH-4@/NT05X3-QF;;A^@KNY1Y9<"@WH$IY^<!&E@J<K9M
MU/ZU)S)5#AJ;3EN0G^',8&7-8)\W*R;N 2+8JH[@='@KPM#8;M/^&2X-5C8-
MZGU:>Q(?P-Y1L;=1F[TZK$/?T0\335J5"X-Z&]:9SR7)<D(?0'(ZC*0ZK$-2
M$:9A61DPV./ ZE/[ %*N8N!N+RS406V+K8BRQ\8I0I4+@[/^!;9JUV5)*4[6
M)"8)!\]OH![WB-^RQ]E.S&VQ+\-NP3((0GF)(^"%S(]2MI.+]W^6SXQ3[/-_
ME1)I;>+97N&::-ZUT)H;.96/1'H?^6G'&<?9<'$+.C:,$KF9*K\R/TTR?7="
M>$YHK)*YYU4V>".8,F"!.-^.0@8(\)MJ1VS5 ^444#"' L@]A>0-+*I$4@ U
MI:U,+=+:/.5H]>,:Z]]YEL9ZJ',T'E;4<(TKJXOT5K<V5OZXM/I7604+IY06
MGI9V&!0TCEC.:6WU4&8!91^1X*Q7W<I(([V1;@P.R_6:DC7F!(1"RS!AH0_V
M.-HI5V<%L-U8]1IF>Z95A*'I=-8VD:HPVSTQ+Z'*+2.]6];9B7/YJG8I%7R[
M84J^BK#3?"LSC 9M5.8?RWGT%%N7R)U:;7K=,.A:L_8F0A$VL#DKTXMZ3.]Q
MV7<NN>[VH]$FUAOBZ8N[=!ZOK#'26V/%RN]<&;I;D]!M[Q*I@J96VT?J:[U4
MB\I HSX#G2WZSN7O=H>L-OMNR+2S+- 7=R[Y2>VP,R9TG1T:,S&?[1*>']B5
M3\N#Z65V'-MZOH)W7GZ\7,'DI]T?,5T+;4!$7@2D,9X*?C0_0,YO>+K-CE2?
M4\[3.+O<$!P0*@/$[R]IRH\W\@7E,?[B?U!+ P04    " #GA$U69F&H?#,#
M  !P"0  &@   'AL+W=O<FMS:&5E=',O<VAE970R,#DN>&ULK59;;]HP%/XK
M1]DT==(@-Z"D@TA<6JW2JJ%6ZQZF/9CD !9)G-D&RK^?[80LI8'QL)?$/C[G
M\_<=7XX'.\;78H4HX25-,C&T5E+F-[8MHA6F1+19CID:63">$JFZ?&F+G".)
M35":V)[C].R4T,P*!\8VX^& ;61",YQQ$)LT)7P_QH3MAI9K'0R/=+F2VF"'
M@YPL\0GE]WS&5<^N4&*:8B8HRX#C8FB-W)M)H/V-PS/%G:BU02N9,[;6G?MX
M:#F:$"8828U U&^+$TP2#:1H_"XQK6I*'5AO']#OC':E94X$3ECR@\9R-;3Z
M%L2X()M$/K+=%RSU=#5>Q!)AOK K?1T+HHV0+"V#%8.49L6?O)1YJ 5X_HD
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MKS_6>Y^H[AA50_'<GNMW7.E;@OU,]+T,A)F@QU><JVW#!&AN>N$?4$L#!!0
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MDN4&XO<-I?SE)@]0G[<O_P-02P,$%     @ YX1-5G<[VT Z @  Z04  !H
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M[+]A77[>05W9)OB#R"VM%&*P,: _F5UC)+O&TDVTJ%VIK84VA>N&I>G%(&V
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M3?' 5S6ECS>IZ;BN"PX%<GMTKI)#W0HLM[KH9X5\@#RQZ0@!R@.!W!ZBL_)
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MTS-TVV]46"&ZD*IN#NUU\\]->CO2:Y->&(S;0W06$O7Q:UAL>GI4=1W:JVO
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M.T-1NP#[?:D4;3<N03^5L]]02P,$%     @ YX1-5GBE+'N' P  -PX  !H
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MQ(X@BMX01%M!9'VW(.MR0C7-,RDV1)K=F,T,;*E6C>98;=[*O9:XRE"G\QO
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MR57=)>N)D97K3 MIJ,^Y84X?%E1V ZTOI30O$]OLVD]5\A=02P,$%     @
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MHL@\!_>>1\'Z.15L_H08_0502P,$%     @ YX1-5I>*NQS     $P(   L
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M]\;);1JZ]\MC?$NSK[,T_?K^_U!+ P04    " #GA$U6&KI#UYT%   T@0
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MU+M[O3N@WMWKW0'UGKW>,Z#>L]=[!M1[]GK/@'K/7N\94._9ZST#ZCU[O6=
MO6>O]PRH]QP7"P+J/7N]9T"]9Z_W#*CWXO5> /5>O-X+H-Z+UWL!U'OQ>B^
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M&/ [ZWU^^=G]V^]_/?SU8KX-K[G>OI]Q^O0O4$L#!!0    ( .>$35;A*'R
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M              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @
MYX1-5G JS^KN    *P(  !$              ( !KP   &1O8U!R;W!S+V-O
M<F4N>&UL4$L! A0#%     @ YX1-5IE<G",0!@  G"<  !,
M ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #GA$U6R-HC
M']("  "8"   &               @($-"   >&PO=V]R:W-H965T<R]S:&5E
M=#$N>&UL4$L! A0#%     @ YX1-5B++-D+ !@  1R(  !@
M ("!%0L  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( .>$
M35;$4.!GO@8  +LQ   8              " @0L2  !X;"]W;W)K<VAE971S
M+W-H965T,RYX;6Q02P$"% ,4    " #GA$U64R>-W\('  "1,P  &
M        @('_&   >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%
M  @ YX1-5IB0&V!F$P  :0 ! !@              ("!]R   'AL+W=O<FMS
M:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( .>$35;0=Z5U:P(  /D$   8
M              " @9,T  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"
M% ,4    " #GA$U6AXZ/C?H(  #I,   &               @($T-P  >&PO
M=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ YX1-5KC=+#BJ"
M'C4  !@              ("!9$   'AL+W=O<FMS:&5E=',O<VAE970X+GAM
M;%!+ 0(4 Q0    ( .>$3585.*<//P0   46   8              " @41)
M  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " #GA$U65P;@
MWLX'  !&-@  &0              @(&Y30  >&PO=V]R:W-H965T<R]S:&5E
M=#$P+GAM;%!+ 0(4 Q0    ( .>$35:\:;U0_Q$  *[R   9
M  " @;Y5  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @
MYX1-5OVE=%' #   R'0  !D              ("!]&<  'AL+W=O<FMS:&5E
M=',O<VAE970Q,BYX;6Q02P$"% ,4    " #GA$U6I#RMEE0&   *'   &0
M            @('K=   >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4
M Q0    ( .>$3597N(; RP,  '@2   9              " @79[  !X;"]W
M;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ YX1-5K5/^+:A"0
MMCL  !D              ("!>'\  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX
M;6Q02P$"% ,4    " #GA$U6RICM]; '  #8(   &0              @(%0
MB0  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( .>$3584
M*/OC;@\  .6E   9              " @3>1  !X;"]W;W)K<VAE971S+W-H
M965T,3<N>&UL4$L! A0#%     @ YX1-5G-A:=26"   Z3@  !D
M     ("!W*   'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .>$358]M@:061\  'B(   9              "
M@>W/  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @ YX1-
M5L4:@X%>&P  V88  !D              ("!?>\  'AL+W=O<FMS:&5E=',O
M<VAE970R-"YX;6Q02P$"% ,4    " #GA$U6L>^92TX$  #*#@  &0
M        @($2"P$ >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0
M   ( .>$359@-F)3V1$  $)7   9              " @9</ 0!X;"]W;W)K
M<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ YX1-5AP^]S--"   4!X
M !D              ("!IR$! 'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q0
M2P$"% ,4    " #GA$U6-N/[I.T+  "M*P  &0              @($K*@$
M>&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( .>$359G\AO&
MZ08   ,@   9              " @4\V 0!X;"]W;W)K<VAE971S+W-H965T
M,CDN>&UL4$L! A0#%     @ YX1-5@&!_V%3"@  4#H  !D
M ("!;ST! 'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4    " #G
MA$U6=R@_34\0   H4@  &0              @('Y1P$ >&PO=V]R:W-H965T
M<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( .>$359%\M@UFQ0  $)&   9
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M970S-BYX;6Q02P$"% ,4    " #GA$U6'#[W,TT(  !0'@  &0
M    @($+OP$ >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    (
M .>$358VX_ND[0L  *TK   9              " @8_' 0!X;"]W;W)K<VAE
M971S+W-H965T,S@N>&UL4$L! A0#%     @ YX1-5H/_,2WL!@  ^A\  !D
M             ("!L],! 'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q02P$"
M% ,4    " #GA$U6 8'_85,*  !0.@  &0              @('6V@$ >&PO
M=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( .>$359W*#]-3Q
M "A2   9              " @6#E 0!X;"]W;W)K<VAE971S+W-H965T-#$N
M>&UL4$L! A0#%     @ YX1-5I5ZM2G_#P  H#(  !D              ("!
MYO4! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"% ,4    " #GA$U6
M1?+8-9L4  !"1@  &0              @($<!@( >&PO=V]R:W-H965T<R]S
M:&5E=#0S+GAM;%!+ 0(4 Q0    ( .>$358 N>[:7Q\  $B(   9
M      " @>X: @!X;"]W;W)K<VAE971S+W-H965T-#0N>&UL4$L! A0#%
M  @ YX1-5G308*)=&P  I88  !D              ("!A#H" 'AL+W=O<FMS
M:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    " #GA$U6;CX$^:L(  !@'P
M&0              @($85@( >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+
M 0(4 Q0    ( .>$35;%[JY[LP@  +8?   9              " @?I> @!X
M;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%     @ YX1-5J9PVK>
M"0  61@  !D              ("!Y&<" 'AL+W=O<FMS:&5E=',O<VAE970T
M."YX;6Q02P$"% ,4    " #GA$U6N2S6LTX0   .4@  &0
M@(&;<0( >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0    ( .>$
M35:5>K4I_P\  * R   9              " @2"" @!X;"]W;W)K<VAE971S
M+W-H965T-3 N>&UL4$L! A0#%     @ YX1-5B)2X6I:"@  A",  !D
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M=#4U+GAM;%!+ 0(4 Q0    ( .>$359%\M@UFQ0  $)&   9
M  " @2S* @!X;"]W;W)K<VAE971S+W-H965T-38N>&UL4$L! A0#%     @
MYX1-5@"Y[MI?'P  2(@  !D              ("!_MX" 'AL+W=O<FMS:&5E
M=',O<VAE970U-RYX;6Q02P$"% ,4    " #GA$U6=-!@HET;  "EA@  &0
M            @(&4_@( >&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+ 0(4
M Q0    ( .>$359N/@3YJP@  & ?   9              " @2@: P!X;"]W
M;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @ YX1-5L7NKGNS"
MMA\  !D              ("!"B,# 'AL+W=O<FMS:&5E=',O<VAE970V,"YX
M;6Q02P$"% ,4    " #GA$U6^A!>%K,+  !A'P  &0              @('T
M*P, >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0    ( .>$35:Y
M+-:S3A    Y2   9              " @=XW P!X;"]W;W)K<VAE971S+W-H
M965T-C(N>&UL4$L! A0#%     @ YX1-5F;F]C^6 @  NP4  !D
M     ("!8T@# 'AL+W=O<FMS:&5E=',O<VAE970V,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .>$35:5>K4I_P\  * R   9              "
M@8-< P!X;"]W;W)K<VAE971S+W-H965T-C@N>&UL4$L! A0#%     @ YX1-
M5H;D[OYA"@  A",  !D              ("!N6P# 'AL+W=O<FMS:&5E=',O
M<VAE970V.2YX;6Q02P$"% ,4    " #GA$U68#9B4]D1  !"5P  &0
M        @(%1=P, >&PO=V]R:W-H965T<R]S:&5E=#<P+GAM;%!+ 0(4 Q0
M   ( .>$35:X*PGTX@8  .@?   9              " @6&) P!X;"]W;W)K
M<VAE971S+W-H965T-S$N>&UL4$L! A0#%     @ YX1-5H82+/WQ"P  E2L
M !D              ("!>I # 'AL+W=O<FMS:&5E=',O<VAE970W,BYX;6Q0
M2P$"% ,4    " #GA$U6/&POG!,#  "E!@  &0              @(&BG ,
M>&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4 Q0    ( .>$358</O<S
M30@  % >   9              " @>R? P!X;"]W;W)K<VAE971S+W-H965T
M-S0N>&UL4$L! A0#%     @ YX1-5F]81K)^!@  B!D  !D
M ("!<*@# 'AL+W=O<FMS:&5E=',O<VAE970W-2YX;6Q02P$"% ,4    " #G
MA$U61?+8-9L4  !"1@  &0              @($EKP, >&PO=V]R:W-H965T
M<R]S:&5E=#<V+GAM;%!+ 0(4 Q0    ( .>$35:P*(4]4B0  /^V   9
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M970X,2YX;6Q02P$"% ,4    " #GA$U6BY>X8U %  #H$   &0
M    @($>; 0 >&PO=V]R:W-H965T<R]S:&5E=#@R+GAM;%!+ 0(4 Q0    (
M .>$358[I;"]BP@  ,DD   9              " @:5Q! !X;"]W;W)K<VAE
M971S+W-H965T.#,N>&UL4$L! A0#%     @ YX1-5EIU4+\A!0  51   !D
M             ("!9WH$ 'AL+W=O<FMS:&5E=',O<VAE970X-"YX;6Q02P$"
M% ,4    " #GA$U6BY>X8U %  #H$   &0              @(&_?P0 >&PO
M=V]R:W-H965T<R]S:&5E=#@U+GAM;%!+ 0(4 Q0    ( .>$358[I;"]BP@
M ,DD   9              " @4:%! !X;"]W;W)K<VAE971S+W-H965T.#8N
M>&UL4$L! A0#%     @ YX1-5K=!3Y"C!@  :1$  !D              ("!
M"(X$ 'AL+W=O<FMS:&5E=',O<VAE970X-RYX;6Q02P$"% ,4    " #GA$U6
M3A['\L8#  #/"@  &0              @('BE 0 >&PO=V]R:W-H965T<R]S
M:&5E=#@X+GAM;%!+ 0(4 Q0    ( .>$3583.#_*#P8  "(4   9
M      " @=^8! !X;"]W;W)K<VAE971S+W-H965T.#DN>&UL4$L! A0#%
M  @ YX1-5C8/@2,[!@  D!,  !D              ("!)9\$ 'AL+W=O<FMS
M:&5E=',O<VAE970Y,"YX;6Q02P$"% ,4    " #GA$U6]#4_0JL"  #@!0
M&0              @(&7I00 >&PO=V]R:W-H965T<R]S:&5E=#DQ+GAM;%!+
M 0(4 Q0    ( .>$359'A^O-B@@  +PD   9              " @7FH! !X
M;"]W;W)K<VAE971S+W-H965T.3(N>&UL4$L! A0#%     @ YX1-5G#L;2#N
M P  TPH  !D              ("!.K$$ 'AL+W=O<FMS:&5E=',O<VAE970Y
M,RYX;6Q02P$"% ,4    " #GA$U6E[KO$JT"   =!@  &0
M@(%?M00 >&PO=V]R:W-H965T<R]S:&5E=#DT+GAM;%!+ 0(4 Q0    ( .>$
M358=YCET104  -X0   9              " @4.X! !X;"]W;W)K<VAE971S
M+W-H965T.34N>&UL4$L! A0#%     @ YX1-5MP-=&J0 @  L04  !D
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M=#$P,"YX;6Q02P$"% ,4    " #GA$U61X?KS8H(  "\)   &@
M    @(&/V@0 >&PO=V]R:W-H965T<R]S:&5E=#$P,2YX;6Q02P$"% ,4
M" #GA$U6I\5HOJ8"  "[!0  &@              @(%1XP0 >&PO=V]R:W-H
M965T<R]S:&5E=#$P,BYX;6Q02P$"% ,4    " #GA$U6=IX<X0H#  "A!@
M&@              @($OY@0 >&PO=V]R:W-H965T<R]S:&5E=#$P,RYX;6Q0
M2P$"% ,4    " #GA$U6-6"E&YX"  "X!0  &@              @(%QZ00
M>&PO=V]R:W-H965T<R]S:&5E=#$P-"YX;6Q02P$"% ,4    " #GA$U6>AT+
M??@&   V$P  &@              @(%'[ 0 >&PO=V]R:W-H965T<R]S:&5E
M=#$P-2YX;6Q02P$"% ,4    " #GA$U6YP4JL#H%    #P  &@
M    @(%W\P0 >&PO=V]R:W-H965T<R]S:&5E=#$P-BYX;6Q02P$"% ,4
M" #GA$U6[V02\38%  "Z$   &@              @('I^ 0 >&PO=V]R:W-H
M965T<R]S:&5E=#$P-RYX;6Q02P$"% ,4    " #GA$U6TO06-[$#  !@"0
M&@              @(%7_@0 >&PO=V]R:W-H965T<R]S:&5E=#$P."YX;6Q0
M2P$"% ,4    " #GA$U6_=3UGDH2  ":[P  &@              @(%  @4
M>&PO=V]R:W-H965T<R]S:&5E=#$P.2YX;6Q02P$"% ,4    " #GA$U6U&AZ
M^$\'  #I3   &@              @('"% 4 >&PO=V]R:W-H965T<R]S:&5E
M=#$Q,"YX;6Q02P$"% ,4    " #GA$U6UJG _M8&  "U.@  &@
M    @(%)' 4 >&PO=V]R:W-H965T<R]S:&5E=#$Q,2YX;6Q02P$"% ,4
M" #GA$U6*>\MZ^\&  #6/   &@              @(%7(P4 >&PO=V]R:W-H
M965T<R]S:&5E=#$Q,BYX;6Q02P$"% ,4    " #GA$U6486 P=$'  "E2
M&@              @(%^*@4 >&PO=V]R:W-H965T<R]S:&5E=#$Q,RYX;6Q0
M2P$"% ,4    " #GA$U6W9NLCU<)  "H<0  &@              @(&',@4
M>&PO=V]R:W-H965T<R]S:&5E=#$Q-"YX;6Q02P$"% ,4    " #GA$U6_L__
MR[T&  #0.@  &@              @($6/ 4 >&PO=V]R:W-H965T<R]S:&5E
M=#$Q-2YX;6Q02P$"% ,4    " #GA$U66$$NPGH'  "310  &@
M    @($+0P4 >&PO=V]R:W-H965T<R]S:&5E=#$Q-BYX;6Q02P$"% ,4
M" #GA$U6%?D(-XD"  !E!P  &@              @(&]2@4 >&PO=V]R:W-H
M965T<R]S:&5E=#$Q-RYX;6Q02P$"% ,4    " #GA$U6XA49[^\%  "P,
M&@              @(%^304 >&PO=V]R:W-H965T<R]S:&5E=#$Q."YX;6Q0
M2P$"% ,4    " #GA$U6JLN%:K8#  !:#P  &@              @(&E4P4
M>&PO=V]R:W-H965T<R]S:&5E=#$Q.2YX;6Q02P$"% ,4    " #GA$U6*?0,
MZ/4$  !]&0  &@              @(&35P4 >&PO=V]R:W-H965T<R]S:&5E
M=#$R,"YX;6Q02P$"% ,4    " #GA$U6%_^"_3T&  #@-0  &@
M    @(' 7 4 >&PO=V]R:W-H965T<R]S:&5E=#$R,2YX;6Q02P$"% ,4
M" #GA$U6AWI]8@,'  #>30  &@              @($U8P4 >&PO=V]R:W-H
M965T<R]S:&5E=#$R,BYX;6Q02P$"% ,4    " #GA$U6GFD@R2H$   Y$P
M&@              @(%P:@4 >&PO=V]R:W-H965T<R]S:&5E=#$R,RYX;6Q0
M2P$"% ,4    " #GA$U6>CIKJT,"  #Q!   &@              @('2;@4
M>&PO=V]R:W-H965T<R]S:&5E=#$R-"YX;6Q02P$"% ,4    " #GA$U64BG8
MMDH3  "A  $ &@              @(%-<04 >&PO=V]R:W-H965T<R]S:&5E
M=#$R-2YX;6Q02P$"% ,4    " #GA$U6)P8VNB$&  !5-@  &@
M    @('/A 4 >&PO=V]R:W-H965T<R]S:&5E=#$R-BYX;6Q02P$"% ,4
M" #GA$U6WG**:? &    .P  &@              @($HBP4 >&PO=V]R:W-H
M965T<R]S:&5E=#$R-RYX;6Q02P$"% ,4    " #GA$U6.O3=+.T&  #6/
M&@              @(%0D@4 >&PO=V]R:W-H965T<R]S:&5E=#$R."YX;6Q0
M2P$"% ,4    " #GA$U6OD#4Q0<'  #%.P  &@              @(%UF04
M>&PO=V]R:W-H965T<R]S:&5E=#$R.2YX;6Q02P$"% ,4    " #GA$U6J-"K
M%C\*   ZAP  &@              @(&TH 4 >&PO=V]R:W-H965T<R]S:&5E
M=#$S,"YX;6Q02P$"% ,4    " #GA$U6K7H\,58$  !5%@  &@
M    @($KJP4 >&PO=V]R:W-H965T<R]S:&5E=#$S,2YX;6Q02P$"% ,4
M" #GA$U64?D/@)4%  " )P  &@              @(&YKP4 >&PO=V]R:W-H
M965T<R]S:&5E=#$S,BYX;6Q02P$"% ,4    " #GA$U6CH\TOXD"  !<!P
M&@              @(&&M04 >&PO=V]R:W-H965T<R]S:&5E=#$S,RYX;6Q0
M2P$"% ,4    " #GA$U6",RE NP%  !_,   &@              @(%'N 4
M>&PO=V]R:W-H965T<R]S:&5E=#$S-"YX;6Q02P$"% ,4    " #GA$U6QA%7
MY4H$  #I%   &@              @(%KO@4 >&PO=V]R:W-H965T<R]S:&5E
M=#$S-2YX;6Q02P$"% ,4    " #GA$U6,[10 J %  !9'   &@
M    @('MP@4 >&PO=V]R:W-H965T<R]S:&5E=#$S-BYX;6Q02P$"% ,4
M" #GA$U6SD9I:;$#   <#P  &@              @('%R 4 >&PO=V]R:W-H
M965T<R]S:&5E=#$S-RYX;6Q02P$"% ,4    " #GA$U6AWI]8@,'  #>30
M&@              @(&NS 4 >&PO=V]R:W-H965T<R]S:&5E=#$S."YX;6Q0
M2P$"% ,4    " #GA$U65P^&1I,$  #3%@  &@              @('ITP4
M>&PO=V]R:W-H965T<R]S:&5E=#$S.2YX;6Q02P$"% ,4    " #GA$U6#T2,
MF&X#  "B$@  &@              @(&TV 4 >&PO=V]R:W-H965T<R]S:&5E
M=#$T,"YX;6Q02P$"% ,4    " #GA$U6O+P$_C4$  "7%   &@
M    @(%:W 4 >&PO=V]R:W-H965T<R]S:&5E=#$T,2YX;6Q02P$"% ,4
M" #GA$U6&Q>P(/,$  !7(   &@              @(''X 4 >&PO=V]R:W-H
M965T<R]S:&5E=#$T,BYX;6Q02P$"% ,4    " #GA$U67X52@-4$  !S)P
M&@              @('RY04 >&PO=V]R:W-H965T<R]S:&5E=#$T,RYX;6Q0
M2P$"% ,4    " #GA$U652-LFL$"  "P"0  &@              @('_Z@4
M>&PO=V]R:W-H965T<R]S:&5E=#$T-"YX;6Q02P$"% ,4    " #GA$U6_#1.
MNZ<#  "L#   &@              @('X[04 >&PO=V]R:W-H965T<R]S:&5E
M=#$T-2YX;6Q02P$"% ,4    " #GA$U6Y*0!4UL"   =!@  &@
M    @('7\04 >&PO=V]R:W-H965T<R]S:&5E=#$T-BYX;6Q02P$"% ,4
M" #GA$U6ZJ9!;QL#  #^"@  &@              @(%J] 4 >&PO=V]R:W-H
M965T<R]S:&5E=#$T-RYX;6Q02P$"% ,4    " #GA$U6(P!B:6("   A!@
M&@              @(&]]P4 >&PO=V]R:W-H965T<R]S:&5E=#$T."YX;6Q0
M2P$"% ,4    " #GA$U6LYU*/6(%  #T+0  &@              @(%7^@4
M>&PO=V]R:W-H965T<R]S:&5E=#$T.2YX;6Q02P$"% ,4    " #GA$U6<91^
M"T($  "#$   &@              @('Q_P4 >&PO=V]R:W-H965T<R]S:&5E
M=#$U,"YX;6Q02P$"% ,4    " #GA$U6. T)#\$$  !H'0  &@
M    @(%K! 8 >&PO=V]R:W-H965T<R]S:&5E=#$U,2YX;6Q02P$"% ,4
M" #GA$U66\1,UD$%  #%)   &@              @(%D"08 >&PO=V]R:W-H
M965T<R]S:&5E=#$U,BYX;6Q02P$"% ,4    " #GA$U6X6&$A?,#   /$P
M&@              @('=#@8 >&PO=V]R:W-H965T<R]S:&5E=#$U,RYX;6Q0
M2P$"% ,4    " #GA$U6>D\I?1P$  !;&   &@              @($($P8
M>&PO=V]R:W-H965T<R]S:&5E=#$U-"YX;6Q02P$"% ,4    " #GA$U68%CU
MDF\$  #_$0  &@              @(%<%P8 >&PO=V]R:W-H965T<R]S:&5E
M=#$U-2YX;6Q02P$"% ,4    " #GA$U6Z[KNU)L"  !W!P  &@
M    @($#' 8 >&PO=V]R:W-H965T<R]S:&5E=#$U-BYX;6Q02P$"% ,4
M" #GA$U6!_-%+"$#  #>#@  &@              @('6'@8 >&PO=V]R:W-H
M965T<R]S:&5E=#$U-RYX;6Q02P$"% ,4    " #GA$U6%]]^S<((  #S50
M&@              @($O(@8 >&PO=V]R:W-H965T<R]S:&5E=#$U."YX;6Q0
M2P$"% ,4    " #GA$U6[*=H@HH'   440  &@              @($I*P8
M>&PO=V]R:W-H965T<R]S:&5E=#$U.2YX;6Q02P$"% ,4    " #GA$U6+'EE
M)9<$  "@&@  &@              @('K,@8 >&PO=V]R:W-H965T<R]S:&5E
M=#$V,"YX;6Q02P$"% ,4    " #GA$U68+_#WVD)   T;   &@
M    @(&Z-P8 >&PO=V]R:W-H965T<R]S:&5E=#$V,2YX;6Q02P$"% ,4
M" #GA$U6\";$J>H$  "^'   &@              @(%;008 >&PO=V]R:W-H
M965T<R]S:&5E=#$V,BYX;6Q02P$"% ,4    " #GA$U60:9=+6T#  "'$0
M&@              @(%]1@8 >&PO=V]R:W-H965T<R]S:&5E=#$V,RYX;6Q0
M2P$"% ,4    " #GA$U6V@@\D4,%   N(P  &@              @($B2@8
M>&PO=V]R:W-H965T<R]S:&5E=#$V-"YX;6Q02P$"% ,4    " #GA$U6PPWK
M? L&  #4'P  &@              @(&=3P8 >&PO=V]R:W-H965T<R]S:&5E
M=#$V-2YX;6Q02P$"% ,4    " #GA$U6%,2W8J\%   R+0  &@
M    @('@508 >&PO=V]R:W-H965T<R]S:&5E=#$V-BYX;6Q02P$"% ,4
M" #GA$U680+OKQ$$  !U%0  &@              @(''6P8 >&PO=V]R:W-H
M965T<R]S:&5E=#$V-RYX;6Q02P$"% ,4    " #GA$U6H+DI-%\*   0<0
M&@              @($08 8 >&PO=V]R:W-H965T<R]S:&5E=#$V."YX;6Q0
M2P$"% ,4    " #GA$U6  2.!"("   .!0  &@              @(&G:@8
M>&PO=V]R:W-H965T<R]S:&5E=#$V.2YX;6Q02P$"% ,4    " #GA$U6M2"?
MO\X#  #W%0  &@              @($!;08 >&PO=V]R:W-H965T<R]S:&5E
M=#$W,"YX;6Q02P$"% ,4    " #GA$U6ZAX@!Q@'   >2@  &@
M    @($'<08 >&PO=V]R:W-H965T<R]S:&5E=#$W,2YX;6Q02P$"% ,4
M" #GA$U6ENR+:J$=   D6P$ &@              @(%7> 8 >&PO=V]R:W-H
M965T<R]S:&5E=#$W,BYX;6Q02P$"% ,4    " #GA$U6ZXVTPUH"  #L!0
M&@              @($PE@8 >&PO=V]R:W-H965T<R]S:&5E=#$W,RYX;6Q0
M2P$"% ,4    " #GA$U6(\T_;&,#   G"P  &@              @('"F 8
M>&PO=V]R:W-H965T<R]S:&5E=#$W-"YX;6Q02P$"% ,4    " #GA$U6Y*0!
M4UL"   =!@  &@              @(%=G 8 >&PO=V]R:W-H965T<R]S:&5E
M=#$W-2YX;6Q02P$"% ,4    " #GA$U6ZJ9!;QL#  #^"@  &@
M    @('PG@8 >&PO=V]R:W-H965T<R]S:&5E=#$W-BYX;6Q02P$"% ,4
M" #GA$U6(P!B:6("   A!@  &@              @(%#H@8 >&PO=V]R:W-H
M965T<R]S:&5E=#$W-RYX;6Q02P$"% ,4    " #GA$U6]JF[PP@#  !O#0
M&@              @('=I 8 >&PO=V]R:W-H965T<R]S:&5E=#$W."YX;6Q0
M2P$"% ,4    " #GA$U6-&07XN("  "!"0  &@              @($=J 8
M>&PO=V]R:W-H965T<R]S:&5E=#$W.2YX;6Q02P$"% ,4    " #GA$U6,C2)
M?QP%  !2*0  &@              @($WJP8 >&PO=V]R:W-H965T<R]S:&5E
M=#$X,"YX;6Q02P$"% ,4    " #GA$U6<91^"T($  "#$   &@
M    @(&+L 8 >&PO=V]R:W-H965T<R]S:&5E=#$X,2YX;6Q02P$"% ,4
M" #GA$U6Z\!\UK0$  !:'0  &@              @($%M08 >&PO=V]R:W-H
M965T<R]S:&5E=#$X,BYX;6Q02P$"% ,4    " #GA$U66\1,UD$%  #%)
M&@              @('QN08 >&PO=V]R:W-H965T<R]S:&5E=#$X,RYX;6Q0
M2P$"% ,4    " #GA$U6(((NP 0$   _&   &@              @(%JOP8
M>&PO=V]R:W-H965T<R]S:&5E=#$X-"YX;6Q02P$"% ,4    " #GA$U6)ZVZ
M+"@$  !'$   &@              @(&FPP8 >&PO=V]R:W-H965T<R]S:&5E
M=#$X-2YX;6Q02P$"% ,4    " #GA$U6?GV=C68"   8!@  &@
M    @($&R 8 >&PO=V]R:W-H965T<R]S:&5E=#$X-BYX;6Q02P$"% ,4
M" #GA$U6Z[KNU)L"  !W!P  &@              @(&DR@8 >&PO=V]R:W-H
M965T<R]S:&5E=#$X-RYX;6Q02P$"% ,4    " #GA$U6=M?NL]T"   2#0
M&@              @(%WS08 >&PO=V]R:W-H965T<R]S:&5E=#$X."YX;6Q0
M2P$"% ,4    " #GA$U6H >3F80(  !25@  &@              @(&,T 8
M>&PO=V]R:W-H965T<R]S:&5E=#$X.2YX;6Q02P$"% ,4    " #GA$U6AF8[
MW<,$   '&   &@              @(%(V08 >&PO=V]R:W-H965T<R]S:&5E
M=#$Y,"YX;6Q02P$"% ,4    " #GA$U6L0C!MH8#  #,#P  &@
M    @(%#W@8 >&PO=V]R:W-H965T<R]S:&5E=#$Y,2YX;6Q02P$"% ,4
M" #GA$U6?EA#LD(&  #J/@  &@              @($!X@8 >&PO=V]R:W-H
M965T<R]S:&5E=#$Y,BYX;6Q02P$"% ,4    " #GA$U6G,.(A-<#  "8%
M&@              @(%[Z 8 >&PO=V]R:W-H965T<R]S:&5E=#$Y,RYX;6Q0
M2P$"% ,4    " #GA$U6XPM^MF )   >;   &@              @(&*[ 8
M>&PO=V]R:W-H965T<R]S:&5E=#$Y-"YX;6Q02P$"% ,4    " #GA$U6\";$
MJ>H$  "^'   &@              @($B]@8 >&PO=V]R:W-H965T<R]S:&5E
M=#$Y-2YX;6Q02P$"% ,4    " #GA$U6=:J92\@"  #("   &@
M    @(%$^P8 >&PO=V]R:W-H965T<R]S:&5E=#$Y-BYX;6Q02P$"% ,4
M" #GA$U6$TV1_JT$   P(0  &@              @(%$_@8 >&PO=V]R:W-H
M965T<R]S:&5E=#$Y-RYX;6Q02P$"% ,4    " #GA$U6KQU[CZ0"  #A!P
M&@              @($I P< >&PO=V]R:W-H965T<R]S:&5E=#$Y."YX;6Q0
M2P$"% ,4    " #GA$U6I[J)Q/("  !L#@  &@              @($%!@<
M>&PO=V]R:W-H965T<R]S:&5E=#$Y.2YX;6Q02P$"% ,4    " #GA$U6S2::
M(!\%  "A*@  &@              @($O"0< >&PO=V]R:W-H965T<R]S:&5E
M=#(P,"YX;6Q02P$"% ,4    " #GA$U6&$R_NDL"  #P!0  &@
M    @(&&#@< >&PO=V]R:W-H965T<R]S:&5E=#(P,2YX;6Q02P$"% ,4
M" #GA$U6$HO(IH<#  "9$0  &@              @($)$0< >&PO=V]R:W-H
M965T<R]S:&5E=#(P,BYX;6Q02P$"% ,4    " #GA$U6; WA8EL$   _(P
M&@              @('(% < >&PO=V]R:W-H965T<R]S:&5E=#(P,RYX;6Q0
M2P$"% ,4    " #GA$U68;@D+2H)  !W7   &@              @(%;&0<
M>&PO=V]R:W-H965T<R]S:&5E=#(P-"YX;6Q02P$"% ,4    " #GA$U6N#//
M_MX#  !\#@  &@              @(&](@< >&PO=V]R:W-H965T<R]S:&5E
M=#(P-2YX;6Q02P$"% ,4    " #GA$U6(!&ZI) '  ".3@  &@
M    @('3)@< >&PO=V]R:W-H965T<R]S:&5E=#(P-BYX;6Q02P$"% ,4
M" #GA$U65B3!;BP&  !?+P  &@              @(&;+@< >&PO=V]R:W-H
M965T<R]S:&5E=#(P-RYX;6Q02P$"% ,4    " #GA$U6E$;4T@D&  #2'P
M&@              @('_- < >&PO=V]R:W-H965T<R]S:&5E=#(P."YX;6Q0
M2P$"% ,4    " #GA$U69F&H?#,#  !P"0  &@              @(% .P<
M>&PO=V]R:W-H965T<R]S:&5E=#(P.2YX;6Q02P$"% ,4    " #GA$U67U[V
M^QD#  #U"0  &@              @(&K/@< >&PO=V]R:W-H965T<R]S:&5E
M=#(Q,"YX;6Q02P$"% ,4    " #GA$U6$0&VR/@$  !['P  &@
M    @('\00< >&PO=V]R:W-H965T<R]S:&5E=#(Q,2YX;6Q02P$"% ,4
M" #GA$U6=SO;0#H"  #I!0  &@              @($L1P< >&PO=V]R:W-H
M965T<R]S:&5E=#(Q,BYX;6Q02P$"% ,4    " #GA$U6I[&E(N (  #!50
M&@              @(&>20< >&PO=V]R:W-H965T<R]S:&5E=#(Q,RYX;6Q0
M2P$"% ,4    " #GA$U6A%0>U0(*  !6<@  &@              @(&V4@<
M>&PO=V]R:W-H965T<R]S:&5E=#(Q-"YX;6Q02P$"% ,4    " #GA$U6(Z5)
M80<&  !5-P  &@              @('P7 < >&PO=V]R:W-H965T<R]S:&5E
M=#(Q-2YX;6Q02P$"% ,4    " #GA$U6"53/EUL"  "A!0  &@
M    @($O8P< >&PO=V]R:W-H965T<R]S:&5E=#(Q-BYX;6Q02P$"% ,4
M" #GA$U6>*4L>X<#   W#@  &@              @('"90< >&PO=V]R:W-H
M965T<R]S:&5E=#(Q-RYX;6Q02P$"% ,4    " #GA$U6$ZE9'9@"  "<!P
M&@              @(&!:0< >&PO=V]R:W-H965T<R]S:&5E=#(Q."YX;6Q0
M2P$"% ,4    " #GA$U6D'VV%F\"  "V!@  &@              @(%1; <
M>&PO=V]R:W-H965T<R]S:&5E=#(Q.2YX;6Q02P$"% ,4    " #GA$U6S/2;
MP$@"  #Y!0  &@              @('X;@< >&PO=V]R:W-H965T<R]S:&5E
M=#(R,"YX;6Q02P$"% ,4    " #GA$U6@@U1S_X!   9!   &@
M    @(%X<0< >&PO=V]R:W-H965T<R]S:&5E=#(R,2YX;6Q02P$"% ,4
M" #GA$U6H; N_WT#  "1&   #0              @ &N<P< >&PO<W1Y;&5S
M+GAM;%!+ 0(4 Q0    ( .>$35:7BKL<P    !,"   +              "
M 59W!P!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( .>$3583=_']SPP  &J/   /
M              "  3]X!P!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #G
MA$U6&KI#UYT%   T@0  &@              @ $[A0< >&PO7W)E;',O=V]R
M:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #GA$U6X2A\@,\#  #]>0  $P
M            @ $0BP< 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     Y0#E
+ +0_   0CP<    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>243
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>244
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>245
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>663</ContextCount>
  <ElementCount>565</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>135</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>13</UnitCount>
  <MyReports>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONDENSED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS</Role>
      <ShortName>CONDENSED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONDENSED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - UNAUDITED CONDENSED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>UNAUDITED CONDENSED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT</Role>
      <ShortName>UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICITParenthetical</Role>
      <ShortName>UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - BALANCE SHEET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/BALANCESHEET</Role>
      <ShortName>BALANCE SHEET</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Statement - BALANCE SHEET (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/BALANCESHEETParenthetical</Role>
      <ShortName>BALANCE SHEET (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Statement - STATEMENT OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS</Role>
      <ShortName>STATEMENT OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Statement - STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT</Role>
      <ShortName>STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Statement - STATEMENT OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS</Role>
      <ShortName>STATEMENT OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND SHAREHOLDERS??? DEFICIT (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND SHAREHOLDERS??? DEFICIT (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND SHAREHOLDERS??? EQUITY (DEFICIT)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND SHAREHOLDERS??? EQUITY (DEFICIT)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Description of Organization and Business Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperations</Role>
      <ShortName>Description of Organization and Business Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Initial Public Offering</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/InitialPublicOffering</Role>
      <ShortName>Initial Public Offering</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Class A Common Stock Subject to Possible Redemption</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemption</Role>
      <ShortName>Class A Common Stock Subject to Possible Redemption</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Stockholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/StockholdersEquityDeficit</Role>
      <ShortName>Stockholders' Equity (Deficit)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/Warrants</Role>
      <ShortName>Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Description of Organization and Business Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperations_1</Role>
      <ShortName>Description of Organization and Business Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPolicies_1</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Initial Public Offering</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/InitialPublicOffering_1</Role>
      <ShortName>Initial Public Offering</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RelatedPartyTransactions_1</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/CommitmentsandContingencies_1</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Class A Common Stock Subject to Possible Redemption</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemption_1</Role>
      <ShortName>Class A Common Stock Subject to Possible Redemption</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Stockholders' Deficit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/StockholdersDeficit</Role>
      <ShortName>Stockholders' Deficit</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/Warrants_1</Role>
      <ShortName>Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/FairValueMeasurements_1</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/SubsequentEvents_1</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Description of the Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/DescriptionoftheBusiness</Role>
      <ShortName>Description of the Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/NetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Revenues</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/Revenues</Role>
      <ShortName>Revenues</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Fair Value</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/FairValue</Role>
      <ShortName>Fair Value</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/IncomeTaxes_1</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/ShareBasedCompensation</Role>
      <ShortName>Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RelatedPartyTransactions_2</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Redeemable, Convertible Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStock</Role>
      <ShortName>Redeemable, Convertible Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/CommitmentsandContingencies_2</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/SubsequentEvents_2</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Description of the Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/DescriptionoftheBusiness_1</Role>
      <ShortName>Description of the Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/SummaryofSignificantAccountingPolicies_1</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/NetLossPerShare_1</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Revenues</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/Revenues_1</Role>
      <ShortName>Revenues</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/Investments_1</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Fair Value</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/FairValue_1</Role>
      <ShortName>Fair Value</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Other Current Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/OtherCurrentAssets</Role>
      <ShortName>Other Current Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - Property, Plant, and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/PropertyPlantandEquipment</Role>
      <ShortName>Property, Plant, and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - SAFE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/SAFE</Role>
      <ShortName>SAFE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - Warrant Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/WarrantLiabilities</Role>
      <ShortName>Warrant Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/IncomeTaxes_2</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RelatedPartyTransactions_3</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - Shareholders??? Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/ShareholdersEquity</Role>
      <ShortName>Shareholders??? Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - Redeemable, Convertible Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStock_1</Role>
      <ShortName>Redeemable, Convertible Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - Benefit Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/BenefitPlans</Role>
      <ShortName>Benefit Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/CommitmentsandContingencies_3</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/Leases_1</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/SubsequentEvents_3</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>9954701 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>9954702 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies_1</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>9954703 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>9954704 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies_1</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>9954705 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>9954706 - Disclosure - Class A Common Stock Subject to Possible Redemption (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionTables</Role>
      <ShortName>Class A Common Stock Subject to Possible Redemption (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemption</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>9954707 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/FairValueMeasurements</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>9954708 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables_1</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>9954709 - Disclosure - Class A Common Stock Subject to Possible Redemption (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionTables_1</Role>
      <ShortName>Class A Common Stock Subject to Possible Redemption (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemption</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>9954710 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/FairValueMeasurementsTables_1</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/FairValueMeasurements</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>9954711 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/IncomeTaxes</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>9954712 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>9954713 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/NetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/NetLossPerShare</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>9954714 - Disclosure - Revenues (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RevenuesTables</Role>
      <ShortName>Revenues (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/Revenues</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>9954715 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/Investments</ParentRole>
      <Position>91</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>9954716 - Disclosure - Fair Value (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/FairValueTables</Role>
      <ShortName>Fair Value (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/FairValueMeasurements</ParentRole>
      <Position>92</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>9954717 - Disclosure - Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/ShareBasedCompensationTables</Role>
      <ShortName>Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/ShareBasedCompensation</ParentRole>
      <Position>93</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>9954718 - Disclosure - Related Party Transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RelatedPartyTransactionsTables</Role>
      <ShortName>Related Party Transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/RelatedPartyTransactions</ParentRole>
      <Position>94</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>9954719 - Disclosure - Redeemable, Convertible Preferred Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockTables</Role>
      <ShortName>Redeemable, Convertible Preferred Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStock</ParentRole>
      <Position>95</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>9954720 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/Leases</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>9954721 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesTables_1</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>9954722 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/NetLossPerShareTables_1</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/NetLossPerShare</ParentRole>
      <Position>98</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>9954723 - Disclosure - Revenues (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RevenuesTables_1</Role>
      <ShortName>Revenues (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/Revenues</ParentRole>
      <Position>99</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>9954724 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/InvestmentsTables_1</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/Investments</ParentRole>
      <Position>100</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>9954725 - Disclosure - Fair Value (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/FairValueTables_1</Role>
      <ShortName>Fair Value (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/FairValueMeasurements</ParentRole>
      <Position>101</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>9954726 - Disclosure - Other Current Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/OtherCurrentAssetsTables</Role>
      <ShortName>Other Current Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/OtherCurrentAssets</ParentRole>
      <Position>102</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>9954727 - Disclosure - Property, Plant, and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/PropertyPlantandEquipmentTables</Role>
      <ShortName>Property, Plant, and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/PropertyPlantandEquipment</ParentRole>
      <Position>103</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>9954728 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/Debt</ParentRole>
      <Position>104</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>9954729 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/IncomeTaxesTables_1</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/IncomeTaxes</ParentRole>
      <Position>105</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>9954730 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/StockBasedCompensation</ParentRole>
      <Position>106</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>9954731 - Disclosure - Redeemable, Convertible Preferred Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockTables_1</Role>
      <ShortName>Redeemable, Convertible Preferred Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStock</ParentRole>
      <Position>107</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>9954732 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/LeasesTables_1</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/Leases</ParentRole>
      <Position>108</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>9954733 - Disclosure - Description of Organization and Business Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails</Role>
      <ShortName>Description of Organization and Business Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperations</ParentRole>
      <Position>109</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>9954734 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>110</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>9954735 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Net Income (Loss) Per Share of Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Net Income (Loss) Per Share of Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>111</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>9954736 - Disclosure - Initial Public Offering (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/InitialPublicOfferingDetails</Role>
      <ShortName>Initial Public Offering (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/InitialPublicOffering</ParentRole>
      <Position>112</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>9954737 - Disclosure - Related Party Transactions - Founder Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails</Role>
      <ShortName>Related Party Transactions - Founder Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>113</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>9954738 - Disclosure - Related Party Transactions - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails</Role>
      <ShortName>Related Party Transactions - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>114</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>9954739 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/CommitmentsandContingencies</ParentRole>
      <Position>115</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>9954740 - Disclosure - Class A Common Stock Subject to Possible Redemption (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails</Role>
      <ShortName>Class A Common Stock Subject to Possible Redemption (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionTables</ParentRole>
      <Position>116</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R117.htm</HtmlFileName>
      <LongName>9954741 - Disclosure - Stockholders' Equity (Deficit) - Preferred Stock Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/StockholdersEquityDeficitPreferredStockSharesDetails</Role>
      <ShortName>Stockholders' Equity (Deficit) - Preferred Stock Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/StockholdersEquityDeficit</ParentRole>
      <Position>117</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R118.htm</HtmlFileName>
      <LongName>9954742 - Disclosure - Stockholders' Equity (Deficit) - Common Stock Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/StockholdersEquityDeficitCommonStockSharesDetails</Role>
      <ShortName>Stockholders' Equity (Deficit) - Common Stock Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/StockholdersEquityDeficit</ParentRole>
      <Position>118</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R119.htm</HtmlFileName>
      <LongName>9954743 - Disclosure - Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/WarrantsDetails</Role>
      <ShortName>Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/Warrants</ParentRole>
      <Position>119</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R120.htm</HtmlFileName>
      <LongName>9954744 - Disclosure - Warrants Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails</Role>
      <ShortName>Warrants Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>120</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R121.htm</HtmlFileName>
      <LongName>9954745 - Disclosure - Fair Value Measurements - Company's financial assets and liabilities that are measured at fair value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails</Role>
      <ShortName>Fair Value Measurements - Company's financial assets and liabilities that are measured at fair value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>121</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R122.htm</HtmlFileName>
      <LongName>9954746 - Disclosure - Fair Value Measurements - Level 3 fair value measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails</Role>
      <ShortName>Fair Value Measurements - Level 3 fair value measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>122</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R123.htm</HtmlFileName>
      <LongName>9954747 - Disclosure - Fair Value Measurements - Change in the fair value of the derivative warrant liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails</Role>
      <ShortName>Fair Value Measurements - Change in the fair value of the derivative warrant liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>123</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R124.htm</HtmlFileName>
      <LongName>9954748 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/SubsequentEvents</ParentRole>
      <Position>124</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R125.htm</HtmlFileName>
      <LongName>9954749 - Disclosure - Description of Organization and Business Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1</Role>
      <ShortName>Description of Organization and Business Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperations</ParentRole>
      <Position>125</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R126.htm</HtmlFileName>
      <LongName>9954750 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails_1</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>126</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R127.htm</HtmlFileName>
      <LongName>9954751 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Net Income (Loss) Per Share of Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails_1</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Net Income (Loss) Per Share of Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>127</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R128.htm</HtmlFileName>
      <LongName>9954752 - Disclosure - Initial Public Offering (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1</Role>
      <ShortName>Initial Public Offering (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/InitialPublicOffering</ParentRole>
      <Position>128</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R129.htm</HtmlFileName>
      <LongName>9954753 - Disclosure - Related Party Transactions - Founder Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails_1</Role>
      <ShortName>Related Party Transactions - Founder Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>129</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R130.htm</HtmlFileName>
      <LongName>9954754 - Disclosure - Related Party Transactions - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1</Role>
      <ShortName>Related Party Transactions - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>130</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R131.htm</HtmlFileName>
      <LongName>9954755 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails_1</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/CommitmentsandContingencies</ParentRole>
      <Position>131</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R132.htm</HtmlFileName>
      <LongName>9954756 - Disclosure - Class A Common Stock Subject to Possible Redemption (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails_1</Role>
      <ShortName>Class A Common Stock Subject to Possible Redemption (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionTables</ParentRole>
      <Position>132</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R133.htm</HtmlFileName>
      <LongName>9954757 - Disclosure - Stockholders' Deficit - Preferred Stock Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/StockholdersDeficitPreferredStockSharesDetails</Role>
      <ShortName>Stockholders' Deficit - Preferred Stock Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>133</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R134.htm</HtmlFileName>
      <LongName>9954758 - Disclosure - Stockholders' Deficit - Common Stock Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/StockholdersDeficitCommonStockSharesDetails</Role>
      <ShortName>Stockholders' Deficit - Common Stock Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>134</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R135.htm</HtmlFileName>
      <LongName>9954759 - Disclosure - Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/WarrantsDetails_1</Role>
      <ShortName>Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/Warrants</ParentRole>
      <Position>135</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R136.htm</HtmlFileName>
      <LongName>9954760 - Disclosure - Warrants - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1</Role>
      <ShortName>Warrants - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>136</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R137.htm</HtmlFileName>
      <LongName>9954761 - Disclosure - Fair Value Measurements - Company's financial assets and liabilities that are measured at fair value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails_1</Role>
      <ShortName>Fair Value Measurements - Company's financial assets and liabilities that are measured at fair value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>137</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R138.htm</HtmlFileName>
      <LongName>9954762 - Disclosure - Fair Value Measurements - Level 3 fair value measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails_1</Role>
      <ShortName>Fair Value Measurements - Level 3 fair value measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>138</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R139.htm</HtmlFileName>
      <LongName>9954763 - Disclosure - Fair Value Measurements - Change in the fair value of the derivative warrant liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails_1</Role>
      <ShortName>Fair Value Measurements - Change in the fair value of the derivative warrant liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>139</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R140.htm</HtmlFileName>
      <LongName>9954764 - Disclosure - Income Taxes - Income tax provision (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/IncomeTaxesIncometaxprovisionDetails</Role>
      <ShortName>Income Taxes - Income tax provision (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>140</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R141.htm</HtmlFileName>
      <LongName>9954765 - Disclosure - Income Taxes - Deferred tax assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/IncomeTaxesDeferredtaxassetsDetails</Role>
      <ShortName>Income Taxes - Deferred tax assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>141</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R142.htm</HtmlFileName>
      <LongName>9954766 - Disclosure - Income Taxes - Reconciliation of the statutory federal income tax rate (benefit) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/IncomeTaxesReconciliationofthestatutoryfederalincometaxratebenefitDetails</Role>
      <ShortName>Income Taxes - Reconciliation of the statutory federal income tax rate (benefit) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>142</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R143.htm</HtmlFileName>
      <LongName>9954767 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/SubsequentEventsDetails_1</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/SubsequentEvents</ParentRole>
      <Position>143</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R144.htm</HtmlFileName>
      <LongName>9954768 - Disclosure - Description of the Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/DescriptionoftheBusinessDetails</Role>
      <ShortName>Description of the Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/DescriptionoftheBusiness</ParentRole>
      <Position>144</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R145.htm</HtmlFileName>
      <LongName>9954769 - Disclosure - Summary of Significant Accounting Policies - Going Concern and Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesGoingConcernandSegmentInformationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Going Concern and Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>145</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R146.htm</HtmlFileName>
      <LongName>9954770 - Disclosure - Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>146</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R147.htm</HtmlFileName>
      <LongName>9954771 - Disclosure - Summary of Significant Accounting Policies - Cash, Cash Equivalents and Restricted Cash Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashReconciliationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Cash, Cash Equivalents and Restricted Cash Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>147</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R148.htm</HtmlFileName>
      <LongName>9954772 - Disclosure - Summary of Significant Accounting Policies - Trade and Other Receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesTradeandOtherReceivablesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Trade and Other Receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>148</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R149.htm</HtmlFileName>
      <LongName>9954773 - Disclosure - Summary of Significant Accounting Policies - Concentration of Credit Risk and Other Risks and Uncertainties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Concentration of Credit Risk and Other Risks and Uncertainties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>149</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R150.htm</HtmlFileName>
      <LongName>9954774 - Disclosure - Net Loss Per Share - Schedule of Calculation of Basic and Diluted Net Loss per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails</Role>
      <ShortName>Net Loss Per Share - Schedule of Calculation of Basic and Diluted Net Loss per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>150</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R151.htm</HtmlFileName>
      <LongName>9954775 - Disclosure - LanzaTech 10Q Net Loss Per Share - Antidilutive Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/LanzaTech10QNetLossPerShareAntidilutiveSharesDetails</Role>
      <ShortName>LanzaTech 10Q Net Loss Per Share - Antidilutive Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>151</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R152.htm</HtmlFileName>
      <LongName>9954776 - Disclosure - Revenues - Disaggregated Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails</Role>
      <ShortName>Revenues - Disaggregated Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>152</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R153.htm</HtmlFileName>
      <LongName>9954777 - Disclosure - Revenues - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RevenuesAdditionalInformationDetails</Role>
      <ShortName>Revenues - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>153</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R154.htm</HtmlFileName>
      <LongName>9954778 - Disclosure - Revenues - Disaggregation by Customer Location (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails</Role>
      <ShortName>Revenues - Disaggregation by Customer Location (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>154</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R155.htm</HtmlFileName>
      <LongName>9954779 - Disclosure - Revenues - Contract Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RevenuesContractBalancesDetails</Role>
      <ShortName>Revenues - Contract Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>155</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R156.htm</HtmlFileName>
      <LongName>9954780 - Disclosure - Revenues - Remaining Performance Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RevenuesRemainingPerformanceObligationsDetails</Role>
      <ShortName>Revenues - Remaining Performance Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>156</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R157.htm</HtmlFileName>
      <LongName>9954781 - Disclosure - Investments - Schedule of Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/InvestmentsScheduleofInvestmentsDetails</Role>
      <ShortName>Investments - Schedule of Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>157</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R158.htm</HtmlFileName>
      <LongName>9954782 - Disclosure - Investments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/InvestmentsNarrativeDetails</Role>
      <ShortName>Investments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>158</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R159.htm</HtmlFileName>
      <LongName>9954783 - Disclosure - Fair Value - Financial Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails</Role>
      <ShortName>Fair Value - Financial Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>159</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R160.htm</HtmlFileName>
      <LongName>9954784 - Disclosure - Fair Value - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/FairValueNarrativeDetails</Role>
      <ShortName>Fair Value - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>160</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R161.htm</HtmlFileName>
      <LongName>9954785 - Disclosure - Fair Value - Level 3 Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails</Role>
      <ShortName>Fair Value - Level 3 Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>161</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R162.htm</HtmlFileName>
      <LongName>9954786 - Disclosure - Fair Value - Change in Fair Value of Derivative Warrant Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails</Role>
      <ShortName>Fair Value - Change in Fair Value of Derivative Warrant Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>162</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R163.htm</HtmlFileName>
      <LongName>9954787 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/IncomeTaxesTables</ParentRole>
      <Position>163</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R164.htm</HtmlFileName>
      <LongName>9954788 - Disclosure - Share-Based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/ShareBasedCompensationNarrativeDetails</Role>
      <ShortName>Share-Based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>164</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R165.htm</HtmlFileName>
      <LongName>9954789 - Disclosure - Share-Based Compensation - Stock Option Award Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/ShareBasedCompensationStockOptionAwardActivityDetails</Role>
      <ShortName>Share-Based Compensation - Stock Option Award Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>165</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R166.htm</HtmlFileName>
      <LongName>9954790 - Disclosure - Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails</Role>
      <ShortName>Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/RelatedPartyTransactionsTables</ParentRole>
      <Position>166</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R167.htm</HtmlFileName>
      <LongName>9954791 - Disclosure - Related Party Transactions - Schedule of Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails</Role>
      <ShortName>Related Party Transactions - Schedule of Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>167</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R168.htm</HtmlFileName>
      <LongName>9954792 - Disclosure - Redeemable, Convertible Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockDetails</Role>
      <ShortName>Redeemable, Convertible Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockTables</ParentRole>
      <Position>168</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R169.htm</HtmlFileName>
      <LongName>9954793 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails_2</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/CommitmentsandContingencies</ParentRole>
      <Position>169</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R170.htm</HtmlFileName>
      <LongName>9954794 - Disclosure - Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/LeasesDetails</Role>
      <ShortName>Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/LeasesTables</ParentRole>
      <Position>170</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R171.htm</HtmlFileName>
      <LongName>9954795 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/SubsequentEventsDetails_2</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/SubsequentEvents</ParentRole>
      <Position>171</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R172.htm</HtmlFileName>
      <LongName>9954796 - Disclosure - Summary of Significant Accounting Policies - Restatement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Restatement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>172</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R173.htm</HtmlFileName>
      <LongName>9954797 - Disclosure - Summary of Significant Accounting Policies - Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>173</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R174.htm</HtmlFileName>
      <LongName>9954798 - Disclosure - Summary of Significant Accounting Policies - Going Concern (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesGoingConcernDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Going Concern (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>174</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R175.htm</HtmlFileName>
      <LongName>9954799 - Disclosure - Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails_1</Role>
      <ShortName>Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>175</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R176.htm</HtmlFileName>
      <LongName>9954800 - Disclosure - Summary of Significant Accounting Policies - Cash, Cash Equivalents and Restricted Cash Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashReconciliationDetails_1</Role>
      <ShortName>Summary of Significant Accounting Policies - Cash, Cash Equivalents and Restricted Cash Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>176</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R177.htm</HtmlFileName>
      <LongName>9954801 - Disclosure - Summary of Significant Accounting Policies - Trade and Other Receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesTradeandOtherReceivablesDetails_1</Role>
      <ShortName>Summary of Significant Accounting Policies - Trade and Other Receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>177</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R178.htm</HtmlFileName>
      <LongName>9954802 - Disclosure - Summary of Significant Accounting Policies - Property, Plant and Equipment, net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentnetDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Property, Plant and Equipment, net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>178</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R179.htm</HtmlFileName>
      <LongName>9954803 - Disclosure - Summary of Significant Accounting Policies - Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesWarrantsDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>179</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R180.htm</HtmlFileName>
      <LongName>9954804 - Disclosure - Summary of Significant Accounting Policies - Concentration of Credit Risk and Other Risks and Uncertainties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails_1</Role>
      <ShortName>Summary of Significant Accounting Policies - Concentration of Credit Risk and Other Risks and Uncertainties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>180</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R181.htm</HtmlFileName>
      <LongName>9954805 - Disclosure - Net Loss Per Share - Schedule of Calculation of Basic and Diluted Net Loss per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails_1</Role>
      <ShortName>Net Loss Per Share - Schedule of Calculation of Basic and Diluted Net Loss per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>181</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R182.htm</HtmlFileName>
      <LongName>9954806 - Disclosure - Net Loss Per Share - Antidilutive Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/NetLossPerShareAntidilutiveSharesDetails</Role>
      <ShortName>Net Loss Per Share - Antidilutive Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>182</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R183.htm</HtmlFileName>
      <LongName>9954807 - Disclosure - Revenues - Disaggregated Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails_1</Role>
      <ShortName>Revenues - Disaggregated Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>183</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R184.htm</HtmlFileName>
      <LongName>9954808 - Disclosure - Revenues - Disaggregation by Customer Location (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails_1</Role>
      <ShortName>Revenues - Disaggregation by Customer Location (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>184</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R185.htm</HtmlFileName>
      <LongName>9954809 - Disclosure - Revenues - Contract Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RevenuesContractBalancesDetails_1</Role>
      <ShortName>Revenues - Contract Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>185</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R186.htm</HtmlFileName>
      <LongName>9954810 - Disclosure - Revenues - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RevenuesAdditionalInformationDetails_1</Role>
      <ShortName>Revenues - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>186</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R187.htm</HtmlFileName>
      <LongName>9954811 - Disclosure - Revenues - Remaining Performance Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RevenuesRemainingPerformanceObligationsDetails_1</Role>
      <ShortName>Revenues - Remaining Performance Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>187</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R188.htm</HtmlFileName>
      <LongName>9954812 - Disclosure - Investments - Equity Method Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/InvestmentsEquityMethodInvestmentsDetails</Role>
      <ShortName>Investments - Equity Method Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>188</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R189.htm</HtmlFileName>
      <LongName>9954813 - Disclosure - Investments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/InvestmentsNarrativeDetails_1</Role>
      <ShortName>Investments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>189</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R190.htm</HtmlFileName>
      <LongName>9954814 - Disclosure - Investments - Summarized Financial Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/InvestmentsSummarizedFinancialInformationDetails</Role>
      <ShortName>Investments - Summarized Financial Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>190</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R191.htm</HtmlFileName>
      <LongName>9954815 - Disclosure - Investments - Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/InvestmentsTransactionsDetails</Role>
      <ShortName>Investments - Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>191</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R192.htm</HtmlFileName>
      <LongName>9954816 - Disclosure - Fair Value - Financial Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails_1</Role>
      <ShortName>Fair Value - Financial Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>192</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R193.htm</HtmlFileName>
      <LongName>9954817 - Disclosure - Fair Value - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/FairValueNarrativeDetails_1</Role>
      <ShortName>Fair Value - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>193</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R194.htm</HtmlFileName>
      <LongName>9954818 - Disclosure - Fair Value - Level 3 Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1</Role>
      <ShortName>Fair Value - Level 3 Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>194</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R195.htm</HtmlFileName>
      <LongName>9954819 - Disclosure - Fair Value - Change in Fair Value of Derivative Warrant Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails_1</Role>
      <ShortName>Fair Value - Change in Fair Value of Derivative Warrant Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>195</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R196.htm</HtmlFileName>
      <LongName>9954820 - Disclosure - Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/OtherCurrentAssetsDetails</Role>
      <ShortName>Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/OtherCurrentAssetsTables</ParentRole>
      <Position>196</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R197.htm</HtmlFileName>
      <LongName>9954821 - Disclosure - Property, Plant, and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/PropertyPlantandEquipmentDetails</Role>
      <ShortName>Property, Plant, and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/PropertyPlantandEquipmentTables</ParentRole>
      <Position>197</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R198.htm</HtmlFileName>
      <LongName>9954822 - Disclosure - Property, Plant, and Equipment - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/PropertyPlantandEquipmentNarrativeDetails</Role>
      <ShortName>Property, Plant, and Equipment - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>198</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R199.htm</HtmlFileName>
      <LongName>9954823 - Disclosure - Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/DebtDetails</Role>
      <ShortName>Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/DebtTables</ParentRole>
      <Position>199</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R200.htm</HtmlFileName>
      <LongName>9954824 - Disclosure - Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/DebtNarrativeDetails</Role>
      <ShortName>Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>200</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R201.htm</HtmlFileName>
      <LongName>9954825 - Disclosure - SAFE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/SAFEDetails</Role>
      <ShortName>SAFE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/SAFE</ParentRole>
      <Position>201</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R202.htm</HtmlFileName>
      <LongName>9954826 - Disclosure - Income Taxes - Components of (Loss) Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/IncomeTaxesComponentsofLossIncomeDetails</Role>
      <ShortName>Income Taxes - Components of (Loss) Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>202</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R203.htm</HtmlFileName>
      <LongName>9954827 - Disclosure - Income Taxes - Income Tax Provision (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/IncomeTaxesIncomeTaxProvisionDetails</Role>
      <ShortName>Income Taxes - Income Tax Provision (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>203</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R204.htm</HtmlFileName>
      <LongName>9954828 - Disclosure - Income Taxes - Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails</Role>
      <ShortName>Income Taxes - Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>204</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R205.htm</HtmlFileName>
      <LongName>9954829 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>205</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R206.htm</HtmlFileName>
      <LongName>9954830 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>206</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R207.htm</HtmlFileName>
      <LongName>9954831 - Disclosure - Stock-Based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/StockBasedCompensationNarrativeDetails</Role>
      <ShortName>Stock-Based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>207</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R208.htm</HtmlFileName>
      <LongName>9954832 - Disclosure - Stock-Based Compensation - Stock Option Award Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/StockBasedCompensationStockOptionAwardActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Stock Option Award Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>208</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R209.htm</HtmlFileName>
      <LongName>9954833 - Disclosure - Stock-Based Compensation - Fair Value Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/StockBasedCompensationFairValueAssumptionsDetails</Role>
      <ShortName>Stock-Based Compensation - Fair Value Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>209</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R210.htm</HtmlFileName>
      <LongName>9954834 - Disclosure - Stock-Based Compensation - Restricted Stock Awards Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/StockBasedCompensationRestrictedStockAwardsActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Restricted Stock Awards Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>210</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R211.htm</HtmlFileName>
      <LongName>9954835 - Disclosure - Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails_1</Role>
      <ShortName>Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/RelatedPartyTransactionsTables</ParentRole>
      <Position>211</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R212.htm</HtmlFileName>
      <LongName>9954836 - Disclosure - Shareholders??? Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/ShareholdersEquityDetails</Role>
      <ShortName>Shareholders??? Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/ShareholdersEquity</ParentRole>
      <Position>212</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R213.htm</HtmlFileName>
      <LongName>9954837 - Disclosure - Redeemable, Convertible Preferred Stock - Authorized, Issued and Outstanding Shares, Issue Price, and Carrying Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockAuthorizedIssuedandOutstandingSharesIssuePriceandCarryingValueDetails</Role>
      <ShortName>Redeemable, Convertible Preferred Stock - Authorized, Issued and Outstanding Shares, Issue Price, and Carrying Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>213</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R214.htm</HtmlFileName>
      <LongName>9954838 - Disclosure - Redeemable, Convertible Preferred Stock - Changes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockChangesDetails</Role>
      <ShortName>Redeemable, Convertible Preferred Stock - Changes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>214</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R215.htm</HtmlFileName>
      <LongName>9954839 - Disclosure - Redeemable, Convertible Preferred Stock - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockNarrativeDetails</Role>
      <ShortName>Redeemable, Convertible Preferred Stock - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>215</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R216.htm</HtmlFileName>
      <LongName>9954840 - Disclosure - Benefit Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/BenefitPlansDetails</Role>
      <ShortName>Benefit Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/BenefitPlans</ParentRole>
      <Position>216</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R217.htm</HtmlFileName>
      <LongName>9954841 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>217</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R218.htm</HtmlFileName>
      <LongName>9954842 - Disclosure - Leases - Lease Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/LeasesLeaseMaturitiesDetails</Role>
      <ShortName>Leases - Lease Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>218</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R219.htm</HtmlFileName>
      <LongName>9954843 - Disclosure - Leases - Lessor, Operating Lease, Payments to be Received (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/LeasesLessorOperatingLeasePaymentstobeReceivedDetails</Role>
      <ShortName>Leases - Lessor, Operating Lease, Payments to be Received (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>219</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R220.htm</HtmlFileName>
      <LongName>9954844 - Disclosure - Leases - Supplemental Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/LeasesSupplementalInformationDetails</Role>
      <ShortName>Leases - Supplemental Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>220</Position>
    </Report>
    <Report instance="amci-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R221.htm</HtmlFileName>
      <LongName>9954845 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amciacquisitioncorp/role/SubsequentEventsDetails_3</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://amciacquisitioncorp/role/SubsequentEvents</ParentRole>
      <Position>221</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 75 fact(s) appearing in ix:hidden were eligible for transformation: amci:AggregateNumberOfSharesOwned, amci:NumberOfSharesSurrendered, amci:NumberOfWarrantsIssuedPerUnit, amci:RedemptionPeriodUponClosure, amci:TemporaryEquityIssuePricePerShare, us-gaap:CommonStockParOrStatedValuePerShare, us-gaap:CommonStockSharesAuthorized, us-gaap:CommonStockSharesIssued, us-gaap:CommonStockSharesOutstanding, us-gaap:PreferredStockParOrStatedValuePerShare, us-gaap:PreferredStockSharesAuthorized, us-gaap:PreferredStockSharesIssued, us-gaap:PreferredStockSharesOutstanding, us-gaap:PropertyPlantAndEquipmentUsefulLife, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1, us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited, us-gaap:TemporaryEquityParOrStatedValuePerShare, us-gaap:TemporaryEquityRedemptionPricePerShare, us-gaap:TemporaryEquitySharesIssued, us-gaap:TemporaryEquitySharesOutstanding -  amci-20230213.htm 4</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Not-Referenced] WARN: 6 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration, us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList -  amci-20230213.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="S-1" original="amci-20230213.htm">amci-20230213.htm</File>
    <File>amci-20230213.xsd</File>
    <File>amci-20230213_cal.xml</File>
    <File>amci-20230213_def.xml</File>
    <File>amci-20230213_lab.xml</File>
    <File>amci-20230213_pre.xml</File>
    <File>exhibit107-resalesx1.htm</File>
    <File>exhibit231-resalesx1.htm</File>
    <File>exhibit232-resalesx1.htm</File>
    <File>exhibit51-resalesx1.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>amci-20230213_g1.jpg</File>
    <File>amci-20230213_g2.jpg</File>
    <File>amci-20230213_g3.jpg</File>
    <File>amci-20230213_g4.jpg</File>
    <File>amci-20230213_g5.jpg</File>
    <File>amci-20230213_g6.jpg</File>
    <File>amci-20230213_g7.jpg</File>
    <File>amci-20230213_g8.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="2296">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="8">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>248
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "amci-20230213.htm": {
   "axisCustom": 2,
   "axisStandard": 37,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 2296,
    "http://xbrl.sec.gov/dei/2022": 8
   },
   "contextCount": 663,
   "dts": {
    "calculationLink": {
     "local": [
      "amci-20230213_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "amci-20230213_def.xml"
     ]
    },
    "inline": {
     "local": [
      "amci-20230213.htm"
     ]
    },
    "labelLink": {
     "local": [
      "amci-20230213_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "amci-20230213_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "amci-20230213.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/2006/xbrldi-2006.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 887,
   "entityCount": 1,
   "hidden": {
    "http://amciacquisitioncorp/20230213": 12,
    "http://fasb.org/us-gaap/2022": 69,
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 83
   },
   "keyCustom": 161,
   "keyStandard": 404,
   "memberCustom": 61,
   "memberStandard": 67,
   "nsprefix": "amci",
   "nsuri": "http://amciacquisitioncorp/20230213",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://amciacquisitioncorp/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000010 - Statement - STATEMENT OF OPERATIONS",
     "menuCat": "Statements",
     "order": "10",
     "role": "http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS",
     "shortName": "STATEMENT OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:GeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954724 - Disclosure - Investments (Tables)",
     "menuCat": "Tables",
     "order": "100",
     "role": "http://amciacquisitioncorp/role/InvestmentsTables_1",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954725 - Disclosure - Fair Value (Tables)",
     "menuCat": "Tables",
     "order": "101",
     "role": "http://amciacquisitioncorp/role/FairValueTables_1",
     "shortName": "Fair Value (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954726 - Disclosure - Other Current Assets (Tables)",
     "menuCat": "Tables",
     "order": "102",
     "role": "http://amciacquisitioncorp/role/OtherCurrentAssetsTables",
     "shortName": "Other Current Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954727 - Disclosure - Property, Plant, and Equipment (Tables)",
     "menuCat": "Tables",
     "order": "103",
     "role": "http://amciacquisitioncorp/role/PropertyPlantandEquipmentTables",
     "shortName": "Property, Plant, and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954728 - Disclosure - Debt (Tables)",
     "menuCat": "Tables",
     "order": "104",
     "role": "http://amciacquisitioncorp/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954729 - Disclosure - Income Taxes (Tables)",
     "menuCat": "Tables",
     "order": "105",
     "role": "http://amciacquisitioncorp/role/IncomeTaxesTables_1",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954730 - Disclosure - Stock-Based Compensation (Tables)",
     "menuCat": "Tables",
     "order": "106",
     "role": "http://amciacquisitioncorp/role/StockBasedCompensationTables",
     "shortName": "Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "amci:TemporaryEquityDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954731 - Disclosure - Redeemable, Convertible Preferred Stock (Tables)",
     "menuCat": "Tables",
     "order": "107",
     "role": "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockTables_1",
     "shortName": "Redeemable, Convertible Preferred Stock (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954732 - Disclosure - Leases (Tables)",
     "menuCat": "Tables",
     "order": "108",
     "role": "http://amciacquisitioncorp/role/LeasesTables_1",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:NatureOfOperations",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "amci:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum",
      "reportCount": 1,
      "unitRef": "item",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954733 - Disclosure - Description of Organization and Business Operations (Details)",
     "menuCat": "Details",
     "order": "109",
     "role": "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
     "shortName": "Description of Organization and Business Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i946f64f7009a4a2082ea5e8ea9ae0377_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000011 - Statement - STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT",
     "menuCat": "Statements",
     "order": "11",
     "role": "http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT",
     "shortName": "STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R110": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954734 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)",
     "menuCat": "Details",
     "order": "110",
     "role": "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i759728e90602443f941d8e14893c6860_D20210128-20210131",
      "decimals": "4",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R111": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954735 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Net Income (Loss) Per Share of Common Stock (Details)",
     "menuCat": "Details",
     "order": "111",
     "role": "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Net Income (Loss) Per Share of Common Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R112": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "amci:SaleOfStockUnderwritingDiscounts",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954736 - Disclosure - Initial Public Offering (Details)",
     "menuCat": "Details",
     "order": "112",
     "role": "http://amciacquisitioncorp/role/InitialPublicOfferingDetails",
     "shortName": "Initial Public Offering (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R113": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i450b257d15c4448cabb4fa176b9c5882_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "amci:NumberOfSharesSubjectToForfeiture",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954737 - Disclosure - Related Party Transactions - Founder Shares (Details)",
     "menuCat": "Details",
     "order": "113",
     "role": "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails",
     "shortName": "Related Party Transactions - Founder Shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i0e2866880e0e48c8bbbc428a81262e75_I20210917",
      "decimals": "INF",
      "lang": "en-US",
      "name": "amci:NumberOfSharesSubjectToForfeiture",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R114": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954738 - Disclosure - Related Party Transactions - Additional Information (Details)",
     "menuCat": "Details",
     "order": "114",
     "role": "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails",
     "shortName": "Related Party Transactions - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R115": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "amci:MaximumNumberOfDemandsForRegistrationOfSecurities",
      "reportCount": 1,
      "unitRef": "item",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954739 - Disclosure - Commitments and Contingencies (Details)",
     "menuCat": "Details",
     "order": "115",
     "role": "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "iff3bcef644df441dabded615618c965f_D20220101-20220930",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromFeesReceived",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R116": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockSharesAuthorized",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954740 - Disclosure - Class A Common Stock Subject to Possible Redemption (Details)",
     "menuCat": "Details",
     "order": "116",
     "role": "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails",
     "shortName": "Class A Common Stock Subject to Possible Redemption (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "amci:TemporaryEquityDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "ie50e9e7d91b842cf814d5cfc02ae90f3_I20220930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "amci:CommonStockNumberOfVotesPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "vote",
      "xsiNil": "false"
     }
    },
    "R117": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954741 - Disclosure - Stockholders' Equity (Deficit) - Preferred Stock Shares (Details)",
     "menuCat": "Details",
     "order": "117",
     "role": "http://amciacquisitioncorp/role/StockholdersEquityDeficitPreferredStockSharesDetails",
     "shortName": "Stockholders' Equity (Deficit) - Preferred Stock Shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R118": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockSharesAuthorized",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954742 - Disclosure - Stockholders' Equity (Deficit) - Common Stock Shares (Details)",
     "menuCat": "Details",
     "order": "118",
     "role": "http://amciacquisitioncorp/role/StockholdersEquityDeficitCommonStockSharesDetails",
     "shortName": "Stockholders' Equity (Deficit) - Common Stock Shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R119": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "amci:WarrantsTextBlockTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954743 - Disclosure - Warrants (Details)",
     "menuCat": "Details",
     "order": "119",
     "role": "http://amciacquisitioncorp/role/WarrantsDetails",
     "shortName": "Warrants (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAdjustmentOfWarrants",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000012 - Statement - STATEMENT OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "12",
     "role": "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
     "shortName": "STATEMENT OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "icf12947ee9af4bb4871b2f93536dd745_D20210128-20211231",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R120": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "amci:WarrantsTextBlockTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WarrantsAndRightsOutstandingTerm",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954744 - Disclosure - Warrants Additional Information (Details)",
     "menuCat": "Details",
     "order": "120",
     "role": "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails",
     "shortName": "Warrants Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "ifa1f55ccc0e14b588cf21c809f2ea5b3_D20220101-20220930",
      "decimals": null,
      "lang": "en-US",
      "name": "amci:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R121": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAdjustmentOfWarrants",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954745 - Disclosure - Fair Value Measurements - Company's financial assets and liabilities that are measured at fair value (Details)",
     "menuCat": "Details",
     "order": "121",
     "role": "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails",
     "shortName": "Fair Value Measurements - Company's financial assets and liabilities that are measured at fair value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R122": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i255bc9e0c6fd4f8a8cfcde46d7515d42_I20220930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954746 - Disclosure - Fair Value Measurements - Level 3 fair value measurements (Details)",
     "menuCat": "Details",
     "order": "122",
     "role": "http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails",
     "shortName": "Fair Value Measurements - Level 3 fair value measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R123": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "if29e2998f81b49e2b4637ccd72f330be_I20220630",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954747 - Disclosure - Fair Value Measurements - Change in the fair value of the derivative warrant liabilities (Details)",
     "menuCat": "Details",
     "order": "123",
     "role": "http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails",
     "shortName": "Fair Value Measurements - Change in the fair value of the derivative warrant liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R124": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i902dff4aa68147929f6d78320ff652e0_D20221018-20221018",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954748 - Disclosure - Subsequent Events (Details)",
     "menuCat": "Details",
     "order": "124",
     "role": "http://amciacquisitioncorp/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i902dff4aa68147929f6d78320ff652e0_D20221018-20221018",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R125": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:NatureOfOperations",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "amci:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum",
      "reportCount": 1,
      "unitRef": "item",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954749 - Disclosure - Description of Organization and Business Operations (Details)",
     "menuCat": "Details",
     "order": "125",
     "role": "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
     "shortName": "Description of Organization and Business Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R126": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i450b257d15c4448cabb4fa176b9c5882_I20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFDICInsuredAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954750 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)",
     "menuCat": "Details",
     "order": "126",
     "role": "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails_1",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R127": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954751 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Net Income (Loss) Per Share of Common Stock (Details)",
     "menuCat": "Details",
     "order": "127",
     "role": "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails_1",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Net Income (Loss) Per Share of Common Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R128": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "amci:SaleOfStockUnderwritingDiscounts",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954752 - Disclosure - Initial Public Offering (Details)",
     "menuCat": "Details",
     "order": "128",
     "role": "http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1",
     "shortName": "Initial Public Offering (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R129": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i450b257d15c4448cabb4fa176b9c5882_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "amci:NumberOfSharesSubjectToForfeiture",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954753 - Disclosure - Related Party Transactions - Founder Shares (Details)",
     "menuCat": "Details",
     "order": "129",
     "role": "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails_1",
     "shortName": "Related Party Transactions - Founder Shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "amci:GoingConcernPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000013 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)",
     "menuCat": "Statements",
     "order": "13",
     "role": "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R130": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954754 - Disclosure - Related Party Transactions - Additional Information (Details)",
     "menuCat": "Details",
     "order": "130",
     "role": "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1",
     "shortName": "Related Party Transactions - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R131": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "amci:MaximumNumberOfDemandsForRegistrationOfSecurities",
      "reportCount": 1,
      "unitRef": "item",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954755 - Disclosure - Commitments and Contingencies (Details)",
     "menuCat": "Details",
     "order": "131",
     "role": "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails_1",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231",
      "decimals": "0",
      "lang": "en-US",
      "name": "amci:UnderwriterCashDiscount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R132": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i450b257d15c4448cabb4fa176b9c5882_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954756 - Disclosure - Class A Common Stock Subject to Possible Redemption (Details)",
     "menuCat": "Details",
     "order": "132",
     "role": "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails_1",
     "shortName": "Class A Common Stock Subject to Possible Redemption (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i6fe7ec324aee4e4b91b8ad46a61f8739_I20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R133": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954757 - Disclosure - Stockholders' Deficit - Preferred Stock Shares (Details)",
     "menuCat": "Details",
     "order": "133",
     "role": "http://amciacquisitioncorp/role/StockholdersDeficitPreferredStockSharesDetails",
     "shortName": "Stockholders' Deficit - Preferred Stock Shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R134": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockSharesAuthorized",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954758 - Disclosure - Stockholders' Deficit - Common Stock Shares (Details)",
     "menuCat": "Details",
     "order": "134",
     "role": "http://amciacquisitioncorp/role/StockholdersDeficitCommonStockSharesDetails",
     "shortName": "Stockholders' Deficit - Common Stock Shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R135": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "amci:WarrantsTextBlockTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WarrantsAndRightsOutstandingTerm",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954759 - Disclosure - Warrants (Details)",
     "menuCat": "Details",
     "order": "135",
     "role": "http://amciacquisitioncorp/role/WarrantsDetails_1",
     "shortName": "Warrants (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R136": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "amci:WarrantsTextBlockTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954760 - Disclosure - Warrants - Additional Information (Details)",
     "menuCat": "Details",
     "order": "136",
     "role": "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1",
     "shortName": "Warrants - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231",
      "decimals": null,
      "lang": "en-US",
      "name": "amci:MaximumThresholdPeriodForFilingRegistrationStatementAfterBusinessCombination",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R137": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "if81ad5ca3f944114a295b408d90c868d_I20220930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954761 - Disclosure - Fair Value Measurements - Company's financial assets and liabilities that are measured at fair value (Details)",
     "menuCat": "Details",
     "order": "137",
     "role": "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails_1",
     "shortName": "Fair Value Measurements - Company's financial assets and liabilities that are measured at fair value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R138": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i255bc9e0c6fd4f8a8cfcde46d7515d42_I20220930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954762 - Disclosure - Fair Value Measurements - Level 3 fair value measurements (Details)",
     "menuCat": "Details",
     "order": "138",
     "role": "http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails_1",
     "shortName": "Fair Value Measurements - Level 3 fair value measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R139": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "if29e2998f81b49e2b4637ccd72f330be_I20220630",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954763 - Disclosure - Fair Value Measurements - Change in the fair value of the derivative warrant liabilities (Details)",
     "menuCat": "Details",
     "order": "139",
     "role": "http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails_1",
     "shortName": "Fair Value Measurements - Change in the fair value of the derivative warrant liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i832a10c8d035443c86f96cddb14c1741_D20210128-20211231",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000014 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)",
     "menuCat": "Statements",
     "order": "14",
     "role": "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R140": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954764 - Disclosure - Income Taxes - Income tax provision (Details)",
     "menuCat": "Details",
     "order": "140",
     "role": "http://amciacquisitioncorp/role/IncomeTaxesIncometaxprovisionDetails",
     "shortName": "Income Taxes - Income tax provision (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:CurrentStateAndLocalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R141": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i450b257d15c4448cabb4fa176b9c5882_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954765 - Disclosure - Income Taxes - Deferred tax assets (Details)",
     "menuCat": "Details",
     "order": "141",
     "role": "http://amciacquisitioncorp/role/IncomeTaxesDeferredtaxassetsDetails",
     "shortName": "Income Taxes - Deferred tax assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R142": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954766 - Disclosure - Income Taxes - Reconciliation of the statutory federal income tax rate (benefit) (Details)",
     "menuCat": "Details",
     "order": "142",
     "role": "http://amciacquisitioncorp/role/IncomeTaxesReconciliationofthestatutoryfederalincometaxratebenefitDetails",
     "shortName": "Income Taxes - Reconciliation of the statutory federal income tax rate (benefit) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R143": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i3e4ce82bb6ca465b8f60e74f553154c0_I20220308",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationAssetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954767 - Disclosure - Subsequent Events (Details)",
     "menuCat": "Details",
     "order": "143",
     "role": "http://amciacquisitioncorp/role/SubsequentEventsDetails_1",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "ia6a395c8f57c4345b9c5c1927223b563_I20220308",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationAssetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R144": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i76d10658df3b4e6bad3f7a990812f829_D20220308-20220308",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SaleOfStockConsiderationReceivedOnTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954768 - Disclosure - Description of the Business (Details)",
     "menuCat": "Details",
     "order": "144",
     "role": "http://amciacquisitioncorp/role/DescriptionoftheBusinessDetails",
     "shortName": "Description of the Business (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i76d10658df3b4e6bad3f7a990812f829_D20220308-20220308",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SaleOfStockConsiderationReceivedOnTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R145": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "amci:GoingConcernPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954769 - Disclosure - Summary of Significant Accounting Policies - Going Concern and Segment Information (Details)",
     "menuCat": "Details",
     "order": "145",
     "role": "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesGoingConcernandSegmentInformationDetails",
     "shortName": "Summary of Significant Accounting Policies - Going Concern and Segment Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R146": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "amci:GoingConcernPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954770 - Disclosure - Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details)",
     "menuCat": "Details",
     "order": "146",
     "role": "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails",
     "shortName": "Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R147": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "amci:GoingConcernPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954771 - Disclosure - Summary of Significant Accounting Policies - Cash, Cash Equivalents and Restricted Cash Reconciliation (Details)",
     "menuCat": "Details",
     "order": "147",
     "role": "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashReconciliationDetails",
     "shortName": "Summary of Significant Accounting Policies - Cash, Cash Equivalents and Restricted Cash Reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R148": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954772 - Disclosure - Summary of Significant Accounting Policies - Trade and Other Receivables (Details)",
     "menuCat": "Details",
     "order": "148",
     "role": "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesTradeandOtherReceivablesDetails",
     "shortName": "Summary of Significant Accounting Policies - Trade and Other Receivables (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R149": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i9e0585e1e90d4bfcaf7ee5c271d12b05_D20220101-20220930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954773 - Disclosure - Summary of Significant Accounting Policies - Concentration of Credit Risk and Other Risks and Uncertainties (Details)",
     "menuCat": "Details",
     "order": "149",
     "role": "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails",
     "shortName": "Summary of Significant Accounting Policies - Concentration of Credit Risk and Other Risks and Uncertainties (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "ia54c798db359416fb9d69e6545adde53_D20220101-20220930",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000015 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)",
     "menuCat": "Statements",
     "order": "15",
     "role": "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R150": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954774 - Disclosure - Net Loss Per Share - Schedule of Calculation of Basic and Diluted Net Loss per Share (Details)",
     "menuCat": "Details",
     "order": "150",
     "role": "http://amciacquisitioncorp/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails",
     "shortName": "Net Loss Per Share - Schedule of Calculation of Basic and Diluted Net Loss per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R151": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954775 - Disclosure - LanzaTech 10Q Net Loss Per Share - Antidilutive Shares (Details)",
     "menuCat": "Details",
     "order": "151",
     "role": "http://amciacquisitioncorp/role/LanzaTech10QNetLossPerShareAntidilutiveSharesDetails",
     "shortName": "LanzaTech 10Q Net Loss Per Share - Antidilutive Shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R152": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954776 - Disclosure - Revenues - Disaggregated Revenue (Details)",
     "menuCat": "Details",
     "order": "152",
     "role": "http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails",
     "shortName": "Revenues - Disaggregated Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R153": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954777 - Disclosure - Revenues - Additional Information (Details)",
     "menuCat": "Details",
     "order": "153",
     "role": "http://amciacquisitioncorp/role/RevenuesAdditionalInformationDetails",
     "shortName": "Revenues - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i44a9fd092f5b4aaaa519e060a4d1a0bb_D20220101-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromRelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R154": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954778 - Disclosure - Revenues - Disaggregation by Customer Location (Details)",
     "menuCat": "Details",
     "order": "154",
     "role": "http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails",
     "shortName": "Revenues - Disaggregation by Customer Location (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i7b913fb20765432a923bd689fe670302_D20220101-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R155": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i450b257d15c4448cabb4fa176b9c5882_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954779 - Disclosure - Revenues - Contract Balances (Details)",
     "menuCat": "Details",
     "order": "155",
     "role": "http://amciacquisitioncorp/role/RevenuesContractBalancesDetails",
     "shortName": "Revenues - Contract Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "amci:ContractWithCustomerAssetCurrentForeignCurrencyTranslationAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R156": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "amci:RevenueRemainingPerformanceObligationCurrentAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954780 - Disclosure - Revenues - Remaining Performance Obligations (Details)",
     "menuCat": "Details",
     "order": "156",
     "role": "http://amciacquisitioncorp/role/RevenuesRemainingPerformanceObligationsDetails",
     "shortName": "Revenues - Remaining Performance Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R157": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954781 - Disclosure - Investments - Schedule of Investments (Details)",
     "menuCat": "Details",
     "order": "157",
     "role": "http://amciacquisitioncorp/role/InvestmentsScheduleofInvestmentsDetails",
     "shortName": "Investments - Schedule of Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R158": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i16f9490902b14332975939591b56c0ce_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954782 - Disclosure - Investments - Narrative (Details)",
     "menuCat": "Details",
     "order": "158",
     "role": "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails",
     "shortName": "Investments - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i65fec460822f43acb02e40736b3b8a79_D20210201-20210404",
      "decimals": "INF",
      "lang": "en-US",
      "name": "amci:NumberOfRoundsOfInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "invesstment_round",
      "xsiNil": "false"
     }
    },
    "R159": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WarrantsAndRightsOutstanding",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954783 - Disclosure - Fair Value - Financial Assets and Liabilities (Details)",
     "menuCat": "Details",
     "order": "159",
     "role": "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails",
     "shortName": "Fair Value - Financial Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i84a93d4537e04f79aeb456018d0705ee_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:WarrantsAndRightsOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000016 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "menuCat": "Statements",
     "order": "16",
     "role": "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R160": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954784 - Disclosure - Fair Value - Narrative (Details)",
     "menuCat": "Details",
     "order": "160",
     "role": "http://amciacquisitioncorp/role/FairValueNarrativeDetails",
     "shortName": "Fair Value - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "ida50a4aa7f4047c9a5bf3fcef6f2d36d_I20220930",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R161": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i80812ae1293f45978d4c5ec6ccb77d63_I20220930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954785 - Disclosure - Fair Value - Level 3 Fair Value Measurements (Details)",
     "menuCat": "Details",
     "order": "161",
     "role": "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails",
     "shortName": "Fair Value - Level 3 Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i4e47b12b058d42d9b8a8500645afac39_I20220930",
      "decimals": "2",
      "lang": "en-US",
      "name": "amci:SAFELiabilityMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R162": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i0945a26d694b428d8419686bb048d18d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954786 - Disclosure - Fair Value - Change in Fair Value of Derivative Warrant Liabilities (Details)",
     "menuCat": "Details",
     "order": "162",
     "role": "http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails",
     "shortName": "Fair Value - Change in Fair Value of Derivative Warrant Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R163": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ForeignEarningsRepatriated",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignEarningsRepatriated",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954787 - Disclosure - Income Taxes (Details)",
     "menuCat": "Details",
     "order": "163",
     "role": "http://amciacquisitioncorp/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8a79cdf54f8341f5939209c59107cddb_D20210101-20210930",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R164": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i450b257d15c4448cabb4fa176b9c5882_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "amci:NumberOfShareBasedStockSchemes",
      "reportCount": 1,
      "unitRef": "scheme",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954788 - Disclosure - Share-Based Compensation - Narrative (Details)",
     "menuCat": "Details",
     "order": "164",
     "role": "http://amciacquisitioncorp/role/ShareBasedCompensationNarrativeDetails",
     "shortName": "Share-Based Compensation - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R165": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i450b257d15c4448cabb4fa176b9c5882_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954789 - Disclosure - Share-Based Compensation - Stock Option Award Activity (Details)",
     "menuCat": "Details",
     "order": "165",
     "role": "http://amciacquisitioncorp/role/ShareBasedCompensationStockOptionAwardActivityDetails",
     "shortName": "Share-Based Compensation - Stock Option Award Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R166": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Investments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954790 - Disclosure - Related Party Transactions (Details)",
     "menuCat": "Details",
     "order": "166",
     "role": "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails",
     "shortName": "Related Party Transactions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i85c0c3423aa7412ca1b42997ac78fe99_I20200531",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R167": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromRelatedParties",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954791 - Disclosure - Related Party Transactions - Schedule of Related Party Transactions (Details)",
     "menuCat": "Details",
     "order": "167",
     "role": "http://amciacquisitioncorp/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails",
     "shortName": "Related Party Transactions - Schedule of Related Party Transactions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i6c25a29e3caa42e99299fc9c41c7bac1_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R168": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954792 - Disclosure - Redeemable, Convertible Preferred Stock (Details)",
     "menuCat": "Details",
     "order": "168",
     "role": "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockDetails",
     "shortName": "Redeemable, Convertible Preferred Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i0e83a5ed9e3a42fbb38d656ae52b386c_D20210101-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "amci:TemporaryEquityExerciseOfWarrants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R169": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LossContingencyEstimateOfPossibleLoss",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyEstimateOfPossibleLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954793 - Disclosure - Commitments and Contingencies (Details)",
     "menuCat": "Details",
     "order": "169",
     "role": "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails_2",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LossContingencyEstimateOfPossibleLoss",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyEstimateOfPossibleLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i946f64f7009a4a2082ea5e8ea9ae0377_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000017 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND SHAREHOLDERS\u2019 DEFICIT (UNAUDITED)",
     "menuCat": "Statements",
     "order": "17",
     "role": "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND SHAREHOLDERS\u2019 DEFICIT (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "amci:TemporaryEquityValueConversionOfConvertibleSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R170": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "ife262e1009764f0ebe3fdfe5ad4fb494_I20200531",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LessorOperatingLeaseTermOfContract",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954794 - Disclosure - Leases (Details)",
     "menuCat": "Details",
     "order": "170",
     "role": "http://amciacquisitioncorp/role/LeasesDetails",
     "shortName": "Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OperatingLeaseLeaseIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i274fc7fa467b4dfca60a8caf5ff1ce05_D20220101-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLeaseIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R171": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954795 - Disclosure - Subsequent Events (Details)",
     "menuCat": "Details",
     "order": "171",
     "role": "http://amciacquisitioncorp/role/SubsequentEventsDetails_2",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i4d01e01ebc9943c18b155b63bbd4d023_I20221002",
      "decimals": "INF",
      "lang": "en-US",
      "name": "amci:FrameworkAgreementRequiredEquityFunding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R172": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954796 - Disclosure - Summary of Significant Accounting Policies - Restatement (Details)",
     "menuCat": "Details",
     "order": "172",
     "role": "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails",
     "shortName": "Summary of Significant Accounting Policies - Restatement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i16f9490902b14332975939591b56c0ce_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "amci:CostOfRevenueFromContractsWithCustomersExcludingDepreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R173": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954797 - Disclosure - Summary of Significant Accounting Policies - Segment Information (Details)",
     "menuCat": "Details",
     "order": "173",
     "role": "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails",
     "shortName": "Summary of Significant Accounting Policies - Segment Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R174": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "amci:GoingConcernPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954798 - Disclosure - Summary of Significant Accounting Policies - Going Concern (Details)",
     "menuCat": "Details",
     "order": "174",
     "role": "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesGoingConcernDetails",
     "shortName": "Summary of Significant Accounting Policies - Going Concern (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R175": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "amci:GoingConcernPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954799 - Disclosure - Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details)",
     "menuCat": "Details",
     "order": "175",
     "role": "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails_1",
     "shortName": "Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R176": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "amci:GoingConcernPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954800 - Disclosure - Summary of Significant Accounting Policies - Cash, Cash Equivalents and Restricted Cash Reconciliation (Details)",
     "menuCat": "Details",
     "order": "176",
     "role": "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashReconciliationDetails_1",
     "shortName": "Summary of Significant Accounting Policies - Cash, Cash Equivalents and Restricted Cash Reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R177": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954801 - Disclosure - Summary of Significant Accounting Policies - Trade and Other Receivables (Details)",
     "menuCat": "Details",
     "order": "177",
     "role": "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesTradeandOtherReceivablesDetails_1",
     "shortName": "Summary of Significant Accounting Policies - Trade and Other Receivables (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R178": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8253259ad4874f5a9b674506631abe14_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954802 - Disclosure - Summary of Significant Accounting Policies - Property, Plant and Equipment, net (Details)",
     "menuCat": "Details",
     "order": "178",
     "role": "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentnetDetails",
     "shortName": "Summary of Significant Accounting Policies - Property, Plant and Equipment, net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8253259ad4874f5a9b674506631abe14_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R179": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954803 - Disclosure - Summary of Significant Accounting Policies - Warrants (Details)",
     "menuCat": "Details",
     "order": "179",
     "role": "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesWarrantsDetails",
     "shortName": "Summary of Significant Accounting Policies - Warrants (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "amci:GoingConcernPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000018 - Statement - CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "18",
     "role": "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "ia996051c39e14c1c956460fb2675ae34_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccountsAndOtherReceivablesNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R180": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i9e0585e1e90d4bfcaf7ee5c271d12b05_D20220101-20220930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954804 - Disclosure - Summary of Significant Accounting Policies - Concentration of Credit Risk and Other Risks and Uncertainties (Details)",
     "menuCat": "Details",
     "order": "180",
     "role": "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails_1",
     "shortName": "Summary of Significant Accounting Policies - Concentration of Credit Risk and Other Risks and Uncertainties (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R181": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954805 - Disclosure - Net Loss Per Share - Schedule of Calculation of Basic and Diluted Net Loss per Share (Details)",
     "menuCat": "Details",
     "order": "181",
     "role": "http://amciacquisitioncorp/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails_1",
     "shortName": "Net Loss Per Share - Schedule of Calculation of Basic and Diluted Net Loss per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R182": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954806 - Disclosure - Net Loss Per Share - Antidilutive Shares (Details)",
     "menuCat": "Details",
     "order": "182",
     "role": "http://amciacquisitioncorp/role/NetLossPerShareAntidilutiveSharesDetails",
     "shortName": "Net Loss Per Share - Antidilutive Shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R183": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954807 - Disclosure - Revenues - Disaggregated Revenue (Details)",
     "menuCat": "Details",
     "order": "183",
     "role": "http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails_1",
     "shortName": "Revenues - Disaggregated Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R184": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954808 - Disclosure - Revenues - Disaggregation by Customer Location (Details)",
     "menuCat": "Details",
     "order": "184",
     "role": "http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails_1",
     "shortName": "Revenues - Disaggregation by Customer Location (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i84559e50cc784ae4947d2762750bee39_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R185": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i450b257d15c4448cabb4fa176b9c5882_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954809 - Disclosure - Revenues - Contract Balances (Details)",
     "menuCat": "Details",
     "order": "185",
     "role": "http://amciacquisitioncorp/role/RevenuesContractBalancesDetails_1",
     "shortName": "Revenues - Contract Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R186": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BilledContractReceivables",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954810 - Disclosure - Revenues - Additional Information (Details)",
     "menuCat": "Details",
     "order": "186",
     "role": "http://amciacquisitioncorp/role/RevenuesAdditionalInformationDetails_1",
     "shortName": "Revenues - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R187": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "amci:RevenueRemainingPerformanceObligationCurrentAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954811 - Disclosure - Revenues - Remaining Performance Obligations (Details)",
     "menuCat": "Details",
     "order": "187",
     "role": "http://amciacquisitioncorp/role/RevenuesRemainingPerformanceObligationsDetails_1",
     "shortName": "Revenues - Remaining Performance Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R188": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954812 - Disclosure - Investments - Equity Method Investments (Details)",
     "menuCat": "Details",
     "order": "188",
     "role": "http://amciacquisitioncorp/role/InvestmentsEquityMethodInvestmentsDetails",
     "shortName": "Investments - Equity Method Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R189": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i16f9490902b14332975939591b56c0ce_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954813 - Disclosure - Investments - Narrative (Details)",
     "menuCat": "Details",
     "order": "189",
     "role": "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails_1",
     "shortName": "Investments - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i16f9490902b14332975939591b56c0ce_D20210101-20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000019 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "menuCat": "Statements",
     "order": "19",
     "role": "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R190": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954814 - Disclosure - Investments - Summarized Financial Information (Details)",
     "menuCat": "Details",
     "order": "190",
     "role": "http://amciacquisitioncorp/role/InvestmentsSummarizedFinancialInformationDetails",
     "shortName": "Investments - Summarized Financial Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8a7398a2daa84714af0a8aedf56e44db_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R191": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromRelatedParties",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954815 - Disclosure - Investments - Transactions (Details)",
     "menuCat": "Details",
     "order": "191",
     "role": "http://amciacquisitioncorp/role/InvestmentsTransactionsDetails",
     "shortName": "Investments - Transactions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R192": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WarrantsAndRightsOutstanding",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954816 - Disclosure - Fair Value - Financial Assets and Liabilities (Details)",
     "menuCat": "Details",
     "order": "192",
     "role": "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails_1",
     "shortName": "Fair Value - Financial Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R193": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAdjustmentOfWarrants",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954817 - Disclosure - Fair Value - Narrative (Details)",
     "menuCat": "Details",
     "order": "193",
     "role": "http://amciacquisitioncorp/role/FairValueNarrativeDetails_1",
     "shortName": "Fair Value - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R194": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i80812ae1293f45978d4c5ec6ccb77d63_I20220930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954818 - Disclosure - Fair Value - Level 3 Fair Value Measurements (Details)",
     "menuCat": "Details",
     "order": "194",
     "role": "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1",
     "shortName": "Fair Value - Level 3 Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i2572a9b98e9a4c54ae3bd8e69a273beb_I20211231",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:DerivativeLiabilityMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R195": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i0945a26d694b428d8419686bb048d18d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954819 - Disclosure - Fair Value - Change in Fair Value of Derivative Warrant Liabilities (Details)",
     "menuCat": "Details",
     "order": "195",
     "role": "http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails_1",
     "shortName": "Fair Value - Change in Fair Value of Derivative Warrant Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R196": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i450b257d15c4448cabb4fa176b9c5882_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MaterialsSuppliesAndOther",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954820 - Disclosure - Other Current Assets (Details)",
     "menuCat": "Details",
     "order": "196",
     "role": "http://amciacquisitioncorp/role/OtherCurrentAssetsDetails",
     "shortName": "Other Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i450b257d15c4448cabb4fa176b9c5882_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MaterialsSuppliesAndOther",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R197": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i450b257d15c4448cabb4fa176b9c5882_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954821 - Disclosure - Property, Plant, and Equipment (Details)",
     "menuCat": "Details",
     "order": "197",
     "role": "http://amciacquisitioncorp/role/PropertyPlantandEquipmentDetails",
     "shortName": "Property, Plant, and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i450b257d15c4448cabb4fa176b9c5882_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R198": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954822 - Disclosure - Property, Plant, and Equipment - Narrative (Details)",
     "menuCat": "Details",
     "order": "198",
     "role": "http://amciacquisitioncorp/role/PropertyPlantandEquipmentNarrativeDetails",
     "shortName": "Property, Plant, and Equipment - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R199": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i450b257d15c4448cabb4fa176b9c5882_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954823 - Disclosure - Debt (Details)",
     "menuCat": "Details",
     "order": "199",
     "role": "http://amciacquisitioncorp/role/DebtDetails",
     "shortName": "Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "amci:GoingConcernPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - CONDENSED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
     "shortName": "CONDENSED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "idae72aba29fc40268c267b6f3b0eff28_I20220930",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:AccruedIncomeTaxesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000020 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS",
     "menuCat": "Statements",
     "order": "20",
     "role": "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R200": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i450b257d15c4448cabb4fa176b9c5882_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954824 - Disclosure - Debt - Narrative (Details)",
     "menuCat": "Details",
     "order": "200",
     "role": "http://amciacquisitioncorp/role/DebtNarrativeDetails",
     "shortName": "Debt - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i404699cd00694919a171cbd57221125e_I20161231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R201": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "amci:SimpleAgreementForFutureEquityLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954825 - Disclosure - SAFE (Details)",
     "menuCat": "Details",
     "order": "201",
     "role": "http://amciacquisitioncorp/role/SAFEDetails",
     "shortName": "SAFE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R202": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i16f9490902b14332975939591b56c0ce_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954826 - Disclosure - Income Taxes - Components of (Loss) Income (Details)",
     "menuCat": "Details",
     "order": "202",
     "role": "http://amciacquisitioncorp/role/IncomeTaxesComponentsofLossIncomeDetails",
     "shortName": "Income Taxes - Components of (Loss) Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i16f9490902b14332975939591b56c0ce_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R203": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i2cf4f75ddf4c491592b161bb13a7695e_D20210128-20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954827 - Disclosure - Income Taxes - Income Tax Provision (Details)",
     "menuCat": "Details",
     "order": "203",
     "role": "http://amciacquisitioncorp/role/IncomeTaxesIncomeTaxProvisionDetails",
     "shortName": "Income Taxes - Income Tax Provision (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i16f9490902b14332975939591b56c0ce_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CurrentForeignTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R204": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i16f9490902b14332975939591b56c0ce_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954828 - Disclosure - Income Taxes - Reconciliation (Details)",
     "menuCat": "Details",
     "order": "204",
     "role": "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails",
     "shortName": "Income Taxes - Reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i16f9490902b14332975939591b56c0ce_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R205": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i450b257d15c4448cabb4fa176b9c5882_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954829 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)",
     "menuCat": "Details",
     "order": "205",
     "role": "http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails",
     "shortName": "Income Taxes - Deferred Tax Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i450b257d15c4448cabb4fa176b9c5882_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "amci:DeferredTaxAssetsLeasingArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R206": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
       "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "id42184778b03400da7d8ae8bccfeca9b_D20210128-20210131",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954830 - Disclosure - Income Taxes - Narrative (Details)",
     "menuCat": "Details",
     "order": "206",
     "role": "http://amciacquisitioncorp/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "ia996051c39e14c1c956460fb2675ae34_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "amci:OperatingLossAndTaxCreditCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R207": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i450b257d15c4448cabb4fa176b9c5882_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "amci:NumberOfShareBasedStockSchemes",
      "reportCount": 1,
      "unitRef": "scheme",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954831 - Disclosure - Stock-Based Compensation - Narrative (Details)",
     "menuCat": "Details",
     "order": "207",
     "role": "http://amciacquisitioncorp/role/StockBasedCompensationNarrativeDetails",
     "shortName": "Stock-Based Compensation - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i3a3ce2d4285046a28faff5151642a219_D20201101-20201130",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R208": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i450b257d15c4448cabb4fa176b9c5882_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954832 - Disclosure - Stock-Based Compensation - Stock Option Award Activity (Details)",
     "menuCat": "Details",
     "order": "208",
     "role": "http://amciacquisitioncorp/role/StockBasedCompensationStockOptionAwardActivityDetails",
     "shortName": "Stock-Based Compensation - Stock Option Award Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R209": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8edc4dc10f9f4f9bbe7fde8514cd754b_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954833 - Disclosure - Stock-Based Compensation - Fair Value Assumptions (Details)",
     "menuCat": "Details",
     "order": "209",
     "role": "http://amciacquisitioncorp/role/StockBasedCompensationFairValueAssumptionsDetails",
     "shortName": "Stock-Based Compensation - Fair Value Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8edc4dc10f9f4f9bbe7fde8514cd754b_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i946f64f7009a4a2082ea5e8ea9ae0377_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000021 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND SHAREHOLDERS\u2019 EQUITY (DEFICIT)",
     "menuCat": "Statements",
     "order": "21",
     "role": "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT",
     "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND SHAREHOLDERS\u2019 EQUITY (DEFICIT)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i2c642c896cb5471f900c04bd8c43ee4b_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R210": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i11fb672b3c844ef88abb79b5adf6a2f6_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954834 - Disclosure - Stock-Based Compensation - Restricted Stock Awards Activity (Details)",
     "menuCat": "Details",
     "order": "210",
     "role": "http://amciacquisitioncorp/role/StockBasedCompensationRestrictedStockAwardsActivityDetails",
     "shortName": "Stock-Based Compensation - Restricted Stock Awards Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8891a21b42fd46edae0f2cb767f54ab4_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R211": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954835 - Disclosure - Related Party Transactions (Details)",
     "menuCat": "Details",
     "order": "211",
     "role": "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails_1",
     "shortName": "Related Party Transactions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i16f9490902b14332975939591b56c0ce_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R212": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954836 - Disclosure - Shareholders\u2019 Equity (Details)",
     "menuCat": "Details",
     "order": "212",
     "role": "http://amciacquisitioncorp/role/ShareholdersEquityDetails",
     "shortName": "Shareholders\u2019 Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R213": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954837 - Disclosure - Redeemable, Convertible Preferred Stock - Authorized, Issued and Outstanding Shares, Issue Price, and Carrying Value (Details)",
     "menuCat": "Details",
     "order": "213",
     "role": "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockAuthorizedIssuedandOutstandingSharesIssuePriceandCarryingValueDetails",
     "shortName": "Redeemable, Convertible Preferred Stock - Authorized, Issued and Outstanding Shares, Issue Price, and Carrying Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R214": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:TemporaryEquitySharesIssued",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "ia996051c39e14c1c956460fb2675ae34_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954838 - Disclosure - Redeemable, Convertible Preferred Stock - Changes (Details)",
     "menuCat": "Details",
     "order": "214",
     "role": "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockChangesDetails",
     "shortName": "Redeemable, Convertible Preferred Stock - Changes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i70266a51f6fd4149be790adbf96c3a30_D20210101-20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R215": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "ie71ca7241b484f92bc8e1ffb53884c68_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "amci:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954839 - Disclosure - Redeemable, Convertible Preferred Stock - Narrative (Details)",
     "menuCat": "Details",
     "order": "215",
     "role": "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockNarrativeDetails",
     "shortName": "Redeemable, Convertible Preferred Stock - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "ia53cc2675c474ab094ee86871334ac6e_D20200201-20200229",
      "decimals": "2",
      "lang": "en-US",
      "name": "amci:TemporaryEquityStockIssuedDuringPeriodPricePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R216": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i16f9490902b14332975939591b56c0ce_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954840 - Disclosure - Benefit Plans (Details)",
     "menuCat": "Details",
     "order": "216",
     "role": "http://amciacquisitioncorp/role/BenefitPlansDetails",
     "shortName": "Benefit Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i16f9490902b14332975939591b56c0ce_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R217": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "amci:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i450b257d15c4448cabb4fa176b9c5882_I20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954841 - Disclosure - Leases - Narrative (Details)",
     "menuCat": "Details",
     "order": "217",
     "role": "http://amciacquisitioncorp/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i16f9490902b14332975939591b56c0ce_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R218": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i450b257d15c4448cabb4fa176b9c5882_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954842 - Disclosure - Leases - Lease Maturities (Details)",
     "menuCat": "Details",
     "order": "218",
     "role": "http://amciacquisitioncorp/role/LeasesLeaseMaturitiesDetails",
     "shortName": "Leases - Lease Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i450b257d15c4448cabb4fa176b9c5882_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R219": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i450b257d15c4448cabb4fa176b9c5882_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954843 - Disclosure - Leases - Lessor, Operating Lease, Payments to be Received (Details)",
     "menuCat": "Details",
     "order": "219",
     "role": "http://amciacquisitioncorp/role/LeasesLessorOperatingLeasePaymentstobeReceivedDetails",
     "shortName": "Leases - Lessor, Operating Lease, Payments to be Received (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i450b257d15c4448cabb4fa176b9c5882_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i16f9490902b14332975939591b56c0ce_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000022 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "22",
     "role": "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i16f9490902b14332975939591b56c0ce_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R220": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "amci:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i450b257d15c4448cabb4fa176b9c5882_I20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954844 - Disclosure - Leases - Supplemental Information (Details)",
     "menuCat": "Details",
     "order": "220",
     "role": "http://amciacquisitioncorp/role/LeasesSupplementalInformationDetails",
     "shortName": "Leases - Supplemental Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "amci:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i450b257d15c4448cabb4fa176b9c5882_I20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R221": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i3e4ce82bb6ca465b8f60e74f553154c0_I20220308",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationAssetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954845 - Disclosure - Subsequent Events (Details)",
     "menuCat": "Details",
     "order": "221",
     "role": "http://amciacquisitioncorp/role/SubsequentEventsDetails_3",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Description of Organization and Business Operations",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperations",
     "shortName": "Description of Organization and Business Operations",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "amci:InitialPublicOfferingTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Initial Public Offering",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://amciacquisitioncorp/role/InitialPublicOffering",
     "shortName": "Initial Public Offering",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Related Party Transactions",
     "menuCat": "Notes",
     "order": "26",
     "role": "http://amciacquisitioncorp/role/RelatedPartyTransactions",
     "shortName": "Related Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "27",
     "role": "http://amciacquisitioncorp/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "amci:TemporaryEquityDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Class A Common Stock Subject to Possible Redemption",
     "menuCat": "Notes",
     "order": "28",
     "role": "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemption",
     "shortName": "Class A Common Stock Subject to Possible Redemption",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Stockholders' Equity (Deficit)",
     "menuCat": "Notes",
     "order": "29",
     "role": "http://amciacquisitioncorp/role/StockholdersEquityDeficit",
     "shortName": "Stockholders' Equity (Deficit)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONDENSED BALANCE SHEETS (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "amci:WarrantsTextBlockTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Warrants",
     "menuCat": "Notes",
     "order": "30",
     "role": "http://amciacquisitioncorp/role/Warrants",
     "shortName": "Warrants",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Fair Value Measurements",
     "menuCat": "Notes",
     "order": "31",
     "role": "http://amciacquisitioncorp/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Subsequent Events",
     "menuCat": "Notes",
     "order": "32",
     "role": "http://amciacquisitioncorp/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Description of Organization and Business Operations",
     "menuCat": "Notes",
     "order": "33",
     "role": "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperations_1",
     "shortName": "Description of Organization and Business Operations",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "34",
     "role": "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPolicies_1",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "amci:InitialPublicOfferingTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Initial Public Offering",
     "menuCat": "Notes",
     "order": "35",
     "role": "http://amciacquisitioncorp/role/InitialPublicOffering_1",
     "shortName": "Initial Public Offering",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Related Party Transactions",
     "menuCat": "Notes",
     "order": "36",
     "role": "http://amciacquisitioncorp/role/RelatedPartyTransactions_1",
     "shortName": "Related Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "37",
     "role": "http://amciacquisitioncorp/role/CommitmentsandContingencies_1",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "amci:TemporaryEquityDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Class A Common Stock Subject to Possible Redemption",
     "menuCat": "Notes",
     "order": "38",
     "role": "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemption_1",
     "shortName": "Class A Common Stock Subject to Possible Redemption",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Stockholders' Deficit",
     "menuCat": "Notes",
     "order": "39",
     "role": "http://amciacquisitioncorp/role/StockholdersDeficit",
     "shortName": "Stockholders' Deficit",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - UNAUDITED CONDENSED STATEMENTS OF OPERATIONS",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS",
     "shortName": "UNAUDITED CONDENSED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i63bac3907ca0434d93c3083cd119368f_D20220701-20220930",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "amci:WarrantsTextBlockTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Warrants",
     "menuCat": "Notes",
     "order": "40",
     "role": "http://amciacquisitioncorp/role/Warrants_1",
     "shortName": "Warrants",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Fair Value Measurements",
     "menuCat": "Notes",
     "order": "41",
     "role": "http://amciacquisitioncorp/role/FairValueMeasurements_1",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "42",
     "role": "http://amciacquisitioncorp/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Subsequent Events",
     "menuCat": "Notes",
     "order": "43",
     "role": "http://amciacquisitioncorp/role/SubsequentEvents_1",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Description of the Business",
     "menuCat": "Notes",
     "order": "44",
     "role": "http://amciacquisitioncorp/role/DescriptionoftheBusiness",
     "shortName": "Description of the Business",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "45",
     "role": "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Net Loss Per Share",
     "menuCat": "Notes",
     "order": "46",
     "role": "http://amciacquisitioncorp/role/NetLossPerShare",
     "shortName": "Net Loss Per Share",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Revenues",
     "menuCat": "Notes",
     "order": "47",
     "role": "http://amciacquisitioncorp/role/Revenues",
     "shortName": "Revenues",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Investments",
     "menuCat": "Notes",
     "order": "48",
     "role": "http://amciacquisitioncorp/role/Investments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Fair Value",
     "menuCat": "Notes",
     "order": "49",
     "role": "http://amciacquisitioncorp/role/FairValue",
     "shortName": "Fair Value",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i946f64f7009a4a2082ea5e8ea9ae0377_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT",
     "shortName": "UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i63bac3907ca0434d93c3083cd119368f_D20220701-20220930",
      "decimals": "0",
      "lang": "en-US",
      "name": "amci:AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "50",
     "role": "http://amciacquisitioncorp/role/IncomeTaxes_1",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Share-Based Compensation",
     "menuCat": "Notes",
     "order": "51",
     "role": "http://amciacquisitioncorp/role/ShareBasedCompensation",
     "shortName": "Share-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Related Party Transactions",
     "menuCat": "Notes",
     "order": "52",
     "role": "http://amciacquisitioncorp/role/RelatedPartyTransactions_2",
     "shortName": "Related Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "amci:TemporaryEquityDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Redeemable, Convertible Preferred Stock",
     "menuCat": "Notes",
     "order": "53",
     "role": "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStock",
     "shortName": "Redeemable, Convertible Preferred Stock",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "54",
     "role": "http://amciacquisitioncorp/role/CommitmentsandContingencies_2",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasesOfLessorDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Leases",
     "menuCat": "Notes",
     "order": "55",
     "role": "http://amciacquisitioncorp/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Subsequent Events",
     "menuCat": "Notes",
     "order": "56",
     "role": "http://amciacquisitioncorp/role/SubsequentEvents_2",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Description of the Business",
     "menuCat": "Notes",
     "order": "57",
     "role": "http://amciacquisitioncorp/role/DescriptionoftheBusiness_1",
     "shortName": "Description of the Business",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "58",
     "role": "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPolicies_1",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Net Loss Per Share",
     "menuCat": "Notes",
     "order": "59",
     "role": "http://amciacquisitioncorp/role/NetLossPerShare_1",
     "shortName": "Net Loss Per Share",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R6": {
     "firstAnchor": null,
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICITParenthetical",
     "shortName": "UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Revenues",
     "menuCat": "Notes",
     "order": "60",
     "role": "http://amciacquisitioncorp/role/Revenues_1",
     "shortName": "Revenues",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Investments",
     "menuCat": "Notes",
     "order": "61",
     "role": "http://amciacquisitioncorp/role/Investments_1",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Fair Value",
     "menuCat": "Notes",
     "order": "62",
     "role": "http://amciacquisitioncorp/role/FairValue_1",
     "shortName": "Fair Value",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCurrentAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Other Current Assets",
     "menuCat": "Notes",
     "order": "63",
     "role": "http://amciacquisitioncorp/role/OtherCurrentAssets",
     "shortName": "Other Current Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCurrentAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - Property, Plant, and Equipment",
     "menuCat": "Notes",
     "order": "64",
     "role": "http://amciacquisitioncorp/role/PropertyPlantandEquipment",
     "shortName": "Property, Plant, and Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - Debt",
     "menuCat": "Notes",
     "order": "65",
     "role": "http://amciacquisitioncorp/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "amci:SimpleAgreementForFutureEquityLiabilityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - SAFE",
     "menuCat": "Notes",
     "order": "66",
     "role": "http://amciacquisitioncorp/role/SAFE",
     "shortName": "SAFE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "amci:SimpleAgreementForFutureEquityLiabilityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativesAndFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - Warrant Liabilities",
     "menuCat": "Notes",
     "order": "67",
     "role": "http://amciacquisitioncorp/role/WarrantLiabilities",
     "shortName": "Warrant Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativesAndFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "68",
     "role": "http://amciacquisitioncorp/role/IncomeTaxes_2",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - Stock-Based Compensation",
     "menuCat": "Notes",
     "order": "69",
     "role": "http://amciacquisitioncorp/role/StockBasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAdjustmentOfWarrants",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS",
     "shortName": "UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8d9df3a7aa874d5aaa27ee8391d8ca5b_D20210128-20210930",
      "decimals": "0",
      "lang": "en-US",
      "name": "amci:IncreaseDecreaseInDueToRelatedParties.",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - Related Party Transactions",
     "menuCat": "Notes",
     "order": "70",
     "role": "http://amciacquisitioncorp/role/RelatedPartyTransactions_3",
     "shortName": "Related Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - Shareholders\u2019 Equity",
     "menuCat": "Notes",
     "order": "71",
     "role": "http://amciacquisitioncorp/role/ShareholdersEquity",
     "shortName": "Shareholders\u2019 Equity",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "amci:TemporaryEquityDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - Redeemable, Convertible Preferred Stock",
     "menuCat": "Notes",
     "order": "72",
     "role": "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStock_1",
     "shortName": "Redeemable, Convertible Preferred Stock",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - Benefit Plans",
     "menuCat": "Notes",
     "order": "73",
     "role": "http://amciacquisitioncorp/role/BenefitPlans",
     "shortName": "Benefit Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "74",
     "role": "http://amciacquisitioncorp/role/CommitmentsandContingencies_3",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasesOfLessorDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - Leases",
     "menuCat": "Notes",
     "order": "75",
     "role": "http://amciacquisitioncorp/role/Leases_1",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - Subsequent Events",
     "menuCat": "Notes",
     "order": "76",
     "role": "http://amciacquisitioncorp/role/SubsequentEvents_3",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954701 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "77",
     "role": "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": null
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954702 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "78",
     "role": "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies_1",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": null
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954703 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "79",
     "role": "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "amci:GoingConcernPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i8fe007d2f6c3443b96f79645ce3c9a76_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - BALANCE SHEET",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://amciacquisitioncorp/role/BALANCESHEET",
     "shortName": "BALANCE SHEET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "ie2b51a1d5bb44074a2fba1d09ac00ecc_I20211231",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954704 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "80",
     "role": "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies_1",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "lang": "en-US",
      "name": "amci:CoronavirusPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954705 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "81",
     "role": "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "amci:TemporaryEquityDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954706 - Disclosure - Class A Common Stock Subject to Possible Redemption (Tables)",
     "menuCat": "Tables",
     "order": "82",
     "role": "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionTables",
     "shortName": "Class A Common Stock Subject to Possible Redemption (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954707 - Disclosure - Fair Value Measurements (Tables)",
     "menuCat": "Tables",
     "order": "83",
     "role": "http://amciacquisitioncorp/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954708 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "84",
     "role": "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables_1",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "amci:TemporaryEquityDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954709 - Disclosure - Class A Common Stock Subject to Possible Redemption (Tables)",
     "menuCat": "Tables",
     "order": "85",
     "role": "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionTables_1",
     "shortName": "Class A Common Stock Subject to Possible Redemption (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954710 - Disclosure - Fair Value Measurements (Tables)",
     "menuCat": "Tables",
     "order": "86",
     "role": "http://amciacquisitioncorp/role/FairValueMeasurementsTables_1",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954711 - Disclosure - Income Taxes (Tables)",
     "menuCat": "Tables",
     "order": "87",
     "role": "http://amciacquisitioncorp/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954712 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "88",
     "role": "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954713 - Disclosure - Net Loss Per Share (Tables)",
     "menuCat": "Tables",
     "order": "89",
     "role": "http://amciacquisitioncorp/role/NetLossPerShareTables",
     "shortName": "Net Loss Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i450b257d15c4448cabb4fa176b9c5882_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000009 - Statement - BALANCE SHEET (Parenthetical)",
     "menuCat": "Statements",
     "order": "9",
     "role": "http://amciacquisitioncorp/role/BALANCESHEETParenthetical",
     "shortName": "BALANCE SHEET (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954714 - Disclosure - Revenues (Tables)",
     "menuCat": "Tables",
     "order": "90",
     "role": "http://amciacquisitioncorp/role/RevenuesTables",
     "shortName": "Revenues (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954715 - Disclosure - Investments (Tables)",
     "menuCat": "Tables",
     "order": "91",
     "role": "http://amciacquisitioncorp/role/InvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954716 - Disclosure - Fair Value (Tables)",
     "menuCat": "Tables",
     "order": "92",
     "role": "http://amciacquisitioncorp/role/FairValueTables",
     "shortName": "Fair Value (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954717 - Disclosure - Share-Based Compensation (Tables)",
     "menuCat": "Tables",
     "order": "93",
     "role": "http://amciacquisitioncorp/role/ShareBasedCompensationTables",
     "shortName": "Share-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954718 - Disclosure - Related Party Transactions (Tables)",
     "menuCat": "Tables",
     "order": "94",
     "role": "http://amciacquisitioncorp/role/RelatedPartyTransactionsTables",
     "shortName": "Related Party Transactions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "amci:TemporaryEquityDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954719 - Disclosure - Redeemable, Convertible Preferred Stock (Tables)",
     "menuCat": "Tables",
     "order": "95",
     "role": "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockTables",
     "shortName": "Redeemable, Convertible Preferred Stock (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLeaseIncomeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954720 - Disclosure - Leases (Tables)",
     "menuCat": "Tables",
     "order": "96",
     "role": "http://amciacquisitioncorp/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLeaseIncomeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954721 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "97",
     "role": "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesTables_1",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954722 - Disclosure - Net Loss Per Share (Tables)",
     "menuCat": "Tables",
     "order": "98",
     "role": "http://amciacquisitioncorp/role/NetLossPerShareTables_1",
     "shortName": "Net Loss Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "amci-20230213.htm",
      "contextRef": "i64d0962e6096455d8d081d939276b2bb_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954723 - Disclosure - Revenues (Tables)",
     "menuCat": "Tables",
     "order": "99",
     "role": "http://amciacquisitioncorp/role/RevenuesTables_1",
     "shortName": "Revenues (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    }
   },
   "segmentCount": 135,
   "tag": {
    "amci_AMCIACQUISITIONCORPIIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AMCI ACQUISITION CORP. II",
        "label": "AMCI ACQUISITION CORP. II [Member]",
        "terseLabel": "AMCI ACQUISITION CORP. II"
       }
      }
     },
     "localname": "AMCIACQUISITIONCORPIIMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETSParenthetical",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails_1",
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredtaxassetsDetails",
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT",
      "http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICITParenthetical",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of adjustment to additional paid in capital extinguishment of deferred underwriting commissions on public shares.",
        "label": "Adjustment To Additional Paid In Capital Extinguishment Of Deferred Underwriting Commissions On Public Shares",
        "terseLabel": "Extinguishment of deferred underwriting commissions on public shares",
        "verboseLabel": "Commissions waiver as reduction to additional paid-in capital"
       }
      }
     },
     "localname": "AdjustmentToAdditionalPaidInCapitalExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Repurchase of Equity Instruments",
        "label": "Adjustments to Additional Paid in Capital, Repurchase of Equity Instruments",
        "negatedTerseLabel": "Repurchase of equity instruments"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalRepurchaseOfEquityInstruments",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_AdministrativeSupportAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Administrative Support Agreement.",
        "label": "Administrative Support Agreement",
        "terseLabel": "Administrative Support Agreement"
       }
      }
     },
     "localname": "AdministrativeSupportAgreementMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_AggregateNumberOfSharesOwned": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares owned by the founders after the impact of the stock dividend.",
        "label": "Aggregate Number Of Shares Owned",
        "terseLabel": "Aggregate number of shares owned"
       }
      }
     },
     "localname": "AggregateNumberOfSharesOwned",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails_1",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICITParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "amci_AnchorInvestorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information about Anchor Investors.",
        "label": "Anchor Investors",
        "terseLabel": "Anchor Investors"
       }
      }
     },
     "localname": "AnchorInvestorsMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets And Liabilities, Lessee",
        "label": "Assets And Liabilities, Lessee [Table Text Block]",
        "terseLabel": "Assets And Liabilities, Lessee"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesTables_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "amci_BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Beijing ShouGang LanzaTech Technology Co., LTD (SGLT)",
        "label": "Beijing ShouGang LanzaTech Technology Co., LTD (SGLT) [Member]",
        "terseLabel": "SGLT"
       }
      }
     },
     "localname": "BeijingShouGangLanzaTechTechnologyCoLTDSGLTMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsEquityMethodInvestmentsDetails",
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails",
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails_1",
      "http://amciacquisitioncorp/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_CapitalBaseTaxExpense": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of capital base tax expense.",
        "label": "Capital Base Tax Expense",
        "terseLabel": "Capital base tax expense"
       }
      }
     },
     "localname": "CapitalBaseTaxExpense",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_CarbonCaptureAndTransformationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carbon Capture And Transformation",
        "label": "Carbon Capture And Transformation [Member]",
        "terseLabel": "Carbon capture and transformation"
       }
      }
     },
     "localname": "CarbonCaptureAndTransformationMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails",
      "http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_CarbonSmartMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CarbonSmart",
        "label": "CarbonSmart [Member]",
        "terseLabel": "CarbonSmart"
       }
      }
     },
     "localname": "CarbonSmartMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails",
      "http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of adjustment of exercise price of warrants based on market value and newly issued price.",
        "label": "Class O fWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrices",
        "verboseLabel": "Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)"
       }
      }
     },
     "localname": "ClassOFwarrantorrightadjustmentofexercisepriceofwarrantsorrightspercentbasedonmarketvalueandnewlyissuedprices",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/WarrantsDetails_1"
     ],
     "xbrltype": "percentItemType"
    },
    "amci_ClassOfWarrantOrRightAmountOfNotesPurchased": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Amount Of Notes Purchased",
        "label": "Class Of Warrant Or Right, Amount Of Notes Purchased",
        "terseLabel": "Amount of Notes purchased"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAmountOfNotesPurchased",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum threshold period during which a written notice is required for redemption of warrants, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Class Of Warrant Or Right, Minimum Threshold Written Notice Period For Redemption Of Warrants",
        "terseLabel": "Minimum threshold written notice period for redemption of public warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/WarrantsDetails_1"
     ],
     "xbrltype": "durationItemType"
    },
    "amci_ClassOfWarrantOrRightPriceOfWarrantsOrRights": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Price of Warrants or Rights",
        "terseLabel": "Price of warrant"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightPriceOfWarrantsOrRights",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/WarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of the entity's common stock which would be required to be attained to trigger the redemption of warrants.",
        "label": "Class Of Warrant Or Right Redemption Of Warrants Or Rights Stock Price Trigger",
        "verboseLabel": "Stock price trigger for redemption of public warrants (in dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/WarrantsDetails_1"
     ],
     "xbrltype": "perShareItemType"
    },
    "amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified consecutive trading days for stock price trigger considered for redemption of warrants.",
        "label": "Class Of Warrant Or Right, Redemption Of Warrants Or Rights, , Threshold Consecutive Trading Days",
        "terseLabel": "Threshold consecutive trading days for redemption of public warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDaysSource2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified consecutive trading days for stock price trigger considered for redemption of warrants.",
        "label": "Class Of Warrant Or Right, Redemption Of Warrants Or Rights, , Threshold Consecutive Trading Days Source2",
        "terseLabel": "Threshold consecutive trading days for redemption of public warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDaysSource2",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1"
     ],
     "xbrltype": "integerItemType"
    },
    "amci_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days for stock price trigger considered for redemption of warrants.",
        "label": "Class Of Warrant Or Right, Redemption Of Warrants Or Rights, , Threshold Trading Days",
        "terseLabel": "Threshold trading days for redemption of public warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/WarrantsDetails_1"
     ],
     "xbrltype": "durationItemType"
    },
    "amci_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redemption price per share or per unit of warrants or rights outstanding.",
        "label": "Class Of Warrant Or Right, Redemption Price Of Warrants Or Rights",
        "terseLabel": "Redemption price per public warrant (in dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/WarrantsDetails_1"
     ],
     "xbrltype": "perShareItemType"
    },
    "amci_CommonClassaNotSubjectToRedemptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation that is not subject to redemption.",
        "label": "Class A Common Stock Not Subject to Redemption",
        "terseLabel": "Class A Common Stock Not Subject to Redemption"
       }
      }
     },
     "localname": "CommonClassaNotSubjectToRedemptionMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/BALANCESHEETParenthetical",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_CommonClassaSubjectToRedemptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation that is subject to redemption.",
        "label": "Class A Common Stock Subject to Redemption",
        "terseLabel": "Class A Common Stock Subject to Redemption"
       }
      }
     },
     "localname": "CommonClassaSubjectToRedemptionMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/BALANCESHEETParenthetical",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails_1",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETSParenthetical",
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails",
      "http://amciacquisitioncorp/role/StockholdersDeficitCommonStockSharesDetails",
      "http://amciacquisitioncorp/role/StockholdersEquityDeficitCommonStockSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_CommonStockNumberOfVotesPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of votes issued per common stock share.",
        "label": "Common Stock, Number of Votes Per Share",
        "terseLabel": "Number of votes per common stock"
       }
      }
     },
     "localname": "CommonStockNumberOfVotesPerShare",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "amci_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum number of businesses which the reporting entity must acquire with the net proceeds of the offering.",
        "label": "Condition for future business combination number of businesses minimum",
        "terseLabel": "Condition for future business combination number of businesses minimum"
       }
      }
     },
     "localname": "ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1"
     ],
     "xbrltype": "integerItemType"
    },
    "amci_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The threshold net tangible assets which the reporting entity must maintain in order to proceed with a business combination utilizing the proceeds of the offering.",
        "label": "Condition for future business combination threshold Net Tangible Assets",
        "terseLabel": "Condition For Future Business Combination Threshold Net Tangible Assets"
       }
      }
     },
     "localname": "ConditionForFutureBusinessCombinationThresholdNetTangibleAssets",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_ConditionForFutureBusinessCombinationThresholdPercentageOwnership": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The threshold percentage of voting interest to be acquired in a future business combination as specified for the use of proceeds from the offering.",
        "label": "Condition for future business combination threshold Percentage Ownership",
        "terseLabel": "Condition For Future Business Combination Threshold Percentage Ownership"
       }
      }
     },
     "localname": "ConditionForFutureBusinessCombinationThresholdPercentageOwnership",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1"
     ],
     "xbrltype": "pureItemType"
    },
    "amci_ConditionForFutureBusinessCombinationUseOfProceedsPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The threshold percentage of the assets held in the trust account funded by proceeds from the offering which must be used for purposes of consummating a business combination.",
        "label": "Condition for future business combination use of proceeds percentage",
        "terseLabel": "Condition for future business combination use of proceeds percentage"
       }
      }
     },
     "localname": "ConditionForFutureBusinessCombinationUseOfProceedsPercentage",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1"
     ],
     "xbrltype": "pureItemType"
    },
    "amci_ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Asset, Current, Additions To Unbilled Accounts Receivable",
        "label": "Contract With Customer, Asset, Current, Additions To Unbilled Accounts Receivable",
        "terseLabel": "Additions to unbilled accounts receivable"
       }
      }
     },
     "localname": "ContractWithCustomerAssetCurrentAdditionsToUnbilledAccountsReceivable",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesContractBalancesDetails",
      "http://amciacquisitioncorp/role/RevenuesContractBalancesDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_ContractWithCustomerAssetCurrentForeignCurrencyTranslationAdjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Asset, Current, Foreign Currency Translation Adjustment",
        "label": "Contract With Customer, Asset, Current, Foreign Currency Translation Adjustment",
        "terseLabel": "Decrease on revaluation on currency"
       }
      }
     },
     "localname": "ContractWithCustomerAssetCurrentForeignCurrencyTranslationAdjustment",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_ContractWithCustomerAssetCurrentReclassifiedToReceivable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Asset, Current, Reclassified To Receivable",
        "label": "Contract With Customer, Asset, Current, Reclassified To Receivable",
        "negatedTerseLabel": "Unbilled accounts receivable recognized in trade receivables"
       }
      }
     },
     "localname": "ContractWithCustomerAssetCurrentReclassifiedToReceivable",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesContractBalancesDetails",
      "http://amciacquisitioncorp/role/RevenuesContractBalancesDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_ContractWithCustomerLiabilityCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Current",
        "label": "Contract With Customer, Liability, Current [Abstract]",
        "terseLabel": "Current Contract Liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrentAbstract",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesContractBalancesDetails",
      "http://amciacquisitioncorp/role/RevenuesContractBalancesDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "amci_ContractWithCustomerLiabilityCurrentAmountsCollected": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Current, Amounts Collected",
        "label": "Contract With Customer, Liability, Current, Amounts Collected",
        "terseLabel": "Increases due to cash received"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrentAmountsCollected",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesContractBalancesDetails",
      "http://amciacquisitioncorp/role/RevenuesContractBalancesDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Current, Reclassification From Noncurrent",
        "label": "Contract With Customer, Liability, Current, Reclassification From Noncurrent",
        "terseLabel": "Reclassification from non-current to current contract liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrentReclassificationFromNoncurrent",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesContractBalancesDetails",
      "http://amciacquisitioncorp/role/RevenuesContractBalancesDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_ContractWithCustomerLiabilityCurrentRevenueRecognized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Current, Revenue Recognized",
        "label": "Contract With Customer, Liability, Current, Revenue Recognized",
        "negatedTerseLabel": "Reclassification to revenue as a result of performance obligations satisfied"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrentRevenueRecognized",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesContractBalancesDetails",
      "http://amciacquisitioncorp/role/RevenuesContractBalancesDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_ContractWithCustomerLiabilityNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Noncurrent",
        "label": "Contract With Customer, Liability, Noncurrent [Abstract]",
        "terseLabel": "Non-current Contract Liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrentAbstract",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesContractBalancesDetails",
      "http://amciacquisitioncorp/role/RevenuesContractBalancesDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "amci_ContractWithCustomerLiabilityNoncurrentAmountsCollected": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Noncurrent, Amounts Collected",
        "label": "Contract With Customer, Liability, Noncurrent, Amounts Collected",
        "terseLabel": "Increases due to cash received"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrentAmountsCollected",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesContractBalancesDetails",
      "http://amciacquisitioncorp/role/RevenuesContractBalancesDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_ContractWithCustomerLiabilityNoncurrentForeignCurrencyTranslationAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Noncurrent, Foreign Currency Translation Adjustment",
        "label": "Contract With Customer, Liability, Noncurrent, Foreign Currency Translation Adjustment",
        "terseLabel": "Decrease on revaluation on currency"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrentForeignCurrencyTranslationAdjustment",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Noncurrent, Reclassification To Current",
        "label": "Contract With Customer, Liability, Noncurrent, Reclassification To Current",
        "negatedTerseLabel": "Reclassification from non-current to current contract liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrentReclassificationToCurrent",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesContractBalancesDetails",
      "http://amciacquisitioncorp/role/RevenuesContractBalancesDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount of Contribution from Sponsor upon sale of Founder Shares to Anchor Investors.",
        "label": "Contribution from Sponsor upon sale of Founder Shares to Anchor Investors",
        "terseLabel": "Contribution from Sponsor upon sale of founder shares to Anchor Investors"
       }
      }
     },
     "localname": "ContributionFromSponsorUponSaleOfFounderSharesToAnchorInvestors",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_ConvertibleStockConversionRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The ratio to be applied to the stock in a conversion of convertible stock.",
        "label": "Convertible Stock Conversion Ratio",
        "terseLabel": "Ratio to be applied to the stock in the conversion"
       }
      }
     },
     "localname": "ConvertibleStockConversionRatio",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/StockholdersDeficitCommonStockSharesDetails",
      "http://amciacquisitioncorp/role/StockholdersEquityDeficitCommonStockSharesDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "amci_CoplacementAgentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents Coplacement Agent Member.",
        "label": "Coplacement Agent",
        "terseLabel": "Coplacement Agent"
       }
      }
     },
     "localname": "CoplacementAgentMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_CoronavirusPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Coronavirus",
        "label": "Coronavirus [Policy Text Block]",
        "terseLabel": "Coronavirus"
       }
      }
     },
     "localname": "CoronavirusPolicyTextBlock",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "amci_CostOfRevenueFromContractsWithCustomersExcludingDepreciation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of Revenue From Contracts with Customers, Excluding Depreciation",
        "label": "Cost of Revenue From Contracts with Customers, Excluding Depreciation",
        "negatedTerseLabel": "Cost of revenues from contracts with customers (exclusive of depreciation shown below)"
       }
      }
     },
     "localname": "CostOfRevenueFromContractsWithCustomersExcludingDepreciation",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_CustomerAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer A",
        "label": "Customer A [Member]",
        "terseLabel": "Customer A"
       }
      }
     },
     "localname": "CustomerAMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_CustomerBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer B",
        "label": "Customer B [Member]",
        "terseLabel": "Customer B"
       }
      }
     },
     "localname": "CustomerBMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_CustomerCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer C",
        "label": "Customer C [Member]",
        "terseLabel": "Customer C"
       }
      }
     },
     "localname": "CustomerCMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_CustomerDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer D",
        "label": "Customer D [Member]",
        "terseLabel": "Customer D"
       }
      }
     },
     "localname": "CustomerDMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_CustomerEMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer E",
        "label": "Customer E [Member]",
        "terseLabel": "Customer E"
       }
      }
     },
     "localname": "CustomerEMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_DeferredOfferingCostsIncludedInNotesPayable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of deferred offering costs included in notes payable.",
        "label": "Deferred Offering Costs Included in Notes Payable",
        "terseLabel": "Offering costs included in notes payable",
        "verboseLabel": "Offering costs included in notes payable"
       }
      }
     },
     "localname": "DeferredOfferingCostsIncludedInNotesPayable",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\" Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from capitalized start up and organization costs.\"",
        "label": "Deferred Tax Assets Capitalized Start Up And Organization Costs",
        "terseLabel": "Start-up/Organization costs"
       }
      }
     },
     "localname": "DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredtaxassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_DeferredTaxAssetsLeasingArrangements": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Leasing Arrangements",
        "label": "Deferred Tax Assets, Leasing Arrangements",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "DeferredTaxAssetsLeasingArrangements",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_DeferredUnderwritingCompensationNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of balance sheet date of underwriting compensation deferred, classified as noncurrent.",
        "label": "Deferred Underwriting Compensation, Noncurrent",
        "verboseLabel": "Deferred underwriting commissions"
       }
      }
     },
     "localname": "DeferredUnderwritingCompensationNoncurrent",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_DeferredUnderwritingDiscountPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to Deferred Underwriting Discount Percentage",
        "label": "Deferred Underwriting Discount Percentage",
        "terseLabel": "Deferred underwriting fee percentage"
       }
      }
     },
     "localname": "DeferredUnderwritingDiscountPercentage",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails",
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails_1"
     ],
     "xbrltype": "percentItemType"
    },
    "amci_DeferredUnderwritingDiscounts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of balance sheet date of underwriting discounts deferred, classified as noncurrent.",
        "label": "Deferred Underwriting Discounts",
        "terseLabel": "Deferred underwriting discount"
       }
      }
     },
     "localname": "DeferredUnderwritingDiscounts",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails",
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails_1",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_DeferredUnderwritingFeePayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of underwriting fee payable deferred during the period, classified as non-cash investing and financing activity.",
        "label": "Deferred Underwriting Fee Payable.",
        "terseLabel": "Offering costs paid by Sponsor in exchange for issuance of Class B common stock"
       }
      }
     },
     "localname": "DeferredUnderwritingFeePayable",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_DeferredUnderwritingFeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for deferred underwritingfees member.",
        "label": "Deferred Underwriting Fees",
        "terseLabel": "Deferred Underwriting Fees"
       }
      }
     },
     "localname": "DeferredUnderwritingFeesMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_DenominatorForCalculationOfEarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition.",
        "label": "Denominator For Calculation Of Earnings Per Share [Abstract]",
        "terseLabel": "Denominator:"
       }
      }
     },
     "localname": "DenominatorForCalculationOfEarningsPerShareAbstract",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "amci_DerivativeLongTermMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Long Term",
        "label": "Derivative Long Term [Member]",
        "terseLabel": "Long-Term"
       }
      }
     },
     "localname": "DerivativeLongTermMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_DerivativeNearTermMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Near Term",
        "label": "Derivative Near Term [Member]",
        "terseLabel": "Near Term"
       }
      }
     },
     "localname": "DerivativeNearTermMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_DueToRelatedParty": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in related party payables classified as other, due within one year or operating cycle, if longer.",
        "label": "Due to Related Party",
        "terseLabel": "Due to related party"
       }
      }
     },
     "localname": "DueToRelatedParty",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_EarningPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition.",
        "label": "Earning Per Share Basic And Diluted [Abstract]",
        "verboseLabel": "Basic and diluted net income (loss) per common share:"
       }
      }
     },
     "localname": "EarningPerShareBasicAndDilutedAbstract",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessAmount": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Debt Forgiveness, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Debt Forgiveness, Amount",
        "negatedTerseLabel": "PPP loan forgiveness"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDebtForgivenessAmount",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_EffectiveIncomeTaxRateReconciliationDebtForgivenessPercent": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Debt Forgiveness, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Debt Forgiveness, Percent",
        "negatedTerseLabel": "PPP loan forgiveness"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDebtForgivenessPercent",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentAmount": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Equity Method Investment, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Equity Method Investment, Amount",
        "terseLabel": "Equity method investment"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentAmount",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentPercent": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Equity Method Investment, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Equity Method Investment, Percent",
        "terseLabel": "Equity method investment"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationEquityMethodInvestmentPercent",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesAmount": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Foreign Exchange Differences, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Exchange Differences, Amount",
        "terseLabel": "Foreign exchange differences"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesAmount",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesPercent": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Foreign Exchange Differences, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Exchange Differences, Percent",
        "terseLabel": "Foreign exchange differences"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignExchangeDifferencesPercent",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyAmount": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Gain From Redomicilation Of Intellectual Property, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Gain From Redomicilation Of Intellectual Property, Amount",
        "terseLabel": "Gain from redomiciliation of intellectual property"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyAmount",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyPercent": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Gain From Redomicilation Of Intellectual Property, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Gain From Redomicilation Of Intellectual Property, Percent",
        "terseLabel": "Gain from redomiciliation of intellectual property"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationGainFromRedomicilationOfIntellectualPropertyPercent",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "amci_EffectiveIncomeTaxRateReconciliationInterestIncomeAmount": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Interest Income, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Interest Income, Amount",
        "terseLabel": "Interest income on receivable"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationInterestIncomeAmount",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_EffectiveIncomeTaxRateReconciliationInterestIncomePercent": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Interest Income, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Interest Income, Percent",
        "terseLabel": "Interest income on receivable"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationInterestIncomePercent",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalAmount": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Legal, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Legal, Amount",
        "terseLabel": "Non-deductible legal costs"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalAmount",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalPercent": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Legal, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Legal, Percent",
        "terseLabel": "Non-deductible legal costs"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalPercent",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "amci_EngineeringAndOtherServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engineering And Other Services",
        "label": "Engineering And Other Services [Member]",
        "terseLabel": "Engineering and other services"
       }
      }
     },
     "localname": "EngineeringAndOtherServicesMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails",
      "http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_EquityMethodInvestmentContingentRightToReceiveAdditionalInterest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Contingent Right To Receive Additional Interest",
        "label": "Equity Method Investment, Contingent Right To Receive Additional Interest",
        "terseLabel": "Contingent right to receive additional interest"
       }
      }
     },
     "localname": "EquityMethodInvestmentContingentRightToReceiveAdditionalInterest",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails",
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails_1"
     ],
     "xbrltype": "sharesItemType"
    },
    "amci_EquityMethodInvestmentGainOnDilutionOfInvestment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Gain On Dilution Of Investment",
        "label": "Equity Method Investment, Gain On Dilution Of Investment",
        "terseLabel": "Gain on dilution"
       }
      }
     },
     "localname": "EquityMethodInvestmentGainOnDilutionOfInvestment",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails",
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails_1",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_ErrorCorrectionEquityMethodInvestmentContributedIntellectualAssetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Error Correction, Equity Method Investment, Contributed Intellectual Asset",
        "label": "Error Correction, Equity Method Investment, Contributed Intellectual Asset [Member]",
        "terseLabel": "Error Correction, Equity Method Investment, Contributed Intellectual Asset"
       }
      }
     },
     "localname": "ErrorCorrectionEquityMethodInvestmentContributedIntellectualAssetMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_ErrorCorrectionEquityMethodInvestmentGainOnDilutionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Error Correction, Equity Method Investment, Gain On Dilution",
        "label": "Error Correction, Equity Method Investment, Gain On Dilution [Member]",
        "terseLabel": "Error Correction, Equity Method Investment, Gain On Dilution"
       }
      }
     },
     "localname": "ErrorCorrectionEquityMethodInvestmentGainOnDilutionMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_ErrorCorrectionEquityMethodInvestmentsIntangiblesAndFixedAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Error Correction, Equity Method Investments, Intangibles And Fixed Assets",
        "label": "Error Correction, Equity Method Investments, Intangibles And Fixed Assets [Member]",
        "terseLabel": "Error Correction, Equity Method Investments, Intangibles And Fixed Assets"
       }
      }
     },
     "localname": "ErrorCorrectionEquityMethodInvestmentsIntangiblesAndFixedAssetsMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_EvercoreGroupL.l.c.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents Evercore Group LLC.",
        "label": "Evercore Group, L.L.C.",
        "terseLabel": "Evercore Group, L.L.C."
       }
      }
     },
     "localname": "EvercoreGroupL.l.c.Member",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_FairValueAdjustmentOfWarrantsAndUnrealizedGainLossOnDerivatives": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Adjustment Of Warrants And Unrealized Gain (Loss) On Derivatives",
        "label": "Fair Value Adjustment Of Warrants And Unrealized Gain (Loss) On Derivatives",
        "terseLabel": "(Gain) loss on change in fair value of SAFE and warrant liabilities"
       }
      }
     },
     "localname": "FairValueAdjustmentOfWarrantsAndUnrealizedGainLossOnDerivatives",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_FinancialAdvisoryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents financial advisory member.",
        "label": "Financial Advisory",
        "terseLabel": "Financial Advisory"
       }
      }
     },
     "localname": "FinancialAdvisoryMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_FounderSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Founder Shares Member",
        "label": "Founder Shares",
        "terseLabel": "Founder Shares"
       }
      }
     },
     "localname": "FounderSharesMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_FrameworkAgreementRequiredEquityFunding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Framework Agreement, Required Equity Funding",
        "label": "Framework Agreement, Required Equity Funding",
        "terseLabel": "Required equity funding"
       }
      }
     },
     "localname": "FrameworkAgreementRequiredEquityFunding",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjects": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Framework Agreement, Required Equity Funding For Qualifying Projects",
        "label": "Framework Agreement, Required Equity Funding For Qualifying Projects",
        "terseLabel": "Required equity funding for qualifying projects"
       }
      }
     },
     "localname": "FrameworkAgreementRequiredEquityFundingForQualifyingProjects",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_FrameworkAgreementRequiredEquityFundingForQualifyingProjectsRemainingAmountReduction": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Framework Agreement, Required Equity Funding For Qualifying Projects, Remaining Amount Reduction",
        "label": "Framework Agreement, Required Equity Funding For Qualifying Projects, Remaining Amount Reduction",
        "terseLabel": "Required equity funding for qualifying projects, remaining amount reduction"
       }
      }
     },
     "localname": "FrameworkAgreementRequiredEquityFundingForQualifyingProjectsRemainingAmountReduction",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_FranchiseTaxPayableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of franchise tax payable current.",
        "label": "Franchise Tax Payable Current",
        "terseLabel": "Franchise tax payable"
       }
      }
     },
     "localname": "FranchiseTaxPayableCurrent",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_FundHeldInTrustAccountPerPublicShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount of funds held in trust account per public share",
        "label": "Fund Held In Trust Account Per Public Share",
        "terseLabel": "Funds in Trust Account per public share"
       }
      }
     },
     "localname": "FundHeldInTrustAccountPerPublicShare",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1"
     ],
     "xbrltype": "perShareItemType"
    },
    "amci_GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from extinguishment of deferred underwriting commissions on public warrants.",
        "label": "Gain Loss From Extinguishment Of Deferred Underwriting Commissions On Public Warrants",
        "negatedLabel": "Gain from extinguishment of deferred underwriting commission on public warrants",
        "terseLabel": "Gain from extinguishment of deferred underwriting commissions on public warrants"
       }
      }
     },
     "localname": "GainLossFromExtinguishmentOfDeferredUnderwritingCommissionsOnPublicWarrants",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of general and administrative expenses paid by Sponsor in exchange for shares.",
        "label": "General And Administrative Expenses Paid By Sponsor In Exchange For Shares",
        "terseLabel": "General and administrative expenses paid by Sponsor in exchange for issuance of Class B common stock"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpensesPaidBySponsorInExchangeForShares",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_GoingConcernPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Going Concern",
        "label": "Going Concern [Policy Text Block]",
        "terseLabel": "Going Concern"
       }
      }
     },
     "localname": "GoingConcernPolicyTextBlock",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "amci_IncomeFromInvestmentsHeldInTrustAccount": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income from investments held in Trust Account.",
        "label": "Income From Investments Held In Trust Account",
        "negatedLabel": "Income from investments held in the trust account",
        "terseLabel": "Income from investments held in trust account"
       }
      }
     },
     "localname": "IncomeFromInvestmentsHeldInTrustAccount",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income (Loss) from Equity Method Investments and Gain On Dilution Of Investment",
        "label": "Income (Loss) from Equity Method Investments and Gain On Dilution Of Investment",
        "negatedTerseLabel": "Gain from equity method investees, net",
        "terseLabel": "Gain from equity method investees, net"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestmentsAndGainOnDilutionOfInvestment",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_IncomeTaxesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Taxes [Line Items]",
        "label": "Income Taxes [Line Items]",
        "terseLabel": "Income Taxes [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxesLineItems",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesComponentsofLossIncomeDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesIncomeTaxProvisionDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "amci_IncomeTaxesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Taxes [Table]",
        "label": "Income Taxes [Table]",
        "terseLabel": "Income Taxes [Table]"
       }
      }
     },
     "localname": "IncomeTaxesTable",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesComponentsofLossIncomeDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesIncomeTaxProvisionDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "amci_IncreaseDecreaseFranchiseTaxPayable": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period of franchise tax payable.",
        "label": "Increase Decrease Franchise Tax Payable",
        "terseLabel": "Franchise tax payable"
       }
      }
     },
     "localname": "IncreaseDecreaseFranchiseTaxPayable",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_IncreaseDecreaseInCapitalBaseTaxPayable": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The of increase (decrease) during the reporting period of capital base tax payable.",
        "label": "Increase (Decrease) in Capital Base Tax Payable",
        "terseLabel": "Capital base tax payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInCapitalBaseTaxPayable",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_IncreaseDecreaseInDueToRelatedParties.": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in related party payables classified as other,",
        "label": "Increase Decrease In Due To Related Parties.",
        "terseLabel": "Due to related party"
       }
      }
     },
     "localname": "IncreaseDecreaseInDueToRelatedParties.",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase or decrease in equity due to re-measurement of common stock subject to possible redemption.",
        "label": "Increase or Decrease in Equity Due to Re-measurement of Common Stock Subject to Possible Redemption",
        "terseLabel": "Subsequent remeasurement of Class A common stock subject to possible redemption"
       }
      }
     },
     "localname": "IncreaseOrDecreaseInEquityDueToReMeasurementOfCommonStockSubjectToPossibleRedemption",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_InitialPublicOfferingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "Initial Public Offering",
        "terseLabel": "Initial Public Offering"
       }
      }
     },
     "localname": "InitialPublicOfferingAbstract",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "xbrltype": "stringItemType"
    },
    "amci_InitialPublicOfferingTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure on information about initial public offering.",
        "label": "Initial Public Offering [Text Block]",
        "terseLabel": "Initial Public Offering"
       }
      }
     },
     "localname": "InitialPublicOfferingTextBlock",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/InitialPublicOffering",
      "http://amciacquisitioncorp/role/InitialPublicOffering_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "amci_InlandRevenueNewZealandMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inland Revenue, New Zealand",
        "label": "Inland Revenue, New Zealand [Member]",
        "terseLabel": "New Zealand"
       }
      }
     },
     "localname": "InlandRevenueNewZealandMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesComponentsofLossIncomeDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesIncomeTaxProvisionDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_InvestmentsHeldInTrustAccountPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investments held trust account.",
        "label": "Investments Held In Trust Account [Policy Text Block]",
        "terseLabel": "Investments Held in the Trust Account"
       }
      }
     },
     "localname": "InvestmentsHeldInTrustAccountPolicyTextBlock",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "amci_InvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments",
        "label": "Investments [Line Items]",
        "terseLabel": "Investments [Line Items]"
       }
      }
     },
     "localname": "InvestmentsLineItems",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails",
      "http://amciacquisitioncorp/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "amci_InvestmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments",
        "label": "Investments [Table]",
        "terseLabel": "Investments [Table]"
       }
      }
     },
     "localname": "InvestmentsTable",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails",
      "http://amciacquisitioncorp/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "amci_JointDevelopmentAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Joint Development Agreements",
        "label": "Joint Development Agreements [Member]",
        "terseLabel": "Joint development agreements"
       }
      }
     },
     "localname": "JointDevelopmentAgreementsMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails",
      "http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_LanzaJetFreedomPinesFuelsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "LanzaJet Freedom Pines Fuels LLC",
        "label": "LanzaJet Freedom Pines Fuels LLC [Member]",
        "terseLabel": "LanzaJet Freedom Pines Fuels LLC"
       }
      }
     },
     "localname": "LanzaJetFreedomPinesFuelsLLCMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_2"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_LanzaJetIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "LanzaJet, Inc.",
        "label": "LanzaJet, Inc. [Member]",
        "terseLabel": "LanzaJet"
       }
      }
     },
     "localname": "LanzaJetIncMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsEquityMethodInvestmentsDetails",
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails",
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails_1",
      "http://amciacquisitioncorp/role/InvestmentsScheduleofInvestmentsDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_LanzatechGlobalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents about LanzaTech Global.",
        "label": "LanzaTech Global",
        "terseLabel": "LanzaTech Global"
       }
      }
     },
     "localname": "LanzatechGlobalMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_LessAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition.",
        "label": "Less [Abstract]",
        "terseLabel": "Less:"
       }
      }
     },
     "localname": "LessAbstract",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails",
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "amci_LesseeOperatingLeaseNumberOfRenewalTerms": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Number Of Renewal Terms",
        "label": "Lessee, Operating Lease, Number Of Renewal Terms",
        "terseLabel": "Lease number of renewal terms"
       }
      }
     },
     "localname": "LesseeOperatingLeaseNumberOfRenewalTerms",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "amci_LesssorOperatingLeaseNumberOfRenewalOptions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lesssor, Operating Lease, Number Of Renewal Options",
        "label": "Lesssor, Operating Lease, Number Of Renewal Options",
        "terseLabel": "Number of renewal options"
       }
      }
     },
     "localname": "LesssorOperatingLeaseNumberOfRenewalOptions",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesDetails",
      "http://amciacquisitioncorp/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "amci_LineOfCreditFacilityInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Interest Rate",
        "label": "Line of Credit Facility, Interest Rate",
        "terseLabel": "Line of credit facility, interest rate"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRate",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_2"
     ],
     "xbrltype": "percentItemType"
    },
    "amci_LiquidityPriceOfSAFEAndSAFEWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liquidity Price of SAFE and SAFE Warrants",
        "label": "Liquidity Price of SAFE and SAFE Warrants",
        "terseLabel": "Liquidity price of SAFE and SAFE warrants"
       }
      }
     },
     "localname": "LiquidityPriceOfSAFEAndSAFEWarrants",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/LanzaTech10QNetLossPerShareAntidilutiveSharesDetails",
      "http://amciacquisitioncorp/role/NetLossPerShareAntidilutiveSharesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "amci_LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liquidity Price of SAFE and SAFE Warrants, Condition One",
        "label": "Liquidity Price of SAFE and SAFE Warrants, Condition One",
        "terseLabel": "Liquidity price of SAFE and SAFE warrants, condition one"
       }
      }
     },
     "localname": "LiquidityPriceOfSAFEAndSAFEWarrantsConditionOne",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/LanzaTech10QNetLossPerShareAntidilutiveSharesDetails",
      "http://amciacquisitioncorp/role/NetLossPerShareAntidilutiveSharesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "amci_MaximumAllowedDissolutionExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum amount permitted to be paid for dissolution expenses if a business combination is not completed within the specified period.",
        "label": "Maximum Allowed Dissolution Expenses",
        "terseLabel": "Maximum allowed dissolution expenses"
       }
      }
     },
     "localname": "MaximumAllowedDissolutionExpenses",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of maximum borrowing capacity of related party promissory note.",
        "label": "Maximum Borrowing Capacity of Related Party Promissory Note",
        "terseLabel": "Maximum borrowing capacity of related party promissory note"
       }
      }
     },
     "localname": "MaximumBorrowingCapacityOfRelatedPartyPromissoryNote",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_MaximumLoansConvertibleIntoWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum amount which a potential loan could have repaid through issuance of warrants.",
        "label": "maximum Loans Convertible Into Warrants",
        "terseLabel": "Loan conversion agreement warrant"
       }
      }
     },
     "localname": "MaximumLoansConvertibleIntoWarrants",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_MaximumNumberOfDemandsForRegistrationOfSecurities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the maximum number of demands for registration of securities.",
        "label": "Maximum Number Of Demands For Registration Of Securities",
        "terseLabel": "Maximum Number Of Demands For Registration Of Securities"
       }
      }
     },
     "localname": "MaximumNumberOfDemandsForRegistrationOfSecurities",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails",
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails_1"
     ],
     "xbrltype": "integerItemType"
    },
    "amci_MaximumThresholdPeriodForFilingRegistrationStatementAfterBusinessCombination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum threshold period for filing registration statement after business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Maximum Threshold Period For Filing Registration Statement After Business Combination",
        "terseLabel": "Threshold period for filling registration statement after business combination"
       }
      }
     },
     "localname": "MaximumThresholdPeriodForFilingRegistrationStatementAfterBusinessCombination",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1"
     ],
     "xbrltype": "durationItemType"
    },
    "amci_MeasurementInputInterestRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Interest Rate",
        "label": "Measurement Input, Interest Rate [Member]",
        "terseLabel": "Interest rate"
       }
      }
     },
     "localname": "MeasurementInputInterestRateMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_MeasurementInputLiquidityPriceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Liquidity Price",
        "label": "Measurement Input, Liquidity Price [Member]",
        "terseLabel": "Liquidity price"
       }
      }
     },
     "localname": "MeasurementInputLiquidityPriceMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_MeasurementInputProbabilityWeightingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Probability Weighting",
        "label": "Measurement Input, Probability Weighting [Member]",
        "terseLabel": "Probability weighting"
       }
      }
     },
     "localname": "MeasurementInputProbabilityWeightingMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_MeasurementInputTimeToConversionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Time To Conversion",
        "label": "Measurement Input, Time To Conversion [Member]",
        "terseLabel": "Time to conversion"
       }
      }
     },
     "localname": "MeasurementInputTimeToConversionMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_MonthsToCompleteAcquisition": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the anticipated business timeline in months for completing a business combination.",
        "label": "Months To Complete Acquisition",
        "terseLabel": "Months to complete acquisition"
       }
      }
     },
     "localname": "MonthsToCompleteAcquisition",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1"
     ],
     "xbrltype": "durationItemType"
    },
    "amci_NoncashDeferredUnderwritingCommissions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash deferred underwriting commissions.",
        "label": "Noncash Deferred Underwriting Commissions",
        "terseLabel": "Deferred underwriting commissions in connection with the initial public offering"
       }
      }
     },
     "localname": "NoncashDeferredUnderwritingCommissions",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_NoncashExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of value of noncash extinguishment of deferred underwriting commissions on public shares.",
        "label": "Noncash Extinguishment Of Deferred Underwriting Commissions On Public Shares",
        "terseLabel": "Extinguishment of deferred underwriting commissions on public shares"
       }
      }
     },
     "localname": "NoncashExtinguishmentOfDeferredUnderwritingCommissionsOnPublicShares",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_NoncashLoanForgiveness": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash Loan Forgiveness",
        "label": "Noncash Loan Forgiveness",
        "terseLabel": "PPP loan forgiveness"
       }
      }
     },
     "localname": "NoncashLoanForgiveness",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash prepaid expenses and other assets paid by related parties.",
        "label": "Noncash Prepaid Expenses And Other Assets Paid By Related Parties",
        "terseLabel": "Prepaid expenses paid by related party under note payable and advances"
       }
      }
     },
     "localname": "NoncashPrepaidExpensesAndOtherAssetsPaidByRelatedParties",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_NoncashRecognitionOfLicensingRevenue": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash Recognition of Licensing Revenue",
        "label": "Noncash Recognition of Licensing Revenue",
        "negatedTerseLabel": "Non-cash recognition of licensing revenue"
       }
      }
     },
     "localname": "NoncashRecognitionOfLicensingRevenue",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_NoncashRepaymentOfNotePayableAndAdvances": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash repayment of note payable and advances.",
        "label": "Noncash Repayment Of Note Payable And Advances",
        "terseLabel": "Repayment of note payable and advances by Sponsor in exchange for issuance of private placement warrants",
        "verboseLabel": "Repayment of note payable and advances by Sponsor in exchange for issuance of private placement warrants"
       }
      }
     },
     "localname": "NoncashRepaymentOfNotePayableAndAdvances",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_NoteReceivableCommitmentToPurchase": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Note Receivable, Commitment To Purchase",
        "label": "Note Receivable, Commitment To Purchase",
        "terseLabel": "Notes receivable, commitment to purchase"
       }
      }
     },
     "localname": "NoteReceivableCommitmentToPurchase",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_NumberOfRoundsOfInvestments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Rounds of Investments",
        "label": "Number of Rounds of Investments",
        "terseLabel": "Number of rounds of investments"
       }
      }
     },
     "localname": "NumberOfRoundsOfInvestments",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "amci_NumberOfShareBasedStockSchemes": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Share Based Stock Schemes",
        "label": "Number of Share Based Stock Schemes",
        "terseLabel": "Number of share based stock schemes"
       }
      }
     },
     "localname": "NumberOfShareBasedStockSchemes",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationNarrativeDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "amci_NumberOfSharesIssuedPerUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of shares in a unit.",
        "label": "Number of Shares Issued Per Unit",
        "terseLabel": "Number of shares in a unit"
       }
      }
     },
     "localname": "NumberOfSharesIssuedPerUnit",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1"
     ],
     "xbrltype": "sharesItemType"
    },
    "amci_NumberOfSharesSubjectToForfeiture": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares owned by the founders subject to forfeiture if the underwriter overallotment option is not exercised in the proposed public offering.",
        "label": "Number Of Shares Subject To Forfeiture",
        "terseLabel": "Number of shares subject to forfeiture"
       }
      }
     },
     "localname": "NumberOfSharesSubjectToForfeiture",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails",
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails_1"
     ],
     "xbrltype": "sharesItemType"
    },
    "amci_NumberOfSharesSurrendered": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to Number Of Shares Surrendered",
        "label": "Number Of Shares Surrendered",
        "terseLabel": "Number of shares surrendered"
       }
      }
     },
     "localname": "NumberOfSharesSurrendered",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails_1",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICITParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "amci_NumberOfWarrantsIssuedPerUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of warrants in a unit.",
        "label": "Number of Warrants Issued Per Unit",
        "terseLabel": "Number of warrants in a unit"
       }
      }
     },
     "localname": "NumberOfWarrantsIssuedPerUnit",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1"
     ],
     "xbrltype": "sharesItemType"
    },
    "amci_NumeratorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "Numerator [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NumeratorAbstract",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "amci_October2022SubscriptionAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents October 2022 subscription agreements.",
        "label": "October 2022 Subscription Agreements",
        "terseLabel": "Subscription Agreements"
       }
      }
     },
     "localname": "October2022SubscriptionAgreementsMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_OfferingCostsAllocatedToDerivativeWarrantLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of offering costs allocated to derivative warrant liabilities.",
        "label": "Offering Costs Allocated To Derivative Warrant Liabilities",
        "negatedLabel": "Offering costs allocated to derivative warrant liabilities",
        "terseLabel": "Offering costs allocated to derivative warrant liabilities"
       }
      }
     },
     "localname": "OfferingCostsAllocatedToDerivativeWarrantLiabilities",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of offering costs associated with the initial public offering.",
        "label": "Offering Costs Associated With The Initial Public Offering [Policy Text Block]",
        "terseLabel": "Offering Costs Associated with Initial Public Offering"
       }
      }
     },
     "localname": "OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "amci_OfferingCostsIncludedInAccountsPayableAccruedExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of offering costs included in accounts payable or accrued expenses that were incurred during a noncash or partial noncash transaction.",
        "label": "Offering Costs Included In Accounts Payable Accrued Expenses",
        "terseLabel": "Offering costs included in accrued expenses"
       }
      }
     },
     "localname": "OfferingCostsIncludedInAccountsPayableAccruedExpenses",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_OneTrancheOfNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One Tranche Of Notes",
        "label": "One Tranche Of Notes [Member]",
        "terseLabel": "One Tranche Of Notes"
       }
      }
     },
     "localname": "OneTrancheOfNotesMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_2"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_OperatingLossAndTaxCreditCarryforwards": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Loss And Tax Credit Carryforwards",
        "label": "Operating Loss And Tax Credit Carryforwards",
        "terseLabel": "Tax losses and credits carried forward"
       }
      }
     },
     "localname": "OperatingLossAndTaxCreditCarryforwards",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_OperatingLossCarryforwardsNotSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Loss Carryforwards, Not Subject To Expiration",
        "label": "Operating Loss Carryforwards, Not Subject To Expiration",
        "terseLabel": "Net operating loss carryforwards, not subject to expiration"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsNotSubjectToExpiration",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_OperatingLossCarryforwardsSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Loss Carryforwards, Subject To Expiration",
        "label": "Operating Loss Carryforwards, Subject To Expiration",
        "terseLabel": "Net operating loss carryforwards, subject to expiration"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsSubjectToExpiration",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_OptionToPurchaseAdditionalUnitsGivenToInvestors": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Option to purchase additional units given to investors.",
        "label": "Option To Purchase Additional Units Given To Investors",
        "terseLabel": "Option to purchase additional units given to investors"
       }
      }
     },
     "localname": "OptionToPurchaseAdditionalUnitsGivenToInvestors",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1"
     ],
     "xbrltype": "sharesItemType"
    },
    "amci_OptionToPurchaseAdditionalUnitsGivenToUnderwriters": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the option to purchase additional Units.",
        "label": "Option to Purchase Additional Units Given to Underwriters",
        "terseLabel": "Option to purchase additional Units"
       }
      }
     },
     "localname": "OptionToPurchaseAdditionalUnitsGivenToUnderwriters",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails",
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails_1",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1"
     ],
     "xbrltype": "sharesItemType"
    },
    "amci_OptionVestingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Option vesting period.",
        "label": "Option Vesting Period",
        "terseLabel": "Option vesting period"
       }
      }
     },
     "localname": "OptionVestingPeriod",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails",
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails_1",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1"
     ],
     "xbrltype": "durationItemType"
    },
    "amci_OtherContractResearchMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Contract Research",
        "label": "Other Contract Research [Member]",
        "terseLabel": "Other contract research"
       }
      }
     },
     "localname": "OtherContractResearchMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails",
      "http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_OtherCurrentAssetsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Current Assets",
        "label": "Other Current Assets [Policy Text Block]",
        "terseLabel": "Other Current Assets"
       }
      }
     },
     "localname": "OtherCurrentAssetsPolicyTextBlock",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "amci_OutstandingWorkingCapitalLoans": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to Outstanding Working Capital Loans",
        "label": "Outstanding Working Capital Loans",
        "terseLabel": "Outstanding working capital loans"
       }
      }
     },
     "localname": "OutstandingWorkingCapitalLoans",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_PPPLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PPP Loan",
        "label": "PPP Loan [Member]",
        "terseLabel": "PPP Loan"
       }
      }
     },
     "localname": "PPPLoanMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/DebtDetails",
      "http://amciacquisitioncorp/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_PaymentsForInvestmentOfCashInTrustAccount": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash outflow for investment of cash in trust account.",
        "label": "Payments for investment of cash in Trust Account",
        "negatedTerseLabel": "Investment income released from Trust Account",
        "terseLabel": "Payments for investment of cash in trust account"
       }
      }
     },
     "localname": "PaymentsForInvestmentOfCashInTrustAccount",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percentage of shares which the reporting entity is obligated to redeem if a business combination is not consummated using the offering proceeds within a specified period.",
        "label": "Percentage Obligation To Redeem Public Shares If Entity Does Not Complete A Business Combination",
        "terseLabel": "Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)"
       }
      }
     },
     "localname": "PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1"
     ],
     "xbrltype": "percentItemType"
    },
    "amci_PercentageOfGrossProceedsOnTotalEquityProceed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percentage of gross proceeds on total equity proceeds.",
        "label": "Percentage Of Gross Proceeds On Total Equity Proceed",
        "terseLabel": "Percentage of gross proceeds on total equity proceeds",
        "verboseLabel": "Percentage of gross proceeds on total equity proceeds"
       }
      }
     },
     "localname": "PercentageOfGrossProceedsOnTotalEquityProceed",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1"
     ],
     "xbrltype": "percentItemType"
    },
    "amci_PeriodForFillingRegistrationStatementAfterBusinessCombination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents period for filling registration statement after business combination.",
        "label": "Period For Filling Registration Statement After Business Combination",
        "terseLabel": "Period for filling registration statement after business combination"
       }
      }
     },
     "localname": "PeriodForFillingRegistrationStatementAfterBusinessCombination",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/WarrantsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "amci_PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "period of time after which warrant holder may do cashless exercise.",
        "label": "Period Of Time After Which Warrant Holder May Do Cashless Exercise",
        "terseLabel": "Period of time after which warrant holder may do cashless exercise"
       }
      }
     },
     "localname": "PeriodOfTimeAfterWhichWarrantHolderMayDoCashlessExercise",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/WarrantsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "amci_PlusAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "Plus [Abstract]",
        "terseLabel": "Plus:"
       }
      }
     },
     "localname": "PlusAbstract",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails",
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "amci_PrepaidExpensesLongTerm": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Prepaid expenses - long-term.",
        "label": "Prepaid expenses - long-term",
        "terseLabel": "Prepaid expenses - long-term"
       }
      }
     },
     "localname": "PrepaidExpensesLongTerm",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_PrivatePlacementWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents a redeemable warrant (Private Placement Warrant) that entitles the holder to purchase shares of common stock if the underwriter's option is exercised in full.",
        "label": "Private Placement Warrants",
        "terseLabel": "Private Placement Warrants",
        "verboseLabel": "private placement warrants"
       }
      }
     },
     "localname": "PrivatePlacementWarrantsMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/WarrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Issuance Or Sale Of Equity, Excluding Warrant Exercises",
        "label": "Proceeds From Issuance Or Sale Of Equity, Excluding Warrant Exercises",
        "terseLabel": "Proceeds from issue of equity instruments of the Company"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOrSaleOfEquityExcludingWarrantExercises",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_ProceedsHeldInOperatingAccountForWorkingCapitalPurpose": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of proceeds held in operating account for working capital purpose.",
        "label": "Proceeds Held In Operating Account For Working Capital Purpose",
        "terseLabel": "Proceeds held in operating account for working capital purpose"
       }
      }
     },
     "localname": "ProceedsHeldInOperatingAccountForWorkingCapitalPurpose",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_PublicWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents a redeemable warrant (Public Warrant) that entitles the holder to purchase shares of common stock subject to adjustment.",
        "label": "Public Warrants",
        "terseLabel": "public warrants"
       }
      }
     },
     "localname": "PublicWarrantsMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails_1",
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/WarrantsDetails",
      "http://amciacquisitioncorp/role/WarrantsDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_PurchasesAndOpenAccountsPayableRelatedParties": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchases and Open Accounts Payable, Related Parties",
        "label": "Purchases and Open Accounts Payable, Related Parties",
        "terseLabel": "Purchases and open accounts payable"
       }
      }
     },
     "localname": "PurchasesAndOpenAccountsPayableRelatedParties",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsTransactionsDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the scenario, where redemption of warrants when the price per share of class a common stock equals or exceeds $10.00.",
        "label": "Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00",
        "terseLabel": "Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00"
       }
      }
     },
     "localname": "RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/WarrantsDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the scenario, where redemption of warrants when the price per share of class a common stock equals or exceeds $18.00.",
        "label": "Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00",
        "terseLabel": "Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00"
       }
      }
     },
     "localname": "RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/WarrantsDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_RedemptionPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redemption period.",
        "label": "Redemption Period",
        "terseLabel": "Redemption period"
       }
      }
     },
     "localname": "RedemptionPeriod",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/WarrantsDetails_1"
     ],
     "xbrltype": "durationItemType"
    },
    "amci_RedemptionPeriodUponClosure": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period of time in which the reporting entity must redeem shares issued pursuant to the offering.",
        "label": "Redemption Period Upon Closure",
        "terseLabel": "Redemption period upon closure"
       }
      }
     },
     "localname": "RedemptionPeriodUponClosure",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1"
     ],
     "xbrltype": "durationItemType"
    },
    "amci_RelatedAndNonrelatedPartyStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related and Nonrelated Party Status",
        "label": "Related and Nonrelated Party Status [Axis]",
        "terseLabel": "Related and Nonrelated Party Status [Axis]"
       }
      }
     },
     "localname": "RelatedAndNonrelatedPartyStatusAxis",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "amci_RelatedAndNonrelatedPartyStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related and Nonrelated Party Status [Domain]",
        "label": "Related and Nonrelated Party Status [Domain]",
        "terseLabel": "Related and Nonrelated Party Status [Domain]"
       }
      }
     },
     "localname": "RelatedAndNonrelatedPartyStatusDomain",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_RelatedPartyInvestmentAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Party Investment Agreement",
        "label": "Related Party Investment Agreement [Member]",
        "terseLabel": "Related Party Investment Agreement"
       }
      }
     },
     "localname": "RelatedPartyInvestmentAgreementMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_RelatedPartyLeaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Party Lease Agreement",
        "label": "Related Party Lease Agreement [Member]",
        "terseLabel": "Related Party Lease Agreement"
       }
      }
     },
     "localname": "RelatedPartyLeaseAgreementMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_RelatedPartyLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for related party loans.",
        "label": "Related Party Loans",
        "terseLabel": "Related Party Loans"
       }
      }
     },
     "localname": "RelatedPartyLoansMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_RelatedPartyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Party",
        "label": "Related Party [Member]",
        "terseLabel": "Related Party"
       }
      }
     },
     "localname": "RelatedPartyMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_RelatedPartySupplyAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Party Supply Agreement",
        "label": "Related Party Supply Agreement [Member]",
        "terseLabel": "Related Party Supply Agreement"
       }
      }
     },
     "localname": "RelatedPartySupplyAgreementMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails_1",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The contractual monthly amount to be paid for support services.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party Per Month",
        "terseLabel": "Expenses per month"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_RelatedPartyTransactionsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Party Transactions, Policy",
        "label": "Related Party Transactions, Policy [Policy Text Block]",
        "terseLabel": "Related Party Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsPolicyPolicyTextBlock",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "amci_RelatedPartyTransitionServicesAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Party Transition Services Agreement",
        "label": "Related Party Transition Services Agreement [Member]",
        "terseLabel": "Related Party Transition Services Agreement"
       }
      }
     },
     "localname": "RelatedPartyTransitionServicesAgreementMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_ResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development",
        "label": "Research And Development [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails",
      "http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period of time after completion of a business combination during which the shares or warrant may not be transferred.",
        "label": "Restrictions On Transfer Period Of Time After Business Combination Completion",
        "terseLabel": "Restrictions on transfer period of time after business combination completion"
       }
      }
     },
     "localname": "RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails_1"
     ],
     "xbrltype": "durationItemType"
    },
    "amci_RevenueFromContractWithCustomerAmortizationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue From Contract With Customer, Amortization Period",
        "label": "Revenue From Contract With Customer, Amortization Period",
        "terseLabel": "Profit amortization period"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAmortizationPeriod",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails",
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails_1"
     ],
     "xbrltype": "durationItemType"
    },
    "amci_RevenueRemainingPerformanceObligationCurrentAmount": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/RevenuesRemainingPerformanceObligationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RevenueRemainingPerformanceObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue, Remaining Performance Obligation, Current, Amount",
        "label": "Revenue, Remaining Performance Obligation, Current, Amount",
        "terseLabel": "Current"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationCurrentAmount",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesRemainingPerformanceObligationsDetails",
      "http://amciacquisitioncorp/role/RevenuesRemainingPerformanceObligationsDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_RevenueRemainingPerformanceObligationNoncurrentAmount": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/RevenuesRemainingPerformanceObligationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RevenueRemainingPerformanceObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue, Remaining Performance Obligation, Noncurrent, Amount",
        "label": "Revenue, Remaining Performance Obligation, Noncurrent, Amount",
        "terseLabel": "Non-current"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationNoncurrentAmount",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesRemainingPerformanceObligationsDetails",
      "http://amciacquisitioncorp/role/RevenuesRemainingPerformanceObligationsDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_ReverseCapitalizationClosingCashCondition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reverse Capitalization, Closing Cash Condition",
        "label": "Reverse Capitalization, Closing Cash Condition",
        "terseLabel": "Minimum closing cash condition"
       }
      }
     },
     "localname": "ReverseCapitalizationClosingCashCondition",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionoftheBusinessDetails",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_SAFELiabilityMeasurementInput": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SAFE Liability, Measurement Input",
        "label": "SAFE Liability, Measurement Input",
        "terseLabel": "SAFE liability, measurement input"
       }
      }
     },
     "localname": "SAFELiabilityMeasurementInput",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "amci_SAFELiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SAFE Liability",
        "label": "SAFE Liability [Member]",
        "terseLabel": "SAFE Liability"
       }
      }
     },
     "localname": "SAFELiabilityMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_SAFEWarrantLongTermMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SAFE Warrant, Long Term",
        "label": "SAFE Warrant, Long Term [Member]",
        "terseLabel": "Long-Term"
       }
      }
     },
     "localname": "SAFEWarrantLongTermMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_SAFEWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SAFE Warrant",
        "label": "SAFE Warrant [Member]",
        "terseLabel": "SAFE warrant"
       }
      }
     },
     "localname": "SAFEWarrantMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails_1",
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_SAFEWarrantNearTermMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SAFE Warrant, Near Term",
        "label": "SAFE Warrant, Near Term [Member]",
        "terseLabel": "Near Term"
       }
      }
     },
     "localname": "SAFEWarrantNearTermMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_SaleOfStockOtherOfferingCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of other offering costs incurred.",
        "label": "Sale of Stock, Other Offering Costs",
        "terseLabel": "Other offering costs"
       }
      }
     },
     "localname": "SaleOfStockOtherOfferingCosts",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_SaleOfStockUnderwritingDiscounts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of offering fees discounts for underwriters.",
        "label": "Sale of Stock, Underwriting Discounts",
        "terseLabel": "Underwriting discount"
       }
      }
     },
     "localname": "SaleOfStockUnderwritingDiscounts",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_ScheduleOfReverseCapitalizationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Reverse Capitalization [Line Items]",
        "label": "Schedule of Reverse Capitalization [Line Items]",
        "terseLabel": "Schedule of Reverse Capitalization [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfReverseCapitalizationLineItems",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionoftheBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "amci_ScheduleOfReverseCapitalizationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Reverse Capitalization [Table]",
        "label": "Schedule of Reverse Capitalization [Table]",
        "terseLabel": "Schedule of Reverse Capitalization [Table]"
       }
      }
     },
     "localname": "ScheduleOfReverseCapitalizationTable",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionoftheBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "amci_SecuritiesSubjectToMandatoryRedemptionLongTermMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities Subject to Mandatory Redemption, Long Term",
        "label": "Securities Subject to Mandatory Redemption, Long Term [Member]",
        "terseLabel": "Long-Term"
       }
      }
     },
     "localname": "SecuritiesSubjectToMandatoryRedemptionLongTermMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_SecuritiesSubjectToMandatoryRedemptionNearTermMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities Subject to Mandatory Redemption, Near Term",
        "label": "Securities Subject to Mandatory Redemption, Near Term [Member]",
        "terseLabel": "Near Term"
       }
      }
     },
     "localname": "SecuritiesSubjectToMandatoryRedemptionNearTermMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_SeniorSecuredNotesReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Secured Notes Receivable",
        "label": "Senior Secured Notes Receivable [Member]",
        "terseLabel": "Senior Secured Notes Receivable"
       }
      }
     },
     "localname": "SeniorSecuredNotesReceivableMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_2"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations, Aggregate Intrinsic Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations, Aggregate Intrinsic Value",
        "terseLabel": "Expired, Aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsAggregateIntrinsicValue",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationStockOptionAwardActivityDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationStockOptionAwardActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures, Aggregate Intrinsic Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures, Aggregate Intrinsic Value",
        "terseLabel": "Cancelled/forfeited, Aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAggregateIntrinsicValue",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationStockOptionAwardActivityDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationStockOptionAwardActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_SharesSurrenderedFairValueOfShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of value of shares surrendered during the period.",
        "label": "Shares Surrendered, Fair Value Of Shares",
        "terseLabel": "Value of shares surrendered"
       }
      }
     },
     "localname": "SharesSurrenderedFairValueOfShares",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_SimpleAgreementForFutureEquityInitialPurchaseAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Simple Agreement For Future Equity, Initial Purchase Amount",
        "label": "Simple Agreement For Future Equity, Initial Purchase Amount",
        "terseLabel": "Initial purchase amount"
       }
      }
     },
     "localname": "SimpleAgreementForFutureEquityInitialPurchaseAmount",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_SimpleAgreementForFutureEquityLiability": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Simple Agreement for Future Equity Liability",
        "label": "Simple Agreement for Future Equity Liability",
        "terseLabel": "SAFE liability",
        "verboseLabel": "SAFE liability"
       }
      }
     },
     "localname": "SimpleAgreementForFutureEquityLiability",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails_1",
      "http://amciacquisitioncorp/role/FairValueNarrativeDetails",
      "http://amciacquisitioncorp/role/SAFEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_SimpleAgreementForFutureEquityLiabilityDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Simple Agreement for Future Equity Liability Disclosure",
        "label": "Simple Agreement for Future Equity Liability Disclosure [Text Block]",
        "terseLabel": "SAFE"
       }
      }
     },
     "localname": "SimpleAgreementForFutureEquityLiabilityDisclosureTextBlock",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/SAFE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "amci_SponsorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for sponsor.",
        "label": "Sponsor",
        "terseLabel": "Sponsor"
       }
      }
     },
     "localname": "SponsorMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails_1",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICITParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_StockIssuanceCostsNoncash": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issuance costs noncash.",
        "label": "Stock Issuance Costs Noncash",
        "terseLabel": "Offering costs included in notes payable"
       }
      }
     },
     "localname": "StockIssuanceCostsNoncash",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_SubordinatedSecuredNotesReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subordinated Secured Notes Receivable",
        "label": "Subordinated Secured Notes Receivable [Member]",
        "terseLabel": "Subordinated Secured Notes Receivable"
       }
      }
     },
     "localname": "SubordinatedSecuredNotesReceivableMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_2"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents tax obligations paid from income from investments held in the trust account.",
        "label": "Tax obligations paid from income from investments held in the trust account",
        "terseLabel": "Tax obligations"
       }
      }
     },
     "localname": "TaxObligationsPaidFromIncomeFromInvestmentsHeldInTrustAccount",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_TemporaryEquityDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure on temporary equity.",
        "label": "Temporary Equity Disclosure [Text Block]",
        "terseLabel": "Class A Common Stock Subject to Possible Redemption",
        "verboseLabel": "Redeemable, Convertible Preferred Stock"
       }
      }
     },
     "localname": "TemporaryEquityDisclosureTextBlock",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemption",
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemption_1",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStock",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStock_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "amci_TemporaryEquityExerciseOfWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Exercise of Warrants",
        "label": "Temporary Equity, Exercise of Warrants",
        "terseLabel": "Exercise of warrants"
       }
      }
     },
     "localname": "TemporaryEquityExerciseOfWarrants",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_TemporaryEquityIssuanceCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of issuance costs related to temporary equity.",
        "label": "Temporary Equity, Issuance Costs",
        "terseLabel": "Offering costs allocated to Class A common stock subject to possible redemption",
        "verboseLabel": "Class A common stock issuance costs"
       }
      }
     },
     "localname": "TemporaryEquityIssuanceCosts",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails",
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_TemporaryEquityIssuePricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Issue Price Per Share",
        "label": "Temporary Equity, Issue Price Per Share",
        "terseLabel": "Issue price (in dollars per share)"
       }
      }
     },
     "localname": "TemporaryEquityIssuePricePerShare",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockAuthorizedIssuedandOutstandingSharesIssuePriceandCarryingValueDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "amci_TemporaryEquityNumberOfVotesPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of votes per common stock subject to possible redemption.",
        "label": "Temporary Equity, Number of Votes Per Share",
        "terseLabel": "Number of votes per common stock subject to possible redemption"
       }
      }
     },
     "localname": "TemporaryEquityNumberOfVotesPerShare",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails_1",
      "http://amciacquisitioncorp/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "amci_TemporaryEquityProceedsAllocatedToWarrants": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gross proceeds allocated from temporary equity to warrants.",
        "label": "Temporary Equity , Proceeds Allocated To Warrants",
        "terseLabel": "Fair value of Public Warrants at issuance",
        "verboseLabel": "Amount allocated to public warrants"
       }
      }
     },
     "localname": "TemporaryEquityProceedsAllocatedToWarrants",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails",
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_TemporaryEquitySharesConversionOfConvertibleSecurities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Shares, Conversion of Convertible Securities",
        "label": "Temporary Equity, Shares, Conversion of Convertible Securities",
        "terseLabel": "Exercise of warrants (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesConversionOfConvertibleSecurities",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT",
      "http://amciacquisitioncorp/role/FairValueNarrativeDetails_1",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "amci_TemporaryEquityStockIssuanceCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Stock Issuance Cost",
        "label": "Temporary Equity, Stock Issuance Cost",
        "terseLabel": "Stock issuance cost"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuanceCost",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_TemporaryEquityStockIssuedDuringPeriodPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Stock Issued During Period, Price Per Share",
        "label": "Temporary Equity, Stock Issued During Period, Price Per Share",
        "terseLabel": "Issuance of preferred stock (in dollars per share)"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodPricePerShare",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "amci_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Stock Issued During Period, Shares, New Issues",
        "label": "Temporary Equity, Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of preferred stock (in shares)"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockChangesDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "amci_TemporaryEquityValueConversionOfConvertibleSecurities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Value, Conversion of Convertible Securities",
        "label": "Temporary Equity, Value, Conversion of Convertible Securities",
        "terseLabel": "Exercise of warrants"
       }
      }
     },
     "localname": "TemporaryEquityValueConversionOfConvertibleSecurities",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period of time after a business combination which must elapse before consideration of the share price condition for transfer of shares.",
        "label": "Threshold Period After Business Combination In Which Specified Trading Days Within Any Specified Trading Day Period Commences",
        "terseLabel": "Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences"
       }
      }
     },
     "localname": "ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails_1"
     ],
     "xbrltype": "durationItemType"
    },
    "amci_TransactionCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of transaction costs incurred.",
        "label": "Transaction Costs",
        "terseLabel": "Transaction Costs",
        "verboseLabel": "Transaction Costs"
       }
      }
     },
     "localname": "TransactionCosts",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_TransactionsWithEquityMethodInvesteesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transactions with Equity Method Investees",
        "label": "Transactions with Equity Method Investees [Member]",
        "terseLabel": "Transactions with Equity Method Investees"
       }
      }
     },
     "localname": "TransactionsWithEquityMethodInvesteesMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsTransactionsDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The share price threshold that must be achieved in order to waive the restriction on transfer of shares during a restricted period after a business combination.",
        "label": "Transfer, Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination, Stock Price Trigger",
        "terseLabel": "Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share)"
       }
      }
     },
     "localname": "TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails_1"
     ],
     "xbrltype": "perShareItemType"
    },
    "amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "When determining the condition for transfer of shares without restriction after a business combination, the number of consecutive trading days used to observe the share price.",
        "label": "Transfer, Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination, Threshold Consecutive Trading Days",
        "terseLabel": "Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination"
       }
      }
     },
     "localname": "TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails_1"
     ],
     "xbrltype": "integerItemType"
    },
    "amci_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "When determining the condition for transfer of shares without restriction after a business combination, the number of days in which the share price must exceed the specified amount.",
        "label": "Transfer, Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination, Threshold Trading Days",
        "terseLabel": "Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination"
       }
      }
     },
     "localname": "TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails_1"
     ],
     "xbrltype": "integerItemType"
    },
    "amci_TransferFromForeignCurrencyTranslationToEquitySecurityInvestment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transfer from Foreign Currency Translation to Equity Security Investment",
        "label": "Transfer from Foreign Currency Translation to Equity Security Investment",
        "terseLabel": "Transfer from foreign currency translation to equity security investment"
       }
      }
     },
     "localname": "TransferFromForeignCurrencyTranslationToEquitySecurityInvestment",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_UnderwriterCashDiscount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the cash underwriting discount per unit.",
        "label": "Underwriter cash discount",
        "terseLabel": "Underwriter cash discount"
       }
      }
     },
     "localname": "UnderwriterCashDiscount",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_UnderwritingDiscountPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to Underwriting Discount Percentage",
        "label": "Underwriting Discount Percentage",
        "terseLabel": "Underwriting Discount Percentage"
       }
      }
     },
     "localname": "UnderwritingDiscountPercentage",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails",
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails_1"
     ],
     "xbrltype": "percentItemType"
    },
    "amci_UnitsIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new units issued during the period.",
        "label": "Units Issued During Period, Shares, New Issues",
        "verboseLabel": "Number of units sold"
       }
      }
     },
     "localname": "UnitsIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1"
     ],
     "xbrltype": "sharesItemType"
    },
    "amci_ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of value of Class B common stock transferred to anchor investors at initial public offering.",
        "label": "Value of Class B common stock transferred to Anchor Investors at Initial Public Offering",
        "terseLabel": "Value of Class B common stock transferred to Anchor Investors at initial public offering"
       }
      }
     },
     "localname": "ValueOfClassBCommonStockTransferredToAnchorInvestorsAtInitialPublicOffering",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1",
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_WTILoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "WTI Loan",
        "label": "WTI Loan [Member]",
        "terseLabel": "2016 WTI Loan"
       }
      }
     },
     "localname": "WTILoanMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/DebtDetails",
      "http://amciacquisitioncorp/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_WarrantConditionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant Condition",
        "label": "Warrant Condition [Axis]",
        "terseLabel": "Warrant Condition [Axis]"
       }
      }
     },
     "localname": "WarrantConditionAxis",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/WarrantsDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "amci_WarrantConditionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant Condition [Domain]",
        "label": "Warrant Condition [Domain]",
        "terseLabel": "Warrant Condition [Domain]"
       }
      }
     },
     "localname": "WarrantConditionDomain",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/WarrantsDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The warrants exercisable term from the closing of the initial public offering, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Warrants And Rights Outstanding Exercisable Term From Closing Of Initial Public Offering",
        "terseLabel": "Threshold period days after the completion of the initial Business Combination for exercise of warrants"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/WarrantsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "amci_WarrantsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants, Policy",
        "label": "Warrants, Policy [Policy Text Block]",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantsPolicyPolicyTextBlock",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "amci_WarrantsTextBlockTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the entire disclosure of warrants",
        "label": "Warrants Text Block [Text Block]",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantsTextBlockTextBlock",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/Warrants",
      "http://amciacquisitioncorp/role/Warrants_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "amci_WorkingCapitalDeficit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount represents the information about working capital deficit.",
        "label": "Working Capital Deficit",
        "terseLabel": "Working capital deficit"
       }
      }
     },
     "localname": "WorkingCapitalDeficit",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_WorkingCapitalLoan": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to Working Capital Loans",
        "label": "Working Capital Loan",
        "terseLabel": "Working Capital Loan"
       }
      }
     },
     "localname": "WorkingCapitalLoan",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amci_WorkingCapitalLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to working capital loans.",
        "label": "Working Capital Loans",
        "terseLabel": "Working Capital Loans"
       }
      }
     },
     "localname": "WorkingCapitalLoansMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "amci_WorkingCapitalLoansWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents working capital loans warrant.",
        "label": "Working capital loans warrant",
        "terseLabel": "Working capital loans warrant"
       }
      }
     },
     "localname": "WorkingCapitalLoansWarrantMember",
     "nsuri": "http://amciacquisitioncorp/20230213",
     "presentation": [
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "country_AU": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "AUSTRALIA",
        "terseLabel": "Australia"
       }
      }
     },
     "localname": "AU",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails",
      "http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETSParenthetical",
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails_1",
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredtaxassetsDetails",
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT",
      "http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_2",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICITParenthetical",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETSParenthetical",
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails_1",
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredtaxassetsDetails",
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT",
      "http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_2",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICITParenthetical",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_AffiliatedEntityMember": {
     "auth_ref": [
      "r675",
      "r774",
      "r798",
      "r799",
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Affiliated Entity [Member]",
        "terseLabel": "Affiliated Entity"
       }
      }
     },
     "localname": "AffiliatedEntityMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AsiaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia [Member]",
        "terseLabel": "Asia"
       }
      }
     },
     "localname": "AsiaMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails",
      "http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r280",
      "r328",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r345",
      "r348",
      "r374",
      "r375",
      "r376",
      "r377",
      "r379",
      "r380",
      "r382",
      "r384",
      "r385",
      "r766",
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails",
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails_1",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r280",
      "r328",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r345",
      "r348",
      "r374",
      "r375",
      "r376",
      "r377",
      "r379",
      "r380",
      "r382",
      "r384",
      "r385",
      "r766",
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails",
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails_1",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsEquityMethodInvestmentsDetails",
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails",
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails_1",
      "http://amciacquisitioncorp/role/InvestmentsScheduleofInvestmentsDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r352",
      "r695",
      "r772",
      "r814"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r369",
      "r370",
      "r371",
      "r372",
      "r469",
      "r620",
      "r646",
      "r676",
      "r677",
      "r692",
      "r705",
      "r713",
      "r768",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionoftheBusinessDetails",
      "http://amciacquisitioncorp/role/FairValueNarrativeDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockAuthorizedIssuedandOutstandingSharesIssuePriceandCarryingValueDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockDetails",
      "http://amciacquisitioncorp/role/ShareBasedCompensationNarrativeDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationNarrativeDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r369",
      "r370",
      "r371",
      "r372",
      "r469",
      "r620",
      "r646",
      "r676",
      "r677",
      "r692",
      "r705",
      "r713",
      "r768",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/DescriptionoftheBusinessDetails",
      "http://amciacquisitioncorp/role/FairValueNarrativeDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockAuthorizedIssuedandOutstandingSharesIssuePriceandCarryingValueDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockDetails",
      "http://amciacquisitioncorp/role/ShareBasedCompensationNarrativeDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationNarrativeDetails",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_1",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r352",
      "r695",
      "r772",
      "r814"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NorthAmericaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "North America [Member]",
        "terseLabel": "North America"
       }
      }
     },
     "localname": "NorthAmericaMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails",
      "http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r349",
      "r624",
      "r693",
      "r711",
      "r763",
      "r764",
      "r772",
      "r813"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails",
      "http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r349",
      "r624",
      "r693",
      "r711",
      "r763",
      "r764",
      "r772",
      "r813"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails",
      "http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r369",
      "r370",
      "r371",
      "r372",
      "r459",
      "r469",
      "r499",
      "r500",
      "r501",
      "r619",
      "r620",
      "r646",
      "r676",
      "r677",
      "r692",
      "r705",
      "r713",
      "r762",
      "r768",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/DescriptionoftheBusinessDetails",
      "http://amciacquisitioncorp/role/FairValueNarrativeDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockAuthorizedIssuedandOutstandingSharesIssuePriceandCarryingValueDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockDetails",
      "http://amciacquisitioncorp/role/ShareBasedCompensationNarrativeDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationNarrativeDetails",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_1",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r369",
      "r370",
      "r371",
      "r372",
      "r459",
      "r469",
      "r499",
      "r500",
      "r501",
      "r619",
      "r620",
      "r646",
      "r676",
      "r677",
      "r692",
      "r705",
      "r713",
      "r762",
      "r768",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/DescriptionoftheBusinessDetails",
      "http://amciacquisitioncorp/role/FairValueNarrativeDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockAuthorizedIssuedandOutstandingSharesIssuePriceandCarryingValueDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockDetails",
      "http://amciacquisitioncorp/role/ShareBasedCompensationNarrativeDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationNarrativeDetails",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_1",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r235",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r314",
      "r361",
      "r362",
      "r532",
      "r555",
      "r556",
      "r557",
      "r558",
      "r587",
      "r605",
      "r606",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]",
        "terseLabel": "Revision of Prior Period [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r235",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r314",
      "r361",
      "r362",
      "r532",
      "r555",
      "r556",
      "r557",
      "r558",
      "r587",
      "r605",
      "r606",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]",
        "terseLabel": "Revision of Prior Period [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember": {
     "auth_ref": [
      "r286",
      "r287",
      "r288",
      "r291",
      "r292",
      "r294",
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period, Error Correction, Adjustment [Member]",
        "terseLabel": "Adjustments"
       }
      }
     },
     "localname": "RevisionOfPriorPeriodErrorCorrectionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "auth_ref": [
      "r235",
      "r281",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r295",
      "r314",
      "r532",
      "r555",
      "r556",
      "r557",
      "r587",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r759",
      "r760",
      "r787",
      "r796",
      "r797"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Previously Reported [Member]",
        "terseLabel": "As Previously Reported"
       }
      }
     },
     "localname": "ScenarioPreviouslyReportedMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsEquityMethodInvestmentsDetails",
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails",
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails_1",
      "http://amciacquisitioncorp/role/InvestmentsScheduleofInvestmentsDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r350",
      "r351",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r694",
      "r712",
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails",
      "http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails_1",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r350",
      "r351",
      "r658",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r694",
      "r712",
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails",
      "http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails_1",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r752",
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsAndOtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.",
        "label": "Accounts and Other Receivables, Net, Current",
        "terseLabel": "Trade and other receivables, net of allowance"
       }
      }
     },
     "localname": "AccountsAndOtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of receivable.",
        "label": "Receivable Type [Axis]",
        "terseLabel": "Receivable Type [Axis]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_2"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r20",
      "r710"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r193",
      "r204",
      "r223",
      "r739"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount for accounts payable to related parties.",
        "label": "Accounts Payable, Related Parties",
        "terseLabel": "Purchases and open accounts payable"
       }
      }
     },
     "localname": "AccountsPayableRelatedPartiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNet": {
     "auth_ref": [
      "r641",
      "r659"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.",
        "label": "Accounts Receivable, after Allowance for Credit Loss",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsTransactionsDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent": {
     "auth_ref": [
      "r143",
      "r204",
      "r222"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes.",
        "label": "Accrual for Taxes Other than Income Taxes",
        "terseLabel": "Capital based tax payable",
        "verboseLabel": "Capital based tax payable"
       }
      }
     },
     "localname": "AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r7",
      "r200",
      "r214"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income tax payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r102",
      "r241"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/PropertyPlantandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Less accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/PropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r34",
      "r35",
      "r36",
      "r248",
      "r642",
      "r652",
      "r656"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r33",
      "r36",
      "r164",
      "r606",
      "r647",
      "r648",
      "r722",
      "r723",
      "r724",
      "r740",
      "r741",
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Cash Flow Elements, Investing Activities [Abstract]",
        "terseLabel": "Additional Cash Flow Elements, Investing Activities [Abstract]"
       }
      }
     },
     "localname": "AdditionalCashFlowElementsInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r15",
      "r710"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r508",
      "r509",
      "r510",
      "r740",
      "r741",
      "r742",
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForErrorCorrectionDomain": {
     "auth_ref": [
      "r286",
      "r287",
      "r288",
      "r291",
      "r292",
      "r294",
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of error correction.",
        "label": "Error Correction, Type [Domain]",
        "terseLabel": "Error Correction, Type [Domain]"
       }
      }
     },
     "localname": "AdjustmentsForErrorCorrectionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings": {
     "auth_ref": [
      "r122",
      "r129"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from dividends legally declared (or paid) in excess of retained earnings balance.",
        "label": "Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings",
        "terseLabel": "Reclass from additional paid-in capital to retained earnings"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r141",
      "r142",
      "r471"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "auth_ref": [
      "r109",
      "r122",
      "r129"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.",
        "label": "Adjustments to Additional Paid in Capital, Warrant Issued",
        "terseLabel": "Excess cash received over the fair value of the private warrants"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:",
        "verboseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r503"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationNarrativeDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r249",
      "r353",
      "r363"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesTradeandOtherReceivablesDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesTradeandOtherReceivablesDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Aggregate purchase of stock",
        "verboseLabel": "Antidilutive shares"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails_1",
      "http://amciacquisitioncorp/role/LanzaTech10QNetLossPerShareAntidilutiveSharesDetails",
      "http://amciacquisitioncorp/role/NetLossPerShareAntidilutiveSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LanzaTech10QNetLossPerShareAntidilutiveSharesDetails",
      "http://amciacquisitioncorp/role/NetLossPerShareAntidilutiveSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LanzaTech10QNetLossPerShareAntidilutiveSharesDetails",
      "http://amciacquisitioncorp/role/NetLossPerShareAntidilutiveSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LanzaTech10QNetLossPerShareAntidilutiveSharesDetails",
      "http://amciacquisitioncorp/role/NetLossPerShareAntidilutiveSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r198",
      "r213",
      "r243",
      "r275",
      "r331",
      "r341",
      "r347",
      "r358",
      "r374",
      "r375",
      "r377",
      "r378",
      "r379",
      "r381",
      "r383",
      "r385",
      "r386",
      "r547",
      "r551",
      "r571",
      "r710",
      "r766",
      "r767",
      "r802"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r237",
      "r252",
      "r275",
      "r358",
      "r374",
      "r375",
      "r377",
      "r378",
      "r379",
      "r381",
      "r383",
      "r385",
      "r386",
      "r547",
      "r551",
      "r571",
      "r710",
      "r766",
      "r767",
      "r802"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "terseLabel": "Total current assets",
        "totalLabel": "Total current assets",
        "verboseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/InvestmentsSummarizedFinancialInformationDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsHeldInTrustCurrent": {
     "auth_ref": [
      "r734"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate within one year of the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.",
        "label": "Assets Held-in-trust, Current",
        "terseLabel": "Cash held in AMCI's trust account",
        "verboseLabel": "Cash held in AMCI's trust account"
       }
      }
     },
     "localname": "AssetsHeldInTrustCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsHeldInTrustNoncurrent": {
     "auth_ref": [
      "r734"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.",
        "label": "Assets Held-in-trust, Noncurrent",
        "verboseLabel": "Investments held in trust account"
       }
      }
     },
     "localname": "AssetsHeldInTrustNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsNet": {
     "auth_ref": [
      "r0",
      "r227",
      "r228",
      "r230",
      "r231"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net assets (liabilities).",
        "label": "Net Assets",
        "terseLabel": "Net tangible assets"
       }
      }
     },
     "localname": "AssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r275",
      "r358",
      "r374",
      "r375",
      "r377",
      "r378",
      "r379",
      "r381",
      "r383",
      "r385",
      "r386",
      "r547",
      "r551",
      "r571",
      "r766",
      "r767",
      "r802"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "terseLabel": "Non-current assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsSummarizedFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AutomobilesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vehicles that are used primarily for transporting people.",
        "label": "Automobiles [Member]",
        "terseLabel": "Vehicles"
       }
      }
     },
     "localname": "AutomobilesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/PropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r474",
      "r475",
      "r476",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationNarrativeDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationFairValueAssumptionsDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationNarrativeDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationRestrictedStockAwardsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]",
        "terseLabel": "Consolidated Balance Sheet"
       }
      }
     },
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies_1",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "Basis of Presentation and Summary of Significant Accounting Policies",
        "verboseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPolicies",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPolicies_1",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPolicies",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPolicies_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BilledContractReceivables": {
     "auth_ref": [
      "r622"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts due for billed services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the Company and, at a minimum, one other party. An example would be amounts billed to customers under contracts or programs but not paid as of the balance sheet date.",
        "label": "Billed Contracts Receivable",
        "terseLabel": "Billed accounts receivable, net of allowance"
       }
      }
     },
     "localname": "BilledContractReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RevenuesAdditionalInformationDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r544",
      "r703",
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r153",
      "r154",
      "r544",
      "r703",
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r157",
      "r158"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "terseLabel": "Consideration consisting of equity interests"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationAssetCurrent": {
     "auth_ref": [
      "r156",
      "r159"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset recognized arising from contingent consideration in a business combination, expected to be realized within one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Asset, Current",
        "terseLabel": "Aggregate consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationAssetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_1",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r71",
      "r72",
      "r73"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Acquisition of property, plant and equipment under accounts payable"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r68",
      "r239",
      "r679"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashReconciliationDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashReconciliationDetails_1",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails_1",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesGoingConcernDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesGoingConcernandSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies_1",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r69",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents, Cash Equivalents, and Restricted Cash",
        "verboseLabel": "Restricted Cash and Other Cash Flows from Operating Activities"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r62",
      "r68",
      "r74"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period",
        "totalLabel": "Cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashReconciliationDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashReconciliationDetails_1",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r62",
      "r188"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r62",
      "r188"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net (decrease) increase in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r718"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFDICInsuredAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.",
        "label": "Cash, FDIC Insured Amount",
        "terseLabel": "Cash, FDIC Insured Amount"
       }
      }
     },
     "localname": "CashFDICInsuredAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Supplemental disclosure of non-cash investing and financing activities:",
        "verboseLabel": "Supplemental disclosure of noncash activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r245",
      "r246",
      "r247",
      "r275",
      "r300",
      "r301",
      "r308",
      "r310",
      "r318",
      "r319",
      "r358",
      "r374",
      "r377",
      "r378",
      "r379",
      "r385",
      "r386",
      "r415",
      "r416",
      "r420",
      "r424",
      "r431",
      "r571",
      "r678",
      "r716",
      "r735",
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/BALANCESHEETParenthetical",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails_1",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETSParenthetical",
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails",
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails_1",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/FairValueNarrativeDetails_1",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockAuthorizedIssuedandOutstandingSharesIssuePriceandCarryingValueDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockChangesDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockNarrativeDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails_1",
      "http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT",
      "http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS",
      "http://amciacquisitioncorp/role/StockholdersDeficitCommonStockSharesDetails",
      "http://amciacquisitioncorp/role/StockholdersEquityDeficitCommonStockSharesDetails",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICITParenthetical",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS",
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Stockholders' Equity (Deficit)"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/StockholdersDeficitCommonStockSharesDetails",
      "http://amciacquisitioncorp/role/StockholdersEquityDeficitCommonStockSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "auth_ref": [
      "r130",
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of warrant or right issued.",
        "label": "Class of Warrant or Right [Axis]",
        "terseLabel": "Class of Warrant or Right [Axis]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails_1",
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails_1",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/WarrantsDetails",
      "http://amciacquisitioncorp/role/WarrantsDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.",
        "label": "Class of Warrant or Right [Domain]",
        "terseLabel": "Class of Warrant or Right [Domain]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails_1",
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails_1",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/WarrantsDetails",
      "http://amciacquisitioncorp/role/WarrantsDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Class of warrant or right, exercise price of warrants or rights (in dollars per share)",
        "verboseLabel": "Exercise price of warrant"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/FairValueNarrativeDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_1",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Warrant or Right [Line Items]",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/WarrantsDetails",
      "http://amciacquisitioncorp/role/WarrantsDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right",
        "verboseLabel": "Number of shares per warrant"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/WarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "terseLabel": "Sale of private placement warrants (in shares)",
        "verboseLabel": "Number of warrants to purchase shares issued"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/FairValueNarrativeDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_2",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "verboseLabel": "Number of warrants outstanding"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/WarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "auth_ref": [
      "r130",
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Class of Warrant or Right [Table]",
        "terseLabel": "Class of Warrant or Right [Table]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/WarrantsDetails",
      "http://amciacquisitioncorp/role/WarrantsDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember": {
     "auth_ref": [
      "r785"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement transaction between parties to collaborative arrangement.",
        "label": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]",
        "terseLabel": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement"
       }
      }
     },
     "localname": "CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r29",
      "r205",
      "r220"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "verboseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r106",
      "r367",
      "r368",
      "r661",
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CommitmentsandContingencies",
      "http://amciacquisitioncorp/role/CommitmentsandContingencies_1",
      "http://amciacquisitioncorp/role/CommitmentsandContingencies_2",
      "http://amciacquisitioncorp/role/CommitmentsandContingencies_3"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r107",
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Legal and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation.",
        "label": "Common Class A [Member]",
        "terseLabel": "Class A Common stock"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/BALANCESHEETParenthetical",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails_1",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails_1",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETSParenthetical",
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails",
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails_1",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1",
      "http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT",
      "http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS",
      "http://amciacquisitioncorp/role/StockholdersDeficitCommonStockSharesDetails",
      "http://amciacquisitioncorp/role/StockholdersEquityDeficitCommonStockSharesDetails",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS",
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.",
        "label": "Common Class B [Member]",
        "terseLabel": "Class B Common Stock"
       }
      }
     },
     "localname": "CommonClassBMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/BALANCESHEETParenthetical",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails_1",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETSParenthetical",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails_1",
      "http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT",
      "http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS",
      "http://amciacquisitioncorp/role/StockholdersDeficitCommonStockSharesDetails",
      "http://amciacquisitioncorp/role/StockholdersEquityDeficitCommonStockSharesDetails",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICITParenthetical",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r740",
      "r741",
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]",
        "verboseLabel": "Common Stock Outstanding"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT",
      "http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common shares, par value (usd per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEETParenthetical",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETSParenthetical",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/ShareholdersEquityDetails",
      "http://amciacquisitioncorp/role/StockholdersDeficitCommonStockSharesDetails",
      "http://amciacquisitioncorp/role/StockholdersEquityDeficitCommonStockSharesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common shares, shares authorized (in shares)",
        "verboseLabel": "Common shares, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEETParenthetical",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETSParenthetical",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails",
      "http://amciacquisitioncorp/role/StockholdersDeficitCommonStockSharesDetails",
      "http://amciacquisitioncorp/role/StockholdersEquityDeficitCommonStockSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common shares, shares issued (in shares)",
        "verboseLabel": "Common shares, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEETParenthetical",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETSParenthetical",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://amciacquisitioncorp/role/StockholdersDeficitCommonStockSharesDetails",
      "http://amciacquisitioncorp/role/StockholdersEquityDeficitCommonStockSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r14",
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance, Common stock, shares outstanding (in shares)",
        "periodStartLabel": "Beginning balance, Common stock, shares outstanding (in shares)",
        "terseLabel": "Common shares, shares outstanding",
        "verboseLabel": "Common shares, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEETParenthetical",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETSParenthetical",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT",
      "http://amciacquisitioncorp/role/StockholdersDeficitCommonStockSharesDetails",
      "http://amciacquisitioncorp/role/StockholdersEquityDeficitCommonStockSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r14",
      "r710"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets [Abstract]",
        "terseLabel": "Components of Deferred Tax Assets [Abstract]"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredtaxassetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r39",
      "r257",
      "r259",
      "r265",
      "r637",
      "r643"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "terseLabel": "Comprehensive loss",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r84",
      "r85",
      "r184",
      "r185",
      "r352",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r84",
      "r85",
      "r184",
      "r185",
      "r352",
      "r657",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r84",
      "r85",
      "r184",
      "r185",
      "r352",
      "r660",
      "r815"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r210",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies_1",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r84",
      "r85",
      "r184",
      "r185",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk, percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails_1"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r81",
      "r84",
      "r85",
      "r86",
      "r184",
      "r186",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r84",
      "r85",
      "r184",
      "r185",
      "r352",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/PropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Changes in contract assets and liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesTables",
      "http://amciacquisitioncorp/role/RevenuesTables_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "auth_ref": [
      "r434",
      "r436",
      "r456"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Contract assets",
        "verboseLabel": "Contract assets"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails",
      "http://amciacquisitioncorp/role/RevenuesContractBalancesDetails",
      "http://amciacquisitioncorp/role/RevenuesContractBalancesDetails_1",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current [Abstract]",
        "terseLabel": "Current Contract Assets"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesContractBalancesDetails",
      "http://amciacquisitioncorp/role/RevenuesContractBalancesDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r434",
      "r435",
      "r456"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails",
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r434",
      "r435",
      "r456"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Contract liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/RevenuesContractBalancesDetails",
      "http://amciacquisitioncorp/role/RevenuesContractBalancesDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r434",
      "r435",
      "r456"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Non-current contract liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/RevenuesContractBalancesDetails",
      "http://amciacquisitioncorp/role/RevenuesContractBalancesDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContributionOfProperty": {
     "auth_ref": [
      "r71",
      "r72",
      "r73"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of property contributed in noncash investing and financing activities.",
        "label": "Contribution of Property",
        "terseLabel": "Contribution of intellectual property"
       }
      }
     },
     "localname": "ContributionOfProperty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails",
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConversionOfStockAmountConverted1": {
     "auth_ref": [
      "r71",
      "r72",
      "r73"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Amount Converted",
        "terseLabel": "Receipt of common shares as payment for option exercises"
       }
      }
     },
     "localname": "ConversionOfStockAmountConverted1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConversionOfStockSharesIssued1": {
     "auth_ref": [
      "r71",
      "r72",
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Shares Issued",
        "terseLabel": "Number of Class A common stock issued upon conversion of each share (in shares)"
       }
      }
     },
     "localname": "ConversionOfStockSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/StockholdersDeficitCommonStockSharesDetails",
      "http://amciacquisitioncorp/role/StockholdersEquityDeficitCommonStockSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r725",
      "r726"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of product sold and service rendered, excluding depreciation, depletion, and amortization.",
        "label": "Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization",
        "negatedTerseLabel": "Cost of revenues from contracts with customers (exclusive of depreciation shown below)"
       }
      }
     },
     "localname": "CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r48",
      "r275",
      "r358",
      "r374",
      "r375",
      "r377",
      "r378",
      "r379",
      "r381",
      "r383",
      "r385",
      "r386",
      "r571",
      "r766"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "negatedTotalLabel": "Total cost and operating expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "Cost and operating expenses:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r738",
      "r780",
      "r782"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredtaxassetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesIncomeTaxProvisionDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesIncometaxprovisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r738",
      "r780"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r152",
      "r528",
      "r536",
      "r738"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesIncomeTaxProvisionDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesIncometaxprovisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r738",
      "r780",
      "r782"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredtaxassetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesIncometaxprovisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r82",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r112",
      "r273",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r403",
      "r410",
      "r411",
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r6",
      "r7",
      "r8",
      "r199",
      "r202",
      "r212",
      "r280",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r393",
      "r399",
      "r400",
      "r401",
      "r402",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r586",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DebtDetails",
      "http://amciacquisitioncorp/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable interest rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentDecreaseForgiveness": {
     "auth_ref": [
      "r736"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease for amounts of indebtedness forgiven by the holder of the debt instrument.",
        "label": "Debt Instrument, Decrease, Forgiveness",
        "terseLabel": "Debt forgiveness"
       }
      }
     },
     "localname": "DebtInstrumentDecreaseForgiveness",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r190",
      "r191",
      "r387",
      "r586",
      "r688",
      "r689"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r26",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DebtDetails",
      "http://amciacquisitioncorp/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r27",
      "r280",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r393",
      "r399",
      "r400",
      "r401",
      "r402",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r586",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DebtDetails",
      "http://amciacquisitioncorp/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r27",
      "r123",
      "r126",
      "r127",
      "r128",
      "r189",
      "r190",
      "r191",
      "r209",
      "r280",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r393",
      "r399",
      "r400",
      "r401",
      "r402",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r412",
      "r586",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-Term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DebtDetails",
      "http://amciacquisitioncorp/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtPolicyTextBlock": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.",
        "label": "Debt, Policy [Policy Text Block]",
        "terseLabel": "Long-Term Debt and Debt Issuance Costs"
       }
      }
     },
     "localname": "DebtPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r738",
      "r781",
      "r782"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredtaxassetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesIncomeTaxProvisionDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesIncometaxprovisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r152",
      "r738",
      "r781"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r66",
      "r152",
      "r529",
      "r535",
      "r536",
      "r738"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income tax",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesIncomeTaxProvisionDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesIncomeTaxProvisionDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesIncometaxprovisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r10",
      "r11",
      "r201",
      "r211",
      "r523"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredOfferingCosts": {
     "auth_ref": [
      "r761"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.",
        "label": "Deferred Offering Costs",
        "terseLabel": "Offering costs"
       }
      }
     },
     "localname": "DeferredOfferingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r738",
      "r781",
      "r782"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredtaxassetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State."
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesIncometaxprovisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "auth_ref": [
      "r150",
      "r779"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.",
        "label": "Deferred Tax Assets, Deferred Income",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsEquityMethodInvestments": {
     "auth_ref": [
      "r150",
      "r779"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from equity method investments.",
        "label": "Deferred Tax Assets, Equity Method Investments",
        "terseLabel": "Equity method investment"
       }
      }
     },
     "localname": "DeferredTaxAssetsEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r524"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "netLabel": "Deferred tax assets, gross",
        "totalLabel": "Gross deferred tax asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredtaxassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r778"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred income tax assets and liabilities:"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r778"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Net deferred tax asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net of Valuation Allowance [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetOfValuationAllowanceAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r150",
      "r779"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss and credit carryforwards",
        "verboseLabel": "Net operating loss carryforward"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredtaxassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r150",
      "r779"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses": {
     "auth_ref": [
      "r150",
      "r779"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee bonuses.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Bonuses",
        "terseLabel": "Accrued bonus"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": {
     "auth_ref": [
      "r150",
      "r779"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r525"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance",
        "negatedTerseLabel": "Valuation allowance",
        "terseLabel": "Deferred tax assets valuation allowance",
        "verboseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredtaxassetsDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesNarrativeDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationofthestatutoryfederalincometaxratebenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "auth_ref": [
      "r150",
      "r779"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "negatedTerseLabel": "Operating lease asset"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Net [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r150",
      "r779"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanTextBlock": {
     "auth_ref": [
      "r467",
      "r623",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for defined benefit plan.",
        "label": "Defined Benefit Plan [Text Block]",
        "terseLabel": "Benefit Plans"
       }
      }
     },
     "localname": "DefinedBenefitPlanTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BenefitPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r468"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Contributions to plan"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r66",
      "r100"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "negatedTerseLabel": "Depreciation expense",
        "terseLabel": "Depreciation expense",
        "verboseLabel": "Depreciation of property, plant and equipment"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://amciacquisitioncorp/role/PropertyPlantandEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents derivative instrument obligations meeting the definition of a liability which are reported as of the balance sheet date. Derivative instrument obligations are generally measured at fair value, and adjustments to the carrying amount of hedged items reflect changes in their fair value (that is, losses) that are attributable to the risk being hedged and that arise while the hedge is in effect.",
        "label": "Derivative Financial Instruments, Liabilities [Member]",
        "terseLabel": "Derivative Financial Instruments, Liabilities [Member]"
       }
      }
     },
     "localname": "DerivativeFinancialInstrumentsLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r169",
      "r170",
      "r171",
      "r172",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r253",
      "r254",
      "r570",
      "r681"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Derivative liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilityMeasurementInput": {
     "auth_ref": [
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure derivative liability.",
        "label": "Derivative Liability, Measurement Input",
        "terseLabel": "Derivatives, measurement input"
       }
      }
     },
     "localname": "DerivativeLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration": {
     "auth_ref": [
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes derivative liability.",
        "label": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails_1"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_DerivativesAndFairValueTextBlock": {
     "auth_ref": [
      "r174",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivatives and fair value of assets and liabilities.",
        "label": "Derivatives and Fair Value [Text Block]",
        "terseLabel": "Warrant Liabilities"
       }
      }
     },
     "localname": "DerivativesAndFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/WarrantLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r168",
      "r173",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Financial Instruments",
        "verboseLabel": "Simple Agreement for Future Equity (SAFE)"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies_1",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails",
      "http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails_1",
      "http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails",
      "http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r455",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails",
      "http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails_1",
      "http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails",
      "http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregated revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesTables",
      "http://amciacquisitioncorp/role/RevenuesTables_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r473",
      "r504",
      "r505",
      "r507",
      "r512",
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Share-Based Compensation",
        "verboseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensation",
      "http://amciacquisitioncorp/role/StockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredtaxassetsDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DueToRelatedPartiesCurrent": {
     "auth_ref": [
      "r20",
      "r376",
      "r377",
      "r378",
      "r384",
      "r385",
      "r386",
      "r610",
      "r739"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Due to Related Parties, Current",
        "terseLabel": "Due to related party"
       }
      }
     },
     "localname": "DueToRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EMEAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regions of Europe, Middle East and Africa.",
        "label": "EMEA [Member]",
        "terseLabel": "Europe, Middle East, Africa (EMEA)"
       }
      }
     },
     "localname": "EMEAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r266",
      "r286",
      "r287",
      "r289",
      "r290",
      "r291",
      "r297",
      "r300",
      "r308",
      "r309",
      "r310",
      "r314",
      "r557",
      "r558",
      "r638",
      "r644",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic net income (loss) per common share",
        "verboseLabel": "Net loss per common share - basic (usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails_1",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://amciacquisitioncorp/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails",
      "http://amciacquisitioncorp/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails_1",
      "http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r266",
      "r286",
      "r287",
      "r289",
      "r290",
      "r291",
      "r300",
      "r308",
      "r309",
      "r310",
      "r314",
      "r557",
      "r558",
      "r638",
      "r644",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per common share - diluted (usd per share)",
        "verboseLabel": "Diluted net income (loss) per common share"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails_1",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://amciacquisitioncorp/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails",
      "http://amciacquisitioncorp/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails_1",
      "http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r79",
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Income (Loss) Per Share of Common Stock",
        "verboseLabel": "Net Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies_1",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r311",
      "r312",
      "r313",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/NetLossPerShare",
      "http://amciacquisitioncorp/role/NetLossPerShare_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r576"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effects of currency translation on cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r517"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Total income tax benefit",
        "verboseLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails_1",
      "http://amciacquisitioncorp/role/IncomeTaxesDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationofthestatutoryfederalincometaxratebenefitDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Percent [Abstract]"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r277",
      "r517",
      "r538"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "netLabel": "Income tax (benefit) at the statutory federal income tax rate",
        "terseLabel": "Statutory tax rate (as a percent)",
        "verboseLabel": "Statutory federal income tax rate (in percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails_1",
      "http://amciacquisitioncorp/role/IncomeTaxesNarrativeDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationofthestatutoryfederalincometaxratebenefitDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r777",
      "r783"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "verboseLabel": "Change in valuation allowance (in percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationofthestatutoryfederalincometaxratebenefitDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r777",
      "r783"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "terseLabel": "Foreign tax rate differential"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses": {
     "auth_ref": [
      "r777",
      "r783"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to impairment loss.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent",
        "terseLabel": "Effects of impairment"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r777",
      "r783"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r777",
      "r783"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Offering costs allocated to derivative warrant liabilities (in percent)",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationofthestatutoryfederalincometaxratebenefitDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": {
     "auth_ref": [
      "r776",
      "r777"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent",
        "negatedLabel": "Change in fair value of derivative warrant liabilities (in percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationofthestatutoryfederalincometaxratebenefitDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r777",
      "r783"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State and local taxes"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued salaries and wages"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized cost, recognition period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationNarrativeDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r775"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation costs"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationNarrativeDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LanzaTech10QNetLossPerShareAntidilutiveSharesDetails",
      "http://amciacquisitioncorp/role/NetLossPerShareAntidilutiveSharesDetails",
      "http://amciacquisitioncorp/role/ShareBasedCompensationNarrativeDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationFairValueAssumptionsDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r122",
      "r234",
      "r261",
      "r262",
      "r263",
      "r281",
      "r282",
      "r283",
      "r285",
      "r292",
      "r295",
      "r317",
      "r360",
      "r433",
      "r508",
      "r509",
      "r510",
      "r531",
      "r532",
      "r556",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r606",
      "r647",
      "r648",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvesteeMember": {
     "auth_ref": [
      "r91",
      "r626",
      "r628",
      "r630",
      "r632",
      "r634",
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity that issued voting stock held by an investor and that is accounted for under the equity method of accounting by the investor.",
        "label": "Equity Method Investee [Member]",
        "terseLabel": "Equity Method Investee"
       }
      }
     },
     "localname": "EquityMethodInvesteeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsTransactionsDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity": {
     "auth_ref": [
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee.",
        "label": "Equity Method Investment, Difference Between Carrying Amount and Underlying Equity",
        "terseLabel": "Carrying value less than proportionate share of book value"
       }
      }
     },
     "localname": "EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails",
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentDividendsOrDistributions": {
     "auth_ref": [
      "r41",
      "r61",
      "r66",
      "r224"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.",
        "label": "Proceeds from Equity Method Investment, Distribution",
        "terseLabel": "Dividends from equity investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails",
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": {
     "auth_ref": [
      "r236",
      "r275",
      "r358",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Axis]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Axis]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsSummarizedFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": {
     "auth_ref": [
      "r236",
      "r275",
      "r358",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Domain]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsSummarizedFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember": {
     "auth_ref": [
      "r717",
      "r737",
      "r756",
      "r790"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonconsolidated equity method investee or group of nonconsolidated investees. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee or Group of Investees"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsSummarizedFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": {
     "auth_ref": [
      "r92"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.",
        "label": "Equity Method Investment, Other than Temporary Impairment",
        "terseLabel": "Impairment on equity method investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Ownership percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails",
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails_1"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r93",
      "r332",
      "r719"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/InvestmentsScheduleofInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "netLabel": "Equity method investments",
        "verboseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/InvestmentsEquityMethodInvestmentsDetails",
      "http://amciacquisitioncorp/role/InvestmentsScheduleofInvestmentsDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails_1",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.",
        "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/Investments_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r61",
      "r95",
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsTables_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue": {
     "auth_ref": [
      "r569"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI) and investment in equity security without readily determinable fair value.",
        "label": "Equity Securities, FV-NI and without Readily Determinable Fair Value",
        "terseLabel": "Equity Security Investment"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiGainLoss": {
     "auth_ref": [
      "r754"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Gain (Loss)",
        "negatedLabel": "Equity securities loss"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r355"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/InvestmentsScheduleofInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Equity Security Investment in SGLT"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsScheduleofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount": {
     "auth_ref": [
      "r356"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative impairment loss on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount",
        "terseLabel": "Impairment on equity method investments"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis": {
     "auth_ref": [
      "r286",
      "r287",
      "r288",
      "r291",
      "r292",
      "r294",
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of error correction.",
        "label": "Error Correction, Type [Axis]",
        "terseLabel": "Error Correction, Type [Axis]"
       }
      }
     },
     "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Error Corrections and Prior Period Adjustments Restatement [Line Items]",
        "terseLabel": "Error Corrections and Prior Period Adjustments Restatement [Line Items]"
       }
      }
     },
     "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "auth_ref": [
      "r66",
      "r113"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.",
        "label": "Fair Value Adjustment of Warrants",
        "negatedLabel": "Change in fair value of derivative warrant liabilities",
        "terseLabel": "(Gain) loss on change in fair value of SAFE and warrant liabilities",
        "verboseLabel": "Change in fair value of derivative warrant liabilities"
       }
      }
     },
     "localname": "FairValueAdjustmentOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails",
      "http://amciacquisitioncorp/role/FairValueNarrativeDetails",
      "http://amciacquisitioncorp/role/FairValueNarrativeDetails_1",
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails_1",
      "http://amciacquisitioncorp/role/FairValueNarrativeDetails",
      "http://amciacquisitioncorp/role/FairValueNarrativeDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r559",
      "r560",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails_1",
      "http://amciacquisitioncorp/role/FairValueNarrativeDetails",
      "http://amciacquisitioncorp/role/FairValueNarrativeDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "auth_ref": [
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Summary of quantitative information regarding Level 3 fair value measurement inputs"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueMeasurementsTables",
      "http://amciacquisitioncorp/role/FairValueMeasurementsTables_1",
      "http://amciacquisitioncorp/role/FairValueTables",
      "http://amciacquisitioncorp/role/FairValueTables_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r401",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r560",
      "r616",
      "r617",
      "r618",
      "r688",
      "r689",
      "r700",
      "r701",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r179",
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r559",
      "r560",
      "r562",
      "r563",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements",
        "verboseLabel": "Fair Value"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValue",
      "http://amciacquisitioncorp/role/FairValueMeasurements",
      "http://amciacquisitioncorp/role/FairValueMeasurements_1",
      "http://amciacquisitioncorp/role/FairValue_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r401",
      "r460",
      "r465",
      "r560",
      "r616",
      "r700",
      "r701",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r401",
      "r460",
      "r465",
      "r560",
      "r617",
      "r688",
      "r689",
      "r700",
      "r701",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r401",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r560",
      "r618",
      "r688",
      "r689",
      "r700",
      "r701",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r177",
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r177",
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Summary of change in the fair value of the derivative warrant liabilities, measured using Level 3 inputs"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueMeasurementsTables",
      "http://amciacquisitioncorp/role/FairValueMeasurementsTables_1",
      "http://amciacquisitioncorp/role/FairValueTables",
      "http://amciacquisitioncorp/role/FairValueTables_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements",
        "verboseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies_1",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3": {
     "auth_ref": [
      "r565"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of financial instrument classified as a liability out of level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3",
        "terseLabel": "Transfer of Public Warrants to Level 1"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r564"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "negatedLabel": "Change in fair value of derivative liabilities",
        "verboseLabel": "Change in fair value of derivative liabilities"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": {
     "auth_ref": [
      "r178"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances",
        "terseLabel": "Issuance of SAFE liability and warrant"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r177"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Derivative warrant liabilities at the end",
        "periodStartLabel": "Derivative warrant liabilities at the beginning",
        "verboseLabel": "Derivative warrant liabilities as expense"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails_1",
      "http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r401",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r616",
      "r617",
      "r618",
      "r688",
      "r689",
      "r700",
      "r701",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r566",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r181",
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement in which net income is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3).",
        "label": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "terseLabel": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]"
       }
      }
     },
     "localname": "FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsChangeinthefairvalueofthederivativewarrantliabilitiesDetails_1"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r572",
      "r573",
      "r574",
      "r575"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "negatedTerseLabel": "Net foreign exchange loss"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currencies"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignEarningsRepatriated": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign earnings repatriated from subsidiaries outside the country of domicile.",
        "label": "Foreign Earnings Repatriated",
        "terseLabel": "Foreign earnings repatriated"
       }
      }
     },
     "localname": "ForeignEarningsRepatriated",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Office Equipment and furniture"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/PropertyPlantandEquipmentDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r66",
      "r110",
      "r111"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Gain on extinguishment of debt",
        "terseLabel": "Gain on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeographicConcentrationRiskMember": {
     "auth_ref": [
      "r83",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).",
        "label": "Geographic Concentration Risk [Member]",
        "terseLabel": "Geographic Concentration Risk"
       }
      }
     },
     "localname": "GeographicConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r46",
      "r275",
      "r331",
      "r340",
      "r346",
      "r348",
      "r358",
      "r374",
      "r375",
      "r377",
      "r378",
      "r379",
      "r381",
      "r383",
      "r385",
      "r386",
      "r571",
      "r686",
      "r766"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "terseLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsSummarizedFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]",
        "terseLabel": "IPO [Member]"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails_1",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r99",
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r47",
      "r67",
      "r160",
      "r286",
      "r287",
      "r289",
      "r290",
      "r306",
      "r310"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "terseLabel": "Allocation of net loss",
        "verboseLabel": "Allocation of net income (loss)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r276",
      "r537"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesComponentsofLossIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "Domestic"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesComponentsofLossIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r40",
      "r196",
      "r207",
      "r226",
      "r331",
      "r340",
      "r346",
      "r348",
      "r639",
      "r686"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r276",
      "r537"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesComponentsofLossIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesComponentsofLossIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r331",
      "r340",
      "r346",
      "r348",
      "r686"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "terseLabel": "Loss before income taxes",
        "totalLabel": "Loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r41",
      "r66",
      "r93",
      "r206",
      "r224",
      "r329"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedLabel": "Net loss",
        "negatedTerseLabel": "Gain from equity method investees, net",
        "terseLabel": "Gain from equity method investees, net"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/InvestmentsSummarizedFinancialInformationDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Consolidated Statement of Operations and Comprehensive Loss"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredtaxassetsDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredtaxassetsDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesComponentsofLossIncomeDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesIncomeTaxProvisionDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesComponentsofLossIncomeDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesIncomeTaxProvisionDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r277",
      "r518",
      "r521",
      "r527",
      "r533",
      "r539",
      "r541",
      "r542",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes",
        "verboseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxes",
      "http://amciacquisitioncorp/role/IncomeTaxes_1",
      "http://amciacquisitioncorp/role/IncomeTaxes_2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r278",
      "r294",
      "r295",
      "r330",
      "r516",
      "r534",
      "r540",
      "r645"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredtaxassetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedTotalLabel": "Income Tax Expense (Benefit)",
        "totalLabel": "Total income tax benefit",
        "verboseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://amciacquisitioncorp/role/IncomeTaxesDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesIncometaxprovisionDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesNarrativeDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationofthestatutoryfederalincometaxratebenefitDetails",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]",
        "terseLabel": "Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r260",
      "r514",
      "r515",
      "r521",
      "r522",
      "r526",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies_1",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r777"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredtaxassetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Valuation allowance",
        "verboseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesIncometaxprovisionDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationofthestatutoryfederalincometaxratebenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r777"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Foreign tax rate differential"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r517"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Income tax (benefit) at the statutory federal income tax rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses": {
     "auth_ref": [
      "r777"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible impairment loss.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount",
        "terseLabel": "Effects of impairment"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r777"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r777"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r777"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State and local taxes"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r70"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash paid for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued salaries and wages"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income tax payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerAsset": {
     "auth_ref": [
      "r731"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Increase (Decrease) in Contract with Customer, Asset",
        "negatedTerseLabel": "Contract assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r621",
      "r731"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Contract liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r731",
      "r792"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedTerseLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Increase (Decrease) in Prepaid Expense",
        "negatedLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT",
      "http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockChangesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntellectualPropertyMember": {
     "auth_ref": [
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights.",
        "label": "Intellectual Property [Member]",
        "terseLabel": "Intellectual Property"
       }
      }
     },
     "localname": "IntellectualPropertyMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of nonoperating interest income (expense).",
        "label": "Interest Income (Expense), Nonoperating, Net",
        "terseLabel": "Interest income (expense), net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r268",
      "r271",
      "r272"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InternalRevenueServiceIRSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.",
        "label": "Internal Revenue Service (IRS) [Member]",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "InternalRevenueServiceIRSMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesComponentsofLossIncomeDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesIncomeTaxProvisionDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r328",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r345",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intra-entity"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails",
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails_1",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentTableTextBlock": {
     "auth_ref": [
      "r753",
      "r755",
      "r757",
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment.",
        "label": "Investment [Table Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTextBlock": {
     "auth_ref": [
      "r753",
      "r755",
      "r757",
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investment.",
        "label": "Investment [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r221"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/InvestmentsScheduleofInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "terseLabel": "Investments",
        "totalLabel": "Total Investment"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsScheduleofInvestmentsDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r559"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Investments held in trust account",
        "verboseLabel": "Investments held in Trust Account"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r773"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/PropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r594",
      "r709"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "terseLabel": "Lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/PropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Lessee, Operating Lease, Liability, Maturity"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesTables_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r595"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/LeasesLeaseMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://amciacquisitioncorp/role/LeasesLeaseMaturitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r595"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/LeasesLeaseMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r595"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/LeasesLeaseMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r595"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/LeasesLeaseMaturitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r595"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/LeasesLeaseMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r595"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/LeasesLeaseMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r595"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/LeasesLeaseMaturitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r595"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: Imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Lease renewal term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/Leases_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LessorLeasesPolicyTextBlock": {
     "auth_ref": [
      "r598",
      "r600",
      "r601",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangements entered into by lessor.",
        "label": "Lessor, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LessorLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceived": {
     "auth_ref": [
      "r599"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/LeasesLessorOperatingLeasePaymentstobeReceivedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payments to be received by lessor for operating lease.",
        "label": "Lessor, Operating Lease, Payments to be Received",
        "terseLabel": "Lease income receivable",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceived",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesLessorOperatingLeasePaymentstobeReceivedDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears": {
     "auth_ref": [
      "r599"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/LeasesLessorOperatingLeasePaymentstobeReceivedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payment to be received by lessor for operating lease in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessor, Operating Lease, Payment to be Received, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedFiveYears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesLessorOperatingLeasePaymentstobeReceivedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears": {
     "auth_ref": [
      "r599"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/LeasesLessorOperatingLeasePaymentstobeReceivedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payment to be received by lessor for operating lease in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessor, Operating Lease, Payment to be Received, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedFourYears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesLessorOperatingLeasePaymentstobeReceivedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock": {
     "auth_ref": [
      "r794"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity of undiscounted cash flows to be received by lessor on annual basis for operating lease.",
        "label": "Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesTables_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths": {
     "auth_ref": [
      "r599"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/LeasesLessorOperatingLeasePaymentstobeReceivedDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payment to be received by lessor for operating lease in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessor, Operating Lease, Payment to be Received, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesLessorOperatingLeasePaymentstobeReceivedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter": {
     "auth_ref": [
      "r599"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/LeasesLessorOperatingLeasePaymentstobeReceivedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payment to be received by lessor for operating lease after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessor, Operating Lease, Payment to be Received, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedThereafter",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesLessorOperatingLeasePaymentstobeReceivedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears": {
     "auth_ref": [
      "r599"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/LeasesLessorOperatingLeasePaymentstobeReceivedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payment to be received by lessor for operating lease in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessor, Operating Lease, Payment to be Received, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedThreeYears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesLessorOperatingLeasePaymentstobeReceivedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears": {
     "auth_ref": [
      "r599"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/LeasesLessorOperatingLeasePaymentstobeReceivedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payment to be received by lessor for operating lease in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessor, Operating Lease, Payment to be Received, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesLessorOperatingLeasePaymentstobeReceivedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r795"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessor's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessor, Operating Lease, Renewal Term",
        "terseLabel": "Renewal term"
       }
      }
     },
     "localname": "LessorOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesDetails",
      "http://amciacquisitioncorp/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LessorOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r795"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessor, Operating Lease, Term of Contract",
        "terseLabel": "Term of contract"
       }
      }
     },
     "localname": "LessorOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesDetails",
      "http://amciacquisitioncorp/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r23",
      "r275",
      "r358",
      "r374",
      "r375",
      "r377",
      "r378",
      "r379",
      "r381",
      "r383",
      "r385",
      "r386",
      "r548",
      "r551",
      "r552",
      "r571",
      "r685",
      "r766",
      "r802",
      "r803"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "terseLabel": "Total liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r19",
      "r203",
      "r218",
      "r710",
      "r737",
      "r756",
      "r790"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "terseLabel": "Total liabilities, contingently redeemable preferred stock, and shareholders' deficit",
        "totalLabel": "Total liabilities, contingently redeemable preferred stock, and shareholders' deficit"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders' Deficit:",
        "verboseLabel": "Liabilities, Contingently Redeemable Preferred Stock, and Shareholders\u2019 Deficit"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r25",
      "r238",
      "r275",
      "r358",
      "r374",
      "r375",
      "r377",
      "r378",
      "r379",
      "r381",
      "r383",
      "r385",
      "r386",
      "r548",
      "r551",
      "r552",
      "r571",
      "r710",
      "r766",
      "r802",
      "r803"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "terseLabel": "Total current liabilities",
        "totalLabel": "Total current liabilities",
        "verboseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/InvestmentsSummarizedFinancialInformationDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r175"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Liabilities, Fair Value Disclosure",
        "terseLabel": "Total Liabilities",
        "totalLabel": "Total Liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsCompanysfinancialassetsandliabilitiesthataremeasuredatfairvalueDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r2",
      "r3",
      "r4",
      "r8",
      "r9",
      "r275",
      "r358",
      "r374",
      "r375",
      "r377",
      "r378",
      "r379",
      "r381",
      "r383",
      "r385",
      "r386",
      "r548",
      "r551",
      "r552",
      "r571",
      "r766",
      "r802",
      "r803"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "terseLabel": "Non-current liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsSummarizedFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LicenseAndServiceMember": {
     "auth_ref": [
      "r773"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to use intangible asset and performance of related service. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark.",
        "label": "License and Service [Member]",
        "terseLabel": "Licensing"
       }
      }
     },
     "localname": "LicenseAndServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails",
      "http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r21"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Notes receivable, aggregate principal amount"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r8",
      "r202",
      "r216",
      "r400",
      "r414",
      "r688",
      "r689"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/DebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "totalLabel": "Total debt, net",
        "verboseLabel": "Outstanding debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DebtDetails",
      "http://amciacquisitioncorp/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/DebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-Term Debt, Current Maturities",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r244"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/DebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyEstimateOfPossibleLoss": {
     "auth_ref": [
      "r369",
      "r370",
      "r373"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.",
        "label": "Loss Contingency, Estimate of Possible Loss",
        "terseLabel": "Estimate of possible loss"
       }
      }
     },
     "localname": "LossContingencyEstimateOfPossibleLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails_2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Instruments and equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/PropertyPlantandEquipmentDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MaterialsSuppliesAndOther": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/OtherCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of capitalized costs of materials, supplies, and other assets, which are not included in inventory but used in production.",
        "label": "Materials, Supplies, and Other",
        "terseLabel": "Materials and supplies"
       }
      }
     },
     "localname": "MaterialsSuppliesAndOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/OtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExercisePriceMember": {
     "auth_ref": [
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using agreed upon price for exchange of underlying asset.",
        "label": "Measurement Input, Exercise Price [Member]",
        "terseLabel": "Weighted average exercise price"
       }
      }
     },
     "localname": "MeasurementInputExercisePriceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "auth_ref": [
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.",
        "label": "Measurement Input, Expected Dividend Rate [Member]",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "MeasurementInputExpectedDividendRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "auth_ref": [
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.",
        "label": "Measurement Input, Expected Term [Member]",
        "terseLabel": "Term"
       }
      }
     },
     "localname": "MeasurementInputExpectedTermMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "auth_ref": [
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.",
        "label": "Measurement Input, Price Volatility [Member]",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "MeasurementInputPriceVolatilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "auth_ref": [
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.",
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputSharePriceMember": {
     "auth_ref": [
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using share price of saleable stock.",
        "label": "Measurement Input, Share Price [Member]",
        "terseLabel": "Stock price"
       }
      }
     },
     "localname": "MeasurementInputSharePriceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r320",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "Description of Organization and Business Operations",
        "verboseLabel": "Description of the Business"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperations",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperations_1",
      "http://amciacquisitioncorp/role/DescriptionoftheBusiness",
      "http://amciacquisitioncorp/role/DescriptionoftheBusiness_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r270"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash Flows From Financing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r270"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash Flows From Investing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r62",
      "r64",
      "r67"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "terseLabel": "Net cash used in operating activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesGoingConcernDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesGoingConcernandSegmentInformationDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r43",
      "r67",
      "r208",
      "r225",
      "r236",
      "r256",
      "r258",
      "r263",
      "r275",
      "r284",
      "r286",
      "r287",
      "r289",
      "r290",
      "r294",
      "r295",
      "r306",
      "r331",
      "r340",
      "r346",
      "r348",
      "r358",
      "r374",
      "r375",
      "r377",
      "r378",
      "r379",
      "r381",
      "r383",
      "r385",
      "r386",
      "r558",
      "r571",
      "r686",
      "r766"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/IncomeTaxesComponentsofLossIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "netLabel": "Net loss for basic and diluted earnings per common share",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://amciacquisitioncorp/role/IncomeTaxesComponentsofLossIncomeDetails",
      "http://amciacquisitioncorp/role/InvestmentsSummarizedFinancialInformationDetails",
      "http://amciacquisitioncorp/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails",
      "http://amciacquisitioncorp/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails_1",
      "http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT",
      "http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesGoingConcernDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesGoingConcernandSegmentInformationDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r286",
      "r287",
      "r289",
      "r290",
      "r297",
      "r298",
      "r307",
      "r310",
      "r331",
      "r340",
      "r346",
      "r348",
      "r686"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Net loss allocated to common shareholders",
        "totalLabel": "Net loss allocated to common shareholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://amciacquisitioncorp/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails",
      "http://amciacquisitioncorp/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails_1",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails",
      "http://amciacquisitioncorp/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r299",
      "r302",
      "r303",
      "r304",
      "r305",
      "r307",
      "r310"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "terseLabel": "Net loss allocated to common shareholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies_1",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "Non-US"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1": {
     "auth_ref": [
      "r71",
      "r72",
      "r73"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of investments that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash or Part Noncash Acquisition, Investments Acquired",
        "terseLabel": "Acquisition of equity method investment in LanzaJet through contribution of license"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionInvestmentsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other (expense) income, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other (expense) income:"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares.",
        "label": "Nonvested Restricted Stock Shares Activity [Table Text Block]",
        "terseLabel": "Restricted Stock Awards Activity"
       }
      }
     },
     "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesGoingConcernandSegmentInformationDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "negatedTerseLabel": "Total cost and operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r331",
      "r340",
      "r346",
      "r348",
      "r686"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Loss from operations",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r590",
      "r709"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease, cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLeaseIncome": {
     "auth_ref": [
      "r316",
      "r597",
      "r603"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.",
        "label": "Operating Lease, Lease Income",
        "terseLabel": "Lease income from operating leases"
       }
      }
     },
     "localname": "OperatingLeaseLeaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesDetails",
      "http://amciacquisitioncorp/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLeaseIncomeTableTextBlock": {
     "auth_ref": [
      "r316",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of income from operating lease.",
        "label": "Operating Lease, Lease Income [Table Text Block]",
        "terseLabel": "Operating Lease, Lease Income"
       }
      }
     },
     "localname": "OperatingLeaseLeaseIncomeTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r589"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r589"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r589"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Non-current lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r588"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right of use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r732"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "terseLabel": "Non-cash lease expense"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r593",
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesNarrativeDetails",
      "http://amciacquisitioncorp/role/LeasesSupplementalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r592",
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term (years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesSupplementalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasesOfLessorDisclosureTextBlock": {
     "auth_ref": [
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for lessor's operating leases.",
        "label": "Lessor, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "OperatingLeasesOfLessorDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/Leases",
      "http://amciacquisitioncorp/role/Leases_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredtaxassetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredtaxassetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities",
        "verboseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r251",
      "r710"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/OtherCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets",
        "totalLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/OtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMiscellaneousCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/OtherCurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer.",
        "label": "Other Assets, Miscellaneous, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAssetsMiscellaneousCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/OtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r242"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r161",
      "r162",
      "r163"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r32"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax": {
     "auth_ref": [
      "r34",
      "r37",
      "r38",
      "r255",
      "r577"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax",
        "negatedTerseLabel": "Transfer from foreign currency translation to equity security investment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive loss:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCurrentAssetsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other current assets.",
        "label": "Other Current Assets [Text Block]",
        "terseLabel": "Other Current Assets"
       }
      }
     },
     "localname": "OtherCurrentAssetsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/OtherCurrentAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other (expense) income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OverAllotmentOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.",
        "label": "Over-Allotment Option [Member]",
        "terseLabel": "Over-allotment option"
       }
      }
     },
     "localname": "OverAllotmentOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails",
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails_1",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICITParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfEquity": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common and preferred stock.",
        "label": "Payments for Repurchase of Equity",
        "negatedTerseLabel": "Repurchase of equity instruments of the Company"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "negatedTerseLabel": "Payments of Stock Issuance Costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r54"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "negatedTerseLabel": "Equity method investments cost",
        "terseLabel": "Equity method investments cost"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails",
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchase of property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireTrustPreferredInvestments": {
     "auth_ref": [
      "r727"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the purchase of trust preferred securities, which possess characteristics of both equity and debt securities.",
        "label": "Payments to Acquire Trust Preferred Investments",
        "negatedLabel": "Cash deposited in trust account",
        "negatedTerseLabel": "Cash deposited in Trust Account"
       }
      }
     },
     "localname": "PaymentsToAcquireTrustPreferredInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PostemploymentBenefitsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Postemployment Benefits [Abstract]"
       }
      }
     },
     "localname": "PostemploymentBenefitsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PreferredStockConvertibleConversionRatio": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common shares issuable upon conversion for each share of preferred stock to be converted.",
        "label": "Preferred Stock, Convertible, Conversion Ratio",
        "terseLabel": "Conversion ratio"
       }
      }
     },
     "localname": "PreferredStockConvertibleConversionRatio",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LanzaTech10QNetLossPerShareAntidilutiveSharesDetails",
      "http://amciacquisitioncorp/role/NetLossPerShareAntidilutiveSharesDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_PreferredStockDividendRatePercentage": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage rate used to calculate dividend payments on preferred stock.",
        "label": "Preferred Stock, Dividend Rate, Percentage",
        "terseLabel": "Dividend rate"
       }
      }
     },
     "localname": "PreferredStockDividendRatePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PreferredStockDividendsIncomeStatementImpact": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.",
        "label": "Preferred Stock Dividends, Income Statement Impact",
        "negatedTerseLabel": "Unpaid cumulative dividends on preferred stock"
       }
      }
     },
     "localname": "PreferredStockDividendsIncomeStatementImpact",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://amciacquisitioncorp/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails",
      "http://amciacquisitioncorp/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r13",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value, (per share)",
        "verboseLabel": "Preferred stock, par value (per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEETParenthetical",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETSParenthetical",
      "http://amciacquisitioncorp/role/StockholdersDeficitPreferredStockSharesDetails",
      "http://amciacquisitioncorp/role/StockholdersEquityDeficitPreferredStockSharesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized",
        "verboseLabel": "Preferred shares, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEETParenthetical",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETSParenthetical",
      "http://amciacquisitioncorp/role/StockholdersDeficitPreferredStockSharesDetails",
      "http://amciacquisitioncorp/role/StockholdersEquityDeficitPreferredStockSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r13",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued",
        "verboseLabel": "Preferred shares, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEETParenthetical",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETSParenthetical",
      "http://amciacquisitioncorp/role/StockholdersDeficitPreferredStockSharesDetails",
      "http://amciacquisitioncorp/role/StockholdersEquityDeficitPreferredStockSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding",
        "verboseLabel": "Preferred shares, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEETParenthetical",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETSParenthetical",
      "http://amciacquisitioncorp/role/StockholdersDeficitPreferredStockSharesDetails",
      "http://amciacquisitioncorp/role/StockholdersEquityDeficitPreferredStockSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r13",
      "r710"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.0001 par value 1,000,000 shares authorized no shares issued or outstanding as of June 30, 2022 and December 31, 2021",
        "verboseLabel": "Preferred stock, $0.0001 par value 1,000,000 shares authorized no shares issued or outstanding as of June 30, 2022 and December 31, 2021"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r250",
      "r365",
      "r366",
      "r680"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/OtherCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid assets"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/OtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrimeRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.",
        "label": "Prime Rate [Member]",
        "terseLabel": "Prime Rate"
       }
      }
     },
     "localname": "PrimeRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrivatePlacementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.",
        "label": "Private Placement [Member]",
        "terseLabel": "Private Placement"
       }
      }
     },
     "localname": "PrivatePlacementMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromFeesReceived": {
     "auth_ref": [
      "r63"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received for fees during the current period. This element excludes cash proceeds from license fees.",
        "label": "Proceeds from Fees Received",
        "terseLabel": "Aggregate fees received"
       }
      }
     },
     "localname": "ProceedsFromFeesReceived",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Proceeds from Issuance Initial Public Offering",
        "terseLabel": "Proceeds received from initial public offering, gross"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1",
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r729"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Proceeds from Issuance of Debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r57"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "terseLabel": "Issuance of debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock": {
     "auth_ref": [
      "r56"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.",
        "label": "Proceeds from Issuance of Redeemable Convertible Preferred Stock",
        "terseLabel": "Gross proceeds from Initial Public Offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails",
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).",
        "label": "Proceeds from Issuance of Warrants",
        "netLabel": "Proceeds from issue of SAFE and warrant instruments",
        "terseLabel": "Proceeds received from private placement",
        "verboseLabel": "Aggregate purchase price"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.",
        "label": "Proceeds from Related Party Debt",
        "terseLabel": "Proceeds from note payable to related party"
       }
      }
     },
     "localname": "ProceedsFromRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfOtherRealEstate": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale of other real estate not otherwise defined in the taxonomy.",
        "label": "Proceeds from Sale of Other Real Estate",
        "terseLabel": "Proceeds from disposal of investment property"
       }
      }
     },
     "localname": "ProceedsFromSaleOfOtherRealEstate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from disposal of property, plant and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "auth_ref": [
      "r728"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.",
        "label": "Proceeds from Warrant Exercises",
        "terseLabel": "Proceeds from exercise of a warrant"
       }
      }
     },
     "localname": "ProceedsFromWarrantExercises",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductionTaxExpense": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A tax assessed on oil and gas production.",
        "label": "Production Tax Expense",
        "terseLabel": "Franchise tax expense"
       }
      }
     },
     "localname": "ProductionTaxExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r236",
      "r256",
      "r258",
      "r269",
      "r275",
      "r284",
      "r294",
      "r295",
      "r331",
      "r340",
      "r346",
      "r348",
      "r358",
      "r374",
      "r375",
      "r377",
      "r378",
      "r379",
      "r381",
      "r383",
      "r385",
      "r386",
      "r546",
      "r549",
      "r550",
      "r558",
      "r571",
      "r639",
      "r686",
      "r707",
      "r708",
      "r724",
      "r766"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "verboseLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails_1",
      "http://amciacquisitioncorp/role/PropertyPlantandEquipmentDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r105",
      "r663",
      "r664",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/PropertyPlantandEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r101",
      "r240"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/PropertyPlantandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/PropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/PropertyPlantandEquipmentDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r103",
      "r219",
      "r640",
      "r710"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/PropertyPlantandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Total property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/PropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentOtherTypesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.",
        "label": "Property, Plant and Equipment, Other Types [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentOtherTypesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/PropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r103",
      "r663",
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/PropertyPlantandEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails_1",
      "http://amciacquisitioncorp/role/PropertyPlantandEquipmentDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r267",
      "r364"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Bad debt expense and recoveries"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivableTypeDomain": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates.",
        "label": "Receivable [Domain]",
        "terseLabel": "Receivable [Domain]"
       }
      }
     },
     "localname": "ReceivableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_2"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RedeemableConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of type or class of redeemable convertible preferred stock. Convertible redeemable preferred stock possess conversion and redemption features. The stock has redemption features that are outside the control of the issuer.",
        "label": "Redeemable Convertible Preferred Stock [Member]",
        "terseLabel": "Redeemable convertible preferred stock (if converted)"
       }
      }
     },
     "localname": "RedeemableConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LanzaTech10QNetLossPerShareAntidilutiveSharesDetails",
      "http://amciacquisitioncorp/role/NetLossPerShareAntidilutiveSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r466",
      "r609",
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/InvestmentsTransactionsDetails",
      "http://amciacquisitioncorp/role/LeasesDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICITParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAmountsOfTransaction": {
     "auth_ref": [
      "r195",
      "r609"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transactions with related party during the financial reporting period.",
        "label": "Related Party Transaction, Amounts of Transaction",
        "terseLabel": "Amount incurred"
       }
      }
     },
     "localname": "RelatedPartyTransactionAmountsOfTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r233",
      "r609",
      "r610",
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/InvestmentsTransactionsDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/InvestmentsTransactionsDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r192"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "terseLabel": "Related party fees"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails_1",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Purchases from Related Party",
        "verboseLabel": "Purchases"
       }
      }
     },
     "localname": "RelatedPartyTransactionPurchasesFromRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of selling, general and administrative expenses resulting from transactions, excluding transactions that are eliminated in consolidated or combined financial statements, with related party.",
        "label": "Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party",
        "terseLabel": "General and administrative expenses - related party"
       }
      }
     },
     "localname": "RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r466",
      "r609",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/InvestmentsTransactionsDetails",
      "http://amciacquisitioncorp/role/LeasesDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICITParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r607",
      "r608",
      "r610",
      "r611",
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Party Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RelatedPartyTransactions",
      "http://amciacquisitioncorp/role/RelatedPartyTransactions_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactions_2",
      "http://amciacquisitioncorp/role/RelatedPartyTransactions_3"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r730"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "negatedTerseLabel": "Repayment of borrowings"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r59"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "terseLabel": "Repayment of debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r144",
      "r232",
      "r810"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "negatedTerseLabel": "Research and development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchMember": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.",
        "label": "Research Tax Credit Carryforward [Member]",
        "terseLabel": "R&amp;D tax credits"
       }
      }
     },
     "localname": "ResearchMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r718",
      "r733",
      "r811",
      "r812"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted cash (presented within Other current assets)"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashReconciliationDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashReconciliationDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "RSAs"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LanzaTech10QNetLossPerShareAntidilutiveSharesDetails",
      "http://amciacquisitioncorp/role/NetLossPerShareAntidilutiveSharesDetails",
      "http://amciacquisitioncorp/role/ShareBasedCompensationNarrativeDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationNarrativeDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationRestrictedStockAwardsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r16",
      "r129",
      "r217",
      "r651",
      "r656",
      "r710"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit",
        "verboseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesGoingConcernDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesGoingConcernandSegmentInformationDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r234",
      "r281",
      "r282",
      "r283",
      "r285",
      "r292",
      "r295",
      "r360",
      "r508",
      "r509",
      "r510",
      "r531",
      "r532",
      "r556",
      "r647",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer": {
     "auth_ref": [
      "r545",
      "r784"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue from collaborative arrangement. Excludes revenue from contract with customer under Topic 606.",
        "label": "Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer",
        "terseLabel": "Revenue from collaborative arrangements"
       }
      }
     },
     "localname": "RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://amciacquisitioncorp/role/RevenuesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r327",
      "r328",
      "r339",
      "r344",
      "r345",
      "r349",
      "r350",
      "r352",
      "r454",
      "r455",
      "r624"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "negatedTerseLabel": "Revenue from contracts with customers",
        "terseLabel": "Revenue from contracts with customers",
        "verboseLabel": "Revenue from contracts with customers"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails",
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails_1",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r327",
      "r328",
      "r339",
      "r344",
      "r345",
      "r349",
      "r350",
      "r352",
      "r454",
      "r455",
      "r624"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "terseLabel": "Revenue from contracts with customers"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r458",
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r444",
      "r445",
      "r457",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/Revenues",
      "http://amciacquisitioncorp/role/Revenues_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromRelatedParties": {
     "auth_ref": [
      "r45",
      "r229",
      "r376",
      "r377",
      "r378",
      "r384",
      "r385",
      "r386"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.",
        "label": "Revenue from Related Parties",
        "netLabel": "Sales",
        "terseLabel": "Revenue from related party transactions",
        "verboseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://amciacquisitioncorp/role/InvestmentsTransactionsDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails",
      "http://amciacquisitioncorp/role/RevenuesAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r682",
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r443"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/RevenuesRemainingPerformanceObligationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesRemainingPerformanceObligationsDetails",
      "http://amciacquisitioncorp/role/RevenuesRemainingPerformanceObligationsDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock": {
     "auth_ref": [
      "r771"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]",
        "terseLabel": "Remaining performance obligations"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RevenuesTables",
      "http://amciacquisitioncorp/role/RevenuesTables_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r264",
      "r275",
      "r327",
      "r328",
      "r339",
      "r344",
      "r345",
      "r349",
      "r350",
      "r352",
      "r358",
      "r374",
      "r375",
      "r377",
      "r378",
      "r379",
      "r381",
      "r383",
      "r385",
      "r386",
      "r571",
      "r639",
      "r766"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenues",
        "totalLabel": "Revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://amciacquisitioncorp/role/InvestmentsSummarizedFinancialInformationDetails",
      "http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails",
      "http://amciacquisitioncorp/role/RevenuesDisaggregatedRevenueDetails_1",
      "http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails",
      "http://amciacquisitioncorp/role/RevenuesDisaggregationbyCustomerLocationDetails_1",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenue:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Purchase price"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionoftheBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails_1",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails_1",
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails",
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails_1",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICITParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Sale of stock price (usd per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionoftheBusinessDetails",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_2"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r352",
      "r750"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue Benchmark"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesConcentrationofCreditRiskandOtherRisksandUncertaintiesDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LanzaTech10QNetLossPerShareAntidilutiveSharesDetails",
      "http://amciacquisitioncorp/role/NetLossPerShareAntidilutiveSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/NetLossPerShareTables",
      "http://amciacquisitioncorp/role/NetLossPerShareTables_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash and cash equivalents.",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Schedule of cash and cash equivalents"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesTables",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesTables_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Income tax provision"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesTables",
      "http://amciacquisitioncorp/role/IncomeTaxesTables_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Significant components of deferred tax assets and liabilities",
        "verboseLabel": "Summary of significant components of the Company's deferred tax assets"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesTables",
      "http://amciacquisitioncorp/role/IncomeTaxesTables_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Calculation of Basic and Diluted Net Loss per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables_1",
      "http://amciacquisitioncorp/role/NetLossPerShareTables",
      "http://amciacquisitioncorp/role/NetLossPerShareTables_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation of income taxes computed at statutory federal income tax rate",
        "verboseLabel": "Schedule of reconciliation of the total income tax provision tax rate to the statutory federal income tax rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesTables",
      "http://amciacquisitioncorp/role/IncomeTaxesTables_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsEquityMethodInvestmentsDetails",
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails_1",
      "http://amciacquisitioncorp/role/InvestmentsSummarizedFinancialInformationDetails",
      "http://amciacquisitioncorp/role/InvestmentsTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r97",
      "r236",
      "r275",
      "r358",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InvestmentsEquityMethodInvestmentsDetails",
      "http://amciacquisitioncorp/role/InvestmentsNarrativeDetails_1",
      "http://amciacquisitioncorp/role/InvestmentsSummarizedFinancialInformationDetails",
      "http://amciacquisitioncorp/role/InvestmentsTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable": {
     "auth_ref": [
      "r286",
      "r287",
      "r288",
      "r291",
      "r292",
      "r294",
      "r295",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of prior period adjustments to correct an error in previously issued financial statements. The disclosure may include, but is not limited to: (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustment (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made. This table can be used to disclose the amounts as previously reported and the effect of the correction or other adjustment on per line item or per share amount basis. This table uses as its line items financial statement line items that are affected by prior period adjustments.",
        "label": "Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]",
        "terseLabel": "Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]"
       }
      }
     },
     "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock": {
     "auth_ref": [
      "r76",
      "r77",
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.",
        "label": "Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]",
        "terseLabel": "Schedule of error corrections"
       }
      }
     },
     "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesTables_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r559",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Summary of assets and liabilities that are measured at fair value on a recurring basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueMeasurementsTables",
      "http://amciacquisitioncorp/role/FairValueMeasurementsTables_1",
      "http://amciacquisitioncorp/role/FairValueTables",
      "http://amciacquisitioncorp/role/FairValueTables_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Components of (loss) income before income taxes and gain from equity method investees, net"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesTables_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other current assets.",
        "label": "Schedule of Other Current Assets [Table Text Block]",
        "terseLabel": "Schedule of Other Current Assets"
       }
      }
     },
     "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/OtherCurrentAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/PropertyPlantandEquipmentDetails",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r194",
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.",
        "label": "Schedule of Related Party Transactions [Table Text Block]",
        "terseLabel": "Amounts related to transactions with related parties"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r470",
      "r472",
      "r474",
      "r475",
      "r476",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationNarrativeDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationFairValueAssumptionsDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationNarrativeDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationRestrictedStockAwardsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r134",
      "r135",
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Stock Options Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationTables",
      "http://amciacquisitioncorp/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule Stock Options Valuation Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis": {
     "auth_ref": [
      "r114",
      "r115",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents settlement terms for the group of mandatorily redeemable securities, including the description and the details of all terms for each outstanding financial instrument and each settlement option.",
        "label": "Schedule of Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Axis]",
        "terseLabel": "Schedule of Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Axis]"
       }
      }
     },
     "localname": "ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r118",
      "r120",
      "r121",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r245",
      "r246",
      "r247",
      "r318",
      "r415",
      "r416",
      "r418",
      "r420",
      "r424",
      "r429",
      "r431",
      "r692",
      "r716",
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/StockholdersDeficitCommonStockSharesDetails",
      "http://amciacquisitioncorp/role/StockholdersEquityDeficitCommonStockSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "auth_ref": [
      "r81",
      "r84",
      "r85",
      "r86",
      "r184",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]",
        "terseLabel": "Customer concentration risk"
       }
      }
     },
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesTables",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesTables_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "negatedTerseLabel": "Selling, general and administrative expense"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "auth_ref": [
      "r720",
      "r721",
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A preferred stock.",
        "label": "Series A Preferred Stock [Member]",
        "terseLabel": "Series A"
       }
      }
     },
     "localname": "SeriesAPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockAuthorizedIssuedandOutstandingSharesIssuePriceandCarryingValueDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockChangesDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "auth_ref": [
      "r720",
      "r721",
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B preferred stock.",
        "label": "Series B Preferred Stock [Member]",
        "terseLabel": "Series B"
       }
      }
     },
     "localname": "SeriesBPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockAuthorizedIssuedandOutstandingSharesIssuePriceandCarryingValueDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockChangesDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesCPreferredStockMember": {
     "auth_ref": [
      "r720",
      "r721",
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series C preferred stock.",
        "label": "Series C Preferred Stock [Member]",
        "terseLabel": "Series C"
       }
      }
     },
     "localname": "SeriesCPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockAuthorizedIssuedandOutstandingSharesIssuePriceandCarryingValueDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockChangesDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesDPreferredStockMember": {
     "auth_ref": [
      "r720",
      "r721",
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series D preferred stock.",
        "label": "Series D Preferred Stock [Member]",
        "terseLabel": "Series D"
       }
      }
     },
     "localname": "SeriesDPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueNarrativeDetails_1",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockAuthorizedIssuedandOutstandingSharesIssuePriceandCarryingValueDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockChangesDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesEPreferredStockMember": {
     "auth_ref": [
      "r720",
      "r721",
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series E preferred stock.",
        "label": "Series E Preferred Stock [Member]",
        "terseLabel": "Series E"
       }
      }
     },
     "localname": "SeriesEPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockAuthorizedIssuedandOutstandingSharesIssuePriceandCarryingValueDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockChangesDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesFPreferredStockMember": {
     "auth_ref": [
      "r720",
      "r721",
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series F preferred stock.",
        "label": "Series F Preferred Stock [Member]",
        "terseLabel": "Series F"
       }
      }
     },
     "localname": "SeriesFPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockAuthorizedIssuedandOutstandingSharesIssuePriceandCarryingValueDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockChangesDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": {
     "auth_ref": [
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period",
        "terseLabel": "Award requisite service period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationNarrativeDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/StockBasedCompensationRestrictedStockAwardsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited, weighted average fair value (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/StockBasedCompensationRestrictedStockAwardsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/StockBasedCompensationRestrictedStockAwardsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted, weighted average fair value (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/StockBasedCompensationRestrictedStockAwardsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r486",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Unvested shares outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationNarrativeDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationNarrativeDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationRestrictedStockAwardsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Nonvested Shares (thousands)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/StockBasedCompensationRestrictedStockAwardsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r486",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Ending balance, weighted average fair value (usd per share)",
        "periodStartLabel": "Beginning balance, weighted average fair value (usd per share)",
        "terseLabel": "Unvested shares weighted average fair value (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationNarrativeDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationNarrativeDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationRestrictedStockAwardsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted Average Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/StockBasedCompensationRestrictedStockAwardsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price",
        "terseLabel": "Exercise price (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/StockBasedCompensationFairValueAssumptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/StockBasedCompensationFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/StockBasedCompensationFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/StockBasedCompensationFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationNarrativeDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationFairValueAssumptionsDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationNarrativeDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationRestrictedStockAwardsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationStockOptionAwardActivityDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationStockOptionAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationStockOptionAwardActivityDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationStockOptionAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r493"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Exercised, Aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationStockOptionAwardActivityDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationStockOptionAwardActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period",
        "negatedTerseLabel": "Expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationStockOptionAwardActivityDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationStockOptionAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Cancelled/forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationStockOptionAwardActivityDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationStockOptionAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Shares granted in period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r140"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Outstanding, Aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationStockOptionAwardActivityDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationStockOptionAwardActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r478",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationStockOptionAwardActivityDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationStockOptionAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Shares under option (thousands)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationStockOptionAwardActivityDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationStockOptionAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r478",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Ending balance (usd per share)",
        "periodStartLabel": "Beginning balance (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationStockOptionAwardActivityDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationStockOptionAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted average exercise price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationStockOptionAwardActivityDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationStockOptionAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "auth_ref": [
      "r495"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
        "terseLabel": "Exercisable, Aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationStockOptionAwardActivityDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationStockOptionAwardActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "terseLabel": "Exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationStockOptionAwardActivityDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationStockOptionAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r494"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Vested and expecting to vest, Aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationStockOptionAwardActivityDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationStockOptionAwardActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Vested and expected to vest (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationStockOptionAwardActivityDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationStockOptionAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Vested and expecting to vest (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationStockOptionAwardActivityDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationStockOptionAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r474",
      "r475",
      "r476",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationNarrativeDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationFairValueAssumptionsDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationNarrativeDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationRestrictedStockAwardsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationStockOptionAwardActivityDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationStockOptionAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Expired (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationStockOptionAwardActivityDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationStockOptionAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Cancelled/forfeited (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationStockOptionAwardActivityDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationStockOptionAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r477",
      "r496",
      "r497",
      "r498",
      "r499",
      "r502",
      "r511",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Stock price (usd per share)",
        "verboseLabel": "Share price"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails_1",
      "http://amciacquisitioncorp/role/StockBasedCompensationFairValueAssumptionsDetails",
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/StockBasedCompensationFairValueAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable, Weighted average remaining contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationStockOptionAwardActivityDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationStockOptionAwardActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding, Weighted average remaining contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationStockOptionAwardActivityDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationStockOptionAwardActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Vested and expecting, Weighted average remaining contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareBasedCompensationStockOptionAwardActivityDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationStockOptionAwardActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of options vested.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant date fair value of options granted (usd per share)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balance at the end (in shares)",
        "periodStartLabel": "Balance at the beginning (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Purchase price, per unit",
        "verboseLabel": "Price per share"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_1"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognition of changes in redemption value of mandatorily redeemable shares. Provides the period over which changes in redemption value are accreted, usually from the issuance date (or from the date that it becomes probable that the security will become redeemable, if later) to the earliest redemption date of the security.",
        "label": "Shares Subject to Mandatory Redemption, Changes in Redemption Value, Policy [Policy Text Block]",
        "terseLabel": "Class A Common Stock Shares Subject to Possible Redemption",
        "verboseLabel": "Class A Common Stock Subject to Possible Redemption"
       }
      }
     },
     "localname": "SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain": {
     "auth_ref": [
      "r115",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifying description of each financial instrument that embodies an unconditional obligation requiring the issuer to redeem the securities by transferring the assets at a specified or determinable date (or dates) or upon an event that is certain to occur. Examples are preferred stock or trust preferred securities, each of which has redemption rights beyond the control of the issuer on a specified date or upon an event that is certain to occur.",
        "label": "Financial Instruments Subject to Mandatory Redemption, Financial Instrument [Domain]",
        "terseLabel": "Financial Instruments Subject to Mandatory Redemption, Financial Instrument [Domain]"
       }
      }
     },
     "localname": "SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of shares that would be issued, determined under the conditions specified in the contract if the settlement were to occur at the reporting date.",
        "label": "Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Fair Value of Shares",
        "verboseLabel": "Derivative warrant liabilities"
       }
      }
     },
     "localname": "SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r5",
      "r199",
      "r215",
      "r710"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-Term Debt",
        "terseLabel": "Outstanding balance"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and local"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r245",
      "r246",
      "r247",
      "r275",
      "r300",
      "r301",
      "r308",
      "r310",
      "r318",
      "r319",
      "r358",
      "r374",
      "r377",
      "r378",
      "r379",
      "r385",
      "r386",
      "r415",
      "r416",
      "r420",
      "r424",
      "r431",
      "r571",
      "r678",
      "r716",
      "r735",
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/BALANCESHEETParenthetical",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails_1",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETSParenthetical",
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails",
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails_1",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/FairValueNarrativeDetails_1",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockAuthorizedIssuedandOutstandingSharesIssuePriceandCarryingValueDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockChangesDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockNarrativeDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails_1",
      "http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT",
      "http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS",
      "http://amciacquisitioncorp/role/StockholdersDeficitCommonStockSharesDetails",
      "http://amciacquisitioncorp/role/StockholdersEquityDeficitCommonStockSharesDetails",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICITParenthetical",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS",
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r30",
      "r122",
      "r234",
      "r261",
      "r262",
      "r263",
      "r281",
      "r282",
      "r283",
      "r285",
      "r292",
      "r295",
      "r317",
      "r360",
      "r433",
      "r508",
      "r509",
      "r510",
      "r531",
      "r532",
      "r556",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r606",
      "r647",
      "r648",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/BALANCESHEETParenthetical",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails_1",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails_1",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETSParenthetical",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT",
      "http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICITParenthetical",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Consolidated Statement of Cash Flows"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Consolidated Statement of Changes in Redeemable Convertible Preferred Stock and Shareholders\u2019 Equity (Deficit)"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r281",
      "r282",
      "r283",
      "r317",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/BALANCESHEETParenthetical",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails_1",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails_1",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETSParenthetical",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://amciacquisitioncorp/role/STATEMENTOFCASHFLOWS",
      "http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT",
      "http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCASHFLOWS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICITParenthetical",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r13",
      "r14",
      "r122",
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of Class B common stock to Sponsor (in shares)",
        "verboseLabel": "Number of shares issued"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails_1",
      "http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares (or other type of equity) forfeited during the period.",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited",
        "negatedLabel": "Forfeited shares (in shares)",
        "terseLabel": "Forfeited shares (in shares)",
        "verboseLabel": "Common stock forfeited"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1",
      "http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICITParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r13",
      "r14",
      "r122",
      "r129",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)",
        "terseLabel": "Issuance of common stock upon exercise of options (in shares)",
        "verboseLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT",
      "http://amciacquisitioncorp/role/ShareBasedCompensationStockOptionAwardActivityDetails",
      "http://amciacquisitioncorp/role/StockBasedCompensationStockOptionAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r13",
      "r14",
      "r122",
      "r129"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of Class B common stock to Sponsor",
        "verboseLabel": "Aggregate purchase price"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails_1",
      "http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited": {
     "auth_ref": [
      "r139"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, Forfeited",
        "negatedLabel": "Forfeited shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensationForfeited",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r30",
      "r122",
      "r129"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Issuance of common stock upon exercise of options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r14",
      "r17",
      "r18",
      "r90",
      "r710",
      "r737",
      "r756",
      "r790"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance at the end",
        "periodStartLabel": "Balance at the beginning",
        "terseLabel": "Total shareholders\u2019 deficit",
        "totalLabel": "Total shareholders\u2019 deficit"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT",
      "http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesRestatementDetails",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders\u2019 Deficit"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r131",
      "r274",
      "r416",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r430",
      "r433",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity (Deficit)",
        "verboseLabel": "Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ShareholdersEquity",
      "http://amciacquisitioncorp/role/StockholdersDeficit",
      "http://amciacquisitioncorp/role/StockholdersEquityDeficit"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SubsequentEventsDetails",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_1",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_2"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r584",
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/DescriptionoftheBusinessDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_1",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_2"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r584",
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SubsequentEventsDetails",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_1",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_2"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r584",
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/DescriptionoftheBusinessDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_1",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_2"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r584",
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/DescriptionoftheBusinessDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_1",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails_2"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r613",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SubsequentEvents",
      "http://amciacquisitioncorp/role/SubsequentEvents_1",
      "http://amciacquisitioncorp/role/SubsequentEvents_2",
      "http://amciacquisitioncorp/role/SubsequentEvents_3"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
        "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails",
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails_1",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails_1",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails_1",
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails",
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails_1",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsAdditionalInformationDetails_1",
      "http://amciacquisitioncorp/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICITParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "terseLabel": "Description of Organization and Business Operations"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails",
      "http://amciacquisitioncorp/role/CommitmentsandContingenciesDetails_1",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r148"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax credits"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]",
        "terseLabel": "Tax Credit Carryforward [Axis]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name [Domain]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.",
        "label": "Temporary Equity, Accretion to Redemption Value, Adjustment",
        "negatedLabel": "Accretion of Class A common stock subject to possible redemption amount",
        "terseLabel": "Accretion of Class A common stock subject to possible redemption amount",
        "verboseLabel": "Accretion of carrying value to redemption value"
       }
      }
     },
     "localname": "TemporaryEquityAccretionToRedemptionValueAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails",
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails_1",
      "http://amciacquisitioncorp/role/STATEMENTOFCHANGESINSTOCKHOLDERSDEFICIT",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityByClassOfStockTable": {
     "auth_ref": [
      "r1",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table of capital stock that is classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. This table may include a description by series, value, shares authorized, shares issued and outstanding, redemption price per share and subscription receivable.",
        "label": "Temporary Equity, by Class of Stock [Table]",
        "terseLabel": "Temporary Equity, by Class of Stock [Table]"
       }
      }
     },
     "localname": "TemporaryEquityByClassOfStockTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails",
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails_1",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockAuthorizedIssuedandOutstandingSharesIssuePriceandCarryingValueDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockChangesDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [
      "r374",
      "r377",
      "r378",
      "r379",
      "r385",
      "r386"
     ],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "netLabel": "Redeemable convertible preferred stock, $0.0001 par value",
        "periodEndLabel": "Ending balance, temporary equity",
        "periodStartLabel": "Beginning balance, temporary equity",
        "terseLabel": "Class A common stock subject to possible redemption",
        "verboseLabel": "Carrying Amount"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEET",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT",
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails",
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails_1",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockAuthorizedIssuedandOutstandingSharesIssuePriceandCarryingValueDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockChangesDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Disclosure [Abstract]",
        "terseLabel": "Temporary Equity Disclosure [Abstract]"
       }
      }
     },
     "localname": "TemporaryEquityDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Temporary Equity [Line Items]",
        "terseLabel": "Temporary Equity [Line Items]"
       }
      }
     },
     "localname": "TemporaryEquityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails",
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails_1",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockAuthorizedIssuedandOutstandingSharesIssuePriceandCarryingValueDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockChangesDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "auth_ref": [
      "r1",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.",
        "label": "Temporary Equity, Par or Stated Value Per Share",
        "terseLabel": "Common stock subject to possible redemption, par value",
        "verboseLabel": "Temporary equity par value (usd per share)"
       }
      }
     },
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEETParenthetical",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETSParenthetical",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails_1"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TemporaryEquityRedemptionPricePerShare": {
     "auth_ref": [
      "r1",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Redemption Price Per Share",
        "terseLabel": "Temporary Equity, Redemption Price Per Share"
       }
      }
     },
     "localname": "TemporaryEquityRedemptionPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEETParenthetical",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Authorized",
        "netLabel": "Shares authorized (in shares)",
        "terseLabel": "Common stock subject to possible redemption, shares authorized",
        "verboseLabel": "Temporary equity, shares authorized (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails_1",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockAuthorizedIssuedandOutstandingSharesIssuePriceandCarryingValueDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Issued",
        "netLabel": "Shares issued (in shares)",
        "terseLabel": "Temporary equity, shares issued (in shares)",
        "verboseLabel": "Common stock subject to possible redemption, issued"
       }
      }
     },
     "localname": "TemporaryEquitySharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEETParenthetical",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETSParenthetical",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockAuthorizedIssuedandOutstandingSharesIssuePriceandCarryingValueDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockDetails",
      "http://amciacquisitioncorp/role/StockholdersDeficitCommonStockSharesDetails",
      "http://amciacquisitioncorp/role/StockholdersEquityDeficitCommonStockSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Outstanding",
        "netLabel": "Shares outstanding (in shares)",
        "periodEndLabel": "Ending balance, Redeemable Convertible Preferred Stock (in shares)",
        "periodStartLabel": "Beginning balance, Redeemable Convertible Preferred Stock (in shares)",
        "terseLabel": "Temporary equity, shares outstanding (in shares)",
        "verboseLabel": "Common stock subject to possible redemption, outstanding"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BALANCESHEETParenthetical",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails_1",
      "http://amciacquisitioncorp/role/CONDENSEDBALANCESHEETSParenthetical",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT",
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails",
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionDetails_1",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockAuthorizedIssuedandOutstandingSharesIssuePriceandCarryingValueDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockChangesDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockDetails",
      "http://amciacquisitioncorp/role/StockholdersDeficitCommonStockSharesDetails",
      "http://amciacquisitioncorp/role/StockholdersEquityDeficitCommonStockSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of new stock classified as temporary equity issued during the period.",
        "label": "Temporary Equity, Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of preferred stock"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSDEFICITUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFCHANGESINREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSHAREHOLDERSEQUITYDEFICIT",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockChangesDetails",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityTableTextBlock": {
     "auth_ref": [
      "r1",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity [Table Text Block]",
        "netLabel": "Redeemable convertible preferred stock",
        "terseLabel": "Summary of reconciliation of common stock subject to possible redemption",
        "verboseLabel": "Authorized, issued and outstanding shares, issue price, and carrying value"
       }
      }
     },
     "localname": "TemporaryEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionTables",
      "http://amciacquisitioncorp/role/ClassACommonStockSubjecttoPossibleRedemptionTables_1",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockTables",
      "http://amciacquisitioncorp/role/RedeemableConvertiblePreferredStockTables_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for treatment of receivables that are billable but have not been billed as of the balance sheet date.",
        "label": "Trade and Other Accounts Receivable, Unbilled Receivables, Policy [Policy Text Block]",
        "terseLabel": "Trade and Other Receivables"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r785"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://amciacquisitioncorp/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r513",
      "r520"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "verboseLabel": "Unrecognized tax position"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredtaxassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r519"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "terseLabel": "Accrued interest and penalties"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/IncomeTaxesDeferredtaxassetsDetails",
      "http://amciacquisitioncorp/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r87",
      "r88",
      "r89",
      "r321",
      "r322",
      "r324",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies_1",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPolicies_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r591",
      "r709"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease, cost"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VehiclesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment used primarily for road transportation.",
        "label": "Vehicles [Member]",
        "terseLabel": "Vehicles"
       }
      }
     },
     "localname": "VehiclesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesPropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://amciacquisitioncorp/role/DescriptionofOrganizationandBusinessOperationsDetails_1",
      "http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueChangeinFairValueofDerivativeWarrantLiabilitiesDetails_1",
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails",
      "http://amciacquisitioncorp/role/InitialPublicOfferingDetails_1",
      "http://amciacquisitioncorp/role/LanzaTech10QNetLossPerShareAntidilutiveSharesDetails",
      "http://amciacquisitioncorp/role/NetLossPerShareAntidilutiveSharesDetails",
      "http://amciacquisitioncorp/role/WarrantsDetails_1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants and Rights Note Disclosure [Abstract]",
        "terseLabel": "Warrants and Rights Note Disclosure [Abstract]"
       }
      }
     },
     "localname": "WarrantsAndRightsNoteDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "auth_ref": [],
     "calculation": {
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.",
        "label": "Warrants and Rights Outstanding",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDBALANCESHEETS",
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails",
      "http://amciacquisitioncorp/role/FairValueFinancialAssetsandLiabilitiesDetails_1",
      "http://amciacquisitioncorp/role/FairValueNarrativeDetails",
      "http://amciacquisitioncorp/role/FairValueNarrativeDetails_1",
      "http://amciacquisitioncorp/role/SummaryofSignificantAccountingPoliciesWarrantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": {
     "auth_ref": [
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.",
        "label": "Warrants and Rights Outstanding, Measurement Input",
        "terseLabel": "Warrants, measurement input"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueLevel3FairValueMeasurementsDetails_1",
      "http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails",
      "http://amciacquisitioncorp/role/FairValueMeasurementsLevel3fairvaluemeasurementsDetails_1"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "auth_ref": [
      "r789"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Warrants and Rights Outstanding, Term",
        "terseLabel": "Public Warrants expiration term"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/WarrantsAdditionalInformationDetails",
      "http://amciacquisitioncorp/role/WarrantsDetails",
      "http://amciacquisitioncorp/role/WarrantsDetails_1"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r299",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted-average shares used in calculating net loss per share, diluted (in shares)",
        "verboseLabel": "Weighted average shares outstanding of common stock, diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails_1",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://amciacquisitioncorp/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails",
      "http://amciacquisitioncorp/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails_1",
      "http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r297",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "netLabel": "Weighted-average shares used in calculating net loss per share, basic and diluted (in shares)",
        "terseLabel": "Weighted-average number of common shares outstanding - basic (in shares)",
        "verboseLabel": "Weighted average shares outstanding of common stock, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails",
      "http://amciacquisitioncorp/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNetIncomeLossPerShareofCommonStockDetails_1",
      "http://amciacquisitioncorp/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED",
      "http://amciacquisitioncorp/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://amciacquisitioncorp/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails",
      "http://amciacquisitioncorp/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails_1",
      "http://amciacquisitioncorp/role/STATEMENTOFOPERATIONS",
      "http://amciacquisitioncorp/role/UNAUDITEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Denominator:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://amciacquisitioncorp/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails",
      "http://amciacquisitioncorp/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossperShareDetails_1"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 13
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=77885760&loc=SL35686385-199418",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=118255708&loc=SL5909891-110878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=109262807&loc=d3e22026-110879",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=109262807&loc=d3e22047-110879",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=109262807&loc=d3e22047-110879",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "c(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6419918&loc=d3e35281-107843",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "44",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5558-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6411-128476",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613673-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "https://asc.fasb.org/topic&trid=2155941",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.17)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262037&loc=d3e9915-115836",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604008-122996",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.1(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900988&loc=SL77927221-108306",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "310",
   "URI": "https://asc.fasb.org/topic&trid=2196771",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "https://asc.fasb.org/topic&trid=2196965",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e709-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(2))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1(e))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/subtopic&trid=2235042",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=126928961&loc=SL5834089-161433",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28228-110885",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=116633155&loc=d3e31531-110899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123420820&loc=SL77919311-209978",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919352-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919396-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL119206284-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL117410129-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL117410129-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888252",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=SL94080555-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55302-109406",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "715",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472162&loc=d3e58407-109430",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942793&loc=d3e3073-115593",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r714": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r715": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(2)(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(2)(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(b))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117546-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "321",
   "URI": "https://asc.fasb.org/topic&trid=75115024",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "https://asc.fasb.org/topic&trid=2196965",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "325",
   "URI": "https://asc.fasb.org/topic&trid=2197064",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.A)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=122040515&loc=d3e105025-122735",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "740",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126970579&loc=d3e23163-113944",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919396-209981",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919359-209981",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=126960272&loc=d3e32014-111567",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=126903467&loc=d3e32787-111569",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>249
<FILENAME>0001628280-23-003312-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-23-003312-xbrl.zip
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MY_GKM$\#;'K#HPD.$SWX=.KFB-)GW^3GO^Z-WO_CV:5I^&=H.3L.?_+PYM_
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M?]9?T\PN_X_?SE_\X[?S0\=1/OWSC]Q[_\O1Y+1/_WZ0>T?O^GCZ^W T)+Z
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MVLC86"I"+V#-9[6MN) 5*%\[P6ITB-Y!-HBH')'706:?T,0K^RQ:*W[%6&3
M^[L=BXZ2E$[E4#*"U.Q3$T?%DIW/: /ZGRXNK@Y/6GPX1N;1)&(!J'LJK/+6
MRX("510)LJ>?+ARO*'@6P@(,D  *"IG#@4DN2-9HS@>O/+_UL5OCS\,"5A0\
M"R$?Z$7TTLA(!B'&C"9@B%D4R*J(##\=^5A1\"R$\QBF.!&T*I0-Z)1C%$A@
ME#,B>VMMRWF6=KY]\9PG"A=43D$8Q;Q'&Z2ZZ]>QE/4R0C MYUD-\"R$\Y 4
M-DOI8Q 1C!,H8J@E%5#4'3?.M)QG-<"S$,XCZQX=7W?-.8(DC#="!E]0!LEZ
MW<B6\ZP&>!;#>:R,GD+2PFKF/!&Q>B);>_(H[UR;K'B[//G;3WN^5:9N<!T-
M^>G13:>>7M.*+,")7 RD0&!M@43$H,NE;@3DZ.>C^6F2VA>'A-5QE[<"0)^E
M(!L9=J(P-F+T01JM:T<R<-')%H#?!\"'.4^+KF'_!?;RQO QONM-L+\BJ-!:
MDH7LHF:W!$6CM<GR:Z)XHIQCBXKO0\4KFF!O2'D=Q\/><.]H1>"04LDAHRS!
M"$A%A2!9['N1HQ:F)']5H.D6%\N&BQ\0:OH2B'YDBL@QK9:J;I#V )&%6 !M
M8\U$J]7AKJULW'L0K:05119(Q+J:;VG-J?49O1?&8@B>I?5LU]^]-UY+6+\I
M%ET!X(_L!D 7&6_*DG9@1"W$JI47SB4(*H-O ;BL(>A6X$!!>*U BNP-@$,,
M%A*"]IA$2*;\+'!8%GO8I*6352/4EN<V^F1J24H9,J$P$"ZB/,RBO&VG8Y=M
MG%XE&?#U),/.9UI6)*EK^D*1(4+*/K@28W0\J!%$S/&G ]%*6A&+LC*"K=41
M@0V)SK*MC-<F*2<Q7KCF>V^\EBI^:RRR\]GDY V1IR0!?*W151#19U-D].Q&
MO((6@,L:@FX%#II9(J"HV?FN[I3Q)'VV(@:38B#]T\!A6>Q!=4:Y .GD!$BR
MW@<EH_8FE(2NF#;A;%76(!:??V:R4=)9Q^/9@2DY6"^%L-&D+(I1/]]&QM7S
M^8L'D6"-8:1W('0&=DJ!J2NE1 %0ID*JW1O?9H/<'!'GM"L_*4A>!)D\TQ-=
MRXO73DU%YAQ,D#FU &P5TZT"L.X]]JS3DW"F+M-AUA!\H!R-B9A%"\ E9V*W
M4X I6>>4D5(*!5X(](5\)BBN*BC1UHQ96DYU.U%*&*F=DTRM%9CH/5&R(@2O
M%,/"G>OHFG'M6CBT-.E2.E(57VX. '16D\#:)"=%(.V"R:Z \*EX5"*;%H M
M3;I5 %+R6FF6A2P701OGI21=7-!DHG6ZM !<'9HT/U24!#E&,(64!1]BB E=
M= Z"(\</6U2L $V:'QQB$,'+I&4*# H,S)AS""H@U55L2S\+');%'I@B4U8/
M*9,"R9(V.Y5%23%[UC':7=TH>.]3AEKZ\&4D_L 6Q3DEW%H?A3-1F5H]"(I%
M:W+2SFN3,R:\5E"LA>VRDHXEP)) DY!"RAC!UQPK:;R-FB+D6F?HI\/22EHQ
M.9]--A2J%<G:H%RJE2,U"IE*:3W"\A/.Q8,(E?9)80@V2DA>,C'-V00"#\%(
MFLVAM-AI)_&NT/$Y)8J;PMP[@W-$&4! +8^8D\-H%5(*O@5@R\)O%8"N-E]F
M)DW>:;!6^D(:2+%C-,I^FJYI ;BL?/I64 ' (= Y+R2C0C&GBD):$:-Q3C!M
M5BTJEI53W0H<@J.@;- R*PM.!8P.$250-1SZGR9*+8L]R'I7<I)$2C-EL-XJ
MK;5R 4+=7C+3/C"K,WCOD[E7;YQ>U3Y?NS%)SFUCDI?&9":=A>4R0+3!:@<J
M14TAZ!+D3P>BE;0B4S=CLTJIL#^VZ".@L2G[F#R[YVPO7/.]-UZK8+\U%LUI
M_TJ45D-4,B8AP%D;LW$R2"$9?3(&; '8*MA;!:!.C#BD*%0A"-EAU"HXZT34
M 0VE%H KI6#GA(IB*)1HR!I,X$O"HI*1,N7,Y%G[UBTM+3.^%3B8F%TMA1QL
M,F!SC"$%8K8497:&__E9X+ L]O!.%2%MPEK_3 "R'42)"9RK1$+_?,WZ5M9[
M7Y5 =U\XWT4J1BL@IQ!\CH$BI21*4(0IHVRQU%+1)82MIB(P)AN9I4"2&B5I
MY4P2,JD<8ML@;?FIRN)!9 !#D+*PZC;@H/9\T+;.U!?F-I1G-+?%3CO]<X7(
MS6D;'//I( $QVFA!A((^J* 8?5H7E:UN =C&W%L%H$PE.=19VV#!..MCD4&Y
M$(R+7I<6@$L;/6\%#B78 B@9 K4R<Q2^("60VD=4P5/\6>"P+/;P(4JO:W*U
M-5-[..&E*2:C<]:$V'8U^]MQ>AR/>KF'X]/7V*<;W?7F>QH_[/='D_I+-M]5
MO7_+)'<AS<TB#V"?*3IDDEL\>45@53'*"1[;9::4@G3-[$&+H>7%T-2Y2/<U
M&+KRT1_9]&%]P!QR$48 I!!=2BB-D\9B<EE?5.\P$EKH7,3_/M_J_(*-<[HU
MQN$1IHJ-HT>GE]^Y=#6OF48<C<;WD:VR*S.-A.\+A\?#W@4&^?=\!-> \.AX
M3.>WKKXS^_;LC=GS^O4;$8U,;;"H8$5"4#IC).4U:84Z&*+9%+H7MID]6#9H
M?X.;VGBQ>?MNR3?"?J5;NOS1'VGZZK3( 2A@2B *^*R42V2DT2$9,:.K]]UV
MM^05;J%#^><D^3(*?B2_UN?HBR#O,4%.-I*W/C$N& L%K?U)4+ LYHAH'<68
M-"D)CA0:E,7E& FC2"DOOSDN1L=;''/DGFR.7_7V]B>78O6+<>\]#Z07?4S3
MT73QP2^)_'G"X>HEK @VZAP"9K#"^0R@3' &2&B9V5W';/,*1=T6)$M! 9B_
M*2\4N% 4*$E>9N%T<L#B5ON+ N!WBZAEO6\?J?3PN!K\&IF^. 8__&8V[0L)
MX;(J-FD '8,MKDXH)]*I;JJXN^J.WRQ-YC13!YJ$<U!D%-.=@,$R"65LIA),
M"6%6/%P+W\P>+*MG>W1\U!L2\[_TW^/>T30/YI)?>X[#,\9<VG_:'\6[* 2O
M&?-?.6-V^:,_4L.[*%3,(876M:FV0.F2*"XBF R(>=8/K#7A5W8%^V25'^&5
MVFL>8D(14>TG')W"4M>H)#L9)I@_EU6^>-*C\>3W5SC<H_-3U*>=WK W.!ZL
MB+V]][J6.BNY!,@V> O@I=-%>N/)RA58^[CEV<#57(XH$H/V2>J001L1',M$
MRCHJG50P9?GEX5(P[UN19S;EJ%V,JG98]J2"<X'UFF%OR[$PSGIT:S4C,6II
M?>WR#CG]E75ZKGST1S22PQ)RX)O,9K7:1)VT(822C<DF7=0CD&KY-J!_P9J7
MS/=V-#[L#?<N$K6?C_@SMSSHI)I3$1N.<$9984/T8!6%3,Z@R H",/$LRUL9
M?WFM,T==9T14QF5I$C#_2!@C%!8$-H9DO+_#L;,H?$*$Y+-#_KD$I(RW(:@8
M"M4>1Q!I^?&Y-(LLT[%P:84%^<H.*$VV1J\HT^"6T@=N95PXP\3-4Q!6* #-
M%%UF3Q)\T,EZ*ZX6$)3+%UP6GC+V Q7\Y'PJ^ 4CT)0BK4<!@"*B9H$=L5 R
M:"U>K6*QA(-\Z:SX#54LYB2IP#N?/4NJ*-F(H()2&2%+K+V2.51=6%'-K-A6
M&OJR%=776W%.U30SWT_67\D2WU-=/ ;C;+;*ZGJG2UY ^\GO4#=WWW'1":MD
MC 7JB@/%FKZ>#  9'5!'D1;@PU;":V10_!.<\W7%0HB,+GLD'U-B[X_A6@G@
M.XC@*Q$S48HH0/OH=(2<32S.,C6.DA6;5\DMP-NNA'_S*H!GHB$A:+ .O2Z1
M$AFPJ&VQ>H7F<Q>>1[7X:=P0DA9L3'*"J09J;TNIE%$K=L0^BQ5HEOP-\O!N
MK7GW,114=J$V,]&I@!?.*QM*+62;BHZL].ZM-6][;_Q"K)D<B6R"K;GYS(HH
M%I1,C23'>)3*J178&[^<8W,AF]3)96=B*+[(!()T*)F<U$&A4T0"[JTU[V7=
M"A <)*-QT@> P':53@4!ECVO9LZ(J\2"EFIL+H0%29=3]J1%RA9T\MY@9L-&
MJ7BD"IGNK37O(&[>O359_))&+,D( T4 %E)D@B@1F2!1N:J([XTU[R!N?H-.
MGU=QEQ*MR" EZ )%YQ"DL:J:4Q2R>'^MN5PM[.8V6P4U;8A-:!QDI9$%BBG!
MB^2#=1\;AJ]VVM!MU,[YAWT*LX]<O+<B24HA(2/!4"(A( :,-EE^R6KGO+8Q
M?,SXU[.,?[W"D%C(!G.VE/[*X7WYHS^2<IV#08=D'8?>VE[0IT)DLHN9-6P6
M*U"D8-F->O=5 V0V.2 ;4R<%:!7RT"VF-APU6(M,?HS H9D]6%:C+GH__Y=3
MK)Z,CH>9QJ_W<4QWTVTP?/6ZRZ>/_@":BJ*8)-96M@6RUDSG1$C*>"B^"*$_
M]L)N0;2L(+K6D_LC+GZ #P@?;12Z9-3(5%_%%#/)VD*ASI45WWJ9!0'DZR/F
MHHN5+-ZY.2"25#1K&@U*",:RM\8$I!()?&Z=6XO=._2I/J+-4)2L<]->NE!0
M$0=;Y8SQJLPZ&"YAO:?["<<?QL7W%V#Z?(84%>28 I1<2ZT87Z03T0;6X)I4
MGM628UPT+4"6'"!7@]YEB'PAZ%W^Z(\P>M+"*Y<+'Q1J/2ZG\K2+LX@1E!/+
MO[/@IP?1K>PM$*2\M=X+$LQ]DH\Q)E >O516D9NUFUGB.:!%D9$EF7JZ6@OW
MTVS2C^S_MT8%L-J:E"#Y%*PCCRH7'U-.TMUGG?=PF/9'XXWA>SJ:C,9SP\O"
MW<?BA9>R#H(7PJA$D!)3&9(<?X! )+;]?9Q5NJ]@NA4EY(I!:8R33CG @E%G
MHV0NL4Q[1X<5RO#XZ<G*0C),/E;=RC=7KUV;?>^KBVTY4W1-_RN.Z5'V!C'I
M; T:+3)PB%Q9EW4)"9<_<1>;^>?E+A)@2M)$QY$$2(2(LBY^196CM"1A^27-
ME^H:WK"5_R[R!^:G+H+05O*P*6 5J+IITB2;I?# -I,IM45.5A(KBR^SXFV4
MW@GI!":(DMF"E-8IDR)B90RK3Q4ND\@\Z U[1Y,Q3GKOZ?7QNW>C\>3AWICN
MHM+H0K)#$Y3"_ \4J@(A9\]F=B[:@F"21[E">V26W[QWOVF&&150(.UL\A =
M>F=D$%;7NK(<TLL*;;-8<O,N9-]%1FM="<%'F4&3C!:#K--)5*WL8(6R@9??
MO M(]E:)99!![1R!B3YRG"U>!ZN24.A7H$C1\EGU5MAW2=FI:*+DP0?",S>"
M%*W7GN\GLJWN0RVZ!1IJ?F6_?%8EL#M,D0.@K>TT#!*K6R5]$FAF?<$OV&QK
ML1]TF%\;#S\S[X_0'7:.7G@?C):U;$7 G W52BK>D%!NA<3*LJQZ+5ZBJ.S)
MEVS8F@:*# %B]"EK<I&@*M"E7SA=%EO>R@IF*3HF*A;8%@ R8\R4K316UM5,
M4U9@S/U]G:YU-DL:C>GI>'3\[OFO_5_3K_=QB%GC@RU$Q9,%)6U4-DE?=.UY
M49MX7]@PG*]"3Q\LFPUK*?BMWJ0.KXUA[KWOY6/L?U:@\MVL;O7#O2^'OU7#
M3/C*->8K'_V1DN=>9@K%2?0 6(N5^2119$ RK$/C/<#,D]X0AZG'K^7WO:/1
M^+0%S0^"IDCGDX524I20//L75K?&2 -:%R?$"H#F*X+Z^1(H%1J/*6_7Q=\/
MX]ZD-]Q[0C^>%O738XB,H$ N!V;UH%+Q$I@<ECHE0D$4O?RS(@NOM#:O29"/
M:0#O1Q.Z.1.@OC/[]E<G QAEO #FE*6F9F,,D*3 8"BD()0/*VWB>U0O6R#H
M6M:5G*::&. 5J^SLJ^W83B$N_[S7,MMICMT8DF#O6'-I9 9)A)!3M!996 /X
MD%=HVFOI#+;X62]C,EF?*:84(&*)V;B8-6J?=.)G*Z# 5\.ZB]'F[%TIL9M%
M8A\+L=*>VFT6K2S>Z;#2/G8!#;KGY5,5V"PL_^M,@"!\<-$)DPQE5Y(OXK[9
MY;9W><[-+D$6S"1R41&L0?0J99L-H58!< 4Z#RV37>;'%2E4UT7::QG!,ZN7
M')RLD&R58G.D^Q&E?I:J@F!D*:!))2,@F(2(SI#"HJ"H8/+RC[(OMCH_CGR$
MKVQPOBR#+/AH0 MC+%,%50+&@K5S>&1]%L"M@"!;(K/,,>W B!BL%HFD8[U%
MT8ND)%IV@HI(K4!,^J)9KO0&7;5QD[3(')9*B/RWBB%%,-$DI93++*?NP;A9
MA('F-X*DUY:2T3DS=ZA4(A;^?R)^(3'C]BO$'A;MX19/'FII:9F1N8,6H*V.
M.EJ9BHE12O#6_*S&_.)9S_>?G!_L\6B8KW9;_S03\O&2CM[NTY '?Z(7%WL0
M-\OTHL\9ZI2ZKO_W&/M'F^/UDT24CZ3_58C[B#LT:$7,*0$".)<CZT$;0%BK
M@S)2M+A;+.[$/<5=4>0U)(B.#)2LO; IRU"<$V RXO+3O_E.X:U,J+R=9'&4
MQ9B4DB )T7B?BI+)B\ P01-_WI9A*P.+)? H7F(V"6N+XMH, %4P$83/021O
M_0I,OSS!WO@-]H_IT>G'A__+1\1QVC]]3N^I_SF./GYH8_CN>'(T_82<%Z N
M74SG/$>A_IHG8_KO,0W3Z=]<R:6/'KVB=#P>]X9[*^*$4M+2!N<L:@.Z1.^#
MUH)J#>M"(%L += CM;#]^VEGZ0H5(2*9 ):=8#1!JNR$=RHSO?HY8*OO#+;?
M-VG4 OCO)QK!HO E98T"R!IOE94R>%F4H%EUR*6>:%PJO[LJ )KC4H+T)"5Z
M*[0#9;*/P#+")RRZR-J<K050&[B7#[9%Z\3:%C1'9]"R^-J]U4)R-4.C./ES
MP+8-W"L+X. #D$HZ)Z>AB%@+^1HIZM1-R@+L\C+/O]\P\K#S>./AXY?;&Z\W
MMC8VNX\W7[W8V)@71"X9>SH"MD[?T>>XN/J)]1,:I]X136>-5X3/H8DB1I.%
M<A9LT#&@,H5B$<@16BUQPD4+BUOT%BI2K<)3&&H20I%!ZN24K-5  ,CYUEO\
M,"RF<'@SZN.DU^<+71%_$9Q4SEO2V1(H]A<%#6AT!;2P6>?67ZP4,.:8X.*"
M#3('DK& J[FR-M?*BSFX+$5,K<?X86!,5Z%7B5Q(@9XA 2D"_^,=2BT,B2#(
M80K+O,6@Q<1M^8F8&1/.1*^,@KKCBVQQQ4&PVGLC3>LGYD XWU&:4-ZB\6!Y
M/<7'O=>G-V^\WIE][ZMW78LH5"!7/$2L[2."D<Y)B %,!M-RDU6"UAP=CI#9
M2H8#L)1)LI8V9(<CI#(BLYQ9XG(+*X.*5[VCPR=CH@V^[6,ZFKS"R:I0%!&U
M-XJL]4!@DO 4,9EB4::H6I^QDNB8G^] U*XHA:0LL-H-"!C!>DR(P?JTQ.BX
M8:+[>0_C5%&>)[-]9K,UFDZX]][3QYI1&WS;QL?3N>[9-WNWWB!H;FJT2)U%
MUAA,@I0114ZL3HF8(EBXGJ.H6PLN))U0SZ>"! B5/$F3132 V@=*@IUX(>=3
M4&DF*EHKSRW\ZOF,4UV*!:M3(5,J.0M@8]0VBX1)>3=KWP"S<6J7CZ6MC@6O
MCE/X^G%JY[61(!"'45^\C, /.9AJEVKQ\:*UB+/TM];*<QNG=CXT.9:(S(F5
M8QD%#G7T46N:+AQG9D5QA=JL++\%%]]VA9UR2M$&QZ(97+(^8/882\D4I*85
MJ%^W_%:^I>4Y0"DT1F<+Y+J.[V2T2J,*$%S("XBGJQ&89,22K/29[YO3): +
M.L945ZZRS6D!>F$EB'<0*I<"B-9+<&%:"L=YK03S.J/H8D<JW[;SMGWUP;)Z
MC 7M!:ME>*=99Y/U]_S7]>F4*Q^8UWGKB3;+PYI6MW=>5?S3!-)FFHSX:]5B
M]>QIW)ONC?W8>N/V8YX4C?S*1H&???1'ZM0%Q\/>1^$R.U&GH_506$@J]@+.
MV(L$N1;!+8*_(IY_!LH?B.?,PT+.1B:7''@%7@KD5Y0P095LES@][WLJ8G9'
MD]6M49N*9)+EB (6J%5XF'FI$K31-K-',5=ZV2VCS>:[I/"C4>";6M;-K1:M
M, JS,A"T M %O<TU[9'-2,9&]=-9<4'19R7!$Q6+XZEHL C68A!!:)E"S,%9
MDK(%SWS <]L5*1<"GE224;(H1QP\@BS>UX4JM&31NRQB"YXO@F?]O\=UFF<T
M>#<:5I)W$X"FR&IA.S?8@I/D5%;)VPA4$(L77B2I*"$:YUK8_B!L'^;S<E78
M?X&]O#%\C.]Z$^S?1RR5;+01%BB  2,IJI1L]E93!BLQM%CZ02R]H@GVAI37
M<3SL#?=N>QYG(2!2J4!Q)N<"B>,H"^4HK8Q1:G0V&%H B%;BOF6!,5OE7((,
MIK;%"\#CL&CKA$NX"OKU"ZV%CQZ=7G[GTMA\S:/E:#2^C\,!@X[296UKG\-H
M('JM0UW6"\%(4*O0?N/+W6<W7FS>&QE[.TG0TGGMK?%.3&L8(! *@\$4%5!
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M^_<R;8\4,8?T"D/R+$5D *.,1.FB=Z:(JQ.AR[R0V,)YJ>#\3=YY;CT%-4#
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M;(VN:D/)L@_)IU79V,X+D+T1H,^NJ@ABK3D9$VL"BV*/O#=MXI;/)>1B>B5
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MR;/Y"YKWA?@Y%2,I3.*8# A53U5TR^364,46T#W89>P!7&LL9'"FS2 SJ)B
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MJT,K:&!VJ%7(I:0>N:5'XSPYXGUZL[>8'TZF<FOGYEA-ICP\&-]K)\RG:SM
M\>&W/J6CLZ6,C\8C&I<7_(K'"W[*KW]A:G_8$:^X& ^7DK3$_*UL'"V+(Y9+
ML'SM]!-.7SK]O7W$Q^,9#@Y< N=$6MCG6+6VEIROCGW$W(/]@NN<(+7Y+8$D
MD8JJLG;B>%M71"3=RA5"#9Z\CZJG@%W5\*/- U9<5(6-3F 2L,68@PU6HDX#
MP!FH!X"=VN&]US0M'Q9I/3@Z'DU.F%_.)_FW9UV/CET$TC7X:I&0TE0(R9'%
MVEIY1%OE>ZSM/Y O>#:?#EM]70?E+H+H02DLRB"0!P@YM6HO,:#9F6@R]6"#
M:%/87<U^'8/6E80AZPJ:K 0N3A#)43M*@E"/J/%6Z-1&$C4^&T<&V68B,(QH
M$&O&##J'1+D'_0!?\$B>O3R7U3K9E\AR1KEYL3,1QIF_SGX:S@\?_'O1)08D
M'BF/QJ\$9.;9NN*="VYG]MW)V5?..>&/W%!/C$"QMNW:MP-<! 4210Q15-ZW
MWI+6P/87>M[(SR8+4EV(M5!MX9"'5LL-L0+78FNJ0LU\CXC9-2&W1L'^X(IA
MN^ E3U\-,\_V#J;<G=[822X96W6E I$Q@NR]! 080_$Z&/%] 7M$7F[DKD=\
MR[*Q[$SP[ M(V$+"N2J&8$UK U=C_^W=!3@OI:Q]Q67QW38%Z*6=BY1321X5
M%0LY8"+K77715*62*]1_.W<C;]MDWZ++*ELPEBB -IE:[A0Q4!:B)^'ELO9-
MN3[' V>O>,PTXZ](PMXKS%/NLX. M_MB4Q[S:QK]:]+EGC^^/_;^-9^\3Q9-
M02<<CW-Q8$%1.X:(6>N"VACJP[;+YPGGR\7Q\>CD*Y+.S?O;3!Z8M8U@&$J;
MKA%+9!6"SS'8:';6WW[=LK817ULRJV0JQ:018B'*.I6BLO')%^5ZD+M].9='
M;^]9-;+HTNSO@RE1X5!BPN=3KCR=]FN'1)>:E2\VMP071V'?2H<4$D'*.?N\
MO0!]=EW&#?2KS;&$BKDUI<@)K(3XF+RS)I+1R6>SQ:<_/[O"XP;Z595/,-:*
MBJM&-]LT2BSM=%8M! S5]&#,[J4!^JZ7 .FJ?;)%0%)BEG6;6FVM:HTQG*MD
M>M#Y^-( W>LE0)1L1J6*R:(QR5 +TU2.QB53//:AR?VE ;K?2X 8<@MN<G08
M0>6,6*MUY)4W:(O?8N_VR0 ]Z"5 NE@B8M18 :SW*,%GEF !$#BA4SL$T,->
M H35A]"Z+HD* 09');"W;&LDJ%:?Y@GL:9[ ;F_"='MLW?F0W%X^)+=G,IE?
M=(HQ6G)<D(4!FIJ2C<4[3^R,_.ASC](_VPOK]6=:*AMO6"N%P4-5G%HQ<671
M6JA);.KU[6I<8XK^W#YBS:Z5VY*X_E@"1HN%E9BJY'19G361%5@*]K8LQ7N2
MTRW&Y23GW+I]@>28 #6'2N!#@E*S<"2*F:JK56=6KO][#Q]-Q;:LP5ZMP]&P
MO?"@>Y!=3/=KC9Q<:*<T'<@'8_+50D#O0W8A^A[9^RV'=R-V'XK2+/\DB7#:
MU)N8M'/)V]2=Y#K-XHE?,-N*ZLM%FO&_%_*F!Z_D7Q_6N)^[X(KILQ;+:M;A
MCDS;8%/!E1Q!5([D%V79ZZJ"B6ZUI=N N7V#T">:T?<P^F,S^MZE7U(UPDBD
M<L5<Q8PJ%XNUN>9V2C+KA*MP58O]W#84"P_O/N8#&BV-X)G-T<<T_IW^P?,V
M1J%,CIX/QQ*K+G@T>_SXWMHRZ1N7G?>UNUG>=60OQ*TJ@;WF4H!*:F/JA#=1
M2&V"H<,;<;@6<;CT]^[E;BS][.EDSK/'$^$.>^/R<#BF<1Z.#UYPYN$K2B-N
M5.+TYW,#C5[R>#B9=D/DN72?\^[2GDAM!.U1&^M3SD#6Q:0"2W1HVAYP5/E&
M:G=/:A=I,BWREG9$L,^R*\[6:&.<R6C!0"N,<\DR819G#*>C4+91=G?=%=K"
M";7GX"U M<A"=BD">%MJU?JK ^8ZU?O9F%LD+,OVK'8?TQ.A,=F#R1%]3@Z"
MKJA45M!FAH-EAK1*UJVR$M?2B?0SDG67#??/-0C]DG#?M?$DF#G(4V12* 34
MD&)E;9!'.W^B?9M/M39)?E;W6JNM@RZ+_[[.W9N,1B2^B^;#5WSFJC.)GW;2
M=9D,FEQT]3:E?-8E U9GEWVM!K5H2DW$.:NJM(TIE8R;T)VO608V8@=T+EVY
MB;%4(.::BDX%R64(Z#"=S^INHPR<K<\6O_=T,IZ>+=:>TWPQNZ"2>Q>U&KT
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M4EY82"UIBSL+W5B.J^H)YFJJXD^T=@3>I\35>2-"(/]):.WVBL2-Y;A&,<&
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MYR\^.X_OD^W'.S>CZKV&,VR23#]"@ -"NB4[/YT: ^?CKEQ>ZWI.[^O8/7I
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M$:XKS0)>7=>H23[2%&%\O'J!0Y0G69XURPA6(L9[3I/"KC"],)S@BLY[8E4
MO%F6R._*64S?6]F$$A^'SF%T#D=D.WI[LR>DLS6'QZ1OT'&@&]/!A=_5QGSL
M_&G2+E>G%\LN_ '_KM-L2@]V!?<W] KT8[H<GE'8;3S-"U/-LP;V;#OZMQLU
MC2N &@1?ZC92$]](8&(>TWX#><%YR31^&8?]%CENC>H/W$OX$FJBE'0U?$Y*
M)RVG+<V1CU%_)E6:@];47Y%BA/].83M!!R_[KJ:_CW3'$O8G>C06KNUDN1T=
MMQ7L"!@>4M"SK #IR9(<UXJ/'SY+W>8-/4@)BTYKR;.M]7U9<$CH>=AU"A^
MJP$7@C>'BT]Q1\I:7G@3-2'8$7S')*^=3DN&M0I$)<V6@;7FG4G@\Y3^9@]E
MKZ, ?P6U%Q[/DDYZN^"YT96L\*!@QZMVQSL>-*>]JS!5IF^B+N_\8N>&]8DZ
M/*K>0=;"UW5:E!0H60X9$U\;U@Q],^BS!OTI<9P^D.K ]SX 47D%XA.]P<'S
M1^Y.V^I7;9XL'L,KF4G5XESVYSS:._K)<QL/\I(\R9>P^O*6/\?1ZZ3X3W)F
M8&G?_D\,*S'=CGZ2'[P&;3-=NF_HCT@R]M\<'*&$@5Z=D\K#.X$YO,S*MD;%
M5A1E"R<\M7H$O<H):!)V_MH*75 1$-#*4W @05BC-Z8ZA^W=/P<-*KJU9GG"
M"?=%]!*\M?D$OO&,7G$W>,7NC]UK3I8LS^#6GD?=%XOY;>QKR65.VXE="_>1
MNV8"#Y,G5V#_X=6JA41Z=)DK,(2P".45GKZZG=19FB6LG?$.8/=K.IYFOF"#
MP:YBS]M[SS+'_Y3@ &^2%;!XJ^]"?^]^3'?+BA8% )T /#9M=9E=X@?=I\<5
MO^X5@G7_3;?XP&VQKA,8$SZFOOS)BJM9R,!6% F[^.Z1?\_+29*+4&[>>7Q?
MD*'&5Z>M_@1.+5C/*1MW5'M7$$/%K,\,')6ZSVT5!:IGN)S#FRQCU5)Z4NWN
M=_YP9;J?@$_3^:1L*_T$-[_.8"T2\#+!D:I%V0YORT^H.4T%@O*Q %%!T:&=
MW9_^V6:<@@.AJ!;;T=$1*P[<:]0;99ZE)/I6MM 1^0F\@KQ%A[A',_T,'FZ>
MEU<:#_>)W79TXM83GEM>$A_*A<SR3H-/"AN0L>\^=!MZE:KO3@-:LV\EK<:]
M]G:;*/^]^_#NY$ 7!-Y8I?H"7G-EG7 MWID2O RA!ZQA:Q?M!)P1RH;ACV)V
M"^((Q,GD% &Q(6I!HW&"8L6C-Y]0PDQTEF17"6\DJ4/X.[JX23K/"G%6+MES
M0<<6KO1WM!W_Q/^#OWF33)-V>_.VY6W9H(4 )ZQ(]2#E(+,Y+MY<XX=>F0^-
M=I^U&OPI1803@]$/N 44(F$T4E-V# *7&E=ZFBRR)LFS__!O,/JC\)A"5S9[
M_'..JD!59" ==71N"@A T%K!W\VBT5#.1.^+#/]UVFA$M0_*"E2PM>OO3Z/?
M]_??.6/EY:SFX)N6*26Y[&W%<.GK-. YXPW$I":H2S".FK*>II=TT5-EP,SR
MP[-\UC&'L_#S%8,]> N[ G*W"C36ZDK1&WA?YI>YP0YU[F?@'I<0,!:4RUQY
M2DP.VNC?'K_"-!AR&PX/<<5B>A9<E(R]G61EOS%KV?=3^V04-\"#-1&\6U/B
M/F)$6C?B\Q1E=%Z6*7T=DS$468"3!#X&I2;ELA4FY<&;Y*C=BUVO5_IVC2Y$
MN=B%6*.@QTH6#9?_'*4L["T82UEC*>M!EK)DS@&V-!Z]??G^].SDW]'+_;/]
M#73=#B087Y\FU<2B7UW"U'D=39*:H_6Z 5\>S1S[;:QH8PH]S9)33*RF(11(
MHG(B=Y#J2U:E6UA%6X)[UU93PS\(/&MR"S'PR'#G,6UDZB:;T^.PBUZ;I$+]
M_.$B ]F[,J"_\PQ<#LDV]]T%T]&:(2>[H5X1)]MZ?$I-[F,&&K=O86@/P2.Y
MQ!W()#\"&_X1[1L%[VD+3N:2W_RZR@7^F(_=DB/XNITOV&KA8_)BXT*:#.SH
M*[!7.184KKKO#"\8KI:N#^Z:OG#,>6?[IXN$4^L38PKW/I116?IO*^O79PIO
MJN"QX62#5<#9R?[+0]0#&UO"MF=:)++N!+D0%J4&Q1CKMOC?E+?ALP;WO<RF
M+.4UBAR$2A1AE'+(X;I2&3YUX=H4B\?@%<(=XEM<WI;1X.H]9X:R\HL%"##Y
MAF7;2!IEY]D>A9YG;Z)Z.9^4.=QI G\5D;?OBED]/LT-YQ[I/IR^B;4P=84%
M:EM4\A+E\+^FJ,O*59G1^:PP0F+W<M;F$+DT$(RB'>2S'5P@N8HI55+A#FD:
M"/6572&.7-TB454[+;VGIN/>UE0?2+-ZD2>4ON/-4&^\%C7J7\K?"*[7^4N/
M*S%?Y.S#YZS3+[(%+315)>#6)41T6AR@&B5\@-_ANNADR86USI,XS>'+__U)
M_.BRKW/9/X_/3D/N1Y]]]-D?I,%^=7SR8?_DY=;KX^-_,N^0AZ[>2 /NV4!K
MPFW!M69CA;8-3.]5 IYO7I8?,TEI)C6;0;5]7IIEEDP;Q95QBIZ25V):\VR>
M-0GC KR;,5Q!DXPN#Z;Z,7:U0<JWFO.E3<>"L1(X03GY@\O*Y(;#*H'N(--"
MR;6V:>%I71:'LDBU\1\#JPW@>( >QM7Y@ZO%"&LH,055-WR;[H*X"PB\0Q;E
MO$VJ!$26'P?N2R%2@7[O*6'$O!LGB <"38F.CSK-M!2PFM9O6*K1YC *ER*;
M8N@ =M;; 725VHKA4+P9'R[ 'V_K >#*55FENI^U9MKAP;-IMD ?IE,%D@BA
M^[&4#7L^;_.T^Z&&7BN??\*'ZG[*/DKW4\3\=3]"&>]^B/*Q\EE9UYCI6_T<
M%1=(WLH?P(',5I],I*3[,8,E5CZ%[5I=MRO\:E]9#=8" JN:0C=T4D4XEFOE
M;R+N*_@3Z)U*. I2SIN<EH8CM+E)!+F5>"@+049U;B#R \$AN(;3%MS3FOQ%
M.8F$"JKX&%)\B_(_3SX*H*GO%.%Q''R)U=.!%[2) GP[$L%9S7"T&NX)KC-6
M"+Q@=XXNJM3R@^0$GPST22\36&<T60B16<T5./VQB36U5X/K.Q0$B;*F?0+A
M2\!Q-X&23B:@P?]VF[4(AJ0]?MI9G:VON#QTX)[^\I7F?:#?%:S-SM[V$UP+
M/%9.\Z;1>55>-1!MHK9'29:T4+G \E!;4(Q\*P32N"-WV1%!OX*9G2<9N4I<
M# 6;BV<+(V74AQY*LHC>)G6:_#ENSGUN#KE_:K)A._YLLQ0W2O,=O9LS;LD7
M/"]5@MT?XM##;LC)86=\W(E[WPETUNJYU.098#9?&$RN7F+JL$CK:;(8-^)+
M'@G< 7 _"8B0)U=:?3IO<T7&N^0N)L0]@/TOXS9]L6VB9!,A9ZG*A0UHF(I?
M.A> '3(,$H+L=JU]2E*VPXIA8:IQ\^Y[\Z@];]%P.\P$86L-P_1LHX"S0[#!
MLU;J'IVF%#J?IN'.H=1<FKQ<D :5/\ZQI=%AS\2_D![%J($0LH"%P+!XW/%[
M]OTDA-?>M.B\O#15@9N%N<.J/*^2>8U-E=EYH84YS")GEW!SZ4,HTW9J<;K<
MIK#0C<W+JZUI4DW@7[/6Y"(?_ '834HHXD=MDZD\C*;T"^KH)#5_MA ;Y]2/
M"T>OH;.(^<(\Q\P&BP&<;_@^UT?',_D%MZ>!(&S:8..",Y@EG#Y,9\#&Y9SJ
MANVIRZ(P.<=MI1I5O)HD0&S#6+X<#]A][Z!42KPJC"M=B 8D-"YL*\&**3LX
M;LL7/%@(JC#6)[$.J6NKM*@MK,I495YS:6'<HOOU1V!?L%XGH?;!\;^.7F[M
MO( ( %9MCLTH11#.;6)=X8.!X]^2@X2-M1;2A,6=\Q)=:\R*4D$!2TE268X2
M1-K/])M#E0DJVGP;S!=<6U[SKEC4HL9^*2U2_&&K7"@F6L3EHFC8-J]5-2[*
MJ,J&8*60(C5>'J(@_!Z9XJAHJ1D6-J'*:D3-8<\M@7<I8\U5?5L_BR/77B>=
M]SXUB=0N3^!*T2L0^;*J_1(FN,J&V1?Z-A,[J=%1IV(A!U_TQ21(3FG\S#7U
M G:%GCLRU-RZ2O:R'1W9 J:6=VV;B8<%\'LQF&"$EI\D5%:F$&:,*R,)M"@\
MW/C5&;]U]T@K!%?0>K8;G5I\Z"?,N^&UBL %Y6(Q'1LX7C5V[Y#WJMP)<"$F
M.?&)$03\C+L3P(*EGVA(\JZ8B@!9-Z@A*$>Q=97BFXE'WTGVQ&^:5=-VCC$X
M0B2U;MP+6E9542+=A2 HPI<G"$'/^]-74^H)"U?#+Z$ASAS,9>9:O=8LS:UT
MSXC]^S6['(;^C1B^!_ L7P?#]W!L\/K#3H"'7J7$&)9TA7N'^CK0LI6S@!=%
M4%E+ICY;9_;KP."C\O=M]W:TGR-2[OPB;$ 1+RMP!6!G,<G!+T"!VWIO [M'
MRX+[-J[0C2L"E)KGR_$3B?J-HQR3H#6WMV+NK &C[,>$B!<94OW!0UZC?5WK
M[P6^-NENL@K;GLFV$"82\L921TU &UH*&&&[X5ZB?'F=19P)WQ&O4$1*:ET;
M#Y=Q"%6D5%0><++LVB_N%64*"[(Q_C92F[E9(.Y? VI"_^7)U2;ZO==P!;'C
MX(BF2.:H(8IZAIC4$%;"?+K()EGCD9#U$R/.Q+_J;A!N#;:,8_'%D6YI9_&R
M0[;E4119?B$2+Z_W75LW>&MO>43BX0,2^*/H"TV,[^-TJ.VNA/&.)<BDP[0"
MHW?RZQKGY#9]"3@F8?1IOB^?9H*-_]56**GR(7WE;T1+HQ_)OFX_>N129W][
M_)3^'0W\[W6GZ($V0GCDNZ?OW[S9/_GW';**%5_PBYHMWC:BD9C>M$>".,NJ
M970!?\BYOPYB3?5G;L8,*;T0>BGKO_BIL2[3))F;I3.E6)?,L/%O8C#1!M^]
M-(P]%-<//!OTXFI)+EA.WC[R/D/ME55 TC<%!Y'@#6'BQ_1E>KH(=H4:OQ;'
MZM3Z0GY.2.G1;";& JU?<G9 :[#[19(OZXPLXRM;@SA0/DGZSHFCE#RVU7N]
M6VT1YXE4^/WV%'M%WSN65I+ /X ],EZ0L#:G]?62T3_\>@LG\2NI#.$BBXXO
ML3L4KKEY;JW/8X/)U 3=ORU.UPH@  Y05C!)'K\N^XQP+&OV1J^2NC'Z;:+D
M(T#>!98&0!XG;9;3L9OD<'!K;7E&.MJ*Z&I<CT[=UJ@ZR*X1,"&.9LD$!%QD
M?I%,/R;GUF]=$#<6]?=R$)8AC0(L4H14L$B_70<T:O9DKH!:EGV-$@IP@I"E
M+>!U^"Q=E17WM=!W9AGXTAYZ9F71L'T$NY&CW4<[S_%_B;5K.SH5\E=3K+TU
MA1#V_DGAHWZ:J]*_,]VI5M0/JU"A"$/.:?C7_J+*<N2,W+&:02F"HE-DC:),
M.G)*^H$ID1_@9I5$]TPI>HKVJ*NL8I1)+ W<75R1!,>+;&%0^*)SHL[+E]L]
M+^UV ]^EH2@T"V$NE$&.+I$ICY$Q+'LS9"Q'LU +6SI_+*EV7)SSI!9:BPP.
M38TA*1B>5C+ \[:@O&H>D??#/[_C(UI*)Z-=/=A&SNUUJP+.@9,<E5K(W+1M
M3CO;YF 3D.>++  FY_6\))>9]!PF+2@6A" @A0"H%H@WX6H7Y=SP$8N[1\X2
MC]2QL.M66A! ; ('DDH&(*RA\^2/TFM6YX::XC*K2L$FP<G#VTPS$16$(-6*
M)VRQ&M!6$J+B^3/U+=CCOI*.[V7!VCP]W\M NL)E=CM:VSLRY-V4B-;QOGX#
M9+'?+0?L$=@G6 G!LEU#+Q=3T(",>F3LT,EM;*K*#>=86.H3)MWKH^6[0H^6
MM&)"P[M8->&0#B.B,##L(VC(]"#K_&ORYFGO-Y#XDM@%;;G<O;_T3[@U6"1+
M>F>QWKT'/2N48A\O81)L;;V@XG_/;BBRBB]/>Y,:Y->EV')HR<TGX72G!<<+
M[VT_?K;W]-FS@'OY4+]V@E]S1)9'SEN*-0QJYRUK$-@O;#Q.:_NR(I?>4).5
MU_ $CQ>/WJ0V#7&L@U+J#B'P5Y5:>G4D#A7O65=I#,P4D)LG5>^NU?A:Y+$P
M+IW9,"A<P?;:G^%CZ_;^;<1\W1_FBTZSI%X(2])6<,3 ]^ZQDY[:X!%.6%3T
MU#;AR L=F 2Z=\@@A/O,)/(\NB30XA,W?8D*::HDR%/&5$\?:RY57(C.&PXI
M.*Q-:^6/"G&51RHP8)GPO<(GN>8Q%*/C*32G<M=K2(YV6:>VZQ6KO_[XB!YY
M[<10%-AO36^U#0DQ>4P1?)YJ/X%O2JF216@;;(V4:5*==^\S//[3CP#V^S[0
MGG.D1_LF!_8FTD'\;@.'0\]#4GM8NV12PC5(L$)12GKU3K_($ N=1LSPK9^2
MGYE\N2MJ'G$DG2>]Q14]D_-#EAIJ+S5-W">UUW@W'CHQN-D-3URLP4WHUK!*
M^&G";[B 9V*E8"?1P259A5WSAN3XZ.O=^#HW51<#SRY0 )YKQGX>[9AHW/TW
MT0>^D3!O=IXFJZ,?=QYM@[A'U]2WQNHP3IL=H6MCF?=KEWE'&WV'1@N!5TL9
MU=I%\6MO:D#(B:W*\N,L,^ _G^Z_.F3WE68 DA4(<WY3;WSIFMP(%3Q'-^V>
MW;1RH6B_'O=G?0 0N'$VM=,QT7U.5]%WU^1:GSWZJ2I;X@9.D5-;Q+$P^-V&
M4J+R[#_C% TL695^=S)>[J=LP&>[]F6[?I:\@7APPC7X4R;7#ST2GK0QX/.4
M0K6&<#3_J?]LRR83=)ZZFIU+.'\JO%ADN]AN[$EQ@HI?8M+[#IN7*CJBHF$A
MTPHM)!$6<=JZ 89]*21*E)-79=.W[02#"5[>1+]9P\ZLG987^^B/(V0:@PT^
M]:]E[ZK BY_Y2:=V) !B5+ ,]U//I=X=O3N,CO0K+AFY^@)>)7?H73KW90Y/
M_@FWDTP1<LW'N.^A^A\&E^5XVI2X*L]UAN#Z5>/!97:XXE/]%0A.K@W,P<K2
MG=<OJW1%=^=?]J]%-#'-%2)IW9S":FI :M]D38/E$>_>U^SF=M3-6 [\@"\:
MKJ'5CER,/S]'AE?&4N\\CY\\>A3#"1K4EBL+1-^S^T*]8J 3J(]\D2=3Z85M
M^&-641P(>9J&0=[>LU@%[OWF^9,(SG/>S:UZ+^=/BQ2J2G?)%>U,XC=T1\$6
M18]Q,=8MB.2F<!"=OYLK142(#]F)Z:O5Q3I$"Z%3#CE-VC?8O,[Q&]CV4"E/
MI5RW)C6X'9$QZ2REFEE;1LWZ=9_]BJ?^>N_RX"OE!U(6#:;);IZ-^F"XJ@-"
MK"]$FV<GG<(^_2,I2 _NLOK<4?0+.3)8P1V<JT@I*PJZB(N)3'Y++)A2#HH[
MV23-*\<\O(M'GBEYM%3KY/0A'T59G2>%I?"I+.EN[PA:$D+$!L$7YPB_U&\Q
M\ZT;5B&8 .8/XD)U)O;.CB.<&8)VX%%JSUMP_]A([%#ENSN6UROS]Y7> ^P!
M(<T2Z2NZ"0K@NZVUGU%'<$;#Z!708VF<:%8@3@=B9^N2IL=+<NWYH[TGL RH
MF/<O#9)=@W($OR*"^\!_?BP_9O#1$8ZY+^'K3Q\]>O;,H5#!E36+"Y0C,1/P
ME9^>[SW[.7J\N[>U"]>XS6)^)>UU-%_8\4RX:+\9SH5'AW@N\;]_9\H6!7V2
M!8Q.YPEX0!7.Y93!AOKWS1.?#TQQ#3<V^LY"4R/(SYAS^#,'"#?1/]KY F+.
MJHF.012LY3K%C]I%#4J0;/+NHYW=6%&'%8.]KXQ.:4%C2PUOZ258?>+(F5F_
M%P16R:\)VX?H/\*7L>915*H;+>G3M_BP;Y[@Y'V#;DP(2V57\KE%(NSE[YU=
MF;3L=(/^X1^Z 5#<ST5>ACR?-X%REE7SP+<Y%6]@[]$>QGAB_D^3:I+ *FX=
M?\K-TJW@HW#4]^K7W&!NN'\[)91#C1X,#0BPC83^6 *G#8BC !2MAJLK#6ZD
M1D"RRA3>BA>CMCH OOAIZ4'/I8+9V3KN>'.[@^^%> M:5-B?8I))\B*]S.H2
M[,5EV9#%'7A.;8 [1]!&@>B*9'I!8PZ2)=^!:!,\]-H"GO32I#0JB/HRX5&8
MPVE(ZB/</6YE,$F59^P'_[3SLXN2'N^067O*^Y,G8/W2Q() 9K )(#]+',44
MCF^>93,"IQ4(&JD3'S<2>H4ZO)E J .F%[;]IUU.%*Q[ ELRTXEM3=E0/%E@
MJ@->G<"Q9 6X[Z^)<H/7^W%G>_?QDVC"803<[/'M;I80Z,?,^=AA.ZQ*,C@H
MYX3. 4/"_A;V2U:V'V-5ZYPZ2FJ;%)%SLO/B\1Z'!!+.]D*%@M-"E;6]G[W.
MV.X:2:!"3E(#5\#%>*1+@0\%LNLG45,S:7S>[)1QKYS[HO#B IR5+5HC/E-=
M$SE6ME8-U.Y8V1HK6U^_LO7 W+6\QF1&+8ZH\U+4?*UJ3U\+DB$D>AY&/!NK
MG(>OB-9!R 1$KQ=EA+,.3;7&CMH[#;MZ8D'0?@3.2QT,-1E\LLSVM=&<<D:8
M<X<+>#/%.4YA!>O/\ <BP, 6&E3";.G$K>MKI5OU%]:L#W5Z\(K@ZJ.KP&1-
M-.3B,LD9?1:DPBZP4C=!QJ "]!;8OXPFN((/EG-?!AJ=W2>/;!K/U7?( -L
MW[/$8(!*;#QA@_PG!."-89XF=!1X)D?!A YB[Z7K<E[6#>&XL#W?,^<N!2#]
MFH.WE]$$J[<G<?%>"52N>Z4B_4P+]>S17U^HKSN+<;3_JROT^//P'CS9&WD/
M1K=AY#V0I.'?#Z/C5Z\.3W#ZXZW2= UCFKL+G">+VOQ-_^,7&;O[MZR@>]./
M?@DO]P0>E$(GT+ZR)+0Z_&=WR&"9Z: U%?S_5.]L]XIT:).N_FT/-FCGR>"?
M'VWO#/YMW66?[&P_>WZSR_X7/3(_-JP,+O+__\/C'YSR80G;77R*=D+90'S(
MRN*4BU#8 C!)UT7=^BI)5=JIHQI37=,5(]XYK+)Z:Q;F$2[+31%G3,+Q>'OO
MR;"S_NO_G53_U54:WDYUK.YC%O@;/>,M7N?[D(T5<T"R<=I?$J9L%N=6V_K6
M<G+;1?HZK_Y^@5',SHMX=^]%O/?L\2"\7;#MV"!6<[84X5(M_7PO?O9L+]Y]
M]G2HN&X'W6+RBE0U<?@%J"7XS3O!&[RS> .!8D.T1.@IOMVS>._%7OQD9^^O
MWHZ3EL$][$V>7 <86',3KS]3R^@A!!)O=:EW>GRG^_@OTL6M4Q+17G\G?OK\
M$?S_H;WU6Q+P2L>2)M?H1B/BVN0YD_K!CZ0U<7M46P]/;7G(RP! XD2FZH@H
MMCH?>#ECE].^+[7'MO)K:KZ=%T_CW=W=^-GC9WHP?N+XO(L0^'D4\@<MY(0E
MEPKB*.!VY79WGH!%WXUW=ZQM^<FUMU.E30W""E9[/ (/Z @<KF##"0PZZ"Q]
MHZ[JCSL[VT\\M&D<#%](_V@%[1@T=R+"(^LB%D?Q?0#B&SK?H\R.,OO@9=;%
M6-^LN(: _@%Q72.:W[>@V/*>Q-#?J)B<^5D"Q"29SBK $:&JNW;*($3IF=<G
M@@F*'Q]O[SQQGXWJ[BM*\7O-OY53I*^\7[']&B_H$!-,",.9L6[;%"$R/V5S
M[HC\<6?/=2I9S*B?=_,FKEW9)&)H*"R0X%BG.MEH-;B:-E;?[:I,9)O4%]1,
M2KE"Q,%T.D(IDSC'?H@)HE*S=8U Z_.7VQ%B4'A @G*A<KMMPX2:($3]2W;K
MMSHWA:D(":TM/8L6_@L).R&*-XJ9X([AC,C/!&#9$>IM 5E:X;;G_;^H$#BB
M'8;1#GLCVG&$+7QUV,)8Y[^'.C^Y/Q'\WT?][LC]9$3O<,KOU3\XFOEH/S:7
M!)T<:A;V$'X]W MHQ86]T[9*7&EUKF/TA)K/^@?4+,R_U5E%=*\\^XA>2>.9
M];7&M'M=;$.P%'@Q4]R[.S&]X<38*A]U>N?8@9'1VBR1CYS,<]8=?W':%R/&
M ^OB/S.3:849$NL$]/_4>T'+Q.4%$5$/F48W**/H1*:;=@,3>(5N7!+M6W($
M)!8HO0[2G4><'7>(3@;@(BEK IL6/OH*/^*/S[8?!P__5Z1P-73WV&,'+G"#
M37<< ^1H]5\G:7IVXC?#4U;7E8^]R\NEA7( VZ,<U<#$Y.45KZ',Z_67*.8G
MQ;-"P6B"73#H+A'S8TDW#AF&.Q(,U^='I>OP)%3P8F=9@TFY!3:?KFQ+=PEF
M";\=/^KJ:GRXR'*Z3&WZ5P(>GX0+WJ!*L,<:O>LJ8\K[B)W(2Z(?IIM7IFFK
M(J0K[E\<:<V2#J"E=S]J2 MNHRW:G;O(];TFHHYLI(S5UT%J4U/;:0L!'8,;
M ]/WK-O1*V(O31#9'7?>3?JG[>K3].80K2,'JN^$LC8Z7<#Q)XH*?@BD!H M
M\@Z*%WLYB:%N[8,<1S7\UF'1L*@8G\)HY=&$=/@&! X_^TVB>G+D,>DQTJR2
MP0O4[DAMT\BT$@[_YC'A 1,)_?J(Z9T]-AD2=CXV(&3H"U(['TL_7% "Y3 P
M?K:]^\)7FC*XSY>( '@PV*#/:TMM +TWVMG;?FY#<)$H%['_1+,UF0A?&(WT
MA@-@OVLP--8N*?0%/IS_/&:FOB)L\\2@)5VU.$3V>L?2T9T0G,]&!.>#$).[
M(CC9@*T:WF\7_\'03D1I>G10'M=3@*F\%L(INI(3!\4U"(1;0BF['$M?%BWI
MD)*[\<[3O?CYXQ=#5[\))!(OF'T)["7=R%OD%SM/UX%BG6V^YKI^S0^?268/
M(E49NW+^. 5"FGI[O?/T4;SW'$%'.T,/XC->3$Q(4Q'*P8D_D?@$1;OVJ'5&
M??OU].T'.POSZVG8!X&<=WKS5GBL45"_T"Z=F%1X7[Y1,3Q;:XC)%,+Y!)6I
M4Y14]0<CTKF6)J'B2^.X"$%Y.ZRLDJ!@3FK65M3-GMK)LJ-"_EXJ^%]-V+6,
MCX&_EO*1Y6"UYJQ1XWH_%1,/?=G9-=:LXZ3TSRC^^B=@K&E?5]-^,M:TQYKV
M6-/^%FO:WYIQ?PWF9POBZQ.#(Z2GWS*T]*!#O[26K'L OM8[QA$=82^Q47E+
M2?DLFB$/_JQC6.1)59;WT)L?E\M^,%U>Z#SK"YR0,86K7V0++M;0)_#4[Y*J
M649G'I4P_O31SB\$%=C]Q2,!7O^3T15_D*?U)*L_1J\2JM)]HZ?T-Z;<XDD/
MZ"$+69>K$,?1LFSA^%)]<0J'#]&MR(R;V*F-5(J4^J E:<<)MBC4."C35IU[
MP)V]CLH]OO.*HU*4M_-1GCQ[TA6-Y%<]Q:3M'FHH\?V=X+=)G29_1F?9]",.
M<%_.)V7^C9[DLV[HBX>STYO'/'F8I"<XAJP.CQF0X_CZ[?_L^[-4O(\_R.>Q
MSNBF"2V#\CT&KM<%KD\_#_4<ZJ,QWOV^XMV-88([.3K]9_1J_^#L^.3T04XO
MX.P #D?)IC<XL_LZJXO2C^(M81T4W'H/5@??*?-+A,E%%_#K*#58[20D'G@.
MB*DDOPM=JSDQU\(WIEDMT_(F[;+_NC3I16=\:7$5KUC+A&6I"3 _.$<1CJ*W
MWP&3JO#6Z[+\B![@J>/;5T/0ZP$&CM_@,]A>:,)3QIW97![8C2EU?0<2R8,3
M1S'<F1S@T'6X4GWTNO0XE01>18F$KA#ZF:02@"QADPE[U[TZ_7+MHKU)"E"P
M.MZ*8.$O;=#&H\2*)%_6&9-PV*>#(RZ;QX$DCI>BKQPO#"L2V]Z$(&),B<OZ
M()LNY[E3^,^\7/ [=A:8QPPA=!$GT/-\!26GC>T;XN %OA_-K>"'2 J?I7AJ
M'Y1AM'6+]>$(\7Q5Q@#JAN?H*#V10W.N'@>^!H@X'BBZ$XH4?YJ7.!82!:'"
M60L$5ESR" P]9SQ9\88R)MS1O+]$R P.?HVDTK-D&J# !Z\H\QUJN#7\_&,A
M<RC;FK'X.-_< E]S!/;GF;E4DNMLKHM$T%RFTDZQ#8_ T QO]/=E P;9G.+<
M")XDX4<^&SB/YHQPM3HO(T,%7;N7<Q.-4#1P0QD7'!ZCTI[5SJ&!STE]$0;;
MI:FVHT.:P3H3V#B+'=R;1C^P-G5"+'H'AY9<9FFKSS*3)?='??J#/[):7^16
M4Z;&<;K#+E[O.-T/.KVC( 5 ^JO6X86@/E!\&J/,][0W)7]9OLE8*[H&ZIFE
M::0U%LV451V6/9T*H0RN%Z3U05)-RN(4/D/CL_=\]Q>=?<M/H1535,.+'H#5
M* ^?4QY0H=3M=.K/1<NI;<MI"3R;X(EGLVR:D,5PLYTLU63=5*6;G20.@KT&
M[2<J$=AIRGQ+8=M%XJ@P6KC(DHQH@:3X9/0JFJ+*@Y.TR]L?R\!_OS#)94:F
M<N4ZM1LJ2&\G Q@(SF?.ES)Q51[<!*J25L+-=)LE6=ZR>R(KQKH/9Q\T/"\)
M3P!Z5JHI5W+O%,MP=T8!FQI^03M^R%="<TV'!Y8-S#,='@B/X=W@5NRS8&]$
M,LER\%;&,W*/9^15WM)$2CX,TD]D._JNDKHQ6]PD-$/P!Z:O:J0B(,&")VK1
M^+4R&L+J.OX/^%);:QA \!%LI#/3BP)>^)QB)GL[O-L,E'"6^S?2I),;).[Y
MLOT/9Z?.Z0P1DB'7?=+[0N0-NG.$B!4>]!8>-PDH0)CK!D]92Z\>RQ0MED:V
M-G)7.M#SA6FZU"NC$']FPR_+'/%H-[MSTPL<$8>&^S\,H*V219:BLX_S:*;D
M P0"21,*:[V>BP<3&8;RB;Y!4[!;;N(".P [#=HTK:?)PERO4_51>1PKQ=;^
M/)M0]%S'I7- )&2QFK_H.,%]H2('W#:F[?C)TB'81Q(T2NIGEE3<48'GT_#S
M)N%^0&\^O&P@.ZBS5N2ILV<ZG(?TFI=XT#_.L1LCR>UPX)FJZ!4US'&SZ&SV
M9>P865'HH!'1IB><H[#9A$\9ER;O=E4^*E?&]LGB'"J9^926.%()28&2R[+B
M3TTU[];L1NG\G-)YB(.^LAEN2:"Q1+INL,U68.9&@J)U=A2EB3QOH4\@JYV6
M%A5-Y F]-W6C6#L.L; YI. X++&45NELU%BM.AIO_AZ$?I4!5V"4J?MT,,4*
MPG82YN8?IE&WB+27/UP<?$GQUISUY!1PE=(6D[R5+",D+?:2*B7LP@KY &M
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M",88\%\#_EFRJIZ??QTB8B"#/E;-[U$BJ)AJTQEN^DEP1M]OGV[+)!0'D9&
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MLZRI5[/DGJ@-M1R/@G_O@O^@U"O'8A+T-R8KW$Z[%(RDOK#B[7"@<'JKQ.)
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ML:. !3_2[_"834)DIOIX3K&0@VIHL83HK"P&\@W@V.@(<I(BUK;-<-)V '*
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M)$/2:!_;P6-+"%^!FT)D/E0I1_%"RH@DB-2Z(2BNJNFP\$\)C^D&B,Y%'J7
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M< M@E'X9SG*"O(CI\D3^(\VI (5:7O'AP3DQVN;_K\@K,503G!9S-,))$=N
MY(\7;R6%SMH32!RC>,W,R'&[,B'R,(FW*E@+KN#D0L+[.]XC1J)F0Q/KLT)+
M=I^'Y]Z>VE=Y?10LC5HS2^.CK8<B_<(2K$=!"XXT_Q!#8$U,>L@RD^7EUY:$
MK)9]EF_&#K*C_=0V1UQ"H86YB!4V4O.Z08;& 3=NVRK![2X0*V(D0O 5Z3>'
MF6Y-?H?I /:@+:(0HOQ-7D<*00+ !9095S[%=(/KZT5H)-DLD!3HYOE(EB:;
M];G&BZ:=P@J<*NJ*1JL-#AY=]F:4PV^T_BOJ>MZDRD:2 NQ%W%<HT0%E&Y97
M7TD=5(SW#(T\VZND85OG,=$ 9/GG?<4)42]<+5#E':449:+6L5%N2LM847A>
M*"16[N(<&VAW'@XR$A="8 U']>5>ZEK_U5QVK'P5OBLN+(7>*VJM;/)5I XL
M?O7%2Z/GH %9PBL;=ZF'[R4Y DRKD"Y%OKF!M9X,$K39G5!9E-T5S#//L_*F
M#1Z/[;P9'3$X(PLGR5\EX%^+_RY:2EP6-']/&NR9OZ\$R2O79EXV;7@9T%PN
M7I2K;/$3=92(,L_W84,VVW))_AR3+.J(6Y20H<U%%1(M#Z,W!OUFIPO(AQN:
MT4_IID* >(4\?ME944@[+HG*#MV+6,MAEW55E!B@];+L#8PT?:^8%J+1DH'E
ML S*K0Y/\PNYLN7ZP-BTM"_^V$*/XF6Z:!8CFGAT2^E"TI[$V/^_0E<XO?'P
M14_3*+YV#3$8>%M6+QO;]9BC[YQP*"TKP#<)E,<JM^'@^9;<^._;QEIAWC#S
M\-M-N89I"O_^66G)RTX4M%2GSXD.$K9O<;4O"<57%P8B" LLKUPOMWA^&D:[
M/@O>:V(0UVV^+4!KRXXGXQB [0I3Z"4[R)0[MU,%X*V-1]F)?%OQJG'$Y^+Q
MJHKI]WMB( \32PU1X:UT7+H"K.;NBIPWI_<>O2FK0QU_5^VMI1>:?ETY\.C,
M6F%/=H6[D98/!\9N8@AIJO**ZM"]=S 3.A/W J9:3\C(+0@0L7<..T:2CX_3
M:/#QP8(;U["^7/ 6:T@GN.^88MWQ#3! RUCD?1M2Q*LY*1.V>#:(@UFCP"%A
M'HQ==LNQTEB8U6IU0Q2#8^N8)=&Y#\$P-3RAJ[%C2>]E]-5C[V*.5(6CP^#5
M!!]AF78?.;#= %SD2/'Q4(GD:WSJCB!AB!M6VC3'$8S$C8GX72\L+"<8+KQI
M*NGX0\E<C;F+HV:8?Y37P5)"&YK,PJMC ]T<F9"L*Y2^FD_[#)EGI_)P)_:3
M;Y>M.XI:SGX7V/)#,0M3D%D-21QS$5 NC5-9F6]>]!$,SQ+QD7S2!?+QJV/?
MQ16 $XH[FGWHE.#>+A7V:<#:R-!UEYN/H S,[H_7#&/@7BN^$RY$!D:H770H
M_8.=BX?S2_SYDW/Q\%P\?"#%PRXXS40= !CHV)A%HJ/4MK*96)7=#LG].YDY
M"6"$Z9ZP]TIV?R2+RS=*1 A<2N?QXJ]XF0()<LHJD(%*FI*2EC<^89T"0:H"
M[0@'IG5SND+.IG!:M,UED72[<?^? = AM]39H9.Q*"#ZEH1QFVQT02X:9*[@
M4\I7F7'FBO(3\@7KA&-ZQB)>^ 0/>8JYK=/ W/1PQ=B9J.D979/42G)=KO84
M4$$DHH\UHKAN4J!M[!^+=!E\X$4=;%ZQ/W*)B0/6MYMF?Q5._,5_42EM\3_A
M7DIF0E?[&9]>RZ>>1S!.'FYB.#<M4S(?VE)H5*CI$(P>['_+CZ/7\;:L@^.S
M?*S_ 6)"-QY&>1@66L_E<D3*(?;$(Q*FV#6 A%L\>_+T*TK<\#N_H1"#A%MP
M>+\49@.:BT=21]4;_X5JG%)$_0SCX*Y0%?OMXO_DV]TWX=,[7(S^IM>*[T:?
M\@MN\Y^I:GVXH"+6"H+AY:K,T<6X2)[(,WRP?:@BO@I&1Z[Q@BLJ;_<[(I6R
M!,0+)RG=).D)U1%'<>YE,(_![]0/WQ1-6+A6O_VI$-X.W;R/D0%B5E655A76
MT"J5CA'AG]5@2FX94"09PLU>[*\(FO[LR;-GF;FB=YP3JE(#I$Z:L4QP1?N+
M_Y4M/O_ZWRU_],L^S,5_7#?<$49[N',3D9#D0Y3#ZJYLN*7A6I>J-\:9$XJ)
M!!V.=LS_$*#APV#O*6"26Y&,'!6;3QY03:DJX9@Y*$0>,Z'7:R;ZK));@D>4
M8H5:-84I=Z-[4C5X-0=QV1"JCH#')LXK5'8H8R97#EO!S)^0J][A/&J+7=ZS
MK"K,8SB>I+DC6HITS+0T$VVFHLRE9[G5WH1!N=UT-_0LU@3:L-=7HM%XZ/+M
MT,DO1)+$EAW5[N;@Z02]D,YHR\ <H=/E<LHL.>L?$$,_F/R'1VQ(T26/%9\D
MMB9G9:?] F)#9%/2DBNU>2J&P+JNIDML+G.)FG-"%BDYN<RWG"1NV)BA("JY
MJ"WPP'KCDQ3:[KS65&NP6\L/*LH5WKRO"J,IK1M21#I!O^G]IJP*S6)OBGQ%
MY [6,O3V0_.A+++%*T+R-&67&>'GE!AM3(: /TR2WSB!PZ]12HLPD@X"D0+
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M05J\L8!NB.6<?1:E^8T@)??2UEK+@\^P>D]<T"3K=&:,2$.;GD)<1 -#Z?J
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M]7'4CI_<E _R529/<#/0$67&&) M*_;=6P6W!<$J,3 +SFUE]%O2-\_I3).
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M&11 L&:GW0T@L/\ZD2H,G+V;T=8TS%!.9))H".HWTFRDC^VM:9ZH&L8W20;
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M@//"B/CM@6KXOD,# A5^<BLU%R:"FJ,6,SF@,B81C!;?*EBB?5NX3>&TXQ&
MN=L![.4=[VA*#2Q9TQ)6<RJ)/"18S;%U X.\(FE+G*)G-Y$,$RG#VQ-B]SI>
MN&@W=25VT=2OZPH^IC7VWC-1_S6V*6+?G\-NH#N&QVM5,5&F@U#SP42&<%H.
MEM5>$1PX(/HBWRYH>!@9PU_Z!O?E\ LY%2).K/P,DR@S!?_LV.75X1]$F22W
M#%_/?/!2V!KQJ^X;R^#PC3):SA5VD-/L6#7+O7T$IVF<..$5+@C$*AR0%7YZ
MKOP=J?P]/U?^SI6_!U+YTU U1K9VE#U>?+<'#H\CGI%MEAS/:A!!:(XI_.H)
M; %E=&;BB7>#5)&E<>#ZZK--F&F1(U(U53BJCXFEUB=D/!-W,\I+9=2<O_A[
M<*L7SP N??KLF\7#ZJ%[2R093)OQUGDN+^)9\$;/@G]F=UTXAX:+PUSZ=!78
MDIE>#G%M$5^!GDCTGMO@\B /YVL:ZH+=+W.#NI2DO^8+8;[99</H^2:1]_$'
M,L#4=5&AM^.RJ$B7$LO-/[9?JE0JY52B>Y#;J@PTBJI^47QD ?"F<$XL.9<;
MXBFJK[2H0UA-:&\R7'HX5M,CA=[DFA*77K,SN+K:3@NOEWAT%4;?[/NEE")1
M1J#K=!I>,+:5OLTL@+QO^2DX280&M. O^')EY+LV$E].@W!<;VI)[&4SPVJW
M7W,MI;<R]1KIU5/TG=]C%OX_>]_:W#:.M/M76-DY[RI5M$:D[LG.5"F^S'@W
ML7-B9^?L?MF"),CBA"*UO-CQ^^L/N@&0($7)DFQ')(6MVDPBB2" ;C3Z^K1Q
MYW#XXC2Z)^V04.%'@0RCDE:-*Q6'E0*9'++J\E8X%O(!,DV-GQIVW4%5HT;*
M,<B9PA?$<>- FF1NZMF448N4[CN\.]^HN="WKS0?5)Q.ZQW\/#4< YA&+ X7
MK[6 00J?PWI8\$7QWT/+5<RN@\@)/)1TY$VG[H]=D6A>@&67YJNF186,Z=*,
M;HY;+ >0"8&B6E]6/V4JC_,@*AQN@7NY;LY/TSQYW@DV0A]T',U]7C68H: (
M;<Q05*'%K2P>LW&9<+US!*(2,\9<L)XP[X0G?A8W^D:T X"P-VY.VC A\?>.
M6A  'D4G6-/M7F*SJYD(,Q+.1<T>_4XGL:!CXDW&>;#Y\#/!N_R)9!=XA&=,
M@(,\[;.'"-C4X15E).3MQ@.:94?%DR:SI,1@OI>9 =>O$ :;BOYTKWI@UW3:
MYND?RUC:D9+)_("WMI==,I7VPME\?Q3FQ/#0$+]75XL)54_V1\_"BK-3P"-M
M:PH5,G?>BR3?5/(N(8&:;:%VY)2P)IU6)ZF7(\&8L.TYN?[NTD=>" SB*@X\
M["8N,X'&CZK;<ATJ_=:)&^M940'_%SD*2G-J//U6Z^0?0JKPPL#$@<^$5D8H
MH6;QJ'R_LEC!ITL?K#]>F"+E*Q==6XA8]E;3N"+AE/SW*9&9[0(M;Q2%D=,=
MX1=ALN.):[=I_.X_0#B#]TD@88+Y*!!7 ?5O00-4#.\"_R&:)VT)TN3ZO\>+
M)1.RC+#@D$X0_&[@HWC)<;P8Z>R699N"@+PA 9]+DCPJ^AZH&0T.(Y&J *@8
M9U J%":H%L_DE)TY&Y7\-/5R_3[!QG*0Q1E(+6@O&Z8Q'1?R0@$<1+QHYH3@
MS<8FM/F<@<O/UQ7-<(2+=48F5"U_2SWT@1-^$ZTOQ-TF-N-(Q>Y(-12I&]('
MO/WA#\=+ Q-/)Q;M=@1*D%B4*F*OFUDDPLJONVL;,D"JR93J\935FJMN@!7_
MFG P@,4@8N4*6W&95\!*IB(@9%5H0)R0LTQB2&6;X\ -P7^C7J</E N?Y&+&
M-RNB*+EHTY+AU![@P>V,B@))\5"2#.QR[W]+L"E$F3SWT!2 BF?;Y(@ADI>+
M?TMTEN2*4%E];1;JKFR[)G5WG04J$\S00P K V'DSU)AY/G&-\]_8!K470)7
MP NJ,]LL-EC1.[C7*$E,7G59K!]%P?4($"TKZQ(8;9P"B!J*^RX\5+,8?1ML
M.#-K<&QI9ID[)K?[*T:F]%VQ=^[6T4)'TW[M='0T34?32JL#G['#^  &%?M/
MKE&2E-V@*Z#SA8.I ()3L!3[R)$$'N$.2< /OH&<B-A_?)&.QHXQ>"8ARPL
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M#F^>"XH >/._$=*EX)@_).9WAK.2S!91.[ #3._'.)1V;P&86A&6&@9*!&#
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M\U#A26[!Y!2L[0W%?FH-VVW>O& ARIZ$O1K$+I4UW1@\QWN5;?4B=N]DB6)
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M+183@#+J-5&J' 0GL.%Y_5D.<;/?M(==145(6]ZGVY-I62V!,@5=,!M)%+K
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MO*1MZ,[F)];!;O^.5=-4?:NPU'#ZV6B$T8"*<HP%0$\B;%NQ.IBLM"&(32P
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M\:*M+M22=P[(>/L9$.6H.GMFNV1]>"I^>-I=LSMLZ<.C#X\^/+LNNCLT.]9
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M:0)+OZ'+B*+[N]TR#;MEV["Q,4PPFC/:K-U ?S*)$32+_7UU$$[Z+>>%G+"
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MQS"9"16C0L:*Q<NSQ-B,;5OPN.X<@T[+I%LB(YL&8!?,?#^"2\0X/^<EH'&
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MP27>$\5=@XI)U>>\]L4W_[4E9]=I>3+\:B&B=83A ;?0C'?:=C%8D!0 D<(
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MV)IE"6PBH?O[F%F/Q3J*.1]=7/.7K^K *9TXV%A.$""\\7DXYXWOZEMUJ--
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M*')0#G;DFD&%+#4]4YZ":9>F4'(VBZ2S+NF5H67+"ENIWK>G6G:L][0?I;\
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M;II8MWZZM$* GYLE@ X1)[0#QWHU[DSR9_+%Z&%X5QH[^=/BFWQQOD3'DC3
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MK-HK)F+1[''0;+>WSB9S(#GT*?FG8P #.<1>406_LNRX7F-<,-8$\ON/8#R
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M2N"0:T//J;@Z/IT*=QD"/RXVI?(R&<*6L1%5EK/FM$ ;/8<OVU99KH\.%XR
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MQ&E*,6\=X-6@NVUDW-\4TLE7DUTA2WW<C]\:LD9GR-/@C&YMSA@."X)\?L8
M+WF\@]+RFEM4,#C8][N7GH;@4I4)U/0)W4]WDZGI$VKZA+Z<&72GT?-I/K_\
MT0FH<_+U4@##OT.]LQ K/DC;A/H[$DE[&GB38-QG^-RB4>M1TVX1+AQVO9V0
M!.'E3((H(1 Y&HALS$4'F4>M1D%09JP_452[:19CH))4A+"M9(W!B0!-=I!C
MH/##5'K>Z-['/I&1CY()S.G\VT:8TG<;SK%/>1^PDUT,T"$H_HC Z,:S(<BO
MBR;HUF].Z##HK _@^*R<M(U6]:<LME;Y2?(8)GA%;I8D2@?##X)-XB>JU:PT
M%GC8$0\^4J4)6<!:749IT$Z%YSAHAL$C;%0+'V)>AZ8?%4M1#Q^V"I@2X5L1
M).)V"72$-)RB;@=3 ,DOS<#^73JIM71NA#43 GT[4.TQ>Z,.(##VB-)O_71I
M_>/:^N7=NS_0/A#RAWEP#8@=:+AR'[$@\SJQ,K*V5\Y7(':%;(8,V#8K98_C
M?ARJZE2F1A3C&3G<2V#AD)6MQZML%42C;FL4ILLK/7A"%&(CB!)@PJ1C_2D(
M@&"WQ? C.JDD5;4SW.H,?J6H608?#P [SZK*UP%P8YPS$-]H*)6#8@!Y/ >+
M8RV!EBQ/+&)!TN*OS%L02Q!L $OP D44*P=,11_ $^>F8:*#DQ"%<BK)P!;D
M7PK (%"/P..M(]1);-/A$R!G@HZ%!*RA!#98HC4@F32*"0P(V]C'%6EW\ .4
M51&@-H*MP*9@OU$LT7B+1!7X@!@YJ\M)HI#D&JE7!J@?N]D*X(>;),0(#&XB
MY*+RKK8(A;@%_KN(\%RP7Q\?7_H!/ZB-6M#1N\XE$6QH%<%_YAG"PA,)H'K&
MA/\[ (D50A_Q?A"[V?IIZ?1XNJHW2[& 'H/ 1M.X$YW,"#8($-(B6_!'*,PS
MHB% Q#R*5PBX>BVGFQ%@^2R#WI^+J'C[)/^?0D7U_RWR,#XQIB2:-':P/)W8
M$K .VP?<5@G7=]?OK7%WS,+U/0@,9&(G2"(0SB!!1)QBU!T=LA!66/IKRT%Y
MP3*'A6;,2Y&0!^/$!>V!X@17ONI>$6\5_B9XN&%YQP""&Q\EA393;PXLZY.,
M!8F2@ETC&1'9S47+"" "D ,Z!0;"K*(,GF#L FT;##P":_P%/)K"3VZ X"G\
MR*)9P<?Z_)_.:OWV)]UKAI?+WX,1!G]:,S]RG115J,Q6Y-L$KS<$?"]\$B!+
M49+GLHU[(K;L-.#6%> C?\F.#I+RN9#&)%%Q$(D L0FNEK+Q-#ZTHAEXE$IC
MATICT"'MG0?IG@(>.4*]"Z!7FRT @^<D40"N:A0"4@5XU"A,\I\+!W95O07+
M1_8 (2@\AO<*L)G%_'P$U),@F&^=V$LL3,(E<[D9.6YQS\%:&-SY0J,A&?JY
MR0(F$:FL111Y3%$Y!_P+5*X_WQ"V?0S( RKVHEDSS$JXP]?QNB@+;GPXB@3L
M+$M\3'T#LV_6*-:#C4T_JMA*'EYBE>D4Z[.JSZ4*\3^^!6TEFFP B [V8;%C
M_18EJ3)%==90;P0M]XURM&PFT5.VM8QN@6%B&Z%'YXU9M^<>2^GW8'IJ_%:8
M5I7$3U%3B1,EF))EE 4>&6(1!KQ !@JO4W(ARA:"XE96\"0_*;E"VW5RD\>B
M&C7+U^"K##P)SHY%+7P%S1*5YHFM6?G:>TG:[F52LEO6:,1*V8*F98JJ?@<"
MM 4_V=IE"_F-:&L?PTBC$M/B"Y#L<8C@1--&)T*V%Z5F!0ZZ07,1MDA:+%5<
M0_XU0C3*TG66JD0T>ADDZOC+;=E&@ES?7<Z_  I *^*0379^0@8'BL[-^K=$
M6$H]*[+5,_U2CQ3'@DVRG:LB_+F&H;6VM,3.NUG#JM<[F(Q/TCO)RL>=$+@4
MS0(+8;R[!'$2)P5"8&6P\LFS0E5Y!SCWXEGAS,H2I?+\4$/3[=)WEX4?5 8#
M,!&X@.JY%1(4T#6@'4/#^7XJL-F("$E-6_B:BF)^)#)\KQ7%M(_S_RQPHU?Z
M.&QE+#")Q;)6  E'&R'%M@<4P(ZCKDO]N%3MPOK5(]=PSFL1(U'T@LA%<,0.
MEU>Z!LAB+GQTF!))<+"_,*FL/6+W>L:6?"QS\M(2\JG 12XA2]CDPE;DNEG<
M1KOH3^8LD R@H>"_.0MNEU-*_)&,T/D]CUR!F)@)UT%Y7%G5Y2<E<1["RXC-
M?:6$9V0];)N=Q?KP[B! W(#PL"[\#F@" CM%-SA)&O@@23QT55 ,IZ\[>GA1
MB56D/N6=EQ? 3[:6*.U-63S%5VB3X/BHE SLA$01%G3N(:XBRE: PN3&[B#/
MJZ[)C9G<6(.%9\FC*1=FDE\N"T@HK, *JU*+:0;2CX$#0O?:748!IH+HR4LT
MX_ 'J\@3@;UM-VEY)@PD!QC[G?V%QA/&7;6P1IZ:JA$N; JP/WQ;LW[_ E+<
MNLS5/D"([0GE"6#VI=]]F_A@7U#H0UJ;]'GO+<=,&&T*YD*MC1J"+-H C.K+
M&R<$E>.H2B%R>6,A*R#*SP@,&# FP ].E_!*W[5@?[&TV/$;5=I'3Z#1LUOU
MKGQ[C/BKS9"B8@JZ ),<ED1+OM>U:";AZQ9:'9_]Y.OESYCL^*C2FY^1'2XI
M]AGCMW/\-L8/"P+>B;3\HW/=L;[$9&YNK'^+.+ITHVQ-18I%<0S9+"M,NW!@
M$2C##YQ8^?L[R-_%BL[%;;3R<M[YR<=0!U!>P3]H+E-ID4=9(T_^0EKE$7T/
M$LK'*Q<I5R%1M#?_'4"[BHZ+^KF.]0ZC49S (F>2[77EBLH"4KFSC2\"3^;>
M$*-M!O<_(S36*'9^:?V4"95+"H "\?NB!I\3/!MY2P=5@'+S 2F75"DP!X&R
ME0<B$0?KW!3O ;7B%#"6W**ET4@SJ?UISTF.TEZ@?XG&-=XU7)._+?F'=T>A
M>I5]6&?@_KL!=>#Q,,CP9>^:N%$J,<-E,MQ-H0,]!Q,4F*S-HVA)'AI7Z<;\
M]9+H5/6FQP%N8NW\TK]RX*0XA;VX&2</=MB?@WG;GD\+R?!N\P0_^7S]+M'
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M$/B":B0$^+%I$9V]Y7RM@P>_0=O 5;4F> $4+<\'F)U^2!%;)3^H_FH?U.Y
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M@9KT;RC )6T@]84;72IYVK%^E),H\<ULR.*!8 ]P2'*>2*P!S%&2HP+Q-B'
MV-5907$M,@,-@W>"R]1?B=R 9M]-#@SFF=KPDA59_&B-I1%2&M\Z12)2)(S6
MH2(DTA4R#B>GKI$]3NZ',L'S*:\,P12G;J-"!*;?J#&NR-4"9\Q92\ QJAGB
M$A#O]49P-XDZ*R2.K\; 20(!V5.R\EBYH1^]C 6: SB6!B@KB)2?IHPTFRUR
M23/25<3YE)8VPWX!LE@..D-C!,@%[?R<*'F^F#3]:"H.('+AE%;KC[HV@ JH
M@==Y_^E8MY?Z>V\O]3K#WEVWE_I'*M4B2B *_RK$.E=7_\I ! 3R/C?:-W+\
MMV?U!U6HB_Q (8B32A8(+Q NOSD;.1 =7(".]0_D,A)+4;P ^RT!UB/KF$>)
MYS16Z!-R?8&"4B#)RYBF_DFY K8IF,:>YE>@.(%=!L3[+63(/V4L*T@B/<2@
MRW4YWDE:KKH81RV:H'[P4SDI-!^MG1O!;-C@FJR5RAJC& T/CG>*T086?!$.
MLB31<(%&<;_[]N,?[^AOO;>O^3<K]+#9V<L-)4#.#<GX'0^B%-0IWEJ6$V"U
M;<@"(?J -W:L/]0Y%B(4/"Q>#TAIRU(7 K!4V#BL%.KPBUSBR;&_U^]^MDO>
MD0<$*%@S B&$X-;@KJK_96&H<KV$)3'?E(/JCP]?%*AP[1C]#T=IOD6PP3J
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M0V4-P#F)2'(OHA GG*M#.O4?2:<V^;*^EG0J5I(7,MA48Z]8[J<@9IVFR,)
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MS.V6FA%C-+[203G!G9V(#8]AY"'W\AT>IJ-_'["GVX.B3;AL@Y3_#2\5W)D
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M],JBJ5=:#ZR#1G6K9+9MBL>7Q\D[--OUKYB7F73WP1+ALBBA8%*7:%^VJF^
MO,I- , MM9)8A!/%PM?2++/=2%[X*F.&R3%]1C$M\PBDH%9A"Q!86!O D1M?
M?7E,1M]*@Z;*EQ$Z#H%%&)A]"RW$C6QZ&D#F*AKD]BZ!!,BU3%M@P6$(5)L7
MM20KT9")75>W=@(EX,[LS+Z1HV,+>[TP7FGC%AN]WP^W_0^\[72+]*KY#(^4
M)[NR8KX]H4X9-$ASK>2W%$PXF%&NA)=T8PN<.D"5_)LRL4!)3]76@)M/KO]*
M (B26(R+0/+Q]-WB5L5UW4E-S)E(%]_EL=#(@D1P^%!/^:IX#M3O+UXZ1TW]
M*7#*,,6X+ /^,T#Z^2O$ACF\JP,:9A<:YLD!#7- PSQ8-,QK[J.%'G/U'-+%
MUTF24C4QLW]!R -NXKY >X6<C*B0J(UPD%.&_"?U$?=7<TP7_:HT_-&AZ.&>
M>Q'0Y+JVF;R2=+G(1X<QP6!D'U"V&&C@<R FA;XW\#+TBV) :PC]DK/EA[VY
M;^V/'/"X'W$8L[O1"A4I2F%:LJ864+@975=-GE?.[ *7TQIHBVP9N&9P3!T"
MPC9Z8+Q-RC[W#/9!5F]>UQVXHERVSQVC)7I+.BIV&GTV]9P<&:*/LA-\!G.,
M/.^7CG6?/5&VD1W""3P>Z)\DK9BB_$<J7[7L2&OC#^#I<=Y16F";C7V0X?<]
MFTP>Z;W?41]W5K1-O^JTB69>QOE3;9HR761*C,PH^J+KNT-+D-^S(RY%56G[
MUPV'/WFQ#KV[88\UR1]D*[H@&>U2[(5NZQV-.ZF+)8C%CCL%6<]P$PI(PT\1
MU').'TJAIAJR"+LPK;*I<&%9$<6<$:PF]$3(%5.N_UIFGZV#7*!OA O[<'SN
M:91)GG0/"\#>!F>8K,G @CR<@GN+=80=(4*DF''#YF83X2[U<XYH!=5<'!M*
MZA7:C")JNQY<:E8.01,%-G3*^N8(:=##+MY?%7A82'@Y_.;]D'=N[RZDJQMD
M-_W9&7P7'W\XNOSP%V<Z6L&;\EBPQW!Y\5KV*L\8">]L+,-S*6#KL'^'G@1_
M^**%-1>;#M$QR[+#4?P=\0'<<C+ST,-W*0W(%&69)=\^^3J WSM;+KE9Y)5D
MU+4P6YB^V!Z=UCUBY,QB3U[@MT^2JZ.7[\_R_W[W Y-IB]S9P8#X<".<7.GA
M>S9_="F6_3.J[J#C W<@3IF2E7Y=EV&+FUPKL9'.% 1&T#+$P071;*[NKZ17
M7)#"XI_Z5J(N'N 39D/B-ZT<YUQXO@0@HF";!%02,DXIQ-8>3ZCO[K@77CS
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M/*'"_(."+$\ FX:E]595S[&N*!HPE)JPG,L)2AA)M&15-LO$[$6NB-Z27-(
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M8M>]:*=]RT)=$\D3L@AN]M#*^5@G,URL&^5N5)O LNVF,VS3CJ &)!BIUQ6
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M4<A+%Q*95BAK$ @/4:U,1/+9&"V?/(W HO;4!QWTW5(D&BS.A:6"F,I[?\/
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MC8G+- <'"#>M^,3AM-Y6R?>T+4L/$&8X=EFZP_8I7P<5]89ZJ>IKX?H2VRU
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M>XB2=1\PUI)*-TSY/9D$62NX<HZ>2\W(C:3 \XJ]_^27-M_X.2ZDWB0?@D?
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MLTJ'0_Y,6G-=TH"Z8_UX#P_']XR_V,^3P:)2#H"DN0*@BN!*^"0(1N4FG[0
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MOL=78K/JY0\>]<XQ&GL?TX]](^W.HD:S[8J4?6$1-MD^3QO!X7P]-I)XXI0
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MNW:HH"/)WEY\_&&@5.G;^..%L"_,@'PSI!5BU)M-(D:7-837"WF=E$:6DBY
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M66DE$?0LS,PT%<@<;6]@Q0##]ES08":5V1=R,['"1G55:[]&#U>[< I+(4D
M2P"*4X4<4* G68/I.MUS]]#IE!H>V$K1*?$:IF6YSX"*"BY-X-9%+I[$0!5^
M_#&%">9(@9Q3(S/GY=XU6G7AW2 XE4H94N%"J[Q%*U@VR["M"O?Q77%"6"<&
MQZ7<*_KCO>F$/-M.V..5C%28P"%7=CXAI4F !F;7+[!O=XW51VBV8<511^MA
MJD9"GS+PSM4N!H@I9HX3*TTIH<3&.TJLW%FBV#F$FS!X1K=K'7$OD\+(5X8A
MO C=RCPO1<9@%Y%TI<8R2R/'&!5TSQK$MX[:)6ZDK7N->G5.(@I$NX:_$K4W
MC2^Q(^Y=[.-S>H>8GB%-*6EE@"0G-_O3-F5ZW4[0-\--572.4,/NM'67R'2Y
M-3C&'=W"S0[\,$@$%X)LVCQOAKSX<3^W_K=*>8ANK1PJU,5?\EO5G)H1VK$9
MVHP2TXDFDQHKQJE_UHQ>^N'?D+G?DP>Z'A\=J_)*J=115?_X;]-_%"\4_KS
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MOD<TC5.']2-S)5^Y-.!,LPY90WQ.<JMU[X_KF3V<=+1_,*0RU&9G%PL$>+/
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MSQ)3Q3#/>!9,! *2GD<=I*-RCF$,5I3DMX6V.- <(4V?62[2N>Z=P_:ED@S
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MKI:2RHU.&7^VL!XZ+I-^<>(<21J<0HP3WG&LF#B,D6KIBLRL0L.P!\$IN@5
M!02$I[5P[L4$^!3R'53QS(@IK>(CT5W,*8BBE2N)IN!V?\UP@!W<W7OU*2K(
M7ZR1,_@KHTEY/(/M+,K'P$9<.PU?>"Z#I)R@SQ]O7IV__1T8S.&CT9/@_!P>
ME>FT V]Y-"-Q2#'-<,U0HYS:.^Y>+TM6JIP#C:0LX]P7R+1=/9@+V*6W></T
MO %? (5G40I&'MPSV/(I\D$0U3HL-/2!,E; (%5PH6#AW.[WF1-P:P#@=\#U
ME":]R]1&V:\Q\9YE5\W;J99LZL8 H D(<':"T0O<0^E]'H4-Z%JX:H=XVW;Q
MY><JIV$L2!(ODBI&7>;Y,ONTDAU?X-CM* 'D;(G<87K2,C1*4Q3@L*Q9EL09
MR;[X4QL>U_=:5.,"U!1@V&Q.8&B-?0NX/R>,1S/U0$0V.\(X_(6!))&*]ZXM
M(:%%V5'MJIZ;8=V.C$[,[;&TEKM#ZBBM22Z7-E;E%8:@<-/X\^>?/F7IZVP<
M.^37(#OB8L(MB?O]%J45>HXQAH,'-C,:T<G/9*>%>O=)Q;&0*_(D,G>PLY0U
MYUL"/2WTA!V/_UEKD'DP_%@X@N'5_C7ZO@)M9^-*;@N"#A^"0,3:\#=>X35P
M1%5D9?1-* JF=VMPG]I!EW+05*8_4S=HU<[;58/?JE1MIAN\$,5Y:,PW^RPH
MMPQ>RB-(*Z !3"2P20(8FJZ_WUHX<>H,APTEX8N,,3,3-/25CKHG1$]&'P1/
MU0RU%R0N"L+JUX5VDU=UZH7=/3V[0&XF*1$<F$/SCE1RY47-V>7G>$^"28(Q
M(<]H,Q%WWY'+KM.! [":"4"7@E+LOT')R"XO'<6?I;AVL[[!\5]78.H"J#Q/
M*ZUEG'84@P+T_2=F*%@OM!<E:Q@++>P &"A.B]U["G(K)OT0?:[EECK];L@>
MVAK-;I7YT-Z;]'/91,>J;;R"WX3F,N!N(98L TPO"T2L$X@RE)1!GB6JG?+%
M!M\_,:P$5W;)AY^-.2VQ2G64M8LWS"O,W@ Q#B";**VYBN[.KB'#+YH'<&A0
M4P JYA7"*8^!9(R[N]WDCA;C/)ZNLZG[F.TOP^%Q'[/M8[:[(Q2\'LA;IC?6
MVN:*D]2DEX'!ITHT>6XM(#9]0;>LL%;7Z*!->>1T(=2#!,*)Y%B),0G\UF9-
M+I.8K.FI5:: %?\6(9!_Q5FGRF00PB?+9$)JT"M@WO.]:09&3PRKA\&;?UX\
M_^GTXO_N)<#5X77&DI9HQ<($5,4"Q:Q4]$R U:@5RHZ7>D?IAB/"*U;2P]#X
M?M"&O@(IE*SVLBNT"=%^CZ>Q0#BVR9&@M,*F%XJNX3F:FB"_GJ.W.8\GL.0@
M9!6\8(\*BU'48<5 9:CZ8$1M\V("%%F U9='DT3MO<PSXSEA'(G0CZ,PE^T*
MG_E'EJ^*X((<3A=JM4"D)/^1B@H%BO1YR)IS%(SS+,+\N$E%V0:YNL3YX!GZ
MAVIYQC*#O @2DQN+$\$O;3!*PU?;QFC8OD EVVC-?\+EN<[R%Z"I8MS\@J,N
MN'6:D*Y* +0KQUD%_LV+RY_A6?X4%1M3.3#T:]?^/;KZ)K3?UO;36Z#^=G4K
MKJ70^6G/M^9X=39FW)N;;H/??*&6I?$N76=4ZQ*#]0OKB-61K.:_HEE7X.7R
M.[X^HX^_AG71+Q6\C K/R^5JX*Y3\US\>&YBI5&B!7$PI2$O)6U8^] W+T H
MEGAR\?>/]MW0,O$.3K!P,FU"Y!=_P1:!:VN[."2COLRK"5\VU311JC<]0#NL
MEE+4P#FY<#J'#2W!Q@4&Q'(A:3NERWK6^]0Z#/1O@F6L;<.[!:QC/4&U]VV]
M:SYRJST1)M4K$1Y=ZZLS>4QR0P0>CR^X.6MM/*(.":W^Z+I!B7AA(#WDG ;.
M5'#9QJ;G0^,?5:SF.?'G3O#J!@L>Z?"^H\)A= \,%<KG:'HEPB;4V%$XP]0#
M?*6$J5Z@9^Y*^P),L8+)]3QGOE1(38T4'B :C)[HW,D'I^_.3_>>/W1ULS7N
MPN9]-C,)09],D;DZ2HW+GRBA(<X6<,$3T,!R7X2* _"YK/4,]Y!5H, YB7[P
M]*2%VWT3#*V]_?\6\[2;-8O_NKSMAGL3DMT@'^T5$@H0,7(IUG60=14M&^IR
M_@5J-@.Y;,HU3+) HBA^/'')A3,IG>"EME!"'=E$E6D!)@^PE(4I%RG!/BC:
MU1-*)44G_9A2BQC4G,[[+YW4[+DJX<0F>0//*P'S^K:IO-'<[PM0OL#J#<X1
MA$BVN9K!/]'D\@,4!9Q4[8%&I+,[W&BG76\<(S)7,[ !*RY::5C%/A>U9"1Z
MG4TH&8XDH<1/0S7144!4-TV<+%J[::IHPXHL"FP3=W8%3JWPQ]E&76TS]ZSJ
M:MOK?_^WT>C1$^"04P!.6F.G%U=JJG1<U81F)Z9$DI;X;R!ZV-M%B4;ZK32_
M._?1MG/!]I;MWP)_O_M.X[=CZK7B\@U9--DE?!9=SH8))Z D$2,^FT<QII]@
MH0@FPRXX7S'](-8R &.21*LB.$?#S-I@$O)D+HSZ%U 1$3S9=$Y2V)%-"FLF
MMCH)8:&S3WMFJE5FG9.85X'I)YC8*-OZ#RE<76#F"X9G*1O7%'W8K%T)NQ(U
MZJKO91XOT&V&S#_&XF;*F@&6FG,BB_.2*/^[ CPO<R37B10R2CF>6\:G56;#
MHR9<;2)9'A%V!HJQ7I#SE/%,E3D@QL=,4B[8HI7.)<E5"AP)>*IFQBV0E/ R
M-4%A5R5L^H/"W"\+V'4(=0XXO\ XK<Y9,G&\1V%[?X-?%>9]%"N3A^N@$'HL
M!\$_PN BB1;R%SG]L):3_6*(<I.!><UHN)W:X5H2=4!KI,8I\?GG5(R,"<TL
M*@BROV;)*ON@3&)M4"\J\6CUML4DS2S+V%[,6&C;2E$I,S'Y$J3.& 3CJI*X
M^#:R@.^\Y?O79.W=RO>&?4@.-ZGJ$&C5=NP6SO6A['6A[),^E-V'LK>D_)@\
M8 YG^#.*YUEEY+>1^(]!N=%B>1_#A-Q:@4J!:XE!CLQWDH+>9_.(^4.^DF*B
M/;0:C3]P KC.7=M\=6691/!:B@>"RH9!5LFA<[/JI)P'*VY+RBG/2Q21BEM2
M4"^=O%*@C"45W90N_\$$9K=BDI6K2%I/X'.\B9"7(C&IJZW,*7F5*@6EC8JP
M81=D&WO,LI4K_PIJ'E7M>H7)?!\N'+65CI?^/RI*J%JKPJ3'-*V8\[\ R(;N
M#XPWH\"D)XIC7L$W ,89_;1>RO0X=-(786^L"\>4 M[T%^#KS!M8M#@@X8)G
M,L[1 )_E$<=5=#&<*=JS%5=%0,&=J##)ZXW7 $TDT5A7/&A?#&&&8(QS*:A9
MPP:*%G<#+DS0$Z YM\0.AZ&N6Z&U7R!5YWGDP(><X1&FJHJ6;[7T[BK;AJ<\
M;'HD6AIW.:GT_^ ,]\)%+ ,=#GY)[ POT(E\O29'VFFM;M%4,^IJ-]8>X>I^
MS](IM7VA*'R!OG*^5LF_R*HR."VP#<'O2+/!Z0*#@A&GV5=YME2F&LAE$=(O
M8(SU^GBT?\3J2G3^!V^B8AK]_7/PCU?/_WQH^<[1(#A%DQ3K0V %6V)WFE+N
MOW=[6N-^"11<X0F?Q<L$>"0>B9]4H5>9KO\-,.Y,7CVM)A^0GK93V[U1@;JI
M(A1XW<RBB(NU%D6](P+Y2#NMC-C'8D)8Z=S95%AK:*._*%I5V?'J.C:YG3=Y
M0[OE:PRC^?I>*7.>%N/";W'8U7<17OG/UV>GE';>T@C-=2ZX>669-.WR-^%O
M8$*O--7C\ K[RC^[7]DA@? 1V_$JT@(+M8>S/+M2P:]9?A65\Y 3HHA5(2]U
M,[1LB01QZHLT6NYEV.3#,'E6:9YFV;^"TP0]TKJ4MP[O6)Q/Z ?D,BMX=H*&
M/G$'[E851!,JI=2]R295GK/L<OO!.$R:?T[A3VQL!P1<-/JNK+_Y&C;%,P5F
M$,CD#.OB?'?1O@,E6J#P6 >Q"]U7[FD2Q2S_V;UQ\6&%ZX(&CY$9JNF3)+ZM
M9!;7NJ <<&HW5(0M\1F,A@!/I\!R8])>\,Q3=0GJ0Y<D_#,N,$,&S@SZ"?6R
M:S2,Z4A;^8]B;46*W)O3I^U99ER*F)R/[3=+JA"EM_P>?5"4G%>4ZQUG'GK?
MU'EFVZY0P4\'\7]7SC)GP-$6Y33?DZ_L8"-?F0;7M?+L^5LRD^$+_<A++N:-
M'.M"RLXHWACG%"#E!CY2"$>J/-6UHPQRV^Z&1O&W!7'PZVR"AW.#R/"=T;X/
M!H%[Y>O _C:%37[P6#)WC&G),W3A8M?[$T,N5'Q*#<PJJG!&HH/507K,9DBW
M[2TT3$W08S%FAR:L<Z:;7VF3RF_$L7$'CNOW7]LLOD<'?RY4JOT6?#[F'B2?
MR-4"'/%7D$R- D(X#;:;#3ZH%69?QT72@EI=LDX'KG3K&=M"Q\;$GR;9Y,-D
M'L7I8()Y*R^(78)A]P_,"H\&46P:JZ$R05'I EO0(N]S.X3JWFFO,U0/(J07
MS&KBU'M_OZ1J7&H;35I=UBH&914##[!N,;7=1E,L@KO-U/[*L 50$A>+[>2W
MMS/7',#=S%ZSMKZQ\8U 8LFUQJBSLLXFH6PG5&\<\K&3N'9&C#D5,<,U25:G
MK\]>&7;692.YC0U,0Z_AY@V]&')$QL15W8QO[/VP-S=^3>L19%^+W]_6"P_+
M! EBG'@,EG^-U]:!AJS1KNJ=7ZPDB[Z</> !5)]_G_-%)=5UJ;CS6"-6J@&C
M-]G8WI5T&W,:6^%93IVV(13[1KE^<7YZQJ1>ZV:S6":*;#?[PHFCN9"Q!V84
M[LC+P.>-D A&EY<:Y_X5KP.FB(^G1GP\LVZ6'(3B$K/BJ(.)!V/I9T9="$VK
M2^J88\7-5/) ,-L$NW;#@0DH&N M._ W0/W[LQ1, 4R4E3+=W\NI5C1 PB4F
M\?>DQ>#&UX5M5T6@?(FA!Q; Y^(VMI+'<:/6>KC5_-TVU6^/XPY3FXOA-/:T
MBD3G?L[F^:J0$$QXFYW,U;K=A!:K=(^5K"H)K#J=-S>3(KQ>!44#@;081U_
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M\+;*V[1;Y [ZPLCNQ/:T'N/WN';HLM^PR7M;>7K;316>9C9H847M3]&%B)*
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M^8!0WD.WAU($J^0YZ4'8]VJ2QTNW?8DIPYA%3#%>ZQ(20I2ST+#YI I#F=D
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MXA!>>1P.3XZU5Q'>[AIX.R@;VR*5G;?GV5#K4C^_1*QRP_5MM!(U2]+:-[+
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MDG@EA5=:&).O$+_YGQ"4W<F ^=@%,5IF,0[KH._.Q=/ W,(R(,=@7V0Y>A9
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MZCI?UYG[E+?D<R_:7+@_\C]4,3Y\R0W;]MUZBIEA0ZGIC0T?(?BLD'7S+%_
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M3:O$2JTBR0/=]\%Z2;K0!CZ0$N\F+3.IZW'[&KQ09.\*9)%FA2*D6+\14ZO
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M3$? _;N$#1(CS'RE1TT#J:_9%XB,0=\6H_$+?:7A__55I[F^).D=(.0U+25
M&H&,*729R1S=H LX)#S/*(%3EWS=9:'ZXU8*H8SZ 5R1@CP&R.:UVLI2P(Q8
M#?)?4#)!><5#CF;+570'L3:\#9*I\"W21O0+O@)T39QEY^5B$4=\#9%1U:A/
M;L@/7W'XK0A@EAQD8Q(# !#DZ>"3RO<1>3\W' 2!C(4> $82(R5"NX(#;2).
M\%DHX.8B:6;N#N"I(^0$?3/JBDNK@3-8*/)I%DWP,$2<WFD6(E!\N!$!FQ$D
M#_F8B:,F(=*[^.WUY0IA47$;/$HYU'M 71 ?#;:L__H.-N&17D2^(<#E11:E
MF4;JD.,5%#:OE5WO@S1/I+-L IZ=V$5KV:J6?<'5/2H7W@6P)BG@[M\%UI4C
M-2-G8J4H//.(*I[C5;5B;!1EP_N)!ETZ4:34>,(S](_EJ%Y)[4KRKEB"+S#@
MFXCB#MU,UD3*QTJ2CA'8+*%#\Z(#'%7=3!S\G_;9Z&" JJ_$N 2=$ B<67&+
M!KN_+7F1RJ+E-^V.UF*3DON $IJL"&+?,N)HI6H;Y7E)AAI<:V56^]^27-HK
MD9#^3637)*EE[8.5J&_#&16QUO=DQ!1Q5O0+P94-[H"YLG9$BAU0X_U#^<\D
M7K5@ZLQ27O@FI'8-U>I%(%XG\"T&M0@R$ HR%1V$/X4H\3.[PZF$MX27*HA@
MAY[)N"!&>/R6CH;%9AMI@&],!9Z?= Y5$1B.##-NZ""U,MSK]ZU/9E+7'O81
M "2#44"<C(_#1Z/^$?RD'\.W41K21"*9DHI3>+% 9\]@+,/IR.SK;,M$(&F
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M%71WVW0 M(8T+N>@.Q&6HOGZ5F0!;+!S9*YR9)YU>7&=1_*[J[G-V*CDLCS
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M\-GQ\<.^7+78P;!W=CS<I\5N!MF?Z=3XY  Y$)O^^M/H)^.*H,Z'+X>+K][
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MN2$FTTU4[3+<5F6X#;H,MR[#;4<RW'1*N5N7A)+*[>QP(AQANEA%DBHYW/,
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MFZXFH'JP@"[8D*+D'G$+047,"<6QCV]R!,2'JY:K8GR N3V#PU355A;2QQK
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M>E!MH/541M?F<G=XDA+3!N.S=0M')^.CUNNG-#5@GW 3=%@J@=<^7N=<PQ0
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M;6RQR9=P(IQ:=ML12H02H40H$4J$$J%$*+4]Q4MN=K=!::XKP-NT^Z<\]5G
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M:NSN8#N)D;HT\9-3-I_$6'_I+ Y <YYS61M\1<P/K@,9"O*@$.YHJ7"G"Y'
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MOT@"Q_Y&'7%NX7UAC'HX]WD>7%(_Q:M48SU5-=!8&02U+(Z/ZH9-?,*O18$
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ME;1--)7+%&D5$9W*BI):UJF*.4(ZJWZU)JX(2F#K"BD[%:%6Q!RFTBUW%=^
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M-JV^:WK.<-GHZQ =#AC^".H6+RHA/K3ZJ]B.;F1YY[CU@O;OX^0&!%E@2'(
M8U>7+M!GN40-5K]KNIYMVI:U;"**BLM-=_ U9^)XJC)&9WA;I,6;VFBS^9+K
MCRP1+;[].,U$82YL!JU4M3&7@:)-$1Q)>4<DX6)QP;SP8;G1J J<18U#]DNM
MUJN0:D:UW;8N"(;%F-)O>=F!";L!QGFQC"76ES2=AJD,356)BD+/3%6;E=O%
M]BE29=(^^QO-/.-D&;U@'81"JVMEMVE-"FBPRSLE1K<K ET%@U]^U<1Y?=#*
M5JVZRZKG3503EAFL<P5WX4W(IZ6.YBI"D"X$S1IFB0J96)@:]A+0LZ\A:BB3
MQVU!/KKH2DY<HSB)5M[5;22+B]4@XQXL.1-%#0TLGG!3"B]MQ,K'RC/Z.Q7H
M2_6/Q3?$.]&9)"D2+59(!/CWRLW'I6!!!,U5FKZE.8RRIJ5&$$<<V=A,6/!%
M:Q@52,LEBU)Q;KK;E.S2HMU7^2L*KJ;.%BP#M71I!U,&NOJZ=1V+Q7G*^@^7
MX3C3,S,K+K!J=]V\T86:^5VLD_GH>).]UF6]0!0RQ<JF[!L^ VJP"O:O9T,H
M(Z(HIZ2K[B->0'(X"F=H$ ,&@@UTU8\YP")E 2=<\E'J9AEBKY54B932@1\Z
MXB#RI%1=-[<1(E.71UT)O=)1 / +'Q::<3D:"U48??%E89,J(EK%=W7O(?4>
MQ4'$?")^&6>A? *WE_FJ8_C2+<;%X@?ZEFD^/3#ZBF,WNJTY<H57%,LL3D=A
MI&]CV?EA'$\F\8U(#^'951Q0:-B3A@;H>T8E6DAW8"?@;"*/K>HRA>6U1$DN
MK> )=W;UVV@5%E4B;HI@_157Y/,/*_J9N,9H)V?)K<*(7?+*@9=.C?(O*KE4
MRBL,UQ;<B%F:2R,)H?:DJ(TF0N/&D(]&1/112^,\9D1>@5DFBEY@?I_BU7G]
MJ5058D+?$#+S2G%[;'^!SQLB+J"P3\B)5,X_C#UF/KJCA'_EJD)01!9/&K\;
M+0H1%9FI(6]>J+LBH@ @/69IP/Y#(#UM"INLSXNG5_2$F, +JO4SQ17;)!^7
MK\DS ,VPNJ->QRK%B^3M_D0)WL(F%^%[,'&XZA!GD=0_Q$26W\&"!XA(E<+'
M6_HTG<]TV35TX(OG65$?$2]\&;,9^DHTENP#Y<228212$2_8  OSM5C"IECK
MK1P5A98S%"DJNT<$^Z0$&Y<;@@M2NP'(A!U4U17,:_JHBX<0>5)$E*:OSK)4
MW_+6-^HXI_7 5L$O7*M78A;GQ>$3[ (&+"E^4G,L:YPEY;+&1W11RD:%4QS8
MTK-E?;-B2M5J,_ ,BKA8%7'1I^(F%#JQM8U7=,\GU=N2J0C9TE5?[E9;.O3Z
MCF&:14S9-YZ;^3#.3'6C6FAVFX:P#M%A3W&_?"PYO+RGZ%9Z4A.1-.P![DNL
MA[3[3VG(4?[K\H83O?\(1:YNGQ:*DK*/R"0.9:'6@M(OD;GV<^T@M^I>D#LO
MFD&'65:+?2@ILQ-VTT8W9C4=/[HMW[%"!<<>4>'X5JC@0D9?M""XKG94">^C
MU [RC\K-W%?ZL=NW>1>QBH1"B2NO7&8N\].R*?H-1>NKPM[!F]RU6 98&2R*
M%%9?F"ID5;;"(K=C'"Q&H)2_D#:Y],V[ A0*=^%2QS2N2B@QTN1TQ8-+$0I5
MOJ_%;*J*?2%R-3;:21L7I"TV^<CF/4=5LT5+MK  8:/6PI)T#P]C41@ND2%I
M^;HQED+IAL*5BNT"T_E41_$L=;TOW5P1^2BLYAOY0N4:I>T]X!-0;I.RN1XC
MC2:8@QW/5>\$^4"^AG5F5\)?B@\UI_H#Z$"Y)'2+")D7(U9QFYL$JKZ*U0.*
MN[-D*U1!$XMA%3J\L_3E^[],%JD5X*VRBF(T3847H 5$L0F1J3.>8/Q G?Q?
MK8.-C'_8C'9$\=S[+%B$$YHR8).AT8C-)YFYX<:IROIE0Z]:3:5W\--L;/NN
MH=U&2W^-/8M6=<+$U7 R8?>20 3*B-!$O* $VRGV&J/?5D0B202*,82[X"YM
M#CA]O2)FLTL FT#[,OF\,=P2N5BQOM14 2KE^>3!)1L=AQ4KUSE[=RVB;*6L
M7$"+6Y+&]17(W-]Y)8(T/Q'HZXEN&VD K>IQDL0W6LI8\45Q*%/IV,TRG)?8
M5W4(D^I]@>-H^VP\XY%ZC;";()^]>T]E_''#LO(XL)43%O'/.,VB]FB-"C:;
ML(YS%$"(A$V,2,/2;4JN+>%<FC0&WBZ"IEU-"S#G 9A _25WB*I;J_)6D:W(
MRB7A0GID\SEY*6*=X +/.GDA%<GU\.-70K*J2_O-C*.H##")F;C4'WR;++F4
M"^-<L6^R5!<L>IY$E;"PRITL3A"6JKA<U"5$#-T]WH@OT5& (K2( Y>)I^AM
MK A%LLR![A@3JOY;E=#L!@Z%^GVD8^5R;RGFB4K38_Y\&V\?H"E%;-K_TB2;
M*S>?CB59%? J!!BDG$OI^)6;5!M2-#I+=%?F'4QS:7ZC%,1DV'8I*-DLQ2N+
M'&-,W961FT4\=]/L, !"%5O(1#WITN463J<\".6=![>?9)HZ,KREV.;D6E(=
M'NOR7*%<ZG"!&NQ80(=_A_.2Z9MI+*LG3K62K=J<2FR4F[/L<2XZIL-D)%^=
M<A:I [GHTVPZSSE3QTYT,A5 -&3'+MBPNV*IS5'$,/U2,:&*)UQ/3 L4F ;"
MX<8HVP2KDG1I,]+:;IB-VY&_3X0J+XO7;RNA)L(IK?)G;HO8I-HU+:A7IU"I
MDD:8[Y)?KN9B @3NT H*%P7XM?E+7_KE+K>I[.>N[;TZFU&J)?!:S"D*%+J"
M'REZK]W82(J5F:\ZE'?-&>A#EU.75CM=QNB67.<K7><#<IV3ZWQ+FO^("F,C
MK"93Y2G2:A_*VIRJ5M>"$J$*X-3J@N7B3S6%,1_37Z@Y5BTP(]K>Z>[CJGAC
M&Z^4+US5;\.:,*I$5N.EGA<OPX[)'7AO.%,5_XJPV*(3KG&T)-92RKVBQ!KJ
MX)N;IE7D@VKP(B:&FJ V>U86HH2-$&A@C(6\\%*I73HW*O\1(RE@-D5/EIH=
MI-Y1I7&OE'RB*[Y*?V86IN,\B[HT9&[N;>K*7I72[K"'(C5-(W1C+4I1,M"T
MT"7D/E83%J[CR74N Y>R/)=F2:I>M?EUK>LKU3)_2[\&N3 4NNRRX+HVGJ'=
M4HP?4YL\SZ-L2G6_[TGH,MI'R&V%UXTML8IH@TKN%!.'F:D/4BZJ3"E9,9I/
M1VIBQ>:/N-0.BBS+3&5,YM2HM:0RN&(\IJ.D;\N&'M,HC.%"3S6;4G%%RR5E
MW:L\7$ZW-4NBNYB;5)?ABU-1H$+:/6 Z97UBQ1 591CSQ(7Q4-:L+/ZANT&)
M8<12\K;,13-P?1SE:G0+3U$:I8W$G%\(6-@@D)8@S5;T.:^QUZI*>W^>L(P7
MR-31>ET :824XCC27[RL$L'24[?4)T;URU:J!-[CU"\;6E2_[)?7)+:U?MGA
M_H?=0^-H]^)B_^R\?=P;Y4/1SU@5N:Q9AI:SOEQ^F+%4=)]'%S=\;2]&D3"#
M?_P/F\Y>&V_GB>#YAX>G3;?;FCQ@:-DOVDPE^_][NG]VT5+Z*!Q&XF[-]8W=
MH[T#N'9!T%1>H+TXF8&:=(">0?C\'0<)%>5&QS(-NVM;LCR0UG5$XIK4J__%
MHCGF2MN>^N)+N/BY4+Q?Y>;!AN%F,\X2Y3JNTV=A V @0622B(]8XL^G2(QF
MN61%V4P@)3&=0(^#8S,SD?13",52IPP3W5\4A4L.._ R+X&&LHQJ2X3Q:2R+
M87V8>7>9L-E511Q)YR/86'@7[' 0ST<91K>J0K*E^K/+MUM8=W&N<ZXJ?<12
MM(5-3"*9KE3*\SN.04"RM"#4A.XKL[2W?)+R&UQ?PRY+\58F0A;UA&%QLE!3
MK(R^:I<N0?:)=#JB;BLJUB:+\\,^XV2QFE0B%7<!G=;("TC:*">O.DF'+/J;
M77#8@^._3.,@ D5@U1&"'[J5LX3M&E2=$AG+4ZWNO,;!>,<G,0;R*JY]$0,@
M7)X3%FUR5#+I^JN>DP4/=&D;5A&1%-@%#56(11*4LM3D]+0Q":U[&3E.JR^C
MO8^[QQ_VC8-CX^+COG&V_P%+K^X>7ZAJUN?&'MQ5!^__/#C^8.SN[9U\.KZ
M3UMXY$XBXST?)>)JD3>+(RT*;V,L*@<L+HE%:26,240U2^CVLQEP3T$Q^:$
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MT:^P#ZX0B"NST]+Q:@&XA83\3K;CJD%Q]Q[KLXT[*#HO9+*X8#C5^I;FX>=
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M&>7\5@YN4W=NSVYG>4B(4FZ4("P.SA1W&ST("6YJHM=0FO4&JK(4I.%ZP*"
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MYS*^;J,^I=K6U1IQ-?=&;PILKYI<I+5<T( VO9E(T-]O*W;J(NZW?B;51HL
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M76JYQW5'U'$_ZGC?$6"V=?KV$E(D#O9<:+3??!&>5V+U3V9<OJ,(RP4=E6/
M8)1=I<I#W,#J5.0^\#7]7 3S6^NQC7-F%L8C?OI\:+7-_!2F[Q _?>8T.ER'
MG^ZI?LUA!!]4.VM;@]?&_G_F&.'[\IUH#IZ]JC%=$>VQ!ALU[\6L'YBI2%SW
M&5-TF[DN3-\EKON\:=3NK<5U67IEO,=,$))&B>8>@^9:S!=Q^CWBB\^<1KT7
M;[#R@0AU6=_>3?SIF6#?9OX$T^^OXD^_"0_E.N[<A[E ZP[/>/:+.3J-;LFY
M5V71Y !MLP-T5UT'Y/2DB^4>G'G0??'F+"\X<% J#G%6%(<XE<4A=HLLJ_=A
M,B71XME00(M%"YR^39;XYTZDSHLWE8B,I>7%7NIH#&)/SP;Y-K,GF+Y-)NOG
M3J3#%V_.RR4%&F(L'J%<*/&VYT<V;>9M,'V;S,[/G$@]N\;;FN,=\HPI%>=
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M6'0P., Q:N=0P"Z9)> !)4:*$4OB9 13:R/9VH8\XH05!"@(L$*'1$& M2#
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MA(,"!-KE.9$!(Y\ .S(7G!=Q:UNW",,M8)?YA0MN/Q1N<P@8@J:&1@G<24V
M,ZFT2BPM_=W?-/Q2U'!M:K@8GB'100S*HR@-3VK($VIK1I!BF/'@&2?DQJC]
M0-NE'//KV##&0C*B8D2,BT2XF2'(4*Z1=Y98<&"E<(5P-P2XD_UL%>'$!F[
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MTP!?3@0$[8+3H,WMV@/<]P8H9_<JQ"^37#!+K,UAGCVZ#)!QT:<]$&)TU.M
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MM[9!Z&3-R 9E#!0=;F::4-'A!]#A!:=$Y($)["FB@DD$BGND*-?(<^D=I\Y
MB$W4X3)[^<>SEX_"V3B<VC!\O .8I_)YSM(N\H-)3FV:7_P3:K=_:6\7#D9K
M0J+UG(,$HE5D0FA&HK(V^/G(C6NT="D3FE>-P[^/%P=L,,TD)P0CGV2#@$6!
M#!B#G 2L=$C4BLG'-RYU-=J[YA#6^I'JNP?7&H#J?]:Z'6ZP#9H$XI?,3+D5
M@I>9UP^(X@L]>4!:<$I(%#%+**Z"11J[/(:6^,"=QDP\PJ'7CP+%"_=<(?<4
MCFN2Z(L55@#6T2A--4VPQ5BD7K 5<,_B"+@;="VV!R32.A%,1)$JBD &0.F4
MD8A@RK&7&)1+!)2U),>7]@XNX%4H:(/PJE#0E5#0VP%Y&41^#WB]V/XQXD"C
MPX@HF0@F%199[1B*.JHD*F^P$ FO)2](79"Z(/5F(O6YI5@TMFAL8W9ET=BK
MU^8F&?_$12<-\TQH 5P*92/15&K-I54L7DVNRE#T]7C[%O-?A*).$!81$R(/
MW?$>Z< =$L1Y303EAIBZ<H<1W2)J>4+R;4>C%V MP%J ]4I@C5I$,"2!*06@
M%JMH@@/"E#54JV +L#8-6!>2DK#$P+'&2%B%$41ID 46D-,Z>$E#VFES8%4M
MA5<PXZ 1P%KG-/TR-NE[YZDQS4H[6K(1:%;-OY;^^S:]Y\(]G)KA^VY_OLRY
M&JRQ=_4365.&5/KV;U=%/1/U*AR?=$=5PIJ<T-7MN][$IZ^;G.7&3K.Q/?.N
MV!=:/L7I=(;),%3=6(U/0C5(>S!MO]Z@KOFL!M,V4/FC!^,J_!.&KCL*/GU#
M%2>]7C7(7U:=F>&XLI_K#ZB[M'T:=L<)#JN?1B%4[<$X5/SG9U6G7QV:SQ6!
M:;I9JW[]O(]W/!]S)Y/:2GY^N>>=JUY\T[FJ5:4G)[UQ6HA\"?FC1K./RG#?
M[4_R,^D>,S17D,#@FT6XXE.?53OIKNK75*;OJ[.T&K/?ZDY8H^K$_!TJ&T(_
M??]X.,B0\G?H?<Y7,S;Y\M-7#D/LU2N<+ZI^]V@R'(:\,L]NL/LOX(-+P@C#
M5>]U@J^UV8_3;1B7EBE]]^>\JFDOI$^?KE%:_'%X/S2]Z2X8U-MHE/?!+)4P
MBR.I:]XUL=LW?==-KZW7JAX->O6"S*Y!T@P$@U$]/O3Y,/1,7O%?/W7]^&3N
ML[[PKMGZX:]O,3:!\61\]5N:N_(O$2PD0U[XF>^@9A!6T4 (.$]T!&X2GY$L
M2",@ (T4J[\HWYJ_Z63X]<1X'Y =!O,1F9AN\;GI?3*?1UN_?+LV:6$N"N+Z
M:SC[2SX3U[.D2U2Q7M*=P]V#:F?W][<'1P?'!YUVM=MY\_I9=7!P \5LZ*V]
M;>^\W3LXWM]+]]3>VV\?I4='QSO'^X?[[>.CJO.RVMTY^JUZ^>_.'T>7;:OO
MW7.ZI9IZ?%6SFO&D6^N9LU%X/G_PJ^^.SGKF\_-NO[[ ^DV_?OMQ?+F*NU["
MZ=-?M]@S/-UFLT3NV3?/GGY6/[7 X*;/2?R,2;CR:?R,7/G<]SZ6T&<*Z*T^
M]OO/ =SNG3^\6':MC_U!LOP/<V*67WJ)-3U5C(>Q&<6U;,:7B2GD [J=GOE?
M._QE^S"]Y614[:?3RM=_6,J0IU>6^3^=Y9I._*K7IY[#\B_3GYCAYXJJ5OW'
M:2%!8J"AIHX_UW\<GR2SZOW)MS4'YR__9E6?2D>)RU=YUXQ.JI>]P:?1=,I-
M)Q%04W/<G4PT$Z$)H^?7V(57+M,%2Y5\8Z;^./=M%<5PJ[_"I]W@-W<@Z0U&
M2V.-[MPM:7W>S\MO],;>SR8Z+^\^# -K24,D' 2#:*/1&'LB:.1<A(A974M)
M,9G64M(?IMZ\'@YB=[PQA92?VW.?Y>E;TOYCG[=?_>O#GW_\_JFS]_N7=Q_>
M=/_\XS^]P],W)^T_?O_2WMLAG>/?^;G/\O0M;K\Z@#]?O8/#+^])>GWO\,/+
MD\ZK_2_I.C__F=[WYX<7I^EYMNBS3-> WWTX^?CGA_=?.MEO^>KMY\,_]N'=
M<?LTW\^?KUZ>'K[Z,SWOXV%WFHMS>(3YX=Z[3YW?_W*,JB0HAK0CN;<3D\B
MQ[EW(_"TQE)ZV-HF+<Q%"ZOEI)R-;\Q:X.AQPI'7/C(CC5$2/#?&4!F"8IIX
MY0RWL])N0M7U2KL+'-T+''U9@",5@HS, H*8>TH&2I%1GJ H28PD8N%D7=4M
M6YS>>9;#"L'HJ9@&5\QR.._$.)KZF),JNFXO5/T9!\Q_S8]=MB$F,R_]X-R
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MU:'4BTNMI]=/JP]1$&IV$0PE.-)*+6$6YWIQ-E-?[8U(F\@IK3RJYJ, G>^
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M;.&1QD/NA$:^DN1G$[#OWB#:F!6E5I',2"8R3I@V)2DH34F9Z9BE.DUCGJ.
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M&[0F?=)WJ[QXU7>J6,5HC"$M#+][GRM<(/0ZHZIC"S&B?AC_MZMT8S0807"
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M"UE@JQ9[$TIL3/=7,#'?H!:6>=1 Q!MT DE^.G/^67IT?'!2&"J9*"A1'&&
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M#%J] +?9CV@TH);8S;A+2_^O+UIB=VFVP/:=6MO&J-^R5JMY+07FH(I8YY'
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M7#NLP$,?=:,NZO:HIS0N+RS[GXY$P]]NJTA^#LWL^.XWI;2CX_? =Q.=Y\+
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MC%K'L9O/G*OXYW!5 -3U[2#@AP$<=U\=2D^5H=S:CZH!3LD! 9WUASFB\^L
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M*;/D0\F=<@PTF*0:+)GTKM!"BY);6.X;(JOKM;[_6H.73;4&914T,<SB6B>
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MD3,&.SD_XJYR52@-'GF,2<="<@9N0.$![@ETU M7R%JNL JD>;&6JP>4JWS
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M%B9GP@I:;%##OT)-+5<5WT=-/4%H]6?W_)Z@=&ZP7P=*GZ""W_+8B+,N=O*
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MEK"O=KE0-4SY7,N:R=R=S@][HS5BT-#X/1_&V*J8QW]YLI[=[S^!9P?B&RB
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M>'YZ:AMB*WRO:=+HSF$WH7C##5RG5W\']M1=>Y,9/#Z*0@OFI);!,N%301E
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M#K!^18#U:[' .L#ZD!O#\]VMPU(G+BVVMHTV H P H\<$I%,1)A_4Y3)WSK
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M2E/9@E0LPU%54Y8I+\9$,DW5?#JOC/9M#$$=5 EVTHCISOUHGO?B:-;H8\,
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M=6&D]"2Z((BDRA*=X!^OG B,!\>00%EL:*[6:?MKE?2CQ_;#79FUU*VE;NU
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M7M?7=>5"KNFFU%EIP<?]GH=?U>5=/VT]UY?VUB$MP%"4L22*E@!<@F'$. O
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M:'397N^LJPW<X[)@UI7Y7;IDQKLX7=9-&[UKBM"B5UQO#'D G;.DG[>!?-H
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MMG??NE?\#;[\_O##F[\Z.[O;N_NO=M]W8AR^M8@=KMR"\B\.OY?MR"@D%U4
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MBA+7.I5&*D.26@,@9S(,%$,831RJ91%;B&PW#TJM:9WVQH':H;7&S:>%-R_
M;!"]WD")$=@%8"C< ["U2MPME;CJ?+;=\6Q5IW,\V*G/I@2V?R8GTT+<RB!N
MWC%"E10\R@2H:YJ XI:!X@8'C.),$4PY_*O-LY<T3;J4M:K;FG!OZ-02PA&Y
MG_D3O"2GIN<](*-3TQD-05?PT?JK9I:T6MLJT2V<BYO7M#<YE;_@4/;ZQ^XX
MML)IM("V,D#+YP!-6\%C+2V*.1, :((CH2U%B8PH-M1R*I@;SA3A^5JGC=?7
M-L['&XS08L9M6Q3&*6]]W530?LZ%NWBSUAJ^5N'"?4S2[NW0> ]MY:]]6L)L
M'3P0(->&1A1FQX3_[O7+,RE]KZU 6Y5 .YQW0L3<6B&T1-PRC*AD&F4FC5":
M*ID*(;E)]+.7F#'0T.DC[1>W<9A5:GHNMG3I4L9:[\(ORJ>8AZKJ*-Z&DVBQ
M:F58->]-8)CH).$QBDVB$$T%1C+3#"6QMERG&B>6/'O)69?%=X:JUIFP&F;=
M&9N07M'SCE*7O'_9JEB_PET .^_FY?A]?^NVO<6FE86H%[2IE"G%DG&!(C^V
M.4X)XJEE2$3"P@%29F, )YIU4S(_ *_5HQYL9O/8W-'V:_6H%>E1[BC:P,R]
MP-7N/%RQ!-2E3"";I )1DW+$A7&=+6.B0='*+([![LL K^([XU6K3*W(GRG.
M\Y'H=:1PR:@C\?U.!F"K4=T^ #.#6N6!O()?CL7WU@9<.7#MS0%78JRFG&6(
MPR$BREQ5MY%@$P)P8469,BQUP,6[</*MHK4>' O[WU>G>6'N#%JMMG5'T*J/
MH@6L^P"L_3G ,E0)&5N)2!*#IB5CB233"N'(QE00HUGBDI<Y[Y(X?7R:UHV+
M#AL5U^4MD/O^'Z2^20/<'J98]^ FQ4 /V">O,U/)_B2TP;7(H@;*<)7<;X>#
M;[DV^M7E!Z"0O7Y=S3TIYF[!=G5@^VX.;%UN3L2)=G,9)*)$<Y0E*D92)8JG
M1E#"[;.7#$?=",^#[4-FZ,RTJ,'$@]S#C4&XHCG1U-V?2!'IS;HWA,2\Z>X-
M*Q_;^[13NMR.:^,[,049?/=4U(VU*1XL%14,!Y]]^MK50E:YJ(?6'4Z;C'I?
MTD[-^T(PC44&5D6$74"<"X&RV"7:JX@H3EE*%7;).W[4QQUKB%K+XI=:%GDM
M21Z+97&'?JI/''AO9W/4.DAK<]P'"I_,H3!/X&1Y; & (U\3 -9'*A)$TC2-
M-8[BQ/!5H?"M>.FA7-7W:WUL C[<<Y+]&FOM-[.37H>NK6V7N]:D<Q48 SA$
M79*&:_I;18A6DSFXL>;=PS:.\V?BJ@V;.80[1K8VW>JTB2_SB3DQ37!,5(92
M:S)$4Y4@+K0S\92)F9+PLW[<O6XV%\"&1IG\&X!563L-<LTU+!_+7JXZ@[(Y
M0;<#.U&T=68/ 65[9:^UO7 T;_W)5%TC6EQ;':[-Y^U(G+!,<8U2ZB;8$*.0
MB"+XE1,:)<:F5)JKK:3'D;OS6-#MW+=4 56M)Y0?N]#J9@\(:&W+KOM L?ED
M'DLMYK$% ,/<>=R)0!D1&,4 7S&/&+'&NA(TTJ5X?HS,QNMGC]+E?EXZ4%V3
M5EL[)EJW>PNZUSO;:T=6ZVR_#P">3_") &<I2PD2V##G;$]0AFF"J*!Q;$2:
M$-\*%M1(SN)5@'#K<7\R3M5[DGG9>HF\NC&O$WZ;+=M:"78+">;$E_N_FSCY
M#600V KO33$:YFIDM/M@JZ^G_]#XYEMXVX&>+X!2O;$[@:H=^GNP"'>M-:IU
M$J]0"GZ<DX*$$H [;%%J+<@^Z^K,F; H(2+1F# @'9"",8V[<;:&15!KD^MZ
MGQFMCTAN^/#M__W_.*#,GQUI3O)^WYE(80AGY]QC0RM)UE:2R"S*.%8Q5IFD
M3&0<#)@L(YDP0CC?:YA?#)(DO3\!,BT/;/[=:/3## >M*+B5*)C//HIC.$_-
M%$JS+ .#R"1(N,@AUB02Q"0D23*G'@/SDC_73Q2LLM?F8T)9T]?KCJ^K,2S7
M;#KAXJ.Y]73"&[[[FDB8Q2]]"PECB&188,W 3J%12@6Q$GZ-,J&BR"@5),S]
MFBBMQ;$Z,?-U0> #6R6T0LP*$#,*Q+>0EJ!(ZBPU,7SF>N\MLS@>$+Q^+N:R
M9NZ^J\K!;GF/QIO%L'P]&+M$NR?I[]O,*/UBL#X:GY_W?!Q>]#HZ+U1O4(R'
M?N06,**/<]UU7F7;['SC^[#,##"J1E-.Y=B"G > F,[##?,MO[E,@[G$M3N;
MUIL[BGK1&ZXU/SQ4O>B1&V1:Y:KXZ4P' 91:I6UE2MN/^9P[3F6B)>=(,<(0
MS:(8<0U*F\)9S(7$F,O83YA+>#?E;7OW->'2&93.?90EE(6*:SJ6WCG1;G/!
M>-$;MF!\W92\O9*XYCK9EPU9J_G'+5"O#JCGTPIIDBA.L4!&6HVHB2SBS,9(
M6AHQ)55L$@'6]4KRHM<OJ_!1H/2JQ[RW:G6+Y->V^#= @D.C/SB+[6*8NZK_
MU\:T;1U7#MGSB8@Z,T3%@-9<Q#&B">5(&H(1C206%L<Z2;-G+PE]Q*4L&P?9
ML[/>[MD!TNK<+5*72%VZ.Z8'VQ5;?7TX.C7#+3^2\BU\\NJR46W=)I.O%,,_
MS">3JT0#>EMD4TT196D$:)Y%R"C* <SC& OZ[&62IEW>ZMWKPL+O@85\][D0
MVU@"TC=5Q>?*&#L792%=JY"W"OE/PGQ-HH?V  BT\JCT]59)G2VLKP[6Y[.C
M8\E$3$6,LI1:1&,FD8SC!,6<2CADDL%Q@FK>36C:9:W;>UV8MK)F@_Y=FK/>
M1P* #>?BYW@#[_9-8.J+?'3J$^26--IH]?163_]) %_D6-F>$&(+WZN#[_FN
MMG! $5.)1"RS&:*9ZVH;$8*B)(VT22UE-'[VDG4):_WA:\2R_Q&]\5+O=F<$
M.G51XOMHT-GJJU/0Q$.OTL&PZ(C1G6&\U<-;&"]AW-/BH?64^&K;TZ%/03F>
M4.'Q(-!@38);H[8KU#UC_7SU"G8^\X029*)$(TH$0T))#4<<Q3@3460CP/JD
MRZ*LFS*^;JKZ[R-GV%6%$8T2DS,Q/,G[*%PRJ3$)-U( WV:X:H[T*:M7LB1Q
M+'D,"K,;EG &S[YT"K9SH0#^#IW_!#!X9$Z&#H3%<%06H!2F:HL"?R]&8N3]
M),6+Z:J0QLN7STN=!/.#&N"D_O N]OR;^?,BUZ/3"A\:5Y5[%4TN$;(8],:C
MY9>L[RZ_1B2=J9II_.M>P<.%Y,1@3)7&&:@UP@J3QB85"3646!+QSYP_JRXZ
MK<MFS\6)07)HQ%<D++SC'Z)W(2Z+9[]/;P[L3/,DUGD3YW*:_29N[6_O=;:V
MWWW8.]H[WCL\Z&P?OG_[HK.WMY3RUF7E!X?'NT>=X\/.\5^[G==[!UL'VWM;
M_W2.CK>.=_=W#XZ/UOX-7H-V-BD^"RW?_A;]L1A>=@CO=IP,[CS/^\J<.U[]
M#;X,2'MRVMDQRIQ),^S$.'QK$1O<X(5?_K<<_OYR?I]NQC<9KOD&)(93-')8
MN]=!_ TBL"JLB4TL=$:MUD)+6#<S*LT2E@@3E!.XQN@M)_H)31G3$BN9*:HC
MS)D2<9P2(TP"-Y+7L-1#D:'SCN-.6?P)1U.H8>[/RT'[X?!$]/,?85><[_S5
MN(!;@.Y>CBT#2W<IG2Y!C=(VP?P7O/-BY V@H?YWG <ITMD>#,\=:'2>.WIV
M>T&B/[>#_/._X3]_Z^0@ 3NR)_I?.^K4@+U2"DB7? G7#X8^/"S<MW9 D%TX
M<5E]X+>S/\<=+SI.U)8/ZES M4Z1=.T3*]8:P_6%-YF,[YGAVXYUSLSPQ R[
M'54.>P[V4Q7 Z,(B"N/F'=5OV"V_ O>#[Q3PE:$9-,\6GE?DL-5BV)'5$</[
M21#J$T?:4E4]!WD_HZL39:E-F=:6*IIAEA&)$RPECD6:9,Q<HZOO';R>TM:W
M!WWMWP1 Y_5X-!Z:BA*W)ZL\&#M4.;351Z;8!X/Q;'PVI: #U2BGI%\,AKHP
M_771S]E^I9^#GGWP99_MGWV\@/M]^7C\+M[_<@+Z^<'7_9V]R_TW>_33V<'I
MP9L/!'3MGOGK_>6G?_6Y)#0YW-DE^S^^PCVWHGWWG1UU>;AS@N'Y%Z#;7WS\
M<GKVD>S"<S\YMSCY3 A/M&+<M04AB I)$%>11)EU[593'!-&GKT<],V<6NU(
MYFP -"[KW9YBGT5D5/'2B\X&@D;AN'!.='4]GU8L#+S5Z9O<!>P[IG\"2EA(
MR8:/!C5@@CH][)R8OBD1H^^22[X9$"3%B\Y6KU=585U.8.#.$K9,7RF<8Z6Q
M8 _[Z9]%R1\5RE_A,>\\+\]WR>?5$7>!F9THD:YIHND-+F:P+H?W!+.BWH?F
M'L%3J@T!C!GEL"-.A_7+<J#;,Y5\RGWN>UC((H+K.J>1N\R(82\'(W[!*NH5
M '6CR0H<JI_Y)ECN>K<__H%._8#[5!\/0H\LOVO^!S.I-@[GY<^OZH^K88_J
M]KA7[;*[G_]2@/2B7H?(AYUOE1O-O;Z_I3>;JK!TIY<+F?=\&5^WD]N..#^'
MFSLS=/KU';46IF=<I7239)P0<[>VN8/&SB5LGFLVL-R:6UNF/5Y ZD45\B\Z
M7A&H4@! _/_SSW:W*;Y[(!+=WE0;>EG+_";2E3>HP6TSMVEH3O)B5.HJM0E?
M0]#L+BXC7*?$@!@'1<*5H 2=Y9OGDZWQB9O"&%>PU=C!R?<T/'<B)0[KJY)%
M: L*1S$^._,HVD2"V34!IRQ578I36&DQH[P(;D'W)UD2*4%)K(4TA(,E0$0,
MJHL1I?+"HP15/UREO'R AQ6NM,WHG;%;46B5=N0?#4?H/]J,B-&OUU*.W]']
M=Y]-Q&*:\0S)U#553I(891&F* 9%)8U3GF34]_1<VAG>G_BTAN+_,B&V7:%.
M_;<\7>4N8?^A":=2: .E! H"VG'TU*JT"XGEP^7!Q6=M>:H3$B%+8HFHPC'B
MF9"(6&8E$UFLB%BBU(; U-9T8*ILLE/"3M<Y/DL9_%]712_@I/S!S39"2>-(
M9]1D0BD:6<HU(:DR#+,X4RR29:NMY:11MT*9!"W>BN'A\,B!MO9QC<FCGRXE
MQ(X2J 0FC FRVE6W1C)!W%J@"2Y38$RE;1H_>QF] ,3 \\0 NF#'L_FT7V !
MB4RT7J>X#9Q\%3WK" =^!M&JC3GS^8>5BC9-4E/W+[\RN:5QP'1Q.FA<#I(Y
M'_6<;',7PD<ZJ,=@U5NGXE=V_BWA*^-:<AL9SH6B6B72\(0K(%8@4"N2Y.:D
MZ?:H'CAP.'SOE(T:S8P:#[UVNBUZ/=<HVT'O]'=;>%M(U J#+-269E&49$@P
M' %1BP0)12RRE*4RP1IGFMX&WIR*]S- ]G/40FY$*[O?S5#EA7D[S)N3*\I/
M"_R4:2 ^!!K(9!8IEB*1L011YC6C-$(2XR3-L(J,=&.=\0NV0!6J<2V8@T$S
MN@#P<$V,M#.9A4MZ#MG/#T@94VJ/6T\KUHY/G(+#&6>1B 1*K<H0-<#\DH->
MK&*& 1Q8POV@)"?7%I^^.\-NY?EP8L3/&YOX*::]1->2P6JUX$<^GNLAB(8>
M;'V6!)0@93D2&'"#1@HCF5",F,HX)E1$BJNKIVMU00O)01?)"]\^:ER4@\A]
M#"G>0+_'47XV[HU$WPS&1>]RDBWL.F,UNA<OG=(W[8SPCDFC2X]?J!DI@.+<
M;>#=Q,G)T)RX/][:K)0B28UT-?X$T]00P02VJ9;2"!DII>]++YL5NRU_+>0O
M]YVMSX2J.'-XK!A5B*8B13)+"8II;)G1W&JJG[V,NVR9AZ*J*IJR!I87']6!
MR1*L*S]F$-^5 7 G.?YS=$>F(W>+2&Z)6O>$26CW\N#=YXP0D5'M,IHMF*N4
M4P1RDX!^IQ+-C#*8"H#HI6)]*;'<GZS/N)%"TR1*N::4L"QEU$0QUIEB4B=Z
M%;)^PR;7/0#U[%WL7WRF@C##F$8&X 91*PP2D38HMEEF4AYSR<E5 !2L@>6
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M1N(K<([^)D)_9^?5*0$0A$#P Y1&\#<!QN;8V2@^9]C/0V]X>T*=Z= TO3W
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M>@_GR71*\^N6/2F625=_4GYNPR+BJ)?;;+ USQ?77N_V%M[8"<LS)RS]I4-
MRZ7EK1.RG.!SZ?CN+Y"'EY,)AOVR-NH*ZG2J_Q4?AUNY4PCC+,I#'Q=5\L 5
M%.S.+5?CGO?FY6>3Y"RCQ+B85$H/1L$E6!^T\J)Z"1X5<R#?1O&OB^*[R3IM
M%+^-XC_\&SQ %/_:J/Q,%#]C)"92DX1*2RUFF3$N,4P2*U/+W9",S;"6W^?%
MUZ#<?^B71IC3FS9/0=Z?-"+*B^JPR@1IX_RHU5P@D#%"U;K5]N%_]G80SL!F
M</X6IR%4O6OT&/30X'YTH@UNZ8=1Z4H_R5V&JG_:HBRVVF7T+1^.BV;!.-A
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MR4+($K,X,D!SL(N%5B* G8NYO69(WY(JG"W@W[2%0!=3S/C77[(1^@;43N3
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MHX*#.-+P5#V%LYHBFUZMI";X:LM'QUT]3.X&K/<RM1$O?BTC#DKJX8RM(RK
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M/#COSBN%I+,"@1@&5]$)AI2$+0Y*EISA+#&6=-S&,:^MM@:??8F-,)[FK^.
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M*H-DY13KTN1E+I=9_-K&-=_;R#49J0([EURGG&Y6@W7=S*IW':2Z%STZZL6
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M^4&7'"\WDY8U^_U(4ZGUS6RE>VLRR%NU-I1NP8;P=H<'Q%/-'.4('& #GG8
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MG!</[LD5WDE-K-_$)_D6]+'V219#N.?MR\,#9ARFL+F(X!*<DH(JI(1U"+O
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MJ;P ASXX"QQ0$"0M,<@0@BTFVI/HT-\PG!K)[[L3P#J@>A^D<'QX('%PV,N
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MH#@]'6MRZ^D.S_M^/*OV(_AV7.WSRTS]_PQZ8&6TLH*-$TW^\4,@IXE),5L
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M/8BBZX$2*+Z:VG:DF"G4A.HQE:QSR'M&O/H\]3)]91GGG@CG=J9Q#ATHIX2
MR('4>B%R4VZ 8AP")+!B7FH5M[)4+P+?D&/],!]9S6+#GE_XN_%18_PD8&BH
M?\[G9^;PUZ62NJNHUW?]WLG;>--V=Q1G<O<R9^&?Q1J6G]M+*[C3[O;Z[>'Y
M)(1AH^NN7V7K/Z/X]HX?'O7B.S_B1XH^-1D^*X3/BSF:*+&%2DD*,*$44&$I
M4 0;( 4,DEN("(:IG' S_EOWL-H<6O\<W'H96U866V:H&3/*0JXT8,2+E'9-
M@%00 JBPI4:*X#U;6R>XJ1[5-C*'[#]!$/>$BKW0XJ'+#=P> ]W8H/RG[_K0
MS@%5%>'6? 51AZP)B"K G<+IN$,!32T!WECH!!,.RY #JEZ *E?N),JJO&A5
MGCW#U,AHB3D05D! "49 8<F!]%I[:[&UL):J_+*]0$54=U$$P1?$O7%2,/=&
MNZ#NW@]>8CC5,BB(/K'M-W<RI:+)E59MM[O9[HS2^';#U;O9SJH0Y.;KC&HB
MM%&4 $L(C7S%,: E(X!#YZQDS',;D@N<4)[SSIZOUE?&5K+6UU+K9ZD-D1@:
M)J-MXJ*50H('BA@!/ R*2NZM(+K0^AM*/BU/ZU^V'Z7EAXU.5*D<C/720A/J
M<6X7Y2\7K%D(/N.YDS6(N;(I<C98G"I#$PPDB4CM8 C<824C/5M;9[2I1"XZ
MFF'NY<'<XHX0,\PM$.9FZW)Y@Y2B$&B&+:"6*J U%P S*J52'C(BUM8);#*U
M*J5')Z.82#8K0*QJ>_4.UYAZ6A(?R?5&IN.O/^YC+K^,(;[L<A5?NJ<Z"JP=
MG8PZ96\DU_[1CF-U@U3%XK3O@^_W?=*#GOW^PLY8EUJ1_\-DZC^GF=^<K$JY
MC7P>ZJ%/+HWMD],XMKRC5+BCT#EW)HYKJ4(@P&*! )5" PFI!@8RRVSZ5?FU
M=2R;"M>DR7T^>*TA-\SZ71?]GF&,%AD<)<V!(&W*3/(<&!%_0&.\"M9;#)-^
MBR;DCTDMK>EI[.J1EHG3LJ$[G9Z-FN(:PUZ<AY.3J,.#(]WW1[U.)(%W]VH^
M/GAVA<W]^SW\\X'T)_)J;OS0[8Z.1LA>[VTAH@7@CR7TGWK0MAG>*X3W^0JH
M@0LOJ3  2:L!%<X#XXT$C)J(_ HC;,7:NB1-J53=HWXK,J@S$&8@?'*_9P;"
MIP;":^D/]$ Q"970!#@$/:":*J!XI+W2"FDDPAY26Z16<59[(*S$,WI7\_<.
MUUB49W2)0WS9(9]EV;R(7:?1G/#=0?*-)J/C86TA*G1P+^P:+SL2YEVO'__L
M-NRHW_==>]X8]N/5.D6"7T.[X]$XPBS[P)=5,_'MM"Z6M&*\:&_':[:7EJP<
MYT;7[5TMX,;E^D5&LAOV],\/O7[QQG#8;YO1L*0E'W2_"!/,1.,>1&/G?-YA
M+J@/QC& .(6 <F^!=$@ G8K'1E[I7.I&+G@%A7ZRM[R.2+#@&HL9"6J+!#.N
M=:)1T!A3( TQJ=XJ!<8*&HT/HP05B$ NU];Q8\R-FKK55X\!O9WCNME_GMU&
MRZ![-^#[!*VSBZA"O)ZIOO,='R@*%0S8 QI_IL:V$:^A$P"GTCM>!XTL6EMG
MK"GH8X+GLJ\\@UY]GKH>S#:#WI.!WLYLBT2B Y%%/5H$*$D5&X,F(.YK!JMH
ML0K!BXAA7O^28]DOGOWB3Q-\<UJZQR]C;AJ@8=(A7D-W7<.E]%OO'I/0^4QW
MS.>R+W[P_<]IV:LU"O"MV^.6[G?CO TF]QT?&.>][SY[WWRI!FHM(MI@('F(
M>Y]V&BCG,""&!LP1BJ2?_3KI?]F"L%E"31:%QXJ"M-@:R0DPB#I )33 :!1_
M8\BC% *O8.H4K5Z+>7==/3JN/)'%EW>I.CW;0W:I1UIQ>9=:-#3-6&B*<BZ(
M8R 0@B,@$00DCOM58"3:;8P8[A^V2SV9(.1=JB)1L"*5DE(!:)@(BV4*&$@\
MX$118P5A7A7IO:]177>IEQUG\[7XPSN@XZCTH6]T1R<FFI*]<,V:'#1ZH^%@
M&&W)^,AW,2V?^>G[K=A6SE:UY!O.HMEDT3;*-6L52[8;"F0;[%XM5([BK1H
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M0'/- 9+<P4 YE]ZLK?_/?TF,\)\U.CO.?H_:<XY[:G7F&X]5[5F^P1S#@7B
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MYGJC\[Z^_+4WB)..#_TV_P)QOEQ#-;RON%SN,24W4YJ$;58Z!<H7ESMP,^[
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M>H4E&8$8^'P/F&D&^W6A\*H<-SPY'2O,(0Y5ONW#Q!32[-IAPA,:8 %X^C(
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MR,73HC,-M4K!".IZJ?;7--F[& T7/N3D?0%CO])II\FD\T?=SO-A2&(;3=-
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MHM]<<_!:\^\1_&<4821V20D>P-"G=@I%M6%F^#N<C,\GXZKM\12D@+H>MNW
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M$OYUR=(Q/^I8FF#CB4LE-Y(K;%V66<6-HAGU<OV.^:VN5O3>A[W:OVQM#0;
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M<+'8P8K."S>^='Z2'&N7R!2GL#7 W@+&27B6*2RDS#)B;VJZLBZJU.^Q'?T
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M&"5L .WA &WYE&^28D5(ZA'!7B#.O$.* :!9DFH .XN55!NOJ6PKNMP.XO:
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M/N?;?^^=;9_LT?W-SQ<@(4=[=/NH^>?GGWLGS7.X[G%S\V-KJBK2SYW=;^S
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MIPD6VEOKF<(KZWI.>&C>\*\/IUY]$'F9;" YU9IJKCEZ<_>4J<Y&5"7*G/'
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M68RXU@SI8!)R2ABA->&8BD<S<^>CV9.:N3=0E1J4WB@H,66\<9A)(D"&N0.
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M$<Q)Q;C(AXU90MRZ@*SA$E&M#976T&3<VJ:HC_R](EJ<'Y:=8S,^FSI?RIT
M+WI!70R>R: X=D*['(AO"? CHUF*M^1+N0?@/?,,"S\([Q:SH^"HI5'"(I<
MZKCT"1D;"!(X$"QQ8#:R''!?9T=YV9IJ?"22&F>82T".B7&4FL"#$(F1:47M
M6E-_I*;.GREVF!G)<NUBD\,KK$"6$88D%@'K*#37?&V3;. 5TM37X"WYL_C/
MN C95U)G8+V5#V"%8W+)*^>XTL2!0 <;'+9,TW#3J93MUKO:!'HJH%G,>T*=
M%KG^+G+<4I3#@Y!)*2"A!(;%03-!/0 -?C30O!0;J':5/(%'U42N,:-<.<PQ
M%5HY@8UT!%B)2:QVE?P$G)@C)-AQ([7U"&-'$-<D B%A''ENL%/>*ZKBVJ:I
M8>(5N4JVBF$9@U@G-KDU)9S1&$>9DHB) Q<R5 &L*>NBC"HY=4MBDQK@E@UP
MBVE,E"$R<!ISQOE,A&3./ADQBBPZK94GA.> =KDJ)M?/A[C:,[-\H)!>,@>R
MEP@/G#MC!+7.D1BMI$R3&RJ'U4#QE$ QQX0,SU/ +<HI9@ MHD8V\HBH- $(
MJ]!1X!HH;CE&^U(B4:>AX'4<:AV'6L>AUG&H=1SJ:L:AKGX0:AV!6D>@WCFT
MC/ HE-")6LVQ94X*%44(!@Q8&MT-D1;+J8GUW.V&-K2--=_OB;W=;>#^;_!^
M=[^SE[/OO/\D6E\^'K?.#VGSZ+=.Z^]YN^'M&?3A=/^HTVX>P35;'[M@7Q3-
MH];Q_NXQV7__@8$=<M9\_XE<%Y/*.',D"8&P)#G;87+(>*K!C#"1*<(D\;R.
M2:TW6IX2.(BA'D>F&66,4QL!(;AUFN<L7R[>Y%ZH@>/' L?\U@NA#,NDD([9
M/6FH1,9ZAJREFJ8@M>.XCE)]7:3Y8^S:HI=//'>*%.L(U3M6]%.@2IXY9;7@
M1C@#G(D'+0A)'O.;R@'75<%^'/I=$[,:L&;,:.1SE$I9#M@(@E&.5"0F)>KS
MT7:Q*M[6>F?DJ;90DY6:<1<H!>LG)>T,XTFE8*U4R:5:=U= =^<3O"=)<90!
M!6=4M;&J#0>31SH=E/;2Y%+>JZ6[K\'C\KDNY'<GR"&*1J]=T#YR2ZE6)CG&
M34Z%G+RX(85:;2W]0,RY)J!5F""$X8A)2A%/5"$; T<B*)A"%S!S;&U3B=I:
MJMTL3P4<'D10&V.%\H('90SVUE.)190BNE"[658"..;("K$V*; )40H:(^Y$
M0DXZAC#5VF'N*$^Z!H[7Y6;9KDOWW94K@1FF >"H(X0;6("3LX%H+PPF6J4;
MS#->0]Z/@[S%F%>63V9;PY!7TN4D"!X9FRSR47'NDV(VX+5-OH$?7;GTI82R
MU9Z=)V!+ :"#$XV)I]PI[B)0>"*-<X8S3VP-':L '7-L*1K%P00.N8J,19Q8
M8$O&4"029]0*QJS3-72\MN)]RT^>\EI,1N$M(X8([*7@"50H$@HF2.2,<,;I
M;<E3:O?VDV/@8J4^GG@$K#/(* 46(W!?9&.DR(J@DY8\!4>7DDYE.29C[>YY
MJD0'*N4C.HYK$[GDS%CF5=*>6<)$H*[6W170W3G^$@!;8=H8BC!7B%/ED-.1
M(.8-959&9I5;2H*5)>KN:_"X?"R&QR@-8JX<4/M>[EK\7!@":U%.*\F]5I;H
ME 0!4TKB"&M1;4#]= #RB^>-%0XTX( L\1*!&!CD4K(HB8"!1#":L%W;9!ML
M19*Q_7P#JO:]/$%$'/6"2<J%-Y8;AZUT42@O"4W2>!EJZ%@%Z)A/6^N%UPY,
M#J J !W 9)"U/D?9A !6AY)25&[;1^]5O13H> V^EZWB:Q%B+S3.BM@)M;/E
M>P:;8\8ESQ@FH"]).C#B(PE44^&#)#>@7EW9? 70\'"!2'G/%2/!(D>C0UQ&
MA303$06MI16<6A9,7=F\COIY^L-5A#N-%9,R2AXQ,UI)&[DFW!B3)*]19951
M93X:R &/HD8BHG!$W%*/M(P8A10$<"^?"(XUJMR>Z.5?<[4-;RAVZ /#%EN*
M V:<*^ILQ"EHH:4."1,]7^S0<1--M(9I97G QG$BN&/8Q42Y3G+M>:28R44G
MJPPP94WW/'"Y4N_)( [+*I*V+-O;\T6GL+,EXJO!.,PI9LIJ\L/+4KNS%4BO
MSTHSK1J:'S2\I6[G/R;9;OY9[N.-VOTQ=#<,__E"\]4(L:',$Z6 >5;Y:IY5
M8^OD.M])+#.E$Z\XM\[5FK&O?2 F*<N>(I:W8O7X&D?)['J+S"**_U02\]ND
MI+TMBUK_88&9#,X:I$K4=E]?V9VJ3-YH ZV<5^F_GJ[_J\UL;[3]QL.PD-V7
M"TMED(8[3G70G!BII7.8ZT!TY4XBA#(R:_@A-F_YO0.Z]CFSM1DS[TLQ:G^:
M(6:EV3?\>(45YC_'@P$,[&]V6 PO<G^6S[IJ(H+ABD)_A";-N+ 3V;,V$_N\
M1=^*G:U#TCP'<V\7OOO2.MK[\JZ]5YJ(Q[SUY7.Q\W[O=&_>3#PZA+8<\YVM
M3^<[7]Y^V]GZ(/9HJYWO+4W$W4.R_V6;[Q_]UO[W^=MKL@8+#%..D51)@9E(
M'') [9%S/"0A(X\^ET]8)WQ9OO@[Z]=//KQ>XV2-DW,XJ9(3C&)M4U \&JZ9
MHRS@R#$G00A1X^3+P<GB*DY:*W#P'J-H8L[BX1G2.GA$%#&"1F-IS$F3]3I5
MCTZ 5@-E#93/&RBQ,DD!G?0I'XP1TDD5HQ2">>VDM36A?$% .;?O()D1PI.(
ML)8"<5@KD3;$H*B2%]$'P['.A%+11^=[^U$XN:3@BV?J7/BS/QPV_M7XQZ$M
M>O\LW?F'/;@]-(I>5GIH]##F2;*C*F5\/S7Z)W%0Z6'#]O*8=4\&L0T7%E]C
MHP//JX,[;D).RH/%5.5"@XH[;(V.+EDM#<NI+HDYV"KW8 DFZ+K-V RA>4L$
M?EL6EMX I>]!'+)H;/=\9QQBV.Z]M8.<T&]80^B]('0QT6[T*G(:%*),<)3W
MY)$-/"(E<(05-<9@Q-HFIVHUMFWK>(P[ \$_[H$$/%+ON XLQ0!K9G+2):&H
M#S(8K*RZ Q+\- "H"=82T6'.$G5<>,FQ0Y@8 ^A %=(@*<BZ8'D2WJ24#_ZL
M8[%X]&?A"&L-#:L"#?= !L:,8\SZB+F =2):ESC869I%2D-0KN8(+Q %YLPL
M2CDFC#*$P=P"%. .&9 *Q.&S0 B),B=[HF:5CN[6F[27F[075;4:TX):#S1[
M)X%%#,8E],<Y3*DLQG)[F9:7[W%[W-"\F.4B>><X)<$%;;D2W#B1JR?P*)FD
M-MZ0S*]VQCV[56(Q]S@C4BK.(I!#CG,0<$!6"/BAK0:::)5E(7-%L"N6ZXQ[
ME.H]C_V,&GAKX+V%IWOA:%0Q*69XTLS:Y(D.DA+N$NAE#;PO!WCGC'3JI%8@
M0 A+#\ ;O$;&!XND E!-UH=$\G:Q6J=TR=O%-?+6R/OJD=?81+D!)4Q"<(NC
M8\DSFA2UQ#FJ58V\+P=YYQPCPE AA6?(RR@RY=7(Q4"0M5Q3;S0Q977S]=+B
M?O; >Z<#:XN?S!QWFJB8HJ"#)_UAD2_X91!S?8VO\?) TG]?/9 VZ2R^O,4Z
MZ-IX=/,M-YQAFSUJ\),.L;U#N?;<['&PV9_MP>51B<.(W"#:8V03-/<7VSFU
M9\.U?UWM)W1R=E#O.1Z+9_HV_]<-X!77-/#:DXB >\3SY(*RDDNLG(X<&QR
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MR3=R]XC4R:@\\)C32X] 6/+HO)AU1 0?K(\Y'Q7C@!N&>Z;!\B1!X\BXJ5(
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M<NK<P]((_NUL@92^R59/^>-C7E2'8!/^70G"7Z7K@2Q"9A@/+B#SM0'EW%;
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M<68M_$8I4IA$K+"T0K(E^H+J-?N9>3ENU]R+\)':"_*$:COO!=&"$Z8MDI+
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MW@9T?GL0HS;28HM$3BO)J:+ RVQ")#+N8@IY#Q^XO%@\67!OEX?/*7@C 89
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M=CJ+KVG;T' Q]F8>4O06'@._Y>X%.XJYL<.Q;S?B5VC>1F/KHCVYQ7[<'7=
M,*"A>9CR1R?VK!Q9&&= KFBAOW94/FXP>=R-F K0!2,W!ZN2!VPDC1)G,!5!
M!ZQ) !I'E734N8.M$E8SR[L.7^D\O/XU'9*_\R1/N_,1VO97''CHHSV\W%]!
M])FBYOZ_V]AW/_?L%S/>Z;:Z.UL?H#W';/_H#04TY,W=/;$/;6AMO>OL?/D
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MJ2B_E_<?QIZ'Q?,Z\W1V]*]MXZWOG&LC="09QXVU%'-8#HUQ*5"P0*(&DR1
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M@ICW;'>$RE/W2_<Y1-" >^C7 K<MM[?]A:BKD5M(C"1LXU]_JFHM79"$#4:
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MU_%)[MZ'!N)G7.AX@W]%K=$)*;+RJG97BOUS/?OG[<4Q=\(K*Q@001- )=/
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M(>UF=4X#*1 $3%@L I'<BVA("%::5QZOB-Y!5>FLB!8;8I7RVYK/<5K-A:4
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MSL>!]ZD6_$5_\.)\=#[P5:GX&*TN"DBM$*388E,IA)I[[8!&7J6Q/!I(;1B
M+ AK:0@LX A2LHG%K8L*UB]64R1Z10;'STMTZ'SU#GSS@WX1YAL+\T*_A[#&
M& B\$@10JQ$PF"1AU@IZYP4C<FL[9U;Q;VLDS4\ZT)%MCB]Z,-"],BSKKF,;
M[ZIS3DN7<LO[\.A\-!SI7CJY8FFL#IP.%H=E$4P$Y%P!@2%+RY84D(9Z0 U$
M3*# '$[UBTV!2V3C\0KRJB(;UQ?D8F#<0H;G#0S,L>58UTL"G#% $D0 ]I!@
M[*1DCJW,P"A!C16O3+MM$N4I.$)WN3=MX@&5^.OJP6IQ7I;4U'&')! (.4 A
MXT B'@ )6!GN$0HV>D.D2469E_5X!?HN%Z<5@;Y;@9ZS/KC$'/K42FY#&IO%
M'9 1J],<<66EPP%[FE84T=LW"I3@QLJJ=W/]QE!W]2#:';G,_XO^6,HX[GYN
MUNE9MW_A_6O?U:.2_KUCM%J<H"5IX-$$(<#F;?'":" C10$E@7N(+.8JKV3"
M?)V62Y=XQWJ:'T6:[UF:YVP/:1VFAE$ /8_2C" &FJ$ #%%.0(T<I"$[$VJ=
MQN$][;C'N$<L#;@MP8\'FQ)>O*0[1*K%@5O,(B>-(0 9#*-OI W01CK@H^\D
M')10<)G*SF 9N?6(1?ENQH074;Y;49XS.@)%!&J1$J6! VJ4 MI'>5:&&4]=
M@#(5@Z,F1[=>+W1_ 8]'95N<]0=9$ONAT>WW/H*1'YQ&>3+7J>1XU/BS*E/B
M93S5=CS4O7BF2T&GI'=_%F_@@NE@M4 V4 <4LR(Z.0EJH-+ 0L@Y#4P017XR
MO7MW-L(-3(%'+7&KTOA+):Y(U@TE:TZ30Z@@M(@#964 5&L/E(I&N?).,^<8
M)0IM;3-Q0Y-\W6($&SHJTRY.DRF;V!]4ZY?PYEWB$UHR7I(0JS@A!"AL4KI"
M"R"5H\ Y20+T, 3&M[:I:F*UJKA!V<?^F&1_9?9'D?T[EOW6O.P;"A5F/D2[
M'XK4!!: %(8!C2'W 6$C2=ICS)H8KFI@S_J-8'Q,X_$.9]:'K";]\11RM7><
M_B@K"^X$T/!"&(-[R"!V A!L.:"$0B"=@"!J)4\C5Q@O6<K58DG6*%=;*B_6
MTQXITGS/TCP7.A%2,$H8 M"QZ)@0+X!&U@!GE5?88X=$2%6?A-S:-EG3RHN-
M-C]LZ3Y9L^Z3@EQW@ER+8U"EUQY)C0'V5 +*) ;&<A'_D I;IWE ,+I5I*E@
MF:WQ>(7Z7CI0BE#?E5#/9W(P#! 3"X1(K2<0!Z "BM8)8\H[+H-1..VK:&*U
M3D+]I,,A+V]:FO$T/::[J-FX"I=*V<;/0M+BS% $/2-.&J <4H J2%/9A@5.
M>6-86JECW#IVY9>(QWH:&M>1WV)7W%:(Y^P*AAUTR$E@D8G.@K(4:,]\Y"F,
MK)!0!J)2T!)RMD8B_*3#'-6(\FG=9XEPW/.0\IE4<5G9_K-0M&0F*!4:,V*
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M"X+T#%!"-% :$H"PX9)ZK 5/TXIYDV#>E&AQ^L<Z9Y<7N+)$R#> +>,S'*-
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MZVK5S2A?[B_-D_V\'?&CHJQ'#E,K#WI\!Z%*L&-E\'6Q)-B!A8)>(PI"=(\
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MED\UB5Z=UFI-;SB/96.B[50T.\PD.PJU=LOP-CR:TJM$)5<(@7C9JD=!J&9
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MI!'$*");D]'%UN%BP!5PVUAPNYD!][.9S6+ /1#,O9_9A]&"K2_'E%N/+>3
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M%4#02V<]A=+ U ]-FA@NKH&]_G26@G(%Y=;GJ6]BQ7D!O0X!28JHL]0@' T
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MO,?Q'MN_=P[;?\%X;7C4/HG/$I_IC\/.X:>33Q_>M;Y^>"'QX<=C'(FH;(#
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MY6S BEL)M[9QDQ'TB.LH'R<P%/PN9"IDVN0T:U&S&ZIF\;R:Y<PSJ160EFM
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MY=1,U"UJ=5O4^SGE.3'O6=(8R20CXE9)9&A*B":AB!8L1!SRN5AQ\V/[ZZ=
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M(Z"P-X&&C1?SD64/WN7[(+6,SEF5FS.%XZE9/M9+MRC1*F^C[6X-1W84:Q&
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M." 6IS0YXZA2JN1P%.N46;KZAM=6)5E>IFNPQPW$>;:"#5,B<J51D(KEL-*
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MAF5%C6"&>P!7^Z=Y3#V\I _B#BL/.IU%?YA' KHW7@<A@@#WCR;GIERG?_Z
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M7GKE_,8+1J]@I/KU_'C:> OM+>/?OJ$_>QFH""8)@ZED.%E.A-5!$>\E,U0
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MVN/R%B6A_B(8:<;^6>OOTHONN%;@A62.[;/.C:M>G!__OY "O8Q[Z.=WE3J
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M-9^!U:)B.%#$6641MYHA1;% *FIM(I:XDN*F/H,>(WN,W)VWW@V?0:]G[BN
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MT'X#&;$,2VJMY\)SQY2-ADM&;<#$QRA4KC8@3;4!Z7NMW3V8_;EA<1(GA*W
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M#?>XV>-FCYL=W.05J)>5]*1R' Z= ^V%1T,DZ* .],\>-W<.-]=CG$Q9:7A
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M)X-?1I/S+]IH]X9R<?='>+]#79>5[O141M^KK4\LPY):"^:BYXXI&PV7C-J
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MQL-/Y7""O@,Z<"C""-X=I,IL/LV1D0C'JC,C#YHI>?##4D;"Z_EP"B>PB!]
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M0[!_$-*\4ZEW7)[+:>@<RG3^&OJ*3-XT/#V;3C[4W J9*6.V)'M*Q/DU\_\
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M8FTUIDJ!PA[W4_DJ6V50]LJ@LUGV3ZIU!I^]Z+!X)3$I*4[%<[[:.F.VH@$
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MGA6CQ!0\*3'5)NBW1:RD1)3Y96,L>S'W//:7U"M>?N\\C,8R'T\*<)>H0FG
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M:.18$2VY5$$Z+G&(528KV/H<1Q@/D6@:L.=<5881+K T\ -FE</[HI1T['R
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M=86P%\SVF>CM?LK+"P6%<:H@#**Y$A,,(G35,&&ZSO?(R%.%VO&E%)CS4>V
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M"L6WZ_R+ 6D 8HLQXV 161ZP,9A2'H735H3 >:5BK0)([\ZI6-8F;BC1R(A
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M;T\ 7'O08^C[H T7ER0EMK4 6XO]8 H4BV,H]7MO:E. AW6Z&:'S966DQ%"
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MR488764ECYPFBO4^9_S-TT9C7F4=T-)IV8\U41L2Q]2&6-$8G,#C_&5PD#S
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M!7SL546%RM);N:94!U3587F<7.&J++W5[ RS5W,!JDE91A<!3(HJ,5D'&=9
M!.WZX' R3'F(WM8V!MU1X9ZB(%4M7DHSFZFH...=K6JK7E=;5;^<VJK7<@',
MI)@K'W3T.B9J",>1@AZ2 AB)"AO'DG#7M/J)YFQ4,_0R>!P6-;;& CLJMS6L
MHY>WB6XW:VX%;H$\WD:G5\$JPXP&<=29I]$1I2,'%8Y2EWA(A4Y/1BP)-^=%
M^P"-6U26>_/'L%K7>J\'D!_#COU1*?Q7*/RXOK&U'ZQ6AF"%DM,6<:$4<D)A
M4/<8U8YI15W,14AA!I=0A-02"<_#Q*K(J68Z**.SV'@2M9)\:.(-E\/-N9VJ
MY;"<Y7"\3QE3@BB&N-,)<9,<<H91Q*(&@SPQ$64.8US#Y(J:M",T*4I?AIAB
MMSL%*K>$CV5%Z2]:&W^-*HU6"^*J!=& !1&<Q$9G0* V(NZQ05IX@Y@,05CB
MD_,6%@1>4WP^P.'6 +&L$.AJPN\VX3N[^YP[(AG6B#BO<[6'A(PA%OE$L=/>
M15"-BD#F1<D5ETH5OZU]&'1S3?-Y?2.VFJ6QDF-%8:80Z!;9! ,K(C6+:KZM
M21'/$CIF2KR/[=A;0@I71'@6E2+><2.%<2JH0&)(BKB@R>-H)*]WC9'&A=^G
M'ELO Z (H0ZVFJ"0458CRT#E!Z2G+*O04LX?4M]>Y5 6% K0YSW!@"S4)!(4
M3E33F(11YG%4CE<\W]L;G_:=]#1B4".\8Z!D.B&029(A&/5H!-<F1L 4P>?#
M7+/_ "1\UO\!/R?&S&7,V9K'D\+7==+I]@L#9^QK^!F]VYT,E_FJ 5>MDO6R
M-84%^G?AZ;BT*8&!YW\+@^X9J%&]V'Y]J^9L>^>80/MH_>B -(Z.+_9UH* %
MJHCR*1$L(6:0T=0@:V'Y"!?!9'?Y9 )E3\_L2>9H]DN+?^A:&CF-*&;\[?,[
M@]MJU_(I<-&CH6=SSL^^=J7;L2B4?09BT2\NZ9Q..UH[>=,>NJ^SR_/49L]W
M_C#F-W6FCOC&;<@ULP?MD+VL9Q96;<T-FJW"3SSQE-=.6S:['PO_;5'"/F8G
MM9UV.O<&;NR@G?AC9UVC)['_MK;>AZO]8>VT SK$91WCK'#VCU_0GF[F^'AB
M*@$_]WQPFAMUY=;2.X07]V9V%VP$"S1@XW $,T4ZGHQ15!'I)0[2E 8*YIA/
M;RI;C0^7P&+QN=3[PN-T +]]SM.^T_E<=F=]W)71--],H96O#D:VSAH[?C\Y
MK:WR##D!.Q"GFB, DX# G)0D8A-IWGSXO'NC] ^#Z+8*9W4Q_X7K_#:'V@F>
M@9G'R4<N/2R.R)P/425+#-%ZN(_0X3[RDY4RTC_^MN<E36AGW<.ZZ<8;10NE
MYH\8T$7L=L;K ;^Z]3"[K6SQ?<V9U]%CQ 3AB*=@L_LKHJ"M%L+Z*()_\Z[=
M6:"83!"E(-L,L3L\G<J0FG\ VA=')X!79\/#QUJ[,WWC&'[^Z !F%HH.3*@'
MT 7L.H7EEH^C)V>*&>%.._VLVQ0X5AY\AC&BE0<U4\_/YSO^,!8JU.BBWB7<
M&T)D /3+^TB^W1\V07D9>7NG$+@W:13THXU..NW8M]WSVG?;;1;'@)<&XO+9
M4[;Z[.EI*Y_VY-<LOJ?X"UH-C<W;].@$JM@QIGS4,(I7W'^%NI@_G[5!0RR/
MS(H&P7R5>F(^= .MT17/+CZWM5X3WIN:'C:OPASM]HKA+X>KJ/=4C-3@9%">
M (UMUJDFGP&,% _O>#_HYO/I\OY!>SC"L,/:7J\#^V2_N'PXWU?T$UH*.V4O
M_N\ 9J-UGG7@3@OF\?*@=^,!-*E;?/^]&<_*K7=P&N =L Y@+<"" *CIYV/3
M]1R[4\1H]&HG-L3Q25[ARBO.\::Z:,/18))+6ZS,4JUJ9L6H69SJE;,V/$Z
M-3T\L2\O[.4^3 W0H#<ZJVN#@E0^'CX>-? 9:FA_Q/Y9A&G^$%UWD.5D:+6L
MGW:;K1H?&3)C6<RTX]#C*W>70B$KQWR_B":<V6ND2-&#L:(I39Q9[S"-'"LF
M'7.P YJ;[S6%5M(H(G&VT^?\JMYVNFIO*8P54#K&QDJUOPSWE_K9ON-@G&@=
MP$Z)&'$O'0)\%HA+[CS\&>'S-^_Z9S_?8(K9'J+X6)<_.VR"\EO&5(1I=/N_
MO7E+X*>J[<*8J[NIMK2*N;K+PH&_/\%[#RX:%UNLOG-,]Z5.W%D>$.<8M%82
M$[+9Z/5::(NY=E'G:.0%\5> Y!FK8=8'K1FS:#HNHW:0MW58!J'9&HRLOUO%
M:]Y/M9TIL[AXG7R$-FZW-X8MG,:@U^Q3NPPS.P=L7U.F!54:*4Y3KJ_"D5%<
M(:Y,4LQ*EV)X\T[@>8_]K,*059&L4F8G_"C2;FQ'5T;TZS.B9[#I:/W'/E;>
M8S"<$=-,(XZ]1(X0^%,IBYGQ!"RGEVY15UK/E5:UV/>.*R&31@D4' 2ZJ$%6
M<(^4)"R)2!AL;+>SJM_6GI_^GX'5VV[W/!LVWVVKC'_H@/47KV++F;%?9R(4
M1T<>M;/2F.YV?A2V$=AW3Q%5L5A,-IHI :""63NT?]X/AZ"LC+S>#E]A9L F
MA8_*)U3G\3?3"@_.]AD56H#X(!Q %^1)2J29X2@88E((.A(!6B%;(XO2,YXJ
M&*-:)X^\3OB^"=*"I2!A8>0#=J((TAQL3VQ4\"P7[E(BKQ.]:)VTBF#Y0P#,
MC%4Y\R$?GG6*V/)BS_X9C,78&Y[4U%RG<USB7F_VD#9#H[.]9@^LC]$R&$5]
MP!MA0KN QUF5_!E<7E(^B^P':%L+MH.,B$6N2&$#Y>;:J1>-'%;]'(-RD+\=
MVD4C*^@*GQNTIK2YSV(1<3_,)2F.FEN%&_9REE-N^OBD;/CHK;_S8T:-+@?B
MBM<-WS)2O@L'HALWOL@!R1V;;)B3[)>)KW>44C%)=RF/^&8'OWQ\Z=R,B_)9
M9H:H\(Q>Y?=]?EOUUH($GNFCR$G^SM3L 7:&6$[S_'7%,_ZP_2*'J%:/)S#\
MA3^F!ZLE'YR.\DA&UXR22-:F<I:Z1<W27B$\>8B+-)V</P>F6K)@%<-Z'R4Y
MY0;E]*"\9#KGMM5OPO $T#G@P]$[RO4&=W8G^LCX;>,#UJD,C;*'113XP<!V
M+:RK6&@?S9.L>!1=NI'*<@OW[<KDYUXBB'PV2WF[7?L23_O#/!B=YX&0JS-T
M/]?_N-KZ\NWS6<)!+F6R$DL107<TQC'AX0<W7DDK1!$^1P@V5*/1+U62[O*V
M^D\7C8V#?0VC+A/%R'D5LV]0(!NT1)8+X8-3QK*0?8.+M_=?2LOA[:UTP6K>
MGWK>C];WDPF1$2Q1M#$A+K5 +IB C 7K#50[S6SVNRQ,SO[UYMG9MSLG<-%*
M'Y.A*7".$];<V,2=BOD(RH3"2IA?$-4YP9V6 :YO?-T7*@<M!(J,)!1QER1R
M$59%\#3ZO$8\!O%G\VO@/R/MKQL/<G'0G)GA[6G>$/,W>;][6_RL@5BV8,\I
M]<< 6F&K<SJ5&]P<?G/<[IRAP\[9(H6Q.!+N=L+ CW1&VSX\#]W.H%>+V;KH
MM,H<LVPSM&K9*9@UBWZ1%)S/HPOWR;3Z?'8Y4:WXJSQ<AM?G1?8,SXC7;Z(\
MK8W"%R;V3!%Z$$Z:_7Z95)N*4_-QR-ZE_7ZJ0.S$:9^G>?S%@O70G/4PW0X5
M[D9,S"M4N LJL,;1P3XS'D=L)6(*H($KK)#UU"(AHS"*!X]5SMS";_$\__Q_
MBJ5VNQF^&VMM-<-WG.&+K_N2"N=REB;6V?E'5$"@Z!'D7/)"A""BS9DYY"WA
M\S.\R -S];'P,/DWWOEP.&DEL+0T11(S?8CEH"5XEFS T5,7;YQF<\?#X4J-
M7+B.>"-G8SA,1#0$$:4XJ)&@LSL&FD1(44H:9%"Q< YB?D6.YVT6@O$PS9:"
M82(UETPZQTRRE,&_"CNL;YQ_4RV$Y2Z$G<U]EJ2PG@DD84$@3AU#5D>*J.28
M9^97)DHO,9G?,FKAY^0:M4M:S.RG<UD[LZ&B8[J%[+[*<:.E0_>R)SCKE"6E
M2=&2SI"V9\*Z<SGH,_O2^H4_;3J@L]E.K4'A OW>M+-AMYT916DN3K?4@_,U
M__?R8T,\S0/2]N>U86#M8N/K"K_,VXJ-Y)9L).;EL)'<@%UDX7V)>$65"$1'
MQZ-C3A#0"AB@K@2U+*99%A,26%8@1&":<R6L9?FX3Q$530PR\COV]BG.V5,G
MYS,5,%"<2 RE.$=)G^3#I$*W.3@ 0Z<(KT[--MA-911]N4-,I3]=>3K_VZV<
MV&5#+M<PAR%IV=->_&WTR^^AV3MMV?/?FNVB8\5-OU]^G#B=H_(L1K[\>K(Z
MW^)RA0YY_8=O'G[]MOAJAIBT_$[AMTSQ*[_&;\F5W_WLL82^U9S>Z;$__X[S
MN]UY;6/9C1Y[][+MJU>>>C%M[8**$,^J5[N@C]0VY]21VQ3@ODUQK[N4Y%Z]
M0<NZVDV*=2VE_/2+&3)\ET7U+#IW#30\TUZ!2? 9MO.L!-RB:S=8TB]B%)94
M#?*Z&@<@]T]$YO\EMDIZR2^Y\Z,<Q^W38>A*K[8U40=_NT_IPN7 Y".4GKQI
M"V^]-'Y2I/0FA4*?;HT,J3OF*E=6=9=?:-D.;14SVM)@K0;KE]N$K;8Q) $V
M, _NKI10KZ-@A]@]^@/:]6=K;^./YN[%5]RX.!;;'QLG<#_=._DJMG<\;6RT
MCAIS!3M:S?K'QG']Y)_C^L<_CQH[G]CVSC'?I;L7VQM[)WL[QZ)QL8NWO]5Q
M407^RTSE/1$QITPC3[U /$6.8/H4"LE&+YS%)I@W[SA>HWS^/*2J E^AT6JB
M$:<FR:2MD1)SKZ)S0B7)A"5&*IS<70G+*C1:+AJ=7T8C;ZBQ6G*$O0,TBAHC
M)VQ CC#MN([)<P(6HUPC=#XPY_74?W\ZM>YCM]/K#0GAKM3L7V8MXE\>5QG*
MQV#PVRP.%1/P=S'^%10M#XJ^SBE&E/ 80#-"B1&)N"84:68=PEK)H ,A7N,W
M[\2:6I ._FM54?PE2/$2E(A*BA]9BF<4"N:]HRX3+TN;:[G*@ S6"83:":J)
M2B854BS(@F#OE:DI_B(]1(W8K[5 #.ZD1MS4/GO> /1P:@0,_E8[)U[^!3-0
M0=#R(&AW3I& J<NDV0!!-AC$0V#(),:1D,Q2YQVA4;]Y9]:DF:?ZN#D$K9YO
MI9+C1U D*CE^.#F>425(4HQ@XY$6#H,J$0/21!HDH@\)IM>07-3%K"DZ3\#^
M)'+\>KP2(U6B9OMEZ&?).]J9C@NMO!57PA.!Q<L--A@T9<X8-4H89H0A3DB/
M_4W2#*Z IPDV90[_UUR1_9%@R\^I'YYQAJUS*&H3$!<VISE+B; ,/C$E#<OJ
M!UF3>+[R4.7'>!'R3;WDU&LCO<N!R<E@[#%W07O8Q2*_A_I1R??CR_><AR/)
MH#Q%RE*!N,HT!F EHICRR:Z.))A2OA><WSZEAV,F[X*(,MQ[61%DCW#I?8-?
MJ[C@5Q7D6L4%/TY<\&L),ZU&X74%V_YA6P5+Q9?#".9N%6+[ZD-LWP^ZW3)!
MMQ?[5:#M:PEM"T[(:$(R45L>6'*$X1AI2BP1*_05I##S$6WKQ;(9+J+*1EN>
MC;9YD>VST@]S?-8XVN3[,"/>8*V1B)ES#'N.M"8$$2Q-9"123^B;=T*N45Q%
MV590]%R@R"NE3/2:6L-Y$$8;J46TPG/%'*/BIMS6%10](!35+T,1EIH*A1W*
MY9LS;PU%1E". DP@8S;PZ A D5@C>IZXI@JQ?83#K$X;^9^J=B_<M?UDNA",
MO*\P:.D8A.?4(9BEX!R5B"M%$8\F(J<X1]9SR[67B43VYAU5>(V+>^M#U='4
MZLKO<A6(2GX?2GYG= C-0P(]@B$;E$?<$1!=(Q@RQ'(NI,#8V3?O"&-KRJR2
M_+X^WU"K:5VSU<QE#%Y9G.T3:!%_30:[LF66CT-D3H]@D3@)6P82+&9EPE+D
M+ N(TL"M$HJ3(-^\DWR-F_F8O&?O5JD$>-EJ1"7 #RW L\X(3Y(P!%8K3PYQ
MS@G2F4E7&,])Q$FQ0-Z\ SU"\"K?]ZF=$??5)5Z%1?, ND1EUCP(&M$Y=<)S
M)X0'34)IFJN%@X%CK.!(><JL\\QHQ]Z\$WI-8[I"5DWEE5A]=:*2X8>2X1F-
M0CCE@@H:16MS.*P1*.,P"I0*84RT,1=-IF1-JI7S3/RWR%NY$5OYRM)(W[ 4
M3_\P=F/M+/]XO$#V!57+KRB<DINW<VC;._'DM-.UW?.MDU/;[,X70TC-'S&@
MB]CM5+7+Q[7+-]F^PPXK*S$B.F#$L0#%'N8,\<ATWF:UX>Y6F'S/'*5JZA]O
MZD$4I308):,#XLP$9&6@L,49F@S!6@6ZL&S]?'6,YGCH"U2YHE+RV]I&645C
M'F.FB_/D^K\_*<_T=$MNH_F]"; =>MO=C69O7*FM5RVW:Y?;UXM]D;#Q/!"4
M&(/E9BU!)EF+8)L+$M9!4-S?"FD>:Y.IIOT^TZX<J.;:4"08=X@;'I'5'$RW
M@$5F6U &^QNB3!A-1%FPZ\K"%6]KBPN&7%L 9*9@B"%< X!(V )AX2H*ZJ.V
MDG#,9(2/_4B)RDB6*XG>N3A0#Y9+;VU4W:<W!,&L8ZX5MYP.NOXPEXDL_NJ<
MQO;DVE-[7B11%U4HKP#>4G^SO6'=D%[MEZ*L>F< "F3H_?K; A7V-J4_%@[V
M]8-7E0QYW25#JGR[*M^NRK>K\NVJ?+MGG&_WI*[B+UEONJT7\&8H\-+2&V[7
M^1=S0F"D4CX%XL'XX\8S$WC@ LP ';B3B=^UV$%FT?B<:T[&\+?MYH.#5W%<
M<+Z]<WBX=[))ZANAM;US &9? ][_1VOWZ!@W+OXYKG]K'-<_?L6[7V:/"[;$
M]D=HU\[7LP;]*K8W/I$ZA;Y^_*>YO?.)-;Y]^@'M/]O;^7SX[T5]CAQ'&D*M
MH!CID"SB6!EDA)$H!IXH*9@U4J[=2L4\R>_=#@MNK"P\Y5%@A745UDW("X,7
M4EMO/9C9-C@C6$A@C7B5J66<N&LIA0KK'ACK9HF".+&)2H6BT8!U1@5DBA_2
M,DJ<<B:Q-^_X&EU :+Z*6+>D8.Z5!J?U>===%<9]9>@58XERH[VR%M0Q9[51
M&F!)8BHTH_S&R6##0?\\'O-&?!UA&X^$3?-5J*0Q23I#4(P!L$DSB9QW"4D?
MN8HP:X*Z3&*&%5FA,- JCGO)$BRI)9Q(XX0BG#EG@V51*A*UU3):>>-TL$J"
M'UR"9[0+(X,+449D$R.(>ZZ1 R1&B1O">;2&$UQ:4FJ%)/@U>+/^OOZ4KPKG
M?BB=PI[XYF_C&5AOAVT8_Q$\_5V.?F4$/11,S5=U2C@H*SA%@7B2'3X$Z619
M$4  NTWD.OHW[^B:4//%&*H([Q<CUO=5-.XKU@NB>BJ)OJ%$SR@>FI) L8W(
M&.H0CUAF+@F-%)& ULY:[,4;D%VXCOZ^0C)].>)[/E#F^ACPN?/#H=R]^Q_7
M_>_5H39#F5$4A.JTTVL6%)+=O%B;W^,DJ"4+U-1=PY 8/+G%NEZG->A??<L5
M,>H+6OS80>H?D,&7QV?Z9^Y"(8I.TT@(]X&8Q(5--BH6E94\<IHHUON<XS>C
MNP['C-:G]B BUXWV&)1AZ.1OMG5FSWMO_GMY=&!HIJ?BEJ,X'^F_:-IO%&?U
ML#,P=[Q,R[S"?JS)VE LKPBL<]800-\8=(ZG$\89Q[14@EG.F79F-K N!DXT
M433:2,'F,!8GY1G\0Z272A*8>-OLUOZQK4&\+C9M88.N?<%,@W1P7#E,1 @1
M3"*C!8LB6<F4$2DJ<560&VB<!MN@N!.))VQLD#I:P4@FS5$JW'&%/+:8[1S&
M86A@CLXNP_).N[%7Q'-/16<7JT#]WJNE/#W?\_34#INQ:V%_/2]"()MP0\F%
M51@Q4YFHM9-H>X-N##7;G[[?WB0/93Y@\1;AB<\FS)"3MQ2K*LRP:NR#-?9F
M0:SW#2BCY'G&4DUVG5J]1*N3DMP/(&JI$7?/=8#F(MJKX-:?#==?\7MLU:KX
MUKN,&JU&[0ZCQJI1N]6H[73ZMO6"XV87][ID8:S*450M7&X+7T.DSWO;*_/L
MP'S-]G%5SN.5<.@;+BW6R0=F,8]2:$DE(4:31'&D"M\T:BDOH/5VR/_;G"RC
M;'H4EL=&L^=;G6Q[K,R)0V-C?7CB<'K8V/CG<._CGT=[)W623PGJ'[?$[K<_
MCQL7\-E1_7QOI]7:_O9G<^_+^,0!;V]\.MO>:1W6=SY=[!VMX[UONV+[6Z.U
M]ZV.M[]M7M0W#ABT7]3G3AP^<7@W7+OYH['1.*EO?&[M'1V+7?H/].&3V-VI
MGVUO>'CG\8_I8*7ZSOI%X^B [$O!&/,R(*FY0=PRBC0U$F'FI!,A*IC2-^\$
MF2^H^NQCE2H8>J$P)#B)-)H4N>3<4NRT(XXIF30+,9KP #"TXC0'SP:>SF?@
MR6.9O%0484\DXCIB9 @.2''&G6-46X.7=B):050%48\$45A2[H*BCOK$8X@Z
M>BZ9X490&JVQ%42M*D0U9C4HQS$+)'ADI"2(,R^093$B)77BUO,DO:L@JH*H
ME>C;;<)%@_ ^*&:I]EQ%Z+WPT@BIB<"&B509<T\.1;/:4K(J$X@)E&-[<EJ<
M14Y*@"(E)4])&<+XJAES0X?83$179A)_\R3^O.H9S^@9+\N;>L6IU21 Z&['
M$3=-V:J>L3K/>%E';(MUD6^VV[6W.1ZX:3C_RO7TUKP,+U.C7-;QP&CA@%;Y
M.;>DMSWH]_JVG8>LLG.7HESZN6PC0ISQ+A&$O?&()R>S;BE0U-F7$36GS*]B
M;L(CT<A4H+1*?7N"PX(*E!X#E,YG4R!U%"9$Y SFB#N!D74.,$IS1:TCL-?8
M"I0J4%J)OCW!\<#-06E5D[.?"S(U9M2EX(@1"D=$C:> 3)0AQ[E$GDB1E/!4
M.9-98 A_@<G9%2Z]4%Q:UIE A4N/ADMS9P0\Q.2"190PAC@Q%EEE')(A."^B
MT::DIUHM8'I9CMXKJ)K7/VS6SDK)J)CQKH(@*PW%@#>41<=CM$Y1Y4'1UQ);
MA96I[+6509^#^7!3AJE75G'$$A>(FV20H2(A!BHNBT%(3,P+#I:HQ'A<D$P'
MR10T)X*MKC5S7ANFI2$B2&MC)<8K)<:S2@1Q.C#,4P[&5(ASA9'US,!OF"7,
MI8I256+\"L18,RZ2=]J;1+@R*A<K"TQ)&RU)U%:.BI63Y;GX189M]-03Y)/$
MB'LOD9':(N%"9%X(ZIC.!H&BII+DERO)P3BGE="12\$I2XXY%UTTSD?+8E*5
M)*^<),_NRIAS88E5B$AJ$7<Y)EF$B(0&]=H809Q904E^#:$NA6D_8GHZKRAJ
M'RI"I."R_-(\.6W%]8-N++AI/G2Z'P;]03>6I6M'X73GE76P%!PZGC?R?1#:
M)N%12@9L D(%,MIZ9+'W6DE)J*<O^%2V$N=EQ594XOP4XCRG5GC!L1&@48BH
M$0?;'FFO-/(Z6$6=)R*02IQ?@3C?-RKA[N)<F0KWD^DYH]]0'4S4%#&"*<BT
MQ4AC0$Q%$U,A$JP\F I4K]'[5ZFI1'IU1?J^!_J52#^92,]NTR+0P(.EN?Z#
M!ZV;!.3^?_;>O*?-I$L?_BH6FD?JEJA,[4O/3TAT0UKTVS9- ITQ_Z!:L<'&
MC&U"X-._IV[;+#8D.!@P4,]"C+F7VLY5USEU%A=@.7NL0P#]G[*TA"+]W"?[
M53KDEXCCJO+HW4SW/!GMEX"(VE1N]0?:>\;)SL;)GAE,>>B=Y=315<*S]UE*
M=9%#\V;VE46%^MP(?BQ)+9YJ,]D\KS:2$4<\KU\V>6/GP&IL#/,*F91 Z]/P
MPQD)OV(>1!+2.[WP(]Y%R-"2I\,H"%H0]%GCD@J"/A."UJ<1E$3-!7,<&:$
M0>$_R!+C48I.$IQ+K>1L' 5!"X(6!%U&<^7/(&BQ:CP61O>F853(F(RG&&'+
M',!H% "H7B.I8G*288V575EC"XE8*"A:4+2@Z).$?!44?4X4]=,HR@(547J&
MF#0,\9 U^8@Q,%(<G(K4*XS?$(K>KDA:2N"]Q4)MI;&E!-Y;*('W&DC4W3O
MJY_*Z6)]^)W.WYLK6K;(LH*OHL/O<X(74P'Q573X?4YP*=8XWZB58HVE6&-I
M82G66(HU+M @_#8-NU[XQ)G1G@7!5;168T>$2QKK%+07E6$7E_H>,V9<5C_Z
M>%3?V&]M_]F ]_K\/-[<W?O6I/!]]V.KL>O/Z[M-LOW'M!G77]2_U,\;W4W>
MI%N\<;F#ZQLMN/[C4?-+_:+Y99,T+M>_-8[V^!W%&L4!-CYP1SC"+%'$I0I(
M:ZZ0(P8;' V)42U;?8]29JC T'<SB.#D#2QJJJ+G6BCKA+6PS -SE":LG@"&
MWK;+T_/!T\44/ GNHF/.H"B<RRGB,7)&,21]\LPI[K5>7(KX E$%HIZ+*46@
M1T9XDYP&7)(VXU2D5DGBDZ*I0-2R0E1CFD%IYWC W*) K<Z14@!1B6EDA0$2
M%8(R:7&QS 6B"D0]$T0E['7",B?<H%SZX+ATW!F')<9)4%Z4N1>'HFFVY'$"
M4I0XHM$+Q+TCR $71D1P3R/&0>:".LNES-U3K%&48HWE&3]\QMNRII9BC>49
M;_*(K11K+*4^%G@\\)X3=#\3N9PMUIAKGU'/$H+)<HAC%Q#H!3KG @E)>*>X
M%6\X95<!I3<*2HLZ+"B@]!R@-%6L,5(-FX@,R"9B$><T( V A)Q/QH8J=7PL
MH%1 :2GZ]@+' ]\'I6)NFPM\INLQ4J:)E8XCF9Q 7/L$C(A0)!1C3'+'@\(K
M:T+3 CP%>%X)\"S*Z%^ 9Y' <\O.?WQQX$4@U$6&@DH&<>,D MK* 7F<9<32
M&(E>-N2Y(WPV-RZOOO;)F:U:]]V VM'[VB<AGL#"UA4>/;,TT<H?OA4G)14'
M-=N/->L]C-DPALSR<\S>C82,M?9)]?=^L"<>[FL/6[7USW_4N,8UD(;J_M-^
M',3J_OQGN*$W;,5^OJU_!E_>?!H(+_PMBVSE9VSS3<YVJF</6C$.!Q]J-]IW
MZ][\JNXHN!#>.ZRE''/XM8HYA-_:\(C3"AURL_(_M7[T9_T^S#N\8M >K(Y:
M[UOVY'#4L1M/F.G#3#-!^H=55&..::SU3F._FO-!]3[?Z\(36O%DT/X::YW>
M8/#A=C;)U[(P;@P)]')X<ZF<P\H X?!GG6H\S@9Y9/,5OW= [M!GW^IUH#';
MHUGXI]_V^8)Z+\3.A]I'6%GYVHMH^X-:A+Z&VB32<"33XW!#4HUG!NG5ZH8_
M8&3MR46>S-[A"?0&YGX\A[7Q--UN\ZWEEFKV]+3?^P8X/XR=B]I__3)//3Z9
M#,]>I-01SA@U2AAFA"%.2(]]/-C([<7P7_2P? ]79\;KX>AL,,R+:3M-=II7
MOZOL_V\+^^Z_)_:+.=ON;N9W'#>[C6[S<N\<GG_>/.JTFMT=5H?OZI=_P7U[
MHMG]JP,[!&[L''!%F!7:H"1I3K^M)<IU3!'6@3()6[;W!O8$R6;VA%^K)?-?
M<\PL]9)3KXWTL.LHD@S&'G,7M.<L1NZJF<63F;V3+@Q@AX!/98H?.,6D?GB@
MA+) RD##(#GAAK8!.2(,(D)1D#&-':,K:P3/9MM8!?D?G$;XY2N(\>ID'YD3
MDV_O3[!C]+JQ]DO\=@K7Q%]7:R=Q^$IA.PZ&%<2%[P%X>P!K>!C[77C$!+_'
M(84P&*=G>?/=.H&AR:'[8VS],;:/*,1@<-8]'8U]/XXVB&&OEH?6CS;/'CSF
M%.Z+M:\]^'N5_7SU^H)..T68Y/;@&*5^S- .#85>U6!&8S6=,!5M&.I0NVC'
M3AC1A,GF,.G^H&KS]0OR$+2KK6L\!$ $8L4.<GKV-GR\<6WJ][HWMYS*ZJ;^
MY\;=N1G55:TV=*B?J>+4RP:Q _VIG4987[YZ3+MJ%! 4:)]O5<^_ZG0_=FW[
M)(]D[O[T?(VZ>-^0M&]T)M^U]^$SW-"O^-%%+1MG@0.?G<)?J_&J 14"*1A?
M?%B1J\QK1I0O-^ZLG_LP:,,*M?T\>7,W]=9DWK7ZJE4R6ADNW@BP&K\-%N[U
M:S)>9^D_@S'.:W;TBJM%<.<8W)B6_'<@?*WV>,PG*P6: FOWM%HKUR^#Z<DC
M-B7\WZ7W8Q%4%&3TM#=HYPM^JY8^H,UU1IO_K-RZ:XP>^/H6ZX!BG@WOO^4>
MW+D9;?M"P/,1&3(U8C=^MJY<HD[M840.EN8QL@F:^YOMG-N+P<I_W^XG=/+F
MH,XY'K,XO/;_7!]><4<#I^9UM!?KX+ARF(@0(O?<:,&B2%8R942*2HPH!-P3
MPWH^""&4$MC+9'+2<VJ8$X$33SBU203%\,I][]&$$(4]3TD!JXS6J!@\(=Y8
M[Z@QT^^14D<J<&))2<Z\=MHZ)1D-7&H,?/0G1^=%E(M>I],[K]2&*K-4/X[5
MKA%NC^[/!!\4<5OQ^[PIP4X%W\%^-%$^)GK'[%8'CTNQG_7#02MO2U?@T[NV
MWHR2TOQ(^?CMX3S@-27*4O@#4P]+9?2VTSFQ9TGG]*#$.,N7,2%+P@,\]=YP
M]^=*>O0FG-D^9X9>JQCZO-;5]YD9=;[.O]X#EG]B_W/>3*=,*$Q@1ZRCDGC'
M(P].1BT$J/2212;=/9FDMQH?YSEIN9%+;BMS@3?B;W+:W=YH=>K=)F]<;E[
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MUF'6H/YAJD[0]WC ??67[BHXE&^KUI(#.".PI@,QB0N;;%0L*@L***<)P.Z
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MM0#F1GD63+!"*2Q'OB?32^2.K7.NR"/\_E;"E/:^@P\4H;"'8H4,YL#SG")
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M[=MAK-V?V/KD+.?R7"R5F0&AS90BO/?K=9F73]"J3[=ZN3Z)L_X\Z<VMBZ\
M"=%7BDC[_]O"OOOOB?UBSK:/MD2#_GNTO;%W"<^E]8V=R\:7?4"9]?/MW3W:
M/&JU&[L[\/TA_=_+^F7C\,#EF&A!!7*&,<1YT,@J8Y&CS"8BO V&K*Q1\@'/
M0,E_[ET758+C6+OE;)5WA%J>UIH]";7Y%LXCMZ^R<!:\<$1CY\!H9:T0'DD0
M7\0]D\A9K9!)-M$8L7!1P\+1/[-P;AR85\OF#L"_E33[N_O!&(,5!9 ^[0W:
M^8+?^K%C\P*X3G3]G]LIQ\?;![Z^Q3K8V  ?[[WEGHWG9D[<%]IY/B(CID;L
MQL]6_SJ7\F%$KA_M,;()FON;[9S;B\'*?]_N)W3RYJ#..1ZS&_':_W/]_YZ>
MTNKGW;GC*;=8<Q!TJ[B+WJFD7%1.\T1,3'QZQY2.>"4I\*/HN2?44>% "7.<
M)NV\]/?MS#_>:7^4K?TEYCH#X"IL]8/3$<1U+GZM#7N56-V1F_X7-R+LO\(=
MJ0-W %Z/A1 &I&)R-G^7N4#LPKQEUM"[JK)687GF#?W8@N?!ZVJ=WF JQ?TJ
MO,U'8']P6Q8#6&1O-NT])Q\H5B7M?6GLDS7V8445'ILUGY+I'/!C"7K-:>"?
MH]R >=BXO9W$^@^I15!&[5'E".8?OM<^0G90^Q0KTG&_RVP9G]GQ6:B+$[[C
MQ/$FA4=FEDV]J$5\ZYK@7A/;AUJS%A9;^=X#L5]9+/9R5#>]-B[=LD+=<[[R
M0^/4.ZCN=U'?W6.-RW6^?U2G^]U-O/]ECVQO''ZK7VZ>-S::YPU:O]S^ D]L
M3Y_!;'UK['I6WVAUZY?[W>;NI\[^[A[?WMB\K.^NY_>PYF5=-"_WVW<5.["!
M)AUD0(1XB7C(T3<4:Z29M[ 4#*=!K:R958W%(XK[S2MES^1]]J#V/,8U[7&P
MNGSP4HY(WA]@M&\#QB/.6!:<]F$!H/$2,O2?IRC=5?A=X7?/5WVY\+NEA>O&
M'U-PC:DTP3-$E:; [WA.&!XD8M$Z)6 WEL:NK!&\*N0L8!>"5PA><65XZX@Q
MI1$^PA>B$+Q9@K?0Y!"OSH@Y#C*Z=HH);9#QG+*O_;CXBE>(K4MMFYN.!LM8
MNG%CK@H1FPM6=V8-;2IA(91 V*B0P[XX,C@Y)(W"4F(78#-=69./,K.5Q!%+
M39=>PA[V8+DN?.FA@CUM$%,NQ*0C8K[*6J4ULMH[1+2!5>VT4,R!AO6!+4?R
MB)=G1 5:ECT@ZJ<Y0K'D+ YGIBTYS',KE;>(.I?3S"N,C'<!$4494\%(S S@
MS"K1CU;,"H]8&M7@B>PN]R@'A5&\B*1/6V"<5))2C*P/,5M@(C(I*PV2NL B
M9\JKE37V@;ZXJO#R9.)]^XA5T6A5W$*G!TT:Q3Z^LRQ92VU6J29H_23\G:?G
MZIHX*%1I<0 Z6[W18D<%CA)Q3#7B )=(V\"0)XRQO-"M!:K$5['4CS_S*EFS
M7EPE6AIKR_WB7CC1G"(]967QPON4*\S 3X(XLPPY*RB2(5IB:.+6XI4U_4$M
M1\:LER=&!5)>O3]-(0_/@333=A8#*I8SF"'A &ZX5Q&YB+,#3=12,\QDY"MK
M=)534\C#ZY'TY?=L*>1A82(]I0]H1B*6,B))<Y"#5@'I9 -*D5@;C$C.B94U
M^8$7\E"<5E;61L(ZJ')*=4]MNY]S1;PS9Y673.IY#QUJ]'*P^QFTQW7BV,5X
MZVI^_NX-!M/4Z.WEZGLF"&W.F%249IY(S9&WT>=Z\PYIZ04RT@4B#0G8E (H
M;T_:E\:RLA#A+P3JH=(_;7VASG)N%&(T1<2Q9,@(AI'!)/(4E90!+YGTOSR)
M*M#S2OU<YL>:8H-Y'-[,^+I():S)00>@GB'N+1 -*C62/#@1=8A&X"IJB6JR
M''!3)/Y-.KL\# H*O9A3W*>4"QFC4I)8A*,#>L&9!&8A)**!*H6)-S:"N%/U
MX3$6U[="*]ZWQ\LDH"A^\RU[<G@=4.2+X\NS.K[8KF_/XR^X.9ZPC>OY6N_"
M1 P+69H+/?V,:89[@2WU!GD3$N*6"^2<QDAXH:7"@7H6@"SQV0"$<ERUM,+]
M,A:9!0CU/Z.\R(44S2W64S87%@@/1E+$I%>(4V.1YB(B@JTBC@$3ED"*\./C
MBM[*H54!EN7W>%D@:RCVE\5AS[3])0G!4A0!":5!(0/U#-D4'!))4VZ=%XRE
ME36QJLUC8A *J5AJ4K$H'YA"*EY0L*=T!1&=--AI1*(.B >:D ;6B&+"F)M$
M:,SI/HE<6'*75\\JWK<KS.=ASQ\C9P=Q5!HEG@PJ42W>,,OH#?.Y9?OQ]SQ9
M?]R8JS]Z@V)DF0\X#V>,+,XJ&PB0(<$Q,")+!;*66"23XUZHQ+ DP(AP.8YZ
M;;+]['4?%WP<]0"A+W3IH5(_G=O%*IJ4Q(C+;%K%E",GM4/::8DC?">\S[E=
M9J7^_9U+%;1Y0^XNA4DL#%-FXHNPP\XH !%-%>+::Z0I?&))&9L,90+F<4VJ
MDL7EM<GV:W=L*4QB@5(_I3\$YF*422'B- /](7&DC3?(@5*!/?$6.&1F$H])
M2/!6F,3[]G#9RN79XF X*>D%.-*//K:_Y@JP[\S%Y27L+@\V5T\F:G1)<6;Y
M"9P\GK6SR$!IT@8T+@(XJ81 3EF)N$]"$<4=<<".@#HMAWVZ'#Z]&CO+3\IU
M.7KZ_]E[UZ8VDFQ=^*\H>/<Y>TX$R>3]XCY!A+NQ^S Q0-N-NP=_(?(*PD)B
MZV(,O_Y=F26!D(1!($""BKW;8TNJJJS,M9Y\ULIU>:AF-Z?.E#%1P'LX%ACL
M'A.1 >*#<.+"@^T3#,^=2!X5X_M:#IUJ1%E67\HCV4$=M+(X@)ETK'#N-(D9
M8,#00IPDBRS!'G$1:8*U)PFS7+B%T"4YW*Y5?65<*S5Y>&;=GBP_P)(+QG,4
MC /R8(U$EAN-O&>>&6DH84 >Q(SR;V^//+SMB)4/_S-H]B\:I[%_W F-9OL[
M*.,;K-^R(LE!U6KME,7:OEJKVI?R -#\<)X!L_*G?#O?/?G #RD5QL/FAZ3-
M8;P2 VH&GU @3"8L@]/.KVWR1V4&U:=,RV+U+$=FT&R-KHG0@W5Z^Z9.XRBL
M@U5"&I82<6H3<L)YQ(Q*/GA%HH\Y+6C:C5*78:E19=73@FJ^L%!L^7036X@G
MR@69D,X%;SEA'!F3&*(^*16,H)3X')KR\F48:LU^+4D_-5]8L$Y_N:G3+E@G
M3"1(.E!GSH J.%@_Q!136-ID->.S T_>*%]XV]$GNYTVN@X,:[3BD6W!-/3Z
M;ZVZRE*'GLR*WOMW7JKZG&GAD/ICRJW":52:&8F "5'$P>[*Y<0%$DQ+'KT2
MG-'<B9&:1V<#U0=-2V,'+5F4RJT04%.G!^OYA*O%D!@"EPIY9S7BHAPH<X>T
MIPP+*:+7<6V3/BIF][4<.M7HLO(1*W.1BKJT_B-P9L+MPB.UGG*+(D\RNUT8
M,BI8I*W2@0H6>5Q<=>V:42R+SB^'_^5N'E$7U5^4WD^X9@+'(6 O$5'. ;\0
M#CF?W:U..RZC\M3:)=/[ER<:;SNZY7?;;#=2MW/:Z,;0.6U>J7%I5@0XTFJ!
MQ@]LJW'6[9S!P"_>6-S+4KMM\NI]A,7[/%J[\NE>VAY;N#^&ZU9[<A:.P!=3
MGIQ(F*0\">15%+E1=$(.N!@2BGGLJ*(F9QOQ=6WJ;.Q50X*5\>3,@PJU<^?!
MJC_AW FPL)SE_".E<CJ2,/E<C*% *<-.82Y]=N+B#?'BA]TO3[IJQ%EY[\YC
MN4?M\'D$]HP,/QC/Y='%[M&A-#E;R2D4N,O$0W%D78HHR& 5C@XG+9>LH5H-
M!*_%Y?,@PE%[@18%!GX2#!3V2E+GD D9#'BBR"@L$:PTF"':QA)VMU1@\/*4
MY&V'Z?QE6X/*[V-;K<ZY;?NZ-,R+E^3]K90MWVYOQ12[W1C@!^][O=CO7:W6
M^]%BU7Z=!6+JY91?QR=8W*AR@UHF$0_8(JNQ0"X1CL'4TSRDM4VU;L2CPQ[K
M\[0WYM>9I\K>7(A0,ZEYM7XR-4K!,BK!4!(F(EX4/N1&]8D*D2OX*@M&%5$S
MFAO4 3LUV"R+2Z=F&<N*-Y/I4B0:1[5$!K82Q!/7P#>X O@)7(&QIEWI"; N
M\+0/N689RZWX+UUPIF892Z/U$U$[U%!E<E$%H2U&/ J,G,1@:FB59/!2,IUR
MN]5'-05X+2SC;4?K_/'''XU6!YX+V_ 1Z' []AZ61K6ZKO!GKD,SIR=\*[K^
MQ^NUJ?/('P*1>$:"%#%)<HZHHC27[@5TI%$@(BVV3J3D+5W;A!^\^-%Z?:BU
MM'5G'AI.,Z'3=<3,@[5ZPKT2G9+668M88A%QYC5R'$O$N$W")6Z5,SF3?%JK
MW^@1U8)PY=%84HC2,DW3?SU&%)9<!)8Z".@6OE/'^2P(,2<<1"PYIJ132!BJ
MP50, 9FD","FSC$^426]N,2NFA MBZ8O1Y3/;3RH#N19E+9/.(9TH-IE]68V
M5]H)AB.CP CB4@K&90*%=TNF[2_/D=YV&,]>_SAVZ\"=EP[<*<OP/IP,JN)C
MO9KYS(>%9,H#9+4+7CJ,$G82<6PC,L*6%KJ28I<L"1IL12WK@[$54]]5"K^Y
M5:]KDG-OQ9ZLB:-YB-'E)BO8(DZC029(@; .&//,:+')Y8<?4U+\M1Q^U8"R
M_)6':V;PU  RX1-).EFG<XUAI33B\'=D-6'(,V>"=@ZL)0;,P$PS@^<&D%J'
ME]P54E.!Y]7D"7\'RQ%OD0D45""(*T,0K"!'SG)I'$Z1NM*)8$F"WUZ>#[SM
M8)C]3M^V1DVM^_9'P\5V3,VIQDQWS8;K=$/LHNI=WC&8C] 9Y%K%^15&W_8[
M9^_R5/4ZK6:HOGD#QV0+F9KEUJBE\!X-RZ3]6@EP?7ZVF!V&7GN1KE)CN= I
M6B]AA128FXDE9)FQ*$2KN#4J)+QPG_HBM&B%3MZ>#$]7"#R>PG6UO?OQ?D3U
M-WAHLSV N=P[B]W"5GOU,=WB0&5G"E2TBY0H@13/>1N*:*1E\(@8#HL8.?,V
MO1)0>7G2^TQ!4#4KK%GA"Z?IU:SPB0!\JGJ2T)QH)2PB@N>X*LJ1HYPC3+F7
M1G,LQ,*K)]6LL&:%"\"/FA4N":A,56$BGKL8'0,:&"CB/&KDI*=(2FV<Y\0P
M0E\)J+P\*RRNT'_V+;PK_&]H?M\L,^HKH2_2/NL3^.%HW,.;*PI//^OTFOD'
M[[HQUS+['G\Y;X;^\4B_QZX:SC2^OL0ZF-=!__9+3FWWJ-D>K9&YB68YI!(@
MXMFGE.91?D3YE&PXJ]4<COUYW!V-Y\P>1>2ZT7Y#-L%PW]G6N;WHK?WSYGO"
M2XY/ZISS,70[$UVVG&I0K@N/F#' B76M($LZDLN@*<.CYYY01X4+-#I.DW9>
M^@J'X9H8WF<$3%'2$(+,5CEG#CM,*7$\)1(D6'/^CE$_W9J5.[YK]D%"_#U6
M<92UW0#@C[V;TS5SHD*4@@4F/+&><R>U!83"PA &,Y48>^!R/;?T_@GZTTP
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MQ*B<15[D$\M*:F"&^[V[1:;9]H.2['$&.WDW7Y[OGE_W>GF&2[;>.&^V6OF
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M@[\S[1Q;P9.S3DHYQJ@4\@$N4^8F'QP7#8^P'74N8@XH"DV@2/U.MU=ELQ4
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M2/9GQRRP)IT1O0\W:/VU3=#.V%5H>BCA5W,?YCX!*LQTQ _C]8H??CQ@Z&\
M\-HO/[_4?>&'UGOB(AB>6CF $XLI,BEI9#!7*6+GN&;Y-)A2MI30\D@YJ45A
M* H']! KS35Q#CG,+8B"=,AB39%V3N'HC6(B!XWP&7O,0^W+%:>4[T,5/Y_=
M[NN5,V,_^N/KZ+D)EW\+\!;D<LR5#9P1Y-RL%X\Q4+_*40(RWAZ>JN<)6\]>
MD2&&CS'6XM[/H\E?P_6CN^?/X8&QU8*IS3[QS$-C#K*\/N8JPQQK<S*\MGAT
M\A,V&MOMR938NF'C'0T;8;0KV;'Q18.29T_F[!C?NV-VXX^J@<--UU6S5SH
M]5N5@%<!*G$H]!FX\JD1*%?EMP33S[;\H+*:R@DP:$\6K5RH?'BNU.U<# ]R
MAC<KYT9%-Z]ZGURK9&^C\=O("[I>_6KLRSRDD;$)M\^&:$:#9FC:;GY"T=H!
M*/:5YD[8EGWXJ T+<S3D?M>#@SN[.#W$?$I5M?W)OF'8 7L(( L->F-O>#W
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M,3#7.-$,=!HC44PX:&:<H)0^\N3A;<*X5J>YC4XC<1+1@!UO/..81D-)D
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MVM;BVP/P;7\5W\#8% $3CD*@'/&8(G(^8F2LECR9 -!'GS*^M8ZH6Q5V<9F
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MO]^YF(])+6I!,QUUF.!CV+UJ3&K'3CH3N-\(KAU?1#BO#[&3+/S[0^X*,>X
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M_L#[GTX^'7QZG?_W\1U+PB8P/A%)SB!.N4-.@':I2'#$D<!]R&.3UC3+_]-
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M+B"4D !5;UT& TD80.P38L_[- KT,;6P;X\G@?=4^D_UUVO0>Z+_I/GYFK\
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MA"<%T6"4&4KIC4HLW[.5VF]U5;W6>*EE]0OH^_JF5]SQ@PVFQQY4F'  =S#
MW*JQD7>'G2PVI_MO?J])RQ?&#I]R6K-8/C%]\\8W)Z. @9L$E+HF_V]+XRC_
MCC]<>\A@/*'PYF0"NJX,<UI7$Y8;BCAS.JNQQ%L!2AR. #32@P'G)1/?\T51
M2L9F H:H_07YP-B&BMOQM&.;MJH)^3;P!LE/K7=6'@\_OE?(-"7DS1JV,A*C
M1WJ2,H;IBV-JKA8!?;?B4ITX?ED"EC[/SH=93"B*.(08"#P%9CF4KUKXR(4"
M&UOL^.M;8WP3QQ\6H2:J[(5)C4 @ L%D+0ZX"P@;1P,<V[RV'3M\2)VND_7^
M:K)WMS"8A;H5C'#'#731PEK?6#%-YL(K%HB;M)%(X:5.Y7!L5;E;FU;XQG01
M.3D.*/4E@4'X!\QMP7@DCM@BQ'_MN2#<@*+3FRI'Y[5(I;%]4HEN[A@17O@_
M&<$ I!IS>)[8O2T6-)19A9^IM9?QJE0!B/3#X&&XM1.Y0*TLIHR4E/_$ETB+
MU6M9^>;VK7P5/'H<BU"/1<0KKO%7X%39.)E3NV16 2;ABDCAJ*G^ L*WS?\J
MVCE'5'+#;^5CC<8A&M;45Z=CY?%H!?& MT<CG?IFKU: 8\DKN%:&_)1X0F92
MURO"0[8PT4/;#T(6H1\E TF)QKD\2&T[; ?KO=A"UNMZJ3G&>+DD3<4,*R6I
M\T2IS(^=WMQ2&8A9IB>"74)&R@B@LK6K'M^=[3B"KZ+*3+53$FA3FF2XPW1K
M="@V&S#J@Y"@W/%$'$'NHPGW02Y%$&_L6?;P02C^])$RW :/C"=FL?>Z,Q>>
M>'P\#G,Z_V.8;ALN=1YFWB0.P29O]%HL2^NE6Y:9Y<Z<*OF(K9G&K26#S 2H
MYCA);>H1SV^!3O<^E98)Q]6WQ[))5HKDIDEQV1W3!J_$X\+8_(WI6P[@>^:.
M=_@4W//CX"-;TB:@-',P/S-D*X[336VP/4?(T)&,63SN+"+_BI5C.J$9SC<E
M=D//<;P[',W &X\C5QTX5#ZE"$'2Y\ Q<W]NF,):QE<!$@5@2U0,08Q4C!-?
M=]:QF!LW;6RN:V.S)W8S@0HA0_<S.YM9#"]7AEG7<KIWD@T<%7-%VNI<UU8G
M+O'0YYS%B)/9O2Y8-Y ),-:2SB";!G>1 S,>/B('<*D ,L^7)"A>^8>2+[V>
ME=^>I4^VA!"//3\VF +RA6.TL$"H(*7,4LG96#*OO2A\1#0PX3L%\W%0?3$9
M>U6[B+=;)#%3@R!%)$,%$M\D]L]C;I8(B&#MI8H^1Q!>"T=O;\TJQAS]U V\
MH>FC@SA[B"02]YB=2^(H$UL*6;E*?)@@MQ?E';",R8&2M>EIDJB6PM\$,BE0
M!7[IN4&. Y"ESJET$@D)@:2><1#GS@Y42D0ZI3%.^C8M^$*<#!++Y 2 :NHB
MX-Z1VGW.3@6*\PV 6A#&_6LF'OSY@-/&[S'%(K7AC5,APC^2%8-Y@U'78-HX
MHN" 8R9$G9VJ5(C;Q&,VV< Q[;&8]_D#/>73Q>C2B_(N%;X2*F,^3'?4,A,!
M[PA#Y6X@4D4&D:\<@(EIRTJ09*V2I9)YTK,+E;-.ZLUA= .8"LQKM\"HN]+;
M0UMBBDTV#![8L<^/F3EP4Y$Z;\+\^2HF(KWTBD.1U0&NVL-+$FE*XL]S B(#
M))$K_*YYN4!3A*V*P/]0B3*B460B5@$/0U5+DQD?IFY9PJT+HFO0!QE_@3NI
M^. $I@#<2HQ&_ ?&&ECV0,$G9Z+22;S0B(OES15*>**,%587S1F%3;M=-]XM
M]UWY(D+5@.8[H#3_B:SX@?'.CAT$$2_.TZ:T"Y%V,=O)9B:WH6K2/O9)>>'9
M&NHWH3?9T"+EY_'W3S^?]ZY^7![W7V 2_\6,953NL]SJ*,TF3B<OY%I+*W(
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MW_%9A!S.]+T5Z#8^MUE&C8VIXFEES^<9-XV<)QDF/+87.?56,37VVQX?>%@
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MINSI=N)YKG?MXGZSRH>E827$L35SQI9-&Z]?DELP5&&1)CTC8:S$CS=Y(AI
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M2[0!M$PR"3]LR+JCMNWC=-E[&"S?S'X[S2?3<D%]0B]U30E$EKW S6>@MUG
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M :NW119Q?=+PUI+FUA=N!9$GSLP;6-;LSXAA('++>)M)B]K;Y U4F<D^-]5
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MK/"TZ]Z K1I)T!L'206$&G3S,NLF_*#-81\F<4QZF@M'MPQ>'HQKO-6%M^S
MR_F"]GZVB2Z7+^_(VEB2).@<FM7U=V?\NF@@>KYGO\T7ZW]8K1;3?+K:K)F4
MS[JGBW*E9*2%F=[+":6'J*,"I:HOS9/$4H-<"AYJ@6,R(X:"]7@1PZA9KL4=
M=$7EDNHYBKF/#O,)$L8*-J3LFI&:7-^#!GIV7],QGM _O7]@9/%$)&^J;!)<
M280,J_L\QN;!DG.@I$.#B3L#93O*QJ4Q]L#']?,T &/8#L)SI%->INL]F>B(
M4O6.P%*ZV#O+",C522BN:2%#*1*YFRI<?O^X9"LC !Z]R8S>V1+I,;V[WG.R
M_D_FGS9QA0WR=!'%Q:+!!5L(>=9 0*LA9UM2]<:5S.^GWT/0F#PN5B#PL8%5
M$[YI?Y_/:U_E,2X^3PM>!)PN(Y?^?H)GVO[H8]?H_[E!M(_!*RTKJ6Q2WL95
M#ZG9""ICLHC5JLH-G_VI'E.* "O&#LQ0-B!>[6X>=5-:24E+[CV-LC"]'EJ
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M;!5D,@"@"A'1**>5YQ:I]W0T?&Q]UGG;I=X)=SH[G<[>G_5VFL_..L%?[@5
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M34/WA%+8DJ66/O#F%4;K(3LV!6DA@ XR >_F(J_<YQ M,]9'\!;)PEDW19E
M9_+)2TR\?8+'>LB>O9IT(( .L@'OHIP9NY.KR>?AJ/\_M $&%D)PAI:-U=;E
M:9]!G<'S8C%%Z:5OO<$\C.C(U&(GPCO(%%R&;NX+L7HIPIR%'%B<IT3:)""S
M0"S8( 7OUE(<E=?9B.@."LB6(;OM_AC+<K91@XI(&JH8&2SE'11T,4BI<LRM
MPX]'(!VE,FQ+>0>58[?*7.XHJI5H)9<,G+*EVBI?'>$(DO8LGQT*8UM7CZV
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M4)_P_56EXGKX^:W2L)_#N)]ZM!.7Y @LJNI1D7L%@?"!R+(8RR@6#*W?]8T
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M)8Q!,]7ZO5\?W1%X AV)HH,PX3:>^5NQ#J*.7(/[:)[&->A*?@^HR0[D=Y*
M< ]9M"851^;,EUK[B+) ,(R#3&@]?=\JW:7->$)?X>FT81/.6Q\.S>OFK],B
MBHH4*#.0QM'>IJ2'Z.B75)MQA6QR7.QLN^(TZ,['[M\+V)7D81.&NNA'?17'
M_=P/HV^S+@??'5J#SC/%#2@16>WQ)\!'\DT*(UV5;%HDVSK*7P7F"/;V-D1W
MT5+V.YSWX0M]><M6S55]'80=;>V/HWNB4X VXEQ4DFYDT44=RN-(HQ#")X6
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M284LP:"O;2A4=7+(MC%)FV!B=5AAZQRJ%5".3N[;4-Q%K<5"8C!/1K(D"L2
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M)[S9@E[C'R.D2+5235]?XI3S03[Y,B0K]#_3[_=\(</#3+UJJ><4/ O:AWP
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M#C0^=1.WZ37,O-*68J[WP\'HUF#(NK"K\;2Q4A3!%@J>0*M$GG'1"4+A J1
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M]]/%V>WYI\.0 ]A_32W W@J3OWV>SA8?<?;EQ70VF_Y9%>]&/BNK2UVNN#!
MHU<0>;U6\Z$XE[6SMKEPU'T8)T&-5F9>X_K],C%_9..[::#MMM%>Q*3 Z%"C
M%*_ %=IS"QJ:\YE10-HO]?O^=Y^$+UO8;8T?]S\UO1[J^6QY7_4++CY/\_*R
M'/&6 5Y\O__+5[^VE%)W4@<E#$((M6&$]#0S,:F <Y84URX9W5QAOB'^@S4N
M&'"J.)8[GTH+A _8J6LN>\C?:E__XOOM3SIM;Z$ERU6*-Z-,=7@&G%,6:$)U
M(<GB=?,;HO[HCM8<X6@$NB>E.X@C!Q%6OL&STHCM@VB@)@OWT1RGP\)0_GN
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M;=Y-Y]<7W-.R/&=8'ED<)\&X/[#CIR#O:,0[2<HE>Q&,8(8'K3 ;'V.11J6
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M>J@:\6&/X =WT5,I!]\POBZ11P7-F#0&6!515E'05C,D!Q3C>!9CMNVS9!^
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M7QGO> $GZ?6)4DG!6PN^/+_,Z&')LHT+#MHZC!;\6@%6P'A)02"+G(8L!04
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M:G.VNA=3J!V3=45E-64J5$5+4304G9PN2:C04_%UW;<_D4AS%]M/6QJN=;[
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MAS\^Y3@NX[P]2?\U7GP83ZJ$[GZX>FB-B,^3F.<CS#9@Q !.Q]I\R])7WGA
M%Z/S4G =NI72&13V1;'[R>J[CZH:?\0/.=W4Z)M#UV$_??GFDV4(CA)<J<@L
MA.!U]2H1D'X"3!9K"@HNL/GQ^V. #I4QW.]!;.\J>BK)P0?&MPSK<(A1>:[)
MLG$9E%5DZ&3AP19+OJ:7K.C6I=[O@7.V0+K^N3#M1R<]7/P<@+8)!.D KJ?(
MN7N!G2=ZKID:N]'C!!T,3A2-W >N:46NO:%5B8(V8TD>5;0A9\\*YP.M+&>,
MICL//XX1?>N>ZM^$^6S2TI0O$GDM[5%+OF03P6%"R$%8Z97V0G;S+_<\_,G8
MR(^1_;2AX'H(&NFV&2[)G#AJ- 32LU3+V&4'/M'F6T2R46%-$V@=(M =W7=O
M5IRJL1YR_;;QK*=.%T0#F!9/T)XX67_WT.0$X?=L4VP2F;2-0B8#1LEEPX^Z
M3]85560KLI0IE3Z7EJ=G/0S AF-DWMJ"^.,3#7$ZVY0X<)[YI ID7VI*>](0
MI.> 1G#/% I3ND4P?//8\UH-CQ'RM(F$&AH)J]"8;QLJK!%QFU-T/D(,I6:;
M9@6X:H5LG<ZHI#;=NA3L??SSUMWI$NLCUG/3RGJ=4/JU-E%, ;E@&FRNG;J8
M(5Y%&2&)(K)+@9G0OL+F 3#?CQG71A\]9%1NXUG/A"Z(^BW,L(7F3#F4;=2U
M/^_^5%GW5X9A&QER[HT7'&S)#!26#$%(FEY<"265="ZU;I0WE/8?2I@<2OG'
MB+C?.FZ;7L+1\)A,ML"L2: *UX J&' >:;^B/8W[UBE&3Z%I\ZFZ>;A)\S&"
M/7MNY-<*XZ\G93K[N+S'[25'\H$W]9LK><PP=W(FE4XR\X3(>%;,D3TGR$X4
M1JN8>,1XT-%[X)T]YTYF%3*B\) %$;#F>1,+C08N-+*HK+!FH!/\7UOE3A[9
MKV.WF\+(1I^+$!8*DG6N%!. V=&Z+IV0$HLVX<P-5W8A/YGS\<?QZL2&*R<I
ML(<3]=/[Q=@0D5Q\"=6T(.%Y"YB*IU&@5Z44%6WKX@3/L.7/4^+@B4IL?;RV
M%_V![C&CQ*U@J:8?L-IL5T<#(=EZU,2TC1R=0O_0;G[T6R^$+OU*>ZCRBP_V
M%XI!.ZV-(@8[XK(AO)A" <9,RL;X%)M777LFK:"&7X2:*JN'XZ-]7=Z_PAQ)
M<G2$SQIRD1*439R\*"M :A[0,U:*;EW"\7Y$%\:9AN)OG<KZ&_X]_GCS\:?I
M;#;]J[9HQ4\8QXLOWYZYT@ ^CN?SZ>S+[]-%3:"/*)$%X X-*(8,/(8 1FA5
ML@O!Y6Y1W8]Y^X5P8QCIM\Z!70/^=4I2>#F=?,ZSQ3A<Y]>3Q?26SLEY)J6N
M); S[:;D@$/@-15?<%/(#Q 8NA4RZ/"R"R1#,]FV3E"]NEG,%SBID?__FL[^
M9T77\0*OEXA'RBCE/2<>,EF/XE" 4]I!3HE9K6I+A(XM!.]]SR5IO*%$6V=T
M'ACT+W_7IG)YN9-M'YC5')%OEJP\^VTZ67P8&<:]=]:!,+7AG,P*?' )HA/,
M"!6TX-U8T0C0)='G'#IJF'3Y@("Z#F,4K.;DNSM:#FN-;7+FP&4A('-:*[D/
M(;#6V3LG0KX0$IY#@3VT S\4*_YQ>E-]N.TF(B,NI3<E&<BF[K^NYK=E7B")
MFMVFBW)RJ+2=/?"^#UZ=K)@^$@]_OLGOIEN ZSGDLBC58L0*<SI[6E2=K/D&
M.M+R*CC$@EX'C5RSW)@SA]%<&$4:B;UY_^V[YAPQ-!=6"Y&1LT_67! :7%0"
MT)+QGF0)B+*3)73WV1>BU!:2ZZ55]J/BT*)%8U,JD*VHA\IH 7FM/JJ2,TP1
M:&Q>T?Q9)Q6?L@[TKZ)GD52LBPQ&T1KGG 0EM 9DUD#R5BFMT2?3^I;\8I**
MC^+",4G%1^AD^*3B#N!^)!4?K<;CDHH?H8/!B>)-1A%3 .:5!^6SA!"4!"^#
M#,4*9'*@<NY/+RVH9WX<(_K6,0LOTD<2['PQPUK"Z(^;3Y^FL\6+][.\W-/6
M09.J:&8E>D@ZT<IIG0<T.8-CR94<ZPUGMZ*"7=[V9$S=QVAGVJ=H6Z<8;8][
M>1Z]QN0Q*19- H\U[<GY DZP D(IX966PLIN1?@.O.!B--Q"@$/U<ERN80(U
M9BT5:.L"F4 \@T\E07(NV!1C*:JUQ_+TFL4.;CRVT<? 76&[0/O1%?8H!1[1
M_?,QTA^X*ZS4A,4)1Z90;;N"-?3)"0U!T#*',5A3>LI+>@9=8?OBQ3%";VTJ
M[KG WNEF*G@]KHNTV1$N%9,%5VJE8B$%"]QZ'KJ%M#[TIJ?5#O8HG=Q_$'J"
M0%L;AV]FX\^T![ZYQKBT5S<!*FMHZ*R/6AC@L4)3.M-^J!68X)0LCAN;N^GZ
M_O=<B*8;"K.G7HVK_K5;;6U7K2F#\I+)!%D4&K G8(YL'_":$=2H):;6QXT'
MP7P_]F(;??31]?<KG-_Q8_[F?G8S13H@[*O][X/HSM<'N($Z=TG2CR[Z6%X>
M1II5XBE$#Z;F]ZK:##=4-UR:D@+3*K/<?)TY$ULZ- D^"UF.44$/)-G=(3<6
M4/:"FUB A6+( BH%G*7A!R85)F%EXJV=C/U(SM QN+'.[F0LG"SP/III'NB1
MK9FP4=:T/E'+-3I"Y+,.8!WCSC-,,C8OEK,?RO=EAIRJBX;)+/? VA0([0"L
M+]MCV$[S74R.DU77N=7\8^3>?\OY+8 F!A&S"<"-05"I$%29:5(4 LB3"M$.
ML'J<V:H8C@_'B+M_'FQ\[&0*,N4@Q1+(?*(-T\? H(B<E5'!,]D\6&L?D#,8
M$FT4=;_Z'R'E\Y95CLIJ66M(2VT\49\F@<LN0&&6<Q4QJ!]EE<\76'6JQAIF
M1>Y#NBD:UP'1C[+*C]+?PX5T'R/\@<HJ>R.L\ R\2;0(1FW .:^ O*<<=$+)
M9>M",L^OK')C-APC\W[+*C,RH)(4'G36-6VW,$ ;$9AB2A9#T':-S>=35OD8
M(1\NJWR,A :KP5=K!8X7]21DCI/:UF\QGKS/DSC.\Y,J[G5Z;IOZ>L</8:>:
M'D>&LF3N(G+E$W,EFYR9YDG*$GP9=7I##Y=1O]ZF$*B$QJ5$UDS("53VRR K
M!HQS3;QQ(OK6Z7GW(VI1;&%3X>KG_)'$.G\UG;W-[]>1@[4/Y=?*5Z.,D<RJ
M+,G,JJ? +B,X&RTPD8LAD7ADW5:7HU]]'L>E$17VE6'H2>JM+^*O/E4X_\SS
M.M=6W1A'UF:'G!L::VUP)$( [WT]I55.\FBLY0\N3(<>?CEZ/E5RK>V$%9YW
MTS<WL_@!Y_EK#=(_2<3S?XS)D7XW_;/V*OJ+B)=G\Y&4*D;F,^VSK-#80P2L
M82#)ZLR9%R69>(2BCWGWI?&@-[DW#,Q<PKVM=[CL5T5"^>\<%^^FM#Z5/%[<
MS/+(29TRN=40(S):DVJ1PV 5\&AE<C[Q4+I-_P=?=3DD:"O5AL$52W2WY*M-
M=\?S6//?:<6*9&GA^SR*INABK840F0&%7D!( :$4EURQ227/.BG\_O=<CK8;
MRK-U/;:M=>8ESC]LT)&-H;6IYH4)@0R-8@A=\A%XL,6*F"3CW2+J#KS@ I5[
M@@1;ETW[.9<\F^7T /$\X]$QI(W$:21#TD6R/(P&<H159)$HZ;I-Y&[ONQR=
M]R#?UM73[H,X']4,(QM%K>96*]"F6&OZ:0=%>AZ$-AA9MS)9][[F^U#X<=)L
M6#CM[J"O9K_\^V:\^/);7GR8IE7SJ9RW1/'3E[N_O/FUU?4)HO$QDTMI?$TL
M52J"MZ+0WB2-2$HSMELVI.&1QNGXAZHNT0/1SJ[.IU)RXG#48>0,%:(&PY6I
M=WOD$ED60) 7730F:TH?H1-/*P+\;/3H'!A^C)K.$^+;!>&/P/#'J//X6-_'
MZ.(\K&$I%(:URY_V!12A(Y]<!##HR%4CBRZ[UG7+GUU@>,]D.48%/9#DZG.>
MO;B^GBYOG58G>>MKQ(0,,7$)HC9N5U+4BON2 ;=&H8Q,>]LZHNL@F"<9'GZ4
MYJ9]B'VXV]N:M?=BU>]M*9/U =]B^F8ZG]<BVV]SRA^7XSCM.O=1+VITOWOZ
M('<N?$MQ3"<;,&)1,K&0E,R!E@Q>H@E<C![WRM-F_#MZWG1&"]W*?/IJX@N=
M-,U( SFP>G>#Y-P7K<'Z[)+PZ!.V+@-\",NIJ]K.<U>'TB]NR*J<C?\WIY$6
M)K&8%.3"R;_E,8//-D)FVBE;5"$WM]^A[D(:?H5KPH/==:VEX'L(8-V!]P9G
M5[-E&]3T3[R^R6_R;(EX)#(+EE9TB$S2^NZY)A'X7%L%R("UI)!K';W:$=IE
M\J2)(EK?)^]@W-QP_7.ZR/-;@+HV3-<Q$D ;:JM<A)"*A1*\*EEQ%(X_M.EU
M?MLS5WX_4NVA<,_>56RKU\1(&Z4*TPJ*H+5,%4+JF4G HU",:2E$Z7E]N(/I
MF7.C%]$/U@BL6FGY8SV VNH[\V:V/F-?6G8CYX319/R!1$7 $ZN=EHT#6YB(
M7%EDO'42]J/!7@B9AE%6ZQOL7S/Y!*$&RL7%B"F3L4@/-GH+2D5>5T(&L62K
M;;*$K%MMR.VG/G/UGB:EUE?3NZ;,FG/5NX_5H'GWM?F493DEK018$VH^8""8
MH=ZA1L5EH"'+CFW?NK]S.%6?J)5[;(16(NW90-RL,"^G\WJ%&FE'$CF 3]R0
MY>H*."/)\6&8C(D, Q./T?4W;[D$[3Y>;*TC ]]<WWP=7@UT"$)Q,,PP F+(
M\PB!C W%!3J60U;=YNKV4R]AX7VTE!H&A!P8W8L89WD5C/KUW&SI4+Y(_WTS
M7QZVCD),S-D@@7,F:\<D#=Z3<\F#<;6RAW(^]6N[=X$Y\,Q^O%+OM]^;:Z2'
M*Y =R"]I:_E"GL:J2]*+Q6(V#C>+:BZ^F[[!96<<'0M/HD3@V=<T;,7 8>*0
M.$JNZ .;6E^;'0WR0@C46!O]'Q;\]&5=XG#I2*R"$FI):L]9A%C+8"NLM:4B
M9R"=$3:[[*3J><G9@VJHP*(AC@E.%?J3"12J1Z#U0=O#6=Y"6\YY\LX 5_5:
MT!H+J*.!%$I&PUW YJ7%#X(Y5Z!0:Z7O7M8W$7Y_9:*7>-9WSUT0]5L^? O-
MF<)[VJAK?W7H4V4]# M068>>*^"BEBTN*H+CY(Q)RU.AKY3-_)EJ_Z%PG:&4
M?XR(^U#Z,C1@%2:PJ0&DK'7!D+F3\C)95H!W9#Q'[9CE@ISEYMUZ[Z(X6^'H
M1^MF5]6G"7:PR)OE>#],K^D=\Y_IH7&\V X765Z/K"-#'A-O<\SCVT39/'I
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M6(85ACT1UB%EX1!:]^%Z(U3SQ3B]FEY/%K.;_G.*Z6B2ILM46K+%K,S@E-)
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MU__<3#\=15VGYZ(%YC@10=?9B*)H*"98'X+D]#IVT@,[+/:3R4HO/&AMS'7
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M=>O2@L<1792@],"$AK6L+5_?E8-=1AN#1P:2UV+_X 3$R O(A!A+06%CIXZ
M ]NB@PZ'>CJZSGGX?NZ,K0>[?_E]O=?E-3[#_[ZN6?1+3W+.!A5S=,A]H;L[
MTY:"236QS62-ND9Z6ZOH'6"=:S35F>1EE]0VXEL/ZODMQ&T U_[I+A /"=0=
M(V*[X0T;O^N-M;M$IS%?SB1"%CEF4U&*.IS"6 ZA< &9^^1TB5+[3A']YR Z
M.Z* 3TER#F''0!(SO[V+U[&K2!9'$DJ DZFJ"T: -\Z ]4[+8%4JV'J^0Q=<
M9_0XM6)H!X$YB1L]N+GO'9K;+__7&&>TR.?O;_$;KN;/)>0Z*Q. 9>5!R>"
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M[/%USM3I8SAA^>&N:TCS'NRAHRFS_.,#KJX8_(BS;^.$[W$VGF8^<IX3<B%
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M_LPO\C^OY\O<R/LKO[T-?F>>F0C)0C22;'WK26?TI.=9YNK SB1%;#WU\B3
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M*)EEUSH/^V"+[XC4]/IQMUJO0Q&=4H*T7A- :>])^2@>4N"*%U)(3&Y]9'X
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M-A_$LB=WY'0C71JGR!) *TEW\S;1EKR#I+(0Q$:70^N4[4>,]"9<TMP8QK0
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M&<D1,I$/9],#5?)@&C?.XWA)%^+T8IR7_?V6J:M7^4F6,]*)+<AD2<5104)
MGJ!(:QS/):?4(G-G\]M_,I6A$1L:%KAL1K12K#M@:IB4N0W'\+F9+7CT*,L/
M('#CS+ZMV(*OQ0W.UWK23(=?K&%-SJMIQ;/*'DONU!'XI)C^2-[F4#S?A:X]
MW/W+]JW7:?Q_7(R_CB?ACG\]DBX3F*>%:JRF=%'@1*J=K;1G(BJ62OOBVD<
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M<>AZ0NW)EAY\E=M73P]85=-V@-A3*D,'>,=);&C.VJZB<R!?CB1"616NI4V
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MBW0,&0Z:H1-.6>FZ.5IWTET[ #M;&6G/EAX\++5:=S%_>3F;U21<;HPE#=T
M74NFM@4G?3LH <BDS#5FJ$.G%NL[R,@] &<K"_N3N6$)XWTP;TG=O\93F%!.
M&[JDO')UDGP!KS2#+$562G,;?.MLYG4,9\[Y/8G=0XGAJO!ZC#?B:*Q!S;$.
MCJBY!X(9B"9'T)8S5KQW9+@W9O]#%&<K  <2O&&!X 9$=^32A21XG2D=.=<U
MK;K.!_,1<FV@YY,7!+$_*?@)3H+#R=Y#_5_7.)-)6'148&6I_= LAT!? (PV
M<:=E*E'^JD\X7$9Z8,>QZQ,>+]RI.^$F'(XWF7'+.$/A=!R2,@PFLSK]+CH(
MTI&:9#6/,F7C>6MOQ<X@3ST^O(N@=*JT:L6P'GP?.P%>A2LZ0.XI>KP'W.-$
MDWL6A$/$[@ NGH@ "BFD4<$"7?2U641V=?Z/ RL$2R+[Q/,PE:1'$+PG8M&G
M+W>[,._8\O9N]I?9]/+;JOD$WDPNM\RE:-"1-2)J.-\B!$?J"Q.$/O/ C>E4
M>=.7!&X#/KRAT+N('"*23?A[C-#YIUF8S$-:UFNW"91O>F+SL/B3L->"X$EZ
M*^D4LB%*A0RCMIX)FY!YSF64HR>>/5C(6Z,CTU-R\-49K8+AM10E@_0:.2O&
M^_6*J^<7\JX>^0]X4??/^S"K)OFH9I<XQ3UHH1AM5*/))*^M*(IR"@WMFS[;
MB]X'<](^D%WDXY$FH@>0OX<H^8NTG.TWOVH-5VVGM[@8E>"++G;98WG9G,E"
M\(Y,>3JY$U=D/74K3-K%,;X)R-G*P^%D;UV!^OYREKZ$.<Y?3/*[;SA9(7P?
M?E1X:U)K=92A-A4)S-/:>;;@O"6MD^E4A,C,JV[5J3N]]NS$H6?*]Q!S[^A_
M8=H*^F4#DM6S++):VZ$DA,*5Q\*]EJV[H#];O^DAYT@/[#@5O^D=N?]Q5R_\
M[<?=[UP5D=E(Y@0M+X7HZ=ST KPM&HQ*1-J,3)O6UU5W="?N*=U)-!YH-;VP
MJ)>^^[=X5L6A'1#UY %]B.8X#LZ^^/>(F!Q _&'$PGO/@G4>;*B#TT)B-7_5
M@#<EAJ2MPM*Z)F8H<7C"[7@\:=B%YH.X$Q%7/2,\"BNY RGKE/I4YZ6IZ(#E
MVK5?*6M]_]-<5FB&5W\/Y=63?KV]"-V#&;Q%]J_*OGAR+$H&R>C:!#9XB$&[
M.CS&\(B9.=<Z4O$(G)]/G=B9"3V8/5N@K4H^.X ;0)5X .RDM(K=V=A-/ [@
M0<\:Q4.02=%]:60$(<G*4TPXB*@R:)3T=2N$,ZU=S$<0D/WTC)[E8Q?2M_:M
MW=6FZI273??@*FK%M31,T=7*$&O5E+'@>) @="B9":U"QYFG.[STN(K%@;R:
M#D#HP<*#K\)X]O=P<8DW1:!7>=1ADN^D41XT_'375[0)(!ZTL+6(HD%#*FCR
M3FJN1%)1ELHQ9(GLDLC\:->7'7;DW[SMZB4O[KWDKQCFES/,[R8?L*:^UG$#
MD_QV.IFM/OTMS,=WO('&<>7*LLLSKXHP_>&<\5 PIAPRD]&T+K5ONH V11HW
MD'X?SZO3D1"\B//EF*R1XIHLSB+!&%U[OV32+BVO!DDISI88,;5.VW\2U/ G
MZ/&D;G.E1RN.]6#<O0SS+[3\^E>]$+Z'BVJO;  \LAFQB.Q QZ1 .3)S ]:6
ME#YSGW/D0;>>GM$9W/ BUIBQZ],1>^%*#RK]G7WU&"W0&)=L;<J?/:&4/I#J
MB@FR-DX&:S3#UJ4"W9#]S&=3#[SK0<+^4:>X3Y:$6D[JF[^[7,P7I*T0,49)
M>U-*B&02L41[S"CP=8"QYAQ3UEI@;AW<>@S/\-+4!P^G/3&@M>7X<:G2O_@\
MPV5P]=5T]NIR<;D:P7<[3#9+34B< UL,&3/"T.(M?<J\K=E%+CK?;3QKQQ>>
ME13T1ND>')&/DV%4"GJ64 $KJLIJY! E>D"I+!G.VM#W!KV$SDI0>F!"#ZT-
M6MR^U\[\FHZF+(/B1)5UTO$<CP@2,U<UO[LTM[2:@1\JT>=T=)WC\/U4TH5N
M5O_;C^NU+H_Q&?[/)4[25=C::>M8%@4BI^VH0A3TD3 DA9JC<#Z@;]W4K .L
M8T7TCB0OVZ2V$=]Z4,]O(&X"N H_=8#84PBP [SC! *;LW:;Z#3FRY%$"+T4
MN20/DJD*E901VDX!-!W\*GG2'51K0^]HHO-$B/ 4)&<7=@PD,?.;LWA5XE:4
MRD49TC0U871"0?0Z@=26OJPMZM(ZGMP%UQ$]3JT8VD%@#N)&#V[N.YOFYL/_
M=XPS>LF7'V_P.UXL]PTCCD9FZEPL62?#ND(J)D9PI'(Z8XV0I;6/NQNR7WI0
M8^[UX'[8N \>XKW><5W #J@4;05Z=/6H&<>['%M-V374S;<5M$D8K*[E<DG'
M.N%%@3=D-DMO8YW[9]NG5)V ;'77GTY#M';A4I\B]7KR[7(Q7U* 7]_:PG A
MT"O(S)J:R^[HUF8!HO2,<6F"8JU3O!^!<QJJ4R-&;A.9 [G0I^YT!YI8C6"(
M-B*S&:21@I:,%96CQ0LGBQ'..=LZL/L(G)]-0/;APD GB%SI_9%$U+$$P5M+
MQZ@AF]24ZKG5S',6R>KH+67K(9R?34#VX4(/FO'+BS"?ORO7D>1WLV4<>7G+
M2N:52R@!,UF$2AA/"V8(45DKO<#$FC<@WPKFY[:QVO"HAY#=1F#7^Z4+M)Z,
MJ$=@'<=D:L3 +F)Q /5[N'X>A2@=+Z8P2%Z3%F_I:(TZR=I0)J7(4,326C\9
M7#">L'>.(!<[$+UY4M"+5W]<@[J^^UC6B4Y!!2':ZGF49,CQ3%>AE46SS"6R
MM?D%V])_UA\]O#;1C.K39B0;OOSC;<6Z&'_'-J4>&Q[7N*SC*<!K)1R^>.VX
MB%9F5$;(F&/";(U!IF)P;O38@X^?'O/F)F$C2JY2]@:R%1D4.A(HXTF,9&#%
M"\$":ZW<G52YQBV8_-^75Y7 -WMW/DI1,ZZT!718FT 6"Y%E!AI#L=DQ)6Q_
M"40; #WW5.A=I&U[>M"AG&KH?[FJVL.OWZ9D(_ZXRK7\^"7,</YR.OF.LWK[
MORM7'R_&I/]_K)19$F^4BBRBE@769MYD35H'+DL+==IFB 6+8K'3I;??^W]&
M61J*74/GV&O/K:7W@XW2@"I&@F.&- +K6!0RYR);SW\ZK1S[XXM6<S[U&?T\
MV(NA(HF[SP9(#Z+-@(+3&K( 8864(M-VR*WSM'_RS-HV5^>0?#^5S-J/B[!8
M/O':,ONXF*9_7AG7CHPO#$B;T)/2D!@I#<)+$")S$XW@1K<^-K>">?Z>S9UD
M8[T/9!,>]>>X6N)9&?$=$/7KT+R#YCA^S$;LVNRO.I36PTB!2;IDY@/XE (H
M8Q%BT0GJO'ODS$?3?/3V4-Q_PEDY&/-W(7$/3/^(L]IEXSTQ#V=T""ZAW7C?
MBDT*"4NPG,S-X( TN@@%$ZVR<*9=\[EJV^$<S<FY-[?6C_]&I![>T7D5PMT8
M06[C^NST@L;.T-T7M>8>M<E:(;C-SA=%?T:K?2C,AN)YLMR,=GO5\:V>^ONA
M4NL3IB^3\?]<XAW5/*2BK<0(FOO:4I(K\-4?7W(6A2D;!3]%'^IC:^K36W&'
MQ\LTB%%.Q:F2$K@B4QVKS" XY8$)IK,J@:$8TGNQCN]Y>C.:2>PN#HZ#6-M#
M6MSO=*]\7T9?;@K@'T ,G B!W((26=66?1R\R84(PKU7B3.G6E_E'6#]$KI>
M&=EGAEU;^EW/ T5K(G>,+.HZ"RP&#U[&"))I$R+9VSX\DROFV;G@>I/IDQ&8
M4W'4K>_H3_1[2[M2"RN)J@&T0TFWB-%$91O)KC11"8^2-9^/L0W+<W;3M1&6
M:0],Z^$XWH3KVE+M@JPG!]YV5,=QY+7A7@>1.(#TPPI'*=Q$-+7YC5LF$C#P
M0G@H3(?@?=)2MDZ&'UHHGO#O#2T3NU!\ %E8Y@.\GXW3:K1#CL)A,0P8DS7K
MWS.HE1R0;)2*.5M0]RT1ZYB&MPY:\>\)L3B(^#T8D.OX_OB3KNSQ_!Y$98OD
M*CL(B11!I6.HPV0(<<PB)VV+EZT-R ZPSE9$#F7! $?('W]^P[3 _ EG7Z\1
MIB#11YV .Z_)4/ .G$(.)093% KDJG7KIJ=1G;&,',2 'E)OUA$NI??OTPO2
MQZ^<&5=5I%;I%), EI@!5=/+0NWN'[UE//IH>>K[JMD([&P%Y7 V]%!-M0[R
MPWC^SU<SQ-=D=<]POO@0%JN#3T2TB*B LQQJSH6'X BI%CJ9$#*+JG7Q=W=T
M9RLUC1CR4'3407G(#X5[&J^=I?_ ZJJ_;?5#NCJ:$@3!-+FJ50C19@-1<%*I
MO%.)KTT)W))[W/V=SUX:^J3Q0U'0345A@Z1B)FLNB #6E=K[7M*%F&H7?.:Q
MQ-KJM=B]1. ,#X(^:/J0Y:8IRS^1P?]I>IO7?@TQ% P\1@V).9)*7A1X;35P
MPS'SC&@YWXOMF]]WGJQO0-N'[+=-V?]F_#^7XTS'TET[29004N#7(]=5G5'F
M-*G#+M&_R+3FMEN;]2YO.T_6'TS7AXQWK17&VLM[>CFY>S)EDP+J.NPT*K*0
M,RDG(9!\AE(8*\6[R'C/BN)#5,]>0GIBP$,1\7VY*'X??Q]GG.0[2 -F$:I]
M7-!488ZA&CX&A+>8;$0L92A7Q4-T9RLRC1BRP;O5,(OF]62^F%U6S-4$6@8%
MC! 8LQ% !DZL;6MJSJ\N=/NQ1':RSD*U+I%]#,^O^.S6S)D#F=>#4^P6&ZE2
MR[$6=S97%VP]16D?PW6<.&T[+FX5CT8LZ,&]_BA&QZPP3&?0P92Z-Q)X*RU8
MC9QC02U9:Y?I\.+Q1,3V.-*Q"^5;MY"Y!?86P^RNF[^V4/-(9V/(C$#1Y1RU
MY6!]\CPEJX//G2R<;6\87@%IQX1I:PJV[J1P)\US.OE\!Q0/6;D<Z08,TI/V
M[!""Y ZLS$9'IPUCW:9*;WO#^;'U  H.U0!L>3X)H1W#O%Q@'9GN,I"$26#2
M*3** L\R-C[ S[*]8"_:8QNV#=QQL NT7QT'=V+@#IWE]J'^P!T'14&RG&D?
MJ,@L0:QV.W<.N&#HT/MJ73]WP=B[XV!O<K$#T7OL.+BF[>CHA4JE0&&D(BN+
M 0(7 52P3ED;N%GO?_9TY\%C*XS-N+"E ^$!)&RM,-Y!M:;O*-*0G&2)%!Q)
M9H_5&GQ=+=V$05GZ%]?'63_-V&.KC'TS]@ 2;MVQO55>O_P2)I]Q/+GYPK3<
M*K^K!=UJ46VJL?=^:>,*[3:+7ZO:5BR7P@++/G(5?/'&&1M8,<+058!R=/CK
M&Y78/:X=+]7AOTVF<8ZS[U4%ODK:P42DI-\*UZ2_+N%*-KO$4!#'JY0S74@]
M9@*B\9P5$GWL;P!+PW4T*U\\'-/+<)$N+Y8??IA>7+R:SOX59GGDG"534R<P
M:"JAR1B)(AJ(R=$%$K-3.9\NH3<OZHAENL?: UO+&$]"</J<K7(G9/>/\>++
M@\7,[Z]F?G_M-X7+RV>-"D]D>9M:/2/JD&U:E*_C07@HB3,FE#2]365IN9!G
MO0-:"%R'N5+#2DN?M>T[+FK+FE[/YY<X'RDE@_.E=HACC!:E#%F:=6RXL)$+
M:9C WHK:6R[DUQ8X-6GILW=JFT7]A=C\9CJ?OYZDBTM2P5]/_@BS"?W8?%0P
ME,S(GF:J("@5"@3E$;B1/-92%;T>PCJU;;%]<;^VRG.0JA[\]?U<B\&+VMT]
M@F.\3D<I')QGD:Y%B8QSY,JU3E4;0(DZJO%V%3/2#G/*3%QY?107$8)A"KCE
M7@I;4N:M@W*MUS!XCYDS-,AV%X93Z25S9X+LS59;ND^O&I6*E"/Z "B0S@W%
M X1B"TB6F7<HK'>M T"/ CIZW/DHHK)]@OB!+.O3 CJ<4NO+6[4Z[K# OH>-
M][6XHP\H/U2@^CMB&TK#LQ3[Y&(PH0Y"$RF!\E;239<UI.1<RCX+BZT+4YZI
MN'>?F?[LI'T7(>AOMLZJW,(98TH.(.H\*26-@,"D LT"BB2"90H;2^211Q:>
M&(,W-YS=@SM]9!O<Z3]Z7?IGHD6R_C-6SZPB3=VYVN;61B?)!"6EIULE_8:'
M_Y*$AL3O,:=H5?V=M"XN2T#2?D'1I^"4=6!RX(C!FUBZE5:?P!33$Q>$_0F_
MU37<.E'E_6Q*EMCBQ_L+ AHFN4Z;^U9-V^MLB'WR4)Y\9ILTD]V@KV61H$LZ
M:.^E,T(%F:..'H,AO<,6S2P;/?GTPR[S>X]_<>?QM]Z5Z&N;ELPA.,M ">3@
M=;'@&5?"%XG2E\8W_-.H#E5BMK[A+[/I?#[*03//'0<6:OA$1PDQ"@661\M%
MB$HI/]2:EXB&/],:2\:ZGM*0 3UD,;Q(Z?)KC5Y@_AV_S3!='<[T\04NR3[)
M+[Y.9XOQOY=?W[J8$=& Z9@L2&]) 7->UG3/ZNSQSAJ?972MH[:ML)^=R!V%
MJ3T88%N!O<7%R D=@E$2DC >%'.&-/Y42$RXCH'(EW3K'F>/X3D[(6I&_!ZB
M[A_3%\R7%_BN;$5YY7BV7FJ;70V]"B2QE0*\#1:*B@0<G0S-DPN[8ALJ$-6S
MF/3"BE,)%VU=TF\_;MI?6^%$XC*"+)ZV@LD*G,X1O(\ZZ^+)^FR=*-P!UK%"
M1_V(0]>C:4^V#'EUW:GF[0*QI]!.!WC'"<XT9VU7T3F0+T<2(<:\"\D( EAJ
M^7;VX'D14"S=Q%8I[9OW[SJ:Z#P1Z#@%R=F%'3U(S)LPR:OQF"P+HST'(5P=
MRJ ,.&%-[=D0DI4Q:-U:,&[??D*Z\+[,F3:A; \&^QL,<_PRO<BOOWZ;3;]?
MS<2\AF:"Y-H;18LK#A3R!#$8#<&:D)BA];O6#JQ'X)RA%#2B?1^S!D+Z0OK\
M[,?=9:\*-J.(5DH&*+RM];>DZ(ML(!F&SAE7R))K+!:/P#D_L6A%^QX,Y1>7
MB^G7:1Q?X$I.2[$NHO(@-2:RW).CA:9(<LHS\PQ)?%L7&#T <7XB<!B=^TBL
MOIP132]G2(M]-?ZS?K1"YCPBCXE!-K7S5TJ%3BHKP0BMC4$K2FI]'&Q'<WZB
MT(CR#:< /+GR=XLO.*O+7P%EQ23CN:(%1UJ_) EV3"@P)>H863 N#Q856@=W
M?A+3#U\:S@Y8 7TY7?813)7<KVO8X#/)]@H;&B\50P.E**R%6 5<$0EX)CU9
M"D?&5>MIG(_A.3\Q:4;]K2,&6N<Z_([QD+2&N[_>)H-A*Z"U9(425 A9B5RP
MJ,2<TX$S3?^Y7!,ES>CN@P[M8AH7M^TY;WWRP5OGZ5H PB! T8?@E'%$(<Q9
M%H.^M&]@NA'*P1;K=?N8^OA1QI@RTL67G25;R3 +KF9J<:^(O'0_%M9:_;S[
M_F/T<SR<OP_LT'TIVH<_X@Z6EY>S60T;*U9HT]"R<JYS#X+PX!P9Q"4%JZ+4
MJOC6]7<;8)P?K_>A;Q]NQCN0WM+Q>HT*2T[*6 N1%5MGVW#PF9-<2C)\D!-"
MW3I!>C.2\V/\GE3NI3?[W95>A?)"%#(9&^D$BK1*K1@$'@)XC3[%Z+(4[7O]
M/X Q5#R]#UX?2M53B9??7\<RY**$)5*0BLL*RV2R) /1)@Y"DZ+*D,7D6X?'
M'Z(X5C3\8+X^*B<[T[>7)OQW$;T-7U>63A=<O<UIV(SI6#,:#N/9HR)P(,&'
M%(A8.(^%#%[EZ_14;C6$Y MP-#G'8+A(K2.2PPK"D],8AI&#7>C<NOCE'Y]>
MOYF&R8U/(@CMZ:0K3I"JXE4$'[@ [8OD+KC 1+?N_/<>>VSM;E]23YO0J77M
MVOOW[^\@*47EK *9D3;0@I+Q$#PMJ(1B<RHRN_6<VBT<N_?8<^#8_G0:K 7N
MTE"H!5"UV^J!;K<'SVGG?WL<XGK5D)7<UB[2SB55,H\FBU**T-RIF(T:;7QB
M/QXY)E#RD 1@[5^ABB6KFX4,%K7@KM!IK5K'S7KRR-U_[*N0\,77.I=P%*PO
M*BH.0==.W2QSB,5;",HY@THJU;SJ?AN68Q\:^_']\5MZ3TKWX+6[CVM9KOGQ
MVPQ#?C?Y>YB-JZ%2)PWR$5U,G@7#((LH0='N R=C )LU*X[;9'+K*HNNV,Y1
M0AIQHG>]_NZ0ZX^+6FCTGJQB^D;X3!:NBHXT&0<L,P0ZI^F2Y3( ,NGIR@W<
M\'Y#%X^A.T>I:<:-_AV&./LZ4E$;%DE^-=9>#1I)WXWHP$9)BG#1JI1^SY2*
MXASE8&?J]I!X] &_A1_+Q,AWY5Z<*F54+@L$+Z6M1482Z!(DL52!&:SC95+K
MR-\V+.?!^R:4[B?-*"'F^2NB0FW2&R8)UQ!&'ZP,M,[,9+G.H=:(8$41G(7$
MI&F=*_(TJO.0BL;4[R&+Z/ZJ?\<TJVG5KXB.9,)-<#X?F:BC=H%#(H.<!#@X
M$N6KCT2Q(A1?6M>2/PGJ/*2C+>VW)A(U2A910?+(A ?M(@?%:PL?0]!"SA@D
M!AMD:SDXOP-A;XH^Y*[M(WH<<[(V+7O:!M)/ R-+.-&5E:7W*KLD,NM9&SR%
MZ'%#)7!GJIYP]%@K%)$,%(C>D-&;7 +'N8;H+#.*!Q2J=?W^:4>/=^+KT]'C
M7>@[9+"P"ZZ?-7J\$\^Z1@WW(?B@ N&=1YX"6$:FK2JLGH],04Z*9<L+EN;9
MY:<>/>Y'#G:@<[_1XUJG[92G5Y<ZOE(+!MX97>.C+$>AM%-K667/+'J\$ZFW
M1X]WH5._T6-73-+.%?"B]ELLG)/I0%)IK),LFAC4NM_WF46/]^;8_G3JX8R]
M&U:X2D-)V>0@$$*(Y6I23< *ST?'G<PAK<_$/?AL7<=P+BK60;3MP?M^%\\J
M3ZP#HIY4JX=HCJ-4'<:E1UA^ (E[WNBK_!<A;998X\PV@:KSJ)R/F4ZP@$D9
M.M]*Z\J,H9C^A +5-\]WH6POS8*($A7.ZHX1SG,52"_TLJ8IT7'HLV:@23&T
M1C.6>.N<_#4(P]_;AW+E@2=]?Y)N5;1:)WV]IH^_XJ?P)\Y?3K]^FTYJ/&A:
MKJ>]T;<.2 3K_.PVR6'[+64M8<P8582-63$KE4XZ(I.&M&##LG$8[*CS6PY0
MB^^\X];#5[)2,7'2*)PD/3TZ$A^1<^T28P1I[=&M5\ELT8XW/?W0X^/JF94(
M-6[T<CI9C">7X\GG=Z1+7<VI^PW+=(9WWDT[#.>+<1H)67*Q0=/.DKGN"[)(
M0ZE*$_UE$P]&M+Y3#H [W+'41A363Z6A.-5#TMD>T%_1I^//DU&)'*W.'EBI
MO@Z4$J*J+2.S0.%9*L6W3DS<'^U/*&+[\*D'+>@M+F[!CY0BDYS6"2[4)L7"
M:;*S,==V;5%CM))HT5AH[@%X[G*P/S4;6K+K2[NRT54QADE:4<FU$8J2I.$9
M%6OE.ZK,0^:BFZMI_<E]QP';<NIPXIQ*[.]F$2\N%U^FL_'B1_6[+0VUXJ0T
M12L@-<Z!2H6!9T6!\8SQ**R-OK4ILQW-T(ZJ!AS>>+H?3.D>3N_-R*XMN2[8
M>G);/8;K. ZL5CSL)!H',&!H(?%.Q>B4@&)RH#.4%[J>0@2KA'0ABAAQF*/B
MB(ZN8\C&+G3O1286.)N$BP_X'2>7^!%GW\<)7W_X>.VY\:$87T0MN3>B]II/
M$#5II=PH@2%:6TSK@H0G( WO'&O'OP>"T8[XK>.3KR<789*OD;W%?_W_&"[N
M='(VDC%+4%S6A33:G"!DDT%&;PR7VA1K.RJ1C[SF#%C=F):#5<3>T9MN/GP_
MFWX?SY?3D%HX1K<_M[E3M.,2UARBO 09G9=!9Z&"8HXA0U%\0I\21C[J](;6
MSE OT#$= W"I#$DAIEI [4 D+#9[QVR*';=>>V?H=9NMFT?_\><WNGOQ-YP0
M'Q>;_"$OXGPQ"VDQ<AP]NFP <ZQ3352JW9D"Q&(U=R:Q(EJ'TO='>PK^B5T$
MX4%#S&'XU(,G]!KY*Z3'A8L'T$?6*>09&0B.1!44#FIO($"M9$A9T 7:O)?J
MXY"&O\6&XNYFH6K"FAY4W16\*W_K0W@Q":N8M2"3)WB,10AT!=.G49+613J8
M;!V,>0+23R<Y+5C30RK0XU0916E"R-Y#LC+4F=FV%@W6<1;"U0)B0M\ZPO(X
MHI]-;EHPIH=ZWM^Q(.'+^U"%^<2"R!JDJ( #7?.D@7)@V=#=;HTWV+X1P-YP
MG[LZ-!2G>DG[OX)^?>MNVPHL!DX$8."-YJ!25!!T,L"9]XK^L=FU[R79!=DQ
M<I0'8O86(6O(J3[EZ>HNWH92)>%M] EX9))VFR="8"Z02J([6EFRG5O/R^J&
M[">4IW:<ZJ6)R:/4&6F5HT3M@.F:,AXMUI1Q 8R+Y%%S3+$O0?HE00UYTU!_
MVARX3=9RC)9!=&0XD@I74V/HF"Q1$L;HC$U=7<ZGDK>PC\IR.'&>0=Y"%-QE
MM :8<B34WD1P)7I E90.R=!R6_L"3SUO82<.=\];V(720X>DNV#[E;>P(P]W
MB4WOPX#!DUOH)J+-4-OZU;1)K1DXYC-(Z4A9EMF(T#I3\3GE+?0F&[O0_0AY
M"Z+P++&&4E7M5NQKOD8UI=!X5<.W.OG6W2^>5]["3OS;,6]A%^(/F[<0:Z*H
M% I$L)F,:U4@$BHP1J(4B7,C4D<E\OGD+>S#ZL:T/$;>0HN&WH\]KGF6PD[M
MO44147@1F)=8.Y-&ST2L+9 9#UFJ,'KLP:US$EQB,2I+EF$=RZAT54Z%,V""
M+5[)E/-ZEMB .0E_E(*IKO[FX;4R\0.269/&%^.E/?UB%;6L/6 OZ7D_[OWP
MR&NT02D-AM49D<ESND:3@FB*,UD'$UCKV& #V*?@EM]%--;OF:$YU_HNNG;7
M3#[7*I 7DTR87LXPCQ<O:4/^*-/9O\(LST<F.>8B1Y!B65N&'()# [Y$:^B0
MUCIT\VQT>]]SE8J^2-J#=KH1U77[>I.9]8(%,+F01LYC)H$L K(L7O.(.:K6
ML_X>@?-<A:$UI5N77=V3TWNR^?$R_C>=:I^F?_SY;7SES1UE)7CAR4-VU1$H
M<FTK2<>5)H4Y5)S"\=U/@*=>^UQYWS.!6WNRMR-].UUL DM74E21S'7F'.GK
M3A--N&1$$\&1^11<ZE;NONN;SU0@&I"YAU[?J^!+-=KF<US,_QXN+J]4FHN+
MZ;]J\^E1##[[X 18D0BB,"2VD6PX](D$EZ-VZ[F^S8)CC\!ZKF+2%^5[:/1]
M'=/](\PF)-'SVJ]^,1O7\10C%YST3$LP2=.M)K,"9ZR&9!22^6>93:T#IMO1
M/'=1:$3G'KIY/Q6;E<DZ;J4"E-S4AA0,B KT*4_6*I>-;BX&)Q,W[_=8:$'Q
M'AJ ;X-5<B@Q,@Z<5U/'9 O.)0[>)9E,5)DW;^]ZI@+0@L(/&>\.9?S?)C-,
MT\^3\;^75]8UJCL51S@)%XLQ5G-X-<[H>@4C5IO3!'3@B(F@0JZ3M1T=8BQH
MP8-2.;9.^SL [G,7H*$X]5#(?-M<&RN-"I&,)+GLUU9[T3A+MR!9%P&C-MJO
M%X.??*[-WG;%0<0YE5R;S6Z2&B#&(DN13-/AEFKZO>809?208K0B8@E"MM8C
MMH(YC4R;G?C;R1VU*YV'\DC>B1%V@==3KLT3T(Z3;M.(D5W$XT N'$%8+"O%
M!>Z R5JR<U6M$R2$))#.484)6P\7.HJ0/)%V<QP9V87X/<C&!YPC/?#+=1*
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M>\>,6[K""V?5F(\0;;0@;<HATIZVZV.N?^7[#BW-1V'VL?-]-T<DO1;<J.3
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MC=#NG,8C)T1&8PWHG&G=3!@(S'%(*0G#/"N^[_/P :9SEHI]2=_0X%^ZNM;
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MT_%C+$16^Z/0L:&#SEITZ\QW; 9N\<JTY]\N!&O,M[\2I;Y>?EV=[2Y$X:4
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M#-;)>_S;YQ<Q!D%UA(.*\]W(."ED.QL6@VP8C0AT!AP_.H5K7$Z][ID[=VU
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M@=3Q]/7!?:*3;_L*H9LK1\,90) 8<99^?PO2#"?T,X#05#IO5"UV8_?6-ED
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M;Z_1HV7+ *38L]&]V"L,(-TS=LHCW:#K8!?F].E#)_4'/(X/44ZCIQ?!$L
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M8\V1%YJ6LH;:L1^'0*C%=/8O7TO_)I2C1N<!W;=.80"-_%39/*QFSIR<K>R
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MU!PT63]A#_HZL@AWO:)X+#*O/B;W_71,=UZF<8R3@6D)[OU&^_N-3H>W!OO
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M9.+6^SL$T=&SO!8Q((KMH02"=C"L@U'4.]#K,E$42P:P&ST5YA7" %@MC1F
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MRJ0<! 4!5GTT$W3'5*UQ6<ECX4;O@XH>MUNW/]5M\:H*VXMX]C1^F&-2F)Q
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M!0@1J8#%'(I&N0L_+=M@BZ%4Q4R[=&20;OC*!ASVT6S";!^8H[5VR1%$:ZT
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M!*?9H.N C6EBD=9#J9N6(3EA*D7?:LAZ$GD%-YR*OG!-1=+%DC).VTT[9C!
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M45]'#KN.9?"I$\,_&"SEYW\BPF:ABEEF?M)Z]2Y7U&"O;L&)_D=M'UX/S0*
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M:L%*^$O/RSMP3R) N+/K&=XA8O?*D"]A:A".E[N)/ MSJ[! =V8JP"RKH$3
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MR!@B J[FMN%5KROMN^..]_BF01D>7'PU0[V=+4&WD?6LC@<&00Z*)B2*-^:
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MQ\ADG:V;9+5]K&KDW"KWL<=XR&R52ZMK6,GU[,==LRV>HW7[J<F#YE\- ]K
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M"-ACJN$B@<&FP[BZC4?P3F7)-RO1V6A\%T.<0>90QVOP")"&")A_C(DCT#!
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MV%=TQ>!!E-S0RO%,O&H5]FP2=Y^+2K[RV,+>&5?)M[DBEX2MG-S/!)<+"<A
MKI,)3+[Z[-A49<\,8\"*I6&;V] 6?C"]]/FJ4!E6^%DETSQ+C<5K(%7'\A,W
M3:O+>4<CY248NQ!,8',OH)KTEYT08PI<?BXN9-L?%STEE>#)V0L2S5K0<8V^
M$R[ MJKQX$)D"-T%QF:A-":)#J=X<.-D$(2NM(O5$ K J:EUX_GR6U$SQ5C*
MTO:^Q7*Q;][]1("EOQ9]Y#=\R4'[W+5B:A]:)0N,>,L>59/:>>B./';.'S4
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MSGV  X  ?%>Z*Q-D.$#6%, W[U S+/VIS.#:WE.*G'1P(=[LW\=Y,AB[O6<
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MFGL=*\)#G$NO*A.=>RKC%DI%P+Q'14?B, G*EIFX7)A$0J;+P8J;7;\=[3W
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M&Z_'??*KSCQ"U@<Y.96]CTF>LE<W\>1NNF@0SCQH:7&$-L]E2:ZZSO48P<J
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M&S+?)FZ!VNHY9$/_Z SFS>XW;%:V\[GM8YJJ&D,_?/VHVZ1;9)04-KB37H.
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M",L*LS4Z!_A8_*$&BC+2FL2[Z.7,Q&QS&'M:PG?K7[IY/@>.@M[8=EM08H>
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MJ #G>98-7GG/+B6-Y^)PQ5,!JEG=$7?R8M[RCI@6'"!RVBZ@)-!E,J+; N0
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M[^ U!5L!MN8KZRSG9BYZV!C;I[UOC*X%$/-&<<[8WQ/]+U\;>0TM_#^4O7=
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MV)J)+66,Y*_W^"X=?T2>OL;W]?0U/O?T56H<B&&C#K)'"CV\);R)' %C%3J
MM>9##N2._&" [/&>9^*L9VPTHIG+&P<BP8%&0JZEB$Y'78OSWUOU-+;M4V=I
MC.L!836H>.MI,RB*!UR,IL]T\9GSE>TL%A-HEONO234U/9B9"-;*<TYL*1-F
MU573-'F[K/RV+&FUT[X?R[_DMN\SH8'L74L?Z"C@"E?99KC__-GU=5I)MJZ$
M?CD<R'S,8GF9+;N=<WAZ7<@D3.A5$#5SV)4K>-:*9VI68E#VPV\<<R+I$HUZ
M(ZT#K9:=AO<4-,N1T"6ZBE3/KE(WLGC:5)\ 0G&]YNO1ZT]#]^\\DN-8GTA5
M'Z@6-G");)@?T>SAL"9;9@Z;JBV"L360/MBJ(NYOI"N>YU/?X]MPIQ1M)9MI
M6EC?*RB%Y7XKSAH=T1^CY&#W?L7T@8W^'O[T:#\KG+2@:]NP<KU.S-P\W5]U
M)PFD.A[I#V+^L"'CF@3:3^NML)?S6M%0('6[;U9/:R'#(2C>5X4:]E)Y- IS
M@N#;XD $SO_4RG\/ZF\Z8^477D)7A8QPH)2>@I-?A_/QL=LJ&(5MJ)PX,Z)9
M &5Z_)(3!]I1&)SU]BP]O>T)-MWY\[:G)JQ/OB_45[T?DHHJ166X0=L)E%)7
MS2U7.MME$G;2\UC,DL[W=(^J.26=H[7L]J!%9:MN&H2G?M/3KN'35%-L>_J$
ML/6&6A-<2+6G<G$G-6=9W?N!>7:*VX.L^U'\@J;'O)^Z,>ZF4R-^5GSM?U&;
M&Q?&= #^"_\J<=Y&Y:S]P4!\?D/ B Z&^WIODE&R3E7<HPI/E)Z3]B$DL335
M=8R4.$C(*G\_1I9<ETIZ9+8R<3YT:=BTT7(%@H_XRLL99>WXH=(JK*Z')_JB
MB8V=T%D283=-=NB5F8^;\\7OEX;Y!#3=WODB-L9:*&:#%5^.IXEZ\M?W&,7U
M:+"DOQ^;6!BUIC208^*(*(<55X%AY<<9CM3MK/KBL//M4Z$PV<-!:D7N+#ST
MB\,!#QRHB*/60M!Y*;F.B[-8H]\X4J_9N#4_NACTQ"EC6^_%FH%T:$]DH;;P
ME6%H=&6AZ,/BMSC0N86Y^4Z5WFK196%%%1@L;20MD7W0[J%N-(5?Y*0,)0&=
MS%F/*YUMYMFHGCWPA5&TQ8A\26G/7*'[ XE5'0(V-G$5AC>R^#V5C>G7$OH-
M-5,P:0B#NEPA3#DP%>W748KJ9;D\WN"8+@RXY\,FT?T)UE0HZAV"W #/&7C-
M& 8+.X7/5&ENU[H9YXXZRSUE[",,P[OCSRRGE+X^-8/W L,_Y:#F8F%GL2(-
M%P-\0;*15O>2G)B>\K&#DJ?B3I#LC&CY4%]*/Y^>^XA"U3T+/^N%\@LFU,]K
MN1@>CW@UBO<[UT] \JJOUVVBPZ6+^W('YDQ?,D1,;4EH49]1)+D]II+J^H#4
M4#,U96ZDS]"P3J<Q5K8ZP%"??W1]=\./ROKU:@Y''H;-&OO""I8[9LUX3OW2
M91HZIQ<3>:[9NN#Z5@3ADM:PHZ]O#YO(D;VUX\4^IJ<1]VYT]-A<) H,EKF3
M+_P^\6/:3"M,3(> 4D<AGM]SSW#667>BGC[#A1'#892:%Y\:FUCT2E!-I=#[
M0-U51$9+U"UFBL5<8.#C*_-L:8J^7.%VH8H12?.JS+XX-WO-)Y#Z[R_A $N[
MGR_AE!]>/:V3HH Z:>&W.FGMZ8\Z*8\Y'X$#^?"B?#$8/:PE#E3?C0,1FLZ
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MW7)(A_<O-;JZP%5P\A\BCDIPH,;38/E3J8%%A##D$ EX0)=H]<R"E-=X.-Y
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M.CPSC ---H"QK/DWZE23E=]G\^4-K#>.H3P)KOIG2T\ME>F(A<.UC&HS\NT
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M"*KS^*]*,<!9@14 :OE@*[C([F_H@.@(]B4#'!\8L_2/,?L0M58N"]@7!G1
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M00C&,P1M-0&,0O]SE)6%JP/!1=694@>7$3E"^2?Q(8*E+FV<V+FPN8#%>XA
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MY'OO'4!PC5V5;&[*&Y5FN)S[=S?YJFV+LH^E4[M41&YHT4E=YU=\4\*$S1U
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M;E"<_4%K6 NK?+IQ!3W>!.6SF#);(59PFVKKZB3E611B[;#[\M6<6J1$7L*
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MU% )IC A[0C5!F9W*N#>E?4'0*.5/<*AL_")DV^NW9'OX]GRP+P>3+.E<7<
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MW<CL@+V!0404C4>ZLWIO3RX5 W^C3;IU%0O=J57;^_&/&[6]SFEVZE*G;#<
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M;-XC_K6>@.=A':(N;QG>(S-!Z%4 SK]N],PB Q1L,JHQ=[=N9R^,]N1)WP>
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M&):*#"",^5"G=)\+)6*&BA9R2)46L(4V4!EENJ&Z2$L4V: T9/ZC(1!;4<T
MZS2@Y.!OM&3 C!LE$8R,)\"M*F+_3C=!!ORKH2NL=IU 2:Q*1V,  $@&1 Q0
M<AA3U2+>!K;2*$WRZ3E 4&HQWZ-CFNDP1Z*Z_BGJ/R3PH_CZN:RFLJSO%<'[
M&Q&4\)(@47IJ!E+N_YL%91Y(5_&WOB"(0WIASK"OL"+"Q-X6>!U&C-ZEY!L1
M,B#@+1D05409"%\RD@&-2Z I=R(G<(OY+_T@$IDL) Z3UD$[$QR48+,]I&3V
M&$42&1 XAG4AO2H'DP @,H CD\3B7D.I0,3^@OF--D6W&P_]"D.R_H/I/U#Q
M'5UCMO_&<(1X71:AX==&=^C12$D123!*#IB%8YHH%W\G%/U71SY4PY';54GK
MP+\K]? _=?K/7GRHU1M 5A7P?_(B Z;<?3C)@/2_% /[]YV5288XZ\%N_!.*
M]XEAMN81HV3 '@\ENQ+,)FA!BX*4B<(D-1F *P?])^7I$R"K@/^-Y>*_58Q\
MR9\Y5#3UO[A;\(Q[S<3^Z240@>)01,=JJHS$8K,F4L7,7[[=$>!WS4<.)_4E
MP9P+\PFA\T@CJRI?97"C6<D,%N)F)JK4B72CMU.;ZEZ;F7#F_6[&[-)\B1K1
M4GWI, 8T6SA,!OQ\AN#T]V<('])3U9K*]KFU4O2;YAXZHRXS\V_9(!V8#]Z"
ML-5^=!1=7X[@(0-.;/P.; MK"/L!42,#:KR/=$1<4;C>1_G-6H]DY0/<7PC[
MY=TDZT4$413Y:F*;M1N$-3_" R= ("<PBV(?8)-5/Z/BA:Y7$J@XCPP0_P==
M#E$4\R\ZV#_HW"[<EH!1^%D?^@22RJ8IP\M/];S;%Z3XS,HDY=^WC=%DP*O=
M7S&\3Z#D1J4_,:QLY6.8RO!_]!!PZ-+PAS'%M_5(+ ,U3OMG;($$T9].1X%
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MA0Q*G(MA5DM&$(,?A;OB6]NY^)DB?GE&+#+'CY[4EL9!")C*M2P/@YB47;G
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M^IOJ:"AE@LD,XK2/",$\C:6D5U[4/6]L^7.FNJQ9 93]'1?=H_<=8PJ+_7X
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MQQ*,D!,*C<(K(&N!'#ZWLCSH:DD<_=L<;2H*5S8UR\[H"7SX4!*>F>8A A*
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M59IK'*NY6Q#)X4XM<]RMR* 60:]2D0?%=7B=;U4Q8O=,WPOW-W%J3F/PZHL
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M,I34P=[U\*/^R%+H,<&KY(79.;.+ L?H@H9>><\&P4\C>]MF![\4VWPU^:\
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M8GIO5D/K:8BL]Q4$7U!44(\8XT11A%^YX@E0PTB.<6^26'O7LHK?.F7V"WP
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MRDW[,G;#Y!E!+A9.^EB+J&*.VH&:BC]8RQCY6*3+\V":GS\U>N'[H8GOA$^
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MK>,,EUW?SI\9TZ7YHN+?)TEG>YJ[AH5(;_AD2Z.#N_(AEP7><[K3&AJ.CC[
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MY#L5\Z<!1^OY[BRTJ*@HG"524ZO?T0Z.'$4$1C[^(>^ETVU&J'N+FV>*G9X
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M6WJ#?NV?33P.HAI[6VVN)5._T(&<*^<<F_+)\[,SK^<?L)%DUE(F$O.!+_I
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MN9_6C$;#.=]DGRO3@6J!(GLI+W^"4#^*".(Z&*O>!^KPE:(2QNSS>AW.]P_
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M/-S,SK/YO8G''#(:+]LJQJ.'E(*)_NKZ#B)9SP[_&@C./I\8 5<NX.+FV:X
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MV+AY<05 :>>#_B>X_Y]8S/^%A?'?6&C_#4[/O\'AEU_Z;W07_J=%>=?V<HR
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MZK3D5J5,T;D4&&'9W_$5Q>DRP6TKG/2E<&5$"Y^2#,XR,5*V^CKBPU:QEEC
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M*RZO%DNKZG"R!#4:?>2U1>M_XX#,"_D8)B8BZF!!/6#GB[0JSWW%I]_S2XR
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M!KC.&2'C2+0.??W*;?/)+EII L&P$&^&Z@2KE9>MYZ7U"SPWP W0!YF;YN)
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M'OIQUN\G,G9UBY$W5BL*-PLE2Z((?6<G9)X..B[Z3.Y&/G$E^Z)F#(!/;NX
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M/(>6?';9ZV?NT3'W"WQ8CVWLGPRO<KPI_2&OGL^KNOZ=:S=[S.U$AD0+GA,
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MH\?QAL\DJYWJFZ<*#E2@?P.Z<?0W_W@\6!;R@^A"7%$K[!\/NO0_#D?R#I\
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M<9*MI-/<%HOG%]XFJTP%M*C%W@7%*<OIGQD%U[IZ.@DTK&*OIX :>DR!J2+
MZ#C$<[I#99<O+GQ/Y?@,X!OI!#'0ZQ.O(W!&C/MUPZ@>2=GI1?(J3M]OR?D-
M?(NNG_.I?I,.]X73"5'0-8>^H&G?E-0E<[QBSYH%-?8-2=6J7\L>^BIB:;==
M>)@1G!Y@[@RE[8-07/= 3V^4)'WI?-V</-4(-\HPSP_F(!30M2C:(Q)Y@2^Q
MX8$*Y43[0UF.E\S.FB?W5K0H??7+!Q<^C#V"HAQ*!BG/CCV].Y^/?)2?D>9?
M4KRB],%9-$3K<L;(V(QJ=-J<JW@FFGIN%[,YF^>47FM$4')>"%=25YYO,.YT
M0++F;6X/;>[I:3N586)/Y1K8-HA*,CN=)A$OIW4L1U)23+2)0QS L20R#RLR
M47P=?)Y2CZY,E8:L [3&LC,I-BEXSS#5,Q%8$8B$+,7@@0^*M/OV B/EP/9[
M^3L;N"SB=)H:/1*3+"_ZJ<UYQ!Z^E_>X=JCM1=JU=(\YA7,]IVE]H9$I 835
MD!IR[*MPY!&TR^NIRI):#?%E^3M5S_CJ'!&@'(PC=8ZL??$;5NA6[*LF>X3.
M#0F7)'O3I[-#&1X<AY9)TX:,YVF:-.4IKN5+7[<WI[;GVJ(\6Z_>@,FB:5>H
M$!,*?RT_UX!KJ=*@=0^JZ0XYQWX?H/^=.)>RF9_XF:/69H^R./@>1AP31OJ$
MS@M:#]B2/$I)Q-RSF)@L?HH6!@_F;;K+2% NZ8C/*[2PE#<6-'TKVJB@EQ?:
MF,;H2G4^S$0Y(^P&#SR5T[%('G/ACBN9SY+K?..KOWU8;?[55++KG9Q>S7 N
M=)YI*YTG:@2K'GR" HM6/W5KHR'>V2?DU4GM\8&+>;F/N$2;Q)7@7:\R ZNT
ME,4'F#?+JU'\>U07'^:7?*PPAII'!1,ZUZ7P]HQLN@9_W6?8-C<%OKS94>^K
M>XMO5W <& J*6CY!$R*]FK"^V35K-N2<"Y>6SZT8C<M=PMRDA@5RL@#%96'H
M%W<(IU<+4Q,E+MR$B])CO4L%BY@]A'4/K>1^^ 52/= 2=2K-?\U#M^GDALAA
M R\?QLS]KBY]Z:5;Z_QUV/TX<ER97Y[;B< SR7.%E[@/[/N",6.\UJ;;N=^^
M"R?9&=N5J*AHZ*R U!J,XH!"UV/\HR'S#B["O%<I44;+:'FO<.'BS*F]Z:Z!
M*[GGO^IOY:A7..+3FY"V;6N4043*>6-!AV5AHRP9M=<WML45[U.Z O!]GO%M
M,/F>F)7J3MSK $>SL@[?JHHWF!MWIN6/&86)%_*,%+U?RSVE'")JE/#@>G21
M]A1NED;IQ8^T/$Q>3-A6=2O,Y?$Z,6SMPT(V!7.#5Y7PGEB8\N&+8QU3N9UN
M8.4.NM*>ISCY^D-J:7R)(>* 1+6@W,*+BW$!F*<-QN&RI0]8@'LPS3L39T3B
MWN<_>]V#%F(Z#Q([6P\R<IB<%O2;9%S*WBB"3:G]X9+!#^7W>&2L"W8N-//2
MARB>#TK '!"?::O.W)[!VKJ]?1DQHW=6SV((UI_+;[N/907NEG$42^T?V@+.
M@I5,-MCN&8$]GD7[R@Q5%K5W)LZ<4P_<&_\$0<,ICM:'2&@^+AB;LB(O]&W,
M!A/W#!V/2JM?\NX( :4SQ2J6YJ0=+\^HH>:-UE76ZM2/?&.*A#9C@903Y%>I
M:)M'(E8J(Y<4*]U3%8JS1QAR0'POX2'.+3M2_6#[*)F](3.\VQ15512&+CMU
MFV+->WE:!T#&Q@%]^'UET3#'+QR&WWS[,J^OY,0\4G \-K8]7#ILEL\Y]+,Z
M1Q=V5P"T/NL@Q?GAACBNQTY9KTZF?[:1NX,"_L/-+5;W$[C&V)]@2X.]!UEY
M8^3U]RO%3JGJI0^84?V@93,!GK7$GO0Z%D"P=W5XAZI_JJM4_>'^6?\4L]Z+
M]U0F04E@:BI-#L("\--/8@]$+!+-V\+J"ON$*H\'G>#TQ818>*C+A7[:EXD(
M'Z79TM>\/[H[B#JFWZ^[ 5VP!/+0I=#!"HRL8+=@6\_322*UR(A>DLS=R0>D
MQG&[Z&:Y)5T/'2N;ZM+. D;K;A7U/4^%.PYU("MH>E.9&(C5@$+-RGG-QNPB
M@Z(A&GR'0DV_52RV>N3L$?B]ETD<(%L6($^;HKCJT:4N1DVO[3V_]J2_"?-%
MO'IGZA;;C&/\[7<P:-A-:Y3A(^*VZM.$PT[IERIC=V5=.2$KL(Q>V#$P111]
M643A1(OA(I1UX@VVX&4O#VSX%[BDC1S5;[A[<9IY'G$[X"[WH[Q]B9F96GM$
M0IZ6@9"+^HC9I'P[^B4<.5&UILK.<GHZ:.$!//49YP8=AX;8,.NR#N@?V;@;
M C&LJ"ZZWM8G!TSA\%>*J[H"B@TRG!T?E1K%] )'MA4BUKQ[#R+>VH&>*0-G
MT5Z'L(K4U(IN).1!TT*B"-KFYK%LY;&:SMW+,VO'\>,5[B[Z,J?S=5W/U0C[
MN]RG;E_U[JBV'CY'%')3S<MZ\,)*]VN3CV_C@MSL^2WM_EIG1H"S:] A=[DK
MG:-=;_S4@-?]+.9SI*D1XV<;+\KUJ0M2%\!D3'@)3=_GPTE2* >$EGSW0\);
MT>[L!/N=9^["VPJ9H& 9,M="K1P,&'!Y8#E,_O'X10>+IR;."K'/."62VO>[
M.S\>>SVW>_9-@AT\WV5'8;/2>YKNB>H.C_E^.[A9TIO1Z;5,Q086H&<-OP']
MP!#P[5D>D U1']3)J]B57T-RAS]][Y2=@EM#M;@PHI7%^%2WTQ8$+7JL=$%=
M>O&M]FU5K;U*M5:M45BN@&WN4@;9UZ):/C;=Z:*D+':\T9865Y^>[,UEE#D[
M4Z%#B?W^Q0E.0>2D^G",7<?TY5>%B9B\.<>.QN'CP9T4$1E7'F.(64)-RE"@
M2Q@+X%3CV;!/OZM@(PD=$;__E8R'L_1:=X/%#M\F*;)R<_ U1E:U#IE@V_[F
MD$G'@0[=:&N43Y+_ 3I"C9][$8.<C% 4"OW"%((H\NB-HOP&*C^UC5WZJ)D%
MZVS*?B673"DB@844@L7)-%LJ##I4(V%=70]36,B\]^X*[;C]A3]ZM<&U97GP
M.E5T4X%)+T1?D%33M_BN\=&GXT;XAN.&F:^+&:0S<JZA=B8EWX@=2]&*W0O7
MTE8).I648^F0D:-SS*^5]C>/[>' GG,RX[\/<\;LHF(:@MAO4BZ59>\Z3B7*
MCS^680%.?]5HU 0;!H ^9$E072B(J^3&R&JQ"54KY;H-QD>NSN//PVMWYJ5(
MJW>CX5Q5V;V@D2VR)K&R\CZ$29)-6S-%X+H7=,VCV':N$#>*).Z(Y#YJ;!R;
M?2Y:IVS5LTH/K)RS%(-[RP)$'6I'0-3,#2H[GK, UK?$(]I;1?L(#RP'91GP
M$AQ_@*8Q06'EKL(EUW<Z"LW'$Y),KG]Y$&? %=0ZB_>2SU*EMDLIB>[XFEFW
ME$G83U"DR18![X.%&@RV9:HTP*:CEVP%ZQVF*P9=%\N7B>GT.)GQ=3]3P^0$
M@Q?(U=*Q2FQO_[J21/$-WN#&M4(O^+-VD.I&T=(W5R4]G<%G$B4TM>! +%5Q
MY'+@#D*0^-?M/K<*KNP%A9B?[=_BV8H.3:!ZUB5+R'^;6]$_YE=1F D]%-UO
M/B:.?E-&.-'7U]#V18[SDD:R0Y #3I,%< :%I6%JB3L&;"%G""? ,V<5$4=[
MGVPA8@95EL6Y@CU"(IZ_0)6Y,F'D@=;VLYK :)\ +0DW/6L60)$.<IQ2'0Z5
MIYNT87<'A%J3I@7F>\1FN]+?!UH_?T^*B4^(@H\0ZFW/#(,C)FHJTD[C?#T+
MK=Y]UL5W[Q\]Y$(";PE8:^S%U7GNTD-!A.2:\0[:>WOC"W1XMQDB9_2#;22_
MH-28AT:N.!_WE8%8L@!C6,_EBP&D1BM$G7AHB*%)N>O+FP>5/>)?!1C9++CQ
MZ\J]9,)09GZO9DR@"9VEW%&:W6W?-)+JZ*Y!(PEMB<O/=V;C84+!QD,DGVW1
MZ/[IKUG([3N ;2AJ=F,:"Q!K*V;=6:!\,-OOU8'1Y3>\,F7&>2.HRM#ZCN#,
M@KFUVR&&(\#'I4&*LY,YFCG4Y!;^71JG N_WSI\NURCY\,DIOL,?DWG>:#06
MVI B\*7 S6?F>@./=L9]DU#3\+G>Y*=F:O+X,YAG,@UVLR8FM].+RLRJ,ALR
M*56-0?HO_4NSI+'W![:)"$1PMT=-'CMOC+(E(=]\#I%/2_MXV/H5Z.P-;_Y)
M2Y/,^C\LEF8<*"+78V9T\DKZ_,_)X6(D3F%Q1379==#" <O)V<5WHG I[OU!
M0C:#[]!@R$9&;UR.]YIY^RZG+,/J;L .)L#T8! O_\%H(6,!N\(2RPHYHME@
M%=BN].M<,5N#4)6VVU*%112%N9HW;@*2E_<:3;<5^H*! 9'XRI(&Q*L9PF[H
M&F>JRZ-[+3I-K>)??!@RS\NBZ\IVSWP>Z#-'(!Q+JZB$T72JAWTY17GVG0TB
MY631#M6E#Z/]3+_'/J,A04OX=U-*,U#!6Y3R^-O=L6&1H4F1&5ZZ!C)O#44?
M(RF="6V]94734YXS$NJ4G<AAZJES-583HU?N3<AI'WBQE)5M9>O2."A)V0V'
MO)RQ*JF?R'2#:GI*\;V^$^0U#\D21QKJ.IW7#SR2,8B41O7<KMES273CNE :
M&"TM^GQB=Y3!,@*]Y<:T8<11Z22IQ_MT]L^9:#QM_,HK^1B1=#!6=,Q;Q/2R
M1<)[@#F!!2CRG)UD1$A2SCR>,UR-L^BU5HI]A]S;_QXZMK;0EE><U#/OK&(@
M=:9.5M@L$WP)ATXQ(A:YS$X-BI]F2E/V6];X\D-N39E\R(KQ(8K7D*8= @YE
MA-SZ:#H)V$+E78]<S63D29%7TJF0VI2W7_+/QXK,#NOQ"&_E1;:<<8+;W.@P
M1IR_M.X0NIQ[;SB8*_EQR"(,14]Y$MJ&*^[$AGG>'?;D:P&;'6I4F[V^]6W,
MK@N-%"?FWFFP<%7QPR)!BY4CD?$O'5KJGZTH-)WJGXS:J!26BHR4-ZQ3NMJ%
M=0?WF04II+ I=]<@7;>T"ON-5!KNM7)]J79+_-9;FZ/6:&"X:AB?8V]8E(V/
MMI%6H[UKS5GA\MRM3_#HO:U6)[)DGFMTP:VL--X_=U 6#RV62'2,XI0!!_63
MB7'*+ "/1LC.V'Q#A%9PSC$S04#BCB$@;1JG6BM^M"--WS+MXLOISVD[6S]K
MV$97W%1Q\/:Q'A2FK#T*%I!_>DNUI"'E4,:Y"Q<4UN&ZDS53VR(2DYZQ'] Q
MX$,,W&K)K0.RJW>D*AV2";:N[) NN4.N?BGXT%<*[F,:;#H:>[>A[%H_J?+E
M1@;YV,>QC/NF(=NX;D@4YZ(/\S1T77Y:9X;T4RD+F1\L[66T1-M0'XR !*=W
M6]DA4?UVTZNWD)Z>DER.O,<!HV_?(ZOU*$KU$B?>WF^T[)KW$[L"ZM12XD.V
M(R3PBP4W$TH.\Q0\"(AJF?Y"<EH)RBMA\+$  @%K=1(*3[^LQ%J-,&8[%"J>
M/1@/^]@H4@5LA 'Q-^2-ZZWN]W(NTI^\!Y1/M^?=L6C5E?$=ZDS3TM[S*"9C
M]+I.S< @%J$W3'R$/<S>Z_M[U=]YV2M_/0A]&#;A(MHJ49MR@9HR N-M"CD2
MS^Y="T'U\SLN<1Q5TQGMJLA*1*!W"MQ%-\4=J7;_?!I=BM%;\#3.(S?6P84"
M3D*0R_IND_K)4_.I0P=$^7$2$\5OU$]327KE55GM=6NE2[:@U'.H'54^3:/]
M!(&N!YH/)= '<Z+KC'4NOGQJ;5FSLZ@.*!)L/5)SM'@ ;%>)>Z<XL?>(?7$9
MQJ!X*E2>BNW#HW.T1K87MXGJBEW VQMW^*X5:)?GY3X5L^3N>K>_);3-W(U0
M55,5)+Z[AK*G+DNZ3<&WQMRB ML^=^6X=?/E[H][]XY^36MK4S]%';W8[MB^
MS ((V?5:'NA]>QE_"YCD92$<N913RV?5N[5^1 IT*U_='0.]ZU]1@:"V6K?Y
ML0!S56JZD!!S+\\22;%% QWZ3&^P'N5JJ$Q"G0[:EL^+X C>>KY6*<-%HK8B
MIBVNH]]A[;(7QDSV6[H5$8J#@94TP805?J$9[QG5O/X40B%C?9SVQ7+D28Q#
MS$2:V3?13P;NGPSFH@>3HPP;4B6U@]34BR66>:R.JB[G'KQ7#IW6TX'7)H?%
MJ-UZOO+<5) #K?YD!Z]5_..5Y]EN5C);<.&J44ISR[EWN@VZ27-V1-HY9JMY
MMG#)V15]716%:A7WDX\MOS[PBCEA*AWCR[G4E<=(9P%<FK!'9O"F7>[CAGQ]
MQXDM^#O=+=LN7QG-"(J#+.A+Z11_+:;*W[YA#;EB[G"I!H"1$HU9A54A<&.A
ML?C@4Q2TXPG(6LB>)=A[.O[RMSE?OF-]AN\>LRV[$-\ >LB;MCJ_?;NK1T'>
ME1OA>M4%'TPOB.NH'57T'&I_,UE9F:0P-WQ]44^*RY3CJ8XR.7O.FG95;U2/
M!.>ENLWQ1XY*>APSN@*)>'^6,[MRIS9'AA_F#-=]9!SJLWAET3*]_51.HOWZ
M./9;%(D% ,!77S->-<+'TFL']R>-?D-/ROG<V2O@>^VM&*R[58H F, Z-00^
MSU@BZ8$1]F\[R(F=LGJ:9!M_U5)[6T+!/'&HZH^+E/8H*[G\R2V#4RP 4%TR
M *9?UKZ\(#*S.]F,5"IST#Y<=.KLFK)F/6Q/M>-HM*0K)N#^DDDIY_$H?TXG
MWSF;6)&6UT;7)ZZ9+SCY?19]G*B6D:_36#* '?6IQ9XE5/,'$8)V(M53O#\7
M-VT!Q#?NA]NOF^+V!!M1P'#[.. N4HK5&Z/,3RF<NQ!DD68C\]FA\=9/&"(R
M#6-JO*KKF;(Y$Y*<4@_:317\--%^@>!1C((D$^7O[.+(-HY?T([$R@84U0:%
MK,3%%PRXKJ8T+_CLN+KU4W..14;<T!:;$N%,68^U*$((]W[]6SV7W:W=[5(&
M!PH\J8:-3$FR\GC]8!C*QA5Z9GNAY8$#>VPFN:.R\>SJH)L.ZZ638J6L*]]F
MT:"]=@>WI)QM"5@5:1:*LO)(4K&C&-"F9 @HSL2;G:6=TR%SW:3J,Q1H@]TN
M)1; @1JQ9"!4I2/]%#_IX,UN'Z@ W(AG5'#0$\PC/Q3:0JO98>A!V7283:=P
MTCXWFQE9QAS24,@6WZ."M2/XT^+:\*/F<;XUW+3=[76$M]-VX*352_9%-T_$
M925IUH,%Z8:C$#EK-:A59<<<6N>X]KFM4M*B#=QOZ:AGC5V)06TF2*TE&=0&
M1QTA,?#PZ:ZNJI(X3"U0Y+SED%R@ EVM8&#ZQ)6^'O=N^\< )PHAS)2NQ^X9
MV.,=SW%=)=&Q%U?W!_I<U7!NO.IE,W>JW60:Z;.(6BM]6:WEPN\TL7[7MF]>
M;5?H5YQ W7&V3G_XYXY?W%;?CSNVC=M3%[VG$2B!?S/@]HWZ8D59[%G=R?X(
ML4SN"P$%PD"WJR8,NRC:]OG+K6)1_C66KA,M" UJ]@AN^X!;BJI9A9^S^BN-
MZH!'S6,>I$::_GJ'A 0U? 3$ZPK=\$] ]5M8@G.B9G@L'$P/W.>7> AOJ!A,
MG$$8I->,E"S.O8NJ,S,K'DS9[,IK*_-'H(*&QAJGBC,AC@ U68B<6*SNO!S$
M(FTDT.*05T->*OP5M[&>O;U7OMT'%\CV5A\ESKA3U_6$NGEIHZLW&,^&J"$N
MGB.&NVJ=*7QULM_>UXF4<$8T &C]BL:D^L#R6;_S?.JN,QO')LL2QY6+W 9;
MLN*ML=%,?@?%'O"J$RP2*?VHVG"K>HFJ9.F]!^GV3ZU!<\"$N&[,*^TC&8A3
MY9AFK[-ISRKCT-HH4-#[&[?&.T1XMVNMX4X'=XX2[P=!X273GBLU/I95&<[7
M_CB@I9$QM&6/R!<6 *\0<$V(G9E\+DP60(L%:'C](@\8/2+3CK(R1@KW>9H5
MU $+B>$G6 #)OR#LDYTE&<'@5,ZF,?:P /M>1$%O LUR6 !U0O\#IJA+;?;R
MKB[8PC*8[@:G.F?SPKYJLD\!N&\P2K[,BUGP7TC(=R3H._(!C4V%!6C^"YKG
M#T*Q[V1#YC58@!U%PX8;/!#0VH8B4UF;?I(0#IJ2?,,"$*DX:J>P<=6>SM>P
MUI*U VQN5G_GEOL[GRB9*JZ(_U^FZFA-9@BF@OL?JP')G^V$68#G$>]8 -@+
M%F#4Q$CW3^QV-M.RWYD2_WQV:I/IM73@#Z:2H.'DZJ,L@,;_4U?[%3?@TES(
MQU]@QY]@)&PXF?[[XR^2NN65^==7L6/2?V,\]=^,M;JQ:,WU/?]T(8RF0#4&
M+OYYR9:+_Z<'VE[DA-5 <G9$M3[CY8NE:^7A/KMJDBQW;=S+KP#9$+[RW@-P
M<WPUTG)4:^VD>L>J6G#-CB3UU23%04?X8BHCPSW='; 5[3&HMZV0HF9 EE>-
M!?\G+#A]U82,KBO4.X8LT)%ZY^]?_C!9&@FJ?!&U0M9_?0ZJ?O>Q_;YGSY"H
M'K\54;:TJ</\&SPDV!H3R%2^ G-:X(&O/R*!OU]JB4SY?*Y8E./;C.HA6TH#
M,IS!Z8>AL0#\;"T1P)YSM5),!U4B@P6(9!^9C+0.JT#%\$9,K35)Q.H/,.XG
MF)TT9VI!RP)=+, "'<26X>C2Y_)?>H'80X)_#L&I3NQW9Q;@Z^;)&D=F =B9
M@YQ,\?X-+="%^QVL_1<X-\L6/],!BM_T.($NQ794P9/M*'[38_RJ_F]!O(AR
M\YYG5QH]>OX"R(GX?2:K/V?RI)^$/H1-2:%A1"J,G6E&K<=&+-Q '[%C0'+3
MH #;_K@2MOW#F_8/TZ0#+L'7>?[43OCHYW+F=\81V6R=5%B )W%E?X)A>.D
M;>9]5<(OY7B]YQ51US:5TY[-'): C3C^7%3Z'QRN3Z9X,:PB%Q4K (R$X(.P
M"2GT9A&QA\XQ195J@;^4B9*M&.]/B<AE1Z9I.)L^O)\%^/B72-SL5=@!G!"'
M_%3F]8NX0"B[D-GPS=Z0.0S<^#,6O>_7^UUH?RGSTQ!M=GCAP$+H0R]V-Q/_
M)3(_>_+?EY/)9],.L0IG<JU);HX*_7UIMBD&Y#C0V%\Q&J?<V2@!CH&]!38S
M\C=/V)96?X_Z+SU^8H68HN=^SXQ_/+J9&(WLZF?[IT@_"?N;JO\4F6WT\ _@
M?QE]A*H-7/Q;)B,_EV?M@[,=X2$60O]KUI\&_8TK_[_(@7\E\G_Q_0=!-BOF
M[ZR,M,]71;+;X$':D]P_U?RYK/2/6 __HF'\W8M-PCM!;,(7?DM-XK]ERVFQ
M_6#/;J7LN8$]9_Z1ROS_NF-DF&5;_X.V7.@_U<O^EYY&QJW'QME=]C]5V71[
MLX!_3U/^'Y4"^UG=OP;SNU+957B6B)\8A @U5DW$SDMMJ8F3XEX\9:338A:4
M8LBGT7+T@V</T-)553DY'(%W1/3EH5_*"AS4>,\!;T"[<ZP;:05_F9]O[;]N
MI'O"3/L9W8]\CX(-DTA01[^>[E*BG/?G$TR]['._.>;"1W$>3!;_;-A0.SN7
M%:"_^&';%1)S(FT*&B<LQ\^:-'S.E(9X8C2XV<#![-Z@!2:GYH^]YLEY,39W
M-2@+L%7RNPYVV=\_L3S/C_K&CFYSV[U ]F1PKA#I/-][!+L*PX:(&W^0<%2!
M'ZU+#6TX 0L(L=NTDKVE<C^ 34D7L !#EWZD/_\VMI:&MBS ^T??L^_[AYG#
M*T$_&MA'"?99_7E6%0L0MNN'U/]BI&^Z2>C_BH_Q_YJ/WO=O.B,[I[[G8C:Y
MD<G72'^X0OS9RU_^1?%7=_\[I9W_#.$Z#'\@X SS?M#DKSZL"-G\G030//?'
MAL"_C<)^E?OE+I)-:O-_PMBD?OF-^DXJ>F89QMYPC&D' D[!FG\%J?@/%:*.
M?O_*E,+X3XT2F*(<'Q!,!ZN_^/#^C;]$'EELU8L,"_/K6;'VK>[PS+71.I(C
M6QX]<#$_AJ&!R?%Z_R**6OW).^N(30L-B' R&3;DD+B2Y[]J-L-[W/#4C SF
M^ 8'J^=_ %!+ P04    " #GA$U6E'G=9[&L  "9MP  %    &%M8VDM,C R
M,S R,3-?9S0N:G!GI+D'6%--M"X<I'?I18H*B B("$@1B*AT 0%IH41 :BC2
M0XUT08J"@%*EUX"4T"%T! 2D5^F])M0 *9?OW'K./??\Y[]WLM=^GF3O/5GO
MK)FUWG</89JP!+BIH:*N B"Z 0 077\ A#G "P#QC1O_'->-Y/H@I2 E)2$A
MI2(G)Z.@H:*AH::BIJ:E8[Q)2\= 1TU]D_4F Q,S"PL+#3T;.RLS.R,S"_,_
MG1 17S]#0DI)2DK)3$M-R_S_NQ':  P41&]OI!,3W07<8" B9B B= %XK_TD
M)?J7!OAOC>C&M8]DY!245-37-R!N FX0$1/?("'^Q^OKJX'7UP$D#*2,=\25
MR)AT+<GONC$_#OZ23<'WO+*=16\$Q2]AY1Y"2<7*QL[!*7!/\+[0 TFI)](R
MLG(O7BJKJ*JI:^B_,3 T,C8!6;^SL;6S=W#T\/3R]H'Z^H6&A4=$?HR*3DC\
MFI2<\NU[:DYN7GY!85%Q255U#:*VKKZAL:.SJ[NG]U=?_^C8^,3DU/3,[/+*
MZMKZQN;6]@[ZZ/CD].P<<W'Y#RXB #'1?V__+BZ&:UPW2$B(2<C_P45TP^>?
M&QA(2.^(DS$JZ9);NC'=?1Q,P?S\2W9E.R6?A!Z*Q<I]A(J57W)9 /T/M']!
M]I\#%O)_A>Q_ /N?N&8!-,1$U\$C9@   5>]9\$8Q(I81 H/?15J(B(ML @:
MJBOG%_NJ/I9]?]8]C&' 8[(J@ U=W6,(8W<.X@UX]J>F1?%*MQK21#W(Z9,@
M2,7^^<4QEG;[U_F@9= TI^0EO@65T[.P<M!7,-4%<ZI:,0V<(_]6R,4PSF1N
M%X&TW>6E@L@51M%_1%0P8LHAE$[[4MPN:VJ3<U_C4P#6%18S,KM@5?;E.R&A
M)2F27QN?+IQIGU>I77P?X)!WFKAW8;4Z 9IL,D3,!=*EX3G)EZ>P KRH.%XV
MAT[CXX#XZA298XG8-'2=-[3'(_,!=I&M^0YI8=3#=U-WXWCIU.Y.F'QI1UB]
M)R)U]Y@N]YAM%8XJ2SD+A(4-+F6HXED_@?<I/(\3!6>EH[![@8MBZT-^L.I!
M3QA'$ _DTJ<;+MQAS]_P$Q/LG-=9.G];YO'LKU*)-5A5-G))I1%9]7X>&^?L
MV@0JFCVRT+)8@'B[$P"0E0;9<::Y=R?N+3G8,00V\]?EB*(H5$5=7I9S]W,U
M)IJM?K3-B !0BS7R?[2Z3J2MO>=S4L+#CCE>HN? ?-CR$XQV\J)]_8X:.AV"
MV?WYF9@ :%.O^!S$B95&&WW*0V]$CPR=*U*@< 1 I"=\J3C9P2X]).]<_.!5
M7+<# 4 E.0!FWD'220IGV!G53$E2?\OG=.)A,HY-R[XU:?I9Z?ZTK.VPV9=4
M_?[W/V,( .A<O+.SYZR?8#Y\SG3WSYVTE<+[%JD:YB<MJ5J.YRU7V\YR6;J[
M, 1YIP*=_ZYI%LML_FEZ0J= 7<K#97Z8KT[?;H^?5Z_&,0$0LH@8MY"N;AW'
M@A4_+>,DYY4='%B*,S6#)<-K^;.$+)XS4F#=3)#5*2&>30,$0 RH&Q_OZE9<
M^%',JJZAH<[0\Y7X!24'Q[R?5X4P 1#F=X+OY2$;?SLF^+UFF %7A7[[H29$
M(/FU<5P]!V\&1(<XN+G(9#%5?,/9P7,A>L%PO+_@*:_]5&.=2-8#'5-)Q-30
M):\M!,94H_74>,*3PG4EL:L6Y)0:?^;/MSE@P"\NTR,1)Y$ZA*%$LYZO(#N<
MJ;M!22TM^?L$0-;&"TC3 /CABEJ$-*/?;06_U(O5E^A 9)?KK'XWSYTQ$2\*
MSZ9XLF$NQH4YR7O.)41OZ9W6Z+,K+'"QRU"@[2&%R,>1^BM;@Q026(%.G/#O
M[K?+$1VU4RU0U\;&-,BAVNG[^ID5-W7!@UE_I_W[_/B-(96YU:SN>";'Q9OD
M$0$*RVE_)3I2\R="/S44Q*T81,V1!,RI/VC]80O?@B$4-J.9EODG.;6:&:"M
M1QL#KZ.];2%V83WT7Y4 H<V92JL\IQW81QAQ#[1$#YB#T945^JG3SQ]:<B8D
M<E(<)FXNK+&60JH-E;DT4D:S+2^DH397V/9.E_=O3"J/2>(T4"Y.38P+FA)-
M?@GJPR<5VOGR],!*7;,^Z1P(WKRNM"5MH]I0OM'+;6%X3E;1<'2BL.5EC6&C
M69WV9H5C5HU19R!;E[N]=*O8S] W<>"[:NI6C*]6(3*WE,A#$[O=0;W[-LOF
MU*LLBZ&N!]E5/ZMJ;;/T$_V)/;Y\-##04>X3+,P/R$)+=S5F?6H67J6FCN74
M(M?_I"_-N,5I%&DH,V+0>UC8V&[EV\O>IQC1,D2KT=D)0Q0D%3EZ,VD6["[<
M0M14U6N^X'?7WDM/C)/C2AR-3+(L4DUUZ*L?T(1/"3>.#9Z#7/I,:A\T7[P=
MU_OJ53US+*P0D&)7_FLKB!(_D1#P:K)9TZ.T-3P':JT1I_XR5CYG_;5<R=/D
M6T]^"A;*LG?[306W2F"$5Y2[!Y$16%6'DGG3\HL[\>[UX$/GMY0\J]&8W5<H
M[4HX_K?<\EA-\6'J<(^[^8)Q.\.QBZB^RQL:FP_\7/YV"#^QR%,MZ97A?=HE
MN'];*NG"]SS[)TR]I19]5LXW(V)*E/ZX/- 6QY%JBQ&%?RW1SEC)_5WC.) D
M#*YH/L-I=MBR%_6D.TH)/C0J\0D8-O4T*X7].=,$S_HOAV^E_$('YA7<MUAN
MBS8KLW_?%9MNS2TW/IE54]%)W5>>\ZDGU=+?/FCDX:8-D<R6&E$\WSJ'0B58
M BN%TLZ 7+%C-HWQOSY"ZLCV:<?FXFN<Z#[<=G*A#O[C9GH3*JP-O FS-::+
M!=0%LN0W@*MCX;?K3(B"9)_VN?@GOC[:8_RZ.BCFU>?2^MMUKKSGT^->F0YM
M\?.O%L/[FBE(K>$2+ N:O'.1X22Q! HQ##6L-*'1$N&X90;0^'G[YGNE-1^6
M-1A/JTB +D;5H10:,JR"ZEX,V\^/D'E7G^KA/7=6\?M'^-7:B8*X =)&2]XA
M4PC33>)- -C6\3S(ZH^Y-T'=@*[Q[-5.RKUR[.0G *H/$%QNS>4NSHIO2!*O
M3D[*.27M1WY;/Y__XR)L,32<CS!ZNFL(-WV8Y%\_* 3T:6S<#>2.^W3MWRD!
M0 VU.C?'5$A'RLM:?HM-GW4Z:JQ_JT[#F_#W$9O";B'JL-N5$EK=:61Q>]3K
MZND@YYA;?1.CL_'[QSX'[1:R:T9A09-^/!6*D:@QLUK3B%%)""+E-<3_#M2Y
M_>6,Q#/H^R;CM^CA%M^R3)(&=$4',KJQ-UR*&]S%!BJ<X8'R/L?_CE[JONW]
M**>23B/T,P 851X-I5&\]Q72;U:N/1L@O*"Q (*47GC).MJRQTB9O([Q_6IP
M^O<*OG@XIGRL^!-5UTM/"L7NW,18=QFF(O;S1"5,"]:=B,;) %_2W24FFZ^6
M>O?MEI&WH':JKLR[G-I1*\X:/E&26^8=2VJZC[6]DWO1#)D3P:C%WB :=.\G
M)_*(9B)?LES+;*F6G@:!XEI-D3L\2B2 KI-?FUE*O1_CJ3MY]Y3R%^XEEY9D
MW8QZU4&C]86O2+8G:(L8!2^VP=@-:N39W.JG-"\M/0Z Y_@+7GR;^.TFG R7
M53&,F:OR]E['>D&\D7Q[62P!, QL*</J2G-*7@M2Z,BJ:)RY8. ^L/%PK8W*
MQ\;WPB,. X]]L5(85I-%/H<I.>QB?8T)6B*+P.5=\ ^]9^-*;%^B04%7FAFG
M.@U3K^<=.E/KA5;<@?CR%J-@)O>.M.G+6RZJ^C%N%EK+?^]>CBW5M=,S.LHI
M;%0OQ]-#.,,:$5]??S=AV"23I0F<\&XXV>3>9;>I=^AA340V!1HV_W&O.FZL
M;<'C"K^O.#34L;CZS2K(VN;Z_#4Y?NJM^+,9@UYN@2P/1V'5E_:M>L$IJM7)
M2QW4-(^+'W!KLQ/'(>%*RQ7QJ<R\E $2J_0<.]X\O,X6\YKKZ]$I!PQ!MC)8
MR";<N!?-U,/+V Q9IN4\?(7ZAHH=_'K."+KE!G-7NEWR]AUZBN/"=_>-IXQI
MNSN6"5T1)0EIT6\_ Q&#^JT0D&";]R:_O%^Y90P,UR%<JN:!@@_K6O:]!E%U
M [/G1Q?LS<,,PX&B$(OAE!7-M!;XYO%.H$]!@#$JHGI9.)[9!!/1XWQC4=$+
ME4C)P/W"[K,O%T.FLI4#L,:U,\-K?W4,JP_Q%]F6Z.42[__]4K/Q5?E\C)C\
MZ7[JA6!7)M5DL\-2173K ]14Y&%9LV#1SIE1<JKEAZ[S1QW@H2]6)P*AGGN!
MPD5C >#E>![\.))6K%DJ6R??854[>>&%0LI,6+=NSQ_Q8Q*2AW[>W$(B!>%Y
M!W\3_:0.9H5F+O[.:2^Z^_;<11E&-VF^P>WVE?;V]U^>*V:GK$J'WD9)(6/
M%A^@+LM=NN ]]_*K?F<J-F^?&^)Q$S,]*VJ==&'OWAEU*C*A+ H6;^VUT@Q2
MNE)C_+OT,3^8SH,&UG.5>.OG,8H'@<('X0 Z4E]VK( (7W2A\#&$ '!!1F[.
MG[GOF9N!$HMON6\3 *YBG]:GO9AU+73W2)EUG_UK>^.A<3M\S6E?6<1MZ_X-
M#6$V+;1W6E%'Q0;N:W78F_H[)E$&EG':4,N+B;RIFFWJL);@:*Y'='1T2\C!
M#UAE@+VN,1*5[##H>5<]^<T#^O2X?#+C&#O%"2"6O]'H*S_^3]W1#/;GPMMV
M5YWQ($^B0F4;"VCT9,_*BK3Z=^<_DJ,Y-GR_?I%<?MEZ&@]*TYI8&9_U--X(
M,5:C9]Y%1*@H+67F?! ;468&Z/X_6KB2_ ?[MOR<#[<J/3)R@1KF/]*7;).C
M ?;*W !F7TCZ/D>A[C-:"O)GI+?(Q(/C-;R8 8NBZE>Y1_E4XC$T?GKCTFSO
M0?>V\]52)N:8B6Z_;@$PLY 7D56?Q()H-55JQ[.3;$/V6>TS=&@JSLG7GL$?
M %R3"S&JZRK=J^M<_OI%/\C"J*>)]M5*6IZQ] <HH5^U<HZ%U>:']RS]>&Q#
MI[036/G'Z,Z2V$>VJ=34&8M6RZ?K9/<OABAO?Y#EQFRTFC)UR;RZ)R=#N?C]
M=*L"00 PM6:2P34>UGBKPO?,K(EYON4.F&W:8XOT&Y1."XW&!3T^N+31/;OQ
MM<CR%_FNIO(C3ET=RS'F[&=< " 5Z#Y1-F"/]!9SC#/[Y3^>?=7S"$[4K+%F
M9S_I%F4&_(TF>R1^DFOUY1JW588RP!W)*$]D@Q;ND/:C79]8R&+N-G]8)G"T
M$36^;J(S=5Q.O$P [$TX+Q$ ;(51"# K)$AD4G0?-#3DK/<L:. 6#7?+<4Q<
MRS#+/HEN]&YA-%PC+9\2)'9Y*K/S=LN@J%1;.N&Z?$7(URT+MOGKA,\N(,J'
M*QR#!*<0-FJ;XUZ&M+=CY6[W*G[OPS.,L>R8W^\1@CQ E!AE*:AZ.ZO$RLLK
M9$B]8]95MG)BUB-.M7[U)<1\0O5*E9FLZZLA:^YJ!>TV":ZIB],\4^[BO++P
MV'']E'Y6<#DN+>MIKQ]EKR[MD8;J4MXDJG.R&*6$?#GDNV(_-NFA.9$[8E_!
M- YT0H;)>;"XLHKL/36=,5//ZE*-GVR :YY=8L!6E!]VI?$AU+<;"(#6&4B5
MK*V<OV[*_)"L;3V[*PCHI_@EI]6$MZX\OE@,JRY/NA+X*C.K\1D]#F7QG0"@
M=4;?TG=NU&D;]'L6M%='*U>!_TA\"D=6HDM70BRJHK$SD6>3Y'N#2+4^O-IE
M06[F'?G'*C-4.V^^3)&UFB:NLNW?*;TO!^YP5OS%,S5ZK63B7WT5BX4Y-@43
M '>E(^#'NW?="(!$E?B]QJA9@]O(_1/>V9J%RD+IZ_P '+\$8!7&5&="Y-'P
M)C+E6U2;CL3M^E-6B8>9WPNS2)]5&Y-FFMQ&)&6]*Z/O5Z5X1$X4DND>I L&
MTEJ?E38 C\A0+7582B!FNY $5[*^^1M5 ][#'V)I@7M#I]?I9@F,(L65SH;K
M8,GQE"<W,*R_53D5)N9SI-[H'310%:[S^OS8-D#P$DNF>'M,__T6D*S7\8Z.
M;D*9RWJ$?'7>*!3WZ:S41?'OLM=Y!PS-S"UQ5N8"0P0\;)V.)P!B1W#?D%MW
ML_"D!   B #N\!3BK\4FR>5C J"3]3)\HJO"S8/3[(=Z=FR;^B,*$G3Z!W^>
MCN^NRSU5]=%J!P7U'O<3',KY<:N >H.+9^P\W_!>QXW3^(GKP?K]HN,(]QR&
MOI%)OZ_+L0:U> V<W[S0Q5U'2^>_HB*^,L)G[\"6@"B=(ON*;REO<$7[%X'"
MG=**[9]A^THZ/)*X@OTY^B48O5G<^CLE J#N>?YZ@JEA 0&P?R*5VGVHDG/]
M&^]6H)1RP%_>;OI9LKFTB@@_SQ]>1[8<N'M2TEBQX>A:(!J'"CD"@ZO5[^#5
MQI%5N\@(7=@9%O:[8A_$;2UU'4!-;'S.5D6F%:XH0),>&Z;(M#OYP>NV!BS]
M;IG@?FCV[.?&P@BO?85XVR@*WC11G3,+,2_J2TD"X)[>X$^?ZHP6?7"JPF4T
MNHE^%MDF'1PPD+8K?Y8Z$@<\3)]2+0P(0-$5U_6A!1KM\$&,:L@3*98PE$Q1
MP)O\<XF<ZSJC$U$6=.)'RQ)9B%GM;*Q5["[?KGMY%K'/CH^H-51^3_731J%]
MT*W_<7Q7F;>*6TK'@6*T]@E"(/Q_*SS_26/YA7V&B;=<4KAQA.FZ1.R))T>^
MJK:1&.K$J&B3CQ, IZ7+KEP$0+M: ,QA1=BR$*K8VWEVL_9>U02K>L&WT..
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M:;??"^S,T0RN/.CVSF#=2PQWQ1#\_%[#<1),3?RZ/KXF %@)  <%"+DFQJC
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M_J$C=P24/)1J*OC]WF0Z>WNSX9I1WJPG1EEK .NRG1(+S2O.62R8+M8)@*2
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MO>M#?SU)3W]SXR91< F0^4 >\A".:OO[)+M )&(948-:DPO?_YEXK@AZ:OI
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M3MY4YW)3^!3Y*>+.HO2'TJ="L^3:/WA-=,'<T+BIU;I/%8==9_A[/T=64Y=
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M7A@*TD\-&T^=[JGAUG"AG-WL 5,0 $O9(*V*"%%) H#'X3)Q9W+DXYS>V(B
M:;JGCUZ_08O;9QUYSS)>YAU%&DSHJJA@UP(]F'5+?S=1S2EY3,6$M+O+][&\
MB*!YWML$A:@*7W3=GBJJM$?D6#E7:WDW96T@5]N*]WP_5 5(RG)QCI8;'6Y?
M9#@( "YE^!B/U^S?6X;O/^2!I0]I\XM3H,A,A=LN*C-/#Y=V>B0\.J79G/U-
MCQ0AO,_U"]FM&=/UQSP/CZH5=S'^5P;&[<NXN[3:BUVM IF7MZ+**K+_C,[/
M=Y(%3/(-O^VF2O\27^ WF(]?!%)YW:H)@628:JO>]CTW),G!>;,"\WVO2]_T
M"]V) -Y",*:S6VXHM(09QJ<UED^\]_Z7XCNKF<XGVNMF=._=/<S%L$\]VI$G
M4A#D^>]KDN6F96DVEWB%+.4)EXZ)N9O-+?]W<=-C9Y#>8JQ9*P^TDZJUQQF7
MX1FBYN(\+R=W&2+<3@ X5X2E]G:#(T#N4'_M0!WC,03I=]&5!]RY-C8![^*N
M=);->=NR9@JU,=3^L(<I*^:N>K5-\=;&%K^R; U_*;Y5UCU&QUPR8?Q%WPL]
M,& N;IH^2>?VTV8QJ&BX$", :#+0'O@PYV>PMEP"8*7T)\8?9;TJW4D [+,G
M+A>>343\J/0] WTF>XQ6Q*0S)[&SN/@M'5%(7;HI>S=WY"6E&ZWB[4C<^]U\
M]&"1%[SI>$Y42N\B_>*.3V* G):5_^ ;2&4:9HJU,>1@SHVGS^A+/1;> .4R
M1.[E7CW!'#[';!9@XKOQ7 UC(B*,_A6*ZXF,VOVZ*BSQLNZ+*$X<H)N]+#\F
M[5-TM)%4W V&K^_6_B)8H^^7$X_]J_>>QSJSP#=HLBB4:3=G9(2KD?:$,[QY
MQ-U8F-\R^'.Q/-E,$P].MMO// !Y98]]A<HZH\M84GC1G3PKM7Y6:H?+I[3B
MC_Z5+'IG]2!&"$O*-?))6_M70%7F%R.[37CW[[H4QGD=OD'Y,@MU?JO?>]KJ
M_*?\XUZ7KMGXH6NI$N"!:KB+6OABZ9&W<Y.W&N(] PE1ZOU6]5,T8^!D1SP4
MG-4JA '#LB%3K*Q5JC :?7G% *<GL64J_N_<)ILL#26FE].YN+]WZYIC@30,
M5BF#+6)W]*L=WQ)/9_J6?7*-3,U+@7 -<+W>W/@JP\?3"0<_EFC(6#8U_51Q
MTQB7]=Y^W82Z E4D*RAU2AZF^& 7!.FS@Y7OZ)EH>$0V>%-=[+A[1!^G:5+[
M4YR9=GRN"(PF"T*XS\Z:]B7?MW9X9_VAY+&6M>!OX=;(\<R;F,(2C,M[NU0M
MO;Z4;_>^)BA050X!D_QAH?(FY#$U;H$T.D1TUM#T30@-#[W;KXHDR5*CZC%1
MT37G467&7-[WXA892ZY13/8HAUE)S@"[WQEZZE^7TSQ.V[@^T\F>E($:FN^-
M52ML?99+U^>$CI4&Z^)BZ1=L78M_&%_/<OGVRV/][+&B/JFGT,L6)<&/(JL[
MOX-"X+CH1=X=:P*@55EL>HGWJ =XM68@2%>47#CRW7EE@&3GW?4EV.4I&_9>
MH_$N7\4$Q+Q,- W>K+H3DA/(V:%[/&-:-RE5JIWR!G_$63I243\,OF5?]M[5
M@/Y*K?.TVSRTB]-YZK+TRD<Q1"D5[K:TS[IU\]*3Z]Q@%J;1TX+1_6%!7"NT
M/URFS[N;6O/SL!3L(>%ZLU'P/+="G57WZ]N!G<*[&1;67BA'?^_%/&C"6=N9
MT44D7D[9=MX!R!+P1'IZYTGJW@N\B8;*"G#I&6S+(*=S+*O=(.  N<0AKZ46
MX)G5__N,4[AC#9>-B*>2T6'#R)UU$[4WU.E7[QZ_AY&5+W: N0+85N^I[7G5
MWVUT29ZRZTO<(GX/NV%?'-RE'_\T=LJKY.J/?N]RB>87[>'J$=SO0_N"B"'9
MU7('5:D.OQNC#(F:RH" +U?Z&&%=C,ZJL_"J71@?PSSH]Q>(86G'4"05=^5,
M,,7"%?UKK4#II7@V8^AQQ[6J]*P3LRYJJV/8/'RH^B"P_1??..<U^:6?QI0J
MC4L&:I,V_&P-WM^,0D:QOR4 %!%'AWL9Y>  84S2RF*HW'JG3,WW0\DH_M7?
M+P:(\$?,B<39Q\*+R"F4]C\Z%W.=7A"P4$6_Q1G,NNOR)%:0 )@3Z^8%C:C)
MYE< +F_^6WI:XM<*=_BQ;92:=)*ST#\JF.F@)NAXGS^=SH]NPKV^(A9VI-9\
M/4?>EL;C6.V)(\:1$%Y:4Q70P LT6?Z7)/NR#C[ZTD? ?'<?8"WIZ9K8F1BY
M>B$78]5._/OIR[+7TL<5'G\.>;4P7GGS+[/SM.06[5V^W_]A=USN>*S"5GF1
MXB-A-B#,ZN.]ND7^3"%<@7)\&O6PVK=L.[F.[1@QV-8(?1G.XEX@.A\.",I,
MFMED63U79*^NK/ZR[S-7 Y/[]M&,UT+<'!@N%2_7G3OI.@)??2/>?'#SB29M
MF?I%_ !>=E<MMUQZ\/VZ*+-Z',T@'AZ4M:#8><R\Y93$I2[,L8&_.KND"\5N
ME)IBXE53'[^=$#%GU'5YY4/Q_->S.S) : @%MR^<(E_]LZ1+E=!6O_M]HI-K
M8NNN4PHV?]J?$N\2_M%X]>7MA^\?FZ@/.F\9'8%!LM\BDH5HG-K>2@-"X[-9
M?H-@1>!BO&T=5O2ZC)]GG:()@"J!)WR.T??S'OV?),.U$?\".H)Y=BV(,9I!
M>*ZQ0S%$BWI/EI/3L@,GV6>N7\]#5  R!( ]W#=R+_^*'Q0@A4"@"V-6U9M?
MOQXD+>MB/UGG>YJF8-.K/^+1*S\UD4<\63\<RW.S]?KO.X#7PDW+/O'UQ$EI
MFK!WQL_@M9B2 QD9#L6(NE@'E;1";K&&P0<,&09ZH#GKBKKZZ!V!9$H]^[G<
MGO:O^+M?Q&XG;)AZIDK7APFK,_X4":ZN^3)N1\Y3+W4,BVZEQNJ-O4P5#)%7
MILO((8-\=%7NF*EBLG9C>BZZ'*;25)@@*UW$SN<].C"H0QO @,G-P92J3MXR
M\86-[H%P+EY17 .NS%.DHWH?X0^G"Z@^5'*POU_=**-+K,/EM4KN BE$:E[D
MFIH,*V;S-V6B.9(,;J!N_%Q+YMI$0'6P3[+B89L#+PB -@<89M\'63N9XEMD
MBGD) NEX59;7^3)([*^(V!%'7\3-M7-._-:Y767_W-W0G<_);_GGLW,9EDM6
M_? V'5*J^H\]!Y=(PR"3C%6/^[9,^>%?RQ)&_(0S9TJ"IEMEJUE5GFJQG4\.
M"+O4?CY2W[X:=MR69[IZB=5#G[SOS;9OO)<;)/"UCTC_YM$7:UG2 JYUG,YH
MJ]]4LU0I0T%P_H*XJ22Y<U.FC_0/.)("C"ELTW60Z_EBZ<N-@Y_LL<#32X7B
M;AM$R.H/^DP,H%R2MCKD9V>OO([E^V4+%(P0?HEKHV>+!5.J?Q=HT4@LOU(9
MXI:0I,[-MN#RFM((TD1<C6771_]'EUR<.[LK^YIG']!UGZPBA)%4IJ"=1XQG
MJ>G/31W>)G*_KKS3R%5XYX,L>X4A1A#=V[7P<"HB:L7Y\21''R7W8$G]PO.G
MC'X5MQZI*)%&<D-6W&1M0$+#RLX@K:=^7I67//0RN2#=PL.G6WDK$XM9FI<.
MVY6'GKK*T,B1?_4"-*#IR@@#FNOB/&VNPCP48Y0WO*4\L%!&^GAMOWUW-\OO
M,AJI"'39-W1#:^]0%"9+1;X*<U:]_>Y H16QOB'Q.KMDQV_F'1>:TUNQ#_4
M]VDI.>$+B/919TX)O$J1 +C]L?5@>8I]UPRY=XJ:4Z[$N!4X^OC9(";SB[(S
M3:-6Z.8TN4LD_KRE.E*XI4$ A%6?!6',>LVG/&> 59FR;!H3M@B3-T\6T_D
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M'U5Y_2KEP>8OE)C&N+A:Z=N"'L$(^]@>"_O>J2DV^K>5A9W'K/%DA&^>K@
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M)TO@VR*94J>=4C<$BOT3 Q"S!7O)5:@@XI<?XJ%^YD=)O,:&ND^'E<Y(S\D
M$9?YGW$94?HA#B>0H T2M#S"L;K44MSFLY(@K]38D?M6V]Y-1K]"SF)_L B.
MS?U/8X\?$*)-'AAC@;LX4+K]4^UA1813&]ND<45#DL1;'A)=F-/M8GP_V)>A
M&EC-J^Z*=QD&:Q<X"^D$WT5;-XP7I'V<L+W_1MM<P$H_+JGWP[>D\^OE$(]E
MLO8YAAQT] <:+&!F"#V5/,]ID[_5$#A(7RR0E9&+!0("L<#:SC]5ZUC@YIX
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M:6$LH-]ZS\N5\L!]/9/F%LEZRGZAVFCNO@Q'1!@NE&_\Y(\K)X,0H!MVQ!S
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MY"^KN_)/*M-N1N6$*$VFQ@P5;Y1#P?!5##D6R%$QQ0(MV7_?61R6C!+"A A
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MJUQ2<GW$WBSNXQP+\/9E-(;+!2$A _>0HG:<3H,/;%97T7?[UT[B@\^I"[%
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M34C.CT8J1*=LA4Y%RN=Q<HP*9XS.W7!]4=T&[C3/TT9UH-_.O><(/EHZ?,X
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MN=X&;QGD_[)78U*I'-5;EP:#(]>QP+\<M[RIH0MKJ69I'(@_)I5_V18L2$7
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MR.XQW*.FI:.GIR>G8F1BH&.BH:.G^^<D.'AW;? )2 @(2.@HR"CH_J_MMA-
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MI=8QQ1TJ=H7Y7XXV(I+J=\'$6+'=%7IY9D](C(UZ7K=:A'YMLT?6A"&SK_T
MWDQ3Q1O^/_$Y$Y-J;[-U:[7L&Y)D(UT>][7[FF@_:BV>*<G7LY%5NWH><(P0
MG+X9Z!'&5Z[ !/WR^^ Z'SD;Z3X7AHI5O_2VVN[23=A%&X\9UG=,VCQ'"R5[
MS;2DIW$=.G]C<V CCU"Q) @2\<XR=Z_*-CEH?*[%_J)NZOYRJYQ$;JN<V76R
MC@+_<!L(G;+>!68(H5K=.1FLRD=S9G<@BY[\<;O_OFD;"O$,BD82K5.Q8L#&
M$V&, :KL0<,:.0M+0$:XHG;S%^]FVJ2PYO,=X._30\X]K-A-21B]>4!RSU$
ML%?6H99G)%5CJW\0PR?@+O-DUN.'@744K0!8SG>B)B&WJJI]9M)%#N)VF<.4
M\XLM5L_]0,^DMO8\Q46J\@2V$YI/P<5FDGBMBEFK=+&Y9]*91XJ:QV3TYO^Q
M6KR OR!VLY?'[8U('90Y>5@5(-</HZTZ\:"FNH=AF1\S^=E L[OO$0:AOX[V
M'VKEY'T^A#T-A!(8&1CQ. 8[S^N,0:#!H)Z\N'Y]7W:9I?HYJ:H6ZQG8M>C.
MC"+7I*2"SKE.'>SCUN4@7_-'7O)QI_ON \I'>0H5^AWT&.9UX9@@_WZE.+BY
M6OCW:4FM8<R"04VHBCV#X);V4137]L;/P8$E:$&88$B 1_1E<?):.Z=*:F^>
MQ/0S9XD8GH5J':^#63F3^\<[)#O\M?1I4P56>L535:E+?MHK5C0=A\4E#(SB
M)>814#V9N?K:@XF&K$:W#"LJJ[M[;AJK&**)L?NY![X70N+FMI;Y5GT3-BG\
M$N+,M,IHZ8T-!<Z&:*.5>[!T*#Q,_]&%4K7B:".U9OM;<K&XCJ)6TO6*<(CV
M@-:Q<Y9+\97+%+(DH< @V\)K[R#+Q7]F/C W-#"Z'QQ_SDGJ?LU)SO(NZ /<
M5V4RM_!KR5=B3I'.IXJ+)@2.Z(QUWCB!A_ ZX2BI]1=?2=Y$G;\F\?:DWC05
M4K1,"//-O-);7MQ['<+0VO[/*SHT:-D,PK;1O4E70_O72XGTL,?Q0.;;B_8L
M_Q9]78?EAB VF02O= Z# I_I>D^@7T/+U&6 MY:U&MIIO2" OX]%[5.(=!&H
M6W>=XF4%Q5.>HQEB'5 @UP>_)+FS[;V5.#";AR+'4H!WSXPLY]EYXFDG/HNE
M^+M8=4YQ9N*K[Q$8<CB8G#XH)SVYSZ_>0G EY3B(?;+_=;2T1 <K;\>AX]9U
M>@E4S]H !>^#T9YRTG2 UW4)YW;O),2FMF8_1O-'EU5U6K_7<_DKDPIC^M(6
ML<U4W?%B&%Z0D9'S,3>\W.7F]^/\N,[9?W<DX;\\XO"_)LF92.,I0>W3R)$F
MMRCG>87E3'RGT_+XVE>Z]AN<<[IGOIA0--7JG3H+B.A![[%\K?V=+*?[)(4>
M14C_H>H6<!:#$HSN <U%]YH+?WJ7E%O".\9-W2I%#19CJ^;-XQ]7Q+L6R%[=
M[LE6(M<N?53&33/TH#F)BTDN6V9> ^L[AXEX48-6C XMW!.)CV>=-2=!\+*F
M15%)'B+$^8;9]HZ;#0Q:3/QJ0FGEV:0LB-\8\1"P)+%!YJR10+^VL4PL(T9M
MW1?>8T.F_1VSW^,W+Y#EV&K6?49N+M-6/U_I=]3YAO.]RSM%LH"*-=WNPP39
M]-I*T[V,2V3"N?*5HI2*F=]3^X^$XGG39?G8L15:+(N*U)=5C]CT&6M&&O$%
M<]>6H!'!ENJAU[/WUWF_)%R2G@KC!IB#R /T#[70PC'%:-_3X]:EQ9%[*F[K
M!/2$?E4*^R74B0EL13J%; Z3-8F%$_YPE8M:,-6G+4W)!S)#CZHV XJGZ\[!
M&\D #-F:;H+T+8 D1$'IT[7;6BL[Q7<.[;H&@0E5[V/^W+8&[ZS##L[K^^CM
MCR%:ZRO,F'CKR?I$)[.)ZT(6'T'.P_QDZIQ[1"IZ?=XS2GAMGJ@)+)8S*DPQ
M61UUNC@B,W&J]4 F/-DJ,>(+AC(":GXJ'"6K%'/-:QN"?816QI08MW]5G_R&
M+]K]_0VW,Q5>&6]'$*GIHH--72Y?5]F)7AW$Y^]2QXTO%Y%RVF2DJ;:,KU>;
M!]!*R*-5FY+KC(X!C/J!'&G^W8_U?J^[O/(%CNJSOW;/FX,!89^H'U$@E!]D
ML+]@= .7!KVSP6VS6>6D<<T DU^[<4;70?3MY2\=3[_E/OQ\RI>3$$1.'C35
M *[-16%2UY)9]ZP%,HSA CPN]63Q\2&L!1^HN4AG$^F<\(C*MNI\?\+,*Q+.
M?DWJU]2VSP<I"&ZVBFG1GIH'Z-H=$K&V5IB+F4,\)JZ$VG6@"&CG+8!F3^F>
M/29BE2)H007]PAQ2>78^GM[8EJA+VHMK\H%(IZ?( O, W6.(AL?X0HD"H"_<
MB/I9!.PL8@K>HT8X7AR^4!A<7_0VLY9"1?<N0!E67#NHT:<=:256,<?%*Z:Q
MZ0R&1CRFVU6+ZW@0753!F@ 6'W[J0;O?<M+!C7Y;_I$U?O)>E$3,O1</<=^+
M$2GI$'AJ%C';/@6.BJ5HI0\=\\ZU\CA6(2_8J\^J^Y83>)@:+JK@_%8SD*7=
M&FLGP2LQMK _MP .V%]>1FQB4PE&>L1C =1/9#B0)7$G0VO;1CMT#.1 JQ8P
M\U0K#!\B5QAA78T8PPGHX*0"N>-CQ^M;:FD/WF@(%%YNY'A^U)5L1QNLPJ]Y
MY_-2$0K\YMD]RQ(3:<8KQG$*>ZO>]9-<7-SGA\LM);$]H[7@.N,R O9<Q$0<
M7+NJQ48Y)??)R4X_QTBCCKM%A88T;W%KX>6"0?W-CXY?BL0!"\@/3*":DGVX
M'*7H88[)\+)@$D)I#KC:&S3+I1/J.HE\87!T\_6 '^S6!%7OP$BOW_'_CRNZ
MF/AU3+T-I<J3X4>Y17."S<W\?^16/?>[KF7AY0'#G9=42=>D6.JIOQ_&VXKB
MN#\@ _P2N!YLXX=2."G3*@/*)K>WSYNS3<;-YZT$?9OK78T\1XMTK'7]TWB!
MC<'[;T\F5J2"Z#_'OEN]9S](G*_0+K6>$$9_;(*LR:@!===82:XGOW8+(?/_
MYLB@#>-3G.MCT>V^!<3/$R0$4>:BS8E#E$@O1(:DTFNLU.ZM"NGJ$S$OS;0F
MQ\"(.1&"R1\$!V+2'J%&-J2]QKQQG-IFO[-=][C8B:] ;",-14Q+C<[*M:Q2
M_R*#J]KK93UI*Q)[=%(*$2=+ RWME2L[[SEKW+; 11AHWZ5N7'Y &'_[1LJ*
MMO]0<P07(2%V5:&]:[OQQ[4GAMD;S:4_+J^QAK2_PNMG866L;OM"UMN36CWP
M0P$5P!MA$.*,(2/JO1H1MIZ0E$)MQY\T&M=-([1O ?>Y__H.+HJ!!DO;@*@K
M1%B%4'QI &C@+$BQQ.VM(/2'FUQH_=2'C5_TF0W;5TU*YA.F,4:]:O2:Y9^R
M:K6ETM,;QI: CI-V]M%I3VAZ# NWZ6NU'YVVGP*7=8TO#^K_]&)LT= ^/QB-
M'<83S:766(TFGQGQ=BHS56=91IO\ 5$^LY/UZ<)M/V@S6#OO3'0?1M!9RZ*W
MX]3B0M3<WLTT #U<&\[.!N>& *'KPT&^\CX#]?#<9!]VPQT+QV!K^#YPWQZ&
M6U'N9M)Q *]'3IQ-7%VW=<<]ADJ<O(A[_!WW_YL_>5J21#P\V'7/]ZT,'0Z/
M9,Y]GAB +V^]MWETPFI"G5^IH\?%SJ*@=V-67]_56Q<RJH,DP/43MB]#\J^X
M\J>00M=J+N[$JL?9X[)AOE^\$8%;@\GO^)%#U_N9QSO'>X%))K&IDGDWFT\#
MF<<J:%S +F-!OQGI6..>)MR4E9Q%[*O- \7'"I"*)]Y$]1+8R4.U^=!]<21N
M<IW>;XZIB2L=N8GX\M]7SPJ0G(F,5*XNV0GG=Y5/,\_BY"^%.*8FKW3;";>7
M:Q7O&H(UUY#:2G5Y_1'>AV9YH9S.?8JVP09V%#I +W*OFO4<I^1?+8F49\!]
MXQ1+SFQ > (<?'$AN3-OU#@G<14P>/$1UW-_N5QHVYI#Q^U,2$^%WBE 3X4.
M\/_+]6G#4SO+91MJ7?+G,P\VJ:'/Y*I/\-H#,V)" GTK&>(>ND%DWQD,A^J>
ME'FI;T!B(RG.__JUK"0B?1!H"[NM53:.,*/+O-,^5Q;D:,FCJUC_2YQ.SDAO
MF M'76AI$.*GUSNTJUV126@BJ.YJ_ SL:<;Y3TEA<)A/E2V2XC\.!@U>F?RH
M;/?O9]&-LJ79RTJ0TESQT5P1#V4LNR8PY'J2LOFQ]8BV/*55%E9W-1%:L=S&
MVFM3UY_M,,+QQ5[H>U!@#5A028#6VA$:XHL.:V%FU,..?D+7C+S@O-H_#%/M
MB*?X;%^QSS/8=@L8"BMA0Y^L-Y3,,IK7M\=Y-#?%X6-/JNC"ZG_M@9G;> KE
M!CPAG0[69?>$0,^ Z_PCYL=Z=N?^J4M/GPI*5&Z?2EKXMX=2"#$6PQ*-8"H>
MQT]Y,K7^]EZVW#&Q7%1[Q1=\_XR(&9F&;>SEPY^'("#K2Z6=/(ZF;T$C7M6W
M ![7BUK?QS*'UCDRP3CLB)4*4%&2?W+5)9;H3^*5N4[88=3G4(_86\"\+P1X
MI6EI:='']T?/O^IO:.DM $U_+ 2LF,R))P.=\V]BP'C1PRB]BJAD@>:4I7:!
MJX; V=\#M*I@"5YXS2V :YGKIF#A_<KW!/\%_S%LN/G[L#^7+S\$MH1N:*^P
MFE+-=(2L'+A(AP*/-A,J6_(,O7^_\\_%JE^&C:T[10E-N7< _12,3;_9H_OY
M"R;;[(M<=R!.I0NC3*NV_;JKP'4D=BO-T>&I_G/V+DA!<A;FRYQN3 4TB03+
MN15:+%0C^T](+V@UT57-^2) !?VM!S?=5ZG8BZ><17Z7T@,0G;F/>\;5UH\
M*XP'"_L[(,V]*-F<#D$JZ^1[MMM%+]<QT/V-4-&U;Y0%E0L#TX:''M^WVM7)
M33Y><V+ZULAVMX#MQH)BE]K5 _1K1UUCEJ(70:N^T("DE^F2/HX^;YC-=)X3
M_2!LUS1(F$8<A,Y8F:>Y6IYLY%Z)GNBIN ?]4*%[C?,O#P /*(",Q]NT?@AB
MZRL#[#N%@4]A,W7J:851?^7#U#-_/8UCC]*W8!IDYHI+UL4TE@5X]&=<&NTE
MJG4%Z49]GTZ.<6Q-TJBZ5_=]U"^\]7TRSK,]DAT5/(7N.-25TGQ)S[C9G@&0
MX18PI^MFE_5)I.BOM*"8?#S- ]$4KL^#.ZT6Q6NI,]5M>N@.7::=AI\N(T+1
MY;.8>-6D/3E!%5XJ@KY^P+'M.Y$W2969R#$ZG!-M^DC$4M!A3XN<U9R+USYM
M%.G])(<80%"M7,Z3I*TV1,]97(3%Y(E!84#8OL&T+[OJH::;(MFWF(];R^)<
M41ERI$AF2DH1%5R%E+@C?JKDW2J+7;\6I6BH+R?-LL*$5O[%$*MY_-N7N7G*
M1VOFZE.<" %1<W#M<BL(H1LY(QM5Q+.P-!Q:&LTX:FU(%OJ^/$%#R=?(D'P5
M0.0*.,EZG/^!]-_VPN\$539]RT_K4-U,44+"WQQMB2+/[6>->7NI8K\XVVDK
M:?NF7R?(1WRAPH WK9\J_N#Y/291Y?!E=.NM?*JI3E&=6FS";RZ-*UF+\[\>
M>RTWH_5^<$:O3&YYG%FJ9T_ \VKM#J&EE]BZT$JXPEB.KV7N@B1V0H%/\8\"
M_^.EK(+*@/2Q%S7!K?N?&L.58I-MWLA-=VEZZ7UL=6@I<QU-13YLAM)?:X[+
MLS-+GYOE)$#JN'P2,7Z7*?Q];4[H^5N @3 POZRZ?E.[QYO_1JE%R?QH[H"[
M.6TS737=^*F3=XIV:+]-C^03\V+1HZIA4/:.IV'_@CI'&6)LGLAT!D^Y2%6B
MPDO$(OHS5F8=!15MZ<B[],O;<FK*O'#AL?L-HC7R5MV[^BU%1O4I69"8Y^)F
M._=)379;IM EGJ%%Z8C?;)*=U91':6W2E'M^UV^MCL13!N<EE8AO&:&^+-Y;
MW53GP!2B1RW9Y$6)'<'%P&.LY*10,B9C8TQ<Q+^P72N[S-]0[J:/M0)U!7[J
MY7;B7NI_-7%PGK_VKS-1'O8G+I]8"KVRD)P-X$=LQ\GC[DGDZALVX+^=L5E^
MJ58\.8GJ\_RG_5Z!-%% *ZM^K^$/H2!]S]"9Z%DP%0R82VONC)37<I\7O*,;
M$'%N\E#T+^S+X+CS7#F]^NE*1&M-4]+>O!%Y2F]76OCN2)BM1Q6LTX9!7@.U
MO/]['!KWPL)[_K?T'3<TNI9-8#DMW=)/2C,:/P_T9Y@NGA*MR/2WN)X90RFI
M/H:R8;2N-)QM[O5*R4:-L%J^$_Z,_+8ELU' "5J3OP'.UHA:G\K^K.!PEBLX
M:1,2BA++JGBAJ76Y\K-.3\75-T>XEY,BH+67,G9MC,9LYRRE$V5EL;S;O:$(
M2M39[.KB(GK8-'@+<+(G52XIKN%\F=&]OY:][R(("WQ2H3[\1$1&.=-BLXN-
MM!KM@:A?B<+R8+BZSJ2]7>Q-7*K<#PLFYS=BUF<9) ?GI<79?WO7";^+L**/
M'M E7%EVE4+MZ3/4-.0A"X-=Z'GBJ#/-'_''XJYCO)^-"G'.E>Y9WYL^47#?
M?VGOBR_ZW+_(661>G8-/WS#%TD%IC(5!A^Y(U 09AK<B%4Z1.[T<"_3)JH_*
M'RO8&7)BA=1EG]64#3-L..20HV1G-I3J=#^Z/YC<B#L[>EY*(Y#V[I&@]X?"
M;_V+/WLBOO3C*)2?7PL+$X)I*<BN]#IFW,/ZMD/S=&MO"F2.0I9:I;<3F_>?
MN:JAX]=R;@&T=:%",V0+P6;OA"<P*L%N9]DN9U&L/,E<7M=SE^&6C3W)<T<>
M.'M!;@NN9^</QRRG)"/HVS\WOA!RZ[4VS\\MI3ON[)>IFN&,7V9N0B=?<ST\
M\IF:5XL2%ZR,):\17G[YM6K&-J)3(;DH,+D[.5%VM$Z>QQ^AH(H_>=#&YUFY
M)\YD1*?!=J6U00EXA9+Y3F&A^R$('NU;!V]30)@*2(XUN H<69H%_AP&^@MX
M?<OTQVMFX7X0?HIHO05$*A(W8_Q7L[5)#_6P,TU1P67+Q[^.KGLD?Z>&+N;8
M_QY8,SVSJ>/\Z('T*-%^L<8P2M_\Y5%MNK0S&<%QFMESYZ,> 1GFJ@YA!I=4
M3)XV[M/,4YF_J:\#NMDKR.0>5KMG"D#ZO?N=\>QE"NZ;X$%"WJ/\HA&,XU6G
M4DE;?.G++I%MB1[XD,3JH<=6,;TU";37RC-M2GU*=<O5)2/KP:T6K3%V-=-V
M?TZNQ//5=RFWC8 9(8Z+8<<DGV'^$5^>F5XVL4W,Z$0&;F)<1Q$'IP>:"Y4I
M2XLO[CLQ#?F] N05>L9MR#]%WP*ZK/GA B=WSUB>5NOL9A[\=VVZ1-YCN+=Z
MPB^\1Y3/V8-?<XT[0Y4FPN0"Q,U8FN,-4JB+YF\:0/7F0Y3[(5^VOCNRPKF8
M+8_4(#[6E.CBW'4(WRF%B)4 "5]DY%)=^F$3(&S_@V<4VQ_"T__+#P8D.289
MUZ\QWUN>96A,%!&>H 5VO#>#J<Y@:4J(L3YZ5*]VD<L$X32WS;+,+2"=- C4
MF>QZ<5H57VVG1>.E(9^U66:\O*?H)/Z[/7='+^@TM*U=6[I5J"]S6/0I=TZ*
MB^*$ E :R7RH<08^SMIL/@K[,WFE!KLC]P'[9E$;E-Y]@?[)6(%OKUK\XB["
MC"U@NHZW ,Y?[6R4A!WV)G-ZUM#\TX=&7XWFY@(6$&G)D4;(-?[ TI,CHR9=
M/X6.7&"WY#_#&HJ/VH$0U<V2U._6<1%_*#_6.&1N^OGQS"5I\*:XM%:<_FWD
M[=FL/C?:GF['6F6<C#+/?#WG%CQ\_L[0MG0):;V;+/K(>42M)7&*ZENJQ-N"
M)=4]W(W,PA%Q7]92^B%Q55>%1;V6#\V/@.4-2CO&L--!$ZZ.E@J3D33HC3?]
MQ3:;2_K -?#(*3<9U'21'R3V1&&VP#>,UGOK0$-%7''*_;3@FY!&UJNIX,Z"
M@+L\[J7Y1.2B()21+$4OQS#,:2;CGTW^KV\Z/_=\5L,W:0MANBDY%2:LD]6-
MY<XV&F]2W_83E/QYQIMN8S_)9A+NSG'BP7$*>3)9(.0LQXZ1#PTA,#*AXE?J
MNJPJV3V/EM<JQC2J1QA,"#_LJ/[FZ!BSX=2D^,F?J,C59)NQAS,^:+M[Q )I
M;KF =.!",N@?LQ7LSJZWA\)18XB\6+362XN;1_HII;B(46ON\':JTA,NZ*Z-
MT:?^GGO-UBG8!J6W0[5[3RL#.5OUW%LOH$=+88^4DJ\)2@.@".E/IX])U4I,
M=^?K<Z>*4#MPT>[J-.M;@&?M;KBU_9KNAY:.C+7AW(>'RGE:5X(LY[JUTU5M
M>H&^^,G<VBQ,2.XO!='ON90>DPVRF4PL$#HO6'\Y54O?X:0\95<R0^$?]P$B
M5%#'NXT$;#2I=)&J*WI'(F,8.(]T]QB3C3/#,F%6?[<"X8J%MHKO=(X'T*>9
M-E)D7=%%2>CO.JP^&-MU^.S98^IC/8S*^H@6@C'JU.JUY=(MP!$3IZV*N P-
M,FE,F<W$!U)\5C0,-OK,F>'W?#O5R.=P;K@W0Y%T_$0+WEB7OM(MODOU1+O=
M>&<QMH"(,Y!RO'6*AG\7^6'B+QWE=NQB *LE&@NCK%YWDQKH:?'+_&[CXD9G
MPB^36Q4"%=-_AF.O\N%>24[C.\.5FH,OI<.K&O)&5:_<Z\'W!E.93;T:_O3_
MM"@=0]7T.PY4CE@WE[DPR([DI =%YC#.I)#+,XK&<GD>5!)+VCWFBI)4GWKX
MN-.("7"7-;HD;2([A*R$!SCNU?VL ;]$&T,5KH!>EH"9+Y9BF88]":U5DW41
M22;%3]QLU@C;/==6:$T7!G""5^C-]QJNBO&DT,-DHKRU=N)]P<V6$X'V, G*
M;8)U4)3YV\8"3)YRV9Z?-$LQV-.-&\[2MS#_C$.L"#LZ<?$$L!W)?@,<Z)A$
M(($(I9X1%BU!8;7IDS$JU[!7,XQ:/A_J6U3H^P$X=@*,SO(YU/,=N2GX65)J
MKW=Z@/SD'Q6(*R%$72U4D6V'?]UH=2;D$>0PV[HDB@V?I3IRK 3.<4DDE@33
M+O_*UX/:>0SR DO7,GXH**E$/>(';Q26K$TI&C*E_N01SO2ZB7F;Z4SX8QX[
MFC,J1#S8!<$?'TNWHG[IV[ZYO>!47_<DVRYE]9B/DOM=-3<A66J=R?=W'"=-
MN.%D_T-S_!?<DK=/-_8>ADQ]@5I#TN+#2VK:<[47&T%44W!EQ J=&4;N><NT
MA\6];IG7@7X*=,&I-NP!C7WP/!&XNZ0<_'<*VY.([L<[!;N6I^5'_()C>2/'
M/!$E?W=A838?#[$OK/:\;2R'/>43!2:J_?V>"N@&Q2,53[.W[U1XW'%5F,]>
MP\&(<!U83_W<EJY6Y/53[A/Z+*=SJ"@F?+TGP.;5SZ\Q.+T395>W@+_)KJ<U
MBQT-3E;Z18TF<R"+AU86M-?/,*F/\L=*7+S2ZMDT9&G(\WH6+N"YV_0<>]*<
M03<P@O""#_FEX^9A@N=O*4/F:[273YP4]A2FWK:3D7U+]6]G;=^3'V])B[C;
MANVK'@8E^VH!W221O>\M>H_'N/#5U_5_]YX *(NC*DD:OV>7+MF\"!&[B6^S
M6">V:X-OV)";-A/]RB6SK-F^RG%;G]J>[RC!!%Z)88C6Y@L;+B7,B[\#",_U
M<?W&RBM"RD[Q%$^/O[6=DT2VV5ULSH'R5C)/9%YET,?6%38SYMT"_*]%42:?
M.L@#%@9(H048]TL$X7V2924AQ>"#=[B*:7^7F6X^A1B4J4(A0#_9QPKZ,B/#
MR9WT-M=!'>MQW%$B7_+S<3Z4BQ!HV/#:Q(KZ2A1^-5F^!; KX>T]?H]E *-9
M4Z\RUK!.(T&<?_E6XYGL9-/+*EW]R<Y_#7[N7U$A-06MJ+8FBI\98>R+2DG6
MFK8'@C.M]4'BULTJ =/B\FZZ<157R N.-K%K'J6HK*LDTH55I9YA%3+.")^P
M;T-U+W37XUI6B$-HT#%CD3XI']SP_L9VGNQ:19H$@\%V7KK,5:2IN;[#QCI:
M8S:_E]9VS$?)#M2H_5&,:S>K/0$F.LG8IF[:"Q/QBK A,)7OBU=^)EG!'&<9
MW&$)3&%I?R/"M2SU>_3243:>(P8"74;&N4RP*U].(4S\V</:%.-0LMY)BX'&
M&$EB_!*EPQ_62JN2FWF\-VG7P6O;CR@4)&/4KNNJ/]. 5GF)3J#MSE6RF6XD
M?R$[ :9)],/ ?>(F)=Y+N8*C!:-QZ E_<?W4NRH!=YS[ Y[,JM>)!M!)9'!W
MEG2<H/6*R012DBGGGO$6O9>8[$?5Y^=L\(\!YV?BX_4BYQST[:$/W=7KF@4%
MU&9%Y:+7LXZ CKZV$.G?,-IUS\4'<06!M@[%K>]N 4,W.YB#N/V08%1)[RV
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M&CCR'ICGR__VLXKZ;3L4$WFE6#$.3I_'AI=B; RS=:8K-ZO;/ZVM?7V3C.9
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M;7#BG>P[]-W^*E<WXGUQ?2].:CX%72Z5A"Q"4[UGC2E9Z;%2J!?3LA93#F/
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M>[L9XQ(%JO"&'_N_W3!%L+4?ADHAU)9O*+>,<\5>R,/$Y_59%#EV70"F]"#
M)2^_?N/"<6'GKX[(^QGY[Z>\ML8LGC\]?JM()[29Q?:C::J#A>XSG7P= H3/
MM:3]/$8(+JBW3U26,_7RL5@1&6/L[;?8_W.'@&(\6'MN,A5^-FCX<7/$CD-.
M)_7(7",@[X0EV$7V"2JGK\^?DN<!T'GX2B:%/D3+YG.57I/M_?;49#L.NV-U
M2#:FX ^O]SUOV.I*;5@<:..ZUGUH KUBA^2X,9R&7W'O?L@#WJN?]@4MQ3T
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M#>:=3+7+K6@L$7 IQAU5L)G*A+(96!?+>SM_@M$K,G.FU#T0/:-;'J<G>6V
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MK 1IO;"JY8F@I[-#[GO?;5K/<W9MN I/6'VDPP'CSTK=(4.-< 7C+:;NE@?
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M'C$*W;M!+.*.[V1"[@7$OVY8/CKS)@#G%*?M**6I!>1:K9+OX(].'AMFHQX
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M=_[IO?RXX/F/SJO/$^H1%#=3/PJ4NP1EAS_S'V+5K[,!\0/>Y/O5.A"*FW;
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M53 "L/!G[AO05S*)&6O2]_W/C^S#-OJY8JRUD>UWO[>8-TRNFN)LUHU;U"Y
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ME-^;!32:A!4T#%HL96PWWNGW@[?9]?MPGYOXR#Z+\I"L?^\"+9J8Y@W'B#@
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MJP9;C5B!V$#7^'V[@K/L0U@K[[HN[I>VOZV6 ;1*Z4T%@U* @5K9&<O$1^$
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M86;:L:FD3:;OH?ZP^Q5@Z%#-LY/:**_N&1J/. (RNB,F88R1_6!*B 6;<^^
M5I-S?IV'=-U]X(J@\!4@=28#GW-Y$UDXQ-<93["*\'UWYCCY6=<0NG@=>P6X
MAB@H[&MBS>= ;W?^V(BUB,>^P8M):%^Z]9A93+8T$NZ.#."\(Y%?-ENB7_2-
ML%P!!K*;4_1Q;/@:QQ\><B'Y)P?A\6>H=DO7WS?WK('03NE?V18IJ<?Y&V><
M)#:I_J0(HC]XQS[U"E!S!4 B%?["V4>!Q\WQ5X#755QX%YJD;\CK:10+UVL
M@2HJ7!?[)1U "E354V"XRD]7<'(6F];;W);-$?Z11OKWB&?UQ+0.T86OY+UD
MM,0MWP*28\_-W4Y'KL00GB=#Q=9Q:P=M@URV)/:06BK^D JN-NSGC#_2>'?]
M?:\CM=!%N/0>V,Z="P,2\W2@KD7EBCZY MQ^*R',=3H]9I^[FO^;;?7R+0_4
M^O3IS#V-'.V/#K'$AD\+P(.6U8H\A_(]T7.^R<\]LQ]]5@K:YHCB5P"2H_6
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M"\YU[IT[<V?F>^_/-RN_G;/.:F>MM=?>9^]DXX9P4\#E^PK*"@ ! 0&@A/\
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M"QT=AS@GCX"@B(@(([LD2$)(AD]81.C4",'Y\^?)+I!17;Q()723[J;0_V_
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MSOQ1 !7)O/$)=V)=]%DF:;Z#KJCZ>I*CK_U.KZ\8-FVI&'Y@[SR\?&8E=+P
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M[A,$>)$VRW]*,$^?@XC[R-Z_2_PQ#O@*4=P;P@$?'?%+Q*>-I=8?R0K6BG#
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M1*K0$N$ )UX<\+U[+]AWIZ@0/X8"<,",C3C,E^]L$G7K0X>RFHZW"C<UBR0
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M =DOCUP?AAN9YJ3?D8;&IFX,=29X0;=U$O'CYC+U07Z#I4F.1>V@K+[5\[;
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M8:Q&C[X9[O;Y.Y#<0G8$PAF?Y75]VJFUV3F'(<N1WU6/;Q9[CUY9]Z--JTC
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M[-L(>ODPFFG45#AH97'TBGP$?DH33RXVM$J&!(CG?;#=FU+N1QVBLLHNP')
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M@YMG@QZS1QK[T\\688<'\PSWVQ315V]0"XXPG['-W[0U>\ Q:%V:#<SX,'E
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M-&*'@BF^8,[\C<N;\[[&0Z.1]=N5\$PH+RY*7$A?#:8VMVWP^NZV'1HRT8X
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MIE2,R8$%XE>1XU47)(FI-E@QZD)"HA -&&K*K%/?=$Z5$Y0Y9!E86=Y-"+_
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M+IG70ZR*?V6#1RE[=(PP9!E-;9Y0DAQXK+G_=7=7; LNEVV0%3'Y43/6T(;
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M-U S^5J!$F[%6A#OP&Z T'=KCQ\WY7>&WWRV9+D+F!F]87IDQDE\9>44J_G
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MV0*7OP!='@\^6XW66/&712Z^CWY+?C_TN"%&_1MAZA,K+5AE):U3;G;I3LZ
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MX1DQZPL0Y/LU!'!& GP# _\._AT2&NXG&@0$V/=O8-\!X#^0D D9(5 $%8F
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M+P9;WR#!<=?;ALS""1\;\-!TWPOO45D^+  ;GS@:'(5+^&5!!;';]'T=)3>
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M?3P!(W'5$ #6"%DI00F#:9L>S"2.N6G?!9)HF5*&_'3\3S3!LI:KA'%N?L?
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M6OY0H>&!8IQ-EH@97<[S*%F?@Z*CPWVK= ]JL<L@$;B+Z *)]#SZ_;V3U4(
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MF?/7VIZW0D<^[ O\*/ 2>D=>G(G":-1,?A9+)3<VVHL5M&6X>\J$W@$HP>V
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M.1^P2_^Z]20Q&)?&S,]P!N6GH#PHK]Q$%Y Q3H.JVU=1'PHMY;-=<"5\' K
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M48_*&N<T'@&R84?B9F<WVHWGK;[8_9L2??9!RFHPUY61;BL1G'R@=KKC1I6
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MBLLP_*"?9RX#/)YT,(A,$%/%J%BJ'W4H%N67.A'^CFE[8/N1LIZ/GIYT+9P
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M)C"JV 3Q!-T**VUV D!CEC(2#J\\M>V+/GI_D?,R!#>=M##(GNLYHT^C.I6
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MQ_E(4EC9<%C??05'[IQV-DDP<8E]>/ 3QP2NV?_+AN_K:P AH<BJ L0.[Y2
ME]361(.L>MGP [] 2J51)S[1$]$:*'UI.96%K1DGA!5 ^.)WD=^^Y\US?N#4
M:#_,89X7:O]]X.#3/CPZVJ'_9_7$;)3+:)"PU?NZW)2%NV(^C/]5@1.K9)V!
M+RT15I6>)[?/G,&?OWI0G$<YV6:2LB'K=L)S>["YYB(I5^KERN6K>QR 4-L1
M1NV<O?X/O%]8?,ZZ-FK2J/]]0J8 &5151507JSDD,JXYY/)^L4AG5J$9*4@V
MD)86Z%;I$XYTX&TH9;&W#XD0YIX7+"KJG6!E*X;/K@LT!FXGI?,R ]V-Q@K9
MEJ";%I93NN@5$P6TDRPHRLL\EF?/'^WJH <JT;69^1<O%$T?K;5':;Z5_&S3
MYR+0-_;&% :'C7R='&V!V 8$V"6.%=;T?@^A815W"OPK9^S9[SOCBM$3FN^*
M(3+925N@LB_D>* *;@^%/AJ@Q1>)%FN"E^YU@?N1Y#HGWN96.8)@ <.-SFM7
ML<'38 TT2;G9*[/4.4],3L9;$D7BN"'U$1E):<#')M.BC)RL T\-*=P*42XN
M/@![!(T@Q$.03R14I'!C3EYV.R('6J?GVT*LH9/%;(2:R"K6V;*U1>DV9OA@
M-/HF6.=3 OJ,L+I#(U_E-C9G?"+0A1@ZPZ4\Q7I:G2#)@^NE&==F36,%8GJ^
M$Z4A*,7!H(:D#!.IK2D\#2YKT2Q(E'(.NR7_U)W8&4UN7P!]U.U<@8W50$J@
MIOY&.(X++U+\35)--"9#]8F+[:;)?=)@N%A$<)?.S9+3Y.%R]T[=-N?&I5A$
M=.P*Q!CV,N%,"4;:6$-]5^JFJ.:2\J ;X[V6@[N8!% :$G04AM] #]+[@%S%
M\^8CHVPIM!?"V(\Y67D^@3!I;,3R!!>X(Y_I$TX!)X'98\,PC2WH0Y42[W&U
MSKFE1SUD)PVJO=0EK[Y.\F]NVFS0V'F1CYI-=G 94A^DLB64S94U:U ^F+4O
M[&^JT[T[_9B0[T:'6DZ[?-??3 NYG@2\X2K>$I"2^&&LOWC@/OKR143(AR3/
MX$U2V39=GFN.5^_ ?*2JC[4WSBG/HUK3-#, )\5O^9Y5GC>3A'-.U(^+V-JJ
MO>>TL?9PI0 WI-L ?"QK- ==S;K\*R@E@JU4QT/AHHE?&QLW*-#FX*?4R&4
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M$'V8R'+%OD(ONE=&(]^UT*'SIV&ZZX>==4* 2H_P0CW<Q27HFRWU.Y3 FHM
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M7_-XIJY6Q'9IA'%[M.Q$JS_+S.56F]<)X'*8)O^I#1H+8H&R;\YK:]4_'=^
MU1LM1_^=\5(>G0==<Q8%U@_<7<3GU2'^:FO=NJ;>'C/*0[GV\O.NEOFN5Z7#
MYPQF%>7/6BW..WWSKJ*^5?Z1-45/V )/3@Y")^:]])XU CO2=";&1%WXZ%0^
MS6WR\L:NN02 >;'\5>:YP#*M]\6UQ<V30!<?AE$8%9K6NQ;XBS"%#]"CI7,:
M^7=2U-4)-!;VL3WXBL[!PH:29.HR:/GY'Y&QUGX@8]G)/4XKRV\H.@"N*V.R
M<8_C___488JVWL/J$\C)N$=M<9@J[%/""2JFIOF;!UTM_J-L-Z"G'R+13B>&
M4(<W894O:'BN'*0CV!D@1;\B1BHA7A+58%*2HTNWPGI\J'HI'+H<5U<G1YG.
M:O[XO45"J&C4>G9\3S\QS@Q.4<D+O7P'T10+R06O2 0R(#>5VJ<;D<=II-I
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M/KCHNG ]^@8U=H_3GLZWD+%\'D%OG1,EZ:U0))>E\9I;:"#^:<<IC*O=^:$
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M= ,BPY*(SK@DO1Q=EZN:$,&]-3RWRB^E3@<6_Z'1+J+6Q@4F8)<PD(Y3,O<
M=@H+]'SVR4>6D)NMAR;MK9$*VU<C<]&'6CA /&@865DMI6@QDD=V+A30;^U)
M>TJGRO$&F,K.6BQ 20!2I.GO7<[;4Q^,0 ,<]=@,V4*;],*:);VPL569Z$'A
M*DF-/PBR6$.9(0K'+&G/_C,WF+CO>U2"KU&]B1Z[6\I6(3#-  P5Z#S,!&FE
MQT-@A @I@_DY ""O5D.W?M)W/!;KKH<Q=09F;O!^>#W^2%]#?ZPX 0HR1>XW
MF8*>KK L:/I+,FVD'2OQ/;-B\.GF+9BECHCC=YJD_J=4M(,]])NE7AIV3?PK
M1__Q:'.V"+?E)VYH]1KT:J^EF5%*7^9LTXXQRS]*MGRQ<CGTZ/MIG;;?4PLS
MOW>*/5_@IK[3T5V=IH'4#;6Y%#9C]5)YJ6QT@Z4(]_;2FX0__:;B] U/J3&#
MJC47NF-1)JUYA :)3!UG9HFZ1?(>7,OSDOWJ\QJ//>W3W575M!VN0]S_%CZR
MV(P$VJW<XU15)!$XK5R2]#TFD;QX9NJ7NOXE.3UCQN@3VZQ)4<(< 4U?52C"
MQ>9;5"&@U>QS>_#-/!&"#L?TA?0^ , O(\S'QMZ_R8Y9<C$W2_FAL^@S&2H2
M^AFK$\EXX;%,W,M^^:SO,^+':;<!N.E6\/,RUP]<ED":2/&EA4=?R\^[7N#*
M_XJ>*;ZQ^JL2QR*YNQG]!]IS]+W_?(M>=E/=;V46+Y;DUY?N.5FM.N.NZX7#
MM,_?CSX[;1S?^4[ RX!R8Q1A#Q%L;P% 4%B4+K'"?SUF8MH[&$E2S=.&B2<Y
M)!EPI/^-O,R</2P5<IUJ9+Q\?BI>O6QHOUSF+G/"LNEAU_KU9YOQ>M"Z\N#F
M2(!E06!M[SU.;[SN"$3"9=QY%UL 0:%*/NYYP-< W)T5GIP<\R@&'N:OJ"%F
M)B']@'*;9T58GD,Y%,#C3 )>^TK#J <HZ*&:[&B(0ON=\3V0:R\U642F@O;H
M0+KH&=;N/M_L41''+RP@+Z1&$5@D=GUO;P+>W)%,'A=L8:Q_ZFAL1/C[]7*S
MPY/'Z,B<]*'LJPZE6Z?$>YQ$1D'DF[/PV*MIEGN<5])V(GZ[1'1GY<IW"O[#
MSN=3M**[IO$W_S%*'B64:M-+.!IB8_[BP:P#C2T#SOI;$S";W(W'W>G8R\(_
MA%[3$W7]9DA=(#<;729@04V]M.2;G>'+L\MUEPY,>_]!V$(Z^O/E/4ZQGL.$
M*D%4ECXTG89 =RW09E6.E(! !>=A/;UQI#Q4!"&VVBOOH!/Y_'3G3/":[3K>
MXHXP/L< FS/+MP#-_?]'.>I%L7['/NN)0XWO-;G@\$/C%"_C0,6>KR'Y*6\2
MX BU SRT&D^5_B\YT-$*WCV.3U ?62V'%> 'D$F\YH33\.7EJW0C#X*=[E"N
M6I;%.M+$NNN7LO\B$<6)R^*,T$. (BSQ0L1"9._^R:O_O'MBUBC28\=#"RBY
M%PCIZ+.AV"R0:9S@2DY!W@AZ +AKF.YI]"YYDF#-=EB_+NLFBAU9=V+L;C9K
M%&KU0D/$0HX>W&VU_8(FLG#4"6&[Z(M0*IZ8>S=[[O!GN[%[5J3+SH![ .:\
MPJQO1&.'^E]/^;1\J+V^F%G)4MK]KK5U<&&KK=?QRA);"!D[5G%0R31Y9:;Z
ML8RYBI[91K7#+S(E)3TKS5%'P^RR$1L6/I.2XM"S^=+-;!<J,*:[%FV E\>F
M'!P5-[R/SX"2,<C3=U 7V]RH+Q;JFZ7*_(A6(V+N2Z&5R_P>5O)059\"J_]5
M1O7K<BHT[M_HO8+.C2'7 W?_<=\NC=9QU'"':3R]QZEG9S4)$.CUA%3[Q?V&
M1KF+@CK7FP?&+5WZPR=L+6P-S$95YV;1!-"LO$$)6%/*R/@FFZ.@0U#3AS>"
M4G_&/WY^3?CO6//2#><=+[%L3&5'S[!A=-:08*U,N*2H!MQT,":+S^ZWX(F#
MS9:Q?/*9A)^P3W^)]X<'0MC&+9MO:'P--K)(>S%<V1J- 7[M^?U$=RA*YE3Q
ME.2-OC6N@T+GD%Z&794BN.[U%RWC3.0'RR$/1S'GM[%I%1,[?IZ:@8&6?7DU
M""4 I8]G0S6?L$9I*RL[:S30X]/"H*" 'RS,3[<XXUW-\T99.H 6'#W-ME5H
MX6L4CBZ&D9.=M+O]96=$C:CU22U4!NI*80H9++W5!W"Y4DWJF'7R(2:H5_4*
M)2V09(53W=E-#BP,K<MJBS'*2$OBLLP(TS?:]NE^;T<Q/Z2!8-/9D8]E5MX6
MH3O9KUQ>T1BYVP4%_5NX+RY5T?<X80(6C<)MJ-GB,_;PB<L,U(1ML2#T7*I%
M)\<X!:,^;J.?E Y7A64PF!$-@O- -K,3*VD*C=P#@-CU]FRLI.+'ZCVI,!T%
MG-;?E,!FM&&3!L/2>O_H[V_!T7S4AFE+5AID4[C-=O98<@'=66A^;IM!8,(,
M(@F97%J<M%:S+K8V!"GF%+J*3+=,??E1:*\R 2E/J,8P_AES-&)@5^BDU/Q4
M)[DH4.]2H5^$SDH!,CJ@N\EF+-9NE&AE;)9"UFSGU<^/0":?6H"L'&UK-69;
M5^944W)J?I?P[*C'[*TYN;@7@ MH**0ZVSM&RK6Q4:7KJ.@2:+?-\$I-E.F0
MM+X=@T:&8U640_<T+VP:>\BLQO!X8S-#OD]^Z/E/D@&P6A$E_M>",!7LU/I+
MC*AB_IB!6N&Y,9 \&ID#UD%K9=H4;FP8"(K!:)T(K, P+$I-;:!/ %YL<TX/
MB38;W]T3W9BW;FO/RKF=@M_C=)J>G-P]Z>HD)A4D!8?=.NU:%EJ4@]ND_S,1
M!.[_Q\:XQR'E<R[#1IO<C!.,F#\D-F P.(E\[N2P^GE,_.2+94I XDCM:_S#
M!/'3FW^&]SC2K45T5,.+>R>_R\$T+Y 9MH$@)\]6-8@Z\V;X62D44;<F2%)3
MR@5*;"9^9OB:\TZ9*+>Q;O1G6?O>\!>7RF\B>XW[\7D=]H&]]LN_"]LVE$=7
M:F3>"[G^@2R?%/S^,,=812MZ!3B\U/XC!B69):*[I3B_*9IOTRG>_-$/TF7?
MM $*"&H"C3S(5/T)#([6'$C0Z^P__D2(JJFRD(- 7Y.6Q')]0_9YW.-9]-T+
M--'G?J\L&P'=FS$#SJ5)_=E$-3HAI][F3UI9\QR>MC>K,LJ'C]XF_&S[J1G4
M__^Z5S.'6N+%[*/C7,*^"Z@!(6R=W2PBT>:H'H/6?XE8DOB+,P]M35DT!-'S
MXKE<45>2W(A115MTV7<4ZEK2G'VGVJ+V';2D^5!CN2LMUBZQNOC>_)%%3M,B
MK;R]@^"$(])D%OB%T')] R9:A?3)EWT2$*$3D686]]A$KA1*1[(C*G/ZZ0U'
M#=G&1W!&0/W420*$SYC7;,[:>6G;A(^) #:!S^<.IQ$M76L,NM/P/*O(:JHX
M,(RH\-^_W4@N#/VQ-E;/#+=5N;:(XU4R/OGBYGPXC#]"W9K%=;2"RZ1I:HM_
M2(/<LN_ZN3O>0=508SX73_+DA?C2J.M11!)?FDS>Q:#I679)(,DAD%?<^QX'
MSW +$YB9WVD"YJ%V39_B!E>XXIF\>M7#(Q##P8^(,9R;?4O5;(*>S0DGT275
MJ(M^CBZ;IA+?SK0\-1E@X*VXQ\'(W'?B0)_C/'B(AXO[Z!'!4R)B?-P'! \>
MXN+@/6?&)^,GE]5^]$K TNTS16)>Y8\C4DJ6UW(Z5C]7'E,Q"4+</9+RJ\98
MA42TWKT/"2NH7=LX?B$LKV=M^R$4A:ZNF5AE>ZO@V<[^L4M)45<_^$M",J+S
M?@[GR8.'#Q[(/+@=<K?#NUKK7O_J2G D\^PH9U*2\<GLA53!J87#7&6.= ?'
M/"15Q&D<<+=JL25ZC;R:DFG(+[EF/?R;<S7V>$+3^"0%CA=_0P?IN-YM?3SA
M&*FSM/&R#[#T(>H>YU*ALWXBR1S*2Q.H^YAB+@JD]+RC8MY"@03[ZC3O,0/&
MTZ:B-M#B,(9OY[5.;DZYQ'10S3W.5.)ME\RPQ;GH62G7#B\$Y!XO>OQ&Y@9%
M4M1XCW,1?SMRZ\"X +G9N,?Q"#+N.:>XQQ$/6EB>JOP_:P6Y:9ZFW@[=.C$N
M:-YL_B\SLG]F;?]MUADT''3.=U83Y,9XFG,[< M]O,.F>8\#,;CX-[;'$Z\W
M*J9EKE.OEF0:[)?[,X+(@DPZ<K25,D#P<KW?//<X(4Z3M^?A@:C8YDW-<I#G
MM;8%1]V7$>K4B<M,"7]5+@9BW#NZN1OXW>.(BM,UJN]L1V/RWFD9F&.>?V+Y
M+M7ZQQ!IZ91., =O<(:!R5]E#NG"&/<P(T@\@?4_+;U_CW/S1?NV4\+B5C.O
M\#S5XOQ?+YF- SSN<1J#RO(LM(%!5QEMG6U3H]+Y;5M\_Q4,D@G]D#;3M@/7
M7<,-CHF!73_\K.XWWX[:\(Z")NZF+J3'V]EG$->N$2W)[/,R<P@DKXG!ZWN<
MMT$0OME6@AN;FY\RE*1WK.%PU,-D^,X3?L&XO3$-^,'=3':/E"2)&R:2$).[
MW$<?B_0C<7=N;E[1Y![-N&%Y_-QFRV8Z'2>55Y"8],\I@1M>TRC%"YTQ*=08
M_A,\!J4U2LQJ^4 [9KR6*$30EA*LY$I5J5%-L1_EU24QR*$R>DTA]<R -_\E
M4LV^$;?NIXRTB0J :0+7VLS2.QIDH[@1#-#6>Q!$;T5?@^AXJ:4L%O4'[+I(
M/0TTRS%* \4Y9B^J\]I:_LUT<]*)B@RGDGHR5]ROLF9L+(VACN[M_.)HA%:Z
M,)AK+REV6H_ X#KB@PA4A? 5</Q].UR@+LG:DT&<49Z7EL9.C+HY,^:"-V8W
M^RQWGZ4QNQ#_FA]32,YGH*P+]8M3ZD#_1]ES38^:BCD:C2)ZRR80:#5543S:
MM&X?CY5_)X8:;VV%_D72A@CK@"LGUESB,VC!ZZ)48C?$O=THL]^K<=K3,QE[
MW WHCRT8Y%4?325VNJ$U&2!O*.U<J")<S*,!3WA'KA]P\ B'OZ"J3*_3$;XH
M>L@A'B##T2]BF+*ERB(6& ')F,*L_-,GA!9/NC:.%]R<_C$J\D\/A,IXK5JT
MLIB6!%X^(A6(.HS3LQ),\O8;'C"P1]20WW"0D21T/TMO+)4V=UA3A*,R?F00
M)6>>=E>*1W&)Z&9X-/SMYA/)[;:1P&\5LLJL3% OL@DC^F;?6V 1SFWEAX#T
M0SYW9265)!W93>R&.99=7--$,K.L*)0XR8-T(D0!%39\U.S/8P::ED19=%6_
MI!M_!ELG-N>G]J"S'$ /-DUFBS%G*J7N+4_%/&@D>-ZD)7YG..Y+S^C'P_WV
M$T_KQY@TEO%KL]W%M\LIY=N'[CJ>U%YOV,16J_+@P[I'(\Q"HR>E3[I]K(7%
M3@=%5A.^& -8-]$J)V,T\/0LUH:":FTV+H[,O.E9%+B?_]6B3E-Q'GM-J0"U
M6RU3$RK,E6*W%(S%LB@U7E?3,7*DT 2YS#W].(S,,-"T4 =<%B@@X/$9K^,,
M!OKZTSVE9'4<*G3?)0M42Z%<G4'IZ4-Z!K"50DO1Z1CPX, O?XS=W 86X+8Y
M5OX5':SL_[JEIL%OA6$^UU[B-JH=J+<[38\&O2E+9V8&T4D0&MR\^N0*4U=%
M@YCK%@#&B@E"L&;UJDN^(@[Q+7-QQ7XC?5*RCN^-Z<#IC];^)9E(5RN$#;U.
M@44&;O''$HE(8=$ES9<7;J8[E)2QDXN4SM%17O)@P!\].&^31U@!P7KHX'@@
MY>NR)%*(F>BRO_4S2V_3KT\"-+#RP,\#CO,?U4ZB*?2I/O31V-X0$ C[91MH
MBOZDC]P(JA6;2\J%5U6X>Q<E#F.+"ZA[/C0. KIMS-6&Q6:UL'AA+W&469:Y
M:"B=OQ9 .CY5GJDPWKZ(N<=Y$23Q3WGGJE]+!Y& 6_C#7LD:35W-$PIO%_E:
M>9!">"4FJL9(B<CEO_UD+&;/E%0F#!/4^3H/5"D2H4WS;"EWS!BKN1+K@(RL
M'+ZTJN)"&M.WU(;S/\*,BCC)3;8 F+);6'YHG;2/'WUZDI"E7KK0U $:''U5
MPR\*JQ6'J9:]*O=6;S-Z[!CKK41G\5#)R9[O*3A1UOE;RQ=+B&5G>R%IDE88
M&D3W&7OL1-W*A0#)+^(6B<"&(97A#/DJDB<A)$GBL@.?MI:&1[6>ZH?4T?J^
M<K&ULAS=_I"!66VVMJ\<8^TXL*'4./9U@5$ H6/!205EC_+9&B4$\ >)DIP=
M?_5MP19,"!$I YS]:MAZH8>JX+PER*JF&C,&;I/QT\;T1X P2I*)L>.&;6OL
M3 <L]_FE]WJ=( ?OW/K2.YL/-L2<)L&-<1!+==#0"YM,D,@V'R&GHRI5G-J@
M.L$V>[8WEM"?:5.D_QND.;2'?;HJ6^>CK%#Y;_.6_-:>28Z__S/]DBK_IE\Q
M6$<VP@,]_$ZB XQ5%CB3:)>'YBER9*4D\@JJ5;3BJN2.,<*AF_UZFOLP&EFF
MG12D$]E%,=*XXB@^9X#L5*/U1&#J:("<:)6[E'5"8A:WE!LR0 _WV<X$ )%%
MAAIWO6_=;'?[/T.MK%R,XCWX"B3"R+A\CV+DX5&I63-B%T2V>2U8ZAPN-E;,
MA)$GL 2<^7WJTII^P[_SIEMIT@I,Y*TP/BXH/+B5P@FQ<E2ZT&8RIH9Z$ YH
M%"%_4*3(A7P7=]+X2>8RN*+9L.I851.*048*E[);,W2-)S1AYG>%XC1_Q0H@
MQ&&EP-0M):D/VRDW+\%,>!^Q;:&O/MDQ_[+^%2M1L)C-PQSF?(!G*15#C7F"
MUN"6%$/6-H>?A$A]O79Y-Q.%-"P,:<P260HS%F>(*W:WH8E#R>FE UA6XZUW
MDJ^?=@=%MV6A@CZ>"&33[F3,.9_4F0ZE2D?).:CW74R6?7)X.1IX?2=_9?_W
MR_GR">/XV^]<]S@E_P5<+=^>WT3\^7G6=GUX2;*=^^L?RYB\QV&^%?*3_6^D
M8(YD.:@W"/Q_\Z!<P]AZCY-PE_$F]W\<[#\^;%N7P<3;RP3\3W7%Z]W_=OCQ
MG\,@EEMN/]7KK4O&;>LYS669?WM.#1>WXJ[DOP&^98O_:N!GX-5_->!)QV'J
MV%CGPD.)YDI4%$:#N<! O\"AA7EAFVWC;'X+5K:P<6F3[TX"/JL1 3P/]1+3
M-BW>'L+>P5\W>>[B5RDJNGH_T=.P1@%01:X1*/U48-0N/0+*Y7\AYY3*:UJW
MV+8%BT!39[_/$R5F6H(7:4V7Q%@:AA;6CK%B:994!E-Z<6518.NG1UU5NG0V
M5!15\4;\ U+0;6[%5!M;"G?QC"CQY$F3;KX8#2MF#8#_FGE8B06]J,"EI.B"
M]J+Q$C(BB@YDJJ7F*!YW6E8;,36C/_1@Z\515?*?CNQ-.C9BG#(/I\VP;P8B
M4-2BL'C%/-FX&ES_';GQ(>D=L]"M!^U#305(%QFA)7&9!S-H\_31WF3SFTC,
MCP0M:7!S9>0J'UXL,FK4-=R-<FMKK'" P$#2/AKAUA Q1CKO6HQE^C+X-08W
M%=9!FI)LP!YE'W.S>:*3JDD[)2XO\)=-I+$PA+005B3G'GWTO'<VYW$VE$!D
M4'CJ]=D^FXG!\[T G2!+[Y'C3Z<U\0<YN+=>6_<X+FT7L7ZL8X*1PTRTMTFI
M\C0CIK9O CE-^I3!#LK+%(4C*M )\5%CO7,TQV  @E8IR$31RO5L8N0>Y\/Y
MC6) ^EA[D\\*D 8 8LQX0B.QBBF^'F.N?VADK&NO$4*'I!PP+U9R_D7-^J1/
MRX/]F$UB[\LZ.@E5HD<T$0]-%!8+Y<:#4J6TQZT6I(Z7BL-D/HM&D-Y-UH5X
M9>Z,!3M1+_.JSU^KNN/,AIY^RN:7C)2,;$Q?=3+1)TJ4]39Q  PZ5WW\TPDO
MZ<D.1>(&_EY/%I,D4G\#*ZNZ\K"1.V/GWYY5SAD<D+=#OA7"Z4 G)=0E"?YV
M^+Y+\_"LWOD]E$F?C&XE0Z1(\T+L6017S@!)7X%S]&C&!KW?*R2_P@):F,G)
M\IF.NP+^K,D*:@ DAF"F\_Q<M#CIG9$FR 5"'/@$DC! J9_UV;UPY<_EHMAM
M?L>+'GR##"G6SU)6>5$FZC3Y?^%DUX4_VLSXC@CO<2*G9VU1=COG<=J]&IHQ
ML>1P!XWG?9<$C13KOFAQS3BN2<J=J#-%S2?8%7*9<EL9XL.MDKV%#T))U;F%
M\,_;X>Q:#9!2MDH=H689D9]5X%\E0AZDH'A38(#4:#+9H=!7PMZPJXM\Q- B
M\6NYL55G5$+>A&)/"F-Z5D8*R/SCP43/E[VQSTAA2$;MV@,AZ8Y3@)R7GU3_
M6JD*[WN!PJ<V/*'(GO!!6S^V3QUJ 3MVV*5 >\5P"RMCL"MM%K/[4*VCW+]5
M2+4#3EZ'^8C:6L@5^2#:7/_*EZ$+X6&..LHQ.FR)E>\Q9./#;/:6^$Y<M7S?
M5$R;UQL,0JM0<Y.,4BJG=AO3/ZQ'Z!/2Y[[.2;\]=0WU\/H"BR_6W..CN>.]
M\TJ\'5]YE,QU\[!M59@F/Y^G4U&9>NC1L<H037ZE"\MT$T^W(*MIQI-Y5 G0
M89G V*L$W^3/"K[I7;&B B&U%HX^D$5*_:XAZ&CXSK=UV%-\(U-E.;EW53-?
M9"!E645]_C##=I/NJ;R :OG/M\NEAV&L' 7?Y= #N<FMWU;=(@RU.(OP#9:?
M:3(7/W8R42B=LZ#?> BP[]4-&.Y8\65>2PH^K Q&89D?U6@ZVQ%0T'HN/>L2
M?H7\$XPJHTFF]F6;%'@AD*MM48ND,ZGC.%9G$X-4N9^L<!FJC$"<48P*4-*(
M2-R,@L &T!B"/@3VVF=A9:PBH;,T]X-'F-^O(6]AK47RE +0-LD@=L. OR*)
M:K7+WKLS*:9SATYV-K<BR^2P92C/,) D;*6LF0JAWAPS6_U;61^YZEXQQ./@
M[>CPEAGU)J4\X_S!9AQXV+)*U=.#**R)"N04L,#"T$T931,^E[R)ET#U_&UV
M@\Y?$O[4#%1BVGG/Q#FI_+8SONY&WCY%[,Y_1@(Q7Y[C9K!53VGP+RFXI5VE
MC>P:%HO%T^O1*\<!XUAZZ)?XAVC3!N.D#?_]& Q0ERC.C1IO940*[$XM?5NU
M(-4.4#/J#T.2O_-C)GY,1A&&KS\ET3UAJ^/QK+<IV:2P[KE(>RJ"MP[]@; M
MBMXLN&Q-?(TF1N;O>1OAUE9.M=;@$U@ZT^9O6SW,_-N+M^:"-A2+3UL3A@-)
M3U7,Y'ILKSN7Z,/(M-=AHF8IXN:;4=F5;SFS'NNW6-6@.)X38>GO<E[N9I?,
M#Q&WT@\$J*!P5CU/.^)U@I/-B](\%=$;9>Z9E>&4-.:!-2$_3#8ZQ>1:V;8?
MN'(M4,!/:_0M2:JK#0FW&0!N:Z2A1=RBK<2V$V0.R*+I 3+BHM$G2$7"J%K6
MLUT*G"1F!_:68S9.W7\9P7%!02,U <?+QH:6?7U4WGGO=MF^M+;LT]PSU&%M
MP7.>>'RMZL]O<[JFQ!G#*Z-6BQPFQU\//BP5.-Z'E?+A=6QPV"2P#82;R8**
M@<D]Y?SBMC\EKCZKRCG!0T@2E">:_#$?16IIH12/XX#BS?H\C+KPQ-Y2IW_B
M8T[Y7#."5JKB!^.(@EWP1FZ)Z S6B)EKF&MZ;S,WK+CV>:3KX6ED%G)F()?H
M+<HRK?D'$5JXZO.Q0K;$VDS-M:-HOP(+';?59\I[' )-;K5F;"A;1PON;-#^
M2"#ER(B,+1C?TBD614FIN((XV[8?%LSH'JK] .M[>Z(QH.W;CL8@S?2,6>>K
MV+*;'OP[H/P^U$HT'$Z%4-WFX3H2_'I7F?:\FZV[CX;9=%R[E$"U\#=FUWC"
MA^M)*HG48%/KHN4T=2H3QQOTW[Y0VO#JI%>&XM4>T+_="WV!M$HOBLZ6R7^?
MMB>_E0R(S9?S^6H*.5@W/\$Y%(5M$\71AT%0CRM27M^XJ$IE4ENOOWCDW!(Z
MQVJ[G)@)0@,I=.1TI;5?O>"!M8BDVF[1R[L61^$KYUOYZC5^6NK].Y5>/U79
M"UB=XH5O'WSIMP*;V!IYK,<+!>CLGB7'!OT7;0W<7I]$3#(F!(F_1N!2OL0(
MDD!H6IS^?>3D@Z#/M4)E71?RWGM)\$?0&RL/^E1B&U"X84*&BZ6P_:1PV[)K
MF):.H.\4 6FU2DY+0,!'V"Q-8TXML>N/NM_MK_? $4A"@E[H1[?#*?8;#I*>
MK6@CN2A5\3!_^6D5S; W456UCN@P(.S5^M3K:9*0FB]JK#X%HN]M]R):%PY7
M7ESV["T*R7UK7@6*_GA4-T:N7:JK_P!733:OL/Q" 2_T-X#D-8/JUU"54#*'
M:0+G$I,.U=XD@%J7^JNKJSGV]A-\I@2G?SE"<T#DH:T6O;B>9\ VC/!-/\Z^
M>PU]$5UPJ>IGT3Y%@00$"?ZKIJFY;LX. >^8N0>$DHK7.3[-EDZ#^T(QBOVX
M<];V!H_(B"'X]4 S6::ZO$+3-^+"PNQS%.B?%!,?INLH0@IU%"WY]DC#8A7Y
MVIKXU8UM.KB?%@,>83 I#VN.Y>1U>;G''?+X0QCQNF;=N$2--2S;IE6^+Q/W
MJA4Q:'&MQA<;W>/\SG2ZJ+^<DS_7Y#/=S*&X[&1-?* D2#U8A#U#N>?^3)E"
M4\R@ HY%J-;^Z<CB)\:S']BL)6T+,H6I8.$<GVKV \^T^YBN6#/GV52E28MM
M:ZL*8WA\=01_F.46<T2ND8T[V'ML(R1OOG:S9$:0/NHC+$9T3&_'Z#D: "Q
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MT4@1S"5V%;FB"GS,#ZP@-TQ0,L;A%"-BH74 9>034"FEQ,G6OYI($"1Z72\
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MB(NWD!@I@+;QU1C;$ \!Q<M.&$UP##CJ37:!@D*XP!XBW!DN\C@VW^:GR$J
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M>**SF 3*$NJ4[).FE3JFIM7JCPEC.RG.D%ZF0=MX;%Z6A>A@TOWPAQI:\B5
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MNIS%M*KD]FL3"S-3"UK-"M9)!ZX1A<PEEMQMDJ3F!M3AVQ+8A,8?-I4XE3:
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M$F&Y5T%>S)1F)-1:M?[8]IIM+JG4NKYU">OUKZUC"I4M*S.<Y7QHFF6G%<]
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M"454HIT3K")IUMPJ22D"U*WX0XZI]9=77,JE:Z\T!/H]XH34CX/.5]Z-?/&
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MH6VR"UGR%:%USKME%+7^^H8 )2"AW,#<'6H,(,TE8.=.4;LM_'36#-S*#0.
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M /+?R?\ WQ[7_P"6_D_^^/:__+?R?_?'M?\ Y;^3_P"^/:__ "W\K+ME4!Q
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M(8AQ)+A+F+8"49(8P=1*B=+4IG T'<.'_&(CG2W#28>*[Y(.TC.$<G2L>&H
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M-)*@4&$^/."?O9HC+$M8[IRO9U#L7CC1[UT)9XV0+N@&:ABXH6 BILG67S;
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MT):)GK+9QR7B--X;&T5Y1;$A%SM*,6WGO;B4.'^,NFS#.*<&5I;L S"B(B8
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MHY@X# L\#43&UT900C-,*$H-:;3*3YU:#Q<V?-$(64I:!%Y"4QOXYV/+Z&
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MY>7^[_L=/ZNQ68K!:LK;W?@#OW'!^!P,F\7OF7ZE5>VX5>?QY33CH73A^5+
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MQ>5KTWGXEJA=AJ0@E*L!UG7;'E4;C%#754_PEL:/@H%V.+Y4C>=OXKNW X<
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MXNX+7*=PN(3ZS[R%#"-8S?=<TRR[D;1%19@'E).0-Q^"B&+,$&#Y>I(U\'U
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M=COD@6.99SRWCVS;0:AM6^S)OP%,Q4IMOE0NXC+,H9WRKE" &8)=@>UPSSI
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M-/I$#HXH1-ZA.6/&,3VK-"U\E1YJ9.Y)&TE">/!^Y>^GZBA%SXSC:1!Y7%/
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M'$J$Q.BMPK@G1Z/P8:$41/-6DM*/U[(K 5@;957CI<^TR[T-2E#NTIK$$\7
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MA!I2_8/JLR<H\!/V?<YCT##9;71T:5.5]A>;3!$)OJY+V?D<P;S R)8/#K]
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M:4+U/8S;O3D%4^1)\S T!L0JNHB^BZ F3-8&_G(H-JC_KO4KHT;>K">%]C@
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MZZM<_+*<=; ^N+TO$DZ*/H+P;*ZRN3@1A ,L/7]\Z(?C,6Q<T^;V:HQ6::@
MWF1)?LNH900S!.7W:D7L **1 (R:-%650L8S>?-]0(/%_L-EJ^6_^AWX2]6_
MI]<G$H#MBLX,^ OY?)\XA/*9N&$'1(DY,I"%=XM!S PC&5Q)C@X8**+?,R7H
M4K -!.A&?>REZRV&*,QZV?O(\*2\NYP]$S0LW@PDA@+%Z;BES5_B(3>N5J>\
M[2I^"@T/C'.=V7U:\YE^^L:_G"S3_DJ#N6>5_1:'R?4]@D@E">J_P4"KGY$F
M]BVHJQF^+SBJ4"H,XPR;]#B1J6P&4#CT[7%O-G!F?GX,J+4H!S:$]\'PI:<Q
M:^5*D.&8?V6'["9Y*6H.,]G,Z@L2DPI,$F!$!ZU5=-/<C1Y^,19D@!"L"21B
M9L/'7]:6/6Y17_X/VVT9U883=?U2"BU6**4XE!9W".Y0W%V"0X(4@KM36MS=
MI10GP=T]08*[%7<H[M+[?YZ[[EIWO>O]^/LRL^?,G#E[_Z$]MK:M<%5OO.:[
M:A]5>FM!I<EW1/.:AON!GQ,:<)PK3A4S;%@Q[>96NLMJ60[.FTL9<#TGXO26
MN9J;=FEGWZLP.]S^0W\C\_())I:B[ZA2<7N/W7!^U0<B@OLNI\97+'MP!&H4
M8A$ 7M;_2_@A"2\1OK'_W?:*70@:&*:<X/#<-"41'G$O=EL&.*Q>W=VLUF^)
M,]>N7&P,=?L\R>ULT6*MIYHO+['O7TAC\G"S 2GS_-1PI[ Z76?JJ0?.CPD_
M%Q5TVT>!XZ@FM<E?2H\W.PFI]AF-5H2F%KTB+P99UW=[^[^5/SG_GRE@906*
M6F^$MZKI"ON)CW</ZE8;2#RX=77,(Q?NSJVS#/F>,T!'6V2@K3\I?]\4UU]%
M^OBHN*7&:Y"GTHJ5#) 59;2R^I-EA.G7VU0GZJI6B]6FUD';C7XE&>("+:;G
MI][JXQ1%E-GV>><$K]=^55<IN<BVA+%_<I';F ?LGBYK3(<5D(XT+V<0+[K;
MSCK;R3S[5'W^T_"*('TM"H6XE+3G4,CA)[@P=<!E88'V?CTH^!1EZ>0#4WA*
M\A"DN%KCX'R]2PK[!1,1F%]R[;=MN<3O,J-VM[(:1'5S3O8@YSAR+Q; =TLS
MO\V.VU=_)SMQS/V8P<A1$*O=><RGVX%NQ1(6UP"<UBM7XC*XYOS;-^71K_R4
M<=^\2P2L[%=PI3&J+'&H8(3+EW<';HZA-(Y/P@T&B__S6%_6)&>H(;W:HMI+
M^+P 3IE&I>J^S[^MZ\<_<!,05!77T-R;-2PW;56VVU"Q3-3_0Q%Y%GFEW*,\
M=L(ST=WYXPXQV>\;@EKH=[$Q#1.7EW-YX G/"1#1:=//>N)=*H2L2 A=;YR1
MBQG9,,9>BH6<;P$2BHP225^3=W"GK[X%41NB2=U-_2V#G)-2*6PU#Z>]G3X<
M:ROV50X_N7OZ4VM\TW_"3KB$LTIM[&K&(VWV@[_W\7J"T\05);1$\O"MO9<1
MG^2[J%7:"AQ28;=;85F:=FGO "I* 04+.Y,!WCL*AS0<0L]/W<1&1@H5OFRZ
MH!M[&E2GO*$4^*K7:XT3_,NRPWAWPV],,U8T?ZA[,\7=$G_&J?.6_:0A=E'Y
M20Q>BZK_((2!NIBR;WP8#4\D([N: X$4WP9DXI%:1>9FD5B [/!K!PU5Y2A]
MK!+_U!$R->2FZ26X&,_-USB0I,\+FYPMSG4\GA7H_- /'XFR3C1+$VV[C7WB
MJMV.T-G51AMM*R04Y4R:>L,O'^TC1]A+./=H(6P?\7Y^Y$\ Y=Z=P#LT&5]P
MO6RFQU/>^ ->%"&I!>JHU;#FA)01M0;WM"M:B)6H:)^P4KNT#>P(SO1!*\J#
M1=2E.-2$#JIU&-V;O]V\W)*\V"I5LAMCMLD0LJR2RO<P*X-LL&SK<=>,+S^0
M1TMQ=C21Y.,OM[!PI6!@T4NO?8)[;2*6O0SLM4ID['F@ Q.F(5&$;Z"6DE.&
M30 T,Y\;QAT_Y,<X->'P3M<K?1><Z[RE9& ZFT@=_G(3Q8AZGAY5;)8^TN4K
MF(_UBLJ_Z9P=/P;Z7DVS,''8RB^1S%FJ1VPUMRV;3W4R I^_N!%/'DVJN!D_
M/3QH\;&,?<6%<.A'R,6I&,U;OYM^"; WE-(1]6Y^8Z_+Z!&>\Q7/1(3[]Y?9
M=U>+)>/ZQR:G!<"8@!ROGMM_*%=I#[__H1QZ$XVRXAJFKPHX>)I^[Q-^$^6$
MYE?&#5)+=P4R4Q(.=F?++-:T!$U_C5/_F7$_SS.<!QX: @LZOI)P89 ">#38
M><C1WC<D&9.71#A8'=6-PS<8M3O25/2P3+22LV #>(N";MS9/5G6;"Z@^RC,
MU-U*;7;@\+O'^GNHK;G*3H#1P(YSN,.;HD@]J#E%8A8?RZ+_GV1I71:*>Z1B
M_8OC]D_KNE(7'UN=+)'5(.B&\U'+\#QL@#G6,::$E%P?._BJS!O;TX8PT@'N
M,NK@-,0D7G0<LA+JO/#'*""@;S:IN)"K'1>?!&L.C75X)^2'OQIN1U*L9?'=
MMF%OQ.(N.TA-A"799OM@=N?:XJ]&S<CU?1\\A37EQ6"G"E* M:=^J5\4)SR$
M#<VWP@)P[,EM,U_Z0+;NI7A3!W9;1@/!3$-SHQJE<]2M>H."+,"C6>6 1?RN
MGR4;JOFO[2U"S\HSR 13']DLJJ98D^<1%Y?B2L %E8@.BB*-YGR6Z"P"8.!I
M+()3C"4*IB,3A=IN7VE49II!FC98D@W5HZ@T)54AQ0H%9AU_']YRGJUN*#[4
MW*\M@HL3L2N5X],4^GNZ?A*;YS+8_?B2='KYAOY&-9:H48T\'I&D94E 8J?+
M0>X0=+W?FMX98?#U]Z!^C1-%9RKS#\'$,7P^;Y:W&6V>5'%]X@S\)PV;<UK9
MQ<)?8N1,+=PW[I8CWU.F0//#.'!!_98GCXJW+*YOJ\?9>+7D+R("L-&1VB="
M'>;&ZK6$W/LE=N5,A(8.T,S(ZSFG^-UC'GTJB/M95Y'5,,%-ARKD>[\ZY'7)
M5,MQ](G(;-N7SW!?YEH_9:(.79=0,3L44^#N\NAV/?-7Y$[%4YM/^7IP^V>3
M74/Y+@7HDEI!;#4&M4;UUK%:JJ.0*^ZG7=F0XF5643'U@\;M]5/!M ?] -T1
M%."WCW.?,<A L0?E4 *.K2Q\J2PN$L+\.]6B89)C0EC1D<;W@O>Z2AQ1@V!B
M71!_"\^Y^\H<J9N]%A"#B.N/+B17K?BPY<T,JH[U2K[-%>MB94$B;?$(A##D
MM_P.]:#NY6*G*[]M<;'IZRU7D0&KTN>"[!+B/#!'2B0RW9YB<K1X@5FAWDM?
MQ]M8J_5O.+X5 QXRM24@JX4C$49X;$QA#"N*K33,'2ZD=KU[*A9J^(;)7<TV
MH%\']AE0*9@4K!EI5K/]'0OYDK5'H:J4#IDNA3^*)[FTV&F8Y,<UUOXB]:N?
M00@D+S6>7PG=#D* QFX1S_&VXP!A?D?2&\%=7+L=V,EQ *E^I#>.I4@PF0MO
M3?,A4&E$)<]J 9&^ ?U)S3;?FB6,'KT]H!4HXVUBK\IU=S4SUO&A>^]O(J_M
MF$Y%ID[&C')%YZFU5K'=APXIRAOMAI&5#8KYX\CLB,@!EX"O+_VQX#.FKN.G
MSM<L>3:&.U.ZMG!'^",Q%6NBNV71.U-2*LSQC(0ALYI?9SWK@LR"V?J6VJ")
MEQS_K.]CQN71R2=N=]@4.1B(=H-&B9,F?D!R2RB"?:LOI46+71FAT;\T5+ZK
M>\O+-JERGQV@&,X&A<^1?^*F])6O[,(@5&DT&$Y(WS6XLZD:(S4Q&+^LGD&P
MEFTRCMDYW^?A^=15)SO^\3>BPX;5R8[1-T3-P=#5JZ8^7HKNNOZ5R_5VXI@O
M&4FS WN#&NA_ ZZ.EVNT:$861!3K1(7C_!6ZC*+(C)DD4XB@0$%_.P?GIRZ"
MX7KZT0=>P-R%+Y@CZ: RK>'0PMDFD<VRHB&F8YO$8 ;-WW*M(G?W:O,4W)(Y
MSX$ <!!JPO78@ZC(I0'-00J3N6#WMXQ&A#6DS,7N'/I5(1_30U3!^6$CNUQ$
MY]['QLR+*_]0F%_2[N,6;K6BFY+\-ER\ HS@RX-3,E'34<T"MLTC2F33/+7O
MI&2O(QL%(_^A %H[,B+JTA%;YQD^FQ#4CR85T7!SY@/19?V"\)+9RNX<.]E8
MCEI5@Y1 8I^JA?ECR$?(N!S$$;@;6%MD  J@GD5S>U)*80TS*6S!8&1QW_3I
M#K6L\;L[YD[SSPB]5'SIMRF*0%-OL'_7%Y#H'=*2<6BD"-A2HS'EYFKS]]B&
MW&F!:]HGDW=3LZU<*'XF>K(RD(=DOQ'KE,IL<1DNW_I+GVZ=Y0 #0$12VE>'
MTS ,)@;TWC*Y_T.IU^/BUY\LD:R(:ERMB3[0+2_P79Q6SU(#?8\"=2\8?$.5
M 5 $?'A605)E-C_1/>2)WT/C>M7*+O^A_,>T_\-5_\MKF7?_@Z+_%Q0OY_X/
M#9U)98R)>N0EF >Y)>XU;5QT=Z3]3E#B-K9V_J%<J_U#\8Q[E38JH^0/<)1;
MO#<D>_64D0B5V2 0;TC\<;_U/XO6_1][_G^<];^:3,M:?E[J405W:;F^W:T4
MQ^PLWL4;-0H@\/]_I=,_I*4'\IP;<H?6;0&:A/Z0C<L.!)2$52]5WO(EAX4B
M\O/WU/\N-[MC?LB;G;W[A]);^@]%I@TQ7=QU\P]%G&K\<4U\>[[ID!($HW$Y
MF]L$3C)]_F/XVB+B;QS/[85-Y6)2#$].,ZS"SE>]/>KD7;@^>@HUR-Q\!O71
MIF(IY8?<'\XF;C,'=L#MX24?\S!E3$&\"]O,[ZR1&GM3^G))6-\<EZ\GLO^I
M;!JX<:T<-%YEQ\+;*R3U#O.=4OVX#5/&\@.@C^=N+B WH;*1F,Q?M'FQ%-$W
M+S\=^%P2JY\O%/]GE[GT&- 8,._L73#=[I=7T$4TGNX$=MK?O \HTAM8ED\P
M.#+00D%M"(GV5/8.MPZ[N/D",,2-GA,LASI"[25&OBG4^L#9G$EYFA@CE8H*
MCQ:N(^O/V^+;@"$FH"&474 CT.7/H39SIL4O94-NJ-@6W/#%L>W9S^>_VA#\
M0W$,PX>3/Q'^%X2DU0[O9Y4^\'&VF*&\H9>/;D&DK9N!Q(0>G">:OX]:LD#=
MEP)HD^)^RRRPM!Q<&C>3*7=\AL (/E26(1W609%OR<I.&CO<)A.>:O.\3->4
M,$HVM1 L!AWQ>ATCF'J_EZ67JTAA^^><$30I\T;?[U>GDZ@OWN3<[6(3O/J$
MN>AGZ^-,LST JBSUA!P:JXM:WXD%$*&[*A>Y\ "K3%F*\IRTL&CR&9C_"J]+
M0[G5+TG5"BWLF5/@C1$4VUQ>?BXV;013F/YA%GKX>H3IA&^F0=^82#%U-U.Y
MS9V*[D* \.4/'L)L)IXT]#$!!@AC[8D($G]9)"^ZZ"U:Z3*9+T+M6^)D",'Y
MA5^>R6J!Z=K6Z-_733#OK5MU*F9JKR*='%GVT>$M\!^_AB&*V)#B[P9Q:<"3
M Z%SDATQ.\9S[<KRL3])0JK"K["_.:2O?$B,R&$PYO=8+4&C'3URR/KY2,##
MF--1T(3HLA<C<]9,9:,D_WOV_0D\4A9_;G9XM/K=CA>S:TZ;>.G6QY-%PC=+
M9?4+G[X:M9QDIGH;498RHPCK%V$V/4O+(DXBEKH3UUO.EU^#;6X(30=K)O.*
M6/+W@' /BT0QL53UB$J]%9(Y(K$ELAH>$;Z@)+)49D3*C>37O^XLU\1*%DE
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M4T2VI;&*#@ZKL<WM)KOYP8D<P7OQ7*^MD(T.^D,=XYTK&6E<KKRV@I-)8^:
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M%\G&#R-==/7YO^B>E*5B.J3'ZN]>[ ;6[/BE0+UT3<81U)8VKA7(M,@*_OM
M&J1'P)"*\[:]_EOSOYLG$^XZ];&_SWZQZ.A<\GE<8[7@%+';MQQ#/:'%(TXU
M GZ*6<<_OGW<6K1VI5\^LJNQPM"^R?P0 DU(2':C#HEULO1,T&?^,=9%?_DC
M37N%OF71O?CCJ.%6?]1N^]&[J8#!A5C-HM@!4-=?_;RVO/Z-F=;T)?V?*D4;
M,%^^7R%8>K7:<AR;*K;&4>4%.JG\D8FNWRMUH.H#EU1\6[:78P:?F9;&*[R,
MC@  9$9(;4<;.'[7K!<\/M#:O7K^!\$[JOQ3*JK91+-,#D]A)2RW"TE"P9RD
M1:BY604B'$F+(]8K42/U_!Q%,?Q^>T[+Y;!0RVSYN/_DD=+,SG ''Q&XTI;Z
M%PP0.1INO*\C2!]TTR;UH"&IM-]I5>F(J&S_ JN<&Q9JK6I(QHH]2@*G"CJ*
MYO7O"%I_&6OZMJT36F'];N1 P^R"#7[Q<Q*2P7W# LK*DL^K6TL1JJP=%FEO
M+84+"L!]F8RZAFMB$)=QM 8-X9D"<Z!S!M?,:AUV(8 =:D%X5'.)OLZ0BD^!
M0Q;L+K9\Y8#5GQ?DS3='\S9V"-U!J<4DQ ]7)"?AG)A;!] P<:AM7SYA8 RU
MC' U+QR+*7^7U<G]+AZ._9K2D53A2@8Q8Z$MM,&[GC4;:.!CZ/\DVKM_^WLW
MHB?M!I$!H>?G@[_F#,$;@V_!6&EN!PLB5))Y6:F 9LD>]UL;@"O$(01D-^5N
M$"_*HIM';2S+)]6WI#HYW1/7_N/#3(/%WX2#?F<R966_K0. Z'K8/N,I58$*
M86%H'XSQP]?*:L,"A3E:ZZ8)C;7]$^8W-O,AP9\6$R_1;,1LIHW]W:>CD):Z
M*P?:SG<Z[$:JWS%S.@#W8'&2$R%("5YUSQ*B(8;Q%/^#)5TA9$U^7GZ^,SOP
M[-GT'TI@K.$_%-; JHL\F(;P.\*W32S2"I"5)USY7[ZO'KJ1#WZB7K]-1#P5
MP\/=!((N.,XCJ,7'JRCZ:Q( V#(S-4)8J,!="ML3X>I0GN56WHC3[E^Q!24O
M[]E_%LG2<=NCOJ<>S+U\KRYL;;J[.:B'&T^)^#2J:.YZ*XKFMRJ*0LT79^_[
M<+XA*:&>K;$&F/FU-.0'D].0N@I'R6D-]C17\.-!VGX3*_\B))6%.W-"2_--
MA? T?DX42TS$VC:RUW:A*:FA5:(065#ZT^A]-8;H8ERF61@PZ.[LX89/6D79
MA4=QD+2:58_0GML[V),Q(I$J^CP>@(EAY7!@3_V#<8;@(MQ7P?.99+UI42+%
MVX*/[F=Y RB2/[85GI\/.1#!$197Q@,N?[IQOW]1W)NRCC6J,DS_EJ65GMKA
MRFTD(4*N36MLCG'*>NPS>%3H[!V%3>Q324*V;VMI^U'"=I^ 3CKK2:*'Z#R&
MD!SD-PTW,)4GTHKO??NCUD=@_7VI5M&U@3'CO"10^8";NS7 MO]3(&94E:JQ
M^:^A-,95-K+U#RXX0$ZTZ!OEBI#*D_QB!_$+59#XHV3@H\#_WT\%#25N$H=>
MHE1'C2*!0<N47[ACBSM$'ZU>>UQ>8#J1"I<"R%F_5RZCSSP:OT:AF<E9MK!0
M+J)KLE S"S]E,:B2):=:L!JT.V]4VD;(JGV5.+CEBA/\A_*6A"*E;4 SI/\_
M9R[%#N\WZ#C%-L4W0T4#MAA]'9O%=YB(]-J+@O!@#7?QB-I744,$LGHE(8",
M:]Q-*?&8Y4A!\A36+1=7R00\3I?G(VA+6Q^CSTTJU9?(*:%:11<^Z6M:6:_.
M]K**4]0NSS3!Y4_5,KU=$_R/P@*MYV1WS:8*;#%$AC]XCX:]EN/70$X9O+._
M;\(THLC#S?FB^?@0LCXH+HD7?TD32)*L#O*8P^9'A7W]\8_$KZS53-A6,8YD
MJ+ [U8"862HII5)V0\1#U$^F20=])+3?(TNB()BAY4,&?FYR942[I([' -C!
M$8*!N#PN&85H8;ZP5U=VDNLM\/J]K9+":0&U/[U C/@BXK_!'#[%AS-5!2CT
MZVBT"R(^"\W6=O*)O9B?GB$>@'RT([,K)AJRQ4" M_1C,\IEODLU\G,)2_?+
MMHNS9-6/9/"SX5M--XZ8;DP3SO5]#@_E+GP-I>>O+O!&I@4(4M$)-#26BT#*
MC+*BSJ:4SGEUVU#HYVA_6\NQ)L904YME=#72']/!L*]8)VI(>C\TX+ZN,WJB
MB>19D32?"A)8$HKXZ'@:C[#XV+_TAAH1YI$UBU=9S,P3(]<Z)K*4%C IVJS1
M,5&:PZ"Z[:.&_((VE/?G=, A14DU3H'M5TWX_?,EVN-_Q^N^]_ GZ_^'DM6$
M#B.>;&28$TO/\2J]!=I,FW)."0VO<C;,-=W]PM_!B+ JU*+<VU&C0$;!0J80
MKKCZ3)7<JRDZ[N<F*B$7>MB+A9Y,]U?K)2LUC[X>1Q3_4&(-?XO[ALU5_*8]
M%(3.H-W>,6$7D=/S/":2 AXKQ0:]#)MR>4_-;*Q\_JAY"HR0&Y-CX BQ26V;
MU)C<F]1R$W3/ )S?+U6S$JMN1$YO#.>I]+TFX"H+@%-DOX=YJL)F;)>(*J[M
M@R@]JXPKOJ=$9&-Z_S3GT942[4EHZH+!B=E-&(@]5_K;&_#7%F:<3,,#H\2C
MQ!FB*0^UYOI-LY-8A(2OHFOT%&V;5"<@,7SC^:%9 <HO1>ZNS7XFMN5V[$L0
MRYIK+D:=(H<0?0,'IA%L[!_L6<'F0<V-R1 1[0#/-$[!$O5T9O81$.">:.H+
MVSDOJ4M;9'N/]$=%"Q[&^?EP_/#P\"EJ86EI'VFY7IJHMR:U+"E-HU"+Y H9
MVYDR^2P^VC=TX\GYF&G<KD(*FK?V0&G]NIB=2E/$0IN-9Z58+#FEQMS?LL0=
MP]H9/?W.J56NV8Y:E3?*Z<D?CWIZ/Q3V&2!J/U8; ?ZR_74^#E^9RQX"A)1E
M>$=:>;4_>.'0Z>VPSP]9K!H2RKP;W+8%DKL[_@'%TSF<0$!\T*4:5A\[C!8K
MUG!V0K.I I\O/\(2NS,3/,:JRY+(Y]\=A&FB@O#,'.;MG/QZ*5I^X#S2R%J_
MQH^CZ.F'K^(Q$#[9R*YQ>/IX7&W4)I=QW8RL,0/9C2[P45T]^MW))*I)S0]=
M/M-4_J0P;S>527'.(->STZS19J.AS?+KRNZN30H*P0YY;U6$Z' DPJ)O89%S
M)SKFXW@5 M\XCOH!IP]ECQ&!P ?=8-BE\Y*']29='ON\RCPB):4W&PWL>C*M
M59B&1_KJ8FVIIDSV2M*IW7GAZ4BUT8$5?EJMG3'5\X["LHM5[U_O%[_7KUEN
ML:WWI(ZU5T/:C^7I+IH$B6;0]9L[]88WG1>/99E3L.2AV?EJ]$D4[F908Z1,
M?<.'EW2_9B,;+D.W^3CS,092 9.PD!N1":A U[NCC>>\J;,<O"<]I9+'7,KO
M12-WBNDL*#M=V'J$,B1IE=W'U4W@Y*#B;B]O(_J,4#QP1"S@KLVO:(2O)CVO
M W@D0*&U#Q8^^N]WG;'7K%+K"FR8ZWR2B)8([\<(A_^@H?Q-35,O+?<M_.IE
MT9A/-0HK%6,W (5)D.D%]XNOSFN:4OUE='.AL8Z&JP?W.[5O&]];,M#_RT7^
MBM0!>K"#JM&'B/WN6-G2!"W!*:&\IG)7(=GY /;.F.4SZDUO1T9-8F9'+,T_
M<(C1_4%RVK!_8/]S\SW(VBX@YDV6PN>VAN@E_.8YSH49N!B76*L?V$1LGOW7
M59\N H[A3CJ]P4!Y-;^_T295/J0OC?- 97.A?#L1X#WE%A-(N_VY73QS.>Y$
M;6&K(TF88,%_0?DX8HJF:7]\WR<@^"6,/3#E'\K\HMH<TU'32&:5F'=XW((@
MR1W2\Q0NJIRY561S:#O@D=/0:5)2V;$K?(Z,6L%OO*FP>.\FH1)]<#_LEI&!
MET10&79U1IZBN:)LG+M98.'?6='Z_OY95/A%/O<3UMIK/@,?THR3F5]F4GYC
M$^&4'AZ7V3<1N1_'M =J=^A!,D2YC3,1].YK=, TT YW>%!*\H?MAKN;S15+
M;_>:*!2%%8@Y*J-ZAPF8=N>8=-_0TUX;^7#F]J8 !MOMJR #W-K_D.T/[Q$:
M<%XV>/,:& IYQY2G<-JC\D1XV*&M2T(S8/E5 \LG/?S#0;65D6W\O?/K@Q(<
M2 KOTE/62G_JR3 ?<PO9,.[GX%2#Z![95D3@9"P^<E8+=D*F_\W@,3[Y!.IT
M]0P[^9J&5)IS(]E0+HOJ7)A9!V;J&E<F+5O-(M5* @O"3 :U&I/!$')[@J,&
M(<54V@'9ZWZTA,$>V8ZP]O/P]ATY.>K)<\F4+",:2X4$RE:%CZ\Q>*;//8=N
MPK?2<1KG-%V3F>7TC17S($4L,TAJ)=V/"O>^T3C1#V<9!UO0G-E6AC[R!7O]
ME49CIA\:D7O^_L^2G/1Y&F!AO65>JGMA(?$>I)SX* 4Q/ISJB3#N'XJTWN%]
MU*)R:]9C=<<;\%SH,M7C^H"[CVVM9"B>7!GNFX^8!:5B=7#QY0RA>0<JP+RA
M?I2I+V?YD?Z[P[%T&25YF<HDU,:S"!J]3(_P*PT=$Q_';PW3MI<0_-.#'.T@
MC<IF/ \L5(S/X>$QK<K#FB\VH3(PG>E*8JU95I[I]U3XNIELE.ZBC[>P.$TB
MMM A4:FH6TY9\SA'+6(G#/K-3WK(]>_X3>IO%>$&UYDD;+QV9H\]K+X+L, _
M#[^DX@9M=198U%4,L;W<AKZ;:*8LQ&;?6WF-3(3O;]MKG(N]&4:M6;:T*DWY
MLLFOWM02SQ1!Q.U4ZR[JU312UKLI*(HY4M-H#MR+68F5[!!)>NB?<9^ZBF8>
M=)#XSE$VF[A T+N8#@<:4*#V&X8?LDO\QJ'IK](@P/^2:%@2$$(6#>E+KDW]
M;\!#;9<O>M0,?UB(TD68]82-[I%>Y^*[](D.>.AY'>SF3/G(YA]JD!>8_.GB
M.1],M3$Q1GJ[Y+7MMY)@-Q KLCI0^D_O.!L9PB"<KPF*LV6SVM206FM/T_ 2
M5KSAT)/IKA-/OS7^C^L!>R0+X3DE9/$[K*3P$'PQD^JCY:U[KW)G GHP2E&_
M7P$HE.:.UJ++]WNT"?/6U3U78;649,:*]&8([#4PG9I>XL54(5)?WN X1;Z%
MA9@9/@DAXZ2U8<(T&QS;CU-=,:8SE-9-:T&2A_9J7,4$;/4EAZ,=#EFH;;FU
M]9_'U2G>&S5$--G55Z FE$+%WD/1U:6#0XMQWP LNZS&$XWOHO0U(N=ZRR%,
M +U"PH/2J%]<O8GNQ<D4?]W+^(]$D:%O@]U"@9/I$=/MXU[WRCEOFQ#M:I/=
MX0,&?6U=VK$]X\\FW7$O3:]8Z]]=G6 %Q02&6O\\.&;K8E2TXKW_9=U5=7FN
MQ*:#K?W'Y6L89B@/J6D^2)$44#PG$\>>5\^8>UY"6D(8GGF/9VVI#F]$D>?8
MLEE:10&0*9/6;9 AT.<;[1FO0G!_F)+&O(">7P"3)@D(W7X]<$/J1V:DBH=W
MR;03*9Y]'LN4EPFU%<WR2AN21/7!AMV#=[SJ@^AO=W_+M[WB#/AA(R0JD=4#
M/\>LW/!O72(R<IX%+&23A!*M>"BEOB/><9\-5ACKJO?^:1G4JW_G'CD^71[4
M82!DAYZ;M.3&%C6!26_\=K[,IYU43A/?'>4Z&FE3]CDB,@D_R(8#&#2M !TA
MCJITRGI7O.O)X:K?KT%V^X,0$[>K@3IN9E+6E#MRH(L)Q PF2!B<*5R)^3U%
MW4"XZ#*V&C''H_@E.@<\LG9%D;)@+\NK##2HPF"8X\;$KTZHS^*-*,LX9&?5
MJXX Q-8:='1K"_J(#6>?KU>XC!ERP54YCLTW?\_B%'](E,![V1-E_,I">V$V
MK)#8HQTE8=;_U[PNPZY1Q[W%-)5-Z^/Z<L:X!5O;EU'WBT5JN$LHKETK)O#)
M.H;9JWZ+24WU*Z^(\K5S1NU0$-B5[>RN#:O*><=E/J3%L:>REJ5V/H9NZZ24
MB4QV<E4;'"03;POY)#8:,>HX3)=J \8?;I]V3%=M528Z>K<3F6[M2JC]:R'?
MUQXTA9E:3B8U:[)M;4TS@S"PT87R'JXV>,S.C@RD'RZ4SV:EU"1KZ-3C#I0G
M;'\8GB,:[OUFAYT3;9^1B0Q>@@:2)_99E'.&>;U#JEH5X>2HEJI>C69&AKW-
MT02O!54D^&_6\6YNS UL<&<\$MK@UT@%/' *'"<Y+UR C%X'W,V5T(9%"VLW
M60F=0+>O+?O5WL-D6$,#;O1=?@4:$D?WZ QNUV*@ 1P@![,NFJEL%9RO2?-J
MV4UITM1=;CDNC8W\L8DFUT7S9+VI$KDX"G>X.GP[.987[>)3(%#6^)7 .C-J
M[4AHC_DY42T38F'[Q6W8POE>Y(T2>N# UJ5(B-J[P-Y+7.90=99>KL5?L%GH
MXJW%,MVFZN\=BO3OGCRNE.SF.]UC-,)ZB8(% ##=UQ1(;<@<'LM%]Y3,4?4:
M@4=DS2RIQ#O:)P]1W7(IP<R=]DOJ2M(4/$98I)9B"4<?@*<257,(,>TK.^N+
MV;Y&:$V]WO#ML"(\"(M)Q!^;."D>C3(_/[UGS]OC)!+"4Y%6IKV+XP"XQV*Q
MC#RR/&2I47]W@.I&((F5XSRTP-CY,(OOYK38VQ>R'/-1.]]5D&0-#*XE,ADH
M^LA%7+X",8A'4Q!4EU&C\Q@$<-:U+S5'CRG&?K&/.?+PI8M!+"-<'NA<\8YV
M3]25]?+>RV'<9ELX73PO]%_$$C!F/O/<.ZP@7='UNBI>S;,7^>A(%:LDQZDY
MH6141]98VHF1NX>6\SC?':="6+QF.!W.!/S8E$-UU^=1"6K=R^I97F&VI])R
M\]2QM9]B)WK/_ H!78R/K+26>@M3&:9-RF3L64 '#+7 %"2+;:9]XK#O!Y]6
M0BT%4;& /SZ/Q P+4K@_::$K^94PA'=I-AI^^OLS\4ZE5<$N'^J&!NLOAJ>Y
MH/4#E+""1K*'O2G2C(QL MZ2D$0,NE+RL3>$ACRAVZ4P*5*LX4]K)&N-/^HX
M1[1?EIE,TD^,1QLMOIGR!TD;E'GCEEA!#Y8E[:D/5:.2B9['"2PJ=OR73: \
M!2DML#J2?RA8]4)]M<U?>L<@^"H*#?I[@0R218PRP>+];MEUS,14SHTZR7KA
M ]!W<4.N[XYS[,LL%A%@)UXN??+9( ](32/SK*UV4^$2B!4SV<J:#ANQ4*^-
M'E?AT9;B]:K8K6+*WW(UW^D+SD^H1X=GQ(E1,""*(-]C:%='4+*.Y,GHHHI7
MC<L@4G7?T/9>W:D.^?*I97BGT1J?<("] F0X46<<O;,[BS0 [LC1:W][)QHY
M["7]7-]V[DJF5RI,3"TS<4[2)),.8F.[^!"DRQ6RS.J?;[-US(^?41(Y$HD*
M/#6W9@=/AHR[S=!>1(L^3A/VI/+LPY .RX-=_4 ]_N?X&HBU"O.RW-OQE9&0
M@0);HNH\[&C$3,5,0IIPT5PU?(&/YQ]*??N@%#<!"4Y_/P*F##ZV 5PA^D*C
M5VH:BLH>IR\#3$M4EYRY8;?/:@=IA&AM[HV-=\46:J"M$6\9*KJ(Y5/KF]P+
MWB6-WL/5SQ3IN%EA#B-.9(<:5%%@QPSHD\,Q'JL-?)4WXX3"G?QO4C-(:8O[
MJ.GB7/7C'B%]/:&]O\)D_- B>E.[+3I Z&D)\=[0;[+P65P\L&1__3B[Q/(P
MW#:88:S:8(/@'17[ZO$/P*D0/.FAZT4\?Z1K)_#ZK]IUI,9RHVW[@6B3C1S-
M\I27OEO?:I4"!\=8V7/)7^M82ZE$3N4N- D;TG=8BKJNS68\2W0 [O:&J^G@
M9.VJPG<9;!_Q*UO0;2X\^A_\GCLI.%^7%7:$O8>3>_QE/T-SD:8ALZ6!=3_(
M)CR0E@K\("VYL&Y7:W\G[KNWE<'ZD!(ZJO4\-</T)2+'][;60*[$@;6PU8D2
M1^!X?EAK3AEI(V2K);SW-<;M^84C,.3O/Q2!PB[?^2MP=(N<?P/OZ?.=L_KW
M;@7GJB'J//V,.4^$8UXL9&4:R+6K#=?6?&,*F1+%\ORH: 6BL;N/=D=EC!$X
M4#$?%">A@#4PLW[G&H"E>P%AE;_LE;KC&2[:^\=Y^CVW,HX?^5DBJV-!A=PZ
MT,IEPHBS4\+Y,NJ=)-U!@DLI8;5D\'RDE^FTEK,NFP47IZ<U&?.P%ZOP!E2H
M3MW6#4GV4CZF8H#/&>?1JE(.\UZRY?1VXYH..#)+R(YG:&I1O55V5T*:@-A?
M\@I"_Z&@@_^A3!(\=(+&=(RM.H/,,?0<H1MCE$B!3"1!,EFV4 6B)M(,8+<$
MTJ"!8X[!Q]Y,<4%K;,&0,H&%X0D'G<-2<LNN0EKS^"K[CO9&MXN!X"V6,48/
ME;>4$6'Z[%ERI>I?Z@F%4ZBB_8O!G>V6QXOU'NDDY%:RT_,.=0<E-XSWIAA7
M5^N+H?U-S%']&(-L\F\D:VZ4%3\-I<_2X'S^XI1.-MY.E-E?(8!3?X'@ONZM
M_ I@^367XV261*[1NGD1:,?H46?1">Y*,_:JC?)2O#VPH#9T!027;*J$-:M5
MQ/=3-)[>"+#-&#I)\AQ$=JKA("W*9^@JEWN:SAYK[Y[BO7 RF<1.:!X]\;S-
M=LHOK\ZI%I:$/=5(&KQP L3JRG7H9;*PA]1;$R+P6MED3:Y]15I0B1BQB/9^
MZA!T;S)Q<5;42=3B@]3OX8J-0(&0S%>[M=SOJSX]O*]#/:4^9=9PMHVOX?5C
MT>SQH@"&K*#_U.%JM@KFGEJ=(5W](-IVT8'8NL(IYDUE%AM^7I[B"J>1K6LH
M>-N*Y9M,/-H6ZM8N<$R2=#"KW]W_<E3T#P4J=';8W^R\8*S'U)T^BT(_'H$F
M6S$G_1.8L+Q6?QY5O:Z!I@D:G! B25@,K6PIDA&.LLXJF\:,D\H1/H\0GIXR
M"-(-9@T=;*@.5L%F(Z4$?>4)47Y.J$]XS;T<G$M \I23HO%;V!C48! 50K<N
MR9-(W<6A3/&%68..R\)7KX#. \A;GA8:^0M#-Q.C5K\D5[^K35$F2PX8PQ/#
M()44Q4?CAXS*F9#G_GJ*\NDLDN<B&<>FIZY_[E<CU9 VRKC-ZB[$,H[K]$B<
MY::FOXPHRVRI](_OF.>Q )M0TII#W1^>Z?W-KF00C8K'38ROM(]< +68RS\4
MZVD1/'^W\/OFCLP!G&,U&0X0O+U!QOV@-#4M_(V$+JEC!T@B;V:Y.*&*%"1B
MO%V>Y(P<V(&5[X6Y+9V-'4[4D,TGJ\B)TN;P<FD3)SG\$:3A4XW'::(!F<>+
M.7K'V&?;(:5OYSZ$1+R/V]E:G7+/*6!H*YY:Q+^(:KX-O]<T]*OI!49V_S),
MGDV2UJOL>TUR6N?VX"<FENUR/9 :58*L#[?B.=6?^P42MEE(O)O?9Q/8(Q/E
M=R]W_20]S:E58U-C=LPL#;9+'> !0WCGMTK/'D[?1X5')*2F+MAA[&/GK7!/
M\=RC+UG1C")8V5+LZ0?-='#_?&!)5EG&*8>(R[)ZU@#$@IH<ZLYV%JF2)I$*
MGO]0!KVI_GL*:C,7+TH9S]#YG6G!2H&C/@T]EAJH*Y/)C\K+S-T!G*%I(4^:
M=O3\N,D!X\CQ3*7M2K/R$:=4+_7ZXU,V7MZ81Q_)FS(\T#3=#&]1,0UU7?HN
M=I'QCS"7*H99G18%R<RE%@<O^\BC@%68I7.+?JQ\<F+H%$Z_^4CB]CFKX7<;
M_Y3.P0P/G"D 6</I^*)\N<6"J$#P[PV+0TK?L 8/O"_ N5X6YB21&X\F46%L
MU]1S8/+2MEW5XBN._$#"I'%#)TL %?@IT<4S)4'5MNE'T_$(M-"-+21M#AMS
M;400*SVN]FUUZ2XWL4L# ;+]+\71ZZ3R8>A8W^$EOJOE.1$=)Q*P:GD'7S-_
M9&>=R32RN!!0-#JLHFCWMS;9,WPZL5IMT& YKLQ,OK^DL>;_RDL:,,E%'RO*
MA[OR?K0BLR@]OF5TP<A[IM3+ER)O&'-<?\30.OP\JNW_ 2A U[^?RN(SW+6
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MB>:(J6.>Z>;MES59YCRN5<=?#'55E;$\T7\GG*-944\?70G(^!*LRL!133+
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MP@TD)+ZD3)C,1,C,3$Z26O>)T]>.5[;FV%U:]#'E:Z0 \H5CW( A<MI"R(B
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M[1614[50X)NH2E=A+&[Q:<Q(\8GIVKM %XA;<BI^28-=V1<9E+JZ!DGP'2%
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M76Z=83_XF/B+"4;]=G6:"]VW3=MWE&NFL:Z>FL?/Q^SZ?\:1_P"_QVO5)_\
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MNA'+IHH,R96[O_"'4G0[T)B%Z!$K[5](9YNYZ<8FI0:4U<77133+"@V]&N,
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M3N#6)A<K&(^7KJP1V1KQFTO]M2((OL7-:T?LPJRJ9@*645;!K15<IF_<0RR
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M^?A1Z%$Q,S)#WC62C9TSB>VV.P],AD?Q9C@%$<6O.L1"S&Z?N@=-?7\KQ7J
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MUC[HL?AVXY6N_;+*[L'3%JCLS*>O5?9J,GPVNSJQL#OLXJ\L6 6-X66;&*9
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MO=<!/E6B3*!2:JGC'OV%LE38ZOE$.MV@!XR-;(\NY<F!>*X#8(;E8T.?-I+
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M>(LVA#[1O-T7<:+A$M4A(FEBS,XGW6ACKK$Z<<I6F6):QRLZ5J4XY%2JZP&
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MF;9, $NU50S8+U-ND*3JTHXR=&IF,KGTV,=C+RLG2!-0V+*W"WG<BXT7*HT
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M%JP@6:#KQG;SFY2AF;5E(,=7R.(=0_X.5-17A:\KAE9%D 63%^>1E8Q&G?C
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MH[<NYR4-S=)//#]!"&=5'O;<!PO[Q=>R(&E?3<.*ZH$K]-'!,IGX$X3\DAJ
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M0550IRJO^<GOL_S-EG^7&*^!S_M-^LRH.74R_@OK!+ [(=J$ZOZL;[:R,^B
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M\&1D?"A 8B"ANSM)_.,=:?DY"T<=$8(M3$GXA&'HO>(SM=]Y;-)CY9YKP=4
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MP7.P6&#VC388E8!ZQQKTI)<T"H;I6^O<*6;?QBX&J7F\5NJ[N0J94[K>_AM
MTW.;-)9_2$$K]01&?='^AV)L$=3B_2PIR7_?*8R_+.J9]V18_&M599W&]A09
M;TVS%M;P1'Q7%>W7[N8QDG90*:=L6WKFJOHVP;6':37$ED-QSIT<M3W0ABR3
MX8'!>P_7DN\6ZF^N8+VH?'8QDOE@;9$4",(:=S 8N1BG-5AZNV855V>V:)-0
MV6OW7S(/K^[.1X6.-?[" V4<\G]DVTA(!A(;?3(V:#^!5'J%Y8ADX%!OH%T&
M":,]Y?;@J9NO>'*)M/ ,B/PI8@945F,E8Z_Q R@4&@C$]49UF@D#EUL:26]E
M=0:5H"-3Q62.^>,#)9QB) G II#5OK*V*Y:<HW<FC>2YJO%RZ/%[^G+Z]5OW
MZGXVG=&!D0@_.7L"*KT59BFGR'MKYR!AQXV8>^\F0G[*\SL/Q?,6I^OKN?L[
MKA#YF*E+WU2Q/$,E)H1Y;MWS=]0OK*6!._R#34DQQNR0NF#1/BKX*/ T@4">
M^32+EY'@J'5;X_+,YTT$4LA 05&R/?6<Z%(#1VKM[>5D?N5E8^\H_+^=44.!
MRU -T>R%$GYY10A*X@?0B@]33*AB+U\TRHQ4N:Y"]VQ4K\A/N$Z1+8'X>S>0
M5"XV!EESW(C67AEI8-B2ET+=?]XY1JZ:@D4T-3NVLZ+9;JE](7A,.@G28]3I
M :94+\UEW9]LC'5WS!^FL*C8YT:*);<EWS-YS >Q G^5EI(OZC6P52&$!KZK
M93,9\$\#DP"X$I=S?#.!'<O412'E@B4I =\:U=@YC96BB-G=45#7L>G&91;]
MF"*CK:SC729R0S'F,>;++SQQ=<OB<X 'EQ[?HC#XB5XA4A+4F2K8,BKJTAT$
M,3[SR&H:'9RX11C7#L(5,Y0X;9K.(I-WL[3EE%.BT[T 1G+7%M9PXQY2$(?X
M3&&9$A4T>M>%;]1B7V9Y@ZN%S(DM*L&84=E1X-JZV%$V,<HK[9:KH9R_9;I0
M 6P,B<0+!+"/_ZE7&[7F!KO^K5-]P2VW*P0(-\(D9]<?HK6^6,8Y1^:8E1&F
MV*G;76(;A@@I*"P$EOST\2,I<NP*QO\<(9>UGWB80K4WRALS#AB$?]0MBOU6
M&UK@PO)5G1(3K[P5S\PYG#>6+H3!+(G_(L!?5*?K"X5>N* 9IJ&0'\*G!5OH
M_B%+*=41>31X!>8+$/J0FTV2HK"6H:M%= *=#"45/ ;$Y#80U64=TZ^X /KK
M1:YJ!,-'X!_"93]]3)$06K2;_6WIM]FAP-;9;9,X#]GJNA2J<X5SR?XLR45+
M-1I6&_# I)"\L'EO7V\E=#P7XR&LMRQ@\+G>@7#/?"0Q$:5,B +1O\9GV1Y
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M!BDJF_!ZU^&OD0PAW\0U5@V3\X^V.64BPF#17Z%K,CTYK>[4/>^L"F(,W!M
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MX'2()^7><EE0KR?@VHV4TIR<V%*-/R"U1'&:XOJP"H9FB-J.8O^JV]P- FB
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MIUAC*SS.Q_9@];-V;Y>5IV<\O][?\0Q=RN0.A?],%_*W_0\#RX*]=M$\:C1
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M-R(<SG=1OW0PAQ[6DZQ!)]T^:Q$U G '5P$Z(ZW[2,(QRJCUW#:Z@",BS#3
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M=*0MA<!-@'5B/)>EZY[@U>.3*+G][E(D/HDMWNX(=)_<+!-QZQO@X4BE>DU
M\8SR3^8F68KVEOOVV(Q'+0$MQ\7%KLU<GHU'E0X($PKGA7E(M(#VGR,>-9L%
M#WM[Q8F_AGEX^54%@8WF$&"-@ V-!3QPT:U]V16'LC-)6A_PJGS4%V1K46?]
M!L=Z0!.<77/W&=(#A\VJR'?$LVCKJ1?R?M3+=1),DH1W30[+J^' :0P.Q1L;
M2.4J;X=9VC='JK.R_883*&.XVR^M5.E4E_7@ZI,C"N/U-IS-D@E;AIA$K'P-
M0BPZ]I]B(^,%#1H3NGH9P.B)J5OMXW,MCNUC8YL8"0&-.CL9:#XUK8K$G=O(
MDSD\H_0#TA>M*!3;K[0ZK/BU_H@T(RU9MU#M:>^@[;-S]2E*$F_29%A1[[<]
MV3Q84C,H"3]#*QK-+Y<^'_&HZ^3J@0:5?N*7I#)/"Z7ODJ(GEEL6QRLHR^'J
M">KE\Q/RG+6\IU-_1;07"J$;?&>0F8-MQNO2O(@!$X(9-0ESX!YXF;P/O.@I
M42?QNT1\9AD:(BD&&[22S77IT*1V82989)"J[7WIG!U_LJ9?PXP>J>^8#WA&
ML>!//#42C&_NLJ>G^;;/2+FZPW=OD@,9(J,\)#$@.R6=W]Z%NA1X>4:*XOW:
M#<]\>N?P C1/CX;&*6ZJWAPRU!*&&Y--DSUMWGS""L1 XA2'8*%@!0S0E4L'
MXCQ.?QSW('@=B3]5+HX^V30BEW7+;(S<P1K1AA+.4CA"G&+#M4@.N_EVD7.5
M@LK7E[^;A,^-Y@X!TU-6!=]B?QJTK%B4^F4J70MUFKQCBD#*D%Z"OYD21J0S
MBXMQAD72\O\:_\9]PA^6^7Z:"8(?_![OYT3#X)/";W;BN\]J>6IKF]WJ K=7
MRJZE2ZKM#_N&8\'"I[,=( >J^D(AN:TDU7<'(J_-N$^B#\EEM/9\#MQ;'.YB
MFDS2SE7S&6NR7KU\A5<>2&[;RFC]=[,X.[%)U!!63UD.$.UY])FQCCD>Z>UV
M3,K[6L@H*FSZYS]LC?4SRJ;F_^A4-XF,#,A(O*NYAC<9PNI)Z,K'37^H$@M0
M6-!J&4RB"BG8OQL].R++CM1+PEQ(_P,VK$6[:ZM>J8T?IM01'%C1N7%T\%7E
M\RK%Y6[FVRSLU=M!TQK::$P[ANIAZ.3DP!EK/NI4SXIS,I'92K@AI6R_H$M/
M:7]]\?X'FE=%] YWW^S8=C:J-M<X9TRIS_V7C$K[V?H*M_+7#-K]8_R4S5A!
M$7&9.6]KM=G\%XU#*K!RLHZE_>1\"W^MQ1E>9^A).3O73UP:K )N0G+03;$>
MLO3/E;/O8@!?MYONZK2^<S/DUL>T3.C%>=F:<W?$<ZV!NJQ+=PAI+PEQHLJ5
MBZHR/1.7A?)N#03R3-?Y#,;=GMRYTZ;,W;+G&2):OKH3.AN56=HC!_+C *2A
M[]6F!NS674F.S-OX<TGB; =T2\T2:E.KB*HC)O38(KG*]:#&WI4U^4OL"7Q@
MC>A-3/2JPAYG 7>.^/J$JD3#+7O+DR@%;U?=O=YIC)9YUMVE97#L=<<5;G0D
M03>OL<'.DN'WQ*Q)-91<XC6J1$FMR 3P>RLCGS29;PWM5>MN.A0VO5NI,6^%
M&> NEERMMQ%(^XT3#^:8G>P]!AH?$[WC>N-BQ,?KHQ9'^=#"8LZYZI$@+I^#
M(PZ&B?0W3/YOO6IIQH0H53%.G<EM1ON(@OJ 0PS?QN2EIWPW"=R01#DV9MS>
MVG(4\,\VFCK,D]![_'FZ%"N-%OO@&UXP<&C.Y?9[:GM:G'OL]I'=A+G-U@2>
M.6_2R&R0V##;G5,ZHQM-=FOL'SQLJ";A]AO;E1*TXT;-6E.!NA$ARH?WBWC^
M6:3"[34W>J=+R4?6I(,;\Y7&- ,93W6Y78<%X)0?/[=[7;R((T%<$K&5/UG5
MMT^8O\7GN7D=^%3'<HU[.&A@"E5D#M286"J/ +<3[<JR\_6L/FX<T[TUNE54
MI(G35(2UJ5%A5U:S\M4L=^A,3U>*,V3R49^T^N8&C;;@RM;5?_[=1"PQ:NSO
M[E077C=QG@A7C*O&"(Z#T?OQPJ5;+P3;3GP@<@!W$3CI+(F7&5C=[EM#5CL.
M""E'EV!P3(R5CJS:<%"0>*]6C8H3UAQAY1R4S;[EVF*O"?/DT!TWE^ ZL!QG
MW%XP0EB&E[!J+'.-O(7&UA[?!+,O#N^XD Q_P2K]:X60QM@13JK@LQ4C2Q[3
M\JGN/2S9H"EV<45<JRZ, ?U]X[K;QO5TM@*A.24VIW#+&5HFBG@G(S]*@ Z9
M"%P_)@!'FL=2*(H#GB50]=D^*T 0(A/0JI(SH\5LT9\I>%C2E!6PF,F 7N=]
M@)I_%99*HE'@GM&!(% <EEN5N?<!-!DF1T![;WW\<Y2:#7_J+EZ>:3-W;-GI
M#P!_D@R:-_)C6_<'90.'UFMW_FK6ZVQ'Q*?K?*Q/:7/*B,*R"]]BT3+_IS=F
M^SU$9P)L?9SNM*X^ 2JN+:G=\J,]F6^5S.U+;.LZPOP/YB5U7Y,EQ;4S_AHW
M<T]GC9@#N3/7=+&5P@A<>]1GG"P^+E?/4:9WMK3V<TFK*60_;:I';K&$3(_)
M#.TXWMQY&.D79MS92"_Z\;(VL>/QPB^^:[YN^R:8Q7G.KB66;<P]3=RD/W!*
MPR"4V43XH7'PC<K1.VGS<;Q]8=S%;R21."\DZH$Q1<7/*'D)?$-/^W[W3U='
MHG^H+N:>47I@RV5/4)/[A\!_D6^5]?$/E7O2W7#P\>F*^C,*L/[QB40M$V#?
MN(.]HD:7!,;I:DZ?.*A')-S:U5S%60%OXWB-P)@=OLCIF..+TP6Z?TN*KO/5
MHLKIW6\05LVV#^R;U3RAD*+"%16Z&Z.1*YK@59G<N^"'59Z3T+9GE +M9Y1
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MU<Q;P%O,-/J@"#I P#@H$F= Y'8*C\IE\;/M?1XS<XWC5KNB0PV;EIS@2<>
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M@)7LAD_F;,=7HJS/U4LX*X\,Z9XI3DG\[SER-V75D>&L7ZG-!ERO8G:S=\W
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MND7NU7#0%9IZ@>4:[F\I2T;1(4%72E[0U$!X+7FPA7KWNZ+E9/P==WWQAZA
M7.)+S8%J49,VW(;U[%'G?XE7*&R5]_B%^&@03>.LX?D;SC?Q",.-V306 !%/
M"(Q%/2CK9N5V$_2CF*KX(JU_7<3R(]:FO Y"W;GAR-"0/,P #L1E=#7(ORR&
M!>]8,'@* $<H(]E3JYZ>WG:% +\%U_%\D/['7%=:IGEN+4<E0SB9T O&1>03
ML6P!:39UNUK"QW8RAAMY6^&]#F$X=.&8D"D7D>Q_M_O]#*P,7S^ )=\? !/)
MKK/$J.,"N"DQ>JB&8.+U=H2-?#O)%H'%70[2)G0P3,_52RX[)[H>-/CK(&.]
MD]6,S@_ @@K$01\V4ZZ!V7OJKJ)I42A<@-@F0,J\5'((,-I'[)_=,@@JL<@X
MC<6$J14X#9C7(1">5;'VOT(&_]!"]6S,)!N#M#AX19UQHQQ0U9$ PF6XMICK
MV:,G7US&)4_(J_E?M")\7!J&L\;D6H*D#W:T3'@?Z4%>\*Q^]=)<-E/_FK14
M,DB"1:A?2<0FY2/5=:J-D>>Y\>3.$V-REYF!6$]1 'DHYY91N80QB9+QIWE^
ML]?1?<J--Y.,KDKM<]?TB.NHJVV=:GAH?,ZNE%O:')$?"]12@O\=C _UI 1E
M4N*>V').HKWN)=FU?_RG]Y*6 S;;7LW^8RAIS=II)VXVLVS%3?U*+5M$@>9(
MQ7H-S3.[UB!3HBJW*?MOY'J5*0:J.,N$1GUU[H*7#/(&=LLW_.=*F(MP9&'\
M9?DT]P9;]>_ Z4:IQXXE_-OX1/"_JI6>- TP_EWP+]-KS;T6FC@ZIR0'&K&V
MJ$PPM1*SI&W2]' '6[3FGG]BZJ>H$_(1[E]E4L\30);%\%'CU> EE@@'*U2P
ML2P*G-C!.6H-1I$:DYQUP)<MF*#Y.Z_9'9'C.W* Y;0V'>YQ3"K>"Y>&8+3G
MSGBT&52Q%]Q:FD&@)1C]#JYN]5 EI::;.M:!1\.V^M?!9.Z/K&<_ )U1Z)Z1
MML%KX^'GCV/*?!?1SQKC:DDT%%RR:\KEJAUKQWK;9?J&3*$I;NT4ZH@PD3%_
MR)BUJ+"!. =?]:NWUR,14EW&B)$G_#Y1R2%<N(&[1_1)G_S6U.+*\[\2@''W
MO_A>M=SX;A;OB=K<DGVLTE=\PZ?FJP_2_%.8+.M91B\]F>8?#H-*4X.N?F7X
MA_^ ?\9\!@B_!Y'X;8ZX]]X'/;&F_>+L+90"2ME5NF3!F.M_ +QIJ+VIBH:^
M..#9Q)71DL'B=766-=#[G.ZRW&19K(RB;!$,U2C4D,85N&!=812/R1HUCS/D
M])O4<]U_A VGHZ:-J4I* [..477KK_LPI[=YF!NA$""IPM=CLL3M^N#7] X_
M>USNI2/"L?![$FEIQ?RAA2:^BNTKK.8]W$;,PN7<]@QEY>Q$@B"4S7*^(PHM
MI,=TYZ6\,)@Y02!Y)WDD=M#71Y<:,<Z=_.;**LPV;"TX^^DC=T:/H47^%J:'
M39DI/-?[]DUAX<J=VQV1C)$2PYKX#@^&N(F+.(XV%<XK(,?Z7#]W"0C9/K'P
M[NON_0#VG-RWZFC_6 F( ^EJ?D%7DLR)GYN#VY9+(5LMXR6&PII[<R\]$]ZA
MCK]E^=@48E8S(FT)X]B*.3TT[7_ABN ,?U#*&ZTT\_-V8/4E@%CI<:GO3(\X
MH72Q-X\KOP(#H_N_,W@4,(Y._EP";(*U5AB2J7FK+LP@H/N]6D9_ -W8-(6L
M<\&$W>GAY>O'-LUG3%UNUPQUX"2GQ_L-<KR$CJGK#T\_ %H.NE'#X3O=!C)S
ML538AOYIL'K#=/A)CS@\L9Q7TG^\ZL[KT@+58YG*RQ,P4C/?P(=]CWJY3Q@[
MXV^0"YX[-Q$ A@;DSAMG!1K@BY[=4U9#VPYX0!(*B@;1?OK*?H"W:;?(U0@I
M,W!B&GL>;?%L:G:*DJ]P'-S\&07>2S^M1X]+&$P]32&/$_TGD[#1CIV'G D&
M57T#RHO^6V/.3[11SN/V13V2#J_I7C\0KN9-&-" 2+!<Z+P#XYHC>>/ ,QKQ
MXH$'LSC;36F4>XY.C&Q5WI%H?0:NKD!NZ^47O\_&*?Y/V:C?0URFB1E=/!RS
MR)T8UH6I:WT%<A_)&5%)L8N@ ID:=@L8HAEJJ EW%)797QR&]Q#]SN?,T:F_
M:C-CPDF#(M]-/[ DD1;O%AN,CW8/DSXSV@$/224F$DE, M:9A#)MQ@T*@@L2
ML9!RFH%.G%AA8'K/L;9#BT<],]SQ85(!8,E%H(U+)(,A 1>/CJ5)S+.[ K2E
M-2[!:FLDLS'A)TP]@:>!9#4JC:H:()9_<&?[6_W73T7\?K.IIE,<&\/_#<U0
MC\3*K;Q'W8G+6\+!X8IHDFFKM%SI^ -P;]:F2"%4[$)01LGP$]MA+W$?"&[C
ML:BDX+;W!XHV68W0-4WT;G$WE9+CA@D1?&8X6<9DT[;;IAR4%86KJ: N2LM/
M5^2&@E B(-NYC =$.ZN^X 0;($1HW'SS?&%M3//W#/;C$XS,19I1U\GK/!P9
M,X.:)P<UWFDOXM#0%I(U+>6Y)8I1PT:Q,"HY_R4V.7T?M2W!T$S#*%Z&'7=>
M2DR/EK%7YS_1(G39T.]8'!\S _/8UM B"HP"#>#1J"PZ"!L'H%T.+Y30^?]:
M]'0D_^U(-LSC E['7Z32K^$RXO#/N4Z57P@-S8_D&UJ2[ -1 7TO\E7L7 YW
MQC \>DRK86"ZS<4&PZ1V-?RN]A.I46\:?\!9'^N_@$,@RE+!8Y&SQBHH"HYL
MT#5KS\Y?9J4I[=*$3*W;"08AN; _KBMD3&", X)B3^B(4:"K>R&X N6WK&+R
MO%^M- %KWD6I4\,_@/D5XL&L?7);)'*?E9A4&^LZ>!/GX\ C%<7'?OM[/-(A
MR2EPX:0[AJ6BH,37R2;87\X*QS!K(7<> FK;+DI%E4];/.QX2F,59OOG(^[Z
M(V OT13[E&(X M$C]HW5KUZ_'O "3W,BV(^D2E"+Q@:EO"M5^MB*@ZK2:.@B
M5_] ED90)C>/#R$C3%>7P>RZ.<N-8G3*(058"@_I&2*6/FN)&F,_:$(NRZQN
MT,Q.$$AG[J*C*QM5:=O4\N0RP&)T8>2+TFX]NK]V7V4+YI1JJ*^,XT4(UI"R
M1C<Q$K!LV!4A\0,>]]KR7A) 74("$F:$5C6O#]GDER8C:-[S-3!]0A\%EFI9
MO9E@/TDM0^,_! C*[O<KH+;"P+VZTPI:*L.8B'*"]DNI>%,H(7V)H@9*>>,1
MZ5F5>>38J8?1S[PIH,21I^S],5_[X3**PJ;?BP1#8TE0% 35%VU?O_&8D56)
M1PHFW8'9O'_,@X/,, ,;CP)Z&B>_J+OB\UGX9K+#=4,]D(G]6JK09EJ_29NE
MF*5HH>[, A 79V-8[UCU*#@4(;<A:Q+5)2V'FHZLU464(#6=6R9E@:'P]^M1
MB?M]SV059&E8+$ RIA[M0,7TM,Q-?.%"U>>2! >,?Y%$4_!'*B.=4_9F'@AQ
M5X,V[J$9#!&OK%+<4/[4ZH"%3ZGUW)2;F>G)CQ_ 3D)/+J65TYRQ AB$ F"(
MGKHYW4F1$J?Q@!NN^N)F8-@&P SV W!T^#XK>UN.>#6WTI;/JE<+,NCE_2=C
MH]>*9_G17;T%PIO"32X&Q\9,<5A"]B]F96TXM#CQ;T8[Z%I+>?6!;6D&7( 2
M"/CT;O"_/CKW>]AY':._DPU4,#UZ$')E(BF.I):-)3PKX.MWH6>AVW"4ZY)C
M=PU0..# "K#<).5@W=L6\9J%][(S'DA)=[)AFI-;#@[1-X\&I5]P5;$H8FYH
M?Y^[1Z#I8QG/0(Q@<1FW[42+*,J3A:])#I5=\>,FR7GR,(Z6&&\A-UN:6+K*
MI6GV1BU)YKF@1.\9&6PD0BH%%L#!=2 I0'OP-,8=[(ZJPQJ0+5\0PV8>]RA[
M7L^")F"PZ)T =-J10V#"D3.GY\4=>-Q4L9ZTA_ /&)TZ^$S.\L3=RJ3#2"BK
M6T4E;&:3<_C+!#S]F6@E#W4<6(2(I58U$4DI'941D/.')5Z:4PI*"1@\M1.W
M=6DBWDPUY3Z,V;)0<(&6S,+$()"1UV)+E*/G!)ZP=D%$MFZKA7$LE,!J/U4T
MTY=N?C]CW'^VPI-!L:3=%R;#00*#)BU+4V?XD!Y$LW4Y\.%AZLV>U6WY(KJ_
MT.YD1^$$3-(>YWQ+."<$5^4E2T"+$L\QA49' L]!@H(&37G83B/V3DPMZ&,5
M#PO_OL+=3"<1JPT3S0P#EL5S<XWN4P(USB"1#BR#A_R>ENTAU:U]7X>F'P!M
MK#IPI=F_=B_UB<'9]RTP6DDI.MAV"$  C4$NM$X_ ($-01Z"P5_A00;$^[S#
M?MJSH3G?K#"_B<\ZSRK*W8NDP<TI.%=YT=,04E351@^S<V<'4E0B"%>+E^K;
MT*(/UJHEPNWV.*>ZN\8U)FOR[MR>JIA/3,MK"*<F%,"=XPKC#X;M$,KY!8E"
MZNOY'QZ-19S\)=O=II5#8>>LD]'+EG\I>1JH$*0]G1I$.H Z;(3RQ-A VCOG
MB"F::4/#8Q(8( -0&M&M=1U'U>B'.$DJQ<9$&T<"J>/P$N5QD)<"B^ M(49P
M_9H[/[(5.93!KG%!B^+YAL&3N1X"%@G'>323FI1](9%QJ[CT%P7;6BO";P&9
MD?NHDN9'5']O!GF='D>$&H08FWU;(V$6&XB/,WP22RT#8"8_BZ#9;3>S<%#X
MG,KG'1P'6L(:EQA@,<7 &316,PNBZ.612+[=79>Y)F&[L.IM41DG9)?O#DRQ
M#B15VTJ"ETBA^DD ^27JB2R0B6A)#8AL\1WS6<W)8%DJJYPDH)^"L4/[GW[Y
MC8STA$A1\S:IX:U4.3U+VZ+0%#\ M+EA!/\?P!K3EXGG</?(<H'#9D0%]@]@
M]N6\ ],MXYAN8G\9<.S?!T2O6*1W(DQ60V)8E;W5?#UXP[L%N[T*-"^<=V>A
M* !K8@Y%?Z<E[RXDS?(T49<?@EEM>%' A5Q%E71'=G2RB]E9]%[!B#/S#A_O
M"B7E*)EGU5QW@![VC8%1]4T;?D2'AD_.MC?>;J!QFD"-"Z]^5"8&VQJ9J]<D
M!00[>MB' Z+/U=]$H4?6N/^=1#]^<_^%XZUJ3SPYC)^GM>W2:%\:KW3=9+\X
M!J4V793HF"#EAZ+S.K;GFHAY=:8?SJ8%(Y!P@K:E/[5A'U?[Y;8!RK=MBHXM
M'6T^D%Y4&UH\QX#XDH/IBKDK]T?=SAE?#':U4' >E]!$M?("HN/ICTXL'(SA
M*&0Z]0,+.WZH<O4K#1&R J1!D1133:I1&E>:G;7E:6>.>*@D^RZ+=X<)0@^/
M8VBS>C @Y.F@$V.:A>V"9*TZG\45E&85V3%Q,9!T*1'FTSL4A/CJQ70YH.?-
MGW/VKF\<731EX%CW4R!A&:EC,YOYXROKY2/3[WM6<-_<K__,[_OL?YW[SS3%
M'VN>UPS$9GL(H2T1Q?2'5_$ A*9+=[YVZO'1Y8/IK#IB&G<'A 8(CX<SD,&8
M,'JOB,.S:1]#FJ*;#[ZSZ#OW-2DF_3^ MV2L[T?#W]&7T&GI<P[!S]I!$6$9
M ^8BF)Q&5W9+/$8J[<&+8[6&S4\#4X6"1O21K'FL4+G0?Q=<[7\OS20/T_WA
M4#(M5D2!8,0N6^Q4K#F2&&U!%U(O#*CNA/>7=9SC)]#FZPY"30F1G <L=2ZH
M<%]B\C[O1KCB9M1N@B)163LPI2I-ZG3?RS/S_(73A2?KF#2:.OZO99E]9T!?
MX8=F$4[74._RB3->YX$^X!7#)"'0-#LFHX8RFA3W;&M+04ZIIIQ7)5_)JY"Q
M*52^1=\9A'6_-;V0]"39H*K%'S)X=977J-G91KGQ^B<_@[)@R\^0P5@A(URU
MPO,^HM/(_H",3(BAWH!X%P>1Z8Q6']XE1K%93<<5,YJ;X.K-W!2L5IB$B*"A
M!E*BUE!);H+MV%2^*2'0,)-P7BM$]Q:0<H(6B8:T'9X]F.DP[N.R\,UL2:(I
M&,I$TMR##=H%C5[26*9_<)"EC278P=X5?/FLAN8+;TP)N,X+VM\/F4>/6*60
MOSY5<KK454D$64N+V]3"_HJ]#RR' [VE)UL TT^4W-64 (4$4.]'X+B:O L"
M=F<)Y-/II@J4TS-^@[F9(-^U@G/NBH/I<E+O_?-Z7N/7!"3VH1!T= HX>PBK
MV!WK4"'3]3OJ_KKK^26^F[_7F=:^G-%URC=F.V<JE^(LR%C;1S-#4L=FEGJO
MD$93Z.1%[N3^XEEYK"KJJ(LALX^KRAV41VK*)<?Y"4! UPH$(!L7O2>Y.\K%
MFKI;]1=GS*. M*L7JX,RY80I"H]T3]/NX<*6,,SA\:K>RV]:*&Q<7&S)H(DY
M%185]@>CE7)G,P?'] 0RT3$Q3O".QD@;.RN(> AJ57JM<O.K^\Q%S#JAVDU&
MZ&>VH4*=FH3.U:"F=+.1E+8)?-6;NVL@1QPV2U\@\)-!E+(B1<:R(Q]. 9@I
M(;(Y835*JW+EF3%1SY8Z&!/70"^*U _2J@\4)-!2T;V6$O"Y/2X='_\-G!PC
MWYEEHN7"EU0?8D>&F'DM@ 17Q=#_P?QV>F QQ>*HV[.L]26K]:LDHTYQ64<(
MUIA=!X/4%(* L4]8,ZO+]H)U9:G;>9K-;HXD8Z**M-/!G<WO0:7^JX]";4<3
MRW/B+TDX1"([Q$M<EVP<6-'MB6NL<*M-D^,C"/5ESJ6B*KW?3N^XDMKSC/YV
M15$\] 3M.W__*N%*\F+P]-PY>K#=Y?@>P)/[&GBDN1(FX#F1PK51^RQ:Y-<X
M7'V3AY+#Q*NH?_QA*@SI:H"0WS;:R<-@O2KUG+X9>/DQ(A?W9=9IK)2*2PM^
M?3-,'_)6-*>KSZ8\7)G_9JR>]UZ[Y.,Q 5X^/FIOU1)&2;9R])DN.P@/'1VP
M,-HKE\3"4:OQKUOVYC@P!@B],8E2L;"FD-ZU*>^U:X>K5OSB$%R@5J%JY8JF
MJTR"!K(/0*+-<1Z[C#JD@VD(>YAFT:12!:T7FZHHDJ9VI1C)AFUU%A6F]Q^S
M6NQ@N*#UDGO-NDM8LS*%5AMG>22(I)N20J3IY;7<*WP+<F4T(KU8*BY\$/+5
M:C29SAPLH](NM;U9L-$2A!6$? 1.1!1,TPU]'OZ5"PHAH?1>'8Z""A@6BW-$
M;08'RK>]\8$Y@03=AHBZ,-7XQ"%QFL=D>G=T+CQ:G"RZ@%^D7PZ,\PVH&I/C
M@PV@TP;:#E"O">,5K'L;&9S0W'D\$2B=>P[+OSR^1="]$K&CI-,X8,,AJ<2H
M!@1.DL YOO!382-Q&U-Y$OH)>FIWLB&Y4-*(6 Y^4V 4Z8VY'JUT, :51 6A
M#V8WD0N;F,(C@\@AO)T(W.$7*X2AORRN6_Q=0Z'^)M=N>5/@76-WK*,Y.< S
MADN1]6[=QV9/G MU,9-_N2PTS<B<9C0-H=01$Q]\RN<]XV%W@^=:\A-X_W>&
MR/OU_#P']7AT!XL$]:)MHB[*42C/-:/J>W"7I3G6BM$ 2I-)MFB=^T=51A,@
M$G(&T+-<'DJE30 .#>J@)*<@0>/CYD,5ZYW2T;2*#(428KY-;Z>(NLLY!'B/
M:+U N_-S>8D]Z4^EM$ ")+_KS*_( O&3,!Q)0I*4WD=2P[JMH:PA9'!)8"6,
M6@XPH.KE*_MF_*_9NVBL5?5W%H@'#[NOL4''TU =(1PF!%0>R:!71<#Y,(S<
M0:U.!C77J4W!J"KTUJOU;B/*XOQE'D@'PZAB;?>K1F'L9(5/B#4EH>:IER?6
M;U_F()?%(+_5RP%0&RBI[]"_X<=51<<>WRT%/0FNL!2L;7E80^"Z7"4@5RA@
ME#Q95W(//_B^VT5]FTF10::/7#V8=;340]H@2A8[E4B2*B_J4&@O%CM_ %9(
M^]\#=&Q@9AW0'HF$>"&'&"!D<F6HOU2Q!_CBF6G2CN!QQQPF]UU\W@K3"3/=
M:H\86W43DQ*C&TU7ON)&0D#YNH;_U3P),@T>*H$DK-UO0C2@E[/6:@]=A#R9
M0"P6^1-G1+<CI0*J8[+B\V^EYRKS&MY4@Z61K$B?$XGG" ;BI;!-+:=%>!CX
M6'\ ^$!U]B, (80#SNS<-2A^AO9\WL JEBM<1A 05591$U,_QCS"#GDU.)0<
M[I<681;0SI'EL=)H5FQT* ;&>Z^O2J##K%V%%"_>J'J@/G8;F"L[*X2VMSC?
MP5=AD<\RCW5ESHTI9P\N;A\Z $IM-:C,D7"QD97B+S62>,1FZ$G:%-4R"C/O
ML]18?;96DF-<49".,+[+\$[%O7ZBUFI-RQ=0L+_QUN.N1NKT1NP0M^SI+XGO
M]+7INXN43S1B]'4K:1E8V1M1DY,@BB<)3UF'/\-K*S;WT-]PQ%7'>7Y0N>[Y
M Z ZWGNZ.;Z3Z)MGDVY0C!C)KRH88))XH)99E$5$G9;6FTB@/)3%QLV7?UAZ
M&[EY.;S\>#][],OS/@"C>A:BP=YR!&;UM,L48>9HI?"$@;4W'[8W3G$-Q P3
M]V0:HC&J[SILLOI^?3DZNI:(";N"R7 _#UHF5X;9E;!C/3P/=9,R#%5)];AJ
M!JWP? J/9I$57ML6TJ@L98#?8[3V,IB,QQ%DF(D.X;6X[P^NV3<X'$8) FRL
MW)Y&0#?_9FARR N+H/,D!S5Z>@X6X&4G9\&Q^M9H&OBS&B\[E6&.%D%;@X/+
M2@=N<8+SLTB"W7FRN1*-TWFW* JC)-FQ_!&:^70F:0UU)JL8]*0WBW$G8[VE
MS)"+4'!]@7V($G8HQI;([G?)FM<:!1!4RRIMM&M!R^MRH9X(B\*B<H/]IJ?:
MDF?6$?9D#EW#4-ZL@"S!TUJ'UP@;8YOT%%L++B]F <<$AXF*99[S#Z<C,Q-'
M$+7FNVE9M1MLE20.&5#8U;A"!1Z@P[F!139U("M0+F,@?[J*EI T7K C >18
ME(K%Y>\6R+? 0DVAB"14@W6YR&\J#/%QSII)AK]@;^5,YI 4PDIUZ6.D:X#L
M]&\WTEK; 5L2C"O-MPS*Y$,2P^=DPJRETZ#*^(GN IS4UYAP ]B62--'FH[9
ME-)\?5EZM6[\3=*5#,-XFB(8\9ZD%#254T])T;+PS<>2-?T\!!GDB;P;? 1)
M+/OE6M#HX44\<]ZVM?'-A72MBJ^&\N6Q^#K$C.2G9KQW8I2:*",^+T0,S8]Y
MV<DZ0OE))40#>_I+HC3>#Y HE ;N"]'$MBX*Y7RP#Y96YUL1>4+JXU9=TN#W
MID?>TC:"0( R4*5(6*PA8(<,PLNUS(B:_SB),OMO@I-+/THG$0_2, KA\XF>
MCB(*9^B9X^=XEMY]GCD;RY:#LN$\\CE!J]%--9U<E<UTC5SL#?R[1_6!'#/7
M_C&%)%52\P_@9*'?3 OME/7"^M;L7\UX*BH:H%1'V;I )_0R4(UE'! ;Y!X/
MGP=^"-<K67_I5FHQZ!F*U8Y]P@OWQ.JD..GGJ+Z.716,EP^7[7F.I-A1[^.R
M_>]YOC>//_6^],V5;YH11"()%"_L ,26@X>%H&I$=&FOMP7*-'U+8>6]')C:
MDY0RNL:A2-B"(;2['ONL-A&PGJ";)!%KBG\5(/BX ^0R$&"]Q;U=US+Z1!0@
M*E+CZ$J1M8IFEAFOI&HOV(+.]("4\=*;!F<)5)(MSXCE%JV,X$8M<F756CU!
MR25,>N?[+>4,XY^$(2+7(EKC%Z=E1M95E V"2?'!>H3*-RCSX%@A>1&PQ]^,
MT\Z1A**T"]V;7RC])[T]RMW[>2"_)5%TXU:&4^_/4JWX*L>F(8K%7*4 JCP*
M2"$Q<5 'JY/2L0" VV6^1H#<+Q!9Z%;0 .8&NW-.=N+<_8'[0;CUNIZ(BF>J
MG5%6V)WP^6Z()XAUR!V,/B<:IY+[#YE3OKPN&01X5O[E<5K1)3"_?3AP&*OR
M HUJ";I6*??>"C[!Z(2AT',R!%^?\\*+4_LDPN<8QDGJE]_08KTA%3U$:+FP
M#6IPS@1WLA[U WF>Q_>&0W="-W>>YC]$EX>&?#GRZO87W?A'CQ(5Q"9)+U5V
MZX'&F3I2XV>D$BS;@;1.*!_\JK(P*5 ++4RY/+ZHC?$U=Q(Q(T1D/N<]45'D
M@0:VS^RHD?"N21AH[Q] 86]+KOZTU+I+0TI O[X!NA?O\YY\^=SXX$495PD+
M96(]<3@N Z7IL+[634X\NV=.,3[4M\$3,_+83N_TA0RX^.*!U]DFI@AS9DI<
MG/7P5EP/7J,E6VX31Q_; X.Q+3$ A*-F[-SZG23UD2!CS;#9+X"A*:Z1'3_2
MF6D,/SD G\#]2< ^J%D=%/83:DK=WZN5%N^F,1>K#AZ'CS:<5O%09PTGY=2D
M524QM?2[2IZ)Y'E\?/ *U<P(:"B!O^OU9N"7<]/[\9BVZMWPES"3'@$"U*89
MUGE#,<A8&F-[4?)CZN1(Y3BP,9&3PEC#4*?)34:9/3)[(L#?B:3D3XZS!\-W
MHT'-][T[3TB"[\KTW0] LQ?8==WQ0=7Z//)V$#$Q2!ZOQ:6@!#XF+9;V=R6*
M@K[$^@B&^'2U_,;/IP.Y&[<^-DQP$T(8'<0KSFJT>J(8 JWN!DRG(^H9A35P
M!].Q&11O>RH-RIG7 2*NJ8$?3=U8H8470!L.Q!0&=UO$R]W-' AN9+E-H@82
MBJ#T')<C*.E8@]R@*6;EZ0D8B\,I8>+BE'I<QZ]*SY7P%J$TH"Z2C^;$O["(
M #,0,\^(-N'\D )N#=NU!]K[ -]R^LZO4&I7].24D8Y.XB^5G:7<T/U#S4<@
M7\7:R3<F:=/UF31YU$=]3D%-@4KH"F/L\4JG/P GS*M>D5('$+<!8:="6'4#
M?"-Y'N!E2LXLY^Z2U#NI)Q$;SS]TP5%)*ERB?;:J&CG.PLWV9FB","%7N_8"
M2B9BQ-YS2P$,[[/-*902_V2PP8MC#&&R&G8-IY6Q2%Y[F&IEQ"(C>)'B3N)!
M8]*M#9OL:!S\X*08.V2YU<*>1K#A.699+T\Q%4P]92AN>8<-.1!A\YA[C>0H
MNA7!31F07'-+G0?MW!&?Z&?- 0'/^:U1,8QN,KQ@DWC&PP=:]S0KE#[\PD-6
MPB5F,,^#\%C9_ENE#NC30YF[4NERURXW@0I:98>>)(X=?78HR@=$G<2Y0"RO
M85 PB5[QAMJ3^T4>.NU_;-),O(0R@1U]WUN?A64DD+61C,B->YH/%L2E$<:9
M*EI-Q :LB/X0%1S;JD7\";^.!YTE%.Z+6Y\?N&-T1B7P44V;CJ -4#P=Q\'.
MAR=X[/)K<R2YT HPX]VJ<)("K[1:_CC5(#"A^]?#<9$EX>[<AL7]/4QPAG='
M+']"<N'FH&2*"2K09".V=MW2@;"<$'[V49S/ ;PL<%_M0$/OM$'"@4EBX2[U
M0'/T8'_A(S!K7@I3P0HZJ[\'/4[3A4E7I%I2\/&?B'8_IVF<7BMX_F;\:A'#
MP)W/!('X<C2*1&$JAPA%CSMD@@OF>S]T[ [9X"+YA3B'K>:96>B:XS[BF@7N
M5)VB/,0@(\QM&^*,QX>; .@9DS]\XLXES.R]/4TPO *]N'T/V),L4/B$1^Z'
M"+B2-/-;@\EL-<II@O'J.B3XV$!K-*YKM>2_JP2J9I^8^;=/Z5^A)];*8"53
M1S7#X8P,2YI/A[FC(9!F9E(:.C?XR)O7WGF.87D';VO%A"[?;EK1D+&M&8?[
M@IY<17$,;/W6 ",1@*Z2= [T <NSH9:8XH59\#A>1T%%X:63+ 7@1UF*DASB
M[G*#P0-P)>#4;/.9(1Q8,S 9847H*_N)9KXD"?N0/N9K$H+(%X[NH2VYY?VG
M*M/,(C7.+0HA:;O(E\Q@P:0$HDTD687N*:&(YEA@AXTH"GC!W"1AJKO]>1UP
M+<&JWL'QRB7VXB2S7G+++7&2%HI$D)6KVK@NKQS#-:]J3_,#0Z-@.DL3U>OR
M&+K#T*C0X2VU@Q.F6HA;X<@&3Z^^;" .#=!F^GE';7>'I21U!_ZDHN_M\C?8
MESO)#/%7<B04/YJ-,;OD$$Z[MRW:(V33IXE#!3NZ>Q[ZN*  X<PLD,?*M'>,
MV&3*R(I^(S]W.'=*+-WVCI. K+*D.0*Z]-):?0YQV!Q$8(;5@CV2EQA1%> @
MI8M/Q,YED=&U06.;;3%@_X#YD4[NS3+EQH&LZE^O\$"_6;N>$]2/T>,>68YH
MP2?V!9Y$)+4LI/.A4^K"F# \-W+P!U.;$S8;W+@O/)U3G<J]!/OBT$%#CB(K
M*D#$G E30R&&)$ )$P, Q)83&&Y!4#JP)%$5'=AV=O4]ZA%$^8OA?!.X38YJ
MA=!T_,:HC3O[;,.6)G89XF#.*U*H[8B"R^B^]VA<.]XNT#>R-C5O2+YP.=]C
M%II#-66<0W!$/L(Q%W/3$SLJX^)!P:-\%<GO%MG!=5:98PZNXGW5:?TO]]=J
M5WTAFPKIC/[5@. Z--VR<Y" 05(DD$   .V9S&K4"3PG2),C!$0-N6=$XPG_
ML'1<ES32/2AH[7'SW]-POZ$_V_:_IR%J=$?Q8*SL?( ]E6>18Z"[@R"./\S7
MQP] ]3S:[=]W2W$Y"=]=6WU$&Q3W KA?3<:8+V[-"2IO4!=_:_$!I<J03QW'
MX,83L ([).7E!^#%F.=S>QIR]>]AW,W@!V#N9,-C0.D7 D_U\CM1,;"DX<P>
MZ@[SL;:W:RI) /W[@*<+' 3NURG/1KR-V0] I=FL7'R_ KL?_2D4IC&:@Z?A
MW7=9ZA#&.G<%WVA*H@8_\->,R770%V4G9&D\JH_)"WW?47;&M_49&\AP)!:*
M \^3!?'7PT7.LS5"TX$\+%B03/UHM&U+B5M*%^K1^!A[>*Q7RH$9?_[TRSY.
MWCQ[N?C'H"3]\^BW@B:I3C^1GF\VQC^DE*LP%$+MJYMSJL7?@]9*73=C%_J[
MF.&R<5\05O.'LS'3V<?]U!"4ODQ:%JC6UM/09U+$:VEB L.'S+DND.!9ZW:(
MQ6=/T7L@,Q$_ !#X@ZP[H?C'VQ#<9][64Q!H* ;L;2J!-;6D1FEF\)TV38#P
M388[<%ZZW!@FZ+X1'Q[3]M<[ @*53?A2;\F-0XK=@P+WO/J[DY""'ZZSJ'IE
M,FEN?W!NBQ2IC1AO,;N5Y9 /\:S*!7IC!NA*,7VP9FH90'9#1'>076K$-X1C
M2NLHT]41;<$$R\BU(]H/+1;)ZX'&T_H:N*5'6FPMPTUDU6N.+I-1&0,5WEKT
MQ[_Q90<N3 D:%J2W&([7LVAS_LX,#\STQ$RKG]^4)=#.'7&_9(,FWH"B_F@P
M.O(RMM>SB.(W]OY>!_MF]"0FO[B:7&L;/UA#^,/*5\B9PJZ.CH[,&-'TA!.7
M])/\DTA,L(G@UM6*  8+$SLN:N%T @/6_P(20.V_%#M4%:@JG(^&<F!L&(<@
M'RIU2B),(=:WXX"*8N6 FS+)JL\(SOKQXK%0"&[.**C)K5TB_!$-*ETM!$!/
MGB&((1U<,OC_ %_7M?WM'7X.A.S;6NJ9.;; VF(@BHH7X.RI9D,^35M /0CR
M"""^['+V]B5M<D>!IQ#-# C1N@"<J4P7R3D:!L'% ")@B#K+'M%#(_X/TH\G
M>K]5R,EL1OP@9'V/OB>EB;/QG@LH..VGC^H-SMER )UX &W&",7LU.R2FPB#
M//>*[+5PCK)6Z&S7V";S4NKGB=JY3%:24_1]>D68%I5Z0>-6/ <^-:.D!73E
MK<FP&$/1R!R<Y3**JMKZMVN O_6 F??6.CSPW6XZS?YPS1;*>4XT6Z7K:):4
M=1Z"T($ )H6Z*_4?(R<,<-+ )R2!UILPK5M4!Y7;1"&E,B%79;1#N +3'$OC
M(F O=3V(LU7*:=>)\L!V<^KW[S5P&_OY9-Y<%UN^JY'H]=L2^/$V8(?P#N[<
MU@>XFZ$ZYR)Q8$(1"K40!\IZY72:T=-)7+.Q<U(@2OI6GI=^\;=X#Y(F= L1
M$!AMGJY#9Y@B@3U%]ABIVB384^DZ3FW$#"EQ!P(%[*8\,<3T^B%:(]-0\ XI
M'*. P8J*+U&X=[.3-6<> BB20[$A?3$!Q;8K*PON<6I\(4+GB4'M%'$+19HS
MV=-$^T1,(35:/5M!#!'4>VT19-'BL%D@%Y/W,-Q\#,:A!Z<LLZ 7+%I'(#87
M*P U&5OIY_L'5'3R297%30:(\5?!/D:HX".&,O,V)$'?AIRIYNUES$LHF/O?
M#1W,Y"Q6<)]E#"R[% *W$B9)(=^3:1, VP?"ZLN09ILR_B-*1X(C>+1Y<$)H
M/G%AR8AY*T*@%I7BGI,4@9)5B*H7?@T-=8\ ,&(*W;QD.&W/^-"@."(9U'J(
M0#$N(T\8J/Q,Q)^MA@@8X98%8I*96TIP7&([/W>:(2A=X)(@H$'64%IA]B*
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M3G+Y0CFS;-+4AZ!W7&1. "1'D$?@0*V LT7/[TR)6]NSDC^<)TP * >IHIE
MZC>]1>0WRW:ETMIU/0HCTGHQAZ=;9>\"Q=6ARX\@1$F^!89FD,6VECU')(HH
MYI7.89SBDVN0+N5C3.3,0T.*0!, =3YZW<=.?IB#01%Y;S,/M@#XH?D480"P
M\/KA]ES)37:F5$0Q/2M#DK=PS-T;#Z[.&FEY("#<0!G8(.1!@41#"3!GKG3D
MSK0.)8=.SY4 +HA&V.^,WMAI^PN<SMYF^MHTR4[ -(ATGBQM7*$$R;?/6YY&
M\,!IH@QH.$G8XJT$XQ&X@#B! 'T6H>,[9+PFW)OEAZ&2EX0<F(BU6AKGD'.3
M%\Z,*-HZ\4$[N)L#\T-#<-'-P9@DGS"C/%X<:S-@&L$)T3=*P"LERFD7BUQ<
M#C=/)@!X/!H)=%PJGV_:GT>^O38.R_&R$6P/>,S3('R^C24(\)?TLHA>L^SK
M)B S9YY[QRWR#QK)#4V;^F=4H=[U@E\B/3#B>0AO7\X!&#6AWP=[R])]0/F_
MMB&VE6M+?;US1CU+"IIIB\8;:1ZX6UH;*]@XG?!4'2_QB@"M:SLCW04"ZN%L
M \0Q'QU=>IE;D:@X-M/,<),<37-3YEPU%&., :!F/+=*YYN-S11H2APNZ(=S
M*<1,C38$5R/!E.)U]1","&CKVA,+&[D^#?67/-'( CUTVDT/*DM &X"BA;&E
M-MW0-FZ:T@1B[GMQY0&G>F0P%T=F-"\=0Y^+.C]8B(A!8:27'>F9X8]2_NX+
M.2*_1>JA%!)BT363,5=IF,\RIQU)TK1.5S>*Q8^6AVL#H0)(\98C+Q9]9*/4
M]+AM[>R'(&ER\:-P0U^L^#B+!B,%:!;R/KKGTSCS\[BM2]A^OWO+)1R4@]U=
MXV4U->;:&"<.\9A!^E3M:/$LP*[?LZZRG#ZF"!\"CTYV5T4AE 8]*,FT)I2
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M  W2D8H(B#0AQ2.G0:AD ."7@FXT/F/58.E7,!Y5B#0[CLR:@34U6VO(O,)
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M4BM*B(:@E\DID6CD!N@#!T(6#$(.HGD0>;RBT$:.'/6M$*]P"[,R#H9I7:\
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MEBI;;W-*N#W$EMY)1P*(?I<;$;'@:#O-7)4IKYG]9$ &#9(_ZQ-VQI$W/[P
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MK6%(H',3U8&.#(3U<6+<&N4*&[-$S#A(4_\ T7C&6Q"6!D@U]\-.UT_'1ZE
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M%Z8NND)1LZ1@S, Q5-*%=L,?5@FTT<FXE *$#FBOZ<]TL@<G N HO4R<@B+
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MTTB\E8UC*GJ\;6APD<%9QEE(VM%VE1#L6X8M';2F2#&PETQH&.-J,,.DM?
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M4?. UK!H$/8ID(TZ$<#O#]\3S)16CC@X18J#RB]2EQHXK)>C!4(EQI6S3,,
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MAN88% C*SW+@'M%A,DX;SG\N1+X1/6D49*DB/"4U6JC%QYJ.3I@2K9@5''(
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MG<2?XF; K:^A?6LXGR$Y%T.>,1B-T("GR\Y5Z#B S<B]1]LV2GR)%J53ZN4
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M"4Z/P'!7@8B-*O5V$S0%5;!U,["._'".';C509)L=::S81GF%;K:>F+O)WS
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MF%<<%LT-C $>;0AS7I$#3H>F\(JXJT$*C!0DMAH,\.YNSP492LE(NSL8N@>
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M:BHFLRBMI)PJ;)&5G-BP>](9,>B@T-@:5VNWXK>?%\1T-/'?Y!4MXHJNUC(
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M?&NY3+YY2B$X6DU\@WY#-B]81SAH];U[OCI2["1(ZS?X53@UWY%S9PX\J<Q
MM)NA1>WO>%YY<A!.O9(==@./V%=?C 5MY;,MK&U,SA?&K"T$:872;;**//0K
M.D3OAK$F6^?+,9X[NL[C4.R-DT( QI=/\*;&H(JZ()1( @N'IN)2,--3;3;J
M.LPVIZ .";9*>[*.3GU"@(P]6E*"V".F  4W,W.&27 [QC0Z%FJL::E!8,ZI
M.\:AO@+!=&8XU<F@@YNE]A)\C7)*I^Z$N5F$WQW*VD) U^3QM'O6R=_4)^,
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M)LP%,33GFN@?*)9P%&RZ(#STNKE""XP_TB8<!Y\.].V]8E.[^=%057V<^6"
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MYVUA,X>0/ME%I6'L:HS/_M>C$EO1DIP#XX6CEJC2 O]D6(4T\ZK+$.S- $
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MJD*^J-T9U<Y65LC,Q#VP.FW[WBU&, ^]*J;/YM1O?E?9;O(T>*)8^%>Y8\C
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M\I_5_QX(5TKR>C>^B[1KJ2<6[0 85QP,:X43^^_8&/U#Z&A5#W(L=VOD.P"
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M_3CMI<2<Q\F7OO:\YIGN/G_>XW+U#D0;.JS*0V(O!'R<V>7(5'_5DM_<?C*
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MUMWJ&A5)O -%Z$SGM^O$V9K!0;%<42^_'I,IWX?/KN=_&M<T!(^_#7.7S?\
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MR_W@YH_47D\^>=EMR:\F\W6=[?MF>0O5_C.=S6IR4*7\S"2NC].!82"5F0"
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MQ''#!I19YPSW1(P-@9,X 5LW!TQ9P,C0DT*HE ,NZ5G("P9H08L^^[MUP#0
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MP F3((BPLA<L+!E>1G'AQ5S5W(Q]XX"+2Q6 +-T3 ?&)Q/GX>R5DF0I>_6>
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MAU-&3@ACR""0$C%;:Q?;TN0"31H6F;_W\B%LEC;24"'5^Q)P=Z4-%F[&7+^
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M[UCC-(%4SUF%NSW'7(^.+I:%N/,QEL)KDG$-Z'R 8]5@]"<("']C_P#+_O\
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MT[*:-OD^&,[X4Q15+7VR6SZQO$T ;,52]^$8_7SN$D8>[]C-ZPF-_P"T&HQ
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M*]XX>(!"# C73HNTP#2D,$AL=*9@B.\B7"\@HN,EGHP&?_.N&MIM.%'@I@7
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MSS,DIY)JF*977@'XY)E4"B=K5C5J6]'A]"?J;_ P>I\!?D0M^.&B8L$ J(5
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MOS>N1=B>#W[_ %QMT/ O6T=ZZ27I,+V).*_15IB@=.ZT\NV,=F4Q/T-4XQE
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M:+$AU@D<J5N4],P<0T-62H,Q]=YRSNDJ$K,0<V!103.P>U4MM/S%_-_P6QS
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M*XEH2"D%X>;PPHL'Y *F4HFLWBGITWD0>)]33)MXX&"TV%$!K+KY^M079(V
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MSV>[$&!6TZ]??I>,],U<X#]^"&9=EY#I8Y>G5_:9]EG%*L&2@PG2)DTR:=\
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M\ 89UX!(>#6/IX[X2&Y)0(KU6@A7DHV[P+R!. Y #C$ PE8P=B:,BIF=Y.&
M!<%B.%P2%<?..N7)&8S+T_/UZM^>21?*!6(5 47Q>GC]D46BI0T6RN&G$ 'Q
M4'4%*L! /#'%2$A0BK$3"1FI>@XBP"J3Y8:^ W+241L9IX"H!BJ(ZG'4BQA
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M)+!!$AP,9089Q7P$_P!!2*=I +T_A($C7+HF&%L^X8?^9CH2V U,SGC34/\
MHQI(&3E75/=J3N@0<16S[<ZIW2P!*-__ #T6M\WK_90@H+HN_CS_ /2,E4&R
M%L7[PCM!RVS,DB"@5K2E)GSP14B-"&@';"'PYYNL0 4<Z+D"EH N^6R#%:!D
MJ*H9<.<IR%^VD+:F,6H*7>.-[("CUNUP3WC))R$Q)>CL,QH&LWPN\P8 F/H
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M\)(2"X?N.OXO@>&)VW: PO(B8^^N-6<@AAD,]-]=MQVH@M93D5F :D7HZO*
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M%[=A/I+ZW]%.2$9%QB0N3N767XYL^G]_[[^ X&2E='V]OZWZ]-,QG7U/./\
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M / -I!QHP M'K_KT5$T48YC&$0GA%'8I_EXXXXXXXXXXXX5<7O:_"QL(B?\
MXLG1Q(&GE!IYG7^9=2O42R$1Z9A!%'_\:?KC]0H%%!FE!$4\5,:083N+<%!O
M,#FT/]N8 V10\0 A 0#$&(B(B4</#8,G.&G"\IHEQ(>UHD6PY<(\/Z=?5#C!
M:F5C_P#'M[]?:%5NQ$$J5X>K?>UB\:O->#"RHJST:*^ &XXF?,Q"&S65D>*@
M.(=4*5NU_'!#UO8<OZ^>82Y#!B4Z[$-=" ?_ (]O?J< *9O- A_O+<+NF!<
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M00!'#3Y/MQ&B%0 '7F_L_;B%H8P3)#NYSC!RZ=U]X?GF$13;6)X&''F_]_\
MXH"2+*[&WY<\:TM54'HPUUK@Y%2@KG*XP^OXXJD*1)D)HS'Y^^>,1 &M-4UL
M(??EYA56YF[X^CSQ2(<7,WU_?/,%*%N;ZQK8=\5"8TI:AZDOG/$7@I/@)G@%
MS60ZH_7OYOQP*91\R_3Z\#"!1959T4(?5>%8E5,A/L-^_P!N!JS5:VEW,?;/
M7!X%)2EM4XI[.  +ABY6&L8SYS_^/@%@%RPV^7_\2__$ "T1 0$  @(" 0,#
M! ,! 0$!  $1(3$ 05%A<8&1H;'1\##!X?$0(&!0<$"0_]H " $" 0$_$/\
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M&<.U^TQJ<)C@B12<#12OF\!K\>X&:PP$MUBEO %8+$@KDT4$PX1>Y08@,R%
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M*B ,SCG\#_P 1O\ .M_R\E@#E/YA_P",^OY?CU^?Z.'O'[]O[<5.5NS67?\
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MZY^QQQVC&)<*-/./[3;R6C!<G88M>^SKYYE&SPSB"?3,>'2F??WSYQHU_=]
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M.GF$X9J9>PUYLG,Q\%_-_P!<DWX$IM(/(*(L*QYDT;,HDUMZ$QE?*-R' XQ
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M+#^==TMPBPQC2A<C'XR;Q>!A,&)D4\.LI?1\' 6O+QAO?RG?1.^5@_P;?O\
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M\*@ Y@\C$-WNW@,10*C*9NC-\T\:PI%2 %'6U,D3SZ2NU<RP+#IS5N<='(4
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M0'K>*FN>5$A7A"]3D2837,=QBVAZ0T$LP^'D#[.!584M1B=QQCC!T$ VH5*
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M\"U3Y#9E<2YGWXA"H AV$A\L\!G'*4&JJ!/@7 BZ-WBN2*Q8"'2YU9W<W?\
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MFQR/3<^//'K9(L0DR(4"42"GA")TE>"EK559;5UGF>Y(@J9UE!NJ5N5>(V#
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M@6*9!A 2><[W3Z*P)J 0RI&>O?N/J$)=5P;N>L=;X)WVP&(5L"MR=D3B!EJ
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M\44B;R YAJS('WWRO['82D,,&?0ZY*/N98SJ?/Z?3D9;*V.T35M=JYW,<<G
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M7L?6>G,3BSZY&4!=8)G%J![(BVM'$8>,Z1;@EE*LHHF3G&RMN>/8_CLB:$+
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M&87TYDOUSC@&OR8P_9KW,7;Q :XJ3"S)-E^*?!Q<96+"HX;C%Q7>:$ ),'4
MPO<R>\8SQ)@MM&T1=_I[IUP*!_-@3K5KXU[Y."HN";\AXIYP<1Q!X4GV/./X
M<8]_8K75O<#77OB5J!)B'>,XLPO]^4YQDRGPTC)UUG4Y45XZV7Y^+C7'B> 5
M"YL]R0UO;X6.2&4)3$U0,S"A;?\ Y;* ?;\/K\)PS$(B=Y)(7/;0^,\-B@A@
M\N9.X??OE!2!%1DDSE'HYN4R<257 @U2=U[SBS,N2;*F#-LBWQC=].N..0SK
MBL!-DR[SQ*U.JTRJ :$\M' B26-&;!:94F%!6;G%;!6-A2AKL EF6>T>(,%"
M@/%)GR:*$2$B@ $'A((T2W@A:((I*%W1TE5-&B)4H9,$<=)@LQH04 7RR7)P
MS )DGB5Q JZL@'FDSDS9R95F<:^W$,1G"Y[%$PRT/CV=Z*3"DLA UU;7/$;4
M,< \-[L4T8,]< 5O@&DO>_89XKP!N34J7-#/63(&?Z&99].7;1V^/?"8*%8+
MEKD4%88#$:3MMP<[%;8L?JU<=M4ZA0S(J5[&SF"YG+&G3L#01@),?5%G HJ$
M%Q- VK)MYX$@"/(#L#6$2S6'HB5.71K<>3![<SUP$E#BHMR9@X=?YX1V("%@
MA*?W[F=Y%3$K1IOD_P"GK_9^_'42,>6[=_S'N%RDV&?W?\G9RAR]G?ZWZFN)
M4H 5: 8T'1]/7!<B8,.+UB]EPG7 MLM ;6,WEW]9BG 1NR7M9Q,7;JF;OF1H
MZFD2> GSO/\ 0;."95\A#RL,=EX>2;B"0/MY]%;[Y1*4E#"5"Y,,<$<^''J&
MD4Y<%CHO]^0N&"55OA1GT]S$X*10$!2FMSA5=;<\ JV%9%E+L+,DS/@XCJRM
MA0U05:N>LCOCGIJFGT7GK,(5IRQE67[X!P:1_OR3HZ)G:M@$Q[^W 5./:[BW
M&7CS]7CC<BA,D(D/!('1R8.N^.V2.:#(UYF?Y-6F,!2W/O1Z5@;A JKDPEI<
M@Y>#A1"\6MFI)@+VV<<TQ!9CRF'PWW..*H\HE:$[2E?IQ&-,F7T!%T??P''W
MD5 O63RWU]7C=HU23E8 >WM'BQJ";75]J+[_ .XV F:-!UC,RCDIX*BEV_<3
M;ZG'4!Z$+-#"]Z_+G@8M5C;W#S^,9Z>*;CI"XQ/K^N#B(%["WW.^J9Q9.*MA
M1ENGDS]7,&!.%5@.ESYU /N_J<5(@#+5,75]7])QHC88!2+,9#S,]63F(W*A
M65"H7]6=(\9X4TJXSV>['.^2-#(1E7JX9'I&>:U&!50SK9K@#1!\TNYMWI<.
MW?;I@V8R;5Z^TN3[KMH^$;TY>L[^OFOX:/G^8Z[MS&+N/D#[>OQAAB9J$[Z#
M@S]*"[QY:F\_8UP.MCGLNF8U[BM[X*$!7MC6$T37G>SD?Y7C_8O[\EV 4L#F
M^>D3WP<2*8K*]Z\]9\>PMAG2ZZ+KKN?MPU,:F?;Y]?;B#$: <UN 3YSGD7:S
M;J^S(XGLURIFKMUW('Q<Z/C E,8K?Q2/OV^J@E+,YGP-]-'X_P#E=3;YSD#(
MEK%E[9\OT'R4FSZO?W'$Z/UG,"K0=&,NG&5CC'+)< E'4,R#8Z31=O&(9$48
M)0-G4^F8H 0E7![+CSVG1EX^<5KDAAQ2@JC.YQP 0J2@"XFYC8$XJ.!JLC (
M$J*0#'G@KOO M%E+WTIPP"[5$C0!6PL&'"%#ABW JH%!8A(-J..6G:S=%$J0
MPPWO,Q NK+:B(2)6UY;!8>:RP %%/2\"9<5 $@M(I1^_#<PA-@R*P+*=7A8*
M9*-T2L")<*69XG%Q4F QNI6XSODC@M" YVLQ>F?GAC1T7P%HGYNDF_Z"!4H,
MGDCCK?SS=8P1MS&)9 <V(TC>*>%@BJ&T<3P$:NB1 Z8#:,1@_*IUWS+)7=,Y
M:6/7N\4"DL!@2>^CS@\]N6SH9LN<GF-'\8Y E'D!])9]6_.8*1I5 V]-?,/Q
MKAG&5-\X=7UG_!R'A^?VX,1;X\>?R?[X0IK^^?\ A0 <RE?O4=I^7KBD)F[$
M,DN+!)7UQH(< EO:#'."=][QO0-%KF377=292V<H54P+&%DTXS<;,!)LP\#I
M&I:Q$Q<#IX-<*HN4-&,6F\=DUQ)U0F& Y$E6CLI(BJB*#R ;X8<=:_H!M ^+
M(&761GKBR-0**HL!>P;CXQQH6$P3!IOS?8XG"(1E<ZS\ ]L^;PQ,[XD7R;DE
M/:MH\H6Z><9%_9^YUPW49I 8S&,A0ZMXY6(*J5)DCMQ,]XMX9=:,T'.%*OWA
MO#U>&!6)A4.;6DSN^N2;X+W#6H8R_/ASN^F=U1B#?M9CTIRXVA3*';7?C%-_
M#5@CHCLBFG!GNR' ZAH,4ZP-^DRS7,/6 !N HKWO&<V8.,+MQF]N&:>,U].H
M0/9G),=/$8WY]\&HCA[A"E@1$5<6:Y./Z!)-?B8KWCAD@<J ARAC4N,?#J(>
M44%O3K-&H2WDX]8OC!_W->R&/E_M].'-"6PVHD23;]]?+AI(RY8_8<'GOC5E
M 1(=^_8>/IQ:$,=AWB_9]=_(@P6%Q^9X#P[G%($$=*C&44R<-5KRNF+3W1TY
M+MU/GEP"6AA@@!+!F??><-#I$(6XON]>ODX1#V05G87R,^FN/"I0Y2,FICSG
M]..93NY;WN^:^_J!H((LP;SO3-'K7&=!CJP<)F#D/VZJ;HO8LK-Y2!UJ^#E=
MP?B?*:!X^#N?\?E<6"G7C'KE9KF7*>>L:GCQ]>*A\_W._?Q@UUS]+UX/C]_P
M?\I8>0GFTW[DS@WZX*L C3LRY( ?-I=G,U))LU\_$RI=XYWG8Q%;[7U\??F9
MGICH^L9;9W[\<<2I,N_&#X&3V5SQ7CQIG]NN_/V."HIBZ7$]P/YG''-;=_K^
M/T8W[_\ ROI?U:8_1ZX%N!104:/[W58GEX%30)N^!SG\+\\,UF)FQ@H.LU\\
MQY"V MJD=93SUCAO!T#3R!]\'=[L[X $QE0.LU9W)@O 0L/P8TO1&)95-CPR
M4=^$X*%XBV<2\152H((;06,X68A-\+^J4I6"X2E:[SO'"J2D@$"*T2?@T9A]
M( 8QZPH5HN^7&(QN*1&B5%52*<7SA!DFU7&1UR$(=X)&"^6<1]SE>)@4AQV,
MR6,JSB"#4KA&02EI/9O#PSGM$[+*@"-:RX\<)GNIUF17G8U\\G^LJ0*>-+OO
MKO:X6QH#0H@-^SMZR?T5 K0*_!E[/U/GC*(Z52.Q*\-M->F.:E5V" !+(RB\
M%YC@%;B_&NJ'7!8&")5 9"XC.F:]&,49@50U$.^R?C@1+I*1K*[/+>\)4/'3
M%G\DZ^TQYZG 35%]Z0^T=YK[AS<Q2Z?CTRY]?2LEP&:N9\.:L9+K&.,2XO\
MB,YSCQW<% 11I>^RIUD^/AG_  5$+EUG27[<-G2=N+J2:T_8]\I895("58X9
M*JJH90+Q C@%F/!4/O-=/>4(%^D&MK0B1'8/@.9P)4YE:6SNZ^G<?L/8Y4.M
MCA+ZSQLU2Z:3\NC?-0>.N_Q7] H8)!:VJ=E,.6Y";CE7L<5[UWUS. *J%83=
M/'V"<3<@D0J@VY]=^GF1'CATVWRY+O6N)0'B8&P?CQ.OH<#*)$ F:CAF#(UZ
MCQ"8H)(2MK[,SL4F.%UE"IS,AYQCO&9A09'H0KOW?#O<U3UVT,X,5[V'O7*O
M&OR9FY<^?:@0Y%$!IE9L/<GTODRF903#6$R5_0S:W/#@$06GE8(WOXXK%1F@
MPH"/2U1VN%F:0K(2KU;6?73B,V#5H'*2?5<GLIH(7:L"H)S+[AB : PT@"(C
M#C(N#IR\0$V @_37UK7;]2.P.TRH*!FW&/MW>NL+X_:O_)B(9J@IH5!G3TIW
MPND,J@.!ET%(^K\P"X:[!$5N/R6$QPR&50YJNH]?+^F>#/J'.=_8?&).^330
M 3W=^CWTS?.M#0C'00:J#85IQ[RAHEI$'MFP%&0:2Q;*6EU&!9EQP%Y28':L
M /6?'+8RF>[XJ&$1M.^N'%0P3T")0&:1Q'X &.0%D$[$=S71YCQ])HL5<!($
MM514#=G '=<)2(4+#2_W'U$;HG (&L-FV8>1V RBE/%WZ]?'&8(:* 4&,PQ\
MK*F>(4)1P$EF2)@JH.>,KTI98-*,@0= <K$%EW@IX6N&Y]\,J)>SH:/K/W/C
M^C7-BV7Y75"]3AL/;DK4Z,UUGSP7:O+8A5FQP6&?38YJ07L:L&/\=R\*=9S)
MB[ G>!$]7BB HRIBA,A/4]8WPT*N)!"^Q*_:L DXU2Y+CHNR7,Z%Q],/*Y":
MKG2W7FYV/ LK2E:!5QFC)HQYR<G0*]J_(/<-Z>]UG@,5P&#38YN'V[<L7!;J
MQ2)]4^V%N7DA?)/"5Q;;2?-N.,1-),'3+D^/%QZX]"5PX\*&5'3XF;.). .+
M2[1@V&B"K1.+15\H&'2UX*Q[F>/)P 6,7-5ZV2WPF490<T%P;8&?AUU>%ZF%
MBWZV5</F$N. @P"F"E*C-4,RAB&N4+N/L?XD_H8X%64O+KND:/+.1I250<ES
MH$4?W],M"IG#D\R+\S?C@DPL"-)B:#2Y=1]<>WE<C::TDSC,F."=$Q7- 8[;
MK&COC0M7Q%$7#ACZ^A465OE15!PZP98I'KC2J( -8"( ?)+5R\:B&8HAKL]'
MY&;WR+T_0L(@]KD+'$AQ$;!X^2XZO>V^7M7H CC8'1D9XZZAQS"M+49;&E->
M*8!YB074O?63$\GS\/2 ,C-E2:=^<\B"SB01"UH=XD_!H@C"V"+EV.M7KLX0
M@+>7(N9W7]N/(!1B6:7/FG<QUD+!5H!EP:SAOI;(W@8GL&P[ J9[ZZ3@07""
MGA+?G^D>$0I>8L55-,BZ4S_5F9F9F9F97&9]62^VI\Q^.1RM%-(@#3$$H,<@
M_P#VZV4 09=2Y+BS>"F.9DKPER3)1DQON.>4=;H.)F6V_I]K!*!N1D&]#C$S
MO!T"ZQ.,YJ<:>OT9+MWA3N$^FN_DUVEQBT%"LS-$[K?-G$)KT+C7)S[!DV!S
M+DX*!%H&LCU\ X00R$5DM25+BYNIS'=))50/8.C)$0N>$"9NB%2*9T/2LUQ;
M#9!#PY!?.$UPW*J "R!5L@+X&'VHYIK "P "!H4VSP*PHE0VW P@5#1'KEC!
M"56@=QH8WL+)R1&VON9*E$$-XL\L GF@!(R*Z)X SS;:FF .G)0QN!C?"LDV
M+Y-XOUSG0MXU28+Y>C]I,RW^C^A@;>^M<EL$U6R:]^._KQ:!HMF,.D[^#Y.%
MSAIH&$ED0NB3;R)B5@51=]WUFM\\L,V!V0#'1($![R9X=<4M#"SAZ=3*F>7D
MH:4W45WK&+/M\\,JWZ[XSEWGYYA0!=J 9-UA?4-9Y0CRER;D\FJ]X'+CB$B1
MC:T5N.F&^VS%JN@1;#-GJ_0YYA$ >#=(7M1 R&N1U9@*#])]/J< L 4*2_.[
M?7$ @=A10<8MQBSOF%:N%<8^,U_N%<<."4TC1S6POAN"%*!5 +PHZ\AG3\>^
M..19".7$?MC$:]W@("G8BT[BC(*@:"\1C:^Q-XZ3K^@ 2AFEU_"\G"8 H7*:
MT7.<?-Y!H1QH2MYMH?C@5T,LK9G<QUCWOD;GD8PF)N3.%(5,\"1K4&1JK%Q;
M"8\,W7JUF9>W!#&NS^T.@ ';&MG9J>+#EH"6 .2TQV:R];O'.!$!EC@<:GCW
MLP<>IL1:EQ$QT]G9UPL4PXU!FIX[ZWZX:RF #%*]W-&T-PYWF:D?,/.I_P %
MH,#XHL^GS?2=</15>SHM'N%PN]=''@7"%^@?R??//U7]7$%Y!WY;-71F]^>;
M$)(>LF3[+X*^N(K5'R\3>/MO??(&#1@^#7X_\GFD@O8-H^=)K@[1K>MW/1?E
MR9EX6F.!P8H=W$0 E>N9/@&,D*,4&)*QXX5M9:!@]^Q7X.'8W!PG9'D"IF^-
MJRD X/"=PPYL3,7E JP&/B*4EFFXG&A12]DT."#)W N@=D%)*%S1G&J%U$XR
M2E=EHUZZK+Z,\:5/WH\P>YEU&L\4P$%#"PQ)JF?DX.L1@PJ]O#GSD=$U0!DB
M$'<TAW7[<S9$:&57#67/U;Q@XA,J^8X*^!.:GB\%63;(6VH_2;>.=@MH6\7&
M04<J[.%C) %D4^G7CV\1?6KX9TGS_$X"U*0/EC]4^G7K^CY0=KH[7T=\CT,Z
MP_MQZH1!44P0Z3WKK8N0U4<J!!&K#Z/'PTO"H9%3*1WGSDRPPX0W)H&,OSW%
M,]?AL+)TDTDH5(:3C:*$Z[^I?[<O&Y"-BTO 9R]'0-8%B-0$!+TR\4?I.)*!
MGO F):?8J_&#DHB+H!.F/BI,N3DL@W G<30Q'MR!RF8;4* :TL);?O.#5J4@
M-2XH8W3%-;G)XRB90Z&D[83.<Z1-(=0-9X) 9EU>,DT6VPQ&A+CWG/3P80PQ
M.PW!FE*F?*)0DE%,(K+LOOH0G 966L45JL@DK5L*%>$0: 5 50F54*C0S,,0
MPIP29\.2[_?^A44 <4@Q4V/1[G?#(AL,KAS,M\IK+BT]@+D9T6&?)XSAW"FH
M%*00BJHW=PY#,A-A @92AV!EVY-M9"T!#9Z'5IYY!F3D06NIB7Z8\\$8 X1)
MG1K[S-C#B)A &!B8[# N8T,YYUC]L%X\2'K<R<-N06\A08(6M)][R[44!Y"(
M/##9DOCE$13+ !P#6")@]=\\,YD WI-._?@/.*  C,/WI[\3Y)S,IP5+E]3Z
M%_0N!3PAD8%3/0CZ/N<>@DW&SYIFXFYRB.XA@!*0L/#@Z^>/U@L%+L9#T6RL
M3)K+3;;IU]L]AUT$FR6@:#7Q]L?G'),>,?U:!X.\H@@C02($RR]/=BHA,14P
MQ%0UP&-E'(UFF <U3D$QI@"H*8$44T!@05XX7C: 8*Z,&@#0"'#%98*"D;!F
M$T-P'&00QL/(F8V H6U&.J4/1":>]/C_ ._G'6NF+O\ C'?,@'H+$N,?W>NQ
MXK'&@5IJ9-=;GCXL&QL95.3,-+K$]\R:#**J=NKFDS/IUL&*&F;E@HJR!DQP
MR:H)M@!N8I" 7C$2V$$"!9*Q3"(=\P-#EC2"(W4-RECB2]@"A$6MRRQ[KPUQ
M6'5=  XQN4&+3(ZA$0+ BN@ [TKFO%5TL]$$'9R<3.73$Q7K!H#0 /3/AZY#
MB!M=QRRJ/C'@G4H@X"N1R> *IT61YE3*E:#$$2""5,9Z7@.P$5<U3.>C&;\W
M.)YI0U09Z08E9C6&I-5XG\H]Y_0/7UTRTC<9]NOGBA5S0/:L]8\:/Z-RP,_P
M.^(U73M^VIHB.#XG$'E$,D1#329.F8-<8L2(TLP?X/6+Q',CG6]^NDQK)X=+
M-*ERR.GHW@$]=<MX;-[MN>Y<&USDD:JR/@S/BX.L_23AG$(CZKG/A\/RCS+@
M&''GM_NX9#5%3,\@B89D1-8L>0W4>R"JY)'&5P+YX:"MP5P,UO:#NZ;>=.#
M\D%Q:1=NIOE/$ >^I/767:<W0 NVCA9E=$BB,P+( JC.!R;,2PVOQQA2U9T8
M5J@US AA=<O9#%8V-XU&&#B#&4$4,LIG(H-RKQN" (I5S;X,%)G-;#*900*R
M!H&XKC!#7%8PECPHFWOR_H)%,1;Y@^1O?TQGC442L-S\8^3(.?+192V01CIB
M3LQFZI"4&"8[8S_,<F\'X'!ZWL-YO(BE@A,/9^F,94Q@SBFO@-E##,]W+'4
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MSMJP2(4.[*>Y SB\ @YN6@D[I,Z<R":XH&**#G+QA?G')6+ST5W8H$]ZUPG
M.9-DP.ZJZP.>,/"TX2]LCG.8XLE9.95*"A@N^ESD<YSCUR 8P.@0X%=PH0<*
M8..(# 7M63[S%SX9P4Y=LZW?GV!,\8X]58&5U!A?.LZN IS'M!A@S>B9CQ9@
M!$I6 .7,--W7#L=VPH>AITYSAX^C5Y0 "N-SNUZ.&Z2%P'88;4=3@P!!;&!J
MF1$=Y$/_ &0V<%ED3[.>LO\ CL.!F+B0C9)4\Y]\P53(8?A;'J;?F]\<3 A#
MRY2_!\KKF8S/ C'#Z*3IWT<%5#P<D"LZ5/$GCBJ*&56F H[[0UXODXRU(^AS
M)<Z61TC<APRF+,HQ&X GZ>)7)RO@"X$4BH:+E-;CC!1^, >Y6GAN,,-EV30K
MLWA.]G1 L9)2@WQZZG<O"YC1)2@ S(,O1AST:I0AFV*J]E#Y%T4Y/ 6@-WJ^
M,O5\^N;E4UR=N)7&Z]>W/"9#)Q,$.N]F-T3J$C"<!8!#0FBPWQQ3!4<2$OBW
MMR2\P$":I-3!(7<^.-3='.C(T#6''O9B7^A47'>\ ^X)Q3-@R*ARTJZ\XS=\
MQ 59!<LSXW*N>N#,7T0P&Z8T B.S20&+^/C?V^> #*:A@DEO8H9-B\-A<02:
M:N9>D5A-!Q+75++R1T*"UHA0X#QR'8W(!0  385-\)AGTXPA;Y?YV(L80\>2
M-5AG.+WR;"%?081G*CDES4%XO,]<ERA9ZSCSWWSII N].=#K.1]W-Y!"4.RD
MA?C!/[XY0:M4IV9/+/3GR<"AAO!26S&G64WQT E!G",N,W<L(]8X)8%)0 V:
M06:#L@T2O+(H0Z'0&96.31QD1?Q*"BPWOOZPKKC.+(P"T5]\)&($"N)[?J7_
M .07!@#># *)88K5[7G\2Y_B7/\ $N?XER5"40,6L!T4L8QZ=<::(GI\^$TC
MD1'(\JJ6<4[$$R9]#6#S^)<_Q+G^)<_Q+G^)<K$H]F1]T?<>)P6HVK^#T$ P
M '_VW0"]PWG#ISP9'622LQ963)G(I>!! Z!@A%:Q!)!Q94&NJ&U6+D1 ,QLH
MLQ<",4:HPP Z0=+9,.,16YD@S/M[X52UFPS2M]H3"^>3,"FF%J@$S25S?>#C
ME5!F>BSO+8(PNN,T AR$# NH3*XV:<5-L@ZH% !!1A:>5UNA;HJE,H>$P0R\
M@2",$<W;CT=\Q)%+S1<1CEF3 1SR[THV=%#--,PLFTO$20ZGI#/5GT;,9G!1
M* CIIZ(X]1[MR/4 BK* GS5,OSY0N%Q2ALIN2FC[XP2I('HV**[+N_%,#B-0
M%,X^=];WC/,S,PV? N<[OWW,_P!$O(!\FA]0.%D 1C@CDR.T;[[H9!9M,6 ,
M#ZYQ?EQA:%P:O(9.O'O#8QP=_N9<1N]<M^6)%JX9T3'WW9S.*9!UCT#+UJ>.
M9=Q(J J"$0HBQG#KF(<#AF0U4!9":'8\,V&7* #-,]U/[\I4N:@=I;C#@<\Q
M!IQ'>Q9P CW<VZ)K(]$HY((-55S<GI0K0$6L<3W,31P[&A:M/CPO??;UPN!D
M5HL3'6+@S]>!.* HC,I<@YC_ )Y*=+(VG8&YGQ9KK@O(H 55IBT;-V\$!?(6
M#&@,7W7&:X)FK[3J8D8/RHA3+";@$YS8#BO9P<(Z( C 8+*//_SG#,R\8Y^-
MZEH42N)O63VMQX#0:"!@_P#!*JPS/B_!\/*D".0 "!;N(SUY)PT0CH,@Z5-?
M79+QQ4:H'&6M)IB!US*EJ,A.F9%VF"[O!= $W< 4^YS7RO)HG860-++D+=RZ
MCS%@ "N$9T;9E,YIPKZ(JBE!TC3N?'*,*%469&X<D6.-\#\J.EK*0LR,FSYC
MB!=U)*"$,L#&AYF1Y*J"+)2B&Z9GD90 M5L#'ZF/GF\-!<FQS)]?+ZO'SJ!$
MW8O6,]I>N3$  &3$WK.UC].+!0B99V$]N^^AJ+JY8ANEZ'O?M/?'-)=.;@N%
MJS+;D^.$#"1C7NEO>\W?<>! =(EVY;DQ]"_T89"BE"T!E*8-ZY>&6EP"B07Q
M3HM-<$'D(-2P)A\L#:<<)D,ZRS;,$M6![QQ71AW<W&!M\SQURO)&.D@R7#MR
M8EG9<#LK5P$\E"%>\,<@0!51H!1I(X((A<SQG1!::5S&RV-<2Y3$D(@Y % R
MX8]O,P"K((.AQE[ 3WWA:8LTH7E$;+?>TMT'?],?UTM6DO&Q9)PX!T%[,1OF
M)D0&6&8J"A+B)AS(SN%^P"*)@U3[4Y58 $<@0VQE<3ODW[@>3,8'@4-/CC=?
M (R*@RZC+"1XJRS(4"HA"6?$*Y7?U-BD!H5H"[^G#Y.())I$1P%KJ.9=17PT
M(8QJ?T I&SE@-IT'PJP!4/ZPX<.'#APX<.'#APXRL"J; K *^AKH%_\ -G6)
MH#A:IP&2FW$UP*20"$5!,>_B[X:KDP!&*=MU3>^G'%*]T\&^LK^OSP,B5D7
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M7$=8,=T.!)K0O=?1DP-G6'F3<J".'"[R]]GZG%XY+;D:&)Y+W'/!.( 2Z!#
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M/WXB#6A/I@0N?'_ RR%$*4M$N1&DQ&ZXB$%0 &U6 'E>)HL5$PLJ(A4+JO\
M^/WSS(F2D9Z5< 044\GF!%H2$%8A&F"@D4$,U/"(??'IA6QM;!=C+3@5T .<
M!.N"2I8&@46L%FJM:29-((.A 2'9J-G$-):L\A0EN.H1?_Q^^>6M"  U #)
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M\-?M?;!]S]CZ#*/95^FR?[Y!=]S$3L_9SH'GT_R<]ZV1?.L_A.(G"^SSBP[
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M$G*Z?U5$$(1&0,E?3[/?\N $-7?;[?XQF4T'GSO([J_?C^3"*25[G>)VMW+
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M>G/)X4A0WD=>[>CF!M:&![EQVCIZ"$@QPG*^&C\YEU^N^0O4&D3"S%3E*O\
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M8"[Q AZP3)@:VDB3M"W=M9X4KB<1N4&'$,U5/3/;A(1]*CB*0RAH@G5P"#B
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M]L*":".UH^>"W>O&0$3-Q4=ASUJ=.][RY"DU&;0XGO\ PS4GGXTKL<'K2H*
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M150A(4QBC6?:->Y*+$PZ!.!8.S<K8&XNLO9 '^Q'Q^"6 GX?^*9,+34PKR$
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MJDGA(@4@4@&.9"A3C%A6!=\QCOKKS_? K='R_P"OD# D5YJ9Y;2I!C 4-CC
MN8*1@-V^&%+$I+I":6DIN1C%" 7'H08++I3$AES[:9"6$ *!(DONI&(.0V)(
M/)P>PBX]4A*N%2K9# <T^A-7RF_=#"V<<,#U#DE@(^*,[5C78.1E!$'=3*JV
M7JTN,!L;HJK7,L&Q&0>TP=K<[D082\40*%D-'&S8"QI4BJ(53$7$!M+*O&W;
M0(EX(C@.T$B8\ D9&1UO\*B5+-](N.".  [['E\%I"#\^J0X8T-1LU<(!I03
MJU#HI$  ,#]96H+TH,MT;(UDVU&N3*;#8C T4Q(8\D<Q. $;SO<XN0_7<T2)
M#+&<1R%U!^<#,/![5;'!+E)S,!!L\<(\55:Z:<,<)R])N3Z!B(&Z0B001W5<
M:(;-MG>W&+S :@A2ETX0(6&ISX\KC@BO@;W+NCR8NJ4H;J$R,.S3Z>?ZGBO#
M_@?#VXVO H<]0\]OU_Q2T \5=P_'[^^4B)"3G6"@[_C],B@3>CZ.^.#E^F&P
MA6F-NBX'395IYY,5Y>[6[.VW[J2*#KX^84?!1%0L!$*L Y"2':C??\3DZU^8
M;;=\;.OM[XAO"EN^?;GL;CM56;!B.R>SE=/'+#"HBIR!!77$</OI'ST*4&V!
M3#= @Z6?Q\C+/-;AW5>+#OM$9@[T(([5:= ER<<V]8O@+R(E@PL6"$G#-V^>
MZZ,7]A-AJ@^;S_[@A> _!?&;@;1044H@)KQ+1+D%QR3)>ET_.HY8:I.;52T;
M"@I* ]X\%66"UH*8\I[F,:-?JE@V:#SSY.):1IP@/OW8ZY-./[074PU"74A>
M N 13J*@S-0@KI#@IUW7)5PZ;5KN@\;Y^ODUX&GY$EM])2/IZXZV!?4$91LG
MJ!6N3S<&P;0]L455!J,*6(<O2$(-<:O2E6< ("IQ'2SA4<M.-^BOB#2EGU+F
M4YJE T%=<GQ.T0@Y<B=#4^7:@YL$QF; 3]:PZ0D1A=GEMFT*VQ*B P.:'^6&
M-@JQD1H'C3KYN$Y:(K9RR8Y04:JR$AQQ/;$)%$E7#$&1JF1M4"?>:'<MX]<L
MN#((4,'"+,)QV0>8+%C9I4KE7(@S$T,2A,'<]B5^L'BU>7#BG^/X]C.QA@$
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MC6*;SJW^?R2X=O)QAMKEU/<]INF+Y;XTC%4HVP)%& \MT7BT4%="+8FF2/\
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MW.)'@0-0)-?(&4QWI17NT,W^WL2\(2YWZ'F"3-PDN^<B!=0)6<PJRKSDA_,
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M## @*D]E*@,DA1@]]@YPG>_/3"VXM1O^'/-<O:JDQ4A&D!L"(AYQ!B:MRDA
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MU 8S+   '!>*=4<H!3+@">77D&Q?*&@DQO<+(N:'H;[7&BC)K_1*8E1N$3#
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MNVRF!!.=PVT0:6XED($H\')QVRFUCA"I](X]$'#G2\BOU+D9WA@K-/'BQ"\
M0*M#: 6C?3B%X!% (Z M&@NV,K?4<8/O!E.)6 1"YH\XTU4%?,!5.)R.P$ZP
M053D5=OM^_X^00$@_-)[T((TS@&NI6J(.!A9JBXPPZZ!6IC!X++,%'D'JZ:"
M( =S(U"\[NE2N!Q0(N'[K2J8T:X)G2/ /VD:9K(,5C;90,14X,S09-A===AF
MI^04XNLI BFD\HMO 4*70KR8087:=;G<D9^K35L^1L/#Z/DNC\+9/^XPM-TQ
MX4F7'!A&4RIN$*0E*DC>A@WA2AEBD:6%@4 R^<"E+2+LL"Z8O.Y+:LW,#M;&
M 3,WV=2@G LJ'6&M3C4#].99&%&HOKB)DLIE&2VKETU7?W G8C\;AR+@$LRG
MPOF$&$?-0(2%[?+3.S9*%Y%9::R"%8"L-:\WLG5C9139\>/AH8+"00N$!@HP
M=30.H4: *NLE>E3K1[%&G7,IK-OKI21 P:'G<1V?"Q$6L5'S+&OSQ?!+9+<%
M;+-_R -J&E!(C#/Q&^*EK_._L+?K] A3,7A&Q;;;S& V9LU:4H#L!A@B$;-8
MMDW*#> !Y8%@"@4("8<PTI.*W0M0$2Q$<G5H;9#\WYEG=#V=F:&3!),88:JL
MT>P)LAA7GL"@&!4 0L>&VK1J56CS*2 M@O1@0L#3"&@#7CA]L2KB@Z(*HG8(
M(!0/*)N3Q]OPV*5"XX%+$IQ-"08_"DXKH0>HM[7LF(2@Q6'<<QH^$.#),,B5
M4_[N5%\(IT$3OV@ %T#HO[<IAZN(;9^40(;:V,OUD;-60V\H)'X@\P$FU%+Y
M$&O'[*GO1"%0[].DR'P&-!U!5#>+,ONO6#50[0I:*_+-F&PRH.?)Z1L"'LR5
M@^]3?@BGV728 ,O3VQ0H/4 .,TG1C!8'!K4F)'V'+7>JOM<3M49!FS\#HB/H
M[<AKUL4 1N('J_E?;S:=H$R*/"-XI%]ZJ:B!ENI][9E?.5D5QUE(5][_ (FJ
M)I@IZC?\K?=J\_3MZ Y7I,9B7AW]W T<Y1SZJ!G\:\QX[:90D:*G\?O*80+$
M."T*A&J#3@!K*-AQ01+V,S^0_>'-)KNI_-#/MC!CH:%%,,(8RY5-_.BV1"-H
M2-S^0^>''0UR.?40GWR]I>=5.;'C#JPP>WP)'V"X0BL<P:]\L8*$.C*C@0*0
M["+IV90O?UL0%X*L"XW8!%)L&/IA!OY[< #4( %5 *_)=27VUZ@]]2D3(G(6
MM:E&H1QNP)*T"/'%!.-B4>>)D@$D %#;:-QL!0BHP)G$MP)-#IQ2/M<V#"8A
M1=A<6_!P0_ S4!NQ=CE@;TC_ (_E!=YQMXP<-\:8,@.M\P4IO)L-XQ5 ;1NA
MQ3'@BQ88,^!S@P"BY7(:)-Q&G5K!@1:>MW_F6 R+,><!3E_;4\?3'H_)?XPP
M*:$Y=?;]L"EHDB7KST&&[M4S1N^Z4WOZ8W,NVY8.N "U@+BZJ'E$R3NJ=QV%
M,X4]F@MY>U5_E15])]/+_P"?D%CX/':7:8K@6@]Y8-)L58E1KG"F.C)%1\*@
MA, (&+[9&\V[9E0JT'D([OCL(L1F3.(.K<D@0B8@:;!U&:#:@MS\%,)HB)!0
M3.>6(>*J%YH-P24,$>*"%1PM/9 \%A0E.-'+]"6//"7[6SPYK=GIJ7N[X:CZ
M[++A=*<L57R,/PIMTFG:$@!9)%@/&CLD.2T::(*5%0TF.(H/C 9Q5,$T$?Y(
M&K%,QCLNK$F,JFF%M$;A<[2< E"!2E9:U/\ !P=J:K @U31'(@-",9D"P(:N
M&!.H&X5^,.>C;Q\9BS,Y4<55N!+/<MH8Y2HG>T7P$2(2Z[QV$'W:&(&'55L#
M;GN-PN*DF:8U.,O8-<B13*!=BQ&/3TF!C8(3U.]@>KZLDX41MT)H$8H+M.9K
M#)"BQ&UHI06]W88$O UD:OLR5&>D&!/V4S)AFZ<-K',H.0'06C!1P#;<&]MQ
M&#,O0=>"?2JT116PN'QD"A9@:VJ^0$!C[E5,CZ/ ^%T,;\'A2611?F$,%-DF
M!W.+C(_..XS"!(@H!D721AZG&-PQ-0R5@-2EN%##6?MPW"N=T9M3< J1KSWY
MI]K<\%H%[(0P&@J2Q$P1A\&U-03,LAQ[9082%^!0E^+ RR'?RO"\L*,2JAL&
M$P5B!L$75-X*9V ?(.2M'"KC&=2L$ (*)4A8I 2+"3(W<=1W*5031KE]4O>7
M>8,1H)^E+B%5+M#KQKQWTS-@IDJ#!2U#=3P;-CP!0)18(A2I7\/#RG>F$\H+
MD:-%NJ7C4]2F*$;:WNOO^><8@'4300 J[]M":FK8C7?5^8+!=%UIN\LLRO@U
MB@$!_P HZ%!79I*",'9J%4XV8*2 FK"305LAJFM.F=LKIS9TC::W)$N<6<JI
M%"24ROWU((F+5H46)!VNT"0T=CZV@YW(PJX]U&KWTDCN'$AN0+2;"D,X#1EU
MH'VUG7(K%:21]L2&UV%]<0M4ZAB5AZ)U1Q,A&\-*!%@#H*R%+"YZ%N#T];6]
M$C815D$<SL#D?DH708H+@*D\-!D&S#HMXS LON*FQ"0Q?) MQ"V?]LEQB!*&
MV IE%!Q/Y$4GI)XG<E@J\HI%#&6M9 &1T:U:<Q/_ #IK0X.QI&'?8D Q_G<)
MB0AWP0)S8Y#8QKB.6!@(!L0C0XURQ.6IP--QI%-G_( @.V'P&II:)QS4,<#!
MMTC0BFG:#8DJJI4)O-0FD%$BK!XFW1Q7CW1?;IT2:5+:_L,=?>BH8B 4A&,'
MQ%&,[QJAN84-I;H I1*=9%SA(%7#E46A1H =.1 ZIP/&+2G@'9(<4O--7C&:
MY/[D_P _(;)]1U)XX;= ,#H?F]46&FV &OCI#J@9V!T\8:(A]0?,(Z@0**&L
M?Q8^R2F@4K*X.43%W!A()HW>BQYF1) C8H8;$);12A@* !P1ZPN.][48KE3I
M1J4YLJ2A7.^,%7AP\DX\06,BD?E\OB[:&IBS@G1/%SM8(H)SD+OR"Z5Z38T0
M]M<([F[=:8MXMP38T"8_K">5RMJA%3@?!'R-%")BP(Y2:< )HW1EF6X8X"F6
MSR-Y3@:^LNX!!6J%0>/!.@#7ARO3(15F%JS6<12$3\1/B+>F\Q?H7D<09O%,
M @(O?(0M!\,SE2Q8PH6T0I"Y;K<-AC98I(*JVCFTVC).1-ZT-H4)SI4QPLY#
MB/):YV)GF3*1B5=&"R9P+_.FE1&NV71*[6EQF1G*I7 P$<@X5&F<1/Y<-D@D
M:F%#8C=6(HY7%9V)B(N: N[,) $!H]@6:B9S#D7D$-(;6L!&@OQVO*%TK@J
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M&Q(*H+;)N[W+V]F&_N2 5<P-H >'@\_()6/208.605.4!7*OT)2RS#$Q 0$
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M)H@MG#+(TD..2..(2@"TE;[AT6C"*D.M.I]8,P-@RA@P=I%X"60(P^)N@U$
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MR$U?L1J$)T0.!C'3^@"I0#>EP=PO@T(>EQ!)M ZES%!^-2(*0; Y2?LRNKK
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M;E^"89<W'V8(Z-2B2XB:E>B"QI,:&9VX'F%!JL\(3H$[$&!(3I9GD5>IQ7^
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M3PJV-8ZRZ&%:9'I&R04Q_;C$PM>36&%5T5(K YXSDC!6NDLP!& D((@  01
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M0%8+6BRY+>]G_NTTU9DT#Q?^GG"!/:2)!E,N$,@*!O!D%!%08T:00 (,7@'
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M&1 3$2?/+I S.J$EC(.YU^\CQ'P)@EIC4)WH56)J8<76*&W*+$ZV:5BSMIC
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M.S>E&[U+3QLZWL X-P2!)<Y6F2J2!CIEK,0IY+82XIB16HF^E#T4=JKH_4L
MCI>V<>4X/#(F26-VR(:"2J978$%,12&3.S':&-_Q/0'H:>5$0<6N6QT/E$]
MP"8 4&S39(1IFU\61@D%PX+0!+66I.$ L*>? 4VG )"6F[/=1A6Q9-VD=1.H
ML"\<'/MK#%8^7!1A6QP4O$K@#1+.<SNRR2J8!)\D"K:] IB6@V&]SK:K\F3G
MJD<3S=<(2  H0 8#2/)H.0=?-'CQX\>/'CQX\>/BW )+Z N/Z;>9'U-BPC!3
M*P-;SA%J/&Z3NX$:X-9EN;CX/(AT'&\,I- ;&+ -A4!:H5QZ,K1?CTK K:HA
MWH6VT"MH%3E7==)!3[C(.FDK4:S$84 \==HC>0,A4&1=ZQ\F^BXR1>1IX966
M95 4#K?&MX"E88&E99=<0*131#H7Z0Z7[@X%!)=>D%@:"5U*2KH1D"X%*9&2
ME!!!04($E/N_\>&==^;.G7OF-_/,/'.^/>><.4@"!,H4Q8S-*B%MI^V,C/%*
M;.94CH&5R&:0:DV3X:'T]G?B*Y.-^;G>.33)09QBL5..^2BJ7TUH#K(BWM\Q
M&MWL#H@R3_A^U[>Z$*KW;((,Q?2+C;)M%AQ''^CIC3_?8L_@7#@FJS^7,X3<
MJ37-=AX@LTGD XZ!.41B25*"*82?/WJ+1X)XE"5BE!EH*1,FM:E#%X[27A@6
MEBGMPE%,CA9+W8$1BQ4&1^CXNJCV)[1[?=D";^9XI&H/:708;-V75CO5!'6^
MVGVF+SW5 Y?RE!#>/+3>:FU0 8+X!0#:E8(JGS<IXSR*0\' VZV2HZTTS!\9
M(:8#=PB.D,@(RD?,0G)@#QNE,5"B)1"*L.**^C,7@R<0I8(0TZ:J4Q4,BC+)
MI R;S5T9(G-X=72#+([HPANQ95TDR;4 Q0^/FPZB[$$2-X#I>W[!I\BH&=QW
M#-V<D,IO> HEOA2(Q $"2:?TI@H/.9T96'L3B8@[^SC8OFI_:6/ %KJ7!6G*
M9*2I_"&U0+ _7V9^J_%?L?]/^O\?86V/8=AP@K2T\;U0HD),<5;R@P1698YB
MF VK) :]T_@IE!&65]C'D%Y*CSZ#\9]Y?26@Z&?SGWY42&KY$PVI3U6L$+PO
MD"T=;>IJPE0U1?;@(>%/7<-0$6Y2GJV-#J0K@JP^CUZV2 017.!GA0D;UB;&
MO6/^,,/4H%])F*7+DKL 58'*C-#A47YGU&1W_TCG"1E7F?!3$@IEGC(6%:>3
MQ*ZV3<8MY]%R<OK/3#C73:?B0=);BD-BJV5=.E2!AT&[+,"89E0P74J*M'DO
MP#P>F[G,>7I7)T*[LP=(9,3L.-C5UZZ/Q!30$4.SBX/R7CAWB0BMOF<0;0?P
M0<3"B'K>Q'4;^9NHPV<Z,*,EX@:_WXB-.DYC>3Z8%\'+'3\QC9]R"0O2:V%)
M3KKS)&<^;YC[>*U6QV4G;$$C);YND![QH$,B'[ERHXX_&<ULR28**O=Y=["I
MV7W7YZW_2,+[#!I\.;AD@X./=93+H18GZ;=H4$^W';OC9?598OM+VD=$H^#6
MPR8OD=RU(.FX7NT&5!H[AE-IB!WNK-?:XKY"41Q7Q![H'J+.\E#D,==)Q5;!
M;7DE6PH3B5#JJ*:GR!-S+YLN9LRT8)6)EF'FKE%.Q@U@#,5)]#RH9,A^C<)6
M-S9=QUHX)6_@R+\P,1AGO>'\/._/X^_ ;MO822:>+Y(N8T[Z]RV^EE@MZ2:P
M2:CXDUS"UH%:FC'TCR^YG?^/<@@:379QH(>5]*F)AW6;)U&SX.)63SM49--O
MD0FH?ZQ &GA76-X Y!!H8$)Q*%K"D[@B&Y-I07?,NO.H5/?4+QE"Q-KJ$C(X
M$S=H6,'.=\O3RTU,JM]LH:I<[W2 \BUU3%=U[%TC[KDRW[=&,ASJN>T,_+[4
MC :L4]& \;+>S]V4#*GWB-B8M(=5*3T_,RD+#6A5V(+MY0F:(@NB-.]'?:,#
M-[WOBI$&C_["(:B"JA@9K#E#^%F!5R=)-/-I)D'=?/>Z"XCJ>& QP;/:$4-_
MDLQX&OCX,GK^H@4(Q\GIX=>D=$M9;$9E37H#0O3-.]S[P$EH;^Y^]T6^_<0D
M\FXT:FZ%TYT302;4BWKH+?'*DZQPCN*;N4II 9,AG_"ECRP?%_"!"-15AH6U
M8NCO-M0B8:64>WG6P6_KD%5]';HCT] 8 ZB(A/="9 ,<HIY^"N:;+$)6L:+;
M&V>(Z(M*HRJV*PJ8TX6=C!\A"DH'(!9)W**,\(+;5QV1&<FO9Q[[*2DJF)M1
M86[;#F9^&7[5I:#&)(-$O5XNIC$$5]X7*1K-ODU&4@\\D$HY_%WR=US,9K^T
M]19Y06'@0A,VW9X>J>98/,=S;6^Q;<J:WVF-/[V;<(WJV%]2A' ?7#S?FNW2
M*US1DC.INPV 6RG@TCFW.7:#7W7%6 S%"'PR#3)1Z+[PIDX$^%62WAF:!@9Z
MRIDV1/@9IAO= %CK]=ZKM@2AXGM?YB:X[QM09U>J>OKTW&)X:N"_-%-+JSE&
MW*YM)&43"C9O<18>F*ABT[&LT-F^@TQFX34F+49ATT;AX"-U#>8O=/8Y4I4_
M'>^5B7C;24U5Q#@V$QYV#9F+V*%K*77MFVV3UM\=F&>V4M@7*1;%CT(_JM6/
M1F-%@;-+_MO6H^8D!AIN6,ACKA+BJ!4336B)7C45K02%Y@/-K7,HPG-6"EPS
MU27!GCMS*#.<JO<@:IK@N;.7:^#:B-C)!+WF/7_0WXJ+M8@3@Q.S\WHXYY$3
M*!F7RHHFDM4@6WDISZC:T@8> =!(UT\?9CM^TN0:*E\G8L$F<?=-7'?AB0^]
MZKF'Y_/IGB(#YP=4\;X*BMI9.^ SQ4$&E$0)><C/RBTJ(><??4QF&Z(C^TQ]
M%#X:7^D9!JD0&[;N^11SP^*9R*\)(T7OU+W%X$/W[!R76^$(U_DW]T>\*,Z+
M#R;A$O#SV0PA@"_)!V>E(VW31$VRC+>I>#6F'E[%&OU*25BBK$^6.X6%WJ*R
M$')ALW?FFS+;6CU>9Z#FV<@3GP+LN.=AUT_ZL;W%8.MW[^7:I%,HBC'UU:O#
MQ2_K/(.4A'Y'7R8%,98$HY&AR%%=@:D OKL1Q[KWF<M6:H1"43.BE#3:(U//
M$X6DB.=KDX0&)CNAQ[I62?Z%Y1.+LL)E91BMUP*3!6(TN@DC.Q)YCILS*X1]
MQ='R0!$&L7K."'J5D!/.O3V[$QBPQQZ)\ 4  .!-T^FR_$]&3J=/'8@NJ@V2
M[GPEEMPVB7QK^Y'4 \<^]\"(^1..U]_Y[!6'IQQ*HL));>F;?'#WQO<&,2?-
MI<5!F6@8=Y/Y:9[I45Q*OCQN7\PU\WOU3W25L"GQV98>8RCKKT41OTTS^>?B
M=U#I HIDW P#?$KMYJY15M94[ED-B)^A/P5SK[W#!"N[+@HH?OC;'K7<,YF7
MB+58;1L;?QRBMO]1.=;OK9Z4^CGWG"US8 ,=_PX^W+/O<[NPWU++IAU52I+Z
MN\QFWJS9@3)ORF;YF'&?YR];9)85^U]7:U'!R%]EG8=B[VCI.V/P4$D23?\T
M:\?.D0SZ ".13>T"HX:8%]F<.)-=!.B0];7OLU;MOS-< IT2*^2*KF00O  !
M]GT]&6PNM+I1/.LQ?-N&SQGD*$EE9,OY7@?6[FK&&_U!LXH8*0"5I'4\O"-O
MDA<3S\1*Q-:X3?ESDA9.F ,N<_[J(Y.+>^DN.?^CM3XL5:C\3K1;3WC/J9NJ
MFT6C>L;8>3?UJ<BY^Q7I:F='%)!-(4K)+@ASD*TQG#GA'2>G_:7WF_TR54!?
M2=/2UR4S%8.0.MIRND!K =41QN>/\XLW#'EE[GWHB--T$.&CO0VD.MCP$MQ\
MRW"\,126@*K';+VQB+L!<&A'X<]RK*V<;5NV @F?U4&UT_(D7]3)^_EY$1G.
M>*4#@7GP;2&FRWS\G4>.8[A2'^/-UQ S&:(_5'TUGZKWI%OBU%T>@\Z@LJ_?
M?Y@(WXPS(VW%$J,$4N=XXTDNW,<YQ:Q&AU&=EP.I #+GMNU!0-=D;+\FVT^%
MO/.];R#+VC6%T:2!&N7<<D73C?;LJ-R3Z'L<1^+V$ Y&HR]#("8/+6^T!\G!
M18YQ ;>T>R]^7'&1=/X,31<E3UA-US=7,9:1BQA,4^U5!;GYJ?GJ<Z630]1@
MDN."//J=A?")-W;IB0>P7I4>S=HW6>=?^JFF J7GO7KE?1$I;/4D.99+ C :
M^AR!H##%Q*BQ/1Y!FF)MNUM)^I@QH#(]YK3\P7$C!",Y-C49WAPP]44RAFI$
M;.;NKZN(5'I_&F5RN^GG&9]!TB9QF2"H?NX%" *E37L@U/]@G5ETSPC:)/I#
M$V#V%_F/3</5J[I__TFVFMZ%N/^!0ZN[*BA/>=^#7ZR_I6) \ _]VEIK%?TX
M1J7 UV9LZN'A@F'F$Y#J\Z;>]K2,6:4Z!1[S7C,)WK?(\&QD]&!Q%G%9_>R4
M%]N:%H'*]*&#D8^G3/F04)S=TG(>J?;K0-5=>PJ/#:5T8SM^Z^EGL>32^F[)
M"8_!ZI27(9X0*?V\(/]=Z2%36 *&A:9^L%"*I=\Z*]QWUQP%4]21BOI,*8U=
MQ\67\1759.8C.B7+IS4TC24@7K8\J#^5S0=0" V)60XHP('5T.=.:ECDU+73
MH]QO[L$O/("@XSL;19[A)"]$P_J]V[C9,KZQEW.\PF]7_[7G/U-,40GS!=4D
MYI#J_7-/ "  "V"*A9+C^!/TC0.!J L,%M[+'!M\ECUFU<_1.E;/[,HE$&8G
M^:07/C2[S<<]<\@OK/Z."I^GT7.-J4-_D;*#XRR+JCFC81>)@%NAP\:T0UY2
M<^#Z/OL9Q^>:#:,=&N2?CTKY@2PDYK=%K:@=$R6PV&4K<:3'9  T.)6XYNM*
M#H9Y(3J3T"K6Z89ES,C5:Z4)VZ#18&>?QGD4?MG4J #A\[UL]"5D[)HOD@D+
MO D\B0GR^Q=3@8'5QF'QRC!ES2H#%_&PA4'J/ "2)<-CQVW%,7F"0()C3%'X
M3J5H M+$'E#;M;2?";^RHU0*8U_+*,'FJQ2AV/)YN('&<4+$V/4I_]J_'K<;
MW_T7XQ(;_![6=G]?IHF"]O/:B;B+X>KEESR^/&_,_L @X7:7CGD$,P9T=_0^
M:&)%?D'W:.*-<12A-,\M(4;S 9/N]'#2$4F.VS=]^% 5K9GB:1,0L=X\R?1-
M-;&@D-XZ.NOENZ>+Z_JN,U3U=T<#+=-LMME-^L6;8Q^"O04KO/S FQL'2//D
MKQPRQ'(U#?5QZQ:E?;/*QGU*6^-0T_'UGP)92TJ@X?>;,HRX06TSNU,5W\T!
MY$M,)@W(,9^N$6O)B>1)]#V0#>V,B@L$9#2PG,B(]F'=*@WB3F5V&<%^#(J*
M1FJO%\@B"N0?PB:WA)*6N?Z*!Q\NMWE_?O,OXO..X7T0N,>N1Q8V38JG7U1\
M=O:'_E\[?FMM2;8"_)_*\%)#5_8;*%KHDA+'L5/7Q#O52)ZC7X[+S9F<#;!9
MR0<"C:EI6C&<=UH7.42_N"4NX5"5Z:;E^UBIV2LC="O7-S,Q&QZ'X?X*5XQ<
MWA#-"U]E>OCAH _3<W7+"K1-[NKGCKKHH*)7DDZL:;/)*#X5_S@,-;)[L4 -
M;[A^B.LD(MJWK$;_'51*'H'J3%!N)RQ-:\892RGS0H#04DLSJBL_T- _-XB)
M20J,KY4854%7#H4THDG0NI8JMFIK/;J<M\X#ULV)7^^:@6YC8XTMZ](+<&9)
MOHL"LQ#:>=QJC^OQO?N2Y$5[USAU]V>R"G=EUMRCES[YR-F=R@B3Z;F_^8.R
M*L4\=+J*^?/W3-HJ[X&L?B3[  D_.JIM_P8P_"L.7.'Y=Y$08>MIW.&5:V#^
M_C.)9</<"@$/YPPZ\!Q1W3E-M:[-C7OTW--YD6-.Z-]3^'=Y>]HC;84AX?R1
M"!N(="!^"U8)X75VVE<=?97XC&?X$;_^]H1C'M-L8V0%LI38.[ &[$(KDHV>
M]BE)J 4-;B?UEO4*1MZU0]C\> ?T*^N""BE*L_@74XYX.\D[XLE4M3_ZLG=-
M!6"; 5CY(PGL-(WYMFG<MYJMYXV>E'90$N!K$V4IM1:R#GXR\F?W%::$>(KJ
M9;\J#L8!'"&YOKO@2'%-WQHFDR$>#'#:D7V:!R@G:.N4@IZH@MSF3?X1$_HH
MQ)_&F!)6,Z,S*ITI&5^'6;%.R0LXZY21?&""*%,CM>5;]I&U6Q_T74$L@"Q^
MG&C$YCXD7O@ @&FM*4.(?L\#OIM(YUH+8:1+A -0E::I3_C-F*,%0@8"N"Z'
M NVGPAS?4,3S#>EBA,UK%!XM\]U15Z714Y]T6O=Z3,U(T/F(IT,;^1GUO=G(
M:^'>'P>H@@A&BXHL%#$@_1_:OLC"=2M@A]*/=W;].7N2O4\-Q:[K]Y\;HT'&
M(ML"A]G4#<;,@P/UW%+"^ (U,%FX33-<<8H\TS1-7<BG=^;P4:;_9G0FG26$
MPI.5O9[GIV\PE@]]RV2+Q:*8X,]OG4E\2SR?D134!:29/?QB-[5."P*0V0+G
M?[LU9=AHPR3[;HG=>J5&S\T_$C?0M=/(YCE;!JBP^,[TM:0T R<2:?Y8?[7!
MI/!U2EEA:Z]L6\,SV.O5FOGEY?$/7HH+_CY>J91WC5QS:'(9 H/G?A[7%%P,
M*5BI]!+CEV7WP&U\_?X[$WDUC][2><\[LEE76:YP4OLNP&Z):M%]!(4\T4C1
MX]OCZC4,&W"*,J/#[5U2BC(X%%DK/L1AJ/??]BK&--MU3<2.IS:AZ_3O*^^O
M#)W/@ @W "U8(<,QW6\SD[@N(@H0%:D-6'TO/.T]9+*K\@8@+'=ZPOM.AZNK
M,2=T#@I]:= 4OY5)F@ D (9W^EG9/C=!68\5GOWJ]!*0_5F1G>K\77<L: &C
M.OV=@JWW0])O7=F SC\C# T$\5A60;56G%-DD4Q$ON8@/-PFIIW%D*M6%=U<
M,6-5X>*'E&4V;O_T8:M?IV $Y$)2=;QQF&9SYI'-]0>J?JBE'%]C;)%KQWO.
M;G1<SPK+UPK'X$ OZ//>*X7H/BUYB)2I\>#+=J5,R3QL',+N"ISQA#)S-GC+
MLG]T@_4K95&:J]$E$T!I20XUV>-&5YOD9)Y4>3^%-L7?RK)XQIX,_EG^U33)
MO2#]BOIC'4G ,D-4=5C+0>"3,+\2LI#'4[V<)Q8J@,\]ZO58J E -)DA1ZF0
M!AO\]>@$_Z"LI/=K$4$A-]&Q-KA<P)9,Y#CYXBGI&R*9-30;62[VV>1DU;>O
MW&PQ*!-K_R]-LU\N5KF$W2$IS='='*W<)@!AY.[5Y94!7"#+B[EA>2GE;V.B
MN_*"HJ[*!WU#)V738TO]H>#MZ_CY!^<IM6K(H=_E$5-UQ$6V* +][UT#)OZ[
M]&;P@H]N*VQ(PU--LK*+[NJ!]G8W<T&'TQZ6YC_37- S1?9P4STH6\-U/]NY
MUZ.0X 3Z:^#//._\^@#J1DIP5Q]=(7G)!\C*%B":UGY;M9%UC8<A)B7'J19L
M2D%FBWYXL)&\@AW]\E(&UF =R\CL2BWC6BU*7!=KA/: ?%J;J6B,C'C7WWQD
MSYG?S>"<,^_%D D#KGK4J*TQG\B0CQK6N;$*N*S1YN>=8E[^_G2MCH.XEDI@
M,2XO8$WWJZG830?MQV52-!]VSX[IW1&KZ%-D(Q5]K722.4ZD9F)BMI$E8%R=
MJK,NE#,XM*#YF,\W?AA/FTV?@PC@7&=)N$BJ-"S3-H#/B)8U@%!J]]=%-30+
M*?"><5DW  W 2.+4 M^U2[/,-\V]>JIB04,\"Q2==4)SICHC1O34&':ZX>+/
MUO1C)L9=PY%ID"3&H$'W>M["*?N_$<&1VOML%T?DZS"7*]<:WL[VQ6],!0Q@
M__.[ M#\K52R*2!^D<DA2W4EQ(\HLCZGTG^Z"?#)3="R1A#4:&\ >!NB!/KZ
MWAWS&T!U9I@:^Q7< 8RZ&^GWZB$Y1:YRV=3NE+KW]R4Q YXP1(@_$T 5HJHD
M$M8<U9SAT@R7USXR5C.!L[\6="?[]97(0?BBM[#*:@S)I!42["M$Y/!J@:!\
MH&),93$?:&#B^9KE):9@X=SH!G#)R/1+K!'2_$V4\J&.-;[7,+="UO5=#SG=
M6-54Z',)Y4<C'9@GXW8D';B RH5A&+$_TO]][IB+6#09^H.;-4KC6FN.]E8+
M SAZO.',XKKF02QIO-X# @*6I"1 %XZ]I4KG\H?JGB[%H%[A:M^B]DAZS2B7
M3EJ<FU5XZ3S3SR)B9Y]NV[4]K>SA5AS.B=?8]SL8H[9F]^,&<&P=GO+EO*=E
M;4R2=%E69N=UE";Y9BP^J>:Y_H\G3O(<D6?B!_XDLM_;<EX)8'WE&=-<G.KK
M)/,N'@@/4P@5IJB_:GUEZR)'W4^K,/&*K-'4GW#+2)0N^M)?JO]T(M*;K8GZ
MTKCH)';O?OX*-];5L$<B)/VO:*BQACE-FBN69I)K&K"/"^@*%%3G\+K]]MU>
MW;G(CY!\@:*B\8[I[.:L->J+NT<M-4]*$M."P7R7Z.^:GX[+_/@0X7RB)"J9
MH?U_0S08G';OIQN"OF<!M-A(7,X(JM1["8IY&0@U$:R%::X^C@<DN"[EN=BI
M>81^S^.9PX'>6BF*#U0%W0!P^?_XK=&A+B?BTZD?+MV,AE^8&D=Y K?V!MZ.
MB3R+^4W#DE\O.9!MMV>X!R;2G#L=='U&$[>D*L&V^Q5K+0.57GB&:W6+@E$C
M!O?NT?IUW_,$/K*SN;UV:"7N6CH4SB%E1&][JOU+6I:#14X&/@C_6!?N,.N>
M0_7):\?E!F!3IL;2J,[^J,V(<DWRSZB5BUM+N>Q_SB\$( $D2+#<WVP[1@![
M0;E]DKG%&LJ^*%9Z@.G3N1@$<.DM".S_Y/Z^=2H-E_65_)78#>!\YO'!P0W@
MZNA;;>?_2D_S%=$A5(.:X\7+&T $>] GF_^5X9?.W47077IO[S#)N,EKAZD+
M?!O)#FM_*Z?02"\;)*IVVD.'/9#F, +)/G1F]$']0OM6=BA-^C^KI>,^#=/@
MVKNK(_X[ZWY8GSXQ-AMZ1WG4+=DUUL+)V_*D(SK%*C(.+J='-#ZAH%7.@^G)
M=;TO?N]#=S_WBOY)>R.)DF5]BPS3%/N,1RR A.BJ@[.X:7HQ7F4B<MW86.(N
M&P.7N1>U//3%8V-<FM# :7S[ W#"^64\M7MPCDJA"K^4;E$NZK-%@;,1FT9:
MHHG"F;+ #:",)K[4G7:2YG'94]I18K#:2V6-!9/H[W(CLA/5P"!GR"F?4-^Z
M-VMEA.)'B].Z:O1 UGB[GUX'#_)C)-_>>TF\#<;H;L<WUOY7%E=(;#;J/6IG
MB-U2?1Z77,2>.-!6&9$X4.&5C\RE8VF]G?349)K:I&J"-%N#T=FP2L:J!%$/
MVNRPGZN<3EG?*)WX"F+9STMQ)_G[DHG^<QF%&ASW_@90^O)F\3\ 4$L#!!0
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MTABCMZY"GS4NVTUC#HD5*G+<*!=(KJ&^?:1<V$ZEF9XR2,=C2C?6GI+%1&<
M&KJ3 +Y;![ZRS7V&AK:>:#LD>%12JLEXIP=M7#I@QCBNE1T5V4+\RD4]T&ZH
M3S9/><?BJ">$GAG[KB ]S#[%M_?7^7.-29OPG6?W5E])1Q"*4,\P]VA4"DG@
M-@]<T5VTA%AHM)^%'/"*VC@S6P5#\NKP'9@G:,A#V+-Q7:9]VFF/"+VAN8[:
M4'=HK,.C%/'UW+"4]86_U>'LCOMRU8F)B-/^3.J,;TWS%:$L1>7B#I5NO[GP
M0-+83Z5E$2GA^U>',4-TQ9!CII\'U[ZGV!L#AG@-5^^$FUQO8D^6F$/=(AM0
M4BUV=N]<LA7MP6[5,OV=!*WS_@Q>$B8AM@DKBN2!7AL2&^-AC*<[-(3C+B;!
MQ@F0S_?^E6'K9\?W/QLRMI4N$%)E/X^XK&3@6U7L(S EQ%<>T,-A/?*>/L!0
M"QZW!ZV76^8CA6C%1'P+4$V)PP6\^N1)-45YKQ1ZU87/LFSGXU"<WN3);VJ,
M(TK&('A!,\QQBN9:NUN[FUT,8<O_END9+DWHI31P7W534&D;9V:ZOF*TK"F8
M-JJ .V@[ZSHT$>AR&UCZ.1A@"2_9% D!FY4=>;9^:V=]9Y.BK*U[,0T*83-4
M0%=9U5XG#%0-HJ!'U<]1RO\J.3)TXP5US"G7-^NS$S VR$G>=^%H9/9^=Q=3
M_,;2V_+#5%TMUR59=_]]3G< GCTY^83GRP))\BC+E'6CQCA*]9JE-YT6UG*]
M-#7<H 1EUF<^0B0H>^0;]:#O0D;AW#5CI]<G;=E&X<N,5G&_68G$PWJ%E_A[
ML._ F7E5 ?A@0NA?(1@M_ 10)R?K[36##-D!4^*H8^NI+?AT7X?PT;:]+W?&
M?.==(_LWT-[+&S>H[N5Q-$L0ASVQNM2H0BU-&OB2?IU$ G5!IVG<"/UG\SL2
MX?._M9*G)R@>W,@6*!X4VG4 B0[IWHEBVB#[-0W%Z9:-H$QN*<4(P,5?J0AF
MHBT:R+3W)4V>U9)W=:R/KJ]\C<A,X.\T2%"DQMZM76L&8!38^;B)*Z;9?73$
M;&H(IH_B&\8N)[%\1#?\'Q:U_R\Z 6RBZ,.?%''2KC"$O$N)-ZM^<PK9G+"R
M05.8KL5J2V\.)S?O<R6A=@V.4*A3",]50)@9@9!]Z=SG!M\*,0<:499Y">6=
MSS&+5DSIS<O3;4^ H')&HRJ9"H&6_ AVG/_4VV_.@"TF7:>V&SD=Y -UUXWA
M3.6:-B7>7%4_3JN7YT?7Z".7E@ :_P_O,!)E3A[*[->Y4PU@2C$-67KS$O6N
M=L5&8DTA], OKP"9FQ\LT5EI/Y6$[<$_PFX'ZN$VH(13H4<R[ZH$C.33K(A,
ML;<TO+_.)R@'V2>BP,0PCG<PH;.NS1HZKG:BNM@3=0W< 11L-!Y%M/B<5GPI
M^ZK93F);?QYDS[RD5K'AV+8O>J"=$ [C9"(_0/,W)HL(JNSG35#!*9?=B)]@
M8\J= 5#HVH;;1[!TR?3B8$[=6Z(Q?<T$'(Y@@1ZHPJVVQ-RJ&,Z9&WV+,OVJ
M73DX4F0!K+F;SE(3.B:]5Y6+N\CYYO "RKKO9T0!$R!:OA/Q@Q8T6@Z-9A96
MUC&NB;P2#9+<LAX#[E#T[7."(W'/ 4V G<?"<PZ\-Y^ G[ZS,9IQ X83%!6Q
M)H#1GH$_W:,]E7["%+\5KS-F&2*,J9_SGG'4HJF$((&I0,-U#"%M3ZV9DHT*
MS"JK&K,I' -_Y@-5CL?#/,UQ7>!\ P='/WC9B/7V[/0)H*+;5<0&5BX#<\[E
MQVG/DI#\2Y'_S_S=ZIJ\S;/$5=4XN2#7829T7;K"["04(5)YC07!-4NQGUV-
MG9C.@\M6B7:W/157RW9+X4(L;KT1;(6\_XND$&W"GT<DZD-HWX(I[E<3,Z,-
M"4W<2G!(U,K;H#'9/R;R$!M'GV"I>E/W;2 !PJFY<V9]0PY"=!AB!X[4IZ2?
M-7&H3C9974/4MF=K<(W4/BOP+LE_Q%< >!DC6>$SY5[9%*<0!QG5R8'-'Q)+
MY^EJ6I+=S-]7/QKD76 M\U<")4E)<3LYX%L6A85C>8>IAE'5"8)VYH;,8U7U
M%%H*TW7(Z[/W(^-/@".OMZ)#'5JR=!:XXFUP]I6^],(%E0I[PZ+K-HGQM\.6
MCL5Q/YV_%)P\Z"J+F?P1'0#!DL^C!7FHCQ.]?#6:.^H3Y6HC>BQUN)) ..XN
M-R$7;\)3]4V%E[%3%\LI/*X_L:'UYL%B!S=>VFWTI4OT2_[1YC,_?-6?<.=)
MK;Y$#89$W8GA_H9?DK7X 97A<X]-TGE2<S/+*O;,YDO)!:.C%6OUXAS&S;%D
MQ7CE\ORO%/30E64TYLFC$49.FTXX9L>I+I(W-Q&5A]3LUQ]:./O1M9J)^C<!
M*H>R="9;7,1#PAL8$ D'MV,1JDS#C.'R =J[!_"\O^4/_?T7%(0_8DA[EBL+
M$B/VVNVW9"+3DT3Z^L2+;M(*,KC4'L3GD2K%'=$Y)Q4$*5:M<OHY#9*^HQ2S
M7Y4_H%X-/X#@WM55].+@I4SE+TTIN\*C&15?S!\/SD'NF=_KH&@O71*C&A_K
MVT4Y]W_8&J9Y)6!87E;=Q/*+)*9)CE7$<B4Y,KFLQ%!0 6[5,=>+OH;<$]+\
M!#(K5^MKE ,NGQND>;KV"1"N9C?DBI$.(23AH1]A<GW&"?/3]EZ0-0V'E[9G
MJL(W"HK,#M84C*\'OX@]0\6LBB;R:$AP8+?A$BI]+FR1R,R<%9VC%5C2PI%]
M-=WZ.>7DY/.4 DD$P0+I%C[IAKVI#&P_UF7O,5&A!1*R8+[5.&Q/4]5\D),V
ML652X2R@+\XPV;7%#"._<8I_K#V0?ZS8"^H*2.C4>P($\%A+U8*H#=8"0&]4
M;_6L'_].*'TM!1+ /Z[K>[P(6:&.;!G6=]BQLZ2W#'ZGLO.'?<#":P+YYM$3
MV<[Z!)ARD*71/1_T[2D>""CQHC;KK$L72I%(>\8[^*N/?8F?.!#S--M'MP8=
MK.Y$/#Y6;CB0+QK'J3>MTG*'^\+HJS=:+JWO5!X B0I5_;G:M10G///K5S"O
M"SR]I$*>?/'EX\@5\L]U,=,D]VD5MR/_1R(3MFZO824M)+P';46(RI;L@M<^
M[E94C%"=8Y@JQYA/3/H .@!^W Z(77\%]:\ILS.4#B\TU3^TW4L_LV.*^V8G
MN$/]FO;CQRBW[@DQNE'HZ."EUV7?/G)[F<- /HEO<#=V(?Y=84:MGKU.M<5>
MGNB6HHN^,-7UV-@JPSS/2YVOY87\NY:NV0$,1O4!98F/,\8QB<C.OJ.ND=($
M,P*XL(G]D#_1PO0>4Z3"@UD:SBLNGBR"UT$KSZQ;1R[/*>T];V3(.NGLYF^U
M%2S 0OB0[I*]#$N41.<;R8@K7+W$C@+_C0J!X!H.ST>"AM1JO&F[R&.OG/Q:
M9'*9@4_+$T!S*G7^-!S!D'B_72R1RA6MRI9?F/O?%&LLT' 6 T'"=W7>M/H8
M-*QS8R;67OD$L"E[2!LR]0$MNL.^YUS$WSP!JG&> ,5;9J\3"Y'U 7?7/)-W
ME:<-UT8!$XO^)4M??C')C66R#0]X=9R?JA=$JCV<LO9FLR] (LG<FN<XW<ZO
MW#EN[SR>[63"3%NJ[<E,::=YA-05W1I^UH>79-O\"2M@1NINBYL-YA"!#:<=
MA_IDL ;(@E,;-0GLZS =X!06-#BI8'\T2:#J5J^6CH9K\'95!;@L(./4J24+
MOGR6$<6@DZ)QSW8I@E1K"_"1(M^R&<3'!W^ MAUWTJ4;<.6[DDR.T0U_=$9S
M^#B3AT$?/V%XV?-@ZX6JAM.2&ZO7W!&R5Z6C'C'C]_MW >=(7M@ROQ@S* ?9
M0ZCR/!C&^"K+,EF(MWJ$%P?=69FVK.LG=[+U#$)Q-GU9 "PDU&04F-LZE&J>
M>_/LPL]9BF.Q*G7+>;J_I7A.A)IC9?OLQ"O)E=.4752_I[0UPM.CJV_)^#HV
M6*9!)@C) 8]11YT2PF,R1HDP^!2'N703%5=(Q(\A*BI45HWP@4PV9)R*M3-L
MK\PWI.6)D/D8)%!BRGA3>S*MMPML0PB7D1MF^-D4\ZS9(^1)N3T>?U.A<8Y.
ML-85:F<\O $FH 97V?23[_?)L*(W^=F-/R99(D'@I^G?3;S<PD=AR%NFM#CC
MM*P@6%/O.-_1'K/*S=Y^.*];SGRH4L+AF*!QTYF1[>WY8 ;75(>19>4=B0/#
M(1T:C].B]!TS_59-G=V+/)DV7;7574,Y-&XY:%[9^'C5J97V2/KL59/BK(*E
MM,PW*BBC1"2X%9ZGIJ\>>,#\LTA&>/'QCF8,:&*V 0O']J;FECXRCAGM)]J>
MY@>CA-<U&C"G4S2K$L3K9B@H6! GAPS>*SJTS-!D&4+M3A,K;/WG.6(3+7KQ
MZ-/Q%B^TWY>*X(N+Z6U'OI][XZA-PU(VD#(L&[BRD!Z8>"NUTMAJMW:6TOBF
M\]EC,5A@1Y.Z*>B,T]WI!?R'C6-.I5%8%K0M[!F10(RSRZDQ^5"5]LW,3004
MO9W<M<^)W? N7HF#7>1>+2CN!3[I?NNE5]$3P.$)$'H)KY.27M#.QBQ4,^%+
MVPD$;@0K>@#:+/E82^A?)/^1@0 1F25]7;=<,E=EQP/;N$*20N+:19!9T]N%
M]&7I93H-5DHCXN_I9>WL@R(-&2"CZOOL@YV-B%9@WU!]T#OO:B'JP17[DJ6A
M?4V^<5&SFB\*Y@9@SVF,\,\0+B>U.3!?J9G%245Y-ZGU<#=*<MCQD- .P1'5
M>LV#@?T"E7MP8XUO\>#4RLJ&YAZS;6E%LH2F#)_H$\!VP0KFV[U!T,EI*]Q(
M!/=5G*GFJGX&72O.-Y@)Q 2V44P XVIPCDE?%K%Q924TWEQ*D:>9VRM6&6)U
MJ@@6C*R=7+?]66\\G=\'QOJ+V\_+4".DK.S(&FSR 8$[JO8*1&L$9SB,UQ]D
M*0X:?!2K8#WFM4DUW]I!/D9[%R]^.&]"E700%2.25G@(("2V]\^U0W0Y5W#^
MFJ#-ES3YT>:@6..%N4)<NKEJ(IV;>E=/52-P2K;"IG2#:3&+KUX5QZ<:)W?/
ME4DX_O9M2%7^W[_9]Z:MA2!)ETU\(@8\GJ43_PEKQ&4"S6>9L^B2ULOT/_XD
M_C-F5 7U*4/:4*&AZ,)P::,P"UZ-G/,D[<* [M>W0M?X?Z7B(1W_ NC=0G4#
MGMXZKV05OUWOLJ*2<Q@*ZUHXHKFZ36WJQ$U-$#)SLEG;J*%';=MOBU\-0.V\
M*'8(R:83+-?6!69=7>QW"2";Q-AVX;^VBPRSS&R '+[KX,8]T-T]TT$TQLX3
M8."A0X]D5AK[$^'AR:)'(%BU8-8)17,FMLJ/TL+YUD/OLIW(L+VV D)L ;;\
MJMJ(14G[ NM09WIA8IM#IW*F1$5^JFNN_A ZRSZI_K[\X"@!D?!7BC2/;_YG
M?BGGS(9B6\,'/X01]\O@@F7LJVR7=1O+K$B:NRZ7@A1#451/I4LHQ89H=#J)
MP=[0VP%?%]K"D#Z0[N]6]YZ[H3(=A,6J/SW(O%?/3;J>8IW:Q.WZQ%G2@]9<
MNN*5H6_A_;VG%'\$6[5 .UM^!."_]G9Y)-6KJRY"KQ ID K?'\5#QDDA-,;>
MU(AZKJH>3]<&W9<,00?HS*;\8H";>XX^QX!/)D*2HND(']JMZ3=3/<R#^C$&
M)X8G'T*[WT7P[P93CCMC$<)+;I(B.$)GW-04<D -S=^J"1T94\B#@^O!U870
M[0-L> _?\%]Z=ZKK+B6\HO\S>^1,@ LRHC7+IQ-KCDE_3_":MF)(DN5!8Q&>
M?ZLXG2K;KNYXS=7^8)G.GS+![_3NM[(H.PY:5/+NBT\+09W2?3#R_GN\['C'
M^<;Z57X3S@F:V(8J.J_9$XN]7T6REI])Q9Y_E=)Y,WG2+E8\]+&DY\;WO8US
MT=)2UFI;FP"105K:CUKFA/X$E8KKO=:2H5,>-?%^[4.J)$\JM7*3NS^U<AG%
M^KJ(>09A)XN4">RHH2B;C-B;\I^S#6H2> *O6]I2#.(MK9K#9Y5NFAKC$S^:
M[Y+B%D3WA. !?!LLCQNGOY%>5UJKM<D9:+FDO7N\.IC](K"*W0U7A\F-;F\$
MKQC5UC7_#+:^ %>$1O] GC)C[)IC$ %>]SPCC.'W^<-MWOIB2M0Y9JI1@E>4
M,=UC-J6ZDLS3Q6RYSQ7G/.3]BRB)0'YVGWZ(1>&G"X/X2*/\&:/LD4<3&>(4
MH!YML,,+!3Q]QC.\A!<<D=#8[TX03:#7L7XSGU^B00LD9<6":,6B(>;E*M_0
M[U!:K^K)!?S-#9)/XD/],F%4NK/E-X8*<YEZM@2HD2R%7Z25=_=^9'_:&;,S
M:NSR8?1H=]JXLG%5(-&SSOOW.3/]=8$G0+R,R1.@!NL)<&6D-_;_HHQ #O\)
MG^*N<K .["W(9^]T/K3$[H;7\+!^=9C966"E?R]>9;D#<V=ANF/E+TF-Q?JY
MUE7EI7DR+P ##F5:WAG:(..'3(\K\*^P.K5F[N>O.WD2$#&&0/PQI,W0$P#8
M204OZ%[G,R,QAN?;5['V+S1%DN7@]0_OL:^,D.K;V*$8I*)%$8E3W1_<N,>;
M=1=RH#5:;QDHTR1.NB%4:GX$V*_9#$XX;?WB=E,3A63XKFR<C'YCG9 Y,Y-
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MPY'O]'MR?ZK+*TV;TF5VQV9P@_SOS( G]O%('@LG2_](337T"RY0]Q-(_C)
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M6-#WCU5WT!QGYI!E2-*?XB^P?D&S%A@;YC%[O2_T K1S4MNV=6&R)G3D'ZR
MP@&MZTOX]!BQ],/7H/Q5-%R#KM6L_E+QP2<4B^KI>^B?%W!3P4//T]<N.(#Z
MN.74&T]X/<'?QSO>Y*&U@C=@WS!A;=1X[L_.TD'^Q 'C@?"K?(BO20<.0!HR
MS/%V02[V?/'ZP6GWD/+\]M@Y#M@2NB#;N>HL'CQ2[6^3R1Q!O67=E/H&5H)
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M!E?F5X2O%QF#)="0I?1W)J8HE1V++J%LHQ:J+_ZN'$R(V)V$3<!D7$-#X#"
MHW&L4+]E4E;/5<>V_@[Z+71EZ5]P:3#GBM[Z'22'@P[N+&S2O:" 3(QND<MW
M8H9&'I<P5;QH26#]?5UUB%H&H;&NK;Y$]J(M%JUP:>,GL;)?[Y:GX@;]XI3.
M1(78IB:O>B\1D:1^ ^DG7:%FPZ=M&6.>HQ2]W#)^4^F%P*^@NN8=-\C.Q-D
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MOA3\.97UQA8J3*2G,XP*J,L)=):VA*:$2'- #"#V&*+-9>/8DQS\!/5#A'!
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MLASGQ'+Z#W\,BPN2:L0DOSD1G^?@9O\34$L#!!0    ( .>$35;-CCE-KCL
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ML;BW0N"EYPY,WNUY&$TX1(<%Y#ECD^9\TY\<8XR#YX(N$(@8210>7F$2 _=
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M=_D8Q3AB)40+"%,#\\Y)%$T\O!)5GFL\UXNM#$ :D?6ZASQ\ZS:9Y0XQ$+<
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M7Z,@F<+I"/HSG%NU:J&T^% #?(R?Q$3]>Y.>O.JGARS@-=T2TJ#6S(^&%#1
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M*U!6$H-\([)M]&$WWDGJ(Q8D'HRIIW,T1Q'$21##D(9IX).4!4$X^R8*FK\
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M[32&'K]Q-A:5A"/@;[:2#8WIP N9>1'L2@FPI<4 *9<N =/18M9+A%'7LDM
MVE_*+FJKYTI6'>+J'42^4,TUYX!$$((B&4&/ZFQ+H1=!$B481B$)@X#$)$V-
MBHIU]C*UM:BI*[^6LN?QZG%$#>GK4IR&YB=KB.Q)IPL"5ZQRM(]Q::-+S0->
MZ'RXQY7BMT61%S=Y46BZR1=U^[^)Y4/.WR^^B89:WB^6:O!UW%AYO>#OLA^"
MUYDOF[J:E#&$N.=#7TH$$9($DD!P&/F$1(&?I%%"C2\;.Q%I<I2BE0(;K:Z:
ML"90*P:V-*O2D+6Z :4<J+1KLK]:W*EU,[;=?/4R(S8TN;D:K/.U6(<:-8L[
MTJ./WDBWIX>?<G9WJIWBW'G;VDU/X]W#=HK,S@UMMRWW3!2UHJ7XQTIU]/:;
M^F,KR"[@RK36?B"/^;HJEXATQ5X$(QK'(?:)3^PN9)_L:6JKX4904$EZ21#C
M:7C-+&TGH V\(/7$RSZST3DL7"4F.MG/N'F%SJE[D!;H[ MN0IVW$RPW"[KT
M(ASX00)3X2FNB!"%F*G=.!4H%0@%6-G9EX0\'W8Y-=)XTS^-NP&^9F3A%K6!
M6>,@\/EJ-S?[>>OTXA#HT_@,% I]I,,7#8D^#<"YT.B.-^U(IBR6LT/#1XB/
MZM-I5DK!$>=!B&'(HE37D4@@#6D"N8]Y(!E&"35*%G:^JZF1RL8*O ):2DLC
MQ #;;F)QB]C A&(/EC&!F./011RJE2W24'_;$(9!!Z,0A;FB+4%8O-$SIB<O
MRYM\H<_,Q8(]ORV7V:,BG5MYUUP6U0_,D,1<)"&!0<0#B%(40<+2"*8)PA@G
M,?7M3@*,>IT:7;125C6%VZNT<_6#90B/$>)F)HES' <F$2T.V!+X"FR#V@H-
M/G2!:A^.8P.2J_ ;HS['#;>Q@>$@O,;J99?A-'6O*]5Q$]R3+\JC1Z+7M%P6
MA"UG+(P1$<J6\>) *K)*4HA3BF&2IE3Z,8]%Y"#"QEJNR=&9<91!$U( OK:J
MV)Z%.AI8P]/3\8=KZ".)(4;*41Q(;UP'#0VQEVH"T2*]H30+(.G??#\Z7V?#
MWMK<WN7SC#W7?WX1/Y:O%2I_S@(FB4PQ@7$4(HB"@$,2^1Z,="$$+$,4I<R&
ML(U[GAHE;R6SWQ+=TKXTQSU* YHB&<(JHA%1P2"A.I@Q2D(4TX"2.+$+9AP$
M^7$B&+>PW\D8NJDJ-=@XF*UK@V [\,IU_(-6ZU0E,?C:_%>+#BK9':Y7UG@Y
M6I',^QUUS;&&8W]5L6^@W[KQ2<RKBFVD6#XW;C3%1Y($:FT(B0@@2CB&*5<_
MB<CS(L:Y+P,C%^7I+J:V$C02@DK$GH>C1X T8YK+X!F84BR1L::-T\H[XH<C
M'8Q*!*<5W)_Q'4_VB#;\3=F?#^677 <PSL527+-_K+(ZM?*,(,8CG.ALHQY7
M%F""(!8\A7XJ$N3I M>!4>*5<QU-;9K7HNIK+JP1%I"-M!:!8UW@=D]ZEY -
M?:99H_4E!ZV<X-HY6A;!<XY0&RDD[I-X4LUI.Q8L'W1*Z&7&LJ>*2^FJS!:B
M5/^0/8JYSN>2+<!CC;;,B_;CU#>TR.9A]5NJS&0MM:M:AP:(=@:_=;T_7DB;
M@18[@6HFS_>I5KLJEVK[7UPW40X)]2CA<0)][NE ;9+ -)8)C%(NB4=C7T9&
MV^QCC4^-6%OQP+5-%=0]P R(\P(8!B;+#0)] I'WH;"I^=H?DI&8T.#CL"S1
M>ESE[BJL>^^,6&CUN+2[M51//-,SVSSY<5,(GBUO2%$\JQ5%5\O;"I-@Q \D
M2GR81.H/)'$,,8L\&&$<1C'C<8BD5;+Y[OZF1E;:G5_+"[8%[A648@JYV4[0
M(9 #T]V%&-HG#39#QE7.X#.]C9LRV$SU@XS!AJ_UL'3N5G2>L;;&<[-DQ:D?
MA3&5D!%]#(S4'S@)$10L82@-L$_2P-C<.=;#U&CDJ9)Q797<8K4_BI^!]7,I
M*@-S0BT>^,,1(!8VT*7 C+\E)%51@*9T0YMHX]4N@C^KC2-9 O5\MM1WI?0V
M\B&?JTE:51=H,P&VA5*DWB$>+41 UA?776T<NP#O-,..OCB>+=8E]XY!UOF@
MFXL'NL 06PK^)ON6<;'@6P'R8>!+CPL/\H@S?5)((<;2@WZ0)A2E<1!3JVI
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MYW"87OHM(GK]*J\77"=B7I2B;.MZSP3# ?&HA%$21!!AQB$-: I]7TJU.."
M1J'-<G"JHZD1>V6UZ8BC?!U+*AJ1_V+'S">A->-8%X"-L!$I*[!:(<'75DR'
M?'<."4?,=;*;43GHG++[;'+V^9[5N';S67T27/VBNJ*S<Z<X2HE4U!!"1#"#
M*/(Q3 .D_@@%C3$1,:%6R:;,NIT:9QSF<=L(;GP[^9)A,&,4]^ .?3+@ E?[
MJEU6,+DJWF76Z;@UO*R ."CE9?=VSQ1X^>)>I_AX(^AR*V<;%QY&J:Y=2D5U
MZ4\H1O)2*#"7C&#/Q[Y5(8?CW4R-AK244">) ES):9G[[CB09L1R.3P#$TF%
MC)80:!&W?6WM-:O?R+(QOQVFQ.N$Q55.O..=C)L4KU/1@ZQXW4_W.!QZ(XKL
M&]&[J+;MIC 2"X. L\2#0:+S\R0$0X+C$ 8L)HB@,&+$:!/3V<LD:: SPY<%
M@@:G*BYP&7C^;T0$6L8J_UF?BL<G8;(XY7 !UT@G&,=@<W0@<0Z%SL.&DR^/
M=Y!P3OZ=0X*S#U^<_W?F$^0Q%G,HJ:\V8B+2Q?<PA3Z+(ZRSS'M<;<3R)9D;
M6CR;MJWX;=W#@+L"W8>3++]5R4+&/0\*Z5&(O#"!-%7X^5CAY6$?AY3TS)4\
MM57!(6J&1F$_+(:V! T N"3WL6OK;JOEE\IS?-*.._*(BT00I[(Z5O^HR=.?
M"4^$Q \X3 C59Y5!HDN-)C! A!(<84%"J[R+M@),;7)W)!"N\T=4N\)7SX(4
MMA<7K,?&C!V&1'Q@"CE(,M&1=+=ZPG&ZW;[0#9*)PJ#[%\Q-80Y.=[8*BW9&
MOO3U(5N(]TOQ6,Y([*<A\6+(DS!6G*AVO20) LA\(94%*/Q8&%47<B?2U%CR
MXKM"X*O6#53*V89I7#[ 9L0Z[K -3+4CC=AX5[D.0'[IFUL;@?XU+FH= .CL
M7M9ARST\D7=%SH3@3?#[>A%I N#?Y<4?>?&GSE!.GC*U'[M;%4]Y*68,>9(*
MPF% (P11''N0JC_59E1&B"3"BY%1@=0+9)@:6;=:K.^+;.(QFOLB0.8%^%[K
M EBM#'BJM;'PZ?4<,@/'Z/ #,3#]KL= :P#>+\#&]&V4T*5%0:,&:/0 =V.-
M@877=?BQ&,DG>_U8X5X53+QDAKBZ;749L)UNWIY-C^<$ODSW'1?QA4WUVW5\
M%,L;4CZHOK]E7/#7S[^K-?']HK[$5?5>51_/MF+7PA"'/.0!%%&*(1(X@A@E
M" H1BH1@GL2)U2[#7H2I+51:?/!NGG\OZQL>:]'!1G;+R,$>XV*V.1@6[8%7
M(R4\J,!NQ=>6_RNM@2*_GX_B/D@X8G\0'1G[/008U;CO#]"^,7]!2SV,]\_7
M[]ZN\Y(V![M>$C+FIQ%4CT<01<R'E/@<^IA+F>*8>%YL;)D?Z6!J;*9%W&3-
MM3#ACH%G8"-?",G0_H<=-/I$#!R#Q<)LO1">D6Q2PX_&SK#L4+W3:CSVWG@F
M88?4._9>UW/]C+GW"U9H=_0;4?_W_6(_ C.?SY4AJ7T=,\QC3V")H<).!TCB
M *:"8T@(%F$L(U\29&/&V70^-<IK90>O6NE_UKNI_>!C\%7K !HE+-V_5H-C
M9LL-!?G E.H8;6OKK0]LCNPVJZY'M=CZ@+)OJ_5JHQ_5O2-9\3<R7XG?5$>K
MHG+KENM?_L],;9X+]O#<9,H.)*6,ZNH1V/,A\G "B> Q1(CZ0:0VKP&W"O*Q
MZGUJ9*?E!)6@8"UIG6#[^F^6R<K[C889N0V&\<#L=AF\UF36"R9';&;7]ZAT
MU@N6?3[KUTC/DE5E*78R)FU=P8ACB;S4ESIWJX!(1@3B*/5TFO,4(4RP&AF[
M4J@=O=E,I7&*H;X_ECK,/N>;"=)FU.0(O8&)J):R.KB!V0)6B%V!C:@.JV&=
MQ\-5;:R.GL:ME'5>Y8.Z60:O]...,^7U[O)YQIZ_B!_+UTJ%/V=>R CRJ0=Y
M@"*(!/<@CC&&:8(H9]@3(C1*]=FO^ZF90VUNID^"Y?>+S#PQ5D_TS2AF.$P'
M9IT63KE3H7,GTQ7X6HL/M/R@4L"A0=0/.4?\9-GYJ)35#YA]%NO92L_4)#4]
MULDEOY ?38:#UV(A9-;DXU]EB_OFL#1?;$[#)$4Q)QZ&-.5,;?DHAVF:,)AR
MY&.4T"@A5O'A_469&N$UFMBF,ND_%&:,-P[  [-?>Y>XU@+HO,:-'N!5H\G/
M;>40K0S8:#-,WI2+07656:6_(./F7KD8L(/L+)>W:$>>7&2S-\VICR[3.N.(
M>9A[$8RX5/8>PDR18D1AY'L^\Q*.%3N:4.%^PU,CME:VJN2O&;L=8-7-59<@
M,##SF"EO3""G-#U"!Z5@O]SGWWY5K]1,H'[8$,!!0Z-,YU/BMY/SY+^_3,&>
MV]6R7)*%3D>Q=\_D[0]1L*P45<84[3Z7S0F18'&4>$D(!:U\0EQ9.@'SH9]X
M%/.4)SBQ2LXVO@I3HX^#&W2B$1P\:<G'+?;3XXLP,[.F/<X#DZ3+4D%;0!RY
M_]>"T>2H&L*V>[F1?.D;*_T5^->XX7+Q +FN5'2!)/T6U+M"1[(OG^_4]%WJ
MU(;_6&5/6JK?2R%7\P^9%+/0BQ.1A"%,68S5#I_%$ ?,@RP,)8J96@:950"+
M09]36[)JR<!<B6:W/)G@:[:>.$9MX 6@E?8*5/+6B4M;B:] @^>'+CRM>=H"
M(4?$:M+CJ$QH <$^==F\VB?@]T)F?)<74F3+E?I(K^_OBZI2R_O%LL@69<:J
M8^)9%$2$)1Z&/H]2B' <P30.?4B(E_@L\G@8&'DB1Y)W:AQW0]0G-I\+_JNL
M91?*"EO+KHM6U\*#;UIZF[C<X8>^FT(G.*#_0O;WEN+;W\-:]SH&9UK?@TW8
M]Z2^B[&BR*?S?5A&JH\V6MV![\.+,6(<_6B8[H;EC]=M#WOEK91"WW@2Z_.$
M3ZI]';NP8-F\+BJDLZHJ*>[54PM1EO5UX5E,@B#R PR)+PA$-$:0!A&" 8Z2
MA! :"B1L*^#UEL:(>\8O?W=W=P?F.5GH6].MP!8K2/_!,3 4AL5ZG/5_K</V
M :E6 ^SJ<54E:09;JB@*?[0L[]I_-"R6Z5%&9:35=\#1L5M-+P:U<Y'LW_IX
M:]_%".PL:9>W=DE,\SI@^DU6LGFN ZDW)8:2& >$,"A\)"!"/(681APRD81)
MD%)?T,#&AW>VQZGM;FN!+6-QSN-JYKMSBM; 2T<MJS+K-]<K-O(.<KYBC([3
MV.:N_EX@PME _>-QSB8O]K!_WQ7J&]'Y;*Z5:5V9XY_$/U99(7A]P^S=JCJE
M4$SV_ZS(/)//ZB]W1?YWQ7_E+/%T:NPD@(0%*42^Q)#&PH=>% 48HQA[7!A[
MXBZ19&HLU$H.1'WS4M:R5\F#_K&67J<;JL2W,,(N&B\#JWBL41B8W=9J@+4>
MNM)1,RK-?=A&ERKAUD8;<#?RJ%A8QV.-SD@&\J"C9&<BNT"VTTJ^J(/Q#&47
M..S8RDX:'#F*K);L_4(MK]4T*&^7#Z+X\D 6C4_J8UY=H1-\[_3^KZKIY1NU
M%UBOUC.,PTAP$L,PP!2BT(L@%I1 SXL"GL8X$M*N!O0$E)K:<OM[(S@HM>8E
M^+X?>2:UD5N=9X%7JY*#)U'4SUIF;I\"^#.UE\.$H13Z DF(XHA"$E,&F<0A
M"I&RO9)DIC3,<OYY28KE?\WO:E_!X;ZNU^(^6U2IYRF9Z\/3J__B'Y@,$!-2
M"$@X"R!BDD(<2P1CA +,%5R(1LT']G;!_RM_7JUZ _H(:^/F_R=?EID;90JB
M3F@OX^ 0MS&EMY !%31@J;#9'/&NX3D2@%M!!#1&6RZC"03?#C#F+QV.ZU*E
M?XT W0$&T5G([A"R]7#4?1)S?6I[I^R=YR^JY;*Z6?]9%-\RID_&F\U5DP^1
M1$$L/2*@#NJ%*))5'KH 2E^DDH<T"2*C:KWV74]M;] (#RKIP49\T,J_\3U8
M.'SL1L/ [S88Q@,O3A;P]LGU:8>SA2=M,+Q'<IVY^*SM/&2]$.MTB=FU.)X/
MK)>F.TZO?BWT\W*]45NUHM YG(]>B)ZA0&*U;XM@P".UFPM\!HFO5P8LDB0*
M RJ%42$4P_ZFQO^MN""K8S"6Y(?=QND<OEP*$F+,8:#_0&F00AK%%')!>"2]
MF& I;<K$NL1WK-*Q;A$UVR4ZQ&G@-7+]"79EL7"WE3($QM$NYUQOHVY #%7?
MWQN8OM8GOK3:/?PFE@\YW^3=^RO)%K>+-]E\I=>%6[GYEYF7TC .10H]%*>*
MKE$,*2,)#&(1A4FJ6)LGQI:[;>]3(V\M*5!&#6]DM8E6M 7>P$@?$LZ!.:CQ
M -6R@XV(5Z#"^'8!6@7 K=SZ]R$1MPD+'1#YL:)!78^ 90QH3P2[0S]M&QTQ
MXK.GOKN!GGT;Z7U+NZI8I9/!_4&T:VK9W@<O9TD8J76 !A"'40R16@@@23B!
M)(TX"UD:R=C(I6/2V=36@775O"H+XCJ/2"X! =]KV:WO:Y]&VLS^=(7?P,2_
M"UTCZ#J=AH/P&1L\W-W'/MW5V!>QSRI]Y ;V^7=ZYG<\DD&R"A^]7O!U:90O
MA,[%)G]J$E'I>9'.?JVO4Z=448KT$$28L\A/:<(]J[0//628&MW</.A#@5+G
MQ69MQE529W_6"0[FC199Q_1Q-CQF9#0PZ -SU/&TME>;=+>5*EM_7ZMT50W(
M)\%$]DUK![Y62@Z3"?<"D%UE?>PAP;CI'OM#=)#G\8*F>IM??,6T3;=Q <R(
M+Z(X$!A2&OL0T22$)&813#FE5% O]!*C9(]=G4R-_]ZI-8D]: MK27XH<ZL2
MTMK .L32V+"Z"*'A#:I&O&U'GE,[ZJ3Z[NRGPR[&MIM.*GG$7CK]; ^7W TI
M:+ZX(4_Z3KDBD^J 1N;%8^4 :(X2DY0D(4\)##T=MHM\ E,1"^BS4*?'HCCP
M(V,WG$F/4^. 6F9=XEH+72VSRQVQ+3Q#1H@;^-]<XSBT65-#V,@+E,!@5^(^
M)^)&6%IXUEQC.I(W[2RVCMQF-O!TNLJ,&AK//6:CUXY+S.K%7G%.7#Q6@55W
M50CN+(AD%#*.(4;5KC1F$&./0A(F$0]DBB-FSL3[K4^-=3?R@3H"V2I69@\Y
M T:]!(^!V7,+BKN+H;"*#.H/R6C!/WM?R2_.8GR.ZWXFC&?OI3$C=8[+NQ>,
M<^*AOO$V=-D[0\#QER<TZZI,) ,G N@&P5E<PM%.1@Y'Z%+T, JA\^F>*4,8
M*U9B[3#)1-G4SYB%<1!P$G#H<R^!*, AQ%QZ4/W?#V44R5@8!1J<[6EJ:VPC
M:.O7L/3AG@;4C &<P#0P";0(;0EY!6Z<5SD\AX2K/" G^QDW_\<Y=0_R?IQ]
MH1\E?,@7]U]$\:CYIOUV44@I12R"O@QUU)'P8!IZ J811WZ$PT3:Y0TZTL?4
M:* M+?64%Y4EE4LP5U)#U?<CX$IN.UXXAJH9(UR(U<!<H*6#6KPJ2=F:!L!O
M1&T N\_ K!FA PE'7'"LAU%9H$/%_?G?]6B_F?]1-&6S/N1E>?V-9//J^"2_
MR1\?\\7G9<[^?,CGJKWR-2DSMK9M \(#0>,4<N[I(V(9P=0G%/HB\OPH08D4
M5F<@/>68&H-\5'N]0G_2ENG&^@Z#&9V, .[ E*,T:$.E7VDE?@9K-< R![4B
M8%N3*U#I,LANY4(\'1%77RE&);<+H=HGP$N;ZTV2-Z1\N"OR;QD7_/7S[Z6.
M#'^7+<B"98O[:YWYL5KX9H02$48>5P83(Q"Q@$#"E/T413Z5"298>,SFZH=Y
MUU94.,(M$#UEF1)=IS2K9-<7TF4K-R!KP:V9TG0LC,EQ (1'X$,M-;C; O>5
MEAQDBY_!6GAP?1[F/O1GB9@[QC/M>&R2LP3D"*_9MM"/RI2-+HJ,S,O/JZ>G
MN6KO>L&KV^LS$@OFZ3)/U/-\B+B?PI3$^F8@EBQ"/DHBS\:B.]G3U&RVM:#5
MB7;92&O'2J=A-2,A)V -S#EK&:] *V4=:U<)ZHY>SF+AB$U.]S,J>9Q5=Y\K
MSK_0VR^L$U+K9'NZPKQNN-UFQ((CB02'U \5-X1)!#%5^[Z(^;%,*.:Q9W3@
M>KZKJ9'#1E+0BFJRI; %V-A1[ "VX3W%?1#KXRL^ X8[9_&ICL;V%I]1^(B[
M^-P;/=-HZHW6^[)<"?YF5>CVZ]1[5:[%XVEUWK65Q681ES&+I80<HQBBB%%(
M C^&'@OU_S!%A+=54LSHY!)QC&;.;IF4@2EG+5J;N_)5MFA^M$WP=LDP)2CR
M41!QZ$E]&!B1$%+B,R@%2TD0<\\W"W<<;9#&C(:>QA"E(@P3CV,H$$40*4L=
MXB!D,*"QEU">IDC2V3=1T'QJ@[0MU(#G.;5;L-1*@75IPQ$'R&Q9'POT@1?^
M6EY0*W)5YQXLKX[G(-SD6%M7D>L8&/O4@0X0=97R[Q)1QDW5YP"T@Q1[+MKL
M9Z/\C:A-$IV+#T+U<).7RQEB 4(T)##!C$-$J3(\B&+/!"%"$Q*(E&.;%>V@
MAZDM4ZV 8*XEO ),R6C'?H<@FE':1= ,S%-K5#[4J-QTH6)-/2<U=\0GA^V/
M2A(GU=N?^:<?[#>=OXC'I[P@Q7.=@.&&%(6N"U 7T;I>+HN,KI;U8= =J4(M
M(A[$L9\@Z/DR@ C%(4S31,UYS+",*9&4$)OI;BW!U.C@9D[*$EPK&M@RB\H5
MU845]"GJ4UZ6F9X8Q3H\UHXM[,<H](-0;31"F$B/0(0]'V(?)9"E@<0>#0/.
MD=H+&B:L'V:$UIN_H;/*ZZAD\5A1$],)9(ME-1I/19LLK!JQ*_#?O5\\S_/!
M$REL*G+W'R42^2E)< "]0,\DGWN0)&J4L"\EYPDB$@O[\@*#SJ<7K06P;#5K
MBCT-/3[,\P1!D0=9XNN39\EA2BF'/ UI3$2(A?!LL_./,#KCI](?>V PC>/
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M'[AC46NT'!&D>;^C<I\U'/NT9M] /\8ZJ#-+JCSI'[*%>+\4C^4,>6$4!9S
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MO<@8N=H%CBO\N)O$%QF8@SWDRTC1HPKOWM7S$YG=[@JEA?JQ4F06>FK_P4@
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M+K/E+$Q1+.HR,5Q E! $4YU(+I9^)!,=4N-9U2G<:GMJI%")IJ^Y2]O:"=N
MF<WYGC ,/,5K!.ZZ$;">TD=T=32#MUL>=<(>46E_?AY[Q&XZ<I'-WBZ6V?+Y
MD[C/= F$Q?*C&KV9]*DG?<YA&DLU)[T(09S$2*WA:MUF<91*WVCG?JJ#J4W,
M6D:P$1)H*<VFZ$D0N^>I"V@&GJR6J!A/VW.J'YF[I6"_W.???E6OUM-6_;"9
MK2<;'&7*GE.GG;=GG^OIU%_14FT'U3;W[3>=N6&3W$0F@2<#+"'1CGQ$/ %I
M&!.(1(!)D+"(18&52_]43U.;SAM!02VII6?_)**&?GT7. WMU=^'"'P=)L/+
M.2Q<.?1/]C.N._^<N@?._+,O7!!=<Q!:?W@X>9!P]!W)"GU;6VPE&=498-A2
M\#?9MXR+!=<7OV=>PN(D] /H)U)"1)$/B2 13&B:TMB/XRBPRVDUM,138ZE6
M-O"<B;GE!:WAA]>0ZJ8T:$-3YN6Q+EKK*N&&V,X/?05:S<'ZF]"Z.PYL&6.8
M7(:Q#"KO^$$K8\!_-$1EE([[K5)J]UHYI-\IR-K;0K=R4QG\9E,8?/>X>\8H
MP0RA&.(H]"&2:0Q304.]&,51*-)(Q,)F]>DMR=16E;6/J3X6TA\C>*\OQ)$Y
MN%O1><; K:Z>E2WN[9:<_F-EMI2,,@(#+Q%WN[!OW7_;JG:_I<A^3(T[QK\8
M34=,WE^.41GZ8KCVF??R!GN$\*A&>77U]5U>O%LM5XK85V6V$-59(,T6%?M_
M42-;ZNJG'\7RB_IXM0AUDJ99@F.>!AC#*!$A1(PBB%GD0Y[$,8]PF@K&C0-V
M+A1F:KRZ5D=7LP2U0J#5"&RI!-8Z :44:+5JTJU9Q&U<.IK=M#OV& W,O)OA
MT:$7LAX>V@X/VQJ>Y42&QR*(9L1A&BUD1FP-Q$(-Q+(="%*G)?S^D+&'*B:F
M$$]Y495_$+5#^G%5+H$^A5RJ_^NTAA5!5AFN:M8%W[/E R#'QW^US.;9/W5S
M=<!-LV*K-5K_/6]L(U>!-(Z&KC-LYM(^Q@N2<83&3DB,JS9[K+?K"\%Z===I
M*4I].XZ4#[.8>#P-$Q]ZDB"(>!C"-/1\&*EE5+ 0I8P8A;YT=S.U-;+=6%19
MB$HU,]E\Q=5T5%-TD2^%Y?W;,Q ;+&].@!O:J[3."5!M%2HI02.F$YPLUADG
M>(VT@M2X92UN]1>WJ,5U1=YG\>BDY=-OCT>X9S78H=+S3_=,+_?;V^LF=)CP
MA"6($B@]]0<*4.6WB:&/J,?B@,<^LCHUV#0]-3)\NRKR)W$%?LLX5V;-6Z(3
MLUW+(F,$O-)BVR94WX!HYE#I!\W0,05*J %N#AWJZBHGV*;A<?-U'2ATD$OK
M\(E^L[,JR%5>T[**\3/\N'9?FM '5@L&OK:B.?S(CNOLZ$/;:WS4C^VX8OL?
MW(FG>MC-S:KR]H?>U:VR\D';"[>RS1K^^T*U\UTG/-4W8!\?U2*OSQ]N%[7_
MNCJQ*&=QRE&4QCZ4<1#KPI,$DA1%,"$()U@J&QL;579S)M'D%J =9?0&E[?.
MYM66/M7%DD8AH/.%UH<$=8YH"PO4R: :&/5C#]7 ?-6H _9&ZU9NBC5LJP2V
M= *WB_9(Y_.+C);%UF+L41MI%W+]J'/FZ+GUK3K55S\T>Q @'$P_5QL9E^AW
M[GF<=#3>]L@E+CL[*:<-]S/K?E/+]:JH3OG?+YY6R_;X7B>2:/814422A*LM
M&%/ 0<02 5,_#2%A"68X"1(_, KS-N]R:FMD9_Z8OK":6=!NP1IXE=H2%E32
M;L4L:8$'V-*9X^/( C?H<%2KW!R ?4O=XLT>UOMKD?U=\=;GAWSU5_6-?""+
M?Y(O@CWH_R_R>7[_?)-_^/+F\U\_?&EYAF'*DM!35GJHG3Z2PI2'$J8DC$/?
M2RGBYJ:Z=?=3XQPMF86E9@^W@1$]*(@#<U$C.VB%!VOIP49\92?_<@64"N"5
M5N+G\P3E GD+@WC0$1C)^NTU$HY,VM[X==JO]JV.9ZSVUGC',NW?2M\, 7NE
MX&Z?1$&TX?LA+\L;4A3/,B^J3/\S+Q!AZB4!%"*5$/DIACA$%-+8\](P"'D8
M<[O*7A:]V\ROD:IXB:7.7US+"^8ZKI-M26R;1L!B'*1/4\F)VA<$4I<K%Y"(
MQ(,"$XY3%D6)V?7/@4=AC,7ZR!CHM-),:9,M=X;#\I*9S7B8;2@&0GG@U?Q(
M25*=$[1%7(L.;HQ@[I$)PAHP9XDAS'L>.4^$-22':2/LF^AYQVU=M_QM4>3%
M3:ZZ9=55A>N%SLJ?%W6"_FO^]U6Y?-R]RBD0IA&3$8Q0K#A.X! 2'R>0!(Q*
M%-$ >7:IH"\09FJDU^JBG99":P/81AW+BVJ7C)$9[XV%_,!$N UZI0C8TJ1:
M="I=VA)>6]J KU^JBP7#7.!U@*ZK6V&7B#+NA2\'H!W<Y7+19I\@QR?515XT
M.UR<!)3Q((5Q'#*(/"^"A"8)3'W.J+(-&0F,T@0?-CTY$JR%LXG!VT'*P O3
M6_^AJ>A"U6U"#OM"\+*Y'<M:;&>!AL=0Z XNW'ECQ(#"8Y+N!A$>?:('\:SK
MS(NR6M]F"8E9DJ0>E"1.($I% C'R0BAD$DF!>42E4>S@T=:G1C^U?* 2L%G@
M;7R7!^ 9T-$ED S,2*[1L&"H2U 9B:2LT+%CIE/:=Y+3P4OC\=,I>7<HZN1#
M=BQ5%LO9;]DB>URU)[^>GTI/AS.CF/L0<8_ 5 8Q9"2*?,I\GYH=J!^T/#5V
M:H0SFX*'.'63T47:#TQ$C5P.S[M/:MNU:U(O;>V8U-\VNZ7#]D:9?2?5:&?>
MZ0?Z)BU\^RB*^VQQ_]<B_[Y\T!DNR.)Y%A$4^SQ&D'J>!U$22+4Y200409"D
MS&><I$:9(<[T,[49V23K:V4%M;"@D=8VE>%Q:+NGK4/ !I[$/;'JD>"P$XD+
M\AP>;W?D=(>=RAUF/>Q^O)\+>"O'^1TI;HO/2UVTL,I<LRX\G(8HP F3T&,)
M5X3 $21^)"$3.(B",&4L]&T\O09]3HT<;IK: 55<X15X(D43K_IJ57+K^MLV
MX)NY<!U#.C!]-&A6XE[I@J>Z#D,M<I/<RV$9YQX0.7*WFO0XJE?5 H)]YZG-
MJ_V8:+VG^"2T.MD\JS9]'_,%%WS%JDPO.@YO48KC6;GT?<M90$D02#^$#'D4
M(I0HK@HB'\HTX'X:DP@SJY()3J2:&IM5PPBKLGHZ>GXMJQU[N1DP,WX;?1B&
M-J"DU&</WP38N!ZJE(5@5\$KL*,B:'2\.IXC<9.6[@K4%RO<T:?3$7!$L&YD
M&I6"G<*X3])N&^]O4&;UZ=GU@NO"%\IB%4H84;[)2C;/=6#U^JYLS#S&D1 Z
M 6&J_I!4Y\G'D">>"'F8DA!992&TZGUJM+PE?'5<O2,^V,AO<C?7P=B86YZ#
M(#Z"#>H*[%ZVJ#5H#JU2\[Y'MT^M83EFJ=HW8N^XW@HG^,=*[<Y_$\N'G+]?
M?!-U\,#A;X70U0JN?V3E3- X(%Z(H90RA$@D$N*8!I"&F*GMML0I8J9^[DL$
MF1H%;J2^JFIEJ-FGI#2DN8M'Y;Q7?2RL!S\-M(/9RA?O J,+7/<7=3^:I]\%
M2-L' T[:ZV?QK5-=;^AU*P312V+$0R(A5[2FF([Z4'V33-EZ3$KDLSCPK/(5
M=?8V-3K;2E>_=:70,@*T&U]!B2_]F$,1H42A&E)(>2!AG&+"<"PCG*1V5SZ<
M(3S.)8\-QBYA-3-^G4$U,-]O?8=;D@Y4L<8(%$?&;'=?HQJO1FKO&ZMF+_7C
MY=OE@RCT[KX0#VJ#GWT3M7] WR)XEQ<BNU_<K(I"F<;/7PJR*$D5#*MLYNIO
M\\HA\$E4U9,SF;&Z\L$Z-E;GY;Z^O7G_29!Y]D_!?W_*%Y^)6H"*#YE::WCM
M>1#+6_F%_)@EDB">Q!+Z::CV^8+IN\O4@S2)$$[#($E"-EN(>U)?LC:EJ@FI
M:#3;<3W;#Q0=;N97BDI1U GU98T)8 TH8+G!0:?_%965 $JA'M _9&O[P8Y;
M)S0NADP^(8DGM&Y4J( =6%J']2N-S,]7H $'M.B +7@JQ\H60& ?H:U+&/4'
MJD&Z BU,8/6DCPF)OM-1@"VHKJK4X[G4;G-W"]<$OP%'R^24-!MU49Z2XB=,
M@"F*V"/8_.#6HLYVF"WNMPZERIE@<4(Y":$G(T_G2]*EJK':NY 8A21 (O2-
M2E4;]SBU#>'F7NY<)X,$\XS0;*Z66HM8;".DNU>]0? ;>"TZ>L^Y$7G[Z-,F
MB9\1E!:A[JXA'2G\_7)H[6+B;6#JC),W:FB\V'D;O7;BZ:U>O"R-2+.DK(^*
MF_/@UV(A9+:<89+PRDGG>VD($4HE))[B:I$FH2_] $78Z'JB7;=3H^E&VGX)
M*<X@;+8?<8_;6/3<;@BV EL:H<&K1FP'*8SZX>0X^\293E\D\809$*=R3AB^
M?>%!P8?&ZLE$V;C%^:VV8969JTCOM:*^\O=%3DM1?-.WBZH4?+LA+:^?VS:>
M;[3E^R;7Y8QFC(7"$XC#-,411-13/^$XAB3%5+" ^!1;Y=T97.+)$=_&44R?
MP5IB4(D,OM9"6T:=##_LEL[Z*0SF> [_/N/8W^<_-+:NSPT&D_=ESAZ&AO_D
M^<7@'=L'Z'S)EOH\_/V"ZWK+*S*O8CS\P$=)2"A,$"(0D81 S$@$PQC'(:91
M2,+0-/+F: ]3H_1*2.TKW8AI'55S',KSX3(7 S0P3?; QBH4IE/_"V)<CK<[
M6O!*IUK;42G=#_;P,MX)-?*+);E7K5:%NMLRP;>++_F2S.LPE^:7,X)%E/I4
M0LJDOLGJ,4@$3B -:10S2GA"C**+[;N>&@ELA-=?^_UNB?/J[$]IT![_M?]@
MX4BS&Q?*_(0G00H9DA(BB2*8>BB G$OJR0 1S_/-8E:&'9EQ EBF-38&CN/!
M\!Z8[;> OI6@DARL"\[?+D E/*BE;_]A,)PMO,J#X3V2>_F3>%+-59'V5<7@
M/M^[JT11O;#L]$';M3B>,[J7ICM>Z7XM]'5/%]DWHF_$E7?Y/&//6Q&D5!"I
MUFN8!H)"Y$5JM9 1A0%&<2RDC,+0ZDKGZ:ZFMFIO) 7OL@51>R4U,=XORF6Q
MZA%'V@&Q9('PA,0P]G&J(,84DD2!367JRR!*D!=(V[SA+D >9P'^G#T^Z0+V
M]X6H"[3H!'5U)>QV-7CU^?K=6\O;_1UXFYX!N,!P<+__6L@K4(L)OC;_'22\
M]#PJSKS\)SL:V;-_3N%#;_[9-WHFC#YZ:W3KE/+U\^:1YEKRM<Y474^C+>JJ
MHEZ^/)#%[5.5@O6OJHEE^7Y1IV"=)2&.L)^DD%3'D!*K/5Q $YABGGI^HNC*
M]ZR22X\D^-16D$HZP<&KK$U>8DEBHXVX&25.<1P')MCMF_[;2F\'9F@G_]&,
M %KUJW81V](>U)&=2Z4_: "X C4$0'TJ-0@.<V"//&RN\F6/)?:XN;5''HR#
M/-QC]]]OK5NGZ-AD52!+4=\G7F6+^R:43W4[PPD70M=W\6*?J-4J(A#+((4X
M\!G'@L5I3.S,9_/.IV=.;W*;+,D/H,2TO)AE 3R1'L(*94BIU(<Y80#3*$;0
M\R(D"8O],%5;0[U7?4G8-P(,>))1.4VR.N9&XT[KD(W!H#=;KX<!=. 5USPY
M3^,A<;=0VN/E:*FSZ'C4Q<H>D/WEID<+/3=':M41Y=N[HHFEJK)L-?EZ"1>!
M%"* W(_4?B;U8Y@2%L' #R(9AB0B&%GM9T[W-;4M2"TJ>&NY[^@ TW"KX :B
MH:W[!AVPEK-.BSA /6 #0%S9S1T]C6OJGE?YP#HU>*5O9JR%7BQJLOF4E7^^
M?GXM%NSAD11_5O$4/*8)CGP* YKX$(DXAI@0"5D82V7?)+&,C6['F'8X-:;8
MD1=H@<%:7JN0%6/$S9C$)8X#T\DE$/;(8F6&B[/$56>Z&SE7E9GRA^FI#-_K
M$1WS4;5-RH=/XJG>-=_*C_E2J"VT#KF[7O!K_HVHWLN99,(7 C%(D? @0IX'
M<9RD,$J\E/L\8=0W"H*SZG5J=+,66!]#+Y3(X*F6N;JV3!JI*]=:79%'>\;$
M#_:@_135&5%6EBO]D&[@J7*YJS;FJK>JU>^DJ/P1%B$$Q@,8A:$@ 6?0IQ1#
M%&,)L0YJ])"0Q)<H2#UJ$4$SQ!".XVSX5Q[$[M5GL($9> EJ1 :;D;F50$L-
M&K&!DANT@@^!JT5HS1#XCA15T^)<&,T 5_$SMH!UALX8-S9>U(RM?CL!,]8O
M]]M(_%[J-&_E,GM47%7.XM"/61RGD,M J&V#+C;N"0Y3+G1!R3 -[5*>[S8_
MM55;25<5>&WEL]L1[$%G9O_W!V1@JMW'8IP C.-P.#+R]QH?U:0_KMB^ 7_B
MJ3[F^DI[%6[EIWRUX*4.DV^S+2D#C\E(A#* (5%3&<6)!VG@(1@S+\),4.XS
M;FZAG^YH:M.[%E5_U44EK/YIDX7*RESH0-?$\G*#V=#&UAJN3VNXWCN'R\:@
M<@/;6#943_@L;:;SF'2;21WOCV@9G==BUQ@R>-[^4M\G\2TKU3=Q*[<J=N_5
M\]YD/VH.#! )B._[:K>,8J3(-$QAJ@PCF(9A0HCP8IH:Y:#M*\#42':KPKGY
M'<!>R'<3[1AX#DS K?B:.2H%FMBI*U#I #9*7&TGNW-;_?(2#"^XA=BKV]$N
M*5X"RO8=QHO:Z5T*J]#IP=Z(^K_O%]>,Z7(^9;.7G'%&E7F(4Y@$>L\7X 1B
M'R$H B1%%/I)9'=4=+;'R5%8(U[K[+ N774&8+.=H5/8!F:J5E;PJI7V9^T+
M70-Y=P;(/A6CS,!Q5PWJ3']C5WHR4_](%:?_C[MW;6Y;1]9&_PJJSJDS:ZJ$
M.;R %[SGDW.;G5U9L4_BF:E=ZX,*UYA[RY1'E)UX?OT+@*1$V1(%4"#->:MF
MLA*;9'<_338:C;Y8WC@PL?'0=NDI*1W+UO$-OBE_3>UQ]=^_%*7XK/Y:+4,2
MTR@7#(HX#2 *$88TXSF,48CC+$UE0%,7RW,1-W.S2B_7_'JT4-<OZ#@!%>B(
M!/[00@$CE>,I]V7ZM#-TDVEI9",XMH+<$_Y\ .LK!_ B7J9-"_0!VZM,02\/
M'6B4CTYMT2S\Y[HHMW]7_]"S 1R'LSD^=4X?:EVR4K/>C<F8#]9P#UKV1QG1
M-A Z7Y^B(_5I/[YAT+SZW 8^YL+F@YU!//\HMG>ONE)5ATG>U6$3JUV/*O.L
M)69<IH1RB%B,E#>4<$B3/(*2\3!C3&:(678R&97/^>5M=$K;FQ2+72]LG0]+
M*B#JUI,#>PUZU;*4DE(11%"$.88H0P02A"(82Y(RPI*4\W#Y8%:)[UNRV?Z;
M:/HEQV^G[:UI#$+%CZ(LE5QST#GGB,@XYS ->*I;B3)(9$IA0"@1%$=9)+)&
MYQ]+_F^E\9;?M]:W*"W;ZXRK:3M7ZLUU-[+#M>\8NNC.J@,_E8R@*R2HI7Q5
M"[63$QA!%YVNH_W3V88W&QU#%;X;C'KE\6V:BHX!\\E&HJ,0&^8RJLW?O=#%
M8LUA5DX)SL,D@A'A(40!HVI)$ )2G*H50;T!3$0NH:\7SY];,,NP9^H>W:ST
M2]CL[.L%8(QL&?<XC%"4=4)L3U;HY=,GM1\G1'OYY9^ZS%.1U;Z)6;BD2. $
M!3$,J"Y[$(+ /(T0#+ ,\BR+,L*=,B7[B,WM:SZL#-HH9A>=3GP7UE5U0;;[
MW'U!-_*W_[J>:E?TW8?:Y:541^ 8JXRJ2^IM2ZB."'VV?.K8/2.=NNL,;L8V
MCX)WNITO0Q$&DB($(Q%HHT(9I%&*890J:Q*A1!#F=" VC(VYF9N7Y_-U,4+-
M-JC(BIBR9_W#GTIUCEG< S7EZ4S_8OSG<=!OP&\$ 1U))DP Z$5RJJR XTS,
M*U6@%RCG_('^IPTVGG5SC?T@ZWV[RRA)* UI#H.81;H/.X6Y##F4>2)R+!&6
M KE%R?O(S2_8O6\C,\#2G895IB1A,@N@C+"$"(4$XC!%,$>Q2$,IXB2Q:F_O
M&]0IUI>1(+5>(KP -?Y"T'8OVC,*_ABE*,@&$G\6_32IJ>WV6:&/6.?S]PRS
MP=_$DR@?A1[Y^TVL](3Y&[(QGH\@89X3F4')N3+ 499 (I,<1C+B(:>!$)E3
M^Z&3E.9F)AI&Z^'BFYI5Y9)NML]@NQ^F[&A!3N,<H%2)EP8PU*L=0KE.RY4I
MS'B62,F))(BY+71>D)ZJ%-^PZ@U,SG2*(8FAD 9,B2"6<0R#/$P#I/9<-$'+
M4EB>MEX&)*Z!;*F-!Z*>S>T-0;O5S,LK-O)2=O =-UR"ADU_B]A9)#RM8*?I
M3+I\G17WY=IU_H:!R6]DHX_]JQNQ:3N_%FQ)E+D44IE0&>AH;4(%)"S.(&,D
MBQ".<(*<%JVC5.:V8!FF@+(S;2_/WY2/4/U9AVJ!^O?]NNGC[9@B?!1@D0LF
M0J*6IU@*B(@>K)'S%$89S60N<QQ'B6/;VDLAGF:E^JK@79FQ,R]0!1!0HX#?
M'BMN?FM^[-@S_3C:=L;X8@1'-L0M?SH*7K<<7YCS?N8Q\[(/ E_YE4=I3)M%
MV2?FJUS)WHLG'N9@_OBF!S15Q59\%YNG@HDZ23I<YA'B(F$!S$2N9[OE&.(L
M(9 E""=)D,@(LTDF-_1Q.3>K;WA5^Y.&65#5W(*'_C[\$ZK5SGJ]N;)&MGX>
M9C'4JMZ)"AI9YS-RP485;SU?H9?'?X]A"C8P>YN<8$5L0 >;IG=V^>.+\J;>
MD\WF6:XWFE;U=;W]_DC_6[#M[?KCKX>B/K!=)CE'89!*& 8H57OZA.E!8PQ2
MFC*,TU $Q*H3PR#J<[/ZV@U=MS+4#BGK2K'0[=Q 50L"MFN=$M^(XM#8Q5E'
M_:9^=.1'-N$[UH'F';P_!%RQ#QK^P>T:?)P$<(?V.F,"/U'/'=\*<.O%,Q3
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M.9N<Q,*P"WXKFA'(E>.PXSZ\:18'A"<<,AFENNT9@B0)&,RBC!":IS1'V&W
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M Q_'Y#[@.">((PPSEE.(4DPAB3F%:D\:\I"$B91.?7,<Z<_-$=BS#W;\@XX
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M@1P*GZ_\1F?ZTR8O#H7G56;BX <--(Q2ZGWXD]BELW]3%+X)+7>QJAN@'G=
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MLBJA>?7DN7W[FK?_Y9#>>(!2_V=^D>PC?]2:+9O*E3, .&1S#@5BHMS-KVO
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M)(ECI[%?+L3G9AY;WA?@?L\I*#2K;B;320-V1G(L7$<VBRW;=73", XZG"]
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M7=[YGORLX]EO5[QS83LJ+R7C)&689B!/*0(HH3'(24R!"!,A8T9SGG$WG\A
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M&,9NUYC>^69X<WG04D)KR%)[N+]KRNL2%67QO<X/;N*ZAE>GZ%\"PG$>9Y"
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MZ[KMEBY!HWY::6=2NT#E#@5?KB0GL"\4N;89:<K2U@Z<'16T=GESV'7KM>9
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MNF&'4J<PN[,X6BB"?M 9VRVP)]*I,I@36$Z!B#Y FRKZT.*K<@T-O,3^A7C
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M_ZO45;UV;=[(9JLVZZ] JF^A/'Q-/^@8/775PD<BC3*(0)9!M? I5RI.E&1
M?1!81#C+A+"JEC+ULD_20?+90N_729C(]*>MJ>RVF=62VIVH4RW4V Z SL:T
M;7_3!.$%FI_ ,.0S'L\#KK[B]JXA9=KX/@^@/8L#]#&F>]N<VZH@;8M'@CDB
M,0=<$ R0;M)-HQ0!05E(>9SPA%LWS=D/.S<IJ2FS;YC3@:=?3@UG>F2)HXGR
MW"KG.9]7-,KI##99FYSG#'2;Y)SX[3 5]S6I'O3_:YU:74^UO_*SJ#9EH0M)
MZE_<KOCA#SI/U@6?E0@H!:G$&U'_5_U[N>7J#MS:"[5HJ 7&(D20LXA$ *8\
M!@@1"C"*,(!QGI-(0IHHVHS>9Z<;34N^DYS8,3'>OODH-L%OO*'[=ZT?F;]I
MTSQ3K-Z8/P.QY]@8^,L='N;W;FK4Q-^+G>(UWZ]@9,'YVJRR_C/H<*1C[W9+
M7#^BU_WHAX=OU"@$+0S!;RT0O^O.A@T6>W>=40%K./SI>2^SC)XTPXF)GU27
M?)F%.=8^7XB* 8$B364H7='U<_'M85/=;3?J.KNJ9]J59;X7Y>,[!?;KY;I2
MO]&A@,6F(,M/6[HL6!NVLHB(C-)(1(#$# &$L=)Y<90!ED8YIPF%$-E7J_-*
MVMSTYGNUEZN']9('3[4XX^27.O.DFMM8B;1Y82FZ)J:B9FO?JZJ37FN\VJ+&
MQ%R&FQIZ+A$*?K\$BY"2%UO?D4^ZEB\38%)S%G18ZQ;]#S1S@>8N:-@+[G0
M>;W2-8>[@,876TN'T),76],)*R"T>ZO=<'5-6+V0INBKV;W-8AYMW:=Z0=N
MRANM_?['I]7_KOY8O;E?_;?ZSY?_T%OYD6QNFBU-M!BX44_!_TW^@/&;_]"5
M%;K1FG6A!:4H2<+JH,V5"'X)4JH1M#'L<;W:/%2U6K5Y*-2C8F6$C:_PEU&6
MO#<6QN^,TP7&C(+4093,.#,,NZ[OS6T'IC:33J#H^Z"^JN7N&5$M<HE"S*4
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M=O)B%.Q&EA\MS3>!H=K$O^[H;LMK&](]9L /!LR3N+&?=U+QXPS'L3AR'V!
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MHZ.[%FD2Y92%&> Q"H%2R# @F*4@SUB2)PP22A.W;@[[P5UVQT1]&P95'>O
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M*S8/=;+:^MS337%%KL11R!D$DJ0"(!%*):]X" 04$<\ER7#J)*5\$C<W>79
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MF->MKZ(0TH!Q&&28QDRDZA]HWG0J_K%6$MAD0>PW13=Y]PX'\O?Z?2#JGTP
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M.)>IV@+$#-(<)Q GL4BDS$@66'$QF@X\-0/8*ZJH&3#L;)TQW&8&S@>(ON-
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MR QF*&.Z4UDB0ZO^[,>'F=J*<</4][I9Z#:;FF[0/D'[!)IFKO[U&'DV_)V
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M@\62E766P&]<-'_3N>3[;Y+Z[ZM>\BO -#%10VM%JB8'?0:X EO[INJVU5*
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ML50@241BOFG[=>?FPTZ%)$IG.,<)]1(B\#1@:A^]/>=7U16?6_NC1J+ 4Y7
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M>?QFM2H6#^:"K\O%JOWK>U86I;V_6G;_KL3CHOCW1I6[=S[5B,721!Q*J1C
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M2F5BPC+( ,FA!AEC>9X(J')$>X@M]3#%Z>L97WFI\:26!V_S'\J:_47CCF>
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M^T;=-##[;I6N]MPZ%C/?\\PP<=UM6^>BVKLJYZGU+QPO#P!Z(+X.:=FH/#X
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M ^U&VIN->F 6B*)\6AZ5MWI <DQF?1XQ<FF$ZH]_6LF!Q4,]0TQF!#%!,DT
MU-Q08(HR0!/(@"9<8YSB&"NON5A(XZ;&D8UUS2K*2'4.3G6:XX[I&W7%T'NK
MUU<OJ/X3M=UYW]V=XY4HZ,#]K:L1G#+MSU%XH /48#4&NMKH&<763R^;G>K#
MBN%Q GF",@%H:F:S,-884,WM-)<D:9Y"(0GO40*PJTVG[W_\FG^MR;M<BSXU
MVIU =XQ'K\5PI "T+V[^P:8#(*&BRZZFQ@TG'9Q^%3^ZW.-')N5J;>?8Y7)>
MR(K*OJS54WG[1U'..%=$(D2!A(P!B)D&#.L8,)EEF.<RIR)Q"?O.-S&UX.W
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M 1)3P11#,N.Q#VN];F)JQ%19&(G:N*;6AQ]1G8!1"T:$();RS1^0B@20-!-
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M6[G%BFU8%:%BL3'--.TM%^5[I9<K55_WG?VARH_FAW)=B%DN2:)UDH)4L Q
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M[PJ9]U=50?W^R!;?U=/S<L56+[ODPUDB8I*B#($D3>VATE0  B4$F<@T)ZG
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MS FA OHIT+NW/;5QO3%OMZIX.\QTQG.-=B!$_QS3FT'6<GL@.MZ,YVW6='M
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MQ1D$.L420$C-U#[/*<@93"EG.=?(Z71'5R-3&Q>V9D:MG1X,= Y(!V8/ ,_
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MH!7/3S8\@4KG78"X53CO?((?>Y6K]>SK<K5^O'TR)"A8,T=0-)6*9BG0*,,
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M(S2A3II<:F[<\R:.SK\Z=>)Z7S^JV>FK[,FK;-55*OV(=BM!91H+J4"<XAA
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M^BK0SIRE3XKKP&QJS\?33Z=5"WL_TERUBX8[V*GN;P=ABCRM%H)2 99!V93
M<_3 F*\9 M+_]%!0Z;JY:B<+;]U<M8NZ.\#-'86X9$UZ4 A@Z\V-2ER#-Q%!
M"I]9+-((W_H(Z/DT5^UDWL>;JW;1=0]HN:/@'WV4CC/P%,+3"D2 4,\<ZL C
MQ9EFB*WO+IY!<]5.=MVBN6H')?<%DXMR?*EBY"0L^&#HY7'UO4'*!2CYB\;%
MD#.V;@U_!CT/C6"RCY([ZWEPJHX.+@5*K?I6R16(7CLH7EGN$L\^/;3I/.^>
MAWTBD4.5V%//@_/"$>P])$].C<)V!4$3;E-&C$R0NW,/G:0\UYZ'G<QU7\_#
M+KKKNN?!<Y%0.8BE("A-7M#;H,!DS5E0++F;7&O/MN=A)Y-MW?.P@_XZ"!'N
M."Z,M'QIK0$F;3TN+ 8"9@O&,Y:+Y(GYP5A WG39\] D0]U/P1U Y.\XPT4X
M/9KEH_QE.IO6,Y[5]!N^^K,.5B'M&&$X)["+$B@5\Z2B8# "R]$4%ITLN36=
MWB,B=9*T[FGQ^7#J[P!-5V9A?C]9A-DRI,V$DU/ZC4^/+';YFK1]Y;>6OT]7
MGZ]^XB05:;.K34E:)5"L=B\G1FF:4-X[PU)N3GTU[(HZ"9#;8+DCXX\=@YVS
M]?X2UE,6+U[FG'PTP3,*12L;1S&5E<QP8+Y@5B:3WL56T=>=']_)IGH8EAII
MKP-7^'XQSV=K*%]9 YJ$P1L%PCE3YZYJB"E98"5JD72N=[;-"_]NR]%=O\0A
M;N=@17< EG=?L7K#V:?-G=N;^7(YD<9999VNH^L8Q:4Z0E3) #D#YP3SZ$1K
MK-PA1G=]#X= Y5 U=T!A_'8^FU]?Q3GD+Z]G8RS&Z$P+<CJ0G]2U5IH)\#%*
M9M&7$%H3\S\J5'>M#H>@J*T).O ^EQ,'C_)_G2U7&W+5W\."HK'5<J+1*!(\
M@/9*U\LX#RY+"Y9VW<)XM/IFU'(PGAX4:-S\K['QYT-98G=8^0VL9OBIQMR'
MQ\!_#]-9]; UL'_U9]77V73Y>;.D>V:Y?IDNES7V?S=[?Q9/I^ERY:88B3(*
ML(7I2G-FP%/$#TQ)Y-Z03A7?*G)N*-2XN=LP.!S5<&,G;>\*/7.]GN5J>72Z
M_FG,)_.7]-UOZUSU?%E7)VZZR)"VCWIF6"H/K,P0JI9%82%JCMH&O14R]WGZ
MN"G?@! <W!3CN\>-QNH[=CS[AAM?O_P53_/Q[&1!OO\HI3KR<.)L--[; LPX
M6I44"$%5KB4OLDI116GR5@#;\H'CYH8#8FH(A7<0O/U(9>K2-F-;STA[Y[D.
M.>5?L,P7N/DY2I%Q24Y]$<B2TUE8?%_'PW5V.OTFB7:Z5CR)1QJ:4/9CD$4$
MFRO)M:8LVI7L*?3(17G/';M)D=:HLG>0Y737+'M($M*+V3M(B2^7>.XJ?L$9
MENEJ@CQ@$DG05B B"1]I&4K5<-EH;1TMSK1N/[I'E.ZZ:P]'WF'J[F)&]%M<
M73D'BHH2*,4]&%5'69&?!R_JE$8N'<\,8TZM&XVN"=!=H^-!1R1[J[8#?_([
M3C]]IACOB, 6/N';LUKZ\:[<ZI#Z)2RG:4+Q1DF.%H>J1IT4@D*@]8#(LAC+
M*%,/K;W,3@+VU_9X"+"&LTT7+NF>Y;V<GI[1=V_WZ$5: ^<N R;2XF;.42P>
M?#)%HPF!N=:,7#N*V%_#Y #P:V*?+@!X,1KTHAU]\Q[E9$)D3$/,E>W !7J/
M @IPEE80F$[T9V.8W2G(=F!Z+O42A^NZ@_3SYB+.7X6)RL@3Q8-@"L^UF2+7
M00,(6D<1H[6"I8<8UEM YER4[4#3>V%$2WTW]#1/W:_]XM>CMW]_]?'X[<>3
M=R_^X]=W;UZ^^O#QU7_^=GSR_[U\]?KXQ?')]46VZ./>XIE/T]^]Z^+;S]Y\
M:  L%J[K&+1H:(-3SD9PCG:^$EQ '[U(H747^%:"->X))\BPD'2D%XMQ4+YD
MB$$)J#V)!ND_16CMUWKJ"6^/A4<ZQ'?1=P?;X?T]K5E9+X4K8".C4#!'#M$[
M U+;0CE)Y#&UOD9_'AWB.UEXZP[Q7=3= 6[N:%NT2:6LZNV#QD0[>F004P[T
M$ADE=.2*]O7&@'D^'>([F??Q#O%==-T#6FXW+SOA4!3*$\3:Y>KB(+KZ%<.(
M63/)3.N^GF?0(;Z371_O$-]%R7W!Y*)Y.>J8G$0+:"C_4%+5J1G) Y9H70K"
MBN:4-L^@0[P13/91<@<PN?2RFRB.%O1U/JN7XVM/6XHL&(.'G&M[7,D2?- *
M@D3O9$K:-J?-?E"@3EIF&L8N!ZN] PS=6,/Y>R4\YY99!O6P'90H J)VKEH\
M<.-2EK;Y(=!=@G02Q1QNZ)N'00=KO0/H7"$A//>?=7*<5=4)6\5H =F "UD#
MLQ932CES/LPF=46(<2'3P+#W4SWNH>4.8'*4\_JP+)R^#]-\/#MO$KL8=.VY
MH?A+0HJT#J6SAUA8!B%UYH6AC<W#WP<%&G>7:@^?=MKO $H?<$7ZP'QQEGZ^
M"LT"\\P',%BG@"4C(11C@2ENG:Z5?\DUQM#=DHQ;UML>/ WTW1F14JK\M\$&
M$$$44%9P<,YH,,(9#"J20LP#4!F&2.FI"#/V"7H/56)/1$HL<*FMDY"Y%76>
M &VAT66P*NL@G5+IP8J?YTJDM).Y[B-2VD5W8_>#/$0$%!"S$,J"*4Z#RG7Z
MJ#0<='!<\X#>L.U:^?LG4MK)9-L2*>VBOPXBAKMXUU-VRE1"P5KDJI*WX)6K
M9S[<JZB]#<TI.?<D4AJ^D;_A8<A^"NX (L>SM,"PQ)>X^??Q[/8%Z8?YZ>GK
M^>*/L,@3[YP5D71D,Y*VC"!M"<[!%RM=4$79Y@4R.XK8R:G)GHBX7;4^F'DZ
M0-_MQ4QX1DS1FEH"5 ^U25$.78!"D3S3RF?=_!3EMA2C,]@/9_1;'NP@"^R-
MH:^XF,XSO2V+51LD71USY4I1DA8..B6*^1ASX+U#RM-J$*@+MZ5YM4LW \B?
M%#W[:KT?W%3=;!;P\JSV[KY?/V#-9O 6_UC_S7)"L!=H*-/G=3Z1XH%#8*'.
M8A,E<RD<2^VCIBT$&S?!?G(_U=1.O6Q_MQ>U>:M^K$J:5-4CP(3$:VUUJ=<L
ME-$6K^M(]JAMZQZO[20;-X[O 'Z'6&KT<X)+KI:3^3WGY'O2:&RT0LFRMP8S
MO8)K OM@D>(('X&B"-)&+-'?I/6_[[!A8$G')0M["ACW9_ .O.\/?2SO5<C+
MZ;=IQEE>'L]>_9FP5N#<O!:8V&AUI7$$Z6O=C*T]#,PDD#PXIC1R;$XWT$CT
M<?G-GM)_CV'KL1W\A7[?+7YH>*/5EV=X,O^ _Z#OG2W.Z^*O#E4\B_^%B;S$
M^SF]Y[%VPF3\\K6J;$+O,V.)DP*2M!1AD3F<+[3-A<!X21Z--%LY]2&D&Y<J
MX\D<^>B&?2;.^YQLZ2(]=?4BR-'&).LYKY!U' (3P+,THD@6PX.7GT.YZ6M"
MCLNXT9M#WM]^'0#TH83UHF\6<ZU7P-ER;6)2:\%I[8J4,4<4QH#Q5M4:)P;.
MJ #&<2TM<L5$^VD7>XL[+@5(!UE@<YN.2O.V5<K[V&JY#%P5M"!D8:"T#!"4
MM\ ]I<@BR$C_/.6110L(#\<VT@&&VYMU?*["2B^VF,:S]1I(Z1^_4LXZ7_Q&
M__H83O%=>3T_JXGM9NVT#<W2Y_EB0[,W7U"P[[V*+%I@D3M2<Z+5<F& J9 <
MZAAYWG+PP6&"C$Q&\F1Q[5/:JX,(X81"[_DB++Z?MR$G4N]Z'L#\1UA^@U5Y
M8M'$6N8,Z$*D2,@(>@'KH#">HPK6!M6<[FL/,4<F/'E*=SJT$;L(!:[SHEF3
M9#29(N_$2N7L*!"Y$%##F*BT2=FWIDS8G7)N.&:4IT37_HKOP+_=45I <:XO
MB!&DU[JRX/(ZA#9 +M*RDK&4TIYM8[_BCG^>:ZO]37#@+?VK6:-,Y&J506#H
M$@H.&A%!!=K?@Y(9"O-6%JZMO!F4/7UM!W_6ET4'J[TI;/JC:GJ_MM1GVN93
M.+V^YJ?A;;HN0"\D3@^HY4D9G51TM0W00(RL(K5(<,DH2!HI.2A%.-VZ'VH,
M1B?-A$VT5!"B]D'Z@."X4(!!^")09/KW4,M\-HQ.NV#A$4:G7?3=1?!U'P=-
MB;0.1N(+Y2B*#$F"9XET4HK1(6E/OGTHX'3-Z+23A;=F=-I%W1W@Y@Z:D:B3
M1>]%Y4$3H) [B-Y[^L]<DA%8=&X]OO;Y,#KM9-['&9UVT74/:+G-(D/1);E9
M4TGT*,F@)-6!MSJ",)R<<,JZN-8IWIY4/4_)Z+2371^GZME%R1W Y)X1R\M?
MOE_]F_7[%#)B(2\,E>4!5$X%O,RA,J11_A&#9NJ)9F7?(5U7)#Z';%<#&:0S
MJ%V\>]:DXNCM\*7FP"@+!,,XR(36T_>MTD-"JH?]:RA[/P"K/90_=L'<^7W3
M!<]#4=$*S4 :1SY620_1T1^I5OV%;'*\V41TS^W?M8_M!P?[&&C>1%L=N(F/
M9W$YS=.P^+ZY6?P1T!ETGBEN0(E8!RO;.J.-]M?"Z+V0;'T.UCH]ND^8KO@S
M#DJ/FJB[!]S\$/]M^$)?7O&F%R^4$,(GA8#%UQ>*HCP?)8,0>2DB&9UX\_.G
M1Z4:.7UJ8_Z;H&IKBP[0]>X;+NK8T,T$Y?7=\85[Y::@9P:8+KKV5EIP+DN(
M.9O(N?>N.27AO<*,C*7&5I\/88+.>)^4< &YUY"D2J",,N Q%$@\91$")O\@
MS=PPO$]/Q>^QS[YUJ!)[XGU*.7HEM 2IT(*R)H-/B%"<Y=9(K0,^=%'P7'F?
M=C+7?;Q/N^AN[.SE(=XBGVE3K4M8A^BTWUJ(R!)(:94M2F#DVPVB[Y_W:2>3
M;<O[M(O^.H@C[B"AD391.*4+[5FQ-JYQ!SX; 4(7:[BF=0TWQ^/-3KQ/@]5.
M#''=LY^"NX#( 67@(?"@%,4^+.;Z.EAZ'52,P"5+TGIEM6P]/'3XZO[!8;<G
M5EK6[^]BN+'WL^M#4C^>T?-K\3>MPH?@40K2EQ)U/*4C]1690:>HM=<QH%!;
M[6;W/J*3@_[#$--0BV-CX>C3I\6ZGOG&Y-P_9K4Q4)@D=>7BM5A "4X[?J;5
M&&DM6BZ*R7:[X.:!IW1R%-< $<UTV0P43U[B=_3QU]=OWOW^<8#BO<N/?J*R
MO+N7TK[@[D58?GY].O]C>5E;E1BF["G09KY0@I4-@V!S@E <MX*;E.1@!6AW
MR-.XO"[%F(2+'(H6M+I@7#WH0=#,E,A=848WOP;HL[SN,,L_4E6WBYH[.U2+
M"87STM#^&0,H#!Z\B J*2+X.VM)%/43[,LRAVE/5RNUDMP<.U7918D^':H6B
MY9R\K\S/M$]J3H&T+!Z2Y\'SHG)T#]44/-=#M9W,==^AVBZZ&SWP?.!0R&7I
MK!<4,3N;:\#DP&F)P+0KF"G3\LQM%W=V?ZBVD\FV/53;17]=G)C<BL%Y#(99
MK6G[BZ4>"R*X5(ES8U">L:B<:W\.LM>AVE,5I>VS+S12< <0>8NK&BV]7\PK
MDUC^Y?MO2\S'LW=?<1$J==Y16DV_47R//V(I%TPRQ02R='&TPJ3J#$<-,G*K
M/&+V#T[EV+.9=D<I.PD]]L3%[9[:(8W4 0QI:66Z6K<,J\A*C"J!J$*K6%O-
MLU% *\HL,H79MJ[&_O'T<6$SM)WG392^-UR^X2+.AR!3^X!I/DO34[S6?'XR
MWU69 J6FL(&R1*-H>\\E0.3! 0H=4,MBLAJ4;ZW1.L;=7I\8Q*,#8>QX_^\X
MHX6<'LWR4?XRG4WK$FA!^.K/>IN"R\I/]\OW\]+7-4_HYS#[A*_GYZ0T$^V#
M*C9&",)BG8N:(#A.D3+WTB:MD*FX55)PJ"3C.M_Q@30?RZH=! "OPW1Q@W3F
M73EG4UQ.&!<B!BT!N:Q$BCR"5]%!2=)850QGS1WS@P*-ZV&[06I[XXWN3,-T
M5O57N;SV9!:_NF[%?'(@=66>"\E3.%5Y0.M4^N"-+V6["J:&0HU[)]@-<$>U
M]?@L@^\*/76]HN5J64N'4_W<D_E+^NZW]39SOK WTQ"GIVM]3YCRF:/RD*.H
M;*#2U'G6 B06*8QSGD"[%9SW>?JXY;E]X79PZXWMA#=:K:_EABAQK?A?\904
M>K(@0QRE-#^;K29,%R4=<LA2TIJ8R1 \%Q#K_]!%SK7<"I%;/G#<6L"^0#B$
MC;H@#KQ-5W6IOW..[Q]4+3ED$;BN8^8J50LM,**M-\L\ZN@BMA],NKUTXP[*
MZ :L YNU@\SI]LK>+_ KI8?GJ>)$Y\),R!Y(\%H@56.3$A/D%+RS1B0C6M=1
M/R93;\,JVV#A4<@=8)A.?>.YFU^^#]\WDXE=4E(P2ZJJ'9*JCBYGL="2C*;7
MEWE?6H\!>%2HWF9;/A'8#C%-!Q'@C=6<CXFYY *@?>&O$X[!QN0,&&-\Y79G
MX(46()*HT[L<*4YO&P!N\;S>1E<V!=)0>N]RAZR<UV<DQY4$26:E.:,W([F:
M('%?*%!%#2+DI'D1E,B'I_!<-^3J;5[ETSFO0PS4G_\Z5U=M=#D)?U[X9!16
MRD01K??9@?*V4%9>"U0I##"!<V7-=E<O6SZPM[&13^'!#M=\;VAZO0@S4O6U
M]5CD-B4K(-79?LHP 8%I#5IKQZS(I+*MST(>>UAO,QB'1]&A&N]Y$]QDY+0P
MO P5"T85?"X@E*%0D>GU3&H-.7MZ2>H,*->:#V8'\7H;F?BT6^*!YNH B=L7
MB$R<R92:T,JDU+7A+[I:Q%O+YVS"7!0KN75+R_;2C9L./'&9S4!&VQ^.<WK3
MAH3CYEC[;D4:S:*T0=6C; 9U( %$IF6][3-1)\DE:UV.L+N4G119OQFR K:5
MD3KPBN3,+T:+UI[*!:ZO4=Y?2'/EEF52/*,7EE(?JXJER(,G<+ER.R5:,/="
M&-9ZHM;VTG590=L,)S<K:(<QVO@5 A<+>WTQK.Y'8^6-"S[AI,R:H@T*0BKY
M:N4DD=:!,2R*Z"D6EFRKQ&/K1W99WMH:80-:X5!TG0P="=ZARXF4RCC#"F"*
MJ<ZBS> LQ2Y8G#6%(FHF6J<DVTO7920XE,\;R&C]1H*OIS/*_N]6),7-O"2;
MP=LH0-4*L*@M?15<%(ZI9&\R+@\%RP>D[(X(9(!(L)61>H@$%_-$R=BZ+O$:
M^S7&U02Y,Y@MIS0_TA\A1_ ^!G"\J%@L.?T'>3'W[(ZZ5YXNH[UF6+C=+]7&
M,)V!K%)SD<+P>$:Z"J>;TM:+*L-)2$YYI( B5]8,E;@ %RG2D,D&77B));5.
M=K<6KLM0\"G@U\YDG6+Q2O\ (D<?L!ZO.TV:0@4^1@]H1!9!91WCD"[OMD1=
MAGM/B;H]C=,!U+97WJ10Z"IXI2=S+-=[05JC395%53+TS*.\65SRA*'=N&4!
M3PS!@8S60<91EU7_J3,@OX73FNM_H"QJ,4T46]2_.)KEZ]^X\I,;%LW;%T7I
M]"R35BY: C]0G/**=H9J!!V-MXJ!EJY> -02,,KTZN:@I%(8LFK-?_:T*^R$
MQ;U-IM,Q.)[[JS/1DDS!HP25H]H<@#AM"C#:Q;3AQB!K7;I_D,"=T%!W .R=
M3'?@6&]:]V+5 5IIH2EEBV"2HUW-:P$^<0O"%,$C!LEM?'9H':Q J"NT[F*Z
MID/H#\-J9<]\.Y^E]4W#Q<'N+-\1<KV<+M/I?'FVP,M8KQA>4&L)Q2/M)*DH
M<#ESH+R3ZX1)^=SZ4/10F<>M*1H L4]FP%'9@-:W9!>]VM?Z8C>13DT3WLY7
M/TJEI&?1%:7KL5P$50=B5'9Y"&@*,BVR5C=ZH>ZYK=SAH2-/]GU2,,R?P"YC
ME^/>LYX;_3;GY7H7?"V3PF30)E \K2EB49H)B)S>;_JVR5&4HLIVE.][/7[<
M@]+Q,#B\K<9&XUU,%:\1+UXLYVR,9EW=GBRH@@9B[=<Q/G,?2K RIIT<WMW/
M&?=(='P?UT#[8P/I7'G7>U27I,)WJ\^X.%HN<77..G6]'8S>EBR+] Z\<(&R
M,F$A1"4@>!5*T;8@AJT@MJ\$XY[ZC >^)[%8)[#\0&O\OBE_JH'#A>.N]&C?
MZI7$<I),KL&"!RV8)#4&! HI..08) 44HIYO[0+#1Y\X[IG,Z+!K:Y%.8/8(
M[],D):%MX@K0YUIGISC$Z#D$;M&@=-'([:*X[9XW[D'*Z!!K:8VQ ;;FQWM7
M7IR&Y?*7NHCY;#T7;3T+>"/.R?QHECY?U'K.%\NCU=WW^];SK***P'VB%\M9
M"]YII*^RMDRPD$S9"H4-A1KW!&4\J(YEU['Q?*[I/8GSSDE*3>:B*&: =@-7
M[X(=N"@YD!Y2I%?89K==UVH+:;9"L/OG0_"36[+C*6R_'+TY>OOBU<=?7[TZ
MN2[N=J/6KOU^JWEJ]PO5?FC:.=;(-<TW8ESB"W,6(L8,G)E*XXID7$V;+>=)
M1*$3-VRPR2$/R-5XB)JR);"4+: HHLXHS!"*E> P6HM19G5S0LX_ZQ"U-DAX
M9)C:+NKNH'SL4OKU=O^NK'?Z]9@I]"[[Y.KM7M5)$/15Y@&T(T69'&P.K0L*
M[A6F$PCM8>'[P'*0NCO S57YS^=3B2R#5\E!X:'.+DV5$[-(,()V4&FUT,TI
MS6]+T0E2#C/OS=O/PW3= UK66<1Z'4?G@\>\55)'[T&82C;"2QT\)B3XPE!H
M7=!B\\J]6U*,?)%YH%UOPN0P)8^=?ET1/WP\B_^%:55YVC)^^5H-<KZBH'A"
M9Q-8IV2M/C$4D/,(R%V6RA5M;I:YW9-?;?6XD?%QH$'G@VJW)[R\G:_N7Q2M
MH/*2UC2R9% FUW'=T@&+/&6CF%1VN]N<;9\X\M7T0*AIIN.^]J-?SE>09>8E
M6U:974*EKN40A<I@&=<\%U6B;SVD[;84(R-GL/UH'R5W-FE:HD3KC*9W2#)0
M2A4(SFI(,H2$G&?]X)C1829-/]5$T7U2GD.5V-.D:=H'K+$F@LN!]D5!X'4R
M!A!!I1QRUMH\Y!R>ZZ3IG<QUWZ3I770W=DSQT*1D;@P+)DN(S-:!.%S7N]\,
M6F#6240KPW8G^_U/FM[)9-M.FMY%?QV$"'=4, ?I@JAN+T54H$J@((?$AA K
M/R9W.OG630M[3IH>GOJBX5'8?@KN "*;>J3+0^1$D8P-7@-%,O6MT1Z\E0HH
M3.*%*>OCS>EHA\]:O29!)V=?>]KSYA34_97;#31>G"VJYGXL(JO,?#!00MU/
M>6748/2'D=P+*Y0/S=M([A1DY+&D!UCV3I <HN8.L'+><76CS^IH]2(L%M^G
MLT_K>HP)\T5BK=NV3M<,F[;C2+LQY."4C\J@5Z4Q=K82K <L'02 .UJ-VEJC
M XA=+Z@]5]>D1*E+,0:DTZI6.'!2DPG 6)1>EAH$MH;4G8*,/'NV.80.UW8'
MD+FFE@E:S"(E!QKK8"=9''@G!*4%PA;A0T#9^C+XF@ C3WEM#I']M3LB4<&&
MP?-Z;?Z;^>S3"2Z^3)@-.@O-@$M?:J4?90'))8B185#:NA2WJ^"\YP$].(F#
M8I9FVNO&.5P9CEDK[B[\G&$EH++@5+T**+0HQY0"PG<@M9A0L#7#_0/B]. X
M&H:ZAZM\U.[FZXN9,,W0Y#HN4-?C [0% @\"M$_<&Z>9B\/L*B,/7VZ-BIT4
MV0'3S94A6!1JK^^;/L]/2>G+&G*OOO^8-\**,\5&D%Y59JU26=FR 4X[;!*H
M8WMNT&UEZ^1^ILUARR &Z<+37%G9S?C-:JU54A$2ADIRZC20NXQ ;QPSJ%WF
MKO6-[_W2C)M&#V/_^T%VB"EZ"'^N-]M?A/&B&(_1>?*]G-?KLKH-%P/1)^D%
M1?%)M:ZTOEN2;L!TD)UO;G6'*[T/Z-P8 WFQ$"^S\\%3)BDM@HJ*HG^7D!;"
M1#8"K?.MV3GO%6;<S6TX #50?0<8NF."[<5* O-1A$B[OK%UCFTM,RY"@S0H
M-)<N\N;G-/=+,V[N-1"*&BF_ QBMWX=P^GJ^6,_>6U,LG'P.LROS^"X4-\M7
MLDU/2DJ"T::/AG0F=0;O0P!F2Y&4=3AO6L\5WE/4<=.\(=W8P&8;GP+MCOFD
M%Z^92\I8FPI8A;6:-4EP*D?0G%PX,SEI<>,6]9Z3QON?,2X11F/@M-1G!V[K
MCOT[)D]K=Q&<"?5JI6B(B25 RTT./)#=6U]D[1DS#<9L,9"S.5#98U]6W-/Q
M70_?UY:YXAYCHM= "0^^9@^J2-)2% C.2RXPI)B,WLJK;/_,;J+L]CG_D-KO
MXEQI0Q)PV1#QCS#+]3>^_^B,^(BKU>FF5@X77Y:OPW1QSJQQ3C!0>R)B0@-"
M9O*[E:/<>Z7KW F5-(6/])*V+B<\6.IN8OKASJF>V+1=P/F*8BD>B#H4%B!1
MI BJOI711079TYOHK;8N#[B;=A.S/\E!Z$[*[N#F9DV7LIG_6HNDYK/JTW&6
MZE)L44(E%B'K0.FO*AZ"XA949"DRJ9-(K2]K'A"GFQ!^.!RU,D87'NB$?.M\
M$1;?-PJZ*+<[^E(/?8]6J\4TGJUJVG(R?[\V 2W1.X8J@_:U6=4P!T'35[$8
MY)+\K->M\;:SD-TD!<.A<%C#=9!P/J"WJ#67.CIP,M<),YF\MW6T$DJ0F$B>
M<]MZJSSP1GHPOKJG"<W:F*(#4%U.5%\O:5-4K'AME.8,N&/K1#V!+Y1HHRDA
MRGJ9[]O/I;PEQMA=)&TL?+LD]R!U=[%%7N%BW*S <H:U0I"V=D<KH!>G%@P&
M"%(SH81+VHD!(JZK,HQ=!C,(6@Y2= ?.Y2CG-;]9.*UDV<>S%^'KE#* B<K<
M<;297"\I1D6C22>L[L-H:A\?\MR\WNYN4<;N8AP$-BW4W@%Z/N J3&>87X7%
MC *YY5%*9U_.UA>>+[%,TW0UR99VZZ0L"%E=I[4>'/.5UZI$;3*ELJ'U3O6X
M5&./2AP$4XV-T0&\;BMJHHJ.)4D#%!DJ4$)&"#XP$$$7C-P[RF$'#Z/''D@X
M"'P.5'8')TZ/Y163$I"Y.J!9)6](/:J *\*!L%**$!PON76_P6,RC<N[_-1G
MF(>;I1G,AJ5/WAQ??,;5-%$$<TWVW;F4KW_8$,3*#XC[E"S+A1!6!/F;O*$&
MT[6NKC* *!&3%E'EU+KI?02699$4LT4D**%2IJ"D50I'N:5-+'.=55&MBZ*>
M'<OR+DAXA&5Y%W5W$?/<SPO+%6?: 6.60K8D!?BH-/AL2G'9A6 '8^?NFF5Y
M)POOP+*\O;H[P,T=C'PF*$R6>_ B:XKVE8%0_Z"0SLGB/0NJ^2C:9\2RO(-Y
M'V=9WD77/:#E-O,GY0TQ.Y[!)*Q35T(E_:2(+QA6T$KZ2\36:.F?97DGNS[.
MLKR+DL=FN-N.!YC)F%32&2B$I^ ]1@6A5K)SG63FEM;#_&/![C-F6=[)H+NS
M+.^BW9[P\B #<!(YDKHX:.4HF73,@^,^0W(^1:N%DLGM#)EGQ;+<!#7-=-S7
M?G1) (R)1ZWK\(/:;A5D!,^9 VF\-49)3?\?;C_JE66YT7ZTCY([@,D=O>S*
M%AD$9R UJ]5+S(+WWH*)R1GNN M%-H;)GDR;3\7 W"0=VD_!'4#D^O7]^[!X
MMU@O*J^O9]_C8EUW.]$*>9"Y@,H^@BHI0="\@!29V5 T$[EU,KV=9)WD2WO:
M_\%:BB;&Z YBFSKNH[/5Y_EB^K\Q3QSCCNDL(!84E:0E@F,I@Y?*<6N+S[EU
MJ<7#$G7BG8: U$'*[Q1*Q\OE&:U$4"C(I"R0N-9U);0F)(=>T$ND&*"8(2@7
M[Y%F["*,P2&TA]([A<^[L]5R%6:YSM3-(8M8"?FM$13>%6$@\B2 4YA8'"JI
M0FO>FD=$&KOR8G @[:O^#M!TI9;MEE\E>1G2VP$ZDW*4UI1W>'I%DC#9!ZYR
M9,TG]MTOSM@%&$U1U$KM/2+HW*VBD[0M2P':T%H4,Y1PZGK-'QU7S(F2L76T
M?8\HXW99#(V</=3=(VJN^E#2"),J._*AFO03 Z_3,&E51F&TPI'"AF@5NT^>
M<3LGAL;/OHKO $0W>HM^'(B^7TS3CU13..E5,A:DYT@!'N<04#$PSG-=@G)"
MM+[EVDZR<0O!&@-K &-T +$KK\N]1QF.69%#%&"TP7H^&R X80&]LVA4T*;Y
M<>068FT%+O],P-7:#!T@Z\;[<FTS5S$;DX,'&P6I*D1:BC:&OLK:QLQTS*W+
MQ1X09[OC2?9,H-1*[[U"Z.I^SG5&;S,'@_6DE14+@24-V2++AF<CANZ!WB^8
MXL_EL+NI!?I#U+V^-@8M4V$)I*T]VL4B!*D2Y:A:^!P"D[YUF=F6HFV'K^=R
M\CV$/9K!K'TY_<>3HY-7_WCU]N3=ZW?O7WTXJE,B/^Y32G_W![4JH]]"S$8E
M]!O6QDM07=9*<\.8YDI 47;=G$SVYI+L'9)D+FODIG7(>8\HC0OE>3*2)5$@
M!@R@I*$,M-X2:NM-"2)9&UI?I/54*-_"WH_4QN^BX0YVI/NK>5,,2<@B(&<F
MR*_R1 L1$4S(";G-0:;6:?WSJ(W?R<);U\;OHNX.<'-''97&H'THBH(O%4$)
MP\!Q06]2ML7HH%4HS4^DGTUM_$[F?;PV?A==]X"6V_6:PCO!-:DA^)H!,HRT
M ATA8[!&\RC;Y^#/H#9^)[L^7AN_BY+[@LE%-664VO@L$HELZ;U)BD$D%PM)
M.Z5D4D6' 5LH>BU9;023?90\(DPR3B=O\%,X?35;U4[JZE>]X*A"<. BULQ,
M9X@,-1A$'H4RVK"'2IJ7F/[Z:?[M9_KH#33HBQ^(N..!G11^[1^)'*K$D>V_
MD?K\-4C*IR#J>:*2",KX>BDK#*#3EMF8L+B']I#'C7_U:>/L%0>;:]Y =V.W
MP1S]X\7QT8O__.WXXW$]"WCQ[L/[X^-SW\71*%%< N=I=U-:!Z!-38",'KDF
M5Y9NMO#>T_GRP$/&,_W^)IL/H+\.0H0[#@!1>FL2;5?2B% I5BN);V7(EY[>
M!6%C;#Y);L]VA>&K.1MFJ/LIN .(_!UGN BG1[-\E+],9]-ZQK.:?L/SL;\3
M*9,0T2)HD0HH;@VX0N]2]"QJQ2)JTYKY_1&1.DE:][3X?#CU=X"F*\.FOI\L
MPFP9TH:$_I1^X],CBUV^)FU?^:WE[]/5YZN?.#'%*N>5JVR\I.FL+(7>Y-TM
M<XQ[YYCDK9W7L"OJ)$!N@^6.C#]V#'9.I_A+6 \QNGB9+;VL,CL+.A=;>V+K
MY!"*4$Q0VC-/BV/;S9V_\^,[V50/PU(C[77@"M\OYOEL#>4K:XA,)".4 J,9
MQ8^95Z:\0#X="X6D7-+Z>&,'=I<<W35!'.)V#E9T!V!Y]Q6K-YQ]VMRYO9DO
ME]7?U6'8'GQRCO#.!;@@&.4:3NL4@G>Q=?_Y'6)TU^EP"%0.57,'')-OY[/Y
M]56<0_[R>A8Q22]= 9LSJY/3$E >3(DJUT;Z[*+AK:_C'Q6JNZZ'0U#4U@0=
M>)_+H5!'^;_.EJL--][O84'1V&HYL<*R'',"*U@F5TI>-%JEZW\J;B)S7K3.
M !\4:-S\K['QYT-98G=8^0VL9OBIQMR'Q\#O"CUU/49ON5H>G:Y_&O/)_"5]
M]]LZ]#]?V-494YIGGT)4M32MYKM&091,U3K%@BIRI<IV U/W>?JXV=@PR'H:
M4XR/MHW&:A)Y//N&FU=G^2N>YN/9R8)>I:.4ZI"?22RE>%'GQA9!681*=<*H
MEY!--*)(&\3-,3CW &S+!XZ;E0V(J2$4WL%>^!975X)#)5)VA2>0(B(H'RJ5
MC? @K0W.\:!R\_GAUP3HKMOOH+AI;]5V$'?_CM-/G\E3'7VCU^D3OCVK]T$7
M0S2O%-G_$I93>D.\Q^)U@L*T)- CI1<J&LC":K1")*5;3PG82<#NFOT.P=5P
MING ']VSN)?3TS/Z[NT>#Z%-0L<DV!#JA'2;(1JM04B9+#K#.&]]:K"CB-WU
M @Z O2;FZ0!]%Z-<+GH[-J\0*TX8+ 9"U()BAA0H*$0.SF<>*3Q,I?ELICL%
MZ:\7\! H':[K+B:_W5S&^:LPT4XE%;($@[X28ZD:!Y(;9I+V^L3J#-C6M8GW
MB-)?UU]+V.RC[^?1A?7BUZ.W?W_U\?CMQY-W+_[CUW=O7K[Z\/'EJ]?'+XY/
MKJ]DY[ZL!S]Z@$ZM[9?2?OS) U-V"N-%5?8QQI"200P9',-,,7D2S/K(?6P]
MGV@KP5KW=;D2A/8.?*1,5R7'(=9^Q:C)I1) E!ENS$L'?5WML?!8E]<.^NX@
MZ+F_+R6F(@0W&8)/G/RTE^!L32 83P5S4G& X6_/HLMK%PMOW>6UB[H[P,T=
MK0>TX]+_F8(B9=4+TB9<$H,HK?,FEGAK.,'_C[J\=C+OXUU>N^BZ![3<;D"*
M7.?:6PM&2$4N%P.]0/1'*5)9+W5)=I@9R5UW>>UDU\>[O'91<E\PN6A 4MY4
M?@55^]0T*:0@U%<)@DBT2]<S53,,(UW775Z-8+*/DCN R:67W41QM*"O\UF]
MD5E[6J$=-\H6*,[28HS@X"WYW%R$U2SI@K;U@<V# G52]MHP=CE8[1U@Z,8:
MSM\K7H0+PD0P,D3:I;.LW/@:6/!:A!Q8P-;$NW<*TDD4<[BA;Y[?'*SU#J!S
MA1+OHE,J>FV5+Y"E-J \*H@N%T"O0W'99&]:E^K?$F)<R#0P[/W$@WMHN0.8
M'.6\/A,+I^_#-!_/S@N]SQ<3F-.LR 19Z)H/! 4NZ03><.ZB$H76TQ@R#PHT
M[B[5'C[MM-\!E#[@BO2!^>+X^WP5K@[F5:& 87I=52 @QCJ*J-;T1B\LLM8I
MU-V2C%OWTQX\#?3=&1D"2SS)&M(SJTATM R<%P(44\$P6>L '@J*AR%#>+*F
MUSV"WD.5V!,90H@F9J8T9"<EO0K24Z)(*W!)<6MYY%P_1+_T7,D0=C+7?60(
MN^AN[$:\AYKY)2(K)2"0YZ,=SW(%7FH+M6\H1"&E=?\L9 @[F6Q;,H1=]-=!
MQ'#'O3O'K.H>!4$Y!8H[7T=42$@\FFQC9-H/=I_S9B<RA.&;\1H>ANRGX X@
M<CQ+"PQ+?(F;?Q_/;E^0?IB?GKZ>+_X(BTSO&7+OA 2=529WFLB="DJ_Z+5(
MQF+0R%NW<^XH8B>G)GLB8OYTYND ?;<7,TFF*"&*H9>0TR[-ZSBX; )XE[6)
MM ;9_$;HMA2CL] .9_1;'NP@"^R-H:^XF,XSO2V+51LD79TCX'2QVAC:H9.G
MF"\G<NY*(!0LGF%0WLOFU+2[#FP8[!3E2=&SK];[P4W5S68!+\]JP]C[]0/6
M'8EO\8_UWRPGTBC#+0]0"X% %2? *1O QF*-\2Q8VW[B]1:"C9M@/[F?:FJG
M7K:_VXO:O%4_5E6D\\Z'"-P4!TIZ!8$6"+X6RJ9"82MO7Z.XC63CQO$=P.\0
M2W6 OQ\MU\N3^3UGY>=MLA=C#CE#+B6ET<S0 AG7$'1V4)L\;!8R2=>Z$&-G
M(<?E[WA*5 YKOPX ^I#7O^@8P5P/_7&V7)N8U%IP6KL!DK4)HXX@W+H+5R5P
MW#G((44T6>DLG\AK;B/NN'0A';C2YC8=M4%_JWWCL=5Z*;@M6E'F%6FU/DI*
MR20#)5@0*#"[YC0DA\@[;N=V!Q!N;]7Q229>S&>KQ32>K== 2O_X=3Y;SA>_
MT;\^AE-\5U[/SV;YO!&K[D*S]'F^V/ CS!?+B69)2&X":/1UP@"WX"D8!PJ-
M<E JL&)N7#G>1P!XF"#CMG\_!3B?W%P=Q <WYK,=)5+OFA9O_F/^[0URH4D.
MD:68/##E2;?&27#."N!,>*M9X"*4QEYU#S'';1E_2F<ZM T[@.EU&A!MF&-,
M4)+H*_],-@:BMPYX4/4J0'*-K;?UW1E6ANLA?TIL[:_X+AK+[SB<+TFQF%B
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MB4 G+ D5$C. NK*UDH.%J+*&NN*00^:%M^X7WEZZWMK7!_%$ QGKT WP9,"
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MR&*2*(S6?K.09"A8/B!E)Y-$!MUX6QFI@W2$EI80\[(6)%P]Z7Z)<36)M=!
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M0A?!K&KMU>]#7S?S,!KAZ.6*HT:RZL#,?+"2QR..N.,^Z-H50N+*E2S@E#*
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M<_!:TC_R[-8A@?8HSC22U#M _.T1]&XZP[?TY7(BHQ#*<&)ED62LV.(@>!_
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M(&,&X3PK(145L75NV(M$C9MHTPTXAQ'B^.!<;;J-+ N2P/HJ\D^\^CHG1O[
M&_Z?S7)=_,5L-:AFM3'O/IW0.C$RF<#%(D#5^33!D:?&>5"VZ&10[-8=^WA:
MQLV7Z0:Q8TAV?#S?AA2>3!>J2ZT,^0,+_<[-",M2DI# 0B3N8DS@23"@I%1%
M>*%*\PDT>Y W;HI--W >6K#]0/=Q"LHM+V\J,&X9&3&X;+D%X6M3<>\$!.T3
M,5*CL2)KQ5H;#+M3-W(F3W?('4BN'<2:'J_L5]2,^([3'ZLV"S84'RU/D&PR
MH!CQ+X3BP,:@6/ "2_/<C5WHZJVJNPTF7H3>D0+J65N^FL]6'/O'].KK*U(!
MM-D7J\C%1"F1:G]>L)83"QD3$+- VLQ96A0YJ]#ZH-^#O-YJP4^$Q#;BZAF0
MJ[3VNU.EKFTYL3[F;$, :Y@$I4T$8FH&8X)&QR0O?G@L;J.LMV+M$\'P:"'U
MC,!?VOY#^%E5/3E\])/%-1$X#7%ZN1X24B0K@:B"K$1M7YP#^,0L!.-9Y%J1
MM=RZX]AAE/96BWWB([N9$+NT'+<=![\6^',2A6)>DS,7))T+*M<N;Z$8.A)D
M+J)X$UWK$H4]2>RM=GO$4_PPL76)ROLW8G<+TX9+7EN^([I 3+0:0M0"4G)9
MT1&1F0JG<\#O$]=;$?>I#O(&HNH3@_<LE$VE[S-'P3  9[4!. \)8A(:1$):
MF+094^M&:7N0UUNI]B@&Y:'BZ@")NR=13V1VVJDBH9"/1GJ>(P2;:&7"E>QL
MC)ZW-B%WIVY<Q^;T!15#".UP.,YIIPT)Q_6-U79&EIP5;6 +6>0:2-!D?JB(
M4)BE0X%QPU5K7WM_*COIB7NBLK%6XNI /Y(_]JMA5BTD72"ME;;9U<\/EV%V
M16Y:O7;]OKY+156,U0A:(>UH)25$Q128X)/,7D:M6NO'W:GKLN"L&4X>IOH.
M([1^@D"TGH285_?^G\(E7I2G5UAB=D&NR\SKN*JL(=K@(7O,*BB)Q;:V'_<@
MK\L2LL%P.9#8>M"3CY:V,I$_8K@\7];C9Z*"TYH;!3S7-AHI6J"E&(A,N*BX
MXEFT3E-_D:@NK<;3H>\8$76 N=WY-S'*>A=EHNU3NV99$2%4/S![;G.RC)PS
M/9J1.&[(^\0H'$AH_?HN;Z:S,$O;&>D,<TQK6A?GH0;TR0DDCPQ\Y@%9* YQ
M@#8$>U+9S73.D_@NK<0U=B7$IK;_-:OV8K'6^[^&P:?+Z]KAZJ88\U>/P>6$
M6Q-200-))+(]T'CPTM3!@\BE#%HR^\"3>2+?]P@BNG18FH%C/H*D.CBQ-Y?Z
M:"U)&E5\K4?/J8"2)9.ZMQ9B8 XC2F%+ZS/Z.7JZ]$Q: ["Y8#H#V>U^NJLX
ME]HI:Q*"K1T/E ZT6T+1(+,PR:-RTK0>XO<\15TZ(:< VI'".2(<TV9:R*\P
MT\W<\,V)\,M)D,8JK-U(G:%-HVOI;T91)\37BN @?&JNS9ZAITL?8S"0M1),
MGQ&_NWVSJDD3*@5=?(&D6*@%DV0.UV0V+6UFR=BD8^LTA:>I&3=#I@MEMK=0
M>C@S;W;,F_GB\020"6,Q>T&>-\:Z92Q'VCS$(Y1)%9X1K6O=;?M9@L9-?AE)
MF1TOFGZT&2WD5D6OMHN/1L?,! B?':A2"KA(%J=S42JI,*OF]2,/:1@WD^7$
MH#I* /W@:'>N3:QEQJD@@8E"W K&0@A>@D>MDG4EY7RB-($MU(U;U7QB[ TD
MM XBP'59]7]5-_\(E[@JP2*.31.AOGYP-LOW?[#QF^O)'P]3S6Y#/_3%US#[
M@A]I!YV7@B0$KYRGG1EIDU8AU(!\+#Z!TPE+%$YQW;KQW6E7.*[3,ECDN6.8
M_.Z;:&*+<2X54D>8&"CFZ2LG%20KN1))1O2M>_ =1?"X_E*?$-]+B-W,CEWO
M-C+,-W;@Q>PX1K@2DXC((/LZ,T^IVN. SK_D2#A16,MM:\=K@&6,ZZX-AO&Q
M!=Y!V."XQ3)II*+S" PGTU%I72^OZK!QZ9-D00K$UH&KX7$\F(?8J:[>1XB]
M3$>Z_O[]<L7*</F+E>?K']QQ-)+?H;,(D!TM244Z@YRK1A07WA5-EI-K/LIS
M![K&]10'PV!SD72@'-_.Z%FT;^I\9?)Y)]YB9F@8:&Z)?/0"R(,-$(JL5ZA&
MY]B^*< ]$D8>7M-<QH_*M YG>!=XJ:V+/H>_</EK!5KIH@2SM(>D )51@<,D
M@)6(.<?DHQR@:O\!%2/7K@R/FJ/8W@%P[D:Y/V30<TF<7A9!QW.JQ=I80WB<
M%#=WP&7F(O@LF6KM6QQ$Z+@M\@8[\8876@?(O&GX>['X0%[VS3=G=P/Y-MM4
MK@MU,I]X%Z,0W (SM16_-Q*"8@*DT;$VI0R^>9_< \@<>\[,X.!Y&+0?6)(=
M@/6F8GS5]IS8>TTRI;.AMJ+,?US3FJ_^"U>FQ40ZZZ-U'(Q0C-;%''CC/="9
M8;U@.6G7/L:X&VUCSYXY-2P'D5D76%SS[V:GW;%OEK?<D[V>+M/E?$FKO[N@
MJYG8V1FH RC(+5<:?$CT#[,\U,KOQ%MKT6-I'KFEZ*#QE9/)<NRR@YM%OIN'
M.F?GR_0'SG"YG.A@K5>5?Y9VMN*JIA=H T8*CTR%G-6#,2'/CUQX\/QQ3^/3
M"GC+0(5CN-V#LIL3QQ;+56_R5<+FV;?:"VW]XZMJ2<B<F'7$%H:^CB!A"0+#
M!!&Y4D:DDGCS2/%+1(U[U(Z"N6$$U@R![<><O\9E6DR_UQ_.R\7B2YC=S,8)
M,[(OEM.ZVVZZKLQGR_L+VFWF^9YO:#4 _9B%-9J&OOE60LYR?CG-Z^TSRQ\V
MUG91;@ =+F^/Z(V>W5$J*XV!*).[:2,KBP:RZGA*3)J(K=/LFQ!^M&<=JK%[
M4>Z$-"F*&VY*@""L 269 9=T!,V2+M)XY43S^>F/J!CW)#X]IA[YR<?)I6-=
M^$=83I?SLLE&4A:?KK]]"XN?\_)I^F4V+=-4^UBL>YG2"?2!!)!J?N,!FO&H
M][72D^T6W4AK/G[-+6RE5#(DQL"X"EO"!L04!!B50K$^A,A*ZX#ND]0<J]]6
MC+^XQWC:P\_R^S.Q^ ]ZQO\[$5EHQ6N)CS&UMUKM3^ 2F2!:&&T+%]JWOC8Y
MAMZ18XEM$/50$9Y,@!VKS+=UR%VX_' =:8$7A6BCU1ZB"[<_J)62VX',([77
MS;BJ+:^YZX?(T&3#/)2B!8G<U4,W2?"$/1%C$?@PF?G)&6//O.;(26I;GGP'
MVJQ0"L,9V0DJ 9WJ#)SGY'4K+K4W,4NWZY2TY]XSCK9H+,$'<\R:\;5C9? 1
M+VOQ2[T_V1QL=9!M].2S6JF$W8AM9-,\];);9(4@"F.10TEU5HC2"6(NK#:]
MB,YFP;5J;=F\1-/Q%7#;GW\7J=DX#3$S@\& KE$:A34IE,D"6=4Q?2;8W-R<
MV8.\<:V7IMAY7"4WC) ZUE*OYM^^3=<7N>3HU,;_I(MQ=J@3]]SC6NFJG4EN
MI*XVWG?VX'U;XJPF<\,J&OC*E$V.\">00:B]1G62JO#6NFLO H\/WN_PLKMM
M0D<V0UL,1&[B>IAXM+J EE*P)%!8W7K&QWX4CGR5-!BV'L?P!Y-;S^KM,BR7
M9W7M\]GJYN+3=?QO3%=7\P_SY7(:Z^,R?EL%Q@_2=_L\OYD"/'A1C33B9WKX
M?!$6/]=-";8@5:+S,68#UD0'*@L)@=,_9-;G1!RTJGE2UXM$'>4+/OGTNRT3
MI!89C8;:(HNVC"T05D5MFMNL8S VA9?PM..[QE5:;<5_SS5LS.:.-=-JXWZ=
M7Y*HEC>+Q3)-TZM#U-#3#VNE<W8DMY&">?RV]_.K.WCE5)35WD)DH0[NI</0
M9^/ ^2*R+BA-;.T@/4_1T15*6Y^^%?TQ"TMK!UYG'JE2$@17IVHF;2WJ[%EH
MG8NX,W$CEYNTP\RC:J5!Q-.Q<KIM57B +KK?YK"!ZME.3"--\^OAM>9Q^N7K
MU?*^9._29TIQ/%M5!^G0B190U$$^ 7A->-9!REA:^S$[DG:46?/K';<(OH,R
ML\%RK3BXY G*O"!$[62=LY9\QF)TVJTI\-/O&%=A#"'Z>\9,(^9VK"?>A.GB
M/\/E-?Z)H?)LY5X>HC2V/ZB5!MF!S$;JY/9-=SC::*//5)!)*)!*9A*Z9^""
MM%"2$):SY)Q2C77(<_0<:[1L>_8=PHL0T<:BP*]NAU2MSHM!0DI*)R65D*EU
MV]UG"1I7US3#Q4/3I)T0.E8SGZ[C$O^_:WK:^8]#-<RC9S3SC)XEKI5#]. E
M=R%!'8M4)4(1M9C&"81Z^P")9>ZU#%'FYO[ $[0<WZ;A_G/O8&R2=3Z5 LRZ
M.ALIT ELLP7)<EAU"/+-1PD]2<S8-?4-</"X&4,+QG>L/_;+?I[P0_3+WN\8
M)[7[X>*Z2NY.W*)+ED&L43W%I('@I0)-GC/G2$9X;IW1W&MR-XOU$ELGL-[7
M^D5MP"GK:5-C=H*\$0RM>SW^>R9W[X.I'9*[]Y%+QQKQF#SGP_3CD6_L(<%[
M(-WY3$(NLZH$9PT(&^HT9X;D&=@()@7&?/(,?>NH4Z\IW@R9,\& X63:J) ]
MN*+J7&NO:\^7G!XF6_YOBO>QB&J;XKV' #M6G%MS5P_3B$\]:M T[\8Z;(<T
MX8(N1Y44A)QJX2D+$)S,Y$,XJT3@HCCV$JO&3?2.RG!IM"3 FMK\'!5$Y1UX
MJ[1US&6M\N$KZ#_1>Q\)[I/HO0]?.U8)3V6-'J85GGG:T,G> ]DW+Z;L"I.2
ML)).(N4TJ!@\>*$*%.V\#%@4-D\6ZBG=&PN+M@[]9@)KV\*$=<J"K*DM(H=2
M2RQ.M?SN+O6;8N>8=.]]A-2QKGHF=_HP=?7\ T^0\CV0TMHO,3<&R7PV J*K
M#>RMK(FYS$#FW@MNK#:EM7?2<])W3K%$VGS 8JV-J*:#DU[2Z:Z$5:X>\JWC
M>/^^2=_[8.O(I.]]Y-:SDMLC/_I K;??&\9(_!Y(+[Z<^RL,<YS3.6QK1UWE
MD(,C)Q]*D89AD5;*UI=UHZ=^BUISQH*&S H')6KG(Z$9D%V (2@LVN[FX_[^
MJ=_[B'_?U.]]V-RQ?MI,)VV4]#UDNO>(B=X^ZIJE$J$VXJFS>QD$'PPP77S*
M-B;A6QL2O21Z:QZ$RK% 3JK6L;I8[ZTX\.""0&:*$ZTO /\]$KWWP<SAB=[[
MB*=C570[B/T@,VCCKULG>P]DONR:\QN+BS() 0')_E7!9'#,9A"29Q$=UT6V
M3JL:.=T[^%0+UP,462^&BHT0L_$0C.*1,W(TW&[]6'[W=.]]1+]KNO<^S.U8
M6VS-HSY,=3SUJ$%3O@=2*L\F]Y*3+IE4"JR.[&8H348+$G74161'A\6_3=*W
ME(DQ7AQ@,;1W(AV-4=,AJ4+Q(0AM(FO=M_=W3?K>!Q?[)7WO(X2.E<W&G)[#
M;M?O_KS=C?H3)#52)+?/WW(L>8M:6#)F3>9TA"3EP#L,$*+D"3UR)EIOK6?(
M:3;[:IMMS2)'7OM:>.L]N?G:0C0L@&?DWRL1-/UG^*5VHD1:8>+),5C'2N!@
M%?(#%W%^XLJ1PXR5+4\9JGID(!/ER;H!$:.3DCLPB<2M7-80Z^">G*T4(3E=
MTM"E%</7C^2(6GMI:K)9'1<G!7AC'#"?;30Q9]HO_\/K1_;!P>[U(_LPOF-3
MY%Z)Q=57_%56<72=R.:S!JD'>9+8KNH^HLF,9:VAM@P%<HDCN&H5RZ2="1X#
M??$_I.Y#>ZN5<QI<9++>]GKP.DHHEGF9I):^M&X?]^]9][$/IG:H^]A'+IU;
M1$,U\#]QJ_X^F_(G;5/B+$+B=.RI;$.=3$O_J)2M4XJ9_RD5&RB"*U$4B"+6
M&Q(F(-@D 8N**?L4C6GML/Y;5FSL@ZBF%1O["+!KE?<>K][-E\L/N/CTE:1Q
MB&Y[^(A62NQ9TAIIJ_.PF)& ;U^RD5F&-KN8(059AW9%LLYU;5O%C<]!L8S-
MXRQ/T7*LIGKXW(T6&+0(+,F!XZ&6L).+$PW2(H-$'C%&S$,OLA,=TP0'#S5,
M&\9W[/M]1/)IKP^SB&[_MEWEQC9BFM5IK![^AH!3,T4K-/XQO?KZZGIY-?^&
MBUNX:.1*,E206#"UU82 Z ,'73*9Q=*I/$"YQDZD'5^U\>QK[K#ME P9I099
M6$V4-04\,@LY!,<4L2!H?UH6=*)CAL#0X[*- :34L0;:F+5^V$78W9^WNPA[
M@J16)LLJ]^I/O/HZSYNCYF?Y_\RGLZO_I&_N7:::8)RM-Q\Q*H(39ZPFG1H2
MMV1)E6B2:5U_L2>)QU^8_7K%1G<>:;V+1M3 :J9SU=61ZIX#8LZ&CMD0'U;6
M-K@G>T3&R$;-@$AY?&5VG PZUC&W&05'Y?*TS]XY?;Y.P<R#6EV$&%YG+"AP
MY&C7;EHJNA*$L:TS_T;,UU':$\H$6%[STDSAX+/+=$**Q))C,87_S=?9'Q=[
MYNOL(82NXRP;Z3&'=L38?,  63L#W:X_EZ.!G''D2.*LM<G*^PBQA 3:,BNU
MR]S'UGG\8^7ME-H *\4 7M;!?<;6P<<J@- ^^Z""T;9U[/OWS-O9!Q-[Y>WL
M(X&N5<DJEO1'6&)^-?_V'6?+U4,/NI7:_J1FMU [$-I(R]P)_*)LONRFC<&K
M^?)JN2(G5G(^A)_W+T2U*$P5;8"%[,CE=A9BR@6*\LH6[4O UK54QU%\K*[:
M^>U_;+Y]LQI:.JZM!9=I@ZJ4$WA%KH*)7.0H"X_*CL6P[22/J_%.B,^'2O&4
MHN[8BWNRL8\X1',^\[3!.Q&)033HB]UD6&8,!9W)+&I&+CWSX&/-@M.&.9VC
ML:&U!=-3)Z*$PFMN:/=YCJ!$(O/!HJ+-F!+&K(.V_SMXM@5VCNE$M(^0NM95
M&?%;B)?X:CXCD_*JMJ_X\(O(52'N84KKY<>VTUY[+N%D/3AX*$Y:=!#1Y]JM
MJN:M$2HULRK*2!_ZUI?>H_?@R&0M,%$T!&Y\;3Q!JQ>*0XHRH,HHK/J?,GYQ
M'_'OVX-C'S9W[6(^UU/L('OI^0>>HA7:,%;3?NVJ6+)62LF %R= R<C!\9+K
M]&"A@U VA]:JI^=6:"58C28+D-S7EC6%K *6.82D&6/>A\#D&.SH1)<-AZTC
M6Z'M([>.K:QW2 [O06D#-W_92FUM(Z21?EH_^N[P8Q*ER1XDUCA"R1+\ZJ*&
M.V4\.D1LG0MPGX)C-<Q-U<'LR_JQ%^4=+I?SQ3:4FJ0SNCH&V6LZC+FR4#M4
M@,>L@B<G(3=WV':G;ES-<@0J'JJ.@032L=IX5)5ZD$&TY2F#E<T.8_H\62Z9
M2W*L>$9PJMT;8@@0E2Z0LBK<:(^<MPX4G;YL-LKB$IU_P+*L(QN$ 2=H]]CB
M-7K)5/+_T\>N[8.#W<MF]V%\QUKDJ4K4!@/6[C]MZ-+9KH>F29$%>=X((D8#
MRMH$3FL'++$H,*F:_-K:!NBT>%8I:;2S!5"[3+O1,@BA;J,HI,].A,A:FT/_
MGL6S^V!JA^+9?>32=<QHR %I)Q^%UNO0,U&[1M1B %GHX%,,"WGY&"$C(S0Z
MQ7EL75_2:0EMM#532$M@TB=R*4R!X*P 74Q,7EA,IG4NZK]E">T^B&I:0KN/
M +M6? _J5 _3<(\?,E 9[4 ZZ\D"2NU5"5C')&>4H&KC\RA8 F3:&RRL5E.V
M+C\Y>2&M8(:\#VW!8G&@5 V^)B8A1G1)<191MNY,\KL5TNZ#@]T+:?=A?,?>
MX*_:U4/'HMW^=>MBVL'&GNU6"BGJ]+N &HQW=4!Q+85,)&.AA(]2)?3^Q+6D
M)R^GU4Y'$X,!K:4&VD,:8B@(24J>@[))\WA:%G2B:8; T,'EM/M(J6,]M%$E
M>&B5RN8#!BBI'<I\V;-4TC$>7/8.K"1;F5QX!:$H#EJF8 QC'%5KQ73BHMHG
M7K?]/E@:D8L%%FJK59<BA) \8-;$B)3(D#]1A7%W-VU#XNJ1E32,Q#I65[>U
M@T?VV1^BM_X8_?03BSSY4,#+7,?A10:>3&NRBXOSEDNF6.OHT'CUN<Y+ENEL
MA=5 &R6#K!B6P&-,3/%20G(G6&PGBJ89+O:KS]U'"%T'<2ZNON+BU?6B\OIL
MN<3#^HEL>4HKQ?(2@:T*Z6X$LRH+>A6^3Z_"Y?1?6.]'OH=IIH-K1<B:@FUM
MUV,I2F&NS3]KXP>EP&>= 54FT]M8269RXUUY),E'IR0]$LQ&KWA'K*BCMD*N
M4]R==A#HC(4@48D0R 6)S>\?GR9GY!*X$R+K4992(QEU; M]6,R_X^+JYX?+
M0 ^<Y6H-?J\&X"%Z[.F'M5)G.Y+;2*O=>]O9QMONCDC'R?1.#$QP#A2W" Y-
M!+1>1I6T,*KU3GV1J&,UTY,OV%X>SXM@Y W(E.DDKRD[(3@)VFKEC65>-9\#
ML ]]X^JNMOAYJ)T&DU/'ZNHUQH,TT^KOVN4T/22BF145K[8<85(%$VMRAXJU
MF2A+=-1D%2 ;II7RQ<C2NJ70=DJ.;A]P[ZD;=[HL29Y]!E,\@DH!(6BT](]U
MQB)Z)H==8"?ZHH'\'Y7Q-V!YQ_K@T]F;\X,R@^K?-<OZ>41$,WVPF/X@FG[@
MVQEAX?I7$/#OF+],9U_.$GU$M&PM[%$Q1C2,3A;&2.'SX,"EI$%F,H<9'0+H
M6S=).H+<HRI9/ZU$?O9E@:N<NS?SQ9OK&A]=1S;?34.<7CY1>ND)Z#R54ALS
M5^^ "_(.0@26BPXBQZ2PO(2E(VD86^6<!F+W:F)/)+".]=;-8-M?2SUP/,B6
MIS0>&OTD@1UHN,P84UK7X;^UX7',9-)JS<!YIK-4R)&USIX90<,]?G5]X6UX
M=</"-]YB\!I$0D[;@UL@'Z* %\$4VJ92B=9WBR_1]/NJMGVP]=CD:BBICG78
M9A/(@XK9[C]@B-Z4PY2P/=>'4$O,#(L&STT=]R#5_\_>NS:W=2MIHW_EU/G>
M,[A?JLX7QTGVZU-)Y),XLS^J<&G8G)%)#TGE,K_^-"CJ8DJ4%DDL+=![*E6*
M;,D$T/V@T0UT/PTNDI8#Z584927[9K@I@W9)6A4!L;+F2./!21?)&S ),7NA
M[2LLM1-CTPH3!W%3'J*!C@W)AM:G#3/ETY_4+- ;,-$^F"EC0F>9L5MDZ.3)
M38Z;(DK-HC$FAM9UIN?-3,E]4,4*#S%@I0 K$:+)"K212LI@+&VHJ03V#3)3
M'H+/ULR4AZBZZ^2#O52/\AC;^<RGC<Y-*4>QH2_R"P8>592A5BW53A/6*H@L
MUFN%4IC0A0[3UA%D3]R4W*))H3:WS_7^QG@%OJ0(UI>@#9?>BM;TQ=\.-^4A
MV#F%F_(0)?7LXU6#_&EQ15I;W5SS'>7?/?Z4IJSCSTRP:<;X/?V6<Z@T'4-9
MT&&HN#$0 F/T1VF=,5KRYHW?OI[!R50GU27^2FR_+-;X))"U<#8$.N@K+[_B
M@2!-!S%%02QFP7CPS=OX#IY<#]G>1V'B$0'**.KHW MZD3+VV/JX(1_\BLRW
M(^6&OTQ^&FJW9%LRF%B[_EF%%9$9,,:BBT=9L/7[_.3<M^@8IVC$@*6X@$YU
M9\"K[$!FIV3TTK)=Y^B;Y;X]1/V'<M\>(N:NS=!W.,<R6]=DK*/>\K[Z]ZV,
MROY)M<J0I&";E'RUV 39V^$><'D%J:.2&AS7BD)M4?/\E::C+%JG2A"9M8XP
MGI_1Z:]P93;'_$"N#X@*=<PE)0G%U,46@K)3JMYN2"436FM$:U_NF>E,G/G8
M#A>/G]?:J*#C8.DY0NJC[G:>_\#7X-$>YX;G,*[C8IQRA1$ZBJ*0/0E%J".<
M%)>#\4&@;DX+T#./MO9&6:<#I(2AMKZ($%A00)%!(O^?,>-:7WE_NSS:AV#K
M1![M0_36L9&[8?X]+C2[^[=MN;1'"K!V>)-#3%:''("CK*GXTI++*P-$'A1C
MJ$O4K6M&)F/3UCY*+FT QT(M]'0, D95Z[!8=BX[+UK3K9TIF_8AJ#B!3?L0
MA30S'J=LG=4*<6=]#^J(:<B0LH>B+*TF:@.Q5A3[I+U"AR'Q]EOIN1D-@I0X
M T@U%'S'9] CSO.CO.LG/F4T4O9Q_.B]9-S:>'(I# ?F!/D:1FN(E5@D>Q%\
M)C^$V]8N\^N3LC-I>)'"0ZX=YI1)!D(EZ149A8LFDJI;WU*<&RG[(3@83LI^
MB. [MB(;/M/%5WRF%/\.XP*^_?]15X8MQFUVU=A<"./3(D>655(.P8;:[5%F
M 1Y#!J:92U'Z&'3K"'AT6N2= ?Z^^?K  60F)DF+M)F9F_8*SL<,J<BBO3#.
MQ=8Y+\-FUBW5\2$HV4-UW%(I'7CE;VGC8^4UW*3=S5;_]9;F,%O7[RXCQ1!(
M$P8A4R6FEQR\QP0B"%:BI?/#MN97>F8ZT_KC(X&JE?A[0%)8?:IW7O2_^D;X
M1[BJ'L+N]I Q"TY[ &*6DOR$XL#5U 44.>M@6,BE.::&3&P0NN2YH:NY2CK
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M<T*#O#72VKVN3<*0=0+0VJMDZA20MPOR L(?L^7UHXMQ%85S)F!]&JPD2RR
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M'>PB**-]\6B=M#O5C7NBP8.&'0:?<[EP'UGL'9BD%QEMG8XQ>$5;HZ;9&FW
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M'<!D/SNI)A=$8HK@2#"@;'*UIM&#(5N<N; EI];%6*<Q"8_W*/OZ9U83K?0
MKY?9!6.BG8+.@+"5%4!S!9[1%V42!ADTA8S-7\3.EC+X(/4?3AE\B"XZ0-=^
M<DF-*@NM#!B[2=ZB8S]0S AD@ TGNRZ2:NT8G<;O.26!\$%:'\SO>8@*.L#2
M'M/^TUWN#3KN52H!T#$.M:$>1,T#U'I(9RC,#?F57DU_.H@;9KP2U%YNF(_3
M40>8>S8EZYZ=Q$2=LRD,#+FDH$AZX RYE$*QA#DKC.U[.@R:63_WCJ>CX9!L
MN>-4TP=QS-/KVM3<WB\K&I<*3PDXDME63)+D>*8@1BK#L3"OF]\K#)I8/Q>>
MKP6X$Q33!][JAMGDV%^&DF1M1 LHB@9%'@"XY,D_8,GJ$F@#N=9EI_>C3WOK
M.2YRCA/Q]-5[7_=L_6U3@4AZP'P9K=4Y20>B2%OYN#PXI1!R85HGZ\BQ');V
ML7>(:6\41L%#0YE._9CV:/8_AMERRPMQ\[/+++)3$0-([2I;,U),C)G61,*1
M#(5W U_67AYK6C=[/*PTEO+4H'GS\>,2/Y*L=GI!_SFO!0S%DG.& I*N#'^%
M%X@6)7C->26AE#'*07!Y;I1I^5C& THSR4X-D5WK&/\3T_K#8EOG<KW$2S*"
MN3BG(02/H*QQX'RM@O8$ U>D\VZ867EQJ&FI5E[O!#I-QE,CYE=<K<FUVEQG
M7,QO*8AN?/.+\F'V&=\4&NJ[ZQ5);K5ZN_@<:[->^O5:2'6%];O+$IP2%A%X
M]I5>5 8RH(53E*BT+EXAC\,XR5K,9EHFE?%P]^J:FAJ:MTM\LUK-/LXOEK_A
MU=6;^=];V[R\K6C>K/I^B1=ERY3UA" V,>@FDOBPG'W\B,O+$"M3EG=@) 6=
M))H$$;,"R9S7/N;L51B$W%>8[+3<+>,!NS<]?WNX_T#077U:7&7ZZ%S9#L/?
MJTL1BB>WID!P-M<B;0.>Y0RU+:>P/J:XVU[IU:#_U'PGIJ8Y)_B?K.YO> >\
MI=,3T_5Z]@<^E(ZS*!AZ 3DP2](1$APA'60M1V&*6[/[2/_ZF^'IJ4_,MG.6
M^Z(!"";?(K=KN7$ ][E^[^;__#1+GW[[@FE69OC0(OQSMOXTFU>)/O[AS8?6
M["^<)UQ=>E=B"C*"4J0_A4I!K+XC*TIJ)3-F,W![O.:T)V;\&7%K=*O\9MOB
M]9@Q[LELWLW+8OEY,]8(#!G/CC,V4\;P1;X68T:,7*;H)7B>"QE;GR#4.]C$
MHV?*!(FX$WE]JXP9V0ENE:&07&!]\J20O 2D4\<X6[+,2K5N//$M,F8<@J=&
MC!D'**Z#9)SG"O1-Y)P7)P%]9*!<<."45<"U9\($E[P=L]KS6V#,. 0,!S!F
M'**9?D&V3<14I?#"G0,4M 3:HPA!!@;9"K0D,F6+?QV8]9 %W4SM!S%F'**#
MJ8.<-_GS;#ZK!KZ&:K]=?_FR6*[??%SBIB#JMB#%:">,$R0@0Z)2M;Y%1PT^
M1UJBYI'Q8;D40T;K$C'':'8QIIBGQLU#.?VT(#EMUQ!$+$'5-GCTW4UU@8^<
M 4W?,"ZMM-X/@LJ> ;I,WSL5'2V$V<')]"1)[L;6!G0H@N# O61;[D=MR/2F
M@)A9XE:VYG':.YFSY%0YP?5IHY5>X;7=>C*SHF*VP&VE 8_&03"6!&23=E*S
MK,RK,&3WX/0T4O@0&!TA_:D/KG\NEO]5>U>$+[-UN-I8V^V:MD8WN63I$#8@
MF:4HUQ1#5ISLN2U<""X"!<##B*U?&JE#E!RCS\58PIT:*>^7LS_(#K^_"FGC
MI=T^AVR7PC'(S5VRB*P6N@4/,>8$/,1,?Y,#,\-X>)X?9]KC:A24-!1L!\?2
M_DI;@])[\@G!<YY!:9? (\L@>5$AZ^2RZ*O\O3?*EA.\GC9:Z0%>+Q??AJA1
M(1I0&"KWI_?@D]/ M+%!!5ZL:WW/?[[E[P>I__#R]T-TT0&Z=DWQ[3$MDM;D
M%8*H2;6*HX"@+0G)6<6SEJ+8UG563\^D^\+W@_3]J#7WR<+O $('<#ABL)HY
MAY#05Q99:R&((B%B"-Z2I5?NE2ZGC^5:[8T@IOV3R*EZZPR1=]O4"(XE@A8U
MP4)3\!'1L%K(%IW/(1;6FB'FC+E6#]+WRURKAPA_ZJ#O:_90G[(PIK:KL344
MX8D$870!YCA)1EHAT[!&D'USK1ZDH/U<JX=(JS,S\63R6++1H\D>*)RE@U@&
M!5XG.N6#,4$(%[1XI8XS/YTU74O[0^HX'76 N0-;->^V%+S,F9D2A0<;"OF<
MON;/ILK@@,E)H9RP^E7NN8=/N1]C=SI^3NN[?9(RNV#B.+W1>(S!A1 2Q4>9
M;$% !%\J.S-2L&2+=S:(:?%[9-_XZ5*<7Q'!)RIT>KJ0)]>[IWTKN3,8Z'"B
M6)X^A9:F:[HC<C"J&(\Y\;+;9VV/\W?(J)V3S!P#MG$EW^NA_F)S8)FU9(EI
MH$EC9?E5X%S:M'%U,:>@T#:G4AZMJ?-T-#?-S5]3Q75Q;+]?+A)B7OU(TJTD
M8&'^<&&7KB1+_W$(7DM0B@*X*). .IFHDTR,M?8IGY]1YV0YIR"NH2JF/TU_
M#G_-/E]__FZQ7"[^O'GV#VFV_OOK\)"6_'FV6BV6?_^R6..ETS8Y3C%@]K1Q
ME/>T>X*S()26P7'C8XZ#3M5C1N^<7>?HTW5T34Q]+;==X":CY.UB3A!>S^(5
MOINO%W>;)TD64 <&EKE$ZTD&HK 2DI#(8O32A&%$$P,&ZYQYYU0@-9/SU+BY
MN%ZOUF%>RRZ?R$VZ= (+T[&>W9&6$@I"5%*"-EH;FQ3/91A!P_/C=,Z7<S1:
M&DIW:J#L$=(/?]5.]K@YKQ_><];BWJ],*RY_7LS7GRX+[0#TM8P$N0&51*#-
M(6QE,(\LHLLF#\L>;#2ASAEMCH;>%/KJ(-0\<=F704B! 07H%&IDS1PX)B+0
M3I2>9\5$\Z8&)TZY=U*:4Z*!U]1FO^!]\WEQ70/LA]DUERFY*+44P+SG% EQ
M2\XI0Q!:\61L#DZ]4N?OIZ;7.R/,"* \64L= /#[:_RP>+"^>K6]H:Y=7X:H
M!.; P99L08EDP8>DH/B:A:P$H]4TQMO^V?3.JG(*O!KI8&I_\;&_>ZF#165]
MK%X$Q=,A1/ < RU$&9]8)H]BV'O!X\\>!H@S?!8X48P=<^%4<I_9IJ71BB(D
MBJ77M$Z<)\+["<PW SZU%<_-H0MHQ&KS8-@WN\/.5NEJL;I>XATEB4O,$40*
MV.CJ$WK.X*++M:@H!RDY&93FA:6'3+!=<<G%\@=2TOKOGW']:9%OVAPC/LA0
M_N[OQ[]\^VLWB3@R)$2=&(C:7UEE,JT^ED*GM8D^"B5,B8V%U7+^$]?+C8;+
M_:4KKZSS#CRT9^HV4HDYZP0F6W(U.:W!(R;PS* I+LA46F>.G%9,]0JU+:^-
MC^$U5@<HJP?4O5SG@2%)M!S!:$>A=A66=[R DR2X*)44O#5]TQG76!VB_L-K
MK [110?HVM_?,@1>"YX+&"\=*!8YB8BBZ51R;63(2(ZI,:C.M\7H05H?W&+T
M$!5,'7-^OQWS]]IJY\^:FC?_^"/B;=UTT865K#+$Y#THQ\B4JZ3!("O&A62E
M'=:?YOEQ)N9/&0<HK>4[(50RSBY_PH_AZ@=R4;<%/4ZQ7-.6:C:)JBE+-=-8
MU)<XYKV(F(MXKOQIA>G?/B[^^'?ZZ!L;0]_<FY8G!IP8(U,[2*>J8&+TW,QZ
MNYNTC=IP GQ$1V=Y]K21!*>SW'G4,OHBW',D!B]#Y^%HTQQ")ZMKT4!V4Q\N
M/] 1F19+_,=R<?WEIW^[^K?T;UN[ESU:FK6';&IW+IL0'.,!+&8Z*B7+I91!
MY\K>(:93^_'J6C27W80(6"W7EQ]FZVH6W\WS[(]9O@Y7FWU@463.I0(78R!7
M/BJ(3"*DRN)?6/"T3X:XJ#3" _>4_G1O!/8./C%GR=2G2!NE](:JNT?L^J+]
M:?;EP^*K/2A5R8'1]M-(XE',,HCD=%7RGV2MXE+S05GQA^+M^6E-8Z : > Y
M.#74QM0'V-O%EULBC3<?[]DTBK<F<2' :T&B\HZ^*S&#3KX86IW2?%CCO*<_
MOR-DM-3EHJU@I\;&C[-YF*<9[9[\QZPF0&_7P-!9C[) D/6:7I-,0BJ.-A/9
M:F>3,3BLOG_/ -/$0:^*CA:B[>"2[LG+S/L';AD")^DD2$5'"@<X ^>J_;7D
MTRGCO&C.7//\C"9FJYG:-QI!;5/;J&WJ_6WU[??X.<SSZL?%\E?\N&4.K[VW
M[JMR+V4)DEEI(3A=V['' M&D",EGY$E8Y<4PZW7PT!T^/!RI]">*'T;2P-3X
MNKGV_@_:>+/YQYL&5)=<>L,4*\!4[5CHDX90I ">8\I1>$R[M,G[ZA\>?W@O
M=X!M,7*J%/M P8?%^^ME^A16>-^UZO?Y;+WZQ^P/I)_>W8#3H)=.A>AY90="
MK*]Y)A'(=8TX!%?1!^^</0 DAXS=RPW &!@:30=30^SA\TE-C:EYP[134E7=
M1[QD2DCEN:3M8>(V9WC3*B$Z+;)42?!A'2*>'Z<7!ZDM=!K*=FJ8/!#,4ZM:
M76;' Z';0^&AIG\*I)"$S*I*DOQ#+6T(PRJ%7QII8E*MD:#25+Y3@^6II]G[
ME5@7@F.*#N"B/<6:R@"91 _16U$9[ 2:82;EV6&F+1X?"R;M)-LS1A[82$'1
M9DDL0^1U22QP<,PGT"XGQ@MFF]S)8#GP'!JM4GP*U!PIZZGA<T=[M>E^38+[
M3TSK#PL*_PK.UM=+O$RUS#W:0J>K(H.94@87:$<D5S(+@2QF'(:<%X>:MF!\
M+-"TE7 'EX8/V5QJHM"OF)"<]WRI OUG.!VMOJY#>]H!SBDH5AL9F(N!M6XX
MNV\NTQ: CP"EIL*?VNB\R?]YO=ID)7Y8W(>![\,LOYMOBZ)^^*L:U^O9ZM,F
M>;$\97HWQ0FK5;W:OYB_OXY7LW2SR2YSLM'69#A+HJS$O %BK-SR&=$QDH0Q
MP^X(QY[IQ'7>8]F\KA0\/674/\)L_M-BM=FT1Z[[GBPK!9.-8Q6L#E3M*N4K
M&0TKRGN+/',<=B_5<%(3%X:/A>*IU-9S?6?E#GQ3%[J8;\2\]6?6B_<DJ$J:
M]"MF_+RYZCNEX/.(89I5@)ZZQ$8EH1]HC,620'WS>OA$N5TL',EU#("&$::B
M#E )S, D*0+9P61<ZWXU+T[J5.=R9X#O_MZR56XT<?-RJ@/*S*( KGD!);R@
M0(M)L$8P27ZTC+)U0>?+LYKV;; M5G9]SL8ZZ2"$^8U4LTGM>;B238Y9-)*B
MKI@@&$=NM$6RTR)20,:],#%S9FWS:N%]D^D*4R=K?3>'H8D*.L#2P_EOTXJB
ML1*5JFP>AKZ@*Q!02!#)A)R<-%FV;DWW>!839RNT4>_3U,7'RKH'M&S\BAL?
M8YLS%DO 0 :XMAP2H$Q*X(US8%DN4OI-CEIKM#R:11=M>8_6ZRY,3A/RU-<C
M#Z8?[NX+[YW.VTQ4:3Q:BFB"C!0"JUR3#D4$:WW*!2G$&9B@,&BXZ6DH3E'H
M8E3I=F!6=@[K^^ WNL -19>0TH:CB->R4(:@N<Z&7$)I4^L*_GUSF38U:F1W
MIHD".@#2P[AW<]7VYGK]:;&<_0_F2QZ$PKH3M*^=SKQ"B)9S<*8RWC%'?S/.
M0?7D=+KRCH_4]Y/GUNG"[PM'[\/R8KGQ!_-_A*MK?/__D_=NS6WE2/[@5]G8
M=\S@?HG8%U_G[XBJDM?EZGIDX)*P.2V1'I*J*L^GW\0A*<D4*1V2.#R0M[O#
M+4LRD<C\(9&9R LLNMU-DHD90* E&/&428V'SHD<"%5H GH+B?':C2!ZD-64
MFJJ.JRK":,- 6K=#V+RN_FN^@N7=9I27):;A2-2E6;O2B@1;TL+ <*5<"-SW
M>[-^;J5Q4S6K@J4^9QM00SL<6FO5!PW<)R&RZ,$Z(I(ICP/.$$1[(%D;E[-7
M: \,;!\]HFG<',Y!%%!5,30\7:BX$7!3C,D'8R0^;HGLCM7$.R-L5HPXGT29
M'=?5LVIDJT7^4O!:U6[>>#*QX^:(#@+%RPAN[!OR%T!/>1O[QZTY)G(B)EM*
M9/9XM2L&)*)+DX+FF<O4ZS9\^*GCYH76O_E.YMC8HMYAQ1;?I?%7+&;>Y_L9
M-BD:*<$F0J$$3B)8XLIH$F$M,).H$SUSR_NO.8Z7=J9$Y\.S=_RDE)V-;77A
MF_D2MQ*D<<;0PJY4ZI@E)38&3R@%#BZAXZGZY98_M<HXGM9PV#B=A>.CX>/U
M[3U#>-!XJ4E&E$DEMBHC"0RY$GCT*N/WG*>]I/_P4\=-":]_89S,L?;<HE<Q
M+F!=G7<?"._" _>)?),H@3EG'*&R:S (BEB=)!'&6 /4T<"?:HE6P5/J0^:(
M]\WI@'C:6ZHNG?&US8<9;LDOX6KQ%M9??9AM4E?6@S)^Q>_=+F"=:_<X%^OS
MGERL26::\D C\0EO7LD4)3XD6G+I U"+ZG:WB=(!K34$=2/>=6?CL@V1M:<V
MWZ#A]WTZ^[(>$O1JM5I,P^VJ.)&XV4XN$W!9"H47BU(Y(+N3(JYCO%4N@,-#
MJVL[^T<3.4X,<U"565DR#2?D=D?LZ_P:A;3<'$?(TSA=_1B\6$?<SLC(/6F=
M6BFYYV^R4D[N8T+*3.$[! M#T<TSB63P94:L$:34BA+II4E@0 17/WGP*8K.
MCW(^YN^#-\G@?$Y) .Z7X1G*@)K;B$ @QA)/\UJF7FT+CPIE/D71V#EOU=#Q
M.&I931"-A,\?[N?@HR3367DI44DG"27)AQ+'T,@UD2?K [K0LGY%81_*1F[S
M<RF@51%,@X!;'Z 2K\'#$[..H!@G29=,LJC*:Z:0A*$E0+5AGD+M-(3#U(S<
M^^>R&NP$ 30+IA]?,Z5CQ7Y5OJ0X,UY:1WA/<E+ I*3:I]JADF=(&KDOT&5A
M=:HH*F+K@H;^HZ2Q(:S\@XL,;N+WV]YE['MJ1: !T:.%8D0*:HBG3A/K\1K4
M23.5:Q?<#6O?_QZ_0KI]T+6T2XK=9,,&'R3-B4A3*E:S1*U,-2,)U35 U"R8
MVK;7$^0T;=D?@XM'=5"51-! >.QPS4_R.L7HD$&06!EQ&XG-!@CE8)3P/(O=
M[G<_:U5=-7'W+J<[AO<-@&A/*1#>TDZ9($ML&.]PD0%WX U1AA6V^.3S4W.<
M?NYRNJ/$^WPYW3&\;@$MCPN#4HY!N1B(C9TWP37QG"D"!K5S2"!MJ!V4>@'E
M=$?)]?ERNF.8/':"5+^"KT ]DZJ<GJZ=L>CZ)_D2VW"*24N9C>PY\_D%E],=
M)=#CR^F.X6Y;:N7U9@?H+8HL%/JG*71T9^)EHL1I;662S)A4>Q+S8RK&#3L.
MIU9.87(+,'G D%_N,HIR%MH+I-KK3$OE,M*/]!&510+#&#!>NZ1@+R$CQZ@'
M,G3/YWD+P'FBT ]B"LI;("P(C6? 6M3$UA%K;!0Y&06AMM_=;)5E!6$?46)Y
M#.>;B$/WJ>N37@OOF"%,<E.FDG/B/+-E>SD[\#**VK'HYHLL!X55%4FTJ*,V
MKS4L,2Y+E9;0VB'Q)I. O$$+@ :0QE@U9-5N.V]E%]!-)W"\-;WT^$7&@;,Z
MRHP;T0A^X)X$)2R)"GT# *OU0/YYBR]C%P#1J;QO DE["T<WQ\))Q:*VB:0L
M KJLF97(ER&9NN1=2)';VH;2$^2,6RI9'T>U.-\NC!X>#!6XHSI9PI+C1#JO
MB=59$8C4F:"H<5Q< DO'*J;!"BPO!*A39= $JM:EPLOU>+S=6YM-.(O&1(?7
MMN2 ^Z&\W-B:A)1XDCY;(VMCZFF*QJW &N*JJ\;_\6/4=U7GW4[NM_:I"&@B
M-=?6)$<@NX@:-TF"9R*2%'0.DBN1U4[T\6!T^LF%QAW!40\BU9G:< G MO[X
MC+R?W8^HE=7S)&F5<G:V:[R:I4_3+U]7RY*:L:<#L@?K=<+[Q"CFB92(H.!1
MVMDS(;V3H%WM5^2>I%4*0V]6NUIT:ZTCK9+GS&4T1#!GB,PI$B=](!YBLIE;
MP^L'$P]2,VXL<0B<' A.GRN)%J(_^W;2)1R@B08. B<A*C33:!FT:+0D,AE'
M768YT=JY/ >):2(Z?;:T^X#H:-:WBJ'-PZ'.CBNPAD1:\G*YP;NWL_T=3P&B
M5CY>!$4M)/=4$G@?&)W _;%-XQ\'J6P>BB4H2T6TQ';C5'QIM<)19V<5K<J1
M2]^SI=&^3V\0#:?(;5Z3B:.C8#']RZ_@X[6/71[<SE:<IFC+:TYBQOW(E#SQ
M+BDBLG5&6N5I?M8([K%.$\]6E9%1C[%M!&7V,>G>F=149/"&$^U*A@DMZ#<^
MEDYN,O!(DY757Z^>I*A!2 UDPIPFA%;MF(>1RQ2D<\%J8J'LIQP2*UD@*?%
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M#BZV!K#Y<3&/ &GY'CE;CIJ?1?B 9NC47W^\#=?3>)61+C1%)]R"I-%20K/
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ME9>4<#  B\<&S&?_S[W%MRP]C+O7[%F<W\#ZJVWL9OE_X#KMA&Y\-@$]Y4A
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MEGZ_O;E!)L[S[],OLVF>1C3R-KJTA(WG>&&C(_D65GYZO9SLA(.7TQ*O>PY
M=1;^S_NM[S)EL_X/^+HD&^"?%<P2I/_[S$>Y1^N]"LO5PL?51$06-:>9*$?+
M" ">$<Y,HU:RTJ;@M3.QLNH_3$VUR9SK;O-,N,"-[,Y3>85@DEAJ\*]4>*9]
M"DG4#H+^2,&X'=(K2?W@1,WCF=R"^7-P8*0#I54PG&@12F6@2,0J)DJ?1V,R
M**I4[9EWYPUO'7ZHY@D2[CU^]1AV-X";/:,C9="&&BF(\0HM@6!BZ=P12/)>
M<5]FLU4?DOARQJ\>)=[GQZ\>P^L6T/)X,BC767B=+,E9EM$G3!%O<BF,M[QD
M$+.T6\CX_X?QJT?)]?GQJ\<P>6RGZ@'Y'GV._X:X6M<%KZNE-CM260EN,NX#
MF5'Z>)0=H8M K0<GH@,?\G-F<O_EQIV]40D? W&W ;6RUS7MU&W@63*35!EO
M[<H=G4L90B:)BQR9TB'Y7-MX.43,R -<*AHO5=C= F[NR?_-W^"7#SI9;0Y:
M,B%0BQ=T9 $/FG(>^<2!,&8ELL[25'TZ^/-4-3AAZGCQ[X*JKBP:0->'CU<;
M=6IM4H)%Y(LO3_].,%2GJ+>3]5W>GS.T]NR,N\5'QDIEJ<YKL+@!;-QIX_L
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MR;M'!\PCF#]V%//'GHX4C8 DN",*%-H%/%/B3?2$2BI%UKB57<OI97; /$9
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MR&O^9B93P"+X&#1X80O6+K=RTP#ZGYCENI? ]\ARW8?[8]O.#V;CZ110)">
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MZ52Z7B.&#$4H@HRSQJK!7M(&VM/SK]T:)#3?%90Z.%J/34O9-$W/0J&M!2O
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M3B<W0$,'Q^,F%_XZ[_WME"Z_RU5F]&TN+6-+:&(I)7!@,F9B/BD7[^BO7L1
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MT)&LCW\7RSD\M%YM#(-G.;$DO-/ 6/6J6"#W)QH+S.F 3*"1HG6T8B?"QG5
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M39(YZ]8O+P\2,JY-V@'ZCA?/P1BC3<?90"A;<^PL8N*%\P3<6;*%1"*N*&N
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M6FD<?#26YFPHUHZ-D^4$WRM[[8I?ZWVX8$M!JT"30B7_CZLZNLN!ESJ$J$I
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MU*!B[=_#B3E9<:9+*9'SG9I?[XV-L4V8%C)]%"(',+B+6-_RLY;S=UZ?3VH
ML^YHK0NE#E*CY\ R^CH_I^9%>0L"O99<8"$N-8_^/4)03_ Y1-[W0H*MF#^V
MD?-@M)2C3S;2L4)FR$IS+()SA4%$X0J6.@92[F3''/S^.7AH^/![I@W;.M @
MRRSO2;Q<3=7Y,)]]Q_G%SS.MF"=).G IUS</X\ K&Z%HF;P-16K6>E35PY3T
M$84Y4+P/E3(>Q^L.$/-P#.']OZ>TPM?)]P\X3U5$7_#,.!FYMJ&>) 2%H3H
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M*>D\<%7QN ,SNE"0;D';5.>1<0/>J0#">D[),"-5GSTN;<SC+W,=]BS,<T@
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M"\ZGS&=8HKP]&)KO/!@:H(AY_T6'+G,^DOUS%4(7SG1$\IFB* '*I5(;<#!
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MWB^F"=_C8L771'')G/(<3*A#L[)3$+(/=51OL)(GI<I^PVB?7&K<4_RF2!E
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M@3*Z@]/&R@)96+3.0Q$BDY7%>AO">8TM>5;98[G[#*41H,8N-6JATT<A<H2
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MH#O87<(98-10(5W$.@_PP*)RQD<+7L4,*MH,M1(5C.9<F821B=8!3V\W V<
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M@AA1 >-.!4KK.?VP=1GK/H3UZ]@.P,B]DM;F*ND@6]VC5Q]RGJK7KWY: S%
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M X%W!YGM? ?#A1)^-8P'ZX,9REG0,)"%,YXSPZ!:!-J[UA]OUVJATT<A<H2
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M8'*LN#M RA^KMAGSK_B66)C8(K@.GG M?6VOYPV$+"6PY$*4A?&"K:<U_43
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MG<2#%Q=AAO/+Y0T[7JELE2I0?-:@LA+U#CA#+C9FR16G:+HQS)XA:=S$:DS
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M;3%?+B<Y:.8Y"8N%VJ>OHX08R2%;'BT7(2JE3G9HKBGJM&1UH/YWA=?^RN@
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MUTV_XPR7RXF).FH7."3#!1E+<&0V5S^)8D4HOK0>P_ L4>-.-1K^C#M6#QT
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M.*:-V#HX<:Y'EMZR\MN?WW"VQ%]PAF6ZVE1#^CG)CJ-'EPU@CG5%J$IU6F6
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M"\"V4^4Y '=KM^T-P\QIM"4:,-Y761<#GNL(/-2AQTQ&-*(9=I^C9MP.ZK.
M;U.%G@."]VFCO9%!#-'Y0*%1M=K:/4NY0XP:8G&J"!F9Q':1PP$$CMQ!?19
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MH/ZVH.1_HCE7WI8",@I!\:L2)!-OP>I48DR\6-?ZVF\S)>.VPXT+J/U5T<%
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M.2 _5F^=(?+:7(U*16B3(1:3R%P-UH%+ C@=Y,K+%&SS%02/J>@RBCI:WT_
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M89X5/_1!]XBFK@Z\ ?%TJ!I& ]6FKLN?37"W+9=,%^-B-F ,,V0@6%LNZP,
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MPFW2K3(8Q(9#P]X=+'NHYLA]TQ]783%(>]0.U]Y9BKK3 T':VOTEZ^MNBC2
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MT,:T[N2]3\&Q?N;=-ZQ"FWU>?^P_<?KYRPKS*PK;Z!RM;1:UZ>O.Z3H),O'
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M<P,/8/*>87^,)\EBFP,:-N9[^\2&SI>$V1 *JP9X/C@N!K7]B&9,NR(9&GI
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MZ<96670](XJQB:C9C[P)_#-* __U_P%02P,$%     @ YX1-5O*(.JZO!
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M43'B*SQJ!-\0HUA:TX0R4[+:9/OJ6O:; +&R1*9TG2D(YTHZX)6^C9*V 6G
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M*6.]V'^;;Z[UAX[[Y)K^ U!+ P04    " #GA$U69 ";<WL#  ";"0  &
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M) @694C.2H5A^S&BB)4Y.X2\J,^YWC1Z:>^"DN*!8/*$Y<=64'>%1GSL'/[
M[@\N3//0DOYIZ_C85^RZKS@Z/94-!_;0?5OLVMZ3S*EM-_:)@2I9<=D).NV&
MDJ4FN*%?/H)'H)_UKARS$Q(-_F]?0S79\[/>AY&J1YAB+KBF9#T_"P8CB 7E
M ,)\?OMTX,_(MT!;:Q?-8?]C0%P3CN\PB),M(=D(*L^<A(*KUP+V/1"]QK6L
MF#R %]3],#@EZM2E^TIS>'[+EZ)YY(1-2WS -^_]8^V[?VUA:VJ:E3[=TH2$
M'B8&Q>G5?!R;9TO]@+KZ$U!+ P04    " #GA$U6ZUWN=6,/   23@  %P
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M):JIL/,6VY$Q$R$*.("]F_+TZE@*$/$R:99_N\'*<&E/P)T"(:[TRF; :]G
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M^>.A<@'U?N)^01_V$"0B=G/'2DXY^L/:WEK\S).T:+QTHJ80U@ND0C%D-9Y
M-Z[;<AZ(S5UB5UFN9.3,;7(#@G+ :ZJE=L9TK?A5\ DWBV9YPDCP3%^ )E!,
M9.HL(NB.8MY!D2'E G-$F!<$I0?[8K5< XD)*-&\:#[LI&62;5*[L'+WJ! P
M#5/7]HB;35[$$C[G&:NG[Y:9)3AHHZN=A'0"#K-3UYA%X/)RA)O[BA8)3 ]
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M     &%M8VDM,C R,S R,3,N:'1M4$L! A0#%     @ YX1-5G34_K[]+
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M,#(S,#(Q,U]G,2YJ<&=02P$"% ,4    " #GA$U6:YUYU&G-  #02 $ %
M            @ $YKPL 86UC:2TR,#(S,#(Q,U]G,BYJ<&=02P$"% ,4
M" #GA$U6.Z*?)O#N 0!9%P( %               @ '4? P 86UC:2TR,#(S
M,#(Q,U]G,RYJ<&=02P$"% ,4    " #GA$U6E'G=9[&L  "9MP  %
M        @ 'V:PX 86UC:2TR,#(S,#(Q,U]G-"YJ<&=02P$"% ,4    " #G
MA$U6V2:X-IJI  ")KP  %               @ '9& \ 86UC:2TR,#(S,#(Q
M,U]G-2YJ<&=02P$"% ,4    " #GA$U6IKGNYUFF!0"QV 4 %
M    @ &EP@\ 86UC:2TR,#(S,#(Q,U]G-BYJ<&=02P$"% ,4    " #GA$U6
M#)@\M<EM   4>P  %               @ $P:14 86UC:2TR,#(S,#(Q,U]G
M-RYJ<&=02P$"% ,4    " #GA$U6S8XY3:X[  "X00  %
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M,2YH=&U02P$"% ,4    " #GA$U6\H@ZKJ\$  #-#0  &
M@ $"&1H 97AH:6)I=#(S,2UR97-A;&5S>#$N:'1M4$L! A0#%     @ YX1-
M5F0 FW-[ P  FPD  !@              ( !YQT: &5X:&EB:70R,S(M<F5S
M86QE<W@Q+FAT;5!+ 0(4 Q0    ( .>$35;K7>YU8P\  !).   7
M      "  9@A&@!E>&AI8FET-3$M<F5S86QE<W@Q+FAT;5!+!08     $@ 2
+ +$$   P,1H    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
